id|nct_id|name|downcase_name
8956|NCT03233672|adjuvant|adjuvant
8957|NCT03233672|hypofractionation|hypofractionation
8958|NCT03233672|IMRT|imrt
8959|NCT03233672|phase I-II|phase i-ii
8960|NCT03233672|prostate neoplasms|prostate neoplasms
8961|NCT03233672|radiotherapy|radiotherapy
8962|NCT03233659|Allogeneic Stem Cell Transplantation, APCs, GVHD|allogeneic stem cell transplantation, apcs, gvhd
8963|NCT03233646|OCT angiography|oct angiography
8964|NCT03233646|Optical Coherence Tomography|optical coherence tomography
8965|NCT03233646|Vessel Density|vessel density
8966|NCT03233646|Superficial Capillary Plexus|superficial capillary plexus
8967|NCT03233646|retinal microvasculature|retinal microvasculature
8968|NCT03233646|OCTA|octa
8971|NCT03233620|knee arthroplasty|knee arthroplasty
8972|NCT03233620|working-age|working-age
8973|NCT03233620|patient related outcome measures|patient related outcome measures
8974|NCT03233607|Postpartum|postpartum
8975|NCT03233607|Hemoglobin|hemoglobin
8976|NCT03233607|Hemoglobin Spot Check|hemoglobin spot check
8977|NCT03233594|Chronic Pain Syndrome|chronic pain syndrome
8978|NCT03233594|Chronic Pain|chronic pain
8979|NCT03233594|Chiropractic|chiropractic
8980|NCT03233594|PET|pet
8981|NCT03233594|MRI|mri
8982|NCT03233594|Positron emission tomography|positron emission tomography
8983|NCT03233594|Magnetic resonance imaging|magnetic resonance imaging
609018|NCT00610246|Lesion|lesion
8986|NCT03233542|Interpretations|interpretations
8987|NCT03233542|Physiological and biological markers|physiological and biological markers
8988|NCT03233529|atopic dermatitis|atopic dermatitis
8989|NCT03233529|atopic eczema|atopic eczema
8990|NCT03233529|eczema|eczema
8991|NCT03233529|topical treatment|topical treatment
8992|NCT03233529|skin diseases|skin diseases
8993|NCT03233529|phosphodiesterase-4 inhibitor|phosphodiesterase-4 inhibitor
8994|NCT03233529|PDE-4 inhibitor|pde-4 inhibitor
8995|NCT03233529|crisaborole|crisaborole
8996|NCT03233516|Community-acquired pneumonia|community-acquired pneumonia
8997|NCT03233516|Pediatrics|pediatrics
8998|NCT03233516|Etiology|etiology
8999|NCT03233516|Point-of-care test|point-of-care test
9001|NCT03233516|CRP|crp
9002|NCT03233516|Procalcitonin|procalcitonin
9003|NCT03233516|Infectious diseases|infectious diseases
9004|NCT03233516|Respiratory viruses|respiratory viruses
9005|NCT03233516|Pediatric asthma|pediatric asthma
9006|NCT03233490|CPR training|cpr training
9007|NCT03233490|students|students
9008|NCT03233490|willingness|willingness
9009|NCT03233477|Posner Schlossman Syndrome|posner schlossman syndrome
9010|NCT03233477|cytokine expression|cytokine expression
9011|NCT03233477|cytomegalovirus|cytomegalovirus
9012|NCT03233438|Critical Pathways|critical pathways
9013|NCT03233438|Health Facilities|health facilities
9014|NCT03233438|Clinical Protocols|clinical protocols
9015|NCT03233438|Patient Satisfaction|patient satisfaction
9016|NCT03233438|Absenteeism|absenteeism
9017|NCT03233438|Anti-Bacterial Agents|anti-bacterial agents
9018|NCT03233438|Quality of Life|quality of life
9019|NCT03233438|Economics, Medical|economics, medical
9020|NCT03233438|Health Resources|health resources
9021|NCT03233438|Health resource utilization|health resource utilization
9022|NCT03233438|Acute bacterial skin and skin structure infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
9023|NCT03233425|Child|child
9024|NCT03233425|adolescent|adolescent
9025|NCT03233425|co-morbidity|co-morbidity
9026|NCT03233425|psychology|psychology
9027|NCT03233425|motivation|motivation
9028|NCT03233425|physical activity|physical activity
9029|NCT03233425|eating disorders|eating disorders
9030|NCT03233425|quality of life|quality of life
9031|NCT03233425|therapy|therapy
9032|NCT03233425|predictors|predictors
9033|NCT03233412|high grade cervical intraepithelial neoplasia|high grade cervical intraepithelial neoplasia
9036|NCT03233399|Magnetoencephalography|magnetoencephalography
9037|NCT03233399|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
9038|NCT03233373|Nasal Airway Obstruction|nasal airway obstruction
9040|NCT03233373|Imaging, Diagnostic|imaging, diagnostic
9041|NCT03233373|Computer-Assisted Image Processing|computer-assisted image processing
9042|NCT03233373|Thermal Analysis, Differential|thermal analysis, differential
9043|NCT03233321|Dry cold application|dry cold application
9044|NCT03233321|Pain|pain
9045|NCT03233321|Bruise|bruise
9046|NCT03233321|Subcutaneous injection|subcutaneous injection
9047|NCT03233243|Rosuvastatin|rosuvastatin
9048|NCT03233243|Sodium fluoride|sodium fluoride
9049|NCT03233243|Positron-emission tomography|positron-emission tomography
9050|NCT03233230|Rheumatoid Arthritis|rheumatoid arthritis
9051|NCT03233230|American College of Rheumatology|american college of rheumatology
9052|NCT03233230|High-sensitivity C-reactive protein|high-sensitivity c-reactive protein
9053|NCT03233230|Bruton's tyrosine kinase|bruton's tyrosine kinase
9054|NCT03233217|Influenza|influenza
9055|NCT03233165|laser therapy|laser therapy
9056|NCT03233165|recurrence|recurrence
9057|NCT03233165|leukoplakia|leukoplakia
9058|NCT03233165|precancerous lesion|precancerous lesion
9059|NCT03233152|recurrence|recurrence
9060|NCT03233139|Japanese patients|japanese patients
9061|NCT03233113|Exposure therapy|exposure therapy
9062|NCT03233113|Cognitive-behavioral therapy|cognitive-behavioral therapy
9063|NCT03233113|Anxiety disorders|anxiety disorders
9064|NCT03233100|FMT|fmt
9065|NCT03233100|gut microbiota|gut microbiota
9066|NCT03233100|gut-brain disorder|gut-brain disorder
9067|NCT03233100|constipation|constipation
9068|NCT03233100|depression|depression
9069|NCT03233100|anxiety|anxiety
9070|NCT03233074|Myelodysplastic Syndromes|myelodysplastic syndromes
9071|NCT03233074|Acute Myeloid Leukemia|acute myeloid leukemia
9072|NCT03233074|Bone Marrow|bone marrow
9073|NCT03233074|Mesenchymal stromal cell|mesenchymal stromal cell
9074|NCT03233074|Healthy donor|healthy donor
9075|NCT03233061|Obesity; cardiorespiratory fitness; oxygen uptake; household activities; physical activity; sedentary; intensity; obese women|obesity; cardiorespiratory fitness; oxygen uptake; household activities; physical activity; sedentary; intensity; obese women
9076|NCT03233035|Ketamine-Intranasal-Acute pain-Emergency departement|ketamine-intranasal-acute pain-emergency departement
9078|NCT03232996|Gait|gait
9079|NCT03232957|Intrathecal morphine, total knee arthroplasty|intrathecal morphine, total knee arthroplasty
9080|NCT03232931|auditory|auditory
9081|NCT03232931|tactile|tactile
9082|NCT03232931|mother's voice|mother's voice
9083|NCT03232931|multisensory|multisensory
9084|NCT03232892|NSCLC|nsclc
9085|NCT03232892|NF-1 mutant|nf-1 mutant
9086|NCT03232879|Motor Imagery|motor imagery
9087|NCT03232879|Action Observation|action observation
9088|NCT03232879|Heart Rate|heart rate
9089|NCT03232879|Respiration Rate|respiration rate
9090|NCT03232879|Electrodermal Activity|electrodermal activity
9091|NCT03232879|Skin Temperature|skin temperature
9092|NCT03232866|Exercise Movement Techniques|exercise movement techniques
9093|NCT03232866|Exercise|exercise
9094|NCT03232866|Monitoring, Physiologic|monitoring, physiologic
9095|NCT03232866|Heart Rate|heart rate
9096|NCT03232866|Autonomic Nervous System|autonomic nervous system
9097|NCT03232866|Heart rate variability|heart rate variability
9098|NCT03232853|medical error in anesthesia|medical error in anesthesia
9099|NCT03232853|drug error in anesthesia|drug error in anesthesia
9100|NCT03232840|wrong site surgery in regional anesthesia|wrong site surgery in regional anesthesia
9101|NCT03232801|hypoactive sexual desire disorder|hypoactive sexual desire disorder
9102|NCT03232801|female sexual dysfunction|female sexual dysfunction
9103|NCT03232801|low libido|low libido
9104|NCT03232801|female sexual interest-arousal disorder|female sexual interest-arousal disorder
9105|NCT03232801|low desire|low desire
9106|NCT03232801|sexual dysfunction|sexual dysfunction
9107|NCT03232788|Periodontal disease|periodontal disease
9108|NCT03232788|Recession|recession
9109|NCT03232788|Black space|black space
9110|NCT03232775|visual pedagogy|visual pedagogy
9111|NCT03232723|Magnetoencephalography|magnetoencephalography
9112|NCT03232723|Whole-cortex MEG System (with optional EEG)|whole-cortex meg system (with optional eeg)
9113|NCT03232554|Iron-Deficiency Anemia|iron-deficiency anemia
9114|NCT03232554|Buxue Yimu Pills|buxue yimu pills
9115|NCT03232554|Ferrous Sulfate|ferrous sulfate
9116|NCT03232554|clinical observations|clinical observations
9117|NCT03232554|adult women|adult women
9118|NCT03232554|Metabonomics|metabonomics
9119|NCT03232515|Bioimpedance Vector Analysis (BIVA)|bioimpedance vector analysis (biva)
9120|NCT03232515|Chronic Renal Failure|chronic renal failure
9121|NCT03232515|Dialysis|dialysis
9122|NCT03232515|Dry weight|dry weight
11980|NCT03214276|cycling|cycling
9123|NCT03232515|Blood Pressure|blood pressure
9124|NCT03232437|HbA1c|hba1c
9125|NCT03232411|prostate disease|prostate disease
9126|NCT03232411|prostatic neoplasm|prostatic neoplasm
9127|NCT03232411|biobank|biobank
9128|NCT03232411|prostate cancer in black males|prostate cancer in black males
9129|NCT03232411|biospecimen|biospecimen
9130|NCT03232411|smoking and the aggressiveness of prostate cancer|smoking and the aggressiveness of prostate cancer
9131|NCT03232372|Bone loss, dental implant desing|bone loss, dental implant desing
9132|NCT03232346|buprenorphine|buprenorphine
9133|NCT03232346|naltrexone|naltrexone
9134|NCT03232346|Vivitrol|vivitrol
9135|NCT03232346|opioid dependence|opioid dependence
9136|NCT03232307|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
9137|NCT03232307|Mantle Cell Lymphoma|mantle cell lymphoma
9138|NCT03232307|MCL|mcl
9139|NCT03232307|Newly-diagnosed|newly-diagnosed
9140|NCT03232307|Ibrutinib|ibrutinib
9141|NCT03232307|PCI-32765|pci-32765
9142|NCT03232307|Imbruvica|imbruvica
9143|NCT03232307|Rituximab|rituximab
9144|NCT03232307|Rituxan|rituxan
9145|NCT03232307|Lenalidomide|lenalidomide
9146|NCT03232307|CC-5013|cc-5013
9147|NCT03232307|Revlimid|revlimid
9148|NCT03232307|Dexamethasone|dexamethasone
9149|NCT03232307|Decadron|decadron
9150|NCT03232294|fetal macrosomia|fetal macrosomia
757169|NCT03268928|Syntax|syntax
9151|NCT03232294|fetal abdominal wall thickness|fetal abdominal wall thickness
9152|NCT03232294|subcutaneous adipose tissue|subcutaneous adipose tissue
9153|NCT03232268|Microtransplantation|microtransplantation
9154|NCT03232268|Myeloid Hemopathy|myeloid hemopathy
9155|NCT03232203|Human leukocyte antigen|human leukocyte antigen
9156|NCT03232203|Key Risk Message|key risk message
9157|NCT03232203|ADA-SCID|ada-scid
9158|NCT03232203|Health care providers|health care providers
9159|NCT03232190|prematurity|prematurity
9160|NCT03232190|psychomotor development|psychomotor development
9161|NCT03232190|parent empowerment|parent empowerment
9162|NCT03232190|e-health|e-health
9163|NCT03232190|parental support|parental support
9164|NCT03232190|post discharge follow-up|post discharge follow-up
9165|NCT03232164|Prostate Cancer|prostate cancer
9166|NCT03232164|Prostate neoplasm|prostate neoplasm
9167|NCT03232151|Stroke|stroke
9168|NCT03232138|Sulforaphane|sulforaphane
9169|NCT03232138|Chemoprevention|chemoprevention
9170|NCT03232138|Former Smokers|former smokers
9171|NCT03232112|Alcohol|alcohol
9185|NCT03232047|Mild Cognitive Impairment|mild cognitive impairment
9186|NCT03232034|Calcium citrate, dairy product, whey protein, appetite, metabolism|calcium citrate, dairy product, whey protein, appetite, metabolism
9187|NCT03232021|urinary bladder|urinary bladder
9188|NCT03232021|urinary catheters|urinary catheters
9189|NCT03232021|pregabalin|pregabalin
9190|NCT03232008|Blood glucose|blood glucose
9191|NCT03232008|Appetite|appetite
9192|NCT03231995|Severe influenza|severe influenza
9193|NCT03231995|biomarkers|biomarkers
9194|NCT03231995|respiratory microbiome|respiratory microbiome
9195|NCT03231995|prognosis|prognosis
9208|NCT03231826|Home monitoring|home monitoring
9210|NCT03231826|Myocardial Infarction|myocardial infarction
9211|NCT03231826|Arrythmia|arrythmia
9216|NCT03231800|Attention-Deficit Hyperactivity Disorder (ADHD)|attention-deficit hyperactivity disorder (adhd)
9217|NCT03231774|Echocardiography|echocardiography
9218|NCT03231774|Right heart catheterization|right heart catheterization
9219|NCT03231722|mFOLFOXIRI + Panitumumab|mfolfoxiri + panitumumab
9220|NCT03231722|RAS and BRAF wt|ras and braf wt
9221|NCT03231696|nerve block|nerve block
9222|NCT03231696|peripheral nerve stimulation|peripheral nerve stimulation
9223|NCT03231657|preeclampsia|preeclampsia
9224|NCT03231657|intrauterine growth restriction|intrauterine growth restriction
9225|NCT03231657|angiogenic factors|angiogenic factors
9226|NCT03231644|Fibrous Dysplasia|fibrous dysplasia
9227|NCT03231644|McCune-Albright Syndrome|mccune-albright syndrome
9228|NCT03231644|Mazabrauds|mazabrauds
9229|NCT03231644|FD/MAS|fd/mas
9230|NCT03231631|Exercise|exercise
9231|NCT03231631|Education|education
9232|NCT03231631|Stents|stents
9233|NCT03231631|Angioplasty|angioplasty
9234|NCT03231631|Cardiac Rehabilitation|cardiac rehabilitation
9235|NCT03231631|Cholesterol, HDL|cholesterol, hdl
9236|NCT03231631|Metabolic Equivalent|metabolic equivalent
9237|NCT03231618|dietary intake|dietary intake
9238|NCT03231618|cross-over intervention|cross-over intervention
9239|NCT03231618|energy expenditure|energy expenditure
9240|NCT03231540|Critical care|critical care
9241|NCT03231540|nutrition|nutrition
9242|NCT03231540|whey protein|whey protein
9243|NCT03231540|mechanical ventilation|mechanical ventilation
9244|NCT03231540|muscle function|muscle function
9245|NCT03231514|body composition|body composition
9246|NCT03231514|exercise performance|exercise performance
9247|NCT03231514|keto-adaptation|keto-adaptation
9248|NCT03231475|NSCLC|nsclc
9249|NCT03231475|EGFR-TKI|egfr-tki
9250|NCT03231449|routine care, evaluation, Africa, observatory|routine care, evaluation, africa, observatory
9251|NCT03231436|intrathecal bupivacaine|intrathecal bupivacaine
9253|NCT03231436|failed spinal|failed spinal
9254|NCT03231423|Obesity|obesity
9255|NCT03231423|VAS|vas
9256|NCT03231423|Pain|pain
9257|NCT03231423|Laparoscopy|laparoscopy
9258|NCT03231423|Bypass|bypass
9259|NCT03231410|arteriovenous fistula|arteriovenous fistula
9260|NCT03231410|maturation|maturation
9261|NCT03231410|monocyte adhesion|monocyte adhesion
9262|NCT03231410|vascular access|vascular access
9263|NCT03231397|Abdominal Aortic Aneurysm (AAA)|abdominal aortic aneurysm (aaa)
9264|NCT03231371|Orthotopic Heart Transplant|orthotopic heart transplant
9265|NCT03231345|Peripheral IV|peripheral iv
9266|NCT03231345|Internal jugular vein|internal jugular vein
9267|NCT03231345|IJ|ij
9268|NCT03231345|Peripheral IJ|peripheral ij
9269|NCT03231345|Ultrasound-guided IJ|ultrasound-guided ij
9270|NCT03231332|Helicobacter pylori|helicobacter pylori
9271|NCT03231332|Eradication|eradication
9272|NCT03231332|Microbiome|microbiome
9273|NCT03231332|ESBL|esbl
9274|NCT03231332|GIT|git
9275|NCT03231306|Neurofibroma, Plexiform|neurofibroma, plexiform
9276|NCT03231306|Genes, Neurofibromatosis|genes, neurofibromatosis
9277|NCT03231306|Peripheral nerve tumors|peripheral nerve tumors
9278|NCT03231306|Neurofibromatosis 1|neurofibromatosis 1
9279|NCT03231306|Neurofibromas|neurofibromas
9280|NCT03231280|knee|knee
9281|NCT03231267|Multiresistant enterobacteriaceae|multiresistant enterobacteriaceae
9282|NCT03231267|digestive colonization|digestive colonization
9283|NCT03231267|bacteriophages|bacteriophages
9807|NCT03227796|LEVI-04|levi-04
9284|NCT03231267|Admission in intensive care unit >72h|admission in intensive care unit >72h
9285|NCT03231267|Presence of at least 2 consecutive stools|presence of at least 2 consecutive stools
9286|NCT03231241|Headaches|headaches
9287|NCT03231241|Tension-Type Headache|tension-type headache
9288|NCT03231241|New Daily Persistent Headache (NDPH)|new daily persistent headache (ndph)
9289|NCT03231241|Migraine|migraine
9290|NCT03231202|Non-operative management|non-operative management
9291|NCT03231202|Splenic Injury|splenic injury
9292|NCT03231202|Blunt|blunt
9293|NCT03231202|Splenic artery embolization|splenic artery embolization
9294|NCT03231202|Trauma|trauma
9295|NCT03231189|Coronary artery disease|coronary artery disease
9296|NCT03231189|cardiac MRI|cardiac mri
9297|NCT03231189|heart failure|heart failure
9298|NCT03231176|Biliary Tract Neoplasms|biliary tract neoplasms
9299|NCT03231176|Bile Duct Neoplasms|bile duct neoplasms
9300|NCT03231176|Gallbladder Neoplasms|gallbladder neoplasms
9301|NCT03231085|Craniosynostosis|craniosynostosis
9302|NCT03231085|hemoglobin|hemoglobin
9303|NCT03231085|iron peros|iron peros
9304|NCT03231085|iron intravenous|iron intravenous
9305|NCT03231072|mechanical ventilation|mechanical ventilation
9306|NCT03231072|pleural effusion|pleural effusion
9307|NCT03231072|EIT|eit
9308|NCT03231059|Coronary artery disease|coronary artery disease
9309|NCT03231059|Percutaneous coronary intervention|percutaneous coronary intervention
9310|NCT03231059|Drug-eluting stent|drug-eluting stent
9311|NCT03231059|Antiplatelet drugs|antiplatelet drugs
9312|NCT03231059|Clinical event committee|clinical event committee
9313|NCT03231020|single ventricle|single ventricle
9314|NCT03231020|pediatric cardiology|pediatric cardiology
9315|NCT03231020|interstage|interstage
9316|NCT03231020|home monitoring|home monitoring
9317|NCT03231020|mHealth|mhealth
9318|NCT03230994|adenomyosis|adenomyosis
9319|NCT03230994|diagnosis|diagnosis
9320|NCT03230994|treatment|treatment
9321|NCT03230994|epidemiology|epidemiology
9322|NCT03230994|Complications|complications
9323|NCT03230981|biomechanics|biomechanics
9324|NCT03230981|cornea|cornea
9325|NCT03230981|optical coherence tomography|optical coherence tomography
9326|NCT03230981|vibrography|vibrography
9327|NCT03230981|brillouin microscopy|brillouin microscopy
9328|NCT03230968|Practical Approach to Lung Health|practical approach to lung health
9329|NCT03230968|Respiratory diseases|respiratory diseases
9330|NCT03230968|Mexico|mexico
9331|NCT03230955|Randomized clinical trial|randomized clinical trial
9332|NCT03230955|Hotlines|hotlines
9333|NCT03230942|patient education|patient education
9334|NCT03230942|arthritis|arthritis
9335|NCT03230942|knee|knee
9336|NCT03230942|arthroplasty|arthroplasty
9337|NCT03230942|gait|gait
9338|NCT03230929|EMG, BIS, phase lag entropy|emg, bis, phase lag entropy
9339|NCT03230903|Multiple Sclerosis|multiple sclerosis
9340|NCT03230903|Telerehabilitation|telerehabilitation
9341|NCT03230903|Physical rehabilitation|physical rehabilitation
9342|NCT03230890|PTSD|ptsd
9343|NCT03230890|military|military
9344|NCT03230890|neurotechnology|neurotechnology
9345|NCT03230890|HIRREM|hirrem
9346|NCT03230890|allostasis|allostasis
9347|NCT03230890|heart rate variability|heart rate variability
9348|NCT03230890|baroreflex sensitivity|baroreflex sensitivity
9349|NCT03230890|closed loop|closed loop
9350|NCT03230890|acoustic stimulation|acoustic stimulation
9351|NCT03230890|neural oscillations|neural oscillations
9357|NCT03230851|Indobufen|indobufen
9358|NCT03230851|Aspirin|aspirin
9359|NCT03230851|Plasma Thromboxane|plasma thromboxane
9360|NCT03230851|Urine 11-dehydro thromboxane|urine 11-dehydro thromboxane
9361|NCT03230825|incomplete abortion|incomplete abortion
9362|NCT03230825|retained products of conception|retained products of conception
9363|NCT03230825|combined oral contraceptives|combined oral contraceptives
9364|NCT03230825|ultrasound|ultrasound
9365|NCT03230812|Insulin sensitivity|insulin sensitivity
9366|NCT03230812|Metabolic flexibility|metabolic flexibility
9367|NCT03230799|dense cataract|dense cataract
9368|NCT03230799|lens-shell technique|lens-shell technique
9369|NCT03230799|secondary intraocular lens implantation|secondary intraocular lens implantation
9370|NCT03230786|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
9371|NCT03230786|KBP-042|kbp-042
9372|NCT03230760|acupuncture|acupuncture
9373|NCT03230760|breast engorgement|breast engorgement
9374|NCT03230760|lactation|lactation
9375|NCT03230734|prostate cancer|prostate cancer
9376|NCT03230734|castration-resistant prostate cancer|castration-resistant prostate cancer
9377|NCT03230734|metastatic prostate cancer|metastatic prostate cancer
9378|NCT03230734|bone only metastatic prostate cancer|bone only metastatic prostate cancer
9380|NCT03230734|Docetaxel|docetaxel
9381|NCT03230721|laser|laser
9382|NCT03230721|HoLEP|holep
9383|NCT03230721|ThuLEP|thulep
9384|NCT03230721|Thulium|thulium
9385|NCT03230721|Thulium-fiber|thulium-fiber
9387|NCT03230721|EEP|eep
9388|NCT03230721|monopolar enucleation|monopolar enucleation
9389|NCT03230708|Microparticles|microparticles
9390|NCT03230708|Erythrocytes|erythrocytes
9391|NCT03230708|Methotrexate|methotrexate
9392|NCT03230695|stroke|stroke
9393|NCT03230695|robotic therapy|robotic therapy
9394|NCT03230695|transcranial direct current stimulation|transcranial direct current stimulation
9395|NCT03230682|early improvement|early improvement
9396|NCT03230682|antidepressants|antidepressants
9397|NCT03230682|major depression diorder|major depression diorder
9398|NCT03230682|resting-state fMRI|resting-state fmri
9399|NCT03230669|substance abuse|substance abuse
9400|NCT03230669|addiction|addiction
9401|NCT03230669|etherapy|etherapy
9402|NCT03230591|Fabry's disease|fabry's disease
9403|NCT03230591|Agalsidase Alfa|agalsidase alfa
9404|NCT03230591|Cardiomyopathy|cardiomyopathy
9405|NCT03230591|Enzyme replacement therapy|enzyme replacement therapy
9406|NCT03230591|Diastolic stress echocardiography|diastolic stress echocardiography
9407|NCT03230591|LV vortex flow|lv vortex flow
9408|NCT03230591|Cardiac MRI|cardiac mri
9409|NCT03230578|Pharmacists|pharmacists
9410|NCT03230578|Prescriptions|prescriptions
9411|NCT03230513|vertigo|vertigo
9412|NCT03230513|benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
9413|NCT03230513|particle repositioning manoeuvre|particle repositioning manoeuvre
9414|NCT03230500|computer guided|computer guided
9415|NCT03230500|immediate implant|immediate implant
9416|NCT03230500|patient satisfaction|patient satisfaction
9417|NCT03230461|CPR|cpr
9418|NCT03230461|Basic life support|basic life support
9420|NCT03230435|anorexia nervosa, health-related quality of life|anorexia nervosa, health-related quality of life
9421|NCT03230422|infant, laryngoscopes, pediatrics|infant, laryngoscopes, pediatrics
9422|NCT03230409|Tuberculosis, Latent Tuberculosis Infection, Adherence, Nursing, Pediatrics, Public Health.|tuberculosis, latent tuberculosis infection, adherence, nursing, pediatrics, public health.
9423|NCT03230396|vitamins|vitamins
9424|NCT03230396|dietary supplements|dietary supplements
9425|NCT03230396|chewing gum|chewing gum
9426|NCT03230396|pharmacokinetics|pharmacokinetics
9427|NCT03230396|healthy human subjects|healthy human subjects
9428|NCT03230370|intensity|intensity
9429|NCT03230370|rehabilitation|rehabilitation
9430|NCT03230318|iCCA|icca
9431|NCT03230318|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
9432|NCT03230318|FGFR2 gene fusion|fgfr2 gene fusion
9433|NCT03230318|ARQ 087|arq 087
9434|NCT03230318|biliary cancer|biliary cancer
9435|NCT03230318|bile duct cancer|bile duct cancer
9436|NCT03230318|FGFR2 gene rearrangement|fgfr2 gene rearrangement
9437|NCT03230318|liver cancer|liver cancer
9438|NCT03230318|targeted therapy|targeted therapy
9439|NCT03230318|combined hepatocellular and cholangiocarcinoma|combined hepatocellular and cholangiocarcinoma
9440|NCT03230318|cHCC-CCA|chcc-cca
9441|NCT03230305|Elderly|elderly
9442|NCT03230305|Cancer|cancer
9443|NCT03230305|Ethnographic interview|ethnographic interview
9444|NCT03230305|Social representation|social representation
9445|NCT03230305|Clinical trials|clinical trials
9446|NCT03230305|Reasons of non-participation|reasons of non-participation
9447|NCT03230305|Qualitative method|qualitative method
9448|NCT03230292|Psoriasis|psoriasis
9449|NCT03230292|Chronic Plaque Psoriasis|chronic plaque psoriasis
9450|NCT03230292|Bimekizumab|bimekizumab
9451|NCT03230279|Sacroiliac pain|sacroiliac pain
9452|NCT03230279|Low back pain|low back pain
9453|NCT03230188|asthma|asthma
9454|NCT03230188|neurocircuitry|neurocircuitry
9455|NCT03230188|severe asthma|severe asthma
9456|NCT03230188|mild to moderate asthma|mild to moderate asthma
9457|NCT03230188|neurocircuitry patterns|neurocircuitry patterns
9458|NCT03230149|Fabry|fabry
9459|NCT03230149|Stroke|stroke
9460|NCT03230149|Cerebrovascular Accident|cerebrovascular accident
9461|NCT03230149|small fiber neuropathy|small fiber neuropathy
9462|NCT03230136|Myocardial injury|myocardial injury
9463|NCT03230136|Ischemia reperfusion|ischemia reperfusion
9464|NCT03230136|cardiac surgery|cardiac surgery
9465|NCT03230136|cardioprotection|cardioprotection
9466|NCT03230123|Diabetes Mellitus|diabetes mellitus
9467|NCT03230123|green banana|green banana
9468|NCT03230123|resistant starch|resistant starch
9469|NCT03230123|glucose|glucose
9470|NCT03230123|prebiotics|prebiotics
9471|NCT03230123|insulin|insulin
9472|NCT03230123|incretins|incretins
9473|NCT03230110|Sleep disordered breathing|sleep disordered breathing
9474|NCT03230110|Obstructive sleep apnea|obstructive sleep apnea
9475|NCT03230110|Hypertension|hypertension
9476|NCT03230110|Pregnancy|pregnancy
9477|NCT03230084|Infertility|infertility
9478|NCT03230084|Ovulation|ovulation
9479|NCT03230084|Pregnanediol 3-glucuronide|pregnanediol 3-glucuronide
757542|NCT03158857|HIV|hiv
9480|NCT03230084|Progesterone|progesterone
9481|NCT03230084|Urine dipstick test|urine dipstick test
9482|NCT03230084|Feasibility study|feasibility study
9483|NCT03230084|Fertile period|fertile period
9484|NCT03230084|Menstrual cycle|menstrual cycle
9485|NCT03230084|Natural family planning|natural family planning
9486|NCT03230084|Fertility awareness methods|fertility awareness methods
9487|NCT03230071|Herbal therapy|herbal therapy
9488|NCT03230071|Randomized controlled trial|randomized controlled trial
9489|NCT03230071|Vascular Dementia|vascular dementia
9490|NCT03230045|acupoint stimulation|acupoint stimulation
9491|NCT03230045|elderly patients|elderly patients
9492|NCT03230045|postoperative pulmonary complications|postoperative pulmonary complications
9493|NCT03230019|wedge resection|wedge resection
9494|NCT03230019|tubeless|tubeless
9495|NCT03229980|myocardial protection|myocardial protection
9496|NCT03229980|potassium cardioplegia|potassium cardioplegia
9497|NCT03229980|tropinin|tropinin
9498|NCT03229980|Custodiol|custodiol
9499|NCT03229967|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
9500|NCT03229967|Microbiome|microbiome
9501|NCT03229967|Microbiota|microbiota
9502|NCT03229967|Premature infant|premature infant
9503|NCT03229967|Observational cohort study|observational cohort study
9504|NCT03229928|Behavior|behavior
9505|NCT03229928|Outcome Measures|outcome measures
9506|NCT03229928|Intellectual/Developmental Disabilities|intellectual/developmental disabilities
9508|NCT03229889|Access Sheath|access sheath
9509|NCT03229889|PCNL|pcnl
9510|NCT03229889|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
9511|NCT03229889|Ureteroscopy|ureteroscopy
9512|NCT03229889|Alpha Blocker|alpha blocker
9513|NCT03229889|Flomax|flomax
9514|NCT03229889|PDE-5 Inhibitor|pde-5 inhibitor
9515|NCT03229889|Cialis|cialis
9516|NCT03229889|Phosphodiesterase Inhibitor|phosphodiesterase inhibitor
9517|NCT03229863|Breastfeeding|breastfeeding
9518|NCT03229863|First foods|first foods
9519|NCT03229850|Diabetes|diabetes
9520|NCT03229850|Insulin|insulin
9521|NCT03229850|Lipohypertrophy|lipohypertrophy
9522|NCT03229850|Euglycemic Clamp|euglycemic clamp
9523|NCT03229837|Construct validity|construct validity
9524|NCT03229837|Minimally important differences|minimally important differences
9525|NCT03229837|Patient-reported outcomes|patient-reported outcomes
9526|NCT03229837|Pediatric cancer survivors|pediatric cancer survivors
9527|NCT03229837|PROMIS pediatric measures|promis pediatric measures
9528|NCT03229824|Drain antisepsis|drain antisepsis
9529|NCT03229824|Bacterial colonization|bacterial colonization
9530|NCT03229824|Surgical site infection|surgical site infection
9531|NCT03229733|Stroke|stroke
9532|NCT03229733|Kinect|kinect
9533|NCT03229733|Rehabilitation|rehabilitation
9534|NCT03229733|Upper limbs|upper limbs
9535|NCT03229720|Audio Visual Distraction|audio visual distraction
9536|NCT03229681|Baduanjin; CHF; 6MWT; CPET|baduanjin; chf; 6mwt; cpet
9537|NCT03229668|urinary bladder|urinary bladder
9538|NCT03229668|urinary catheters|urinary catheters
9539|NCT03229668|pregabalin|pregabalin
9540|NCT03229642|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
9541|NCT03229642|opioid use disorder|opioid use disorder
9542|NCT03229642|craving|craving
9543|NCT03229642|functional magnetic resonance imaging|functional magnetic resonance imaging
9545|NCT03229629|Behavior change communication|behavior change communication
9546|NCT03229629|Ethiopia|ethiopia
9547|NCT03229629|Food voucher|food voucher
9548|NCT03229629|complementary feeding practice|complementary feeding practice
9549|NCT03229629|affordability|affordability
9550|NCT03229629|accessibility|accessibility
9551|NCT03229629|gender|gender
9552|NCT03229603|HPV infection and Cervical cancer|hpv infection and cervical cancer
9553|NCT03229564|Burns|burns
9554|NCT03229564|Scar|scar
9555|NCT03229564|Skin|skin
9556|NCT03229564|Wound healing|wound healing
9557|NCT03229564|Tissue Engineering|tissue engineering
9558|NCT03229564|Dermis|dermis
9559|NCT03229564|Epidermis|epidermis
9560|NCT03229564|Thermal Injuries|thermal injuries
9561|NCT03229512|Hand Foot Skin Reaction|hand foot skin reaction
9562|NCT03229512|Sildenafil|sildenafil
9563|NCT03229499|Randomized Controlled Trial|randomized controlled trial
9564|NCT03229499|clinical trial|clinical trial
9565|NCT03229499|anastrozole|anastrozole
9566|NCT03229499|pulmonary hypertension|pulmonary hypertension
9567|NCT03229499|pulmonary arterial hypertension|pulmonary arterial hypertension
9568|NCT03229499|PAH|pah
9569|NCT03229486|emergence delirium|emergence delirium
9570|NCT03229486|tonsillectomy|tonsillectomy
9571|NCT03229473|Balance|balance
9572|NCT03229473|Falls|falls
9573|NCT03229473|Screening|screening
9574|NCT03229473|COPD|copd
9575|NCT03229434|affective responses|affective responses
9576|NCT03229434|stress-related parameters|stress-related parameters
9577|NCT03229434|green exercise|green exercise
9578|NCT03229421|Zika Virus|zika virus
9579|NCT03229408|Inflammation|inflammation
9580|NCT03229408|Hyperandrogenism|hyperandrogenism
9581|NCT03229408|Anovulation|anovulation
9582|NCT03229408|Insulin Resistance|insulin resistance
9583|NCT03229395|skeletal muscle|skeletal muscle
9584|NCT03229395|muscle mass|muscle mass
9585|NCT03229395|glucocorticoids|glucocorticoids
9586|NCT03229395|biomarkers|biomarkers
9587|NCT03229382|MCL, obinutuzumab|mcl, obinutuzumab
9589|NCT03229369|ALL|all
9590|NCT03229369|Ligament injury|ligament injury
9591|NCT03229369|Reconstruction|reconstruction
9592|NCT03229343|idiopathic pulmonary fibrosis, palliative care|idiopathic pulmonary fibrosis, palliative care
9593|NCT03229330|Wound Healing|wound healing
9594|NCT03229330|Outcome Assessment (Health Care)|outcome assessment (health care)
9595|NCT03229317|Lung function|lung function
9596|NCT03229317|Children|children
9597|NCT03229317|Vitamin D|vitamin d
9598|NCT03229317|COPD|copd
9599|NCT03229291|SM04755|sm04755
9600|NCT03229291|topical|topical
9601|NCT03229291|Samumed|samumed
9602|NCT03229291|Wnt inhibitor|wnt inhibitor
9603|NCT03229226|Simulation|simulation
9604|NCT03229226|Task Trainer|task trainer
9605|NCT03229213|cystic fibrosis|cystic fibrosis
9606|NCT03229213|video games|video games
9607|NCT03229213|exercise|exercise
9608|NCT03229213|maximal oxygen consumption|maximal oxygen consumption
9609|NCT03229148|Anesthesia or Conscious sedation for Thrombectomy for Stroke|anesthesia or conscious sedation for thrombectomy for stroke
9610|NCT03229148|Thrombectomy|thrombectomy
9611|NCT03229148|Anesthesia|anesthesia
9612|NCT03229148|Conscious sedation|conscious sedation
9613|NCT03229148|Stroke|stroke
9614|NCT03229122|ovarian cancer, gBRCAm|ovarian cancer, gbrcam
9615|NCT03229109|dehydration|dehydration
9616|NCT03229109|spectrophon|spectrophon
9617|NCT03229109|device|device
9618|NCT03229109|perspiration|perspiration
9619|NCT03229096|gastric cancer|gastric cancer
9620|NCT03229096|neoadjuvant chemotherapy|neoadjuvant chemotherapy
9621|NCT03229096|apatinib|apatinib
9622|NCT03229070|Thoracic Surgery|thoracic surgery
9623|NCT03229070|Postoperative Period|postoperative period
9624|NCT03229070|Rehabilitation|rehabilitation
9625|NCT03229070|Early mobilization|early mobilization
9626|NCT03229070|Cycle-ergometer|cycle-ergometer
9627|NCT03229044|adipokine, tetranectin, lipid metabolism, body mass index|adipokine, tetranectin, lipid metabolism, body mass index
9628|NCT03229031|spinal cord, spinal cord injury|spinal cord, spinal cord injury
9629|NCT03229005|soft tissue; implant; abutment;|soft tissue; implant; abutment;
9630|NCT03228966|Pediatric|pediatric
9631|NCT03228953|Pharmacogenomic testing|pharmacogenomic testing
9632|NCT03228953|Depression|depression
9633|NCT03228940|Cardiovascular Disease, Renal Disease|cardiovascular disease, renal disease
9634|NCT03228901|Oxytocin|oxytocin
9635|NCT03228901|Affiliation|affiliation
9636|NCT03228888|Rhythm|rhythm
9637|NCT03228888|Ecological sounds|ecological sounds
9638|NCT03228888|Auditory stimuli|auditory stimuli
9639|NCT03228888|rhythmic auditory stimulation|rhythmic auditory stimulation
9640|NCT03228888|Parkinson's Disease|parkinson's disease
9641|NCT03228888|Gait|gait
9642|NCT03228888|Gait analysis|gait analysis
9643|NCT03228888|Spatio-temporal parameters|spatio-temporal parameters
9644|NCT03228875|pregnancy outcomes, birth outcomes|pregnancy outcomes, birth outcomes
9656|NCT03228745|mindfulness based stress reduction|mindfulness based stress reduction
9657|NCT03228745|total knee arthroplasty|total knee arthroplasty
9658|NCT03228745|pre-operative|pre-operative
9659|NCT03228719|Total Knee Replacement|total knee replacement
9660|NCT03228719|Physical Therapy|physical therapy
9661|NCT03228706|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
9662|NCT03228706|Medication Adherence|medication adherence
9663|NCT03228706|Malay patients|malay patients
9664|NCT03228706|Structured Group-Based Intervention|structured group-based intervention
9665|NCT03228706|Randomised controlled trial|randomised controlled trial
9666|NCT03228693|Keloid|keloid
9667|NCT03228667|Pembrolizumab|pembrolizumab
9668|NCT03228667|Nivolumab|nivolumab
9669|NCT03228667|Non-Small Cell Lung Cancer|non-small cell lung cancer
9670|NCT03228667|Immunotherapy|immunotherapy
9671|NCT03228667|Interleukin-15|interleukin-15
9672|NCT03228667|PD-1 Checkpoint Inhibitor|pd-1 checkpoint inhibitor
9673|NCT03228641|skin rejuvenation|skin rejuvenation
9674|NCT03228641|wrinkle removal|wrinkle removal
9677|NCT03228628|Pain|pain
9678|NCT03228628|Anxiety|anxiety
9679|NCT03228628|Nitrous oxyde|nitrous oxyde
9680|NCT03228615|shared decision making|shared decision making
9681|NCT03228576|Tacrolimus|tacrolimus
9682|NCT03228576|Envarsus|envarsus
9683|NCT03228576|Everolimus|everolimus
9684|NCT03228576|kidney|kidney
9685|NCT03228576|Transplant|transplant
9686|NCT03228550|omega-3 fatty acid|omega-3 fatty acid
9687|NCT03228550|B vitamins|b vitamins
9688|NCT03228550|vitamin E|vitamin e
9689|NCT03228550|Phosphatidylserine|phosphatidylserine
9690|NCT03228550|Gingko biloba|gingko biloba
9691|NCT03228550|Gait|gait
9692|NCT03228550|Aerobic Exercise|aerobic exercise
9693|NCT03228550|Memory|memory
9694|NCT03228550|Cognitive function|cognitive function
9695|NCT03228485|Smartphone|smartphone
9696|NCT03228485|Application|application
9697|NCT03228485|Pilot|pilot
9698|NCT03228485|mhealth|mhealth
9699|NCT03228459|Kidney Diseases|kidney diseases
9700|NCT03228459|Subclinical Disease and/or Syndrome|subclinical disease and/or syndrome
9701|NCT03228459|Atherosclerosis|atherosclerosis
9702|NCT03228459|Biomarkers|biomarkers
9703|NCT03228459|Prevention|prevention
9704|NCT03228459|Lung capacity|lung capacity
9705|NCT03228459|Early diagnosis|early diagnosis
9706|NCT03228459|Advanced glycation end products|advanced glycation end products
9707|NCT03228459|Atrial fibrillation|atrial fibrillation
9708|NCT03228459|Diabetes|diabetes
9709|NCT03228459|Arterial ultrasound|arterial ultrasound
9710|NCT03228446|training intervention|training intervention
9711|NCT03228446|filter training|filter training
9712|NCT03228446|distractor inhibition|distractor inhibition
9713|NCT03228433|Drug Therapy|drug therapy
9714|NCT03228394|Postpartum Care|postpartum care
9715|NCT03228394|Postpartum Depression|postpartum depression
9718|NCT03228355|Levcromakalim|levcromakalim
9719|NCT03228342|Rheumatoid Arthritis|rheumatoid arthritis
9720|NCT03228342|Ultrasound|ultrasound
9721|NCT03228342|Impact|impact
9722|NCT03228329|cardiometry|cardiometry
9723|NCT03228329|stroke volume|stroke volume
9724|NCT03228329|liver transplantation|liver transplantation
9725|NCT03228290|Cirrhosis|cirrhosis
9726|NCT03228290|Liver|liver
9727|NCT03228290|Liver Transplant|liver transplant
9728|NCT03228290|Frailty|frailty
9729|NCT03228290|end stage|end stage
9730|NCT03228277|Extracellular vesicles|extracellular vesicles
9731|NCT03228277|Bronchoalveolar lavage fluid|bronchoalveolar lavage fluid
9732|NCT03228277|Liquid biopsy|liquid biopsy
9733|NCT03228277|T790M|t790m
9734|NCT03228277|NSCLC|nsclc
9735|NCT03228277|Exosomes|exosomes
9736|NCT03228277|EGFR mutation testing|egfr mutation testing
9737|NCT03228199|Randomised Control Trial|randomised control trial
9738|NCT03228199|Productivity|productivity
9739|NCT03228199|Agricultural workers|agricultural workers
9740|NCT03228199|India|india
12559|NCT03210506|Cytokines|cytokines
9741|NCT03228199|Vision correction|vision correction
9742|NCT03228173|Cognition|cognition
9743|NCT03228173|Executive functioning|executive functioning
9744|NCT03228173|Depression|depression
9745|NCT03228173|Affect|affect
9746|NCT03228173|adult females|adult females
9747|NCT03228160|Sympathetically Maintained Pain|sympathetically maintained pain
9748|NCT03228160|Linear-Polarized Near-Infrared Irradiation|linear-polarized near-infrared irradiation
9749|NCT03228160|Stellate Ganglion|stellate ganglion
9750|NCT03228160|Heart Rate Variability|heart rate variability
9751|NCT03228160|Autonomic Dysfunction Outcome|autonomic dysfunction outcome
9752|NCT03228134|treatment； bronchial asthma|treatment； bronchial asthma
9753|NCT03228108|Culture-guided|culture-guided
9754|NCT03228108|Targeted prophylaxis|targeted prophylaxis
9755|NCT03228108|Prostate biopsy|prostate biopsy
9756|NCT03228108|Antibiotic prophylaxis|antibiotic prophylaxis
9757|NCT03228095|Volatile Organic Compounds|volatile organic compounds
9758|NCT03228095|Tuberculosis|tuberculosis
9759|NCT03228095|Nano-sensors|nano-sensors
9760|NCT03228095|Electronic nose|electronic nose
9761|NCT03228095|Digestive cancers|digestive cancers
9762|NCT03228082|Patient empowerment|patient empowerment
9763|NCT03228082|Women's Health|women's health
9764|NCT03228082|Home Blood Pressure Monitoring|home blood pressure monitoring
9765|NCT03228069|rabies vaccination|rabies vaccination
9766|NCT03228056|postoperative pain|postoperative pain
9767|NCT03228056|videothoracoscopic surgery|videothoracoscopic surgery
9768|NCT03228056|thoracic epidural analgesia|thoracic epidural analgesia
9769|NCT03228056|lung lobectomy|lung lobectomy
9770|NCT03228043|Apatinib|apatinib
9771|NCT03228043|Outcome, Fatal|outcome, fatal
9772|NCT03228043|Colorectal Cancer|colorectal cancer
9773|NCT03228043|surgery|surgery
9774|NCT03228043|adjuvant chemotherapy|adjuvant chemotherapy
9775|NCT03228030|thiamine|thiamine
9776|NCT03228030|heart failure|heart failure
9777|NCT03228030|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
9778|NCT03228030|geriatric|geriatric
9779|NCT03228030|thiamin|thiamin
9780|NCT03228030|vitamin b1|vitamin b1
9781|NCT03228030|congestive heart failure|congestive heart failure
9782|NCT03228017|cardiovascular disease|cardiovascular disease
9783|NCT03228017|CVD|cvd
9784|NCT03227991|Suicide|suicide
9785|NCT03227978|pleurodesis|pleurodesis
9786|NCT03227978|PCL|pcl
9787|NCT03227965|cancer|cancer
9788|NCT03227926|RAS|ras
9789|NCT03227926|Panitumumab|panitumumab
9790|NCT03227926|EGFR|egfr
9791|NCT03227926|Clonal evolution|clonal evolution
9792|NCT03227835|contrast-induced nephropathy|contrast-induced nephropathy
9793|NCT03227835|contrast-induced acute kidney injury|contrast-induced acute kidney injury
9794|NCT03227835|prophylaxis|prophylaxis
9795|NCT03227835|intravenous hydration|intravenous hydration
9796|NCT03227809|College student risk behavior prevention|college student risk behavior prevention
9797|NCT03227809|Substance use|substance use
9798|NCT03227809|Alcohol|alcohol
9799|NCT03227809|Marijuana|marijuana
9800|NCT03227809|Illicit drugs|illicit drugs
9801|NCT03227809|Prescription drug misuse|prescription drug misuse
9802|NCT03227809|Risky sexual behaviors|risky sexual behaviors
9803|NCT03227796|osteoarthritis|osteoarthritis
9804|NCT03227796|knee|knee
9805|NCT03227796|healthy|healthy
9806|NCT03227796|volunteer|volunteer
9808|NCT03227770|Hemoperfusion|hemoperfusion
9809|NCT03227770|Hemodialysis|hemodialysis
9810|NCT03227770|Mortality|mortality
9811|NCT03227757|TRILUMINATE|triluminate
9812|NCT03227757|Percutaneous transcatheter intervention|percutaneous transcatheter intervention
9813|NCT03227757|Tricuspid regurgitation|tricuspid regurgitation
9814|NCT03227757|Tricuspid Valve Repair System|tricuspid valve repair system
9815|NCT03227744|Prostate Cancer, Anxiety|prostate cancer, anxiety
9816|NCT03227731|Preexposure prophylaxis|preexposure prophylaxis
9817|NCT03227731|safety|safety
9818|NCT03227731|HIV prevention|hiv prevention
9819|NCT03227731|pregnant women|pregnant women
9820|NCT03227731|lactating women|lactating women
9821|NCT03227718|VOR|vor
9822|NCT03227705|Preterm birth|preterm birth
9823|NCT03227705|Short cervix|short cervix
9824|NCT03227705|Pessary|pessary
9825|NCT03227705|Progesterone|progesterone
9826|NCT03227679|Personalized Medicine|personalized medicine
9827|NCT03227679|Nicotine Metabolite Ratio (NMR)|nicotine metabolite ratio (nmr)
9828|NCT03227679|Varenicline|varenicline
9829|NCT03227679|Nicotine Replacement Therapy (NRT)|nicotine replacement therapy (nrt)
9830|NCT03227679|Smoking Cessation|smoking cessation
9831|NCT03227679|Pharmacotherapy|pharmacotherapy
9832|NCT03227666|Postural sway|postural sway
9833|NCT03227666|Progressive balance exercise|progressive balance exercise
9834|NCT03227666|RCT|rct
9835|NCT03227666|Functional balance|functional balance
9836|NCT03227653|Efavirenz|efavirenz
9837|NCT03227653|Child Behavior|child behavior
9838|NCT03227653|Cognition|cognition
9839|NCT03227653|Medication Adherence|medication adherence
9840|NCT03227653|Drug-Related Side Effects|drug-related side effects
9842|NCT03227614|social support|social support
9843|NCT03227614|Anxiety|anxiety
9844|NCT03227614|Pain|pain
9845|NCT03227588|Fractional Flow Reserve|fractional flow reserve
9846|NCT03227588|Percutaneous Coronary Intervention|percutaneous coronary intervention
9847|NCT03227562|risperidone|risperidone
9848|NCT03227562|anxiety|anxiety
9849|NCT03227562|cognition|cognition
9850|NCT03227562|stress|stress
9851|NCT03227536|Neonatal asphyxia|neonatal asphyxia
9852|NCT03227536|neonatal acidosis|neonatal acidosis
9853|NCT03227536|fetal ECG|fetal ecg
9854|NCT03227536|umbilical cord acid-base status|umbilical cord acid-base status
9855|NCT03227523|low back pain|low back pain
9856|NCT03227523|respiratory disorders|respiratory disorders
9857|NCT03227523|pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
9858|NCT03227523|postural balance|postural balance
9859|NCT03227523|functional laterality|functional laterality
9860|NCT03227523|diaphragm|diaphragm
9861|NCT03227510|Hepatocellular Carcinoma , MicroRNAs, Somalia|hepatocellular carcinoma , micrornas, somalia
9862|NCT03227497|Blood Pressure|blood pressure
9863|NCT03227497|Cholesterol|cholesterol
9864|NCT03227497|Triglycerides|triglycerides
9865|NCT03227497|Walnuts|walnuts
9866|NCT03227458|areal bone mineral density|areal bone mineral density
9867|NCT03227458|dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
9868|NCT03227458|postmenopause|postmenopause
9869|NCT03227458|exercise|exercise
9870|NCT03227458|sex hormones|sex hormones
9871|NCT03227445|DISKUS|diskus
9872|NCT03227445|HandiHaler|handihaler
9873|NCT03227445|COPD|copd
9874|NCT03227445|Placebo|placebo
9875|NCT03227445|Cross-over|cross-over
9876|NCT03227445|Dry powder inhaler|dry powder inhaler
9877|NCT03227445|ELLIPTA|ellipta
9878|NCT03227432|Multiple Myeloma|multiple myeloma
9879|NCT03227406|sleep|sleep
9880|NCT03227406|memory|memory
9881|NCT03227406|REM sleep|rem sleep
9882|NCT03227406|slow wave sleep|slow wave sleep
9883|NCT03227406|cognition|cognition
9884|NCT03227406|sleep spindles|sleep spindles
9885|NCT03227393|Heart Failure, Systolic|heart failure, systolic
9886|NCT03227393|Defibrillators, Implantable|defibrillators, implantable
609019|NCT00610246|Cancer|cancer
9887|NCT03227393|Pacemaker, Artificial|pacemaker, artificial
9888|NCT03227367|biomaterials|biomaterials
9889|NCT03227367|apoptosis|apoptosis
9890|NCT03227367|bone regeneration|bone regeneration
9891|NCT03227354|Medical Device|medical device
9892|NCT03227341|asthma control|asthma control
9893|NCT03227341|pulmonary rehabilitation|pulmonary rehabilitation
9894|NCT03227328|luminal B breast cancer|luminal b breast cancer
9895|NCT03227328|metastatic breast cancer|metastatic breast cancer
9896|NCT03227328|First line treatment|first line treatment
9897|NCT03227328|endocrine therapy|endocrine therapy
9898|NCT03227328|chemotherapy|chemotherapy
9899|NCT03227328|randomized phase III trial|randomized phase iii trial
9900|NCT03227328|aromatase inhibitor|aromatase inhibitor
9901|NCT03227276|Litramine|litramine
9902|NCT03227276|Opuntia ficus-indica|opuntia ficus-indica
9903|NCT03227276|weight loss|weight loss
9904|NCT03227263|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
9905|NCT03227263|VEGF therapy|vegf therapy
9906|NCT03227263|Bevacizumab|bevacizumab
9907|NCT03227250|freezing of gait|freezing of gait
9908|NCT03227250|Parkinson disease|parkinson disease
9910|NCT03227237|Impact, Interpersonal Relationship, Juvenile delinquency|impact, interpersonal relationship, juvenile delinquency
9911|NCT03227211|COPD exacerbated|copd exacerbated
9912|NCT03227211|Readmission|readmission
9913|NCT03227211|Prospective cohort study|prospective cohort study
9914|NCT03227211|Nested case control study|nested case control study
9915|NCT03227211|Clinical prediction rules|clinical prediction rules
9916|NCT03227159|Acute Myocardial Infarction|acute myocardial infarction
9917|NCT03227159|Troponin|troponin
9918|NCT03227159|Emergency department|emergency department
9919|NCT03227146|Burns|burns
9920|NCT03227146|Scar|scar
9921|NCT03227146|Skin|skin
9922|NCT03227146|Wound healing|wound healing
9923|NCT03227146|Tissue Engineering|tissue engineering
9924|NCT03227146|Dermis|dermis
9925|NCT03227146|Epidermis|epidermis
9926|NCT03227146|Thermal Injuries|thermal injuries
9927|NCT03227120|Exercise Therapy|exercise therapy
9928|NCT03227094|Diabetes|diabetes
9929|NCT03227094|Screening test|screening test
9930|NCT03227094|Continuous glucose monitoring|continuous glucose monitoring
9931|NCT03227094|Oral glucose tolerance test|oral glucose tolerance test
9932|NCT03227068|pediatric oncology|pediatric oncology
9933|NCT03227068|parent|parent
9934|NCT03227055|Arterial stiffness, children, chronic kidney disease, hypertension, microRNA|arterial stiffness, children, chronic kidney disease, hypertension, microrna
9935|NCT03227042|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
9936|NCT03227042|MPS IIIB|mps iiib
9937|NCT03227042|MPS 3 B|mps 3 b
9938|NCT03226990|pressure area|pressure area
9940|NCT03226990|wax spacer|wax spacer
9941|NCT03226964|endobronchial ultrasound|endobronchial ultrasound
9942|NCT03226964|high flow nasal oxygen|high flow nasal oxygen
9943|NCT03226938|dietary patterns|dietary patterns
9944|NCT03226938|dietary adherence|dietary adherence
9945|NCT03226938|popular diets|popular diets
9946|NCT03226938|Paleo|paleo
9947|NCT03226938|vegan|vegan
9948|NCT03226938|behavior change|behavior change
9949|NCT03226938|adherence|adherence
9950|NCT03226938|compliance|compliance
9951|NCT03226938|vegetarian|vegetarian
9952|NCT03226938|low carb|low carb
9953|NCT03226938|low-carb|low-carb
9954|NCT03226938|whole food plant-based|whole food plant-based
9955|NCT03226938|social ecological model|social ecological model
9956|NCT03226925|thoracic tumors|thoracic tumors
9957|NCT03226925|motion management|motion management
9958|NCT03226925|radiotherapy|radiotherapy
9959|NCT03226925|ventilator|ventilator
9960|NCT03226873|HIV prevention|hiv prevention
9961|NCT03226873|PrEP|prep
9962|NCT03226873|peer navigation|peer navigation
9963|NCT03226873|women|women
9964|NCT03226847|Atrial Fibrillation, Athletes, Pulmonary Vein Isolation|atrial fibrillation, athletes, pulmonary vein isolation
9965|NCT03226821|HIV Lipodystrophy|hiv lipodystrophy
9966|NCT03226821|Tesamorelin|tesamorelin
9967|NCT03226821|Body Composition|body composition
9968|NCT03226821|Visceral Adiposity|visceral adiposity
9969|NCT03226795|Cystic fibrosis|cystic fibrosis
9970|NCT03226795|Therapeutic adherence|therapeutic adherence
9971|NCT03226795|Co-constructed intervention|co-constructed intervention
9972|NCT03226795|Patient involvement|patient involvement
9973|NCT03226743|stepped and collaborative care|stepped and collaborative care
9974|NCT03226743|cluster-randomized controlled trial|cluster-randomized controlled trial
9975|NCT03226743|health services research|health services research
9976|NCT03226743|evidence-based medicine|evidence-based medicine
9977|NCT03226743|complex intervention|complex intervention
9978|NCT03226743|guideline implementation|guideline implementation
9979|NCT03226743|collaborative network|collaborative network
9980|NCT03226730|Female Adolescent|female adolescent
9981|NCT03226730|Married|married
9982|NCT03226730|West Africa|west africa
9983|NCT03226730|Family Planning|family planning
9984|NCT03226730|Contraceptive Use|contraceptive use
9985|NCT03226730|Birth Spacing|birth spacing
9986|NCT03226704|CD19|cd19
9987|NCT03226704|CD22|cd22
9988|NCT03226704|CD19/22|cd19/22
9989|NCT03226704|Immunotherapy|immunotherapy
9990|NCT03226704|Apheresis|apheresis
758216|NCT02729259|VRD|vrd
9991|NCT03226691|Plerixafor|plerixafor
9992|NCT03226691|Leukapheresis|leukapheresis
9993|NCT03226691|Mobilization|mobilization
9994|NCT03226691|Stem Cells|stem cells
9995|NCT03226691|Sickle Cell Disease|sickle cell disease
9996|NCT03226665|obstruction|obstruction
9997|NCT03226665|small bowel|small bowel
9998|NCT03226665|ultrasound|ultrasound
9999|NCT03226639|Atrial Fibrillation|atrial fibrillation
10000|NCT03226639|First Ablation|first ablation
10001|NCT03226626|Tumescent|tumescent
10002|NCT03226626|Lidocaine|lidocaine
10003|NCT03226626|Epinephrine|epinephrine
10004|NCT03226626|Cefazolin|cefazolin
10005|NCT03226626|Metronidazole|metronidazole
10006|NCT03226626|Surgical Site Infection|surgical site infection
10007|NCT03226626|Thrombosis|thrombosis
10008|NCT03226626|Sepsis|sepsis
10009|NCT03226626|Prevention|prevention
10010|NCT03226626|Prophylaxis|prophylaxis
10011|NCT03226613|Human Papillomavirus|human papillomavirus
10012|NCT03226613|Oropharyngeal Cancer|oropharyngeal cancer
10013|NCT03226613|Base of Tongue Cancer|base of tongue cancer
10014|NCT03226613|Tonsil Cancer|tonsil cancer
10015|NCT03226600|Gingival Recession|gingival recession
10016|NCT03226600|Connective Tissue Graft|connective tissue graft
10017|NCT03226600|OrACELL|oracell
10018|NCT03226600|Decellularized Dermis|decellularized dermis
10019|NCT03226600|Periodontics|periodontics
10020|NCT03226587|blue light|blue light
10021|NCT03226587|blood pressure|blood pressure
10022|NCT03226587|vascular function|vascular function
10023|NCT03226587|endothelial function|endothelial function
10024|NCT03226587|health volunteers|health volunteers
10025|NCT03226574|Resiniferatoxin|resiniferatoxin
10026|NCT03226574|RTX|rtx
10027|NCT03226574|Cancer pain|cancer pain
10028|NCT03226548|Earned Income Tax Credit (EITC)|earned income tax credit (eitc)
10029|NCT03226548|Tax Credit|tax credit
10030|NCT03226548|Paycheck Plus|paycheck plus
10031|NCT03226535|Computer Assisted Instrument Guidance (CAIG)|computer assisted instrument guidance (caig)
10032|NCT03226535|Ultrasound-CT Fusion|ultrasound-ct fusion
10033|NCT03226535|Image Fusion|image fusion
10034|NCT03226535|Clear Guide SCENERGY|clear guide scenergy
10035|NCT03226535|Needle path|needle path
10036|NCT03226535|Needle Guidance|needle guidance
10037|NCT03226535|CT|ct
10038|NCT03226535|Ultrasound|ultrasound
10039|NCT03226509|cascade of care|cascade of care
10040|NCT03226483|Brain Metastases|brain metastases
10041|NCT03226483|Intraoperative Radiotherapy|intraoperative radiotherapy
10043|NCT03226470|Transcription Activator-like Effector Nucleases|transcription activator-like effector nucleases
10044|NCT03226470|Human papillomavirus|human papillomavirus
10045|NCT03226470|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
10046|NCT03226457|Heart Failure|heart failure
10047|NCT03226457|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
10048|NCT03226457|Sodium-Glucose co-Transporter 2 (SGLT2) inhibitors|sodium-glucose co-transporter 2 (sglt2) inhibitors
10049|NCT03226457|Natriuresis|natriuresis
10050|NCT03226457|Diuresis|diuresis
10051|NCT03226444|Dry Eye|dry eye
10052|NCT03226444|Primary Sjogren's Syndrome|primary sjogren's syndrome
10053|NCT03226444|Sjogren's Syndrome|sjogren's syndrome
10054|NCT03226405|Cancer|cancer
10055|NCT03226392|QAW039, uncontrolled asthma|qaw039, uncontrolled asthma
10056|NCT03226366|door-to-antibiotic time|door-to-antibiotic time
10057|NCT03226366|emergency department care|emergency department care
10058|NCT03226366|antimicrobial|antimicrobial
10059|NCT03226366|care reorganization|care reorganization
10060|NCT03226366|severe sepsis|severe sepsis
10061|NCT03226366|swarming|swarming
10062|NCT03226314|bacterial multi-resitance|bacterial multi-resitance
10063|NCT03226288|Plantar Fascitis|plantar fascitis
10064|NCT03226288|orthopedic|orthopedic
10065|NCT03226288|3D surface scanning|3d surface scanning
10066|NCT03226275|Concor AM®|concor am®
10067|NCT03226275|Concor®|concor®
10068|NCT03226275|Norvasc®|norvasc®
10069|NCT03226275|Bisoprolol|bisoprolol
10070|NCT03226275|Amlodipine|amlodipine
10071|NCT03226275|Bisoprolol-Amlodipine fixed dose combination|bisoprolol-amlodipine fixed dose combination
10072|NCT03226275|Chinese Subjects|chinese subjects
10073|NCT03226236|Carcinoma, Renal Cell|carcinoma, renal cell
10074|NCT03226236|vaccination|vaccination
10075|NCT03226236|dendritic cells|dendritic cells
10076|NCT03226236|autologous tumor homogenate|autologous tumor homogenate
10077|NCT03226236|High Dose -IL2|high dose -il2
10078|NCT03226236|immunomodulating radiotherapy|immunomodulating radiotherapy
10079|NCT03226236|secondary|secondary
10080|NCT03226210|Diabetes Mellitus|diabetes mellitus
10081|NCT03226210|Rapid-acting insulin analogues|rapid-acting insulin analogues
10082|NCT03226210|Continuous glucose monitoring system (CGMS)|continuous glucose monitoring system (cgms)
10083|NCT03226210|Continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
10084|NCT03226184|Er:YAG laser, laser, biofilm removal, biofilm, disinfection, septic revision surgery|er:yag laser, laser, biofilm removal, biofilm, disinfection, septic revision surgery
10085|NCT03226158|Next generation pathogen sequencing (NGPS)|next generation pathogen sequencing (ngps)
10086|NCT03226158|Pediatric|pediatric
10087|NCT03226158|Cancer|cancer
10088|NCT03226158|Bloodstream infection (BSI)|bloodstream infection (bsi)
10089|NCT03226119|HTLV|htlv
10090|NCT03226119|Confirmatory|confirmatory
10091|NCT03226119|Supplemental|supplemental
10092|NCT03226119|Blot|blot
10093|NCT03226119|HTLV-I|htlv-i
10094|NCT03226119|HTLV-II|htlv-ii
10095|NCT03226106|Rehabilitation|rehabilitation
10096|NCT03226106|Total Knee Arthroplasty|total knee arthroplasty
10097|NCT03226106|Telemedicine|telemedicine
10098|NCT03226106|Physical Activity|physical activity
10099|NCT03226054|Proton Pump Inhibitor|proton pump inhibitor
10100|NCT03226041|transcutaneous carbon dioxide|transcutaneous carbon dioxide
10101|NCT03226041|retroperitoneoscopic|retroperitoneoscopic
10102|NCT03226041|urologic surgery|urologic surgery
10103|NCT03226041|anesthesia|anesthesia
10104|NCT03226015|Limbal Stem-cell Deficiency|limbal stem-cell deficiency
10105|NCT03226015|Oral mucosa transplantation|oral mucosa transplantation
10106|NCT03226015|Amniotic membrane|amniotic membrane
10107|NCT03226015|Mesenchymal stem cells|mesenchymal stem cells
10108|NCT03226002|Airtraq NT|airtraq nt
10109|NCT03226002|nasotracheal intubation|nasotracheal intubation
10110|NCT03226002|right|right
10111|NCT03226002|left|left
10112|NCT03225976|Phototherapy|phototherapy
10113|NCT03225976|Athletic Performance|athletic performance
10114|NCT03225976|Muscle Strength|muscle strength
10115|NCT03225976|Fatigue|fatigue
10116|NCT03225963|Glioblastoma|glioblastoma
10117|NCT03225963|Bevacizumab|bevacizumab
10118|NCT03225950|Periodontal disease|periodontal disease
10119|NCT03225950|Periodontitis|periodontitis
10120|NCT03225950|Aggressive periodontitis|aggressive periodontitis
10121|NCT03225950|Dysbiosis|dysbiosis
10122|NCT03225950|Inflammation|inflammation
10123|NCT03225950|Regulation|regulation
10124|NCT03225950|Cytokines|cytokines
10125|NCT03225950|Bacteria|bacteria
10126|NCT03225950|Porphyromonas gingivalis|porphyromonas gingivalis
10127|NCT03225950|Saliva|saliva
10128|NCT03225950|Anti-CCP|anti-ccp
10129|NCT03225950|Peptidyl arginine deiminases|peptidyl arginine deiminases
10130|NCT03225950|Single nucleotide polymorphisms|single nucleotide polymorphisms
10131|NCT03225898|blood flow restriction|blood flow restriction
10132|NCT03225898|resistance exercise|resistance exercise
10133|NCT03225885|gestational age|gestational age
10150|NCT03225807|Mechanical Ventilation|mechanical ventilation
10151|NCT03225807|Meta-Analysis|meta-analysis
10152|NCT03225807|Tidal Volume|tidal volume
10153|NCT03225807|Tidal Volumes|tidal volumes
10154|NCT03225807|inflammation|inflammation
10155|NCT03225807|cytokines|cytokines
10156|NCT03225807|Pulmonary Infiltrate|pulmonary infiltrate
10157|NCT03225807|Pulmonary Infiltrates|pulmonary infiltrates
10158|NCT03225807|Low Tidal Volumes|low tidal volumes
10159|NCT03225807|Protective Ventilation|protective ventilation
10160|NCT03225794|Retrovirus|retrovirus
10161|NCT03225794|Viral emergence|viral emergence
10162|NCT03225755|Growth Hormone Deficiency|growth hormone deficiency
10163|NCT03225755|Adipose Tissue|adipose tissue
10164|NCT03225755|Inflammation|inflammation
10165|NCT03225716|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
10166|NCT03225703|Exercise|exercise
10167|NCT03225703|Osteoporosis|osteoporosis
10168|NCT03225703|Osteoarthritis|osteoarthritis
10169|NCT03225703|MRI|mri
10170|NCT03225703|DXA|dxa
10171|NCT03225703|High Impact|high impact
10172|NCT03225703|Cartilage|cartilage
10173|NCT03225703|Bone|bone
10174|NCT03225664|Non-Small Cell Lung Cancer|non-small cell lung cancer
10175|NCT03225664|NSCLC|nsclc
10176|NCT03225664|Trametinib|trametinib
10183|NCT03225664|Unresectable|unresectable
10184|NCT03225664|Locally advanced|locally advanced
10185|NCT03225664|Recurrent|recurrent
10186|NCT03225651|Stem cell|stem cell
10187|NCT03225651|Autism|autism
10188|NCT03225651|Psychological|psychological
10189|NCT03225651|Rehabilitation|rehabilitation
10190|NCT03225625|spinal cord injury|spinal cord injury
10191|NCT03225625|spinal cord compression|spinal cord compression
10192|NCT03225625|spinal cord ischemia|spinal cord ischemia
10193|NCT03225625|spinal cord diseases|spinal cord diseases
10194|NCT03225625|spinal paralysis|spinal paralysis
10195|NCT03225625|paraplegia|paraplegia
10196|NCT03225625|paraparesis|paraparesis
10197|NCT03225586|Non-communicable Diseases, Risk Factors|non-communicable diseases, risk factors
10198|NCT03225573|second mesiobuccal canal CBCT prevalence population|second mesiobuccal canal cbct prevalence population
10199|NCT03225560|Smart Phone Application|smart phone application
10200|NCT03225560|Bowel Preparation|bowel preparation
10201|NCT03225560|Colorectal Cancer Screening|colorectal cancer screening
10202|NCT03225547|HER-2 negative breast cancer|her-2 negative breast cancer
10203|NCT03225547|breast cancer|breast cancer
10204|NCT03225547|pembrolizumab|pembrolizumab
10205|NCT03225547|mifepristone|mifepristone
758433|NCT02628067|anal cancer|anal cancer
10206|NCT03225534|Asthma|asthma
10207|NCT03225534|Allergy|allergy
10208|NCT03225534|Epidemiology|epidemiology
10209|NCT03225534|Environment|environment
10210|NCT03225534|Exposures|exposures
10211|NCT03225521|Physical Activity|physical activity
10212|NCT03225521|Mobile Health|mobile health
10213|NCT03225521|Self Monitoring|self monitoring
10214|NCT03225521|Wearable Sensors|wearable sensors
10215|NCT03225521|Tailored Health Communication|tailored health communication
10216|NCT03225521|Implementation Intentions|implementation intentions
10217|NCT03225521|Mobile Apps|mobile apps
10218|NCT03225521|Anti-Sedentary Behavior|anti-sedentary behavior
10219|NCT03225521|Opportunistic Physical Activity|opportunistic physical activity
10220|NCT03225521|Health Belief Model|health belief model
10221|NCT03225482|Mild Cognitive Impairment|mild cognitive impairment
10222|NCT03225482|Cognitive rehabilitation|cognitive rehabilitation
10223|NCT03225482|Cognitive training|cognitive training
10224|NCT03225482|Cognitive remediation|cognitive remediation
10225|NCT03225469|Bowel Preparation|bowel preparation
10226|NCT03225469|Colonoscopy|colonoscopy
10227|NCT03225469|Quality|quality
10228|NCT03225469|Family Support|family support
10229|NCT03225469|Education|education
10230|NCT03225456|appetite regulation|appetite regulation
10231|NCT03225456|obesity|obesity
10232|NCT03225456|oxytocin|oxytocin
10233|NCT03225443|Locally advanced cervical cancer|locally advanced cervical cancer
10234|NCT03225443|Particle radiotherapy|particle radiotherapy
10235|NCT03225443|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
10236|NCT03225417|Ixazomib|ixazomib
10237|NCT03225404|Tendinopathy|tendinopathy
10238|NCT03225404|Electrolysis|electrolysis
10239|NCT03225404|Exercise|exercise
10240|NCT03225404|Dry needing|dry needing
10241|NCT03225391|Residents|residents
10242|NCT03225391|Naps|naps
10243|NCT03225391|decision making|decision making
10244|NCT03225378|Fluid responsiveness|fluid responsiveness
10245|NCT03225378|Passive leg raising|passive leg raising
10246|NCT03225378|Pulse pressure variation|pulse pressure variation
10247|NCT03225365|Melanoma|melanoma
10248|NCT03225365|Nivolumab|nivolumab
10249|NCT03225365|Ipilimumab|ipilimumab
10250|NCT03225365|Immune modulation|immune modulation
10251|NCT03225326|articaine|articaine
10252|NCT03225326|local anesthesia|local anesthesia
10253|NCT03225326|AMSA|amsa
10254|NCT03225300|Glioblastoma|glioblastoma
10255|NCT03225300|Chemoradiation|chemoradiation
10256|NCT03225300|Simultaneous integrated boost|simultaneous integrated boost
10257|NCT03225274|Breathing exercises|breathing exercises
10258|NCT03225274|Respiratory status|respiratory status
10259|NCT03225274|Nebulization therapy|nebulization therapy
10260|NCT03225274|lower respiratory tract disorders|lower respiratory tract disorders
10261|NCT03225235|Prostate cancer, SBRT, Ultrafractionation, CyberKnife|prostate cancer, sbrt, ultrafractionation, cyberknife
10262|NCT03225222|Prostate cancer|prostate cancer
10263|NCT03225222|multivariate risk assessment|multivariate risk assessment
10264|NCT03225222|MRI|mri
10265|NCT03225222|biopsy|biopsy
10266|NCT03225222|screening|screening
10267|NCT03225222|multicenter|multicenter
10268|NCT03225209|Roux-en-y gastric bypass|roux-en-y gastric bypass
10269|NCT03225209|GLP-1|glp-1
10270|NCT03225209|Liraglutide|liraglutide
10271|NCT03225209|OPTIFAST|optifast
10301|NCT03225092|Chronic Knee Pain|chronic knee pain
10302|NCT03225092|Status-Post Total Knee Arthroplasty|status-post total knee arthroplasty
10303|NCT03225092|Platelet Rich Plasma|platelet rich plasma
10304|NCT03225079|Pentaglobin® use|pentaglobin® use
10305|NCT03225079|severe bacterial infection|severe bacterial infection
10306|NCT03225053|Percutaneous microelectrolysis|percutaneous microelectrolysis
10307|NCT03225053|Physiotherapy|physiotherapy
10308|NCT03225040|Acromegaly|acromegaly
10309|NCT03225040|Pegvisomant|pegvisomant
10310|NCT03225040|Osteoporosis|osteoporosis
10311|NCT03225027|Emotional prosody, schizophrenia|emotional prosody, schizophrenia
10312|NCT03225001|Sapien XT|sapien xt
10313|NCT03225001|Partner II|partner ii
10314|NCT03225001|cardiovascular disease|cardiovascular disease
10315|NCT03225001|heart disease|heart disease
10316|NCT03225001|aortic disease|aortic disease
10319|NCT03225001|failing surgical valve|failing surgical valve
10320|NCT03225001|failing valve|failing valve
10321|NCT03225001|failing bioprosthetic valve|failing bioprosthetic valve
10322|NCT03224988|Alzheimer's Disease|alzheimer's disease
10323|NCT03224988|AD|ad
10324|NCT03224988|MCI-AD|mci-ad
10325|NCT03224988|MCI|mci
10326|NCT03224988|Memory|memory
10327|NCT03224988|TMS|tms
10328|NCT03224988|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
10329|NCT03224988|Neuropsychological evaluation|neuropsychological evaluation
10330|NCT03224988|MRI|mri
10331|NCT03224988|DTI|dti
10332|NCT03224988|EEG|eeg
10333|NCT03224975|Pain|pain
10334|NCT03224975|Brain responses|brain responses
10335|NCT03224975|Neuroimaging|neuroimaging
10336|NCT03224975|fMRI|fmri
10337|NCT03224975|Burn|burn
10338|NCT03224975|Memory|memory
10339|NCT03224962|pit and fissure caries|pit and fissure caries
10340|NCT03224936|DISE|dise
10341|NCT03224936|OSAS|osas
10342|NCT03224936|PSI|psi
10343|NCT03224910|FNA, smears, imprints, ROSE|fna, smears, imprints, rose
10344|NCT03224897|Reappraisal|reappraisal
10345|NCT03224897|Emotion Regulation|emotion regulation
10346|NCT03224897|tDCS|tdcs
10347|NCT03224897|Reinterpretation|reinterpretation
10348|NCT03224858|Patient-Centered Care|patient-centered care
10349|NCT03224858|Comorbidity|comorbidity
10350|NCT03224754|Atypia, thyroid, malignancy|atypia, thyroid, malignancy
10351|NCT03224741|Behavioral Economics|behavioral economics
10352|NCT03224702|M6495|m6495
10353|NCT03224702|anti-A disintegrin and metalloproteinase with thrombospondin motifs-5 nanobody|anti-a disintegrin and metalloproteinase with thrombospondin motifs-5 nanobody
10354|NCT03224702|Osteoarthritis|osteoarthritis
10355|NCT03224676|Quality of sleep|quality of sleep
10356|NCT03224676|Perceived sleep distractors|perceived sleep distractors
10360|NCT03224663|Mobile application based learning|mobile application based learning
10361|NCT03224663|Facility based newborn care|facility based newborn care
10363|NCT03224663|Practices|practices
10364|NCT03224663|Nursing students|nursing students
10365|NCT03224585|anakinra|anakinra
10366|NCT03224585|Kineret|kineret
10367|NCT03224585|pericarditis|pericarditis
10368|NCT03224572|vitamin C|vitamin c
10369|NCT03224572|quality of life|quality of life
10370|NCT03224572|terminal cancer|terminal cancer
10371|NCT03224533|nut consumption|nut consumption
10372|NCT03224533|NHANES|nhanes
10373|NCT03224533|epidemiology|epidemiology
10374|NCT03224533|plasma glucose|plasma glucose
10375|NCT03224533|hemoglobin A1c|hemoglobin a1c
10376|NCT03224507|multiple myeloma|multiple myeloma
10377|NCT03224507|induction therapy|induction therapy
10378|NCT03224507|autologous hematopoietic cell transplantation|autologous hematopoietic cell transplantation
10379|NCT03224507|KRdD|krdd
10380|NCT03224507|Daratumumab|daratumumab
10381|NCT03224507|Carfilzomib|carfilzomib
10382|NCT03224507|Lenalidomide|lenalidomide
10383|NCT03224468|medical marijuana|medical marijuana
10384|NCT03224468|cannabis|cannabis
10386|NCT03224468|insomnia|insomnia
10387|NCT03224468|depression|depression
10388|NCT03224468|anxiety|anxiety
10389|NCT03224468|addiction|addiction
10390|NCT03224468|dependence|dependence
10391|NCT03224468|neurocognition|neurocognition
10392|NCT03224468|MRI|mri
10393|NCT03224455|sleep|sleep
10394|NCT03224455|sleep in children|sleep in children
10395|NCT03224455|children and sleep|children and sleep
10396|NCT03224455|environment|environment
10397|NCT03224455|environment and sleep|environment and sleep
10398|NCT03224455|environment and children|environment and children
10399|NCT03224416|Alcohol|alcohol
10400|NCT03224416|Delay Discounting|delay discounting
10401|NCT03224416|Risky Sexual Behavior|risky sexual behavior
10402|NCT03224416|Decision Making|decision making
10403|NCT03224416|MSM|msm
10404|NCT03224390|Contraception|contraception
10405|NCT03224390|Family Planning|family planning
10406|NCT03224390|Digital Health|digital health
10407|NCT03224390|Kenya|kenya
10408|NCT03224390|Unmet Need|unmet need
10409|NCT03224364|Solo surgery|solo surgery
10410|NCT03224364|Camera holder|camera holder
10411|NCT03224364|Laparoscopic Appendectomy|laparoscopic appendectomy
10412|NCT03224325|Drug therapy|drug therapy
10413|NCT03224312|Primary aldosteronism|primary aldosteronism
10414|NCT03224312|cardiovascular events|cardiovascular events
10415|NCT03224312|cerebrovascular events|cerebrovascular events
10416|NCT03224286|Pressure sensitive mat|pressure sensitive mat
10417|NCT03224273|box-shaped inlay-retained bridges|box-shaped inlay-retained bridges
10418|NCT03224273|proximal box design preparation|proximal box design preparation
10419|NCT03224273|zirconia bridge|zirconia bridge
10420|NCT03224247|vertical splitting|vertical splitting
10421|NCT03224247|Cesarean Section Complications|cesarean section complications
10422|NCT03224247|uterine vessels|uterine vessels
10423|NCT03224247|injury|injury
10424|NCT03224234|Uncontrolled Type 2 Diabetes|uncontrolled type 2 diabetes
10425|NCT03224234|Insulclock|insulclock
10426|NCT03224234|Electronic device|electronic device
10427|NCT03224234|Alarm system|alarm system
10428|NCT03224221|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
10429|NCT03224221|apatinib|apatinib
10430|NCT03224208|melanoma|melanoma
10431|NCT03224208|advanced|advanced
10432|NCT03224208|vemurafenib|vemurafenib
10433|NCT03224208|cobimetinib|cobimetinib
10434|NCT03224195|rehabilitation|rehabilitation
10435|NCT03224195|patient perspective|patient perspective
10436|NCT03224195|semi-structured interview|semi-structured interview
10437|NCT03224143|dementia|dementia
10438|NCT03224143|doll therapy|doll therapy
10439|NCT03224143|attachment|attachment
10440|NCT03224130|transitions of care|transitions of care
10441|NCT03224130|reutilization|reutilization
10442|NCT03224130|nurse phone call|nurse phone call
10443|NCT03224104|elderly|elderly
10444|NCT03224104|TG02|tg02
10445|NCT03224104|newly diagnosed|newly diagnosed
10446|NCT03224104|first relapse|first relapse
10447|NCT03224091|Eating disorders|eating disorders
10448|NCT03224091|psychopathology|psychopathology
10449|NCT03224091|pathophysiology|pathophysiology
10450|NCT03224091|prospective|prospective
10451|NCT03224091|longitudinal|longitudinal
10452|NCT03224052|Anti-Bacterial Agents|anti-bacterial agents
10453|NCT03224052|Falciparum|falciparum
10454|NCT03224052|Vivax|vivax
10455|NCT03224000|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
10456|NCT03224000|Oropharyngeal Cancer|oropharyngeal cancer
10457|NCT03224000|Human papilloma virus positive|human papilloma virus positive
10459|NCT03224000|Squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
10460|NCT03224000|Squamous cell carcinoma of the tonsil|squamous cell carcinoma of the tonsil
10461|NCT03224000|Squamous cell carcinoma of the base of tongue|squamous cell carcinoma of the base of tongue
10462|NCT03224000|Squamous cell carcinoma of the soft palate|squamous cell carcinoma of the soft palate
10463|NCT03224000|Squamous cell carcinoma of the oropharyngeal walls|squamous cell carcinoma of the oropharyngeal walls
10464|NCT03224000|Magnetic Resonance Imaging Guided Radiotherapy|magnetic resonance imaging guided radiotherapy
10465|NCT03224000|Standard of Care Radiotherapy Planning|standard of care radiotherapy planning
10466|NCT03224000|Radiation Therapy|radiation therapy
10467|NCT03224000|Intensity modulated radiotherapy|intensity modulated radiotherapy
10468|NCT03224000|IMRT|imrt
10469|NCT03224000|Modified Barium Swallow|modified barium swallow
10471|NCT03224000|Swallowing questionnaire|swallowing questionnaire
10472|NCT03224000|The M.D. Anderson Dysphagia Inventory (MDADI)|the m.d. anderson dysphagia inventory (mdadi)
10473|NCT03224000|Symptom questionnaire|symptom questionnaire
10474|NCT03224000|The M.D. Anderson Symptom Inventory for Head and Neck Cancer (MDASI-HN)|the m.d. anderson symptom inventory for head and neck cancer (mdasi-hn)
10475|NCT03224000|Video-Strobe Procedure|video-strobe procedure
10491|NCT03223896|nasal|nasal
10492|NCT03223857|visual outcomes|visual outcomes
10493|NCT03223857|multifocal intraocular lens|multifocal intraocular lens
10494|NCT03223857|patient satisfaction|patient satisfaction
10495|NCT03223857|spectacle independence|spectacle independence
10496|NCT03223844|Dopamine|dopamine
10497|NCT03223844|Amphetamine|amphetamine
10498|NCT03223844|Positron Emission Tomography|positron emission tomography
10499|NCT03223844|Magnetic Resonance Imaging|magnetic resonance imaging
10500|NCT03223844|Schizophrenia|schizophrenia
10501|NCT03223844|Psychosis|psychosis
10502|NCT03223844|[18F]FDOPA|[18f]fdopa
10503|NCT03223844|[11C]-(+)-PHNO|[11c]-(+)-phno
10504|NCT03223831|unresectable malignant gastric outlet obstruction|unresectable malignant gastric outlet obstruction
10505|NCT03223831|Partially covered pyloro-duodenal stents|partially covered pyloro-duodenal stents
10506|NCT03223831|uncovered pyloro-duodenal stents|uncovered pyloro-duodenal stents
10507|NCT03223818|Liver|liver
10508|NCT03223818|Digestive system|digestive system
10509|NCT03223779|Colorectal Cancer|colorectal cancer
10510|NCT03223766|Proton therapy|proton therapy
10511|NCT03223766|Long-term effects|long-term effects
10512|NCT03223727|Radium-223|radium-223
10513|NCT03223714|Conbercept ophthalmic injection|conbercept ophthalmic injection
10514|NCT03223714|ME|me
10515|NCT03223714|CRVO|crvo
10519|NCT03223649|Metabolism|metabolism
10520|NCT03223649|Children|children
10521|NCT03223649|Walking Bouts|walking bouts
10522|NCT03223649|Glucose|glucose
10534|NCT03223597|Radium-223|radium-223
10535|NCT03223597|quality of life|quality of life
10536|NCT03223597|Pain|pain
10537|NCT03223571|stroke|stroke
10538|NCT03223571|Upper arm|upper arm
10539|NCT03223571|Cerebral plasticity|cerebral plasticity
10540|NCT03223571|Functional connectivity|functional connectivity
10541|NCT03223571|Rehabilitation|rehabilitation
10542|NCT03223558|cardiac rehabilitation|cardiac rehabilitation
10543|NCT03223545|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
10544|NCT03223545|Meditation|meditation
10545|NCT03223519|DOMS|doms
10546|NCT03223519|Exercise|exercise
10547|NCT03223519|Ibuprofen|ibuprofen
10548|NCT03223519|Magnesium|magnesium
10549|NCT03223519|Vitamin C|vitamin c
10550|NCT03223519|Muscle pain|muscle pain
10551|NCT03223467|Obesity|obesity
10552|NCT03223467|Obstructive sleep apnea|obstructive sleep apnea
10553|NCT03223467|Bariatric surgery candidate|bariatric surgery candidate
10554|NCT03223467|Metabolic syndrome|metabolic syndrome
10555|NCT03223441|Pulse wave velocity|pulse wave velocity
10556|NCT03223441|anesthesia|anesthesia
10557|NCT03223415|Clostridium difficile infection|clostridium difficile infection
10558|NCT03223415|Infection Control|infection control
10559|NCT03223415|Prevention|prevention
10560|NCT03223415|Asymptomatic carriage|asymptomatic carriage
10561|NCT03223415|Colonization|colonization
10562|NCT03223415|Pilot Study|pilot study
10563|NCT03223415|Contact Precaution|contact precaution
10564|NCT03223415|Detection|detection
758827|NCT02284308|NSCLC|nsclc
10565|NCT03223363|Birth weight Prediction|birth weight prediction
10566|NCT03223363|Two-dimensional Ultrasonography|two-dimensional ultrasonography
10567|NCT03223363|Three-dimensional Ultrasonography|three-dimensional ultrasonography
10568|NCT03223337|GSK1278863|gsk1278863
10569|NCT03223337|Daprodustat|daprodustat
10570|NCT03223337|Healthy control|healthy control
10571|NCT03223337|Single dose|single dose
10572|NCT03223337|Hepatic Impairment|hepatic impairment
10573|NCT03223324|Threatened Premature Labor|threatened premature labor
10574|NCT03223324|Abdominal Fetal ECG|abdominal fetal ecg
10575|NCT03223298|Myofascial Pain|myofascial pain
10576|NCT03223298|Myofascial Pain Disorder|myofascial pain disorder
10577|NCT03223298|Maxillofacial Pain|maxillofacial pain
10578|NCT03223298|Masseter Muscle|masseter muscle
10581|NCT03223285|Cervical spine;|cervical spine;
10582|NCT03223285|Diaphragm;|diaphragm;
10583|NCT03223285|Manual Therapy|manual therapy
10584|NCT03223285|Pain|pain
10585|NCT03223285|Range of Motion|range of motion
10586|NCT03223272|hypertension|hypertension
10587|NCT03223272|sympathetic tone|sympathetic tone
10588|NCT03223272|resperpine|resperpine
10589|NCT03223259|Dance Injuries|dance injuries
10590|NCT03223259|Injury Prevention Workshops|injury prevention workshops
10591|NCT03223259|Motor Skill Theory|motor skill theory
10592|NCT03223259|Gross Motor Skills|gross motor skills
10687|NCT03222596|Quality of Life|quality of life
10593|NCT03223220|Stroke, Neuroprotection, Ketamine|stroke, neuroprotection, ketamine
10594|NCT03223194|Crigler-Najjar|crigler-najjar
10596|NCT03223194|AAV8 Delivered Gene Transfer|aav8 delivered gene transfer
10597|NCT03223194|Adeno Associated Virus|adeno associated virus
10598|NCT03223181|Comiss|comiss
10599|NCT03223155|Small cell lung cancer|small cell lung cancer
10600|NCT03223155|ipilimumab|ipilimumab
10601|NCT03223155|nivolumab|nivolumab
10602|NCT03223155|stereotactic body radiotherapy|stereotactic body radiotherapy
10603|NCT03223129|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
10604|NCT03223129|Impaired glucose tolerance|impaired glucose tolerance
10605|NCT03223129|Metabolomics|metabolomics
10606|NCT03223116|heartburn|heartburn
10607|NCT03223116|regurgitation|regurgitation
10608|NCT03223103|Brain cancer|brain cancer
10609|NCT03223103|Glioblastoma|glioblastoma
10610|NCT03223103|Personalized vaccine|personalized vaccine
10611|NCT03223103|Poly-ICLC|poly-iclc
10612|NCT03223103|Immunotherapy|immunotherapy
10613|NCT03223103|Cancer|cancer
10614|NCT03223103|NovoTTF-200A|novottf-200a
10615|NCT03223103|Optune|optune
10616|NCT03223103|GBM|gbm
10617|NCT03223103|immunogenicity|immunogenicity
10618|NCT03223090|Language|language
10619|NCT03223090|learning|learning
10620|NCT03223090|plasticity|plasticity
10621|NCT03223051|Spinal Muscular Atrophy|spinal muscular atrophy
10622|NCT03223051|Children|children
10623|NCT03223051|Motor assessment|motor assessment
10624|NCT03223051|Space exploration|space exploration
10625|NCT03223051|Upper limbs|upper limbs
10626|NCT03223038|Nutrition|nutrition
10627|NCT03223025|IGHD|ighd
10628|NCT03223025|somatropin|somatropin
10629|NCT03223012|Humira®|humira®
10630|NCT03223012|Adalimumab|adalimumab
10631|NCT03223012|AbbVie patient care support program|abbvie patient care support program
10632|NCT03222999|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
10633|NCT03222986|sepsis, nanoparticle tracking analysis|sepsis, nanoparticle tracking analysis
10634|NCT03222973|Remyelination|remyelination
10635|NCT03222973|Re-myelination|re-myelination
10636|NCT03222973|DMT|dmt
10637|NCT03222973|LINGO-1|lingo-1
10638|NCT03222973|Anti-LINGO-1|anti-lingo-1
10639|NCT03222973|Opicinumab|opicinumab
10640|NCT03222921|high tibial osteotomy|high tibial osteotomy
10641|NCT03222908|Behavior|behavior
10642|NCT03222908|Perioperative/Postoperative Complications|perioperative/postoperative complications
10643|NCT03222908|contract agreement|contract agreement
10644|NCT03222908|implementation intentions|implementation intentions
10645|NCT03222908|precommitment|precommitment
10646|NCT03222908|smoking cessation|smoking cessation
10647|NCT03222895|Esophageal Neoplasms|esophageal neoplasms
10648|NCT03222895|Lymph node metastases|lymph node metastases
10649|NCT03222895|Esophagectomy|esophagectomy
10650|NCT03222843|ITP|itp
10651|NCT03222804|Infants|infants
10652|NCT03222804|Probiotic|probiotic
10653|NCT03222804|B. Infantis|b. infantis
10654|NCT03222791|Diabetes|diabetes
10655|NCT03222778|fluid responsiveness|fluid responsiveness
10656|NCT03222778|tissue doppler|tissue doppler
10657|NCT03222778|off-pump coronary bypass surgery|off-pump coronary bypass surgery
10658|NCT03222765|prediabetes lifestyle drugs microvascular complications|prediabetes lifestyle drugs microvascular complications
10659|NCT03222752|Alpha-Stim|alpha-stim
10660|NCT03222752|Cranial Electrotherapy Stimulation|cranial electrotherapy stimulation
10661|NCT03222752|CES|ces
10662|NCT03222726|exercise, diabetic kidney disease, complications|exercise, diabetic kidney disease, complications
402894|NCT01229267|autologous hematopoietic cell transplants|autologous hematopoietic cell transplants
758936|NCT02154425|CZP|czp
10663|NCT03222687|tacrolimus, Henoch-Schönlein purpura nephritis, children|tacrolimus, henoch-schönlein purpura nephritis, children
10664|NCT03222674|AML|aml
10665|NCT03222674|CAR T|car t
10666|NCT03222674|Muc1, CD33, CD38, CD56, CD117 or CD123|muc1, cd33, cd38, cd56, cd117 or cd123
10667|NCT03222648|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
10668|NCT03222648|Exercise training|exercise training
10669|NCT03222648|Health related quality of life|health related quality of life
10670|NCT03222648|Biomarkers|biomarkers
10671|NCT03222635|Barrett's esophagus|barrett's esophagus
10672|NCT03222635|Submucosal esophageal adenocarcinoma|submucosal esophageal adenocarcinoma
10673|NCT03222635|Endoscopic treatment|endoscopic treatment
10674|NCT03222635|Endoscopic follow-up|endoscopic follow-up
200972|NCT02112747|Colorectal Cancer Screening|colorectal cancer screening
10675|NCT03222622|EGFR inhibitor, topical agent, psoriasis, phase 2|egfr inhibitor, topical agent, psoriasis, phase 2
10676|NCT03222609|navitoclax|navitoclax
10677|NCT03222609|splenomegaly|splenomegaly
10678|NCT03222609|bone marrow fibrosis|bone marrow fibrosis
10679|NCT03222609|ruxolitinib|ruxolitinib
10680|NCT03222609|ABT 263|abt 263
10681|NCT03222609|Post-essential thrombocythemia (PET-MF)|post-essential thrombocythemia (pet-mf)
10682|NCT03222609|enlarged spleen|enlarged spleen
10683|NCT03222609|splenic volume|splenic volume
10684|NCT03222609|Post-polycythemia vera MF (PPV-MF)|post-polycythemia vera mf (ppv-mf)
10685|NCT03222609|Jakafi|jakafi
10686|NCT03222609|Primary Myelofibrosis|primary myelofibrosis
10688|NCT03222596|Fatigue|fatigue
10689|NCT03222596|Physical Disability|physical disability
10690|NCT03222596|Disabilities Psychological|disabilities psychological
10691|NCT03222596|Pain|pain
10692|NCT03222596|Motivation|motivation
10693|NCT03222596|Multiple sclerosis|multiple sclerosis
10694|NCT03222583|Treatment-naïve|treatment-naïve
10695|NCT03222583|co-infection|co-infection
10696|NCT03222583|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
10697|NCT03222583|non-cirrhotic|non-cirrhotic
10698|NCT03222583|Asian|asian
10699|NCT03222583|Human Immunodeficiency Virus|human immunodeficiency virus
10700|NCT03222583|Genotype 1 to 6|genotype 1 to 6
10701|NCT03222583|interferon|interferon
10702|NCT03222583|Treatment-experienced|treatment-experienced
10703|NCT03222544|Indocyanine Green|indocyanine green
10704|NCT03222544|Photodynamics Therapy|photodynamics therapy
10705|NCT03222518|acute pain, trauma, paracetamol, NSAID|acute pain, trauma, paracetamol, nsaid
10706|NCT03222505|Stroke|stroke
10707|NCT03222505|Gait Stride Management Assist|gait stride management assist
10708|NCT03222505|Stroke, post 1 year or longer|stroke, post 1 year or longer
10709|NCT03222492|Diffuse Cutaneous Systemic Sclerosis (dcSSc)|diffuse cutaneous systemic sclerosis (dcssc)
10710|NCT03222492|Phase 1/2 clinical trial|phase 1/2 clinical trial
10711|NCT03222492|dose escalation randomized trial|dose escalation randomized trial
10712|NCT03222492|Brentuximab vedotin|brentuximab vedotin
10713|NCT03222466|Patient educational materials; prostate cancer; co-creation|patient educational materials; prostate cancer; co-creation
10714|NCT03222453|thalassemia|thalassemia
10715|NCT03222453|stem cell|stem cell
10716|NCT03222388|IIEF|iief
10717|NCT03222388|electronic validation|electronic validation
10718|NCT03222375|Yaroshuk's MEGA-DISCOVERY · DIAGNOSTICS · TREATMENT|yaroshuk's mega-discovery · diagnostics · treatment
10719|NCT03222375|Yaroshuk's Scientific Medical School|yaroshuk's scientific medical school
10720|NCT03222375|Center of Synergetics|center of synergetics
10721|NCT03222375|Controlling spatiotemporal chaos/Dr. Synergetic|controlling spatiotemporal chaos/dr. synergetic
10722|NCT03222375|Autowave processes in Medicine|autowave processes in medicine
609020|NCT00610246|Radiation|radiation
10723|NCT03222375|Autowave Reverberator|autowave reverberator
10724|NCT03222375|Bifurcation of Dynamic systems on a plane|bifurcation of dynamic systems on a plane
10725|NCT03222375|Spiral Autowaves|spiral autowaves
10726|NCT03222375|Drift of Spiral Autowaves|drift of spiral autowaves
10727|NCT03222375|Excitable medium and Cellular Automata|excitable medium and cellular automata
10728|NCT03222375|Stochastic Resonance and Coherence Resonance|stochastic resonance and coherence resonance
10729|NCT03222375|Autowaves/SQUED|autowaves/squed
10730|NCT03222375|Theory of Semiconducting QUantum Excitonic Device|theory of semiconducting quantum excitonic device
10731|NCT03222362|retinal detachment|retinal detachment
10732|NCT03222362|trauma|trauma
10733|NCT03222362|age related macular degeneration|age related macular degeneration
10734|NCT03222349|interictal state|interictal state
10735|NCT03222349|ictal/peri-ictal state|ictal/peri-ictal state
10736|NCT03222323|volunteers|volunteers
10737|NCT03222284|diabetes|diabetes
10738|NCT03222284|type 2 diabetes|type 2 diabetes
10739|NCT03222284|type ii diabetes|type ii diabetes
10740|NCT03222284|insulin|insulin
10741|NCT03222284|mobile applications|mobile applications
10742|NCT03222284|Diabetes Mellitus|diabetes mellitus
10743|NCT03222284|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
10744|NCT03222284|smartphone application|smartphone application
10745|NCT03222284|health application|health application
759069|NCT02018926|Vidaza|vidaza
10746|NCT03222271|NIV weaning strategy|niv weaning strategy
10747|NCT03222258|Palliative Care|palliative care
10748|NCT03222258|Quality of Life|quality of life
10749|NCT03222258|Prospective Cohort Study|prospective cohort study
10750|NCT03222258|Treatment decision|treatment decision
10751|NCT03222258|Utilization of health care|utilization of health care
10752|NCT03222232|intestinal failure|intestinal failure
10753|NCT03222232|catheter-related bloodstream infections|catheter-related bloodstream infections
10754|NCT03222232|catheter salvage|catheter salvage
10755|NCT03222232|recurrent infections|recurrent infections
10756|NCT03222232|home parenteral support|home parenteral support
10757|NCT03222219|dental implant insertional torque stability|dental implant insertional torque stability
10758|NCT03222206|Hepatokine|hepatokine
10759|NCT03222206|Adipokine|adipokine
10760|NCT03222206|Saccharometabolism|saccharometabolism
11266|NCT03218943|ARDS|ards
10761|NCT03222206|Lipid metabolism|lipid metabolism
10762|NCT03222193|Medical device|medical device
10763|NCT03222193|Retraining|retraining
10764|NCT03222193|Snoring|snoring
10765|NCT03222193|TRP|trp
10766|NCT03222193|Tongue|tongue
10767|NCT03222167|Elbasvir|elbasvir
10768|NCT03222167|Grazoprevir|grazoprevir
10769|NCT03222167|SVR12|svr12
10770|NCT03222167|hepatitis C|hepatitis c
10771|NCT03222167|metabolic syndrome|metabolic syndrome
10772|NCT03222154|High Energy Shock Waves|high energy shock waves
10773|NCT03222154|physiotherapy|physiotherapy
10774|NCT03222141|Sapien 3|sapien 3
10775|NCT03222141|Transfemoral|transfemoral
10776|NCT03222141|Transapical|transapical
10777|NCT03222141|Transaortic|transaortic
10778|NCT03222141|TAVI|tavi
10779|NCT03222141|Aortic Stenosis|aortic stenosis
10780|NCT03222141|THV|thv
10781|NCT03222141|Aortic Valve|aortic valve
10782|NCT03222141|Transcatheter Heart Valve|transcatheter heart valve
10783|NCT03222141|TAVR|tavr
10784|NCT03222128|SAPIEN 3|sapien 3
10785|NCT03222128|Transfemoral|transfemoral
10786|NCT03222128|Transapical|transapical
10787|NCT03222128|Transaortic|transaortic
10788|NCT03222128|NovaFlex|novaflex
10789|NCT03222128|TAVI|tavi
10790|NCT03222128|Aortic Stenosis|aortic stenosis
10791|NCT03222128|THV|thv
10792|NCT03222128|Aortic Valve|aortic valve
10793|NCT03222128|Transcatheter Heart Valve|transcatheter heart valve
10794|NCT03222128|TAVR|tavr
10795|NCT03222076|Hepatocellular carcinoma|hepatocellular carcinoma
10796|NCT03222076|Resectable|resectable
10797|NCT03222076|Potentially resectable|potentially resectable
10798|NCT03222076|Nivolumab|nivolumab
10799|NCT03222076|BMS-936558|bms-936558
10800|NCT03222076|Opdivo|opdivo
10801|NCT03222076|Ipilimumab|ipilimumab
10802|NCT03222076|Yervoy|yervoy
10803|NCT03222076|BMS-734016|bms-734016
10804|NCT03222076|MDX010|mdx010
10805|NCT03222063|Play interventions, anxiety|play interventions, anxiety
10806|NCT03222024|ischaemic stroke|ischaemic stroke
10807|NCT03222024|severe|severe
10808|NCT03222024|malignant|malignant
10809|NCT03222024|courses|courses
10810|NCT03222024|risk factors|risk factors
10811|NCT03222024|clinical course|clinical course
10812|NCT03222024|management|management
10813|NCT03222024|prognosis|prognosis
10814|NCT03222011|Crohn Disease|crohn disease
10815|NCT03222011|Inflammatory Bowel Disease|inflammatory bowel disease
10816|NCT03222011|Intestinal stricture|intestinal stricture
10817|NCT03221998|morbidly obese|morbidly obese
10818|NCT03221998|,elective sleeve|,elective sleeve
10819|NCT03221998|gastrectomy|gastrectomy
10820|NCT03221998|paracetamol|paracetamol
10821|NCT03221998|IV Perfelgan|iv perfelgan
10822|NCT03221985|experience sampling method|experience sampling method
10823|NCT03221972|25 hydroxyvitamin D|25 hydroxyvitamin d
10824|NCT03221972|6-17 years old|6-17 years old
10825|NCT03221972|vitamin D deficiency|vitamin d deficiency
10826|NCT03221959|malignant middle cerebral artery infarction|malignant middle cerebral artery infarction
10827|NCT03221920|Very Low Carbohydrate Diet|very low carbohydrate diet
10828|NCT03221920|Colorectal Adenocarcinoma|colorectal adenocarcinoma
10829|NCT03221894|Complementary therapies|complementary therapies
10830|NCT03221868|motor activity|motor activity
10832|NCT03221842|Antibody-mediated kidney transplant rejection|antibody-mediated kidney transplant rejection
10833|NCT03221842|Renal|renal
10834|NCT03221829|spinal anaesthesia|spinal anaesthesia
10835|NCT03221829|elderly patients|elderly patients
10836|NCT03221829|transurethral resection of bladder tumour|transurethral resection of bladder tumour
10837|NCT03221816|Menopause|menopause
10838|NCT03221816|homocysteine|homocysteine
10839|NCT03221816|lipid profile|lipid profile
10840|NCT03221790|Irritable bowel syndrome|irritable bowel syndrome
10841|NCT03221790|Low FODMAP diet|low fodmap diet
10842|NCT03221790|Mucosal Inflammation|mucosal inflammation
10843|NCT03221751|randomized controlled trial|randomized controlled trial
10844|NCT03221738|BDD|bdd
10845|NCT03221725|sacrospinous ligament fixation|sacrospinous ligament fixation
10846|NCT03221725|stress urinary incontinence|stress urinary incontinence
10847|NCT03221712|cardiopulmonary exercise test|cardiopulmonary exercise test
10848|NCT03221712|chronic total occlusion|chronic total occlusion
10849|NCT03221712|cardiac rehabilitation|cardiac rehabilitation
10850|NCT03221673|Exercise|exercise
10851|NCT03221673|Children|children
10852|NCT03221673|Arkansas|arkansas
10853|NCT03221673|Physical activity|physical activity
10854|NCT03221673|Sedentary|sedentary
10855|NCT03221660|filling material, polymerization|filling material, polymerization
10856|NCT03221647|Celiac Disease; P31-43; Loxorubine; TLR7.|celiac disease; p31-43; loxorubine; tlr7.
10857|NCT03221634|Programmed cell death 1 receptor (PD1)|programmed cell death 1 receptor (pd1)
10858|NCT03221634|PD-1|pd-1
10859|NCT03221634|Programmed cell death ligand 1 receptor (PDL1)|programmed cell death ligand 1 receptor (pdl1)
10860|NCT03221634|PD-L1|pd-l1
10861|NCT03221621|Acne inversa|acne inversa
10862|NCT03221621|Adalimumab|adalimumab
11462|NCT03217747|MSBOO10718C|msboo10718c
200973|NCT02112747|ACCS|accs
10865|NCT03221608|HIPEC|hipec
10866|NCT03221608|Peritoneal Carcinomatosis|peritoneal carcinomatosis
10867|NCT03221608|Lobaplatin|lobaplatin
10868|NCT03221556|Comparative effectiveness research|comparative effectiveness research
10869|NCT03221556|Patient-centered medical home|patient-centered medical home
10870|NCT03221556|Shared decision-making|shared decision-making
10871|NCT03221530|suicidal ideation|suicidal ideation
10872|NCT03221530|mental health|mental health
10873|NCT03221530|adolescent|adolescent
10874|NCT03221530|Latino|latino
10875|NCT03221530|immigrant|immigrant
10876|NCT03221504|urinary tract infections|urinary tract infections
10877|NCT03221504|pyelonephritis|pyelonephritis
10878|NCT03221504|cefuroxime|cefuroxime
10879|NCT03221504|children|children
10880|NCT03221491|Analgesia|analgesia
10881|NCT03221491|Colorectal Surgery|colorectal surgery
10882|NCT03221491|Background Infusion|background infusion
10883|NCT03221439|back pain|back pain
10884|NCT03221439|physiotherapy|physiotherapy
10885|NCT03221439|exercise therapy|exercise therapy
10886|NCT03221439|cognitive functional therapy|cognitive functional therapy
10887|NCT03221439|low back pain|low back pain
10888|NCT03221439|backache|backache
10889|NCT03221439|lower back pain|lower back pain
10890|NCT03221439|lumbago|lumbago
10891|NCT03221439|multidimensional|multidimensional
10892|NCT03221439|biopsychosocial|biopsychosocial
10893|NCT03221426|PD1|pd1
10894|NCT03221426|PD-1|pd-1
10895|NCT03221426|PDL1|pdl1
10896|NCT03221426|PD-L1|pd-l1
10897|NCT03221413|transcranial alternating current stimulation|transcranial alternating current stimulation
10898|NCT03221413|Neuroimaging|neuroimaging
10899|NCT03221413|EEG|eeg
10900|NCT03221387|Therapy|therapy
10901|NCT03221387|Noninvasive Ventilation|noninvasive ventilation
10902|NCT03221335|EUS-guided RFA|eus-guided rfa
10903|NCT03221335|liver|liver
10904|NCT03221335|stomach|stomach
10905|NCT03221335|adrenal|adrenal
10906|NCT03221335|kidney tumour|kidney tumour
10907|NCT03221283|Music therapy|music therapy
10908|NCT03221283|Depression|depression
10909|NCT03221283|Emotion|emotion
10910|NCT03221283|Motivation|motivation
10911|NCT03221270|tACS|tacs
10912|NCT03221270|Sham|sham
10913|NCT03221270|Auditory Hallucinations|auditory hallucinations
10914|NCT03221270|Schizophrenia|schizophrenia
10915|NCT03221270|Schizo Affective Disorder|schizo affective disorder
10916|NCT03221270|EEG|eeg
10917|NCT03221244|Distractibility|distractibility
10918|NCT03221244|Virtual Reality|virtual reality
10919|NCT03221244|Attention|attention
10920|NCT03221244|Child|child
10935|NCT03221166|Thalidomide|thalidomide
10936|NCT03221166|Mucosal healing|mucosal healing
10937|NCT03221153|Patient Safety|patient safety
10938|NCT03221153|Quality|quality
10939|NCT03221153|Simulation|simulation
10940|NCT03221153|Undergraduate|undergraduate
10941|NCT03221153|Medical Student|medical student
10942|NCT03221114|Hispanics/Latinos|hispanics/latinos
10943|NCT03221114|Underserved Population|underserved population
10944|NCT03221075|Invasive Aspergillosis|invasive aspergillosis
10945|NCT03221075|Azole resistance|azole resistance
10946|NCT03221075|Aspergillus fumigatus|aspergillus fumigatus
10947|NCT03221075|Efficacy of antifungal therapy|efficacy of antifungal therapy
10948|NCT03221075|Patient registry|patient registry
10949|NCT03221049|diagnosis performance|diagnosis performance
10950|NCT03221049|hepatocellular carcinoma|hepatocellular carcinoma
10951|NCT03221049|liver fibrosis|liver fibrosis
10952|NCT03221049|progression|progression
10953|NCT03221036|Drug therapy|drug therapy
10954|NCT03221023|Vancomycin|vancomycin
10955|NCT03221023|Implantable Neural Stimulator|implantable neural stimulator
10956|NCT03221023|Deep Brain Stimulation|deep brain stimulation
10957|NCT03221023|Surgical Site Infection|surgical site infection
10958|NCT03221010|Smoking|smoking
10959|NCT03221010|Smoking cessation|smoking cessation
402895|NCT01229254|Betrixaban|betrixaban
10960|NCT03221010|Motivational Interviewing|motivational interviewing
10961|NCT03221010|Primary health care|primary health care
10962|NCT03221010|Randomized clinical trial|randomized clinical trial
10963|NCT03220997|Sequela|sequela
10964|NCT03220997|Ketosis|ketosis
10965|NCT03220971|Lipoprotein and Apolipoproteins metabolism|lipoprotein and apolipoproteins metabolism
11069|NCT03219931|gut microbiome|gut microbiome
11463|NCT03217747|Utomilumab|utomilumab
10966|NCT03220932|Epithelial Ovarian Cancer - Platinum-resistant - Cytoreductive surgery - HIPEC - Quality of Life|epithelial ovarian cancer - platinum-resistant - cytoreductive surgery - hipec - quality of life
10967|NCT03220919|Insulin|insulin
10968|NCT03220919|Type 2 diabetes|type 2 diabetes
10969|NCT03220880|Dexmedetomidine|dexmedetomidine
10970|NCT03220880|Sedation|sedation
10971|NCT03220880|Pediatric|pediatric
10972|NCT03220841|Crohn Disease|crohn disease
10973|NCT03220841|Inflammatory Bowel Disease|inflammatory bowel disease
10974|NCT03220841|Intestinal stricture|intestinal stricture
10975|NCT03220698|endotracheal intubation|endotracheal intubation
10976|NCT03220698|confirmation|confirmation
10977|NCT03220698|ultrasonography|ultrasonography
10978|NCT03220685|Microbiota|microbiota
10979|NCT03220672|Pelvic floor muscles|pelvic floor muscles
10980|NCT03220672|pelvic floor muscle training|pelvic floor muscle training
10981|NCT03220672|motor control|motor control
10982|NCT03220672|Educational intervention|educational intervention
10983|NCT03220672|menopause|menopause
10984|NCT03220646|Abemaciclib (LY2835219)|abemaciclib (ly2835219)
10985|NCT03220646|17-261|17-261
10986|NCT03220620|fluid therapy|fluid therapy
10987|NCT03220620|perioperative|perioperative
10988|NCT03220620|hemodilution|hemodilution
10989|NCT03220607|uterocervical angle, second trimester abortion|uterocervical angle, second trimester abortion
10990|NCT03220594|hypogastric artery|hypogastric artery
10991|NCT03220594|anti-mullerian hormone|anti-mullerian hormone
10992|NCT03220594|ovarian reserve|ovarian reserve
10993|NCT03220594|postpartum|postpartum
10994|NCT03220555|Buzzy|buzzy
10995|NCT03220555|anesthetic cream|anesthetic cream
10996|NCT03220555|pediatric|pediatric
10997|NCT03220555|pain|pain
10998|NCT03220555|venipuncture|venipuncture
10999|NCT03220555|vaccination|vaccination
11000|NCT03220555|vibration|vibration
11001|NCT03220555|cold|cold
11002|NCT03220555|distraction|distraction
11003|NCT03220555|vaccination center|vaccination center
11004|NCT03220542|Helicobacter Pylori|helicobacter pylori
11005|NCT03220542|Probiotics|probiotics
11006|NCT03220542|Sulforaphane|sulforaphane
11007|NCT03220477|Pembrolizumab|pembrolizumab
11008|NCT03220477|guadecitabine|guadecitabine
11009|NCT03220477|mocetinostat|mocetinostat
11010|NCT03220477|17-241|17-241
11011|NCT03220451|pressure ulcer|pressure ulcer
11012|NCT03220451|pressure sore|pressure sore
11013|NCT03220451|decubitus ulcer|decubitus ulcer
11014|NCT03220451|spinal cord injury|spinal cord injury
11015|NCT03220451|adhesive elastic bandage|adhesive elastic bandage
11016|NCT03220451|taping|taping
11017|NCT03220451|kinesio taping|kinesio taping
11018|NCT03220451|neuro taping|neuro taping
11019|NCT03220412|adolescent|adolescent
11020|NCT03220412|gun|gun
11021|NCT03220412|violence|violence
11022|NCT03220412|media|media
11023|NCT03220386|staphylococcus aureus|staphylococcus aureus
11024|NCT03220386|nosocomial infection|nosocomial infection
11025|NCT03220386|decolonization|decolonization
11026|NCT03220386|emergency department|emergency department
11027|NCT03220373|Neuropsychology|neuropsychology
11028|NCT03220373|Cognition|cognition
11029|NCT03220373|Drop-out|drop-out
11030|NCT03220373|Follow-up|follow-up
11031|NCT03220347|Non-Hodgkin's Lymphomas|non-hodgkin's lymphomas
11032|NCT03220347|Safety|safety
11033|NCT03220347|Efficacy|efficacy
11034|NCT03220347|CC-90010|cc-90010
11035|NCT03220347|Solid Tumors|solid tumors
11036|NCT03220347|Relapsed/Refractory|relapsed/refractory
11037|NCT03220308|Self-control|self-control
11038|NCT03220308|Well-being|well-being
11039|NCT03220269|Utstein|utstein
11040|NCT03220269|Resuscitation|resuscitation
11041|NCT03220269|Epidemiology|epidemiology
11042|NCT03220269|Emergency medicine|emergency medicine
11043|NCT03220269|Resuscitation Registry|resuscitation registry
11044|NCT03220230|Next generation sequencing|next generation sequencing
11045|NCT03220230|Lung cancer|lung cancer
11046|NCT03220230|target therapies|target therapies
11047|NCT03220204|Heart Failure|heart failure
11048|NCT03220204|Positive Psychology|positive psychology
11049|NCT03220204|Adherence to Health Behaviors|adherence to health behaviors
11050|NCT03220178|breast cancer|breast cancer
11051|NCT03220178|HER2 negative|her2 negative
11052|NCT03220178|hormone receptor positive|hormone receptor positive
11053|NCT03220178|advanced|advanced
11054|NCT03220178|metastatic|metastatic
11055|NCT03220113|Migraine|migraine
11056|NCT03220113|Craniofacial Neuralgia|craniofacial neuralgia
11057|NCT03220100|Lung Cancer|lung cancer
402896|NCT01229254|MK-4448|mk-4448
11058|NCT03219983|interscalene block|interscalene block
11059|NCT03219983|liposomal bupivacaine|liposomal bupivacaine
11060|NCT03219957|HCV|hcv
11061|NCT03219957|Hepatitis C Virus|hepatitis c virus
11062|NCT03219957|RNA Viruses|rna viruses
11063|NCT03219957|Flavivirus|flavivirus
11064|NCT03219957|Liver Diseases|liver diseases
11065|NCT03219957|Hepatitis, Viral, Human|hepatitis, viral, human
11066|NCT03219957|Flaviviridae Infections|flaviviridae infections
11067|NCT03219931|infant colics|infant colics
11068|NCT03219931|probiotic|probiotic
11070|NCT03219931|bifidobacterium breve|bifidobacterium breve
11071|NCT03219931|crying time|crying time
11072|NCT03219918|Colorectal adenoma|colorectal adenoma
11073|NCT03219918|Colonoscopy|colonoscopy
11074|NCT03219918|Caps|caps
11075|NCT03219918|Adenoma detection rate|adenoma detection rate
11076|NCT03219892|freezing of gait|freezing of gait
11077|NCT03219892|rTMS|rtms
11078|NCT03219892|fMRI|fmri
11079|NCT03219879|Relapse prevention|relapse prevention
11080|NCT03219879|Persistent depressive disorder|persistent depressive disorder
11083|NCT03219879|Cognitive behavioral therapy|cognitive behavioral therapy
11084|NCT03219866|Nebulizer|nebulizer
11085|NCT03219866|Inhaler|inhaler
11086|NCT03219840|Cetylpyridium Chloride (CPC)|cetylpyridium chloride (cpc)
11087|NCT03219840|Chewing Gum|chewing gum
11088|NCT03219814|body-image|body-image
11089|NCT03219814|attention|attention
11090|NCT03219814|cognitive dissonance|cognitive dissonance
11091|NCT03219814|eating disorder prevention|eating disorder prevention
11092|NCT03219788|emergence|emergence
11093|NCT03219788|remifentanil|remifentanil
11094|NCT03219788|recovery|recovery
11095|NCT03219788|desflurene|desflurene
11096|NCT03219775|tailored immuno therapy|tailored immuno therapy
11097|NCT03219775|Nivolumab|nivolumab
11098|NCT03219775|Ipilimumab|ipilimumab
11099|NCT03219775|boost|boost
11100|NCT03219749|obstructive sleep apnea|obstructive sleep apnea
11101|NCT03219749|exercise training|exercise training
11102|NCT03219749|vascular function|vascular function
11103|NCT03219710|Chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
11104|NCT03219710|olanzapine|olanzapine
11105|NCT03219697|Childhood obesity prevention;|childhood obesity prevention;
11106|NCT03219658|Parenting|parenting
11107|NCT03219658|Home visiting|home visiting
11108|NCT03219658|Childhood obesity treatment|childhood obesity treatment
11109|NCT03219606|Systemic sclerosis|systemic sclerosis
11110|NCT03219606|Education|education
11111|NCT03219606|Modified Rodnan skin score|modified rodnan skin score
11112|NCT03219528|Irritable Bowel Syndrome|irritable bowel syndrome
11113|NCT03219528|Diarrhea|diarrhea
11114|NCT03219528|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
11115|NCT03219528|Gut Microbiota|gut microbiota
11116|NCT03219502|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
11117|NCT03219502|Colorectal Cancer|colorectal cancer
583396|NCT00511576|Gastric Cancer|gastric cancer
11118|NCT03219502|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
11119|NCT03219502|rTMS|rtms
11120|NCT03219502|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
11121|NCT03219502|CIPN|cipn
11122|NCT03219502|Electroencephalogram|electroencephalogram
11123|NCT03219502|EEG|eeg
11124|NCT03219502|Assessment Questionnaires|assessment questionnaires
11125|NCT03219502|Pain Questionnaires|pain questionnaires
11126|NCT03219502|Surveys|surveys
11127|NCT03219489|Electronic Medical Record|electronic medical record
11128|NCT03219489|Progesterone|progesterone
11129|NCT03219476|aromatase inhibitor|aromatase inhibitor
11130|NCT03219476|breast cancer|breast cancer
11131|NCT03219476|estrogen receptor|estrogen receptor
11132|NCT03219476|progesterone receptor|progesterone receptor
11133|NCT03219476|endocrine-targeted therapy|endocrine-targeted therapy
11134|NCT03219476|Anti-estrogen therapy|anti-estrogen therapy
11135|NCT03219476|HR+|hr+
11136|NCT03219476|HER2-negative|her2-negative
11137|NCT03219476|Neoadjuvant Treatment|neoadjuvant treatment
11138|NCT03219450|Leukemia|leukemia
11139|NCT03219450|Lymphocytic Leukemia|lymphocytic leukemia
11140|NCT03219437|ABBV-066|abbv-066
11141|NCT03219437|BI 655066|bi 655066
11142|NCT03219424|Return to work status|return to work status
11143|NCT03219424|Functional outcome|functional outcome
11144|NCT03219424|Quality of life|quality of life
11145|NCT03219398|Living donor laparoscopic nephrectomy|living donor laparoscopic nephrectomy
11146|NCT03219398|Pneumoperitoneum|pneumoperitoneum
11147|NCT03219398|Renal resistive index|renal resistive index
11148|NCT03219398|Syndecan-1|syndecan-1
11149|NCT03219398|soluble VEGF-R2|soluble vegf-r2
11150|NCT03219398|Occludin|occludin
11151|NCT03219398|KIM-1|kim-1
11152|NCT03219398|Interleukin-6|interleukin-6
11153|NCT03219385|uterine leiomyoma|uterine leiomyoma
11154|NCT03219385|uterine fibroid|uterine fibroid
11155|NCT03219385|uterine myoma|uterine myoma
11156|NCT03219385|abnormal menstrual bleeding|abnormal menstrual bleeding
759573|NCT01261728|ureterectomy|ureterectomy
759574|NCT01261728|10-208|10-208
759575|NCT01271998|antibiotic|antibiotic
759576|NCT01271998|healthy subjects|healthy subjects
759577|NCT01271998|pharmacokinetics|pharmacokinetics
759578|NCT01255826|Preterm|preterm
759579|NCT01255826|Neonates|neonates
759580|NCT01255826|Delivery room|delivery room
11157|NCT03219385|heavy menstrual bleeding|heavy menstrual bleeding
11158|NCT03219385|menorrhagia|menorrhagia
11159|NCT03219385|high-intensity focused ultrasound|high-intensity focused ultrasound
11160|NCT03219385|ultrasound imaging|ultrasound imaging
11161|NCT03219359|IBD|ibd
11162|NCT03219359|Inflammatory Bowel Diseases|inflammatory bowel diseases
11163|NCT03219359|Gastroenteritis|gastroenteritis
11164|NCT03219359|Crohn's disease|crohn's disease
11165|NCT03219359|Colitis|colitis
11166|NCT03219359|Vedolizumab|vedolizumab
11265|NCT03218943|volumetric capnography|volumetric capnography
11167|NCT03219346|stroke , swallowing function ,oral health quality of life|stroke , swallowing function ,oral health quality of life
11168|NCT03219333|Enfortumab vedotin|enfortumab vedotin
11169|NCT03219333|Metastatic Urothelial Cancer|metastatic urothelial cancer
11170|NCT03219333|ASG-22CE|asg-22ce
11171|NCT03219333|Locally Advanced Urothelial Cancer|locally advanced urothelial cancer
11172|NCT03219333|Antibody-Drug Conjugate|antibody-drug conjugate
11173|NCT03219333|Nectin-4|nectin-4
11174|NCT03219333|Antineoplastic Agents|antineoplastic agents
11175|NCT03219333|Drug Therapy|drug therapy
11176|NCT03219333|ASG-22ME|asg-22me
11177|NCT03219320|Type 2 Diabetes|type 2 diabetes
11178|NCT03219320|Neuropathic Pain|neuropathic pain
11179|NCT03219320|Peripheral Nervous System|peripheral nervous system
11180|NCT03219294|neuromuscular blockade|neuromuscular blockade
11181|NCT03219294|sugammadex|sugammadex
11182|NCT03219255|Post-marketing|post-marketing
11183|NCT03219255|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
11184|NCT03219255|Drug use investigation|drug use investigation
11185|NCT03219255|RELVAR 100 ELLIPTA|relvar 100 ellipta
11186|NCT03219242|Advanced ovarian cancer|advanced ovarian cancer
11187|NCT03219229|Fat-free mass|fat-free mass
11188|NCT03219229|Tanner stage 1|tanner stage 1
11189|NCT03219229|Pre-pubertal|pre-pubertal
11190|NCT03219216|Pibrentasvir|pibrentasvir
11191|NCT03219216|Cirrhosis|cirrhosis
11192|NCT03219216|Glecaprevir|glecaprevir
11193|NCT03219216|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
11194|NCT03219216|Genotype 1 - 6|genotype 1 - 6
11195|NCT03219216|Treatment naïve|treatment naïve
11196|NCT03219216|Compensated cirrhosis|compensated cirrhosis
11197|NCT03219216|Metavir System Fibrosis Score|metavir system fibrosis score
11198|NCT03219203|HBV vaccination|hbv vaccination
11199|NCT03219203|immunity|immunity
11200|NCT03219138|muscle function tests|muscle function tests
11201|NCT03219125|marrow adipose tissue|marrow adipose tissue
11202|NCT03219125|bone marrow adiposity|bone marrow adiposity
11203|NCT03219112|balance|balance
11204|NCT03219112|rehabilitation|rehabilitation
11205|NCT03219112|exergaming|exergaming
11206|NCT03219112|virtual reality|virtual reality
11207|NCT03219086|combined spinal epidural anesthesia|combined spinal epidural anesthesia
11208|NCT03219086|caesarian section|caesarian section
11209|NCT03219086|prilocaine|prilocaine
11210|NCT03219086|bupivacaine|bupivacaine
11211|NCT03219073|multiple sclerosis|multiple sclerosis
609510|NCT00620451|Celiac|celiac
11212|NCT03219073|neuropathic pain|neuropathic pain
11213|NCT03219073|[18F] FDG-PET CT|[18f] fdg-pet ct
11214|NCT03219073|tDCS|tdcs
11215|NCT03219073|transcranial direct current stimulation|transcranial direct current stimulation
11216|NCT03219060|Cognitive dissonance|cognitive dissonance
11217|NCT03219060|Motivational interviewing|motivational interviewing
11218|NCT03219060|Health Professional role|health professional role
11219|NCT03219060|Nurses|nurses
11220|NCT03219060|Health Promotion|health promotion
11221|NCT03219060|Lifestyle|lifestyle
11222|NCT03219060|Smoking cessation|smoking cessation
11223|NCT03219047|Mantle Cell Lymphoma|mantle cell lymphoma
11225|NCT03219047|Relapsed/refractory|relapsed/refractory
11226|NCT03219047|Xenograft|xenograft
11227|NCT03219047|PDX|pdx
11228|NCT03219047|Ibrutinib|ibrutinib
11229|NCT03219047|PCI-32765|pci-32765
11230|NCT03219047|Imbruvica|imbruvica
11231|NCT03219034|oral appliance|oral appliance
11232|NCT03219034|sleep quality|sleep quality
11233|NCT03219034|sleep apnea|sleep apnea
11234|NCT03219021|Cleft lip and Palate|cleft lip and palate
11235|NCT03219021|unilateral cleft lip and palate|unilateral cleft lip and palate
11236|NCT03219021|surgically repaired cleft lip and palate|surgically repaired cleft lip and palate
11237|NCT03219021|arch dimensions|arch dimensions
754207|NCT03268070|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
754208|NCT03268070|Neurophysiology|neurophysiology
754209|NCT03268070|Neuroscience|neuroscience
754210|NCT03268070|Stroke Rehabilitation|stroke rehabilitation
754211|NCT03267849|biomarker|biomarker
754215|NCT03267862|biomarker|biomarker
754216|NCT03267992|COPD|copd
754217|NCT03267992|Coils|coils
754218|NCT03267992|App|app
754221|NCT03269266|Scrub Typhus|scrub typhus
754222|NCT03269266|Positive Rapid Diagnostic Test|positive rapid diagnostic test
754223|NCT03269253|ALSPAC|alspac
754224|NCT03269253|longitudinal|longitudinal
754225|NCT03268148|neonates|neonates
754226|NCT03268148|pain|pain
754227|NCT03268148|low level laser|low level laser
754232|NCT03268161|anti-MAG neuropathy|anti-mag neuropathy
754233|NCT03268161|Waldenström disease|waldenström disease
754234|NCT03268161|Mutational analysis|mutational analysis
754235|NCT03267706|Primary care|primary care
754236|NCT03267706|Palliative care|palliative care
754243|NCT03268291|Adherence to therapy|adherence to therapy
754244|NCT03268291|Myocardial Infarction|myocardial infarction
754245|NCT03268291|Coronary Artery Disease|coronary artery disease
754246|NCT03268291|Communicational program|communicational program
754251|NCT03268421|juvenile fibromyalgia|juvenile fibromyalgia
754252|NCT03268421|pain in children|pain in children
754253|NCT03268421|musculoskeletal pain|musculoskeletal pain
754254|NCT03268421|cognitive behavioral therapy|cognitive behavioral therapy
754255|NCT03268421|coping skills training|coping skills training
754256|NCT03268421|neuromuscular exercise|neuromuscular exercise
754257|NCT03268421|graded aerobic exercise|graded aerobic exercise
754274|NCT03268785|Parathyroid glands|parathyroid glands
754275|NCT03268785|Needle puncture|needle puncture
754276|NCT03268785|Diff-quik staining|diff-quik staining
754277|NCT03268785|PTH test assay|pth test assay
754278|NCT03268785|Thyroid cancer|thyroid cancer
11238|NCT03219021|arch discrepancies|arch discrepancies
11239|NCT03219021|dental arch dimensions|dental arch dimensions
11240|NCT03219021|arch parameter|arch parameter
11241|NCT03219021|arch circumference|arch circumference
11242|NCT03219021|intercanine width|intercanine width
11243|NCT03219021|first deciduous molar width|first deciduous molar width
11244|NCT03219021|second deciduous molar width|second deciduous molar width
11245|NCT03219021|permanent first molar width|permanent first molar width
11246|NCT03219008|depressive disorder|depressive disorder
11247|NCT03219008|multi-dimensional diagnosis technique|multi-dimensional diagnosis technique
11248|NCT03219008|individualized therapy|individualized therapy
11249|NCT03219008|management technique|management technique
11250|NCT03219008|e-MBC|e-mbc
11251|NCT03219008|MBC|mbc
11252|NCT03218995|DMD|dmd
11253|NCT03218995|Duchenne|duchenne
11254|NCT03218995|Eteplirsen|eteplirsen
11255|NCT03218995|dystrophy|dystrophy
11256|NCT03218995|dystrophin|dystrophin
11257|NCT03218995|exon 51|exon 51
11258|NCT03218982|Caregiver|caregiver
11259|NCT03218982|Vietnamese|vietnamese
11260|NCT03218982|Alzheimer's Disease|alzheimer's disease
11261|NCT03218956|Protein requirement|protein requirement
11262|NCT03218943|BiPAP|bipap
754291|NCT03266471|Cytokines|cytokines
754292|NCT03266471|Pharmacogenetics|pharmacogenetics
754295|NCT03265769|Femoral approach|femoral approach
754296|NCT03265769|Radial approach|radial approach
754297|NCT03265769|Chronic total occlusion|chronic total occlusion
754298|NCT03267797|Recurrent Implantation Failure|recurrent implantation failure
754299|NCT03267797|Pregnancy Rate|pregnancy rate
754300|NCT03267797|Lymphocyte Therapy|lymphocyte therapy
754307|NCT03266952|stroke|stroke
754308|NCT03266952|race|race
754309|NCT03266952|diet|diet
754310|NCT03266952|diabetes|diabetes
754311|NCT03266952|ethnicity|ethnicity
754312|NCT03266952|myocardial infarction|myocardial infarction
754313|NCT03266809|Cardiac function|cardiac function
754314|NCT03266809|Cardio-toxicity|cardio-toxicity
754315|NCT03266250|inferior vena caca ultrasound|inferior vena caca ultrasound
754331|NCT03266627|adenovirus|adenovirus
754332|NCT03266627|primary immune deficiency disorder|primary immune deficiency disorder
754333|NCT03266627|cytotoxic t-lymphocytes|cytotoxic t-lymphocytes
754334|NCT03265353|Potassium|potassium
754335|NCT03265353|Sodium|sodium
754336|NCT03265353|Vascular function|vascular function
754337|NCT03268655|gingerol|gingerol
754338|NCT03268655|microbiome|microbiome
754339|NCT03268655|gut|gut
754340|NCT03268655|ginger|ginger
754342|NCT03267979|pain assessment|pain assessment
754343|NCT03267979|pupillary diameter|pupillary diameter
754344|NCT03267979|variation coefficient of pupillary diameter|variation coefficient of pupillary diameter
754345|NCT03267979|pain self assessment|pain self assessment
754346|NCT03267979|video-pupillometer|video-pupillometer
754347|NCT03267979|electrocardiogram|electrocardiogram
754348|NCT03267979|analgesic treatment|analgesic treatment
754349|NCT03268759|substance abuse|substance abuse
754352|NCT03265366|Ultrashort echo time magnetic resonance imaging|ultrashort echo time magnetic resonance imaging
754356|NCT03267823|Bleeding|bleeding
754357|NCT03267823|heart surgery|heart surgery
754358|NCT03267823|coagulation|coagulation
754359|NCT03267823|coagulopathy|coagulopathy
754360|NCT03267823|INR|inr
754361|NCT03267056|drug-coated balloon|drug-coated balloon
754362|NCT03266874|total hip arthroplasty|total hip arthroplasty
754381|NCT03268798|stroke|stroke
754382|NCT03268798|strength training|strength training
754383|NCT03268798|rehabilitation|rehabilitation
754384|NCT03268382|Ovarian Cancer|ovarian cancer
754385|NCT03268382|Ovarian Carcinoma|ovarian carcinoma
754387|NCT03268382|Recurrent Cancer|recurrent cancer
11263|NCT03218943|APRV|aprv
754388|NCT03268382|Resistant Cancer|resistant cancer
754396|NCT03264144|Social norms|social norms
754397|NCT03264144|Adolescent|adolescent
754398|NCT03264144|Smoking|smoking
754399|NCT03264144|Randomised controlled trial|randomised controlled trial
754400|NCT03266744|Metastatic Breast Cancer|metastatic breast cancer
754401|NCT03266744|Whole Body MRI|whole body mri
754402|NCT03266744|Computerised Tomography|computerised tomography
754403|NCT03266744|Bone scan|bone scan
754404|NCT03265405|pulmonary sarcoidosis|pulmonary sarcoidosis
754405|NCT03265405|corticosteroids|corticosteroids
754406|NCT03265405|glucocorticoids|glucocorticoids
754407|NCT03265405|relapse|relapse
754408|NCT03265405|interstitial lung disease|interstitial lung disease
754409|NCT03265405|diffuse parenchymal lung disease|diffuse parenchymal lung disease
754410|NCT03265405|immunosuppression|immunosuppression
754411|NCT03265405|mediastinal lymphadenopathy|mediastinal lymphadenopathy
754412|NCT03262766|Acute Intermittent Hypoxia|acute intermittent hypoxia
754413|NCT03262766|Upper Extremity Training|upper extremity training
754414|NCT03263156|sleep|sleep
754415|NCT03263156|ADHD|adhd
754416|NCT03263156|behavioural intervention|behavioural intervention
754417|NCT03263156|insomnia|insomnia
754418|NCT03267810|Neuropathic Pain|neuropathic pain
754419|NCT03267810|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
754431|NCT03265223|Ropivacaine|ropivacaine
754432|NCT03265223|local anesthesia|local anesthesia
754433|NCT03265223|intraincisional infiltration|intraincisional infiltration
754434|NCT03265223|intraperitoneal instillation|intraperitoneal instillation
754435|NCT03265223|post-laparoscopic cholecystectomy pain|post-laparoscopic cholecystectomy pain
754436|NCT03265223|shoulder pain|shoulder pain
754437|NCT03265223|rescue analgesia|rescue analgesia
754438|NCT03265223|triple blinding|triple blinding
754444|NCT03269201|parkinsonism|parkinsonism
754445|NCT03269201|ataxia|ataxia
754446|NCT03269201|tremor|tremor
754447|NCT03269201|dystonia|dystonia
754460|NCT03263780|Diagnostic imaging|diagnostic imaging
754461|NCT03263780|High-Intensity Focused Ultrasound|high-intensity focused ultrasound
754462|NCT03263780|HIFU|hifu
754463|NCT03263780|18F-Fluciclovine|18f-fluciclovine
754464|NCT03263780|high resolution diffusion-weighted imaging|high resolution diffusion-weighted imaging
754469|NCT03262688|INL-001|inl-001
754470|NCT03262688|Bupivacaine|bupivacaine
754471|NCT03262688|Collagen|collagen
11264|NCT03218943|Physiological dead space|physiological dead space
11267|NCT03218943|impaired oxygenation|impaired oxygenation
11268|NCT03218943|ICU|icu
11269|NCT03218943|Mechanical ventilation|mechanical ventilation
754483|NCT03260218|total joint replacement|total joint replacement
754484|NCT03260218|risk factors for delirium|risk factors for delirium
754485|NCT03260218|postoperative confusion|postoperative confusion
754508|NCT03267784|diabetic neuropathic ulcer|diabetic neuropathic ulcer
754509|NCT03267784|ABCB5|abcb5
754510|NCT03267784|allogeneic|allogeneic
754511|NCT03267784|mesenchymal stem cells|mesenchymal stem cells
754512|NCT03267784|skin ulcer|skin ulcer
754513|NCT03267784|advanced therapy medicinal product|advanced therapy medicinal product
754514|NCT03267784|somatic cell therapy|somatic cell therapy
754515|NCT03267784|phase I/IIa|phase i/iia
754516|NCT03267784|Diabetic Foot Ulcer|diabetic foot ulcer
754534|NCT03269136|Multiple Myeloma|multiple myeloma
754535|NCT03269136|relapse/ refractory multiple myeloma|relapse/ refractory multiple myeloma
754536|NCT03269136|bispecific antibody|bispecific antibody
754537|NCT03269136|bispecific|bispecific
754538|NCT03269136|BCMA|bcma
754539|NCT03269136|BCMA- CD3 bispecific|bcma- cd3 bispecific
754540|NCT03269136|Phase 1|phase 1
754541|NCT03269136|PF-06863135|pf-06863135
754544|NCT03269123|Sensory trick|sensory trick
754545|NCT03269123|Geste Antagoniste|geste antagoniste
754546|NCT03269227|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
754547|NCT03269227|Radiotherapy|radiotherapy
754548|NCT03269227|Tomotherapy|tomotherapy
754549|NCT03269227|Hypofractionation|hypofractionation
754550|NCT03268720|gluten sensitivity|gluten sensitivity
754551|NCT03268720|gluten-free diet|gluten-free diet
754552|NCT03268720|FODMAP diet|fodmap diet
754553|NCT03268720|microbiome|microbiome
754560|NCT03251495|Vaccination|vaccination
754561|NCT03251495|Contagious Diseases|contagious diseases
754562|NCT03251495|Tropical Medicine|tropical medicine
754563|NCT03251495|Infectious Diseases|infectious diseases
754564|NCT03254160|Stroke|stroke
754565|NCT03254160|Rehabilitation|rehabilitation
754566|NCT03254160|Ischemic|ischemic
754573|NCT03267966|periampullary cancer|periampullary cancer
754574|NCT03267966|margin status|margin status
754575|NCT03267966|R1 resection|r1 resection
754576|NCT03267966|clearance margin|clearance margin
11270|NCT03218930|General Practice|general practice
11271|NCT03218930|Social Marketing|social marketing
11272|NCT03218930|Behavior Change|behavior change
11273|NCT03218930|Antibiotic Prescribing|antibiotic prescribing
11274|NCT03218917|P aeruginosa|p aeruginosa
11275|NCT03218917|bronchiectasis|bronchiectasis
11276|NCT03218917|active neutrophil elastase|active neutrophil elastase
11277|NCT03218904|Glucose Breath Test|glucose breath test
11278|NCT03218891|Refractory Angina|refractory angina
11279|NCT03218891|Rehabilitation|rehabilitation
11280|NCT03218839|PrePex|prepex
11281|NCT03218839|HIV Seropositivity|hiv seropositivity
11282|NCT03218800|subcutaneous|subcutaneous
11283|NCT03218800|ertapenem|ertapenem
11284|NCT03218800|urinary tract infection|urinary tract infection
11285|NCT03218800|advanced cancer|advanced cancer
754583|NCT03250676|HER2|her2
754584|NCT03250676|estrogen receptor alpha|estrogen receptor alpha
754585|NCT03250676|H3B-6545|h3b-6545
754586|NCT03250676|breast cancer|breast cancer
754587|NCT03269110|neurological|neurological
754588|NCT03269110|autism|autism
754590|NCT03269110|behaviour|behaviour
754591|NCT03269110|folic acid|folic acid
754592|NCT03269110|pre-eclampsia|pre-eclampsia
754593|NCT03269110|asthma|asthma
754594|NCT03269110|executive function|executive function
754600|NCT03260205|SPD489|spd489
754601|NCT03260205|Lisdexamfetamine dimesylate|lisdexamfetamine dimesylate
754602|NCT03260205|ADHD|adhd
754603|NCT03260205|hyperactivity|hyperactivity
754604|NCT03260205|Neurobehavioral disorder|neurobehavioral disorder
754606|NCT03267745|protein|protein
754607|NCT03267745|skeletal muscle|skeletal muscle
754608|NCT03267745|immobilization|immobilization
754616|NCT03238326|Brexpiprazole|brexpiprazole
754617|NCT03238326|Schizophrenia|schizophrenia
754623|NCT03268863|pain tolerance|pain tolerance
754624|NCT03268863|perioperative pain|perioperative pain
754625|NCT03268863|virtual reality therapy|virtual reality therapy
754626|NCT03233633|pain management|pain management
754627|NCT03233633|terminally ill|terminally ill
754628|NCT03240003|Social Anxiety|social anxiety
754629|NCT03240003|Social Anxiety Disorder|social anxiety disorder
754630|NCT03240003|SAD|sad
754631|NCT03235492|diabetes|diabetes
754632|NCT03235492|salivary glycated albumin|salivary glycated albumin
754633|NCT03235492|HbA1c|hba1c
754635|NCT03231813|irritant contact dermatitis|irritant contact dermatitis
754636|NCT03231813|sodium lauryl sulphate|sodium lauryl sulphate
754637|NCT03231813|emollients|emollients
754638|NCT03231813|transepidermal water loss|transepidermal water loss
754673|NCT03228381|Functional Mitral Regurgitation|functional mitral regurgitation
754674|NCT03228381|Heart Failure|heart failure
754675|NCT03246464|Contact lenses|contact lenses
754676|NCT03246464|Children|children
754677|NCT03246464|Myopia|myopia
754678|NCT03214848|Long-acting reversible contraceptive|long-acting reversible contraceptive
11286|NCT03218800|palliative care|palliative care
11287|NCT03218787|Coronary Artery Lesions|coronary artery lesions
11288|NCT03218787|XIENCE|xience
11289|NCT03218787|Dual Antiplatelet Therapy (DAPT)|dual antiplatelet therapy (dapt)
11290|NCT03218787|Short term DAPT|short term dapt
11291|NCT03218787|High risk of bleeding|high risk of bleeding
11292|NCT03218787|DES|des
11293|NCT03218761|norepinephrine|norepinephrine
11294|NCT03218761|norepinephrine transporter|norepinephrine transporter
11295|NCT03218748|Mental illness|mental illness
11296|NCT03218748|Disclosure|disclosure
11297|NCT03218748|stigma|stigma
11298|NCT03218748|soldiers|soldiers
11299|NCT03218748|secrecy|secrecy
11300|NCT03218735|large for gestational age fetal growth|large for gestational age fetal growth
11301|NCT03218722|Acute traumatic coagulopathy, severe hemorrhage, hemostasis|acute traumatic coagulopathy, severe hemorrhage, hemostasis
11302|NCT03218696|cough|cough
754679|NCT03214848|Post Abortion|post abortion
754680|NCT03214848|Iintrauterine device|iintrauterine device
754681|NCT03214848|Contraceptive implant|contraceptive implant
754682|NCT03214848|LARC|larc
754683|NCT03214848|IUD|iud
754684|NCT03267589|immunotherapy|immunotherapy
754685|NCT03267589|ovarian cancer|ovarian cancer
754686|NCT03267589|durvalumab|durvalumab
754687|NCT03267589|tremelilumab|tremelilumab
754688|NCT03267589|MEDI 9447|medi 9447
754689|NCT03267589|MEDI 0562|medi 0562
754690|NCT03212352|miscarriage|miscarriage
754691|NCT03212352|mifepristone|mifepristone
754692|NCT03212352|misoprostol|misoprostol
754693|NCT03212352|medical treatment|medical treatment
754694|NCT03212352|patient satisfaction|patient satisfaction
754695|NCT03212352|abortifacient agents|abortifacient agents
754703|NCT03214224|Telemedicine|telemedicine
754704|NCT03214224|Pulmonary Function Testing|pulmonary function testing
754705|NCT03214224|Telehealth|telehealth
754732|NCT03210155|Cranial Electrotherapy Stimulation (CES)|cranial electrotherapy stimulation (ces)
754733|NCT03210155|Efficacy|efficacy
754734|NCT03210155|Post Partum|post partum
754735|NCT03210155|Anxiety|anxiety
754736|NCT03210155|Depression|depression
754737|NCT03210155|Insomnia|insomnia
754738|NCT03210155|Sleep Quality|sleep quality
754739|NCT03210155|Maternal Functioning|maternal functioning
754740|NCT03231930|Diagnosis|diagnosis
754741|NCT03231930|Point of Care Diagnostics|point of care diagnostics
754742|NCT03231930|Hepatitis|hepatitis
754743|NCT03200847|Pembrolizumab|pembrolizumab
754744|NCT03200847|All-Trans Retinoic Acid|all-trans retinoic acid
754749|NCT03198039|Meditation|meditation
754750|NCT03198039|Cognitive Dysfunction|cognitive dysfunction
754751|NCT03198039|Postoperative Period|postoperative period
754752|NCT03198039|Cardiac Surgery|cardiac surgery
754756|NCT03194789|FGBMM|fgbmm
754757|NCT03194789|LPSE|lpse
754758|NCT03194789|UDI - 6|udi - 6
754759|NCT03194789|UIQ - 7|uiq - 7
754772|NCT03192176|Menopause|menopause
754773|NCT03192176|Hot flashes|hot flashes
754774|NCT03192176|Perimenopause|perimenopause
754775|NCT03192176|Vasomotor symptoms|vasomotor symptoms
11303|NCT03218696|children|children
11304|NCT03218696|Acute Upper Respiratory Tract Infection|acute upper respiratory tract infection
11305|NCT03218683|relapsed|relapsed
11306|NCT03218683|refractory|refractory
11307|NCT03218683|AZD5991|azd5991
11308|NCT03218683|Non-Hodgkin lymphoma|non-hodgkin lymphoma
11309|NCT03218683|Richter syndrome|richter syndrome
11310|NCT03218683|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
11311|NCT03218683|Small lymphocytic lymphoma|small lymphocytic lymphoma
11312|NCT03218683|T-cell lymphoma, Multiple myeloma|t-cell lymphoma, multiple myeloma
11313|NCT03218657|Aplastic Anemia|aplastic anemia
11314|NCT03218657|levamisole hydrochloride|levamisole hydrochloride
754788|NCT03189719|PD1|pd1
754789|NCT03189719|PD-1|pd-1
754790|NCT03189719|PDL1|pdl1
754791|NCT03189719|PD-L1|pd-l1
754794|NCT03198559|HIV latency|hiv latency
754795|NCT03198559|Disulfiram|disulfiram
754796|NCT03198559|Vorinostat|vorinostat
754797|NCT03198559|Latency Reversing Agents|latency reversing agents
754798|NCT03198559|Histone Deacetylase Inhibitors (HDACi)|histone deacetylase inhibitors (hdaci)
754809|NCT03187353|Cognitive complaints|cognitive complaints
754810|NCT03187353|RRSO|rrso
754811|NCT03187353|Oophorectomy|oophorectomy
754812|NCT03187353|Memory|memory
754813|NCT03187353|Cognition|cognition
754814|NCT03187353|Early menopause|early menopause
754815|NCT03185013|Cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
754816|NCT03185013|Human papillomavirus (HPV)|human papillomavirus (hpv)
754817|NCT03185013|High grade squamous intraepithelial lesion (HSIL)|high grade squamous intraepithelial lesion (hsil)
754818|NCT03185013|CIN 2|cin 2
754819|NCT03185013|CIN 3|cin 3
754820|NCT03185013|papillomavirus|papillomavirus
754825|NCT03180684|High-grade squamous intraepithelial lesions (HSIL)|high-grade squamous intraepithelial lesions (hsil)
754826|NCT03180684|Human papillomavirus (HPV)|human papillomavirus (hpv)
754827|NCT03180684|HPV-16|hpv-16
754828|NCT03180684|HPV-18|hpv-18
754829|NCT03180684|Vulvar intraepithelial neoplasia (VIN)|vulvar intraepithelial neoplasia (vin)
754830|NCT03264781|Cyclofem®|cyclofem®
754831|NCT03264781|Implant|implant
754832|NCT03264781|Jadelle|jadelle
754833|NCT03264781|Implanon|implanon
754834|NCT03264781|irregular uterine bleeding|irregular uterine bleeding
754835|NCT03264781|randomized controlled trial|randomized controlled trial
754836|NCT03173924|Small Molecule|small molecule
754837|NCT03173924|Radiolabeled|radiolabeled
754838|NCT03173924|PSA|psa
754839|NCT03173924|Diagnostic|diagnostic
754840|NCT03173924|PMSA|pmsa
754841|NCT03264430|Perianal fistula|perianal fistula
754842|NCT03264430|Hemorrhoids|hemorrhoids
11315|NCT03218657|clinical study|clinical study
11316|NCT03218644|Proprioception|proprioception
11317|NCT03218631|oxandrolone, cardiac|oxandrolone, cardiac
11318|NCT03218605|Achilles tendon|achilles tendon
11319|NCT03218605|Warming-up|warming-up
11320|NCT03218605|Vascularisation|vascularisation
11321|NCT03218605|Physical activity|physical activity
11322|NCT03218605|Oxygen-to-See (O2C)|oxygen-to-see (o2c)
11323|NCT03218592|Adherence|adherence
11324|NCT03218592|Hair|hair
11325|NCT03218579|microbiome|microbiome
11326|NCT03218579|intestinal bacteria|intestinal bacteria
11327|NCT03218566|pulmonary embolism|pulmonary embolism
11328|NCT03218566|clot|clot
11329|NCT03218540|stroke volume variation|stroke volume variation
11330|NCT03218540|central venous pressure|central venous pressure
11331|NCT03218540|serum lactate|serum lactate
11332|NCT03218540|serum creatinine|serum creatinine
11333|NCT03218514|Obesity|obesity
11334|NCT03218514|Venous thromboembolism|venous thromboembolism
11335|NCT03218514|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
11336|NCT03218514|Body Composition|body composition
754883|NCT03179540|Non-operative Management|non-operative management
754885|NCT03142334|PD1|pd1
754886|NCT03142334|PD-1|pd-1
754887|NCT03142334|PDL1|pdl1
754888|NCT03142334|PD-L1|pd-l1
754889|NCT03142334|Adjuvant|adjuvant
754893|NCT03267030|Hypersensitivity to PEG-asparaginase|hypersensitivity to peg-asparaginase
754894|NCT03138395|acute myeloid leukemia|acute myeloid leukemia
754895|NCT03138395|myelodysplastic syndrome|myelodysplastic syndrome
754896|NCT03138395|relapse|relapse
754897|NCT03138395|PCR|pcr
754898|NCT03138395|droplet digital|droplet digital
754899|NCT03138395|polymerase chain reaction|polymerase chain reaction
754900|NCT03131791|Extracorporeal Shock Wave|extracorporeal shock wave
754901|NCT03131791|Spasticity in stokes|spasticity in stokes
754902|NCT03131791|Botulinum toxin|botulinum toxin
754903|NCT03134053|hypertrophy scar|hypertrophy scar
754904|NCT03134053|burn|burn
754905|NCT03131050|Scopolamine|scopolamine
754906|NCT03126942|Aged patients|aged patients
754907|NCT03126942|Cost Estimates|cost estimates
754908|NCT03126942|Complete Denture|complete denture
754909|NCT03126942|Dental Economics|dental economics
754910|NCT03126942|Dental Implants|dental implants
754911|NCT03126942|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
754912|NCT03126942|Denture Retention|denture retention
754913|NCT03126942|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
754914|NCT03126942|Oral Health-Related Quality of Life|oral health-related quality of life
754915|NCT03126942|Overdenture|overdenture
754916|NCT03126942|Patient Acceptance of Health Care|patient acceptance of health care
754917|NCT03126942|Quality of Healthcare|quality of healthcare
754918|NCT03126942|Quality of Life|quality of life
754919|NCT03126942|Patient Satisfaction|patient satisfaction
754920|NCT03126942|Single implant overdenture|single implant overdenture
754924|NCT03116828|epilepsy|epilepsy
754925|NCT03116828|seizures|seizures
754926|NCT03116828|partial on-set seizures|partial on-set seizures
754934|NCT03112226|cognitive impairment|cognitive impairment
754935|NCT03112226|menopause|menopause
11337|NCT03218514|Glomerular filtration rate|glomerular filtration rate
11338|NCT03218514|Bariatric Surgery|bariatric surgery
11339|NCT03218501|Uremic Pruritus|uremic pruritus
11340|NCT03218462|sensory adapted environment|sensory adapted environment
11341|NCT03218462|pediatric dentistry|pediatric dentistry
11342|NCT03218462|oral health|oral health
11343|NCT03218462|Developmental Disability|developmental disability
11344|NCT03218462|Intellectual Disability|intellectual disability
11345|NCT03218462|dental anxiety|dental anxiety
11346|NCT03218462|autism spectrum|autism spectrum
11347|NCT03218423|screening|screening
11348|NCT03218423|plasma|plasma
11349|NCT03218423|DNA methylation|dna methylation
11350|NCT03218410|surgical embolectomy|surgical embolectomy
11351|NCT03218410|catheter-directed therapy|catheter-directed therapy
11352|NCT03218397|Gram-negative Bacteremia|gram-negative bacteremia
11354|NCT03218397|Critically ill|critically ill
11369|NCT03218345|EUS-guided RFA|eus-guided rfa
754976|NCT03106987|polymerisation inhibitor (PARPi)|polymerisation inhibitor (parpi)
754977|NCT03106987|PARPi re-treatment|parpi re-treatment
754978|NCT03106987|BRCA1/2 (+ve)|brca1/2 (+ve)
754979|NCT03106987|BRCA1/2 (-ve)|brca1/2 (-ve)
754980|NCT03106987|Olaparib|olaparib
754981|NCT03106987|ovarian cancer|ovarian cancer
754982|NCT03106987|progression free survival (PFS)|progression free survival (pfs)
754986|NCT03102437|Cardiac Contractility Modulation|cardiac contractility modulation
754987|NCT03102437|CCM|ccm
754988|NCT03096431|whole-brain radiation therapy|whole-brain radiation therapy
754989|NCT03096431|sterotactic radiosurgery|sterotactic radiosurgery
754990|NCT03096431|cognitive rehabilitation|cognitive rehabilitation
754991|NCT03096431|physical activity|physical activity
754992|NCT03098030|Dinutuximab|dinutuximab
754993|NCT03098030|Irinotecan|irinotecan
754994|NCT03098030|Topotecan|topotecan
755008|NCT03090997|resveratrol, vitamin C, antioxidant therapy, antioxidant capacity|resveratrol, vitamin c, antioxidant therapy, antioxidant capacity
755009|NCT03087058|Treatment of Hyperkalemia|treatment of hyperkalemia
755010|NCT03087058|Hyperkalemia|hyperkalemia
755011|NCT03087058|Potassium|potassium
755012|NCT03087058|Chronic Kidney Disease|chronic kidney disease
755013|NCT03096938|cell-free DNA|cell-free dna
755014|NCT03096938|methylation|methylation
755015|NCT03096938|markers|markers
755016|NCT03096938|cancer|cancer
755017|NCT03096938|screening|screening
755044|NCT03065959|CK-2127107|ck-2127107
755045|NCT03065959|Mobility Limitation|mobility limitation
755046|NCT03065959|Phase 1b|phase 1b
755047|NCT03065959|skeletal muscle fatigue|skeletal muscle fatigue
755048|NCT03066778|Extensive stage small cell lung cancer (ES-SCLC)|extensive stage small cell lung cancer (es-sclc)
755049|NCT03066778|Programmed cell death protein-1 (PD-1)|programmed cell death protein-1 (pd-1)
755050|NCT03066778|Programmed cell death-ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
755051|NCT03066778|PD1|pd1
755052|NCT03066778|PDL1|pdl1
755053|NCT03066804|Cardiovascular Diseases|cardiovascular diseases
755054|NCT03066804|Heart Failure|heart failure
755055|NCT03066804|Heart failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
755056|NCT03066804|NT-proBNP|nt-probnp
755057|NCT03066804|KCCQ|kccq
11355|NCT03218397|Intensive Care Unit|intensive care unit
11356|NCT03218397|Rapid identification|rapid identification
11357|NCT03218397|Rapid susceptibility|rapid susceptibility
11358|NCT03218397|Accelerate PhenoTest™ BC Kit|accelerate phenotest™ bc kit
11359|NCT03218397|Accelerate Pheno™ System (AXDX)|accelerate pheno™ system (axdx)
11360|NCT03218397|Antimicrobial stewardship|antimicrobial stewardship
11361|NCT03218397|Antimicrobial use|antimicrobial use
11362|NCT03218384|Injectafer|injectafer
11363|NCT03218384|ferric carboxymaltose|ferric carboxymaltose
11364|NCT03218384|Supplemental Iron|supplemental iron
11365|NCT03218371|scleral indentation|scleral indentation
755070|NCT03065088|Healthy Lifestyle|healthy lifestyle
755071|NCT03065088|Health Promotion|health promotion
755072|NCT03065088|Health Behavior|health behavior
755073|NCT03065088|Aging|aging
755074|NCT03065088|Activities of Daily Living|activities of daily living
755075|NCT03065088|Mobile Applications|mobile applications
755076|NCT03065023|advanced tumor|advanced tumor
755077|NCT03065023|intratumoral injection|intratumoral injection
755078|NCT03065023|intralesional injection|intralesional injection
755111|NCT03045029|PAH|pah
755112|NCT03045029|Oral Treprostiinil|oral treprostiinil
755113|NCT03045029|Orenitram|orenitram
755114|NCT03046927|Type 1 diabetes|type 1 diabetes
755115|NCT03046927|vitamin D|vitamin d
755116|NCT03046927|honeymoon phase|honeymoon phase
755117|NCT03036488|PD1|pd1
755118|NCT03036488|PD-1|pd-1
755119|NCT03036488|PDL1|pdl1
755120|NCT03036488|PD-L1|pd-l1
755121|NCT03030183|PNH|pnh
755122|NCT03027999|Rituximab|rituximab
755123|NCT03027999|tight monitoring|tight monitoring
755124|NCT03028597|Hypertension|hypertension
755125|NCT03028597|Medication Adherence|medication adherence
755126|NCT03028597|Values Affirmation|values affirmation
755127|NCT03028597|African Americans|african americans
755128|NCT03021499|lupus nephritis|lupus nephritis
755129|NCT03021499|calcineurin inhibitors|calcineurin inhibitors
755130|NCT03021499|voclosporin|voclosporin
755131|NCT03019588|PD1|pd1
755132|NCT03019588|PD-1|pd-1
755133|NCT03019588|PDL1|pdl1
755134|NCT03019588|PD-L1|pd-l1
755138|NCT03008382|Interstitial Cystitis|interstitial cystitis
755139|NCT03008382|Pelvic Pain|pelvic pain
755140|NCT03009396|Crohn's Disease,|crohn's disease,
755141|NCT03009396|moderate to severe|moderate to severe
755142|NCT03009396|remission|remission
755143|NCT03009396|Mycobacterium avium paratuberculosis|mycobacterium avium paratuberculosis
755144|NCT03009396|antibiotic|antibiotic
755145|NCT03005548|Transcranial Direct Current Stimulation|transcranial direct current stimulation
755146|NCT03005548|Pain Postoperative|pain postoperative
755147|NCT03005548|Thoracotomy|thoracotomy
755150|NCT02994953|Avelumab|avelumab
755151|NCT02994953|M9241|m9241
11366|NCT03218371|chandelier light|chandelier light
11367|NCT03218371|air vitrectomy|air vitrectomy
11368|NCT03218371|rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
11370|NCT03218345|pancreatic ca|pancreatic ca
11371|NCT03218345|interventional EUS|interventional eus
11372|NCT03218306|SPI|spi
11373|NCT03218306|Remifentanil|remifentanil
11374|NCT03218306|Target controlled infusion|target controlled infusion
11375|NCT03218280|trauma|trauma
11376|NCT03218280|antioxidant|antioxidant
11377|NCT03218280|oxidative stress|oxidative stress
11378|NCT03218280|Vitamin C|vitamin c
11379|NCT03218280|Ascorbic Acid|ascorbic acid
755176|NCT03070925|Antimicrobial|antimicrobial
755177|NCT03070925|Collagen|collagen
755178|NCT03070925|Bioburden|bioburden
755179|NCT03070925|Biofilm|biofilm
755180|NCT03070925|PHMB|phmb
755181|NCT03070925|Chronic wounds|chronic wounds
755182|NCT03070925|Acute wounds|acute wounds
755183|NCT03266562|Positron Emission Mammography|positron emission mammography
755188|NCT02966028|CAC|cac
755189|NCT02966028|calcium|calcium
755190|NCT02966028|ESRD|esrd
755191|NCT02966028|calcification|calcification
755192|NCT02966028|cardiovascular|cardiovascular
755193|NCT02966028|heart|heart
755194|NCT02966028|kidney|kidney
755195|NCT02966028|hemodialysis|hemodialysis
755196|NCT02966028|Agatston|agatston
755204|NCT02964325|hypoproliferative thrombocytopenia|hypoproliferative thrombocytopenia
755205|NCT02964325|hematologic malignancies|hematologic malignancies
755206|NCT02964325|thrombocytopenia|thrombocytopenia
755207|NCT02964325|platelet therapy|platelet therapy
755208|NCT02964325|apheresis|apheresis
755209|NCT02964325|pathogen reduction therapy|pathogen reduction therapy
755210|NCT02960594|Immunotherapy|immunotherapy
755211|NCT02960594|Human Telomerase Reverse Transcriptase (hTERT)|human telomerase reverse transcriptase (htert)
755212|NCT02960594|Breast Neoplasms|breast neoplasms
755213|NCT02960594|Lung Neoplasms|lung neoplasms
755214|NCT02960594|Pancreatic Neoplasms|pancreatic neoplasms
755215|NCT02960594|High Risk of Relapse|high risk of relapse
755216|NCT02960594|Post Definitive Surgery|post definitive surgery
755217|NCT02960594|Post Adjuvant Therapy|post adjuvant therapy
755218|NCT02960594|No Evidence of Disease|no evidence of disease
755236|NCT02981381|sTMS|stms
755237|NCT02981381|NeoSync|neosync
755238|NCT02981381|NEST|nest
755239|NCT02981381|synchronous|synchronous
755240|NCT02981381|non-invasive neuromodulation|non-invasive neuromodulation
755241|NCT02981381|TMS|tms
755242|NCT02981381|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
755243|NCT02981381|PTSD|ptsd
755244|NCT02981381|EEG|eeg
11380|NCT03218267|total hip replacement|total hip replacement
11381|NCT03218267|static disbalance|static disbalance
11382|NCT03218254|hematological cancer, fatigue, quality of life|hematological cancer, fatigue, quality of life
11383|NCT03218241|Healthy Volunteers|healthy volunteers
11384|NCT03218228|aggressive periodontitis|aggressive periodontitis
11385|NCT03218215|cough assits|cough assits
11386|NCT03218202|Inflammatory Bowel Disease|inflammatory bowel disease
11387|NCT03218202|Crohn Disease|crohn disease
11388|NCT03218202|Ulcerative Colitis|ulcerative colitis
11389|NCT03218202|Intestinal stricture|intestinal stricture
11390|NCT03218189|Essential medicines lists|essential medicines lists
11391|NCT03218163|bone marrow|bone marrow
11392|NCT03218163|bone marrow transplant|bone marrow transplant
11393|NCT03218163|allogeneic|allogeneic
11394|NCT03218163|Medi-551|medi-551
11395|NCT03218137|Subjects|subjects
11396|NCT03218137|diagnosed|diagnosed
11397|NCT03218124|Thyroidectomy|thyroidectomy
755270|NCT03002896|Pep-Pal + Treatment as Usual|pep-pal + treatment as usual
755271|NCT03002896|Treatment as Usual|treatment as usual
755272|NCT02918292|Unrelated Cord Blood (UCB)|unrelated cord blood (ucb)
755273|NCT02918292|Haploidentical Bone Marrow|haploidentical bone marrow
755274|NCT02918292|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
755275|NCT02918292|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
755276|NCT02918292|Antithymocyte Globulin (ATG)|antithymocyte globulin (atg)
755282|NCT03240198|occupational|occupational
755283|NCT03240198|cohort|cohort
755284|NCT03240198|biomarkers|biomarkers
755290|NCT02917954|eHealth/mHealth solutions|ehealth/mhealth solutions
755291|NCT02917954|complex care needs|complex care needs
755292|NCT02917954|seniors|seniors
755293|NCT02917954|patient-centred care|patient-centred care
755294|NCT02917954|goal-oriented care|goal-oriented care
755295|NCT02917954|primary health care|primary health care
755296|NCT02917954|implementation|implementation
755297|NCT02917954|pragmatic trial|pragmatic trial
755298|NCT02917954|health outcomes|health outcomes
755299|NCT02917954|cost-effectiveness analysis|cost-effectiveness analysis
755300|NCT02947152|HKT288|hkt288
755301|NCT02947152|CDH6|cdh6
755302|NCT02947152|ADC|adc
755303|NCT02947152|maytansine|maytansine
755304|NCT02947152|epithelial ovarian cancer|epithelial ovarian cancer
755305|NCT02947152|renal cell carcinoma|renal cell carcinoma
755306|NCT02947152|RCC|rcc
755314|NCT02906670|Epithelial malignancies|epithelial malignancies
755315|NCT02905435|burns|burns
755316|NCT02905435|autografts|autografts
755317|NCT02905435|humans|humans
755318|NCT02905435|biodegradable polyurethane|biodegradable polyurethane
755319|NCT02905435|dermal matrix|dermal matrix
11398|NCT03218124|Remifentanil|remifentanil
11399|NCT03218124|Extubation|extubation
11400|NCT03218124|Cough|cough
11401|NCT03218124|Target controlled infusion|target controlled infusion
11402|NCT03218111|Glymphatic network|glymphatic network
11403|NCT03218111|healthy|healthy
11404|NCT03218111|central nervous system|central nervous system
11405|NCT03218085|tenofovir|tenofovir
11406|NCT03218085|prevention|prevention
11407|NCT03218085|microbiome|microbiome
11408|NCT03218085|cervicovaginal|cervicovaginal
11409|NCT03218085|biopsy|biopsy
11410|NCT03218085|swab|swab
11411|NCT03218085|cytokines|cytokines
11412|NCT03218085|inflammation|inflammation
11413|NCT03218085|pharmacology|pharmacology
11414|NCT03218059|Cesarean Scar Pregnancy|cesarean scar pregnancy
11415|NCT03218033|systemic lupus|systemic lupus
11416|NCT03218033|self-management|self-management
11417|NCT03218033|social media|social media
11418|NCT03217942|Muscle soreness|muscle soreness
11419|NCT03217942|NGF-induced pain|ngf-induced pain
11420|NCT03217942|Pain model|pain model
11421|NCT03217942|Long-lasting sensitization|long-lasting sensitization
11422|NCT03217929|vagus nerve|vagus nerve
11423|NCT03217929|obesity|obesity
11424|NCT03217929|craving|craving
11425|NCT03217929|food|food
11426|NCT03217916|podocyte glycoprotein|podocyte glycoprotein
11427|NCT03217916|kidney injury|kidney injury
11428|NCT03217916|preeclampsia|preeclampsia
11429|NCT03217903|Myelodysplastic syndromes|myelodysplastic syndromes
11430|NCT03217877|noninvasive stress testing|noninvasive stress testing
11431|NCT03217877|hign risk|hign risk
755367|NCT02859337|body weight|body weight
755368|NCT02859337|BMI|bmi
755369|NCT02859337|emergency contraception|emergency contraception
755370|NCT02859337|levonorgestrel|levonorgestrel
755371|NCT02859337|ulipristal acetate|ulipristal acetate
755373|NCT02864043|Barrett's Esophagus|barrett's esophagus
755374|NCT02864043|Barrett's|barrett's
755375|NCT02864043|OCT|oct
755376|NCT02864043|VLE|vle
755377|NCT02854033|amyloid|amyloid
755378|NCT02854033|plaques|plaques
755379|NCT02854033|neuroimaging|neuroimaging
755380|NCT02854033|biomarkers|biomarkers
755381|NCT02854033|cognition disorder|cognition disorder
755382|NCT02854033|early detection|early detection
755383|NCT02854033|pre-dementia|pre-dementia
755384|NCT02854033|dementia|dementia
755385|NCT02854033|Alzheimer's disease|alzheimer's disease
755386|NCT02854033|tau|tau
755397|NCT02843230|Brain Tumor|brain tumor
755398|NCT02846571|Islet Transplantation|islet transplantation
755399|NCT02846571|Type 1 Diabetes|type 1 diabetes
755400|NCT02846571|Immune Tolerance Induction|immune tolerance induction
755401|NCT02846571|Diabetes Complications|diabetes complications
755402|NCT02846571|Intraocular Transplantation|intraocular transplantation
755403|NCT02846571|Eye Anterior Chamber|eye anterior chamber
755404|NCT02846571|Kidney Transplantation|kidney transplantation
755405|NCT02846571|Immunosuppression|immunosuppression
755406|NCT02846571|Type 2 Diabetes|type 2 diabetes
755412|NCT02833402|Sacral Neuromodulation|sacral neuromodulation
755413|NCT02833402|Urinary leakage|urinary leakage
11432|NCT03217877|unstable angina|unstable angina
11433|NCT03217864|Cancer|cancer
11434|NCT03217864|palliative care|palliative care
11435|NCT03217864|hospitalization at home|hospitalization at home
11436|NCT03217864|home health care provider|home health care provider
11437|NCT03217851|Plasmodium falciparum|plasmodium falciparum
11438|NCT03217851|Prevalence Survey|prevalence survey
11439|NCT03217851|Antimalarial Drug|antimalarial drug
11440|NCT03217838|AML|aml
11441|NCT03217838|Acute Myeloid Leukaemia|acute myeloid leukaemia
11442|NCT03217838|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
11443|NCT03217838|AZD2811|azd2811
11444|NCT03217838|AZD1152|azd1152
11445|NCT03217838|AZD1152 hQPA|azd1152 hqpa
11446|NCT03217838|barasertib|barasertib
11447|NCT03217786|Macrovascular Disease|macrovascular disease
11448|NCT03217786|Microvascular Coronary Artery Disease|microvascular coronary artery disease
11449|NCT03217786|Cardiac Transplant Rejection|cardiac transplant rejection
11450|NCT03217786|Transplant; Failure, Heart|transplant; failure, heart
11451|NCT03217786|Intravascular ultrasound (IVUS)|intravascular ultrasound (ivus)
11452|NCT03217786|Optical Coherence Tomography|optical coherence tomography
11453|NCT03217786|Index of Microcirculatory Resistance|index of microcirculatory resistance
11454|NCT03217786|Fractional Flow Reserve|fractional flow reserve
11455|NCT03217786|Coronary Flow Reserve|coronary flow reserve
11456|NCT03217786|Positron Emission Tomography|positron emission tomography
11457|NCT03217786|Endomyocardial Biopsies|endomyocardial biopsies
11458|NCT03217760|Induced stress, dental anxiety, endodontic treatment, salivary cortisol, cardiovascular parameters, pain, discomfort.|induced stress, dental anxiety, endodontic treatment, salivary cortisol, cardiovascular parameters, pain, discomfort.
11459|NCT03217747|Metastatic solid tumors|metastatic solid tumors
11460|NCT03217747|Advanced solid tumors|advanced solid tumors
11461|NCT03217747|Avelumab|avelumab
11464|NCT03217747|PF-05082566|pf-05082566
11465|NCT03217747|Anti-CD137|anti-cd137
11466|NCT03217747|PF-04518600|pf-04518600
11467|NCT03217747|Cisplatin|cisplatin
11468|NCT03217747|Platinol-AQ|platinol-aq
11469|NCT03217747|Platinol|platinol
755467|NCT02806947|Steroid-Free|steroid-free
755468|NCT02820740|Epilepsy|epilepsy
755469|NCT02820740|Medial Temporal Lobe Epilepsy|medial temporal lobe epilepsy
755470|NCT02820740|Seizure|seizure
755471|NCT02820740|NeuroBlate|neuroblate
755472|NCT02820740|LITT|litt
755473|NCT02820740|Quality of Life|quality of life
755474|NCT02799238|glioblastoma, GBM, immunotherapy, autologous lymphoid effector cells specific against tumour cells, ALECSAT, Stupp regimen, TMZ, radiotherapy/TMZ|glioblastoma, gbm, immunotherapy, autologous lymphoid effector cells specific against tumour cells, alecsat, stupp regimen, tmz, radiotherapy/tmz
755475|NCT02805699|Clinical Efficacy|clinical efficacy
755476|NCT02805699|Baofeikang Granules|baofeikang granules
755477|NCT02805699|Combined Pulmonary Fibrosis and Emphysema|combined pulmonary fibrosis and emphysema
755478|NCT02796391|nicotine|nicotine
755479|NCT02796391|cigarettes|cigarettes
755480|NCT02796391|very low nicotine content (VLNC)|very low nicotine content (vlnc)
755485|NCT02798276|Myocardial infarction|myocardial infarction
755486|NCT02798276|Cardiac regeneration|cardiac regeneration
755488|NCT02798354|Depression|depression
11470|NCT03217747|CDDP|cddp
11471|NCT03217747|Radiation Therapy|radiation therapy
11479|NCT03217682|Palliative Care|palliative care
11480|NCT03217682|Integrative Medicine|integrative medicine
11481|NCT03217682|Massage Therapy|massage therapy
11482|NCT03217682|Music Therapy|music therapy
11483|NCT03217682|Caregivers|caregivers
11484|NCT03217669|epacadostat|epacadostat
11485|NCT03217669|sirolimus|sirolimus
11486|NCT03217617|SCID-X1|scid-x1
11487|NCT03217617|lentiviral vector|lentiviral vector
11488|NCT03217604|PF-06852231|pf-06852231
11489|NCT03217604|Safety|safety
11490|NCT03217604|Tolerability|tolerability
11491|NCT03217604|Pharmacokinetics|pharmacokinetics
11492|NCT03217604|First-in-human|first-in-human
11493|NCT03217604|Healthy subjects|healthy subjects
11494|NCT03217578|Spinal Muscular Atrophy|spinal muscular atrophy
11495|NCT03217578|Newborn Screening|newborn screening
11496|NCT03217526|Burn injury|burn injury
11497|NCT03217526|Gait|gait
11498|NCT03217526|Physical Function|physical function
11499|NCT03217513|osteoporosis|osteoporosis
11500|NCT03217513|osteoarthritis|osteoarthritis
11501|NCT03217513|knee|knee
11502|NCT03217422|Type 1, Type 2, autoimmune hepatitis, AIH,|type 1, type 2, autoimmune hepatitis, aih,
11503|NCT03217396|synaptic plasticity|synaptic plasticity
11504|NCT03217396|neuroinflammation|neuroinflammation
11505|NCT03217396|neurodegeneration|neurodegeneration
11506|NCT03217383|Oral appliance therapy|oral appliance therapy
11507|NCT03217383|mandibular protrusion|mandibular protrusion
11508|NCT03217370|patient blood management|patient blood management
11509|NCT03217370|restrictive transfusion|restrictive transfusion
11510|NCT03217357|tDCS, non invasive brain stimulation|tdcs, non invasive brain stimulation
11511|NCT03217318|ureteral stent|ureteral stent
11512|NCT03217305|EIT. NAVA. Endexpiratory Lung Impedance.|eit. nava. endexpiratory lung impedance.
11513|NCT03217279|stroke-participation|stroke-participation
11514|NCT03217279|restriction-needs-cohort-patients-caregivers|restriction-needs-cohort-patients-caregivers
11515|NCT03217201|Breast Cancer|breast cancer
11516|NCT03217201|Oncology|oncology
11517|NCT03217201|Circadian Rhythm|circadian rhythm
11518|NCT03217201|Light Therapy|light therapy
11519|NCT03217201|Chemotherapy side effects|chemotherapy side effects
11520|NCT03217188|Proton Re-Irradiation|proton re-irradiation
11521|NCT03217188|17-300|17-300
11522|NCT03217175|bionic pancreas|bionic pancreas
11523|NCT03217175|type 1 diabetes|type 1 diabetes
11524|NCT03217123|OCD, DBS, fMRI, Y-BOCS, tractography|ocd, dbs, fmri, y-bocs, tractography
11525|NCT03217110|Cerebellum|cerebellum
11526|NCT03217097|Pancreatic neuroendocrine tumors|pancreatic neuroendocrine tumors
11527|NCT03217097|Broncho-pulmonary neuroendocrine tumors|broncho-pulmonary neuroendocrine tumors
11528|NCT03217097|O6-Methylguanine-DNA methyltransferase (MGMT) methylation|o6-methylguanine-dna methyltransferase (mgmt) methylation
11529|NCT03217097|Alkylating agents|alkylating agents
11530|NCT03217097|Oxaliplatin|oxaliplatin
755564|NCT02733042|Lymphoma|lymphoma
755565|NCT02733042|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
755566|NCT02733042|Durvalumab|durvalumab
755567|NCT02733042|Anti-PD-L1 Antibody|anti-pd-l1 antibody
755568|NCT02733042|MEDI4736|medi4736
755569|NCT02733042|Immune Checkpoint|immune checkpoint
755570|NCT02733042|Lymphatic Disease|lymphatic disease
755571|NCT02733042|B-Cell Malignancies|b-cell malignancies
755572|NCT02733042|Abscopal Effect|abscopal effect
755573|NCT02733042|Lenalidomide|lenalidomide
755574|NCT02733042|Bendamustine|bendamustine
755575|NCT02733042|Rituximab|rituximab
755576|NCT02733042|Ibrutinib|ibrutinib
755577|NCT02733042|Lymphoma, B-Cell|lymphoma, b-cell
755578|NCT02733042|Lymphoma, Non Hodgkin,|lymphoma, non hodgkin,
755579|NCT02733042|Hodgkin Disease|hodgkin disease
755580|NCT02733042|Leukemia, Lymphocytic, Chronic, B-Cell,|leukemia, lymphocytic, chronic, b-cell,
755581|NCT02733042|Lymphoma, Follicular|lymphoma, follicular
755582|NCT02733042|Lymphoma, Diffuse Large B-Cell|lymphoma, diffuse large b-cell
755583|NCT02733042|Lymphoma, Mantle Cell|lymphoma, mantle cell
755584|NCT02733042|Lymphoma, Small Lymphocytic|lymphoma, small lymphocytic
755585|NCT02733042|Immune System Diseases|immune system diseases
755586|NCT02733042|Immunoproliferative Disorders|immunoproliferative disorders
755587|NCT02733042|Lymphoproliferative Disorders|lymphoproliferative disorders
755606|NCT02717598|cold snare polypectomy|cold snare polypectomy
755607|NCT02717598|hot snare polypectomy|hot snare polypectomy
755608|NCT02726360|Communication|communication
755609|NCT02726360|15-316|15-316
755610|NCT02726360|Physician|physician
755611|NCT02726360|Use|use
755612|NCT02726360|Non-English|non-english
755613|NCT02726360|Language Skills|language skills
755647|NCT02682316|undergoing laparotomy|undergoing laparotomy
755648|NCT02682316|15-309|15-309
755652|NCT02676986|Primary Breast Cancer|primary breast cancer
755653|NCT02676986|ER|er
755654|NCT02676986|AR|ar
755655|NCT02676986|TNBC|tnbc
755656|NCT02673333|Pembrolizumab|pembrolizumab
755657|NCT02673333|15-286|15-286
11531|NCT03217084|White spot lesion ,fluoride varnish|white spot lesion ,fluoride varnish
11532|NCT03217071|non small cell lung cancer, resectable|non small cell lung cancer, resectable
11533|NCT03217058|digital health|digital health
11534|NCT03217058|implementation|implementation
11535|NCT03217058|primary care|primary care
11536|NCT03217032|Hemophilia A|hemophilia a
11537|NCT03217032|Hemophilia B|hemophilia b
11538|NCT03217032|factor IX|factor ix
11539|NCT03217032|factor VIII|factor viii
11540|NCT03217019|Radial Artery|radial artery
11541|NCT03217019|Vascular Catheters|vascular catheters
11542|NCT03217006|coronary artery bypass surgery|coronary artery bypass surgery
11543|NCT03217006|multiple arterial graft|multiple arterial graft
11544|NCT03217006|radial artery graft|radial artery graft
11545|NCT03216993|feeding protocol|feeding protocol
11546|NCT03216980|cardiovascular disease|cardiovascular disease
11547|NCT03216980|vascular function|vascular function
11548|NCT03216980|PTSD|ptsd
755662|NCT02674204|Statin therapy|statin therapy
755663|NCT02674204|trastuzumab|trastuzumab
755671|NCT02662309|Muscle invasive bladder cancer|muscle invasive bladder cancer
755672|NCT02662309|Transitional cell carcinoma|transitional cell carcinoma
755675|NCT02648724|Advanced Solid Tumor Malignancies|advanced solid tumor malignancies
755683|NCT02808949|Prevention|prevention
755684|NCT02808949|Lactating Women|lactating women
755685|NCT02808949|Healthy|healthy
755693|NCT02639676|Infant|infant
755694|NCT02639676|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
755695|NCT02639676|Premature|premature
755729|NCT02809482|Volunteers|volunteers
755730|NCT02622516|Rehabilitation|rehabilitation
755731|NCT02622516|Physical Therapy Specialty|physical therapy specialty
755732|NCT02622516|Postural Balance|postural balance
755733|NCT02622516|Vertigo|vertigo
755734|NCT02622516|Dizziness|dizziness
755735|NCT02616640|Multiple Myeloma|multiple myeloma
755736|NCT02616640|Relapsed|relapsed
755737|NCT02616640|Refractory|refractory
755738|NCT02616640|MEDI4736|medi4736
755739|NCT02616640|Durvalumab|durvalumab
755740|NCT02616640|Pomalidomide (POM)|pomalidomide (pom)
755741|NCT02616640|Dexamethasone (DEX)|dexamethasone (dex)
755742|NCT02616640|PD-L1|pd-l1
755743|NCT02619318|Balancing Everyday Life (BEL)|balancing everyday life (bel)
755744|NCT02619318|activity-based lifestyle intervention|activity-based lifestyle intervention
755745|NCT02619318|standard occupational therapy|standard occupational therapy
755746|NCT02611921|Ketamine|ketamine
755747|NCT02611921|Social Impairment|social impairment
755748|NCT02611921|Autism|autism
755749|NCT02611921|Autistic Disorder|autistic disorder
755750|NCT02607033|Exercise|exercise
755751|NCT02607033|Weight Loss|weight loss
755752|NCT02607033|Mobility Limitation|mobility limitation
755759|NCT02598752|functional performance testing|functional performance testing
755760|NCT02598752|exercise fitness testing|exercise fitness testing
755761|NCT02598752|15-274|15-274
755762|NCT02596893|Crohn's Disease|crohn's disease
755763|NCT02596893|GED-0301|ged-0301
11549|NCT03216941|Psychomotor agitation; Tranquilizing agents|psychomotor agitation; tranquilizing agents
11550|NCT03216928|Reverse Signaling|reverse signaling
11551|NCT03216928|Anti-TNF|anti-tnf
11552|NCT03216915|Heart Rhythm|heart rhythm
11553|NCT03216915|Fingolimod|fingolimod
11554|NCT03216915|autonomic nervous system|autonomic nervous system
11555|NCT03216915|Effects of Medicinal Substance|effects of medicinal substance
11556|NCT03216902|Glaucoma|glaucoma
11557|NCT03216889|Multiple Sclerosis|multiple sclerosis
11558|NCT03216837|Perinatal stroke|perinatal stroke
11559|NCT03216837|hemiplegia|hemiplegia
11560|NCT03216837|hemiplegic cerebral palsy|hemiplegic cerebral palsy
11561|NCT03216772|Gynecologic Surgery|gynecologic surgery
11562|NCT03216772|larscopy|larscopy
11566|NCT03216759|laparotomy|laparotomy
11567|NCT03216746|oral health|oral health
11568|NCT03216746|knowledge|knowledge
11569|NCT03216746|adolescent|adolescent
11570|NCT03216733|DES|des
755764|NCT02596893|Mongersen|mongersen
755765|NCT02596893|IBD|ibd
755766|NCT02596893|Safety|safety
755767|NCT02596893|Efficacy|efficacy
755771|NCT02592642|lumbar spinal stenosis|lumbar spinal stenosis
755772|NCT02592642|neurogenic claudication|neurogenic claudication
755773|NCT02592642|non-operative|non-operative
755774|NCT02592642|treatment|treatment
755775|NCT02592642|outcomes|outcomes
755776|NCT02592642|clinical trial|clinical trial
755777|NCT02588326|Bioequivalence|bioequivalence
755778|NCT02588326|Suspension nasal spray|suspension nasal spray
755779|NCT02588326|Mometasone furoate|mometasone furoate
755780|NCT02588326|Pharmacokinetics|pharmacokinetics
755781|NCT02588326|Particle size distribution|particle size distribution
755782|NCT02610374|Gut microbiota composition|gut microbiota composition
755783|NCT02578836|Weight Loss|weight loss
755784|NCT02578836|Overweight|overweight
755785|NCT02578836|Endoscopic treatment for obesity|endoscopic treatment for obesity
755796|NCT02564263|PD1|pd1
755797|NCT02564263|PD-L1|pd-l1
755798|NCT02564263|PDL1|pdl1
755799|NCT02564263|Gene expression profiling (GEP)|gene expression profiling (gep)
755800|NCT02562443|Myelodysplastic Syndrome|myelodysplastic syndrome
755801|NCT02562443|MDS|mds
755802|NCT02609451|quality of life|quality of life
755803|NCT02609451|feasibility|feasibility
755804|NCT02609451|safety|safety
755805|NCT02609451|protective ileostomy closure|protective ileostomy closure
755806|NCT03247933|COPD|copd
755807|NCT03247933|RESPIRATORY REHABILITATION TELEMEDICINE|respiratory rehabilitation telemedicine
755819|NCT02546999|Botulinum Toxins, Type A|botulinum toxins, type a
755820|NCT02546999|Walking|walking
755821|NCT02535689|Anti-DNA Antibody|anti-dna antibody
755822|NCT02535689|Tofacitinib|tofacitinib
755823|NCT02535689|Lupus|lupus
755824|NCT02535689|Safety|safety
755833|NCT02577601|Emergency contraception|emergency contraception
755834|NCT02577601|Birth Control Pills|birth control pills
755835|NCT02553096|exacerbations|exacerbations
755836|NCT02553096|self-management support|self-management support
11571|NCT03216733|Angina pectoris|angina pectoris
11572|NCT03216733|Stent|stent
11573|NCT03216720|Coronary artery bypass grafting|coronary artery bypass grafting
11574|NCT03216720|Miniaturized extracorporeal circulation|miniaturized extracorporeal circulation
11575|NCT03216720|Thrombin generation|thrombin generation
11576|NCT03216655|congenital cataract|congenital cataract
11577|NCT03216655|anxiety|anxiety
11578|NCT03216655|guardian|guardian
11579|NCT03216642|Dacryocystitis|dacryocystitis
11580|NCT03216642|Bacteriology|bacteriology
11581|NCT03216642|Microbial Sensitivity Tests|microbial sensitivity tests
11582|NCT03216629|Pain|pain
11583|NCT03216629|Empathy|empathy
11584|NCT03216629|Dressing change|dressing change
11585|NCT03216616|fatigue|fatigue
11586|NCT03216616|Inflammatory Rheumatism|inflammatory rheumatism
11587|NCT03216616|Coping|coping
11588|NCT03216616|self-efficacy|self-efficacy
11589|NCT03216603|Health literacy|health literacy
11590|NCT03216590|Shoulder Arthroscopy|shoulder arthroscopy
755872|NCT02488616|Closed-loop system|closed-loop system
755873|NCT02488616|Artificial pancreas|artificial pancreas
755874|NCT02488616|Type 1 diabetes|type 1 diabetes
755875|NCT02488616|Hypoglycemia|hypoglycemia
755876|NCT02488616|Insulin|insulin
755877|NCT02486016|Bioequivalence|bioequivalence
755878|NCT02486016|Therapeutic Equivalency|therapeutic equivalency
755884|NCT02472860|Autism Spectrum Disorder|autism spectrum disorder
755885|NCT02472860|Neuroplasticity-based Cognitive Training|neuroplasticity-based cognitive training
755886|NCT02468817|parathyroid hormone (PTH)|parathyroid hormone (pth)
755887|NCT02468817|bone mineral density (BMD)|bone mineral density (bmd)
755888|NCT02464670|Ebola|ebola
755889|NCT02464670|Vaccine|vaccine
755890|NCT02463305|Colitis, ulcerative|colitis, ulcerative
755891|NCT02463305|Inflammatory bowel diseases|inflammatory bowel diseases
755892|NCT02474355|NSCLC|nsclc
755893|NCT02474355|EGFRm|egfrm
755894|NCT02474355|T790M|t790m
755895|NCT02456077|MCV4: Meningococcal Conjugate Vaccine|mcv4: meningococcal conjugate vaccine
755896|NCT02456077|HPV: Human Papillomavirus|hpv: human papillomavirus
755897|NCT02453737|Proton|proton
755898|NCT02453737|Brachytherapy|brachytherapy
755899|NCT02453737|Partial Breast Irradiation|partial breast irradiation
755900|NCT02453737|3D Conformal Photon|3d conformal photon
755901|NCT02464410|Opioid analgesics|opioid analgesics
755902|NCT02464410|Primary care|primary care
755903|NCT02464410|Veterans|veterans
755904|NCT02464410|Motivational interviewing|motivational interviewing
755905|NCT02464410|Cognitive behavioral therapy|cognitive behavioral therapy
11591|NCT03216590|Soft Tissue Swelling|soft tissue swelling
11592|NCT03216590|Rotator Cuff Repair|rotator cuff repair
11593|NCT03216590|Shoulder Arthroscopy Complications|shoulder arthroscopy complications
11594|NCT03216577|health-related quality of life|health-related quality of life
11595|NCT03216551|selective mediastinal lymphadenectomy|selective mediastinal lymphadenectomy
11596|NCT03216551|minimally invasive surgery|minimally invasive surgery
11597|NCT03216460|T1D, Omnipod|t1d, omnipod
11598|NCT03216447|adherence|adherence
11599|NCT03216447|conversion|conversion
11600|NCT03216447|advagraf|advagraf
11601|NCT03216447|prograf|prograf
11602|NCT03216434|post-traumatic stress disorder|post-traumatic stress disorder
11603|NCT03216434|dopamine|dopamine
11604|NCT03216434|biomarker|biomarker
11605|NCT03216421|DCIS|dcis
11606|NCT03216421|Intraoperative Radiation (IORT)|intraoperative radiation (iort)
11607|NCT03216421|Lumpectomy|lumpectomy
11608|NCT03216421|Breast Conserving Surgery|breast conserving surgery
11609|NCT03216382|High worry|high worry
11610|NCT03216382|Anxiety|anxiety
11611|NCT03216382|Attention Training Technique|attention training technique
11612|NCT03216382|Attention Control|attention control
11613|NCT03216382|Attention|attention
11614|NCT03216382|Mindfulness|mindfulness
11615|NCT03216382|Attention Bias|attention bias
11616|NCT03216382|Worry|worry
11617|NCT03216382|Pathological Worry|pathological worry
11618|NCT03216382|Anxiety Disorder|anxiety disorder
11619|NCT03216369|Arterial Spin Labeling|arterial spin labeling
11620|NCT03216369|MRI|mri
11621|NCT03216369|Perfusion|perfusion
11622|NCT03216369|Carotid artery stenting|carotid artery stenting
11623|NCT03216369|Carotid endarterectomy|carotid endarterectomy
11624|NCT03216330|Quantitative sensory test (QST)|quantitative sensory test (qst)
11625|NCT03216330|Deep dyspareunia|deep dyspareunia
11626|NCT03216330|Electronic Thimble Algometer|electronic thimble algometer
11627|NCT03216317|Hypertension|hypertension
11628|NCT03216317|Hypotension|hypotension
755960|NCT02412735|Injection of Degenerated Lumbar Disc|injection of degenerated lumbar disc
755961|NCT02412735|Intervertebral Disc Degeneration|intervertebral disc degeneration
755962|NCT02412735|Bone Diseases|bone diseases
755963|NCT02412735|Musculoskeletal Diseases|musculoskeletal diseases
755964|NCT02412735|Nervous System Diseases|nervous system diseases
755965|NCT02412735|Neurologic Manifestations|neurologic manifestations
755966|NCT02412735|Pain|pain
755967|NCT02412735|Spinal Diseases|spinal diseases
755968|NCT02412735|Stem Cells|stem cells
755969|NCT02412735|Adult Stem Cells|adult stem cells
755970|NCT02412735|Allogeneic Mesenchymal Precursor cells (MPCs)|allogeneic mesenchymal precursor cells (mpcs)
755971|NCT02412735|Mesoblast|mesoblast
755972|NCT02412735|Hyaluronic Acid|hyaluronic acid
755973|NCT02412735|Pharmaceutical Solutions|pharmaceutical solutions
755974|NCT02412735|Adjuvants, Immunologic|adjuvants, immunologic
755975|NCT02412735|Immunologic Factors|immunologic factors
755976|NCT02412735|Pharmacologic Actions|pharmacologic actions
755977|NCT02412735|Protective Agents|protective agents
755978|NCT02412735|rexlemestrocel-L|rexlemestrocel-l
755979|NCT02412735|Viscosupplements|viscosupplements
755980|NCT02402153|evaluation of subcutaneous EEG recording|evaluation of subcutaneous eeg recording
755981|NCT02401542|Urothelial Cell Carcinoma|urothelial cell carcinoma
755982|NCT02401542|UCC|ucc
755983|NCT02401542|bladder cancer|bladder cancer
755984|NCT02401542|B-701|b-701
755985|NCT02401542|FGFR3|fgfr3
755986|NCT02401542|invasive bladder cancer|invasive bladder cancer
755987|NCT02401542|targeted therapy|targeted therapy
755988|NCT02401542|Transitional Cell Carcinoma|transitional cell carcinoma
755989|NCT02401542|TCC|tcc
755990|NCT02401542|Phase 2|phase 2
755993|NCT02401542|docetaxel|docetaxel
11629|NCT03216317|Cardiovascular system|cardiovascular system
11630|NCT03216278|healthy,|healthy,
11631|NCT03216278|fasted,|fasted,
11632|NCT03216278|fed|fed
11633|NCT03216226|Glucagon|glucagon
11634|NCT03216148|FET PET|fet pet
11635|NCT03216135|Microbiome|microbiome
11636|NCT03216109|Supportive Care|supportive care
11637|NCT03216109|Quality of Life|quality of life
11638|NCT03216083|colpocleisis|colpocleisis
11639|NCT03216083|vaginectomy|vaginectomy
11640|NCT03216083|tranexamic acid|tranexamic acid
11641|NCT03216070|Dasatinib|dasatinib
11642|NCT03216057|hypertriglyceridemia|hypertriglyceridemia
11643|NCT03216057|pediatric obesity|pediatric obesity
11644|NCT03216057|omega 3|omega 3
11645|NCT03216044|childbirth|childbirth
11646|NCT03216044|caesarean delivery|caesarean delivery
11647|NCT03216044|vaginal delivery|vaginal delivery
11648|NCT03216044|chronic pain|chronic pain
11649|NCT03216044|painful sexual intercourse|painful sexual intercourse
11650|NCT03216031|Falls prevention|falls prevention
11651|NCT03216031|Gardening|gardening
11652|NCT03216018|resilience|resilience
11653|NCT03216018|prevention program|prevention program
11654|NCT03216018|body-image|body-image
11655|NCT03216018|self-esteem|self-esteem
11656|NCT03215992|Diffuse Optical Tomography|diffuse optical tomography
11657|NCT03215966|bioequivalence|bioequivalence
11658|NCT03215953|offloading|offloading
11659|NCT03215953|plantar pressure|plantar pressure
11660|NCT03215953|Diabetic Foot Ulcer|diabetic foot ulcer
11661|NCT03215953|cast shoe|cast shoe
756059|NCT02300610|Ureteral Diseases|ureteral diseases
756060|NCT02300610|Urinary Bladder Diseases|urinary bladder diseases
756061|NCT02300610|Transitional Cell Carcinoma|transitional cell carcinoma
756062|NCT02300610|Bladder|bladder
756063|NCT02300610|Carcinoma|carcinoma
756064|NCT02300610|Renal|renal
756065|NCT02300610|Pelvis|pelvis
756066|NCT02300610|Ureter|ureter
756067|NCT02300610|Urethra|urethra
756068|NCT02294825|deep endometriosis;|deep endometriosis;
756069|NCT02294825|colorectal endometriosis|colorectal endometriosis
756070|NCT02294825|surgery|surgery
756071|NCT02294825|medical treatment|medical treatment
756072|NCT02294825|fertility|fertility
756073|NCT02285062|R-CHOP chemotherapy|r-chop chemotherapy
756074|NCT02285062|DLBCL front line therapy|dlbcl front line therapy
756075|NCT02285062|gene expression profiling (GEP) activated B-cell (ABC) type DLBCL biomarkers|gene expression profiling (gep) activated b-cell (abc) type dlbcl biomarkers
756076|NCT02285062|Activated B-Cell (ABC) type|activated b-cell (abc) type
756077|NCT02285062|Diffuse Large B-Cell Lymphoma, not otherwise specified|diffuse large b-cell lymphoma, not otherwise specified
756078|NCT02285062|Diffuse Large B-Cell Lymphoma, associated with chronic inflammation|diffuse large b-cell lymphoma, associated with chronic inflammation
756079|NCT02285062|Diffuse Large B-Cell Lymphoma, Epstein-Barr virus positive (EBS+) of the elderly|diffuse large b-cell lymphoma, epstein-barr virus positive (ebs+) of the elderly
756082|NCT02278965|Breast Cancer|breast cancer
756083|NCT02278965|Early Stage|early stage
11662|NCT03215953|forefoot offloading shoe|forefoot offloading shoe
11663|NCT03215927|ILD|ild
11664|NCT03215914|Closed loop insulin delivery system|closed loop insulin delivery system
11665|NCT03215914|Insulin Pump|insulin pump
11666|NCT03215914|Glycemic control|glycemic control
11667|NCT03215914|Glucose Counterregulation|glucose counterregulation
11668|NCT03215901|Population-based survey|population-based survey
11669|NCT03215901|HIV treatment|hiv treatment
11670|NCT03215901|HIV testing|hiv testing
11671|NCT03215901|Survival expectations|survival expectations
11672|NCT03215901|Condom use|condom use
11673|NCT03215901|Life plans|life plans
11674|NCT03215901|South African young adults|south african young adults
11675|NCT03215862|Post-ERCP Acute Pancreatitis|post-ercp acute pancreatitis
11676|NCT03215862|Normal Saline|normal saline
11677|NCT03215862|Lactated Ringer's|lactated ringer's
11678|NCT03215823|Intubation|intubation
11679|NCT03215823|videolaryngoscope|videolaryngoscope
11680|NCT03215810|Stage IV|stage iv
11681|NCT03215810|NSCLC|nsclc
11682|NCT03215810|Recurrent|recurrent
11683|NCT03215810|TIL|til
11684|NCT03215810|Tumor-infiltrating Lymphocyte Therapy (TIL)|tumor-infiltrating lymphocyte therapy (til)
11685|NCT03215797|svv|svv
11686|NCT03215797|norepinephrine|norepinephrine
11687|NCT03215797|phenylephrine|phenylephrine
11688|NCT03215797|elderly|elderly
11689|NCT03215784|obesity|obesity
11690|NCT03215784|placenta|placenta
11691|NCT03215784|inflammation|inflammation
11692|NCT03215784|fish oil|fish oil
11693|NCT03215784|probiotics|probiotics
11694|NCT03215758|QAW039, uncontrolled asthma|qaw039, uncontrolled asthma
11695|NCT03215745|Delirium|delirium
11696|NCT03215745|Critical Care|critical care
11697|NCT03215745|Prevention & control|prevention & control
11698|NCT03215745|Clinical Trial|clinical trial
11699|NCT03215732|prevalence|prevalence
11700|NCT03215732|vaccine coverage|vaccine coverage
11701|NCT03215732|risk factors|risk factors
11702|NCT03215732|morbidity|morbidity
11703|NCT03215732|mortality|mortality
11704|NCT03215732|quality of life|quality of life
11705|NCT03215732|economic vulnerability|economic vulnerability
11706|NCT03215732|food security|food security
756148|NCT02172911|Cervical cancer|cervical cancer
756149|NCT02172911|Papillomavirus|papillomavirus
756150|NCT02172911|Chemoradiation|chemoradiation
756151|NCT02172911|Recurrent cervical cancer|recurrent cervical cancer
756152|NCT02172911|Persistent cervical cancer|persistent cervical cancer
756159|NCT02130466|PD1|pd1
756160|NCT02130466|PD-1|pd-1
756161|NCT02130466|PDL1|pdl1
756162|NCT02130466|PD-L1|pd-l1
756163|NCT02120014|Heart Failure|heart failure
756164|NCT02120014|Heart Failure Reduced Ejection Fraction|heart failure reduced ejection fraction
756165|NCT02120014|Heart Failure Preserved Ejection Fraction|heart failure preserved ejection fraction
756166|NCT02120014|Venous Plethysmography|venous plethysmography
756167|NCT02120014|Blood Volume Study|blood volume study
756168|NCT02117635|Efficacy|efficacy
756169|NCT02117635|Non comparative|non comparative
756170|NCT02117635|Neural stem cells|neural stem cells
756171|NCT02117635|Intracranial administration|intracranial administration
756172|NCT02116582|MDV3100|mdv3100
756173|NCT02116582|Xtandi|xtandi
756174|NCT02116582|Abiraterone|abiraterone
756184|NCT02117934|Healthy|healthy
11707|NCT03215732|treatment needs|treatment needs
11708|NCT03215732|decentralized care|decentralized care
11709|NCT03215732|health costs|health costs
11710|NCT03215732|caregivers training|caregivers training
11711|NCT03215719|Radiation Therapy|radiation therapy
11712|NCT03215680|Urinary iodine concentration|urinary iodine concentration
11713|NCT03215654|mental health|mental health
11714|NCT03215654|promotion|promotion
11715|NCT03215654|prevention|prevention
11716|NCT03215654|adolescence|adolescence
11717|NCT03215654|school programs|school programs
11718|NCT03215654|intervention|intervention
11719|NCT03215641|obesity|obesity
11720|NCT03215641|pediatrics|pediatrics
11721|NCT03215641|weight management program|weight management program
11722|NCT03215641|Fitbit|fitbit
11723|NCT03215641|personal activity tracker|personal activity tracker
11724|NCT03215628|CEUS|ceus
11725|NCT03215628|TCEUS|tceus
11726|NCT03215628|contrast enhanced ultrasound|contrast enhanced ultrasound
11727|NCT03215628|perfusion|perfusion
11728|NCT03215628|cerebral perfusion|cerebral perfusion
11729|NCT03215628|sulphur hexafluoride|sulphur hexafluoride
11730|NCT03215628|SonoVue|sonovue
11731|NCT03215602|knee|knee
11732|NCT03215602|osteoarthritis|osteoarthritis
11733|NCT03215602|exercise|exercise
11734|NCT03215602|quadriceps|quadriceps
11735|NCT03215602|strength|strength
11736|NCT03215602|activities of daily living|activities of daily living
11737|NCT03215602|treatment outcome|treatment outcome
11738|NCT03215589|Near-infrared spectroscopy-derived cerebral oximetry|near-infrared spectroscopy-derived cerebral oximetry
11739|NCT03215563|atherosclerosis, imaging|atherosclerosis, imaging
11740|NCT03215550|atherosclerosis, imaging|atherosclerosis, imaging
11741|NCT03215537|physical activity|physical activity
11742|NCT03215537|cardiopulmonary function|cardiopulmonary function
11743|NCT03215537|quality of life|quality of life
11744|NCT03215537|Perioperative management|perioperative management
11745|NCT03215537|comprehensive intervention|comprehensive intervention
11746|NCT03215537|health behavior model|health behavior model
11747|NCT03215511|NTRK Fusion Positive|ntrk fusion positive
11748|NCT03215511|LOXO-195|loxo-195
11749|NCT03215511|Loxo|loxo
11750|NCT03215511|TRK|trk
11751|NCT03215511|TRK Fusion|trk fusion
11752|NCT03215511|NTRK1|ntrk1
11753|NCT03215511|NTRK2|ntrk2
11754|NCT03215511|NTRK3|ntrk3
11755|NCT03215511|TRKA|trka
11756|NCT03215511|TRKB|trkb
11757|NCT03215511|TRKC|trkc
11758|NCT03215511|NTRK|ntrk
11759|NCT03215511|ETV6|etv6
11760|NCT03215511|fusion|fusion
11761|NCT03215511|tumors|tumors
11762|NCT03215511|CNS tumors|cns tumors
11763|NCT03215511|solid tumors|solid tumors
11764|NCT03215511|central nervous system tumors|central nervous system tumors
11765|NCT03215511|advanced cancer|advanced cancer
756244|NCT02041468|ALK-positive|alk-positive
756245|NCT02019420|Pneumonia|pneumonia
756246|NCT02019420|Tedizolid Phosphate|tedizolid phosphate
756247|NCT02019420|TR-701|tr-701
756248|NCT02016781|Myelodysplastic Syndrome|myelodysplastic syndrome
756249|NCT02016924|Pediatrics|pediatrics
756250|NCT02016924|Adolescents|adolescents
756251|NCT02016924|HIV|hiv
756252|NCT02016924|HIV-1|hiv-1
756253|NCT02016924|Treatment experienced|treatment experienced
756254|NCT02012309|HIV|hiv
756255|NCT02012309|Streptococcus pneumoniae infection|streptococcus pneumoniae infection
756256|NCT02012309|Streptococcus pneumoniae colonization|streptococcus pneumoniae colonization
756257|NCT02012309|Pneumococcal vaccines|pneumococcal vaccines
756258|NCT02012309|Prevnar|prevnar
756259|NCT02012309|Pneumovax|pneumovax
756260|NCT02012309|Nasopharyngeal microbiome|nasopharyngeal microbiome
756266|NCT01999751|Magnetic Resonance Imaging|magnetic resonance imaging
756267|NCT01999751|Pacemaker, Artificial|pacemaker, artificial
756268|NCT01999751|Defibrillators, Implantable|defibrillators, implantable
756269|NCT01996865|Lymphoma, Mantle cell Lymphoma, Follicular Lymphoma, Marginal zone Lymphoma, Lenalidomide treatment, rituximab treatment, Non Hodgkins Lymphoma|lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, lenalidomide treatment, rituximab treatment, non hodgkins lymphoma
756270|NCT01997333|Metastatic Breast Cancer|metastatic breast cancer
756271|NCT01997333|Locally advanced breast cancer|locally advanced breast cancer
756272|NCT01997333|Breast cancer|breast cancer
756273|NCT01997333|Triple negative|triple negative
11766|NCT03215511|primary CNS tumor|primary cns tumor
11777|NCT03215485|sports|sports
11778|NCT03215485|nutrition|nutrition
11779|NCT03215485|physical activity|physical activity
11780|NCT03215485|body mass index|body mass index
11781|NCT03215485|virtual world|virtual world
11782|NCT03215459|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
11783|NCT03215394|Social ABCs|social abcs
11784|NCT03215394|autism|autism
11785|NCT03215394|autism spectrum disorder|autism spectrum disorder
11786|NCT03215394|Early Intervention|early intervention
11787|NCT03215394|Toddler|toddler
11788|NCT03215394|Early Identification|early identification
11789|NCT03215394|Pivotal Response Treatment|pivotal response treatment
11790|NCT03215394|ASD|asd
11791|NCT03215394|PRT|prt
11792|NCT03215394|Control Group|control group
11793|NCT03215394|treatment Group|treatment group
11794|NCT03215394|At Risk|at risk
11795|NCT03215394|Social Communication|social communication
11796|NCT03215394|Positive Affect|positive affect
11797|NCT03215394|Smiling|smiling
11798|NCT03215394|Social Orienting|social orienting
11799|NCT03215394|Attentional Control|attentional control
11800|NCT03215394|Attentional Disengagement|attentional disengagement
11801|NCT03215394|Naturalistic Developmental Behaviour Intervention|naturalistic developmental behaviour intervention
11802|NCT03215394|NDBI|ndbi
11803|NCT03215381|Healthy Volunteer Male Subjects|healthy volunteer male subjects
11804|NCT03215355|Adaptive radiotherapy|adaptive radiotherapy
11805|NCT03215355|Contrast media|contrast media
11806|NCT03215355|Cone-beam computed tomography|cone-beam computed tomography
11807|NCT03215355|Stereotactic body radiation therapy|stereotactic body radiation therapy
11808|NCT03215342|Child|child
11809|NCT03215342|Rehabilitation|rehabilitation
11810|NCT03215342|Psychotherapy, groups|psychotherapy, groups
11811|NCT03215303|Asthma|asthma
11812|NCT03215303|Continuous positive airway pressure|continuous positive airway pressure
11813|NCT03215303|Oxygen consumption|oxygen consumption
11814|NCT03215277|Ankylosing Spondylitis|ankylosing spondylitis
11815|NCT03215277|Bimekizumab|bimekizumab
11816|NCT03215277|AS|as
756339|NCT01939769|fMRI|fmri
756340|NCT01939769|Catecholamines|catecholamines
756341|NCT01939769|Stress|stress
756342|NCT01939769|Exercise|exercise
756343|NCT01939769|Memory|memory
756345|NCT01920932|Pediatric cancer|pediatric cancer
756346|NCT01920932|Hodgkin lymphoma|hodgkin lymphoma
756347|NCT01920932|Targeted therapy|targeted therapy
756348|NCT01920932|Frontline therapy|frontline therapy
756349|NCT01920932|Brentuximab vedotin|brentuximab vedotin
756350|NCT01920932|Quality of Life|quality of life
756351|NCT01920932|OEPA/COPDac|oepa/copdac
756352|NCT01915238|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
756353|NCT01915238|AMD|amd
756354|NCT01904188|microbial identification|microbial identification
756355|NCT01904188|antibiotic resistance|antibiotic resistance
756356|NCT01904188|GeneZ|genez
756357|NCT01904188|sepsis|sepsis
756358|NCT01904188|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
756372|NCT01890421|Myocardial Perfusion Imaging|myocardial perfusion imaging
756373|NCT01889394|pilonidal sinus|pilonidal sinus
756374|NCT01889394|excision|excision
756375|NCT01889394|primary wound closure|primary wound closure
756376|NCT01889394|limberg flap|limberg flap
756380|NCT01873326|newly diagnosed GCT|newly diagnosed gct
756381|NCT01873326|Intermediate|intermediate
756382|NCT01873326|Poor-Risk|poor-risk
756383|NCT01873326|BLEOMYCIN|bleomycin
756384|NCT01873326|CISPLATIN|cisplatin
756385|NCT01873326|ETOPOSIDE (VP-16)|etoposide (vp-16)
756386|NCT01873326|IFOSFAMIDE|ifosfamide
756387|NCT01873326|TAXOL (PACLITAXEL)|taxol (paclitaxel)
756388|NCT01873326|13-074|13-074
756392|NCT01856907|prediabetes|prediabetes
756393|NCT01856907|impaired fasting/impaired glucose tolerance|impaired fasting/impaired glucose tolerance
756394|NCT01856907|post gestational diabetes|post gestational diabetes
756395|NCT01856907|diabetes prevention|diabetes prevention
756396|NCT01847001|Breast Cancer|breast cancer
756397|NCT01847001|Neoadjuvant|neoadjuvant
756398|NCT01847001|Experimental|experimental
756399|NCT01847001|Biomarker|biomarker
756400|NCT01847001|Breast imaging|breast imaging
756408|NCT01810003|Cardiovascular disease|cardiovascular disease
756409|NCT01810003|Inflammation|inflammation
756410|NCT01810003|EPA/DHA supplementation|epa/dha supplementation
756419|NCT01771471|back pain|back pain
756420|NCT01771471|intervertebral disc|intervertebral disc
11817|NCT03215277|Certolizumab Pegol|certolizumab pegol
11818|NCT03215277|Cimzia|cimzia
11819|NCT03215251|Thirst, Dry Mouth, Intervention Bundle|thirst, dry mouth, intervention bundle
11820|NCT03215225|Endodontology|endodontology
11821|NCT03215225|Endodontics|endodontics
11822|NCT03215212|ear plug|ear plug
756443|NCT01793909|Blood Flow|blood flow
756444|NCT01793909|Muscle Oxygen Uptake|muscle oxygen uptake
756445|NCT01793909|Exercise Training|exercise training
756447|NCT01728038|Bronchiolitis|bronchiolitis
756448|NCT01728038|Cough|cough
756449|NCT01728038|Ear Infection|ear infection
756450|NCT01728038|Respiratory Infection|respiratory infection
756451|NCT01728038|Wheezing|wheezing
756452|NCT01682083|MEK inhibitor|mek inhibitor
756453|NCT01682083|trametinib|trametinib
756454|NCT01682083|Oncology|oncology
756455|NCT01682083|adjuvant melanoma|adjuvant melanoma
756456|NCT01682083|dabrafenib|dabrafenib
756457|NCT01682083|dabrafenib and trametinib combination therapy|dabrafenib and trametinib combination therapy
756458|NCT01682083|BRAF mutation-positive melanoma|braf mutation-positive melanoma
756459|NCT01682083|BRAF inhibitor|braf inhibitor
756460|NCT01680965|Graft vs. Host Disease|graft vs. host disease
756461|NCT01680965|GVHD|gvhd
756462|NCT01680965|chronic graft versus host disease (cGVHD)|chronic graft versus host disease (cgvhd)
756463|NCT01680965|Allogeneic Transplant|allogeneic transplant
756464|NCT01680965|Ofatumumab|ofatumumab
756474|NCT01656187|memantine|memantine
756475|NCT01656187|cognition|cognition
756476|NCT01656187|corticosteroid|corticosteroid
756477|NCT01656187|prednisone|prednisone
756478|NCT01656187|memory|memory
756479|NCT01656187|hippocampus|hippocampus
756480|NCT01647321|SPMS|spms
756487|NCT01597778|Haplo identical transplant|haplo identical transplant
756488|NCT01597778|Cord blood transplant|cord blood transplant
756489|NCT01597778|Reduced intensity conditioning regimen|reduced intensity conditioning regimen
756490|NCT01597778|Lymphoma|lymphoma
756491|NCT01597778|Leukemia|leukemia
756492|NCT01585675|Lung Cancer|lung cancer
756502|NCT01544088|randomized controlled trial|randomized controlled trial
756503|NCT01544088|PTSD|ptsd
756504|NCT01544088|cognitive behavioral treatment|cognitive behavioral treatment
756505|NCT01544088|group treatment|group treatment
756542|NCT01410344|HIV|hiv
756543|NCT01410344|ALL|all
756544|NCT01410344|AML|aml
756545|NCT01410344|MDS|mds
756546|NCT01410344|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
11823|NCT03215212|eye mask|eye mask
11824|NCT03215212|ocean sound|ocean sound
11825|NCT03215212|sleep quality|sleep quality
11826|NCT03215212|intensive care unit|intensive care unit
11827|NCT03215186|congenital cataract|congenital cataract
11828|NCT03215186|risk factor|risk factor
11829|NCT03215186|mathematic model|mathematic model
11830|NCT03215160|Mobilization|mobilization
11831|NCT03215160|Manual Therapies|manual therapies
11832|NCT03215160|Exercise|exercise
11833|NCT03215147|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
11834|NCT03215147|Airway Disease|airway disease
11835|NCT03215134|Improving Access to Psychological Therapies (IAPT)|improving access to psychological therapies (iapt)
11836|NCT03215134|Primary mental health service|primary mental health service
756572|NCT01400607|knee surgery|knee surgery
756573|NCT01400607|cartilage injury|cartilage injury
756574|NCT01400607|knee pain|knee pain
756575|NCT01400607|cartilage repair|cartilage repair
756576|NCT01400607|cartilage damage|cartilage damage
756577|NCT01400607|cartilage lesion|cartilage lesion
756578|NCT01400607|cartilage defect|cartilage defect
756579|NCT01400607|articular cartilage lesion|articular cartilage lesion
756580|NCT01400607|articular cartilage defect|articular cartilage defect
756581|NCT01400607|juvenile|juvenile
756582|NCT01400607|cells|cells
756583|NCT01400607|ISTO Technologies|isto technologies
756584|NCT01400607|Neocartilage|neocartilage
756585|NCT01400607|RevaFlex|revaflex
756589|NCT01343043|Sarcoma|sarcoma
756590|NCT01343043|Cell Therapy|cell therapy
756591|NCT01343043|T Cell Therapy|t cell therapy
756592|NCT01343043|NY-ESO-1|ny-eso-1
756593|NCT01343043|Immuno-oncology|immuno-oncology
756594|NCT01343043|Metastatic|metastatic
756595|NCT01343043|Previously treated|previously treated
756596|NCT01343043|T Cell Receptor|t cell receptor
756599|NCT01304940|Stress|stress
756600|NCT01304940|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
756601|NCT01304940|Stress Disorders, Traumatic|stress disorders, traumatic
756602|NCT01277263|Breast Cancer|breast cancer
756603|NCT01262560|pain|pain
756604|NCT01262560|dysphagia|dysphagia
756605|NCT01262560|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
756606|NCT01262560|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
756607|NCT01262560|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
756608|NCT01262560|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
756609|NCT01262560|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
756610|NCT01262560|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
756611|NCT01262560|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
756612|NCT01262560|extensive stage small cell lung cancer|extensive stage small cell lung cancer
756613|NCT01262560|limited stage small cell lung cancer|limited stage small cell lung cancer
756614|NCT01262560|recurrent small cell lung cancer|recurrent small cell lung cancer
756615|NCT01262560|esophagitis|esophagitis
756632|NCT01256268|metastatic|metastatic
756633|NCT01256268|recurrent|recurrent
756634|NCT01256268|Solid Cancer|solid cancer
11837|NCT03215134|Compassion Focused Therapy (CFT)|compassion focused therapy (cft)
11838|NCT03215095|Radioiodine (RAI)|radioiodine (rai)
11839|NCT03215095|Durvalumab (Medi4736)|durvalumab (medi4736)
11840|NCT03215095|RAI-avid|rai-avid
11841|NCT03215095|17-218|17-218
11842|NCT03215043|Eriocitrin|eriocitrin
11843|NCT03215043|Intermediate hyperglycemia|intermediate hyperglycemia
756652|NCT02171377|COPD|copd
756653|NCT02171377|electrical stimulation|electrical stimulation
756654|NCT02171377|Rehabilitation|rehabilitation
756655|NCT02171377|exercise test|exercise test
756656|NCT01205776|Drug eluting stents|drug eluting stents
756657|NCT01205776|Stents|stents
756658|NCT01205776|Unprotected Left Main Coronary Artery Disease|unprotected left main coronary artery disease
756659|NCT01205776|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
756668|NCT01132482|Cystic fibrosis|cystic fibrosis
756669|NCT01132482|CFTR|cftr
756670|NCT01132482|Phosphodiesterase inhibitor|phosphodiesterase inhibitor
756671|NCT01132482|Nasal potential difference|nasal potential difference
756672|NCT01132482|Sweat test|sweat test
756673|NCT01104220|NAFLD|nafld
756674|NCT01104220|Obesity|obesity
756675|NCT01104220|Metabolic syndrome|metabolic syndrome
756676|NCT01112306|Open-label|open-label
756677|NCT01112306|PAH|pah
756678|NCT01112306|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
756679|NCT01085864|Lung Nodules|lung nodules
756680|NCT01085864|A need exists for non-invasive testing to aid in clinical decision-making for CT scan detected lung nodules of indeterminate etiology.|a need exists for non-invasive testing to aid in clinical decision-making for ct scan detected lung nodules of indeterminate etiology.
756681|NCT01071824|size|size
756682|NCT01071824|limb|limb
756683|NCT01071824|transverse coloplasty pouch|transverse coloplasty pouch
756684|NCT01071824|rectal resection|rectal resection
756685|NCT01071824|mesorectal excision|mesorectal excision
756686|NCT01071824|treatment outcome|treatment outcome
756690|NCT01005407|HBV vaccine|hbv vaccine
756691|NCT01005407|Hepatitis B vaccine|hepatitis b vaccine
756692|NCT01005407|Hepatitis B|hepatitis b
756693|NCT01005407|Hepatitis|hepatitis
11844|NCT03215043|Citrus bioflavonoids|citrus bioflavonoids
11845|NCT03215030|Drug therapy|drug therapy
11846|NCT03215004|Volunteer|volunteer
11847|NCT03215004|HIV|hiv
11848|NCT03215004|Leukapheresis|leukapheresis
11849|NCT03214978|thyroid|thyroid
11850|NCT03214965|Kidney transplantation|kidney transplantation
11851|NCT03214965|Facebook|facebook
11852|NCT03214965|Education|education
11853|NCT03214965|Adolescent|adolescent
11854|NCT03214965|Social Networking|social networking
11855|NCT03214939|dendritic cell, IL-12, IL-18, cytotoxicity|dendritic cell, il-12, il-18, cytotoxicity
11856|NCT03214926|Parkinson's disease|parkinson's disease
11857|NCT03214926|Dance|dance
11858|NCT03214926|Google Glass|google glass
11859|NCT03214926|Mobility|mobility
11860|NCT03214926|Balance|balance
11861|NCT03214913|resuscitation|resuscitation
11862|NCT03214913|fluid therapy|fluid therapy
11863|NCT03214887|Hyaluronan|hyaluronan
11864|NCT03214887|Bone marrow mononuclear cells|bone marrow mononuclear cells
11871|NCT03214835|Larynx|larynx
11872|NCT03214835|reflux|reflux
11873|NCT03214835|LPR|lpr
11874|NCT03214835|tumor|tumor
11875|NCT03214835|lesion|lesion
11876|NCT03214822|Microbiome|microbiome
11877|NCT03214809|ultrasound|ultrasound
11878|NCT03214809|MET team|met team
11879|NCT03214809|Concordance|concordance
11880|NCT03214783|artificial intelligence|artificial intelligence
11881|NCT03214783|facial recognition|facial recognition
11882|NCT03214783|facial characteristic|facial characteristic
11883|NCT03214731|artesunate|artesunate
11884|NCT03214705|CT perfusion|ct perfusion
756727|NCT00877903|Heart attack|heart attack
756728|NCT00877903|Mesenchymal stem cells|mesenchymal stem cells
756729|NCT00877903|MSC|msc
756730|NCT00877903|Adult human stem cells|adult human stem cells
756731|NCT00877903|Osiris|osiris
756735|NCT00804583|Cystic Fibrosis|cystic fibrosis
756736|NCT00804583|Liver Disease|liver disease
756737|NCT00804583|Genetic Modifiers|genetic modifiers
756745|NCT00697632|MET|met
756746|NCT00697632|AXL|axl
756747|NCT00697632|VEGFR|vegfr
756748|NCT00697632|NSCLC|nsclc
756749|NCT00697632|HNSCC (Head and neck squamous cell carcinoma)|hnscc (head and neck squamous cell carcinoma)
756750|NCT00697632|Tumor|tumor
756751|NCT00697632|Safety|safety
756752|NCT00697632|Phase 1|phase 1
756753|NCT00697632|Solid tumor|solid tumor
756760|NCT00656955|Kidney Cancer|kidney cancer
756761|NCT00656955|Renal Cell Cancer|renal cell cancer
756762|NCT00656955|Heterogeneity|heterogeneity
756763|NCT00656955|Molecular Epidemiology|molecular epidemiology
756764|NCT00656955|Survival|survival
756765|NCT00656955|Occupational Exposure|occupational exposure
756766|NCT00656955|Renal Cancer|renal cancer
756767|NCT00656955|Survival Study|survival study
756768|NCT00670631|Multiple Myeloma|multiple myeloma
756769|NCT00670631|myeloma|myeloma
756773|NCT00578643|Stem Cell Transplant|stem cell transplant
756774|NCT00578643|Chronic Granulomatous Disease|chronic granulomatous disease
756775|NCT00578643|Fludarabine|fludarabine
756776|NCT00578643|Busulfan|busulfan
756777|NCT00578643|Cyclophosphamide|cyclophosphamide
756783|NCT00573014|Obtunded blunt trauma patients|obtunded blunt trauma patients
756784|NCT00435812|HBV vaccine|hbv vaccine
756785|NCT00435812|Hepatitis B vaccine|hepatitis b vaccine
756786|NCT00435812|Hepatitis B|hepatitis b
756787|NCT00435812|Hepatitis|hepatitis
11885|NCT03214705|Subarachnoid hemorrhage|subarachnoid hemorrhage
11886|NCT03214705|Vasospasm|vasospasm
11887|NCT03214705|Delayed cerebral ischemia|delayed cerebral ischemia
11888|NCT03214692|Gum Arabic|gum arabic
11889|NCT03214692|Renal failure|renal failure
11890|NCT03214692|Hemodialysis|hemodialysis
11891|NCT03214692|Antioxidant and anti-inflammatory|antioxidant and anti-inflammatory
11892|NCT03214679|Hepatitis C|hepatitis c
11893|NCT03214679|HCV|hcv
11894|NCT03214679|PWID|pwid
11895|NCT03214679|People who inject drugs|people who inject drugs
11896|NCT03214666|MDS|mds
11897|NCT03214666|AML|aml
11898|NCT03214666|ALL|all
11899|NCT03214640|neuraxial analgesia|neuraxial analgesia
11900|NCT03214640|spinal block|spinal block
11901|NCT03214640|epidural block|epidural block
11902|NCT03214588|Drug Therapy|drug therapy
11903|NCT03214575|Central Venous Vascular Access|central venous vascular access
11904|NCT03214575|Intensive Care Unit|intensive care unit
11905|NCT03214575|Needle Navigation Technology|needle navigation technology
11906|NCT03214562|Other diseases of blood and blood-forming organs|other diseases of blood and blood-forming organs
11907|NCT03214562|Acute Myeloid Leukemia|acute myeloid leukemia
11908|NCT03214562|AML|aml
11909|NCT03214562|Newly diagnosed|newly diagnosed
11910|NCT03214562|Relapsed/refractory|relapsed/refractory
11911|NCT03214562|Fludarabine|fludarabine
11912|NCT03214562|Fludarabine phosphate|fludarabine phosphate
11913|NCT03214562|Fludara|fludara
11914|NCT03214562|Cytarabine|cytarabine
756826|NCT00281684|Dental Pain|dental pain
756827|NCT00281684|Vanilloid|vanilloid
756829|NCT00281684|TRPV1|trpv1
756830|NCT00281684|Inflammation|inflammation
756831|NCT00241722|bowel dysfunction|bowel dysfunction
756832|NCT00241722|constipation|constipation
756833|NCT00241722|gastrointestinal|gastrointestinal
756834|NCT00241722|opioids|opioids
756835|NCT00241722|pain|pain
756836|NCT00241722|non-cancer pain|non-cancer pain
756837|NCT00241722|opioid-induced|opioid-induced
756838|NCT00368355|haploidenticalstem cell transplant|haploidenticalstem cell transplant
756839|NCT00368355|acute lymphoblastic leukemia|acute lymphoblastic leukemia
756840|NCT00368355|Non Hodgkins Lymphoma|non hodgkins lymphoma
756841|NCT00368355|Myelodysplastic Syndrome|myelodysplastic syndrome
756842|NCT00368355|Acute myeloid leukemia|acute myeloid leukemia
756843|NCT00368355|Chronic myelogenous leukemia|chronic myelogenous leukemia
756844|NCT00368355|Hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
756845|NCT00368355|Familial hemophagocytic lymphohistiocytosis (FLH)|familial hemophagocytic lymphohistiocytosis (flh)
756846|NCT00368355|Viral-associated hemophagocytic syndrome (VAHS)|viral-associated hemophagocytic syndrome (vahs)
756847|NCT00368355|X-linked lymphoproliferative disease (XLP)|x-linked lymphoproliferative disease (xlp)
756848|NCT00216710|Child abuse|child abuse
756849|NCT00216710|Neglect|neglect
756850|NCT00216710|Home visitation|home visitation
756851|NCT00216710|Program evaluation|program evaluation
756852|NCT00101998|OBD (Induced Bowel Dysfunction)|obd (induced bowel dysfunction)
756853|NCT00101998|cancer pain|cancer pain
756854|NCT00101998|pain medication|pain medication
756855|NCT00101998|constipation|constipation
756856|NCT00101998|bowel|bowel
756857|NCT00101998|bowel dysfunction|bowel dysfunction
756864|NCT00062868|Lymphoma|lymphoma
756865|NCT00062868|EBV-T/NK lymphoproliferative disease|ebv-t/nk lymphoproliferative disease
756866|NCT00062868|Severe Chronic EBV|severe chronic ebv
756867|NCT00062868|LMP1/2|lmp1/2
11915|NCT03214562|Ara-C|ara-c
11916|NCT03214562|Cytosar|cytosar
11917|NCT03214562|DepoCyt|depocyt
11918|NCT03214562|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
11919|NCT03214562|Idarubicin|idarubicin
11920|NCT03214562|Idamycin|idamycin
11921|NCT03214562|Filgrastim|filgrastim
11922|NCT03214562|G-CSF|g-csf
11923|NCT03214562|Neupogen|neupogen
11924|NCT03214562|Pegylated filgrastim|pegylated filgrastim
11925|NCT03214562|Neulasta|neulasta
11926|NCT03214562|Venetoclax|venetoclax
11927|NCT03214562|ABT-199|abt-199
11928|NCT03214562|GDC-0199|gdc-0199
11929|NCT03214536|spine surgery|spine surgery
11930|NCT03214536|regional anaesthesia|regional anaesthesia
11931|NCT03214536|opioid consumption|opioid consumption
11932|NCT03214536|acute postoperative pain|acute postoperative pain
11933|NCT03214523|sleep|sleep
11934|NCT03214523|actigraphy|actigraphy
11935|NCT03214510|Diseases of liver|diseases of liver
11936|NCT03214510|Thoracic epidural analgesia|thoracic epidural analgesia
11937|NCT03214510|TEA|tea
11938|NCT03214510|Transversus abdominus plane|transversus abdominus plane
11939|NCT03214510|TAP|tap
11940|NCT03214510|Liver resection|liver resection
11941|NCT03214510|Bupivacaine|bupivacaine
11942|NCT03214510|Liposomal Bupivacaine|liposomal bupivacaine
11943|NCT03214510|Hydromorphone|hydromorphone
11944|NCT03214510|Questionnaires|questionnaires
11945|NCT03214510|Surveys|surveys
11946|NCT03214497|laryngeal mask|laryngeal mask
11947|NCT03214497|Supreme|supreme
11948|NCT03214497|Protector|protector
11949|NCT03214471|bariatric surgery|bariatric surgery
11950|NCT03214471|healthy lifestyle|healthy lifestyle
11951|NCT03214458|Therapy|therapy
11952|NCT03214458|Noninvasive Ventilation|noninvasive ventilation
11953|NCT03214432|Mild traumatic brain injury|mild traumatic brain injury
11954|NCT03214432|Concussion|concussion
11955|NCT03214432|Labour market affiliation|labour market affiliation
11956|NCT03214432|Return to work|return to work
11957|NCT03214432|Sickness absence|sickness absence
11958|NCT03214432|Long-term sickness absence|long-term sickness absence
11959|NCT03214432|Disability pension|disability pension
11960|NCT03214419|Breast cancer|breast cancer
11961|NCT03214419|3D Optical scanning|3d optical scanning
11962|NCT03214419|Preoperative MRI|preoperative mri
11963|NCT03214419|Tumor localization|tumor localization
11964|NCT03214354|sickle cell disease|sickle cell disease
11965|NCT03214354|stem cell transplant|stem cell transplant
11966|NCT03214354|red blood cell engraftment|red blood cell engraftment
11967|NCT03214354|nonmyeloablative|nonmyeloablative
11968|NCT03214354|pure red cell aplasia|pure red cell aplasia
11969|NCT03214341|mediastinal masses|mediastinal masses
11970|NCT03214341|MRI diffusion|mri diffusion
11971|NCT03214315|Prostatectomy|prostatectomy
11972|NCT03214302|antiviral treatment|antiviral treatment
11973|NCT03214302|hepatitis B virus|hepatitis b virus
11974|NCT03214302|pregnant woman|pregnant woman
12066|NCT03213782|Patients|patients
11977|NCT03214289|Intestinal Acute Graft Versus Host Disease|intestinal acute graft versus host disease
11978|NCT03214289|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
11979|NCT03214276|polyphenols|polyphenols
11981|NCT03214276|endurance|endurance
11982|NCT03214276|aerobic|aerobic
11983|NCT03214276|pain|pain
11984|NCT03214263|Inflammatory rheumatic diseases|inflammatory rheumatic diseases
11985|NCT03214263|Biomarkers|biomarkers
11986|NCT03214263|Tailored treatment|tailored treatment
11987|NCT03214263|Personalised medicine|personalised medicine
11988|NCT03214263|DANBIO|danbio
11989|NCT03214263|Danish Rheumatologic Biobank|danish rheumatologic biobank
11990|NCT03214263|clinical data|clinical data
11991|NCT03214250|Nivolumab|nivolumab
11992|NCT03214250|APX005M|apx005m
11993|NCT03214250|previously untreated metastatic pancreatic adenocarcinoma|previously untreated metastatic pancreatic adenocarcinoma
11994|NCT03214250|Gemcitabine|gemcitabine
11995|NCT03214250|nab-Paclitaxel|nab-paclitaxel
11999|NCT03214185|unexplained recurrent pregnancy loss|unexplained recurrent pregnancy loss
12000|NCT03214185|infertility, female|infertility, female
12001|NCT03214185|preimplantation genetic screening|preimplantation genetic screening
12002|NCT03214185|in vitro fertilization|in vitro fertilization
12003|NCT03214185|intracytoplasmic sperm injection|intracytoplasmic sperm injection
12004|NCT03214146|ALS|als
12005|NCT03214146|Motor Neuron Disease|motor neuron disease
12006|NCT03214146|Neuromuscular Disease|neuromuscular disease
12007|NCT03214146|Neurodegenerative Disease|neurodegenerative disease
12008|NCT03214146|Central Nervous System Disease|central nervous system disease
12009|NCT03214146|HLA-haplo matched allogenic bone marrow derived stem cells|hla-haplo matched allogenic bone marrow derived stem cells
12010|NCT03214120|thromboelastography, modified ultrafiltration|thromboelastography, modified ultrafiltration
12011|NCT03214107|Exercise|exercise
12012|NCT03214107|Hypoglycemia|hypoglycemia
12013|NCT03214107|Carbohydrates|carbohydrates
12014|NCT03214029|troponin|troponin
12015|NCT03214029|high-sensitivity cardiac troponin|high-sensitivity cardiac troponin
12016|NCT03214029|acute myocardial infarction|acute myocardial infarction
12017|NCT03214016|Pilates Training|pilates training
12018|NCT03214016|Aerobic Exercises|aerobic exercises
12019|NCT03214016|Hypertension|hypertension
12020|NCT03214016|Clinical trial|clinical trial
12021|NCT03214003|small cell lung cancer limited stage|small cell lung cancer limited stage
12022|NCT03214003|twice-daily radiotherapy|twice-daily radiotherapy
12023|NCT03214003|simultaneous integrated boosting technique|simultaneous integrated boosting technique
12024|NCT03213990|Sepsis|sepsis
12025|NCT03213990|Beta-lactam antibiotics|beta-lactam antibiotics
12026|NCT03213977|DLBCL, R-DA-EPOCH, R-CEOP90, auto-HSCT|dlbcl, r-da-epoch, r-ceop90, auto-hsct
12027|NCT03213964|Recurrent|recurrent
12028|NCT03213964|Platinum Resistant|platinum resistant
12029|NCT03213964|Platinum Sensitive|platinum sensitive
12030|NCT03213951|Surgical resection|surgical resection
12031|NCT03213951|Margins of resection|margins of resection
12032|NCT03213951|Beta radiopharmaceutical|beta radiopharmaceutical
12033|NCT03213951|Beta probe device|beta probe device
12034|NCT03213951|Ex-vivo|ex-vivo
12035|NCT03213938|Chronic prostatitis|chronic prostatitis
12036|NCT03213938|chronic pelvic pain syndrome|chronic pelvic pain syndrome
12037|NCT03213938|acupuncture|acupuncture
12038|NCT03213938|randomized controlled trial|randomized controlled trial
12039|NCT03213912|effective concentration|effective concentration
12040|NCT03213899|Subjective Global Assessment|subjective global assessment
12041|NCT03213899|Nutritional Status|nutritional status
12042|NCT03213899|Hospital Mortality|hospital mortality
12043|NCT03213899|Length of Stay|length of stay
12044|NCT03213899|Malnutrition|malnutrition
12045|NCT03213886|hip fracture|hip fracture
12046|NCT03213886|elderly|elderly
12047|NCT03213886|vitamin D|vitamin d
12048|NCT03213886|rehabilitation|rehabilitation
12049|NCT03213873|Balance control|balance control
12050|NCT03213873|Exercise|exercise
12051|NCT03213873|Magnetic Resonance Imaging|magnetic resonance imaging
12052|NCT03213873|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
12053|NCT03213847|Carpal Tunnel Syndrome|carpal tunnel syndrome
12054|NCT03213847|Superb microvascular imaging|superb microvascular imaging
12055|NCT03213847|Doppler ultrasound|doppler ultrasound
12056|NCT03213847|Ultrasound|ultrasound
12057|NCT03213847|Median Nerve Entrapment|median nerve entrapment
12058|NCT03213847|Diagnoses Disease|diagnoses disease
12059|NCT03213808|Allergic diseases|allergic diseases
12060|NCT03213808|hypersensitivity|hypersensitivity
12061|NCT03213808|International Classification of Diseases (ICD)|international classification of diseases (icd)
12062|NCT03213808|World Health Organization (WHO)|world health organization (who)
12063|NCT03213782|Nature Based Sounds|nature based sounds
12064|NCT03213782|Agitation|agitation
12065|NCT03213782|Anxiety|anxiety
12067|NCT03213782|Intensive Care Units|intensive care units
12068|NCT03213769|oral minor aphthous ulcer|oral minor aphthous ulcer
12069|NCT03213769|topical Q10 gel|topical q10 gel
12070|NCT03213769|topical antioxidant|topical antioxidant
12071|NCT03213769|oral recurrent aphthous ulcer|oral recurrent aphthous ulcer
12072|NCT03213769|oral aphthous stomatitis|oral aphthous stomatitis
12073|NCT03213756|doppler ultrasound|doppler ultrasound
12074|NCT03213756|physical exercise|physical exercise
12077|NCT03213717|Loading|loading
12078|NCT03213717|Edema|edema
12079|NCT03213717|Urine|urine
12080|NCT03213613|Teen health|teen health
12081|NCT03213613|Teen development|teen development
12082|NCT03213613|Adolescent development|adolescent development
12083|NCT03213613|Memory|memory
12084|NCT03213613|Attention|attention
12085|NCT03213613|Reward processing|reward processing
12086|NCT03213574|Goal directed fluid therapy|goal directed fluid therapy
12087|NCT03213548|alar base reduction|alar base reduction
12088|NCT03213548|alar facial groove|alar facial groove
12089|NCT03213548|alectomy|alectomy
12090|NCT03213548|Flare|flare
12091|NCT03213548|Nose|nose
12092|NCT03213535|PROM|prom
12093|NCT03213496|clinical trial, non cardiac surgery, walking.|clinical trial, non cardiac surgery, walking.
12094|NCT03213483|gingival recession|gingival recession
12095|NCT03213483|connective tissue graft|connective tissue graft
12096|NCT03213483|deepithelialized free gingival graft|deepithelialized free gingival graft
12097|NCT03213483|free gingival graft|free gingival graft
12098|NCT03213457|Endometriosis associated pain|endometriosis associated pain
12099|NCT03213457|Elagolix|elagolix
12100|NCT03213457|Non-menstrual pelvic pain (NMPP)|non-menstrual pelvic pain (nmpp)
12101|NCT03213457|Dysmenorrhea (DYS)|dysmenorrhea (dys)
12102|NCT03213444|Colon cancer|colon cancer
12103|NCT03213444|adjuvant chemotherapy|adjuvant chemotherapy
12104|NCT03213444|sympathetic nerve activity|sympathetic nerve activity
12105|NCT03213444|peripheral vascular function|peripheral vascular function
12106|NCT03213431|Cancer survivors|cancer survivors
12107|NCT03213431|Instrument development|instrument development
12108|NCT03213431|Neurocognitive functioning|neurocognitive functioning
12109|NCT03213431|Patient-reported outcomes|patient-reported outcomes
12110|NCT03213431|Qualitative interview|qualitative interview
12111|NCT03213405|human Respiratory Syncytial Virus|human respiratory syncytial virus
12112|NCT03213405|Phase I|phase i
12113|NCT03213405|Recombinant BCG vaccine|recombinant bcg vaccine
12114|NCT03213379|actimeter|actimeter
12115|NCT03213379|apomorphin pump|apomorphin pump
12116|NCT03213366|PrEP|prep
12117|NCT03213366|HIV prevention|hiv prevention
12118|NCT03213366|Public Health Social Media Campaign|public health social media campaign
12119|NCT03213366|Peer Intervention|peer intervention
12120|NCT03213327|mental health|mental health
12121|NCT03213327|assessment|assessment
12122|NCT03213327|health promotion|health promotion
12123|NCT03213327|case management|case management
12124|NCT03213327|health insurance|health insurance
12125|NCT03213314|LiverMultiScan|livermultiscan
12126|NCT03213314|multiparameter MRI|multiparameter mri
12127|NCT03213314|functional liver remnant|functional liver remnant
12128|NCT03213314|liver resection|liver resection
12129|NCT03213314|hepatic resection|hepatic resection
12130|NCT03213314|portal vein embolisation|portal vein embolisation
12131|NCT03213314|preoperative liver function|preoperative liver function
12132|NCT03213314|postoperative liver failure|postoperative liver failure
12133|NCT03213301|Progressive Malignant Pleural Mesothelioma|progressive malignant pleural mesothelioma
12134|NCT03213301|Lurbinectedin|lurbinectedin
12135|NCT03213301|Mesothelioma|mesothelioma
12136|NCT03213301|Phase II Trial|phase ii trial
12137|NCT03213275|Extremely premature infants|extremely premature infants
12138|NCT03213275|gut-immune-brain axis|gut-immune-brain axis
12139|NCT03213275|neonatal brain injury|neonatal brain injury
12140|NCT03213275|gut microbiome|gut microbiome
12141|NCT03213275|neurodevelopmental outcome|neurodevelopmental outcome
12142|NCT03213275|neonatal immunity|neonatal immunity
12143|NCT03213223|retention|retention
12144|NCT03213223|attrition|attrition
12145|NCT03213223|PMTCT|pmtct
12146|NCT03213223|elimination of mother to child transmission of HIV|elimination of mother to child transmission of hiv
12147|NCT03213184|Birth cohort|birth cohort
12148|NCT03213184|asthma|asthma
12149|NCT03213184|allergies|allergies
12150|NCT03213171|organ donation|organ donation
12151|NCT03213171|family physician|family physician
12152|NCT03213171|primary care|primary care
12153|NCT03213171|clinical trial|clinical trial
12154|NCT03213171|registry trial|registry trial
12155|NCT03213171|cluster trial|cluster trial
12156|NCT03213171|stepped-wedge|stepped-wedge
12157|NCT03213145|drug-drug interaction|drug-drug interaction
12158|NCT03213132|sleep|sleep
12159|NCT03213132|insomnia|insomnia
12160|NCT03213132|CBT|cbt
12161|NCT03213119|Caloric Vestibular Stimulation Reward|caloric vestibular stimulation reward
12162|NCT03213119|Brain Stimulation|brain stimulation
12163|NCT03213119|Reward|reward
12164|NCT03213119|Vestibular System|vestibular system
12165|NCT03213119|Cingulate Cortex|cingulate cortex
12166|NCT03213119|Cancellation Tasks|cancellation tasks
12168|NCT03213106|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
12169|NCT03213106|Cerebellar Ataxia|cerebellar ataxia
12170|NCT03213093|Diabetes|diabetes
12171|NCT03213093|Diabetic Foot Ulcer|diabetic foot ulcer
12172|NCT03213093|Plantar pressure|plantar pressure
12173|NCT03213080|Targeted Lung Denervation|targeted lung denervation
12175|NCT03213054|esophageal cancer|esophageal cancer
12176|NCT03213054|OBP-301|obp-301
12177|NCT03213054|radiation|radiation
12178|NCT03213054|Telomelysin|telomelysin
12179|NCT03213054|radiotherapy|radiotherapy
12180|NCT03213054|oncolytic|oncolytic
12181|NCT03213054|virotherapy|virotherapy
12182|NCT03213054|loco regional|loco regional
12183|NCT03213015|confiability|confiability
12184|NCT03213015|ankle|ankle
12185|NCT03213015|patellofemoral pain syndrome|patellofemoral pain syndrome
12186|NCT03212989|HIV|hiv
12187|NCT03212989|HXTC|hxtc
12188|NCT03212989|Antiretroviral Therapy|antiretroviral therapy
12189|NCT03212989|HIV-Infected|hiv-infected
12190|NCT03212989|Vorinostat|vorinostat
12191|NCT03212989|AIDS|aids
12192|NCT03212976|Non-Invasive|non-invasive
12193|NCT03212976|Magnetic Resonance Imaging|magnetic resonance imaging
12194|NCT03212976|Ventricular catheters|ventricular catheters
12195|NCT03212924|cochlear implant|cochlear implant
12196|NCT03212924|Listening effort|listening effort
12197|NCT03212924|pupillometry|pupillometry
12198|NCT03212911|HBV vaccination, HIV, isolated anti-HBc|hbv vaccination, hiv, isolated anti-hbc
12199|NCT03212898|pharmacist interventions, warfarin, elderly rural patients|pharmacist interventions, warfarin, elderly rural patients
12200|NCT03212885|Deep Brain Stimulation|deep brain stimulation
12201|NCT03212872|Ammonia|ammonia
12202|NCT03212872|bleeding risk factors|bleeding risk factors
12203|NCT03212872|endoscopic risk signs for bleeding|endoscopic risk signs for bleeding
12204|NCT03212872|esophageal varices|esophageal varices
12205|NCT03212859|older adults|older adults
12206|NCT03212859|physiotherapy|physiotherapy
12207|NCT03212859|physical activity|physical activity
12208|NCT03212846|hippotherapy|hippotherapy
12209|NCT03212846|cerebral palsy|cerebral palsy
12210|NCT03212846|spasticity|spasticity
12211|NCT03212807|Checkpoint inhibition|checkpoint inhibition
12212|NCT03212807|PDL1|pdl1
12213|NCT03212807|EBV DLBCL|ebv dlbcl
12214|NCT03212807|PCNSL|pcnsl
12215|NCT03212716|Infectiology|infectiology
12216|NCT03212716|Biology of infectious agents|biology of infectious agents
12217|NCT03212716|Flu|flu
12218|NCT03212716|Intensive care|intensive care
12219|NCT03212703|Mindfulness training|mindfulness training
12220|NCT03212703|Parents and families|parents and families
12221|NCT03212703|Pediatric OCD|pediatric ocd
12222|NCT03212690|mechanical ventilation|mechanical ventilation
12223|NCT03212690|echocardiography|echocardiography
12224|NCT03212690|right ventricular function|right ventricular function
12225|NCT03212690|Ang (1-7)|ang (1-7)
12226|NCT03212690|Ang II|ang ii
12227|NCT03212690|Renin-angiotensin system|renin-angiotensin system
12228|NCT03212625|Urea Cream|urea cream
12229|NCT03212625|Sorafenib|sorafenib
12230|NCT03212612|Galectin-3 ,endometrosis|galectin-3 ,endometrosis
12231|NCT03212599|APP-processing|app-processing
12232|NCT03212599|Disulfiram|disulfiram
12233|NCT03212599|ADAM10|adam10
12234|NCT03212599|Alzheimer's disease|alzheimer's disease
12235|NCT03212599|blood|blood
12236|NCT03212560|Exercise capacity|exercise capacity
12237|NCT03212560|Physical activity|physical activity
12238|NCT03212560|Quality of life|quality of life
12239|NCT03212560|Pulmonary functions|pulmonary functions
12240|NCT03212560|Muscle strength|muscle strength
12241|NCT03212560|Respiratory muscle strength|respiratory muscle strength
12242|NCT03212560|Respiratory muscle endurance|respiratory muscle endurance
12243|NCT03212560|Dyspnea|dyspnea
12244|NCT03212560|Anxiety|anxiety
12245|NCT03212560|Fatigue|fatigue
12246|NCT03212547|Social withdrawal|social withdrawal
12247|NCT03212547|Preterm Infant|preterm infant
12248|NCT03212547|Parent's mental health|parent's mental health
12249|NCT03212534|Dascena|dascena
12250|NCT03212534|patient mortality|patient mortality
12251|NCT03212534|machine learning|machine learning
12252|NCT03212534|algorithm|algorithm
12253|NCT03212534|diagnostic|diagnostic
12254|NCT03212521|Aspartate aminotransferase to Platelet Ratio Index (APRI)|aspartate aminotransferase to platelet ratio index (apri)
12255|NCT03212521|platelet|platelet
12256|NCT03212521|HCV genotype|hcv genotype
12257|NCT03212521|aspartate aminotransferase|aspartate aminotransferase
12258|NCT03212521|Sustained Virologic Response 12 weeks post dosing (SVR12)|sustained virologic response 12 weeks post dosing (svr12)
12259|NCT03212521|glecaprevir|glecaprevir
12260|NCT03212521|pibrentasvir|pibrentasvir
12261|NCT03212521|chronic hepatitis C virus (HCV)|chronic hepatitis c virus (hcv)
12262|NCT03212521|Hepatitis|hepatitis
12267|NCT03212482|brain-injured patients, patient-ventilator asychrony|brain-injured patients, patient-ventilator asychrony
12269|NCT03212456|cancer recurrence|cancer recurrence
12270|NCT03212456|opioids analgesics|opioids analgesics
12271|NCT03212456|neoplasm|neoplasm
12272|NCT03212430|L-kynurenine|l-kynurenine
12273|NCT03212430|Cerebral hemodynamic|cerebral hemodynamic
12274|NCT03212430|Headache|headache
12275|NCT03212430|Mohammad Al-Mahdi Al-Karagholi|mohammad al-mahdi al-karagholi
12276|NCT03212404|Cancer|cancer
12277|NCT03212404|PD-L1|pd-l1
12278|NCT03212404|PDL1|pdl1
12279|NCT03212404|PD-1|pd-1
12280|NCT03212404|PD1|pd1
12281|NCT03212404|Solid tumors|solid tumors
12282|NCT03212404|Anti PD-L1|anti pd-l1
12289|NCT03212339|parent-child interactions|parent-child interactions
12290|NCT03212339|mental health care|mental health care
12291|NCT03212339|child health services|child health services
12292|NCT03212339|parenting confidence|parenting confidence
12293|NCT03212339|adverse childhood events|adverse childhood events
12294|NCT03212339|dyadic care model|dyadic care model
12295|NCT03212313|Adults|adults
12296|NCT03212313|Liver Disease|liver disease
12297|NCT03212300|aerobic exercise training|aerobic exercise training
12298|NCT03212300|delirium|delirium
12299|NCT03212261|Lymphoma|lymphoma
12300|NCT03212222|screening|screening
12301|NCT03212222|cell phone application|cell phone application
12302|NCT03212209|Sleep Apnea|sleep apnea
12303|NCT03212209|CPAP|cpap
12304|NCT03212196|Pancreaticoduodenectomy|pancreaticoduodenectomy
12305|NCT03212196|Pancreaticogastrostomy|pancreaticogastrostomy
12306|NCT03212196|Pancreaticojejunostomy|pancreaticojejunostomy
12307|NCT03212196|Stent|stent
12308|NCT03212196|Transanastomotic drain|transanastomotic drain
12309|NCT03212183|web-based intervention|web-based intervention
12310|NCT03212183|self-management|self-management
12311|NCT03212183|nursing|nursing
12312|NCT03212183|epilepsy|epilepsy
12313|NCT03212183|seizures|seizures
12314|NCT03212170|Invasive Breast Cancer|invasive breast cancer
12315|NCT03212170|Metastatic Breast Cancer|metastatic breast cancer
12316|NCT03212170|PR Positive Breast Cancer|pr positive breast cancer
12317|NCT03212144|nuts|nuts
12318|NCT03212144|exercise|exercise
12319|NCT03212144|vagal activity|vagal activity
12320|NCT03212144|peanuts|peanuts
12321|NCT03212144|heart rate variability|heart rate variability
12322|NCT03212118|Sick Leave|sick leave
12323|NCT03212118|Return to work|return to work
609511|NCT00620451|Remission|remission
12324|NCT03212118|Motivational interviewing|motivational interviewing
12325|NCT03212118|Absenteeism|absenteeism
12326|NCT03212118|Occupational Health|occupational health
12327|NCT03212092|Aggression|aggression
12328|NCT03212092|aggressive behavior|aggressive behavior
12329|NCT03212092|nutritional supplements|nutritional supplements
12330|NCT03212092|dietary supplements|dietary supplements
12331|NCT03212092|vitamin, mineral|vitamin, mineral
12332|NCT03212092|omega-3|omega-3
12333|NCT03212092|n-3 fatty acids|n-3 fatty acids
12334|NCT03212092|intellectual disability|intellectual disability
12335|NCT03212079|Cancer Survivors|cancer survivors
12336|NCT03212079|Physical Activities|physical activities
12337|NCT03212079|Baltimore|baltimore
12338|NCT03212079|State of Maryland|state of maryland
12339|NCT03212053|Essential thrombocythemia|essential thrombocythemia
12340|NCT03212053|Multiplate|multiplate
12341|NCT03212053|ROTEM|rotem
4310|NCT03263312|myocardial fibrosis|myocardial fibrosis
4311|NCT03263312|exercise training|exercise training
4312|NCT03263312|Fontan|fontan
12342|NCT03212053|haemorrhage|haemorrhage
12343|NCT03212053|thrombosis|thrombosis
12344|NCT03212053|Vasodilatator Stimulated Phosphoprotein (VASP)|vasodilatator stimulated phosphoprotein (vasp)
12345|NCT03212027|apparent diffusion coefficient|apparent diffusion coefficient
12346|NCT03212027|aquaporins|aquaporins
12347|NCT03212014|Parkinson Disease|parkinson disease
12348|NCT03212014|intelligent|intelligent
12349|NCT03212014|Rehabilitaion|rehabilitaion
12350|NCT03211988|abdominal|abdominal
12351|NCT03211988|neuroendocrine tumor|neuroendocrine tumor
12352|NCT03211988|columbia|columbia
12353|NCT03211988|relapsed|relapsed
12354|NCT03211988|refractory|refractory
12355|NCT03211949|axillary nerve block|axillary nerve block
12356|NCT03211923|muscle relaxation|muscle relaxation
12357|NCT03211923|transcranial magnetic stimulation|transcranial magnetic stimulation
12358|NCT03211923|myopathy|myopathy
12359|NCT03211910|Sacral and trochenteric pressure ulcers|sacral and trochenteric pressure ulcers
12360|NCT03211884|Problem solving therapy|problem solving therapy
12361|NCT03211884|Military family caregivers|military family caregivers
12362|NCT03211884|Cognitive impariment|cognitive impariment
12363|NCT03211884|Traumatic brain injury|traumatic brain injury
12364|NCT03211871|pain management, dexmedetomidine|pain management, dexmedetomidine
12365|NCT03211845|Ehealth|ehealth
12366|NCT03211845|Older adults|older adults
12367|NCT03211845|Undernutrition|undernutrition
12368|NCT03211845|Feasibility study|feasibility study
12369|NCT03211832|Dissemination research|dissemination research
12370|NCT03211832|Public health workforce|public health workforce
12371|NCT03211832|Diabetes prevention|diabetes prevention
12372|NCT03211832|Diabetes control|diabetes control
12373|NCT03211832|Chronic disease prevention|chronic disease prevention
12374|NCT03211832|Evidence-based public health|evidence-based public health
12375|NCT03211832|Public health accreditation|public health accreditation
12376|NCT03211819|immediate|immediate
12377|NCT03211819|esthetics|esthetics
12378|NCT03211793|systemic sclerosis|systemic sclerosis
12382|NCT03211793|mesenchymal stromal cell|mesenchymal stromal cell
12383|NCT03211793|mesenchymal stem cell|mesenchymal stem cell
12384|NCT03211754|Walnuts|walnuts
12385|NCT03211754|almonds|almonds
12386|NCT03211754|adiponectin|adiponectin
12387|NCT03211754|lipocalin-2|lipocalin-2
12388|NCT03211754|obesity|obesity
12389|NCT03211741|Bevacizumab|bevacizumab
12390|NCT03211702|geriatric assessments|geriatric assessments
12391|NCT03211702|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
12392|NCT03211702|activity of daily living|activity of daily living
12393|NCT03211702|instrumental activity of daily living|instrumental activity of daily living
12394|NCT03211702|Charlson's comorbidity index|charlson's comorbidity index
12395|NCT03211689|Exercise|exercise
12396|NCT03211689|Stress|stress
12397|NCT03211689|Fatigue|fatigue
12398|NCT03211689|Quality of Life|quality of life
12399|NCT03211676|dialyzer|dialyzer
12400|NCT03211676|beta2-microglobilin|beta2-microglobilin
12401|NCT03211676|myoglobin|myoglobin
12402|NCT03211637|nursing care|nursing care
12403|NCT03211637|skin lesions|skin lesions
12404|NCT03211637|wound healing|wound healing
12405|NCT03211637|varicose ulcers|varicose ulcers
12406|NCT03211611|BRCA1/2 Mutation|brca1/2 mutation
12407|NCT03211611|Breast cancer|breast cancer
12408|NCT03211611|General practitionner|general practitionner
12409|NCT03211572|breast|breast
12410|NCT03211559|ankylosing spondylitis|ankylosing spondylitis
12411|NCT03211559|clinical pilates exercise|clinical pilates exercise
12412|NCT03211559|aerobic exercise|aerobic exercise
12413|NCT03211559|functional exercise capacity|functional exercise capacity
12414|NCT03211559|pulmonary function|pulmonary function
12415|NCT03211546|Pediatric femur fracture|pediatric femur fracture
12416|NCT03211546|Spica casting|spica casting
12417|NCT03211546|Traction|traction
12418|NCT03211546|Intramedullary nailing|intramedullary nailing
12419|NCT03211546|Children|children
12420|NCT03211546|Internal fixation|internal fixation
12421|NCT03211546|External fixation|external fixation
12422|NCT03211533|infants at risk of cerebral palsy|infants at risk of cerebral palsy
12424|NCT03211533|general movements|general movements
12425|NCT03211520|Cancer treatment|cancer treatment
12426|NCT03211520|Anthracyclines|anthracyclines
12427|NCT03211520|Cardiac MRI|cardiac mri
12428|NCT03211494|Mechanical ventilation|mechanical ventilation
12429|NCT03211494|Driving pressure|driving pressure
12430|NCT03211494|Closed-loop ventilation|closed-loop ventilation
12431|NCT03211494|Esophageal catheter|esophageal catheter
12432|NCT03211455|bariatric surgery|bariatric surgery
12433|NCT03211455|rehabilitation|rehabilitation
12434|NCT03211455|lidocaine|lidocaine
12435|NCT03211442|Breast cancer|breast cancer
4501|NCT03261986|RSA|rsa
12436|NCT03211442|Radiotherapy|radiotherapy
12437|NCT03211442|Cardiac complications|cardiac complications
12438|NCT03211442|Acute coronary events|acute coronary events
12439|NCT03211442|NTCP model|ntcp model
12440|NCT03211325|Transient Receptor Potential Channels|transient receptor potential channels
12441|NCT03211325|Raynaud's Phenomenon Isolated Primary|raynaud's phenomenon isolated primary
12442|NCT03211325|Raynaud's Phenomenon (Secondary)|raynaud's phenomenon (secondary)
12443|NCT03211286|Hip fracture|hip fracture
12444|NCT03211286|Tranexamic acid|tranexamic acid
12445|NCT03211286|Perioperative blood loss|perioperative blood loss
12446|NCT03211286|Blood Transfusion|blood transfusion
12447|NCT03211260|Parkinson Disease|parkinson disease
12448|NCT03211260|Freezing of gait|freezing of gait
12449|NCT03211260|Equistasi|equistasi
12450|NCT03211247|EPIT|epit
12451|NCT03211247|Epicutaneous|epicutaneous
12452|NCT03211247|Immunotherapy|immunotherapy
12453|NCT03211247|Viaskin|viaskin
12455|NCT03211221|TMS|tms
12456|NCT03211182|lifestyle intervention|lifestyle intervention
12457|NCT03211182|prediabetes|prediabetes
12458|NCT03211156|Amoxicillin|amoxicillin
12459|NCT03211156|Gardnerella vaginalis|gardnerella vaginalis
12460|NCT03211156|Vaginal Colonization|vaginal colonization
12461|NCT03211143|GERD|gerd
12462|NCT03211143|CKD-381|ckd-381
12464|NCT03211143|Bioeqivalence|bioeqivalence
12465|NCT03211130|medication adherence|medication adherence
12466|NCT03211130|self-management|self-management
12467|NCT03211130|antithrombotic|antithrombotic
12468|NCT03211104|intermittent androgen deprivation therapy|intermittent androgen deprivation therapy
12469|NCT03211104|curcumin|curcumin
12470|NCT03211078|Early lung cancer|early lung cancer
12471|NCT03211078|Photodynamic therapy|photodynamic therapy
12472|NCT03211078|ENB|enb
12473|NCT03211065|Rituximab|rituximab
12474|NCT03211065|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
12475|NCT03211065|Subcutaneous Immunoglobulin|subcutaneous immunoglobulin
12476|NCT03211039|Rady Children's|rady children's
15243|NCT03193333|timolol|timolol
12477|NCT03211039|Pediatric|pediatric
12479|NCT03211039|Precision Medicine|precision medicine
12480|NCT03211039|Neonate|neonate
12481|NCT03211026|Urinary tract infection|urinary tract infection
12482|NCT03211026|Multidrug resistant bacteria|multidrug resistant bacteria
12483|NCT03211026|Candiduria|candiduria
12484|NCT03211026|Epidemiology|epidemiology
12485|NCT03211026|Graft rejection|graft rejection
12486|NCT03211026|Solid organ transplantation|solid organ transplantation
12487|NCT03211013|oxytocin|oxytocin
12488|NCT03211013|PTSD|ptsd
12489|NCT03211013|attention bias|attention bias
12490|NCT03211013|startle|startle
12491|NCT03211000|aortic aneurysm|aortic aneurysm
12492|NCT03211000|autophagy|autophagy
12493|NCT03211000|oxidative stress|oxidative stress
12494|NCT03211000|Hippo pathway|hippo pathway
12495|NCT03210987|ward round|ward round
12496|NCT03210987|patient case presentation|patient case presentation
12497|NCT03210987|communication|communication
12498|NCT03210987|patient-centered care|patient-centered care
12499|NCT03210935|Adnexal cutaneous carcinoma|adnexal cutaneous carcinoma
12500|NCT03210935|Merkel cell carcinoma|merkel cell carcinoma
12501|NCT03210935|Advanced basal cell carcinoma requiring systemic treatment|advanced basal cell carcinoma requiring systemic treatment
12502|NCT03210922|cervical collar, nasoendotracheal intubation, glidescope|cervical collar, nasoendotracheal intubation, glidescope
12503|NCT03210870|Maternal health|maternal health
12504|NCT03210870|maternal nutrition|maternal nutrition
12505|NCT03210870|fetal health related to maternal nutrition|fetal health related to maternal nutrition
12506|NCT03210857|apnea|apnea
12507|NCT03210857|neck extension|neck extension
12508|NCT03210857|syncope|syncope
12509|NCT03210857|diving blackout|diving blackout
12510|NCT03210857|right internal carotid arteria|right internal carotid arteria
12511|NCT03210857|pulsatility index|pulsatility index
12512|NCT03210857|healthy trained apnoea divers|healthy trained apnoea divers
12513|NCT03210857|doppler ultrasonography|doppler ultrasonography
12514|NCT03210844|total hip arthroplasty|total hip arthroplasty
12515|NCT03210844|direct anterior|direct anterior
12516|NCT03210844|posterior approach|posterior approach
12517|NCT03210831|NEC, tissue oxygenation, gut inflammation|nec, tissue oxygenation, gut inflammation
12518|NCT03210779|oral wound healing|oral wound healing
12519|NCT03210779|probiotics|probiotics
12520|NCT03210766|Cannabinoids, nabilone, FBSS, THC/CBD, refractory pain|cannabinoids, nabilone, fbss, thc/cbd, refractory pain
12521|NCT03210753|Multiple Myeloma|multiple myeloma
12522|NCT03210753|Peripheral neuropathy|peripheral neuropathy
12523|NCT03210753|Subcutaneous injection|subcutaneous injection
12524|NCT03210753|Bortezomib|bortezomib
12525|NCT03210753|Risk factors|risk factors
12526|NCT03210701|pharmacy|pharmacy
12527|NCT03210701|pharmacist|pharmacist
12529|NCT03210701|Implementation science|implementation science
12530|NCT03210688|Prednisolone|prednisolone
12531|NCT03210688|alfacalcidol|alfacalcidol
4531|NCT03261791|resection|resection
4532|NCT03261739|NAFLD, CB1 receptor blockade, anti-CB1 monoclonal antibody|nafld, cb1 receptor blockade, anti-cb1 monoclonal antibody
4533|NCT03261726|unilateral deafness|unilateral deafness
4534|NCT03261726|acoustic neuroma|acoustic neuroma
4535|NCT03261726|cochlear implant|cochlear implant
12532|NCT03210688|Minimal change nephropathy|minimal change nephropathy
12533|NCT03210662|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
12534|NCT03210662|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
12535|NCT03210662|NHL|nhl
12536|NCT03210662|Relapsed|relapsed
12537|NCT03210662|Refractory|refractory
12538|NCT03210662|Pembrolizumab|pembrolizumab
12539|NCT03210662|Keytruda|keytruda
12540|NCT03210662|MK-3475|mk-3475
12541|NCT03210662|SCH-900475|sch-900475
12542|NCT03210662|External Beam Radiotherapy|external beam radiotherapy
12543|NCT03210662|EBRT|ebrt
12544|NCT03210662|Radiation therapy|radiation therapy
12545|NCT03210649|Dyslipidemia|dyslipidemia
12546|NCT03210597|water-base exercise|water-base exercise
12547|NCT03210584|Knee joint|knee joint
12548|NCT03210584|Cartilage degeneration|cartilage degeneration
12549|NCT03210584|Ultrasound imaging|ultrasound imaging
12550|NCT03210584|Full-Field Optical Coherence Tomography|full-field optical coherence tomography
12551|NCT03210584|9,4 Tesla MRI|9,4 tesla mri
12552|NCT03210584|Multimodal evaluation|multimodal evaluation
12553|NCT03210558|female athletes, testosterone, physical performance, body composition|female athletes, testosterone, physical performance, body composition
12554|NCT03210545|Biomarker|biomarker
12555|NCT03210545|Glucocorticoids|glucocorticoids
12556|NCT03210545|Metabolism|metabolism
12557|NCT03210506|chronic hepatitis B|chronic hepatitis b
12568|NCT03210480|Prolonged release formulation|prolonged release formulation
12569|NCT03210480|Lithium carbonate|lithium carbonate
12570|NCT03210480|Immediate release formulation|immediate release formulation
12571|NCT03210480|Bipolar Disorder|bipolar disorder
12572|NCT03210480|Tremor|tremor
12573|NCT03210467|chronic hepatitis B|chronic hepatitis b
12574|NCT03210467|hepatitis B virus|hepatitis b virus
12575|NCT03210467|Pegylated Interferon α-2a|pegylated interferon α-2a
12576|NCT03210467|entecavir|entecavir
12577|NCT03210467|Plasmacytoid Dendritic Cells|plasmacytoid dendritic cells
12578|NCT03210415|Preterm Labor|preterm labor
12579|NCT03210415|China|china
12580|NCT03210415|Pregnant Women|pregnant women
12581|NCT03210415|≥35 Years Old|≥35 years old
12585|NCT03210376|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
12586|NCT03210376|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
12587|NCT03210376|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
12588|NCT03210376|Neuromuscular blockade|neuromuscular blockade
12590|NCT03210376|Sugammadex|sugammadex
12591|NCT03210376|Neostigmine|neostigmine
12592|NCT03210376|Pain Assessment|pain assessment
12593|NCT03210376|Survey|survey
12594|NCT03210324|mifepristone antiprogestins|mifepristone antiprogestins
12595|NCT03210298|Pressurized IntraPeritoneal Aerosol Chemotherapy|pressurized intraperitoneal aerosol chemotherapy
12596|NCT03210298|PIPAC|pipac
12597|NCT03210298|Pressurized IntraThoracic Aerosol Chemotherapy|pressurized intrathoracic aerosol chemotherapy
12598|NCT03210298|PITAC|pitac
12599|NCT03210298|Cisplatin|cisplatin
12600|NCT03210298|Oxaliplatin|oxaliplatin
12601|NCT03210298|Gemcitabine|gemcitabine
12602|NCT03210298|Paclitaxel|paclitaxel
12603|NCT03210298|nab-Paclitaxel|nab-paclitaxel
12604|NCT03210298|Doxorubicine|doxorubicine
12605|NCT03210298|Mitomycin|mitomycin
12606|NCT03210285|Whole exome sequencing|whole exome sequencing
12607|NCT03210285|Neurofibromatosis Type 2|neurofibromatosis type 2
12608|NCT03210285|Acoustic Neuroma|acoustic neuroma
12609|NCT03210285|Vestibular schwannoma|vestibular schwannoma
12621|NCT03210142|Sleep Apnea, Neural Stimulation|sleep apnea, neural stimulation
12622|NCT03210129|Motivation|motivation
12623|NCT03210129|Behavior|behavior
12624|NCT03210129|Exercise|exercise
12625|NCT03210129|Motivational interview|motivational interview
12626|NCT03210129|Cancer|cancer
12627|NCT03210129|economic evaluation|economic evaluation
12628|NCT03210103|Transoral Surgery|transoral surgery
12629|NCT03210103|Head and Neck Cancer|head and neck cancer
12630|NCT03210090|Stem cells transplantation|stem cells transplantation
12631|NCT03210090|Cytomegalovirus infection|cytomegalovirus infection
12632|NCT03210090|CMV-Specific Immune response|cmv-specific immune response
12633|NCT03210090|Immune reconstitution|immune reconstitution
12634|NCT03210090|Humoral/Cellular mismatch|humoral/cellular mismatch
12635|NCT03210090|Interferon-gamma|interferon-gamma
12636|NCT03210077|general anesthesia|general anesthesia
12637|NCT03210077|Entropy|entropy
10470|NCT03224000|MBS|mbs
12638|NCT03210077|Hypnosis|hypnosis
12639|NCT03210064|Apatinib|apatinib
12640|NCT03210051|Acute ischemic stroke|acute ischemic stroke
12641|NCT03210051|Endovascular treatment|endovascular treatment
12642|NCT03210051|Remote ischemic conditioning|remote ischemic conditioning
12643|NCT03210051|Reperfusion therapy|reperfusion therapy
12644|NCT03210051|Neuroprotection|neuroprotection
12645|NCT03210038|Cystoscopy|cystoscopy
12646|NCT03209986|Liver Cirrhosis|liver cirrhosis
12647|NCT03209986|Mesenchymal Sem Cells|mesenchymal sem cells
12648|NCT03209947|Ulnar Neuropathies|ulnar neuropathies
12649|NCT03209947|Ultrasound|ultrasound
12650|NCT03209934|Bone and Joint Infection|bone and joint infection
12651|NCT03209934|Daptomycin|daptomycin
12652|NCT03209934|Eosinophilic pneumonia|eosinophilic pneumonia
12653|NCT03209921|Bone and Joint Infection|bone and joint infection
12654|NCT03209921|Daptomycin|daptomycin
12655|NCT03209908|antiviral treatment|antiviral treatment
12656|NCT03209908|hepatitis B virus|hepatitis b virus
12657|NCT03209908|mother-to-child transmission|mother-to-child transmission
12658|NCT03209908|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
12659|NCT03209882|Transcranial infrared laser stimulation (TILS)|transcranial infrared laser stimulation (tils)
12660|NCT03209882|Near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
12661|NCT03209830|mental fatigue|mental fatigue
12662|NCT03209830|drug therapy|drug therapy
12663|NCT03209830|subarachnoid hemorrhage|subarachnoid hemorrhage
12664|NCT03209830|stroke|stroke
12665|NCT03209804|Intracranial Arteriovenous Malformations|intracranial arteriovenous malformations
12666|NCT03209752|3D analysis|3d analysis
12667|NCT03209752|Brace|brace
12668|NCT03209752|EOS imagind system|eos imagind system
12669|NCT03209752|Anatomical transfer|anatomical transfer
12670|NCT03209713|Mexican|mexican
12671|NCT03209713|Mexican-American|mexican-american
12672|NCT03209713|17-336|17-336
12673|NCT03209674|Cardiac surgery|cardiac surgery
12674|NCT03209674|Thoracic surgery|thoracic surgery
12675|NCT03209661|vascular function|vascular function
12676|NCT03209622|Smoking Cessation|smoking cessation
12677|NCT03209622|Acute Coronary Syndrome|acute coronary syndrome
12678|NCT03209622|Cardiology|cardiology
12679|NCT03209609|Coronary artery bypass|coronary artery bypass
12680|NCT03209596|Athletes|athletes
12681|NCT03209596|Food intake|food intake
12682|NCT03209596|Supplementation|supplementation
12683|NCT03209596|Biochemical biomarkers|biochemical biomarkers
12684|NCT03209596|Soccer Players|soccer players
12685|NCT03209570|urinary incontinence, nursing home|urinary incontinence, nursing home
12686|NCT03209557|Mobile Techology|mobile techology
12687|NCT03209557|Sociobehavioral|sociobehavioral
12688|NCT03209544|Suicidal ideation|suicidal ideation
12689|NCT03209544|Suicide|suicide
12690|NCT03209544|Cognitive behavioral therapy|cognitive behavioral therapy
12691|NCT03209544|Online intervention|online intervention
12692|NCT03209531|Quadriceps activation deficits|quadriceps activation deficits
12693|NCT03209531|ACL|acl
12694|NCT03209531|Surgery|surgery
12695|NCT03209531|Quadrcieps weakness|quadrcieps weakness
12696|NCT03209531|Operant conditioning|operant conditioning
12697|NCT03209531|Cortical excitability|cortical excitability
12698|NCT03209505|Lid Wiper Epitheliopahty|lid wiper epitheliopahty
12699|NCT03209505|Coefficient of Friction|coefficient of friction
12700|NCT03209466|Chlorhexidine gluconate|chlorhexidine gluconate
12701|NCT03209466|Diabetic foot ulcer syndrome|diabetic foot ulcer syndrome
12702|NCT03209466|Wound healing|wound healing
12703|NCT03209453|family work shop|family work shop
12704|NCT03209427|morphine, pruritus, serotonin|morphine, pruritus, serotonin
12705|NCT03209414|Frailty syndrome|frailty syndrome
12706|NCT03209414|Coronary heart disease|coronary heart disease
12707|NCT03209414|Coronary revascularization|coronary revascularization
12708|NCT03209414|Major adverse cardiovascular events|major adverse cardiovascular events
12709|NCT03209414|Arterial stiffness|arterial stiffness
12710|NCT03209414|Applanation tonometry|applanation tonometry
12711|NCT03209414|Lean body mass|lean body mass
12712|NCT03209414|ST2 biomarker|st2 biomarker
12713|NCT03209401|Niraparib|niraparib
12714|NCT03209401|Carboplatin|carboplatin
12715|NCT03209375|triage|triage
12716|NCT03209375|early warning system|early warning system
12717|NCT03209362|Knee|knee
12718|NCT03209362|Osteoarthritis|osteoarthritis
12719|NCT03209362|Intra-articular injection|intra-articular injection
12720|NCT03209349|Sigmoidoscopy|sigmoidoscopy
12721|NCT03209336|Ultra-low rectal cancer|ultra-low rectal cancer
609512|NCT00620451|Induction|induction
12722|NCT03209336|Intersphincteric resection|intersphincteric resection
12723|NCT03209336|IORT|iort
12724|NCT03209323|Epileptiform patterns|epileptiform patterns
12725|NCT03209323|sevoflurane|sevoflurane
12726|NCT03209323|propofol|propofol
12727|NCT03209323|bispectral index|bispectral index
12728|NCT03209323|state entropy|state entropy
12729|NCT03209323|response entropy|response entropy
12730|NCT03209323|A-line Auto Regressive Index|a-line auto regressive index
10595|NCT03223194|CN|cn
12731|NCT03209323|middle latency auditory evoked potentials|middle latency auditory evoked potentials
12732|NCT03209284|maxillary atrophy|maxillary atrophy
12733|NCT03209284|transcrestal sinus floor elevation|transcrestal sinus floor elevation
12734|NCT03209271|Fluid therapy|fluid therapy
12735|NCT03209258|Stroke|stroke
12736|NCT03209258|Intracerebral Hemorrhage|intracerebral hemorrhage
12737|NCT03209258|Care Bundle|care bundle
12738|NCT03209258|Clinical Trial|clinical trial
12739|NCT03209258|Stepped-wedge Cluster|stepped-wedge cluster
12740|NCT03209258|Management|management
12741|NCT03209258|Blood Pressure|blood pressure
12742|NCT03209219|effectiveness, safety|effectiveness, safety
12743|NCT03209206|Intravesical Chemotherapy|intravesical chemotherapy
12744|NCT03209206|Docetaxel|docetaxel
12745|NCT03209206|Radical Nephroureterectomy|radical nephroureterectomy
12746|NCT03209193|off-pump coronary artery bypass|off-pump coronary artery bypass
12747|NCT03209193|sevoflurane|sevoflurane
12748|NCT03209193|desflurane|desflurane
12750|NCT03209180|HFrEF|hfref
12751|NCT03209180|Carvedilol|carvedilol
12752|NCT03209180|Slow Release|slow release
12753|NCT03209180|NT-proBNP|nt-probnp
12754|NCT03209167|Breast reconstruction; abdominoplasty; patient satisfaction|breast reconstruction; abdominoplasty; patient satisfaction
12755|NCT03209154|Adherence|adherence
12756|NCT03209154|Therapeutic Drug Monitoring|therapeutic drug monitoring
12757|NCT03209154|Patient perspective|patient perspective
12758|NCT03209141|hypertension|hypertension
12759|NCT03209141|Diastolic Dysfunction|diastolic dysfunction
12760|NCT03209141|impedance cardiography|impedance cardiography
12761|NCT03209141|echocardiography|echocardiography
12762|NCT03209076|rectal neoplasms|rectal neoplasms
12763|NCT03209076|sexual dysfunctions|sexual dysfunctions
12764|NCT03209076|Urinary incontinence|urinary incontinence
12765|NCT03209076|Quality of life|quality of life
12766|NCT03209076|robotic surgical procedures|robotic surgical procedures
12767|NCT03209076|laparoscopy|laparoscopy
12768|NCT03209037|chronic hepatitis B|chronic hepatitis b
12769|NCT03209037|hepatitis B virus|hepatitis b virus
12770|NCT03209037|CD8+T Cells|cd8+t cells
12771|NCT03209037|Pegylated Interferon α-2a|pegylated interferon α-2a
12772|NCT03209037|Nucleoside Analogues|nucleoside analogues
12773|NCT03209024|hypertension|hypertension
12774|NCT03209024|home blood pressure monitoring|home blood pressure monitoring
12775|NCT03209024|self blood pressure monitoring|self blood pressure monitoring
12776|NCT03209024|telemedicine|telemedicine
12786|NCT03209011|CD4+T Cells|cd4+t cells
12787|NCT03209011|Pegylated Interferon α-2a|pegylated interferon α-2a
12788|NCT03209011|Nucleoside Analogues|nucleoside analogues
12789|NCT03208998|hepatitis B virus|hepatitis b virus
12790|NCT03208998|Chronic Hepatitis B Infection|chronic hepatitis b infection
12791|NCT03208998|Pegylated Interferon α-2a|pegylated interferon α-2a
12792|NCT03208998|Nucleoside Analogues|nucleoside analogues
12793|NCT03208998|Natural Killer Cells|natural killer cells
12794|NCT03208985|Emergency contraception|emergency contraception
12795|NCT03208972|IVF|ivf
12796|NCT03208972|ovarian stimulation|ovarian stimulation
12797|NCT03208972|low dose hCG|low dose hcg
12798|NCT03208972|hp-FSH|hp-fsh
12799|NCT03208972|Corifollitropin Alfa|corifollitropin alfa
12800|NCT03208972|costs of IVF|costs of ivf
12801|NCT03208946|Advanced glycation end products|advanced glycation end products
12802|NCT03208946|Absorption|absorption
12803|NCT03208946|Excretion|excretion
12804|NCT03208933|Pirfenidone, UIP, IPF, FVC|pirfenidone, uip, ipf, fvc
12805|NCT03208907|Vivax malaria|vivax malaria
12806|NCT03208907|Radical cure|radical cure
12807|NCT03208907|Elimination|elimination
12808|NCT03208881|Osteoarthritis, Obesity, Liraglutide, Ultrasound|osteoarthritis, obesity, liraglutide, ultrasound
12809|NCT03208855|Cognitive Behavioral Therapy|cognitive behavioral therapy
12810|NCT03208816|pain|pain
12811|NCT03208816|constipation|constipation
12812|NCT03208803|Myelofibrosis|myelofibrosis
12813|NCT03208803|Erythropoiesis-stimulating Agents|erythropoiesis-stimulating agents
12814|NCT03208803|Janus Kinase 2 inhibitors|janus kinase 2 inhibitors
12815|NCT03208803|Ruxolitinib|ruxolitinib
12816|NCT03208725|Malnutrition|malnutrition
12817|NCT03208725|Hospitalization|hospitalization
12818|NCT03208725|Acute Illness|acute illness
12819|NCT03208725|Pediatric|pediatric
12820|NCT03208725|Post-discharge mortality|post-discharge mortality
12821|NCT03208725|Mortality|mortality
12822|NCT03208725|Cohort|cohort
12823|NCT03208725|Nested case control|nested case control
12824|NCT03208725|Antimicrobial resistance|antimicrobial resistance
12825|NCT03208725|Antibiotic|antibiotic
12826|NCT03208725|Feeding|feeding
12827|NCT03208725|Undernutrition|undernutrition
12828|NCT03208699|anorexia|anorexia
12829|NCT03208699|bulimia|bulimia
12830|NCT03208686|Gender|gender
12832|NCT03208686|Black/African American|black/african american
12833|NCT03208686|Self-management|self-management
12834|NCT03208660|seizure|seizure
12835|NCT03208660|Fycompa|fycompa
12836|NCT03208647|case-control study|case-control study
12837|NCT03208647|Multiple risk factors|multiple risk factors
12838|NCT03208634|robotics|robotics
12839|NCT03208634|motor performance|motor performance
12840|NCT03208634|stroke patient|stroke patient
12841|NCT03208634|upper limb|upper limb
12842|NCT03208634|rehabilitation|rehabilitation
12843|NCT03208608|RBANS-H|rbans-h
12844|NCT03208608|Older adults|older adults
12845|NCT03208608|Normal hearing|normal hearing
12846|NCT03208608|Cognition|cognition
12847|NCT03208608|Age-related hearing loss|age-related hearing loss
12851|NCT03208504|Thoracic Aneurysm|thoracic aneurysm
12852|NCT03208465|Empagliflozin|empagliflozin
12853|NCT03208465|Sitagliptin|sitagliptin
12854|NCT03208465|Myocardial perfusion reserve|myocardial perfusion reserve
12855|NCT03208426|Efficacy, Self|efficacy, self
12856|NCT03208413|thalidomide|thalidomide
12857|NCT03208413|radiation-induced brain injury|radiation-induced brain injury
12858|NCT03208387|17-338|17-338
12859|NCT03208387|Cognitive function|cognitive function
12860|NCT03208387|Behavioral function|behavioral function
12861|NCT03208374|Histologically confirmed cancer|histologically confirmed cancer
12862|NCT03208374|IMPACT testing|impact testing
12863|NCT03208374|17-327|17-327
12864|NCT03208335|rh-endostatin|rh-endostatin
12865|NCT03208335|radiotherapy|radiotherapy
12866|NCT03208296|Basal Cell Nevus Syndrome|basal cell nevus syndrome
12867|NCT03208296|Basal Cell Carcinoma|basal cell carcinoma
12868|NCT03208257|esmolol|esmolol
12869|NCT03208257|adrenergic storm|adrenergic storm
12870|NCT03208257|septic shock|septic shock
12871|NCT03208244|Heart Disease|heart disease
12872|NCT03208244|Heart Transplant|heart transplant
12875|NCT03208218|Evaluation of the pharmacokinetics equivalence|evaluation of the pharmacokinetics equivalence
12877|NCT03208218|Single dose over the period I and II(crossover)|single dose over the period i and ii(crossover)
12878|NCT03208218|Healthy male volunteers|healthy male volunteers
12879|NCT03208192|colorectal liver metastases|colorectal liver metastases
12880|NCT03208192|hepatocellular carcinoma|hepatocellular carcinoma
12881|NCT03208192|intrahepatic cholangiocellular carcinoma|intrahepatic cholangiocellular carcinoma
12882|NCT03208192|tumor of liver|tumor of liver
12883|NCT03208192|focal nodular hyperplasia liver|focal nodular hyperplasia liver
12884|NCT03208192|hemangioma liver|hemangioma liver
12885|NCT03208140|intubation to supraglottic devices|intubation to supraglottic devices
12886|NCT03208140|intubation device|intubation device
12887|NCT03208140|laryngeal vision|laryngeal vision
12888|NCT03208140|success intubation|success intubation
12889|NCT03208140|videolaryngoscope|videolaryngoscope
12890|NCT03208140|direct intubation|direct intubation
12891|NCT03208127|HCV|hcv
12892|NCT03208127|Epclusa|epclusa
12893|NCT03208127|ESLD|esld
12894|NCT03208114|breastfeeding, support, promotion|breastfeeding, support, promotion
12895|NCT03208075|phosphorus,diet|phosphorus,diet
12896|NCT03208075|phosphorus|phosphorus
12897|NCT03208075|healthy subject|healthy subject
12898|NCT03208062|Biobank|biobank
12899|NCT03208062|Waste material|waste material
12900|NCT03208062|Orthopaedic|orthopaedic
12901|NCT03208049|Insomnia|insomnia
12902|NCT03208049|CBT|cbt
12903|NCT03208049|Gulf War Veterans|gulf war veterans
12904|NCT03208036|schizophrenia|schizophrenia
12905|NCT03208036|tdcs|tdcs
12906|NCT03208036|working memory|working memory
12907|NCT03208036|cognitive remediation|cognitive remediation
12908|NCT03208036|cognition|cognition
12909|NCT03207997|Scleroderma|scleroderma
12910|NCT03207997|Pulmonary fibrosis|pulmonary fibrosis
12911|NCT03207997|MRI|mri
12912|NCT03207997|quantification|quantification
12913|NCT03207984|Gingival Recession|gingival recession
12914|NCT03207984|Collagen Matrix|collagen matrix
12915|NCT03207984|Periodontics|periodontics
12916|NCT03207971|Gingival recession|gingival recession
12917|NCT03207971|Laser-Doppler Flowmetry|laser-doppler flowmetry
12918|NCT03207971|Periodontics|periodontics
12919|NCT03207919|maternal-fetal attachment|maternal-fetal attachment
12920|NCT03207919|maternal health|maternal health
12921|NCT03207919|maternal stress|maternal stress
12922|NCT03207919|Lullaby Project|lullaby project
12923|NCT03207880|pregnancy test|pregnancy test
12924|NCT03207867|Immunotherapy, A2aR, PDR001, NIR178, NSCLC, solid tumors|immunotherapy, a2ar, pdr001, nir178, nsclc, solid tumors
12925|NCT03207841|SCI|sci
12926|NCT03207841|High Protein|high protein
12927|NCT03207841|Low Carbohydrate|low carbohydrate
12928|NCT03207841|Metabolic Health|metabolic health
12929|NCT03207841|Microbiome|microbiome
12930|NCT03207828|Behavioral activation|behavioral activation
12931|NCT03207763|Safety|safety
12932|NCT03207763|Reactogenicity|reactogenicity
12933|NCT03207763|Acceptability|acceptability
12934|NCT03207763|Microneedle patch|microneedle patch
12935|NCT03207750|Immunogenicity|immunogenicity
12936|NCT03207750|lyophilized formulation|lyophilized formulation
12937|NCT03207750|United States|united states
12938|NCT03207750|Reactogenicity|reactogenicity
12939|NCT03207750|Safety|safety
12940|NCT03207750|Porcine circovirus -free|porcine circovirus -free
12941|NCT03207750|Human rotavirus vaccine|human rotavirus vaccine
12942|NCT03207750|liquid formulation|liquid formulation
12943|NCT03207750|Healthy infants|healthy infants
12944|NCT03207737|Spinal Cord Injuries|spinal cord injuries
12945|NCT03207737|SCI|sci
12946|NCT03207737|Telehealth|telehealth
12947|NCT03207737|Mindfulness|mindfulness
12948|NCT03207737|Nutrition|nutrition
12949|NCT03207737|Exercise|exercise
12950|NCT03207724|advanced pancreatic cancer|advanced pancreatic cancer
12951|NCT03207724|locally advanced pancreatic cancer|locally advanced pancreatic cancer
12952|NCT03207724|recurrent diagnosis|recurrent diagnosis
12953|NCT03207724|new diagnosis|new diagnosis
12954|NCT03207724|adenocarcinoma|adenocarcinoma
12955|NCT03207685|Epilepsy|epilepsy
12956|NCT03207685|Epilepsy Monitoring Unit|epilepsy monitoring unit
12958|NCT03207685|Seizure|seizure
12959|NCT03207685|Seizure Detection|seizure detection
12960|NCT03207672|E7389 liposomal formulation|e7389 liposomal formulation
12961|NCT03207672|dose escalation|dose escalation
12962|NCT03207672|maximum tolerated dose|maximum tolerated dose
12963|NCT03207672|pharmacokinetics|pharmacokinetics
12964|NCT03207646|Cardiac Rehabiliation|cardiac rehabiliation
12965|NCT03207646|Percutaneous Coronary Intervention|percutaneous coronary intervention
12966|NCT03207646|Cardiovascular Risk Factor|cardiovascular risk factor
12967|NCT03207646|Digital Health Solution|digital health solution
12968|NCT03207646|Medication Adherence|medication adherence
200974|NCT02112747|Lynch Syndrome|lynch syndrome
12973|NCT03207607|Blood glucose|blood glucose
12974|NCT03207607|Insulin|insulin
12975|NCT03207555|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
12976|NCT03207555|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
12977|NCT03207555|CLL|cll
12978|NCT03207555|Small Lymphocytic Leukemia|small lymphocytic leukemia
12979|NCT03207555|SLL|sll
12980|NCT03207555|Ibrutinib|ibrutinib
12981|NCT03207555|PCI-32765|pci-32765
12982|NCT03207555|Imbruvica|imbruvica
12983|NCT03207542|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
12984|NCT03207542|B-Cell Precursor Acute Lymphoblastic Leukemia|b-cell precursor acute lymphoblastic leukemia
12985|NCT03207542|T-Cell Precursor Acute Lymphoblastic Leukemia|t-cell precursor acute lymphoblastic leukemia
12986|NCT03207542|ALL|all
12987|NCT03207542|Daratumumab|daratumumab
12988|NCT03207529|Malignant neoplasm of breast|malignant neoplasm of breast
12989|NCT03207529|Metastatic breast cancer|metastatic breast cancer
12990|NCT03207529|Androgen receptor (AR)-positive and PTEN positive|androgen receptor (ar)-positive and pten positive
12991|NCT03207529|Alpelisib|alpelisib
12992|NCT03207529|BY719|by719
12993|NCT03207529|Enzalutamide|enzalutamide
12994|NCT03207529|MDV3100|mdv3100
12995|NCT03207529|XTANDI|xtandi
12996|NCT03207516|sourdough; leavening process; fermentation; brewer's yeast|sourdough; leavening process; fermentation; brewer's yeast
12997|NCT03207490|Hand|hand
12998|NCT03207490|Rehabilitation|rehabilitation
12999|NCT03207490|sEMG|semg
13000|NCT03207477|Infant|infant
13001|NCT03207477|Prematurely born|prematurely born
13002|NCT03207477|maturation|maturation
13003|NCT03207451|Anti-Platelet Therapy|anti-platelet therapy
13004|NCT03207425|Hepatic Impairment|hepatic impairment
13005|NCT03207386|Sexual Violence|sexual violence
13006|NCT03207386|Prevention|prevention
13007|NCT03207386|Mixed-Methods|mixed-methods
13008|NCT03207386|Outcome Evaluation|outcome evaluation
13009|NCT03207386|Process Evaluation|process evaluation
13010|NCT03207386|Adolescence|adolescence
13011|NCT03207347|BAP1|bap1
13012|NCT03207347|niraparib|niraparib
13013|NCT03207347|DNA repair|dna repair
13014|NCT03207347|PARP inhibitor|parp inhibitor
13015|NCT03207347|homologous repair deficiency|homologous repair deficiency
13016|NCT03207347|renal cell carcinoma|renal cell carcinoma
13017|NCT03207347|cholangiocarcinoma|cholangiocarcinoma
13018|NCT03207347|mesothelioma|mesothelioma
13019|NCT03207347|uveal melanoma|uveal melanoma
13020|NCT03207334|acute myeloid leukemia|acute myeloid leukemia
13021|NCT03207334|genomic signatures|genomic signatures
13022|NCT03207334|midostaurin|midostaurin
13023|NCT03207334|relapsed|relapsed
13024|NCT03207334|refractory|refractory
13025|NCT03207334|PKC412|pkc412
13026|NCT03207308|Vitamin A Status|vitamin a status
13027|NCT03207308|Retinol Isotope dilution|retinol isotope dilution
13028|NCT03207308|Total body vitamin A stores|total body vitamin a stores
13029|NCT03207308|Children|children
13030|NCT03207308|Senegal|senegal
13031|NCT03207295|Nesiritide|nesiritide
13032|NCT03207295|Total Cavo-Pulmonary Connection|total cavo-pulmonary connection
13033|NCT03207295|Congenital Heart Disease|congenital heart disease
13034|NCT03207243|Severe asthma|severe asthma
13035|NCT03207243|Safety|safety
13036|NCT03207243|GSK3772847|gsk3772847
13037|NCT03207243|Efficacy|efficacy
13038|NCT03207217|Safety Planning|safety planning
13039|NCT03207217|Access to Lethal Means|access to lethal means
13040|NCT03207217|Zero Suicide|zero suicide
13041|NCT03207204|Dental bleaching|dental bleaching
13042|NCT03207204|Color|color
13043|NCT03207204|Sensitivity|sensitivity
13044|NCT03207204|violet LED|violet led
13045|NCT03207204|Quality of life|quality of life
13046|NCT03207165|Cardiogenic shock|cardiogenic shock
13063|NCT03207074|Point-of-care|point-of-care
13064|NCT03207074|Diagnosis|diagnosis
13065|NCT03207074|Endometrial Cancer|endometrial cancer
13066|NCT03207061|endometrial cancer|endometrial cancer
13067|NCT03207061|staging|staging
13068|NCT03207061|3 Dimensional|3 dimensional
13069|NCT03207061|Ultrasound|ultrasound
13070|NCT03207061|Myometrial invasion|myometrial invasion
13071|NCT03206996|autism|autism
13072|NCT03206996|sensory over-responsiveness|sensory over-responsiveness
13073|NCT03206996|auditory hyper-sensitivity|auditory hyper-sensitivity
13074|NCT03206996|auditory processing|auditory processing
13075|NCT03206996|exposure therapy|exposure therapy
13076|NCT03206996|exposure and response prevention|exposure and response prevention
13077|NCT03206996|cognitive behavior therapy|cognitive behavior therapy
13078|NCT03206996|occupational therapy|occupational therapy
13079|NCT03206983|Small pupil|small pupil
13085|NCT03206138|Investigator trial|investigator trial
13086|NCT03206138|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
13094|NCT03206099|Genetic Disorders and Defects|genetic disorders and defects
13095|NCT03206099|Novel Clinical Phenotypes|novel clinical phenotypes
13096|NCT03206099|Immune Diseases|immune diseases
13097|NCT03206099|Proband|proband
13098|NCT03206099|Mendelian Disorders|mendelian disorders
13108|NCT03206034|Memory|memory
13109|NCT03206034|Cognition|cognition
13110|NCT03206892|LESS surgery|less surgery
13111|NCT03206892|conventional multi-port laparoscopy|conventional multi-port laparoscopy
13112|NCT03206892|SILS|sils
13113|NCT03206892|Single-site surgery|single-site surgery
13114|NCT03206892|Covidien|covidien
13115|NCT03206892|laparoscopy|laparoscopy
13116|NCT03206892|minimally invasive surgery|minimally invasive surgery
13117|NCT03206892|ovarian drilling|ovarian drilling
13118|NCT03206892|PCOS|pcos
13119|NCT03206892|Diagnostic laparoscopy|diagnostic laparoscopy
13120|NCT03206879|ESBL|esbl
13121|NCT03206879|Enterobacteriaceae|enterobacteriaceae
13122|NCT03206879|multidrug-resistance|multidrug-resistance
13123|NCT03206840|mindfulness meditation|mindfulness meditation
13124|NCT03206840|hypnosis|hypnosis
13125|NCT03206840|meta-awareness|meta-awareness
13126|NCT03206840|absorption|absorption
13127|NCT03206840|consciousness|consciousness
13128|NCT03206840|self|self
13129|NCT03206827|colorectal cancer|colorectal cancer
13130|NCT03206827|type 2 diabetes|type 2 diabetes
13131|NCT03206827|diet|diet
13132|NCT03206827|plant protein|plant protein
13133|NCT03206827|animal protein|animal protein
13134|NCT03206814|Hypertension|hypertension
13135|NCT03206814|Ambulatory Systolic Blood Pressure|ambulatory systolic blood pressure
13136|NCT03206814|Home Blood Pressure|home blood pressure
13137|NCT03206814|ESH-CARE APP|esh-care app
13138|NCT03206801|Urine biomarker|urine biomarker
13139|NCT03206801|CXCL10 chemokine|cxcl10 chemokine
13140|NCT03206801|Post-transplant monitoring|post-transplant monitoring
13141|NCT03206801|Protocol biopsy|protocol biopsy
13142|NCT03206723|corneal abrasion|corneal abrasion
13143|NCT03206723|contact lens|contact lens
13144|NCT03206723|eye trauma|eye trauma
13145|NCT03206710|vitamin C|vitamin c
13146|NCT03206710|ascorbic acid|ascorbic acid
13147|NCT03206710|wheeze|wheeze
13148|NCT03206710|nicotine|nicotine
13149|NCT03206710|smoke exposure|smoke exposure
13150|NCT03206710|long term follow up|long term follow up
13151|NCT03206710|pulmonary function testing|pulmonary function testing
13152|NCT03206710|forced expiratory flows|forced expiratory flows
13153|NCT03206697|mitochondrial copy, number and energy|mitochondrial copy, number and energy
13471|NCT03204318|Pain|pain
13154|NCT03206658|acute kidney injury|acute kidney injury
13155|NCT03206658|prevention|prevention
13156|NCT03206658|severity|severity
13157|NCT03206658|biomarker|biomarker
13158|NCT03206619|smoking|smoking
13159|NCT03206619|habit|habit
13160|NCT03206619|preference|preference
13161|NCT03206619|behavior|behavior
13162|NCT03206619|tailoring|tailoring
13163|NCT03206619|cessation|cessation
13164|NCT03206619|engagement|engagement
13165|NCT03206619|digital|digital
13166|NCT03206619|mobile app|mobile app
13167|NCT03206619|recommender system|recommender system
13168|NCT03206606|COPD|copd
13169|NCT03206606|Spirometry|spirometry
13170|NCT03206606|Mobile application|mobile application
13171|NCT03206580|aging|aging
13172|NCT03206580|strength training|strength training
13173|NCT03206580|functionality|functionality
13174|NCT03206567|Hair thinning, Hair loss, Women, Nutraceutical supplement|hair thinning, hair loss, women, nutraceutical supplement
13175|NCT03206541|Neurological syndromes|neurological syndromes
13176|NCT03206541|Arbovirus infection|arbovirus infection
13177|NCT03206515|Renal Pelvic Pressure|renal pelvic pressure
13178|NCT03206476|Food Habits|food habits
13179|NCT03206476|Adolescents|adolescents
13180|NCT03206476|Educative Intervention|educative intervention
13181|NCT03206476|Nutrition Assessment|nutrition assessment
13182|NCT03206476|Behavior Modifications|behavior modifications
13183|NCT03206437|mindfulness|mindfulness
13184|NCT03206437|meditation|meditation
13185|NCT03206359|Unfolded Protein Response|unfolded protein response
13186|NCT03206359|GADD34|gadd34
13187|NCT03206359|Type I IFN|type i ifn
13188|NCT03206359|IFN response genes|ifn response genes
13189|NCT03206359|Type II IFN|type ii ifn
13190|NCT03206359|anti-DNA autoantibodies|anti-dna autoantibodies
13191|NCT03206333|Breast cancer|breast cancer
13192|NCT03206333|Cardiovascular diseases|cardiovascular diseases
13193|NCT03206333|Coronary artery calcium|coronary artery calcium
13194|NCT03206333|Prediction|prediction
13195|NCT03206333|Risk stratification|risk stratification
13196|NCT03206333|Deep learning technique|deep learning technique
13197|NCT03206333|Software development|software development
13198|NCT03206333|Computed tomography scan|computed tomography scan
13199|NCT03206307|Return to work|return to work
13200|NCT03206307|medical rehabilitation|medical rehabilitation
13201|NCT03206281|clinical weight estimation|clinical weight estimation
13202|NCT03206268|retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
13203|NCT03206268|uveitis|uveitis
13204|NCT03206268|SD-OCT|sd-oct
13205|NCT03206268|GDx VCC|gdx vcc
13206|NCT03206255|Human Papilloma Virus 16|human papilloma virus 16
13207|NCT03206255|Human Papilloma Virus 18|human papilloma virus 18
13208|NCT03206255|adolescent girl|adolescent girl
13209|NCT03206255|non-inferiority|non-inferiority
13210|NCT03206255|immuno-persistence|immuno-persistence
13211|NCT03206242|Rehabilitation|rehabilitation
13212|NCT03206242|Physiotherapy|physiotherapy
13213|NCT03206242|Trismus|trismus
13214|NCT03206242|Pain|pain
13215|NCT03206242|Return to work|return to work
13216|NCT03206242|Quality of life|quality of life
13217|NCT03206190|SPG4|spg4
13218|NCT03206190|presymptomatic|presymptomatic
13219|NCT03206190|at risk|at risk
13220|NCT03206190|mutation carriers|mutation carriers
13221|NCT03206190|biomarkers|biomarkers
13222|NCT03206190|longitudinal progression|longitudinal progression
13224|NCT03205995|aHUS|ahus
13225|NCT03205969|Breast Cancer|breast cancer
13226|NCT03205969|chemotherapy side effect|chemotherapy side effect
13227|NCT03205969|mobile game|mobile game
13228|NCT03205956|Parkinson's disease|parkinson's disease
13229|NCT03205956|PD|pd
13230|NCT03205956|levodopa|levodopa
13231|NCT03205943|ICON|icon
13232|NCT03205904|cystic fibrosis related diabetes|cystic fibrosis related diabetes
13233|NCT03205891|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
13234|NCT03205891|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
13235|NCT03205891|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
13236|NCT03205891|CD30+ peripheral T-cell lymphoma|cd30+ peripheral t-cell lymphoma
13237|NCT03205891|Brentuximab Vedotin|brentuximab vedotin
13238|NCT03205891|SGN-35|sgn-35
13239|NCT03205891|Adcetris|adcetris
13240|NCT03205891|TAK228|tak228
13241|NCT03205891|TAK-228|tak-228
13242|NCT03205891|MLN0128|mln0128
13243|NCT03205891|Glucose Monitor|glucose monitor
13244|NCT03205891|Glucometer|glucometer
13245|NCT03205826|Emphysema|emphysema
13246|NCT03205826|Bronchoscopic intervention|bronchoscopic intervention
13247|NCT03205826|CHARTIS measurement|chartis measurement
13248|NCT03205813|Pain, Postoperative|pain, postoperative
13249|NCT03205813|Cesarean delivery|cesarean delivery
13253|NCT03205761|olaparib|olaparib
13254|NCT03205761|lynparza|lynparza
13256|NCT03205761|Methylation|methylation
13257|NCT03205709|memory|memory
13258|NCT03205709|computerized training|computerized training
13259|NCT03205709|cognition|cognition
13260|NCT03205709|MRI|mri
13261|NCT03205709|mci|mci
13262|NCT03205709|memory problems|memory problems
13263|NCT03205709|memory complaints|memory complaints
13264|NCT03205670|Autologous Cells|autologous cells
13265|NCT03205670|Buccal Mucosa|buccal mucosa
13266|NCT03205670|Urethroplasty|urethroplasty
13267|NCT03205670|Tissue-engineered Construct|tissue-engineered construct
13268|NCT03205670|Hybrid matrix|hybrid matrix
13269|NCT03205670|Collagen|collagen
13270|NCT03205670|Polylactoglycolide Fibers|polylactoglycolide fibers
13271|NCT03205540|Continuous epidural analgesia|continuous epidural analgesia
13272|NCT03205540|Bilateral single-shot adductor canal blocks|bilateral single-shot adductor canal blocks
13273|NCT03205527|Fall risk|fall risk
13274|NCT03205527|Stroke survivors|stroke survivors
13275|NCT03205527|Perturbation training|perturbation training
13276|NCT03205501|BE|be
13277|NCT03205501|EAC|eac
13278|NCT03205501|HGD|hgd
13279|NCT03205501|Esophagus|esophagus
13285|NCT03205475|Training|training
13286|NCT03205475|Intervention|intervention
13287|NCT03205475|Social Communication|social communication
13288|NCT03205475|Play|play
13289|NCT03205462|Pseudomanas Aeruginosa|pseudomanas aeruginosa
13290|NCT03205462|antibiotic resistance|antibiotic resistance
13291|NCT03205462|nosocomial infection|nosocomial infection
13292|NCT03205462|factors of pathogenicity of bacteria|factors of pathogenicity of bacteria
13293|NCT03205462|the system of secretion of type III pathogenic bacteria|the system of secretion of type iii pathogenic bacteria
13294|NCT03205462|chronic infection|chronic infection
13295|NCT03205410|remote ischemic preconditioning|remote ischemic preconditioning
13296|NCT03205410|cardiac surgery-associated acute kidney injury|cardiac surgery-associated acute kidney injury
13297|NCT03205410|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
13298|NCT03205384|Urgent abdominal surgery|urgent abdominal surgery
13299|NCT03205358|Meningitis|meningitis
200975|NCT02112747|LS|ls
13305|NCT03205345|Decompensated NASH cirrhosis|decompensated nash cirrhosis
13306|NCT03205345|Cirrhosis, Liver|cirrhosis, liver
13307|NCT03205345|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
13308|NCT03205332|Worry|worry
13309|NCT03205332|Anxiety|anxiety
13310|NCT03205319|Oesophagoduodenoscopy|oesophagoduodenoscopy
13311|NCT03205319|E-learning|e-learning
13312|NCT03205319|Appropriate use of healthcare|appropriate use of healthcare
13313|NCT03205319|Deimplementation|deimplementation
13314|NCT03205306|Myasthenia Gravis|myasthenia gravis
13315|NCT03205306|Psyche|psyche
13316|NCT03205306|Depression|depression
13317|NCT03205306|Anxiety Disorder|anxiety disorder
13318|NCT03205306|Posttraumatic Stress Disorder|posttraumatic stress disorder
13319|NCT03205306|Disease Processing|disease processing
13320|NCT03205293|School-Based Intervention|school-based intervention
13321|NCT03205293|Ecological Model|ecological model
13322|NCT03205293|Participatory Approach|participatory approach
13323|NCT03205293|Palestinian Female Schoolchildren|palestinian female schoolchildren
13324|NCT03205280|Multiple Sclerosis, Relapsing-Remitting, Computer-Assisted Diagnosis, MRI, Diagnosis, Treatment Efficacy|multiple sclerosis, relapsing-remitting, computer-assisted diagnosis, mri, diagnosis, treatment efficacy
13325|NCT03205254|Mediterranean diet|mediterranean diet
13326|NCT03205254|HDL|hdl
13327|NCT03205254|Fast food|fast food
13328|NCT03205254|Gut microbiota|gut microbiota
13329|NCT03205254|Inflammation|inflammation
13330|NCT03205241|Exercise|exercise
13331|NCT03205241|Fish Oil|fish oil
13332|NCT03205241|Cycling|cycling
13333|NCT03205241|Inflammation|inflammation
13334|NCT03205241|Oxidative stress|oxidative stress
13335|NCT03205215|Hyperbaric oxygen|hyperbaric oxygen
13336|NCT03205215|Pressurized oxygen|pressurized oxygen
13337|NCT03205215|Concussion|concussion
13338|NCT03205215|Post concussive syndrome|post concussive syndrome
13339|NCT03205215|Oxygen therapy|oxygen therapy
13340|NCT03205189|postoperative pain|postoperative pain
13341|NCT03205189|ambulatory surgery|ambulatory surgery
13342|NCT03205189|general anesthesia|general anesthesia
13343|NCT03205189|anesthesia consultation|anesthesia consultation
13344|NCT03205189|post-op prescription|post-op prescription
13345|NCT03205176|AZD5153|azd5153
13346|NCT03205176|Malignant solid tumors|malignant solid tumors
13347|NCT03205176|Lymphoma|lymphoma
13348|NCT03205176|Ovarian Cancer|ovarian cancer
13350|NCT03205150|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
13351|NCT03205150|NASH|nash
13352|NCT03205150|Obese|obese
13353|NCT03205150|Type 2 diabetes mellitus|type 2 diabetes mellitus
13354|NCT03205150|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
13355|NCT03205098|biological markers|biological markers
610621|NCT00622258|everolimus|everolimus
13356|NCT03205098|mesenteric ischemia|mesenteric ischemia
13357|NCT03205098|ultratrail|ultratrail
13358|NCT03205072|ERCP|ercp
13359|NCT03205072|Per-Oral Cholangioscopy|per-oral cholangioscopy
13360|NCT03205072|Liver Transplantation|liver transplantation
13361|NCT03205072|Spy Glass|spy glass
13362|NCT03205033|Melatonin|melatonin
13363|NCT03205033|Breast cancer|breast cancer
13364|NCT03205033|Chemotherapy|chemotherapy
13365|NCT03205033|Sleep-wake rhytms|sleep-wake rhytms
13366|NCT03205033|Circadian rhythms|circadian rhythms
13367|NCT03205007|Health Promotion|health promotion
13368|NCT03205007|Nutrition|nutrition
13369|NCT03205007|Older Adults|older adults
13370|NCT03204994|Colorectal surgery|colorectal surgery
13371|NCT03204994|Fluorescence guided surgery|fluorescence guided surgery
13372|NCT03204981|intramural needle ablation|intramural needle ablation
13373|NCT03204981|ventricular arrhythmia|ventricular arrhythmia
13374|NCT03204968|vagus nerve|vagus nerve
13375|NCT03204968|Lung lobectomy|lung lobectomy
13376|NCT03204955|Osmolar therapy|osmolar therapy
13377|NCT03204955|Acetate|acetate
13378|NCT03204942|Bone metastasis,Thoracic secondary, Cancer Pain,|bone metastasis,thoracic secondary, cancer pain,
13379|NCT03204903|Dry eye|dry eye
13380|NCT03204903|Laser acupuncture|laser acupuncture
13381|NCT03204903|Traditional Chinese medicine|traditional chinese medicine
13382|NCT03204877|Melatonin|melatonin
13383|NCT03204877|Insulin sensitivity|insulin sensitivity
13384|NCT03204877|Insulin secretion|insulin secretion
13385|NCT03204877|Incretin response|incretin response
13386|NCT03204838|IDH1, IDH2, MUTATION, AML|idh1, idh2, mutation, aml
13387|NCT03204825|Patient education|patient education
13388|NCT03204825|Pain management|pain management
13389|NCT03204825|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
200976|NCT02112734|vitamin D|vitamin d
13395|NCT03204812|Immunotherapies|immunotherapies
13396|NCT03204812|PD-L1-dependent immunosuppressive effects|pd-l1-dependent immunosuppressive effects
13397|NCT03204812|cytotoxic activity|cytotoxic activity
13398|NCT03204812|anti-tumor T-cells|anti-tumor t-cells
13399|NCT03204786|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
13400|NCT03204786|Autism|autism
13401|NCT03204747|Gait speed|gait speed
13402|NCT03204747|multiple sclerosis|multiple sclerosis
13403|NCT03204747|lower urinary tract symptoms|lower urinary tract symptoms
13404|NCT03204747|overactive bladder|overactive bladder
13405|NCT03204734|therapy|therapy
13406|NCT03204734|Capecitabine|capecitabine
13407|NCT03204734|breast cancer|breast cancer
13408|NCT03204708|mastectomy|mastectomy
13409|NCT03204708|postoperative analgesia|postoperative analgesia
13410|NCT03204708|pectoral catheter|pectoral catheter
13411|NCT03204695|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
13412|NCT03204695|Atrial Fibrillation|atrial fibrillation
13413|NCT03204695|Stroke|stroke
13414|NCT03204695|Left Atrial Appendage (LAA)|left atrial appendage (laa)
13415|NCT03204695|LAA Closure|laa closure
13416|NCT03204695|LAA Occlusion|laa occlusion
13417|NCT03204695|WaveCrest|wavecrest
13418|NCT03204682|Endometriosis|endometriosis
13419|NCT03204682|Magnetic transcranial stimulation|magnetic transcranial stimulation
13420|NCT03204682|Chronic pain|chronic pain
13421|NCT03204682|Analgesic|analgesic
13422|NCT03204669|Copper|copper
13423|NCT03204669|Selenium|selenium
13424|NCT03204669|Zinc|zinc
13425|NCT03204669|Continuous renal replacement therapy|continuous renal replacement therapy
13426|NCT03204656|difficult orotracheal intubation|difficult orotracheal intubation
13427|NCT03204656|selective lung intubation|selective lung intubation
13428|NCT03204656|unexpected difficult selective lung intubation|unexpected difficult selective lung intubation
13429|NCT03204630|infant nutrition|infant nutrition
13430|NCT03204630|probiotic|probiotic
13431|NCT03204617|HIV infection|hiv infection
13432|NCT03204617|First in Human|first in human
13433|NCT03204617|Therapeutic Vaccines|therapeutic vaccines
13434|NCT03204617|HTI|hti
13435|NCT03204617|HIV reservoir|hiv reservoir
13436|NCT03204604|Memory|memory
13437|NCT03204604|Dietary Treatment|dietary treatment
13438|NCT03204565|gingival recession, clinical trial(s).|gingival recession, clinical trial(s).
13439|NCT03204539|inhibitor|inhibitor
13440|NCT03204539|Factor VIII inhibitor|factor viii inhibitor
13441|NCT03204513|Prosthesis|prosthesis
13442|NCT03204513|Powered Prosthesis|powered prosthesis
13443|NCT03204500|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
13445|NCT03204500|Randomized controlled trial|randomized controlled trial
13447|NCT03204487|tear film thickness|tear film thickness
13448|NCT03204487|ocular surface disease|ocular surface disease
13449|NCT03204487|OCT|oct
13450|NCT03204474|Lacosamide|lacosamide
13451|NCT03204474|Bioequivalence|bioequivalence
13452|NCT03204474|Intravenous solution|intravenous solution
13453|NCT03204474|Tablet|tablet
13454|NCT03204422|urinary sodium excretion|urinary sodium excretion
13455|NCT03204422|24-hout urine|24-hout urine
13456|NCT03204422|salt intakes|salt intakes
13457|NCT03204422|hypertension|hypertension
13458|NCT03204409|CHIKV|chikv
13459|NCT03204409|DENGUE|dengue
13460|NCT03204409|Chikungunya|chikungunya
13461|NCT03204409|DENV|denv
13462|NCT03204357|Cardiac surgery|cardiac surgery
13463|NCT03204344|Gastrointestinal surgery|gastrointestinal surgery
13464|NCT03204344|Preoperative oral carbohydrate|preoperative oral carbohydrate
13465|NCT03204344|Diabetic patients|diabetic patients
13466|NCT03204344|Postoperative recovery|postoperative recovery
13467|NCT03204331|Endometriosis|endometriosis
13468|NCT03204331|Pain|pain
13469|NCT03204331|Dysmenorrhea|dysmenorrhea
13470|NCT03204318|Endometriosis|endometriosis
13472|NCT03204318|Dysmenorrhea|dysmenorrhea
13473|NCT03204305|Marijuana|marijuana
13474|NCT03204305|cannabis|cannabis
13475|NCT03204305|cannabinoid receptor|cannabinoid receptor
13476|NCT03204292|Inferior vena cava|inferior vena cava
13477|NCT03204292|Fluid responsiveness|fluid responsiveness
13478|NCT03204292|Central venous pressure|central venous pressure
13479|NCT03204266|urinary tract|urinary tract
13480|NCT03204266|Bladder cancer|bladder cancer
13481|NCT03204266|Radical cystectomy|radical cystectomy
13482|NCT03204266|Omega-3 Fatty Acids|omega-3 fatty acids
13483|NCT03204240|Spinal Cord Injury|spinal cord injury
13484|NCT03204240|Skeletal Muscle|skeletal muscle
13485|NCT03204240|Functional Electrical Stimulation|functional electrical stimulation
13486|NCT03204240|Diabetes|diabetes
13487|NCT03204227|Japanese Encephalitis|japanese encephalitis
13488|NCT03204227|JECEVAX|jecevax
13489|NCT03204227|Vietnam|vietnam
13490|NCT03204214|binge drinking|binge drinking
13491|NCT03204201|Fluorescence|fluorescence
13494|NCT03204123|prostate cancer|prostate cancer
13495|NCT03204123|prostatectomy|prostatectomy
13496|NCT03204123|biochemical recurrence|biochemical recurrence
13497|NCT03204123|Ga-HBED-iPSMA|ga-hbed-ipsma
13498|NCT03204123|16-306|16-306
13499|NCT03204110|Reversible cerebral vasoconstriction syndrome|reversible cerebral vasoconstriction syndrome
13500|NCT03204110|Anatomic and morphological retinal network analysis|anatomic and morphological retinal network analysis
13501|NCT03204110|Retinal vessel analyser|retinal vessel analyser
13502|NCT03204110|retinography|retinography
13503|NCT03204110|Prospective analysis|prospective analysis
13504|NCT03204084|pterygium,Low temperature plasma|pterygium,low temperature plasma
13505|NCT03204045|oxycodone, fentanyl, tracheal extubation|oxycodone, fentanyl, tracheal extubation
13506|NCT03204032|Tegafur|tegafur
13507|NCT03204032|Temozolomide|temozolomide
13508|NCT03204032|Thalidomide|thalidomide
13509|NCT03204032|Extrapancreatic Neuroendocrine Tumor|extrapancreatic neuroendocrine tumor
13510|NCT03204019|Tegafur|tegafur
13511|NCT03204019|Temozolomide|temozolomide
13512|NCT03204019|Thalidomide|thalidomide
13513|NCT03204019|Pancreatic Neuroendocrine Tumor|pancreatic neuroendocrine tumor
13514|NCT03203993|BRCA mutation|brca mutation
13515|NCT03203967|Adults|adults
13516|NCT03203967|Unilateral TKA|unilateral tka
13517|NCT03203967|Single femoral nerve block|single femoral nerve block
13518|NCT03203967|Low-dose epidural morphine|low-dose epidural morphine
13519|NCT03203967|Effect of postoperative analgesia|effect of postoperative analgesia
13520|NCT03203967|Quality of life|quality of life
13521|NCT03203941|Autologous Cord Blood Stem Cells|autologous cord blood stem cells
13522|NCT03203928|ADHD|adhd
13523|NCT03203928|Occupational Therapy|occupational therapy
13524|NCT03203915|cholesterol|cholesterol
13525|NCT03203915|triglyceride|triglyceride
13526|NCT03203915|grape seed extract|grape seed extract
13527|NCT03203915|chardonnay pomace powder|chardonnay pomace powder
13528|NCT03203915|polyphenol|polyphenol
13529|NCT03203915|gut microbiome|gut microbiome
13530|NCT03203902|Therapeutic touch|therapeutic touch
13531|NCT03203902|Post-traumatic Stress Disorder|post-traumatic stress disorder
13532|NCT03203902|Homeless|homeless
13533|NCT03203889|American Indians|american indians
13534|NCT03203889|Native Americans|native americans
13535|NCT03203889|Community Reinforcement Approach and Family Training|community reinforcement approach and family training
13536|NCT03203889|Nar-Anonymous Facilitation|nar-anonymous facilitation
13537|NCT03203889|Treatment Entry|treatment entry
13538|NCT03203889|Cultural adaptations|cultural adaptations
13539|NCT03203889|Spirituality|spirituality
13540|NCT03203850|hereditary hemochromatosis|hereditary hemochromatosis
13541|NCT03203850|ICL670|icl670
13542|NCT03203850|deferasirox FCT|deferasirox fct
13543|NCT03203850|iron overload|iron overload
13544|NCT03203837|Radioembolization|radioembolization
13545|NCT03203837|Y90|y90
13546|NCT03203837|TheraSphere|therasphere
13547|NCT03203837|HCC|hcc
13548|NCT03203837|Biomarker|biomarker
13549|NCT03203837|Prognostic factor|prognostic factor
13550|NCT03203837|Angiogenesis|angiogenesis
13551|NCT03203837|Inflammatory|inflammatory
13553|NCT03203811|Healthy Subjects|healthy subjects
13554|NCT03203746|Lycopene|lycopene
13555|NCT03203746|Chronic periodontitis|chronic periodontitis
13556|NCT03203746|Protein carbonyl|protein carbonyl
13557|NCT03203733|Oral Mucositis , cooling, cryotherapy|oral mucositis , cooling, cryotherapy
13558|NCT03203720|adherence|adherence
13559|NCT03203720|adolescent|adolescent
13560|NCT03203720|Motivational Intervention|motivational intervention
13561|NCT03203707|IPSRT|ipsrt
13562|NCT03203707|early intervention|early intervention
13563|NCT03203707|bipolar disorder|bipolar disorder
13564|NCT03203668|Hyperparathyroidism|hyperparathyroidism
13565|NCT03203668|Imaging|imaging
13566|NCT03203668|Scintigraphy|scintigraphy
13567|NCT03203668|18F-choline|18f-choline
13568|NCT03203668|18F-fluorocholine|18f-fluorocholine
13569|NCT03203668|PET|pet
13570|NCT03203668|PET/CT|pet/ct
13571|NCT03203655|Mobile text|mobile text
13572|NCT03203655|Obesity|obesity
13573|NCT03203655|Hispanic|hispanic
13574|NCT03203655|Women|women
13575|NCT03203642|ADPKD|adpkd
13576|NCT03203642|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
13577|NCT03203642|Polycystic Kidney|polycystic kidney
13578|NCT03203642|Tesevatinib|tesevatinib
13579|NCT03203642|Polycystic Kidney Disease|polycystic kidney disease
13580|NCT03203642|PKD|pkd
13581|NCT03203603|asthma|asthma
13582|NCT03203603|pulmonary function testing|pulmonary function testing
13583|NCT03203603|wheeze|wheeze
13584|NCT03203603|vitamin C|vitamin c
13585|NCT03203603|antioxidants|antioxidants
13586|NCT03203603|forced expiratory flows|forced expiratory flows
13587|NCT03203551|Dentures|dentures
13588|NCT03203551|Biofilms|biofilms
13589|NCT03203551|Disinfection|disinfection
13590|NCT03203551|Candidiasis|candidiasis
13591|NCT03203551|Candida|candida
13592|NCT03203538|night work|night work
13593|NCT03203538|shift work|shift work
13594|NCT03203538|light|light
13595|NCT03203538|bright light|bright light
13596|NCT03203538|sleep|sleep
13597|NCT03203538|cognitive performance|cognitive performance
13598|NCT03203538|circadian rhythm|circadian rhythm
13599|NCT03203525|Liver Cancer|liver cancer
13600|NCT03203525|Hepatic metastases|hepatic metastases
13601|NCT03203525|Advanced liver cancer|advanced liver cancer
13602|NCT03203525|Eloxatin|eloxatin
13603|NCT03203525|Oxaliplatin|oxaliplatin
13604|NCT03203525|Leucovorin|leucovorin
13605|NCT03203525|Citrovorum|citrovorum
13606|NCT03203525|Wellcovorin|wellcovorin
13607|NCT03203525|5-fluorouracil|5-fluorouracil
13608|NCT03203525|Fluorouracil|fluorouracil
13609|NCT03203525|5-FU|5-fu
13610|NCT03203525|Adrucil|adrucil
13611|NCT03203525|Efudex|efudex
13612|NCT03203525|Bevacizumab|bevacizumab
13613|NCT03203525|Avastin|avastin
13614|NCT03203525|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
13615|NCT03203525|rhuMab-VEGF|rhumab-vegf
13616|NCT03203525|Liposomal Doxorubicin|liposomal doxorubicin
13617|NCT03203525|Doxil|doxil
13618|NCT03203525|Doxorubicin Hydrochloride (Liposomal)|doxorubicin hydrochloride (liposomal)
13619|NCT03203525|Temsirolimus|temsirolimus
13620|NCT03203525|CCI-779|cci-779
13621|NCT03203525|Torisel|torisel
13622|NCT03203525|NovoTTF-100L System|novottf-100l system
13623|NCT03203512|Fish oil; N-3 polyunsaturated fatty acids|fish oil; n-3 polyunsaturated fatty acids
13624|NCT03203499|Substance abuse disorder|substance abuse disorder
13625|NCT03203486|NAFLD|nafld
13626|NCT03203486|no fibrosis|no fibrosis
13627|NCT03203486|Mediterranean diet|mediterranean diet
13628|NCT03203486|STAT3|stat3
13629|NCT03203486|GCKR|gckr
13630|NCT03203486|visfatin|visfatin
13631|NCT03203486|oxidized LDL|oxidized ldl
13632|NCT03203486|fasting glucose|fasting glucose
13633|NCT03203486|inflammation|inflammation
13634|NCT03203473|Renal Cancer|renal cancer
13635|NCT03203460|Prostate Cancer|prostate cancer
13636|NCT03203460|Active Surveillance|active surveillance
13637|NCT03203460|Exercise|exercise
13638|NCT03203460|High-Intensity Interval Training|high-intensity interval training
13639|NCT03203460|Randomized Controlled Trial|randomized controlled trial
13640|NCT03203447|RVO|rvo
13641|NCT03203447|ME|me
13642|NCT03203447|Microneedle|microneedle
13643|NCT03203447|Microinjection|microinjection
13644|NCT03203447|Triamcinolone|triamcinolone
13645|NCT03203447|Choroid|choroid
13646|NCT03203447|Choroid injection|choroid injection
13647|NCT03203447|Aflibercept|aflibercept
13648|NCT03203447|Suprachoroidal|suprachoroidal
13649|NCT03203447|Anti-VEGF|anti-vegf
13650|NCT03203447|Eylea|eylea
13651|NCT03203447|Subretinal Fluid|subretinal fluid
13652|NCT03203447|Cystoid Macular Edema|cystoid macular edema
13653|NCT03203447|Optical Coherence Tomography|optical coherence tomography
13654|NCT03203447|OCT|oct
13655|NCT03203447|Central Subfield Thickness|central subfield thickness
13656|NCT03203434|Pancreatic cancer|pancreatic cancer
13657|NCT03203434|Esophageal cancer|esophageal cancer
13658|NCT03203434|volatile organic compounds|volatile organic compounds
13659|NCT03203434|Field asymmetric ion mobility spectrometry|field asymmetric ion mobility spectrometry
13660|NCT03203395|Depression|depression
13661|NCT03203395|Anxiety|anxiety
13662|NCT03203395|Panic Attacks|panic attacks
13663|NCT03203395|Collaborative Care|collaborative care
13664|NCT03203395|Heart disease and depression|heart disease and depression
13665|NCT03203395|Heart disease and anxiety|heart disease and anxiety
13666|NCT03203395|Heart disease and panic attacks|heart disease and panic attacks
13667|NCT03203369|Blastic plasmacytoid dendritic cell neoplasm|blastic plasmacytoid dendritic cell neoplasm
13668|NCT03203369|Natural Killer (NK) cell blastic lymphoma|natural killer (nk) cell blastic lymphoma
13669|NCT03203369|Hematologic malignancies|hematologic malignancies
13670|NCT03203369|Cluster of differentiation (CD) CD4+CD56+ hematodermic tumor|cluster of differentiation (cd) cd4+cd56+ hematodermic tumor
13671|NCT03203369|Acute leukemia and myeloid neoplasms|acute leukemia and myeloid neoplasms
13672|NCT03203369|Chimeric Antigen Receptor T-cell (CAR-T) therapy|chimeric antigen receptor t-cell (car-t) therapy
13673|NCT03203369|Allogeneic|allogeneic
13780|NCT03202576|microbridle|microbridle
13674|NCT03203369|Cluster of differentiation 4 (CD4)|cluster of differentiation 4 (cd4)
13675|NCT03203369|Cluster of differentiation 56 (CD56)|cluster of differentiation 56 (cd56)
13676|NCT03203356|growth hormone|growth hormone
13677|NCT03203356|children|children
13678|NCT03203356|adrenal function|adrenal function
13679|NCT03203343|Inguinal Hernia, Indirect|inguinal hernia, indirect
13680|NCT03203343|Children, Only|children, only
13681|NCT03203343|Inflammatory Response|inflammatory response
13682|NCT03203343|Surgery|surgery
13683|NCT03203343|Interleukin-6|interleukin-6
13684|NCT03203343|Tumor necrosis factor alpha|tumor necrosis factor alpha
13685|NCT03203343|C reactive protein|c reactive protein
13686|NCT03203343|Leukocytes|leukocytes
13687|NCT03203304|hepatocellular carcinoma|hepatocellular carcinoma
13696|NCT03203265|HIV home testing|hiv home testing
13697|NCT03203239|red light|red light
13698|NCT03203239|vasodilation|vasodilation
13699|NCT03203239|nitric oxide|nitric oxide
13700|NCT03203226|Intellectual Disability|intellectual disability
13701|NCT03203226|Feldenkrais Method|feldenkrais method
13702|NCT03203226|Short Physical Performance Battery|short physical performance battery
13703|NCT03203226|Stabilometry|stabilometry
13704|NCT03203226|Supported employment|supported employment
13705|NCT03203213|Poisoning|poisoning
13706|NCT03203213|Psychoactive substances|psychoactive substances
13707|NCT03203174|microneedle|microneedle
13708|NCT03203174|botulinum toxin|botulinum toxin
13709|NCT03203174|botox|botox
13710|NCT03203174|palmar hyperhidrosis|palmar hyperhidrosis
13711|NCT03203174|sweating|sweating
13712|NCT03203174|hyperhidrosis|hyperhidrosis
13713|NCT03203148|Cardiopulmonary Bypass|cardiopulmonary bypass
13714|NCT03203148|Blood Coagulation Testing|blood coagulation testing
13715|NCT03203148|Point-of-Care Testing|point-of-care testing
13716|NCT03203109|lateropulsion|lateropulsion
13717|NCT03203109|pusher syndrome|pusher syndrome
13718|NCT03203109|posture|posture
13719|NCT03203109|balance|balance
13720|NCT03203109|PASS|pass
13721|NCT03203109|verticality perception|verticality perception
13722|NCT03203109|gait|gait
13723|NCT03203096|magnesium, stress, metabolomics, heart rate variability|magnesium, stress, metabolomics, heart rate variability
13724|NCT03203083|Reproducibility of Results|reproducibility of results
13725|NCT03203083|Clinical Assessment|clinical assessment
13726|NCT03203044|Dietary Intervention|dietary intervention
13727|NCT03203031|pain|pain
13728|NCT03203031|neonate|neonate
13729|NCT03203031|regional anesthesia|regional anesthesia
13730|NCT03203031|postoperative|postoperative
13731|NCT03203018|Cardiovascular Diseases (CVD)|cardiovascular diseases (cvd)
13732|NCT03203018|Community-based intervention|community-based intervention
13733|NCT03203018|Socio-economic status (SES)|socio-economic status (ses)
13734|NCT03203018|Health literacy (HL)|health literacy (hl)
13735|NCT03202979|Trazodone|trazodone
13736|NCT03202979|Placebo|placebo
13737|NCT03202979|Gabapentin|gabapentin
13738|NCT03202979|Neuropathic pain|neuropathic pain
13739|NCT03202940|Lung Cancer|lung cancer
13740|NCT03202901|knee-pain, curcuma, inflammation|knee-pain, curcuma, inflammation
13741|NCT03202862|fulvestrant|fulvestrant
13742|NCT03202862|ESR1|esr1
13743|NCT03202849|hematopoietic stem cell transplant|hematopoietic stem cell transplant
13744|NCT03202849|vitamin a|vitamin a
13746|NCT03202810|optical imaging technology, loss of heterozygosity, prevention, miRNA, cost-effectiveness|optical imaging technology, loss of heterozygosity, prevention, mirna, cost-effectiveness
13748|NCT03202758|Tremelimumab|tremelimumab
13749|NCT03202758|FOLFOX|folfox
583403|NCT00511615|Cervical Cancer|cervical cancer
13750|NCT03202758|metastatic colorectal cancer|metastatic colorectal cancer
13751|NCT03202732|Self-management|self-management
13752|NCT03202732|Patient Activeted measure|patient activeted measure
13753|NCT03202732|Patient-reported outcome|patient-reported outcome
13754|NCT03202732|Type 1 diabetes Mellitus|type 1 diabetes mellitus
13755|NCT03202732|Non-inferiority study|non-inferiority study
13756|NCT03202719|Inactivated polio vaccine|inactivated polio vaccine
13757|NCT03202719|Polio|polio
13758|NCT03202719|oral polio vaccine|oral polio vaccine
13759|NCT03202693|Tuberculosis, PA-824|tuberculosis, pa-824
13762|NCT03202641|ARDS|ards
13763|NCT03202641|PEEP titration|peep titration
13764|NCT03202641|Open Lung Strategy|open lung strategy
13765|NCT03202641|Right heart function|right heart function
13766|NCT03202641|Lung recruitment maneuver|lung recruitment maneuver
13767|NCT03202641|Esophageal Pressure|esophageal pressure
13768|NCT03202641|Respiratory system compliance|respiratory system compliance
13769|NCT03202615|lactoferrin|lactoferrin
13770|NCT03202615|iron deficiency anemia in pregnancy|iron deficiency anemia in pregnancy
13771|NCT03202602|Obstructive sleep apnea|obstructive sleep apnea
13772|NCT03202602|Continuous positive airway pressure|continuous positive airway pressure
13773|NCT03202602|Telemoedicine|telemoedicine
13774|NCT03202589|Preoperative assessement for geriatric patients|preoperative assessement for geriatric patients
13775|NCT03202589|FOCUS Echocardiography|focus echocardiography
13776|NCT03202589|Orthopedic|orthopedic
13777|NCT03202589|Surgery|surgery
13778|NCT03202589|Geriatric|geriatric
16537|NCT03185247|Therapy|therapy
13781|NCT03202550|Oral Sedation|oral sedation
13782|NCT03202550|Lorazepam|lorazepam
13783|NCT03202550|Oxycodone|oxycodone
13784|NCT03202524|Paracentesis|paracentesis
13785|NCT03202524|Albumin|albumin
13786|NCT03202524|Plasma|plasma
13787|NCT03202498|Cirrhosis, Liver|cirrhosis, liver
13788|NCT03202498|Fibrosis, Liver|fibrosis, liver
13789|NCT03202498|Hepatic Cirrhosis|hepatic cirrhosis
13790|NCT03202498|Liver Fibrosis|liver fibrosis
13791|NCT03202485|astigmatism|astigmatism
13792|NCT03202485|high myopia|high myopia
13793|NCT03202485|phakic intraocular lens|phakic intraocular lens
13794|NCT03202485|astigmatic keratotomy|astigmatic keratotomy
13795|NCT03202485|toric|toric
13796|NCT03202459|Anesthesia|anesthesia
13797|NCT03202459|Complications|complications
13798|NCT03202459|Nausea|nausea
13799|NCT03202459|Vomiting|vomiting
13800|NCT03202433|Virtual Reality|virtual reality
13801|NCT03202433|Stress Reduction|stress reduction
13802|NCT03202433|Needle Aspiration|needle aspiration
13803|NCT03202433|Blood Donors|blood donors
13804|NCT03202433|Intervention|intervention
13805|NCT03202394|intubation|intubation
13806|NCT03202394|aerosol|aerosol
13807|NCT03202394|sepsis|sepsis
13808|NCT03202394|edema|edema
13809|NCT03202381|Androgen deprivation therapy|androgen deprivation therapy
13810|NCT03202381|GnRH antagonist|gnrh antagonist
13811|NCT03202355|Alignment phase|alignment phase
13812|NCT03202355|Photobiomodulation|photobiomodulation
13813|NCT03202355|Orthodontic treatment|orthodontic treatment
13814|NCT03202355|Malocclusion|malocclusion
13815|NCT03202355|OrthoPulse™|orthopulse™
13816|NCT03202316|Malignant neoplasm of breast|malignant neoplasm of breast
13817|NCT03202316|Metastatic inflammatory breast cancer|metastatic inflammatory breast cancer
13818|NCT03202316|mIBC|mibc
13819|NCT03202316|Cobimetinib|cobimetinib
13820|NCT03202316|Atezolizumab|atezolizumab
13821|NCT03202316|MPDL3280A|mpdl3280a
13822|NCT03202316|Eribulin|eribulin
13823|NCT03202316|E7389|e7389
13824|NCT03202303|Autism|autism
13825|NCT03202303|Irritability|irritability
13826|NCT03202303|cannabinoids|cannabinoids
13827|NCT03202277|physical activity, sleep, sedentary behavior, dietary intake, smartphone|physical activity, sleep, sedentary behavior, dietary intake, smartphone
13828|NCT03202264|Polypharmacy|polypharmacy
13829|NCT03202264|Mobility|mobility
13830|NCT03202264|Multimorbidity|multimorbidity
13831|NCT03202264|Drug Discontinuation|drug discontinuation
13832|NCT03202264|Patient Preference|patient preference
13833|NCT03202264|eHealth|ehealth
13834|NCT03202199|Adenocarcinoma, pancreas, PET/MRI|adenocarcinoma, pancreas, pet/mri
13835|NCT03202173|Probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
13836|NCT03202173|Optical biopsy|optical biopsy
13837|NCT03202160|Goiter|goiter
13838|NCT03202147|Ischemic stroke, post-stroke cognitive impairment, PSCI|ischemic stroke, post-stroke cognitive impairment, psci
13839|NCT03202108|Ketogenic|ketogenic
13840|NCT03202108|Diet|diet
13841|NCT03202108|Epilepsy|epilepsy
13842|NCT03202108|Glut-1 DS|glut-1 ds
13843|NCT03202108|Krio|krio
13844|NCT03202095|Depression|depression
13845|NCT03202095|Type 2 Diabetes|type 2 diabetes
13846|NCT03202095|Creatine|creatine
13847|NCT03202095|Diabetes|diabetes
13848|NCT03202069|Protein|protein
13849|NCT03202069|Weight Loss|weight loss
13850|NCT03202056|hip osteoarthritis|hip osteoarthritis
13851|NCT03202056|physiotherapy|physiotherapy
13852|NCT03202056|manual therapy|manual therapy
13853|NCT03202030|immediate dentoalveolar restoration|immediate dentoalveolar restoration
13854|NCT03202030|bio-oss|bio-oss
13855|NCT03202030|immediate dental implant|immediate dental implant
13856|NCT03202030|bovine bone|bovine bone
13857|NCT03202004|PGA|pga
13858|NCT03202004|efficacy|efficacy
13859|NCT03202004|PASI|pasi
13860|NCT03202004|GSK2894512|gsk2894512
13861|NCT03202004|NRS|nrs
13862|NCT03202004|Topical|topical
13863|NCT03202004|psoriasis|psoriasis
13864|NCT03201991|ALS|als
13865|NCT03201978|Healthy adults|healthy adults
13866|NCT03201978|GSK2894512|gsk2894512
13867|NCT03201978|Topical|topical
13868|NCT03201978|Psoriasis|psoriasis
13869|NCT03201978|Pharmacokinetics|pharmacokinetics
13870|NCT03201952|Glucose|glucose
13871|NCT03201952|Ileostomy|ileostomy
13872|NCT03201939|HIV/AIDS|hiv/aids
13873|NCT03201939|sub-Saharan Africa|sub-saharan africa
13874|NCT03201939|Kidney disease|kidney disease
13875|NCT03201939|Albuminuria|albuminuria
13876|NCT03201939|Genetic risk|genetic risk
13877|NCT03201900|perampanel|perampanel
13878|NCT03201848|Huaiqihuang granule|huaiqihuang granule
13879|NCT03201848|immune thrombocytopenia|immune thrombocytopenia
13880|NCT03201848|randomized|randomized
13881|NCT03201848|double-blind|double-blind
13882|NCT03201848|placebo-controlled,|placebo-controlled,
13883|NCT03201822|flavanol|flavanol
13884|NCT03201822|ADME|adme
13886|NCT03201822|polyphenols|polyphenols
13887|NCT03201796|Bacterial prostatitis|bacterial prostatitis
13888|NCT03201796|CBP|cbp
13889|NCT03201796|Levofloxacin|levofloxacin
13890|NCT03201796|Prulifloxacin|prulifloxacin
13891|NCT03201783|frozen-thawed embryo transfer|frozen-thawed embryo transfer
13892|NCT03201783|time interval|time interval
13893|NCT03201770|Uncomplicated Malaria|uncomplicated malaria
13894|NCT03201770|Pyramax|pyramax
13895|NCT03201770|Pyronaridine artesunate|pyronaridine artesunate
13896|NCT03201757|Alkermes|alkermes
13897|NCT03201757|ALKS 3831|alks 3831
13898|NCT03201757|Olanzapine|olanzapine
13899|NCT03201757|Samidorphan|samidorphan
13900|NCT03201757|Schizophrenia|schizophrenia
13901|NCT03201757|Schizophreniform|schizophreniform
13902|NCT03201757|Bipolar I|bipolar i
13903|NCT03201718|Hepatitis C|hepatitis c
13904|NCT03201718|Paritaprevir|paritaprevir
13905|NCT03201718|Ritonavir|ritonavir
13906|NCT03201718|Ombitasvir|ombitasvir
13907|NCT03201718|Dasabuvir|dasabuvir
13908|NCT03201705|Failed Back Surgery Syndrome|failed back surgery syndrome
13909|NCT03201705|Spinal Cord Stimulation|spinal cord stimulation
13910|NCT03201705|Pain Management|pain management
13911|NCT03201705|Implantable Neurostimulator|implantable neurostimulator
13912|NCT03201679|SIRS, systemic inflammatory response syndrome|sirs, systemic inflammatory response syndrome
13913|NCT03201679|Hip Fracture Surgery|hip fracture surgery
13914|NCT03201679|Sepsis|sepsis
13915|NCT03201679|Mortality|mortality
13916|NCT03201666|prenatal diagnosis|prenatal diagnosis
13917|NCT03201666|non-invasive prenatal tests|non-invasive prenatal tests
13918|NCT03201666|chromosome microarray analysis|chromosome microarray analysis
13919|NCT03201653|Distal Pancreatectomy|distal pancreatectomy
13920|NCT03201653|Pancreatic Fistula|pancreatic fistula
13921|NCT03201653|Oxidized Regenerated Cellulose|oxidized regenerated cellulose
13922|NCT03201653|Pancreatectomy|pancreatectomy
13923|NCT03201601|Polycystic ovarian syndrome|polycystic ovarian syndrome
13924|NCT03201601|D-chiro-inositol|d-chiro-inositol
13925|NCT03201601|Fertility|fertility
13926|NCT03201588|Retinopathy of Prematurity|retinopathy of prematurity
13927|NCT03201575|Intensive care|intensive care
13928|NCT03201575|septic shock|septic shock
13929|NCT03201575|multiple organ failure|multiple organ failure
13930|NCT03201575|Ischemia-reperfusion|ischemia-reperfusion
13931|NCT03201575|ischemic conditioning|ischemic conditioning
13932|NCT03201575|remote conditioning|remote conditioning
13933|NCT03201575|SOFA score|sofa score
13934|NCT03201536|ZipLine3 device vs. conventional sutures|zipline3 device vs. conventional sutures
13935|NCT03201523|Community-based Intervention|community-based intervention
13936|NCT03201523|Socio-ecological Model|socio-ecological model
13937|NCT03201523|Participatory Approach|participatory approach
13938|NCT03201523|Ultra-Orthodox Jewish women|ultra-orthodox jewish women
13939|NCT03201432|Vertebral Artery Stenosis|vertebral artery stenosis
13940|NCT03201432|Ischemic Stroke|ischemic stroke
13941|NCT03201432|Stent|stent
13942|NCT03201406|Renal biopsy, Chronic kidney disease,Diabetic nephropathy,Lupus Nephritis|renal biopsy, chronic kidney disease,diabetic nephropathy,lupus nephritis
13943|NCT03201393|Back pain|back pain
13944|NCT03201393|Neuropathic Pain|neuropathic pain
13948|NCT03201367|thrombosis|thrombosis
13949|NCT03201367|acute|acute
13950|NCT03201367|rivaroxaban|rivaroxaban
13951|NCT03201354|Glaucoma|glaucoma
13952|NCT03201354|Ocular hypertension|ocular hypertension
13953|NCT03201354|Filtration surgery|filtration surgery
13954|NCT03201354|Trabeculectomy with Ex-PRESS|trabeculectomy with ex-press
13955|NCT03201354|Non penetrating deep sclerectomy|non penetrating deep sclerectomy
13956|NCT03201354|Phacoemulsification|phacoemulsification
13957|NCT03201354|Combined surgery|combined surgery
13958|NCT03201341|Stroke|stroke
13959|NCT03201341|Multisensory|multisensory
13960|NCT03201341|Plasticity|plasticity
13961|NCT03201341|Body|body
13962|NCT03201341|Space|space
13963|NCT03201341|MRI|mri
13964|NCT03201315|Fentanyl, opioids|fentanyl, opioids
13965|NCT03201302|bone|bone
13966|NCT03201302|childhood|childhood
13967|NCT03201302|pre-adolescence|pre-adolescence
13968|NCT03201302|bone turnover markers|bone turnover markers
13969|NCT03201302|sclerostin|sclerostin
13970|NCT03201302|sports|sports
13971|NCT03201302|physical activity|physical activity
13972|NCT03201302|nutrition|nutrition
13973|NCT03201276|glucosamine sulfate|glucosamine sulfate
13974|NCT03201276|individual differences|individual differences
13975|NCT03201276|gene polymorphism|gene polymorphism
13976|NCT03201250|carfilzomib|carfilzomib
13977|NCT03201250|cabozantinib|cabozantinib
13978|NCT03201250|proteasome inhibitor|proteasome inhibitor
13979|NCT03201250|resistance|resistance
13980|NCT03201237|Cerebral palsy|cerebral palsy
13981|NCT03201211|Safety|safety
13982|NCT03201211|Immunogenicity|immunogenicity
13983|NCT03201198|physical activity|physical activity
13984|NCT03201198|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
13985|NCT03201185|Cardiovascular events|cardiovascular events
13986|NCT03201185|Ventricular remodeling|ventricular remodeling
13987|NCT03201159|ASH|ash
13988|NCT03201081|elderly|elderly
13989|NCT03201081|motivation|motivation
13990|NCT03201081|adherence|adherence
13991|NCT03201081|resistance-training|resistance-training
13992|NCT03201081|health|health
13993|NCT03201029|center for ethnic skin|center for ethnic skin
13994|NCT03201029|skin of color clinic|skin of color clinic
13995|NCT03201029|ethnic skin center|ethnic skin center
13996|NCT03201016|cirrhosis|cirrhosis
13997|NCT03201003|AR101|ar101
13998|NCT03201003|Characterized Peanut Allergen|characterized peanut allergen
13999|NCT03201003|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
14000|NCT03201003|OIT (oral immunotherapy)|oit (oral immunotherapy)
14001|NCT03201003|Peanut Allergy|peanut allergy
14002|NCT03201003|Peanut-Allergic Children|peanut-allergic children
14003|NCT03201003|Desensitization|desensitization
14004|NCT03201003|ARTEMIS|artemis
14005|NCT03201003|Allergy|allergy
14006|NCT03200990|pressure-volume loops|pressure-volume loops
14007|NCT03200990|cardiac mechanics|cardiac mechanics
14008|NCT03200990|high-risk PCI|high-risk pci
14009|NCT03200938|pulpotomy|pulpotomy
14010|NCT03200938|Biological cement|biological cement
14011|NCT03200938|Deciduous tooth|deciduous tooth
14012|NCT03200925|video|video
14013|NCT03200925|skin-to-skin|skin-to-skin
14014|NCT03200925|kangaroo care|kangaroo care
14015|NCT03200925|prenatal education|prenatal education
14016|NCT03200899|cognitive rehabilitation|cognitive rehabilitation
14017|NCT03200886|hyaluronic acid|hyaluronic acid
14018|NCT03200886|intra-articular injections|intra-articular injections
14019|NCT03200886|triamcinolone|triamcinolone
14020|NCT03200886|osteoarthritis of the thumb|osteoarthritis of the thumb
14021|NCT03200873|transcranial magnetic stimulation|transcranial magnetic stimulation
14022|NCT03200873|theta burst stimulation|theta burst stimulation
14023|NCT03200873|impulsivity|impulsivity
14024|NCT03200860|heart failure|heart failure
14025|NCT03200860|diuretic response|diuretic response
14026|NCT03200860|empagliflozin|empagliflozin
14029|NCT03200834|Right colon cancer|right colon cancer
14030|NCT03200834|D3 dissection|d3 dissection
14031|NCT03200834|complete mesocolic excision|complete mesocolic excision
14032|NCT03200834|Hemicolectomy|hemicolectomy
14033|NCT03200808|Nonneoplastic Epithelial Disorders|nonneoplastic epithelial disorders
14034|NCT03200808|methylene blue|methylene blue
14035|NCT03200808|treatment|treatment
14036|NCT03200795|Diabetes|diabetes
14037|NCT03200795|Musculoskelatal pain|musculoskelatal pain
14038|NCT03200795|Rebound exercises|rebound exercises
14039|NCT03200795|Depression|depression
14040|NCT03200795|Glucose|glucose
14041|NCT03200795|Quality of life|quality of life
14042|NCT03200782|postprandial hypoglycemia|postprandial hypoglycemia
14043|NCT03200782|bariatric surgery|bariatric surgery
14044|NCT03200782|late dumping syndrome|late dumping syndrome
14045|NCT03200782|anakinra|anakinra
14046|NCT03200782|empagliflozin|empagliflozin
14047|NCT03200782|SGLT2 inhibitor|sglt2 inhibitor
14048|NCT03200782|IL-1Beta|il-1beta
14049|NCT03200782|IL1|il1
14050|NCT03200769|CPAP|cpap
14051|NCT03200769|Sleep Apnea Syndrome|sleep apnea syndrome
14052|NCT03200769|Pharmacoresistant Epilepsy|pharmacoresistant epilepsy
14053|NCT03200769|Apnea Hypopnea-Index|apnea hypopnea-index
583404|NCT00511615|Colposcopy|colposcopy
14054|NCT03200756|sedentary behavior|sedentary behavior
14055|NCT03200743|Hypertension|hypertension
14056|NCT03200743|Pregnancy|pregnancy
14057|NCT03200743|Catestatin|catestatin
14058|NCT03200730|Family Dignity Intervention|family dignity intervention
14059|NCT03200730|Multicentre Randomized Control Trial|multicentre randomized control trial
14060|NCT03200730|Palliative Care|palliative care
14061|NCT03200730|End-of-Life Care|end-of-life care
14062|NCT03200717|renal cell carcinoma|renal cell carcinoma
14063|NCT03200717|metastatic renal cell|metastatic renal cell
14064|NCT03200717|pazopanib|pazopanib
14065|NCT03200717|checkpoint inhibitor therapy|checkpoint inhibitor therapy
14067|NCT03200717|hypernephroma|hypernephroma
14068|NCT03200717|renal adenocarcinoma|renal adenocarcinoma
14069|NCT03200717|kidney cancer|kidney cancer
14070|NCT03200717|renal cancer|renal cancer
14071|NCT03200717|adult|adult
14072|NCT03200691|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
14073|NCT03200691|PD-1|pd-1
14074|NCT03200691|Neoadjuvant treatment|neoadjuvant treatment
14075|NCT03200678|knee muscle|knee muscle
14076|NCT03200678|strength|strength
14077|NCT03200678|fatigue|fatigue
14078|NCT03200678|MRI|mri
14079|NCT03200678|ACL|acl
14080|NCT03200652|Lysine|lysine
14081|NCT03200652|Adult|adult
14082|NCT03200652|Protein Quality|protein quality
14083|NCT03200639|Breast Cancer Female|breast cancer female
14084|NCT03200639|Gynecologic Cancer|gynecologic cancer
14085|NCT03200639|Menopause|menopause
14086|NCT03200639|Physical Activity|physical activity
14087|NCT03200613|Spinal cord injury|spinal cord injury
14088|NCT03200613|Venous thromboembolism|venous thromboembolism
14089|NCT03200613|Hemorrhage|hemorrhage
14090|NCT03200600|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
14091|NCT03200600|Surgery|surgery
14092|NCT03200600|Dexamethasone|dexamethasone
14093|NCT03200600|Flubiprofen Axetil|flubiprofen axetil
14094|NCT03200600|Delirium|delirium
14095|NCT03200587|Metastatic|metastatic
14096|NCT03200574|Perceval|perceval
14097|NCT03200574|Mitroflow|mitroflow
14098|NCT03200574|CROWN PRT|crown prt
14099|NCT03200574|Freedom Solo|freedom solo
14100|NCT03200574|Solo Smart|solo smart
14101|NCT03200522|Asthma, Diet|asthma, diet
14102|NCT03200509|nonspecific low back pain|nonspecific low back pain
14103|NCT03200509|chronic pain|chronic pain
14104|NCT03200483|Autonomic Nervous System|autonomic nervous system
14105|NCT03200483|Aerobic exercise|aerobic exercise
14106|NCT03200483|Recuperation|recuperation
14107|NCT03200483|Music|music
14108|NCT03200457|Liver iron|liver iron
14109|NCT03200457|Liver steatosis|liver steatosis
14110|NCT03200457|MRI|mri
14111|NCT03200405|umbilical hernia|umbilical hernia
14112|NCT03200405|mesh repair|mesh repair
14113|NCT03200405|MRI-visibility|mri-visibility
14114|NCT03200405|underlay|underlay
14115|NCT03200405|NANEP|nanep
14116|NCT03200405|DynaMeshCICAT|dynameshcicat
14117|NCT03200405|DynaMeshVisible|dynameshvisible
14118|NCT03200405|preperitoneal|preperitoneal
14119|NCT03200392|Er,Cr:YSGG laser|er,cr:ysgg laser
14120|NCT03200392|connective tissue graft|connective tissue graft
14121|NCT03200392|root coverage|root coverage
14122|NCT03200392|mucogingival surgery|mucogingival surgery
14123|NCT03200392|gingival recession|gingival recession
14124|NCT03200366|Cancer Screening Tests|cancer screening tests
14125|NCT03200366|Colonoscopy|colonoscopy
14126|NCT03200275|Legionella urine antigen test|legionella urine antigen test
14127|NCT03200249|dose escalation, chemo-radiation, rectum cancer, phase 2|dose escalation, chemo-radiation, rectum cancer, phase 2
14128|NCT03200236|Lung Cancer Screening|lung cancer screening
14129|NCT03200236|Smoking Cessation|smoking cessation
14130|NCT03200236|Tobacco Use|tobacco use
14131|NCT03200210|Continuous Ambulatory Peritoneal Dialysis (CAPD)|continuous ambulatory peritoneal dialysis (capd)
14132|NCT03200210|Hyperuricemia|hyperuricemia
14133|NCT03200210|Cardiovascular events|cardiovascular events
14134|NCT03200210|Treatment|treatment
14135|NCT03200197|Chewing gum|chewing gum
14136|NCT03200197|Artificial saliva|artificial saliva
14137|NCT03200197|Saliva|saliva
14138|NCT03200197|Mastication|mastication
14139|NCT03200197|Salivary glands|salivary glands
14140|NCT03200197|Xerostomia|xerostomia
14141|NCT03200184|Hepatitis C|hepatitis c
14142|NCT03200184|sofosbuvir|sofosbuvir
14143|NCT03200184|daclatasvir|daclatasvir
14144|NCT03200171|Carcinoma, Hepatocellular|carcinoma, hepatocellular
14145|NCT03200171|Hepatitis C|hepatitis c
14146|NCT03200158|Stress related mucosal disease (SRMD)|stress related mucosal disease (srmd)
14147|NCT03200158|APACHEII score|apacheii score
14148|NCT03200158|C-reactive protein|c-reactive protein
14547|NCT03197636|Vitamin D|vitamin d
14149|NCT03200158|Malondialdehyde (MDA)|malondialdehyde (mda)
14150|NCT03200158|transforming growth factor (TGF)|transforming growth factor (tgf)
14151|NCT03200158|interleukin (IL)|interleukin (il)
14152|NCT03200093|Clostridium difficile|clostridium difficile
14153|NCT03200093|C diff|c diff
14154|NCT03200093|Oral Vancomycin|oral vancomycin
14155|NCT03200093|Prophylaxis|prophylaxis
14156|NCT03200054|therapy|therapy
14157|NCT03200054|postnatal|postnatal
14158|NCT03200002|Lupus Nephritis, cyclophosphamide, Mycophenolate mofetil|lupus nephritis, cyclophosphamide, mycophenolate mofetil
14159|NCT03199989|colon cancer|colon cancer
14160|NCT03199989|adjuvant chemotherapy|adjuvant chemotherapy
14161|NCT03199989|high risk|high risk
14162|NCT03199976|wheeze|wheeze
14163|NCT03199976|shortness of breath|shortness of breath
14164|NCT03199963|Mammographic|mammographic
14165|NCT03199963|Breast|breast
14166|NCT03199963|Density|density
14167|NCT03199963|BIRADS C or D|birads c or d
14168|NCT03199950|Delirium|delirium
14169|NCT03199950|Haloperidol|haloperidol
14170|NCT03199950|Prophylactic|prophylactic
14171|NCT03199950|High-risk|high-risk
14172|NCT03199937|Autism Spectrum Disorder|autism spectrum disorder
14173|NCT03199937|Executive Functioning|executive functioning
14174|NCT03199937|Intervention|intervention
14175|NCT03199937|Flexible|flexible
14176|NCT03199937|Unstuck|unstuck
14177|NCT03199937|Transition|transition
14178|NCT03199937|Behavior|behavior
14179|NCT03199937|High school|high school
14180|NCT03199937|Problem Solving|problem solving
14181|NCT03199937|Self-Control|self-control
14182|NCT03199937|Coping|coping
14183|NCT03199924|acute pain|acute pain
14184|NCT03199924|Renal colic|renal colic
14185|NCT03199924|Diclofenac|diclofenac
14186|NCT03199924|Lidocain|lidocain
14187|NCT03199924|Magnesium sulfate|magnesium sulfate
14188|NCT03199898|Lung/Growth & Development|lung/growth & development
14189|NCT03199898|Respiration, artificial|respiration, artificial
14190|NCT03199898|Reproducibility of Results|reproducibility of results
14191|NCT03199898|Observer Variation|observer variation
14192|NCT03199859|gastric cancer|gastric cancer
14193|NCT03199859|postoperative|postoperative
14194|NCT03199859|subsyndromal delirium|subsyndromal delirium
14195|NCT03199859|quality of life|quality of life
14196|NCT03199833|rehabilitation|rehabilitation
14197|NCT03199833|orthosis|orthosis
14198|NCT03199833|functional electrical stimulation|functional electrical stimulation
14199|NCT03199833|electrode array|electrode array
14200|NCT03199833|upper limb|upper limb
14201|NCT03199833|sub-acute|sub-acute
14202|NCT03199833|motor relearning|motor relearning
6208|NCT03251248|Healthy subjects|healthy subjects
6211|NCT03251157|Asthma|asthma
14204|NCT03199807|NRT|nrt
14205|NCT03199807|TOMO radiotherapy|tomo radiotherapy
14206|NCT03199781|cellulits of leg|cellulits of leg
14207|NCT03199781|Motorized power massage|motorized power massage
14208|NCT03199781|massage|massage
14209|NCT03199768|architecture|architecture
14210|NCT03199768|delirium|delirium
14211|NCT03199768|environment|environment
14212|NCT03199768|hospital design and construction|hospital design and construction
14213|NCT03199755|therapeutic|therapeutic
14214|NCT03199755|ACT|act
14215|NCT03199755|gametocyte|gametocyte
14216|NCT03199729|Overground training|overground training
14217|NCT03199729|Dynamic Stability|dynamic stability
14218|NCT03199729|Fall risk|fall risk
14219|NCT03199703|PVI Ablation|pvi ablation
14220|NCT03199703|Cryoballoon|cryoballoon
14221|NCT03199677|apatinib,refractory thyroid cancer|apatinib,refractory thyroid cancer
14222|NCT03199638|Continuous Glucose Monitoring|continuous glucose monitoring
14223|NCT03199638|Children|children
14224|NCT03199638|Exercise|exercise
14225|NCT03199638|Glycated hemoglobin|glycated hemoglobin
14226|NCT03199638|Adolescents|adolescents
14227|NCT03199638|Insulin sensitivity|insulin sensitivity
14228|NCT03199638|Glutamine|glutamine
14229|NCT03199625|cognitive-behavior therapy|cognitive-behavior therapy
14230|NCT03199625|magnetic resonance imaging|magnetic resonance imaging
14231|NCT03199625|Panic Disorder|panic disorder
14232|NCT03199612|Thrombosis during Continuous Flow Pump Support|thrombosis during continuous flow pump support
14233|NCT03199599|PET/CT|pet/ct
14234|NCT03199599|image processing|image processing
14235|NCT03199599|outcome|outcome
14236|NCT03199573|sunscreen|sunscreen
14237|NCT03199534|Pelvic Pain|pelvic pain
14238|NCT03199534|Dyspareunia|dyspareunia
14239|NCT03199534|Pelvic Floor Dysfunction|pelvic floor dysfunction
14240|NCT03199534|Pelvic Floor Physical Therapy|pelvic floor physical therapy
14241|NCT03199534|Chemodenervation|chemodenervation
14242|NCT03199534|Botulinum Toxin A|botulinum toxin a
14243|NCT03199534|Vaginismus|vaginismus
14244|NCT03199521|apixaban|apixaban
14245|NCT03199521|endogenous fibrinolysis|endogenous fibrinolysis
14246|NCT03199521|warfarin|warfarin
14247|NCT03199521|aspirin|aspirin
14248|NCT03199521|thrombotic status|thrombotic status
14249|NCT03199508|Nocturnal Enuresis|nocturnal enuresis
14250|NCT03199508|Voiding Diary|voiding diary
14251|NCT03199495|traditional Chinese medicine|traditional chinese medicine
14252|NCT03199495|electroacupuncture|electroacupuncture
14253|NCT03199495|abdominal pain|abdominal pain
610825|NCT00623857|Iron|iron
14259|NCT03199443|Pelvic floor|pelvic floor
14260|NCT03199430|catecholamines|catecholamines
14261|NCT03199430|Exercise|exercise
14262|NCT03199430|lipid metabolism|lipid metabolism
14263|NCT03199365|Cancer Prevention|cancer prevention
14264|NCT03199365|Latino Families|latino families
14265|NCT03199365|Healthy eating|healthy eating
14266|NCT03199365|Physical activity|physical activity
14267|NCT03199365|PA|pa
14268|NCT03199365|Food inventory|food inventory
14269|NCT03199365|Questionnaires|questionnaires
14270|NCT03199365|Surveys|surveys
14271|NCT03199365|Interviews|interviews
14272|NCT03199365|Accelerometer|accelerometer
14273|NCT03199339|tuberculosis|tuberculosis
14274|NCT03199339|TBA7371|tba7371
14275|NCT03199339|TBA-7371|tba-7371
14276|NCT03199339|TB Alliance|tb alliance
14277|NCT03199339|TB|tb
14278|NCT03199339|Pulmonary Tuberculosis|pulmonary tuberculosis
14279|NCT03199313|tuberculosis|tuberculosis
14280|NCT03199313|TB|tb
14281|NCT03199313|Sutezolid|sutezolid
14282|NCT03199313|pulmonary tuberculosis|pulmonary tuberculosis
14283|NCT03199300|bleomycin|bleomycin
14284|NCT03199300|cisplatin|cisplatin
14285|NCT03199300|trastuzumab|trastuzumab
14286|NCT03199300|anthracyclines|anthracyclines
14287|NCT03199300|toxicity|toxicity
14288|NCT03199287|metagenomics|metagenomics
14289|NCT03199287|next-generation sequencing|next-generation sequencing
14290|NCT03199287|bioinformatics|bioinformatics
14291|NCT03199287|antibiotic susceptibility|antibiotic susceptibility
14292|NCT03199248|Digital Mucous Cyst|digital mucous cyst
14293|NCT03199248|capsulotomy|capsulotomy
14294|NCT03199235|iron intake|iron intake
14295|NCT03199235|iron bioavailability|iron bioavailability
14296|NCT03199222|amputation|amputation
14297|NCT03199222|transtibial|transtibial
14298|NCT03199222|socket|socket
14299|NCT03199222|pressure|pressure
14300|NCT03199209|Physical Activity and Nutrition|physical activity and nutrition
14302|NCT03199209|Questionnaires|questionnaires
14303|NCT03199209|Surveys|surveys
14304|NCT03199209|Community Health Worker|community health worker
14305|NCT03199209|CHW|chw
14306|NCT03199209|Accelerometer|accelerometer
14307|NCT03199196|Cancer Prevention|cancer prevention
14308|NCT03199196|African-American woman|african-american woman
14309|NCT03199196|Hispanic woman|hispanic woman
14310|NCT03199196|Sedentary|sedentary
14311|NCT03199196|Activity Tracker|activity tracker
14312|NCT03199196|Smartphone Application|smartphone application
14313|NCT03199196|Questionnaires|questionnaires
14314|NCT03199196|Surveys|surveys
14315|NCT03199196|Focus Group|focus group
14316|NCT03199196|Electronic Newsletters|electronic newsletters
14317|NCT03199196|Telephone Counseling|telephone counseling
14318|NCT03199183|Takayasu Arteritis|takayasu arteritis
14319|NCT03199183|registry|registry
14325|NCT03199144|Pancreatic Neoplasms|pancreatic neoplasms
14326|NCT03199144|Borderline resectable|borderline resectable
14327|NCT03199144|Neoadjuvant treatment|neoadjuvant treatment
14328|NCT03199144|Chemotherapy|chemotherapy
14329|NCT03199144|Stereotactic radiation|stereotactic radiation
14330|NCT03199118|root coverage|root coverage
14331|NCT03199092|Reading|reading
14332|NCT03199092|Developmental Dyslexia|developmental dyslexia
14333|NCT03199092|Music|music
14334|NCT03199092|Rhythm|rhythm
14335|NCT03199092|Intervention|intervention
14336|NCT03199066|survival|survival
14337|NCT03199066|therapy|therapy
14338|NCT03199066|epidemiology|epidemiology
14339|NCT03199053|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
14340|NCT03199027|Adherence|adherence
14341|NCT03199001|Fabry Disease|fabry disease
14342|NCT03199001|T1 Mapping|t1 mapping
14343|NCT03199001|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
14344|NCT03198975|magnetic resonance image features|magnetic resonance image features
14345|NCT03198975|pathological differentiation|pathological differentiation
14346|NCT03198975|machine learning-based model|machine learning-based model
14469|NCT03198052|Immunotherapy|immunotherapy
14347|NCT03198962|ATS, Thai MSM TG, Use of amphetamine-type stimulants, HIV, adherence|ats, thai msm tg, use of amphetamine-type stimulants, hiv, adherence
14348|NCT03198923|Non-small Cell Lung Cancer|non-small cell lung cancer
14349|NCT03198897|high cholesterol levels|high cholesterol levels
14350|NCT03198897|low-density lipoprotein|low-density lipoprotein
14351|NCT03198897|xanthelasma palpebrarum|xanthelasma palpebrarum
14352|NCT03198897|atherosclerosis|atherosclerosis
610826|NCT00623857|Iodine|iodine
14358|NCT03198871|Gastric surgery|gastric surgery
14359|NCT03198858|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
14360|NCT03198845|knee osteoarthritis|knee osteoarthritis
14361|NCT03198845|video game|video game
14362|NCT03198845|therapeutic effects|therapeutic effects
14363|NCT03198832|Periodontal Disease|periodontal disease
14364|NCT03198832|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
14365|NCT03198832|Z-scan|z-scan
14366|NCT03198832|Atherosclerosis|atherosclerosis
14367|NCT03198819|Topical rifampicin, neural tube defects, infection, newborn|topical rifampicin, neural tube defects, infection, newborn
14368|NCT03198806|Autonomic Nervous System|autonomic nervous system
14369|NCT03198806|Fluid Therapy|fluid therapy
14370|NCT03198806|Heart Rate|heart rate
14371|NCT03198806|Exercise|exercise
14372|NCT03198767|obesity|obesity
14373|NCT03198767|overweight|overweight
14374|NCT03198767|body mass index|body mass index
14375|NCT03198767|BMI|bmi
14376|NCT03198767|diarrhea|diarrhea
14377|NCT03198754|Autologous Stem Cell Transplant|autologous stem cell transplant
14378|NCT03198754|Multiple Myeloma|multiple myeloma
14379|NCT03198754|oncology|oncology
14380|NCT03198754|circadian rhythms|circadian rhythms
14381|NCT03198754|light therapy|light therapy
14382|NCT03198754|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
14383|NCT03198715|Fibrinolysis enhancer|fibrinolysis enhancer
14384|NCT03198715|TAFIa inhibitor|tafia inhibitor
14385|NCT03198715|Developmental Phase I|developmental phase i
14386|NCT03198702|physiotherapy|physiotherapy
14387|NCT03198702|children|children
14388|NCT03198702|shoulder deformation|shoulder deformation
14389|NCT03198702|obstetrical brachial plexus palsy|obstetrical brachial plexus palsy
14390|NCT03198689|systemic sclerosis|systemic sclerosis
14391|NCT03198689|scleroderma|scleroderma
14392|NCT03198689|brentuximab vedotin|brentuximab vedotin
14393|NCT03198689|CD30-directed antibody-drug conjugate|cd30-directed antibody-drug conjugate
14394|NCT03198689|antirheumatic agents|antirheumatic agents
14395|NCT03198689|antineoplastic agents|antineoplastic agents
14396|NCT03198689|connective tissue diseases|connective tissue diseases
14397|NCT03198689|skin diseases|skin diseases
14398|NCT03198689|immunologic factors|immunologic factors
14399|NCT03198637|efficient|efficient
14400|NCT03198637|neuromuscular|neuromuscular
14401|NCT03198637|blockade|blockade
14402|NCT03198572|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
14408|NCT03198546|Hepatocellular carcinoma|hepatocellular carcinoma
14409|NCT03198546|immunotherapy|immunotherapy
14415|NCT03198533|Knee|knee
14416|NCT03198533|Arthrosis|arthrosis
14417|NCT03198533|Implant|implant
14418|NCT03198481|midurethral sling|midurethral sling
14419|NCT03198481|movie|movie
14420|NCT03198481|preparedness|preparedness
14421|NCT03198481|Video Counseling|video counseling
14422|NCT03198468|Non Small Cell Lung Cancer|non small cell lung cancer
14423|NCT03198468|Metastatic Lung Cancer|metastatic lung cancer
14424|NCT03198468|Lung Cancer|lung cancer
14425|NCT03198468|Vapor Ablation|vapor ablation
14426|NCT03198468|BTVA|btva
14427|NCT03198429|domestic violence|domestic violence
14428|NCT03198429|dyadic mother-child intervention|dyadic mother-child intervention
14429|NCT03198429|fathers|fathers
14430|NCT03198429|parenting|parenting
14431|NCT03198429|young children|young children
14432|NCT03198377|Pain Threshold|pain threshold
14433|NCT03198377|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
14434|NCT03198377|Habituation|habituation
14435|NCT03198325|HIV-1|hiv-1
14436|NCT03198299|therapeutic effects|therapeutic effects
14437|NCT03198299|insoles|insoles
14438|NCT03198299|children|children
14439|NCT03198273|clinical pilates|clinical pilates
14440|NCT03198273|exercise|exercise
14441|NCT03198273|lumbar disc herniation|lumbar disc herniation
14442|NCT03198273|chronic low back pain|chronic low back pain
14443|NCT03198234|Pediatric|pediatric
14444|NCT03198234|GvHD|gvhd
14445|NCT03198234|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
14446|NCT03198234|Stem Cells|stem cells
14447|NCT03198234|Transplant|transplant
14448|NCT03198234|BMT - bone marrow transplant|bmt - bone marrow transplant
14449|NCT03198221|Golytely, Prepopik, bowel prep|golytely, prepopik, bowel prep
14453|NCT03198143|Ghrelin|ghrelin
14454|NCT03198143|Healthy Volunteers|healthy volunteers
14455|NCT03198143|Obese|obese
14456|NCT03198104|Multiparametric MR Imaging|multiparametric mr imaging
14457|NCT03198104|Paediatric|paediatric
14458|NCT03198091|stable angina pectoris|stable angina pectoris
14459|NCT03198091|Dun Ye Guan Xin Ning|dun ye guan xin ning
14460|NCT03198078|Brexpiprazole|brexpiprazole
14461|NCT03198078|Schizophrenia|schizophrenia
14462|NCT03198078|Adolescent|adolescent
14463|NCT03198065|Laparoscopic appendectomy|laparoscopic appendectomy
14464|NCT03198065|Single-incision laparoscopic appendectomy|single-incision laparoscopic appendectomy
14465|NCT03198065|Single-incision laparoscopic surgery setting|single-incision laparoscopic surgery setting
14466|NCT03198065|Simple appendicitis|simple appendicitis
14467|NCT03198065|Complicated appendicitis|complicated appendicitis
14468|NCT03198052|Lung Cancer|lung cancer
14470|NCT03198052|CAR-T Cell Therapy|car-t cell therapy
14471|NCT03198052|PSCA|psca
14472|NCT03198052|MUC1|muc1
14473|NCT03198052|PD-L1|pd-l1
14474|NCT03198052|CD80/86|cd80/86
14475|NCT03198052|Cancer expressing PSCA,MUC1,PD-L1,or/and CD80/86|cancer expressing psca,muc1,pd-l1,or/and cd80/86
14480|NCT03198000|Eye Redness|eye redness
14481|NCT03198000|Eye Comfort|eye comfort
14482|NCT03198000|Red Eyes|red eyes
14483|NCT03197987|adenoma detection rate|adenoma detection rate
14484|NCT03197987|cap-assisted colonoscopy|cap-assisted colonoscopy
14485|NCT03197987|endocuff|endocuff
14486|NCT03197974|stage|stage
14487|NCT03197974|online|online
14488|NCT03197974|self-help|self-help
14489|NCT03197974|coaching support|coaching support
14490|NCT03197974|quality of life|quality of life
14491|NCT03197974|mindfulness|mindfulness
14492|NCT03197974|psychoeducation|psychoeducation
14493|NCT03197974|persuasive systems design|persuasive systems design
14494|NCT03197974|psychosocial|psychosocial
14495|NCT03197922|Autism Spectrum Disorder|autism spectrum disorder
14496|NCT03197922|Constipation|constipation
14497|NCT03197909|COPD (Chronic Obstructive Pulmonary Patients)|copd (chronic obstructive pulmonary patients)
14498|NCT03197909|Atrophy|atrophy
14499|NCT03197909|cell cultur|cell cultur
14500|NCT03197909|systemic inflammation|systemic inflammation
14501|NCT03197909|Catabolism|catabolism
14502|NCT03197857|Bariatric surgery|bariatric surgery
14503|NCT03197857|Morbid obesity|morbid obesity
14504|NCT03197857|Physical condition|physical condition
14505|NCT03197857|Muscle|muscle
14506|NCT03197857|6-minute walking test|6-minute walking test
14507|NCT03197857|Protein supplementation|protein supplementation
14508|NCT03197857|Physical activity program|physical activity program
14509|NCT03197831|Medicaid Expansion, Affordable Care Act, Health Care Reform|medicaid expansion, affordable care act, health care reform
17248|NCT03181100|ATC|atc
14514|NCT03197805|Genomic test|genomic test
14515|NCT03197792|Transesophageal ultrasound|transesophageal ultrasound
14516|NCT03197792|TEE|tee
14517|NCT03197792|Portal vein pulsatility|portal vein pulsatility
14518|NCT03197792|Splenic vein pulsatility|splenic vein pulsatility
14519|NCT03197792|Venous congestion|venous congestion
14520|NCT03197792|Strain|strain
14521|NCT03197792|Right ventricular dysfunction|right ventricular dysfunction
14522|NCT03197792|Pulmonary hypertension|pulmonary hypertension
14523|NCT03197792|Venous hypertension|venous hypertension
14524|NCT03197766|Achondroplasia|achondroplasia
14525|NCT03197766|Dwarfism|dwarfism
14526|NCT03197766|Bone Diseases|bone diseases
14527|NCT03197766|Bone Diseases, Developmental|bone diseases, developmental
14528|NCT03197766|ACH|ach
14529|NCT03197766|Natriuretic Peptide, C-Type|natriuretic peptide, c-type
14530|NCT03197766|Musculoskeletal Diseases|musculoskeletal diseases
6502|NCT03249623|Spontaneous breathing Tests|spontaneous breathing tests
6582|NCT03248999|CRE|cre
14531|NCT03197766|Natriuretic Agents|natriuretic agents
14532|NCT03197766|Physiological Effects of Drugs|physiological effects of drugs
14533|NCT03197766|Skeletal Dysplasias|skeletal dysplasias
14534|NCT03197766|Genetic Diseases, Inborn|genetic diseases, inborn
14535|NCT03197766|Osteochondrodysplasias|osteochondrodysplasias
14536|NCT03197753|laryngeal mask airway|laryngeal mask airway
14537|NCT03197753|nasotracheal intubation|nasotracheal intubation
14538|NCT03197753|dental treatment|dental treatment
14539|NCT03197727|Tooth wear, risk factors, saliva, diet, oral hygiene|tooth wear, risk factors, saliva, diet, oral hygiene
14540|NCT03197714|Myeloid Leukemia|myeloid leukemia
14541|NCT03197701|Lung function|lung function
14542|NCT03197701|Inspiratory flow rates|inspiratory flow rates
14543|NCT03197675|Chronic pain|chronic pain
14544|NCT03197675|Acupuncture|acupuncture
14545|NCT03197662|Prader-Willi Syndrome|prader-willi syndrome
14546|NCT03197662|Hyperphagia|hyperphagia
14548|NCT03197636|Soluble PD-1|soluble pd-1
14549|NCT03197623|Glucocorticoids|glucocorticoids
14550|NCT03197610|gingival recession|gingival recession
14551|NCT03197610|sub epithelial connective tissue graft|sub epithelial connective tissue graft
14552|NCT03197610|enamel matrix derivatives|enamel matrix derivatives
14553|NCT03197610|root coverage aesthetic score|root coverage aesthetic score
14554|NCT03197597|B. pertussis|b. pertussis
14555|NCT03197597|Acellular vaccination|acellular vaccination
14556|NCT03197597|Strain variation|strain variation
14557|NCT03197532|fertility|fertility
14558|NCT03197532|hormones|hormones
14559|NCT03197532|healthy|healthy
14560|NCT03197532|chemotherapy|chemotherapy
14561|NCT03197532|oncofertility|oncofertility
14562|NCT03197532|alkylating agent|alkylating agent
14563|NCT03197532|fertility after cancer|fertility after cancer
14564|NCT03197532|late effects|late effects
14565|NCT03197532|survivorship|survivorship
14566|NCT03197532|healthy volunteers|healthy volunteers
14567|NCT03197532|perimenopause|perimenopause
14568|NCT03197532|middle age|middle age
14570|NCT03197519|Eating Disorders|eating disorders
14571|NCT03197519|Randomised Controlled Trial|randomised controlled trial
14572|NCT03197519|Cognitive Behavioural Therapy|cognitive behavioural therapy
14573|NCT03197519|cost effectiveness|cost effectiveness
14574|NCT03197480|Anti-Vascular Endothelial Growth Factor|anti-vascular endothelial growth factor
14575|NCT03197480|Aflibercept|aflibercept
14576|NCT03197480|Intravitreal injection|intravitreal injection
14577|NCT03197480|Diabetic Macular Edema|diabetic macular edema
14578|NCT03197441|Platelet-rich plasma|platelet-rich plasma
14579|NCT03197441|Osteoarthritis Knee|osteoarthritis knee
14580|NCT03197428|Platelet-Rich Plasma|platelet-rich plasma
14581|NCT03197428|Ankle Injuries|ankle injuries
14582|NCT03197428|Lateral Ligament, Ankle|lateral ligament, ankle
14583|NCT03197415|Platelet-rich plasma|platelet-rich plasma
14584|NCT03197415|Intervertebral Disc Degeneration|intervertebral disc degeneration
14585|NCT03197415|Low Back Pain|low back pain
14586|NCT03197402|Leucine|leucine
14587|NCT03197402|Protein|protein
14588|NCT03197402|Supplementation|supplementation
14589|NCT03197389|Biomarker|biomarker
14590|NCT03197363|Civilization diseases|civilization diseases
14591|NCT03197363|Cardiovascular Risk Factor|cardiovascular risk factor
14592|NCT03197363|Population study|population study
14593|NCT03197363|Intestinal microbiome|intestinal microbiome
14594|NCT03197363|Oral microbiome|oral microbiome
14595|NCT03197350|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
14596|NCT03197350|Imaging|imaging
14597|NCT03197350|Prognosis|prognosis
14598|NCT03197337|Vulvodynia|vulvodynia
14599|NCT03197337|Localized Provoked Vulvodynia (LPV)|localized provoked vulvodynia (lpv)
14600|NCT03197337|Referred pain|referred pain
14601|NCT03197337|Utero-Sacral ligaments laxity|utero-sacral ligaments laxity
14602|NCT03197311|Oral surgery|oral surgery
14605|NCT03197298|Percutaneous Coronary Intervention|percutaneous coronary intervention
14607|NCT03197298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
14608|NCT03197298|Ticagrelor|ticagrelor
14609|NCT03197298|clopidogrel|clopidogrel
14610|NCT03197298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists
14611|NCT03197285|neck pain|neck pain
14612|NCT03197285|eye|eye
14613|NCT03197285|propioception|propioception
14614|NCT03197285|range of motion|range of motion
14615|NCT03197285|pain|pain
14616|NCT03197272|Myopia|myopia
14617|NCT03197272|corneal Crosslinking|corneal crosslinking
14618|NCT03197259|CLL, del(17p)|cll, del(17p)
14619|NCT03197246|PICC line|picc line
14620|NCT03197246|ECG|ecg
14621|NCT03197246|chest x-ray|chest x-ray
14622|NCT03197246|IVECG|ivecg
14623|NCT03197246|ICECG|icecg
14624|NCT03197194|Central retinal artery occlusion|central retinal artery occlusion
14625|NCT03197194|visual acuity|visual acuity
14626|NCT03197194|visual field|visual field
14627|NCT03197194|mRs|mrs
14628|NCT03197194|NEI-VFQ-25|nei-vfq-25
14629|NCT03197168|stigma|stigma
14630|NCT03197168|psychosocial intervention|psychosocial intervention
14631|NCT03197168|low-and-middle income countries|low-and-middle income countries
14632|NCT03197142|cardiac arrest|cardiac arrest
14633|NCT03197142|resuscitation|resuscitation
14634|NCT03197142|Out-Of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
14635|NCT03197142|CPR|cpr
14636|NCT03197103|Autologous fat grafting|autologous fat grafting
14637|NCT03197103|Breast|breast
14638|NCT03197103|Deformity|deformity
14639|NCT03197103|Asymmetry|asymmetry
14640|NCT03197103|Tuberous breast|tuberous breast
14641|NCT03197103|Acetylcysteine|acetylcysteine
14642|NCT03197090|Screening|screening
14643|NCT03197090|Zenicor|zenicor
14644|NCT03197051|Endothelial glycocalyx|endothelial glycocalyx
14645|NCT03197051|Acute kidney injury|acute kidney injury
14646|NCT03197051|Valvular heart disease|valvular heart disease
14746|NCT03196518|18F-TFB|18f-tfb
14654|NCT03197012|neuroendocrine tumor (NET)|neuroendocrine tumor (net)
14655|NCT03197012|Peptide Receptor Radionuclide Therapy (PRRT)|peptide receptor radionuclide therapy (prrt)
14656|NCT03197012|somatostatin receptor (SSTR)|somatostatin receptor (sstr)
14658|NCT03196999|Attention bias modification|attention bias modification
14659|NCT03196999|Remote app-based study|remote app-based study
14660|NCT03196999|Digital Health|digital health
14661|NCT03196960|Mobilization Therapy|mobilization therapy
14662|NCT03196960|Critical Illness|critical illness
14663|NCT03196960|Muscle Strength|muscle strength
14664|NCT03196960|Functional Mobility|functional mobility
14665|NCT03196960|Outcome|outcome
14666|NCT03196960|Intensive Care Unit|intensive care unit
14667|NCT03196960|Quality of Life|quality of life
14668|NCT03196947|multiple myeloma|multiple myeloma
14669|NCT03196947|APO010|apo010
14670|NCT03196947|Drug Response Predictor|drug response predictor
14671|NCT03196947|DRP|drp
14672|NCT03196921|amphotericin B|amphotericin b
14673|NCT03196921|cryptococcal|cryptococcal
14674|NCT03196908|ECG|ecg
14675|NCT03196908|Blood Pressure|blood pressure
14676|NCT03196908|Energy Drinks|energy drinks
14677|NCT03196895|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
14678|NCT03196895|Continuous Glucose Monitoring|continuous glucose monitoring
14679|NCT03196895|Lifestyle Modification|lifestyle modification
14680|NCT03196882|pregnancy|pregnancy
14681|NCT03196882|iron|iron
14682|NCT03196882|hemoglobin|hemoglobin
14683|NCT03196882|supplementation|supplementation
14684|NCT03196882|neurodevelopment|neurodevelopment
14685|NCT03196882|newborn|newborn
14686|NCT03196882|anemia|anemia
14687|NCT03196882|clinical trial|clinical trial
14688|NCT03196869|NPC peripheral blood dendritic cell chronic-chemotherap|npc peripheral blood dendritic cell chronic-chemotherap
14689|NCT03196856|Greek Yogurt|greek yogurt
14690|NCT03196856|Muscle Size|muscle size
14691|NCT03196856|Bone Health|bone health
14692|NCT03196856|Body Composition|body composition
14693|NCT03196856|Exercise|exercise
14694|NCT03196843|raltitrexed|raltitrexed
14695|NCT03196843|radiotherapy|radiotherapy
14696|NCT03196843|older patient|older patient
14697|NCT03196843|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
14698|NCT03196830|Relapse/refractory non-Hodgkin lymphoma|relapse/refractory non-hodgkin lymphoma
14699|NCT03196830|CAR - T CD19/CD20/CD22/CD30|car - t cd19/cd20/cd22/cd30
14700|NCT03196817|Random Allocation|random allocation
14701|NCT03196817|Injections|injections
14702|NCT03196817|Orthotic Devices|orthotic devices
14703|NCT03196752|cricothyroid membrane|cricothyroid membrane
14704|NCT03196726|cognitive-behavioral therapy|cognitive-behavioral therapy
14705|NCT03196713|Allegiance|allegiance
14706|NCT03196713|Knowledge|knowledge
14707|NCT03196713|Supervision|supervision
14708|NCT03196713|Early intervention|early intervention
14710|NCT03196700|palliative care|palliative care
14711|NCT03196700|head and neck cancer|head and neck cancer
14712|NCT03196700|radiotherapy|radiotherapy
14713|NCT03196700|pain|pain
14714|NCT03196700|quality of life|quality of life
14715|NCT03196687|diastolic dysfunction|diastolic dysfunction
14716|NCT03196661|safety investigation|safety investigation
14717|NCT03196648|Gingivitis|gingivitis
14718|NCT03196648|Periodontal disease|periodontal disease
14719|NCT03196648|Inflammation|inflammation
14720|NCT03196648|Teeth whitening|teeth whitening
14721|NCT03196648|Breath freshening|breath freshening
14722|NCT03196648|Periodontal pathogens|periodontal pathogens
14723|NCT03196648|Bleeding on probing|bleeding on probing
14724|NCT03195569|QL1101 Avastin® Non Small Cell Lung Cancer|ql1101 avastin® non small cell lung cancer
14725|NCT03195543|Blood coagulation disorders|blood coagulation disorders
14726|NCT03195543|Platelets|platelets
14727|NCT03195543|Thrombin|thrombin
14728|NCT03195543|Treatment|treatment
14729|NCT03195517|Osteopenia|osteopenia
14730|NCT03195517|Physical activity|physical activity
14731|NCT03195517|Bone turnover markers|bone turnover markers
14732|NCT03195517|Osteoprogenitor cells|osteoprogenitor cells
14733|NCT03195517|Quality of life|quality of life
14734|NCT03196622|Sarcopenia|sarcopenia
14735|NCT03196622|Elderly people|elderly people
14736|NCT03196622|Hospitalization|hospitalization
14738|NCT03196596|TAVI|tavi
14739|NCT03196596|Computer simulation|computer simulation
14740|NCT03196583|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
14741|NCT03196583|video-polysomnography|video-polysomnography
14742|NCT03196583|mandibular advancement device|mandibular advancement device
14743|NCT03196583|oral device|oral device
14744|NCT03196583|cephalometry|cephalometry
14745|NCT03196518|PET Imaging|pet imaging
14747|NCT03196518|17-315|17-315
14748|NCT03196505|Anesthetics, Local|anesthetics, local
14749|NCT03196505|Liposomal Bupivacaine|liposomal bupivacaine
14750|NCT03196505|Bupivacaine|bupivacaine
14751|NCT03196505|Postoperative Complications|postoperative complications
14752|NCT03196505|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
14753|NCT03196505|Sleeve Gastrectomy|sleeve gastrectomy
14754|NCT03196505|Laparoscopic Bariatric Surgery|laparoscopic bariatric surgery
14755|NCT03196466|antiepileptics|antiepileptics
14756|NCT03196466|pharmacokinetics|pharmacokinetics
14757|NCT03196466|children|children
14758|NCT03196453|overweight|overweight
14759|NCT03196453|probiotic|probiotic
14760|NCT03196453|weight management|weight management
14761|NCT03196440|elderly|elderly
14762|NCT03196440|taste|taste
14763|NCT03196440|thresholds|thresholds
14764|NCT03196427|Drug therapy|drug therapy
14765|NCT03196401|Durvalumb|durvalumb
14766|NCT03196401|Radiation Therapy|radiation therapy
583405|NCT00511615|Molecular Imaging|molecular imaging
14767|NCT03196401|Clonal Bone Marrow Plasmacytosis|clonal bone marrow plasmacytosis
14768|NCT03196401|MEDI4736|medi4736
14769|NCT03196401|17-269|17-269
14770|NCT03196388|ENZALUTAMIDE|enzalutamide
14771|NCT03196388|External Beam Hypofractionated Radiotherapy Intermediate Risk Prostate Cancer|external beam hypofractionated radiotherapy intermediate risk prostate cancer
14772|NCT03196375|Motor Neuron Disease|motor neuron disease
14773|NCT03196375|Neurodegenerative Diseases|neurodegenerative diseases
14774|NCT03196375|Nervous System Diseases|nervous system diseases
14775|NCT03196375|Neuromuscular Diseases|neuromuscular diseases
14776|NCT03196375|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
14777|NCT03196375|Primary Lateral Sclerosis|primary lateral sclerosis
14778|NCT03196375|Progressive Muscular Atrophy|progressive muscular atrophy
14779|NCT03196375|Muscle cramps|muscle cramps
14780|NCT03196375|Muscle cramping|muscle cramping
14781|NCT03196375|ALS|als
14782|NCT03196375|MND|mnd
14783|NCT03196375|PMA|pma
14784|NCT03196375|PLS|pls
14785|NCT03196375|FLX-787|flx-787
14786|NCT03196362|short-term intensive insulin therapy|short-term intensive insulin therapy
14787|NCT03196362|pioglitazone|pioglitazone
14788|NCT03196362|metformin|metformin
14789|NCT03196362|remission|remission
14790|NCT03196362|sequential therapy|sequential therapy
14791|NCT03196258|fracture|fracture
14792|NCT03196258|persistent pain|persistent pain
14793|NCT03196258|cognitive behavioural therapy|cognitive behavioural therapy
14794|NCT03196258|post surgical pain|post surgical pain
14795|NCT03196258|health-related quality of life|health-related quality of life
14796|NCT03196167|sugammadex|sugammadex
14797|NCT03196167|extubation|extubation
14798|NCT03196167|CABG|cabg
14799|NCT03196154|Homeostasis Model Assessment|homeostasis model assessment
14800|NCT03196154|Insulin Resistance|insulin resistance
14801|NCT03196154|Beta Cell Function|beta cell function
14802|NCT03196154|Liquid Chromatography Tandem Mass Spectrometry|liquid chromatography tandem mass spectrometry
14803|NCT03196115|Autosomal Recessive Disorder|autosomal recessive disorder
14804|NCT03196115|Gingival Hypertrophy|gingival hypertrophy
14805|NCT03196115|Skin and Connective Tissue Diseases|skin and connective tissue diseases
14806|NCT03196102|tobacco prevention; tobacco intervention; military; brief intervention|tobacco prevention; tobacco intervention; military; brief intervention
14807|NCT03196063|Exercise Therapy|exercise therapy
14808|NCT03196063|Heavy Slow Resistance Program|heavy slow resistance program
14809|NCT03196063|Rehabilitation|rehabilitation
14810|NCT03196024|Diabetes; CVD; Lifestyle; Hispanic; Promotora|diabetes; cvd; lifestyle; hispanic; promotora
14811|NCT03196024|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
14812|NCT03196024|Cardiovascular Diseases|cardiovascular diseases
14813|NCT03196024|Risk Reduction Behavior|risk reduction behavior
14814|NCT03196024|Hispanic Americans; Latinos|hispanic americans; latinos
14815|NCT03196024|Community Health Workers|community health workers
14816|NCT03195972|Adherence, Patient, oncology, oral therapy|adherence, patient, oncology, oral therapy
14817|NCT03195959|Pulmonary arterial hypertension|pulmonary arterial hypertension
14818|NCT03195959|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
14819|NCT03195959|Hypoxia|hypoxia
14820|NCT03195959|Hyperoxia|hyperoxia
14821|NCT03195933|Depression|depression
14822|NCT03195933|Childhood Adversity|childhood adversity
14823|NCT03195933|Childhood Abuse|childhood abuse
14824|NCT03195933|Cortisol|cortisol
14825|NCT03195933|Emotional Memory|emotional memory
14826|NCT03195933|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
14827|NCT03195907|Stroke|stroke
14828|NCT03195907|Mortality|mortality
14829|NCT03195907|Intensive care unit|intensive care unit
14830|NCT03195907|Pulmonary rehabilitation|pulmonary rehabilitation
15035|NCT03194659|Nutrition|nutrition
14831|NCT03195894|Alcohol abuse, Alcoholometer, Medical Device, App|alcohol abuse, alcoholometer, medical device, app
14832|NCT03195868|chemotherapy|chemotherapy
14833|NCT03195868|chemo-induced|chemo-induced
14834|NCT03195868|CIPN|cipn
14835|NCT03195829|Mild Cognitive Impairment|mild cognitive impairment
14836|NCT03195829|Computerized Cognitive Stimulation|computerized cognitive stimulation
14837|NCT03195829|Cognition|cognition
14838|NCT03195829|Psychosocial factors|psychosocial factors
14839|NCT03195816|Mild Cognitive Impairment|mild cognitive impairment
14840|NCT03195816|white matter hyperintensities|white matter hyperintensities
14968|NCT03194971|glioblastoma|glioblastoma
14841|NCT03195816|computerized cognitive training|computerized cognitive training
14842|NCT03195816|brain plasticity|brain plasticity
14843|NCT03195751|telemonitoring|telemonitoring
14844|NCT03195738|pediatrics|pediatrics
14845|NCT03195738|case series|case series
14846|NCT03195738|feasibility|feasibility
14848|NCT03195712|Obesity|obesity
14849|NCT03195699|STAT3, cancer, inhibitor, advanced cancer|stat3, cancer, inhibitor, advanced cancer
14850|NCT03195673|Carotid artery stenting|carotid artery stenting
14851|NCT03195673|Silent embolism|silent embolism
14852|NCT03195673|Terazosin|terazosin
14853|NCT03195660|adaptive servo-ventilation|adaptive servo-ventilation
14854|NCT03195660|ASV|asv
14855|NCT03195660|HFpEF|hfpef
14856|NCT03195647|cardiovascular|cardiovascular
14857|NCT03195647|potassium supplementation|potassium supplementation
14858|NCT03195647|coronary artery by pass surgery|coronary artery by pass surgery
14859|NCT03195634|Cirrhosis|cirrhosis
14860|NCT03195634|Portal Hypertension|portal hypertension
14861|NCT03195621|Coronary Artery Disease|coronary artery disease
14862|NCT03195621|Critical lesion|critical lesion
14863|NCT03195608|In-vehicle technologies|in-vehicle technologies
14864|NCT03195608|Parkinson's disease|parkinson's disease
14865|NCT03195608|Driving performance|driving performance
14866|NCT03195452|HIV|hiv
14867|NCT03195452|Antiretrovirals|antiretrovirals
14868|NCT03195452|Raltegravir|raltegravir
14869|NCT03195413|Hand blast injury|hand blast injury
14870|NCT03195413|Nerve block|nerve block
14871|NCT03195413|Hand injury|hand injury
14872|NCT03195413|Forearm nerve block|forearm nerve block
14873|NCT03195413|Ultrasound guided nerve block|ultrasound guided nerve block
14874|NCT03195413|Ultrasound nerve block|ultrasound nerve block
14875|NCT03195413|Emergency department|emergency department
14876|NCT03195413|Emergency physician|emergency physician
14877|NCT03195413|Emergency room|emergency room
14878|NCT03195387|malaria, P. falciparum, chemoprotection, Phase Ib|malaria, p. falciparum, chemoprotection, phase ib
14879|NCT03195374|Analgesic opioids|analgesic opioids
14880|NCT03195374|Misuse|misuse
14881|NCT03195374|Use disorder|use disorder
14882|NCT03195374|Pain|pain
14883|NCT03195335|Cerebral Palsy|cerebral palsy
14884|NCT03195335|Participation|participation
14885|NCT03195335|LIFE Habits (life-H)|life habits (life-h)
14886|NCT03195335|Validity|validity
14887|NCT03195335|Reliability|reliability
14888|NCT03195322|Immediate Breast Reconstruction|immediate breast reconstruction
14889|NCT03195322|Pain Control|pain control
14890|NCT03195322|Post Mastectomy Pain Control|post mastectomy pain control
14891|NCT03195322|Acellular Dermal Matrix|acellular dermal matrix
14892|NCT03195309|Cesarean Delivery|cesarean delivery
14893|NCT03195309|Ropivacaine|ropivacaine
14894|NCT03195309|Fentanyl|fentanyl
14895|NCT03195309|Patient-controlled Epidural Analgesia|patient-controlled epidural analgesia
14896|NCT03195283|meal service|meal service
14897|NCT03195283|protein intake|protein intake
14898|NCT03195283|satisfaction|satisfaction
14899|NCT03195283|hospitalized patients|hospitalized patients
14900|NCT03195270|Positron emission tomography|positron emission tomography
14901|NCT03195270|Magnetic Resonance Imaging|magnetic resonance imaging
14902|NCT03195270|PET/MRI|pet/mri
14903|NCT03195270|Fluorodeoxyglucose|fluorodeoxyglucose
14904|NCT03195270|FDG|fdg
14905|NCT03195270|Pain|pain
14906|NCT03195270|Chronic Pain|chronic pain
14907|NCT03195270|Neuropathic Pain|neuropathic pain
14908|NCT03195270|Inflammatory Pain|inflammatory pain
14909|NCT03195270|Nociceptive Pain|nociceptive pain
14910|NCT03195244|aquatic therapy, hydrotherapy|aquatic therapy, hydrotherapy
14911|NCT03195231|Parkinson`s disease|parkinson`s disease
14912|NCT03195231|Depression|depression
14913|NCT03195231|Wuling Powder|wuling powder
14914|NCT03195218|Cancer prevention|cancer prevention
14915|NCT03195218|Diagnosis|diagnosis
14916|NCT03195218|Microendoscope|microendoscope
14917|NCT03195218|High Resolution Microendoscope|high resolution microendoscope
14918|NCT03195179|pelvic fracture urethral injury|pelvic fracture urethral injury
14919|NCT03195179|urethra|urethra
14920|NCT03195179|disruption|disruption
14921|NCT03195179|trauma|trauma
13223|NCT03205995|TMA|tma
14922|NCT03195166|elderly spinal anesthesia|elderly spinal anesthesia
14923|NCT03195140|Diabetes Mellitus|diabetes mellitus
14924|NCT03195140|Diabetes|diabetes
14925|NCT03195140|Sensor Augmented Pump|sensor augmented pump
14926|NCT03195140|Hypoglycemia|hypoglycemia
14927|NCT03195127|Physical Therapy Modalities|physical therapy modalities
14928|NCT03195127|Rehabilitation|rehabilitation
14929|NCT03195127|Exercise Therapy|exercise therapy
14930|NCT03195127|Critical Illness|critical illness
14931|NCT03195127|Respiration, Artificial|respiration, artificial
14932|NCT03195127|Chronic Disease|chronic disease
14933|NCT03195114|post TAVR quantification|post tavr quantification
14934|NCT03195114|cardiac MRI|cardiac mri
14935|NCT03195114|echocardiography|echocardiography
14936|NCT03195114|biomarkers|biomarkers
14939|NCT03195062|Fructose|fructose
14940|NCT03195062|Obesity|obesity
14941|NCT03195062|Metabolism|metabolism
14942|NCT03195062|Post-prandial kinetics|post-prandial kinetics
14943|NCT03195049|hyperbilirubinemia|hyperbilirubinemia
14944|NCT03195049|kernicterus|kernicterus
14945|NCT03195036|HIV-exposed|hiv-exposed
14946|NCT03195036|Early Childhood Development|early childhood development
14947|NCT03195036|Cameroon|cameroon
14948|NCT03195023|Renal Insufficiency, Chronic|renal insufficiency, chronic
14949|NCT03194997|Breast Cancer|breast cancer
14950|NCT03194997|Quality of life|quality of life
14951|NCT03194997|Lymphedema|lymphedema
14952|NCT03194997|Fatigue|fatigue
14953|NCT03194997|Depressive symptoms|depressive symptoms
14954|NCT03194997|Body image|body image
14955|NCT03194997|Self Esteem|self esteem
14956|NCT03194997|Optimism|optimism
14957|NCT03194997|Sexual function|sexual function
14958|NCT03194997|Stress|stress
14959|NCT03194997|Sleep quality|sleep quality
14960|NCT03194997|Pain|pain
14961|NCT03194997|Muscular strength|muscular strength
14962|NCT03194997|Postural|postural
14963|NCT03194997|Balance|balance
14964|NCT03194997|Range of motion|range of motion
14965|NCT03194997|Cardiorespiratory fitness|cardiorespiratory fitness
14966|NCT03194984|dental whitening|dental whitening
14967|NCT03194984|Dental office whitening|dental office whitening
14969|NCT03194971|brain tumor autopsy|brain tumor autopsy
14970|NCT03194971|autopsy|autopsy
14971|NCT03194971|Optune therapy|optune therapy
14972|NCT03194971|tumor treatment fields|tumor treatment fields
14973|NCT03194971|TTFields|ttfields
14974|NCT03194971|Recurrent glioblastoma|recurrent glioblastoma
14975|NCT03194971|grade IV|grade iv
14976|NCT03194971|brain tumor|brain tumor
14977|NCT03194971|newly diagnosed glioblastoma|newly diagnosed glioblastoma
14978|NCT03194945|Type 2 diabetes mellitus|type 2 diabetes mellitus
14979|NCT03194945|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
14980|NCT03194945|Metformin|metformin
14981|NCT03194945|Linagliptin|linagliptin
14982|NCT03194919|online intervention|online intervention
14983|NCT03194919|e-Health|e-health
14984|NCT03194919|negotiating quit date|negotiating quit date
14985|NCT03194906|Pediatric oncology|pediatric oncology
14986|NCT03194906|Brain tumor|brain tumor
14987|NCT03194906|Low grade glioma|low grade glioma
14988|NCT03194906|Cognitive late effects|cognitive late effects
14989|NCT03194906|Radiation therapy|radiation therapy
14990|NCT03194906|Neuroprotection|neuroprotection
14991|NCT03194906|Memantine|memantine
14992|NCT03194893|Non−small cell lung cancer (NSCLC)|non−small cell lung cancer (nsclc)
14993|NCT03194893|Anaplastic lymphoma kinase (ALK)|anaplastic lymphoma kinase (alk)
14994|NCT03194893|Rearranged during transfection (RET)|rearranged during transfection (ret)
14995|NCT03194893|Alectinib|alectinib
14996|NCT03194893|Crizotinib|crizotinib
14997|NCT03194854|Well-Being|well-being
14998|NCT03194854|e-Health|e-health
14999|NCT03194854|Randomized Controlled Trial|randomized controlled trial
15000|NCT03194854|Self-Efficacy|self-efficacy
15001|NCT03194854|Interpersonal well-being|interpersonal well-being
15002|NCT03194854|Community well-being|community well-being
15003|NCT03194854|Occupational well-being|occupational well-being
15004|NCT03194854|Physical well-being|physical well-being
15005|NCT03194854|Psychological well-being|psychological well-being
15006|NCT03194854|Economic well-being|economic well-being
15007|NCT03194828|Adherence|adherence
15008|NCT03194828|Mobile health|mobile health
15009|NCT03194828|Real-time data|real-time data
15010|NCT03194815|Psychosis|psychosis
15011|NCT03194815|Immunotherapy|immunotherapy
15012|NCT03194815|Autoantibodies|autoantibodies
15017|NCT03194776|PAD|pad
15018|NCT03194776|peripheral artery/arterial disease|peripheral artery/arterial disease
15019|NCT03194776|peripheral vascular disease|peripheral vascular disease
15020|NCT03194776|leg pain|leg pain
15021|NCT03194776|claudication|claudication
15022|NCT03194776|leg pain with exercise|leg pain with exercise
15023|NCT03194776|exercise test|exercise test
15024|NCT03194776|walk test|walk test
15025|NCT03194737|Benign prostatic hyperplasia|benign prostatic hyperplasia
15026|NCT03194737|BPH|bph
15027|NCT03194737|Urinary retention|urinary retention
15028|NCT03194737|prostate|prostate
15029|NCT03194737|hypertrophy|hypertrophy
15030|NCT03194711|Percutaneous Coronary Revascularization|percutaneous coronary revascularization
15031|NCT03194711|Optical Coherence Tomography|optical coherence tomography
15032|NCT03194711|Stents, Drug-Eluting|stents, drug-eluting
15033|NCT03194698|Intense Pulsed Light|intense pulsed light
15034|NCT03194685|Acute Myeloid Leukemia|acute myeloid leukemia
15036|NCT03194659|choline|choline
15037|NCT03194659|pregnancy|pregnancy
15038|NCT03194659|docosahexaenoic acid|docosahexaenoic acid
15039|NCT03194659|DHA|dha
15040|NCT03194659|fatty acids|fatty acids
15041|NCT03194646|Uterine Fibroid|uterine fibroid
15042|NCT03194620|Flavanols|flavanols
15043|NCT03194620|Cocoa Flavanols|cocoa flavanols
15044|NCT03194620|Epicatechins|epicatechins
15045|NCT03194620|Polyphenols|polyphenols
15046|NCT03194620|Procyanidins|procyanidins
15047|NCT03194620|EGCG|egcg
15048|NCT03194620|EGC|egc
15049|NCT03194620|ECG|ecg
15050|NCT03194620|Theaflavins|theaflavins
15051|NCT03194620|Thearubigins|thearubigins
15052|NCT03194594|Ketamine, dexamethasone, mood|ketamine, dexamethasone, mood
15053|NCT03194568|Scoliosis|scoliosis
15054|NCT03194568|Idiopathic Scoliosis|idiopathic scoliosis
15055|NCT03194568|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
15056|NCT03194555|Innate Immune System|innate immune system
15057|NCT03194555|Cytokines|cytokines
15058|NCT03194555|Cox-2|cox-2
15059|NCT03194555|Headache|headache
15060|NCT03194555|Migraine|migraine
15061|NCT03194555|Migraine Prevention|migraine prevention
15062|NCT03194542|Luspatercept|luspatercept
15063|NCT03194542|ACE-536|ace-536
15064|NCT03194542|Myeloproliferative Neoplasm-Associated Myelofibrosis|myeloproliferative neoplasm-associated myelofibrosis
15065|NCT03194542|Primary Myelofibrosis|primary myelofibrosis
15066|NCT03194542|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
15067|NCT03194542|Post-Essential Thrombocythemia|post-essential thrombocythemia
15068|NCT03194542|Anemia|anemia
15069|NCT03194542|Red Blood Cell (RBC) Transfusion|red blood cell (rbc) transfusion
15070|NCT03194542|Ruxolitinib|ruxolitinib
15071|NCT03194529|Crohn's Disease|crohn's disease
15072|NCT03194529|PCDAI|pcdai
15073|NCT03194529|16s rRNA|16s rrna
15074|NCT03194529|Fecal Microbiota Transplantation|fecal microbiota transplantation
15075|NCT03194529|Gut Microbiome|gut microbiome
15076|NCT03194529|FMT|fmt
15077|NCT03194516|prostate cancer|prostate cancer
15078|NCT03194516|ketogenic diet|ketogenic diet
15079|NCT03194516|overweight, obese|overweight, obese
15080|NCT03194503|Intubation|intubation
15081|NCT03194503|Video Laryngoscope|video laryngoscope
15082|NCT03194503|Coaching/training|coaching/training
15083|NCT03194477|HIV young Black men who have sex with men substance use|hiv young black men who have sex with men substance use
15084|NCT03194464|hemiparesis|hemiparesis
15085|NCT03194451|bone tissue engineering, dental stem cell differentiation|bone tissue engineering, dental stem cell differentiation
15086|NCT03194438|Pulmonary Hypertension|pulmonary hypertension
15087|NCT03194438|Symptom Management|symptom management
15088|NCT03194438|Behavioral Intervention|behavioral intervention
15089|NCT03194438|Integrative Therapy|integrative therapy
15090|NCT03194438|Quality of Life|quality of life
15091|NCT03194425|Sacral neuromodulation|sacral neuromodulation
15092|NCT03194425|Electromyography|electromyography
15093|NCT03194425|Pelvic floor|pelvic floor
15094|NCT03194412|Frail Elderly|frail elderly
15095|NCT03194412|Geriatric Assessment|geriatric assessment
15096|NCT03194412|Humans|humans
15097|NCT03194412|Aged|aged
15098|NCT03194386|Post-Traumatic Syndrome|post-traumatic syndrome
15099|NCT03194386|Eye-Movement Desensitization and Reprocessing|eye-movement desensitization and reprocessing
15100|NCT03194334|vegetarianism|vegetarianism
15101|NCT03194334|creatine|creatine
15102|NCT03194334|carnosine|carnosine
15103|NCT03194334|carnitine|carnitine
15104|NCT03194308|HIV risk reduction|hiv risk reduction
15105|NCT03194308|Safer Conception|safer conception
15106|NCT03194308|Pre-exposure prophylaxis|pre-exposure prophylaxis
15107|NCT03194308|South Africa|south africa
15108|NCT03194308|Women|women
15109|NCT03194308|Reproductive Health|reproductive health
15110|NCT03194295|Drug-free community support|drug-free community support
15111|NCT03194295|Methadone maintenance|methadone maintenance
15112|NCT03194295|Social networks|social networks
15113|NCT03194256|Smoking|smoking
15114|NCT03194256|Cigarettes|cigarettes
15115|NCT03194256|E-Cigarettes|e-cigarettes
15116|NCT03194243|acute dyspnea|acute dyspnea
15117|NCT03194243|acute heart failure|acute heart failure
15118|NCT03194243|emergency|emergency
15119|NCT03194230|Cervical dilators|cervical dilators
15120|NCT03194230|induction of labor|induction of labor
15121|NCT03194230|cervical ripening|cervical ripening
15122|NCT03194230|medical termination of pregnancy|medical termination of pregnancy
15123|NCT03194230|second-trimester of pregnancy.|second-trimester of pregnancy.
15124|NCT03194191|Insomnia|insomnia
15125|NCT03194191|Pregnancy|pregnancy
15126|NCT03194191|Acupuncture|acupuncture
15127|NCT03194191|Insomnia severity index|insomnia severity index
15128|NCT03194191|Pittsburgh Sleep Quality Index|pittsburgh sleep quality index
15129|NCT03194191|Anxiety|anxiety
15130|NCT03194191|Depression|depression
15131|NCT03194165|antiretroviral|antiretroviral
15132|NCT03194165|children|children
15133|NCT03194165|pharmacokinetics|pharmacokinetics
15134|NCT03194139|Healthy Adult|healthy adult
15135|NCT03194139|Superoxide Dismutase|superoxide dismutase
15136|NCT03194139|First in Human|first in human
15137|NCT03194139|Free Radical Dismutase|free radical dismutase
15138|NCT03194087|Secondary Hyperparathyroidism|secondary hyperparathyroidism
15139|NCT03194087|Low parathyroid hormone|low parathyroid hormone
15140|NCT03194087|Hemodialysis|hemodialysis
15141|NCT03194074|Laser Laryngeal Surgery|laser laryngeal surgery
15142|NCT03194074|Desflurane|desflurane
15143|NCT03194074|Propofol|propofol
15144|NCT03194061|chemotherapy|chemotherapy
15145|NCT03194061|complication|complication
15146|NCT03194048|drooling|drooling
15147|NCT03194048|tongue thrust|tongue thrust
15148|NCT03194035|inflammation|inflammation
15149|NCT03194035|exercise|exercise
15150|NCT03194035|ultra endurance|ultra endurance
15151|NCT03194009|diabetes|diabetes
15152|NCT03194009|prevention|prevention
15153|NCT03194009|metformin|metformin
15154|NCT03194009|Mexico City|mexico city
15155|NCT03193983|occlusive dressing|occlusive dressing
15156|NCT03193970|Bladder Cancer|bladder cancer
15157|NCT03193970|Registry|registry
15158|NCT03193970|Post‐surgical outcomes|post‐surgical outcomes
15159|NCT03193970|Radical cystectomy|radical cystectomy
15160|NCT03193970|MD Anderson Symptom inventory|md anderson symptom inventory
15161|NCT03193970|MDASI|mdasi
15162|NCT03193892|registry|registry
15163|NCT03193892|China|china
15164|NCT03193892|lymphangioleiomyomatosis|lymphangioleiomyomatosis
15165|NCT03193879|Pulmonary function|pulmonary function
15166|NCT03193879|Particulate matter|particulate matter
15167|NCT03193879|COPD|copd
15168|NCT03193879|Asthma|asthma
15169|NCT03193866|Immunomodulating treatment|immunomodulating treatment
15170|NCT03193866|Cohort study|cohort study
15171|NCT03193866|Dimethyl fumarate|dimethyl fumarate
15172|NCT03193866|Fingolimod|fingolimod
15173|NCT03193866|Interferon-beta|interferon-beta
15174|NCT03193866|Natalizumab|natalizumab
15175|NCT03193866|Rituximab|rituximab
15176|NCT03193866|Glatiramer acetate|glatiramer acetate
15177|NCT03193840|old acetabular fracture; posterior wall osteotomy|old acetabular fracture; posterior wall osteotomy
15178|NCT03193827|vip score|vip score
15179|NCT03193827|peripheral venous cannulation|peripheral venous cannulation
15180|NCT03193827|particles|particles
15181|NCT03193801|SAPIEN 3|sapien 3
15182|NCT03193801|PARTNER 3|partner 3
15183|NCT03193801|cardiovascular disease|cardiovascular disease
15184|NCT03193801|TMVR|tmvr
15185|NCT03193801|failing valve|failing valve
15186|NCT03193801|failing bioprosthetic valve|failing bioprosthetic valve
15187|NCT03193775|HBV vaccine|hbv vaccine
15188|NCT03193775|persistent|persistent
15189|NCT03193775|HBsAg|hbsag
15190|NCT03193775|IP-10|ip-10
15191|NCT03193762|pain|pain
15192|NCT03193762|pain management|pain management
15193|NCT03193762|anxiety|anxiety
15194|NCT03193749|Chagas disease, cardiomyopathy, amiodarone, clinical trial|chagas disease, cardiomyopathy, amiodarone, clinical trial
15195|NCT03193723|Hernia|hernia
15196|NCT03193723|Local anesthesia|local anesthesia
15197|NCT03193723|ultrasound|ultrasound
15198|NCT03193710|Intravenous anesthesia|intravenous anesthesia
15199|NCT03193710|Inhalational anesthesia|inhalational anesthesia
15200|NCT03193710|Colorectal cancer resection|colorectal cancer resection
15201|NCT03193710|Lymphocytes|lymphocytes
15202|NCT03193710|Metastasis|metastasis
15203|NCT03193710|Survival|survival
15204|NCT03193710|Molecular mechanism|molecular mechanism
15206|NCT03193671|CA125|ca125
15207|NCT03193671|RMI|rmi
15209|NCT03193658|spine surgery|spine surgery
15210|NCT03193658|Thoracolumbar Interfascial Plane block|thoracolumbar interfascial plane block
15211|NCT03193658|regional anesthesia|regional anesthesia
15212|NCT03193658|postoperative analgesia|postoperative analgesia
15213|NCT03193658|opioid consumption|opioid consumption
15214|NCT03193632|lean body mass|lean body mass
15215|NCT03193632|resting energy expenditure|resting energy expenditure
15216|NCT03193632|oxygen consumption|oxygen consumption
15217|NCT03193632|Indirect calorimetry|indirect calorimetry
15218|NCT03193632|carbon dioxide excretion|carbon dioxide excretion
15219|NCT03193632|respiratory quotient|respiratory quotient
15347|NCT03192722|Illumination|illumination
15220|NCT03193580|Anodal Stimulation Transcranial Direct Current Stimulation|anodal stimulation transcranial direct current stimulation
15221|NCT03193580|High-Definition Transcranial Direct Current Stimulation|high-definition transcranial direct current stimulation
15222|NCT03193580|tDCS|tdcs
15223|NCT03193580|Non-invasive brain stimulation|non-invasive brain stimulation
7213|NCT03244644|CDI|cdi
15224|NCT03193580|Pediatrics|pediatrics
15225|NCT03193489|Balance|balance
15226|NCT03193489|Posturograpy|posturograpy
15227|NCT03193489|quality of life|quality of life
15228|NCT03193463|Topotecan|topotecan
15229|NCT03193463|Convection-Enhanced Delivery|convection-enhanced delivery
15230|NCT03193450|helicobactor pylori|helicobactor pylori
15231|NCT03193437|Thymus|thymus
15232|NCT03193437|Selinexor|selinexor
15233|NCT03193437|KPT-330|kpt-330
15234|NCT03193398|Major Depressive Disorder|major depressive disorder
15235|NCT03193398|Anhedonia|anhedonia
15236|NCT03193398|antidepressant|antidepressant
15237|NCT03193398|Nociceptin|nociceptin
15238|NCT03193398|NOPR|nopr
15239|NCT03193333|glaucoma|glaucoma
15242|NCT03193333|Krytantek Ofteno®.|krytantek ofteno®.
15244|NCT03193333|brimonidine|brimonidine
15245|NCT03193333|dorzolamide|dorzolamide
15246|NCT03193320|plethysmographic variability index|plethysmographic variability index
15247|NCT03193320|PVI|pvi
15248|NCT03193281|Dasatinib|dasatinib
15249|NCT03193281|Imatinib|imatinib
15250|NCT03193268|sensorimotor training|sensorimotor training
15251|NCT03193268|quality of life|quality of life
15252|NCT03193268|posture|posture
15253|NCT03193242|Asthma|asthma
15254|NCT03193242|Asthma Action Plan|asthma action plan
15255|NCT03193216|Barrett's|barrett's
15256|NCT03193216|GERD|gerd
15257|NCT03193216|reflux|reflux
15258|NCT03193216|alginate solution|alginate solution
583406|NCT00511615|LEEP|leep
15259|NCT03193216|proton pump inhibitor|proton pump inhibitor
15260|NCT03193177|fasting-like diet|fasting-like diet
15261|NCT03193177|chronic diseases|chronic diseases
15262|NCT03193177|autoimmune diseases|autoimmune diseases
15263|NCT03193177|metabolic disorder|metabolic disorder
15264|NCT03193164|Electric Stimulation Therapy; Endothelial Progenitor Cells.|electric stimulation therapy; endothelial progenitor cells.
15265|NCT03193151|Liver transplant|liver transplant
15266|NCT03193151|global gene expression|global gene expression
15267|NCT03193151|molecular diagnostics|molecular diagnostics
15268|NCT03193138|Cardiotoxicity|cardiotoxicity
15269|NCT03193138|Androgens|androgens
15270|NCT03193138|Hormone Replacement Therapy|hormone replacement therapy
15271|NCT03193138|Testosterone|testosterone
15272|NCT03193138|Androgen Antagonists|androgen antagonists
15273|NCT03193112|Agomelatine|agomelatine
15274|NCT03193112|Depression|depression
15275|NCT03193112|Intraocular pressure|intraocular pressure
15276|NCT03193086|Multiple Sclerosis|multiple sclerosis
15277|NCT03193086|Blood-Brain-Barrier|blood-brain-barrier
15278|NCT03193086|Treatment response|treatment response
15279|NCT03193086|Metabolism|metabolism
15280|NCT03193086|Alemtuzumab|alemtuzumab
15281|NCT03193086|Perfusion|perfusion
15282|NCT03193086|Oxygen consumption|oxygen consumption
15283|NCT03193047|Cholesterol|cholesterol
15284|NCT03193047|PCSK9|pcsk9
15285|NCT03193047|Repatha|repatha
15286|NCT03193047|evolocumab|evolocumab
15287|NCT03193047|LDL-C|ldl-c
15288|NCT03193034|Arthroplasty|arthroplasty
15289|NCT03193034|replacement|replacement
15290|NCT03193034|Knee|knee
15291|NCT03193034|function|function
15292|NCT03193034|radiographic|radiographic
15293|NCT03193034|survivorship|survivorship
15294|NCT03192202|Lymphoma|lymphoma
15295|NCT03192202|Cutaneous Lymphoma|cutaneous lymphoma
15296|NCT03192202|cutaneous T-cell lymphoma (CTCL)|cutaneous t-cell lymphoma (ctcl)
15297|NCT03192202|CD30-Positive Cutaneous Lymphoma|cd30-positive cutaneous lymphoma
15302|NCT03193008|Breast Cancer|breast cancer
15303|NCT03193008|Axillary ultrasound|axillary ultrasound
15304|NCT03193008|Sentinel lymph node biopsy|sentinel lymph node biopsy
15305|NCT03193008|Axillary management|axillary management
15306|NCT03192995|HIV|hiv
15307|NCT03192995|sexual behavior|sexual behavior
15308|NCT03192956|Hyperbaric|hyperbaric
15309|NCT03192956|Decompression sickness|decompression sickness
15310|NCT03192956|Decompression injury|decompression injury
15311|NCT03192956|Inflammation|inflammation
15312|NCT03192956|Central nervous injury|central nervous injury
15313|NCT03192956|Hybervaric oxygen therapy|hybervaric oxygen therapy
15315|NCT03192930|Saturation|saturation
15316|NCT03192930|Decompression injury|decompression injury
15317|NCT03192930|Decompression sickness|decompression sickness
15318|NCT03192930|Inflammation|inflammation
15319|NCT03192930|Central nervous system injury|central nervous system injury
15320|NCT03192930|Diving medicine|diving medicine
15321|NCT03192917|Shock wave therapy|shock wave therapy
15322|NCT03192917|erectile dysfunction|erectile dysfunction
15323|NCT03192904|Lung cancer|lung cancer
15324|NCT03192904|Segmentectomy|segmentectomy
15325|NCT03192904|Postoperative Complication|postoperative complication
15326|NCT03192904|Stapling Device|stapling device
15327|NCT03192904|Energy Device|energy device
15328|NCT03192878|infliximab|infliximab
15329|NCT03192878|biosimilars|biosimilars
15330|NCT03192878|treatment|treatment
15331|NCT03192852|Tooth bleaching color|tooth bleaching color
15332|NCT03192852|dental esthetic|dental esthetic
15333|NCT03192852|Clinical Trial|clinical trial
15334|NCT03192852|Violet LED light|violet led light
15335|NCT03192852|Violet LED|violet led
15336|NCT03192852|color|color
15337|NCT03192852|sensibility|sensibility
15338|NCT03192852|dental aesthetic|dental aesthetic
15339|NCT03192826|Nd-YAG capsulotomy|nd-yag capsulotomy
15340|NCT03192826|ocular hypertension|ocular hypertension
15341|NCT03192826|brimonidine|brimonidine
15342|NCT03192826|brinzolamide|brinzolamide
15343|NCT03192800|clinical outcome|clinical outcome
15344|NCT03192800|prognositic factor|prognositic factor
15345|NCT03192800|spinal dural arteriovenous fistula|spinal dural arteriovenous fistula
15346|NCT03192722|Filters|filters
15348|NCT03192722|Low vision|low vision
15350|NCT03192709|Sildenafil IVF ICI failure|sildenafil ivf ici failure
15351|NCT03192631|financial incentive|financial incentive
15352|NCT03192579|neoatherosclerosis|neoatherosclerosis
15353|NCT03192566|Acetaminophen|acetaminophen
15354|NCT03192566|Anesthesia|anesthesia
15355|NCT03192566|Adolescent|adolescent
15356|NCT03192566|Obesity|obesity
15357|NCT03192553|donning|donning
15358|NCT03192553|doffing|doffing
15359|NCT03192553|self-contamination|self-contamination
15360|NCT03192553|healthcare workers|healthcare workers
15361|NCT03192540|Exercise|exercise
15362|NCT03192527|KN015|kn015
15363|NCT03192527|Long-acting FSH|long-acting fsh
15364|NCT03192514|Polypharmacy|polypharmacy
15365|NCT03192514|Benzodiazepine use|benzodiazepine use
15366|NCT03192501|lung cancer|lung cancer
15367|NCT03192501|iCAGES|icages
15368|NCT03192501|gene mutation|gene mutation
15369|NCT03192501|precision medicine|precision medicine
15370|NCT03192501|advanced cancers|advanced cancers
15371|NCT03192462|Pancreatic Cancer|pancreatic cancer
15372|NCT03192462|Immune-based therapies|immune-based therapies
15373|NCT03192462|CytotoxicT Lymphocytes|cytotoxict lymphocytes
15374|NCT03192423|Stress|stress
15375|NCT03192423|Performance of procedures|performance of procedures
15376|NCT03192423|Lumbar Puncture|lumbar puncture
15377|NCT03192410|myocardial infarction|myocardial infarction
15378|NCT03192410|cardiovascular diseases|cardiovascular diseases
15379|NCT03192410|mortality|mortality
15380|NCT03192410|post-myocardial infarction patients|post-myocardial infarction patients
15381|NCT03192410|risk prediction|risk prediction
15382|NCT03192410|kidney function|kidney function
15383|NCT03192410|mental well-being|mental well-being
15384|NCT03192410|cardiovascular drug treatment|cardiovascular drug treatment
15385|NCT03192384|Hospital falls|hospital falls
15386|NCT03192371|Zagreb regimen|zagreb regimen
15387|NCT03192371|Encephalitis|encephalitis
15388|NCT03192371|Antibody persistence|antibody persistence
15389|NCT03192371|Essen regimen|essen regimen
15390|NCT03192371|Post-Exposure Prophylaxis (PEP)|post-exposure prophylaxis (pep)
15391|NCT03192371|Rabies|rabies
15392|NCT03192358|Thickened Liquids|thickened liquids
15393|NCT03192358|Dysphagia Management|dysphagia management
15394|NCT03192358|Videofluoroscopy|videofluoroscopy
15395|NCT03192358|Swallowing Physiology|swallowing physiology
15396|NCT03192332|Intravenous thrombolysis|intravenous thrombolysis
15397|NCT03192332|Endovascular treatment|endovascular treatment
15398|NCT03192332|Mechanical thrombectomy|mechanical thrombectomy
15399|NCT03192332|Bridging thrombolysis|bridging thrombolysis
15400|NCT03192332|Acute ischemic stroke|acute ischemic stroke
15401|NCT03192319|Herpes zoster vaccine|herpes zoster vaccine
15402|NCT03192319|Cell-mediated immunity|cell-mediated immunity
15403|NCT03192319|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
15404|NCT03192306|Herpes Labialis|herpes labialis
15405|NCT03192306|Cold Sore|cold sore
15406|NCT03192267|newly diagnosed rheumatoid arthritis|newly diagnosed rheumatoid arthritis
15407|NCT03192267|lung disease|lung disease
15408|NCT03192241|reading|reading
15409|NCT03192228|Diabetes Mellitus, Type 2 +|diabetes mellitus, type 2 +
15410|NCT03192228|Patient Education|patient education
15411|NCT03192215|Atrial Cardiopathy|atrial cardiopathy
15412|NCT03192215|Cryptogenic stroke|cryptogenic stroke
15413|NCT03192215|Ischemic stroke|ischemic stroke
15423|NCT03192111|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
15425|NCT03192059|Immunotherapy|immunotherapy
15426|NCT03192059|Radiotherapy|radiotherapy
15427|NCT03192059|Immune-modulatory cocktail|immune-modulatory cocktail
15428|NCT03192020|Hand dysfunction|hand dysfunction
15429|NCT03192020|Xiapex|xiapex
15430|NCT03192020|Xiaflex|xiaflex
15431|NCT03192020|Aponeurectomy|aponeurectomy
15432|NCT03192020|Aponeurotomy|aponeurotomy
15433|NCT03192020|Dupuytren disease|dupuytren disease
15434|NCT03192020|Joint contracture|joint contracture
15435|NCT03192020|Surgery|surgery
15436|NCT03191968|Behavior change|behavior change
15437|NCT03191968|Prostate cancer|prostate cancer
15438|NCT03191968|Behavioral counseling|behavioral counseling
15439|NCT03191968|Physical Activity|physical activity
15440|NCT03191968|Randomized controlled trial|randomized controlled trial
15441|NCT03191942|Myopia control|myopia control
15442|NCT03191942|Orthokeratology|orthokeratology
15443|NCT03191942|Children|children
15444|NCT03191942|Treatment zone|treatment zone
15448|NCT03191929|Primary Care Provider|primary care provider
15449|NCT03191929|Mental Health Screening|mental health screening
15451|NCT03191916|Mild Cognitive Impairment|mild cognitive impairment
15452|NCT03191916|tDCS|tdcs
15453|NCT03191916|Cognitive function|cognitive function
15454|NCT03191890|in vivo culture|in vivo culture
15455|NCT03191877|coffee consumption|coffee consumption
15456|NCT03191877|Cesarean section|cesarean section
15457|NCT03191877|intestinal motility|intestinal motility
15458|NCT03191864|Esophagitis|esophagitis
15459|NCT03191864|Eosinophilic Esophagitis|eosinophilic esophagitis
15460|NCT03191864|Fluticasone|fluticasone
15461|NCT03191864|Dysphagia|dysphagia
15462|NCT03191864|Safety|safety
15463|NCT03191864|Efficacy|efficacy
15464|NCT03191864|Pharmacokinetics|pharmacokinetics
15465|NCT03191864|Esophageal Diseases|esophageal diseases
15466|NCT03191864|Gastrointestinal Diseases|gastrointestinal diseases
15467|NCT03191864|Digestive System Diseases|digestive system diseases
15468|NCT03191864|Glucocorticoids|glucocorticoids
15469|NCT03191864|Orally Disintegrating Tablet|orally disintegrating tablet
15470|NCT03191825|online intervention|online intervention
15471|NCT03191825|mHealth m-Health|mhealth m-health
15472|NCT03191825|eHealth e-Health|ehealth e-health
15473|NCT03191825|smoking cessation|smoking cessation
15474|NCT03191825|lapse management|lapse management
15475|NCT03191825|relapse prevention|relapse prevention
15477|NCT03191812|transcranial Direct Current Stimulation|transcranial direct current stimulation
15478|NCT03191812|Mobility|mobility
15479|NCT03191812|Dual Task|dual task
15480|NCT03191760|Posttraumatic Stress Disorder|posttraumatic stress disorder
15481|NCT03191760|Social Support|social support
15482|NCT03191760|Primary Care|primary care
15483|NCT03191747|Masculine Norms|masculine norms
15484|NCT03191747|Skin Care|skin care
15485|NCT03191747|Gender|gender
15490|NCT03191721|Peri-implantitis|peri-implantitis
15491|NCT03191721|Triclosan|triclosan
15492|NCT03191721|Toothpastes|toothpastes
15493|NCT03191721|Therapeutics|therapeutics
15494|NCT03191721|Periodontal Diseases|periodontal diseases
15495|NCT03191721|Periodontitis|periodontitis
15496|NCT03191721|Dentifrices|dentifrices
15497|NCT03191708|Fractional Flow Reserve|fractional flow reserve
15498|NCT03191708|Quantitative Coronary Angiography|quantitative coronary angiography
15499|NCT03191708|Coronary artery disease|coronary artery disease
15500|NCT03191708|Angina pectoris|angina pectoris
15501|NCT03191708|Quantitative Flow Ratio|quantitative flow ratio
15502|NCT03191695|Participation|participation
15503|NCT03191695|Activity|activity
15504|NCT03191695|Cerebral Palsy|cerebral palsy
15505|NCT03191695|LIFE Habits (life-H)|life habits (life-h)
15506|NCT03191695|Gross Motor Function|gross motor function
15507|NCT03191695|Health-related Quality of Life|health-related quality of life
15508|NCT03191695|Family|family
15509|NCT03191630|Kidney transplant|kidney transplant
15510|NCT03191630|SystemCHANGE|systemchange
15511|NCT03191630|physical activity|physical activity
15512|NCT03191630|smart phone|smart phone
15513|NCT03191630|Fitbit|fitbit
15514|NCT03191630|activity monitor|activity monitor
15516|NCT03191630|post-surgery|post-surgery
15517|NCT03191630|quality of life|quality of life
15518|NCT03191630|cardiovascular|cardiovascular
15519|NCT03191604|Endoscopy|endoscopy
15520|NCT03191604|Narrow band imaging|narrow band imaging
15521|NCT03191604|Dysplasia|dysplasia
15522|NCT03191591|Overweight|overweight
15523|NCT03191591|Obesity|obesity
15524|NCT03191591|Maternal-child|maternal-child
15525|NCT03191591|Social Determinants of Health|social determinants of health
15526|NCT03191578|NMIBC|nmibc
15527|NCT03191578|Immunotherapy|immunotherapy
15528|NCT03191578|RUTI|ruti
15529|NCT03191578|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
15530|NCT03191565|mhealth|mhealth
15531|NCT03191565|self-monitoring|self-monitoring
15532|NCT03191565|Outcome monitoring|outcome monitoring
15533|NCT03191552|Cerebral palsy|cerebral palsy
15534|NCT03191552|lycra garments|lycra garments
15535|NCT03191552|orthosis|orthosis
15536|NCT03191552|suit therapy|suit therapy
15537|NCT03191552|trunk control|trunk control
15538|NCT03191513|Interesterified|interesterified
15539|NCT03191513|Postprandial|postprandial
15540|NCT03191513|Lipid|lipid
15541|NCT03191474|PrEP|prep
15542|NCT03191474|Pre-exposure Prophylaxis|pre-exposure prophylaxis
15543|NCT03191474|Truvada|truvada
15544|NCT03191474|Client-centered case management|client-centered case management
15545|NCT03191474|Transgender|transgender
15546|NCT03191474|Gender non-conforming|gender non-conforming
15547|NCT03191461|Anthracycline-based chemotherapy|anthracycline-based chemotherapy
15548|NCT03191461|Anth-bC|anth-bc
15549|NCT03191461|Chemotherapy|chemotherapy
15550|NCT03191461|Myocardial Perfusion|myocardial perfusion
15551|NCT03191435|Diabetes mellitus, type 2|diabetes mellitus, type 2
15552|NCT03191435|Inspiratory muscle training|inspiratory muscle training
15553|NCT03191435|Glycemic control|glycemic control
15554|NCT03191435|Glucose|glucose
15555|NCT03191435|Exercise|exercise
15556|NCT03191435|Diaphragm exercise|diaphragm exercise
15557|NCT03191435|Inspiratory loading|inspiratory loading
15558|NCT03191422|Rehabilitation|rehabilitation
15559|NCT03191422|Occupational Performance|occupational performance
15560|NCT03191409|cognitive impairment|cognitive impairment
15561|NCT03191409|ESRD|esrd
15562|NCT03191409|functional MRI|functional mri
15563|NCT03191383|Maternal immunization|maternal immunization
15564|NCT03191383|Immunogenicity|immunogenicity
15565|NCT03191383|Vaccines|vaccines
15566|NCT03191383|Safety|safety
15567|NCT03191383|Reactogenicity|reactogenicity
15568|NCT03191383|Respiratory Syncytial Virus|respiratory syncytial virus
15688|NCT03190837|gaucher disease|gaucher disease
15569|NCT03191370|pain during laryngoscopy, Flexible nasal endoscopy|pain during laryngoscopy, flexible nasal endoscopy
15570|NCT03191357|traumatic brain injury (TBI), posttraumatic stress (PTSD), service members, family members|traumatic brain injury (tbi), posttraumatic stress (ptsd), service members, family members
15571|NCT03191344|Intraoperative Parathyroid Scores System|intraoperative parathyroid scores system
15572|NCT03191344|total thyroidectomy|total thyroidectomy
15573|NCT03191344|thyroid cancer|thyroid cancer
15574|NCT03191344|hypoparathyroidism|hypoparathyroidism
15575|NCT03191344|prediction|prediction
15576|NCT03191331|dietary intervention|dietary intervention
15577|NCT03191331|gestational weight gain|gestational weight gain
15578|NCT03191331|gestational diabetes|gestational diabetes
15579|NCT03191331|overweight|overweight
15580|NCT03191331|obesity|obesity
15581|NCT03191318|ERAS|eras
15582|NCT03191318|Enhanced recovery after sugery in bariatric surgery|enhanced recovery after sugery in bariatric surgery
15583|NCT03191318|sleeve gastrectomy|sleeve gastrectomy
15584|NCT03191292|probabilistic antibiotherapy|probabilistic antibiotherapy
15585|NCT03191292|prosthetic joint infection|prosthetic joint infection
15586|NCT03191292|treatment failure|treatment failure
15587|NCT03191279|Wounds and injury|wounds and injury
15588|NCT03191279|Trauma|trauma
15589|NCT03191279|First aid|first aid
15590|NCT03191279|Bystander|bystander
15591|NCT03191279|Laypersons|laypersons
15592|NCT03191266|transcranial magnetic stimulation|transcranial magnetic stimulation
15593|NCT03191266|alcohol use disorder|alcohol use disorder
15594|NCT03191266|neuroimaging|neuroimaging
15595|NCT03191266|relapse|relapse
15596|NCT03191266|Veterans|veterans
15597|NCT03191253|food insecurity|food insecurity
15598|NCT03191253|community-based|community-based
15599|NCT03191253|food assistance|food assistance
15600|NCT03191253|food support|food support
15601|NCT03191253|intervention|intervention
15602|NCT03191253|medically tailored|medically tailored
15603|NCT03191253|nutrition|nutrition
15604|NCT03191240|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
15605|NCT03191240|Vasopressin|vasopressin
15606|NCT03191214|Infra-red thermography|infra-red thermography
15607|NCT03191201|Metabolomics, Transcriptomics, Ironomics|metabolomics, transcriptomics, ironomics
15608|NCT03191175|HIV|hiv
15609|NCT03191175|Inflammasome|inflammasome
15610|NCT03191162|Benznidazole|benznidazole
15611|NCT03191162|PCR|pcr
15612|NCT03191123|Hepatocellular Carcinoma|hepatocellular carcinoma
15613|NCT03191123|Hepatic Resection|hepatic resection
15614|NCT03191123|TACE|tace
15615|NCT03191123|Solitary Huge Tumor|solitary huge tumor
15616|NCT03191123|Overall Survival|overall survival
15617|NCT03191110|COLON|colon
15618|NCT03191110|colorectal cancer|colorectal cancer
15619|NCT03191110|nutrition|nutrition
15620|NCT03191110|lifestyle|lifestyle
15621|NCT03191110|survival|survival
15622|NCT03191110|recurrence|recurrence
15623|NCT03191110|quality of life|quality of life
15624|NCT03191084|marijuana|marijuana
15626|NCT03191084|cannabis|cannabis
15627|NCT03191084|driving|driving
15628|NCT03191084|impairment|impairment
15629|NCT03191084|intoxication|intoxication
15630|NCT03191071|pneumonia|pneumonia
15631|NCT03191071|procalcitonin|procalcitonin
15632|NCT03191071|lung ultrassound|lung ultrassound
15633|NCT03191071|point of care testing|point of care testing
15634|NCT03191071|antibiotic prescription|antibiotic prescription
15635|NCT03191071|respiratory pathogens|respiratory pathogens
15636|NCT03191071|host biomarkers|host biomarkers
15637|NCT03191045|MRI|mri
15638|NCT03191045|motility|motility
15639|NCT03191045|perfused manometry|perfused manometry
15640|NCT03191045|stomach|stomach
15641|NCT03191045|bowel|bowel
15642|NCT03191045|water|water
15643|NCT03191032|Peripheral nerves/lesions; hands; rehabilitation; fMRI|peripheral nerves/lesions; hands; rehabilitation; fmri
15644|NCT03191019|Cell phones|cell phones
15663|NCT03190928|Disease Monitoring|disease monitoring
15664|NCT03190928|Molecular Monitoring|molecular monitoring
15665|NCT03190928|Novel Biomarker Identification|novel biomarker identification
15666|NCT03190928|Gene Expression Analyses|gene expression analyses
15667|NCT03190928|Watchful-Waiting|watchful-waiting
15668|NCT03190889|ACL Reconstruction|acl reconstruction
15669|NCT03190889|Rehabilitation|rehabilitation
15670|NCT03190889|Sports Injury|sports injury
15671|NCT03190889|Neuromuscular Intervention|neuromuscular intervention
15672|NCT03190889|Knee Injury|knee injury
15673|NCT03190876|Drain usage|drain usage
15674|NCT03190863|Tenodesis grasp|tenodesis grasp
15675|NCT03190863|Neurofeedback|neurofeedback
15676|NCT03190863|Motor imagery|motor imagery
15677|NCT03190863|Reach-to-grasp|reach-to-grasp
15678|NCT03190863|Rehabilitation|rehabilitation
15679|NCT03190863|Physical therapy|physical therapy
15680|NCT03190863|Cervical spinal cord injury|cervical spinal cord injury
15681|NCT03190863|Tetraplegia|tetraplegia
15682|NCT03190863|AIS A|ais a
15683|NCT03190863|AIS B|ais b
15684|NCT03190850|Sleep Apnea|sleep apnea
15685|NCT03190850|Elderly|elderly
15686|NCT03190850|Inspiratory training|inspiratory training
15687|NCT03190837|gaucher|gaucher
15689|NCT03190824|melanoma|melanoma
15690|NCT03190824|immunotherapy|immunotherapy
15691|NCT03190824|immune oncology|immune oncology
15692|NCT03190824|loco regional therapy|loco regional therapy
15693|NCT03190824|adenovirus|adenovirus
15694|NCT03190824|oncolytic virus|oncolytic virus
15695|NCT03190824|unresectable|unresectable
15696|NCT03190824|telomerase|telomerase
15697|NCT03190811|advanced solid tumor|advanced solid tumor
15698|NCT03190811|DC-CIK|dc-cik
15699|NCT03190811|anti-PD-1 antibody|anti-pd-1 antibody
15700|NCT03190811|immunotherapy|immunotherapy
15701|NCT03190785|benzoic acid|benzoic acid
15702|NCT03190785|endocrine disrupting chemicals|endocrine disrupting chemicals
15703|NCT03190785|leptin|leptin
15704|NCT03190785|metabolic rate|metabolic rate
15705|NCT03190733|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
15706|NCT03190733|ATG|atg
15707|NCT03190733|chronic GVHD|chronic gvhd
15708|NCT03190733|leukemia relapse|leukemia relapse
15709|NCT03190694|chronic kidney disease|chronic kidney disease
15710|NCT03190694|non diabetic|non diabetic
15711|NCT03190668|tissue microdialysis|tissue microdialysis
15712|NCT03190668|spinal fusion|spinal fusion
15713|NCT03190668|surgical site infection|surgical site infection
15714|NCT03190642|Orthognathic Surgery|orthognathic surgery
15715|NCT03190642|Swelling|swelling
15716|NCT03190629|body composition|body composition
15717|NCT03190629|bioimpedance|bioimpedance
15718|NCT03190629|hemodialysis|hemodialysis
15719|NCT03190629|hemodiafiltration|hemodiafiltration
15720|NCT03190629|nutritional status|nutritional status
15721|NCT03190629|protein energy wasting|protein energy wasting
15722|NCT03190590|transcranial magnetic stimulation|transcranial magnetic stimulation
15723|NCT03190577|Transthyretin mutation|transthyretin mutation
15724|NCT03190551|infraclavicular brachial plexus block|infraclavicular brachial plexus block
15725|NCT03190551|retroclavicular approach|retroclavicular approach
15726|NCT03190551|costoclavicular approach|costoclavicular approach
15727|NCT03190551|upper limb surgery|upper limb surgery
15728|NCT03190551|needle shaft visibility|needle shaft visibility
15729|NCT03190512|Periodontal disease|periodontal disease
15730|NCT03190512|depression|depression
18439|NCT03172910|PER977|per977
15731|NCT03190512|body image|body image
15732|NCT03190512|self-esteem|self-esteem
15733|NCT03190499|Cancer|cancer
15734|NCT03190499|Leukemia|leukemia
15735|NCT03190486|Baby cries|baby cries
15736|NCT03190486|pain|pain
15737|NCT03190486|brain responses|brain responses
15738|NCT03190486|neuroimaging|neuroimaging
15739|NCT03190486|fMRI|fmri
15740|NCT03190395|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
15741|NCT03190395|Circumferential Pulmonary Vein Isolation(CPVI)|circumferential pulmonary vein isolation(cpvi)
15742|NCT03190395|Leftatrium Roofline Ablation(LARA)|leftatrium roofline ablation(lara)
15743|NCT03190395|Longterm success rate|longterm success rate
15847|NCT03189680|exergaming|exergaming
15746|NCT03190317|Veteran|veteran
15747|NCT03190317|self-management|self-management
15748|NCT03190278|Acute Myeloid Leukemia|acute myeloid leukemia
15749|NCT03190278|Relapsed/Refractory Acute Myeloid Leukemia|relapsed/refractory acute myeloid leukemia
15750|NCT03190278|Newly diagnosed AML|newly diagnosed aml
15751|NCT03190278|ELN adverse genetic risk group|eln adverse genetic risk group
15752|NCT03190278|Chimeric Antigen Receptor T-Cell (CAR-T) therapy|chimeric antigen receptor t-cell (car-t) therapy
15753|NCT03190278|Allogeneic|allogeneic
15754|NCT03190265|cy|cy
15755|NCT03190265|Cyclophosphamide|cyclophosphamide
15756|NCT03190265|Pancreatic Vaccine|pancreatic vaccine
15757|NCT03190265|GVAX|gvax
15758|NCT03190265|Nivolumab|nivolumab
15759|NCT03190265|Vaccine|vaccine
15760|NCT03190265|Ipilimumab|ipilimumab
15761|NCT03190265|CRS-207|crs-207
15762|NCT03190265|Immunotherapy|immunotherapy
15763|NCT03190265|PD-1|pd-1
15764|NCT03190265|Adenocarcinoma|adenocarcinoma
15765|NCT03190265|Carcinoma|carcinoma
15766|NCT03190265|Neoplasms|neoplasms
15767|NCT03190252|Diving medicine|diving medicine
15768|NCT03190252|Inflammation|inflammation
15769|NCT03190252|Central nervous system injury|central nervous system injury
15770|NCT03190252|Trimix|trimix
15771|NCT03190252|Decompression sickness|decompression sickness
15772|NCT03190252|Venous gas emboli|venous gas emboli
15773|NCT03190226|L-PRF|l-prf
15774|NCT03190226|keratinised tissues|keratinised tissues
15775|NCT03190226|implant|implant
15776|NCT03190226|free gingival graft|free gingival graft
15777|NCT03190213|Poorly differentiated|poorly differentiated
15778|NCT03190213|high grade|high grade
15779|NCT03190161|Schizophrenia|schizophrenia
15780|NCT03190148|GLP-1|glp-1
15781|NCT03190148|Ectopic Lipids|ectopic lipids
15782|NCT03190135|Overweight|overweight
15783|NCT03190135|Obesity|obesity
15784|NCT03190135|School|school
15785|NCT03190135|Physical Activity|physical activity
15786|NCT03190109|bone age measurement|bone age measurement
15787|NCT03190109|skeletal age measurement|skeletal age measurement
15788|NCT03190109|ultrasound|ultrasound
15789|NCT03190109|x-Ray|x-ray
15790|NCT03190083|mastectomy|mastectomy
15791|NCT03190083|lumpectomy|lumpectomy
15792|NCT03190083|3-Dimensional Mammogram|3-dimensional mammogram
15793|NCT03190083|digital breast tomosynthesis|digital breast tomosynthesis
15794|NCT03190070|Renal reserve, physiological study, diagnostic testing|renal reserve, physiological study, diagnostic testing
15795|NCT03190057|BioFreedom|biofreedom
15796|NCT03190057|Drug Eluting Stent|drug eluting stent
15797|NCT03190057|Coronary Artery Disease|coronary artery disease
15798|NCT03190031|training|training
15799|NCT03190031|exercise|exercise
15800|NCT03190031|quality of life|quality of life
15801|NCT03190005|PRU|pru
15802|NCT03190005|P2Y12 receptor|p2y12 receptor
15803|NCT03189979|community based participatory research|community based participatory research
15804|NCT03189979|Childhood obesity|childhood obesity
15805|NCT03189966|transversalis fascia plane block|transversalis fascia plane block
15806|NCT03189966|quadratus lumborum block|quadratus lumborum block
15807|NCT03189966|ultrasound-guided|ultrasound-guided
15808|NCT03189966|Developmental Dysplasia of the Hip|developmental dysplasia of the hip
15809|NCT03189966|postoperative analgesia|postoperative analgesia
15810|NCT03189914|pancreatic cancer|pancreatic cancer
15811|NCT03189914|Abraxane|abraxane
15812|NCT03189914|first line|first line
15813|NCT03189875|Systemic Lupus Erythematosus Disease|systemic lupus erythematosus disease
15814|NCT03189849|Farming environment|farming environment
15815|NCT03189836|CD20+|cd20+
15816|NCT03189836|B cell|b cell
15817|NCT03189836|ACTR|actr
15818|NCT03189836|ACTR707|actr707
15819|NCT03189836|relapsed|relapsed
15820|NCT03189836|refractory|refractory
15821|NCT03189836|T cell|t cell
15822|NCT03189836|T cell product|t cell product
15823|NCT03189836|adoptive T cells|adoptive t cells
15824|NCT03189836|gene therapy|gene therapy
15825|NCT03189810|Sham Repetitive Transcranial Magnetic Stimulation (rTMS)|sham repetitive transcranial magnetic stimulation (rtms)
15826|NCT03189810|Schizophrenia|schizophrenia
15827|NCT03189810|Cannabis Use Disorder|cannabis use disorder
15828|NCT03189810|Cognitive Function|cognitive function
15829|NCT03189758|chronic kidney disease|chronic kidney disease
15830|NCT03189758|hemodialysis|hemodialysis
15831|NCT03189758|sodium restriction|sodium restriction
15832|NCT03189758|MRI|mri
15833|NCT03189732|lipolysis|lipolysis
15834|NCT03189732|adipose tissue|adipose tissue
15835|NCT03189732|exercise|exercise
15841|NCT03189706|Irinotecan|irinotecan
15842|NCT03189706|Temozolomide|temozolomide
15843|NCT03189706|Sargramostim|sargramostim
15844|NCT03189706|Chemoimmunotherapy|chemoimmunotherapy
15845|NCT03189706|17-251|17-251
15846|NCT03189680|sensorimotor training|sensorimotor training
15852|NCT03189641|Coronary artery stenosis|coronary artery stenosis
15853|NCT03189641|Myocardial ischemia|myocardial ischemia
15854|NCT03189641|Angioplasty|angioplasty
15855|NCT03189628|stromal vascular fraction|stromal vascular fraction
15856|NCT03189628|skin regeneration|skin regeneration
15857|NCT03189628|skin texture|skin texture
15858|NCT03189628|anti-aging|anti-aging
15859|NCT03189602|Takayasu Arteritis|takayasu arteritis
15860|NCT03189602|Pulmonary artery hypertension|pulmonary artery hypertension
15861|NCT03189589|Pharmacokinetics|pharmacokinetics
15862|NCT03189589|Healthy|healthy
15863|NCT03189589|ELLIPTA|ellipta
15864|NCT03189589|Safety|safety
15865|NCT03189589|GSK2269557|gsk2269557
15866|NCT03189589|Inhalation|inhalation
15867|NCT03189589|Tolerability|tolerability
15868|NCT03189537|Profilaxis|profilaxis
15869|NCT03189537|Ingavirin|ingavirin
15870|NCT03189511|Brown Adipose Tissue|brown adipose tissue
15871|NCT03189511|Brown Fat|brown fat
15872|NCT03189511|Fluvastatin|fluvastatin
15873|NCT03189511|Prospective Clinical Trial|prospective clinical trial
15874|NCT03189446|Endometrial Cancer|endometrial cancer
15875|NCT03189446|Gynecologic Cancer|gynecologic cancer
15876|NCT03189420|glioma|glioma
15877|NCT03189420|glioblastoma|glioblastoma
15878|NCT03189420|low grade tumor|low grade tumor
15879|NCT03189407|Moringa Oleifera tea|moringa oleifera tea
15880|NCT03189407|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
15881|NCT03189407|Metformin Steady state concentrations|metformin steady state concentrations
15882|NCT03189407|Herb-drug interaction|herb-drug interaction
15883|NCT03189394|HIV|hiv
15884|NCT03189394|gay couples|gay couples
15885|NCT03189394|relationships|relationships
15886|NCT03189394|dyads|dyads
15887|NCT03189381|Whole Brain Radiation|whole brain radiation
15888|NCT03189381|Simultaneous Integrated Boost|simultaneous integrated boost
15889|NCT03189368|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
15890|NCT03189368|Multi-site Pacing|multi-site pacing
15891|NCT03189368|Ventriculoarterial Coupling|ventriculoarterial coupling
15892|NCT03189368|Energy Efficiency|energy efficiency
15893|NCT03189342|Balance|balance
15894|NCT03189342|Dual-task interference|dual-task interference
15895|NCT03189342|Falls|falls
15896|NCT03189342|Gait|gait
15897|NCT03189342|Older Adults|older adults
15898|NCT03189329|NIR spectroscopy, cognitive function, eye, nerve block|nir spectroscopy, cognitive function, eye, nerve block
15899|NCT03189316|Peritoneal fluid|peritoneal fluid
15900|NCT03189316|B cells|b cells
15901|NCT03189316|Regulatory B cells|regulatory b cells
15902|NCT03189316|Human|human
15903|NCT03189264|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
15904|NCT03189264|Postoperative Complications|postoperative complications
15905|NCT03189264|Renal Stone|renal stone
15906|NCT03189264|Surgical Success|surgical success
15907|NCT03189264|Surgical Complications|surgical complications
15908|NCT03189264|Pneumatic Dilation|pneumatic dilation
15909|NCT03189212|Telemedicine|telemedicine
15910|NCT03189186|Kidney Cancer|kidney cancer
15911|NCT03189186|Immunotherapy|immunotherapy
15912|NCT03189186|Renal Cell Carcinoma|renal cell carcinoma
15913|NCT03189186|Cryoablation|cryoablation
15914|NCT03189186|Metastatic Renal Cancer|metastatic renal cancer
15915|NCT03189173|Obstructive Sleep Apnea|obstructive sleep apnea
15916|NCT03189173|Ventilatory Control Instability|ventilatory control instability
15917|NCT03189173|Complex Sleep Apnea|complex sleep apnea
15923|NCT03189108|Paracentesis|paracentesis
15924|NCT03189108|Thoracentesis|thoracentesis
15925|NCT03189095|exercise|exercise
15926|NCT03189095|physical activity|physical activity
15927|NCT03189095|SCI|sci
15928|NCT03189095|spinal cord injury|spinal cord injury
15929|NCT03189095|online|online
15930|NCT03189056|chronic Chagas disease|chronic chagas disease
15931|NCT03189056|bladder|bladder
15932|NCT03189056|lower urinary tract|lower urinary tract
15933|NCT03189056|urodynamic|urodynamic
15934|NCT03189030|metastatic|metastatic
15935|NCT03189030|microsatellite stable (MSS)|microsatellite stable (mss)
15936|NCT03189004|mHealth, health services, technology, smartphones, Bangladesh|mhealth, health services, technology, smartphones, bangladesh
15937|NCT03188965|First in human|first in human
15938|NCT03188965|Solid tumors|solid tumors
15939|NCT03188965|Lymphomas|lymphomas
15940|NCT03188965|Dose escalation|dose escalation
15941|NCT03188965|Dose expansion|dose expansion
15942|NCT03188913|Burns|burns
15943|NCT03188913|Coagulation|coagulation
15944|NCT03188913|Factor XIII|factor xiii
15945|NCT03188913|Glycocalix|glycocalix
15946|NCT03188913|Cicatrization|cicatrization
15947|NCT03188900|Preeclampsia|preeclampsia
15949|NCT03188900|sflt-1|sflt-1
15956|NCT03188861|health care utilization|health care utilization
15957|NCT03188809|Postoperative Pain|postoperative pain
15958|NCT03188809|Functional Outcomes|functional outcomes
15959|NCT03188809|Total Knee Arthroplasty|total knee arthroplasty
15960|NCT03188809|Adductor Canal Block|adductor canal block
15961|NCT03188809|Femoral Nerve Block|femoral nerve block
15962|NCT03188796|vitamin D|vitamin d
15963|NCT03188796|critical care|critical care
15964|NCT03188770|Middle-income countries|middle-income countries
15965|NCT03188744|Cervical cancer|cervical cancer
15966|NCT03188744|Pelvic floor muscles|pelvic floor muscles
15967|NCT03188744|Physiotherapy|physiotherapy
15968|NCT03188744|Quality of life|quality of life
15969|NCT03188731|ZIKA|zika
15970|NCT03188731|Dengue|dengue
15971|NCT03188731|Chikungunya|chikungunya
15972|NCT03188731|Pregnant Women|pregnant women
15973|NCT03188731|Pregnant Woman|pregnant woman
15974|NCT03188731|ZIKV|zikv
15975|NCT03188718|Polysomnogram|polysomnogram
15976|NCT03188718|Sleep Disordered Breathing|sleep disordered breathing
15977|NCT03188705|pharmacogenetics|pharmacogenetics
15978|NCT03188705|carboxylesterase|carboxylesterase
15979|NCT03188705|Personalized Medicine|personalized medicine
15980|NCT03188692|Haemophilus influenza type b|haemophilus influenza type b
16103|NCT03187951|Questionnaires|questionnaires
15981|NCT03188692|Adsorbed Diphtheria-Purified Pertussis-Tetanus-Inactivate|adsorbed diphtheria-purified pertussis-tetanus-inactivate
15982|NCT03188692|poliovirus combined vaccine|poliovirus combined vaccine
15983|NCT03188692|Hib|hib
15984|NCT03188692|DPT-IPV|dpt-ipv
15985|NCT03188692|Intramuscular|intramuscular
15986|NCT03188679|CMV|cmv
15987|NCT03188679|neurological impairment|neurological impairment
15988|NCT03188679|outcome prediction|outcome prediction
15989|NCT03188679|amniotic fluid biomarkers|amniotic fluid biomarkers
15990|NCT03188640|Bariatric surgery|bariatric surgery
15991|NCT03188640|Sex hormones|sex hormones
15992|NCT03188640|Women|women
15993|NCT03188640|Quality of life|quality of life
15994|NCT03188614|shock|shock
15995|NCT03188614|crystalloid|crystalloid
15996|NCT03188614|acute kidney injury|acute kidney injury
15997|NCT03188601|Graft vs Host Disease|graft vs host disease
15998|NCT03188601|Immune System Diseases|immune system diseases
15999|NCT03188601|Protease Inhibitors|protease inhibitors
16000|NCT03188601|Alpha 1-Antitrypsin|alpha 1-antitrypsin
16001|NCT03188601|Enzyme Inhibitors|enzyme inhibitors
16002|NCT03188601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
610827|NCT00623857|Copper|copper
16003|NCT03188601|Trypsin Inhibitors|trypsin inhibitors
16004|NCT03188601|Serine Proteinase Inhibitors|serine proteinase inhibitors
16005|NCT03188484|Atrial Fibrillation|atrial fibrillation
16006|NCT03188484|Electrocardiography|electrocardiography
16007|NCT03188484|Biological Markers|biological markers
16008|NCT03188484|Risk Assessment|risk assessment
16009|NCT03188458|Infants|infants
16010|NCT03188458|Cord blood sample|cord blood sample
16011|NCT03188458|Acellular pertussis|acellular pertussis
16012|NCT03188458|Boostrix|boostrix
16013|NCT03188458|Colombia|colombia
16014|NCT03188458|Pregnant women|pregnant women
16021|NCT03188380|nec|nec
16022|NCT03188380|abdominal ultrasound|abdominal ultrasound
16023|NCT03188380|abdominal radiograph|abdominal radiograph
16024|NCT03188380|preterm|preterm
16025|NCT03188367|dose-finding|dose-finding
16026|NCT03188367|extraintestinal symptoms|extraintestinal symptoms
16027|NCT03188367|gluten|gluten
16028|NCT03188367|intestinal symptoms|intestinal symptoms
16029|NCT03188367|placebo|placebo
16030|NCT03188354|Positron-Emission Tomography|positron-emission tomography
16031|NCT03188354|Magnetic Resonance Imaging|magnetic resonance imaging
16032|NCT03188341|vascular surgery|vascular surgery
16033|NCT03188341|repolarization disturbances|repolarization disturbances
16034|NCT03188341|cardiac complications|cardiac complications
16035|NCT03188341|high risk patient|high risk patient
16036|NCT03188341|high risk procedure|high risk procedure
16037|NCT03188302|Stool consistency|stool consistency
16038|NCT03188302|Texture Analyser|texture analyser
16039|NCT03188302|Bristol Stool Form Scale|bristol stool form scale
16040|NCT03188289|chitosan|chitosan
16041|NCT03188289|clorhexidine|clorhexidine
16042|NCT03188289|suture|suture
16043|NCT03188289|bacteria|bacteria
16044|NCT03188289|wisdom|wisdom
16045|NCT03188276|Chronic Hepatitis C|chronic hepatitis c
16046|NCT03188276|direct-acting antiviral agents|direct-acting antiviral agents
16047|NCT03188276|Myeloid-Derived Suppressor Cells|myeloid-derived suppressor cells
16048|NCT03188276|NK cells|nk cells
16049|NCT03188263|diabetes|diabetes
16050|NCT03188263|sleep|sleep
16051|NCT03188263|circadian rhythm|circadian rhythm
16052|NCT03188263|light treatment|light treatment
16053|NCT03188224|Transition|transition
16054|NCT03188224|Improved patient outcomes|improved patient outcomes
16055|NCT03188224|RCT|rct
16056|NCT03188224|Child health|child health
16057|NCT03188224|Empower youth|empower youth
16058|NCT03188185|Alkermes|alkermes
16059|NCT03188185|Major Depressive Disorder|major depressive disorder
16060|NCT03188185|Treatment Refractory MDD|treatment refractory mdd
16061|NCT03188185|ALKS 5461|alks 5461
16062|NCT03188133|Schizophrenia|schizophrenia
16063|NCT03188133|Visual Hallucination|visual hallucination
16064|NCT03188133|False Perception|false perception
16065|NCT03188133|emotional priming|emotional priming
16066|NCT03188107|Risky Infant|risky infant
16067|NCT03188107|Cerebral Palsy|cerebral palsy
16068|NCT03188107|Down Syndrome|down syndrome
16069|NCT03188107|Spina Bifida|spina bifida
16070|NCT03188107|Infant Motor Profile|infant motor profile
16071|NCT03188068|Kaposiform Hemangioendothelioma|kaposiform hemangioendothelioma
16072|NCT03188068|Kasabach Merritt Phenomenon|kasabach merritt phenomenon
16073|NCT03188068|Sirolimus|sirolimus
16074|NCT03188068|Prednisolone|prednisolone
16075|NCT03188055|patient decision making|patient decision making
16076|NCT03188055|surgical decision making|surgical decision making
16077|NCT03188055|shared decision making|shared decision making
16078|NCT03188055|decision support techniques|decision support techniques
16079|NCT03188042|Transorbital Alternating Current Stimulation|transorbital alternating current stimulation
16080|NCT03188042|Glaucoma|glaucoma
16081|NCT03188029|ethomidate adrenocortical insufficiency|ethomidate adrenocortical insufficiency
16082|NCT03188016|"music therapy"|"music therapy"
16083|NCT03188016|"Intensive Interaction"|"intensive interaction"
16084|NCT03188016|"non-verbal communication"|"non-verbal communication"
16085|NCT03188016|"musical improvisation"|"musical improvisation"
16086|NCT03188016|"feasibility study"|"feasibility study"
16087|NCT03188016|"randomised controlled trial"|"randomised controlled trial"
16088|NCT03188003|Exercise Movement Techniques|exercise movement techniques
7999|NCT03239470|PolyTregs|polytregs
8000|NCT03239470|open-label|open-label
8001|NCT03239470|Phase 1 (safety)|phase 1 (safety)
8002|NCT03239444|ICE|ice
8003|NCT03239444|Ablation|ablation
8005|NCT03239444|Septum|septum
16089|NCT03188003|Low Back Pain|low back pain
16090|NCT03188003|Exercise|exercise
16091|NCT03187990|PSMA PET/MRI|psma pet/mri
16092|NCT03187990|Guided Biopsy|guided biopsy
16093|NCT03187990|Prostate Cancer|prostate cancer
16094|NCT03187977|Cognitive intervention|cognitive intervention
16095|NCT03187977|Survivors|survivors
16096|NCT03187977|Childhood ALL|childhood all
16097|NCT03187964|People Living with HIV (PLHIV)|people living with hiv (plhiv)
16098|NCT03187964|Xpert HIV-1 Viral Load (Xpert VL)|xpert hiv-1 viral load (xpert vl)
16099|NCT03187964|Xpert Ultra|xpert ultra
16100|NCT03187964|Antiretroviral treatment (ART)|antiretroviral treatment (art)
16101|NCT03187951|Other disorders of glucose regulation and pancreatic internal secretion|other disorders of glucose regulation and pancreatic internal secretion
16102|NCT03187951|Pancreatic cancer|pancreatic cancer
16104|NCT03187951|Surveys|surveys
16105|NCT03187951|Nutritional Questionnaire|nutritional questionnaire
16106|NCT03187951|Nutritional Counseling|nutritional counseling
16107|NCT03187951|Booklet|booklet
16108|NCT03187951|Pamphlet|pamphlet
16109|NCT03187951|Educational materials|educational materials
16110|NCT03187951|Aerobic Exercise|aerobic exercise
16111|NCT03187951|Strength Training Exercises|strength training exercises
16112|NCT03187951|Physical Assessments|physical assessments
16113|NCT03187951|Walk Test|walk test
16114|NCT03187938|Alkaline Phosphatase|alkaline phosphatase
16115|NCT03187938|Pregnancy|pregnancy
16116|NCT03187938|Suboptimal fetal growth|suboptimal fetal growth
16117|NCT03187938|Placental insufficiency|placental insufficiency
16118|NCT03187938|Low birth weight|low birth weight
16119|NCT03187938|IUGR|iugr
16120|NCT03187899|cervical plexus block|cervical plexus block
16121|NCT03187899|clavicle fracture|clavicle fracture
16122|NCT03187899|interscalene brachial plexus block|interscalene brachial plexus block
16123|NCT03187886|Cerebral amyloid angiopathy|cerebral amyloid angiopathy
16124|NCT03187886|CAA-RI|caa-ri
16125|NCT03187886|MRI|mri
16126|NCT03187886|Intracerebral hemorrhage|intracerebral hemorrhage
16127|NCT03187873|community participation|community participation
16128|NCT03187873|Maternal and child health|maternal and child health
16129|NCT03187873|Kenya|kenya
16130|NCT03187860|Bronchial epithelial cell|bronchial epithelial cell
16131|NCT03187860|mucus|mucus
16132|NCT03187860|Air Liquid Interface|air liquid interface
16133|NCT03187847|Physical Activity|physical activity
16134|NCT03187847|Fatigue|fatigue
16135|NCT03187834|infection|infection
16136|NCT03187834|azithromycin|azithromycin
16137|NCT03187834|amoxicillin|amoxicillin
16138|NCT03187834|co-trimoxazole|co-trimoxazole
16139|NCT03187834|trachoma|trachoma
16140|NCT03187834|mass treatment|mass treatment
16141|NCT03187808|Neck pain, Thoracic manipulation, special massage|neck pain, thoracic manipulation, special massage
16142|NCT03187795|Spinal Cord Injuries|spinal cord injuries
16143|NCT03187795|Randomized Controlled Trial|randomized controlled trial
16150|NCT03187769|Schizophrenia|schizophrenia
16151|NCT03187769|Schizophreniform|schizophreniform
16152|NCT03187769|Bipolar I|bipolar i
16153|NCT03187756|Hematopoietic Malignancies|hematopoietic malignancies
16154|NCT03187756|Nonmyeloablative Peripheral Blood Stem Cell Transplant|nonmyeloablative peripheral blood stem cell transplant
16155|NCT03187756|Posttransplantation|posttransplantation
16156|NCT03187743|Lupus erythematosus|lupus erythematosus
16157|NCT03187743|Systemic|systemic
16158|NCT03187743|Corticosteroid|corticosteroid
16159|NCT03187743|Prednisone|prednisone
16160|NCT03187743|Pharmacokinetics|pharmacokinetics
16161|NCT03187730|Smoking Cassation|smoking cassation
16162|NCT03187730|Immigrants|immigrants
16163|NCT03187730|Economic Disparity|economic disparity
16164|NCT03187717|Postoperative pain|postoperative pain
16165|NCT03187717|Recovery period|recovery period
16166|NCT03187717|Total intravenous anesthesia|total intravenous anesthesia
16167|NCT03187717|Inhalation anesthesia|inhalation anesthesia
16168|NCT03187704|air filtration, HEPA, In-home,|air filtration, hepa, in-home,
16169|NCT03187678|switch|switch
16170|NCT03187678|intravenous|intravenous
16171|NCT03187678|selexipag|selexipag
16172|NCT03187665|Pediatric|pediatric
16173|NCT03187665|Pulse Oximeter|pulse oximeter
16174|NCT03187665|Wireless|wireless
16175|NCT03187665|Motion|motion
16176|NCT03187665|False Alarm|false alarm
16177|NCT03187639|Coronary artery disease|coronary artery disease
16178|NCT03187639|CT coronary angiography|ct coronary angiography
16179|NCT03187639|FFRct|ffrct
16180|NCT03187639|Rapid access chest pain clinic|rapid access chest pain clinic
16181|NCT03187639|Stable chest pain|stable chest pain
16182|NCT03187639|Resource utilisation|resource utilisation
16183|NCT03187639|Quality of life|quality of life
16184|NCT03187626|Base-of-thumb osteoarthritis|base-of-thumb osteoarthritis
16185|NCT03187626|Botulinum toxin A|botulinum toxin a
16186|NCT03187626|Intra-articular therapy|intra-articular therapy
16187|NCT03187626|Randomized trial|randomized trial
16188|NCT03187613|Retinal shift|retinal shift
16189|NCT03187613|Aniseikonia|aniseikonia
16190|NCT03187613|Metamorphopsia|metamorphopsia
16191|NCT03187613|Autofluorescence|autofluorescence
16192|NCT03187587|Hyperthermia, Induced|hyperthermia, induced
16193|NCT03187587|Laser Coagulation|laser coagulation
16194|NCT03187587|Laser Therapy|laser therapy
16195|NCT03187574|vaginal prolapse, mesh kit, anatomic assessment, quality of life|vaginal prolapse, mesh kit, anatomic assessment, quality of life
16196|NCT03187561|Sleep|sleep
16197|NCT03187561|Parenting|parenting
16198|NCT03187561|Marital relationship|marital relationship
16199|NCT03187561|Parent-child relations|parent-child relations
16200|NCT03187548|WSL|wsl
16201|NCT03187548|CPP-ACP|cpp-acp
16202|NCT03187535|Transcutaneous Electrical Acupoint Stimulation|transcutaneous electrical acupoint stimulation
16203|NCT03187522|AAA|aaa
16204|NCT03187522|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
16205|NCT03187509|Torsemide, loop diuretics, weight-based|torsemide, loop diuretics, weight-based
16206|NCT03187496|drug-drug interaction|drug-drug interaction
16207|NCT03187444|Cardiovascular risk|cardiovascular risk
16208|NCT03187444|Chronic inflammatory rheumatism|chronic inflammatory rheumatism
16209|NCT03187444|Rheumatoid arthritis|rheumatoid arthritis
16210|NCT03187444|Spondyloarthritis|spondyloarthritis
16211|NCT03187444|Inflammation|inflammation
16212|NCT03187431|Stem cell|stem cell
16213|NCT03187431|Therapy|therapy
16214|NCT03187431|IPF|ipf
16215|NCT03187418|Cyclophotocoagulation|cyclophotocoagulation
16216|NCT03187418|Micropulse TSCPC|micropulse tscpc
16217|NCT03187418|Laser ablation|laser ablation
16218|NCT03187418|Laser therapy|laser therapy
16219|NCT03187405|Subarachnoid Hemorrhage|subarachnoid hemorrhage
16220|NCT03187405|Intracranial Aneurysm|intracranial aneurysm
16221|NCT03187405|Cerebral Ischemia|cerebral ischemia
16222|NCT03187405|Ventriculostomy|ventriculostomy
16223|NCT03187405|Tissue Plasminogen Activator|tissue plasminogen activator
16230|NCT03187327|prophylactic salpingectomy|prophylactic salpingectomy
16231|NCT03187327|vaginal hysterectomy|vaginal hysterectomy
16232|NCT03187327|p53 expression|p53 expression
16233|NCT03187327|ovarian cancers|ovarian cancers
16234|NCT03187314|Esophageal cancer|esophageal cancer
16235|NCT03187314|Radiation|radiation
16236|NCT03187314|Anti-PD-1 Antibody|anti-pd-1 antibody
16237|NCT03187301|Parkinson's Disease|parkinson's disease
16238|NCT03187301|Off episodes|off episodes
16239|NCT03187275|Cancer Related Fatigue (CRF)|cancer related fatigue (crf)
16240|NCT03187275|Prostate Cancer|prostate cancer
16241|NCT03187275|Swedish Massage Therapy (SMT)|swedish massage therapy (smt)
16246|NCT03187223|Bendamustine|bendamustine
16248|NCT03187223|ASCT|asct
16249|NCT03187210|CD30+ Lymphoma|cd30+ lymphoma
16250|NCT03187210|ASCT|asct
16251|NCT03187210|Brentuximab Vedotin|brentuximab vedotin
16252|NCT03187171|Anterior Cervical Spine Fusion|anterior cervical spine fusion
16253|NCT03187132|virtual reality|virtual reality
16254|NCT03187132|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
16255|NCT03187132|analgesia|analgesia
16256|NCT03187119|Pediatric|pediatric
16257|NCT03187119|Education|education
16258|NCT03187119|Technology-supported intervention|technology-supported intervention
16259|NCT03187119|Asthma Action Plan|asthma action plan
16260|NCT03187119|Health literacy|health literacy
16261|NCT03187093|MDD|mdd
16262|NCT03187093|Vortioxetine|vortioxetine
16263|NCT03187093|IGF-1|igf-1
16264|NCT03187093|Cognitive dysfunction|cognitive dysfunction
16265|NCT03187067|pneumonia|pneumonia
16266|NCT03187067|diagnostic|diagnostic
16268|NCT03187067|Pakistan|pakistan
16269|NCT03187067|Mozambique|mozambique
16270|NCT03187041|blood draw tourniquets|blood draw tourniquets
16271|NCT03187041|skin surface pressure|skin surface pressure
16272|NCT03187041|blood draw band|blood draw band
16273|NCT03187041|elastic tourniquet|elastic tourniquet
16274|NCT03187041|phlebotomy|phlebotomy
16275|NCT03187041|tourniquet pressure|tourniquet pressure
16276|NCT03187028|Cancer of Pancreas|cancer of pancreas
16277|NCT03187028|Neoplasms, Pancreatic|neoplasms, pancreatic
16278|NCT03187028|Pancreas Cancer|pancreas cancer
16279|NCT03187028|Pancreas Neoplasms|pancreas neoplasms
16280|NCT03187028|Cancer of the Pancreas|cancer of the pancreas
16281|NCT03187028|Pancreatic Cancer|pancreatic cancer
16282|NCT03187015|Healthy Volunteers|healthy volunteers
16283|NCT03187015|Entinostat|entinostat
16284|NCT03187015|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
16285|NCT03187015|HDAC|hdac
16286|NCT03186989|Mild Alzheimer's Disease|mild alzheimer's disease
16287|NCT03186989|ISIS 814907|isis 814907
16288|NCT03186976|Risk Factor Modification|risk factor modification
16289|NCT03186976|Catheter ablation|catheter ablation
16290|NCT03186963|distal radius fracture|distal radius fracture
16291|NCT03186963|volar plate|volar plate
16292|NCT03186963|immobilization|immobilization
16293|NCT03186898|hepatocellular carcinoma|hepatocellular carcinoma
16294|NCT03186898|HCC|hcc
16295|NCT03186898|Proton Therapy|proton therapy
16296|NCT03186898|Photon Therapy|photon therapy
16297|NCT03186898|Liver cancer|liver cancer
16298|NCT03186859|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
16299|NCT03186859|bariatric surgery|bariatric surgery
16300|NCT03186846|cognitive decline|cognitive decline
16301|NCT03186846|hemodynamic monitoring|hemodynamic monitoring
16302|NCT03186846|LIDCO|lidco
16303|NCT03186846|INVOS|invos
16304|NCT03186846|BIS|bis
16305|NCT03186846|brain injury biomarkers|brain injury biomarkers
16306|NCT03186820|Endometriosis|endometriosis
16307|NCT03186820|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
16308|NCT03186820|Susceptibility-weighted imaging (SWI)|susceptibility-weighted imaging (swi)
16309|NCT03186807|normogram|normogram
16310|NCT03186807|brain lumination|brain lumination
16311|NCT03186807|fetal cortex|fetal cortex
16312|NCT03186807|ultrasound|ultrasound
16319|NCT03186742|Eplerenone|eplerenone
16320|NCT03186742|Concentric hypertrophy|concentric hypertrophy
16321|NCT03186729|Intracerebral hemorrhage|intracerebral hemorrhage
16323|NCT03186716|Enteral Nutrition|enteral nutrition
16324|NCT03186716|Intestinal Permeability|intestinal permeability
16325|NCT03186716|Intensive Care Unit|intensive care unit
16326|NCT03186703|Cancer prevention|cancer prevention
16327|NCT03186703|Knowledge translation|knowledge translation
16543|NCT03185208|Dementia|dementia
16328|NCT03186703|Physical activity|physical activity
16329|NCT03186703|Diet|diet
16330|NCT03186703|Alcohol|alcohol
16331|NCT03186703|Smoking|smoking
16332|NCT03186690|vital pulp therapy|vital pulp therapy
16333|NCT03186690|Biodentine|biodentine
16334|NCT03186690|Mineral Trioxide Aggregate|mineral trioxide aggregate
16335|NCT03186677|ISU304|isu304
16336|NCT03186677|previously treated hemophilia B patients|previously treated hemophilia b patients
16337|NCT03186677|FIX|fix
16338|NCT03186677|Factor IX|factor ix
16339|NCT03186677|CB2679d|cb2679d
16340|NCT03186651|Vaginal|vaginal
16341|NCT03186651|Medical Device|medical device
16342|NCT03186651|Female Stress Urinary Incontinence|female stress urinary incontinence
16343|NCT03186625|acute coronary syndrome|acute coronary syndrome
16344|NCT03186625|gut microbiota|gut microbiota
16345|NCT03186625|Trimethylamine N-oxide|trimethylamine n-oxide
16346|NCT03186625|percutaneous coronary intervention|percutaneous coronary intervention
16347|NCT03186612|Video games; Virtual reality; Occupational therapy, Manual dexterity; Multiple sclerosis.|video games; virtual reality; occupational therapy, manual dexterity; multiple sclerosis.
16348|NCT03186599|Medication Event Monitoring System|medication event monitoring system
16349|NCT03186599|adherence|adherence
16350|NCT03186586|Heavy Menstrual Bleeding|heavy menstrual bleeding
16351|NCT03186586|Levonorgestrel relesing intrauterine system|levonorgestrel relesing intrauterine system
16352|NCT03186560|Leg ulcers and use of geko device|leg ulcers and use of geko device
16353|NCT03186508|obesity prevention|obesity prevention
16354|NCT03186508|sleep|sleep
16355|NCT03186508|behavioral intervention|behavioral intervention
16356|NCT03186456|acute cerebral infarction|acute cerebral infarction
16357|NCT03186456|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
16358|NCT03186443|herpetic neuralgia|herpetic neuralgia
16359|NCT03186443|post-herpetic neuralgia|post-herpetic neuralgia
16360|NCT03186443|pregabalin|pregabalin
16361|NCT03186430|Vaccine|vaccine
16362|NCT03186430|Vaccination|vaccination
16363|NCT03186430|Behavioral Research|behavioral research
16364|NCT03186430|Adolescent|adolescent
16365|NCT03186430|Health Promotion|health promotion
16366|NCT03186430|Public Health|public health
16367|NCT03186417|Arthritis, Rheumatoid, Stem Cells, Mesenchymal, Autoimmune|arthritis, rheumatoid, stem cells, mesenchymal, autoimmune
16375|NCT03186339|TAVI|tavi
16376|NCT03186339|surgical aortic valve replacement|surgical aortic valve replacement
16377|NCT03186339|Aortic stenosis|aortic stenosis
16378|NCT03186326|immunotherapy|immunotherapy
16379|NCT03186326|second line|second line
16380|NCT03186313|HCV|hcv
16381|NCT03186313|Sofosbuvir|sofosbuvir
16382|NCT03186313|Ribavirin|ribavirin
16384|NCT03186248|Achalasia cardia|achalasia cardia
16385|NCT03186248|myotomy|myotomy
16386|NCT03186248|Per oral endoscopic myotomy|per oral endoscopic myotomy
16387|NCT03186248|laparoscopic fundoplication|laparoscopic fundoplication
16388|NCT03186209|Asthma,|asthma,
16389|NCT03186209|Bronchial Diseases,|bronchial diseases,
16390|NCT03186209|Respiratory Tract Diseases,|respiratory tract diseases,
16391|NCT03186209|Lung Diseases,|lung diseases,
16392|NCT03186209|Obstructive Lung Diseases|obstructive lung diseases
16393|NCT03186196|Folate|folate
16394|NCT03186196|Polymorphism|polymorphism
16395|NCT03186196|Overweight and Obesity|overweight and obesity
16396|NCT03186196|Inflammatory markers|inflammatory markers
16397|NCT03186183|HIV prevention|hiv prevention
16398|NCT03186183|Sexual health|sexual health
16399|NCT03186183|Motivational interviewing|motivational interviewing
16400|NCT03186183|Information-Motivation-Behavioural skills model|information-motivation-behavioural skills model
16401|NCT03186183|Health promotion|health promotion
16402|NCT03186157|trephined syndrome|trephined syndrome
16403|NCT03186157|sinking skin flap syndrome|sinking skin flap syndrome
16404|NCT03186157|craniectomy|craniectomy
16405|NCT03186157|decompressive craniectomy|decompressive craniectomy
16406|NCT03186157|neurosurgical complications|neurosurgical complications
16407|NCT03186118|pediatric|pediatric
16408|NCT03186118|young adult|young adult
16409|NCT03186118|acute lymphoblastic leukemia|acute lymphoblastic leukemia
16410|NCT03186118|CD 19|cd 19
16411|NCT03186118|leukemia|leukemia
16412|NCT03186118|chimeric antigen receptor|chimeric antigen receptor
16413|NCT03186118|T cell|t cell
16414|NCT03186105|Appendicitis Acute|appendicitis acute
16415|NCT03186105|AMBULATORY|ambulatory
16416|NCT03186092|Respiratory muscle strength|respiratory muscle strength
16417|NCT03186092|Pulmonary hypertension|pulmonary hypertension
16418|NCT03186092|Respiratory muscle training|respiratory muscle training
16419|NCT03186027|chronic fatigue|chronic fatigue
16420|NCT03186027|Sleep problems|sleep problems
16421|NCT03186027|Autonomic dysfunction|autonomic dysfunction
16422|NCT03186027|Health-Related Quality of Life|health-related quality of life
16423|NCT03186027|Coenzyme Q10|coenzyme q10
16424|NCT03186027|NADH|nadh
16425|NCT03186014|Malignant dysphagia|malignant dysphagia
16426|NCT03186014|Stent|stent
16427|NCT03186014|Esophageal neoplasms|esophageal neoplasms
16428|NCT03186014|Brachytherapy|brachytherapy
16429|NCT03186001|frontalis|frontalis
16430|NCT03186001|frontal line|frontal line
16544|NCT03185208|Alzheimer|alzheimer
16431|NCT03186001|glabellar line|glabellar line
16432|NCT03186001|botulinum toxin|botulinum toxin
16433|NCT03186001|abobotulinum|abobotulinum
16434|NCT03185988|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
16435|NCT03185988|Biliary tract cancer|biliary tract cancer
16436|NCT03185988|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
16437|NCT03185988|Targeted therapy|targeted therapy
16438|NCT03185975|HIV|hiv
16439|NCT03185975|transgender|transgender
16440|NCT03185975|trans|trans
16441|NCT03185975|youth|youth
16442|NCT03185975|home testing|home testing
16443|NCT03185936|optic disc pit|optic disc pit
16444|NCT03185936|retinal detachment|retinal detachment
16445|NCT03185936|maculopathy|maculopathy
16446|NCT03185923|Community-Acquired Infections|community-acquired infections
16447|NCT03185923|Humans|humans
16448|NCT03185923|Medicine, Chinese Traditional|medicine, chinese traditional
16449|NCT03185871|Invasive breast carcinoma|invasive breast carcinoma
16450|NCT03185871|breast carcinoma stage T1cN0 to N3N0|breast carcinoma stage t1cn0 to n3n0
16451|NCT03185858|secondary prevention|secondary prevention
16452|NCT03185858|primary healthcare|primary healthcare
16453|NCT03185858|village doctors|village doctors
16454|NCT03185858|rural China|rural china
16455|NCT03185858|medication adherence|medication adherence
16456|NCT03185858|physical activity|physical activity
16457|NCT03185832|Hear failure|hear failure
16458|NCT03185832|Sudden Cardiac Death|sudden cardiac death
16459|NCT03185832|Arrhythmia|arrhythmia
19127|NCT03168048|radiotherapy|radiotherapy
16463|NCT03185806|severe acute pancreatitis|severe acute pancreatitis
16464|NCT03185806|sterile acute peripancreatic fluid collections|sterile acute peripancreatic fluid collections
16465|NCT03185806|percutaneous catheter drainage|percutaneous catheter drainage
16466|NCT03185793|SHR4640, Phase II, monotherapy, dose-finding|shr4640, phase ii, monotherapy, dose-finding
16467|NCT03185780|complementary/integrative medicine|complementary/integrative medicine
16468|NCT03185780|glioblastoma|glioblastoma
16469|NCT03185780|quality of life|quality of life
16470|NCT03185780|adherence|adherence
16471|NCT03185754|lung cancer|lung cancer
16472|NCT03185754|surgery|surgery
16473|NCT03185754|lobectomy|lobectomy
16474|NCT03185754|sublobar resection|sublobar resection
16475|NCT03185728|Child Abuse|child abuse
16476|NCT03185728|Mandated Reporting|mandated reporting
16477|NCT03185728|Online Learning|online learning
16478|NCT03185728|Child Protection|child protection
16479|NCT03185728|GAMIFICATION|gamification
16480|NCT03185728|Early Childhood Education|early childhood education
16481|NCT03185715|oocyte donation|oocyte donation
16482|NCT03185715|recipient counselling|recipient counselling
16483|NCT03185715|single embryo transfer (SET)|single embryo transfer (set)
16484|NCT03185715|double embryo transfer (DET)|double embryo transfer (det)
16485|NCT03185715|decision-making|decision-making
16486|NCT03185689|Glycemic control|glycemic control
16487|NCT03185689|Diabetes self-management education|diabetes self-management education
16488|NCT03185650|Healthy Volunteers|healthy volunteers
16489|NCT03185637|Outcomes|outcomes
16490|NCT03185637|Mortality|mortality
16491|NCT03185637|Complications|complications
16492|NCT03185637|Neonatal surgery|neonatal surgery
16493|NCT03185637|Paediatric surgery|paediatric surgery
16494|NCT03185637|Childrens surgery|childrens surgery
16495|NCT03185637|Sub-Saharan Africa|sub-saharan africa
16496|NCT03185637|Research Collaboration|research collaboration
16497|NCT03185637|Gastroschisis|gastroschisis
16498|NCT03185637|Anorectal malformation|anorectal malformation
16499|NCT03185637|Appendicitis|appendicitis
16500|NCT03185637|Intussuception|intussuception
16501|NCT03185637|Inguinal hernia|inguinal hernia
16502|NCT03185585|Nutritional screenings|nutritional screenings
16503|NCT03185520|Stroke|stroke
16504|NCT03185520|Ischemic Stroke|ischemic stroke
16505|NCT03185520|Cryptogenic Stroke|cryptogenic stroke
16506|NCT03185520|Embolic stroke of undetermined source|embolic stroke of undetermined source
16507|NCT03185520|ESUS|esus
16508|NCT03185520|Cerebrovascular Disease|cerebrovascular disease
610828|NCT00623857|Selenium|selenium
16517|NCT03185442|fMRI|fmri
16518|NCT03185442|PRF|prf
16519|NCT03185416|Quality of Life|quality of life
16520|NCT03185416|Caregiver|caregiver
16521|NCT03185416|Quality Improvement|quality improvement
16522|NCT03185403|hemodynamic effect|hemodynamic effect
16523|NCT03185403|para vertebral block|para vertebral block
16524|NCT03185390|periampullary lesions|periampullary lesions
16525|NCT03185351|midazolam|midazolam
16526|NCT03185351|brachial plexus block|brachial plexus block
16527|NCT03185338|physical activity, promotion, school|physical activity, promotion, school
16528|NCT03185299|Polyp detection rate|polyp detection rate
16529|NCT03185299|Adenoma detection rate|adenoma detection rate
16530|NCT03185299|Boston Bowel Preparation Scale|boston bowel preparation scale
16531|NCT03185286|3D printing, metal implant, bone defect|3d printing, metal implant, bone defect
16532|NCT03185260|Cardio-Pulmonary Resuscitation|cardio-pulmonary resuscitation
16533|NCT03185260|Cardiac Arrest|cardiac arrest
16534|NCT03185260|Training|training
16535|NCT03185247|Transdiagnostic|transdiagnostic
16545|NCT03185208|Alzheimer's Disease|alzheimer's disease
16546|NCT03185208|Cognition|cognition
16547|NCT03185208|Memory|memory
16548|NCT03185208|Thinking|thinking
16549|NCT03185208|Prevention|prevention
16550|NCT03185208|amyloid|amyloid
16551|NCT03185208|imaging|imaging
16552|NCT03185208|MRI|mri
16553|NCT03185208|PET|pet
16554|NCT03185208|tau|tau
16555|NCT03185208|plaques|plaques
16556|NCT03185208|tangles|tangles
16557|NCT03185182|Diagnosis|diagnosis
16558|NCT03185182|Imaging|imaging
16559|NCT03185169|breast cancer survivor|breast cancer survivor
16560|NCT03185169|postmenopausal|postmenopausal
16561|NCT03185169|dysuria|dysuria
16562|NCT03185169|dyspareunia|dyspareunia
16563|NCT03185169|vaginal dryness|vaginal dryness
16564|NCT03185169|urinary tract infections|urinary tract infections
16565|NCT03185169|urinary frequency|urinary frequency
16566|NCT03185169|urinary urgency|urinary urgency
16567|NCT03185169|genital burning|genital burning
16568|NCT03185169|genital itching|genital itching
16569|NCT03185169|genital dryness|genital dryness
16570|NCT03185156|nausea and vomiting|nausea and vomiting
16571|NCT03185156|hemabate|hemabate
16572|NCT03185156|propofol|propofol
16573|NCT03185130|Headache|headache
16574|NCT03185130|Benign Headache|benign headache
16575|NCT03185117|opioid consumption|opioid consumption
16576|NCT03185117|postdischarge|postdischarge
16577|NCT03185117|major orthopedic surgery|major orthopedic surgery
16578|NCT03185104|removable partial denture|removable partial denture
16579|NCT03185104|silver diamine fluoride|silver diamine fluoride
16580|NCT03185078|physical therapy|physical therapy
16581|NCT03185078|ESWT|eswt
16582|NCT03185026|Psychiatry|psychiatry
16583|NCT03185026|Suicide|suicide
16584|NCT03185026|Psychoeducation|psychoeducation
16585|NCT03185026|Randomized controlled trial|randomized controlled trial
16586|NCT03185026|current suicidal behavior disorder|current suicidal behavior disorder
16587|NCT03185026|DSM-5|dsm-5
16601|NCT03184935|Myelodysplastic Syndromes|myelodysplastic syndromes
16602|NCT03184935|mesenchymal stem cells|mesenchymal stem cells
16603|NCT03184922|femoral suspensory loops|femoral suspensory loops
16604|NCT03184857|maxillary sinus|maxillary sinus
16605|NCT03184857|augmentation|augmentation
16606|NCT03184857|bovine bone|bovine bone
16607|NCT03184857|Nano hydroxy appatite|nano hydroxy appatite
16608|NCT03184844|Thalidomide TI|thalidomide ti
16609|NCT03184831|sinus lift, injectable platelet rich fibrin, sticky bone, bovine bone|sinus lift, injectable platelet rich fibrin, sticky bone, bovine bone
16610|NCT03184792|Spinal electrical stimulation|spinal electrical stimulation
16612|NCT03184779|Snowboard|snowboard
16613|NCT03184779|Snow Sport|snow sport
16614|NCT03184779|Injury|injury
16615|NCT03184779|Injury Prevention|injury prevention
16616|NCT03184779|Safety|safety
16617|NCT03184779|Safety Video|safety video
16618|NCT03184779|Video Intervention|video intervention
16619|NCT03184779|Youth|youth
16620|NCT03184779|Children|children
16621|NCT03184779|Adolescent|adolescent
16622|NCT03184779|Education|education
16623|NCT03184779|Knowledge|knowledge
16624|NCT03184753|Autologous|autologous
8509|NCT03236129|DLI|dli
16625|NCT03184753|IgT|igt
16626|NCT03184753|Ovarian Cancer|ovarian cancer
16627|NCT03184701|Telehealth|telehealth
16628|NCT03184701|Quality of Life|quality of life
16629|NCT03184688|platelet rich plasma|platelet rich plasma
16630|NCT03184688|Perineural injection therapy|perineural injection therapy
16631|NCT03184688|hydrodissection|hydrodissection
16632|NCT03184662|High-intensity physical activity|high-intensity physical activity
16633|NCT03184662|Diabetes|diabetes
16634|NCT03184662|Renal function decline|renal function decline
16635|NCT03184636|ACLF|aclf
16636|NCT03184636|SOFA|sofa
16637|NCT03184636|Zagazig university|zagazig university
16638|NCT03184610|Keratoconus|keratoconus
16838|NCT03183193|NAFLD|nafld
16639|NCT03184610|Optical Coherence Tomography|optical coherence tomography
16640|NCT03184610|Corneal Epithelium Thickness Maps|corneal epithelium thickness maps
16641|NCT03184597|HLA screening|hla screening
16643|NCT03184597|MPE|mpe
16644|NCT03184597|AEDs|aeds
16645|NCT03184571|BGB324|bgb324
16646|NCT03184571|NSCLC|nsclc
16647|NCT03184571|pembrolizumab|pembrolizumab
16648|NCT03184571|Keytruda|keytruda
16649|NCT03184558|BGB324|bgb324
16650|NCT03184558|TNBC|tnbc
16651|NCT03184558|pembrolizumab|pembrolizumab
16652|NCT03184558|Keytruda|keytruda
16653|NCT03184545|anterior knee pain|anterior knee pain
16654|NCT03184480|Drug Use Investigation|drug use investigation
16655|NCT03184480|GW685698|gw685698
16656|NCT03184480|asthma|asthma
16657|NCT03184480|Post-marketing surveillance|post-marketing surveillance
16658|NCT03184480|ARNUITY ELLIPTA|arnuity ellipta
16659|NCT03184467|GV1001|gv1001
16660|NCT03184467|Alzheimer Disease|alzheimer disease
16661|NCT03184454|OCD|ocd
16662|NCT03184454|deep brain stimulation|deep brain stimulation
16663|NCT03184454|treatment-resistant OCD|treatment-resistant ocd
16664|NCT03184428|YAG-Laser Capsulotomy|yag-laser capsulotomy
16665|NCT03184389|Behavioral Counseling|behavioral counseling
16666|NCT03184389|Cigarette Smoking|cigarette smoking
16667|NCT03184389|Mobile Health|mobile health
16668|NCT03184389|Heart Rate Variability Monitoring|heart rate variability monitoring
16669|NCT03184389|Mindfulness-Based Exercises|mindfulness-based exercises
16670|NCT03184389|Mobile Apps|mobile apps
16671|NCT03184389|Physiological Monitoring|physiological monitoring
16672|NCT03184389|Respiratory Pattern Monitoring|respiratory pattern monitoring
16673|NCT03184389|Stress-Management Interventions|stress-management interventions
16674|NCT03184389|Sensor-Triggered Stress Intervention|sensor-triggered stress intervention
16675|NCT03184389|Smartphone Apps|smartphone apps
16676|NCT03184389|Smoking Cessation|smoking cessation
16677|NCT03184389|Wearable Sensors|wearable sensors
16678|NCT03184389|Eating Behavior|eating behavior
16679|NCT03184389|Stress-Related Eating|stress-related eating
16680|NCT03184376|Gut microbiota|gut microbiota
16681|NCT03184376|Prebiotic|prebiotic
16682|NCT03184376|Liver biopsy|liver biopsy
16683|NCT03184376|Oligofructose|oligofructose
16684|NCT03184350|cervical cancer|cervical cancer
16685|NCT03184350|endometrial cancer|endometrial cancer
16686|NCT03184350|proton therapy|proton therapy
16694|NCT03184311|Iron deficiency|iron deficiency
16695|NCT03184311|Therapy response prediction|therapy response prediction
16696|NCT03184311|Exercise tolerance|exercise tolerance
16697|NCT03184298|Military Personnel|military personnel
16698|NCT03184298|Sexual Assault|sexual assault
16699|NCT03184298|Military Sexual Trauma|military sexual trauma
16700|NCT03184298|Alcohol and Substance Abuse|alcohol and substance abuse
16701|NCT03184285|limitation in conventional monitoring|limitation in conventional monitoring
16702|NCT03184272|limitation in conventional monitoring|limitation in conventional monitoring
16703|NCT03184246|Videolaryngoscopy (GlideScope)|videolaryngoscopy (glidescope)
16704|NCT03184246|Direct laryngoscopy|direct laryngoscopy
16705|NCT03184220|Neck Pain|neck pain
16706|NCT03184220|Physical Therapy Modalities|physical therapy modalities
16707|NCT03184220|Fascia|fascia
16708|NCT03184220|Manual Therapy|manual therapy
16709|NCT03184220|Massage|massage
16710|NCT03184194|daratumumab|daratumumab
16711|NCT03184194|nivolumab|nivolumab
16712|NCT03184194|lenalidomide|lenalidomide
16713|NCT03184181|tendinopathy|tendinopathy
16714|NCT03184181|electrolysis|electrolysis
16715|NCT03184181|exercise|exercise
16716|NCT03184181|dry needling|dry needling
16717|NCT03184168|healthy volunteers, lorlatinib, PF-06463922, ADME, NSCLC, radiolabel, metabolism|healthy volunteers, lorlatinib, pf-06463922, adme, nsclc, radiolabel, metabolism
16718|NCT03184155|Nicardipine|nicardipine
16719|NCT03184155|Percutaneous Coronary Intervention|percutaneous coronary intervention
16720|NCT03184155|Coronary Artery Disease|coronary artery disease
16721|NCT03184142|Intimidation|intimidation
16722|NCT03184142|Simulation|simulation
16723|NCT03184142|Medical education|medical education
16724|NCT03184142|Surgical education|surgical education
16725|NCT03184077|Postpartum dyspareunia|postpartum dyspareunia
16726|NCT03184077|Obestric laceration|obestric laceration
16727|NCT03184064|Blackcurrant|blackcurrant
15349|NCT03192722|Reading|reading
16728|NCT03184064|Citrus|citrus
16729|NCT03184064|Polyphenols|polyphenols
16730|NCT03184064|Glucose|glucose
16731|NCT03184064|Postprandial|postprandial
16732|NCT03184064|Metabolism|metabolism
16733|NCT03184051|Knee|knee
16734|NCT03184051|Osteoarthritis|osteoarthritis
16735|NCT03184051|Ultrasonography evaluation/ultrasound|ultrasonography evaluation/ultrasound
16736|NCT03184051|Articular cartilage|articular cartilage
16737|NCT03184051|UltraSound Speed Of Sound (US-SOS)|ultrasound speed of sound (us-sos)
16738|NCT03184051|UltraSound Time of Flight (US-TOF)|ultrasound time of flight (us-tof)
16739|NCT03184012|caries|caries
16740|NCT03184012|full coverage|full coverage
16741|NCT03184012|strip crown|strip crown
16742|NCT03184012|Zirconia crown|zirconia crown
16743|NCT03184012|primary anterior teeth|primary anterior teeth
16744|NCT03184012|crown|crown
16745|NCT03183960|Self-management|self-management
16746|NCT03183960|Quality of Life|quality of life
16747|NCT03183960|Self-efficacy|self-efficacy
16748|NCT03183960|Support|support
16749|NCT03183960|Stroke|stroke
16750|NCT03183960|Older adults|older adults
16751|NCT03183947|fMRI|fmri
16752|NCT03183947|neurofeedback|neurofeedback
16753|NCT03183947|emotion regulation|emotion regulation
16754|NCT03183947|schizophrenia|schizophrenia
16755|NCT03183947|cognitive reappraisal|cognitive reappraisal
16756|NCT03183947|depression|depression
16757|NCT03183934|Epidermolysis Bullosa|epidermolysis bullosa
16758|NCT03183934|Stem cell|stem cell
16759|NCT03183908|influenza vaccine|influenza vaccine
16760|NCT03183908|fever following vaccination|fever following vaccination
16761|NCT03183908|pain following vaccination|pain following vaccination
16762|NCT03183908|quality of life|quality of life
16763|NCT03183869|microbiome|microbiome
16764|NCT03183869|multiple sclerosis|multiple sclerosis
16765|NCT03183869|microbiota|microbiota
16766|NCT03183869|gut|gut
16767|NCT03183843|Atrial Fibrillation|atrial fibrillation
16768|NCT03183843|Mitral Valve Stenosis|mitral valve stenosis
16769|NCT03183843|Mitral Valve Insufficiency|mitral valve insufficiency
16770|NCT03183843|Dabigatran|dabigatran
16771|NCT03183843|Biological Prosthesis|biological prosthesis
16772|NCT03183843|Mitral Valve Replacement|mitral valve replacement
16773|NCT03183843|Cox-Maze Procedure|cox-maze procedure
16774|NCT03183830|Cardiovascular Disease|cardiovascular disease
16775|NCT03183830|Inorganic nitrate|inorganic nitrate
16776|NCT03183830|Nitric Oxide|nitric oxide
16777|NCT03183830|Inflammation|inflammation
16778|NCT03183817|Person-centred care|person-centred care
16779|NCT03183778|Chronic kidney disease, stages 3B-4|chronic kidney disease, stages 3b-4
16780|NCT03183752|thyroid|thyroid
16782|NCT03183752|thyroid nodule|thyroid nodule
16783|NCT03183752|insulin resistance|insulin resistance
16784|NCT03183752|thyroid volume|thyroid volume
16785|NCT03183752|metformin|metformin
16786|NCT03183739|ASP8062|asp8062
16787|NCT03183739|Pharmacokinetics|pharmacokinetics
16788|NCT03183739|Safety|safety
16789|NCT03183700|Screening HPV|screening hpv
16790|NCT03183700|Self sampling|self sampling
16791|NCT03183700|DNA Methylation|dna methylation
16792|NCT03183687|neurosurgery|neurosurgery
16793|NCT03183687|resident wellness|resident wellness
16794|NCT03183687|health|health
16795|NCT03183687|mental health|mental health
16796|NCT03183687|physical activity|physical activity
16797|NCT03183687|physician health|physician health
16798|NCT03183622|Deep Second-Degree Burn Wound|deep second-degree burn wound
16799|NCT03183596|Deep Serratus Block|deep serratus block
16800|NCT03183596|Reconstructive Breast Surgery|reconstructive breast surgery
16801|NCT03183596|Superficial Serratus block|superficial serratus block
16802|NCT03183583|Tissue Adhesive|tissue adhesive
16803|NCT03183492|Israel|israel
16804|NCT03183492|Universal Mass Vaccination|universal mass vaccination
16805|NCT03183492|Havrix®|havrix®
16806|NCT03183492|Hepatitis A|hepatitis a
16807|NCT03183492|Healthy adults|healthy adults
16808|NCT03183492|Long term persistence|long term persistence
16809|NCT03183492|Toddlers|toddlers
16810|NCT03183479|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
16811|NCT03183479|fibrinogen concentrate|fibrinogen concentrate
16812|NCT03183479|perioperative blood loss|perioperative blood loss
16813|NCT03183479|transfusion|transfusion
16814|NCT03183453|Confabulations|confabulations
16815|NCT03183453|Neuropsychological rehabilitation|neuropsychological rehabilitation
16816|NCT03183453|Memory|memory
16817|NCT03183440|Atopic dermatitis|atopic dermatitis
16818|NCT03183440|Prevention|prevention
16819|NCT03183440|Prebiotics|prebiotics
16820|NCT03183440|Pregnancy|pregnancy
16821|NCT03183414|cardiac surgery|cardiac surgery
16822|NCT03183414|transoesophageal echocardiography|transoesophageal echocardiography
16823|NCT03183401|childhood cancer survivor|childhood cancer survivor
16824|NCT03183388|psychotherapy|psychotherapy
16825|NCT03183362|Barbed sutures,Cesarean Section, adhesions|barbed sutures,cesarean section, adhesions
16826|NCT03183323|hfpef|hfpef
8691|NCT03235349|co-infection|co-infection
8692|NCT03235349|Treatment-naïve|treatment-naïve
16827|NCT03183323|hfref|hfref
16828|NCT03183323|cardiorenal syndrome|cardiorenal syndrome
16829|NCT03183323|exercise|exercise
16830|NCT03183323|telerehabilitation|telerehabilitation
16831|NCT03183323|rehabilitation|rehabilitation
16832|NCT03183284|dexamethazone|dexamethazone
16833|NCT03183284|prednislone|prednislone
16834|NCT03183284|severe ITP|severe itp
16835|NCT03183232|Immunotherapy, γδ T Cell, Lung Cancer|immunotherapy, γδ t cell, lung cancer
16836|NCT03183219|Immunotherapy, γδ T Cell, Liver Cancer|immunotherapy, γδ t cell, liver cancer
16837|NCT03183206|Immunotherapy, γδ T Cell, Breast Cancer|immunotherapy, γδ t cell, breast cancer
16839|NCT03183193|NASH|nash
16840|NCT03183193|Obesity|obesity
16841|NCT03183193|AASLD|aasld
16842|NCT03183193|AHA|aha
16843|NCT03183193|Energy-restricted diet|energy-restricted diet
16844|NCT03183193|Lifestyle intervention|lifestyle intervention
16845|NCT03183193|Mediterranean diet|mediterranean diet
16846|NCT03183193|Weight loss|weight loss
16847|NCT03183193|Liver damage|liver damage
16848|NCT03183193|Inflammation|inflammation
16849|NCT03183193|Oxidative stress|oxidative stress
16850|NCT03183193|Microbiota composition|microbiota composition
16851|NCT03183193|Eating behaviour|eating behaviour
16852|NCT03183193|Satiety|satiety
16853|NCT03183193|Physical activity|physical activity
16854|NCT03183193|Sedentary behaviours|sedentary behaviours
16855|NCT03183193|Sleep quality|sleep quality
16856|NCT03183193|Sleep duration|sleep duration
16857|NCT03183193|Psychological factors|psychological factors
16858|NCT03183193|Nutrigenomics|nutrigenomics
16859|NCT03183193|Nutrigenetics|nutrigenetics
16860|NCT03183193|Transcriptomics|transcriptomics
16861|NCT03183193|Epigenetics|epigenetics
16862|NCT03183193|Metabolomics|metabolomics
16863|NCT03183193|miRNAs|mirnas
16864|NCT03183193|Lipidomics|lipidomics
16865|NCT03183115|Early esophageal squamous cell neoplasm|early esophageal squamous cell neoplasm
16866|NCT03183115|Radiofrequency ablation|radiofrequency ablation
16867|NCT03183115|Endoscopic submucosal dissection|endoscopic submucosal dissection
16868|NCT03183115|Esophageal cancer|esophageal cancer
16869|NCT03183115|Recurrence|recurrence
16870|NCT03183115|Field cancerization|field cancerization
16871|NCT03183076|epilepsy|epilepsy
16872|NCT03183076|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
16873|NCT03183076|Drug Resistance|drug resistance
16874|NCT03183037|Acupuncture|acupuncture
16875|NCT03183037|17-298|17-298
16876|NCT03183011|cardiac resynchronization therapy|cardiac resynchronization therapy
16877|NCT03183011|implantable cardioverter defibrillator|implantable cardioverter defibrillator
16878|NCT03183011|heart failure|heart failure
16879|NCT03183011|magnetic resonance imaging|magnetic resonance imaging
19514|NCT03165162|natural|natural
16880|NCT03182972|medication reconciliation|medication reconciliation
16881|NCT03182972|implementation|implementation
16883|NCT03182972|southwestern Nigeria|southwestern nigeria
16884|NCT03182959|Nrf2 pathway|nrf2 pathway
16885|NCT03182959|Oral mucosa|oral mucosa
16886|NCT03182959|HNSCC|hnscc
16887|NCT03182959|Head and Neck Cancer|head and neck cancer
16888|NCT03182959|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
16889|NCT03182959|Avmacol|avmacol
16890|NCT03182959|Tobacco-related Head and Neck Cancer|tobacco-related head and neck cancer
16891|NCT03182959|broccoli sprout powder|broccoli sprout powder
16892|NCT03182959|broccoli seed extract powder|broccoli seed extract powder
16893|NCT03182933|10 meter walk test|10 meter walk test
16894|NCT03182933|Opioid consumption|opioid consumption
16895|NCT03182894|chemo-refractory|chemo-refractory
16896|NCT03182894|pembrolizumab|pembrolizumab
16897|NCT03182894|epacadostat|epacadostat
16898|NCT03182894|azacitidine|azacitidine
16899|NCT03182894|recommended phase 2 dose (RP2D)|recommended phase 2 dose (rp2d)
16900|NCT03182894|microsatellite-stable (MSS) Metastatic Colorectal Cancer|microsatellite-stable (mss) metastatic colorectal cancer
16901|NCT03182881|Myofascial-reléase|myofascial-reléase
16902|NCT03182881|Fibromyalgia|fibromyalgia
16903|NCT03182881|Lymphatic drainage|lymphatic drainage
16904|NCT03182881|Breast cancer|breast cancer
16905|NCT03182855|Acute Coronary Syndrome|acute coronary syndrome
16906|NCT03182855|STEMI|stemi
16907|NCT03182855|Platelet reactivity|platelet reactivity
16908|NCT03182855|Anti-thrombotic therapy|anti-thrombotic therapy
16909|NCT03182829|direct oral anticoagulants|direct oral anticoagulants
16910|NCT03182829|apixaban|apixaban
16911|NCT03182829|dabigatran|dabigatran
16912|NCT03182829|edoxaban|edoxaban
16913|NCT03182829|rivaroxaban|rivaroxaban
16914|NCT03182829|urine|urine
16915|NCT03182829|LC-MS/MS|lc-ms/ms
16916|NCT03182829|evaluation study|evaluation study
16917|NCT03182829|point of care test|point of care test
16918|NCT03182816|epidermal growth factor receptor|epidermal growth factor receptor
16919|NCT03182816|CTLA-4|ctla-4
16920|NCT03182816|PD-1|pd-1
16921|NCT03182816|chimeric antigen receptor T cells|chimeric antigen receptor t cells
16922|NCT03182816|solid tumor|solid tumor
16923|NCT03182803|mesothelin|mesothelin
16924|NCT03182803|CTLA-4|ctla-4
16925|NCT03182803|PD-1|pd-1
16926|NCT03182803|chimeric antigen receptor T cells|chimeric antigen receptor t cells
16927|NCT03182803|solid tumor|solid tumor
16928|NCT03182790|Smoking Cessation|smoking cessation
16929|NCT03182790|Quit to Win|quit to win
16930|NCT03182790|Brief intervention|brief intervention
16931|NCT03182790|Semi-personalized Instant messaging|semi-personalized instant messaging
16932|NCT03182790|Incentives|incentives
16933|NCT03182790|AWARD model|award model
16934|NCT03182790|Smoking Cessation Intervention|smoking cessation intervention
16935|NCT03182790|Regular messages|regular messages
16936|NCT03182777|arrhythmias, cardiac|arrhythmias, cardiac
16937|NCT03182777|channelopathies|channelopathies
16938|NCT03182777|death, sudden|death, sudden
16939|NCT03182777|genetic testing|genetic testing
16940|NCT03182777|electrocardiography, ambulatory|electrocardiography, ambulatory
16941|NCT03182777|anesthesia, local|anesthesia, local
16942|NCT03182777|dentistry|dentistry
16943|NCT03182738|HIV/AIDS Health Management App|hiv/aids health management app
16944|NCT03182738|HIV/AIDS symptoms|hiv/aids symptoms
16945|NCT03182725|POTS|pots
16946|NCT03182725|tachycardia|tachycardia
16947|NCT03182725|ivabradine|ivabradine
16948|NCT03182699|Secondary Hyperparathyroidism|secondary hyperparathyroidism
16949|NCT03182699|Hemodialysis|hemodialysis
16950|NCT03182699|Left Ventricular Hypertrophy|left ventricular hypertrophy
16951|NCT03182699|FGF 23|fgf 23
16952|NCT03182699|Etelcalcetide|etelcalcetide
16953|NCT03182699|Alfacalcidol|alfacalcidol
16954|NCT03182686|osteoarthritis|osteoarthritis
16955|NCT03182686|osteoarthritis of the knee|osteoarthritis of the knee
16956|NCT03182686|OA|oa
16957|NCT03182686|OAK|oak
16958|NCT03182686|Kellgren Lawrence (KL)|kellgren lawrence (kl)
16959|NCT03182673|advanced solid tumor|advanced solid tumor
16960|NCT03182673|Protein Kinase MEK inhibitor (MEKi)|protein kinase mek inhibitor (meki)
16961|NCT03182673|Programmed Death 1(PD-1)|programmed death 1(pd-1)
16962|NCT03182673|Safety|safety
16963|NCT03182673|Pharmacokinetics|pharmacokinetics
16964|NCT03182621|Physical Fitness|physical fitness
16965|NCT03182621|Body Composition|body composition
16966|NCT03182621|Executive Cognitive Function|executive cognitive function
16967|NCT03182582|Laser Debridement|laser debridement
16968|NCT03182582|Debridement|debridement
16969|NCT03182556|Dance Therapy|dance therapy
16970|NCT03182556|Exercise|exercise
16971|NCT03182556|Myofeedback|myofeedback
16972|NCT03182556|Fibromyalgia|fibromyalgia
16973|NCT03182543|Exercise|exercise
16974|NCT03182543|Oxidative stress|oxidative stress
16975|NCT03182543|Antioxidant|antioxidant
16976|NCT03182491|Platelet activating factor|platelet activating factor
16977|NCT03182491|Basophil activation test|basophil activation test
16979|NCT03182478|skin picking|skin picking
16980|NCT03182478|SPD|spd
16981|NCT03182478|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
16983|NCT03182478|Group treatment|group treatment
16984|NCT03182478|Rothbaum protocol|rothbaum protocol
16985|NCT03182452|Alarms|alarms
16986|NCT03182452|Alarm Fatigue|alarm fatigue
16987|NCT03182452|Alarm Nuisance|alarm nuisance
16988|NCT03182452|Alarm Reduction|alarm reduction
16989|NCT03182452|Patient Monitoring|patient monitoring
16990|NCT03182452|Intensive Care|intensive care
16991|NCT03182439|WEARABLE HEART RATE MONITORS, ACCURACY|wearable heart rate monitors, accuracy
16992|NCT03182413|modafinil|modafinil
16993|NCT03182413|connexin|connexin
16994|NCT03182413|sleep deprivation|sleep deprivation
16995|NCT03182413|cognitive performance|cognitive performance
16996|NCT03182387|Bronchoalveolar lavage|bronchoalveolar lavage
16997|NCT03182387|amylase assay|amylase assay
16998|NCT03182387|aspiration pneumonia|aspiration pneumonia
16999|NCT03182374|Autologous Protein Solution (APS)|autologous protein solution (aps)
17000|NCT03182374|Intra-articular Injection|intra-articular injection
17001|NCT03182374|Osteoarthritis|osteoarthritis
17002|NCT03182361|Auricular, nasal, orbital, extraoral prostheses, extraoral implants, peri-implant reactions, Holgers|auricular, nasal, orbital, extraoral prostheses, extraoral implants, peri-implant reactions, holgers
17003|NCT03182348|Microvessels|microvessels
17004|NCT03182348|Cardiovascular disease|cardiovascular disease
17005|NCT03182348|OCT|oct
17006|NCT03182322|Type 1 diabetes|type 1 diabetes
17007|NCT03182322|T1D|t1d
17008|NCT03182322|diabetes mellitus|diabetes mellitus
17009|NCT03182322|intranasal insulin|intranasal insulin
17010|NCT03182322|mucosal tolerance|mucosal tolerance
17011|NCT03182322|autoantigen|autoantigen
17012|NCT03182322|self tolerance|self tolerance
17013|NCT03182322|prevention|prevention
17014|NCT03182322|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
17015|NCT03182322|juvenile diabetes|juvenile diabetes
17016|NCT03182296|beta cell mass|beta cell mass
17017|NCT03182296|exendin|exendin
17018|NCT03182296|GLP-1 PET|glp-1 pet
17019|NCT03182283|Person-centered care|person-centered care
17020|NCT03182283|Psychosis care|psychosis care
17021|NCT03182283|Integrated care|integrated care
17022|NCT03182257|TRK|trk
17023|NCT03182257|TRKA|trka
17024|NCT03182257|TRKB|trkb
17025|NCT03182257|TRKC|trkc
17026|NCT03182257|NTRK1|ntrk1
17027|NCT03182257|NTRK2|ntrk2
17028|NCT03182257|NTRK3|ntrk3
17029|NCT03182257|NTRK fusion positive|ntrk fusion positive
17030|NCT03182257|NTRK1 fusion|ntrk1 fusion
17031|NCT03182257|NTRK2 fusion|ntrk2 fusion
17032|NCT03182257|NTRK3 fusion|ntrk3 fusion
17033|NCT03182257|NTRK1 gene rearrangement|ntrk1 gene rearrangement
17034|NCT03182257|NTRK2 gene rearrangement|ntrk2 gene rearrangement
17035|NCT03182257|NTRK3 gene fusion|ntrk3 gene fusion
17036|NCT03182257|ETV6-NTRK3|etv6-ntrk3
17037|NCT03182257|fusion|fusion
17038|NCT03182257|tumors|tumors
17138|NCT03181789|Gag|gag
17039|NCT03182257|solid tumors|solid tumors
17040|NCT03182257|CNS tumors|cns tumors
17041|NCT03182257|central nervous system tumors|central nervous system tumors
17042|NCT03182257|TRK fusion|trk fusion
17043|NCT03182257|ETV6|etv6
17044|NCT03182257|ETV6 fusion|etv6 fusion
17045|NCT03182257|solid CNS tumor|solid cns tumor
17046|NCT03182257|advanced CNS tumor|advanced cns tumor
17047|NCT03182257|primary CNS tumor|primary cns tumor
17048|NCT03182244|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
17049|NCT03182244|ASP2215|asp2215
17050|NCT03182231|exendin|exendin
17051|NCT03182231|GLP1|glp1
17052|NCT03182231|beta cell mass|beta cell mass
17053|NCT03182218|Periprocedural|periprocedural
17054|NCT03182218|Anticoagulation|anticoagulation
17055|NCT03182218|Dabigatran|dabigatran
17056|NCT03182218|Rivaroxaban|rivaroxaban
17057|NCT03182218|Apixaban|apixaban
17058|NCT03182218|Edoxaban|edoxaban
17059|NCT03182218|Direct oral anticoagulant|direct oral anticoagulant
17060|NCT03182218|Surgery|surgery
17061|NCT03182218|Anaesthesia|anaesthesia
17062|NCT03182218|Novel oral anticoagulant|novel oral anticoagulant
17063|NCT03182218|Perioperative medicine|perioperative medicine
17064|NCT03182205|Breathing Exercises|breathing exercises
17065|NCT03182205|Autonomic Nervous System|autonomic nervous system
17066|NCT03182205|Hemodynamics|hemodynamics
17067|NCT03182192|Betal cells|betal cells
17068|NCT03182192|Roux- and Y gastic bypass|roux- and y gastic bypass
17069|NCT03182192|exendin|exendin
17070|NCT03182192|GLP1|glp1
17071|NCT03182166|golimumab|golimumab
17072|NCT03182166|clinical response|clinical response
17073|NCT03182166|mayo score|mayo score
17074|NCT03182166|rectosigmoidoscopy|rectosigmoidoscopy
17075|NCT03182166|ulcerative colitis|ulcerative colitis
17076|NCT03182140|long-acting contraception,|long-acting contraception,
17077|NCT03182140|unintended pregnancy|unintended pregnancy
17078|NCT03182140|satisfaction|satisfaction
17079|NCT03182140|bleeding profile|bleeding profile
17080|NCT03182140|amenorrhea|amenorrhea
17081|NCT03182075|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
17082|NCT03182075|OCD|ocd
17083|NCT03182075|Obsessive Personality Disorder|obsessive personality disorder
17084|NCT03182075|Compulsive Behavior|compulsive behavior
17085|NCT03182075|Personality Disorders|personality disorders
17086|NCT03182075|Mental Disorders|mental disorders
17087|NCT03182075|Anxiety Disorders|anxiety disorders
17088|NCT03182075|Impulsive Behavior|impulsive behavior
17089|NCT03182075|Cognition|cognition
17090|NCT03182075|Emotion|emotion
17091|NCT03182075|Emotional Regulation|emotional regulation
17092|NCT03182062|one lung ventilation|one lung ventilation
17093|NCT03182062|postoperative pulmonary complication|postoperative pulmonary complication
17094|NCT03182062|perioperative lung protective ventilation|perioperative lung protective ventilation
17095|NCT03182049|GPA|gpa
17096|NCT03182049|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
17097|NCT03182049|Wegener's granulomatosis|wegener's granulomatosis
17098|NCT03182049|Subglottic Stenosis|subglottic stenosis
17099|NCT03182049|Bronchial Stenosis|bronchial stenosis
17100|NCT03182023|outcome,ECMO,Respiratory Failure,Circulatory Failure|outcome,ecmo,respiratory failure,circulatory failure
17101|NCT03182010|Cesarean section scar, Barbed suture, Conventional suture|cesarean section scar, barbed suture, conventional suture
17102|NCT03181997|Aortic Valve Stenosis|aortic valve stenosis
17103|NCT03181997|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
17104|NCT03181997|Cancer|cancer
17105|NCT03181997|Malignancy|malignancy
17106|NCT03181971|water|water
17107|NCT03181971|sugar-sweetened beverages|sugar-sweetened beverages
17108|NCT03181971|schools|schools
17109|NCT03181958|nasal high frequency oscillation ventilation|nasal high frequency oscillation ventilation
17110|NCT03181958|mechanical ventilation|mechanical ventilation
17111|NCT03181906|medication discrepancy|medication discrepancy
17112|NCT03181906|primary care|primary care
17113|NCT03181906|transition of care|transition of care
17114|NCT03181880|ASTUTE|astute
610829|NCT00623857|Magnesium|magnesium
8984|NCT03233542|Cognitive biases|cognitive biases
8985|NCT03233542|Associations|associations
17115|NCT03181880|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
17116|NCT03181880|Randomised|randomised
17117|NCT03181880|Pragmatic|pragmatic
17118|NCT03181880|Standard of Care|standard of care
17119|NCT03181880|Aclidinium bromide/formoterol fumarate fixed-dose combination|aclidinium bromide/formoterol fumarate fixed-dose combination
17120|NCT03181880|Duaklir|duaklir
17121|NCT03181880|Genuair|genuair
17122|NCT03181867|PET/ CT|pet/ ct
17123|NCT03181867|Endorectal MRI|endorectal mri
17124|NCT03181867|Imaging|imaging
17125|NCT03181867|PSMA|psma
17126|NCT03181854|Integrated Early Palliative Care|integrated early palliative care
17127|NCT03181828|CPSI deficiency|cpsi deficiency
17128|NCT03181828|OTC Deficiency|otc deficiency
17129|NCT03181828|AS Deficiency|as deficiency
17130|NCT03181828|AL Deficiency|al deficiency
17131|NCT03181815|CLADRIBINE|cladribine
17132|NCT03181815|ACUTE MYELOID LEUKEMIA|acute myeloid leukemia
17133|NCT03181789|HIV vaccine|hiv vaccine
17134|NCT03181789|DNA vaccine|dna vaccine
17135|NCT03181789|IL-12|il-12
17136|NCT03181789|Electroporation|electroporation
17139|NCT03181789|Adjuvant|adjuvant
17140|NCT03181789|Healthy|healthy
17141|NCT03181763|MDMA|mdma
17142|NCT03181763|Startle response|startle response
17143|NCT03181763|sleep|sleep
17144|NCT03181750|Palliative Care|palliative care
17145|NCT03181750|Latino|latino
17146|NCT03181750|Patient Navigation|patient navigation
17147|NCT03181737|diabetes mellitus typ 2, adherence, psychological online-intervention, randomized controlled study|diabetes mellitus typ 2, adherence, psychological online-intervention, randomized controlled study
17148|NCT03181711|Dental caries|dental caries
17149|NCT03181711|Tooth, deciduous|tooth, deciduous
17150|NCT03181711|Children|children
17151|NCT03181711|Radiography/bitewing|radiography/bitewing
17152|NCT03181711|diagnostic imaging|diagnostic imaging
17153|NCT03181685|Progesterone supplementation|progesterone supplementation
17154|NCT03181685|IVF|ivf
17155|NCT03181685|Preference expressed by the patient|preference expressed by the patient
17156|NCT03181672|Stellate ganglion block Tourniquet reaction|stellate ganglion block tourniquet reaction
17157|NCT03181659|Musculoskeletal Manipulations|musculoskeletal manipulations
17158|NCT03181659|Exercise|exercise
17159|NCT03181659|Patient Education|patient education
17160|NCT03181659|Low back pain|low back pain
17161|NCT03181633|PNH|pnh
17162|NCT03181633|Paroxysmal|paroxysmal
17163|NCT03181633|Hemoglobinuria|hemoglobinuria
17164|NCT03181633|ACH-0144471|ach-0144471
17165|NCT03181581|ultrasonography|ultrasonography
17166|NCT03181581|ultrasonics|ultrasonics
17167|NCT03181581|brain|brain
17168|NCT03181581|surgery|surgery
17169|NCT03181555|Pregnant|pregnant
17170|NCT03181555|Obese|obese
17171|NCT03181555|Omic|omic
17172|NCT03181490|Pulmonary Nodule|pulmonary nodule
17173|NCT03181490|Solitary|solitary
17174|NCT03181477|Phase II|phase ii
17175|NCT03181477|Radiotherapy with SIB-IMRT|radiotherapy with sib-imrt
17176|NCT03181477|Tomozolomide|tomozolomide
17177|NCT03181438|Renal Transplantation|renal transplantation
17182|NCT03181425|Early Osteoarthritis|early osteoarthritis
17183|NCT03181425|MRI tractography|mri tractography
17184|NCT03181425|Diffusion Tensor Imaging|diffusion tensor imaging
17185|NCT03181386|Dabigatran|dabigatran
17186|NCT03181386|Rivaroxaban|rivaroxaban
17187|NCT03181386|Apixaban|apixaban
17188|NCT03181386|Warfarin|warfarin
17189|NCT03181386|Tooth Extraction|tooth extraction
17190|NCT03181373|Craniocerebral injury|craniocerebral injury
17191|NCT03181373|Mild and severe brain traumatic injury|mild and severe brain traumatic injury
17192|NCT03181373|Neuropsychological abilities|neuropsychological abilities
17193|NCT03181373|Clinical assessment|clinical assessment
17194|NCT03181373|Anatomical and functional imaging|anatomical and functional imaging
17195|NCT03181360|ischemic stroke|ischemic stroke
17196|NCT03181360|wake-up|wake-up
17197|NCT03181360|thrombolysis|thrombolysis
17198|NCT03181360|tenecteplase|tenecteplase
17199|NCT03181360|computed tomography|computed tomography
17200|NCT03181347|Bariatrics|bariatrics
17201|NCT03181347|Microbiology|microbiology
17202|NCT03181334|colorectal|colorectal
17203|NCT03181334|cancer|cancer
17204|NCT03181334|neoplasm|neoplasm
17205|NCT03181334|CRC screening|crc screening
17206|NCT03181334|FIT|fit
17207|NCT03181334|Fecal Immunochemical Test|fecal immunochemical test
17208|NCT03181321|nutrition|nutrition
17209|NCT03181321|fitness|fitness
17210|NCT03181321|cardiovascular disease|cardiovascular disease
17211|NCT03181321|firefighters|firefighters
17212|NCT03181321|obesity|obesity
17213|NCT03181321|injury|injury
17214|NCT03181295|Family Medicine|family medicine
17215|NCT03181295|Primary Care|primary care
17216|NCT03181295|Exercise prescriptions|exercise prescriptions
17217|NCT03181295|Technology|technology
9077|NCT03232996|Balance|balance
610830|NCT00623857|Calcium|calcium
17218|NCT03181282|Deep brain stimulation|deep brain stimulation
17219|NCT03181282|Balance|balance
17220|NCT03181282|Gait|gait
17221|NCT03181282|Physical Therapy|physical therapy
17222|NCT03181282|Parkinson disease|parkinson disease
17223|NCT03181230|Turner syndrome|turner syndrome
17224|NCT03181230|45,XO|45,xo
17225|NCT03181230|body composition|body composition
17226|NCT03181230|cardiometabolism|cardiometabolism
17227|NCT03181230|quality of life|quality of life
17228|NCT03181230|fitness|fitness
17229|NCT03181178|Complementary food supplement|complementary food supplement
17230|NCT03181178|Protein quality and linear growth|protein quality and linear growth
17231|NCT03181178|Intervention targeting complementary foods and growth|intervention targeting complementary foods and growth
17232|NCT03181165|Low-carbohydrate|low-carbohydrate
17233|NCT03181165|Low calorie|low calorie
17234|NCT03181165|Energy restricted|energy restricted
17235|NCT03181139|Enhanced Recovery after Surgery (ERAS)|enhanced recovery after surgery (eras)
17236|NCT03181139|Fast-track surgery|fast-track surgery
17237|NCT03181139|Pec Blocks|pec blocks
17238|NCT03181139|Mastectomy|mastectomy
17341|NCT03180450|Heart Failure|heart failure
17244|NCT03181113|HBeAg seroconversion|hbeag seroconversion
17245|NCT03181113|immune control|immune control
17246|NCT03181100|Malignant neoplasms of thyroid and other endocrine glands|malignant neoplasms of thyroid and other endocrine glands
17247|NCT03181100|Anaplastic thyroid carcinoma|anaplastic thyroid carcinoma
17249|NCT03181100|Poorly differentiated thyroid cancer|poorly differentiated thyroid cancer
17250|NCT03181100|PDTC|pdtc
17251|NCT03181100|Nab-paclitaxel|nab-paclitaxel
17252|NCT03181100|Paclitaxel (protein bound)|paclitaxel (protein bound)
17253|NCT03181100|Abraxane|abraxane
17254|NCT03181100|ABI-007|abi-007
17255|NCT03181100|Paclitaxel|paclitaxel
17256|NCT03181100|Taxol|taxol
17257|NCT03181100|Vemurafenib|vemurafenib
17258|NCT03181100|PLX4032|plx4032
17259|NCT03181100|R05185426|r05185426
17260|NCT03181100|Cobimetinib|cobimetinib
17261|NCT03181100|Atezolizumab|atezolizumab
17262|NCT03181100|MPDL3280A|mpdl3280a
17263|NCT03181100|Bevacizumab|bevacizumab
17264|NCT03181100|Avastin|avastin
17265|NCT03181100|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
17266|NCT03181100|rhuMAb-VEGF|rhumab-vegf
17267|NCT03181100|BRAF|braf
17268|NCT03181100|BRAF inhibitor|braf inhibitor
17269|NCT03181100|MEK|mek
17270|NCT03181100|MEK inhibitor|mek inhibitor
17271|NCT03181100|Immunotherapy|immunotherapy
17272|NCT03181100|Targeted therapy|targeted therapy
17273|NCT03181087|Mesenchyme Stem Cells|mesenchyme stem cells
17378|NCT03180151|corticotomy|corticotomy
17274|NCT03181087|Cesarean Section|cesarean section
17275|NCT03181087|Uterine Scar|uterine scar
17276|NCT03181035|Oral Tongue Cancer|oral tongue cancer
17277|NCT03181035|Tumor Hypoxia|tumor hypoxia
17278|NCT03181022|Patient-Provider Communication|patient-provider communication
19906|NCT03162627|Selumetinib|selumetinib
17279|NCT03181022|Motivational Interviewing|motivational interviewing
17280|NCT03181022|Medication Adherence|medication adherence
17281|NCT03181009|Oral Immunotherapy|oral immunotherapy
17283|NCT03181009|OIT|oit
17284|NCT03181009|Xolair|xolair
17285|NCT03180996|FEVAR|fevar
17286|NCT03180996|Fenestrated|fenestrated
17287|NCT03180996|Endovascular|endovascular
17288|NCT03180996|AAA|aaa
17289|NCT03180996|Custom device|custom device
17290|NCT03180957|Dupuytren|dupuytren
17291|NCT03180957|adalimumab|adalimumab
17292|NCT03180957|anti TNF|anti tnf
17293|NCT03180957|phase II clinical trial|phase ii clinical trial
17294|NCT03180957|randomized controlled trial|randomized controlled trial
17295|NCT03180957|double-blind method|double-blind method
17296|NCT03180892|Iodine|iodine
17297|NCT03180892|thyroid peroxidase antibody|thyroid peroxidase antibody
17298|NCT03180840|Enzyme-Replacement Therapy|enzyme-replacement therapy
17299|NCT03180840|pegunigalsidase alfa|pegunigalsidase alfa
17300|NCT03180840|Fabry Disease|fabry disease
17301|NCT03180801|broad|broad
17302|NCT03180801|universal|universal
17303|NCT03180801|vaccine|vaccine
17304|NCT03180801|influenza|influenza
17305|NCT03180801|peptide|peptide
17306|NCT03180801|T cell|t cell
17307|NCT03180801|H1N1|h1n1
17308|NCT03180801|human challenge|human challenge
17309|NCT03180788|ESD|esd
17310|NCT03180788|Traction assisted ESD|traction assisted esd
17311|NCT03180788|Polypectomy|polypectomy
17312|NCT03180788|Clip and thread ESD|clip and thread esd
17313|NCT03180775|Amino acids|amino acids
17314|NCT03180775|Macrophage atherogenicity|macrophage atherogenicity
17315|NCT03180775|Triglycerides|triglycerides
17316|NCT03180775|Cholesterol|cholesterol
17317|NCT03180775|Lipoproteins|lipoproteins
17318|NCT03180697|Amide Proton Transfer|amide proton transfer
17319|NCT03180697|bevacizumab|bevacizumab
17320|NCT03180697|recurrent malignant gliomas|recurrent malignant gliomas
17321|NCT03180697|efficacy|efficacy
17327|NCT03180671|anterior deprogrammer|anterior deprogrammer
9172|NCT03232112|Addiction|addiction
9173|NCT03232112|Glucagon Like Peptide-1|glucagon like peptide-1
9174|NCT03232112|GLP-1|glp-1
9175|NCT03232099|trimethylamine-N-oxide|trimethylamine-n-oxide
9184|NCT03232047|Computerized Working Memory Training|computerized working memory training
9209|NCT03231826|ECG|ecg
17328|NCT03180671|muscle pain|muscle pain
17329|NCT03180671|centric relation|centric relation
17331|NCT03180606|Frail|frail
17332|NCT03180606|Primary care|primary care
17333|NCT03180580|Childhood, Overweight, Obesity|childhood, overweight, obesity
17334|NCT03180554|Vagal nerve stimulation|vagal nerve stimulation
17335|NCT03180554|diaphragmatic breathing|diaphragmatic breathing
17336|NCT03180554|chronic widespread pain|chronic widespread pain
17337|NCT03180554|parasympathetic nervous system|parasympathetic nervous system
17338|NCT03180554|heart rate variability|heart rate variability
17339|NCT03180463|Osteonecrosis of Femoral Head|osteonecrosis of femoral head
17340|NCT03180463|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
17345|NCT03180437|Pancreatic Cancer|pancreatic cancer
17346|NCT03180424|carnitine|carnitine
17347|NCT03180424|elderly|elderly
17348|NCT03180424|functional status|functional status
17349|NCT03180411|Colorectal Cancer|colorectal cancer
17350|NCT03180411|CRC|crc
17351|NCT03180411|Colorectal cancer surveillance|colorectal cancer surveillance
17352|NCT03180411|Decision support tool|decision support tool
17353|NCT03180411|Interviews|interviews
17354|NCT03180411|Questionnaire|questionnaire
17355|NCT03180411|Survey|survey
17356|NCT03180385|NAVA|nava
17357|NCT03180385|BiPAP|bipap
17358|NCT03180385|Pediatrics|pediatrics
17359|NCT03180385|Cardiac Surgery|cardiac surgery
17360|NCT03180359|solid transplant|solid transplant
17361|NCT03180359|grafted children|grafted children
17362|NCT03180359|vaccine recommendation|vaccine recommendation
17363|NCT03180359|immunization efficacy|immunization efficacy
17364|NCT03180359|solid grafted children|solid grafted children
17365|NCT03180359|solid transplant candidate children|solid transplant candidate children
17366|NCT03180333|Chronic Hepatitis B|chronic hepatitis b
17367|NCT03180320|chronic heart failure|chronic heart failure
17368|NCT03180320|exercise-based cardiac rehabilitation|exercise-based cardiac rehabilitation
17369|NCT03180320|Baduanjin|baduanjin
17370|NCT03180203|INTELLiVENT-ASV|intellivent-asv
17371|NCT03180203|Fully closed-loop ventilation|fully closed-loop ventilation
17372|NCT03180203|Wean|wean
17373|NCT03180177|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
17374|NCT03180177|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
17375|NCT03180177|Interval Debulking Surgery|interval debulking surgery
17376|NCT03180177|Advanced-Stage Epithelial Ovarian Cancer|advanced-stage epithelial ovarian cancer
17377|NCT03180177|Postoperative Chemotherapy|postoperative chemotherapy
17379|NCT03180151|enmass retraction|enmass retraction
17380|NCT03180151|mini implant|mini implant
17381|NCT03180138|mobile phone|mobile phone
17382|NCT03180138|Children's Health|children's health
17383|NCT03180125|hydrodissection|hydrodissection
17384|NCT03180125|sodium hyaluorinate|sodium hyaluorinate
17385|NCT03180099|Lumbar Disk Hernia|lumbar disk hernia
17386|NCT03180099|Thoracolumbar Interfascial Plane Block|thoracolumbar interfascial plane block
17387|NCT03180099|Lumbar Disk Surgery|lumbar disk surgery
17389|NCT03180086|Primary Care|primary care
17390|NCT03180086|Women|women
17391|NCT03180060|Likelihood Ratio|likelihood ratio
17392|NCT03180060|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
17393|NCT03180060|CMR|cmr
17394|NCT03180060|Myocardial Perfusion|myocardial perfusion
17395|NCT03180060|Predictive Values|predictive values
17396|NCT03180060|Computed Tomography Perfusion|computed tomography perfusion
17397|NCT03180060|CTP|ctp
17398|NCT03180060|SPECT|spect
17399|NCT03180060|PET|pet
17400|NCT03180060|Diagnostic Accuracy|diagnostic accuracy
17401|NCT03180060|Quantitative Coronary Angiography|quantitative coronary angiography
17402|NCT03180060|Area Under the Curve|area under the curve
17403|NCT03180060|ROC Curve|roc curve
17408|NCT03179995|Octreotide, Major Liver Resection|octreotide, major liver resection
17409|NCT03179930|Entinostat|entinostat
17410|NCT03179930|Pembrolizumab|pembrolizumab
17411|NCT03179930|17-073|17-073
17412|NCT03179917|Pembrolizumab|pembrolizumab
17413|NCT03179917|Radiation Therapy|radiation therapy
17414|NCT03179917|17-054|17-054
17415|NCT03179891|Interictal Period A|interictal period a
17416|NCT03179891|Icta/peri-ictal Period B|icta/peri-ictal period b
17417|NCT03179839|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
17418|NCT03179813|hydrocortisone|hydrocortisone
17419|NCT03179813|third molar|third molar
17420|NCT03179813|oral surgery|oral surgery
17421|NCT03179813|postoperative pain|postoperative pain
17422|NCT03179813|edema|edema
17423|NCT03179800|Hypertension|hypertension
17424|NCT03179800|Resistant Hypertension|resistant hypertension
17425|NCT03179800|Baroreceptor|baroreceptor
17426|NCT03179800|BAT|bat
17427|NCT03179722|Aging|aging
17428|NCT03179722|Drug-related problems|drug-related problems
17429|NCT03179722|Medication review|medication review
17430|NCT03179722|Community pharmacist|community pharmacist
17431|NCT03179722|Medication use|medication use
17432|NCT03179709|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
17433|NCT03179709|Neuromuscular Blockade|neuromuscular blockade
17434|NCT03179709|Interviews|interviews
17435|NCT03179709|Implementation Science|implementation science
17436|NCT03179696|Schizophrenia|schizophrenia
17437|NCT03179696|CBSST|cbsst
17438|NCT03179696|mobile CBT|mobile cbt
17439|NCT03179696|negative symptoms|negative symptoms
17741|NCT03177616|Safety|safety
17443|NCT03179683|digital densitometry|digital densitometry
17444|NCT03179683|low level laser therapy|low level laser therapy
17445|NCT03179683|maxillary sinus augmentation.|maxillary sinus augmentation.
17446|NCT03179657|Prospective Cohort study|prospective cohort study
17447|NCT03179657|Nutrition|nutrition
17448|NCT03179657|Diet|diet
17449|NCT03179657|Guangzhou|guangzhou
17450|NCT03179657|Chinese|chinese
17451|NCT03179631|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
17452|NCT03179631|Dystrophinopathy|dystrophinopathy
17453|NCT03179631|Nonsense Mutation|nonsense mutation
17454|NCT03179631|Premature Stop Codon|premature stop codon
17455|NCT03179631|Becker Muscular Dystrophy|becker muscular dystrophy
17456|NCT03179631|DMD/BMD|dmd/bmd
17457|NCT03179631|PTC124|ptc124
17458|NCT03179631|Ataluren|ataluren
17459|NCT03179618|Unstable Angina|unstable angina
17460|NCT03179618|Xuefu Zhuyu Decoction|xuefu zhuyu decoction
17461|NCT03179592|Computed Tomography|computed tomography
17462|NCT03179579|Gastric Cancer|gastric cancer
17463|NCT03179579|Peritoneal Carcinomatosis|peritoneal carcinomatosis
17464|NCT03179579|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
17465|NCT03179579|Systemic Chemotherapy|systemic chemotherapy
17466|NCT03179579|Cytoreductive Surgery|cytoreductive surgery
17467|NCT03179566|drug disposal|drug disposal
17471|NCT03179527|Unstable Angina|unstable angina
17472|NCT03179527|Shuanghe Decoction|shuanghe decoction
17473|NCT03179514|Unstable Angina|unstable angina
17474|NCT03179514|Gualou Xiebai Banxia Decoction|gualou xiebai banxia decoction
17475|NCT03179514|Danshen Decoction|danshen decoction
17476|NCT03179475|Spinal Cord Injury|spinal cord injury
17477|NCT03179475|Traumatic Spinal Cord Injury|traumatic spinal cord injury
17478|NCT03179475|Targin®|targin®
17479|NCT03179475|Opioids|opioids
17480|NCT03179475|Naloxone|naloxone
17481|NCT03179475|Opioid Induced Constipation|opioid induced constipation
17482|NCT03179475|Oxycodone-Naloxone|oxycodone-naloxone
17484|NCT03179436|PD-1|pd-1
17485|NCT03179436|PDL1|pdl1
17486|NCT03179436|PD-L1|pd-l1
17487|NCT03179423|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
17488|NCT03179423|T1D|t1d
17489|NCT03179423|Monoclonal antibody|monoclonal antibody
17490|NCT03179423|Multiple Sclerosis associated retrovirus MSRV|multiple sclerosis associated retrovirus msrv
17491|NCT03179423|Human Endogenous Retrovirus Type w (HERV-W)|human endogenous retrovirus type w (herv-w)
17492|NCT03179423|GNbAC1|gnbac1
17493|NCT03179410|metastatic castrate-resistant prostate cancer (mCRPC)|metastatic castrate-resistant prostate cancer (mcrpc)
17494|NCT03179410|neuroendocrine prostate cancer (NEPC)|neuroendocrine prostate cancer (nepc)
17497|NCT03179345|Pharmacokinetics|pharmacokinetics
17499|NCT03179319|HIV testing|hiv testing
17500|NCT03179319|Sexually transmitted disease (STD) testing|sexually transmitted disease (std) testing
17501|NCT03179319|Mobile app|mobile app
17502|NCT03179319|Young men who have sex with men|young men who have sex with men
17503|NCT03179319|Technology|technology
17504|NCT03179306|Cervix|cervix
17505|NCT03179306|HPV|hpv
17506|NCT03179306|Imaging|imaging
17507|NCT03179306|Costa Rica|costa rica
17508|NCT03179280|Type 1 diabetes|type 1 diabetes
17509|NCT03179280|Dual-wave bolus|dual-wave bolus
17510|NCT03179280|Postprandial euglycaemia|postprandial euglycaemia
17511|NCT03179267|vital signs|vital signs
17512|NCT03179267|monitoring|monitoring
17513|NCT03179267|early warning score|early warning score
17514|NCT03179202|Electrical Stimulation|electrical stimulation
17515|NCT03179202|Neurostimulation|neurostimulation
17516|NCT03179202|Neuromodulation|neuromodulation
17517|NCT03179202|Back Pain|back pain
17518|NCT03179202|Low Back Pain|low back pain
17519|NCT03179163|Hypertension|hypertension
17520|NCT03179163|Blood Pressure|blood pressure
17521|NCT03179163|Cardiovascular Disease|cardiovascular disease
17522|NCT03179163|ACE Inhibitor|ace inhibitor
17523|NCT03179163|Diuretic|diuretic
17524|NCT03179163|Nitric Oxide|nitric oxide
17525|NCT03179163|Hydrogen Sulfide|hydrogen sulfide
17526|NCT03179163|Captopril|captopril
17527|NCT03179163|Enalapril|enalapril
17528|NCT03179163|Hydrochlorothiazide|hydrochlorothiazide
17529|NCT03179163|Microcirculation|microcirculation
17530|NCT03179163|Skin|skin
17531|NCT03179150|computer-aided diagnosis|computer-aided diagnosis
17532|NCT03179150|Web|web
17533|NCT03179150|Cloud computing|cloud computing
17534|NCT03179150|lung cancer|lung cancer
17535|NCT03179124|cerebral palsy|cerebral palsy
17536|NCT03179124|trunk control|trunk control
17537|NCT03179124|upper extremity|upper extremity
17538|NCT03179098|Elbow|elbow
17539|NCT03179098|Stretching|stretching
17540|NCT03179098|Joint amplitude|joint amplitude
17541|NCT03179098|Electromyography|electromyography
17542|NCT03179098|Surface heat|surface heat
17543|NCT03179098|Orthosis|orthosis
17544|NCT03179098|Posttraumatic|posttraumatic
17545|NCT03179085|Diabetes|diabetes
17546|NCT03179085|American Indians|american indians
17547|NCT03179085|Disparity|disparity
17548|NCT03179085|microalbuminuria|microalbuminuria
17549|NCT03179085|Telemedicine|telemedicine
17550|NCT03179085|Community health representative (CHR)|community health representative (chr)
17551|NCT03179085|Patient Activation Measure (PAM)|patient activation measure (pam)
17552|NCT03179085|Home base kidney care|home base kidney care
17553|NCT03179059|Reproductive Health|reproductive health
17554|NCT03179059|Family Planning|family planning
17555|NCT03179059|Randomization Trial|randomization trial
17556|NCT03179059|Uganda|uganda
17557|NCT03179033|LVAD|lvad
17558|NCT03179033|Passive leg raising|passive leg raising
17559|NCT03179020|Intensive Care Units|intensive care units
17560|NCT03179020|Brain Death|brain death
17561|NCT03179020|Organ Donation|organ donation
17562|NCT03179020|Family interview|family interview
17563|NCT03179007|MUC1|muc1
17564|NCT03179007|CTLA-4|ctla-4
17565|NCT03179007|PD-1|pd-1
17566|NCT03179007|chimeric antigen receptor T cells|chimeric antigen receptor t cells
17567|NCT03179007|solid tumor|solid tumor
17568|NCT03178994|Post - adolescence acne|post - adolescence acne
17569|NCT03178994|Topical 2% ketoconazole cream|topical 2% ketoconazole cream
17570|NCT03178877|IBS, Rome IV criteria, anxiety|ibs, rome iv criteria, anxiety
17571|NCT03178864|cerebral venous thrombosis|cerebral venous thrombosis
17572|NCT03178864|anticoagulation|anticoagulation
17573|NCT03178799|Fractures|fractures
17574|NCT03178799|Osteoporosis|osteoporosis
17575|NCT03178799|Care management|care management
17576|NCT03178799|cost-effeciveness|cost-effeciveness
17577|NCT03178799|Randomized controlled trial|randomized controlled trial
17578|NCT03178786|Art Therapy|art therapy
17579|NCT03178773|mobile health|mobile health
17580|NCT03178773|social support|social support
17581|NCT03178773|health disparity|health disparity
17582|NCT03178773|Latino|latino
17583|NCT03178760|Optic nerve sheath diameter|optic nerve sheath diameter
17584|NCT03178760|average optic nerve sheath diameter for healthy children|average optic nerve sheath diameter for healthy children
17585|NCT03178747|Methylene blue|methylene blue
17586|NCT03178747|Giemsa|giemsa
17587|NCT03178747|Tzanck smear|tzanck smear
17588|NCT03178695|Infertility|infertility
17589|NCT03178695|Pregnancy|pregnancy
17590|NCT03178695|Menopause|menopause
17591|NCT03178695|Perimenopause|perimenopause
17592|NCT03178695|Premature Ovarian Failure|premature ovarian failure
17593|NCT03178669|Colitis, Ulcerative|colitis, ulcerative
17594|NCT03178669|Gastrointestinal Diseases|gastrointestinal diseases
17595|NCT03178669|Inflammatory Bowel Disease|inflammatory bowel disease
17596|NCT03178669|Immunomodulator Therapy|immunomodulator therapy
17597|NCT03178669|Glucocorticoids|glucocorticoids
17598|NCT03178669|Anti-Inflammatory Agents|anti-inflammatory agents
17599|NCT03178669|Therapeutic uses|therapeutic uses
17600|NCT03178669|Kappaproct|kappaproct
17601|NCT03178669|IDX0150|idx0150
17602|NCT03178669|DIMS0150|dims0150
17603|NCT03178656|sorafenib, operation|sorafenib, operation
17604|NCT03178578|Fluid therapy|fluid therapy
17605|NCT03178565|Respiratory Failure|respiratory failure
17606|NCT03178565|Mechanical Ventilation|mechanical ventilation
17607|NCT03178565|Mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
17608|NCT03178565|Airway mucus clearance|airway mucus clearance
17609|NCT03178539|tonsillectomy|tonsillectomy
17610|NCT03178539|post operative analgesia|post operative analgesia
17611|NCT03178539|diklofanic|diklofanic
17612|NCT03178539|ketorolac|ketorolac
17613|NCT03178500|clomiphene citrate|clomiphene citrate
17614|NCT03178500|stair- step|stair- step
17615|NCT03178500|poly cystic ovary|poly cystic ovary
17616|NCT03178487|Efficacy|efficacy
17617|NCT03178487|ABT-494|abt-494
17618|NCT03178487|Safety|safety
17619|NCT03178487|Ankylosing Spondylitis (AS)|ankylosing spondylitis (as)
17620|NCT03178487|Upadacitinib|upadacitinib
17621|NCT03178474|infant formula|infant formula
17622|NCT03178474|Clinical trial|clinical trial
17623|NCT03178474|Chinese infant|chinese infant
17624|NCT03178474|body growth|body growth
17625|NCT03178474|gut microbiota|gut microbiota
17626|NCT03178474|Stool characteristics|stool characteristics
17627|NCT03178461|Caesarean Section|caesarean section
9507|NCT03229902|stroke|stroke
17628|NCT03178461|Delivery|delivery
17629|NCT03178435|risk score|risk score
17630|NCT03178435|Acute kidney injury|acute kidney injury
17631|NCT03178435|critical care|critical care
17632|NCT03178422|tobacco use cessation|tobacco use cessation
17633|NCT03178422|smoking prevention|smoking prevention
17635|NCT03178370|Gastroparesis|gastroparesis
17636|NCT03178370|Nausea and Vomiting|nausea and vomiting
17637|NCT03178370|Abdominal Pain|abdominal pain
17638|NCT03178370|Gastric Emptying|gastric emptying
17639|NCT03178370|Electrophysiology|electrophysiology
17640|NCT03178370|Hormones|hormones
17641|NCT03178370|Inflammation|inflammation
17642|NCT03178370|Enteric Nervous System|enteric nervous system
17643|NCT03178370|Autonomic Nervous System|autonomic nervous system
17644|NCT03178331|School health services|school health services
17645|NCT03178331|Screening|screening
17646|NCT03178331|Student|student
17647|NCT03178331|School doctor|school doctor
17648|NCT03178331|Health check|health check
17649|NCT03178331|Children|children
17650|NCT03178279|physical health|physical health
17651|NCT03178188|lupus erythematosus, Discoid|lupus erythematosus, discoid
17652|NCT03178188|Pulsed-dye Laser|pulsed-dye laser
17653|NCT03178175|Scalp acupuncture|scalp acupuncture
17654|NCT03178175|Parkinson's disease|parkinson's disease
17655|NCT03178175|Balance|balance
17656|NCT03178162|limitation in conventional monitoring|limitation in conventional monitoring
17657|NCT03178149|Age-related Macular Degeneration|age-related macular degeneration
17658|NCT03178149|ASP7317|asp7317
17659|NCT03178136|HR-HPV opportunistic screening|hr-hpv opportunistic screening
17660|NCT03178136|virus load|virus load
17661|NCT03178136|multi-site|multi-site
17662|NCT03178123|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
17663|NCT03178123|Mucosal Melanoma|mucosal melanoma
17664|NCT03178123|Interferons|interferons
17665|NCT03178110|physical therapy|physical therapy
17666|NCT03178110|cancer rehabilitation|cancer rehabilitation
17667|NCT03178097|limitation in conventional monitoring|limitation in conventional monitoring
17669|NCT03178084|CD4/CD8 ratio|cd4/cd8 ratio
17670|NCT03178084|immune recovery|immune recovery
17671|NCT03178084|maraviroc|maraviroc
17672|NCT03178084|efavirenz|efavirenz
17673|NCT03178071|NSCLC|nsclc
17674|NCT03178032|Diffuse intrinsic pontine gliomas|diffuse intrinsic pontine gliomas
17675|NCT03178032|Oncolytic adenovirus|oncolytic adenovirus
17676|NCT03177980|Term infants|term infants
17677|NCT03177980|Analgesia|analgesia
17678|NCT03177980|fentanyl|fentanyl
17679|NCT03177980|clonidine|clonidine
17680|NCT03177980|pharmacokinetics|pharmacokinetics
17681|NCT03177980|sedation|sedation
17682|NCT03177980|pharmacodynamics|pharmacodynamics
17683|NCT03177980|neurophysiology|neurophysiology
17684|NCT03177980|pharmacogenetics|pharmacogenetics
17685|NCT03177980|asphyxia|asphyxia
17686|NCT03177980|hypothermia|hypothermia
17687|NCT03177967|Insomnia|insomnia
17688|NCT03177967|Cognitive behavioral treatment for insomnia (CBT-I)|cognitive behavioral treatment for insomnia (cbt-i)
17689|NCT03177941|Melanoma|melanoma
17690|NCT03177941|Skin Self-Examination|skin self-examination
17691|NCT03177941|First-degree Relative|first-degree relative
17692|NCT03177941|Mobile Application|mobile application
18003|NCT03176069|Muscle Tone|muscle tone
17693|NCT03177876|tenting Hydroxyapetite nano particles implant immediate|tenting hydroxyapetite nano particles implant immediate
17694|NCT03177863|neoplasm|neoplasm
17695|NCT03177863|uterine cervix|uterine cervix
17697|NCT03177850|respiratory polygraphy|respiratory polygraphy
17698|NCT03177850|airway disease|airway disease
17699|NCT03177850|emphysema|emphysema
17700|NCT03177850|acetazolamide|acetazolamide
17701|NCT03177850|altitude|altitude
17702|NCT03177850|nocturnal pulse oxymetry|nocturnal pulse oxymetry
17703|NCT03177837|exercise performance|exercise performance
17704|NCT03177837|maximal spiroergometry|maximal spiroergometry
17705|NCT03177837|airway disease|airway disease
17706|NCT03177837|emphysema|emphysema
17707|NCT03177837|prevention|prevention
17708|NCT03177837|acetazolamide|acetazolamide
17709|NCT03177837|altitude|altitude
17710|NCT03177811|postural control|postural control
17711|NCT03177811|balance performance|balance performance
17712|NCT03177811|airway disease|airway disease
17713|NCT03177811|altitude|altitude
17714|NCT03177811|prevention|prevention
17715|NCT03177811|acetazolamide|acetazolamide
17716|NCT03177772|caregivers|caregivers
17717|NCT03177772|grief|grief
17718|NCT03177772|dementia|dementia
17719|NCT03177772|long-term care|long-term care
17720|NCT03177772|psychotherapy group|psychotherapy group
17721|NCT03177733|breast surgery|breast surgery
17722|NCT03177733|acute pain|acute pain
17723|NCT03177733|regional anesthesia|regional anesthesia
17724|NCT03177694|cough|cough
17725|NCT03177694|exacerbation|exacerbation
17726|NCT03177694|connected device|connected device
17727|NCT03177681|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
17728|NCT03177681|Gastrointestinal symptoms|gastrointestinal symptoms
17729|NCT03177681|Probiotics|probiotics
17730|NCT03177681|Yogurt|yogurt
17731|NCT03177681|Stool sample|stool sample
17732|NCT03177681|Questionnaires|questionnaires
17733|NCT03177681|Surveys|surveys
17734|NCT03177681|Holter monitor|holter monitor
17735|NCT03177629|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
17736|NCT03177629|Helicobacter pylori|helicobacter pylori
17737|NCT03177616|Migraine|migraine
17738|NCT03177616|Women|women
17739|NCT03177616|Adult|adult
17740|NCT03177616|Feasibility|feasibility
17742|NCT03177616|Pilot Randomized Trial|pilot randomized trial
17743|NCT03177616|Randomized Control Trial|randomized control trial
17744|NCT03177616|Chiropractic|chiropractic
17745|NCT03177603|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
17746|NCT03177603|Dose-escalation|dose-escalation
17747|NCT03177603|Safety|safety
17748|NCT03177603|Tolerability|tolerability
17749|NCT03177603|GSK2586881|gsk2586881
17750|NCT03177590|autism|autism
17751|NCT03177590|Pervasive Developmental Disorder|pervasive developmental disorder
17752|NCT03177564|driving pressure|driving pressure
17753|NCT03177564|one-lung ventilation|one-lung ventilation
17754|NCT03177551|Prostatic Neoplasms|prostatic neoplasms
17755|NCT03177551|Nomograms|nomograms
17756|NCT03177551|Drug Resistance, Neoplasm|drug resistance, neoplasm
17757|NCT03177538|suboptimal response|suboptimal response
17758|NCT03177538|Corifollitropin alfa|corifollitropin alfa
17759|NCT03177538|IVF|ivf
17760|NCT03177538|Ovarian stimulation|ovarian stimulation
17761|NCT03177525|parent training|parent training
17762|NCT03177525|social skills|social skills
17763|NCT03177512|PrEP|prep
17764|NCT03177512|HIV Testing|hiv testing
17765|NCT03177512|STI Testing|sti testing
17766|NCT03177512|Mobile app|mobile app
17767|NCT03177512|Technology|technology
17768|NCT03177512|Young men who have sex with men|young men who have sex with men
17769|NCT03177499|Portal pressure gradient|portal pressure gradient
17770|NCT03177499|Transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
17771|NCT03177499|Virtual imaging-based portal pressure gradient|virtual imaging-based portal pressure gradient
17772|NCT03177486|Syntax score|syntax score
17773|NCT03177486|Frank sign|frank sign
17774|NCT03177486|Coronary angiography|coronary angiography
17775|NCT03177473|degenerative disc disease|degenerative disc disease
17776|NCT03177473|CervicalStim devic|cervicalstim devic
17777|NCT03177473|cervical|cervical
17778|NCT03177473|cervical fusion|cervical fusion
17779|NCT03177460|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
17780|NCT03177460|Prostate Cancer|prostate cancer
17781|NCT03177460|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
17782|NCT03177460|High-risk|high-risk
17783|NCT03177460|Localized|localized
17784|NCT03177460|Daratumumab|daratumumab
17785|NCT03177460|Prostatectomy|prostatectomy
17786|NCT03177447|Cardiac Failure|cardiac failure
17787|NCT03177447|Congestive Heart Failure|congestive heart failure
17788|NCT03177447|Heart Decompensation|heart decompensation
17789|NCT03177447|Heart Failure, Congestive|heart failure, congestive
17790|NCT03177434|constipation|constipation
17791|NCT03177434|children|children
17792|NCT03177434|polyethylene glycols (PEG)|polyethylene glycols (peg)
17793|NCT03177434|lactulose|lactulose
18416|NCT03173053|Eradication|eradication
20396|NCT03159390|dietary supplements|dietary supplements
17794|NCT03177408|Diastolic Dysfunction|diastolic dysfunction
17795|NCT03177408|Hypertension|hypertension
17796|NCT03177408|HMGB1|hmgb1
17797|NCT03177382|Total Neoadjuvant Treatment|total neoadjuvant treatment
17798|NCT03177382|Rectal Cancer|rectal cancer
17799|NCT03177382|High Risk Factors|high risk factors
17800|NCT03177382|Chemoradiotherapy|chemoradiotherapy
17801|NCT03177369|Bone and joint infection|bone and joint infection
17802|NCT03177369|Staphylococcus aureus|staphylococcus aureus
17803|NCT03177369|Teicoplanin|teicoplanin
17804|NCT03177369|Subcutaneous administration|subcutaneous administration
17805|NCT03177356|Platelet rich fibrin,xenograft|platelet rich fibrin,xenograft
17806|NCT03177343|Pristinamycin|pristinamycin
17807|NCT03177343|Staphylococcus aureus|staphylococcus aureus
17808|NCT03177343|Bone and joint infection|bone and joint infection
17809|NCT03177304|Interpersonal Psychotherapy|interpersonal psychotherapy
17810|NCT03177304|Internet|internet
17811|NCT03177304|Training|training
17812|NCT03177304|Depression|depression
17813|NCT03177304|Dissemination|dissemination
17814|NCT03177291|NSCLC|nsclc
17815|NCT03177291|SCLC|sclc
17816|NCT03177265|nicotine dependence|nicotine dependence
17817|NCT03177265|tobacco cessation|tobacco cessation
17818|NCT03177174|locally advanced nasopharyngeal carcinoma|locally advanced nasopharyngeal carcinoma
17819|NCT03177174|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
17820|NCT03177174|Toxic reaction|toxic reaction
17821|NCT03177161|PROM|prom
17822|NCT03177161|Patient Reported Outcome Measure|patient reported outcome measure
17823|NCT03177161|PROMIS|promis
17824|NCT03177161|PROMIS-10|promis-10
17825|NCT03177161|PROMIS Global Health|promis global health
17826|NCT03177161|RiksStroke|riksstroke
17827|NCT03177161|ICHOM|ichom
17828|NCT03177161|International Consortium for Health Outcomes Measurement|international consortium for health outcomes measurement
17829|NCT03177161|Wales|wales
17830|NCT03177161|Administration|administration
17831|NCT03177161|Method|method
17832|NCT03177161|Delivery|delivery
610831|NCT00623857|Malaria|malaria
17835|NCT03177122|Assisted Reproductive Technology|assisted reproductive technology
17836|NCT03177122|oocyte performance|oocyte performance
17837|NCT03177122|pregnancy|pregnancy
17932|NCT03176459|exparel|exparel
17838|NCT03177109|Dentine Hypersensitivity|dentine hypersensitivity
17839|NCT03177109|Fluoride varnish|fluoride varnish
17840|NCT03177109|Desensitizing agents|desensitizing agents
17841|NCT03177096|Type 1 diabetes children,School,Childcare facilities,Sensor|type 1 diabetes children,school,childcare facilities,sensor
17842|NCT03177070|Ureteric injury|ureteric injury
17843|NCT03177070|Colorectal Surgery|colorectal surgery
17844|NCT03177044|Inflammatory bowel disease, pelvic floor exercise|inflammatory bowel disease, pelvic floor exercise
17845|NCT03176992|ablation|ablation
17846|NCT03176992|surgicel|surgicel
17847|NCT03176953|PTSD|ptsd
17848|NCT03176953|alcohol use disorder|alcohol use disorder
17849|NCT03176953|Veterans|veterans
17850|NCT03176940|Escalating Dosage|escalating dosage
17851|NCT03176927|magnetogastrogram|magnetogastrogram
17852|NCT03176927|gastroparesis|gastroparesis
17853|NCT03176927|electrogastrogram|electrogastrogram
17854|NCT03176927|gastric slow wave|gastric slow wave
17855|NCT03176914|Community mobilisation|community mobilisation
17856|NCT03176901|urinary urge incontinence|urinary urge incontinence
17857|NCT03176901|urinary incontinence|urinary incontinence
17858|NCT03176901|older adult women|older adult women
17859|NCT03176901|older adults|older adults
17860|NCT03176901|mindfulness-based stress reduction|mindfulness-based stress reduction
17861|NCT03176901|health enhancement program|health enhancement program
17862|NCT03176901|feasibility|feasibility
17863|NCT03176901|randomized controlled trial|randomized controlled trial
17864|NCT03176901|complementary|complementary
17865|NCT03176901|integrative|integrative
17866|NCT03176901|therapies|therapies
17867|NCT03176888|Exercise|exercise
17868|NCT03176888|Aerobic capacity|aerobic capacity
17869|NCT03176888|Rehabilitation|rehabilitation
17870|NCT03176810|percutaneous coronary intervention|percutaneous coronary intervention
17871|NCT03176810|optical coherence tomography|optical coherence tomography
17872|NCT03176797|Liver Fibrosis, multiparametric magnetic resonance imaging|liver fibrosis, multiparametric magnetic resonance imaging
17873|NCT03176784|Varenicline|varenicline
17874|NCT03176784|Nicotine Patch|nicotine patch
17875|NCT03176784|Quit Smoking|quit smoking
17876|NCT03176784|Tobacco|tobacco
17877|NCT03176784|Cigarettes|cigarettes
17878|NCT03176732|Sleep Apnea|sleep apnea
17879|NCT03176732|Hypertension|hypertension
17880|NCT03176732|Positive Airway Pressure|positive airway pressure
17881|NCT03176732|Blood Pressure|blood pressure
17882|NCT03176680|Anesthesia,Esophagectomy,Esophageal cancer,Treatment outcome|anesthesia,esophagectomy,esophageal cancer,treatment outcome
17883|NCT03176667|regional, erector spinae block, lobectomy, video-assisted|regional, erector spinae block, lobectomy, video-assisted
17884|NCT03176641|Platelet-Rich Plasma|platelet-rich plasma
17885|NCT03176641|Meniscus|meniscus
17886|NCT03176641|Knee Injuries|knee injuries
17889|NCT03176615|Gastric Bypass|gastric bypass
17890|NCT03176602|Subjective Global Assessment|subjective global assessment
17891|NCT03176602|Nutrition Risk in Critically ill Score|nutrition risk in critically ill score
17892|NCT03176602|Critical Illness|critical illness
17893|NCT03176589|positive expiratory pressure|positive expiratory pressure
17894|NCT03176589|oxygen saturation|oxygen saturation
17895|NCT03176589|abdominal surgery|abdominal surgery
17897|NCT03176576|cancer among adolescents|cancer among adolescents
17898|NCT03176576|cancer among young adults|cancer among young adults
17899|NCT03176576|adolescents and young adults (AYA)|adolescents and young adults (aya)
17900|NCT03176576|quality of life|quality of life
17901|NCT03176576|reduce stress|reduce stress
17902|NCT03176576|patient navigation|patient navigation
17903|NCT03176576|questionnaire|questionnaire
17904|NCT03176576|supportive care|supportive care
17905|NCT03176576|distress levels|distress levels
17906|NCT03176576|support resources|support resources
17907|NCT03176576|satisfaction survey|satisfaction survey
17908|NCT03176576|teen cancer|teen cancer
17909|NCT03176563|herbal treatment|herbal treatment
17910|NCT03176563|antibiotics|antibiotics
17911|NCT03176563|uncomplicated urinary tract infection|uncomplicated urinary tract infection
17912|NCT03176511|older adults|older adults
17913|NCT03176511|dual task|dual task
17914|NCT03176511|A Matter of Balance|a matter of balance
17915|NCT03176498|cerebral Infarction|cerebral infarction
17916|NCT03176498|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
17917|NCT03176485|metastatic|metastatic
17918|NCT03176485|melanoma|melanoma
17919|NCT03176485|cancer|cancer
17920|NCT03176485|colon|colon
17921|NCT03176485|thyroid|thyroid
17922|NCT03176485|Differentiated|differentiated
17923|NCT03176485|Hepatocellular Carcinoma|hepatocellular carcinoma
17925|NCT03176485|RCC|rcc
17926|NCT03176485|Renal Cell Carcinoma|renal cell carcinoma
17927|NCT03176472|Diabetic Neuropathic Pain|diabetic neuropathic pain
17928|NCT03176472|Neuropathic Pain|neuropathic pain
17929|NCT03176472|HDAC6|hdac6
17930|NCT03176472|ricolinostat|ricolinostat
17931|NCT03176459|bupvacaine|bupvacaine
17933|NCT03176459|analgesic|analgesic
17934|NCT03176459|TAP Block|tap block
17935|NCT03176407|sensor capsule|sensor capsule
17936|NCT03176394|Foley, UTI, Biofilm, DNA|foley, uti, biofilm, dna
17937|NCT03176381|Prostatic Neoplasms|prostatic neoplasms
17938|NCT03176381|Abiraterone Acetate|abiraterone acetate
17939|NCT03176381|FK506 binding protein 5|fk506 binding protein 5
17940|NCT03176381|Neurotensin|neurotensin
17941|NCT03176381|yes-associated protein 1|yes-associated protein 1
17942|NCT03176381|AKR1C3 protein|akr1c3 protein
17943|NCT03176381|Proliferating Cell Nuclear Antigen|proliferating cell nuclear antigen
17944|NCT03176368|dry mouth|dry mouth
17945|NCT03176368|coconut oil|coconut oil
17946|NCT03176368|radiation|radiation
17947|NCT03176342|Drug patch tests|drug patch tests
17948|NCT03176329|Full closed-loop ventilation control|full closed-loop ventilation control
17949|NCT03176329|Critical care|critical care
17950|NCT03176316|ileus|ileus
17951|NCT03176316|fusion of spine|fusion of spine
17952|NCT03176277|Leukemia|leukemia
17953|NCT03176277|Leukemia, Myeloid|leukemia, myeloid
17954|NCT03176277|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
17956|NCT03176277|MERTK|mertk
17957|NCT03176277|TYRO3|tyro3
17958|NCT03176277|AXL|axl
17959|NCT03176277|AML|aml
17960|NCT03176277|de novo AML|de novo aml
17961|NCT03176277|Relapsed/ Refractory AML|relapsed/ refractory aml
17962|NCT03176277|TAM|tam
17963|NCT03176264|PDR001|pdr001
17964|NCT03176264|immunotherapy|immunotherapy
17965|NCT03176264|bevacizumab|bevacizumab
17966|NCT03176264|mFOLFOX6|mfolfox6
17967|NCT03176264|CRC|crc
17968|NCT03176264|MMS|mms
17969|NCT03176264|CMS4|cms4
17970|NCT03176264|ElevatION;CRC-101|elevation;crc-101
17971|NCT03176238|post menopausal|post menopausal
17972|NCT03176238|advanced breast cancer|advanced breast cancer
17973|NCT03176238|metastatic breast cancer|metastatic breast cancer
17974|NCT03176238|everolimus|everolimus
17975|NCT03176238|exemestane|exemestane
17976|NCT03176238|mTor inhibitor|mtor inhibitor
17977|NCT03176238|endocrine therapy|endocrine therapy
17978|NCT03176212|Gut permeability|gut permeability
17979|NCT03176212|Cytokine|cytokine
17980|NCT03176212|Endotoxin|endotoxin
17981|NCT03176199|control-released oxycodone|control-released oxycodone
17982|NCT03176199|immediate-released oxycodone|immediate-released oxycodone
17983|NCT03176199|cancer pain|cancer pain
17984|NCT03176199|opioid-naive|opioid-naive
17985|NCT03176186|ischemic-reperfusion injury|ischemic-reperfusion injury
17986|NCT03176186|out of hospital cardiac arrest|out of hospital cardiac arrest
17987|NCT03176160|LASR|lasr
17988|NCT03176160|Fecci|fecci
17989|NCT03176160|Pro00079623|pro00079623
17990|NCT03176160|Glioblastoma|glioblastoma
17991|NCT03176160|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
17992|NCT03176160|short-course radiation therapy|short-course radiation therapy
17993|NCT03176147|Anemia|anemia
18002|NCT03176069|Vaginismus|vaginismus
18004|NCT03176069|Sexual dysfunctions|sexual dysfunctions
18005|NCT03176056|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
18006|NCT03176056|Low carbohydrate diet|low carbohydrate diet
18007|NCT03176017|Transurethral Incision Of The Prostate|transurethral incision of the prostate
18008|NCT03176017|Prostate|prostate
18009|NCT03176017|Holmium Laser|holmium laser
18010|NCT03176017|Ejaculatory Sparing|ejaculatory sparing
18011|NCT03175965|Heart arrest, hypothermia, SEP, prognosis|heart arrest, hypothermia, sep, prognosis
18012|NCT03175939|adjuvant chemotherapy|adjuvant chemotherapy
18013|NCT03175939|NPC|npc
18014|NCT03175926|Asthma|asthma
18015|NCT03175926|inhaler device|inhaler device
18016|NCT03175926|handling|handling
18017|NCT03175900|Migraine|migraine
18018|NCT03175900|Naoandiwan|naoandiwan
18019|NCT03175900|Traditional Chinese Medicine|traditional chinese medicine
18020|NCT03175900|fMRI|fmri
18021|NCT03175900|Randomized Controlled trial|randomized controlled trial
18022|NCT03175887|depression|depression
18023|NCT03175887|trd|trd
18024|NCT03175887|treatment-resistant depression|treatment-resistant depression
18025|NCT03175887|TMS|tms
18026|NCT03175874|Osteoporosis|osteoporosis
18027|NCT03175874|Alzheimer Disease|alzheimer disease
18028|NCT03175848|Cervical Cancer|cervical cancer
18029|NCT03175848|Radiotherapy|radiotherapy
18030|NCT03175848|Chemotherapy|chemotherapy
18031|NCT03175848|stage IVB cervical cancer|stage ivb cervical cancer
18032|NCT03175835|Dyslipidemia|dyslipidemia
16982|NCT03182478|CBT|cbt
9909|NCT03227250|GPi|gpi
18033|NCT03175835|CKD-519|ckd-519
18034|NCT03175835|Rosuvastatin|rosuvastatin
18035|NCT03175835|Drug-Drug Interaction|drug-drug interaction
18036|NCT03175809|Chronic pelvic pain|chronic pelvic pain
18037|NCT03175809|Pain|pain
18038|NCT03175809|Dry needling|dry needling
18039|NCT03175809|Biofeedback|biofeedback
18040|NCT03175809|Pelvic pain|pelvic pain
18041|NCT03175718|Sarcoma|sarcoma
18042|NCT03175718|Wound|wound
18043|NCT03175718|Therapy|therapy
18044|NCT03175627|Dental caries|dental caries
18045|NCT03175627|Proximal surfaces|proximal surfaces
18046|NCT03175627|Posterior teeth|posterior teeth
18047|NCT03175627|Carious lesions|carious lesions
18048|NCT03175627|Tooth diseases|tooth diseases
18049|NCT03175627|Dental restorations|dental restorations
18050|NCT03175627|Composite resin|composite resin
18051|NCT03175614|Physical activity|physical activity
18052|NCT03175614|Food Habits|food habits
18053|NCT03175614|Information and communiation Technology|information and communiation technology
18054|NCT03175614|Health education|health education
18055|NCT03175601|Sleep disturbances|sleep disturbances
18056|NCT03175601|Biomarkers|biomarkers
18057|NCT03175601|Prefrailty|prefrailty
18058|NCT03175601|Insulin resistance|insulin resistance
18059|NCT03175601|Olfactory impairment|olfactory impairment
18060|NCT03175601|Multiplex array|multiplex array
18061|NCT03175601|Gait speed|gait speed
18062|NCT03175536|high-deductible health plan|high-deductible health plan
18063|NCT03175536|medication adherence|medication adherence
18064|NCT03175536|out-of-pocket costs|out-of-pocket costs
18065|NCT03175536|preventive drug list|preventive drug list
18066|NCT03175536|value-based insurance design|value-based insurance design
18067|NCT03175523|BioResorbable Scaffold|bioresorbable scaffold
18068|NCT03175523|Quantitative Coronary Angiography|quantitative coronary angiography
18069|NCT03175523|Intravascular Imaging|intravascular imaging
18070|NCT03175510|validity, reliability, low back pain|validity, reliability, low back pain
18071|NCT03175497|Gastric Cancer, VEGFR inhibitor|gastric cancer, vegfr inhibitor
18072|NCT03175484|High Fidelity Simulation|high fidelity simulation
18073|NCT03175484|Cognitive Load|cognitive load
18074|NCT03175484|Simulation Training/methods*|simulation training/methods*
18075|NCT03175484|Task Performance and Analysis*|task performance and analysis*
18076|NCT03175484|Students, Medical|students, medical
18077|NCT03175484|Prospective Studies|prospective studies
18078|NCT03175458|tenting|tenting
18079|NCT03175458|grafting|grafting
18080|NCT03175458|implant placement|implant placement
18081|NCT03175432|Melanoma and other malignant neoplasms of skin|melanoma and other malignant neoplasms of skin
18082|NCT03175432|Untreated Melanoma Brain Metastases|untreated melanoma brain metastases
18083|NCT03175432|Bevacizumab|bevacizumab
18084|NCT03175432|rhuMA-VEGF|rhuma-vegf
18085|NCT03175432|Avastin|avastin
18086|NCT03175432|ANTI-VEGF monoclonal antibody|anti-vegf monoclonal antibody
18087|NCT03175432|Atezolizumab|atezolizumab
18088|NCT03175432|MPDL3280A|mpdl3280a
18089|NCT03175432|Questionnaires|questionnaires
18090|NCT03175432|Surveys|surveys
18091|NCT03175432|Neurocognitive Exam|neurocognitive exam
18092|NCT03175419|laparoscopic liver resection|laparoscopic liver resection
18093|NCT03175341|breast cancer|breast cancer
18094|NCT03175341|ascorbic acid|ascorbic acid
18095|NCT03175341|vitamin C|vitamin c
18096|NCT03175341|vitamin supplementation|vitamin supplementation
18097|NCT03175341|quality of life|quality of life
18098|NCT03175315|psychoeducation|psychoeducation
18099|NCT03175315|treatment and education programme|treatment and education programme
18100|NCT03175315|self-management|self-management
18101|NCT03175315|diabetes education|diabetes education
18102|NCT03175315|flash glucose monitoring|flash glucose monitoring
18103|NCT03175302|cognitive processes|cognitive processes
18104|NCT03175302|perioperative cognition|perioperative cognition
18105|NCT03175302|neurocognitive impairment|neurocognitive impairment
18106|NCT03175276|Delirium|delirium
18107|NCT03175276|Cognitive decline|cognitive decline
18108|NCT03175276|IQCODE|iqcode
18109|NCT03175263|onabotulinumtoxinA, chronic migraine, myofascial pain|onabotulinumtoxina, chronic migraine, myofascial pain
18110|NCT03175224|Advanced Solid Tumor|advanced solid tumor
18111|NCT03175224|Relapsed Solid Tumor|relapsed solid tumor
18112|NCT03175224|Recurrent Solid Tumor|recurrent solid tumor
18113|NCT03175159|Risk Reduction|risk reduction
18114|NCT03175159|Crystal Methamphetamine|crystal methamphetamine
18115|NCT03175159|Cocaine|cocaine
18116|NCT03175159|Stimulant Abuse|stimulant abuse
18117|NCT03175159|HIV|hiv
18118|NCT03175159|Behavioral Activation|behavioral activation
18119|NCT03175133|rehabilitation|rehabilitation
18120|NCT03175133|physical therapy|physical therapy
18121|NCT03175107|exergaming|exergaming
18122|NCT03175107|physiotherapy|physiotherapy
18123|NCT03175107|upper extremities|upper extremities
18124|NCT03175107|telerehabilitation|telerehabilitation
18125|NCT03175094|women|women
18126|NCT03175094|HIV prevention|hiv prevention
17137|NCT03181789|p24|p24
18127|NCT03175094|criminal justice|criminal justice
18128|NCT03175081|Intraperitoneal local anesthetic|intraperitoneal local anesthetic
18129|NCT03175081|Ropivacaine|ropivacaine
18130|NCT03175081|Postoperative pain|postoperative pain
18131|NCT03175081|Bariatric surgery|bariatric surgery
18132|NCT03175068|Functional magnetic resonance imaging|functional magnetic resonance imaging
18623|NCT03171610|sufentanil|sufentanil
18133|NCT03175068|Electroencephalography|electroencephalography
18134|NCT03175068|Cognitive Behavioral Therapy|cognitive behavioral therapy
18135|NCT03175068|Supportive Therapy|supportive therapy
18136|NCT03175029|Lower Urinary Tract Symptoms|lower urinary tract symptoms
18137|NCT03174990|aspirin|aspirin
18138|NCT03174990|clopidogrel|clopidogrel
18139|NCT03174990|peripheral arterial disease|peripheral arterial disease
18140|NCT03174990|genetics|genetics
18141|NCT03174964|Recurrent Implantation Failure|recurrent implantation failure
18142|NCT03174964|IVIg|ivig
18143|NCT03174964|Pregnancy Rate|pregnancy rate
18144|NCT03174951|Recurrent Pregnancy Loss|recurrent pregnancy loss
18145|NCT03174951|IVIg|ivig
18146|NCT03174951|Pregnancy Rate|pregnancy rate
18147|NCT03174938|Early diagnosis, biomarker, PET, MRI, β-amyloid, tau, CSF, cognitive test|early diagnosis, biomarker, pet, mri, β-amyloid, tau, csf, cognitive test
18148|NCT03174912|EORTC|eortc
18149|NCT03174912|CUETO|cueto
18150|NCT03174912|bladder neoplasm|bladder neoplasm
18151|NCT03174912|disease progression|disease progression
18152|NCT03174912|recurrence|recurrence
18154|NCT03174886|neurofibrillary|neurofibrillary
18155|NCT03174886|degeneration|degeneration
18156|NCT03174886|primary progressive aphasia|primary progressive aphasia
18157|NCT03174886|agrammatic|agrammatic
18158|NCT03174886|tauopathy|tauopathy
18159|NCT03174886|immunotherapy|immunotherapy
18160|NCT03174886|immunization|immunization
18161|NCT03174860|Pulpitis, irreversible Pulpitis, Hot tooth|pulpitis, irreversible pulpitis, hot tooth
18162|NCT03174860|Cataflam, Diclofenac Potassium, Preoperative, Premedication, Analgesic|cataflam, diclofenac potassium, preoperative, premedication, analgesic
18163|NCT03174860|Local anesthesia, Articaine, Buccal infiltration|local anesthesia, articaine, buccal infiltration
18164|NCT03174847|Primary aldosteronism|primary aldosteronism
18165|NCT03174847|Blood pressure|blood pressure
18166|NCT03174847|Adrenalectomy|adrenalectomy
18167|NCT03174847|Mineralocorticoid-receptor Antagonists|mineralocorticoid-receptor antagonists
18168|NCT03174847|Cardiovascular|cardiovascular
18169|NCT03174847|Endothelial|endothelial
18170|NCT03174847|Renal|renal
18171|NCT03174834|Bladder Stimulation Technique|bladder stimulation technique
18172|NCT03174834|Clean Catch Urine|clean catch urine
18173|NCT03174834|UTI in infants less than 6 months|uti in infants less than 6 months
18174|NCT03174821|Diabetic nephropathy|diabetic nephropathy
18175|NCT03174821|Insulin pump intensive therapy|insulin pump intensive therapy
18176|NCT03174808|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
18177|NCT03174756|Hypochlorous Acid|hypochlorous acid
18178|NCT03174756|Chlorhexidine|chlorhexidine
18179|NCT03174756|Antiplaque agents|antiplaque agents
18180|NCT03174756|Substantivity|substantivity
18181|NCT03174730|smoking|smoking
18182|NCT03174730|smartphone|smartphone
18183|NCT03174730|technology|technology
18184|NCT03174730|addiction|addiction
18185|NCT03174678|Dexmedetomidine|dexmedetomidine
18186|NCT03174678|child|child
18187|NCT03174678|premedication|premedication
18188|NCT03174678|emergence delirium|emergence delirium
18189|NCT03174678|dental treatment|dental treatment
18190|NCT03174626|caregiver|caregiver
18191|NCT03174626|stress management|stress management
18192|NCT03174600|Stroke|stroke
18193|NCT03174600|Lower urinary tract dysfunction|lower urinary tract dysfunction
18194|NCT03174600|Functional status|functional status
18195|NCT03174600|Mini mental test|mini mental test
18196|NCT03174587|Systemic lupus erythematosus|systemic lupus erythematosus
18197|NCT03174587|HLA-haplo-matching|hla-haplo-matching
18198|NCT03174587|allogenic bone marrow derived mesenchymal stem cell|allogenic bone marrow derived mesenchymal stem cell
18199|NCT03174587|Phase 1 clinical trial|phase 1 clinical trial
18200|NCT03174535|Ischemic Stroke|ischemic stroke
18201|NCT03174535|Secondary Prevention|secondary prevention
18202|NCT03174535|Endpoint Events|endpoint events
18203|NCT03174535|Risk Assessment|risk assessment
18204|NCT03174535|Traditional Chinese Medicine|traditional chinese medicine
18205|NCT03174535|Registry Study|registry study
18206|NCT03174522|Autologous|autologous
18207|NCT03174522|Bone Marrow-derived Mononuclear Cells (BM-MNCs)|bone marrow-derived mononuclear cells (bm-mncs)
18208|NCT03174522|Advanced Therapy Medicinal Product (ATMP)|advanced therapy medicinal product (atmp)
18209|NCT03174522|Tissue-engineered Medicinal Product|tissue-engineered medicinal product
18210|NCT03174522|Revascularization|revascularization
18211|NCT03174522|Angiogenesis|angiogenesis
18212|NCT03174522|Vasculogenesis|vasculogenesis
18213|NCT03174522|Arteriogenesis|arteriogenesis
18214|NCT03174509|airway extubation|airway extubation
18215|NCT03174509|positive-pressure respiration|positive-pressure respiration
18216|NCT03174509|suction|suction
18217|NCT03174509|ventilator weaning|ventilator weaning
18218|NCT03174457|Oesophageal Candidiasis|oesophageal candidiasis
18219|NCT03174457|Paediatric|paediatric
18220|NCT03174457|Invasive Candidiasis|invasive candidiasis
18221|NCT03174457|Prophylaxis of Candida Infections|prophylaxis of candida infections
18222|NCT03174457|Candidemia|candidemia
18223|NCT03174457|Aspergillosis|aspergillosis
18224|NCT03174457|Micafungin|micafungin
18225|NCT03174444|Chinese American|chinese american
18234|NCT03174392|Balance|balance
18235|NCT03174392|Resistance|resistance
18236|NCT03174392|Mobility|mobility
18237|NCT03174314|Visual Impairment|visual impairment
18238|NCT03174275|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
18239|NCT03174275|durvalumab|durvalumab
18240|NCT03174275|neoadjuvant induction|neoadjuvant induction
18241|NCT03174275|post-operative treatment|post-operative treatment
18242|NCT03174262|Ergonomics|ergonomics
18243|NCT03174262|Computer Workstation|computer workstation
18244|NCT03174262|Habit|habit
18245|NCT03174262|Self-efficacy|self-efficacy
18246|NCT03174262|Knowledge|knowledge
18247|NCT03174249|Behavioural therapy|behavioural therapy
18248|NCT03174249|Exposure in vivo|exposure in vivo
18249|NCT03174249|Cortical reorganisation|cortical reorganisation
18250|NCT03174249|Mirror therapy|mirror therapy
18251|NCT03174210|COPD|copd
18252|NCT03174210|supplemental oxygen|supplemental oxygen
18253|NCT03174210|oxygen concentrator|oxygen concentrator
18254|NCT03174197|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
18255|NCT03174197|Glioblastoma (GBM)|glioblastoma (gbm)
18257|NCT03174197|Gliosarcoma|gliosarcoma
18258|NCT03174197|Temozolomide|temozolomide
18259|NCT03174197|Temodar|temodar
18261|NCT03174197|Atezolizumab|atezolizumab
18262|NCT03174197|MPDL3280A|mpdl3280a
18263|NCT03174197|Radiation therapy|radiation therapy
18264|NCT03174197|External beam|external beam
18265|NCT03174197|XRT|xrt
18266|NCT03174171|Everolimus, mTor inhibitor|everolimus, mtor inhibitor
18267|NCT03174158|text messaging|text messaging
18268|NCT03174093|Mobile Health|mobile health
18269|NCT03174080|Positron-Emission|positron-emission
18270|NCT03174080|PET Scan Tomography|pet scan tomography
18271|NCT03174067|buprenorphine|buprenorphine
18272|NCT03174067|emergency department|emergency department
18273|NCT03174054|Men aged 40 and over|men aged 40 and over
18274|NCT03174054|multi parametric MRI|multi parametric mri
18275|NCT03174015|Sanitation|sanitation
18276|NCT03174015|Demand|demand
18277|NCT03174015|Peri-urban|peri-urban
18278|NCT03174015|Behavior Change|behavior change
18279|NCT03174015|Lusaka|lusaka
18280|NCT03174015|Zambia|zambia
18281|NCT03174002|Oxygenation|oxygenation
18282|NCT03174002|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
18283|NCT03174002|Mechanical ventilation|mechanical ventilation
18284|NCT03174002|Critical illness|critical illness
18285|NCT03174002|Critical care|critical care
18286|NCT03173989|osteoarthritis|osteoarthritis
18287|NCT03173989|hand deformities|hand deformities
18288|NCT03173989|hand strength|hand strength
18289|NCT03173989|assistive technology|assistive technology
18291|NCT03173989|health education|health education
18297|NCT03173950|Immunotherapy|immunotherapy
18298|NCT03173950|Anti-PD-1 Antibody|anti-pd-1 antibody
18299|NCT03173950|Brain Tumors|brain tumors
18300|NCT03173950|MDASI-BT|mdasi-bt
18301|NCT03173950|Spinal Cord Tumors|spinal cord tumors
18302|NCT03173937|Haploidentical|haploidentical
18303|NCT03173937|Nonmyeloablative|nonmyeloablative
18309|NCT03173911|Balance|balance
18310|NCT03173911|Postural control|postural control
18311|NCT03173911|Elastic Bandages|elastic bandages
18312|NCT03173911|Force plate|force plate
18313|NCT03173898|PDL Injection; Infiltration; Anesthesia; Extraction|pdl injection; infiltration; anesthesia; extraction
18314|NCT03173872|Reiki|reiki
18315|NCT03173872|Chronic Pain|chronic pain
18316|NCT03173872|Military|military
18317|NCT03173859|prostate cancer, abiraterone, apalutamide|prostate cancer, abiraterone, apalutamide
18318|NCT03173846|neurofeedback|neurofeedback
18319|NCT03173846|episodic memory|episodic memory
18320|NCT03173846|real-time functional MRI|real-time functional mri
18321|NCT03173833|cancer patients, quality of life|cancer patients, quality of life
18322|NCT03173820|tacrolimus|tacrolimus
18323|NCT03173820|transplantation|transplantation
18324|NCT03173820|CYP3A5|cyp3a5
18325|NCT03173820|genotype|genotype
18326|NCT03173768|intravenous antibiotics|intravenous antibiotics
18327|NCT03173768|appropriateness|appropriateness
18328|NCT03173768|outpatient antimicrobial therapy|outpatient antimicrobial therapy
18329|NCT03173716|DEFINITY contrast|definity contrast
18330|NCT03173677|Mononuclear cells|mononuclear cells
18331|NCT03173677|Whey proteins|whey proteins
18332|NCT03173677|Metabolically-Activated Macrophage|metabolically-activated macrophage
18333|NCT03173677|Macrophage Polarization|macrophage polarization
18334|NCT03173677|Macronutrients|macronutrients
18335|NCT03173638|acute non arteritic anterior ischemic optic neuropathy|acute non arteritic anterior ischemic optic neuropathy
18336|NCT03173638|mesenchymal stem cells|mesenchymal stem cells
18337|NCT03173638|intravitreal injection|intravitreal injection
18338|NCT03173638|safety|safety
18339|NCT03173599|Chronic Hepatitis B|chronic hepatitis b
18340|NCT03173586|Sugar sweetened beverage, biomarker|sugar sweetened beverage, biomarker
18341|NCT03173573|Cystic Fibrosis|cystic fibrosis
18342|NCT03173560|Renal Cell Carcinoma|renal cell carcinoma
18343|NCT03173560|lenvatinib|lenvatinib
18344|NCT03173560|everolimus|everolimus
18345|NCT03173560|E7080|e7080
18346|NCT03173560|VEGF-targeted treatment|vegf-targeted treatment
18347|NCT03173508|right ventricular function|right ventricular function
18348|NCT03173508|echocardiography|echocardiography
18349|NCT03173508|obstructive airway disease|obstructive airway disease
18350|NCT03173508|emphysema|emphysema
18351|NCT03173508|acetazolamide|acetazolamide
18352|NCT03173508|altitude|altitude
18353|NCT03173495|fat metabolism|fat metabolism
18354|NCT03173495|fructose|fructose
18355|NCT03173495|exercise|exercise
18356|NCT03173456|acute pain|acute pain
18357|NCT03173456|musculoskeletal pain|musculoskeletal pain
18358|NCT03173456|emergency medicine|emergency medicine
18359|NCT03173456|Emergency Service, Hospital|emergency service, hospital
18360|NCT03173456|analgesics|analgesics
18361|NCT03173456|Acetaminophen|acetaminophen
18362|NCT03173456|Ibuprofen|ibuprofen
18363|NCT03173456|oxycodone|oxycodone
18364|NCT03173456|hydrocodone|hydrocodone
18365|NCT03173456|codeine|codeine
18366|NCT03173456|adult|adult
18367|NCT03173443|Fiberoptic intubation|fiberoptic intubation
18368|NCT03173443|double lumen tube|double lumen tube
18369|NCT03173391|GKA|gka
18370|NCT03173391|T2DM|t2dm
18371|NCT03173391|HMS5552|hms5552
18372|NCT03173391|mono therapy|mono therapy
18373|NCT03173365|Hand-foot Syndrome|hand-foot syndrome
18374|NCT03173365|Brimonidine|brimonidine
18375|NCT03173365|Mirvaso|mirvaso
18376|NCT03173365|palmar-plantar erythrodysesthesia syndrome|palmar-plantar erythrodysesthesia syndrome
18377|NCT03173365|Brimonidine Tartrate|brimonidine tartrate
18378|NCT03173352|Hemangioma|hemangioma
18379|NCT03173339|intubation|intubation
18380|NCT03173339|pharyngitis|pharyngitis
18381|NCT03173339|remifentanil|remifentanil
18382|NCT03173313|Hypothermia|hypothermia
18383|NCT03173313|Acute Myocardial Infarction|acute myocardial infarction
18384|NCT03173313|AMI|ami
18385|NCT03173313|PCI|pci
18386|NCT03173313|Therapeutic Hypothermia|therapeutic hypothermia
18387|NCT03173300|PMM2-CDG|pmm2-cdg
18388|NCT03173300|CDG-Ia|cdg-ia
18389|NCT03173287|Hepatic fibrosis|hepatic fibrosis
18390|NCT03173287|IVIM|ivim
18391|NCT03173287|1.5T MRI|1.5t mri
18392|NCT03173248|Acute Myeloid Leukemia|acute myeloid leukemia
18393|NCT03173248|Leukemia|leukemia
18394|NCT03173248|Azacitidine|azacitidine
18395|NCT03173248|AG-120|ag-120
18396|NCT03173248|ivosidenib|ivosidenib
18397|NCT03173209|school|school
18398|NCT03173196|severe sepsis|severe sepsis
18399|NCT03173196|encephalopathy|encephalopathy
18400|NCT03173170|Drug Therapy|drug therapy
18402|NCT03173144|Diet|diet
18403|NCT03173144|Food|food
18404|NCT03173144|Exercise|exercise
18405|NCT03173144|Treatment Outcome|treatment outcome
18406|NCT03173144|Biomarkers|biomarkers
18407|NCT03173144|Smoking|smoking
18408|NCT03173105|Visually Impaired Persons|visually impaired persons
18409|NCT03173105|Postural Balance|postural balance
18410|NCT03173105|Rehabilitation|rehabilitation
18411|NCT03173105|Transcranial Direct Current Stimulation|transcranial direct current stimulation
18412|NCT03173092|Drug therapy|drug therapy
18413|NCT03173053|S. aureus|s. aureus
18414|NCT03173053|Home Parenteral Nutrition|home parenteral nutrition
18415|NCT03173053|Intestinal failure|intestinal failure
18417|NCT03173053|Decolonization|decolonization
18418|NCT03173040|Traditional Chinese medicine|traditional chinese medicine
18419|NCT03173040|Niu Bang Zi pill|niu bang zi pill
18420|NCT03173040|methotrexate|methotrexate
18421|NCT03173040|active rheumatoid arthritis|active rheumatoid arthritis
18422|NCT03173001|intestinal helminths; protozoan infections;|intestinal helminths; protozoan infections;
18423|NCT03173001|colorectal cancer; chemotherapy; cancer pathogenesis;|colorectal cancer; chemotherapy; cancer pathogenesis;
18424|NCT03172988|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
18425|NCT03172988|Surgery|surgery
18426|NCT03172988|Dexamethasone|dexamethasone
18624|NCT03171610|fentanyl|fentanyl
18427|NCT03172988|Flurbiprofen axetil|flurbiprofen axetil
18428|NCT03172988|Long-term survival|long-term survival
18429|NCT03172975|Controlled infection|controlled infection
18430|NCT03172975|Na-GST-1|na-gst-1
18431|NCT03172975|Hookworm vaccine|hookworm vaccine
18432|NCT03172936|injected lesion|injected lesion
18433|NCT03172936|distal lesion|distal lesion
18434|NCT03172936|abscopal activity|abscopal activity
10318|NCT03225001|TAVR|tavr
18435|NCT03172936|intratumoral|intratumoral
18436|NCT03172936|checkpoint inhibitor|checkpoint inhibitor
18437|NCT03172936|cyclic dinucleotide|cyclic dinucleotide
18438|NCT03172936|programmed cell death|programmed cell death
18440|NCT03172910|Ciraparantag|ciraparantag
18441|NCT03172910|Whole Blood Clotting Time (WBCT)|whole blood clotting time (wbct)
18442|NCT03172910|Rivaroxaban|rivaroxaban
18443|NCT03172897|Adult|adult
18444|NCT03172897|Intensive care unit|intensive care unit
18445|NCT03172897|Mechanical ventilation|mechanical ventilation
18446|NCT03172897|Delirium|delirium
18447|NCT03172897|Dexmedetomidine|dexmedetomidine
18448|NCT03172884|Renal Impairment|renal impairment
18449|NCT03172884|Pharmacokinetics|pharmacokinetics
18450|NCT03172871|Schizophrenia|schizophrenia
18451|NCT03172871|Aripiprazole Intramuscular Depot|aripiprazole intramuscular depot
18452|NCT03172871|Acute treatment|acute treatment
18453|NCT03172858|cervical ripening|cervical ripening
18454|NCT03172858|term premature rupture of membrane|term premature rupture of membrane
18455|NCT03172858|intracervical balloon catheter|intracervical balloon catheter
18456|NCT03172845|coronary bifurcation lesion|coronary bifurcation lesion
18457|NCT03172845|optical coherence tomography|optical coherence tomography
18458|NCT03172845|vulnerable plaque|vulnerable plaque
18459|NCT03172793|telavancin|telavancin
18460|NCT03172793|lipoglycopeptide|lipoglycopeptide
18461|NCT03172793|MRSA|mrsa
18462|NCT03172793|pharmacokinetics|pharmacokinetics
18463|NCT03172767|Preterm|preterm
18464|NCT03172767|Sensory processing|sensory processing
18465|NCT03172767|School Readiness|school readiness
18466|NCT03172741|Cannabis|cannabis
18467|NCT03172715|Open reduction internal fixation|open reduction internal fixation
18468|NCT03172715|Arthroplasty|arthroplasty
18469|NCT03172715|Surgery|surgery
18470|NCT03172715|Randomized controlled trial|randomized controlled trial
18471|NCT03172663|obesity|obesity
18472|NCT03172624|Nivolumab|nivolumab
18473|NCT03172624|Ipilimumab|ipilimumab
18474|NCT03172624|17-219|17-219
18475|NCT03172572|minimally invasive surgical procedures|minimally invasive surgical procedures
18476|NCT03172572|pancreas surgery|pancreas surgery
18477|NCT03172572|pancreatoduodenectomy|pancreatoduodenectomy
18478|NCT03172559|Stereotactic body radiotherapy|stereotactic body radiotherapy
18479|NCT03172559|SBRT|sbrt
18480|NCT03172559|Radiotherapy|radiotherapy
18481|NCT03172559|Bridging therapy|bridging therapy
18482|NCT03172559|Transplant|transplant
18483|NCT03172546|direct oral anticoagulant|direct oral anticoagulant
18484|NCT03172546|hemorrhagic complication|hemorrhagic complication
18485|NCT03172546|thrombotic complication|thrombotic complication
18486|NCT03172546|genetic polymorphisms|genetic polymorphisms
18487|NCT03172533|anorexia nervosa|anorexia nervosa
18488|NCT03172533|estrogen|estrogen
18489|NCT03172533|psychotherapy|psychotherapy
18490|NCT03172533|cortisol|cortisol
18491|NCT03172533|appetite regulation|appetite regulation
18492|NCT03172533|neurocognitive performance|neurocognitive performance
18493|NCT03172533|eating disorder|eating disorder
18494|NCT03172533|sexual hormone|sexual hormone
18496|NCT03172507|Hematopoietic Stem Cells|hematopoietic stem cells
18497|NCT03172442|Class III treatment|class iii treatment
18498|NCT03172442|orthodontic removable traction appliance|orthodontic removable traction appliance
18499|NCT03172442|RCT|rct
18500|NCT03172429|pulmonary hypertension|pulmonary hypertension
18501|NCT03172429|cerebral tissue oxygenation|cerebral tissue oxygenation
18502|NCT03172429|disease progression|disease progression
18503|NCT03172429|hypoxia|hypoxia
18504|NCT03172416|Gastric Cancer|gastric cancer
18505|NCT03172416|Unresectable Peritoneal Carcinomatosis|unresectable peritoneal carcinomatosis
18506|NCT03172416|Oxaliplatin|oxaliplatin
18507|NCT03172416|Pressurized intraperitoneal aerosol chemotherapy|pressurized intraperitoneal aerosol chemotherapy
18508|NCT03172403|Cachexia|cachexia
18509|NCT03172403|Colon cancer|colon cancer
18510|NCT03172403|Myostatin|myostatin
18511|NCT03172403|Skeletal muscle|skeletal muscle
18714|NCT03170947|Foot|foot
18512|NCT03172390|Ascending aorta aneurysm|ascending aorta aneurysm
18513|NCT03172390|Aortic wall shear stress|aortic wall shear stress
18514|NCT03172390|4D phase contrast Cardiovascular Magnetic Resonance|4d phase contrast cardiovascular magnetic resonance
18515|NCT03172390|Aortic dissection|aortic dissection
18516|NCT03172377|adalimumab|adalimumab
18517|NCT03172377|anti-TNF|anti-tnf
18518|NCT03172377|Humira|humira
18519|NCT03172377|interval lengthening|interval lengthening
18520|NCT03172377|dosing interval|dosing interval
18521|NCT03172377|inflammatory bowel disease|inflammatory bowel disease
18522|NCT03172377|antidrug antibodies|antidrug antibodies
18523|NCT03172377|trough levels|trough levels
18524|NCT03172377|pharmacokinetics|pharmacokinetics
18525|NCT03172377|immunogenicity|immunogenicity
18526|NCT03172377|cost-effectiveness|cost-effectiveness
18527|NCT03172377|dose reduction|dose reduction
18528|NCT03172312|Intraoperative Parathyroid Scores System|intraoperative parathyroid scores system
17634|NCT03178422|NRT|nrt
18529|NCT03172312|total thyroidectomy|total thyroidectomy
18530|NCT03172312|thyroid cancer|thyroid cancer
18531|NCT03172312|hypoparathyroidism|hypoparathyroidism
18532|NCT03172312|prediction|prediction
18533|NCT03172273|Liver Cirrhosis|liver cirrhosis
18534|NCT03172273|Transjugular Intrahepatic Portosystemic shunt|transjugular intrahepatic portosystemic shunt
18535|NCT03172273|Refractory ascites|refractory ascites
18536|NCT03172247|cardiology diabetes|cardiology diabetes
18537|NCT03172234|β-endorphins,laryngoscopy and tracheal intubation|β-endorphins,laryngoscopy and tracheal intubation
18538|NCT03172221|malaria|malaria
18539|NCT03172221|pregnancy|pregnancy
18540|NCT03172221|diagnosis|diagnosis
18541|NCT03172221|low-transmission|low-transmission
18542|NCT03172221|Plasmodium falciparum|plasmodium falciparum
18543|NCT03172221|rapid diagnostic test|rapid diagnostic test
18544|NCT03172195|ulcerative colitis|ulcerative colitis
18545|NCT03172195|inflammation|inflammation
18546|NCT03172195|immunosuppressive drugs|immunosuppressive drugs
18547|NCT03172195|herpesvirus|herpesvirus
18548|NCT03172195|qPCR|qpcr
18549|NCT03172195|colonic mucosa|colonic mucosa
18550|NCT03172156|NSCLC|nsclc
18551|NCT03172156|stage I|stage i
18552|NCT03172156|The next generation of high-throughput gene sequencing (NGS)|the next generation of high-throughput gene sequencing (ngs)
18553|NCT03172156|ctDNA|ctdna
18554|NCT03172130|Obstructive Sleep Apnea|obstructive sleep apnea
18555|NCT03172130|CPAP|cpap
18556|NCT03172091|Lung transplant|lung transplant
18557|NCT03172091|Acute resection|acute resection
18558|NCT03172091|Volatile Organic Compounds|volatile organic compounds
18559|NCT03172078|advanced endoscopic procedure|advanced endoscopic procedure
18560|NCT03172078|ERCP|ercp
18561|NCT03172078|EUS|eus
18562|NCT03172078|target-controlled infusion|target-controlled infusion
18563|NCT03172078|sedation|sedation
18564|NCT03172078|propofol|propofol
18565|NCT03172039|hemodialysis|hemodialysis
18566|NCT03172039|antimicrobial stewardship|antimicrobial stewardship
18567|NCT03172039|antimicrobial agents|antimicrobial agents
18568|NCT03172039|bacterial infections|bacterial infections
18569|NCT03172039|ambulatory care|ambulatory care
18570|NCT03172026|Telerehabilitation|telerehabilitation
18571|NCT03172026|Maraviroc|maraviroc
18572|NCT03171987|lidocaine patch|lidocaine patch
18573|NCT03171987|flurbiprofen patch|flurbiprofen patch
18574|NCT03171987|acute back pain|acute back pain
18575|NCT03171974|breast capsular contructure|breast capsular contructure
18576|NCT03171961|weight loss|weight loss
18577|NCT03171961|Diet|diet
18578|NCT03171961|online visit|online visit
18579|NCT03171961|clinic visit|clinic visit
18580|NCT03171948|almond|almond
18581|NCT03171948|weight loss|weight loss
18582|NCT03171948|Weight maintenance|weight maintenance
18583|NCT03171948|hypoenergetic diet|hypoenergetic diet
18584|NCT03171922|weight loss|weight loss
18585|NCT03171922|internet-based diet|internet-based diet
18586|NCT03171922|online dietary coach|online dietary coach
18587|NCT03171922|clinic visit approach|clinic visit approach
18588|NCT03171922|Diet|diet
18589|NCT03171792|Musculoskeletal pain|musculoskeletal pain
18590|NCT03171792|Adolescent|adolescent
21211|NCT03154931|CBT|cbt
18591|NCT03171792|Qualitative research|qualitative research
18592|NCT03171792|Attitude|attitude
18593|NCT03171792|Health professionals|health professionals
18594|NCT03171740|Emergence Delirium|emergence delirium
18595|NCT03171740|Emergence Agitation|emergence agitation
18596|NCT03171740|premedication|premedication
18597|NCT03171740|dexmedetomidine|dexmedetomidine
18598|NCT03171740|midazolam|midazolam
18599|NCT03171714|Drainage Catheter|drainage catheter
18600|NCT03171688|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
18601|NCT03171688|cesarean|cesarean
18602|NCT03171688|risk factors|risk factors
18603|NCT03171675|Chronic Periodontitis|chronic periodontitis
18604|NCT03171675|Preterm Labor|preterm labor
18605|NCT03171675|Preterm Birth|preterm birth
18606|NCT03171675|Interleukin-17|interleukin-17
18607|NCT03171675|IL-17|il-17
18608|NCT03171675|Periodontal Disease|periodontal disease
18609|NCT03171675|Periodontitis|periodontitis
18610|NCT03171675|Periodontal risk factors|periodontal risk factors
18611|NCT03171675|Medical risk factors|medical risk factors
18612|NCT03171649|rehabilitation|rehabilitation
18613|NCT03171649|exoskeleton|exoskeleton
18614|NCT03171649|functional electrical stimulation|functional electrical stimulation
18615|NCT03171649|upper limb|upper limb
18616|NCT03171649|sub-acute|sub-acute
18617|NCT03171649|motor re-learning|motor re-learning
18618|NCT03171623|T2DM|t2dm
18619|NCT03171623|Diabetes|diabetes
18620|NCT03171623|GKA|gka
18621|NCT03171610|laparoscopic nephrectomy|laparoscopic nephrectomy
18622|NCT03171610|Patient-controlled analgesia (PCA)|patient-controlled analgesia (pca)
18625|NCT03171597|Unstable Angina|unstable angina
610832|NCT00623857|Immunity|immunity
18626|NCT03171597|Traditional Chinese Medicine|traditional chinese medicine
10523|NCT03223649|Insulin|insulin
18627|NCT03171571|eating Behavior|eating behavior
18628|NCT03171571|Volunteers|volunteers
18629|NCT03171545|Peer Mentoring|peer mentoring
18630|NCT03171545|Team Training|team training
18631|NCT03171545|Checklist|checklist
18632|NCT03171532|ACL|acl
18633|NCT03171519|Physical activity|physical activity
18634|NCT03171519|Disorders of onset and maintenance of sleep|disorders of onset and maintenance of sleep
18635|NCT03171519|non-pharmacological treatment|non-pharmacological treatment
18636|NCT03171519|Acupuncture|acupuncture
18637|NCT03171506|ketogenic diet|ketogenic diet
18638|NCT03171506|carbohydrate-restricted diet|carbohydrate-restricted diet
18639|NCT03171493|Bladder cancer, Radical cystectomy|bladder cancer, radical cystectomy
18640|NCT03171480|Preeclampsia|preeclampsia
18641|NCT03171480|Induction|induction
18642|NCT03171454|hysteroscopic operation|hysteroscopic operation
18643|NCT03171454|intrauterine balloon|intrauterine balloon
18644|NCT03171454|adhesions|adhesions
18645|NCT03171415|Obesity|obesity
18646|NCT03171415|Overweight|overweight
18647|NCT03171415|Thermogenesis|thermogenesis
18648|NCT03171415|Fat reduction|fat reduction
18649|NCT03171389|GIST|gist
18650|NCT03171389|KIT secondary mutation|kit secondary mutation
18651|NCT03171389|ponatinib|ponatinib
18652|NCT03171376|Root canal treatment|root canal treatment
18653|NCT03171376|Coronal leakage|coronal leakage
18654|NCT03171376|Intraorifice barrier|intraorifice barrier
18655|NCT03171363|Attention bias modification treatment|attention bias modification treatment
18656|NCT03171363|Anxiety disorders|anxiety disorders
18657|NCT03171363|Attention training|attention training
18658|NCT03171337|Chronic tension-type headache|chronic tension-type headache
18659|NCT03171337|Acupuncture|acupuncture
18660|NCT03171337|Fu's subcutaneous needling(FSN)|fu's subcutaneous needling(fsn)
18661|NCT03171337|fMRI|fmri
18662|NCT03171337|Regional homogeneity (ReHo)|regional homogeneity (reho)
18663|NCT03171246|dietary intervention|dietary intervention
18664|NCT03171220|Neoantigen|neoantigen
18665|NCT03171220|Neoantigen Reactive T cells (NRTs)|neoantigen reactive t cells (nrts)
18666|NCT03171220|PD-1 Inhibitor|pd-1 inhibitor
18667|NCT03171220|Advanced Solid Tumor|advanced solid tumor
18668|NCT03171220|Adoptive Cell Therapy(ACT)|adoptive cell therapy(act)
18669|NCT03171220|PD-1 antibody|pd-1 antibody
18670|NCT03171220|SHR1210|shr1210
18671|NCT03171207|Gait Therapy|gait therapy
18672|NCT03171194|Lupus|lupus
18673|NCT03171194|Stem Cell|stem cell
18674|NCT03171194|Systemic Lupus Erythematosus|systemic lupus erythematosus
18675|NCT03171181|Spatial cognition, vestibular system, motor control|spatial cognition, vestibular system, motor control
18676|NCT03171168|Gait Analysis|gait analysis
18677|NCT03171168|WOMAC|womac
18678|NCT03171168|SF-36|sf-36
18679|NCT03171142|Heliox|heliox
18680|NCT03171129|Respiratory Distress|respiratory distress
18681|NCT03171129|Nasal CPAP|nasal cpap
18682|NCT03171129|high flow nasal canula|high flow nasal canula
18683|NCT03171116|ghrelin|ghrelin
18684|NCT03171116|obestatin|obestatin
18685|NCT03171116|children|children
18686|NCT03171064|Exercise|exercise
18687|NCT03171064|Cancer|cancer
18688|NCT03171064|Melanoma|melanoma
18689|NCT03171064|Feasibility|feasibility
18690|NCT03171064|PD-1 antibodies|pd-1 antibodies
18691|NCT03171064|Checkpoint inhibitors|checkpoint inhibitors
18692|NCT03171064|Immune system|immune system
18693|NCT03171038|Telemonitoring|telemonitoring
18694|NCT03171038|Chronic Heart Failure|chronic heart failure
18696|NCT03171038|Mortality|mortality
18697|NCT03171025|Muscle Invasive|muscle invasive
18698|NCT03171012|Muscle Stretching Exercises|muscle stretching exercises
18699|NCT03170999|China|china
18700|NCT03170999|Cognitive testing|cognitive testing
18701|NCT03170999|COPD exacerbation|copd exacerbation
18702|NCT03170999|CERT|cert
18703|NCT03170973|Obesity|obesity
18704|NCT03170973|Motor Activity|motor activity
18705|NCT03170973|Fatty acids|fatty acids
18706|NCT03170973|Lipid|lipid
18707|NCT03170960|Kidney|kidney
18708|NCT03170960|Bladder|bladder
18709|NCT03170960|Renal pelvis|renal pelvis
18710|NCT03170960|Ureter|ureter
18711|NCT03170960|Urethra|urethra
18712|NCT03170960|Cancer|cancer
18713|NCT03170947|Rheumatoid arthritis|rheumatoid arthritis
18715|NCT03170947|Insoles|insoles
18716|NCT03170947|Quality of life|quality of life
18717|NCT03170947|Physical Activity|physical activity
18718|NCT03170895|FLT3-ITD (+) Acute Myeloid Leukemia (AML)|flt3-itd (+) acute myeloid leukemia (aml)
18719|NCT03170882|Drug therapy|drug therapy
18720|NCT03170778|Congenital Heart Disease|congenital heart disease
18721|NCT03170778|CHD|chd
18722|NCT03170778|Fontan|fontan
18723|NCT03170752|RCT, Cardiovascular Risk Factors, Screening|rct, cardiovascular risk factors, screening
18724|NCT03170739|dexmedetomidine|dexmedetomidine
18725|NCT03170739|dopamine|dopamine
18726|NCT03170739|surgery|surgery
18826|NCT03169985|Rosuvastatin|rosuvastatin
18729|NCT03170726|Third molar tooth surgery|third molar tooth surgery
18730|NCT03170713|Preemptive intravenous ibuprofen|preemptive intravenous ibuprofen
18732|NCT03170713|edema|edema
18733|NCT03170713|Third molar tooth extraction|third molar tooth extraction
18734|NCT03170713|Antiinflammatory effect|antiinflammatory effect
18735|NCT03170700|preschool|preschool
18736|NCT03170700|eating behaviors|eating behaviors
18737|NCT03170700|family|family
18738|NCT03170648|Acupuncture|acupuncture
18739|NCT03170648|Breast Cancer|breast cancer
18740|NCT03170635|recess, occupational therapy|recess, occupational therapy
18741|NCT03170622|children|children
18742|NCT03170622|paediatrics|paediatrics
18743|NCT03170622|faecal volitile organic compounds|faecal volitile organic compounds
18744|NCT03170622|diagnosis|diagnosis
18745|NCT03170622|pathogenesis|pathogenesis
18746|NCT03170583|bradycardia, pacemaker, MRI scan|bradycardia, pacemaker, mri scan
18747|NCT03170570|recurrent cervical cancer|recurrent cervical cancer
18748|NCT03170570|re-irradiation|re-irradiation
18749|NCT03170570|intensity-modulated raditherapy|intensity-modulated raditherapy
18750|NCT03170557|Persistent pain|persistent pain
18751|NCT03170557|Spinal cord injury|spinal cord injury
18752|NCT03170557|Acupuncture|acupuncture
18753|NCT03170557|Randomized Controlled Trial|randomized controlled trial
18756|NCT03170531|MR imaging|mr imaging
18757|NCT03170531|17-267|17-267
18758|NCT03170505|cleft palate|cleft palate
18759|NCT03170466|Palliative care|palliative care
18760|NCT03170453|Autism|autism
18761|NCT03170453|Autism Spectrum Disorder|autism spectrum disorder
18762|NCT03170453|Asperger's Syndrome|asperger's syndrome
18763|NCT03170453|Pervasive Developmental Disorder|pervasive developmental disorder
18764|NCT03170453|Cognition|cognition
18765|NCT03170453|Social Cognition|social cognition
18766|NCT03170453|Psychosocial Treatment|psychosocial treatment
18767|NCT03170453|Cognitive Enhancement Therapy|cognitive enhancement therapy
18768|NCT03170453|Enriched Supportive Therapy|enriched supportive therapy
18769|NCT03170453|Therapy|therapy
18770|NCT03170453|Psychotherapy|psychotherapy
18771|NCT03170440|Sleep|sleep
18772|NCT03170440|Vagal nerve stimulation|vagal nerve stimulation
18773|NCT03170414|HIV|hiv
18774|NCT03170414|Kidney Transplant|kidney transplant
18775|NCT03170414|Liver Transplant|liver transplant
18776|NCT03170414|Transplant|transplant
18777|NCT03170414|HOPE Act|hope act
18778|NCT03170375|obesity|obesity
18779|NCT03170375|sodium|sodium
18780|NCT03170375|DASH diet|dash diet
18781|NCT03170375|hypertension|hypertension
18782|NCT03170375|vascular stiffness|vascular stiffness
18783|NCT03170375|diastolic function|diastolic function
18784|NCT03170362|Treatment|treatment
18785|NCT03170362|Pharmacogenetics|pharmacogenetics
18786|NCT03170362|Depression|depression
18787|NCT03170271|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
18788|NCT03170271|Additional relevant MeSH terms:|additional relevant mesh terms:
18789|NCT03170271|Asthma|asthma
18790|NCT03170271|Inflammation|inflammation
18791|NCT03170271|Bronchial Diseases|bronchial diseases
18792|NCT03170271|Respiratory Tract Diseases|respiratory tract diseases
18793|NCT03170271|Lung Diseases, Obstructive|lung diseases, obstructive
18794|NCT03170271|Lung Diseases Respiratory Hypersensitivity|lung diseases respiratory hypersensitivity
21445|NCT03153371|MRI|mri
18798|NCT03170271|Pathologic Processes|pathologic processes
18803|NCT03170232|HRQoL|hrqol
18804|NCT03170232|Disease Progression|disease progression
18805|NCT03170232|Danirixin|danirixin
18806|NCT03170232|COPD|copd
18807|NCT03170206|Lung Cancer|lung cancer
18808|NCT03170141|CAR T|car t
18809|NCT03170141|EGFRviii|egfrviii
18810|NCT03170141|GBM|gbm
18811|NCT03170141|PDL1|pdl1
18812|NCT03170141|PD1|pd1
18813|NCT03170115|Rectal Cancer|rectal cancer
18814|NCT03170115|Total neoadjuvant therapy|total neoadjuvant therapy
18815|NCT03170115|Induction chemotherapy|induction chemotherapy
18816|NCT03170115|Aspirin colorectal cancer|aspirin colorectal cancer
18817|NCT03170102|occupational therapy|occupational therapy
18818|NCT03170089|oral-health-awareness, Diabetes|oral-health-awareness, diabetes
18819|NCT03170076|skin manifestations - hepatitis c virus|skin manifestations - hepatitis c virus
18820|NCT03170063|Parkinson's Disease|parkinson's disease
18821|NCT03170063|Alpha-Synuclein|alpha-synuclein
18822|NCT03170063|Biomarker|biomarker
18823|NCT03170011|Cardiac rehabilitation|cardiac rehabilitation
18824|NCT03170011|Sit to Stand|sit to stand
18825|NCT03170011|Function|function
18827|NCT03169985|Ezetimibe|ezetimibe
18828|NCT03169985|Atherosclerotic plaque|atherosclerotic plaque
18829|NCT03169985|Intravascular ultrasound|intravascular ultrasound
18830|NCT03169959|Anti-diabetic|anti-diabetic
18831|NCT03169959|Anti-hyperglycemic agents|anti-hyperglycemic agents
18832|NCT03169959|Bioequivalence|bioequivalence
402897|NCT01229254|nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
402898|NCT01229241|local anesthetic|local anesthetic
18833|NCT03169959|Fixed-Combination Drug Product (FCDP) of saxagliptin / dapagliflozin / metformin extended-release (XR).|fixed-combination drug product (fcdp) of saxagliptin / dapagliflozin / metformin extended-release (xr).
18834|NCT03169959|Fed-state bioequivalence (BE)|fed-state bioequivalence (be)
18835|NCT03169959|XIGDUO® XR|xigduo® xr
18836|NCT03169959|ONGLYZA®|onglyza®
18837|NCT03169933|adjuvant|adjuvant
18838|NCT03169933|androgen suppressive therapy|androgen suppressive therapy
18839|NCT03169933|literature review|literature review
18840|NCT03169933|phase II|phase ii
18841|NCT03169933|prostate neoplasms|prostate neoplasms
18842|NCT03169933|radiotherapy|radiotherapy
18843|NCT03169907|Cardiac functions|cardiac functions
18844|NCT03169907|Intrauterine fetal anemia|intrauterine fetal anemia
18845|NCT03169907|Intrauterine Fetal blood transfusion|intrauterine fetal blood transfusion
18846|NCT03169907|Myocardial performance index|myocardial performance index
18847|NCT03169907|spatiotemporal imaging correlation|spatiotemporal imaging correlation
18848|NCT03169868|clinical decision support|clinical decision support
18849|NCT03169868|drug levels in blood|drug levels in blood
18850|NCT03169868|therapeutic drug monitoring|therapeutic drug monitoring
18851|NCT03169868|medication adherence|medication adherence
18852|NCT03169868|medication therapy management|medication therapy management
18853|NCT03169855|Traffic Ophthalmology|traffic ophthalmology
18854|NCT03169855|Glare|glare
18855|NCT03169855|Cataract|cataract
18856|NCT03169855|Nighttime driving|nighttime driving
18857|NCT03169855|contrast sensitivity|contrast sensitivity
18858|NCT03169855|mesopic vision|mesopic vision
18859|NCT03169829|Hemodialysis|hemodialysis
18860|NCT03169829|Renal Disease|renal disease
18861|NCT03169803|Electrical Stimulation Therapy|electrical stimulation therapy
18862|NCT03169803|Electrodes|electrodes
18863|NCT03169803|Parasympathetic Nervous System|parasympathetic nervous system
18864|NCT03169803|Sympathetic Fibers|sympathetic fibers
18865|NCT03169803|Post Ganglionic|post ganglionic
18866|NCT03169803|Congestive Heart Failure|congestive heart failure
18867|NCT03169803|Heart Failure|heart failure
18868|NCT03169673|Magnetic Resonance Imaging|magnetic resonance imaging
18869|NCT03169673|Pulmonary Function|pulmonary function
18870|NCT03169634|Failed knee replacement|failed knee replacement
18871|NCT03169634|loosening|loosening
18872|NCT03169634|wear|wear
18873|NCT03169634|reoperation|reoperation
18874|NCT03169621|Chronic Endometritis|chronic endometritis
18875|NCT03169621|Endometrial pathogens|endometrial pathogens
18876|NCT03169621|Microbiological diagnosis|microbiological diagnosis
18877|NCT03169621|Next Generation Sequencing|next generation sequencing
18878|NCT03169621|Metagenomics|metagenomics
18879|NCT03169621|Endometrial receptivity|endometrial receptivity
18880|NCT03169608|autonomic nervous system|autonomic nervous system
18881|NCT03169608|atrial fibrillation|atrial fibrillation
18882|NCT03169608|acute kidney injury|acute kidney injury
18883|NCT03169608|baroreflex sensitivity|baroreflex sensitivity
18884|NCT03169608|microcirculation|microcirculation
18885|NCT03169608|coronary artery bypass graft|coronary artery bypass graft
18886|NCT03169569|hemostatic powder|hemostatic powder
18887|NCT03169569|post-ESD bleeding|post-esd bleeding
18888|NCT03169569|antithrombotic therapy|antithrombotic therapy
18889|NCT03169569|high risk of bleeding|high risk of bleeding
18890|NCT03169569|endoscopic submucosal dissection|endoscopic submucosal dissection
18892|NCT03169556|Intubation|intubation
18893|NCT03169556|light wand|light wand
18894|NCT03169556|video laryngoscopy|video laryngoscopy
18895|NCT03169556|cervical spine immobilization|cervical spine immobilization
18896|NCT03169530|cardiovascular, alcohol, diabetes|cardiovascular, alcohol, diabetes
18897|NCT03169517|Peripheral nerve block|peripheral nerve block
18898|NCT03169517|laser speckle contrast imaging|laser speckle contrast imaging
18899|NCT03169517|blood flow index|blood flow index
18900|NCT03169504|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
18901|NCT03169504|Acupuncture Therapy|acupuncture therapy
18902|NCT03169504|Humans|humans
18903|NCT03169491|Sleep Apnea, Obstructive|sleep apnea, obstructive
18904|NCT03169491|Child|child
18905|NCT03169491|Continuous Positive Airway Pressure|continuous positive airway pressure
18906|NCT03169491|Perioperative management|perioperative management
18907|NCT03169491|Adenotonsillectomy|adenotonsillectomy
18908|NCT03169491|Acoustic pharyngometry|acoustic pharyngometry
18909|NCT03169478|hysteroscopic myomectomy|hysteroscopic myomectomy
18910|NCT03169478|balloon dilatation|balloon dilatation
18911|NCT03169478|adhesions|adhesions
18912|NCT03169426|remote ischemic conditioning|remote ischemic conditioning
18913|NCT03169426|beta-blocker|beta-blocker
611213|NCT00625430|phase I|phase i
18914|NCT03169400|vascular calcification|vascular calcification
18915|NCT03169400|haemodialysis|haemodialysis
18916|NCT03169400|dialysis membrane|dialysis membrane
18917|NCT03169387|Virtual Reality Exposure Therapy|virtual reality exposure therapy
18918|NCT03169374|Virtual Reality|virtual reality
18919|NCT03169374|Mechanical Ventilation|mechanical ventilation
18920|NCT03169374|Anxiety|anxiety
402899|NCT01229241|epidural|epidural
10831|NCT03221868|women|women
18921|NCT03169309|complementary and alternative medicine|complementary and alternative medicine
18922|NCT03169309|military|military
18923|NCT03169309|binaural beat technology|binaural beat technology
18924|NCT03169309|brain entrainment technology|brain entrainment technology
18925|NCT03169309|sleep|sleep
18926|NCT03169296|Myelodysplastic syndrome|myelodysplastic syndrome
18927|NCT03169296|Mutations|mutations
18928|NCT03169296|Next-generation sequencing|next-generation sequencing
18929|NCT03169270|Exercise training|exercise training
18930|NCT03169270|Muscle dysfunction|muscle dysfunction
18931|NCT03169270|COPD|copd
18932|NCT03169257|paediatric obesity|paediatric obesity
18933|NCT03169257|cardiovascular dysfunction|cardiovascular dysfunction
18934|NCT03169257|metabolic syndrome|metabolic syndrome
18935|NCT03169257|adipokines|adipokines
18936|NCT03169257|inflammation|inflammation
18937|NCT03169257|oxidative stress|oxidative stress
18938|NCT03169218|Adult|adult
18939|NCT03169218|Chronic pain|chronic pain
18940|NCT03169218|Entrapment neuropathy. Carpal tunnel|entrapment neuropathy. carpal tunnel
18941|NCT03169218|Exercise therapy|exercise therapy
18942|NCT03169218|Humans|humans
18943|NCT03169218|Neuronal plasticity|neuronal plasticity
18944|NCT03169218|Mirror neurons|mirror neurons
18945|NCT03169218|Pain/cognitive aspects|pain/cognitive aspects
18946|NCT03169218|Physiotherapy|physiotherapy
18947|NCT03169218|Somatosensory cortex|somatosensory cortex
18948|NCT03169179|Physical activity|physical activity
18949|NCT03169179|Mobile health|mobile health
18950|NCT03169179|Wearable fitness technology|wearable fitness technology
18951|NCT03169179|Organisational wellness|organisational wellness
18952|NCT03169179|Occupational health|occupational health
18953|NCT03169179|Police force|police force
18954|NCT03169166|GnRH agonist|gnrh agonist
18955|NCT03169166|In Vitro fertilization|in vitro fertilization
18956|NCT03169166|Assisted Reproductive Technology|assisted reproductive technology
18957|NCT03169166|Follicule Maturation|follicule maturation
18958|NCT03169166|Pregnancy|pregnancy
18959|NCT03169153|contact lenses|contact lenses
18960|NCT03169153|lipids|lipids
18961|NCT03169153|deposits|deposits
18962|NCT03169140|pain management|pain management
18963|NCT03169140|topical analgesic|topical analgesic
18964|NCT03169140|acute low back pain|acute low back pain
18965|NCT03169140|kinesiology tape|kinesiology tape
18966|NCT03169127|Ibuprofen|ibuprofen
18967|NCT03169127|Lower third molar|lower third molar
18968|NCT03169127|Oral Surgery|oral surgery
18969|NCT03169114|Appendicitis|appendicitis
18970|NCT03169114|Surgery|surgery
18971|NCT03169114|Antibiotic therapy|antibiotic therapy
18972|NCT03169114|RIPASA Score|ripasa score
18973|NCT03169101|Smoking Cessation|smoking cessation
18974|NCT03169101|HIV|hiv
18975|NCT03169101|Cognition|cognition
18976|NCT03169088|eating Behavior|eating behavior
18977|NCT03169088|Volunteers|volunteers
18978|NCT03169075|Adapted physical ctivity|adapted physical ctivity
18979|NCT03169075|Oral targeted thérapy|oral targeted thérapy
18980|NCT03169075|Advanced cancer|advanced cancer
18981|NCT03169075|Fatigue|fatigue
18982|NCT03169075|Quality of life|quality of life
18983|NCT03169075|Randomized Study|randomized study
18984|NCT03169049|nerve conduction block|nerve conduction block
18986|NCT03169049|handgrip|handgrip
18987|NCT03169010|registry|registry
18988|NCT03169010|pulmonary hypertension|pulmonary hypertension
18989|NCT03169010|survival|survival
18990|NCT03169010|biomarker|biomarker
18991|NCT03169010|whole genome sequencing|whole genome sequencing
18992|NCT03168997|Alzheimer Disease Memantine|alzheimer disease memantine
18993|NCT03168984|Healthy Japanese subjects|healthy japanese subjects
18994|NCT03168984|Healthy Caucasian subjects|healthy caucasian subjects
18995|NCT03168984|UCB0942|ucb0942
18996|NCT03168971|Cancer|cancer
18997|NCT03168971|Anxiety|anxiety
18998|NCT03168971|Cognitive behavior therapy|cognitive behavior therapy
18999|NCT03168971|Elderly|elderly
19000|NCT03168971|Caregivers|caregivers
19001|NCT03168945|Active Case Finding|active case finding
19002|NCT03168906|Amyloidosis|amyloidosis
19003|NCT03168906|NEOD001|neod001
19004|NCT03168906|RAIN|rain
19005|NCT03168893|deep brain stimulation|deep brain stimulation
19006|NCT03168867|insulin dependent diabetes mellitus|insulin dependent diabetes mellitus
19007|NCT03168867|adolescents/young adults|adolescents/young adults
19008|NCT03168867|e-health intervention|e-health intervention
19009|NCT03168867|parental monitoring|parental monitoring
19010|NCT03168854|Anopheles stephensi|anopheles stephensi
19011|NCT03168854|GAP3KO|gap3ko
19012|NCT03168854|Malaria|malaria
19013|NCT03168854|Mosquitoes|mosquitoes
19014|NCT03168854|Plasmodium falciparum|plasmodium falciparum
19015|NCT03168815|HFNC|hfnc
19016|NCT03168815|Bronchoscopy|bronchoscopy
19017|NCT03168815|Hypoxia|hypoxia
19018|NCT03168815|Immunocompromised|immunocompromised
19019|NCT03168815|Hematological malignancy|hematological malignancy
10921|NCT03221244|Pediatric|pediatric
10922|NCT03221205|sleep apnea, obstructive|sleep apnea, obstructive
10923|NCT03221205|obesity|obesity
10924|NCT03221205|DM2|dm2
10925|NCT03221205|TEI index|tei index
10926|NCT03221205|CPAP|cpap
10933|NCT03221166|Children|children
10934|NCT03221166|Crohn disease|crohn disease
19020|NCT03168802|Focused ultrasound Ablation|focused ultrasound ablation
19021|NCT03168802|Radiofrequency Ablation|radiofrequency ablation
19022|NCT03168802|Facet joint syndrome|facet joint syndrome
19023|NCT03168802|Chronic low back pain|chronic low back pain
19024|NCT03168789|Breathing Awareness Meditation,|breathing awareness meditation,
19025|NCT03168776|Drug-eluting stent|drug-eluting stent
19026|NCT03168763|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
19027|NCT03168763|Advanced Cancer|advanced cancer
19028|NCT03168763|Videos|videos
19029|NCT03168763|Questionnaires|questionnaires
19030|NCT03168763|Surveys|surveys
19031|NCT03168737|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
19032|NCT03168737|Solid tumors|solid tumors
19033|NCT03168737|PET-CT|pet-ct
19034|NCT03168737|18F-fluoroazomycin arabinoside|18f-fluoroazomycin arabinoside
19035|NCT03168737|18F-FAZA|18f-faza
19036|NCT03168724|Cognition|cognition
19037|NCT03168724|Intervention|intervention
19038|NCT03168724|Self-management|self-management
19039|NCT03168724|Rehabilitation|rehabilitation
19041|NCT03168711|Inosine|inosine
19042|NCT03168711|Uric acid|uric acid
19043|NCT03168711|Urate|urate
19044|NCT03168711|Glutathione|glutathione
19045|NCT03168711|Biomarker|biomarker
19046|NCT03168711|Oxidative stress|oxidative stress
19047|NCT03168711|Oxidative damage|oxidative damage
19048|NCT03168698|pregnancy|pregnancy
19049|NCT03168698|postpartum hemorrhage|postpartum hemorrhage
19050|NCT03168698|cesarean delivery|cesarean delivery
19051|NCT03168698|carbetocin|carbetocin
19052|NCT03168698|duratocin|duratocin
19053|NCT03168698|oxytocin|oxytocin
19054|NCT03168685|smartphones|smartphones
19055|NCT03168685|clinical trials|clinical trials
19056|NCT03168685|weight|weight
19057|NCT03168685|actigraph|actigraph
19058|NCT03168685|tracking|tracking
19059|NCT03168685|hemophilia|hemophilia
19060|NCT03168633|: Type 2 Diabetes Mellitus|: type 2 diabetes mellitus
19061|NCT03168633|Web-based intervention|web-based intervention
19062|NCT03168633|medication adherence|medication adherence
19063|NCT03168633|lifestyle changes|lifestyle changes
19065|NCT03168607|OS|os
19066|NCT03168607|PFS|pfs
19067|NCT03168607|safety|safety
19068|NCT03168594|chemotherapy|chemotherapy
19069|NCT03168594|OS|os
19070|NCT03168594|ORR|orr
19071|NCT03168594|PFS|pfs
19072|NCT03168594|safety|safety
19073|NCT03168529|Acute Heart Failure|acute heart failure
19074|NCT03168529|Observation|observation
19075|NCT03168529|Ivabradine|ivabradine
19076|NCT03168516|Oxygen|oxygen
19077|NCT03168516|closed-loop automatic control|closed-loop automatic control
19078|NCT03168516|Oxygen saturation|oxygen saturation
19079|NCT03168516|preterm infants|preterm infants
19080|NCT03168451|text messaging|text messaging
19081|NCT03168438|Cell Therapy|cell therapy
19082|NCT03168438|Multiple Myeloma|multiple myeloma
19083|NCT03168438|Immuno-oncology|immuno-oncology
19084|NCT03168438|T Cell Therapy|t cell therapy
19085|NCT03168438|Metastatic|metastatic
19086|NCT03168438|SPEAR T Cell|spear t cell
19087|NCT03168438|T Cell Receptor|t cell receptor
19088|NCT03168438|Previously Treated|previously treated
19090|NCT03168425|safe opioid prescribing|safe opioid prescribing
19091|NCT03168412|Hepatitis E|hepatitis e
19092|NCT03168399|Phenylketonuria|phenylketonuria
19093|NCT03168399|PKU|pku
19094|NCT03168399|Metabolism|metabolism
19095|NCT03168399|Metabolic|metabolic
19096|NCT03168399|Control|control
19097|NCT03168399|Acceptability|acceptability
19098|NCT03168347|Decision making|decision making
19099|NCT03168269|CCTA interpretation|ccta interpretation
19100|NCT03168269|technicians|technicians
19101|NCT03168269|experts|experts
19102|NCT03168269|comparison|comparison
19103|NCT03168243|nutrition support, home enteral feeding|nutrition support, home enteral feeding
19104|NCT03168217|Periodontitis|periodontitis
19105|NCT03168217|classification|classification
19106|NCT03168217|Cluster analysis|cluster analysis
19107|NCT03168139|Metastatic colorectal cancer|metastatic colorectal cancer
19108|NCT03168139|Metastatic pancreatic cancer|metastatic pancreatic cancer
19109|NCT03168139|NOX-A12|nox-a12
19110|NCT03168139|Olaptesed pegol|olaptesed pegol
19111|NCT03168139|Spiegelmer|spiegelmer
19112|NCT03168139|Pembrolizumab|pembrolizumab
19113|NCT03168139|PD-1 inhibitor|pd-1 inhibitor
19114|NCT03168139|Stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
19115|NCT03168139|CXCL12|cxcl12
19116|NCT03168139|Tumor microenvironment|tumor microenvironment
19117|NCT03168139|Immunotherapy|immunotherapy
19118|NCT03168139|Checkpoint inhibition|checkpoint inhibition
19119|NCT03168113|skin barrier function|skin barrier function
19120|NCT03168113|microbiome|microbiome
19121|NCT03168113|transepidermal water loss (TEWL)|transepidermal water loss (tewl)
19128|NCT03168048|patient-care|patient-care
19129|NCT03168048|mhealth|mhealth
19130|NCT03168048|follow-up|follow-up
19131|NCT03168048|patient satisfaction|patient satisfaction
19132|NCT03168048|quality of life|quality of life
19133|NCT03168009|BAT|bat
19134|NCT03168009|Bariatric Surgery|bariatric surgery
19135|NCT03168009|Energy Metabolism|energy metabolism
19136|NCT03167996|South Asian|south asian
19137|NCT03167996|Cardiovascular Risk Reduction|cardiovascular risk reduction
19138|NCT03167996|Metabolic Disorders|metabolic disorders
19139|NCT03167996|Lifestyle modifications|lifestyle modifications
19140|NCT03167957|fluconazole|fluconazole
19141|NCT03167957|fluconazole-resistant|fluconazole-resistant
19142|NCT03167944|Mastectomy|mastectomy
19143|NCT03167944|Seroma|seroma
19144|NCT03167931|non-invasive brain stimulation|non-invasive brain stimulation
19145|NCT03167931|neuromodulation|neuromodulation
19146|NCT03167931|semantic tasks|semantic tasks
19147|NCT03167918|calcium dobesilate|calcium dobesilate
19148|NCT03167918|Xuefuzhuyu Decoction|xuefuzhuyu decoction
19149|NCT03167918|pulmonary function|pulmonary function
19150|NCT03167905|Anesthesia, Obstetrical|anesthesia, obstetrical
19151|NCT03167905|Epidural anesthesia|epidural anesthesia
19152|NCT03167905|Postnatal depression|postnatal depression
19153|NCT03167905|Persistent pain|persistent pain
19154|NCT03167879|family planning|family planning
19155|NCT03167879|safer conception|safer conception
19156|NCT03167879|HIV|hiv
19157|NCT03167879|serodiscordant couples|serodiscordant couples
19158|NCT03167879|Uganda|uganda
19159|NCT03167879|contraception|contraception
19160|NCT03167840|falls prevention, older adults, mild cognitive impairment|falls prevention, older adults, mild cognitive impairment
19161|NCT03167827|pelvic floor|pelvic floor
19162|NCT03167827|climateric|climateric
19163|NCT03167827|exercise|exercise
19164|NCT03167827|Supplementation of Isoflavone|supplementation of isoflavone
19165|NCT03167801|tetraplegia|tetraplegia
19166|NCT03167801|spinal cord injury|spinal cord injury
19167|NCT03167801|melatonin|melatonin
19168|NCT03167801|sleep quality|sleep quality
19169|NCT03167801|sleepiness|sleepiness
19170|NCT03167723|Chest tube size|chest tube size
19171|NCT03167723|Hemothorax|hemothorax
19172|NCT03167723|Empyema|empyema
19173|NCT03167697|Phenylketonuria|phenylketonuria
19174|NCT03167697|Hyperphenylalaninaemia|hyperphenylalaninaemia
19175|NCT03167697|Inherited Metabolic Disorders|inherited metabolic disorders
19176|NCT03167671|Oswestry|oswestry
19177|NCT03167671|SF 36|sf 36
19178|NCT03167671|Promis Pain and Function|promis pain and function
19179|NCT03167671|Berg Balance|berg balance
19180|NCT03167658|Wellness|wellness
19181|NCT03167658|Prevention|prevention
19182|NCT03167619|Mestastic|mestastic
19183|NCT03167619|Platinum Sensitive|platinum sensitive
19184|NCT03167619|Advanced|advanced
19185|NCT03167619|PARP inhibitor|parp inhibitor
19186|NCT03167606|myPEEPS|mypeeps
19187|NCT03167606|Mobile Intervention|mobile intervention
19188|NCT03167606|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
19189|NCT03167606|Men who have sex with men (MSM)|men who have sex with men (msm)
19190|NCT03167593|Lactobacillus coryniformis|lactobacillus coryniformis
19191|NCT03167593|Flu|flu
19192|NCT03167593|Vaccine|vaccine
19193|NCT03167528|Pain|pain
19194|NCT03167528|Quality of life|quality of life
19195|NCT03167476|miRNA|mirna
19196|NCT03167476|biomarker|biomarker
19204|NCT03167424|In-stent restenosis|in-stent restenosis
19205|NCT03167424|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
19206|NCT03167424|Coronary angiography|coronary angiography
19207|NCT03167398|fecal microbiota transplantation|fecal microbiota transplantation
19208|NCT03167398|carbapenem-resistant enterobacteriaceae|carbapenem-resistant enterobacteriaceae
19209|NCT03167398|multidrug resistant bacteria|multidrug resistant bacteria
19210|NCT03167398|carrier|carrier
19211|NCT03167385|locally advanced differentiated thyroid carcinoma|locally advanced differentiated thyroid carcinoma
19212|NCT03167385|radioiodine refractory thyroid carcinoma|radioiodine refractory thyroid carcinoma
19213|NCT03167372|Light Therapy|light therapy
19214|NCT03167372|N-of-1|n-of-1
19215|NCT03167359|Psychiatry|psychiatry
19216|NCT03167359|Radiation Therapy|radiation therapy
19217|NCT03167346|stroke|stroke
19218|NCT03167346|core symptoms|core symptoms
19219|NCT03167346|public awareness|public awareness
19220|NCT03167346|FAST|fast
19223|NCT03167307|docosahexaenoic acid|docosahexaenoic acid
19224|NCT03167307|antidepressants|antidepressants
19225|NCT03167307|suicidality|suicidality
19226|NCT03167307|cognition|cognition
19731|NCT03163667|Glutamine|glutamine
19227|NCT03167307|childhood depression|childhood depression
19228|NCT03167307|pediatric depression|pediatric depression
19229|NCT03167281|Chest tube|chest tube
19230|NCT03167281|Thoracostomy|thoracostomy
19231|NCT03167281|Pleural Diseases|pleural diseases
19232|NCT03167281|Lung Neoplasms|lung neoplasms
19233|NCT03167281|Pulmonary Embolism|pulmonary embolism
19234|NCT03167281|Pneumothorax|pneumothorax
19235|NCT03167281|Thoracic Surgery|thoracic surgery
19236|NCT03167281|Deoxyribonucleases|deoxyribonucleases
19237|NCT03167281|Fibrinolytic Agents|fibrinolytic agents
19238|NCT03167281|Drainage|drainage
19239|NCT03167281|Pleural Effusion|pleural effusion
19240|NCT03167268|Lycopene|lycopene
19241|NCT03167268|Anti EGFR therapy|anti egfr therapy
19242|NCT03167229|Tenofovir|tenofovir
19243|NCT03167229|Hepatitis B|hepatitis b
19247|NCT03167203|hESC-RPE|hesc-rpe
19248|NCT03167203|Macular Degenerative Disease|macular degenerative disease
19249|NCT03167190|Point of Care Ultrasound|point of care ultrasound
19250|NCT03167151|Recurrent intermediate risk NMIBC|recurrent intermediate risk nmibc
19251|NCT03167151|Intravesical Pembrolizumab|intravesical pembrolizumab
19252|NCT03167151|Intravenous Pembrolizumab|intravenous pembrolizumab
19253|NCT03167151|Phase I/II|phase i/ii
19254|NCT03167151|Marker-lesion|marker-lesion
19255|NCT03167151|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
19256|NCT03167138|Shoulder pain|shoulder pain
19257|NCT03167138|Rotator cuff disease|rotator cuff disease
19258|NCT03167138|Spinal cord injuries|spinal cord injuries
19259|NCT03167138|Mesenchymal stromal cells|mesenchymal stromal cells
19260|NCT03167138|Regenerative medicine|regenerative medicine
19261|NCT03167138|Rehabilitation|rehabilitation
19262|NCT03167125|colorectal cancer screening|colorectal cancer screening
19263|NCT03167125|cancer screening|cancer screening
19264|NCT03167125|pragmatic trial|pragmatic trial
19265|NCT03167125|boot camp translation|boot camp translation
19266|NCT03167112|Potentially Curable|potentially curable
19267|NCT03167112|Preoperative|preoperative
19268|NCT03167112|FOLFIRINOX|folfirinox
19269|NCT03167073|smart-phone application|smart-phone application
19270|NCT03167073|low-income women|low-income women
19271|NCT03167073|breastfeeding|breastfeeding
19272|NCT03167073|health education|health education
19273|NCT03167073|health disparities|health disparities
19274|NCT03167034|exercise|exercise
19275|NCT03167034|echocardiography|echocardiography
19276|NCT03167034|right ventricular function|right ventricular function
19277|NCT03167034|obstructive airway disease|obstructive airway disease
19278|NCT03167034|emphysema|emphysema
19279|NCT03167034|acetazolamide|acetazolamide
19280|NCT03167034|altitude|altitude
19281|NCT03167021|Cannabis|cannabis
19282|NCT03167021|Community pharmacy|community pharmacy
19283|NCT03167021|Prevention|prevention
19284|NCT03167021|Students|students
19285|NCT03166995|Fibromyalgia,postural exercises|fibromyalgia,postural exercises
19286|NCT03166982|Tubo-ovarian abscess|tubo-ovarian abscess
19287|NCT03166982|Transvaginal drainage|transvaginal drainage
19288|NCT03166982|Laparoscopic treatment|laparoscopic treatment
19289|NCT03166956|Vitamin C|vitamin c
19290|NCT03166956|Glutamine|glutamine
19291|NCT03166956|Interleukin-6|interleukin-6
19292|NCT03166956|Clinical outcomes|clinical outcomes
19293|NCT03166930|Muscle Spasticity|muscle spasticity
19294|NCT03166930|Muscle Stretching Exercises|muscle stretching exercises
19295|NCT03166891|ovarian cancer, relapsed or refractory,chiauranib|ovarian cancer, relapsed or refractory,chiauranib
19296|NCT03166878|CAR-T|car-t
19297|NCT03166878|Cancer treatment|cancer treatment
19298|NCT03166878|Immunotherapy|immunotherapy
19299|NCT03166878|Adoptive cell therapy|adoptive cell therapy
19300|NCT03166878|Chimeric antigen receptor|chimeric antigen receptor
19301|NCT03166878|Universal CAR-T|universal car-t
19302|NCT03166865|osteoarthritis (OA)|osteoarthritis (oa)
19303|NCT03166865|mesenchymal stem cells(MSC)|mesenchymal stem cells(msc)
19304|NCT03166839|maternal health|maternal health
19305|NCT03166839|statistical analysis plan|statistical analysis plan
19306|NCT03166813|remote ischaemic preconditioning|remote ischaemic preconditioning
19307|NCT03166813|childhood cancer|childhood cancer
19308|NCT03166813|cardio-oncology|cardio-oncology
19309|NCT03166813|anthracycline|anthracycline
19310|NCT03166813|myocardial reperfusion injury|myocardial reperfusion injury
19311|NCT03166800|mitoquinone|mitoquinone
19312|NCT03166800|Fatigue|fatigue
19313|NCT03166800|Multiple Sclerosis|multiple sclerosis
19314|NCT03166748|Incomplete lower first molar|incomplete lower first molar
19315|NCT03166748|Immature permanent molar|immature permanent molar
19316|NCT03166748|Potassium nitrate in polycarboxylate|potassium nitrate in polycarboxylate
19317|NCT03166748|Mineral trioxide aggregate .Mineral trioxid|mineral trioxide aggregate .mineral trioxid
19318|NCT03166644|Analgesia Nociception Index (ANI)|analgesia nociception index (ani)
19319|NCT03166644|Postoperative Analgesia|postoperative analgesia
19320|NCT03166644|Postoperative Hypoxemia|postoperative hypoxemia
19321|NCT03166566|glaucoma|glaucoma
19322|NCT03166566|glaucoma surgery|glaucoma surgery
19323|NCT03166566|glaucoma drainage device|glaucoma drainage device
19324|NCT03166566|glaucoma implant|glaucoma implant
19325|NCT03166566|blindness|blindness
19326|NCT03166540|coffee|coffee
19327|NCT03166540|cocoa|cocoa
19328|NCT03166540|bioavailability|bioavailability
19329|NCT03166540|pharmacokinetics|pharmacokinetics
19330|NCT03166540|cardiometabolic risk factors|cardiometabolic risk factors
19331|NCT03166540|caffeoylquinic acids|caffeoylquinic acids
19332|NCT03166540|flavan-3-ol|flavan-3-ol
19333|NCT03166540|caffeine|caffeine
19334|NCT03166540|trigonelline|trigonelline
19335|NCT03166540|diterpene|diterpene
19336|NCT03166449|Traumatic Brain injury|traumatic brain injury
19337|NCT03166449|Immunonutrition|immunonutrition
19338|NCT03166384|electrosurgical bipolar sealing devices, breast cancer|electrosurgical bipolar sealing devices, breast cancer
19339|NCT03166371|Endocrinology|endocrinology
19340|NCT03166371|Nutrition|nutrition
19341|NCT03166371|Aging|aging
19342|NCT03166332|Mindfulness|mindfulness
19343|NCT03166332|Mediterranean diet|mediterranean diet
19344|NCT03166332|Neurodevelopment|neurodevelopment
19345|NCT03166332|Epigenetics|epigenetics
19346|NCT03166332|Fetal growth restriction|fetal growth restriction
19347|NCT03166306|pulmonary vascular disease|pulmonary vascular disease
19348|NCT03166306|pulmonary vascular imaging|pulmonary vascular imaging
19349|NCT03166293|Cerebral Palsy|cerebral palsy
19350|NCT03166293|Physical Therapy|physical therapy
19351|NCT03166293|Rehabilitation|rehabilitation
19352|NCT03166280|hepatitis C|hepatitis c
19353|NCT03166280|vitamin D|vitamin d
19354|NCT03166280|iron|iron
19355|NCT03166280|hepcidin|hepcidin
19356|NCT03166215|Drug therapy|drug therapy
19357|NCT03166202|age-related macular degeneration|age-related macular degeneration
19358|NCT03166189|Repeated IVF failure|repeated ivf failure
19359|NCT03166189|Stem cell|stem cell
19360|NCT03166163|bleeding on brushing|bleeding on brushing
19361|NCT03166150|Urinary Incontinence, pelvic floor muscle training|urinary incontinence, pelvic floor muscle training
19362|NCT03166137|Warts,Laser,Cryotherapy|warts,laser,cryotherapy
19363|NCT03166098|Psychotic Spectrum Disorders|psychotic spectrum disorders
19364|NCT03166085|HER2-Negative|her2-negative
19365|NCT03166085|PU-H71|pu-h71
19366|NCT03166085|Nab-paclitaxel (Abraxane)|nab-paclitaxel (abraxane)
19367|NCT03166085|17-093|17-093
19368|NCT03166072|Low-vision|low-vision
19369|NCT03166072|health related quality of life|health related quality of life
19370|NCT03166072|visual aids|visual aids
19371|NCT03166072|randomized controlled trial|randomized controlled trial
19372|NCT03166059|Catheter directed thrombolysis (CDT)|catheter directed thrombolysis (cdt)
19373|NCT03166033|Carpal Tunnel Syndrome|carpal tunnel syndrome
19374|NCT03166033|etiology|etiology
19375|NCT03166033|risk factor|risk factor
19376|NCT03166020|Serious Game|serious game
19377|NCT03166020|Stroke|stroke
19378|NCT03166020|Rehabilitation|rehabilitation
19379|NCT03166020|Connected objects|connected objects
19380|NCT03166007|Multiple Sclerosis|multiple sclerosis
19381|NCT03166007|Neurogenic Bowel Dysfunction|neurogenic bowel dysfunction
19382|NCT03166007|Abdominal massage|abdominal massage
19383|NCT03165994|esophagus|esophagus
19384|NCT03165994|gastroesoophageal (GE) junction|gastroesoophageal (ge) junction
19385|NCT03165994|T1-3N0-1|t1-3n0-1
19386|NCT03165981|Influenza vaccine|influenza vaccine
19387|NCT03165981|fever following vaccination|fever following vaccination
19388|NCT03165981|PCV13 vaccine|pcv13 vaccine
19389|NCT03165981|DTaP vaccine|dtap vaccine
19390|NCT03165981|pneumococcal vaccine|pneumococcal vaccine
19391|NCT03165955|breast cancer|breast cancer
19392|NCT03165955|paclitaxel|paclitaxel
19393|NCT03165929|free gingival grafts|free gingival grafts
19394|NCT03165929|connective tissue grafts|connective tissue grafts
19395|NCT03165929|flurbiprofen|flurbiprofen
19396|NCT03165890|cognition|cognition
19397|NCT03165890|visuomotor learning|visuomotor learning
19398|NCT03165890|airway disease|airway disease
19399|NCT03165890|altitude|altitude
19401|NCT03165890|acetazolamide|acetazolamide
19402|NCT03165877|GLYCEMIC INDEX|glycemic index
19403|NCT03165877|NAFLD|nafld
19404|NCT03165877|METABOLIC PARAMETERS|metabolic parameters
19405|NCT03165877|SATIETY|satiety
19406|NCT03165864|Thalassaemia, IONIS TMPRSS6-Lrx|thalassaemia, ionis tmprss6-lrx
19407|NCT03165838|postpartum|postpartum
19408|NCT03165838|pregnancy|pregnancy
19409|NCT03165838|contraception|contraception
19410|NCT03165838|RROP|rrop
19411|NCT03165812|Sleeve Gastrectomy|sleeve gastrectomy
19412|NCT03165812|Duodeno Jejunal Bypass|duodeno jejunal bypass
19413|NCT03165812|Single Anastomosis|single anastomosis
19414|NCT03165812|Intensive Medical Therapy|intensive medical therapy
19420|NCT03165760|protective mechanical ventilation|protective mechanical ventilation
19423|NCT03165734|myelofibrosis|myelofibrosis
19424|NCT03165734|pacritinib|pacritinib
19425|NCT03165734|Post-polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
18754|NCT03170557|RCT|rct
11353|NCT03218397|ICU|icu
19426|NCT03165734|Post-essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
19427|NCT03165734|Ruxolitinib|ruxolitinib
19428|NCT03165734|Bone Marrow Disease|bone marrow disease
19429|NCT03165734|Hematologic Diseases|hematologic diseases
19430|NCT03165734|Blood Platelet Disorders|blood platelet disorders
19431|NCT03165734|Hemorrhagic Disorders|hemorrhagic disorders
19432|NCT03165734|Splenomegaly|splenomegaly
19433|NCT03165734|Anemia|anemia
19434|NCT03165734|Spleen volume|spleen volume
19435|NCT03165734|Spleen|spleen
19436|NCT03165721|Renal Cancer|renal cancer
19437|NCT03165721|DNA Hypermethylation|dna hypermethylation
19438|NCT03165721|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
19439|NCT03165721|DNA Methyltransferase (DNMT) Inhibitor|dna methyltransferase (dnmt) inhibitor
19440|NCT03165721|Succinate Dehydrogenase (SDH) Deficiency|succinate dehydrogenase (sdh) deficiency
19441|NCT03165708|Epidural technique|epidural technique
19442|NCT03165695|Delirium|delirium
19443|NCT03165695|Insomnia|insomnia
19444|NCT03165695|Ramelteon|ramelteon
19445|NCT03165682|fatigue|fatigue
19446|NCT03165682|depression|depression
19447|NCT03165682|cortical excitability|cortical excitability
19448|NCT03165669|education|education
19449|NCT03165669|sleep|sleep
19450|NCT03165669|pillow|pillow
19451|NCT03165669|neck|neck
19452|NCT03165656|Echocardiography|echocardiography
19453|NCT03165656|right ventricular function|right ventricular function
19454|NCT03165656|pulmonary hypertension|pulmonary hypertension
19455|NCT03165656|disease progression|disease progression
19456|NCT03165656|hypoxia|hypoxia
19457|NCT03165617|Influenza vaccine|influenza vaccine
19458|NCT03165604|Physical fitness|physical fitness
19459|NCT03165604|Exercise|exercise
19460|NCT03165604|Childhood Obesity|childhood obesity
19461|NCT03165604|Information|information
19462|NCT03165539|Postoperative|postoperative
19463|NCT03165539|One-lung ventilation|one-lung ventilation
19464|NCT03165539|Cerebral oximetry|cerebral oximetry
19465|NCT03165539|Cerebral desaturation|cerebral desaturation
19466|NCT03165513|Traditional healer|traditional healer
19467|NCT03165513|faith healer|faith healer
19468|NCT03165513|depression|depression
19469|NCT03165513|mhGAP|mhgap
19470|NCT03165513|Kenya|kenya
19471|NCT03165500|Exodontia|exodontia
19472|NCT03165500|Sedation|sedation
19473|NCT03165500|Nitrous Oxide|nitrous oxide
19474|NCT03165500|Benzodiazepines|benzodiazepines
19475|NCT03165487|Triple Negative Breast Cancer|triple negative breast cancer
19476|NCT03165487|microenvironment|microenvironment
19477|NCT03165487|IORT|iort
19478|NCT03165487|Hormone Receptor Positive, HER 2 negative|hormone receptor positive, her 2 negative
19479|NCT03165474|childhood obesity|childhood obesity
19480|NCT03165474|mhealth|mhealth
19481|NCT03165474|digital health|digital health
19482|NCT03165474|nutrition|nutrition
19483|NCT03165474|intervention|intervention
19484|NCT03165461|intubation to supraglottic devices|intubation to supraglottic devices
19485|NCT03165461|intubating laryngeal tube|intubating laryngeal tube
19486|NCT03165448|oral surgery|oral surgery
19487|NCT03165448|psychology|psychology
19488|NCT03165448|fear|fear
19489|NCT03165448|pain|pain
19490|NCT03165448|dentistry|dentistry
19491|NCT03165396|mild cognitive impairment|mild cognitive impairment
19492|NCT03165383|Transverse Abdominis Plane (TAP) Block|transverse abdominis plane (tap) block
19493|NCT03165383|Patient Control Analgesia (PCA)|patient control analgesia (pca)
19494|NCT03165357|Crossfit|crossfit
19495|NCT03165357|Sodium bicarbonate|sodium bicarbonate
19496|NCT03165357|Physical capacity|physical capacity
19497|NCT03165318|Pulsed electromagnetic field|pulsed electromagnetic field
19498|NCT03165318|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
19499|NCT03165318|Muscle|muscle
19500|NCT03165253|Helicobacter pylori infection|helicobacter pylori infection
19501|NCT03165253|Children|children
19502|NCT03165253|Synbiotic|synbiotic
19503|NCT03165253|Standard Triple Therapy|standard triple therapy
19506|NCT03165175|prescription drug abuse|prescription drug abuse
19507|NCT03165175|prescription drug misuse|prescription drug misuse
19508|NCT03165175|risk reduction|risk reduction
19509|NCT03165175|education|education
19510|NCT03165175|military|military
19511|NCT03165175|mobile application|mobile application
19512|NCT03165175|substance misuse|substance misuse
19513|NCT03165175|substance abuse|substance abuse
19515|NCT03165162|Food Label Choices|food label choices
19516|NCT03165136|Unexplained Recurrent Miscarriage|unexplained recurrent miscarriage
19517|NCT03165136|First trimester abortion|first trimester abortion
19518|NCT03165136|Hydroxychloroquine|hydroxychloroquine
19519|NCT03165136|Antiphospholipide antibody|antiphospholipide antibody
19520|NCT03165097|tolerability|tolerability
19521|NCT03165097|safety|safety
19522|NCT03165084|Self-management|self-management
19523|NCT03165084|Primary Health Care|primary health care
19524|NCT03165084|eHealth|ehealth
19525|NCT03165032|exercise|exercise
19526|NCT03165032|echocardiography|echocardiography
19527|NCT03165032|right ventricular function|right ventricular function
19528|NCT03165032|pulmonary hypertension|pulmonary hypertension
19529|NCT03165032|hypoxia|hypoxia
19530|NCT03165019|high altitude illness|high altitude illness
19531|NCT03165019|pulmonary hypertension|pulmonary hypertension
19532|NCT03165019|sleep apnea|sleep apnea
19533|NCT03165019|disease progression|disease progression
19534|NCT03165019|hypoxia|hypoxia
19535|NCT03165006|Breast cancer, screening, survival|breast cancer, screening, survival
19536|NCT03164993|Neoplasms|neoplasms
19537|NCT03164980|Quality of life|quality of life
19538|NCT03164980|ovarian cancer|ovarian cancer
19539|NCT03164980|platinum sensitive|platinum sensitive
19540|NCT03164980|recurrent|recurrent
19541|NCT03164941|selective laser trabeculoplasty|selective laser trabeculoplasty
19542|NCT03164941|practice|practice
19543|NCT03164941|treatment|treatment
19544|NCT03164941|intraocular pressure|intraocular pressure
19545|NCT03164928|Denosumab|denosumab
19546|NCT03164928|Pediatric GIOP|pediatric giop
19547|NCT03164928|Glucocorticoid-induced|glucocorticoid-induced
19548|NCT03164928|Osteoporosis|osteoporosis
19549|NCT03164889|Chronic hepatitis B, antiviral treatment|chronic hepatitis b, antiviral treatment
19550|NCT03164863|Neoadjuvant Chemotherapy, Triple Negative Breast Cancer|neoadjuvant chemotherapy, triple negative breast cancer
19551|NCT03164824|Questionnaire|questionnaire
19552|NCT03164824|Functional Rating Index|functional rating index
19553|NCT03164824|Cross-cultural adaptation|cross-cultural adaptation
19554|NCT03164824|Psychometric properties testing|psychometric properties testing
19555|NCT03164772|mRNA Vaccine|mrna vaccine
19556|NCT03164772|Durvalumab|durvalumab
19557|NCT03164772|MEDI4736|medi4736
19558|NCT03164772|anti-PD-L1|anti-pd-l1
19559|NCT03164772|tremelimumab|tremelimumab
19560|NCT03164772|anti-CTLA-4|anti-ctla-4
19561|NCT03164772|BI 1361849|bi 1361849
19562|NCT03164746|Autism|autism
19563|NCT03164746|Therapeutic body wraps|therapeutic body wraps
19564|NCT03164681|sheerly|sheerly
19565|NCT03164642|Depressive Symptoms|depressive symptoms
19566|NCT03164642|Developmental Disabilities|developmental disabilities
19567|NCT03164642|Early Intervention|early intervention
19568|NCT03164642|Language Development|language development
19569|NCT03164642|Communication|communication
19570|NCT03164642|Maternal Empowerment|maternal empowerment
19572|NCT03164629|Lower Urinary Track Infection|lower urinary track infection
19573|NCT03164629|Urine Retention|urine retention
19574|NCT03164616|NSCLC|nsclc
19575|NCT03164616|PD-L1|pd-l1
19576|NCT03164616|Durvalumab|durvalumab
19577|NCT03164616|Tremelimumab|tremelimumab
19579|NCT03164551|GERI+|geri+
19580|NCT03164551|TICON|ticon
19581|NCT03164551|EEVA|eeva
19582|NCT03164551|Embryo culture|embryo culture
19583|NCT03164551|In Vitro Fertilization|in vitro fertilization
19584|NCT03164551|Intracytoplasmic Sperm Injection|intracytoplasmic sperm injection
19585|NCT03164525|Thai version|thai version
19586|NCT03164525|validated|validated
19587|NCT03164525|Critical Care Pain Observation Tool|critical care pain observation tool
19588|NCT03164525|Behavioral Pain Scale|behavioral pain scale
19589|NCT03164525|adult ICU patients|adult icu patients
19590|NCT03164499|Health education|health education
19591|NCT03164499|Life style|life style
19592|NCT03164499|Risk factors|risk factors
19593|NCT03164499|Cardiovascular diseases|cardiovascular diseases
19594|NCT03164499|Cognitive performance|cognitive performance
19595|NCT03164499|Quality of life|quality of life
19596|NCT03164473|Eosinophilic granulomatosis with polyangiitis in remission|eosinophilic granulomatosis with polyangiitis in remission
19597|NCT03164473|double-blind randomized controlled trial|double-blind randomized controlled trial
19598|NCT03164473|maintenance therapy|maintenance therapy
19599|NCT03164473|rituximab versus azathioprine|rituximab versus azathioprine
19600|NCT03164473|vasculitis remission|vasculitis remission
19601|NCT03164473|asthma control|asthma control
19602|NCT03164473|rhinosinusal manifestations control|rhinosinusal manifestations control
19603|NCT03164473|glucocorticoid therapy reduction/withdrawal|glucocorticoid therapy reduction/withdrawal
19604|NCT03164473|steroid sparing effect|steroid sparing effect
19606|NCT03164460|Head and Neck Cancer|head and neck cancer
19607|NCT03164460|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
19608|NCT03164460|SBRT|sbrt
19609|NCT03164460|Intensity modulated radiation therapy|intensity modulated radiation therapy
19610|NCT03164460|IMRT|imrt
19611|NCT03164460|Intensity modulated proton therapy|intensity modulated proton therapy
19612|NCT03164460|IMPT|impt
19613|NCT03164460|Questionnaires|questionnaires
19614|NCT03164460|Surveys|surveys
19615|NCT03164434|intracranial pressure|intracranial pressure
19616|NCT03164434|cerebrospinal fluid drainage|cerebrospinal fluid drainage
19617|NCT03164434|waveform analysis|waveform analysis
19618|NCT03164395|atrial fibrillation|atrial fibrillation
19619|NCT03164395|implantable cardiac defibrillator|implantable cardiac defibrillator
19620|NCT03164395|cardioversion|cardioversion
19621|NCT03164369|epidural block, ultrasound|epidural block, ultrasound
19622|NCT03164356|Limb Fluid Volume Management|limb fluid volume management
19623|NCT03164356|Prosthetic Socket Modification|prosthetic socket modification
19624|NCT03164343|Pain Neuroscience Education|pain neuroscience education
19625|NCT03164330|Health Care|health care
19626|NCT03164330|Workplace Wellness|workplace wellness
19627|NCT03164330|Preventative Health Care|preventative health care
19628|NCT03164330|Health Costs|health costs
19629|NCT03164317|Hypertension|hypertension
19630|NCT03164317|High blood pressure|high blood pressure
19631|NCT03164317|Task shifting|task shifting
19632|NCT03164317|Decision support system|decision support system
19633|NCT03164291|MAC and NTM|mac and ntm
19634|NCT03164278|Wheelchair|wheelchair
19635|NCT03164278|Biomechanics|biomechanics
19636|NCT03164278|Transfer|transfer
19637|NCT03164278|Participation|participation
19638|NCT03164278|Training|training
19639|NCT03164265|Regulatory Dendritic Cells|regulatory dendritic cells
19640|NCT03164252|Third molar;|third molar;
19641|NCT03164252|Third molar surgery;|third molar surgery;
19642|NCT03164252|Laser;|laser;
19643|NCT03164252|Tissue Repair.|tissue repair.
19644|NCT03164226|endothelial function|endothelial function
19645|NCT03164226|acute coronary syndrome|acute coronary syndrome
19646|NCT03164213|tDCS|tdcs
19647|NCT03164213|aphasia|aphasia
19648|NCT03164161|Pain Sensitivity|pain sensitivity
19649|NCT03164161|Measurement|measurement
19650|NCT03164161|Cold Pressor|cold pressor
19651|NCT03164161|β-endorphins|β-endorphins
19652|NCT03164161|saliva|saliva
19653|NCT03164161|oral surgery|oral surgery
19654|NCT03164109|Healthy Adult|healthy adult
19655|NCT03164109|Superoxide Dismutase|superoxide dismutase
19656|NCT03164109|Free Radical Dismutase|free radical dismutase
19657|NCT03164109|Cardiodynamic Assessment|cardiodynamic assessment
19658|NCT03164083|Joint Diseases|joint diseases
19659|NCT03164083|Musculoskeletal Diseases|musculoskeletal diseases
19660|NCT03164083|Arthritis|arthritis
19661|NCT03164070|Osteoarthritis|osteoarthritis
19662|NCT03164070|Flow cytometry|flow cytometry
19663|NCT03164070|Synovial fluid|synovial fluid
19664|NCT03164057|DNA methyltransferase inhibitors|dna methyltransferase inhibitors
19665|NCT03164057|Acute myeloid leukemia|acute myeloid leukemia
19666|NCT03164044|Allergy|allergy
19667|NCT03164044|Drug allergy|drug allergy
19668|NCT03164044|Basophil activation test|basophil activation test
19669|NCT03164044|Flow cytometry|flow cytometry
19670|NCT03164005|VEGF-B|vegf-b
19671|NCT03163979|locally advanced cervical cancer; radiotherapy|locally advanced cervical cancer; radiotherapy
19672|NCT03163953|Physical Activity|physical activity
19673|NCT03163953|Sedentary Lifestyle|sedentary lifestyle
19674|NCT03163953|Office Workers|office workers
19675|NCT03163940|Laughter Yoga|laughter yoga
19676|NCT03163940|Major Depressive Disorder|major depressive disorder
19677|NCT03163940|Anxiety|anxiety
19678|NCT03163940|Stress|stress
19679|NCT03163940|Depression|depression
19680|NCT03163940|Quality of Life|quality of life
19681|NCT03163940|Mood Disorder|mood disorder
19682|NCT03163914|vasopressor|vasopressor
19683|NCT03163914|spinal anaesthesia|spinal anaesthesia
19684|NCT03163901|traumatic brain injury|traumatic brain injury
19685|NCT03163875|erythema|erythema
19686|NCT03163875|wheal formation|wheal formation
19687|NCT03163875|vascular reaction of the skin|vascular reaction of the skin
19688|NCT03163862|IVF|ivf
19689|NCT03163836|Double Valve Replacement|double valve replacement
19690|NCT03163836|Atrial Fibrillation Ablation|atrial fibrillation ablation
19691|NCT03163797|Oropharyngeal cancer|oropharyngeal cancer
19692|NCT03163797|integrated PET/MR|integrated pet/mr
19693|NCT03163797|diffusion-weighted imaging|diffusion-weighted imaging
19694|NCT03163797|perfusion-weighted imaging|perfusion-weighted imaging
19695|NCT03163758|Ischemic stroke|ischemic stroke
19696|NCT03163758|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
19697|NCT03163758|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
19698|NCT03163758|Brain Reorganization|brain reorganization
19699|NCT03163732|Solid tumor|solid tumor
19700|NCT03163732|Advanced tumor|advanced tumor
19701|NCT03163732|Profiling panel|profiling panel
19702|NCT03163719|Seizure|seizure
19703|NCT03163719|Generalized convulsive seizure|generalized convulsive seizure
19704|NCT03163719|Convulsions|convulsions
19705|NCT03163719|Creatine Kinase|creatine kinase
19706|NCT03163719|Lactate|lactate
19707|NCT03163719|Lactacidaemia|lactacidaemia
19708|NCT03163719|Diagnostic|diagnostic
19709|NCT03163719|Losing consciousness|losing consciousness
19710|NCT03163719|Epilepsy|epilepsy
19711|NCT03163719|Epileptic generalized tonic-clonic seizure|epileptic generalized tonic-clonic seizure
19712|NCT03163706|Schizophrenia|schizophrenia
19713|NCT03163706|Stroop effect|stroop effect
19714|NCT03163706|Semantic conflict|semantic conflict
19715|NCT03163706|Response conflict|response conflict
19716|NCT03163693|Dexmedetomidine|dexmedetomidine
19717|NCT03163693|Cardiac Troponin I|cardiac troponin i
19718|NCT03163693|Glycogen Phosphorylase Isoenzyme BB|glycogen phosphorylase isoenzyme bb
19719|NCT03163680|Gastroduodenal Ulcer|gastroduodenal ulcer
19720|NCT03163680|Marginal Ulcer|marginal ulcer
19721|NCT03163680|Peptic Ulcer Hemorrhage|peptic ulcer hemorrhage
19722|NCT03163680|Peptic Ulcer|peptic ulcer
19727|NCT03163667|CBE|cbe
19728|NCT03163667|Glutaminase Inhibitor|glutaminase inhibitor
19729|NCT03163667|Glutaminase|glutaminase
19730|NCT03163667|Tumor Metabolism|tumor metabolism
19732|NCT03163654|multiple gingival recessions|multiple gingival recessions
19733|NCT03163654|collagen matrix|collagen matrix
19734|NCT03163654|connective tissue graft|connective tissue graft
19735|NCT03163654|tunnel technique|tunnel technique
19736|NCT03163628|severe bacterial infection|severe bacterial infection
19737|NCT03163628|acute infection|acute infection
19738|NCT03163628|infection viral|infection viral
19739|NCT03163628|biomarker combination|biomarker combination
19740|NCT03163628|diagnostic|diagnostic
19741|NCT03163628|child|child
19742|NCT03163602|Peri-Implantitis|peri-implantitis
19743|NCT03163602|Infection|infection
19744|NCT03163602|Bone substitutes|bone substitutes
19745|NCT03163524|family planning|family planning
19746|NCT03163524|reproductive health|reproductive health
19747|NCT03163524|m-health|m-health
19748|NCT03163498|Hypertension|hypertension
19749|NCT03163498|Exercise|exercise
19750|NCT03163498|Sleep|sleep
19751|NCT03163485|epilepsy|epilepsy
19752|NCT03163485|multimodal neuromonitoring|multimodal neuromonitoring
19753|NCT03163485|depth EEG|depth eeg
19754|NCT03163485|microdialysis|microdialysis
19755|NCT03163485|brain injury|brain injury
19756|NCT03163485|brain tissue at risk|brain tissue at risk
19757|NCT03163485|NCSE|ncse
19758|NCT03163485|short time monitoring|short time monitoring
19759|NCT03163485|neurologic ICU|neurologic icu
19760|NCT03163459|mechanical thrombectomy|mechanical thrombectomy
19761|NCT03163459|selective brain cooling|selective brain cooling
19765|NCT03163433|Patient activation measure|patient activation measure
19766|NCT03163433|Self-efficacy|self-efficacy
19767|NCT03163433|Patient participation in research|patient participation in research
19768|NCT03163420|Anesthetic efficacy|anesthetic efficacy
19769|NCT03163420|Diclofenac|diclofenac
19770|NCT03163420|Irreversible pulpitis|irreversible pulpitis
19771|NCT03163381|first-line treatment failure|first-line treatment failure
19772|NCT03163381|one measurable lesion|one measurable lesion
19773|NCT03163368|metastatic tumor|metastatic tumor
19774|NCT03163368|brain lesion|brain lesion
19775|NCT03163368|stereotactic radiosurgery|stereotactic radiosurgery
19776|NCT03163368|neoadjuvant|neoadjuvant
19777|NCT03163368|maximum tolerated dose|maximum tolerated dose
19778|NCT03163368|dose escalation|dose escalation
19779|NCT03163368|neurosurgical resection|neurosurgical resection
19780|NCT03163355|pureed diet|pureed diet
19781|NCT03163355|dysphasia|dysphasia
19782|NCT03163342|Seasonal|seasonal
19783|NCT03163303|Tobacco|tobacco
19784|NCT03163303|Cigarettes|cigarettes
19785|NCT03163303|Alcohol|alcohol
19786|NCT03163303|Cessation|cessation
19787|NCT03163303|Intervention|intervention
19788|NCT03163303|Young adults|young adults
19789|NCT03163303|Internet|internet
19790|NCT03163303|Social media|social media
19791|NCT03163264|obesity|obesity
19792|NCT03163264|weight loss|weight loss
19793|NCT03163264|weight gain|weight gain
19794|NCT03163264|weight management|weight management
19795|NCT03163264|primary care|primary care
19796|NCT03163264|health coach|health coach
19797|NCT03163251|READ-SG|read-sg
19798|NCT03163251|Burnout|burnout
19799|NCT03163251|Professional identity|professional identity
19800|NCT03163251|Empathy|empathy
19801|NCT03163251|Emotional intelligence|emotional intelligence
19802|NCT03163238|Dexmedetomidine|dexmedetomidine
19803|NCT03163238|Congenital Heart Disease|congenital heart disease
19804|NCT03163238|Cardiopulmonary Bypass|cardiopulmonary bypass
19805|NCT03163238|Interleukin|interleukin
19806|NCT03163225|outpatient care|outpatient care
19807|NCT03163225|emergency department visits|emergency department visits
19808|NCT03163212|Lactoferrin/FOS Supplementation|lactoferrin/fos supplementation
19809|NCT03163173|Healthy Adult|healthy adult
19810|NCT03163173|Superoxide Dismutase|superoxide dismutase
19811|NCT03163173|Absorption|absorption
19812|NCT03163173|Metabolism|metabolism
19813|NCT03163173|Elimination|elimination
19814|NCT03163173|Mass Balance|mass balance
19815|NCT03163173|Male Subjects|male subjects
19816|NCT03163160|pelvic floor muscles|pelvic floor muscles
19817|NCT03163160|pelvic floor myalgia|pelvic floor myalgia
19818|NCT03163160|manual therapy|manual therapy
19819|NCT03163160|electrolysis|electrolysis
19820|NCT03163160|galvanic|galvanic
19821|NCT03163147|frequency|frequency
19822|NCT03163134|Lumbar Drain, CSF Leak|lumbar drain, csf leak
19823|NCT03163121|Plasmodium falciparum|plasmodium falciparum
19824|NCT03163121|PfSPZ Vaccine|pfspz vaccine
19825|NCT03163121|PfSPZ-GA1 Vaccine|pfspz-ga1 vaccine
19826|NCT03163121|Controlled human malaria infection (CHMI)|controlled human malaria infection (chmi)
19827|NCT03163121|Genetically attenuated sporozoites|genetically attenuated sporozoites
19828|NCT03163121|Plasmodium falciparum sporozoites (PfSPZ)|plasmodium falciparum sporozoites (pfspz)
19829|NCT03163108|controller|controller
19830|NCT03163108|hyperoxia|hyperoxia
19832|NCT03163108|ventilation|ventilation
19833|NCT03163108|cerebral oxygenation|cerebral oxygenation
19835|NCT03163095|abdominal infection|abdominal infection
19836|NCT03163095|open abdomen management|open abdomen management
19942|NCT03162341|Gout|gout
19837|NCT03163095|Negative pressure peritoneal therapy|negative pressure peritoneal therapy
19838|NCT03163082|Coercion theory|coercion theory
19839|NCT03163082|Corrosive Couple Coercion|corrosive couple coercion
19840|NCT03163069|bleaching|bleaching
19841|NCT03163056|Smoking cessation|smoking cessation
19842|NCT03163056|Depression|depression
19843|NCT03163056|Clinical trial|clinical trial
19844|NCT03163030|Heart Failure|heart failure
19845|NCT03163030|Preserved Ejection Fraction|preserved ejection fraction
19846|NCT03163030|VNS|vns
19847|NCT03163030|Vagus Nerve|vagus nerve
19848|NCT03163030|Autonomic Regulation Therapy|autonomic regulation therapy
19849|NCT03163017|3D Fluoroscopy|3d fluoroscopy
19850|NCT03163004|Sedentary behavior|sedentary behavior
19851|NCT03162978|Exercise|exercise
19852|NCT03162978|behavior economics|behavior economics
19853|NCT03162952|Chronic pain|chronic pain
19854|NCT03162913|Strawberry|strawberry
19855|NCT03162913|Cognition|cognition
19856|NCT03162913|Gait|gait
19857|NCT03162913|Posture|posture
19858|NCT03162900|Glasdegib|glasdegib
19859|NCT03162900|PF-04449913|pf-04449913
19860|NCT03162900|Pharmacokinetics|pharmacokinetics
19861|NCT03162900|QTc|qtc
19862|NCT03162900|TQT|tqt
19863|NCT03162874|Levodopa-Induced Dyskinesia (LID)|levodopa-induced dyskinesia (lid)
19864|NCT03162874|Wearing-off|wearing-off
19865|NCT03162874|Foliglurax|foliglurax
19866|NCT03162874|Parkinson's Disease|parkinson's disease
19867|NCT03162874|mGluR4 PAM|mglur4 pam
19868|NCT03162835|Pain Neuroscience Education|pain neuroscience education
19869|NCT03162822|Caregiver-Child Coercion|caregiver-child coercion
19870|NCT03162822|Early Childhood Caries|early childhood caries
19871|NCT03162809|infertility|infertility
19872|NCT03162809|in vitro fertilization|in vitro fertilization
19873|NCT03162809|Estradiol|estradiol
19874|NCT03162809|Progesterone|progesterone
19875|NCT03162783|Aldeyra|aldeyra
19876|NCT03162770|mindfulness meditation|mindfulness meditation
19877|NCT03162770|hemodialysis|hemodialysis
19878|NCT03162770|quality of life|quality of life
19879|NCT03162770|stress|stress
19880|NCT03162718|lung cancer|lung cancer
19881|NCT03162718|exercise|exercise
19882|NCT03162718|pre-operative exercise program|pre-operative exercise program
19883|NCT03162679|trauma treatment|trauma treatment
19884|NCT03162679|Refugees|refugees
19885|NCT03162679|Emotion regulation|emotion regulation
19886|NCT03162679|Group therapy|group therapy
19887|NCT03162679|randomized controlled|randomized controlled
19888|NCT03162679|PTSD|ptsd
19889|NCT03162653|Allopurinol|allopurinol
19890|NCT03162653|hypothermia therapy|hypothermia therapy
19891|NCT03162653|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
19892|NCT03162653|neonatal oxygen deficiency|neonatal oxygen deficiency
19893|NCT03162653|childbirth outcome|childbirth outcome
19894|NCT03162653|perinatal asphyxia|perinatal asphyxia
19895|NCT03162640|Early onset of cannabis use|early onset of cannabis use
19896|NCT03162640|Addiction|addiction
19897|NCT03162640|Time perception|time perception
19898|NCT03162627|Malignant neoplasm of breast|malignant neoplasm of breast
19899|NCT03162627|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
19900|NCT03162627|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
19901|NCT03162627|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
19902|NCT03162627|Malignant neoplasms of thyroid and other endocrine glands|malignant neoplasms of thyroid and other endocrine glands
19903|NCT03162627|Solid tumors|solid tumors
19904|NCT03162627|Ras Pathway Alterations|ras pathway alterations
20005|NCT03162107|HIV|hiv
19909|NCT03162627|Lynparza|lynparza
19910|NCT03162614|healthy volunteers|healthy volunteers
19911|NCT03162614|Malaria|malaria
19913|NCT03162614|controlled human challenge|controlled human challenge
19914|NCT03162614|RTS,S/AS01|rts,s/as01
19915|NCT03162536|ARQ 531|arq 531
19916|NCT03162536|Hematologic Malignancies|hematologic malignancies
19917|NCT03162536|SLL|sll
19918|NCT03162536|CLL|cll
19919|NCT03162536|B-cell NHL|b-cell nhl
19920|NCT03162536|WM|wm
19921|NCT03162536|BTK|btk
19922|NCT03162536|cancer|cancer
19923|NCT03162536|refractory|refractory
19924|NCT03162536|relapsed|relapsed
19925|NCT03162510|SOLAR regimen|solar regimen
19926|NCT03162471|Corneal astigmatism|corneal astigmatism
19927|NCT03162471|Cataract surgery|cataract surgery
19928|NCT03162471|Corneal hysteresis|corneal hysteresis
19929|NCT03162471|Corneal resistance factor|corneal resistance factor
19930|NCT03162471|Intraocular pressure|intraocular pressure
19931|NCT03162445|bone mineral density|bone mineral density
19932|NCT03162445|Autism Spectrum Disorder|autism spectrum disorder
19933|NCT03162445|Autism|autism
19934|NCT03162432|IBD|ibd
19935|NCT03162393|brachial plexus; avulsion injury|brachial plexus; avulsion injury
19936|NCT03162380|Bipolar Disorder|bipolar disorder
19937|NCT03162380|occupational stress|occupational stress
19938|NCT03162367|Burn|burn
19939|NCT03162367|Epidermal cell suspension|epidermal cell suspension
19940|NCT03162341|Dual-Energy Computed Tomography|dual-energy computed tomography
19941|NCT03162341|UltraSonography|ultrasonography
19943|NCT03162341|Urate deposition|urate deposition
19944|NCT03161275|cerebral saturation|cerebral saturation
19945|NCT03161275|epidural anaesthesia|epidural anaesthesia
19946|NCT03161275|Near Infrared Spectroscopy (NIRS)|near infrared spectroscopy (nirs)
19947|NCT03161275|Regional cerebral oxygen saturation|regional cerebral oxygen saturation
19948|NCT03161262|Text-message reminder|text-message reminder
19949|NCT03161262|Post-operative medication|post-operative medication
19950|NCT03161262|Behavioral Research|behavioral research
19951|NCT03161262|Social Research|social research
19952|NCT03161262|Short Message Service (SMS)|short message service (sms)
19953|NCT03161249|first psychotic episode, mobile app intervention|first psychotic episode, mobile app intervention
19954|NCT03161197|CKD, Dialysis, ESRD|ckd, dialysis, esrd
19955|NCT03161197|Mindfulness-Based Stress Reduction (MBSR)|mindfulness-based stress reduction (mbsr)
19956|NCT03161184|maternal health|maternal health
19957|NCT03161184|community health|community health
19958|NCT03161184|health services|health services
19959|NCT03161184|Tanzania|tanzania
19960|NCT03161184|evaluation|evaluation
19961|NCT03161184|cluster randomized trial|cluster randomized trial
19965|NCT03162302|MRI|mri
19966|NCT03162302|magnetic resonance imaging|magnetic resonance imaging
19967|NCT03162302|fat quantification|fat quantification
19968|NCT03162302|iron quantification|iron quantification
19969|NCT03162289|Fasting|fasting
19970|NCT03162289|Vegan|vegan
19971|NCT03162276|BRCA 1/2 Carriers|brca 1/2 carriers
19972|NCT03162276|The Work|the work
19973|NCT03162276|RCT|rct
19974|NCT03162276|IBSR|ibsr
19975|NCT03162263|Ekso|ekso
19976|NCT03162263|neuroplasticity|neuroplasticity
19977|NCT03162263|functional recovery|functional recovery
19978|NCT03162237|Type1 diabetes|type1 diabetes
19979|NCT03162237|porcine islets|porcine islets
19980|NCT03162237|treg cells|treg cells
19981|NCT03162237|immunosuppress|immunosuppress
19982|NCT03162237|xenotransplantation|xenotransplantation
19983|NCT03162224|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
19984|NCT03162224|Oropharyngeal Cancer|oropharyngeal cancer
19985|NCT03162224|HPV|hpv
19986|NCT03162224|Human Papilloma Virus|human papilloma virus
19987|NCT03162224|Cancer Immunotherapy|cancer immunotherapy
19988|NCT03162224|Check point inhibitors|check point inhibitors
19989|NCT03162224|PD-L1 inhibitor|pd-l1 inhibitor
19990|NCT03162224|Recurrent or Metastatic Cancer|recurrent or metastatic cancer
19991|NCT03162224|Durvalumab|durvalumab
19992|NCT03162224|MEDI0457|medi0457
19993|NCT03162224|Antineoplastic agents|antineoplastic agents
19994|NCT03162224|Neoplasms|neoplasms
19995|NCT03162185|Neuroplasticity|neuroplasticity
19996|NCT03162185|SSRI|ssri
19997|NCT03162185|Motor Learning|motor learning
19998|NCT03162172|congenital adrenal hyperplasia|congenital adrenal hyperplasia
19999|NCT03162172|short stature|short stature
20000|NCT03162172|growth hormone treatment|growth hormone treatment
20001|NCT03162133|Breast Cancer|breast cancer
20002|NCT03162133|Aromatase Inhibitor Therapy|aromatase inhibitor therapy
20003|NCT03162133|Baduanjin Exercise|baduanjin exercise
20004|NCT03162107|adherence|adherence
20006|NCT03162107|MDR/XDR TB|mdr/xdr tb
20007|NCT03162107|Health Care Worker|health care worker
20008|NCT03162081|addiction|addiction
20009|NCT03162081|cognition|cognition
20010|NCT03162081|impulsivity|impulsivity
20011|NCT03162081|neuropsychology|neuropsychology
20012|NCT03162081|prescription drug misuse|prescription drug misuse
20013|NCT03162081|dependence|dependence
20014|NCT03162068|Cushing's syndrome|cushing's syndrome
20015|NCT03162068|Osteoporosis|osteoporosis
20016|NCT03162068|peripheral Quantitative Computed|peripheral quantitative computed
20017|NCT03162068|volumetric Bone Mineral Density|volumetric bone mineral density
20018|NCT03162068|Cortical and trabecular bone|cortical and trabecular bone
20020|NCT03162055|COPD|copd
20021|NCT03162042|Activin A|activin a
20022|NCT03162042|Myostatin|myostatin
20023|NCT03162042|Follistatin|follistatin
20024|NCT03162042|Cachexia|cachexia
20025|NCT03162042|Squamous cell carcinoma|squamous cell carcinoma
20026|NCT03162029|CBCT|cbct
20027|NCT03162029|Bone quality|bone quality
20028|NCT03162029|Renal failure|renal failure
20029|NCT03161990|DAIR|dair
20030|NCT03161990|Transgluteal approach|transgluteal approach
19571|NCT03164629|BPH|bph
20031|NCT03161990|Posterior approach|posterior approach
20032|NCT03161964|Hypoglycemia|hypoglycemia
20033|NCT03161964|Impaired Awareness of Hypoglycemia|impaired awareness of hypoglycemia
20034|NCT03161964|Propranolol|propranolol
20035|NCT03161951|acute Infections, flow cytometry, cell activation|acute infections, flow cytometry, cell activation
20036|NCT03161912|Diabetes|diabetes
20037|NCT03161912|Retinal Diseases|retinal diseases
20038|NCT03161912|Diabetic Retinopathy|diabetic retinopathy
20039|NCT03161912|Diabetic macular edema|diabetic macular edema
20040|NCT03161912|Retinal vein occlusion|retinal vein occlusion
20041|NCT03161912|Macular edema secondary to retinal vein occlusion|macular edema secondary to retinal vein occlusion
20042|NCT03161912|Intravitreal anti-VEGF (vascular endothelial growth factor)|intravitreal anti-vegf (vascular endothelial growth factor)
20146|NCT03161314|Gait|gait
20043|NCT03161912|VEGF inhibitor|vegf inhibitor
20044|NCT03161912|aflibercept|aflibercept
20045|NCT03161912|real world data|real world data
20046|NCT03161912|treatment pattern|treatment pattern
20047|NCT03161899|thalassemia - nutrition -growth|thalassemia - nutrition -growth
20048|NCT03161886|colon capsule endoscopy|colon capsule endoscopy
20049|NCT03161860|Program evaluation|program evaluation
20050|NCT03161860|Cost-effectiveness|cost-effectiveness
20051|NCT03161860|Community participation|community participation
20052|NCT03161860|empowerment|empowerment
20053|NCT03161847|OPMD|opmd
20055|NCT03161834|Circulating tumor cells|circulating tumor cells
20056|NCT03161795|Chemical coping|chemical coping
20057|NCT03161795|Adequacy consumption measure|adequacy consumption measure
20058|NCT03161795|Long-term opioids use|long-term opioids use
20059|NCT03161795|CAGE-Opioid|cage-opioid
20060|NCT03161782|pain|pain
20061|NCT03161782|exercise|exercise
20062|NCT03161782|proprioceptive neuromuscular facilitation stretching|proprioceptive neuromuscular facilitation stretching
20063|NCT03161782|static stretching|static stretching
20064|NCT03161743|platelet-rich plasma|platelet-rich plasma
20065|NCT03161743|platelet|platelet
20066|NCT03161730|videolaryngoscope, novice|videolaryngoscope, novice
20067|NCT03161717|electrical stimulation|electrical stimulation
20068|NCT03161717|vaginal delivery|vaginal delivery
20069|NCT03161678|Pharmacogenetics|pharmacogenetics
20070|NCT03161678|Carboxylesterase 1 (CES1)|carboxylesterase 1 (ces1)
20071|NCT03161678|Antiplatelet therapy|antiplatelet therapy
20072|NCT03161652|diabetic retinopathy|diabetic retinopathy
20073|NCT03161652|blindness|blindness
20074|NCT03161652|eye|eye
20075|NCT03161652|macular edema|macular edema
20076|NCT03161652|prolactin|prolactin
20077|NCT03161652|dopamine antagonists|dopamine antagonists
20078|NCT03161652|peptide hormones|peptide hormones
20079|NCT03161639|Pulpectomy|pulpectomy
20080|NCT03161639|Primary teeth|primary teeth
20081|NCT03161639|Working length|working length
20082|NCT03161639|Apex locator|apex locator
20083|NCT03161587|FEV1|fev1
20084|NCT03161587|COPD|copd
20085|NCT03161587|CAT|cat
20086|NCT03161587|treatment modality|treatment modality
20087|NCT03161587|FVC|fvc
20088|NCT03161587|GOLD 2016|gold 2016
20089|NCT03161587|mMRC|mmrc
20090|NCT03161574|neochemotherapy|neochemotherapy
20091|NCT03161574|CRM|crm
20092|NCT03161522|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
20093|NCT03161522|Esophageal Cancer|esophageal cancer
20094|NCT03161522|Gastric Cancer|gastric cancer
20095|NCT03161522|Oligometastatic|oligometastatic
20096|NCT03161522|Chemotherapy|chemotherapy
20097|NCT03161522|Radiation therapy|radiation therapy
20098|NCT03161522|Surgery|surgery
20099|NCT03161522|Questionnaires|questionnaires
20100|NCT03161522|Surveys|surveys
20101|NCT03161483|CC-220|cc-220
20102|NCT03161483|Safety|safety
20103|NCT03161483|Efficacy|efficacy
20104|NCT03161483|Active Systemic Lupus Erythematosus|active systemic lupus erythematosus
20105|NCT03161457|RA|ra
20107|NCT03161457|Moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
20108|NCT03161457|Severe RA|severe ra
20109|NCT03161457|Severe Rheumatoid Arthritis|severe rheumatoid arthritis
20110|NCT03161457|Moderate to Severe RA|moderate to severe ra
20111|NCT03161457|Moderate to Severe Rheumatoid Arthritis|moderate to severe rheumatoid arthritis
20112|NCT03161431|Immunotherapy|immunotherapy
20113|NCT03161431|Chemokine receptor blockade|chemokine receptor blockade
20114|NCT03161431|Myeloid-derived suppressor cells|myeloid-derived suppressor cells
20115|NCT03161405|Drug Therapy|drug therapy
20116|NCT03161392|mammography|mammography
20117|NCT03161392|ductal ectasia|ductal ectasia
20118|NCT03161392|breast neoplasm/diagnostic imaging|breast neoplasm/diagnostic imaging
20119|NCT03161392|mammary Glands, Human/pathology|mammary glands, human/pathology
20120|NCT03161392|female|female
20121|NCT03161379|Neoadjuvant therapy|neoadjuvant therapy
20122|NCT03161379|immunotherapy|immunotherapy
20123|NCT03161379|Cytoxan|cytoxan
20124|NCT03161379|Cyclophosphamide|cyclophosphamide
20125|NCT03161379|Pancreatic Vaccine|pancreatic vaccine
20126|NCT03161379|SBRT|sbrt
20127|NCT03161379|GVAX|gvax
20128|NCT03161379|Nivolumab|nivolumab
20129|NCT03161379|borderline resectable|borderline resectable
20130|NCT03161379|Radioimmunotherapy|radioimmunotherapy
20131|NCT03161379|Vaccine|vaccine
20132|NCT03161379|Antibody|antibody
20133|NCT03161379|Anti-PD-1|anti-pd-1
20134|NCT03161366|Ebola Zaire Outbreak|ebola zaire outbreak
20135|NCT03161366|Safety of rVSVΔG-ZEBOV-GP vaccine|safety of rvsvδg-zebov-gp vaccine
20136|NCT03161366|Effectiveness of rVSVΔG-ZEBOV-GP vaccine|effectiveness of rvsvδg-zebov-gp vaccine
20137|NCT03161340|Recurrent Implantation Failure|recurrent implantation failure
20138|NCT03161340|Rapamycin|rapamycin
20139|NCT03161340|Pregnancy Rate|pregnancy rate
20140|NCT03161327|ankle brachial index|ankle brachial index
20141|NCT03161327|peripheral arterial disease|peripheral arterial disease
20142|NCT03161314|Plantar Fasciitis|plantar fasciitis
20143|NCT03161314|Plantar Heel Pain|plantar heel pain
20144|NCT03161314|Multisegment Foot Motion|multisegment foot motion
20147|NCT03161067|Tetraplegia|tetraplegia
20148|NCT03161054|Metronomic Chemotherapy|metronomic chemotherapy
20149|NCT03161054|Elderly non-fit patients|elderly non-fit patients
20150|NCT03161054|Aggressive B-Cell lymphomas|aggressive b-cell lymphomas
20151|NCT03161041|Cytoreductive surgery, HIPEC, perioperative chemotherapy, peritoneal carcinomatosis, bevacizumab, colorectal surgery|cytoreductive surgery, hipec, perioperative chemotherapy, peritoneal carcinomatosis, bevacizumab, colorectal surgery
20152|NCT03161028|multiple sclerosis|multiple sclerosis
20153|NCT03161028|magnetic resonance imaging|magnetic resonance imaging
20154|NCT03161028|gait|gait
20155|NCT03161028|neuroprotective agents|neuroprotective agents
20156|NCT03161028|thioctic acid|thioctic acid
20157|NCT03161028|alpha-lipoic acid|alpha-lipoic acid
20158|NCT03161028|mobility|mobility
20159|NCT03161028|chronic progressive multiple sclerosis|chronic progressive multiple sclerosis
20160|NCT03160989|Blood pressure variability|blood pressure variability
20161|NCT03160989|Combined physical exercise|combined physical exercise
20162|NCT03160989|Hypertension|hypertension
20163|NCT03160963|elderly|elderly
20164|NCT03160937|pain|pain
20165|NCT03160924|Enhanced recovery after surgery|enhanced recovery after surgery
20166|NCT03160924|ERAS|eras
20167|NCT03160924|Fast track recovery|fast track recovery
20168|NCT03160924|Laparoscopic gastrectomy|laparoscopic gastrectomy
20169|NCT03160924|Gastric Cancer|gastric cancer
20170|NCT03160911|Over-the-scope clip|over-the-scope clip
20171|NCT03160911|endoscopic haemostasis|endoscopic haemostasis
20172|NCT03160898|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
20174|NCT03160898|CK-2127107|ck-2127107
20175|NCT03160872|Donor sperm insemination|donor sperm insemination
20176|NCT03160872|Anti Mullerian Hormone|anti mullerian hormone
20177|NCT03160872|Ovarian reserve|ovarian reserve
20178|NCT03160872|Antral follicle count|antral follicle count
20179|NCT03160859|unsedated colonoscopy|unsedated colonoscopy
20180|NCT03160859|water exchange colonoscopy|water exchange colonoscopy
20181|NCT03160859|cap|cap
20182|NCT03160859|colonoscopy pain|colonoscopy pain
20183|NCT03160846|Inotrope|inotrope
20184|NCT03160846|Milrinone|milrinone
20185|NCT03160846|Dopamine|dopamine
20186|NCT03160846|Dobutamine|dobutamine
20187|NCT03160833|HMPL453|hmpl453
20188|NCT03160833|solid tumor|solid tumor
20189|NCT03160833|dose escalation|dose escalation
20190|NCT03160794|Prostate cancer|prostate cancer
20191|NCT03160794|stereotactic ablative radiotherpy|stereotactic ablative radiotherpy
20192|NCT03160794|PET/MR|pet/mr
20193|NCT03160768|p16|p16
20194|NCT03160768|T cell isolation|t cell isolation
20195|NCT03160768|physiologic age|physiologic age
20196|NCT03160703|Dental stain, stannous fluoride, dentifrice|dental stain, stannous fluoride, dentifrice
20197|NCT03160690|Choroidal thickness|choroidal thickness
20198|NCT03160690|Open Angle Glaucoma|open angle glaucoma
20199|NCT03160690|Non penetrating deep sclerectomy|non penetrating deep sclerectomy
20602|NCT03158051|Young Adult|young adult
20204|NCT03160664|electroconvulsive therapy|electroconvulsive therapy
20206|NCT03160664|cognition|cognition
20207|NCT03160664|randomized controlled trial|randomized controlled trial
20208|NCT03160651|alcoholic hepatitis|alcoholic hepatitis
20209|NCT03160651|spontaneous improvement|spontaneous improvement
20210|NCT03160651|corticosteroids|corticosteroids
20211|NCT03160638|Azithromycin|azithromycin
20212|NCT03160638|Immunomodulation|immunomodulation
20213|NCT03160638|Pharmacokinetics|pharmacokinetics
20214|NCT03160638|Tissue degradation|tissue degradation
20215|NCT03160638|Tissue remodelling|tissue remodelling
20216|NCT03160612|Wheelchair|wheelchair
20217|NCT03160612|Biomechanics|biomechanics
20218|NCT03160612|Transfer|transfer
20219|NCT03160612|Training|training
20220|NCT03160586|Stuttering|stuttering
20222|NCT03160495|PET/MR|pet/mr
20223|NCT03160495|Squamous cell carcinoma|squamous cell carcinoma
20224|NCT03160495|Heterogeneity|heterogeneity
20225|NCT03160482|Thyroid Neoplasm|thyroid neoplasm
20226|NCT03160482|Papillary Carcinoma|papillary carcinoma
612996|NCT00633620|diagnosis|diagnosis
20227|NCT03160482|Follicular Carcinoma|follicular carcinoma
20228|NCT03160482|Colloid Nodule|colloid nodule
20229|NCT03160482|Hyperplastic Nodule|hyperplastic nodule
20230|NCT03160482|Adenomatoid Nodule|adenomatoid nodule
20231|NCT03160482|Follicular Adenoma|follicular adenoma
20232|NCT03160482|Thyroid Cancer|thyroid cancer
20233|NCT03160482|Bethesda Classification|bethesda classification
20234|NCT03160482|Biomarkers|biomarkers
20235|NCT03160482|Protein convertase|protein convertase
20236|NCT03160469|obesity|obesity
20237|NCT03160456|upper airway|upper airway
20238|NCT03160456|genioglossus|genioglossus
20239|NCT03160456|CPAP|cpap
20240|NCT03160456|electrical stimulation|electrical stimulation
20241|NCT03160456|sleep|sleep
20242|NCT03160456|sleep disordered breathing|sleep disordered breathing
20243|NCT03160443|Anorexia nervosa|anorexia nervosa
20244|NCT03160443|Bulimia|bulimia
20245|NCT03160443|Binge eating disorders|binge eating disorders
20246|NCT03160443|Neuropsychology|neuropsychology
20247|NCT03160443|Neurocognition|neurocognition
20248|NCT03160443|Daily functioning|daily functioning
20659|NCT03157830|Natalizumab|natalizumab
20249|NCT03160430|Chronic Kidney Failure|chronic kidney failure
20250|NCT03160430|ESRD|esrd
20251|NCT03160430|End-Stage Kidney Disease|end-stage kidney disease
20252|NCT03160430|End-Stage Renal Disease|end-stage renal disease
20253|NCT03160430|Renal Disease, End-Stage|renal disease, end-stage
20254|NCT03160430|Renal Failure, Chronic|renal failure, chronic
20255|NCT03160430|Renal Failure, End-Stage|renal failure, end-stage
20256|NCT03160404|Exercise|exercise
20257|NCT03160404|Zolpidem|zolpidem
20258|NCT03160404|Sleep|sleep
20259|NCT03160326|chronic kidney disease|chronic kidney disease
20260|NCT03160326|ultrasound|ultrasound
20261|NCT03160326|muscle loss|muscle loss
20262|NCT03160313|Social engagement|social engagement
20263|NCT03160313|Physical Activity|physical activity
20264|NCT03160313|Sleep Quality|sleep quality
20265|NCT03160313|Traumatic Brain Injury|traumatic brain injury
20266|NCT03160313|Veteran|veteran
20267|NCT03160287|mobile, sleep, physical activity, older adults|mobile, sleep, physical activity, older adults
20268|NCT03160274|tumor suppressor gene|tumor suppressor gene
20269|NCT03160274|oncogene|oncogene
20270|NCT03160274|mutation|mutation
20271|NCT03160274|susceptibility gene|susceptibility gene
20272|NCT03160222|reliability|reliability
20273|NCT03160222|bioelectrical impedance analysis|bioelectrical impedance analysis
20274|NCT03160222|computed tomography|computed tomography
20275|NCT03160222|strength|strength
20276|NCT03160222|mobility|mobility
20277|NCT03160209|risk factors|risk factors
20278|NCT03160209|case-control study|case-control study
20279|NCT03160196|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
20280|NCT03160196|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
20281|NCT03160183|initiating chemotherapy|initiating chemotherapy
20282|NCT03160183|prospective, open label, single arm, cohort|prospective, open label, single arm, cohort
20283|NCT03160183|non randomized, non interventional|non randomized, non interventional
20284|NCT03160170|open lumbar spine surgery|open lumbar spine surgery
20285|NCT03160170|operative time and efficiency|operative time and efficiency
20286|NCT03160170|Suction-Integrated Surgical Tissue Elevator and Retractor|suction-integrated surgical tissue elevator and retractor
20287|NCT03160144|laparoscopic resection of colorectal cancer|laparoscopic resection of colorectal cancer
20288|NCT03160144|open lung approach|open lung approach
20289|NCT03160131|Stroke|stroke
20290|NCT03160131|Visual impairment|visual impairment
20291|NCT03160131|Hemianopia|hemianopia
20292|NCT03160131|Neuro Vision Technology|neuro vision technology
20293|NCT03160131|Rehabilitation|rehabilitation
20294|NCT03160079|blinatumomab|blinatumomab
20295|NCT03160079|pembrolizumab|pembrolizumab
20296|NCT03160079|MK-3475|mk-3475
20297|NCT03160079|relapsed|relapsed
20298|NCT03160079|refractory|refractory
20299|NCT03160079|B-lineage acute lymphoblastic leukemia|b-lineage acute lymphoblastic leukemia
20300|NCT03160079|ALL|all
20301|NCT03160066|Psychobiotic|psychobiotic
20302|NCT03160066|Brain-gut axis|brain-gut axis
20303|NCT03160066|Stress|stress
20304|NCT03160066|Cognition|cognition
20305|NCT03160066|EEG|eeg
20306|NCT03160001|Niclosamide|niclosamide
20307|NCT03160001|Rheumatoid arthritis|rheumatoid arthritis
20308|NCT03160001|diseases activity|diseases activity
20309|NCT03160001|Efficacy|efficacy
20310|NCT03160001|Safety|safety
20311|NCT03159975|Tuberculosis|tuberculosis
20312|NCT03159975|DNA vaccine|dna vaccine
22918|NCT03143842|VNS|vns
20314|NCT03159975|GX-70|gx-70
20315|NCT03159962|Rapid maxillary expansion|rapid maxillary expansion
20316|NCT03159962|Mandibular response|mandibular response
20317|NCT03159962|Class II malocclusion|class ii malocclusion
20318|NCT03159962|Growing subjects|growing subjects
20319|NCT03159949|VO2max, maximal oxygen uptake|vo2max, maximal oxygen uptake
20320|NCT03159910|Shoulder Pain|shoulder pain
20321|NCT03159910|Occupational Exposure|occupational exposure
20322|NCT03159910|Clinical Trial|clinical trial
20323|NCT03159897|advanced stage (IIB-IV)|advanced stage (iib-iv)
20324|NCT03159897|ABVD DD-DI|abvd dd-di
20325|NCT03159897|PET|pet
20326|NCT03159871|Cesarean section|cesarean section
20327|NCT03159871|C- section|c- section
20328|NCT03159871|Suture|suture
20329|NCT03159858|Complex Abdominal Aortic Aneurysm|complex abdominal aortic aneurysm
20330|NCT03159845|zinc|zinc
20331|NCT03159832|Efficacy|efficacy
20332|NCT03159832|PK/PD study|pk/pd study
20333|NCT03159832|Renal Insufficiency|renal insufficiency
20334|NCT03159832|Type 2 Diabetes|type 2 diabetes
20335|NCT03159728|Ability Care|ability care
20336|NCT03159728|Caregiver overload|caregiver overload
20337|NCT03159728|Family caregiver|family caregiver
20338|NCT03159715|Internet, Behavioral Activation, Positive Psychology|internet, behavioral activation, positive psychology
20339|NCT03159702|hematological malignancy|hematological malignancy
20340|NCT03159702|EVOMELA|evomela
20341|NCT03159702|Melphalan HCl|melphalan hcl
20342|NCT03159702|Total Body Irradiation|total body irradiation
20343|NCT03159702|Reduced Intensity Conditioning|reduced intensity conditioning
20344|NCT03159702|Haploidentical Transplantation|haploidentical transplantation
20345|NCT03159702|Fludarabine|fludarabine
20660|NCT03157830|Tysabri|tysabri
20346|NCT03159702|Hematologic Diseases|hematologic diseases
20347|NCT03159702|Neoplasms, Plasma Cell|neoplasms, plasma cell
20348|NCT03159702|Neoplasms by Histologic Type|neoplasms by histologic type
20349|NCT03159702|Lymphoproliferative Disorders|lymphoproliferative disorders
20350|NCT03159676|Prostate cancer|prostate cancer
20351|NCT03159676|Radiation therapy|radiation therapy
20352|NCT03159676|Radiotherapy|radiotherapy
20353|NCT03159676|Proton|proton
20354|NCT03159676|Proton beam|proton beam
20355|NCT03159676|Stereotactic ablative body radiotherapy|stereotactic ablative body radiotherapy
20356|NCT03159676|Stereotactic body radiotherapy|stereotactic body radiotherapy
20357|NCT03159676|SABR|sabr
20358|NCT03159676|SBRT|sbrt
20359|NCT03159676|Localized|localized
20360|NCT03159676|Low risk|low risk
20361|NCT03159676|Intermediate risk|intermediate risk
20362|NCT03159637|Pneumoperitoneum|pneumoperitoneum
20363|NCT03159637|Trendelenburg position|trendelenburg position
20364|NCT03159637|intra-abdominal pressure|intra-abdominal pressure
20365|NCT03159624|nasoseptal flap|nasoseptal flap
20366|NCT03159624|tissue repair|tissue repair
20367|NCT03159624|wound healing|wound healing
20368|NCT03159624|remucosalization|remucosalization
20369|NCT03159624|upper airway|upper airway
20370|NCT03159624|granulation tissue|granulation tissue
20371|NCT03159624|tissue graft|tissue graft
20372|NCT03159598|A-BR|a-br
20373|NCT03159598|Abdominal-based breast reconstruction|abdominal-based breast reconstruction
20374|NCT03159598|Seroma|seroma
20375|NCT03159572|Ovarian cancer|ovarian cancer
20376|NCT03159572|Fallopian tube cancer|fallopian tube cancer
20377|NCT03159572|Primary peritoneal cancer|primary peritoneal cancer
20378|NCT03159572|Germline Breast Cancer Susceptibility Gene (BRCA1/2 gene)|germline breast cancer susceptibility gene (brca1/2 gene)
20379|NCT03159572|Homologous Recombination Deficiency (HRD)|homologous recombination deficiency (hrd)
20380|NCT03159520|Pain|pain
20381|NCT03159507|Omega-3 Index|omega-3 index
20382|NCT03159507|Cellular metabolism|cellular metabolism
20383|NCT03159507|EPA Monoglyceride|epa monoglyceride
20384|NCT03159507|Quality of life|quality of life
20385|NCT03159442|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
20386|NCT03159442|Asthma|asthma
20387|NCT03159442|AZD8871|azd8871
20388|NCT03159442|muscarinic receptor antagonist and β2 adrenoceptor agonist (MABA)|muscarinic receptor antagonist and β2 adrenoceptor agonist (maba)
20389|NCT03159442|Phase I|phase i
20390|NCT03159442|Safety|safety
20391|NCT03159442|Tolerability|tolerability
20392|NCT03159442|Pharmacokinetics|pharmacokinetics
20393|NCT03159442|long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
20394|NCT03159442|long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
20395|NCT03159442|Japanese|japanese
20397|NCT03159377|pulmonary nodule, CT, low dose|pulmonary nodule, ct, low dose
20400|NCT03159364|CMV|cmv
20401|NCT03159364|ADV|adv
20402|NCT03159364|BKV|bkv
20403|NCT03159325|internet|internet
20404|NCT03159325|chronic disease management|chronic disease management
20405|NCT03159325|technology|technology
20406|NCT03159325|telehealth|telehealth
20407|NCT03159325|application|application
20408|NCT03159312|obesity,bariatric surgery,physical activity|obesity,bariatric surgery,physical activity
20409|NCT03159299|mHealth|mhealth
20410|NCT03159299|Hispanic/Latinos|hispanic/latinos
20414|NCT03159273|Stress|stress
20415|NCT03159273|Immunity|immunity
20416|NCT03159273|Exhaled nitric oxide|exhaled nitric oxide
20417|NCT03159273|Lung function|lung function
20418|NCT03159273|Cardiovascular activity|cardiovascular activity
20419|NCT03159260|night-time leg cramps|night-time leg cramps
20420|NCT03159260|topical|topical
20421|NCT03159260|spasm|spasm
20422|NCT03159247|education|education
20423|NCT03159247|counseling|counseling
20424|NCT03159247|motivational interviewing|motivational interviewing
20425|NCT03159247|tailoring|tailoring
20426|NCT03159221|type 2 diabetes in adolescents|type 2 diabetes in adolescents
20427|NCT03159221|obesity in adolescents|obesity in adolescents
20428|NCT03159221|behavioral family systems therapy|behavioral family systems therapy
20429|NCT03159208|Prognosis|prognosis
20430|NCT03159208|Critical Illness|critical illness
20431|NCT03159208|Ventilation, Mechanical|ventilation, mechanical
20432|NCT03159208|Disease Attributes|disease attributes
20433|NCT03159208|Socioeconomic Factors|socioeconomic factors
20434|NCT03159208|Activities of Daily LIving|activities of daily living
20435|NCT03159208|Cognition|cognition
20436|NCT03159195|metastatic breast cancer|metastatic breast cancer
20437|NCT03159195|advanced breast cancer|advanced breast cancer
20438|NCT03159195|HR+/ HER2-|hr+/ her2-
20439|NCT03159182|Hypertrophic scarring|hypertrophic scarring
20440|NCT03159182|Silicone Material|silicone material
20441|NCT03159182|Pressure garments|pressure garments
20442|NCT03159169|Neck Pain|neck pain
20443|NCT03159169|Upper Limb Pain|upper limb pain
20444|NCT03159130|Pain pump catheters|pain pump catheters
20445|NCT03159130|bariatric surgery|bariatric surgery
20446|NCT03159130|OnQ pump|onq pump
20447|NCT03159130|sleeve gastrectomy|sleeve gastrectomy
20661|NCT03157791|simethicone|simethicone
20448|NCT03159130|continuous infusion catheter|continuous infusion catheter
20449|NCT03159117|GD3 ADC (Pfizer PF-06688992)|gd3 adc (pfizer pf-06688992)
20450|NCT03159117|Stage III Melanoma|stage iii melanoma
20451|NCT03159117|Stage IV Melanoma|stage iv melanoma
20453|NCT03159078|Acinetobacter|acinetobacter
20454|NCT03159078|Polymyxins|polymyxins
20455|NCT03159078|Imipenem|imipenem
20456|NCT03159026|Amish/Mennonite variant|amish/mennonite variant
20457|NCT03159013|Pyrethroids|pyrethroids
20458|NCT03159013|Lambda-cyhalothrin|lambda-cyhalothrin
20459|NCT03159013|Biomarkers|biomarkers
20460|NCT03159013|Toxicokinetics|toxicokinetics
20461|NCT03158974|External Genital Warts|external genital warts
20462|NCT03158961|Thyroid|thyroid
20463|NCT03158961|Thyroidectomy|thyroidectomy
20464|NCT03158961|Transoral|transoral
20465|NCT03158961|Endoscopic|endoscopic
20466|NCT03158961|Surgery|surgery
20467|NCT03158948|Sepsis|sepsis
20468|NCT03158948|LR12|lr12
20469|NCT03158948|TREM1|trem1
20470|NCT03158948|TREM-1|trem-1
20471|NCT03158935|adoptive cell therapy|adoptive cell therapy
20472|NCT03158935|melanoma|melanoma
20473|NCT03158935|ovarian|ovarian
20474|NCT03158935|cyclophosphamide|cyclophosphamide
20475|NCT03158935|fludarabine|fludarabine
20476|NCT03158935|tumor-infiltrating lymphocytes (TILs)|tumor-infiltrating lymphocytes (tils)
20477|NCT03158935|pembrolizumab|pembrolizumab
20478|NCT03158935|interleukin-2|interleukin-2
20479|NCT03158935|anti-PD-1|anti-pd-1
20480|NCT03158935|immune checkpoint|immune checkpoint
20481|NCT03158909|Eyemask|eyemask
20482|NCT03158909|Earplugs|earplugs
20483|NCT03158896|mesenchymal stem cell|mesenchymal stem cell
20484|NCT03158896|hematopoietic stem cell transplant|hematopoietic stem cell transplant
20485|NCT03158896|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
20486|NCT03158896|Autologous hematopoietic stem cell transplant|autologous hematopoietic stem cell transplant
20487|NCT03158896|Wharton's jelly|wharton's jelly
20488|NCT03158896|umbilical cord blood|umbilical cord blood
20489|NCT03158896|steroid refractory graft versus host disease|steroid refractory graft versus host disease
20490|NCT03158883|Avelumab|avelumab
20491|NCT03158883|NSCLC|nsclc
20492|NCT03158883|Stereotactic ablative radiotherapy (SAR)|stereotactic ablative radiotherapy (sar)
20495|NCT03158831|Drug Allergy|drug allergy
20496|NCT03158831|Penicillin Allergy|penicillin allergy
20497|NCT03158831|Antibiotic Allergy|antibiotic allergy
20498|NCT03158831|Graded Drug Challenge|graded drug challenge
20499|NCT03158792|Anticoagulation|anticoagulation
20500|NCT03158792|Thromboprophylaxis|thromboprophylaxis
20501|NCT03158792|Anti-Xa levels|anti-xa levels
20502|NCT03158792|Elderly|elderly
20503|NCT03158792|Prevention|prevention
20504|NCT03158792|Enoxaparin|enoxaparin
20505|NCT03158792|Low molecular weight heparin|low molecular weight heparin
20506|NCT03158766|infection|infection
20507|NCT03158766|intervertebral disc|intervertebral disc
20508|NCT03158766|Propionibacterium acnes|propionibacterium acnes
20510|NCT03158727|intensive care|intensive care
20511|NCT03158701|evaluation|evaluation
20512|NCT03158675|fractional co2 laser, topical steroid,UVB narrow band|fractional co2 laser, topical steroid,uvb narrow band
20513|NCT03158662|Epidermolysis Bullosa|epidermolysis bullosa
20514|NCT03158662|Recessive Dystrophic|recessive dystrophic
20515|NCT03158662|Simplex|simplex
20516|NCT03158662|Junctional Non-Herlitz|junctional non-herlitz
20517|NCT03158649|Pregnancy|pregnancy
20518|NCT03158649|Prenatal well-being|prenatal well-being
20519|NCT03158649|Mental maternal prenatal well-being|mental maternal prenatal well-being
20520|NCT03158649|Positive Psychology|positive psychology
20521|NCT03158649|Positive Psychology Intervention|positive psychology intervention
20522|NCT03158649|Web-based intervention|web-based intervention
20523|NCT03158623|total joint arthroplasty|total joint arthroplasty
20524|NCT03158623|platelet-rich plasma|platelet-rich plasma
20525|NCT03158623|activated collagen|activated collagen
20145|NCT03161314|EMG|emg
12423|NCT03211533|MRI|mri
20526|NCT03158571|Gastric Cancer|gastric cancer
20527|NCT03158571|gastric adenocarcinoma|gastric adenocarcinoma
20528|NCT03158571|cancer subtypes|cancer subtypes
20529|NCT03158571|prognosis|prognosis
20530|NCT03158571|survival|survival
20531|NCT03158571|molecular classification|molecular classification
20532|NCT03158571|chemotherapy|chemotherapy
20533|NCT03158571|immunotherapy|immunotherapy
20534|NCT03158519|Physical activity|physical activity
20536|NCT03158480|interferon|interferon
20537|NCT03158441|MRI|mri
20538|NCT03158441|Diffusion|diffusion
20539|NCT03158441|DTI|dti
20540|NCT03158415|mHealth|mhealth
20541|NCT03158402|Inspiratory muscle training|inspiratory muscle training
20542|NCT03158402|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
20543|NCT03158389|MGMT methylation|mgmt methylation
20544|NCT03158389|targeted therapy|targeted therapy
20545|NCT03158389|umbrella protocol|umbrella protocol
20546|NCT03158376|gabapentin|gabapentin
20547|NCT03158376|thoracotomy|thoracotomy
20548|NCT03158376|chronic post-thoracotomy pain|chronic post-thoracotomy pain
20549|NCT03158376|acute post-thoracotomy pain|acute post-thoracotomy pain
20550|NCT03158376|quality of life|quality of life
20551|NCT03158376|neuropathic pain|neuropathic pain
20552|NCT03158363|immobilization|immobilization
20553|NCT03158363|fasting|fasting
20554|NCT03158363|endotoxemia|endotoxemia
20555|NCT03158363|LPS|lps
20556|NCT03158363|metabolism|metabolism
20557|NCT03158363|model of disease|model of disease
20558|NCT03158337|Exercise|exercise
20559|NCT03158337|Physical Activity|physical activity
20560|NCT03158337|Brain blood flow|brain blood flow
20561|NCT03158337|Cognition|cognition
20562|NCT03158337|Fitness|fitness
20563|NCT03158259|IS|is
20564|NCT03158259|ICH|ich
20565|NCT03158259|rtPa|rtpa
20566|NCT03158259|Prehospital|prehospital
20567|NCT03158259|MSU|msu
20568|NCT03158246|zoledronic acid|zoledronic acid
20569|NCT03158246|Yigu|yigu
20570|NCT03158246|Aclasta|aclasta
20571|NCT03158246|Osteoporosis|osteoporosis
20572|NCT03158246|Postmenopausal|postmenopausal
20573|NCT03158246|BMD|bmd
20574|NCT03158246|fracture|fracture
20575|NCT03158246|Biochemical markers|biochemical markers
20576|NCT03158233|Zika virus disease|zika virus disease
20577|NCT03158194|Anxiety|anxiety
20578|NCT03158194|Stress|stress
20579|NCT03158194|Asthma|asthma
20580|NCT03158181|Behavior; Operational block; Monitoring; Social Sciences ; New technologies|behavior; operational block; monitoring; social sciences ; new technologies
20581|NCT03158129|Non-Small Cell Lung Cancer|non-small cell lung cancer
20582|NCT03158129|NSCLC|nsclc
20583|NCT03158129|Nivolumab|nivolumab
20584|NCT03158129|BMS-936558|bms-936558
20585|NCT03158129|Opdivo|opdivo
20586|NCT03158129|Ipilimumab|ipilimumab
20587|NCT03158129|Yervoy|yervoy
20588|NCT03158129|BMS-734016|bms-734016
20589|NCT03158129|MDX010|mdx010
20590|NCT03158129|Amenable For Surgical Resection|amenable for surgical resection
20591|NCT03158116|tracheostomy tube|tracheostomy tube
20592|NCT03158116|Pseudomonas aeruginosa|pseudomonas aeruginosa
20593|NCT03158103|MEK162 (Binimetinib)|mek162 (binimetinib)
20594|NCT03158103|Pexidartinib|pexidartinib
20595|NCT03158103|17-056|17-056
20596|NCT03158090|Acromegaly|acromegaly
20597|NCT03158064|17-160|17-160
20598|NCT03158064|durvalumab|durvalumab
20599|NCT03158064|tremelimumab|tremelimumab
20600|NCT03158064|MEDI4736|medi4736
20601|NCT03158051|Hypertension|hypertension
20603|NCT03158051|Self-Management|self-management
20604|NCT03158051|Health coach|health coach
20605|NCT03158038|Trivalent|trivalent
20606|NCT03158038|Influenza|influenza
20607|NCT03158038|FluMist Quadrivalent|flumist quadrivalent
20608|NCT03158038|Vaccine|vaccine
20609|NCT03158038|Prevention|prevention
20610|NCT03158038|Healthy|healthy
20611|NCT03158038|Monovalent|monovalent
20612|NCT03158025|Recreational sedatives|recreational sedatives
20613|NCT03158025|Healthy participants|healthy participants
20614|NCT03158025|Lemborexant|lemborexant
20615|NCT03158025|E2006|e2006
20616|NCT03158025|Zolpidem|zolpidem
20617|NCT03158025|Suvorexant|suvorexant
20618|NCT03157999|Older Adults|older adults
20619|NCT03157999|Transitional Care|transitional care
20620|NCT03157999|Caregiver|caregiver
20621|NCT03157999|Intervention|intervention
20622|NCT03157986|COPD|copd
20623|NCT03157986|Balance|balance
20624|NCT03157986|Whole Body Vibration Training|whole body vibration training
20625|NCT03157986|pulmonary rehabilitation|pulmonary rehabilitation
20626|NCT03157986|exercise|exercise
20627|NCT03157973|Information Literacy|information literacy
20628|NCT03157973|Nursing Care|nursing care
20629|NCT03157973|Social Support|social support
20630|NCT03157960|Fructose|fructose
20631|NCT03157960|Uric acid|uric acid
20632|NCT03157960|Oxidised LDL|oxidised ldl
12528|NCT03210701|POCT|poct
20633|NCT03157960|Interleukin 6|interleukin 6
20634|NCT03157947|decision aid|decision aid
20635|NCT03157947|focus group|focus group
20636|NCT03157934|stroke network|stroke network
20637|NCT03157934|acute stroke care|acute stroke care
20638|NCT03157934|emergency medical services|emergency medical services
20639|NCT03157934|integrated care|integrated care
20640|NCT03157908|South Africa|south africa
20641|NCT03157908|Retention in care|retention in care
20642|NCT03157908|Pregnancy|pregnancy
20643|NCT03157908|Mobile health|mobile health
20644|NCT03157895|Foster Families|foster families
20645|NCT03157882|pediatric|pediatric
20646|NCT03157882|children|children
20647|NCT03157882|Faces Pain Scale Revised|faces pain scale revised
20648|NCT03157882|Wong Baker FACES|wong baker faces
20649|NCT03157882|pain scales|pain scales
20650|NCT03157882|BRIGANCE|brigance
20651|NCT03157869|Learning, Automatism, Motor Activity, Electric Stimulation|learning, automatism, motor activity, electric stimulation
20652|NCT03157856|Fluorescence imaging technique|fluorescence imaging technique
20653|NCT03157856|Biopsies from resected prostate|biopsies from resected prostate
20654|NCT03157856|Medical device|medical device
20655|NCT03157830|Multiple Sclerosis|multiple sclerosis
20657|NCT03157830|ocrelizumab|ocrelizumab
20658|NCT03157830|OCREVUS|ocrevus
20662|NCT03157778|pregnenolone|pregnenolone
20663|NCT03157778|endocannabinoid|endocannabinoid
20664|NCT03157778|food intake|food intake
20665|NCT03157778|type-1 cannabinoid receptor|type-1 cannabinoid receptor
20666|NCT03157765|recurrent implantation failure|recurrent implantation failure
20667|NCT03157765|frozen embryo transfer|frozen embryo transfer
20668|NCT03157765|IVF|ivf
20669|NCT03157765|endometrial scratch|endometrial scratch
20670|NCT03157765|endometrial injury|endometrial injury
20671|NCT03157739|Migraine|migraine
20672|NCT03157726|benign prostatic hyperplasia|benign prostatic hyperplasia
20673|NCT03157726|multicenter randomized control clinical trial|multicenter randomized control clinical trial
20674|NCT03157726|transurethral plasmakinetic enucleation of prostate|transurethral plasmakinetic enucleation of prostate
20675|NCT03157726|transurethral resection of prostate|transurethral resection of prostate
20676|NCT03157713|Obesity|obesity
20677|NCT03157713|Weight-loss|weight-loss
20678|NCT03157713|Financial Incentives|financial incentives
20679|NCT03157713|Behavioral Economics|behavioral economics
20680|NCT03157648|Shivering temperature|shivering temperature
20681|NCT03157622|Chronic Low Back Pain|chronic low back pain
20682|NCT03157622|Cognitive-Behavioural Therapy|cognitive-behavioural therapy
20683|NCT03157622|Exposure|exposure
20684|NCT03157622|Therapeutic processes|therapeutic processes
20685|NCT03157622|Single-case study|single-case study
20686|NCT03157609|Thermometry|thermometry
20687|NCT03157609|SpotOn|spoton
20688|NCT03157596|disability|disability
20689|NCT03157596|developmental disability|developmental disability
20690|NCT03157596|special healthcare needs|special healthcare needs
20691|NCT03157557|Treatment|treatment
20692|NCT03157557|Sheltered Housing|sheltered housing
20693|NCT03157544|Chronic Neck Pain|chronic neck pain
20694|NCT03157544|Chronic Back Pain|chronic back pain
20695|NCT03157544|non-pharmacological|non-pharmacological
20696|NCT03157544|pain relief|pain relief
20697|NCT03156491|recurrent miscarriages (RM)|recurrent miscarriages (rm)
20698|NCT03156491|recurrent pregnancy loss (RPL)|recurrent pregnancy loss (rpl)
20699|NCT03156491|fetal-maternal interface|fetal-maternal interface
20700|NCT03156491|decidualization|decidualization
20701|NCT03156491|co-culture|co-culture
20702|NCT03156491|implantation|implantation
20710|NCT03156478|Health economics|health economics
20711|NCT03156478|Environmental choice architecture|environmental choice architecture
20712|NCT03156478|Socio-economic facilitators|socio-economic facilitators
20713|NCT03156478|Socio-economic barriers|socio-economic barriers
20714|NCT03156478|Wellbeing|wellbeing
20715|NCT03156387|diode laser|diode laser
20716|NCT03156387|scalpel surgery|scalpel surgery
20717|NCT03156387|frenectomy|frenectomy
20718|NCT03156387|postoperative complications|postoperative complications
20719|NCT03156348|Pharmaceutical intervention|pharmaceutical intervention
20720|NCT03156348|Older adult|older adult
20721|NCT03156348|Internal medicine|internal medicine
20722|NCT03156348|Adverse drug event|adverse drug event
20723|NCT03157518|Asthma|asthma
20724|NCT03157518|obesity|obesity
20725|NCT03157518|micorbiome|micorbiome
20726|NCT03157518|probiotics|probiotics
20727|NCT03157492|Adult|adult
20728|NCT03157492|Post-lingual|post-lingual
20729|NCT03157492|Auditory training|auditory training
20730|NCT03157492|Communication strategies|communication strategies
20731|NCT03157492|Speech tracking|speech tracking
20732|NCT03157492|Speech recognition|speech recognition
20733|NCT03157492|Quality of Life|quality of life
20734|NCT03157479|Mechanical ventilation|mechanical ventilation
20735|NCT03157453|Evaluation scale|evaluation scale
20399|NCT03159364|EBV|ebv
20736|NCT03157453|Brain injury|brain injury
20737|NCT03157453|Severity of Brain Injury|severity of brain injury
20738|NCT03157453|Initial Evaluation|initial evaluation
20739|NCT03157427|Solar Lentigo, Cryotherapy, Difluoroethane|solar lentigo, cryotherapy, difluoroethane
20740|NCT03157388|inflammation|inflammation
20741|NCT03157388|Macrophages|macrophages
20742|NCT03157388|CD163|cd163
20743|NCT03157375|IOL, IOL Rotation, Axial Rotation|iol, iol rotation, axial rotation
20744|NCT03157349|Biofreeze|biofreeze
20745|NCT03157349|Acute Neck Pain|acute neck pain
20746|NCT03157349|Placebo|placebo
20747|NCT03157349|chiropractic|chiropractic
20756|NCT03157323|Glycemic Index|glycemic index
20757|NCT03157323|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
20758|NCT03157323|Dietary Change|dietary change
20759|NCT03157323|Pediatric Oncology|pediatric oncology
20760|NCT03157284|Lactobacillus, Probiotics|lactobacillus, probiotics
20761|NCT03157219|Heart failure|heart failure
20762|NCT03157219|Institutional level registry|institutional level registry
20763|NCT03157219|Systolic heart failure|systolic heart failure
20764|NCT03157219|Acute heart failure|acute heart failure
20765|NCT03157219|Heart failure India|heart failure india
20766|NCT03157193|Peri-Implantitis|peri-implantitis
20767|NCT03157193|Dental Implants|dental implants
20768|NCT03157193|Hyaluronic Acid|hyaluronic acid
20769|NCT03157193|Clinical Trial|clinical trial
20770|NCT03157167|Kaposi Sarcoma, KS, HIV|kaposi sarcoma, ks, hiv
20771|NCT03157154|Haemophilia|haemophilia
20772|NCT03157154|Atherosclerosis|atherosclerosis
20773|NCT03157154|Atrial fibrillation|atrial fibrillation
20774|NCT03157154|Antiplatelets|antiplatelets
20775|NCT03157154|Anticoagulant|anticoagulant
20776|NCT03157141|Ankle osteoarthritis|ankle osteoarthritis
20777|NCT03157141|total ankle replacement|total ankle replacement
20778|NCT03157141|ankle arthrodesis|ankle arthrodesis
20779|NCT03157141|kinematics|kinematics
20780|NCT03157141|kinetics|kinetics
20781|NCT03157141|plantar pressure measurements|plantar pressure measurements
20782|NCT03157141|functional compensatory adaptations|functional compensatory adaptations
20783|NCT03157128|LOXO-292|loxo-292
20784|NCT03157128|KIF5B-RET|kif5b-ret
20785|NCT03157128|M918T|m918t
20786|NCT03157128|CCDC6-RET|ccdc6-ret
20787|NCT03157128|RET-PTC1|ret-ptc1
20788|NCT03157128|NCOA4-RET|ncoa4-ret
20789|NCT03157128|RET-PTC|ret-ptc
20790|NCT03157128|RET-PTC3|ret-ptc3
20791|NCT03157128|RET-PTC4|ret-ptc4
20792|NCT03157128|PRKAR1A-RET|prkar1a-ret
20793|NCT03157128|RET-PTC2|ret-ptc2
20794|NCT03157128|GOLGA5-RET|golga5-ret
20795|NCT03157128|RET-PTC5|ret-ptc5
20796|NCT03157128|ERC1-RET|erc1-ret
20797|NCT03157128|KTN1-RET|ktn1-ret
20798|NCT03157128|RET-PTC8|ret-ptc8
20799|NCT03157128|HOOK3-RET|hook3-ret
20800|NCT03157128|PCM1-RET|pcm1-ret
20801|NCT03157128|TRIM24-RET|trim24-ret
20802|NCT03157128|RET-PTC6|ret-ptc6
20803|NCT03157128|TRIM27-RET|trim27-ret
20804|NCT03157128|TRIM33-RET|trim33-ret
20805|NCT03157128|RET-PTC7|ret-ptc7
20806|NCT03157128|AKAP13-RET|akap13-ret
20807|NCT03157128|FKBP15-RET|fkbp15-ret
20808|NCT03157128|SPECC1L-RET|specc1l-ret
20809|NCT03157128|TBL1XR1-RET|tbl1xr1-ret
20810|NCT03157128|BCR-RET|bcr-ret
20811|NCT03157128|FGRF1OP-RET|fgrf1op-ret
20812|NCT03157128|RFG8-RET|rfg8-ret
20813|NCT03157128|RET-PTC9|ret-ptc9
20814|NCT03157128|ACBD5-RET|acbd5-ret
20815|NCT03157128|MYH13-RET|myh13-ret
20816|NCT03157128|CUX1-RET|cux1-ret
20817|NCT03157128|KIAA1468-RET|kiaa1468-ret
20818|NCT03157128|FRMD4A-RET|frmd4a-ret
20819|NCT03157128|SQSTM1-RET|sqstm1-ret
20820|NCT03157128|AFAP1L2-RET|afap1l2-ret
20821|NCT03157128|PPFIBP2-RET|ppfibp2-ret
20822|NCT03157128|EML4-RET|eml4-ret
20823|NCT03157128|PARD3-RET|pard3-ret
20824|NCT03157128|G533C|g533c
20825|NCT03157128|C609F|c609f
20826|NCT03157128|C609G|c609g
20827|NCT03157128|C609R|c609r
20828|NCT03157128|C609S|c609s
20829|NCT03157128|C609Y|c609y
20830|NCT03157128|C611F|c611f
20831|NCT03157128|C611G|c611g
20832|NCT03157128|C611S|c611s
20833|NCT03157128|C611Y|c611y
20834|NCT03157128|C611W|c611w
20835|NCT03157128|C618F|c618f
20836|NCT03157128|C618R|c618r
20837|NCT03157128|C618S|c618s
20838|NCT03157128|C620F|c620f
20839|NCT03157128|C620R|c620r
20840|NCT03157128|C620S|c620s
20841|NCT03157128|C630R|c630r
20842|NCT03157128|C630Y|c630y
20843|NCT03157128|D631Y|d631y
20844|NCT03157128|C634F|c634f
20845|NCT03157128|C634G|c634g
20846|NCT03157128|C634R|c634r
20847|NCT03157128|C634S|c634s
20848|NCT03157128|C634W|c634w
20849|NCT03157128|C634Y|c634y
20850|NCT03157128|K666E|k666e
20851|NCT03157128|E768D|e768d
20852|NCT03157128|L790F|l790f
20853|NCT03157128|V804L|v804l
20854|NCT03157128|V804M|v804m
20855|NCT03157128|A883F|a883f
20856|NCT03157128|S891A|s891a
20857|NCT03157128|R912P|r912p
20858|NCT03157128|CLIP1-RET|clip1-ret
20859|NCT03157128|Y806C|y806c
20860|NCT03157128|RET fusion|ret fusion
20861|NCT03157128|RET alteration|ret alteration
20862|NCT03157128|RET mutation|ret mutation
20863|NCT03157128|RET rearrangement|ret rearrangement
20864|NCT03157128|RET translocation|ret translocation
20865|NCT03157128|Neoplasms by Site|neoplasms by site
20866|NCT03157128|Neoplasms|neoplasms
20867|NCT03157128|Non-Small Cell Lung Cancer|non-small cell lung cancer
20868|NCT03157128|Lung Neoplasms|lung neoplasms
20869|NCT03157128|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
20870|NCT03157128|Cancer of Lung|cancer of lung
20871|NCT03157128|Cancer of the Lung|cancer of the lung
20872|NCT03157128|Lung Cancer|lung cancer
20873|NCT03157128|Neoplasms, Lung|neoplasms, lung
20874|NCT03157128|Neoplasms, Pulmonary|neoplasms, pulmonary
20875|NCT03157128|Pulmonary Cancer|pulmonary cancer
20876|NCT03157128|Pulmonary Neoplasms|pulmonary neoplasms
20877|NCT03157128|Respiratory Tract Neoplasms|respiratory tract neoplasms
20878|NCT03157128|Lung Diseases|lung diseases
20879|NCT03157128|Respiratory Tract Diseases|respiratory tract diseases
20880|NCT03157128|Carcinoma, Bronchogenic|carcinoma, bronchogenic
20881|NCT03157128|Bronchial Neoplasms|bronchial neoplasms
20882|NCT03157128|Medullary Thyroid Cancer|medullary thyroid cancer
20883|NCT03157128|Papillary Thyroid Cancer|papillary thyroid cancer
20884|NCT03157128|Thyroid Diseases|thyroid diseases
20885|NCT03157128|Thyroid Neoplasms|thyroid neoplasms
20886|NCT03157128|Cancer of the Thyroid|cancer of the thyroid
20887|NCT03157128|Cancer of Thyroid|cancer of thyroid
20888|NCT03157128|Neoplasms, Thyroid|neoplasms, thyroid
20889|NCT03157128|Thyroid Ademona|thyroid ademona
20890|NCT03157128|Thyroid Cancer|thyroid cancer
20891|NCT03157128|Thyroid Carcinoma|thyroid carcinoma
20892|NCT03157128|Endocrine System Diseases|endocrine system diseases
20893|NCT03157128|Endocrine Gland Neoplasms|endocrine gland neoplasms
20894|NCT03157128|Head and Neck Neoplasms|head and neck neoplasms
20895|NCT03157128|Thoracic Neoplasms|thoracic neoplasms
20896|NCT03157128|CNS tumor|cns tumor
20897|NCT03157128|Primary CNS tumor|primary cns tumor
20898|NCT03157128|Cancer of Colon|cancer of colon
20899|NCT03157128|Cancer of the Colon|cancer of the colon
20900|NCT03157128|Colon Cancer|colon cancer
20901|NCT03157128|Colon Neoplasms|colon neoplasms
20902|NCT03157128|Colonic Cancer|colonic cancer
20903|NCT03157128|Neoplasms, Colonic|neoplasms, colonic
20904|NCT03157128|Malignant tumor of Breast|malignant tumor of breast
20905|NCT03157128|Mammary Cancer|mammary cancer
20906|NCT03157128|Mammary Carcinoma, Human|mammary carcinoma, human
20907|NCT03157128|Mammary Neoplasm, Human|mammary neoplasm, human
20908|NCT03157128|Neoplasms, Breast|neoplasms, breast
20909|NCT03157128|Tumors, Breast|tumors, breast
20910|NCT03157128|Human Mammary Carcinoma|human mammary carcinoma
20911|NCT03157128|Malignant Neoplasm of Breast|malignant neoplasm of breast
20912|NCT03157128|Breast Carcinoma|breast carcinoma
20913|NCT03157128|Breast Tumors|breast tumors
20914|NCT03157128|Cancer of the Breast|cancer of the breast
20915|NCT03157128|Breast Neoplasms|breast neoplasms
20916|NCT03157128|Breast Cancer|breast cancer
20917|NCT03157115|Kinocardiography|kinocardiography
20918|NCT03157115|Cardiac contractility|cardiac contractility
20919|NCT03157115|Heart kinetic energy|heart kinetic energy
20920|NCT03157102|children|children
20921|NCT03157102|status asthmaticus|status asthmaticus
20922|NCT03157102|HFNC|hfnc
20923|NCT03157011|Primary Sjögren syndrome - Digestive symptoms|primary sjögren syndrome - digestive symptoms
20924|NCT03156998|CARE|care
20925|NCT03156998|Paediatric asthma|paediatric asthma
20926|NCT03156998|Compliance|compliance
20927|NCT03156998|Home nebulizer|home nebulizer
20928|NCT03156959|Eating disorders|eating disorders
20929|NCT03156959|Cognitive Behavioral Therapy|cognitive behavioral therapy
20930|NCT03156959|Eye Movement Desensitization and Processing|eye movement desensitization and processing
20931|NCT03156946|breastfeeding|breastfeeding
20932|NCT03156946|mother-to-mother support|mother-to-mother support
20933|NCT03156946|lactation consultant|lactation consultant
20934|NCT03156946|stepped wedge cluster randomized trial|stepped wedge cluster randomized trial
20935|NCT03156946|peer counseling|peer counseling
20936|NCT03156907|High dosage Buprenorphine (HDB)|high dosage buprenorphine (hdb)
20937|NCT03156907|Chronic pain|chronic pain
20938|NCT03156907|Analgesics opioids|analgesics opioids
20939|NCT03156907|Withdrawal symptoms|withdrawal symptoms
20940|NCT03156894|Graft Dysfunction|graft dysfunction
20946|NCT03156855|efficacy|efficacy
20947|NCT03156855|safety|safety
20948|NCT03156855|H. pylori eradication|h. pylori eradication
20949|NCT03156842|Hypertension|hypertension
20950|NCT03156842|Dyslipidemia|dyslipidemia
20951|NCT03156842|Fimasartan|fimasartan
20952|NCT03156842|Rosuvastatin|rosuvastatin
20953|NCT03156829|splinting|splinting
20954|NCT03156829|steroid|steroid
20955|NCT03156829|cortisone|cortisone
20956|NCT03156829|trigger digit|trigger digit
20957|NCT03156816|Myocardial Infarction|myocardial infarction
20958|NCT03156816|STEMI|stemi
20959|NCT03156816|Inflammation|inflammation
20960|NCT03156816|Left ventricular remodeling|left ventricular remodeling
20961|NCT03156816|Colchicine|colchicine
20962|NCT03156816|CMR|cmr
20963|NCT03156790|recombinant L-Asparaginase|recombinant l-asparaginase
20964|NCT03156790|Spectrila®|spectrila®
20965|NCT03156790|Lymphoblastic Leukaemia|lymphoblastic leukaemia
20966|NCT03156790|BRALL 2014|brall 2014
20967|NCT03156777|Gastric cancer; Circulating tumor cells; Prognosis|gastric cancer; circulating tumor cells; prognosis
20968|NCT03156764|Qp/Qs ratio|qp/qs ratio
20969|NCT03156764|Pediatric congenital heart disease|pediatric congenital heart disease
20970|NCT03156751|Syphilis screening|syphilis screening
20971|NCT03156751|antenatal care|antenatal care
20972|NCT03156751|prenatal diagnosis|prenatal diagnosis
20973|NCT03156751|rapid diagnosis test|rapid diagnosis test
20974|NCT03156751|Burkina Faso|burkina faso
20975|NCT03156751|feasibility|feasibility
20976|NCT03156725|Iron Bioavailability|iron bioavailability
20977|NCT03156725|hepcidin|hepcidin
20978|NCT03156725|ferritin|ferritin
20979|NCT03156725|iron absorption|iron absorption
20980|NCT03156725|iron status|iron status
20981|NCT03156712|Anemia|anemia
20982|NCT03156712|Iron deficiency anemia|iron deficiency anemia
20983|NCT03156712|Iron fortification|iron fortification
20984|NCT03156712|ferrous sulfate|ferrous sulfate
20985|NCT03156712|aspergillus oryzae|aspergillus oryzae
20986|NCT03156712|iron supplementation|iron supplementation
20987|NCT03156712|AUC|auc
20988|NCT03156686|Acute Heart Failure|acute heart failure
20989|NCT03156686|Chronic Heart Failure|chronic heart failure
20990|NCT03156686|Home care services|home care services
20991|NCT03156686|Cost-Benefit Analysis|cost-benefit analysis
20992|NCT03156686|Quality of life|quality of life
20993|NCT03156634|Patient education|patient education
20994|NCT03156634|Internet|internet
20995|NCT03156608|External Fetal Heart Rate Monitor|external fetal heart rate monitor
20996|NCT03156608|Fetal Heart Rate Monitor|fetal heart rate monitor
20997|NCT03156582|liver transplantation, hepatocellular carcinoma, alpha-foetoproteins, AFP|liver transplantation, hepatocellular carcinoma, alpha-foetoproteins, afp
20998|NCT03156569|saliva , dental , oral health|saliva , dental , oral health
20999|NCT03156530|Acupunture|acupunture
21000|NCT03156530|Acupunture Therapy|acupunture therapy
21001|NCT03156530|Acupunture Points|acupunture points
21002|NCT03156530|Acupunture Ear|acupunture ear
21003|NCT03156530|Postural Balance|postural balance
21004|NCT03156517|Treatment|treatment
21005|NCT03156517|Deep Brain Stimulation|deep brain stimulation
21006|NCT03156517|VIM Nucleus of the Thalamus|vim nucleus of the thalamus
21007|NCT03156517|Posterior Subthalamic Area|posterior subthalamic area
21008|NCT03156517|Zona Incerta|zona incerta
21009|NCT03156517|Efficacy|efficacy
21010|NCT03156517|Safety|safety
21011|NCT03156322|cesarean section|cesarean section
21012|NCT03156322|combined spinal epidural anesthesia|combined spinal epidural anesthesia
21013|NCT03156322|patient controlled epidural analgesia|patient controlled epidural analgesia
21014|NCT03156322|postoperative pain|postoperative pain
21015|NCT03156296|transversus abdominis plane block , Dexmedetomidine|transversus abdominis plane block , dexmedetomidine
21016|NCT03156283|smartphone|smartphone
21017|NCT03156283|obstructive sleep apnea|obstructive sleep apnea
21018|NCT03156283|adherence|adherence
21019|NCT03156270|nasal valve|nasal valve
21020|NCT03156270|nasal airway obstruction|nasal airway obstruction
21021|NCT03156257|Microgravity Effects on Vascular Cells|microgravity effects on vascular cells
21022|NCT03156244|PROMIS|promis
21023|NCT03156231|airway disease|airway disease
21024|NCT03156231|bronchitis|bronchitis
21025|NCT03156231|emphysema|emphysema
21026|NCT03156231|altitude|altitude
21027|NCT03156231|prevention|prevention
21028|NCT03156231|acetazolamide|acetazolamide
21029|NCT03156218|PaO2/FiO2 ratio, hyperoxia, mechanical ventilation, ARDS|pao2/fio2 ratio, hyperoxia, mechanical ventilation, ards
21030|NCT03156205|critically ill patients|critically ill patients
21031|NCT03156205|music therapy|music therapy
21032|NCT03156205|sleep|sleep
21033|NCT03156205|delirium|delirium
21034|NCT03156205|melatonin|melatonin
21035|NCT03156205|elderly|elderly
21036|NCT03156192|Caregivers|caregivers
21037|NCT03156192|Family-centered care|family-centered care
21038|NCT03156192|Music use|music use
21039|NCT03156192|Psycho-social benefits of music|psycho-social benefits of music
21040|NCT03156088|Predictors|predictors
21041|NCT03156088|Sacral neuromodulation|sacral neuromodulation
21042|NCT03156088|Outcomes|outcomes
21043|NCT03156088|Overactive bladder|overactive bladder
21044|NCT03156075|hip fracture, intervention, mortality, mobility|hip fracture, intervention, mortality, mobility
21045|NCT03156036|Temozolomide|temozolomide
21046|NCT03156036|Capecitabine|capecitabine
21047|NCT03156036|MGMT|mgmt
21048|NCT03156010|oculomotor testing|oculomotor testing
21049|NCT03155997|early stage breast cancer|early stage breast cancer
21050|NCT03155997|cyclin-dependent kinase (CDK)|cyclin-dependent kinase (cdk)
21051|NCT03155971|Drug-Coated Balloon|drug-coated balloon
21052|NCT03155971|Main Coronary Artery|main coronary artery
21053|NCT03155971|De Novo Lesion|de novo lesion
21054|NCT03155919|taurine|taurine
21055|NCT03155919|triathletes|triathletes
21056|NCT03155919|oxidative stress|oxidative stress
21057|NCT03155919|chocolate milk|chocolate milk
21058|NCT03155906|Chronic hepatitis C|chronic hepatitis c
21059|NCT03155906|Opiate Substitution Treatment|opiate substitution treatment
21060|NCT03155906|Integrated Delivery of Health Care|integrated delivery of health care
21061|NCT03155906|Substance Abuse Treatment Centers|substance abuse treatment centers
21062|NCT03155841|Prevention|prevention
21063|NCT03155841|Internet|internet
21064|NCT03155841|Adolescence|adolescence
21065|NCT03155841|LGBT|lgbt
21066|NCT03155841|Sexuality|sexuality
21067|NCT03155828|PCOS, OSA, CPAP|pcos, osa, cpap
21068|NCT03155763|kidney transplantation|kidney transplantation
21069|NCT03155763|implantation biopsy|implantation biopsy
21070|NCT03155763|histology|histology
21071|NCT03155763|allograft function|allograft function
21072|NCT03155763|allograft survival|allograft survival
21073|NCT03155750|insomnia|insomnia
21074|NCT03155737|Knee Osteoarthritis|knee osteoarthritis
21075|NCT03155685|antipsychotic|antipsychotic
21076|NCT03155685|palliative care|palliative care
21077|NCT03155659|Fish|fish
21078|NCT03155659|Polyunsaturated fatty acids|polyunsaturated fatty acids
21079|NCT03155659|Mortality|mortality
21080|NCT03155659|CHNS|chns
21081|NCT03155659|NHANES|nhanes
21082|NCT03155646|TAP block|tap block
21083|NCT03155646|Dexmedetomidine|dexmedetomidine
21084|NCT03155646|Clonidine|clonidine
21085|NCT03155633|Marathon, runners, biomarkers, recovery|marathon, runners, biomarkers, recovery
21086|NCT03155594|Diabetes|diabetes
21087|NCT03155594|Diabetes Mellitus|diabetes mellitus
21088|NCT03155594|Diabetes Type 1|diabetes type 1
21089|NCT03155594|Diabetes Type 2|diabetes type 2
21090|NCT03155594|CGM|cgm
21091|NCT03155594|Continuous Glucose Monitoring|continuous glucose monitoring
21092|NCT03155594|Inpatient|inpatient
21093|NCT03155594|Outpatient|outpatient
21094|NCT03155594|Transition of care|transition of care
21095|NCT03155594|DM-1|dm-1
21096|NCT03155594|DM-2|dm-2
21097|NCT03155594|Freestyle Libre|freestyle libre
21098|NCT03155555|Fluid Responsiveness|fluid responsiveness
21099|NCT03155555|Pediatric surgery|pediatric surgery
21100|NCT03155555|General endotracheal anaesthesia|general endotracheal anaesthesia
21101|NCT03155542|alcohol|alcohol
21102|NCT03155542|gene polymorphisms|gene polymorphisms
21103|NCT03155542|Colorectal cancer|colorectal cancer
21104|NCT03155529|cervical cancer|cervical cancer
21105|NCT03155529|radical hysterectomy|radical hysterectomy
21106|NCT03155529|Postoperative pelvic floor dysfunction|postoperative pelvic floor dysfunction
21107|NCT03155529|the injure of pelvic floor|the injure of pelvic floor
21108|NCT03155529|Three-dimensional reconstruction|three-dimensional reconstruction
21109|NCT03155529|structural destruction of pelvic organs|structural destruction of pelvic organs
21110|NCT03155529|structural destruction of pelvoic floor|structural destruction of pelvoic floor
21111|NCT03155516|Cancer pain|cancer pain
21112|NCT03155516|GPM|gpm
21113|NCT03155516|pain assessment|pain assessment
21114|NCT03155503|SUVN-911|suvn-911
21115|NCT03155503|Depression|depression
21116|NCT03155503|single dose|single dose
21117|NCT03155503|multiple dose|multiple dose
21118|NCT03155503|alpha4 beta2 receptor|alpha4 beta2 receptor
21119|NCT03155503|first in human|first in human
21120|NCT03155503|safety|safety
21121|NCT03155503|pharmacokinetics|pharmacokinetics
21122|NCT03155503|tolerability|tolerability
21123|NCT03155490|Hospital medical emergency team|hospital medical emergency team
21124|NCT03155490|Leadership|leadership
21125|NCT03155490|Simulation training|simulation training
21126|NCT03155477|SLE, vitamin D, SLEDAI, IL-6, TGF- β1|sle, vitamin d, sledai, il-6, tgf- β1
21127|NCT03155464|indocyanine-green|indocyanine-green
21128|NCT03155464|systemic scerlosis|systemic scerlosis
21129|NCT03155438|Oxidative stress|oxidative stress
21130|NCT03155438|Cumulus cell|cumulus cell
21131|NCT03155438|Controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
21132|NCT03155438|In vitro fertilization|in vitro fertilization
21133|NCT03155438|Low responder|low responder
21134|NCT03155412|Type 2 Diabetes|type 2 diabetes
21135|NCT03155412|adipose tissue|adipose tissue
21136|NCT03155412|preadipocytes|preadipocytes
21137|NCT03155412|expandability|expandability
21138|NCT03155412|hypertrophy|hypertrophy
21139|NCT03155412|hyperplasia|hyperplasia
21140|NCT03155412|lipogenesis|lipogenesis
21141|NCT03155412|adipogenesis|adipogenesis
21142|NCT03155412|insulin sensitivity|insulin sensitivity
21143|NCT03155399|Stroke|stroke
21144|NCT03155399|Neurorehabilitation|neurorehabilitation
21145|NCT03155399|Proprioceptive Training|proprioceptive training
21146|NCT03155399|Bilateral Arm Training|bilateral arm training
21147|NCT03155399|Intracortical Inhibition|intracortical inhibition
21148|NCT03155373|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
21149|NCT03155360|Colics|colics
21150|NCT03155360|infant colics|infant colics
21151|NCT03155360|Migraine equivalent|migraine equivalent
21152|NCT03155360|Migraine|migraine
21153|NCT03155360|Episodic symptoms associated to migraine|episodic symptoms associated to migraine
21154|NCT03155360|Colic|colic
21155|NCT03155334|Multiple Sclerosis; Patient Information Sheet; User Testing|multiple sclerosis; patient information sheet; user testing
21156|NCT03155256|EUS, cyanoacrylate, coils, gastric varices|eus, cyanoacrylate, coils, gastric varices
21157|NCT03155243|Humira®|humira®
21158|NCT03155243|Ocular inflammation|ocular inflammation
21159|NCT03155243|Adalimumab|adalimumab
21160|NCT03155243|Active non-infectious intermediate, posterior and panuveitis|active non-infectious intermediate, posterior and panuveitis
21161|NCT03155230|Inguinal hernia|inguinal hernia
21162|NCT03155217|melanoma|melanoma
21163|NCT03155217|elderly|elderly
21164|NCT03155217|tolerance|tolerance
21165|NCT03155217|adverse effects|adverse effects
21166|NCT03155217|targeted therapies|targeted therapies
21167|NCT03155204|inhalation|inhalation
21168|NCT03155204|LABA|laba
21169|NCT03155204|corticosteroid|corticosteroid
21170|NCT03155191|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
21171|NCT03155191|Leukemia|leukemia
21172|NCT03155191|Lymphoblastic|lymphoblastic
21173|NCT03155191|TBI-1501|tbi-1501
21174|NCT03155191|Anti-CD19 CAR Expressing T cells Therapy|anti-cd19 car expressing t cells therapy
21175|NCT03155191|CD19 CAR Gene-Transduced Lymphocyte|cd19 car gene-transduced lymphocyte
21176|NCT03155191|Adoptive Immunotherapy|adoptive immunotherapy
21177|NCT03155191|Genetically Engineered Lymphocyte Therapy|genetically engineered lymphocyte therapy
21178|NCT03155191|Retroviral Vector|retroviral vector
21179|NCT03155191|Neoplasms by Histologic Type|neoplasms by histologic type
21180|NCT03155191|Neoplasms|neoplasms
21181|NCT03155191|Neoplasms, Experimental|neoplasms, experimental
21182|NCT03155191|Immune System Diseases|immune system diseases
21183|NCT03155191|Chimeric antigen receptor|chimeric antigen receptor
21184|NCT03155165|Colonoscopy, Retroview™ colonoscope, retrofex colonoscopy|colonoscopy, retroview™ colonoscope, retrofex colonoscopy
21185|NCT03155139|prevalence|prevalence
21186|NCT03155139|primary aldosteronism|primary aldosteronism
21187|NCT03155139|hypertension|hypertension
21188|NCT03155139|nationwide|nationwide
21189|NCT03155126|shock|shock
21190|NCT03155126|acute kidney injury|acute kidney injury
21191|NCT03155126|crystalloid|crystalloid
21192|NCT03155113|Chronic infection|chronic infection
21193|NCT03155113|HCV|hcv
21194|NCT03155113|DAA therapy|daa therapy
21195|NCT03155113|immune response|immune response
21196|NCT03155087|T2DM|t2dm
21197|NCT03155087|genetic polymorphism|genetic polymorphism
21198|NCT03155087|diabetic nephropathy|diabetic nephropathy
21199|NCT03155035|deworming|deworming
21200|NCT03155035|STH|sth
21201|NCT03155022|ST-elevation myocardial infarction|st-elevation myocardial infarction
21202|NCT03154996|Gliomas|gliomas
21203|NCT03154996|Recurrent|recurrent
21204|NCT03154996|Chronic Convection|chronic convection
21205|NCT03154996|High Grade Gliomas|high grade gliomas
21206|NCT03154983|Mesylate Apatinib|mesylate apatinib
21207|NCT03154983|The First-line Treatment|the first-line treatment
21208|NCT03154983|Metastatic Gastric Cancer|metastatic gastric cancer
21209|NCT03154970|Physical Therapy Specialty|physical therapy specialty
21210|NCT03154931|PTSD|ptsd
21212|NCT03154931|CFT|cft
21213|NCT03154931|compassion|compassion
21214|NCT03154931|shame|shame
21215|NCT03154931|guilty|guilty
21216|NCT03154931|self-criticism|self-criticism
21217|NCT03154879|Heart arrest|heart arrest
21218|NCT03154879|Hypothermia|hypothermia
21219|NCT03154879|EEG|eeg
21220|NCT03154879|Prognosis|prognosis
21221|NCT03154866|Lactobacillus kefiri LKF01 DSM32079|lactobacillus kefiri lkf01 dsm32079
21222|NCT03154866|Microbial Colonization|microbial colonization
21223|NCT03154853|Electromyography,Excessive Foot Pronation,exercise,neurology,physical therapy|electromyography,excessive foot pronation,exercise,neurology,physical therapy
21224|NCT03154814|ulinastatin|ulinastatin
21225|NCT03154814|cardiopulmonary bypass|cardiopulmonary bypass
21226|NCT03154814|cardiac surgery|cardiac surgery
21227|NCT03154788|Falls prevention|falls prevention
21228|NCT03154788|Community-Based Participatory Research|community-based participatory research
21229|NCT03154749|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
21230|NCT03154749|Triple-Negative Breast Cancer|triple-negative breast cancer
21232|NCT03154736|FDRCV|fdrcv
21233|NCT03154736|Developing countries|developing countries
21234|NCT03154736|Rcih countries|rcih countries
21235|NCT03154710|Web-mediated follow up|web-mediated follow up
21236|NCT03154710|Lymphoma|lymphoma
21237|NCT03154710|Personalized medicine|personalized medicine
21238|NCT03154684|Autonomy|autonomy
21239|NCT03154684|Rehabilitation|rehabilitation
21240|NCT03154684|Falls|falls
21241|NCT03154684|Quality of life|quality of life
21242|NCT03154684|Senior|senior
21243|NCT03154671|older adult;|older adult;
21244|NCT03154671|comprehensive geriatric assessment|comprehensive geriatric assessment
21245|NCT03154671|chemotherapy|chemotherapy
21246|NCT03154671|integrated care|integrated care
21247|NCT03154671|randomized controlled trial|randomized controlled trial
21248|NCT03154632|Myofascial trigger point|myofascial trigger point
21249|NCT03154632|Trapezius Muscle|trapezius muscle
21250|NCT03154632|Diathermy|diathermy
21251|NCT03154632|Ultrasound|ultrasound
21252|NCT03154593|Prevalence|prevalence
21253|NCT03154541|Chronic Rhinosinusitis (CRS), Cystic Fibrosis related CRS|chronic rhinosinusitis (crs), cystic fibrosis related crs
21254|NCT03154515|Respiratory Tract Infections|respiratory tract infections
21255|NCT03154515|Acute Respiratory Viral Infection|acute respiratory viral infection
21256|NCT03154502|Sodium intake|sodium intake
21257|NCT03154502|Urinary sodium excretion|urinary sodium excretion
21258|NCT03154411|ABY-029|aby-029
21259|NCT03154411|Affibody|affibody
21260|NCT03154411|molecular fluorescence-guided surgery|molecular fluorescence-guided surgery
21261|NCT03154411|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
21262|NCT03154398|evaluation of thyroid function in diabetes patients|evaluation of thyroid function in diabetes patients
21264|NCT03154346|Baseline|baseline
21265|NCT03154346|Project Baseline|project baseline
21266|NCT03154346|Baseline Study|baseline study
21267|NCT03154346|Project Baseline Study|project baseline study
21268|NCT03154333|Epidermolysis|epidermolysis
21269|NCT03154333|bullosa|bullosa
21270|NCT03154333|simplex|simplex
21271|NCT03154333|blister|blister
21272|NCT03154333|EBS|ebs
21273|NCT03154333|topical|topical
21274|NCT03154333|ointment|ointment
21275|NCT03154333|lesion|lesion
21276|NCT03154281|Breast|breast
21277|NCT03154281|Ovarian|ovarian
21278|NCT03154268|Gestational weight gain|gestational weight gain
21279|NCT03154268|Chinese pregnant women|chinese pregnant women
21280|NCT03154268|Retrospective longitudinal study|retrospective longitudinal study
21281|NCT03154268|China|china
21282|NCT03154268|IOM guideline|iom guideline
21283|NCT03154268|Adverse outcome|adverse outcome
21284|NCT03154268|Model|model
21285|NCT03154255|Obesity|obesity
21286|NCT03154255|Paediatric|paediatric
21287|NCT03154255|Mediterranean diet|mediterranean diet
21288|NCT03154255|Gamification|gamification
21289|NCT03154255|Insulin-resistance|insulin-resistance
21290|NCT03154242|non small cell lung cancer|non small cell lung cancer
21291|NCT03154242|NSCLC|nsclc
21292|NCT03154242|Platinum|platinum
21293|NCT03154151|PTSD|ptsd
21294|NCT03154151|Post-Traumatic Stress Disorder|post-traumatic stress disorder
21295|NCT03154151|Post-Traumatic Stress Disorder symptoms|post-traumatic stress disorder symptoms
21296|NCT03154151|World Trade Center|world trade center
21297|NCT03154151|9/11|9/11
21298|NCT03154151|first responder|first responder
21299|NCT03154151|rescue/recovery/clean-up worker|rescue/recovery/clean-up worker
21300|NCT03154138|Stroke|stroke
21301|NCT03154138|hemiplegia|hemiplegia
21302|NCT03154138|rehabilitation|rehabilitation
21303|NCT03154138|prismatic adaptation|prismatic adaptation
21304|NCT03154138|postural imbalance|postural imbalance
21305|NCT03154138|posture|posture
21306|NCT03154138|spatial cognition|spatial cognition
21307|NCT03154099|CIRCI|circi
21308|NCT03154086|REarranged during Transfection|rearranged during transfection
21309|NCT03154073|Exercise|exercise
21310|NCT03154073|Physical activity|physical activity
21311|NCT03154073|Blood glucose|blood glucose
21312|NCT03154073|Sleep|sleep
21313|NCT03154060|Flash glucose monitoring|flash glucose monitoring
21314|NCT03154060|Accuracy|accuracy
21315|NCT03154060|Precision|precision
21316|NCT03154034|Stress echocardiography|stress echocardiography
21317|NCT03154034|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
21318|NCT03154034|ergospirometry|ergospirometry
21319|NCT03154021|Gingival Index|gingival index
21320|NCT03154021|Plaque Index|plaque index
21321|NCT03154021|Bleeding|bleeding
21322|NCT03154021|Pocket Depth|pocket depth
21323|NCT03154008|reward|reward
21324|NCT03154008|emotion regulation|emotion regulation
21325|NCT03154008|electroencephalogram|electroencephalogram
21326|NCT03154008|event-related potentials|event-related potentials
21327|NCT03154008|cognitive behavior therapy|cognitive behavior therapy
21328|NCT03153995|expander|expander
21329|NCT03153982|HNSCC|hnscc
21330|NCT03153956|AposTherapy® System|apostherapy® system
21332|NCT03153956|Total knee arthroplasties|total knee arthroplasties
21333|NCT03153956|Degenerative joint disease|degenerative joint disease
21334|NCT03153930|sedentary behavior|sedentary behavior
21335|NCT03153930|youth|youth
21336|NCT03153930|moderating factors|moderating factors
21337|NCT03153930|metabolic outcomes|metabolic outcomes
21338|NCT03153917|shift work|shift work
21339|NCT03153917|melatonin|melatonin
21340|NCT03153917|sleep|sleep
21341|NCT03153904|anxiety|anxiety
21342|NCT03153904|depression|depression
21343|NCT03153904|trauma|trauma
21344|NCT03153904|behavior problems|behavior problems
21345|NCT03153904|evidence-based treatments|evidence-based treatments
21346|NCT03153904|manualized treatments|manualized treatments
21347|NCT03153904|cognitive-behavioral therapy|cognitive-behavioral therapy
21348|NCT03153904|youth|youth
21349|NCT03153904|mental health|mental health
21350|NCT03153891|environment|environment
21351|NCT03153891|nature|nature
21352|NCT03153878|Unruptured Intracranial Aneurysm|unruptured intracranial aneurysm
21353|NCT03153878|Benefit-risk|benefit-risk
21354|NCT03153878|Ischemic heart disease|ischemic heart disease
21355|NCT03153878|Ischemic cerebrovascular disease|ischemic cerebrovascular disease
21356|NCT03153878|Antithrombotic|antithrombotic
21357|NCT03153878|Anticoagulant|anticoagulant
21358|NCT03153878|People's Republic of China|people's republic of china
21359|NCT03153878|Multicenter Studies|multicenter studies
21360|NCT03153839|Children|children
21361|NCT03153839|Babies|babies
21362|NCT03153839|Infant|infant
21363|NCT03153839|Swimming pool|swimming pool
21364|NCT03153839|Aquatic physical activity|aquatic physical activity
21365|NCT03153839|Motor development|motor development
21366|NCT03153839|Neurodevelopment|neurodevelopment
21367|NCT03153826|COPD Exacerbation|copd exacerbation
21368|NCT03153826|Muscle atrophy|muscle atrophy
21369|NCT03153826|Inflammation|inflammation
21370|NCT03153826|Oxidative stress|oxidative stress
21371|NCT03153813|pain|pain
21372|NCT03153813|knee osteoarthritis|knee osteoarthritis
21373|NCT03153813|obesity|obesity
21374|NCT03153813|capsaicin|capsaicin
21375|NCT03153787|implantation failure|implantation failure
21376|NCT03153787|fertility|fertility
21377|NCT03153787|microbiome|microbiome
21378|NCT03153787|Assisted reproduction|assisted reproduction
21379|NCT03153774|Sarcopenia|sarcopenia
21380|NCT03153774|Heart failure (HF)|heart failure (hf)
21381|NCT03153774|The trans aortic valvular implantation (TAVI)|the trans aortic valvular implantation (tavi)
21382|NCT03153748|Treatment strategy|treatment strategy
21383|NCT03153735|Hyaluronic acid|hyaluronic acid
21384|NCT03153735|Small Penis|small penis
21385|NCT03153735|Penile Enhancement|penile enhancement
21386|NCT03153722|pediatric|pediatric
21387|NCT03153722|hospital discharge|hospital discharge
21388|NCT03153722|quality improvement|quality improvement
21389|NCT03153722|transition of care|transition of care
21390|NCT03153709|Pregnancy rates|pregnancy rates
21391|NCT03153709|pharmacokinetic interactions|pharmacokinetic interactions
21392|NCT03153709|Women on efavirenz|women on efavirenz
21393|NCT03153709|initiating the Levonorgestrel Implant|initiating the levonorgestrel implant
21394|NCT03153709|initiating the Depot Medroxyprogesterone Acetate Injectable|initiating the depot medroxyprogesterone acetate injectable
21395|NCT03153683|Acute, Ischemic, Stroke, Biomarkers, Proteins, Leukocyte, Inflammatory Cells; Acid/Base Balance|acute, ischemic, stroke, biomarkers, proteins, leukocyte, inflammatory cells; acid/base balance
21396|NCT03153657|Tooth Bleaching|tooth bleaching
21397|NCT03153644|Qualitative Research|qualitative research
21398|NCT03153644|Medical conditions|medical conditions
21399|NCT03153644|Birth control methods|birth control methods
21400|NCT03153644|Intrauterine Devices|intrauterine devices
21401|NCT03153644|Physicians, Primary Care|physicians, primary care
21402|NCT03153644|Long-acting reversible contraceptives (LARC)|long-acting reversible contraceptives (larc)
21403|NCT03153540|Aphasia|aphasia
21404|NCT03153540|Agrammatism|agrammatism
21405|NCT03153540|Frontotemporal Dementia|frontotemporal dementia
21406|NCT03153540|Tauopathies|tauopathies
21407|NCT03153540|Neurodegenerative Diseases|neurodegenerative diseases
21408|NCT03153540|Language Disorders|language disorders
21409|NCT03153540|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
21411|NCT03153488|ADHD|adhd
21412|NCT03153488|Methylphenidate|methylphenidate
21413|NCT03153488|Amphetamine|amphetamine
21414|NCT03153488|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
21415|NCT03153488|Treatment|treatment
21416|NCT03153475|Revision knee surgery, implant replacement|revision knee surgery, implant replacement
21417|NCT03153449|complex primary, deformity, ligamentous laxity|complex primary, deformity, ligamentous laxity
21418|NCT03153410|Pancreas vaccine|pancreas vaccine
21419|NCT03153410|immunotherapy|immunotherapy
21420|NCT03153410|antibody|antibody
21421|NCT03153410|PD-1|pd-1
21422|NCT03153410|IMC-CS4|imc-cs4
21423|NCT03153410|Pembrolizumab|pembrolizumab
21424|NCT03153410|GVAX|gvax
21425|NCT03153410|Borderline Resectable|borderline resectable
21426|NCT03153397|trauma|trauma
21427|NCT03153397|brain|brain
21428|NCT03153397|neurological|neurological
21429|NCT03153397|injury|injury
21430|NCT03153397|enteral|enteral
21431|NCT03153397|tube|tube
21432|NCT03153397|feeding|feeding
21433|NCT03153397|nutrition|nutrition
21434|NCT03153384|Diagnosis|diagnosis
21435|NCT03153384|Blood Culture|blood culture
21436|NCT03153371|Alzheimer's disease|alzheimer's disease
21437|NCT03153371|Young-onset|young-onset
21438|NCT03153371|variant|variant
21439|NCT03153371|visuospatial|visuospatial
21440|NCT03153371|language|language
21441|NCT03153371|apraxia|apraxia
21442|NCT03153371|control|control
21443|NCT03153371|dementia|dementia
21444|NCT03153371|memory|memory
21446|NCT03153371|neurology|neurology
21447|NCT03153371|neuropsychology|neuropsychology
21448|NCT03153371|brain|brain
21449|NCT03153358|EGFR mutation icotinib SBRT|egfr mutation icotinib sbrt
21450|NCT03153306|Albumin|albumin
21451|NCT03153293|Leber's Hereditary Optic Neuropathy,G11778A mutation, rAAV2-ND4，gene therapy|leber's hereditary optic neuropathy,g11778a mutation, raav2-nd4，gene therapy
21452|NCT03153254|Upper extremity|upper extremity
21453|NCT03153254|Rehabilitation|rehabilitation
21454|NCT03153254|Robot assisted therapy|robot assisted therapy
21455|NCT03153254|Robotics|robotics
21456|NCT03153254|Devices|devices
21457|NCT03153254|Orthosis|orthosis
21458|NCT03153228|E-cigarettes|e-cigarettes
21459|NCT03153202|Ibrutinib|ibrutinib
21460|NCT03153202|Pembrolizumab|pembrolizumab
21461|NCT03153202|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
21462|NCT03153202|Mantle Cell Lymphoma|mantle cell lymphoma
21463|NCT03153189|PA,menatal health,QOL|pa,menatal health,qol
21464|NCT03153176|physical activity|physical activity
21465|NCT03153176|physical fitness|physical fitness
21466|NCT03153176|eating habits|eating habits
21467|NCT03153176|sedentary behavior|sedentary behavior
21468|NCT03153176|sleep quality|sleep quality
21469|NCT03153176|satisfaction personal|satisfaction personal
21470|NCT03153176|school health|school health
21471|NCT03153176|adolescent|adolescent
21472|NCT03153150|Oral anticoagulant|oral anticoagulant
21473|NCT03153150|Factor Xa inhibitors|factor xa inhibitors
21474|NCT03153150|Direct thrombin inhibitor|direct thrombin inhibitor
21475|NCT03153150|Vitamin K antagonist|vitamin k antagonist
21476|NCT03153150|Antiplatelet drug|antiplatelet drug
21477|NCT03153124|Respiratory muscle strength|respiratory muscle strength
21478|NCT03153124|Renal insufficiency|renal insufficiency
21479|NCT03153124|Respiratory muscle training|respiratory muscle training
21480|NCT03153098|physical activity|physical activity
21481|NCT03153098|intervention|intervention
21482|NCT03153098|behaviour change|behaviour change
21483|NCT03153098|inactive adults|inactive adults
21589|NCT03152461|Coagulation|coagulation
21484|NCT03153098|behaviour change techniques|behaviour change techniques
21485|NCT03153098|well-being|well-being
21486|NCT03153085|Unresectable melanoma|unresectable melanoma
21487|NCT03153085|Metastatic melanoma|metastatic melanoma
21488|NCT03153085|Recurrent Melanoma|recurrent melanoma
21489|NCT03153085|TBI-1401(HF10)|tbi-1401(hf10)
21490|NCT03153085|HF10|hf10
21491|NCT03153085|HSV-1|hsv-1
21492|NCT03153085|Oncolytic virus|oncolytic virus
21493|NCT03153085|Oncolytic viral immunotherapy|oncolytic viral immunotherapy
21494|NCT03153085|Ipilimumab|ipilimumab
21495|NCT03153085|Intratumoral administration|intratumoral administration
21496|NCT03153059|gut microbiota|gut microbiota
21497|NCT03153059|stool frequency|stool frequency
21498|NCT03153046|prebiotics|prebiotics
21499|NCT03153046|cognitive impairment|cognitive impairment
21500|NCT03153046|weight gain|weight gain
21501|NCT03153033|Wheelchair propulsion|wheelchair propulsion
21502|NCT03153033|Shoulder|shoulder
21503|NCT03153033|Biomechanics|biomechanics
21504|NCT03152994|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
21505|NCT03152994|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
21508|NCT03152994|lymphocyte-monocyte ratio|lymphocyte-monocyte ratio
21510|NCT03152955|trigeminal neuralgia|trigeminal neuralgia
21511|NCT03152955|nerve block|nerve block
21512|NCT03152929|Surgery|surgery
21513|NCT03152929|Breast|breast
21514|NCT03152929|Pectoral Never Block|pectoral never block
21515|NCT03152929|Paravertebral Block|paravertebral block
21516|NCT03152929|Analgesia|analgesia
21517|NCT03152929|Mastectomy|mastectomy
21518|NCT03152916|subtalar joint|subtalar joint
21519|NCT03152916|arthrodesis|arthrodesis
21520|NCT03152916|3d printing|3d printing
21521|NCT03152903|Recombinant BCG vaccine|recombinant bcg vaccine
21522|NCT03152903|Category 1 pulmonary tuberculosis|category 1 pulmonary tuberculosis
21523|NCT03152903|Recurrence|recurrence
21524|NCT03152903|Efficacy|efficacy
21525|NCT03152890|Insulin|insulin
21526|NCT03152890|Liver transplantation|liver transplantation
21527|NCT03152890|Hyperglycemia|hyperglycemia
21528|NCT03152825|myocardial ischaemia|myocardial ischaemia
21529|NCT03152825|myocardial viability|myocardial viability
21530|NCT03152825|coronary chronic total occlusions|coronary chronic total occlusions
21531|NCT03152825|cardiac magnetic resonance|cardiac magnetic resonance
21533|NCT03152799|remote ischaemic conditioning|remote ischaemic conditioning
21534|NCT03152799|remote ischemic conditioning|remote ischemic conditioning
21535|NCT03152799|cerebral infarction|cerebral infarction
21536|NCT03152799|ischaemia reperfusion injury|ischaemia reperfusion injury
21537|NCT03152799|ischemia reperfusion injury|ischemia reperfusion injury
21538|NCT03152799|anterior circulation stroke|anterior circulation stroke
21539|NCT03152799|mechanical thrombectomy|mechanical thrombectomy
21540|NCT03152773|MRI Catheterization|mri catheterization
21541|NCT03152773|Real-time MRI|real-time mri
21546|NCT03152734|Elderly patients, Mortality, morbidity, post-intervention|elderly patients, mortality, morbidity, post-intervention
21547|NCT03152721|accelerometry|accelerometry
21410|NCT03153514|CLL|cll
21548|NCT03152721|home based|home based
21549|NCT03152721|motor complications|motor complications
21550|NCT03152721|Parkinson KinetiGraph|parkinson kinetigraph
21551|NCT03152721|Registry|registry
21552|NCT03152682|glucose|glucose
21553|NCT03152682|glucose homeostasis|glucose homeostasis
21554|NCT03152669|asthma|asthma
21555|NCT03152669|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
21556|NCT03152669|Salford Lung Study|salford lung study
21557|NCT03152656|Familial hypercholesterolemia|familial hypercholesterolemia
21558|NCT03152656|total cholesterol|total cholesterol
21559|NCT03152656|low-density lipoprotein cholesterol|low-density lipoprotein cholesterol
21560|NCT03152656|tendon xanthomas|tendon xanthomas
21561|NCT03152656|premature atherosclerosis|premature atherosclerosis
21562|NCT03152630|lncRNAs|lncrnas
21563|NCT03152630|Alzheimer's disease|alzheimer's disease
21564|NCT03152630|vascular dementia|vascular dementia
21565|NCT03152617|bariatric surgery|bariatric surgery
21566|NCT03152617|gastric bypass|gastric bypass
21567|NCT03152617|malnutrition|malnutrition
21568|NCT03152617|bone disease|bone disease
21569|NCT03152617|oral health|oral health
21570|NCT03152591|Polycystic ovary syndrome|polycystic ovary syndrome
21571|NCT03152591|PCOS|pcos
21572|NCT03152591|hyperandrogenism|hyperandrogenism
21573|NCT03152591|insulin resistance|insulin resistance
21574|NCT03152591|overweight|overweight
21575|NCT03152591|obesity|obesity
21576|NCT03152552|diabetes type 2|diabetes type 2
21577|NCT03152552|heart failure|heart failure
21578|NCT03152500|IOL|iol
21579|NCT03152500|Stability|stability
21580|NCT03152500|FEMTIS IOL|femtis iol
21581|NCT03152500|Acrysof IOL|acrysof iol
21582|NCT03152500|FLACS|flacs
21583|NCT03152500|Capsulotomy|capsulotomy
21584|NCT03152487|endoscopic ultrasound|endoscopic ultrasound
21585|NCT03152487|celiac plexus neurolysis|celiac plexus neurolysis
21586|NCT03152487|radiofrequency ablation|radiofrequency ablation
21587|NCT03152487|pancreatic cancer|pancreatic cancer
21588|NCT03152461|Viscoelastic testing|viscoelastic testing
21590|NCT03152461|Quantra|quantra
21591|NCT03152461|Hemostasis|hemostasis
21592|NCT03152448|Prolaris|prolaris
21593|NCT03152448|Prostate Cancer|prostate cancer
21594|NCT03152409|Aspirin|aspirin
21595|NCT03152409|Treatment|treatment
21596|NCT03152409|Salicylic acid|salicylic acid
21597|NCT03152409|anti-inflammatory|anti-inflammatory
21598|NCT03152396|modifiable cardiovascular risk factors|modifiable cardiovascular risk factors
21599|NCT03152396|cardiovascular risk factors|cardiovascular risk factors
21600|NCT03152396|blood pressure|blood pressure
21601|NCT03152396|LDL-cholesterol|ldl-cholesterol
21602|NCT03152396|total-cholesterol|total-cholesterol
21603|NCT03152396|HDL-cholesterol|hdl-cholesterol
21604|NCT03152396|hemoglobin A1C|hemoglobin a1c
21605|NCT03152396|tobacco cessation|tobacco cessation
21606|NCT03152396|patient satisfaction|patient satisfaction
21607|NCT03152383|Autism Spectrum Disorder|autism spectrum disorder
21608|NCT03152383|Behavioral Research|behavioral research
21609|NCT03152383|Psychology|psychology
21610|NCT03152383|Cognitive Disorders|cognitive disorders
21611|NCT03152370|E7046|e7046
21612|NCT03152370|Radiotherapy/Chemoradiotherapy|radiotherapy/chemoradiotherapy
21613|NCT03152370|Neoadjuvant therapy|neoadjuvant therapy
21614|NCT03152370|Rectal cancer|rectal cancer
21615|NCT03152357|osteoarthritis|osteoarthritis
21616|NCT03152357|total knee arthroplasty|total knee arthroplasty
21617|NCT03152357|TKA|tka
21618|NCT03152357|TKR|tkr
21619|NCT03152357|patient specific|patient specific
21620|NCT03152357|Conformis|conformis
21621|NCT03152344|Fall|fall
21622|NCT03152344|Balance control|balance control
21623|NCT03152344|Screening test|screening test
21624|NCT03152344|Oxygen|oxygen
21625|NCT03152344|Skeletal muscle mass|skeletal muscle mass
21626|NCT03152331|Neurofeedback|neurofeedback
21627|NCT03152318|Malignant Glioma|malignant glioma
21628|NCT03152305|Migraine|migraine
21629|NCT03152305|Intracranial pressure|intracranial pressure
21630|NCT03152305|Headache|headache
21631|NCT03152253|Tobacco, Smoking, Text Message|tobacco, smoking, text message
21632|NCT03152240|Acute Coronary Syndrome|acute coronary syndrome
21633|NCT03152240|Primary Angioplasty|primary angioplasty
21636|NCT03152188|Hepatic Encephalopathy|hepatic encephalopathy
21643|NCT03152175|Propranolol|propranolol
21644|NCT03152175|Police officers|police officers
21645|NCT03152175|911 operators|911 operators
21646|NCT03152175|Efficacy|efficacy
21647|NCT03152175|Cost-effectiveness|cost-effectiveness
21648|NCT03152162|osteoarthritis|osteoarthritis
21649|NCT03152162|patient-specific|patient-specific
21650|NCT03152162|knee replacement|knee replacement
21652|NCT03152162|knee arthroplasty|knee arthroplasty
21653|NCT03152162|total knee replacement|total knee replacement
21654|NCT03152162|posterior stabilized|posterior stabilized
21655|NCT03152149|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
13552|NCT03203837|Liver|liver
21656|NCT03152110|High Intensity Interval Training|high intensity interval training
21657|NCT03152110|HIIT|hiit
21658|NCT03152110|Physical Activity|physical activity
21659|NCT03152071|thoracoscopic surgery|thoracoscopic surgery
21660|NCT03152071|RATS|rats
21661|NCT03152071|VATS|vats
21662|NCT03152071|Robot|robot
21663|NCT03152045|communication between adolescent patients and their clinician|communication between adolescent patients and their clinician
21664|NCT03152032|employment service|employment service
21665|NCT03152032|vocational counseling|vocational counseling
21666|NCT03152032|employment outcome|employment outcome
21667|NCT03152032|schizophrenia|schizophrenia
21668|NCT03152032|bipolar|bipolar
21669|NCT03152032|occupational therapy in mental health|occupational therapy in mental health
21670|NCT03152019|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
21671|NCT03152019|Antiangiogenic therapy|antiangiogenic therapy
21672|NCT03152019|Tacrolimus|tacrolimus
21673|NCT03152006|Healthcare transition|healthcare transition
21674|NCT03152006|Adolescents|adolescents
21675|NCT03152006|Nigeria|nigeria
21676|NCT03151993|Ischemic Stroke|ischemic stroke
21677|NCT03151993|Fibrinolysis|fibrinolysis
21678|NCT03151993|Fortelyzin|fortelyzin
21679|NCT03151954|nasal epithelium stem cells|nasal epithelium stem cells
21680|NCT03151954|Hippo-YAP pathway|hippo-yap pathway
21681|NCT03151954|proliferation|proliferation
21682|NCT03151954|differentiation|differentiation
21683|NCT03151863|Dexmedetomidine|dexmedetomidine
21684|NCT03151863|Opioids|opioids
21685|NCT03151863|Palliative Care|palliative care
21686|NCT03151863|Elderly people|elderly people
21687|NCT03151863|Nursing care|nursing care
21688|NCT03151863|Analgesia|analgesia
21689|NCT03151863|Sedation|sedation
21690|NCT03151863|Anxiolysis|anxiolysis
21691|NCT03151863|Intranasal|intranasal
21692|NCT03151850|fungal|fungal
21693|NCT03151850|mucosa|mucosa
21694|NCT03151850|diversity|diversity
21695|NCT03151850|Basidiomycete|basidiomycete
21696|NCT03151837|Diabetes|diabetes
21697|NCT03151837|Bitter melon(Momordica charantia)|bitter melon(momordica charantia)
21698|NCT03151837|Insulin sensitivity|insulin sensitivity
23145|NCT03142191|Efficacy|efficacy
21704|NCT03151798|Nonalcoholic fatty liver|nonalcoholic fatty liver
21705|NCT03151798|Exercise|exercise
21706|NCT03151798|Weight loss diet|weight loss diet
21707|NCT03151785|CPR|cpr
21709|NCT03151785|Education|education
21710|NCT03151785|Lifesaver|lifesaver
21711|NCT03151733|SILS|sils
21712|NCT03151733|colorectal cancer|colorectal cancer
21713|NCT03151694|childhood obesity|childhood obesity
21714|NCT03151694|body weight|body weight
21715|NCT03151694|nutritional risk|nutritional risk
21716|NCT03151681|Reconsolidation|reconsolidation
21717|NCT03151681|Propranolol|propranolol
21718|NCT03151681|Infidelity|infidelity
21719|NCT03151681|Attachment injury|attachment injury
21720|NCT03151681|Romantic relationships|romantic relationships
21721|NCT03151603|Uva Ursi|uva ursi
21722|NCT03151603|fosfomycin|fosfomycin
21723|NCT03151603|uncomplicated urinary tract infection of women|uncomplicated urinary tract infection of women
21724|NCT03151564|Diseases of liver|diseases of liver
21725|NCT03151564|Colon carcinoma|colon carcinoma
21726|NCT03151564|Colorectal carcinoma|colorectal carcinoma
21727|NCT03151564|Liver metastases|liver metastases
21728|NCT03151564|Computed tomography|computed tomography
21730|NCT03151564|Reduced radiation doses|reduced radiation doses
21731|NCT03151538|Pedography|pedography
21732|NCT03151538|Exercise|exercise
21733|NCT03151538|Play Training|play training
21734|NCT03151538|Pes Planus|pes planus
21735|NCT03151538|Femoral Anteversion|femoral anteversion
21736|NCT03151512|MRI|mri
21737|NCT03151512|distortion correction|distortion correction
21738|NCT03151512|Magnetic Resonance Imaging|magnetic resonance imaging
21739|NCT03151512|prostheses|prostheses
21740|NCT03151447|Breast Cancer|breast cancer
21741|NCT03151447|Anti-PD1 Antibody|anti-pd1 antibody
21742|NCT03151447|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
21743|NCT03151434|VATS|vats
21744|NCT03151434|pain|pain
21745|NCT03151421|air quality feedback|air quality feedback
21746|NCT03151421|second-hand smoke|second-hand smoke
21747|NCT03151421|passive smoking|passive smoking
21748|NCT03151421|exposure to second-hand smoke|exposure to second-hand smoke
21749|NCT03151421|second-hand smoke exposure prevention|second-hand smoke exposure prevention
21751|NCT03151395|COPD|copd
21752|NCT03151395|AECOPD|aecopd
21753|NCT03151395|GOLD (Global Initiative for Chronic Obstructive Lung Disease)|gold (global initiative for chronic obstructive lung disease)
21754|NCT03151395|Asia Pacific|asia pacific
21755|NCT03151382|Alzheimer Disease|alzheimer disease
21756|NCT03151382|Cognitive Function|cognitive function
21757|NCT03151382|tandospirone|tandospirone
21759|NCT03151291|cancer cachexia|cancer cachexia
21760|NCT03151291|WB-EMS|wb-ems
21761|NCT03151291|skeletal muscle mass|skeletal muscle mass
21762|NCT03151291|exercise|exercise
21763|NCT03151291|nutrition|nutrition
21764|NCT03151291|dietary supplements|dietary supplements
21765|NCT03151278|Fluoroscopy|fluoroscopy
21766|NCT03151278|Ablation|ablation
21767|NCT03151278|Three dimensional|three dimensional
21768|NCT03151278|Atrial arrhythmia|atrial arrhythmia
21769|NCT03151278|Radiation|radiation
21770|NCT03151265|Functional Outcome Measures|functional outcome measures
21771|NCT03151265|Wearable Sensors|wearable sensors
21772|NCT03151265|ViMove|vimove
21773|NCT03151265|Low Back Pain|low back pain
21774|NCT03151265|Range of Movement|range of movement
21775|NCT03151265|Muscle Activity|muscle activity
21776|NCT03151265|ThermaCare|thermacare
21777|NCT03151226|obstructive sleep apnea screen negative|obstructive sleep apnea screen negative
21778|NCT03151226|respiratory depression|respiratory depression
21779|NCT03151226|cesarean section|cesarean section
21780|NCT03151200|Amblyopia treatment|amblyopia treatment
21781|NCT03151161|chemotherapy|chemotherapy
21782|NCT03151161|maintenance therapy|maintenance therapy
21783|NCT03151161|icotinib|icotinib
21784|NCT03151148|allogeneic targeted microbiome transplant (TMT)|allogeneic targeted microbiome transplant (tmt)
21785|NCT03151148|dysbiosis in AD|dysbiosis in ad
21786|NCT03151148|Staphylococcus aureus colonized skin|staphylococcus aureus colonized skin
21787|NCT03151148|antimicrobial peptides (AMPs)|antimicrobial peptides (amps)
21788|NCT03151148|randomized trial|randomized trial
21789|NCT03151135|Energy metabolism|energy metabolism
21790|NCT03151109|reverse total shoulder arthroplasty|reverse total shoulder arthroplasty
21791|NCT03151109|glenoid bone loss|glenoid bone loss
21792|NCT03151083|Health Technology|health technology
21793|NCT03151083|Internet-Based Psychotherapy|internet-based psychotherapy
21794|NCT03151083|self-care|self-care
21795|NCT03151083|Primary Care|primary care
21796|NCT03151083|Mental Health|mental health
21797|NCT03151057|Idelalisib|idelalisib
21798|NCT03151057|Gilead|gilead
21799|NCT03151057|Gladstone|gladstone
21800|NCT03151057|RIC allogeneic BMT|ric allogeneic bmt
21801|NCT03151057|Phase 1|phase 1
21802|NCT03151057|Hopkins|hopkins
21803|NCT03151057|B cell malignancies|b cell malignancies
21804|NCT03151044|epirubicin|epirubicin
21805|NCT03151044|high-dose|high-dose
21806|NCT03151044|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
23146|NCT03142191|IPF|ipf
21807|NCT03151044|medium/high-risk|medium/high-risk
21808|NCT03151031|balance|balance
21809|NCT03151031|college students|college students
21810|NCT03151031|star excursion balance test|star excursion balance test
21811|NCT03151018|coronary artery disease|coronary artery disease
21812|NCT03151018|percutaneous coronary intervention|percutaneous coronary intervention
21813|NCT03151018|zotarolimus-eluting stents|zotarolimus-eluting stents
21814|NCT03151005|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
21815|NCT03151005|Overweight|overweight
21817|NCT03151005|GLP-1 Agonist|glp-1 agonist
21818|NCT03151005|Oral contraceptives (OCs)|oral contraceptives (ocs)
21819|NCT03151005|Metformin|metformin
21820|NCT03151005|Reproductive Disorders|reproductive disorders
21821|NCT03151005|Cardiovascular risk factor|cardiovascular risk factor
21822|NCT03151005|Lipid Metabolism|lipid metabolism
21823|NCT03150992|Feasibility|feasibility
21824|NCT03150992|Elemental Diet|elemental diet
21825|NCT03150992|Quality of life|quality of life
21826|NCT03150992|Palliative|palliative
21827|NCT03150992|Nutrition|nutrition
21828|NCT03150992|Ovarian|ovarian
21829|NCT03150992|Peritoneal|peritoneal
21830|NCT03150992|Advanced|advanced
21831|NCT03150992|Metastatic|metastatic
21832|NCT03150992|Bowel obstruction|bowel obstruction
21833|NCT03150992|Inoperable|inoperable
21834|NCT03150979|Stroke|stroke
21835|NCT03150979|Assistive devices|assistive devices
21836|NCT03150979|Gait|gait
21837|NCT03150979|Rehabilitation|rehabilitation
21838|NCT03150979|Clinical trial|clinical trial
21839|NCT03150966|Multiple sclerosis|multiple sclerosis
21840|NCT03150966|Nanocurcumin|nanocurcumin
21841|NCT03150966|MicroRNAs|micrornas
21842|NCT03150966|Th17 cells|th17 cells
21843|NCT03150953|anesthesia|anesthesia
21844|NCT03150953|MRI|mri
21845|NCT03150953|thermoregulation|thermoregulation
21846|NCT03150862|Adult glioblastoma, adult gian cell glioblastoma, adult gliosarcoma, glioma neoplasms|adult glioblastoma, adult gian cell glioblastoma, adult gliosarcoma, glioma neoplasms
21847|NCT03150862|recurrent adult brain tumor|recurrent adult brain tumor
21848|NCT03150862|neoplasms, central nervous system neoplasms, neoplasms by histologic type, neoplasms by site|neoplasms, central nervous system neoplasms, neoplasms by histologic type, neoplasms by site
21851|NCT03150862|neuroectodermal tumors|neuroectodermal tumors
21852|NCT03150862|germ cell and embryonal|germ cell and embryonal
21853|NCT03150862|antineoplastic agents|antineoplastic agents
21854|NCT03150862|glandular and epithelial|glandular and epithelial
21855|NCT03150862|nerve tissue, nervous system diseases|nerve tissue, nervous system diseases
21856|NCT03150862|temozolomide|temozolomide
21857|NCT03150862|BGB-290|bgb-290
21858|NCT03150862|alkylating, alkylating agents|alkylating, alkylating agents
402900|NCT01229241|pharmacokinetics|pharmacokinetics
21750|NCT03151408|AML|aml
21859|NCT03150862|molecular mechanisms of pharmacological action|molecular mechanisms of pharmacological action
21860|NCT03150862|Poly(ADP-ribose) polymerase inhibitors|poly(adp-ribose) polymerase inhibitors
21861|NCT03150862|enzyme inhibitors|enzyme inhibitors
21862|NCT03150836|bladder cancer|bladder cancer
21863|NCT03150836|urothelial|urothelial
21864|NCT03150823|Direct current|direct current
21865|NCT03150823|Galvanic current|galvanic current
21866|NCT03150823|Handgrip Force|handgrip force
21867|NCT03150823|Palmar Grip|palmar grip
21868|NCT03150823|Dynamometry|dynamometry
21869|NCT03150823|Miofeedback|miofeedback
21870|NCT03150810|Ovarian cancer|ovarian cancer
21871|NCT03150810|Triple negative breast cancer|triple negative breast cancer
21872|NCT03150810|Small cell lung cancer|small cell lung cancer
21873|NCT03150810|Prostate cancer,|prostate cancer,
21874|NCT03150810|Gastric cancer|gastric cancer
21875|NCT03150810|neoplasms|neoplasms
21876|NCT03150810|temozolomide|temozolomide
21878|NCT03150810|antineoplastic agents|antineoplastic agents
21879|NCT03150810|alkylating, alkylating agents,|alkylating, alkylating agents,
21880|NCT03150810|Poly (ADP-ribose) polymerase inhibitors|poly (adp-ribose) polymerase inhibitors
21881|NCT03150810|enzyme inhibitors|enzyme inhibitors
21882|NCT03150797|UCSF|ucsf
21883|NCT03150797|UCLA|ucla
21884|NCT03150797|melatonin|melatonin
21885|NCT03150797|migraine|migraine
21886|NCT03150797|headache|headache
21887|NCT03150784|Motor Learning|motor learning
21888|NCT03150784|Coordination|coordination
21889|NCT03150784|Children|children
21890|NCT03150784|Motor Skills Disorders|motor skills disorders
21891|NCT03150784|Movement|movement
21892|NCT03150758|Erectile Disfunction|erectile disfunction
21893|NCT03150758|Urinary Function|urinary function
21894|NCT03150706|POLE mutation|pole mutation
21895|NCT03150706|mismatch repair deficient|mismatch repair deficient
21896|NCT03150706|Avelumab|avelumab
21897|NCT03150680|SYNTAX score|syntax score
21898|NCT03150680|SNPs|snps
21899|NCT03150680|Genetics|genetics
21900|NCT03150680|Pharmacogenetics|pharmacogenetics
21901|NCT03150680|Genetic Risk Score|genetic risk score
21902|NCT03150680|Precision Medicine|precision medicine
21903|NCT03150654|macular pigment|macular pigment
21904|NCT03150654|macular pigment optical density|macular pigment optical density
23844|NCT03137147|pain|pain
21905|NCT03150654|diabetic retinopathy|diabetic retinopathy
21906|NCT03150654|laser pan-retinal photocoagulation|laser pan-retinal photocoagulation
21907|NCT03150641|Maternal blood loss|maternal blood loss
21908|NCT03150641|Cesarean delivery|cesarean delivery
21909|NCT03150641|Delayed cord clamping|delayed cord clamping
21910|NCT03150641|Neonatal health|neonatal health
21911|NCT03150576|Triple negative breast cancer|triple negative breast cancer
21912|NCT03150576|germline BRCA|germline brca
21913|NCT03150576|platinum and PARP inhibitor|platinum and parp inhibitor
21914|NCT03150576|neoadjuvant chemotherapy|neoadjuvant chemotherapy
21915|NCT03150576|olaparib|olaparib
21916|NCT03150563|Stretching|stretching
21917|NCT03150563|Stretching sensation|stretching sensation
21918|NCT03150563|Isokinetic dynamometry|isokinetic dynamometry
21919|NCT03150563|Stretching load.|stretching load.
21920|NCT03150550|Mindfulness|mindfulness
21921|NCT03150550|Alcohol|alcohol
21922|NCT03150550|Alcohol Use Disorder|alcohol use disorder
21923|NCT03150550|Relapse|relapse
21924|NCT03150550|Relapse Prevention|relapse prevention
21925|NCT03150550|Cognitive-behavioral therapy|cognitive-behavioral therapy
21926|NCT03150537|jet injector|jet injector
21927|NCT03150537|influenza vaccine|influenza vaccine
21928|NCT03150537|immune response|immune response
21929|NCT03150524|stroke|stroke
21930|NCT03150524|RCVS|rcvs
21931|NCT03150498|Food Effect|food effect
21932|NCT03150498|Pharmacokinetics|pharmacokinetics
21933|NCT03150472|Dental Instruments|dental instruments
21934|NCT03150472|Dental Technology|dental technology
21935|NCT03150446|laparoscopy|laparoscopy
21936|NCT03150446|ureteral catheterization|ureteral catheterization
21937|NCT03150420|calciphylaxis|calciphylaxis
21938|NCT03150420|calcific uremic arteriolopathy, calcinosis|calcific uremic arteriolopathy, calcinosis
21939|NCT03150420|calcium metabolism disorders|calcium metabolism disorders
21940|NCT03150420|metabolic diseases|metabolic diseases
21941|NCT03150420|sodium thiosulfate|sodium thiosulfate
21945|NCT03150303|Periprocedural period|periprocedural period
21946|NCT03150303|Anticoagulant treatment|anticoagulant treatment
21947|NCT03150303|Thromboembolic events|thromboembolic events
21948|NCT03150303|Bleeding events|bleeding events
21949|NCT03150264|lung protective ventilation strategies|lung protective ventilation strategies
21951|NCT03150225|andropause|andropause
21952|NCT03150225|depressive symptoms|depressive symptoms
21953|NCT03150225|stress|stress
21954|NCT03150225|abdominal Obesity|abdominal obesity
21955|NCT03150225|testosterone|testosterone
21956|NCT03150225|erectile dysfunction|erectile dysfunction
21957|NCT03150186|second hand smoke|second hand smoke
21958|NCT03150186|passive smoking|passive smoking
21877|NCT03150810|BGB-290|bgb-290
21959|NCT03150186|airborne nicotine|airborne nicotine
21960|NCT03150186|private settings|private settings
21961|NCT03150186|outdoors|outdoors
21962|NCT03150173|opioid use disorder, syringe exchange, HIV risk reduction|opioid use disorder, syringe exchange, hiv risk reduction
21963|NCT03150160|travoprost|travoprost
21964|NCT03150160|brinzolamide 1% / brimonidine 0.2%|brinzolamide 1% / brimonidine 0.2%
21965|NCT03150160|normal tension glaucoma|normal tension glaucoma
21966|NCT03150160|intraocular pressure|intraocular pressure
21967|NCT03150160|efficacy|efficacy
21968|NCT03150160|safety|safety
21969|NCT03150147|Organ preservation|organ preservation
21970|NCT03150147|Survival|survival
21971|NCT03150147|Graft function|graft function
21972|NCT03150147|Reperfusion injury|reperfusion injury
21973|NCT03150147|Heart transplantation|heart transplantation
21974|NCT03150134|Acute Myeloid Leukemia|acute myeloid leukemia
21975|NCT03150134|transplantation|transplantation
21976|NCT03150134|allogeneic transplantation|allogeneic transplantation
21977|NCT03150134|immunosuppressive agents|immunosuppressive agents
21978|NCT03150082|GR37547|gr37547
21979|NCT03150082|Cross-over|cross-over
21980|NCT03150082|Bioequivalence|bioequivalence
21981|NCT03150082|Ciprofloxacin|ciprofloxacin
21982|NCT03150069|Pregnancy|pregnancy
21983|NCT03150056|abiraterone|abiraterone
21984|NCT03150056|castrate-resistant prostate cancer|castrate-resistant prostate cancer
21985|NCT03150056|androgen receptor targeted therapy|androgen receptor targeted therapy
21986|NCT03150056|RP2D|rp2d
21987|NCT03150056|enzalutamide|enzalutamide
21988|NCT03150056|GSK525762|gsk525762
21989|NCT03150043|Hemoglobin|hemoglobin
21990|NCT03150043|Cesarean delivery|cesarean delivery
21991|NCT03150004|Acute myeloid leukemia|acute myeloid leukemia
21992|NCT03150004|AML|aml
21993|NCT03150004|salvage chemotherapy|salvage chemotherapy
21994|NCT03150004|CLAG-M|clag-m
21995|NCT03150004|relapse acute myeloid leukemia|relapse acute myeloid leukemia
21996|NCT03150004|secondary acute myeloid leukemia|secondary acute myeloid leukemia
21997|NCT03150004|phase II|phase ii
21998|NCT03150004|pharmacogenomics|pharmacogenomics
21999|NCT03149991|treatment resistant|treatment resistant
22000|NCT03149991|inadequate response|inadequate response
22001|NCT03149978|Neoadjuvant Chemoradiation|neoadjuvant chemoradiation
22100|NCT03149419|paroxetine|paroxetine
22002|NCT03149978|treatment effect prediction|treatment effect prediction
22003|NCT03149978|metabonomics|metabonomics
22004|NCT03149913|below the knee artery|below the knee artery
22005|NCT03149913|endovascular|endovascular
22006|NCT03149913|drug coated balloon|drug coated balloon
22007|NCT03149913|critical limb ischemia|critical limb ischemia
22008|NCT03149848|Tuberculosis|tuberculosis
22009|NCT03149848|Human Immunodeficiency Virus|human immunodeficiency virus
22010|NCT03149848|Rifabutin|rifabutin
22011|NCT03149848|Drug-drug interaction|drug-drug interaction
22012|NCT03149848|Cabotegravir|cabotegravir
22013|NCT03149809|Urinary incontinence|urinary incontinence
22014|NCT03149809|Parkinson disease|parkinson disease
22015|NCT03149809|Overactive urinary bladder|overactive urinary bladder
22016|NCT03149809|Nocturia|nocturia
22017|NCT03149757|Treatment Adherence|treatment adherence
22018|NCT03149757|Alcohol or Drugs|alcohol or drugs
22019|NCT03149757|Behavioral|behavioral
22020|NCT03149757|Internet|internet
22021|NCT03149757|Adolescents|adolescents
22022|NCT03149757|Young Adults|young adults
22023|NCT03149757|Social Support|social support
22024|NCT03149718|Pharmacy|pharmacy
22025|NCT03149718|Intervention|intervention
22026|NCT03149718|Medication Adherence|medication adherence
22027|NCT03149705|Ischemic stroke, stroke, bio-collection, Imaging markers, biomarkers, clinical outcomes|ischemic stroke, stroke, bio-collection, imaging markers, biomarkers, clinical outcomes
613100|NCT00633919|Allergy|allergy
22028|NCT03149679|Cyclophosphamide|cyclophosphamide
22029|NCT03149679|Colorectal Cancer Metastatic|colorectal cancer metastatic
22030|NCT03149679|TP53 Gene Mutation|tp53 gene mutation
22031|NCT03149653|lipid emulsion|lipid emulsion
22034|NCT03149653|intestinal failure|intestinal failure
22035|NCT03149653|home parenteral nutrition|home parenteral nutrition
22036|NCT03149640|Prevention|prevention
22037|NCT03149640|inhaled amikacin|inhaled amikacin
22038|NCT03149640|placebo|placebo
22039|NCT03149614|mobilization|mobilization
22040|NCT03149614|resonant oscillation|resonant oscillation
22041|NCT03149575|Glioma|glioma
22042|NCT03149575|Glioblastoma|glioblastoma
22043|NCT03149575|Glioblastoma multiforme|glioblastoma multiforme
22044|NCT03149575|GBM|gbm
22045|NCT03149575|brain tumor|brain tumor
22046|NCT03149575|brain cancer|brain cancer
22047|NCT03149575|recurrent brain tumor|recurrent brain tumor
22048|NCT03149575|recurrent brain cancer|recurrent brain cancer
22049|NCT03149575|refractory brain tumor|refractory brain tumor
22050|NCT03149575|refractory brain cancer|refractory brain cancer
22051|NCT03149575|recurrent GBM|recurrent gbm
22052|NCT03149575|refractory GBM|refractory gbm
22053|NCT03149575|recurrent glioma|recurrent glioma
22054|NCT03149575|refractory glioma|refractory glioma
22055|NCT03149575|recurrent glioblastoma|recurrent glioblastoma
22056|NCT03149575|refractory glioblastoma|refractory glioblastoma
22057|NCT03149575|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
22058|NCT03149575|refractory glioblastoma multiforme|refractory glioblastoma multiforme
22059|NCT03149575|failed temodar|failed temodar
22060|NCT03149575|failed temozolomide|failed temozolomide
22061|NCT03149575|temodar refractory|temodar refractory
22062|NCT03149575|temozolomide refractory|temozolomide refractory
22063|NCT03149575|failed avastin|failed avastin
22064|NCT03149575|avastin refractory|avastin refractory
22065|NCT03149575|failed bevacizumab|failed bevacizumab
22066|NCT03149575|bevacizumab refractory|bevacizumab refractory
22067|NCT03149575|avastin failure|avastin failure
22068|NCT03149575|bevacizumab failure|bevacizumab failure
22069|NCT03149575|STAR-3|star-3
22070|NCT03149549|cancer|cancer
22071|NCT03149549|solid tumor|solid tumor
22072|NCT03149549|PROCLAIM|proclaim
22073|NCT03149549|CX-2009|cx-2009
22074|NCT03149549|PROBODY™ Therapeutic|probody™ therapeutic
22075|NCT03149549|Drug Conjugate|drug conjugate
22076|NCT03149549|Antibody drug conjugate|antibody drug conjugate
22077|NCT03149549|CD166|cd166
22078|NCT03149536|pharmacogenetic|pharmacogenetic
22079|NCT03149536|pharmacogenomic|pharmacogenomic
22080|NCT03149536|polymorphism|polymorphism
22081|NCT03149536|individualized controlled ovarian stimulation|individualized controlled ovarian stimulation
22082|NCT03149536|algorithm|algorithm
22083|NCT03149536|assisted reproduction|assisted reproduction
22084|NCT03149523|exhaustive genetic and immunological analyses|exhaustive genetic and immunological analyses
22085|NCT03149523|targeted therapies|targeted therapies
22086|NCT03149523|colon cancer|colon cancer
22087|NCT03149523|kidney cancer|kidney cancer
22088|NCT03149523|liver cancer|liver cancer
22089|NCT03149523|immunological tumor microenvironment|immunological tumor microenvironment
22090|NCT03149523|tumor microenvironment heterogeneity|tumor microenvironment heterogeneity
22091|NCT03149510|mobile application|mobile application
22092|NCT03149510|mHealth|mhealth
22093|NCT03149458|stroke|stroke
22094|NCT03149458|balance|balance
22095|NCT03149458|dance|dance
22096|NCT03149432|mirror therapy|mirror therapy
22097|NCT03149432|amputation|amputation
22098|NCT03149432|phantom pain|phantom pain
22099|NCT03149419|postmenopause|postmenopause
22101|NCT03149419|endothelial dysfunction|endothelial dysfunction
22102|NCT03149419|blood pressure|blood pressure
22103|NCT03149419|heart rate variability|heart rate variability
22104|NCT03149419|sleep quality|sleep quality
22105|NCT03149419|perceived stress|perceived stress
22106|NCT03149419|sleepiness|sleepiness
22107|NCT03149393|Functional Dyspepsia|functional dyspepsia
22108|NCT03149393|Qizhi Weitong Granules|qizhi weitong granules
22109|NCT03149393|Traditional Chinese Medicine|traditional chinese medicine
22110|NCT03149328|Home Dialysis|home dialysis
22111|NCT03149328|Person-Centred Care|person-centred care
22112|NCT03149328|Patient-Reported Outcome Measures|patient-reported outcome measures
22113|NCT03149328|Process Evaluation|process evaluation
22114|NCT03149328|Educational Support|educational support
22115|NCT03149328|Electronic Patient-Reported Outcome Measures|electronic patient-reported outcome measures
22116|NCT03149328|Patient-Reported Experience Measures|patient-reported experience measures
22117|NCT03149302|Manual therapy|manual therapy
22118|NCT03149302|Sensorimotor exercises|sensorimotor exercises
22119|NCT03149302|Balance exercises|balance exercises
22120|NCT03149302|Cervical mobilization|cervical mobilization
22121|NCT03149302|Specific neck muscle exercises|specific neck muscle exercises
22122|NCT03149263|botulinum toxin|botulinum toxin
22123|NCT03149263|anxiety reduction|anxiety reduction
22124|NCT03149263|pain reduction|pain reduction
22125|NCT03149263|medical clowns|medical clowns
22126|NCT03149263|distraction|distraction
22127|NCT03149250|Aggregometry|aggregometry
22128|NCT03149237|Mozambique|mozambique
22129|NCT03149237|Couples-based services|couples-based services
22130|NCT03149237|HIV/AIDS|hiv/aids
22131|NCT03149237|Ante-natal Care|ante-natal care
22132|NCT03149198|Fibromyalgia, pilates, exercises|fibromyalgia, pilates, exercises
22133|NCT03149185|prostate cancer|prostate cancer
22134|NCT03149185|advanced prostate cancer|advanced prostate cancer
22135|NCT03149185|technology based|technology based
22136|NCT03149146|Clinical Decision Making|clinical decision making
22137|NCT03149146|Myanmar Physical therapists|myanmar physical therapists
22138|NCT03149146|Educational workshop|educational workshop
22139|NCT03149133|Biomechanics|biomechanics
22140|NCT03149133|Strength training|strength training
22141|NCT03149133|Elastography|elastography
22142|NCT03149133|Ultrasound|ultrasound
22143|NCT03149120|Metastatic|metastatic
22144|NCT03149120|Unresectable|unresectable
22145|NCT03149120|anthracycline|anthracycline
22146|NCT03149120|chemotherapy|chemotherapy
22147|NCT03149120|systemic therapy|systemic therapy
22150|NCT03149094|mHealth|mhealth
14066|NCT03200717|RCC|rcc
22148|NCT03149107|Ultra-high-risk for psychosis, clinical high risk, prodrom, schizophrenia, psychotic disorder, prevention, N-acetylcysteine, therapy|ultra-high-risk for psychosis, clinical high risk, prodrom, schizophrenia, psychotic disorder, prevention, n-acetylcysteine, therapy
22149|NCT03149094|Self-Management|self-management
22151|NCT03149042|FFR|ffr
22152|NCT03149042|Fractional Flow Reserve|fractional flow reserve
22153|NCT03149042|Atherosclerosis|atherosclerosis
22154|NCT03149042|Coronary|coronary
22155|NCT03149042|stenosis|stenosis
22156|NCT03149029|Metastatic Melanoma|metastatic melanoma
22157|NCT03149003|Glioblastoma|glioblastoma
22158|NCT03149003|Wilms Tumor 1|wilms tumor 1
22159|NCT03149003|Cancer Vaccines|cancer vaccines
22160|NCT03149003|Neoplasms|neoplasms
22161|NCT03148990|Double Viral Vaccine Measles and Rubella|double viral vaccine measles and rubella
22162|NCT03148990|Safety Efficacy Imunogenicity|safety efficacy imunogenicity
22163|NCT03148977|Matrix Metalloproteinases|matrix metalloproteinases
22164|NCT03148951|MPV|mpv
22165|NCT03148951|NLR|nlr
22166|NCT03148951|Postoperative pain|postoperative pain
22167|NCT03148938|DAM|dam
22168|NCT03148938|multiple sclerosis|multiple sclerosis
22169|NCT03148938|MSFC|msfc
22170|NCT03148938|application|application
22171|NCT03148938|mobile|mobile
22172|NCT03148925|nicotine vaccine|nicotine vaccine
22173|NCT03148925|smoking vaccine|smoking vaccine
22174|NCT03148925|smoking cessation|smoking cessation
22175|NCT03148925|SELA-070|sela-070
22176|NCT03148899|Sleep Apnea|sleep apnea
22177|NCT03148899|Oxytocin Nasal Spray|oxytocin nasal spray
22178|NCT03148886|Physical activity|physical activity
22179|NCT03148860|Psoriatic Arthritis|psoriatic arthritis
22180|NCT03148860|Ustekinumab|ustekinumab
22181|NCT03148860|Methotrexate|methotrexate
22182|NCT03148860|DAS28|das28
22183|NCT03148834|Acute Myocardial Infarction Reperfusion Injury|acute myocardial infarction reperfusion injury
22184|NCT03148821|pressure ulcer|pressure ulcer
22185|NCT03148821|pressure sore|pressure sore
22186|NCT03148821|patient positioning|patient positioning
22187|NCT03148769|Bloodstream infections, epidemiology|bloodstream infections, epidemiology
22188|NCT03148678|Emotional reactivity|emotional reactivity
22189|NCT03148678|Cognitive flexibility|cognitive flexibility
22190|NCT03148665|Oral Cancer|oral cancer
22191|NCT03148665|Head and Neck Cancer|head and neck cancer
22192|NCT03148639|auditory hallucination|auditory hallucination
22193|NCT03148639|schizophrenia|schizophrenia
22194|NCT03148639|treatment-resistant|treatment-resistant
22195|NCT03148639|psychotherapy|psychotherapy
22196|NCT03148639|virtual reality|virtual reality
22197|NCT03148639|avatar|avatar
22198|NCT03148626|mindfulness curriculum|mindfulness curriculum
22199|NCT03148600|Ileoanal pouch, pelvic floor exercise|ileoanal pouch, pelvic floor exercise
22200|NCT03148587|abortion|abortion
22201|NCT03148587|medical abortion|medical abortion
22202|NCT03148587|mifepristone|mifepristone
22203|NCT03148587|pregnancy test|pregnancy test
22204|NCT03148548|VTE|vte
22205|NCT03148548|thrombophilia screening|thrombophilia screening
22206|NCT03148548|patients|patients
22207|NCT03148548|risk factors|risk factors
22208|NCT03148548|post-thrombotic syndrome|post-thrombotic syndrome
22209|NCT03148496|abdominal surgery|abdominal surgery
22210|NCT03148496|wound complication|wound complication
22211|NCT03148483|Pregnancy outcome|pregnancy outcome
22212|NCT03148483|Feasibility|feasibility
22213|NCT03148483|Milk Fortification|milk fortification
22214|NCT03148483|Periodontitis|periodontitis
22215|NCT03148483|Pregnant women|pregnant women
22216|NCT03148483|Periodontal Therapy|periodontal therapy
22217|NCT03148470|theta burst stimulation|theta burst stimulation
22218|NCT03148470|Language switching|language switching
22219|NCT03148470|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
22220|NCT03148457|stroke|stroke
615775|NCT00642863|behavior|behavior
22221|NCT03148457|direct oral anticoagulation|direct oral anticoagulation
22222|NCT03148457|Apixaban|apixaban
22223|NCT03148457|Dabigatran|dabigatran
22224|NCT03148457|Rivaroxaban|rivaroxaban
22225|NCT03148457|Edoxaban|edoxaban
22226|NCT03148457|therapy initiation|therapy initiation
22227|NCT03148457|major bleeding|major bleeding
22228|NCT03148457|atrial fibrillation|atrial fibrillation
22229|NCT03148379|Total Knee Replacement|total knee replacement
22230|NCT03148366|Self Efficacy|self efficacy
22231|NCT03148353|ultrasonography, corticosteroid, subacromial impingement syndrome, shoulder pain|ultrasonography, corticosteroid, subacromial impingement syndrome, shoulder pain
22232|NCT03148249|Randomized control trial|randomized control trial
22233|NCT03148249|Charles Bonnet syndrome|charles bonnet syndrome
22234|NCT03148249|visual hallucinations|visual hallucinations
22235|NCT03148249|age related macular degeneration|age related macular degeneration
22236|NCT03148249|patient education|patient education
22237|NCT03148223|Dysmenorrhea|dysmenorrhea
22238|NCT03148223|acupuncture|acupuncture
22239|NCT03148223|auriculotherapy|auriculotherapy
22240|NCT03148197|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
22241|NCT03148197|Graft-versus-host-disease|graft-versus-host-disease
22242|NCT03148197|Acute Myeloid Leukemia|acute myeloid leukemia
22243|NCT03148184|reverse total shoulder arthroplasty|reverse total shoulder arthroplasty
22244|NCT03148184|60 years old or younger|60 years old or younger
22245|NCT03148184|outcomes|outcomes
22246|NCT03148171|Pre-Exposure Prophylaxis (PrEP); Retention in PrEP Care|pre-exposure prophylaxis (prep); retention in prep care
22247|NCT03148158|Bladder Cancer|bladder cancer
22248|NCT03148158|Flexible cystoscopy|flexible cystoscopy
22249|NCT03148158|Diagnosis|diagnosis
22250|NCT03148132|Retinopathy of Prematurity|retinopathy of prematurity
22251|NCT03148132|VEGF|vegf
22252|NCT03148132|Bevacizumab|bevacizumab
22253|NCT03148132|Ranibizumab|ranibizumab
22254|NCT03148093|Metastatic Colorectal Cancer|metastatic colorectal cancer
22255|NCT03148093|Registry|registry
22256|NCT03148093|Patient Reported Outcomes|patient reported outcomes
22257|NCT03148093|Treatment Patterns|treatment patterns
22258|NCT03148093|Prescription Use|prescription use
22259|NCT03148067|Risk Factors|risk factors
22260|NCT03148067|Incidence|incidence
22261|NCT03148067|Epidemiology|epidemiology
22262|NCT03148054|Anastomosis|anastomosis
22263|NCT03148054|Colon|colon
22264|NCT03148054|CT|ct
22265|NCT03148054|Endoscopy|endoscopy
22266|NCT03148054|Enema|enema
22267|NCT03148054|Detection leak|detection leak
22268|NCT03148054|Anastomotic leak|anastomotic leak
22269|NCT03147989|MultiHance|multihance
22270|NCT03147989|MRI|mri
22271|NCT03147989|CNS|cns
22272|NCT03147989|Gadobenate Dimeglumine|gadobenate dimeglumine
22273|NCT03147963|therapy|therapy
22274|NCT03147963|breast cancer|breast cancer
22275|NCT03147963|docetaxel|docetaxel
22276|NCT03147963|metastasis|metastasis
22277|NCT03147950|Prone-Flexed Position|prone-flexed position
22278|NCT03147950|Percutaneous Nephrolithotomy (PCNL)|percutaneous nephrolithotomy (pcnl)
22279|NCT03147950|Clavien-Dindo Classification Score|clavien-dindo classification score
22280|NCT03147911|Stroke or systemic embolism|stroke or systemic embolism
22281|NCT03147911|CHA2DS2-VASc score|cha2ds2-vasc score
22282|NCT03147898|Whooping cough|whooping cough
22283|NCT03147898|Pertussis|pertussis
22284|NCT03147807|Carbapenems de-escalation, rapid diagnostic test,|carbapenems de-escalation, rapid diagnostic test,
22285|NCT03147807|Carbapenem-antimicrobial de-escalation-rapid diagnostic test|carbapenem-antimicrobial de-escalation-rapid diagnostic test
22286|NCT03147781|auriculotherapy, human milk, breast feeding, lactogenesis|auriculotherapy, human milk, breast feeding, lactogenesis
22287|NCT03147768|Laser Tissue Welding|laser tissue welding
22288|NCT03147768|Pancreatic Sealing|pancreatic sealing
22289|NCT03147768|Hemostasis|hemostasis
22290|NCT03147768|Pancreatic Tumors|pancreatic tumors
22393|NCT03147391|Stroke|stroke
22291|NCT03147768|Pancreatic Resection|pancreatic resection
22292|NCT03147768|Pancreatic leakage|pancreatic leakage
22293|NCT03147768|LTW|ltw
22294|NCT03147755|stroke|stroke
22295|NCT03147742|ruxolitinib|ruxolitinib
22296|NCT03147742|acute or chronic steroid-refractory GVHD|acute or chronic steroid-refractory gvhd
22297|NCT03147742|hematopoietic stem cell transplantation (allo-HSCT)|hematopoietic stem cell transplantation (allo-hsct)
22298|NCT03147729|Radiofrequency|radiofrequency
22299|NCT03147729|Anal incontinence|anal incontinence
22300|NCT03147729|Fecal incontinence|fecal incontinence
22301|NCT03147729|Women sexual function|women sexual function
22302|NCT03147729|Sexuality|sexuality
22303|NCT03147703|Microbiota|microbiota
22304|NCT03147703|Food timing|food timing
22305|NCT03147703|Obesity|obesity
22306|NCT03147690|Solid Organ Injury|solid organ injury
22307|NCT03147677|Type 2 diabetic nephropathy|type 2 diabetic nephropathy
22308|NCT03147677|Alfacalcidol|alfacalcidol
22309|NCT03147664|pompe disease|pompe disease
22310|NCT03147664|exercise capacity|exercise capacity
616030|NCT00646152|Interferon|interferon
22311|NCT03147664|cardiopulmonary exercise testing|cardiopulmonary exercise testing
22312|NCT03147651|Cystic fibrosis|cystic fibrosis
22313|NCT03147651|exercise capacity|exercise capacity
22314|NCT03147651|non-cystic fibrosis|non-cystic fibrosis
22315|NCT03147651|bronchiectasis|bronchiectasis
22316|NCT03147625|Aged|aged
22317|NCT03147625|Independent living|independent living
22318|NCT03147625|Health Promotion|health promotion
22319|NCT03147625|Residence Characteristics|residence characteristics
22320|NCT03147625|Elderly-only household|elderly-only household
22321|NCT03147612|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
22323|NCT03147612|Philadelphia Chromosome (Ph)-Positive|philadelphia chromosome (ph)-positive
22324|NCT03147612|BCR-ABL Positive|bcr-abl positive
22325|NCT03147612|Ponatinib|ponatinib
22326|NCT03147612|Iclusig|iclusig
22327|NCT03147612|AP24534|ap24534
22328|NCT03147612|Cyclophosphamide|cyclophosphamide
22329|NCT03147612|Cytoxan|cytoxan
22330|NCT03147612|Neosar|neosar
22331|NCT03147612|Mesna|mesna
22332|NCT03147612|Mesnex|mesnex
22333|NCT03147612|Rituximab|rituximab
22334|NCT03147612|Rituxan|rituxan
14254|NCT03199469|AAV8-Delivered Gene Therapy|aav8-delivered gene therapy
14255|NCT03199469|XLMTM|xlmtm
14256|NCT03199469|Adeno Associated Virus|adeno associated virus
14257|NCT03199443|Sacral neuromodulation|sacral neuromodulation
14258|NCT03199443|Electromyography|electromyography
22335|NCT03147612|Vincristine|vincristine
22336|NCT03147612|Dexamethasone|dexamethasone
22337|NCT03147612|Decadron|decadron
22338|NCT03147612|G-CSF|g-csf
22339|NCT03147612|Filgrastim|filgrastim
22340|NCT03147612|Neupogen|neupogen
22341|NCT03147612|Methotrexate|methotrexate
22342|NCT03147612|Cytarabine|cytarabine
22343|NCT03147612|Ara-C|ara-c
22344|NCT03147612|Cytosar|cytosar
22345|NCT03147612|DepoCyt|depocyt
22346|NCT03147612|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
22347|NCT03147612|Prednisone|prednisone
22348|NCT03147599|Mebeverine|mebeverine
22349|NCT03147599|Incontinence|incontinence
22350|NCT03147599|Orthotopic Neobladder|orthotopic neobladder
22351|NCT03147586|Immune Nutrition|immune nutrition
22352|NCT03147586|Morbidity|morbidity
22353|NCT03147573|Hypertension|hypertension
22354|NCT03147573|Blood pressure monitoring|blood pressure monitoring
22355|NCT03147560|Immunogenicity|immunogenicity
22356|NCT03147560|Safety|safety
22357|NCT03147560|Sabin IPV|sabin ipv
22358|NCT03147560|bOPV|bopv
22359|NCT03147508|Diagnostics, clinical criteria, clincal reasoning, neck pain|diagnostics, clinical criteria, clincal reasoning, neck pain
22360|NCT03146663|Platinum-resistant|platinum-resistant
22361|NCT03146663|ovarian neoplasm|ovarian neoplasm
22362|NCT03146663|antineoplastic agents|antineoplastic agents
22363|NCT03146663|ovarian diseases|ovarian diseases
22364|NCT03146663|cancer of the ovary|cancer of the ovary
22365|NCT03146637|PD-1 activated CIK|pd-1 activated cik
22366|NCT03146637|MUC1|muc1
22367|NCT03146637|Bispecfic antibody|bispecfic antibody
22368|NCT03146637|liver cancer|liver cancer
22369|NCT03146598|Foot deformity|foot deformity
22370|NCT03146598|Orthopaedic management|orthopaedic management
22371|NCT03146598|prevention|prevention
22372|NCT03146598|side pole static ankle foot orthosis|side pole static ankle foot orthosis
22373|NCT03146585|Glycocalyx|glycocalyx
22374|NCT03146559|Cross education|cross education
22375|NCT03146559|EMG|emg
22376|NCT03146520|Syndecan 2|syndecan 2
22377|NCT03146520|Methylation biomarker|methylation biomarker
22378|NCT03146520|Colorectal cancer|colorectal cancer
22379|NCT03146520|EarlyTect Colon Cancer test|earlytect colon cancer test
22380|NCT03147456|bariatric|bariatric
22381|NCT03147456|obesity|obesity
22382|NCT03147456|protein supplements|protein supplements
22383|NCT03147443|traditional Chinese medicine|traditional chinese medicine
22384|NCT03147443|Drugs, Chinese Herbal|drugs, chinese herbal
22385|NCT03147443|N-of-1 trials|n-of-1 trials
22386|NCT03147443|sputum|sputum
22387|NCT03147443|symptoms|symptoms
22388|NCT03147443|individualized treatment|individualized treatment
22389|NCT03147443|stable bronchiectasis|stable bronchiectasis
22390|NCT03147391|Atrial Fibrillation|atrial fibrillation
22391|NCT03147391|Left Atrial Appendage Closure|left atrial appendage closure
22392|NCT03147391|LAmbre device|lambre device
22394|NCT03147352|Fasciitis|fasciitis
22395|NCT03147352|Gangrene|gangrene
22396|NCT03147352|Fasciitis, Necrotizing|fasciitis, necrotizing
22397|NCT03147352|Soft Tissue Infections|soft tissue infections
22398|NCT03147352|Fournier's Gangrene|fournier's gangrene
22399|NCT03147352|Streptococcal septic shock syndrome|streptococcal septic shock syndrome
22400|NCT03147352|Flesh eating bacteria|flesh eating bacteria
22401|NCT03147352|Meleneys ulcer|meleneys ulcer
22402|NCT03147352|Wounds and Injuries|wounds and injuries
22403|NCT03147352|Streptococcus pyogenes|streptococcus pyogenes
22404|NCT03147352|Staphylococcus aureus|staphylococcus aureus
22405|NCT03147352|Soft Tissue Infections/blood|soft tissue infections/blood
22406|NCT03147352|Necrosis/blood|necrosis/blood
22407|NCT03147352|Necrosis/diagnosis|necrosis/diagnosis
22408|NCT03147352|Necrosis/mortality|necrosis/mortality
22409|NCT03147352|Necrosis/surgery|necrosis/surgery
22410|NCT03147352|Prognosis|prognosis
22411|NCT03147352|Risk Factors|risk factors
22412|NCT03147352|Bacterial Infections|bacterial infections
22413|NCT03147352|Infection|infection
22414|NCT03147352|Skin Diseases, Bacterial|skin diseases, bacterial
22415|NCT03147352|Observational study|observational study
22416|NCT03147352|Biological markers|biological markers
22417|NCT03147352|Endothelium|endothelium
22418|NCT03147352|suPAR|supar
22419|NCT03147352|sTM|stm
22420|NCT03147352|syndecan-1|syndecan-1
22421|NCT03147352|sE-selectin|se-selectin
22422|NCT03147352|VE-cadherin|ve-cadherin
22423|NCT03147352|protein C|protein c
22424|NCT03147352|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
22425|NCT03147352|HBOT|hbot
22426|NCT03147339|AGEs( Advanced glycation end products)|ages( advanced glycation end products)
22427|NCT03147313|extracorporeal shock wave|extracorporeal shock wave
22428|NCT03147313|microsurgical nerve coaptation|microsurgical nerve coaptation
22429|NCT03147313|nerve regeneration|nerve regeneration
22430|NCT03147300|Low back pain|low back pain
22431|NCT03147300|Model of care|model of care
22432|NCT03147300|Primary health care|primary health care
22433|NCT03147300|Implementation|implementation
22434|NCT03147300|Patient-rated outcome|patient-rated outcome
22435|NCT03147300|Clinician-rated outcome|clinician-rated outcome
22436|NCT03147300|Cost-effectiveness|cost-effectiveness
22437|NCT03147287|Breast Cancer|breast cancer
22438|NCT03147274|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
22439|NCT03147274|Adolescence|adolescence
22440|NCT03147222|hip fracture|hip fracture
22441|NCT03147222|dementia|dementia
22442|NCT03147222|intervention|intervention
22443|NCT03147157|tacrolimus|tacrolimus
22444|NCT03147157|histocompatibility antigens|histocompatibility antigens
22445|NCT03147131|Total Hip Arthroplasty|total hip arthroplasty
22446|NCT03147131|Short Stem|short stem
22447|NCT03147131|DEXA|dexa
22448|NCT03147118|trapeziometacarpal arthritis|trapeziometacarpal arthritis
22449|NCT03147105|chronic progressive multiple sclerosis, mobility, arm ergometry, rehabilitation|chronic progressive multiple sclerosis, mobility, arm ergometry, rehabilitation
22450|NCT03147079|obesity|obesity
22451|NCT03147079|pregnancy|pregnancy
22452|NCT03147079|lifestyle|lifestyle
22453|NCT03147079|gestational weight gain|gestational weight gain
22454|NCT03147079|weight of offspring|weight of offspring
22455|NCT03147079|antenatal care|antenatal care
22456|NCT03147079|health behavior|health behavior
22457|NCT03147079|physical activity|physical activity
22458|NCT03147079|diet|diet
22459|NCT03147079|programme evaluation|programme evaluation
22460|NCT03147079|costs and costs analysis|costs and costs analysis
22461|NCT03147066|Dezocine|dezocine
22462|NCT03147066|CRBD|crbd
22463|NCT03147066|General anesthesia|general anesthesia
22464|NCT03147066|Urinary catheter|urinary catheter
22465|NCT03147040|Lobular|lobular
22466|NCT03147040|Metastatic or incurable locally advanced cancer|metastatic or incurable locally advanced cancer
22467|NCT03147040|Disease progression on endocrine therapy in advanced setting|disease progression on endocrine therapy in advanced setting
22468|NCT03147027|ischemic cardiomyopathy|ischemic cardiomyopathy
22469|NCT03147027|prophylactic ablation|prophylactic ablation
22470|NCT03147014|Echocardiography|echocardiography
22471|NCT03147014|Congenital Heart Disease|congenital heart disease
22472|NCT03147014|Maternal hyperoxygenation|maternal hyperoxygenation
22473|NCT03147001|Endurance exercise|endurance exercise
22474|NCT03147001|Dietary protein|dietary protein
22475|NCT03146975|Beta-defensins|beta-defensins
22476|NCT03146975|Chronic periodontitis|chronic periodontitis
22477|NCT03146975|Diabetes mellitus|diabetes mellitus
22478|NCT03146975|Non-surgical periodontal therapy|non-surgical periodontal therapy
22479|NCT03146897|Food Aid, Malnutrition, RUSF, FBF, Supplementary Food|food aid, malnutrition, rusf, fbf, supplementary food
22480|NCT03146845|Diabetic Foot Ulcer|diabetic foot ulcer
22481|NCT03146845|Pressure Ulcer|pressure ulcer
22482|NCT03146845|Leg Ulcer|leg ulcer
22483|NCT03146819|osteoarthritis|osteoarthritis
22484|NCT03146819|osteoarthritis knee|osteoarthritis knee
22485|NCT03146819|total knee replacement|total knee replacement
22486|NCT03146819|patient specific|patient specific
22487|NCT03146819|total knee arthroplasty|total knee arthroplasty
22488|NCT03146819|orthopedics|orthopedics
22489|NCT03146806|Cancer pain|cancer pain
22490|NCT03146806|Anesthesiology|anesthesiology
22491|NCT03146806|Opiates|opiates
22492|NCT03146806|Intranasal ketamine|intranasal ketamine
22493|NCT03146793|Calciphylaxis/complications|calciphylaxis/complications
22494|NCT03146793|Kidney Failure, Chronic/complications|kidney failure, chronic/complications
22495|NCT03146793|Renal Dialysis|renal dialysis
22496|NCT03146793|Thiosulfates/therapeutic use|thiosulfates/therapeutic use
22497|NCT03146793|Time Factors|time factors
22498|NCT03146741|Heart Failure|heart failure
22499|NCT03146702|Quality of Life|quality of life
22500|NCT03146689|osteoarthritis|osteoarthritis
22501|NCT03146689|n-of-1|n-of-1
22502|NCT03146689|ibuprofen|ibuprofen
22503|NCT03146689|capsaicin|capsaicin
22504|NCT03146689|NSAID|nsaid
22505|NCT03146689|topical|topical
22506|NCT03146481|Anesthetic efficacy, Irriversible pulpitis, Aceclofenac|anesthetic efficacy, irriversible pulpitis, aceclofenac
22507|NCT03146455|Thrombelastograghy|thrombelastograghy
22508|NCT03146455|reference ranges|reference ranges
22510|NCT03146455|geographic|geographic
22511|NCT03146455|Blood Transfusion|blood transfusion
22512|NCT03146442|increased dietary protein|increased dietary protein
22513|NCT03146442|breakfast|breakfast
22514|NCT03146442|weight management|weight management
22515|NCT03146442|satiety|satiety
22516|NCT03146442|glucose control|glucose control
22517|NCT03146442|fMRI|fmri
22518|NCT03146442|cognitive performance|cognitive performance
22519|NCT03146442|memory|memory
22520|NCT03146442|attention|attention
22606|NCT03145844|DAA|daa
22521|NCT03146442|executive function|executive function
22522|NCT03146442|structural MRI|structural mri
22523|NCT03146442|sleep quality|sleep quality
22524|NCT03146403|HSV|hsv
22525|NCT03146403|Herpes|herpes
22526|NCT03146403|Genital Herpes|genital herpes
22527|NCT03146403|Vaccine|vaccine
22528|NCT03146390|biofilms|biofilms
22529|NCT03146390|essential oils|essential oils
22530|NCT03146390|microscopy, confocal|microscopy, confocal
22531|NCT03146390|mouthwashes|mouthwashes
22532|NCT03146364|Virtual Reality|virtual reality
22533|NCT03146351|preterm|preterm
22534|NCT03146351|infant|infant
22535|NCT03146351|physiotherapy|physiotherapy
22536|NCT03146338|Anti-EGFR|anti-egfr
22537|NCT03146338|Hypomagnesemia|hypomagnesemia
22538|NCT03146338|Magnesium-rich mineral water|magnesium-rich mineral water
22539|NCT03146338|Metastatic colorectal or head and neck cancers|metastatic colorectal or head and neck cancers
22540|NCT03146325|H. pylori infection|h. pylori infection
22541|NCT03146312|gene expression|gene expression
22542|NCT03146312|gene array|gene array
22543|NCT03146312|epigenetics|epigenetics
22544|NCT03146312|DNA methylation|dna methylation
22545|NCT03146260|TESE|tese
22546|NCT03146260|Sperm retreival|sperm retreival
22547|NCT03146260|Azoospermia|azoospermia
22548|NCT03146260|FSH|fsh
22549|NCT03146260|LH|lh
22550|NCT03146208|Growth differentiation factor-15|growth differentiation factor-15
22551|NCT03146208|Dipeptidyl-peptidase inhibitors (DPP4 -I)|dipeptidyl-peptidase inhibitors (dpp4 -i)
22552|NCT03146208|Coronroy artery diseases|coronroy artery diseases
22553|NCT03146195|pelvic organ prolapse|pelvic organ prolapse
22554|NCT03146195|dynamic magnetic resonance imaging|dynamic magnetic resonance imaging
22555|NCT03146195|three-dimensional reconstruction|three-dimensional reconstruction
22556|NCT03146195|space coordinates|space coordinates
22557|NCT03146182|C-reactive protein|c-reactive protein
22558|NCT03146182|Procalcitonin|procalcitonin
22559|NCT03146182|Community-acquired pneumonia|community-acquired pneumonia
22560|NCT03146182|Antibiotic stewardship|antibiotic stewardship
22561|NCT03146156|obesity|obesity
22562|NCT03146156|overweight|overweight
22563|NCT03146156|lifestyle intervention|lifestyle intervention
22564|NCT03146156|fetal growth/adiposity|fetal growth/adiposity
22565|NCT03146156|Mediterranean diet|mediterranean diet
22566|NCT03146117|PET CT|pet ct
22567|NCT03146091|Antibiotics|antibiotics
22568|NCT03146052|Colon cleansing|colon cleansing
22569|NCT03146013|HTLV|htlv
22570|NCT03146013|Confirmatory|confirmatory
22571|NCT03146013|Supplemental|supplemental
22572|NCT03146013|Blot|blot
22573|NCT03146013|HTLV-I|htlv-i
22574|NCT03146013|HTLV-II|htlv-ii
22575|NCT03145987|Cognitive functioning|cognitive functioning
22576|NCT03145987|Neuropsychological status|neuropsychological status
22577|NCT03145987|Vitis vinifera|vitis vinifera
22578|NCT03145974|respiratory failure|respiratory failure
22579|NCT03145974|mechanical ventilation|mechanical ventilation
22580|NCT03145961|Breast cancer early stage|breast cancer early stage
22581|NCT03145961|circulating tumour DNA|circulating tumour dna
22582|NCT03145961|pembrolizumab|pembrolizumab
22583|NCT03145961|targeted therapy|targeted therapy
22584|NCT03145961|randomised clinical trial|randomised clinical trial
22585|NCT03145961|phase II|phase ii
22586|NCT03145961|mutation screening|mutation screening
22587|NCT03145961|intermediate endpoint|intermediate endpoint
22588|NCT03145948|Tolerability|tolerability
22589|NCT03145948|Psoriasis|psoriasis
22590|NCT03145948|Pharmacokinetics|pharmacokinetics
22591|NCT03145948|Safety|safety
22592|NCT03145948|Healthy Volunteers|healthy volunteers
22593|NCT03145909|Prolactin Receptor (PRLR)|prolactin receptor (prlr)
22594|NCT03145909|Colorectal cancer|colorectal cancer
22595|NCT03145909|Cancer|cancer
22596|NCT03145909|Chromophobe renal cell carcinoma|chromophobe renal cell carcinoma
22597|NCT03145909|Adrenocortical carcinoma,|adrenocortical carcinoma,
22598|NCT03145909|Breast cancer|breast cancer
22599|NCT03145909|Metastatic|metastatic
22600|NCT03145909|Hepatocellular carcinoma|hepatocellular carcinoma
22601|NCT03145896|vitamin D|vitamin d
22602|NCT03145896|Anemia|anemia
22603|NCT03145896|IBD|ibd
22604|NCT03145857|Gallium-68|gallium-68
22605|NCT03145857|Positron Emission Tomography|positron emission tomography
22610|NCT03145805|blood chemical analysis|blood chemical analysis
22611|NCT03145805|bupivacaine|bupivacaine
22612|NCT03145805|local anesthetic toxicity|local anesthetic toxicity
22613|NCT03145805|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
22614|NCT03145766|Rabies virus|rabies virus
22615|NCT03145753|HIV testing program|hiv testing program
22616|NCT03145753|HCV testing program|hcv testing program
22617|NCT03145753|education|education
22618|NCT03145727|Chemotherapy|chemotherapy
22619|NCT03145727|nausea|nausea
22620|NCT03145727|vomiting|vomiting
22621|NCT03145727|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
22622|NCT03145714|POCD|pocd
14569|NCT03197519|mHealth|mhealth
22640|NCT03145597|facings|facings
22641|NCT03145597|veneers|veneers
22642|NCT03145597|laminates|laminates
22643|NCT03145597|existing|existing
22644|NCT03145597|restorations|restorations
22645|NCT03145597|esthetics|esthetics
22646|NCT03145597|dental|dental
22647|NCT03145584|Total Knee Arthroplasty|total knee arthroplasty
22648|NCT03145584|Physiotherapy|physiotherapy
22649|NCT03145558|Tirapazamine, embolization, TACE, Hepatocellular carcinoma|tirapazamine, embolization, tace, hepatocellular carcinoma
22650|NCT03145493|Drainage, Suction|drainage, suction
22651|NCT03145493|tranexamic acid|tranexamic acid
22652|NCT03145480|leukemia|leukemia
22653|NCT03145480|richter|richter
22654|NCT03145467|Migraine|migraine
22655|NCT03145467|Paracetamol|paracetamol
22656|NCT03145467|Zolmitriptan|zolmitriptan
22657|NCT03145467|Emergency services|emergency services
22658|NCT03145454|Pain|pain
22659|NCT03145454|children|children
22660|NCT03145454|emergency|emergency
22661|NCT03145454|electroencephalography|electroencephalography
22662|NCT03145454|heart rate|heart rate
22663|NCT03145454|skin conductance|skin conductance
22664|NCT03145454|pupillary diameter|pupillary diameter
22665|NCT03145415|pudendal nerve block|pudendal nerve block
22666|NCT03145415|hypospadias|hypospadias
22667|NCT03145415|caudal block|caudal block
22668|NCT03145376|TAVI|tavi
22669|NCT03145376|MitraClip|mitraclip
22670|NCT03145376|geriatric assessment|geriatric assessment
22671|NCT03145376|heart rate variability|heart rate variability
22672|NCT03145376|elderly|elderly
22673|NCT03145350|NAFLD|nafld
22674|NCT03145350|Fat intake|fat intake
22675|NCT03145350|Sugar intake|sugar intake
22676|NCT03145311|Repetitive transcranial magnetic stimulation, Drug Induced Tardive Syndrome|repetitive transcranial magnetic stimulation, drug induced tardive syndrome
22677|NCT03145298|HPAH (heritable)|hpah (heritable)
22678|NCT03145298|IPAH (idiopathic)|ipah (idiopathic)
22679|NCT03145298|PAH-CTD (connective tissue diseases)|pah-ctd (connective tissue diseases)
22680|NCT03145298|PAH-HIV (human immunodeficiency virus)|pah-hiv (human immunodeficiency virus)
22681|NCT03145285|Abiraterone Acetate|abiraterone acetate
22682|NCT03145285|Cushing Syndrome|cushing syndrome
22683|NCT03145285|Adrenocortical Carcinoma|adrenocortical carcinoma
22687|NCT03145246|intrabony defect|intrabony defect
22688|NCT03145246|periodontal regeneration|periodontal regeneration
22689|NCT03145233|physiotherapy|physiotherapy
22690|NCT03145220|EA-230|ea-230
22691|NCT03145220|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
22692|NCT03145220|Acute Kidney Injury|acute kidney injury
22693|NCT03145220|Interleukin-6|interleukin-6
22695|NCT03145220|Tolerability|tolerability
22696|NCT03145220|Phase II|phase ii
22697|NCT03145220|Randomized clinical trial|randomized clinical trial
22698|NCT03145155|continuum of care|continuum of care
22699|NCT03145155|maternal|maternal
22700|NCT03145155|newborn|newborn
22701|NCT03145155|child health|child health
22702|NCT03145155|noncommunicable diseases|noncommunicable diseases
22703|NCT03145142|Near-Infrared Spectroscopy|near-infrared spectroscopy
22704|NCT03145129|Intraocular pressure|intraocular pressure
22706|NCT03145129|CPAP|cpap
22711|NCT03145077|Head and Neck Cancer|head and neck cancer
22713|NCT03145077|ORN|orn
22714|NCT03145077|Dynamic contrast-enhanced magnetic resonance imaging|dynamic contrast-enhanced magnetic resonance imaging
22715|NCT03145077|DCE-MRI|dce-mri
22716|NCT03145077|Questionnaires|questionnaires
22717|NCT03145077|Surveys|surveys
22718|NCT03145064|relapsed/refractory non-GCB type|relapsed/refractory non-gcb type
22724|NCT03145012|Cancer|cancer
22725|NCT03145012|Immunity|immunity
22726|NCT03145012|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
22727|NCT03145012|Ranitidine|ranitidine
22728|NCT03144999|Dry AMD|dry amd
22729|NCT03144999|Dry Age-related Macular Degeneration|dry age-related macular degeneration
22730|NCT03144999|Gene Therapy|gene therapy
22731|NCT03144999|Complement|complement
22732|NCT03144999|Intravitreal Injection|intravitreal injection
22733|NCT03144999|Geographic Atrophy|geographic atrophy
22734|NCT03144999|Drusen|drusen
22735|NCT03144999|Membrane Attack Complex|membrane attack complex
22736|NCT03144999|CD59|cd59
22737|NCT03144934|HPV|hpv
22738|NCT03144921|Early-stage Dementia|early-stage dementia
22739|NCT03144921|Early-stage Alzheimer's disease|early-stage alzheimer's disease
22740|NCT03144921|Care partner|care partner
22741|NCT03144921|Caregivers|caregivers
22742|NCT03144921|Caregiving|caregiving
22743|NCT03144869|type 1 diabetes mellitus|type 1 diabetes mellitus
22744|NCT03144869|physical activity|physical activity
22745|NCT03144869|children|children
22746|NCT03144869|constant glucose monitoring|constant glucose monitoring
22747|NCT03144856|Biliary Tract Cancer|biliary tract cancer
22748|NCT03144856|Second line thrapy|second line thrapy
22749|NCT03144856|Apatinib|apatinib
22750|NCT03144843|Gastric cancer|gastric cancer
22751|NCT03144843|Peritoneal metastasis|peritoneal metastasis
22752|NCT03144843|Paclitaxol|paclitaxol
22753|NCT03144843|Apatinib|apatinib
22754|NCT03144843|Second-line chemotherapy|second-line chemotherapy
22755|NCT03144817|hemodialysis|hemodialysis
22756|NCT03144817|fluid overload|fluid overload
22757|NCT03144817|dialysis disequilibrium|dialysis disequilibrium
22758|NCT03144817|intra-dialytic hypotension|intra-dialytic hypotension
22759|NCT03144817|dialysate sodium lowering|dialysate sodium lowering
22760|NCT03144804|Colorectal Cancer|colorectal cancer
22761|NCT03144778|Malignant Neoplasms of Oropharynx|malignant neoplasms of oropharynx
22762|NCT03144778|CD8+ tumor infiltrating lymphocytes|cd8+ tumor infiltrating lymphocytes
22763|NCT03144778|Biomarkers|biomarkers
22764|NCT03144778|Durvalumab|durvalumab
22765|NCT03144778|MEDI4736|medi4736
22766|NCT03144778|Tremelimumab|tremelimumab
22767|NCT03144778|Ticilimumab|ticilimumab
22768|NCT03144778|CP-675,206|cp-675,206
22769|NCT03144765|taTME|tatme
22770|NCT03144765|Transanal|transanal
22771|NCT03144765|Rectal cancer|rectal cancer
22772|NCT03144765|Colorectal|colorectal
22773|NCT03144765|Total mesorectal excision|total mesorectal excision
22774|NCT03144765|TME|tme
22775|NCT03144687|Myelofibrosis|myelofibrosis
22776|NCT03144687|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
22777|NCT03144687|itacitinib|itacitinib
22778|NCT03144687|ruxolitinib|ruxolitinib
22779|NCT03144674|Marginal zone lymphoma|marginal zone lymphoma
22780|NCT03144674|phosphatidylinositol 3-kinase (PI3K)δ inhibitor|phosphatidylinositol 3-kinase (pi3k)δ inhibitor
22781|NCT03144674|indolent (slow-growing) non-Hodgkin lymphoma B-cell lymphoma|indolent (slow-growing) non-hodgkin lymphoma b-cell lymphoma
22782|NCT03144661|hepatocellular carcinoma|hepatocellular carcinoma
22783|NCT03144661|cholangiocarcinoma|cholangiocarcinoma
22784|NCT03144661|esophageal|esophageal
22785|NCT03144661|nasopharyngeal|nasopharyngeal
22786|NCT03144661|serous ovarian|serous ovarian
22787|NCT03144661|solid tumors|solid tumors
22788|NCT03144661|fibroblast growth factor (FGF)|fibroblast growth factor (fgf)
22789|NCT03144661|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
22790|NCT03144635|Direct Acting Antivirals|direct acting antivirals
22791|NCT03144635|Grazoprevir|grazoprevir
22792|NCT03144635|Elbasvir|elbasvir
22793|NCT03144622|(4S)-4-(3-[18F]fluoropropyl-)-L-glutamate|(4s)-4-(3-[18f]fluoropropyl-)-l-glutamate
22794|NCT03144622|18F-FSPG|18f-fspg
22795|NCT03144622|PET/CT|pet/ct
22796|NCT03144622|system xC-transporter|system xc-transporter
22797|NCT03144609|mechanical ventilation, obesity, oral-surgical procedures|mechanical ventilation, obesity, oral-surgical procedures
22798|NCT03144583|CART19|cart19
22799|NCT03144570|ICU, encephalitis, meningo-encephalitis, seizures|icu, encephalitis, meningo-encephalitis, seizures
22800|NCT03144557|Education|education
22801|NCT03144557|COPD|copd
22813|NCT03144505|High Intensity Interval Training|high intensity interval training
22814|NCT03144505|Glycemic Control|glycemic control
22815|NCT03144492|Cell Culture|cell culture
22816|NCT03144492|Microgravity co-culture|microgravity co-culture
22817|NCT03144453|Curare|curare
22818|NCT03144453|Robotic surgery|robotic surgery
22819|NCT03144440|ZEPATIER|zepatier
22820|NCT03144427|albumin|albumin
22821|NCT03144427|resuscitation|resuscitation
22822|NCT03144427|burns|burns
22823|NCT03144427|shock|shock
22824|NCT03144427|fluid creep|fluid creep
22825|NCT03144401|cesarean section|cesarean section
22826|NCT03144401|Misoprostol|misoprostol
22827|NCT03144401|sublingual|sublingual
22828|NCT03144401|uterotonics|uterotonics
22829|NCT03144323|Intraoral elastics|intraoral elastics
22830|NCT03144258|congenital heart defects|congenital heart defects
22831|NCT03144258|systemic microcirculation|systemic microcirculation
22832|NCT03144258|laser Doppler perfusion imaging|laser doppler perfusion imaging
22833|NCT03144258|cardiac corrective surgery|cardiac corrective surgery
22834|NCT03144245|AML|aml
22835|NCT03144245|treatment|treatment
22836|NCT03144245|relapsed|relapsed
22837|NCT03144245|refractory|refractory
22838|NCT03144245|phase 1|phase 1
22839|NCT03144219|intracranial pressure|intracranial pressure
22840|NCT03144219|transcranial Doppler|transcranial doppler
22841|NCT03144219|jugular compression|jugular compression
22842|NCT03144219|cerebral compliance|cerebral compliance
22843|NCT03144193|topical treatment|topical treatment
22844|NCT03144193|wrinkles|wrinkles
22845|NCT03144193|extracellular matrix|extracellular matrix
22846|NCT03144180|pregnant|pregnant
22847|NCT03144180|third trimester|third trimester
22848|NCT03144180|umbilical cord blood collection|umbilical cord blood collection
22849|NCT03144154|Cancer|cancer
22850|NCT03144154|Fatigue|fatigue
22851|NCT03144154|Hypnosis|hypnosis
22852|NCT03144154|Self-hypnosis|self-hypnosis
22853|NCT03144154|Self-care|self-care
22854|NCT03144154|Emotional distress|emotional distress
22855|NCT03144154|Cancer survivors|cancer survivors
22856|NCT03144128|vitamin D|vitamin d
22857|NCT03144128|muscle|muscle
22858|NCT03144128|metabolism|metabolism
23019|NCT03142919|MDD|mdd
22859|NCT03144128|cancer cachexia|cancer cachexia
22860|NCT03144115|oxytocin|oxytocin
22861|NCT03144115|sex hormone|sex hormone
22862|NCT03144115|verbal reward|verbal reward
22863|NCT03144115|mate selection|mate selection
22864|NCT03144115|metaphorical language|metaphorical language
22865|NCT03144089|Morbid obesity|morbid obesity
22866|NCT03144089|Obstructive sleep apnea|obstructive sleep apnea
22867|NCT03144089|Mask ventilation|mask ventilation
22868|NCT03144089|Upper airway obstruction|upper airway obstruction
22869|NCT03144076|healthcare|healthcare
22870|NCT03144076|India|india
22871|NCT03144076|health insurance|health insurance
22872|NCT03144076|RSBY|rsby
22873|NCT03144076|free health insurance|free health insurance
22874|NCT03144076|inpatient insurance|inpatient insurance
22875|NCT03144076|wealth transfer|wealth transfer
22876|NCT03144063|Disease Activity|disease activity
22877|NCT03144063|SLEDAI-2K|sledai-2k
22878|NCT03144024|Tricuspid Regurgitation|tricuspid regurgitation
22879|NCT03144024|Insufficiency, Tricuspid Valve|insufficiency, tricuspid valve
22880|NCT03144024|Valvular Annuloplasty|valvular annuloplasty
22881|NCT03144024|Cardiac Valve Annulus Repair|cardiac valve annulus repair
22882|NCT03144011|acute kidney injury, cardiosurgery|acute kidney injury, cardiosurgery
22883|NCT03143985|TEW-7197|tew-7197
22884|NCT03143985|Pomalidomide|pomalidomide
22885|NCT03143972|Dexmedetomidine|dexmedetomidine
22886|NCT03143972|Remifentanil|remifentanil
22887|NCT03143972|Pharmacodynamics|pharmacodynamics
22888|NCT03143972|Interaction|interaction
22889|NCT03143946|neuroendocrine tumor|neuroendocrine tumor
22890|NCT03143946|vitamin|vitamin
22891|NCT03143946|diet|diet
22892|NCT03143933|propofol, BIS, general anesthesia|propofol, bis, general anesthesia
22893|NCT03143920|hyperbaric oxygen|hyperbaric oxygen
22894|NCT03143920|inflammation|inflammation
22895|NCT03143920|chronic disease|chronic disease
22896|NCT03143920|urinary bladder|urinary bladder
22897|NCT03143920|urinary tract infection|urinary tract infection
22898|NCT03143920|recurrent urinary tract infection|recurrent urinary tract infection
22899|NCT03143920|painful bladder syndrome|painful bladder syndrome
22900|NCT03143920|chronic pain|chronic pain
22901|NCT03143920|hypoxia|hypoxia
22902|NCT03143920|bacterial infection|bacterial infection
22903|NCT03143907|Mindfulness|mindfulness
22904|NCT03143907|Group Therapy|group therapy
22905|NCT03143894|Breast Cancer|breast cancer
22906|NCT03143894|Cognition|cognition
22907|NCT03143894|Fatigue|fatigue
22908|NCT03143894|Cancer-related Cognitive Impairment|cancer-related cognitive impairment
22909|NCT03143894|Transcranial Direct Current Stimulation|transcranial direct current stimulation
22910|NCT03143868|acute exercise|acute exercise
22911|NCT03143868|resistance exercise|resistance exercise
22912|NCT03143868|aerobic exercise|aerobic exercise
22913|NCT03143868|appetite|appetite
22914|NCT03143868|energy intake|energy intake
22915|NCT03143855|oxycodone|oxycodone
22916|NCT03143855|lorcaserin|lorcaserin
22917|NCT03143855|Belviq|belviq
22919|NCT03143842|accelerate learning|accelerate learning
22920|NCT03143842|memory|memory
22921|NCT03143829|gerontology|gerontology
22922|NCT03143829|symptom self-management|symptom self-management
22923|NCT03143829|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
22924|NCT03143816|diabetes|diabetes
22925|NCT03143816|time in range|time in range
22926|NCT03143816|inhaled insulin|inhaled insulin
22927|NCT03143816|continuous glucose monitoring|continuous glucose monitoring
22928|NCT03143816|type 1 diabetes|type 1 diabetes
22929|NCT03143816|hypoglycemia|hypoglycemia
22930|NCT03143816|post prandial hypergylcemia|post prandial hypergylcemia
22931|NCT03143790|Erectile Function|erectile function
22932|NCT03143790|Prostatectomy|prostatectomy
22933|NCT03143790|Extracorporeal Shock Wave Therapy|extracorporeal shock wave therapy
22934|NCT03143790|IIEF-5|iief-5
22935|NCT03143777|physiotherapy|physiotherapy
22936|NCT03143777|rehabilitation|rehabilitation
22937|NCT03143777|critical care|critical care
22938|NCT03143777|seating|seating
22939|NCT03143738|regional anesthesia|regional anesthesia
22940|NCT03143738|knee replacement|knee replacement
22941|NCT03143738|pain treatment|pain treatment
22942|NCT03143738|rehabilitation|rehabilitation
22943|NCT03143686|Severe symptomatic Aortic Stenosis|severe symptomatic aortic stenosis
22944|NCT03143673|Severe Symptomatic Aortic Valve Stenosis|severe symptomatic aortic valve stenosis
22945|NCT03143660|obesity|obesity
22946|NCT03143608|GERD|gerd
22947|NCT03143608|Hiatal hernia repair|hiatal hernia repair
22948|NCT03143608|Transoral Incision less fundoplication|transoral incision less fundoplication
22949|NCT03143595|Preexisting cognitive impairment|preexisting cognitive impairment
22950|NCT03143595|Elderly|elderly
22951|NCT03143595|Outcomes|outcomes
22952|NCT03143556|renal transplant|renal transplant
22953|NCT03143556|magnetic ureteral stent|magnetic ureteral stent
22954|NCT03143556|Black-Star®|black-star®
22955|NCT03143543|cocaine disorder|cocaine disorder
22956|NCT03143543|opioid disorder|opioid disorder
22957|NCT03143543|lorcaserin|lorcaserin
22958|NCT03143543|MRI|mri
22959|NCT03143543|fMRI|fmri
22960|NCT03143530|Ropivacaine|ropivacaine
22961|NCT03143517|Inflammatory Bowel Diseases|inflammatory bowel diseases
22962|NCT03143517|Irritable Bowel Syndrome|irritable bowel syndrome
22963|NCT03143517|Ulcerative Colitis|ulcerative colitis
22964|NCT03143517|Crohn Disease|crohn disease
22965|NCT03143517|Indeterminate Colitis|indeterminate colitis
22966|NCT03143426|3D laparoscopic cholecystectomy|3d laparoscopic cholecystectomy
22967|NCT03143426|Junior surgeons|junior surgeons
22968|NCT03143426|Complication|complication
22969|NCT03143426|Conversion|conversion
22970|NCT03143413|Salivary glands ultrasonography|salivary glands ultrasonography
22971|NCT03143413|Systemic sclerosis|systemic sclerosis
22972|NCT03143413|Gougerot Sjogren syndrome|gougerot sjogren syndrome
22973|NCT03143413|Sicca syndrome|sicca syndrome
22974|NCT03143400|Probiotics|probiotics
22975|NCT03143400|Galenic form|galenic form
22976|NCT03143400|Digestive tract|digestive tract
22977|NCT03143400|Intestinal microbiota|intestinal microbiota
22978|NCT03143400|Lactobacillus salivarius|lactobacillus salivarius
22979|NCT03143361|aortic valve stenosis|aortic valve stenosis
22980|NCT03143361|heart valves|heart valves
22981|NCT03143361|heart surgery|heart surgery
22982|NCT03143335|Breast; Reconstruction; BAD; Implant; ADM|breast; reconstruction; bad; implant; adm
22983|NCT03143322|Bone-only metastases|bone-only metastases
22984|NCT03143322|solid tumors|solid tumors
22985|NCT03143322|SBRT|sbrt
22986|NCT03143283|suicide|suicide
22987|NCT03143283|lethal means|lethal means
22988|NCT03143283|counseling|counseling
22989|NCT03143283|youth|youth
22990|NCT03143283|parents|parents
22991|NCT03143283|firearms|firearms
22992|NCT03143283|medication|medication
22993|NCT03143283|suicidal|suicidal
22994|NCT03143283|emergency department|emergency department
22995|NCT03143270|nivolumab|nivolumab
22996|NCT03143270|deb-TACE|deb-tace
22997|NCT03143270|17-087|17-087
22998|NCT03143218|Malaria|malaria
22999|NCT03143218|Seasonal vaccination|seasonal vaccination
23000|NCT03143218|Seasonal chemoprevention|seasonal chemoprevention
23001|NCT03143192|DME, Micropulse Laser, Anti-VEGF|dme, micropulse laser, anti-vegf
23002|NCT03143140|Ablation Techniques|ablation techniques
23003|NCT03143101|FluMist Quadrivalent|flumist quadrivalent
23004|NCT03143101|Trivalent|trivalent
23005|NCT03143101|Influenza|influenza
23006|NCT03143101|Vaccine|vaccine
23007|NCT03143101|Prevention|prevention
23008|NCT03143088|Blood pressure|blood pressure
23009|NCT03143088|Medical clown|medical clown
23010|NCT03143088|Pediatric|pediatric
23011|NCT03143062|National Early Warning Score|national early warning score
23012|NCT03143062|Rapid response system|rapid response system
23013|NCT03143049|Pomalidomide|pomalidomide
23014|NCT03143036|daratumumab|daratumumab
23015|NCT03142971|Shock waves|shock waves
23016|NCT03142971|Greater trochanteric pain syndrome|greater trochanteric pain syndrome
23017|NCT03142932|smoking|smoking
23018|NCT03142919|Mood Disorder|mood disorder
23020|NCT03142919|Endotoxin|endotoxin
23021|NCT03142919|MRI|mri
23022|NCT03142919|CRP|crp
23023|NCT03142906|preoperative, perioperative, point-of-care ultrasound|preoperative, perioperative, point-of-care ultrasound
23024|NCT03142893|testosterone|testosterone
23025|NCT03142893|cortisol|cortisol
23026|NCT03142880|marginally hyperbaric|marginally hyperbaric
23027|NCT03142880|ropivacaine|ropivacaine
23028|NCT03142880|cesarean|cesarean
23029|NCT03142867|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
23030|NCT03142867|Non Alcoholic Steatohepatitis|non alcoholic steatohepatitis
23031|NCT03142867|Prevalence|prevalence
23953|NCT03136315|athlete|athlete
23032|NCT03142867|Coronary Artery Disease|coronary artery disease
23033|NCT03142867|PDFF|pdff
23034|NCT03142854|bowel preparation|bowel preparation
23035|NCT03142854|colonoscopy|colonoscopy
23036|NCT03142854|predictive model|predictive model
23037|NCT03142841|Depression|depression
23038|NCT03142841|Burden|burden
23039|NCT03142841|Problem Solving Ability|problem solving ability
23040|NCT03142841|Caregivers|caregivers
23041|NCT03142841|Stroke|stroke
23042|NCT03142841|Veterans|veterans
23043|NCT03142828|chlorhexidine, dental implant, in-situ drug delivery,|chlorhexidine, dental implant, in-situ drug delivery,
23044|NCT03142815|Coronary Artery Bypass Graft (CABG), Arterial stiffness|coronary artery bypass graft (cabg), arterial stiffness
23045|NCT03142802|Testicular cancer|testicular cancer
23046|NCT03142802|low-dose CT|low-dose ct
23047|NCT03142802|CT scan|ct scan
23048|NCT03142789|Pain|pain
23049|NCT03142789|Total knee arthroplasty|total knee arthroplasty
23050|NCT03142789|Regional anesthesia|regional anesthesia
23051|NCT03142776|clarithromycin|clarithromycin
23052|NCT03142776|photodynamic therapy|photodynamic therapy
23053|NCT03142776|Antimicrobial therapy|antimicrobial therapy
23054|NCT03142776|Periodontal pocket|periodontal pocket
23055|NCT03142724|HV|hv
23056|NCT03142698|hepatic steatosis|hepatic steatosis
23057|NCT03142698|MRImaging|mrimaging
23058|NCT03142685|NEC|nec
23059|NCT03142685|Bowel Ultrasound|bowel ultrasound
23060|NCT03142685|CHD|chd
23061|NCT03142672|Postoperative pain|postoperative pain
23062|NCT03142672|child|child
23063|NCT03142672|pulpotomy|pulpotomy
23064|NCT03142672|general anesthesia|general anesthesia
23065|NCT03142620|Drug resistant H.pylori infection|drug resistant h.pylori infection
23066|NCT03142620|vitamin D|vitamin d
23067|NCT03142620|gastritis|gastritis
23068|NCT03142529|Non dialysis|non dialysis
23069|NCT03142516|Clinical Trial, Phase II|clinical trial, phase ii
23070|NCT03142516|Elderly|elderly
23071|NCT03142516|Aged|aged
23072|NCT03142516|Disease-Free Survival|disease-free survival
23073|NCT03142516|Safety|safety
23074|NCT03142516|Tolerability|tolerability
23075|NCT03142516|Chemotherapy regimen|chemotherapy regimen
23076|NCT03142516|Monoclonal antibody|monoclonal antibody
23077|NCT03142516|FOLFIRI|folfiri
23078|NCT03142516|Panitumumab|panitumumab
23079|NCT03142516|RAS/BRAF Wild-type|ras/braf wild-type
23080|NCT03142503|psoriatic arthritis|psoriatic arthritis
23081|NCT03142503|psoriasis|psoriasis
23082|NCT03142503|body composition|body composition
23083|NCT03142503|DXA measurements|dxa measurements
23084|NCT03142503|spondyloarthritis|spondyloarthritis
23085|NCT03142503|diet therapy|diet therapy
23086|NCT03142503|adipose tissue|adipose tissue
23087|NCT03142490|Acupuncture|acupuncture
23088|NCT03142490|Infertility|infertility
23089|NCT03142490|In vitro fertilization|in vitro fertilization
23090|NCT03142490|Quality of life|quality of life
23091|NCT03142490|Stress|stress
23092|NCT03142490|Anxiety|anxiety
23093|NCT03142477|Therapeutic touch|therapeutic touch
23094|NCT03142477|Reiki|reiki
23095|NCT03142477|Laying-on-of-Hands|laying-on-of-hands
23100|NCT03142464|outcomes|outcomes
23101|NCT03142412|Lupus|lupus
23102|NCT03142412|SLE|sle
23103|NCT03142412|Systemic Lupus Erythematosus|systemic lupus erythematosus
23104|NCT03142399|heart failure|heart failure
23105|NCT03142399|cardiac reabilitation|cardiac reabilitation
23106|NCT03142399|nutritional status|nutritional status
23107|NCT03142399|quality of life|quality of life
23108|NCT03142399|milk protein|milk protein
23109|NCT03142386|geriatric oncology|geriatric oncology
23110|NCT03142386|pain|pain
23111|NCT03142386|osteopathic manipulative treatment|osteopathic manipulative treatment
23112|NCT03142386|quality of life|quality of life
23113|NCT03142373|heart rate variability|heart rate variability
23114|NCT03142373|autonomic nervous system|autonomic nervous system
23115|NCT03142373|osteopathic manipulative treatment|osteopathic manipulative treatment
23116|NCT03142373|skin conductance|skin conductance
23117|NCT03142347|remote endarterectomy|remote endarterectomy
23118|NCT03142347|DCB balloon|dcb balloon
23124|NCT03142308|Satisfaction|satisfaction
23125|NCT03142308|Training program|training program
23126|NCT03142308|Egypt|egypt
23127|NCT03142308|Cross-sectional|cross-sectional
23128|NCT03142308|Multi-center|multi-center
23129|NCT03142295|Urine transfusion|urine transfusion
23130|NCT03142295|Recurrent urinary tract infection|recurrent urinary tract infection
23131|NCT03142295|Urinary microbiota|urinary microbiota
23132|NCT03142282|maintenance treatment|maintenance treatment
23133|NCT03142243|Tennis|tennis
23134|NCT03142243|Asymmetry|asymmetry
23135|NCT03142243|Morphological|morphological
23136|NCT03142230|feeding tube|feeding tube
23137|NCT03142230|gastric|gastric
23138|NCT03142230|newborn infant|newborn infant
23139|NCT03142230|nursing|nursing
23140|NCT03142230|pain|pain
23141|NCT03142191|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
23142|NCT03142191|Pulmonary Fibrosis|pulmonary fibrosis
23143|NCT03142191|CC-90001|cc-90001
23144|NCT03142191|Safety|safety
23147|NCT03142191|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
23148|NCT03142178|neuralgia|neuralgia
23149|NCT03142178|pain|pain
23150|NCT03142178|post herpetic|post herpetic
23151|NCT03142152|Functional Mitral Regurgitation|functional mitral regurgitation
23152|NCT03142152|Percutaneous Mitral Valve Repair|percutaneous mitral valve repair
23153|NCT03142152|Percutaneous Mitral Valve Annuloplasty|percutaneous mitral valve annuloplasty
23154|NCT03142152|Coronary sinus Annuloplasty|coronary sinus annuloplasty
23155|NCT03142152|Secondary Mitral Regurgitation|secondary mitral regurgitation
23156|NCT03142152|Functional MR|functional mr
23157|NCT03142152|FMR|fmr
23158|NCT03142139|Observational study; DTaP-IPV-Hib; Atopic Dermatitis; AD; Heterologous immunity; Non-specific effects; Non-targeted effects; Immunization;|observational study; dtap-ipv-hib; atopic dermatitis; ad; heterologous immunity; non-specific effects; non-targeted effects; immunization;
23159|NCT03142113|optimization|optimization
23160|NCT03142113|adalimumab|adalimumab
23161|NCT03142087|balance|balance
23162|NCT03142087|brain tumor|brain tumor
23163|NCT03142087|virtual reality|virtual reality
23164|NCT03142074|Improve diagnosis|improve diagnosis
23377|NCT03140488|BMI|bmi
23165|NCT03142009|Community-Based Participatory Research|community-based participatory research
23166|NCT03141996|vibration|vibration
23167|NCT03141996|stroke|stroke
23168|NCT03141996|activities of daily living|activities of daily living
23169|NCT03141983|ESRD|esrd
23170|NCT03141983|End-Stage Kidney Disease|end-stage kidney disease
23171|NCT03141970|Proteinuria Hypoproteinemia Edema Hypoalbuminemia Prednisone|proteinuria hypoproteinemia edema hypoalbuminemia prednisone
23172|NCT03141957|Aging|aging
23173|NCT03141957|Hypermetabolism|hypermetabolism
23174|NCT03141944|non motor symptoms|non motor symptoms
23175|NCT03141931|Nutraceutical supplement|nutraceutical supplement
23176|NCT03141905|patient safety|patient safety
23177|NCT03141905|self-management|self-management
23178|NCT03141905|remote monitoring|remote monitoring
23179|NCT03141879|Frailty|frailty
23180|NCT03141879|Physical Activity|physical activity
23181|NCT03141879|Resistance training|resistance training
23182|NCT03141853|Randomized Controlled Trial|randomized controlled trial
23183|NCT03141853|Intervention Study|intervention study
23184|NCT03141827|Lipoprotein|lipoprotein
23185|NCT03141827|Apolipoprotein|apolipoprotein
23186|NCT03141827|Pancreatic clamp|pancreatic clamp
23187|NCT03141827|Insulin|insulin
23188|NCT03141827|Nasal|nasal
23189|NCT03141801|ACL|acl
23190|NCT03141801|Knee|knee
23191|NCT03141801|Muscle|muscle
23192|NCT03141788|Aligners|aligners
23193|NCT03141775|Clostridium difficile associated diarrhea (CDAD)|clostridium difficile associated diarrhea (cdad)
23194|NCT03141762|Falls|falls
23195|NCT03141762|Intensive care|intensive care
23196|NCT03141736|Infant|infant
23197|NCT03141736|Newborn|newborn
23198|NCT03141736|Preterm|preterm
23199|NCT03141736|Hypothermia|hypothermia
23200|NCT03141736|Kangaroo|kangaroo
23201|NCT03141736|Plastic|plastic
23203|NCT03141723|Infant|infant
23204|NCT03141723|Newborn|newborn
23205|NCT03141723|Preterm|preterm
23206|NCT03141723|Hypothermia|hypothermia
23207|NCT03141723|Kangaroo|kangaroo
23208|NCT03141723|Plastic|plastic
23209|NCT03141723|Bag|bag
23210|NCT03141697|Carbon Dioxide|carbon dioxide
23211|NCT03141697|Coloboscopy|coloboscopy
23212|NCT03141671|Prostate Cancer|prostate cancer
23213|NCT03141658|TS-134|ts-134
23214|NCT03141658|ketamine|ketamine
23215|NCT03141658|fMRI|fmri
23216|NCT03141619|cerebral oximetry|cerebral oximetry
23217|NCT03141619|near-infrared spectroscopy|near-infrared spectroscopy
23218|NCT03141619|neurocognitive|neurocognitive
23219|NCT03141619|post-ICU syndrome|post-icu syndrome
23220|NCT03141593|adherence to medication|adherence to medication
23221|NCT03141593|electronic monitoring|electronic monitoring
23222|NCT03141567|Lymphangiogenesis|lymphangiogenesis
23223|NCT03141567|Heart Failure|heart failure
23224|NCT03141541|low back pain|low back pain
23225|NCT03141541|cognitive behavioural therapy|cognitive behavioural therapy
23226|NCT03141541|randomised controlled trial|randomised controlled trial
23227|NCT03141528|Self-learning|self-learning
23228|NCT03141528|Instructor-led learning|instructor-led learning
23229|NCT03141528|Long-term retention|long-term retention
23230|NCT03141515|lung ultrasound|lung ultrasound
23231|NCT03141515|recruitment maneuver|recruitment maneuver
23232|NCT03141515|atelectasis|atelectasis
23233|NCT03141515|children|children
23234|NCT03141502|tension wound|tension wound
23235|NCT03141502|skin stretching device|skin stretching device
23236|NCT03141502|skin grafting|skin grafting
23237|NCT03141476|Surgery|surgery
23238|NCT03141476|Obesity|obesity
23239|NCT03141476|Drug|drug
23240|NCT03141476|Antibiotics|antibiotics
23241|NCT03141476|Cefuroxime|cefuroxime
23242|NCT03141463|Therapeutic vaccination|therapeutic vaccination
23243|NCT03141437|Malignant Neoplasm of Breast|malignant neoplasm of breast
23244|NCT03141437|Malignant Neoplasm of Female Genital Organs|malignant neoplasm of female genital organs
23245|NCT03141437|Lymphoma|lymphoma
23246|NCT03141437|Myeloma|myeloma
23251|NCT03141437|Surveys|surveys
23252|NCT03141437|Educational materials|educational materials
23253|NCT03141372|Total Laparoscopic Hysterectomy|total laparoscopic hysterectomy
23254|NCT03141372|Urinary Retention|urinary retention
23255|NCT03141372|Backfill Void Trial|backfill void trial
23256|NCT03141372|Autofill Void Trial|autofill void trial
23257|NCT03141307|Neonatal screening|neonatal screening
23258|NCT03141307|Biobank|biobank
23259|NCT03141307|Broad Consent|broad consent
23260|NCT03141294|tracheostomy，fascia，force gauge|tracheostomy，fascia，force gauge
23261|NCT03141281|aging|aging
23262|NCT03141281|cognitive ability|cognitive ability
23263|NCT03141281|IADL|iadl
23264|NCT03141281|driving|driving
23265|NCT03141281|financial fraud|financial fraud
23266|NCT03141281|perception|perception
23267|NCT03141281|attention|attention
23268|NCT03141281|memory|memory
23269|NCT03141255|Therapeutic Hypothermia (TH)|therapeutic hypothermia (th)
23270|NCT03141242|Advance Care Planning|advance care planning
23271|NCT03141242|Group Medial Visit|group medial visit
23272|NCT03141242|Shared Medical Appointment|shared medical appointment
23273|NCT03141229|MBSR|mbsr
23274|NCT03141229|Children|children
23275|NCT03141229|Teacher|teacher
23276|NCT03141229|School|school
23277|NCT03141229|Burnout|burnout
23278|NCT03141229|Classroom behavior|classroom behavior
23279|NCT03141125|Erythrocyte sedimentation rate|erythrocyte sedimentation rate
23280|NCT03141125|Modified Rodnan Skin Score|modified rodnan skin score
23281|NCT03141125|B-cell Activating Factor|b-cell activating factor
23282|NCT03141125|soluble-CD40Ligand|soluble-cd40ligand
23283|NCT03141125|Procollagen Type-1 N-terminal Propeptide|procollagen type-1 n-terminal propeptide
23284|NCT03141125|Scleroderma|scleroderma
23285|NCT03141099|OHCA|ohca
23286|NCT03141099|Hemodynamic|hemodynamic
23287|NCT03141099|TTM|ttm
23288|NCT03141099|post-rescusitation care|post-rescusitation care
23289|NCT03141099|Blood pressure targets|blood pressure targets
23290|NCT03141099|Oxygenation targets|oxygenation targets
23291|NCT03141086|shift work disorder|shift work disorder
23292|NCT03141073|GKA|gka
23293|NCT03141073|T2DM|t2dm
23294|NCT03141073|HMS5552|hms5552
23295|NCT03141073|Add on therapy|add on therapy
23296|NCT03141073|Metformin|metformin
23297|NCT03141047|Sexual trauma, Lifespan Integration|sexual trauma, lifespan integration
23298|NCT03141008|Ketosis|ketosis
23299|NCT03141008|NAFLD|nafld
23300|NCT03141008|Obesity|obesity
23301|NCT03140995|Exercise|exercise
23302|NCT03140995|Sleep|sleep
23303|NCT03140982|propofol|propofol
23304|NCT03140982|pharmacology|pharmacology
23305|NCT03140982|anesthesic induction|anesthesic induction
23306|NCT03140982|drug titration|drug titration
23307|NCT03140969|CEP290|cep290
23308|NCT03140969|p.Cys998X|p.cys998x
23309|NCT03140969|c.2991+1655A>G|c.2991+1655a>g
23310|NCT03140969|RNA therapy|rna therapy
23311|NCT03140969|Antisense oligonucleotide|antisense oligonucleotide
23312|NCT03140969|Leber's congenital amaurosis|leber's congenital amaurosis
23313|NCT03140943|carfilzomib|carfilzomib
23314|NCT03140917|Liver function|liver function
23315|NCT03140917|Future liver remnant|future liver remnant
23316|NCT03140917|Chemotherapy|chemotherapy
23317|NCT03140891|preterm infant|preterm infant
616031|NCT00646152|Prophylaxis|prophylaxis
23318|NCT03140891|respiratory distress syndrome|respiratory distress syndrome
23319|NCT03140891|high frequence oscillation|high frequence oscillation
23320|NCT03140865|Alzheimer's|alzheimer's
23321|NCT03140865|observational|observational
23322|NCT03140865|prediabetes|prediabetes
23323|NCT03140865|mild cognitive impairment|mild cognitive impairment
23324|NCT03140774|Ebola vaccine|ebola vaccine
23325|NCT03140774|immunogenicity|immunogenicity
23326|NCT03140774|persistence|persistence
23327|NCT03140722|anemia|anemia
23328|NCT03140722|kidney|kidney
23329|NCT03140722|dialysis-dependent chronic kidney disease|dialysis-dependent chronic kidney disease
23330|NCT03140722|CKD|ckd
23331|NCT03140722|DD-CKD|dd-ckd
23332|NCT03140722|renal|renal
23333|NCT03140722|vadadustat|vadadustat
23334|NCT03140722|AKB-6548|akb-6548
23335|NCT03140722|hypoxia-inducible factor|hypoxia-inducible factor
23336|NCT03140722|HIF|hif
23337|NCT03140722|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
23338|NCT03140722|HIF-PHI|hif-phi
23339|NCT03140722|hyporesponder|hyporesponder
23340|NCT03140722|hyporesponsive|hyporesponsive
23341|NCT03140722|epoetin alfa|epoetin alfa
23342|NCT03140722|hemoglobin|hemoglobin
23343|NCT03140722|erythropoiesis stimulating agent|erythropoiesis stimulating agent
23344|NCT03140722|ESA|esa
23345|NCT03140709|Salivary|salivary
23346|NCT03140709|Oxytocin|oxytocin
23347|NCT03140709|Induction|induction
23348|NCT03140709|Labor|labor
23349|NCT03140657|Ankylosing spondylitis, Nanocurcumin, MicroRNA, Th17 cells|ankylosing spondylitis, nanocurcumin, microrna, th17 cells
23350|NCT03140644|thoracic sarcoidosis|thoracic sarcoidosis
23351|NCT03140644|ultra-low dose computed tomography|ultra-low dose computed tomography
23352|NCT03140644|Magnetic resonance imaging using Ultrashort echo time|magnetic resonance imaging using ultrashort echo time
23353|NCT03140631|atrial fibrillation|atrial fibrillation
23354|NCT03140631|catheter ablation|catheter ablation
23355|NCT03140631|protamine sulfate|protamine sulfate
23356|NCT03140631|anticoagulation reversal|anticoagulation reversal
23357|NCT03140618|single-system-design|single-system-design
23358|NCT03140618|mixed methods|mixed methods
23359|NCT03140618|psychiatric inpatient care|psychiatric inpatient care
23360|NCT03140618|work environment|work environment
23361|NCT03140618|rebuilding|rebuilding
23362|NCT03140579|recruitment|recruitment
23363|NCT03140579|lung homogeneity|lung homogeneity
23364|NCT03140579|airway pressure release ventilation|airway pressure release ventilation
23365|NCT03140566|heart failure|heart failure
23366|NCT03140566|acute decompensated heart failure|acute decompensated heart failure
23367|NCT03140566|congestion|congestion
23368|NCT03140566|inferior vena cava|inferior vena cava
23369|NCT03140553|Neoadjuvant Treatment|neoadjuvant treatment
23370|NCT03140553|HER2-Positive Breast Cancer|her2-positive breast cancer
23371|NCT03140540|Fluid management|fluid management
23372|NCT03140540|goal-directed therapy|goal-directed therapy
23373|NCT03140540|transesophageal echocardiography|transesophageal echocardiography
23374|NCT03140514|Urine chemokine monitoring|urine chemokine monitoring
23375|NCT03140488|Induction of labor|induction of labor
23376|NCT03140488|Pitocin|pitocin
23378|NCT03140475|Metacognition|metacognition
23379|NCT03140475|Mousetracking|mousetracking
23380|NCT03140475|EEG|eeg
23381|NCT03140475|Event related potentials|event related potentials
23382|NCT03140475|Frequency analysis|frequency analysis
23383|NCT03140475|Depression|depression
23384|NCT03140462|Tacrolimus|tacrolimus
23385|NCT03140462|Pharmacokinetics|pharmacokinetics
23386|NCT03140462|Genetic polymorphisms|genetic polymorphisms
23387|NCT03140449|Tuberous sclerosis complex|tuberous sclerosis complex
23388|NCT03140449|facial angiofibroma|facial angiofibroma
23389|NCT03140449|rapamycin|rapamycin
23390|NCT03140449|calcitriol|calcitriol
23391|NCT03140436|stain removal efficacy, air polishing powder|stain removal efficacy, air polishing powder
23392|NCT03140423|MRSA|mrsa
23393|NCT03140423|healthcare-associated infections|healthcare-associated infections
23394|NCT03140423|mupirocin|mupirocin
23395|NCT03140423|iodophor|iodophor
23396|NCT03140423|resistance|resistance
23397|NCT03140410|Staphylococci|staphylococci
23398|NCT03140410|Blood-stream infections|blood-stream infections
23399|NCT03140410|Linezolid|linezolid
23400|NCT03140397|Bioavailability|bioavailability
23401|NCT03140397|Pharmacokinetics|pharmacokinetics
23402|NCT03140397|8-prenylnaringenin|8-prenylnaringenin
23403|NCT03140397|6-prenylnaringenin|6-prenylnaringenin
23404|NCT03140397|Prenylflavonoids|prenylflavonoids
23405|NCT03140397|PBMC|pbmc
23406|NCT03140371|Enteral feeding|enteral feeding
23407|NCT03140371|Oral nutritional supplements|oral nutritional supplements
23408|NCT03140371|Peptide-based feed|peptide-based feed
23409|NCT03140371|Hydrolysed feed|hydrolysed feed
23410|NCT03140371|Semi-elemental feed|semi-elemental feed
23411|NCT03140345|Hemodialysis|hemodialysis
23412|NCT03140345|Microcirculation|microcirculation
23413|NCT03140345|Traditional Chinese Medicine|traditional chinese medicine
23414|NCT03140345|Hemodialysis vascular access|hemodialysis vascular access
23415|NCT03140319|Fibroblast|fibroblast
23416|NCT03140319|Cell transplantation|cell transplantation
23417|NCT03140306|Computed tomography|computed tomography
23418|NCT03140306|Model based iterative reconstruction|model based iterative reconstruction
23419|NCT03140306|Low dose CT|low dose ct
23420|NCT03140293|Chorionic villus sampling|chorionic villus sampling
23421|NCT03140293|Pain|pain
23422|NCT03140293|Anxiety|anxiety
23423|NCT03140280|Black raspberries|black raspberries
23425|NCT03140280|Myelodysplastic Syndromes|myelodysplastic syndromes
23426|NCT03140280|hypomethylating effects|hypomethylating effects
23427|NCT03140280|chemopreventive agent|chemopreventive agent
23428|NCT03140280|BRB|brb
23429|NCT03140280|pharmokinetics|pharmokinetics
23430|NCT03140267|Ventilated induced diaphragmatic dysfunction|ventilated induced diaphragmatic dysfunction
23431|NCT03140267|Weaning|weaning
23432|NCT03140267|Inspiratory muscle training|inspiratory muscle training
23433|NCT03140215|Baska|baska
23434|NCT03140215|seal pressure|seal pressure
23435|NCT03140215|I-Gel|i-gel
23436|NCT03140215|Supraglottic airway device|supraglottic airway device
23437|NCT03140189|Esophageal cancer|esophageal cancer
23438|NCT03140189|Robotic|robotic
23439|NCT03140189|Ivor-Lewis esophagectomy|ivor-lewis esophagectomy
23440|NCT03140176|Sunitinib|sunitinib
23441|NCT03140176|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
23442|NCT03140176|Africa Middle East|africa middle east
23443|NCT03140098|Collagen membrane|collagen membrane
23444|NCT03140098|Cardiac surgery|cardiac surgery
23445|NCT03140098|Postoperative complication|postoperative complication
23446|NCT03140072|Asthma, Single Ascending Dose (SAD), Multiple Ascending Dose (MAD), AZD9898|asthma, single ascending dose (sad), multiple ascending dose (mad), azd9898
23447|NCT03140059|surgical procedure|surgical procedure
23448|NCT03140059|residual pockets|residual pockets
23449|NCT03140059|agressive periodontitis|agressive periodontitis
23450|NCT03140059|antimicrobial photodynamic therapy|antimicrobial photodynamic therapy
23452|NCT03140020|cognition|cognition
23453|NCT03140020|functional connectivity|functional connectivity
23454|NCT03140020|frontal lobe function|frontal lobe function
23455|NCT03140020|neuropsychological testing|neuropsychological testing
23456|NCT03140020|coiling|coiling
23457|NCT03140020|clipping|clipping
23458|NCT03140007|ERCP|ercp
23459|NCT03140007|cholangioscopy|cholangioscopy
23460|NCT03139994|occlusion|occlusion
23461|NCT03139994|pain|pain
23462|NCT03139981|eczema|eczema
23463|NCT03139955|Feasibility Study|feasibility study
23464|NCT03139955|Pre/Post-Operative Patient Monitoring|pre/post-operative patient monitoring
23465|NCT03139955|Continuous Patient Monitoring|continuous patient monitoring
23466|NCT03139955|Patient Deterioration Identification|patient deterioration identification
23467|NCT03139955|Bodytrak|bodytrak
23468|NCT03139955|National Early Warning System|national early warning system
23469|NCT03139955|Patient Safety|patient safety
23470|NCT03139942|Endoscopy|endoscopy
23471|NCT03139942|Colonoscopy|colonoscopy
23472|NCT03139942|Hyperspectral imaging|hyperspectral imaging
23473|NCT03139942|Tissue classification|tissue classification
23474|NCT03139942|Tissue autofluorescence|tissue autofluorescence
23475|NCT03139942|Advanced imaging techniques|advanced imaging techniques
23476|NCT03139916|Glioblastoma|glioblastoma
23477|NCT03139903|Seckel Syndrome|seckel syndrome
23478|NCT03139903|Microcephalic Osteodysplastic Primordial Dwarfism Type II|microcephalic osteodysplastic primordial dwarfism type ii
23479|NCT03139864|Type 1 diabetes|type 1 diabetes
23480|NCT03139864|Control|control
23481|NCT03139864|Physical activity|physical activity
23482|NCT03139864|Substrate utilization|substrate utilization
23483|NCT03139864|Hormonal regulation|hormonal regulation
23484|NCT03139851|Solid tumor|solid tumor
23485|NCT03139851|Breast cancer|breast cancer
23486|NCT03139851|Metastatic cancer|metastatic cancer
23487|NCT03139851|Pembrolizumab|pembrolizumab
23488|NCT03139851|Metronomic cyclophosphamide|metronomic cyclophosphamide
23489|NCT03139838|Palliative Care|palliative care
23490|NCT03139838|Pragmatic Clinical Trial|pragmatic clinical trial
23491|NCT03139838|Electronic Health Records|electronic health records
23492|NCT03139838|Economics, Behavioral|economics, behavioral
23493|NCT03139812|continuous contact lens wear|continuous contact lens wear
23687|NCT03138200|Hemoglobin|hemoglobin
23494|NCT03139812|silicone hydrogel contact lenses|silicone hydrogel contact lenses
23495|NCT03139812|irrigation|irrigation
23496|NCT03139812|corneal epithelial permeability|corneal epithelial permeability
23497|NCT03139812|contact lens-related adverse events|contact lens-related adverse events
23498|NCT03139734|Sacral Nerve Modulation|sacral nerve modulation
23499|NCT03139708|Mydriasis|mydriasis
23500|NCT03139708|Cycloplegics|cycloplegics
23501|NCT03139630|HIV, Dyslipidemia|hiv, dyslipidemia
23502|NCT03139630|Dyslipidemia|dyslipidemia
23503|NCT03139630|Protease Inhibitor|protease inhibitor
23504|NCT03139630|Ritonavir|ritonavir
23505|NCT03139630|PCSK9|pcsk9
23506|NCT03139630|Observational|observational
23507|NCT03139617|Fascia Iliaca Block|fascia iliaca block
23508|NCT03139617|Femoral 3-in-1 block|femoral 3-in-1 block
23509|NCT03139617|Fracture femur|fracture femur
23510|NCT03139617|Spinal anesthesia|spinal anesthesia
23511|NCT03139604|Acute graft-versus-host disease|acute graft-versus-host disease
23512|NCT03139604|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
23513|NCT03139604|itacitinib|itacitinib
23514|NCT03139604|corticosteroids|corticosteroids
23515|NCT03139604|allogeneic hematopoietic stem cell transplant (allo-HSCT)|allogeneic hematopoietic stem cell transplant (allo-hsct)
23516|NCT03139565|Influenza|influenza
23517|NCT03139565|Solid Organ Transplant|solid organ transplant
23518|NCT03139565|Infection|infection
23519|NCT03139565|Vaccine|vaccine
23520|NCT03139565|Immunogenicity|immunogenicity
23521|NCT03139552|Taste Test|taste test
23522|NCT03139552|Spices|spices
23523|NCT03139552|Reduced sugar|reduced sugar
23524|NCT03139552|Food liking|food liking
23525|NCT03139526|Craniopharyngioma|craniopharyngioma
23526|NCT03139526|Children|children
23527|NCT03139526|Social participation|social participation
23528|NCT03139526|Life-H questionnaire|life-h questionnaire
23529|NCT03139487|Anticoagulant Adverse Reaction|anticoagulant adverse reaction
23530|NCT03139487|Cancer-associated Thrombosis|cancer-associated thrombosis
23531|NCT03139487|Low molecular weight heparin|low molecular weight heparin
23532|NCT03139487|Direct oral anticoagulant|direct oral anticoagulant
23533|NCT03139461|Physical Therapy|physical therapy
23534|NCT03139461|Capacity Building|capacity building
23535|NCT03139461|Clinical-Community Linkages|clinical-community linkages
23536|NCT03139396|inlay bridge, tub shaped design|inlay bridge, tub shaped design
23537|NCT03139383|postoperative nausea|postoperative nausea
23538|NCT03139383|postoperative vomiting|postoperative vomiting
23539|NCT03139383|gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
23540|NCT03139344|metabolism|metabolism
23541|NCT03139344|exercise|exercise
23542|NCT03139344|glucose|glucose
23543|NCT03139344|secondary health conditions|secondary health conditions
23544|NCT03139344|quality of life|quality of life
23545|NCT03139305|glucagon|glucagon
23546|NCT03139266|cystic fibrosis|cystic fibrosis
23547|NCT03139266|mindfulness|mindfulness
23548|NCT03139266|cognitive behavioral therapy|cognitive behavioral therapy
23549|NCT03139266|UPLIFT|uplift
23550|NCT03139266|anxiety|anxiety
23551|NCT03139266|depression|depression
23552|NCT03139266|web based intervention|web based intervention
23553|NCT03139253|Helicobacter Pylori Infection|helicobacter pylori infection
23554|NCT03139253|Antimicrobial susceptibility testing (AST)|antimicrobial susceptibility testing (ast)
23555|NCT03139253|Triple Therapy|triple therapy
23556|NCT03139201|silicone hydrogel soft contact lens|silicone hydrogel soft contact lens
23557|NCT03139188|Cancer|cancer
23558|NCT03139188|incurable pathologies|incurable pathologies
15476|NCT03191812|Falls|falls
23559|NCT03139188|palliative care|palliative care
23560|NCT03139162|Home Care Services|home care services
23561|NCT03139162|Aging|aging
23562|NCT03139162|Frailty|frailty
23563|NCT03139162|Complexity|complexity
23564|NCT03139162|Nursing|nursing
23565|NCT03139149|conservative treatment|conservative treatment
23566|NCT03139149|laparoscopic adhesiolysis|laparoscopic adhesiolysis
23567|NCT03139149|strangulation|strangulation
23568|NCT03139071|coffee consumption|coffee consumption
23569|NCT03139071|cardiovascular diseases|cardiovascular diseases
23570|NCT03139071|coronary artery calcium|coronary artery calcium
23571|NCT03139071|subclinical atherosclerosis|subclinical atherosclerosis
23572|NCT03139019|Diabetes prevention|diabetes prevention
23573|NCT03139019|Weight loss|weight loss
23574|NCT03139019|Lifestyle change|lifestyle change
23575|NCT03138967|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
23576|NCT03138967|Bladder cancer|bladder cancer
23577|NCT03138967|Outpatient bladder procedures|outpatient bladder procedures
23578|NCT03138967|Outpatient cystoscopy procedure|outpatient cystoscopy procedure
23579|NCT03138967|Transurethral resection of the bladder|transurethral resection of the bladder
23580|NCT03138967|TURB|turb
23581|NCT03138967|Rocuronium|rocuronium
23582|NCT03138967|Rocuronium Bromide|rocuronium bromide
23583|NCT03138967|Zemuron|zemuron
23584|NCT03138967|Sugammadex|sugammadex
23585|NCT03138967|Neostigmine|neostigmine
23586|NCT03138967|Glycopyrrolate|glycopyrrolate
23587|NCT03138928|glaucoma|glaucoma
23588|NCT03138928|trabeculectomy|trabeculectomy
23589|NCT03138928|minimally invasive glaucoma surgery|minimally invasive glaucoma surgery
23595|NCT03138889|Atezolizumab|atezolizumab
23596|NCT03138889|Tecentriq|tecentriq
23597|NCT03138889|Metastatic Urothelial Bladder Cancer|metastatic urothelial bladder cancer
23598|NCT03138889|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
23599|NCT03138850|intravenous sedation|intravenous sedation
23600|NCT03138850|esophagogastroduodenalscopy|esophagogastroduodenalscopy
23601|NCT03138850|upper airway|upper airway
23602|NCT03138850|mandibular advancement device|mandibular advancement device
23603|NCT03138850|high flow nasal cannula|high flow nasal cannula
23604|NCT03138837|Bladder cancer|bladder cancer
23605|NCT03138837|Magnetic Resonance Imaging|magnetic resonance imaging
23606|NCT03138837|Bladder Cancer Superficial|bladder cancer superficial
23607|NCT03138824|Bladder Urothelial Carcinoma|bladder urothelial carcinoma
23608|NCT03138824|TURBT|turbt
23609|NCT03138824|Recurrence|recurrence
23610|NCT03138824|Progression|progression
23611|NCT03138811|asthma|asthma
23612|NCT03138811|allergen bronchoprovocation|allergen bronchoprovocation
23613|NCT03138811|pharmacodynamics|pharmacodynamics
23614|NCT03138811|pharmacokinetics|pharmacokinetics
23615|NCT03138811|safety|safety
23616|NCT03138811|tolerability|tolerability
23617|NCT03138798|Labor|labor
23618|NCT03138798|Second stage|second stage
23619|NCT03138798|Dental device|dental device
23620|NCT03138746|hyperbaric oxygenation|hyperbaric oxygenation
23621|NCT03138746|insulin sensitivity|insulin sensitivity
23622|NCT03138746|human|human
23623|NCT03138746|inflammation|inflammation
23624|NCT03138655|Drug therapy|drug therapy
23625|NCT03138642|mucosal melanoma|mucosal melanoma
23626|NCT03138642|radiotherapy|radiotherapy
23627|NCT03138616|Gestational diabetes mellitus|gestational diabetes mellitus
23628|NCT03138616|vitamin D|vitamin d
23629|NCT03138616|postpartum|postpartum
23630|NCT03138603|surgery|surgery
23631|NCT03138603|heart disease|heart disease
23632|NCT03138603|metoprolol|metoprolol
23633|NCT03138603|myocardial injury|myocardial injury
23634|NCT03138590|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
23635|NCT03138590|accelerate learning|accelerate learning
23636|NCT03138590|memory|memory
23638|NCT03138564|Nephrology|nephrology
23639|NCT03138564|Behavioral Research|behavioral research
23640|NCT03138564|Social Research|social research
23641|NCT03138551|Sensory Food Aversions|sensory food aversions
23642|NCT03138538|Advanced Solid Tumors|advanced solid tumors
23643|NCT03138538|M8891|m8891
23644|NCT03138538|Methionine Aminopeptidase 2 Inhibitor|methionine aminopeptidase 2 inhibitor
23645|NCT03138512|localized; resected; adjuvant|localized; resected; adjuvant
23646|NCT03138473|SYNTAX Score|syntax score
23647|NCT03138473|residual SYNTAX score|residual syntax score
23648|NCT03138473|SYNTAX Revascularization Index|syntax revascularization index
23649|NCT03138447|insulin|insulin
23650|NCT03138447|basal|basal
23651|NCT03138447|titration|titration
23652|NCT03138447|digital health|digital health
23653|NCT03138434|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
23654|NCT03138434|4D flow MRI|4d flow mri
23655|NCT03138434|DCE-MRI|dce-mri
23656|NCT03138434|T1 and T2 mapping|t1 and t2 mapping
23657|NCT03138408|Ovarian cancer|ovarian cancer
23658|NCT03138408|SC-004|sc-004
23659|NCT03138408|Solid tumor cancers|solid tumor cancers
23660|NCT03138408|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
23661|NCT03138408|Endometrial cancer|endometrial cancer
23662|NCT03138408|Cancer|cancer
23669|NCT03138382|obesity|obesity
23670|NCT03138382|metabolic syndrome|metabolic syndrome
23671|NCT03138382|weight loss|weight loss
23672|NCT03138369|Obesity|obesity
23673|NCT03138369|Metabolic Syndrome|metabolic syndrome
23674|NCT03138369|Prediabetes|prediabetes
23675|NCT03138369|Glycemic control|glycemic control
23676|NCT03138369|Hypercholesterolemia|hypercholesterolemia
23677|NCT03138369|Abdominal obesity|abdominal obesity
23678|NCT03138369|Weight Loss|weight loss
23679|NCT03138356|Type 2 diabetes mellitus, saxagliptin, dapagliflozin, metformin XR, fixed-dose combination, healthy subjects, crossover, cohorts.|type 2 diabetes mellitus, saxagliptin, dapagliflozin, metformin xr, fixed-dose combination, healthy subjects, crossover, cohorts.
23680|NCT03138304|decision making|decision making
23681|NCT03138304|heuristics|heuristics
23682|NCT03138226|uterus, transplantation, infertility, twin|uterus, transplantation, infertility, twin
23683|NCT03138213|pancreaticoduodenectomy|pancreaticoduodenectomy
23684|NCT03138213|surgical outcome|surgical outcome
23685|NCT03138200|Transfusion|transfusion
23686|NCT03138200|ScvO2|scvo2
23688|NCT03138187|spontaneous physical activity|spontaneous physical activity
23689|NCT03138187|caloric intake|caloric intake
23690|NCT03138174|Blood Glucose Monitor System Accuracy|blood glucose monitor system accuracy
23691|NCT03138161|cancer immunotherapy, combination chemo-/immunotherapy|cancer immunotherapy, combination chemo-/immunotherapy
23692|NCT03138148|intensive care|intensive care
23693|NCT03138135|PrEP|prep
23694|NCT03138135|HIV prevention|hiv prevention
23695|NCT03138135|Risk reduction|risk reduction
23696|NCT03138135|STI prevention|sti prevention
23697|NCT03138135|Home HIV testing|home hiv testing
23698|NCT03138135|HIV testing|hiv testing
23699|NCT03138135|STI testing|sti testing
23700|NCT03138109|non-cardiac surgery|non-cardiac surgery
23701|NCT03138109|major adverse cardiac event|major adverse cardiac event
23702|NCT03138083|Mesenchymal-epithelial transition factor (MET) inhibitor|mesenchymal-epithelial transition factor (met) inhibitor
23703|NCT03138044|Hepatocellular Carcinoma|hepatocellular carcinoma
616032|NCT00646152|SARS|sars
23704|NCT03138044|Ipsilateral Liver Lobe Devascularization|ipsilateral liver lobe devascularization
23705|NCT03138044|Alcohol Treatment|alcohol treatment
23706|NCT03138044|CILDAT|cildat
23707|NCT03138031|Percutaneuos Ethanol alcohol injection|percutaneuos ethanol alcohol injection
23708|NCT03138005|Emergency Care, Prehospital|emergency care, prehospital
23709|NCT03138005|Resuscitation|resuscitation
23710|NCT03138005|Oxygen|oxygen
23711|NCT03138005|Cardiac Arrest|cardiac arrest
23712|NCT03138005|Heart Arrest|heart arrest
23713|NCT03137992|COPD|copd
23714|NCT03137979|Periodontitis|periodontitis
23715|NCT03137979|Gingiva mesenchymal stem cells|gingiva mesenchymal stem cells
23716|NCT03137966|Diabetes mellitus, foot ulcer, deferoxamine|diabetes mellitus, foot ulcer, deferoxamine
23717|NCT03137940|Unilateral Cerebral Palsy|unilateral cerebral palsy
23718|NCT03137940|tDCS|tdcs
23719|NCT03137940|Safety|safety
23720|NCT03137940|Upper Limb functions|upper limb functions
23721|NCT03137927|bordetella pertussis|bordetella pertussis
23722|NCT03137927|vaccine|vaccine
23723|NCT03137927|Immunologic Factors|immunologic factors
23724|NCT03137927|whooping cough|whooping cough
23725|NCT03137914|orthognathic surgery|orthognathic surgery
23726|NCT03137914|TMJ|tmj
23727|NCT03137914|osteoarthritis|osteoarthritis
23728|NCT03137875|Tuberculosis|tuberculosis
23729|NCT03137875|TB|tb
23730|NCT03137875|MDR-TB|mdr-tb
23731|NCT03137875|LIPA|lipa
23732|NCT03137875|filter paper|filter paper
23733|NCT03137875|slides|slides
23734|NCT03137875|MTBDR Plus|mtbdr plus
23735|NCT03137849|Yoga|yoga
23736|NCT03137849|Hypertension|hypertension
23737|NCT03137849|Post-Menopausal Women|post-menopausal women
23738|NCT03137849|Heart Rate Variability|heart rate variability
23739|NCT03137823|diagnosis, tonsillitis, streptococcus, GABHS|diagnosis, tonsillitis, streptococcus, gabhs
23740|NCT03137784|asthma,|asthma,
23741|NCT03137784|NVA237,|nva237,
23742|NCT03137784|glycopyrronium bromide|glycopyrronium bromide
23743|NCT03137784|allergic asthma,|allergic asthma,
23744|NCT03137784|allergy triggered asthma,|allergy triggered asthma,
23745|NCT03137784|reactive asthma,|reactive asthma,
23746|NCT03137784|asthma attack,|asthma attack,
23747|NCT03137784|difficulty breathing|difficulty breathing
23748|NCT03137745|Thromboelastography, chemotherapy,hyperthermic|thromboelastography, chemotherapy,hyperthermic
23749|NCT03137693|histologically proven|histologically proven
23750|NCT03137693|invasive adenocarcinoma of breast|invasive adenocarcinoma of breast
23751|NCT03137693|node negative (N0)|node negative (n0)
23752|NCT03137693|breast-conserving surgery|breast-conserving surgery
23753|NCT03137693|negative for Her-2 amplification|negative for her-2 amplification
23754|NCT03137693|estrogen receptor (ER) positive|estrogen receptor (er) positive
23755|NCT03137693|progesterone receptor (PR) positive|progesterone receptor (pr) positive
23756|NCT03137680|Arteriovenous Fistula|arteriovenous fistula
24124|NCT03135366|TB|tb
23757|NCT03137680|Pre-operative Exercise|pre-operative exercise
23758|NCT03137680|Fistula Maturation|fistula maturation
23759|NCT03137667|Influenza Vaccination Rates|influenza vaccination rates
23760|NCT03137654|Cognitive Training|cognitive training
23761|NCT03137654|Emotion Processing|emotion processing
23762|NCT03137641|occupational exposure|occupational exposure
23763|NCT03137641|antineoplastic drugs|antineoplastic drugs
23764|NCT03137641|biomonitoring|biomonitoring
23765|NCT03137628|general anesthesia,mechanical ventilation,colectomy|general anesthesia,mechanical ventilation,colectomy
23766|NCT03137589|Telemedicine|telemedicine
23767|NCT03137576|Awake Thoracic Surgery, Serratus block|awake thoracic surgery, serratus block
23768|NCT03137563|Women|women
23769|NCT03137563|25-65 years|25-65 years
23770|NCT03137537|Lymphoma|lymphoma
23771|NCT03137537|Abnormal resting heart rate|abnormal resting heart rate
23772|NCT03137537|Autonomic imbalance|autonomic imbalance
23773|NCT03137537|Cancer survivorship|cancer survivorship
23774|NCT03137524|Fan or Air Therapy|fan or air therapy
23775|NCT03137511|Public Health|public health
23776|NCT03137511|General Medicine|general medicine
23777|NCT03137511|Dermatology|dermatology
23778|NCT03137498|renal colic|renal colic
23779|NCT03137498|lidocaine|lidocaine
23780|NCT03137498|ketorolac|ketorolac
23781|NCT03137498|acute pain|acute pain
23782|NCT03137472|TMS, CRPS, Sham|tms, crps, sham
23783|NCT03137459|Transtheoretical Model (TTM)|transtheoretical model (ttm)
23784|NCT03137446|Intravenous fluid resuscitation|intravenous fluid resuscitation
23785|NCT03137446|Septic shock|septic shock
23786|NCT03137446|Severe sepsis|severe sepsis
23787|NCT03137446|Fluid restriction|fluid restriction
23788|NCT03137433|Weight loss|weight loss
23789|NCT03137433|Cardiometabolic|cardiometabolic
23790|NCT03137433|Meal-replacement therapy|meal-replacement therapy
23791|NCT03137407|heel pain|heel pain
23792|NCT03137394|spinal cord injury|spinal cord injury
23793|NCT03137394|shoulder pain|shoulder pain
23794|NCT03137394|psychosocial|psychosocial
23795|NCT03137368|ovarian function suppression/ablation|ovarian function suppression/ablation
23796|NCT03137368|breast cancer|breast cancer
23797|NCT03137368|Exemestane|exemestane
23798|NCT03137368|Tamoxifen|tamoxifen
23799|NCT03137368|CYP2D6*10 mutations|cyp2d6*10 mutations
23800|NCT03137355|Leigh Syndrome|leigh syndrome
23801|NCT03137355|Leigh Disease|leigh disease
23802|NCT03137355|Leigh's Necrotizing Encephalopathy|leigh's necrotizing encephalopathy
23803|NCT03137355|Subacute Necrotizing Encephalomyelopathy|subacute necrotizing encephalomyelopathy
23804|NCT03137355|Subacute Necrotizing Encephalomyopathy|subacute necrotizing encephalomyopathy
23805|NCT03137342|PrEP|prep
23806|NCT03137342|Adherence|adherence
23807|NCT03137342|Risk Reduction|risk reduction
23808|NCT03137342|Stimulant Use|stimulant use
23809|NCT03137290|Paediatric general anaesthesia|paediatric general anaesthesia
23810|NCT03137290|Rocuronium|rocuronium
23811|NCT03137290|Neostigmine|neostigmine
23812|NCT03137290|Sugammadex|sugammadex
23813|NCT03137277|Colonoscopy|colonoscopy
23814|NCT03137277|ADR|adr
23815|NCT03137277|Adenoma detection rate|adenoma detection rate
23816|NCT03137277|colonoscopic imaging feature improvement|colonoscopic imaging feature improvement
23817|NCT03137277|Olympus colonoscopes|olympus colonoscopes
23818|NCT03137264|T790M mutation|t790m mutation
23819|NCT03137264|EGFR epidermal growth factor receptor|egfr epidermal growth factor receptor
23820|NCT03137264|non-invasive testing|non-invasive testing
23821|NCT03137264|lung cancer|lung cancer
23822|NCT03137251|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
23823|NCT03137251|TENS|tens
23824|NCT03137251|Analgesia|analgesia
23825|NCT03137251|Labour pain|labour pain
23826|NCT03137251|Physical therapy modality|physical therapy modality
23827|NCT03137238|Self-motion perception|self-motion perception
23828|NCT03137238|Optic flow|optic flow
23829|NCT03137238|Vestibular system|vestibular system
23830|NCT03137238|Multisensory integration|multisensory integration
23831|NCT03137238|Parkinson's disease|parkinson's disease
23832|NCT03137212|Percutaneous Coronary Intervention|percutaneous coronary intervention
23833|NCT03137212|STEMI|stemi
23834|NCT03137212|Thrombosis|thrombosis
23835|NCT03137199|stem cell|stem cell
23836|NCT03137199|mesenchymal stem cell|mesenchymal stem cell
23837|NCT03137199|lung|lung
23838|NCT03137199|asthma|asthma
23839|NCT03137186|Metformin, prostate cancer|metformin, prostate cancer
23840|NCT03137147|pediatric|pediatric
23841|NCT03137147|children|children
23842|NCT03137147|adolescent|adolescent
23843|NCT03137147|sleep|sleep
23845|NCT03137147|cognitive-behavioral therapy|cognitive-behavioral therapy
23846|NCT03137121|nausea|nausea
23847|NCT03137121|vomiting|vomiting
23848|NCT03137121|olanzapine|olanzapine
23849|NCT03137082|Alcohol Use Disorder|alcohol use disorder
23850|NCT03137082|Guanfacine|guanfacine
23851|NCT03137082|Stress|stress
23852|NCT03137082|Craving|craving
23853|NCT03137082|Gender|gender
23854|NCT03137082|Relapse|relapse
23855|NCT03137056|Hemodialysis|hemodialysis
23856|NCT03137056|Membrane|membrane
23857|NCT03137056|Albumin|albumin
23858|NCT03137056|Proteomics|proteomics
23859|NCT03137043|GINA guidelines|gina guidelines
23860|NCT03137043|Prevalence|prevalence
23861|NCT03137043|Mepolizumab|mepolizumab
23862|NCT03137043|severe asthma|severe asthma
23863|NCT03137043|Spain|spain
23864|NCT03137030|Abuse deterrent formulation|abuse deterrent formulation
23865|NCT03137030|Hydrocodone|hydrocodone
23866|NCT03137030|Analgesics, Opioid|analgesics, opioid
23867|NCT03137030|Narcotics|narcotics
23868|NCT03137017|Abuse deterrent formulation|abuse deterrent formulation
23869|NCT03137017|Hydrocodone|hydrocodone
23870|NCT03137017|Analgesics, Opioid|analgesics, opioid
23871|NCT03137017|Narcotics|narcotics
23872|NCT03136991|Oral myeloperoxidase inhibitor|oral myeloperoxidase inhibitor
23873|NCT03136978|Macrophages|macrophages
23874|NCT03136978|Macrophages, Peritoneal|macrophages, peritoneal
23875|NCT03136978|Endometriosis|endometriosis
23876|NCT03136952|NIRS|nirs
23877|NCT03136952|Monitoring|monitoring
23878|NCT03136952|Pediatric|pediatric
23879|NCT03136874|donors|donors
23880|NCT03136874|gametes|gametes
23881|NCT03136874|motivation|motivation
23882|NCT03136874|psychological|psychological
23883|NCT03136861|axial spondyloarthritis|axial spondyloarthritis
23884|NCT03136861|ankylosing spondylitis|ankylosing spondylitis
23885|NCT03136861|non-radiographic axial spondyloarthritis|non-radiographic axial spondyloarthritis
23886|NCT03136861|inflammatory back pain|inflammatory back pain
23887|NCT03136861|spinal pain|spinal pain
23888|NCT03136861|secukinumab|secukinumab
23889|NCT03136861|AIN457|ain457
23890|NCT03136848|perfusion|perfusion
23891|NCT03136822|Diabetic Foot|diabetic foot
23892|NCT03136744|Sedentary behaviour|sedentary behaviour
23893|NCT03136744|Co-morbidity|co-morbidity
23894|NCT03136744|Intervention|intervention
23895|NCT03136731|Celiac disease, Gluten, Microbiome, Genetic|celiac disease, gluten, microbiome, genetic
23896|NCT03136718|mHealth|mhealth
23897|NCT03136718|Hearing aids|hearing aids
23898|NCT03136718|Auditory rehabilitation|auditory rehabilitation
23899|NCT03136718|Adult|adult
23900|NCT03136718|Reusable Learning Object|reusable learning object
23901|NCT03136718|Education|education
23902|NCT03136718|Personalised|personalised
23903|NCT03136718|Telehealth|telehealth
23904|NCT03136718|Teleaudiology|teleaudiology
23905|NCT03136705|Phosphorus Homeostasis|phosphorus homeostasis
23906|NCT03136705|FGF23|fgf23
23907|NCT03136705|Vitamin D|vitamin d
23908|NCT03136692|app|app
23909|NCT03136692|weight loss|weight loss
23910|NCT03136692|diet|diet
23911|NCT03136692|behavior|behavior
23912|NCT03136653|DARPin|darpin
23913|NCT03136653|MP0250|mp0250
23914|NCT03136653|VEGF|vegf
23915|NCT03136653|HGF|hgf
23916|NCT03136653|RRMM|rrmm
23917|NCT03136627|RCC, Tivozanib, Nivolumab, Metastatic Renal Cell Cancer|rcc, tivozanib, nivolumab, metastatic renal cell cancer
23918|NCT03136588|Information and Communication Technology|information and communication technology
23919|NCT03136588|Adherence|adherence
23920|NCT03136588|Kidney transplantation|kidney transplantation
23921|NCT03136523|NSCLC|nsclc
23922|NCT03136523|SCLC|sclc
23923|NCT03136523|MOLECULAR BIOMARKERS|molecular biomarkers
23924|NCT03136523|EGFR|egfr
23925|NCT03136523|PD-L1|pd-l1
23926|NCT03136523|ALK|alk
23927|NCT03136523|KRAS|kras
23928|NCT03136458|contrast media|contrast media
23929|NCT03136458|nephropathy|nephropathy
23930|NCT03136458|ischemic preconditioning|ischemic preconditioning
23931|NCT03136445|Tranexamic acid|tranexamic acid
23932|NCT03136445|Platelet transfusion|platelet transfusion
23933|NCT03136432|Cerebral Palsy|cerebral palsy
23934|NCT03136432|Functional Exercise Capacity|functional exercise capacity
23935|NCT03136432|Quality of Life|quality of life
23936|NCT03136419|microbiota|microbiota
23937|NCT03136419|innate immunity|innate immunity
23938|NCT03136393|nutrition|nutrition
23939|NCT03136393|pregnancy|pregnancy
23940|NCT03136393|birth weight|birth weight
23941|NCT03136380|healthy Japanese subjects|healthy japanese subjects
23942|NCT03136380|CXCR2 inhibitor|cxcr2 inhibitor
23943|NCT03136380|Danirixin|danirixin
23944|NCT03136367|encounter decision aids|encounter decision aids
23945|NCT03136367|shared decision making|shared decision making
23946|NCT03136367|socioeconomic status|socioeconomic status
23947|NCT03136367|disparities|disparities
23948|NCT03136367|decision quality|decision quality
23949|NCT03136341|Upper Limb|upper limb
23951|NCT03136341|task-dependent|task-dependent
23952|NCT03136315|Renal failure|renal failure
23954|NCT03136315|ultra endurance|ultra endurance
23955|NCT03136263|Attention|attention
23956|NCT03136263|Attention deficit/hyperactivity disorder|attention deficit/hyperactivity disorder
23957|NCT03136263|Cognitive control|cognitive control
23958|NCT03136263|Executive control|executive control
23959|NCT03136263|Executive functions|executive functions
23960|NCT03136263|Impulse control|impulse control
23961|NCT03136263|Impulsivity|impulsivity
23962|NCT03136263|Oxytocin|oxytocin
23963|NCT03136250|Muscle Energy Techniques|muscle energy techniques
23964|NCT03136250|Autogenic Inhibition|autogenic inhibition
23965|NCT03136250|Reciprocal Inhibition|reciprocal inhibition
23966|NCT03136250|Stretching|stretching
23967|NCT03136250|Range of Motion|range of motion
23968|NCT03136250|Muscle Strength|muscle strength
23969|NCT03136250|VAS|vas
23970|NCT03136250|Neck Disability Index|neck disability index
23971|NCT03136250|NDI|ndi
23972|NCT03136224|circumcision|circumcision
23973|NCT03136224|Thermocautery|thermocautery
23974|NCT03136224|Clamp|clamp
23975|NCT03136224|Surgical Circumcision|surgical circumcision
23976|NCT03136198|Heart Failure|heart failure
23977|NCT03136198|Acute Heart Failure|acute heart failure
23978|NCT03136198|Pulmonary Edema|pulmonary edema
23979|NCT03136198|Lung ultrasound|lung ultrasound
23980|NCT03136198|Extra vascular lung water|extra vascular lung water
23981|NCT03136198|B-lines|b-lines
23982|NCT03136159|pregnancy|pregnancy
23983|NCT03136159|delivery|delivery
23984|NCT03136159|cesarean section|cesarean section
23985|NCT03136159|wound healing|wound healing
23986|NCT03136159|silver-containing dressing|silver-containing dressing
23987|NCT03136146|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
23988|NCT03136146|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
23990|NCT03136146|Lymphoblastic Lymphoma|lymphoblastic lymphoma
23991|NCT03136146|LL|ll
23992|NCT03136146|Relapsed/Refractory|relapsed/refractory
23993|NCT03136146|Clofarabine|clofarabine
23994|NCT03136146|Clofarex|clofarex
23995|NCT03136146|Clolar|clolar
23996|NCT03136146|Etoposide|etoposide
23997|NCT03136146|VePesid|vepesid
23998|NCT03136146|Cyclophosphamide|cyclophosphamide
23999|NCT03136146|Cytoxan|cytoxan
24000|NCT03136146|Neosar|neosar
24001|NCT03136146|Liposomal Vincristine|liposomal vincristine
24002|NCT03136146|Vincristine Sulfate Liposomes Injection|vincristine sulfate liposomes injection
24003|NCT03136146|VSLI|vsli
24004|NCT03136146|Marqibo|marqibo
24005|NCT03136146|Bortezomib|bortezomib
24006|NCT03136146|Velcade|velcade
24007|NCT03136146|LDP-341|ldp-341
24008|NCT03136146|MLN341|mln341
24009|NCT03136146|PS-341|ps-341
24010|NCT03136146|Ofatumumab|ofatumumab
24011|NCT03136146|Arzerra|arzerra
24012|NCT03136146|Rituximab|rituximab
24013|NCT03136146|Rituxan|rituxan
24014|NCT03136146|Pegfilgrastim|pegfilgrastim
24015|NCT03136146|Neulasta|neulasta
24016|NCT03136146|PEG-G-CSF|peg-g-csf
24017|NCT03136120|Ipratropium bromide|ipratropium bromide
24018|NCT03136120|Cryobiopsy|cryobiopsy
24019|NCT03136120|TBCB|tbcb
24020|NCT03136120|IPF|ipf
24021|NCT03136120|Transbronchial cryobiopsy|transbronchial cryobiopsy
24022|NCT03136120|Interstitial lung disease|interstitial lung disease
24023|NCT03136094|American Indian|american indian
24024|NCT03136094|Alaska Native|alaska native
24025|NCT03136094|Youth and Young Adult|youth and young adult
24026|NCT03136094|SBIRT|sbirt
24027|NCT03136081|Septic shock|septic shock
24028|NCT03136081|Candidiasis|candidiasis
24029|NCT03136081|Candidemia|candidemia
24030|NCT03136081|Bacteremia|bacteremia
24031|NCT03136081|Immunoparalysis|immunoparalysis
24032|NCT03136055|NEC|nec
24033|NCT03136029|HFrEF|hfref
24034|NCT03136029|Exercise Intolerance|exercise intolerance
24035|NCT03136029|Nitric Oxide|nitric oxide
24036|NCT03135990|Virtual Reality|virtual reality
24037|NCT03135990|Exposure Therapy|exposure therapy
24038|NCT03135990|Cognitive Behavioral Therapy|cognitive behavioral therapy
24039|NCT03135990|Extinction Learning|extinction learning
24040|NCT03135964|NPWT|npwt
24041|NCT03135964|foam|foam
24042|NCT03135964|gauze|gauze
24043|NCT03135951|Breast Cancer|breast cancer
24044|NCT03135951|Pharmacokinetics|pharmacokinetics
24045|NCT03135951|Long-acting Myeloid Growth Factor|long-acting myeloid growth factor
24046|NCT03135951|Early Stage Breast Cancer|early stage breast cancer
24047|NCT03135951|Docetaxel + Cyclophosphamide (TC) Chemotherapy|docetaxel + cyclophosphamide (tc) chemotherapy
24048|NCT03135912|Tinea Pedis|tinea pedis
24049|NCT03135912|Athlete's Foot|athlete's foot
24051|NCT03135886|HIV Testing|hiv testing
24052|NCT03135886|Hepatitis C Virus Testing|hepatitis c virus testing
24053|NCT03135886|Opioid Use Disorder Treatment|opioid use disorder treatment
24054|NCT03135886|Substance Use Disorders Treatment|substance use disorders treatment
24055|NCT03135886|Hepatitis C Virus|hepatitis c virus
24056|NCT03135886|Practice Coaching|practice coaching
24057|NCT03135860|Inhaled Nitric Oxide|inhaled nitric oxide
24058|NCT03135860|COPD|copd
24059|NCT03135860|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
24060|NCT03135860|Idopathic Pulmonary Fibrosis|idopathic pulmonary fibrosis
24061|NCT03135860|Long Term Oxygen Therapy (LTOT)|long term oxygen therapy (ltot)
24062|NCT03135808|MRI|mri
24063|NCT03135808|Imaging,|imaging,
24064|NCT03135808|Anatomy|anatomy
24065|NCT03135808|Tissue|tissue
24547|NCT03132454|AML|aml
24066|NCT03135808|Colorectal|colorectal
24067|NCT03135808|Sigmoid|sigmoid
24068|NCT03135808|Colon|colon
24069|NCT03135808|Pathology|pathology
24070|NCT03135795|sufentanil|sufentanil
24071|NCT03135795|DNA methylation|dna methylation
24072|NCT03135769|avelumab|avelumab
24073|NCT03135769|PDL1|pdl1
24074|NCT03135769|Gestational Trophoblastic Neoplasias|gestational trophoblastic neoplasias
24075|NCT03135769|GTN|gtn
24076|NCT03135769|Hydatiform mole|hydatiform mole
24077|NCT03135769|hCG|hcg
24078|NCT03135717|Chronic kidney disease|chronic kidney disease
24079|NCT03135717|Enteral nutrition|enteral nutrition
24080|NCT03135717|Oral nutritional supplements|oral nutritional supplements
24081|NCT03135717|Parenteral nutrition|parenteral nutrition
24082|NCT03135717|Refeeding|refeeding
24083|NCT03135717|Wasting|wasting
24084|NCT03135652|Radiotherapy|radiotherapy
24085|NCT03135652|Colorectal Cancer|colorectal cancer
24086|NCT03135652|Liver Metastases|liver metastases
24087|NCT03135639|tACS|tacs
24088|NCT03135639|transcranial alternating current stimulation|transcranial alternating current stimulation
24089|NCT03135639|stimulation|stimulation
24090|NCT03135639|healthy control|healthy control
24091|NCT03135639|alpha oscillations|alpha oscillations
24092|NCT03135639|heart rate variability|heart rate variability
24093|NCT03135626|Pulpotomy|pulpotomy
24094|NCT03135626|Primary molars|primary molars
24095|NCT03135613|Knee tumor|knee tumor
24096|NCT03135613|Microwave|microwave
24097|NCT03135613|Gait|gait
24098|NCT03135600|Knee|knee
24099|NCT03135600|ACL Injury|acl injury
24100|NCT03135600|Kinematics|kinematics
24101|NCT03135587|Knee|knee
24102|NCT03135587|Loading|loading
24103|NCT03135587|Kinematics|kinematics
24104|NCT03135522|Chronic cough|chronic cough
24105|NCT03135522|Refractory cough|refractory cough
24106|NCT03135522|Chronic refractory cough|chronic refractory cough
24107|NCT03135522|Zinc|zinc
24108|NCT03135522|Zinc acetate|zinc acetate
24109|NCT03135509|Healthy Subjects|healthy subjects
24110|NCT03135509|CC-220 Capsules|cc-220 capsules
24111|NCT03135509|Relative Bioavailability|relative bioavailability
24112|NCT03135509|Phase 1|phase 1
24113|NCT03135470|pain|pain
24114|NCT03135470|ambulatory surgery|ambulatory surgery
24115|NCT03135470|oxycodone|oxycodone
24116|NCT03135470|adverse effect|adverse effect
24117|NCT03135444|Screening|screening
24118|NCT03135444|Shared Decision Making|shared decision making
24119|NCT03135418|Virtual Reality|virtual reality
24120|NCT03135392|Breast Cancer|breast cancer
24121|NCT03135392|sensation recovery|sensation recovery
24122|NCT03135392|Neurotization|neurotization
24123|NCT03135366|Tuberculosis|tuberculosis
24125|NCT03135366|Adherence|adherence
24126|NCT03135366|Mobile Health|mobile health
24127|NCT03135366|mHealth|mhealth
24128|NCT03135366|Behavior change|behavior change
24129|NCT03135366|Social and Behavior Change Communication (SBCC)|social and behavior change communication (sbcc)
24130|NCT03135366|Drug-Resistance|drug-resistance
24131|NCT03135366|Keheala|keheala
24132|NCT03135275|ST-elevation Myocardial Infarction|st-elevation myocardial infarction
24133|NCT03135275|Multivessel coronary disease|multivessel coronary disease
24134|NCT03135275|Immediate complete coronary revascularization|immediate complete coronary revascularization
24135|NCT03135275|Staged complete coronary revascularization|staged complete coronary revascularization
24136|NCT03135275|Percutaneous coronary intervention|percutaneous coronary intervention
24137|NCT03135275|Biodegradable-polymer everolimus-eluting stent|biodegradable-polymer everolimus-eluting stent
24138|NCT03135236|Parent training|parent training
24139|NCT03135236|Family education|family education
24140|NCT03135236|Young adults|young adults
24141|NCT03135236|Down syndrome|down syndrome
24142|NCT03135236|sexuality|sexuality
24143|NCT03135223|Physical activity|physical activity
24144|NCT03135145|Single Event Multilevel Lower Extremity Orthopedic Surgery (SEMLS)|single event multilevel lower extremity orthopedic surgery (semls)
24145|NCT03135145|Physical Therapy|physical therapy
26695|NCT03117972|LDH|ldh
24148|NCT03135145|Selective Dorsal Rhizotomy (SDR)|selective dorsal rhizotomy (sdr)
24150|NCT03135132|Low calorie diet|low calorie diet
24151|NCT03135132|Mild weight loss|mild weight loss
24152|NCT03135132|Metabolomics|metabolomics
24153|NCT03135132|Metabolites|metabolites
24154|NCT03135132|Acylcarnitines|acylcarnitines
24155|NCT03135093|synergies|synergies
24156|NCT03135093|upper limb|upper limb
24157|NCT03135093|vision|vision
24158|NCT03135067|HIV self-testing|hiv self-testing
24159|NCT03135067|female sex workers|female sex workers
24160|NCT03135067|partner testing|partner testing
24161|NCT03135067|couples testing|couples testing
24162|NCT03135067|transactional sex|transactional sex
24773|NCT03130985|microRNA|microrna
24163|NCT03135054|FLT3-ITD (+) AML; Quizartinib, Omacetaxine mepesuccinate|flt3-itd (+) aml; quizartinib, omacetaxine mepesuccinate
24164|NCT03135041|Prebiotics|prebiotics
24165|NCT03135041|Microbiome|microbiome
24166|NCT03135041|Glucose metabolism|glucose metabolism
24167|NCT03134976|Salvage surgery|salvage surgery
24168|NCT03134976|Head and neck cancer|head and neck cancer
24169|NCT03134976|Wound healing|wound healing
24170|NCT03134976|Hypothyroidism|hypothyroidism
24171|NCT03134976|Levothyroxine|levothyroxine
24172|NCT03134937|Gastric Ultrasound|gastric ultrasound
24173|NCT03134937|Gastric Distension|gastric distension
24174|NCT03134937|Gastric Volume|gastric volume
24175|NCT03134937|Gastric Fluid Volume|gastric fluid volume
24176|NCT03134937|High-flow oxygen therapy|high-flow oxygen therapy
24177|NCT03134937|HFNO|hfno
24178|NCT03134924|Bacterial Vaginosis|bacterial vaginosis
24179|NCT03134885|suicide|suicide
24180|NCT03134885|suicidal conducts|suicidal conducts
24181|NCT03134885|post discharge monitoring system|post discharge monitoring system
24182|NCT03134872|PD-1|pd-1
24183|NCT03134872|PD-L1|pd-l1
24184|NCT03134872|SHR-1210|shr-1210
24185|NCT03134872|Carboplatin|carboplatin
24186|NCT03134872|Pemetrexed|pemetrexed
24187|NCT03134859|motor development|motor development
24188|NCT03134846|Intraoperative fluorescence imaging|intraoperative fluorescence imaging
24189|NCT03134846|Cetuximab-IRDye800CW|cetuximab-irdye800cw
24190|NCT03134846|Molecular imaging|molecular imaging
24191|NCT03134833|HIV|hiv
24192|NCT03134833|STI|sti
24193|NCT03134833|Mental Health|mental health
24194|NCT03134833|Substance Use|substance use
24195|NCT03134833|Peer Support|peer support
24196|NCT03134820|Low molecular weight heparins|low molecular weight heparins
24197|NCT03134820|Procoagulants|procoagulants
24198|NCT03134820|Phospholipid-dependent Microparticles|phospholipid-dependent microparticles
24199|NCT03134794|neuroeconomics|neuroeconomics
24200|NCT03134794|multiple sclerosis|multiple sclerosis
24201|NCT03134794|educational intervention|educational intervention
24202|NCT03134794|traffic light system|traffic light system
616130|NCT00646620|asthma|asthma
24203|NCT03134794|aversion to ambiguity|aversion to ambiguity
24205|NCT03134794|outcomes|outcomes
24206|NCT03134794|knowledge|knowledge
24207|NCT03134794|action|action
24208|NCT03134794|gaps|gaps
24209|NCT03134794|disease modifying agents|disease modifying agents
24210|NCT03134755|Asthma|asthma
24211|NCT03134755|Children|children
24212|NCT03134755|Stress|stress
24213|NCT03134755|Puerto Rican|puerto rican
24214|NCT03134755|Health disparities|health disparities
24215|NCT03134755|Treatment response|treatment response
24216|NCT03134742|soft tissue sarcoma extremities|soft tissue sarcoma extremities
24217|NCT03134729|Serratus Block, Pain Management, lung lobectomy|serratus block, pain management, lung lobectomy
24218|NCT03134690|Poor ovarian response gonadotropins antagonist|poor ovarian response gonadotropins antagonist
24219|NCT03134677|Spinal anesthesia|spinal anesthesia
24220|NCT03134677|General anesthesia|general anesthesia
24221|NCT03134677|P wave dispersion|p wave dispersion
24222|NCT03134651|Anxiety|anxiety
24223|NCT03134651|Oocyte retrieval|oocyte retrieval
24224|NCT03134651|Monitoring of brain function|monitoring of brain function
24225|NCT03134625|metabolomics|metabolomics
24226|NCT03134625|biomarker|biomarker
24227|NCT03134625|acute rejection|acute rejection
24228|NCT03134612|lidocain|lidocain
24229|NCT03134612|ondansetron|ondansetron
24230|NCT03134612|pain|pain
24231|NCT03134612|propofol|propofol
24232|NCT03134586|Capsule endoscopy|capsule endoscopy
24233|NCT03134586|Crohn's disease|crohn's disease
24234|NCT03134586|Magnetic resonance enterography|magnetic resonance enterography
24235|NCT03134586|Ileocolonoscopy|ileocolonoscopy
24236|NCT03134586|Bowel Ultrasound|bowel ultrasound
24237|NCT03134586|diagnostic imaging|diagnostic imaging
24238|NCT03134573|Relapsing Remitting Multiple Sclerosis (RRMS),|relapsing remitting multiple sclerosis (rrms),
24239|NCT03134573|Clinically isolated Syndrome (CIS),|clinically isolated syndrome (cis),
24240|NCT03134573|Secondary Progressive Multiple Sclerosis (SPMS)|secondary progressive multiple sclerosis (spms)
24244|NCT03134560|vein cannulation|vein cannulation
24245|NCT03134547|emergence agitation|emergence agitation
24246|NCT03134547|sevoflurane|sevoflurane
24247|NCT03134547|children|children
24248|NCT03134534|lobectomy|lobectomy
24249|NCT03134534|robot-assisted thoracoscopic surgery|robot-assisted thoracoscopic surgery
24250|NCT03134534|lung cancer|lung cancer
24251|NCT03134521|bone and joint infection|bone and joint infection
24252|NCT03134521|daptomycin|daptomycin
24253|NCT03134521|population pharmacokinetics|population pharmacokinetics
24254|NCT03134521|Glycoprotein-P (PgP)|glycoprotein-p (pgp)
24255|NCT03134482|in vitro maturation (IVM)|in vitro maturation (ivm)
24256|NCT03134482|polycystic ovarian syndrome (PCOS)|polycystic ovarian syndrome (pcos)
24257|NCT03134482|ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
24258|NCT03134482|assisted reproductive technology (ART)|assisted reproductive technology (art)
24259|NCT03134430|Regional nerve block|regional nerve block
24260|NCT03134430|cancer recurrence|cancer recurrence
24261|NCT03134404|RAMP|ramp
24262|NCT03134404|Rapid Access|rapid access
24263|NCT03134404|Metastasis to Bone|metastasis to bone
24264|NCT03134404|Cancer|cancer
24265|NCT03134378|Helicobacter pylori|helicobacter pylori
24266|NCT03134378|triple therapy|triple therapy
24267|NCT03134378|eradication|eradication
24268|NCT03134365|meal ingestion|meal ingestion
24269|NCT03134365|palatability|palatability
24270|NCT03134365|postprandial responses|postprandial responses
24271|NCT03134365|hedonic response|hedonic response
24272|NCT03134352|subacute|subacute
24273|NCT03134339|nicotine, smoking|nicotine, smoking
24274|NCT03134209|Monocryl|monocryl
24275|NCT03134209|Dermabond|dermabond
24276|NCT03134209|Polyester mesh|polyester mesh
24277|NCT03134209|Joint Disease|joint disease
24278|NCT03134209|Arthropathy|arthropathy
24279|NCT03134209|Joint Replacement|joint replacement
24280|NCT03134196|Herpes Zoster Ophthalmicus|herpes zoster ophthalmicus
24281|NCT03134196|Zoster Eye Disease Study|zoster eye disease study
24282|NCT03134196|Varicella Zoster Virus|varicella zoster virus
24283|NCT03134196|Zoster|zoster
24284|NCT03134196|Shingles|shingles
24285|NCT03134183|D&E|d&e
24286|NCT03134183|dilation and evacuation|dilation and evacuation
24287|NCT03134183|abortion|abortion
24288|NCT03134183|second trimester|second trimester
24289|NCT03134183|mifepristone|mifepristone
24290|NCT03134183|misoprostol|misoprostol
24291|NCT03134170|pharmacist|pharmacist
24292|NCT03134170|diabetes|diabetes
24295|NCT03134157|Leiomyoma simvastatin infertility|leiomyoma simvastatin infertility
24296|NCT03134144|Exoskeleton|exoskeleton
24297|NCT03134144|Manual materials handling|manual materials handling
24298|NCT03134144|Musculoskeletal disorders|musculoskeletal disorders
24299|NCT03134144|Posture|posture
24300|NCT03134144|Standing work|standing work
24301|NCT03134144|Muscle activity|muscle activity
24302|NCT03134118|Thymoma|thymoma
24303|NCT03134118|Phase II|phase ii
24304|NCT03134118|nivolumab|nivolumab
24305|NCT03134118|Thymic carcinoma|thymic carcinoma
24306|NCT03134079|Taste Testing|taste testing
24307|NCT03134079|Spices|spices
24308|NCT03134079|Reduced sugar|reduced sugar
24309|NCT03134079|Food liking|food liking
24312|NCT03134040|Incentives|incentives
24313|NCT03134040|Motivation|motivation
24314|NCT03133975|high dose vitamin D|high dose vitamin d
24315|NCT03133975|dyslipidemia|dyslipidemia
24316|NCT03133975|premenopausal women|premenopausal women
24317|NCT03133923|Attenuated Mumps Vaccine(F-genotype，Human Diploid Cell, KMB-17), safety, immunogenecity|attenuated mumps vaccine(f-genotype，human diploid cell, kmb-17), safety, immunogenecity
24318|NCT03133910|Pharmacokinetics|pharmacokinetics
24319|NCT03133910|Ceftazidime|ceftazidime
24320|NCT03133897|dexamethasone|dexamethasone
24321|NCT03133897|prednisone|prednisone
24322|NCT03133897|inpatient|inpatient
24323|NCT03133897|paediatrics|paediatrics
24324|NCT03133884|chronic tension-type headache|chronic tension-type headache
24325|NCT03133884|acupuncture|acupuncture
24326|NCT03133884|Deqi|deqi
24327|NCT03133845|delirium|delirium
24328|NCT03133845|elderly|elderly
24329|NCT03133845|lumbar|lumbar
24330|NCT03133845|surgery|surgery
24331|NCT03133832|Schistosomiasis haematobium|schistosomiasis haematobium
24332|NCT03133832|Praziquantel|praziquantel
24333|NCT03133832|A randomized controlled trial|a randomized controlled trial
24334|NCT03133806|Percutaneous Occlusion|percutaneous occlusion
24335|NCT03133793|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
24336|NCT03133767|Normal saline|normal saline
24337|NCT03133767|Lactated ringers|lactated ringers
24338|NCT03133767|Emergency department|emergency department
24339|NCT03133741|GIP|gip
24340|NCT03133741|GIP receptor antagonist|gip receptor antagonist
24341|NCT03133728|EID HIV|eid hiv
24342|NCT03133728|Early Infant Diagnosis|early infant diagnosis
24343|NCT03133728|Point of Care|point of care
24344|NCT03133728|Infant|infant
24345|NCT03133728|HIV|hiv
24346|NCT03133715|robot-assisted|robot-assisted
24347|NCT03133689|Alcohol|alcohol
24348|NCT03133689|Coronary heart disease|coronary heart disease
24349|NCT03133689|Ischemic heart disease|ischemic heart disease
24350|NCT03133689|Cardiovascular health|cardiovascular health
24351|NCT03133689|Individual participant data meta-analysis|individual participant data meta-analysis
24352|NCT03133689|Longitudinal|longitudinal
24353|NCT03133676|Osteoarthritis|osteoarthritis
24354|NCT03133676|Arthritis|arthritis
24355|NCT03133676|Joint Disease|joint disease
24356|NCT03133676|Osteoarthritis, Knee|osteoarthritis, knee
24357|NCT03133663|electrocardiogram|electrocardiogram
24358|NCT03133663|premature|premature
24359|NCT03133663|resuscitation|resuscitation
24360|NCT03133650|Vascular-Targeted Photodynamic Therapy (VTP)|vascular-targeted photodynamic therapy (vtp)
24361|NCT03133650|15-319|15-319
24362|NCT03133624|unruptured intracranial aneurysms|unruptured intracranial aneurysms
24363|NCT03133624|rupture risk|rupture risk
24364|NCT03133624|computational fluid dynamic|computational fluid dynamic
24365|NCT03133624|high resolution magnetic resonance images|high resolution magnetic resonance images
24366|NCT03133624|gene|gene
24367|NCT03133624|multi dimensional prediction model|multi dimensional prediction model
16322|NCT03186716|Colostrum|colostrum
24368|NCT03133624|clinical features|clinical features
24369|NCT03133624|risk factors|risk factors
24370|NCT03133624|registry study|registry study
24371|NCT03133624|china|china
24372|NCT03133624|biomarkers|biomarkers
24373|NCT03133611|Speech disorder|speech disorder
24374|NCT03133611|Acoustic analysis|acoustic analysis
24375|NCT03133611|Dysarthria|dysarthria
24376|NCT03133598|Un-ruptured intracranial aneurysm|un-ruptured intracranial aneurysm
24377|NCT03133598|Interventional therapy and craniotomy|interventional therapy and craniotomy
24378|NCT03133598|Prospective cohort study|prospective cohort study
24379|NCT03133598|China|china
24380|NCT03133546|NSCLC|nsclc
24381|NCT03133546|EGFR|egfr
24382|NCT03133546|TKI|tki
24383|NCT03133546|EGFRm|egfrm
24384|NCT03133546|T790M|t790m
24385|NCT03133533|robot-assisted|robot-assisted
24386|NCT03133520|Respiratory failure|respiratory failure
24387|NCT03133520|immuncompromise patients|immuncompromise patients
24388|NCT03133520|high flow oxygen|high flow oxygen
24389|NCT03133507|cancer|cancer
24390|NCT03133507|salivary alpha amylase|salivary alpha amylase
24391|NCT03133507|pain|pain
24392|NCT03133507|positive affect|positive affect
24393|NCT03133507|emotion regulation strategies|emotion regulation strategies
24394|NCT03133481|Adductor Canal Block|adductor canal block
24395|NCT03133481|Femoral Canal Block|femoral canal block
24396|NCT03133468|AJM347|ajm347
24397|NCT03133468|pharmacokinetics|pharmacokinetics
24398|NCT03133468|food effect study|food effect study
24399|NCT03133468|pharmacodynamics|pharmacodynamics
24400|NCT03133455|Rumination|rumination
24401|NCT03133429|carotid artery|carotid artery
24402|NCT03133429|stroke|stroke
24403|NCT03133429|stent|stent
24404|NCT03133416|rotator cuff tendinopathy|rotator cuff tendinopathy
24405|NCT03133416|rotator cuff tear|rotator cuff tear
24406|NCT03133416|platelet-rich plasma|platelet-rich plasma
24407|NCT03133416|physiotherapy|physiotherapy
24408|NCT03133416|exercise|exercise
24409|NCT03133377|Early activity and mobilization, rehabilitation, intensive care|early activity and mobilization, rehabilitation, intensive care
24410|NCT03133325|Hyaluronic Acid, Lidocaine|hyaluronic acid, lidocaine
24411|NCT03133286|Anal Cancer|anal cancer
24412|NCT03133286|Bladder|bladder
24413|NCT03133286|Cervical|cervical
24414|NCT03133286|Colorectal|colorectal
24415|NCT03133286|Esophageal|esophageal
24416|NCT03133286|Gallbladder|gallbladder
24417|NCT03133286|Liver|liver
24418|NCT03133286|Ovarian|ovarian
24419|NCT03133286|Pancreas|pancreas
24420|NCT03133286|Pancreatic|pancreatic
24421|NCT03133286|Prostate|prostate
24422|NCT03133286|Rectal|rectal
24423|NCT03133286|Renal|renal
24424|NCT03133286|Kidney|kidney
24425|NCT03133286|Stomach|stomach
24426|NCT03133286|Testicular|testicular
24427|NCT03133286|Uterine|uterine
24428|NCT03133286|Cancer|cancer
24429|NCT03133286|Radiation Therapy|radiation therapy
24430|NCT03133286|Radiation Treatment|radiation treatment
24431|NCT03133273|Colorectal Cancer Metastatic|colorectal cancer metastatic
24432|NCT03133273|Chemosensitivity|chemosensitivity
24433|NCT03133221|NHL|nhl
24434|NCT03133221|indolent NHL|indolent nhl
24435|NCT03133221|Zydelig|zydelig
24436|NCT03133221|Idelalisib|idelalisib
24437|NCT03133221|B-cell NHL|b-cell nhl
24438|NCT03133221|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
24439|NCT03133221|Maintenance|maintenance
24440|NCT03133221|Transformed B-cell Non-Hodgkin's lymphoma|transformed b-cell non-hodgkin's lymphoma
24441|NCT03133221|Autologous Stem Cell Transplantation|autologous stem cell transplantation
24442|NCT03133208|sepsis|sepsis
24443|NCT03133208|sepsis associated encephalopathy|sepsis associated encephalopathy
24444|NCT03133208|sepsis associated delirium|sepsis associated delirium
24445|NCT03133208|altered mental status|altered mental status
24446|NCT03133195|Terriparatide, bone fracture healing, PFNA|terriparatide, bone fracture healing, pfna
24447|NCT03133169|Thalassemia|thalassemia
24448|NCT03133169|Glutamine/glutamate ratio|glutamine/glutamate ratio
24449|NCT03133169|Pulmonary hypertension|pulmonary hypertension
24450|NCT03133156|Exercise|exercise
24451|NCT03133156|Training|training
24452|NCT03133156|Type 2 Diabetes|type 2 diabetes
24453|NCT03133156|Mellitus|mellitus
24454|NCT03133143|Cognitive Function|cognitive function
24455|NCT03133143|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
24456|NCT03133143|Computers, Digital|computers, digital
24458|NCT03133130|Scar prevention|scar prevention
24459|NCT03133130|siRNA|sirna
24460|NCT03133091|PIEB|pieb
24461|NCT03133091|PCEA|pcea
24462|NCT03133091|LEVOBUPIVACAINE|levobupivacaine
24463|NCT03133078|Side Hop|side hop
24464|NCT03133078|Forward Hop|forward hop
24465|NCT03133078|Step test|step test
24466|NCT03133078|Vertical Jump|vertical jump
24467|NCT03133052|cognitive control training|cognitive control training
24468|NCT03133052|aMCI|amci
24469|NCT03133052|MRI|mri
24470|NCT03133052|RCT|rct
24471|NCT03133026|obstructive Jaundice|obstructive jaundice
24472|NCT03133026|Self Expandable Metal Stents (SEMS)|self expandable metal stents (sems)
24473|NCT03133026|Cholangitis|cholangitis
24474|NCT03133000|Recurrent abdominal wall hernia|recurrent abdominal wall hernia
24475|NCT03133000|Incisional hernia|incisional hernia
24476|NCT03132987|quadriceps strength|quadriceps strength
24477|NCT03132987|quadriceps voluntary activation|quadriceps voluntary activation
24478|NCT03132987|progressive strength program|progressive strength program
24479|NCT03132961|Vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
24480|NCT03132961|Electrocochleography|electrocochleography
24481|NCT03132961|Infrasound|infrasound
24482|NCT03132948|ALL Cancer Patients|all cancer patients
24483|NCT03132948|Quality of Life|quality of life
24484|NCT03132948|Fitness|fitness
24485|NCT03132935|Non-STEMI Acute Coronary Syndrome|non-stemi acute coronary syndrome
24486|NCT03132935|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
24487|NCT03132935|Telemedicine|telemedicine
24488|NCT03132922|Cell Therapy|cell therapy
24489|NCT03132922|T Cell Therapy|t cell therapy
24490|NCT03132922|SPEAR T Cell|spear t cell
24491|NCT03132922|MAGE-A4|mage-a4
24492|NCT03132922|Immuno-oncology|immuno-oncology
24493|NCT03132922|Metastatic|metastatic
24496|NCT03132922|T Cell Receptor|t cell receptor
24497|NCT03132922|Squamous, adenosquamous, or large cell NSCLC|squamous, adenosquamous, or large cell nsclc
24498|NCT03132922|Squamous or adenocarcinoma esophageal cancer|squamous or adenocarcinoma esophageal cancer
24499|NCT03132818|Procreation with donation|procreation with donation
24500|NCT03132792|Alpha-fetoprotein|alpha-fetoprotein
24501|NCT03132792|Cell Therapy|cell therapy
24502|NCT03132792|T Cell Therapy|t cell therapy
24503|NCT03132792|SPEAR T Cell|spear t cell
24504|NCT03132792|Immuno-oncology|immuno-oncology
24505|NCT03132792|Metastatic|metastatic
24506|NCT03132792|Previously treated|previously treated
24507|NCT03132792|T Cell Receptor|t cell receptor
24508|NCT03132779|Intralipid|intralipid
24509|NCT03132779|NK cells|nk cells
24510|NCT03132779|Recurrent miscarriage|recurrent miscarriage
24511|NCT03132740|Hepatic Carcinoma,Three-dimensional Visualization|hepatic carcinoma,three-dimensional visualization
24512|NCT03132714|Full-mouth ultrasonic debridement|full-mouth ultrasonic debridement
24513|NCT03132714|Clarithromycin|clarithromycin
24514|NCT03132714|Amoxicillin|amoxicillin
24515|NCT03132714|Metronidazole|metronidazole
24516|NCT03132714|Antimicrobial therapy|antimicrobial therapy
24517|NCT03132714|Photodynamic therapy|photodynamic therapy
24518|NCT03132714|Low-level laser therapy|low-level laser therapy
24519|NCT03132675|Melanoma|melanoma
24520|NCT03132675|pIL-12|pil-12
24521|NCT03132675|pembrolizumab|pembrolizumab
24522|NCT03132649|Three dimensional visualization|three dimensional visualization
24523|NCT03132649|Operation strategy|operation strategy
24524|NCT03132597|stress|stress
24525|NCT03132597|anxiety|anxiety
24526|NCT03132597|depression|depression
24527|NCT03132597|quality of life|quality of life
24528|NCT03132597|Mindfulness|mindfulness
24529|NCT03132584|Non Hodgkin Lymphoma|non hodgkin lymphoma
24530|NCT03132571|Schizophrenia|schizophrenia
24531|NCT03132571|Diabetes|diabetes
24532|NCT03132571|Obesity|obesity
24533|NCT03132519|Cough|cough
24534|NCT03132519|Hypertension|hypertension
24535|NCT03132519|Remifentanil|remifentanil
24536|NCT03132519|Sevoflurane|sevoflurane
24537|NCT03132519|Desflurane|desflurane
24538|NCT03132467|Breast Cancer|breast cancer
24539|NCT03132467|Hormone Receptor Positive, HER2 Negative Breast Cancer|hormone receptor positive, her2 negative breast cancer
24540|NCT03132467|Tremelimumab|tremelimumab
24541|NCT03132467|Ticilimumab|ticilimumab
24542|NCT03132467|CP-675,206|cp-675,206
24543|NCT03132467|Durvalumab|durvalumab
24544|NCT03132467|MEDI4736|medi4736
24545|NCT03132454|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
24546|NCT03132454|Acute myeloid leukemia|acute myeloid leukemia
24548|NCT03132454|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
24549|NCT03132454|ALL|all
24550|NCT03132454|Relapsed or refractory|relapsed or refractory
24551|NCT03132454|R/R|r/r
24552|NCT03132454|Palbociclib|palbociclib
24553|NCT03132454|PD-0332991|pd-0332991
24554|NCT03132454|Ibrance|ibrance
24555|NCT03132454|Sorafenib|sorafenib
24556|NCT03132454|Nexavar|nexavar
24557|NCT03132454|BAY 43-9006|bay 43-9006
24558|NCT03132454|Decitabine|decitabine
24559|NCT03132454|Dacogen|dacogen
24560|NCT03132454|Dexamethasone|dexamethasone
24561|NCT03132454|Decadron|decadron
24562|NCT03132441|advanced heart failure|advanced heart failure
24563|NCT03132441|NYHA Class III-IV|nyha class iii-iv
24564|NCT03132441|frailty|frailty
24565|NCT03132441|cardiac rehabilitation|cardiac rehabilitation
24566|NCT03132415|Prevention & Control|prevention & control
24567|NCT03132415|Internet|internet
24568|NCT03132415|Adolescents|adolescents
24569|NCT03132415|Young adults|young adults
24570|NCT03132402|Elisa|elisa
24571|NCT03132402|Plasmodium Falciparum|plasmodium falciparum
16509|NCT03185481|Parkinson's Disease|parkinson's disease
16510|NCT03185481|Motor Fluctuations|motor fluctuations
16511|NCT03185481|D1 partial agonist|d1 partial agonist
16512|NCT03185468|CAR T|car t
16513|NCT03185468|Bladder|bladder
16514|NCT03185455|Hypertension|hypertension
16515|NCT03185455|Pregnancy|pregnancy
16516|NCT03185455|Text|text
24572|NCT03132389|Sexual assault|sexual assault
24573|NCT03132389|Sexually transmitted diseases|sexually transmitted diseases
24574|NCT03132389|Chlamydia trachomatis|chlamydia trachomatis
24575|NCT03132389|Mycoplasma genitalium|mycoplasma genitalium
24576|NCT03132389|Neisseria gonorrhoeae|neisseria gonorrhoeae
24577|NCT03132389|Hepatitis B and C|hepatitis b and c
24578|NCT03132389|HIV|hiv
24579|NCT03132389|Syphilis|syphilis
24580|NCT03132389|Follow up visits after sexual assault|follow up visits after sexual assault
24581|NCT03132324|Sickle cell disease (SCD)|sickle cell disease (scd)
24582|NCT03132324|sickle cell SS|sickle cell ss
24583|NCT03132324|lysine demethylase 1 (LSD1) inhibition|lysine demethylase 1 (lsd1) inhibition
24584|NCT03132311|yellow fever vaccine|yellow fever vaccine
24585|NCT03132311|hiv|hiv
24586|NCT03132272|ADAsorb apheresis|adasorb apheresis
24587|NCT03132272|Globaffin adsorber|globaffin adsorber
24588|NCT03132272|Agonistic Autoantibodies|agonistic autoantibodies
24589|NCT03132272|Immunoadsorption|immunoadsorption
24590|NCT03132272|Alzheimer Dementia|alzheimer dementia
24591|NCT03132259|Dexmedethomidine|dexmedethomidine
24791|NCT03130829|Fucoidan|fucoidan
24599|NCT03132233|Beta-hydroxybutyrate|beta-hydroxybutyrate
24600|NCT03132233|Double-blind|double-blind
24601|NCT03132233|Randomised|randomised
24602|NCT03132233|Placebo controlled|placebo controlled
24603|NCT03132233|Mitochondrial functioning|mitochondrial functioning
24604|NCT03132233|Energy metabolism|energy metabolism
24605|NCT03132233|Intervention|intervention
24606|NCT03132233|Dietary Supplement|dietary supplement
24607|NCT03132220|critical care nurses|critical care nurses
24608|NCT03132220|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
24609|NCT03132220|Burn-out Syndrome|burn-out syndrome
583407|NCT00511628|Schizophrenia|schizophrenia
24610|NCT03132220|Post-traumatic Stress Disorder|post-traumatic stress disorder
24611|NCT03132220|Cognitive Behavioral Therapy|cognitive behavioral therapy
24613|NCT03132207|Pregnancy|pregnancy
24614|NCT03132207|Prevention|prevention
24615|NCT03132207|adverse pregnancy outcomes|adverse pregnancy outcomes
24616|NCT03132181|Empagliflozin|empagliflozin
24617|NCT03132181|Diabetes|diabetes
24618|NCT03132181|Systemic vascular resistance|systemic vascular resistance
24619|NCT03132181|Cardiac output|cardiac output
24620|NCT03132181|Blood pressure|blood pressure
24621|NCT03132168|cystectomy|cystectomy
24622|NCT03132168|urology|urology
24623|NCT03132168|surgery|surgery
24624|NCT03132129|Type 2 diabetes|type 2 diabetes
24625|NCT03132129|Diabetic cardiomyopathy|diabetic cardiomyopathy
24626|NCT03132129|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
24627|NCT03132116|Cat Scratch Disease's lymphadenitis|cat scratch disease's lymphadenitis
24628|NCT03132116|Infectious Diseases|infectious diseases
24629|NCT03132103|Vitamin D deficiency|vitamin d deficiency
24630|NCT03132103|Simulated sunlight radiation|simulated sunlight radiation
24631|NCT03132103|Oral vitamin D3|oral vitamin d3
24632|NCT03132051|carpal tunnel syndrome|carpal tunnel syndrome
24633|NCT03132025|Metastatic Colorectal Cancer|metastatic colorectal cancer
24634|NCT03132025|Apatinib|apatinib
24635|NCT03132025|Capecitabine|capecitabine
24636|NCT03131999|VEGF-D|vegf-d
24637|NCT03131999|Imatinib mesylate|imatinib mesylate
24638|NCT03131999|Sirolimus|sirolimus
24639|NCT03131921|Energy expenditure|energy expenditure
24640|NCT03131921|Nutrition|nutrition
24641|NCT03131921|Colorectal cancer|colorectal cancer
24642|NCT03131921|Dietary needs|dietary needs
24643|NCT03131908|Melanoma and other malignant neoplasms of skin|melanoma and other malignant neoplasms of skin
24644|NCT03131908|Metastatic Melanoma|metastatic melanoma
24645|NCT03131908|GSK2633771|gsk2633771
24646|NCT03131908|Pembrolizumab|pembrolizumab
24647|NCT03131908|Keytruda|keytruda
24648|NCT03131908|MK-3475|mk-3475
24649|NCT03131908|SCH-900475|sch-900475
24650|NCT03131895|Drug therapy|drug therapy
24651|NCT03131882|trigger finger|trigger finger
24652|NCT03131882|trigger thumb|trigger thumb
24653|NCT03131882|ultrasound guided|ultrasound guided
24654|NCT03131882|hyaluronic acid|hyaluronic acid
24655|NCT03131856|Geriatrics|geriatrics
24656|NCT03131856|Nutritional risk|nutritional risk
24657|NCT03131856|Multi-disciplinary intervention|multi-disciplinary intervention
24658|NCT03131856|Randomized Controlled Trial|randomized controlled trial
24659|NCT03131843|skin infection|skin infection
24660|NCT03131843|vaccination|vaccination
24661|NCT03131843|children|children
24662|NCT03131843|alcohol swab|alcohol swab
24663|NCT03131843|skin preparation|skin preparation
24664|NCT03131804|Aerobic|aerobic
24665|NCT03131804|Intradialytic|intradialytic
24666|NCT03131804|Cardio-metabolic markers|cardio-metabolic markers
24667|NCT03131804|Dialysis Adequacy|dialysis adequacy
24668|NCT03131804|Quality of Life|quality of life
24669|NCT03131804|Cost Effectiveness|cost effectiveness
24774|NCT03130985|biomarker|biomarker
24673|NCT03131752|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
24674|NCT03131752|muscle strength|muscle strength
24675|NCT03131752|physical activity|physical activity
24676|NCT03131739|Resilience|resilience
24677|NCT03131739|Alaska Native|alaska native
24678|NCT03131739|Community Based Participatory Research|community based participatory research
24679|NCT03131739|Culture and Community Factors|culture and community factors
24680|NCT03131739|Protective Factors|protective factors
24681|NCT03131739|Risk Factors|risk factors
24682|NCT03131726|simvastatin|simvastatin
24683|NCT03131726|diclofenac|diclofenac
24684|NCT03131713|Mohs micrographic surgery|mohs micrographic surgery
24685|NCT03131713|pain|pain
24686|NCT03131713|functional status|functional status
24687|NCT03131700|RPH101|rph101
24688|NCT03131700|RPH-101|rph-101
24689|NCT03131700|Biosimilar|biosimilar
24690|NCT03131700|Bevacizumab|bevacizumab
24691|NCT03131700|Safety|safety
24692|NCT03131674|Somatic tinnitus|somatic tinnitus
24695|NCT03131596|hysteroscopy|hysteroscopy
24696|NCT03131583|SHR4640 Febuxostat Colchicine pharmacodynamics|shr4640 febuxostat colchicine pharmacodynamics
24697|NCT03131570|Psoriasis|psoriasis
24698|NCT03131570|Chronic Plaque Psoriasis|chronic plaque psoriasis
24699|NCT03131570|Secukinumab|secukinumab
24700|NCT03131544|BPH|bph
24701|NCT03131544|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
24702|NCT03131544|MRI|mri
24703|NCT03131544|Prostate|prostate
24704|NCT03131544|Lower Urinary Tract Symptoms|lower urinary tract symptoms
24705|NCT03131544|Nocturia|nocturia
24706|NCT03131544|Incomplete bladder emptying|incomplete bladder emptying
24707|NCT03131479|renal function|renal function
24708|NCT03131479|sodium-glucose co-transporter|sodium-glucose co-transporter
24709|NCT03131479|pharmacokinetics|pharmacokinetics
583408|NCT00511628|Risperidone|risperidone
24710|NCT03131479|decreased renal function|decreased renal function
24711|NCT03131479|decreased kidney function|decreased kidney function
24712|NCT03131479|kidney disease|kidney disease
24713|NCT03131479|urinary glucose excretion|urinary glucose excretion
24714|NCT03131479|UGE|uge
24715|NCT03131466|Trigeminal Neuralgia|trigeminal neuralgia
24716|NCT03131466|Pulsed Radiofrequency|pulsed radiofrequency
24717|NCT03131466|Gasserian Ganglion|gasserian ganglion
24718|NCT03131453|Placebo controlled,|placebo controlled,
24719|NCT03131453|APOE4 carriers,|apoe4 carriers,
24720|NCT03131453|Homozygotes,|homozygotes,
24721|NCT03131453|Heterozygotes,|heterozygotes,
24722|NCT03131453|Brain Amyloid,|brain amyloid,
24723|NCT03131453|Preclinical Alzheimer's Disease (AD),|preclinical alzheimer's disease (ad),
24724|NCT03131453|Aβ lowering,|aβ lowering,
24725|NCT03131453|BACE-1 inhibitor|bace-1 inhibitor
24726|NCT03131427|Wilson's Disease|wilson's disease
24727|NCT03131427|Hereditary Hemochromatosis|hereditary hemochromatosis
24728|NCT03131427|Hereditary Hyperbilirubinemias|hereditary hyperbilirubinemias
24729|NCT03131427|Inherited Cholestatic Liver Disease|inherited cholestatic liver disease
24730|NCT03131427|Genetic Testing|genetic testing
24731|NCT03131375|dexmedetomidine|dexmedetomidine
24732|NCT03131375|emergence delirium|emergence delirium
24733|NCT03131375|anesthesia|anesthesia
24734|NCT03131375|propofol|propofol
24735|NCT03131375|children|children
24736|NCT03131362|COPD|copd
24737|NCT03131323|delineate the prevalence of abnormal nasal finding in wheezy child|delineate the prevalence of abnormal nasal finding in wheezy child
24738|NCT03131297|anal fistulas|anal fistulas
24739|NCT03131297|evaluation of radiofrequency|evaluation of radiofrequency
24740|NCT03131271|Percutaneous coronary intervention|percutaneous coronary intervention
24741|NCT03131271|Femoral arterial catheter|femoral arterial catheter
24742|NCT03131271|Pain|pain
24743|NCT03131271|Cold application|cold application
24744|NCT03131271|Nursing|nursing
24745|NCT03131206|Non-small cell lung cancer|non-small cell lung cancer
24746|NCT03131206|NSCLC|nsclc
24747|NCT03131206|ALK|alk
24748|NCT03131206|RET|ret
24749|NCT03131206|alectinib|alectinib
24750|NCT03131206|Thyroid cancer|thyroid cancer
24751|NCT03131128|Mindfulness-based intervention|mindfulness-based intervention
24752|NCT03131128|Weight loss|weight loss
24753|NCT03131128|Workplace health promotion|workplace health promotion
24754|NCT03131128|Obesity|obesity
24755|NCT03131063|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
24756|NCT03131063|Sepsis|sepsis
24757|NCT03131063|Antibiotics|antibiotics
24758|NCT03131063|Pharmacokinetic|pharmacokinetic
24759|NCT03131063|Intensive Care Unit|intensive care unit
25374|NCT03126838|weaning|weaning
24761|NCT03131037|immunotherapy|immunotherapy
24762|NCT03131037|immuno-oncology|immuno-oncology
24763|NCT03131037|tumor vaccine|tumor vaccine
24764|NCT03131024|anthracyclines|anthracyclines
24765|NCT03130998|smoking cessation|smoking cessation
24766|NCT03130998|depression|depression
24767|NCT03130998|mental health|mental health
24768|NCT03130998|mood management|mood management
24769|NCT03130998|primary care|primary care
24770|NCT03130998|screening|screening
24771|NCT03130998|brief intervention|brief intervention
24772|NCT03130998|referral to treatment|referral to treatment
24775|NCT03130946|breast neoplasms|breast neoplasms
24776|NCT03130946|Ultrasonography, Interventional|ultrasonography, interventional
24777|NCT03130946|Biopsy, Large-Core Needle|biopsy, large-core needle
24778|NCT03130946|Biopsy, Fine-Needle|biopsy, fine-needle
24779|NCT03130933|third molar|third molar
24780|NCT03130933|oral surgical procedures|oral surgical procedures
24781|NCT03130933|antibiotic prophylaxis|antibiotic prophylaxis
24782|NCT03130933|placebo effect|placebo effect
24783|NCT03130920|preconditioning, resection|preconditioning, resection
24784|NCT03130894|trimethylamine-N-oxide|trimethylamine-n-oxide
24785|NCT03130894|type2 Diabetes|type2 diabetes
24786|NCT03130894|enzyme flavin monooxygenase 3 polymorphisms|enzyme flavin monooxygenase 3 polymorphisms
24787|NCT03130855|pediatric patients|pediatric patients
24788|NCT03130855|articaine local anesthesia|articaine local anesthesia
24789|NCT03130829|NSCLC|nsclc
24792|NCT03130816|Umbilical cord blood transplantation|umbilical cord blood transplantation
24793|NCT03130816|Cytokine changes|cytokine changes
24794|NCT03130764|Non-small Cell Lung Cancer|non-small cell lung cancer
24795|NCT03130712|immunotherapy|immunotherapy
24796|NCT03130712|GPC3-CART|gpc3-cart
24797|NCT03130712|HCC|hcc
24798|NCT03130699|Diabetes|diabetes
24799|NCT03130699|mHealth|mhealth
24800|NCT03130699|Medical Assistant|medical assistant
24801|NCT03130699|Automated|automated
24802|NCT03130699|Adaptive Feedback|adaptive feedback
24803|NCT03130699|Self-Management Support|self-management support
24804|NCT03130699|Hispanics|hispanics
24805|NCT03130699|HbA1c|hba1c
24806|NCT03130699|Cyberinfrastructure|cyberinfrastructure
24807|NCT03130699|Federally-Qualified Health Centers|federally-qualified health centers
616509|NCT00639054|pathology|pathology
24808|NCT03130699|Cost-Effectiveness|cost-effectiveness
24809|NCT03130699|T2DM|t2dm
24810|NCT03130699|Pay-for-Performance|pay-for-performance
24811|NCT03130699|Medication Adherence|medication adherence
24812|NCT03130699|LDL-C|ldl-c
24813|NCT03130699|Systolic Blood Pressure|systolic blood pressure
24814|NCT03130699|Text Messaging|text messaging
24815|NCT03130673|hip fracture|hip fracture
24816|NCT03130673|trochanteric fracure|trochanteric fracure
24817|NCT03130673|subtrocantheric fracture|subtrocantheric fracture
24818|NCT03130673|femoral head fracture|femoral head fracture
24819|NCT03130673|epidemiology|epidemiology
24820|NCT03130660|central line|central line
24821|NCT03130660|Central Line Complication|central line complication
24822|NCT03130634|CPT-11(irinotecan)|cpt-11(irinotecan)
24823|NCT03130634|silymarin|silymarin
24824|NCT03130634|GI toxicity|gi toxicity
24825|NCT03130608|liver disease|liver disease
24826|NCT03130608|transplant|transplant
24827|NCT03130608|muscle wasting|muscle wasting
24828|NCT03130608|breathing exercise|breathing exercise
24829|NCT03130595|accelerometry|accelerometry
24830|NCT03130595|Parkinson Kinetigraph|parkinson kinetigraph
24831|NCT03130582|high-dose etoposide,autologous peripheral blood stem cell transplantation|high-dose etoposide,autologous peripheral blood stem cell transplantation
24832|NCT03130569|Risk Assessment|risk assessment
24833|NCT03130569|Personal Genomic Testing|personal genomic testing
24834|NCT03130569|Skin Cancer|skin cancer
24835|NCT03130569|Primary Care|primary care
24836|NCT03130556|Glasdegib|glasdegib
24837|NCT03130556|PF-04449913|pf-04449913
24838|NCT03130556|Pharmacokinetics|pharmacokinetics
24839|NCT03130556|Bioavailability|bioavailability
24840|NCT03130543|Brief resolved unexplained event|brief resolved unexplained event
24841|NCT03130530|robotic|robotic
24842|NCT03130530|colorectal|colorectal
24843|NCT03130530|surgery|surgery
24844|NCT03130517|hemolysis,newborn|hemolysis,newborn
24845|NCT03130478|long-acting injectable antipsychotic|long-acting injectable antipsychotic
24846|NCT03130478|persistence|persistence
24847|NCT03130465|adherence|adherence
24848|NCT03130465|long-acting injectable antipsychotic|long-acting injectable antipsychotic
24849|NCT03130465|all-cause treatment discontinuation|all-cause treatment discontinuation
24850|NCT03130465|recent-onset schizophrenia|recent-onset schizophrenia
24851|NCT03130465|daily oral atypical antipsychotic|daily oral atypical antipsychotic
24853|NCT03130426|Diabetes|diabetes
24854|NCT03130426|iGlarLixi|iglarlixi
24855|NCT03130426|Metformin|metformin
24856|NCT03130426|Insulin|insulin
24857|NCT03130426|Diet|diet
24858|NCT03130426|Exercise|exercise
24859|NCT03130426|Lifestyle|lifestyle
24860|NCT03130413|Ambu Aura Gain|ambu aura gain
24861|NCT03130413|Air-Q intubating laryngeal airway|air-q intubating laryngeal airway
24862|NCT03130413|Paediatric surgery|paediatric surgery
24863|NCT03130400|Knee|knee
24864|NCT03130400|Gait|gait
24865|NCT03130400|Injuries|injuries
24866|NCT03130400|Arthritis|arthritis
24867|NCT03130387|Hytsteroscopy|hytsteroscopy
24868|NCT03130374|mesenchymal stem cells|mesenchymal stem cells
24869|NCT03130374|Tracheal Stenosis|tracheal stenosis
24870|NCT03130374|Laryngeal Stenosis|laryngeal stenosis
24871|NCT03130374|cell therapy|cell therapy
24872|NCT03130309|Knee|knee
24873|NCT03130309|Replacement|replacement
24874|NCT03130309|Mobile-bearing|mobile-bearing
25183|NCT03128021|Lexapro|lexapro
24875|NCT03130309|unicompartmental prosthesis|unicompartmental prosthesis
24876|NCT03130296|HIV infection|hiv infection
24877|NCT03130296|Fc receptor polymorphism (FcR)|fc receptor polymorphism (fcr)
24878|NCT03130283|Acute patients|acute patients
24879|NCT03130283|Exacerbated chronic patients|exacerbated chronic patients
24880|NCT03130270|nasopharyngeal carcinoma|nasopharyngeal carcinoma
24881|NCT03130270|disease-free survival|disease-free survival
24882|NCT03130270|adverse reaction|adverse reaction
24883|NCT03130257|blood pressure measurement|blood pressure measurement
24884|NCT03130231|Delirium β2-microspheres|delirium β2-microspheres
24885|NCT03130179|Bioequivalence|bioequivalence
24886|NCT03130166|Postoperative pain|postoperative pain
24887|NCT03130166|Postoperative recovery|postoperative recovery
24888|NCT03130166|Intracorporeal anastomosis|intracorporeal anastomosis
24889|NCT03130166|Robotic right colectomy|robotic right colectomy
24890|NCT03130114|Mortality|mortality
24891|NCT03130114|Infant|infant
24892|NCT03130114|Antibiotics|antibiotics
24893|NCT03130114|Linear Growth|linear growth
24894|NCT03130101|Type 1 Diabetes|type 1 diabetes
24895|NCT03130101|Exercise|exercise
24896|NCT03130101|Basal insulin|basal insulin
24897|NCT03130101|CSII|csii
24898|NCT03130101|OmniPod|omnipod
24900|NCT03130088|Out-Of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
24901|NCT03130088|Resuscitation Registry|resuscitation registry
24902|NCT03130088|EuReCa TWO|eureca two
24903|NCT03130062|Resistance Exercise|resistance exercise
24904|NCT03130062|Functional Fitness|functional fitness
24905|NCT03130062|Actigraphy|actigraphy
24906|NCT03130062|Primary Sjögren Syndrome|primary sjögren syndrome
24907|NCT03130049|Peripheral nerve block|peripheral nerve block
24908|NCT03130049|Ultrasound|ultrasound
24909|NCT03130036|Memory|memory
24910|NCT03130036|Cognitive|cognitive
24911|NCT03129984|mandibular movements|mandibular movements
24912|NCT03129958|NECK PAIN, OFFICE WORKERS|neck pain, office workers
24913|NCT03129945|Obstetric Labor, Premature|obstetric labor, premature
24914|NCT03129945|Tocolytic Agents|tocolytic agents
24915|NCT03129932|gluten|gluten
24916|NCT03129932|adipokine|adipokine
24917|NCT03129932|obesity|obesity
24918|NCT03129932|diet|diet
24919|NCT03129906|Fibromyalgia; non-celiac gluten sensitivity|fibromyalgia; non-celiac gluten sensitivity
24920|NCT03129880|Voice disorder|voice disorder
24921|NCT03129880|Hoarseness|hoarseness
24922|NCT03129880|Phonation Disorders|phonation disorders
24923|NCT03129880|Speech Disorders|speech disorders
24924|NCT03129854|prostate cancer|prostate cancer
24925|NCT03129854|metastatic|metastatic
24926|NCT03129854|cryotherapy|cryotherapy
24927|NCT03129854|ADT|adt
24928|NCT03129841|weight loss|weight loss
24929|NCT03129841|dietary pattern|dietary pattern
24930|NCT03129841|late dinner|late dinner
24931|NCT03129841|early dinner|early dinner
24932|NCT03129828|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
24933|NCT03129828|Ibrutinib|ibrutinib
24934|NCT03129828|Bortezomib|bortezomib
24935|NCT03129815|extubation|extubation
24936|NCT03129815|pediatric resuscitation|pediatric resuscitation
24937|NCT03129815|reintubation|reintubation
24938|NCT03129815|failures of extubation.|failures of extubation.
24939|NCT03129802|extubation|extubation
24940|NCT03129802|pediatric resuscitation|pediatric resuscitation
24941|NCT03129802|reintubation|reintubation
24942|NCT03129802|failures of extubation.|failures of extubation.
24943|NCT03129802|Respiratory Insufficiency|respiratory insufficiency
24944|NCT03129763|SPY-ICG Angiography|spy-icg angiography
24945|NCT03129763|Tissue Expander|tissue expander
24946|NCT03129763|Capsule Pressure|capsule pressure
24947|NCT03129763|Blood Supply|blood supply
24948|NCT03129724|Kidney Neoplasms|kidney neoplasms
24949|NCT03129724|Kidney|kidney
24950|NCT03129724|Neoplasms|neoplasms
24951|NCT03129724|TKI|tki
24952|NCT03129724|Axitinib|axitinib
24953|NCT03129724|VEGF|vegf
24954|NCT03129724|mTORi|mtori
24962|NCT03129620|Ampicillin|ampicillin
24963|NCT03129607|POPF|popf
24964|NCT03129607|Classification system|classification system
24965|NCT03129581|obesity, diet, sleep activity|obesity, diet, sleep activity
24966|NCT03129555|Non-vitamin K antagonist oral anticoagulation|non-vitamin k antagonist oral anticoagulation
402901|NCT01229241|plasmatic concentration|plasmatic concentration
24967|NCT03129555|Non-vitamin K Antagonist Oral Anticoagulants|non-vitamin k antagonist oral anticoagulants
24968|NCT03129555|Direct-acting Oral Anticoagulants|direct-acting oral anticoagulants
24969|NCT03129555|Novel oral anticoagulant drugs|novel oral anticoagulant drugs
24970|NCT03129516|imaginary|imaginary
24971|NCT03129516|Turkish version|turkish version
24972|NCT03129516|motor imagery|motor imagery
24973|NCT03129516|reliability|reliability
24974|NCT03129503|Optical coherence tomography (OCT)|optical coherence tomography (oct)
24975|NCT03129490|Atrial Fibrillation|atrial fibrillation
24976|NCT03129490|Non-vitamin K antagonist oral anticoagulation|non-vitamin k antagonist oral anticoagulation
24977|NCT03129490|Direct-acting oral anticoagulants|direct-acting oral anticoagulants
24978|NCT03129490|Novel oral anticoagulant drugs|novel oral anticoagulant drugs
25184|NCT03128021|Placebo|placebo
24979|NCT03129490|Non-vitamin K antagonist oral anticoagulants|non-vitamin k antagonist oral anticoagulants
24980|NCT03129477|Non invasive ventilation in COPD|non invasive ventilation in copd
24981|NCT03129477|Noninvasive ventilation|noninvasive ventilation
24982|NCT03129477|Tele-monitoring|tele-monitoring
24983|NCT03129438|continuous EEG|continuous eeg
24984|NCT03129438|routine EEG|routine eeg
24985|NCT03129438|prognosis|prognosis
24986|NCT03129425|Patient|patient
24987|NCT03129425|Caregiver|caregiver
24988|NCT03129425|Coping|coping
24989|NCT03129425|Psychosocial adaptation|psychosocial adaptation
24990|NCT03129399|anesthesia|anesthesia
24991|NCT03129399|King Vision|king vision
24992|NCT03129399|videolaryngoscope|videolaryngoscope
24993|NCT03129399|nasotracheal|nasotracheal
24994|NCT03129360|Early Psychosis|early psychosis
24995|NCT03129360|Levetiracetam|levetiracetam
24996|NCT03129308|HIV|hiv
24997|NCT03129308|Cutaneous Autoantibodies|cutaneous autoantibodies
24998|NCT03129308|Indirect Immunofluorescence|indirect immunofluorescence
24999|NCT03129269|Cognitive decline|cognitive decline
25000|NCT03129269|frailty|frailty
25001|NCT03129269|mild cognitive impairment|mild cognitive impairment
583409|NCT00511628|Schizoaffective disorder|schizoaffective disorder
25002|NCT03129269|Positron Emission Tomography, PET|positron emission tomography, pet
25003|NCT03129269|Alzheimer disease|alzheimer disease
25004|NCT03129269|amyloid load|amyloid load
25005|NCT03129269|Magnetic resonance imaging, MRI|magnetic resonance imaging, mri
25006|NCT03129256|non-small cell lung cancer|non-small cell lung cancer
25007|NCT03129256|Apatinib|apatinib
25008|NCT03129256|S1|s1
25009|NCT03129217|Diaphragm function|diaphragm function
25010|NCT03129217|Acute respiratory failure|acute respiratory failure
25011|NCT03129217|Weaning|weaning
25012|NCT03129204|intensive care unit|intensive care unit
25013|NCT03129204|critical care|critical care
25014|NCT03129204|family|family
25015|NCT03129204|caregiver|caregiver
25016|NCT03129204|actigraphy|actigraphy
25017|NCT03129178|Nitrate|nitrate
25018|NCT03129178|Nitric oxide|nitric oxide
25019|NCT03129178|Microvascular|microvascular
25020|NCT03129165|Cardiovascular diseases|cardiovascular diseases
25021|NCT03129165|Public Health|public health
25022|NCT03129165|Hypertension|hypertension
25023|NCT03129165|Smoking|smoking
25024|NCT03129165|Hypercholesterolemia|hypercholesterolemia
25025|NCT03129165|Food Habits|food habits
25026|NCT03129165|Exercise|exercise
25027|NCT03129165|Anxiety|anxiety
25028|NCT03129165|Depression|depression
25029|NCT03129165|Obesity|obesity
25030|NCT03129165|Diabetes|diabetes
25031|NCT03129139|Metastatic|metastatic
25032|NCT03128996|Bone marrow transplant|bone marrow transplant
25033|NCT03128996|Transplant|transplant
25034|NCT03128996|Transplantation|transplantation
25035|NCT03128996|Reduced Intensity|reduced intensity
25036|NCT03128996|Familial HLA mismatched|familial hla mismatched
25037|NCT03128905|Colchicine|colchicine
25038|NCT03128905|Corticoids|corticoids
25039|NCT03128905|Prednisone|prednisone
25040|NCT03128905|CPPD|cppd
25041|NCT03128905|Calcium Pyrophosphate Deposition Disease|calcium pyrophosphate deposition disease
25042|NCT03128879|Primary lymphoid haematopoietic neoplasms|primary lymphoid haematopoietic neoplasms
25046|NCT03128879|SLL|sll
25047|NCT03128879|High risk|high risk
25048|NCT03128879|Venetoclax|venetoclax
25049|NCT03128879|ABT-199|abt-199
25050|NCT03128879|GDC-0199|gdc-0199
25051|NCT03128879|Ibrutinib|ibrutinib
25052|NCT03128879|PCI-32765|pci-32765
25053|NCT03128879|Imbruvica|imbruvica
25054|NCT03128879|Allopurinol|allopurinol
25055|NCT03128879|Lopurin|lopurin
25056|NCT03128879|Zurinol|zurinol
25057|NCT03128879|Zyloprim|zyloprim
25058|NCT03128866|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
25059|NCT03128866|Pelvic Tumor|pelvic tumor
25060|NCT03128866|Tranexamic acid|tranexamic acid
25061|NCT03128489|Safety|safety
25062|NCT03128489|Infanrix™-IPV/Hib|infanrix™-ipv/hib
25063|NCT03128489|Immunogenicity|immunogenicity
25064|NCT03128489|Indian infants|indian infants
25065|NCT03128489|Combined vaccine|combined vaccine
25066|NCT03128463|Age-Related Macular Degeneration|age-related macular degeneration
25067|NCT03128463|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
25068|NCT03128463|Pathological Myopia|pathological myopia
25069|NCT03128463|Conbercept|conbercept
25070|NCT03128814|Tennis|tennis
25071|NCT03128814|Asymmetry|asymmetry
25072|NCT03128814|Structural|structural
25073|NCT03128814|Functional|functional
25074|NCT03128801|Low Back Pain|low back pain
25075|NCT03128801|Back Pain|back pain
25076|NCT03128801|Muscle Stretching Exercises|muscle stretching exercises
25077|NCT03128801|Stabilization Exercise|stabilization exercise
25078|NCT03128801|Exercise Therapy|exercise therapy
25079|NCT03128801|Exercise Movement|exercise movement
25080|NCT03128801|Exercise Movement Tecniques|exercise movement tecniques
25081|NCT03128801|Pain|pain
25082|NCT03128801|Disability|disability
25083|NCT03128788|epidurography epidural pressure patient posture|epidurography epidural pressure patient posture
25084|NCT03128749|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
25085|NCT03128749|Mindfulness Based Intervention|mindfulness based intervention
25086|NCT03128749|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
25087|NCT03128749|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
25088|NCT03128749|Neuropsychology|neuropsychology
25089|NCT03128749|Childhood Maltreatment|childhood maltreatment
25090|NCT03128723|Acne|acne
25091|NCT03128710|Survey|survey
25092|NCT03128710|Focus Group|focus group
25093|NCT03128710|Treatment Preferences|treatment preferences
25094|NCT03128697|Obesity|obesity
25095|NCT03128697|Satiety quotient|satiety quotient
25096|NCT03128697|Appetite control|appetite control
25097|NCT03128697|Weight loss|weight loss
25098|NCT03128697|Satiety phenotype|satiety phenotype
25099|NCT03128697|Functional food|functional food
25100|NCT03128684|lentils|lentils
25101|NCT03128684|satiety|satiety
25102|NCT03128684|appetite|appetite
25103|NCT03128684|food intake|food intake
25104|NCT03128684|24-hour energy intake|24-hour energy intake
25105|NCT03128671|intensive care unit|intensive care unit
25106|NCT03128671|critical care|critical care
25107|NCT03128671|mechanical ventilation|mechanical ventilation
25108|NCT03128671|confusion|confusion
25109|NCT03128671|polysomnography|polysomnography
25110|NCT03128671|delirium|delirium
25111|NCT03128671|adult|adult
25112|NCT03128658|Trauma induced coagulopathy|trauma induced coagulopathy
25113|NCT03128554|Not Ready to Quit|not ready to quit
25114|NCT03128554|Primary Care|primary care
25115|NCT03128554|Tobacco|tobacco
25116|NCT03128554|Reduce to Quit|reduce to quit
25117|NCT03128554|Smoking Reduction|smoking reduction
25118|NCT03128528|SGLT-2 inhibitor, Chronic heart failure, tissue sodium,|sglt-2 inhibitor, chronic heart failure, tissue sodium,
25119|NCT03128515|Hydroxyurea|hydroxyurea
25120|NCT03128502|saliva|saliva
25121|NCT03128502|GCF|gcf
25122|NCT03128502|pentraxin-3|pentraxin-3
25123|NCT03128450|Parkinson Disease|parkinson disease
25124|NCT03128450|Neural stem cell|neural stem cell
25125|NCT03128450|Nasal delivery|nasal delivery
25126|NCT03128437|Anxiety|anxiety
25127|NCT03128437|Young Adults|young adults
25128|NCT03128437|Health Behaviors|health behaviors
25129|NCT03128411|Leukemia, Chronic Myelogenous|leukemia, chronic myelogenous
25130|NCT03128398|Gastroparesis|gastroparesis
25131|NCT03128385|Upper limb neurorehabilitation|upper limb neurorehabilitation
25132|NCT03128385|Neurological rehabilitation|neurological rehabilitation
25133|NCT03128385|Upper extremity|upper extremity
25134|NCT03128281|Malignant Neoplasms of Female Genital Organs|malignant neoplasms of female genital organs
25135|NCT03128281|Laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
25136|NCT03128281|Robotic gynecologic surgery|robotic gynecologic surgery
25137|NCT03128281|AirSeal® Insufflation System|airseal® insufflation system
25138|NCT03128281|AIS|ais
27685|NCT03111901|IL-2|il-2
25139|NCT03128281|Conventional Insufflation System|conventional insufflation system
25141|NCT03128281|Questionnaires|questionnaires
25142|NCT03128281|Surveys|surveys
25143|NCT03128255|Fusion|fusion
25144|NCT03128255|Hybrid Imaging|hybrid imaging
25145|NCT03128255|Mapping|mapping
25146|NCT03128255|Iodine|iodine
25147|NCT03128255|Ultrasound|ultrasound
25148|NCT03128242|oxytocin|oxytocin
25149|NCT03128242|attention bias|attention bias
25150|NCT03128242|attention training|attention training
25151|NCT03128242|eye-tracking|eye-tracking
25152|NCT03128203|Oxytocin|oxytocin
25153|NCT03128203|Resting-state|resting-state
25154|NCT03128203|Functional connectivity|functional connectivity
25155|NCT03128203|BOLD|bold
25156|NCT03128190|high-risk surgery|high-risk surgery
25157|NCT03128190|pulse-pressure variation|pulse-pressure variation
25158|NCT03128190|monitoring|monitoring
25159|NCT03128190|Postoperative Complications|postoperative complications
25160|NCT03128177|nocturnal hypertension|nocturnal hypertension
25161|NCT03128177|non-dipping blood pressure|non-dipping blood pressure
25162|NCT03128177|obstructive sleep apnea|obstructive sleep apnea
25163|NCT03128151|NMB (Neuromuscular Blockade)|nmb (neuromuscular blockade)
25164|NCT03128151|Anesthesia|anesthesia
25165|NCT03128151|Curarization|curarization
25166|NCT03128151|TOFr (train of four)|tofr (train of four)
25167|NCT03128151|PACU (postanesthesia care unit)|pacu (postanesthesia care unit)
25168|NCT03128151|Monitorization|monitorization
25169|NCT03128112|Parental perception, obesity, overweight|parental perception, obesity, overweight
25170|NCT03128099|Social Skills|social skills
25171|NCT03128099|Social attention|social attention
25172|NCT03128099|Virtual reality|virtual reality
25173|NCT03128099|Eye tracking|eye tracking
25174|NCT03128073|Heart failure, Cardio-Renal Syndrome|heart failure, cardio-renal syndrome
25175|NCT03128047|pediatric cancer|pediatric cancer
25176|NCT03128047|brain tumor|brain tumor
25177|NCT03128047|glioblastoma|glioblastoma
25178|NCT03128047|high grade brain tumor|high grade brain tumor
25179|NCT03128047|malignant brain tumor|malignant brain tumor
25180|NCT03128021|Depression|depression
25181|NCT03128021|fMRI|fmri
25182|NCT03128021|Escitalopram|escitalopram
25185|NCT03128021|Randomized Clinical Trial|randomized clinical trial
25186|NCT03127995|Breast Cancer pT1-3, pN0-N3, M0|breast cancer pt1-3, pn0-n3, m0
25187|NCT03127995|Lymph Node Irradiation|lymph node irradiation
25188|NCT03127982|Anxiety Depression Emotion PTSD Randomized Clinical Trial|anxiety depression emotion ptsd randomized clinical trial
25189|NCT03127969|Rheumatoid hand|rheumatoid hand
25190|NCT03127969|Fluidotherapy|fluidotherapy
25191|NCT03127969|Rehabilitation|rehabilitation
25192|NCT03127943|lidocaine, mandible|lidocaine, mandible
25193|NCT03127930|Cognitive Impairment|cognitive impairment
25194|NCT03127930|Memory loss|memory loss
25195|NCT03127930|Caregivers|caregivers
25196|NCT03127930|Medication adherence|medication adherence
25197|NCT03127930|Medication compliance|medication compliance
25198|NCT03127930|Medication management|medication management
25199|NCT03127930|Problem solving|problem solving
25206|NCT03127904|Compressive therapy|compressive therapy
25207|NCT03127904|Venous ulcer|venous ulcer
25208|NCT03127904|Chronic venous disease|chronic venous disease
25209|NCT03127891|pranayama yoga|pranayama yoga
25210|NCT03127878|Exercise|exercise
25211|NCT03127878|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
25212|NCT03127878|Activities of Daily Living|activities of daily living
25213|NCT03127878|Upper Extremity|upper extremity
25214|NCT03127878|Motor Activity|motor activity
25215|NCT03127839|Exercise|exercise
25216|NCT03127839|Pain Neuroscience Education|pain neuroscience education
25217|NCT03127839|Physical Therapy|physical therapy
25218|NCT03127839|Subacromial Pain|subacromial pain
25219|NCT03127839|Rotator Cuff|rotator cuff
25220|NCT03127826|Low Back Pain|low back pain
25221|NCT03127826|Risk-Stratified Care|risk-stratified care
25222|NCT03127813|glaucoma|glaucoma
25224|NCT03127813|apnoea|apnoea
25225|NCT03127813|intraocular|intraocular
25226|NCT03127813|CPAP|cpap
25227|NCT03127813|airway|airway
25228|NCT03127813|pressure|pressure
25229|NCT03127813|blindness|blindness
25230|NCT03127800|Obstructive Sleep Apnoea|obstructive sleep apnoea
25231|NCT03127800|Morphine sulphate|morphine sulphate
25232|NCT03127800|Sleep Disordered Breathing|sleep disordered breathing
25233|NCT03127800|Central Sleep Apnoea|central sleep apnoea
25234|NCT03127800|Hypoxaemia|hypoxaemia
25235|NCT03127800|Hypercapnia|hypercapnia
25236|NCT03127800|Cheyne-Stokes Respiration|cheyne-stokes respiration
25237|NCT03127800|Analgesia|analgesia
25238|NCT03127800|Respiration|respiration
25239|NCT03127800|Apnoea-Hypopnea Index|apnoea-hypopnea index
25240|NCT03127800|Oxygen Desaturation Index|oxygen desaturation index
25241|NCT03127800|Oximetry|oximetry
25242|NCT03127800|Respiratory Polygraphy|respiratory polygraphy
25243|NCT03127800|Polysomnography|polysomnography
25244|NCT03127761|Multiple Myeloma|multiple myeloma
25252|NCT03127696|Fecal Microbiota Transplant|fecal microbiota transplant
25253|NCT03127631|Androgen Deprivation Therapy|androgen deprivation therapy
25254|NCT03127553|salt intake|salt intake
25255|NCT03127553|functional food|functional food
25256|NCT03127553|low-salt bread|low-salt bread
25257|NCT03127553|blood pressure|blood pressure
25264|NCT03127475|Parkinson's disease|parkinson's disease
25265|NCT03127475|freezing of gait|freezing of gait
25266|NCT03127475|electrophysiology|electrophysiology
25267|NCT03127475|magnetic resonance image|magnetic resonance image
25268|NCT03127475|direct current stimulation|direct current stimulation
25269|NCT03127423|Hybrid ablation|hybrid ablation
25270|NCT03127423|Thoracoscope|thoracoscope
25271|NCT03127397|antiretroviral therapy|antiretroviral therapy
25272|NCT03127397|HIV/AIDS|hiv/aids
25273|NCT03127397|ART adherence|art adherence
25274|NCT03127371|Nitrous Oxide|nitrous oxide
25275|NCT03127371|Abscess|abscess
25276|NCT03127371|Incision and drainage|incision and drainage
25277|NCT03127358|Addiction|addiction
25278|NCT03127358|Sustained Viral Response|sustained viral response
25279|NCT03127358|Adherence|adherence
25280|NCT03127358|Adverse Effects|adverse effects
25281|NCT03127358|Direct Acting Antiviral Agent|direct acting antiviral agent
25282|NCT03127358|Chronic Hepatitis C|chronic hepatitis c
25283|NCT03127358|Resistance Development|resistance development
25284|NCT03127358|Methadone Clinic|methadone clinic
25285|NCT03127358|Primary Care|primary care
25286|NCT03127358|Directly Observed Therapy|directly observed therapy
25287|NCT03127358|Randomized Controlled Trial|randomized controlled trial
25288|NCT03127358|Resistance|resistance
25289|NCT03127358|Reinfection|reinfection
25290|NCT03127358|Treatment Outcome|treatment outcome
25308|NCT03127241|Randomized controlled trial (RCT)|randomized controlled trial (rct)
25309|NCT03127241|Upper limbs|upper limbs
25310|NCT03127241|Robotic devices|robotic devices
25311|NCT03127228|Laser|laser
25312|NCT03127202|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
25313|NCT03127150|Chylous leakage|chylous leakage
25314|NCT03127150|Diagnostic criteria|diagnostic criteria
25315|NCT03127150|Pancreas surgery|pancreas surgery
25316|NCT03127150|Therapy|therapy
25317|NCT03127098|locally advanced or metastatic|locally advanced or metastatic
25318|NCT03127098|carcinoembryonic antigen (CEA)-expressing|carcinoembryonic antigen (cea)-expressing
25320|NCT03127098|carcinoembryonic antigen|carcinoembryonic antigen
25321|NCT03127072|colorectal cancer|colorectal cancer
25322|NCT03127072|liver metastasis|liver metastasis
25323|NCT03127072|Radiofrequency Ablation|radiofrequency ablation
25324|NCT03127072|chemotherapy|chemotherapy
25325|NCT03127072|target therapy|target therapy
25326|NCT03127059|Dysfunctional Breathing|dysfunctional breathing
25327|NCT03127059|Uncontrolled Asthma|uncontrolled asthma
25328|NCT03127059|Breathing Exercises|breathing exercises
25329|NCT03127059|Adults|adults
25330|NCT03127007|immunotherapy|immunotherapy
25331|NCT03127007|anti-PD-L1|anti-pd-l1
25332|NCT03126955|microvascular decompression, Xth nerve|microvascular decompression, xth nerve
25348|NCT03126929|disorders of consciousness|disorders of consciousness
25349|NCT03126929|Vegetative state|vegetative state
25350|NCT03126929|Minimally conscious state|minimally conscious state
25351|NCT03126929|Emergence from MCS|emergence from mcs
25352|NCT03126929|Coma Recovery Scale-Revised|coma recovery scale-revised
25353|NCT03126890|Pharmacokinetics,adverse events|pharmacokinetics,adverse events
25354|NCT03126890|Linezolid|linezolid
25355|NCT03126890|Therapeutic drug monitoring|therapeutic drug monitoring
25356|NCT03126890|Myelosuppression|myelosuppression
25357|NCT03126890|Lactic acidosis|lactic acidosis
25358|NCT03126890|Peripheral neuropathy|peripheral neuropathy
25359|NCT03126864|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
25360|NCT03126864|Acute Myeloid Leukemia|acute myeloid leukemia
25361|NCT03126864|AML|aml
25362|NCT03126864|Relapsed or Refractory CD33-Positive|relapsed or refractory cd33-positive
25363|NCT03126864|CD33-CAR-T cells|cd33-car-t cells
25364|NCT03126864|Fludarabine|fludarabine
25365|NCT03126864|Fludarabine phosphate|fludarabine phosphate
25366|NCT03126864|Fludara|fludara
25367|NCT03126864|Cyclophosphamide|cyclophosphamide
25368|NCT03126864|Cytoxan|cytoxan
25369|NCT03126864|Neosar|neosar
25370|NCT03126838|diaphragm|diaphragm
25371|NCT03126838|ultrasound|ultrasound
25372|NCT03126838|dysfunction|dysfunction
25378|NCT03126786|Diabetic Retinopathy|diabetic retinopathy
25380|NCT03126786|Mircoinjection|mircoinjection
25381|NCT03126786|Triamcinolone|triamcinolone
25382|NCT03126786|Choroid|choroid
25383|NCT03126786|Choroid Injection|choroid injection
25384|NCT03126786|Aflibercept|aflibercept
25385|NCT03126786|Suprachoroidal|suprachoroidal
25386|NCT03126773|non-interventional|non-interventional
25387|NCT03126773|cohort|cohort
25388|NCT03126773|Angeliq Micro|angeliq micro
25389|NCT03126773|menopause|menopause
25390|NCT03126773|Russia|russia
25391|NCT03126734|Down Syndrome|down syndrome
25392|NCT03126734|Acceptance|acceptance
25393|NCT03126734|Commitment|commitment
25394|NCT03126734|Concience of influence|concience of influence
25395|NCT03126721|drug interaction|drug interaction
25396|NCT03126721|PF-06751979|pf-06751979
25397|NCT03126721|oral midazolam|oral midazolam
25398|NCT03126695|Abnormal hemoglobin (called hemoglobin S or sickle hemoglobin) in the red blood cells|abnormal hemoglobin (called hemoglobin s or sickle hemoglobin) in the red blood cells
25399|NCT03126695|Thrombotic cardiovascular events|thrombotic cardiovascular events
25400|NCT03126695|Acute coronary syndrome|acute coronary syndrome
25401|NCT03126695|P2Y12 platelet inhibitor|p2y12 platelet inhibitor
25402|NCT03126695|Brilinta|brilinta
25403|NCT03126682|Wellbutrin|wellbutrin
25404|NCT03126682|Electroconvulsive therapy|electroconvulsive therapy
25405|NCT03126682|Right Unilateral Ultra Brief|right unilateral ultra brief
25406|NCT03126669|Hyperbaric oxygen|hyperbaric oxygen
25407|NCT03126669|multitasking performance|multitasking performance
25408|NCT03126669|cognitive funcitons|cognitive funcitons
25409|NCT03126656|testosterone|testosterone
25410|NCT03126656|chronic heart failure|chronic heart failure
25411|NCT03126552|hookworm|hookworm
25412|NCT03126552|controlled human infection model|controlled human infection model
25413|NCT03126539|aging|aging
17330|NCT03180606|Elderly|elderly
25414|NCT03126539|ultraviolet exposure|ultraviolet exposure
25415|NCT03126539|skin fragility|skin fragility
25416|NCT03126539|sulforaphane|sulforaphane
25417|NCT03126513|G-POEM|g-poem
25418|NCT03126513|Safety|safety
25419|NCT03126513|Efficacy|efficacy
25420|NCT03126500|Malnutrition|malnutrition
25421|NCT03126500|Disease-related malnutrition|disease-related malnutrition
25422|NCT03126500|Frailty|frailty
25423|NCT03126500|Sarcopenia|sarcopenia
25424|NCT03126500|Hospital discharge|hospital discharge
25425|NCT03126500|Geriatrics|geriatrics
25426|NCT03126461|metastatic melanoma|metastatic melanoma
25432|NCT03126435|folinic acid|folinic acid
25433|NCT03126435|irinotecan|irinotecan
25434|NCT03126435|oxaliplatin|oxaliplatin
25435|NCT03126435|Gemcitabine|gemcitabine
25436|NCT03126409|coronary artery disease|coronary artery disease
25437|NCT03126409|coronary artery bypass graft|coronary artery bypass graft
25438|NCT03126344|King Vision|king vision
25439|NCT03126331|Kidney Cancer|kidney cancer
25440|NCT03126331|Metastatic|metastatic
25441|NCT03126331|Nivolumab|nivolumab
25442|NCT03126305|exposure|exposure
25443|NCT03126305|response prevention|response prevention
25854|NCT03123471|Safety|safety
25444|NCT03126305|web-based application|web-based application
25445|NCT03126292|Medical home|medical home
25446|NCT03126292|Primary care|primary care
25447|NCT03126292|Children|children
25448|NCT03126292|Development|development
25449|NCT03126279|Osteoarthritis|osteoarthritis
25450|NCT03126279|Pain|pain
25451|NCT03126279|Postoperative Pain|postoperative pain
25452|NCT03126253|childhood anemia, socioeconomic status|childhood anemia, socioeconomic status
25453|NCT03126227|AR101|ar101
25454|NCT03126227|Characterized Peanut Allergen|characterized peanut allergen
25455|NCT03126227|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
25456|NCT03126227|OIT (oral immunotherapy)|oit (oral immunotherapy)
25457|NCT03126227|Peanut Allergy|peanut allergy
25458|NCT03126227|Peanut-Allergic Children|peanut-allergic children
25459|NCT03126227|Desensitization|desensitization
25460|NCT03126227|ARC007|arc007
25461|NCT03126227|Characterized Oral Desensitization Immunotherapy (CODIT™)|characterized oral desensitization immunotherapy (codit™)
25462|NCT03126214|atrial fibrillation|atrial fibrillation
25463|NCT03126214|stroke|stroke
25464|NCT03126214|oral anticoagulation therapy|oral anticoagulation therapy
25465|NCT03126214|pharmacist case management|pharmacist case management
25466|NCT03126201|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
25467|NCT03126201|disease progression|disease progression
25468|NCT03126162|minimally invasive gynecologic surgery|minimally invasive gynecologic surgery
25469|NCT03126162|same-day discharge|same-day discharge
25470|NCT03126162|bladder testing|bladder testing
25471|NCT03126136|Fetal heart rate abnormalities|fetal heart rate abnormalities
25475|NCT03126123|Anal condylomatosis|anal condylomatosis
25476|NCT03126123|surgery|surgery
25477|NCT03126123|acetic acid|acetic acid
25478|NCT03126123|dysplastic areas|dysplastic areas
25479|NCT03126110|cervical cancer|cervical cancer
25480|NCT03126110|endometrial cancer|endometrial cancer
25481|NCT03126110|gastric cancer (stomach, esophageal, and gastroesophageal junction [GEJ])|gastric cancer (stomach, esophageal, and gastroesophageal junction [gej])
25482|NCT03126110|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
25483|NCT03126110|melanoma|melanoma
25484|NCT03126110|Merkel cell carcinoma|merkel cell carcinoma
25485|NCT03126110|mesothelioma|mesothelioma
25486|NCT03126110|microsatellite instability-high (MSI-H) colorectal cancer (CRC)|microsatellite instability-high (msi-h) colorectal cancer (crc)
25487|NCT03126110|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
25488|NCT03126110|ovarian cancer|ovarian cancer
25489|NCT03126110|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
25490|NCT03126110|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
25491|NCT03126110|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
25492|NCT03126110|triple-negative breast cancer (TNBC)|triple-negative breast cancer (tnbc)
25493|NCT03126110|urothelial carcinoma|urothelial carcinoma
25494|NCT03126110|glucocorticoid-induced tumor necrosis factor receptor (GITR)|glucocorticoid-induced tumor necrosis factor receptor (gitr)
25495|NCT03126058|enhanced recovery after surgery|enhanced recovery after surgery
25496|NCT03126058|colorectal cancer|colorectal cancer
25497|NCT03126045|Lumbar puncture|lumbar puncture
25498|NCT03126045|Post lumbar puncture headache|post lumbar puncture headache
25499|NCT03126045|Atraumatic needle|atraumatic needle
25500|NCT03126045|Haematology|haematology
25501|NCT03126032|Sepsis|sepsis
25502|NCT03126032|SIRS|sirs
25503|NCT03126032|Glycocalyx|glycocalyx
25504|NCT03126032|Glycocheck™-System|glycocheck™-system
25505|NCT03126032|Infection|infection
25509|NCT03125993|obesity; brisk walking|obesity; brisk walking
25510|NCT03125928|Atezolizumab|atezolizumab
25511|NCT03125928|PD-L1|pd-l1
25512|NCT03125915|couples HIV testing; drug intervention; communication skills|couples hiv testing; drug intervention; communication skills
25513|NCT03125889|image-guided|image-guided
17483|NCT03179436|PD1|pd1
25514|NCT03125889|BPH|bph
25515|NCT03125889|Aquablation|aquablation
25516|NCT03125889|AQUABEAM|aquabeam
25517|NCT03125889|lower urinary tract symptoms|lower urinary tract symptoms
25518|NCT03125889|prostate tissue resection|prostate tissue resection
25519|NCT03125889|robotics|robotics
25520|NCT03125863|minimally invasive|minimally invasive
25521|NCT03125863|image-guided|image-guided
25522|NCT03125863|bph|bph
25523|NCT03125863|aquablation|aquablation
25524|NCT03125863|AquaBeam|aquabeam
25525|NCT03125863|lower urinary tract symptoms|lower urinary tract symptoms
25526|NCT03125863|tissue resection|tissue resection
25527|NCT03125863|robotics|robotics
25528|NCT03125850|day-ward|day-ward
25529|NCT03125850|inpatient|inpatient
25530|NCT03125811|Isopropyl alcohol|isopropyl alcohol
25531|NCT03125811|Zofran|zofran
25532|NCT03125811|antiemetics|antiemetics
25533|NCT03125798|video-assisted thoracic surgery|video-assisted thoracic surgery
25534|NCT03125798|LigaSure|ligasure
25535|NCT03125798|mediastinal lymph node dissection|mediastinal lymph node dissection
25536|NCT03125785|congenital cataract, contact lens|congenital cataract, contact lens
25537|NCT03125772|coronary artery disease|coronary artery disease
25538|NCT03125772|diabetes mellitus|diabetes mellitus
25539|NCT03125772|everolimus|everolimus
25540|NCT03125772|paclitaxel stents|paclitaxel stents
25541|NCT03125759|Ischemic Stroke|ischemic stroke
25542|NCT03125759|Omentin|omentin
25543|NCT03125733|Endoscopy, Digestive system|endoscopy, digestive system
25544|NCT03125733|Natural orifice transluminal endoscopic surgery|natural orifice transluminal endoscopic surgery
25545|NCT03125733|Therapeutic|therapeutic
25546|NCT03125733|Complications|complications
25547|NCT03125720|cardiac resynchronization therapy|cardiac resynchronization therapy
25548|NCT03125720|chronic heart failure|chronic heart failure
25549|NCT03125720|image fusion-guided implantation|image fusion-guided implantation
25550|NCT03125720|SPECT|spect
25551|NCT03125720|venogram|venogram
25552|NCT03125681|remote ischemic conditioning|remote ischemic conditioning
25553|NCT03125681|off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
25554|NCT03125655|cytokines|cytokines
25555|NCT03125642|Lymphoblastic Lymphoma|lymphoblastic lymphoma
25556|NCT03125642|Mature B-cell Lymphomas|mature b-cell lymphomas
25557|NCT03125642|Follicular Lymphoma|follicular lymphoma
25558|NCT03125642|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
25559|NCT03125642|Mantle Cell Lymphoma|mantle cell lymphoma
25560|NCT03125642|Burkitt's/Burkitt's like|burkitt's/burkitt's like
25561|NCT03125642|Mature T-Cell Lymphoma|mature t-cell lymphoma
25562|NCT03125616|Prematurity|prematurity
25563|NCT03125616|Vaccination|vaccination
25564|NCT03125603|Immunotherapy|immunotherapy
25565|NCT03125603|Anti-PD-(L)-1|anti-pd-(l)-1
25566|NCT03125603|Anti-CTLA-4|anti-ctla-4
25567|NCT03125590|Osteoporosis, osteopenia, test-retest, validity, PEQ, questionnaire, facilitators, barriers, exercise, physical activity|osteoporosis, osteopenia, test-retest, validity, peq, questionnaire, facilitators, barriers, exercise, physical activity
25568|NCT03125577|4S CAR-T|4s car-t
25570|NCT03125577|CD20|cd20
25571|NCT03125577|CD22|cd22
25572|NCT03125577|CD38|cd38
25573|NCT03125577|CD123|cd123
25574|NCT03125577|B cell leukemia|b cell leukemia
25575|NCT03125577|B-ALL|b-all
25576|NCT03125551|Dietary supplements|dietary supplements
25577|NCT03125551|Bleeding tendency|bleeding tendency
25578|NCT03125538|Motor Imagery|motor imagery
25579|NCT03125538|Amputation|amputation
25580|NCT03125538|Functional rehabilitation|functional rehabilitation
25581|NCT03125538|Locomotion|locomotion
25582|NCT03125538|Phantom-limb pain|phantom-limb pain
25583|NCT03125525|migraine|migraine
25584|NCT03125525|transcutaneous|transcutaneous
25585|NCT03125525|supraorbital|supraorbital
25586|NCT03125525|nerve|nerve
25587|NCT03125525|stimulation|stimulation
25588|NCT03125512|Sleep Apnea Syndromes|sleep apnea syndromes
25589|NCT03125512|Positional sleep apnea|positional sleep apnea
25590|NCT03125512|CPAP|cpap
25591|NCT03125512|Night Shift|night shift
25592|NCT03125486|subcutaneous Belimumab|subcutaneous belimumab
25593|NCT03125486|Individual Patient Compassionate Use|individual patient compassionate use
25594|NCT03125486|SLE|sle
25595|NCT03125486|GSK1550188|gsk1550188
25596|NCT03125447|Prematurely born children|prematurely born children
25597|NCT03125447|Attention function|attention function
25598|NCT03125447|Posture|posture
25599|NCT03125447|Mobility|mobility
25600|NCT03125356|diet soda|diet soda
25601|NCT03125356|low-calorie sweeteners|low-calorie sweeteners
25602|NCT03125356|obesity|obesity
25603|NCT03125343|radiotherapy|radiotherapy
25604|NCT03125343|chemotherapy|chemotherapy
25605|NCT03125343|complete response|complete response
25606|NCT03125330|Coaching|coaching
25607|NCT03125330|Professional coaching|professional coaching
25608|NCT03125330|Emergency physicians|emergency physicians
25609|NCT03125330|Emergency medicine|emergency medicine
25610|NCT03125330|Goal attainment|goal attainment
25611|NCT03125330|Leadership strengths|leadership strengths
25613|NCT03125330|Burnout|burnout
25614|NCT03125330|Adult level of development|adult level of development
25615|NCT03125330|Group coaching|group coaching
25616|NCT03125330|Instructor|instructor
25617|NCT03125330|Assistant professor|assistant professor
25618|NCT03125330|Academic faculty|academic faculty
25619|NCT03125330|Subject-Object Interview|subject-object interview
25620|NCT03125304|Endometriosis|endometriosis
25621|NCT03125304|acupuncture|acupuncture
25622|NCT03125304|pain|pain
25623|NCT03125304|dysmenorrhea|dysmenorrhea
25624|NCT03125291|Substance Use and Abuse|substance use and abuse
25625|NCT03125291|Risky Sexual Behavior|risky sexual behavior
25626|NCT03125291|Behavior Problems|behavior problems
25627|NCT03125291|Academic Achievement|academic achievement
25628|NCT03125265|nutrition|nutrition
25629|NCT03125265|hemodialysis|hemodialysis
25630|NCT03125265|mortality|mortality
25631|NCT03125265|omega 3|omega 3
25632|NCT03125252|Delirium|delirium
25633|NCT03125252|Reanimation|reanimation
25634|NCT03125252|Conversational hypnosis|conversational hypnosis
25635|NCT03125239|Refractory Adult Acute Myeloid Leukemia|refractory adult acute myeloid leukemia
25636|NCT03125239|Relapsed Adult Acute Myeloid Leukemia|relapsed adult acute myeloid leukemia
25637|NCT03125187|Sodium Heparin|sodium heparin
25638|NCT03125187|Intravenous administration|intravenous administration
25639|NCT03125187|Pharmacokinetics|pharmacokinetics
25640|NCT03125187|Coagulation factor|coagulation factor
25641|NCT03125174|sputum|sputum
25642|NCT03125174|bronchiectasis|bronchiectasis
25643|NCT03125174|lung disease|lung disease
25644|NCT03125161|colorectal cancer|colorectal cancer
25645|NCT03125161|liver metastasis|liver metastasis
25646|NCT03125161|hepatic arterial infusion|hepatic arterial infusion
25647|NCT03125161|chemotherapy|chemotherapy
25648|NCT03125161|target therapy|target therapy
25649|NCT03125161|conversional resection rates|conversional resection rates
25650|NCT03125083|Skin restricted lupus|skin restricted lupus
25651|NCT03125083|Psychiatric disorders|psychiatric disorders
25652|NCT03125083|Inflammation|inflammation
25653|NCT03125083|Kynurenine pathway|kynurenine pathway
25654|NCT03124355|vagal stimulation|vagal stimulation
25655|NCT03124355|POTS|pots
25656|NCT03124355|galantamine|galantamine
25657|NCT03124355|pyridostigmine|pyridostigmine
25658|NCT03121365|Digital literacy|digital literacy
25659|NCT03121365|Reading|reading
25660|NCT03121352|Carboplatin|carboplatin
25661|NCT03121352|Nab-Paclitaxel|nab-paclitaxel
25662|NCT03121352|Pembrolizumab|pembrolizumab
25663|NCT03121326|Sarcopenia|sarcopenia
25664|NCT03121326|Aging|aging
25665|NCT03121326|Biomarkers|biomarkers
25666|NCT03121326|Metabolomics|metabolomics
25667|NCT03121313|Tegafur-uracil|tegafur-uracil
25668|NCT03121313|distant metastasis|distant metastasis
25669|NCT03121313|oral cavity cancer|oral cavity cancer
25670|NCT03121261|levobupivacaine|levobupivacaine
25671|NCT03121261|nerve fibers|nerve fibers
25672|NCT03121261|clonidine|clonidine
25673|NCT03124667|adherence|adherence
25674|NCT03124667|cognition|cognition
25675|NCT03124667|exercise|exercise
25676|NCT03124667|aging|aging
25677|NCT03124667|brain training|brain training
25678|NCT03124667|cognitive training|cognitive training
25679|NCT03124667|executive function|executive function
25777|NCT03123874|human milk|human milk
25680|NCT03124641|Hypothermic oxygenated machine perfusion|hypothermic oxygenated machine perfusion
25681|NCT03124641|Orthotopic liver transplantation|orthotopic liver transplantation
25682|NCT03124641|Extended criteria donation|extended criteria donation
25683|NCT03124641|Donation after brain death|donation after brain death
25684|NCT03124641|HOPE|hope
25685|NCT03124563|Exercise|exercise
25686|NCT03124563|Health Behavior|health behavior
25687|NCT03124563|Aging|aging
25688|NCT03124550|Caregivers|caregivers
25689|NCT03124550|Exercise|exercise
25690|NCT03124550|Behavior Change|behavior change
25691|NCT03124537|Physical Exercise|physical exercise
25692|NCT03124537|Behavior Change|behavior change
25693|NCT03124524|estradiol valerate/dienogest|estradiol valerate/dienogest
25694|NCT03124524|ethinylestradiol/ drospirenone|ethinylestradiol/ drospirenone
25695|NCT03124524|pelvic pain|pelvic pain
25696|NCT03124524|primary dysmenorrhea|primary dysmenorrhea
25697|NCT03124524|uterine artery doppler indices|uterine artery doppler indices
25698|NCT03124498|Hepatocellular Carcinoma, Autologous Cytokine-Induced Killer|hepatocellular carcinoma, autologous cytokine-induced killer
25700|NCT03124446|mindfulness|mindfulness
25701|NCT03124433|prostate cancer|prostate cancer
25702|NCT03124433|prostatectomy, retropubic|prostatectomy, retropubic
25703|NCT03124433|Androgen Receptor Antagonists|androgen receptor antagonists
25704|NCT03124420|Helicobacter Infection|helicobacter infection
25705|NCT03124420|Eradication therapy|eradication therapy
25706|NCT03124420|Antibiotics|antibiotics
25707|NCT03124238|massage|massage
25708|NCT03124212|mutation carrier|mutation carrier
25709|NCT03124212|blood relative|blood relative
25710|NCT03124212|genetic testing|genetic testing
25711|NCT03124212|family-based cohort|family-based cohort
25712|NCT03124199|Eradication|eradication
25713|NCT03124199|Helicobacter pylori|helicobacter pylori
25714|NCT03124199|rifaximin|rifaximin
25715|NCT03124199|therapy|therapy
25716|NCT03124199|standard triple therapy|standard triple therapy
25717|NCT03124186|motor recovery|motor recovery
25718|NCT03124186|neuroplasticity|neuroplasticity
25719|NCT03124186|subacute|subacute
25720|NCT03124186|human|human
25721|NCT03124186|sensory|sensory
25722|NCT03124186|nerve stimulation|nerve stimulation
25723|NCT03124173|fMRI|fmri
25724|NCT03124173|cingulate cortex|cingulate cortex
25725|NCT03124173|adaptation|adaptation
25726|NCT03124173|frontal cortex|frontal cortex
25727|NCT03124160|Healthy Women|healthy women
25728|NCT03124160|Female Contraception|female contraception
25730|NCT03124147|motor recovery|motor recovery
25731|NCT03124147|neuroplasticity|neuroplasticity
25732|NCT03124147|chronic|chronic
25733|NCT03124147|human|human
25734|NCT03124147|noninvasive brain stimulation|noninvasive brain stimulation
25735|NCT03124147|neuromodulation|neuromodulation
25736|NCT03124108|Elafibranor|elafibranor
25737|NCT03124108|Primary Biliary Cholangitis|primary biliary cholangitis
25738|NCT03124108|Alkaline phosphatase|alkaline phosphatase
25739|NCT03124095|physical exercise|physical exercise
25740|NCT03124095|combined training|combined training
25741|NCT03124095|physical activity|physical activity
25742|NCT03124095|physical fitness|physical fitness
25743|NCT03124056|Extracorporeal photopheresis|extracorporeal photopheresis
25744|NCT03124056|Biomarker of response|biomarker of response
25745|NCT03124056|Steroid resistant|steroid resistant
25746|NCT03124030|direct oral anticoagulant|direct oral anticoagulant
25747|NCT03124030|oral anticoagulant therapy|oral anticoagulant therapy
25748|NCT03124030|dental extraction|dental extraction
25749|NCT03124030|bleeding complication|bleeding complication
25750|NCT03124030|atrial fibrillation|atrial fibrillation
25751|NCT03124030|deep venous thrombosis|deep venous thrombosis
25752|NCT03124004|direct oral anticoagulant|direct oral anticoagulant
25753|NCT03124004|oral anticoagulant therapy|oral anticoagulant therapy
25754|NCT03124004|periodontal disease|periodontal disease
25755|NCT03124004|periodontal debridement|periodontal debridement
25756|NCT03124004|ultrasonic periodontal debridement|ultrasonic periodontal debridement
25757|NCT03124004|ultrasonic scaling|ultrasonic scaling
25758|NCT03124004|periodontal scaling|periodontal scaling
25759|NCT03124004|subgingival scaling|subgingival scaling
25760|NCT03123978|castration resistant prostate cancer|castration resistant prostate cancer
25761|NCT03123965|Special Access Scheme|special access scheme
25762|NCT03123965|Expanded Access|expanded access
25763|NCT03123965|Pre-approval Access|pre-approval access
25771|NCT03123952|Named Patient Basis|named patient basis
25772|NCT03123952|Special Access Scheme|special access scheme
25774|NCT03123926|spontaneous preterm birth|spontaneous preterm birth
25775|NCT03123926|lipids|lipids
25776|NCT03123926|biomarkers|biomarkers
25778|NCT03123874|breast milk|breast milk
25779|NCT03123874|expressed human milk|expressed human milk
25780|NCT03123874|bacterial communities|bacterial communities
25781|NCT03123874|microbiome|microbiome
25782|NCT03123874|breast pump|breast pump
25783|NCT03123874|bacterial growth|bacterial growth
25784|NCT03123861|Pelvic Organ Prolapse|pelvic organ prolapse
25785|NCT03123861|postoperative gluteal pain|postoperative gluteal pain
25786|NCT03123861|opioid use|opioid use
25787|NCT03123835|Achalasia|achalasia
25788|NCT03123835|Fistula|fistula
25789|NCT03123835|Obesity|obesity
25790|NCT03123835|POEM|poem
25791|NCT03123835|GERD|gerd
25792|NCT03123835|endoscopic|endoscopic
25793|NCT03123835|treatments|treatments
25794|NCT03123835|post bariatric surger weight gain|post bariatric surger weight gain
25795|NCT03123835|endoluminal|endoluminal
25796|NCT03123835|Bariatric Surgery|bariatric surgery
25797|NCT03123835|Barretts|barretts
25798|NCT03123809|Diabetes|diabetes
25799|NCT03123809|gastroparesis|gastroparesis
25800|NCT03123809|gastric electrical stimulation|gastric electrical stimulation
25801|NCT03123809|pyloroplasty|pyloroplasty
25802|NCT03123796|chronic rejection|chronic rejection
25803|NCT03123796|transplant outcome|transplant outcome
25804|NCT03123783|CD40|cd40
25805|NCT03123783|Immunotherapy|immunotherapy
25806|NCT03123783|Nivolumab|nivolumab
25807|NCT03123783|APX005M|apx005m
25808|NCT03123783|PD-1|pd-1
25809|NCT03123770|Breast cancer|breast cancer
25810|NCT03123770|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
25811|NCT03123770|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
25812|NCT03123770|PLD|pld
25813|NCT03123744|Palbociclib|palbociclib
25814|NCT03123744|Cyclin Pathway|cyclin pathway
25815|NCT03123744|kinase inhibitor|kinase inhibitor
25816|NCT03123731|physical activity|physical activity
25817|NCT03123731|diet|diet
25818|NCT03123731|mHealth|mhealth
25819|NCT03123731|Fitbit|fitbit
25820|NCT03123731|neurocognition|neurocognition
25821|NCT03123731|text messaging|text messaging
25822|NCT03123718|methotrexate|methotrexate
25823|NCT03123640|Medication reconciliation|medication reconciliation
25824|NCT03123640|Medication review|medication review
25825|NCT03123640|Drug related admission|drug related admission
25826|NCT03123627|Cytomegalovirus, Seropositive|cytomegalovirus, seropositive
25827|NCT03123614|Photorefractive keratectomy|photorefractive keratectomy
25828|NCT03123601|Nursing home|nursing home
25829|NCT03123601|Falls|falls
25830|NCT03123601|Dysphasia|dysphasia
25831|NCT03123601|Choking|choking
25832|NCT03123601|Dehydration|dehydration
25833|NCT03123588|Essential thrombocythemia|essential thrombocythemia
25834|NCT03123588|hydroxyurea-resistant|hydroxyurea-resistant
25835|NCT03123588|hydroxyurea-intolerant|hydroxyurea-intolerant
25836|NCT03123588|ruxolitinib|ruxolitinib
25837|NCT03123588|anagrelide|anagrelide
25838|NCT03123562|Cerebral palsy|cerebral palsy
25839|NCT03123562|Stem cell|stem cell
25840|NCT03123562|Jaundice|jaundice
25841|NCT03123536|high risk|high risk
25842|NCT03123536|complication|complication
25843|NCT03123536|Ultrasonography|ultrasonography
25844|NCT03123510|probiotics|probiotics
25845|NCT03123510|prebiotics|prebiotics
25846|NCT03123510|synbiotics|synbiotics
25847|NCT03123510|obesity|obesity
25848|NCT03123497|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
25849|NCT03123484|beta-elemene|beta-elemene
25850|NCT03123471|Plaque Psoriasis|plaque psoriasis
25851|NCT03123471|Scalp|scalp
25852|NCT03123471|Double-Blind|double-blind
25853|NCT03123471|Efficacy|efficacy
25855|NCT03123471|CC-10004|cc-10004
25856|NCT03123471|Apremilast|apremilast
25857|NCT03123471|Otezla|otezla
25858|NCT03123471|Itch|itch
25859|NCT03123471|Head|head
25860|NCT03123458|MSC|msc
25861|NCT03123458|GVHDs|gvhds
25862|NCT03123458|transplantation|transplantation
25863|NCT03123445|endostar|endostar
25864|NCT03123432|immunomodulating nutrients|immunomodulating nutrients
25865|NCT03123406|cinacalcet|cinacalcet
25866|NCT03123406|secondary hyperparathyroidism|secondary hyperparathyroidism
25867|NCT03123406|calcimimetics|calcimimetics
25868|NCT03123406|CKD-MBD|ckd-mbd
25869|NCT03123393|Drug therapy|drug therapy
25870|NCT03121573|near infrared spectroscopy, NIRS, duloxetine|near infrared spectroscopy, nirs, duloxetine
25871|NCT03121560|Hysteroscopy|hysteroscopy
25872|NCT03121560|Saline infusion hysterosonography|saline infusion hysterosonography
25873|NCT03121534|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
25874|NCT03121534|Richter's transformation|richter's transformation
25875|NCT03121534|RT|rt
25876|NCT03121534|Blinatumomab|blinatumomab
25877|NCT03121534|Dexamethasone|dexamethasone
25878|NCT03121534|Decadron|decadron
25879|NCT03121521|statins liver enzymes melatonin|statins liver enzymes melatonin
25880|NCT03123315|hysterectomy|hysterectomy
25881|NCT03123315|ureter|ureter
25882|NCT03123302|MRI scan, sedation, epilepsia|mri scan, sedation, epilepsia
25883|NCT03123289|PET/CT|pet/ct
25892|NCT03123224|TBI|tbi
25893|NCT03123224|dementia|dementia
25894|NCT03123224|Alzheimer's disease|alzheimer's disease
25895|NCT03123224|physical exercise|physical exercise
25896|NCT03123224|physical activity|physical activity
25897|NCT03123224|psychosocial|psychosocial
25898|NCT03123224|caregiver skills training|caregiver skills training
25899|NCT03123211|Expanded Access|expanded access
25900|NCT03123211|Pre-approval Access|pre-approval access
25901|NCT03123211|Compassionate Use|compassionate use
25902|NCT03123211|Special Access Program|special access program
25903|NCT03123211|Named Patient Basis|named patient basis
25904|NCT03123211|Special Access Scheme|special access scheme
25905|NCT03123198|borderline personality disorder, dialectical behavior therapy, suicidal behaviors|borderline personality disorder, dialectical behavior therapy, suicidal behaviors
25906|NCT03123172|co2 gap|co2 gap
25907|NCT03123172|PPV|ppv
25908|NCT03123172|resuscitation|resuscitation
25909|NCT03123172|liver transplantation|liver transplantation
25910|NCT03123146|Cognitive Behavioral Therapy|cognitive behavioral therapy
25911|NCT03123107|Vitamin C|vitamin c
25912|NCT03123107|Postoperative atrial fibrillation|postoperative atrial fibrillation
25913|NCT03123107|coronary artery bypass graft|coronary artery bypass graft
25914|NCT03123107|ascorbic acid|ascorbic acid
25915|NCT03123055|Urothelial Cell Carcinoma|urothelial cell carcinoma
25916|NCT03123055|UCC|ucc
25917|NCT03123055|bladder cancer|bladder cancer
25918|NCT03123055|B-701|b-701
25919|NCT03123055|FGFR3|fgfr3
25920|NCT03123055|invasive bladder cancer|invasive bladder cancer
25921|NCT03123055|Transitional Cell Carcinoma|transitional cell carcinoma
25922|NCT03123055|TCC|tcc
25923|NCT03123055|second line therapy|second line therapy
25924|NCT03123055|monoclonal antibody|monoclonal antibody
25925|NCT03123055|combination therapy|combination therapy
25926|NCT03123055|Phase 1|phase 1
25927|NCT03123055|pembrolizumab|pembrolizumab
25928|NCT03123055|checkpoint inhibitor|checkpoint inhibitor
26745|NCT03117608|OA|oa
17833|NCT03177122|Polycystic Ovary Syndrome|polycystic ovary syndrome
17834|NCT03177122|Myo-Inositol|myo-inositol
25929|NCT03123042|Sentinel lymph node|sentinel lymph node
25930|NCT03123042|Early gastric cancer|early gastric cancer
25931|NCT03123042|Non-curative endoscopic resection|non-curative endoscopic resection
25932|NCT03123029|Expanded Access|expanded access
25933|NCT03123029|Pre-approval Access|pre-approval access
25934|NCT03123029|Compassionate Use|compassionate use
25935|NCT03123029|Special Access Program|special access program
25936|NCT03123029|Named Patient Basis|named patient basis
25937|NCT03123029|Special Access Scheme|special access scheme
25938|NCT03123016|Vitiligo|vitiligo
25939|NCT03123003|Bone age,|bone age,
25940|NCT03123003|Height prediction|height prediction
25941|NCT03123003|Growth|growth
25942|NCT03122938|lactoferrin|lactoferrin
25943|NCT03122938|Iron Metabolism|iron metabolism
25944|NCT03122938|iron-deficiency anemia|iron-deficiency anemia
25945|NCT03122938|pregnant women|pregnant women
25946|NCT03122938|fetal development|fetal development
25947|NCT03122912|fish oil|fish oil
25948|NCT03122899|SI-BONE|si-bone
25949|NCT03122899|sacroiliac joint|sacroiliac joint
25950|NCT03122899|degenerative sacroiliitis|degenerative sacroiliitis
25951|NCT03122899|sacroiliac joint disruption|sacroiliac joint disruption
25952|NCT03122899|iFuse|ifuse
25953|NCT03122860|SM04690|sm04690
25954|NCT03122860|Wnt pathway inhibitor|wnt pathway inhibitor
25955|NCT03122860|osteoarthritis|osteoarthritis
25956|NCT03122860|Samumed|samumed
25957|NCT03122834|Heart Failure|heart failure
25958|NCT03122834|Genetic Polymorphism|genetic polymorphism
25959|NCT03122834|RAAS|raas
25960|NCT03122834|Cardiac Fibrosis|cardiac fibrosis
25961|NCT03122834|Remodeling|remodeling
25962|NCT03122808|Tachysystole|tachysystole
25963|NCT03122808|Excessive Uterine Activity|excessive uterine activity
25964|NCT03122769|Metformin|metformin
25965|NCT03122769|Heart Failure|heart failure
25966|NCT03122769|Organic cation transporter|organic cation transporter
25967|NCT03122769|Pharmacogenetics|pharmacogenetics
25968|NCT03122769|Pharmacokinetics|pharmacokinetics
25969|NCT03122769|Positron Emission Tomography|positron emission tomography
25970|NCT03122756|Intravenous Dexamethasone|intravenous dexamethasone
25971|NCT03122756|Spinal Anesthesia|spinal anesthesia
25972|NCT03122756|Post-cesarean Section Pain|post-cesarean section pain
25973|NCT03122730|Cardiac surgery|cardiac surgery
25974|NCT03122730|Cardiopulmonary bypass|cardiopulmonary bypass
25975|NCT03122730|Epoprostenol|epoprostenol
25976|NCT03122717|Non-Small Cell Lung Cancer|non-small cell lung cancer
25977|NCT03122665|Nefopam|nefopam
25978|NCT03122665|Pharmacokinetics|pharmacokinetics
25979|NCT03122665|Shivering,|shivering,
25980|NCT03122665|Thermoregulation|thermoregulation
25981|NCT03122665|Anesthesia|anesthesia
25982|NCT03122626|stroke|stroke
25983|NCT03122626|community-based exercise program|community-based exercise program
25984|NCT03122626|task-oriented exercise|task-oriented exercise
25985|NCT03122626|group exercise program|group exercise program
25986|NCT03122626|healthcare-recreation partnership|healthcare-recreation partnership
25987|NCT03122626|randomized controlled pilot trial|randomized controlled pilot trial
25988|NCT03122626|mixed methods|mixed methods
25989|NCT03122587|tACS|tacs
25990|NCT03122587|Brain Stimulation|brain stimulation
25991|NCT03122587|Transcranial Alternating Current Stimulation|transcranial alternating current stimulation
25992|NCT03122587|Substance Use|substance use
25993|NCT03122574|aromatherapy|aromatherapy
25994|NCT03122574|pediatric|pediatric
25995|NCT03122574|venipuncture|venipuncture
25996|NCT03122574|lavender|lavender
25997|NCT03122574|pain management|pain management
25998|NCT03122548|stomach cancer|stomach cancer
25999|NCT03122548|gastric cancer|gastric cancer
26000|NCT03122548|esophageal cancer|esophageal cancer
26001|NCT03122548|digestive system diseases|digestive system diseases
26002|NCT03122548|gastrointestinal diseases|gastrointestinal diseases
26003|NCT03122548|stomach diseases|stomach diseases
26004|NCT03122535|Femtosecond LASIK (FS--LASIK)|femtosecond lasik (fs--lasik)
26005|NCT03122535|Visual acuity|visual acuity
26006|NCT03122535|Refractive errors|refractive errors
26007|NCT03122535|Side-cut angles|side-cut angles
26008|NCT03122522|unresectable|unresectable
26009|NCT03122522|III or stage IV|iii or stage iv
26010|NCT03122522|Ipilimumab|ipilimumab
26011|NCT03122522|Nivolumab|nivolumab
26012|NCT03122522|17-162|17-162
26013|NCT03122509|Durvalumab|durvalumab
26014|NCT03122509|Tremelimumab|tremelimumab
26015|NCT03122509|Radiation Therapy|radiation therapy
26016|NCT03122509|Ablation|ablation
26017|NCT03122509|17-139|17-139
26018|NCT03122496|Durvalumab (Medi4736)|durvalumab (medi4736)
26019|NCT03122496|Tremelimumab|tremelimumab
26020|NCT03122496|Image Guided Stereotactic Body Radiotherapy (SBRT)|image guided stereotactic body radiotherapy (sbrt)
17924|NCT03176485|HCC|hcc
26021|NCT03122496|17-108|17-108
26022|NCT03122470|TRUS biopsy|trus biopsy
26023|NCT03122470|Pelvic MRI|pelvic mri
26024|NCT03122457|Actinic Keratosis|actinic keratosis
26025|NCT03121430|peripheral arterial disease|peripheral arterial disease
26026|NCT03121430|Drug eluting peripheral vascular stent system|drug eluting peripheral vascular stent system
26027|NCT03121430|primary patency|primary patency
26028|NCT03121378|Hip Joint Alloplasty|hip joint alloplasty
26029|NCT03121378|Bone Cements|bone cements
26030|NCT03121378|Impedance Aggregometry|impedance aggregometry
26031|NCT03121378|Platelet Activation|platelet activation
26032|NCT03122366|single nucleotide polymorphisms|single nucleotide polymorphisms
26033|NCT03122366|Toll-like receptor-4|toll-like receptor-4
26034|NCT03122340|Acute Coronary Syndrome|acute coronary syndrome
26035|NCT03122340|Polyprenols|polyprenols
26036|NCT03122340|Cholesterol|cholesterol
26037|NCT03122314|paracetamol|paracetamol
26038|NCT03122314|dexketoprofen|dexketoprofen
26039|NCT03122314|emergency department|emergency department
26040|NCT03122314|musculoskeletal pain|musculoskeletal pain
26041|NCT03122275|Adherence|adherence
26042|NCT03122275|Directive Counseling|directive counseling
26043|NCT03122262|Antiretroviral Agents, first-line antiretroviral therapy|antiretroviral agents, first-line antiretroviral therapy
26044|NCT03122262|dolutegravir|dolutegravir
26045|NCT03122262|Tenofovir alafenamide|tenofovir alafenamide
26046|NCT03122249|Palliative care|palliative care
26047|NCT03122249|Symptom management|symptom management
26048|NCT03122249|Self-management|self-management
26049|NCT03122249|Rural area|rural area
26050|NCT03122249|eHealth|ehealth
26051|NCT03122249|telehealth|telehealth
26052|NCT03122223|HIV|hiv
26053|NCT03122158|major depressive disorder|major depressive disorder
26054|NCT03122158|anxiety disorders|anxiety disorders
26055|NCT03122158|adolescent|adolescent
26056|NCT03122158|child|child
26057|NCT03122145|healthy|healthy
26058|NCT03122145|volunteer|volunteer
26059|NCT03122132|Hepatitis C Infection|hepatitis c infection
26060|NCT03122132|Ombitasvir/Paritaprevir/Ritonavir+dasabuvir|ombitasvir/paritaprevir/ritonavir+dasabuvir
26061|NCT03122119|Sacroiliac|sacroiliac
26062|NCT03122119|Joint Injection|joint injection
26063|NCT03122119|Platelet Rich Plasma|platelet rich plasma
26064|NCT03122119|Ultrasound|ultrasound
26065|NCT03122119|Low Back Pain|low back pain
26066|NCT03122119|Corticosteroid|corticosteroid
26067|NCT03122093|pediatric|pediatric
26070|NCT03122093|T1D|t1d
26071|NCT03122080|acupuncture|acupuncture
26072|NCT03122080|insomnia|insomnia
26073|NCT03122080|depression|depression
26074|NCT03122080|antidepressants|antidepressants
26075|NCT03122067|oxytocin|oxytocin
26076|NCT03122067|social cognition|social cognition
26077|NCT03122067|fMRI|fmri
26078|NCT03122067|empathy|empathy
26079|NCT03122054|Laparoscopic Cholecystectomy, Delayed Cholecystectomy|laparoscopic cholecystectomy, delayed cholecystectomy
26080|NCT03122041|metformin intolerance|metformin intolerance
26081|NCT03122041|PCOS|pcos
26082|NCT03122041|Sitagliptin|sitagliptin
26083|NCT03122041|beta cell function|beta cell function
26084|NCT03122028|LAmbre|lambre
26085|NCT03122002|Ischemic Stroke|ischemic stroke
26086|NCT03122002|Cerebral Infarction|cerebral infarction
26087|NCT03122002|Cerebrovascular Disorders|cerebrovascular disorders
26088|NCT03121950|dementia|dementia
26089|NCT03121924|oocyte denudation|oocyte denudation
26090|NCT03121924|preincubation|preincubation
26091|NCT03121924|icsi|icsi
26092|NCT03121924|oocyte donation|oocyte donation
26093|NCT03121911|Recent Myocardial Infarction|recent myocardial infarction
26094|NCT03121911|Interval Physical Training|interval physical training
26095|NCT03121911|Inspiratory Muscle Training|inspiratory muscle training
26096|NCT03121911|Expiratory Flow Limitation|expiratory flow limitation
26097|NCT03121911|Ventilatory Efficiency|ventilatory efficiency
26098|NCT03121911|Inflammatory Markers|inflammatory markers
26099|NCT03121911|Heart Rate Variability|heart rate variability
26100|NCT03121859|TENS|tens
26101|NCT03121859|interferential current therapy|interferential current therapy
26102|NCT03121859|Chronic neck pain|chronic neck pain
26103|NCT03121846|Apatinib|apatinib
26104|NCT03121846|Soft Tissue Sarcoma|soft tissue sarcoma
26105|NCT03121833|Endostar|endostar
26106|NCT03121833|Soft Tissue Sarcoma|soft tissue sarcoma
26107|NCT03121833|Chemotherapy|chemotherapy
26108|NCT03121807|home parenteral nutrition|home parenteral nutrition
26109|NCT03121794|ultrasonography|ultrasonography
26110|NCT03121794|Intraosseous Vascular access|intraosseous vascular access
26111|NCT03121794|humerus|humerus
26112|NCT03121794|anatomic landmark|anatomic landmark
26113|NCT03121768|Prognostic Model|prognostic model
26114|NCT03121768|Bladder Cancer|bladder cancer
617227|NCT00651820|Santyl|santyl
26115|NCT03121768|Superficial Bladder Cancer|superficial bladder cancer
26116|NCT03121768|Recurrence|recurrence
26117|NCT03121768|Progression|progression
26119|NCT03121742|Suicide|suicide
26120|NCT03121729|enhanced recovery after surgery|enhanced recovery after surgery
26121|NCT03121729|gastric cancer|gastric cancer
26122|NCT03121664|Drug drug interaction, CYP3A4, itraconazole|drug drug interaction, cyp3a4, itraconazole
26123|NCT03121651|Mobile technology|mobile technology
26124|NCT03121651|Reinforcement-learning|reinforcement-learning
26125|NCT03121651|Medication management|medication management
26126|NCT03121638|Varicella Vaccine|varicella vaccine
26127|NCT03121638|Herpes Zoster Vaccine|herpes zoster vaccine
26128|NCT03121612|RDS|rds
26129|NCT03121248|Accelerated radiotherapy|accelerated radiotherapy
26130|NCT03121248|Older women|older women
26131|NCT03121248|Hypo-fractonation|hypo-fractonation
26132|NCT03121235|aspergillosis|aspergillosis
26133|NCT03121235|mycosis|mycosis
26134|NCT03121235|neutropenia|neutropenia
26135|NCT03121235|hematologic diseases|hematologic diseases
26136|NCT03121235|AsperGenius PCR|aspergenius pcr
26137|NCT03121235|Ambisome|ambisome
26138|NCT03121235|Voriconazole|voriconazole
26139|NCT03121196|Social deprivation|social deprivation
26140|NCT03121196|Adverse perinatal outcomes|adverse perinatal outcomes
26141|NCT03121183|Cardiology|cardiology
26142|NCT03121183|Device Removal|device removal
26143|NCT03121183|Pacemaker|pacemaker
26144|NCT03121183|Defibrillators|defibrillators
26145|NCT03121183|Catheterization|catheterization
26146|NCT03121183|Laser Therapy|laser therapy
26147|NCT03121183|Cost-Benefit Analysis|cost-benefit analysis
26148|NCT03121170|primary dysmenorrhea|primary dysmenorrhea
26149|NCT03121170|extracorporeal shock wave therapy|extracorporeal shock wave therapy
26150|NCT03121170|traditional Chinese medicine|traditional chinese medicine
26151|NCT03121157|African Americans|african americans
26152|NCT03121157|Emerging adults|emerging adults
26153|NCT03121157|Medication adherence|medication adherence
26154|NCT03121157|eHealth|ehealth
26155|NCT03121118|Mild Cognitive Impairment|mild cognitive impairment
26156|NCT03121118|Amyvid|amyvid
26157|NCT03121118|Amyloid Imaging|amyloid imaging
26158|NCT03121118|PET Brain Scan|pet brain scan
26159|NCT03121118|Amyloid Plaque|amyloid plaque
26160|NCT03121118|Ethics|ethics
26161|NCT03121118|Results disclosure|results disclosure
26162|NCT03121105|Idiopathic Inflammatory demyelinating disorders of the central nervous system|idiopathic inflammatory demyelinating disorders of the central nervous system
26163|NCT03121105|Multiple Sclerosis|multiple sclerosis
28675|NCT03105752|Volunteers|volunteers
26169|NCT03121079|prevention|prevention
26170|NCT03121079|hematopietic stem cell transplantation|hematopietic stem cell transplantation
26171|NCT03121079|acute myeloid leukemia|acute myeloid leukemia
26172|NCT03121066|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
26173|NCT03121066|Non invasive brain stimulation|non invasive brain stimulation
26174|NCT03121066|Theta Burst Protocol|theta burst protocol
26175|NCT03121066|Brain connectivity|brain connectivity
26176|NCT03121066|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
26177|NCT03121066|Parietal cortex|parietal cortex
26479|NCT03119363|light therapy|light therapy
26178|NCT03121053|transcatheter aortic valve implantation|transcatheter aortic valve implantation
26179|NCT03121053|transcatheter aortic valve replacement|transcatheter aortic valve replacement
26180|NCT03121040|Vespa amino acid mixture (VAAM®)|vespa amino acid mixture (vaam®)
26181|NCT03121040|Young athletes|young athletes
26182|NCT03121040|Nutrition|nutrition
26183|NCT03121040|lactic acid accumulation|lactic acid accumulation
26184|NCT03121040|Anaerobic metabolism|anaerobic metabolism
26185|NCT03121040|ATP|atp
26186|NCT03121040|Sports damage|sports damage
26187|NCT03121027|Anemia|anemia
26188|NCT03121027|Ever married women|ever married women
26189|NCT03121027|Economic inequality|economic inequality
26190|NCT03121027|Diabetes|diabetes
26191|NCT03121027|Maternity|maternity
26192|NCT03121027|BMI|bmi
26193|NCT03120988|Knee OA|knee oa
26194|NCT03120988|lavage|lavage
26195|NCT03120988|Platelet Poor Plasma (PPP)|platelet poor plasma (ppp)
26196|NCT03120975|Anti-Infective Agents|anti-infective agents
26197|NCT03120975|Decision Support Systems, Clinical|decision support systems, clinical
26198|NCT03120975|Quality Improvement|quality improvement
26199|NCT03120949|Rheumatoid Arthritis|rheumatoid arthritis
26200|NCT03120949|moderate|moderate
26201|NCT03120949|severe|severe
26202|NCT03120949|subcutaneous|subcutaneous
26203|NCT03120949|Olokizumab|olokizumab
26204|NCT03120949|open-label|open-label
26205|NCT03120936|Adherence|adherence
26206|NCT03120936|Transgender|transgender
26207|NCT03120936|PrEP|prep
26208|NCT03120936|HIV Prevention|hiv prevention
26209|NCT03120936|Truvada|truvada
26210|NCT03120936|HIV Risk Reduction|hiv risk reduction
26211|NCT03120923|subacromial injection|subacromial injection
26212|NCT03120871|Beta cell failure|beta cell failure
26213|NCT03120871|Puberty|puberty
26214|NCT03120871|Microbiome|microbiome
26215|NCT03120871|Insulin Sensitivity|insulin sensitivity
26216|NCT03120858|motor imagery|motor imagery
26217|NCT03120858|kinesthetic imagery|kinesthetic imagery
26218|NCT03120858|reliability|reliability
26219|NCT03120858|Turkish version|turkish version
26220|NCT03120845|Pain,|pain,
26221|NCT03120845|one-visit|one-visit
26222|NCT03120845|two visits|two visits
26223|NCT03120819|exercise|exercise
26224|NCT03120819|fatigue|fatigue
26225|NCT03120819|physical activity|physical activity
26226|NCT03120754|ERAS|eras
26227|NCT03120754|Peritoneal drainage|peritoneal drainage
26228|NCT03120754|Primary Closure|primary closure
26229|NCT03120741|Healthcare Quality|healthcare quality
26230|NCT03120728|Emergency contraception|emergency contraception
26231|NCT03120728|Contraceptive vaginal ring|contraceptive vaginal ring
26232|NCT03120728|NuvaRing|nuvaring
26233|NCT03120728|Contraception|contraception
26234|NCT03120715|low molecular weight heparin (LMWH)|low molecular weight heparin (lmwh)
26235|NCT03120715|frozen embryo transfer (FET)|frozen embryo transfer (fet)
26236|NCT03120715|pregnancy|pregnancy
26237|NCT03119662|Acute kidney injury (AKI)|acute kidney injury (aki)
26238|NCT03119662|Acute kidney injury network (AKIN)|acute kidney injury network (akin)
26239|NCT03119662|Chronic kidney disease (CKD)|chronic kidney disease (ckd)
26240|NCT03119662|Contrast-enhanced computed tomography (CECT)|contrast-enhanced computed tomography (cect)
26241|NCT03119662|Endovascular Aneurysm Repair (EVAR)|endovascular aneurysm repair (evar)
26242|NCT03119662|Iodixanol|iodixanol
26243|NCT03119662|Non-enhanced computed tomography (NECT)|non-enhanced computed tomography (nect)
26244|NCT03119662|Serum creatinine (SCr)|serum creatinine (scr)
26245|NCT03119623|Heart Failure|heart failure
26246|NCT03119623|Endothelial function|endothelial function
26247|NCT03119623|Brachial Artery Reactivity Test|brachial artery reactivity test
26248|NCT03119623|Sacubitril/Valsartan|sacubitril/valsartan
26249|NCT03119623|Enalapril|enalapril
26250|NCT03119623|HFREF|hfref
26251|NCT03120689|VITOM|vitom
26252|NCT03120689|Adult learners|adult learners
26253|NCT03120689|Medical students|medical students
26254|NCT03120689|Residents|residents
26255|NCT03120689|Vaginal surgery|vaginal surgery
26256|NCT03120689|Medical education|medical education
26257|NCT03120676|Relapsed|relapsed
26258|NCT03120676|Refractory|refractory
26259|NCT03120676|Atezolizumab|atezolizumab
26260|NCT03120676|17-191|17-191
26261|NCT03120663|antimicrobials|antimicrobials
26262|NCT03120663|pharmacokinetics|pharmacokinetics
26263|NCT03120663|augmented renal clearance|augmented renal clearance
26264|NCT03120663|non critically ill|non critically ill
26265|NCT03120637|Methylene Blue|methylene blue
26266|NCT03120637|Septic Shock|septic shock
26267|NCT03120637|Vasoplegia|vasoplegia
26268|NCT03120637|Cirrhosis|cirrhosis
26269|NCT03120611|Exercise|exercise
26270|NCT03120611|Hemodialysis|hemodialysis
26271|NCT03120611|Virtual Reality|virtual reality
26272|NCT03120598|preparation strategies|preparation strategies
26273|NCT03120598|implementation strategies|implementation strategies
26274|NCT03120598|sustainment strategies|sustainment strategies
26275|NCT03120585|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
26276|NCT03120585|fluid restriction|fluid restriction
26277|NCT03120572|Respiratory muscle strength|respiratory muscle strength
26278|NCT03120572|Diaphragmatic surface electromyography|diaphragmatic surface electromyography
26279|NCT03120572|Functional capacity|functional capacity
26280|NCT03120559|Gingivitis|gingivitis
26281|NCT03120559|SMS|sms
26282|NCT03120559|Dental floss|dental floss
26283|NCT03120559|behavior change|behavior change
26284|NCT03120559|HAPA|hapa
26285|NCT03120546|cervical spine motion|cervical spine motion
26286|NCT03120546|video laryngoscope|video laryngoscope
26287|NCT03120546|rigid video stylet|rigid video stylet
26288|NCT03120533|iontophoresis|iontophoresis
26289|NCT03120533|treprostinil|treprostinil
26290|NCT03120507|in-hospital cardiac arrest|in-hospital cardiac arrest
26291|NCT03120507|IHCA|ihca
26292|NCT03120507|quality of life|quality of life
26293|NCT03120507|QoL|qol
26294|NCT03120507|patient-reported outcomes|patient-reported outcomes
26295|NCT03120494|HIV prevention, high risk MSM, sero-discordant couples, PrEP|hiv prevention, high risk msm, sero-discordant couples, prep
26296|NCT03120468|alcohol, alcohol dependence, addiction, alcohol use disorder|alcohol, alcohol dependence, addiction, alcohol use disorder
26297|NCT03120455|weight loss|weight loss
26298|NCT03120455|Almond|almond
26299|NCT03120455|Pistachio|pistachio
26300|NCT03120455|hypoenergetic diet|hypoenergetic diet
26301|NCT03120455|Nut|nut
26302|NCT03120442|postoperative delirium|postoperative delirium
26303|NCT03120442|total knee arthroplasty|total knee arthroplasty
26304|NCT03120442|propofol|propofol
26305|NCT03120442|dexmedetomidine|dexmedetomidine
26306|NCT03120442|fentanyl|fentanyl
617328|NCT00652262|Vardenafil|vardenafil
26307|NCT03120442|inflammatory response|inflammatory response
26308|NCT03120442|interleukins|interleukins
26309|NCT03120442|CAM-ICU|cam-icu
26310|NCT03120429|lean fish|lean fish
26311|NCT03120429|weight loss|weight loss
26312|NCT03120429|Diet|diet
26313|NCT03120364|Herpes Zoster Vaccine|herpes zoster vaccine
26314|NCT03120364|Prevention of Herpes Zoster|prevention of herpes zoster
18256|NCT03174197|GBM|gbm
26315|NCT03120338|Child and Adolescent|child and adolescent
26316|NCT03120338|Randomised Controlled Trial|randomised controlled trial
26317|NCT03120338|Paediatrics|paediatrics
26318|NCT03120338|DAWBA|dawba
26319|NCT03120338|eHealth Services|ehealth services
26320|NCT03120312|outcome|outcome
26321|NCT03120286|OBESITY|obesity
26322|NCT03120286|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
26323|NCT03120286|Polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
26324|NCT03120260|Caloric Restriction|caloric restriction
26325|NCT03120260|weight loss|weight loss
26326|NCT03120260|sleep|sleep
26327|NCT03120221|Pregnancy|pregnancy
26328|NCT03120221|Iodine deficiency|iodine deficiency
26329|NCT03120221|Thyroid|thyroid
26330|NCT03120208|Postpartum psychological disorders|postpartum psychological disorders
26331|NCT03120208|immediate postpartum hemorrhage.|immediate postpartum hemorrhage.
26332|NCT03120182|aspirin|aspirin
26333|NCT03120182|bleeding risk|bleeding risk
26334|NCT03120182|intracranial bleeding|intracranial bleeding
26335|NCT03120182|burr-hole drainage|burr-hole drainage
26336|NCT03120182|chronic subdural hematoma|chronic subdural hematoma
26337|NCT03120182|anticoagulation|anticoagulation
26338|NCT03120169|COPD|copd
26339|NCT03120169|exercise|exercise
26340|NCT03120169|training|training
26341|NCT03120169|cycling|cycling
26342|NCT03120169|treadmill|treadmill
26343|NCT03120169|walking|walking
26344|NCT03120169|pulmonary rehabilitation|pulmonary rehabilitation
26345|NCT03120156|sensomotoric insoles|sensomotoric insoles
26346|NCT03120156|postural control|postural control
26347|NCT03120156|proprioceptive insoles|proprioceptive insoles
26348|NCT03120156|insoles|insoles
26349|NCT03120143|Small-sided ball games|small-sided ball games
26350|NCT03120143|Aging|aging
26351|NCT03120143|Muscle mass|muscle mass
26352|NCT03120143|Health|health
26353|NCT03120143|Training|training
26354|NCT03120143|Protein intake|protein intake
26355|NCT03120143|Physical function|physical function
26356|NCT03120143|Physiological adaptations|physiological adaptations
26359|NCT03120078|Ultrasound|ultrasound
26360|NCT03120065|adherence|adherence
26361|NCT03120013|Transcranial direct current stimulation|transcranial direct current stimulation
26362|NCT03120013|Transcranial magnetic stimulation|transcranial magnetic stimulation
26363|NCT03120013|Spinocerebellar ataxia|spinocerebellar ataxia
26364|NCT03120013|Cerebellar ataxia|cerebellar ataxia
26366|NCT03119987|Red cell Distribution Width|red cell distribution width
26367|NCT03119987|Risk|risk
26368|NCT03119987|Mortality|mortality
26369|NCT03119987|Hemorrhage|hemorrhage
26371|NCT03119974|TPO-RAS|tpo-ras
26372|NCT03119974|Thrombopoietin-receptor agonists|thrombopoietin-receptor agonists
26373|NCT03119961|Amyloid Amyloid Plaque|amyloid amyloid plaque
26374|NCT03119961|Tau Protein|tau protein
26375|NCT03119961|Sonication|sonication
26376|NCT03119948|Muscle spasticity|muscle spasticity
26377|NCT03119948|Botulinum toxin|botulinum toxin
26378|NCT03119935|ambu bag, ventilation, tidal volume|ambu bag, ventilation, tidal volume
26379|NCT03119922|major sickle cell disease (SCD)|major sickle cell disease (scd)
26380|NCT03119922|children|children
26381|NCT03119922|pneumococcal preventive measures|pneumococcal preventive measures
26382|NCT03119909|fMRI|fmri
26383|NCT03119909|cingulate cortex|cingulate cortex
26384|NCT03119909|adaptation|adaptation
26385|NCT03119909|frontal cortex|frontal cortex
26386|NCT03119896|chronic pain|chronic pain
26387|NCT03119896|self-management|self-management
26388|NCT03119896|pain management|pain management
26389|NCT03119896|doctor patient communication|doctor patient communication
26390|NCT03119896|primary care|primary care
26391|NCT03119883|Myeloma|myeloma
26392|NCT03119883|Metabolism|metabolism
26393|NCT03119883|Glutamine|glutamine
26394|NCT03119870|fMRI|fmri
26395|NCT03119870|EEG|eeg
26396|NCT03119870|behavior|behavior
26397|NCT03119870|cingulate cortex|cingulate cortex
26398|NCT03119857|Non-metastatic Prostate Cancer|non-metastatic prostate cancer
26399|NCT03119831|chlorhexidine|chlorhexidine
26400|NCT03119831|alcohol|alcohol
26401|NCT03119831|C31G|c31g
26402|NCT03119831|Mouthrinses|mouthrinses
26403|NCT03119831|Early postsurgical wound healing|early postsurgical wound healing
26404|NCT03119818|ESRD|esrd
26405|NCT03119818|hemodialysis|hemodialysis
26406|NCT03119818|phosphate|phosphate
26407|NCT03119818|ATP|atp
26408|NCT03119818|magnetic resonance spectroscopy|magnetic resonance spectroscopy
26409|NCT03119805|composite scores|composite scores
26410|NCT03119805|patient reported outcomes|patient reported outcomes
26411|NCT03119805|patient perpective|patient perpective
26412|NCT03119805|physician perspective|physician perspective
26413|NCT03119805|cut-off values|cut-off values
26414|NCT03119805|flare|flare
26415|NCT03119805|remission|remission
26416|NCT03119805|minimal disease activity|minimal disease activity
26417|NCT03119805|low disease activity|low disease activity
26418|NCT03119792|Behavioral Modification|behavioral modification
26419|NCT03119792|Health Community|health community
26420|NCT03119792|Community Intervention|community intervention
26421|NCT03119792|Prevention|prevention
26422|NCT03119792|Cardiovascular Health|cardiovascular health
26423|NCT03119792|Education Intervention|education intervention
26424|NCT03119792|Colombia|colombia
26425|NCT03119779|pulpotomy|pulpotomy
26426|NCT03119779|deep caries|deep caries
26427|NCT03119779|permanent molars|permanent molars
26428|NCT03119779|MTA|mta
26429|NCT03119753|Rapid Prototyping technique|rapid prototyping technique
26430|NCT03119753|complete denture|complete denture
26431|NCT03119714|bronchoprovocation|bronchoprovocation
26432|NCT03119714|early-late asthmatic reaction|early-late asthmatic reaction
26433|NCT03119714|mast cell stabilizer|mast cell stabilizer
26434|NCT03119714|mast cell mediators|mast cell mediators
26435|NCT03119714|sputum eosinophils|sputum eosinophils
26436|NCT03119701|Patients Surviving Open Surgery|patients surviving open surgery
26437|NCT03119701|Ruptured Abdominal Aortic Aneurysm|ruptured abdominal aortic aneurysm
26438|NCT03119675|Myopia|myopia
26439|NCT03119675|Hyperopia|hyperopia
26440|NCT03119675|Anisometropia|anisometropia
26441|NCT03119675|Amblyopia Risk Factors|amblyopia risk factors
26442|NCT03119675|Risk Factors|risk factors
26443|NCT03119675|Smartphone Application (App)|smartphone application (app)
26444|NCT03119675|Photoscreening|photoscreening
26445|NCT03119675|Vision Screening|vision screening
26446|NCT03119675|Mobile Vision Screening|mobile vision screening
26447|NCT03119597|low mood, depression|low mood, depression
26448|NCT03119584|chronic constipation, diabetes|chronic constipation, diabetes
26449|NCT03119571|Cardiac arrest|cardiac arrest
26450|NCT03119571|Ventricular fibrillation|ventricular fibrillation
26451|NCT03119571|coronary artery disease|coronary artery disease
26452|NCT03119545|intervention|intervention
26453|NCT03119545|support program|support program
28982|NCT03104101|TPTNS|tptns
26456|NCT03119519|NSCLC|nsclc
26457|NCT03119519|Oligometastases|oligometastases
26458|NCT03119519|radiotherapy|radiotherapy
26459|NCT03119493|Metabolic syndrome X|metabolic syndrome x
26460|NCT03119493|Autonomic nervous system|autonomic nervous system
26461|NCT03119493|Aerobic exercise|aerobic exercise
26462|NCT03119493|Exercise|exercise
26463|NCT03119493|Heart rate|heart rate
26464|NCT03119480|Acute Kidney Injury|acute kidney injury
26465|NCT03119480|Electronic alerts|electronic alerts
26466|NCT03119402|Reading|reading
26467|NCT03119402|Developmental Dyslexia|developmental dyslexia
26468|NCT03119402|Music|music
26469|NCT03119402|Rhythm|rhythm
26470|NCT03119402|transcranial electrical stimulation|transcranial electrical stimulation
26471|NCT03119402|transcranial direct current stimulation|transcranial direct current stimulation
26472|NCT03119389|Hand Hygiene|hand hygiene
26473|NCT03119389|Non-sterile glove use|non-sterile glove use
26474|NCT03119376|peer review|peer review
26475|NCT03119376|online tool|online tool
26476|NCT03119376|Randomized Controlled Trial|randomized controlled trial
26477|NCT03119363|cancer-related fatigue|cancer-related fatigue
26478|NCT03119363|circadian rhythms|circadian rhythms
26480|NCT03119363|systematic light exposure|systematic light exposure
26481|NCT03119363|cancer survivors|cancer survivors
26482|NCT03119363|oncology|oncology
26483|NCT03119363|Multiple Myeloma|multiple myeloma
26484|NCT03119363|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
26485|NCT03119363|Autologous stem cell transplantation|autologous stem cell transplantation
26486|NCT03119337|male circumcision, text-based follow-up, Zimbabwe,|male circumcision, text-based follow-up, zimbabwe,
26487|NCT03119324|Biomodulation|biomodulation
26488|NCT03119324|LLLT|lllt
26489|NCT03119324|Temporomandibular Joint Disorders|temporomandibular joint disorders
26490|NCT03119324|Pain management|pain management
26491|NCT03119285|ovarian cancer|ovarian cancer
26492|NCT03119285|BRCA1|brca1
26493|NCT03119285|BRCA2|brca2
26494|NCT03119285|BROCA|broca
26495|NCT03119246|beta testing|beta testing
26496|NCT03119246|assessment battery|assessment battery
26498|NCT03119207|ICU|icu
26499|NCT03119168|screening|screening
26500|NCT03119168|adenoma detection rate|adenoma detection rate
26501|NCT03119168|simethicone|simethicone
26502|NCT03119155|Congenital Heart Disease|congenital heart disease
26503|NCT03119155|Echocardiography|echocardiography
26504|NCT03119155|Diagnosis|diagnosis
26505|NCT03119129|prevention|prevention
26506|NCT03119129|health disparities|health disparities
26507|NCT03119129|Native Hawaiians and other Pacific Islanders|native hawaiians and other pacific islanders
26508|NCT03119116|Stroke Prevention in NVAF patients|stroke prevention in nvaf patients
26509|NCT03119103|respiratory pattern|respiratory pattern
26510|NCT03119103|sensor data|sensor data
26511|NCT03119103|bed sheet|bed sheet
26512|NCT03119103|pressure|pressure
26513|NCT03119103|respiration rate|respiration rate
26514|NCT03119090|biomarkers|biomarkers
26515|NCT03119090|Fontan operation|fontan operation
26516|NCT03119090|Single ventricle|single ventricle
26517|NCT03119090|congenital heart disease|congenital heart disease
26518|NCT03119077|PCOS|pcos
26519|NCT03119051|mild cognitive impairment|mild cognitive impairment
26520|NCT03119038|total hip|total hip
26521|NCT03119038|degenerative joint disease|degenerative joint disease
26522|NCT03119038|osteoarthritis|osteoarthritis
26523|NCT03119025|Dendritic Cells|dendritic cells
26524|NCT03119025|DC-based Vaccines|dc-based vaccines
26525|NCT03119025|Chronic HCV Infection|chronic hcv infection
26526|NCT03119025|Antigen-Specific T cell response|antigen-specific t cell response
26527|NCT03119025|Recombinant HCV-Core antigen|recombinant hcv-core antigen
26528|NCT03119025|Recombinant HCV-NS3 antigen|recombinant hcv-ns3 antigen
26529|NCT03119012|Bioresorbable scaffold|bioresorbable scaffold
26530|NCT03119012|Dual antiplatelet therapy|dual antiplatelet therapy
26531|NCT03119012|P2Y12 receptor inhibitor|p2y12 receptor inhibitor
26532|NCT03119012|Coronary artery disease|coronary artery disease
26533|NCT03118986|olanzapine|olanzapine
26534|NCT03118986|vomiting|vomiting
26535|NCT03118986|children|children
26536|NCT03118986|adolescents|adolescents
26537|NCT03118986|bone marrow transplant|bone marrow transplant
26538|NCT03118986|supportive care|supportive care
26539|NCT03118934|contact lenses|contact lenses
26540|NCT03118934|presbyopia|presbyopia
26541|NCT03118934|multifocal|multifocal
26542|NCT03118908|Succinate|succinate
26543|NCT03118908|B complex vitamins|b complex vitamins
26544|NCT03118908|menopause|menopause
26545|NCT03118882|Breast cancer screening|breast cancer screening
26546|NCT03118882|Colorectal Cancer screening|colorectal cancer screening
26547|NCT03118882|Primary prevention|primary prevention
26548|NCT03118882|Lifestyles|lifestyles
26549|NCT03118882|Teachable moment|teachable moment
26550|NCT03118869|Asthma|asthma
29084|NCT03103269|Self efficacy|self efficacy
26551|NCT03118869|B2 adrenergic receptors|b2 adrenergic receptors
26552|NCT03118869|Polymorphism|polymorphism
26554|NCT03118804|Mechanical ventilation|mechanical ventilation
26555|NCT03118804|Electrical impedance tomography|electrical impedance tomography
26556|NCT03118804|Tidal distribution|tidal distribution
26557|NCT03118778|Stress Ulcer Prevention|stress ulcer prevention
26558|NCT03118726|LARC|larc
26559|NCT03118726|New Mexico|new mexico
26560|NCT03118726|Contraception|contraception
26561|NCT03118713|Glimepride|glimepride
26562|NCT03118713|Metformin|metformin
26563|NCT03118713|Ipragliflozin|ipragliflozin
26564|NCT03118713|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
26565|NCT03118713|ASP1941|asp1941
26566|NCT03118687|Immune system|immune system
26567|NCT03118674|Interventional, Open-label, PCT, Hepatitis C|interventional, open-label, pct, hepatitis c
26568|NCT03118648|upper limb|upper limb
26569|NCT03118648|functional recovery|functional recovery
26570|NCT03118648|activities of daily living|activities of daily living
26571|NCT03118635|Summer|summer
26572|NCT03118635|Diet|diet
26573|NCT03118635|Physical Activity|physical activity
26574|NCT03118635|Sedentary behavior|sedentary behavior
26575|NCT03118635|Low-income|low-income
26576|NCT03118609|Caregivers|caregivers
26577|NCT03118609|Chronic Pain|chronic pain
26578|NCT03118596|intubation|intubation
26579|NCT03118596|tracheal|tracheal
26580|NCT03118596|airway device|airway device
26581|NCT03118596|supra-glottic airway device|supra-glottic airway device
26582|NCT03118596|fibreoptic scope|fibreoptic scope
26583|NCT03118570|Osteogenesis Imperfecta|osteogenesis imperfecta
26584|NCT03118570|Brittle Bone Disease|brittle bone disease
26585|NCT03118557|pelvic floor|pelvic floor
26586|NCT03118557|strengthening|strengthening
26588|NCT03118557|urinary|urinary
26589|NCT03118557|incontinence|incontinence
26590|NCT03118544|Chronic Total Occlusion|chronic total occlusion
26591|NCT03118544|Coronary Artery Disease|coronary artery disease
26592|NCT03118544|Percutaneous Coronary Intervention|percutaneous coronary intervention
26593|NCT03118544|CTO|cto
26594|NCT03118544|PCI|pci
26595|NCT03118531|Long Lesion|long lesion
26596|NCT03118531|In-stent Late Lumen Loss (LLL)|in-stent late lumen loss (lll)
26597|NCT03118531|Major Adverse Cardiac Events (MACE)|major adverse cardiac events (mace)
26598|NCT03118531|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
26599|NCT03118531|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
26600|NCT03118531|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
26601|NCT03118531|Target Vessel Failure (TVF)|target vessel failure (tvf)
26602|NCT03118531|Target Lesion Failure (TLF)|target lesion failure (tlf)
26603|NCT03118531|Stent Thrombosis (ST)|stent thrombosis (st)
26604|NCT03118479|IHH|ihh
26605|NCT03118479|KS|ks
26606|NCT03118479|Idiopathic hypogonadotropic hypogonadism|idiopathic hypogonadotropic hypogonadism
26607|NCT03118479|GnRH deficiency|gnrh deficiency
26608|NCT03118466|AML|aml
26609|NCT03118453|Musculoskeletal pain/*therapy|musculoskeletal pain/*therapy
26610|NCT03118453|Behavioral medicine|behavioral medicine
26611|NCT03118453|Physical therapy|physical therapy
26612|NCT03118453|Cost-benefit analyses|cost-benefit analyses
26613|NCT03118453|Treatment outcome|treatment outcome
26614|NCT03118453|Adults|adults
26615|NCT03118440|Fluoroscopy|fluoroscopy
26616|NCT03118440|Pacemaker|pacemaker
26617|NCT03118440|Three dimensional|three dimensional
26618|NCT03118440|Radiation|radiation
26619|NCT03118440|Imaging|imaging
26620|NCT03118427|Fluoroscopy|fluoroscopy
26621|NCT03118427|Pacemaker|pacemaker
26622|NCT03118427|Three dimensional|three dimensional
26623|NCT03118427|Radiation|radiation
26624|NCT03118427|Imaging|imaging
26625|NCT03118414|Balance|balance
26626|NCT03118414|Cognition|cognition
26627|NCT03118414|Exercise|exercise
26628|NCT03118362|Burns|burns
26629|NCT03118362|Critically ill|critically ill
26630|NCT03118362|Acid-Base status|acid-base status
26631|NCT03118349|CA19-9 Positive Malignancies|ca19-9 positive malignancies
26632|NCT03118323|willingness topay|willingness topay
26633|NCT03118323|WTP|wtp
26634|NCT03118323|health economic|health economic
26635|NCT03118323|preference-based measures|preference-based measures
26636|NCT03118310|Reduction of liver fat|reduction of liver fat
26637|NCT03118297|Etonogestrel Implant|etonogestrel implant
26638|NCT03118284|Foley catheter|foley catheter
26639|NCT03118271|lumbar disc herniation|lumbar disc herniation
26640|NCT03118271|lumbar traction|lumbar traction
26641|NCT03118271|spinal manipulation|spinal manipulation
26642|NCT03118271|lumbar surgery|lumbar surgery
26643|NCT03118258|Vaginal HPV self-sampling|vaginal hpv self-sampling
26644|NCT03118258|Pap test smear|pap test smear
26645|NCT03118258|cervical cancer screening|cervical cancer screening
26646|NCT03118258|deprivation|deprivation
26647|NCT03118258|sexual and reproductive health|sexual and reproductive health
26648|NCT03118258|Precariousness|precariousness
26649|NCT03118232|Nursing Homes|nursing homes
26650|NCT03118232|Health Facilities|health facilities
26651|NCT03118232|Infections|infections
26652|NCT03118232|Readmissions|readmissions
26653|NCT03118232|Multi-Drug resistance|multi-drug resistance
26654|NCT03118232|Antibiotic Use|antibiotic use
26655|NCT03118219|assisted reproductive technology|assisted reproductive technology
26656|NCT03118219|embryo transfer|embryo transfer
26657|NCT03118219|online intervention|online intervention
26659|NCT03118206|Lumbar spinal stenosis|lumbar spinal stenosis
26660|NCT03118206|spinal manipulation|spinal manipulation
26661|NCT03118206|physical therapy|physical therapy
26662|NCT03118206|surgery|surgery
26663|NCT03118193|depression|depression
26664|NCT03118193|antidepressant|antidepressant
26665|NCT03118193|resistance|resistance
26666|NCT03118167|Acrylamide|acrylamide
26667|NCT03118167|Tea polyphenols|tea polyphenols
26668|NCT03118167|Water-soluble antioxidant of bamboo leaves|water-soluble antioxidant of bamboo leaves
26669|NCT03118154|endometriosis|endometriosis
26670|NCT03118154|pelvic pain|pelvic pain
26671|NCT03118154|dysmenorrhea|dysmenorrhea
26672|NCT03118141|preimplantation genetic screening|preimplantation genetic screening
26673|NCT03118141|single embryo transfer|single embryo transfer
26674|NCT03118141|frozen embryo transfer|frozen embryo transfer
26675|NCT03118141|cumulative live birth rate|cumulative live birth rate
26676|NCT03118128|Acute Lymphoblastic Leukemia (ALL), ABCB1, Metformin|acute lymphoblastic leukemia (all), abcb1, metformin
26677|NCT03118115|bioimpedance|bioimpedance
26678|NCT03118115|thrombosis|thrombosis
26679|NCT03118115|free flap|free flap
26680|NCT03118115|microsurgerie|microsurgerie
26681|NCT03118115|breast reconstruction|breast reconstruction
26682|NCT03118089|Oral nutritional supplements|oral nutritional supplements
26683|NCT03118037|Radiofrequency Ablation|radiofrequency ablation
26684|NCT03118024|deep inferior epigastric perforator flap|deep inferior epigastric perforator flap
26685|NCT03118024|fluid restriction|fluid restriction
26686|NCT03118024|catecholamine restriction|catecholamine restriction
26687|NCT03118011|Tobacco use, withdrawal symptoms|tobacco use, withdrawal symptoms
26688|NCT03117985|HIV reservoirs|hiv reservoirs
26689|NCT03117985|HIV persistence|hiv persistence
26690|NCT03117985|Viral rebound|viral rebound
26691|NCT03117972|Metastatic colorectal cancer|metastatic colorectal cancer
26692|NCT03117972|Biomarker|biomarker
26693|NCT03117972|Chemotherapy intensification|chemotherapy intensification
26694|NCT03117972|Syndecan1|syndecan1
26696|NCT03117972|CD138|cd138
26697|NCT03117946|immunomonitoring|immunomonitoring
26698|NCT03117946|immune checkpoint|immune checkpoint
26699|NCT03117946|chemoradiation|chemoradiation
26700|NCT03117946|T cells|t cells
26701|NCT03117933|BRCA1/2 mutation|brca1/2 mutation
26702|NCT03117933|Platinum resistance|platinum resistance
26708|NCT03117881|Yoga|yoga
26709|NCT03117881|Pilates|pilates
26710|NCT03117881|Telerehabilitation|telerehabilitation
26711|NCT03117881|Physical activity|physical activity
26712|NCT03117842|Female entertainment workers|female entertainment workers
26713|NCT03117842|mHealth|mhealth
26714|NCT03117842|HIV testing|hiv testing
26715|NCT03117842|Cambodia|cambodia
26716|NCT03117816|deep molecular remission of MR4 or better|deep molecular remission of mr4 or better
26717|NCT03117803|Aneurysm, Intracranial|aneurysm, intracranial
26718|NCT03117803|Registries|registries
26719|NCT03117803|Multicenter Studies|multicenter studies
26720|NCT03117803|People's Republic of China|people's republic of china
26721|NCT03117790|elderly|elderly
26722|NCT03117790|surgery|surgery
26723|NCT03117790|analgesia|analgesia
26724|NCT03117790|dexmedetomidine|dexmedetomidine
26725|NCT03117790|sleep quality|sleep quality
26726|NCT03117751|Leukemia|leukemia
26727|NCT03117751|Lymphoma|lymphoma
26728|NCT03117751|Pediatric|pediatric
26729|NCT03117751|B-Cell|b-cell
26730|NCT03117751|T-Cell|t-cell
26731|NCT03117725|oxidative stress|oxidative stress
26732|NCT03117725|antioxidants|antioxidants
26733|NCT03117725|diminished ovarian reserve|diminished ovarian reserve
26734|NCT03117712|cerebral blood supply|cerebral blood supply
26735|NCT03117712|cardiopulmonary bypass|cardiopulmonary bypass
26736|NCT03117712|open-heart cardiac surgery|open-heart cardiac surgery
26737|NCT03117699|Hemiplegia|hemiplegia
26738|NCT03117699|transport device|transport device
26739|NCT03117673|right ventricular systolic pressure (RVSP)|right ventricular systolic pressure (rvsp)
26740|NCT03117673|Transesophageal echocardiography|transesophageal echocardiography
26741|NCT03117634|anti vegf|anti vegf
26742|NCT03117634|aflibercept|aflibercept
26743|NCT03117634|treat and extend|treat and extend
26744|NCT03117621|Blincyto|blincyto
26746|NCT03117608|aMAT|amat
26747|NCT03117608|PRP|prp
26753|NCT03117582|C. diff|c. diff
26754|NCT03117582|CDI|cdi
26755|NCT03117582|Clostridium Difficile Infection|clostridium difficile infection
26756|NCT03117582|Diarrhea|diarrhea
26757|NCT03117582|Fecal microbiota transplantation|fecal microbiota transplantation
26758|NCT03117582|FMT|fmt
26759|NCT03117543|Screening|screening
26760|NCT03117530|minocycline|minocycline
26761|NCT03117530|brain inflammation|brain inflammation
26762|NCT03117530|microglia|microglia
26764|NCT03117517|PCOS|pcos
26765|NCT03117504|Stress urinary incontinence|stress urinary incontinence
26766|NCT03117504|SUI|sui
26767|NCT03117491|Gow-Gates nerve block|gow-gates nerve block
26768|NCT03117491|Inferior alveolar nerve block|inferior alveolar nerve block
26769|NCT03117491|local anesthesia|local anesthesia
26770|NCT03117491|molar|molar
26771|NCT03117491|pulpitis|pulpitis
26772|NCT03117452|schizophrenia|schizophrenia
26773|NCT03117452|visual processing|visual processing
26774|NCT03117452|cognitive training|cognitive training
26775|NCT03117452|visual training|visual training
26776|NCT03117426|Symfony Extended Range of Vision IOL|symfony extended range of vision iol
26777|NCT03117426|AT LISA tri 839MP IOL|at lisa tri 839mp iol
26778|NCT03117426|Trifocal IOL|trifocal iol
26782|NCT03117413|Auditory cortex|auditory cortex
26783|NCT03117413|Auditory plasticity|auditory plasticity
26784|NCT03117413|Tinnitus|tinnitus
26785|NCT03117361|multiple myeloma|multiple myeloma
26786|NCT03117361|plitidepsin|plitidepsin
26787|NCT03117361|Aplidin|aplidin
26788|NCT03117348|Enteral Nutrition|enteral nutrition
26789|NCT03117348|Digestive System Neoplasms|digestive system neoplasms
26790|NCT03117348|Randomized Controlled Trial|randomized controlled trial
26791|NCT03117348|Clinical Outcomes|clinical outcomes
26792|NCT03117335|Non-small Cell Lung Cancer|non-small cell lung cancer
26793|NCT03117335|Sulijia|sulijia
26794|NCT03117335|Recombinant endostatin|recombinant endostatin
26795|NCT03117335|Vinorelbine|vinorelbine
26796|NCT03117335|Cisplatin|cisplatin
26797|NCT03117322|cerebral palsy|cerebral palsy
26798|NCT03117322|children|children
26799|NCT03117322|chronic constipation|chronic constipation
26800|NCT03117322|synbiotic|synbiotic
26801|NCT03117322|prebiotics|prebiotics
26802|NCT03117322|probiotics|probiotics
26803|NCT03117322|agave inulin|agave inulin
26804|NCT03117322|microbiota|microbiota
26805|NCT03117309|Nivolumab|nivolumab
26806|NCT03117309|Ipilimumab|ipilimumab
26807|NCT03117309|OPDIVO|opdivo
26808|NCT03117309|IgG1 kappa immunoglobulin|igg1 kappa immunoglobulin
26809|NCT03117296|physical therapy|physical therapy
26810|NCT03117296|occupational therapy|occupational therapy
26811|NCT03117296|tAVR|tavr
26812|NCT03117283|Laparoscopic surgery|laparoscopic surgery
26813|NCT03117283|Radical total gastrectomy|radical total gastrectomy
26814|NCT03117283|Bursectomy|bursectomy
26815|NCT03117283|Advanced posterior gastric wall cancer|advanced posterior gastric wall cancer
26816|NCT03117257|Lobaplatin|lobaplatin
26817|NCT03117257|head and neck cancer|head and neck cancer
26818|NCT03117257|chronic-chemotherapy|chronic-chemotherapy
26819|NCT03117231|osteoarthritis|osteoarthritis
26820|NCT03117231|elderly|elderly
26821|NCT03117231|musculoskeletal pain|musculoskeletal pain
26822|NCT03117231|transcranial direct current stimulation|transcranial direct current stimulation
26823|NCT03117192|zinc supplementation|zinc supplementation
26824|NCT03117192|immunity|immunity
26825|NCT03117192|thalassemia|thalassemia
26826|NCT03117166|lidocaine implantation ICD|lidocaine implantation icd
26827|NCT03117140|Brachial Plexus Block|brachial plexus block
26828|NCT03117140|Clonidine|clonidine
26829|NCT03117140|Dexamethasone|dexamethasone
18727|NCT03170726|Preemptive intravenous ibuprofen|preemptive intravenous ibuprofen
18728|NCT03170726|Intraoperative analgesia|intraoperative analgesia
18731|NCT03170713|trismus|trismus
26830|NCT03117140|Buprenorphine|buprenorphine
26831|NCT03117114|colonoscopy|colonoscopy
26832|NCT03117114|polyp|polyp
26833|NCT03117114|resection|resection
26834|NCT03117101|Tolerability Pharmacokinetics|tolerability pharmacokinetics
26835|NCT03117088|Standardized handover|standardized handover
26836|NCT03117088|Online-based|online-based
26837|NCT03117088|SOFA-Score|sofa-score
26838|NCT03117088|ICU|icu
26839|NCT03117088|ISBAR3|isbar3
26840|NCT03117075|cancer pain, wearable device|cancer pain, wearable device
26841|NCT03117036|lymphoma|lymphoma
26842|NCT03117036|cohort|cohort
26843|NCT03117036|serum|serum
26844|NCT03117036|cell-free DNA|cell-free dna
26845|NCT03117023|dexmedetomidine|dexmedetomidine
26846|NCT03117023|sleep deprivation|sleep deprivation
26847|NCT03117023|gastric cancer|gastric cancer
26848|NCT03117023|middle-aged and elderly patient|middle-aged and elderly patient
26849|NCT03117010|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
26850|NCT03116997|neuromuscular blockade|neuromuscular blockade
26851|NCT03116997|sugammadex|sugammadex
26852|NCT03116997|SUG|sug
26853|NCT03116997|neostigmine|neostigmine
26854|NCT03116997|NEO/GLYCO|neo/glyco
26855|NCT03116997|17-207|17-207
26856|NCT03116984|Hepatocellular Carcinoma|hepatocellular carcinoma
26857|NCT03116984|external- beam radiotherapy (EBRT)|external- beam radiotherapy (ebrt)
26858|NCT03116984|transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
26860|NCT03116958|CPAP compliance|cpap compliance
26861|NCT03116958|Telemedicine integrated platform|telemedicine integrated platform
26862|NCT03116958|Standard management|standard management
26863|NCT03116958|Cost-effectiveness|cost-effectiveness
26864|NCT03116945|PET/CT|pet/ct
26865|NCT03116945|68Gallium Citrate|68gallium citrate
26866|NCT03116945|Hepatocellular carcinoma|hepatocellular carcinoma
26867|NCT03116932|HIV prevention, high risk MSM, PrEP|hiv prevention, high risk msm, prep
26868|NCT03116919|nutrition|nutrition
26869|NCT03116919|Potatoes|potatoes
26870|NCT03116919|endothelial function|endothelial function
26871|NCT03116919|feeding trial|feeding trial
26872|NCT03116880|Aorta, Abdominal/surgery|aorta, abdominal/surgery
26873|NCT03116880|Endovascular Procedures|endovascular procedures
26874|NCT03116854|Acute Coronary Syndrome|acute coronary syndrome
26875|NCT03116854|Beta Blockers|beta blockers
26876|NCT03116854|Prognosis|prognosis
26883|NCT03116815|patient reported outcomes|patient reported outcomes
26884|NCT03116776|walnut shell glasses moxibustion|walnut shell glasses moxibustion
26885|NCT03116776|dry eye|dry eye
26886|NCT03116776|randomized controlled trial|randomized controlled trial
26887|NCT03116750|mechanical thrombectomy|mechanical thrombectomy
26888|NCT03116737|AOM|aom
26889|NCT03116724|catheterization, central venous|catheterization, central venous
26890|NCT03116724|jugular veins|jugular veins
26891|NCT03116724|echocardiography, transesophageal|echocardiography, transesophageal
26892|NCT03116672|pain|pain
26893|NCT03116672|Diclofenac|diclofenac
26894|NCT03116672|NSAID|nsaid
26895|NCT03116672|Ketorolac|ketorolac
26896|NCT03116646|mastication|mastication
26897|NCT03116646|cerebral palsy|cerebral palsy
26898|NCT03116646|family|family
26899|NCT03116633|lung cancer|lung cancer
26900|NCT03116633|biopsy|biopsy
26901|NCT03116620|mastication|mastication
26902|NCT03116620|children with neuromuscular disorders|children with neuromuscular disorders
26903|NCT03116607|User satisfaction|user satisfaction
26904|NCT03116607|Readmission|readmission
26905|NCT03116607|Emergency department|emergency department
26906|NCT03116607|Pharmaceutical intervention|pharmaceutical intervention
26907|NCT03116594|Herpes Zoster Vaccine|herpes zoster vaccine
26908|NCT03116594|Prevention of Herpes Zoster|prevention of herpes zoster
26909|NCT03116581|Perceptual Decision|perceptual decision
26910|NCT03116581|Social Cognition|social cognition
26911|NCT03116581|Motivation|motivation
26912|NCT03116568|IBD|ibd
26913|NCT03116568|Meconium|meconium
26914|NCT03116568|Pregnancy|pregnancy
26915|NCT03116568|Microbiota|microbiota
26916|NCT03116568|Newborn|newborn
26917|NCT03116555|Apatinib|apatinib
26918|NCT03116555|Irinotecan|irinotecan
26919|NCT03116555|Second-line|second-line
26920|NCT03116555|Metastatic Gastric Adenocarcinoma|metastatic gastric adenocarcinoma
26921|NCT03116529|Neoadjuvant|neoadjuvant
26922|NCT03116529|Soft Tissue Sarcoma|soft tissue sarcoma
26923|NCT03116529|Immunotherapy|immunotherapy
26924|NCT03116529|Checkpoint Inhibitor|checkpoint inhibitor
26925|NCT03116529|PD-1 (Programmed Cell Death Protein 1)|pd-1 (programmed cell death protein 1)
26926|NCT03116529|PD-L1 (Programmed Death Ligand 1)|pd-l1 (programmed death ligand 1)
26927|NCT03116529|CTLA-4 (Cytotoxic T-Lymphocyte-Associated Protein 4)|ctla-4 (cytotoxic t-lymphocyte-associated protein 4)
26928|NCT03116529|Radiotherapy|radiotherapy
26929|NCT03116529|Durvalumab|durvalumab
26930|NCT03116529|Tremelimumab|tremelimumab
26931|NCT03116529|Surgery|surgery
26932|NCT03116529|Radiation|radiation
26933|NCT03116529|Combined|combined
26934|NCT03116529|Preoperative|preoperative
26935|NCT03116503|Suicide|suicide
26936|NCT03116490|morbidity|morbidity
26937|NCT03116490|mortality|mortality
26938|NCT03116490|hip fracture|hip fracture
26939|NCT03116490|anesthesia type|anesthesia type
26940|NCT03116490|POSSUM|possum
26941|NCT03116451|foot health|foot health
26942|NCT03116451|nurses|nurses
26943|NCT03116451|work well-being|work well-being
26944|NCT03116438|Coronary Artery Disease|coronary artery disease
26945|NCT03116438|Nuclear Stress Test|nuclear stress test
26946|NCT03116438|CT Angiography|ct angiography
26947|NCT03116438|Angiography|angiography
26948|NCT03116425|Precision Medicine|precision medicine
26949|NCT03116425|Functional Neuroimaging|functional neuroimaging
26950|NCT03116425|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
26951|NCT03116425|Transcranial Direct Current Stimulation|transcranial direct current stimulation
26952|NCT03116425|Monocentric|monocentric
26953|NCT03116425|Comparative balanced, randomized|comparative balanced, randomized
26954|NCT03116425|double-blind cross-over 3 Arms Study|double-blind cross-over 3 arms study
26955|NCT03116412|Malignant melanoma|malignant melanoma
26956|NCT03116412|Follow up|follow up
26957|NCT03116412|Radiology|radiology
26958|NCT03116412|Survival|survival
26959|NCT03116399|Older adults|older adults
26960|NCT03116399|Social Support|social support
26961|NCT03116399|Technology uptake|technology uptake
26962|NCT03116373|Posture|posture
26963|NCT03116373|Physiology|physiology
26964|NCT03116373|Head|head
26965|NCT03116373|Intubation|intubation
26966|NCT03116373|Intratracheal methods|intratracheal methods
26967|NCT03116334|Obesity|obesity
26968|NCT03116334|BMI|bmi
26969|NCT03116334|executive functioning|executive functioning
26970|NCT03116334|general cognitive ability|general cognitive ability
26971|NCT03116334|twin study|twin study
26972|NCT03116334|heritability|heritability
26973|NCT03116334|cognition|cognition
26974|NCT03116334|GCTA|gcta
26975|NCT03116243|migrant and seasonal head start|migrant and seasonal head start
26976|NCT03116243|early childhood education|early childhood education
26977|NCT03116243|head start|head start
26978|NCT03116230|Knee pathology|knee pathology
26979|NCT03116217|renal function|renal function
26980|NCT03116217|post natal|post natal
26981|NCT03116217|peptidome|peptidome
26982|NCT03116204|Dependency|dependency
26983|NCT03116204|FRC department|frc department
26984|NCT03116204|scale validation|scale validation
26985|NCT03116204|validity|validity
26986|NCT03116204|reliability|reliability
26987|NCT03116178|Fluid therapy|fluid therapy
26988|NCT03116178|oximetry|oximetry
26989|NCT03116178|thromboelastography|thromboelastography
26990|NCT03116178|intraoperative/method|intraoperative/method
26991|NCT03116178|monitoring|monitoring
26992|NCT03116139|Computed tomography scan|computed tomography scan
26993|NCT03116139|Ventilation-perfusion lung scan|ventilation-perfusion lung scan
26994|NCT03116139|Acute kidney injury|acute kidney injury
26995|NCT03116139|Pulmonary embolism|pulmonary embolism
26996|NCT03116139|Contrast-induced nephropathy|contrast-induced nephropathy
26997|NCT03116087|Postmenopausal women|postmenopausal women
26998|NCT03116061|Multimorbidity|multimorbidity
26999|NCT03116061|Family Medicine|family medicine
27000|NCT03116061|decompensation|decompensation
27001|NCT03116061|predictive value|predictive value
27002|NCT03116022|menopause|menopause
27003|NCT03116022|sexual dysfunction|sexual dysfunction
27004|NCT03116022|coital pain|coital pain
27005|NCT03116022|vagina|vagina
27006|NCT03116009|Obesity|obesity
27007|NCT03116009|Pregnancy|pregnancy
27008|NCT03116009|Diabetes Mellitus|diabetes mellitus
27009|NCT03116009|Perinatal Outcomes|perinatal outcomes
27010|NCT03115957|Parenteral Nutrition|parenteral nutrition
27011|NCT03115957|Digestive System Neoplasms|digestive system neoplasms
27012|NCT03115957|Randomized Controlled Trials|randomized controlled trials
27020|NCT03115866|Fruits and Vegetables|fruits and vegetables
27022|NCT03115866|Microbiome|microbiome
27023|NCT03115866|Young Adults|young adults
27024|NCT03115788|Thermal|thermal
27025|NCT03115762|ASKB1202|askb1202
27026|NCT03115749|Crohn's disease|crohn's disease
27027|NCT03115749|ulcerative colitis|ulcerative colitis
27028|NCT03115749|mesenchymal stem cells|mesenchymal stem cells
27029|NCT03115749|intestinal inflammation|intestinal inflammation
27031|NCT03115736|Hepatitis B|hepatitis b
27032|NCT03115736|Renal dysfunction|renal dysfunction
27033|NCT03115736|tenofovir alafenamide|tenofovir alafenamide
27034|NCT03115723|Hospitalization|hospitalization
27035|NCT03115723|Health Care Economics and Organizations|health care economics and organizations
27036|NCT03115710|Keratoconus|keratoconus
27037|NCT03115710|Prevalence|prevalence
27038|NCT03115671|Phosphatidylserine|phosphatidylserine
27039|NCT03115671|Omega-3|omega-3
27040|NCT03115606|videolaryngoscope|videolaryngoscope
27041|NCT03115606|Fastrach LMA|fastrach lma
27042|NCT03115606|cervical motion|cervical motion
27043|NCT03115593|hysteroscopy|hysteroscopy
27044|NCT03115593|pipette|pipette
27045|NCT03115593|biopsy|biopsy
27046|NCT03115593|endometrial cancer|endometrial cancer
27047|NCT03115541|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
27048|NCT03115541|deep vein thrombosis|deep vein thrombosis
27049|NCT03115541|pulmonary embolus|pulmonary embolus
27050|NCT03115541|esophageal resection|esophageal resection
27051|NCT03115541|incidence|incidence
27052|NCT03115528|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
27053|NCT03115528|Medical oncologists|medical oncologists
27054|NCT03115528|Palliative care physicians|palliative care physicians
27055|NCT03115528|Questionnaire|questionnaire
27056|NCT03115528|Survey|survey
27057|NCT03115515|Thyroid Stimulating Hormone|thyroid stimulating hormone
27058|NCT03115489|seizure|seizure
27059|NCT03115489|glutamate activation|glutamate activation
27060|NCT03115489|N-Methyl D-Aspartate|n-methyl d-aspartate
27061|NCT03115489|GABA receptor|gaba receptor
27062|NCT03115489|Ketamine|ketamine
27063|NCT03115463|Neonatal Resuscitation|neonatal resuscitation
27064|NCT03115463|Prematurity|prematurity
27065|NCT03115463|Oxygen|oxygen
27066|NCT03115450|External ventricular drain (EVD)|external ventricular drain (evd)
27067|NCT03115450|Placement of Bolt|placement of bolt
27068|NCT03115437|Body mass|body mass
27069|NCT03115437|Running-related injury|running-related injury
27070|NCT03115437|Sports injury prevention|sports injury prevention
27071|NCT03115437|Impact forces|impact forces
27072|NCT03115437|Epidemiology|epidemiology
27073|NCT03115437|Running biomechanics|running biomechanics
27074|NCT03115437|Sports footwear|sports footwear
27075|NCT03115437|Shoe cushioning|shoe cushioning
27076|NCT03115424|Weight Loss|weight loss
27077|NCT03115424|Bariatric Surgery|bariatric surgery
27078|NCT03115398|Fitness Tracker|fitness tracker
27079|NCT03115398|Activity Monitoring|activity monitoring
27080|NCT03115398|Chemotherapy|chemotherapy
27081|NCT03115398|Radiation Therapy|radiation therapy
27093|NCT03115307|Triptoreline|triptoreline
27094|NCT03115268|social support|social support
27095|NCT03115255|retinopathy of prematurity|retinopathy of prematurity
27096|NCT03115255|ranibizumab|ranibizumab
27097|NCT03115255|vascular endothelial growth factor|vascular endothelial growth factor
27098|NCT03115229|Obesity|obesity
27099|NCT03115229|Overweight|overweight
27100|NCT03115229|Physical Activity|physical activity
27101|NCT03115229|Nutrition|nutrition
27102|NCT03115229|Nursing|nursing
27103|NCT03115203|muscle skin|muscle skin
27104|NCT03115203|IRM 3 tesla|irm 3 tesla
27105|NCT03115138|Biopsy|biopsy
27106|NCT03115125|B lymphocyte|b lymphocyte
27107|NCT03115086|Bile Acid Synthesis Disorder|bile acid synthesis disorder
27108|NCT03115086|Zellweger Spectrum Disorder|zellweger spectrum disorder
27109|NCT03115086|Peroxisomal Disorder|peroxisomal disorder
27110|NCT03115086|Cholic Acid|cholic acid
27111|NCT03115086|Cholbam|cholbam
27112|NCT03115086|Kolbam|kolbam
27113|NCT03115086|The Replace Registry|the replace registry
27114|NCT03115073|Vulvovaginal candidiasis|vulvovaginal candidiasis
27115|NCT03115073|Candiplus|candiplus
27116|NCT03115073|Clotrimazole|clotrimazole
27117|NCT03115073|Safety|safety
27118|NCT03115073|Tolerability|tolerability
27119|NCT03115073|Clinical efficacy|clinical efficacy
27120|NCT03115034|carotid stenosis|carotid stenosis
27121|NCT03115034|melatonin|melatonin
27122|NCT03115034|vascular injury|vascular injury
27123|NCT03115034|ischemia reperfusion|ischemia reperfusion
27124|NCT03114995|Tirofiban|tirofiban
27125|NCT03114995|Resistance to antiplatelet agents|resistance to antiplatelet agents
27126|NCT03114982|Prevention of varicella|prevention of varicella
27127|NCT03114982|Varicella-zoster vaccine|varicella-zoster vaccine
27128|NCT03114969|Overall error|overall error
27129|NCT03114969|Error rate|error rate
27130|NCT03114969|Critical error|critical error
27131|NCT03114969|COPD|copd
27132|NCT03114969|ELLIPTA|ellipta
27133|NCT03114969|Dry powder inhaler|dry powder inhaler
27134|NCT03114943|prevention of varicella|prevention of varicella
27135|NCT03114943|Varicella-zoster vaccine|varicella-zoster vaccine
27136|NCT03114917|Suicide|suicide
27137|NCT03114917|Self-harm|self-harm
27138|NCT03114917|Psychosis|psychosis
27139|NCT03114917|Community|community
27140|NCT03114917|Suicide Prevention|suicide prevention
27142|NCT03114917|CARMS|carms
27143|NCT03114917|Randomised controlled trial|randomised controlled trial
27144|NCT03114891|depression|depression
27145|NCT03114891|post-traumatic stress|post-traumatic stress
27146|NCT03114865|bone marrow|bone marrow
27147|NCT03114865|bone marrow transplant|bone marrow transplant
27148|NCT03114865|allogeneic|allogeneic
27149|NCT03114865|tacrolimus|tacrolimus
27150|NCT03114865|cyclophosphamide|cyclophosphamide
27151|NCT03114865|Blinatumomab|blinatumomab
27152|NCT03114839|Lactobacillus casei strain Shirota|lactobacillus casei strain shirota
27153|NCT03114839|Yakult|yakult
27154|NCT03114839|IntelliCap|intellicap
27155|NCT03114761|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
27156|NCT03114761|Internal Herniation|internal herniation
27157|NCT03114761|Computed Tomography|computed tomography
27158|NCT03114748|deep brain stimulation|deep brain stimulation
27159|NCT03114748|EEG|eeg
27160|NCT03114709|Mindfulness|mindfulness
27161|NCT03114709|Exercise|exercise
27162|NCT03114709|Physical activity|physical activity
27163|NCT03114709|Behavior change|behavior change
27164|NCT03114709|Aging|aging
27165|NCT03114709|Randomized controlled trial|randomized controlled trial
27166|NCT03114709|Pilot|pilot
27167|NCT03114670|Leukemia|leukemia
27168|NCT03114670|Leukemia, Myeloid|leukemia, myeloid
27169|NCT03114670|Recurrence|recurrence
27170|NCT03114670|Neoplasms by Histologic Type|neoplasms by histologic type
27171|NCT03114670|Disease Attributes|disease attributes
27172|NCT03114670|Cyclophosphamide|cyclophosphamide
27173|NCT03114670|Fludarabine|fludarabine
27174|NCT03114670|CD123|cd123
27175|NCT03114670|Chimeric Antigen Receptor modified T-cells|chimeric antigen receptor modified t-cells
27176|NCT03114631|dendritic cells, pancreatic cancer, immunotherapy|dendritic cells, pancreatic cancer, immunotherapy
27177|NCT03114566|transplant donor|transplant donor
27178|NCT03114566|HLA typed|hla typed
27179|NCT03114566|17-211|17-211
27180|NCT03114553|family health history|family health history
27181|NCT03114553|prevention|prevention
27182|NCT03114553|genetic risk|genetic risk
27183|NCT03114553|clinical decision support|clinical decision support
27184|NCT03114527|Dedifferentiated liposarcoma|dedifferentiated liposarcoma
27185|NCT03114527|DDL|ddl
27186|NCT03114527|Leiomyosarcoma|leiomyosarcoma
27187|NCT03114527|LMS|lms
27188|NCT03114527|Ribociclib|ribociclib
27189|NCT03114501|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
27190|NCT03114501|Head and Neck Cancer|head and neck cancer
27191|NCT03114501|Yoga|yoga
27192|NCT03114501|Questionnaires|questionnaires
27193|NCT03114501|Surveys|surveys
27194|NCT03114462|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
27195|NCT03114462|Squamous cell carcinoma of the larynx|squamous cell carcinoma of the larynx
27196|NCT03114462|Stereotactic hypofractionated radioablation|stereotactic hypofractionated radioablation
27197|NCT03114462|HYDRA|hydra
27198|NCT03114462|Questionnaires|questionnaires
27199|NCT03114462|Surveys|surveys
27200|NCT03114423|EMDR|emdr
27201|NCT03114423|Psychotherapy|psychotherapy
27202|NCT03114423|Substance Use Disorders|substance use disorders
27203|NCT03114423|Eye Movement Desensitization and Reprocessing|eye movement desensitization and reprocessing
27204|NCT03114371|Prader-Willi syndrome|prader-willi syndrome
27205|NCT03114371|Oxytocin|oxytocin
27206|NCT03114371|Behavioural troubles|behavioural troubles
27207|NCT03114358|De-escalation|de-escalation
27208|NCT03114358|Carbapenems|carbapenems
617923|NCT00653029|fmri|fmri
27209|NCT03114358|Antimicrobial stewardship|antimicrobial stewardship
27210|NCT03114345|Pressure ulcer|pressure ulcer
27211|NCT03114345|Interface pressure|interface pressure
27212|NCT03114345|Pressure mapping device|pressure mapping device
27213|NCT03114345|Monitoring|monitoring
27214|NCT03114345|Microvascularization|microvascularization
27215|NCT03114319|TNO155|tno155
27216|NCT03114319|SHP2|shp2
27217|NCT03114319|advanced solid tumor|advanced solid tumor
27218|NCT03114319|NSCLC|nsclc
27219|NCT03114319|HNSCC|hnscc
27220|NCT03114319|EGFR|egfr
27221|NCT03114319|GIST|gist
27222|NCT03114319|PTPN11|ptpn11
27223|NCT03114319|cancers with a mass|cancers with a mass
27224|NCT03114319|bulky tumor|bulky tumor
27225|NCT03114319|nodule|nodule
27226|NCT03114319|lump|lump
27227|NCT03114319|advanced solid malignancies|advanced solid malignancies
27228|NCT03114306|ERAS|eras
27229|NCT03114306|pain|pain
27230|NCT03114306|knee arthroplasty|knee arthroplasty
27231|NCT03114306|joint pain|joint pain
27232|NCT03114306|regional anaesthesia|regional anaesthesia
27233|NCT03114293|Physical activity|physical activity
27234|NCT03114293|Mobility|mobility
27235|NCT03114254|Recurrent|recurrent
27236|NCT03114254|Locally advanced|locally advanced
27237|NCT03114254|Metastatic|metastatic
27238|NCT03114241|COPD|copd
27239|NCT03114241|Physical activity|physical activity
27240|NCT03114241|Endothelial function|endothelial function
27241|NCT03114228|myeloid|myeloid
27242|NCT03114228|leukemia|leukemia
27243|NCT03114228|FLT3-mutated|flt3-mutated
27244|NCT03114228|PKC412|pkc412
27245|NCT03114228|midostaurin|midostaurin
27246|NCT03114228|adult|adult
27247|NCT03114228|AML|aml
27248|NCT03114228|ETP|etp
27249|NCT03114228|FMS-like tyrosine kinase receptor|fms-like tyrosine kinase receptor
27250|NCT03114228|Acute myeloid leukemia|acute myeloid leukemia
27251|NCT03114215|Biotin|biotin
27252|NCT03114215|MD1003|md1003
27253|NCT03114215|ALSFRS-R|alsfrs-r
27254|NCT03114189|Sleep disturbance|sleep disturbance
27255|NCT03114189|footbath|footbath
27256|NCT03114189|Kneipp|kneipp
27257|NCT03114189|care of sleep|care of sleep
27258|NCT03114189|sleep|sleep
27259|NCT03114150|physical activity|physical activity
27260|NCT03114150|aging|aging
27261|NCT03114150|learning and memory|learning and memory
27262|NCT03114150|exercise|exercise
27263|NCT03114150|brain|brain
27264|NCT03114137|Sub-Saharan Africa|sub-saharan africa
27265|NCT03114137|Sickle Cell Disease|sickle cell disease
27266|NCT03114137|Vasculopathy|vasculopathy
27267|NCT03114137|Nephropathy|nephropathy
27268|NCT03114137|Pulmonary hypertension|pulmonary hypertension
27269|NCT03114137|cardiac disease|cardiac disease
27270|NCT03114137|hemolysis|hemolysis
27271|NCT03114137|pulse wave velocity|pulse wave velocity
27272|NCT03114137|blood viscosity|blood viscosity
27273|NCT03114124|ablation|ablation
27274|NCT03114124|atrioventricular node|atrioventricular node
27275|NCT03114124|microfidelity|microfidelity
27276|NCT03114098|Drug Resistance|drug resistance
27277|NCT03114098|CYP2D6|cyp2d6
27278|NCT03114098|cytochrom P450|cytochrom p450
27279|NCT03114072|Pregnancy|pregnancy
27280|NCT03114072|Blue-blockers|blue-blockers
27281|NCT03114072|Sleep quality|sleep quality
27282|NCT03114072|Melatonin|melatonin
27283|NCT03114059|Late Effects of Surgery|late effects of surgery
27284|NCT03114033|Cardiac Arrest|cardiac arrest
27285|NCT03114033|Intensive Care Unit|intensive care unit
27286|NCT03114033|Therapeutic Mild Hypercapnia|therapeutic mild hypercapnia
27287|NCT03114033|Normocapnia|normocapnia
27288|NCT03114033|Mortality|mortality
27289|NCT03114033|Neurological function|neurological function
27290|NCT03114020|Emphysema|emphysema
27291|NCT03114020|COPD|copd
27294|NCT03114007|Substance misuse|substance misuse
27295|NCT03114007|Psychosocial difficulties|psychosocial difficulties
27296|NCT03114007|Youth|youth
27297|NCT03113994|Spinal Cord Injury|spinal cord injury
27298|NCT03113994|Osteoporosis|osteoporosis
27299|NCT03113994|Cardiometabolic Syndrome|cardiometabolic syndrome
27300|NCT03113916|Culturally-tailored|culturally-tailored
27301|NCT03113916|Weight Loss|weight loss
27302|NCT03113916|Diabetes|diabetes
27303|NCT03113916|Women|women
27304|NCT03113916|Hispanic|hispanic
27305|NCT03113916|Obesity|obesity
27306|NCT03113903|Pain|pain
27307|NCT03113903|psychophysics|psychophysics
27308|NCT03113903|Nociception|nociception
27309|NCT03113903|Sensitivity|sensitivity
27310|NCT03113903|Senses|senses
27311|NCT03113903|Phenotyping|phenotyping
27312|NCT03113903|Questionnaire|questionnaire
27313|NCT03113903|Anxiety|anxiety
27314|NCT03113903|Depression|depression
27315|NCT03113903|Catastrophizing|catastrophizing
27316|NCT03113890|pharmacogenetic testing|pharmacogenetic testing
27317|NCT03113890|genomic|genomic
27318|NCT03113890|assay|assay
27319|NCT03113890|PTSD|ptsd
27320|NCT03113890|pharmacodynamic|pharmacodynamic
27321|NCT03113890|pharmacokinetic|pharmacokinetic
27322|NCT03113890|psychiatric disorders|psychiatric disorders
27323|NCT03113864|Vision|vision
27324|NCT03113864|Eye Health|eye health
27325|NCT03113864|Lutein|lutein
27326|NCT03113864|Carotenoids|carotenoids
27327|NCT03113838|Drug-Induced Liver Injury|drug-induced liver injury
27328|NCT03113825|breast carcinoma|breast carcinoma
27329|NCT03113825|DCIS|dcis
27330|NCT03113786|Discectomy|discectomy
27331|NCT03113786|Lumbar discectomy|lumbar discectomy
27332|NCT03113786|Protruding disc|protruding disc
27333|NCT03113747|Allogeneic adipose-derived stem cells|allogeneic adipose-derived stem cells
27334|NCT03113747|burn wounds|burn wounds
27335|NCT03113747|wound healing|wound healing
27336|NCT03113747|regeneration|regeneration
27337|NCT03113747|repair|repair
27338|NCT03113747|skin tissue engineering|skin tissue engineering
27339|NCT03113708|heparin|heparin
27340|NCT03113708|heparin antagonists|heparin antagonists
27341|NCT03113708|cardiac surgery|cardiac surgery
27342|NCT03113708|active clotting time|active clotting time
27343|NCT03113695|Richter's Syndrome|richter's syndrome
27344|NCT03113695|CLL|cll
27345|NCT03113695|Chronic Lumphocytic Leukemia|chronic lumphocytic leukemia
27346|NCT03113695|obinutuzumab|obinutuzumab
27347|NCT03113695|HDMP|hdmp
27348|NCT03113695|lenalidomide|lenalidomide
27349|NCT03113695|cancer|cancer
27350|NCT03113695|methylprednisolone|methylprednisolone
27351|NCT03113643|Acute Myeloid Leukemia|acute myeloid leukemia
27352|NCT03113643|Myelodysplastic Syndrome|myelodysplastic syndrome
27353|NCT03113630|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
27354|NCT03113630|Virtual Reality Exposure Therapy|virtual reality exposure therapy
27355|NCT03113630|User-Computer Interface|user-computer interface
27356|NCT03113630|Rehabilitation|rehabilitation
27357|NCT03113630|Motor Activity|motor activity
27358|NCT03113591|total hip arthroplasty|total hip arthroplasty
27359|NCT03113591|minimal invasive|minimal invasive
27360|NCT03113578|Balloon enteroscopy|balloon enteroscopy
27361|NCT03113578|colonoscopy|colonoscopy
27362|NCT03113578|polyps|polyps
27363|NCT03113461|cognitive impairment|cognitive impairment
27364|NCT03113461|sleep apnea|sleep apnea
27365|NCT03113461|positive airway pressure therapy|positive airway pressure therapy
27366|NCT03113448|capsaicin|capsaicin
27367|NCT03113448|neuropathic pain|neuropathic pain
27368|NCT03113448|diabetic neuropathy|diabetic neuropathy
27369|NCT03113448|topical lotion|topical lotion
27370|NCT03113435|CO2 gap|co2 gap
27371|NCT03113435|oxygen consumption|oxygen consumption
27372|NCT03113435|Stroke volume optimization|stroke volume optimization
27373|NCT03113422|High Tumor Burden Follicular Lymphoma|high tumor burden follicular lymphoma
27374|NCT03113422|Venetoclax|venetoclax
27375|NCT03113422|Obinutuzumab|obinutuzumab
27376|NCT03113422|Bendamustine|bendamustine
27377|NCT03113422|Bcl-2 Family Protein Inhibitor|bcl-2 family protein inhibitor
27378|NCT03113422|Monoclonal Antibody|monoclonal antibody
27379|NCT03113409|Outpatient detoxification|outpatient detoxification
27380|NCT03113409|Opioid dependence|opioid dependence
27381|NCT03113409|Naltrexone|naltrexone
27382|NCT03113409|Vivitrol|vivitrol
27383|NCT03113409|Buprenorphine|buprenorphine
27384|NCT03113370|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
27385|NCT03113370|tobacco use|tobacco use
27386|NCT03113370|postpartum|postpartum
27387|NCT03113357|myofascial release|myofascial release
27388|NCT03113357|cervicogenic headache|cervicogenic headache
27389|NCT03113357|pain intensity|pain intensity
27390|NCT03113357|exercise therapy|exercise therapy
27391|NCT03113357|pressure pain threshold|pressure pain threshold
27392|NCT03113331|Intrauterine growth restriction|intrauterine growth restriction
27393|NCT03113331|Preterm birth|preterm birth
27394|NCT03113331|Birth defect|birth defect
27395|NCT03113331|Infant growth|infant growth
27396|NCT03113331|Neurodevelopmental outcomes|neurodevelopmental outcomes
27397|NCT03113318|Pulmonary neoplasm|pulmonary neoplasm
27398|NCT03113318|Metastasis|metastasis
27399|NCT03113318|colorectal neoplasm|colorectal neoplasm
27400|NCT03113305|Gastric bypass|gastric bypass
27401|NCT03113305|Morbid obesity|morbid obesity
27402|NCT03113305|Food choice|food choice
27403|NCT03113305|Ingestive behaviour|ingestive behaviour
27404|NCT03113292|physical therapy|physical therapy
27405|NCT03113292|therapeutic exercises|therapeutic exercises
27406|NCT03113292|low back pain|low back pain
27407|NCT03113266|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
27408|NCT03113266|Metastatic|metastatic
27409|NCT03113266|Advanced|advanced
27410|NCT03113266|Bladder Urothelial Carcinoma|bladder urothelial carcinoma
27411|NCT03113253|Tranexamic Acid|tranexamic acid
27413|NCT03113253|Surgery|surgery
27414|NCT03113253|Excision|excision
27415|NCT03113240|Glutamin|glutamin
27416|NCT03113240|Enteral Nutrition|enteral nutrition
618224|NCT00655226|Infection|infection
27417|NCT03113240|Intensive Care Unit|intensive care unit
27418|NCT03113240|Intestinal Permeability|intestinal permeability
27419|NCT03113227|induction of labor|induction of labor
27420|NCT03113227|Bishop score|bishop score
27421|NCT03113227|posterior cervical angle|posterior cervical angle
27422|NCT03113227|cervical length|cervical length
27423|NCT03113201|Depression|depression
27424|NCT03113201|Collaborative care|collaborative care
27425|NCT03113201|Care manager|care manager
27426|NCT03113201|Anxiety|anxiety
27427|NCT03113201|Psychiatry|psychiatry
27428|NCT03113201|Consultation-liaison|consultation-liaison
27429|NCT03113201|General practitioner|general practitioner
27430|NCT03113175|Anxiety|anxiety
27431|NCT03113175|Collaborative care|collaborative care
27432|NCT03113175|Consultation-liaison|consultation-liaison
27433|NCT03113175|General practitioner|general practitioner
27434|NCT03113175|Psychiatry|psychiatry
27435|NCT03113162|multiple sclerosis|multiple sclerosis
27436|NCT03113162|HSCT|hsct
27437|NCT03113149|Physical Therapy Modalities|physical therapy modalities
27438|NCT03113149|Recovery of Function|recovery of function
27439|NCT03113149|Predictive Value of Tests|predictive value of tests
27440|NCT03113149|Cohort Studies|cohort studies
27441|NCT03113123|Adherence|adherence
27442|NCT03113123|Prevention|prevention
27443|NCT03113123|Tenofovir|tenofovir
27444|NCT03113123|Emtricitabine|emtricitabine
27445|NCT03113123|Antiretroviral|antiretroviral
27446|NCT03113123|Prophylaxis|prophylaxis
27447|NCT03113123|Men who have sex with men|men who have sex with men
27448|NCT03113110|Empagliflozin|empagliflozin
27449|NCT03113110|SGLT-2 Inhibition|sglt-2 inhibition
27450|NCT03113110|Glucose Metabolism|glucose metabolism
27451|NCT03113084|Sodium Heparin|sodium heparin
27452|NCT03113084|Pharmacokinetics|pharmacokinetics
27453|NCT03113084|Coagulation factor|coagulation factor
27454|NCT03113058|HBV infection,γδT cells,Adoptive treatment|hbv infection,γδt cells,adoptive treatment
27455|NCT03113032|total knee replacement|total knee replacement
27456|NCT03113032|sensorimotor training|sensorimotor training
27457|NCT03113032|pre-surgery exercise|pre-surgery exercise
27458|NCT03113032|sensorimotor function|sensorimotor function
27459|NCT03113032|neuromuscular|neuromuscular
27460|NCT03113019|dendritic cell, IL-12, IL-18, сytotoxicity|dendritic cell, il-12, il-18, сytotoxicity
27461|NCT03112993|spine surgery|spine surgery
27462|NCT03112993|neuromuscular blockade|neuromuscular blockade
27463|NCT03112993|sugammadex|sugammadex
27464|NCT03112993|elderly|elderly
27465|NCT03112993|reversal|reversal
27466|NCT03112993|neostigmine|neostigmine
27467|NCT03112993|recovery|recovery
27468|NCT03112980|Aortic Valve Stenosis|aortic valve stenosis
27469|NCT03112980|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
27470|NCT03112980|Surgical aortic valve replacement|surgical aortic valve replacement
27471|NCT03112980|Intermediate operative risk|intermediate operative risk
27472|NCT03112915|postoperative pain|postoperative pain
27473|NCT03112915|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
27474|NCT03112915|Quadratus lumborum block|quadratus lumborum block
27475|NCT03112915|transversus abdominis plan block|transversus abdominis plan block
27476|NCT03112889|McArdle Disease|mcardle disease
27477|NCT03112889|McArdle's Disease|mcardle's disease
27478|NCT03112889|Glycogen Storage Disease Type V|glycogen storage disease type v
27479|NCT03112889|GSDV|gsdv
27480|NCT03112889|Sodium Valproate|sodium valproate
27481|NCT03112889|Valproic Acid|valproic acid
27482|NCT03112889|Myophosphorylase Deficiency|myophosphorylase deficiency
27483|NCT03112889|Muscle Phosphorylase Deficiency|muscle phosphorylase deficiency
27484|NCT03112889|Glycogenosis|glycogenosis
27485|NCT03112889|Glycogen Storage Disorder|glycogen storage disorder
27486|NCT03112876|younger age|younger age
27487|NCT03112876|older age|older age
27492|NCT03112850|Randomized controlled trial|randomized controlled trial
27493|NCT03112850|Aural rehabilitation intervention|aural rehabilitation intervention
27495|NCT03112798|Macintosh blade|macintosh blade
27496|NCT03112798|Miller blade|miller blade
27498|NCT03112785|Arthroplasty|arthroplasty
27499|NCT03112785|Stem|stem
27500|NCT03112785|Outcome|outcome
27501|NCT03112746|child|child
27502|NCT03112746|goal|goal
27503|NCT03112746|intervention|intervention
27504|NCT03112746|motor skills disorder|motor skills disorder
27505|NCT03112746|occupational therapy|occupational therapy
27506|NCT03112655|diagnosis|diagnosis
27507|NCT03112655|sensitivity|sensitivity
27508|NCT03112655|specificity|specificity
27509|NCT03112655|therapeutic outcome|therapeutic outcome
27510|NCT03112655|cerebrospinal fluid|cerebrospinal fluid
27511|NCT03112629|Quality of Care|quality of care
27512|NCT03112629|aortic stenosis|aortic stenosis
27513|NCT03112629|transcatheter aortic valve implantation|transcatheter aortic valve implantation
27514|NCT03112629|surgical aortic valve replacement|surgical aortic valve replacement
27515|NCT03112629|facilitated data relay|facilitated data relay
27516|NCT03112603|Graft-versus-host disease (GvHD)|graft-versus-host disease (gvhd)
27517|NCT03112603|Chronic GvHD (cGvHD)|chronic gvhd (cgvhd)
27518|NCT03112603|steroid-refractory|steroid-refractory
27519|NCT03112603|ruxolitinib|ruxolitinib
27520|NCT03112603|Janus kinase inhibitor|janus kinase inhibitor
27521|NCT03112590|Histologically confirmed HER2 positive breast cancer|histologically confirmed her2 positive breast cancer
27522|NCT03112590|Unresectable breast cancer|unresectable breast cancer
27523|NCT03112590|Locally advanced breast cancer|locally advanced breast cancer
27524|NCT03112590|Metastatic breast cancer|metastatic breast cancer
27525|NCT03112590|Clinical stage 2-3 early stage breast cancer|clinical stage 2-3 early stage breast cancer
27526|NCT03112564|Endotracheal intubation|endotracheal intubation
27527|NCT03112564|muscle relaxants|muscle relaxants
27528|NCT03112564|inhalational anesthesia|inhalational anesthesia
27529|NCT03112538|insulin pump|insulin pump
27530|NCT03112538|basal bolus insulin|basal bolus insulin
27531|NCT03112525|rivaroxaban|rivaroxaban
27532|NCT03112525|apixaban|apixaban
27533|NCT03112525|cytochrome|cytochrome
27534|NCT03112525|anticoagulant|anticoagulant
27535|NCT03112525|transporter|transporter
27536|NCT03112525|polymorphism|polymorphism
27537|NCT03112525|genotyping|genotyping
27538|NCT03112525|phenotyping|phenotyping
27539|NCT03112512|optimal positive end-expiratory pressure determination|optimal positive end-expiratory pressure determination
27540|NCT03112512|Electrical impedance tomography|electrical impedance tomography
27541|NCT03112499|Acute Kidney Injury|acute kidney injury
27542|NCT03112499|PCNL|pcnl
27543|NCT03112499|mini-PCNL|mini-pcnl
27544|NCT03112499|RIRS|rirs
27545|NCT03112499|urine biomarkers|urine biomarkers
27546|NCT03112486|out-of-hospital cardiac arrrest|out-of-hospital cardiac arrrest
27547|NCT03112486|neurological outcome|neurological outcome
27548|NCT03112486|prognostication|prognostication
27549|NCT03112486|cerebral performance category|cerebral performance category
27550|NCT03112486|hypoxic-ischemic brain injury|hypoxic-ischemic brain injury
27551|NCT03112486|biomarkers|biomarkers
27552|NCT03112460|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
27553|NCT03112447|medial epicondyle humerus|medial epicondyle humerus
27554|NCT03112447|absorbable cartilage nail|absorbable cartilage nail
27555|NCT03112421|IVD|ivd
27556|NCT03112408|cerebellar lesion|cerebellar lesion
27557|NCT03112408|saccadic adaptation|saccadic adaptation
27558|NCT03112408|spatial localization|spatial localization
27559|NCT03112408|visuo spatial perception|visuo spatial perception
27560|NCT03112408|eye movements|eye movements
27561|NCT03112369|American Indian / Alaska Native|american indian / alaska native
27562|NCT03112369|HIV Prevention|hiv prevention
27563|NCT03112369|Sexual Risk Behavior|sexual risk behavior
27564|NCT03112369|Trauma|trauma
27565|NCT03112369|Substance Use|substance use
27566|NCT03112356|infectious endocarditis|infectious endocarditis
27567|NCT03112356|prosthetic valve infection|prosthetic valve infection
27568|NCT03112356|implantable cardiac device infection|implantable cardiac device infection
27569|NCT03112356|99mTc-Leukoscan® scintigraphy|99mtc-leukoscan® scintigraphy
27570|NCT03112343|ICT based clinical trial|ict based clinical trial
27571|NCT03112343|Contract research organization (CRO)|contract research organization (cro)
27572|NCT03112343|eCRF|ecrf
27573|NCT03112343|Joint Electronic-institutional review board (eIRB)|joint electronic-institutional review board (eirb)
27574|NCT03112343|Centralized monitoring|centralized monitoring
27575|NCT03112330|atrophic rhinitis|atrophic rhinitis
27576|NCT03112317|Surgery|surgery
27590|NCT03112304|cognitive-behavioral therapy|cognitive-behavioral therapy
27591|NCT03112304|mental health|mental health
27592|NCT03112291|anti-microbial agents|anti-microbial agents
27593|NCT03112291|apexification|apexification
27594|NCT03112291|dental pulp|dental pulp
27595|NCT03112291|endodontics|endodontics
27596|NCT03112291|root canal therapy|root canal therapy
27597|NCT03112291|dental trauma|dental trauma
27598|NCT03112278|tooth erosion|tooth erosion
27599|NCT03112278|Computer-Aided Design|computer-aided design
27600|NCT03112278|occlusal veneers|occlusal veneers
27601|NCT03112278|dental veneers|dental veneers
27603|NCT03112265|depression|depression
27604|NCT03112265|trauma|trauma
27605|NCT03112265|behavior problems|behavior problems
27606|NCT03112265|evidence-based treatments|evidence-based treatments
27607|NCT03112265|manualized treatments|manualized treatments
27608|NCT03112265|cognitive-behavioral therapy|cognitive-behavioral therapy
27609|NCT03112265|youth|youth
27610|NCT03112265|mental health|mental health
27611|NCT03112265|self-regulation|self-regulation
27612|NCT03112265|neuroimaging|neuroimaging
27613|NCT03112252|Immunotherapy|immunotherapy
27614|NCT03112239|Asthma|asthma
27634|NCT03112187|Liposomal iron|liposomal iron
27635|NCT03112174|PCYC|pcyc
27636|NCT03112174|MCL|mcl
27637|NCT03112174|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
27638|NCT03112174|NHL|nhl
27639|NCT03112174|ibrutinib|ibrutinib
27640|NCT03112174|venetoclax|venetoclax
27641|NCT03112174|Pharmacyclics|pharmacyclics
27642|NCT03112122|Bone Marrow Edema|bone marrow edema
27643|NCT03112122|Mesenchymal Stem Cells|mesenchymal stem cells
27644|NCT03112096|Tau|tau
27645|NCT03112096|neurodegeneration|neurodegeneration
27646|NCT03112096|positron emission tomography|positron emission tomography
27647|NCT03112083|krill powder|krill powder
27648|NCT03112083|krill oil|krill oil
27649|NCT03112083|safety|safety
27650|NCT03112083|tolerability|tolerability
27651|NCT03112083|adverse event|adverse event
27652|NCT03112083|omega-3 fatty acids|omega-3 fatty acids
27653|NCT03112083|eicosapentaenoic acid|eicosapentaenoic acid
27654|NCT03112083|docosahexaenoic acid|docosahexaenoic acid
27655|NCT03112044|Lung|lung
27656|NCT03112044|Transplant|transplant
27657|NCT03112044|Hepatitis C|hepatitis c
27658|NCT03112044|DAAs|daas
27659|NCT03112044|Epclusa|epclusa
27660|NCT03112031|Tamoxifen|tamoxifen
27661|NCT03112031|Cryptococcal meningitis|cryptococcal meningitis
27662|NCT03112031|Cryptococcus neoformans|cryptococcus neoformans
27663|NCT03112031|Human immunodeficiency virus|human immunodeficiency virus
27664|NCT03112018|premature birth|premature birth
27665|NCT03112018|neonatal mortality|neonatal mortality
27666|NCT03112018|premature infant|premature infant
27667|NCT03112005|Diabetic Eye Disease|diabetic eye disease
27668|NCT03111992|Myeloma,|myeloma,
27669|NCT03111992|Multiple Myeloma,|multiple myeloma,
27670|NCT03111992|Hematologic Diseases,|hematologic diseases,
27671|NCT03111992|Myeloma, Multiple,|myeloma, multiple,
27672|NCT03111992|Myeloma-Multiple,|myeloma-multiple,
27673|NCT03111992|Programmed Cell Death 1 Receptor|programmed cell death 1 receptor
27674|NCT03111979|beta-alanine|beta-alanine
27675|NCT03111979|Carnosine|carnosine
27676|NCT03111979|Neuromuscular|neuromuscular
27677|NCT03111979|Stimulation|stimulation
27678|NCT03111979|Skeletal muscle|skeletal muscle
27679|NCT03111966|Hepatitis C|hepatitis c
27680|NCT03111953|Bariatric Surgery|bariatric surgery
27681|NCT03111953|Roux-en-Y gastric bypass|roux-en-y gastric bypass
27682|NCT03111953|Biliopancreatic Diversion|biliopancreatic diversion
27779|NCT03111368|eus-fna|eus-fna
27686|NCT03111901|interleukin-2|interleukin-2
27687|NCT03111901|MK-3475|mk-3475
27688|NCT03111875|Hypothermia|hypothermia
27689|NCT03111875|Intraoperative warming|intraoperative warming
27690|NCT03111875|non-cardiac surgery|non-cardiac surgery
27691|NCT03111875|myocardial injury|myocardial injury
27692|NCT03111849|COPD|copd
27693|NCT03111849|Sarcopenia|sarcopenia
27694|NCT03111849|Prevalence|prevalence
27695|NCT03111849|Mortality|mortality
27696|NCT03111849|Malnutrition|malnutrition
27697|NCT03111849|Nutritional assessment|nutritional assessment
27698|NCT03111849|Body composition|body composition
27699|NCT03111849|Pulmonary cachexia|pulmonary cachexia
27700|NCT03111810|Corticosteroids|corticosteroids
27701|NCT03111810|Prednisolone|prednisolone
27702|NCT03111810|11 beta-Hydroxysteroid dehydrogenase1 inhibitor|11 beta-hydroxysteroid dehydrogenase1 inhibitor
27703|NCT03111810|Iatrogenic Cushing's disease|iatrogenic cushing's disease
27704|NCT03111810|AZD4017|azd4017
27705|NCT03111784|Fish Consumption, Fatty acid composition, Lipid Profile, Tocopherol, Sociodemographics|fish consumption, fatty acid composition, lipid profile, tocopherol, sociodemographics
27706|NCT03111771|Cancer|cancer
27707|NCT03111771|Cachexia|cachexia
27708|NCT03111771|Myosteatosis|myosteatosis
27709|NCT03111771|Mitochondrial activity|mitochondrial activity
27710|NCT03111771|Upper aerodigestive pathways|upper aerodigestive pathways
27711|NCT03111771|Lipotoxicity|lipotoxicity
27715|NCT03111732|Immune-Based Strategies|immune-based strategies
27716|NCT03111732|Anti-PD1 Therapy|anti-pd1 therapy
27717|NCT03111732|Chronic Inflammation|chronic inflammation
27718|NCT03111732|Combination Chemotherapy|combination chemotherapy
27719|NCT03111693|Epicardial fat|epicardial fat
27720|NCT03111693|Obesity|obesity
27721|NCT03111693|Cardiovascular risks markers|cardiovascular risks markers
27722|NCT03111693|Metabolic syndrome|metabolic syndrome
27723|NCT03111693|Low dose computed tomography|low dose computed tomography
27724|NCT03111667|Marijuana|marijuana
583410|NCT00511628|Schizophreniform disorder|schizophreniform disorder
27725|NCT03111667|Motivational Enhancement Therapy|motivational enhancement therapy
27726|NCT03111667|Adolescents|adolescents
27727|NCT03111615|Aromatase inhibitors|aromatase inhibitors
27728|NCT03111615|Luminal Breast Cancer neoadjuvant hormone therapy|luminal breast cancer neoadjuvant hormone therapy
27729|NCT03111602|polyphenols|polyphenols
27730|NCT03111602|pregnant|pregnant
27731|NCT03111602|fetal ductal constriction|fetal ductal constriction
27732|NCT03111602|prostaglandin E2|prostaglandin e2
27733|NCT03111589|Sickle Cell Disease|sickle cell disease
27734|NCT03111589|Heme oxidase-1 (HO-1)|heme oxidase-1 (ho-1)
27735|NCT03110497|Cervical cancer|cervical cancer
27736|NCT03110497|Image guided Brachytherapy|image guided brachytherapy
27737|NCT03110497|single application|single application
27738|NCT03110471|Cognitive impairment|cognitive impairment
27739|NCT03110471|antipsychotics|antipsychotics
27740|NCT03110471|antidepressants|antidepressants
27741|NCT03110458|Acute unilateral vestibulopathy, AUV|acute unilateral vestibulopathy, auv
27742|NCT03110419|Elderly|elderly
27743|NCT03110419|Frailty|frailty
27744|NCT03110419|Multicomponent training|multicomponent training
27745|NCT03110419|Physical exercise|physical exercise
27746|NCT03110419|Functional capacity|functional capacity
27747|NCT03110419|Complexity|complexity
27748|NCT03110419|Physical Therapy|physical therapy
27749|NCT03110406|renal transplant recipients|renal transplant recipients
27750|NCT03110406|exercise|exercise
27751|NCT03110406|heart rate variability|heart rate variability
27752|NCT03110406|Cardiovascular mortality|cardiovascular mortality
27753|NCT03111537|cigarette|cigarette
27754|NCT03111537|smoking|smoking
27755|NCT03111537|snus|snus
27756|NCT03111537|e-cigarette|e-cigarette
27757|NCT03111537|nicotine replacement therapy|nicotine replacement therapy
27758|NCT03111537|nrt|nrt
27759|NCT03111537|tobacco|tobacco
27760|NCT03111524|stuttering|stuttering
27761|NCT03111524|children who stutter|children who stutter
27762|NCT03111524|peer attitudes|peer attitudes
27763|NCT03111524|classroom-based intervention|classroom-based intervention
27764|NCT03111524|teasing|teasing
27765|NCT03111524|bullying|bullying
27766|NCT03111498|Vacuum assisted delivery|vacuum assisted delivery
27767|NCT03111498|technical skills|technical skills
27768|NCT03111498|training|training
27769|NCT03111459|endograft repair,|endograft repair,
27770|NCT03111433|Type 1 Diabetes mellitus|type 1 diabetes mellitus
27771|NCT03111433|Coenzyme Q10|coenzyme q10
27772|NCT03111433|endothelial dysfunction|endothelial dysfunction
27773|NCT03111433|pediatric patients|pediatric patients
27774|NCT03111407|primary total knee arthroplasty|primary total knee arthroplasty
27775|NCT03111394|MS|ms
27776|NCT03111394|23andMe|23andme
27777|NCT03111394|MRI|mri
27778|NCT03111394|Genome-wide association studies|genome-wide association studies
27780|NCT03111368|pancreatic neoplasm|pancreatic neoplasm
27781|NCT03111368|slow-pull|slow-pull
27782|NCT03111368|negative pressure|negative pressure
27783|NCT03111355|nuts|nuts
27784|NCT03111355|micronutrients|micronutrients
27785|NCT03111355|nutrigenomics|nutrigenomics
27786|NCT03111355|nutrigenetics|nutrigenetics
27787|NCT03111342|Intrauterine contraception|intrauterine contraception
27788|NCT03111342|Pain|pain
27789|NCT03111342|Anesthesia|anesthesia
27790|NCT03111342|LNG-IUD|lng-iud
27791|NCT03111342|nulligravida|nulligravida
27792|NCT03111329|Gastric residuals assessment|gastric residuals assessment
27793|NCT03111329|Prematurity|prematurity
27794|NCT03111329|Necrotizing Enterocolitis of Newborn|necrotizing enterocolitis of newborn
27795|NCT03111329|Sepsis Newborn|sepsis newborn
27796|NCT03111329|Nutrition of newborn|nutrition of newborn
27797|NCT03111329|feeding tolerance of newborn|feeding tolerance of newborn
27798|NCT03111316|Cervical Ripening|cervical ripening
27799|NCT03111316|Induction of Labor|induction of labor
27800|NCT03111290|Facial recognition|facial recognition
27801|NCT03111277|neuropathic pain|neuropathic pain
27802|NCT03111264|Overweight|overweight
27803|NCT03111264|Obesity|obesity
27804|NCT03111264|Prevention|prevention
27806|NCT03111264|Childcare|childcare
27807|NCT03111264|Physical Activity|physical activity
27808|NCT03111264|Nutrition|nutrition
27809|NCT03111264|Wellness|wellness
27810|NCT03111264|Environment|environment
27811|NCT03111264|Intervention|intervention
27812|NCT03111264|Feeding|feeding
27813|NCT03111238|Autologous|autologous
27814|NCT03111238|Bone Marrow-derived Mononuclear Cells (BM-MNCs)|bone marrow-derived mononuclear cells (bm-mncs)
27815|NCT03111238|Advanced Therapy Medicinal Product (ATMP)|advanced therapy medicinal product (atmp)
27816|NCT03111238|Tissue-engineered Medicinal Product|tissue-engineered medicinal product
27817|NCT03111238|Revascularization|revascularization
27818|NCT03111238|Angiogenesis|angiogenesis
27819|NCT03111238|Vasculogenesis|vasculogenesis
27820|NCT03111238|Arteriogenesis|arteriogenesis
27821|NCT03111212|Acute respiratory distress syndrome|acute respiratory distress syndrome
27822|NCT03111199|Low back pain|low back pain
27823|NCT03111199|Analgesia|analgesia
27824|NCT03111199|Physical therapy|physical therapy
27825|NCT03111186|oxycodone|oxycodone
27826|NCT03111186|ibuprofen|ibuprofen
27827|NCT03111186|acetaminophen|acetaminophen
27828|NCT03111186|soft-tissue hand surgery|soft-tissue hand surgery
27829|NCT03111186|carpal tunnel release|carpal tunnel release
27830|NCT03111186|Dupuytren contracture release|dupuytren contracture release
27831|NCT03111186|Trigger digit release|trigger digit release
27832|NCT03111186|Ganglion cyst removal|ganglion cyst removal
27833|NCT03111186|De Quervain's release|de quervain's release
27834|NCT03111173|ECG|ecg
27835|NCT03111173|Fetus|fetus
27836|NCT03111173|R peak extraction|r peak extraction
27837|NCT03111160|Small-incision lenticule extraction|small-incision lenticule extraction
27838|NCT03111160|femtosecond laser|femtosecond laser
27839|NCT03111160|lower laser energy level|lower laser energy level
27840|NCT03111160|early visual recovery|early visual recovery
27841|NCT03111134|abdominal wound closure techniques|abdominal wound closure techniques
27842|NCT03111134|layered closure|layered closure
27843|NCT03111134|component separation technique|component separation technique
27844|NCT03111121|deeply anesthetized|deeply anesthetized
27845|NCT03111121|ideal surgical exposure|ideal surgical exposure
27846|NCT03111121|muscle relaxation|muscle relaxation
27847|NCT03111121|Adults|adults
27848|NCT03111069|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
27849|NCT03111069|Pelvic and Abdominal Rhabdomyosarcoma|pelvic and abdominal rhabdomyosarcoma
27850|NCT03111069|Undifferentiated Sarcomas|undifferentiated sarcomas
28516|NCT03106727|NCD|ncd
27851|NCT03111069|Unresectable or Refractory|unresectable or refractory
27852|NCT03111069|Abdominal tumors|abdominal tumors
27853|NCT03111069|Hyperthermic intra-peritoneal chemotherapy|hyperthermic intra-peritoneal chemotherapy
27854|NCT03111069|HIPEC|hipec
27855|NCT03111069|Abdominal surgery|abdominal surgery
27856|NCT03111069|Doxorubicin|doxorubicin
27857|NCT03111069|Doxorubicin Hydrochloride|doxorubicin hydrochloride
27858|NCT03111069|Adriamycin PFS|adriamycin pfs
27859|NCT03111069|Adriamycin RDF|adriamycin rdf
27860|NCT03111069|Adriamycin|adriamycin
27861|NCT03111069|Rubex|rubex
27862|NCT03111069|Intra-operative radiation|intra-operative radiation
27863|NCT03111069|IORT|iort
27864|NCT03111069|Brachytherapy|brachytherapy
27865|NCT03111043|computed tomography|computed tomography
27866|NCT03111043|Sudden cardiac arrest|sudden cardiac arrest
27867|NCT03111043|Cardiac computed tomography|cardiac computed tomography
27868|NCT03111043|Diagnostic accuracy|diagnostic accuracy
27869|NCT03111043|Clinical outcome|clinical outcome
27870|NCT03111017|muscle sympathetic nerve activity|muscle sympathetic nerve activity
27871|NCT03111017|exercise tolerance|exercise tolerance
27872|NCT03111017|exercise training|exercise training
27873|NCT03111017|peak oxygen uptake|peak oxygen uptake
27874|NCT03111004|information technology|information technology
27875|NCT03111004|telemedicine|telemedicine
27883|NCT03110991|Prevention|prevention
27884|NCT03110991|Non-professional caregivers|non-professional caregivers
27885|NCT03110991|App|app
27886|NCT03110978|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
19723|NCT03163667|advanced, metastatic RCC|advanced, metastatic rcc
19725|NCT03163667|CB-839|cb-839
19726|NCT03163667|Everolimus|everolimus
27887|NCT03110978|Non-small Cell Lung Cancer|non-small cell lung cancer
27888|NCT03110978|NSCLC|nsclc
27889|NCT03110978|Squamous cell carcinoma|squamous cell carcinoma
27890|NCT03110978|Adenocarcinoma|adenocarcinoma
27891|NCT03110978|Large cell carcinoma|large cell carcinoma
27892|NCT03110978|Bronchioloalveolar cell carcinoma|bronchioloalveolar cell carcinoma
27893|NCT03110978|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
27894|NCT03110978|SABR|sabr
27895|NCT03110978|Nivolumab|nivolumab
27896|NCT03110978|BMS-936558|bms-936558
27897|NCT03110978|Opdivo|opdivo
27898|NCT03110978|Immunotherapy|immunotherapy
27899|NCT03110913|Healthy|healthy
27900|NCT03110913|Men|men
27901|NCT03110913|Adults|adults
27902|NCT03110913|Methionine|methionine
27903|NCT03110887|Dynamic prediction model|dynamic prediction model
27904|NCT03110822|Ruxolitinib|ruxolitinib
27905|NCT03110822|Steroids|steroids
27906|NCT03110822|Lenalidomide|lenalidomide
27907|NCT03110822|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
27908|NCT03110809|obesity|obesity
27909|NCT03110809|brown|brown
27911|NCT03110809|weight|weight
27912|NCT03110809|loss|loss
27913|NCT03110783|Bioseal as an Adjunct to Sutured Dural Repair|bioseal as an adjunct to sutured dural repair
27914|NCT03110783|elective posterior fossa|elective posterior fossa
27915|NCT03110783|supratentorial procedure|supratentorial procedure
27923|NCT03110757|AP 10-701|ap 10-701
27924|NCT03110757|healthy adults|healthy adults
27925|NCT03110757|Immunogenicity|immunogenicity
27926|NCT03110757|Phase Ib|phase ib
27927|NCT03110757|Reactogenicity|reactogenicity
27928|NCT03110757|Safety|safety
27929|NCT03110757|Schistosomiasis|schistosomiasis
27930|NCT03110757|Sm-TSP-2/Alhydrogel®|sm-tsp-2/alhydrogel®
27931|NCT03110718|robotic rehabilitation|robotic rehabilitation
27932|NCT03110718|muscle vibration|muscle vibration
27938|NCT03110666|injections|injections
27939|NCT03110627|Single-chamber ICD (implantable cardioverter-defibrillator)|single-chamber icd (implantable cardioverter-defibrillator)
27940|NCT03110627|Cardiac Arrhythmias|cardiac arrhythmias
27941|NCT03110627|Atrial fibrillation|atrial fibrillation
27942|NCT03110627|Atrial flutter|atrial flutter
27943|NCT03110627|Stroke|stroke
27944|NCT03110614|COPD|copd
27945|NCT03110614|acute|acute
27946|NCT03110614|exacerbation|exacerbation
27947|NCT03110614|lung ultrasound|lung ultrasound
27948|NCT03110588|metastatic prostate cancer|metastatic prostate cancer
27949|NCT03110588|castration-resistant prostate cancer|castration-resistant prostate cancer
27950|NCT03110588|PACE (Prednisone, Abiraterone, Cabazitaxel, and Enzalutamide)|pace (prednisone, abiraterone, cabazitaxel, and enzalutamide)
27951|NCT03110575|TNX-102 SL|tnx-102 sl
27952|NCT03110575|Bedtime|bedtime
27953|NCT03110575|Sublingual|sublingual
27954|NCT03110575|3-month|3-month
27955|NCT03110575|Safety|safety
27956|NCT03110575|Efficacy|efficacy
27957|NCT03110575|PTSD|ptsd
27958|NCT03110562|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
27959|NCT03110562|RRMM|rrmm
27960|NCT03110562|Bortezomib|bortezomib
27961|NCT03110562|Dexamethasone|dexamethasone
27962|NCT03110536|Burnout syndrome|burnout syndrome
27963|NCT03110536|Triage|triage
27964|NCT03110536|Nurse|nurse
27965|NCT03110536|Emergency Department|emergency department
27966|NCT03110536|Romania|romania
27967|NCT03110393|Obese|obese
27968|NCT03110393|Laryngeal Mask Airway|laryngeal mask airway
27969|NCT03110393|Anaesthesia|anaesthesia
27970|NCT03110354|AML|aml
27971|NCT03110354|ALL|all
27972|NCT03110315|Multiple Sclerosis|multiple sclerosis
27973|NCT03110315|Fatigue|fatigue
27974|NCT03110315|Insomnia|insomnia
27975|NCT03110315|Suvorexant|suvorexant
27976|NCT03110315|Belsomra|belsomra
27977|NCT03110315|Sleep disorder|sleep disorder
27978|NCT03110315|Sleep|sleep
27983|NCT03110302|Prolonged Exposure|prolonged exposure
27984|NCT03110289|Fecal microbiota transplantation|fecal microbiota transplantation
27985|NCT03110250|Familial Hypercholesterolemia|familial hypercholesterolemia
27986|NCT03110250|registry|registry
27987|NCT03110250|Turkey|turkey
27988|NCT03110250|Lipid lowering therapy|lipid lowering therapy
27995|NCT03110198|Mesalazine|mesalazine
27996|NCT03110198|Ulcerative Colitis(UC)|ulcerative colitis(uc)
27997|NCT03110198|Enema|enema
27998|NCT03110172|Osteoarthritis|osteoarthritis
27999|NCT03110172|Depression|depression
28000|NCT03110172|Pain|pain
28001|NCT03110159|Photodynamic therapy|photodynamic therapy
28002|NCT03110159|Prevention|prevention
28003|NCT03110159|Actinic Keratosis|actinic keratosis
28004|NCT03110159|Skin Cancer|skin cancer
28005|NCT03110159|Non-melanoma Skin Cancer|non-melanoma skin cancer
28006|NCT03110159|Sun Damaged Skin|sun damaged skin
19831|NCT03163108|hypoxia|hypoxia
28007|NCT03110159|Solid Organ Transplant|solid organ transplant
28008|NCT03110159|PDT|pdt
28009|NCT03110133|Clostridium Difficile Infection|clostridium difficile infection
28010|NCT03110133|CP101|cp101
28011|NCT03110133|Crestovo|crestovo
28012|NCT03110133|FMT|fmt
28013|NCT03110133|CDI|cdi
28014|NCT03110133|C. difficile|c. difficile
28015|NCT03110068|microvascular invasion|microvascular invasion
28016|NCT03110068|serum biomarker|serum biomarker
28017|NCT03110068|radiological feature|radiological feature
28018|NCT03110068|pathological differentiation|pathological differentiation
28019|NCT03110003|Neuraxial epidural techniques|neuraxial epidural techniques
28020|NCT03110003|Combined spinal epidural|combined spinal epidural
28021|NCT03110003|Epidural volume extension|epidural volume extension
28022|NCT03110003|Transient Neurologic Symptoms (TNS)|transient neurologic symptoms (tns)
28023|NCT03109977|17-059|17-059
28024|NCT03109977|Zr-DFO-pertuzumab|zr-dfo-pertuzumab
28025|NCT03109951|Type 2 diabetes|type 2 diabetes
28026|NCT03109951|colonoscopy|colonoscopy
28027|NCT03109951|hypoglycemia|hypoglycemia
28028|NCT03109951|hyperglycemia|hyperglycemia
28029|NCT03109951|polyethylene glycol|polyethylene glycol
28030|NCT03109925|PAE|pae
28031|NCT03109925|embolization|embolization
28033|NCT03109925|prostate artery embolization|prostate artery embolization
28034|NCT03109925|radio-opaque embolic|radio-opaque embolic
28035|NCT03109899|mHealth|mhealth
28036|NCT03109899|HIV Prevention|hiv prevention
28040|NCT03109860|Chronic neuropathic pain|chronic neuropathic pain
28041|NCT03109834|Weight Management Programs|weight management programs
28042|NCT03109834|Weight loss stabilization|weight loss stabilization
28043|NCT03109834|Cardiometabolic risk|cardiometabolic risk
28044|NCT03109821|Exercise Therapy|exercise therapy
28045|NCT03109821|Rehabilitation|rehabilitation
28046|NCT03109782|Spinal Cord Injury|spinal cord injury
28047|NCT03109782|Spine Surgery|spine surgery
28048|NCT03109782|Patient Registry|patient registry
28049|NCT03109782|Trauma|trauma
28050|NCT03109743|HIV treatment|hiv treatment
28051|NCT03109743|Adherence Group Treatment|adherence group treatment
28052|NCT03109717|Treatment Resistant Depression|treatment resistant depression
28053|NCT03109704|scapular kinematics|scapular kinematics
28054|NCT03109704|thoracic spine|thoracic spine
28055|NCT03109704|thrust manipulation|thrust manipulation
28056|NCT03109652|total knee replacement arthroplasty|total knee replacement arthroplasty
28057|NCT03109652|total knee arthroplasty|total knee arthroplasty
28058|NCT03109652|tranexamic acid|tranexamic acid
28059|NCT03109652|oral tranexamic acid|oral tranexamic acid
28060|NCT03109652|transfusion|transfusion
28061|NCT03109652|blood loss|blood loss
28062|NCT03109639|EUS|eus
28063|NCT03109639|FNA|fna
28064|NCT03109639|FNB|fnb
28065|NCT03109639|Core Histology|core histology
28066|NCT03109626|DHA, replacement, treatment, brain PET-FDG, ataxia|dha, replacement, treatment, brain pet-fdg, ataxia
28067|NCT03109613|Positive end-expiratory pressure|positive end-expiratory pressure
28068|NCT03109613|PEEP|peep
28069|NCT03109613|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
28070|NCT03109613|Ventilator Induced Lung Injury|ventilator induced lung injury
28071|NCT03109613|V/Q mismatch|v/q mismatch
28072|NCT03109522|axillary reverse mapping (ARM)|axillary reverse mapping (arm)
28073|NCT03109522|sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
28074|NCT03109522|axillary lymph node dissection (ALND)|axillary lymph node dissection (alnd)
28079|NCT03109496|Otitis Media with Effusion|otitis media with effusion
28080|NCT03109496|Microbiota|microbiota
28081|NCT03109496|Microbiome|microbiome
28082|NCT03109496|URT|urt
28083|NCT03109496|Upper Respiratory Tract|upper respiratory tract
28084|NCT03109496|Healthy URT microbiota|healthy urt microbiota
28085|NCT03109483|geriatric patients|geriatric patients
28086|NCT03109483|elderly|elderly
28087|NCT03109483|multicomponent physical therapy|multicomponent physical therapy
28088|NCT03109470|Tocilizumab|tocilizumab
28089|NCT03109470|Early Rheumatoid Arthritis|early rheumatoid arthritis
28090|NCT03109470|Observational|observational
28091|NCT03109470|Canadian|canadian
28092|NCT03109457|Hepatitis C Virus|hepatitis c virus
28093|NCT03109457|Oral squamous cell carcinoma|oral squamous cell carcinoma
28094|NCT03109444|Hip Growth Chart|hip growth chart
28095|NCT03109431|HIV Treatment Continuum|hiv treatment continuum
28096|NCT03109431|HIV Disease Progression|hiv disease progression
28097|NCT03109431|Mental Health|mental health
28098|NCT03109431|Substance Use|substance use
28099|NCT03109431|ARV Adherence|arv adherence
28100|NCT03109431|Retention in Care|retention in care
28101|NCT03109431|STI|sti
28102|NCT03109418|Ketamine|ketamine
28103|NCT03109418|Postoperative morbidity|postoperative morbidity
28104|NCT03109353|Photopheresis|photopheresis
28105|NCT03109353|5-aminolevulinic acid|5-aminolevulinic acid
28106|NCT03109353|Extracorporeal Circulation|extracorporeal circulation
28107|NCT03109340|abdominal obesity|abdominal obesity
28108|NCT03109340|walking|walking
28109|NCT03109340|aerobic exercise|aerobic exercise
28110|NCT03109314|amblyopia|amblyopia
28111|NCT03109314|donepezil|donepezil
28112|NCT03109314|perceptual learning|perceptual learning
28113|NCT03109314|crowding|crowding
28114|NCT03109314|contrast sensitivity|contrast sensitivity
28115|NCT03109314|visual acuity|visual acuity
28119|NCT03109288|Targeted Therapy|targeted therapy
28120|NCT03109288|Multiple Sclerosis|multiple sclerosis
28121|NCT03109288|Biomarkers|biomarkers
28122|NCT03109288|Combination Therapy|combination therapy
28123|NCT03109184|Dating violence prevention|dating violence prevention
28124|NCT03109184|Adolescent boys|adolescent boys
28125|NCT03109184|Middle school|middle school
28126|NCT03109184|Web-based prevention|web-based prevention
28127|NCT03109171|Endoscopy|endoscopy
28128|NCT03109171|Lasers|lasers
28129|NCT03109171|Fiber Optic Technology|fiber optic technology
28130|NCT03109171|Bronchoscopy|bronchoscopy
28131|NCT03109171|Esthesiometer|esthesiometer
28132|NCT03109171|Mechanoreceptors|mechanoreceptors
28133|NCT03109171|Diagnosis|diagnosis
28134|NCT03109171|Reflex|reflex
28135|NCT03109171|Reproducibility of Results|reproducibility of results
28136|NCT03109171|Reliability of Results|reliability of results
28137|NCT03109171|Validity of Results|validity of results
28138|NCT03109171|Sensory Thresholds|sensory thresholds
28139|NCT03109158|squamous cell carcinoma|squamous cell carcinoma
28140|NCT03109158|head|head
28141|NCT03109158|neck|neck
28142|NCT03109145|Shared decision making|shared decision making
28143|NCT03109145|Knowledge|knowledge
28144|NCT03109145|Patient portal|patient portal
28147|NCT03109119|Sevoflurane|sevoflurane
28148|NCT03109119|General anaesthesia|general anaesthesia
28149|NCT03109106|MICU|micu
28150|NCT03109106|CICU|cicu
28151|NCT03109106|PCT - Procalcitonin|pct - procalcitonin
28152|NCT03109106|B·R·A·H·M·S PCT sensitive Kryptor®|b·r·a·h·m·s pct sensitive kryptor®
28153|NCT03109106|Antibiotic initiation|antibiotic initiation
28154|NCT03109106|Antibiotic de-escalation|antibiotic de-escalation
28155|NCT03109093|ALL|all
28156|NCT03109093|acute lymphoblastic leukemia|acute lymphoblastic leukemia
28157|NCT03109093|MRD positive|mrd positive
28158|NCT03109093|minimal residual disease|minimal residual disease
28159|NCT03109093|blinatumomab|blinatumomab
28160|NCT03109067|Cholesterol, HDL, Postprandial Period, Polymorphism, Genetic|cholesterol, hdl, postprandial period, polymorphism, genetic
28161|NCT03109054|Melatonin|melatonin
28162|NCT03109054|Anxiety|anxiety
28163|NCT03109041|Whipple|whipple
28164|NCT03109041|brachytherapy|brachytherapy
28165|NCT03109041|CivaSheet|civasheet
28166|NCT03109041|CivaTech Oncology|civatech oncology
28167|NCT03109041|radiation|radiation
28168|NCT03109041|intraoperative radiation|intraoperative radiation
28169|NCT03109041|IORT|iort
28170|NCT03109041|resectable pancreatic cancer|resectable pancreatic cancer
28171|NCT03109041|Pd-103|pd-103
28172|NCT03109015|metastatic renal cell carcinoma|metastatic renal cell carcinoma
28173|NCT03109015|sunitinib|sunitinib
28174|NCT03109015|Sutent|sutent
28175|NCT03109015|cardiopulmonary function|cardiopulmonary function
28177|NCT03108976|Sensori-motor learning|sensori-motor learning
28178|NCT03108976|Development|development
28179|NCT03108976|Neuroimaging|neuroimaging
28180|NCT03108872|Anticoagulants|anticoagulants
28181|NCT03108872|Atrial Appendage|atrial appendage
28182|NCT03108872|Stroke|stroke
28183|NCT03108846|Alzheimer's Disease|alzheimer's disease
28184|NCT03108846|Agitation|agitation
28185|NCT03108807|Emergency Department|emergency department
28186|NCT03108807|Medical patients|medical patients
28187|NCT03108807|D-dimer|d-dimer
28188|NCT03108807|National Early Warning Score|national early warning score
28189|NCT03108807|NEWS|news
28190|NCT03108807|30-days mortality|30-days mortality
28191|NCT03108807|Mortality|mortality
28192|NCT03108794|hepatitis B，registry,cirrhosis, HCC|hepatitis b，registry,cirrhosis, hcc
28193|NCT03108781|Dementia|dementia
28194|NCT03108781|Behavioral Psychiatric symptoms|behavioral psychiatric symptoms
28195|NCT03108781|Treatment|treatment
28196|NCT03108755|ASP7713|asp7713
28197|NCT03108729|epilepsy|epilepsy
28198|NCT03108729|partial on-set seizures|partial on-set seizures
28199|NCT03108703|RCC|rcc
28200|NCT03108703|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
28201|NCT03108703|SBRT|sbrt
28202|NCT03108703|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
28203|NCT03108703|SABR|sabr
28204|NCT03108690|Therapeutic drug monitoring|therapeutic drug monitoring
28205|NCT03108690|Continuous infusion|continuous infusion
28206|NCT03108690|Beta-lactam|beta-lactam
28207|NCT03108690|Antibiotics|antibiotics
28208|NCT03108690|Bacteraemia|bacteraemia
28209|NCT03108677|RNA profiling|rna profiling
28210|NCT03108677|Exosome|exosome
28211|NCT03108677|Lung Metastases|lung metastases
28212|NCT03108677|Osteosarcoma|osteosarcoma
28213|NCT03108664|SYL1001|syl1001
28214|NCT03108664|siRNA|sirna
28215|NCT03108625|children|children
28216|NCT03108625|adolescent|adolescent
28219|NCT03108599|Health Promotion|health promotion
28220|NCT03108599|Injury Prevention|injury prevention
28221|NCT03108599|Safety|safety
28222|NCT03108599|Wellbeing|wellbeing
28223|NCT03108599|Physical Activity|physical activity
28224|NCT03108599|Sleep|sleep
28225|NCT03108599|Whole Body Vibration|whole body vibration
28226|NCT03108599|Self-Monitoring|self-monitoring
28227|NCT03108586|restorations|restorations
28228|NCT03108586|diagnosis|diagnosis
28229|NCT03108586|secondary caries|secondary caries
28230|NCT03108586|treatment decision|treatment decision
28231|NCT03108560|sublobar resection|sublobar resection
28232|NCT03108560|lobectomy|lobectomy
28233|NCT03108547|Sarcoidosis|sarcoidosis
28234|NCT03108547|Scalp hair cortisol and testosterone|scalp hair cortisol and testosterone
28235|NCT03108547|Fatigue|fatigue
28236|NCT03108547|Biomarker|biomarker
28237|NCT03108547|Psychological distress|psychological distress
28238|NCT03108521|DPP - 4; GLP1R ; gene polymorphism research; diabetes|dpp - 4; glp1r ; gene polymorphism research; diabetes
28239|NCT03108495|LN-145|ln-145
28240|NCT03108495|Cell Therapy|cell therapy
28241|NCT03108495|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
28242|NCT03108495|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
28243|NCT03108495|Cellular Immuno-therapy|cellular immuno-therapy
28244|NCT03108495|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
28245|NCT03108495|TIL|til
28246|NCT03108495|IL-2|il-2
28247|NCT03108482|Acute Pain|acute pain
28248|NCT03108482|Post-surgical Pain|post-surgical pain
28249|NCT03108482|Bunionectomy|bunionectomy
28250|NCT03108482|Co-crystal|co-crystal
28251|NCT03108482|Tramadol|tramadol
28252|NCT03108482|Celecoxib|celecoxib
28253|NCT03108469|migraine|migraine
28254|NCT03108456|atherectomy|atherectomy
28255|NCT03108456|CAD|cad
28256|NCT03108456|severe calcium|severe calcium
28257|NCT03108456|orbital atherectomy|orbital atherectomy
28258|NCT03108456|minimum stent area|minimum stent area
28259|NCT03108404|predictive score|predictive score
28260|NCT03108378|Gadolinium|gadolinium
28261|NCT03108378|Bone|bone
28262|NCT03108378|Skin|skin
28263|NCT03108300|efficacy|efficacy
28264|NCT03108300|propranolol hydrochloride|propranolol hydrochloride
28265|NCT03108300|sts|sts
28266|NCT03108274|Midazolam|midazolam
28267|NCT03108274|Fexofenadine|fexofenadine
28268|NCT03108274|Mycophenolate Mofetil|mycophenolate mofetil
28269|NCT03108248|transarterial chemoembolization|transarterial chemoembolization
28270|NCT03108248|stent|stent
28271|NCT03108248|irradiation|irradiation
28272|NCT03108248|survival|survival
28273|NCT03108248|decompensation|decompensation
28274|NCT03108248|tumor response|tumor response
28275|NCT03108222|chronic kidney disease|chronic kidney disease
28276|NCT03108222|CKD|ckd
28277|NCT03108222|renal failure|renal failure
28278|NCT03108222|phosphorus|phosphorus
28279|NCT03108222|phosphate|phosphate
28280|NCT03108222|intestinal absorption|intestinal absorption
28281|NCT03108196|bladder cancer， neobladder, detaenial sigmoid, ileal|bladder cancer， neobladder, detaenial sigmoid, ileal
28282|NCT03108157|IVF|ivf
28283|NCT03108157|DONOR EGGS|donor eggs
28284|NCT03108157|ENDOMETRIAL SCRATCH|endometrial scratch
28285|NCT03108157|PIPELLE|pipelle
28286|NCT03108157|ONGOING PREGNANCY|ongoing pregnancy
28287|NCT03108144|smoking cessation|smoking cessation
28288|NCT03108144|alcohol|alcohol
28289|NCT03108144|primary care|primary care
28290|NCT03108144|screening|screening
28291|NCT03108144|brief intervention|brief intervention
28292|NCT03108144|referral to treatment|referral to treatment
28293|NCT03108144|cancer risk|cancer risk
28294|NCT03108131|Malignant Neoplasms of Digestive Organs|malignant neoplasms of digestive organs
28295|NCT03108131|Melanoma and Other Malignant Neoplasms of Skin|melanoma and other malignant neoplasms of skin
28296|NCT03108131|Appendiceal Adenocarcinoma|appendiceal adenocarcinoma
28297|NCT03108131|Cutaneous Squamous Cell Carcinoma|cutaneous squamous cell carcinoma
28298|NCT03108131|Small Bowel Adenocarcinoma|small bowel adenocarcinoma
28299|NCT03108131|Advanced rare tumors|advanced rare tumors
28300|NCT03108131|Cobimetinib|cobimetinib
28301|NCT03108131|Atezolizumab|atezolizumab
28302|NCT03108131|MPDL3280A|mpdl3280a
28303|NCT03108118|Diaphragm dysfunction|diaphragm dysfunction
28304|NCT03108118|Acute respiratory failure|acute respiratory failure
28305|NCT03108118|Weaning|weaning
28306|NCT03108092|Drug Utilization Review|drug utilization review
28307|NCT03108092|Older people|older people
28308|NCT03108092|Health economics|health economics
28309|NCT03108079|Urologic Injuries|urologic injuries
28310|NCT03108079|Urologic Diseases|urologic diseases
28311|NCT03108079|Bladder Infection|bladder infection
28312|NCT03108079|Urinary Tract Infections|urinary tract infections
28313|NCT03108079|Mucosal Inflammation|mucosal inflammation
28314|NCT03108079|Mucosal Infection|mucosal infection
28315|NCT03108079|Bladder Injury|bladder injury
28316|NCT03108079|Catheter Related Infections|catheter related infections
28317|NCT03108079|Catheter Complications|catheter complications
28318|NCT03108079|Catheter Infection|catheter infection
28319|NCT03108079|Indwelling Catheter|indwelling catheter
28320|NCT03108079|Pelvic Floor Disorders|pelvic floor disorders
28321|NCT03108079|Urinary Incontinence|urinary incontinence
28322|NCT03108053|urinary stones|urinary stones
28323|NCT03108053|semirigid ureteroscopy|semirigid ureteroscopy
28324|NCT03108053|guidewire|guidewire
28325|NCT03108027|QVM149,|qvm149,
28326|NCT03108027|asthma,|asthma,
28327|NCT03108027|allergic asthma,|allergic asthma,
28328|NCT03108027|allergy triggered asthma,|allergy triggered asthma,
28329|NCT03108027|reactive asthma,|reactive asthma,
28330|NCT03108027|asthma attack,|asthma attack,
28331|NCT03108027|difficulty breathing|difficulty breathing
28332|NCT03107962|NK/T cell lymphoma|nk/t cell lymphoma
28333|NCT03107962|immunotherapy|immunotherapy
28334|NCT03107962|clinical trial|clinical trial
28335|NCT03107962|RR|rr
28336|NCT03107962|PFS|pfs
28337|NCT03107962|OS|os
28338|NCT03107949|Diaphragm atrophy|diaphragm atrophy
28339|NCT03107949|VIDD|vidd
28340|NCT03107949|weaning failure|weaning failure
28341|NCT03107949|SBT|sbt
28342|NCT03107923|Myocardial fibrosis|myocardial fibrosis
28343|NCT03107923|Aortic Valve Stenosis|aortic valve stenosis
28344|NCT03107923|TAVI|tavi
28345|NCT03107923|Outcome|outcome
28346|NCT03107897|TAVR|tavr
583411|NCT00511628|Weight gain|weight gain
28347|NCT03107897|elevated frailty score|elevated frailty score
28357|NCT03107819|Biomarker discovery|biomarker discovery
28358|NCT03107806|acute coronary syndromes|acute coronary syndromes
28359|NCT03107806|hyperglycemia|hyperglycemia
28360|NCT03107806|hypoglycemia|hypoglycemia
28361|NCT03107806|continuous glucose monitoring|continuous glucose monitoring
28362|NCT03107741|Metabolic Syndrome|metabolic syndrome
28363|NCT03107741|Waist circumference|waist circumference
28364|NCT03107741|Blood pressure|blood pressure
28365|NCT03107741|Triglyceride|triglyceride
28366|NCT03107741|HDL cholesterol|hdl cholesterol
28367|NCT03107728|orthotics|orthotics
28368|NCT03107728|high-energy lower extremity trauma|high-energy lower extremity trauma
28369|NCT03107728|physical therapy|physical therapy
28370|NCT03107728|bracing|bracing
28371|NCT03107728|functional performance|functional performance
28372|NCT03107728|performance assessment|performance assessment
28373|NCT03107715|exclusive breastfeeding|exclusive breastfeeding
28374|NCT03107715|health disparity|health disparity
28375|NCT03107715|prenatal intervention|prenatal intervention
28376|NCT03107689|ILE|ile
28377|NCT03107689|lipid|lipid
28378|NCT03107689|overdose|overdose
28379|NCT03107689|resuscitation|resuscitation
28386|NCT03107637|Embolic Stroke of Undetermined Source|embolic stroke of undetermined source
28387|NCT03107637|transesophageal echocardiography|transesophageal echocardiography
28389|NCT03107637|ischemic stroke|ischemic stroke
28390|NCT03107598|spinal anesthesia|spinal anesthesia
28391|NCT03107598|neonatal outcome|neonatal outcome
28392|NCT03107598|Caesarean Section|caesarean section
28393|NCT03107585|cervical plexus block|cervical plexus block
28394|NCT03107585|thyroidectomy|thyroidectomy
28395|NCT03107585|opioid consumption|opioid consumption
28396|NCT03107559|perfüsion index|perfüsion index
28397|NCT03107559|epidural analgesia|epidural analgesia
28398|NCT03107559|labor|labor
28399|NCT03107546|Syndactyly|syndactyly
28400|NCT03107546|Syndactyly release surgery|syndactyly release surgery
28401|NCT03107546|Full thickness skin graft|full thickness skin graft
28402|NCT03107546|Hyalomatrix|hyalomatrix
28403|NCT03107546|Scar formation|scar formation
28404|NCT03107520|contrast-enhanced ultrasound|contrast-enhanced ultrasound
28405|NCT03107520|Lumason|lumason
28406|NCT03107520|developmental dysplasia of the hip (DDH)|developmental dysplasia of the hip (ddh)
28407|NCT03107520|avascular necrosis|avascular necrosis
28408|NCT03107507|EEG with Periodic Abnormalities|eeg with periodic abnormalities
28409|NCT03107507|Levetiracetam|levetiracetam
28410|NCT03107507|Phenobarbitone|phenobarbitone
28411|NCT03107507|neonatal seizures|neonatal seizures
28412|NCT03107507|Neurodevelopmental Abnormality|neurodevelopmental abnormality
28413|NCT03107481|Acetaminophen|acetaminophen
28414|NCT03107481|Hydromorphone|hydromorphone
28415|NCT03107481|Emergency Department|emergency department
28416|NCT03107481|Narcotics|narcotics
28417|NCT03107481|Analgesics, Opioid|analgesics, opioid
28418|NCT03107481|Analgesics, Non-Narcotic|analgesics, non-narcotic
28419|NCT03107468|Non-surgical treatment|non-surgical treatment
28420|NCT03107468|Acupuncture|acupuncture
28421|NCT03107468|Chuna|chuna
28422|NCT03107468|Physiotherapy|physiotherapy
28423|NCT03107468|Epidural steroid injection|epidural steroid injection
28424|NCT03107455|MitraClip|mitraclip
28425|NCT03107455|Acute mitral regurgitation|acute mitral regurgitation
28426|NCT03107455|Acute myocardial infarction|acute myocardial infarction
28427|NCT03107442|Arterial stiffness|arterial stiffness
28428|NCT03107442|Markers of Inflammation|markers of inflammation
28429|NCT03107442|Exercise|exercise
28430|NCT03107442|Physical fitness|physical fitness
28431|NCT03107442|Cardiovascular risk|cardiovascular risk
28432|NCT03107442|Autoimmune diseases|autoimmune diseases
28433|NCT03107429|Trendelenburg|trendelenburg
28434|NCT03107429|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
28435|NCT03107429|POVL|povl
28436|NCT03107416|Bumetanide|bumetanide
28437|NCT03107416|Diuretic|diuretic
28438|NCT03107416|Transarterial Embolization (TAE)|transarterial embolization (tae)
28439|NCT03107416|17-141|17-141
28440|NCT03107403|dreams bereavement|dreams bereavement
28441|NCT03107403|emotional|emotional
28442|NCT03107403|regulation|regulation
28443|NCT03107403|bereavement|bereavement
28444|NCT03107338|Pre-emptive analgesia; Dexketoprofen trometamol|pre-emptive analgesia; dexketoprofen trometamol
28446|NCT03107208|type 1 diabetes|type 1 diabetes
28447|NCT03107208|children|children
28448|NCT03107208|continuous glucose monitoring|continuous glucose monitoring
618225|NCT00655226|Hepatitis|hepatitis
28449|NCT03107182|HPV- positive HNSCC|hpv- positive hnscc
28450|NCT03107182|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
28451|NCT03107156|Treatment care planning|treatment care planning
28452|NCT03107143|Pressure ulcer prevention|pressure ulcer prevention
28453|NCT03107143|Pressure injury|pressure injury
28454|NCT03107091|Terlipressin|terlipressin
28455|NCT03107091|Terlipressin acetate|terlipressin acetate
28456|NCT03107065|Sweating|sweating
28457|NCT03107026|Binge eating Disorder|binge eating disorder
28458|NCT03107026|dasotraline|dasotraline
28459|NCT03107013|Mass Balance|mass balance
28468|NCT03106935|recurrent pregnancy loss|recurrent pregnancy loss
28469|NCT03106935|Clinical hypothyroidism|clinical hypothyroidism
28470|NCT03106935|Subclinical hypothyroidism|subclinical hypothyroidism
28471|NCT03106935|thyroid stimulating hormone|thyroid stimulating hormone
28472|NCT03106935|thyroid peroxidase antibody|thyroid peroxidase antibody
28473|NCT03106935|Levothyroxine|levothyroxine
28474|NCT03106922|Polyethylene glycol|polyethylene glycol
28475|NCT03106922|Bowel cleansing|bowel cleansing
28476|NCT03106922|Colonoscopy|colonoscopy
28477|NCT03106909|stroke|stroke
28478|NCT03106909|pneumonia|pneumonia
28479|NCT03106909|biomarkers|biomarkers
28480|NCT03106909|pulmonary CT|pulmonary ct
28481|NCT03106883|Attention bias modification|attention bias modification
28482|NCT03106883|Cognitive bias modification|cognitive bias modification
28483|NCT03106883|Eye-tracking|eye-tracking
28484|NCT03106883|Treatment|treatment
28485|NCT03106844|FMT|fmt
28486|NCT03106844|IBD|ibd
28487|NCT03106805|intrauterine device|intrauterine device
28488|NCT03106779|Phase 3|phase 3
28489|NCT03106779|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
28490|NCT03106779|CML|cml
28491|NCT03106779|bosutinib|bosutinib
28492|NCT03106779|ABL001|abl001
28493|NCT03106779|tyrosine kinase inhibitor|tyrosine kinase inhibitor
28494|NCT03106779|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
28495|NCT03106779|chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
28496|NCT03106779|chronic myelocytic leukemia (CML)|chronic myelocytic leukemia (cml)
28497|NCT03106779|chronic granulocytic leukemia (CGL)|chronic granulocytic leukemia (cgl)
28498|NCT03106779|cancer of the white blood cells|cancer of the white blood cells
28499|NCT03106779|clonal bone marrow stem cell disorder|clonal bone marrow stem cell disorder
28500|NCT03106779|proliferation of mature granulocytes|proliferation of mature granulocytes
28501|NCT03106753|External Cephalic Version|external cephalic version
28502|NCT03106753|neuraxial analgesia|neuraxial analgesia
28503|NCT03106740|Microglia|microglia
28504|NCT03106740|Minocycline|minocycline
28505|NCT03106740|Magnetic Resonance Imaging|magnetic resonance imaging
28506|NCT03106740|Positron Emission Tomography|positron emission tomography
28507|NCT03106740|Pain|pain
28508|NCT03106740|Astrocytes|astrocytes
28509|NCT03106740|Glia|glia
28510|NCT03106740|Human|human
28511|NCT03106740|Back Pain|back pain
28512|NCT03106727|Community Health Workers|community health workers
28513|NCT03106727|Maternal and Child Health|maternal and child health
28514|NCT03106727|Integrated Care|integrated care
28515|NCT03106727|Malawi|malawi
28517|NCT03106714|persistence|persistence
28518|NCT03106714|body fluids|body fluids
28519|NCT03106688|PET imaging|pet imaging
28520|NCT03106688|Cannabinoid receptor|cannabinoid receptor
28521|NCT03106688|Opioid receptor|opioid receptor
28522|NCT03106688|Addiction|addiction
28523|NCT03106688|fMRI imaging|fmri imaging
28524|NCT03106675|HIFU|hifu
28525|NCT03106675|MR-HIFU|mr-hifu
28526|NCT03106675|MRgFUs|mrgfus
28527|NCT03106675|MRI-intervention|mri-intervention
28528|NCT03106675|Palliation|palliation
28529|NCT03106662|Mesenchymal stem cell|mesenchymal stem cell
28530|NCT03106662|haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
28531|NCT03106662|graft-versus-host disease|graft-versus-host disease
28532|NCT03106662|engraftment|engraftment
28533|NCT03106636|Preschool-aged|preschool-aged
28534|NCT03106636|Foster children|foster children
28535|NCT03106636|child welfare|child welfare
28536|NCT03106636|Fostercare|fostercare
28537|NCT03106636|Parent training|parent training
28538|NCT03106636|early adversity|early adversity
28539|NCT03106636|curriculum based|curriculum based
28540|NCT03106636|early intervention|early intervention
28541|NCT03106636|preschool|preschool
28542|NCT03106636|foster placement disruptions|foster placement disruptions
28543|NCT03106636|manualized intervention|manualized intervention
28544|NCT03106636|group based intervention|group based intervention
28545|NCT03106636|high-risk children|high-risk children
28546|NCT03106610|Bladder cancer|bladder cancer
28548|NCT03106610|Transitional cell carcinoma|transitional cell carcinoma
28550|NCT03106610|Nivolumab|nivolumab
28551|NCT03106610|BMS-936558|bms-936558
28552|NCT03106610|Opdivo|opdivo
28553|NCT03106610|Questionnaires|questionnaires
28554|NCT03106610|Surveys|surveys
28555|NCT03106597|Peripheral Edema|peripheral edema
28556|NCT03106597|Bioimpedance Analysis|bioimpedance analysis
28557|NCT03106584|Knee pain|knee pain
28558|NCT03106584|Glucosamine|glucosamine
28559|NCT03106584|WOMAC|womac
28560|NCT03106584|Osteoarthritis|osteoarthritis
28561|NCT03106571|Phase 1 clinical trial|phase 1 clinical trial
28562|NCT03106506|Implants|implants
28563|NCT03106506|Conjunctive tissue graft|conjunctive tissue graft
28564|NCT03106506|Prospective study|prospective study
28565|NCT03106480|Pre-diabetes|pre-diabetes
28566|NCT03106480|Diabetes Mellitus|diabetes mellitus
28567|NCT03106480|HIV|hiv
28568|NCT03106480|ART|art
28569|NCT03106480|Body composition|body composition
28570|NCT03106480|Inflammation|inflammation
28571|NCT03106480|Insulin resistance|insulin resistance
28572|NCT03106480|Beta-cell function|beta-cell function
28573|NCT03106480|Pre-Hypertension|pre-hypertension
28574|NCT03106480|Hypertension|hypertension
28575|NCT03106467|appendectomy|appendectomy
28576|NCT03106467|laparoscopic|laparoscopic
28577|NCT03106467|single port|single port
28578|NCT03106467|randomized|randomized
28579|NCT03106389|misoprostol|misoprostol
28580|NCT03106389|transcervical balloon catheter|transcervical balloon catheter
28581|NCT03106389|second trimester|second trimester
28582|NCT03106389|induced abortion|induced abortion
28583|NCT03106337|Thyroid|thyroid
28584|NCT03106337|Follicular Neoplasms|follicular neoplasms
28585|NCT03106337|Bethesda System|bethesda system
28586|NCT03106337|Elastography|elastography
28587|NCT03106337|Doppler ultrasound|doppler ultrasound
28588|NCT03106337|Thyroidectomy|thyroidectomy
28589|NCT03106324|Multiple Myeloma|multiple myeloma
28590|NCT03106324|Non transplant eligible|non transplant eligible
28591|NCT03106324|Revlimid|revlimid
28592|NCT03106324|PASS|pass
28593|NCT03106324|Non-interventional|non-interventional
28594|NCT03106324|Lenalidomide|lenalidomide
28595|NCT03106298|Iron Deficiency|iron deficiency
28596|NCT03106298|Fibroblast Growth Factor 23|fibroblast growth factor 23
28597|NCT03106298|Phosphate|phosphate
28598|NCT03106259|FURESTEM-RA|furestem-ra
28599|NCT03106246|Extracellular vesicles|extracellular vesicles
28600|NCT03106246|Autoimmunity|autoimmunity
28601|NCT03106246|Beta-cell injury|beta-cell injury
28602|NCT03106233|Breast reconstruction|breast reconstruction
28603|NCT03106233|Perforator flap|perforator flap
28604|NCT03106233|Microsurgery|microsurgery
28605|NCT03106168|Extraction|extraction
28606|NCT03106168|Local Anesthetic|local anesthetic
28607|NCT03106168|Mepivacaine|mepivacaine
28608|NCT03106168|Mandibular Molar|mandibular molar
28609|NCT03106142|intervention, improvement strategy|intervention, improvement strategy
28610|NCT03106116|Coronary Heart Disease|coronary heart disease
28611|NCT03106116|Ventricular Function|ventricular function
28612|NCT03106116|Vascular Endothelium|vascular endothelium
28613|NCT03106116|Counterpulsation, External|counterpulsation, external
28614|NCT03106103|urodynamics|urodynamics
28615|NCT03106103|cystitis|cystitis
28616|NCT03106103|prophylactic antibiotics|prophylactic antibiotics
28617|NCT03106103|bacteriuria|bacteriuria
28618|NCT03106090|survivorship care plan|survivorship care plan
28619|NCT03106090|head and neck cancer|head and neck cancer
28620|NCT03106090|survivorship|survivorship
28621|NCT03106077|Malignant neoplasm of breast|malignant neoplasm of breast
28622|NCT03106077|Triple-Negative Breast Cancer|triple-negative breast cancer
28623|NCT03106077|TNBC|tnbc
28624|NCT03106077|Metastatic Triple-Negative Breast Cancer|metastatic triple-negative breast cancer
28625|NCT03106077|Newly Diagnosed Triple-Negative Breast Cancer|newly diagnosed triple-negative breast cancer
28626|NCT03106077|Mirvetuximab Soravtansine|mirvetuximab soravtansine
28627|NCT03106077|IMGN853|imgn853
28628|NCT03106051|Arthritis|arthritis
28629|NCT03106051|Psoriatic|psoriatic
28630|NCT03106051|Observational|observational
28631|NCT03106051|Apremilast|apremilast
28632|NCT03106038|contrast agent|contrast agent
28633|NCT03106038|ureter imaging|ureter imaging
28634|NCT03106038|intraoperative monitoring|intraoperative monitoring
28635|NCT03106038|intraoperative procedures|intraoperative procedures
20452|NCT03159117|17-165|17-165
28636|NCT03106038|near infrared fluorescence|near infrared fluorescence
28637|NCT03106038|minimally invasive|minimally invasive
28638|NCT03105973|jail|jail
28639|NCT03105973|prison|prison
28640|NCT03105973|technology|technology
28641|NCT03105973|depression|depression
28642|NCT03105973|CBT|cbt
28643|NCT03105947|lipids|lipids
28644|NCT03105947|dietary fats|dietary fats
28645|NCT03105921|Locally advanced pancreatic carcinoma|locally advanced pancreatic carcinoma
28650|NCT03105895|Mesh augmentation|mesh augmentation
28651|NCT03105882|Spinal Cord Injury|spinal cord injury
28652|NCT03105882|SCI|sci
28653|NCT03105882|Complete (AIS A) Traumatic Acute Spinal Cord Injury|complete (ais a) traumatic acute spinal cord injury
28654|NCT03105869|repeatability|repeatability
28655|NCT03105869|positron emission tomography (PET)|positron emission tomography (pet)
28656|NCT03105869|fluorocholine|fluorocholine
28657|NCT03105856|Mass screening|mass screening
28658|NCT03105856|Vaccination|vaccination
28659|NCT03105856|Mexico|mexico
28660|NCT03105843|Asthma|asthma
28661|NCT03105843|Cough|cough
28662|NCT03105843|Eucapneic Voluntary Hyperventilation|eucapneic voluntary hyperventilation
28663|NCT03105843|Hypertonic Saline|hypertonic saline
28664|NCT03105817|Asymmetric cellulose triacetate|asymmetric cellulose triacetate
28665|NCT03105817|Biocompatibility|biocompatibility
28666|NCT03105817|Hemodiafiltration on-line|hemodiafiltration on-line
28667|NCT03105817|Convective volume|convective volume
28668|NCT03105817|Adequacy|adequacy
28669|NCT03105778|BNP|bnp
28670|NCT03105778|IVD|ivd
28671|NCT03105765|Neuropathic Pain|neuropathic pain
28672|NCT03105765|Chronic Pain|chronic pain
28673|NCT03105765|Posterolateral thoracotomy|posterolateral thoracotomy
28674|NCT03105752|Outcome Assessments (Health Care)|outcome assessments (health care)
28677|NCT03105752|Comprehension|comprehension
28678|NCT03105752|Language tests|language tests
28679|NCT03105726|End Stage Heart Failure|end stage heart failure
28680|NCT03105726|New York Heart Association functional class III or IV|new york heart association functional class iii or iv
28681|NCT03105726|Heart transplantation|heart transplantation
28682|NCT03105726|Ventricular assisted devices|ventricular assisted devices
28683|NCT03105726|Cardiogenic shock|cardiogenic shock
28684|NCT03105713|Checklist|checklist
28685|NCT03105713|Patient Checklist|patient checklist
28686|NCT03105713|Surgery|surgery
28687|NCT03105713|Safety|safety
28688|NCT03105713|Patient Involvement|patient involvement
28689|NCT03105700|epilepsy|epilepsy
28690|NCT03105700|depression|depression
28691|NCT03105700|refractory|refractory
28692|NCT03105700|temporal lobe|temporal lobe
28693|NCT03105700|TMS|tms
28694|NCT03105700|biomarker|biomarker
28695|NCT03105687|mHealth|mhealth
28696|NCT03105687|SMS reminders|sms reminders
28697|NCT03105687|adherence|adherence
28698|NCT03105687|antihypertensive drugs|antihypertensive drugs
28699|NCT03105687|pharmacists|pharmacists
28700|NCT03105687|cost-effectiveness|cost-effectiveness
28701|NCT03105674|analgesia|analgesia
28702|NCT03105674|peri-anal procedure|peri-anal procedure
28703|NCT03105674|peri-anal block|peri-anal block
28704|NCT03105674|anal surgery|anal surgery
28705|NCT03105635|Community Resources|community resources
28706|NCT03105635|Health Navigator|health navigator
28707|NCT03105622|Exercise|exercise
28708|NCT03105622|Screen|screen
28709|NCT03105622|Music|music
28710|NCT03105622|Energy compensation|energy compensation
28711|NCT03105622|Adolescents|adolescents
28712|NCT03105622|Running+screen|running+screen
28713|NCT03105622|Running+music|running+music
28714|NCT03105622|Running without stimulus (control condition)|running without stimulus (control condition)
28715|NCT03105609|hyperspectral imaging, Ranibizumab|hyperspectral imaging, ranibizumab
28716|NCT03105583|Medication beliefs|medication beliefs
28717|NCT03105583|Information desire|information desire
28718|NCT03105583|Vitamin deficiencies|vitamin deficiencies
28719|NCT03105570|breast neoplasms|breast neoplasms
28720|NCT03105570|Mastectomy, Subcutaneous|mastectomy, subcutaneous
28721|NCT03105570|Areola|areola
28722|NCT03105557|Prematurely born newborns|prematurely born newborns
28723|NCT03105557|Urine|urine
28724|NCT03105557|Collecting device|collecting device
28833|NCT03104816|Opioid|opioid
28725|NCT03105544|simulation-based training|simulation-based training
28726|NCT03105544|obstetric ultrasound|obstetric ultrasound
28727|NCT03105544|intrauterine growth restriction|intrauterine growth restriction
28728|NCT03105544|ultrasound simulation|ultrasound simulation
28729|NCT03105531|primary aldosteronism|primary aldosteronism
28730|NCT03105531|hypertension|hypertension
28731|NCT03105531|screening|screening
28732|NCT03105531|secondary hypertension|secondary hypertension
28733|NCT03105518|assisted reproduction|assisted reproduction
28734|NCT03105518|postoperative pain|postoperative pain
28735|NCT03105518|opioid|opioid
28738|NCT03105479|vancomycin|vancomycin
28739|NCT03105479|children|children
28740|NCT03105479|cadazolid|cadazolid
20535|NCT03158480|DC-CIK|dc-cik
28741|NCT03105479|clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
28742|NCT03105466|Corneal Transplantation|corneal transplantation
28743|NCT03105466|Xenotransplantation|xenotransplantation
28744|NCT03105466|Bioegineered cornea|bioegineered cornea
28745|NCT03105453|Assisted reproductive technologies|assisted reproductive technologies
28746|NCT03105453|Microbiome|microbiome
28747|NCT03105440|breast cancer|breast cancer
28748|NCT03105440|lymphedema|lymphedema
28749|NCT03105440|pain|pain
28750|NCT03105440|range of motion|range of motion
28751|NCT03105440|technologic innovation|technologic innovation
28752|NCT03105440|rehabilitation|rehabilitation
618328|NCT00655577|Aging|aging
28753|NCT03105414|Mechanical ventilation|mechanical ventilation
28754|NCT03105414|Pediatrics|pediatrics
28755|NCT03105414|Cross infection|cross infection
28756|NCT03105414|Intensive care|intensive care
28757|NCT03105414|Diagnosis|diagnosis
28758|NCT03105375|Potassium competitive acid blocker|potassium competitive acid blocker
28759|NCT03105375|X842|x842
28760|NCT03105375|Gastroesophageal reflux disease|gastroesophageal reflux disease
28761|NCT03105375|Esophagitis|esophagitis
28762|NCT03105375|Intragastric pH|intragastric ph
28763|NCT03105375|Acid inhibition|acid inhibition
28764|NCT03105362|Oral Rehydration Solutions|oral rehydration solutions
28765|NCT03105310|Hepatitis D|hepatitis d
28766|NCT03105310|Ezetimibe|ezetimibe
28767|NCT03105310|Pegylated interferon|pegylated interferon
28768|NCT03105297|Nasal dilator strip|nasal dilator strip
28769|NCT03105297|Sleep disordered breathing|sleep disordered breathing
28770|NCT03105284|stem cell|stem cell
28771|NCT03105284|liposuction|liposuction
28772|NCT03105284|regenerative medicine|regenerative medicine
28773|NCT03105245|electroconvulsive therapy|electroconvulsive therapy
28774|NCT03105245|anaesthesia|anaesthesia
28779|NCT03105193|Lignocaine|lignocaine
28780|NCT03105193|Lidocaine|lidocaine
28781|NCT03105193|Analgesia|analgesia
28782|NCT03105193|Local anaesthetic|local anaesthetic
28784|NCT03105167|RCT|rct
28785|NCT03105167|TLIF|tlif
28786|NCT03105141|Intracranial atherosclerotic stenosis|intracranial atherosclerotic stenosis
28787|NCT03105141|Remote ischemic conditioning|remote ischemic conditioning
28788|NCT03105141|Stroke|stroke
28789|NCT03105115|fentanyl|fentanyl
28790|NCT03105115|dexmedetomidine|dexmedetomidine
28791|NCT03105102|ABBV-066|abbv-066
28792|NCT03105102|risankizumab|risankizumab
28793|NCT03105102|BI 655066|bi 655066
28794|NCT03105050|access|access
28795|NCT03105050|policy|policy
28796|NCT03105024|specific phobia|specific phobia
28797|NCT03105024|height phobia|height phobia
28798|NCT03105024|exposure|exposure
28799|NCT03105024|virtual reality|virtual reality
28800|NCT03105024|extinction|extinction
28801|NCT03105024|self-efficacy|self-efficacy
28802|NCT03105011|Type 2 diabetes|type 2 diabetes
28803|NCT03104998|Idiopathic|idiopathic
28804|NCT03104998|Infertility|infertility
28805|NCT03104998|coenzyme q10|coenzyme q10
28806|NCT03104998|Pakistan|pakistan
28807|NCT03104985|Trophic ulcer; low level laser therapy; Chronic Venous Insufficiency|trophic ulcer; low level laser therapy; chronic venous insufficiency
28808|NCT03104972|ADHD|adhd
28809|NCT03104972|TRANS CRANIAL ELECTRIC STIMULATION|trans cranial electric stimulation
28810|NCT03104959|hangovers|hangovers
28811|NCT03104959|N-acetyl cysteine|n-acetyl cysteine
28812|NCT03104959|alcohol|alcohol
28813|NCT03104933|Proadrenomedullin|proadrenomedullin
28814|NCT03104933|Copeptin|copeptin
28815|NCT03104933|Vasopressors|vasopressors
28816|NCT03104933|Septic Shock|septic shock
28817|NCT03104920|ERAS|eras
28818|NCT03104920|Time to ready for discharge|time to ready for discharge
28819|NCT03104907|IPSS|ipss
28820|NCT03104907|Quality of Life|quality of life
28821|NCT03104907|DAN-PSS|dan-pss
28822|NCT03104907|Complications|complications
28823|NCT03104907|Prostate cancer|prostate cancer
28824|NCT03104881|stroke|stroke
28825|NCT03104855|cystic fibrosis|cystic fibrosis
28826|NCT03104855|vitamin d catabolism|vitamin d catabolism
28827|NCT03104816|Acetaminophen po|acetaminophen po
28828|NCT03104816|Acetaminophen IV|acetaminophen iv
28829|NCT03104816|Pain management|pain management
28830|NCT03104816|minimally invasive lumbar fusions|minimally invasive lumbar fusions
28831|NCT03104816|Ofirmev|ofirmev
28832|NCT03104816|Analgesics|analgesics
28834|NCT03104816|Pain|pain
28835|NCT03104816|Postoperative|postoperative
28836|NCT03104816|Spinal|spinal
28837|NCT03104764|labial frenulum|labial frenulum
28838|NCT03104764|surgery|surgery
28839|NCT03104764|scalpel technique|scalpel technique
28840|NCT03104764|Er:YAG laser|er:yag laser
28841|NCT03104751|Complex Congenital Heart Defect|complex congenital heart defect
28842|NCT03104751|Infants|infants
28847|NCT03104712|glycemic index|glycemic index
28848|NCT03104699|Antibodies|antibodies
28849|NCT03104699|Immunologic effects|immunologic effects
28850|NCT03104699|Physiological Effects of Drugs|physiological effects of drugs
28851|NCT03104673|Molecular signature|molecular signature
28852|NCT03104673|Thailand-Myanmar border|thailand-myanmar border
28853|NCT03104621|preservative-free, tafluprost|preservative-free, tafluprost
28854|NCT03104595|EC-18, febrile neutropenia, breast cancer, chemotherapy|ec-18, febrile neutropenia, breast cancer, chemotherapy
28856|NCT03104582|PTBD|ptbd
28857|NCT03104582|EBD|ebd
28858|NCT03104582|Cholangitis|cholangitis
28859|NCT03104582|Complication|complication
28860|NCT03104582|Klatskin tumor|klatskin tumor
28861|NCT03104569|ERCP|ercp
28862|NCT03104569|Contrast agent|contrast agent
28863|NCT03104569|Hilar cholangiocarcinoma|hilar cholangiocarcinoma
28866|NCT03104543|survivor|survivor
28867|NCT03104543|undertreatment|undertreatment
28868|NCT03104543|adherence|adherence
28869|NCT03104543|self-efficacy|self-efficacy
28870|NCT03104530|Crab|crab
28871|NCT03104530|Brown meat|brown meat
28872|NCT03104530|Cadmium body burden|cadmium body burden
28873|NCT03104530|Ferritin|ferritin
28874|NCT03104530|Zinc|zinc
28875|NCT03104530|Selenium|selenium
28876|NCT03104530|Creatinine|creatinine
28877|NCT03104530|B2-Microglobulin|b2-microglobulin
28878|NCT03104517|Urinary Incontinence|urinary incontinence
28879|NCT03104517|Urinary Stress Incontinence|urinary stress incontinence
28880|NCT03104517|Lower Urinary Tract Symptoms|lower urinary tract symptoms
28881|NCT03104517|Urinary Bladder|urinary bladder
28882|NCT03104517|Urinary Tract Diseases|urinary tract diseases
28883|NCT03104517|Bladder|bladder
28884|NCT03104517|Urinary Leak|urinary leak
28885|NCT03104517|Urine Leak|urine leak
28886|NCT03104517|Bladder Leak|bladder leak
28887|NCT03104517|Urethra|urethra
28888|NCT03104517|Urethral Sphincter|urethral sphincter
28889|NCT03104504|Suicide Screening|suicide screening
28890|NCT03104504|Safety Planning|safety planning
28891|NCT03104491|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
28892|NCT03104491|donor chimerism|donor chimerism
28893|NCT03104478|DLBCL|dlbcl
28894|NCT03104478|Real time molecular characterization|real time molecular characterization
28895|NCT03104465|Chronic Pain|chronic pain
28896|NCT03104465|Mindfulness|mindfulness
28897|NCT03104465|Behavioral Health|behavioral health
28898|NCT03104465|Quality of Life|quality of life
28899|NCT03104439|Pancreatic Cancer|pancreatic cancer
28900|NCT03104439|Microsatellite Stable Colorectal Cancer|microsatellite stable colorectal cancer
28901|NCT03104426|Hemolytic disease of the fetus and newborn|hemolytic disease of the fetus and newborn
28902|NCT03104426|HDFN|hdfn
28903|NCT03104426|Red blood cell alloimmunization|red blood cell alloimmunization
28904|NCT03104413|BI 655066|bi 655066
28905|NCT03104413|ABBV-066|abbv-066
28906|NCT03104400|Psoriasis|psoriasis
28907|NCT03104400|Anti-Rheumatic|anti-rheumatic
28908|NCT03104400|Anti-inflammatory|anti-inflammatory
28909|NCT03104400|Musculoskeletal disease|musculoskeletal disease
28910|NCT03104400|Joint disease|joint disease
28911|NCT03104400|Arthritis|arthritis
28912|NCT03104387|Air pollution|air pollution
28913|NCT03104387|Diesel exhaust|diesel exhaust
28914|NCT03104387|Ultrafine particles|ultrafine particles
28915|NCT03104387|Vascular function|vascular function
28916|NCT03104387|Endothelium function|endothelium function
28917|NCT03104387|Heart rate variability|heart rate variability
28918|NCT03104387|DNA damage|dna damage
28919|NCT03104374|Musculoskeletal disease|musculoskeletal disease
28920|NCT03104374|Anti-Rheumatic|anti-rheumatic
28921|NCT03104374|Joint disease|joint disease
28922|NCT03104374|Psoriasis|psoriasis
28923|NCT03104374|Anti-inflammatory|anti-inflammatory
28924|NCT03104374|Arthritis|arthritis
28925|NCT03104361|intersitial cystitis|intersitial cystitis
28926|NCT03104361|Bladder pain syndrome|bladder pain syndrome
28927|NCT03104361|Intravesical treatment|intravesical treatment
28930|NCT03104335|soft tissue sarcoma|soft tissue sarcoma
28931|NCT03104335|advanced|advanced
28932|NCT03104335|apatinib|apatinib
28933|NCT03104335|tyrosine-kinase inhibitors|tyrosine-kinase inhibitors
28934|NCT03104322|digital health|digital health
28935|NCT03104322|home spirometry|home spirometry
28936|NCT03104322|patient reported outcome measure|patient reported outcome measure
28937|NCT03104322|e-health|e-health
28938|NCT03104322|pirfenidone|pirfenidone
28939|NCT03104322|nintedanib|nintedanib
28941|NCT03104322|antifibrotic|antifibrotic
28942|NCT03104296|NIRS|nirs
28943|NCT03104296|Griffiths Mental Development Scales|griffiths mental development scales
28944|NCT03104296|prematurity|prematurity
28945|NCT03104283|apatinib|apatinib
28946|NCT03104283|gastric cancer|gastric cancer
28947|NCT03104283|elderly patients|elderly patients
28948|NCT03104270|Elotuzumab, Multiple Myeloma, Phase 2|elotuzumab, multiple myeloma, phase 2
28949|NCT03104257|Healthy Control, Cannabis, Dependence|healthy control, cannabis, dependence
28950|NCT03104244|concussion|concussion
28951|NCT03104244|subconcussive impacts|subconcussive impacts
28952|NCT03104244|brain function|brain function
28953|NCT03104244|football|football
28954|NCT03104231|atrial fibrillation|atrial fibrillation
28955|NCT03104231|oral anticoagulantion|oral anticoagulantion
28956|NCT03104231|stroke prevention|stroke prevention
28957|NCT03104231|education|education
28958|NCT03104231|e-medicine|e-medicine
28959|NCT03104205|frail elderly|frail elderly
28960|NCT03104205|telemedicine|telemedicine
28961|NCT03104205|obesity|obesity
28962|NCT03104205|rural health|rural health
28963|NCT03104205|health promotion|health promotion
28969|NCT03104192|health promotion|health promotion
28971|NCT03104127|Lower-limb robotic device|lower-limb robotic device
28972|NCT03104127|Gait|gait
28973|NCT03104127|Balance|balance
28974|NCT03104127|Pressure|pressure
28975|NCT03104127|Chronic stroke|chronic stroke
28976|NCT03104127|Blood pressure|blood pressure
28977|NCT03104127|Blood velocity|blood velocity
28978|NCT03104127|Aerobic fitness|aerobic fitness
28979|NCT03104127|Strength|strength
28980|NCT03104101|PTNS|ptns
28981|NCT03104101|Neuromodulation|neuromodulation
28985|NCT03104075|Epigenomics|epigenomics
28986|NCT03104075|Pneumococcal vaccine|pneumococcal vaccine
28987|NCT03104075|Elderly|elderly
28988|NCT03104049|Parkinson's Disease|parkinson's disease
28989|NCT03104049|Neuromuscular taping|neuromuscular taping
28990|NCT03104049|Trunk|trunk
28991|NCT03104049|Posture|posture
28992|NCT03104049|Kinematic|kinematic
28993|NCT03104049|rehabilitation|rehabilitation
28994|NCT03104036|Feacal bacterial transplantation|feacal bacterial transplantation
28995|NCT03104036|Left-sided ulcerative colitis|left-sided ulcerative colitis
28996|NCT03103997|Liver|liver
28997|NCT03103997|EUS|eus
28998|NCT03103997|Biopsy|biopsy
28999|NCT03103997|Heparin|heparin
29000|NCT03103984|Obesity|obesity
29001|NCT03103984|Liver transplantation|liver transplantation
29002|NCT03103984|weight loss diet|weight loss diet
29003|NCT03103984|immunosuppression|immunosuppression
29004|NCT03103958|probiotic|probiotic
29005|NCT03103958|metagenomic|metagenomic
29006|NCT03103958|constipation|constipation
29007|NCT03103945|Atrial Fibrillation|atrial fibrillation
29008|NCT03103945|Atrial Arrhythmia|atrial arrhythmia
29009|NCT03103945|Arrhythmias, Cardiac|arrhythmias, cardiac
29010|NCT03103945|Cardiac Diseases|cardiac diseases
29011|NCT03103945|Electrophysiologic Techniques, Cardiac|electrophysiologic techniques, cardiac
29012|NCT03103945|Electrophysiology|electrophysiology
29013|NCT03103945|Remote Magnetic Navigation|remote magnetic navigation
29014|NCT03103945|Contact Detection System|contact detection system
29015|NCT03103932|biomarkers|biomarkers
29016|NCT03103932|heart failure|heart failure
29017|NCT03103932|hospital admission|hospital admission
29022|NCT03103880|Patient Adherence|patient adherence
29023|NCT03103880|Mobile Applications|mobile applications
29024|NCT03103880|Mobile Health|mobile health
29025|NCT03103854|Exercise|exercise
29026|NCT03103854|Secondary Prevention|secondary prevention
29027|NCT03103854|Diabetes|diabetes
29028|NCT03103854|Rehabilitation|rehabilitation
29029|NCT03103841|Children|children
29030|NCT03103815|Amyotrophic lateral sclerosis, survival, adverse event|amyotrophic lateral sclerosis, survival, adverse event
29031|NCT03103763|Elderly|elderly
29032|NCT03103763|Anticoagulation|anticoagulation
29033|NCT03103763|Risk Assessment|risk assessment
29034|NCT03103750|Vitamin D|vitamin d
29035|NCT03103737|Well-being|well-being
29036|NCT03103737|Information and communication technologies|information and communication technologies
29037|NCT03103737|Hospital|hospital
29038|NCT03103711|Virtual reality|virtual reality
29039|NCT03103711|Well-being|well-being
29040|NCT03103711|Hospital|hospital
29041|NCT03103698|analgesia per-operative|analgesia per-operative
29042|NCT03103685|Dual antiplatelet therapy|dual antiplatelet therapy
29043|NCT03103685|Dental procedure|dental procedure
29044|NCT03103672|quality of anesthesia|quality of anesthesia
29045|NCT03103672|reduce recovery time|reduce recovery time
29046|NCT03103633|oxygen dynamics|oxygen dynamics
29047|NCT03103633|Prognosis|prognosis
29048|NCT03103555|Anti-interferon gamma autoantibody|anti-interferon gamma autoantibody
29053|NCT03103425|New onset seizures|new onset seizures
29054|NCT03103412|Active Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy Subjects|active mild ulcerative colitis, active moderate ulcerative colitis, healthy subjects
29055|NCT03103386|fermented rye bran|fermented rye bran
29056|NCT03103386|H. pylori infections|h. pylori infections
29057|NCT03103386|non-communicable diseases|non-communicable diseases
29058|NCT03103373|Echocardiography|echocardiography
29059|NCT03103373|anesthesia|anesthesia
29060|NCT03103373|general surgery|general surgery
29061|NCT03103347|EEG|eeg
29062|NCT03103347|Parkinson Disease|parkinson disease
29063|NCT03103347|Beta Oscillations|beta oscillations
29064|NCT03103308|Cancer|cancer
29065|NCT03103308|Exercise|exercise
29066|NCT03103308|Physical Function|physical function
29067|NCT03103295|tissue engineering,|tissue engineering,
29068|NCT03103295|regeneration,|regeneration,
29069|NCT03103295|repair,|repair,
29071|NCT03103295|regenerative therapy|regenerative therapy
29072|NCT03103269|Overweight|overweight
29073|NCT03103269|Obesity|obesity
29074|NCT03103269|Prevention|prevention
29075|NCT03103269|Diet|diet
29076|NCT03103269|Physical activity|physical activity
29077|NCT03103269|Depression|depression
29078|NCT03103269|Anxiety|anxiety
29079|NCT03103269|Stages of change|stages of change
29080|NCT03103269|Barriers|barriers
29081|NCT03103269|Perceptions|perceptions
29082|NCT03103269|Environment|environment
29083|NCT03103269|Eating Disorder|eating disorder
29088|NCT03103230|Motor evoked potentials|motor evoked potentials
29090|NCT03103230|prognosis|prognosis
29091|NCT03103230|stroke|stroke
29092|NCT03103204|Obesity|obesity
29093|NCT03103204|Periodontitis|periodontitis
29094|NCT03103204|Therapeutics|therapeutics
29095|NCT03103204|Chlorhexidine|chlorhexidine
29096|NCT03103152|Prostate Cancer|prostate cancer
29097|NCT03103152|Active Surveillance|active surveillance
29098|NCT03103152|Chemo-prevention|chemo-prevention
29099|NCT03103126|pedometer-determined walking|pedometer-determined walking
29100|NCT03103126|resistance exercise|resistance exercise
29101|NCT03103100|Local anesthetic|local anesthetic
29102|NCT03103100|Labor epidural|labor epidural
29103|NCT03103074|botulinum toxin|botulinum toxin
29104|NCT03103061|Computed Tomography|computed tomography
29105|NCT03102996|Alkali|alkali
29106|NCT03102996|Graft|graft
29107|NCT03102996|Acid base|acid base
29108|NCT03102996|Metabolic acidosis|metabolic acidosis
29109|NCT03102996|Chronic kidney disease|chronic kidney disease
29110|NCT03102983|MRI, Functional|mri, functional
29111|NCT03102970|COPD, Pain, Exacerbation|copd, pain, exacerbation
29112|NCT03102918|Cannabidiol|cannabidiol
29113|NCT03102879|mesenchymal stem cells|mesenchymal stem cells
29114|NCT03102879|regenerative procedures|regenerative procedures
29115|NCT03102879|tissue engineering|tissue engineering
29116|NCT03102879|regenerative endodontic|regenerative endodontic
29117|NCT03102879|scaffold|scaffold
29118|NCT03102879|cell encapsulation|cell encapsulation
29119|NCT03102879|dental pulp|dental pulp
29120|NCT03102879|pulp regeneration|pulp regeneration
29121|NCT03102879|plasma-derived biomaterial|plasma-derived biomaterial
29122|NCT03102879|allogenic stem cells|allogenic stem cells
29123|NCT03102879|mesenchymal stromal cells|mesenchymal stromal cells
29124|NCT03102879|adult stem cells|adult stem cells
29125|NCT03102879|umbilical cord stem cells|umbilical cord stem cells
29126|NCT03102840|Carriage|carriage
29127|NCT03102840|Immunogenicity|immunogenicity
29128|NCT03102840|Pneumococcal conjugate vaccine 13 (PCV 13)|pneumococcal conjugate vaccine 13 (pcv 13)
29129|NCT03102840|Children|children
29130|NCT03102840|Pneumococcus|pneumococcus
29131|NCT03102775|poverty|poverty
29132|NCT03102775|unemployment|unemployment
29133|NCT03102775|cluster-randomized|cluster-randomized
29134|NCT03102775|family-project|family-project
29135|NCT03102762|Erectile dysfunction|erectile dysfunction
29136|NCT03102762|Botulinum toxin A|botulinum toxin a
29137|NCT03102762|Botox|botox
29138|NCT03102749|Airways|airways
29139|NCT03102749|asthma|asthma
29140|NCT03102749|overweight|overweight
29141|NCT03102736|depression|depression
29142|NCT03102736|ketamine|ketamine
29143|NCT03102736|nitroprusside|nitroprusside
29144|NCT03102723|STEMI|stemi
29145|NCT03102723|primary percutaneous coronary intervention (PPCI)|primary percutaneous coronary intervention (ppci)
29146|NCT03102723|cangrelor|cangrelor
29147|NCT03102723|reperfusion|reperfusion
29148|NCT03102697|Intragastric balloon|intragastric balloon
29149|NCT03102697|obesity|obesity
29150|NCT03102697|metabolic syndrome|metabolic syndrome
29151|NCT03102697|bariatric surgery|bariatric surgery
29152|NCT03102684|e-cigarette|e-cigarette
29153|NCT03102684|electronic cigarette|electronic cigarette
29154|NCT03102684|passive exposure|passive exposure
29155|NCT03102684|secondhand exposure|secondhand exposure
29156|NCT03102684|smoking|smoking
29157|NCT03102684|respiratory system|respiratory system
29158|NCT03102619|Wireless monitoring|wireless monitoring
29159|NCT03102619|Postoperative complications|postoperative complications
29160|NCT03102619|Vital parameters|vital parameters
29161|NCT03102619|Continuous monitoring|continuous monitoring
29162|NCT03102606|Plinabulin|plinabulin
29163|NCT03102606|Pegfilgrastim|pegfilgrastim
29164|NCT03102606|Duration of Severe Neutropenia|duration of severe neutropenia
29165|NCT03102606|Bone Pain|bone pain
29166|NCT03102580|Shared Decision Making|shared decision making
29167|NCT03102554|Exome Sequencing|exome sequencing
29168|NCT03102502|Coronary Heart Disease|coronary heart disease
29169|NCT03102502|Atherosclerosis|atherosclerosis
29170|NCT03102502|Vascular Endothelium|vascular endothelium
29171|NCT03102502|Counterpulsation, External|counterpulsation, external
29172|NCT03102463|Insulin sensitivity|insulin sensitivity
29173|NCT03102463|Obesity|obesity
29174|NCT03102463|Insulin resistance|insulin resistance
29175|NCT03102463|Milk derived hydrolysate|milk derived hydrolysate
29176|NCT03102463|Hyperinsulinemic-euglycaemic clamp|hyperinsulinemic-euglycaemic clamp
29179|NCT03102385|blood donation|blood donation
29180|NCT03102385|motivation|motivation
29181|NCT03102385|donor retention|donor retention
29182|NCT03102372|FFM|ffm
29183|NCT03102372|VLCD|vlcd
29184|NCT03102372|exercise|exercise
29185|NCT03102372|Protein|protein
29186|NCT03102372|Obesity|obesity
29187|NCT03102346|cardiorespiratory fitness|cardiorespiratory fitness
29188|NCT03102346|coronary artery disease|coronary artery disease
29189|NCT03102346|cardiac rehabilitation|cardiac rehabilitation
29190|NCT03102346|remote control|remote control
29191|NCT03102346|major adverse cardiac and cerebrovascular events|major adverse cardiac and cerebrovascular events
29192|NCT03102320|cholangiocarcinoma|cholangiocarcinoma
29193|NCT03102320|pancreatic cancer|pancreatic cancer
29194|NCT03102320|triple-negative breast cancer|triple-negative breast cancer
29195|NCT03102320|non-small cell lung cancer|non-small cell lung cancer
29196|NCT03102320|thymic carcinoma|thymic carcinoma
29197|NCT03102320|gastric including gastroesophageal junction cancer|gastric including gastroesophageal junction cancer
29198|NCT03102307|Targeted axillary dissection|targeted axillary dissection
29199|NCT03102307|Sentinel node biopsy|sentinel node biopsy
29200|NCT03102307|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
29201|NCT03102255|Nasotracheal intubation|nasotracheal intubation
29202|NCT03102229|Activity Monitoring|activity monitoring
29203|NCT03102229|Chemotherapy|chemotherapy
29204|NCT03102229|Radiotherapy|radiotherapy
29205|NCT03102164|heart failure|heart failure
29206|NCT03102164|decompensation|decompensation
29207|NCT03102125|heart transplant, acute graft rejection, chronic graft rejection|heart transplant, acute graft rejection, chronic graft rejection
29208|NCT03102112|Glioma APT MRI|glioma apt mri
29209|NCT03102073|Reading speed|reading speed
29210|NCT03102047|microsatellite stable|microsatellite stable
29211|NCT03102047|MSS|mss
29212|NCT03102047|durvalumab|durvalumab
29213|NCT03102047|NSABP|nsabp
29214|NCT03102008|Transdiagnostic Treatment|transdiagnostic treatment
29215|NCT03102008|Emotional Disorders|emotional disorders
29216|NCT03102008|Adolescence|adolescence
29217|NCT03102008|Psychotherapy|psychotherapy
29218|NCT03101995|Treatment|treatment
29219|NCT03101995|Locally advanced cervical cancer|locally advanced cervical cancer
29220|NCT03101995|Renal failure|renal failure
29221|NCT03101995|Gemcitabine|gemcitabine
29222|NCT03101969|language|language
29223|NCT03101969|scheduled|scheduled
29224|NCT03101969|appointment|appointment
29225|NCT03101956|Spine Manipulation|spine manipulation
29226|NCT03101943|Sugar|sugar
29227|NCT03101943|Sweetened|sweetened
29228|NCT03101943|Beverages|beverages
29229|NCT03101891|Amnioinfusion|amnioinfusion
29230|NCT03101891|Fetal therapy|fetal therapy
29231|NCT03101878|Hypertension, ISIS 757456|hypertension, isis 757456
29232|NCT03101865|Type 1 diabetes|type 1 diabetes
29233|NCT03101865|Artificial Pancreas|artificial pancreas
29234|NCT03101865|Closed-loop glucose control|closed-loop glucose control
29235|NCT03101865|Very young children|very young children
29236|NCT03101865|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
29237|NCT03101865|Continuous glucose monitoring|continuous glucose monitoring
29238|NCT03101852|severe acute malnutrition|severe acute malnutrition
29239|NCT03101852|moderate acute malnutrition|moderate acute malnutrition
29240|NCT03101852|HIV-infection|hiv-infection
29241|NCT03101852|adolescents|adolescents
29242|NCT03101852|antiretroviral|antiretroviral
29243|NCT03101852|Africa|africa
29244|NCT03101852|ready-to-use food|ready-to-use food
29245|NCT03101852|outpatient care|outpatient care
29246|NCT03101826|Polyvagal Theory|polyvagal theory
29247|NCT03101826|Respiratory Sinus Arrhythmia|respiratory sinus arrhythmia
29248|NCT03101826|Heart rate|heart rate
29249|NCT03101826|Social Behavior|social behavior
29250|NCT03101826|Arginine Vasopressin|arginine vasopressin
29251|NCT03101826|Dichotic Listening Tests|dichotic listening tests
29252|NCT03101826|Oxytocin|oxytocin
29253|NCT03101826|Hyperacusis|hyperacusis
29254|NCT03101826|Affect|affect
29255|NCT03101826|Auditory perception|auditory perception
29256|NCT03101826|Sound spectrography|sound spectrography
29257|NCT03101800|Azathioprine|azathioprine
29258|NCT03101800|Allopurinol|allopurinol
29259|NCT03101800|Antimetabolites|antimetabolites
29260|NCT03101800|Ulcerative Colitis|ulcerative colitis
29261|NCT03101787|ECPR|ecpr
29262|NCT03101787|Extracorporeal CardioPulmonary Resuscitation|extracorporeal cardiopulmonary resuscitation
29263|NCT03101787|OHCA|ohca
29264|NCT03101787|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
29265|NCT03101787|CPR|cpr
29266|NCT03101787|CardioPulmonary Resuscitation|cardiopulmonary resuscitation
29267|NCT03101787|ECMO|ecmo
29268|NCT03101787|ExtraCorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
29790|NCT03098784|Air France|air france
29269|NCT03101787|Refractory Cardiac Arrest|refractory cardiac arrest
29270|NCT03101774|inspiratory muscle training|inspiratory muscle training
29271|NCT03101748|Malignant neoplasm of breast|malignant neoplasm of breast
29272|NCT03101748|Metastatic breast cancer|metastatic breast cancer
29273|NCT03101748|Locally advanced breast cancer|locally advanced breast cancer
30783|NCT03093415|HCV|hcv
29274|NCT03101748|HER2-positive|her2-positive
29275|NCT03101748|HER2+|her2+
29276|NCT03101748|HER2-negative/ER-positive|her2-negative/er-positive
29277|NCT03101748|HER2-/ER+|her2-/er+
29278|NCT03101748|Locally advanced inflammatory breast cancer|locally advanced inflammatory breast cancer
29279|NCT03101748|IBC|ibc
29280|NCT03101748|Neratinib|neratinib
29281|NCT03101748|Paclitaxel|paclitaxel
29287|NCT03101748|Adriamycin|adriamycin
29288|NCT03101748|Rubex|rubex
29289|NCT03101748|Pertuzumab|pertuzumab
29290|NCT03101748|Perjeta|perjeta
29291|NCT03101748|Trastuzumab|trastuzumab
29292|NCT03101748|Herceptin|herceptin
29293|NCT03101748|Cyclophosphamide|cyclophosphamide
29294|NCT03101748|Cytoxan|cytoxan
29295|NCT03101748|Neosar|neosar
29296|NCT03101722|presbycusis|presbycusis
29297|NCT03101722|tinnitus|tinnitus
29298|NCT03101722|cognitive impairment|cognitive impairment
29299|NCT03101722|Huperzine A|huperzine a
29300|NCT03101722|hearing aid|hearing aid
29301|NCT03101722|age-related hearing impairment|age-related hearing impairment
29302|NCT03101696|coronary angiography|coronary angiography
29303|NCT03101696|coronary conductance|coronary conductance
29304|NCT03101696|hyperemia|hyperemia
29305|NCT03101696|regadenoson|regadenoson
29306|NCT03101696|fractional flow reserve|fractional flow reserve
29307|NCT03101696|coronary flow reserve|coronary flow reserve
29308|NCT03101696|index of microcirculatory resistance|index of microcirculatory resistance
29309|NCT03101631|Elderly population with cancer|elderly population with cancer
29310|NCT03101631|Toxicity risk|toxicity risk
29311|NCT03101631|Mortality risk|mortality risk
29312|NCT03101631|Frailty conditions in elderly population|frailty conditions in elderly population
29313|NCT03101631|Chemotherapy in elderly population|chemotherapy in elderly population
29314|NCT03101618|allergen|allergen
29315|NCT03101618|allergy|allergy
29316|NCT03101618|pet|pet
29317|NCT03101592|antiretroviral therapy|antiretroviral therapy
29318|NCT03101592|retention|retention
29319|NCT03101592|ART|art
29320|NCT03101592|cost-effectiveness|cost-effectiveness
29321|NCT03101592|virologic suppression|virologic suppression
29322|NCT03101579|Leptomeningeal metastasis|leptomeningeal metastasis
29323|NCT03101579|Recurrence|recurrence
29324|NCT03101579|Intrathecal chemotherapy|intrathecal chemotherapy
29325|NCT03101579|Pemetrexed|pemetrexed
29326|NCT03101540|Major Depressive Disorder,|major depressive disorder,
29327|NCT03101540|omega-3 polyunsaturated fatty acid|omega-3 polyunsaturated fatty acid
29328|NCT03101540|PUFA|pufa
29329|NCT03101540|Pregnancy|pregnancy
29330|NCT03101540|eicosapentaenoic acid (EPA) supplementation|eicosapentaenoic acid (epa) supplementation
29331|NCT03101540|cytokine|cytokine
29332|NCT03101540|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
29333|NCT03101527|Major Depressive Disorder|major depressive disorder
29334|NCT03101527|omega-3 polyunsaturated fatty acid|omega-3 polyunsaturated fatty acid
29335|NCT03101527|PUFA|pufa
29336|NCT03101527|Pregnancy|pregnancy
29337|NCT03101527|eicosapentaenoic acid (EPA) supplementation|eicosapentaenoic acid (epa) supplementation
29338|NCT03101514|head and neck|head and neck
29339|NCT03101514|tumor|tumor
29340|NCT03101514|radiotherapy|radiotherapy
29341|NCT03101514|mucositis|mucositis
29342|NCT03101514|toxicity|toxicity
29343|NCT03101514|Kanglaite injection|kanglaite injection
29344|NCT03101488|KN035|kn035
29345|NCT03101488|phase 1|phase 1
29346|NCT03101475|Colorectal Cancer|colorectal cancer
29347|NCT03101475|Liver Metastases|liver metastases
29348|NCT03101475|Durvalumab|durvalumab
29349|NCT03101475|Tremelimumab|tremelimumab
29350|NCT03101436|Insulin Resistance|insulin resistance
29351|NCT03101436|Extra Virgin Olive Oil|extra virgin olive oil
29352|NCT03101436|Red Wine|red wine
29353|NCT03101436|Diet|diet
29354|NCT03101436|Microbiota|microbiota
29355|NCT03101423|thalassemia|thalassemia
29356|NCT03101423|transplantation|transplantation
29357|NCT03101423|chimerism|chimerism
29358|NCT03101423|donor ymphocytes|donor ymphocytes
29359|NCT03101410|Gluten|gluten
29360|NCT03101410|sport performance|sport performance
29361|NCT03101397|serum KL-6|serum kl-6
29362|NCT03101397|pulmonary function test|pulmonary function test
29363|NCT03101397|CT score|ct score
29364|NCT03101397|evaluation|evaluation
29365|NCT03101306|cervix, radiotherapy, magnetic resonance imaging|cervix, radiotherapy, magnetic resonance imaging
29366|NCT03101293|Drug therapy|drug therapy
29367|NCT03101267|Cedar pollinosis|cedar pollinosis
29368|NCT03101267|ASP4070|asp4070
618431|NCT00656045|Energy|energy
29369|NCT03101267|DNA plasmid vaccine|dna plasmid vaccine
29370|NCT03101254|Melanoma|melanoma
29371|NCT03101241|Essential Tremor|essential tremor
29372|NCT03101241|Movement Disorders|movement disorders
29373|NCT03101241|thalamocortical dysrhythmias|thalamocortical dysrhythmias
29374|NCT03101228|Physical Activity|physical activity
29375|NCT03101228|Metabolic Syndrome|metabolic syndrome
29376|NCT03101228|Insulin Sensitivity|insulin sensitivity
29377|NCT03101228|Cardiovascular Risk Factor|cardiovascular risk factor
29378|NCT03101228|Sedentary Lifestyle|sedentary lifestyle
29379|NCT03101228|Accelerometry|accelerometry
29381|NCT03101189|Japanese|japanese
29382|NCT03101189|pharmacokinetics|pharmacokinetics
29383|NCT03101176|multiparametric ultrasound|multiparametric ultrasound
29384|NCT03101176|prostate cancer|prostate cancer
29385|NCT03101176|contrast ultrasound|contrast ultrasound
29386|NCT03101176|CEUS|ceus
29387|NCT03101176|radical prostatectomy|radical prostatectomy
29388|NCT03101150|Maternal vitamin D|maternal vitamin d
29389|NCT03101150|Deficiency|deficiency
29390|NCT03101150|Insufficiency|insufficiency
29391|NCT03101150|Pregnancy|pregnancy
29392|NCT03101150|Pre-eclampsia|pre-eclampsia
29393|NCT03101150|IUGR|iugr
29394|NCT03101124|Hemostasis, Surgical|hemostasis, surgical
29395|NCT03101124|Tranexamic Acid|tranexamic acid
29396|NCT03101124|Antifibrinolytic Agents|antifibrinolytic agents
29397|NCT03101124|Administration, Cutaneous|administration, cutaneous
29398|NCT03101124|Administration, Intravenous|administration, intravenous
29399|NCT03101124|Administration, Topical|administration, topical
29400|NCT03101072|Gram-negative bacteremia|gram-negative bacteremia
29401|NCT03101072|antibiotic durations|antibiotic durations
29402|NCT03101072|point-of-care randomization|point-of-care randomization
29403|NCT03101059|Tracheal|tracheal
29404|NCT03101059|Bronchial|bronchial
29405|NCT03101059|Tracheobronchiomegaly|tracheobronchiomegaly
29406|NCT03101059|Collapse|collapse
29407|NCT03101059|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
29408|NCT03101059|Computer Tomography|computer tomography
29409|NCT03101059|Impedance Tomography|impedance tomography
29410|NCT03101046|Docetaxel|docetaxel
29411|NCT03101046|Cabazitaxel|cabazitaxel
29412|NCT03101033|Herniated lumbar disc|herniated lumbar disc
29413|NCT03101033|Epidural neuroplasty|epidural neuroplasty
29414|NCT03101033|Epidural injection|epidural injection
29415|NCT03101020|Visceral Manipulation|visceral manipulation
29416|NCT03101007|Comparative study|comparative study
29417|NCT03101007|Knee Prosthesis|knee prosthesis
29418|NCT03101007|Prosthesis Design|prosthesis design
29419|NCT03101007|Treatment Outcome|treatment outcome
29420|NCT03101007|Follow-up studies|follow-up studies
29421|NCT03101007|Arthroplast, Replacement, Knee/methods|arthroplast, replacement, knee/methods
29422|NCT03100981|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
29423|NCT03100981|Internet-delivered|internet-delivered
29424|NCT03100981|Breast cancer|breast cancer
29425|NCT03100981|Prostate cancer|prostate cancer
29426|NCT03100981|Survivors|survivors
29427|NCT03100981|Depression|depression
29428|NCT03100981|Anxiety|anxiety
29429|NCT03100981|Stress|stress
29430|NCT03100838|Proton Pump Inhibitor|proton pump inhibitor
29431|NCT03100838|Bioequivalence|bioequivalence
29432|NCT03100838|Drug-Drug Interaction|drug-drug interaction
29433|NCT03100838|Modified Release|modified release
29434|NCT03100838|Nifedipine|nifedipine
29435|NCT03100825|QVM149,|qvm149,
29436|NCT03100825|Asthma,|asthma,
29437|NCT03100825|Japanese,|japanese,
29438|NCT03100825|Allergic asthma,|allergic asthma,
29439|NCT03100825|Allergy triggered asthma,|allergy triggered asthma,
29440|NCT03100825|Reactive asthma,|reactive asthma,
29441|NCT03100825|Asthma attack,|asthma attack,
29442|NCT03100825|Difficulty breathing|difficulty breathing
29443|NCT03100812|Hypertensive|hypertensive
29444|NCT03100812|Hypertension|hypertension
29445|NCT03100812|Filipino|filipino
29446|NCT03100799|Osteoarthritis|osteoarthritis
29447|NCT03100799|Senescence|senescence
29448|NCT03100799|Magnetic resonance imaging|magnetic resonance imaging
29449|NCT03100799|Arthroscopy|arthroscopy
29450|NCT03100799|Arthrocentesis|arthrocentesis
29451|NCT03100799|Biomarker|biomarker
29452|NCT03100786|Tuberculosis|tuberculosis
29453|NCT03100786|tuberculous meningitis|tuberculous meningitis
29454|NCT03100786|drug induced liver injury|drug induced liver injury
29455|NCT03100786|dexamethasone|dexamethasone
29456|NCT03100786|LTA4H|lta4h
29457|NCT03100786|host genotype|host genotype
29458|NCT03100786|personalized medicine|personalized medicine
29459|NCT03100773|alpha-amylases|alpha-amylases
29460|NCT03100773|child|child
29461|NCT03100773|cortisol|cortisol
29462|NCT03100773|dental anxiety|dental anxiety
29463|NCT03100773|dental atraumatic restorative treatment|dental atraumatic restorative treatment
29464|NCT03100773|health education|health education
29465|NCT03100773|microbiota|microbiota
29466|NCT03100773|oral hygiene|oral hygiene
29467|NCT03100773|quality of life|quality of life
29468|NCT03100773|saliva|saliva
29469|NCT03100734|Biosimilar|biosimilar
29470|NCT03100734|etanercept|etanercept
29471|NCT03100734|Benepali|benepali
29472|NCT03100734|Enbrel|enbrel
29473|NCT03100721|Chronic pain|chronic pain
30111|NCT03096925|anxiety|anxiety
29474|NCT03100721|Musculoskeletal diseases|musculoskeletal diseases
29475|NCT03100721|Pain Neuroscience Education|pain neuroscience education
29476|NCT03100721|Physiotherapy|physiotherapy
29477|NCT03100656|psychopathology|psychopathology
21263|NCT03154385|ITP|itp
29478|NCT03100656|treatment|treatment
29480|NCT03100656|polyunsaturated fatty acids|polyunsaturated fatty acids
29481|NCT03100656|eicosanoids|eicosanoids
29482|NCT03100643|HIV/AIDS, mHealth, intervention development, African American men|hiv/aids, mhealth, intervention development, african american men
29483|NCT03100617|Family caregiver|family caregiver
29484|NCT03100604|middle ear pressure|middle ear pressure
29485|NCT03100604|sevoflurane|sevoflurane
29486|NCT03100604|desflurane|desflurane
29487|NCT03100578|PANCREAS|pancreas
29488|NCT03100578|ENDOSCOPIC INTERVENTION|endoscopic intervention
29489|NCT03100578|PLASTIC STENT|plastic stent
29490|NCT03100578|SELF EXPANDING METALLIC STENT|self expanding metallic stent
29491|NCT03100578|ENDOSCOPIC TRANSMURAL DRAINAGE|endoscopic transmural drainage
29492|NCT03100578|WALLED OFF PANCREATIC NECROSIS|walled off pancreatic necrosis
29493|NCT03100565|colposcopy|colposcopy
29494|NCT03100565|pain|pain
29495|NCT03100565|coughing|coughing
29496|NCT03100565|anesthetic spray|anesthetic spray
29497|NCT03100552|Colonoscopy|colonoscopy
29498|NCT03100552|Endoscopic resection|endoscopic resection
29499|NCT03100552|Sessile serrated adenoma|sessile serrated adenoma
29500|NCT03100539|Massage|massage
29501|NCT03100539|Caregiver|caregiver
29502|NCT03100539|Fascia|fascia
29503|NCT03100526|High-Risk Patients|high-risk patients
29504|NCT03100500|QVM149,|qvm149,
29505|NCT03100500|Asthma,|asthma,
29506|NCT03100500|Japanese,|japanese,
29507|NCT03100500|Allergic asthma,|allergic asthma,
29508|NCT03100500|Allergy triggered asthma,|allergy triggered asthma,
29509|NCT03100500|Reactive asthma,|reactive asthma,
29510|NCT03100500|Asthma attack,|asthma attack,
29511|NCT03100500|Difficulty breathing|difficulty breathing
29512|NCT03100474|tremor|tremor
29513|NCT03100474|Parkinson's|parkinson's
29514|NCT03100474|movement|movement
29515|NCT03100474|neuropathic|neuropathic
29516|NCT03100474|pain|pain
29517|NCT03100461|Cancer Screening|cancer screening
29518|NCT03100461|Colon Cancer|colon cancer
29519|NCT03100461|Colon Cancer Screening|colon cancer screening
29520|NCT03100409|Cervical cancer|cervical cancer
29521|NCT03100383|gestational diabetes|gestational diabetes
29522|NCT03100383|Type2 Diabetes|type2 diabetes
29523|NCT03100331|neuropsychological outcomes|neuropsychological outcomes
29524|NCT03100331|HIV/AIDS|hiv/aids
29525|NCT03100331|international adoption|international adoption
29526|NCT03100331|perinatal infection|perinatal infection
29527|NCT03100292|primary bariatric surgery|primary bariatric surgery
29528|NCT03100292|morbid obesity|morbid obesity
29529|NCT03100292|South Korea|south korea
29530|NCT03100292|sleeve gastrectomy|sleeve gastrectomy
29531|NCT03100292|Roux-en Y gastric bypass|roux-en y gastric bypass
29532|NCT03100279|cognitive behavioral therapy|cognitive behavioral therapy
29533|NCT03100279|treatment mediators|treatment mediators
29534|NCT03100279|trajectories of change|trajectories of change
29535|NCT03100253|Rheumatoid Arthritis|rheumatoid arthritis
29536|NCT03100253|Tocilizumab|tocilizumab
29537|NCT03100253|anti-TNF treatment|anti-tnf treatment
29538|NCT03100201|robotic-assisted rehabilitation|robotic-assisted rehabilitation
29539|NCT03100201|humeral fracture|humeral fracture
29540|NCT03100201|randomised controlled study|randomised controlled study
29541|NCT03100188|peritoneal dialysis|peritoneal dialysis
29542|NCT03100188|incremental peritoneal dialysis|incremental peritoneal dialysis
29543|NCT03100188|quality of life|quality of life
29544|NCT03100188|end stage renal disease|end stage renal disease
29545|NCT03100188|adequacy|adequacy
29546|NCT03100162|probiotics|probiotics
29547|NCT03100162|metabolic syndrome|metabolic syndrome
29548|NCT03100162|obesity|obesity
29549|NCT03100162|microbiome|microbiome
29550|NCT03100136|PET|pet
29551|NCT03100136|[11C]PF-06809247|[11c]pf-06809247
29552|NCT03100136|Reliability|reliability
29553|NCT03100136|Scan, Safety|scan, safety
29554|NCT03100110|Brain-Computer Interface|brain-computer interface
29555|NCT03100110|Brain-Machine Interface|brain-machine interface
29556|NCT03100110|Prefrontal Cortex|prefrontal cortex
29557|NCT03100084|Preeclampsia|preeclampsia
29558|NCT03100084|Diabetes in Pregnancy|diabetes in pregnancy
29559|NCT03100084|Fetal Growth Restriction|fetal growth restriction
29560|NCT03100084|Reduced Fetal Movements|reduced fetal movements
29561|NCT03100058|Obesity|obesity
29562|NCT03100058|Overweight|overweight
29563|NCT03100045|HPV|hpv
29564|NCT03100045|suppository|suppository
29565|NCT03100045|Artesunate|artesunate
29566|NCT03100045|artemisinin|artemisinin
29567|NCT03100045|anal dysplasia|anal dysplasia
29568|NCT03100045|treatment|treatment
29569|NCT03100045|alternative treatment|alternative treatment
29570|NCT03100045|anal precancer|anal precancer
29571|NCT03100045|Johns Hopkins|johns hopkins
29572|NCT03100045|Sandy Fang|sandy fang
29573|NCT03100045|Frantz Viral Therapeutics|frantz viral therapeutics
30328|NCT03096093|Pancreatic|pancreatic
29574|NCT03100032|Spinal Fusion|spinal fusion
29575|NCT03100032|Lumbar Interbody Fusion|lumbar interbody fusion
29576|NCT03100032|Autologous Stem Cell Therapy|autologous stem cell therapy
29577|NCT03100032|Bone Graft|bone graft
29581|NCT03100019|Cerebral blood flow|cerebral blood flow
29582|NCT03100019|Cognition|cognition
29583|NCT03099993|Unilateral cerebral palsy|unilateral cerebral palsy
29584|NCT03099993|kinematics|kinematics
29585|NCT03099993|electromyography|electromyography
29586|NCT03099993|constraint-induced therapy|constraint-induced therapy
29587|NCT03099993|muscle activation|muscle activation
29588|NCT03099993|upper limb|upper limb
29589|NCT03099993|child|child
29590|NCT03099941|Low Back Pain, Mechanical, Biofeedback, Pain, Chronic|low back pain, mechanical, biofeedback, pain, chronic
29591|NCT03099902|Asthma|asthma
29592|NCT03099902|Wheezing|wheezing
29593|NCT03099902|GSTP1|gstp1
29594|NCT03099902|TNFa|tnfa
29595|NCT03099902|Secondhand smoking|secondhand smoking
29596|NCT03099902|Passive smoking|passive smoking
29597|NCT03099902|Intrauterine smoking|intrauterine smoking
29598|NCT03099850|Chronic Pancreatitis|chronic pancreatitis
29599|NCT03099850|Data management|data management
29600|NCT03099850|Regulatory compliance|regulatory compliance
29601|NCT03099850|Protocol monitoring|protocol monitoring
29602|NCT03099824|Healthy Adult|healthy adult
29603|NCT03099824|Oral Capsule|oral capsule
29604|NCT03099824|Superoxide Dismutase|superoxide dismutase
29605|NCT03099824|Free Radical Oxygen|free radical oxygen
29606|NCT03099824|Single Ascending Dose|single ascending dose
29607|NCT03099824|GC4702 Oral Form Capsule|gc4702 oral form capsule
29608|NCT03099824|Food Effect Cohort|food effect cohort
29609|NCT03099772|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
29610|NCT03099759|Vitamin D Dosing Regimens|vitamin d dosing regimens
29611|NCT03099759|Blood Serum 25(OH)D3 Levels|blood serum 25(oh)d3 levels
29612|NCT03099746|chronically critically ill|chronically critically ill
29613|NCT03099746|surrogate decision maker|surrogate decision maker
29614|NCT03099707|Treatment|treatment
29615|NCT03099707|ART|art
29616|NCT03099707|South Africa|south africa
29617|NCT03099694|NRDS|nrds
29618|NCT03099694|nHFOV|nhfov
29619|NCT03099694|nCPAP|ncpap
29620|NCT03099694|preterm infants|preterm infants
29621|NCT03099655|Heart Failure|heart failure
29622|NCT03099655|Cardiac Pacing|cardiac pacing
29623|NCT03099655|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
29624|NCT03099655|Left Ventricular Lead|left ventricular lead
29625|NCT03099642|lumbar puncture|lumbar puncture
29626|NCT03099642|Point of care ultrasound|point of care ultrasound
29627|NCT03099642|children|children
29628|NCT03099629|Inspiratory muscle training|inspiratory muscle training
29629|NCT03099629|Diaphragmatic surface electromyography|diaphragmatic surface electromyography
29630|NCT03099629|Respiratory muscle strength|respiratory muscle strength
29631|NCT03099629|Functional capacity|functional capacity
29632|NCT03099616|propofol|propofol
29633|NCT03099616|CLADS|clads
29634|NCT03099616|Desflurane|desflurane
29635|NCT03099616|Obesity|obesity
29636|NCT03099564|Pembrolizumab|pembrolizumab
29637|NCT03099564|Y90 Radioembolization|y90 radioembolization
29638|NCT03099564|KEYTRUDA®|keytruda®
29639|NCT03099564|TheraSphere®|therasphere®
29640|NCT03099564|PD-1|pd-1
29641|NCT03099564|IgG4/kappa isotype|igg4/kappa isotype
29642|NCT03099551|Plaque|plaque
29643|NCT03099551|oral hygiene|oral hygiene
29644|NCT03099551|gingivitis|gingivitis
29645|NCT03099551|sonic toothbrush|sonic toothbrush
29646|NCT03099551|manual toothbrush|manual toothbrush
29647|NCT03099538|Ixekizumab|ixekizumab
29648|NCT03099538|Bullous Pemphigoid|bullous pemphigoid
29649|NCT03099538|Pemphigoid|pemphigoid
29650|NCT03099538|IL17|il17
29651|NCT03099538|IL-17|il-17
29652|NCT03099538|Interleukin 17|interleukin 17
29653|NCT03099512|Patellofemoral pain|patellofemoral pain
29654|NCT03099512|foot deformity|foot deformity
29655|NCT03099512|foot pronation|foot pronation
29656|NCT03099512|short foot exercise|short foot exercise
29657|NCT03099473|electroacupuncture|electroacupuncture
29658|NCT03099473|trochlear nerve palsy|trochlear nerve palsy
29659|NCT03099473|eyeball movement|eyeball movement
29660|NCT03099473|diplopia|diplopia
29661|NCT03099473|ocular motility disorder|ocular motility disorder
29662|NCT03099460|electroacupuncture|electroacupuncture
29663|NCT03099460|abducens nerve palsy|abducens nerve palsy
29664|NCT03099460|eyeball movement|eyeball movement
29665|NCT03099460|diplopia|diplopia
618432|NCT00656045|Behavioral|behavioral
29669|NCT03099447|rehabilitation|rehabilitation
29670|NCT03099447|diplopia|diplopia
29671|NCT03099447|ocular motility disorder|ocular motility disorder
29672|NCT03099434|Live Donor Transplant, Social Media, Education, Advocacy, Live Donor|live donor transplant, social media, education, advocacy, live donor
29673|NCT03099421|Benign prostatic obstruction|benign prostatic obstruction
29674|NCT03099421|benign prostatic enlargement|benign prostatic enlargement
29675|NCT03099421|benign prostatic hyperplasia|benign prostatic hyperplasia
29676|NCT03099421|prostatic artery embolization|prostatic artery embolization
29677|NCT03099421|Quality of Life|quality of life
29678|NCT03099421|IPSS|ipss
29679|NCT03099421|DAN-PSS|dan-pss
29680|NCT03099421|Complications|complications
29681|NCT03099408|Recurrence|recurrence
30084|NCT03097003|Otezla|otezla
29685|NCT03099369|Peripheral Arterial Disease|peripheral arterial disease
29687|NCT03099369|Step Count|step count
29688|NCT03099369|Fitness Monitor|fitness monitor
29689|NCT03099369|Mobile Health|mobile health
29690|NCT03099369|Walking Ability|walking ability
29691|NCT03099369|Quality of Life|quality of life
29692|NCT03099343|sodium|sodium
29693|NCT03099343|salt|salt
29694|NCT03099343|diet|diet
29695|NCT03099343|tailored messaging|tailored messaging
29696|NCT03099343|mobile application|mobile application
29697|NCT03099317|Knee Osteoarthritis|knee osteoarthritis
29698|NCT03099317|Sinew Acupuncture|sinew acupuncture
29699|NCT03099317|Pain|pain
29703|NCT03099278|hepatitis D|hepatitis d
29704|NCT03099278|Ezetimibe|ezetimibe
29705|NCT03099278|HDV RNA|hdv rna
29706|NCT03099161|Advanced Solid Tumor|advanced solid tumor
29707|NCT03099161|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
29708|NCT03099161|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
29709|NCT03099161|PD1|pd1
29710|NCT03099161|PD-1|pd-1
29711|NCT03099161|PDL1|pdl1
29712|NCT03099161|PD-L1|pd-l1
29713|NCT03099109|TIM-3|tim-3
29714|NCT03099109|PD-L1|pd-l1
29715|NCT03099096|SB240563|sb240563
29716|NCT03099096|Mepolizumab|mepolizumab
29717|NCT03099096|self-administration|self-administration
29718|NCT03099096|eosinophilic asthma|eosinophilic asthma
29719|NCT03099096|autoinjector|autoinjector
29720|NCT03099083|Adalimumab|adalimumab
29721|NCT03099083|Psoriasis|psoriasis
29722|NCT03099083|Humira|humira
29723|NCT03099083|Korea|korea
29724|NCT03099070|Stress|stress
29725|NCT03099070|Fasting|fasting
29726|NCT03099070|Migraine|migraine
29727|NCT03099031|Ottawa score|ottawa score
29728|NCT03099031|tinzaparin|tinzaparin
29729|NCT03099031|low-molecular weight heparin|low-molecular weight heparin
29730|NCT03099031|anticoagulants|anticoagulants
29731|NCT03099031|venous thrombosis|venous thrombosis
29732|NCT03099031|thromboembolism|thromboembolism
29733|NCT03099031|hemostatic disorders|hemostatic disorders
29734|NCT03099031|vascular disease|vascular disease
29735|NCT03099031|neoplasms|neoplasms
29736|NCT03099031|breast neoplasms|breast neoplasms
29737|NCT03099031|lung neoplasms|lung neoplasms
29738|NCT03099031|prostatic neoplasms|prostatic neoplasms
29739|NCT03099031|colorectal neoplasms|colorectal neoplasms
29740|NCT03099031|genital neoplasms|genital neoplasms
29741|NCT03099031|urogenital neoplasms|urogenital neoplasms
29742|NCT03099031|intestinal neoplasms|intestinal neoplasms
29743|NCT03099031|digestive system neoplasms|digestive system neoplasms
29744|NCT03099031|lymphoma|lymphoma
29745|NCT03099031|leukemia|leukemia
29746|NCT03099031|multiple myeloma|multiple myeloma
29747|NCT03099031|lymphoproliferative disorders|lymphoproliferative disorders
29748|NCT03099031|myeloproliferative disorders|myeloproliferative disorders
29749|NCT03099031|lymphatic disease|lymphatic disease
29750|NCT03099018|GAS|gas
29751|NCT03099018|pharyngitis|pharyngitis
29752|NCT03099018|children|children
29753|NCT03099018|RADT|radt
29754|NCT03099005|neuropathic pain|neuropathic pain
29755|NCT03099005|human immunovirus|human immunovirus
29756|NCT03099005|vaporized cannabis|vaporized cannabis
29757|NCT03098979|Chronic Heart Failure|chronic heart failure
29758|NCT03098979|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
29759|NCT03098953|Ocular Installation|ocular installation
29760|NCT03098927|Motor Imagery|motor imagery
29761|NCT03098927|Spinal Cord Injury|spinal cord injury
29762|NCT03098927|Motor Function Improvement|motor function improvement
29763|NCT03098914|Pathogen|pathogen
29764|NCT03098914|Mortality|mortality
29892|NCT03098316|Cross sectional studies|cross sectional studies
619031|NCT00658255|formoterol|formoterol
29765|NCT03098914|Community-acquired Pneumonia|community-acquired pneumonia
29766|NCT03098914|Risk factors|risk factors
29767|NCT03098901|TTR Amyloidosis|ttr amyloidosis
29768|NCT03098901|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
29769|NCT03098901|Ventricular arrhythmia|ventricular arrhythmia
29770|NCT03098901|Cardiac Conduction Disturbances|cardiac conduction disturbances
29771|NCT03098888|side effects|side effects
29772|NCT03098888|decision making|decision making
29773|NCT03098888|indications|indications
29774|NCT03098888|risk factors|risk factors
29780|NCT03098849|Buteyko-based breathing technique training|buteyko-based breathing technique training
29781|NCT03098836|metastatic|metastatic
29782|NCT03098836|castrate resistant|castrate resistant
29783|NCT03098797|Barth Syndrome|barth syndrome
29784|NCT03098797|elamipretide|elamipretide
29785|NCT03098797|MTP-131|mtp-131
29786|NCT03098797|Stealth|stealth
29787|NCT03098797|Stealth BT|stealth bt
29788|NCT03098797|BTHS|bths
29789|NCT03098784|airport environment|airport environment
29791|NCT03098784|flightline employees|flightline employees
29792|NCT03098784|administrative employees|administrative employees
29793|NCT03098758|Polymerase Chain Reaction|polymerase chain reaction
29794|NCT03098758|gastric cancer|gastric cancer
29795|NCT03098758|citology|citology
29796|NCT03098758|peritoneal washing|peritoneal washing
29797|NCT03098758|CK20|ck20
29798|NCT03098758|CEA|cea
29799|NCT03098758|BER-EP4|ber-ep4
29800|NCT03098732|Stroke|stroke
29801|NCT03098732|Ischemic|ischemic
29802|NCT03098732|Tissue Plasminogen Activator|tissue plasminogen activator
29803|NCT03098732|Thrombolysis|thrombolysis
29804|NCT03098732|Vascular Diseases|vascular diseases
29805|NCT03098732|Cerebrovascular Disorders|cerebrovascular disorders
29806|NCT03098732|Fibrinolytic Agents|fibrinolytic agents
29807|NCT03098732|Plasminogen|plasminogen
29808|NCT03098693|Serodiscordant|serodiscordant
29809|NCT03098693|Pre-exposure Prophylaxis|pre-exposure prophylaxis
29810|NCT03098693|Self-testing|self-testing
29811|NCT03098693|Tanzania|tanzania
29812|NCT03098680|Adverse reactions|adverse reactions
29813|NCT03098680|Cardiovascular|cardiovascular
29814|NCT03098680|Translation|translation
29815|NCT03098680|Modelling|modelling
29816|NCT03098680|Pharmacokinetics|pharmacokinetics
29817|NCT03098680|Pharmacodynamics|pharmacodynamics
29818|NCT03098654|Human Immunodeficiency Virus|human immunodeficiency virus
29819|NCT03098654|Community Health Services|community health services
29820|NCT03098654|Chronic Disease|chronic disease
29821|NCT03098654|Integrated Delivery of Health Care|integrated delivery of health care
29822|NCT03098654|Tanzania|tanzania
29823|NCT03098589|Adult T-cell Leukemia Lymphoma|adult t-cell leukemia lymphoma
29824|NCT03098589|Teratogenicity|teratogenicity
29825|NCT03098589|Myelosuppression|myelosuppression
29826|NCT03098589|Haemorrhage|haemorrhage
29827|NCT03098589|Infection|infection
29828|NCT03098589|Thromboembolism|thromboembolism
29829|NCT03098589|Hypersensitivity|hypersensitivity
29830|NCT03098589|Tumor lysis syndrome|tumor lysis syndrome
29831|NCT03098589|Peripheral neuropathy|peripheral neuropathy
29832|NCT03098589|Ischaemic heart disease|ischaemic heart disease
29833|NCT03098589|Cardiac failure|cardiac failure
29834|NCT03098589|Arrhythmia|arrhythmia
29835|NCT03098589|Renal failure|renal failure
29836|NCT03098589|Interstitial lung disease|interstitial lung disease
29837|NCT03098589|Hepatic disorder|hepatic disorder
29838|NCT03098589|Hypothyroidism|hypothyroidism
29839|NCT03098589|Gastrointestinal perforation|gastrointestinal perforation
29840|NCT03098589|Orthostatic hypotension|orthostatic hypotension
29841|NCT03098589|Convulsion|convulsion
29842|NCT03098589|Somnolence|somnolence
29843|NCT03098589|Confusion|confusion
29844|NCT03098589|Fatigue|fatigue
29845|NCT03098589|Dizziness|dizziness
29846|NCT03098589|Blurred vision|blurred vision
29847|NCT03098589|Second primary cancer|second primary cancer
29848|NCT03098589|Cataract|cataract
29849|NCT03098589|Revlimid capsules|revlimid capsules
29850|NCT03098576|advanced|advanced
29851|NCT03098576|metastatic solid tumors|metastatic solid tumors
29852|NCT03098563|Clinical Trial|clinical trial
29853|NCT03098563|Phase II|phase ii
29854|NCT03098550|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
29855|NCT03098550|Triple Negative Breast Cancer (TNBC)|triple negative breast cancer (tnbc)
29856|NCT03098550|Pancreatic Cancer (PAC)|pancreatic cancer (pac)
29857|NCT03098524|Cardiac surgery|cardiac surgery
29858|NCT03098524|Mechanical ventilation|mechanical ventilation
29859|NCT03098524|Cardiopulmonary bypass|cardiopulmonary bypass
29860|NCT03098524|Pneumonia|pneumonia
29861|NCT03098524|Atelectasis|atelectasis
29862|NCT03098511|Neurological Determination of Death|neurological determination of death
29863|NCT03098511|Determination of Death|determination of death
29864|NCT03098511|CT-Perfusion scan|ct-perfusion scan
29865|NCT03098511|Ancillary Test|ancillary test
29866|NCT03098511|Organ Donation|organ donation
29867|NCT03098498|periodontitis|periodontitis
29873|NCT03098394|RTAT|rtat
29874|NCT03098394|Gonorrhea|gonorrhea
29875|NCT03098394|Chlamydia|chlamydia
29877|NCT03098368|Parkinson's disease|parkinson's disease
29878|NCT03098368|Rotigotine transdermal patch|rotigotine transdermal patch
29879|NCT03098368|Nocturnal hypokinesia|nocturnal hypokinesia
29880|NCT03098355|CART|cart
29881|NCT03098355|CD19|cd19
29882|NCT03098355|CD22|cd22
29883|NCT03098355|Interleukin-2|interleukin-2
29886|NCT03098342|methylene blue|methylene blue
29887|NCT03098342|amorolfine, nail lacquer|amorolfine, nail lacquer
29888|NCT03098342|Asians|asians
29889|NCT03098329|Screening|screening
29890|NCT03098329|men|men
29891|NCT03098329|expedited treatment|expedited treatment
29893|NCT03098316|Metabolomics|metabolomics
29894|NCT03098316|Glaucoma|glaucoma
29895|NCT03098316|Low tension glaucoma|low tension glaucoma
200977|NCT02112734|food allergy|food allergy
21637|NCT03152188|Cirrhosis|cirrhosis
21638|NCT03152188|Liver|liver
21639|NCT03152188|Openbiome|openbiome
21640|NCT03152188|FMT Capsule|fmt capsule
21641|NCT03152188|Placebo|placebo
21642|NCT03152175|Memory Reconsolidation|memory reconsolidation
21651|NCT03152162|TKA|tka
29896|NCT03098316|Ophthalmologic surgical procedures|ophthalmologic surgical procedures
29897|NCT03098290|GermanVasc|germanvasc
29898|NCT03098290|Peripheral Arterial Disease|peripheral arterial disease
29899|NCT03098290|IDOMENEO|idomeneo
29900|NCT03098290|Routine Data|routine data
29901|NCT03098290|Registry Data|registry data
29902|NCT03098290|Data Validity|data validity
29903|NCT03098199|Antimullerian Hormone|antimullerian hormone
29904|NCT03098199|In vitro fertilization|in vitro fertilization
29905|NCT03098199|Medications|medications
29906|NCT03098199|Dosing|dosing
29907|NCT03098186|Medication adherence|medication adherence
29908|NCT03098186|mHealth|mhealth
29909|NCT03098173|Early colonoscopy|early colonoscopy
29910|NCT03098173|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
29911|NCT03098173|Rebleeding|rebleeding
29912|NCT03098160|Immunotherapy|immunotherapy
29913|NCT03098160|Hypoxia|hypoxia
29914|NCT03098160|Evofosfamide|evofosfamide
29915|NCT03098160|Ipilimumab|ipilimumab
29916|NCT03098160|TH-302|th-302
29917|NCT03098069|Kangaroo Mother Care|kangaroo mother care
29918|NCT03098069|Low Birth Weight|low birth weight
29919|NCT03098069|Implementation research|implementation research
29920|NCT03098043|Hypothermic machine perfusion|hypothermic machine perfusion
29921|NCT03098043|Donation after circulatory death|donation after circulatory death
29922|NCT03098043|Extended criteria liver grafts|extended criteria liver grafts
29926|NCT03097991|Coparenting Unmarried African-American Prenatal|coparenting unmarried african-american prenatal
29927|NCT03097913|nasotracheal intubation|nasotracheal intubation
29928|NCT03097913|video-stylet|video-stylet
29929|NCT03097913|nasal cavity injury|nasal cavity injury
29930|NCT03097900|Postoperative Ileus|postoperative ileus
29931|NCT03097900|Caffeine Citrate|caffeine citrate
29932|NCT03097887|Omega Loop Gastric Bypass|omega loop gastric bypass
29933|NCT03097887|Reflux|reflux
29934|NCT03097887|Mini Gastric Bypass|mini gastric bypass
29935|NCT03097874|anorexia|anorexia
29936|NCT03097874|anorexia nervosa|anorexia nervosa
29937|NCT03097874|eating disorder|eating disorder
29938|NCT03097874|weight|weight
29939|NCT03097874|eating|eating
29940|NCT03097874|weight loss|weight loss
29941|NCT03097874|family based treatment|family based treatment
29942|NCT03097874|FBT|fbt
29943|NCT03097874|family treatment|family treatment
29944|NCT03097874|therapy|therapy
29945|NCT03097874|Maudsley method|maudsley method
29946|NCT03097783|hyaluronic acid, midface|hyaluronic acid, midface
29947|NCT03097757|Ultrasound|ultrasound
29948|NCT03097757|Forearm Fracture Reduction|forearm fracture reduction
29949|NCT03097757|Pediatric Emergency Department|pediatric emergency department
29950|NCT03097744|Lateral Meniscus Tear|lateral meniscus tear
29951|NCT03097744|Medial Meniscus Tear|medial meniscus tear
29952|NCT03097731|interleukin-10|interleukin-10
29953|NCT03097731|inflammatory bowel disease|inflammatory bowel disease
29954|NCT03097692|cardiac preconditioning|cardiac preconditioning
29955|NCT03097692|open heart surgery|open heart surgery
29956|NCT03097653|breast cancer screening|breast cancer screening
29957|NCT03097653|mammography|mammography
29958|NCT03097653|decision-aid|decision-aid
29959|NCT03097653|informed choice|informed choice
29960|NCT03097653|National Cancer Screening Program|national cancer screening program
29961|NCT03097627|Indocyanine Green|indocyanine green
29962|NCT03097627|Near-infrared imaging|near-infrared imaging
29963|NCT03097575|Lung lesions|lung lesions
29964|NCT03097575|Navigational bronchoscopy|navigational bronchoscopy
29965|NCT03097575|Near infrared imaging|near infrared imaging
29966|NCT03097575|Lymphadenectomy|lymphadenectomy
29973|NCT03097549|urinary incontinence|urinary incontinence
29974|NCT03097549|urgency urinary incontinence|urgency urinary incontinence
29975|NCT03097549|mixed urinary incontinence|mixed urinary incontinence
29976|NCT03097549|smartphone application|smartphone application
29977|NCT03097549|ehealth|ehealth
29978|NCT03097549|mhealth|mhealth
29979|NCT03097549|randomized controlled trial|randomized controlled trial
29980|NCT03097549|self management|self management
29981|NCT03097549|treatment|treatment
29982|NCT03097536|Blood Sugar|blood sugar
29983|NCT03097523|NSBRI|nsbri
29984|NCT03097510|Perceived stress|perceived stress
29985|NCT03097510|Leadership|leadership
29986|NCT03097510|Transcendental Meditation|transcendental meditation
29987|NCT03097497|Chronic Non-specific Low-Back Pain|chronic non-specific low-back pain
29988|NCT03097497|Chronic Low-Back Pain|chronic low-back pain
29989|NCT03097497|Physiotherapy|physiotherapy
29990|NCT03097497|Therapeutic Exercise|therapeutic exercise
29991|NCT03097497|Primary Care|primary care
29992|NCT03097497|Transverse Abdominal Muscle|transverse abdominal muscle
29993|NCT03097458|Counselling for Families|counselling for families
29994|NCT03097458|Parental cancer|parental cancer
29995|NCT03097458|Psychological distress and adjustment|psychological distress and adjustment
29996|NCT03097445|Smoking|smoking
29997|NCT03097445|Nicotine|nicotine
29998|NCT03097445|Nicotine Replacement Therapy|nicotine replacement therapy
29999|NCT03097445|Nicotine Patch|nicotine patch
30000|NCT03097445|Mass Distribution|mass distribution
200978|NCT02112734|eczema|eczema
30001|NCT03097445|Tobacco Control|tobacco control
30002|NCT03097445|Cancer Prevention|cancer prevention
30003|NCT03097445|Randomized Controlled Trial|randomized controlled trial
30004|NCT03097419|non-ST segment elevation myocardial infarction|non-st segment elevation myocardial infarction
30005|NCT03097419|myocardial infarction|myocardial infarction
30006|NCT03097419|remote ischemic conditioning|remote ischemic conditioning
30007|NCT03097419|ischemic conditioning|ischemic conditioning
30008|NCT03097419|sphygmomanometer|sphygmomanometer
30009|NCT03097419|metabolomics|metabolomics
30010|NCT03097380|Healthy volunteer study|healthy volunteer study
30011|NCT03097367|laparoscopic radical prostatectomy|laparoscopic radical prostatectomy
30012|NCT03097367|urinary incontinence|urinary incontinence
30013|NCT03097367|prostate cancer|prostate cancer
30014|NCT03097367|bladder neck level|bladder neck level
30015|NCT03097367|urodynamics|urodynamics
30016|NCT03097354|alcohol use|alcohol use
30017|NCT03097354|consumption measure|consumption measure
30018|NCT03097354|Composite International Diagnostic Interview (CIDI)|composite international diagnostic interview (cidi)
30019|NCT03097354|internet survey|internet survey
30020|NCT03097354|standardized assessment|standardized assessment
30021|NCT03097328|Renal Cell Carcinoma|renal cell carcinoma
30022|NCT03097315|Uveitis|uveitis
30023|NCT03097315|UME|ume
30024|NCT03097315|Posterior Uveitis|posterior uveitis
30025|NCT03097315|Anterior Uveitis|anterior uveitis
30026|NCT03097315|Intermediate Uveitis|intermediate uveitis
30027|NCT03097315|Panuveitis|panuveitis
30028|NCT03097315|Non-infectious Uveitis|non-infectious uveitis
30029|NCT03097315|Triamcinolone|triamcinolone
30030|NCT03097315|Choroid|choroid
30031|NCT03097315|Choroidal Injection|choroidal injection
30032|NCT03097315|Suprachoroidal|suprachoroidal
30033|NCT03097315|Microneedle|microneedle
30034|NCT03097315|Microinjection|microinjection
30035|NCT03097302|laser-assisted keratotomy|laser-assisted keratotomy
30036|NCT03097302|anterior astigmatism|anterior astigmatism
30037|NCT03097302|posterior astigmatism|posterior astigmatism
30038|NCT03097302|total corneal refractive power|total corneal refractive power
30039|NCT03097302|nomogram|nomogram
30040|NCT03097289|Healthy Adults|healthy adults
30041|NCT03097250|PKU|pku
30042|NCT03097250|Neuropsychology|neuropsychology
30043|NCT03097250|MRI|mri
30044|NCT03097198|Juvenile|juvenile
30045|NCT03097198|Traditional Chinese Medicine|traditional chinese medicine
30046|NCT03097198|Plum-blossom needle|plum-blossom needle
30047|NCT03097185|pancreatitis|pancreatitis
30048|NCT03097185|islet cell|islet cell
30049|NCT03097172|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
30050|NCT03097172|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
30051|NCT03097172|Cardiac MRI|cardiac mri
30052|NCT03097172|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
30053|NCT03097172|Doppler Flow Velocity|doppler flow velocity
30054|NCT03097172|Cardiovascular Disease|cardiovascular disease
30055|NCT03097172|Atherosclerosis|atherosclerosis
30056|NCT03097172|Hydrostatic Pressure|hydrostatic pressure
30057|NCT03097159|costoclavicular block|costoclavicular block
30058|NCT03097146|Stroke|stroke
30059|NCT03097146|Aftercare|aftercare
30060|NCT03097146|Comprehensive Care|comprehensive care
30061|NCT03097107|hypertriglyceridemia|hypertriglyceridemia
30062|NCT03097107|dyslipidemia|dyslipidemia
30063|NCT03097107|saroglitazar magnesium|saroglitazar magnesium
30064|NCT03097107|lipid disorder|lipid disorder
30065|NCT03097094|Dog allergy|dog allergy
30066|NCT03097094|Can f 5|can f 5
30067|NCT03097094|Male dog|male dog
30068|NCT03097094|Female dog|female dog
30069|NCT03097094|Allergen components|allergen components
30071|NCT03097055|Acupuncture|acupuncture
30072|NCT03097055|antiinflammatory|antiinflammatory
30073|NCT03097055|NIHSS|nihss
30074|NCT03097029|pancreatic enzymes|pancreatic enzymes
30075|NCT03097016|Renal Impairment|renal impairment
30076|NCT03097016|Pharmacokinetics|pharmacokinetics
30077|NCT03097016|CC-122|cc-122
30078|NCT03097016|Mild|mild
30079|NCT03097016|Moderate|moderate
30080|NCT03097016|Severe|severe
30081|NCT03097003|Proriasis|proriasis
30082|NCT03097003|Real-life management|real-life management
30083|NCT03097003|Observational|observational
30089|NCT03096990|Psoriatic Arthritis|psoriatic arthritis
30091|NCT03096990|Otezla|otezla
30092|NCT03096990|Apremilast|apremilast
30093|NCT03096990|Real-Life management|real-life management
30094|NCT03096990|Belgium|belgium
30095|NCT03096990|APOLO|apolo
30096|NCT03096990|CC-10004|cc-10004
30097|NCT03096977|Hand dexterity|hand dexterity
30098|NCT03096977|Multiple sclerosis|multiple sclerosis
30099|NCT03096977|Nine Holes Peg|nine holes peg
30100|NCT03096964|Elderly training|elderly training
30101|NCT03096964|Pole walking|pole walking
30102|NCT03096964|Locomotor Rehabilitation Index|locomotor rehabilitation index
30103|NCT03096964|Self-selected speed of walking|self-selected speed of walking
30104|NCT03096964|Recovery|recovery
30110|NCT03096925|non-cardiac chest pain|non-cardiac chest pain
30112|NCT03096912|CDK4 inhibitor|cdk4 inhibitor
30114|NCT03096912|ribociclib|ribociclib
30115|NCT03096912|liposarcoma dedifferentiated|liposarcoma dedifferentiated
30116|NCT03096912|liposarcoma well differentiated|liposarcoma well differentiated
30117|NCT03096886|Cognitive Behavioral Therapy|cognitive behavioral therapy
30118|NCT03096886|Computer-Assisted Cognitive Behavioral Therapy|computer-assisted cognitive behavioral therapy
30119|NCT03096886|Computer-Augmented Cognitive Behavioral Therapy|computer-augmented cognitive behavioral therapy
30120|NCT03096886|CBT|cbt
30121|NCT03096886|Computer-Assisted CBT|computer-assisted cbt
30122|NCT03096886|Computer-Augmented CBT|computer-augmented cbt
30123|NCT03096847|ribociclib|ribociclib
30124|NCT03096847|LEE011|lee011
30125|NCT03096847|RIBECCA|ribecca
30126|NCT03096847|breast cancer|breast cancer
30127|NCT03096847|breast carcinoma|breast carcinoma
30128|NCT03096847|HR-positive|hr-positive
30129|NCT03096847|HER2-negative|her2-negative
30130|NCT03096847|advanced breast cancer|advanced breast cancer
30131|NCT03096847|Letrozole|letrozole
30132|NCT03096847|CDK4/6|cdk4/6
30133|NCT03096834|Migraine|migraine
30134|NCT03096834|attack|attack
30135|NCT03096834|headache|headache
30136|NCT03096834|episodic|episodic
30137|NCT03096834|aura|aura
30138|NCT03096834|AMG 334|amg 334
30139|NCT03096834|CGRP receptor agonist|cgrp receptor agonist
30140|NCT03096834|erenumab|erenumab
30141|NCT03096808|adaptive radiotherapy|adaptive radiotherapy
30142|NCT03096808|ART|art
30143|NCT03096808|intensity modulated radiation therapy|intensity modulated radiation therapy
30144|NCT03096808|IMRT|imrt
30145|NCT03096795|MEDI3506|medi3506
30146|NCT03096795|Safety|safety
30147|NCT03096795|Tolerability|tolerability
30148|NCT03096795|Pharmacokinetics|pharmacokinetics
30149|NCT03096795|Immunogenicity|immunogenicity
30150|NCT03096782|Acute Myelogenous Leukemia|acute myelogenous leukemia
30151|NCT03096782|AML|aml
30152|NCT03096782|Myelodysplastic Syndrome|myelodysplastic syndrome
30153|NCT03096782|MDS|mds
30154|NCT03096782|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
30155|NCT03096782|ALL|all
30156|NCT03096782|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
30157|NCT03096782|NHL|nhl
30158|NCT03096782|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
30159|NCT03096782|SLL|sll
30160|NCT03096782|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
30161|NCT03096782|CLL|cll
30162|NCT03096782|Hodgkin's Disease|hodgkin's disease
30163|NCT03096782|HD|hd
30164|NCT03096782|Busulfan|busulfan
30165|NCT03096782|Busulfex|busulfex
30166|NCT03096782|Myleran|myleran
30167|NCT03096782|Rituximab|rituximab
30168|NCT03096782|Rituxan|rituxan
30169|NCT03096782|ATG|atg
30170|NCT03096782|ATG(rabbit)|atg(rabbit)
30171|NCT03096782|Rabbit Antithymocyte Globulin|rabbit antithymocyte globulin
30172|NCT03096782|Rabbit Antilymphocyte Globulin|rabbit antilymphocyte globulin
30173|NCT03096782|Rabbit ATG|rabbit atg
30174|NCT03096782|rATg|ratg
30175|NCT03096782|Thymoglobulin|thymoglobulin
30176|NCT03096782|Fludarabine|fludarabine
30177|NCT03096782|Fludarabine Phosphate|fludarabine phosphate
30178|NCT03096782|Fludara|fludara
30179|NCT03096782|Clofarabine|clofarabine
30180|NCT03096782|Clofarex|clofarex
30181|NCT03096782|Clolar|clolar
30182|NCT03096782|Total Body Irradiation|total body irradiation
30183|NCT03096782|TBI|tbi
30184|NCT03096782|XRT|xrt
30185|NCT03096782|External Beam Radiotherapy|external beam radiotherapy
30186|NCT03096782|Mycophenolate Mofetil|mycophenolate mofetil
30187|NCT03096782|MMF|mmf
30188|NCT03096782|CellCept|cellcept
30189|NCT03096782|Tacrolimus|tacrolimus
30190|NCT03096782|Prograf|prograf
30191|NCT03096782|G-CSF|g-csf
30192|NCT03096782|Filgrastim|filgrastim
30193|NCT03096782|Neupogen|neupogen
30200|NCT03096782|Mesnex|mesnex
30201|NCT03096782|Cord Blood Transplantation|cord blood transplantation
30202|NCT03096782|Stem Cell Transplant|stem cell transplant
30203|NCT03096756|Oral Formulation|oral formulation
30204|NCT03096756|Food Effect|food effect
30205|NCT03096756|Superoxide Dismutase|superoxide dismutase
30206|NCT03096756|Single Ascending Dose|single ascending dose
30207|NCT03096756|GC4702|gc4702
30208|NCT03096756|Bioavailability|bioavailability
30209|NCT03096756|Pharmacokinetics|pharmacokinetics
30210|NCT03096756|Active Comparator|active comparator
30211|NCT03096730|Remifentanil|remifentanil
30212|NCT03096730|Opioid-induced hyperalgesia|opioid-induced hyperalgesia
30213|NCT03096730|Postoperative pain|postoperative pain
30214|NCT03096730|pain intensity|pain intensity
30215|NCT03096691|cervical pessary|cervical pessary
30216|NCT03096691|preterm labor|preterm labor
30217|NCT03096691|Cervical insufficiency|cervical insufficiency
30218|NCT03096678|Left Bundle Branch Block|left bundle branch block
30219|NCT03096678|Regional/Globle cardiac function|regional/globle cardiac function
30220|NCT03096678|Mechanical asynchrony|mechanical asynchrony
30221|NCT03096678|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
30222|NCT03096678|Outcome|outcome
32592|NCT03081780|AML|aml
30223|NCT03096678|Cardiovascular events|cardiovascular events
30225|NCT03096665|arterial blood|arterial blood
30226|NCT03096665|capillary blood|capillary blood
30227|NCT03096652|gynecologic cancer - panniculectomy|gynecologic cancer - panniculectomy
30228|NCT03096639|Diaphragm atrophy|diaphragm atrophy
30229|NCT03096639|VIDD|vidd
30230|NCT03096639|Weaning failure|weaning failure
30231|NCT03096626|Depression|depression
30232|NCT03096613|heart failure|heart failure
30233|NCT03096613|Subclinical Hyperthyroidism|subclinical hyperthyroidism
30234|NCT03096613|levothyroxine|levothyroxine
30235|NCT03096613|6-minute walk test|6-minute walk test
30236|NCT03096600|spine|spine
30237|NCT03096587|XP Endo Finisher|xp endo finisher
30238|NCT03096587|ultrasonic activated irrigation|ultrasonic activated irrigation
30239|NCT03096587|postoperative pain|postoperative pain
30240|NCT03096574|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
30241|NCT03096574|Maternal vaccination|maternal vaccination
30242|NCT03096574|Attitudes|attitudes
30243|NCT03096574|Pregnancy|pregnancy
30244|NCT03096548|Skin Cancer|skin cancer
30245|NCT03096548|Tattoo|tattoo
30246|NCT03096496|Quality of life|quality of life
30247|NCT03096496|acute promyelocytic leukemia|acute promyelocytic leukemia
30248|NCT03096496|ATO|ato
30249|NCT03096457|leishmaniasis|leishmaniasis
30250|NCT03096457|L.braziliensis|l.braziliensis
30251|NCT03096457|paromomycin cream|paromomycin cream
30252|NCT03096457|intralesional pentamidine|intralesional pentamidine
30253|NCT03096457|leishmaniasis local therapy|leishmaniasis local therapy
30258|NCT03096379|TB|tb
30259|NCT03096379|CD|cd
30260|NCT03096379|MRE|mre
30261|NCT03096379|ileocecal|ileocecal
30262|NCT03096366|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
30263|NCT03096353|NALOXONE|naloxone
30264|NCT03096353|fMRI|fmri
30265|NCT03096353|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
30266|NCT03096340|SN-38|sn-38
30267|NCT03096340|irinotecan|irinotecan
30268|NCT03096327|Quality of Life|quality of life
30269|NCT03096327|Asthma control test|asthma control test
30270|NCT03096327|Montelukast|montelukast
30271|NCT03096327|Asthma|asthma
30272|NCT03096314|ARDS|ards
30273|NCT03096314|Vitamin D|vitamin d
30274|NCT03096301|temporomandibular disorder|temporomandibular disorder
30275|NCT03096301|photobiomodulation|photobiomodulation
30276|NCT03096301|pain|pain
30277|NCT03096275|Mycophenolate mofetil|mycophenolate mofetil
30278|NCT03096275|Methotrexate|methotrexate
30279|NCT03096275|cyclophosphamide|cyclophosphamide
30280|NCT03096262|cognitive skills|cognitive skills
30281|NCT03096262|technical|technical
30282|NCT03096262|internet platform|internet platform
30283|NCT03096262|Stroke|stroke
30284|NCT03096262|Hemiparesis|hemiparesis
30285|NCT03096249|oxytocin|oxytocin
30286|NCT03096249|emotion recognition|emotion recognition
30287|NCT03096249|emotion processing|emotion processing
30288|NCT03096249|social salience|social salience
30289|NCT03096249|face processing|face processing
30290|NCT03096249|Electroencephalography (EEG)|electroencephalography (eeg)
30291|NCT03096210|Maxillar sinus|maxillar sinus
30292|NCT03096210|Titanium-Prepared Platelet Rich Fibrin|titanium-prepared platelet rich fibrin
30293|NCT03096210|Allograft|allograft
30294|NCT03096210|implant|implant
30295|NCT03096197|Spinal Cord injury (SCI)|spinal cord injury (sci)
619032|NCT00658255|Symbicort|symbicort
30296|NCT03096197|Transcutaneous lumbosacral stimulation (TLS)|transcutaneous lumbosacral stimulation (tls)
30297|NCT03096197|Exoskeleton-Assisted Walking (EAW)|exoskeleton-assisted walking (eaw)
30298|NCT03096184|head and neck cancer|head and neck cancer
30299|NCT03096184|Apatinib|apatinib
30300|NCT03096184|Tegafur Gimeracil Oteracil|tegafur gimeracil oteracil
30301|NCT03096171|Stress|stress
30302|NCT03096171|Well-being|well-being
30303|NCT03096171|Positive Psychology|positive psychology
30304|NCT03096158|Coronary artery bypass grafting|coronary artery bypass grafting
30305|NCT03096158|Cardiorespiratory rehabilitation|cardiorespiratory rehabilitation
30306|NCT03096158|Functional electrical stimulation|functional electrical stimulation
30307|NCT03096158|Inspiratory muscle training|inspiratory muscle training
30308|NCT03096158|Aerobic training|aerobic training
30309|NCT03096158|Isometric handgrip training|isometric handgrip training
30310|NCT03096158|Functional capacity|functional capacity
30311|NCT03096158|Endothelial function|endothelial function
30312|NCT03096158|Cardiac function|cardiac function
30313|NCT03096145|tobacco|tobacco
30314|NCT03096145|quitlines|quitlines
30315|NCT03096145|social support|social support
30316|NCT03096145|mobile support|mobile support
30317|NCT03096132|Obesity|obesity
30318|NCT03096132|Overweight|overweight
30319|NCT03096132|Overeating|overeating
30320|NCT03096132|Body Mass Index|body mass index
30321|NCT03096132|Treatment|treatment
30322|NCT03096132|Intervention|intervention
30323|NCT03096132|Family Based Therapy|family based therapy
30324|NCT03096132|Weight|weight
30325|NCT03096132|Children|children
30326|NCT03096119|blood pressure monitoring, home|blood pressure monitoring, home
30329|NCT03096093|Late stage cancer|late stage cancer
30330|NCT03096093|Immunotherapy|immunotherapy
30331|NCT03096093|Phase I|phase i
30332|NCT03096093|Vaccination|vaccination
30333|NCT03096080|ARPKD|arpkd
30334|NCT03096080|Autosomal Recessive Polycystic Kidney Disease|autosomal recessive polycystic kidney disease
30335|NCT03096080|Pediatric Polycystic Kidney|pediatric polycystic kidney
30336|NCT03096080|Tesevatinib|tesevatinib
30337|NCT03096080|Polycystic Kidney Disease|polycystic kidney disease
30338|NCT03096041|auriculotherapy|auriculotherapy
30339|NCT03096041|aromatase inhibitors|aromatase inhibitors
30340|NCT03096041|adjuvant treatment|adjuvant treatment
30341|NCT03096028|maternal nutrition|maternal nutrition
30342|NCT03096028|neurocognitive development|neurocognitive development
30343|NCT03096028|brain volume|brain volume
30344|NCT03096002|PreDiabetes, Lifestyle intervention, Exercise Behavior, Adherence|prediabetes, lifestyle intervention, exercise behavior, adherence
30345|NCT03095989|mindfulness|mindfulness
30346|NCT03095976|Guided Tissue Regeneration,|guided tissue regeneration,
30347|NCT03095976|Amnion-Chorion,|amnion-chorion,
30348|NCT03095976|Intrabony defects,|intrabony defects,
30349|NCT03095976|furcation|furcation
30350|NCT03095950|Spin|spin
30351|NCT03095950|Misleading reporting|misleading reporting
30352|NCT03095950|Misleading interpretation|misleading interpretation
30353|NCT03095950|Misleading extrapolation|misleading extrapolation
30354|NCT03095950|Randomized controlled trials|randomized controlled trials
30355|NCT03095950|Patients|patients
30356|NCT03095924|Spin|spin
30357|NCT03095924|Misleading reporting|misleading reporting
30358|NCT03095924|Misleading interpretation|misleading interpretation
30359|NCT03095924|Misleading extrapolation|misleading extrapolation
30360|NCT03095924|Randomized controlled trials|randomized controlled trials
30361|NCT03095924|Patients|patients
30362|NCT03095911|Spin|spin
30363|NCT03095911|Misleading reporting|misleading reporting
30364|NCT03095911|Misleading interpretation|misleading interpretation
30365|NCT03095911|Misleading extrapolation|misleading extrapolation
30366|NCT03095911|Randomized controlled trials|randomized controlled trials
30367|NCT03095911|Patients|patients
30368|NCT03095898|Colonoscopy|colonoscopy
30369|NCT03095898|Acupuncture|acupuncture
30370|NCT03095885|Urine Oxalate|urine oxalate
30371|NCT03095885|Nephrolithiasis|nephrolithiasis
30372|NCT03095885|Kidney Stones|kidney stones
30373|NCT03095885|Hyperoxaluria|hyperoxaluria
30374|NCT03095885|Enteric Hyperoxaluria|enteric hyperoxaluria
30375|NCT03095885|urological Diseases|urological diseases
30376|NCT03095885|Kidney Diseases|kidney diseases
30377|NCT03095885|Dietary Oxalate|dietary oxalate
30378|NCT03095885|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
30379|NCT03095885|Oxalate Absorption|oxalate absorption
30380|NCT03095872|photodamaged skin|photodamaged skin
30381|NCT03095872|wound healing|wound healing
30382|NCT03095872|CO2 laser|co2 laser
30383|NCT03095820|Community|community
30384|NCT03095820|Depressive Symptoms|depressive symptoms
30385|NCT03095820|Mental Health Program|mental health program
30386|NCT03095820|Older adults|older adults
30387|NCT03095768|Lifestyle|lifestyle
30388|NCT03095768|Nutrition|nutrition
30389|NCT03095768|Cooking|cooking
30390|NCT03095742|Microdialysis|microdialysis
30391|NCT03095742|Cerebral metabolism|cerebral metabolism
30392|NCT03095742|Cardiac arrest|cardiac arrest
30393|NCT03095742|Intravenous|intravenous
30394|NCT03095742|Neurological prognosis|neurological prognosis
30395|NCT03095716|Carbon dioxide pneumoperitoneum|carbon dioxide pneumoperitoneum
30396|NCT03095716|Intraperitoneal pressure|intraperitoneal pressure
30397|NCT03095716|Post-operative recovery|post-operative recovery
30398|NCT03095716|Laparoscopic Humidification System|laparoscopic humidification system
30399|NCT03095703|Sirolimus|sirolimus
30400|NCT03095703|Intestinal adenomas|intestinal adenomas
30401|NCT03095690|Osteoporosis|osteoporosis
30402|NCT03095690|Parkinson|parkinson
30403|NCT03095690|HR-pQCT|hr-pqct
30404|NCT03095690|bone microstructure|bone microstructure
30405|NCT03095690|fracture risk|fracture risk
30406|NCT03095677|dynamic apnea|dynamic apnea
30407|NCT03095677|muscle oxygenation|muscle oxygenation
30408|NCT03095677|physical performance|physical performance
30409|NCT03095664|lifestyle intervention|lifestyle intervention
30410|NCT03095664|endometrial cancer|endometrial cancer
30411|NCT03095664|survival|survival
30412|NCT03095638|Dispersible tablets|dispersible tablets
30413|NCT03095638|Bioavailability|bioavailability
30414|NCT03095638|Dolutegravir|dolutegravir
30415|NCT03095638|Healthy|healthy
30416|NCT03095638|Conventional tablets|conventional tablets
30417|NCT03095625|Sepsis|sepsis
30418|NCT03095625|Bleeding disorder|bleeding disorder
30419|NCT03095625|Viscoelastic tests|viscoelastic tests
30420|NCT03095599|Influenza|influenza
30421|NCT03095599|Vaccine|vaccine
30422|NCT03095586|Spin|spin
30423|NCT03095586|Misleading reporting|misleading reporting
30424|NCT03095586|Misleading interpretation|misleading interpretation
30425|NCT03095586|Misleading extrapolation|misleading extrapolation
30426|NCT03095586|Randomized controlled trials|randomized controlled trials
30427|NCT03095586|Patients|patients
30428|NCT03095573|Celiac disease|celiac disease
30429|NCT03095573|Enteropathy associated T cell lymphoma|enteropathy associated t cell lymphoma
30430|NCT03095573|Refractory celiac disease|refractory celiac disease
30431|NCT03095573|Small bowel adenocarcinoma|small bowel adenocarcinoma
30432|NCT03095534|Occupational Therapy|occupational therapy
30433|NCT03095534|Aging in place|aging in place
30434|NCT03095534|Activities of daily living|activities of daily living
30435|NCT03095534|Community program|community program
30436|NCT03095521|Angal|angal
30437|NCT03095521|ANTI-ANGIN® FORMULA|anti-angin® formula
30438|NCT03095521|sore throat|sore throat
30439|NCT03095521|no less therapeutic efficacy|no less therapeutic efficacy
30440|NCT03095508|Angal S|angal s
30441|NCT03095508|ANTI-ANGIN FORMULA|anti-angin formula
30442|NCT03095508|Sore Throat|sore throat
30443|NCT03095508|no less therapeutic efficacy|no less therapeutic efficacy
30444|NCT03095495|Heated Humidified High Flow Nasal Cannula (HHHFNC)|heated humidified high flow nasal cannula (hhhfnc)
30445|NCT03095495|Low Flow Nasal Cannula|low flow nasal cannula
30446|NCT03095495|Bronchiolitis|bronchiolitis
30447|NCT03095495|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
30448|NCT03095495|Respiratory Failure|respiratory failure
30449|NCT03095495|High Flow Nasal Cannula (HFNC)|high flow nasal cannula (hfnc)
30450|NCT03095495|Lung Diseases, Obstructive|lung diseases, obstructive
30451|NCT03095482|Arachnophobia (fear of spiders)|arachnophobia (fear of spiders)
30452|NCT03095482|Ophidophobia (fear of snakes)|ophidophobia (fear of snakes)
30453|NCT03095482|Claustrophobia (fear of tightly enclosed spaces)|claustrophobia (fear of tightly enclosed spaces)
30454|NCT03095482|Germaphobia (fear of germs, dirtiness, and contamination)|germaphobia (fear of germs, dirtiness, and contamination)
30455|NCT03095456|Chronic Obstructive Pulmonary Disease, COPD, Low Peak Inspiratory Flow Rate|chronic obstructive pulmonary disease, copd, low peak inspiratory flow rate
30456|NCT03095443|Delirium|delirium
30457|NCT03095443|Critical Illness|critical illness
30458|NCT03095443|Music Therapy|music therapy
30459|NCT03095430|Trauma|trauma
30460|NCT03095430|General Anesthesia|general anesthesia
30461|NCT03095430|Surgical Pleth Index|surgical pleth index
30462|NCT03095430|Entropy|entropy
30463|NCT03095417|Delirium|delirium
30464|NCT03095417|Alzheimer's Disease|alzheimer's disease
30465|NCT03095417|Aging|aging
30466|NCT03095417|Exercise Therapy|exercise therapy
30467|NCT03095417|Cognitive Training|cognitive training
30468|NCT03095378|gingival recession|gingival recession
30469|NCT03095339|Burkina Faso|burkina faso
30470|NCT03095339|Community-based randomized controlled trial|community-based randomized controlled trial
30471|NCT03095339|Cysticercosis|cysticercosis
30472|NCT03095339|Implementation Research|implementation research
30473|NCT03095339|Effectiveness|effectiveness
30474|NCT03095313|Transcatheter Aortic Valve Replacement (TAVR).|transcatheter aortic valve replacement (tavr).
30475|NCT03095313|Surgical bioprosthetic aortic valve replacement|surgical bioprosthetic aortic valve replacement
30476|NCT03095300|Prone Position|prone position
30477|NCT03095300|High-flow oxygen therapy|high-flow oxygen therapy
30478|NCT03095287|Factor VIII|factor viii
30479|NCT03095287|von Willebrand Factor|von willebrand factor
30480|NCT03095287|Plasma-derived|plasma-derived
30481|NCT03095287|Inhibitors|inhibitors
30482|NCT03095287|Immune tolerance induction|immune tolerance induction
30484|NCT03095287|Antibodies|antibodies
30485|NCT03095287|Hemophilia A|hemophilia a
30486|NCT03095261|Cardiovascular Disease|cardiovascular disease
30487|NCT03095261|Cardiac Rehabilitation|cardiac rehabilitation
30488|NCT03095261|Financial Incentives|financial incentives
30489|NCT03095261|Outpatient (Phase II) Cardiac Rehabilitation Exercise Adherence|outpatient (phase ii) cardiac rehabilitation exercise adherence
30490|NCT03095235|keratoconus|keratoconus
30491|NCT03095235|cornea ectasia|cornea ectasia
30492|NCT03095183|Posterior oropharynx exam|posterior oropharynx exam
30493|NCT03095183|Pediatric|pediatric
30494|NCT03095183|Tongue Depressor|tongue depressor
30495|NCT03095183|Flavored Tongue Depressor|flavored tongue depressor
30496|NCT03095144|pyloromyotomy|pyloromyotomy
30497|NCT03095144|spinal anaesthesia|spinal anaesthesia
30498|NCT03095144|surgical outcomes|surgical outcomes
32272|NCT03083730|Eczema|eczema
30499|NCT03095144|general anaesthesia|general anaesthesia
30500|NCT03095144|infants|infants
30501|NCT03095131|Heart Spectrum Blood Pressure MonitorHeart Spectrum|heart spectrum blood pressure monitorheart spectrum
30502|NCT03095079|endostar|endostar
30503|NCT03095079|dacarbazine|dacarbazine
30504|NCT03095079|cisplatin|cisplatin
30505|NCT03095066|aggression|aggression
30506|NCT03095066|agitation|agitation
30507|NCT03095066|irritability|irritability
30508|NCT03095066|non-penetrating brain injury|non-penetrating brain injury
30509|NCT03095066|traumatic brain injury|traumatic brain injury
30510|NCT03095066|AVP-786|avp-786
30511|NCT03095053|blastocyst|blastocyst
30512|NCT03095053|comprehensive chromosome screening|comprehensive chromosome screening
30513|NCT03095053|euploidy|euploidy
30514|NCT03095053|frozen embryo transfer|frozen embryo transfer
30515|NCT03095001|bevacizumab|bevacizumab
30516|NCT03095001|Intraperitoneal administration|intraperitoneal administration
31047|NCT03091530|Throwing|throwing
30517|NCT03095001|Ovarian Cancer|ovarian cancer
30518|NCT03095001|Peritoneal Adhesion|peritoneal adhesion
30519|NCT03094962|Kinematics|kinematics
30520|NCT03094962|MRI Scans|mri scans
30521|NCT03094962|CT Scan, Single-Photon Emission|ct scan, single-photon emission
30522|NCT03094962|finger interphalangeal joint|finger interphalangeal joint
30523|NCT03094949|microwave ablation|microwave ablation
30524|NCT03094949|partial nephrectomy|partial nephrectomy
30525|NCT03094910|Raynaud Phenomenon|raynaud phenomenon
30526|NCT03094910|Hand and Arm Vibration Syndrome|hand and arm vibration syndrome
30527|NCT03094910|Autonomic Imbalance|autonomic imbalance
30528|NCT03094910|Thermography|thermography
30529|NCT03094897|Breast Neoplasms,Prostatic Neoplasms|breast neoplasms,prostatic neoplasms
30530|NCT03094858|Smartphone, sedentary behavior, smartphone intervention|smartphone, sedentary behavior, smartphone intervention
30531|NCT03094832|ARQ 092|arq 092
30532|NCT03094832|ArQule|arqule
30533|NCT03094832|AKT|akt
30534|NCT03094832|PIK3CA|pik3ca
30535|NCT03094832|Overgrowth|overgrowth
30536|NCT03094832|Congenital malformations|congenital malformations
30537|NCT03094793|abnormal EEGs (AIC)|abnormal eegs (aic)
30538|NCT03094767|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
30539|NCT03094767|Heart Rate Variability|heart rate variability
30540|NCT03094767|Rehabilitation|rehabilitation
30541|NCT03094767|Hemoglobin Glycated|hemoglobin glycated
30542|NCT03094715|Mechanical thrombectomy|mechanical thrombectomy
30543|NCT03094715|Endovascular thrombectomy|endovascular thrombectomy
30544|NCT03094689|Physical activity|physical activity
30545|NCT03094689|Muscle pain|muscle pain
30546|NCT03094689|Cryotherapy|cryotherapy
30547|NCT03094676|Massage|massage
30548|NCT03094676|Autonomic nervous system|autonomic nervous system
30549|NCT03094676|Recovery of Physiological Function|recovery of physiological function
30550|NCT03094676|Heart Rate|heart rate
30551|NCT03094663|IPACK|ipack
30552|NCT03094663|PAI|pai
30553|NCT03094650|stroke|stroke
30554|NCT03094650|neurorehabilitation|neurorehabilitation
30555|NCT03094650|virtual reality|virtual reality
30556|NCT03094650|rehabilitation dose|rehabilitation dose
30557|NCT03094650|motor rehabilitation|motor rehabilitation
30558|NCT03094637|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
30559|NCT03094637|Myelodysplastic Syndrome|myelodysplastic syndrome
30560|NCT03094637|MDS|mds
30561|NCT03094637|Higher risk|higher risk
30562|NCT03094637|Azacitidine|azacitidine
30563|NCT03094637|5-azacytidine|5-azacytidine
30564|NCT03094637|5-aza|5-aza
30565|NCT03094637|Vidaza|vidaza
30566|NCT03094637|5-AZC|5-azc
30567|NCT03094637|AZA-CR|aza-cr
30568|NCT03094637|Ladakamycin|ladakamycin
30569|NCT03094637|NSC-102816|nsc-102816
30570|NCT03094637|Azacytidine|azacytidine
30571|NCT03094637|Pembrolizumab|pembrolizumab
30572|NCT03094637|Keytruda|keytruda
30573|NCT03094637|MK-3475|mk-3475
30574|NCT03094637|SCH-900475|sch-900475
30575|NCT03094624|Amusia|amusia
30576|NCT03094624|Audition|audition
30577|NCT03094624|Short-term memory|short-term memory
30578|NCT03094624|Emotions|emotions
30579|NCT03094624|EEG|eeg
30580|NCT03094624|MEG|meg
30581|NCT03094624|MRI|mri
30582|NCT03094611|Acute lymphocytic leukemia|acute lymphocytic leukemia
30583|NCT03094611|ALL|all
30584|NCT03094611|CD22-positive|cd22-positive
31075|NCT03091270|BOLD-fMRI|bold-fmri
30585|NCT03094611|Inotuzumab Ozogamicin|inotuzumab ozogamicin
30586|NCT03094611|CMC-544|cmc-544
30587|NCT03094585|Healthy nurses|healthy nurses
30588|NCT03094572|spinal cord circuitry|spinal cord circuitry
30589|NCT03094572|hemiplegia|hemiplegia
30590|NCT03094572|rhythmic task|rhythmic task
30591|NCT03094559|peripheral arterial disease|peripheral arterial disease
30592|NCT03094546|subjective cognitive decline|subjective cognitive decline
30593|NCT03094546|Alzheimer's disease, dementia|alzheimer's disease, dementia
30594|NCT03094546|dietary supplement|dietary supplement
30595|NCT03094546|polyamine|polyamine
30596|NCT03094546|prevention|prevention
30597|NCT03094546|treatment|treatment
30598|NCT03094546|lifestyle|lifestyle
30599|NCT03094546|memory|memory
30600|NCT03094546|autophagy|autophagy
30601|NCT03094533|Anesthesia, intravenous|anesthesia, intravenous
30602|NCT03094533|Anesthesia, inhalation|anesthesia, inhalation
30603|NCT03094533|propofol|propofol
30604|NCT03094533|sevoflurane|sevoflurane
30605|NCT03094533|glucose|glucose
30606|NCT03094468|terbinafine nail solution|terbinafine nail solution
30607|NCT03094468|nail fungal infection|nail fungal infection
30608|NCT03094468|topical antifungal drug|topical antifungal drug
30609|NCT03094455|Tele-rehabilitation|tele-rehabilitation
30610|NCT03094455|Action Observation|action observation
30611|NCT03094455|Mirror neurons|mirror neurons
30613|NCT03094442|Quality of Recovery|quality of recovery
30614|NCT03094442|Minimally Invasive Sacrocolpopexy|minimally invasive sacrocolpopexy
30615|NCT03094442|Dexamethasone|dexamethasone
754063|NCT01178788|Progestagens|progestagens
30627|NCT03094351|minimally invasive esophagectomy|minimally invasive esophagectomy
30629|NCT03094338|Psychology, Educational [F02.784.629]|psychology, educational [f02.784.629]
31147|NCT03090802|resilience|resilience
30630|NCT03094325|Septal Myectomy|septal myectomy
30631|NCT03094312|SEEG|seeg
30632|NCT03094312|ISD|isd
30633|NCT03094312|cognitive disorder|cognitive disorder
30634|NCT03094312|epilepsy surgery|epilepsy surgery
30635|NCT03094286|HIV|hiv
30636|NCT03094286|HIV with cancer patient|hiv with cancer patient
30637|NCT03094286|D006678|d006678
30638|NCT03094273|Melanocytic neoplasm|melanocytic neoplasm
30639|NCT03094273|Biopsy|biopsy
30640|NCT03094273|Saucerization biopsy|saucerization biopsy
30641|NCT03094273|Skin lesion|skin lesion
30642|NCT03094247|Malnutrition|malnutrition
30643|NCT03094247|Micronutrients|micronutrients
30644|NCT03094247|Polyunsaturated fatty acids|polyunsaturated fatty acids
30645|NCT03094247|Ready-to-use therapeutic foods|ready-to-use therapeutic foods
30646|NCT03094247|Omega-3 fatty acids|omega-3 fatty acids
30647|NCT03094247|Peanuts|peanuts
30648|NCT03094195|post-herpetic neuralgia|post-herpetic neuralgia
30649|NCT03094195|neuropathic pain|neuropathic pain
30650|NCT03094195|angiotensin II type 2 receptor antagonist|angiotensin ii type 2 receptor antagonist
30651|NCT03094195|dose ranging|dose ranging
30652|NCT03094130|Spin|spin
30653|NCT03094130|Misleading reporting|misleading reporting
30654|NCT03094130|Misleading interpretation|misleading interpretation
30655|NCT03094130|Misleading extrapolation|misleading extrapolation
30656|NCT03094130|phase I/II trials|phase i/ii trials
30657|NCT03094130|non-randomized trials|non-randomized trials
30658|NCT03094130|Patients|patients
30659|NCT03094117|Spin|spin
30660|NCT03094117|Misleading reporting|misleading reporting
30661|NCT03094117|Misleading interpretation|misleading interpretation
30662|NCT03094117|Misleading extrapolation|misleading extrapolation
30663|NCT03094117|phase I/II trials|phase i/ii trials
30664|NCT03094117|non-randomized trials|non-randomized trials
30665|NCT03094117|Patients|patients
30666|NCT03094104|Spin|spin
30667|NCT03094104|Misleading reporting|misleading reporting
30668|NCT03094104|Misleading interpretation|misleading interpretation
30669|NCT03094104|Misleading extrapolation|misleading extrapolation
30670|NCT03094104|phase I/II trials|phase i/ii trials
30671|NCT03094104|non-randomized trials|non-randomized trials
30672|NCT03094104|Patients|patients
30673|NCT03094091|Spin|spin
30674|NCT03094091|Misleading reporting|misleading reporting
30675|NCT03094091|Misleading interpretation|misleading interpretation
30676|NCT03094091|Misleading extrapolation|misleading extrapolation
30677|NCT03094091|phase I/II trials|phase i/ii trials
30678|NCT03094091|non-randomized trials|non-randomized trials
30682|NCT03094078|Misleading interpretation|misleading interpretation
30683|NCT03094078|Misleading extrapolation|misleading extrapolation
30684|NCT03094078|Animal studies|animal studies
30685|NCT03094078|Cell culture studies|cell culture studies
30686|NCT03094078|Pre-clinical studies|pre-clinical studies
30687|NCT03094065|Spin|spin
30688|NCT03094065|Misleading reporting|misleading reporting
30689|NCT03094065|Misleading interpretation|misleading interpretation
30690|NCT03094065|Misleading extrapolation|misleading extrapolation
30691|NCT03094065|Animal studies|animal studies
30692|NCT03094065|Cell culture studies|cell culture studies
30693|NCT03094065|Pre-clinical studies|pre-clinical studies
30697|NCT03094026|Hematologic cancers|hematologic cancers
30698|NCT03094026|Hematopoietic cell transplantation|hematopoietic cell transplantation
30699|NCT03094026|cognitive training|cognitive training
30700|NCT03094026|genetic knowledge|genetic knowledge
30701|NCT03094026|genetic attitude|genetic attitude
30702|NCT03094026|adult cancer survivors|adult cancer survivors
30703|NCT03094013|psycho-social factors, psychological symptoms|psycho-social factors, psychological symptoms
30704|NCT03094000|Bulimia Nervosa|bulimia nervosa
30705|NCT03094000|Binge-Eating|binge-eating
30706|NCT03094000|Self monitoring|self monitoring
30707|NCT03094000|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
30708|NCT03094000|Mindfulness|mindfulness
30709|NCT03093987|Shock|shock
30710|NCT03093987|Critical Care Ultrasound|critical care ultrasound
32536|NCT03082079|ESD|esd
30711|NCT03093987|Lactate|lactate
30712|NCT03093987|Mortality|mortality
30713|NCT03093987|Prognosis|prognosis
30714|NCT03093935|Post-Stroke|post-stroke
30715|NCT03093935|Neuromodulation|neuromodulation
30716|NCT03093935|Axillary nerve|axillary nerve
30717|NCT03093935|Peripheral Nerve Stimulation|peripheral nerve stimulation
30718|NCT03093922|Gemcitabine|gemcitabine
30719|NCT03093922|Atezolizumab|atezolizumab
30720|NCT03093922|Cisplatin|cisplatin
30721|NCT03093922|16-1621|16-1621
30722|NCT03093909|Solid Tumors and Pulmonary Metastases|solid tumors and pulmonary metastases
30723|NCT03093909|aerosol gemcitabine|aerosol gemcitabine
30724|NCT03093909|aerosol GCB|aerosol gcb
30725|NCT03093909|Lung metastases|lung metastases
30726|NCT03093909|osteosarcoma|osteosarcoma
30727|NCT03093896|almonds|almonds
30728|NCT03093896|cereal snack|cereal snack
30729|NCT03093870|Neoplasms|neoplasms
30730|NCT03093870|Biliary Tract Neoplasms|biliary tract neoplasms
30731|NCT03093870|Bile Duct Neoplasms|bile duct neoplasms
30732|NCT03093870|Gallbladder Neoplasms|gallbladder neoplasms
30733|NCT03093844|Stem Cell Transplant|stem cell transplant
30734|NCT03093844|Umbilical Cord Blood Transplant|umbilical cord blood transplant
30735|NCT03093844|Haploidentical CD34+ Selected Cells|haploidentical cd34+ selected cells
30736|NCT03093805|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
30737|NCT03093805|Graft Versus Host Disease|graft versus host disease
30738|NCT03093779|Hearing Loss|hearing loss
30739|NCT03093779|Deaf|deaf
30740|NCT03093779|Health Literacy|health literacy
30741|NCT03093779|Health Information|health information
30742|NCT03093779|Visual Learning|visual learning
30743|NCT03093766|Aetiology|aetiology
30744|NCT03093740|hemodialysis|hemodialysis
30745|NCT03093740|renal failure|renal failure
30746|NCT03093740|kidney transplant|kidney transplant
30747|NCT03093714|Cystic Fibrosis|cystic fibrosis
30748|NCT03093636|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
30749|NCT03093636|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
30750|NCT03093636|Multiple Daily Injections (MDI)|multiple daily injections (mdi)
30751|NCT03093636|Insulin Pen|insulin pen
30752|NCT03093636|inControl Advice|incontrol advice
30753|NCT03093636|Decision Support System (DSS)|decision support system (dss)
30754|NCT03093623|physical activity|physical activity
30755|NCT03093623|abstain from smoking|abstain from smoking
30756|NCT03093623|human papillomavirus (HPV)|human papillomavirus (hpv)
30757|NCT03093623|cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
30758|NCT03093558|adherence|adherence
30759|NCT03093558|quality of life|quality of life
30760|NCT03093558|health literacy|health literacy
30761|NCT03093545|rabies|rabies
30762|NCT03093545|obese|obese
30763|NCT03093545|immunoglobulin|immunoglobulin
30764|NCT03093545|rabies vaccine|rabies vaccine
30765|NCT03093545|post-exposure|post-exposure
30766|NCT03093545|immunogenicity|immunogenicity
30767|NCT03093532|emergency department|emergency department
30768|NCT03093532|stage 2 hypertension|stage 2 hypertension
30769|NCT03093532|minorities|minorities
30770|NCT03093506|Erythropoietin|erythropoietin
30771|NCT03093506|Randomized controlled trial|randomized controlled trial
30772|NCT03093506|Human volunteers|human volunteers
30773|NCT03093506|Mitochondrial function|mitochondrial function
30774|NCT03093506|Cognitive performance|cognitive performance
30775|NCT03093467|Internet|internet
30776|NCT03093467|Mental Health|mental health
30777|NCT03093441|High-intensity interval training|high-intensity interval training
30778|NCT03093441|cardiometabolic|cardiometabolic
31850|NCT03086395|relapsed|relapsed
30779|NCT03093441|physical performance|physical performance
30780|NCT03093441|psychosocial adaptation|psychosocial adaptation
30781|NCT03093428|Prostate Cancer|prostate cancer
30782|NCT03093415|Hepatitis C|hepatitis c
30784|NCT03093415|People Who Inject Drugs|people who inject drugs
30785|NCT03093415|PWID|pwid
30786|NCT03093415|Medication Assisted Therapy|medication assisted therapy
30787|NCT03093415|MAT|mat
30788|NCT03093415|Needle Exchange Program|needle exchange program
30789|NCT03093402|JBT-101|jbt-101
30790|NCT03093402|SLE|sle
30791|NCT03093402|efficacy|efficacy
30792|NCT03093402|musculoskeletal disease|musculoskeletal disease
30793|NCT03093402|randomized trial|randomized trial
30794|NCT03093376|Anxiety|anxiety
30795|NCT03093376|Effortful Control|effortful control
30796|NCT03093376|Preschool|preschool
30797|NCT03093376|ERN|ern
30798|NCT03093350|Breast Cancer|breast cancer
30799|NCT03093350|Tumor Associated Antigen Specific T cells|tumor associated antigen specific t cells
30800|NCT03093337|Neuromotor sequelae|neuromotor sequelae
30801|NCT03093337|Cognitive disorders|cognitive disorders
30802|NCT03093337|Cerebral development|cerebral development
30803|NCT03093337|Psychomotoricity|psychomotoricity
30809|NCT03093324|Multiple Sclerosis|multiple sclerosis
30810|NCT03093324|MS|ms
30811|NCT03093324|Alkermes|alkermes
30812|NCT03093324|ALKS 8700|alks 8700
22509|NCT03146455|racial|racial
30813|NCT03093324|Dimethyl Fumarate|dimethyl fumarate
30814|NCT03093324|DMF|dmf
30815|NCT03093324|Tecfidera|tecfidera
30816|NCT03093311|Near-Infrared Spectroscopy|near-infrared spectroscopy
30817|NCT03093311|Neurosurgical Procedures|neurosurgical procedures
30818|NCT03093311|Cognitive Dysfunction|cognitive dysfunction
30819|NCT03093272|Prostate Cancer|prostate cancer
30820|NCT03093259|ABX464|abx464
30821|NCT03093259|Ulcerative Colitis|ulcerative colitis
30822|NCT03093259|Refractory|refractory
30823|NCT03093246|Full-mouth ultrasonic debridement|full-mouth ultrasonic debridement
30824|NCT03093246|Aspirin|aspirin
30825|NCT03093246|Omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
30826|NCT03093246|Non-surgical therapy|non-surgical therapy
30827|NCT03093207|Aggressive periodontitis|aggressive periodontitis
30828|NCT03093207|Aspirin|aspirin
30829|NCT03093207|Omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
30830|NCT03093207|Surgical therapy|surgical therapy
30831|NCT03093142|transcranial direct current stimulation (tDCs)|transcranial direct current stimulation (tdcs)
30832|NCT03093142|neurofeedback|neurofeedback
30833|NCT03093116|ALK Gene Rearrangement|alk gene rearrangement
31362|NCT03089801|telehealth|telehealth
30834|NCT03093116|ROS1 Gene Rearrangement|ros1 gene rearrangement
30835|NCT03093116|NTRK 1/2/3 Gene Rearrangement|ntrk 1/2/3 gene rearrangement
30836|NCT03093103|empagliflozin|empagliflozin
30837|NCT03093103|kidney|kidney
30838|NCT03093103|BOLD-MRI|bold-mri
30839|NCT03093090|furosemide|furosemide
30840|NCT03093051|Termination|termination
30841|NCT03093051|Unpinning|unpinning
30842|NCT03093051|Therapy|therapy
30843|NCT03093025|Major Depressive Disorder|major depressive disorder
30844|NCT03093025|Adjunctive Treatment|adjunctive treatment
30845|NCT03092999|Pharmacokinetics|pharmacokinetics
30846|NCT03092960|Latino|latino
30847|NCT03092960|Male|male
30848|NCT03092934|Small Cell Lung Carcinoma|small cell lung carcinoma
30849|NCT03092908|calcium oxalate|calcium oxalate
30850|NCT03092908|nephrolithiasis|nephrolithiasis
30851|NCT03092908|Mature vinegar|mature vinegar
30852|NCT03092908|prophylaxis|prophylaxis
30853|NCT03092869|Feet|feet
30854|NCT03092869|Ankle|ankle
30855|NCT03092869|Balance|balance
30856|NCT03092869|Manual Therapy|manual therapy
30857|NCT03092869|Older Adult|older adult
30858|NCT03092830|SCC|scc
30859|NCT03092830|BCC|bcc
30860|NCT03092830|DNA|dna
30861|NCT03092830|RNA|rna
30862|NCT03092830|HEDGE HOG|hedge hog
30863|NCT03092830|epidermal growth factor receptor|epidermal growth factor receptor
30864|NCT03092817|Tuberculosis|tuberculosis
30865|NCT03092817|tuberculous meningitis|tuberculous meningitis
30866|NCT03092817|drug induced liver injury|drug induced liver injury
30867|NCT03092817|HIV|hiv
30868|NCT03092817|IRIS|iris
30869|NCT03092817|randomized controlled trial|randomized controlled trial
30870|NCT03092817|dexamethasone|dexamethasone
30871|NCT03092804|Shunting|shunting
30872|NCT03092804|Brain constructure|brain constructure
30873|NCT03092804|Neural network|neural network
30874|NCT03092791|Drug Therapy|drug therapy
30875|NCT03092778|Cryoablation|cryoablation
30876|NCT03092778|Radiology|radiology
30877|NCT03092765|E6011|e6011
30878|NCT03092765|Ursodeoxycholic acid|ursodeoxycholic acid
30879|NCT03092765|Japan|japan
30880|NCT03092726|ASP8062|asp8062
30881|NCT03092726|Fibromyalgia|fibromyalgia
30882|NCT03092713|Cognitive Rehabilitation|cognitive rehabilitation
30883|NCT03092713|Supported employment|supported employment
30896|NCT03092596|HIV infection|hiv infection
30897|NCT03092596|drug abuse|drug abuse
30898|NCT03092596|substance use|substance use
30899|NCT03092596|alcohol abuse|alcohol abuse
30900|NCT03092596|screening|screening
30901|NCT03092596|treatment|treatment
30902|NCT03092596|primary care|primary care
30903|NCT03092596|motivational interviewing|motivational interviewing
30904|NCT03092570|Motor learning|motor learning
30906|NCT03092570|tDCS|tdcs
30907|NCT03092570|upper limb|upper limb
30908|NCT03092531|HIV|hiv
30909|NCT03092531|ART Adherence|art adherence
30910|NCT03092531|Adolescents|adolescents
30911|NCT03092518|Surgical Resection|surgical resection
30912|NCT03092518|Progression Free Survival|progression free survival
30913|NCT03092518|Gastroesophageal Junction (Siewert III) Adenocarcinoma|gastroesophageal junction (siewert iii) adenocarcinoma
30921|NCT03092466|femoral nerve block|femoral nerve block
30922|NCT03092466|elderly patient|elderly patient
30923|NCT03092466|cognitive impairment|cognitive impairment
30924|NCT03092466|hip fracture|hip fracture
30925|NCT03092466|regional anesthesia|regional anesthesia
30926|NCT03092440|Medical Education|medical education
30927|NCT03092440|simulation|simulation
30928|NCT03092440|serious game|serious game
30929|NCT03092440|validity|validity
30930|NCT03092401|Liver transplantation|liver transplantation
30931|NCT03092401|Hepatopulmonary Syndrome|hepatopulmonary syndrome
30932|NCT03092401|Liver Cirrhosis|liver cirrhosis
22607|NCT03145844|Hepatitis|hepatitis
22608|NCT03145831|Pediatrics|pediatrics
22609|NCT03145818|dissemination|dissemination
22705|NCT03145129|IOP|iop
30933|NCT03092388|Sleep-Disordered Breathing|sleep-disordered breathing
30934|NCT03092388|Heart Failure|heart failure
30935|NCT03092388|Leg Fluid Shift|leg fluid shift
30936|NCT03092375|HCV|hcv
30937|NCT03092375|Previously treated|previously treated
30938|NCT03092362|persistent atrial fibrillation|persistent atrial fibrillation
30939|NCT03092362|Heart rate variability|heart rate variability
30940|NCT03092362|quality of life|quality of life
30941|NCT03092336|Peripheral Arterial Disease, training|peripheral arterial disease, training
30942|NCT03092310|Artificial Pancreas|artificial pancreas
30943|NCT03092271|suicide|suicide
30944|NCT03092271|suicide attempt|suicide attempt
30945|NCT03092271|self harm|self harm
30946|NCT03092271|depression|depression
30947|NCT03092193|Naproxen|naproxen
30948|NCT03092193|Association of naproxen-esomeprazole|association of naproxen-esomeprazole
30949|NCT03092193|High pressure liquid chromatography|high pressure liquid chromatography
30950|NCT03092193|Cytochrome P450|cytochrome p450
30951|NCT03092180|Dermatomyositis|dermatomyositis
30952|NCT03092180|Immunomodulation|immunomodulation
30953|NCT03092180|Immunosuppressive agents|immunosuppressive agents
30954|NCT03092180|Myositis|myositis
30955|NCT03092180|Polymyositis|polymyositis
30956|NCT03092180|Necrotizing myopathies|necrotizing myopathies
30957|NCT03092180|Antisynthetase syndrome|antisynthetase syndrome
30958|NCT03092128|Gastrointestinal stromal tumor (GIST)|gastrointestinal stromal tumor (gist)
30959|NCT03092128|Imatinib|imatinib
30960|NCT03092128|Pharmacogenetics|pharmacogenetics
30961|NCT03092128|Pharmacokinetics|pharmacokinetics
30962|NCT03092128|Precision medicine|precision medicine
30963|NCT03092128|Somatic and germ-line mutations|somatic and germ-line mutations
30964|NCT03092115|Men who have sex with men (MSM)|men who have sex with men (msm)
30965|NCT03092115|mHealth|mhealth
30966|NCT03092115|antiretroviral therapy (ART)|antiretroviral therapy (art)
30967|NCT03092115|native android app|native android app
30968|NCT03092089|Sonothrombolysis, STEMI, PPCI, Microbubbles|sonothrombolysis, stemi, ppci, microbubbles
30969|NCT03092076|pharmacokinetics|pharmacokinetics
30970|NCT03092076|antiplatelet effects|antiplatelet effects
30971|NCT03092076|single nucleotide polymorphism (SNP)|single nucleotide polymorphism (snp)
30972|NCT03092024|Systemic Sclerosis|systemic sclerosis
30973|NCT03092024|Scleroderma|scleroderma
30974|NCT03092024|Hand|hand
30975|NCT03092024|Intervention|intervention
30976|NCT03092024|Exercise|exercise
30977|NCT03091985|Breastshield|breastshield
30978|NCT03091985|Breastpump|breastpump
30979|NCT03091985|Breastfeeding|breastfeeding
30980|NCT03091972|Persistent Atrial Fibrillation|persistent atrial fibrillation
30981|NCT03091972|Linear ablation|linear ablation
30982|NCT03091972|Catheter ablation|catheter ablation
30983|NCT03091972|Contact force|contact force
30984|NCT03091946|Oatmeal; Post-prandial glycemic response ; Post-prandial insulin response; Post-prandial hunger|oatmeal; post-prandial glycemic response ; post-prandial insulin response; post-prandial hunger
30985|NCT03091933|AML, ALL, MDS|aml, all, mds
30986|NCT03091933|relapsed hematopoietic malignancy|relapsed hematopoietic malignancy
30987|NCT03091933|Stem cell transplantation|stem cell transplantation
30988|NCT03091933|minor histocompatibilty antigen (MiHA)|minor histocompatibilty antigen (miha)
619129|NCT00658710|stroke|stroke
30989|NCT03091907|Necrotizing enterocolitis|necrotizing enterocolitis
30990|NCT03091907|Followup|followup
30991|NCT03091907|Neurodevelopmental impairments|neurodevelopmental impairments
30992|NCT03091907|Growth impairments|growth impairments
30993|NCT03091907|Gut function|gut function
30994|NCT03091907|Behavioural impairments|behavioural impairments
30995|NCT03091894|dexmedetomidine,propofol,sleep endoscopy,sedation|dexmedetomidine,propofol,sleep endoscopy,sedation
30996|NCT03091881|Granisetron|granisetron
30997|NCT03091881|Spinal induced hypotension|spinal induced hypotension
30998|NCT03091790|ventral hernia|ventral hernia
31000|NCT03091777|bacterial vaginosis|bacterial vaginosis
31001|NCT03091777|vaginal infection|vaginal infection
31003|NCT03091764|NMIBC|nmibc
31004|NCT03091764|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
31005|NCT03091764|Patient reported outcome|patient reported outcome
31006|NCT03091764|Symptom burden|symptom burden
31007|NCT03091764|Questionnaire|questionnaire
31008|NCT03091751|Factor IX (FIX)|factor ix (fix)
31009|NCT03091738|sleep|sleep
31010|NCT03091725|Obesity|obesity
31011|NCT03091725|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
31012|NCT03091725|Very low calorie diet|very low calorie diet
31013|NCT03091725|Fibroblast growth factor 21 (FGF21)|fibroblast growth factor 21 (fgf21)
31014|NCT03091712|Degludec|degludec
31015|NCT03091712|MIDS|mids
31020|NCT03091699|Smoking|smoking
31021|NCT03091699|Nicotine|nicotine
31022|NCT03091699|Exercise|exercise
22707|NCT03145090|bone scintigraphy|bone scintigraphy
22708|NCT03145090|knee arthroplasty|knee arthroplasty
22709|NCT03145090|spect-ct|spect-ct
22710|NCT03145090|quantification|quantification
22712|NCT03145077|Osteoradionecrosis|osteoradionecrosis
31023|NCT03091699|Cognition|cognition
31024|NCT03091686|Sedentary Behaviour|sedentary behaviour
31025|NCT03091686|Health Behaviour Change|health behaviour change
31026|NCT03091686|Health Action Process Approach|health action process approach
31027|NCT03091686|Intervention|intervention
31028|NCT03091686|Prolonged Sitting|prolonged sitting
31029|NCT03091686|Light Intensity Physical Activity|light intensity physical activity
31030|NCT03091686|Motivational Factors|motivational factors
31031|NCT03091686|Intentions|intentions
31032|NCT03091686|Diabetes|diabetes
31033|NCT03091686|Self-Efficacy|self-efficacy
31034|NCT03091686|Risk Perception|risk perception
31035|NCT03091686|Outcome Expectancies|outcome expectancies
31036|NCT03091647|Chinese women|chinese women
31037|NCT03091647|Cancer-related fatigue|cancer-related fatigue
31038|NCT03091647|Acupressure|acupressure
31039|NCT03091634|Xue-Fu-Zhu-Yu Capsule|xue-fu-zhu-yu capsule
31040|NCT03091634|Qi Stagnation and Blood Stasis syndrome|qi stagnation and blood stasis syndrome
31041|NCT03091634|National Center for Complementary and Integrative Health|national center for complementary and integrative health
31042|NCT03091621|Deep Vein Thrombosis|deep vein thrombosis
31043|NCT03091621|pulmonary embolism|pulmonary embolism
31044|NCT03091608|Drug-Induced Liver Injury|drug-induced liver injury
31045|NCT03091582|Psychological Therapy|psychological therapy
31046|NCT03091556|Drug-Induced Liver Injury|drug-induced liver injury
31048|NCT03091530|Sleeper Stretch|sleeper stretch
31049|NCT03091530|Balloon Blow|balloon blow
31050|NCT03091530|GIRD (Glenohumeral internal rotation deficit)|gird (glenohumeral internal rotation deficit)
31051|NCT03091517|Online lifestyle modification|online lifestyle modification
31052|NCT03091517|Self-management|self-management
31053|NCT03091517|HbA1c|hba1c
31054|NCT03091439|Osteomyelitis|osteomyelitis
31055|NCT03091439|dalbavancin|dalbavancin
31056|NCT03091439|antibiotic|antibiotic
31057|NCT03091400|Memory Disorders|memory disorders
31058|NCT03091400|Multiple Sclerosis|multiple sclerosis
31059|NCT03091400|Atomoxetine Hydrochloride|atomoxetine hydrochloride
31060|NCT03091387|neonates, extubation|neonates, extubation
31061|NCT03091361|Bacterial imaging|bacterial imaging
31062|NCT03091361|PPV|ppv
31063|NCT03091361|Chronic wounds|chronic wounds
31064|NCT03091309|Inflammatory Bowel Diseases|inflammatory bowel diseases
31065|NCT03091309|Medication Adherence|medication adherence
31066|NCT03091309|Crohn Disease|crohn disease
31067|NCT03091309|Ulcerative Colitis|ulcerative colitis
31068|NCT03091309|Pregnancy|pregnancy
31069|NCT03091309|Counselling|counselling
31070|NCT03091309|Patient Education|patient education
31071|NCT03091283|time management, anaesthesia training program|time management, anaesthesia training program
31072|NCT03091270|gliomas|gliomas
31073|NCT03091270|motor functional cortex|motor functional cortex
31074|NCT03091270|ZOOMit-fMRI|zoomit-fmri
31078|NCT03091218|Drug-Induced Liver Injury|drug-induced liver injury
31079|NCT03091192|Papillary Renal Cell Cancer|papillary renal cell cancer
31080|NCT03091192|AZD6094|azd6094
31081|NCT03091192|Savolitinib|savolitinib
31082|NCT03091179|airway management|airway management
31083|NCT03091179|high flow nasal oxygen|high flow nasal oxygen
31084|NCT03091179|high flow nasal cannula|high flow nasal cannula
31085|NCT03091179|THRIVE|thrive
31086|NCT03091140|Parathyroidectomy|parathyroidectomy
31087|NCT03091140|Muscular Functional Characteristics|muscular functional characteristics
31088|NCT03091140|Parathyroid Glands|parathyroid glands
31089|NCT03091114|fractures, risk prediction|fractures, risk prediction
31090|NCT03091101|keratoconus|keratoconus
31091|NCT03091101|corneal innervation|corneal innervation
31092|NCT03091101|scleral contact lenses|scleral contact lenses
31093|NCT03091075|Rotator Cuff Tear|rotator cuff tear
31094|NCT03091075|Rotator Cuff|rotator cuff
31095|NCT03091075|Anabolic Steroid|anabolic steroid
31096|NCT03091075|Testosterone|testosterone
31097|NCT03091075|Oxandrolone|oxandrolone
31098|NCT03091049|coronary|coronary
31099|NCT03091049|catheterization|catheterization
31100|NCT03091049|transradial|transradial
31101|NCT03091049|anesthesia|anesthesia
31102|NCT03091036|Chronic|chronic
31103|NCT03091036|Complex|complex
31104|NCT03091023|Endometrial receptivity|endometrial receptivity
31105|NCT03091023|Transcriptomic|transcriptomic
31106|NCT03091023|Single cell|single cell
31107|NCT03091023|Endometrial fluid|endometrial fluid
31109|NCT03090984|Hemodialysis|hemodialysis
31110|NCT03090984|Coagulation activation|coagulation activation
31111|NCT03090958|technology|technology
31112|NCT03090958|app|app
31113|NCT03090958|YMSM|ymsm
22802|NCT03144557|Inhalation Devices|inhalation devices
22803|NCT03144544|Similarity|similarity
22804|NCT03144544|Diversity|diversity
22805|NCT03144531|School-age child|school-age child
22811|NCT03144505|Type 2 Diabetes|type 2 diabetes
22812|NCT03144505|Exercise|exercise
31114|NCT03090958|HIV|hiv
31115|NCT03090945|Endoscopy|endoscopy
31116|NCT03090945|GI Bleeding|gi bleeding
31117|NCT03090945|Pediatrics|pediatrics
31118|NCT03090945|Upper Gastrointestinal Bleeding|upper gastrointestinal bleeding
31119|NCT03090945|Gastro Intestinal Bleeding|gastro intestinal bleeding
31120|NCT03090906|volume gain|volume gain
31121|NCT03090906|soft tissue augmentation|soft tissue augmentation
31122|NCT03090906|dental implants|dental implants
31123|NCT03090906|histology|histology
31124|NCT03090880|Low-molecular-weight Heparin|low-molecular-weight heparin
31125|NCT03090880|Tinzaparin|tinzaparin
31126|NCT03090867|Clinical Practice Guideline|clinical practice guideline
31127|NCT03090867|Critical care|critical care
31128|NCT03090867|Family-centered care|family-centered care
31129|NCT03090867|Professional-family relations|professional-family relations
31130|NCT03090867|Family nursing|family nursing
31131|NCT03090867|Anxiety|anxiety
31132|NCT03090867|Depression|depression
31133|NCT03090867|Participation in care|participation in care
31134|NCT03090854|Alzheimer's Disease|alzheimer's disease
31135|NCT03090854|Cognition|cognition
31136|NCT03090854|Cholinergic target|cholinergic target
31137|NCT03090841|Cytomegalovirus Congenital|cytomegalovirus congenital
31138|NCT03090841|Non-invasive diagnosis|non-invasive diagnosis
31139|NCT03090841|Omics|omics
31140|NCT03090841|Biomarkers|biomarkers
31141|NCT03090828|economic evaluation|economic evaluation
31142|NCT03090828|e health|e health
31143|NCT03090815|Circulating Tumor DNA|circulating tumor dna
31144|NCT03090815|Prognostic|prognostic
31145|NCT03090815|Molecular tests|molecular tests
31146|NCT03090802|Human Immunodeficiency Virus|human immunodeficiency virus
31148|NCT03090802|adolescent mothers|adolescent mothers
31149|NCT03090802|Sub-Saharan Africa|sub-saharan africa
31150|NCT03090802|intimate partner violence|intimate partner violence
31151|NCT03090802|postpartum period|postpartum period
31152|NCT03090789|Friedreich Ataxia|friedreich ataxia
31153|NCT03090789|Neuro-degenerative disease|neuro-degenerative disease
31154|NCT03090698|osteoarthritis|osteoarthritis
31155|NCT03090698|knee|knee
31156|NCT03090698|treatment|treatment
31157|NCT03090685|Chikungunya Fever|chikungunya fever
31158|NCT03090685|Pain|pain
31159|NCT03090685|Mobility Limitation|mobility limitation
31160|NCT03090685|Auriculotherapy|auriculotherapy
31161|NCT03090685|Complementary Therapies|complementary therapies
31162|NCT03090685|Physical Therapy|physical therapy
31163|NCT03090672|Arthritis|arthritis
31164|NCT03090672|Degenerative|degenerative
31165|NCT03090672|Tendinosis|tendinosis
31166|NCT03090672|Jont disease|jont disease
31167|NCT03090672|Low back pain|low back pain
31168|NCT03090659|multiple myeloma|multiple myeloma
31169|NCT03090659|BCMA|bcma
31170|NCT03090659|CAR-T|car-t
31171|NCT03090646|social behavioral|social behavioral
31172|NCT03090646|living donor kidney transplant|living donor kidney transplant
31173|NCT03090646|follow-up|follow-up
31174|NCT03090646|health utilization|health utilization
31175|NCT03090646|incentives|incentives
31176|NCT03090633|Fetoscopy|fetoscopy
31181|NCT03090594|Acute cellular rejection|acute cellular rejection
31182|NCT03090581|Graft Rejection/diagnosis|graft rejection/diagnosis
31184|NCT03090581|Cryoprobe|cryoprobe
31185|NCT03090555|adhesive capsulitis|adhesive capsulitis
31186|NCT03090555|clinical trial|clinical trial
31187|NCT03090555|manipulation|manipulation
31188|NCT03090529|Exercise training|exercise training
31189|NCT03090529|Ambulatory blood pressure|ambulatory blood pressure
31190|NCT03090529|Resistant Hypertension|resistant hypertension
31191|NCT03090529|Nitric Oxide|nitric oxide
31192|NCT03090516|Ginkgo biloba dispersible tablets|ginkgo biloba dispersible tablets
31193|NCT03090516|Alzheimer's|alzheimer's
31194|NCT03090503|Antipsychotic agents|antipsychotic agents
31195|NCT03090503|Treatment|treatment
31196|NCT03090503|Effectiveness|effectiveness
31197|NCT03090503|Aripiprazole|aripiprazole
31198|NCT03090503|Risperidone|risperidone
31199|NCT03090490|Treatment|treatment
31200|NCT03090490|Maintenance|maintenance
31201|NCT03090464|Type 2 diabetes mellitus|type 2 diabetes mellitus
31202|NCT03090464|Digital disease management|digital disease management
31203|NCT03090464|T2DM|t2dm
31204|NCT03090464|Hyperglycemia|hyperglycemia
31205|NCT03090464|Diabetes mellitus|diabetes mellitus
31206|NCT03090451|Insulin|insulin
31207|NCT03090451|Glucose Clamp|glucose clamp
31208|NCT03090451|Glucose Tracer|glucose tracer
31209|NCT03090451|Artificial Pancreas|artificial pancreas
31210|NCT03090451|Exercise|exercise
31211|NCT03090451|Aerobic|aerobic
31212|NCT03090399|Goal Directed Fluid Therapy|goal directed fluid therapy
31213|NCT03090373|Catheter|catheter
31214|NCT03090373|UTI's|uti's
31215|NCT03090360|Healthy babies|healthy babies
31216|NCT03090360|Infant formula|infant formula
31217|NCT03090360|Growth|growth
31218|NCT03090334|beta-d-glucan|beta-d-glucan
31219|NCT03090334|abdominal candidiasis|abdominal candidiasis
31220|NCT03090321|fitness|fitness
31221|NCT03090321|health|health
31222|NCT03090321|activity|activity
31223|NCT03090321|heart risk|heart risk
31224|NCT03090321|wellness|wellness
31225|NCT03090282|mechanical treatment|mechanical treatment
31226|NCT03090282|implant|implant
31227|NCT03090269|cocaine|cocaine
31228|NCT03090269|methylphenidate|methylphenidate
31229|NCT03090269|psychostimulant|psychostimulant
31230|NCT03090269|ADHD|adhd
31231|NCT03090269|effective dose|effective dose
31232|NCT03090269|pharmacokinetics|pharmacokinetics
31233|NCT03090269|crack|crack
31240|NCT03089177|Randomized Controlled Trial|randomized controlled trial
31241|NCT03089177|Community Gardening|community gardening
31242|NCT03089177|Health Behavior Change|health behavior change
31243|NCT03089177|Physical Activity|physical activity
31244|NCT03089177|Diet|diet
31245|NCT03089177|Obesity|obesity
31246|NCT03089177|Cancer Prevention|cancer prevention
31247|NCT03089177|Neighborhood|neighborhood
31248|NCT03089151|Pilot Randomized Controlled Trial|pilot randomized controlled trial
31249|NCT03089151|Community Garden|community garden
31250|NCT03089151|Health Behavior Change|health behavior change
31251|NCT03089151|Physical Activity|physical activity
31252|NCT03089151|Diet|diet
31253|NCT03089151|Obesity|obesity
31254|NCT03089151|Neighborhood|neighborhood
31255|NCT03089151|Microbiome|microbiome
31256|NCT03089151|Inflammatory biomarkers|inflammatory biomarkers
31257|NCT03089125|Lung Cancer|lung cancer
31258|NCT03089099|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
31259|NCT03089099|circulating tumor cells|circulating tumor cells
31260|NCT03089099|Prognosis|prognosis
31261|NCT03089099|Liquid biopsy|liquid biopsy
31262|NCT03089086|meningococcal B vaccine|meningococcal b vaccine
31263|NCT03089086|herd immunity|herd immunity
31264|NCT03089086|adolescents|adolescents
31265|NCT03089086|young adults|young adults
31266|NCT03089086|south australia|south australia
31267|NCT03089060|Fingertip Amputation|fingertip amputation
31268|NCT03089060|Fingertip Regeneration|fingertip regeneration
31269|NCT03089060|Infection|infection
31270|NCT03089060|Occlusive Dressings|occlusive dressings
31271|NCT03089060|Pediatric Surgery|pediatric surgery
31272|NCT03089060|Silicone Finger Cap|silicone finger cap
31273|NCT03089021|neck pain,|neck pain,
31274|NCT03090243|Glaucoma|glaucoma
31275|NCT03090243|Intraocular pressure|intraocular pressure
31276|NCT03090243|Colonoscopy|colonoscopy
31277|NCT03090243|Virtual Colonoscopy|virtual colonoscopy
31278|NCT03090243|Valsalva|valsalva
31279|NCT03090230|Descending Thoracic Aorta|descending thoracic aorta
31280|NCT03090230|DTA|dta
31281|NCT03090230|Transection|transection
31282|NCT03090230|Traumatic Injury of the Descending Thoracic Aorta|traumatic injury of the descending thoracic aorta
31283|NCT03090217|Radiotherapy|radiotherapy
31284|NCT03090217|Brachytherapy|brachytherapy
31285|NCT03090217|Physiotherapy|physiotherapy
31286|NCT03090217|Vaginal dilators|vaginal dilators
31287|NCT03090217|Pelvic floor exercises|pelvic floor exercises
31288|NCT03090217|Vaginal Stenosis|vaginal stenosis
31289|NCT03090204|strain|strain
31290|NCT03090204|myocarditic deformation imaging|myocarditic deformation imaging
31291|NCT03090204|right ventricle (RV)|right ventricle (rv)
31292|NCT03090204|systolic RV function|systolic rv function
31293|NCT03090204|preload dependence|preload dependence
31294|NCT03090204|contractility|contractility
31295|NCT03090204|intermittent hemodialysis (HDI)|intermittent hemodialysis (hdi)
31296|NCT03090165|Triple Negative Breast Neoplasms|triple negative breast neoplasms
31297|NCT03090165|ribociclib|ribociclib
31298|NCT03090165|LEE011|lee011
31299|NCT03090165|CDK 4/6 inhibitor|cdk 4/6 inhibitor
31300|NCT03090165|bicalutamide|bicalutamide
31301|NCT03090152|Total Hip Replacement|total hip replacement
31302|NCT03090152|Total Hip Arthroplasty|total hip arthroplasty
31303|NCT03090139|Drug therapy|drug therapy
31304|NCT03090113|Stroke|stroke
31305|NCT03090113|Embolic Stroke|embolic stroke
31306|NCT03090113|Shuxuetong|shuxuetong
31307|NCT03090113|Recurrence|recurrence
31308|NCT03090113|Symptomatic New Cerebral Infarction|symptomatic new cerebral infarction
31309|NCT03090113|Asymptomatic New Cerebral Infarction|asymptomatic new cerebral infarction
31310|NCT03090087|Diameter of retinal arteries|diameter of retinal arteries
31311|NCT03090087|Adenosine|adenosine
31312|NCT03090087|Hypoxia|hypoxia
31313|NCT03090035|HCV genotype 2, HCV genotype 3, IL-28B, PEG-INF.|hcv genotype 2, hcv genotype 3, il-28b, peg-inf.
31314|NCT03090009|Peri-implant Mucositis|peri-implant mucositis
31315|NCT03090009|NSAID|nsaid
31316|NCT03090009|Microbiome|microbiome
31317|NCT03090009|16s Ribosomal Pyro-sequencing|16s ribosomal pyro-sequencing
31318|NCT03089996|piezocision|piezocision
31319|NCT03089996|corticotomy|corticotomy
31320|NCT03089996|Gingival Crevicular Fluid|gingival crevicular fluid
31321|NCT03089983|prison|prison
31322|NCT03089957|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
31323|NCT03089957|Critical Illness|critical illness
31324|NCT03089957|Randomized Controlled Trial|randomized controlled trial
31325|NCT03089957|Ulinastatin|ulinastatin
31326|NCT03089944|Glecaprevir|glecaprevir
31327|NCT03089944|Pibrentasvir|pibrentasvir
31328|NCT03089944|Pangenotypic|pangenotypic
31329|NCT03089944|Compensated Cirrhosis|compensated cirrhosis
31330|NCT03089944|Genotype (GT) 1, 2, 4, 5 or 6|genotype (gt) 1, 2, 4, 5 or 6
31331|NCT03089944|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
31332|NCT03089944|Treatment Naïve|treatment naïve
31333|NCT03089944|Cirrhosis|cirrhosis
31334|NCT03089879|Immunogenicity, Vaccine|immunogenicity, vaccine
31335|NCT03089879|Immunologic Memory|immunologic memory
31337|NCT03089879|Shigella Vaccines|shigella vaccines
31338|NCT03089879|Shigellosis|shigellosis
31339|NCT03089879|Dysentery, Bacillary|dysentery, bacillary
31340|NCT03089879|Healthy Volunteers|healthy volunteers
31341|NCT03089879|Safety|safety
31342|NCT03089879|Bacteria|bacteria
31343|NCT03089879|Clinical Trials, Phase 1|clinical trials, phase 1
31344|NCT03089879|Shigella sonnei|shigella sonnei
31345|NCT03089866|Central nervous System|central nervous system
31346|NCT03089866|Memory functions|memory functions
31347|NCT03089866|Executive functions|executive functions
31348|NCT03089866|Cognitive impairment|cognitive impairment
31349|NCT03089853|COPD|copd
31350|NCT03089853|pulmonary rehabilitation|pulmonary rehabilitation
31351|NCT03089853|telehealth|telehealth
31352|NCT03089853|smart|smart
31353|NCT03089853|technology|technology
31354|NCT03089853|NEMS|nems
31355|NCT03089853|acute exacerbation|acute exacerbation
31356|NCT03089840|normothermic perfusion|normothermic perfusion
31357|NCT03089840|liver transplantation|liver transplantation
31358|NCT03089827|Memory|memory
31359|NCT03089814|tissue oxygen saturation, ischemic conditioning|tissue oxygen saturation, ischemic conditioning
31360|NCT03089801|health care access|health care access
31361|NCT03089801|eHealth|ehealth
31363|NCT03089775|Contact|contact
31364|NCT03089775|Treatment|treatment
31365|NCT03089775|Prevention|prevention
31366|NCT03089775|BBI-2000|bbi-2000
31367|NCT03089775|Dermatitis|dermatitis
31368|NCT03089775|Allergic|allergic
31369|NCT03089736|Pain|pain
31370|NCT03089736|Head and neck cancer|head and neck cancer
31371|NCT03089736|depression|depression
31372|NCT03089736|anxiety|anxiety
31373|NCT03089736|health|health
31374|NCT03089736|catastrophizing|catastrophizing
31375|NCT03089723|carpometacarpal joint ostearthritis|carpometacarpal joint ostearthritis
31376|NCT03089723|hyaluronic acid|hyaluronic acid
31377|NCT03089723|Rhizarthrosis|rhizarthrosis
31378|NCT03089697|N-Rephasin SAL200|n-rephasin sal200
31379|NCT03089697|Methicillin-Sensitive Staphylococcus aureus|methicillin-sensitive staphylococcus aureus
31851|NCT03086395|refractory|refractory
31380|NCT03089697|Methicillin Resistant Staphylococcus Aureus|methicillin resistant staphylococcus aureus
31381|NCT03089684|NHANES|nhanes
31382|NCT03089684|Folate|folate
31383|NCT03089684|Folic Acid|folic acid
31384|NCT03089671|Vitamin B|vitamin b
31385|NCT03089671|5% Dextrose in Water|5% dextrose in water
31386|NCT03089671|Cystoscopy|cystoscopy
31387|NCT03089671|Ureter|ureter
31388|NCT03089658|Metastatic Merkel Cell Carcinoma|metastatic merkel cell carcinoma
31389|NCT03089658|Expanded Access Program|expanded access program
31390|NCT03089658|Temporary Authorisation for Use|temporary authorisation for use
31391|NCT03089658|Avelumab|avelumab
31392|NCT03089632|gluten-free diet|gluten-free diet
31393|NCT03089632|gluten sensitivity|gluten sensitivity
31394|NCT03089632|dyspepsia|dyspepsia
31395|NCT03089632|diabetes mellitus, type 1|diabetes mellitus, type 1
31396|NCT03089632|gastroparesis|gastroparesis
31397|NCT03089632|motility|motility
31398|NCT03089619|Alveolar bone|alveolar bone
31399|NCT03089619|Bone resorption|bone resorption
31400|NCT03089619|dental implants|dental implants
31401|NCT03089593|Thermic Effect of Food|thermic effect of food
31402|NCT03089593|Energy Expenditure|energy expenditure
31403|NCT03089593|Ginger|ginger
31404|NCT03089567|Silver diamine Fluoride|silver diamine fluoride
31405|NCT03089567|Streptococcus mutans|streptococcus mutans
31406|NCT03089567|Caries prevention|caries prevention
31407|NCT03089567|Fluoride|fluoride
31408|NCT03089528|Direct laryngoscopy|direct laryngoscopy
31409|NCT03089528|Videolaryngoscopy|videolaryngoscopy
31410|NCT03089528|Diabetes Mellitus|diabetes mellitus
31411|NCT03089528|Intubation|intubation
31412|NCT03089528|Anesthesia|anesthesia
31413|NCT03089515|World Trade Center|world trade center
31414|NCT03089515|World Trade Center Survivors|world trade center survivors
31415|NCT03089502|Exercise|exercise
31416|NCT03089502|Cardiac Rehabilitation|cardiac rehabilitation
31417|NCT03089502|Breast Caner|breast caner
31418|NCT03089502|Left Ventricular Dysfunction|left ventricular dysfunction
31419|NCT03089502|Trastuzumab|trastuzumab
31420|NCT03089502|Anthracyclines|anthracyclines
31421|NCT03089489|Primary graft dysfunction|primary graft dysfunction
31422|NCT03089489|Lung transplantation|lung transplantation
31423|NCT03089489|Surfactant Protein|surfactant protein
31424|NCT03089489|inflammation|inflammation
31425|NCT03089476|Prevention|prevention
31426|NCT03089476|Predictors|predictors
31428|NCT03089463|Diabetic Foot|diabetic foot
31429|NCT03089463|Biomechanics|biomechanics
31430|NCT03089463|Stratification|stratification
31431|NCT03089463|Diabetes Complications|diabetes complications
31432|NCT03089463|Diabetes; Neuropathic (Manifestation)|diabetes; neuropathic (manifestation)
31433|NCT03089463|Risk Factors|risk factors
31434|NCT03089463|Prospective Studies|prospective studies
31435|NCT03089424|low back pain, photobiomodulation therapy, LLLT|low back pain, photobiomodulation therapy, lllt
31436|NCT03089411|myeloma multiple|myeloma multiple
31437|NCT03089411|newly diagnosed|newly diagnosed
31438|NCT03089398|Hybrid Coronary Revascularization|hybrid coronary revascularization
31439|NCT03089398|Coronary Artery Bypass Grafting|coronary artery bypass grafting
31440|NCT03089398|Percutaneous Coronary Intervention|percutaneous coronary intervention
31441|NCT03089372|Erectile Dysfunction|erectile dysfunction
31442|NCT03089372|Low intensity extracorporeal shock wave treatment|low intensity extracorporeal shock wave treatment
31443|NCT03089359|Unspecific symptoms|unspecific symptoms
31444|NCT03089359|Soluvent urokinase plasminogen activator receptor|soluvent urokinase plasminogen activator receptor
31445|NCT03089359|Lactate|lactate
31446|NCT03089359|Emergency Medical Services|emergency medical services
31447|NCT03089346|Imaging|imaging
31448|NCT03089346|Bronchial Remodeling|bronchial remodeling
31449|NCT03089320|HIV, Heavy drinking, Alcohol Abuse, AIDS|hiv, heavy drinking, alcohol abuse, aids
31450|NCT03089307|Erectile Dysfunction|erectile dysfunction
31451|NCT03089307|Low intensity extracorporeal shock wave treatment|low intensity extracorporeal shock wave treatment
31452|NCT03089294|Erectile Dysfunction|erectile dysfunction
31453|NCT03089294|Low intensity extracorporeal shock wave treatment|low intensity extracorporeal shock wave treatment
31454|NCT03089268|sessile serrated polyp|sessile serrated polyp
31455|NCT03089268|prevalence|prevalence
31456|NCT03089268|colorectal cancer|colorectal cancer
31457|NCT03089268|molecular biology|molecular biology
31458|NCT03089255|Thrombophylaxis|thrombophylaxis
31459|NCT03089255|Deep Venous Thrombosis|deep venous thrombosis
31460|NCT03089255|Pulmonary Embolism|pulmonary embolism
31461|NCT03089255|Lower Leg Trauma|lower leg trauma
31462|NCT03089229|Topical Cream|topical cream
31463|NCT03089229|Novel|novel
31464|NCT03088982|Family Medicine|family medicine
31465|NCT03088982|multimorbidity|multimorbidity
31466|NCT03088982|prevention|prevention
31467|NCT03088969|Chronic Low Back Pain|chronic low back pain
31468|NCT03088969|Function|function
31469|NCT03088969|Self-efficacy|self-efficacy
31470|NCT03088969|Return to work|return to work
31471|NCT03088969|Questionnaire|questionnaire
31472|NCT03088956|longitudinal|longitudinal
31473|NCT03088956|caregiver|caregiver
31852|NCT03086382|Lacosamide|lacosamide
31474|NCT03088956|cognitive assessments|cognitive assessments
31475|NCT03088904|Inactivated, quadrivalent influenza vaccine|inactivated, quadrivalent influenza vaccine
31476|NCT03088904|Live, attenuated quadrivalent influenza vaccine|live, attenuated quadrivalent influenza vaccine
31477|NCT03088904|Monozygotic twins|monozygotic twins
31478|NCT03088904|Dizygotic twins|dizygotic twins
31479|NCT03088904|Adults|adults
31480|NCT03088904|Adolescents|adolescents
31481|NCT03088891|altitude training|altitude training
31482|NCT03088891|antioxidants|antioxidants
31483|NCT03088891|oxidative stress|oxidative stress
31484|NCT03088891|elite athletes|elite athletes
31485|NCT03088891|inflammation|inflammation
31486|NCT03088891|diet|diet
31487|NCT03088878|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
31488|NCT03088878|Small lymphocytic lymphoma|small lymphocytic lymphoma
31489|NCT03088878|Mantle cell lymphoma|mantle cell lymphoma
619130|NCT00658710|TRIDENT|trident
31490|NCT03088878|Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1)|receptor tyrosine kinase-like orphan receptor 1 (ror1)
31491|NCT03088878|Bruton Tyrosine Kinase (BTK)|bruton tyrosine kinase (btk)
31492|NCT03088774|Low back pain|low back pain
31493|NCT03088761|tracheal tube|tracheal tube
31494|NCT03088761|cuff pressure|cuff pressure
31495|NCT03088748|total knee arthroplasty|total knee arthroplasty
31496|NCT03088722|Contraceptive implant|contraceptive implant
31497|NCT03088722|Task sharing|task sharing
31498|NCT03088722|Nigeria|nigeria
31499|NCT03088709|NHL|nhl
31500|NCT03088709|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
31501|NCT03088709|Haploidentical|haploidentical
31502|NCT03088709|Bone Marrow Transplant|bone marrow transplant
31503|NCT03088709|Stem Cell Transplant|stem cell transplant
31504|NCT03088709|Acute Myeloid Leukemia|acute myeloid leukemia
31505|NCT03088709|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
31506|NCT03088709|Myelodysplastic Syndrome|myelodysplastic syndrome
31507|NCT03088709|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
31508|NCT03088709|GVHD|gvhd
31509|NCT03088696|laparoscopic|laparoscopic
31510|NCT03088696|acupuncture|acupuncture
31511|NCT03088683|sleeve gastrectomy|sleeve gastrectomy
31512|NCT03088683|liver retractor|liver retractor
31513|NCT03088683|nathanson|nathanson
31514|NCT03088683|reveel|reveel
31515|NCT03088683|liver trauma|liver trauma
31516|NCT03088657|Cohort study|cohort study
31517|NCT03088657|early-onset mood disorders|early-onset mood disorders
31518|NCT03088618|Nasal obstruction|nasal obstruction
31519|NCT03088618|Septal deformity|septal deformity
31521|NCT03088618|TnR Mesh|tnr mesh
31522|NCT03088618|polycaprolactone|polycaprolactone
31523|NCT03088592|Deep Brain Stimulation|deep brain stimulation
31524|NCT03088579|radiation shielding|radiation shielding
31525|NCT03088553|Ganciclovir|ganciclovir
31526|NCT03088553|trough concentrations|trough concentrations
31527|NCT03088553|CMV viral load|cmv viral load
31528|NCT03088553|safety|safety
31529|NCT03088553|Solid organ transplantation (heart, kidney or liver)|solid organ transplantation (heart, kidney or liver)
31530|NCT03088514|Hypertension|hypertension
31531|NCT03088514|Left Ventricular Hypertrophy|left ventricular hypertrophy
31532|NCT03088514|Endothelial Dysfunction|endothelial dysfunction
31533|NCT03088514|Nitrate|nitrate
31534|NCT03088501|Birth cohort, follow-up, IVRS|birth cohort, follow-up, ivrs
31535|NCT03088488|25-OH vitamin D|25-oh vitamin d
31536|NCT03088488|RANKL|rankl
31537|NCT03088488|Osteoprotogerin|osteoprotogerin
31538|NCT03088488|TNF-α|tnf-α
31539|NCT03088462|Bipolar Disorder|bipolar disorder
31540|NCT03088462|Smartphone|smartphone
31541|NCT03088462|Behavior Therapy|behavior therapy
31542|NCT03088449|Crohns disease|crohns disease
31543|NCT03088449|primary non response|primary non response
31544|NCT03088449|lose of response|lose of response
31545|NCT03088449|personalising anti-TNF therapy|personalising anti-tnf therapy
31546|NCT03088449|Anti-TNF|anti-tnf
31547|NCT03088449|PANTS|pants
31548|NCT03088449|Biosimilars|biosimilars
31549|NCT03088436|MRI|mri
31550|NCT03088436|Breast|breast
31551|NCT03088423|MRI|mri
31552|NCT03088423|Stereotactic body radiation therapy|stereotactic body radiation therapy
31553|NCT03088384|Post Traumatic Stress Disorder|post traumatic stress disorder
31554|NCT03088384|PTSD|ptsd
31555|NCT03088384|Combat Trauma|combat trauma
32079|NCT03085030|infertility|infertility
31556|NCT03088371|Total knee replacement|total knee replacement
31557|NCT03088371|Psoas Sciatic block|psoas sciatic block
31558|NCT03088371|Epidural anaesthesia|epidural anaesthesia
31559|NCT03088345|Fontan Palliation Surgery|fontan palliation surgery
31560|NCT03088345|Post-Operative Care|post-operative care
31561|NCT03088319|postnatal depression stress mindfulness allostatic load|postnatal depression stress mindfulness allostatic load
31562|NCT03088293|idiopathic refractory scleritis|idiopathic refractory scleritis
31563|NCT03088293|infliximab|infliximab
31564|NCT03088293|cyclophosphamide|cyclophosphamide
31565|NCT03088241|randomized clinical trial|randomized clinical trial
31566|NCT03088241|low level viremia|low level viremia
31567|NCT03088241|lesotho|lesotho
31568|NCT03088241|resource-limited setting|resource-limited setting
31569|NCT03088241|ART first-line failure|art first-line failure
31570|NCT03088215|Trigger Point Pain, Myofascial|trigger point pain, myofascial
31571|NCT03088215|shock-waves|shock-waves
31572|NCT03088215|extracorporeal shock-wave treatment (ESWT)|extracorporeal shock-wave treatment (eswt)
31573|NCT03088215|pain|pain
31574|NCT03088215|trigger point|trigger point
31575|NCT03088215|referred pain|referred pain
31576|NCT03088202|cancer|cancer
31577|NCT03088202|palliative care|palliative care
31578|NCT03088202|PROMs|proms
31579|NCT03088202|survival|survival
31580|NCT03088202|QoL|qol
31581|NCT03088202|referral|referral
31582|NCT03088189|maternal nutrition|maternal nutrition
31583|NCT03088189|periconceptional|periconceptional
31584|NCT03088189|neurocognitive development|neurocognitive development
31585|NCT03088176|Melanoma|melanoma
31586|NCT03088176|BRAF inhibitor|braf inhibitor
31587|NCT03088176|Intratumoral injection|intratumoral injection
31588|NCT03088176|Talimogene laherparepvec|talimogene laherparepvec
31589|NCT03088176|MEK inhibitor|mek inhibitor
31590|NCT03088176|dabrafenib|dabrafenib
31591|NCT03088176|trametinib|trametinib
31592|NCT03088150|Hepatic resection|hepatic resection
31593|NCT03088150|Liver surgery|liver surgery
31594|NCT03088150|Thermal ablation|thermal ablation
31595|NCT03088150|Radiofrequency ablation|radiofrequency ablation
31596|NCT03088150|Microwave ablation|microwave ablation
31598|NCT03088150|MWA|mwa
31599|NCT03088137|in vitro fertilization|in vitro fertilization
31600|NCT03088111|Anthim®|anthim®
31601|NCT03088111|Obiltoxaximab|obiltoxaximab
31602|NCT03088111|anthrax|anthrax
31603|NCT03088111|anti-toxin|anti-toxin
31604|NCT03088098|left atrial appendage occlusion|left atrial appendage occlusion
31605|NCT03088098|transcatheter aortic valve implantation|transcatheter aortic valve implantation
31606|NCT03088098|atrial fibrillation|atrial fibrillation
31607|NCT03088072|Edoxaban|edoxaban
31608|NCT03088072|WATCHMAN device|watchman device
31609|NCT03088020|CCHS|cchs
31610|NCT03088020|PHOX2B|phox2b
31611|NCT03088020|Paired-like Homeobox gene PHOX2B|paired-like homeobox gene phox2b
31612|NCT03088020|autonomic nervous system dysregulation|autonomic nervous system dysregulation
31613|NCT03088020|control of breathing|control of breathing
31614|NCT03088020|Hirschsprung disease|hirschsprung disease
33964|NCT03073798|Smoking|smoking
31615|NCT03088020|neural crest tumors|neural crest tumors
31616|NCT03088020|neuroblastoma|neuroblastoma
31617|NCT03088020|ganglioneuroma|ganglioneuroma
31618|NCT03088020|ganglioneuroblastoma|ganglioneuroblastoma
31619|NCT03088020|artificial ventilation|artificial ventilation
31620|NCT03088020|diaphragm pacing|diaphragm pacing
31621|NCT03088007|Intellectual Deficiency|intellectual deficiency
31622|NCT03088007|cognitive, adaptive|cognitive, adaptive
31623|NCT03088007|behavioral and academic profile|behavioral and academic profile
31624|NCT03088007|regular and special schools|regular and special schools
31625|NCT03087942|end stage renal disase ESRD|end stage renal disase esrd
31626|NCT03087942|dialysis effect on pharmacokinetics PK|dialysis effect on pharmacokinetics pk
31627|NCT03087942|renal impairment|renal impairment
31628|NCT03087903|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
31629|NCT03087903|Non-Metastatic Prostate Cancer|non-metastatic prostate cancer
31630|NCT03087890|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination
31631|NCT03086824|Bone Metastasis|bone metastasis
31632|NCT03086811|feeding interaction, infant eating habits, hunger satiety cues, childhood obesity|feeding interaction, infant eating habits, hunger satiety cues, childhood obesity
31633|NCT03086798|Magill forceps|magill forceps
31634|NCT03086798|cuff inflation|cuff inflation
31635|NCT03086798|Nasotracheal Intubation|nasotracheal intubation
31636|NCT03086746|Remodeling|remodeling
31637|NCT03086733|Lung Cancer|lung cancer
31638|NCT03086733|Non small cell lung cancer|non small cell lung cancer
31639|NCT03086733|Metformin|metformin
31640|NCT03086733|Pre-operative treatment|pre-operative treatment
31641|NCT03086733|Neoadjuvant treatments|neoadjuvant treatments
31642|NCT03086733|Cancer|cancer
31643|NCT03086733|Phase II|phase ii
31644|NCT03086720|Adhesive system|adhesive system
31645|NCT03086720|Controlled clinical trial|controlled clinical trial
31646|NCT03086720|Dental restoration|dental restoration
31647|NCT03086720|Noncarious cervical lesions|noncarious cervical lesions
31648|NCT03086720|Dental restoration failure|dental restoration failure
31649|NCT03086720|Sodium hypochlorite|sodium hypochlorite
31650|NCT03086707|nasal mucociliary clearance|nasal mucociliary clearance
31651|NCT03086707|saccharine transit time|saccharine transit time
31652|NCT03086694|oromaxillofacial surgery|oromaxillofacial surgery
31653|NCT03086694|nasotracheal intubation|nasotracheal intubation
31654|NCT03086694|stroke volume variation|stroke volume variation
31655|NCT03087864|esophageal cancer|esophageal cancer
31656|NCT03087864|PD-L1 inhibition|pd-l1 inhibition
31657|NCT03087864|chemoradiation|chemoradiation
31658|NCT03087851|Denosumab|denosumab
31659|NCT03087851|Bone Turnover markers|bone turnover markers
31660|NCT03087851|Drug Holiday|drug holiday
31661|NCT03087812|Microbiological burden|microbiological burden
31662|NCT03087812|kidney|kidney
31663|NCT03087812|stone|stone
31664|NCT03087812|durability of flexible endoscopes|durability of flexible endoscopes
31665|NCT03087734|Prostheses and Implants|prostheses and implants
31666|NCT03087721|Metabolic Syndrome|metabolic syndrome
31667|NCT03087721|Exercise Training|exercise training
31668|NCT03087721|Interval Training|interval training
31669|NCT03087721|Skeletal Muscle|skeletal muscle
31670|NCT03087721|Risk Factors|risk factors
31671|NCT03087721|Insulin Resistance|insulin resistance
31672|NCT03087695|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
31673|NCT03087695|EBV DNA|ebv dna
31674|NCT03087695|Chemoradiotherapy|chemoradiotherapy
31675|NCT03087669|Left Ventricular Assist Device|left ventricular assist device
31676|NCT03087669|Hemodynamic monitoring|hemodynamic monitoring
31677|NCT03087656|levofloxacin|levofloxacin
31678|NCT03087656|Ceftriaxone|ceftriaxone
31679|NCT03087656|Cholangitis|cholangitis
31680|NCT03087656|ERCP|ercp
31681|NCT03087643|Flow-mediated dilation|flow-mediated dilation
31682|NCT03087643|Passive limb movement|passive limb movement
31683|NCT03087604|epidural catheter placement|epidural catheter placement
31684|NCT03087578|overactive bladder, acupuncture|overactive bladder, acupuncture
31685|NCT03087526|Non Invasive Prenatal Diagnosis (NIPD)|non invasive prenatal diagnosis (nipd)
31686|NCT03087526|Circulating Fetal Trophoblastic Cells (CFTC)|circulating fetal trophoblastic cells (cftc)
31687|NCT03087526|Triplet repeat diseases|triplet repeat diseases
31688|NCT03087526|Huntington Disease - Myotonic Dystrophy Type 1 - Spinocerebellar Ataxia 1, 2 and 3|huntington disease - myotonic dystrophy type 1 - spinocerebellar ataxia 1, 2 and 3
31689|NCT03087500|Down Syndrome|down syndrome
23424|NCT03140280|MDS|mds
31690|NCT03087500|Typically Developing Participants|typically developing participants
31691|NCT03087500|Children|children
31692|NCT03087500|Adolescents|adolescents
31693|NCT03087500|Adults|adults
31694|NCT03087448|ALK rearranged|alk rearranged
31695|NCT03087448|Stage IIIB NSCLC|stage iiib nsclc
31696|NCT03087448|Stage IV NSCLC|stage iv nsclc
31697|NCT03087448|ROS-1 rearranged NSCLC|ros-1 rearranged nsclc
31698|NCT03087396|bone marrow defect|bone marrow defect
31699|NCT03087396|bone marrow lesion|bone marrow lesion
31700|NCT03087396|stress fracture|stress fracture
31701|NCT03087396|calcium phosphate|calcium phosphate
31702|NCT03087396|bone substitute material|bone substitute material
31703|NCT03087370|CXCR4 Mutation|cxcr4 mutation
31704|NCT03087370|Primary immunodeficiency disorder|primary immunodeficiency disorder
31705|NCT03087370|Warts|warts
31706|NCT03087370|Hypogammaglobulinemia|hypogammaglobulinemia
31707|NCT03087370|Infections|infections
31708|NCT03087370|Myelokathexis|myelokathexis
31709|NCT03087370|Human papillomavirus (HPV)|human papillomavirus (hpv)
31710|NCT03087370|Neutropenia|neutropenia
31711|NCT03087370|Herpes|herpes
31712|NCT03087344|Postprandial liver and spleen stiffness measurements|postprandial liver and spleen stiffness measurements
31713|NCT03087344|Transient elastography|transient elastography
31714|NCT03087344|Cirrhosis|cirrhosis
31715|NCT03087344|Acoustic radiation force impulse|acoustic radiation force impulse
31716|NCT03087318|Obstructive sleep apnea (OSA)|obstructive sleep apnea (osa)
31717|NCT03087318|Overweight and moderate obesity|overweight and moderate obesity
31718|NCT03087318|Sport prescription|sport prescription
31719|NCT03087318|Physical activity|physical activity
31720|NCT03087305|Interventional Pulmonary|interventional pulmonary
31721|NCT03087305|EBUS-TBNA|ebus-tbna
31722|NCT03087305|Lung cancer staging|lung cancer staging
31723|NCT03087292|blood flow restriction|blood flow restriction
31724|NCT03087292|resistance training|resistance training
31725|NCT03087292|coronary heart disease|coronary heart disease
31726|NCT03087240|Disease Activity Score 28 (DAS28)|disease activity score 28 (das28)
31727|NCT03087240|Health Assessment Questionnaire (HAQ)|health assessment questionnaire (haq)
31728|NCT03087240|Dental Scaling|dental scaling
31729|NCT03087240|Dental Polishing|dental polishing
31730|NCT03087240|Oral Health|oral health
31731|NCT03087240|Gingival Crevicular Fluid|gingival crevicular fluid
31732|NCT03087240|Inflammatory Cytokine Profile|inflammatory cytokine profile
31733|NCT03087240|Biofilm|biofilm
31734|NCT03087240|Oral Microbiome|oral microbiome
31735|NCT03087240|Intestinal Microbiome|intestinal microbiome
31736|NCT03087227|mHealth|mhealth
31737|NCT03087227|febrile neutropenia|febrile neutropenia
31738|NCT03087227|neutropenia/chemically induced/*complications|neutropenia/chemically induced/*complications
31739|NCT03087227|antineoplastic agents/*adverse events|antineoplastic agents/*adverse events
32080|NCT03085030|IVF|ivf
31740|NCT03087227|Patient readmission|patient readmission
31741|NCT03087227|disease management|disease management
31742|NCT03087201|Chronic tic disorders|chronic tic disorders
31743|NCT03087201|Tourette syndrome|tourette syndrome
31744|NCT03087149|vitamin D|vitamin d
31745|NCT03087149|supplementation|supplementation
31746|NCT03087149|hydroxyvitamin D|hydroxyvitamin d
31747|NCT03087149|pretrem infants|pretrem infants
31748|NCT03087149|osteopenia|osteopenia
31749|NCT03087136|multiple sclerosis|multiple sclerosis
31750|NCT03087136|pediatric|pediatric
31751|NCT03087123|single-case design|single-case design
31752|NCT03087123|children|children
31753|NCT03087123|health equity|health equity
31754|NCT03087123|mobile health|mobile health
31755|NCT03087071|Colorectal cancer|colorectal cancer
31756|NCT03087071|Colorectal adenocarcinoma|colorectal adenocarcinoma
31758|NCT03087071|Detectable KRAS or NRAS mutations in exons 2, 3, or 4; or BRAF codon 600 mutations in circulating free tumor DNA|detectable kras or nras mutations in exons 2, 3, or 4; or braf codon 600 mutations in circulating free tumor dna
31760|NCT03087071|Panitumumab|panitumumab
31761|NCT03087071|Vectibix|vectibix
31762|NCT03087071|Trametinib|trametinib
31763|NCT03087071|GSK1120212|gsk1120212
31768|NCT03087032|Liraglutide|liraglutide
31769|NCT03087032|Insulin Glargine|insulin glargine
31770|NCT03087032|Prandial Insulin|prandial insulin
31771|NCT03087019|adenoid cystic carcinoma|adenoid cystic carcinoma
31772|NCT03086980|health related quality of life|health related quality of life
31773|NCT03086980|utility|utility
31774|NCT03086980|regression|regression
31775|NCT03086967|cervical ripening|cervical ripening
31776|NCT03086967|double lumen catheter|double lumen catheter
31777|NCT03086954|CD19 positive lymphoma|cd19 positive lymphoma
31778|NCT03086915|neuromuscular blockade|neuromuscular blockade
31779|NCT03086915|muscle relaxation|muscle relaxation
31780|NCT03086915|muscle relaxant|muscle relaxant
31781|NCT03086902|Ablation; Cryo Energy; Radofrequency Ablation|ablation; cryo energy; radofrequency ablation
31782|NCT03086863|electroacupuncture|electroacupuncture
31783|NCT03086863|randomized controlled trial|randomized controlled trial
31784|NCT03086681|Cervical carcinoma|cervical carcinoma
31785|NCT03086681|endostar|endostar
31786|NCT03086681|concurrent chemoradiotherapy|concurrent chemoradiotherapy
31787|NCT03086668|Nasotracheal Intubation|nasotracheal intubation
31788|NCT03086668|jaw thrust|jaw thrust
31789|NCT03086668|hook-finger|hook-finger
31790|NCT03086655|biological markers|biological markers
31791|NCT03086655|monitoring device|monitoring device
31792|NCT03086655|wireless technology|wireless technology
31793|NCT03086642|locally advanced pancreatic cancer|locally advanced pancreatic cancer
31794|NCT03086642|locally advanced pancreas cancer|locally advanced pancreas cancer
31795|NCT03086642|metastatic pancreatic cancer|metastatic pancreatic cancer
31796|NCT03086642|metastatic pancreas cancer|metastatic pancreas cancer
31797|NCT03086642|refractory|refractory
31798|NCT03086642|refractory pancreatic cancer|refractory pancreatic cancer
31799|NCT03086642|refractory pancreas cancer|refractory pancreas cancer
31800|NCT03086642|T-Vec|t-vec
31801|NCT03086642|T Vec|t vec
31802|NCT03086616|DIPG|dipg
31803|NCT03086616|CED|ced
31804|NCT03086616|glioma|glioma
31805|NCT03086590|Body composition|body composition
31806|NCT03086590|Ultrasound|ultrasound
31807|NCT03086590|Chronic Pulmonary Obstructive Disease|chronic pulmonary obstructive disease
31808|NCT03086590|Respiratory muscles|respiratory muscles
31809|NCT03086564|HCC|hcc
31810|NCT03086564|ADCC|adcc
31811|NCT03086564|TACE|tace
31812|NCT03086564|immuno therapy|immuno therapy
31813|NCT03086551|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
31814|NCT03086551|Motor Impairment|motor impairment
31815|NCT03086551|Rehabilitation|rehabilitation
31816|NCT03086551|Motor Learning|motor learning
31817|NCT03086525|Chronic pain|chronic pain
31818|NCT03086525|Psychological factors|psychological factors
31819|NCT03086525|Musculoskeletal pain|musculoskeletal pain
31820|NCT03086525|Prognosis|prognosis
31821|NCT03086499|pectus excavatum|pectus excavatum
31822|NCT03086486|Tuberculosis|tuberculosis
31823|NCT03086486|Multi Drug-Resistant Tuberculosis|multi drug-resistant tuberculosis
31824|NCT03086486|Extensively Drug-Resistant Tuberculosis|extensively drug-resistant tuberculosis
31825|NCT03086486|Drug-Resistant Tuberculosis|drug-resistant tuberculosis
31826|NCT03086486|Pretomanid|pretomanid
31827|NCT03086486|PA-824|pa-824
31828|NCT03086486|Bedaquiline|bedaquiline
31829|NCT03086486|Linezolid|linezolid
31830|NCT03086486|NC-007|nc-007
31831|NCT03086486|TB Alliance|tb alliance
31832|NCT03086486|pre-XDR-TB|pre-xdr-tb
31833|NCT03086473|caffeine|caffeine
31834|NCT03086473|intubation|intubation
31835|NCT03086473|hemodynamics|hemodynamics
31836|NCT03086473|mechanical ventilation|mechanical ventilation
31837|NCT03086473|cardiac output|cardiac output
31838|NCT03086473|near infrared spectroscopy|near infrared spectroscopy
31839|NCT03086473|functional echocardiography|functional echocardiography
31840|NCT03086434|Culturally tailored intervention|culturally tailored intervention
31841|NCT03086434|American Indian early adolescents|american indian early adolescents
31842|NCT03086434|Prevention of substance use|prevention of substance use
31843|NCT03086421|Childhood cancer|childhood cancer
31844|NCT03086421|Social functioning|social functioning
31845|NCT03086421|Social development|social development
31846|NCT03086408|airway management|airway management
31847|NCT03086408|high flow nasal oxygen|high flow nasal oxygen
31848|NCT03086408|high flow nasal cannula|high flow nasal cannula
31849|NCT03086408|THRIVE|thrive
31853|NCT03086382|Syrup|syrup
31854|NCT03086382|Bioequivalence|bioequivalence
31855|NCT03086382|Tablet|tablet
31856|NCT03086343|Anti-inflammatory agents|anti-inflammatory agents
31857|NCT03086343|Arthritis|arthritis
31858|NCT03086343|Joint Disease|joint disease
31859|NCT03086343|Musculoskeletal Disease|musculoskeletal disease
31860|NCT03086343|Antirheumatic agents|antirheumatic agents
31861|NCT03086317|Pulmonary Medicine|pulmonary medicine
31862|NCT03086317|Therapy Evaluation|therapy evaluation
31863|NCT03086304|postoperative intestinal obstruction;TEAS|postoperative intestinal obstruction;teas
31864|NCT03086265|airway management|airway management
31865|NCT03086265|high flow nasal oxygen high flow nasal cannula THRIVE|high flow nasal oxygen high flow nasal cannula thrive
31866|NCT03086265|high flow nasal cannula THRIVE|high flow nasal cannula thrive
31867|NCT03086265|THRIVE|thrive
31868|NCT03086239|Rovalpituzumab tesirine|rovalpituzumab tesirine
31869|NCT03086239|Small Cell Lung Cancer|small cell lung cancer
31870|NCT03086239|Cancer|cancer
619131|NCT00658749|AIR645|air645
31878|NCT03086200|Pre-exposure Prophylaxis|pre-exposure prophylaxis
31879|NCT03086200|Text messaging|text messaging
31881|NCT03086200|Motivational interviewing|motivational interviewing
31882|NCT03086200|Transgender|transgender
31883|NCT03086200|Gender Non-conforming|gender non-conforming
31884|NCT03086187|weight bearing|weight bearing
31885|NCT03086187|muscle unloading|muscle unloading
31886|NCT03086187|bone loss|bone loss
31887|NCT03086187|arterial adaptation|arterial adaptation
31888|NCT03086187|muscular adaptation|muscular adaptation
31889|NCT03086174|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
31890|NCT03086174|advanced|advanced
31891|NCT03086174|melanoma|melanoma
34030|NCT03073265|IVD|ivd
31892|NCT03086174|kidney cancer|kidney cancer
31893|NCT03086122|OSA|osa
31894|NCT03086122|Erectile Dysfunction|erectile dysfunction
31895|NCT03086122|CPAP treatment|cpap treatment
31896|NCT03086122|Endothelial Dysfunction|endothelial dysfunction
31897|NCT03086122|Cardiovascular risk|cardiovascular risk
31898|NCT03086109|prevalence|prevalence
31899|NCT03086109|Bone Degenerative Disease|bone degenerative disease
31900|NCT03086083|Traumatic memories|traumatic memories
31901|NCT03086083|comparative study|comparative study
31902|NCT03086083|single session|single session
31903|NCT03086083|EMDR|emdr
31904|NCT03086083|Beck inventory|beck inventory
31905|NCT03086070|omeprazole|omeprazole
31906|NCT03086070|placebo|placebo
31907|NCT03086070|treatment|treatment
31908|NCT03086070|adults|adults
31909|NCT03086057|PrEP|prep
31910|NCT03086057|Prevention|prevention
31911|NCT03086057|Male Sex Workers (MSW)|male sex workers (msw)
754064|NCT01178788|Tertiary Prophylaxis|tertiary prophylaxis
31921|NCT03085953|Well-being|well-being
31922|NCT03085953|Employee|employee
31923|NCT03085927|music therapy|music therapy
31924|NCT03085927|neoplasms|neoplasms
31925|NCT03085927|play|play
31926|NCT03085927|children|children
31927|NCT03085927|parents|parents
31928|NCT03085914|solid tumors|solid tumors
31929|NCT03085914|colorectal cancer|colorectal cancer
31930|NCT03085914|pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
31931|NCT03085914|non-small cell lung cancer|non-small cell lung cancer
31932|NCT03085914|PD-1|pd-1
31933|NCT03085914|PD-L1|pd-l1
31934|NCT03085914|epacadostat|epacadostat
31935|NCT03085914|IDO inhibitor|ido inhibitor
31941|NCT03085875|Weight Change|weight change
31942|NCT03085875|Healthy Pregnancy|healthy pregnancy
31943|NCT03085875|Physiologic Sensors|physiologic sensors
31944|NCT03085862|Ultrasonography|ultrasonography
31945|NCT03085862|Extravascular lung water|extravascular lung water
31946|NCT03085862|PaO2/FiO2 ratio|pao2/fio2 ratio
31947|NCT03085836|Drug Therapy|drug therapy
31954|NCT03085758|Early Septic Shock|early septic shock
31955|NCT03085745|Writer's cramp|writer's cramp
31956|NCT03085745|Sensorimotor plasticity|sensorimotor plasticity
31957|NCT03085745|TMS|tms
31958|NCT03085745|Afferent inhibition|afferent inhibition
31959|NCT03085745|Motor mapping|motor mapping
31960|NCT03085745|Sensory mapping|sensory mapping
31961|NCT03085745|adaptive sensorimotor synergies|adaptive sensorimotor synergies
31962|NCT03085745|fine motor control|fine motor control
31963|NCT03085732|saline irrigation|saline irrigation
31964|NCT03085732|abdominal hysterectomy|abdominal hysterectomy
31965|NCT03085732|postoperative infectious morbidities|postoperative infectious morbidities
31966|NCT03085732|gastrointestinal disturbances|gastrointestinal disturbances
31967|NCT03085719|Head and Neck Cancer|head and neck cancer
31968|NCT03085680|Curcumin, physical function, cognitive function|curcumin, physical function, cognitive function
32081|NCT03085030|ICSI|icsi
31969|NCT03085667|Left atrial appendage occluder|left atrial appendage occluder
31970|NCT03085667|Watchman device|watchman device
31971|NCT03085667|Atrial fibrillation|atrial fibrillation
31972|NCT03085667|atrial natriureitc peptide|atrial natriureitc peptide
31973|NCT03085667|brain natriuretic peptide|brain natriuretic peptide
31974|NCT03085654|multiple doses|multiple doses
31975|NCT03085654|oxytocin|oxytocin
31976|NCT03085654|trait anxiety|trait anxiety
31977|NCT03085641|High flow oxygen therapy|high flow oxygen therapy
31978|NCT03085628|social sharing|social sharing
31979|NCT03085628|social reward|social reward
31980|NCT03085628|functional magnetic resonance imaging|functional magnetic resonance imaging
31981|NCT03085628|reward circuit|reward circuit
31982|NCT03085589|elderly|elderly
31983|NCT03085589|telemedicine|telemedicine
31984|NCT03085589|obesity|obesity
31985|NCT03085589|rural health|rural health
31986|NCT03085589|health promotion|health promotion
31987|NCT03085576|Atrial Fibrillation|atrial fibrillation
31988|NCT03085576|Anticoagulation|anticoagulation
31989|NCT03085576|Stroke|stroke
31990|NCT03085576|Vitamin K antagonist|vitamin k antagonist
31991|NCT03085576|Cardioversion|cardioversion
31992|NCT03085576|INR (International Normalized Ratio)|inr (international normalized ratio)
31993|NCT03085550|diabetic foot ulcer|diabetic foot ulcer
31994|NCT03085550|diabetes mellitus|diabetes mellitus
31995|NCT03085550|fat grafting|fat grafting
31996|NCT03085550|platelet rich plasma|platelet rich plasma
31997|NCT03085550|wound healing|wound healing
31998|NCT03085537|home monitoring|home monitoring
31999|NCT03085537|Non-invasive mechanical ventilation|non-invasive mechanical ventilation
32000|NCT03085511|Egg breakfast|egg breakfast
32001|NCT03085511|Weight loss|weight loss
32002|NCT03085511|Satiety|satiety
32003|NCT03085511|Insulin|insulin
32004|NCT03085511|Glucagon-Like Peptide 1|glucagon-like peptide 1
32005|NCT03085511|PYY (3-36) peptide|pyy (3-36) peptide
32006|NCT03085511|Ghrelin|ghrelin
32007|NCT03085511|Glucose|glucose
32008|NCT03085511|Protein quality|protein quality
34149|NCT03072381|CLE|cle
32009|NCT03085498|retinal vessels|retinal vessels
32010|NCT03085498|physical activity|physical activity
32011|NCT03085498|children|children
32012|NCT03085498|psychosocial health|psychosocial health
32013|NCT03085485|COPD|copd
32014|NCT03085485|CFTR|cftr
32015|NCT03085485|ivacaftor|ivacaftor
32016|NCT03085485|topic trial|topic trial
32017|NCT03085472|intracerebral hemrrohage|intracerebral hemrrohage
32018|NCT03085472|stroke|stroke
32019|NCT03085472|China|china
32020|NCT03085472|hematoma|hematoma
32022|NCT03085472|predictor|predictor
32023|NCT03085472|prognosis|prognosis
32024|NCT03085472|outcome|outcome
32025|NCT03085420|Burns|burns
32026|NCT03085420|Pediatrics|pediatrics
32027|NCT03085420|Cardiac Arrhythmia|cardiac arrhythmia
32028|NCT03085394|Morbid Obesity|morbid obesity
32029|NCT03085394|Sleeve gastrectomy|sleeve gastrectomy
32030|NCT03085368|breast cancer|breast cancer
32031|NCT03085368|her-2 positive|her-2 positive
32032|NCT03085368|lapatinib|lapatinib
32033|NCT03085368|herceptin|herceptin
32034|NCT03085355|neck pain|neck pain
32035|NCT03085342|liver|liver
32036|NCT03085342|fibrosis|fibrosis
32037|NCT03085342|MRI|mri
32038|NCT03085329|bubble nasal continuous positive airway pressure|bubble nasal continuous positive airway pressure
32039|NCT03085329|respiratory support|respiratory support
32040|NCT03085290|dry eye syndrome|dry eye syndrome
32041|NCT03085290|serum eye drops|serum eye drops
32042|NCT03085277|Bovine colostrum|bovine colostrum
32043|NCT03085277|Preterm formula|preterm formula
32044|NCT03085277|Very preterm infants|very preterm infants
32045|NCT03085277|Enteral feeding|enteral feeding
32046|NCT03085225|Advanced tumor|advanced tumor
32047|NCT03085225|Pretreated tumor|pretreated tumor
32048|NCT03085225|Soft Tissue Sarcomas|soft tissue sarcomas
32049|NCT03085225|Ovarian Carcinomas|ovarian carcinomas
32050|NCT03085225|Phase Ib|phase ib
32051|NCT03085225|Circulating DNA|circulating dna
32054|NCT03085199|laparoscopic reinforcement suture (LARS)|laparoscopic reinforcement suture (lars)
32059|NCT03085147|Mouth|mouth
32060|NCT03085147|Fluorescent PARP1 Binding Imaging Agent|fluorescent parp1 binding imaging agent
32061|NCT03085147|PARPi-FL|parpi-fl
32062|NCT03085147|15-336|15-336
32063|NCT03085121|extramedullary|extramedullary
32064|NCT03085121|intramedullary|intramedullary
32065|NCT03085121|total knee arthroplasty (TKA)|total knee arthroplasty (tka)
32066|NCT03085069|PD-1|pd-1
32067|NCT03085069|PD-L1|pd-l1
32068|NCT03085069|shr-1210|shr-1210
32069|NCT03085056|Trametinib|trametinib
32070|NCT03085056|Paclitaxel|paclitaxel
32071|NCT03085056|15-055|15-055
32072|NCT03085043|Prostate Cancer|prostate cancer
32073|NCT03085043|Whole body MRI|whole body mri
32074|NCT03085043|MRI of the pelvis|mri of the pelvis
32075|NCT03085043|Magnetic resonance imaging|magnetic resonance imaging
32076|NCT03085043|Bone scan|bone scan
32077|NCT03085043|Computed tomography scan of abdomen and pelvis|computed tomography scan of abdomen and pelvis
32078|NCT03085043|CT|ct
32082|NCT03085030|poor responders in IVF/ICSI cycles|poor responders in ivf/icsi cycles
32083|NCT03085030|antioxidant|antioxidant
32084|NCT03085004|Pancreatic cyst|pancreatic cyst
32085|NCT03085004|Cyst Ablation|cyst ablation
32086|NCT03085004|Eus-FNA (fine-needle aspiration )|eus-fna (fine-needle aspiration )
32087|NCT03085004|Chemotherapy|chemotherapy
32088|NCT03084952|safety|safety
32089|NCT03084952|pharmacokynetics|pharmacokynetics
32090|NCT03084952|leishmaniasis treatment|leishmaniasis treatment
32091|NCT03084913|dietary treatment|dietary treatment
32092|NCT03084887|Tissue Expansion Devices|tissue expansion devices
32093|NCT03084887|Tissue Expansion|tissue expansion
32094|NCT03084887|common complications|common complications
32095|NCT03084887|intervention study|intervention study
32096|NCT03084874|COPD|copd
32097|NCT03084874|Physical Activity|physical activity
32098|NCT03084874|Sedentary behaviour|sedentary behaviour
32099|NCT03084874|Hospitalization|hospitalization
32100|NCT03084848|brain/cognitive measures|brain/cognitive measures
32101|NCT03084848|condition|condition
32102|NCT03084848|inhibitor control|inhibitor control
32103|NCT03084848|training at adolescence|training at adolescence
32104|NCT03084835|tobacco|tobacco
32105|NCT03084835|smoking|smoking
32106|NCT03084835|low dose computed tomography|low dose computed tomography
32107|NCT03084835|lung screening|lung screening
32108|NCT03084835|text messaging|text messaging
32109|NCT03084783|dexamethasone|dexamethasone
32110|NCT03084783|HSV encephalitis|hsv encephalitis
32111|NCT03084770|NF-PNEN|nf-pnen
32112|NCT03084731|Microbiota|microbiota
32113|NCT03084731|Complementary Food|complementary food
32114|NCT03084692|caregiver|caregiver
32115|NCT03084692|lung cancer|lung cancer
32116|NCT03084692|yoga|yoga
32117|NCT03084692|resistance exercise|resistance exercise
32118|NCT03084679|Heart Failure|heart failure
32119|NCT03084679|Hypertrophy|hypertrophy
32120|NCT03084679|Fibrosis|fibrosis
32121|NCT03084679|Magnetic Resonance|magnetic resonance
32122|NCT03084653|Trocar entery|trocar entery
32123|NCT03084653|Surgery, Laparoscopic|surgery, laparoscopic
32124|NCT03084627|tailored dietary advice|tailored dietary advice
32125|NCT03084627|nutrient adequacy|nutrient adequacy
32126|NCT03084627|dietary modifications|dietary modifications
32127|NCT03084614|Infectious Diseases|infectious diseases
32128|NCT03084614|Dendritic Cells|dendritic cells
32129|NCT03084614|Pathogens|pathogens
32130|NCT03084614|Passive Cellular Immunity|passive cellular immunity
32131|NCT03084614|Immune-Modulating|immune-modulating
32132|NCT03084575|neuroaxial rhizolysis -selective rhizolysis-thermal radiofrequency|neuroaxial rhizolysis -selective rhizolysis-thermal radiofrequency
32133|NCT03084510|High risk for surgical valve replacement|high risk for surgical valve replacement
32134|NCT03084510|transcatheter aortic valve replacement|transcatheter aortic valve replacement
32135|NCT03084497|Massage|massage
32136|NCT03084497|Development|development
32137|NCT03084471|Programmed death ligand 1 (PD-L1)|programmed death ligand 1 (pd-l1)
32138|NCT03084471|Cytotoxic T-lymphocyte antigen-4 (CTLA-4)|cytotoxic t-lymphocyte antigen-4 (ctla-4)
32139|NCT03084471|Durvalumab in combination with tremelimumab|durvalumab in combination with tremelimumab
32140|NCT03084458|Increasing daily physical activity|increasing daily physical activity
32141|NCT03084445|Brominated Flame Retardants (BFRs)|brominated flame retardants (bfrs)
32142|NCT03084445|Phthalates|phthalates
32143|NCT03084445|pregnant women|pregnant women
32144|NCT03084445|newborn|newborn
32145|NCT03084445|Heavy Metals|heavy metals
32146|NCT03084445|Volatile Organic Compounds|volatile organic compounds
32147|NCT03084432|caffeine|caffeine
32148|NCT03084432|bone mineral content|bone mineral content
32748|NCT03080584|IVF|ivf
32149|NCT03084419|Rheumatoid Arthritis|rheumatoid arthritis
32150|NCT03084419|Interstitial Lung Disease|interstitial lung disease
32151|NCT03084419|RA-ILD|ra-ild
32152|NCT03084419|Abatacept|abatacept
32153|NCT03084406|Substance Abuse|substance abuse
32154|NCT03084406|Implementation Science|implementation science
32155|NCT03084406|Evidence-based Practices|evidence-based practices
32156|NCT03084393|non-cardiac surgery|non-cardiac surgery
32157|NCT03084393|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
32158|NCT03084354|pelvic floor|pelvic floor
32159|NCT03084354|women's experiences|women's experiences
32160|NCT03084354|bladder care|bladder care
32161|NCT03084354|pregnancy|pregnancy
32162|NCT03084354|labour|labour
32163|NCT03084354|postpartum|postpartum
32164|NCT03084341|Elasticity|elasticity
32165|NCT03084341|Electric Stimulation|electric stimulation
32166|NCT03084341|Muscle Stretching Exercises|muscle stretching exercises
32167|NCT03084315|smoking|smoking
32168|NCT03084315|electronic cigarettes|electronic cigarettes
32169|NCT03084315|nicotine|nicotine
32170|NCT03084302|sedentary behavior|sedentary behavior
32171|NCT03084302|physical activity|physical activity
32172|NCT03084276|meal ingestion|meal ingestion
32173|NCT03084276|meal composition|meal composition
32174|NCT03084276|postprandial responses|postprandial responses
32175|NCT03084276|hedonic sensations|hedonic sensations
32176|NCT03084276|homeostatic sensations|homeostatic sensations
32380|NCT03082807|Exercise|exercise
32177|NCT03084276|new composition|new composition
32178|NCT03084211|emergency department|emergency department
32179|NCT03084211|concussion|concussion
32180|NCT03084211|head injury|head injury
32181|NCT03084198|Bioartificial Liver|bioartificial liver
32182|NCT03084198|Acute Liver Failure|acute liver failure
32183|NCT03084185|decompensation|decompensation
32185|NCT03084185|metabolomics|metabolomics
32186|NCT03084185|portal hypertension|portal hypertension
32187|NCT03084133|Therapeutic education strategy|therapeutic education strategy
32188|NCT03084107|Elder care|elder care
32189|NCT03084107|Active aging|active aging
32190|NCT03084107|Intelligent Care Facilities for Elders|intelligent care facilities for elders
32191|NCT03084094|Fibromyalgia|fibromyalgia
32192|NCT03084094|tDCS|tdcs
32193|NCT03084081|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
32194|NCT03084081|Cryotherapy|cryotherapy
32195|NCT03084081|Thermoablation|thermoablation
32196|NCT03084081|Thermocoagulation|thermocoagulation
32197|NCT03084081|Low and Middle Income Countries (LMICs)|low and middle income countries (lmics)
32198|NCT03084042|emotional impairments|emotional impairments
32199|NCT03084042|cognitive impairments|cognitive impairments
32200|NCT03084029|oxytocin|oxytocin
32201|NCT03084029|fMRI|fmri
32202|NCT03084029|empathy|empathy
32203|NCT03083964|Middle aged women|middle aged women
32204|NCT03083964|35-64yrs|35-64yrs
32205|NCT03083964|BMI= >30|bmi= >30
32206|NCT03083951|Complete mesocolon excision|complete mesocolon excision
32207|NCT03083951|Sigmoid cancer|sigmoid cancer
32208|NCT03083951|Colorectal cancer|colorectal cancer
32209|NCT03083938|Pancreatoduodenectomy|pancreatoduodenectomy
32210|NCT03083938|Omentum|omentum
32211|NCT03083938|Wrapping|wrapping
32212|NCT03083938|Roll-up|roll-up
34404|NCT03071055|AMD|amd
32213|NCT03083938|Whipple|whipple
32214|NCT03083912|Malnutrition|malnutrition
32215|NCT03083912|Disability|disability
32216|NCT03083912|Oral Nutritional Supplementation|oral nutritional supplementation
32217|NCT03083899|Diabetes|diabetes
32218|NCT03083899|Organization|organization
32219|NCT03083899|Out-patient control|out-patient control
32221|NCT03083873|Cell Therapy|cell therapy
32222|NCT03083873|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
32223|NCT03083873|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
32224|NCT03083873|Cellular Immuno-therapy|cellular immuno-therapy
32225|NCT03083873|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
32227|NCT03083873|IL-2|il-2
32228|NCT03083847|Malaria|malaria
32229|NCT03083847|Parasitemia|parasitemia
32230|NCT03083847|Immune|immune
32231|NCT03083847|Responses|responses
32232|NCT03083847|Sporozoites|sporozoites
32233|NCT03083834|cosyntropin|cosyntropin
32234|NCT03083834|salivary free cortisol|salivary free cortisol
32235|NCT03083834|mitotane|mitotane
32236|NCT03083808|PD-1|pd-1
32237|NCT03083808|PD-L1 Inhibitor|pd-l1 inhibitor
32238|NCT03083808|Pembrolizumab|pembrolizumab
32239|NCT03083808|Docetaxel|docetaxel
32240|NCT03083808|Pemetrexed|pemetrexed
32241|NCT03083808|Gemcitabine|gemcitabine
32242|NCT03083795|Social relationships|social relationships
32243|NCT03083795|Vulnerable connections|vulnerable connections
32244|NCT03083795|Diabetes Distress|diabetes distress
32245|NCT03083795|Support group|support group
32246|NCT03083782|Apixaban|apixaban
32247|NCT03083782|Cyclosporine|cyclosporine
32248|NCT03083782|Tacrolimus|tacrolimus
32249|NCT03083782|Cytochrome P450 CYP3A4|cytochrome p450 cyp3a4
32250|NCT03083782|Permeability Glycoprotein P-gp|permeability glycoprotein p-gp
32251|NCT03083782|Breast cancer resistance protein BCRP|breast cancer resistance protein bcrp
32252|NCT03083782|Factor Xa Inhibitors|factor xa inhibitors
32253|NCT03083782|Anticoagulants|anticoagulants
32254|NCT03083782|Enzyme Inhibitors|enzyme inhibitors
32255|NCT03083769|tacrolimus|tacrolimus
32256|NCT03083769|genetic variants|genetic variants
32257|NCT03083769|side effects|side effects
32258|NCT03083743|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
32259|NCT03083743|Carcinoma, Bronchogenic|carcinoma, bronchogenic
32260|NCT03083743|Bronchial Neoplasms|bronchial neoplasms
32261|NCT03083743|Lung Neoplasms|lung neoplasms
32262|NCT03083743|Thoracic Neoplasms|thoracic neoplasms
32263|NCT03083743|Neoplasms|neoplasms
32264|NCT03083743|Lung Diseases|lung diseases
32265|NCT03083743|Antineoplastic Agents, Cytokines|antineoplastic agents, cytokines
32266|NCT03083743|Antineoplastic Agents|antineoplastic agents
32267|NCT03083743|Biological activity factor|biological activity factor
32268|NCT03083743|Genetic Engineering|genetic engineering
32269|NCT03083743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
32270|NCT03083743|Physiological Effects of Drugs|physiological effects of drugs
32271|NCT03083730|Atopic Dermatitis|atopic dermatitis
32273|NCT03083730|Systemic Inflammation|systemic inflammation
32274|NCT03083730|UVB Phototherapy|uvb phototherapy
32275|NCT03083691|Nivolumab|nivolumab
32276|NCT03083691|Ipilimumab|ipilimumab
32277|NCT03083678|EGFR|egfr
32278|NCT03083678|Afatinib|afatinib
32279|NCT03083665|Epilepsy|epilepsy
32280|NCT03083665|Partial seizures with or without secondary generalization|partial seizures with or without secondary generalization
32281|NCT03083665|Brivaracetam|brivaracetam
32282|NCT03083665|Asian subjects|asian subjects
32283|NCT03083652|physiotherapy|physiotherapy
32284|NCT03083652|neuromuscular electrical stimulation|neuromuscular electrical stimulation
32285|NCT03083652|exercise capacity|exercise capacity
32286|NCT03083639|Drug Therapy|drug therapy
32287|NCT03083626|Chronic pain|chronic pain
32288|NCT03083626|Narcotic abuse|narcotic abuse
32289|NCT03083626|Opioid related disorders|opioid related disorders
32290|NCT03083626|Opiate substitution treatment|opiate substitution treatment
32291|NCT03083626|Buprenorphine|buprenorphine
32292|NCT03083626|Pregabalin|pregabalin
32293|NCT03083626|Methadone|methadone
32294|NCT03083613|Raltitrexed|raltitrexed
32295|NCT03083613|Paclitaxel|paclitaxel
32296|NCT03083613|chemotherapy|chemotherapy
32297|NCT03083613|Gastric cancer|gastric cancer
32298|NCT03083613|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
32299|NCT03083600|protein hydrolysates|protein hydrolysates
32300|NCT03083600|HbA1c|hba1c
32301|NCT03083600|prediabetes|prediabetes
32302|NCT03083574|Hematology|hematology
32303|NCT03083574|Chronic graft versus host disease (cGVHD)|chronic graft versus host disease (cgvhd)
32304|NCT03083574|Extracorporeal photopheresis|extracorporeal photopheresis
32305|NCT03083574|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
32306|NCT03083574|Donor lymphocyte infusion|donor lymphocyte infusion
32307|NCT03083522|Cold Hypersensitivity|cold hypersensitivity
32308|NCT03083522|Korean medicine|korean medicine
32309|NCT03083522|Ojeok-san|ojeok-san
32310|NCT03083522|Cold intolerance|cold intolerance
32311|NCT03083418|AECOPD|aecopd
32312|NCT03083418|EDP|edp
32313|NCT03083418|Neural Respiratory Drive|neural respiratory drive
32314|NCT03083418|Surface EMGdi|surface emgdi
32315|NCT03083392|DIVA|diva
32316|NCT03083392|sinusitis|sinusitis
32320|NCT03083379|Electrical impedance tomography|electrical impedance tomography
32321|NCT03083366|spinal cord injury|spinal cord injury
32322|NCT03083366|Neurogenic|neurogenic
32323|NCT03083366|bladder|bladder
32324|NCT03083366|electrical stimulation|electrical stimulation
32325|NCT03083366|neuromodulation|neuromodulation
32326|NCT03083301|Cardiac resynchronisation|cardiac resynchronisation
32327|NCT03083223|patient positioning|patient positioning
32328|NCT03083223|lung diseases|lung diseases
32329|NCT03083223|oxygenation|oxygenation
32330|NCT03083223|hemodynamic parameters|hemodynamic parameters
32331|NCT03083223|vital signs|vital signs
32332|NCT03083197|Scrub Typhus|scrub typhus
32333|NCT03083197|Antibiotic Resistance|antibiotic resistance
32334|NCT03083184|Hemodialysis|hemodialysis
32335|NCT03083184|hemodiafiltration|hemodiafiltration
32336|NCT03083184|tunnelled dialysis catheter|tunnelled dialysis catheter
32337|NCT03083184|interdialytic lock solution|interdialytic lock solution
32338|NCT03083184|preventing tunnelled catheter infection|preventing tunnelled catheter infection
32339|NCT03083171|Adrecizumab|adrecizumab
32340|NCT03083171|Adrenomedullin|adrenomedullin
32341|NCT03083171|Healthy volunteers|healthy volunteers
32342|NCT03083171|LPS|lps
32343|NCT03083171|Monoclonal recombinant antibody|monoclonal recombinant antibody
32344|NCT03083132|freezing of gait|freezing of gait
32345|NCT03083067|AECOPD|aecopd
32346|NCT03083067|air pollution|air pollution
32347|NCT03083067|COPD|copd
32749|NCT03080584|AMH|amh
32348|NCT03083067|salvational Intervention|salvational intervention
32349|NCT03083041|SHR-1210|shr-1210
32350|NCT03083041|Apatinib|apatinib
32351|NCT03083041|NSCLC|nsclc
32352|NCT03083028|Ankle Fracture|ankle fracture
32353|NCT03083015|regeneration, MTA apexification and TAP|regeneration, mta apexification and tap
32354|NCT03083015|revascularization|revascularization
32355|NCT03082963|atrial fibrillation|atrial fibrillation
32356|NCT03082963|ablation|ablation
32357|NCT03082950|hpv prevalence|hpv prevalence
32358|NCT03082950|recurrence rate|recurrence rate
32359|NCT03082950|survival|survival
32360|NCT03082924|surface EMGdi|surface emgdi
32361|NCT03082924|pulmonary rehabilitation|pulmonary rehabilitation
32362|NCT03082924|inspiratory muscle training|inspiratory muscle training
32363|NCT03082924|exercise training|exercise training
32364|NCT03082911|screening|screening
32365|NCT03082911|early detection|early detection
32366|NCT03082911|participation|participation
32367|NCT03082872|Reduction, Fracture|reduction, fracture
32368|NCT03082859|Exercise|exercise
32369|NCT03082859|Interval Training|interval training
32370|NCT03082859|Glycaemic Control|glycaemic control
32371|NCT03082859|Type 2 Diabetes|type 2 diabetes
32372|NCT03082846|malignant glioma|malignant glioma
32373|NCT03082846|intensity modulated radiation therapy|intensity modulated radiation therapy
32374|NCT03082846|simultaneous integrated boost|simultaneous integrated boost
32375|NCT03082846|hypofractionation|hypofractionation
32376|NCT03082846|temozolomide|temozolomide
32377|NCT03082846|maximum tolerated dose|maximum tolerated dose
32378|NCT03082807|Caloric Restriction|caloric restriction
32379|NCT03082807|Diet|diet
32381|NCT03082807|Obesity|obesity
32382|NCT03082807|Overweight|overweight
32383|NCT03082807|Sedentary lifestyle|sedentary lifestyle
32384|NCT03082807|weight loss|weight loss
32385|NCT03082807|Men|men
32386|NCT03082794|Dietary Formulations|dietary formulations
32387|NCT03082794|Lifestyle|lifestyle
32388|NCT03082794|Obesity|obesity
32389|NCT03082794|Overweight|overweight
32390|NCT03082794|weight loss|weight loss
32391|NCT03082781|Diet|diet
32392|NCT03082781|Exercise|exercise
32393|NCT03082781|Obesity|obesity
32394|NCT03082781|Overweight|overweight
32395|NCT03082781|Weight loss|weight loss
32396|NCT03082768|HV|hv
32397|NCT03082742|diuretics|diuretics
32398|NCT03082742|furosemide|furosemide
32399|NCT03082742|hydrochlorothiazide|hydrochlorothiazide
32400|NCT03082742|CKD-MBD|ckd-mbd
32401|NCT03082742|peripheral micro-CT|peripheral micro-ct
32402|NCT03082742|parathyroid hormone|parathyroid hormone
32403|NCT03082716|cardioplegia|cardioplegia
32404|NCT03082716|myocardial protection|myocardial protection
32405|NCT03082716|custodiol|custodiol
32406|NCT03082716|htk|htk
32407|NCT03082677|Ixazomib|ixazomib
32408|NCT03082677|Graft-versus-Host Disease|graft-versus-host disease
32409|NCT03082677|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
32410|NCT03082677|16-076|16-076
32411|NCT03082651|Running injuries, footwear, alternating load|running injuries, footwear, alternating load
32412|NCT03082612|Behavioral research|behavioral research
32413|NCT03082612|Social research|social research
34681|NCT03069469|ALL|all
32414|NCT03082612|Spirituality|spirituality
32415|NCT03082612|Late stage cancer|late stage cancer
32416|NCT03082547|Headache|headache
32417|NCT03082547|Neuropsychological tests|neuropsychological tests
32418|NCT03082547|Myofascial trigger points|myofascial trigger points
32419|NCT03082547|electrophysiology|electrophysiology
32420|NCT03082534|Head and Neck Cancer|head and neck cancer
32421|NCT03082534|Pembrolizumab|pembrolizumab
32422|NCT03082534|Keytruda®|keytruda®
32423|NCT03082534|Cetuximab|cetuximab
32424|NCT03082534|Erbitux®|erbitux®
32425|NCT03082534|Recurrent|recurrent
32426|NCT03082534|Metastatic|metastatic
32427|NCT03082534|PD-1|pd-1
32428|NCT03082534|PD-L1|pd-l1
32429|NCT03082534|non-EBV related Nasopharynx|non-ebv related nasopharynx
32430|NCT03082521|After hours care; Primary care; Antibiotics; Action Research|after hours care; primary care; antibiotics; action research
32431|NCT03082508|Algisyl|algisyl
32432|NCT03082508|Heart Failure|heart failure
32433|NCT03082508|Dilated Cardiomyopathy|dilated cardiomyopathy
32434|NCT03082508|Alginate Hydrogel|alginate hydrogel
32435|NCT03082508|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
32436|NCT03082508|Congestive Heart Failure|congestive heart failure
32437|NCT03082495|Exercise|exercise
32438|NCT03082495|Cancer|cancer
32439|NCT03082495|Symptom management|symptom management
32440|NCT03082495|Quality of life|quality of life
32441|NCT03082495|presurgical|presurgical
32442|NCT03082495|chemoradiotherapy|chemoradiotherapy
32443|NCT03082495|Physical Fitness|physical fitness
32444|NCT03082482|Smoking Cessation|smoking cessation
32446|NCT03082482|AIDS|aids
32447|NCT03082469|Severe acute pancreatitis|severe acute pancreatitis
32448|NCT03082469|Haemodynamic monitoring|haemodynamic monitoring
32449|NCT03082469|Cytokine removal|cytokine removal
32450|NCT03082469|Vasopressor dependency index|vasopressor dependency index
32451|NCT03082456|molecuiar breast imaging|molecuiar breast imaging
32452|NCT03082456|MBI|mbi
32453|NCT03082456|breast cancer|breast cancer
32454|NCT03082456|mammography|mammography
32455|NCT03082456|sonography|sonography
32456|NCT03082456|recall rate|recall rate
32457|NCT03082456|diagnostic accuracy|diagnostic accuracy
32458|NCT03082456|breast echo|breast echo
32459|NCT03082456|female population|female population
32460|NCT03082443|Cardiac rehabilitation|cardiac rehabilitation
32461|NCT03082443|psychology|psychology
32462|NCT03082443|nutrition|nutrition
32463|NCT03082443|stress|stress
32464|NCT03082443|quality of life|quality of life
32465|NCT03082417|Bone Fracture|bone fracture
32466|NCT03082417|75 years old|75 years old
32467|NCT03082417|Elderly|elderly
32468|NCT03082417|Older adults|older adults
32469|NCT03082417|Pain scale|pain scale
32470|NCT03082417|Pain documentation|pain documentation
32471|NCT03082417|Analgesics|analgesics
32472|NCT03082417|Acetaminophen|acetaminophen
32473|NCT03082417|Opioid|opioid
32474|NCT03082417|Nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
32475|NCT03082417|Emergency Department|emergency department
32476|NCT03082404|Chronic kidney disease|chronic kidney disease
32477|NCT03082404|Inspiratory muscle training|inspiratory muscle training
32478|NCT03082391|Ventral Hernia Repair|ventral hernia repair
32479|NCT03082391|Heavyweight Mesh|heavyweight mesh
32480|NCT03082391|Mediumweight Mesh|mediumweight mesh
32481|NCT03082365|oral findings or oral manifestations|oral findings or oral manifestations
32482|NCT03082365|pre-dialysis or end stage renal disease|pre-dialysis or end stage renal disease
32483|NCT03082326|shock|shock
32484|NCT03082326|critical care ultrasound|critical care ultrasound
32485|NCT03082326|hemodynamics|hemodynamics
32486|NCT03082326|lung pathology|lung pathology
32487|NCT03082326|epidemic|epidemic
32488|NCT03082326|prognosis|prognosis
32489|NCT03082313|infant|infant
32490|NCT03082313|leg movement|leg movement
32491|NCT03082313|wearable sensors|wearable sensors
32492|NCT03082313|early intervention|early intervention
32493|NCT03082300|ASP8273|asp8273
32494|NCT03082300|Epidermal growth factor receptor (EGFR) mutations|epidermal growth factor receptor (egfr) mutations
32495|NCT03082300|naquotinib|naquotinib
32496|NCT03082300|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
32497|NCT03082300|Bioequivalence|bioequivalence
32498|NCT03082261|Failed Back Surgery Syndrome|failed back surgery syndrome
32499|NCT03082261|Radiculopathy|radiculopathy
32500|NCT03082261|Post Laminectomy Syndrome|post laminectomy syndrome
32501|NCT03082248|Low Back Pain|low back pain
32502|NCT03082248|Surgery|surgery
32503|NCT03082248|Lumbar Spine|lumbar spine
32504|NCT03082248|Physical Therapy Modalities|physical therapy modalities
32505|NCT03082248|Rehabilitation|rehabilitation
32506|NCT03082235|Healthy participants|healthy participants
32507|NCT03082235|E6742|e6742
32508|NCT03082235|pharmacokinetics|pharmacokinetics
32509|NCT03082222|partial onset seizures|partial onset seizures
32510|NCT03082222|secondary generalization|secondary generalization
32511|NCT03082209|non-Hodgkin lymphoma|non-hodgkin lymphoma
32512|NCT03082209|Solid Tumors|solid tumors
32513|NCT03082209|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
32514|NCT03082209|Cancer|cancer
32515|NCT03082209|Hematologic Malignancies|hematologic malignancies
32516|NCT03082209|colorectal cancer (CRC)|colorectal cancer (crc)
32517|NCT03082196|sodium fluoride|sodium fluoride
32518|NCT03082196|povidone iodine|povidone iodine
32519|NCT03082196|varnish|varnish
32520|NCT03082170|sleep apnea|sleep apnea
32521|NCT03082170|robotic surgery for base of tongue|robotic surgery for base of tongue
32522|NCT03082170|soft palate surgery|soft palate surgery
32523|NCT03082170|post operative swallowing evaluation|post operative swallowing evaluation
32524|NCT03082170|dysphagia|dysphagia
32525|NCT03082131|Gut Microbiota|gut microbiota
32526|NCT03082131|Glycemic Response|glycemic response
32527|NCT03082131|Resistant Starch|resistant starch
32528|NCT03082131|Fiber|fiber
32529|NCT03082092|Knee|knee
32530|NCT03082092|Pain|pain
32531|NCT03082092|Recovery|recovery
32532|NCT03082092|Steroid|steroid
32533|NCT03082092|Replacement|replacement
32534|NCT03082092|Arthroplasty|arthroplasty
32535|NCT03082079|GIST|gist
32537|NCT03082066|bone access|bone access
32538|NCT03082066|intraosseus needle|intraosseus needle
32539|NCT03082066|resuscitation|resuscitation
32540|NCT03082066|infusion|infusion
32541|NCT03082066|volume therapy|volume therapy
32542|NCT03082066|emergency|emergency
32543|NCT03082027|ultrasonography|ultrasonography
32544|NCT03082027|carpal tunnel syndrome|carpal tunnel syndrome
32545|NCT03082014|Hypertension|hypertension
32546|NCT03082014|Cerebrovascular Reactivity|cerebrovascular reactivity
32547|NCT03082014|Blood Pressure Variability|blood pressure variability
32548|NCT03082001|Neonate|neonate
32549|NCT03082001|Pain|pain
32550|NCT03082001|ELBW|elbw
32551|NCT03081988|Esophageal Cancer|esophageal cancer
32552|NCT03081988|chemoradiotherapy response|chemoradiotherapy response
32553|NCT03081988|molecular factors|molecular factors
32554|NCT03081975|adenoma detection rate|adenoma detection rate
32555|NCT03081975|narrow band imaging|narrow band imaging
32556|NCT03081949|peripartum cardiomyopathy|peripartum cardiomyopathy
32557|NCT03081949|Ventricular remodelling|ventricular remodelling
32558|NCT03081949|Survival|survival
32559|NCT03081949|Selenium|selenium
32560|NCT03081949|Oxidative stress|oxidative stress
32561|NCT03081949|Nigeria|nigeria
32562|NCT03081923|Immunotherapy|immunotherapy
32563|NCT03081923|Durvalumab|durvalumab
32564|NCT03081923|Tremelimumab|tremelimumab
32565|NCT03081923|Combination therapy|combination therapy
32566|NCT03081923|Testicular cancer|testicular cancer
32567|NCT03081910|Autologous CAR T cells|autologous car t cells
619884|NCT00660387|levodopa|levodopa
32568|NCT03081910|T-cell acute lymphoblastic lymphoma|t-cell acute lymphoblastic lymphoma
32569|NCT03081910|T-non-Hodgkin Lymphoma|t-non-hodgkin lymphoma
32570|NCT03081910|T-cell Acute Lymphoblastic Leukemia|t-cell acute lymphoblastic leukemia
32571|NCT03081884|Prostate cancer|prostate cancer
32572|NCT03081884|Metastatic cancer|metastatic cancer
32573|NCT03081884|Urogenital disorders|urogenital disorders
32574|NCT03081884|Oncology|oncology
32575|NCT03081884|Radiology|radiology
32576|NCT03081858|NMIBC|nmibc
32577|NCT03081858|Paclitaxel|paclitaxel
32578|NCT03081858|Antineoplastic Agents|antineoplastic agents
32579|NCT03081832|Prader-Willi|prader-willi
32580|NCT03081832|Oxytocin|oxytocin
32581|NCT03081832|Communication skills|communication skills
32582|NCT03081832|Oral skills|oral skills
32583|NCT03081832|Brain activity|brain activity
32584|NCT03081832|Hormonal disease|hormonal disease
32585|NCT03081806|Phase 3|phase 3
32586|NCT03081806|Efficacy|efficacy
32587|NCT03081806|Safety|safety
32588|NCT03081806|Osteoarthritis, Knee|osteoarthritis, knee
32589|NCT03081793|postoperative monitoring|postoperative monitoring
32590|NCT03081793|plethysmography|plethysmography
32591|NCT03081793|monitoring|monitoring
32593|NCT03081767|PET/CT|pet/ct
32594|NCT03081767|digital PET/CT|digital pet/ct
32595|NCT03081715|esophageal cancer|esophageal cancer
32596|NCT03081715|immune checkpoint|immune checkpoint
32597|NCT03081715|PD-1|pd-1
32598|NCT03081715|CRISPER|crisper
32599|NCT03081715|autologous cell infusion|autologous cell infusion
32600|NCT03081676|Maturity-Onset Diabetes of the Young, Type 3|maturity-onset diabetes of the young, type 3
32601|NCT03081676|Glucose-dependent insulinotropic peptide|glucose-dependent insulinotropic peptide
32602|NCT03081676|Glucagon-like-peptide 1|glucagon-like-peptide 1
32603|NCT03081676|Dipeptidyl peptidase 4|dipeptidyl peptidase 4
32604|NCT03081676|Glimepiride|glimepiride
32605|NCT03081676|Sulphonylurea|sulphonylurea
32606|NCT03081676|Glucose clamp|glucose clamp
32607|NCT03081676|Hepatocyte nuclear factor 1 alpha|hepatocyte nuclear factor 1 alpha
32608|NCT03081663|total knee arthroplasty|total knee arthroplasty
32609|NCT03081663|quadriceps sparing mid-vastus|quadriceps sparing mid-vastus
32610|NCT03081663|medial para-patellar|medial para-patellar
32611|NCT03081624|preterm|preterm
32612|NCT03081624|neurological status|neurological status
32613|NCT03081624|School Readiness|school readiness
32614|NCT03081585|fmri|fmri
32615|NCT03081585|neuronal reward processing|neuronal reward processing
32638|NCT03081468|Pupillometry|pupillometry
32639|NCT03081468|Automated|automated
32640|NCT03081468|Binocular|binocular
32641|NCT03081455|Screening|screening
32642|NCT03081455|Hereditary Cancer|hereditary cancer
32643|NCT03081403|Sensitive skin|sensitive skin
32644|NCT03081403|Quantitative Sensory Testing|quantitative sensory testing
32645|NCT03081364|Cardiac Implanted Device|cardiac implanted device
32646|NCT03081351|Extended retroperitoneal lymphadenectomy, Nerve plexus clearance, Survival benefit|extended retroperitoneal lymphadenectomy, nerve plexus clearance, survival benefit
32647|NCT03081338|ALS, MND, Care, Patient journey|als, mnd, care, patient journey
32649|NCT03081312|Family Cancer Caregivers,|family cancer caregivers,
32650|NCT03081312|Needs|needs
32651|NCT03081312|Burden of Care|burden of care
32652|NCT03081312|Quality of Life|quality of life
32653|NCT03081273|Antimicrobial susceptibility|antimicrobial susceptibility
32654|NCT03081273|Biofilm formation|biofilm formation
32655|NCT03081273|Bone and joint infection|bone and joint infection
32656|NCT03081273|Corynebacterium spp|corynebacterium spp
32657|NCT03081273|Osteoblast|osteoblast
32658|NCT03081273|Outcome|outcome
32659|NCT03081273|Prosthetic joint infection|prosthetic joint infection
32660|NCT03081260|Total Knee Arthroplasty|total knee arthroplasty
32661|NCT03081260|Patella|patella
32662|NCT03081260|Resurfacing|resurfacing
32663|NCT03081260|IKS score|iks score
32664|NCT03081234|Hormone receptor-positive|hormone receptor-positive
32665|NCT03081234|Estrogen and/or progesterone receptor-positive|estrogen and/or progesterone receptor-positive
32666|NCT03081234|HER2-negative|her2-negative
32667|NCT03081234|Intermediate risk early breast cancer|intermediate risk early breast cancer
32668|NCT03081234|Adjuvant|adjuvant
32669|NCT03081234|Ribociclib|ribociclib
32670|NCT03081234|LEE011|lee011
32671|NCT03081234|CDK4/6 inhibitor|cdk4/6 inhibitor
32672|NCT03081234|Endocrine therapy|endocrine therapy
32673|NCT03081234|Phase III|phase iii
32674|NCT03081234|breast carcinoma|breast carcinoma
32675|NCT03081234|breast cancer|breast cancer
32676|NCT03081208|IVF|ivf
32677|NCT03081208|ICSI|icsi
32678|NCT03081195|child behavior|child behavior
32679|NCT03081195|intervention|intervention
32680|NCT03081195|multiple family group|multiple family group
32681|NCT03081195|Sub Saharan Africa|sub saharan africa
32682|NCT03081195|caregivers|caregivers
32683|NCT03081182|Pediatric Chronic Pancreatitis|pediatric chronic pancreatitis
32684|NCT03081182|Data management|data management
32685|NCT03081182|Regulatory compliance|regulatory compliance
32686|NCT03081182|Protocol monitoring|protocol monitoring
32687|NCT03081156|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
32688|NCT03081156|exercise intolerance|exercise intolerance
32689|NCT03081156|dynamic hyperinflation|dynamic hyperinflation
32690|NCT03081117|HIV-Associated Neurocognitive Disorder (HAND)|hiv-associated neurocognitive disorder (hand)
32691|NCT03081117|Intranasal|intranasal
32692|NCT03081052|Heart and Lung transplantation surgery|heart and lung transplantation surgery
35058|NCT03067207|Adolescent|adolescent
32693|NCT03081052|Pulmonary vasodilation therapy|pulmonary vasodilation therapy
32694|NCT03081039|cholangiocarcinoma|cholangiocarcinoma
32695|NCT03081039|gemcitabine|gemcitabine
32696|NCT03081039|carboplatin|carboplatin
32697|NCT03081039|cisplatin|cisplatin
32699|NCT03081026|ages 6-16|ages 6-16
32700|NCT03081013|adolescents|adolescents
32701|NCT03081013|social norms|social norms
32702|NCT03080974|irreversible electroporation|irreversible electroporation
32703|NCT03080974|Nivolumab|nivolumab
32704|NCT03080961|Barrier cream|barrier cream
32705|NCT03080922|Acute Myeloid Leukemia|acute myeloid leukemia
32706|NCT03080922|Relapsed|relapsed
32707|NCT03080922|Refractory|refractory
32708|NCT03080922|hematopoietic stem cell|hematopoietic stem cell
32709|NCT03080909|Satiety|satiety
32710|NCT03080909|Nutrient|nutrient
32711|NCT03080909|Appetite|appetite
32712|NCT03080909|Encapsulation|encapsulation
32713|NCT03080909|Lipid|lipid
32714|NCT03080909|Amino acid|amino acid
32715|NCT03080909|Probiotic bacteria|probiotic bacteria
32716|NCT03080870|Art intervention|art intervention
32717|NCT03080870|Quality of Life|quality of life
32718|NCT03080870|Well-being|well-being
32719|NCT03080870|Physical performance|physical performance
32720|NCT03080870|Family caregivers|family caregivers
32721|NCT03080870|Older adults|older adults
32722|NCT03080831|Maintenance Fluid Therapy|maintenance fluid therapy
32723|NCT03080818|Probiotic, Cognitive Function, Mood|probiotic, cognitive function, mood
32724|NCT03080792|stem cell transplantation|stem cell transplantation
32725|NCT03080792|exercise|exercise
32726|NCT03080792|high intensity interval training|high intensity interval training
32727|NCT03080792|resistance training|resistance training
32728|NCT03080792|physical fitness|physical fitness
32729|NCT03080792|cancer|cancer
32730|NCT03080753|Sphinkeeper|sphinkeeper
32731|NCT03080753|Intersphincteric implants|intersphincteric implants
32732|NCT03080753|Gatekeeper|gatekeeper
32733|NCT03080714|no known ocular pathology|no known ocular pathology
32734|NCT03080714|Glaucoma|glaucoma
32735|NCT03080714|Retinal Disease|retinal disease
32736|NCT03080701|Behavioral: Automated Mailing|behavioral: automated mailing
32737|NCT03080675|Aging population|aging population
32738|NCT03080649|dental caries, Er:YAG laser, rotary bur|dental caries, er:yag laser, rotary bur
32739|NCT03080636|Post-exercise hypotension|post-exercise hypotension
32740|NCT03080636|Aerobic Exercise|aerobic exercise
32741|NCT03080636|Resistance Exercise|resistance exercise
32742|NCT03080636|Autonomic Stress|autonomic stress
32743|NCT03080636|Heart Rate Variability|heart rate variability
32744|NCT03080636|Sex difference|sex difference
32745|NCT03080610|Post-Dural Puncture Headache [C10.228.140.546.699.124]|post-dural puncture headache [c10.228.140.546.699.124]
32746|NCT03080610|Blood Patch, Epidural [E02.319.267.530.580.300.145]|blood patch, epidural [e02.319.267.530.580.300.145]
32747|NCT03080584|acupuncture|acupuncture
32750|NCT03080584|ovarian reserve|ovarian reserve
32751|NCT03080558|Indocyanine green fluorescence|indocyanine green fluorescence
32752|NCT03080558|Rectal vascularisation|rectal vascularisation
32753|NCT03080558|Vaginal vascularisation|vaginal vascularisation
32754|NCT03080558|Laparoscopic surgery|laparoscopic surgery
32755|NCT03080558|Rectal shaving|rectal shaving
32756|NCT03080558|Recto vaginal node|recto vaginal node
32757|NCT03080558|Deep Endometriosis|deep endometriosis
32758|NCT03080532|Microbiome|microbiome
32759|NCT03080532|Mediterranean diet|mediterranean diet
32760|NCT03080519|renal artery stenosis|renal artery stenosis
32761|NCT03080519|balloon angioplasty|balloon angioplasty
32762|NCT03080519|stents|stents
32763|NCT03080493|Abortion|abortion
32764|NCT03080493|Osmotic dilators|osmotic dilators
32765|NCT03080493|Gabapentin|gabapentin
32766|NCT03080493|Text message|text message
32767|NCT03080480|Chronic Granulomatous Disease|chronic granulomatous disease
32768|NCT03080480|Severe Infection|severe infection
32769|NCT03080480|PPARγ|pparγ
32770|NCT03080480|Pioglitazone|pioglitazone
32771|NCT03080480|phagocytes|phagocytes
32772|NCT03080467|Trauma|trauma
32773|NCT03080467|Laceration|laceration
32774|NCT03080467|Suture|suture
32775|NCT03080467|Cosmesis|cosmesis
32776|NCT03080467|Ethyl-2-Cyanoacrylate|ethyl-2-cyanoacrylate
32777|NCT03080467|Tissue adhesive|tissue adhesive
32778|NCT03080467|Lip lacerations|lip lacerations
32779|NCT03080467|Skalp lacerations|skalp lacerations
32780|NCT03080467|Facial injuries|facial injuries
32781|NCT03080454|stroke|stroke
32782|NCT03080454|CVA|cva
32783|NCT03080454|Spasticity|spasticity
32784|NCT03080454|hemiparesis|hemiparesis
32785|NCT03080454|rehabilitation|rehabilitation
32786|NCT03080454|tsDCS|tsdcs
32787|NCT03080454|non-invasive stimulation|non-invasive stimulation
32788|NCT03080428|Breast cancer|breast cancer
32789|NCT03080428|ER-positive|er-positive
32790|NCT03080428|Her-2 negative|her-2 negative
32791|NCT03080428|genomic test|genomic test
32792|NCT03080402|Anterior Cruciate Ligament|anterior cruciate ligament
32793|NCT03080402|ACL injury|acl injury
32794|NCT03080402|Injury prevention|injury prevention
32798|NCT03080389|overactive detrusor|overactive detrusor
32799|NCT03080389|urgency-frequency|urgency-frequency
32800|NCT03080389|urinary tract infection|urinary tract infection
32801|NCT03080376|Exercise|exercise
32802|NCT03080376|Web-based intervention|web-based intervention
32803|NCT03080363|Extracorporeal Shockwave Lithotripsy|extracorporeal shockwave lithotripsy
32804|NCT03080363|Quadratus Lumborum Block|quadratus lumborum block
32805|NCT03080363|bupivacaine|bupivacaine
32806|NCT03080363|lidocaine|lidocaine
32807|NCT03080350|Fentanyl|fentanyl
32808|NCT03080350|Transmucosal administration|transmucosal administration
32809|NCT03080350|Endovenous administration|endovenous administration
32810|NCT03080350|Pain therapy|pain therapy
32811|NCT03080350|Mountain emergency medicine|mountain emergency medicine
32812|NCT03080324|Fentanyl|fentanyl
32813|NCT03080324|Transmucosal administration|transmucosal administration
32814|NCT03080324|Endovenous administration|endovenous administration
32815|NCT03080324|Pain therapy|pain therapy
32816|NCT03080311|Bcl-2/Bcl-xL dual inhibitor|bcl-2/bcl-xl dual inhibitor
32817|NCT03080272|individual patient|individual patient
32819|NCT03080259|Stimulant Misuse|stimulant misuse
32820|NCT03080259|Stimulant Diversion|stimulant diversion
32821|NCT03080233|stroke|stroke
32822|NCT03080233|Validation|validation
32823|NCT03080233|Clinical decision support tool|clinical decision support tool
32824|NCT03080207|Lower Extremity Lymphedema|lower extremity lymphedema
32825|NCT03080207|Physiotherapy|physiotherapy
32826|NCT03080207|Complex Decongestive Physiotherapy|complex decongestive physiotherapy
32827|NCT03080207|Low Level Laser|low level laser
32828|NCT03080207|Platelet rich plasma|platelet rich plasma
32829|NCT03080194|schizophrenia|schizophrenia
32830|NCT03080194|violence risk|violence risk
32831|NCT03080194|long-acting antipsychotics|long-acting antipsychotics
32832|NCT03080194|community-based|community-based
32833|NCT03080168|suicidal ideation|suicidal ideation
32834|NCT03080168|suicidal behavior|suicidal behavior
32835|NCT03080168|Veterans|veterans
32836|NCT03080168|inpatients|inpatients
32837|NCT03080168|Actigraphy|actigraphy
32838|NCT03080168|implicit associations|implicit associations
32839|NCT03080168|risk factors|risk factors
32840|NCT03080129|Liver cirrhosis|liver cirrhosis
32841|NCT03080129|Sarcopenia|sarcopenia
32842|NCT03080129|Microbiome|microbiome
32843|NCT03080116|Randomized|randomized
32844|NCT03080116|Placebo-controlled|placebo-controlled
32845|NCT03080116|Neoadjuvant|neoadjuvant
32846|NCT03080116|Androgen deprivation|androgen deprivation
32847|NCT03080116|Antiandrogen|antiandrogen
32848|NCT03080116|Radical Prostatectomy|radical prostatectomy
32849|NCT03080103|Acute Appendicitis|acute appendicitis
32850|NCT03080103|Uncomplicated Acute Appendicitis|uncomplicated acute appendicitis
32851|NCT03080103|Appendectomy|appendectomy
32852|NCT03080103|Conservative Treatment|conservative treatment
32853|NCT03080103|Antibiotic-first Treatment|antibiotic-first treatment
32854|NCT03080103|Recurrent Appendicitis|recurrent appendicitis
32855|NCT03080103|Prospective Study|prospective study
32856|NCT03080051|PSP|psp
32857|NCT03080051|AD|ad
32858|NCT03080051|HV|hv
32859|NCT03080038|Sepsis|sepsis
32860|NCT03080038|Shock|shock
32861|NCT03080038|Septic Shock|septic shock
32862|NCT03080038|Fluid Therapy|fluid therapy
32863|NCT03080038|Resuscitation|resuscitation
32864|NCT03080038|Pediatrics|pediatrics
32865|NCT03080038|Emergency Medicine|emergency medicine
32866|NCT03080038|Critical Care|critical care
32867|NCT03080025|CBCT® (Cognitively Based Compassion-Training)|cbct® (cognitively based compassion-training)
32868|NCT03080025|Psychobiological Evaluation|psychobiological evaluation
32869|NCT03080025|Real Time Social Interaction|real time social interaction
32870|NCT03080025|Eye-Tracking|eye-tracking
32871|NCT03080025|Heart Rate Variability|heart rate variability
32872|NCT03080025|IL-6|il-6
32873|NCT03080025|IL-1b|il-1b
32874|NCT03080025|Cortisol|cortisol
32875|NCT03080025|Alpha-Amylase|alpha-amylase
32876|NCT03080025|Randomised Controlled Trial|randomised controlled trial
32877|NCT03080025|Compassion|compassion
32878|NCT03080025|Empathy|empathy
32879|NCT03080025|Relationship Quality|relationship quality
32880|NCT03080025|Interpersonal Relations|interpersonal relations
32881|NCT03080025|Stress|stress
32882|NCT03079986|Pancreatic surgery|pancreatic surgery
32883|NCT03079986|Chylous ascites|chylous ascites
32884|NCT03079973|Calcipotriene|calcipotriene
32885|NCT03079960|Parkinson|parkinson
32886|NCT03079960|DBS|dbs
32887|NCT03079960|Deep Brain Stimulation|deep brain stimulation
32888|NCT03079960|LFP|lfp
32889|NCT03079960|Local Field Potentials|local field potentials
32890|NCT03079960|EEG|eeg
35252|NCT03066297|Wedge resection|wedge resection
32891|NCT03079960|Electroencephalogram|electroencephalogram
32893|NCT03079947|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
32894|NCT03079947|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
32895|NCT03079947|prognosis|prognosis
32896|NCT03079934|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
32897|NCT03079934|Optical coherence tomography|optical coherence tomography
32898|NCT03079934|strut coverage|strut coverage
32899|NCT03079934|acute coronary syndrome|acute coronary syndrome
32900|NCT03079921|Islet Graft Function|islet graft function
32901|NCT03079921|Islet Cell transplantation|islet cell transplantation
32902|NCT03079921|Auto-islet transplantation|auto-islet transplantation
32903|NCT03079921|Intra-hepatic islets|intra-hepatic islets
32904|NCT03079921|Extra-hepatic islets|extra-hepatic islets
32905|NCT03079908|Laparoscopy|laparoscopy
32906|NCT03079908|Surgery|surgery
32907|NCT03079908|Training|training
33653|NCT03075709|Adherence|adherence
32908|NCT03079908|Virtual reality|virtual reality
32909|NCT03079908|Simulation|simulation
32910|NCT03079908|Robotic Surgery|robotic surgery
32911|NCT03079908|Da Vinci|da vinci
32912|NCT03079895|Depression|depression
32913|NCT03079895|internet|internet
32914|NCT03079895|Cognitive Behavioral Therapy|cognitive behavioral therapy
32915|NCT03079895|CBT|cbt
32916|NCT03079895|computer|computer
32917|NCT03079895|Primary Care|primary care
32918|NCT03079895|Psychiatry|psychiatry
32919|NCT03079895|treatment|treatment
32920|NCT03079895|self-help|self-help
32921|NCT03079895|managed care|managed care
32922|NCT03079882|Ultrasound|ultrasound
32923|NCT03079882|Viscoelasticity|viscoelasticity
32924|NCT03079882|Viscoelastic Response (VisR) Ultrasound|viscoelastic response (visr) ultrasound
32925|NCT03079856|Emerging adults|emerging adults
32926|NCT03079856|Drugs|drugs
32927|NCT03079856|HIV|hiv
32928|NCT03079856|Risky Sex Behaviors|risky sex behaviors
32929|NCT03079830|aortic valve surgery|aortic valve surgery
32930|NCT03079830|postoperative pain|postoperative pain
32931|NCT03079791|OCT|oct
32932|NCT03079791|cardiac allograft vasculopathy|cardiac allograft vasculopathy
35283|NCT03066193|PEA|pea
24612|NCT03132207|Oral Health|oral health
32933|NCT03079791|CAV|cav
32934|NCT03079791|intravascular imaging|intravascular imaging
32935|NCT03079765|Telehealth|telehealth
32936|NCT03079765|Functional behavior assessment|functional behavior assessment
32937|NCT03079713|pain|pain
32938|NCT03079713|anesthesia|anesthesia
32939|NCT03079713|vibrator|vibrator
32940|NCT03079713|intravitreal|intravitreal
32941|NCT03079713|injection|injection
32942|NCT03079687|Ovarian cancer|ovarian cancer
32943|NCT03079687|gynaecological cancer|gynaecological cancer
32944|NCT03079687|platinum-sensitive disease|platinum-sensitive disease
32945|NCT03079687|platinum-sensitive relapsed|platinum-sensitive relapsed
32946|NCT03079687|Olaparib|olaparib
32947|NCT03079687|Ovarian Neoplasms|ovarian neoplasms
32948|NCT03079687|Neoplasms|neoplasms
32949|NCT03079687|Ovarian Disease|ovarian disease
32950|NCT03079687|fallopean tube cancer|fallopean tube cancer
32951|NCT03079687|primary peritoneal cancer|primary peritoneal cancer
32952|NCT03079687|epithelial ovarian cancer|epithelial ovarian cancer
32953|NCT03079687|PARP inhibitors|parp inhibitors
32954|NCT03079687|Poly (ADP-ribose) polymerase inhibitors.|poly (adp-ribose) polymerase inhibitors.
32955|NCT03079674|transient Ischemic Attack|transient ischemic attack
32956|NCT03079674|minor Stroke|minor stroke
32957|NCT03079674|non-disabling ischemic cerebrovascular events|non-disabling ischemic cerebrovascular events
32958|NCT03079674|biomarker|biomarker
32959|NCT03079674|epidemiology|epidemiology
32960|NCT03079674|prognosis|prognosis
32961|NCT03079661|pollution|pollution
32962|NCT03079661|ozone|ozone
32963|NCT03079661|Copd|copd
32964|NCT03079661|particles|particles
32965|NCT03079648|Angelica gigas N. extract|angelica gigas n. extract
32966|NCT03079648|Hyperlipidemia|hyperlipidemia
32967|NCT03079648|Clinical Trial|clinical trial
32968|NCT03079596|gastric cancer|gastric cancer
32969|NCT03079596|ERAS (early recovery after surgery)|eras (early recovery after surgery)
32970|NCT03079596|laparoscopic total gastrectomy|laparoscopic total gastrectomy
32971|NCT03079557|Adolescent|adolescent
32972|NCT03079557|Injections, intraperitoneal|injections, intraperitoneal
32973|NCT03079557|Endoscopy|endoscopy
32974|NCT03079557|Botulinum Toxins, Type A|botulinum toxins, type a
32975|NCT03079557|OnabotulinumtoxinA|onabotulinumtoxina
32976|NCT03079518|iron deficiency|iron deficiency
32977|NCT03079518|HFREF|hfref
32978|NCT03079518|FGF23|fgf23
32979|NCT03079518|ferric carboxymaltose|ferric carboxymaltose
32980|NCT03079479|Arthoplasty|arthoplasty
32981|NCT03079479|Gait|gait
32982|NCT03079479|muscle strenght|muscle strenght
32983|NCT03079479|Quality of life|quality of life
32984|NCT03079466|Sleep apnea|sleep apnea
32985|NCT03079466|Elderly|elderly
32986|NCT03079466|CPAP|cpap
32987|NCT03079453|Dexamethasone|dexamethasone
32988|NCT03079453|Tonsillectomy|tonsillectomy
32989|NCT03079453|Uvula|uvula
32990|NCT03079453|Edema|edema
32991|NCT03079453|Uvula edema|uvula edema
33001|NCT03079414|Electrophysiology Study|electrophysiology study
33003|NCT03079401|biventricular conversion|biventricular conversion
33004|NCT03079375|cross sectional|cross sectional
33005|NCT03079375|medication review|medication review
33006|NCT03079375|readmissions|readmissions
33007|NCT03079375|follow-up|follow-up
33008|NCT03079336|Randomized controlled design development|randomized controlled design development
33009|NCT03079336|Translational Research|translational research
33010|NCT03079336|Psychological Interventions|psychological interventions
33011|NCT03079336|Contextual Model of Psychotherapy|contextual model of psychotherapy
33012|NCT03079323|External beam radiotherapy|external beam radiotherapy
33013|NCT03079323|Prostate cancer|prostate cancer
33014|NCT03079323|Elective para-aortic radiation therapy|elective para-aortic radiation therapy
33015|NCT03079323|PART|part
33016|NCT03079310|spinal cord stimulation|spinal cord stimulation
33017|NCT03079310|gait analysis|gait analysis
33018|NCT03079310|whole-body kinematics|whole-body kinematics
33019|NCT03079310|Parkinson's disease|parkinson's disease
33020|NCT03079310|Neuromodulation|neuromodulation
33021|NCT03079310|Feature extraction|feature extraction
33022|NCT03079297|Antidepressant|antidepressant
33023|NCT03079297|Inflammation|inflammation
33024|NCT03079297|Biomarker|biomarker
33025|NCT03079297|Depression|depression
33026|NCT03079297|Treatment Resistant Depression|treatment resistant depression
33027|NCT03079297|Leucine|leucine
33028|NCT03079258|vascular structure|vascular structure
33029|NCT03079258|vascular function|vascular function
33030|NCT03079258|cerebrovascular reactivity|cerebrovascular reactivity
33031|NCT03079258|physical activity|physical activity
33032|NCT03079258|sedentary behaviour|sedentary behaviour
33033|NCT03079258|offspring health|offspring health
33034|NCT03079258|maternal health|maternal health
33035|NCT03079245|Neonatal ICU|neonatal icu
33036|NCT03079245|antimicrobial stewardship|antimicrobial stewardship
33037|NCT03079232|Optical biopsy|optical biopsy
33038|NCT03079232|Skin cancer|skin cancer
33039|NCT03079232|Diagnostic performance|diagnostic performance
33040|NCT03079206|hazelnut|hazelnut
33041|NCT03079206|allergens|allergens
33042|NCT03079206|basophile-activation-test|basophile-activation-test
33043|NCT03079206|food|food
33044|NCT03079206|allergy|allergy
33045|NCT03079193|post thyroidectomy|post thyroidectomy
33046|NCT03079193|laryngeoscopic examination|laryngeoscopic examination
33047|NCT03079180|Tendon|tendon
33048|NCT03079180|Ageing|ageing
33049|NCT03079180|Training|training
33050|NCT03079180|Achilles tendon|achilles tendon
33051|NCT03079180|Patella tendon|patella tendon
33052|NCT03079180|Skeletal muscle|skeletal muscle
33053|NCT03079180|Adaptation|adaptation
33063|NCT03078998|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
33065|NCT03078998|Obstetric Brachial Plexus Palsy|obstetric brachial plexus palsy
33066|NCT03078998|Human Computer Interaction|human computer interaction
33067|NCT03078998|Leap Motion|leap motion
33068|NCT03078998|Video Game Based Rehabilitation|video game based rehabilitation
33069|NCT03078985|real-time MRI|real-time mri
33070|NCT03078985|electrophysiology study|electrophysiology study
619885|NCT00660387|dyskinesia|dyskinesia
33071|NCT03078985|atrial flutter ablation|atrial flutter ablation
33072|NCT03078985|active tracking|active tracking
33073|NCT03078946|Cardiac surgery|cardiac surgery
33074|NCT03078946|delirium|delirium
33075|NCT03078946|dexmedetomidine|dexmedetomidine
33076|NCT03078946|morphine|morphine
33077|NCT03078946|midazolam|midazolam
33078|NCT03078933|DFU|dfu
33079|NCT03078907|daily life|daily life
33080|NCT03078907|physical activity|physical activity
33081|NCT03078907|actigraphy|actigraphy
33082|NCT03078907|PAH-SYMPACT|pah-sympact
33083|NCT03078894|Zika|zika
33084|NCT03078894|Dengue|dengue
33085|NCT03078894|Chikagunya|chikagunya
33086|NCT03078894|Peru|peru
33087|NCT03078829|gender identity|gender identity
33088|NCT03078829|trans female|trans female
33089|NCT03078829|GnRH agonists|gnrh agonists
35462|NCT03065192|PD|pd
33090|NCT03078829|QTc interval|qtc interval
33091|NCT03078803|fecal transplant|fecal transplant
33092|NCT03078803|inflammatory bowel disease|inflammatory bowel disease
33093|NCT03078777|Pharmacokinetics|pharmacokinetics
33094|NCT03078764|Mobile health (mHealth)|mobile health (mhealth)
33107|NCT03078738|OMT-28|omt-28
33108|NCT03078738|Atrial Fibrillation|atrial fibrillation
33110|NCT03078738|MAD|mad
33111|NCT03078738|First-in-Man|first-in-man
33112|NCT03078738|Cardiovascular|cardiovascular
33113|NCT03078725|gestational diabetes|gestational diabetes
33114|NCT03078725|glyburide|glyburide
33115|NCT03078725|metformin|metformin
33116|NCT03078725|failure rate|failure rate
33117|NCT03078712|Septic Shock|septic shock
33118|NCT03078712|Lactate|lactate
33119|NCT03078712|Capillary Refill Time|capillary refill time
33120|NCT03078712|Fluid Responsiveness|fluid responsiveness
33121|NCT03078712|Mortality|mortality
33122|NCT03078699|Thymoma|thymoma
33123|NCT03078699|Thymic tumor|thymic tumor
33124|NCT03078699|Stereotactic body radiotherapy|stereotactic body radiotherapy
33125|NCT03078686|Stem Cells,PRP, tSVF,cSVF,Alopecia Areata,Scarring Alopecia|stem cells,prp, tsvf,csvf,alopecia areata,scarring alopecia
33126|NCT03078673|Cross country poling, motor skill, strength training|cross country poling, motor skill, strength training
33127|NCT03078634|Irritable bowel syndrome|irritable bowel syndrome
33128|NCT03078634|Constipation|constipation
33129|NCT03078634|Functional dyspepsia|functional dyspepsia
33130|NCT03078634|Multi-disciplinary treatment|multi-disciplinary treatment
33131|NCT03078621|stem cells|stem cells
33132|NCT03078608|anxiety|anxiety
33133|NCT03078608|quality of life|quality of life
33134|NCT03078608|mindfulness|mindfulness
33135|NCT03078608|meditation|meditation
33136|NCT03078608|depression|depression
33137|NCT03078595|periodontal disease|periodontal disease
33138|NCT03078595|plaque-induced gingivitis|plaque-induced gingivitis
33139|NCT03078595|bleeding on probing|bleeding on probing
33140|NCT03078595|von willebrand disease|von willebrand disease
33141|NCT03078595|gingival bleeding|gingival bleeding
33142|NCT03078582|PNH|pnh
33143|NCT03078569|Poor responders|poor responders
33144|NCT03078556|FDC|fdc
33145|NCT03078556|Lamivudine|lamivudine
33146|NCT03078556|Bio-equivalence|bio-equivalence
33147|NCT03078556|Dolutegravir|dolutegravir
33148|NCT03078556|HIV|hiv
33149|NCT03078530|GWI|gwi
33150|NCT03078530|IBS|ibs
33151|NCT03078530|Irritable Bowel Syndrome|irritable bowel syndrome
33152|NCT03078530|Gulf War Illness|gulf war illness
33153|NCT03078530|Probiotics|probiotics
33154|NCT03078517|I-gel|i-gel
33155|NCT03078517|Laryngeal mask airway protector|laryngeal mask airway protector
33156|NCT03078491|type 1 diabetes|type 1 diabetes
33157|NCT03078491|geriatrics|geriatrics
33158|NCT03078491|older adults|older adults
33159|NCT03078491|technology|technology
33160|NCT03078491|CGM|cgm
33161|NCT03078491|clinical decision support|clinical decision support
33162|NCT03078491|hypoglycemia|hypoglycemia
24899|NCT03130101|CGM|cgm
33163|NCT03078439|very preterm birth|very preterm birth
33164|NCT03078439|developmental disorders|developmental disorders
33165|NCT03078439|health problems|health problems
33166|NCT03078439|prospective population-based cohort|prospective population-based cohort
33167|NCT03078426|Lung|lung
33168|NCT03078426|MRI|mri
33169|NCT03078426|CT|ct
33170|NCT03078426|Usual interstitial pneumonia|usual interstitial pneumonia
33171|NCT03078426|Ultra-short echo time|ultra-short echo time
33172|NCT03078413|Mustard Procedure|mustard procedure
33173|NCT03078374|Reduced anti-coagulation, mechanical circulatory support.|reduced anti-coagulation, mechanical circulatory support.
33174|NCT03078361|cancer screening|cancer screening
33175|NCT03078361|colon|colon
33176|NCT03078348|cancer screening|cancer screening
33177|NCT03078335|Late onset sepsis|late onset sepsis
33178|NCT03078335|glove based care|glove based care
33179|NCT03078335|NICU|nicu
33180|NCT03078335|Non sterile gloves|non sterile gloves
33181|NCT03078335|infection control|infection control
33182|NCT03078309|retinitis pigmentosa|retinitis pigmentosa
33183|NCT03078309|retinal degeneration|retinal degeneration
33184|NCT03078309|cannabis|cannabis
33185|NCT03078309|THC|thc
33186|NCT03078309|CBD|cbd
33187|NCT03078309|electrophysiology|electrophysiology
33188|NCT03078309|visual functions|visual functions
33189|NCT03078309|eye|eye
33190|NCT03078309|retina|retina
33191|NCT03078270|social anxiety|social anxiety
33192|NCT03078270|botulinum toxin|botulinum toxin
33193|NCT03078270|botox|botox
33194|NCT03078257|Platelet Activities|platelet activities
33195|NCT03078257|light aggregometry|light aggregometry
33196|NCT03078257|VerifyNow P2Y12-assay|verifynow p2y12-assay
33197|NCT03078257|peripheral vein|peripheral vein
33198|NCT03078257|peripheral artery|peripheral artery
33199|NCT03078257|intracoronary artery|intracoronary artery
33200|NCT03078257|tirofiban|tirofiban
33201|NCT03078257|antiplatelet thrombolysin|antiplatelet thrombolysin
33202|NCT03078218|Pulse oximetry|pulse oximetry
33203|NCT03078218|Asymptomatic newborns|asymptomatic newborns
33204|NCT03078205|TCM multi-channel therapy|tcm multi-channel therapy
33205|NCT03078205|ART failure|art failure
33206|NCT03078179|Probiotic|probiotic
33207|NCT03078179|Child|child
33208|NCT03078179|Care, dental|care, dental
33209|NCT03078166|Cardiac Failure|cardiac failure
33210|NCT03078166|Congestive Heart Failure|congestive heart failure
33211|NCT03078166|Heart Decompensation|heart decompensation
33212|NCT03078166|Heart Failure, Congestive|heart failure, congestive
33213|NCT03078166|Heart Failure, Left-Sided|heart failure, left-sided
33214|NCT03078166|Heart Failure, Right-Sided|heart failure, right-sided
33215|NCT03078166|Left-Sided Heart Failure|left-sided heart failure
33216|NCT03078166|Myocardial Failure|myocardial failure
33217|NCT03078166|Right-Sided Heart Failure|right-sided heart failure
33218|NCT03078166|Outcomes|outcomes
33219|NCT03078166|Co-morbidities|co-morbidities
33220|NCT03078166|Biomarkers|biomarkers
33221|NCT03078101|Empagliflozin|empagliflozin
33222|NCT03078101|SGLT-2 Inhibiton and RAS in CKD|sglt-2 inhibiton and ras in ckd
33223|NCT03078075|Methamphetamine|methamphetamine
33224|NCT03078075|Methamphetamine Use Disorder|methamphetamine use disorder
33225|NCT03078075|Naltrexone|naltrexone
33226|NCT03078075|Bupropion|bupropion
33227|NCT03078075|Vivitrol®|vivitrol®
33228|NCT03078062|Spinal anesthesia|spinal anesthesia
33229|NCT03078062|Motor block|motor block
33230|NCT03078062|Sensory block|sensory block
33231|NCT03078062|Dexamethasone|dexamethasone
33232|NCT03078036|HER2-ve metastatic breast cancer|her2-ve metastatic breast cancer
33233|NCT03078036|gBRCA, sBRCA and HRR gene mutations|gbrca, sbrca and hrr gene mutations
33235|NCT03078010|Antibiotic|antibiotic
33236|NCT03078010|piperacillin-tazobactam|piperacillin-tazobactam
33237|NCT03078010|cefepime|cefepime
33238|NCT03078010|aztreonam|aztreonam
33239|NCT03078010|17-097|17-097
33240|NCT03077997|Diabetes|diabetes
33241|NCT03077997|Diabetes distress|diabetes distress
33242|NCT03077971|Carers of People with Multiple Sclerosis|carers of people with multiple sclerosis
33243|NCT03077971|Carer Strain|carer strain
33244|NCT03077971|Acceptance and Commitment Therapy|acceptance and commitment therapy
33245|NCT03077945|biofeedback|biofeedback
33246|NCT03077945|heart rate variability|heart rate variability
33247|NCT03077945|HRV|hrv
33248|NCT03077945|psychophysiology|psychophysiology
33249|NCT03077945|reappraisal|reappraisal
33250|NCT03077945|cognitive reappraisal|cognitive reappraisal
33251|NCT03077945|arousal reappraisal|arousal reappraisal
33252|NCT03077945|woman|woman
33253|NCT03077945|women|women
33254|NCT03077945|female|female
33255|NCT03077945|smoker|smoker
33262|NCT03077945|cognitive behavioral intervention|cognitive behavioral intervention
33263|NCT03077945|respiratory sinus arrhythmia|respiratory sinus arrhythmia
33264|NCT03077945|smoking cessation intervention|smoking cessation intervention
33265|NCT03077919|Posttraumatic Stress Disorder|posttraumatic stress disorder
33266|NCT03077919|Generalized Anxiety Disorder|generalized anxiety disorder
33267|NCT03077919|Depression|depression
33268|NCT03077919|Distress|distress
33269|NCT03077919|Alcohol Use|alcohol use
33270|NCT03077919|Pain|pain
33271|NCT03077906|Gastroœsophageal Reflux|gastroœsophageal reflux
33272|NCT03077906|Sleeve Gastrectomy|sleeve gastrectomy
33273|NCT03077880|implant insertion|implant insertion
33274|NCT03077880|bone resorption|bone resorption
33275|NCT03077880|soft tissue|soft tissue
33276|NCT03077867|sinus lift|sinus lift
33277|NCT03077867|synthetic hydroxyapatite|synthetic hydroxyapatite
33278|NCT03077867|bone graft|bone graft
33279|NCT03077854|Lung Cancer|lung cancer
33280|NCT03077854|Radiotherapy|radiotherapy
33281|NCT03077854|Biomarkers|biomarkers
33282|NCT03077854|Radiation Lung Injury|radiation lung injury
33283|NCT03077854|Quality of Life|quality of life
33284|NCT03077841|Malignant neoplasm of breast|malignant neoplasm of breast
33285|NCT03077841|Breast cancer|breast cancer
33286|NCT03077841|Radiation therapy|radiation therapy
33287|NCT03077841|XRT|xrt
33288|NCT03077841|External beam radiation therapy|external beam radiation therapy
619886|NCT00660387|Duodopa|duodopa
33290|NCT03077841|Questionnaires|questionnaires
33291|NCT03077841|Surveys|surveys
33292|NCT03077802|Seldinger technique|seldinger technique
33293|NCT03077802|Modified Seldinger technique|modified seldinger technique
33294|NCT03077802|Complication|complication
33295|NCT03077802|Success rate|success rate
33296|NCT03077789|visual acuity|visual acuity
33297|NCT03077789|prognosis epidemiology|prognosis epidemiology
33298|NCT03077763|nitrite|nitrite
33299|NCT03077763|haemoglobin|haemoglobin
33300|NCT03077763|normoxia|normoxia
33301|NCT03077763|hypoxia|hypoxia
33302|NCT03077763|vasodilatation|vasodilatation
33303|NCT03077763|blood|blood
33304|NCT03077750|viral skin disease|viral skin disease
33305|NCT03077737|Treatment access|treatment access
33306|NCT03077737|Treatment utilization|treatment utilization
33307|NCT03077737|Smoking cessation|smoking cessation
33308|NCT03077737|Low income|low income
33309|NCT03077737|Electronic health record system|electronic health record system
33310|NCT03077737|Electronic referral|electronic referral
33311|NCT03077724|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
33312|NCT03077724|tobacco use|tobacco use
33313|NCT03077724|pregnancy|pregnancy
33318|NCT03077672|Mitochondrial DNA|mitochondrial dna
33319|NCT03077672|Lactate|lactate
33320|NCT03077672|Mortality|mortality
33321|NCT03077672|Emergency Department|emergency department
33322|NCT03077672|Intensive Care Unit|intensive care unit
33323|NCT03077672|Triage|triage
33324|NCT03077672|Organ Dysfunction|organ dysfunction
33325|NCT03077672|Biomarker|biomarker
33326|NCT03077672|Prognosis|prognosis
33327|NCT03077646|firearm|firearm
33328|NCT03077646|gun|gun
33329|NCT03077646|safety|safety
33330|NCT03077646|pediatric|pediatric
33331|NCT03077646|inpatient|inpatient
33332|NCT03077633|Cerclage|cerclage
33333|NCT03077633|Cervical shortening|cervical shortening
33334|NCT03077633|Twins|twins
33335|NCT03077633|Progesterone|progesterone
33336|NCT03077568|internet|internet
33337|NCT03077568|web-based|web-based
33338|NCT03077568|behavior change|behavior change
33339|NCT03077568|stress-management|stress-management
33341|NCT03077542|Peripheral Blood Stem Cells|peripheral blood stem cells
33342|NCT03077542|Host-Donor Chimerism|host-donor chimerism
33343|NCT03077542|Graft Versus Host Disease|graft versus host disease
33344|NCT03077542|Haploidentical|haploidentical
33345|NCT03077542|Donor Apheresis|donor apheresis
33346|NCT03077503|Hemodynamic response|hemodynamic response
33347|NCT03077503|Skull pins application|skull pins application
33348|NCT03077503|Dexmedetomidine|dexmedetomidine
33349|NCT03077503|Fentanyl|fentanyl
33350|NCT03077490|Pelvic organ prolapse|pelvic organ prolapse
33351|NCT03077490|transvaginal mesh|transvaginal mesh
33352|NCT03077490|complications|complications
33353|NCT03077464|nutrition education|nutrition education
33354|NCT03077464|Vegetables|vegetables
33355|NCT03077464|Fruit|fruit
33356|NCT03077438|Meningitis|meningitis
33357|NCT03077438|Meningococcal Meningitis|meningococcal meningitis
33358|NCT03077438|MenACYW conjugate vaccine|menacyw conjugate vaccine
33359|NCT03077438|MENVEO®|menveo®
33360|NCT03077399|lateropulsion|lateropulsion
33361|NCT03077399|stroke|stroke
33362|NCT03077399|Pusher syndrome|pusher syndrome
33363|NCT03077386|patient navigator|patient navigator
33364|NCT03077386|multi-morbidity|multi-morbidity
33365|NCT03077386|vulnerable populations|vulnerable populations
33366|NCT03077373|systolic blood pressure|systolic blood pressure
33367|NCT03077373|physical activity|physical activity
33368|NCT03077373|sedentary time|sedentary time
33369|NCT03077373|smoking|smoking
33370|NCT03077347|Schizophrenia|schizophrenia
33371|NCT03077347|Transcranial Direct Current Stimulation|transcranial direct current stimulation
33372|NCT03077347|tDCS|tdcs
33373|NCT03077347|Cognitive Control|cognitive control
33374|NCT03077347|fMRI|fmri
33375|NCT03077347|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
33376|NCT03077308|Auditory ERP, Visual ERP, EEG|auditory erp, visual erp, eeg
33377|NCT03077282|Prasaprohyai extract, Healthy volunteers|prasaprohyai extract, healthy volunteers
33378|NCT03077269|burn|burn
33379|NCT03077269|coagulation|coagulation
33380|NCT03077269|inflammation|inflammation
33381|NCT03077256|Ankle Arthrodesis|ankle arthrodesis
33382|NCT03077256|Cellular Allograft|cellular allograft
33383|NCT03077243|Human Papillomavirus|human papillomavirus
33384|NCT03077243|Oropharynx|oropharynx
33385|NCT03077243|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
33386|NCT03077243|Squamous Cell Carcinoma|squamous cell carcinoma
33387|NCT03077243|Radiation Therapy|radiation therapy
33388|NCT03077243|Chemotherapy|chemotherapy
33389|NCT03077243|p16|p16
33390|NCT03077217|covert hepatic encephalopathy|covert hepatic encephalopathy
33391|NCT03077217|low-dose rifaximin|low-dose rifaximin
33392|NCT03077204|Total cervical vertebrectomy|total cervical vertebrectomy
620701|NCT00657566|duration|duration
33393|NCT03077204|Partial cervical vertebrectomy|partial cervical vertebrectomy
33394|NCT03077204|Failed previous fusion|failed previous fusion
33395|NCT03077204|Spinal stenosis|spinal stenosis
33396|NCT03077204|Tumor|tumor
33397|NCT03077204|Decompression of the spinal cord|decompression of the spinal cord
33398|NCT03077204|Pseudoarthrosis|pseudoarthrosis
33399|NCT03077204|Curvatures|curvatures
33400|NCT03077204|Deformities|deformities
33401|NCT03077191|hypofractionated whole breast radiotherapy|hypofractionated whole breast radiotherapy
33402|NCT03077191|breast cancer|breast cancer
33403|NCT03077191|conservative treatment|conservative treatment
33404|NCT03077191|quality of life|quality of life
33405|NCT03077178|Soft Tissue Sarcoma|soft tissue sarcoma
33406|NCT03077178|Surgery|surgery
33407|NCT03077178|Functional Impact|functional impact
33408|NCT03077178|Elderly Patient|elderly patient
33409|NCT03077178|Geriatrics|geriatrics
33410|NCT03077152|copd, aecopd, antibiotic use|copd, aecopd, antibiotic use
33411|NCT03077126|elastography|elastography
33412|NCT03077126|ultrasound|ultrasound
33413|NCT03077126|prostate|prostate
33414|NCT03077126|cancer screening|cancer screening
33415|NCT03077113|lung cancer|lung cancer
33416|NCT03077113|radiation therapy|radiation therapy
33418|NCT03077048|Ketosteril|ketosteril
33419|NCT03077048|keto-acids|keto-acids
33420|NCT03077048|ketoanalogues|ketoanalogues
33421|NCT03077048|Chronic kidney disease|chronic kidney disease
33422|NCT03077035|ICDAS|icdas
33423|NCT03077035|DIAGNOdent|diagnodent
33424|NCT03077035|glass ionomer sealant|glass ionomer sealant
33425|NCT03077035|resin-based sealant|resin-based sealant
33426|NCT03077035|pit and fissure sealants|pit and fissure sealants
33427|NCT03077035|effectiveness of preventing caries|effectiveness of preventing caries
33428|NCT03076983|Ventilation Monitoring|ventilation monitoring
33429|NCT03076983|Electrical Impedance Tomography|electrical impedance tomography
33430|NCT03076931|Voice|voice
33431|NCT03076931|Biomarker|biomarker
33432|NCT03076931|Airway Reconstruction|airway reconstruction
33433|NCT03076918|PDT, Methyl Aminolevulinate, Light Emitting Textile|pdt, methyl aminolevulinate, light emitting textile
33434|NCT03076892|PDT|pdt
33435|NCT03076892|Methyl Aminolevulinate|methyl aminolevulinate
33436|NCT03076892|light emitting textile|light emitting textile
33437|NCT03076879|Cervical Cancer|cervical cancer
33438|NCT03076879|Pap smear|pap smear
33439|NCT03076879|Screening|screening
33440|NCT03076879|Beliefs|beliefs
33441|NCT03076879|Attitude|attitude
33442|NCT03076879|Nursing|nursing
33443|NCT03076840|hamstring tightness|hamstring tightness
33444|NCT03076801|Choral Singing|choral singing
33445|NCT03076801|Music|music
33446|NCT03076801|Quality of Life|quality of life
33447|NCT03076801|Psychosocial Stress|psychosocial stress
33448|NCT03076801|Cardiac Rehabilitation|cardiac rehabilitation
33449|NCT03076788|echocardiography|echocardiography
33450|NCT03076788|intraventricular pressure gradients|intraventricular pressure gradients
33451|NCT03076788|cardiac remodeling|cardiac remodeling
33452|NCT03076788|athletes|athletes
33453|NCT03076775|Betamethasone|betamethasone
33454|NCT03076775|Late preterm|late preterm
33455|NCT03076775|Steroids|steroids
33456|NCT03076762|interstitial cystitis|interstitial cystitis
33462|NCT03076749|Decision tree|decision tree
33463|NCT03076749|Drug hypersensitivity|drug hypersensitivity
33464|NCT03076749|Logistic regression|logistic regression
33465|NCT03076749|Predictive modelling|predictive modelling
33466|NCT03076710|spine surgery|spine surgery
33467|NCT03076710|post-operative pain|post-operative pain
33468|NCT03076710|patient controlled analgesia|patient controlled analgesia
33469|NCT03076710|Exparel®|exparel®
33470|NCT03076710|bupivacaine|bupivacaine
33471|NCT03076697|fundus photography|fundus photography
33472|NCT03076697|smartphone-based photography|smartphone-based photography
33473|NCT03076671|Palliative Care|palliative care
33474|NCT03076671|Supportive Care|supportive care
33475|NCT03076671|Movement Disorders|movement disorders
33476|NCT03076671|Brain Disease|brain disease
33477|NCT03076671|Neurodegeneration|neurodegeneration
33478|NCT03076671|Parkinson's Disease|parkinson's disease
33479|NCT03076632|transcranial magnetic stimulation|transcranial magnetic stimulation
33480|NCT03076632|neurostimulation|neurostimulation
33481|NCT03076632|non-invasive stimulation|non-invasive stimulation
33482|NCT03076632|closed-loop stimulation|closed-loop stimulation
33483|NCT03076619|pregnancy induced hypertension|pregnancy induced hypertension
33484|NCT03076619|ophthalmoscopy|ophthalmoscopy
33485|NCT03076593|geriatric|geriatric
33491|NCT03076554|Programmed Death 1 (PD-1)|programmed death 1 (pd-1)
33492|NCT03076554|Immune Checkpoint Blockade|immune checkpoint blockade
33493|NCT03076541|Restless legs syndrome|restless legs syndrome
33494|NCT03076541|Periodic leg movements|periodic leg movements
33495|NCT03076541|Heart rate|heart rate
33496|NCT03076541|Heart rate variability|heart rate variability
33497|NCT03076541|Microarousals|microarousals
33498|NCT03076541|Autonomic nervous system activity|autonomic nervous system activity
33499|NCT03076528|exercise|exercise
33500|NCT03076528|exergame|exergame
33501|NCT03076528|hemodialysis|hemodialysis
33502|NCT03076528|balance|balance
33503|NCT03076502|ctDNA|ctdna
33504|NCT03076502|Gastrointestinal Cancer|gastrointestinal cancer
33505|NCT03076502|ROS|ros
33506|NCT03076502|Hepatobiliary Pancreatic Cancer|hepatobiliary pancreatic cancer
33507|NCT03076476|Coronary Stent|coronary stent
33508|NCT03076476|PCI|pci
33509|NCT03076476|BVS|bvs
33510|NCT03076476|Index of microcirculatory resistance|index of microcirculatory resistance
33511|NCT03076463|Polyphenols|polyphenols
33512|NCT03076463|Metabolic syndrome|metabolic syndrome
33513|NCT03076463|Cardiometabolic risk|cardiometabolic risk
33514|NCT03076463|Grape pomace|grape pomace
33515|NCT03076463|Postprandial glucose|postprandial glucose
33516|NCT03076463|Insulin resistance|insulin resistance
33517|NCT03076463|Obesity|obesity
33518|NCT03076450|Acute respiratory distress syndrome, ARDS|acute respiratory distress syndrome, ards
33519|NCT03076450|Point-of-care lung ultrasound,POC-LUS|point-of-care lung ultrasound,poc-lus
33520|NCT03076450|Pressure-volume curve, PVC|pressure-volume curve, pvc
33643|NCT03075735|DNA-repair|dna-repair
35865|NCT03062683|lactate|lactate
33521|NCT03076450|Positive end-expiratory pressure, PEEP|positive end-expiratory pressure, peep
33522|NCT03076450|Ultrasound re-aeration score, US-RAS|ultrasound re-aeration score, us-ras
33523|NCT03076411|Dyspepsia|dyspepsia
33524|NCT03076411|Observational trial|observational trial
33525|NCT03076411|Enzyme therapy|enzyme therapy
33526|NCT03076411|Pepsin|pepsin
33527|NCT03076385|VAL-506440|val-506440
33528|NCT03076385|H10N8 antigen mRNA|h10n8 antigen mrna
33529|NCT03076385|Influenza vaccine|influenza vaccine
33530|NCT03076372|Cancer|cancer
33531|NCT03076372|Oncology|oncology
33532|NCT03076372|Phase I|phase i
33533|NCT03076372|Gemcitabine|gemcitabine
33534|NCT03076372|Carboplatin|carboplatin
33535|NCT03076372|MM-310|mm-310
33536|NCT03076372|EphA2|epha2
33537|NCT03076372|Ephrin A2|ephrin a2
33538|NCT03076372|Solid tumors|solid tumors
33539|NCT03076372|urothelial carcinoma|urothelial carcinoma
33540|NCT03076372|gastric carcinoma|gastric carcinoma
33541|NCT03076372|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
33542|NCT03076372|ovarian cancer|ovarian cancer
33543|NCT03076372|pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
33544|NCT03076372|prostate adenocarcinoma|prostate adenocarcinoma
33545|NCT03076372|non-small cell lung cancer|non-small cell lung cancer
33546|NCT03076372|small cell lung cancer|small cell lung cancer
33547|NCT03076372|triple negative breast cancer|triple negative breast cancer
33548|NCT03076372|endometrial carcinoma|endometrial carcinoma
33549|NCT03076372|soft tissue sarcoma|soft tissue sarcoma
33550|NCT03076372|Merrimack|merrimack
33551|NCT03076320|Modified diallyl disulfide oxide (M-DDO)|modified diallyl disulfide oxide (m-ddo)
33552|NCT03076320|Pirfenidone (PFD)|pirfenidone (pfd)
33651|NCT03075709|COPD|copd
33553|NCT03076320|Adapalene + Benzoyl peroxide (A-BPO)|adapalene + benzoyl peroxide (a-bpo)
33554|NCT03076294|knee ostearthritis|knee ostearthritis
33555|NCT03076294|transcranial magnetic stimulation|transcranial magnetic stimulation
33556|NCT03076294|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
33557|NCT03076294|chronic pain|chronic pain
33558|NCT03076294|musculoskeletal manipulations|musculoskeletal manipulations
33559|NCT03076216|Pancreatic Cancer|pancreatic cancer
33560|NCT03076216|Pancreas|pancreas
33561|NCT03076216|metastases|metastases
33562|NCT03076216|pancreatic tumour|pancreatic tumour
33563|NCT03076216|unresectable|unresectable
33564|NCT03076216|locally advanced|locally advanced
33565|NCT03076216|implantable|implantable
33566|NCT03076216|radiographic|radiographic
33567|NCT03076216|device|device
33568|NCT03076216|Phosphorous-32 (P32)|phosphorous-32 (p32)
33569|NCT03076216|OncoSil™|oncosil™
33570|NCT03076216|brachytherapy|brachytherapy
33571|NCT03076216|gemcitabine|gemcitabine
33572|NCT03076216|nab-paclitaxel|nab-paclitaxel
36055|NCT03061435|HPV|hpv
25200|NCT03127930|Quality of Life|quality of life
25201|NCT03127930|Health resource utilization|health resource utilization
25202|NCT03127930|Community dwelling|community dwelling
25203|NCT03127917|Gait Speed|gait speed
25204|NCT03127917|Cognitive Function|cognitive function
25205|NCT03127904|Varicose ulcer|varicose ulcer
25223|NCT03127813|OSA|osa
33573|NCT03076216|Abraxane|abraxane
33574|NCT03076190|psychology|psychology
33575|NCT03076190|pain|pain
33576|NCT03076190|surgery|surgery
33577|NCT03076190|treatment|treatment
33578|NCT03076190|catastrophizing|catastrophizing
33579|NCT03076190|cancer|cancer
33580|NCT03076177|knee osteoarthritis, kinesio taping, knee function, pain|knee osteoarthritis, kinesio taping, knee function, pain
33581|NCT03076164|erlotinib|erlotinib
33582|NCT03076164|trametinib|trametinib
33583|NCT03076164|15-098|15-098
33584|NCT03076151|Transplantation|transplantation
33585|NCT03076151|Kidney|kidney
33586|NCT03076151|pharmacokinetic|pharmacokinetic
33587|NCT03076151|bayesian estimators|bayesian estimators
33588|NCT03076138|Gene-activated matrix|gene-activated matrix
33589|NCT03076138|Bone substitute|bone substitute
33590|NCT03076138|Bone grafting|bone grafting
33591|NCT03076138|Dental implantation|dental implantation
33592|NCT03076138|gene therapy|gene therapy
33593|NCT03076138|plasmid DNA|plasmid dna
33594|NCT03076138|VEGF gene|vegf gene
33595|NCT03076138|octacalcium phosphate|octacalcium phosphate
33596|NCT03076125|Primary Stroke Prevention, Risk Factors for Stroke|primary stroke prevention, risk factors for stroke
33597|NCT03076112|Ipragliflozin|ipragliflozin
33598|NCT03076112|Sitagliptin|sitagliptin
33599|NCT03076099|Dexmedetomidine|dexmedetomidine
33600|NCT03076099|brain arteriovenous malformation|brain arteriovenous malformation
33601|NCT03076099|embolization|embolization
33602|NCT03076099|post-operative hypertension|post-operative hypertension
33603|NCT03076073|Ultrasound|ultrasound
33604|NCT03076073|Achilles tendon|achilles tendon
33605|NCT03076073|Patellar tendon|patellar tendon
33606|NCT03076073|obesity|obesity
33607|NCT03076060|Ketogenic Diet|ketogenic diet
33608|NCT03076060|Very low calories diet|very low calories diet
33609|NCT03076060|ketone bodies|ketone bodies
33610|NCT03075995|lapatinib|lapatinib
33611|NCT03075995|steady state plasma concentration|steady state plasma concentration
33612|NCT03075995|high-fat breakfast|high-fat breakfast
33613|NCT03075969|Chronic myeloid leukemia; quality of life|chronic myeloid leukemia; quality of life
33614|NCT03075930|Atrial fibrillation|atrial fibrillation
33615|NCT03075930|ECG|ecg
33616|NCT03075930|Body surface potential map|body surface potential map
33617|NCT03075930|Recurrence of AF|recurrence of af
33618|NCT03075917|Allergic rhinitis|allergic rhinitis
33619|NCT03075865|intermaxillary fixation|intermaxillary fixation
33620|NCT03075865|maxillo-mandibular fixation|maxillo-mandibular fixation
33621|NCT03075852|Heads-up display, NGENUITY, Vitreoretinal surgery|heads-up display, ngenuity, vitreoretinal surgery
33622|NCT03075800|Assertive Community Treatment (ACT) Only|assertive community treatment (act) only
33623|NCT03075800|Assertive Community Treatment (ACT) + Illness Management and Recovery (IMR)|assertive community treatment (act) + illness management and recovery (imr)
33624|NCT03075787|Obstructive sleep apnea|obstructive sleep apnea
33625|NCT03075787|Heart rate|heart rate
33626|NCT03075787|Heart rate variability|heart rate variability
33627|NCT03075787|Microarousals|microarousals
33628|NCT03075787|Autonomic nervous system activity|autonomic nervous system activity
33629|NCT03075761|Venous thromboembolism|venous thromboembolism
33630|NCT03075761|Deep Vein Thrombosis|deep vein thrombosis
33631|NCT03075761|Lower Extremity|lower extremity
33632|NCT03075761|Blood clot|blood clot
33633|NCT03075761|Anticoagulation|anticoagulation
33634|NCT03075761|Physical Activity|physical activity
33636|NCT03075761|Post-thrombotic syndrome|post-thrombotic syndrome
33637|NCT03075761|Post-phlebitic syndrome|post-phlebitic syndrome
33638|NCT03075761|Thrombosis|thrombosis
33639|NCT03075748|Vascular|vascular
33640|NCT03075748|Stent|stent
33641|NCT03075748|Graft|graft
33642|NCT03075735|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
33644|NCT03075735|BRCA1|brca1
33645|NCT03075735|BRCA2|brca2
33646|NCT03075735|ATM|atm
33647|NCT03075735|PALB2|palb2
33648|NCT03075709|Clinical Pathway|clinical pathway
33649|NCT03075709|CPW|cpw
33650|NCT03075709|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
33652|NCT03075709|Protocol|protocol
33654|NCT03075709|Readmission|readmission
33655|NCT03075709|Length of Stay|length of stay
33656|NCT03075709|Cost|cost
33657|NCT03075683|Cognitive behavioural therapy|cognitive behavioural therapy
33658|NCT03075683|Non-pharmacological treatment|non-pharmacological treatment
33659|NCT03075683|Internet mediated|internet mediated
33660|NCT03075579|ADHD, cortisol, α-amylase, actometer|adhd, cortisol, α-amylase, actometer
33661|NCT03075566|coronary artery disease|coronary artery disease
33662|NCT03075566|risk factors|risk factors
33663|NCT03075566|inflammation|inflammation
33664|NCT03075566|biomarkers|biomarkers
33665|NCT03075566|atherosclerosis|atherosclerosis
33666|NCT03075540|Latinas|latinas
33667|NCT03075527|Mesothelioma|mesothelioma
33668|NCT03075514|ketogenic|ketogenic
33669|NCT03075501|drug cues|drug cues
33670|NCT03075475|Child|child
33671|NCT03075475|Adolescent|adolescent
33672|NCT03075475|Mental Health|mental health
33673|NCT03075475|Randomized Controlled Trial|randomized controlled trial
33674|NCT03075462|PARP inhibitor|parp inhibitor
33675|NCT03075462|VEGFR inhibitor|vegfr inhibitor
33676|NCT03075462|Combination therapy|combination therapy
33677|NCT03075462|Ovarian Cancer|ovarian cancer
33678|NCT03075462|Triple Negative Breast Cancer|triple negative breast cancer
33679|NCT03075436|Sanitation|sanitation
33680|NCT03075436|Hygiene|hygiene
33681|NCT03075436|Public Health|public health
33682|NCT03075436|Behavior change|behavior change
33683|NCT03075436|Neglected tropical diseases|neglected tropical diseases
33684|NCT03075436|Demand-side sanitation and hygiene|demand-side sanitation and hygiene
33685|NCT03075436|Mental well-being|mental well-being
33686|NCT03075436|Water insecurity|water insecurity
33687|NCT03075436|Sanitation insecurity|sanitation insecurity
33688|NCT03075436|Collective efficacy|collective efficacy
33689|NCT03075410|ascending dose|ascending dose
33690|NCT03075410|Pharmacokinetics|pharmacokinetics
33691|NCT03075410|GSK3036656|gsk3036656
33692|NCT03075410|FTIH|ftih
33693|NCT03075410|Safety|safety
33694|NCT03075397|HIV-1|hiv-1
33695|NCT03075397|Colo-rectal transmission|colo-rectal transmission
33696|NCT03075397|seminal plasma|seminal plasma
33697|NCT03075384|computer-assisted navigation system|computer-assisted navigation system
33698|NCT03075332|Detraining|detraining
33699|NCT03075332|Physical aptitude|physical aptitude
33700|NCT03075332|HIV|hiv
33701|NCT03075280|ERCP|ercp
33702|NCT03075280|ERAS|eras
33703|NCT03075280|complication|complication
33704|NCT03075280|fatigue|fatigue
33705|NCT03075280|high carbohydrate diet|high carbohydrate diet
33706|NCT03075254|Pain|pain
33707|NCT03075241|Sleep Disturbances|sleep disturbances
33708|NCT03075241|Alzheimer Disease|alzheimer disease
33709|NCT03075241|Insomnia|insomnia
33710|NCT03075241|Z-Drugs|z-drugs
33711|NCT03075241|Treatment|treatment
33712|NCT03075228|microbiota|microbiota
33713|NCT03075228|small intestine|small intestine
33714|NCT03075228|metabolic disease|metabolic disease
33715|NCT03075202|Schizophrenia|schizophrenia
33716|NCT03075202|Smoking|smoking
33717|NCT03075202|E-cigarette|e-cigarette
33718|NCT03075189|Frailty|frailty
33719|NCT03075189|geriatric|geriatric
33720|NCT03075189|hospitalized|hospitalized
33721|NCT03075189|enrichment|enrichment
33722|NCT03075189|whey protein|whey protein
33723|NCT03075189|protein intake|protein intake
33724|NCT03075189|sarcopenia|sarcopenia
33725|NCT03075189|dietary counseling|dietary counseling
33726|NCT03075176|Photorefractive keratectomy|photorefractive keratectomy
33727|NCT03075176|Laser-assisted in situ keratomileusis|laser-assisted in situ keratomileusis
33728|NCT03075163|PONV|ponv
33729|NCT03075163|Nausea|nausea
33730|NCT03075163|Vomiting|vomiting
33731|NCT03075163|Acupressure|acupressure
33732|NCT03075150|PVI|pvi
33733|NCT03075150|Dynamic Cardiac Monitors|dynamic cardiac monitors
33734|NCT03075150|SVV|svv
33735|NCT03075150|PPV|ppv
33736|NCT03075137|ischemic stroke|ischemic stroke
33737|NCT03075137|external counter pulsation|external counter pulsation
33738|NCT03075137|mRS|mrs
33739|NCT03075124|Coronary Artery Disease|coronary artery disease
33740|NCT03075124|external counter pulsation|external counter pulsation
33741|NCT03075124|major adverse cardiovascular events|major adverse cardiovascular events
33742|NCT03075098|Colposcopy|colposcopy
33743|NCT03075098|oral epithelial dysplasia|oral epithelial dysplasia
33744|NCT03075098|diagnostic accuracy|diagnostic accuracy
33745|NCT03075072|Brain metastases|brain metastases
33746|NCT03075072|Brain metastasis|brain metastasis
33747|NCT03075072|Lung cancer|lung cancer
33748|NCT03075072|Melanoma|melanoma
33749|NCT03075072|Breast cancer|breast cancer
33750|NCT03075072|Kidney cancer|kidney cancer
33751|NCT03075072|Renal cell carcinoma|renal cell carcinoma
33752|NCT03075072|Stereotactic radiation|stereotactic radiation
33753|NCT03075072|Stereotactic radiosurgery|stereotactic radiosurgery
33754|NCT03075072|SRS|srs
33755|NCT03075072|Stereotactic|stereotactic
33756|NCT03075072|Whole brain radiation|whole brain radiation
33757|NCT03075072|WBRT|wbrt
33846|NCT03074513|MPDL3280A|mpdl3280a
33758|NCT03075072|Hippocampal avoidance|hippocampal avoidance
33759|NCT03075072|Hippocampal sparing|hippocampal sparing
33760|NCT03075072|Hippocampal|hippocampal
33761|NCT03075072|Hippocampus|hippocampus
36360|NCT03059121|HIV|hiv
25427|NCT03126448|Infection|infection
25428|NCT03126448|Nonunion|nonunion
25429|NCT03126448|Fracture healing|fracture healing
25430|NCT03126435|FOLFIRINOX|folfirinox
25431|NCT03126435|5-Fluorouracil|5-fluorouracil
33762|NCT03075072|Radiation|radiation
33763|NCT03075072|Quality of Life|quality of life
33764|NCT03075072|Neurocognitive|neurocognitive
33765|NCT03075072|Neurocognition|neurocognition
33766|NCT03075072|Survival|survival
33767|NCT03075072|Salvage|salvage
33768|NCT03075072|MDASI|mdasi
33769|NCT03075072|Chemotherapy|chemotherapy
33770|NCT03075072|Recurrence|recurrence
33771|NCT03075046|Blue Light Emitting Diode|blue light emitting diode
33772|NCT03075046|Women|women
33896|NCT03074214|myocardial infarct size|myocardial infarct size
33897|NCT03074214|prognosis|prognosis
33773|NCT03075033|Shikani optical stylet, rigid optical stylets, awake, fiber-optic intubation, and cervical spine injury.|shikani optical stylet, rigid optical stylets, awake, fiber-optic intubation, and cervical spine injury.
33774|NCT03075007|Alzheimer Disease|alzheimer disease
33775|NCT03075007|Aging|aging
33776|NCT03075007|Dementia|dementia
33777|NCT03075007|PET|pet
33778|NCT03074994|Tranexamic acid|tranexamic acid
33779|NCT03074994|Peri-articular injection|peri-articular injection
33780|NCT03074994|Intraarticular injection|intraarticular injection
33781|NCT03074994|Total knee arthroplasty|total knee arthroplasty
33782|NCT03074994|Blood loss|blood loss
33783|NCT03074955|Hypotension|hypotension
33784|NCT03074955|Propofol|propofol
33785|NCT03074955|Trendelenburg|trendelenburg
33786|NCT03074955|leg wrapping|leg wrapping
33787|NCT03074929|risk communication|risk communication
33788|NCT03074903|intrauterine device|intrauterine device
33789|NCT03074903|bleeding|bleeding
33790|NCT03074877|Substance Use|substance use
33791|NCT03074864|Activating mutations,lung cancer,radiotherapy|activating mutations,lung cancer,radiotherapy
33792|NCT03074851|low sodium salt|low sodium salt
33793|NCT03074851|blood pressure|blood pressure
33794|NCT03074851|reporter|reporter
33795|NCT03074838|Cardiac surgery|cardiac surgery
33796|NCT03074838|TAVI|tavi
33797|NCT03074825|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
33798|NCT03074825|Relapsed/Refractory|relapsed/refractory
33799|NCT03074825|Aurora kinase B|aurora kinase b
33800|NCT03074734|secondhand smoke|secondhand smoke
33801|NCT03074734|passive smoking|passive smoking
33802|NCT03074734|respiratory diseases|respiratory diseases
33803|NCT03074734|COPD|copd
33804|NCT03074734|asthma|asthma
33805|NCT03074734|SHS health effect|shs health effect
33806|NCT03074708|Three-Dimensional Image|three-dimensional image
33807|NCT03074708|Three Dimensional Printing|three dimensional printing
33808|NCT03074682|Resuscitation|resuscitation
33809|NCT03074669|Anxiety symptoms/disorders (OCD, PTSD, GAD, SAD, Panic)|anxiety symptoms/disorders (ocd, ptsd, gad, sad, panic)
33810|NCT03074656|infliximab|infliximab
33811|NCT03074656|therapeutic drug monitoring|therapeutic drug monitoring
33812|NCT03074656|anti drug antibodies|anti drug antibodies
33813|NCT03074604|Brain Injuries|brain injuries
33814|NCT03074604|Neurological Injury|neurological injury
33815|NCT03074604|Stroke|stroke
33816|NCT03074604|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
33817|NCT03074604|Postoperative Delirium|postoperative delirium
33818|NCT03074604|Coronary Artery Disease|coronary artery disease
33819|NCT03074604|Coronary Artery Bypass Grafting|coronary artery bypass grafting
33820|NCT03074604|Coronary Artery Bypass Surgery|coronary artery bypass surgery
33821|NCT03074604|Bypass surgery|bypass surgery
33822|NCT03074604|Beating Heart Coronary Artery Bypass|beating heart coronary artery bypass
33823|NCT03074604|Off-Pump Coronary Artery Bypass|off-pump coronary artery bypass
33824|NCT03074591|Iron deficiency|iron deficiency
33825|NCT03074591|Heart failure|heart failure
33826|NCT03074578|sleep|sleep
33827|NCT03074578|verbal abuse|verbal abuse
33828|NCT03074578|polysomnography|polysomnography
33829|NCT03074578|perception|perception
33830|NCT03074578|neuropsychological tests|neuropsychological tests
33831|NCT03074565|Sanative Therapy|sanative therapy
33832|NCT03074565|Ultrasonic Therapy|ultrasonic therapy
33833|NCT03074565|Deep Scaling|deep scaling
33834|NCT03074565|Hand Scaling|hand scaling
33835|NCT03074552|probiotics|probiotics
33836|NCT03074552|VAP|vap
33837|NCT03074552|microbiome|microbiome
33838|NCT03074552|trauma|trauma
33839|NCT03074552|infections|infections
33840|NCT03074513|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
33841|NCT03074513|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
33842|NCT03074513|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
33843|NCT03074513|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
36429|NCT03058666|RDS|rds
33844|NCT03074513|Rare Solid Tumors|rare solid tumors
33845|NCT03074513|Atezolizumab|atezolizumab
33847|NCT03074513|Bevacizumab|bevacizumab
33848|NCT03074513|Avastin|avastin
33849|NCT03074513|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
33850|NCT03074513|rhuMAb-VEGF|rhumab-vegf
33851|NCT03074513|Phone call|phone call
33852|NCT03074500|Kinesio taping|kinesio taping
33853|NCT03074500|lateral epicondylitis|lateral epicondylitis
33854|NCT03074500|tennis elbow|tennis elbow
33855|NCT03074500|treatment|treatment
33856|NCT03074487|Spinal cord ischemia|spinal cord ischemia
33857|NCT03074487|Postoperative|postoperative
33858|NCT03074487|Thoracoabdominal Aneurysm|thoracoabdominal aneurysm
33859|NCT03074487|Monitoring|monitoring
33860|NCT03074474|use of mesh|use of mesh
33861|NCT03074461|Rectal Cancer|rectal cancer
33862|NCT03074461|Low Anterior Resection|low anterior resection
33863|NCT03074461|Coloplasty Pouch|coloplasty pouch
33864|NCT03074461|Side-to-end Anastomosis|side-to-end anastomosis
33865|NCT03074461|Continence|continence
33866|NCT03074461|Quality of Life|quality of life
33867|NCT03074448|Colonoscopy|colonoscopy
33868|NCT03074448|Intestinal Cleaning|intestinal cleaning
33869|NCT03074448|Picoprep|picoprep
33870|NCT03074448|Aquanet|aquanet
33871|NCT03074422|Functional neurosurgery|functional neurosurgery
33872|NCT03074422|Pain management|pain management
33873|NCT03074422|Hypnosis|hypnosis
33874|NCT03074422|Stereotaxy|stereotaxy
33875|NCT03074422|Parkinson disease|parkinson disease
33876|NCT03074422|Essential tremor|essential tremor
33877|NCT03074422|Dystonia|dystonia
33878|NCT03074422|Invasive monitoring of epilepsy|invasive monitoring of epilepsy
33879|NCT03074409|Oxytocin|oxytocin
33880|NCT03074344|Dry Eye Syndrome|dry eye syndrome
33881|NCT03074344|artificial tear|artificial tear
33882|NCT03074344|CoQ10|coq10
33883|NCT03074344|Hyaluronic acid|hyaluronic acid
33884|NCT03074305|In-bioresorbable vascular scaffold restenosis|in-bioresorbable vascular scaffold restenosis
33885|NCT03074305|drug-eluting stent|drug-eluting stent
33886|NCT03074305|drug-eluting balloon|drug-eluting balloon
33887|NCT03074305|bioresorbable scaffold|bioresorbable scaffold
33888|NCT03074279|Epilepsy|epilepsy
33889|NCT03074279|SUDEP|sudep
33890|NCT03074279|case-control study|case-control study
33891|NCT03074279|risks factors|risks factors
33892|NCT03074240|Truncal block|truncal block
33893|NCT03074240|Surgical anesthesia|surgical anesthesia
33894|NCT03074240|Postoperative pain control|postoperative pain control
33895|NCT03074214|copeptin|copeptin
33898|NCT03074214|ST-elevation myocardial infarction|st-elevation myocardial infarction
33899|NCT03074214|percutaneous coronary intervention|percutaneous coronary intervention
33900|NCT03074201|ERCP, choledocholithiasis, cholangioscopy|ercp, choledocholithiasis, cholangioscopy
33901|NCT03074188|oral findings or oral manifestation|oral findings or oral manifestation
33902|NCT03074188|pre-dialysis stage or end stage renal disease|pre-dialysis stage or end stage renal disease
33903|NCT03074136|photodynamic therapy|photodynamic therapy
33904|NCT03074136|diode laser|diode laser
33905|NCT03074136|immature permanent teeth|immature permanent teeth
33906|NCT03074136|endodontic therapy|endodontic therapy
33907|NCT03074123|cosyntropin stimulation test|cosyntropin stimulation test
33908|NCT03074123|low-dose|low-dose
33909|NCT03074110|Inhalation Anaesthetics, Sevoflurane|inhalation anaesthetics, sevoflurane
33910|NCT03074110|Carbon Dioxide|carbon dioxide
33911|NCT03074110|Hyperventilation|hyperventilation
33912|NCT03074110|Anaesthesia Recovery Period|anaesthesia recovery period
33913|NCT03074110|Ventilators|ventilators
33914|NCT03074084|abdominal pain|abdominal pain
33915|NCT03074084|adult|adult
33916|NCT03074084|emergency department|emergency department
33918|NCT03074084|celiac disease|celiac disease
33919|NCT03074071|Disambiguation, Depression, Burnout|disambiguation, depression, burnout
33920|NCT03074045|Intrauterine|intrauterine
33921|NCT03074045|Birth control|birth control
33922|NCT03073993|nasogastric|nasogastric
33923|NCT03073993|orogastric|orogastric
33924|NCT03073993|nutrition|nutrition
33925|NCT03073993|preterm|preterm
33926|NCT03073993|feeding tube|feeding tube
33927|NCT03073993|insertion|insertion
33928|NCT03073993|episodes|episodes
33929|NCT03073993|bradycardia|bradycardia
33930|NCT03073993|desaturation|desaturation
33931|NCT03073980|in vitro fertilization|in vitro fertilization
33932|NCT03073980|oocyte retrieval|oocyte retrieval
33933|NCT03073980|acetaminophen|acetaminophen
33934|NCT03073980|postoperative pain control|postoperative pain control
33935|NCT03073954|Health Behavior|health behavior
33936|NCT03073954|Executive function|executive function
33937|NCT03073954|Working-memory training|working-memory training
33938|NCT03073954|Feasibility|feasibility
33939|NCT03073954|Impulsivity|impulsivity
33940|NCT03073941|Knee arthroplasty|knee arthroplasty
33941|NCT03073941|Knee function|knee function
33942|NCT03073941|Total knee replacement|total knee replacement
25612|NCT03125330|Well-being|well-being
33943|NCT03073941|Persona total knee system|persona total knee system
33944|NCT03073941|NexGen total knee system|nexgen total knee system
33945|NCT03073928|Nerve block|nerve block
33946|NCT03073928|Diaphragm function|diaphragm function
34147|NCT03072433|counseling|counseling
33947|NCT03073889|Aneurysm Clipping|aneurysm clipping
33948|NCT03073889|Scalp nerve block|scalp nerve block
33949|NCT03073889|Scalp infiltration|scalp infiltration
33950|NCT03073889|Ropivacaine|ropivacaine
33951|NCT03073876|Alzheimer Disease|alzheimer disease
33952|NCT03073876|Attention|attention
33953|NCT03073876|Donepezil hydrochloride|donepezil hydrochloride
33954|NCT03073863|LDL Cholesterol|ldl cholesterol
33955|NCT03073863|Statin intensity|statin intensity
33956|NCT03073863|post hoc analysis|post hoc analysis
33957|NCT03073863|Achieved LDL Cholesterol level|achieved ldl cholesterol level
33958|NCT03073811|protein supplementation|protein supplementation
33959|NCT03073811|older adults|older adults
33960|NCT03073811|nutrition perihabilitation|nutrition perihabilitation
33961|NCT03073811|perioperative optimization|perioperative optimization
33962|NCT03073798|Lung Disease|lung disease
33963|NCT03073798|Breathing Difficulty|breathing difficulty
33965|NCT03073798|Mucociliary|mucociliary
33966|NCT03073746|Google|google
33967|NCT03073746|Knowledge Panels|knowledge panels
33968|NCT03073746|Health Search|health search
33969|NCT03073746|Online|online
33970|NCT03073746|Internet|internet
33971|NCT03073746|Smartphone|smartphone
33972|NCT03073746|Tablet|tablet
33973|NCT03073746|Digital|digital
33974|NCT03073746|Mobile|mobile
33975|NCT03073746|Symptoms|symptoms
33976|NCT03073746|Differential diagnosis|differential diagnosis
33977|NCT03073746|Diagnosis|diagnosis
33978|NCT03073746|Anxiety|anxiety
33979|NCT03073707|Non-Typhoid Salmonella|non-typhoid salmonella
33980|NCT03073707|Invasive blood stream infections|invasive blood stream infections
33981|NCT03073707|Reservoir|reservoir
33982|NCT03073707|Household environment|household environment
33983|NCT03073707|Children|children
33984|NCT03073694|Peritoneal Surface Disease|peritoneal surface disease
33985|NCT03073694|mitomycin-c|mitomycin-c
33986|NCT03073694|melphalan|melphalan
33987|NCT03073694|Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC)|cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (crs-hipec)
33988|NCT03073694|Peritoneal Carcinomatosis|peritoneal carcinomatosis
33989|NCT03073681|cataract|cataract
33990|NCT03073655|shoulder pain|shoulder pain
33991|NCT03073655|shoulder function|shoulder function
33992|NCT03073642|Hydrotherapy|hydrotherapy
33993|NCT03073642|Pain education|pain education
33994|NCT03073577|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
33995|NCT03073577|Islet Transplantation|islet transplantation
33996|NCT03073577|Diabetes|diabetes
33997|NCT03073577|Diabetes Treatment|diabetes treatment
33998|NCT03073564|Dyspnea|dyspnea
33999|NCT03073564|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
34000|NCT03073564|Positive-Pressure Respiration|positive-pressure respiration
34001|NCT03073525|Stage IIIb|stage iiib
34002|NCT03073525|Stage IV|stage iv
34003|NCT03073525|Ovarian Cancer|ovarian cancer
34004|NCT03073525|Cervical Cancer|cervical cancer
34005|NCT03073525|Uterine Cancer|uterine cancer
34006|NCT03073525|Immunotherapy|immunotherapy
34007|NCT03073447|Myocardial infarction|myocardial infarction
34008|NCT03073447|Women|women
34009|NCT03073447|Young|young
34010|NCT03073447|Primary PCI|primary pci
34011|NCT03073447|Hormone|hormone
34012|NCT03073408|Propofol|propofol
34013|NCT03073408|Bispectral index (BIS)|bispectral index (bis)
34014|NCT03073408|Closed loop|closed loop
34015|NCT03073356|Myocardial metabolism|myocardial metabolism
34016|NCT03073356|Positron emission tomography|positron emission tomography
34017|NCT03073356|Echocardiography|echocardiography
34018|NCT03073356|Right sided heart catheterization|right sided heart catheterization
34019|NCT03073317|Preterm Infants|preterm infants
34020|NCT03073317|Premature Birth|premature birth
34021|NCT03073317|Placenta growth factor|placenta growth factor
34022|NCT03073317|Prenatal Care|prenatal care
34023|NCT03073317|PERINATAL MORTALITY|perinatal mortality
34024|NCT03073317|Pre-Eclampsia|pre-eclampsia
34025|NCT03073304|isolated limb perfusion|isolated limb perfusion
34026|NCT03073291|cannabis|cannabis
34027|NCT03073291|commerce|commerce
34028|NCT03073265|DOAC|doac
34029|NCT03073265|apixaban|apixaban
34031|NCT03073239|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
34032|NCT03073239|Bulbar disfunction|bulbar disfunction
34033|NCT03073239|Rik factors ALS|rik factors als
34034|NCT03073200|children|children
34035|NCT03073200|psoriasis treatment|psoriasis treatment
34036|NCT03073200|adolescents|adolescents
34037|NCT03073187|Asthma|asthma
34038|NCT03073187|Sleep|sleep
34039|NCT03073187|Adolescents|adolescents
34040|NCT03073187|Urban|urban
34041|NCT03073187|Intervention|intervention
34042|NCT03073187|High school|high school
34043|NCT03073174|dietary intake|dietary intake
25729|NCT03124160|IUD|iud
34044|NCT03073174|nutritional supplements|nutritional supplements
34045|NCT03073174|sanative therapy|sanative therapy
34046|NCT03073174|healing|healing
34047|NCT03073174|flavonoids|flavonoids
34048|NCT03073174|tea|tea
34049|NCT03073161|flavonoids|flavonoids
34050|NCT03073161|tea|tea
34051|NCT03073161|dietary intake|dietary intake
34052|NCT03073161|nutritional supplements|nutritional supplements
34053|NCT03073161|periodontal disease|periodontal disease
34054|NCT03073161|healing|healing
34055|NCT03073161|sanative therapy|sanative therapy
34056|NCT03073096|axillary nodal dissection|axillary nodal dissection
34057|NCT03073096|groin nodal dissection|groin nodal dissection
34058|NCT03073083|autograft|autograft
34059|NCT03073070|diabetic children|diabetic children
34060|NCT03073070|RBC lifespan|rbc lifespan
34061|NCT03073044|Quality of life|quality of life
34062|NCT03073044|psychosocial and psychological problems|psychosocial and psychological problems
34063|NCT03073005|ventricular assist device (VAD)|ventricular assist device (vad)
34064|NCT03073005|heart failure|heart failure
34065|NCT03073005|simulation|simulation
34066|NCT03072966|Distress|distress
34067|NCT03072966|Exercise|exercise
34068|NCT03072966|Wearable device|wearable device
34069|NCT03072966|Smartphone|smartphone
34070|NCT03072927|Lumbar Spinal Stenosis|lumbar spinal stenosis
34071|NCT03072927|Interspinous process decompression|interspinous process decompression
34072|NCT03072927|MILD|mild
34073|NCT03072927|Medicare|medicare
34074|NCT03072888|acute pain|acute pain
34075|NCT03072888|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
34076|NCT03072888|Anesthesia Recovery Period|anesthesia recovery period
34077|NCT03072875|Suicidality|suicidality
34078|NCT03072875|Collaborative Assessment and Management of Suicidality|collaborative assessment and management of suicidality
34079|NCT03072875|Technology|technology
34080|NCT03072875|Suicide Prevention|suicide prevention
34081|NCT03072875|Suicide Intervention|suicide intervention
34082|NCT03072862|Cochlear implant treatment, aging adults|cochlear implant treatment, aging adults
34083|NCT03072849|Pediatrics|pediatrics
34084|NCT03072849|Airflow obstruction|airflow obstruction
34085|NCT03072849|Chronic graft-vs-host disease|chronic graft-vs-host disease
34086|NCT03072849|Bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
34087|NCT03072823|CVDs|cvds
620702|NCT00657566|antibiotics|antibiotics
34088|NCT03072823|cardiovascular diseases|cardiovascular diseases
34089|NCT03072823|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
34090|NCT03072823|depression|depression
34091|NCT03072810|Positive psychology|positive psychology
34092|NCT03072810|Wellbeing|wellbeing
34093|NCT03072810|Chronic pain|chronic pain
34094|NCT03072810|Mindfulness|mindfulness
34095|NCT03072797|Atherosclerosis|atherosclerosis
34096|NCT03072797|Longitudinal|longitudinal
34097|NCT03072797|Biomarker|biomarker
34098|NCT03072797|Coronary angiography|coronary angiography
34099|NCT03072797|Follow-up|follow-up
34100|NCT03072797|Metabolomics|metabolomics
34101|NCT03072797|Risk factor|risk factor
34102|NCT03072758|Male partner involvement|male partner involvement
34103|NCT03072745|Cognitive Impairment|cognitive impairment
34104|NCT03072706|hip replacement|hip replacement
34105|NCT03072706|acetabulum|acetabulum
34106|NCT03072706|anteversion|anteversion
34107|NCT03072706|position|position
34108|NCT03072706|guide|guide
34109|NCT03072667|prematurity|prematurity
34110|NCT03072667|bowel atresia|bowel atresia
34111|NCT03072667|necrotizing entercolitis|necrotizing entercolitis
34112|NCT03072667|parenteral nutrition associated liver disease (PNALD)|parenteral nutrition associated liver disease (pnald)
34113|NCT03072667|intestinal failure|intestinal failure
34114|NCT03072667|parenteral nutrition associated cholestasis|parenteral nutrition associated cholestasis
34115|NCT03072667|fish oil|fish oil
34116|NCT03072641|Probiotics|probiotics
34117|NCT03072641|Epigenetics|epigenetics
34118|NCT03072641|Microbiota|microbiota
34119|NCT03072628|nicotine|nicotine
34120|NCT03072628|sympathetic nerve activity|sympathetic nerve activity
34121|NCT03072628|oxidative stress|oxidative stress
34122|NCT03072602|Racial differences|racial differences
34123|NCT03072576|Diagnosis|diagnosis
34124|NCT03072576|Xpert MTB/RIF|xpert mtb/rif
34125|NCT03072576|Ultra Xpert MTB/RIF|ultra xpert mtb/rif
34126|NCT03072550|fungal nail|fungal nail
34127|NCT03072550|toenail fungus|toenail fungus
34128|NCT03072537|growth, BMI, obesity, overweight, weight, height, childhood, adolescence, development|growth, bmi, obesity, overweight, weight, height, childhood, adolescence, development
34129|NCT03072524|pre-hospital stroke scale test|pre-hospital stroke scale test
34130|NCT03072524|severe hemiparesis|severe hemiparesis
34131|NCT03072524|large vessel occlusion|large vessel occlusion
34132|NCT03072524|mechanical thrombectomy|mechanical thrombectomy
34133|NCT03072485|aging|aging
34134|NCT03072472|Colorectal Cancer|colorectal cancer
34135|NCT03072472|Endoscopy|endoscopy
34136|NCT03072472|Screening|screening
34137|NCT03072472|Colonic Adenoma|colonic adenoma
34138|NCT03072472|Adenoma Detection Rate|adenoma detection rate
34139|NCT03072472|Endocuff|endocuff
34140|NCT03072472|Endocuff Vision|endocuff vision
34141|NCT03072446|Uterine Fibroid|uterine fibroid
34142|NCT03072446|Embolization|embolization
34143|NCT03072446|symptoms|symptoms
34144|NCT03072446|Gel-Beads|gel-beads
34145|NCT03072433|child malnutrition|child malnutrition
34146|NCT03072433|child development|child development
34148|NCT03072420|MRI, fingers compression|mri, fingers compression
34150|NCT03072381|epicondylosis|epicondylosis
34151|NCT03072381|platelet rich plasma|platelet rich plasma
34152|NCT03072381|PRP|prp
34153|NCT03072381|ultrasound|ultrasound
34154|NCT03072381|shear wave ultrasound|shear wave ultrasound
34155|NCT03072381|tendinopathy|tendinopathy
34156|NCT03072381|elbow|elbow
34157|NCT03072381|tenis elbow|tenis elbow
34158|NCT03072381|plasma|plasma
34159|NCT03072381|plasma injection|plasma injection
34160|NCT03072381|tendinosis|tendinosis
34161|NCT03072381|tendinitis|tendinitis
34162|NCT03072355|fatigue|fatigue
34163|NCT03072355|resistance test|resistance test
34164|NCT03072316|breast cancer|breast cancer
34165|NCT03072316|mastectomy|mastectomy
34166|NCT03072316|deep inferior perforator flap reconstruction|deep inferior perforator flap reconstruction
34167|NCT03072316|post mastectomy radiotherapy|post mastectomy radiotherapy
34168|NCT03072303|Brittle Bone|brittle bone
34169|NCT03072303|Osteogenesis Imperfecta|osteogenesis imperfecta
34170|NCT03072303|BBD|bbd
34171|NCT03072303|OI|oi
34172|NCT03072303|Congenital Abnormalities|congenital abnormalities
34173|NCT03072303|Congenital Bone Disorder|congenital bone disorder
34174|NCT03072303|Lobstein Syndrome|lobstein syndrome
34175|NCT03072277|DHA|dha
34176|NCT03072277|Docosa Hexaenoic Acid|docosa hexaenoic acid
34177|NCT03072277|Omega 3 fatty acid|omega 3 fatty acid
34178|NCT03072277|Newborn Outcome|newborn outcome
34179|NCT03072277|Birth Size|birth size
34180|NCT03072277|Gestational Age|gestational age
34181|NCT03072277|DASII|dasii
34182|NCT03072277|Prenatal Supplementation|prenatal supplementation
34183|NCT03072277|Randomized Controlled Trial|randomized controlled trial
34184|NCT03072277|Neurodevelopment|neurodevelopment
34185|NCT03072264|Generalized Anxiety Disorder, GAD, mindfulness, anxiety|generalized anxiety disorder, gad, mindfulness, anxiety
583397|NCT00511576|Advanced Gastric Adenocarcinoma|advanced gastric adenocarcinoma
34186|NCT03072238|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
34187|NCT03072225|herbal medicine|herbal medicine
34188|NCT03072225|stroke|stroke
34189|NCT03072225|vulnerable plaques of carotid artery|vulnerable plaques of carotid artery
34190|NCT03072212|HIV|hiv
34191|NCT03072212|Stroke|stroke
34192|NCT03072212|Cerebral vascular accident|cerebral vascular accident
34193|NCT03072212|Uganda|uganda
34194|NCT03072199|Rituximab|rituximab
34195|NCT03072199|B cells|b cells
34196|NCT03072160|Anti-PD1/PDL1|anti-pd1/pdl1
34197|NCT03072160|Vaccine Therapy|vaccine therapy
34198|NCT03072160|TKI-Naive|tki-naive
34199|NCT03072134|Glioma|glioma
34200|NCT03072134|Glioblastoma|glioblastoma
34201|NCT03072134|Astrocytoma|astrocytoma
34202|NCT03072134|Brain Cancer|brain cancer
34203|NCT03072134|New Diagnosed Glioma|new diagnosed glioma
34204|NCT03072134|Temozolomide|temozolomide
34205|NCT03072134|Radiation|radiation
34206|NCT03072134|Neural Stem Cells|neural stem cells
34207|NCT03072134|Virotherapy|virotherapy
34208|NCT03072134|Adenovirus|adenovirus
34209|NCT03072134|Oncolytic virotherapy|oncolytic virotherapy
34210|NCT03072121|coronary artery disease|coronary artery disease
34211|NCT03072121|revascularization|revascularization
34212|NCT03072121|Shexiang Baoxin Pill|shexiang baoxin pill
34213|NCT03072095|Colorectal Neoplasms|colorectal neoplasms
34214|NCT03072095|Colonic Neoplasms|colonic neoplasms
34215|NCT03072095|Gastrointestinal Neoplasms|gastrointestinal neoplasms
34216|NCT03072095|Digestive System Neoplasms|digestive system neoplasms
34218|NCT03072095|Digestive System Diseases|digestive system diseases
34219|NCT03072095|Gastrointestinal Diseases|gastrointestinal diseases
34220|NCT03072095|Colonic Diseases|colonic diseases
34221|NCT03072095|Rectal Diseases|rectal diseases
34222|NCT03072082|coronary artery disease|coronary artery disease
34223|NCT03072082|revascularization|revascularization
34224|NCT03072082|Danlou Tablet|danlou tablet
34225|NCT03072043|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
34226|NCT03072043|TP53 mutant myelodysplastic syndrome|tp53 mutant myelodysplastic syndrome
34227|NCT03072043|MDS/myeloproliferative neoplasm (MPN)|mds/myeloproliferative neoplasm (mpn)
34228|NCT03072043|chronic myelomonocytic leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
34229|NCT03072043|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
34230|NCT03072030|Ebola Virus Disease|ebola virus disease
34231|NCT03072030|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
34232|NCT03072030|Vaccines|vaccines
34233|NCT03072030|GP protein, Ebola virus|gp protein, ebola virus
34234|NCT03072030|Ebola Virus Vaccines|ebola virus vaccines
34235|NCT03072004|Leprosy|leprosy
34236|NCT03072004|Neuropathy|neuropathy
34237|NCT03072004|LLLT|lllt
34238|NCT03071991|preinsicional bupivacain|preinsicional bupivacain
34239|NCT03071991|laparoscopic bariatric surgery|laparoscopic bariatric surgery
34240|NCT03071991|postoperative pain|postoperative pain
34241|NCT03071978|Heart Failure|heart failure
34242|NCT03071978|LV-fusion pacing|lv-fusion pacing
34243|NCT03071978|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
34244|NCT03071952|Heart Failure|heart failure
34245|NCT03071952|Chronotropic Incompetence|chronotropic incompetence
34246|NCT03071952|Rate Response|rate response
34247|NCT03071952|Exercise Test|exercise test
34248|NCT03071874|Meningioma|meningioma
34249|NCT03071861|darbepoetin|darbepoetin
34250|NCT03071861|Brain Diseases|brain diseases
34251|NCT03071835|Stem Cells|stem cells
34252|NCT03071835|Cardiovascular|cardiovascular
34253|NCT03071835|Quality of Life|quality of life
34254|NCT03071835|Cardiomyopathy|cardiomyopathy
34255|NCT03071822|PTCLs|ptcls
34256|NCT03071809|Solid tumor|solid tumor
34257|NCT03071809|carcinoma|carcinoma
34258|NCT03071809|sarcoma|sarcoma
34259|NCT03071809|stage I|stage i
34260|NCT03071809|stage II|stage ii
34261|NCT03071809|stage III|stage iii
34262|NCT03071770|Healthy Volunteers|healthy volunteers
34263|NCT03071770|Japanese|japanese
34264|NCT03071770|Caucasian|caucasian
34265|NCT03071757|Cholangiocarcinoma|cholangiocarcinoma
34266|NCT03071757|Merkel cell carcinoma|merkel cell carcinoma
34267|NCT03071757|Mesothelioma|mesothelioma
34268|NCT03071757|Metastatic Solid Tumors|metastatic solid tumors
34269|NCT03071757|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
34270|NCT03071757|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
34271|NCT03071757|Triple negative breast cancer|triple negative breast cancer
34272|NCT03071757|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
34273|NCT03071757|Ovarian cancer|ovarian cancer
34274|NCT03071757|Cancer|cancer
34275|NCT03071757|Gastric cancer|gastric cancer
34276|NCT03071757|Solid Tumors|solid tumors
34277|NCT03071757|Melanoma|melanoma
34278|NCT03071757|Advanced Solid Tumors|advanced solid tumors
34279|NCT03071731|Glittre|glittre
34280|NCT03071731|COPD|copd
34281|NCT03071731|sit-to-stand|sit-to-stand
34282|NCT03071731|responsiveness|responsiveness
34283|NCT03071731|bronchodilation|bronchodilation
34284|NCT03071718|cardiovascular diseases|cardiovascular diseases
34285|NCT03071718|gut microbiota|gut microbiota
34286|NCT03071718|Mediterranean diet|mediterranean diet
34287|NCT03071705|NSCLC|nsclc
34288|NCT03071705|metformin|metformin
34289|NCT03071705|metformin plus TKI|metformin plus tki
34290|NCT03071705|EGFR positive status|egfr positive status
34291|NCT03071666|Nepal|nepal
34292|NCT03071666|South Asia|south asia
34293|NCT03071666|Nutrition|nutrition
34294|NCT03071666|Pregnancy|pregnancy
34295|NCT03071666|Neurodevelopment|neurodevelopment
34296|NCT03071666|Growth|growth
34297|NCT03071653|Cardiomyopathy|cardiomyopathy
34298|NCT03071653|Left Cardiac Sympathetic Denervation|left cardiac sympathetic denervation
34300|NCT03071640|elderly|elderly
34301|NCT03071640|radiotherapy|radiotherapy
34302|NCT03071640|geriatric assessment|geriatric assessment
34303|NCT03071627|Spin|spin
34304|NCT03071627|Misleading reporting|misleading reporting
34305|NCT03071627|Misleading interpretation|misleading interpretation
34306|NCT03071627|Misleading extrapolation|misleading extrapolation
34307|NCT03071627|Animal studies|animal studies
34308|NCT03071627|Cell culture studies|cell culture studies
34309|NCT03071627|Pre-clinical studies|pre-clinical studies
34310|NCT03071614|Spin, misleading reporting, misleading interpretation, misleading extrapolation, animal studies, cell culture studies, pre-clinical studies|spin, misleading reporting, misleading interpretation, misleading extrapolation, animal studies, cell culture studies, pre-clinical studies
34311|NCT03071614|Misleading reporting|misleading reporting
34312|NCT03071614|Misleading interpretation|misleading interpretation
34313|NCT03071614|Misleading extrapolation|misleading extrapolation
34315|NCT03071614|Cell culture studies|cell culture studies
34316|NCT03071614|Pre-clinical studies|pre-clinical studies
34317|NCT03071601|Laceration|laceration
34318|NCT03071601|Suture|suture
34319|NCT03071601|Topical anesthesia|topical anesthesia
34320|NCT03071601|Lidocaine|lidocaine
34321|NCT03071575|measles|measles
34322|NCT03071575|rubella|rubella
34323|NCT03071575|immunogenicity|immunogenicity
34324|NCT03071575|congenital rubella syndrome|congenital rubella syndrome
34325|NCT03071575|measles-rubella vaccine|measles-rubella vaccine
34326|NCT03071562|HIV|hiv
34327|NCT03071562|Cognitive impairment|cognitive impairment
34328|NCT03071562|Aging|aging
34329|NCT03071562|Physical Activity|physical activity
34330|NCT03071562|Exercise|exercise
34331|NCT03071562|Yoga|yoga
34332|NCT03071562|Neuroplasticity|neuroplasticity
34333|NCT03071549|Acne vulgaris|acne vulgaris
34334|NCT03071549|Chemical peeling|chemical peeling
34335|NCT03071549|Dermoscopy|dermoscopy
34336|NCT03071536|furosemide stress test|furosemide stress test
34337|NCT03071536|kidney transplantation|kidney transplantation
34338|NCT03071536|urine output|urine output
34339|NCT03071536|perioperation|perioperation
34340|NCT03071536|delayed graft function|delayed graft function
34341|NCT03071497|Iron-deficiency|iron-deficiency
34342|NCT03071497|Anemia|anemia
34343|NCT03071497|Iron-deficiency Anemia|iron-deficiency anemia
34344|NCT03071497|Zinc protoporphyrin|zinc protoporphyrin
34345|NCT03071484|Early Stages of Psychosis|early stages of psychosis
34346|NCT03071484|Schizophrenia|schizophrenia
34347|NCT03071484|Transcranial Direct Current Stimulation|transcranial direct current stimulation
34348|NCT03071484|Cognitive Symptomatology|cognitive symptomatology
34349|NCT03071484|Double-blind Randomized Controlled Trial|double-blind randomized controlled trial
34350|NCT03071419|fathers|fathers
34361|NCT03071393|acute intermittent hypoxia|acute intermittent hypoxia
34363|NCT03071393|breathing|breathing
34364|NCT03071393|standing|standing
34365|NCT03071393|sitting|sitting
34366|NCT03071393|spinal cord injury|spinal cord injury
34367|NCT03071367|Airway Management|airway management
34368|NCT03071367|Medical students|medical students
34369|NCT03071367|Intratracheal intubation|intratracheal intubation
34370|NCT03071367|Educational Technology|educational technology
34371|NCT03071354|ICU-acquired weakness|icu-acquired weakness
34372|NCT03071341|MPS I; Hurler Syndrome|mps i; hurler syndrome
34373|NCT03071315|Economic evaluation|economic evaluation
34374|NCT03071315|Heroin dependence|heroin dependence
34375|NCT03071315|Compulsory treatment|compulsory treatment
34376|NCT03071315|Methadone treatment|methadone treatment
34377|NCT03071315|Vietnam|vietnam
34378|NCT03071315|East and Southeast Asia|east and southeast asia
34379|NCT03071315|Cost-effectiveness|cost-effectiveness
34380|NCT03071302|Keratoconus,Corneal Dystrophies, corneal Tomography, topography|keratoconus,corneal dystrophies, corneal tomography, topography
34381|NCT03071263|Treatment of Hyperkalemia|treatment of hyperkalemia
34382|NCT03071263|Hyperkalemia|hyperkalemia
34383|NCT03071263|Potassium|potassium
34384|NCT03071263|Chronic Kidney Disease|chronic kidney disease
34385|NCT03071263|Hypertension|hypertension
34386|NCT03071263|Resistant Hypertension|resistant hypertension
34387|NCT03071263|Spironolactone|spironolactone
34388|NCT03071237|infrapyloric artery|infrapyloric artery
34401|NCT03071159|Usability|usability
34402|NCT03071159|Metabolic control|metabolic control
34403|NCT03071055|Macular Degeneration|macular degeneration
34405|NCT03071055|Wet AMD|wet amd
34406|NCT03071055|Lucentis|lucentis
34407|NCT03071029|family planning|family planning
34408|NCT03071029|reproductive health|reproductive health
34409|NCT03071029|abortion|abortion
34410|NCT03071029|health providers|health providers
34411|NCT03071016|T2D,|t2d,
34412|NCT03071016|Type 2 Diabetes,|type 2 diabetes,
34413|NCT03071016|T2DM|t2dm
34414|NCT03071003|Pharmacokinetics|pharmacokinetics
34415|NCT03071003|Healthy Volunteer Study|healthy volunteer study
34416|NCT03070990|Enfortumab vedotin|enfortumab vedotin
34417|NCT03070990|ASG-22CE|asg-22ce
34418|NCT03070990|ASG-22ME|asg-22me
34419|NCT03070990|Metastatic Urothelial Cancer|metastatic urothelial cancer
34420|NCT03070977|Interprofessional education|interprofessional education
34421|NCT03070977|study unit|study unit
34422|NCT03070977|Psychiatry|psychiatry
34423|NCT03070951|Uterine Fibroid|uterine fibroid
34424|NCT03070951|Leiomyomata|leiomyomata
34425|NCT03070951|Heavy Menstrual Bleeding|heavy menstrual bleeding
34426|NCT03070951|HMB|hmb
34427|NCT03070951|Heavy Uterine Bleeding|heavy uterine bleeding
34428|NCT03070951|Menorrhagia|menorrhagia
34429|NCT03070951|OBE2109 + Add-back|obe2109 + add-back
34443|NCT03070912|mechanical circulatory support|mechanical circulatory support
34444|NCT03070912|bleeding, acquired von willebrand disease|bleeding, acquired von willebrand disease
34445|NCT03070912|acquired von willebrand disease|acquired von willebrand disease
34446|NCT03070899|Uterine Fibroid|uterine fibroid
34447|NCT03070899|Leiomyomata|leiomyomata
34448|NCT03070899|Heavy Menstrual Bleeding|heavy menstrual bleeding
34450|NCT03070899|Heavy Uterine Bleeding|heavy uterine bleeding
34451|NCT03070899|Menorrhagia|menorrhagia
34452|NCT03070899|OBE2109 + Add-back|obe2109 + add-back
34453|NCT03070873|Quality of life|quality of life
34454|NCT03070873|Vaginal mesh|vaginal mesh
34455|NCT03070873|Mesh complications|mesh complications
34456|NCT03070860|Low Grade Chronic vascular and skin Inflammation|low grade chronic vascular and skin inflammation
34457|NCT03070860|Molecular vascular and skin Calcification|molecular vascular and skin calcification
34458|NCT03070860|Calcium Score|calcium score
34459|NCT03070847|tranexamic acid|tranexamic acid
34460|NCT03070847|rhinoplasty|rhinoplasty
34461|NCT03070847|bleeding reduction|bleeding reduction
34462|NCT03070821|neurofeedback|neurofeedback
34463|NCT03070821|real-time functional MRI|real-time functional mri
34464|NCT03070821|parahippocampus|parahippocampus
34465|NCT03070808|obesity|obesity
34466|NCT03070808|voice|voice
34467|NCT03070795|post-operative ileus|post-operative ileus
34468|NCT03070795|early feeding|early feeding
26118|NCT03121768|BCG|bcg
34469|NCT03070795|delayed feeding|delayed feeding
34483|NCT03070756|auto-CPAP|auto-cpap
34484|NCT03070756|forced oscillation technique|forced oscillation technique
34485|NCT03070756|obstructive sleep apnea|obstructive sleep apnea
34486|NCT03070743|basilar invagination|basilar invagination
34487|NCT03070743|atlantoaxial dislocation|atlantoaxial dislocation
34488|NCT03070743|surgery|surgery
34489|NCT03070743|restoration technique|restoration technique
34490|NCT03070730|Tachycardia|tachycardia
34491|NCT03070730|orthostatic symptoms|orthostatic symptoms
34492|NCT03070730|autonomic reflex|autonomic reflex
34493|NCT03070717|High myopia, shortsightedness, retinal changes|high myopia, shortsightedness, retinal changes
34494|NCT03070691|Basal cell carcinoma|basal cell carcinoma
34495|NCT03070691|Nevoid Basal Cell Carcinoma Syndrome|nevoid basal cell carcinoma syndrome
34496|NCT03070691|NBCCS, Gorlin syndrome|nbccs, gorlin syndrome
34497|NCT03070691|Gorlin-Goltz Syndrome|gorlin-goltz syndrome
34498|NCT03070691|Basal Cell Nevus Syndrome|basal cell nevus syndrome
621399|NCT00666445|Diagnosis|diagnosis
34502|NCT03070665|endoscopic submucosal dissection|endoscopic submucosal dissection
34504|NCT03070652|attachment|attachment
34505|NCT03070652|bonding psychological|bonding psychological
34506|NCT03070626|General Surgery|general surgery
34507|NCT03070626|Carbohydrates|carbohydrates
34508|NCT03070626|Perioperative|perioperative
34509|NCT03070613|Colonoscopy|colonoscopy
34510|NCT03070613|Fluorescence guided surgery|fluorescence guided surgery
34511|NCT03070600|PrEP|prep
34512|NCT03070574|Lynch Syndrome|lynch syndrome
34513|NCT03070574|Chemoprevention|chemoprevention
34514|NCT03070574|Mesalazine|mesalazine
34515|NCT03070535|APOE E4; cognition; metabolic markers; beta-amyloid|apoe e4; cognition; metabolic markers; beta-amyloid
34516|NCT03070496|Myocardial infarction|myocardial infarction
34517|NCT03070496|bio-collection|bio-collection
34518|NCT03070496|Imaging markers|imaging markers
34519|NCT03070496|biomarkers|biomarkers
34520|NCT03070496|STEMI|stemi
34521|NCT03070496|clinical outcomes|clinical outcomes
34522|NCT03070457|bariatric surgery|bariatric surgery
34523|NCT03070457|sleeve gastrectomy|sleeve gastrectomy
34524|NCT03070457|eras|eras
34525|NCT03070444|Essix retainer|essix retainer
34526|NCT03070444|Cuspid-to-cuspid retainer|cuspid-to-cuspid retainer
34527|NCT03070431|spinal cord compression, radiotherapy|spinal cord compression, radiotherapy
34528|NCT03070418|DHS|dhs
34529|NCT03070418|DCS|dcs
34530|NCT03070418|Boyd and Griffin Classification|boyd and griffin classification
34531|NCT03070405|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
34532|NCT03070405|4-Aminosalicylic Acid|4-aminosalicylic acid
34533|NCT03070405|Tuberculosis|tuberculosis
34534|NCT03070405|HIV|hiv
34539|NCT03070366|Oligometastasis|oligometastasis
34540|NCT03070366|stereotactic irradiation|stereotactic irradiation
34541|NCT03070353|Cirrhosis|cirrhosis
34542|NCT03070353|AKI|aki
34543|NCT03070353|Albumin|albumin
34544|NCT03070353|Dextran|dextran
34545|NCT03070340|mastectomy|mastectomy
34546|NCT03070340|breast MRI|breast mri
34547|NCT03070340|contrast enhanced mammography|contrast enhanced mammography
34548|NCT03070340|CEDM|cedm
34549|NCT03070340|17-045|17-045
34550|NCT03070327|B-cell Maturation Antigen (BCMA)|b-cell maturation antigen (bcma)
34955|NCT03067922|Severity|severity
34551|NCT03070327|Targeted EGFRt/BCMA-41BBz|targeted egfrt/bcma-41bbz
34552|NCT03070327|Chimeric antigen receptor (CAR)|chimeric antigen receptor (car)
34553|NCT03070327|17-025|17-025
34554|NCT03070314|Echinacea|echinacea
34555|NCT03070314|bioavailability|bioavailability
34556|NCT03070314|children|children
34557|NCT03070301|LEE011|lee011
34558|NCT03070301|Everolimus|everolimus
34559|NCT03070301|16-1535|16-1535
34560|NCT03070288|RGB|rgb
34561|NCT03070288|red-green-blue|red-green-blue
34562|NCT03070288|rhinitis|rhinitis
34563|NCT03070288|allergic rhinitis|allergic rhinitis
34564|NCT03070288|nasal mucosa|nasal mucosa
34565|NCT03070275|surgical implant placement|surgical implant placement
34566|NCT03070275|crestal bone|crestal bone
34567|NCT03070275|mucosa thickness|mucosa thickness
34568|NCT03070275|stem cells|stem cells
34569|NCT03070275|fibrin glue|fibrin glue
34570|NCT03070275|collagen fleece|collagen fleece
34571|NCT03070262|esophageal cancer|esophageal cancer
34572|NCT03070262|caffeic acid|caffeic acid
34573|NCT03070249|Emergency Department|emergency department
34574|NCT03070236|Breast Cancer|breast cancer
34575|NCT03070184|Racial differences|racial differences
34576|NCT03070158|Premature Infant|premature infant
34577|NCT03070158|Mother-Infant Interaction|mother-infant interaction
34578|NCT03070158|Acoustic stimulation/methods|acoustic stimulation/methods
34579|NCT03070158|Touch|touch
34580|NCT03070158|Visual Stimulation|visual stimulation
34581|NCT03070158|Vestibule, Labyrinth/physiology|vestibule, labyrinth/physiology
34582|NCT03070145|Prostate Cancer|prostate cancer
34583|NCT03070093|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
34584|NCT03070093|FMS-like Tyrosine kinase-3 (FLT3) mutations|fms-like tyrosine kinase-3 (flt3) mutations
34585|NCT03070093|gilteritinib|gilteritinib
34586|NCT03070093|Expanded access|expanded access
34587|NCT03070093|ASP2215|asp2215
34588|NCT03070015|Weight Loss|weight loss
34589|NCT03070015|Obesity|obesity
34590|NCT03070015|Overweight|overweight
34591|NCT03069989|Tolerability|tolerability
34592|NCT03069989|IPF|ipf
34593|NCT03069989|PET imaging|pet imaging
34594|NCT03069989|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
34595|NCT03069989|Safety|safety
34596|NCT03069989|Pharmacokinetics|pharmacokinetics
34597|NCT03069989|Double-blind|double-blind
34598|NCT03069950|Hepatic Arterial Infusion|hepatic arterial infusion
34599|NCT03069950|Floxuridine (FUDR)|floxuridine (fudr)
34600|NCT03069950|Irinotecan (CPT-11)|irinotecan (cpt-11)
34601|NCT03069950|FLUOROURACIL|fluorouracil
34602|NCT03069950|PANITUMUMAB|panitumumab
34603|NCT03069950|16-1341|16-1341
34604|NCT03069911|Parkinson Disease|parkinson disease
34605|NCT03069911|Parkinsonism|parkinsonism
34606|NCT03069911|Depression|depression
34607|NCT03069911|OnabotulinumtoxinA|onabotulinumtoxina
34608|NCT03069911|BOTOX|botox
34609|NCT03069898|Marital relationship|marital relationship
34610|NCT03069872|Transvaginal ultrasound|transvaginal ultrasound
34611|NCT03069872|General practice|general practice
34612|NCT03069872|Early diagnosis|early diagnosis
34613|NCT03069872|Symptoms|symptoms
34614|NCT03069859|Post partum hemorrhage|post partum hemorrhage
34615|NCT03069859|Tranexamic acid|tranexamic acid
34616|NCT03069859|Spontaneous vaginal delivery|spontaneous vaginal delivery
34617|NCT03069859|C-section|c-section
34618|NCT03069846|skin cancer|skin cancer
34619|NCT03069846|laser spectroscopy|laser spectroscopy
34620|NCT03069846|non-invasive diagnostics|non-invasive diagnostics
34621|NCT03069781|estrogen|estrogen
34622|NCT03069768|Nicotine addiction|nicotine addiction
34623|NCT03069768|Cigarette smoking|cigarette smoking
34624|NCT03069768|Smoking cessation|smoking cessation
34625|NCT03069768|Quit smoking|quit smoking
34626|NCT03069755|India|india
34627|NCT03069755|Perioperative mortality|perioperative mortality
34628|NCT03069755|Trauma|trauma
34629|NCT03069755|Surgery|surgery
34630|NCT03069742|Breast Cancer Prevention|breast cancer prevention
34631|NCT03069742|Risk Assessment|risk assessment
34632|NCT03069742|Chemoprevention|chemoprevention
34633|NCT03069742|Decision Making|decision making
34634|NCT03069729|screen|screen
34635|NCT03069716|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
34636|NCT03069703|Vaccine|vaccine
34637|NCT03069703|ANCA- associated vasculitides|anca- associated vasculitides
34638|NCT03069703|pneumo 23|pneumo 23
34639|NCT03069703|prevenar|prevenar
34640|NCT03069703|pneumovas|pneumovas
34641|NCT03069677|midazolam|midazolam
34642|NCT03069664|Pancreatic Cancer|pancreatic cancer
34643|NCT03069664|Pancreatic Duct Stricture|pancreatic duct stricture
34644|NCT03069664|Endoscopic treatment|endoscopic treatment
34645|NCT03069638|sedation|sedation
34646|NCT03069638|pediatrics|pediatrics
34647|NCT03069638|intranasal sedation|intranasal sedation
34648|NCT03069638|dexmedetomidine|dexmedetomidine
34649|NCT03069638|dinitrous oxide|dinitrous oxide
34775|NCT03068936|Cisplatin|cisplatin
34650|NCT03069638|intra-articular joint injection|intra-articular joint injection
34651|NCT03069625|Cystic Fibrosis|cystic fibrosis
34652|NCT03069625|Exercise Testing|exercise testing
34653|NCT03069625|Muscular strength|muscular strength
34654|NCT03069625|Pediatrics|pediatrics
34655|NCT03069625|Quality of life|quality of life
34656|NCT03069612|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
34657|NCT03069612|working memory|working memory
34658|NCT03069612|gamma oscillations|gamma oscillations
34659|NCT03069612|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
34660|NCT03069573|Eosinophilic Esophagitis|eosinophilic esophagitis
34661|NCT03069573|Gastroesophageal Reflux|gastroesophageal reflux
34662|NCT03069573|Diagnose|diagnose
34663|NCT03069573|Biomarker|biomarker
34664|NCT03069560|suicide attempt|suicide attempt
34665|NCT03069560|SMS monitoring|sms monitoring
34666|NCT03069560|Phone|phone
34667|NCT03069560|Prevention control|prevention control
34668|NCT03069560|tertiary healthcare|tertiary healthcare
34669|NCT03069534|MDR-TB|mdr-tb
34670|NCT03069534|rhIL-2|rhil-2
34671|NCT03069534|immunotherapy|immunotherapy
34672|NCT03069495|Allergy|allergy
34673|NCT03069495|Asthma|asthma
34674|NCT03069495|Urticaria|urticaria
34675|NCT03069482|Smoking|smoking
34676|NCT03069482|mHealth|mhealth
34677|NCT03069482|Serious Mental Illness|serious mental illness
34678|NCT03069482|Acceptance and Commitment Therapy|acceptance and commitment therapy
34679|NCT03069482|US DHHS Clinical Practice Guidelines|us dhhs clinical practice guidelines
34680|NCT03069469|CSF1R|csf1r
34682|NCT03069469|CML|cml
34683|NCT03069469|AML|aml
34684|NCT03069469|MDS|mds
34685|NCT03069456|sevoflurane|sevoflurane
34686|NCT03069456|Bistpectral index|bistpectral index
26370|NCT03119974|ITP|itp
34687|NCT03069456|Anesthetic Depth Monitoring System|anesthetic depth monitoring system
34688|NCT03069456|population pharmacodynamics|population pharmacodynamics
34689|NCT03069443|Isometric handgrip training|isometric handgrip training
34690|NCT03069443|home training|home training
34691|NCT03069443|older adults|older adults
34692|NCT03069443|Hypertension|hypertension
34693|NCT03069417|HIV|hiv
34694|NCT03069417|Medication adherence|medication adherence
34695|NCT03069417|PMTCT|pmtct
34696|NCT03069417|Depression|depression
34697|NCT03069391|exercise|exercise
34698|NCT03069391|exergame|exergame
34699|NCT03069378|Metastatic|metastatic
34700|NCT03069378|Locally Advanced|locally advanced
621887|NCT00668070|NASH|nash
34701|NCT03069378|Talimogene Laherparepvec (T-VEC)|talimogene laherparepvec (t-vec)
34702|NCT03069378|Pembrolizumab|pembrolizumab
34703|NCT03069378|16-1534|16-1534
34704|NCT03069365|non-cirrhotic|non-cirrhotic
34705|NCT03069365|Chronic Kidney Disease|chronic kidney disease
34706|NCT03069365|compensated cirrhosis|compensated cirrhosis
34707|NCT03069365|sofosbuvir (SOF)|sofosbuvir (sof)
34708|NCT03069365|ribavirin (RBV)|ribavirin (rbv)
34709|NCT03069365|treatment naïve|treatment naïve
34710|NCT03069365|interferon (IFN)|interferon (ifn)
34711|NCT03069365|Hepatitis C Virus Genotype|hepatitis c virus genotype
34712|NCT03069365|Chronic Hepatitis C Virus|chronic hepatitis c virus
34713|NCT03069365|pegylated interferon (pegIFN)|pegylated interferon (pegifn)
34714|NCT03069365|Glecaprevir|glecaprevir
34715|NCT03069365|Pibrentasvir|pibrentasvir
34716|NCT03069352|Treatment naïve|treatment naïve
34717|NCT03069352|Leukemia|leukemia
34718|NCT03069352|Venetoclax|venetoclax
34719|NCT03069352|Acute Myeloid Leukemia|acute myeloid leukemia
34720|NCT03069352|Cytarabine|cytarabine
34721|NCT03069326|Ruxolitinib|ruxolitinib
34722|NCT03069326|Thalidomide|thalidomide
34723|NCT03069326|16-1498|16-1498
34724|NCT03069313|Aromatase Inhibitor|aromatase inhibitor
34725|NCT03069313|Breast Cancer|breast cancer
34726|NCT03069313|Arthralgia|arthralgia
34727|NCT03069313|Musculoskeletal symptoms|musculoskeletal symptoms
34728|NCT03069313|Joint pain|joint pain
34729|NCT03069261|Breast reconstruction|breast reconstruction
34730|NCT03069261|Autologous tissue flaps|autologous tissue flaps
34731|NCT03069261|Indocyanine green angiography|indocyanine green angiography
34732|NCT03069261|Breast cancer|breast cancer
34734|NCT03069235|Breast Feeding|breast feeding
34735|NCT03069222|diffusion tensor imaging|diffusion tensor imaging
34736|NCT03069196|Prevalence|prevalence
34737|NCT03069196|Incidence|incidence
34738|NCT03069196|Type 1 diabetes and its Micro-vascular complications|type 1 diabetes and its micro-vascular complications
34739|NCT03069196|Type 1 diabetes and its Macro-vascular complications|type 1 diabetes and its macro-vascular complications
34740|NCT03069196|Type 1 Diabetes and its complications in India|type 1 diabetes and its complications in india
34741|NCT03069183|Fascia Iliaca Block|fascia iliaca block
34742|NCT03069183|Total Hip Arthroplasty|total hip arthroplasty
34743|NCT03069183|Total Hip Replacement|total hip replacement
34744|NCT03069183|Ultrasound|ultrasound
34745|NCT03069144|Psoriasis|psoriasis
34746|NCT03069144|Topical|topical
34747|NCT03069131|primary prophylaxis|primary prophylaxis
34748|NCT03069131|rifaximin|rifaximin
34749|NCT03069118|Telemedicine|telemedicine
34750|NCT03069118|Online Treatment|online treatment
34751|NCT03069118|Digital Intervention|digital intervention
34752|NCT03069079|primary immunodeficiency|primary immunodeficiency
34753|NCT03069079|dental health|dental health
34757|NCT03069066|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
34758|NCT03069066|Stent|stent
34759|NCT03069066|Drug-eluting stent|drug-eluting stent
34760|NCT03069066|Coronary angiography|coronary angiography
34761|NCT03069066|Scoring balloon|scoring balloon
34762|NCT03069040|cervical cancer|cervical cancer
34763|NCT03069040|NSRH|nsrh
34764|NCT03069040|RH|rh
34765|NCT03069040|urine flow mechanics|urine flow mechanics
34766|NCT03069040|anorectal dynamics|anorectal dynamics
34767|NCT03069027|Nasal surgery|nasal surgery
34768|NCT03069027|external nasal nerve block|external nasal nerve block
34769|NCT03069027|postoperative agitation|postoperative agitation
34770|NCT03069001|HCV treatment|hcv treatment
34785|NCT03068923|fibrinolysis|fibrinolysis
34786|NCT03068923|coagulation|coagulation
34787|NCT03068923|anticoagulation|anticoagulation
34788|NCT03068923|Post trombotic syndrome|post trombotic syndrome
34789|NCT03068923|Post pulmonary embolism syndrome|post pulmonary embolism syndrome
34790|NCT03068923|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
34791|NCT03068910|PCOS|pcos
34792|NCT03068845|non-maturing arteriovenous fistula|non-maturing arteriovenous fistula
34793|NCT03068845|stenosis of arteriovenous fistula|stenosis of arteriovenous fistula
34794|NCT03068845|drug-eluting balloon|drug-eluting balloon
34795|NCT03068767|HBV DNA, qHBsAg|hbv dna, qhbsag
34796|NCT03068754|ALS|als
34797|NCT03068728|bilateral chronic rhino sinusitis|bilateral chronic rhino sinusitis
34798|NCT03068715|transcranial magnetic stimulation|transcranial magnetic stimulation
34799|NCT03068715|theta burst|theta burst
34801|NCT03068676|Depression|depression
34802|NCT03068676|Anxiety|anxiety
34803|NCT03068676|Internet-delivered|internet-delivered
34804|NCT03068676|CBT|cbt
34805|NCT03068676|Primary Care|primary care
34806|NCT03068663|lung cancer|lung cancer
34807|NCT03068663|intestinal microbiota|intestinal microbiota
34808|NCT03068663|lung microbiota|lung microbiota
34809|NCT03068663|surgery|surgery
34810|NCT03068663|chemotherapy|chemotherapy
34811|NCT03068624|Melanoma and Other Malignant Neoplasms of Skin|melanoma and other malignant neoplasms of skin
34812|NCT03068624|Metastatic uveal melanoma|metastatic uveal melanoma
34813|NCT03068624|Autologous CD8+ T cells|autologous cd8+ t cells
34814|NCT03068624|Cyclophosphamide|cyclophosphamide
34815|NCT03068624|Cytoxan|cytoxan
34816|NCT03068624|Neosar|neosar
34817|NCT03068624|Interleukin-2|interleukin-2
34818|NCT03068624|IL-2|il-2
34819|NCT03068624|Aldesleukin|aldesleukin
34820|NCT03068624|Proleukin|proleukin
34821|NCT03068624|Ipilimumab|ipilimumab
34822|NCT03068624|Yervoy|yervoy
34823|NCT03068624|BMS-734016|bms-734016
34824|NCT03068624|MDX010|mdx010
34825|NCT03068585|PAD|pad
34826|NCT03068585|CLI|cli
34827|NCT03068585|stage 2a-3 of Pokrovsky-Fonteine|stage 2a-3 of pokrovsky-fonteine
34828|NCT03068572|minimal change esophageal reflux disease diagnosis|minimal change esophageal reflux disease diagnosis
34829|NCT03068572|Linked Color imaging|linked color imaging
34830|NCT03068572|non-erosive reflux disease|non-erosive reflux disease
34832|NCT03068533|DH, dentin hypersensitivity, chronic periodontitis|dh, dentin hypersensitivity, chronic periodontitis
34833|NCT03068520|PET|pet
34834|NCT03068520|MRI|mri
34835|NCT03068520|BRAIN METASTASIS|brain metastasis
34836|NCT03068520|BRAIN PRIMARY TUMOR|brain primary tumor
34837|NCT03068520|RESPONSE TO TREATMENT|response to treatment
34838|NCT03068507|Perioperative|perioperative
34839|NCT03068507|functional capability|functional capability
34840|NCT03068507|Prehabilitation|prehabilitation
34841|NCT03068507|thoracoscopic lobectomy|thoracoscopic lobectomy
34842|NCT03068507|Lung Cancer|lung cancer
34843|NCT03068494|Coronary Bifurcation Lesion|coronary bifurcation lesion
34844|NCT03068494|2md generation drug-eluting stent|2md generation drug-eluting stent
34845|NCT03068442|Carotid artery|carotid artery
34846|NCT03068442|MRI|mri
34847|NCT03068442|PET|pet
34848|NCT03068442|Intraplaque hemorrhage|intraplaque hemorrhage
34849|NCT03068429|obsessive-compulsive disorder|obsessive-compulsive disorder
34850|NCT03068429|fear conditioning|fear conditioning
34851|NCT03068429|functional neuroimaging|functional neuroimaging
34852|NCT03068429|sertraline|sertraline
34853|NCT03068403|CEUS Perfusion|ceus perfusion
34854|NCT03068403|Rectal Cancer|rectal cancer
34855|NCT03068403|Tumor Perfusion|tumor perfusion
34856|NCT03068403|Radiochemotherapy|radiochemotherapy
34857|NCT03068377|lycopene|lycopene
34859|NCT03068364|Mortality|mortality
34860|NCT03068364|Hypertension|hypertension
34876|NCT03068260|reduction of opioid consumption|reduction of opioid consumption
34877|NCT03068208|Methylene blue|methylene blue
34878|NCT03068208|photodynamic therapy|photodynamic therapy
34879|NCT03068208|primary cutaneous localized amyloidosis|primary cutaneous localized amyloidosis
34880|NCT03068208|lichen amyloidosis|lichen amyloidosis
34881|NCT03068195|laparoscopy|laparoscopy
34882|NCT03068195|microwave|microwave
34883|NCT03068195|ablation technique|ablation technique
34884|NCT03068182|Exercise ,Autonomic cardiac function ,Adult subjects|exercise ,autonomic cardiac function ,adult subjects
34885|NCT03068169|remote ECG|remote ecg
34886|NCT03068169|atrial fibrillation|atrial fibrillation
34887|NCT03068169|cardiac rehabilitation|cardiac rehabilitation
34888|NCT03068169|cardiac resynchronization therapy|cardiac resynchronization therapy
34889|NCT03068169|supraventricular tachycardia|supraventricular tachycardia
34890|NCT03068156|308-nm excimer laser|308-nm excimer laser
34891|NCT03068156|primary localized cutaneous amyloidosis|primary localized cutaneous amyloidosis
34892|NCT03068156|lichen amyloidosis|lichen amyloidosis
34893|NCT03068156|Asians|asians
34894|NCT03068130|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
34895|NCT03068130|Pulmonary Hypertension|pulmonary hypertension
34896|NCT03068130|PH|ph
34897|NCT03068130|PAH|pah
34898|NCT03068130|Bardoxolone methyl|bardoxolone methyl
34899|NCT03068130|6-minute walk distance|6-minute walk distance
34900|NCT03068130|CDDO-ME|cddo-me
34901|NCT03068130|RTA 402|rta 402
34902|NCT03068130|LARIAT|lariat
34903|NCT03068130|CATALYST|catalyst
34904|NCT03068130|RANGER|ranger
34905|NCT03068117|Specialist Palliative Care|specialist palliative care
34906|NCT03068117|Symptom Control|symptom control
34907|NCT03068117|Early Referral|early referral
34908|NCT03068117|Quality of Life|quality of life
34909|NCT03068117|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
34910|NCT03068117|Mesothelioma|mesothelioma
34911|NCT03068104|Trauma|trauma
34912|NCT03068104|Haemorrhage|haemorrhage
34913|NCT03068104|Massive transfusion|massive transfusion
34914|NCT03068104|India|india
34915|NCT03068091|Interstitial Lung Disease|interstitial lung disease
34916|NCT03068091|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
34917|NCT03068065|Liraglutide|liraglutide
34918|NCT03068065|Metformin|metformin
34919|NCT03068065|Gliclazide|gliclazide
34920|NCT03068039|MRI|mri
34921|NCT03068039|blood glucose|blood glucose
34922|NCT03068039|porridge|porridge
34923|NCT03068039|breakfast|breakfast
34924|NCT03068039|satiety|satiety
34925|NCT03068039|plasma peptides|plasma peptides
34926|NCT03068026|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
34927|NCT03068026|Non-invasive ventilation|non-invasive ventilation
34928|NCT03068013|CALM|calm
34929|NCT03068013|Depression|depression
34930|NCT03068013|Demoralization|demoralization
34931|NCT03068013|Cancer|cancer
34932|NCT03068013|Spirituality|spirituality
34933|NCT03068013|Psychotherapy|psychotherapy
34934|NCT03068013|Quality of Life|quality of life
34935|NCT03068013|Anxiety|anxiety
35182|NCT03066531|CBT obesity|cbt obesity
34936|NCT03068013|Post-Traumatic Growth|post-traumatic growth
34937|NCT03068000|Martial arts|martial arts
34938|NCT03068000|Judo|judo
34939|NCT03068000|Motor skills|motor skills
34940|NCT03068000|Physical fitness|physical fitness
34941|NCT03068000|Cardiovascular parameters|cardiovascular parameters
34942|NCT03068000|Quality of life|quality of life
34943|NCT03068000|Physical Activity|physical activity
34944|NCT03067974|ketamine|ketamine
34945|NCT03067974|pediatric|pediatric
34946|NCT03067974|procedural sedation|procedural sedation
34947|NCT03067961|Enteric fever|enteric fever
34948|NCT03067961|Typhoid|typhoid
34949|NCT03067961|Salmonella Typhi|salmonella typhi
34950|NCT03067961|Challenge study|challenge study
34951|NCT03067961|Human model of infection|human model of infection
34952|NCT03067961|Typhoid toxin|typhoid toxin
34953|NCT03067922|Mastectomy|mastectomy
34954|NCT03067922|Pain|pain
34956|NCT03067922|Life quality|life quality
34957|NCT03067896|spinal block|spinal block
34958|NCT03067896|stress response|stress response
34959|NCT03067896|dexmedetomidine|dexmedetomidine
34960|NCT03067896|intrathecally|intrathecally
34961|NCT03067870|Stem cells|stem cells
34962|NCT03067870|Rheumatoid arthritis|rheumatoid arthritis
34963|NCT03067831|stem cells|stem cells
34964|NCT03067818|arm|arm
34965|NCT03067818|rehabilitation|rehabilitation
34966|NCT03067818|non-invasive brain stimulation|non-invasive brain stimulation
34967|NCT03067818|transcranial magnetic stimulation|transcranial magnetic stimulation
34968|NCT03067818|upper extremity|upper extremity
34969|NCT03067805|Oxytocin effect|oxytocin effect
34970|NCT03067805|romantic jealousy|romantic jealousy
34971|NCT03067805|Arousal Rating|arousal rating
34972|NCT03067805|Jealousy Rating|jealousy rating
34973|NCT03067792|inoperable gastric cancer|inoperable gastric cancer
34974|NCT03067792|palliative chemotherapy|palliative chemotherapy
34975|NCT03067740|appendicectomy|appendicectomy
34976|NCT03067740|children|children
34977|NCT03067740|local anesthetics|local anesthetics
34978|NCT03067740|laparoscopy|laparoscopy
34979|NCT03067740|peritoneum|peritoneum
34980|NCT03067675|no known ocular pathology|no known ocular pathology
34981|NCT03067623|Thin endometrium|thin endometrium
34982|NCT03067623|Endometrial thickness|endometrial thickness
34983|NCT03067584|Familial cancer|familial cancer
34984|NCT03067584|Genetic predisposition|genetic predisposition
34985|NCT03067584|Heritable disease|heritable disease
34986|NCT03067584|Cancer risk|cancer risk
34987|NCT03067584|Genome analysis|genome analysis
34988|NCT03067584|Genetic modifiers|genetic modifiers
34989|NCT03067584|Next generation sequencing (NGS)|next generation sequencing (ngs)
34990|NCT03067584|Genetic counseling|genetic counseling
34991|NCT03067584|DNA|dna
34992|NCT03067571|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
34993|NCT03067571|Acute Myelogenous Leukemia|acute myelogenous leukemia
34994|NCT03067571|AML|aml
34995|NCT03067571|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
34996|NCT03067571|MDA|mda
34997|NCT03067571|Daratumumab|daratumumab
34998|NCT03067558|Pneumonia|pneumonia
34999|NCT03067558|Diagnostics|diagnostics
35000|NCT03067558|Childhood|childhood
35001|NCT03067558|Respiratory rate|respiratory rate
35002|NCT03067558|Ethiopia|ethiopia
35003|NCT03067506|Drug Therapy|drug therapy
622068|NCT00668876|Th1|th1
35004|NCT03067454|early mobilisation|early mobilisation
35005|NCT03067454|metacarpal fracture|metacarpal fracture
35006|NCT03067454|operation|operation
35007|NCT03067441|hyperlipidemia|hyperlipidemia
35008|NCT03067441|cholesterol|cholesterol
35009|NCT03067441|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
35010|NCT03067441|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
35011|NCT03067441|ASCVD|ascvd
35012|NCT03067441|HeFH|hefh
35013|NCT03067441|LDL|ldl
35014|NCT03067428|Fructose|fructose
35015|NCT03067428|Diet|diet
35016|NCT03067415|Glaucoma, Primary Open Angle|glaucoma, primary open angle
35017|NCT03067415|Ocular hypertension|ocular hypertension
35018|NCT03067415|CKD-351|ckd-351
35019|NCT03067402|Myocardial Infarction|myocardial infarction
35020|NCT03067402|Physiological Stress Test|physiological stress test
35021|NCT03067402|Nuclear Image Perfusion|nuclear image perfusion
35022|NCT03067402|Angioplasty|angioplasty
35023|NCT03067402|Coronary Artery Bypass Graft|coronary artery bypass graft
35024|NCT03067402|Percutaneous Coronary Intervention|percutaneous coronary intervention
35025|NCT03067402|Angina|angina
35026|NCT03067402|Ischemia|ischemia
35027|NCT03067376|ADME|adme
35028|NCT03067376|Metabolism|metabolism
35029|NCT03067376|Metabolite Profiling|metabolite profiling
35030|NCT03067376|Excretion|excretion
35031|NCT03067350|voriconazole|voriconazole
35032|NCT03067350|pharmacogenetics|pharmacogenetics
35033|NCT03067350|pharmacokinetics|pharmacokinetics
35034|NCT03067350|therapeutic drug monitoring|therapeutic drug monitoring
35035|NCT03067337|Stainless Steel Crowns|stainless steel crowns
35036|NCT03067337|Zirconia Crowns|zirconia crowns
35037|NCT03067337|Aesthetic restorations|aesthetic restorations
35038|NCT03067324|Islet Transplantation|islet transplantation
35039|NCT03067298|pregnancy|pregnancy
35040|NCT03067298|screening|screening
35041|NCT03067298|doppler|doppler
35042|NCT03067298|markers|markers
35043|NCT03067298|PlGF|plgf
35044|NCT03067298|sFlt-1|sflt-1
35045|NCT03067298|placenta|placenta
35046|NCT03067272|Permanent contraception|permanent contraception
35047|NCT03067272|Birth control|birth control
35048|NCT03067259|eldery patients|eldery patients
35052|NCT03067246|Endotracheal intubation|endotracheal intubation
35053|NCT03067220|outpatients|outpatients
35054|NCT03067220|general surgery|general surgery
35055|NCT03067220|virtual clinic|virtual clinic
35056|NCT03067220|patient satisfaction|patient satisfaction
35057|NCT03067207|mindfulness meditation|mindfulness meditation
35077|NCT03067116|fall risk|fall risk
35078|NCT03067116|anthropometrics|anthropometrics
35079|NCT03067116|blood pressure|blood pressure
35080|NCT03067116|SpO2|spo2
35081|NCT03067116|heart rate|heart rate
35082|NCT03067116|heart rate variability|heart rate variability
35083|NCT03067116|stance width|stance width
35084|NCT03067103|Adenotonsillectomy|adenotonsillectomy
35085|NCT03067103|pain|pain
35086|NCT03067103|topic analgesia|topic analgesia
35087|NCT03067103|child|child
35088|NCT03067077|SMILE|smile
35089|NCT03067077|LASIK|lasik
35090|NCT03067077|Myopia|myopia
35091|NCT03067077|Wavefront-guided|wavefront-guided
35092|NCT03067012|Oncometabolic surgery|oncometabolic surgery
35093|NCT03067012|Long limb uncut Roux-en-Y gastrojejunostomy|long limb uncut roux-en-y gastrojejunostomy
35094|NCT03067012|Obesity|obesity
35095|NCT03067012|Diabetes|diabetes
35096|NCT03067012|Early gastric cancer|early gastric cancer
35097|NCT03066986|Venom anaphylaxis|venom anaphylaxis
35098|NCT03066986|Myrmecia piluosa|myrmecia piluosa
35099|NCT03066986|Immunological adjuvant|immunological adjuvant
35100|NCT03066986|Immunotherapy|immunotherapy
35101|NCT03066986|Jack jumper ant|jack jumper ant
35102|NCT03066973|breath exercises|breath exercises
35103|NCT03066973|labor pain|labor pain
35104|NCT03066973|labor duration|labor duration
35105|NCT03066973|VAS|vas
35106|NCT03066934|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
35107|NCT03066934|Nasal high flow|nasal high flow
35108|NCT03066934|Respiratory Failure|respiratory failure
35109|NCT03066934|Childhood|childhood
35110|NCT03066921|Lactic acid bacteria|lactic acid bacteria
35111|NCT03066921|dyslipidemia uremic toxins|dyslipidemia uremic toxins
35112|NCT03066921|Hemodialysis|hemodialysis
35113|NCT03066908|Chronic Rhinosinusitis|chronic rhinosinusitis
35114|NCT03066882|Caloric Restriction|caloric restriction
35115|NCT03066882|Diet|diet
35116|NCT03066882|Obesity|obesity
35117|NCT03066882|Overweight|overweight
35118|NCT03066882|Sedentary Lifestyle|sedentary lifestyle
35119|NCT03066882|Weight loss|weight loss
35120|NCT03066882|Women|women
35121|NCT03066856|BRCA genes|brca genes
35122|NCT03066856|Mutation carriers|mutation carriers
35123|NCT03066856|IGF-I|igf-i
35124|NCT03066856|Diet|diet
35125|NCT03066817|Vitamin D|vitamin d
35130|NCT03066817|Polytrauma|polytrauma
35150|NCT03066726|Biophysical profile|biophysical profile
35151|NCT03066726|Cesarean section|cesarean section
35152|NCT03066726|Estimated fetal weight|estimated fetal weight
35153|NCT03066726|Middle cerebral artery|middle cerebral artery
35154|NCT03066726|Umbilical artery|umbilical artery
35278|NCT03066206|Poziotinib|poziotinib
35155|NCT03066726|Fetal growth restriction|fetal growth restriction
35156|NCT03066726|Pulsatility index|pulsatility index
35157|NCT03066726|Estimated gestational age|estimated gestational age
35159|NCT03065894|stratified care|stratified care
35160|NCT03065894|psychologically informed practice|psychologically informed practice
35161|NCT03065894|matched care|matched care
35162|NCT03066648|Acute Myeloid Leukemia|acute myeloid leukemia
35163|NCT03066648|Myelodysplastic syndromes|myelodysplastic syndromes
26703|NCT03117920|Refractory pancreatic cancer|refractory pancreatic cancer
26704|NCT03117920|Minnelide|minnelide
26705|NCT03117920|Minnelide002|minnelide002
26706|NCT03117920|2017-000126-36|2017-000126-36
26707|NCT03117881|Multiple Sclerosis|multiple sclerosis
35164|NCT03066635|Nerve block|nerve block
35165|NCT03066635|Ganglia, Parasympathetic|ganglia, parasympathetic
35166|NCT03066635|Botulinum Toxins, Type A|botulinum toxins, type a
35167|NCT03066635|Injection|injection
35168|NCT03066609|Plaque psoriasis, Secukinumab, Skin condition, skin disease, itching, psoriasis vulgaris, immune-mediated systemic disease, skin lesions, scaly patches, papules|plaque psoriasis, secukinumab, skin condition, skin disease, itching, psoriasis vulgaris, immune-mediated systemic disease, skin lesions, scaly patches, papules
35169|NCT03066583|meniscus repair|meniscus repair
35170|NCT03066583|platelet rich plasma|platelet rich plasma
35175|NCT03066557|Hepatocellular Carcinoma|hepatocellular carcinoma
35176|NCT03066557|Apatinib|apatinib
35177|NCT03066544|migraine|migraine
35178|NCT03066544|responder|responder
35179|NCT03066544|non-responder|non-responder
35180|NCT03066544|treatment|treatment
35181|NCT03066531|ACT|act
35183|NCT03066531|Eating disorders|eating disorders
35184|NCT03066531|Health psychology|health psychology
35185|NCT03066518|melatonin|melatonin
35186|NCT03066518|sleep|sleep
35187|NCT03066518|dementia|dementia
35188|NCT03066518|cognition|cognition
35189|NCT03066492|Tertiary Care Center|tertiary care center
35190|NCT03066492|Patient Readmission|patient readmission
35191|NCT03066492|Health Services Research|health services research
35192|NCT03066492|Hospital Readmissions|hospital readmissions
35193|NCT03066466|Acute Myeloid Leukemia|acute myeloid leukemia
35194|NCT03066466|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
35195|NCT03066466|Myelodysplastic Syndrome|myelodysplastic syndrome
35197|NCT03066466|Matched unrelated donor transplant|matched unrelated donor transplant
35198|NCT03066466|Graft versus Host Disease|graft versus host disease
35199|NCT03066466|GVHD|gvhd
35200|NCT03066453|cystic fibrosis, tobramycin, antibiotic courses, FEV1|cystic fibrosis, tobramycin, antibiotic courses, fev1
35201|NCT03066440|diabetic ketoacidosis|diabetic ketoacidosis
35202|NCT03066440|fluid management|fluid management
35203|NCT03066440|hyperchloremia|hyperchloremia
35204|NCT03066427|Clear Cell Renal Carcinoma|clear cell renal carcinoma
35205|NCT03066427|Sunitinib|sunitinib
35206|NCT03066414|hemochromatosis|hemochromatosis
35207|NCT03066414|blood withdrawal|blood withdrawal
35208|NCT03066414|respiratory variations|respiratory variations
35209|NCT03066414|inferior vena cava|inferior vena cava
35210|NCT03066414|internal jugular vein|internal jugular vein
35211|NCT03066414|ultrasound|ultrasound
35212|NCT03066414|ultrasonography|ultrasonography
35213|NCT03066414|echography|echography
35214|NCT03066401|hyperferritinemia|hyperferritinemia
35215|NCT03066401|dysmetabolic hyperferritinemia|dysmetabolic hyperferritinemia
35216|NCT03066401|obese|obese
35217|NCT03066401|blood withdrawal|blood withdrawal
35218|NCT03066401|respiratory variations|respiratory variations
35219|NCT03066401|inferior vena cava|inferior vena cava
35220|NCT03066401|internal jugular vein|internal jugular vein
35221|NCT03066401|ultrasound|ultrasound
35222|NCT03066401|ultrasonography|ultrasonography
35223|NCT03066401|echography|echography
35224|NCT03066388|fluid|fluid
35225|NCT03066388|fluid responsiveness|fluid responsiveness
35226|NCT03066388|pulse pressure|pulse pressure
35227|NCT03066388|noninvasive monitoring|noninvasive monitoring
35228|NCT03066388|pulse pressure variations|pulse pressure variations
35229|NCT03066388|volume expansion|volume expansion
35230|NCT03066388|SIRS|sirs
35231|NCT03066388|systemic inflammatory response syndrome|systemic inflammatory response syndrome
35232|NCT03066375|vena cava|vena cava
35233|NCT03066375|fluid|fluid
35234|NCT03066375|sepsis|sepsis
35235|NCT03066375|echocardiography|echocardiography
35236|NCT03066375|ultrasound|ultrasound
35237|NCT03066375|ultrasonography|ultrasonography
35238|NCT03066375|collapsibility index|collapsibility index
35243|NCT03066362|Spontaneous ventilation|spontaneous ventilation
35244|NCT03066323|Blood glucose|blood glucose
35245|NCT03066310|Bladder cancer|bladder cancer
35246|NCT03066310|Urine|urine
35247|NCT03066310|DNA biomarker|dna biomarker
35248|NCT03066310|Diagnosis|diagnosis
35249|NCT03066297|Clinical stage IA non-small cell lung cancer|clinical stage ia non-small cell lung cancer
35250|NCT03066297|Lobectomy|lobectomy
35251|NCT03066297|Segmentectomy|segmentectomy
35256|NCT03066284|Adolescents|adolescents
35257|NCT03066284|Parents|parents
35258|NCT03066284|Insulin Pump Therapy|insulin pump therapy
35259|NCT03066271|Aerobic exercise|aerobic exercise
35260|NCT03066271|Lung Cancer|lung cancer
35261|NCT03066258|nAMD|namd
38061|NCT03047993|MDS|mds
35262|NCT03066258|wet AMD|wet amd
35263|NCT03066258|gene therapy|gene therapy
35264|NCT03066245|Aneurysmal bone cysts|aneurysmal bone cysts
35265|NCT03066245|PLGA|plga
35266|NCT03066245|Platelet Lysate|platelet lysate
35267|NCT03066245|Bone marrow|bone marrow
35268|NCT03066245|Mesenchymal stem cells|mesenchymal stem cells
35269|NCT03066232|Delirium|delirium
35270|NCT03066232|Dementia|dementia
35271|NCT03066232|Physical function|physical function
35272|NCT03066206|Malignant Neoplasm of Respiratory and Intrathoracic Organ|malignant neoplasm of respiratory and intrathoracic organ
35273|NCT03066206|Non-Small Cell Lung Cancer|non-small cell lung cancer
35274|NCT03066206|NSCLC|nsclc
35275|NCT03066206|Advanced|advanced
35276|NCT03066206|EGFR exon 20 mutation|egfr exon 20 mutation
35277|NCT03066206|EGFR-positive|egfr-positive
35279|NCT03066193|Motor tics|motor tics
35280|NCT03066193|Vocal tics|vocal tics
35281|NCT03066193|Cannabinoids|cannabinoids
35282|NCT03066193|Dronabinol|dronabinol
35284|NCT03066193|Palmitoylethanolamide|palmitoylethanolamide
35285|NCT03066193|Tourettes|tourettes
35286|NCT03066193|TS|ts
35287|NCT03066167|Cancer of the gastro-esophageal junction|cancer of the gastro-esophageal junction
35288|NCT03066167|Watson score|watson score
35289|NCT03066167|Ogilvie score|ogilvie score
35290|NCT03066167|Goldschmid score|goldschmid score
35291|NCT03066167|Validation|validation
35292|NCT03066167|Quality of Life|quality of life
35293|NCT03066154|High risk prostate cancer|high risk prostate cancer
35294|NCT03066154|>T2cN+M0|>t2cn+m0
35295|NCT03066128|Task shifting|task shifting
35296|NCT03066128|HIV care|hiv care
35297|NCT03066115|Cerebral blood flow|cerebral blood flow
35298|NCT03066115|Cyclooxygenase|cyclooxygenase
35299|NCT03066115|Nitric oxide synthase|nitric oxide synthase
35300|NCT03066115|Reactive Oxygen Species|reactive oxygen species
35301|NCT03066102|sensorimotor system|sensorimotor system
35302|NCT03066102|scapular joint position sense|scapular joint position sense
35304|NCT03066089|FBS,HbA1C, PPBS|fbs,hba1c, ppbs
35309|NCT03066037|regional-anaesthesiological infiltration|regional-anaesthesiological infiltration
35310|NCT03066037|block series|block series
35311|NCT03066037|invasive pain treatment|invasive pain treatment
35312|NCT03066011|mold-active triazoles|mold-active triazoles
35313|NCT03065972|kidney disease|kidney disease
35314|NCT03065972|vascular access|vascular access
35315|NCT03065972|graft|graft
35316|NCT03065972|fistula|fistula
35317|NCT03065972|hemodialysis|hemodialysis
35318|NCT03065972|dialysis|dialysis
35323|NCT03065946|Therapeutic hypothermia|therapeutic hypothermia
35324|NCT03065946|Electroencephalogram|electroencephalogram
35325|NCT03065946|Neuron-Specific Enolase|neuron-specific enolase
35326|NCT03065946|Return of Spontaneous Circulation|return of spontaneous circulation
35327|NCT03065946|S-100B|s-100b
35328|NCT03065933|mania|mania
35329|NCT03065933|clonidine|clonidine
35330|NCT03065933|bipolar disorder|bipolar disorder
35331|NCT03065868|gastric polyp|gastric polyp
35332|NCT03065868|Helicobacter pylori eradication|helicobacter pylori eradication
35333|NCT03065855|laparoscopic mesorectal excision|laparoscopic mesorectal excision
35334|NCT03065855|rectal cancer|rectal cancer
35335|NCT03065855|urinary distention|urinary distention
35336|NCT03065842|Stigma|stigma
35337|NCT03065842|Pregnancy|pregnancy
35338|NCT03065842|Abortion|abortion
35339|NCT03065842|Contraception|contraception
35340|NCT03065842|Adolescence|adolescence
35341|NCT03065829|caregiver|caregiver
35342|NCT03065829|chronically critically ill|chronically critically ill
35343|NCT03065777|single file.|single file.
35344|NCT03065777|ONE ENDO.|one endo.
35345|NCT03065777|F6 SkyTaper.|f6 skytaper.
35346|NCT03065777|ProTaper Universal.|protaper universal.
35347|NCT03065777|irreversible pulpitis.|irreversible pulpitis.
35348|NCT03065777|postoperative pain.|postoperative pain.
35349|NCT03065764|Pembrolizumab|pembrolizumab
35350|NCT03065764|89Zirconium|89zirconium
35351|NCT03065738|reduction osteotomy|reduction osteotomy
35352|NCT03065738|knee arthroplasty|knee arthroplasty
35353|NCT03065712|Breast Cancer|breast cancer
35354|NCT03065712|PET/CT|pet/ct
35356|NCT03065712|18F Fluoroestradiol|18f fluoroestradiol
35357|NCT03065712|Breast|breast
35358|NCT03065699|Medical device|medical device
35359|NCT03065699|Liver dialysis|liver dialysis
35360|NCT03065699|Haemofilter|haemofilter
35361|NCT03065699|ACLF|aclf
35362|NCT03065686|Cleft Lip and Palate|cleft lip and palate
35363|NCT03065686|CL/P|cl/p
35364|NCT03065686|WES|wes
35365|NCT03065673|Tooth bleaching|tooth bleaching
35366|NCT03065673|Tooth sensitivity|tooth sensitivity
35367|NCT03065660|Missed miscarriage|missed miscarriage
35368|NCT03065660|Mifepristone|mifepristone
35369|NCT03065660|Misoprostol|misoprostol
35370|NCT03065660|Medical management|medical management
35371|NCT03065647|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
35372|NCT03065647|Cardiac Arrest|cardiac arrest
35373|NCT03065647|Heart Arrest|heart arrest
35374|NCT03065647|Sudden Cardiac Arrest|sudden cardiac arrest
35375|NCT03065647|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
35376|NCT03065647|Extracorporeal Cardiopulmonary Resuscitation|extracorporeal cardiopulmonary resuscitation
35377|NCT03065647|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
35378|NCT03065647|CPR|cpr
35379|NCT03065647|ECPR|ecpr
35380|NCT03065647|ECMO|ecmo
35381|NCT03065647|Emergency Medical Services|emergency medical services
35382|NCT03065647|EMS|ems
35383|NCT03065647|OHCA|ohca
35384|NCT03065621|Breast|breast
35385|NCT03065595|Ophiocephalus striatus|ophiocephalus striatus
35386|NCT03065595|IGF-1|igf-1
35387|NCT03065595|hypoalbuminemia|hypoalbuminemia
35388|NCT03065595|MNA score|mna score
35389|NCT03065595|elderly|elderly
35390|NCT03065543|Hyperlipidemias|hyperlipidemias
35391|NCT03065543|Secondary prevention|secondary prevention
35392|NCT03065543|high risk patients|high risk patients
35393|NCT03065543|very high risk patients|very high risk patients
35394|NCT03065530|Dexmedetomidine|dexmedetomidine
35395|NCT03065530|Butorphanol tartrate|butorphanol tartrate
35396|NCT03065530|Analgesia|analgesia
35397|NCT03065530|Breastfeeding|breastfeeding
35398|NCT03065530|Relative infant dose|relative infant dose
35399|NCT03065517|Criminal Justice|criminal justice
35400|NCT03065517|Juvenile Delinquency|juvenile delinquency
35401|NCT03065491|Red yeast rice|red yeast rice
35402|NCT03065491|Phytosterols|phytosterols
35403|NCT03065491|L-Tyrosol|l-tyrosol
35404|NCT03065491|Lipids|lipids
35405|NCT03065491|LDL-cholesterol|ldl-cholesterol
35406|NCT03065491|Endothelial function|endothelial function
35407|NCT03065478|Peripheral Neuropathy|peripheral neuropathy
35408|NCT03065478|Chemotherapy induced|chemotherapy induced
35409|NCT03065478|CIPN|cipn
35410|NCT03065465|Upper GI hemorrhage|upper gi hemorrhage
35411|NCT03065465|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
35412|NCT03065465|Diverticular Hemorrhage|diverticular hemorrhage
35413|NCT03065465|Ulcers|ulcers
35414|NCT03065400|Myelofibrosis|myelofibrosis
35415|NCT03065400|Acute Leukemia|acute leukemia
35416|NCT03065387|Metastatic solid tumors|metastatic solid tumors
35417|NCT03065387|Genetic mutation|genetic mutation
35418|NCT03065387|Biomarkers|biomarkers
35419|NCT03065387|Neratinib|neratinib
35420|NCT03065387|Everolimus|everolimus
35421|NCT03065387|Afinitor|afinitor
35422|NCT03065387|Zortress|zortress
35423|NCT03065387|RAD001|rad001
35424|NCT03065387|Palbociclib|palbociclib
35425|NCT03065387|PD-0332991|pd-0332991
35426|NCT03065387|Ibrance|ibrance
35427|NCT03065387|Trametinib|trametinib
35428|NCT03065361|Chronic Kidney Disease|chronic kidney disease
35429|NCT03065361|Handgrip Strength|handgrip strength
35430|NCT03065361|Fine Motor Skills|fine motor skills
35431|NCT03065361|Sensitivity|sensitivity
35432|NCT03065348|prehabilitation|prehabilitation
35433|NCT03065348|nutrition|nutrition
35434|NCT03065348|hydration|hydration
35435|NCT03065348|cystectomy and urinary diversion|cystectomy and urinary diversion
35436|NCT03065348|regional anesthesia|regional anesthesia
35437|NCT03065348|cognition|cognition
35438|NCT03065335|Magnetic Resonance Imaging|magnetic resonance imaging
35439|NCT03065335|Magnetoencephalography|magnetoencephalography
35440|NCT03065335|Major Depressive Disorder|major depressive disorder
35441|NCT03065335|Ketamine|ketamine
35442|NCT03065335|NEUROPHARMACOLOGY|neuropharmacology
35443|NCT03065322|PCOS|pcos
35445|NCT03065296|Behavior|behavior
35446|NCT03065296|education|education
35447|NCT03065296|medical residents|medical residents
35448|NCT03065296|knowledge|knowledge
35449|NCT03065296|confidence|confidence
35450|NCT03065296|skills assessment|skills assessment
35451|NCT03065257|EMR|emr
35452|NCT03065257|ESD|esd
35453|NCT03065257|Resection|resection
35454|NCT03065257|STER|ster
35455|NCT03065257|EFTR|eftr
35456|NCT03065257|Submucosal dissection|submucosal dissection
35457|NCT03065257|Endoscopic resection|endoscopic resection
35458|NCT03065244|Kawasaki disease|kawasaki disease
35459|NCT03065218|Thyroid|thyroid
35460|NCT03065218|sestamibi|sestamibi
35473|NCT03065153|Torso|torso
35474|NCT03065153|Trunk|trunk
35483|NCT03065062|Lung Cancer Squamous Cell|lung cancer squamous cell
35484|NCT03065062|Head & Neck Cancer|head & neck cancer
35485|NCT03065062|Neoplasms|neoplasms
35486|NCT03065062|Endometrial Cancer|endometrial cancer
35487|NCT03065049|Physical Activity|physical activity
35488|NCT03065049|Peer-facilitation|peer-facilitation
35489|NCT03065049|Methadone Maintenance Therapy|methadone maintenance therapy
35490|NCT03065036|Primary Open Angle Glaucoma|primary open angle glaucoma
35491|NCT03065036|POAG|poag
35495|NCT03064997|prebiotic|prebiotic
35496|NCT03064997|pediatric patients|pediatric patients
35497|NCT03064997|health status|health status
35498|NCT03064997|intestine permeability|intestine permeability
35499|NCT03064971|Quitline|quitline
35500|NCT03064971|culturally specific|culturally specific
27013|NCT03115957|Clinical Outcomes|clinical outcomes
27014|NCT03115957|Postoperative Period|postoperative period
27015|NCT03115905|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
27016|NCT03115905|Emergency Medical Services|emergency medical services
27017|NCT03115905|Registry Study|registry study
27018|NCT03115905|China|china
27019|NCT03115866|Healthy Diet|healthy diet
27021|NCT03115866|Metabolome|metabolome
35501|NCT03064958|glucose regulation|glucose regulation
35502|NCT03064958|lipids|lipids
35503|NCT03064958|Immune markers|immune markers
35504|NCT03064958|Endothelium, Vascular|endothelium, vascular
35505|NCT03064945|Livia TENS|livia tens
35506|NCT03064945|safety and efficacy|safety and efficacy
35507|NCT03064945|menstruating women|menstruating women
35508|NCT03064919|hunger and fullness|hunger and fullness
35509|NCT03064919|regulation of energy intake|regulation of energy intake
35510|NCT03064919|energy compensation|energy compensation
35511|NCT03064919|nutrition knowledge|nutrition knowledge
35512|NCT03064906|T1D, Omnipod|t1d, omnipod
35513|NCT03064880|Thoracic surgery|thoracic surgery
35514|NCT03064880|Fluid responsiveness|fluid responsiveness
35515|NCT03064880|Hemodynamics|hemodynamics
35516|NCT03064880|Oxidative stress|oxidative stress
35517|NCT03064880|Goal-directed fluid therapy|goal-directed fluid therapy
35518|NCT03064867|venetoclax|venetoclax
35519|NCT03064867|rituximab|rituximab
35520|NCT03064867|ifosfamide|ifosfamide
35521|NCT03064867|carboplatin|carboplatin
35522|NCT03064867|etoposide|etoposide
35523|NCT03064854|PDR001|pdr001
35524|NCT03064854|immunotherapy|immunotherapy
35525|NCT03064854|Non-small cell lung cancer|non-small cell lung cancer
35526|NCT03064854|lung|lung
35527|NCT03064854|NSCLC|nsclc
35528|NCT03064802|BioBurst|bioburst
35529|NCT03064802|Spinal Fusion|spinal fusion
35530|NCT03064802|Cellular Allograft|cellular allograft
35531|NCT03064789|Candidiases|candidiases
35532|NCT03064789|Vaginal Infections|vaginal infections
35533|NCT03064776|telemedicine|telemedicine
35534|NCT03064763|Unresectable Stage IIIB-IV Malignant Melanoma|unresectable stage iiib-iv malignant melanoma
35535|NCT03064750|Exercise Therapy|exercise therapy
35536|NCT03064750|Pelvic Floor|pelvic floor
35537|NCT03064750|Preoperative Care|preoperative care
37764|NCT03049904|MSM|msm
35539|NCT03064724|tobacco use|tobacco use
35540|NCT03064724|Asian|asian
35541|NCT03064724|patients|patients
35542|NCT03064724|provider advice|provider advice
35543|NCT03064724|digital health intervention|digital health intervention
35544|NCT03064685|Pyogenic Liver abscess|pyogenic liver abscess
35545|NCT03064685|Liver transplantation|liver transplantation
35546|NCT03064685|Biliary disease|biliary disease
35547|NCT03064659|Postoperative pulmonary complications|postoperative pulmonary complications
35548|NCT03064659|Driving Pressure|driving pressure
35549|NCT03064659|Limitation of Expiratory Flow|limitation of expiratory flow
35550|NCT03064659|Cardiac Surgery|cardiac surgery
35551|NCT03064659|Cardio-pulmonary bypass|cardio-pulmonary bypass
35552|NCT03064646|ORGAN PRESERVATION|organ preservation
35553|NCT03064646|WATCH AND WAIT|watch and wait
35554|NCT03064646|TRANSANAL ENDOSCOPIC MICROSURGERY|transanal endoscopic microsurgery
35555|NCT03064633|Dexamethasone|dexamethasone
35556|NCT03064633|Dexmedetomidine|dexmedetomidine
35557|NCT03064633|Transversus abdominis plane block|transversus abdominis plane block
35558|NCT03064633|Local anesthetic adjuvants|local anesthetic adjuvants
35559|NCT03064633|postoperative pain|postoperative pain
35560|NCT03064620|PCV effects|pcv effects
35561|NCT03064620|S. pneumoniae carriage|s. pneumoniae carriage
35562|NCT03064620|S. aureus carriage|s. aureus carriage
35563|NCT03064620|Indirect vaccination effects|indirect vaccination effects
35564|NCT03064620|Palestinian-Israeli Collaborative Research (PICR)|palestinian-israeli collaborative research (picr)
35565|NCT03064607|Neonates|neonates
35566|NCT03064607|biomarkers|biomarkers
35567|NCT03064607|EXIT procedure|exit procedure
35568|NCT03064607|Cesarean Section|cesarean section
35569|NCT03064581|Cervical Cancer|cervical cancer
35570|NCT03064581|Screening|screening
35571|NCT03064581|Pap Test|pap test
35572|NCT03064581|Pacific Islander Americans|pacific islander americans
35573|NCT03064568|Myomectomy, Misoprostol, Vasopressin, Blood loss|myomectomy, misoprostol, vasopressin, blood loss
35574|NCT03064555|Renal|renal
35575|NCT03064555|Acute|acute
35576|NCT03064555|Exercise|exercise
35577|NCT03064555|Dialysis|dialysis
35578|NCT03064555|Hemodialysis|hemodialysis
35579|NCT03064555|End stage renal disease|end stage renal disease
35580|NCT03064555|Aerobic|aerobic
35581|NCT03064503|myocardial fibrosis|myocardial fibrosis
35582|NCT03064503|cardiac function|cardiac function
35583|NCT03064503|ageing|ageing
35584|NCT03064477|Unified Protocol|unified protocol
35585|NCT03064477|Transdiagnostic approach|transdiagnostic approach
35586|NCT03064477|Public health|public health
35587|NCT03064464|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
35588|NCT03064451|persistent atrial fibrillation - ablation procedure|persistent atrial fibrillation - ablation procedure
35589|NCT03064373|S. aureus|s. aureus
35590|NCT03064373|carriage|carriage
35591|NCT03064373|mother-neonatal transmission|mother-neonatal transmission
35592|NCT03064373|microbiome|microbiome
35593|NCT03064347|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
35594|NCT03064347|Obesity|obesity
35595|NCT03064347|Nutrient|nutrient
35596|NCT03064321|cognitive behavioral treatment|cognitive behavioral treatment
35597|NCT03064308|Frailty|frailty
35598|NCT03064308|Surgery|surgery
35599|NCT03064308|Physical function|physical function
35600|NCT03064308|Cognitive function|cognitive function
35601|NCT03064308|Quality of life|quality of life
35602|NCT03064308|Exercise|exercise
35603|NCT03064308|Rehabilitation|rehabilitation
35604|NCT03064308|Delirium|delirium
35605|NCT03064308|Morbidity|morbidity
35606|NCT03064308|Mortality|mortality
35607|NCT03064308|Length of stay|length of stay
35608|NCT03064308|Well-being|well-being
35609|NCT03064308|Elderly|elderly
35610|NCT03064308|Older surgical patient|older surgical patient
35611|NCT03064308|Radical prostatectomy|radical prostatectomy
35612|NCT03064308|Radical cystectomy|radical cystectomy
35613|NCT03064308|Radical cystoprostatectomy|radical cystoprostatectomy
35614|NCT03064308|Aortic Aneurysm Repair|aortic aneurysm repair
35615|NCT03064308|Major Cavity Surgery|major cavity surgery
35616|NCT03064308|Abdominal Surgery|abdominal surgery
35617|NCT03064308|Recovery|recovery
35618|NCT03064308|Nephrectomy|nephrectomy
35619|NCT03064269|CNS B cell acute lymphocytic leukemia|cns b cell acute lymphocytic leukemia
35620|NCT03064256|Exercisy therapy|exercisy therapy
35621|NCT03064256|Hypertension|hypertension
35622|NCT03064256|Physiopathology|physiopathology
35623|NCT03064256|Heart rate|heart rate
35624|NCT03064256|Nonlinear dynamics|nonlinear dynamics
35625|NCT03064217|Clinical crown lengthening|clinical crown lengthening
35626|NCT03064217|intraoral imaging|intraoral imaging
35627|NCT03064217|Emax crown|emax crown
35628|NCT03064191|intra-canal medications|intra-canal medications
35629|NCT03064178|periodontal therapy|periodontal therapy
35630|NCT03064178|anticipated pain|anticipated pain
35631|NCT03064178|experienced pain|experienced pain
35632|NCT03064178|pain medication use|pain medication use
35633|NCT03064139|physical activity|physical activity
35634|NCT03064139|gait|gait
35636|NCT03064126|Artery|artery
35637|NCT03064126|Atherosclerosis|atherosclerosis
35638|NCT03064126|Arterial|arterial
35639|NCT03064126|Peripheral|peripheral
35640|NCT03064126|Plaque|plaque
35641|NCT03064126|Angioplasty|angioplasty
35642|NCT03064126|PTA|pta
35643|NCT03064113|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
35644|NCT03064087|Self-Sampling|self-sampling
35645|NCT03064087|HPV Testing|hpv testing
35646|NCT03064087|Diagnostic Test Accuracy|diagnostic test accuracy
35647|NCT03064087|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
35648|NCT03064087|Urine|urine
35649|NCT03064087|Cervical Cancer Screening|cervical cancer screening
35650|NCT03064048|Argininosuccinate Lyase Deficiency|argininosuccinate lyase deficiency
35651|NCT03064048|Urea Cycle Disorder|urea cycle disorder
35652|NCT03064022|weight gain|weight gain
35653|NCT03064022|head circumference|head circumference
35654|NCT03064022|length|length
35655|NCT03064022|neurodevelopment|neurodevelopment
35656|NCT03063983|osteosarcoma|osteosarcoma
35657|NCT03063983|metastatic|metastatic
35658|NCT03063983|metronomic therapy|metronomic therapy
35659|NCT03063970|Upper extremity|upper extremity
35660|NCT03063970|Rehabilitation|rehabilitation
35661|NCT03063931|Breast cancer|breast cancer
35662|NCT03063931|Mastectomy|mastectomy
35663|NCT03063931|Pain|pain
35664|NCT03063931|Anxiety and Depression|anxiety and depression
35665|NCT03063931|Cognition|cognition
35666|NCT03063931|Quality of life|quality of life
35667|NCT03063905|Opioid related disorders|opioid related disorders
35668|NCT03063905|Narcotic abuse|narcotic abuse
35669|NCT03063879|hepatitis C|hepatitis c
35670|NCT03063879|renal failure|renal failure
35671|NCT03063879|sofosbuvir|sofosbuvir
35672|NCT03063879|daclatasvir|daclatasvir
35673|NCT03063840|hepatocellular carcinoma|hepatocellular carcinoma
35674|NCT03063840|microwave ablation|microwave ablation
35675|NCT03063840|liver cancer|liver cancer
35676|NCT03063801|Congenital Heart Disease|congenital heart disease
35677|NCT03063801|Blood products transfusion|blood products transfusion
35679|NCT03063762|RO6874281|ro6874281
35680|NCT03063762|Atezolizumab|atezolizumab
35681|NCT03063762|Bevacizumab|bevacizumab
35682|NCT03063723|Chronic Hepatitis C|chronic hepatitis c
35683|NCT03063723|Monocytes|monocytes
35684|NCT03063723|Nk cells|nk cells
35685|NCT03063723|direct-acting antiviral agents|direct-acting antiviral agents
35686|NCT03063697|Carvedilol SR Cap|carvedilol sr cap
35687|NCT03063697|Essential hypertension|essential hypertension
35688|NCT03063697|Chronic stable angina|chronic stable angina
35689|NCT03063697|Congestive heart failure|congestive heart failure
35690|NCT03063671|postmastectomy pain|postmastectomy pain
35691|NCT03063658|Ibuprofen|ibuprofen
35692|NCT03063658|Paracetamol|paracetamol
35693|NCT03063658|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
35694|NCT03063658|Morphine|morphine
35695|NCT03063658|Visual analog scale|visual analog scale
35696|NCT03063645|Healthy volunteer|healthy volunteer
35697|NCT03063645|AC-1202|ac-1202
35698|NCT03063645|AC-SD-01|ac-sd-01
35699|NCT03063645|Pharacokinetic|pharacokinetic
35700|NCT03063645|ketone body|ketone body
35701|NCT03063554|Endoscopy|endoscopy
35702|NCT03063554|Pancreatic Cancer|pancreatic cancer
35703|NCT03063554|Bile duct|bile duct
35704|NCT03063554|Periampullary|periampullary
35705|NCT03063554|ERCP|ercp
35706|NCT03063554|Biliary drainage|biliary drainage
35707|NCT03063554|Biliary obstruction|biliary obstruction
35708|NCT03063554|EUSBD|eusbd
35709|NCT03063554|TEUS|teus
35711|NCT03063554|Endoscopic Ultrasound|endoscopic ultrasound
35712|NCT03063528|Pregnancy|pregnancy
35713|NCT03063528|Weight|weight
35714|NCT03063528|Gestational weight gain|gestational weight gain
35715|NCT03063528|Stress reduction|stress reduction
35716|NCT03063528|Exercise|exercise
35718|NCT03063450|anti PD-L1|anti pd-l1
35719|NCT03063450|nivolumab|nivolumab
35720|NCT03063450|immunotherapy|immunotherapy
35721|NCT03063450|RECIST|recist
35722|NCT03063450|quality of life|quality of life
35723|NCT03063450|survival|survival
35724|NCT03063450|immune checkpoint inhibition|immune checkpoint inhibition
35725|NCT03063437|vancomycin resistant enterococcus|vancomycin resistant enterococcus
35726|NCT03063437|VRE|vre
35727|NCT03063437|decolonization|decolonization
35728|NCT03063437|VRE colonization|vre colonization
35729|NCT03063437|fecal microbiota transplantation|fecal microbiota transplantation
35730|NCT03063437|FMT|fmt
35731|NCT03063437|FMT capsule|fmt capsule
35732|NCT03063437|capsule|capsule
35733|NCT03063437|antimicrobial resistance|antimicrobial resistance
35734|NCT03063437|antibiotic resistance|antibiotic resistance
35735|NCT03063437|MDRO|mdro
35736|NCT03063437|multidrug-resistant organism|multidrug-resistant organism
35737|NCT03063437|OpenBiome|openbiome
35738|NCT03063424|isocapnic voluntary hyperventilation|isocapnic voluntary hyperventilation
35739|NCT03063424|eucapnic voluntary hyperventilation|eucapnic voluntary hyperventilation
35740|NCT03063424|exercise induced bronchoconstriction|exercise induced bronchoconstriction
35741|NCT03063424|exercise challenge cycle ergometer|exercise challenge cycle ergometer
35742|NCT03063411|Maths reasoning|maths reasoning
35743|NCT03063411|Working memory|working memory
35744|NCT03063411|Executive Functions|executive functions
35745|NCT03063411|Cognitive Control|cognitive control
35746|NCT03063411|Academic Skills|academic skills
35747|NCT03063411|Randomised Control Trial|randomised control trial
35748|NCT03063385|Adolescents|adolescents
35749|NCT03063385|Parents|parents
35750|NCT03063385|Web-based|web-based
35751|NCT03063385|Puerto Rico|puerto rico
35752|NCT03063385|Latino|latino
35753|NCT03063385|Sexual communication|sexual communication
35754|NCT03063385|Stigma|stigma
35755|NCT03063385|Randomized controlled trial|randomized controlled trial
35756|NCT03063385|STD|std
35757|NCT03063385|Intercourse|intercourse
35758|NCT03063385|Sexual behavior|sexual behavior
35759|NCT03063385|HIV/AIDS|hiv/aids
35760|NCT03063372|Pomegranate|pomegranate
35761|NCT03063372|Burnout|burnout
35762|NCT03063372|Psychological Distress|psychological distress
35763|NCT03063372|Antioxidant|antioxidant
35764|NCT03063359|traumatic pain|traumatic pain
35765|NCT03063359|children|children
35766|NCT03063359|fentanyl|fentanyl
35767|NCT03063359|intranasal use|intranasal use
35768|NCT03063333|spinal cord injury|spinal cord injury
35769|NCT03063333|hypnosis|hypnosis
35770|NCT03063333|pain|pain
35771|NCT03063333|pain catastrophizing|pain catastrophizing
35772|NCT03063333|coping|coping
35773|NCT03063307|Tooth, Deciduous|tooth, deciduous
35774|NCT03063307|Dental Caries|dental caries
35775|NCT03063307|Glass Ionomer Cements|glass ionomer cements
35776|NCT03063307|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
35777|NCT03063307|Cariostatic Agents|cariostatic agents
35778|NCT03063307|Fluorides|fluorides
35779|NCT03063294|Coordination, Administrative|coordination, administrative
35780|NCT03063294|Coaching|coaching
35781|NCT03063294|Primary Care|primary care
35782|NCT03063294|Quality Improvement|quality improvement
35783|NCT03063281|ficolin-2|ficolin-2
35784|NCT03063281|anti-ficolin-2 antibodies|anti-ficolin-2 antibodies
35785|NCT03063281|lupus nephritis|lupus nephritis
35786|NCT03063281|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
35787|NCT03063281|biomarker|biomarker
35788|NCT03063281|ficolin-3|ficolin-3
35789|NCT03063281|anti-ficolin-3 antibodies|anti-ficolin-3 antibodies
35790|NCT03063268|Electronic Consent|electronic consent
35791|NCT03063268|Human Behavior|human behavior
35792|NCT03063268|Bioethics|bioethics
35793|NCT03063268|Research Ethics|research ethics
35794|NCT03063268|Electronic Medical Records (EMR)|electronic medical records (emr)
35795|NCT03063268|Electronic Health Records (EHR)|electronic health records (ehr)
35796|NCT03063268|Informed Consent Form|informed consent form
35797|NCT03063268|Interactive Consent|interactive consent
35798|NCT03063268|Health Record Data|health record data
35799|NCT03063242|Sargramostim|sargramostim
35800|NCT03063229|Insulin Pump Therapy|insulin pump therapy
35801|NCT03063229|Islet Cell Transplant|islet cell transplant
35802|NCT03063229|Energy Expenditure|energy expenditure
35803|NCT03063177|chronic thoracic pain|chronic thoracic pain
35804|NCT03063177|spine stiffness|spine stiffness
35805|NCT03063177|spinal manipulation|spinal manipulation
35806|NCT03063177|spinal manipulative therapy|spinal manipulative therapy
35807|NCT03063164|Femtosecond laser|femtosecond laser
35808|NCT03063164|Visumax|visumax
35809|NCT03063164|Intralase IFS150|intralase ifs150
35810|NCT03063164|LASIK|lasik
35811|NCT03063138|Diabetic foot ulcer|diabetic foot ulcer
35812|NCT03063138|Measurement|measurement
35813|NCT03063138|Wound healing|wound healing
35814|NCT03063138|Measurement device|measurement device
35815|NCT03063138|Three-dimensional measurements|three-dimensional measurements
35816|NCT03063125|radical cystectomy|radical cystectomy
35817|NCT03063125|hypogonadism|hypogonadism
35818|NCT03063008|Lumbar spine; Fusion; Titanium; PEEK|lumbar spine; fusion; titanium; peek
35819|NCT03062930|stroke|stroke
35820|NCT03062930|hemiparesis|hemiparesis
35821|NCT03062930|lesion hemisphere|lesion hemisphere
35822|NCT03062930|ipsilesional deficits|ipsilesional deficits
35823|NCT03062930|contralesional deficits|contralesional deficits
35824|NCT03062930|rehabilitation|rehabilitation
35825|NCT03062930|remediation|remediation
35826|NCT03062930|paretic arm|paretic arm
35827|NCT03062904|healthy|healthy
35828|NCT03062904|respiratory system|respiratory system
35829|NCT03062904|ventilation|ventilation
35830|NCT03062904|paradoxical effect|paradoxical effect
35831|NCT03062904|methacholine|methacholine
35832|NCT03062904|bronchodilator|bronchodilator
35833|NCT03062904|NEP|nep
35834|NCT03062904|EFL|efl
35835|NCT03062865|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
35836|NCT03062865|TNF-alpha inhibitors|tnf-alpha inhibitors
35837|NCT03062852|Medication Errors/prevention & control|medication errors/prevention & control
35838|NCT03062852|Nursing Staff, Hospital/organization & administration|nursing staff, hospital/organization & administration
35839|NCT03062852|Drug Therapy/nursing|drug therapy/nursing
35841|NCT03062852|Medication Systems, Hospital/organization & administration|medication systems, hospital/organization & administration
35844|NCT03062813|Hepatitis B virus, tacrolimus,membranous nephropathy|hepatitis b virus, tacrolimus,membranous nephropathy
35845|NCT03062800|thalidomide|thalidomide
35846|NCT03062800|pemetrexed|pemetrexed
35847|NCT03062800|nsclc|nsclc
35848|NCT03062800|maintenance treatment|maintenance treatment
35849|NCT03062722|microsurgical treatment|microsurgical treatment
35850|NCT03062722|pain|pain
35851|NCT03062722|dexterity|dexterity
35852|NCT03062722|Phalen sign|phalen sign
35853|NCT03062722|functional status|functional status
35854|NCT03062709|tobacco cessation|tobacco cessation
35855|NCT03062709|bronchiolitis|bronchiolitis
35856|NCT03062709|pneumonia|pneumonia
35857|NCT03062709|pediatric|pediatric
35858|NCT03062709|environmental tobacco smoke|environmental tobacco smoke
35859|NCT03062709|secondhand tobacco smoke|secondhand tobacco smoke
35860|NCT03062709|thirdhand tobacco smoke|thirdhand tobacco smoke
35861|NCT03062709|tobacco smoke|tobacco smoke
35862|NCT03062709|asthma|asthma
35863|NCT03062709|reactive airway disease|reactive airway disease
35864|NCT03062709|bronchopulmonary dysplasia|bronchopulmonary dysplasia
35866|NCT03062683|syncope|syncope
35867|NCT03062644|Open Total or Subtotal Abdominal Hysterectomy|open total or subtotal abdominal hysterectomy
35868|NCT03062631|Congenital Myasthenic Syndrome|congenital myasthenic syndrome
35869|NCT03062631|Lambert-Eaton Myasthenic Syndrome|lambert-eaton myasthenic syndrome
35870|NCT03062631|3,4 DAP|3,4 dap
35871|NCT03062631|3,4 Diaminopyridine|3,4 diaminopyridine
35872|NCT03062592|incretin|incretin
35873|NCT03062592|insulin|insulin
35874|NCT03062592|glucose|glucose
35875|NCT03062566|biomarkers|biomarkers
35876|NCT03062566|point-of-care analysis|point-of-care analysis
35877|NCT03062540|PTSD|ptsd
35878|NCT03062540|Military-related PTSD|military-related ptsd
35879|NCT03062527|Nutrition|nutrition
35880|NCT03062527|Training support|training support
35881|NCT03062527|Low Glycemic Index|low glycemic index
35882|NCT03062527|Moderate Glycemic Index|moderate glycemic index
35883|NCT03062527|Endurance|endurance
35884|NCT03062527|Running|running
35885|NCT03062449|L-Serine, Alzheimer's Disease, AD, Memory,|l-serine, alzheimer's disease, ad, memory,
35886|NCT03062436|CML, treatment free remission|cml, treatment free remission
35887|NCT03062410|Health Related Quality of Life|health related quality of life
35888|NCT03062410|Routine clinical practice|routine clinical practice
35889|NCT03062410|Electronic Patient Reported Outcome|electronic patient reported outcome
35890|NCT03062410|EORTC QLQ-C30|eortc qlq-c30
35891|NCT03062410|Pazopanib|pazopanib
35892|NCT03062410|Sunitinib|sunitinib
35893|NCT03062410|Tyrosine Kinase Inhibitor anti-VEGF|tyrosine kinase inhibitor anti-vegf
35894|NCT03062410|Patient Reported Outcome|patient reported outcome
35895|NCT03062410|Supportive Care|supportive care
35896|NCT03062410|Quality of Life|quality of life
35897|NCT03062384|brain|brain
35898|NCT03062384|health|health
35899|NCT03062358|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
35900|NCT03062358|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
35901|NCT03062358|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
35903|NCT03062358|PD-1|pd-1
35904|NCT03062358|PDL1|pdl1
35905|NCT03062358|PD-L1|pd-l1
35906|NCT03062358|PDL2|pdl2
35907|NCT03062345|Stroke|stroke
35908|NCT03062345|Virtual Reality Therapy|virtual reality therapy
35909|NCT03062345|Rehabilitation|rehabilitation
35910|NCT03062345|Upper Extremity|upper extremity
35911|NCT03062345|Arm|arm
35912|NCT03062345|Telerehabilitation|telerehabilitation
35913|NCT03062319|anticoagulant|anticoagulant
35914|NCT03062319|antiplatelet|antiplatelet
35915|NCT03062306|Cerebral Oxygenation|cerebral oxygenation
35916|NCT03062306|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
35917|NCT03062306|Chest Compression|chest compression
35918|NCT03062293|Lumbo-pelvic muscles|lumbo-pelvic muscles
35919|NCT03062293|Rehabilitation|rehabilitation
35920|NCT03062293|Exercise|exercise
35921|NCT03062293|Low back pain|low back pain
35922|NCT03062293|Functional Re-adaptive Exercise Device|functional re-adaptive exercise device
35923|NCT03062280|Extension study|extension study
35924|NCT03062267|mhealth|mhealth
35925|NCT03062267|texting intervention|texting intervention
35926|NCT03062267|mobile health|mobile health
35927|NCT03062267|mobile mental health|mobile mental health
35928|NCT03062254|PSMA|psma
35929|NCT03062241|cryoablation|cryoablation
36833|NCT03055819|Brow Ptosis|brow ptosis
35930|NCT03062241|conventional treatment of heart failure|conventional treatment of heart failure
35931|NCT03062228|stillbirth|stillbirth
35932|NCT03062228|sleep|sleep
35933|NCT03062228|low birth weight|low birth weight
35934|NCT03062228|pregnancy|pregnancy
35935|NCT03062228|supine|supine
38137|NCT03047577|Intensive care unit|intensive care unit
35936|NCT03062228|small for gestational age|small for gestational age
35937|NCT03062215|Culturally adapted psychotherapy|culturally adapted psychotherapy
35938|NCT03062215|Internet-delivered treatment|internet-delivered treatment
35939|NCT03062215|Depression|depression
35940|NCT03062215|Latin America|latin america
35941|NCT03062202|Depression|depression
35943|NCT03062202|Online interventions|online interventions
35944|NCT03062202|CBT|cbt
35945|NCT03062202|IAPT|iapt
35946|NCT03062176|Heart failure|heart failure
35947|NCT03062176|End-stage renal disease|end-stage renal disease
35948|NCT03062176|Interleukin-1|interleukin-1
35949|NCT03062176|Interleukin-1 receptor antagonist|interleukin-1 receptor antagonist
35950|NCT03062176|Metabolomics|metabolomics
35951|NCT03062176|Lipidomics|lipidomics
35952|NCT03062137|bronchoscopy|bronchoscopy
35953|NCT03062137|saturation|saturation
35954|NCT03062124|SpyGlass|spyglass
35955|NCT03062124|Pancreatoscopy|pancreatoscopy
35956|NCT03062072|normoglycemia|normoglycemia
35957|NCT03062072|cancer|cancer
35958|NCT03062072|chemotherapy|chemotherapy
35959|NCT03062072|Hyperglycemia Drug Induced|hyperglycemia drug induced
35960|NCT03062046|Atrial Fibrillation|atrial fibrillation
35961|NCT03062020|Preterm Birth|preterm birth
35962|NCT03062020|Asymptomatic high-risk women|asymptomatic high-risk women
35963|NCT03062020|QUIPP|quipp
35964|NCT03062020|Quantitative fetal fibronectin|quantitative fetal fibronectin
35965|NCT03062020|Cervical length|cervical length
35966|NCT03061968|acupressure|acupressure
35967|NCT03061968|very-low- birth-weight premature|very-low- birth-weight premature
35968|NCT03061968|body weight|body weight
35969|NCT03061968|behavioral state|behavioral state
35970|NCT03061968|developmental status|developmental status
35971|NCT03061903|total hip arthroplasty|total hip arthroplasty
35972|NCT03061903|direct anterior approach|direct anterior approach
35973|NCT03061903|wound complication|wound complication
35974|NCT03061890|children's environmental health|children's environmental health
35975|NCT03061890|prematurity|prematurity
35976|NCT03061890|preterm birth|preterm birth
35977|NCT03061890|phthalates|phthalates
35978|NCT03061890|NICU|nicu
35979|NCT03061890|stress|stress
35980|NCT03061890|lung health|lung health
35981|NCT03061890|neurodevelopment|neurodevelopment
35982|NCT03061890|growth|growth
35983|NCT03061877|Rheumatoid arthritis|rheumatoid arthritis
35984|NCT03061877|Anxiety|anxiety
35985|NCT03061877|Depression|depression
35986|NCT03061825|Aneurysm|aneurysm
35987|NCT03061825|Aortic Aneurysm|aortic aneurysm
35988|NCT03061825|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
35989|NCT03061825|Iliac Aneurysm|iliac aneurysm
35990|NCT03061825|Vascular Diseases|vascular diseases
35991|NCT03061825|Cardiovascular Diseases|cardiovascular diseases
35992|NCT03061825|Aortic Diseases|aortic diseases
35993|NCT03061812|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
35994|NCT03061812|rovalpituzumab tesirine|rovalpituzumab tesirine
35995|NCT03061812|metastatic|metastatic
35996|NCT03061812|Delta-like protein 3 (DLL3)|delta-like protein 3 (dll3)
35997|NCT03061812|topotecan|topotecan
35998|NCT03061760|Prostate cancer|prostate cancer
35999|NCT03061760|Incontinence|incontinence
36000|NCT03061760|Radical prostatectomy|radical prostatectomy
36001|NCT03061760|Urge urinary incontinence|urge urinary incontinence
36002|NCT03061734|Migraine Disorders|migraine disorders
36003|NCT03061734|Headache Disorders|headache disorders
36004|NCT03061734|Migraine with Aura|migraine with aura
36005|NCT03061734|Migraine without Aura|migraine without aura
36006|NCT03061721|NASH|nash
36007|NCT03061721|NAFLD|nafld
36008|NCT03061721|Saroglitazar|saroglitazar
36009|NCT03061669|heart failure|heart failure
36010|NCT03061669|pulmonary hypertension|pulmonary hypertension
36011|NCT03061669|right heart catheterization|right heart catheterization
36012|NCT03061591|Turmeric|turmeric
36013|NCT03061591|Curcumin|curcumin
36014|NCT03061591|colorectal polyps|colorectal polyps
36015|NCT03061591|colorectal neoplasia|colorectal neoplasia
36016|NCT03061591|mutyh mutation|mutyh mutation
36017|NCT03061591|apc mutation|apc mutation
36018|NCT03061578|Tear Film|tear film
36019|NCT03061578|Hyperspectral imaging|hyperspectral imaging
36020|NCT03061578|Low Humidity Environmental Exposure Chamber|low humidity environmental exposure chamber
36021|NCT03061565|erythropoietin|erythropoietin
36022|NCT03061565|traumatic brain injury|traumatic brain injury
36023|NCT03061539|Immunogenic signature|immunogenic signature
36024|NCT03061513|Parkinson Disease|parkinson disease
36025|NCT03061513|ubiquinol|ubiquinol
36026|NCT03061513|CoQ10|coq10
36027|NCT03061513|magnetic resonance spectroscopy|magnetic resonance spectroscopy
36028|NCT03061513|lactate|lactate
36029|NCT03061513|glutathione|glutathione
36030|NCT03061500|Proadrenomedullin|proadrenomedullin
36031|NCT03061500|Sepsis|sepsis
36032|NCT03061500|Intraabdominal Infections|intraabdominal infections
36033|NCT03061500|prognosis|prognosis
36034|NCT03061474|Mild Cognitive Impairment|mild cognitive impairment
38233|NCT03046836|Alcohol|alcohol
36035|NCT03061474|Alzheimer's Disease|alzheimer's disease
36036|NCT03061474|Nicotinamide|nicotinamide
36037|NCT03061474|Niacinamide|niacinamide
36038|NCT03061474|Niacin|niacin
36039|NCT03061474|Nicotinic Acids|nicotinic acids
36040|NCT03061474|Vitamin|vitamin
36041|NCT03061474|Neurodegenerative Diseases|neurodegenerative diseases
36042|NCT03061474|Tauopathies|tauopathies
36043|NCT03061474|Dementia|dementia
36044|NCT03061461|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
36045|NCT03061461|ESWT|eswt
36046|NCT03061461|Radial extracorporeal shock wave therapy|radial extracorporeal shock wave therapy
36047|NCT03061461|rESWT|reswt
36048|NCT03061461|Diabetes|diabetes
36049|NCT03061435|Vulvar Cancer|vulvar cancer
36050|NCT03061435|Cervical Cancer|cervical cancer
36051|NCT03061435|Vulvar Dysplasia|vulvar dysplasia
36052|NCT03061435|Cervical Dysplasia|cervical dysplasia
36053|NCT03061435|Anal Cancer|anal cancer
36054|NCT03061435|Anal Dysplasia|anal dysplasia
36056|NCT03061357|activity tracker|activity tracker
36057|NCT03061357|behavior change|behavior change
36058|NCT03061318|Fine Needle Aspiration, Genetic Classifier|fine needle aspiration, genetic classifier
36059|NCT03061279|Medial Malleolus fractures|medial malleolus fractures
36060|NCT03061279|headless screws|headless screws
36061|NCT03061279|headed screws|headed screws
36160|NCT03060473|Azithromycin|azithromycin
36062|NCT03061266|type 2 diabetes mellitus, application, e-health education|type 2 diabetes mellitus, application, e-health education
36063|NCT03061253|Electronic Cigarettes|electronic cigarettes
36064|NCT03061253|Laser Doppler Flowmetry|laser doppler flowmetry
36065|NCT03061253|Ultrasound|ultrasound
36066|NCT03061253|Nicotine Replacement Therapy|nicotine replacement therapy
36067|NCT03061240|Internet of Things|internet of things
36068|NCT03061136|Cognition|cognition
36071|NCT03061136|Executive function|executive function
36072|NCT03061136|Benzodiazepine|benzodiazepine
36075|NCT03061084|Spina Bifida,Neurogenic bladder, Myelomeningocele, Meningocele|spina bifida,neurogenic bladder, myelomeningocele, meningocele
36076|NCT03061071|Positional Sleep Apnea|positional sleep apnea
36077|NCT03061071|Positional Obstructive Sleep Apnea|positional obstructive sleep apnea
36078|NCT03061071|POSA|posa
36080|NCT03061071|Obstructive Sleep Apnea|obstructive sleep apnea
36081|NCT03061071|Sleep Apnea|sleep apnea
36082|NCT03061019|child|child
36083|NCT03061019|myofunctional therapy|myofunctional therapy
36084|NCT03061019|adenotonsillectomy|adenotonsillectomy
27615|NCT03112239|Photobiomodulation|photobiomodulation
27616|NCT03112239|Resistance Training|resistance training
27630|NCT03112187|IDA|ida
27631|NCT03112187|iron deficiency anemia|iron deficiency anemia
27632|NCT03112187|iron supplements|iron supplements
27633|NCT03112187|Pakistan|pakistan
36085|NCT03061019|randomized controlled trial|randomized controlled trial
36086|NCT03060993|Cannabis|cannabis
36087|NCT03060993|Marijuana|marijuana
36088|NCT03060967|motivation, instrumental tasks, food-related stimuli, size/time discrimination, major depression|motivation, instrumental tasks, food-related stimuli, size/time discrimination, major depression
36089|NCT03060954|Visual Disorder|visual disorder
36090|NCT03060928|Rotator Cuff Tear|rotator cuff tear
36091|NCT03060928|Artelon®|artelon®
36092|NCT03060915|Actigraphy|actigraphy
36093|NCT03060915|Polysomnography|polysomnography
36094|NCT03060915|Obstructive Sleep Apnea|obstructive sleep apnea
36095|NCT03060889|Cesarean section|cesarean section
36096|NCT03060889|placenta previa|placenta previa
36097|NCT03060889|Tranexamic acid|tranexamic acid
36098|NCT03060876|shoulder fractures|shoulder fractures
36099|NCT03060876|humeral fractures|humeral fractures
36100|NCT03060876|operative therapy|operative therapy
36101|NCT03060876|conservative therapy|conservative therapy
36102|NCT03060876|range of motion, articular|range of motion, articular
36103|NCT03060876|quality of life|quality of life
36104|NCT03060876|proximal|proximal
36105|NCT03060863|children|children
36106|NCT03060837|RIRS|rirs
36107|NCT03060837|Kidney Stone|kidney stone
36108|NCT03060837|Single lung ventilation|single lung ventilation
36109|NCT03060837|Simultaneous normal ventilation|simultaneous normal ventilation
36110|NCT03060824|Osmolality|osmolality
36111|NCT03060824|Sodium|sodium
36112|NCT03060824|CABG|cabg
36113|NCT03060824|Cardiovascular Diseases|cardiovascular diseases
36114|NCT03060824|Cardiopulmonary bypass|cardiopulmonary bypass
36115|NCT03060772|Pulmonary Medicine|pulmonary medicine
36116|NCT03060772|Oxidative Stress|oxidative stress
36117|NCT03060772|Pioglitazone|pioglitazone
36118|NCT03060772|Immunology|immunology
36119|NCT03060772|Addictive/Compulsive Behavior|addictive/compulsive behavior
36120|NCT03060759|Multiple Sclerosis|multiple sclerosis
36121|NCT03060759|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
36122|NCT03060759|Fatigue|fatigue
36123|NCT03060759|Light Therapy|light therapy
36834|NCT03055806|Sex|sex
36124|NCT03060720|Pancreatic Cancer|pancreatic cancer
36125|NCT03060694|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
36126|NCT03060694|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
36127|NCT03060668|Critical Illness|critical illness
36128|NCT03060668|Indirect Calorimetry|indirect calorimetry
36129|NCT03060668|Dietary Proteins|dietary proteins
36130|NCT03060655|PLGA-Mg|plga-mg
36131|NCT03060655|fracture|fracture
36132|NCT03060655|fixation|fixation
36133|NCT03060655|union|union
36134|NCT03060642|Microenvironment|microenvironment
36138|NCT03060642|Esophageal Adenocarcinoma|esophageal adenocarcinoma
36139|NCT03060603|Erythropoietin|erythropoietin
36140|NCT03060603|Endometrium|endometrium
36141|NCT03060603|Doppler Ultrasonography|doppler ultrasonography
36142|NCT03060590|sarcopenia, uremic toxins|sarcopenia, uremic toxins
36143|NCT03060564|shoulder|shoulder
36144|NCT03060564|orthopaedics|orthopaedics
36145|NCT03060525|Deaf|deaf
36146|NCT03060525|American Sign Language|american sign language
36147|NCT03060525|Overweight|overweight
36148|NCT03060525|Obese|obese
36149|NCT03060512|Opioid Induced constipation,|opioid induced constipation,
36150|NCT03060512|constipation,|constipation,
36151|NCT03060512|laxative,|laxative,
36152|NCT03060512|bowel movement,|bowel movement,
36153|NCT03060512|Movantik,|movantik,
36154|NCT03060512|Naloxegol|naloxegol
36155|NCT03060499|Thyroidectomy|thyroidectomy
36156|NCT03060499|Myocardial Function|myocardial function
36157|NCT03060499|Thyroid gland|thyroid gland
36158|NCT03060499|Heart|heart
36159|NCT03060473|PPROM|pprom
36161|NCT03060473|Erythromycin|erythromycin
36162|NCT03060434|pentoxifylline|pentoxifylline
36163|NCT03060434|Disc hernia|disc hernia
36164|NCT03060434|sciatica|sciatica
36165|NCT03060434|lumbar radiculopathy|lumbar radiculopathy
36166|NCT03060408|Fluid Therapy|fluid therapy
36167|NCT03060408|Laparoscopy|laparoscopy
36168|NCT03060369|Tissue Perfusion|tissue perfusion
36169|NCT03060369|Noninvasive Monitoring|noninvasive monitoring
36170|NCT03060369|Near-infrared spectroscopy|near-infrared spectroscopy
36171|NCT03060369|CareGuide|careguide
36172|NCT03060317|Disorders of consciousness|disorders of consciousness
36173|NCT03060317|validation studies|validation studies
36174|NCT03060317|coma|coma
36175|NCT03060317|vegetative state|vegetative state
36176|NCT03060304|tamoxifen|tamoxifen
36177|NCT03060304|thin endometrium|thin endometrium
36178|NCT03060304|frozen embryo transfer|frozen embryo transfer
36179|NCT03060304|pregnancy rate|pregnancy rate
36180|NCT03060291|Family Check-up|family check-up
36181|NCT03060278|smoking cessation, food pantry|smoking cessation, food pantry
36182|NCT03060265|multimodal analgesia|multimodal analgesia
36183|NCT03060265|paracetamol|paracetamol
36184|NCT03060265|cesarean section|cesarean section
36185|NCT03060252|Drug-Induced Liver Injury|drug-induced liver injury
36186|NCT03060239|Parkinson Disease|parkinson disease
36187|NCT03060239|Near infrared Spectroscopy|near infrared spectroscopy
36188|NCT03060239|REM sleep behaviour disorder|rem sleep behaviour disorder
36189|NCT03060239|Supplementary motor area|supplementary motor area
36190|NCT03060213|Well-Being|well-being
36191|NCT03060213|e-Health|e-health
36192|NCT03060213|Randomized Controlled Trial|randomized controlled trial
36193|NCT03060213|Self-Efficacy|self-efficacy
36194|NCT03060213|Interpersonal well-being|interpersonal well-being
36195|NCT03060213|Community well-being|community well-being
36196|NCT03060213|Occupational well-being|occupational well-being
36197|NCT03060213|Physical well-being|physical well-being
36198|NCT03060213|Psychological well-being|psychological well-being
36199|NCT03060213|Economic well-being|economic well-being
36200|NCT03060200|depression|depression
36201|NCT03060200|treatment|treatment
36202|NCT03060200|CBT|cbt
36203|NCT03060200|online|online
36204|NCT03060200|app|app
36205|NCT03060161|Health promotion|health promotion
36206|NCT03060161|Healthy Diet|healthy diet
36207|NCT03060161|Exercise|exercise
36208|NCT03060148|Heart failure|heart failure
36209|NCT03060148|Spinal cord stimulation|spinal cord stimulation
36210|NCT03060109|Traumatic brain injury|traumatic brain injury
36211|NCT03060109|Head injury|head injury
36212|NCT03060031|Oxytocin|oxytocin
36213|NCT03060005|Sjögren's syndrome|sjögren's syndrome
36214|NCT03060005|meibomian gland dysfunction|meibomian gland dysfunction
36215|NCT03060005|dry eye disease|dry eye disease
36216|NCT03059940|Smoking Cessation|smoking cessation
36217|NCT03059940|Low Dose computed tomography|low dose computed tomography
36218|NCT03059940|LDCT|ldct
36219|NCT03059940|Quitline|quitline
36220|NCT03059940|Questionnaires|questionnaires
36221|NCT03059940|Surveys|surveys
36222|NCT03059940|Counseling|counseling
36223|NCT03059940|Smoking cessation drugs|smoking cessation drugs
36224|NCT03059940|Anti-Smoking Drug|anti-smoking drug
36225|NCT03059940|Nicotine replacement therapy|nicotine replacement therapy
36226|NCT03059940|NRT|nrt
36227|NCT03059940|Nicotine Patch|nicotine patch
36228|NCT03059927|Cruciate retaining|cruciate retaining
36229|NCT03059927|Anterior stabilized|anterior stabilized
36230|NCT03059927|Posterior stabilized|posterior stabilized
36231|NCT03059927|Posterior cruciate ligament|posterior cruciate ligament
36232|NCT03059927|Degenerative knee joint disease|degenerative knee joint disease
36233|NCT03059927|Knee injury and Osteoarthritis Outcome Score|knee injury and osteoarthritis outcome score
36234|NCT03059927|Kinematic radiostereometry|kinematic radiostereometry
36235|NCT03059901|Physical Activity|physical activity
36236|NCT03059901|Latina Women|latina women
36237|NCT03059901|Minority Health|minority health
36238|NCT03059901|Mobile Technology|mobile technology
36239|NCT03059901|Social Support|social support
36240|NCT03059875|Breastcancer|breastcancer
36241|NCT03059875|Standardized Geriatric Evaluation|standardized geriatric evaluation
36242|NCT03059875|Onco-Geriatric Filter|onco-geriatric filter
36244|NCT03059862|Aryl-hydrocarbon receptor|aryl-hydrocarbon receptor
36245|NCT03059862|immune homeostasis|immune homeostasis
36246|NCT03059862|microbiota|microbiota
36247|NCT03059862|tryptophan|tryptophan
36248|NCT03059836|n3 PUFA|n3 pufa
36249|NCT03059823|Solid tumors|solid tumors
36250|NCT03059823|Metastatic cancer|metastatic cancer
36251|NCT03059745|Cholecystitis|cholecystitis
36252|NCT03059745|Cholelithiasis|cholelithiasis
36253|NCT03059732|Gastric cancer|gastric cancer
36254|NCT03059732|Thailand|thailand
36255|NCT03059732|Japan|japan
36256|NCT03059719|safety|safety
36257|NCT03059719|pharmacokinetics|pharmacokinetics
36258|NCT03059719|pharmacodynamics|pharmacodynamics
36259|NCT03059693|Eczema|eczema
36260|NCT03059693|Topical|topical
36261|NCT03059680|Potassium|potassium
36262|NCT03059680|Nutrition|nutrition
36263|NCT03059667|Small Cell Lun cancer|small cell lun cancer
36264|NCT03059667|IFCT|ifct
36265|NCT03059667|immune therapy|immune therapy
622069|NCT00668876|Th2|th2
36266|NCT03059654|Percutaneous tracheostomy|percutaneous tracheostomy
36267|NCT03059654|surgical tracheostomy|surgical tracheostomy
36268|NCT03059654|airway ultrasound|airway ultrasound
36269|NCT03059654|intensive care|intensive care
36270|NCT03059641|Next Generation Sequencing (NGS)|next generation sequencing (ngs)
36271|NCT03059641|Tyrosine Kinase Inhibitor (TKI)|tyrosine kinase inhibitor (tki)
36272|NCT03059641|liquid biopsy|liquid biopsy
36273|NCT03059641|EGFR Gene mutation|egfr gene mutation
36274|NCT03059589|food anaphylaxis|food anaphylaxis
36275|NCT03059589|peanut anaphylaxis|peanut anaphylaxis
36276|NCT03059589|food oral immunotherapy|food oral immunotherapy
36277|NCT03059589|food allergy|food allergy
36278|NCT03059589|food allergy treatment|food allergy treatment
36279|NCT03059576|Chronobiology|chronobiology
36280|NCT03059576|Circadian rhythms|circadian rhythms
36281|NCT03059576|Heritability|heritability
36282|NCT03059576|Twins|twins
36283|NCT03059563|Varenicline|varenicline
36284|NCT03059563|Positron Emission Tomography|positron emission tomography
36285|NCT03059563|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
36286|NCT03059563|Methamphetamine Abuse|methamphetamine abuse
36287|NCT03059550|cardiac rehabilitation|cardiac rehabilitation
36288|NCT03059550|prediabetes|prediabetes
36289|NCT03059524|microRNA|microrna
36290|NCT03059498|PECS I and II|pecs i and ii
36291|NCT03059498|PECS blocks|pecs blocks
36292|NCT03059485|Leukemia|leukemia
36293|NCT03059472|physical activity|physical activity
36294|NCT03059472|nutrition|nutrition
36295|NCT03059472|social network|social network
36296|NCT03059472|civic engagement|civic engagement
36297|NCT03059459|Lung Diseases, Obstructive|lung diseases, obstructive
36298|NCT03059459|Air Pollution|air pollution
36299|NCT03059459|Particulate Matter|particulate matter
36300|NCT03059433|Substance use|substance use
36301|NCT03059433|adolescent|adolescent
36302|NCT03059433|health|health
36303|NCT03059433|social network|social network
36304|NCT03059420|CFEOM (Congenital Fibrosis of Extraocular Muscles)|cfeom (congenital fibrosis of extraocular muscles)
36305|NCT03059420|CCDD (Congenital Cranial Dysinnervation Disorders)|ccdd (congenital cranial dysinnervation disorders)
36306|NCT03059420|DRS (Duane Retraction Syndrome)|drs (duane retraction syndrome)
36307|NCT03059420|DRRS (Duane Radial Ray Syndrome)|drrs (duane radial ray syndrome)
36308|NCT03059420|Strabismus|strabismus
36309|NCT03059420|MGJWS (Marcus Gunn Jaw Winking Syndrome)|mgjws (marcus gunn jaw winking syndrome)
36310|NCT03059420|HGP (Horizontal Gaze Palsy)|hgp (horizontal gaze palsy)
36311|NCT03059420|HGPPS (Horizontal Gaze Palsy with Progressive Scoliosis)|hgpps (horizontal gaze palsy with progressive scoliosis)
36312|NCT03059420|Moebius|moebius
36313|NCT03059394|reliability|reliability
36314|NCT03059394|validity|validity
36315|NCT03059394|measurement error|measurement error
36316|NCT03059381|adolescent epilepsy participants|adolescent epilepsy participants
36317|NCT03059381|partial seizures|partial seizures
36318|NCT03059381|primary generalized Tonic-clonic seizures|primary generalized tonic-clonic seizures
36319|NCT03059342|spastic diplegic CP|spastic diplegic cp
36320|NCT03059342|self-care|self-care
36321|NCT03059342|functional mobility|functional mobility
36322|NCT03059342|multilevel surgery|multilevel surgery
36323|NCT03059329|adult epilepsy participants|adult epilepsy participants
36324|NCT03059329|partial seizures|partial seizures
36325|NCT03059329|primary generalized Tonic-clonic seizures|primary generalized tonic-clonic seizures
36326|NCT03059316|controlled hypotension, perfusion|controlled hypotension, perfusion
36327|NCT03059290|post operative pain|post operative pain
36328|NCT03059290|Post operative flare ups|post operative flare ups
36329|NCT03059290|Post endodontic pain|post endodontic pain
36330|NCT03059290|Post endodontic flare ups|post endodontic flare ups
36331|NCT03059290|Necrotic teeth|necrotic teeth
36332|NCT03059290|Non vital teeth|non vital teeth
36333|NCT03059290|Neolix file|neolix file
36334|NCT03059290|Single rotating file|single rotating file
36335|NCT03059290|Protaper next file|protaper next file
36336|NCT03059290|Multiple rotating file|multiple rotating file
36337|NCT03059290|Single visit|single visit
36338|NCT03059277|Diabetic Macular Edema|diabetic macular edema
36339|NCT03059277|Diabetes|diabetes
36340|NCT03059277|reduced treatment frequency|reduced treatment frequency
36341|NCT03059251|CLL, obinutuzumab, treatment|cll, obinutuzumab, treatment
36342|NCT03059238|Pain control|pain control
36343|NCT03059238|TACE|tace
36344|NCT03059238|Opioids|opioids
36345|NCT03059238|NSAIDs|nsaids
36346|NCT03059225|Stroke|stroke
36347|NCT03059225|Aphasia|aphasia
36348|NCT03059225|rTMS|rtms
36349|NCT03059225|Functional MRI|functional mri
36350|NCT03059225|Speech training|speech training
36351|NCT03059212|working memory|working memory
36352|NCT03059212|parkinson's disease|parkinson's disease
36353|NCT03059199|Prospective/Retrospective|prospective/retrospective
36354|NCT03059173|Polycystic ovary syndrome|polycystic ovary syndrome
36355|NCT03059173|Reproductive medicine|reproductive medicine
36356|NCT03059160|Rett syndrome, Triheptanoic acid, Walking, EEG|rett syndrome, triheptanoic acid, walking, eeg
36357|NCT03059134|Overactive bladder|overactive bladder
36358|NCT03059134|Pharmacotherapy|pharmacotherapy
36359|NCT03059134|Adverse event|adverse event
36361|NCT03059121|Lipodystrophy|lipodystrophy
36362|NCT03059043|Phakic Intraocular Lenses|phakic intraocular lenses
36363|NCT03059043|viscoelastic|viscoelastic
36364|NCT03059030|Thrombocytopenia|thrombocytopenia
36365|NCT03059030|cirrhosis|cirrhosis
36366|NCT03059030|Therasphere®|therasphere®
36368|NCT03059030|Radioembolization|radioembolization
27933|NCT03110718|combined approach|combined approach
27934|NCT03110679|osteoarthritis|osteoarthritis
27935|NCT03110679|autologous bone marrow concentrate|autologous bone marrow concentrate
27936|NCT03110666|knee osteoarthritis ,|knee osteoarthritis ,
27937|NCT03110666|bone marrow aspirate|bone marrow aspirate
36369|NCT03059004|physical therapy|physical therapy
36371|NCT03058965|HV|hv
36372|NCT03058965|PSP|psp
36373|NCT03058952|pain management|pain management
36374|NCT03058952|fatigue|fatigue
36375|NCT03058952|mindfulness|mindfulness
36376|NCT03058952|Gulf War|gulf war
36377|NCT03058939|Breast Cancer|breast cancer
36378|NCT03058939|Breast Cancer Stage II|breast cancer stage ii
36379|NCT03058939|Breast Cancer Stage III|breast cancer stage iii
36380|NCT03058939|Paclitaxel|paclitaxel
36381|NCT03058939|Taxol|taxol
36382|NCT03058926|Chronic Pancreatitis|chronic pancreatitis
36383|NCT03058926|Diabetes|diabetes
36384|NCT03058926|Pancreatic Cancer|pancreatic cancer
36385|NCT03058926|Data Management|data management
36386|NCT03058926|Protocol compliance|protocol compliance
36387|NCT03058926|Regulatory compliance|regulatory compliance
36388|NCT03058926|Consortium studies|consortium studies
36389|NCT03058900|Fecal Microbiota Transplantation|fecal microbiota transplantation
36390|NCT03058900|FMT|fmt
36391|NCT03058900|Randomized Controlled Trial|randomized controlled trial
36392|NCT03058900|Intestinal microbiome|intestinal microbiome
36393|NCT03058900|RCT|rct
36394|NCT03058887|High Intensity Interval Training|high intensity interval training
36395|NCT03058887|Exercise|exercise
36396|NCT03058887|Microcirculation|microcirculation
36397|NCT03058874|Chronic Kidney Disease|chronic kidney disease
36398|NCT03058874|Hemodialysis|hemodialysis
36399|NCT03058874|Hypertension|hypertension
36400|NCT03058874|Arterial Stifness|arterial stifness
36401|NCT03058874|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
36402|NCT03058848|Phenylketonuria|phenylketonuria
36403|NCT03058848|PKU|pku
36404|NCT03058848|Metabolism|metabolism
36405|NCT03058848|Metabolic|metabolic
36406|NCT03058848|Control|control
36407|NCT03058848|Acceptability|acceptability
36408|NCT03058835|HIV|hiv
36409|NCT03058835|Truvada|truvada
36410|NCT03058796|stroke|stroke
36411|NCT03058796|rehabilitation|rehabilitation
36412|NCT03058796|Hemipelegia|hemipelegia
36413|NCT03058770|chronic stroke, sensorimotor retraining|chronic stroke, sensorimotor retraining
36414|NCT03058692|Immunogenicity|immunogenicity
36415|NCT03058692|Influenza A/H7N9 Vaccine|influenza a/h7n9 vaccine
36416|NCT03058692|M-001 vaccine|m-001 vaccine
36417|NCT03058692|MF59 Adjuvant|mf59 adjuvant
36418|NCT03058692|Reactogenicity|reactogenicity
36419|NCT03058692|Safety|safety
36420|NCT03058679|diet|diet
36421|NCT03058679|specific carbohydrate diet|specific carbohydrate diet
36422|NCT03058679|Mediterranean style diet|mediterranean style diet
36423|NCT03058679|randomized controlled trial|randomized controlled trial
36424|NCT03058666|Aerosol|aerosol
36425|NCT03058666|surfactant|surfactant
36426|NCT03058666|calfactant|calfactant
36427|NCT03058666|Infasurf|infasurf
36428|NCT03058666|Respiratory Distress Syndrome|respiratory distress syndrome
36430|NCT03058666|Premature|premature
36431|NCT03058666|Neonates|neonates
36432|NCT03058614|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
36433|NCT03058614|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
36434|NCT03058575|Microbiome|microbiome
36435|NCT03058575|Gut|gut
36436|NCT03058575|Skin|skin
36437|NCT03058575|Fiber|fiber
36438|NCT03058575|Starch|starch
36439|NCT03058549|Expectant parents|expectant parents
36440|NCT03058549|Relationship education|relationship education
36441|NCT03058536|twin short cervix pessary progesterone preterm birth|twin short cervix pessary progesterone preterm birth
36442|NCT03058523|Flavour|flavour
36443|NCT03058523|Infants|infants
36444|NCT03058523|Taste|taste
36445|NCT03058523|Pregnancy|pregnancy
36446|NCT03058523|Programming|programming
36447|NCT03058523|Fruit|fruit
36448|NCT03058523|Vegetables|vegetables
36449|NCT03058523|Bitter profile|bitter profile
36450|NCT03058523|Food preferences|food preferences
36451|NCT03058510|bifurcation lesion|bifurcation lesion
36452|NCT03058510|atherectomy|atherectomy
36453|NCT03058510|calcification|calcification
36454|NCT03058510|stent|stent
36455|NCT03058445|Central venous catheter|central venous catheter
36456|NCT03058445|MMode echocardiography|mmode echocardiography
36457|NCT03058406|Sarcoma, Soft Tissue|sarcoma, soft tissue
36458|NCT03058406|Halaven Injection|halaven injection
36459|NCT03058406|E7389|e7389
36460|NCT03058341|postoperative pain|postoperative pain
36461|NCT03058341|propofol|propofol
36462|NCT03058341|TIVA|tiva
583398|NCT00511576|HDAC Inhibitor|hdac inhibitor
36463|NCT03058328|Inflammation/physiopathology, Immune System/immunology,|inflammation/physiopathology, immune system/immunology,
36464|NCT03058328|Neuroimmunomodulation/physiology, General Surgery|neuroimmunomodulation/physiology, general surgery
36465|NCT03058328|Heart Rate/physiology*Vagus Nerve/physiology*|heart rate/physiology*vagus nerve/physiology*
36466|NCT03058315|Physical activity|physical activity
36467|NCT03058315|Disease perception|disease perception
36468|NCT03058315|Pain beliefs|pain beliefs
36469|NCT03058315|Disability|disability
36470|NCT03058315|Advice|advice
36471|NCT03058289|Neoplasm|neoplasm
36472|NCT03058289|Malignancy|malignancy
36473|NCT03058289|Intratumoral|intratumoral
36474|NCT03058289|Intralesional|intralesional
36475|NCT03058289|anti-PD-1 antibodies|anti-pd-1 antibodies
36476|NCT03058289|Immuno therapy|immuno therapy
36477|NCT03058289|Dose escalation|dose escalation
36478|NCT03058289|Platinum|platinum
36479|NCT03058289|Intensity Therapeutics|intensity therapeutics
36480|NCT03058289|INT230-6|int230-6
36481|NCT03058289|cisplatin|cisplatin
36482|NCT03058289|vinblastine|vinblastine
36483|NCT03058289|PD-1|pd-1
36484|NCT03058276|rTMS|rtms
36485|NCT03058276|AAT|aat
36486|NCT03058276|Alcohol-Dependence|alcohol-dependence
36487|NCT03058276|Relapses|relapses
36488|NCT03058224|Pain, Symptom Severity|pain, symptom severity
36489|NCT03058224|Immunoglobulin IgY|immunoglobulin igy
36490|NCT03058224|Fibromyalgia|fibromyalgia
36491|NCT03058224|Widespread Pain Index|widespread pain index
36492|NCT03058224|Eggyolk|eggyolk
36493|NCT03058224|FIQ-R|fiq-r
36494|NCT03058224|SF-36v2TM|sf-36v2tm
36495|NCT03058224|MOS-SS|mos-ss
36496|NCT03058224|FSS|fss
36497|NCT03058224|PGIC|pgic
36498|NCT03058224|Quality of life|quality of life
36499|NCT03058211|Pneumococcal pneumonia|pneumococcal pneumonia
36500|NCT03058211|Acute cardiovascular events|acute cardiovascular events
36501|NCT03058198|Glioma|glioma
36502|NCT03058198|PET|pet
36503|NCT03058198|EGFR vIII|egfr viii
36504|NCT03058198|Multimodal neuronavigation|multimodal neuronavigation
36505|NCT03058198|Molecular pathology|molecular pathology
36506|NCT03058198|PET-CT|pet-ct
36507|NCT03058198|Neuronavigation|neuronavigation
36508|NCT03058185|Lamin A/C|lamin a/c
36509|NCT03058185|Emerin|emerin
36510|NCT03058146|Exercise|exercise
36511|NCT03058146|Fitness|fitness
36512|NCT03058146|Physical Activity|physical activity
36513|NCT03058146|Cognitive Aging|cognitive aging
36514|NCT03058146|Cerebral Blood Flow|cerebral blood flow
36515|NCT03058146|Brain Imaging|brain imaging
36516|NCT03058146|Unsupervised Intervention|unsupervised intervention
36517|NCT03058146|Mobile Health|mobile health
36518|NCT03058146|Free-living exercise intervention|free-living exercise intervention
36519|NCT03058133|fMRI, perception, face-voice processing|fmri, perception, face-voice processing
36520|NCT03058107|Nutrition Therapy|nutrition therapy
36521|NCT03058081|COPD|copd
36522|NCT03058081|Exercise|exercise
36523|NCT03058081|High Flow Nasal|high flow nasal
36524|NCT03058081|Muscle Oxygenation|muscle oxygenation
36525|NCT03058081|Pulmonary Rehabilitation|pulmonary rehabilitation
36526|NCT03058042|Urinary Incontinence, Stress|urinary incontinence, stress
36527|NCT03058042|Pelvic Floor; Exercise|pelvic floor; exercise
36528|NCT03058042|Physical Therapy Modalities|physical therapy modalities
36529|NCT03058003|balance, postural|balance, postural
36530|NCT03058003|postural equilibrium|postural equilibrium
36531|NCT03058003|chronic pain|chronic pain
36532|NCT03058003|Chronic nonspecific low back pain|chronic nonspecific low back pain
36533|NCT03058003|Fibromyalgia|fibromyalgia
36534|NCT03058003|Cervicogenic headache|cervicogenic headache
36535|NCT03058003|Chronic tension type headache|chronic tension type headache
36536|NCT03058003|Irritable bowel syndrome|irritable bowel syndrome
36537|NCT03058003|Whiplash associated disorder|whiplash associated disorder
36538|NCT03058003|Temporomandibular disorder|temporomandibular disorder
36539|NCT03057990|Pyrimethamine|pyrimethamine
36540|NCT03057990|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
36541|NCT03057990|Refractory|refractory
36542|NCT03057990|Relapsed|relapsed
36543|NCT03057938|Alzheimer|alzheimer
36544|NCT03057938|Subjective Cognitive Decline|subjective cognitive decline
36545|NCT03057938|Florbetaben|florbetaben
36546|NCT03057925|thyroid nodule|thyroid nodule
36547|NCT03057925|microwave ablation|microwave ablation
36548|NCT03057912|Cervical intraepithelial neoplasiaⅠ|cervical intraepithelial neoplasiaⅰ
36549|NCT03057912|TALEN|talen
36550|NCT03057912|CRISPR/Cas9|crispr/cas9
36551|NCT03057899|Herbal medicine|herbal medicine
36552|NCT03057899|phytotherapy|phytotherapy
36553|NCT03057899|testosterone|testosterone
36554|NCT03057873|protein|protein
36555|NCT03057873|fiber|fiber
36556|NCT03057873|weight loss|weight loss
36557|NCT03057873|fat loss|fat loss
36558|NCT03057821|hydrogen peroxide|hydrogen peroxide
36559|NCT03057821|Propionibacterium Acnes|propionibacterium acnes
36560|NCT03057821|shoulder arthroplasty|shoulder arthroplasty
28145|NCT03109145|Secure messaging|secure messaging
28146|NCT03109119|genomic instability|genomic instability
36561|NCT03057808|Pregnancy|pregnancy
36562|NCT03057808|Postpartum|postpartum
36563|NCT03057782|Pain|pain
36564|NCT03057782|Sedation|sedation
36565|NCT03057782|Surgery|surgery
36566|NCT03057769|ERCP, post-ERCP pancreatitis, indomethacin, epinephrine|ercp, post-ercp pancreatitis, indomethacin, epinephrine
36567|NCT03057756|Multi-drug Resistant Tuberculosis|multi-drug resistant tuberculosis
36568|NCT03057756|short course regimen protocol|short course regimen protocol
36569|NCT03057730|acellular dermal matrix|acellular dermal matrix
36570|NCT03057704|Propofol|propofol
36571|NCT03057704|lidocaine|lidocaine
36572|NCT03057704|pain|pain
36573|NCT03057691|Acute Coronary Syndrome|acute coronary syndrome
36574|NCT03057691|Major Depressive Disorder|major depressive disorder
36575|NCT03057691|Generalized Anxiety Disorder|generalized anxiety disorder
36576|NCT03057691|Percutaneous Coronary Intervention|percutaneous coronary intervention
36577|NCT03057691|Major Adverse Cardiovascular Events|major adverse cardiovascular events
36578|NCT03057613|radiation|radiation
36579|NCT03057613|resected|resected
36580|NCT03057600|African ancestry|african ancestry
36581|NCT03057600|African American|african american
36582|NCT03057600|CB-839|cb-839
36583|NCT03057600|Glutaminase Inhibitor|glutaminase inhibitor
36584|NCT03057600|Glutaminase|glutaminase
36585|NCT03057600|TNBC|tnbc
36586|NCT03057600|Tumor Metabolism|tumor metabolism
36587|NCT03057600|Glutamine|glutamine
36588|NCT03057561|CAD|cad
36589|NCT03057548|Atrial Fibrillation|atrial fibrillation
36590|NCT03057548|Long-Standing Atrial Fibrillation|long-standing atrial fibrillation
36591|NCT03057548|Posterior Left Atrial Wall Ablation|posterior left atrial wall ablation
36592|NCT03057535|Exercise|exercise
36593|NCT03057535|Sodium Bicarbonate|sodium bicarbonate
36594|NCT03057535|Ventilatory equivalent for carbon dioxide|ventilatory equivalent for carbon dioxide
36595|NCT03057522|Run|run
36596|NCT03057522|Cadence|cadence
36597|NCT03057522|Home exercise|home exercise
36598|NCT03057509|Carcinoid Tumors|carcinoid tumors
36599|NCT03057470|Diabetes|diabetes
36600|NCT03057470|Exercise|exercise
36601|NCT03057470|Insulin|insulin
36602|NCT03057444|resistant starch type III|resistant starch type iii
36603|NCT03057444|butyrate-producing gut bacteria|butyrate-producing gut bacteria
36604|NCT03057444|diabetes mellitus type 2|diabetes mellitus type 2
36605|NCT03057444|prediabetes|prediabetes
36606|NCT03057431|kidney stones|kidney stones
36607|NCT03057431|hydrochlorothiazide|hydrochlorothiazide
36608|NCT03057405|intra-operative navigation|intra-operative navigation
36609|NCT03057405|3D virtual planning|3d virtual planning
36610|NCT03057405|intra-operative cone beam computed tomography (CBCT)|intra-operative cone beam computed tomography (cbct)
36611|NCT03057392|immersion|immersion
36612|NCT03057392|ultrafiltration|ultrafiltration
36613|NCT03057392|dialysis|dialysis
36614|NCT03057379|HPV vaccine|hpv vaccine
36615|NCT03057379|Immunization registry|immunization registry
36616|NCT03057379|Reminder recall|reminder recall
36617|NCT03057366|Drug therapy|drug therapy
36618|NCT03057340|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
36619|NCT03057340|Dribbles|dribbles
36620|NCT03057275|Threatened Premature Labor|threatened premature labor
36621|NCT03057275|Abdominal Fetal ECG|abdominal fetal ecg
36622|NCT03057262|temporomandibular joint disorders|temporomandibular joint disorders
36623|NCT03057262|disc displacement with reduction|disc displacement with reduction
36624|NCT03057262|anterior repositioning splint|anterior repositioning splint
36625|NCT03057249|Surgery|surgery
36626|NCT03057249|Thermography|thermography
36627|NCT03057249|Perfusion|perfusion
36628|NCT03057249|Imaging|imaging
36629|NCT03057236|psychological, behavioral, psychosocial, antiviral, liver|psychological, behavioral, psychosocial, antiviral, liver
36630|NCT03057223|3D printing|3d printing
36631|NCT03057223|patient-specific titanium plate|patient-specific titanium plate
36632|NCT03057223|mandibular malignancy|mandibular malignancy
36633|NCT03057223|dento-maxillofacial deformity|dento-maxillofacial deformity
36634|NCT03057223|orthognathic surgery|orthognathic surgery
36635|NCT03057223|mandibular reconstruction|mandibular reconstruction
36636|NCT03057210|Exercise|exercise
36637|NCT03057210|Massage|massage
36638|NCT03057210|Post-exercise recovery|post-exercise recovery
36639|NCT03057210|Athletic performance|athletic performance
36640|NCT03057184|Adult Day Care Center|adult day care center
36641|NCT03057184|behavioral problems|behavioral problems
36642|NCT03057184|caregivers|caregivers
36643|NCT03057171|Helicobacter pylori|helicobacter pylori
36644|NCT03057171|long non-coding RNA|long non-coding rna
36645|NCT03057171|THRIL|thril
36646|NCT03057171|PACER|pacer
36647|NCT03057171|cagA|caga
36648|NCT03057158|OAB|oab
36649|NCT03057158|Insulin resistance|insulin resistance
36650|NCT03057158|diabetes|diabetes
36651|NCT03057158|pre-diabetes|pre-diabetes
36652|NCT03057145|Solid Tumor|solid tumor
36653|NCT03057093|NSTEMI, ECG|nstemi, ecg
36654|NCT03057067|Embolization, Therapeutic|embolization, therapeutic
36655|NCT03057067|Pelvis|pelvis
36656|NCT03056976|Overdenture|overdenture
36664|NCT03056911|ozone therapy|ozone therapy
36665|NCT03056911|percutaneous treatment|percutaneous treatment
36666|NCT03056911|Oswestry Disability Index (ODI)|oswestry disability index (odi)
36667|NCT03056911|Visual analog Scale (VAS)|visual analog scale (vas)
36668|NCT03056911|Neuropathic Pain Questionnaire (DN-4)|neuropathic pain questionnaire (dn-4)
36669|NCT03056911|cervical|cervical
36670|NCT03056898|eicosapentaenoic acid|eicosapentaenoic acid
36672|NCT03056898|docosahexaenoic acid|docosahexaenoic acid
36673|NCT03056898|DHA|dha
36674|NCT03056898|omega-3 index|omega-3 index
36675|NCT03056885|one-lung ventilation|one-lung ventilation
36676|NCT03056885|broncho-alveolar lavage|broncho-alveolar lavage
36677|NCT03056885|protective ventilation|protective ventilation
36678|NCT03056885|cytokines|cytokines
36679|NCT03056885|thoracic surgery|thoracic surgery
36680|NCT03056859|Operator satisfaction with device|operator satisfaction with device
36681|NCT03056846|probiotic|probiotic
36682|NCT03056846|gastrointestinal|gastrointestinal
36683|NCT03056846|stress|stress
36684|NCT03056846|student|student
36685|NCT03056820|tracheal intubation|tracheal intubation
36686|NCT03056807|tolerable apneic time|tolerable apneic time
36687|NCT03056807|bariatric surgery|bariatric surgery
36688|NCT03056807|gastric band surgery|gastric band surgery
36689|NCT03056807|intubation|intubation
36690|NCT03056794|pyruvate|pyruvate
36691|NCT03056794|pyruvate dehydrogenase|pyruvate dehydrogenase
36692|NCT03056794|PDC|pdc
36693|NCT03056794|PDCD|pdcd
36702|NCT03056716|thoracic surgery|thoracic surgery
36703|NCT03056716|silastic drains|silastic drains
36704|NCT03056716|conventional drains|conventional drains
36705|NCT03056690|ASP0819|asp0819
36706|NCT03056690|Fibromyalgia|fibromyalgia
36707|NCT03056677|Whey protein|whey protein
36708|NCT03056677|Dietary supplementation|dietary supplementation
36709|NCT03056677|Glucose|glucose
36710|NCT03056677|GLP-1|glp-1
36711|NCT03056677|Satiety|satiety
36712|NCT03056651|heart failure|heart failure
36713|NCT03056651|day care|day care
36714|NCT03056651|prognosis|prognosis
36715|NCT03056638|Androgen Deprivation Therapy|androgen deprivation therapy
36716|NCT03056638|Ultra-Hypofractionated SBRT|ultra-hypofractionated sbrt
36717|NCT03056638|16-1686|16-1686
36718|NCT03056625|fortified rice|fortified rice
36719|NCT03056625|lactating women|lactating women
36720|NCT03056625|13C2-retinol isotope dilution|13c2-retinol isotope dilution
36721|NCT03056625|vitamin A liver store|vitamin a liver store
36722|NCT03056599|in vivo drug sensitivity|in vivo drug sensitivity
36723|NCT03056599|personalized medicine|personalized medicine
36724|NCT03056599|precision oncology|precision oncology
36725|NCT03056599|in vivo oncology|in vivo oncology
36726|NCT03056599|soft tissue sarcoma|soft tissue sarcoma
36727|NCT03056599|chemotherapy|chemotherapy
36728|NCT03056599|microinjection|microinjection
36729|NCT03056599|microdosing|microdosing
36730|NCT03056573|TAVI|tavi
36731|NCT03056573|Valvular heart disease|valvular heart disease
36732|NCT03056573|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
36733|NCT03056534|Primary Total Hip Arthroplasty|primary total hip arthroplasty
36734|NCT03056534|Non-Inflammatory Arthritis|non-inflammatory arthritis
36735|NCT03056534|Degenerative Joint Disease|degenerative joint disease
36736|NCT03056534|R3 Delta Ceramic Acetabular Insert|r3 delta ceramic acetabular insert
36737|NCT03056508|diet|diet
36738|NCT03056508|nutrition|nutrition
36739|NCT03056508|aerobic exercise|aerobic exercise
36740|NCT03056508|cognition|cognition
36741|NCT03056508|grey matter|grey matter
36742|NCT03056508|cerebral blood flow|cerebral blood flow
36743|NCT03056508|neural activity|neural activity
36744|NCT03056508|resting state connectivity|resting state connectivity
36745|NCT03056482|cannabis|cannabis
36746|NCT03056482|haloperidol|haloperidol
36747|NCT03056482|ondansetron|ondansetron
36748|NCT03056482|hyperemesis|hyperemesis
36749|NCT03056482|cyclic vomiting syndrome|cyclic vomiting syndrome
36750|NCT03056469|patient-reported outcomes|patient-reported outcomes
36751|NCT03056469|supportive care|supportive care
36752|NCT03056469|clinical practice|clinical practice
36753|NCT03056469|hematological cancer|hematological cancer
36754|NCT03056430|MRI, Neuroplasticity, Balance, Spatial orientation, Hippocampus, Slacklining|mri, neuroplasticity, balance, spatial orientation, hippocampus, slacklining
36755|NCT03056417|chronic pain|chronic pain
36757|NCT03056417|telomerase|telomerase
36758|NCT03056417|life style|life style
36759|NCT03056391|knowlesi malaria|knowlesi malaria
36760|NCT03056391|paracetamol|paracetamol
36761|NCT03056391|renal function|renal function
36762|NCT03056391|haemolysis|haemolysis
36763|NCT03056391|oxidative stress|oxidative stress
36764|NCT03056365|Detoxification|detoxification
36765|NCT03056365|Outpatient|outpatient
36766|NCT03056365|Advanced Nursing|advanced nursing
36767|NCT03056365|Health Services|health services
36768|NCT03056339|B-Lymphoid Malignancies|b-lymphoid malignancies
36769|NCT03056339|Relapsed/Refractory|relapsed/refractory
36770|NCT03056339|Acute lymphocytic leukemia|acute lymphocytic leukemia
36771|NCT03056339|ALL|all
36772|NCT03056339|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
36773|NCT03056339|CLL|cll
36774|NCT03056339|Non-Hodgkin lymphoma|non-hodgkin lymphoma
36775|NCT03056339|NHL|nhl
36776|NCT03056339|(CAR).CD19-CD28-zeta-2A-iCasp9-IL15-transduced cord blood natural killer cells|(car).cd19-cd28-zeta-2a-icasp9-il15-transduced cord blood natural killer cells
36777|NCT03056339|CB-NK cells|cb-nk cells
36778|NCT03056339|Fludarabine|fludarabine
36779|NCT03056339|Fludarabine phosphate|fludarabine phosphate
36780|NCT03056339|Fludara|fludara
36781|NCT03056339|Cyclophosphamide|cyclophosphamide
36782|NCT03056339|Cytoxan|cytoxan
36783|NCT03056339|Neosar|neosar
36784|NCT03056339|AP1903|ap1903
36785|NCT03056339|Mesna|mesna
36786|NCT03056339|Mesnex|mesnex
36787|NCT03056313|Delivery, Obstetric|delivery, obstetric
36788|NCT03056313|Uterine Contraction|uterine contraction
36789|NCT03056313|Cervix Uteri|cervix uteri
36790|NCT03056274|Metformin|metformin
36791|NCT03056274|Ursodeoxycholic acid|ursodeoxycholic acid
36792|NCT03056274|Outcomes|outcomes
36793|NCT03056261|Combined general-epidural anesthesia intestinal recovery|combined general-epidural anesthesia intestinal recovery
36794|NCT03056235|Atrophic acne scar|atrophic acne scar
36795|NCT03056209|Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation|mitochondrial dna trnaleu(uur) m.3243a<g mutation
36796|NCT03056157|Moral Injury|moral injury
36797|NCT03056157|Post-traumatic Stress Disorder|post-traumatic stress disorder
36798|NCT03056157|Traumatic Loss|traumatic loss
36799|NCT03056157|Adaptive Disclosure|adaptive disclosure
36800|NCT03056157|Veterans|veterans
36801|NCT03056144|spinal muscular atrophy|spinal muscular atrophy
36802|NCT03056144|total body vibration|total body vibration
36803|NCT03056144|children|children
36804|NCT03056118|OPTIMA-C|optima-c
36805|NCT03056105|Well-being, affiliation, inflammation|well-being, affiliation, inflammation
36806|NCT03056092|ranibizumab|ranibizumab
36807|NCT03056092|aqueous cytokine|aqueous cytokine
36808|NCT03056092|age related macular degeneration|age related macular degeneration
36809|NCT03056092|diabetic macular edema|diabetic macular edema
36810|NCT03056092|retinal vein occlusion|retinal vein occlusion
36811|NCT03056079|neovascular age related macular degeneration|neovascular age related macular degeneration
36812|NCT03056079|diabetic macular edema|diabetic macular edema
36813|NCT03056079|retinal vein occlusion|retinal vein occlusion
36814|NCT03056079|aflibercept|aflibercept
36815|NCT03056079|aqueous humor cytokine|aqueous humor cytokine
36816|NCT03056053|insomnia|insomnia
36817|NCT03055975|Bacteria|bacteria
36818|NCT03055975|Root canal treatment|root canal treatment
36819|NCT03055975|Endodontics|endodontics
36820|NCT03055962|Healthy Participants|healthy participants
36821|NCT03055962|E2609|e2609
36822|NCT03055962|Pharmacokinetics|pharmacokinetics
36823|NCT03055962|Japan|japan
36824|NCT03055949|early rehabilitation|early rehabilitation
36825|NCT03055949|early mobilization|early mobilization
36826|NCT03055949|surgical intensive care unit|surgical intensive care unit
36827|NCT03055884|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
36828|NCT03055884|accelerated learning|accelerated learning
36829|NCT03055884|memory|memory
36830|NCT03055871|Behavioural: Family physical activity habit|behavioural: family physical activity habit
36831|NCT03055858|PDA, ADO II AS|pda, ado ii as
36832|NCT03055819|Brow Lift|brow lift
36835|NCT03055806|Sexual Dysfunction|sexual dysfunction
36836|NCT03055806|IX-01|ix-01
36837|NCT03055741|Alzheimer's disease|alzheimer's disease
36838|NCT03055728|streptococcal infections|streptococcal infections
36839|NCT03055728|rapid strep testing|rapid strep testing
36840|NCT03055728|rapid antigen detection test|rapid antigen detection test
36841|NCT03055715|NSCLC|nsclc
36842|NCT03055715|Radiotherapy|radiotherapy
36843|NCT03055715|young DEGRO|young degro
36844|NCT03055715|tumor volume|tumor volume
36845|NCT03055715|lung cancer|lung cancer
36846|NCT03055715|radiochemotherapy|radiochemotherapy
36847|NCT03055715|prognostic factors|prognostic factors
36848|NCT03055702|Short Message Service|short message service
36849|NCT03055702|appointment reminder|appointment reminder
36850|NCT03055702|Attendance rate|attendance rate
36851|NCT03055689|Colonoscopy|colonoscopy
36852|NCT03055689|Educational intervention|educational intervention
36853|NCT03055676|Pancreaticoduodenectomy|pancreaticoduodenectomy
36854|NCT03055676|Time of drain removal|time of drain removal
36855|NCT03055624|prostate artery embolization (PAE)|prostate artery embolization (pae)
36856|NCT03055624|benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
36857|NCT03055624|lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
36858|NCT03055611|Blood Coagulation Disorder|blood coagulation disorder
36859|NCT03055611|Hematologic Diseases|hematologic diseases
28460|NCT03107013|Phase 1|phase 1
36860|NCT03055611|Coagulation Protein Disorder|coagulation protein disorder
36861|NCT03055611|Hemorrhagic Disorder|hemorrhagic disorder
36862|NCT03055611|Genetic Diseases, Inborn|genetic diseases, inborn
36863|NCT03055585|Wolbachia; Aedes aegypti; Indonesia; Dengue; Cluster-randomised trial|wolbachia; aedes aegypti; indonesia; dengue; cluster-randomised trial
36864|NCT03055572|Rhinitis|rhinitis
36865|NCT03055572|Chronic Rhinosinusitis|chronic rhinosinusitis
36866|NCT03055572|Olfactory Training|olfactory training
36867|NCT03055559|Iron, Hemoglobin, Feritin, erytrocyty. transferin|iron, hemoglobin, feritin, erytrocyty. transferin
36868|NCT03055546|oxytocin|oxytocin
36869|NCT03055546|emotion regulation|emotion regulation
36870|NCT03055533|Behavioral|behavioral
36871|NCT03055533|Social|social
36872|NCT03055533|Headsprout reading program|headsprout reading program
36873|NCT03055520|schizophrenia|schizophrenia
36874|NCT03055520|cognition|cognition
36875|NCT03055520|arithmetic training|arithmetic training
36876|NCT03055520|Kumon method|kumon method
36877|NCT03055481|neonatal jaundice|neonatal jaundice
36878|NCT03055481|phototherapy|phototherapy
36879|NCT03055481|neonate|neonate
36880|NCT03055429|Prisoners|prisoners
36881|NCT03055429|End-of-life care|end-of-life care
36882|NCT03055429|Geriatric care|geriatric care
36883|NCT03055429|Palliative care|palliative care
36884|NCT03055429|Hospice care|hospice care
36885|NCT03055416|Overweight|overweight
36886|NCT03055416|Obesity|obesity
36887|NCT03055416|Physical Activity|physical activity
36888|NCT03055416|African-American Men|african-american men
36889|NCT03055416|mHealth|mhealth
36890|NCT03055416|Mobile Health|mobile health
36891|NCT03055390|hyoscine butylbromide|hyoscine butylbromide
36892|NCT03055390|progress of labor|progress of labor
36893|NCT03055390|duration of labor|duration of labor
36894|NCT03055377|cannabis|cannabis
36895|NCT03055377|marijuana|marijuana
36896|NCT03055377|youth|youth
36897|NCT03055377|adolescent|adolescent
36898|NCT03055377|pharmacotherapy|pharmacotherapy
36899|NCT03055377|medication|medication
36900|NCT03055377|n-acetylcysteine|n-acetylcysteine
36901|NCT03055377|trial|trial
36902|NCT03055351|Exercise motivation|exercise motivation
36903|NCT03055351|Psychological well-being|psychological well-being
36904|NCT03055351|Healthy living|healthy living
36905|NCT03055351|Physical activity|physical activity
36906|NCT03055351|Autonomy support|autonomy support
36907|NCT03055351|Self-determination theory|self-determination theory
36908|NCT03055338|Schizophrenia, acute episode|schizophrenia, acute episode
36909|NCT03055338|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
36910|NCT03055338|Mental Disorders|mental disorders
36911|NCT03055247|Chronic granulomatous disease X-linked|chronic granulomatous disease x-linked
36912|NCT03055247|Ibuprofen|ibuprofen
36913|NCT03055247|Mobilization regimen|mobilization regimen
36914|NCT03055247|Gene Therapy|gene therapy
36915|NCT03055234|Oral treprostinil|oral treprostinil
36916|NCT03055234|6-Minute Walk Distance|6-minute walk distance
36918|NCT03055234|sickle cell|sickle cell
36919|NCT03055221|Remodulin|remodulin
36920|NCT03055221|6-Minute Walk Test|6-minute walk test
36921|NCT03055208|Glioblastoma|glioblastoma
36922|NCT03055208|Radiosurgery|radiosurgery
36923|NCT03055208|Gamma Knife|gamma knife
36924|NCT03055195|subcutaneous|subcutaneous
36925|NCT03055195|safety|safety
36926|NCT03055195|mepolizumab|mepolizumab
36927|NCT03055195|efficacy|efficacy
36928|NCT03055195|atopic dermatitis|atopic dermatitis
36929|NCT03055182|Isokinetic|isokinetic
36930|NCT03055182|oxygenation|oxygenation
36931|NCT03055182|deoxygenation|deoxygenation
36932|NCT03055182|aerobic metabolism|aerobic metabolism
36933|NCT03055169|hyperglycemia|hyperglycemia
36934|NCT03055169|Multiple Organ Failure|multiple organ failure
36935|NCT03055169|biobank|biobank
36936|NCT03055169|diabetes|diabetes
36937|NCT03055156|Sleep Apnea|sleep apnea
36938|NCT03055156|Insomnia|insomnia
36939|NCT03055156|sleep disorders|sleep disorders
36940|NCT03055156|sleep environment|sleep environment
36941|NCT03055156|core body temperature|core body temperature
36942|NCT03055117|Shoulder pain|shoulder pain
36943|NCT03055117|Physiotherapy|physiotherapy
36944|NCT03055117|Rehabilitation|rehabilitation
36945|NCT03055117|Exercise|exercise
36946|NCT03055104|severe malnutrition|severe malnutrition
36947|NCT03055104|Critically Ill|critically ill
36948|NCT03055104|refeeding syndrome|refeeding syndrome
36949|NCT03055104|guideline|guideline
36950|NCT03055065|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
36951|NCT03055000|Mosquito-Borne Diseases|mosquito-borne diseases
36952|NCT03055000|Universal Mosquito Vaccine|universal mosquito vaccine
36953|NCT03055000|Mosquito Transmission|mosquito transmission
36954|NCT03055000|Vector Borne Viruses|vector borne viruses
36955|NCT03055000|Vaccine|vaccine
36956|NCT03054974|Stroke|stroke
36957|NCT03054974|Traditional Chinese Medicine|traditional chinese medicine
36958|NCT03054974|Rehabilitation|rehabilitation
36959|NCT03054961|epilepsy|epilepsy
36960|NCT03054961|cytochrome oxidase redox state|cytochrome oxidase redox state
36961|NCT03054961|childhood epilepsy|childhood epilepsy
36962|NCT03054961|partial epilepsy|partial epilepsy
36963|NCT03054961|NIRS|nirs
36964|NCT03054961|near-infrared spectroscopy|near-infrared spectroscopy
36965|NCT03054961|regional cerebral oxygen saturation|regional cerebral oxygen saturation
36966|NCT03054935|Energy Expenditure|energy expenditure
36967|NCT03054935|Body Composition|body composition
36968|NCT03054935|Food Intake|food intake
36969|NCT03054896|Richter Syndrome|richter syndrome
36970|NCT03054883|Mantle Cell Lymphoma|mantle cell lymphoma
36971|NCT03054883|minimal residual disease|minimal residual disease
36972|NCT03054883|cytosine arabinoside|cytosine arabinoside
36973|NCT03054870|pulmonary ventilation|pulmonary ventilation
36974|NCT03054870|ventilation scintigraphy|ventilation scintigraphy
36975|NCT03054844|Intranasal|intranasal
36976|NCT03054844|Pain|pain
36977|NCT03054844|Lidocaine|lidocaine
36978|NCT03054844|Midazolam|midazolam
36979|NCT03054844|Emergency department|emergency department
36980|NCT03054766|Laser Photocoagulation|laser photocoagulation
36981|NCT03054766|Ranibizumab|ranibizumab
36982|NCT03054766|Branch Retinal Vein Occlusion|branch retinal vein occlusion
36983|NCT03054766|Vascular Endothecial Growth Factor|vascular endothecial growth factor
36984|NCT03054753|Abduction brace|abduction brace
36985|NCT03054753|Compliance|compliance
36986|NCT03054753|Rotator cuff tear|rotator cuff tear
36987|NCT03054753|Rotator cuff repair|rotator cuff repair
36988|NCT03054740|Vapocoolant applied prior to IV access|vapocoolant applied prior to iv access
36989|NCT03054727|Post Thrombotic Syndrome|post thrombotic syndrome
36990|NCT03054727|Venous Thromboembolism|venous thromboembolism
36991|NCT03054727|Incidence|incidence
36992|NCT03054727|Risk factors|risk factors
36993|NCT03054727|Venous ulcer|venous ulcer
36994|NCT03054701|Patellofemoral pain|patellofemoral pain
36995|NCT03054701|PFP|pfp
36996|NCT03054701|PFPS|pfps
36997|NCT03054675|lung resection|lung resection
36998|NCT03054675|lung function|lung function
36999|NCT03054675|VATS|vats
37000|NCT03054675|Thoracotomy|thoracotomy
37001|NCT03054662|Haemophilia|haemophilia
37002|NCT03054610|plantar fascitis|plantar fascitis
37003|NCT03054610|Botulinum toxin A|botulinum toxin a
37004|NCT03054610|Betamethason Sodium Phosphate|betamethason sodium phosphate
37005|NCT03054610|infiltration|infiltration
37006|NCT03054610|plantar fascia|plantar fascia
37007|NCT03054558|Junctional zone|junctional zone
37008|NCT03054558|recurrent pregnancy loss|recurrent pregnancy loss
37009|NCT03054558|3D power Doppler|3d power doppler
37010|NCT03054480|Fractional Micro-Needle Radiofrequency|fractional micro-needle radiofrequency
37011|NCT03054480|Intradermal Botulinum Toxin A|intradermal botulinum toxin a
37012|NCT03054441|Upper limb|upper limb
37013|NCT03054441|Inertial sensors|inertial sensors
37014|NCT03054415|neuronal-glial-epithelial unit, anorectal function|neuronal-glial-epithelial unit, anorectal function
37015|NCT03054376|Immobilization|immobilization
37016|NCT03054376|Angiogenesis|angiogenesis
37017|NCT03054376|Skeletal muscle|skeletal muscle
37018|NCT03054376|Exercise training|exercise training
37019|NCT03054376|Vascular function|vascular function
37020|NCT03054363|Metastatic Breast Cancer|metastatic breast cancer
37021|NCT03054363|Tucatinib|tucatinib
37022|NCT03054363|Palbociclib|palbociclib
37023|NCT03054363|Letrozole|letrozole
37024|NCT03054363|HR-positive|hr-positive
37025|NCT03054363|HER2-positive|her2-positive
37026|NCT03054363|ER-positive|er-positive
37027|NCT03054363|PR-positive|pr-positive
37028|NCT03054363|HER2-targeted therapy|her2-targeted therapy
37029|NCT03054363|CDK4/6 inhibitor|cdk4/6 inhibitor
37030|NCT03054363|ONT-380|ont-380
37031|NCT03054363|Ibrance|ibrance
37032|NCT03054350|Anemia|anemia
37033|NCT03054350|kidney|kidney
37034|NCT03054350|dialysis-dependent chronic kidney disease|dialysis-dependent chronic kidney disease
37035|NCT03054350|CKD|ckd
37036|NCT03054350|DD-CKD|dd-ckd
37037|NCT03054350|renal|renal
37038|NCT03054350|vadadustat|vadadustat
37039|NCT03054350|AKB-6548|akb-6548
37040|NCT03054350|hypoxia-inducible factor|hypoxia-inducible factor
37041|NCT03054350|HIF|hif
37042|NCT03054350|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
37043|NCT03054350|HIF-PHI|hif-phi
37044|NCT03054350|Japan|japan
37045|NCT03054350|Japanese|japanese
37046|NCT03054337|Anemia|anemia
37047|NCT03054337|kidney|kidney
37048|NCT03054337|non-dialysis dependent chronic kidney disease|non-dialysis dependent chronic kidney disease
37049|NCT03054337|CKD|ckd
37050|NCT03054337|NDD-CKD|ndd-ckd
37051|NCT03054337|renal|renal
37052|NCT03054337|vadadustat|vadadustat
37053|NCT03054337|AKB-6548|akb-6548
37054|NCT03054337|hypoxia-inducible factor|hypoxia-inducible factor
37055|NCT03054337|HIF|hif
37056|NCT03054337|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
37057|NCT03054337|HIF-PHI|hif-phi
37058|NCT03054337|Japan|japan
37059|NCT03054337|Japanese|japanese
37060|NCT03054324|Cardiovascular Diseases|cardiovascular diseases
37061|NCT03054324|Fractional Flow Reserve|fractional flow reserve
37062|NCT03054324|Ischemic Heart Disease|ischemic heart disease
37063|NCT03054324|CT Angiogram|ct angiogram
37064|NCT03054285|Seizures|seizures
37065|NCT03054285|Traumatic Brain Injury|traumatic brain injury
37066|NCT03054285|Prophylaxis|prophylaxis
37067|NCT03054285|Levetiracetam|levetiracetam
37068|NCT03054272|High-fidelity simulation|high-fidelity simulation
37069|NCT03054272|Eye-tracking|eye-tracking
37070|NCT03054272|Difficult intubation|difficult intubation
37071|NCT03054233|spinal anesthesia|spinal anesthesia
37072|NCT03054233|spinal-bone contact|spinal-bone contact
37073|NCT03054233|caesarian section|caesarian section
37074|NCT03054233|crossed leg sitting position|crossed leg sitting position
37075|NCT03054194|Healthy participants|healthy participants
37076|NCT03054194|E2730|e2730
37077|NCT03054194|Pharmacokinetics|pharmacokinetics
37078|NCT03054181|Observational|observational
37079|NCT03054181|Infection|infection
37080|NCT03054181|Utilisation|utilisation
37081|NCT03054181|Safety|safety
37082|NCT03054181|Tolerability|tolerability
37083|NCT03054181|Infusion|infusion
37084|NCT03054181|chronic|chronic
37085|NCT03054168|Protein Synthesis|protein synthesis
37086|NCT03054168|Hypertrophy|hypertrophy
37087|NCT03054168|Testosterone|testosterone
37088|NCT03054155|hidradenitis suppurativa|hidradenitis suppurativa
37089|NCT03054155|hidradenitis|hidradenitis
37090|NCT03054155|laser|laser
37091|NCT03054103|ketamine|ketamine
37092|NCT03054103|midazolam|midazolam
37093|NCT03054103|sedation|sedation
37094|NCT03054090|Cardiovascular Diseases|cardiovascular diseases
37095|NCT03054090|Primary Care|primary care
37096|NCT03054077|pre-procedural anxiety|pre-procedural anxiety
37097|NCT03054077|children|children
37098|NCT03054077|pediatric sedation|pediatric sedation
37099|NCT03054051|HIV prevention|hiv prevention
37100|NCT03054051|Preadolescence|preadolescence
37101|NCT03054051|Mobile phone game|mobile phone game
37102|NCT03054051|Feasibility|feasibility
37103|NCT03054012|CAD-CAM software|cad-cam software
37104|NCT03054012|accuracy|accuracy
37105|NCT03054012|head and neck region|head and neck region
37106|NCT03054012|mandibular reconstruction|mandibular reconstruction
37107|NCT03053999|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
37108|NCT03053999|Pancreatic Neuroendocrine Tumors|pancreatic neuroendocrine tumors
37109|NCT03053999|Hyperparathyroidism|hyperparathyroidism
37110|NCT03053999|HPTH|hpth
37111|NCT03053999|PNET|pnet
37112|NCT03053999|Biomarkers|biomarkers
37113|NCT03053999|Parathyroidectomy|parathyroidectomy
37114|NCT03053999|Genome sequencing|genome sequencing
37115|NCT03053999|Data review|data review
37116|NCT03053973|COPD|copd
37117|NCT03053973|airway inflammation|airway inflammation
37118|NCT03053973|airway remodeling|airway remodeling
37119|NCT03053973|health-related auality of life|health-related auality of life
37120|NCT03053973|forced expiratory volume 1 second|forced expiratory volume 1 second
37121|NCT03053947|Intranasal Ketamine|intranasal ketamine
37122|NCT03053947|Pain Management|pain management
37123|NCT03053934|Online counselling|online counselling
37124|NCT03053921|gingival recession|gingival recession
37125|NCT03053921|Zuchellis technique,|zuchellis technique,
37126|NCT03053921|placental membrane|placental membrane
37127|NCT03053908|Orexin|orexin
37128|NCT03053908|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
37129|NCT03053882|mouth wash , green tea , peppermint , bad breath|mouth wash , green tea , peppermint , bad breath
37130|NCT03053856|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
37131|NCT03053856|Adjuvant pembrolizumab|adjuvant pembrolizumab
37132|NCT03053843|Atrial fibrillation|atrial fibrillation
37133|NCT03053843|Mediterranean Diet|mediterranean diet
37134|NCT03053843|Extra Virgin Olive Oil|extra virgin olive oil
37135|NCT03053843|Ablation|ablation
37136|NCT03053830|Ketamine|ketamine
37137|NCT03053830|Major Depressive Disorder|major depressive disorder
37138|NCT03053804|MR/PET|mr/pet
37139|NCT03053804|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
37140|NCT03053791|Deep brain stimulation|deep brain stimulation
37147|NCT03053791|Pedunculopontine nucleus|pedunculopontine nucleus
37149|NCT03053778|Readmission|readmission
37150|NCT03053778|Early follow-up|early follow-up
37151|NCT03053778|Heart valves|heart valves
37152|NCT03053778|Heart valve surgery|heart valve surgery
37539|NCT03051191|cancer|cancer
37162|NCT03053661|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
37163|NCT03053661|cancer-specific immunity|cancer-specific immunity
37165|NCT03053661|cancer-testis antigens|cancer-testis antigens
37166|NCT03053661|human papilloma virus|human papilloma virus
37167|NCT03053661|immune modulatory cells|immune modulatory cells
37168|NCT03053648|Insomnia|insomnia
37169|NCT03053648|Randomized controlled trial|randomized controlled trial
37170|NCT03053648|Acupressure|acupressure
37171|NCT03053648|Self-help|self-help
37172|NCT03053635|Photodynamic Therapy|photodynamic therapy
37173|NCT03053635|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
37174|NCT03053635|Urothelial carcinoma|urothelial carcinoma
37175|NCT03053635|Ta bladder cancer|ta bladder cancer
37176|NCT03053635|T1 bladder cancer|t1 bladder cancer
37177|NCT03053635|Refractory to BCG|refractory to bcg
37178|NCT03053609|gastroesophageal reflux|gastroesophageal reflux
37179|NCT03053609|apnea|apnea
37180|NCT03053609|bradycardia|bradycardia
37181|NCT03053609|desaturation|desaturation
37182|NCT03053609|impedance|impedance
37183|NCT03053596|HCC|hcc
37184|NCT03053596|LifePearl|lifepearl
37185|NCT03053583|larynx, laryngoscopy|larynx, laryngoscopy
37186|NCT03053583|vocal cords, laryngoscopy|vocal cords, laryngoscopy
37187|NCT03053583|airway|airway
37188|NCT03053583|pediatric|pediatric
37189|NCT03053570|Cryoballoon|cryoballoon
37190|NCT03053570|Contact Force|contact force
37191|NCT03053570|Persistent Atrial Fibrillation|persistent atrial fibrillation
37192|NCT03053557|mental health consumers|mental health consumers
37193|NCT03053544|rectal cancer|rectal cancer
37194|NCT03053544|adenocarcinoma of the rectum|adenocarcinoma of the rectum
37195|NCT03053544|node positive rectal tumors|node positive rectal tumors
37196|NCT03053544|metformin|metformin
37197|NCT03053544|neoadjuvant chemoradiation|neoadjuvant chemoradiation
37198|NCT03053518|Type 2 Diabetes|type 2 diabetes
37199|NCT03053518|Hyperglycemia|hyperglycemia
37200|NCT03053518|Personal Nutrition Project|personal nutrition project
37201|NCT03053505|fecal microbiota transplantation (FMT)|fecal microbiota transplantation (fmt)
37202|NCT03053505|Clostridium difficile infection|clostridium difficile infection
37203|NCT03053505|gut flora|gut flora
37204|NCT03053505|human microbiome|human microbiome
37205|NCT03053505|colitis|colitis
37206|NCT03053492|Video Games|video games
37207|NCT03053479|surgery|surgery
37208|NCT03053479|native tissue prolapse repair|native tissue prolapse repair
37209|NCT03053479|laparoscopic sacrocolpopexy|laparoscopic sacrocolpopexy
37210|NCT03053479|vaginal mesh|vaginal mesh
37214|NCT03053453|Total Knee Replacement Arthroplasty|total knee replacement arthroplasty
37215|NCT03053427|Restless Legs Syndrome|restless legs syndrome
37216|NCT03053427|Gabapentin enacarbil|gabapentin enacarbil
37217|NCT03053401|Quadriceps muscle strength|quadriceps muscle strength
37218|NCT03053401|Anterior cruciate ligament repair|anterior cruciate ligament repair
37219|NCT03053401|Femoral nerve block|femoral nerve block
37220|NCT03053401|Adductor Canal block|adductor canal block
37221|NCT03053401|Saphenous nerve block in the Adductor Canal|saphenous nerve block in the adductor canal
37222|NCT03053401|Pediatrics|pediatrics
37223|NCT03053401|Postoperative analgesia|postoperative analgesia
37224|NCT03053401|Ultrasound guided nerve block|ultrasound guided nerve block
37225|NCT03053323|Preconception|preconception
37226|NCT03053323|Pregnancy|pregnancy
37227|NCT03053323|Lifestyle|lifestyle
37228|NCT03053310|surgery|surgery
37229|NCT03053310|curative intent|curative intent
37230|NCT03053310|geriatric assessment|geriatric assessment
37231|NCT03053310|30-day postoperative morbidity|30-day postoperative morbidity
37641|NCT03050554|PD-L1|pd-l1
37276|NCT03053180|Ribavirin free|ribavirin free
37277|NCT03053180|Ritonavir|ritonavir
37278|NCT03053167|Raltitrexed|raltitrexed
37279|NCT03053167|Irinotecan|irinotecan
37280|NCT03053167|Second-line Treatment|second-line treatment
37281|NCT03053167|Advanced Colorectal Cancer(ACC)|advanced colorectal cancer(acc)
37282|NCT03053154|Pelvic Inclination|pelvic inclination
37283|NCT03053154|Sit to Stand|sit to stand
37284|NCT03053154|Stroke|stroke
37285|NCT03053154|Anterior pelvic tilt|anterior pelvic tilt
37286|NCT03053154|Posterior pelvic tilt|posterior pelvic tilt
37287|NCT03053128|cardiac ischemia|cardiac ischemia
37288|NCT03053102|PNH|pnh
37289|NCT03053102|Paroxysmal|paroxysmal
37992|NCT03048331|Tetraplegia|tetraplegia
37290|NCT03053102|Hemoglobinuria|hemoglobinuria
37291|NCT03053089|MPS I; Hurler Syndrome|mps i; hurler syndrome
37294|NCT03053076|effect|effect
37295|NCT03053076|neonates|neonates
37296|NCT03053037|apical size|apical size
39420|NCT03039218|Dornier|dornier
37297|NCT03053037|root canal treatment success|root canal treatment success
37298|NCT03053037|micro biome analysis|micro biome analysis
37299|NCT03053037|pulp necrosis|pulp necrosis
37300|NCT03052985|medical devices (meshes)|medical devices (meshes)
37301|NCT03052985|surgery|surgery
37302|NCT03052946|fecal incontinence, anorectal manometry, bulking agents|fecal incontinence, anorectal manometry, bulking agents
37303|NCT03052933|copanlisib|copanlisib
37304|NCT03052933|gemcitabine|gemcitabine
37305|NCT03052933|peripheral T-cell lymphoma|peripheral t-cell lymphoma
37306|NCT03052933|extranodal NK/T-cell lymphoma|extranodal nk/t-cell lymphoma
37307|NCT03052920|cochlear implant|cochlear implant
37308|NCT03052920|asymmetric hearing loss|asymmetric hearing loss
37309|NCT03052894|anesthesiology|anesthesiology
28864|NCT03104569|Cholangitis|cholangitis
28865|NCT03104569|Nonionic|nonionic
28940|NCT03104322|FVC|fvc
37310|NCT03052894|neuromuscular blockade|neuromuscular blockade
37311|NCT03052894|monitoring device|monitoring device
37312|NCT03052855|Psychiatry|psychiatry
37313|NCT03052855|Suicidal behaviour|suicidal behaviour
37314|NCT03052855|Cerebral metabolites|cerebral metabolites
37315|NCT03052855|MRI|mri
37316|NCT03052855|Inflammatory markers|inflammatory markers
37317|NCT03052803|coronary stenosis|coronary stenosis
37318|NCT03052803|fractional flow reserve|fractional flow reserve
37321|NCT03052738|central nervous system (brain or spinal) tumor|central nervous system (brain or spinal) tumor
37322|NCT03052712|Disorders of socio-emotional|disorders of socio-emotional
37323|NCT03052712|Alzheimer|alzheimer
37324|NCT03052712|frontal temporal dementia|frontal temporal dementia
37325|NCT03052712|Parkinson|parkinson
37326|NCT03052712|Huntington|huntington
37327|NCT03052712|traumatic brain injury|traumatic brain injury
37328|NCT03052712|stroke|stroke
37329|NCT03052712|focal lesions|focal lesions
37330|NCT03052699|Complications; Cesarean Section|complications; cesarean section
37331|NCT03052686|Uterine rupture|uterine rupture
37332|NCT03052673|ketamine|ketamine
37333|NCT03052673|fentanyl|fentanyl
37334|NCT03052673|postoperative pain|postoperative pain
37335|NCT03052660|Midazolam|midazolam
37336|NCT03052660|Anxiety|anxiety
37337|NCT03052660|Clinical trial|clinical trial
37338|NCT03052660|Patient Satisfaction|patient satisfaction
37339|NCT03052647|dermaclip|dermaclip
37340|NCT03052647|subcuticular|subcuticular
37341|NCT03052647|cesarean section|cesarean section
37342|NCT03052647|staples|staples
37343|NCT03052647|adhesive latch|adhesive latch
37344|NCT03052647|rousseau|rousseau
37345|NCT03052608|ALK; anaplastic lymphoma kinase; Non-Small-Cell Lung cancer; NSCLC|alk; anaplastic lymphoma kinase; non-small-cell lung cancer; nsclc
37346|NCT03052556|cystic Fibrosis|cystic fibrosis
37347|NCT03052556|cervical cancer|cervical cancer
37348|NCT03052556|screening|screening
37349|NCT03052556|human papilloma virus (HPV)|human papilloma virus (hpv)
37350|NCT03052556|pap smear test|pap smear test
37351|NCT03052517|Asthma, QAW039|asthma, qaw039
37352|NCT03052465|Motility|motility
37353|NCT03052413|thinning hair|thinning hair
37354|NCT03052413|female pattern hair loss|female pattern hair loss
37355|NCT03052400|type 2 diabetes mellitus|type 2 diabetes mellitus
37356|NCT03052400|insulin resistance|insulin resistance
37357|NCT03052400|mifepristone|mifepristone
37358|NCT03052400|glucocorticoids|glucocorticoids
37359|NCT03052374|Video-Feedback Interaction Guidance|video-feedback interaction guidance
37360|NCT03052374|Depressed Mothers and their Infants|depressed mothers and their infants
37361|NCT03052361|Children|children
37362|NCT03052361|emergency department|emergency department
37363|NCT03052361|ondansetron|ondansetron
37364|NCT03052348|Topical Antibiotics|topical antibiotics
37365|NCT03052348|Supiroban|supiroban
37366|NCT03052348|Atopic Dermatitis|atopic dermatitis
37367|NCT03052348|Eczema|eczema
37368|NCT03052335|colorectal cancer|colorectal cancer
37369|NCT03052335|screening|screening
37370|NCT03052335|colon capsule|colon capsule
37371|NCT03052335|colonoscopy|colonoscopy
37372|NCT03052283|Cystic fibrosis|cystic fibrosis
37373|NCT03052283|Abdomen|abdomen
37374|NCT03052283|Pancreas|pancreas
37375|NCT03052283|Liver|liver
37376|NCT03052283|Gut|gut
37377|NCT03052283|Symptom Score|symptom score
37378|NCT03052283|Patient reported outcome measure (PROM)|patient reported outcome measure (prom)
37379|NCT03052257|Glaucoma|glaucoma
37380|NCT03052257|Disease management|disease management
37381|NCT03052257|Smart bottle|smart bottle
37382|NCT03052244|tDCS (trans cranial direct current stimulation)|tdcs (trans cranial direct current stimulation)
37383|NCT03052244|Visual illusion|visual illusion
37384|NCT03052244|Neuropathic pain|neuropathic pain
37385|NCT03052244|Spinal cord Injury|spinal cord injury
37386|NCT03052231|adherence|adherence
37387|NCT03052231|cystic fibrosis|cystic fibrosis
37388|NCT03052218|children|children
37389|NCT03052218|pain|pain
37392|NCT03052218|Pupillometry|pupillometry
37393|NCT03052127|Uveal melanoma|uveal melanoma
37394|NCT03052127|Eye cancer|eye cancer
37395|NCT03052127|Ocular melanoma|ocular melanoma
37396|NCT03052127|Choroidal melanoma|choroidal melanoma
37397|NCT03052114|Electrical Impedance Tomography|electrical impedance tomography
37398|NCT03052114|EIT|eit
37399|NCT03052114|Stroke|stroke
37400|NCT03052114|Craniocerebral Injury|craniocerebral injury
37401|NCT03052114|Head Injury|head injury
37402|NCT03052101|PLCH|plch
37403|NCT03052101|Air travel|air travel
37404|NCT03052101|pneumothorax|pneumothorax
37405|NCT03052101|pleurodesis|pleurodesis
37406|NCT03052075|Primary Hyperparathyroidism|primary hyperparathyroidism
37407|NCT03052075|Parathyroidectomy|parathyroidectomy
37408|NCT03052075|Bone mineral density|bone mineral density
28964|NCT03104205|weight loss|weight loss
28965|NCT03104192|frail elderly|frail elderly
28966|NCT03104192|telemedicine|telemedicine
28967|NCT03104192|obesity|obesity
28968|NCT03104192|rural health|rural health
28970|NCT03104192|weight loss|weight loss
37410|NCT03052075|Data Review|data review
37411|NCT03052049|Prostate Artery Embolization|prostate artery embolization
37412|NCT03052036|Acute Coronory Syndrome|acute coronory syndrome
37413|NCT03052023|dual approach|dual approach
37414|NCT03052023|laparoscopic hernioplasty|laparoscopic hernioplasty
37415|NCT03052010|HIV-1 serodiscordant couples|hiv-1 serodiscordant couples
37416|NCT03052010|PrEP as Bridge to ART|prep as bridge to art
37417|NCT03051919|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
37418|NCT03051919|reinforcement|reinforcement
37419|NCT03051919|leak|leak
37420|NCT03051906|Carcinoma, squamous cell|carcinoma, squamous cell
37421|NCT03051906|Head and Neck Neoplasms|head and neck neoplasms
37422|NCT03051906|Radiotherapy|radiotherapy
37423|NCT03051906|Immunotherapy|immunotherapy
37424|NCT03051880|Epidermal Growth Factor|epidermal growth factor
37425|NCT03051854|Violence|violence
37426|NCT03051854|Children|children
37427|NCT03051854|Prevalence|prevalence
37428|NCT03051854|Abuse|abuse
37429|NCT03051854|Prevention|prevention
37430|NCT03051828|fencing, cancer|fencing, cancer
37431|NCT03051815|obstructive sleep apnea|obstructive sleep apnea
37432|NCT03051802|Endoscopy|endoscopy
37433|NCT03051802|HDR Brachytherapy|hdr brachytherapy
37434|NCT03051802|navigation|navigation
37435|NCT03051789|Menstrual hygiene management|menstrual hygiene management
37436|NCT03051789|Sexual and Reproductive Health|sexual and reproductive health
37437|NCT03051789|Adolescent schoolgirls|adolescent schoolgirls
37438|NCT03051789|School dropoout|school dropoout
37439|NCT03051789|sub-Saharan Africa|sub-saharan africa
37440|NCT03051789|Kenya|kenya
37441|NCT03051776|Compression garments|compression garments
37442|NCT03051776|Kinesio Taping|kinesio taping
37443|NCT03051776|Breast Cancer-Related Lymphedema|breast cancer-related lymphedema
37446|NCT03051750|Breast Cancer-Related Lymphedema|breast cancer-related lymphedema
37447|NCT03051750|Complex Physical Therapy|complex physical therapy
37449|NCT03051750|Kinesio Taping|kinesio taping
37450|NCT03051750|Physiotherapy|physiotherapy
37451|NCT03051750|Manual Lymph Drainage|manual lymph drainage
37452|NCT03051750|Multilayer Bandage|multilayer bandage
37453|NCT03051750|TTDL questionnaire|ttdl questionnaire
37454|NCT03051737|Multi-scale|multi-scale
37455|NCT03051737|Prediction|prediction
37456|NCT03051737|Patient Flow|patient flow
37457|NCT03051737|Emergency Department|emergency department
37458|NCT03051737|Hospitalization|hospitalization
37459|NCT03051737|Ile-de-France|ile-de-france
37460|NCT03051724|OSA|osa
37461|NCT03051724|CPAP management|cpap management
37462|NCT03051724|Telemedicine|telemedicine
37463|NCT03051698|C1-inhibitor|c1-inhibitor
37464|NCT03051698|house dust mite|house dust mite
37465|NCT03051698|complement system|complement system
37466|NCT03051672|Breast Cancer|breast cancer
37467|NCT03051659|Breast Cancer|breast cancer
37468|NCT03051646|Exercise|exercise
37469|NCT03051646|Time to Exhaustion|time to exhaustion
37470|NCT03051620|Bone turnover markers|bone turnover markers
37471|NCT03051620|Alendronate|alendronate
37472|NCT03051620|Drug Holiday|drug holiday
37477|NCT03051581|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
37478|NCT03051581|Positron-Emission Tomography|positron-emission tomography
37479|NCT03051581|Prognosis|prognosis
37480|NCT03051568|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
37481|NCT03051568|Positron-Emission Tomography|positron-emission tomography
37482|NCT03051568|Prognosis|prognosis
37483|NCT03051555|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
37484|NCT03051555|Positron-Emission Tomography|positron-emission tomography
37485|NCT03051555|Prognosis|prognosis
37486|NCT03051542|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
37487|NCT03051542|Positron-Emission Tomography|positron-emission tomography
37488|NCT03051542|Prognosis|prognosis
37492|NCT03051425|Probiotics|probiotics
37493|NCT03051425|Immune function|immune function
37494|NCT03051425|Natural killer cell activity|natural killer cell activity
37495|NCT03051425|Interleukin-12|interleukin-12
37496|NCT03051425|Interferon-gamma|interferon-gamma
37497|NCT03051425|Immunoglobulin|immunoglobulin
37498|NCT03051399|Constipation|constipation
37499|NCT03051399|Gastrointestinal symptoms of discomfort|gastrointestinal symptoms of discomfort
37500|NCT03051399|Quality of life|quality of life
37501|NCT03051399|Saccharomyces cerevisiae|saccharomyces cerevisiae
37502|NCT03051399|Gut microbiome|gut microbiome
37503|NCT03051360|aortic valve stenosis|aortic valve stenosis
37504|NCT03051360|PCSK9 inhibitor|pcsk9 inhibitor
29070|NCT03103295|traumatic bone defects,|traumatic bone defects,
37505|NCT03051308|Parathyroid cell viability|parathyroid cell viability
37506|NCT03051308|Ischemia|ischemia
37509|NCT03051308|Calcium Sensing Receptor|calcium sensing receptor
37510|NCT03051295|Communication Barriers|communication barriers
37511|NCT03051295|Persuasive Communication|persuasive communication
37513|NCT03051269|Electroporation|electroporation
37514|NCT03051269|Calcium|calcium
37515|NCT03051269|Head and Neck cancer|head and neck cancer
37516|NCT03051256|REL-1017|rel-1017
37517|NCT03051256|d-Methadone|d-methadone
37518|NCT03051256|Methadone|methadone
37519|NCT03051256|Depression|depression
37520|NCT03051256|Refractory Depression|refractory depression
37521|NCT03051256|Antidepressant|antidepressant
37522|NCT03051256|Adjunctive Treatment|adjunctive treatment
37523|NCT03051256|NMDA Receptor Antagonist|nmda receptor antagonist
37524|NCT03051256|Excitatory Amino Acid Antagonist|excitatory amino acid antagonist
37525|NCT03051256|Glutamate Antagonist|glutamate antagonist
37526|NCT03051230|Blood Coagulation Disorders|blood coagulation disorders
37527|NCT03051230|Cell-Derived Microparticles|cell-derived microparticles
37528|NCT03051230|Superovulation|superovulation
37529|NCT03051230|Fertilization in Vitro|fertilization in vitro
37530|NCT03051230|Biomarkers|biomarkers
37531|NCT03051217|Psoriasis|psoriasis
37532|NCT03051217|PSO|pso
37659|NCT03050489|Ischemic Heart Disease|ischemic heart disease
37533|NCT03051217|Chronic plaque psoriasis|chronic plaque psoriasis
37534|NCT03051217|Certolizumb Pegol|certolizumb pegol
37535|NCT03051217|Cimzia|cimzia
37536|NCT03051217|Generalized pustular psoriasis and erythrodermic psoriasis|generalized pustular psoriasis and erythrodermic psoriasis
37537|NCT03051191|atherosclerotic cardiovascular diseases|atherosclerotic cardiovascular diseases
37538|NCT03051191|nonischemic heart failure|nonischemic heart failure
37540|NCT03051165|Cardiovascular Disease|cardiovascular disease
37541|NCT03051165|Pulmonary Medicine|pulmonary medicine
37542|NCT03051165|Hypoglossal Nerve Stimulation|hypoglossal nerve stimulation
37543|NCT03051139|Implementation Science|implementation science
37544|NCT03051139|Low Tidal Volume Ventilation (LTVV)|low tidal volume ventilation (ltvv)
37545|NCT03051126|Parathyroid disease|parathyroid disease
37546|NCT03051126|Parathyroid Tissue Bank|parathyroid tissue bank
37547|NCT03051126|Database|database
37548|NCT03051126|Blood samples|blood samples
37549|NCT03051100|hyperlididemia|hyperlididemia
37550|NCT03051100|LDL|ldl
37551|NCT03051100|cholesterol|cholesterol
37552|NCT03051074|Anxiety|anxiety
37553|NCT03051074|Floating|floating
37554|NCT03051061|Atrial Fibrillation|atrial fibrillation
37555|NCT03051061|Coronary Heart Disease|coronary heart disease
37556|NCT03051061|antithrombotic treatment|antithrombotic treatment
37557|NCT03051061|clinical prognosis|clinical prognosis
37558|NCT03051048|Acute Myocardial Infarction|acute myocardial infarction
37559|NCT03051035|non-hematological malignancies|non-hematological malignancies
37560|NCT03051035|non-squamous|non-squamous
37561|NCT03051035|squamous|squamous
37562|NCT03051035|BRAF|braf
37563|NCT03051035|KRAS|kras
37564|NCT03051035|NRAS|nras
37565|NCT03051022|Bupivacaine|bupivacaine
37566|NCT03051022|adjuvant|adjuvant
37567|NCT03051022|regional anesthesia|regional anesthesia
37568|NCT03051022|dexamethasone|dexamethasone
37569|NCT03051022|morphine|morphine
37570|NCT03050983|Respiratory Compromise|respiratory compromise
37571|NCT03050970|minor head trauma|minor head trauma
37572|NCT03050970|child|child
37573|NCT03050970|age less than 2 years|age less than 2 years
37574|NCT03050970|Clinically-important traumatic brain injury (ciTBI)|clinically-important traumatic brain injury (citbi)
37575|NCT03050970|Computed tomography scan|computed tomography scan
37576|NCT03050970|Radiation exposure from CT scans|radiation exposure from ct scans
37577|NCT03050944|Fertility|fertility
37578|NCT03050944|Infertility|infertility
37579|NCT03050944|Dietary Patterns|dietary patterns
37580|NCT03050944|Mediterranean diet|mediterranean diet
37581|NCT03050944|Adiponectin|adiponectin
37582|NCT03050944|Follistatin|follistatin
37583|NCT03050944|Assisted Reproduction|assisted reproduction
37584|NCT03050944|In Vitro Fertilization|in vitro fertilization
37585|NCT03050944|Semen quality|semen quality
37586|NCT03050944|Diet|diet
37587|NCT03050944|IVF|ivf
37588|NCT03050931|Electrical Impedance Tomography|electrical impedance tomography
37590|NCT03050931|Epilepsy|epilepsy
37591|NCT03050879|Stomach Neoplasms|stomach neoplasms
37592|NCT03050879|Indocyanine Green Tracer|indocyanine green tracer
37593|NCT03050879|Laparoscopic Gastrectomy|laparoscopic gastrectomy
37594|NCT03050879|Lymph Node Dissection|lymph node dissection
37595|NCT03050866|Androgen Receptor|androgen receptor
37596|NCT03050866|AR-V7|ar-v7
37597|NCT03050866|Predictive Factor|predictive factor
37598|NCT03050814|Anti-PDL1 Antibody|anti-pdl1 antibody
37599|NCT03050814|Therapeutic Cancer Vaccine|therapeutic cancer vaccine
37600|NCT03050814|Mismatch Repair Deficiency|mismatch repair deficiency
37601|NCT03050814|Progression Free Survival|progression free survival
37602|NCT03050814|Adenovirus Based, CEA-Targeting Vaccine|adenovirus based, cea-targeting vaccine
37603|NCT03050801|Explicit Memory|explicit memory
37604|NCT03050801|Implicit Memory|implicit memory
37605|NCT03050801|Memory Disorder|memory disorder
37606|NCT03050788|Smartphone confocal microscopy|smartphone confocal microscopy
37607|NCT03050788|Kaposi Sarcoma|kaposi sarcoma
37608|NCT03050788|Point of care diagnosis|point of care diagnosis
37609|NCT03050762|Endocrine Disease|endocrine disease
37610|NCT03050762|Thyroid disease|thyroid disease
37611|NCT03050762|Parathyroid disease|parathyroid disease
37612|NCT03050762|Adrenal disease|adrenal disease
37613|NCT03050762|Data Review|data review
37614|NCT03050762|Database|database
37615|NCT03050736|Glioma|glioma
37616|NCT03050736|Glioblastoma|glioblastoma
37617|NCT03050736|Glioblastoma multiforme|glioblastoma multiforme
37618|NCT03050736|GBM|gbm
37619|NCT03050736|brain tumor|brain tumor
37620|NCT03050736|brain cancer|brain cancer
37621|NCT03050632|working memory|working memory
37622|NCT03050632|adherence|adherence
37623|NCT03050606|Exercise Therapy|exercise therapy
37624|NCT03050606|Exercise Movement Techniques|exercise movement techniques
37625|NCT03050606|Pilates-Based Exercises|pilates-based exercises
37626|NCT03050606|Cost-effectiveness|cost-effectiveness
37627|NCT03050593|HFpEF|hfpef
37628|NCT03050593|HFrEF|hfref
37629|NCT03050580|Abused women|abused women
37630|NCT03050580|treatment group|treatment group
37631|NCT03050580|family violence|family violence
37632|NCT03050567|Microemboli|microemboli
37633|NCT03050554|cancer|cancer
37634|NCT03050554|Non-Small Cell Lung Cancer|non-small cell lung cancer
37635|NCT03050554|SBRT|sbrt
37636|NCT03050554|Avelumab|avelumab
37637|NCT03050554|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
37638|NCT03050554|radiation|radiation
37639|NCT03050554|NSCLC|nsclc
37640|NCT03050554|PD-1|pd-1
37642|NCT03050554|Immunotherapy|immunotherapy
37643|NCT03050554|Lung|lung
37644|NCT03050541|MDMA|mdma
37645|NCT03050541|adult|adult
37646|NCT03050528|Acceptance and Commitment Therapy|acceptance and commitment therapy
37647|NCT03050528|Exercise|exercise
37648|NCT03050528|Psychology|psychology
37649|NCT03050528|Psychological therapy|psychological therapy
37650|NCT03050528|Physiotherapy|physiotherapy
37651|NCT03050528|Physical therapy|physical therapy
37652|NCT03050502|Hemothorax|hemothorax
37653|NCT03050502|Management|management
37654|NCT03050489|CABG|cabg
37655|NCT03050489|Off-Pump CABG|off-pump cabg
37656|NCT03050489|On-Pump CABG|on-pump cabg
37657|NCT03050489|ischemic-reperfusion injury during CABG|ischemic-reperfusion injury during cabg
37658|NCT03050489|comparison of On- and Off- Pump CABG|comparison of on- and off- pump cabg
37660|NCT03050489|Myocardial ischemia-reperfusion and myeloperoxidase|myocardial ischemia-reperfusion and myeloperoxidase
37661|NCT03050489|Myocardial ischemia-reperfusion biomarkers|myocardial ischemia-reperfusion biomarkers
37662|NCT03050476|side-effects|side-effects
37663|NCT03050476|heart-lung machine|heart-lung machine
37664|NCT03050476|alkaline phosphatase|alkaline phosphatase
37665|NCT03050437|Failed in First Line EGFR-TKI|failed in first line egfr-tki
37666|NCT03050437|EGFR Activating Mutation|egfr activating mutation
37667|NCT03050437|Pemetrexed|pemetrexed
37668|NCT03050424|COPD|copd
37669|NCT03050424|Iron|iron
37670|NCT03050424|Exercise Capacity|exercise capacity
37671|NCT03050424|Non-anaemic iron deficiency|non-anaemic iron deficiency
37672|NCT03050411|Non Small Cell Lung Cancer|non small cell lung cancer
37673|NCT03050411|EGFR-TKI resistance|egfr-tki resistance
37674|NCT03050411|Apatinib|apatinib
37675|NCT03050411|anti-angiogenesis drugs|anti-angiogenesis drugs
37676|NCT03050398|HR-positive|hr-positive
37677|NCT03050398|HER2-negative|her2-negative
37678|NCT03050398|Advanced breast cancer|advanced breast cancer
37679|NCT03050398|LEE011|lee011
37680|NCT03050398|ribociclib|ribociclib
37681|NCT03050398|letrozole|letrozole
37682|NCT03050398|femara|femara
37683|NCT03050398|CDK|cdk
37684|NCT03050398|CDK4|cdk4
37685|NCT03050398|CDK6|cdk6
37686|NCT03050398|CDK4/6|cdk4/6
37687|NCT03050398|CDK4/6 inhibitor|cdk4/6 inhibitor
37688|NCT03050398|Phase III|phase iii
37689|NCT03050398|Phase IIIb|phase iiib
37690|NCT03050398|ER-positive|er-positive
37691|NCT03050398|PR-positive|pr-positive
37692|NCT03050398|Postmenopausal|postmenopausal
37693|NCT03050398|Premenopausal|premenopausal
37694|NCT03050398|Men|men
37695|NCT03050385|cognitive rehabilitation|cognitive rehabilitation
37696|NCT03050359|Drug therapy|drug therapy
37697|NCT03050359|Gastrointestinal Diseases|gastrointestinal diseases
37698|NCT03050359|Digestive System Diseases|digestive system diseases
37699|NCT03050359|Lansoprazole|lansoprazole
37700|NCT03050359|Anti-Ulcer Agents|anti-ulcer agents
37701|NCT03050359|Gastrointestinal Agents|gastrointestinal agents
37702|NCT03050359|Proton Pump Inhibitors|proton pump inhibitors
37703|NCT03050359|Enzyme Inhibitors|enzyme inhibitors
41129|NCT03028337|XRT|xrt
37704|NCT03050359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
37705|NCT03050346|Magnetic Resonance Imaging|magnetic resonance imaging
37706|NCT03050346|Coronary Artery Disease|coronary artery disease
37708|NCT03050346|Hyperventilation|hyperventilation
37709|NCT03050346|BOLD|bold
37710|NCT03050346|Breathing Maneuvers|breathing maneuvers
37711|NCT03050346|Myocardial Oxygenation|myocardial oxygenation
37712|NCT03050320|Resilience|resilience
37713|NCT03050320|Exercise in the workplace|exercise in the workplace
37714|NCT03050307|Drug therapy|drug therapy
37715|NCT03050268|Familial cancer|familial cancer
37716|NCT03050268|Genetic predisposition|genetic predisposition
37717|NCT03050268|Heritable disease|heritable disease
37718|NCT03050268|Cancer risk|cancer risk
37719|NCT03050268|Genome analysis|genome analysis
37720|NCT03050268|Genetic modifiers|genetic modifiers
37721|NCT03050268|Next generation sequencing (NGS)|next generation sequencing (ngs)
37722|NCT03050268|Genetic counseling|genetic counseling
37723|NCT03050268|DNA|dna
37724|NCT03050255|supplemental oxygen|supplemental oxygen
37725|NCT03050255|walking capacity|walking capacity
37726|NCT03050255|exercise capacity|exercise capacity
37727|NCT03050255|endurance shuttle walk test|endurance shuttle walk test
37728|NCT03050190|4s CAR-T|4s car-t
37729|NCT03050190|CD19|cd19
37730|NCT03050190|B cell leukemia|b cell leukemia
37731|NCT03050190|B-ALL|b-all
37732|NCT03050177|Bioequivalence Study|bioequivalence study
37733|NCT03050138|Postthrombotic Syndrome|postthrombotic syndrome
37734|NCT03050138|Venous Thrombosis|venous thrombosis
37735|NCT03050138|Quality of Life|quality of life
37736|NCT03050138|Hemorrhage|hemorrhage
37737|NCT03050138|Recurrence|recurrence
37738|NCT03050112|MacNew questionnaire|macnew questionnaire
37739|NCT03050112|Quality of life|quality of life
37740|NCT03050034|Wireless monitoring system|wireless monitoring system
37741|NCT03050034|Acute Medicine|acute medicine
37742|NCT03050034|Poly-pathological patients|poly-pathological patients
37743|NCT03050034|Internal Medicine core competencies|internal medicine core competencies
37744|NCT03050034|Acute Complex Care Model|acute complex care model
37745|NCT03050021|Delirium|delirium
37746|NCT03050021|Intensive care unit|intensive care unit
37747|NCT03050008|Cataract Surgery|cataract surgery
37748|NCT03049995|effectiveness; imaging; prognosis; stress echocardiography|effectiveness; imaging; prognosis; stress echocardiography
37749|NCT03049982|Oral appliance therapy|oral appliance therapy
37750|NCT03049969|Working Memory|working memory
37751|NCT03049969|Cognitive Training|cognitive training
37752|NCT03049969|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
37753|NCT03049956|Ocular Vestibular Evoked Myogenic Potentials|ocular vestibular evoked myogenic potentials
37754|NCT03049943|low level laser therapy|low level laser therapy
37755|NCT03049943|hyposalivation|hyposalivation
37756|NCT03049930|Burns|burns
37757|NCT03049930|Ketamine|ketamine
37758|NCT03049930|Anesthesia|anesthesia
37759|NCT03049917|financial incentive|financial incentive
37760|NCT03049917|pediatric HIV testing|pediatric hiv testing
37761|NCT03049904|Indian, North America|indian, north america
37762|NCT03049904|Male, Two-Spirit|male, two-spirit
37763|NCT03049904|HIV Prevention|hiv prevention
37765|NCT03049891|Antiretroviral Therapy|antiretroviral therapy
37766|NCT03049891|Retention|retention
37767|NCT03049891|Loss to Follow Up|loss to follow up
37768|NCT03049878|postoperative pain|postoperative pain
37769|NCT03049878|paracetamol|paracetamol
37770|NCT03049878|codeine|codeine
37771|NCT03049878|tooth extractions|tooth extractions
37772|NCT03049878|analgesia|analgesia
37773|NCT03049878|premedication|premedication
37774|NCT03049826|nutrient|nutrient
37775|NCT03049800|Recent onset psychotic illness|recent onset psychotic illness
37776|NCT03049800|Healthy controls|healthy controls
37777|NCT03049800|Cognitive training|cognitive training
37778|NCT03049800|7T Magnetic Resonance Imaging|7t magnetic resonance imaging
37779|NCT03049787|physical therapy|physical therapy
37780|NCT03049787|home exercise|home exercise
37781|NCT03049787|adhesive capsulitis|adhesive capsulitis
37782|NCT03049748|Heart-Assist Devices, Self-care, Quality of Life|heart-assist devices, self-care, quality of life
37783|NCT03049709|central blood pressure|central blood pressure
37784|NCT03049709|measurement|measurement
583399|NCT00511576|Taxotere|taxotere
37785|NCT03049709|oscillometric radial pulse wave analysis|oscillometric radial pulse wave analysis
37786|NCT03049696|Roux-En-Y Gastric Bypass|roux-en-y gastric bypass
37787|NCT03049696|Bariatric Surgery|bariatric surgery
37788|NCT03049696|Pre-Operative Physical Activity and Education Program|pre-operative physical activity and education program
37790|NCT03049696|Exercise|exercise
37791|NCT03049696|Behaviour Modification|behaviour modification
37792|NCT03049696|Surgical Outcomes|surgical outcomes
37793|NCT03049696|Quality of Life|quality of life
37794|NCT03049683|Vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
37795|NCT03049670|Safety Issue|safety issue
37796|NCT03049644|chronic lower back pain|chronic lower back pain
37797|NCT03049644|Manual Therapy|manual therapy
37798|NCT03049644|Mechanical Diagnosis and Treatment|mechanical diagnosis and treatment
39954|NCT03035604|MNA|mna
37799|NCT03049631|Pre-diabetes|pre-diabetes
37800|NCT03049631|red raspberry|red raspberry
37801|NCT03049631|fructooligosaccharide|fructooligosaccharide
37802|NCT03049631|metagenomics|metagenomics
37803|NCT03049631|polyphenol bioavailability|polyphenol bioavailability
37804|NCT03049631|glycemic response|glycemic response
37805|NCT03049631|insulin response|insulin response
37806|NCT03049605|Neuropathies laser and magnetic therapy|neuropathies laser and magnetic therapy
37807|NCT03049592|Diabetes|diabetes
37808|NCT03049592|Contraception|contraception
37809|NCT03049592|Prenatal Counseling|prenatal counseling
37810|NCT03049566|Bleeding|bleeding
37811|NCT03049566|Adverse Cardiac Events|adverse cardiac events
37812|NCT03049566|Adherence, Medication|adherence, medication
37813|NCT03049566|Aspirin|aspirin
37814|NCT03049566|Acetylsalicylic acid|acetylsalicylic acid
37815|NCT03049553|Cervical screening|cervical screening
37816|NCT03049553|Human papillomavirus (HPV)|human papillomavirus (hpv)
37817|NCT03049553|Cytology|cytology
37818|NCT03049553|HPV-test|hpv-test
37819|NCT03049553|Cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
37820|NCT03049527|Chronic Kidney Disease|chronic kidney disease
37821|NCT03049527|Unknown Origin|unknown origin
37822|NCT03049514|Thrombolysis|thrombolysis
37823|NCT03049514|Recanalization|recanalization
37824|NCT03049514|Dynamic retinal angiography|dynamic retinal angiography
37825|NCT03049501|Alzheimer's caregivers|alzheimer's caregivers
37826|NCT03049501|Technology-based intervention|technology-based intervention
37827|NCT03049501|Culturally-tailored intervention|culturally-tailored intervention
37828|NCT03049488|Immune Response|immune response
37829|NCT03049488|Respiratory Syncytial Virus|respiratory syncytial virus
37830|NCT03049488|Vaccine-Mediated Protection|vaccine-mediated protection
37831|NCT03049488|Neutralizing Antibody|neutralizing antibody
37832|NCT03049488|Antibody Response|antibody response
37833|NCT03049475|Pain|pain
37834|NCT03049475|Cell Free DNA|cell free dna
37835|NCT03049475|Inflammatory Markers|inflammatory markers
37836|NCT03049475|Microparticles|microparticles
37837|NCT03049475|NETosis|netosis
37838|NCT03049462|Brown Adipose Tissue|brown adipose tissue
37839|NCT03049462|Energy Expenditure|energy expenditure
37840|NCT03049462|Energy Metabolism|energy metabolism
37841|NCT03049462|Obesity|obesity
37842|NCT03049449|Gene Therapy|gene therapy
37843|NCT03049449|Adoptive T Cell Therapy|adoptive t cell therapy
37844|NCT03049449|T-cell infusion|t-cell infusion
37845|NCT03049449|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
37846|NCT03049449|Immunohistochemistry|immunohistochemistry
37847|NCT03049436|Physical activity|physical activity
37848|NCT03049436|cancer|cancer
37849|NCT03049436|chemotherapy|chemotherapy
37850|NCT03049436|daily care unit|daily care unit
37851|NCT03049410|Cystectomy|cystectomy
37852|NCT03049332|Quality of Life|quality of life
37853|NCT03049306|Obstructive sleep apnea|obstructive sleep apnea
37854|NCT03049306|CPAP|cpap
37855|NCT03049306|Propranolol|propranolol
37856|NCT03049306|Metabolism|metabolism
37857|NCT03049293|COPD,IVF|copd,ivf
37858|NCT03049267|acne inversa|acne inversa
37859|NCT03049241|Children|children
37860|NCT03049241|Neuromuscular fatigue|neuromuscular fatigue
37861|NCT03049241|Muscle group|muscle group
37862|NCT03049241|Magnetic Nerve stimulation|magnetic nerve stimulation
37863|NCT03049241|Muscle length|muscle length
37864|NCT03049241|Stiffness|stiffness
37865|NCT03049241|prepubertal children|prepubertal children
37866|NCT03049241|adults|adults
37867|NCT03049228|Spectrum Analysis|spectrum analysis
37868|NCT03049228|Mitochondria|mitochondria
37869|NCT03049228|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
37870|NCT03049228|Respirometry|respirometry
37871|NCT03049228|Human|human
37872|NCT03049228|Heart|heart
37873|NCT03049189|non-functional and functional P-NET|non-functional and functional p-net
37874|NCT03049189|non-functional GE-NET|non-functional ge-net
37875|NCT03049176|HIV-discordant couple|hiv-discordant couple
37877|NCT03049176|PrEP|prep
37878|NCT03049176|semen washing|semen washing
37879|NCT03049176|artificial vaginal insemination|artificial vaginal insemination
37880|NCT03049176|safer conception|safer conception
37881|NCT03049176|pregnancy|pregnancy
37882|NCT03049150|Urine|urine
37883|NCT03049150|Mass Spectometry|mass spectometry
37884|NCT03049150|Observational|observational
37885|NCT03049124|Exercise|exercise
37886|NCT03049124|Feasibility trial|feasibility trial
37887|NCT03049124|Cancer|cancer
37888|NCT03049124|Chemoradiation|chemoradiation
37889|NCT03049111|Der F (House Dust Mite)|der f (house dust mite)
37890|NCT03049098|Eye-tracking|eye-tracking
37891|NCT03049098|High Fidelity Simulation Training|high fidelity simulation training
37892|NCT03049098|Visual Perception|visual perception
37893|NCT03049085|OPCAB|opcab
37894|NCT03049085|ASA|asa
37895|NCT03049085|Aspirin|aspirin
37896|NCT03049020|pelvic organ prolapse|pelvic organ prolapse
37897|NCT03049020|sacrocolpopexy|sacrocolpopexy
37898|NCT03049020|pelvic floor ultrasound|pelvic floor ultrasound
37899|NCT03049007|bereavement|bereavement
37900|NCT03049007|natural grief|natural grief
37901|NCT03049007|prolonged grief|prolonged grief
37902|NCT03049007|complicated grief|complicated grief
37903|NCT03048994|Glutamine|glutamine
37904|NCT03048994|Severe sepsis|severe sepsis
37905|NCT03048981|Thrombocyte aggregation|thrombocyte aggregation
37906|NCT03048981|Fish oil|fish oil
37907|NCT03048981|Alternative medicine|alternative medicine
37908|NCT03048981|Point of care testing|point of care testing
37909|NCT03048981|Coagulation monitoring|coagulation monitoring
37910|NCT03048968|Exoskeleton Device|exoskeleton device
37911|NCT03048968|elderly|elderly
37912|NCT03048968|stroke|stroke
37913|NCT03048942|Breast cancer|breast cancer
37914|NCT03048942|HER2 negative|her2 negative
37915|NCT03048942|Cabazitaxel|cabazitaxel
37916|NCT03048942|Paclitaxel|paclitaxel
37917|NCT03048942|Chemotherapy|chemotherapy
37918|NCT03048916|dysphagia|dysphagia
37919|NCT03048916|stroke|stroke
37920|NCT03048916|magnetic resonance imaging|magnetic resonance imaging
37921|NCT03048916|videofluoroscopy|videofluoroscopy
37922|NCT03048903|Gastrointestinal dysfunction|gastrointestinal dysfunction
37923|NCT03048903|sepsis|sepsis
37924|NCT03048903|trauma|trauma
37925|NCT03048890|PAD|pad
37926|NCT03048877|Radioactive iodine-refractory|radioactive iodine-refractory
37927|NCT03048877|differentiated thyroid cancer|differentiated thyroid cancer
37928|NCT03048877|Apatinib|apatinib
37929|NCT03048877|anti-angiogenesis drugs|anti-angiogenesis drugs
37930|NCT03048864|Metabolic Screening|metabolic screening
37931|NCT03048864|24 hour urine|24 hour urine
37932|NCT03048851|Cerebral palsy|cerebral palsy
37933|NCT03048851|sensory electrical stimulation|sensory electrical stimulation
37934|NCT03048851|virtual reality constraint-induced therapy|virtual reality constraint-induced therapy
37935|NCT03048812|Dental implant|dental implant
37936|NCT03048812|Mandibular overdenture|mandibular overdenture
37937|NCT03048812|Cross-over study|cross-over study
37938|NCT03048786|Peer mentoring|peer mentoring
37939|NCT03048786|social support|social support
37940|NCT03048786|text messaging|text messaging
37941|NCT03048786|smoking cessation|smoking cessation
37942|NCT03048773|shockwave therapy|shockwave therapy
37943|NCT03048773|knee osteoarthritis|knee osteoarthritis
37944|NCT03048760|MRI scan|mri scan
37945|NCT03048760|Organs at Risk|organs at risk
37946|NCT03048708|Bariatric surgery|bariatric surgery
37947|NCT03048708|Leptin|leptin
37948|NCT03048708|Thyroid function tests|thyroid function tests
37949|NCT03048617|Primary Mitochondrial Disease|primary mitochondrial disease
37950|NCT03048617|Stealth|stealth
37951|NCT03048617|Myopathy|myopathy
37952|NCT03048617|exercise intolerance|exercise intolerance
37953|NCT03048617|muscle pain|muscle pain
37954|NCT03048617|Mitochondrial Myopathy|mitochondrial myopathy
37955|NCT03048617|Primary Mitochondrial Myopathy|primary mitochondrial myopathy
37956|NCT03048578|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
37957|NCT03048565|mindfulness|mindfulness
37958|NCT03048565|caregivers|caregivers
37959|NCT03048552|drug use|drug use
37960|NCT03048552|drug addiction|drug addiction
37961|NCT03048552|drug habituation|drug habituation
37962|NCT03048552|drug use disorders|drug use disorders
37963|NCT03048552|organic mental disorders|organic mental disorders
37964|NCT03048552|substance-induced|substance-induced
37965|NCT03048552|substance abuse|substance abuse
37966|NCT03048552|substance addiction|substance addiction
37967|NCT03048552|substance dependence|substance dependence
37968|NCT03048552|substance use disorders|substance use disorders
37969|NCT03048539|Endoscopic surgery|endoscopic surgery
37970|NCT03048539|Thyroidectomy|thyroidectomy
37971|NCT03048539|Quality of life|quality of life
37972|NCT03048513|Melioidosis|melioidosis
37973|NCT03048513|Head and Neck|head and neck
37974|NCT03048513|Clinical|clinical
37975|NCT03048474|progressive disease after at least 1 course of chemotherapy|progressive disease after at least 1 course of chemotherapy
37976|NCT03048448|Hepatic impairment,|hepatic impairment,
37977|NCT03048448|Fevipiprant,|fevipiprant,
37978|NCT03048448|adults,|adults,
37979|NCT03048448|pharmacokinetics|pharmacokinetics
37980|NCT03048435|Cervical Cancer|cervical cancer
37981|NCT03048435|Patient Reported Outcomes|patient reported outcomes
37982|NCT03048435|Radiation Therapy|radiation therapy
37983|NCT03048435|EORTC QLQ-CX24|eortc qlq-cx24
37984|NCT03048435|Quality of Life|quality of life
37985|NCT03048383|Facial paralysis|facial paralysis
37986|NCT03048383|Facial synkinesis|facial synkinesis
37987|NCT03048383|Botulinum toxin|botulinum toxin
37988|NCT03048344|acute promyelocytic leukemia|acute promyelocytic leukemia
37989|NCT03048344|APL|apl
37990|NCT03048344|arsenic trioxide|arsenic trioxide
37991|NCT03048331|Functional Electrical Stimulation|functional electrical stimulation
37993|NCT03048331|Reconstructive Hand Surgery|reconstructive hand surgery
37994|NCT03048292|Embolectomy|embolectomy
37995|NCT03048292|Embolus|embolus
37996|NCT03048292|Thrombectomy|thrombectomy
37997|NCT03048292|Thrombolysis|thrombolysis
37998|NCT03048292|Thrombus|thrombus
37999|NCT03048292|Mobile|mobile
38000|NCT03048292|Interventional|interventional
38001|NCT03048292|Neurointervention|neurointervention
38002|NCT03048292|Stroke|stroke
38003|NCT03048292|Ischemic|ischemic
38004|NCT03048292|Acute|acute
38005|NCT03048292|Endovascular|endovascular
38006|NCT03048292|Cerebrovascular|cerebrovascular
38007|NCT03048292|Clot|clot
38008|NCT03048292|Stent Retriever|stent retriever
38009|NCT03048292|Tissue Plasminogen Activator|tissue plasminogen activator
38010|NCT03048292|Drip and Ship|drip and ship
38011|NCT03048292|Mothership|mothership
38012|NCT03048292|Trip and Treat|trip and treat
38013|NCT03048279|Multiple Endocrine Neoplasia Syndromes|multiple endocrine neoplasia syndromes
38014|NCT03048279|MEN1|men1
38015|NCT03048279|MEN2|men2
38016|NCT03048279|Relatives|relatives
38017|NCT03048279|Database|database
38018|NCT03048279|Questionnaires|questionnaires
38019|NCT03048279|Surveys|surveys
38020|NCT03048266|Multiple endocrine neoplasia|multiple endocrine neoplasia
38021|NCT03048266|MEN1|men1
38022|NCT03048266|Aggressive pancreatic neuroendocrine tumors|aggressive pancreatic neuroendocrine tumors
38023|NCT03048266|PNET|pnet
38024|NCT03048266|Non-aggressive pancreatic neuroendocrine tumors|non-aggressive pancreatic neuroendocrine tumors
38025|NCT03048266|Metabolomics|metabolomics
38026|NCT03048266|Genetics|genetics
38027|NCT03048266|Biomarkers|biomarkers
38028|NCT03048240|Glioblastoma|glioblastoma
38029|NCT03048227|TIDM|tidm
38030|NCT03048227|Type1diabetes|type1diabetes
38031|NCT03048227|Implantable Pump|implantable pump
38032|NCT03048227|CGM|cgm
38033|NCT03048214|Nerve block; Infraclavicular; Acute pain|nerve block; infraclavicular; acute pain
38034|NCT03048201|Physica KR|physica kr
38035|NCT03048201|Physica CR|physica cr
38036|NCT03048201|Physica PS|physica ps
38037|NCT03048201|Kinematic Retaining|kinematic retaining
38230|NCT03046836|Couples|couples
38038|NCT03048201|Cruciate Retaining|cruciate retaining
38039|NCT03048201|Posterior Stabilized|posterior stabilized
38040|NCT03048201|Physica System|physica system
38041|NCT03048175|C-reactive protein|c-reactive protein
38042|NCT03048175|Systemic inflammation|systemic inflammation
38043|NCT03048175|Third molar|third molar
38044|NCT03048175|Wisdom tooth|wisdom tooth
38045|NCT03048149|hazelnut allergy|hazelnut allergy
38046|NCT03048123|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
38047|NCT03048123|Transarterial Chemoembolization|transarterial chemoembolization
38048|NCT03048123|Large and unresectable HCC|large and unresectable hcc
38049|NCT03048071|Contegra|contegra
38050|NCT03048071|Homograft|homograft
38051|NCT03048045|chronic periodontitis|chronic periodontitis
38052|NCT03048045|aggressive periodontitis|aggressive periodontitis
38053|NCT03048045|supportive periodontal treatment|supportive periodontal treatment
38054|NCT03048032|acute heart failure|acute heart failure
38055|NCT03048032|right ventricular failure|right ventricular failure
38056|NCT03048032|cardiac biomarkers|cardiac biomarkers
38057|NCT03048032|echocardiography|echocardiography
38058|NCT03048032|diagnosis|diagnosis
38059|NCT03048032|prognosis|prognosis
38060|NCT03047993|Myelodysplastic syndrome|myelodysplastic syndrome
38062|NCT03047993|Other diseases of blood and blood-forming organs|other diseases of blood and blood-forming organs
38063|NCT03047993|CB-839|cb-839
38064|NCT03047993|Azacitidine|azacitidine
38065|NCT03047993|5-azacytidine|5-azacytidine
38066|NCT03047993|5-aza|5-aza
38067|NCT03047993|Vidaza|vidaza
38068|NCT03047993|5-AZC|5-azc
38069|NCT03047993|AZA-CR|aza-cr
38070|NCT03047993|Ladakamycin|ladakamycin
38071|NCT03047993|NSC-102816|nsc-102816
38072|NCT03047993|Azacytidine|azacytidine
38073|NCT03047993|Pharmacokinetic testing|pharmacokinetic testing
38074|NCT03047993|Pharmacodynamic testing|pharmacodynamic testing
38075|NCT03047980|SWS|sws
38076|NCT03047980|Cognitive impairment|cognitive impairment
38077|NCT03047980|sirolimus|sirolimus
38078|NCT03047915|Anxiety|anxiety
38079|NCT03047915|Music intervention|music intervention
38080|NCT03047915|Emergency department (ED)|emergency department (ed)
38081|NCT03047902|Adolescent Smoking Cessation Asthma Carbon Monoxide.|adolescent smoking cessation asthma carbon monoxide.
38082|NCT03047876|cardiac|cardiac
38083|NCT03047876|aortic arch surgery|aortic arch surgery
38084|NCT03047876|Brain vascular reactivity|brain vascular reactivity
38085|NCT03047876|neonates|neonates
38086|NCT03047876|infants|infants
38087|NCT03047863|Epidermal Growth Factor|epidermal growth factor
38088|NCT03047850|Sternotomy|sternotomy
38089|NCT03047837|Colorectal cancer|colorectal cancer
38090|NCT03047837|aspirin|aspirin
38091|NCT03047837|metformin|metformin
38092|NCT03047837|chemoprevention|chemoprevention
38093|NCT03047798|centella asiatica|centella asiatica
41540|NCT03025828|ACTH|acth
29666|NCT03099460|ocular motility disorder|ocular motility disorder
29667|NCT03099447|electroacupuncture|electroacupuncture
29668|NCT03099447|oculomotor nerve palsy|oculomotor nerve palsy
38094|NCT03047798|bamboo salt|bamboo salt
38095|NCT03047798|magnolia bark|magnolia bark
38096|NCT03047798|gingivitis|gingivitis
38097|NCT03047798|dental plaque|dental plaque
38098|NCT03047798|mouthrinse|mouthrinse
38099|NCT03047785|Myocardial Infarction|myocardial infarction
38100|NCT03047785|Highly sensitive troponin|highly sensitive troponin
38101|NCT03047785|Hospital population|hospital population
38102|NCT03047785|99th percentile|99th percentile
38103|NCT03047785|Upper limit of normal|upper limit of normal
38104|NCT03047733|Vitiligo|vitiligo
38105|NCT03047733|308 nm excimer laser|308 nm excimer laser
38106|NCT03047720|bedwetting|bedwetting
38107|NCT03047707|ultrasound elastography|ultrasound elastography
38108|NCT03047707|S-Shearwave|s-shearwave
38109|NCT03047707|liver|liver
38110|NCT03047707|fibrosis|fibrosis
38111|NCT03047694|Lexico-semantic stimulation|lexico-semantic stimulation
38112|NCT03047694|tactile tablet|tactile tablet
38113|NCT03047681|TAVR|tavr
38114|NCT03047681|tryptse|tryptse
38115|NCT03047681|mast|mast
38116|NCT03047642|biomarker|biomarker
38117|NCT03047642|low and middle income countries|low and middle income countries
38118|NCT03047642|fever|fever
38119|NCT03047642|antimicrobial resistance|antimicrobial resistance
38120|NCT03047642|diagnostic|diagnostic
38121|NCT03047629|non-motor symptoms|non-motor symptoms
38122|NCT03047603|Hepatocellular carcinoma|hepatocellular carcinoma
38123|NCT03047603|Protein induced by vitamin K absence or antagonist-II|protein induced by vitamin k absence or antagonist-ii
38124|NCT03047603|Differential diagnosis|differential diagnosis
38125|NCT03047603|Des-γ-carboxy prothrombin|des-γ-carboxy prothrombin
38126|NCT03047603|Alpha-fetoprotein|alpha-fetoprotein
38127|NCT03047603|Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein-fetoprotein|lens culinaris agglutinin-reactive fraction of alpha-fetoprotein-fetoprotein
38128|NCT03047590|exercise behavior|exercise behavior
38129|NCT03047590|exercise prescription|exercise prescription
38130|NCT03047590|affect-based exercise|affect-based exercise
38131|NCT03047590|affect-guided exercise|affect-guided exercise
38132|NCT03047590|self-paced exercise|self-paced exercise
38133|NCT03047590|self-selected exercise|self-selected exercise
38134|NCT03047577|Brief intervention|brief intervention
38135|NCT03047577|Alcohol|alcohol
38231|NCT03046836|Oxytocin|oxytocin
38138|NCT03047577|Critically ill|critically ill
38140|NCT03047564|Total Knee Arthroplasty|total knee arthroplasty
38141|NCT03047564|Total Knee Replacement|total knee replacement
38142|NCT03047564|Outcome|outcome
38143|NCT03047564|Metal ion concentration|metal ion concentration
38144|NCT03047564|Results|results
38145|NCT03047551|Abortion, induced|abortion, induced
38146|NCT03047551|Ultrasonography|ultrasonography
38147|NCT03047551|Health Services accessibility|health services accessibility
38148|NCT03047551|Pragmatic Clinical Trial|pragmatic clinical trial
38149|NCT03047551|Randomized controlled trial as topic|randomized controlled trial as topic
38150|NCT03047538|Arterial hypertension|arterial hypertension
38151|NCT03047538|Dyslipidemia|dyslipidemia
38152|NCT03047538|Blood pressure control|blood pressure control
38153|NCT03047538|Fixed combination|fixed combination
38154|NCT03047525|cytokine-induced killer cell|cytokine-induced killer cell
38155|NCT03047525|dendritic and cytokine-induced killer cells|dendritic and cytokine-induced killer cells
38156|NCT03047512|Depression in adolescents|depression in adolescents
38157|NCT03047512|Mental Health|mental health
38158|NCT03047512|E-mental health|e-mental health
38159|NCT03047512|Prevention and Early intervention|prevention and early intervention
38160|NCT03047486|insulin pump|insulin pump
38161|NCT03047486|continuous glucose monitoring sensor|continuous glucose monitoring sensor
38162|NCT03047486|predictive low glucose suspend|predictive low glucose suspend
38163|NCT03047473|newly diagnosed|newly diagnosed
38164|NCT03047460|motor evoked potential|motor evoked potential
38165|NCT03047460|somatosensory evoked potentials|somatosensory evoked potentials
38166|NCT03047460|biomarker|biomarker
38167|NCT03047408|REM Sleep Behavior Disorder|rem sleep behavior disorder
38168|NCT03047408|Parkinson's Disease|parkinson's disease
38169|NCT03047408|REM sleep without Atonia|rem sleep without atonia
38170|NCT03047395|ABBV-066|abbv-066
38171|NCT03047395|BI 655066|bi 655066
38172|NCT03047369|leukodystrophy|leukodystrophy
38173|NCT03047369|white matter disease|white matter disease
38174|NCT03047369|leukoencephalopathy|leukoencephalopathy
38175|NCT03047369|myelin|myelin
38176|NCT03047369|demyelinating|demyelinating
38177|NCT03047369|mdbp|mdbp
38178|NCT03047343|pulmonary artery strapping|pulmonary artery strapping
38179|NCT03047330|menopause|menopause
38180|NCT03047330|sleep fragmentation|sleep fragmentation
38181|NCT03047330|leuprolide|leuprolide
38182|NCT03047330|adipokine|adipokine
38183|NCT03047330|weight gain|weight gain
38184|NCT03047330|leptin|leptin
38185|NCT03047317|pharmacokinetics|pharmacokinetics
38186|NCT03047291|mucositis, periimplantitis, probiotic|mucositis, periimplantitis, probiotic
38187|NCT03047226|Lynch Syndrome|lynch syndrome
38188|NCT03047226|mismatch repair|mismatch repair
38189|NCT03047226|microsatellite instability|microsatellite instability
38190|NCT03047226|next-generation sequencing|next-generation sequencing
38191|NCT03047226|immunohistochemistry|immunohistochemistry
38192|NCT03047200|Diabetes Mellitus|diabetes mellitus
38193|NCT03047200|Hypoglycemia|hypoglycemia
38194|NCT03047200|Hyperglycemia|hyperglycemia
38195|NCT03047200|Type 1 Diabetes|type 1 diabetes
38196|NCT03047200|Islet Cell Transplantation|islet cell transplantation
38197|NCT03047174|Head and Neck Neoplasms, Radio(chemo)therapy|head and neck neoplasms, radio(chemo)therapy
38198|NCT03047161|magnetocardiography|magnetocardiography
38199|NCT03047135|high-risk biochemically-recurrent|high-risk biochemically-recurrent
38200|NCT03047122|Breast|breast
38201|NCT03047122|ultrasonography|ultrasonography
38202|NCT03047109|Ephedrine|ephedrine
38203|NCT03047109|Phenylephrine|phenylephrine
38204|NCT03047109|Spinal Hypotension|spinal hypotension
38205|NCT03047109|Cesarean Section|cesarean section
38206|NCT03047109|Maternal Cardiodynamics|maternal cardiodynamics
38207|NCT03047083|Retrospective|retrospective
38208|NCT03047083|Non-interventional Study|non-interventional study
38209|NCT03047083|FMS-like tyrosine kinase-3 (FLT3) mutations|fms-like tyrosine kinase-3 (flt3) mutations
38210|NCT03047044|lumbar fusion surgery|lumbar fusion surgery
38211|NCT03047044|Patient Controlled Analgesia|patient controlled analgesia
38212|NCT03047044|Optimizing Basal Infusion Mode|optimizing basal infusion mode
38213|NCT03047018|Nutrition|nutrition
38214|NCT03046992|EGFR|egfr
38215|NCT03046992|Non-Small Cell Lung Cancer|non-small cell lung cancer
38216|NCT03046992|T790M|t790m
38217|NCT03046992|Brain Metastasis|brain metastasis
38218|NCT03046979|apatinib|apatinib
38219|NCT03046979|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
38220|NCT03046953|Lymphoma|lymphoma
38224|NCT03046901|Vancomycin|vancomycin
38225|NCT03046901|Primary Sclerosing cholangitis|primary sclerosing cholangitis
38226|NCT03046901|Post-liver transplantation|post-liver transplantation
38227|NCT03046849|Lynch Syndrome|lynch syndrome
38228|NCT03046849|next-generation sequencing|next-generation sequencing
38229|NCT03046849|germline mutation|germline mutation
38232|NCT03046836|Aggression|aggression
38234|NCT03046771|falls|falls
38235|NCT03046771|readmissions|readmissions
38236|NCT03046771|emergency department visits|emergency department visits
38237|NCT03046771|transitions of care|transitions of care
38238|NCT03046745|Gastric cancer, endoscopy, pepsinogen, TFF3, biomarker|gastric cancer, endoscopy, pepsinogen, tff3, biomarker
38239|NCT03046732|Kidney Transplant Education|kidney transplant education
38240|NCT03046732|Transplant Readiness|transplant readiness
38241|NCT03046732|Living Donor Kidney Transplant|living donor kidney transplant
38242|NCT03046732|Chronic Kidney Disease|chronic kidney disease
38243|NCT03046732|End Stage Kidney Disease|end stage kidney disease
38244|NCT03046732|Renal Replacement Therapy|renal replacement therapy
38245|NCT03046719|bupivacaine|bupivacaine
38246|NCT03046719|intravitreal|intravitreal
38247|NCT03046719|analgesia|analgesia
38248|NCT03046719|silicone oil removal|silicone oil removal
38249|NCT03046719|retinal detachment|retinal detachment
38250|NCT03046719|subconjunctival|subconjunctival
38251|NCT03046706|voice rest|voice rest
38252|NCT03046706|laryngeal surgery|laryngeal surgery
38253|NCT03046706|glottic polyp|glottic polyp
38254|NCT03046706|glottic cyst|glottic cyst
38255|NCT03046693|Non-arteritic anterior ischemic optic neuropathy|non-arteritic anterior ischemic optic neuropathy
38256|NCT03046693|pattern electroretinography|pattern electroretinography
38257|NCT03046693|citicoline|citicoline
38258|NCT03046693|retinal ganglion cell|retinal ganglion cell
38259|NCT03046693|visual field|visual field
38260|NCT03046667|Beta glucans|beta glucans
38261|NCT03046667|Barley|barley
38262|NCT03046667|SCFA|scfa
38263|NCT03046667|Calprotectin|calprotectin
38264|NCT03046667|Microbiota|microbiota
38265|NCT03046667|Hydrogene|hydrogene
38266|NCT03046667|Methane|methane
38267|NCT03046667|Metabolomics|metabolomics
38268|NCT03046667|Stool volume|stool volume
38269|NCT03046667|Stool frequency|stool frequency
38270|NCT03046641|Caloric Restriction|caloric restriction
38271|NCT03046641|Dietary Formulations|dietary formulations
38278|NCT03046563|stroke patients|stroke patients
38279|NCT03046563|Traditional Chinese medicine|traditional chinese medicine
38280|NCT03046524|Parathyroid Carcinoma|parathyroid carcinoma
38281|NCT03046524|Parathyroid Neoplasm|parathyroid neoplasm
38282|NCT03046524|Chart Review|chart review
38283|NCT03046485|AMD|amd
38284|NCT03046485|vision loss|vision loss
38285|NCT03046485|self-management strategies|self-management strategies
38286|NCT03046485|low-vision rehabilitation|low-vision rehabilitation
29868|NCT03098498|scaling|scaling
29869|NCT03098498|attachment gain|attachment gain
29870|NCT03098498|air polishing|air polishing
29871|NCT03098498|periodontal lesion|periodontal lesion
29872|NCT03098394|Rapid turnaround test|rapid turnaround test
29876|NCT03098394|STI|sti
38287|NCT03046485|IVI|ivi
38288|NCT03046472|thorax curve angle|thorax curve angle
38289|NCT03046459|cytokines|cytokines
38290|NCT03046459|interleukin-2|interleukin-2
38291|NCT03046459|Safety Issues|safety issues
38298|NCT03046433|children|children
38299|NCT03046433|asthma|asthma
38300|NCT03046433|China|china
38301|NCT03046394|prosthetic feet|prosthetic feet
38302|NCT03046394|gait pattern|gait pattern
38303|NCT03046394|one leg standing|one leg standing
38304|NCT03046394|walking speed|walking speed
38305|NCT03046342|Gastroenteritis, Polymerase chain reaction|gastroenteritis, polymerase chain reaction
38306|NCT03046329|patient care planning|patient care planning
38307|NCT03046316|Therapeutics|therapeutics
38308|NCT03046303|ERAS,gastric cancer|eras,gastric cancer
38309|NCT03046264|central blood pressure|central blood pressure
38311|NCT03046264|oscillometric radial pulse wave analysis|oscillometric radial pulse wave analysis
38312|NCT03046186|Gastric sleeve|gastric sleeve
38313|NCT03046186|Gastric bypass|gastric bypass
38314|NCT03046160|PPT|ppt
38315|NCT03046160|Scapula|scapula
38316|NCT03046160|Intervention|intervention
38317|NCT03046160|Manual therapy|manual therapy
38318|NCT03046160|mobilization|mobilization
38319|NCT03046121|dementia|dementia
38320|NCT03046121|acute care|acute care
38321|NCT03046121|post-acute recovery|post-acute recovery
38322|NCT03046121|family caregivers|family caregivers
38323|NCT03046095|Muscle Hypertrophy|muscle hypertrophy
38324|NCT03046095|Muscle Atrophy|muscle atrophy
38325|NCT03046095|Resistance Training|resistance training
38326|NCT03046095|Immobilization|immobilization
38327|NCT03046069|Triple therapy|triple therapy
38328|NCT03046069|COPD|copd
38329|NCT03046069|DCE|dce
38330|NCT03046069|Qualitative|qualitative
38331|NCT03046004|breast cancer|breast cancer
38332|NCT03046004|screening|screening
38333|NCT03046004|decision aid|decision aid
38334|NCT03046004|informed choice|informed choice
38335|NCT03046004|decisional conflict|decisional conflict
38336|NCT03045965|Salpingectomy|salpingectomy
38337|NCT03045965|Hysterectomy|hysterectomy
38338|NCT03045965|Ovarian cancer|ovarian cancer
38339|NCT03045952|Multicenter study|multicenter study
38340|NCT03045952|microwave|microwave
38341|NCT03045939|cervical ripening|cervical ripening
38342|NCT03045939|labor induction|labor induction
38343|NCT03045939|double balloon device|double balloon device
38344|NCT03045939|cervical ripening device|cervical ripening device
38345|NCT03045939|unfavorable cervix|unfavorable cervix
38346|NCT03045913|Observational registry|observational registry
38347|NCT03045913|All-comers open label registry|all-comers open label registry
38348|NCT03045913|Genoss DES|genoss des
38349|NCT03045913|Multicenter|multicenter
38350|NCT03045913|Stenting|stenting
38351|NCT03045913|Coronary Artery Disease|coronary artery disease
38352|NCT03045913|Coronary revascularization|coronary revascularization
38353|NCT03045913|Percutaneous Coronary Intervention|percutaneous coronary intervention
38354|NCT03045887|repeat dose|repeat dose
38355|NCT03045887|GSK2292767|gsk2292767
38356|NCT03045887|smoke|smoke
38357|NCT03045887|tolerability|tolerability
38358|NCT03045887|safety|safety
38359|NCT03045887|dry powder inhalation|dry powder inhalation
38360|NCT03045887|pharmacokinetics|pharmacokinetics
38361|NCT03045887|single dose|single dose
38362|NCT03045848|Observational registry|observational registry
38363|NCT03045848|All-comers open label registry|all-comers open label registry
38364|NCT03045848|Drug coated stent|drug coated stent
38365|NCT03045848|Multicenter|multicenter
38366|NCT03045848|Stenting|stenting
38367|NCT03045848|Coronary Artery Disease|coronary artery disease
38368|NCT03045848|Coronary revascularization|coronary revascularization
38369|NCT03045848|Percutaneous Coronary Intervention|percutaneous coronary intervention
38370|NCT03045835|laparoscopic surgery BASKA mask ambulatory care|laparoscopic surgery baska mask ambulatory care
38371|NCT03045822|Bioimpedance analysis|bioimpedance analysis
38372|NCT03045822|implantable cardioverter-defibrillators|implantable cardioverter-defibrillators
38373|NCT03045822|pacemakers|pacemakers
38374|NCT03045809|Syndromic management|syndromic management
38375|NCT03045809|Point of care testing|point of care testing
38376|NCT03045783|gastric varices|gastric varices
38377|NCT03045783|endoscopic injection of tissue adhesive|endoscopic injection of tissue adhesive
38378|NCT03045731|kidney transplantation|kidney transplantation
38379|NCT03045731|ultrasound|ultrasound
38380|NCT03045731|mathematical model|mathematical model
38381|NCT03045718|Horticultural Therapy|horticultural therapy
38382|NCT03045718|Dementia|dementia
38383|NCT03045718|Randomized Controlled Trial|randomized controlled trial
38384|NCT03045718|Elderly|elderly
38385|NCT03045718|Prevention|prevention
38386|NCT03045692|drug dosing, eGFR, CCr|drug dosing, egfr, ccr
38387|NCT03045679|Roux-en Y gastric bypass|roux-en y gastric bypass
38388|NCT03045679|One-anastomosis gastric bypass|one-anastomosis gastric bypass
38389|NCT03045679|Mini-gastric bypass|mini-gastric bypass
38390|NCT03045679|metabolic surgery|metabolic surgery
38391|NCT03045653|Breast Cancer|breast cancer
38392|NCT03045653|high dose Tamoxifen|high dose tamoxifen
38393|NCT03045653|endocrine therapy|endocrine therapy
38394|NCT03045653|Hormone Receptor Positive Malignant Neoplasm of Breast|hormone receptor positive malignant neoplasm of breast
38395|NCT03045653|Tamoxifen|tamoxifen
38396|NCT03045653|Breast Cancer Metastatic|breast cancer metastatic
38397|NCT03045640|ECD|ecd
38398|NCT03045640|parenting program|parenting program
38399|NCT03045640|home visiting|home visiting
38400|NCT03045627|Acute Myeloid Leukemia|acute myeloid leukemia
38401|NCT03045627|PEG-G-CSF|peg-g-csf
38402|NCT03045601|Diagnostic Techniques, Cardiovascular|diagnostic techniques, cardiovascular
38403|NCT03045601|Coronary Angiography|coronary angiography
38404|NCT03045601|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
38405|NCT03045601|Echocardiography, Stress|echocardiography, stress
38406|NCT03045510|Decitabine Myelodysplastic syndrome|decitabine myelodysplastic syndrome
38407|NCT03045484|nasopharyngeal carcinoma|nasopharyngeal carcinoma
38408|NCT03045484|Oral Mucositis Pain|oral mucositis pain
38409|NCT03045484|Oxycodone|oxycodone
38410|NCT03045458|one stage dental implant|one stage dental implant
38411|NCT03045458|two stage dental implant|two stage dental implant
38412|NCT03045458|Interleukin-1β|interleukin-1β
38414|NCT03045445|dual energy|dual energy
38415|NCT03045445|low dose|low dose
38416|NCT03045432|Stroke|stroke
38417|NCT03045432|Hemiplegia|hemiplegia
38418|NCT03045432|Rotator Cuff Injury|rotator cuff injury
38419|NCT03045419|MRI|mri
38420|NCT03045419|gadoxetic acid|gadoxetic acid
38421|NCT03045419|CT|ct
38422|NCT03045393|Neoadjuvant|neoadjuvant
38423|NCT03045393|Breast Cancer|breast cancer
38424|NCT03045393|Folate Receptor Alpha|folate receptor alpha
38425|NCT03045393|FRa|fra
38426|NCT03045393|TNBC|tnbc
38427|NCT03045393|Triple Negative Breast Cancer|triple negative breast cancer
38428|NCT03045393|Preoperative|preoperative
38429|NCT03045393|Presurgery|presurgery
38430|NCT03045393|Mirvetuximab Soravtansine|mirvetuximab soravtansine
38433|NCT03045367|Epiretinal membrane|epiretinal membrane
38435|NCT03045354|children|children
38436|NCT03045354|dietary carbohydrates|dietary carbohydrates
38437|NCT03045354|satiety|satiety
38438|NCT03045354|appetite|appetite
38439|NCT03045354|blood glucose|blood glucose
38440|NCT03045354|solanum tuberosum|solanum tuberosum
38441|NCT03045354|obesity|obesity
38442|NCT03045354|breakfast|breakfast
38443|NCT03045276|Spina Bifida|spina bifida
38444|NCT03045276|Kidney Transplant|kidney transplant
38445|NCT03045263|ASD|asd
38446|NCT03045237|Pregnancy|pregnancy
38447|NCT03045237|Physical activity|physical activity
38448|NCT03045237|Newborn|newborn
38449|NCT03045237|Depressive Symptoms|depressive symptoms
38450|NCT03045237|Dietary habits|dietary habits
38451|NCT03045237|Healthy lifestyles|healthy lifestyles
38452|NCT03045224|PAD, PTA, mortality, morbidity, amputation rate, quality of life|pad, pta, mortality, morbidity, amputation rate, quality of life
38453|NCT03045224|Percutaneous transluminal angioplasty (PTA), Stenting, balloon angioplasty|percutaneous transluminal angioplasty (pta), stenting, balloon angioplasty
38454|NCT03045198|cystic fibrosis|cystic fibrosis
38455|NCT03045185|Non Vital teeth|non vital teeth
38456|NCT03045185|Traumatised teeth|traumatised teeth
38457|NCT03045185|Immature teeth|immature teeth
38458|NCT03045185|Regenerative Endodontics|regenerative endodontics
38459|NCT03045172|Lichen Sclerosus|lichen sclerosus
38460|NCT03045172|Platelet Rich Plasma|platelet rich plasma
38461|NCT03045172|Vulvar|vulvar
38462|NCT03045172|Vulva|vulva
38463|NCT03045159|deployment cycle|deployment cycle
38464|NCT03045159|military family|military family
38465|NCT03045159|prevention|prevention
38466|NCT03045159|stress|stress
38467|NCT03045159|military child|military child
38468|NCT03045159|parenting|parenting
38469|NCT03045159|coparenting|coparenting
38470|NCT03045146|Acute Ischemic Stroke, Thrombectomy|acute ischemic stroke, thrombectomy
38471|NCT03045133|Postoperative pain|postoperative pain
38472|NCT03045133|Postoperative nausea and vomiting|postoperative nausea and vomiting
38473|NCT03045133|Quality of recovery|quality of recovery
38474|NCT03045133|QoR-40|qor-40
38475|NCT03045133|Total intravenous anesthesia|total intravenous anesthesia
38476|NCT03045107|right colon|right colon
38477|NCT03045107|laparoscopic right colectomy|laparoscopic right colectomy
38478|NCT03045107|intracorporeal anastomosis|intracorporeal anastomosis
38479|NCT03045107|extracorporeal anastomosis|extracorporeal anastomosis
38480|NCT03045107|hospital stay|hospital stay
38481|NCT03045107|quality of life|quality of life
30070|NCT03097055|Stroke|stroke
38482|NCT03045107|costs|costs
38483|NCT03045094|pediatric|pediatric
38484|NCT03045094|intubation|intubation
38485|NCT03045094|neck movement|neck movement
38486|NCT03045055|Acute ischemic stroke|acute ischemic stroke
38487|NCT03045055|Endovascular treatment|endovascular treatment
38488|NCT03045055|Remote ischemic conditioning|remote ischemic conditioning
38489|NCT03045042|Pompe|pompe
38490|NCT03045042|microRNA|microrna
38491|NCT03045042|biomarker|biomarker
38492|NCT03045042|muscle MRI|muscle mri
38493|NCT03045042|glycogenosis|glycogenosis
38497|NCT03045016|Acute stress Disorder|acute stress disorder
38498|NCT03045016|Post Traumatic Stress Disorder|post traumatic stress disorder
38499|NCT03045016|Prevention|prevention
38500|NCT03045016|trauma|trauma
38501|NCT03045016|prazosin|prazosin
38502|NCT03045003|Resilience, Supportive Care, Psychosocial Care, Nursing|resilience, supportive care, psychosocial care, nursing
38503|NCT03044990|Acute coronary syndrome|acute coronary syndrome
38504|NCT03044990|renal insufficiency|renal insufficiency
38505|NCT03044990|mortality|mortality
38506|NCT03044977|3-Iodobenzylguanidine|3-iodobenzylguanidine
38507|NCT03044977|dose-response relationship, radiation|dose-response relationship, radiation
38508|NCT03044977|theranostic|theranostic
38509|NCT03044977|radionuclide|radionuclide
38510|NCT03044977|MIBG|mibg
38511|NCT03044977|DOTA|dota
38512|NCT03044964|Angina, Chest Pain|angina, chest pain
38513|NCT03044951|atrial fibrillation|atrial fibrillation
38514|NCT03044951|cryoablation|cryoablation
38515|NCT03044951|irrigated radiofrequency ablation|irrigated radiofrequency ablation
38516|NCT03044951|pulmonary vein isolation|pulmonary vein isolation
38517|NCT03044938|Asthma|asthma
38518|NCT03044938|Salbutamol|salbutamol
38519|NCT03044938|Exercise|exercise
38520|NCT03044938|Heart Rate|heart rate
38521|NCT03044938|Blood pressure|blood pressure
38522|NCT03044925|persistent atrial fibrillation|persistent atrial fibrillation
38523|NCT03044925|remote magnetic navigation|remote magnetic navigation
38524|NCT03044925|cryoablation|cryoablation
38525|NCT03044899|Surgery|surgery
38526|NCT03044899|Complications|complications
38527|NCT03044899|Mortality|mortality
38528|NCT03044886|Vitamin D|vitamin d
38529|NCT03044821|Neural Tube Defect|neural tube defect
38530|NCT03044795|homologous recombination deficiency|homologous recombination deficiency
38531|NCT03044795|veliparib|veliparib
38532|NCT03044795|PARP inhibitor|parp inhibitor
38533|NCT03044795|biomarker|biomarker
38534|NCT03044769|Congenital Lung Anomalies|congenital lung anomalies
38535|NCT03044756|GnRH antagonist|gnrh antagonist
38536|NCT03044756|Pituitary downregulation|pituitary downregulation
38537|NCT03044756|IVF|ivf
38538|NCT03044756|ICSI|icsi
38539|NCT03044743|PD-1|pd-1
38540|NCT03044743|CRISPR Cas9|crispr cas9
38541|NCT03044743|EBV|ebv
38542|NCT03044743|advanced stage malignancies|advanced stage malignancies
38543|NCT03044717|Nutrition Education|nutrition education
38544|NCT03044717|Cardiology Fellows|cardiology fellows
38545|NCT03044652|Vulvovaginal Dryness|vulvovaginal dryness
38546|NCT03044626|Nivolumab|nivolumab
38547|NCT03044626|Radiotherapy|radiotherapy
38548|NCT03044600|Parathyroid disease|parathyroid disease
38549|NCT03044600|Hyperparathyroidism|hyperparathyroidism
38550|NCT03044600|Chart review|chart review
38551|NCT03044600|MEN1-negative|men1-negative
38552|NCT03044600|HRPT2 mutations|hrpt2 mutations
38553|NCT03044587|Biliary Tract Cancer|biliary tract cancer
38554|NCT03044587|NaI-IRI|nai-iri
38555|NCT03044574|venous thromboembolism|venous thromboembolism
38556|NCT03044574|deep vein thrombosis|deep vein thrombosis
38557|NCT03044574|pulmonary embolism|pulmonary embolism
38558|NCT03044574|prevention|prevention
38559|NCT03044574|intermittent pneumatic compression|intermittent pneumatic compression
38560|NCT03044574|sequential pneumatic compression|sequential pneumatic compression
38561|NCT03044574|surgery|surgery
38562|NCT03044574|elastic compression|elastic compression
38563|NCT03044574|low-molecular weight heparin|low-molecular weight heparin
38564|NCT03044574|prophylaxis|prophylaxis
38565|NCT03044535|quality of life|quality of life
38566|NCT03044535|mechanical circulatory support|mechanical circulatory support
38567|NCT03044509|Immunodiagnostics tests|immunodiagnostics tests
38568|NCT03044509|TB exposure|tb exposure
38569|NCT03044509|Latent TB|latent tb
38570|NCT03044509|TB disease|tb disease
38571|NCT03044509|Biomarkers|biomarkers
583400|NCT00511576|Docetaxel|docetaxel
38572|NCT03044496|NIR Spectroscopy|nir spectroscopy
38573|NCT03044496|Nerve Blockade|nerve blockade
38574|NCT03044496|Surgical Arteriovenous Shunt|surgical arteriovenous shunt
38575|NCT03044483|Sepsis|sepsis
38576|NCT03044483|Microcirculatory function|microcirculatory function
38577|NCT03044444|performance|performance
38578|NCT03044444|polyphenols|polyphenols
38579|NCT03044444|nutrition|nutrition
38580|NCT03044444|sports|sports
38581|NCT03044431|Shortness of breath|shortness of breath
38582|NCT03044431|Breathlessness|breathlessness
38583|NCT03044431|Stem cells|stem cells
38584|NCT03044431|Platelet rich plasma|platelet rich plasma
38585|NCT03044431|Quality of life|quality of life
38586|NCT03044431|Pulmonary Function|pulmonary function
38587|NCT03044418|laser|laser
38588|NCT03044418|endotracheal tube|endotracheal tube
38589|NCT03044418|total intravenous anesthesia|total intravenous anesthesia
38590|NCT03044418|side effect|side effect
38591|NCT03044418|endolaryngeal surgery|endolaryngeal surgery
38592|NCT03044405|fluid responsiveness|fluid responsiveness
38593|NCT03044405|focused echocardiography|focused echocardiography
38594|NCT03044405|major surgery|major surgery
38595|NCT03044353|echocardiography (ECHO)|echocardiography (echo)
38596|NCT03044353|skin biopsy|skin biopsy
38597|NCT03044353|monoclonal anti-serum amyloid p component antibody (anti-SAP mAb)|monoclonal anti-serum amyloid p component antibody (anti-sap mab)
38598|NCT03044353|Amyloidosis|amyloidosis
38700|NCT03043768|Autonomic|autonomic
38599|NCT03044353|cardiac magnetic resonance imaging (CMR)|cardiac magnetic resonance imaging (cmr)
38600|NCT03044353|biomarkers|biomarkers
38601|NCT03044353|cardiac functional measures|cardiac functional measures
38602|NCT03044353|left ventricular mass|left ventricular mass
38603|NCT03044314|pulmonary hypertension|pulmonary hypertension
38604|NCT03044314|vasodilator challenge|vasodilator challenge
38605|NCT03044314|echocardiography|echocardiography
38606|NCT03044314|outcomes|outcomes
38607|NCT03044314|iloprost|iloprost
38608|NCT03044314|inhaled nitric oxide|inhaled nitric oxide
38609|NCT03044249|Psychotic Disorders|psychotic disorders
38610|NCT03044223|pseudomonas aeruginosa|pseudomonas aeruginosa
38611|NCT03044223|critically ill patient|critically ill patient
38613|NCT03044223|monocyte|monocyte
38614|NCT03044223|macrophage|macrophage
38615|NCT03044223|cytokine|cytokine
38616|NCT03044223|severity of disease|severity of disease
38617|NCT03044210|Rest energetic cost measured by indirect calorimetry|rest energetic cost measured by indirect calorimetry
38618|NCT03044210|Hormonal axis|hormonal axis
38619|NCT03044210|Mitochondrial oxidative phosphorylation|mitochondrial oxidative phosphorylation
38620|NCT03044210|Basal metabolism|basal metabolism
38621|NCT03044197|prostate cancer|prostate cancer
38622|NCT03044197|magnetic resonance imaging|magnetic resonance imaging
38623|NCT03044197|transperineal biopsy|transperineal biopsy
38624|NCT03044197|target lesion|target lesion
38625|NCT03044197|fusion biopsy|fusion biopsy
38626|NCT03044184|Tranexamic Acid|tranexamic acid
38627|NCT03044184|Antifibrinolytic|antifibrinolytic
38628|NCT03044158|tuberculosis|tuberculosis
38629|NCT03044158|implementation science|implementation science
38630|NCT03044158|point-of-care|point-of-care
38631|NCT03044158|diagnostics|diagnostics
38632|NCT03044158|GeneXpert|genexpert
38633|NCT03044158|Uganda|uganda
38634|NCT03044145|Cultural Competence|cultural competence
38635|NCT03044145|Patient-Clinician communication|patient-clinician communication
38636|NCT03044132|Diabetic Foot Ulcer|diabetic foot ulcer
38637|NCT03044132|DFU|dfu
38638|NCT03044132|Lower Extremity Wound|lower extremity wound
38639|NCT03044132|Skin Substitute|skin substitute
38640|NCT03044106|hamstrings|hamstrings
38641|NCT03044106|flexibility|flexibility
38642|NCT03044106|strength|strength
38643|NCT03044106|pain pressure threshold|pain pressure threshold
38644|NCT03044106|lllt|lllt
38645|NCT03044106|photobiomodulation|photobiomodulation
38646|NCT03044106|cranial reflex|cranial reflex
38647|NCT03044106|cranial laser reflex technique|cranial laser reflex technique
38648|NCT03044106|CLRT|clrt
38649|NCT03044080|Walking Disorder|walking disorder
38650|NCT03044080|Stroke|stroke
38651|NCT03044080|Botulinum Toxin|botulinum toxin
38652|NCT03044080|Spasticity|spasticity
38653|NCT03044067|Chronic pain|chronic pain
38654|NCT03044067|Fibromyalgia|fibromyalgia
38655|NCT03044067|Pain neuroscience education|pain neuroscience education
38656|NCT03044067|Exercise|exercise
38657|NCT03044054|HIFU|hifu
38658|NCT03044041|Blood loss|blood loss
38659|NCT03044041|Tranexamic acid|tranexamic acid
38660|NCT03044041|Total knee arthroplasty|total knee arthroplasty
38661|NCT03044041|Topical administration|topical administration
38662|NCT03043989|docetaxel|docetaxel
38663|NCT03043989|cabazitaxel|cabazitaxel
38664|NCT03043989|phase 1b|phase 1b
38665|NCT03043989|castration-resistant|castration-resistant
38666|NCT03043989|bone metastasis|bone metastasis
38667|NCT03043976|Physical activity|physical activity
38668|NCT03043976|Steps count|steps count
38669|NCT03043950|mCRC|mcrc
38670|NCT03043950|First line|first line
38671|NCT03043950|Panitumumab|panitumumab
38672|NCT03043950|mCCS Prognostic Score|mccs prognostic score
38673|NCT03043950|Prognosis|prognosis
38674|NCT03043950|Ras wild type|ras wild type
38675|NCT03043924|hypothalamus|hypothalamus
38676|NCT03043924|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
38677|NCT03043924|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
38678|NCT03043911|early detection|early detection
38679|NCT03043911|respiratory events|respiratory events
38681|NCT03043872|Carcinoma, Small Cell Lung|carcinoma, small cell lung
38682|NCT03043872|Oat Cell Carcinoma of Lung|oat cell carcinoma of lung
38683|NCT03043872|Oat Cell Lung Cancer|oat cell lung cancer
38684|NCT03043872|Small Cell Cancer Of The Lung|small cell cancer of the lung
38685|NCT03043872|Small Cell Lung Cancer|small cell lung cancer
38686|NCT03043846|Treat to Target approach|treat to target approach
38687|NCT03043820|raloxifene|raloxifene
38688|NCT03043820|selective estrogen receptor modulator (SERM)|selective estrogen receptor modulator (serm)
38689|NCT03043820|schizophrenia|schizophrenia
38690|NCT03043820|psychosis|psychosis
38691|NCT03043820|cognition|cognition
38692|NCT03043820|negative symptoms|negative symptoms
38693|NCT03043807|prostatectomy|prostatectomy
38694|NCT03043807|androgen deprivation|androgen deprivation
38695|NCT03043807|chemotherapy|chemotherapy
38696|NCT03043807|radiation|radiation
38697|NCT03043794|early stage|early stage
38698|NCT03043794|low risk|low risk
38699|NCT03043768|Parkinson's disease|parkinson's disease
38701|NCT03043768|Diagnosis|diagnosis
38702|NCT03043768|Pilomotor|pilomotor
38703|NCT03043768|Alpha-synuclein|alpha-synuclein
38704|NCT03043768|Axon-reflex|axon-reflex
38705|NCT03043768|Peripheral nerve fibers|peripheral nerve fibers
38706|NCT03043729|neoadjuvant|neoadjuvant
38707|NCT03043729|MRI-defined T3|mri-defined t3
38708|NCT03043729|mFOLFOX6|mfolfox6
38709|NCT03043729|Aflibercept|aflibercept
38710|NCT03043690|menopause|menopause
38711|NCT03043690|ammonium succinate|ammonium succinate
38712|NCT03043664|GEP-NET|gep-net
38713|NCT03043664|Pembrolizumab|pembrolizumab
38714|NCT03043664|Lanreotide depot|lanreotide depot
38715|NCT03043664|PD-1|pd-1
38716|NCT03043651|Pulmonary Hypertension|pulmonary hypertension
38717|NCT03043651|HFpEF|hfpef
38718|NCT03043651|6-Minute Walk Test|6-minute walk test
38719|NCT03043651|Oral Treprostinil|oral treprostinil
38720|NCT03043638|multiple adjacent gingival recessions|multiple adjacent gingival recessions
38721|NCT03043638|platelet rich plasma|platelet rich plasma
38722|NCT03043638|acellular dermal matrix|acellular dermal matrix
38723|NCT03043638|coronally advanced flap|coronally advanced flap
38724|NCT03043638|gingival recession|gingival recession
38725|NCT03043638|root coverage|root coverage
38726|NCT03043638|clinical attachment level|clinical attachment level
38727|NCT03043625|Neck pain|neck pain
38728|NCT03043625|visceral manipulation|visceral manipulation
38729|NCT03043625|functional dyspepsia|functional dyspepsia
38730|NCT03043625|electromyography|electromyography
38731|NCT03043625|pain|pain
38732|NCT03043612|Ureteroscopy for urolithiasis|ureteroscopy for urolithiasis
38733|NCT03043599|Thoracic|thoracic
38734|NCT03043599|Radiotherapy|radiotherapy
38735|NCT03043599|Platinum Based Chemotherapy|platinum based chemotherapy
38736|NCT03043599|Immunotherapy|immunotherapy
38737|NCT03043599|Ipilimumab|ipilimumab
38738|NCT03043599|Nivolumab|nivolumab
38739|NCT03043599|Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC)|extensive-stage disease small cell lung cancer (ed-sclc)
38740|NCT03043586|Acromegaly|acromegaly
38741|NCT03043560|depression|depression
38742|NCT03043560|anhedonia|anhedonia
38743|NCT03043560|reward|reward
38744|NCT03043547|nal-IRI|nal-iri
38745|NCT03043547|5-Fluorouracil|5-fluorouracil
38746|NCT03043508|Genetic mutation|genetic mutation
38747|NCT03043508|MEN1|men1
38748|NCT03043508|Pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
38749|NCT03043508|PNET|pnet
38750|NCT03043508|Chart review|chart review
38751|NCT03043508|Questionnaire|questionnaire
38752|NCT03043508|Survey|survey
38753|NCT03043495|dexamethasone|dexamethasone
38754|NCT03043495|supraclavicular brachial plexus block|supraclavicular brachial plexus block
38755|NCT03043495|ultrasound|ultrasound
38756|NCT03043482|VS-105|vs-105
38757|NCT03043482|Renal Insufficiency, Chronic|renal insufficiency, chronic
38758|NCT03043482|Secondary hyperparathyroidism|secondary hyperparathyroidism
38759|NCT03043469|dysfunctional breathing|dysfunctional breathing
38760|NCT03043443|sleep|sleep
38761|NCT03043443|Alcohol dependence|alcohol dependence
38762|NCT03043443|Melatonin|melatonin
38763|NCT03043417|Stigma|stigma
38764|NCT03043417|Primary Health Care|primary health care
38765|NCT03043417|Recovery|recovery
38766|NCT03043391|Pediatric Malignant Glioma|pediatric malignant glioma
38767|NCT03043391|PVSRIPO|pvsripo
38768|NCT03043391|Pro00071228|pro00071228
38769|NCT03043391|Eric Thompson|eric thompson
38770|NCT03043391|Darell Bigner|darell bigner
38771|NCT03043391|Oncolytic Poliovirus|oncolytic poliovirus
38772|NCT03043378|Malignant Neoplasms of Independent (Primary) Multiple Sites|malignant neoplasms of independent (primary) multiple sites
38773|NCT03043378|Non-malignant pain|non-malignant pain
38774|NCT03043378|Supportive care|supportive care
38775|NCT03043378|Questionnaires|questionnaires
38776|NCT03043378|Surveys|surveys
38777|NCT03043378|Chronic non-malignant pain|chronic non-malignant pain
38778|NCT03043365|Fish Oils|fish oils
38779|NCT03043365|Long Chain Monounsaturated Fatty Acids|long chain monounsaturated fatty acids
38780|NCT03043365|Lipoproteins|lipoproteins
38781|NCT03043365|Cardiovascular Disease|cardiovascular disease
38783|NCT03043352|Malnutrition|malnutrition
38784|NCT03043352|LHW|lhw
38785|NCT03043352|CMAM|cmam
38786|NCT03043339|Microbiota composition|microbiota composition
38787|NCT03043339|Kidney transplant recipient|kidney transplant recipient
38788|NCT03043339|Kidney transplant donor|kidney transplant donor
38789|NCT03043339|Antibiotics|antibiotics
38790|NCT03043339|Drug resistance|drug resistance
38791|NCT03043339|Transplantation surgery|transplantation surgery
38792|NCT03043326|Pre-exposure Prophylaxis|pre-exposure prophylaxis
38793|NCT03043326|MSM and transgender women|msm and transgender women
38794|NCT03043300|Travelers' diarrhea|travelers' diarrhea
38795|NCT03043300|Intestinal microbiota|intestinal microbiota
38796|NCT03043300|Antibiotic resistance|antibiotic resistance
38797|NCT03043300|Antibiotics|antibiotics
38798|NCT03043300|Gastrointestinal disorders|gastrointestinal disorders
38799|NCT03043300|Infectious diseases|infectious diseases
38800|NCT03043300|International Travel|international travel
38801|NCT03043300|Travel Medicine|travel medicine
38802|NCT03043300|Resistome|resistome
38803|NCT03043300|Microbiome|microbiome
38804|NCT03043261|CHF|chf
38805|NCT03043248|TRK-700|trk-700
38806|NCT03043248|PK|pk
38807|NCT03043248|Digoxin|digoxin
38808|NCT03043248|Midazolam|midazolam
38809|NCT03043248|Drug-Drug interaction|drug-drug interaction
38810|NCT03043248|P-glycoprotein|p-glycoprotein
38811|NCT03043248|CYP3A4|cyp3a4
38812|NCT03043248|MDR1|mdr1
38813|NCT03043248|pharmacokinetics|pharmacokinetics
38817|NCT03043222|Minimally invasive|minimally invasive
38818|NCT03043222|non-surgical|non-surgical
38819|NCT03043222|maintenance of sexual function|maintenance of sexual function
38820|NCT03043222|complications of TURP , surgery|complications of turp , surgery
38821|NCT03043183|gastric cancer|gastric cancer
38822|NCT03043183|Enhanced recovery after surgery|enhanced recovery after surgery
38824|NCT03043170|Emergency Department|emergency department
38825|NCT03043170|Haemodynamics|haemodynamics
38826|NCT03043170|Resuscitation|resuscitation
38827|NCT03043170|Shock|shock
38828|NCT03043170|Uscom|uscom
38829|NCT03043131|Cardiopulmonary bypass prime|cardiopulmonary bypass prime
38830|NCT03043131|Plasma Lyte - A|plasma lyte - a
39221|NCT03040726|Placebo|placebo
38831|NCT03043131|Ringer;s lactate|ringer;s lactate
38832|NCT03043131|Acidosis|acidosis
38833|NCT03043118|Eating Behaviors|eating behaviors
38834|NCT03043118|Preschool|preschool
38835|NCT03043118|Vegetable Intake|vegetable intake
38836|NCT03043105|Multicentric Castleman's Disease|multicentric castleman's disease
38837|NCT03043105|Thalidomide, cyclophosphamide and prednisone (TCP regimen)|thalidomide, cyclophosphamide and prednisone (tcp regimen)
38838|NCT03043105|Efficacy|efficacy
38839|NCT03043105|Safety|safety
38840|NCT03043092|ultrasound, transcranial Doppler, arterial diseases|ultrasound, transcranial doppler, arterial diseases
38841|NCT03043066|Chronic Periodontitis|chronic periodontitis
38842|NCT03043066|TRAP-5b|trap-5b
38843|NCT03043066|Non-surgical periodontal therapy|non-surgical periodontal therapy
38844|NCT03043066|Systemic antibiotics|systemic antibiotics
38845|NCT03043053|weight loss|weight loss
38846|NCT03043053|body mass index|body mass index
38847|NCT03043053|oxytocin|oxytocin
38848|NCT03043053|magnetic resonance imaging|magnetic resonance imaging
38849|NCT03043040|suicide, attempted|suicide, attempted
38850|NCT03043040|prevention|prevention
38851|NCT03043040|telemedicine|telemedicine
38852|NCT03042988|supine hypertension|supine hypertension
38853|NCT03042988|autonomic failure|autonomic failure
38854|NCT03042988|heat stress|heat stress
38855|NCT03042988|orthostatic hypotension|orthostatic hypotension
38856|NCT03042975|spasmodic dysphonia|spasmodic dysphonia
38857|NCT03042975|dystonia|dystonia
38858|NCT03042975|laryngeal dystonia|laryngeal dystonia
38859|NCT03042975|imaging|imaging
38860|NCT03042975|genetics|genetics
38861|NCT03042962|dystonia|dystonia
38862|NCT03042962|imaging|imaging
38863|NCT03042962|genetics|genetics
38864|NCT03042962|neuropathology|neuropathology
38865|NCT03042936|Children|children
38866|NCT03042936|Teens|teens
38867|NCT03042936|Adolescents|adolescents
38868|NCT03042936|Type 2 diabetes|type 2 diabetes
38869|NCT03042936|Impaired glucose tolerance|impaired glucose tolerance
38870|NCT03042936|Exercise|exercise
38871|NCT03042936|Nutrition|nutrition
38872|NCT03042936|Education|education
38873|NCT03042884|Benign Neoplasms|benign neoplasms
38874|NCT03042884|In Situ Neoplasms|in situ neoplasms
38875|NCT03042884|Malignant Neoplasms of Independent (Primary) Multiple Sites|malignant neoplasms of independent (primary) multiple sites
38876|NCT03042884|Wearable exercise trackers|wearable exercise trackers
38877|NCT03042884|Questionnaires|questionnaires
38878|NCT03042884|Surveys|surveys
38879|NCT03042871|PM-CNV ,Ranibizumab, Dosing Strategy|pm-cnv ,ranibizumab, dosing strategy
38880|NCT03042858|PPV|ppv
38881|NCT03042858|patent processus vaginalis|patent processus vaginalis
38882|NCT03042858|inguinal hernia|inguinal hernia
30483|NCT03095287|ITI|iti
38883|NCT03042832|Leadership|leadership
38884|NCT03042832|Organizational Climate|organizational climate
38885|NCT03042832|Implementation|implementation
38886|NCT03042832|Implementation Climate|implementation climate
38887|NCT03042832|Motivational Interviewing|motivational interviewing
38888|NCT03042832|Fidelity|fidelity
38889|NCT03042806|Physical Activity|physical activity
38890|NCT03042806|Questionnaire|questionnaire
38891|NCT03042793|myeloma|myeloma
38892|NCT03042793|vaccination|vaccination
38893|NCT03042793|PD-L1|pd-l1
38894|NCT03042793|peptide vaccine|peptide vaccine
38895|NCT03042793|cancer vaccine|cancer vaccine
38896|NCT03042793|immunotherapy|immunotherapy
38897|NCT03042780|Gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs)|gastroenteropancreatic neuroendocrine carcinomas (gep-necs)
38898|NCT03042780|Metastatic|metastatic
38899|NCT03042780|High grade|high grade
38900|NCT03042780|Pancreas|pancreas
38901|NCT03042780|Neuroendocrine carcinoma of gastrointestinal tract|neuroendocrine carcinoma of gastrointestinal tract
38902|NCT03042754|LAM|lam
38903|NCT03042754|XpertMTB/RIF|xpertmtb/rif
38904|NCT03042754|treatment outcome|treatment outcome
38905|NCT03042754|Microbacterial tuberculosis|microbacterial tuberculosis
38912|NCT03042663|arterial cannula|arterial cannula
38914|NCT03042663|septic shock|septic shock
38915|NCT03042611|Gastric Cancer|gastric cancer
38916|NCT03042611|Gastric Adenocarcinoma|gastric adenocarcinoma
38917|NCT03042611|Gastro-esophageal Cancer|gastro-esophageal cancer
38918|NCT03042611|Gastro-esophageal junction Cancer|gastro-esophageal junction cancer
38919|NCT03042611|Stomach Cancer|stomach cancer
38920|NCT03042611|Tumor|tumor
38921|NCT03042611|Oncology|oncology
38922|NCT03042611|Antiangiogenesis|antiangiogenesis
38923|NCT03042611|Metastatic|metastatic
38924|NCT03042598|Safe Apneic Period|safe apneic period
38925|NCT03042598|Emergency Intubation|emergency intubation
38926|NCT03042598|Biphasic Cuirass Ventilation (BCV)|biphasic cuirass ventilation (bcv)
38927|NCT03042598|Non-invasive ventilation|non-invasive ventilation
39222|NCT03040726|Sugar pill|sugar pill
38928|NCT03042598|Peri-intubation Hemodynamic instability|peri-intubation hemodynamic instability
38929|NCT03042598|desaturation|desaturation
38930|NCT03042598|waveform capnography|waveform capnography
38931|NCT03042598|Patient safety|patient safety
38932|NCT03042585|BMT|bmt
38933|NCT03042585|NHL|nhl
38934|NCT03042585|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
38935|NCT03042585|Relapsed Non-Hodgkin Lymphoma|relapsed non-hodgkin lymphoma
38936|NCT03042585|Refractory Non-Hodgkin Lymphoma|refractory non-hodgkin lymphoma
38937|NCT03042585|autologous stem cell transplantation|autologous stem cell transplantation
38938|NCT03042572|Critical Limb Ischemia (CLI)|critical limb ischemia (cli)
38939|NCT03042572|Severe Limb Ischemia (SLI)|severe limb ischemia (sli)
38940|NCT03042572|Peripheral Artery Disease (PAD)|peripheral artery disease (pad)
38941|NCT03042572|Peripheral Artery Occlusive Disease (PAOD)|peripheral artery occlusive disease (paod)
38942|NCT03042572|Cardiovascular disease|cardiovascular disease
38943|NCT03042572|Mesenchymal stromal cell (MSC)|mesenchymal stromal cell (msc)
38944|NCT03042572|Mesenchymal stem cell (MSC)|mesenchymal stem cell (msc)
38945|NCT03042494|Prebiotic|prebiotic
38946|NCT03042494|Gut microbiota|gut microbiota
38947|NCT03042494|Dietary fiber|dietary fiber
38948|NCT03042494|Gastrointestinal tolerance|gastrointestinal tolerance
38949|NCT03042481|chronic hepatitis B|chronic hepatitis b
38950|NCT03042481|entecavir|entecavir
38951|NCT03042481|tenofovir|tenofovir
38952|NCT03042481|off-therapy|off-therapy
38953|NCT03042481|relapse|relapse
38954|NCT03042442|pancreatic cancer|pancreatic cancer
38955|NCT03042442|cachexia|cachexia
38956|NCT03042442|perineural invasion|perineural invasion
38957|NCT03042442|pain|pain
38958|NCT03042442|diabetes|diabetes
38959|NCT03042429|neuroblastoma|neuroblastoma
38960|NCT03042429|chemotherapy|chemotherapy
38961|NCT03042429|autologous stem cell transplantation|autologous stem cell transplantation
38962|NCT03042429|radiotherapy|radiotherapy
38963|NCT03042429|mIBG|mibg
38964|NCT03042429|tumor resection|tumor resection
38965|NCT03042416|18F-DOPA PET/CT|18f-dopa pet/ct
38966|NCT03042403|hemodynamics|hemodynamics
38967|NCT03042403|physiotherapy|physiotherapy
38968|NCT03042403|breath stacking|breath stacking
38969|NCT03042377|Endodontics|endodontics
38970|NCT03042377|Retreatment|retreatment
38971|NCT03042377|Postoperative Pain|postoperative pain
38972|NCT03042377|Visual Analogue Pain Scale|visual analogue pain scale
38973|NCT03042364|Endometrium, Cytokines, Endometrial secretion, Implantation, Endometrial scratching|endometrium, cytokines, endometrial secretion, implantation, endometrial scratching
38974|NCT03042351|Urinary Incontinence|urinary incontinence
38975|NCT03042351|Pelvic Floor|pelvic floor
38976|NCT03042325|Drug therapy|drug therapy
38977|NCT03042286|statin|statin
38978|NCT03042286|myalgia|myalgia
38979|NCT03042286|myopathy|myopathy
38980|NCT03042286|adverse drug reactions (ADRs)|adverse drug reactions (adrs)
38981|NCT03042286|pharmacokinetics and pharmacogenetics|pharmacokinetics and pharmacogenetics
38982|NCT03042273|recurrent|recurrent
38983|NCT03042260|trimethoprim, sulfamethoxazole drug combination|trimethoprim, sulfamethoxazole drug combination
38984|NCT03042260|Infection|infection
38985|NCT03042260|Prophylaxis|prophylaxis
38986|NCT03042234|Obesity|obesity
38987|NCT03042234|Exercise|exercise
38988|NCT03042234|Fat oxidation|fat oxidation
38989|NCT03042234|Adolescent|adolescent
38990|NCT03042234|Insulin resistance|insulin resistance
38991|NCT03042195|Supplementary Parenteral Nutrition|supplementary parenteral nutrition
38992|NCT03042195|Postoperative Nutrition|postoperative nutrition
38993|NCT03042195|Postoperative complications|postoperative complications
38994|NCT03042169|Stage IV gastric cancer|stage iv gastric cancer
38995|NCT03042169|palliative surgery|palliative surgery
38996|NCT03042169|chemotherapy|chemotherapy
38997|NCT03042169|survival|survival
38998|NCT03042169|quality of life|quality of life
38999|NCT03042143|Acute respiratory distress syndrome|acute respiratory distress syndrome
39000|NCT03042143|Human umbilical cord-derived mesenchymal stem cells|human umbilical cord-derived mesenchymal stem cells
39001|NCT03042104|Stenosis|stenosis
39002|NCT03042104|Heart Disease|heart disease
39003|NCT03042104|Valve|valve
39004|NCT03042104|Tricuspid|tricuspid
39005|NCT03042104|Aortic Valve|aortic valve
39006|NCT03042104|Asymptomatic|asymptomatic
39007|NCT03042078|Fluoroscopy|fluoroscopy
39008|NCT03042078|Ablation|ablation
39009|NCT03042078|Three dimensional|three dimensional
39010|NCT03042078|Paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
39011|NCT03042078|Radiation|radiation
39012|NCT03042065|pediatrics|pediatrics
39013|NCT03042065|asthma|asthma
39014|NCT03042065|nebulization|nebulization
39015|NCT03042065|vibrating mesh|vibrating mesh
39016|NCT03042065|salbutamol|salbutamol
39017|NCT03042065|Efficiency|efficiency
39018|NCT03042013|ASP8273|asp8273
39019|NCT03042013|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
39020|NCT03042013|EGFR mutations|egfr mutations
39021|NCT03042013|Oncology|oncology
39022|NCT03042000|rectal cancer|rectal cancer
39023|NCT03042000|neoadjuvant chemoradiation|neoadjuvant chemoradiation
39024|NCT03042000|circulating tumor DNA|circulating tumor dna
39025|NCT03042000|local recurrence|local recurrence
39026|NCT03042000|long-term survival|long-term survival
39027|NCT03041987|Cohort studies|cohort studies
39028|NCT03041987|Prognosis|prognosis
39029|NCT03041974|Red Blood Cell Transfusion|red blood cell transfusion
39030|NCT03041974|Cell-Derived Microparticles|cell-derived microparticles
39031|NCT03041961|Vascular function|vascular function
39032|NCT03041961|Endothelial function|endothelial function
39033|NCT03041961|(Poly)phenols|(poly)phenols
39034|NCT03041948|Inguinal hernia|inguinal hernia
39035|NCT03041948|Caudal nerve block|caudal nerve block
39036|NCT03041948|Ilioinguinal nerve block|ilioinguinal nerve block
39037|NCT03041948|Pain|pain
39038|NCT03041935|Testicle|testicle
39039|NCT03041935|Pain|pain
39040|NCT03041935|Orchiopexy|orchiopexy
39041|NCT03041935|Caudal nerve block|caudal nerve block
39042|NCT03041935|Ilioinguinal nerve block|ilioinguinal nerve block
39043|NCT03041922|Elastography|elastography
39044|NCT03041922|Buttocks|buttocks
39045|NCT03041922|Ultrasound|ultrasound
39046|NCT03041922|Soft tissue|soft tissue
39047|NCT03041870|PET-fMRI|pet-fmri
39048|NCT03041870|dominance|dominance
39049|NCT03041870|5HT transporter|5ht transporter
39050|NCT03041857|Videofluoroscopy|videofluoroscopy
39051|NCT03041857|GMK Sphere|gmk sphere
39052|NCT03041857|GMK PS Fixed Bearing|gmk ps fixed bearing
39053|NCT03041857|GMK UC Mobile Bearing|gmk uc mobile bearing
39054|NCT03041844|therapeutic ultrasound|therapeutic ultrasound
39055|NCT03041844|quality of life|quality of life
39056|NCT03041831|frail elderly|frail elderly
39057|NCT03041831|telemedicine|telemedicine
39059|NCT03041831|rural health|rural health
39060|NCT03041831|health promotion|health promotion
39061|NCT03041818|cerebral palsy|cerebral palsy
39062|NCT03041818|horseback riding|horseback riding
39063|NCT03041805|venous thromboembolism|venous thromboembolism
39064|NCT03041805|deep vein thrombosis|deep vein thrombosis
39065|NCT03041805|pulmonary embolism|pulmonary embolism
39066|NCT03041805|varicose veins|varicose veins
39067|NCT03041805|surgery|surgery
39068|NCT03041805|endovenous laser treatment|endovenous laser treatment
39069|NCT03041805|radiofrequency ablation|radiofrequency ablation
39070|NCT03041805|ultrasound-guided foam sclerotherapy|ultrasound-guided foam sclerotherapy
39071|NCT03041805|register|register
39072|NCT03041805|anticoagulation|anticoagulation
39073|NCT03041766|Schistosomiasis|schistosomiasis
39074|NCT03041766|Recombinant vaccine|recombinant vaccine
39075|NCT03041766|rSm14|rsm14
39076|NCT03041766|GLA-SE|gla-se
39077|NCT03041766|Fatty acid-binding protein (FABP)|fatty acid-binding protein (fabp)
39078|NCT03041766|Phase II Clinical Trial|phase ii clinical trial
39079|NCT03041766|Senegal|senegal
39080|NCT03041753|stroke|stroke
39081|NCT03041753|thrombolysis|thrombolysis
39082|NCT03041753|metalloproteinases|metalloproteinases
30679|NCT03094091|Patients|patients
30680|NCT03094078|Spin|spin
30681|NCT03094078|Misleading reporting|misleading reporting
39083|NCT03041753|blood brain barrier|blood brain barrier
39084|NCT03041740|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
39085|NCT03041740|Neonates|neonates
39086|NCT03041714|Essential Tremor|essential tremor
39087|NCT03041714|Cervical Dystonia|cervical dystonia
39088|NCT03041714|Hand Dystonia|hand dystonia
39089|NCT03041714|Neurophysiology|neurophysiology
39090|NCT03041714|Dystonic Tremor|dystonic tremor
39091|NCT03041701|ERMS|erms
39092|NCT03041701|ARMS|arms
39093|NCT03041701|Monoclonal Antibody|monoclonal antibody
39095|NCT03041701|RMS|rms
39097|NCT03041675|Paralytic ileus|paralytic ileus
39098|NCT03041649|Gastroesophageal Reflux|gastroesophageal reflux
39099|NCT03041649|Feeding Disorder|feeding disorder
39100|NCT03041649|Gastrostomy tube|gastrostomy tube
39101|NCT03041649|Family Satisfaction|family satisfaction
39102|NCT03041649|GT button|gt button
39103|NCT03041649|Enteral nutrition|enteral nutrition
39104|NCT03041649|Gastrostomy button|gastrostomy button
39105|NCT03041636|Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
39106|NCT03041636|Other Diseases of Blood and Blood-Forming Organs|other diseases of blood and blood-forming organs
39107|NCT03041636|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
39108|NCT03041636|CLL|cll
39109|NCT03041636|Ruxolitinib|ruxolitinib
39110|NCT03041636|Jakafi|jakafi
39111|NCT03041636|INCB018424|incb018424
39112|NCT03041623|IIPs|iips
39113|NCT03041558|healthy relationships|healthy relationships
39114|NCT03041558|interpersonal relations|interpersonal relations
39115|NCT03041558|domestic violence|domestic violence
39116|NCT03041532|retroflexion proximal|retroflexion proximal
39117|NCT03041532|colorectal cancer screening programme|colorectal cancer screening programme
39118|NCT03041532|adenoma detection rate|adenoma detection rate
39119|NCT03041532|right colon|right colon
39120|NCT03041519|Fluoroscopy|fluoroscopy
39121|NCT03041519|Ablation|ablation
39122|NCT03041519|Three dimensional|three dimensional
39123|NCT03041519|Ventricular arrhythmias|ventricular arrhythmias
39124|NCT03041519|Radiation|radiation
39419|NCT03039218|shockwave|shockwave
39125|NCT03041506|Shoulder dislocation reduction|shoulder dislocation reduction
39126|NCT03041506|Ultrasound guided interscalene block (ISCB)|ultrasound guided interscalene block (iscb)
39127|NCT03041506|Sedation|sedation
39128|NCT03041493|Electronic Cigarettes|electronic cigarettes
39129|NCT03041493|17-071|17-071
39130|NCT03041480|chronic periodontitis|chronic periodontitis
39131|NCT03041480|lipids|lipids
39132|NCT03041480|Lp-PLA2|lp-pla2
39133|NCT03041402|non-invasive ventilation|non-invasive ventilation
39134|NCT03041402|Pressure Support Ventilation|pressure support ventilation
39135|NCT03041402|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
39136|NCT03041402|patient-ventilator interaction|patient-ventilator interaction
39137|NCT03041402|ventilator performance|ventilator performance
39138|NCT03041402|asynchrony|asynchrony
39139|NCT03041389|Computerized Cognitive Behavioral Therapy|computerized cognitive behavioral therapy
39140|NCT03041350|Emergency Medical Services|emergency medical services
39141|NCT03041350|Smartphone|smartphone
39142|NCT03041350|Survival|survival
39143|NCT03041311|Small Cell Lung Cancer|small cell lung cancer
39144|NCT03041311|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
39145|NCT03041311|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
39146|NCT03041246|pelvic floor|pelvic floor
39147|NCT03041207|ventilator associated infection|ventilator associated infection
39148|NCT03041207|ventilator associated pneumonia|ventilator associated pneumonia
39149|NCT03041207|ventilator associated tracheitis|ventilator associated tracheitis
39150|NCT03041207|Lower respiratory infection|lower respiratory infection
39157|NCT03041142|Interdisciplinary intervention|interdisciplinary intervention
39158|NCT03041129|hepatic de novo lipogenesis|hepatic de novo lipogenesis
39160|NCT03041090|infiltration|infiltration
39161|NCT03041090|extravasation|extravasation
39162|NCT03041090|PET/CT|pet/ct
39163|NCT03041090|PET|pet
39164|NCT03041090|PET-CT|pet-ct
39165|NCT03041025|Systemic Sclerosis|systemic sclerosis
39166|NCT03041025|Repeat-dose|repeat-dose
39167|NCT03041025|Phase IIA|phase iia
39168|NCT03041025|GSK2330811|gsk2330811
39169|NCT03041025|Pharmacodynamics|pharmacodynamics
39170|NCT03041025|Pharmacokinetics|pharmacokinetics
39171|NCT03041025|Proof of mechanism study|proof of mechanism study
39172|NCT03041012|HIV-1|hiv-1
39173|NCT03041012|Latency Reversal Agent|latency reversal agent
39174|NCT03041012|Immunotherapy|immunotherapy
39175|NCT03040999|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
39176|NCT03040999|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
39177|NCT03040999|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
39178|NCT03040999|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
39179|NCT03040999|PD1|pd1
39180|NCT03040999|PD-1|pd-1
39181|NCT03040999|PDL1|pdl1
39182|NCT03040999|PD-L1|pd-l1
39183|NCT03040999|PDL2|pdl2
39184|NCT03040973|capmatinib|capmatinib
39185|NCT03040973|cMET|cmet
39186|NCT03040973|advanced solid tumor|advanced solid tumor
39187|NCT03040973|cancer|cancer
39188|NCT03040960|infection|infection
39189|NCT03040960|wound infection|wound infection
39190|NCT03040960|surgical wound infection|surgical wound infection
39191|NCT03040960|Staphylococcal infections|staphylococcal infections
39192|NCT03040960|wound and injuries|wound and injuries
39193|NCT03040960|postoperative complications|postoperative complications
39194|NCT03040960|Gram-positive bacterial infections|gram-positive bacterial infections
39195|NCT03040960|bacterial infections|bacterial infections
39196|NCT03040895|Parenting practices|parenting practices
39197|NCT03040856|Omega 3|omega 3
39198|NCT03040856|Supplements|supplements
39199|NCT03040856|Alpha Linolenic Acid|alpha linolenic acid
39200|NCT03040843|documentation|documentation
39201|NCT03040843|altered mental status|altered mental status
39202|NCT03040843|definition|definition
39203|NCT03040843|clinically|clinically
39204|NCT03040804|hidradenitis suppurativa|hidradenitis suppurativa
39205|NCT03040804|HS|hs
39206|NCT03040804|radiotherapy|radiotherapy
39207|NCT03040791|prostate cancer|prostate cancer
39208|NCT03040778|MRONJ|mronj
39209|NCT03040778|BRONJ|bronj
39210|NCT03040765|Osteoporosis|osteoporosis
39211|NCT03040765|Beta-Thalassemia Major|beta-thalassemia major
39212|NCT03040765|Denosumab|denosumab
39213|NCT03040765|Zoledronic Acid|zoledronic acid
39214|NCT03040739|O'ARM|o'arm
39215|NCT03040726|In situ neoplasm|in situ neoplasm
39216|NCT03040726|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
39217|NCT03040726|Symptoms and signs involving the digestive system and abdomen|symptoms and signs involving the digestive system and abdomen
39218|NCT03040726|Chronic nausea and vomiting|chronic nausea and vomiting
39219|NCT03040726|Netupitant/Palonosetron|netupitant/palonosetron
39220|NCT03040726|NEPA|nepa
39223|NCT03040726|Symptom questionnaires|symptom questionnaires
39224|NCT03040726|Surveys|surveys
39225|NCT03040726|Pill diary|pill diary
39226|NCT03040726|Akynzeo|akynzeo
39227|NCT03040700|coronary artery disease|coronary artery disease
39228|NCT03040700|surgery|surgery
39229|NCT03040700|angina|angina
39230|NCT03040700|myocardial ischemia|myocardial ischemia
39231|NCT03040700|non-invasive testing|non-invasive testing
39232|NCT03040687|ETEC|etec
39233|NCT03040687|Escherichia coli|escherichia coli
39234|NCT03040687|enteritis|enteritis
39235|NCT03040687|challenge|challenge
39236|NCT03040687|CS6|cs6
39237|NCT03040687|B7A|b7a
39238|NCT03040674|Shortness of breath|shortness of breath
39239|NCT03040674|Breathlessness|breathlessness
39240|NCT03040674|Stem cells|stem cells
39241|NCT03040674|Platelet rich plasma|platelet rich plasma
39242|NCT03040674|Quality of life|quality of life
39243|NCT03040674|Pulmonary function|pulmonary function
39244|NCT03040622|WATCHMAN|watchman
39245|NCT03040622|Left Atrial Appendage Closure|left atrial appendage closure
39246|NCT03040622|Thrombosis|thrombosis
39247|NCT03040622|Platelet Function|platelet function
39248|NCT03040609|Profound Multiple Intellectual Disabilities|profound multiple intellectual disabilities
39249|NCT03040609|Visual-Behavioral Scale|visual-behavioral scale
39250|NCT03040596|vocal fold nodules|vocal fold nodules
39251|NCT03040596|inhaled steroid|inhaled steroid
39252|NCT03040596|steroid|steroid
39253|NCT03040596|children|children
39254|NCT03040596|nodules|nodules
39255|NCT03040583|Primary Sjögren's syndrome (PSS)|primary sjögren's syndrome (pss)
39256|NCT03040583|auto-immune diseases|auto-immune diseases
39257|NCT03040557|plantar fasciitis|plantar fasciitis
39258|NCT03040557|shoes|shoes
39259|NCT03040557|insoles|insoles
39260|NCT03040557|pain|pain
39261|NCT03040557|foot|foot
39262|NCT03040544|minimally invasive surgery|minimally invasive surgery
39263|NCT03040544|video-based trainer|video-based trainer
39264|NCT03040531|glucocorticoid|glucocorticoid
39265|NCT03040531|genistein|genistein
39266|NCT03040531|alendronate|alendronate
39267|NCT03040518|Behaviour change|behaviour change
39268|NCT03040518|Male obesity|male obesity
39269|NCT03040518|SMS|sms
39270|NCT03040518|Financial Incentive|financial incentive
39271|NCT03040518|Endowment incentive|endowment incentive
39272|NCT03040466|ureteroscopy|ureteroscopy
39273|NCT03040466|flexible ureteroscope|flexible ureteroscope
39274|NCT03040466|randomized controlled trial|randomized controlled trial
39275|NCT03040453|Irreversible electroporation|irreversible electroporation
39276|NCT03040453|Microwave ablation|microwave ablation
39277|NCT03040427|F-18 florbetapir|f-18 florbetapir
39278|NCT03040427|Amyvid|amyvid
39279|NCT03040427|PET scan|pet scan
39280|NCT03040427|Early detection|early detection
39281|NCT03040414|Hybrid closed loop|hybrid closed loop
39282|NCT03040414|Closed loop|closed loop
39283|NCT03040414|Artificial pancreas|artificial pancreas
39284|NCT03040401|CMML|cmml
39285|NCT03040401|Ceplene|ceplene
39286|NCT03040401|Interleukin-2|interleukin-2
39287|NCT03040388|Electroconvulsive therapy|electroconvulsive therapy
39288|NCT03040388|Depressive Disorder|depressive disorder
39289|NCT03040388|Magnetic Resonance Imaging|magnetic resonance imaging
39290|NCT03040388|Hippocampus|hippocampus
39291|NCT03040388|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
39292|NCT03040388|Vascular Endothelial Growth Factor|vascular endothelial growth factor
39293|NCT03040388|Blood-Brain Barrier|blood-brain barrier
39294|NCT03040349|primary care|primary care
39295|NCT03040349|greece|greece
39296|NCT03040349|cyprus|cyprus
39297|NCT03040349|tobacco use treatment|tobacco use treatment
39298|NCT03040349|evidence-based guidelines|evidence-based guidelines
39300|NCT03040336|prehabilitation|prehabilitation
39301|NCT03040336|exercise therapy|exercise therapy
39302|NCT03040336|nutrition support|nutrition support
39303|NCT03040297|Weaning from mechanical ventilation|weaning from mechanical ventilation
39304|NCT03040297|tracheostomized patients|tracheostomized patients
39305|NCT03040297|Tracheal gas insufflation|tracheal gas insufflation
39306|NCT03040284|noninvasive monitoring|noninvasive monitoring
39307|NCT03040284|intracranial pressure|intracranial pressure
39308|NCT03040284|cochlear electrophysiology|cochlear electrophysiology
39309|NCT03040284|aneurysmal subarachnoid haemorrhage|aneurysmal subarachnoid haemorrhage
39310|NCT03040284|cerebrovascular disorders|cerebrovascular disorders
39311|NCT03040284|brain diseases|brain diseases
39312|NCT03040271|School-based intervention|school-based intervention
39313|NCT03040258|School-based intervention|school-based intervention
39314|NCT03040245|Emergency physician|emergency physician
39315|NCT03040245|Whiplash Book|whiplash book
39316|NCT03040245|Whiplash trauma|whiplash trauma
39317|NCT03040245|Fears|fears
39318|NCT03040245|Beliefs|beliefs
39319|NCT03040193|Lignocaine|lignocaine
39320|NCT03040180|Neoplasms|neoplasms
39321|NCT03040180|Neoplasms, primary|neoplasms, primary
39322|NCT03040180|Cancer|cancer
39323|NCT03040180|Colorectal cancer|colorectal cancer
39324|NCT03040180|rectal cancer|rectal cancer
39325|NCT03040180|rectal cancer, locally advanced|rectal cancer, locally advanced
39326|NCT03040180|Electrochemotherapy|electrochemotherapy
39327|NCT03040180|Electroporation|electroporation
39328|NCT03040180|Neoadjuvant therapy|neoadjuvant therapy
39329|NCT03040180|Antineoplastic, antibodies|antineoplastic, antibodies
39330|NCT03040180|Bleomycin|bleomycin
39331|NCT03040180|Pathologic processes|pathologic processes
39332|NCT03040180|Neoplastic processes|neoplastic processes
39333|NCT03040154|Filipino|filipino
39334|NCT03040102|Advanced Cancer|advanced cancer
39335|NCT03040063|aneurysm, poplietl artery, acute limb ischemia|aneurysm, poplietl artery, acute limb ischemia
39336|NCT03040024|Anesthesiology|anesthesiology
39337|NCT03040011|Vaginal Surgery|vaginal surgery
39338|NCT03040011|Pelvic Organ Prolapse|pelvic organ prolapse
39339|NCT03040011|Postoperative Pain|postoperative pain
39340|NCT03039959|Chronic Kidney Disease|chronic kidney disease
39341|NCT03039946|Fluid therapy|fluid therapy
39342|NCT03039946|Hemodynamic flow monitoring|hemodynamic flow monitoring
39343|NCT03039946|Closed-loop system|closed-loop system
39344|NCT03039946|Goal-directed fluid therapy|goal-directed fluid therapy
39345|NCT03039946|Anesthesiology|anesthesiology
39346|NCT03039907|Knee|knee
39347|NCT03039907|Replacement|replacement
39348|NCT03039894|school-based, evaluation, interrupted time series|school-based, evaluation, interrupted time series
39349|NCT03039881|Minute ventilation, ExSpiron monitor|minute ventilation, exspiron monitor
39358|NCT03039842|dextromethorphan; memantine; treatment response|dextromethorphan; memantine; treatment response
39359|NCT03039790|Immunogenicity, Norovirus vaccination|immunogenicity, norovirus vaccination
39361|NCT03039686|Duchenne's Muscular Dystrophy|duchenne's muscular dystrophy
39362|NCT03039686|DMD|dmd
39363|NCT03039673|interleukin-2|interleukin-2
39364|NCT03039673|low-dose interleukin-2|low-dose interleukin-2
39365|NCT03039608|esophageal stricture|esophageal stricture
39366|NCT03039608|endoscopic submucosal dissection|endoscopic submucosal dissection
39367|NCT03039608|prevention|prevention
39368|NCT03039595|Early rectal cancer|early rectal cancer
39369|NCT03039595|Ploidy|ploidy
39370|NCT03039595|Tumour:stroma ratio|tumour:stroma ratio
39371|NCT03039582|perineal tear|perineal tear
39372|NCT03039582|bidigital palpation|bidigital palpation
39373|NCT03039582|perineal ultrasound|perineal ultrasound
39374|NCT03039582|post partum diagnostics|post partum diagnostics
39375|NCT03039569|Type 2 diabetes patients|type 2 diabetes patients
39376|NCT03039569|Diabetes self-management|diabetes self-management
39377|NCT03039569|Cardiovascular diseases awareness|cardiovascular diseases awareness
39378|NCT03039569|Home food environment|home food environment
39379|NCT03039569|Text message|text message
39380|NCT03039530|Postpartum Depression|postpartum depression
39381|NCT03039530|Cognitive Behavioral Therapy|cognitive behavioral therapy
31002|NCT03091777|BV|bv
39382|NCT03039530|Public Health|public health
39383|NCT03039530|Mother|mother
39384|NCT03039530|Infant|infant
39385|NCT03039530|Emotion|emotion
39386|NCT03039517|Adaptive Compression Therapy Delivery System|adaptive compression therapy delivery system
39387|NCT03039504|Succinates|succinates
39388|NCT03039504|Dietary supplement|dietary supplement
39389|NCT03039491|pneumococcal vaccination|pneumococcal vaccination
39390|NCT03039465|Indwelling Trachea-oesophageal Prosthesis|indwelling trachea-oesophageal prosthesis
39391|NCT03039465|Voice Rehabilitation|voice rehabilitation
39392|NCT03039465|Total Laryngectomy|total laryngectomy
39393|NCT03039439|Immunohistochemical profiling of tumors|immunohistochemical profiling of tumors
39394|NCT03039439|Biomarkers|biomarkers
39395|NCT03039374|OASI|oasi
39396|NCT03039374|Faecal incontinence|faecal incontinence
39397|NCT03039374|Obstetric anal sphincter injury|obstetric anal sphincter injury
39398|NCT03039374|MRI|mri
41521|NCT03026036|MRI|mri
39399|NCT03039348|Breast Cancer Female|breast cancer female
39401|NCT03039348|Breast Reconstruction|breast reconstruction
39402|NCT03039348|questionnaire|questionnaire
39403|NCT03039309|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
39404|NCT03039296|Low back pain|low back pain
39405|NCT03039296|Facet joints|facet joints
39406|NCT03039296|Endoscopic rhizotomy|endoscopic rhizotomy
39407|NCT03039283|Moderate to profound sensorineural hearing loss|moderate to profound sensorineural hearing loss
39408|NCT03039270|Tooth Sensitivity|tooth sensitivity
39409|NCT03039270|Tooth Bleaching|tooth bleaching
39410|NCT03039270|Desensitizing agent|desensitizing agent
39411|NCT03039270|Sonic vibration|sonic vibration
39412|NCT03039257|hematopoietic stem cell transplant|hematopoietic stem cell transplant
39413|NCT03039257|vitamin a|vitamin a
39414|NCT03039244|Photochemotherapy|photochemotherapy
39415|NCT03039244|Photosensitizing agents|photosensitizing agents
39416|NCT03039244|Smokers|smokers
39417|NCT03039231|PTSD|ptsd
39418|NCT03039218|erectile dysfunction|erectile dysfunction
39422|NCT03039205|Adenosine|adenosine
39423|NCT03039205|Coronary artery disease|coronary artery disease
39424|NCT03039205|Kidney dysfunction|kidney dysfunction
39425|NCT03039205|Ticagrelor|ticagrelor
39426|NCT03039205|Clopidogrel|clopidogrel
39427|NCT03039127|Hyperthermia|hyperthermia
39428|NCT03039127|Laser Coagulation|laser coagulation
39429|NCT03039127|Laser Therapy|laser therapy
39430|NCT03039127|Induced|induced
39439|NCT03039062|Serum miR-122|serum mir-122
39440|NCT03039062|drug-induced liver injury by chemotherapy|drug-induced liver injury by chemotherapy
39441|NCT03039062|malignant tumor patients|malignant tumor patients
39442|NCT03039049|GnRH agonist trigger|gnrh agonist trigger
39443|NCT03039049|IVF|ivf
39444|NCT03039049|Luteal phase support|luteal phase support
39445|NCT03039049|Mid-luteal GnRH agonist|mid-luteal gnrh agonist
39446|NCT03039036|Labor Induction|labor induction
39447|NCT03039036|Early Amniotomy|early amniotomy
39448|NCT03039036|Foley catheter|foley catheter
39449|NCT03039023|TMAO|tmao
39450|NCT03039023|choline|choline
39451|NCT03039023|eggs|eggs
39452|NCT03039023|gastrointestinal microbiome|gastrointestinal microbiome
39453|NCT03039023|healthy volunteers|healthy volunteers
39454|NCT03038984|IBD|ibd
39455|NCT03038984|Telemedicine|telemedicine
39456|NCT03038984|At-home monitoring|at-home monitoring
39457|NCT03038984|Disease activity|disease activity
39458|NCT03038984|fecal calprotectin|fecal calprotectin
39459|NCT03038984|Total inflammation burden|total inflammation burden
39460|NCT03038984|11 years follow up|11 years follow up
39461|NCT03038958|Local Anaesthetic|local anaesthetic
39462|NCT03038958|spinal anesthesia|spinal anesthesia
39463|NCT03038958|Knee arthroscopy|knee arthroscopy
39464|NCT03038945|Laparoscopy|laparoscopy
39465|NCT03038945|Hysterectomy|hysterectomy
39466|NCT03038945|Suture Techniques|suture techniques
39467|NCT03038932|whole genome sequencing (WGS)|whole genome sequencing (wgs)
39468|NCT03038919|prolonged mechanical ventilation|prolonged mechanical ventilation
39469|NCT03038919|critically ill patients|critically ill patients
39470|NCT03038919|anabolic steroid|anabolic steroid
39471|NCT03038893|Ultrasonography|ultrasonography
39472|NCT03038893|Point-of-care systems|point-of-care systems
39473|NCT03038893|Deep venous thrombosis|deep venous thrombosis
39474|NCT03038893|Hospitalization|hospitalization
39475|NCT03038776|vaccine|vaccine
39476|NCT03038750|Healthy Volunteers|healthy volunteers
39477|NCT03038750|Genetic Risk Markers for Cardiovascular Disease|genetic risk markers for cardiovascular disease
39478|NCT03038750|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
39479|NCT03038750|Coronary Disease|coronary disease
39480|NCT03038750|Hypertension|hypertension
39481|NCT03038750|Venous Thromboses|venous thromboses
39482|NCT03038750|Venous Thromboembolism|venous thromboembolism
39483|NCT03038750|Coronary Heart Disease|coronary heart disease
39484|NCT03038750|Coronary Artery Disease|coronary artery disease
39485|NCT03038737|nylon|nylon
39486|NCT03038737|polyamide|polyamide
39487|NCT03038737|PEEK|peek
39488|NCT03038737|partial denture|partial denture
39489|NCT03038724|HIV testing|hiv testing
39490|NCT03038698|spirometry|spirometry
39491|NCT03038698|normative values|normative values
39492|NCT03038698|health|health
39493|NCT03038698|south africa|south africa
39494|NCT03038698|children|children
39495|NCT03038685|Secondary prevention|secondary prevention
39496|NCT03038685|Web-based intervention|web-based intervention
39497|NCT03038685|Strokecoach|strokecoach
39500|NCT03038620|Obesity|obesity
39501|NCT03038620|Visceral|visceral
39502|NCT03038620|Cardiovascular Disease|cardiovascular disease
39503|NCT03038620|Fat|fat
39504|NCT03038594|Burns|burns
39505|NCT03038594|Growth Hormone|growth hormone
39506|NCT03038594|Lean Body Mass|lean body mass
39507|NCT03038594|Strength|strength
39508|NCT03038594|Exercise Endurance|exercise endurance
39509|NCT03038581|Deep wrist injury|deep wrist injury
39510|NCT03038581|Self inflicted|self inflicted
39511|NCT03038581|Traumatic wrist injury|traumatic wrist injury
39512|NCT03038568|colorectal liver metastases|colorectal liver metastases
39514|NCT03038568|17-010|17-010
39515|NCT03038555|Medical staff|medical staff
39516|NCT03038555|preeclampsia|preeclampsia
39517|NCT03038555|cohort study|cohort study
39518|NCT03038555|further effect|further effect
39519|NCT03038529|low back pain , Ozone|low back pain , ozone
39520|NCT03038503|refractory septic shock|refractory septic shock
39616|NCT03038061|Laparoscopy|laparoscopy
39521|NCT03038503|catecholamine resistance septic shock|catecholamine resistance septic shock
39522|NCT03038503|terlipressin|terlipressin
39523|NCT03038503|methylene blue|methylene blue
39524|NCT03038477|Borderline Resectable Pancreatic Ductal Adenocarcinoma|borderline resectable pancreatic ductal adenocarcinoma
39525|NCT03038477|Durvalumab|durvalumab
39526|NCT03038399|Duchenne muscular dystrophy|duchenne muscular dystrophy
39527|NCT03038399|vamorolone|vamorolone
39528|NCT03038347|cross-cultural competencies|cross-cultural competencies
39529|NCT03038347|internet-based training|internet-based training
39530|NCT03038347|cognitive-behavioural therapy (CBT)|cognitive-behavioural therapy (cbt)
39531|NCT03038347|psychotherapy training|psychotherapy training
39532|NCT03038347|competence training|competence training
39533|NCT03038321|BCG Cystitis|bcg cystitis
39534|NCT03038321|Bladder Cancer|bladder cancer
39535|NCT03038321|Levofloxacin|levofloxacin
39536|NCT03038321|Solifenacin|solifenacin
39537|NCT03038321|Lornoxicam|lornoxicam
39538|NCT03038308|ropinirole|ropinirole
39539|NCT03038308|hyperprolactinemia|hyperprolactinemia
39540|NCT03038308|prolactin|prolactin
39541|NCT03038295|Retinopathy of Prematurity|retinopathy of prematurity
39542|NCT03038295|propranolol|propranolol
39543|NCT03038295|ROP|rop
39544|NCT03038269|Robotics|robotics
39545|NCT03038269|Upper Extremity|upper extremity
39546|NCT03038256|High Risk Rectal Cancer|high risk rectal cancer
39547|NCT03038256|Total neoadjuvant chemoradiotherapy|total neoadjuvant chemoradiotherapy
39548|NCT03038256|Lengthening interval between radiotherapy and surgery|lengthening interval between radiotherapy and surgery
39549|NCT03038243|Shigella|shigella
39550|NCT03038243|vaccine|vaccine
39551|NCT03038243|shigellosis|shigellosis
39552|NCT03038243|dysentery|dysentery
39553|NCT03038243|whole cell|whole cell
39554|NCT03038230|human bispecific full length IgG antibody, CLEC12A, CD3|human bispecific full length igg antibody, clec12a, cd3
39555|NCT03038230|MCLA-117|mcla-117
39556|NCT03038230|First in Human|first in human
39557|NCT03038230|Antibodies, Bispecific|antibodies, bispecific
39558|NCT03038230|Immunologic Factors|immunologic factors
39559|NCT03038230|relapsed, refractory patient|relapsed, refractory patient
39560|NCT03038230|AML, minimal residual disease (MRD)|aml, minimal residual disease (mrd)
39561|NCT03038230|Acute Myelogenous Leukemia|acute myelogenous leukemia
39562|NCT03038230|Acute Myeloid Leukemia|acute myeloid leukemia
39563|NCT03038230|CD34+CD38|cd34+cd38
39564|NCT03038230|T-cell recruiting|t-cell recruiting
39565|NCT03038217|rectal cancer|rectal cancer
39566|NCT03038217|neoajuvant chemoradiation|neoajuvant chemoradiation
39567|NCT03038217|circulating tumor DNA|circulating tumor dna
39568|NCT03038204|Papillary muscles approximation|papillary muscles approximation
39569|NCT03038178|Mycobacterium Infections, Nontuberculous|mycobacterium infections, nontuberculous
39570|NCT03038178|Mycobacteria, Atypical|mycobacteria, atypical
39571|NCT03038178|Amikacin|amikacin
39572|NCT03038178|Inhalation|inhalation
39573|NCT03038165|Hemodialysis|hemodialysis
39574|NCT03038165|Intradialytic hypertension|intradialytic hypertension
39575|NCT03038165|Hemodynamics changes|hemodynamics changes
39576|NCT03038152|Disorder of breast|disorder of breast
39577|NCT03038152|Breast Cancer|breast cancer
39578|NCT03038152|Lymph node metastasis|lymph node metastasis
39579|NCT03038152|Magseed marker|magseed marker
39580|NCT03038152|Lymph node removal|lymph node removal
39581|NCT03038139|forward head posture|forward head posture
39582|NCT03038139|postural correction|postural correction
39583|NCT03038139|spinal muscles|spinal muscles
39584|NCT03038126|chronic kidney disease|chronic kidney disease
39585|NCT03038126|patient safety|patient safety
39586|NCT03038126|home telehealth|home telehealth
39587|NCT03037021|Sickle Cell Disease|sickle cell disease
39588|NCT03037021|Needs Assessment|needs assessment
39589|NCT03037021|Barriers to care|barriers to care
39590|NCT03037021|Access to care|access to care
39591|NCT03037021|Primary care|primary care
39592|NCT03037008|perineal sonography|perineal sonography
39593|NCT03037008|male sling|male sling
39594|NCT03037008|post prostatectomy incontinence|post prostatectomy incontinence
39595|NCT03037008|ultrasonography|ultrasonography
39596|NCT03036956|subclinical hypothyroidism in pregnancy|subclinical hypothyroidism in pregnancy
39597|NCT03036904|venetoclax|venetoclax
39598|NCT03036904|dose-adjusted EPOCH-R|dose-adjusted epoch-r
39599|NCT03036904|aggressive B-Cell lymphoma|aggressive b-cell lymphoma
39600|NCT03036904|Lymphoma|lymphoma
39601|NCT03036904|Non-Hodgkin lymphoma|non-hodgkin lymphoma
39602|NCT03036904|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
39603|NCT03036904|Double hit lymphoma|double hit lymphoma
39604|NCT03036891|Gastroparesis|gastroparesis
39605|NCT03036891|Opioid-Induced|opioid-induced
39606|NCT03036891|Delayed Gastric Emptying|delayed gastric emptying
39607|NCT03036878|Osteochondral|osteochondral
39608|NCT03036878|Marrow Stimulation|marrow stimulation
39609|NCT03036878|ReNu|renu
39610|NCT03036865|Healthy participants|healthy participants
39611|NCT03036865|BOS161721|bos161721
39612|NCT03036865|Pharmacokinetics|pharmacokinetics
39613|NCT03036865|Pharmacodynamics|pharmacodynamics
39614|NCT03038061|Diaphragm|diaphragm
39617|NCT03038009|Coronary Artery Bypass Graft|coronary artery bypass graft
39618|NCT03038009|Dual Antiplatelet Therapy|dual antiplatelet therapy
39619|NCT03038009|Gastrointestinal|gastrointestinal
39620|NCT03038009|Mucosal Injury|mucosal injury
39621|NCT03038009|Proton Pump Inhibitor|proton pump inhibitor
39622|NCT03037996|anesthesia|anesthesia
39623|NCT03037996|satisfaction|satisfaction
39624|NCT03037983|Schizophrenia|schizophrenia
39625|NCT03037983|Transcranial magnetic stimulation|transcranial magnetic stimulation
39626|NCT03037983|Electroencephalography|electroencephalography
39627|NCT03037944|Adenomyosis|adenomyosis
39628|NCT03037944|Contraceptive pills|contraceptive pills
39629|NCT03037944|Levonorgestrel-releasing Intrauterine System|levonorgestrel-releasing intrauterine system
39630|NCT03037918|Gut Microbiota|gut microbiota
39631|NCT03037918|High Fat Diets|high fat diets
39632|NCT03037918|Probiotics|probiotics
39633|NCT03037918|Glycaemic Control|glycaemic control
39634|NCT03037853|Atlas|atlas
39635|NCT03037853|Full human Body|full human body
39637|NCT03037840|RF EMF|rf emf
39638|NCT03037840|In Vivo|in vivo
39639|NCT03037840|tumor specific frequencies|tumor specific frequencies
39643|NCT03037827|1470 nm|1470 nm
39644|NCT03037827|occlusion rate|occlusion rate
39645|NCT03037814|restorative materials|restorative materials
39646|NCT03037814|primary teeth|primary teeth
39647|NCT03037814|children|children
39648|NCT03037788|Excessive sweating|excessive sweating
39649|NCT03037775|tobacco|tobacco
39650|NCT03037775|cardiovascular system|cardiovascular system
39651|NCT03037775|sympathetic nervous system|sympathetic nervous system
39652|NCT03037684|neuropathic pain|neuropathic pain
39653|NCT03037684|chronic postoperative pain|chronic postoperative pain
39654|NCT03037671|Malglycemia|malglycemia
39655|NCT03037658|physical activity|physical activity
39656|NCT03037658|walking|walking
39657|NCT03037658|incentive|incentive
39658|NCT03037658|step count|step count
39659|NCT03037645|CLL|cll
39660|NCT03037645|Hematological diseases|hematological diseases
39661|NCT03037645|Relapsed|relapsed
39662|NCT03037645|cancer|cancer
39663|NCT03037645|malignancy|malignancy
39664|NCT03037645|SNS-062|sns-062
39665|NCT03037645|B-lymphoid|b-lymphoid
39666|NCT03037645|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
39667|NCT03037645|Small lymphocytic lymphoma|small lymphocytic lymphoma
39668|NCT03037645|Lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
39669|NCT03037645|Waldenström's macrogloulinemia|waldenström's macrogloulinemia
39670|NCT03037645|Mantle cell lymphoma|mantle cell lymphoma
39671|NCT03037645|SLL|sll
39672|NCT03037645|LPL|lpl
39673|NCT03037645|WM|wm
39674|NCT03037645|MCL|mcl
39675|NCT03037645|Refractory|refractory
39676|NCT03037593|Pregnancy|pregnancy
39677|NCT03037593|Gestational Diabetes|gestational diabetes
39678|NCT03037580|Pulmonary Hypertension|pulmonary hypertension
39679|NCT03037580|6-Minute Walk Test|6-minute walk test
39680|NCT03037580|HFpEF|hfpef
39681|NCT03037580|Oral Treprostinil|oral treprostinil
39682|NCT03037554|Skin Temperature|skin temperature
39683|NCT03037554|Hot Flashes|hot flashes
39684|NCT03037554|Sleep Disturbance|sleep disturbance
39685|NCT03037541|Wake Forest|wake forest
39686|NCT03037541|Actinic Keratosis|actinic keratosis
39687|NCT03037541|Cryosurgery|cryosurgery
39688|NCT03037541|Cream|cream
39689|NCT03037502|Men's Health|men's health
39690|NCT03037502|weight loss|weight loss
39691|NCT03037502|African American men|african american men
39692|NCT03037502|Latino men|latino men
39693|NCT03037437|Hepatocellular Cancer|hepatocellular cancer
39694|NCT03037437|Sorafenib|sorafenib
39695|NCT03037437|Hydroxychloroquine|hydroxychloroquine
39696|NCT03037424|Cyroprecipitate|cyroprecipitate
39697|NCT03037424|Fibrinogen|fibrinogen
39698|NCT03037424|Cardiac Surgery|cardiac surgery
39699|NCT03037411|Atherosclerosis|atherosclerosis
39700|NCT03037411|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
39701|NCT03037411|Proximal Popliteal Artery (PPA)|proximal popliteal artery (ppa)
39702|NCT03037411|Stenting|stenting
39703|NCT03037411|Paclitaxel|paclitaxel
39704|NCT03037411|Health Economics|health economics
39708|NCT03037372|adults|adults
39709|NCT03037372|antiretroviral therapy|antiretroviral therapy
39710|NCT03037359|PID|pid
39711|NCT03037346|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
39712|NCT03037346|Invasive gynecologic malignancy|invasive gynecologic malignancy
39713|NCT03037346|Medical Power of Attorney Documents|medical power of attorney documents
39714|NCT03037346|MPOAD|mpoad
39715|NCT03037346|Questionnaires|questionnaires
39716|NCT03037346|Surveys|surveys
39717|NCT03037333|echocardiogram|echocardiogram
39918|NCT03035773|Oncology|oncology
39720|NCT03037229|Myocardial Infarction|myocardial infarction
39721|NCT03037229|Ischemia|ischemia
39722|NCT03037229|Myocardial Ischemia|myocardial ischemia
39723|NCT03037229|Heart Diseases|heart diseases
39724|NCT03037229|Cardiovascular Diseases|cardiovascular diseases
39725|NCT03037229|Vascular Diseases|vascular diseases
39726|NCT03037216|Exercise|exercise
39727|NCT03037164|INTERCEPT|intercept
39728|NCT03037164|Red Blood Cells|red blood cells
39730|NCT03037164|Pathogen Inactivation|pathogen inactivation
39731|NCT03037164|Zika|zika
39732|NCT03037164|Cerus|cerus
39733|NCT03037164|Pathogen Reduction|pathogen reduction
39734|NCT03037151|Safety|safety
39735|NCT03037151|Efficacy|efficacy
39736|NCT03037151|grazoprevir|grazoprevir
39737|NCT03037151|elbasvir|elbasvir
39738|NCT03037151|compensated cirrhosis|compensated cirrhosis
39739|NCT03037151|genotype 1 (GT1)|genotype 1 (gt1)
39740|NCT03037151|genotype 6 (GT6)|genotype 6 (gt6)
39741|NCT03037151|hepatitis virus C (HCV)|hepatitis virus c (hcv)
39742|NCT03037151|human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
622070|NCT00668876|Th17|th17
39743|NCT03037138|postdialysis washed-out|postdialysis washed-out
39744|NCT03037099|Glycemic index|glycemic index
39745|NCT03037099|dietary intakes|dietary intakes
39746|NCT03037086|NSCLC|nsclc
39747|NCT03037073|Duloxetine|duloxetine
39748|NCT03037073|Succinylcholine|succinylcholine
39749|NCT03037073|Postoperative Myalgia|postoperative myalgia
39750|NCT03037073|Microlaryngoscopy|microlaryngoscopy
39751|NCT03037060|Alcohol use, problem|alcohol use, problem
39752|NCT03036826|renal replacement therapy|renal replacement therapy
39753|NCT03036787|Premature Baby|premature baby
39754|NCT03036787|motor development|motor development
39755|NCT03036787|cognitive development|cognitive development
39756|NCT03036774|Gastric contents|gastric contents
39757|NCT03036774|Ultrasound|ultrasound
39758|NCT03036774|Diabetes|diabetes
39759|NCT03036761|Auriculotherapy|auriculotherapy
39760|NCT03036696|Retention|retention
39761|NCT03036696|Lactation|lactation
39762|NCT03036696|Human milk|human milk
39763|NCT03036696|Pregnancy|pregnancy
39764|NCT03036696|Clinical Research Studies|clinical research studies
39765|NCT03036696|BEACH|beach
39766|NCT03036657|Acupuncture|acupuncture
39767|NCT03036657|Electroacupuncture|electroacupuncture
39768|NCT03036657|Nerve Conduction Studies|nerve conduction studies
39769|NCT03036657|Quantitative Sensory Testing|quantitative sensory testing
39770|NCT03036644|electronic cigarette|electronic cigarette
39771|NCT03036644|e-cigarette|e-cigarette
39772|NCT03036644|oxidative stress|oxidative stress
39773|NCT03036644|tobacco smoking|tobacco smoking
39774|NCT03036618|BMI|bmi
39775|NCT03036618|Blood Cholesterol|blood cholesterol
39776|NCT03036618|Glucose|glucose
39777|NCT03036618|Insulin|insulin
39778|NCT03036618|Gut health|gut health
39779|NCT03036605|dexamethasone|dexamethasone
39780|NCT03036605|bupivacaine|bupivacaine
39781|NCT03036605|nasal surgery|nasal surgery
39782|NCT03036605|nasal packing|nasal packing
39783|NCT03036592|Glucose tolerance test, MTNR1B, nutrigenomics, food timing|glucose tolerance test, mtnr1b, nutrigenomics, food timing
39784|NCT03036579|CAD/CAM|cad/cam
39785|NCT03036579|Ceramic|ceramic
39786|NCT03036579|Crown|crown
39787|NCT03036553|Chronic pain|chronic pain
39788|NCT03036553|Psychological factors|psychological factors
39789|NCT03036553|Musculoskeletal pain|musculoskeletal pain
39790|NCT03036553|Prognosis|prognosis
39791|NCT03036540|upper limb thrombosis, midline catheter|upper limb thrombosis, midline catheter
39792|NCT03036527|Bladder|bladder
39793|NCT03036527|Sexual Function|sexual function
39794|NCT03036514|numeric rating scale|numeric rating scale
39795|NCT03036514|opioid side effects|opioid side effects
39800|NCT03036462|intravenous iron|intravenous iron
39801|NCT03036462|systolic heart failure|systolic heart failure
39802|NCT03036462|iron deficiency|iron deficiency
39803|NCT03036462|morbidity|morbidity
39804|NCT03036462|mortality|mortality
39805|NCT03036449|Medication errors|medication errors
39806|NCT03036449|Patient safety|patient safety
39807|NCT03036436|Cancer|cancer
39808|NCT03036436|EHealth|ehealth
39809|NCT03036436|Cancer Survivor|cancer survivor
39810|NCT03036436|Rehabilitation|rehabilitation
39811|NCT03036410|Hearing Aid Usage (monaural, binaural)|hearing aid usage (monaural, binaural)
39812|NCT03036410|Cochlear Implant Usage (monaural, binaural)|cochlear implant usage (monaural, binaural)
39813|NCT03036410|Hearing Aid and Cochlear Implant Usage (monaural)|hearing aid and cochlear implant usage (monaural)
39814|NCT03036397|Anxiety|anxiety
39815|NCT03036397|Vasopressin|vasopressin
39816|NCT03036397|Fear-Potentiated Startle|fear-potentiated startle
39817|NCT03036397|Shock Threat|shock threat
39818|NCT03036397|Emotion Recognition|emotion recognition
39819|NCT03036384|scheduled cesarean delivery|scheduled cesarean delivery
39820|NCT03036384|spinal anesthesia|spinal anesthesia
39821|NCT03036384|local anesthesia|local anesthesia
39822|NCT03036371|Neurogenesis|neurogenesis
39823|NCT03036371|Memory|memory
39824|NCT03036371|Spatial Processing|spatial processing
39825|NCT03036371|Hippocampus|hippocampus
39826|NCT03036371|Cognition|cognition
39827|NCT03036371|Aerobic Exercise|aerobic exercise
39828|NCT03036332|aerobic interval training|aerobic interval training
39829|NCT03036332|biomarkers|biomarkers
39830|NCT03036306|scar|scar
39831|NCT03036306|nefopam|nefopam
39832|NCT03036306|cicatrix|cicatrix
39833|NCT03036280|E2609|e2609
39834|NCT03036280|elenbecestat|elenbecestat
39835|NCT03036280|Alzheimer's Disease|alzheimer's disease
39836|NCT03036280|Early Alzheimer's Disease|early alzheimer's disease
39837|NCT03036280|Prodromal Alzheimer's Disease|prodromal alzheimer's disease
39838|NCT03036280|Dementia|dementia
39839|NCT03036280|Dementia, Alzheimer's type|dementia, alzheimer's type
39840|NCT03036280|mild cognitive impairment|mild cognitive impairment
39841|NCT03036280|MissionAD2|missionad2
39842|NCT03036267|health disparity|health disparity
39843|NCT03036267|motivational interviewing|motivational interviewing
39844|NCT03036267|African American adults|african american adults
39845|NCT03036267|Federally Qualified Health Centers|federally qualified health centers
39846|NCT03036267|adherence|adherence
39847|NCT03036267|health beliefs|health beliefs
39848|NCT03036267|self-management|self-management
39849|NCT03036267|asthma control|asthma control
39850|NCT03036254|Diabetes Mellitus|diabetes mellitus
39851|NCT03036254|Cognition|cognition
39852|NCT03036241|drug-eluting balloon,|drug-eluting balloon,
39853|NCT03036241|target lesion revascularization (TLR)|target lesion revascularization (tlr)
39854|NCT03036241|restenosis|restenosis
39855|NCT03036228|Solid tumours|solid tumours
39856|NCT03036202|epinephrine|epinephrine
39857|NCT03036163|Tuberculosis|tuberculosis
39858|NCT03036150|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
39859|NCT03036150|Cardiovascular Events (CV)|cardiovascular events (cv)
39860|NCT03036150|Phase III outcome trial|phase iii outcome trial
39861|NCT03036137|Tinnitus|tinnitus
39862|NCT03036137|Electroencephalogram|electroencephalogram
39863|NCT03036137|Transcranial Direct Current Stimulation|transcranial direct current stimulation
39864|NCT03036124|HFrEF|hfref
39865|NCT03036124|Heart Failure (HF)|heart failure (hf)
39866|NCT03036124|Cardiovascular Events (CV)|cardiovascular events (cv)
39867|NCT03036124|Phase III outcome trial|phase iii outcome trial
39868|NCT03036085|postoperative pain|postoperative pain
39869|NCT03036085|video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
39870|NCT03036085|opioids|opioids
39871|NCT03036085|bupivacaine|bupivacaine
39872|NCT03036085|liposomal bupivacaine|liposomal bupivacaine
39873|NCT03036085|analgesia|analgesia
39874|NCT03036085|local anesthetics|local anesthetics
39875|NCT03036072|Therapeutic Hypothermia|therapeutic hypothermia
39876|NCT03036059|Twice a year treatment|twice a year treatment
39877|NCT03036059|Biannual treatment|biannual treatment
39878|NCT03036059|Wuchereria bancrofti|wuchereria bancrofti
39879|NCT03036007|Spine, Disc, Neck pain, Rehabilitation, Exercise Therapy, Internet|spine, disc, neck pain, rehabilitation, exercise therapy, internet
39880|NCT03035968|Vojta therapy|vojta therapy
39881|NCT03035968|reflex locomotion|reflex locomotion
39882|NCT03035968|stroke rehabilitation|stroke rehabilitation
39883|NCT03035968|stroke|stroke
39884|NCT03035968|physiotherapy|physiotherapy
39885|NCT03035955|Rosacea|rosacea
39886|NCT03035955|Wake Forest|wake forest
39887|NCT03035955|Demodex|demodex
39888|NCT03035955|Finacea Gel|finacea gel
39889|NCT03035942|Intrathecal morphine|intrathecal morphine
39890|NCT03035942|Nausea and vomiting|nausea and vomiting
39891|NCT03035942|Quality of recovery|quality of recovery
39892|NCT03035942|Patient satisfaction|patient satisfaction
39893|NCT03035942|Pruritus|pruritus
39894|NCT03035942|Postoperative pain|postoperative pain
39895|NCT03035916|transversus abdominal plane block|transversus abdominal plane block
39896|NCT03035916|epidural anesthesia|epidural anesthesia
39897|NCT03035916|stress response|stress response
39898|NCT03035916|anesthetic recovery|anesthetic recovery
39899|NCT03035890|NSCLC|nsclc
39900|NCT03035890|Lung Cancer|lung cancer
39901|NCT03035890|Non Small Cell Lung Cancer|non small cell lung cancer
39902|NCT03035877|Antisocial Behavior|antisocial behavior
39903|NCT03035877|Alcohol Abuse|alcohol abuse
39904|NCT03035877|Drug Abuse|drug abuse
39905|NCT03035877|Young Adults|young adults
39906|NCT03035864|Ocular discomfort after cataract and refractive surgery|ocular discomfort after cataract and refractive surgery
39907|NCT03035864|cataract surgery|cataract surgery
39908|NCT03035864|refractive surgery|refractive surgery
39909|NCT03035851|Alzheimer Disease|alzheimer disease
39910|NCT03035851|Dementia|dementia
39911|NCT03035851|Exercise|exercise
39912|NCT03035851|Physical Activity|physical activity
39913|NCT03035851|Brain blood flow|brain blood flow
39914|NCT03035851|Cognition|cognition
39915|NCT03035851|Fitness|fitness
39916|NCT03035812|Bicarbonate|bicarbonate
39917|NCT03035773|Cancer|cancer
39919|NCT03035773|Survivorship|survivorship
39921|NCT03035760|Oxfendazole|oxfendazole
39922|NCT03035760|Pharmacokinetics|pharmacokinetics
39923|NCT03035760|Safety|safety
39924|NCT03035747|registry|registry
39925|NCT03035747|varicose veins|varicose veins
39926|NCT03035747|conventional surgery|conventional surgery
39927|NCT03035747|thermal ablation|thermal ablation
39928|NCT03035747|radiofrequency|radiofrequency
39929|NCT03035747|laser|laser
39930|NCT03035747|sclerotherapy|sclerotherapy
39931|NCT03035721|Full term healthy infants|full term healthy infants
39932|NCT03035721|Low protein content formula|low protein content formula
39933|NCT03035721|Safety|safety
39934|NCT03035721|Growth|growth
39935|NCT03035721|Body composition|body composition
39936|NCT03035695|Trauma|trauma
39937|NCT03035695|Scalp injuries|scalp injuries
39938|NCT03035695|Profused Bleeding|profused bleeding
39939|NCT03035695|Accident|accident
39940|NCT03035656|Pain|pain
39941|NCT03035656|analgesic|analgesic
39942|NCT03035656|spinal fusion|spinal fusion
39943|NCT03035630|Avelumab|avelumab
39944|NCT03035630|Sunitinib|sunitinib
39945|NCT03035630|MSB0010718C|msb0010718c
39946|NCT03035630|Sutent|sutent
39947|NCT03035630|IgG1 antibody|igg1 antibody
39948|NCT03035630|Anti-PD-L1|anti-pd-l1
39949|NCT03035630|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
39950|NCT03035617|Bupivacaine|bupivacaine
39951|NCT03035604|Malnutrition|malnutrition
39952|NCT03035604|Nutritional status|nutritional status
39953|NCT03035604|Mini Nutritional Assessment|mini nutritional assessment
39955|NCT03035604|Weight loss|weight loss
39956|NCT03035604|Body Mass Index|body mass index
39957|NCT03035604|BMI|bmi
39958|NCT03035604|Lean muscle mas|lean muscle mas
39959|NCT03035604|American Society for Parenteral and Enteral Nutrition|american society for parenteral and enteral nutrition
39960|NCT03035604|ASPEN|aspen
39961|NCT03035578|Pharmacokinetics|pharmacokinetics
39962|NCT03035578|Pharmacodynamics|pharmacodynamics
39963|NCT03035578|Morphine|morphine
39964|NCT03035578|Neonatal|neonatal
39965|NCT03035565|Heart Failure|heart failure
39966|NCT03035565|Cognition in Heart Failure|cognition in heart failure
39967|NCT03035552|Congenital heart disease (CCHD)|congenital heart disease (cchd)
39968|NCT03035552|Non-Nutritive Suck|non-nutritive suck
39969|NCT03035539|Rehabilitation|rehabilitation
39970|NCT03035513|Continuous spikes|continuous spikes
39971|NCT03035513|Epilepsy|epilepsy
39972|NCT03035513|Nervous system disease|nervous system disease
39973|NCT03035513|Neuronal plasticity|neuronal plasticity
39974|NCT03035513|Diffusion MRI|diffusion mri
39975|NCT03035513|Functional MRI|functional mri
39976|NCT03035513|waves during slow sleep (CSWS)|waves during slow sleep (csws)
39977|NCT03035474|Heart Failure|heart failure
39978|NCT03035474|Quality Improvement|quality improvement
39979|NCT03035461|diagnosis annoucement|diagnosis annoucement
39980|NCT03035461|patient's feelings|patient's feelings
39981|NCT03035448|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
39982|NCT03035448|Advanced cancer|advanced cancer
39983|NCT03035448|Recurrent cancer|recurrent cancer
39984|NCT03035448|Metastatic disease|metastatic disease
39985|NCT03035448|Palliative care|palliative care
39986|NCT03035448|Videos|videos
39987|NCT03035448|Questionnaires|questionnaires
39988|NCT03035448|Surveys|surveys
39989|NCT03035435|fast-track rehabilitation|fast-track rehabilitation
39990|NCT03035435|fast-track surgery|fast-track surgery
39991|NCT03035422|Allogenic cell stem transplant, Sequential chemotherapy Haploidentical transplant|allogenic cell stem transplant, sequential chemotherapy haploidentical transplant
39992|NCT03035409|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
39993|NCT03035409|Advanced Cancer|advanced cancer
39994|NCT03035409|Metastatic or recurrent incurable solid tumors|metastatic or recurrent incurable solid tumors
39995|NCT03035409|Anamorelin|anamorelin
39996|NCT03035409|Physical activity|physical activity
31597|NCT03088150|RFA|rfa
39997|NCT03035409|Questionnaires|questionnaires
39998|NCT03035409|Surveys|surveys
39999|NCT03035409|Dietary Counseling|dietary counseling
40000|NCT03035409|Exercise Counseling|exercise counseling
40001|NCT03035383|Large thyroid|large thyroid
40002|NCT03035383|purse string suture|purse string suture
40003|NCT03035383|thyroidectomy|thyroidectomy
40004|NCT03035370|Pertussis|pertussis
40005|NCT03035370|Epicutaneous ImmunoTherapy (EPIT)|epicutaneous immunotherapy (epit)
40006|NCT03035370|Vaccine|vaccine
40007|NCT03035370|Viaskin PT|viaskin pt
40008|NCT03035357|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
40009|NCT03035357|Prostate cancer|prostate cancer
40010|NCT03035357|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
40011|NCT03035357|Daratumumab|daratumumab
40012|NCT03035357|Biomarker response|biomarker response
40013|NCT03035305|Seasonal malaria chemoprevention|seasonal malaria chemoprevention
40014|NCT03035305|Lipid-based nutrient supplement|lipid-based nutrient supplement
40015|NCT03035305|Children|children
40016|NCT03035305|Mali|mali
40017|NCT03035279|Advanced colorectal cancer|advanced colorectal cancer
40020|NCT03035279|Metastatic colorectal cancer|metastatic colorectal cancer
40022|NCT03035279|Pharmacokinetics|pharmacokinetics
40023|NCT03035266|blood flow restriction|blood flow restriction
40024|NCT03035266|strength|strength
40025|NCT03035266|muscle atrophy|muscle atrophy
40026|NCT03035266|post-operative therapy|post-operative therapy
40027|NCT03035266|knee|knee
40028|NCT03035201|Memory|memory
40029|NCT03035201|Mild Cognitive Impairment|mild cognitive impairment
40030|NCT03035201|Alzheimer's Disease|alzheimer's disease
40031|NCT03035201|Cognition|cognition
40032|NCT03035188|resectable|resectable
40033|NCT03035175|Residences|residences
40034|NCT03035175|Video Laryngoscopy|video laryngoscopy
40035|NCT03035175|Intubations|intubations
40036|NCT03035175|Neonatal|neonatal
40037|NCT03035175|NICU|nicu
40038|NCT03035175|neonates|neonates
40039|NCT03035175|Medical Education|medical education
40040|NCT03035162|dual tDCS|dual tdcs
40275|NCT03033914|dacarbazine|dacarbazine
40041|NCT03035162|physical rehabilitation|physical rehabilitation
40052|NCT03035071|Minimal-invasive esophagectomy|minimal-invasive esophagectomy
40053|NCT03035071|Esophageal resection|esophageal resection
40054|NCT03035071|Hybrid esophagectomy|hybrid esophagectomy
40055|NCT03035058|Drug therapy|drug therapy
40056|NCT03035032|Leuprolide acetate|leuprolide acetate
40057|NCT03035032|Prostate cancer|prostate cancer
40058|NCT03035019|anxiety|anxiety
40059|NCT03035019|behavioral app|behavioral app
40060|NCT03035006|Hepatocellular carcinoma|hepatocellular carcinoma
40061|NCT03035006|Portal vein tumor thrombosis|portal vein tumor thrombosis
40062|NCT03035006|TLC388|tlc388
40063|NCT03035006|Chemoradiotherapy|chemoradiotherapy
40064|NCT03035006|Lipotecan|lipotecan
40071|NCT03034941|Obesity|obesity
40072|NCT03034941|PCOS|pcos
40073|NCT03034941|Infertility|infertility
40074|NCT03034941|Liraglutide|liraglutide
40075|NCT03034941|Metformin|metformin
40076|NCT03034941|IVF|ivf
40077|NCT03034109|Transcranial Direct Current Stimulation|transcranial direct current stimulation
40078|NCT03034109|Stroke|stroke
40079|NCT03034109|Electric Stimulation Therapy|electric stimulation therapy
40080|NCT03034109|Prefrontal Cortex|prefrontal cortex
40081|NCT03034109|Electroencephalography|electroencephalography
40082|NCT03034109|Cognition|cognition
40083|NCT03034109|Neurological Rehabilitation|neurological rehabilitation
40084|NCT03034109|Memory|memory
40085|NCT03034109|Working Memory|working memory
40086|NCT03034109|Attention|attention
40087|NCT03034109|Concentration|concentration
40088|NCT03034109|Short-Term Memory|short-term memory
40089|NCT03034109|Planning|planning
40090|NCT03034109|Executive Function|executive function
40091|NCT03034109|Cerebrovascular disease|cerebrovascular disease
40092|NCT03034083|healthy marriage|healthy marriage
40093|NCT03034083|healthy relationships|healthy relationships
40094|NCT03034083|parenting|parenting
40095|NCT03034083|healthy marriage and relationship education|healthy marriage and relationship education
40096|NCT03034070|MRI|mri
40097|NCT03034070|MRI sequences|mri sequences
40098|NCT03034070|prostate cancer|prostate cancer
40099|NCT03034070|cancer|cancer
40100|NCT03034070|staging|staging
40101|NCT03034070|bone metastasis|bone metastasis
40102|NCT03034070|node metastasis|node metastasis
40103|NCT03034031|Traumatic Brain Injury|traumatic brain injury
40104|NCT03034031|Children|children
40105|NCT03034031|Pediatric|pediatric
40106|NCT03034031|MRI|mri
40107|NCT03034031|fMRI|fmri
40108|NCT03034031|Cognition|cognition
40109|NCT03034031|DTI|dti
40110|NCT03034031|Longitudinal|longitudinal
40111|NCT03034031|Connectivity|connectivity
40112|NCT03034031|DAI|dai
40113|NCT03034031|Neuropsychology|neuropsychology
40114|NCT03034031|Rehabilitation|rehabilitation
40115|NCT03034018|insomnia|insomnia
40116|NCT03034018|hot flashes|hot flashes
40117|NCT03034018|menopause|menopause
40118|NCT03034018|suvorexant|suvorexant
40119|NCT03034018|belsomra|belsomra
40120|NCT03034005|Inhaled corticosteroids|inhaled corticosteroids
40121|NCT03034005|Airway hyper-responsiveness|airway hyper-responsiveness
40122|NCT03034005|Airway smooth muscle|airway smooth muscle
40123|NCT03034005|sodium-potassium pump|sodium-potassium pump
40129|NCT03034889|Anesthesia|anesthesia
40130|NCT03034889|Children|children
40131|NCT03034889|General Anesthesia|general anesthesia
40132|NCT03034889|Neurocognitive Outcome|neurocognitive outcome
40133|NCT03034876|"Acute Kidney Injury, diagnosis, children, shock"|"acute kidney injury, diagnosis, children, shock"
40134|NCT03034863|Family Caregivers|family caregivers
40135|NCT03034863|Spouse Caregivers|spouse caregivers
40136|NCT03034863|Veterans|veterans
40137|NCT03034863|Suicide|suicide
40138|NCT03034863|Clinical Trial|clinical trial
40139|NCT03034863|Military Families|military families
40140|NCT03034863|Military Psychology|military psychology
40141|NCT03034850|cytoreductive surgery|cytoreductive surgery
40142|NCT03034850|hyperthermic intraperitoneal peroperative chemotherapy|hyperthermic intraperitoneal peroperative chemotherapy
40143|NCT03034850|platelet function|platelet function
40144|NCT03034850|thrombin generation|thrombin generation
40159|NCT03034772|age-related|age-related
40160|NCT03034772|macular degeneration|macular degeneration
40161|NCT03034772|dorzolamide|dorzolamide
40162|NCT03034772|timolol|timolol
40163|NCT03034759|continuous glucose monitoring|continuous glucose monitoring
40164|NCT03034746|alzheimer's disease, physical activity, cognitive training|alzheimer's disease, physical activity, cognitive training
40165|NCT03034733|Arthroplasty|arthroplasty
40166|NCT03034733|Knee Replacement|knee replacement
40167|NCT03034733|Pain, Postoperative|pain, postoperative
40168|NCT03034733|Glucocorticoids|glucocorticoids
40169|NCT03034733|Dexamethasone|dexamethasone
40170|NCT03034720|Concussion|concussion
40171|NCT03034720|persistent post-concussive symptoms|persistent post-concussive symptoms
40172|NCT03034720|CBT|cbt
40173|NCT03034720|collaborative care|collaborative care
40174|NCT03034720|Depression|depression
40175|NCT03034720|Anxiety|anxiety
40176|NCT03034707|biotin pharmacokinetic|biotin pharmacokinetic
40276|NCT03033914|16-1536|16-1536
40177|NCT03034707|biotinylated assay|biotinylated assay
40178|NCT03034707|hormone measurement|hormone measurement
40179|NCT03034707|thyroid|thyroid
40180|NCT03034707|parathyroid|parathyroid
40181|NCT03034707|prolactin|prolactin
40182|NCT03034668|Botanical Supplement|botanical supplement
40183|NCT03034668|Performance-Enhancing Supplement|performance-enhancing supplement
40184|NCT03034655|Vestibular rehabilitation|vestibular rehabilitation
40185|NCT03034655|Falls in elderly|falls in elderly
40186|NCT03034655|Computerized dynamic posturography|computerized dynamic posturography
40187|NCT03034655|Mobile posturography|mobile posturography
40188|NCT03034642|Apoptosis|apoptosis
40189|NCT03034642|Bronchoscopy|bronchoscopy
40190|NCT03034642|Human|human
40191|NCT03034642|Mice, inbred strains|mice, inbred strains
40192|NCT03034642|Macrophages, Alveolar|macrophages, alveolar
40193|NCT03034642|MicroRNAs|micrornas
40194|NCT03034642|Streptococcus pneumoniae|streptococcus pneumoniae
40195|NCT03034642|Fluticasone|fluticasone
40196|NCT03034616|Primary ovarian insufficiency|primary ovarian insufficiency
40197|NCT03034616|In-vivo activation|in-vivo activation
40198|NCT03034551|Adherence|adherence
40199|NCT03034551|Financial Incentives|financial incentives
40200|NCT03034551|Remote Monitoring|remote monitoring
40201|NCT03034551|Self-Weighing|self-weighing
40202|NCT03034551|Behavioral Economics|behavioral economics
40203|NCT03034551|Telehealth|telehealth
40204|NCT03034551|mobile health (mHealth)|mobile health (mhealth)
40205|NCT03034551|Smartphone App|smartphone app
40206|NCT03034551|Wellth App|wellth app
40207|NCT03034486|Glaucoma|glaucoma
40208|NCT03034473|locally advanced rectal cancer|locally advanced rectal cancer
40209|NCT03034473|translational research|translational research
40210|NCT03034473|Biomarker|biomarker
40211|NCT03034447|Asthma|asthma
40212|NCT03034447|Obstructive Sleep Apnea|obstructive sleep apnea
40213|NCT03034447|Children|children
40214|NCT03034447|Teenagers|teenagers
40215|NCT03034408|Impulsivity|impulsivity
40216|NCT03034408|Nalmefene|nalmefene
40217|NCT03034408|Baclofen|baclofen
40218|NCT03034395|Melanoma|melanoma
40219|NCT03034395|cT2N0M0|ct2n0m0
40220|NCT03034382|morphine|morphine
40221|NCT03034382|nalbuphine|nalbuphine
40222|NCT03034382|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
40223|NCT03034382|ultrasound guided interscalene block|ultrasound guided interscalene block
40224|NCT03034369|Integration|integration
40225|NCT03034369|Primary Care|primary care
40226|NCT03034369|Behavioral Health|behavioral health
40227|NCT03034369|Health Care Reform|health care reform
40228|NCT03034369|Medical Home|medical home
40229|NCT03034369|Accountable Care Organization|accountable care organization
40230|NCT03034356|Schizophrenia|schizophrenia
40231|NCT03034343|Mindfulness|mindfulness
40232|NCT03034343|Internet program|internet program
40233|NCT03034343|Depression|depression
40234|NCT03034343|Cost-effectiveness|cost-effectiveness
40235|NCT03034330|informal care|informal care
40236|NCT03034330|empowerment|empowerment
40237|NCT03034330|family-focused intervention|family-focused intervention
40238|NCT03034330|stroke rehabilitation|stroke rehabilitation
40239|NCT03034317|Diaphragm Pacing|diaphragm pacing
40240|NCT03034304|MASCT-I，DC，T cell|masct-i，dc，t cell
40241|NCT03034304|Advanced solid tumors|advanced solid tumors
40242|NCT03034304|Bladder Cancer|bladder cancer
40243|NCT03034304|Soft Tissue Sarcoma|soft tissue sarcoma
40244|NCT03034291|Cocoa|cocoa
40245|NCT03034291|obesity|obesity
40246|NCT03034291|HOMA-IR|homa-ir
40248|NCT03034291|Quality of life|quality of life
40249|NCT03034278|opioid use|opioid use
40250|NCT03034265|hypertension; exosome; angiotensin; sodium channel; kidney; aldosterone; renin; urine|hypertension; exosome; angiotensin; sodium channel; kidney; aldosterone; renin; urine
40251|NCT03034226|Hypoglycemia-Associated Autonomic Failure (HAAF)|hypoglycemia-associated autonomic failure (haaf)
40252|NCT03034213|mesh|mesh
40253|NCT03034200|Pheochromocytoma-paraganglioma|pheochromocytoma-paraganglioma
40254|NCT03034200|ONC201|onc201
40255|NCT03034187|Acute toxicity|acute toxicity
40256|NCT03034187|Late toxicity|late toxicity
40257|NCT03034187|Quality of Life since 2011(set-up SFP-prostate)|quality of life since 2011(set-up sfp-prostate)
40258|NCT03034174|tigecycline|tigecycline
40259|NCT03034174|pharmacokinetics|pharmacokinetics
40260|NCT03034148|Coronary artery disease|coronary artery disease
40261|NCT03034148|Atherothrombosis|atherothrombosis
40262|NCT03034148|Thrombin generation|thrombin generation
40263|NCT03034148|Platelet Acetyl Coenzyme A carboxylase phosphorylation|platelet acetyl coenzyme a carboxylase phosphorylation
40264|NCT03033966|Cerebral Oximetry|cerebral oximetry
40265|NCT03033966|Cerebral Venous Thrombosis|cerebral venous thrombosis
40266|NCT03033966|Decompressive Craniectomy|decompressive craniectomy
40267|NCT03033927|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
40268|NCT03033927|FOLFIRINOX|folfirinox
40269|NCT03033927|gem/nab-P chemotherapy|gem/nab-p chemotherapy
40270|NCT03033927|17-042|17-042
40271|NCT03033914|Nivolumab|nivolumab
40272|NCT03033914|adriamycin|adriamycin
40273|NCT03033914|bleomycin|bleomycin
40274|NCT03033914|vinblastine|vinblastine
40277|NCT03033901|Veterans|veterans
40278|NCT03033901|Comparative Effectiveness Research|comparative effectiveness research
40279|NCT03033901|Diagnosis|diagnosis
40280|NCT03033836|transgender women|transgender women
40281|NCT03033823|Alcoholism|alcoholism
40282|NCT03033823|Delirium|delirium
40283|NCT03033823|Magnesium Deficiency|magnesium deficiency
40284|NCT03033797|assitive technology|assitive technology
40285|NCT03033797|virtual reality games|virtual reality games
40286|NCT03033797|intellectual disability|intellectual disability
40287|NCT03033797|augmentative and alternative communication|augmentative and alternative communication
40288|NCT03033784|Neuroscience|neuroscience
40289|NCT03033758|comorbidities|comorbidities
40290|NCT03033732|opioid agonist treatment|opioid agonist treatment
40291|NCT03033732|pragmatic|pragmatic
40292|NCT03033732|prescription opioid use|prescription opioid use
40293|NCT03033732|patient engagement|patient engagement
40294|NCT03033719|Colorectal Surgery|colorectal surgery
40295|NCT03033719|Geriatrics|geriatrics
40296|NCT03033719|Digestive Oncology|digestive oncology
40297|NCT03033719|Colon cancer|colon cancer
40298|NCT03033719|Elderly patients|elderly patients
40299|NCT03033719|Laparoscopy|laparoscopy
40300|NCT03033719|Laparotomy|laparotomy
40301|NCT03033719|Morbidity|morbidity
40302|NCT03033667|perioperative fasting|perioperative fasting
40303|NCT03033667|free fatty acids|free fatty acids
40304|NCT03033667|coronary bypass grfting|coronary bypass grfting
40305|NCT03033589|Pain control|pain control
40306|NCT03033589|Anterior Cruciate Ligament (ACL_ Reconstruction)|anterior cruciate ligament (acl_ reconstruction)
40307|NCT03033589|Regional Anesthesia|regional anesthesia
40308|NCT03033511|Cancer|cancer
40309|NCT03033511|Platinum-Based Chemotherapy|platinum-based chemotherapy
40310|NCT03033511|Extensive-Stage Small Cell Lung Cancer (ED SCLC)|extensive-stage small cell lung cancer (ed sclc)
40311|NCT03033511|Rovalpituzumab tesirine|rovalpituzumab tesirine
40312|NCT03033511|first-line chemotherapy|first-line chemotherapy
40313|NCT03033485|Picolinamide|picolinamide
40314|NCT03033485|PET/CT|pet/ct
40315|NCT03033485|Diagnosis|diagnosis
40316|NCT03033485|Melanoma|melanoma
40317|NCT03033459|breast feeding|breast feeding
40318|NCT03033459|motivational interviewing|motivational interviewing
40319|NCT03033420|Unipolar disorder|unipolar disorder
40320|NCT03033420|Bipolar disorder|bipolar disorder
40321|NCT03033420|Randomized controlled trial|randomized controlled trial
40322|NCT03033420|Smartphone|smartphone
40323|NCT03033420|Re-admission|re-admission
40324|NCT03033420|CBT|cbt
40325|NCT03033381|Children|children
40326|NCT03033381|Inguinal hernia|inguinal hernia
40327|NCT03033381|Testis|testis
40328|NCT03033381|Doppler ultrasonography|doppler ultrasonography
31871|NCT03086239|Advanced, Recurrent Small Cell Lung Cancer|advanced, recurrent small cell lung cancer
31872|NCT03086226|Mycetoma Fosravuconazole Itraconazole Surgery Sudan|mycetoma fosravuconazole itraconazole surgery sudan
31873|NCT03086213|nonintubated uniport thoracoscopic surgery|nonintubated uniport thoracoscopic surgery
31874|NCT03086213|paravertebral nerve block|paravertebral nerve block
31875|NCT03086213|intercostal nerve block|intercostal nerve block
31876|NCT03086213|peripheral solitary pulmonary nodule|peripheral solitary pulmonary nodule
31877|NCT03086200|PrEP|prep
31880|NCT03086200|Truvada|truvada
40329|NCT03033368|immunological outcome|immunological outcome
40330|NCT03033368|virologic outcomes|virologic outcomes
40331|NCT03033368|HIV-1 infected adolescents|hiv-1 infected adolescents
40332|NCT03033368|EFV switch to RPV|efv switch to rpv
40333|NCT03033368|Rilpivirine pharmacokinetic|rilpivirine pharmacokinetic
40334|NCT03033368|neuropsychiatric adverse events|neuropsychiatric adverse events
622071|NCT00668889|Hygiene|hygiene
40335|NCT03033355|Neurogenic Bladder, Detrusor Overactivity, Botox, fMRI, neurogenic detrusor overactivity|neurogenic bladder, detrusor overactivity, botox, fmri, neurogenic detrusor overactivity
40336|NCT03033342|Phase 1|phase 1
40337|NCT03033316|Multiple Myeloma|multiple myeloma
40338|NCT03033316|Liposomal Dexamethasone|liposomal dexamethasone
40339|NCT03033316|Targeted Drug Delivery|targeted drug delivery
40340|NCT03033303|Hu3F8|hu3f8
40341|NCT03033303|GM-CSF|gm-csf
40342|NCT03033303|Isotretinoin|isotretinoin
40343|NCT03033303|16-1643|16-1643
40344|NCT03033290|Qi-tonifying regimen|qi-tonifying regimen
40348|NCT03033251|Work of breathing|work of breathing
40349|NCT03033251|Non invasive ventilation|non invasive ventilation
40350|NCT03033251|High Flow Oxygen Cannula|high flow oxygen cannula
40351|NCT03033225|Pancrease|pancrease
40352|NCT03033225|Cancer|cancer
40353|NCT03033225|Photodynamic Therapy|photodynamic therapy
40354|NCT03033225|Pancreatic|pancreatic
40355|NCT03033225|Tumor|tumor
40356|NCT03033225|unresectable|unresectable
40357|NCT03033199|Gut microbiota|gut microbiota
40358|NCT03033199|Immune thrombocytopenia|immune thrombocytopenia
40359|NCT03033186|Everolimus|everolimus
40360|NCT03033186|Long term site effects|long term site effects
40361|NCT03033186|Dried Blood Spot|dried blood spot
40362|NCT03033186|Therapeutic Drug Monitoring|therapeutic drug monitoring
40363|NCT03033160|Estrogen|estrogen
40364|NCT03033160|Hematuria|hematuria
40365|NCT03033121|growth hormone|growth hormone
40366|NCT03033121|children|children
40367|NCT03033121|metabolism|metabolism
40368|NCT03033095|TNF inhibitor|tnf inhibitor
40369|NCT03033095|Etanercept|etanercept
40370|NCT03033095|Spondyloarthritis|spondyloarthritis
40371|NCT03033095|Biomarkers analysis|biomarkers analysis
40372|NCT03033095|Personnalized medicine|personnalized medicine
40373|NCT03033056|fear-conditioning|fear-conditioning
40374|NCT03033056|behavioral avoidance|behavioral avoidance
40375|NCT03033056|anxiety disorders|anxiety disorders
40376|NCT03033056|fMRI|fmri
40377|NCT03033043|aortic|aortic
40378|NCT03033043|dissection|dissection
40379|NCT03033043|type B|type b
40380|NCT03033043|thoracic|thoracic
40381|NCT03033030|Ultrasound|ultrasound
40382|NCT03033030|Digital Breast Tomosynthesis|digital breast tomosynthesis
40383|NCT03033030|Cancer Detection rate|cancer detection rate
40384|NCT03033030|Sensitivity|sensitivity
40385|NCT03033030|Specificity|specificity
40386|NCT03033030|Breast density|breast density
40387|NCT03033017|HIV|hiv
40388|NCT03032991|Gestational diabetes|gestational diabetes
40389|NCT03032991|Neurodevelopment|neurodevelopment
40390|NCT03032991|Placenta|placenta
40391|NCT03032991|Gut microbiota|gut microbiota
40392|NCT03032991|Protectins|protectins
40393|NCT03032991|MFSD2a|mfsd2a
40394|NCT03032991|AdipoRon|adiporon
40395|NCT03032965|atrial fibrillation|atrial fibrillation
40396|NCT03032965|ablation|ablation
40397|NCT03032965|adenosine|adenosine
40398|NCT03032952|RCT|rct
40399|NCT03032952|Computerised interventions|computerised interventions
40400|NCT03032952|Mobile applications|mobile applications
40401|NCT03032952|Stress, Psychological|stress, psychological
40402|NCT03032952|Depressive symptoms|depressive symptoms
40403|NCT03032952|Anxious symptoms|anxious symptoms
40404|NCT03032952|Students|students
40405|NCT03032952|Mental health|mental health
40406|NCT03032926|Anxiety|anxiety
40407|NCT03032913|Pancreas|pancreas
40408|NCT03032913|Pancreatic|pancreatic
40409|NCT03032913|Cancer|cancer
40410|NCT03032913|Circulating tumor cell (CTC)|circulating tumor cell (ctc)
32021|NCT03085472|CT|ct
40411|NCT03032913|Adenocarcinoma|adenocarcinoma
40412|NCT03032913|Ductal|ductal
40413|NCT03032913|Exosome|exosome
40414|NCT03032900|Major lung resection|major lung resection
40415|NCT03032900|Right Ventricular Dysfunction|right ventricular dysfunction
40416|NCT03032900|2D Strain|2d strain
40417|NCT03032887|hygiene|hygiene
40418|NCT03032887|prenatal care|prenatal care
40419|NCT03032887|postnatal care|postnatal care
40420|NCT03032874|Colorectal cancer|colorectal cancer
40421|NCT03032874|Polyps|polyps
40422|NCT03032874|Colonoscopy|colonoscopy
40423|NCT03032874|Rectal bleeding|rectal bleeding
40424|NCT03032874|Nigeria|nigeria
40425|NCT03032861|Orange juice|orange juice
40426|NCT03032861|Microbiota|microbiota
40427|NCT03032861|Prebiotic|prebiotic
40428|NCT03032861|Flavanones|flavanones
40429|NCT03032861|Bioavailability|bioavailability
40430|NCT03032835|Calciphylaxis|calciphylaxis
40431|NCT03032835|Warfarin|warfarin
40432|NCT03032835|Dialysis|dialysis
40433|NCT03032822|Opioid consumption|opioid consumption
40434|NCT03032822|postdischarge|postdischarge
40435|NCT03032822|cystectomy|cystectomy
40436|NCT03032744|Pediatric|pediatric
40437|NCT03032744|School Based Health Center|school based health center
40438|NCT03032731|Physical activity|physical activity
40450|NCT03032640|Sweet taste receptors|sweet taste receptors
40451|NCT03032640|Artificial sweeteners|artificial sweeteners
40452|NCT03032601|MS (Multiple Sclerosis)|ms (multiple sclerosis)
40453|NCT03032601|Acute Fulminating|acute fulminating
40454|NCT03032601|Sclerosis|sclerosis
40455|NCT03032601|FDG|fdg
40456|NCT03032601|18F Fluorodeoxyglucose|18f fluorodeoxyglucose
40457|NCT03032601|18F-FDG|18f-fdg
40458|NCT03032601|18FDG|18fdg
42505|NCT03019718|Psychodynamic|psychodynamic
40459|NCT03032601|2-Fluoro-2-deoxy-D-glucose|2-fluoro-2-deoxy-d-glucose
40460|NCT03032601|2-Fluoro-2-deoxyglucose|2-fluoro-2-deoxyglucose
40461|NCT03032601|Fludeoxyglucose F 18|fludeoxyglucose f 18
40462|NCT03032601|Fluorine-18-fluorodeoxyglucose|fluorine-18-fluorodeoxyglucose
40463|NCT03032601|Fluorodeoxyglucose F 18|fluorodeoxyglucose f 18
40465|NCT03032601|Tomography, Positron-Emission|tomography, positron-emission
40466|NCT03032601|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
40467|NCT03032601|fMRI|fmri
40468|NCT03032601|PET-MRI|pet-mri
40469|NCT03032601|Acetylcysteine|acetylcysteine
40470|NCT03032601|N-acetyl cysteine|n-acetyl cysteine
40471|NCT03032601|NAC|nac
40472|NCT03032601|Oral supplements|oral supplements
40473|NCT03032575|HIV|hiv
40474|NCT03032562|respiratory muscle strength|respiratory muscle strength
40475|NCT03032562|sleep-disordered breathing|sleep-disordered breathing
40476|NCT03032562|neuromuscular disease|neuromuscular disease
40477|NCT03032562|chronic-obstructive pulmonary disease|chronic-obstructive pulmonary disease
40478|NCT03032497|Brain Computer Interface|brain computer interface
40479|NCT03032497|Electroencephalogram (EEG)|electroencephalogram (eeg)
40480|NCT03032497|Chronic Pain|chronic pain
40481|NCT03032471|Subarachnoid Hemorrhage|subarachnoid hemorrhage
40482|NCT03032471|Delayed cerebral ischemia|delayed cerebral ischemia
40483|NCT03032471|Cognitive Impairment|cognitive impairment
40484|NCT03032471|Montreal Cognitive Assessment|montreal cognitive assessment
40485|NCT03032471|MoCA|moca
40486|NCT03032471|Cognitive Deterioration|cognitive deterioration
40487|NCT03032458|Shock Wave Lithotripsy|shock wave lithotripsy
40488|NCT03032458|Ketorolac|ketorolac
40489|NCT03032458|Xylocaine Gel|xylocaine gel
40490|NCT03032458|Pethidine|pethidine
40491|NCT03032445|Body Water/physiology|body water/physiology
40492|NCT03032445|Hyponatremia/etiology|hyponatremia/etiology
40493|NCT03032445|Physical Exertion/physiology|physical exertion/physiology
40494|NCT03032445|Running/physiology|running/physiology
40495|NCT03032445|Sodium/blood|sodium/blood
40496|NCT03032445|Ethanol|ethanol
40507|NCT03032354|probiotics|probiotics
40508|NCT03032354|children|children
40509|NCT03032354|remission|remission
40510|NCT03032341|mobility assessment tool|mobility assessment tool
40511|NCT03032302|TBI|tbi
40512|NCT03032289|active transport|active transport
40513|NCT03032289|cycling|cycling
40514|NCT03032289|walking|walking
40515|NCT03032276|Safe motherhood|safe motherhood
40516|NCT03032276|Newborn survival|newborn survival
40517|NCT03032276|Community|community
40518|NCT03032276|Cluster Randomized Trial|cluster randomized trial
40519|NCT03032237|Protein intake|protein intake
40520|NCT03032237|Older adults|older adults
40521|NCT03032237|Protein-rich|protein-rich
40522|NCT03032237|Acceptance|acceptance
40523|NCT03032237|Liking|liking
40524|NCT03032237|Readymade meals|readymade meals
40525|NCT03032224|Body composition|body composition
40526|NCT03032224|sarcopenia|sarcopenia
40527|NCT03032224|Dysphagia|dysphagia
40528|NCT03032224|Surgery|surgery
40529|NCT03032224|Quality of Life|quality of life
40530|NCT03032224|Morbidity|morbidity
40531|NCT03032185|menopause|menopause
40532|NCT03032185|post-menopause|post-menopause
40533|NCT03032185|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
40534|NCT03032185|electrical stimulation therapy|electrical stimulation therapy
40535|NCT03032185|women's health|women's health
622072|NCT00668902|CYP2C19|cyp2c19
40536|NCT03032133|Total Knee Arthroplasty|total knee arthroplasty
40537|NCT03032133|Total Knee Replacement|total knee replacement
40538|NCT03032133|Outcome|outcome
40539|NCT03032133|Results|results
40540|NCT03032133|Pain|pain
40541|NCT03032107|Breast Cancer|breast cancer
40542|NCT03032094|Gingival Recession|gingival recession
40543|NCT03032055|sickle cell desease|sickle cell desease
40544|NCT03032055|vaso occlusive crisis|vaso occlusive crisis
40545|NCT03032055|acute chest syndrome|acute chest syndrome
40546|NCT03032055|Validation of predictif score of acute chest syndrome|validation of predictif score of acute chest syndrome
40547|NCT03032042|intestinal microbiome|intestinal microbiome
40548|NCT03032042|soil-transmitted helminths|soil-transmitted helminths
40549|NCT03032042|mass drug administration|mass drug administration
40550|NCT03032016|VOD|vod
40551|NCT03032016|Defibrotide|defibrotide
40552|NCT03032016|Defitelio|defitelio
40553|NCT03032016|Registry|registry
40554|NCT03032016|SOS|sos
40555|NCT03031990|Yoga|yoga
40556|NCT03031990|Oocyte cryopreservation|oocyte cryopreservation
40557|NCT03031990|In-vitro fertilization|in-vitro fertilization
40558|NCT03031951|Former athletes|former athletes
40559|NCT03031951|Body composition|body composition
40560|NCT03031951|Adaptive thermogenesis|adaptive thermogenesis
40561|NCT03031951|Physical activity|physical activity
40562|NCT03031951|Energy expenditure|energy expenditure
40563|NCT03031951|Sedentary behavior|sedentary behavior
40564|NCT03031951|Fat mass|fat mass
40565|NCT03031951|Abdominal fat mass|abdominal fat mass
40566|NCT03031951|Nutrition|nutrition
40568|NCT03031938|Exposure in utero in tanezumab program|exposure in utero in tanezumab program
40569|NCT03031925|Annexin A2|annexin a2
40570|NCT03031925|biomarker|biomarker
40571|NCT03031821|Prostate Cancer|prostate cancer
40573|NCT03031821|iADT|iadt
40574|NCT03031821|Metabolic Syndrome|metabolic syndrome
40575|NCT03031821|Androgen Deprivation Therapy|androgen deprivation therapy
40576|NCT03031821|Phase III|phase iii
40577|NCT03031821|Phase 3|phase 3
40578|NCT03031821|Randomized|randomized
40579|NCT03031821|Intermittent Androgen Deprivation Therapy|intermittent androgen deprivation therapy
40580|NCT03031795|intrauterine device|intrauterine device
40581|NCT03031782|JIA, JPsA, ERA, Secukinumab, ILAR|jia, jpsa, era, secukinumab, ilar
40582|NCT03031756|Air polishing|air polishing
40583|NCT03031743|rotavirus vaccine|rotavirus vaccine
40584|NCT03031743|human microbiome|human microbiome
40585|NCT03031743|fecal microbiome|fecal microbiome
40586|NCT03031743|vaccine immunogenicity|vaccine immunogenicity
40587|NCT03031743|Rotarix|rotarix
40588|NCT03031743|immune response, mucosal|immune response, mucosal
40589|NCT03031665|GABA|gaba
40590|NCT03031665|Depression|depression
40591|NCT03031665|Stress|stress
40592|NCT03031665|Androgens|androgens
40593|NCT03031652|pain|pain
40594|NCT03031652|axial length|axial length
40595|NCT03031652|anterior chamber depth|anterior chamber depth
40596|NCT03031652|intraocular pressure|intraocular pressure
40597|NCT03031639|endoscopic|endoscopic
40598|NCT03031639|thyroidectomy|thyroidectomy
40599|NCT03031613|intraocular pressure|intraocular pressure
40600|NCT03031613|intracerebral pressure|intracerebral pressure
40601|NCT03031587|Thermometric MRI|thermometric mri
40602|NCT03031587|Myocardium|myocardium
40603|NCT03031574|Serotonin 4 (5-HT4) receptor|serotonin 4 (5-ht4) receptor
40604|NCT03031574|Phase 1|phase 1
40605|NCT03031509|Nonunion Fracture of limb|nonunion fracture of limb
40606|NCT03031496|Cross-over|cross-over
40607|NCT03031496|Hydrochlorothiazide|hydrochlorothiazide
40608|NCT03031496|Amiloride hydrochloride|amiloride hydrochloride
40609|NCT03031496|Phase I|phase i
40610|NCT03031496|GSK3542503|gsk3542503
40611|NCT03031496|Bioequivalence|bioequivalence
40612|NCT03031496|FTIH|ftih
40613|NCT03031470|Liver Transplant|liver transplant
40614|NCT03031470|Ischemia-reperfusion injury|ischemia-reperfusion injury
40615|NCT03031470|Early allograft dysfunction|early allograft dysfunction
40616|NCT03031444|colorectal liver metastasis|colorectal liver metastasis
40617|NCT03031444|preoperative|preoperative
40618|NCT03031444|chemotherapy|chemotherapy
40619|NCT03031444|targeted therapy|targeted therapy
40620|NCT03031431|Hypothermia|hypothermia
40621|NCT03031431|Infant Warmer|infant warmer
40622|NCT03031340|Spinal fusion|spinal fusion
40623|NCT03031340|pregabalin|pregabalin
40624|NCT03031340|Spinal fusion surgeries|spinal fusion surgeries
40625|NCT03031340|two or more vertebrae|two or more vertebrae
40626|NCT03031327|Ocular Discomfort Following Refractive Surgery|ocular discomfort following refractive surgery
40627|NCT03031327|Refractive Surgery|refractive surgery
40628|NCT03031314|Joint Replacement|joint replacement
40629|NCT03031314|Knee Replacement|knee replacement
40630|NCT03031314|Wound Healing|wound healing
40631|NCT03031314|Hip Replacement|hip replacement
32184|NCT03084185|deficit|deficit
40632|NCT03031288|gastroesophageal reflux|gastroesophageal reflux
40633|NCT03031288|swallow|swallow
40634|NCT03031288|feeding bottle|feeding bottle
40635|NCT03031288|cardiorespiratory|cardiorespiratory
40636|NCT03031288|apnoea|apnoea
40637|NCT03031288|preterm|preterm
40638|NCT03031288|impedance-pH-metry|impedance-ph-metry
40639|NCT03031275|extracorporeal circulation|extracorporeal circulation
40640|NCT03031275|critical care outcomes|critical care outcomes
40641|NCT03031236|Early Childhood Development (ECD)|early childhood development (ecd)
40642|NCT03031236|Psychosocial stimulation|psychosocial stimulation
40643|NCT03031236|Cognition|cognition
40644|NCT03031236|Parenting|parenting
40645|NCT03031236|Malnutrition|malnutrition
40646|NCT03031236|Bangladesh|bangladesh
40647|NCT03031236|Childhood Maltreatment|childhood maltreatment
40648|NCT03031223|Spinal cord injuries|spinal cord injuries
40649|NCT03031223|low-level laser therapy|low-level laser therapy
40650|NCT03031210|Non-severe community-acquired pneumonia|non-severe community-acquired pneumonia
40651|NCT03031210|Amoxicillin treatment|amoxicillin treatment
40652|NCT03031210|Twice daily antibiotic regimen|twice daily antibiotic regimen
40653|NCT03031197|adherence|adherence
40654|NCT03031197|adolescent|adolescent
40655|NCT03031197|HIV/AIDS|hiv/aids
40656|NCT03031197|Vietnam|vietnam
40657|NCT03031184|Agitation|agitation
40658|NCT03031184|Agitated behaviours|agitated behaviours
40659|NCT03031184|Alzheimer's Disease|alzheimer's disease
40660|NCT03031171|community engagement, navigation, cancer screening|community engagement, navigation, cancer screening
40661|NCT03031132|Protein-rich breakfast|protein-rich breakfast
40662|NCT03031132|Breakfast Skipping|breakfast skipping
40663|NCT03031132|Young Adults|young adults
40665|NCT03031132|Food form|food form
40666|NCT03031132|fMRI|fmri
40667|NCT03031132|Ghrelin|ghrelin
40668|NCT03031132|PYY|pyy
40669|NCT03031132|Sleep|sleep
40670|NCT03031119|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
40671|NCT03031106|Patient-reported outcomes, Health-related QoL, Internet-based tool|patient-reported outcomes, health-related qol, internet-based tool
40672|NCT03031093|aerosol therapy|aerosol therapy
40673|NCT03031093|pulmonary scintigraphy|pulmonary scintigraphy
40674|NCT03031093|upper airways anatomy|upper airways anatomy
40675|NCT03031080|Collagenase, Night-splinting, Dupuytrens, Contracture|collagenase, night-splinting, dupuytrens, contracture
40676|NCT03031067|Donors and donation|donors and donation
40677|NCT03031067|Extended criteria donor|extended criteria donor
40678|NCT03031067|Organ perfusion and preservation|organ perfusion and preservation
40679|NCT03031067|Liver transplantation|liver transplantation
40680|NCT03031067|Kidney transplantation|kidney transplantation
40681|NCT03031067|Preservation injury|preservation injury
40682|NCT03031067|Ischemia reperfusion injury|ischemia reperfusion injury
40683|NCT03031054|Hydrodissection|hydrodissection
40684|NCT03031054|hyaluronic acid|hyaluronic acid
40685|NCT03031041|Hydrodissection|hydrodissection
40686|NCT03031041|short-axis|short-axis
40687|NCT03031041|long-axis|long-axis
40688|NCT03031028|refractory epilepsy,|refractory epilepsy,
40689|NCT03031028|ketogenic diet|ketogenic diet
40690|NCT03031028|classic ketogenic diet|classic ketogenic diet
40691|NCT03031028|seizure rate|seizure rate
40692|NCT03031028|efficacy|efficacy
40693|NCT03031028|epilepsy|epilepsy
40694|NCT03031015|Reduction, Fracture|reduction, fracture
40695|NCT03031002|exposure|exposure
40696|NCT03031002|spider phobia|spider phobia
40697|NCT03031002|generalization|generalization
40698|NCT03031002|extinction|extinction
40699|NCT03030976|CD19|cd19
40700|NCT03030976|CAR-T|car-t
40701|NCT03030976|SLE|sle
40702|NCT03030963|Equal ratio ventilation(ERV)|equal ratio ventilation(erv)
40703|NCT03030963|Peak inspiratory pressure(PIP)|peak inspiratory pressure(pip)
40704|NCT03030963|Blood loss|blood loss
40705|NCT03030963|Posterior lumbar interbody fusion(PLIF)|posterior lumbar interbody fusion(plif)
40706|NCT03030963|Prone position|prone position
40707|NCT03030924|suicide|suicide
40708|NCT03030885|Radiopharmaceutical (131I-MIP-1095)|radiopharmaceutical (131i-mip-1095)
40709|NCT03030885|16-1110|16-1110
40710|NCT03030846|pregnancy|pregnancy
40711|NCT03030846|pelvic floor muscles|pelvic floor muscles
40712|NCT03030846|Lumbo-pelvic pain|lumbo-pelvic pain
40713|NCT03030846|Stabilization exercises|stabilization exercises
40714|NCT03030846|abdominal muscles thickness|abdominal muscles thickness
40715|NCT03030846|Multifidus muscles thickness|multifidus muscles thickness
40912|NCT03029871|SBRT|sbrt
40716|NCT03030846|Multifidus muscles cross section area|multifidus muscles cross section area
40717|NCT03030820|cirrhosis|cirrhosis
40718|NCT03030820|Periodontitis|periodontitis
40719|NCT03030794|Gulf War Illness|gulf war illness
40720|NCT03030794|Headache|headache
40721|NCT03030794|Muscle Pain|muscle pain
40722|NCT03030794|Joint Pain|joint pain
40723|NCT03030794|TMS|tms
40724|NCT03030768|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
40725|NCT03030768|Fertility|fertility
40726|NCT03030768|mHealth|mhealth
40727|NCT03030768|Pregnancy|pregnancy
40728|NCT03029767|Hypertension|hypertension
40729|NCT03029767|Anthropometry|anthropometry
622373|NCT00663884|mitiglinide|mitiglinide
40730|NCT03029767|Aerobic exercise|aerobic exercise
40731|NCT03029767|Resistance exercise|resistance exercise
40732|NCT03029728|Hereditary and acquired C1-inhibitor deficiency|hereditary and acquired c1-inhibitor deficiency
40733|NCT03029728|C1 esterase inhibitor, hereditary angioedema,|c1 esterase inhibitor, hereditary angioedema,
40734|NCT03029715|Sleeve gastrectomy|sleeve gastrectomy
40735|NCT03029715|TIVA|tiva
40736|NCT03029702|Gestational diabetes|gestational diabetes
40737|NCT03029702|Diabetes in pregnancy|diabetes in pregnancy
40738|NCT03029702|Insulin resistance|insulin resistance
40739|NCT03029702|Insulin secretion deficiency|insulin secretion deficiency
40740|NCT03029689|HIV infection|hiv infection
40741|NCT03029689|Gut microbiome|gut microbiome
40742|NCT03029689|Raltegravir|raltegravir
40743|NCT03029689|Raltegravir intensification|raltegravir intensification
40744|NCT03029689|Bacterial richness|bacterial richness
40745|NCT03029676|spinal anesthesia, TURBT, POCD, premedication|spinal anesthesia, turbt, pocd, premedication
40746|NCT03029663|bladder cancer|bladder cancer
40747|NCT03029663|postoperative complications|postoperative complications
40748|NCT03029650|Peer Review|peer review
40749|NCT03029650|Research|research
40750|NCT03029637|Resin bonded bridges|resin bonded bridges
40751|NCT03029637|Randomized controlled trial|randomized controlled trial
40752|NCT03029559|Inspiratory threshold loading|inspiratory threshold loading
40753|NCT03029520|Endodontic Postoperative Pain|endodontic postoperative pain
40754|NCT03029520|iRoot SP Sealer|iroot sp sealer
40755|NCT03029520|Randomized Clinical Trial|randomized clinical trial
40756|NCT03029520|Herofill carrier-based obturation|herofill carrier-based obturation
40757|NCT03030716|antinutrients|antinutrients
40758|NCT03030716|tannins|tannins
40759|NCT03030716|proanthocyanidins|proanthocyanidins
40760|NCT03030716|salivary proline-rich proteins|salivary proline-rich proteins
40761|NCT03030703|Phytic acid|phytic acid
40762|NCT03030703|Cystatin|cystatin
40763|NCT03030703|Salivary proline-rich protein|salivary proline-rich protein
40764|NCT03030703|antinutrient|antinutrient
40765|NCT03030690|Proximal Dental Caries|proximal dental caries
40766|NCT03030690|Glass Carbomer|glass carbomer
40767|NCT03030690|Hydroxyapatite Enhanced Glass Ionomer|hydroxyapatite enhanced glass ionomer
40768|NCT03030690|Primary Teeth|primary teeth
40769|NCT03030677|pecs block|pecs block
40770|NCT03030677|breast surgery|breast surgery
40771|NCT03030677|ultrasound guidence|ultrasound guidence
40772|NCT03030664|constipation|constipation
40773|NCT03030664|Lactobacillus reuteri|lactobacillus reuteri
40774|NCT03030664|probiotics|probiotics
40775|NCT03030651|Breastfeeding|breastfeeding
40776|NCT03030651|Education and support|education and support
40777|NCT03030651|Ethiopia|ethiopia
40778|NCT03030651|Timely initiation of breastfeeding|timely initiation of breastfeeding
40779|NCT03030625|Prostate Cancer|prostate cancer
40780|NCT03030625|VMAT|vmat
40781|NCT03030625|Dominant Intraprostatic Lesion|dominant intraprostatic lesion
40782|NCT03030625|Intensity modulated radiotherapy|intensity modulated radiotherapy
40885|NCT03029975|beef|beef
40886|NCT03029975|protein|protein
40783|NCT03030586|Blood cell biomarkers, peripheral circulating biomarkers|blood cell biomarkers, peripheral circulating biomarkers
40784|NCT03030573|Bile duct injury|bile duct injury
40785|NCT03030573|Bile duct defect|bile duct defect
40786|NCT03030573|Round ligament|round ligament
40787|NCT03030573|Reconstruction|reconstruction
40788|NCT03030508|biomarks|biomarks
40789|NCT03030508|colorectal cancer|colorectal cancer
40790|NCT03030508|capecitabine|capecitabine
40791|NCT03030508|gene polymorphism|gene polymorphism
40792|NCT03030495|Ischemic Heart Disease|ischemic heart disease
40793|NCT03030495|Stable angina|stable angina
40794|NCT03030495|Fractional flow reserve|fractional flow reserve
40795|NCT03030495|Index of Microcirculatory Resistance|index of microcirculatory resistance
40796|NCT03030495|Coronary Flow Reserve|coronary flow reserve
40797|NCT03030495|Intravascular Imaging|intravascular imaging
40798|NCT03030482|Anxiety|anxiety
40799|NCT03030482|intensive care|intensive care
40800|NCT03030482|mechanical ventilation|mechanical ventilation
40801|NCT03030482|touch massage|touch massage
40802|NCT03030456|whole body vibration|whole body vibration
40803|NCT03030456|Oxidative Stress|oxidative stress
40804|NCT03030456|Aged|aged
40805|NCT03030456|Biochemical profile|biochemical profile
40806|NCT03030456|muscle strength|muscle strength
40807|NCT03030456|flexibility|flexibility
40808|NCT03030443|Pain management|pain management
40809|NCT03030443|Nitrous|nitrous
40810|NCT03030417|Topoisomerase 1 Inhibitor|topoisomerase 1 inhibitor
40811|NCT03030417|Epithelial-Mesenchymal Transition|epithelial-mesenchymal transition
40812|NCT03030417|Pharmacodynamics|pharmacodynamics
40813|NCT03030417|DNA Damage|dna damage
40814|NCT03030417|Pharmacokinetics|pharmacokinetics
40815|NCT03030404|Genetics|genetics
40816|NCT03030404|Familial Background|familial background
40817|NCT03030404|Inherited Cancer Syndrome|inherited cancer syndrome
40818|NCT03030404|Germline Mutation in the CDH1 Gene|germline mutation in the cdh1 gene
40819|NCT03030404|Genetic Testing|genetic testing
40821|NCT03030391|Radiation Absorbed Dose|radiation absorbed dose
40822|NCT03030391|Compartmental Analysis|compartmental analysis
40823|NCT03030365|Orientation, Disorientation.|orientation, disorientation.
40824|NCT03030352|Child Mental Health|child mental health
40825|NCT03030352|Parenting|parenting
40826|NCT03030352|Autonomy Support|autonomy support
40827|NCT03030352|How-to Parenting Program|how-to parenting program
40828|NCT03030352|Randomized Controlled Trial|randomized controlled trial
40829|NCT03030352|Primary Prevention|primary prevention
40830|NCT03030352|Parental Mental Health|parental mental health
40831|NCT03030352|Child Well-Being|child well-being
40832|NCT03030339|Vitamin A status|vitamin a status
40833|NCT03030339|infant|infant
40834|NCT03030339|dietary assessment|dietary assessment
40835|NCT03030339|retinol isotope dilution|retinol isotope dilution
40836|NCT03030339|breast milk intake|breast milk intake
40837|NCT03030300|type 2 diabetes|type 2 diabetes
40838|NCT03030300|remission|remission
40839|NCT03030300|short-term intensive insulin therapy|short-term intensive insulin therapy
40840|NCT03030235|diabetes|diabetes
40841|NCT03030235|heart failure|heart failure
40842|NCT03030235|dapagliflozin|dapagliflozin
40843|NCT03030235|SGLT-2 inhibitors|sglt-2 inhibitors
40844|NCT03030222|diabetes|diabetes
40845|NCT03030222|heart failure|heart failure
40846|NCT03030222|empagliflozin|empagliflozin
40847|NCT03030222|SGLT-2 inhibitors|sglt-2 inhibitors
40848|NCT03030209|pancreatectomy|pancreatectomy
40849|NCT03030209|diabetes mellitus|diabetes mellitus
40851|NCT03030157|urothelial cancer|urothelial cancer
40852|NCT03030157|bladder cancer|bladder cancer
40853|NCT03030157|nephroureterectomy|nephroureterectomy
40854|NCT03030131|IFCT|ifct
40856|NCT03030131|immune therapy|immune therapy
40857|NCT03030131|Non small cell lung cancer|non small cell lung cancer
40858|NCT03030118|hydroxychloroquine|hydroxychloroquine
40859|NCT03030105|Cognition|cognition
40860|NCT03030105|Dementia|dementia
40861|NCT03030105|Phosphodiesterase Type 4D|phosphodiesterase type 4d
40862|NCT03030105|PDE4D|pde4d
40863|NCT03030105|Scopolamine|scopolamine
40864|NCT03030105|Donepezil|donepezil
40865|NCT03030066|DS-1001b|ds-1001b
40866|NCT03030066|IDH1 mutation|idh1 mutation
40867|NCT03030066|Developmental Phase I|developmental phase i
40868|NCT03030066|Glioma|glioma
40869|NCT03030053|Flavanols|flavanols
40870|NCT03030053|Flavonoids|flavonoids
40871|NCT03030053|Polyphenols|polyphenols
40872|NCT03030053|Cognition|cognition
40873|NCT03030053|Aging|aging
40874|NCT03030040|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
40875|NCT03030040|self-help|self-help
40876|NCT03030040|healthcare staff|healthcare staff
40877|NCT03030027|Intergeneration|intergeneration
40878|NCT03030027|Reappraisal|reappraisal
40879|NCT03030027|Caregiving|caregiving
40880|NCT03030001|mesothelin|mesothelin
40881|NCT03030001|PD-1|pd-1
40882|NCT03030001|CAR T|car t
40883|NCT03030001|solid tumor|solid tumor
40884|NCT03029988|adenocarcinoma, Colorectal Carcinoma, liver metastases|adenocarcinoma, colorectal carcinoma, liver metastases
40887|NCT03029975|resistance training|resistance training
40888|NCT03029975|strength|strength
40889|NCT03029975|performance|performance
40890|NCT03029962|Teenage Pregnancy Prevention|teenage pregnancy prevention
40891|NCT03029962|LGB Girls|lgb girls
40892|NCT03029962|Text-Messaging|text-messaging
40893|NCT03029962|Information-Motivation-Behavioral Skills(IMB)Model|information-motivation-behavioral skills(imb)model
40894|NCT03029949|chronic dizziness|chronic dizziness
40895|NCT03029949|persistent postural-perceptual dizziness|persistent postural-perceptual dizziness
40896|NCT03029949|acceptance and commitment therapy|acceptance and commitment therapy
40897|NCT03029949|behavior therapy|behavior therapy
40898|NCT03029949|vestibular rehabilitation|vestibular rehabilitation
40899|NCT03029936|obesity|obesity
40900|NCT03029936|asthma|asthma
40901|NCT03029936|diaphragm excursion|diaphragm excursion
40902|NCT03029936|pulmonary function test|pulmonary function test
40903|NCT03029923|smoking|smoking
40904|NCT03029923|depression|depression
40905|NCT03029923|Behavioral Activation|behavioral activation
40906|NCT03029910|Eccentric exercise|eccentric exercise
40907|NCT03029910|Whole body vibration|whole body vibration
40908|NCT03029910|Cryotherapy|cryotherapy
40909|NCT03029871|lung cancer|lung cancer
40910|NCT03029871|adenovirus|adenovirus
40911|NCT03029871|gene therapy|gene therapy
40913|NCT03029793|Esophageal Cancer|esophageal cancer
40914|NCT03029793|Prediction|prediction
40915|NCT03029793|Biomarker|biomarker
40916|NCT03029793|MRI-DWI|mri-dwi
40917|NCT03029793|PET-CT|pet-ct
40918|NCT03029507|Obesity|obesity
40919|NCT03029507|Military|military
40920|NCT03029507|Acceptance and Commitment Therapy|acceptance and commitment therapy
40921|NCT03029507|Overweight|overweight
40922|NCT03029507|Weight-management|weight-management
40923|NCT03029507|Navy Personnel|navy personnel
40924|NCT03029507|Fitness|fitness
40927|NCT03029442|Spinal Cord Injury|spinal cord injury
40928|NCT03029442|Denosumab|denosumab
40929|NCT03029442|Osteoporosis|osteoporosis
40930|NCT03029442|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
40931|NCT03029429|pseudohypoparathyroidism|pseudohypoparathyroidism
40932|NCT03029429|AHO|aho
40933|NCT03029429|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
40934|NCT03029390|Prediabetes|prediabetes
40935|NCT03029390|hyperglycemia|hyperglycemia
40936|NCT03029390|Impaired Fasting Glucose|impaired fasting glucose
40937|NCT03029390|Metformin|metformin
40938|NCT03029390|Berberine|berberine
40939|NCT03029390|glucose intolerance|glucose intolerance
40940|NCT03029377|CFS|cfs
40941|NCT03029377|Stress|stress
40942|NCT03029377|Norepinephrine Transporter (NET)|norepinephrine transporter (net)
40943|NCT03029377|Norepinephrine (NE)|norepinephrine (ne)
40944|NCT03029377|Healthy Controls|healthy controls
40945|NCT03029377|Fatigue|fatigue
40946|NCT03029364|Maximal Fat Oxidation|maximal fat oxidation
40947|NCT03029364|Exercise|exercise
40948|NCT03029364|Intra-individual variability|intra-individual variability
40949|NCT03029364|Determinants|determinants
40950|NCT03029364|Whole-body fat oxidation|whole-body fat oxidation
40951|NCT03029364|Body composition|body composition
40952|NCT03029351|albuminuria|albuminuria
40953|NCT03029351|GLP-1 Receptor Agonist|glp-1 receptor agonist
40954|NCT03029351|Type 2 Diabetes|type 2 diabetes
40955|NCT03029338|lymphoma|lymphoma
40956|NCT03029338|non-hodgkin|non-hodgkin
40957|NCT03029338|B-cell|b-cell
40958|NCT03029338|CD19 CAR T cells|cd19 car t cells
40959|NCT03029338|refractory|refractory
40960|NCT03029338|relapse|relapse
40961|NCT03029312|whole body vibration|whole body vibration
40963|NCT03029312|Physical activity|physical activity
40964|NCT03029312|bone density|bone density
40967|NCT03029247|Anemia|anemia
40968|NCT03029247|Daprodustat|daprodustat
40969|NCT03029247|Blood pressure|blood pressure
40970|NCT03029247|ESA|esa
40971|NCT03029247|CKD|ckd
40972|NCT03029208|Daprodustat, recombinant human erythropoietin, darbepoetin, anemia, chronic kidney disease, dialysis, ESRD|daprodustat, recombinant human erythropoietin, darbepoetin, anemia, chronic kidney disease, dialysis, esrd
40973|NCT03029195|cleft lip and palate|cleft lip and palate
40974|NCT03029195|nasoalveolar molding|nasoalveolar molding
40975|NCT03029195|Egyptian infants|egyptian infants
40976|NCT03029195|quantitative analysis|quantitative analysis
40977|NCT03029182|Exercise|exercise
40978|NCT03029182|Cancer|cancer
40979|NCT03029182|Obesity|obesity
40980|NCT03029169|Supraventricular Arrhythmia|supraventricular arrhythmia
40981|NCT03029169|Septic shock|septic shock
40982|NCT03029169|Propafenone|propafenone
40983|NCT03029169|Amiodarone|amiodarone
40984|NCT03029169|Intensive Care|intensive care
40985|NCT03029156|Asthma|asthma
40986|NCT03029156|Aeroneb|aeroneb
40987|NCT03029156|Aerogen|aerogen
40988|NCT03029156|Bronchodilator|bronchodilator
40989|NCT03029143|Drug Therapy|drug therapy
40990|NCT03029130|vesicovaginal fistula|vesicovaginal fistula
40991|NCT03029130|urinary catheter|urinary catheter
40992|NCT03029130|catheter extension|catheter extension
40993|NCT03029117|rheumatic pregnancy|rheumatic pregnancy
40994|NCT03029104|Keratoconus|keratoconus
40995|NCT03029104|Forme fruste keratoconus|forme fruste keratoconus
40996|NCT03029104|Post-LASIK ectasia|post-lasik ectasia
40997|NCT03029104|Pellucid marginal degeneration|pellucid marginal degeneration
40998|NCT03029104|Forme fruste pellucid marginal degeneration|forme fruste pellucid marginal degeneration
40999|NCT03029104|Diurnal fluctuation post-radial keratotomy|diurnal fluctuation post-radial keratotomy
41000|NCT03029104|Terrien's marginal degeneration|terrien's marginal degeneration
41001|NCT03029078|XDR|xdr
41002|NCT03029078|fecal microbiota transplant|fecal microbiota transplant
41003|NCT03029078|eradicate|eradicate
41004|NCT03029078|colonization|colonization
41005|NCT03029078|CRE|cre
41006|NCT03029078|GRE|gre
41007|NCT03029078|bacteria|bacteria
41008|NCT03029065|lung Adenocarcinoma with brain (meningeal) metastasis|lung adenocarcinoma with brain (meningeal) metastasis
41009|NCT03029039|Platelet|platelet
41010|NCT03029039|severe sepsis|severe sepsis
41011|NCT03029039|inflammation|inflammation
41012|NCT03029039|S. aureus|s. aureus
41013|NCT03029039|biomarkers|biomarkers
41213|NCT03027843|live birth|live birth
41018|NCT03028987|Quadrivalent, live, attenuated influenza vaccine|quadrivalent, live, attenuated influenza vaccine
41019|NCT03028987|Identical twin adults|identical twin adults
41020|NCT03028974|Inactivated influenza vaccine|inactivated influenza vaccine
41021|NCT03028974|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
41022|NCT03028974|Young children|young children
41023|NCT03028974|Adults|adults
41024|NCT03028922|creos xenogain|creos xenogain
41025|NCT03028909|Influenza A|influenza a
41026|NCT03028909|MEDI8852|medi8852
41027|NCT03028896|LMA Flexible|lma flexible
41028|NCT03028870|Osteoarthritis|osteoarthritis
41030|NCT03028870|Osteoarthritis Knee|osteoarthritis knee
41031|NCT03028844|Neonate|neonate
41032|NCT03028844|preterm|preterm
41033|NCT03028844|pain|pain
41034|NCT03028844|music|music
41035|NCT03028844|EEG|eeg
41036|NCT03028844|venepuncture|venepuncture
41037|NCT03028805|Informatics|informatics
41038|NCT03028805|COPD|copd
41039|NCT03028805|quality improvement|quality improvement
41040|NCT03028792|attention training, youth, latino|attention training, youth, latino
41041|NCT03028779|Outpatient,fast-track, arthroplasty, Total knee arthroplasty (TKA), Total hip Arthroplasty (THA)|outpatient,fast-track, arthroplasty, total knee arthroplasty (tka), total hip arthroplasty (tha)
41042|NCT03028714|University|university
41043|NCT03028714|College|college
41044|NCT03028714|University students|university students
41045|NCT03028714|Health education|health education
41046|NCT03028714|Educational techonology|educational techonology
41047|NCT03028714|Internet|internet
41048|NCT03028714|Nutrition knowledge|nutrition knowledge
41049|NCT03028714|Eating behaviour|eating behaviour
41050|NCT03028714|Diet|diet
41051|NCT03028714|Physical Activity|physical activity
41052|NCT03028714|Weight gain prevention|weight gain prevention
41053|NCT03028701|Formoterol|formoterol
41054|NCT03028701|Budesonide|budesonide
41055|NCT03028701|Dry powder inhalation|dry powder inhalation
41056|NCT03028701|Discair|discair
41057|NCT03028701|COPD|copd
41058|NCT03028662|Alcohol Dependence|alcohol dependence
41059|NCT03028662|Brain Connectivity|brain connectivity
41060|NCT03028662|Inhibition|inhibition
41061|NCT03028649|β-hydroxy-β-methylbutyric acid|β-hydroxy-β-methylbutyric acid
41062|NCT03028649|Sport supplements|sport supplements
41063|NCT03028649|Training support|training support
41064|NCT03028649|Adaptation|adaptation
41065|NCT03028636|fecal incontinence|fecal incontinence
41067|NCT03028636|accidental bowel leakage|accidental bowel leakage
41068|NCT03028636|medical device|medical device
41069|NCT03028636|women's health|women's health
41070|NCT03028636|vaginal insert|vaginal insert
41071|NCT03028636|pessary|pessary
41072|NCT03028636|incontinence|incontinence
41073|NCT03028636|bowel continence|bowel continence
41074|NCT03028636|pump|pump
41079|NCT03028584|BrCa|brca
41080|NCT03028584|PrCa|prca
41081|NCT03028584|CRCa|crca
41082|NCT03028558|Electronic Cigarettes|electronic cigarettes
41083|NCT03028558|Healthy Volunteers|healthy volunteers
41084|NCT03028558|E-Cigarettes Smokers|e-cigarettes smokers
41085|NCT03028558|E-Cigarettes|e-cigarettes
41086|NCT03028545|schizophrenia|schizophrenia
41087|NCT03028545|anorexia|anorexia
41088|NCT03028545|bipolar disorders|bipolar disorders
41089|NCT03028545|personality disorders|personality disorders
41090|NCT03028532|Healthy Volunteers|healthy volunteers
41091|NCT03028532|Sports Medicine|sports medicine
41092|NCT03028532|Anti-doping|anti-doping
41093|NCT03028532|Athletes|athletes
41094|NCT03028532|Men's Health|men's health
41095|NCT03028480|Exacerbation|exacerbation
41096|NCT03028480|Mepolizumab|mepolizumab
41097|NCT03028480|NUCALA|nucala
41098|NCT03028467|GSK3196165|gsk3196165
41099|NCT03028467|Active Rheumatoid Arthritis|active rheumatoid arthritis
41100|NCT03028467|Methotrexate|methotrexate
41101|NCT03028467|Monoclonal Antibody|monoclonal antibody
41102|NCT03028467|Efficacy|efficacy
41103|NCT03028467|Electrocardiogram|electrocardiogram
41104|NCT03028467|Tolerability|tolerability
41105|NCT03028467|Pharmacokinetics|pharmacokinetics
41106|NCT03028467|Japanese Subjects|japanese subjects
41107|NCT03028441|Chikungunya|chikungunya
41108|NCT03028441|Immunogenicity|immunogenicity
41109|NCT03028441|Measles|measles
41110|NCT03028441|Vaccine|vaccine
41111|NCT03028428|Osteoarthritis|osteoarthritis
41112|NCT03028428|Stem Cell|stem cell
41113|NCT03028428|Knee|knee
41114|NCT03028428|Mesenchymal Stem Cell|mesenchymal stem cell
41115|NCT03028389|elderly patients|elderly patients
41121|NCT03028337|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
41123|NCT03028337|Radiographic evidence of spine metastasis|radiographic evidence of spine metastasis
41124|NCT03028337|Spine radiosurgery|spine radiosurgery
41125|NCT03028337|Radiation therapy|radiation therapy
41127|NCT03028337|Questionnaires|questionnaires
41128|NCT03028337|Surveys|surveys
41130|NCT03028311|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
41131|NCT03028311|Metastatic liver tumors|metastatic liver tumors
41132|NCT03028311|SIR-Spheres treatment|sir-spheres treatment
41133|NCT03028311|90Y-radioembolization|90y-radioembolization
41134|NCT03028285|succinate|succinate
41135|NCT03028285|arginine|arginine
41136|NCT03028285|vasodilation|vasodilation
41137|NCT03028285|peripheral vascular disease|peripheral vascular disease
41138|NCT03028272|tympanic membrane perforation|tympanic membrane perforation
41139|NCT03028233|physical activity|physical activity
41140|NCT03028233|healthy eating|healthy eating
41141|NCT03028233|weight|weight
41142|NCT03028233|families|families
41143|NCT03028233|Community Health Worker|community health worker
41144|NCT03028233|childhood obesity|childhood obesity
41145|NCT03028233|built environment|built environment
41146|NCT03028207|EPI-Scan-II Study|epi-scan-ii study
41147|NCT03028207|COPD|copd
41148|NCT03028207|Epidemiology|epidemiology
41149|NCT03028207|Spain|spain
41150|NCT03028207|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
41151|NCT03028207|Prevalence|prevalence
41152|NCT03028207|Cross-sectional|cross-sectional
41153|NCT03028194|Pre-eclampsia|pre-eclampsia
41154|NCT03028194|Eclampsia|eclampsia
41155|NCT03028194|Postpartum uterine curettage|postpartum uterine curettage
41156|NCT03028181|smoke|smoke
41157|NCT03028181|acute pancreatitis|acute pancreatitis
41158|NCT03028181|pro/antioxidant status|pro/antioxidant status
41159|NCT03028181|pro-inflammatory factors|pro-inflammatory factors
41160|NCT03028181|lipid profile|lipid profile
41161|NCT03028181|exocrine functions of pancreas|exocrine functions of pancreas
41162|NCT03028168|Yôga|yôga
41163|NCT03028168|Breathing Techniques|breathing techniques
41164|NCT03028168|Heart Failure and Preserved Ejection Fraction|heart failure and preserved ejection fraction
41170|NCT03028116|vaccine|vaccine
41171|NCT03028116|1 phase|1 phase
41172|NCT03028116|safety|safety
41173|NCT03028077|ultrafiltered red ginseng|ultrafiltered red ginseng
41174|NCT03028077|hydrolyzed ginseng|hydrolyzed ginseng
41175|NCT03028077|acute respiratory illness|acute respiratory illness
41176|NCT03028077|clinical trial|clinical trial
41177|NCT03028038|Platelet-rich plasma|platelet-rich plasma
41178|NCT03028038|Rapid maxillary expansion|rapid maxillary expansion
41179|NCT03028038|Buccal bone thickness|buccal bone thickness
41180|NCT03028038|Alveolar bone loss|alveolar bone loss
41181|NCT03028038|Alveolar bone resorption|alveolar bone resorption
41182|NCT03028025|radial artery occlusion|radial artery occlusion
41183|NCT03028025|time to hemostasis|time to hemostasis
41184|NCT03028025|radial artery|radial artery
41185|NCT03028025|transradial catheterization|transradial catheterization
41186|NCT03028025|TR band|tr band
41187|NCT03028025|Statseal|statseal
41188|NCT03028025|hemostasis band|hemostasis band
41189|NCT03028025|potassium ferrate|potassium ferrate
41190|NCT03028025|percutaneous coronary intervention|percutaneous coronary intervention
41191|NCT03028012|Trigger Point Injections|trigger point injections
41192|NCT03028012|steroid|steroid
41193|NCT03028012|nsaid|nsaid
41196|NCT03027960|cardio-renal|cardio-renal
41197|NCT03027947|Phantom Limb Pain|phantom limb pain
41198|NCT03027947|Lower-Limb Amputation|lower-limb amputation
41199|NCT03027947|Electrodes|electrodes
41200|NCT03027947|Stimulation|stimulation
41201|NCT03027947|Pain|pain
41202|NCT03027947|Sensation|sensation
41203|NCT03027882|Reliability|reliability
41204|NCT03027882|Validity|validity
41205|NCT03027882|Functional Testing|functional testing
41206|NCT03027856|Percutaneous intervention (PCI)|percutaneous intervention (pci)
41207|NCT03027856|Optical coherence tomography (OCT)|optical coherence tomography (oct)
41208|NCT03027856|Bifurcation lesion|bifurcation lesion
41209|NCT03027856|Bioresorbable stents (BRS)|bioresorbable stents (brs)
41210|NCT03027843|low ovarian reserve|low ovarian reserve
41211|NCT03027843|growth hormone|growth hormone
41212|NCT03027843|embryo quality|embryo quality
41214|NCT03027843|clinical pregnancy|clinical pregnancy
41215|NCT03027830|Provisional side-branch intervention strategy|provisional side-branch intervention strategy
41217|NCT03027830|Pilot study|pilot study
41218|NCT03027817|Prone positioning|prone positioning
41219|NCT03027817|Non-invasive Cardiac Output Monitoring|non-invasive cardiac output monitoring
41220|NCT03027791|Biosensors|biosensors
41221|NCT03027791|Virtual Reality|virtual reality
41222|NCT03027791|Dietary Sodium|dietary sodium
41223|NCT03027778|arterial stiffness|arterial stiffness
41224|NCT03027778|hemodialysis|hemodialysis
41225|NCT03027778|intradialytic pedalling exercise|intradialytic pedalling exercise
41226|NCT03027778|carotid-femoral pulse wave velocity|carotid-femoral pulse wave velocity
41227|NCT03027778|chronic kidney disease|chronic kidney disease
41228|NCT03027778|hemodynamics|hemodynamics
41229|NCT03027778|augmentation index|augmentation index
41230|NCT03027752|carotid endaretectomy|carotid endaretectomy
41231|NCT03027713|NAVA: neurally adjusted ventilatory assist|nava: neurally adjusted ventilatory assist
41232|NCT03027713|Diaphragm electromyographic activity|diaphragm electromyographic activity
41233|NCT03027713|Weaning|weaning
41234|NCT03027687|Smoking|smoking
41236|NCT03027687|ERPs|erps
41237|NCT03027687|tDCS|tdcs
41238|NCT03027687|Cigarette consumption|cigarette consumption
41239|NCT03027687|Inhibitory control|inhibitory control
41240|NCT03027687|Reward processing|reward processing
41241|NCT03027674|Raynaud Phenomena|raynaud phenomena
41242|NCT03027674|System; Sclerosis|system; sclerosis
41243|NCT03027674|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
41244|NCT03027674|Ultrasound|ultrasound
41245|NCT03027674|sildenafil|sildenafil
41246|NCT03027674|Nifedipine|nifedipine
41247|NCT03027661|para-cervical block|para-cervical block
41248|NCT03027661|laparoscopic hysterectomy|laparoscopic hysterectomy
41249|NCT03027648|levonorgestrel-releasing intrauterine system|levonorgestrel-releasing intrauterine system
41250|NCT03027648|adenomyosis|adenomyosis
41251|NCT03027635|diuretic resistant ascites|diuretic resistant ascites
41252|NCT03027635|Paracentesis|paracentesis
41253|NCT03027635|PleurX|pleurx
41254|NCT03027635|Peritoneal tunnelated catheter|peritoneal tunnelated catheter
41255|NCT03027622|quality of life|quality of life
41256|NCT03027622|pericoronitis|pericoronitis
41257|NCT03027622|third molar|third molar
41258|NCT03027609|Pseudomonas aeruginosa|pseudomonas aeruginosa
41259|NCT03027609|pneumonia|pneumonia
41260|NCT03027570|Exergame|exergame
41261|NCT03027570|Cellular apps|cellular apps
41262|NCT03027570|Smartphone|smartphone
41263|NCT03027570|Overweight|overweight
41264|NCT03027570|Obesity|obesity
41265|NCT03027570|Children|children
41266|NCT03027570|Physical activity|physical activity
41267|NCT03027570|Fitness|fitness
41268|NCT03027570|Motivation|motivation
41269|NCT03027570|BMI|bmi
41270|NCT03027557|Primary Hyperparathyroidism|primary hyperparathyroidism
41271|NCT03027557|Parathyroid Adenoma|parathyroid adenoma
41272|NCT03027557|Parathyroid Hyperplasia|parathyroid hyperplasia
41273|NCT03027557|Cinacalcet|cinacalcet
41274|NCT03027557|Denosumab|denosumab
41275|NCT03027557|Drug Therapy|drug therapy
41276|NCT03027557|Bone Mineral Density|bone mineral density
41277|NCT03027557|Calcium|calcium
41278|NCT03027544|multiple brain metastases|multiple brain metastases
41279|NCT03027544|large brain metastases|large brain metastases
41280|NCT03027544|meningeal metastases|meningeal metastases
41281|NCT03027544|tomotherapy|tomotherapy
41282|NCT03027531|reproductive health, condoms, sexually transmitted diseases, contraception|reproductive health, condoms, sexually transmitted diseases, contraception
41283|NCT03027505|MUAC|muac
41284|NCT03027505|Acute malnutrition|acute malnutrition
41285|NCT03027505|RUTF|rutf
41286|NCT03027505|Children|children
41287|NCT03027505|Burkina Faso|burkina faso
41288|NCT03027492|Non-celiac Wheat Sensitivity|non-celiac wheat sensitivity
41289|NCT03027492|gynaecological disorders|gynaecological disorders
41290|NCT03027492|gluten-free diet|gluten-free diet
41291|NCT03027479|weight loss|weight loss
41292|NCT03027479|ovarian cancer|ovarian cancer
41293|NCT03027479|endometrial cancer|endometrial cancer
41294|NCT03027479|energy metabolism|energy metabolism
41295|NCT03027479|Body mass index|body mass index
41296|NCT03027479|obesity|obesity
41297|NCT03027479|muscle energy|muscle energy
41298|NCT03027466|Quitting Smoking|quitting smoking
41299|NCT03027466|Phone Application|phone application
41300|NCT03027440|Stress Response|stress response
41301|NCT03027440|Neurodevelopment|neurodevelopment
41302|NCT03027440|Biomarkers|biomarkers
41303|NCT03027440|Cohort Study|cohort study
41304|NCT03027427|Screening|screening
41305|NCT03027427|Heritable Gastric Malignancy|heritable gastric malignancy
41306|NCT03027427|Molecular Profiling|molecular profiling
41307|NCT03027427|Molecular Alterations|molecular alterations
41308|NCT03027414|Anxiety|anxiety
41309|NCT03027414|Startle|startle
41310|NCT03027414|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
41311|NCT03027414|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
41312|NCT03027414|Working Memory|working memory
41313|NCT03027401|Genetic Testing|genetic testing
41314|NCT03027401|Tumor Profiling|tumor profiling
41315|NCT03027401|Biorepository|biorepository
41316|NCT03027388|Brain Tumor|brain tumor
41621|NCT03025477|Paclitaxel|paclitaxel
41317|NCT03027388|Blood Brain Barrier|blood brain barrier
41318|NCT03027388|Pharmacokinetics|pharmacokinetics
41319|NCT03027388|Pharmacodynamics|pharmacodynamics
41320|NCT03027375|chronic heart failure|chronic heart failure
41321|NCT03027375|traditional Chinese medicine|traditional chinese medicine
41322|NCT03027375|Qishen granules|qishen granules
41323|NCT03027336|dyslipidemia|dyslipidemia
41324|NCT03027336|dietary supplement|dietary supplement
41325|NCT03027323|undifferentiated hypotension|undifferentiated hypotension
41326|NCT03027323|central venous cannulation|central venous cannulation
41327|NCT03027310|Dystonic Tremor|dystonic tremor
41328|NCT03027310|Essential Tremor|essential tremor
41329|NCT03027310|Tremor|tremor
41330|NCT03027310|Voice Tremor|voice tremor
41331|NCT03027310|Parkinson's Disease|parkinson's disease
41332|NCT03027284|Neoplasm|neoplasm
41333|NCT03027258|Mobile health technology|mobile health technology
41334|NCT03027245|locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
41335|NCT03027245|peripheral neuropathy|peripheral neuropathy
41336|NCT03027245|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
41337|NCT03027245|eribulin|eribulin
41338|NCT03027232|infection|infection
41339|NCT03027154|diagnostic test|diagnostic test
41340|NCT03027154|children|children
41341|NCT03027154|diagnosis of tuberculosis|diagnosis of tuberculosis
41342|NCT03027141|Face Transplant|face transplant
41343|NCT03027128|Phase 1|phase 1
41344|NCT03027128|Metastatic|metastatic
41345|NCT03027128|Locally Advanced|locally advanced
41346|NCT03027128|Cancer|cancer
41347|NCT03027128|Cell Therapy|cell therapy
41348|NCT03027102|allogenic double negative T cells|allogenic double negative t cells
41349|NCT03027102|DNT cells|dnt cells
41350|NCT03027089|Aspergillus-specific IgG|aspergillus-specific igg
41351|NCT03027076|prostatitis|prostatitis
41352|NCT03027076|chronic prostatitis|chronic prostatitis
41353|NCT03027076|chronic pelvic pain syndrome|chronic pelvic pain syndrome
41354|NCT03027076|interstitial cystitis|interstitial cystitis
41355|NCT03027076|painful bladder syndrome|painful bladder syndrome
41356|NCT03027076|bladder pain syndrome|bladder pain syndrome
41357|NCT03027076|biomarkers|biomarkers
41358|NCT03027076|biological markers|biological markers
41359|NCT03027076|bacteria|bacteria
41360|NCT03027076|microbiome|microbiome
41361|NCT03027076|inflammation|inflammation
41362|NCT03027063|Speckle tracking echocardiography|speckle tracking echocardiography
41363|NCT03027050|periodontitis|periodontitis
41364|NCT03027050|Growth factors|growth factors
41365|NCT03027050|Periodontal healing|periodontal healing
41366|NCT03027024|Intraocular Lens|intraocular lens
41367|NCT03027024|trifocal|trifocal
41368|NCT03027024|cataract|cataract
41369|NCT03027024|PhysIOL|physiol
41370|NCT03026998|hereditary retinoblastoma,|hereditary retinoblastoma,
41371|NCT03026998|External beam radiation therapy (EBRT)|external beam radiation therapy (ebrt)
41372|NCT03026985|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
41373|NCT03026985|Ultrasonography|ultrasonography
41374|NCT03026985|Intensive Care Units|intensive care units
41375|NCT03026972|Safety|safety
41376|NCT03026972|Tolerance|tolerance
41377|NCT03026946|Alitretinoin|alitretinoin
41378|NCT03026946|Cyclosporine A|cyclosporine a
41379|NCT03026946|Hand eczema|hand eczema
41380|NCT03026920|Fracture|fracture
41381|NCT03026920|outcome|outcome
41383|NCT03026920|acetabular|acetabular
41384|NCT03026907|Alitretinoin|alitretinoin
41385|NCT03026907|Azathioprine|azathioprine
41386|NCT03026907|Hand eczema|hand eczema
41387|NCT03026881|PARP inhibitor|parp inhibitor
41388|NCT03026881|VEGFR inhibitor|vegfr inhibitor
41389|NCT03026881|Combination therapy|combination therapy
41390|NCT03026881|Gastric cancer|gastric cancer
41391|NCT03026868|acetabular|acetabular
41392|NCT03026868|quadrilateral surface plate|quadrilateral surface plate
41393|NCT03026855|Autologous PRP|autologous prp
41394|NCT03026855|Non-healing ulcer|non-healing ulcer
41395|NCT03026855|Point-of-care|point-of-care
41396|NCT03026829|Sound therapy|sound therapy
41397|NCT03026829|Tinnitus relief|tinnitus relief
41398|NCT03026816|epidural stimulation|epidural stimulation
41399|NCT03026816|spinal cord stimulation|spinal cord stimulation
41400|NCT03026816|autonomic dysfunction|autonomic dysfunction
41401|NCT03026790|Opioid analgesics|opioid analgesics
41402|NCT03026790|Opioid partial agonists|opioid partial agonists
41403|NCT03026790|Health care delivery|health care delivery
41404|NCT03026790|Back pain|back pain
41405|NCT03026790|Osteoarthritis|osteoarthritis
41406|NCT03026790|Veterans health|veterans health
41407|NCT03026764|cost|cost
41408|NCT03026764|total hip replacement|total hip replacement
41409|NCT03026764|outpatient Surgery|outpatient surgery
41410|NCT03026764|satisfaction|satisfaction
41411|NCT03026764|arthroplasty|arthroplasty
41412|NCT03026725|tooth sensitivity|tooth sensitivity
41413|NCT03026725|tri calcium phosphate|tri calcium phosphate
41414|NCT03026725|at-home whitening|at-home whitening
41415|NCT03026712|Robotic therapy|robotic therapy
41416|NCT03026712|tDCS|tdcs
41417|NCT03026712|non invasive electrical stimulation|non invasive electrical stimulation
41418|NCT03026712|ArmeoPower|armeopower
41419|NCT03026712|interhemispheric balance|interhemispheric balance
41420|NCT03026699|Brain|brain
41421|NCT03026699|Nervous system|nervous system
41422|NCT03026699|Neuro-oncology|neuro-oncology
41423|NCT03026699|Caregivers|caregivers
41424|NCT03026699|Cancer patient|cancer patient
41425|NCT03026699|Family caregivers|family caregivers
41426|NCT03026699|Brain tumors|brain tumors
41427|NCT03026699|Quality of life|quality of life
41428|NCT03026699|Stress|stress
41429|NCT03026699|Social support|social support
41430|NCT03026699|Feasibility|feasibility
41431|NCT03026699|Electronic Social Network Assessment Program (eSNAP)|electronic social network assessment program (esnap)
41432|NCT03026660|Moringa Oleifera|moringa oleifera
41433|NCT03026634|Sleep-Disordered Breathing|sleep-disordered breathing
41434|NCT03026634|Heart Failure|heart failure
41435|NCT03026634|Heart Transplantation|heart transplantation
41436|NCT03026569|orange juice|orange juice
41437|NCT03026569|chronic hepatitis C|chronic hepatitis c
41438|NCT03026569|biochemical markers|biochemical markers
41439|NCT03026569|oxidative stress|oxidative stress
41440|NCT03026569|nutritional status|nutritional status
41441|NCT03026569|antioxidants|antioxidants
41442|NCT03026517|Phenformin|phenformin
41443|NCT03026517|Dabrafenib|dabrafenib
45713|NCT02999906|PAH|pah
41444|NCT03026517|Trametinib|trametinib
41446|NCT03026517|15-318|15-318
41447|NCT03026478|oral lichen planus|oral lichen planus
41448|NCT03026478|betamethasone|betamethasone
41449|NCT03026478|clobetasol|clobetasol
41450|NCT03026478|orabase|orabase
41451|NCT03026439|mild COPD|mild copd
41452|NCT03026439|early COPD|early copd
41453|NCT03026439|six-min walk test|six-min walk test
41454|NCT03026439|computed tomography|computed tomography
41455|NCT03026439|emphysema|emphysema
41456|NCT03026439|airway disease|airway disease
41457|NCT03026439|peripheral muscle mass|peripheral muscle mass
41458|NCT03026439|Saint George's Respiratory Questionnaire|saint george's respiratory questionnaire
41459|NCT03026426|Depression|depression
41460|NCT03026426|Chronic diseases|chronic diseases
41461|NCT03026426|Mobile technology|mobile technology
41462|NCT03026426|Clinical trial|clinical trial
41463|NCT03026413|atrial fibrillation|atrial fibrillation
41464|NCT03026413|pulmonary vein isolation|pulmonary vein isolation
41465|NCT03026413|Contact Force|contact force
41466|NCT03026413|antrum|antrum
41467|NCT03026387|Suicidal behavior|suicidal behavior
41468|NCT03026387|Suicide attempt|suicide attempt
41469|NCT03026387|Emergency department|emergency department
41470|NCT03026387|Psychometrics|psychometrics
41471|NCT03026387|Neuropsychological tests|neuropsychological tests
41472|NCT03026387|Suicidal ideation|suicidal ideation
41473|NCT03026374|psychosocial support|psychosocial support
41474|NCT03026374|resilience|resilience
41475|NCT03026374|metastatic breast cancer|metastatic breast cancer
41476|NCT03026374|survival|survival
41477|NCT03026374|Quality of Life|quality of life
41478|NCT03026348|RSV|rsv
41479|NCT03026335|Positive Youth Development|positive youth development
41480|NCT03026296|Physical Fitness|physical fitness
41481|NCT03026296|Health Status|health status
41482|NCT03026296|Exercise|exercise
41483|NCT03026296|Tobacco Use Cessation|tobacco use cessation
41484|NCT03026296|Quality of Life|quality of life
41485|NCT03026296|Healthy Diet|healthy diet
41486|NCT03026296|Health Promotion|health promotion
41487|NCT03026296|Patient Education as Topic|patient education as topic
41488|NCT03026296|Counseling|counseling
41489|NCT03026270|Physiotherapy|physiotherapy
41490|NCT03026270|Paraffin|paraffin
41491|NCT03026270|Burn|burn
41492|NCT03026270|Contracture|contracture
41493|NCT03026244|Immunity|immunity
41494|NCT03026244|Elderly|elderly
41495|NCT03026244|Inflammation|inflammation
41496|NCT03026244|Milk protein|milk protein
41497|NCT03026244|Prebiotics|prebiotics
41498|NCT03026231|Fecal microbiota transplantation|fecal microbiota transplantation
41499|NCT03026166|Nivolumab|nivolumab
41500|NCT03026166|Rovalpituzumab tesirine|rovalpituzumab tesirine
41501|NCT03026166|Cancer|cancer
41502|NCT03026166|Ipilimumab|ipilimumab
41503|NCT03026166|Extensive-Stage Small Cell Lung Cancer|extensive-stage small cell lung cancer
41504|NCT03026140|MSI tumors|msi tumors
41505|NCT03026140|MSS tumors|mss tumors
41506|NCT03026140|short-term immunotherapy|short-term immunotherapy
41507|NCT03026140|surgical resection|surgical resection
41508|NCT03026140|nivolumab|nivolumab
41509|NCT03026140|ipilimumab|ipilimumab
41510|NCT03026127|Suicide|suicide
41511|NCT03026127|Middle-aged and Older Adults|middle-aged and older adults
41512|NCT03026127|Cognitive Reappraisal|cognitive reappraisal
41513|NCT03026127|Emotion Regulation|emotion regulation
41514|NCT03026088|Chronic Heart Failure|chronic heart failure
41515|NCT03026088|Bisoprolol|bisoprolol
41516|NCT03026088|Heart rate control|heart rate control
41517|NCT03026062|Recurrent Platinum-Resistant Epithelial Ovarian Cancer|recurrent platinum-resistant epithelial ovarian cancer
41518|NCT03026062|Ovarian Cancer|ovarian cancer
41519|NCT03026062|epithelial ovarian cancer|epithelial ovarian cancer
41520|NCT03026036|Depression|depression
41522|NCT03026036|PET|pet
41523|NCT03026036|Reward|reward
41524|NCT03026023|Heart Transplant|heart transplant
41525|NCT03026023|Cardiac Transplant|cardiac transplant
41526|NCT03026023|Hepatitis C|hepatitis c
41527|NCT03026023|Zepatier|zepatier
41528|NCT03025971|Severe Aortic Stenosis and/or severe aortic regurgitation|severe aortic stenosis and/or severe aortic regurgitation
41529|NCT03025919|Advanced glycation end-product|advanced glycation end-product
41530|NCT03025919|Glycosuria|glycosuria
41531|NCT03025893|Sunitinib|sunitinib
41532|NCT03025893|Lomustine|lomustine
41533|NCT03025893|High-dose|high-dose
41534|NCT03025893|Intermittent|intermittent
41535|NCT03025880|Advanced Breast Cancer|advanced breast cancer
41536|NCT03025880|Pembrolizumab|pembrolizumab
41537|NCT03025880|HER2-negative|her2-negative
41538|NCT03025828|Membranous nephropathy|membranous nephropathy
41539|NCT03025828|adrenocorticotropic hormone|adrenocorticotropic hormone
41541|NCT03025828|proteinuria|proteinuria
41542|NCT03025828|glomerulonephritis|glomerulonephritis
41543|NCT03025815|Infant, Premature|infant, premature
41544|NCT03025802|Molecular diagnosis|molecular diagnosis
45877|NCT02998918|HDL|hdl
41545|NCT03025802|Pathogen identification|pathogen identification
41546|NCT03025802|Sepsis|sepsis
41547|NCT03025802|Bacteremia|bacteremia
41548|NCT03025802|Rapid diagnostics|rapid diagnostics
41549|NCT03025789|T.b gambiense|t.b gambiense
41550|NCT03025789|HAT|hat
41551|NCT03025789|outpatients|outpatients
41552|NCT03025763|Craniosynostosis|craniosynostosis
41553|NCT03025763|Bone|bone
41554|NCT03025763|Birth Defect|birth defect
41555|NCT03025763|Congenital Anomaly|congenital anomaly
41556|NCT03025763|Malformation|malformation
41557|NCT03025763|Genetics|genetics
41558|NCT03025763|Genomics|genomics
41559|NCT03025763|Skull|skull
41560|NCT03025763|Human|human
41561|NCT03025763|Mouse|mouse
41562|NCT03025763|Imaging|imaging
41563|NCT03025763|Cell Biology|cell biology
41564|NCT03025763|Induced Pluripotent Stem Cells|induced pluripotent stem cells
41565|NCT03025763|System Biology|system biology
41566|NCT03025737|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
41567|NCT03025737|Ventricular Remodeling|ventricular remodeling
41568|NCT03025711|Advanced HER2+ breast cancer|advanced her2+ breast cancer
41569|NCT03025711|Pertuzumab|pertuzumab
41570|NCT03025711|Trastuzumab emtansine|trastuzumab emtansine
41571|NCT03025711|Compassionate use|compassionate use
41572|NCT03025711|Early access program|early access program
41573|NCT03025711|Effectiveness|effectiveness
41574|NCT03025711|Safety|safety
41575|NCT03025698|Eltrombopag|eltrombopag
41576|NCT03025698|hATG|hatg
41577|NCT03025698|CsA|csa
41578|NCT03025698|previously untreated or relapsed severe aplastic anemia|previously untreated or relapsed severe aplastic anemia
41579|NCT03025698|recurrent aplastic anemia|recurrent aplastic anemia
41580|NCT03025698|Severe aplastic anemia|severe aplastic anemia
41581|NCT03025698|Pharmacokinetics|pharmacokinetics
41582|NCT03025698|Immunosuppressive therapy|immunosuppressive therapy
41583|NCT03025698|ETB115|etb115
41584|NCT03025685|Percutaneous Coronary Intervention|percutaneous coronary intervention
41585|NCT03025685|Coronary Artery Disease|coronary artery disease
41586|NCT03025685|Wire|wire
41587|NCT03025685|Coronary stenting|coronary stenting
41588|NCT03025659|pediatric|pediatric
41589|NCT03025659|congenital heart disease|congenital heart disease
41590|NCT03025646|Maternal depression|maternal depression
41591|NCT03025646|ASD|asd
41592|NCT03025646|Home based training program|home based training program
41593|NCT03025633|PEARL|pearl
41594|NCT03025620|Alphalinolenic acid|alphalinolenic acid
41595|NCT03025620|Lipid cardiovascular risk factors|lipid cardiovascular risk factors
41596|NCT03025620|Inflammation|inflammation
41597|NCT03025607|Prevention|prevention
41598|NCT03025607|Mobile health|mobile health
41599|NCT03025607|Autonomous motivation|autonomous motivation
41600|NCT03025594|Paralytic sellfish toxins|paralytic sellfish toxins
41601|NCT03025594|Gonyautoxin|gonyautoxin
41602|NCT03025594|Post surgery pain management|post surgery pain management
41603|NCT03025594|total knee arthroplasty|total knee arthroplasty
41604|NCT03025568|nylon|nylon
41605|NCT03025568|polyamide|polyamide
41606|NCT03025568|denture base|denture base
41607|NCT03025555|nylon|nylon
41608|NCT03025555|polyamide|polyamide
41609|NCT03025555|PEEK|peek
41610|NCT03025555|partial denture|partial denture
41611|NCT03025542|Psoriasis|psoriasis
41612|NCT03025542|Chronic Plaque Psoriasis|chronic plaque psoriasis
41613|NCT03025542|Bimekizumab|bimekizumab
41614|NCT03025490|Capnography|capnography
41615|NCT03025490|Electrophysiology|electrophysiology
41616|NCT03025477|Intraperitoneal|intraperitoneal
41617|NCT03025477|Intravenous|intravenous
41618|NCT03025477|Completeness of cytoreduction score|completeness of cytoreduction score
41619|NCT03025477|Carboplatin|carboplatin
41620|NCT03025477|Epirubicin|epirubicin
41622|NCT03025477|Cisplatin|cisplatin
41623|NCT03025451|nutrition|nutrition
41624|NCT03025451|exercise|exercise
41625|NCT03025451|stress|stress
41626|NCT03025451|gender|gender
41627|NCT03025451|age|age
41628|NCT03025451|community support|community support
41629|NCT03025451|cardiovascular disease|cardiovascular disease
41630|NCT03025451|diabetes|diabetes
41631|NCT03025451|hypertension|hypertension
41632|NCT03025451|dyslipidemia|dyslipidemia
41633|NCT03025451|cholesterol|cholesterol
41634|NCT03025451|overweight|overweight
41635|NCT03025451|obesity|obesity
41636|NCT03025451|lifestyle|lifestyle
41637|NCT03025438|angiosarcoma|angiosarcoma
41638|NCT03025438|Cytology|cytology
41639|NCT03025438|liver|liver
41640|NCT03025438|cancer|cancer
41641|NCT03025412|Achilles Tendon|achilles tendon
41642|NCT03025412|Endoscopy|endoscopy
41643|NCT03025412|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
41644|NCT03025412|Exercise therapy|exercise therapy
41645|NCT03025399|tang wang prescription|tang wang prescription
41647|NCT03025321|tDCS|tdcs
41648|NCT03025321|EMA|ema
41649|NCT03025321|Inhibitory control|inhibitory control
41650|NCT03025321|Reward processing|reward processing
41651|NCT03025321|Addiction|addiction
41652|NCT03025321|dlPFC|dlpfc
41653|NCT03025321|craving|craving
41654|NCT03025321|cognitive control|cognitive control
41655|NCT03025256|Melanoma and other malignant neoplasms of skin|melanoma and other malignant neoplasms of skin
41656|NCT03025256|Leptomeningeal disease|leptomeningeal disease
41657|NCT03025256|LMD|lmd
41658|NCT03025256|Nivolumab|nivolumab
41659|NCT03025256|BMS-936558|bms-936558
41660|NCT03025256|Opdivo|opdivo
41661|NCT03025243|computer aided design , dental implants , accuracy|computer aided design , dental implants , accuracy
41662|NCT03025204|Regeneration Procedures|regeneration procedures
41663|NCT03025204|Intrabony Defects|intrabony defects
41664|NCT03025204|Cronic Periodontitis|cronic periodontitis
41665|NCT03025191|incarceration|incarceration
41666|NCT03025191|HIV|hiv
41667|NCT03025152|Hou Gu Mi Xi|hou gu mi xi
41668|NCT03025152|Shen Ling Bai Zhu San|shen ling bai zhu san
41669|NCT03025152|radical gastrectomy|radical gastrectomy
41670|NCT03025152|gastric cancer|gastric cancer
41671|NCT03025152|traditional Chinese medicine|traditional chinese medicine
41672|NCT03025152|randomized controlled trial|randomized controlled trial
41673|NCT03025139|breast cancer|breast cancer
41674|NCT03025139|younger women|younger women
41675|NCT03025139|education|education
41676|NCT03025139|mindfulness meditation|mindfulness meditation
41677|NCT03025139|depression|depression
41678|NCT03025139|cancer survivor|cancer survivor
41679|NCT03025074|Liver Disease|liver disease
41680|NCT03025074|Obesity|obesity
41681|NCT03025074|Hepatitis|hepatitis
41682|NCT03025074|HIV|hiv
41683|NCT03025074|Hepatology|hepatology
41684|NCT03025061|Breath pattern|breath pattern
41685|NCT03025061|Children|children
41686|NCT03025061|Repeatability|repeatability
41687|NCT03025035|BRCA-mutation|brca-mutation
41688|NCT03025035|Immune checkpoint inhibition|immune checkpoint inhibition
41689|NCT03025035|Immunotherapy|immunotherapy
41690|NCT03025035|Advanced BRCA-mutated breast cancer|advanced brca-mutated breast cancer
41691|NCT03024957|morphine|morphine
41692|NCT03024957|dexmedetomidine|dexmedetomidine
41693|NCT03024957|immune system|immune system
41694|NCT03024944|Diabetes Mellitus|diabetes mellitus
41695|NCT03024944|Alzheimer's Disease|alzheimer's disease
41696|NCT03024944|Dementia|dementia
41697|NCT03024944|THK|thk
41698|NCT03024918|monochorionic|monochorionic
41699|NCT03024918|placental sharing|placental sharing
41700|NCT03024892|Fluorenscent image guided surgery|fluorenscent image guided surgery
41701|NCT03024892|indocyanide green|indocyanide green
41702|NCT03024892|laparoscopic cholecystectomy|laparoscopic cholecystectomy
41703|NCT03024892|common bile duct injury|common bile duct injury
41704|NCT03024879|Motilin|motilin
41705|NCT03024879|Erythromycin|erythromycin
41706|NCT03024879|Food intake|food intake
41707|NCT03024853|Best Possible Self|best possible self
41708|NCT03024853|Positive Intervention|positive intervention
41709|NCT03024853|Optimism|optimism
41710|NCT03024840|Propofol|propofol
41711|NCT03024840|Neurocognitive Disorders|neurocognitive disorders
41712|NCT03024840|Liver transplantation|liver transplantation
41713|NCT03024840|Pediatrics|pediatrics
41714|NCT03024840|Brain Injuries|brain injuries
41715|NCT03024827|Infantile Spasms|infantile spasms
41716|NCT03024827|Lennox Gastaut Syndrome|lennox gastaut syndrome
41717|NCT03024827|Doose Syndrome|doose syndrome
41718|NCT03024827|Continuous Spike Wave in Sleep|continuous spike wave in sleep
41719|NCT03024827|Landau-Kleffner Syndrome|landau-kleffner syndrome
41720|NCT03024827|Dravet Syndrome|dravet syndrome
41721|NCT03024827|Malignant Migrating Partial Seizures of Infancy (MMPSI)|malignant migrating partial seizures of infancy (mmpsi)
41722|NCT03024788|Glycosylated haemoglobin|glycosylated haemoglobin
41723|NCT03024788|advanced glycation end products|advanced glycation end products
41724|NCT03024775|Non-celiac Wheat Sensitivity|non-celiac wheat sensitivity
41725|NCT03024775|ancient wheats|ancient wheats
41726|NCT03024775|modern wheats|modern wheats
41727|NCT03024775|ATIs|atis
41728|NCT03024749|Spinal Arteriovenous Malformation|spinal arteriovenous malformation
41729|NCT03024749|Spinal Arteriovenous Fistula|spinal arteriovenous fistula
41730|NCT03024723|Obese patient|obese patient
41731|NCT03024723|nasal CPAP|nasal cpap
41732|NCT03024710|Stunting|stunting
41733|NCT03024710|complementary feeding Index|complementary feeding index
41734|NCT03024710|Bangladesh|bangladesh
41735|NCT03024697|Breast surgery|breast surgery
41736|NCT03024697|Pectoral plane block|pectoral plane block
41737|NCT03024697|PECs|pecs
41738|NCT03024697|Local anaesthesia infusion|local anaesthesia infusion
41739|NCT03024697|Analgesia|analgesia
41740|NCT03024684|Hepatocellular carcinoma|hepatocellular carcinoma
41741|NCT03024684|statin|statin
41742|NCT03024684|curative ablation|curative ablation
41743|NCT03024658|Pulmonary artery systolic pressure|pulmonary artery systolic pressure
41744|NCT03024658|Positive end expiratory pressure|positive end expiratory pressure
33289|NCT03077841|Shorter course|shorter course
41745|NCT03024658|morbidly obese|morbidly obese
41746|NCT03024658|laparoscopic bariatric surgery|laparoscopic bariatric surgery
41747|NCT03024645|Postpartum Depression|postpartum depression
41748|NCT03024645|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
41749|NCT03024645|Prevention|prevention
41750|NCT03024645|Web-Based Psychological Intervention|web-based psychological intervention
41751|NCT03024593|Cyberchondria|cyberchondria
41752|NCT03024593|health-related internet use|health-related internet use
41753|NCT03024593|pathological health anxiety|pathological health anxiety
41754|NCT03024580|Megestrol Acetate|megestrol acetate
41755|NCT03024580|Steroid, Receptors|steroid, receptors
41756|NCT03024567|Calorimetry|calorimetry
41757|NCT03024567|Blood pressure|blood pressure
41758|NCT03024567|Immunophenotyping|immunophenotyping
41759|NCT03024567|Gut microbial composition|gut microbial composition
41760|NCT03024554|aortic aneurysm involving iliac arteries|aortic aneurysm involving iliac arteries
41761|NCT03024554|abdominal aortic aneurysm|abdominal aortic aneurysm
41762|NCT03024554|MFM|mfm
41763|NCT03024554|Multilayer Flow Modulator|multilayer flow modulator
41764|NCT03024554|Multilayer Stent|multilayer stent
41765|NCT03024528|Pain|pain
41766|NCT03024528|CPOT|cpot
41767|NCT03024528|ICU Delirium|icu delirium
41768|NCT03024528|Critical Care Pain Observation Tool|critical care pain observation tool
41769|NCT03024528|NRS|nrs
41770|NCT03024528|Behaviour|behaviour
41771|NCT03024528|Critical care|critical care
41772|NCT03024528|Intensive Care|intensive care
41773|NCT03024502|vulvovaginal candidiasis|vulvovaginal candidiasis
41774|NCT03024502|EPPAF mucoadhesive gel|eppaf mucoadhesive gel
41775|NCT03024502|clotrimazol|clotrimazol
41776|NCT03024489|Phase I/II|phase i/ii
41777|NCT03024476|behavioral intervention|behavioral intervention
41778|NCT03024476|prespecified medication algorithm|prespecified medication algorithm
41779|NCT03024476|bluetooth-equipped sphygmomanometer|bluetooth-equipped sphygmomanometer
41780|NCT03024450|Gastric cancer|gastric cancer
41781|NCT03024450|HER2|her2
41782|NCT03024450|trastuzumab|trastuzumab
41783|NCT03024450|prognosis|prognosis
41784|NCT03024437|PD-L1 inhibitor|pd-l1 inhibitor
41785|NCT03024359|Obesity|obesity
41786|NCT03024359|Brown adipose tissue|brown adipose tissue
41787|NCT03024359|Monounsaturated fatty acids|monounsaturated fatty acids
41790|NCT03024333|Swallowing Sound|swallowing sound
41791|NCT03024333|Acoustic Analysis|acoustic analysis
41792|NCT03024307|Pharmaceutical Care|pharmaceutical care
41793|NCT03024307|Medication Adherence|medication adherence
41795|NCT03024281|Aspergillus|aspergillus
41796|NCT03024281|Antifungal susceptibility|antifungal susceptibility
41797|NCT03024281|Azole resistance|azole resistance
41798|NCT03024255|sweat gland disease|sweat gland disease
41799|NCT03024255|sweating|sweating
41800|NCT03024255|underarm|underarm
41801|NCT03024190|stroke|stroke
41802|NCT03024190|spasticity|spasticity
41803|NCT03024190|Kinesiotaping|kinesiotaping
41804|NCT03024190|sonography|sonography
41805|NCT03024190|exercise|exercise
41806|NCT03024177|Human rhinovirus|human rhinovirus
41807|NCT03024177|HRV|hrv
41808|NCT03024177|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
41809|NCT03024177|HSCT|hsct
41810|NCT03024177|Antiviral|antiviral
41811|NCT03024177|vapendavir|vapendavir
41812|NCT03024177|Allogeneic|allogeneic
41813|NCT03024177|Autologous|autologous
41814|NCT03024164|youth; etiology; prognosis; recurrence; biomarkers|youth; etiology; prognosis; recurrence; biomarkers
41815|NCT03024125|lean mass|lean mass
41816|NCT03024125|postmenopausal|postmenopausal
41818|NCT03024099|hippotherapy Gross Motor Function Functional performance.|hippotherapy gross motor function functional performance.
41819|NCT03024060|Actinic Keratosis|actinic keratosis
41820|NCT03024021|therapeutic hypothermia|therapeutic hypothermia
41821|NCT03024021|targeted temperature management|targeted temperature management
41822|NCT03024021|neurological outcome|neurological outcome
41823|NCT03024021|post-cardiac arrest syndrome|post-cardiac arrest syndrome
42028|NCT03022552|Genomics|genomics
41824|NCT03024008|Critical Gap|critical gap
41825|NCT03024008|Comminuted Fracture|comminuted fracture
41826|NCT03024008|Extra-Articular|extra-articular
41827|NCT03023930|Opioid Use Disorder|opioid use disorder
41828|NCT03023917|jaundice,complication|jaundice,complication
41829|NCT03023891|glucocorticoids|glucocorticoids
41830|NCT03023891|efficacy|efficacy
41831|NCT03023891|metabolic toxicity|metabolic toxicity
41832|NCT03023865|Long gap esophageal atresia|long gap esophageal atresia
41833|NCT03023839|Delirium|delirium
41834|NCT03023839|Trauma|trauma
41835|NCT03023839|Injury|injury
41836|NCT03023839|restraints|restraints
41837|NCT03023761|Endodontic retreatments|endodontic retreatments
41838|NCT03023761|Low level laser|low level laser
41839|NCT03023761|Pain|pain
41840|NCT03023748|activated vitamin D treatment|activated vitamin d treatment
41841|NCT03023709|Quadrivalent inactivated influenza vaccine|quadrivalent inactivated influenza vaccine
41842|NCT03023709|Quadrivalent live, attenuated influenza vaccine|quadrivalent live, attenuated influenza vaccine
41843|NCT03023709|Adults with obstructive sleep apnea|adults with obstructive sleep apnea
41844|NCT03023696|C5 Palsy|c5 palsy
41845|NCT03023683|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
41846|NCT03023683|Children and young adults|children and young adults
41847|NCT03023670|Lung|lung
41848|NCT03023670|Cardiopulmonary Bypass|cardiopulmonary bypass
41849|NCT03023670|Pediatric|pediatric
41850|NCT03023670|Cardiac surgery|cardiac surgery
41851|NCT03023657|arousal|arousal
41852|NCT03023657|Consciousness Disorders|consciousness disorders
41853|NCT03023657|vegetative state|vegetative state
41854|NCT03023657|minimally conscious state|minimally conscious state
41855|NCT03023644|Congenital Heart Disease|congenital heart disease
41856|NCT03023644|Neurodevelopmental Disorders|neurodevelopmental disorders
41857|NCT03023644|Children|children
41858|NCT03023644|Executive Function|executive function
41859|NCT03023644|Working Memory|working memory
41860|NCT03023644|Cognitive interventions|cognitive interventions
41861|NCT03023644|Infant Open Heart Surgery|infant open heart surgery
41862|NCT03023631|GARDASIL 9|gardasil 9
41863|NCT03023631|Post allogeneic stem cell transplantation|post allogeneic stem cell transplantation
41864|NCT03023631|HPV infection prevention|hpv infection prevention
41865|NCT03023618|[G09.330.380]|[g09.330.380]
41866|NCT03023605|Pulmonary embolism|pulmonary embolism
41867|NCT03023605|Adherence to practice guidelines|adherence to practice guidelines
41868|NCT03023605|Age-adjusted D-dimer|age-adjusted d-dimer
41869|NCT03023605|Clinical prediction rules|clinical prediction rules
41870|NCT03023605|Elderly patients|elderly patients
41871|NCT03023592|Sjogren's Syndrome|sjogren's syndrome
41872|NCT03023592|Iguratimod|iguratimod
41873|NCT03023566|Dotarem|dotarem
41874|NCT03023566|MRI|mri
41875|NCT03023566|pediatric|pediatric
41876|NCT03023566|safety|safety
41877|NCT03023566|efficacy|efficacy
41878|NCT03023553|Trivalent, inactivated influenza vaccine|trivalent, inactivated influenza vaccine
41879|NCT03023553|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
41880|NCT03023553|Nasopharyngeal swabs|nasopharyngeal swabs
41881|NCT03023553|Young adults|young adults
41882|NCT03023540|Charcot Marie Tooth Type 1A|charcot marie tooth type 1a
41883|NCT03023540|Peripheral neuropathy|peripheral neuropathy
41884|NCT03023540|PXT3003|pxt3003
41885|NCT03023527|Refractory|refractory
41886|NCT03023527|Relapsed|relapsed
41887|NCT03023527|Nivolumab|nivolumab
41888|NCT03023514|Oocyte donation|oocyte donation
41889|NCT03023514|IVF|ivf
41890|NCT03023514|Lipoic acid|lipoic acid
41891|NCT03023514|Implantation rate|implantation rate
41892|NCT03023514|Endometrial receptivity|endometrial receptivity
41893|NCT03023488|flexible ureteroscopy|flexible ureteroscopy
41894|NCT03023488|blood flow|blood flow
41895|NCT03023436|Stomach Neoplasms|stomach neoplasms
41896|NCT03023436|Cytoreduction Surgical Procedures|cytoreduction surgical procedures
41897|NCT03023410|Revision TKA|revision tka
41898|NCT03023410|Instability|instability
41899|NCT03023410|Stiffness|stiffness
41900|NCT03023410|Aseptic Loosening|aseptic loosening
41901|NCT03023410|Polyethylene Wear|polyethylene wear
41902|NCT03023410|Malrotation|malrotation
41903|NCT03023410|Soft Tissue Imbalance|soft tissue imbalance
41904|NCT03023397|E-cig smokers|e-cig smokers
41905|NCT03023384|Acute Myeloid Leukemia|acute myeloid leukemia
41906|NCT03023384|Chemotherapy|chemotherapy
41907|NCT03023384|Autologous Stem Cell Transplantation|autologous stem cell transplantation
41908|NCT03023384|Developing country|developing country
41909|NCT03023384|Clinical network|clinical network
41910|NCT03023371|Registry; cohort study; IgG4-related disease|registry; cohort study; igg4-related disease
41911|NCT03023358|peripheral T cell lymphoma|peripheral t cell lymphoma
41912|NCT03023345|cancer|cancer
41913|NCT03023345|prostate|prostate
41914|NCT03023345|PSA|psa
41915|NCT03023345|biopsies|biopsies
41916|NCT03023345|microwave trans rectal focal treatment|microwave trans rectal focal treatment
41917|NCT03023332|Caregiver|caregiver
41918|NCT03023332|Biofeedback|biofeedback
41919|NCT03023332|Resourcefulness|resourcefulness
41920|NCT03023332|Self-Management|self-management
41921|NCT03023293|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
41922|NCT03023293|irisin|irisin
41923|NCT03023241|BPS/IC|bps/ic
41924|NCT03023241|OAB|oab
41925|NCT03023228|Diabetes mellitus|diabetes mellitus
41926|NCT03023228|Hyperglycemia|hyperglycemia
41927|NCT03023228|Inpatient|inpatient
41928|NCT03023228|self-management education|self-management education
41929|NCT03023215|Meditation|meditation
41930|NCT03023215|Breast Biopsy|breast biopsy
41931|NCT03023215|Stereotactic Breast Biopsy|stereotactic breast biopsy
41932|NCT03023215|SBB|sbb
41933|NCT03023215|Guided meditation|guided meditation
41934|NCT03023215|Focused breathing|focused breathing
41935|NCT03023215|Electroencephalogram|electroencephalogram
41936|NCT03023215|EEG|eeg
41937|NCT03023215|Heart rate|heart rate
41938|NCT03023215|HR|hr
41939|NCT03023215|Questionnaires|questionnaires
41940|NCT03023215|Surveys|surveys
41941|NCT03023189|Upper digestive bleeding|upper digestive bleeding
41942|NCT03023189|Haemorrhage|haemorrhage
41943|NCT03023189|Cirrhosis|cirrhosis
41944|NCT03023189|Portal hypertension|portal hypertension
41945|NCT03023189|Antifibrinolytic|antifibrinolytic
41946|NCT03023189|Tranexamic acid|tranexamic acid
41947|NCT03023189|Emergency|emergency
41948|NCT03023176|Trivalent, inactivated influenza vaccine|trivalent, inactivated influenza vaccine
41949|NCT03023176|Child identical twins|child identical twins
41950|NCT03023176|Child fraternal twins|child fraternal twins
41951|NCT03023163|autonomic dysreflexia|autonomic dysreflexia
41952|NCT03023163|baroreceptor integrity|baroreceptor integrity
41953|NCT03023163|sympathetic integrity|sympathetic integrity
41954|NCT03023163|vagal integrity|vagal integrity
41955|NCT03023163|autonomic integrity|autonomic integrity
41956|NCT03023163|arterial stiffness|arterial stiffness
41957|NCT03023163|cognitive function|cognitive function
41958|NCT03023163|traumatic brain injury|traumatic brain injury
41959|NCT03023163|cerebral blood flow|cerebral blood flow
41960|NCT03023163|white matter hyperintensities|white matter hyperintensities
41961|NCT03023163|cerebral vascular resistance index|cerebral vascular resistance index
41962|NCT03023137|prevention|prevention
41963|NCT03023137|carbohydrate|carbohydrate
41964|NCT03023137|exercise|exercise
41965|NCT03023137|neonatal hypoglycemia|neonatal hypoglycemia
41966|NCT03023111|Cutaneous leishmaniasis|cutaneous leishmaniasis
41967|NCT03023111|miltefosine|miltefosine
41968|NCT03023111|cytokines|cytokines
41969|NCT03023111|treatment|treatment
41970|NCT03023098|Restenosis|restenosis
41971|NCT03023098|Drug-eluting balloon|drug-eluting balloon
41972|NCT03023098|Vein graft|vein graft
41973|NCT03023059|L-DOPA|l-dopa
41974|NCT03023059|GPR143|gpr143
41975|NCT03023059|PEDF|pedf
41976|NCT03023059|VEGF|vegf
41977|NCT03023033|PMTCT|pmtct
41978|NCT03023033|MNCH|mnch
41979|NCT03023020|Dual Antiplatelet Therapy|dual antiplatelet therapy
41980|NCT03022994|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
41981|NCT03022994|eosinophils|eosinophils
41982|NCT03022994|lymphocytes|lymphocytes
41983|NCT03022994|duodenal biopsies|duodenal biopsies
41990|NCT03022825|non-muscle invasive|non-muscle invasive
41991|NCT03022812|Neck pain|neck pain
41992|NCT03022812|Rehabilitation|rehabilitation
41993|NCT03022812|Exercise Therapy|exercise therapy
41994|NCT03022812|Internet|internet
41995|NCT03022799|FAF1|faf1
41996|NCT03022799|Fas (TNFRSF6)-associated factor 1|fas (tnfrsf6)-associated factor 1
41997|NCT03022799|FAF1 inhibitor|faf1 inhibitor
41998|NCT03022799|KM-819|km-819
41999|NCT03022786|Dermatitis|dermatitis
42000|NCT03022760|Exhaustion Disorder|exhaustion disorder
42001|NCT03022682|ethnicity|ethnicity
42002|NCT03022682|inflammation|inflammation
42003|NCT03022669|mobile health|mobile health
42004|NCT03022669|veterans|veterans
42005|NCT03022669|cardiovascular disease|cardiovascular disease
42006|NCT03022669|medication adherence|medication adherence
42007|NCT03022656|Orthotic treatment, Ultrasound Imaging|orthotic treatment, ultrasound imaging
42008|NCT03022630|palliative care|palliative care
42009|NCT03022630|cirrhosis|cirrhosis
42010|NCT03022630|liver disease|liver disease
42011|NCT03022630|hepatology|hepatology
42012|NCT03022630|end of life care|end of life care
42013|NCT03022630|supportive care|supportive care
42108|NCT03022266|Aspirin|aspirin
42109|NCT03022266|Wellth App|wellth app
42014|NCT03022578|Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System|malignant neoplasms of eye brain and other parts of central nervous system
42015|NCT03022578|Glioblastoma|glioblastoma
42016|NCT03022578|Anaplastic Astrocytoma|anaplastic astrocytoma
42017|NCT03022578|AA|aa
42018|NCT03022578|Laser interstitial thermal therapy|laser interstitial thermal therapy
42019|NCT03022578|LITT|litt
42020|NCT03022578|Lomustine|lomustine
42021|NCT03022578|CeeNU|ceenu
42022|NCT03022578|CCNU|ccnu
42023|NCT03022565|Uveal Melanoma|uveal melanoma
42024|NCT03022552|Myocardial Infarction|myocardial infarction
42025|NCT03022552|Women|women
42026|NCT03022552|Platelets|platelets
42027|NCT03022552|Blood Collection|blood collection
42029|NCT03022526|Pregnant|pregnant
42030|NCT03022526|Analgesia|analgesia
42031|NCT03022526|Labor analgesia|labor analgesia
42032|NCT03022526|Epidural|epidural
42033|NCT03022526|Combined spinal epidural|combined spinal epidural
42034|NCT03022513|Non-celiac Wheat Sensitivity|non-celiac wheat sensitivity
42035|NCT03022513|fibromyalgia|fibromyalgia
42036|NCT03022513|synovitis|synovitis
42037|NCT03022487|Sudden Cardiac Death (SCD)|sudden cardiac death (scd)
42038|NCT03022487|implantable cardioverter defibrillator|implantable cardioverter defibrillator
42039|NCT03022487|electrophysiological|electrophysiological
42040|NCT03022487|EP|ep
42041|NCT03022487|Ischaemic cardiomyopathy|ischaemic cardiomyopathy
42042|NCT03022487|Ventricular Arrhythmia|ventricular arrhythmia
46454|NCT02994927|MPA|mpa
42043|NCT03022487|ICD|icd
42044|NCT03022474|Childhood obesity|childhood obesity
42045|NCT03022461|Heart Failure|heart failure
42046|NCT03022461|Ventricular Dysfunction|ventricular dysfunction
42047|NCT03022461|Cardiomyopathies|cardiomyopathies
42048|NCT03022461|Heart Disease|heart disease
42049|NCT03022461|Cardiovascular Disease|cardiovascular disease
42050|NCT03022461|Heart-assist Devices|heart-assist devices
42051|NCT03022461|Thoratec Corporation|thoratec corporation
42052|NCT03022448|soft tissue sarcomas (STS)|soft tissue sarcomas (sts)
42053|NCT03022448|trabectedin|trabectedin
42054|NCT03022448|metastatic STS patients|metastatic sts patients
42055|NCT03022448|overall survival|overall survival
42056|NCT03022435|Inactivated influenza vaccine|inactivated influenza vaccine
42057|NCT03022435|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
42058|NCT03022435|Adult and elderly identical twins|adult and elderly identical twins
42059|NCT03022435|Adult fraternal twins|adult fraternal twins
42060|NCT03022422|Trivalent, inactivated influenza vaccine|trivalent, inactivated influenza vaccine
42061|NCT03022422|High-Dose trivalent, inactivated influenza vaccine|high-dose trivalent, inactivated influenza vaccine
42062|NCT03022422|Adult and elderly identical twins|adult and elderly identical twins
42063|NCT03022422|Adult fraternal twins|adult fraternal twins
42064|NCT03022409|Treatment naïve|treatment naïve
42065|NCT03022409|Head and Neck Squamous Cell Carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
42066|NCT03022409|DNA Damage Repair (DDR)|dna damage repair (ddr)
42067|NCT03022396|Inactivated influenza vaccine|inactivated influenza vaccine
42068|NCT03022396|Identical twins|identical twins
42069|NCT03022396|Fraternal twins|fraternal twins
42070|NCT03022396|High-Dose influenza vaccine|high-dose influenza vaccine
42071|NCT03022396|Elderly twins|elderly twins
42072|NCT03022396|Child twins|child twins
42073|NCT03022396|Inactivated influenza vaccine, high-dose|inactivated influenza vaccine, high-dose
42074|NCT03022383|no known ocular pathology|no known ocular pathology
42075|NCT03022370|informal settlements|informal settlements
42076|NCT03022370|poverty|poverty
42077|NCT03022344|DD2 plaque study|dd2 plaque study
42078|NCT03022344|Coronary plaque|coronary plaque
42079|NCT03022344|Type-2 diabetes mellitus|type-2 diabetes mellitus
42080|NCT03022331|Idiopathic aortitis|idiopathic aortitis
42081|NCT03022331|Isolated aortitis|isolated aortitis
42082|NCT03022331|Vasculitis|vasculitis
42083|NCT03022318|GPR143|gpr143
42084|NCT03022318|PEDF|pedf
42085|NCT03022318|VEGF|vegf
42086|NCT03022318|LDOPA|ldopa
42087|NCT03022305|Hip alignment|hip alignment
42088|NCT03022305|Hip misalignment|hip misalignment
42089|NCT03022305|Shoulder function|shoulder function
42090|NCT03022305|Shoulder rotation|shoulder rotation
42091|NCT03022305|Athletic shoulder injuries|athletic shoulder injuries
42092|NCT03022305|Athletic hip alignment|athletic hip alignment
42093|NCT03022305|Hip and shoulder alignment|hip and shoulder alignment
42094|NCT03022305|Hip joint|hip joint
42095|NCT03022305|Hip joint alignment|hip joint alignment
42096|NCT03022305|Hip joint misalignment|hip joint misalignment
42097|NCT03022279|Pediatric|pediatric
42098|NCT03022279|post-operative pain prevention|post-operative pain prevention
42099|NCT03022279|Anesthesia, Infiltration|anesthesia, infiltration
42100|NCT03022279|Nerve Blockade|nerve blockade
42101|NCT03022266|Adherence|adherence
42102|NCT03022266|CleverCap® Lite BLE C035|clevercap® lite ble c035
42103|NCT03022266|Smartphone App|smartphone app
42104|NCT03022266|Telehealth|telehealth
42105|NCT03022266|Digital Health|digital health
42106|NCT03022266|Mobile Phone App|mobile phone app
42107|NCT03022266|Behavioral Economics|behavioral economics
42110|NCT03022253|PDA|pda
42111|NCT03022253|Platelets|platelets
42112|NCT03022214|Dietary supplementation|dietary supplementation
42113|NCT03022214|Exercise|exercise
42114|NCT03022214|Increase Resilience|increase resilience
42115|NCT03022214|Oxidative Stress|oxidative stress
42116|NCT03022214|Efficacy|efficacy
42117|NCT03022201|Motilitone|motilitone
42118|NCT03022188|pancreatic incidentaloma|pancreatic incidentaloma
42119|NCT03022188|pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
42120|NCT03022188|EUS-guided fine-needle aspiration|eus-guided fine-needle aspiration
42121|NCT03022188|contrast-enhanced endoscopic ultrasound|contrast-enhanced endoscopic ultrasound
42122|NCT03022175|Safety|safety
42123|NCT03022175|Tolerability|tolerability
42124|NCT03022175|Pharmacokinetics|pharmacokinetics
42125|NCT03022162|Neuropathic Pain, Paclitaxel, CIPN|neuropathic pain, paclitaxel, cipn
42126|NCT03022136|epidural block|epidural block
42127|NCT03022136|dermatome|dermatome
42128|NCT03022136|human|human
42129|NCT03022136|spinal nerve|spinal nerve
42130|NCT03022136|thoracic|thoracic
42131|NCT03022071|Cognitive behavior therapy|cognitive behavior therapy
42132|NCT03022071|Psychodynamic therapy|psychodynamic therapy
42133|NCT03022071|Mediators|mediators
42134|NCT03022071|Moderators|moderators
42135|NCT03022045|risankizumab|risankizumab
42136|NCT03022045|Erythrodermic Psoriasis|erythrodermic psoriasis
42137|NCT03022045|Japanese|japanese
42138|NCT03022045|Generalized Pustular Psoriasis|generalized pustular psoriasis
42139|NCT03022032|Gynecologic cancer|gynecologic cancer
42140|NCT03022019|autologous cell suspension grafting|autologous cell suspension grafting
42141|NCT03022019|vitiligo|vitiligo
42142|NCT03022019|non-segmental|non-segmental
42143|NCT03022019|ReNovaCell|renovacell
42144|NCT03021967|incurable pathologies|incurable pathologies
42145|NCT03021967|palliative care|palliative care
42146|NCT03021954|platelet rich plasma|platelet rich plasma
42147|NCT03021954|pelvic floor disorders|pelvic floor disorders
42148|NCT03021954|primipara|primipara
42149|NCT03021941|Gaucher Disease|gaucher disease
42150|NCT03021941|Enzyme Replacement Therapy|enzyme replacement therapy
42151|NCT03021928|Stroke|stroke
42152|NCT03021928|Atrial Fibrillation|atrial fibrillation
42153|NCT03021928|Anticoagulation|anticoagulation
42154|NCT03021928|NOAC|noac
42155|NCT03021889|HIV / AIDS|hiv / aids
42156|NCT03021889|Dyslipidemia|dyslipidemia
42157|NCT03021889|Adolescents|adolescents
42158|NCT03021889|Nutritional Therapy|nutritional therapy
42159|NCT03021863|Dissemination|dissemination
42160|NCT03021863|Tone|tone
42161|NCT03021863|Survey reminders|survey reminders
42162|NCT03021863|Questionnaires|questionnaires
42163|NCT03021850|Pliability|pliability
42164|NCT03021850|Cryotherapy|cryotherapy
42165|NCT03021850|Hot temperature|hot temperature
42166|NCT03021850|Hyperthermia, induced|hyperthermia, induced
42167|NCT03021850|Randomized Controlled Trial|randomized controlled trial
42168|NCT03021850|Hamstring muscles|hamstring muscles
42169|NCT03021850|Muscle stretching exercises|muscle stretching exercises
42170|NCT03021824|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
42171|NCT03021824|ARDS|ards
42172|NCT03021824|Acute Lung Injury|acute lung injury
42173|NCT03021824|ALI|ali
42174|NCT03021824|Mechanical Ventilation|mechanical ventilation
42176|NCT03021824|Neuromuscular Blockade|neuromuscular blockade
42178|NCT03021824|Prone Position|prone position
42179|NCT03021824|ECMO|ecmo
42180|NCT03021824|Acute Respiratory Failure|acute respiratory failure
42181|NCT03021798|Sarcopenia|sarcopenia
42182|NCT03021798|Sarcopenic Obesity|sarcopenic obesity
42183|NCT03021798|observational study|observational study
42184|NCT03021798|6-minute walking distance|6-minute walking distance
42185|NCT03021798|400 meters walking test|400 meters walking test
42186|NCT03021798|Patient Reported Outcomes|patient reported outcomes
42187|NCT03021785|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
42188|NCT03021785|Anti-VEGF|anti-vegf
42189|NCT03021785|CNV|cnv
42190|NCT03021785|TK001|tk001
42191|NCT03021772|Neostigmine|neostigmine
42192|NCT03021772|Dexamethasone|dexamethasone
42193|NCT03021772|Intravenous Local Anesthesia|intravenous local anesthesia
42194|NCT03021746|African-American|african-american
42195|NCT03021720|Uterine fibroid embolization|uterine fibroid embolization
42196|NCT03021720|Uterine artery embolization|uterine artery embolization
42197|NCT03021720|Arterial access|arterial access
42198|NCT03021720|Radial access|radial access
42199|NCT03021720|Interventional radiology|interventional radiology
42200|NCT03021720|Quality of life|quality of life
42201|NCT03021720|Patient Satisfaction|patient satisfaction
42202|NCT03021720|Patient centered care|patient centered care
42203|NCT03021720|Uterine fibroid|uterine fibroid
42204|NCT03021655|Youth|youth
42205|NCT03021655|Randomized controlled trial|randomized controlled trial
42206|NCT03021655|Adventure-based training|adventure-based training
42207|NCT03021655|WhatsApp|whatsapp
42303|NCT03021109|ultrasound|ultrasound
42210|NCT03021642|Mesenchymal-epithelial transition factor|mesenchymal-epithelial transition factor
42212|NCT03021616|energy drink|energy drink
42213|NCT03021616|qtc interval|qtc interval
42214|NCT03021616|clotting time|clotting time
42215|NCT03021616|thorough qt study|thorough qt study
42216|NCT03021603|Hope|hope
42217|NCT03021603|psychotherapy|psychotherapy
42218|NCT03021603|palliative|palliative
42219|NCT03021603|low-intensity intervention|low-intensity intervention
42220|NCT03021590|Helicobacter pylori|helicobacter pylori
42221|NCT03021590|Helicobacter Infections|helicobacter infections
42222|NCT03021590|Proton Pump Inhibitors|proton pump inhibitors
42223|NCT03021590|sequential therapy|sequential therapy
42224|NCT03021590|Clarithromycin|clarithromycin
42225|NCT03021590|Tinidazole|tinidazole
42226|NCT03021577|orbital atherectomy system|orbital atherectomy system
42227|NCT03021577|rotational atherectomy|rotational atherectomy
42228|NCT03021577|Fractional flow reserve|fractional flow reserve
42229|NCT03021577|coronary flow reserve|coronary flow reserve
42230|NCT03021577|index of microcirculatory resistance (IMR)|index of microcirculatory resistance (imr)
42231|NCT03021551|oxygen|oxygen
42232|NCT03021551|desaturation|desaturation
42233|NCT03021551|obesity|obesity
42234|NCT03021538|Cardiopulmonary Bypass|cardiopulmonary bypass
42235|NCT03021538|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
42236|NCT03021538|Primary Graft Dysfunction|primary graft dysfunction
42237|NCT03021538|Hemorrhage|hemorrhage
42238|NCT03021538|Mechanical Ventilator|mechanical ventilator
42239|NCT03021525|Goal-directed therapy|goal-directed therapy
42240|NCT03021525|postoperative morbidity|postoperative morbidity
42241|NCT03021525|haemodynamic optimisation|haemodynamic optimisation
42242|NCT03021525|individualised medicine|individualised medicine
42243|NCT03021525|Pulse pressure variation|pulse pressure variation
42244|NCT03021525|Cardiac output|cardiac output
42248|NCT03021486|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
42249|NCT03021486|Haloperidol|haloperidol
42250|NCT03021486|Chlorpromazine|chlorpromazine
42251|NCT03021486|Chlorpromazine hydrochloride|chlorpromazine hydrochloride
42252|NCT03021486|Thorazine|thorazine
42253|NCT03021486|Symptom questionnaire|symptom questionnaire
42254|NCT03021486|Survey|survey
42255|NCT03021486|Delirium|delirium
42256|NCT03021486|Acute palliative care unit|acute palliative care unit
42257|NCT03021486|APCU|apcu
42258|NCT03021473|oxygen reserve index|oxygen reserve index
42259|NCT03021473|desaturation|desaturation
42260|NCT03021473|safety|safety
42261|NCT03021434|Water Supply/standards|water supply/standards
42262|NCT03021434|Water microbiology|water microbiology
42263|NCT03021434|India|india
42264|NCT03021434|Hand disinfection|hand disinfection
42265|NCT03021434|Escherichia coli Infections/prevention & control|escherichia coli infections/prevention & control
42266|NCT03021434|Hygiene|hygiene
42267|NCT03021434|Health behavior|health behavior
42268|NCT03021434|Drinking water|drinking water
42269|NCT03021434|Informational intervention|informational intervention
42270|NCT03021421|Total knee arthroplasty|total knee arthroplasty
42271|NCT03021421|unilateral spinal anaesthesia|unilateral spinal anaesthesia
42272|NCT03021421|psoas compartment block|psoas compartment block
42273|NCT03021421|sciatic nerve block|sciatic nerve block
42274|NCT03021421|haemodynamic effects|haemodynamic effects
42275|NCT03021343|Atrial fibrillation|atrial fibrillation
42276|NCT03021343|Colchicine|colchicine
42277|NCT03021343|Cardiac surgery|cardiac surgery
42278|NCT03021304|SB240563|sb240563
42279|NCT03021304|self-administration|self-administration
42280|NCT03021304|Mepolizumab|mepolizumab
42281|NCT03021304|safety syringe|safety syringe
42282|NCT03021304|Eosinophilic asthma|eosinophilic asthma
42283|NCT03021278|Tactile acuity|tactile acuity
42284|NCT03021278|Chronic pain|chronic pain
42285|NCT03021278|Two-point discrimination|two-point discrimination
42286|NCT03021278|Point-to-point test|point-to-point test
42287|NCT03021278|Two-point estimation|two-point estimation
42288|NCT03021278|Body image|body image
42289|NCT03021239|Ramp Test|ramp test
42290|NCT03021239|Continuous Flow -Left Ventricular Assist Device (CF-LVAD)|continuous flow -left ventricular assist device (cf-lvad)
42291|NCT03021239|LVAD Hemodynamics|lvad hemodynamics
42292|NCT03021226|Health Behavior|health behavior
42293|NCT03021174|CIPN|cipn
42294|NCT03021174|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
42295|NCT03021161|probiotic|probiotic
42296|NCT03021148|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
42297|NCT03021148|self-reported|self-reported
42298|NCT03021122|Medication errors|medication errors
42299|NCT03021122|Resuscitation|resuscitation
42300|NCT03021122|Drugs|drugs
42301|NCT03021122|Pediatrics|pediatrics
42302|NCT03021122|Biomedical technology|biomedical technology
42304|NCT03021109|pediatrics|pediatrics
42305|NCT03021109|gastroenteritis|gastroenteritis
42306|NCT03021083|Lumbar multi-level fusions|lumbar multi-level fusions
42307|NCT03021083|Patient Controlled Analgesia|patient controlled analgesia
42308|NCT03021083|Fentanyl|fentanyl
42309|NCT03021083|Opioid Analgesia|opioid analgesia
42310|NCT03021070|Ante natal visit|ante natal visit
42311|NCT03021070|Facility delivery|facility delivery
42312|NCT03021070|Post natal visit|post natal visit
42313|NCT03021070|Continuum of care|continuum of care
42314|NCT03021070|Conditional cash transfer|conditional cash transfer
42315|NCT03021070|Maternal and child health|maternal and child health
42316|NCT03021070|Cluster randomized trial|cluster randomized trial
42317|NCT03021031|Parkinson's Disease|parkinson's disease
42318|NCT03021018|Epilepsy|epilepsy
42319|NCT03021018|Brivaracetam|brivaracetam
42320|NCT03021018|Epilepsy Monitoring Unit|epilepsy monitoring unit
42321|NCT03021018|Increased seizure activity|increased seizure activity
622559|NCT00670293|PET Imaging|pet imaging
42322|NCT03020992|Axial Spondyloarthritis|axial spondyloarthritis
42323|NCT03020992|axSpA|axspa
42324|NCT03020992|Anterior Uveitis|anterior uveitis
42325|NCT03020992|Certolizumab Pegol|certolizumab pegol
42326|NCT03020992|Cimzia|cimzia
42327|NCT03020875|Acetaminophen|acetaminophen
42328|NCT03020875|Pain management|pain management
42329|NCT03020862|Dietary nitrate|dietary nitrate
42330|NCT03020862|Physical performance|physical performance
42331|NCT03020862|Blood pressure|blood pressure
42332|NCT03020862|Nitrite|nitrite
42333|NCT03020862|Exercise|exercise
42334|NCT03020849|hypofibrinogenemia|hypofibrinogenemia
42335|NCT03020849|prediction score|prediction score
42336|NCT03020849|severe trauma|severe trauma
42337|NCT03020823|SCB01A|scb01a
42338|NCT03020823|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
42339|NCT03020784|acute neuroinflammatory|acute neuroinflammatory
42340|NCT03020771|Crimean-congo hemorrhagic fever|crimean-congo hemorrhagic fever
42341|NCT03020771|vaccine|vaccine
42342|NCT03020771|human|human
42343|NCT03020771|phase I|phase i
42344|NCT03020745|Pharmacokinetics|pharmacokinetics
42345|NCT03020745|Safety|safety
42346|NCT03020745|Pharmacodynamics|pharmacodynamics
42347|NCT03020745|Efficacy|efficacy
42348|NCT03020745|Chronic Hepatitis B|chronic hepatitis b
42349|NCT03020745|GSK3389404|gsk3389404
42350|NCT03020732|growth factor|growth factor
42351|NCT03020732|mucogingival surgery|mucogingival surgery
42352|NCT03020732|gingival recession|gingival recession
42353|NCT03020719|Growth Parameters|growth parameters
42354|NCT03020719|Cystic Fibrosis|cystic fibrosis
42355|NCT03020706|magnesium sulphate|magnesium sulphate
42356|NCT03020706|neostigmine|neostigmine
42357|NCT03020693|electrostimulation|electrostimulation
42358|NCT03020693|exercise program|exercise program
42359|NCT03020667|Conventional cigarette|conventional cigarette
42360|NCT03020667|iQOS|iqos
42361|NCT03020667|Never smoker|never smoker
42362|NCT03020667|THS|ths
42363|NCT03020641|low pressure pneumoperitoneum|low pressure pneumoperitoneum
42364|NCT03020641|standard pressure pneumoperitoneum|standard pressure pneumoperitoneum
42365|NCT03020641|laparoscopy cholecystectomy|laparoscopy cholecystectomy
42366|NCT03020628|Influenza Vaccines|influenza vaccines
42367|NCT03020628|Vaccines, Inactivated|vaccines, inactivated
42368|NCT03020628|Cell Culture-Derived|cell culture-derived
42369|NCT03020615|Sickle cell|sickle cell
42370|NCT03020615|Hydroxyurea|hydroxyurea
42374|NCT03020589|UNC|unc
42375|NCT03020589|Phase IV|phase iv
42376|NCT03020550|GERD|gerd
42377|NCT03020550|Galvanic Skin Response|galvanic skin response
42378|NCT03020550|Heart Rate Variability|heart rate variability
42379|NCT03020537|Trivalent inactivated influenza vaccine|trivalent inactivated influenza vaccine
42380|NCT03020537|Young children|young children
42381|NCT03020537|Young adults|young adults
42382|NCT03020511|Modern grains|modern grains
42383|NCT03020511|ancient grains|ancient grains
42384|NCT03020511|immunologic response|immunologic response
42385|NCT03020511|microbiota|microbiota
42386|NCT03020498|Inactivated influenza vaccine|inactivated influenza vaccine
42387|NCT03020498|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
42388|NCT03020498|Child identical twins and non-twins|child identical twins and non-twins
42389|NCT03020498|Young and elderly non-twin adults|young and elderly non-twin adults
42390|NCT03020472|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
42391|NCT03020472|Children|children
42392|NCT03020459|macular holes|macular holes
42393|NCT03020433|Stroke|stroke
42394|NCT03020433|rehab|rehab
42395|NCT03020433|rehabilitation|rehabilitation
42396|NCT03020433|paresis|paresis
42397|NCT03020433|paralysis|paralysis
42398|NCT03020433|stroke therapy|stroke therapy
42399|NCT03020433|CVA|cva
42400|NCT03020433|cerebrovascular accident|cerebrovascular accident
42401|NCT03020433|brain diseases|brain diseases
42402|NCT03020433|TMS|tms
42403|NCT03020433|transcranial magnetic stimulation|transcranial magnetic stimulation
42404|NCT03020433|CIMT|cimt
42405|NCT03020433|constraint induced movement therapy|constraint induced movement therapy
42406|NCT03020433|MRI|mri
42407|NCT03020407|Septic Shock|septic shock
42408|NCT03020407|Inferior vene cava diameter|inferior vene cava diameter
42409|NCT03020407|Resuscitation|resuscitation
42410|NCT03020407|Mortality|mortality
42411|NCT03020394|COPD Exacerbation|copd exacerbation
42412|NCT03020394|Noninvasive Positive Ventilation|noninvasive positive ventilation
42413|NCT03020394|Invasive Positive Ventilation|invasive positive ventilation
42414|NCT03020394|severe|severe
42415|NCT03020342|HCC|hcc
42416|NCT03020342|chimera DNA|chimera dna
42417|NCT03020342|circulating DNA|circulating dna
42418|NCT03020342|biomarker|biomarker
42419|NCT03020329|Induction Chemotherapy|induction chemotherapy
42420|NCT03020329|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
42421|NCT03020329|Chemoradiotherapy|chemoradiotherapy
42422|NCT03020290|femoropopliteal artery|femoropopliteal artery
42423|NCT03020290|interwoven nitinol stent|interwoven nitinol stent
42424|NCT03020290|self-expanding-endovascular|self-expanding-endovascular
42425|NCT03020290|TASC C and TASC D|tasc c and tasc d
42426|NCT03020290|Peripheral Arterial Disease|peripheral arterial disease
42427|NCT03020264|Type 2 Diabetes|type 2 diabetes
42428|NCT03020264|Hypoglycemia|hypoglycemia
42429|NCT03020264|Elderly|elderly
42430|NCT03020264|Insulinotherapy|insulinotherapy
42431|NCT03020251|preoperative rehabilitation program|preoperative rehabilitation program
42432|NCT03020251|chest physiotherapy|chest physiotherapy
42433|NCT03020251|lung cancer resection|lung cancer resection
42434|NCT03020212|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
42435|NCT03020212|High altitude|high altitude
42436|NCT03020212|Oxygen|oxygen
42437|NCT03020212|long-term oxygen therapy|long-term oxygen therapy
42438|NCT03020212|pulmonary hypertension|pulmonary hypertension
42439|NCT03020212|chronic hypoxemia|chronic hypoxemia
42440|NCT03020199|Psoriasis|psoriasis
42441|NCT03020134|pharmacokinetics|pharmacokinetics
42442|NCT03020134|Danoprevir/r|danoprevir/r
42443|NCT03020134|Ravidasvir|ravidasvir
42444|NCT03020095|Ravidasvir|ravidasvir
42445|NCT03020095|HCV GT1|hcv gt1
42446|NCT03020095|SVR12|svr12
42447|NCT03020095|Danoprevir/r|danoprevir/r
42448|NCT03020082|Danoprevir|danoprevir
42449|NCT03020082|non-cirrhotic|non-cirrhotic
42450|NCT03020082|Chinese HCV G1|chinese hcv g1
42451|NCT03020082|SVR12|svr12
42452|NCT03020069|Type 1 Diabetes|type 1 diabetes
42453|NCT03020069|Adolescents|adolescents
42454|NCT03020069|Glucose Monitoring|glucose monitoring
42455|NCT03020056|cataract surgery|cataract surgery
42456|NCT03020056|economy|economy
42457|NCT03020056|quality of life|quality of life
42458|NCT03020056|rural area|rural area
42459|NCT03020030|acute lymphoblastic leukemia|acute lymphoblastic leukemia
42460|NCT03020004|Danoprevir|danoprevir
42461|NCT03020004|SVR12|svr12
42462|NCT03020004|Chinese HCV G1|chinese hcv g1
42463|NCT03020004|non-cirrhotic|non-cirrhotic
42464|NCT03019991|pharmacokinetics,Danoprevir|pharmacokinetics,danoprevir
42465|NCT03019939|Acute Myeloid Leukemia|acute myeloid leukemia
42466|NCT03019939|AML|aml
42467|NCT03019939|Myelodysplastic Syndrome|myelodysplastic syndrome
42468|NCT03019939|MDS|mds
42469|NCT03019939|Neutropenia|neutropenia
42470|NCT03019939|Invasive fungal infection|invasive fungal infection
42472|NCT03019939|Isavuconazole|isavuconazole
42473|NCT03019939|BAL8557|bal8557
42474|NCT03019926|systemic lupus erythematosus|systemic lupus erythematosus
42475|NCT03019926|observance|observance
42476|NCT03019926|hydroxychloroquine dosage|hydroxychloroquine dosage
42477|NCT03019926|risk factors of non-observance|risk factors of non-observance
42478|NCT03019926|SLICC score|slicc score
42479|NCT03019926|SLEDAI score|sledai score
42480|NCT03019913|Skeletal muscle|skeletal muscle
42481|NCT03019861|Ayurveda|ayurveda
42482|NCT03019861|IBS|ibs
42483|NCT03019861|Complementary medicine|complementary medicine
42484|NCT03019861|nutritional counseling|nutritional counseling
42485|NCT03019848|Redox and pro-inflammatory status|redox and pro-inflammatory status
42486|NCT03019835|mivacurium|mivacurium
42487|NCT03019835|neostigmine|neostigmine
42488|NCT03019835|antagonism|antagonism
42489|NCT03019783|Endothelial function|endothelial function
42490|NCT03019770|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
42491|NCT03019770|HIV|hiv
42492|NCT03019770|Decision Aid|decision aid
42493|NCT03019770|Shared Decision Making|shared decision making
42494|NCT03019744|Functional Electrical Stimulation|functional electrical stimulation
42495|NCT03019744|Cerebrovascular accident|cerebrovascular accident
42496|NCT03019744|Stroke|stroke
42497|NCT03019744|Electromyography|electromyography
42498|NCT03019731|Tics|tics
42499|NCT03019731|Behavioral therapy|behavioral therapy
42500|NCT03019731|Neurologic Examination|neurologic examination
42501|NCT03019718|Inpatient rehabilitation|inpatient rehabilitation
42502|NCT03019718|Internet-based intervention|internet-based intervention
42503|NCT03019718|Aftercare|aftercare
42504|NCT03019718|Return to work|return to work
42507|NCT03019705|health-related internet use|health-related internet use
42508|NCT03019705|pathological health anxiety|pathological health anxiety
42510|NCT03019666|MM|mm
42511|NCT03019666|NHL|nhl
42512|NCT03019640|B-Cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
42513|NCT03019640|Relapsed follicular lymphoma|relapsed follicular lymphoma
42514|NCT03019640|Indolent B-cell histology|indolent b-cell histology
42515|NCT03019640|Natural killer cells|natural killer cells
42516|NCT03019640|NK|nk
42517|NCT03019640|Stem cell transplant|stem cell transplant
42518|NCT03019640|Rituximab|rituximab
42519|NCT03019640|Rituxan|rituxan
42520|NCT03019640|Carmustine|carmustine
42521|NCT03019640|BCNU|bcnu
42522|NCT03019640|BiCNU|bicnu
42523|NCT03019640|Etoposide|etoposide
42524|NCT03019640|VePesid|vepesid
42525|NCT03019640|Cytarabine|cytarabine
42526|NCT03019640|Ara-C|ara-c
42527|NCT03019640|Cytosar|cytosar
42528|NCT03019640|DepoCyt|depocyt
42529|NCT03019640|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
42530|NCT03019640|Melphalan|melphalan
42531|NCT03019640|Alkeran|alkeran
42532|NCT03019640|Lenalidomide|lenalidomide
42533|NCT03019640|CC-5013|cc-5013
42534|NCT03019640|Revlimid|revlimid
42535|NCT03019640|G-CSF|g-csf
42536|NCT03019640|Filgrastim|filgrastim
42537|NCT03019640|Neupogen|neupogen
42538|NCT03019601|HIV|hiv
42539|NCT03019601|PMTCT|pmtct
42544|NCT03019562|postoperative pain|postoperative pain
42545|NCT03019523|caffeine|caffeine
42546|NCT03019523|mental performance|mental performance
42547|NCT03019523|reaction time|reaction time
42548|NCT03019523|focus|focus
42549|NCT03019497|PTSD|ptsd
42550|NCT03019497|Related Problems|related problems
42551|NCT03019497|Therapy|therapy
42552|NCT03019497|Traumatic Event|traumatic event
42553|NCT03019497|Quality of Life|quality of life
42554|NCT03019497|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
42555|NCT03019497|Major depression|major depression
42556|NCT03019497|Sleep disorders|sleep disorders
42557|NCT03019497|Pain|pain
42558|NCT03019497|Stressors|stressors
42559|NCT03019497|Social support|social support
42560|NCT03019497|Substance use disorder|substance use disorder
42561|NCT03019497|Anxiety disorder|anxiety disorder
42562|NCT03019484|Self-efficacy|self-efficacy
42563|NCT03019484|Self Efficacy|self efficacy
42564|NCT03019484|Nurses's Role|nurses's role
42565|NCT03019484|Professional Role|professional role
42566|NCT03019484|Clinical Trial|clinical trial
42567|NCT03019484|Breast Feeding|breast feeding
42568|NCT03019458|prospective randomized trial|prospective randomized trial
42569|NCT03019419|sporadic ALS|sporadic als
42570|NCT03019419|perampanel|perampanel
42571|NCT03019393|non-transferrin bound iron (NTBI)|non-transferrin bound iron (ntbi)
42572|NCT03019393|Red meat|red meat
42573|NCT03019393|Non-transferrin bound iron (NTBI) in serum|non-transferrin bound iron (ntbi) in serum
42574|NCT03019367|Premature infants|premature infants
42575|NCT03019367|Umbilical cord milking|umbilical cord milking
42576|NCT03019367|Delayed cord clamping|delayed cord clamping
42577|NCT03019367|Intraventricular Hemorrhage|intraventricular hemorrhage
42578|NCT03019367|Death|death
42579|NCT03019354|high flow oxygen|high flow oxygen
42583|NCT03019341|Vomiting|vomiting
42584|NCT03019341|Non-ionic contrast media|non-ionic contrast media
42585|NCT03019341|Side effect|side effect
42586|NCT03019328|peanut allergy|peanut allergy
42587|NCT03019328|food allergens|food allergens
42588|NCT03019328|atopic dermatitis|atopic dermatitis
42590|NCT03019328|infant food allergy testing|infant food allergy testing
42591|NCT03019328|skin prick testing|skin prick testing
42592|NCT03019328|peanut IgE|peanut ige
42593|NCT03019328|early peanut introduction|early peanut introduction
42594|NCT03019328|food allergy prevention|food allergy prevention
42595|NCT03019315|Ovarian Cancer|ovarian cancer
42596|NCT03019315|Chemotherapy|chemotherapy
42597|NCT03019315|Response Rate|response rate
42598|NCT03019315|Survival|survival
42599|NCT03019250|Colostrum|colostrum
42600|NCT03019250|Critical Care Outcomes|critical care outcomes
42601|NCT03019250|Intensive Care Unit|intensive care unit
42602|NCT03019250|Inflammation|inflammation
42603|NCT03019250|Infection|infection
42604|NCT03019250|mortality|mortality
42605|NCT03019224|Tooth whitening|tooth whitening
42606|NCT03019224|Dentifrice|dentifrice
42607|NCT03019224|Sensitivity|sensitivity
42608|NCT03019211|Physical Therapy Modalities|physical therapy modalities
42609|NCT03019211|Accidental Fall|accidental fall
42610|NCT03019211|Elderly|elderly
42611|NCT03019211|Hydrotherapy|hydrotherapy
42612|NCT03019211|Nursing Home|nursing home
42613|NCT03019198|Tranexamic Acid|tranexamic acid
42614|NCT03019198|Blood loss|blood loss
42615|NCT03019198|Tranfusion|tranfusion
42616|NCT03019185|Alport Syndrome|alport syndrome
42617|NCT03019185|Bardoxolone methyl|bardoxolone methyl
42618|NCT03019185|CDDO-ME|cddo-me
42619|NCT03019185|RTA 402|rta 402
42620|NCT03019146|Prehabilitation|prehabilitation
42621|NCT03019133|Heart rate|heart rate
42622|NCT03019133|Blood pressure variability|blood pressure variability
42623|NCT03019094|overactive bladder|overactive bladder
42624|NCT03019094|urge urinary incontinence|urge urinary incontinence
42625|NCT03019094|urgency frequency|urgency frequency
42626|NCT03019068|recruitment potential|recruitment potential
42627|NCT03019068|prediction|prediction
42628|NCT03019068|databases|databases
42629|NCT03019068|Clinical Trial Recruitment Support Systems (CTRSS)|clinical trial recruitment support systems (ctrss)
42630|NCT03019042|Hou Gu Mi Xi|hou gu mi xi
42631|NCT03019042|Shen Ling Bai Zhu San|shen ling bai zhu san
622560|NCT00670293|Dopamine|dopamine
42632|NCT03019042|mild gastrointestinal disorders|mild gastrointestinal disorders
42633|NCT03019042|traditional Chinese medicine|traditional chinese medicine
42634|NCT03019042|randomized controlled trial|randomized controlled trial
42635|NCT03019029|Peripheral Nerve Amyloidosis|peripheral nerve amyloidosis
42636|NCT03019003|Head and Neck Cancer|head and neck cancer
42637|NCT03018964|Single incision|single incision
42638|NCT03018964|Solo surgery|solo surgery
42639|NCT03018951|frailty, assessement|frailty, assessement
42640|NCT03018938|mid mixture insulin analog|mid mixture insulin analog
42641|NCT03018938|basal insulin analog|basal insulin analog
42642|NCT03018912|Subjective Sleep Vital Sign (VS)|subjective sleep vital sign (vs)
42643|NCT03018912|Primary Care|primary care
42644|NCT03018912|Sleep Medicine|sleep medicine
42645|NCT03018912|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
42646|NCT03018912|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
42647|NCT03018912|Insomnia|insomnia
42648|NCT03018912|Complex Sleep Disorders|complex sleep disorders
42649|NCT03018912|Predictive Analytics|predictive analytics
42650|NCT03018912|Screening|screening
42651|NCT03018912|Therapy Outcomes|therapy outcomes
42652|NCT03018899|paravertebral block|paravertebral block
42653|NCT03018899|ultrasound|ultrasound
42654|NCT03018899|percutaneous nephrolithotomy|percutaneous nephrolithotomy
42655|NCT03018899|postoperative pain|postoperative pain
42656|NCT03018873|remote ischemic preconditioning|remote ischemic preconditioning
42657|NCT03018873|acute myocardial infarction|acute myocardial infarction
42658|NCT03018860|Active second stage|active second stage
42659|NCT03018860|Neonatal morbidity|neonatal morbidity
42660|NCT03018860|Operative delivery|operative delivery
42661|NCT03018860|Labor|labor
42662|NCT03018834|Acute Myocarditis|acute myocarditis
42663|NCT03018834|ANAKINRA|anakinra
42664|NCT03018808|Eosinophilia|eosinophilia
42665|NCT03018808|COPD prevalence|copd prevalence
42666|NCT03018808|Primary care subjects|primary care subjects
42667|NCT03018795|peri-implantitis|peri-implantitis
42668|NCT03018795|Surgical regenerative treatment|surgical regenerative treatment
42669|NCT03018795|ozone therapy|ozone therapy
42670|NCT03018704|alcoholism|alcoholism
42671|NCT03018704|treatment|treatment
42672|NCT03018652|COPD|copd
42673|NCT03018652|Ig|ig
42674|NCT03018652|IPRAC|iprac
42675|NCT03018652|outpatient|outpatient
42676|NCT03018626|Non-germinal b-cell-like|non-germinal b-cell-like
42677|NCT03018626|R-ACVBP|r-acvbp
42678|NCT03018626|DA-EPOCH-R|da-epoch-r
42679|NCT03018613|Chronic Functional Constipation|chronic functional constipation
42680|NCT03018613|Intestinal Bacteria Flora Disturbance|intestinal bacteria flora disturbance
42681|NCT03018613|Fecal Microbiota Transplantation|fecal microbiota transplantation
42682|NCT03018600|prednisone, autoimmune disease|prednisone, autoimmune disease
42683|NCT03018509|JTE-451|jte-451
42684|NCT03018509|psoriasis|psoriasis
42685|NCT03018470|COPD|copd
42686|NCT03018470|Non invasive ventilation|non invasive ventilation
42688|NCT03018470|Acute exacerbation COPD|acute exacerbation copd
42689|NCT03018470|AECOPD|aecopd
42690|NCT03018470|Telemonitoring|telemonitoring
42691|NCT03018457|Trabecular microarchitecture|trabecular microarchitecture
42692|NCT03018457|alveolar bone|alveolar bone
42693|NCT03018457|osseointegration|osseointegration
42694|NCT03018457|dental implant|dental implant
42695|NCT03018431|Lung ultrasonography|lung ultrasonography
42696|NCT03018431|Chest CT scan|chest ct scan
42697|NCT03018431|ventilator-associated pneumonia|ventilator-associated pneumonia
42698|NCT03018431|ventilator-associated tracheobronchitis|ventilator-associated tracheobronchitis
42699|NCT03018431|antibiotic stewardship|antibiotic stewardship
42700|NCT03018418|Anal Cancer|anal cancer
42701|NCT03018379|Obesity|obesity
42702|NCT03018379|Body composition|body composition
42703|NCT03018379|energy expenditure|energy expenditure
42704|NCT03018379|sedentarity|sedentarity
42705|NCT03018379|dietary behaviors|dietary behaviors
42706|NCT03018366|estrogen|estrogen
42707|NCT03018366|premenopause|premenopause
42710|NCT03018353|Hepatitis C, Chronic|hepatitis c, chronic
42711|NCT03018353|Jail|jail
42712|NCT03018353|Patient Navigation|patient navigation
42713|NCT03018353|Incarcerated Population|incarcerated population
42714|NCT03018353|HCV|hcv
42715|NCT03018353|Sofosbuvir/Velpatasvir|sofosbuvir/velpatasvir
42716|NCT03018353|Hepatitis C|hepatitis c
42717|NCT03018288|Malignant Gliomas|malignant gliomas
42718|NCT03018288|Immunotherapy|immunotherapy
42719|NCT03018275|Lyophilized Biotherapeutic, Microbiome, Probiotic|lyophilized biotherapeutic, microbiome, probiotic
42720|NCT03018275|Commensal Gram-negative Bacteria|commensal gram-negative bacteria
42721|NCT03018275|Staphylococcus Aureus|staphylococcus aureus
42722|NCT03018275|Transepidermal Water Loss|transepidermal water loss
42723|NCT03018275|Allergic Diseases|allergic diseases
42724|NCT03018262|Surround Inhibition|surround inhibition
42725|NCT03018262|Motor Control|motor control
42726|NCT03018262|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
42727|NCT03018262|TMS-Evoked Potential|tms-evoked potential
42728|NCT03018236|cocaine|cocaine
42729|NCT03018236|alcohol|alcohol
42730|NCT03018236|substance use disorders|substance use disorders
42731|NCT03018236|addiction|addiction
42732|NCT03018236|N-acetylcysteine|n-acetylcysteine
42733|NCT03018236|randomized controlled trial|randomized controlled trial
42734|NCT03018223|Acute leukemia in CR|acute leukemia in cr
42735|NCT03018223|Chronic myeloid leukemia|chronic myeloid leukemia
42736|NCT03018223|Non-Hodgkin lymphoma in high risk|non-hodgkin lymphoma in high risk
42737|NCT03018223|Graft vs. Host Disease|graft vs. host disease
42738|NCT03018223|GVHD|gvhd
42739|NCT03018223|Hematopoietic cell transplant (HCT)|hematopoietic cell transplant (hct)
42740|NCT03018197|Personal Health Record|personal health record
42741|NCT03018197|Medication Knowledge|medication knowledge
42742|NCT03018197|Anticoagulants|anticoagulants
42743|NCT03018197|Patient Engagement|patient engagement
42744|NCT03018184|MRI|mri
42745|NCT03018184|CCSA|ccsa
34299|NCT03071640|old|old
42746|NCT03018184|Contractile Cross Sectional Area|contractile cross sectional area
42747|NCT03018184|Strength|strength
42748|NCT03018171|clonidine, spinal injections|clonidine, spinal injections
42749|NCT03018132|perinatal mental health|perinatal mental health
42750|NCT03018106|Female sexual disorder|female sexual disorder
42751|NCT03018106|Aging|aging
42752|NCT03018106|Menopause|menopause
42753|NCT03018106|Obstetrics/Gynecology|obstetrics/gynecology
42754|NCT03018106|Female urogenital disorder|female urogenital disorder
42755|NCT03018093|Relapsed or refractory acute lymphoblastic leukemia|relapsed or refractory acute lymphoblastic leukemia
42756|NCT03018093|Anti-CD19 chimeric antigen receptor T-cell|anti-cd19 chimeric antigen receptor t-cell
42757|NCT03018054|moderate active ulcerative colitis|moderate active ulcerative colitis
42758|NCT03018054|Japanese|japanese
42759|NCT03018041|Kidney transplantation|kidney transplantation
42760|NCT03018041|Renal transplantation|renal transplantation
42761|NCT03018041|Omega-3 fatty acids|omega-3 fatty acids
42762|NCT03018041|Marine n-3 fatty acids|marine n-3 fatty acids
42763|NCT03018041|Fatty acids|fatty acids
42764|NCT03018041|Inflammation|inflammation
42765|NCT03018041|Interstitial fibrosis|interstitial fibrosis
42766|NCT03018041|Glomerular filtration rate|glomerular filtration rate
42767|NCT03018041|Renal function|renal function
42768|NCT03018041|Allograft function|allograft function
42769|NCT03018041|Proteinuria|proteinuria
42770|NCT03018041|Blood pressure|blood pressure
42771|NCT03018041|Heart rate variability|heart rate variability
42772|NCT03018041|Lipids|lipids
42773|NCT03018041|Blood glucose|blood glucose
42774|NCT03018041|Body mass index|body mass index
42775|NCT03018041|Fatty acid composition|fatty acid composition
42776|NCT03018041|Gas chromatography|gas chromatography
42777|NCT03018041|Interventional study|interventional study
42778|NCT03018041|Allograft biopsy|allograft biopsy
42779|NCT03018041|Kidney biopsy|kidney biopsy
42780|NCT03018015|Bioequivalence|bioequivalence
42781|NCT03018015|Healthy|healthy
42782|NCT03018015|Bioavailability|bioavailability
42783|NCT03018015|Ibuprofen|ibuprofen
42784|NCT03018002|HIV, PMTCT|hiv, pmtct
42785|NCT03017989|Near Infrared Fluorescence Imaging|near infrared fluorescence imaging
42786|NCT03017989|Indocyanine green (ICG)|indocyanine green (icg)
42787|NCT03017963|acute coronary syndrome|acute coronary syndrome
42788|NCT03017963|sodium thiosulfate|sodium thiosulfate
42789|NCT03017963|maximum tolerable dose|maximum tolerable dose
42790|NCT03017963|dose-limiting toxicity|dose-limiting toxicity
42791|NCT03017911|PICC Line|picc line
42792|NCT03017911|Complications|complications
42793|NCT03017911|Thrombosis|thrombosis
42794|NCT03017911|Infection|infection
42795|NCT03017898|FiLaC|filac
42796|NCT03017898|Fistula Laser Closure|fistula laser closure
42797|NCT03017898|Laser Coagulation|laser coagulation
42799|NCT03017833|Solid Tumors|solid tumors
42800|NCT03017833|Advanced Cancer|advanced cancer
42801|NCT03017833|Metformin|metformin
42802|NCT03017833|Metformin ER|metformin er
42803|NCT03017833|TAK-228|tak-228
42804|NCT03017833|MLN0128|mln0128
42805|NCT03017833|TAK228|tak228
42806|NCT03017794|Radiotherapy|radiotherapy
42807|NCT03017794|Chromogranin A|chromogranin a
42808|NCT03017794|Neuroendocrine differentiation|neuroendocrine differentiation
42809|NCT03017781|Bipolar|bipolar
42810|NCT03017781|High-Risk Off-Spring|high-risk off-spring
42811|NCT03017781|Psychosocial Functioning|psychosocial functioning
42812|NCT03017768|Acute tryptophan depletion, esophageal sensitivity,|acute tryptophan depletion, esophageal sensitivity,
42813|NCT03017716|Inflammatory back pain|inflammatory back pain
42814|NCT03017716|gluten-free diet|gluten-free diet
42815|NCT03017716|celiac disease|celiac disease
42816|NCT03017716|non-celiac wheat sensitivity|non-celiac wheat sensitivity
42817|NCT03017703|Endothelial dysfunction|endothelial dysfunction
42818|NCT03017703|Insulin resistance|insulin resistance
42819|NCT03017703|Type 2 diabetes|type 2 diabetes
42820|NCT03017703|Mineralocorticoid blocker|mineralocorticoid blocker
42821|NCT03017625|COPD|copd
42822|NCT03017625|Cardiovascular Disease|cardiovascular disease
42823|NCT03017625|Platelets|platelets
42824|NCT03017625|Inflammation|inflammation
42825|NCT03017612|Presbyopia|presbyopia
42826|NCT03017573|Immunological biomarkers|immunological biomarkers
42827|NCT03017573|molecular profil|molecular profil
42828|NCT03017573|Circulating tumor DNA (ctDNA)|circulating tumor dna (ctdna)
42829|NCT03017560|Breast Cancer|breast cancer
42830|NCT03017560|Chemotherapy|chemotherapy
42831|NCT03017560|Verbal Memory|verbal memory
42832|NCT03017560|Processing Speed|processing speed
42833|NCT03017534|Patient-Therapist Interaction|patient-therapist interaction
42834|NCT03017534|Non-Specific Effects|non-specific effects
42835|NCT03017534|Manual Therapy|manual therapy
42836|NCT03017534|Neurodynamics|neurodynamics
42837|NCT03017534|Sham|sham
42838|NCT03017521|Refractory solid tumors|refractory solid tumors
42839|NCT03017521|AKT inhibitor|akt inhibitor
42840|NCT03017508|Cross-over study|cross-over study
34389|NCT03071237|gastric cancer|gastric cancer
34390|NCT03071224|AD|ad
34391|NCT03071224|HV|hv
34392|NCT03071211|pelvic organ prolapse|pelvic organ prolapse
34393|NCT03071211|urinary catheters|urinary catheters
34394|NCT03071198|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
34395|NCT03071185|free flap|free flap
34396|NCT03071185|nerve block|nerve block
34397|NCT03071185|elective reconstructive surgery|elective reconstructive surgery
34398|NCT03071185|free fibular|free fibular
34399|NCT03071185|anterolateral thigh flaps|anterolateral thigh flaps
34400|NCT03071159|Flash Glucose Monitoring|flash glucose monitoring
42841|NCT03017508|Riluzole|riluzole
42842|NCT03017508|Double-blind study|double-blind study
42843|NCT03017508|Speech task|speech task
42844|NCT03017508|Social Anxiety Disorder|social anxiety disorder
42845|NCT03017495|food-drug interaction|food-drug interaction
42846|NCT03017495|drug-drug interaction|drug-drug interaction
42847|NCT03017495|pharmacokinetics|pharmacokinetics
42848|NCT03017469|Resilience|resilience
42849|NCT03017469|Workplace Stress|workplace stress
42850|NCT03017469|Occupational Fatigue|occupational fatigue
42851|NCT03017469|Compassion Fatigue|compassion fatigue
42852|NCT03017469|Peer Support|peer support
42853|NCT03017469|Self-Care|self-care
42854|NCT03017469|Employee Assistance|employee assistance
42855|NCT03017456|Survivorship|survivorship
42856|NCT03017456|Prostate Cancer|prostate cancer
42857|NCT03017456|Survivorship Care Plan|survivorship care plan
42858|NCT03017443|Weight Loss|weight loss
42859|NCT03017443|Obesity|obesity
42860|NCT03017443|Overweight|overweight
42861|NCT03017391|palliative care|palliative care
42862|NCT03017391|palliative medicine|palliative medicine
42863|NCT03017391|palliative|palliative
42864|NCT03017378|influenza vector|influenza vector
42865|NCT03017378|tuberculosis|tuberculosis
42866|NCT03017378|vaccine|vaccine
42867|NCT03017365|Motor Control|motor control
42868|NCT03017365|Balance|balance
42869|NCT03017352|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
42870|NCT03017352|Exenatide|exenatide
42871|NCT03017352|Incretins|incretins
42872|NCT03017352|GLP-1|glp-1
42873|NCT03017352|Insulin|insulin
42874|NCT03017339|Low Lever Laser Therapy|low lever laser therapy
42875|NCT03017339|Exercise Therapy|exercise therapy
42876|NCT03017339|Chronic Pain|chronic pain
42877|NCT03017287|Glucose blood measurements, glucometer, BGM, Diabetes App|glucose blood measurements, glucometer, bgm, diabetes app
42878|NCT03017274|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
42879|NCT03017274|celiac disease|celiac disease
42880|NCT03017274|abdominal ultrasonography;|abdominal ultrasonography;
42881|NCT03017261|Osteoarthritis|osteoarthritis
42882|NCT03017261|Arthroplasty|arthroplasty
42883|NCT03017261|Robotic Surgery|robotic surgery
42884|NCT03017261|Knee|knee
42885|NCT03017248|pain|pain
42886|NCT03017248|ketamine|ketamine
42887|NCT03017248|morphine|morphine
42888|NCT03017248|analgesia|analgesia
42889|NCT03017248|emergency|emergency
42890|NCT03017144|non-technical skills (NTS)|non-technical skills (nts)
42891|NCT03017144|human factors|human factors
42892|NCT03017144|team work|team work
42893|NCT03017144|Crew Resource Management / Crisis Resource Management (CRM)|crew resource management / crisis resource management (crm)
42894|NCT03017144|technical skills (TS)|technical skills (ts)
42895|NCT03017144|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
42896|NCT03017144|Advanced cardiac life support|advanced cardiac life support
42897|NCT03017079|Semi-solidification|semi-solidification
42898|NCT03017079|caloric debt|caloric debt
42899|NCT03017079|enteral nutrition|enteral nutrition
42900|NCT03017079|critical illness|critical illness
42901|NCT03017066|Ultrasonography|ultrasonography
42902|NCT03017066|Child|child
42903|NCT03017066|Preoperative period|preoperative period
42904|NCT03017053|Neck dissection|neck dissection
42905|NCT03017053|Survival|survival
42906|NCT03017053|Early oral cancer|early oral cancer
42907|NCT03017053|Early oral cavity squamous cancer with node negative neck|early oral cavity squamous cancer with node negative neck
42908|NCT03017027|human-animal interaction|human-animal interaction
42909|NCT03017014|Humira®|humira®
42910|NCT03017014|Adalimumab|adalimumab
42911|NCT03017014|Crohn's Disease|crohn's disease
42912|NCT03016988|Mantle cell lymphoma|mantle cell lymphoma
42913|NCT03016988|Bortezomib|bortezomib
42914|NCT03016988|Fludarabine|fludarabine
42915|NCT03016988|Cytarabine|cytarabine
34499|NCT03070691|BCNS, Hedgehog pathway inhibitor|bcns, hedgehog pathway inhibitor
34500|NCT03070691|topical|topical
34501|NCT03070691|Smoothened|smoothened
34503|NCT03070665|postoperation bleeding|postoperation bleeding
42916|NCT03016975|Edwards Cardioband|edwards cardioband
42917|NCT03016975|Mitral Valve|mitral valve
42918|NCT03016975|Transcatheter|transcatheter
42919|NCT03016975|Mitral repair|mitral repair
42920|NCT03016975|Functional mitral regurgitation|functional mitral regurgitation
42921|NCT03016975|Secondary mitral regurgitation|secondary mitral regurgitation
42922|NCT03016975|Annuloplasty|annuloplasty
43126|NCT03015662|Pain|pain
42923|NCT03016936|Metabolic equivalents (METs)|metabolic equivalents (mets)
42924|NCT03016936|European Society of Anaesthesiology (ESA)|european society of anaesthesiology (esa)
42925|NCT03016936|Noncardiac surgery|noncardiac surgery
42926|NCT03016936|Cardiovascular Mortality|cardiovascular mortality
42927|NCT03016923|cerebral palsy|cerebral palsy
42928|NCT03016923|hemiplegia|hemiplegia
42929|NCT03016923|fes|fes
42930|NCT03016923|grasping|grasping
42931|NCT03016897|ALS|als
42932|NCT03016897|neurodegenerative|neurodegenerative
42933|NCT03016884|Herpes Zoster|herpes zoster
42934|NCT03016884|anti TNF alpha|anti tnf alpha
42935|NCT03016884|tofacitinib|tofacitinib
42936|NCT03016884|Rheumatoid Arthritis|rheumatoid arthritis
42937|NCT03016845|ciprofloxacin|ciprofloxacin
42938|NCT03016845|pharmacokinetics|pharmacokinetics
42939|NCT03016845|Intensive Care Unit|intensive care unit
42940|NCT03016845|Cystatin C|cystatin c
42941|NCT03016845|CKD-EPI|ckd-epi
42942|NCT03016845|renal function|renal function
42943|NCT03016780|Ulcerative Colitis|ulcerative colitis
42944|NCT03016780|Intestinal Bacteria Flora Disturbance|intestinal bacteria flora disturbance
42945|NCT03016780|Fecal Microbiota Transplantation|fecal microbiota transplantation
42946|NCT03016780|Intestinal Mucosal Immunity|intestinal mucosal immunity
42947|NCT03016767|oral feeding|oral feeding
42948|NCT03016767|oral stimulation|oral stimulation
42949|NCT03016767|physiotherapy intervention|physiotherapy intervention
42950|NCT03016754|sudden cardiac death|sudden cardiac death
42951|NCT03016754|SCD|scd
42952|NCT03016754|sudden cardiac arrest|sudden cardiac arrest
42953|NCT03016754|SCA|sca
42954|NCT03016754|heart failure|heart failure
42955|NCT03016754|HF|hf
42956|NCT03016741|cognitive function|cognitive function
42957|NCT03016741|hormonal therapy|hormonal therapy
42958|NCT03016741|cancer survivorship|cancer survivorship
42959|NCT03016741|dementia|dementia
42960|NCT03016741|cognitive dysfunction|cognitive dysfunction
42961|NCT03016741|mild cognitive impairment|mild cognitive impairment
42962|NCT03016728|exercise|exercise
42963|NCT03016728|physical activity|physical activity
42964|NCT03016728|pilot study|pilot study
42965|NCT03016728|randomized controlled trial|randomized controlled trial
42966|NCT03016728|cancer|cancer
42967|NCT03016728|adolescent and young adult|adolescent and young adult
42968|NCT03016728|AYA|aya
42969|NCT03016715|Epidermolysis bullosa simplex|epidermolysis bullosa simplex
42974|NCT03016650|Ibuprofen|ibuprofen
42975|NCT03016637|endoscopic ultrasonography|endoscopic ultrasonography
42976|NCT03016637|EUS-FNA|eus-fna
42977|NCT03016598|oxytocin|oxytocin
42978|NCT03016598|substance-related disorders|substance-related disorders
42979|NCT03016598|Methadone Maintenance Therapy|methadone maintenance therapy
42980|NCT03016598|Psychophysiology|psychophysiology
42981|NCT03016598|Stress Biomarkers|stress biomarkers
42982|NCT03016572|Suicide|suicide
42983|NCT03016572|Adolescent|adolescent
42984|NCT03016572|Intervention|intervention
42985|NCT03016572|Crisis|crisis
42986|NCT03016572|Follow-Up|follow-up
42987|NCT03016559|releasing muscle, quadratus lumborum, hip angle|releasing muscle, quadratus lumborum, hip angle
42988|NCT03016546|Pregnancy|pregnancy
42989|NCT03016533|Dolutegravir|dolutegravir
42990|NCT03016533|Continued access study|continued access study
42991|NCT03016533|HIV-1|hiv-1
42992|NCT03016533|GSK1349572|gsk1349572
42993|NCT03016533|Pediatric|pediatric
42994|NCT03016507|intraocular pressure|intraocular pressure
42995|NCT03016507|phacoemulsification|phacoemulsification
42996|NCT03016507|cataract|cataract
42997|NCT03016468|Oral Treprostinil|oral treprostinil
42998|NCT03016468|Remodulin|remodulin
42999|NCT03016468|Selexipag|selexipag
43000|NCT03016468|6 Minute Walk Test|6 minute walk test
43001|NCT03016455|Kidney Transplant|kidney transplant
43002|NCT03016455|Immunology|immunology
43003|NCT03016442|Double balloon catheter|double balloon catheter
43004|NCT03016442|Dinoprostone|dinoprostone
43005|NCT03016442|Labor induction|labor induction
43006|NCT03016429|pacemaker|pacemaker
43007|NCT03016429|defibrillator|defibrillator
43008|NCT03016429|magnetic resonance imaging|magnetic resonance imaging
43009|NCT03016429|cardiac implantable electronic device|cardiac implantable electronic device
43010|NCT03016390|Cardiac Implantable Electronic Device|cardiac implantable electronic device
43011|NCT03016390|Pacemaker|pacemaker
43012|NCT03016390|Automatic Implantable Cardioverter-Defibrillator (AICD)|automatic implantable cardioverter-defibrillator (aicd)
43013|NCT03016390|Electromagnetic interference (EMI)|electromagnetic interference (emi)
43014|NCT03016390|Keyless access system|keyless access system
43015|NCT03016390|Keyless entry system|keyless entry system
43016|NCT03016377|CAR T cells|car t cells
43017|NCT03016377|CD19|cd19
43018|NCT03016377|Leukemia|leukemia
43019|NCT03016377|T Lymphocytes|t lymphocytes
43020|NCT03016377|AP1903|ap1903
43021|NCT03016377|Cytokine Release Syndrome|cytokine release syndrome
43022|NCT03016351|Hypertension|hypertension
43023|NCT03016351|Exercise|exercise
43024|NCT03016351|African Americans|african americans
43025|NCT03016351|Arterial Function|arterial function
43026|NCT03016351|Arterial Stiffness|arterial stiffness
43027|NCT03016286|Whole body vibration|whole body vibration
43028|NCT03016286|Bone myoregulation reflex|bone myoregulation reflex
43029|NCT03016286|H-reflex|h-reflex
43030|NCT03016260|Rheumatoid Arthritis|rheumatoid arthritis
43031|NCT03016260|Anti TNF|anti tnf
43032|NCT03016260|Infliximab|infliximab
43033|NCT03016260|Adalimumab|adalimumab
43034|NCT03016260|Etanercept|etanercept
43035|NCT03016260|Golimumab|golimumab
43036|NCT03016260|Certolizumab Pegol|certolizumab pegol
43037|NCT03016260|Infliximab biosimilar|infliximab biosimilar
43038|NCT03016260|Etanercept biosimilar|etanercept biosimilar
43039|NCT03016260|Methotrexate|methotrexate
43040|NCT03016247|magnetic resonance imaging, trust, reward|magnetic resonance imaging, trust, reward
43041|NCT03016234|intraocular pressure|intraocular pressure
43042|NCT03016234|trendelenburg position|trendelenburg position
43043|NCT03016234|pneumoperitoneum|pneumoperitoneum
43044|NCT03016221|local skin responses|local skin responses
43045|NCT03016221|hyperemia|hyperemia
43046|NCT03016221|thermal sensation|thermal sensation
43047|NCT03016221|topical warming ointments|topical warming ointments
43048|NCT03016221|topical cooling ointments|topical cooling ointments
43049|NCT03016221|skin perfusion|skin perfusion
43050|NCT03016221|subjective thermal sensation|subjective thermal sensation
43051|NCT03016221|muscle tissue oxygenation|muscle tissue oxygenation
43052|NCT03016221|skin temperature|skin temperature
43053|NCT03016221|skin redness|skin redness
43054|NCT03016221|erythema|erythema
43055|NCT03016143|phase II|phase ii
43056|NCT03016143|split|split
43057|NCT03016143|vaccine|vaccine
43058|NCT03016130|leukemia|leukemia
43059|NCT03016130|myelodysplastic|myelodysplastic
43060|NCT03016130|myeloid|myeloid
43061|NCT03016130|lymphoblastic|lymphoblastic
43062|NCT03016130|diet|diet
43063|NCT03016130|infection|infection
43064|NCT03016130|hematopoietic|hematopoietic
43065|NCT03016130|stem cell|stem cell
43066|NCT03016130|transplant|transplant
43067|NCT03016104|magnetic seizure therapy|magnetic seizure therapy
43068|NCT03016104|electroconvulsive therapy|electroconvulsive therapy
43069|NCT03016104|bipolar mania|bipolar mania
43070|NCT03016104|cognition|cognition
43071|NCT03016104|controlled trial|controlled trial
43072|NCT03016052|ABMT|abmt
43073|NCT03016052|social anxiety|social anxiety
43074|NCT03016052|generalized anxiety|generalized anxiety
43075|NCT03016026|ERAS,Laparoscopy,Distal Gastrectomy,Safety,Effectiveness|eras,laparoscopy,distal gastrectomy,safety,effectiveness
43076|NCT03016000|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
43077|NCT03016000|Thalidomide|thalidomide
43078|NCT03016000|Maintenance|maintenance
43079|NCT03015987|Diode laser|diode laser
43080|NCT03015987|asymptomatic pulp|asymptomatic pulp
43081|NCT03015987|Laser activated irrigation|laser activated irrigation
43082|NCT03015987|continuous ultrasonic activation|continuous ultrasonic activation
43083|NCT03015987|post obturation pain|post obturation pain
43084|NCT03015935|Obesity, Morbid|obesity, morbid
43085|NCT03015883|Squamous Cell Carcinoma|squamous cell carcinoma
43086|NCT03015883|Alpha emitting radiation|alpha emitting radiation
43087|NCT03015870|vocal dysfunction|vocal dysfunction
43088|NCT03015870|voice|voice
43089|NCT03015870|vocal folds|vocal folds
43090|NCT03015870|vocal aging|vocal aging
43091|NCT03015844|MIBG|mibg
43092|NCT03015844|131I-MIBG|131i-mibg
43093|NCT03015844|relapsed|relapsed
43094|NCT03015844|neuroblastoma|neuroblastoma
43095|NCT03015844|pheochromocytoma|pheochromocytoma
43096|NCT03015831|Atrial fibrillation|atrial fibrillation
43097|NCT03015831|Cardiac surgery|cardiac surgery
43098|NCT03015831|Colchicine|colchicine
43099|NCT03015766|insomnia|insomnia
43100|NCT03015766|hemodialysis|hemodialysis
43405|NCT03014232|cytokines|cytokines
43101|NCT03015766|auricular acupressure|auricular acupressure
43102|NCT03015766|randomized controlled trial|randomized controlled trial
43103|NCT03015753|Migraine|migraine
43104|NCT03015753|Tai Chi|tai chi
43105|NCT03015753|Prophylaxis|prophylaxis
43106|NCT03015753|Randomized controlled trial|randomized controlled trial
34733|NCT03069235|HIV|hiv
43107|NCT03015740|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
43108|NCT03015740|Other disorders of kidney and ureter|other disorders of kidney and ureter
43109|NCT03015740|Renal cell carcinoma|renal cell carcinoma
43111|NCT03015740|Metastatic|metastatic
43112|NCT03015740|MGCD516|mgcd516
43113|NCT03015740|Nivolumab|nivolumab
43114|NCT03015740|BMS-936558|bms-936558
43115|NCT03015740|Opdivo|opdivo
43116|NCT03015727|nasopharyngeal carcinoma|nasopharyngeal carcinoma
43117|NCT03015727|Induction chemotherapy|induction chemotherapy
43118|NCT03015727|radiotherapy|radiotherapy
43119|NCT03015727|chemoradiotherapy|chemoradiotherapy
43120|NCT03015701|Unresectable|unresectable
43121|NCT03015688|Biomarkers|biomarkers
43122|NCT03015662|Quality of Life|quality of life
43123|NCT03015662|Fatigue|fatigue
43124|NCT03015662|Anxiety|anxiety
43125|NCT03015662|Physical Therapy Modalities|physical therapy modalities
43127|NCT03015649|breast cancer, surgical guidance system|breast cancer, surgical guidance system
43128|NCT03015636|Cognitive Behaviour Therapy|cognitive behaviour therapy
43129|NCT03015636|Psychological Intervention|psychological intervention
43130|NCT03015623|Mesenchymal stromal cells|mesenchymal stromal cells
43131|NCT03015623|MSC|msc
43132|NCT03015623|Stem cells|stem cells
43133|NCT03015623|Mesenchymal stem cells|mesenchymal stem cells
43134|NCT03015610|Personalized Medicine|personalized medicine
43135|NCT03015610|CYP2C19|cyp2c19
43136|NCT03015610|Lansoprazole|lansoprazole
43137|NCT03015610|Pharmacokinetics|pharmacokinetics
43138|NCT03015597|Smoking|smoking
43139|NCT03015597|Tobacco Smoking|tobacco smoking
43140|NCT03015597|Smoking, Tobacco|smoking, tobacco
43141|NCT03015597|Smoking Cessation|smoking cessation
43142|NCT03015597|Opiate Addiction|opiate addiction
43143|NCT03015597|Opiate Dependence|opiate dependence
43144|NCT03015597|Contingency Management|contingency management
43145|NCT03015571|heterotopic gastric mucosa|heterotopic gastric mucosa
43146|NCT03015571|cervical inlet patch|cervical inlet patch
43147|NCT03015571|narrow band imaging|narrow band imaging
43148|NCT03015571|endoscopy|endoscopy
43149|NCT03015558|Drug Resistance|drug resistance
43150|NCT03015558|Neuropathic Pain|neuropathic pain
43151|NCT03015558|opercular-insular cortex|opercular-insular cortex
43152|NCT03015558|Transcranial Direct Current Stimulation|transcranial direct current stimulation
43153|NCT03015545|Muscle Stiffness|muscle stiffness
43154|NCT03015545|Ultrasound elastography|ultrasound elastography
43155|NCT03015545|H-reflex|h-reflex
43156|NCT03015545|Whole body vibration|whole body vibration
43157|NCT03015519|GSK716155|gsk716155
43158|NCT03015519|Type 2 diabetes mellitus|type 2 diabetes mellitus
43159|NCT03015519|albiglutide|albiglutide
43160|NCT03015519|safety|safety
43161|NCT03015519|pediatric|pediatric
43162|NCT03015519|efficacy|efficacy
43163|NCT03015493|Neck pain|neck pain
43164|NCT03015493|Neurodynamics|neurodynamics
43165|NCT03015493|Spinal manipulative therapy|spinal manipulative therapy
43166|NCT03015480|Mobile Application|mobile application
43167|NCT03015480|Chronic Kidney Disease|chronic kidney disease
43168|NCT03015480|Diabetes Mellitus|diabetes mellitus
43170|NCT03015480|Diet|diet
43171|NCT03015467|acute pancreatitis|acute pancreatitis
43172|NCT03015467|intestinal mucosal barrier|intestinal mucosal barrier
43173|NCT03015467|Fecal Microbiota Transplantation|fecal microbiota transplantation
43174|NCT03015454|InSight|insight
43175|NCT03015454|Dascena|dascena
43176|NCT03015441|Healthy subjects|healthy subjects
43177|NCT03015441|Probiotics|probiotics
43178|NCT03015441|Breath test|breath test
43179|NCT03015441|Dihydrogen|dihydrogen
43180|NCT03015441|Methane|methane
43181|NCT03015441|Intestinal gas production|intestinal gas production
43182|NCT03015441|Gut microbiota|gut microbiota
43183|NCT03015428|Family caregivers|family caregivers
43184|NCT03015428|training programme|training programme
43185|NCT03015428|dementia|dementia
43186|NCT03015415|elbow|elbow
43187|NCT03015415|posttraumatic stiffness|posttraumatic stiffness
43188|NCT03015415|elbow contractures|elbow contractures
43189|NCT03015415|stiff elbow|stiff elbow
43190|NCT03015415|dynamic orthoses|dynamic orthoses
43191|NCT03015415|Dynamic splint|dynamic splint
43192|NCT03015415|Rehabilitation|rehabilitation
43193|NCT03015415|Splint|splint
43194|NCT03015415|Effectiveness of bracing|effectiveness of bracing
43195|NCT03015376|epithelial ovarian cancer|epithelial ovarian cancer
43196|NCT03015376|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
43197|NCT03015376|next-generation sequencing|next-generation sequencing
43198|NCT03015376|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
43199|NCT03015363|Hypertension|hypertension
43200|NCT03015363|Telemonitoring|telemonitoring
43201|NCT03015363|Vital signs|vital signs
43202|NCT03015350|blood sevoflurane concentration|blood sevoflurane concentration
43203|NCT03015350|blood desflurane concentration|blood desflurane concentration
43204|NCT03015350|one lung ventilation|one lung ventilation
43205|NCT03015311|Blood pressure control|blood pressure control
43206|NCT03015298|gastric cancer|gastric cancer
43207|NCT03015298|Simultaneous PET/MRI|simultaneous pet/mri
43208|NCT03015298|PET/CT|pet/ct
43209|NCT03015272|minimally-verbal|minimally-verbal
43210|NCT03015272|children|children
43211|NCT03015272|intervention|intervention
43212|NCT03015272|singing|singing
43213|NCT03015272|music|music
43214|NCT03015233|Lactate|lactate
622561|NCT00670306|Cetrorelix|cetrorelix
43215|NCT03015233|Acute Abdominal Pain|acute abdominal pain
43216|NCT03015233|Acute Abdomen|acute abdomen
43217|NCT03015233|Strong Ion Gap|strong ion gap
43218|NCT03015233|Renal Colic|renal colic
43219|NCT03015233|Emergency Department|emergency department
43220|NCT03015233|Emergency|emergency
43221|NCT03015233|Surgery|surgery
43222|NCT03015233|Stewart|stewart
43223|NCT03015194|LVOT (left ventricular outflow tract, obstruction)|lvot (left ventricular outflow tract, obstruction)
43224|NCT03015194|Transcatheter Mitral Valve Implantation|transcatheter mitral valve implantation
43225|NCT03015194|Transcatheter Heart Valve|transcatheter heart valve
43226|NCT03015194|Mitral Valve Regurgitation|mitral valve regurgitation
43227|NCT03015194|Mitral Valve Stenosis|mitral valve stenosis
43228|NCT03015181|Broadly Neutralizing|broadly neutralizing
43229|NCT03015181|HIV Prevention|hiv prevention
43230|NCT03015181|Anti-Drug Antibody|anti-drug antibody
43231|NCT03015181|HIV-1|hiv-1
43232|NCT03015181|Immune Response|immune response
43233|NCT03015129|Durvalumab|durvalumab
43234|NCT03015129|MEDI4736|medi4736
43235|NCT03015129|Tremelimumab|tremelimumab
43236|NCT03015129|anti-PD-L1 Antibody|anti-pd-l1 antibody
43237|NCT03015129|anti-CTLA-4 antibody|anti-ctla-4 antibody
43238|NCT03015129|16-1491|16-1491
43239|NCT03015116|photobiomodulation|photobiomodulation
43240|NCT03015116|plantar fasciitis|plantar fasciitis
43241|NCT03015090|COPD|copd
43242|NCT03015090|CYP1A2|cyp1a2
43243|NCT03015090|Theophylline|theophylline
43244|NCT03015077|Glutamine|glutamine
43245|NCT03015051|Bronchiolitis|bronchiolitis
43246|NCT03015051|High flow nasal cannula|high flow nasal cannula
43247|NCT03015051|Oxygen therapy|oxygen therapy
43248|NCT03015025|Acenocoumarol|acenocoumarol
43249|NCT03015025|Cytochrome P450|cytochrome p450
43250|NCT03015025|Pharmacogenetics|pharmacogenetics
43251|NCT03015025|Algorithm|algorithm
43252|NCT03015025|CYP2C9|cyp2c9
43253|NCT03015025|VKORC1|vkorc1
43254|NCT03015025|CYP4F2|cyp4f2
43255|NCT03015025|P450 oxidoreductase (POR)|p450 oxidoreductase (por)
43256|NCT03015012|Nutrigenomics|nutrigenomics
43257|NCT03015012|Genetics|genetics
43258|NCT03015012|Overweight|overweight
43259|NCT03015012|Obesity|obesity
43260|NCT03015012|Transplantation|transplantation
43261|NCT03015012|Nutrition|nutrition
43262|NCT03015012|Dietetics|dietetics
43264|NCT03015012|Body Composition|body composition
43265|NCT03014999|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
43266|NCT03014999|Spinal Cord Injury|spinal cord injury
43268|NCT03014986|HCV|hcv
43269|NCT03014947|MSB11022|msb11022
43270|NCT03014947|Humira®|humira®
43271|NCT03014934|Aspergillosis|aspergillosis
43272|NCT03014934|IA|ia
43273|NCT03014908|Type 1 diabetes|type 1 diabetes
43274|NCT03014908|1H-NMR spectroscopy|1h-nmr spectroscopy
43275|NCT03014908|Metabolomics|metabolomics
43276|NCT03014908|Pediatrics|pediatrics
43277|NCT03014895|E3112|e3112
43278|NCT03014895|Pharmacokinetics|pharmacokinetics
43279|NCT03014895|Japanese|japanese
43280|NCT03014869|COPD Exacerbation|copd exacerbation
43281|NCT03014869|High Flow Oxygen|high flow oxygen
43282|NCT03014869|Noninvasive Positive Ventilation|noninvasive positive ventilation
43283|NCT03014869|moderate|moderate
43284|NCT03014856|Metabolic syndrome|metabolic syndrome
43285|NCT03014856|Metabolomics|metabolomics
43286|NCT03014856|NMR spectroscopy|nmr spectroscopy
43287|NCT03014843|Esophagal sensitivity, GERD, endogenous opiods|esophagal sensitivity, gerd, endogenous opiods
43288|NCT03014791|Epidemiology|epidemiology
43289|NCT03014791|Ethnicity|ethnicity
43290|NCT03014791|Age|age
43291|NCT03014791|Weight|weight
43292|NCT03014791|Hypertensive|hypertensive
43293|NCT03014791|Cardiac Output|cardiac output
43294|NCT03014791|Peripheral Vascular Resistance|peripheral vascular resistance
43295|NCT03014791|Arterial Stiffness|arterial stiffness
43296|NCT03014791|Healthy Volunteers|healthy volunteers
43297|NCT03014791|Endothelial function|endothelial function
43298|NCT03014791|Arterial Structure|arterial structure
43299|NCT03014791|Left ventricular mass/function|left ventricular mass/function
43300|NCT03014765|endothelial dysfunction|endothelial dysfunction
43301|NCT03014765|perioperative stress|perioperative stress
43302|NCT03014765|cardiovascular complications|cardiovascular complications
43303|NCT03014765|inflammatory markers|inflammatory markers
43304|NCT03014739|Elastography|elastography
43305|NCT03014739|Musculoskeletal System|musculoskeletal system
43306|NCT03014726|reduced urine flow rate|reduced urine flow rate
43307|NCT03014726|low peak flow rate|low peak flow rate
43308|NCT03014726|urinary tract infections|urinary tract infections
43309|NCT03014713|Dexmedetomidine|dexmedetomidine
43310|NCT03014713|Dezocine|dezocine
43311|NCT03014713|Flubiprofen|flubiprofen
43312|NCT03014713|Analgesia|analgesia
43313|NCT03014713|Colorectal Surgery|colorectal surgery
43314|NCT03014687|transsphenoidal surgery|transsphenoidal surgery
43315|NCT03014674|SB-240563|sb-240563
43316|NCT03014674|subcutaneous|subcutaneous
43317|NCT03014674|lyophilized drug product|lyophilized drug product
43318|NCT03014674|Mepolizumab|mepolizumab
43319|NCT03014674|liquid drug product|liquid drug product
43320|NCT03014674|safety syringe|safety syringe
43321|NCT03014674|auto injector|auto injector
43322|NCT03014661|pollinosis, quality of life, specific immunotherapy|pollinosis, quality of life, specific immunotherapy
43323|NCT03014635|glabellar lines, frown lines|glabellar lines, frown lines
43324|NCT03014622|glabellar lines, frown lines|glabellar lines, frown lines
43325|NCT03014609|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
43326|NCT03014609|cardiovascular risk|cardiovascular risk
43434|NCT03014050|depression|depression
43327|NCT03014609|inflammation|inflammation
43328|NCT03014609|oxidative stress|oxidative stress
43329|NCT03014609|peripheral muscle function|peripheral muscle function
43330|NCT03014570|behavior,|behavior,
43331|NCT03014570|apathy|apathy
43332|NCT03014570|mood|mood
43333|NCT03014570|function|function
43334|NCT03014570|cognition|cognition
43335|NCT03014557|atrial fibrillation|atrial fibrillation
43336|NCT03014557|left atrial appendage closure|left atrial appendage closure
43337|NCT03014557|WATCHMAN|watchman
43338|NCT03014518|Adolescent|adolescent
43339|NCT03014518|Biological Markers|biological markers
43340|NCT03014518|Biomarkers|biomarkers
43341|NCT03014518|Biomarkers for suicidality|biomarkers for suicidality
43342|NCT03014518|Blood brain barrier|blood brain barrier
43343|NCT03014518|Clinical predictors|clinical predictors
43344|NCT03014518|Cytokine|cytokine
43345|NCT03014518|Feeling suicidal|feeling suicidal
43346|NCT03014518|Inflammation|inflammation
43347|NCT03014518|Inflammatory marker|inflammatory marker
43348|NCT03014518|Inpatient discharge|inpatient discharge
43349|NCT03014518|Interleukin-1 beta|interleukin-1 beta
43350|NCT03014518|IL-1ß|il-1ß
43351|NCT03014518|Interleukin-6|interleukin-6
43352|NCT03014518|IL-6|il-6
43353|NCT03014518|Kynurenic acid|kynurenic acid
43354|NCT03014518|Kynurenine pathway|kynurenine pathway
43355|NCT03014518|Neuroinflammation|neuroinflammation
43356|NCT03014518|Novel marker|novel marker
43357|NCT03014518|Peripheral blood biomarkers|peripheral blood biomarkers
43358|NCT03014518|Picolinic acid|picolinic acid
43359|NCT03014518|Plasma biomarker|plasma biomarker
43360|NCT03014518|Psychiatric inpatient|psychiatric inpatient
43361|NCT03014518|S100B|s100b
43362|NCT03014518|Serum biomarker|serum biomarker
43363|NCT03014518|Stress|stress
43364|NCT03014518|Suicide|suicide
43365|NCT03014518|Suicidal behavior|suicidal behavior
43366|NCT03014518|Suicidal risk|suicidal risk
43367|NCT03014518|Tumor necrosis factor alpha|tumor necrosis factor alpha
43368|NCT03014518|TNF-α|tnf-α
43369|NCT03014505|Cirrhosis|cirrhosis
43370|NCT03014505|Fecal Microbiota Transplantation|fecal microbiota transplantation
43371|NCT03014505|Intestinal flora|intestinal flora
43372|NCT03014505|Intestinal mucosal barrier|intestinal mucosal barrier
43373|NCT03014505|Intestinal Bacteria Flora Disturbance|intestinal bacteria flora disturbance
43374|NCT03014401|stem cell|stem cell
43375|NCT03014401|knee pain|knee pain
43376|NCT03014401|osteoarthritis|osteoarthritis
43377|NCT03014401|arthritis|arthritis
43378|NCT03014401|ADSC|adsc
43379|NCT03014401|fat stem cell|fat stem cell
43380|NCT03014349|Glaucoma|glaucoma
43381|NCT03014349|Ocular hypertension|ocular hypertension
43382|NCT03014336|co2 removal, anesthesia|co2 removal, anesthesia
43383|NCT03014323|insulin sensitivity|insulin sensitivity
43384|NCT03014323|African American|african american
43385|NCT03014323|obese|obese
43386|NCT03014310|A/H5N8|a/h5n8
43387|NCT03014310|Adjuvants|adjuvants
43388|NCT03014310|AS03|as03
43389|NCT03014310|Inactivated|inactivated
43390|NCT03014310|Influenza|influenza
43391|NCT03014310|MF59|mf59
43392|NCT03014310|Monovalent|monovalent
43393|NCT03014284|Tissue collection|tissue collection
43394|NCT03014284|colonoscopic surgical procedures|colonoscopic surgical procedures
43395|NCT03014258|Biology|biology
43396|NCT03014258|falciparum|falciparum
43397|NCT03014258|Immunity|immunity
43398|NCT03014258|Infections|infections
43399|NCT03014258|Malaria|malaria
43400|NCT03014258|Pf|pf
43401|NCT03014258|Plasmodium|plasmodium
43402|NCT03014258|Systems|systems
43403|NCT03014232|sustained low-efficiency diafiltration (SLED-f)|sustained low-efficiency diafiltration (sled-f)
43404|NCT03014232|high cut-off dialyzer|high cut-off dialyzer
43406|NCT03014180|Heart failure, CRT|heart failure, crt
43407|NCT03014167|transmission interruption|transmission interruption
43408|NCT03014167|intestinal nematodes|intestinal nematodes
43409|NCT03014167|soil-transmitted helminths|soil-transmitted helminths
43410|NCT03014167|mass drug administration|mass drug administration
43411|NCT03014167|Benin|benin
43412|NCT03014167|India|india
43413|NCT03014167|Malawi|malawi
43414|NCT03014154|video games|video games
43415|NCT03014154|asthma|asthma
43416|NCT03014154|physical exercise|physical exercise
43417|NCT03014128|musculoskeletal disorders|musculoskeletal disorders
43418|NCT03014128|upper extremity|upper extremity
43419|NCT03014128|work|work
43420|NCT03014128|surgical instruments|surgical instruments
43421|NCT03014115|arachidonic|arachidonic
43422|NCT03014115|docosahexaenoic acid|docosahexaenoic acid
43423|NCT03014115|infant formula|infant formula
43424|NCT03014089|mRNA-1325|mrna-1325
43425|NCT03014089|Zika vaccine|zika vaccine
43426|NCT03014063|sepsis|sepsis
43427|NCT03014063|septic shock|septic shock
43428|NCT03014063|vasopressin|vasopressin
43429|NCT03014063|AVP|avp
43430|NCT03014050|physical activity|physical activity
43431|NCT03014050|fitness|fitness
43432|NCT03014050|cognition|cognition
43433|NCT03014050|mood|mood
43435|NCT03014050|anxiety|anxiety
43436|NCT03014050|sleep quality|sleep quality
43437|NCT03014050|tremor|tremor
43438|NCT03014050|gait|gait
43439|NCT03014037|Orthopedics|orthopedics
43440|NCT03014024|Distal Radius Fracture|distal radius fracture
43441|NCT03014024|Low Level Laser Therapy|low level laser therapy
43442|NCT03013985|Blood glucose|blood glucose
43443|NCT03013972|ColoRectal Cancer|colorectal cancer
43444|NCT03013972|Adjuvant Chemotherapy|adjuvant chemotherapy
43445|NCT03013972|Cancer-related Fatigue|cancer-related fatigue
43446|NCT03013972|Brief fatigue inventory (BFI)|brief fatigue inventory (bfi)
43447|NCT03013972|Functional Assessment of Cancer Therapy-General 7 (FACT-G7)|functional assessment of cancer therapy-general 7 (fact-g7)
43448|NCT03013920|upper urinary tract cancer|upper urinary tract cancer
43449|NCT03013920|confocal laser endomicroscopy|confocal laser endomicroscopy
43450|NCT03013920|urothelial carcinoma|urothelial carcinoma
43451|NCT03013907|Hypertension|hypertension
43452|NCT03013907|Coping|coping
43453|NCT03013907|Relaxing|relaxing
43454|NCT03013894|bladder neoplasm|bladder neoplasm
43455|NCT03013894|urothelium carcinoma|urothelium carcinoma
43456|NCT03013894|confocal laser endomicroscopy|confocal laser endomicroscopy
43457|NCT03013881|UB-921|ub-921
43458|NCT03013881|anti-HER2 monoclonal antibody|anti-her2 monoclonal antibody
43459|NCT03013881|breast neoplasm|breast neoplasm
43460|NCT03013881|breast cancer|breast cancer
43461|NCT03013881|Herceptin|herceptin
43462|NCT03013881|Trastuzumab|trastuzumab
43463|NCT03013881|HER2|her2
43464|NCT03013855|Digital rectal exam|digital rectal exam
43465|NCT03013855|Colon cancer screening|colon cancer screening
43466|NCT03013842|pregnancy|pregnancy
43467|NCT03013842|fetal monitoring|fetal monitoring
43468|NCT03013842|fetal oximetry|fetal oximetry
43469|NCT03013842|fetal heart rate|fetal heart rate
43470|NCT03013842|pulse oximetry|pulse oximetry
43471|NCT03013842|near infrared spectroscopy|near infrared spectroscopy
43472|NCT03013829|Kidney Paired Donation|kidney paired donation
43473|NCT03013777|Familial dysautonomia|familial dysautonomia
43475|NCT03013699|nutrition|nutrition
43476|NCT03013699|survival|survival
43477|NCT03013699|recurrence|recurrence
43478|NCT03013699|cruciferous|cruciferous
43479|NCT03013699|dark leafy greens|dark leafy greens
43480|NCT03013673|leishmaniasis, visceral, neglected, HIV, co-infection, asymptomatic, Ethiopia|leishmaniasis, visceral, neglected, hiv, co-infection, asymptomatic, ethiopia
43481|NCT03013647|actinic keratosis|actinic keratosis
43482|NCT03013647|field cancerization|field cancerization
43483|NCT03013647|photodynamic therapy|photodynamic therapy
43484|NCT03013647|daylight photodynamic therapy|daylight photodynamic therapy
43485|NCT03013634|dexmedetomidine|dexmedetomidine
43486|NCT03013621|Renal Failure|renal failure
43487|NCT03013621|Renal Insufficiency|renal insufficiency
43488|NCT03013621|Acute Renal Failure|acute renal failure
43489|NCT03013621|Acute Renal Injury|acute renal injury
43490|NCT03013621|Kidney Failure|kidney failure
43491|NCT03013621|Kidney Insufficiency|kidney insufficiency
43492|NCT03013621|Acute Kidney Failure|acute kidney failure
43493|NCT03013621|Acute Kidney Injury|acute kidney injury
43494|NCT03013621|Ventricular dysfunction|ventricular dysfunction
43495|NCT03013621|Venous congestion|venous congestion
43496|NCT03013621|Renal function|renal function
43497|NCT03013621|Kidney function|kidney function
43498|NCT03013621|Venous heart failure|venous heart failure
43499|NCT03013608|Nail bed injury|nail bed injury
43500|NCT03013608|Nail bed injuries|nail bed injuries
43501|NCT03013608|Nail|nail
43502|NCT03013608|Children|children
43503|NCT03013608|Fingertip injury|fingertip injury
43504|NCT03013595|Mental health|mental health
43505|NCT03013595|Youth mental health|youth mental health
43506|NCT03013595|Adolescent|adolescent
43507|NCT03013595|Health services|health services
43508|NCT03013595|Transition|transition
35126|NCT03066817|Deficiency|deficiency
35127|NCT03066817|Insufficiency|insufficiency
35128|NCT03066817|Bone turnover|bone turnover
35129|NCT03066817|Bone healing|bone healing
43509|NCT03013595|Longitudinal cohort study|longitudinal cohort study
43510|NCT03013595|Cluster randomised controlled trial|cluster randomised controlled trial
43511|NCT03013595|Young adult|young adult
43512|NCT03013556|HBeAg positive|hbeag positive
43513|NCT03013543|POMC deficiency obesity|pomc deficiency obesity
43514|NCT03013543|LepR deficiency obesity|lepr deficiency obesity
43515|NCT03013543|Bardet-Biedl syndrome|bardet-biedl syndrome
43516|NCT03013543|Alström Syndrome|alström syndrome
43517|NCT03013530|Intensive care unit|intensive care unit
43518|NCT03013530|Triage and Therapy.|triage and therapy.
43519|NCT03013530|Advance Directives (AD).|advance directives (ad).
43520|NCT03013530|Simulation model of real situations. (hypothetical scenario)|simulation model of real situations. (hypothetical scenario)
43521|NCT03013530|Intensivist physician.|intensivist physician.
43522|NCT03013517|Allergy|allergy
43523|NCT03013517|food allergy|food allergy
43524|NCT03013517|viaskin|viaskin
43525|NCT03013517|peanut|peanut
43526|NCT03013517|epicutaneous|epicutaneous
43527|NCT03013504|randomized|randomized
43528|NCT03013504|double-blind|double-blind
43529|NCT03013504|parallel group|parallel group
43530|NCT03013504|equivalence|equivalence
43531|NCT03013504|multicentre|multicentre
43532|NCT03013504|phase III|phase iii
43533|NCT03013504|efficacy|efficacy
43534|NCT03013504|safety|safety
43535|NCT03013504|pharmacokinetics|pharmacokinetics
43536|NCT03013504|HD201|hd201
43537|NCT03013504|docetaxel|docetaxel
43538|NCT03013504|Herceptin|herceptin
43539|NCT03013504|HER2 positive|her2 positive
43540|NCT03013504|breast cancer|breast cancer
43541|NCT03013504|early breast cancer|early breast cancer
43542|NCT03013491|cancer|cancer
43543|NCT03013491|checkpoint inhibitor|checkpoint inhibitor
43544|NCT03013491|monotherapy|monotherapy
43545|NCT03013491|combination|combination
43546|NCT03013491|PD-L1|pd-l1
43547|NCT03013491|CTLA-4|ctla-4
43548|NCT03013491|solid tumor|solid tumor
43549|NCT03013491|lymphoma|lymphoma
43550|NCT03013491|BRAF|braf
43551|NCT03013491|PROCLAIM|proclaim
43552|NCT03013491|CX-072|cx-072
43553|NCT03013491|PROCLAIM-CX-072|proclaim-cx-072
43554|NCT03013374|protein accretion|protein accretion
43555|NCT03013374|body composition|body composition
43556|NCT03013361|ropivacaine, bupivacaine|ropivacaine, bupivacaine
43557|NCT03013335|Clear-cell|clear-cell
43558|NCT03013335|Nivolumab|nivolumab
43559|NCT03013335|Renal cell carcinoma|renal cell carcinoma
43560|NCT03013335|Immunotherapy|immunotherapy
43561|NCT03013309|Hybrid|hybrid
43562|NCT03013309|Implementation|implementation
43563|NCT03013309|Effectiveness|effectiveness
43564|NCT03013309|Parent training|parent training
43565|NCT03013309|Fidelity|fidelity
43566|NCT03013309|Cost-Effectiveness|cost-effectiveness
43567|NCT03013309|Primary Care|primary care
43568|NCT03013296|GIP|gip
43569|NCT03013296|GIP receptor antagonist|gip receptor antagonist
43570|NCT03013270|Rehabilitation|rehabilitation
43571|NCT03013270|Exercise|exercise
43572|NCT03013270|Training|training
43573|NCT03013257|Relapsed Graves' disease|relapsed graves' disease
43574|NCT03013257|High Intensity Focused Ultrasound|high intensity focused ultrasound
43575|NCT03013257|RAI|rai
43576|NCT03013244|prevention|prevention
43577|NCT03013244|eating disorder|eating disorder
43578|NCT03013244|men|men
43579|NCT03013244|intervention|intervention
43580|NCT03013244|muscle dysmorphia|muscle dysmorphia
43581|NCT03013244|peer-led|peer-led
43582|NCT03013231|ACL Reconstruction|acl reconstruction
43583|NCT03013231|Return to Sport|return to sport
43584|NCT03013231|Resilience|resilience
43585|NCT03013218|Neoplasms|neoplasms
43586|NCT03013218|CD47|cd47
43587|NCT03013218|SIRPα|sirpα
43588|NCT03013218|ALX148|alx148
43589|NCT03013205|adhesive capsulitis|adhesive capsulitis
43590|NCT03013153|Rectal Cancer|rectal cancer
43591|NCT03013153|Inferior Mesenteric Artery|inferior mesenteric artery
43592|NCT03013153|Ligation|ligation
43593|NCT03013153|Apical Lymph Nodes|apical lymph nodes
43594|NCT03013153|Laparoscopy|laparoscopy
43595|NCT03013153|IMA Types|ima types
43596|NCT03013140|Anesthesia, Obstetric|anesthesia, obstetric
43597|NCT03013140|fluid therapy|fluid therapy
43598|NCT03013140|cesarean section|cesarean section
43599|NCT03013140|spinal anesthesia|spinal anesthesia
43600|NCT03013127|Osteogenic Sarcoma|osteogenic sarcoma
43601|NCT03013127|Osteosarcoma|osteosarcoma
43602|NCT03013127|Sarcoma, Osteogenic|sarcoma, osteogenic
43603|NCT03013127|Pembrolizumab|pembrolizumab
43604|NCT03013127|Immunotherapy|immunotherapy
43605|NCT03013114|Bortezomib Immune thrombocytopenia|bortezomib immune thrombocytopenia
35239|NCT03066375|circulatory failure|circulatory failure
35240|NCT03066375|irregular cardiac rhythm|irregular cardiac rhythm
35241|NCT03066375|fluid responsiveness|fluid responsiveness
35242|NCT03066375|Spontaneous breathing|spontaneous breathing
43606|NCT03013101|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
43607|NCT03013101|advanced|advanced
43608|NCT03013101|metastatic|metastatic
43609|NCT03013101|melanoma|melanoma
43610|NCT03013088|Chronic|chronic
43611|NCT03013088|Occlusion|occlusion
43612|NCT03013088|CTO|cto
43613|NCT03013023|Behavioral and Transaction Interventions|behavioral and transaction interventions
43614|NCT03013023|Parents' Biopsychosocial Well-being|parents' biopsychosocial well-being
43615|NCT03013023|Preterm Infants|preterm infants
43616|NCT03013023|Sleep|sleep
43617|NCT03013023|Salivary cortisol|salivary cortisol
43618|NCT03013010|Randomized|randomized
43619|NCT03013010|Open Label|open label
43620|NCT03013010|Multicenter|multicenter
43621|NCT03012984|elderly|elderly
43622|NCT03012984|surgery|surgery
43623|NCT03012984|analgesia|analgesia
43624|NCT03012984|dexmedetomidine|dexmedetomidine
43625|NCT03012984|delirium|delirium
43626|NCT03012971|Elderly|elderly
43627|NCT03012971|Surgery|surgery
43628|NCT03012971|Analgesia|analgesia
43629|NCT03012971|Dexmedetomidine|dexmedetomidine
43630|NCT03012971|Long-term outcome|long-term outcome
43631|NCT03012945|Elderly|elderly
43632|NCT03012945|Cancer surgery|cancer surgery
44350|NCT03008070|IVA337|iva337
43633|NCT03012945|Epidural anesthesia and analgesia|epidural anesthesia and analgesia
43634|NCT03012945|Long-term survival|long-term survival
43635|NCT03012945|Quality of life|quality of life
43636|NCT03012919|active decision support system|active decision support system
43637|NCT03012919|goal directed therapy|goal directed therapy
43638|NCT03012919|Lidco|lidco
43639|NCT03012919|vascular surgery|vascular surgery
43640|NCT03012919|hemodynamic optimization|hemodynamic optimization
43641|NCT03012893|ultrasonography to identify C7 spinous process|ultrasonography to identify c7 spinous process
43642|NCT03012867|criticall illness|criticall illness
43643|NCT03012867|enteral nutrition|enteral nutrition
43644|NCT03012854|Esophageal achalasia|esophageal achalasia
43645|NCT03012854|Peroral endoscopic myotomy|peroral endoscopic myotomy
43646|NCT03012854|POEM|poem
43647|NCT03012815|gabapentin|gabapentin
43648|NCT03012815|Alcohol Withdrawal Syndrome|alcohol withdrawal syndrome
43649|NCT03012815|benzodiazepine|benzodiazepine
43650|NCT03012815|symptom-triggered|symptom-triggered
43651|NCT03012724|TMS|tms
43652|NCT03012724|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
43653|NCT03012724|MDD|mdd
43654|NCT03012724|Major Depressive Disorder|major depressive disorder
43655|NCT03012659|contraceptive counseling|contraceptive counseling
43656|NCT03012659|cluster randomized trial|cluster randomized trial
43657|NCT03012659|provider counseling training|provider counseling training
43658|NCT03012646|Treprostinil|treprostinil
43659|NCT03012646|PH|ph
43660|NCT03012646|COPD|copd
43661|NCT03012646|6 Minute Walk Test|6 minute walk test
43662|NCT03012633|hyperfibrinolysis, Lysis Timer|hyperfibrinolysis, lysis timer
43663|NCT03012607|PrEP|prep
43664|NCT03012594|Small bowel motility disorder|small bowel motility disorder
43665|NCT03012594|Slow intestinal motility|slow intestinal motility
43666|NCT03012594|Small bowel bacterial overgrowth|small bowel bacterial overgrowth
43667|NCT03012555|Sickle Cell Disease|sickle cell disease
43668|NCT03012555|Vitamin D|vitamin d
43669|NCT03012529|Rifampin|rifampin
43670|NCT03012529|Double-blind|double-blind
43671|NCT03012529|Clinical Trial|clinical trial
43672|NCT03012529|Veterans|veterans
43673|NCT03012529|Diabetes|diabetes
43674|NCT03012516|Physical Therapy Specialty|physical therapy specialty
43675|NCT03012516|Exercise Test|exercise test
43676|NCT03012516|Prescriptions|prescriptions
43677|NCT03012516|Counseling|counseling
43678|NCT03012516|Primary Health Care|primary health care
43679|NCT03012516|Exercise|exercise
43680|NCT03012490|Remote monitoring|remote monitoring
43681|NCT03012477|Triple-negative metastatic breast cancer|triple-negative metastatic breast cancer
43682|NCT03012451|Stress|stress
43683|NCT03012451|Insecurity|insecurity
43684|NCT03012451|Mental Health|mental health
43685|NCT03012438|Near infrared fluorescence|near infrared fluorescence
43686|NCT03012438|ICG|icg
43687|NCT03012438|Parathyroid gland|parathyroid gland
43688|NCT03012425|Cognitive Behavioral Therapy|cognitive behavioral therapy
43689|NCT03012425|Acupuncture|acupuncture
43690|NCT03012425|17-001|17-001
43691|NCT03012399|Malignant Neoplasm of Breast|malignant neoplasm of breast
43692|NCT03012399|Breast Cancer|breast cancer
43693|NCT03012399|Hypnosedation|hypnosedation
43694|NCT03012399|Hypnotherapist|hypnotherapist
43695|NCT03012399|Questionnaires|questionnaires
43696|NCT03012399|Surveys|surveys
43697|NCT03012386|CD36|cd36
43698|NCT03012386|Endothelial dysfunction|endothelial dysfunction
43699|NCT03012386|African Americans|african americans
43700|NCT03012373|methadone|methadone
43701|NCT03012373|heroin|heroin
43702|NCT03012373|acupuncture|acupuncture
43703|NCT03012360|Infectiology|infectiology
43704|NCT03012360|Biology of infectious agents|biology of infectious agents
43705|NCT03012360|Hygiene|hygiene
43706|NCT03012360|Pneumology|pneumology
43707|NCT03012360|Critical Care|critical care
43708|NCT03012308|Myocardial Dysfunction|myocardial dysfunction
43709|NCT03012308|left ventricular|left ventricular
43710|NCT03012308|mitral valve doppler|mitral valve doppler
43711|NCT03012308|mitral ring doppler|mitral ring doppler
43712|NCT03012308|ultrasound signs|ultrasound signs
43713|NCT03012308|lung edema|lung edema
43714|NCT03012295|Genetic Testing|genetic testing
43715|NCT03012295|Chinese Population|chinese population
43716|NCT03012256|Cardio-Respiratory Disease Management|cardio-respiratory disease management
43717|NCT03012256|Chronic Disease Management|chronic disease management
43718|NCT03012256|Cluster-randomized Trial|cluster-randomized trial
43719|NCT03012256|Multi-component Intervention|multi-component intervention
43726|NCT03012204|Cerebrovascular Disease|cerebrovascular disease
43727|NCT03012204|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
43728|NCT03012178|Mitral Regurgitation|mitral regurgitation
43729|NCT03012178|Mitral valve Surgery|mitral valve surgery
43730|NCT03012178|MRI|mri
43731|NCT03012165|ADX-102|adx-102
43732|NCT03012165|Allergic Conjunctivitis|allergic conjunctivitis
43733|NCT03012152|Oncoplastic surgery|oncoplastic surgery
43734|NCT03012152|Standard conservative surgery|standard conservative surgery
44351|NCT03008057|vitamin D|vitamin d
43735|NCT03012152|Patient satisfaction|patient satisfaction
43736|NCT03012152|Margin Status|margin status
43737|NCT03012113|Adipose tissue|adipose tissue
43738|NCT03012113|Type 2 Diabetes|type 2 diabetes
43745|NCT03012048|water treatment|water treatment
43746|NCT03012035|psychotherapy|psychotherapy
43747|NCT03012035|exposition|exposition
43748|NCT03012035|spider fear|spider fear
43749|NCT03012035|expectation|expectation
43750|NCT03012022|Healthy Volunteers|healthy volunteers
43751|NCT03012022|Congestive Heart Failure|congestive heart failure
43752|NCT03012022|Cardiomyopathies|cardiomyopathies
43753|NCT03012022|Heart Failure|heart failure
43754|NCT03012022|Risk Factors|risk factors
43755|NCT03012009|Bowen's Disease|bowen's disease
43756|NCT03012009|Superficial Basal Cel Carcinoma|superficial basal cel carcinoma
43757|NCT03012009|Non melanoma skin cancer|non melanoma skin cancer
43758|NCT03012009|Photodynamic therapy|photodynamic therapy
43759|NCT03012009|PDT|pdt
43760|NCT03012009|CO2 laser|co2 laser
43761|NCT03012009|Laser assisted drug delivery|laser assisted drug delivery
43762|NCT03012009|Carbon dioxide laser|carbon dioxide laser
43763|NCT03012009|Laser assisted photodynamic therapy|laser assisted photodynamic therapy
43764|NCT03011983|Magnetoencephalography (MEG)|magnetoencephalography (meg)
43765|NCT03011983|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
43766|NCT03011892|Atopic dermatitis|atopic dermatitis
43767|NCT03011892|eczema|eczema
43768|NCT03011892|pruritus|pruritus
43769|NCT03011892|Janus kinase (JAK) inhibitors|janus kinase (jak) inhibitors
43770|NCT03011840|Patient education handout|patient education handout
43771|NCT03011840|Patient satisfaction|patient satisfaction
43772|NCT03011775|Pioglitazone, Insulin Resistance|pioglitazone, insulin resistance
43773|NCT03011775|Atherosclerosis, Coronary Heart Disease|atherosclerosis, coronary heart disease
43774|NCT03011749|Radium-223 therapy|radium-223 therapy
43775|NCT03011710|e-cigarette|e-cigarette
43776|NCT03011710|blood flow|blood flow
43777|NCT03011710|oral effects|oral effects
43778|NCT03011710|oral pH|oral ph
43779|NCT03011684|Fertility Preservation|fertility preservation
43780|NCT03011684|Breast Cancer|breast cancer
43781|NCT03011671|Malignant Glioma of Brain|malignant glioma of brain
43782|NCT03011671|Acetazolamide|acetazolamide
43783|NCT03011671|Temozolomide|temozolomide
43784|NCT03011619|Depression|depression
43785|NCT03011619|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
43786|NCT03011606|prostate|prostate
43787|NCT03011606|ablation|ablation
43788|NCT03011606|focal|focal
43789|NCT03011606|cancer|cancer
43790|NCT03011580|Vitamin D|vitamin d
43791|NCT03011567|Postpartum|postpartum
43792|NCT03011541|Stem Cells|stem cells
43793|NCT03011541|Bone Marrow Derived Stem Cells|bone marrow derived stem cells
43794|NCT03011541|BMSC|bmsc
43795|NCT03011541|Mesenchymal Stem Cells|mesenchymal stem cells
43796|NCT03011541|MSC|msc
43797|NCT03011541|Eye Disease|eye disease
43798|NCT03011541|Ophthalmology|ophthalmology
43799|NCT03011541|Ophthalmic Disease|ophthalmic disease
43800|NCT03011541|Retina|retina
43801|NCT03011541|Retinal Disease|retinal disease
43802|NCT03011541|Macular Degeneration|macular degeneration
43803|NCT03011541|Age Related Macular Degeneration|age related macular degeneration
43804|NCT03011541|Myopic Macular Degeneration|myopic macular degeneration
43805|NCT03011541|Geographic Atrophy|geographic atrophy
43806|NCT03011541|Dry Macular Degeneration|dry macular degeneration
43807|NCT03011541|Wet Macular Degeneration|wet macular degeneration
43808|NCT03011541|Retinal Atrophy|retinal atrophy
43809|NCT03011541|Retinal Dystrophy|retinal dystrophy
43810|NCT03011541|Hereditary Retinal Dystrophy|hereditary retinal dystrophy
43811|NCT03011541|Malattia Leventinese|malattia leventinese
43812|NCT03011541|Retinitis Pigmentosa|retinitis pigmentosa
43813|NCT03011541|Stargardt Disease|stargardt disease
43814|NCT03011541|Cone Dystrophy|cone dystrophy
43815|NCT03011541|Rod-Cone Dystrophy|rod-cone dystrophy
43816|NCT03011541|Cone-Rod Dystrophy|cone-rod dystrophy
43817|NCT03011541|Maculopathy|maculopathy
43818|NCT03011541|Optic Nerve Disease|optic nerve disease
43819|NCT03011541|Optic Atrophy|optic atrophy
43820|NCT03011541|Optic Neuropathy|optic neuropathy
43821|NCT03011541|Ischemic Optic Neuropathy|ischemic optic neuropathy
43822|NCT03011541|Optic Nerve Damage|optic nerve damage
43823|NCT03011541|Optic Nerve Compression|optic nerve compression
43824|NCT03011541|Compressive Optic Neuropathy|compressive optic neuropathy
43825|NCT03011541|Devics Syndrome|devics syndrome
43826|NCT03011541|Ushers Syndrome|ushers syndrome
43827|NCT03011541|Neuromyelitis Optica|neuromyelitis optica
43828|NCT03011541|Dominant Optic Atrophy|dominant optic atrophy
43829|NCT03011541|Kjers Optic Atrophy|kjers optic atrophy
43830|NCT03011541|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
43831|NCT03011437|linked color imaging|linked color imaging
43832|NCT03011437|Helicobacter Pylori|helicobacter pylori
43833|NCT03011424|Liver resection|liver resection
43834|NCT03011424|post hepatectomy liver failure|post hepatectomy liver failure
43835|NCT03011424|liver dialysis|liver dialysis
43836|NCT03011424|encephalopathy|encephalopathy
43837|NCT03011424|mortality|mortality
43838|NCT03011411|methods, qualitative research|methods, qualitative research
43839|NCT03011372|Myeloid neoplasm|myeloid neoplasm
43840|NCT03011372|fibroblast growth factor receptor inhibitor|fibroblast growth factor receptor inhibitor
43841|NCT03011372|FGFR1 rearrangement|fgfr1 rearrangement
43843|NCT03011372|eosinophilia|eosinophilia
43844|NCT03011372|eosinophilic syndrome|eosinophilic syndrome
43845|NCT03011372|Lymphoid neoplasm|lymphoid neoplasm
43846|NCT03011359|Colon resection|colon resection
43847|NCT03011359|Patient Controlled Analgesia|patient controlled analgesia
43848|NCT03011359|Optimizing Basal Infusion Mode|optimizing basal infusion mode
43849|NCT03011346|Aortic valve stenosis|aortic valve stenosis
43850|NCT03011346|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
43851|NCT03011346|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
43852|NCT03011346|Randomized controlled trial|randomized controlled trial
43853|NCT03011320|ovarian cancer|ovarian cancer
43854|NCT03011320|specimen collection|specimen collection
43855|NCT03011268|Tumor Necrosis Factor-alpha/antagonists & inhibitors|tumor necrosis factor-alpha/antagonists & inhibitors
43856|NCT03011268|Infliximab|infliximab
43857|NCT03011268|Adalimumab|adalimumab
43858|NCT03011268|Golimumab|golimumab
43859|NCT03011268|Recurrence|recurrence
43860|NCT03011255|Esophageal cancer|esophageal cancer
43861|NCT03011255|Peptide specific CTL|peptide specific ctl
43862|NCT03011255|Radiation|radiation
43863|NCT03011242|Psoriatic Arthritis|psoriatic arthritis
43864|NCT03011242|PDUS|pdus
43865|NCT03011203|glycogen storage disease type IIIa|glycogen storage disease type iiia
43866|NCT03011203|exercise|exercise
43867|NCT03011203|ketone esters|ketone esters
43868|NCT03011203|magnetic resonance spectroscopy|magnetic resonance spectroscopy
43869|NCT03011190|Terapia Iconica|terapia iconica
43870|NCT03011190|BPD|bpd
43871|NCT03011190|adolescence|adolescence
43872|NCT03011190|suicide|suicide
43873|NCT03011164|Running|running
43874|NCT03011164|Gait velocity|gait velocity
43875|NCT03011164|Kinematics|kinematics
43876|NCT03011151|pediatric|pediatric
43877|NCT03011151|critical illness|critical illness
43878|NCT03011151|surgery|surgery
43879|NCT03011151|gastrointestinal dysfunction|gastrointestinal dysfunction
43880|NCT03011151|gastric emptying|gastric emptying
43882|NCT03011151|nutrition|nutrition
43883|NCT03011138|knee|knee
43884|NCT03011138|gait velocity|gait velocity
43885|NCT03011138|kinematic parameters|kinematic parameters
43886|NCT03011112|Osteoarthritis, Knee|osteoarthritis, knee
43887|NCT03011112|WOMAC|womac
43888|NCT03011112|gait|gait
43889|NCT03011112|kinematics|kinematics
43890|NCT03011086|Autoantibodies, Oral Submucous Fibrosis|autoantibodies, oral submucous fibrosis
43891|NCT03011060|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
43892|NCT03011060|pathological complete response|pathological complete response
43893|NCT03011060|Neoadjuvant Therapy|neoadjuvant therapy
43894|NCT03011060|Capecitabine|capecitabine
43895|NCT03011060|Chemotherapy, Adjuvant|chemotherapy, adjuvant
43896|NCT03011047|endoscopic, trans-antral, subciliary|endoscopic, trans-antral, subciliary
43897|NCT03011021|Autoimmune Diabetes|autoimmune diabetes
43898|NCT03011021|Umbilical Cord Blood Regulatory T Lymphocyte|umbilical cord blood regulatory t lymphocyte
43899|NCT03011021|Liraglutide|liraglutide
43900|NCT03010995|electronic cigarette|electronic cigarette
43901|NCT03010995|endothelial function|endothelial function
43902|NCT03010969|Endothelial dysfunction|endothelial dysfunction
43903|NCT03010969|Surgery|surgery
44388|NCT03007784|CRS-R|crs-r
43906|NCT03010969|Patient-related outcomes|patient-related outcomes
43907|NCT03010956|Arterial stiffness|arterial stiffness
43908|NCT03010956|Endothelial glycocalyx|endothelial glycocalyx
43909|NCT03010956|Coronary flow reserve|coronary flow reserve
43913|NCT03010943|brain tumor|brain tumor
43915|NCT03010943|neurosurgery|neurosurgery
43916|NCT03010917|Alcohol Dependence|alcohol dependence
43917|NCT03010917|Fish Oil|fish oil
43918|NCT03010891|Preterm infant|preterm infant
43919|NCT03010891|Stress|stress
43920|NCT03010891|Salivary DHEA|salivary dhea
43921|NCT03010891|Salivary cortisol|salivary cortisol
43922|NCT03010891|Actigraphy|actigraphy
43923|NCT03010878|yoga|yoga
43924|NCT03010878|chronic pain|chronic pain
43925|NCT03010878|occupational therapy|occupational therapy
43926|NCT03010878|self-management|self-management
43927|NCT03010865|HDAC inhibitors|hdac inhibitors
43928|NCT03010865|Inflammation|inflammation
43931|NCT03010761|addiction|addiction
43932|NCT03010761|betel-quid|betel-quid
43933|NCT03010761|drug therapy|drug therapy
43934|NCT03010761|clinical trial|clinical trial
43935|NCT03010748|corneal morphology|corneal morphology
43936|NCT03010748|Chinese population|chinese population
43937|NCT03010748|corneal curvature|corneal curvature
43938|NCT03010748|corneal thickness|corneal thickness
43939|NCT03010748|higher order aberrations|higher order aberrations
43940|NCT03010735|Kidney Failure, Chronic|kidney failure, chronic
43941|NCT03010735|Probiotics|probiotics
43942|NCT03010735|Uremic toxins|uremic toxins
43943|NCT03010735|Gastrointestinal Microbiome|gastrointestinal microbiome
43944|NCT03010709|Aneurysmal Subarachnoid Haemorrhage|aneurysmal subarachnoid haemorrhage
43945|NCT03010709|Delayed Ischaemic Neurological Deficit|delayed ischaemic neurological deficit
43946|NCT03010709|Induced Hypertension|induced hypertension
43947|NCT03010709|Partial Brain Tissue Oxygen Tension|partial brain tissue oxygen tension
43948|NCT03010709|Cerebral Microdialysis|cerebral microdialysis
43949|NCT03010696|Kidney Failure, Chronic|kidney failure, chronic
43950|NCT03010696|Uremic toxins|uremic toxins
43951|NCT03010696|Gastrointestinal Microbiome|gastrointestinal microbiome
43952|NCT03010696|Metabolomics|metabolomics
43953|NCT03010683|Arterial stiffness|arterial stiffness
43954|NCT03010683|Endothelial glycocalyx|endothelial glycocalyx
43955|NCT03010683|Coronary flow reserve|coronary flow reserve
43956|NCT03010670|Oxytocin|oxytocin
43957|NCT03010670|Gaze processing|gaze processing
43958|NCT03010670|Interpersonal motor resonance|interpersonal motor resonance
43959|NCT03010618|hall technique|hall technique
43960|NCT03010618|stainless steel crowns|stainless steel crowns
43961|NCT03010618|temporomandibular joint|temporomandibular joint
43962|NCT03010618|dental caries|dental caries
43963|NCT03010618|occlusion|occlusion
43964|NCT03010605|physical therapy post total knee replacement|physical therapy post total knee replacement
43965|NCT03010605|range of motion|range of motion
43966|NCT03010605|goniometry|goniometry
43967|NCT03010592|Lung volume reduction treatment|lung volume reduction treatment
43968|NCT03010592|Endobronchial cryotherapy|endobronchial cryotherapy
43969|NCT03010592|Microvesicles|microvesicles
43970|NCT03010579|Anemia|anemia
43971|NCT03010579|Lymphoma|lymphoma
43972|NCT03010579|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
43973|NCT03010579|Erythropoietin|erythropoietin
43974|NCT03010566|Lung volume reduction coil|lung volume reduction coil
43975|NCT03010566|Lung Microbiome|lung microbiome
43979|NCT03010488|Chronotherapy|chronotherapy
43980|NCT03010488|Light Therapy|light therapy
43981|NCT03010462|Stroke|stroke
43982|NCT03010462|rTMS|rtms
43983|NCT03010462|Motor rehabilitation|motor rehabilitation
43984|NCT03010449|Lung volume reduction treatment|lung volume reduction treatment
43985|NCT03010449|Autologous blood instillation|autologous blood instillation
43988|NCT03010423|Non-obstructive coronary artery disease|non-obstructive coronary artery disease
43990|NCT03010371|positive psychotherapy, online, breast cancer, survivors|positive psychotherapy, online, breast cancer, survivors
43991|NCT03010332|Cytomegalovirus|cytomegalovirus
43992|NCT03010332|Cytomegalovirus Viremia|cytomegalovirus viremia
43993|NCT03010332|Cytomegalovirus Infection|cytomegalovirus infection
43994|NCT03010332|CMV Infection|cmv infection
43995|NCT03010332|Hematopoietic Cell Transplant|hematopoietic cell transplant
43996|NCT03010332|Solid Organ Transplant|solid organ transplant
43997|NCT03010332|Human Immunodeficiency Virus|human immunodeficiency virus
43998|NCT03010332|Cytomegalovirus Disease|cytomegalovirus disease
43999|NCT03010332|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
44000|NCT03010332|CMV|cmv
44001|NCT03010332|CMV syndrome|cmv syndrome
44002|NCT03010332|Cytomegalovirus syndrome|cytomegalovirus syndrome
44003|NCT03010332|CMV disease|cmv disease
44004|NCT03010332|CMV viremia|cmv viremia
44005|NCT03010332|allogeneic|allogeneic
48944|NCT02979028|TEAS|teas
35678|NCT03063762|Renal Cell Carcinoma|renal cell carcinoma
44006|NCT03010332|third-party|third-party
44007|NCT03010293|Antimicrobial therapy|antimicrobial therapy
44008|NCT03010293|Debridement|debridement
44009|NCT03010293|Osteomyelitis|osteomyelitis
44010|NCT03010293|Muscular flap|muscular flap
44011|NCT03010293|Pressure ulcer|pressure ulcer
44012|NCT03010293|Treatment failure|treatment failure
44013|NCT03010293|Vacuum-assisted closure therapy|vacuum-assisted closure therapy
44014|NCT03010267|DP-R213|dp-r213
44015|NCT03010241|Diabetes Distal Symmetric Polyneuropathy|diabetes distal symmetric polyneuropathy
44016|NCT03010241|Chinese medicine|chinese medicine
44017|NCT03010228|VLA15|vla15
44018|NCT03010228|Lyme Borreliosis|lyme borreliosis
44019|NCT03010228|Multivalent Recombinant OspA Vaccine|multivalent recombinant ospa vaccine
44020|NCT03010215|Minimally Invasive Surgery|minimally invasive surgery
44021|NCT03010215|Percutaneous distal osteotomy|percutaneous distal osteotomy
44022|NCT03010215|Distal Metatarsal Minimally-invasive Osteotomy (DMMO)|distal metatarsal minimally-invasive osteotomy (dmmo)
44023|NCT03010215|Percutaneous Tenotomy|percutaneous tenotomy
44024|NCT03010215|Forefoot|forefoot
44025|NCT03010215|Metatarsal bones|metatarsal bones
44026|NCT03010202|immune thrombocytopenia|immune thrombocytopenia
44027|NCT03010202|rituximab|rituximab
44028|NCT03010202|thrombocytopenia|thrombocytopenia
44029|NCT03010189|Cluster headache|cluster headache
44030|NCT03010189|Actigraphy|actigraphy
44031|NCT03010189|Pupillometry|pupillometry
44032|NCT03010163|pedometer|pedometer
44033|NCT03010163|walking|walking
44034|NCT03010163|taxi driver|taxi driver
44035|NCT03010163|16-1659|16-1659
44036|NCT03010150|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
44037|NCT03010150|Head and Neck Cancer|head and neck cancer
44038|NCT03010150|Nasopharyngeal cancer|nasopharyngeal cancer
44039|NCT03010150|Oropharyngeal cancer|oropharyngeal cancer
44040|NCT03010150|Hypopharyngeal cancer|hypopharyngeal cancer
44041|NCT03010150|Laryngeal cancer|laryngeal cancer
44042|NCT03010150|Unknown primary cancer with cervical metastases|unknown primary cancer with cervical metastases
44043|NCT03010150|Questionnaire|questionnaire
44044|NCT03010150|Survey|survey
44045|NCT03010150|Blood draw|blood draw
44046|NCT03010150|Cytokines|cytokines
44047|NCT03010111|Latent Tuberculosis|latent tuberculosis
44048|NCT03010111|Interferons|interferons
44049|NCT03010111|Tuberculosis|tuberculosis
44050|NCT03010111|Healthcare|healthcare
44051|NCT03010098|POCD|pocd
44052|NCT03010098|narcotrend|narcotrend
44053|NCT03010098|closed-loop of target controlled infusion|closed-loop of target controlled infusion
44054|NCT03010033|pulmonary rehabilitation|pulmonary rehabilitation
44055|NCT03010033|lobectomy|lobectomy
44056|NCT03010033|smoker|smoker
44057|NCT03010020|HIV Prevention|hiv prevention
44058|NCT03010020|MSM|msm
44059|NCT03010020|Rectal Gonorrhea|rectal gonorrhea
44060|NCT03010020|Rectal Chlamydia|rectal chlamydia
44061|NCT03010020|Personalized Cognitive Counseling|personalized cognitive counseling
44062|NCT03010007|Influenza|influenza
44063|NCT03010007|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
44064|NCT03010007|Viral Transmission|viral transmission
44065|NCT03009981|PSA|psa
44066|NCT03009981|Degarelix|degarelix
44067|NCT03009981|Apalutamide|apalutamide
44068|NCT03009981|Abiraterone Acetate|abiraterone acetate
44069|NCT03009981|Radical Prostatectomy|radical prostatectomy
44070|NCT03009942|nitric oxide|nitric oxide
44071|NCT03009942|arginase|arginase
44072|NCT03009942|loading|loading
44073|NCT03009890|elderly|elderly
44074|NCT03009890|intra articular|intra articular
44075|NCT03009890|RCT|rct
44076|NCT03009864|Diabetic Kidney Disease|diabetic kidney disease
44077|NCT03009864|TCM|tcm
44078|NCT03009864|RCT|rct
44079|NCT03009825|Trauma exposure|trauma exposure
44080|NCT03009825|Psychological distress|psychological distress
44081|NCT03009825|Emotion regulation|emotion regulation
44082|NCT03009825|Mindfulness|mindfulness
44083|NCT03009825|Eating pathology|eating pathology
44084|NCT03009799|adenoviral conjunctivis|adenoviral conjunctivis
44085|NCT03009799|iota-carrageenan|iota-carrageenan
44086|NCT03009773|subacute stroke|subacute stroke
44087|NCT03009773|multitasking rehabilitation|multitasking rehabilitation
44088|NCT03009773|walking|walking
44089|NCT03009747|rectal cancer|rectal cancer
44090|NCT03009747|anterior resection syndrome|anterior resection syndrome
44091|NCT03009747|sphincter-preserving surgery|sphincter-preserving surgery
44092|NCT03009708|Allograft|allograft
44093|NCT03009708|Cytomegalovirus|cytomegalovirus
44094|NCT03009708|Platelets|platelets
44095|NCT03009708|Hematopoietic stem cells|hematopoietic stem cells
44096|NCT03009708|Graft Versus Host Disease (GVH)|graft versus host disease (gvh)
44097|NCT03009708|Hemostasis|hemostasis
44389|NCT03007784|EEG|eeg
44103|NCT03009695|Food Craving|food craving
44104|NCT03009695|Appetite/Satiety Hormones|appetite/satiety hormones
44105|NCT03009695|fMRI|fmri
44106|NCT03009695|Intestinal microbiota|intestinal microbiota
44107|NCT03009695|Physical activity|physical activity
44108|NCT03009669|pleth variability index|pleth variability index
44109|NCT03009669|stroke volume variation|stroke volume variation
44110|NCT03009669|perfusion Index|perfusion index
44111|NCT03009669|intraoperative|intraoperative
44112|NCT03009669|intestinal tumor|intestinal tumor
44113|NCT03009656|Stroke|stroke
44114|NCT03009656|Emergency|emergency
44115|NCT03009656|Focal Neurological Deficits|focal neurological deficits
44116|NCT03009656|Diagnostic|diagnostic
44117|NCT03009643|Nitric Oxide|nitric oxide
44118|NCT03009643|hypoxemia|hypoxemia
44119|NCT03009643|aortic surgery|aortic surgery
44120|NCT03009630|Electromagnetic navigation bronchoscopy(ENB)|electromagnetic navigation bronchoscopy(enb)
44121|NCT03009630|Radiofrequency ablation(RFA)|radiofrequency ablation(rfa)
44122|NCT03009630|Peripheral lung cancer|peripheral lung cancer
44123|NCT03009617|adolescents|adolescents
44124|NCT03009617|web-based health education|web-based health education
44125|NCT03009617|eHealth literacy|ehealth literacy
44126|NCT03009591|Hemophilia|hemophilia
44127|NCT03009591|Elbow|elbow
44128|NCT03009591|Arthropathy|arthropathy
44129|NCT03009591|Joint pain|joint pain
44130|NCT03009591|Range of motion|range of motion
44131|NCT03009591|Myofascial techniques|myofascial techniques
44132|NCT03009591|Safety patients|safety patients
44133|NCT03009591|Quality of life|quality of life
44134|NCT03009591|Functionality|functionality
44135|NCT03009565|coronary artery disease|coronary artery disease
44136|NCT03009565|human gut microbiota|human gut microbiota
44137|NCT03009565|microbiome|microbiome
44138|NCT03009552|speckle tracking echocardiography|speckle tracking echocardiography
44139|NCT03009552|strain|strain
44140|NCT03009552|strain rate|strain rate
44141|NCT03009552|torsion|torsion
44142|NCT03009539|Prevention with Hispanic youth|prevention with hispanic youth
44143|NCT03009539|eHealth preventive intervention in primary care|ehealth preventive intervention in primary care
44144|NCT03009539|Hispanic adolescent|hispanic adolescent
44145|NCT03009539|Familias Unidas|familias unidas
44146|NCT03009539|eHealth Familias Unidas|ehealth familias unidas
44147|NCT03009539|effectiveness trial|effectiveness trial
44148|NCT03009539|sexually transmitted disease|sexually transmitted disease
44149|NCT03009539|parent-centered|parent-centered
44150|NCT03009539|Hispanic|hispanic
44151|NCT03009539|sexual risk behavior|sexual risk behavior
44152|NCT03009526|Malaria|malaria
44153|NCT03009526|Pregnancy|pregnancy
44154|NCT03009526|Malawi|malawi
44155|NCT03009526|Intermittent preventive treatment|intermittent preventive treatment
44156|NCT03009526|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
44157|NCT03009526|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
44158|NCT03009461|Hepatocellular carcinoma|hepatocellular carcinoma
44159|NCT03009461|Portal vein tumor thrombosis|portal vein tumor thrombosis
44160|NCT03009461|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
44161|NCT03009461|Sorafenib|sorafenib
44167|NCT03009370|Ovarian reserve, pregnancy loss|ovarian reserve, pregnancy loss
44168|NCT03009357|wearable activity tracker|wearable activity tracker
44169|NCT03009357|thyrotoxicosis|thyrotoxicosis
44294|NCT03008447|cognitive performance|cognitive performance
44170|NCT03009344|relapsed or refractory B-cell non-Hodgkin's lymphoma|relapsed or refractory b-cell non-hodgkin's lymphoma
44171|NCT03009344|tazemetostat|tazemetostat
44172|NCT03009344|Japan|japan
44173|NCT03009331|Postoperative pulmonary dysfunction|postoperative pulmonary dysfunction
44174|NCT03009331|Postoperative pulmonary complication|postoperative pulmonary complication
44175|NCT03009331|Recruitment manouver|recruitment manouver
44176|NCT03009331|Prone position|prone position
44177|NCT03009318|Glioma|glioma
44178|NCT03009318|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
44179|NCT03009318|Methionine|methionine
44180|NCT03009318|PET/CT|pet/ct
44181|NCT03009292|solid tumor|solid tumor
44182|NCT03009292|Lenvatinib|lenvatinib
44183|NCT03009292|pharmacokinetics|pharmacokinetics
44184|NCT03009279|blood pressure|blood pressure
44185|NCT03009279|fasting plasma glucose|fasting plasma glucose
44186|NCT03009279|thyroid stimulating hormone|thyroid stimulating hormone
44187|NCT03009253|Neoadjuvant therapy|neoadjuvant therapy
44188|NCT03009253|Pancreatic Cancer|pancreatic cancer
44189|NCT03009227|colon cancer|colon cancer
44190|NCT03009227|lymph node dissection|lymph node dissection
44191|NCT03009227|D3 lymph node dissection|d3 lymph node dissection
44192|NCT03009214|solid epithelial cancer|solid epithelial cancer
44194|NCT03009214|c-Met|c-met
44195|NCT03009214|VEGFR-2|vegfr-2
44196|NCT03009214|RON|ron
44197|NCT03009214|receptor tyrosine kinase|receptor tyrosine kinase
44198|NCT03009188|Axenfeld-Rieger syndrom, genetic findings|axenfeld-rieger syndrom, genetic findings
44199|NCT03009136|Perennial Allergic Rhinitis|perennial allergic rhinitis
44200|NCT03009136|Herbal Medicine|herbal medicine
44201|NCT03009136|Korean Medicine|korean medicine
35902|NCT03062358|PD1|pd1
44202|NCT03009136|So-Cheong-Ryong-Tang|so-cheong-ryong-tang
44203|NCT03009123|cohort study|cohort study
44204|NCT03009123|prostate cancer|prostate cancer
44205|NCT03009123|population-based study|population-based study
44206|NCT03009123|benign prostatic hypertrophy|benign prostatic hypertrophy
44207|NCT03009097|Chronic periodontitis|chronic periodontitis
44208|NCT03009097|atorvastatin|atorvastatin
44209|NCT03009097|intrabony defect|intrabony defect
44210|NCT03009071|Neck Pain|neck pain
44211|NCT03009071|Disability Evaluation|disability evaluation
44212|NCT03009071|Costs and Cost Analysis|costs and cost analysis
44213|NCT03009071|Doin Exercise Therapy|doin exercise therapy
44214|NCT03009071|Acupuncture|acupuncture
44215|NCT03009058|Unresectable cancer|unresectable cancer
44216|NCT03009058|pancreatic|pancreatic
44217|NCT03009058|melanoma|melanoma
44218|NCT03009058|breast|breast
44219|NCT03009058|lung|lung
44220|NCT03009058|colorectal|colorectal
44221|NCT03009058|cholangio|cholangio
44222|NCT03009058|sarcoma|sarcoma
44223|NCT03009045|bone and joint infection|bone and joint infection
44224|NCT03009045|osteomyelitis|osteomyelitis
44225|NCT03009045|tedizolid|tedizolid
44226|NCT03009032|HIV|hiv
44227|NCT03009032|immunologic recovery|immunologic recovery
44228|NCT03009032|microbiota|microbiota
44229|NCT03009032|prebiotics|prebiotics
44230|NCT03009032|probiotics|probiotics
44231|NCT03009032|synbiotics|synbiotics
44232|NCT03009006|Calcium hydroxide intracanal medication|calcium hydroxide intracanal medication
44233|NCT03009006|Ca(OH)2 intracanal medication|ca(oh)2 intracanal medication
44234|NCT03009006|Chlorhexidene gel|chlorhexidene gel
44235|NCT03009006|CHX gel|chx gel
44236|NCT03009006|Root canal treatment|root canal treatment
44237|NCT03008967|Total Knee Arthroplasty|total knee arthroplasty
44238|NCT03008967|Total Hip Arthroplasty|total hip arthroplasty
44239|NCT03008967|Rehabilitation|rehabilitation
44240|NCT03008941|HIV|hiv
44241|NCT03008941|microbiota|microbiota
44242|NCT03008941|inflammation|inflammation
44243|NCT03008941|fecal microbiota restoration|fecal microbiota restoration
44244|NCT03008915|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
44245|NCT03008915|Emphysema|emphysema
44246|NCT03008915|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
44247|NCT03008889|Repetitive Self-Injurious Behavior|repetitive self-injurious behavior
44248|NCT03008889|N-acetylcysteine (NAC)|n-acetylcysteine (nac)
44249|NCT03008876|neonate|neonate
44250|NCT03008876|acetaminophen|acetaminophen
44251|NCT03008850|Shivering|shivering
44252|NCT03008850|Intrathecal|intrathecal
44253|NCT03008850|Magnesium Sulfate|magnesium sulfate
44254|NCT03008811|Atrial Fibrillation|atrial fibrillation
44255|NCT03008811|Catheter Ablation|catheter ablation
44256|NCT03008798|Intracranial Artery|intracranial artery
44257|NCT03008798|in-stent restenosis|in-stent restenosis
44258|NCT03008798|Herbal Medicine|herbal medicine
44259|NCT03008785|isoflavone|isoflavone
44260|NCT03008785|blood pressure|blood pressure
44261|NCT03008785|climateric symptoms|climateric symptoms
44262|NCT03008785|exercise|exercise
44263|NCT03008759|Fluoride|fluoride
44264|NCT03008759|Dental caries|dental caries
44265|NCT03008759|Dentifrice|dentifrice
44266|NCT03008720|functional electrical simulation|functional electrical simulation
44267|NCT03008707|Laparoscopic peritoneal lavage|laparoscopic peritoneal lavage
44268|NCT03008707|laparoscopic sigmoidectomy|laparoscopic sigmoidectomy
44269|NCT03008707|complicated acute diverticulitis|complicated acute diverticulitis
44270|NCT03008707|D004238|d004238
44271|NCT03008694|PET/CT|pet/ct
44272|NCT03008642|Polycythemia|polycythemia
44273|NCT03008642|CO-Rebreathing|co-rebreathing
44274|NCT03008642|red cell mass determination|red cell mass determination
44275|NCT03008642|myeloproliferative neoplasms|myeloproliferative neoplasms
44276|NCT03008603|CT-guided minimally invasive procedures|ct-guided minimally invasive procedures
44277|NCT03008603|Robot|robot
44278|NCT03008590|Pain management|pain management
44279|NCT03008590|Naltrexone|naltrexone
44280|NCT03008590|Controlled clinical trials, randomized|controlled clinical trials, randomized
44281|NCT03008512|Liver Neoplasms|liver neoplasms
44285|NCT03008512|Neoplasms by Site|neoplasms by site
44286|NCT03008512|Sorafenib|sorafenib
44287|NCT03008512|Liver Diseases|liver diseases
44288|NCT03008512|Digestive System Neoplasms|digestive system neoplasms
44289|NCT03008499|Metastatic colorectal cancer|metastatic colorectal cancer
44586|NCT03006302|MK-3475|mk-3475
44291|NCT03008447|E2006|e2006
44292|NCT03008447|postural stability|postural stability
44293|NCT03008447|auditory awakening threshold|auditory awakening threshold
44295|NCT03008447|healthy participants|healthy participants
44296|NCT03008434|yoga|yoga
44297|NCT03008434|Traumatic Brain Injury|traumatic brain injury
44298|NCT03008408|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
44299|NCT03008408|Endometrial carcinoma|endometrial carcinoma
44300|NCT03008408|Advanced or Recurrent|advanced or recurrent
44301|NCT03008408|Endometrioid and mixed endometrioid tumors|endometrioid and mixed endometrioid tumors
44302|NCT03008408|Ribociclib|ribociclib
44303|NCT03008408|LEE011|lee011
44304|NCT03008408|Everolimus|everolimus
44305|NCT03008408|Afinitor|afinitor
44306|NCT03008408|Zortress|zortress
44307|NCT03008408|RAD001|rad001
44308|NCT03008408|Letrozole|letrozole
44309|NCT03008408|Femara|femara
44312|NCT03008343|Irreversible Electroporation|irreversible electroporation
44313|NCT03008343|NK Immunotherapy|nk immunotherapy
44314|NCT03008343|Recurrent Liver Carcinoma|recurrent liver carcinoma
44315|NCT03008330|Metastatic tongue cancer|metastatic tongue cancer
44316|NCT03008330|High-activity natural killer|high-activity natural killer
44317|NCT03008304|Metastatic pancreatic cancer|metastatic pancreatic cancer
44318|NCT03008304|High-activity natural killer Immunotherapy|high-activity natural killer immunotherapy
44319|NCT03008265|Fascial dehiscence|fascial dehiscence
44320|NCT03008265|Mortality|mortality
44321|NCT03008252|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
44322|NCT03008252|lactose intolerance|lactose intolerance
44323|NCT03008252|cow's milk protein allergy|cow's milk protein allergy
44325|NCT03008174|tracheostomy|tracheostomy
44326|NCT03008174|quality of life|quality of life
44327|NCT03008174|speaking valve|speaking valve
44328|NCT03008174|speech|speech
44329|NCT03008174|mechanically ventilated patients|mechanically ventilated patients
44330|NCT03008161|GAIM|gaim
44331|NCT03008161|amyloid|amyloid
44332|NCT03008161|anti-aBeta|anti-abeta
44333|NCT03008161|anti-tau|anti-tau
44334|NCT03008122|Flavivirus|flavivirus
44335|NCT03008122|Inactivated|inactivated
44336|NCT03008122|Phase I|phase i
44337|NCT03008122|Vaccine|vaccine
44338|NCT03008122|ZIKA|zika
44339|NCT03008122|ZPIV|zpiv
44340|NCT03008109|EGFR-TKI|egfr-tki
44341|NCT03008109|Recombinant human endostatin|recombinant human endostatin
44342|NCT03008070|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
44343|NCT03008070|NASH|nash
44344|NCT03008070|peroxisome proliferator-activated receptor (PPAR)|peroxisome proliferator-activated receptor (ppar)
44345|NCT03008070|Liver Diseases|liver diseases
44346|NCT03008070|Fibrosis|fibrosis
44347|NCT03008070|Fatty Liver|fatty liver
44348|NCT03008070|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
44349|NCT03008070|Digestive System Diseases|digestive system diseases
44352|NCT03008057|YKL40|ykl40
44353|NCT03008057|PAI-1|pai-1
44354|NCT03008057|RAGE|rage
44355|NCT03008057|AGEs|ages
44356|NCT03008057|glyoxalase enzyme|glyoxalase enzyme
44357|NCT03008057|TNF-alpha|tnf-alpha
44358|NCT03008057|IL-6|il-6
44359|NCT03008057|Diabetes|diabetes
44360|NCT03007992|Breast cancer|breast cancer
44361|NCT03007992|Vinorelbine|vinorelbine
44362|NCT03007992|Metronomic chemotherapy|metronomic chemotherapy
44363|NCT03007953|Palliative Care|palliative care
44364|NCT03007953|Supportive Care|supportive care
44365|NCT03007940|Implementation Strategies|implementation strategies
44366|NCT03007940|Sustainability|sustainability
44367|NCT03007940|Integrated Services|integrated services
44368|NCT03007927|pain|pain
44369|NCT03007927|hernia repair|hernia repair
44370|NCT03007927|Dexamethasone|dexamethasone
44371|NCT03007914|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
44372|NCT03007914|Medicine, Chinese Traditional|medicine, chinese traditional
44373|NCT03007914|Humans|humans
44374|NCT03007914|Treatment Outcome|treatment outcome
44375|NCT03007888|IPX203 (carbidopa-levodopa) Extended-Release capsules|ipx203 (carbidopa-levodopa) extended-release capsules
44376|NCT03007875|Metastatic lung cancer|metastatic lung cancer
44377|NCT03007875|High-activity natural killer|high-activity natural killer
44378|NCT03007836|Metastatic Nasopharyngeal Cancer|metastatic nasopharyngeal cancer
46395|NCT02995460|Exercise Therapy|exercise therapy
44379|NCT03007836|High-activity natural killer|high-activity natural killer
44380|NCT03007823|Metastatic Melanoma|metastatic melanoma
44381|NCT03007823|High-activity natural killer|high-activity natural killer
44382|NCT03007784|Consciousness|consciousness
44383|NCT03007784|Disorder of consciousness|disorder of consciousness
44384|NCT03007784|Minimally conscious state|minimally conscious state
44385|NCT03007784|Vegetative state|vegetative state
44386|NCT03007784|Exit-MCS|exit-mcs
44387|NCT03007784|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
44390|NCT03007784|Cognitive ERPs|cognitive erps
44391|NCT03007758|Hernia repair|hernia repair
44392|NCT03007758|Robotic hernia repair|robotic hernia repair
44393|NCT03007758|Open hernia repair|open hernia repair
44394|NCT03007758|Incisional hernia|incisional hernia
44395|NCT03007745|Continuous positive airway pressure|continuous positive airway pressure
44396|NCT03007628|magnetic seizure therapy|magnetic seizure therapy
44397|NCT03007628|electroconvulsive therapy|electroconvulsive therapy
44398|NCT03007628|controlled trial|controlled trial
44399|NCT03007602|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
36069|NCT03061136|Gamma oscillations|gamma oscillations
36070|NCT03061136|EEG|eeg
36073|NCT03061136|GABA|gaba
44400|NCT03007602|Aerobic exercise|aerobic exercise
44401|NCT03007602|Quality of Life|quality of life
44402|NCT03007602|Muscle Strength|muscle strength
44403|NCT03007602|Depression|depression
44404|NCT03007602|exercise capacity|exercise capacity
44406|NCT03007602|anxiety|anxiety
44407|NCT03007602|fatigue|fatigue
44408|NCT03007602|pulmonary functions|pulmonary functions
44409|NCT03007589|erythema|erythema
44410|NCT03007589|persistent pigment darkening|persistent pigment darkening
44411|NCT03007589|sunburn|sunburn
44412|NCT03007589|suntan|suntan
44413|NCT03007563|Diagnosis|diagnosis
44414|NCT03007563|Cell Phones|cell phones
44415|NCT03007563|Infant, Newborn|infant, newborn
44416|NCT03007550|Gastric cancer|gastric cancer
44417|NCT03007550|Laparoscopic total gastrectomy|laparoscopic total gastrectomy
44418|NCT03007550|Open total gastrectomy|open total gastrectomy
44419|NCT03007537|Erythropoietin|erythropoietin
44420|NCT03007537|Cardiac Surgery Associated-acute Kidney Injury|cardiac surgery associated-acute kidney injury
44421|NCT03007524|rosuvastatin|rosuvastatin
44422|NCT03007524|optical coherence tomography|optical coherence tomography
44423|NCT03007524|acute coronary syndrome|acute coronary syndrome
44424|NCT03007511|Percutaneous Endoscopic Gastrostomy|percutaneous endoscopic gastrostomy
44425|NCT03007511|Feeding tube|feeding tube
44426|NCT03007511|Enteral nutrition|enteral nutrition
44427|NCT03007511|Endoscopy|endoscopy
44428|NCT03007511|Gastrointestinal|gastrointestinal
44429|NCT03007459|Body composition|body composition
44430|NCT03007459|Bone mineral density|bone mineral density
44431|NCT03007459|Binge Eating|binge eating
44432|NCT03007459|Eating Disorder|eating disorder
44433|NCT03007459|Exercise Dependency|exercise dependency
44434|NCT03007459|Depression|depression
44435|NCT03007459|Perfectionism|perfectionism
44436|NCT03007459|Body building|body building
44437|NCT03007459|Drive for Muscularity|drive for muscularity
44438|NCT03007459|Drive for leanness|drive for leanness
44439|NCT03007446|Apatinib|apatinib
44440|NCT03007446|SOX|sox
44441|NCT03007446|Conversion Surgery|conversion surgery
44442|NCT03007446|unresectable gastric cancer|unresectable gastric cancer
44443|NCT03007433|gastric emptying|gastric emptying
44444|NCT03007433|functional dyspepsia|functional dyspepsia
44445|NCT03007433|non invasive imaging|non invasive imaging
44446|NCT03007433|MRI|mri
44447|NCT03007433|gamma scintigraphy|gamma scintigraphy
44448|NCT03007433|gastroparesis|gastroparesis
44449|NCT03007407|microsatellite stable|microsatellite stable
44450|NCT03007407|MSS|mss
44451|NCT03007407|durvalumab|durvalumab
44452|NCT03007407|tremelimumab|tremelimumab
44453|NCT03007407|mCRC|mcrc
44454|NCT03007407|NSABP|nsabp
44455|NCT03007394|Cocaine Use Disorder|cocaine use disorder
44456|NCT03007342|Amoxicillin|amoxicillin
44457|NCT03007342|clavulanic acid|clavulanic acid
44458|NCT03007342|Periapical periodontitis|periapical periodontitis
44459|NCT03007342|Post-operative pain|post-operative pain
44460|NCT03007329|SGLT2 inhibitor|sglt2 inhibitor
44461|NCT03007329|GLP1 agonist|glp1 agonist
44462|NCT03007329|type 2 Diabetes|type 2 diabetes
44463|NCT03007329|steatosis of the liver|steatosis of the liver
44464|NCT03007329|ectopic lipids|ectopic lipids
44465|NCT03007329|combined therapy|combined therapy
44466|NCT03007264|cold atmospheric plasma|cold atmospheric plasma
44467|NCT03007264|pain|pain
44468|NCT03007264|bacteria|bacteria
44469|NCT03007264|skin parameters|skin parameters
44470|NCT03007186|Blood glucose monitoring|blood glucose monitoring
44471|NCT03007186|Glucose tolerance|glucose tolerance
44472|NCT03007186|HbA1C|hba1c
44473|NCT03007186|Insulin|insulin
44474|NCT03007186|Betamethasone|betamethasone
44475|NCT03007173|umbilical pilonidal sinus|umbilical pilonidal sinus
44476|NCT03007082|endovascular treatment|endovascular treatment
44477|NCT03007082|mechanical thrombectomy|mechanical thrombectomy
44478|NCT03007082|stent retriever|stent retriever
44479|NCT03007082|human|human
44480|NCT03007056|high flow nasal cannula|high flow nasal cannula
44481|NCT03007056|nasal continuous positive airway pressure|nasal continuous positive airway pressure
44482|NCT03007056|noninvasive ventilatory support|noninvasive ventilatory support
44483|NCT03007056|newborn developmental care|newborn developmental care
44484|NCT03007056|bronchopulmonary dysplasia|bronchopulmonary dysplasia
44485|NCT03007056|weaning|weaning
44486|NCT03007056|pain|pain
44487|NCT03007056|length of stay|length of stay
44488|NCT03007030|Lung Diseases Due to External Agents|lung diseases due to external agents
44490|NCT03007030|Unresectable malignant pleural mesothelioma|unresectable malignant pleural mesothelioma
44493|NCT03007030|Brentuximab vedotin|brentuximab vedotin
44494|NCT03007030|SGN-35|sgn-35
44495|NCT03007030|Adcetris|adcetris
44496|NCT03007004|Systemic aclerosis|systemic aclerosis
44497|NCT03007004|digital ulcer|digital ulcer
44498|NCT03007004|botulinum toxin|botulinum toxin
44499|NCT03006991|methotrexate, Juvenile Idiopathic Arthritis|methotrexate, juvenile idiopathic arthritis
44500|NCT03006965|hemophilia|hemophilia
44501|NCT03006965|Hemophilia A|hemophilia a
44502|NCT03006965|Factor VIII|factor viii
44503|NCT03006965|Advate|advate
44504|NCT03006965|Antithrombotic factor|antithrombotic factor
44505|NCT03006965|Pharmacokinetic dosing|pharmacokinetic dosing
44506|NCT03006965|hemarthrosis|hemarthrosis
44507|NCT03006965|myPKFiT|mypkfit
44508|NCT03006926|hepatocellular carcinoma|hepatocellular carcinoma
44509|NCT03006926|E7080|e7080
44510|NCT03006926|lenvatinib|lenvatinib
44511|NCT03006926|pembrolizumab|pembrolizumab
44512|NCT03006926|Japan|japan
44513|NCT03006913|Genetic counseling modes|genetic counseling modes
44514|NCT03006887|solid tumors|solid tumors
44515|NCT03006887|non-small cell lung cancer|non-small cell lung cancer
44516|NCT03006887|predominantly clear cell renal cell carcinoma|predominantly clear cell renal cell carcinoma
44517|NCT03006887|endometrial carcinoma|endometrial carcinoma
44518|NCT03006887|urothelial carcinoma|urothelial carcinoma
44519|NCT03006887|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
44520|NCT03006887|non-uveal melanoma|non-uveal melanoma
44521|NCT03006887|E7080|e7080
44522|NCT03006887|lenvatinib|lenvatinib
44523|NCT03006887|pembrolizumab|pembrolizumab
44524|NCT03006887|Japan|japan
44525|NCT03006835|Clopidogrel; Platelet Inhibition Ratio|clopidogrel; platelet inhibition ratio
44526|NCT03006822|Myofascial Trigger Points|myofascial trigger points
44527|NCT03006822|Liberation for Pression|liberation for pression
44528|NCT03006822|Therapy Soft Tissue|therapy soft tissue
44529|NCT03006809|Ulcerative colitis|ulcerative colitis
44530|NCT03006809|FMT|fmt
44531|NCT03006809|fecal transplant|fecal transplant
44532|NCT03006796|Obesity|obesity
44533|NCT03006705|ONO-4538,BMS-936558,Nivolumab,gastric,adjuvant,S-1,CapeOX|ono-4538,bms-936558,nivolumab,gastric,adjuvant,s-1,capeox
44534|NCT03006614|Breast Cancer Model|breast cancer model
44535|NCT03006614|Effects of Chemotherapy|effects of chemotherapy
44536|NCT03006614|breast cancer|breast cancer
44537|NCT03006588|FNA,EUS,retropharyngeal lymph node (RPLN),NPC|fna,eus,retropharyngeal lymph node (rpln),npc
44538|NCT03006575|Non-small cell lung cancer|non-small cell lung cancer
44539|NCT03006575|Split-course Chemoradiotherapy|split-course chemoradiotherapy
44540|NCT03006575|Locoregional recurrence|locoregional recurrence
44541|NCT03006575|Postoperative recurrence|postoperative recurrence
44542|NCT03006575|Consolidation chemotherapy|consolidation chemotherapy
44543|NCT03006549|Emergency Manual|emergency manual
44544|NCT03006549|Crisis Checklist|crisis checklist
44545|NCT03006523|donor intrauterine insemination|donor intrauterine insemination
44757|NCT03005236|Envarsus|envarsus
44546|NCT03006523|insemination volume|insemination volume
44547|NCT03006523|Live Birth Rates|live birth rates
44548|NCT03006523|donor sperm|donor sperm
44549|NCT03006510|inpatient diabetes|inpatient diabetes
44550|NCT03006510|hypoglycemia|hypoglycemia
44551|NCT03006497|neck|neck
44552|NCT03006497|motor control|motor control
44553|NCT03006497|motor learning|motor learning
44554|NCT03006484|Cardiac arrest|cardiac arrest
44555|NCT03006484|Inhospital Cardiac Arrest|inhospital cardiac arrest
44556|NCT03006484|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
44557|NCT03006471|Prediabetes|prediabetes
44558|NCT03006471|Prehypertension|prehypertension
44559|NCT03006471|Variability of blood pressure|variability of blood pressure
44560|NCT03006471|ABPM|abpm
44561|NCT03006471|Dapagliflozin|dapagliflozin
44562|NCT03006471|SGLT2|sglt2
44563|NCT03006432|OESOPHAGO-GASTRIC CARCINOMA|oesophago-gastric carcinoma
44564|NCT03006419|kidney transplantation|kidney transplantation
44565|NCT03006419|induction|induction
44566|NCT03006419|thymoglobulin|thymoglobulin
44567|NCT03006419|basiliximab|basiliximab
44568|NCT03006419|acute rejection|acute rejection
44569|NCT03006419|graft loss|graft loss
44570|NCT03006406|endometriosis|endometriosis
44571|NCT03006406|long term GnRH-a|long term gnrh-a
44572|NCT03006393|Neuroscience|neuroscience
44573|NCT03006393|Behavioral|behavioral
44574|NCT03006393|Social|social
44575|NCT03006354|high frequency oscillatory ventilation|high frequency oscillatory ventilation
44576|NCT03006354|newborn|newborn
44577|NCT03006354|noninvasive ventilation|noninvasive ventilation
44578|NCT03006354|transient tachypnea of the newborn|transient tachypnea of the newborn
44579|NCT03006328|weight gain|weight gain
44580|NCT03006328|weight loss|weight loss
44583|NCT03006302|pancreatic cancer|pancreatic cancer
44584|NCT03006302|vaccine|vaccine
44585|NCT03006302|immunotherapy|immunotherapy
44587|NCT03006302|PD-1|pd-1
44588|NCT03006302|IDO|ido
44589|NCT03006289|Metabolic Syndrome|metabolic syndrome
44590|NCT03006289|fasting plasma glucose|fasting plasma glucose
44591|NCT03006263|Stomach Neoplasms|stomach neoplasms
44592|NCT03006263|Totally Laparoscopic Total Gastrectomy|totally laparoscopic total gastrectomy
44593|NCT03006263|Laparoscopy Assisted Total Gastrectomy|laparoscopy assisted total gastrectomy
44594|NCT03006250|Desflurane|desflurane
44595|NCT03006250|Sevoflurane|sevoflurane
44596|NCT03006250|Respiratory Complications|respiratory complications
44597|NCT03006224|secondary smoking|secondary smoking
44598|NCT03006224|one lung ventilation|one lung ventilation
44599|NCT03006224|arterial oxygen tension|arterial oxygen tension
44600|NCT03006224|lobectomy|lobectomy
44601|NCT03006211|nitrogen protoxide|nitrogen protoxide
44602|NCT03006211|oxygen|oxygen
44603|NCT03006211|corneal endothelial|corneal endothelial
44604|NCT03006211|pediatric|pediatric
44605|NCT03006107|Irreversible pulpitis|irreversible pulpitis
44606|NCT03006107|Post endodontic pain|post endodontic pain
44607|NCT03006107|Symptomatic pulpitis pain|symptomatic pulpitis pain
44608|NCT03006107|Single visit RCT pain|single visit rct pain
44609|NCT03006107|Root canal treatment flare up|root canal treatment flare up
44610|NCT03006107|Single dose piroxicam|single dose piroxicam
44611|NCT03006107|Intraligamentary piroxicam|intraligamentary piroxicam
44612|NCT03006107|Intraligamentary mepecaine|intraligamentary mepecaine
44613|NCT03006094|questionnaire|questionnaire
44614|NCT03006094|hip|hip
44615|NCT03006094|pain|pain
44616|NCT03006081|Retinal nonperfusion|retinal nonperfusion
44617|NCT03006081|Aflibercept|aflibercept
44618|NCT03006068|Ulcerative Colitis (UC)|ulcerative colitis (uc)
44619|NCT03006068|Safety|safety
44620|NCT03006068|Open-Label Extension (OLE)|open-label extension (ole)
44621|NCT03006068|Efficacy|efficacy
44622|NCT03006068|ABT-494|abt-494
44623|NCT03006042|bupivacaine|bupivacaine
44624|NCT03006042|local anaesthetics|local anaesthetics
44625|NCT03006042|cesarean section|cesarean section
44626|NCT03006042|transversus abdominis plane block|transversus abdominis plane block
44627|NCT03006042|toxicity|toxicity
44628|NCT03006042|ultrasound guidance|ultrasound guidance
44629|NCT03006042|QTc interval|qtc interval
44630|NCT03006003|Osteoporosis|osteoporosis
44631|NCT03006003|Raloxifene|raloxifene
44632|NCT03006003|Central nervous disorders|central nervous disorders
44633|NCT03005990|Sleep disturbance|sleep disturbance
44634|NCT03005990|Body composition|body composition
44635|NCT03005990|Energy metabolism|energy metabolism
44636|NCT03005990|Exercise training|exercise training
44637|NCT03005990|Community-dwelling elderly|community-dwelling elderly
44638|NCT03005977|Urodynamics|urodynamics
44639|NCT03005977|Pyridium pad test|pyridium pad test
44640|NCT03005977|Cough stress test|cough stress test
44641|NCT03005977|Pelvic organ prolapse|pelvic organ prolapse
44642|NCT03005938|Cerebral Palsy|cerebral palsy
44643|NCT03005938|Spinal Manipulation|spinal manipulation
44644|NCT03005938|Muscle Spasticity|muscle spasticity
44645|NCT03005938|Manual Dexterity|manual dexterity
44646|NCT03005912|Speech Comprehension|speech comprehension
44647|NCT03005912|Telephony|telephony
44648|NCT03005912|VoIP|voip
44649|NCT03005886|Periodontitis|periodontitis
44650|NCT03005886|Periodontal-systemic disease|periodontal-systemic disease
44651|NCT03005886|Cardiovascular diseases|cardiovascular diseases
44652|NCT03005886|Gingival crevicular fluid|gingival crevicular fluid
44653|NCT03005886|Acute myocardial infarction|acute myocardial infarction
44654|NCT03005886|Neopterin|neopterin
44655|NCT03005886|Vascular cell adhesion molecule-1|vascular cell adhesion molecule-1
44656|NCT03005873|osteoarthritis of the knee|osteoarthritis of the knee
44657|NCT03005873|TLC599|tlc599
44658|NCT03005873|Dexamethasone|dexamethasone
44659|NCT03005873|DSP|dsp
44660|NCT03005834|Atherosclerotic cardiovascular diseases, cancers|atherosclerotic cardiovascular diseases, cancers
44661|NCT03005821|pediatric massage|pediatric massage
44662|NCT03005821|Tuina therapy|tuina therapy
44663|NCT03005821|acute diarrhea|acute diarrhea
44664|NCT03005808|appendectomy, pediatrics, nerve block, abdominal wall|appendectomy, pediatrics, nerve block, abdominal wall
44665|NCT03005795|cervical dysplasia|cervical dysplasia
44666|NCT03005795|colposcopy|colposcopy
44667|NCT03005795|anxiety|anxiety
44668|NCT03005795|music|music
44669|NCT03005795|mozart|mozart
44670|NCT03005795|randomized controlled trial|randomized controlled trial
44671|NCT03005769|persistence|persistence
44672|NCT03005769|long-acting injectable antipsychotic|long-acting injectable antipsychotic
44673|NCT03005769|adherence|adherence
44674|NCT03005743|Cervical cancer|cervical cancer
44675|NCT03005743|Brachytherapy|brachytherapy
44676|NCT03005743|Conventional planning|conventional planning
44682|NCT03005704|Ticagrelor|ticagrelor
44683|NCT03005704|Acetylsalicylic acid|acetylsalicylic acid
44687|NCT03005691|central sensitization|central sensitization
44688|NCT03005691|whiplash|whiplash
44689|NCT03005678|glucocorticoids, steroids, osteoporosis|glucocorticoids, steroids, osteoporosis
44690|NCT03005665|optic nerve sheath diameter|optic nerve sheath diameter
44691|NCT03005665|acetazolamide|acetazolamide
44692|NCT03005652|Subjective Cognitive Decline|subjective cognitive decline
44693|NCT03005652|Mental Health|mental health
44694|NCT03005652|Meditation|meditation
44695|NCT03005652|Health Education|health education
44696|NCT03005613|Pelvic organ prolapse|pelvic organ prolapse
622562|NCT00670306|BPH|bph
44697|NCT03005613|Sacrospinous ligament fixation|sacrospinous ligament fixation
36370|NCT03058965|AD|ad
44698|NCT03005613|Ischial spine fascia fixation|ischial spine fascia fixation
44699|NCT03005613|Clinical outcome|clinical outcome
44700|NCT03005600|Screening, diagnosis, risk stratification, ethnic|screening, diagnosis, risk stratification, ethnic
44701|NCT03005574|Severe Mental Illness|severe mental illness
44702|NCT03005574|Cognitive Remediation|cognitive remediation
44703|NCT03005574|Employment|employment
44707|NCT03005509|Quality improvement|quality improvement
44708|NCT03005509|Injury|injury
44709|NCT03005509|Injuries|injuries
44710|NCT03005483|GABAPENTIN POSTOPERATIVE PAIN CHILD|gabapentin postoperative pain child
44711|NCT03005470|Prehypertension|prehypertension
44712|NCT03005470|Hypertension|hypertension
44713|NCT03005470|Blood pressure|blood pressure
44714|NCT03005470|Intervention|intervention
44715|NCT03005470|Lifestyle|lifestyle
44716|NCT03005470|Blood pressure monitoring|blood pressure monitoring
44717|NCT03005470|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
44718|NCT03005470|Text Messages|text messages
44719|NCT03005444|liver cirrhosis|liver cirrhosis
44720|NCT03005444|Transjugular Intrahepatic Portosystemic Stent Shunt|transjugular intrahepatic portosystemic stent shunt
44721|NCT03005444|Anticoagulation|anticoagulation
44722|NCT03005444|Survival|survival
44723|NCT03005444|Additional decompensation|additional decompensation
44724|NCT03005431|Parenting|parenting
44725|NCT03005431|Training|training
44726|NCT03005431|Support|support
44727|NCT03005431|On-line|on-line
44728|NCT03005431|Stress|stress
44729|NCT03005405|Dental Caries|dental caries
44730|NCT03005405|Primary tooth|primary tooth
44731|NCT03005405|Ionomer Sealants|ionomer sealants
44732|NCT03005405|Glass Ionomer Restoration|glass ionomer restoration
44733|NCT03005392|Cancer|cancer
44734|NCT03005392|Physical therapy|physical therapy
44735|NCT03005392|Cardiorespiratory fitness|cardiorespiratory fitness
44737|NCT03005379|recurrent c. difficile|recurrent c. difficile
44738|NCT03005379|infectious disease|infectious disease
44739|NCT03005379|intestine|intestine
44740|NCT03005379|clinical trial|clinical trial
44741|NCT03005379|gastrointestinal|gastrointestinal
44742|NCT03005379|prevention|prevention
44743|NCT03005379|randomized|randomized
44744|NCT03005379|diarrhea|diarrhea
44745|NCT03005379|fecal microbiota therapy|fecal microbiota therapy
44746|NCT03005366|Atrial fibrillation|atrial fibrillation
44747|NCT03005366|vernakalant|vernakalant
44748|NCT03005366|flecainide|flecainide
44749|NCT03005366|cardioversion|cardioversion
44750|NCT03005301|electroacupuncture instrument|electroacupuncture instrument
44751|NCT03005288|type 2 diabetes|type 2 diabetes
44752|NCT03005288|obesity|obesity
44753|NCT03005288|DXA|dxa
44754|NCT03005288|MRI|mri
44755|NCT03005236|Kidney transplant|kidney transplant
44756|NCT03005236|Tacrolimus|tacrolimus
44758|NCT03005236|Older adult|older adult
44759|NCT03005236|Elderly|elderly
44760|NCT03004209|Erythropoietin|erythropoietin
44761|NCT03004209|Autoimmune encephalitis|autoimmune encephalitis
44762|NCT03004196|White Spot Lesion|white spot lesion
44763|NCT03004196|Probiotics|probiotics
44764|NCT03004196|Chlorhexidine|chlorhexidine
44765|NCT03004196|Streptococcus Mutans|streptococcus mutans
44766|NCT03004196|Fixed Orthodontic Treatment|fixed orthodontic treatment
44767|NCT03004170|HIV|hiv
44768|NCT03004170|Motivational Interviewing|motivational interviewing
44769|NCT03004170|Telephone|telephone
44770|NCT03004170|Telehealth|telehealth
44771|NCT03004170|Risky Sex|risky sex
44772|NCT03004170|Unprotected Sex|unprotected sex
44773|NCT03004170|Condoms|condoms
44774|NCT03004170|Older Adults|older adults
44775|NCT03004157|infant|infant
44776|NCT03004157|cardiopulmonary resuscitation|cardiopulmonary resuscitation
44777|NCT03004157|hemodynamics|hemodynamics
44779|NCT03004105|Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma|malignant neoplasm of respiratory and intrathoracic organ carcinoma
44780|NCT03004105|Advanced Lung Cancer|advanced lung cancer
44781|NCT03004105|Recurrent Nonsmall Cell Lung Cancer|recurrent nonsmall cell lung cancer
44782|NCT03004105|Selumetinib|selumetinib
44784|NCT03004105|Durvalumab|durvalumab
44785|NCT03004105|MEDI4736|medi4736
44786|NCT03004092|bis(methylthio)gliotoxin|bis(methylthio)gliotoxin
44787|NCT03004092|lateral flow device|lateral flow device
44788|NCT03004092|JF5|jf5
44789|NCT03004092|Galactomannan|galactomannan
44790|NCT03004092|Invasive aspergillosis|invasive aspergillosis
44791|NCT03005158|High-sensitivity cardiac troponin I|high-sensitivity cardiac troponin i
44792|NCT03005158|Myocardial infarction|myocardial infarction
44793|NCT03005158|Acute coronary syndrome|acute coronary syndrome
44794|NCT03005158|Cluster-randomized trial|cluster-randomized trial
44795|NCT03005132|GBM; Integrative Analysis; WES|gbm; integrative analysis; wes
44796|NCT03004989|Qualitative study|qualitative study
44797|NCT03004989|Musculoskeletal Disorders|musculoskeletal disorders
44798|NCT03004989|Return to Work Programme|return to work programme
44799|NCT03004976|hematopoietic stem cells|hematopoietic stem cells
49953|NCT02973789|TTF|ttf
44800|NCT03004976|umbilical cord blood|umbilical cord blood
44801|NCT03004976|stroke|stroke
44802|NCT03004976|ischemic stroke|ischemic stroke
44803|NCT03004963|Peritoneal Dialysis|peritoneal dialysis
44804|NCT03004963|Volume Status|volume status
44805|NCT03004963|Body Composition Monitor|body composition monitor
44806|NCT03004911|fibromyalgia|fibromyalgia
44807|NCT03004911|mobile application|mobile application
44808|NCT03004911|self-care|self-care
44809|NCT03004911|quality of life|quality of life
44810|NCT03004872|birth experience|birth experience
44811|NCT03004872|postpartum depression|postpartum depression
44812|NCT03004872|PTSD|ptsd
44813|NCT03004872|pain during labor|pain during labor
44814|NCT03004872|pain during cesarean delivery|pain during cesarean delivery
44815|NCT03004872|non-elective induction of labor|non-elective induction of labor
44816|NCT03004872|unplanned surgery for urgent/emergent cesarean delivery|unplanned surgery for urgent/emergent cesarean delivery
44817|NCT03004872|postpartum hemorrhage|postpartum hemorrhage
44818|NCT03004859|atrial fibrillation|atrial fibrillation
44819|NCT03004859|screening|screening
44820|NCT03004859|electrocardiogram|electrocardiogram
44821|NCT03004859|community pharmacy|community pharmacy
44822|NCT03004859|Germany|germany
44823|NCT03004846|Vehicle- controlled|vehicle- controlled
44824|NCT03004846|GSK2981278|gsk2981278
44825|NCT03004846|Plaque psoriasis|plaque psoriasis
44826|NCT03004820|Minor Ischemic Stroke|minor ischemic stroke
44827|NCT03004820|Transient Ischemic Attack|transient ischemic attack
44828|NCT03004820|Remote Ischemic Conditioning|remote ischemic conditioning
44829|NCT03004807|Nutrition|nutrition
44830|NCT03004807|Aging|aging
44831|NCT03004807|Multivitamin|multivitamin
44832|NCT03004781|parenting intervention|parenting intervention
44833|NCT03004781|externalizing behavior|externalizing behavior
44834|NCT03004781|emotion coaching practices|emotion coaching practices
44835|NCT03004781|self-efficacy beliefs|self-efficacy beliefs
44836|NCT03004742|polyphenols|polyphenols
44837|NCT03004742|metabolomics|metabolomics
44838|NCT03004742|oxidative stress|oxidative stress
44839|NCT03004729|Allergy|allergy
44840|NCT03004729|Atopic Dermatitis|atopic dermatitis
44841|NCT03004729|Immunoglobulin E (IgE)|immunoglobulin e (ige)
44842|NCT03004729|CMPA|cmpa
44843|NCT03004703|Interleukin 6|interleukin 6
44844|NCT03004703|Tocilizumab|tocilizumab
44845|NCT03004703|Acute coronary syndrome|acute coronary syndrome
44846|NCT03004703|STEMI|stemi
44847|NCT03004703|Inflammation|inflammation
44848|NCT03004690|biosafety|biosafety
44849|NCT03004690|outbreaks|outbreaks
44850|NCT03004690|clinic|clinic
44851|NCT03004690|personal protective equipment|personal protective equipment
44852|NCT03004690|ergonomics|ergonomics
44853|NCT03004690|error rates|error rates
44854|NCT03004664|Latinos|latinos
44855|NCT03004664|Low Income|low income
44856|NCT03004664|Self Management|self management
44857|NCT03004664|Education|education
44858|NCT03004664|Cultural Competence|cultural competence
44859|NCT03004638|Atherosclerosis|atherosclerosis
44860|NCT03004638|Cardiovascular Disease|cardiovascular disease
44861|NCT03004638|CAD|cad
44862|NCT03004638|Atherosclerotic Cardiovascular Disease|atherosclerotic cardiovascular disease
44863|NCT03004612|prediabetes|prediabetes
44864|NCT03004599|Valvular Heart Disease|valvular heart disease
44865|NCT03004599|Critical Aortic Stenosis|critical aortic stenosis
44866|NCT03004599|Severe Aortic Stenosis|severe aortic stenosis
44867|NCT03004599|High Risk|high risk
44868|NCT03004599|Aortic Valve Replacement|aortic valve replacement
44869|NCT03004599|Cardiovascular Disease|cardiovascular disease
44870|NCT03004599|Aortic Stenosis|aortic stenosis
44871|NCT03004599|Heart Valve Therapy|heart valve therapy
44872|NCT03004599|Transcatheter|transcatheter
44873|NCT03004599|Transfemoral|transfemoral
44874|NCT03004599|TAVI|tavi
44876|NCT03004599|ACURATE neo™ Aortic Bioprosthesis|acurate neo™ aortic bioprosthesis
44877|NCT03004599|ACURATE TF™ Transfemoral Delivery System|acurate tf™ transfemoral delivery system
44878|NCT03004586|Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma|malignant neoplasm of respiratory and intrathoracic organ carcinoma
44879|NCT03004586|Lung cancer|lung cancer
45190|NCT03002818|Ombitasivir|ombitasivir
44880|NCT03004586|Ultrasound-guided transbronchial needle aspiration|ultrasound-guided transbronchial needle aspiration
44881|NCT03004586|EBUS-TBNA|ebus-tbna
44882|NCT03004586|25-gauge needle|25-gauge needle
44883|NCT03004586|22-gauge needle|22-gauge needle
44884|NCT03004573|Parkinson Disease|parkinson disease
44885|NCT03004573|emotional recognition|emotional recognition
44886|NCT03004573|Deep Brain Stimulation|deep brain stimulation
44887|NCT03004560|Bariatric|bariatric
44888|NCT03004560|standard laparoscopic surgery|standard laparoscopic surgery
44889|NCT03004560|minimally invasive|minimally invasive
44890|NCT03004560|scars|scars
44891|NCT03004560|psychology|psychology
44892|NCT03004534|Breast Cancer|breast cancer
44893|NCT03004534|Breast Carcinoma|breast carcinoma
44894|NCT03004534|Breast Tumours|breast tumours
44895|NCT03004534|Early Breast Cancer|early breast cancer
44896|NCT03004521|Lithium|lithium
44897|NCT03004521|Quetiapine|quetiapine
44898|NCT03004521|Augmentation|augmentation
44899|NCT03004508|Ginkgo Biloba Extract|ginkgo biloba extract
44900|NCT03004508|Safety|safety
44901|NCT03004508|Genomic Stability|genomic stability
44902|NCT03004508|DNA cell maintenance|dna cell maintenance
44903|NCT03004482|NICU|nicu
44904|NCT03004482|Recorded video images|recorded video images
44905|NCT03004482|physiological disorders|physiological disorders
44906|NCT03004456|Phlebotomy|phlebotomy
44907|NCT03004456|Pain|pain
44908|NCT03004456|Distress|distress
44909|NCT03004443|Psychiatry|psychiatry
44910|NCT03004430|Mantra|mantra
44911|NCT03004430|Meditation|meditation
44912|NCT03004391|Shared decision making|shared decision making
44913|NCT03004391|Follow-up|follow-up
44914|NCT03004378|obesity|obesity
44915|NCT03004378|adolescent|adolescent
44916|NCT03004378|tracking device|tracking device
44917|NCT03004378|fitbit|fitbit
44918|NCT03004326|DIV|div
44919|NCT03004326|CSS|css
44920|NCT03004326|EGPA|egpa
44921|NCT03004326|HSP|hsp
44922|NCT03004326|GPA|gpa
44923|NCT03004326|MPA|mpa
44924|NCT03004326|PAN|pan
44925|NCT03004326|Wegeners|wegeners
44926|NCT03004313|migraine|migraine
44927|NCT03004300|maxillary expansion|maxillary expansion
44928|NCT03004300|adenotonsillar hypertrophy|adenotonsillar hypertrophy
44929|NCT03004300|airway volume|airway volume
44930|NCT03004261|cytomegalovirus infection|cytomegalovirus infection
44931|NCT03004261|cytotoxic T lymphocyte|cytotoxic t lymphocyte
44932|NCT03004261|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
44933|NCT03004248|glabellar lines, frown lines|glabellar lines, frown lines
44934|NCT03004053|Reflectance Confocal Microscopy|reflectance confocal microscopy
44935|NCT03004053|Normal Oral Tissue|normal oral tissue
44936|NCT03004053|16-1652|16-1652
44937|NCT03004027|health behaviour change|health behaviour change
44938|NCT03004027|implementation intention|implementation intention
44939|NCT03004027|if then plan|if then plan
44940|NCT03004027|skin condition|skin condition
44941|NCT03004027|visible difference|visible difference
44942|NCT03004027|self help|self help
44943|NCT03004014|sleep endoscopy|sleep endoscopy
44944|NCT03004014|sedation|sedation
44945|NCT03004001|Severe proteinuria|severe proteinuria
44946|NCT03004001|Dyslipidemia|dyslipidemia
44947|NCT03003975|Ablation|ablation
44948|NCT03003975|Cryoballoon|cryoballoon
44949|NCT03003975|Achieve|achieve
44950|NCT03003962|NSCLC|nsclc
44951|NCT03003962|PD-L1|pd-l1
44952|NCT03003962|Durvalumab|durvalumab
44953|NCT03003962|MEDI4736|medi4736
44954|NCT03003962|PFS|pfs
44955|NCT03003962|OS|os
44956|NCT03003949|perimenopause|perimenopause
44957|NCT03003949|menopause transition|menopause transition
44958|NCT03003949|estrogen|estrogen
44959|NCT03003949|stress|stress
44960|NCT03003949|mood|mood
44961|NCT03003936|Glucose tolerance|glucose tolerance
44962|NCT03003936|MTNR1B|mtnr1b
44963|NCT03003936|nutrigenomics|nutrigenomics
44964|NCT03003936|Food timing|food timing
44965|NCT03003923|Vegetable intake|vegetable intake
44966|NCT03003923|Taste exposures|taste exposures
44967|NCT03003923|Educational intervention|educational intervention
44968|NCT03003923|Preschool children|preschool children
44969|NCT03003923|Healthy eating intervention|healthy eating intervention
44970|NCT03003910|Best Possible Self|best possible self
44971|NCT03003897|Dietary Fiber|dietary fiber
44972|NCT03003897|Soluble Fiber|soluble fiber
44973|NCT03003897|Body Mass Index|body mass index
44974|NCT03003897|Body Weight|body weight
44975|NCT03003897|Blood Glucose|blood glucose
44976|NCT03003897|Insulin|insulin
44977|NCT03003871|stroke|stroke
46995|NCT02991118|ASCVD|ascvd
44978|NCT03003871|randomized controled clinical trial|randomized controled clinical trial
44979|NCT03003871|oral health promotion|oral health promotion
44981|NCT03003858|hyaluronic acid|hyaluronic acid
44982|NCT03003858|pediatrics|pediatrics
44983|NCT03003858|medical devices|medical devices
44984|NCT03003806|Insulin pump treatment|insulin pump treatment
44985|NCT03003806|Type 1 diabetes|type 1 diabetes
44986|NCT03003806|Pump setting advisor|pump setting advisor
44987|NCT03003689|Scaling and Root Planing|scaling and root planing
44988|NCT03003689|Er:YAG|er:yag
44989|NCT03003663|Fall Prevention|fall prevention
44990|NCT03003663|Interrupted Time-Series Study|interrupted time-series study
44991|NCT03003663|Patient Safety|patient safety
44992|NCT03003663|Patient-Centered Care|patient-centered care
44993|NCT03003663|Patient Monitoring|patient monitoring
44994|NCT03003663|Health Care Technology|health care technology
44995|NCT03003663|Mobile Applications|mobile applications
44996|NCT03003663|Bedside Monitor|bedside monitor
44997|NCT03003663|Mechanical Fall|mechanical fall
44998|NCT03003650|Severe Symptomatic Aortic Valve Stenosis|severe symptomatic aortic valve stenosis
44999|NCT03003624|Incisions|incisions
36657|NCT03056976|Dental implant|dental implant
36658|NCT03056976|Complete denture|complete denture
36659|NCT03056976|Cost analysis|cost analysis
36660|NCT03056963|Guided Imagery|guided imagery
36661|NCT03056950|Blood Flow Restriciton|blood flow restriciton
36662|NCT03056950|Occlusion training|occlusion training
36663|NCT03056950|Distal radius fracture|distal radius fracture
45000|NCT03003624|microdissection needle|microdissection needle
45001|NCT03003598|Intraocular pressure|intraocular pressure
45002|NCT03003598|videolaryngoscope|videolaryngoscope
45003|NCT03003598|direct laryngoscope|direct laryngoscope
45004|NCT03003585|intraocular pressure|intraocular pressure
45005|NCT03003585|direct laryngoscopy|direct laryngoscopy
45006|NCT03003585|fiberoptic bronchoscopy|fiberoptic bronchoscopy
45007|NCT03003572|Sjögren's syndrome|sjögren's syndrome
45008|NCT03003572|Immunoglobulin E|immunoglobulin e
45009|NCT03003572|Anti-Ro/SSA|anti-ro/ssa
45010|NCT03003572|Autoimmune disease|autoimmune disease
45011|NCT03003572|Biomarker|biomarker
45012|NCT03003559|COPD Exacerbation|copd exacerbation
45013|NCT03003559|High Flow Oxygen|high flow oxygen
45014|NCT03003559|Nasal Cannula|nasal cannula
45015|NCT03003559|mild|mild
45016|NCT03003533|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
45017|NCT03003533|Blood Coagulation Disorders|blood coagulation disorders
45018|NCT03003533|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
45019|NCT03003533|Coagulation Protein Disorders|coagulation protein disorders
45020|NCT03003533|Factor VIII (FVIII)|factor viii (fviii)
45021|NCT03003533|Factor VIII (FVIII) Deficiency|factor viii (fviii) deficiency
45022|NCT03003533|Factor VIII (FVIII) Gene|factor viii (fviii) gene
45023|NCT03003533|Factor VIII (FVIII) Protein|factor viii (fviii) protein
45024|NCT03003533|Genetic Diseases, Inborn|genetic diseases, inborn
45025|NCT03003533|Genetic Diseases, X-Linked|genetic diseases, x-linked
45026|NCT03003533|Gene Therapy|gene therapy
45027|NCT03003533|Gene Transfer|gene transfer
45028|NCT03003533|Hematologic Diseases|hematologic diseases
45029|NCT03003533|Hemorrhagic Disorders|hemorrhagic disorders
45030|NCT03003533|Recombinant|recombinant
45031|NCT03003533|Vector|vector
45032|NCT03003520|Lymphoma|lymphoma
45033|NCT03003520|Diffuse-large B-Cell Lymphoma|diffuse-large b-cell lymphoma
45034|NCT03003520|Durvalumab|durvalumab
45035|NCT03003520|Anti-PD-L1 Antibody|anti-pd-l1 antibody
45036|NCT03003520|MEDI4736|medi4736
45037|NCT03003520|Immune Checkpoint|immune checkpoint
45038|NCT03003520|Rituximab|rituximab
45039|NCT03003520|Cyclophosphamide|cyclophosphamide
45040|NCT03003520|Doxorubicin|doxorubicin
45041|NCT03003520|Vincristine|vincristine
45042|NCT03003520|Prednisone/Prednisolone|prednisone/prednisolone
45043|NCT03003520|Lenalidomide|lenalidomide
45044|NCT03003507|Hyperglycemia|hyperglycemia
45045|NCT03003507|Fructose|fructose
45046|NCT03003507|Diabetes mellitus|diabetes mellitus
45047|NCT03003507|Enteral Nutrition|enteral nutrition
45048|NCT03003507|Glycemic Variability|glycemic variability
45049|NCT03003468|Anti-PD-1|anti-pd-1
45050|NCT03003468|Pembrolizumab|pembrolizumab
45051|NCT03003468|Imprime PGG|imprime pgg
45052|NCT03003468|MK-3475|mk-3475
45162|NCT03003039|GB241|gb241
45053|NCT03003455|Nasotracheal Intubation|nasotracheal intubation
45054|NCT03003442|Multivitamin/mineral|multivitamin/mineral
45055|NCT03003442|Exercise|exercise
45056|NCT03003442|Fatigue|fatigue
45057|NCT03003442|Stress|stress
45058|NCT03003442|Arousal|arousal
45059|NCT03003442|Energy expenditure|energy expenditure
45060|NCT03003442|Recovery biomarkers|recovery biomarkers
45061|NCT03003442|Cognition|cognition
45062|NCT03003429|Heart rate variability|heart rate variability
45063|NCT03003429|anxiety|anxiety
45064|NCT03003429|Autonomic dysfunction|autonomic dysfunction
45065|NCT03003403|mHealth|mhealth
45066|NCT03003403|Digital Health|digital health
45067|NCT03003403|Primary Care|primary care
45068|NCT03003403|Pragmatic Clinical Trial|pragmatic clinical trial
45069|NCT03003403|Behavior Change|behavior change
45070|NCT03003403|Weight Management|weight management
45071|NCT03003390|child|child
45072|NCT03003390|critical illness|critical illness
45073|NCT03003390|venous thromboembolism|venous thromboembolism
45074|NCT03003390|enoxaparin|enoxaparin
45075|NCT03003390|thrombin generation|thrombin generation
45076|NCT03003377|Sevoflurane|sevoflurane
45077|NCT03003377|Remifentanil|remifentanil
45078|NCT03003377|Laryngeal mask supreme|laryngeal mask supreme
45079|NCT03003377|laryngeal mask proseal|laryngeal mask proseal
45080|NCT03003351|Fistula|fistula
45081|NCT03003351|Cohort Study|cohort study
45082|NCT03003338|chronic HCV Genotype 1b infection|chronic hcv genotype 1b infection
45083|NCT03003338|HCV RNA|hcv rna
45084|NCT03003338|OBV/PTV/r in combination with DSV|obv/ptv/r in combination with dsv
45191|NCT03002818|Genotype 1|genotype 1
45089|NCT03003312|Uyghur|uyghur
45090|NCT03003312|Prevalence|prevalence
45091|NCT03003312|Associated factors|associated factors
45092|NCT03003312|Children|children
45093|NCT03003299|Sapien 3|sapien 3
45094|NCT03003299|Partner 3|partner 3
45095|NCT03003299|cardiovascular disease|cardiovascular disease
45096|NCT03003299|heart disease|heart disease
45097|NCT03003299|aortic stenosis|aortic stenosis
45098|NCT03003299|SAVR|savr
45099|NCT03003299|TAVR|tavr
45100|NCT03003299|failing surgical valve|failing surgical valve
45101|NCT03003299|failing bioprosthetic valve|failing bioprosthetic valve
45102|NCT03003299|failing valve|failing valve
45103|NCT03003286|Contingency Behavior Management|contingency behavior management
45104|NCT03003286|Flexible|flexible
45105|NCT03003286|Unstuck|unstuck
45106|NCT03003286|Low Income|low income
45107|NCT03003286|Behavior|behavior
45108|NCT03003286|Coping|coping
45109|NCT03003286|Disparity|disparity
45110|NCT03003286|Problem Solving|problem solving
45111|NCT03003286|Self-Control|self-control
45112|NCT03003286|impulsive|impulsive
45113|NCT03003286|intervention|intervention
45114|NCT03003221|Parent training|parent training
45115|NCT03003221|Dental care|dental care
45116|NCT03003169|surgery|surgery
45117|NCT03003169|breast cancer|breast cancer
45118|NCT03003169|quality of life|quality of life
45119|NCT03003156|magnetic seizure therapy|magnetic seizure therapy
45120|NCT03003156|schizophrenia|schizophrenia
45121|NCT03003156|controlled trial|controlled trial
45122|NCT03003156|cognition|cognition
45123|NCT03003130|Hyaluronic acid|hyaluronic acid
45124|NCT03003130|Comparative study|comparative study
45125|NCT03003130|NLF|nlf
45126|NCT03003117|Infant|infant
45127|NCT03003117|Diet|diet
45128|NCT03003117|Growth|growth
45129|NCT03003117|Breastfeeding|breastfeeding
45130|NCT03003117|Complementary feeding|complementary feeding
45131|NCT03003117|Pregnancy|pregnancy
45132|NCT03003117|Body mass index|body mass index
45133|NCT03003117|Social disadvantage|social disadvantage
45134|NCT03003117|Randomized controlled trial|randomized controlled trial
45135|NCT03003117|Education|education
45136|NCT03003117|Food vouchers|food vouchers
45137|NCT03003104|Skin diseases|skin diseases
45138|NCT03003104|rosacea|rosacea
45139|NCT03003078|Pancreatic cancer|pancreatic cancer
45140|NCT03003078|Pancreas|pancreas
45141|NCT03003078|metastases|metastases
45142|NCT03003078|pancreatic tumour|pancreatic tumour
45143|NCT03003078|unresectable|unresectable
45144|NCT03003078|locally advanced|locally advanced
45145|NCT03003078|implantable|implantable
45146|NCT03003078|radiographic|radiographic
45147|NCT03003078|device|device
45148|NCT03003078|Phosphorous-32|phosphorous-32
45149|NCT03003078|OncoSil™|oncosil™
45150|NCT03003078|brachytherapy|brachytherapy
45151|NCT03003078|FOLFIRINOX|folfirinox
45152|NCT03003078|gemcitabine|gemcitabine
45153|NCT03003078|nab-paclitaxel|nab-paclitaxel
45154|NCT03003078|Abraxane|abraxane
45155|NCT03003065|Inoperable cholangiocarcinoma|inoperable cholangiocarcinoma
45156|NCT03003065|Photodynamic therapy|photodynamic therapy
45157|NCT03003065|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
45158|NCT03003052|dental implants|dental implants
45159|NCT03003052|edentulous|edentulous
45160|NCT03003052|dental hygiene|dental hygiene
45161|NCT03003052|evidence-based dentistry|evidence-based dentistry
45163|NCT03003039|Rituximab|rituximab
45164|NCT03003039|B-cell Lymphoma|b-cell lymphoma
45165|NCT03003026|motor learning|motor learning
45166|NCT03003026|participation|participation
45167|NCT03003013|Odontogenic cysts|odontogenic cysts
45168|NCT03003013|Bone substitutes materials|bone substitutes materials
45169|NCT03003013|SYMBIOS®|symbios®
45170|NCT03003013|Platelets rich fibrin (PRF)|platelets rich fibrin (prf)
45171|NCT03003013|Bone regeneration|bone regeneration
45172|NCT03002974|Gout|gout
45173|NCT03002974|Interleukin 1 receptor antagonist|interleukin 1 receptor antagonist
45174|NCT03002974|IL-1 receptor antagonist|il-1 receptor antagonist
45180|NCT03002857|Laryngeal Mask Airway|laryngeal mask airway
45181|NCT03002857|Urologic Surgical Procedure|urologic surgical procedure
45182|NCT03002831|CIK|cik
45183|NCT03002831|Chemotherapy|chemotherapy
45184|NCT03002831|Pancreatic Cancer|pancreatic cancer
45185|NCT03002818|Ritonavir|ritonavir
45186|NCT03002818|Chronic Hepatitis C (HCV)|chronic hepatitis c (hcv)
45187|NCT03002818|Dasabuvir|dasabuvir
45188|NCT03002818|Paritaprevir|paritaprevir
45189|NCT03002818|Sustained Virological Response|sustained virological response
45193|NCT03002805|CBT-1®|cbt-1®
45194|NCT03002805|Doxorubicin|doxorubicin
45195|NCT03002805|Sarcoma|sarcoma
45196|NCT03002792|anesthesia|anesthesia
45197|NCT03002792|neurodevelopment|neurodevelopment
45198|NCT03002792|dental caries|dental caries
45199|NCT03002753|OCD|ocd
36917|NCT03055234|PH|ph
45200|NCT03002753|obsessive-compulsive disorder|obsessive-compulsive disorder
45201|NCT03002753|cognitive therapy|cognitive therapy
45202|NCT03002753|metacognitive therapy|metacognitive therapy
45203|NCT03002753|cognitive restructuring|cognitive restructuring
45204|NCT03002753|detached mindfulness|detached mindfulness
45205|NCT03002753|comparison|comparison
45206|NCT03002753|Germany|germany
45207|NCT03002753|Muenster|muenster
45208|NCT03002753|Christoph-Dornier-Stiftung|christoph-dornier-stiftung
45209|NCT03002753|metacognition|metacognition
45210|NCT03002727|Colorectal cancer|colorectal cancer
45211|NCT03002727|Microsatellite|microsatellite
45212|NCT03002727|Colorectal cancer stem cells|colorectal cancer stem cells
45213|NCT03002714|Resistance Training|resistance training
45214|NCT03002714|Psychological Stress|psychological stress
45215|NCT03002714|Aging|aging
45216|NCT03002714|Hypertension|hypertension
45217|NCT03002714|Autonomic Nervous System|autonomic nervous system
45218|NCT03002701|Prevention|prevention
45219|NCT03002701|Critical care|critical care
45220|NCT03002701|Delirium|delirium
45221|NCT03002701|Nurse|nurse
45222|NCT03002701|RCT|rct
45223|NCT03002675|Adipose tissue|adipose tissue
45224|NCT03002675|Type 2 diabetes|type 2 diabetes
45225|NCT03002649|Dermatomyositis|dermatomyositis
45226|NCT03002649|Tofacitinib|tofacitinib
45227|NCT03002649|Refractory dermatomyositis|refractory dermatomyositis
45228|NCT03002636|Obesity|obesity
45229|NCT03002636|Anesthesia Complications|anesthesia complications
45230|NCT03002636|Body Mass Index (BMI)|body mass index (bmi)
45231|NCT03002623|Dual Inhibitor of HDAC and P13K Signaling|dual inhibitor of hdac and p13k signaling
45232|NCT03002623|HDSC2|hdsc2
45233|NCT03002623|EGFR/RAS/RAF/MEK/ERK Signaling Pathway Inhibition|egfr/ras/raf/mek/erk signaling pathway inhibition
45234|NCT03002584|IBS, population|ibs, population
45235|NCT03002558|Hypertension|hypertension
45236|NCT03002558|Continuous Positive Airway Pressure|continuous positive airway pressure
45237|NCT03002558|Obstructive Sleep Apnea|obstructive sleep apnea
45238|NCT03002558|Cardiovascular Diseases|cardiovascular diseases
45239|NCT03002545|Magnesium|magnesium
45240|NCT03002545|Type II diabetes|type ii diabetes
45241|NCT03002545|magnesium-sensitive genes|magnesium-sensitive genes
45242|NCT03002532|Breast cancer|breast cancer
45243|NCT03002532|Brain metastasis|brain metastasis
45244|NCT03002532|Whole brain radiotherapy|whole brain radiotherapy
45245|NCT03002532|Hippocampal avoidance|hippocampal avoidance
45246|NCT03002532|Neurocognitive function|neurocognitive function
45247|NCT03002532|intracranial failure|intracranial failure
45248|NCT03002506|ceftolozane|ceftolozane
45249|NCT03002506|tazobactam|tazobactam
45250|NCT03002493|Rifampicin|rifampicin
45251|NCT03002493|Pharmacokinetics|pharmacokinetics
45252|NCT03002493|Eribulin Mesylate|eribulin mesylate
45253|NCT03002493|E7389|e7389
45254|NCT03002493|Advanced Solid Tumors|advanced solid tumors
45255|NCT03002493|Tumors|tumors
45256|NCT03002454|99mTc Pertechnetate|99mtc pertechnetate
45257|NCT03002454|Sodium Pertechnetate|sodium pertechnetate
45258|NCT03002454|Technetium|technetium
45259|NCT03002454|Molybdenum|molybdenum
45260|NCT03002454|MDP|mdp
45261|NCT03002454|neutron activation|neutron activation
45262|NCT03002402|asthma|asthma
45263|NCT03002402|insomnia|insomnia
45264|NCT03002402|cognitive-behavioral treatment|cognitive-behavioral treatment
45265|NCT03002389|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
45266|NCT03002389|COPD|copd
45267|NCT03002389|emphysema|emphysema
45268|NCT03002389|MRI|mri
45269|NCT03002389|hyper polarized gas MRI|hyper polarized gas mri
45270|NCT03002363|autism|autism
45271|NCT03002363|audiology|audiology
45272|NCT03002363|video modeling|video modeling
45273|NCT03002363|testing compliance|testing compliance
45274|NCT03002350|Circulating tumor cells (CTCs)|circulating tumor cells (ctcs)
45275|NCT03002350|Optically induced dielectrophoresis (ODEP)|optically induced dielectrophoresis (odep)
45276|NCT03002350|Cell sorting|cell sorting
45277|NCT03002350|Next-generation sequencing (NGS)|next-generation sequencing (ngs)
45278|NCT03002350|disruptive mutation|disruptive mutation
45279|NCT03002337|aromatherapy massage, yoga|aromatherapy massage, yoga
45280|NCT03002324|Vaccines|vaccines
45281|NCT03002324|Childhood Vaccination|childhood vaccination
45282|NCT03002324|Decision Making|decision making
45283|NCT03002324|Health Belief Model|health belief model
45284|NCT03002311|Bioinformatics|bioinformatics
45285|NCT03002311|Electronic pharmacology|electronic pharmacology
45286|NCT03002311|Mobile health|mobile health
45287|NCT03002311|Electronic health|electronic health
45288|NCT03002311|Adherence|adherence
45289|NCT03002311|Digital health|digital health
45290|NCT03002311|Health information technology|health information technology
45292|NCT03002311|eHealth|ehealth
45293|NCT03002259|cardiac surgery|cardiac surgery
45294|NCT03002233|TRK-820|trk-820
45295|NCT03002233|Hemodialysis|hemodialysis
45296|NCT03002233|Uremic Pruritus|uremic pruritus
45297|NCT03002194|rhytides|rhytides
45298|NCT03002194|wrinkle|wrinkle
45299|NCT03002142|Alzheimer|alzheimer
45300|NCT03002142|Hearing loss|hearing loss
45301|NCT03002142|Cognition|cognition
45302|NCT03002142|Quality of life|quality of life
45303|NCT03002142|Hearing aids|hearing aids
45304|NCT03002090|iron deficiency|iron deficiency
45305|NCT03002090|anemia|anemia
45306|NCT03002090|exercise training|exercise training
45307|NCT03002090|aerobic|aerobic
45308|NCT03002090|performance|performance
45309|NCT03002090|Chinese medicine|chinese medicine
45316|NCT03002038|neuromyelitis optica spectrum disorder|neuromyelitis optica spectrum disorder
45317|NCT03002038|azathioprine|azathioprine
45318|NCT03002038|rituximab|rituximab
45319|NCT03002038|clinical trial|clinical trial
45320|NCT03002038|annual relapse rate|annual relapse rate
45321|NCT03002038|expanded disability status scale|expanded disability status scale
45329|NCT03001999|Diabetes|diabetes
45330|NCT03001999|Positive Psychology|positive psychology
45331|NCT03001999|Physical Activity|physical activity
45333|NCT03001986|efficacy|efficacy
45334|NCT03001986|hand, foot and mouth disease (HFMD)|hand, foot and mouth disease (hfmd)
45335|NCT03001973|Lupus nephritis|lupus nephritis
45336|NCT03001973|Patient survival|patient survival
45337|NCT03001973|Renal survival|renal survival
45338|NCT03001947|IgA nephropathy|iga nephropathy
45339|NCT03001947|All-cause mortality|all-cause mortality
45340|NCT03001947|Cardiovascular mortality|cardiovascular mortality
45341|NCT03001947|A composite renal outcome|a composite renal outcome
45342|NCT03001934|Nephrotic syndrome|nephrotic syndrome
45343|NCT03001934|Treatment response|treatment response
45344|NCT03001934|Renal function|renal function
45345|NCT03001921|Hemodialysis|hemodialysis
45346|NCT03001921|Patient survival|patient survival
45347|NCT03001921|Quality of life|quality of life
45348|NCT03001921|Hemodialysis access|hemodialysis access
45349|NCT03001908|shoulder|shoulder
45350|NCT03001908|mobilization|mobilization
45351|NCT03001908|electromyography|electromyography
45352|NCT03001908|imaging ultrasound|imaging ultrasound
45353|NCT03001804|Multiple Myeloma|multiple myeloma
45354|NCT03001804|Revlimid|revlimid
45355|NCT03001804|Lenalidomide|lenalidomide
45356|NCT03001804|Non-transplantable|non-transplantable
45357|NCT03001791|CO2 laser|co2 laser
45358|NCT03001791|thermal damage zone|thermal damage zone
45359|NCT03001791|Er:YAG laser|er:yag laser
45360|NCT03001778|Physical Activity|physical activity
45361|NCT03001778|Older Adults|older adults
45362|NCT03001778|Independent Living Facilities|independent living facilities
45363|NCT03001778|Multimedia technology|multimedia technology
45364|NCT03001752|post-extraction dental implant|post-extraction dental implant
45365|NCT03001752|immediate dental implant|immediate dental implant
45366|NCT03001752|open flap|open flap
45367|NCT03001752|flapless|flapless
45368|NCT03001752|bone grafting|bone grafting
45369|NCT03001752|CT Cone Beam|ct cone beam
45370|NCT03001687|hepcidin|hepcidin
45371|NCT03001687|sepsis|sepsis
45372|NCT03001687|surgery|surgery
45373|NCT03001687|vitamin D|vitamin d
45374|NCT03001661|Propess|propess
45375|NCT03001661|Dilapan-S|dilapan-s
45376|NCT03001661|Dinoprostone|dinoprostone
45377|NCT03001661|Labour|labour
45378|NCT03001661|Induction|induction
45379|NCT03001661|Child birth|child birth
45380|NCT03001596|Neoadjuvant Chemoradiotherapy|neoadjuvant chemoradiotherapy
45381|NCT03001596|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
45382|NCT03001596|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
45383|NCT03001596|Esophageal Squamous Cell Carcinoma（cT3-4aN0-1M0）|esophageal squamous cell carcinoma（ct3-4an0-1m0）
45384|NCT03001583|Mediterranean diet|mediterranean diet
45385|NCT03001583|weight loss|weight loss
45386|NCT03001583|type 2 diabetes|type 2 diabetes
45387|NCT03001583|education program|education program
45388|NCT03001583|cooking|cooking
45389|NCT03001557|Mild to Moderate Alzheimer's Disease Dementia|mild to moderate alzheimer's disease dementia
45390|NCT03001557|sleep|sleep
45391|NCT03001557|circadian rhythms|circadian rhythms
45392|NCT03001531|Complete paraplegia|complete paraplegia
45393|NCT03001466|Cataract|cataract
45394|NCT03001466|Urea-loaded NPs|urea-loaded nps
45395|NCT03001466|TEM examination|tem examination
45396|NCT03001453|Exparel|exparel
45397|NCT03001453|total hip replacement|total hip replacement
45398|NCT03001453|bupivacaine|bupivacaine
45399|NCT03001440|REMS|rems
45400|NCT03001440|Smoking cessation|smoking cessation
45401|NCT03001440|WELLBUTRIN|wellbutrin
45402|NCT03001440|ZYBAN|zyban
45403|NCT03001440|Neuropsychiatric adverse events|neuropsychiatric adverse events
45404|NCT03001388|Cystic Fibrosis Liver Disease|cystic fibrosis liver disease
45405|NCT03001388|Pancreatic insufficiency|pancreatic insufficiency
45406|NCT03001388|Cystic Fibrosis|cystic fibrosis
45407|NCT03001388|Transient Elastography|transient elastography
623157|NCT00672269|cancer|cancer
45408|NCT03001375|Laparoscopic colectomy.|laparoscopic colectomy.
45409|NCT03001375|Splenic flexure mobilization.|splenic flexure mobilization.
45410|NCT03001375|Anastomotic leakage.|anastomotic leakage.
45411|NCT03001349|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
45412|NCT03001349|Neuroendocrine Tumors|neuroendocrine tumors
45414|NCT03001349|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
45415|NCT03001349|PET/CT scan|pet/ct scan
45416|NCT03001349|68Ga-DOTATOC|68ga-dotatoc
45417|NCT03001336|Thyroid|thyroid
45418|NCT03001336|Diabetes Mellitus|diabetes mellitus
45419|NCT03001297|atherosclerosis; acute coronary syndrome; MEDI5884|atherosclerosis; acute coronary syndrome; medi5884
45420|NCT03001271|Angiotensin-(1-7)|angiotensin-(1-7)
45421|NCT03001271|Renin-angiotensin System|renin-angiotensin system
45422|NCT03001271|Autonomic Nervous System|autonomic nervous system
45423|NCT03001245|adolescents|adolescents
45424|NCT03001245|depression|depression
45425|NCT03001245|psychotherapy|psychotherapy
45426|NCT03001245|interpersonal therapy|interpersonal therapy
45427|NCT03001232|Movement-oriented Dementia Care|movement-oriented dementia care
45428|NCT03001232|QoL|qol
45429|NCT03001232|ADL|adl
45430|NCT03001232|Nursing Home|nursing home
45431|NCT03001193|Primary slow progress|primary slow progress
45432|NCT03001193|Prolonged latent phase|prolonged latent phase
45433|NCT03001193|Labor arrest|labor arrest
45434|NCT03001180|Generalized Lymphatic Anomaly|generalized lymphatic anomaly
45435|NCT03001180|Vascular Anomaly|vascular anomaly
45436|NCT03001180|Kaposiform Hemangioendothelioma|kaposiform hemangioendothelioma
45437|NCT03001180|Kaposiform Lymphangiomatosis|kaposiform lymphangiomatosis
45438|NCT03001180|Vascular Endothelial Growth Factor|vascular endothelial growth factor
45439|NCT03001180|Biomarkers|biomarkers
45440|NCT03001180|GLA|gla
45441|NCT03001180|KLA|kla
45442|NCT03001180|KHE|khe
45443|NCT03001180|GSD|gsd
45444|NCT03001167|Microbiome|microbiome
45445|NCT03001167|Antibiotics|antibiotics
45446|NCT03001167|Growth|growth
45447|NCT03001141|MultiPoint Pacing|multipoint pacing
45448|NCT03001141|Heart Failure|heart failure
45449|NCT03001141|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
45450|NCT03001141|Quadripolar pacing|quadripolar pacing
45451|NCT03001115|Korean participants|korean participants
45452|NCT03001115|Hidradenitis Suppurativa|hidradenitis suppurativa
45453|NCT03001115|Safety|safety
45454|NCT03001115|Adalimumab|adalimumab
45455|NCT03001102|Preoperative Care|preoperative care
45456|NCT03001102|Baths|baths
45457|NCT03001102|Chlorhexidine|chlorhexidine
45458|NCT03001102|Soaps|soaps
45459|NCT03001102|Povidone-Iodine|povidone-iodine
45460|NCT03001102|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
45461|NCT03001102|Surgical Wound Infection|surgical wound infection
45462|NCT03001089|Neonatology|neonatology
45463|NCT03001089|Endocrinology|endocrinology
45464|NCT03001076|hyperlididemia|hyperlididemia
45465|NCT03001076|LDL|ldl
45466|NCT03001076|cholesterol|cholesterol
45467|NCT03001076|statin intolerance|statin intolerance
45468|NCT03001037|Functional Outcome Measures|functional outcome measures
45469|NCT03001037|Wearable Sensors|wearable sensors
45470|NCT03001037|ViMove|vimove
45471|NCT03001037|Low Back Pain|low back pain
45472|NCT03001037|Range of Movement|range of movement
45473|NCT03001037|Muscle Activity|muscle activity
45474|NCT03000998|HPV|hpv
45475|NCT03000998|Cancer|cancer
45476|NCT03000985|schizophrenia|schizophrenia
45477|NCT03000985|psychoeducation program|psychoeducation program
45478|NCT03000985|family caregiver|family caregiver
45479|NCT03000985|relapse|relapse
45480|NCT03000985|medication adherence|medication adherence
45481|NCT03000985|burden|burden
45482|NCT03000972|Augmentation|augmentation
45483|NCT03000972|PET-CT|pet-ct
45484|NCT03000972|Positron Emission Tomography|positron emission tomography
45485|NCT03000972|Fluorine-18|fluorine-18
45486|NCT03000946|Pancreatectomy|pancreatectomy
45487|NCT03000946|Somatostatin analogue|somatostatin analogue
45488|NCT03000946|Octreotide|octreotide
45489|NCT03000946|Pancreatic fistula|pancreatic fistula
45490|NCT03000920|short message service (SMS)|short message service (sms)
45491|NCT03000920|screening|screening
45492|NCT03000920|cost-effectiveness|cost-effectiveness
45493|NCT03000907|prevention|prevention
45494|NCT03000907|frailty|frailty
45495|NCT03000907|obese|obese
45496|NCT03000907|elderly|elderly
45497|NCT03000907|physical exercise|physical exercise
45498|NCT03000894|cognitive-behavioral therapy for insomnia|cognitive-behavioral therapy for insomnia
45499|NCT03000894|insomnia|insomnia
45500|NCT03000894|mood disorder|mood disorder
45501|NCT03000868|Colonic Polyps|colonic polyps
45502|NCT03000868|Endoscopic Mucosal Resection|endoscopic mucosal resection
45503|NCT03000868|Colonoscopy|colonoscopy
45504|NCT03000855|Malignant biliary obstruction|malignant biliary obstruction
45505|NCT03000855|EUS - guided choledocho-duodenostomy|eus - guided choledocho-duodenostomy
45506|NCT03000855|ERCP with covered metallic stents|ercp with covered metallic stents
45507|NCT03000842|autonomic control|autonomic control
37144|NCT03053791|Paraplegia|paraplegia
37145|NCT03053791|Mesencephalic locomotor region|mesencephalic locomotor region
37146|NCT03053791|MLR|mlr
37148|NCT03053791|PPN|ppn
45508|NCT03000842|transcutaneous vagal nerve stimulation|transcutaneous vagal nerve stimulation
45509|NCT03000842|transauricular vagal nerve stimulation|transauricular vagal nerve stimulation
45510|NCT03000829|Code blue|code blue
45511|NCT03000829|Code team|code team
45512|NCT03000829|Crisis team leadership|crisis team leadership
45513|NCT03000829|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
45514|NCT03000829|Telemedicine|telemedicine
45515|NCT03000829|Simulation|simulation
45516|NCT03000829|Mock code|mock code
45517|NCT03000829|In-hospital cardiac arrest|in-hospital cardiac arrest
45518|NCT03000790|Anterior disc displacement|anterior disc displacement
45519|NCT03000790|TMD therapy|tmd therapy
45520|NCT03000790|internal derangement|internal derangement
45521|NCT03000790|Lingual Ring|lingual ring
45522|NCT03000777|melatonin|melatonin
45524|NCT03000777|Myalgic Encephalomyelitis|myalgic encephalomyelitis
45525|NCT03000777|Chronic Fatigue Syndrome|chronic fatigue syndrome
45526|NCT03000777|sleep|sleep
45527|NCT03000777|pain|pain
45528|NCT03000764|Skin biopsy|skin biopsy
45529|NCT03000764|Radiotherapy|radiotherapy
45530|NCT03000764|RNA biomarker|rna biomarker
45531|NCT03000764|HSP biomarker|hsp biomarker
45532|NCT03000764|Exon junction array|exon junction array
45533|NCT03000764|Gene expression|gene expression
45534|NCT03000764|Radiosensitivity prediction|radiosensitivity prediction
45535|NCT03000751|CT scan|ct scan
45536|NCT03000751|CT exam|ct exam
45537|NCT03000751|ionizing radiation|ionizing radiation
45538|NCT03000751|medical imaging|medical imaging
45539|NCT03000751|cat scan|cat scan
45540|NCT03000751|radiation|radiation
45541|NCT03000738|CD16- monocyte/CD16+ monocyte ratio|cd16- monocyte/cd16+ monocyte ratio
45542|NCT03000738|CytoDiff flow cytometric system|cytodiff flow cytometric system
45543|NCT03000738|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
45544|NCT03000738|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
45545|NCT03000738|prognosis|prognosis
45546|NCT03000712|adipose tissue derived mesenchymal stem cell|adipose tissue derived mesenchymal stem cell
45547|NCT03000712|osteoarthritis|osteoarthritis
45548|NCT03000712|degenerative arthritis|degenerative arthritis
45549|NCT03000712|kyung hee university hospital|kyung hee university hospital
45550|NCT03000712|biostar|biostar
45551|NCT03000712|Rbio|rbio
45552|NCT03000712|Osteoarthritis, Knee|osteoarthritis, knee
45553|NCT03000712|High tibial osteotomy|high tibial osteotomy
45554|NCT03000712|Joint Diseases|joint diseases
45555|NCT03000699|cognitive bias modification|cognitive bias modification
45556|NCT03000699|interpretation bias|interpretation bias
45557|NCT03000699|suicidal ideation|suicidal ideation
45558|NCT03000699|depression|depression
45559|NCT03000686|GSK2586881, Acute hypoxia, Exercise|gsk2586881, acute hypoxia, exercise
45560|NCT03000660|Amyloidosis|amyloidosis
45561|NCT03000660|AL Amyloidosis|al amyloidosis
45562|NCT03000660|Amyloid Light Chain Amylodosis|amyloid light chain amylodosis
45563|NCT03000660|ABT-199|abt-199
45564|NCT03000660|Venetoclax|venetoclax
45565|NCT03000647|Pelvic floor muscle exercise|pelvic floor muscle exercise
45566|NCT03000647|Supervision|supervision
45567|NCT03000647|Physiotherapy|physiotherapy
45568|NCT03000621|MicroRNA|microrna
45569|NCT03000621|miR-122|mir-122
45570|NCT03000621|Diagnosis|diagnosis
45571|NCT03000621|Prognosis|prognosis
45572|NCT03000595|eczema|eczema
45573|NCT03000569|Parkinson|parkinson
45574|NCT03000543|Infants|infants
45575|NCT03000543|Children|children
45576|NCT03000543|Adequate or high vitamin A store|adequate or high vitamin a store
45577|NCT03000530|Depression|depression
45578|NCT03000517|levofloxacin|levofloxacin
45579|NCT03000517|multi-drug resistant TB|multi-drug resistant tb
45580|NCT03000517|pharmacokinetics|pharmacokinetics
45781|NCT02999360|Aphasia|aphasia
45581|NCT03000465|pneumoperitoneum pressure|pneumoperitoneum pressure
45582|NCT03000465|laparoscopic pressure|laparoscopic pressure
45583|NCT03000465|intra-abdominal insufflation|intra-abdominal insufflation
45584|NCT03000465|intra-abdominal pressures|intra-abdominal pressures
45585|NCT03000465|abdominal compliance|abdominal compliance
45586|NCT03000452|Multiple Myeloma|multiple myeloma
45587|NCT03000452|Daratumumab|daratumumab
45588|NCT03000452|Durvalumab|durvalumab
45589|NCT03000452|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
45693|NCT03000010|Posterior Spinal Fusion|posterior spinal fusion
45590|NCT03000439|systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
45591|NCT03000439|Xeljanz|xeljanz
45592|NCT03000439|Tofacitinib|tofacitinib
45593|NCT03000439|sJIA|sjia
45594|NCT03000439|CP-690 550|cp-690 550
45595|NCT03000426|Low level laser therapy|low level laser therapy
45596|NCT03000387|Nicotine Replacement Therapy|nicotine replacement therapy
37292|NCT03053076|cord blood mononuclear cells|cord blood mononuclear cells
37293|NCT03053076|safety|safety
45597|NCT03000387|Smoking Cessation|smoking cessation
45598|NCT03000387|Randomized Clinical Trial|randomized clinical trial
45601|NCT03000387|Placebo|placebo
45603|NCT03000361|Colonoscopy|colonoscopy
45604|NCT03000361|motorized spiral endoscopy|motorized spiral endoscopy
45605|NCT03000361|adenoma detection rate|adenoma detection rate
45606|NCT03000348|Exacerbation|exacerbation
45607|NCT03000348|CF|cf
45608|NCT03000348|Lung disease|lung disease
45609|NCT03000348|Lung infection|lung infection
45610|NCT03000348|Gram negative|gram negative
45611|NCT03000348|Bacterial Infection|bacterial infection
45612|NCT03000348|pneumonia|pneumonia
45613|NCT03000348|bronchitis|bronchitis
45614|NCT03000335|microRNA|microrna
45615|NCT03000335|relapse|relapse
45616|NCT03000335|blood|blood
45617|NCT03000335|in vitro diagnostics|in vitro diagnostics
45618|NCT03000335|prediction|prediction
45619|NCT03000335|lab test|lab test
45620|NCT03000296|autologous|autologous
45621|NCT03000296|lymphoablation|lymphoablation
45622|NCT03000296|hematopoetic stem cell transplant|hematopoetic stem cell transplant
45623|NCT03000296|immune system|immune system
45624|NCT03000296|Bone marrow transplant|bone marrow transplant
45625|NCT03000283|Conivaptan|conivaptan
45626|NCT03000270|Infarct Size|infarct size
45627|NCT03000270|Impella|impella
45628|NCT03000270|Unloading|unloading
45629|NCT03000270|Left Ventricle|left ventricle
45630|NCT03000270|PPCI|ppci
45631|NCT03000270|STEMI|stemi
45632|NCT03000257|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
45633|NCT03000257|Mesothelioma|mesothelioma
45634|NCT03000257|Gastric cancer|gastric cancer
45635|NCT03000257|Merkel cell carcinoma|merkel cell carcinoma
45636|NCT03000257|Cholangiocarcinoma|cholangiocarcinoma
45637|NCT03000257|Advanced Solid Tumors|advanced solid tumors
45638|NCT03000257|Ovarian cancer|ovarian cancer
45639|NCT03000257|Triple negative breast cancer|triple negative breast cancer
45640|NCT03000257|Hepatocellular carcinoma|hepatocellular carcinoma
45641|NCT03000257|Small cell lung cancer|small cell lung cancer
45642|NCT03000257|Head and neck cancer|head and neck cancer
45643|NCT03000257|Cancer|cancer
45644|NCT03000244|Natural History|natural history
45645|NCT03000244|HCT|hct
45648|NCT03000192|Survivorship|survivorship
45649|NCT03000192|Cancer|cancer
45650|NCT03000192|Recovery|recovery
45651|NCT03000192|Self-management|self-management
45652|NCT03000192|Cohort|cohort
45653|NCT03000127|testosterone|testosterone
45654|NCT03000127|multiple sclerosis|multiple sclerosis
45655|NCT03000127|fatigue|fatigue
45656|NCT03000114|Collagenase injection|collagenase injection
45657|NCT03000114|percutaneous needle aponeurotomy|percutaneous needle aponeurotomy
45658|NCT03000101|Biomarkers|biomarkers
45659|NCT03000101|Colitis|colitis
45660|NCT03000101|Colitis, Ulcerative|colitis, ulcerative
45661|NCT03000101|Colonic Diseases|colonic diseases
45662|NCT03000101|Crohn Disease|crohn disease
45663|NCT03000101|Digestive System Diseases|digestive system diseases
45664|NCT03000101|Fruit|fruit
45665|NCT03000101|Fruit and Vegetable Juices|fruit and vegetable juices
45666|NCT03000101|Gastroenteritis|gastroenteritis
45667|NCT03000101|Gastrointestinal Diseases|gastrointestinal diseases
45668|NCT03000101|Humans|humans
45669|NCT03000101|Hydrolysable Tannins|hydrolysable tannins
45670|NCT03000101|Inflammation|inflammation
45671|NCT03000101|Inflammatory Bowel Diseases|inflammatory bowel diseases
45672|NCT03000101|Intestinal Diseases|intestinal diseases
45673|NCT03000101|Punicaceae|punicaceae
45674|NCT03000075|BI 655066|bi 655066
45675|NCT03000075|ABBV-066|abbv-066
45676|NCT03000075|risankizumab|risankizumab
45677|NCT03000062|overweight, general practice|overweight, general practice
45678|NCT03000049|sepsis|sepsis
45679|NCT03000049|septic shock|septic shock
45680|NCT03000049|blood cultures|blood cultures
45681|NCT03000049|anti-infective therapy|anti-infective therapy
45682|NCT03000036|Breast cancer|breast cancer
45683|NCT03000036|Doxorubicin|doxorubicin
45894|NCT02998853|STEMI PCI|stemi pci
45684|NCT03000036|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
45685|NCT03000036|T1 mapping|t1 mapping
45686|NCT03000023|Hepatitis C|hepatitis c
45687|NCT03000023|Patient-Reported Outcomes|patient-reported outcomes
45688|NCT03000023|DAA Treatment|daa treatment
45689|NCT03000023|Qualitative|qualitative
45690|NCT03000023|Mixed methods|mixed methods
45691|NCT03000010|Wound Vac|wound vac
45692|NCT03000010|Neuromuscular Scoliosis|neuromuscular scoliosis
45793|NCT02999334|Malawi|malawi
45694|NCT02999997|Physical therapy modalities|physical therapy modalities
45695|NCT02999997|Dual-task performance|dual-task performance
45696|NCT02999997|Parkinson's disease|parkinson's disease
45697|NCT02999997|Active music therapy|active music therapy
45698|NCT02999997|Physical activity|physical activity
37390|NCT03052218|Cytochrome P450 CYP2D6 genotype|cytochrome p450 cyp2d6 genotype
37391|NCT03052218|Cytochrome P450 CYP2D6 phenotype|cytochrome p450 cyp2d6 phenotype
45699|NCT02999971|circuit class therapy|circuit class therapy
45700|NCT02999971|ICF model|icf model
45701|NCT02999971|aquatic therapy|aquatic therapy
45702|NCT02999971|neuro-rehabilitation|neuro-rehabilitation
45703|NCT02999945|preterm infants|preterm infants
45704|NCT02999945|SGA infants|sga infants
45705|NCT02999945|IUGR infants|iugr infants
45706|NCT02999945|growth|growth
45707|NCT02999945|body composition|body composition
45708|NCT02999945|metabolomics|metabolomics
45709|NCT02999945|microbiome|microbiome
45710|NCT02999945|adiposity markers|adiposity markers
45711|NCT02999945|metabolic programming|metabolic programming
45712|NCT02999945|neurodevelopmental outcome|neurodevelopmental outcome
45714|NCT02999906|Oral Treprostinil|oral treprostinil
45715|NCT02999906|dual therapy|dual therapy
45716|NCT02999906|6 Minute Walk Test|6 minute walk test
45717|NCT02999854|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
45718|NCT02999854|Graft-versus-host disease|graft-versus-host disease
45719|NCT02999854|Immune reconstitution|immune reconstitution
45720|NCT02999854|Alloreactive T-cells|alloreactive t-cells
45721|NCT02999854|Photodynamic treatment|photodynamic treatment
45722|NCT02999854|Hematologic malignancy|hematologic malignancy
45723|NCT02999854|Transplant-related mortality|transplant-related mortality
45724|NCT02999854|Overall survival|overall survival
45725|NCT02999854|GRFS|grfs
45726|NCT02999854|GVHD|gvhd
45727|NCT02999841|Visceral fat|visceral fat
45728|NCT02999828|safety|safety
45729|NCT02999828|immune persistence|immune persistence
45730|NCT02999815|Tetanus|tetanus
45731|NCT02999802|Nutrient Sensing|nutrient sensing
45732|NCT02999802|Exercise|exercise
45733|NCT02999802|Elderly|elderly
45734|NCT02999776|Plaques Psoriasis|plaques psoriasis
45735|NCT02999776|Topical|topical
45736|NCT02999776|Laser microporation|laser microporation
45737|NCT02999763|lipolysis|lipolysis
45738|NCT02999763|fat reduction|fat reduction
45739|NCT02999763|circumference reduction|circumference reduction
45740|NCT02999737|Platelet Rich Plasma|platelet rich plasma
45741|NCT02999737|PRP|prp
45742|NCT02999737|Hair loss|hair loss
45743|NCT02999737|Alopecia|alopecia
45744|NCT02999737|Hypotrichosis|hypotrichosis
45745|NCT02999737|Hair diseases|hair diseases
45746|NCT02999698|Psoriasis|psoriasis
45747|NCT02999698|Hidradenitis|hidradenitis
45748|NCT02999698|Psychological impact|psychological impact
45749|NCT02999698|Quality of life|quality of life
45750|NCT02999659|pupillometry|pupillometry
45751|NCT02999659|autonomous nerve system|autonomous nerve system
45752|NCT02999646|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
45753|NCT02999646|cancer|cancer
45754|NCT02999646|HNSCC|hnscc
45755|NCT02999646|immunotherapy|immunotherapy
45756|NCT02999646|MVX-ONCO-1|mvx-onco-1
45757|NCT02999607|Transcranial direct current stimulation|transcranial direct current stimulation
45758|NCT02999607|Positron emission tomography|positron emission tomography
45759|NCT02999529|Chemotherapy|chemotherapy
45760|NCT02999529|Oncology|oncology
45761|NCT02999503|adhd treatment|adhd treatment
45762|NCT02999503|nutrition|nutrition
45763|NCT02999477|Breast Cancer|breast cancer
45764|NCT02999464|stroke|stroke
45765|NCT02999464|qigong|qigong
45766|NCT02999464|randomized controlled trial|randomized controlled trial
45767|NCT02999464|body-mind exercise|body-mind exercise
45768|NCT02999464|balance|balance
45769|NCT02999464|quality of life|quality of life
45770|NCT02999464|wellbeing|wellbeing
45771|NCT02999412|Integrated Healthcare System|integrated healthcare system
45772|NCT02999412|Inappropriate Prescribing|inappropriate prescribing
45773|NCT02999412|Pragmatic Clinical Trial|pragmatic clinical trial
45774|NCT02999412|Crossover Design|crossover design
45775|NCT02999412|Randomised Controlled Trial|randomised controlled trial
45776|NCT02999399|Smoker|smoker
45777|NCT02999399|Former smoker|former smoker
45778|NCT02999386|stress, hyperglycemia, inflammatory markers, trauma, HbA1c|stress, hyperglycemia, inflammatory markers, trauma, hba1c
45779|NCT02999386|interleukin-6|interleukin-6
45780|NCT02999373|prevention, infection, preterm, cord blood mononuclear cells|prevention, infection, preterm, cord blood mononuclear cells
45782|NCT02999360|Speech Therapy|speech therapy
45783|NCT02999360|Aerobic Exercise (AE)|aerobic exercise (ae)
45784|NCT02999347|Treatment Outcome|treatment outcome
45785|NCT02999347|Mid-urethral slings|mid-urethral slings
45786|NCT02999347|Gynecologic Surgery Procedures|gynecologic surgery procedures
45787|NCT02999334|Group healthcare models|group healthcare models
45788|NCT02999334|Antenatal care|antenatal care
45789|NCT02999334|Prenatal care|prenatal care
45790|NCT02999334|Perinatal health|perinatal health
45791|NCT02999334|CenteringPregnancy|centeringpregnancy
51184|NCT02965638|LHH|lhh
45792|NCT02999334|sub-Saharan Africa|sub-saharan africa
45794|NCT02999334|Tanzania|tanzania
45795|NCT02999334|Pregnancy|pregnancy
45796|NCT02999308|haemophilia|haemophilia
45797|NCT02999308|prophylaxis|prophylaxis
45798|NCT02999308|children|children
45799|NCT02999282|TMS|tms
45800|NCT02999282|tDCS|tdcs
45804|NCT02999269|major depressive disorder|major depressive disorder
45806|NCT02999256|Fat Oxidation|fat oxidation
45807|NCT02999256|Lipid Profile|lipid profile
45808|NCT02999256|Anthocyanins|anthocyanins
45809|NCT02999256|Exercise|exercise
45810|NCT02999256|Calorie Restrictive Mimetic|calorie restrictive mimetic
45811|NCT02999230|Cavities|cavities
45812|NCT02999217|iron isomaltoside|iron isomaltoside
45813|NCT02999217|plasma ferritin|plasma ferritin
45815|NCT02999217|colorectal cancer|colorectal cancer
45816|NCT02999165|Breastfeeding|breastfeeding
45817|NCT02999165|CPAP|cpap
45818|NCT02999165|Humidified High Flow Nasal Cannula Oxygen|humidified high flow nasal cannula oxygen
45819|NCT02999165|preterm neonate|preterm neonate
45820|NCT02999152|Bio-markers|bio-markers
45821|NCT02999152|Radiation|radiation
45822|NCT02999152|Appropriate therapeutic strategy|appropriate therapeutic strategy
45823|NCT02999152|Total Body Irradiation|total body irradiation
45824|NCT02999152|Partial Body Irradiation|partial body irradiation
45825|NCT02999139|Injury|injury
45826|NCT02999139|Prevention|prevention
45827|NCT02999126|Total Intravenous Anesthesia|total intravenous anesthesia
45828|NCT02999126|Titration|titration
45829|NCT02999126|Target Controlled Infusion|target controlled infusion
45830|NCT02999126|Propofol|propofol
45831|NCT02999126|Bispectral index|bispectral index
45832|NCT02999113|non-technical skills|non-technical skills
45833|NCT02999113|patient safety|patient safety
45834|NCT02999113|medical education|medical education
45839|NCT02999087|Head and Neck cancer|head and neck cancer
45840|NCT02999087|Immunotherapy|immunotherapy
45841|NCT02999074|exercise|exercise
45842|NCT02999074|resistance training|resistance training
45843|NCT02999074|aerobic training|aerobic training
45844|NCT02999074|breast cancer|breast cancer
45845|NCT02999074|neoadjuvant chemotherapy|neoadjuvant chemotherapy
45846|NCT02999074|fatigue|fatigue
45847|NCT02999074|quality of life|quality of life
45848|NCT02999074|tumor response|tumor response
45849|NCT02999061|pre-term children|pre-term children
45850|NCT02999048|panax notoginseng saponins|panax notoginseng saponins
45851|NCT02999048|hypertensive intracerebral hemorrhage|hypertensive intracerebral hemorrhage
45852|NCT02999048|hematoma|hematoma
45853|NCT02999048|neurological function|neurological function
45854|NCT02999035|ocular surface sensitivity|ocular surface sensitivity
45855|NCT02999022|bone fractures|bone fractures
45856|NCT02999022|bony callus|bony callus
45857|NCT02999022|fractures, bone|fractures, bone
45858|NCT02999022|lithium|lithium
45859|NCT02999022|lithium carbonate|lithium carbonate
45860|NCT02999022|osteogenesis|osteogenesis
45861|NCT02999022|bone development|bone development
45862|NCT02999022|fracture healing|fracture healing
45863|NCT02999022|fracture repair|fracture repair
45864|NCT02998970|Cardiovascular Disease|cardiovascular disease
45865|NCT02998970|Type 2 Diabetes|type 2 diabetes
45866|NCT02998970|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
45867|NCT02998957|Acupuncture|acupuncture
45868|NCT02998957|TENS|tens
45869|NCT02998957|Physiotherapy|physiotherapy
45870|NCT02998931|Glutamin|glutamin
45871|NCT02998931|Enteral Nutrition|enteral nutrition
45872|NCT02998931|Intensive Care Unit|intensive care unit
45873|NCT02998931|Critical Care Outcomes|critical care outcomes
45874|NCT02998931|inflammatory|inflammatory
45875|NCT02998931|Immune System|immune system
45876|NCT02998918|Inflammation|inflammation
45878|NCT02998918|Anti-inflammatory|anti-inflammatory
45879|NCT02998918|Supplementation|supplementation
45880|NCT02998918|Curcumin|curcumin
45881|NCT02998918|polyphenol|polyphenol
45882|NCT02998918|V-cam|v-cam
45883|NCT02998918|I-cam|i-cam
45884|NCT02998918|atherosclerosis|atherosclerosis
45885|NCT02998918|cardiovascular disease|cardiovascular disease
45886|NCT02998918|atherogenesis|atherogenesis
45887|NCT02998918|antioxidant|antioxidant
45888|NCT02998918|resveratrol|resveratrol
45889|NCT02998918|quercetin|quercetin
45890|NCT02998892|Sedentary Behavior|sedentary behavior
45891|NCT02998866|Cryoballoon Pulmonary Vein Isolation|cryoballoon pulmonary vein isolation
45892|NCT02998866|Esophageal Effects|esophageal effects
45893|NCT02998853|Non culprit|non culprit
45895|NCT02998853|angio QFR|angio qfr
45896|NCT02998853|FFR|ffr
45897|NCT02998853|Staged procedure|staged procedure
45898|NCT02998840|elevated blood pressure|elevated blood pressure
45899|NCT02998814|fissure sealant|fissure sealant
45900|NCT02998814|etch and rinse|etch and rinse
45901|NCT02998814|self etch|self etch
45902|NCT02998788|heart failure|heart failure
37589|NCT03050931|EIT|eit
45903|NCT02998788|risk factor|risk factor
45904|NCT02998788|cardiovascular disease|cardiovascular disease
45905|NCT02998788|lifestyle behavior|lifestyle behavior
45906|NCT02998775|in vitro protein binding|in vitro protein binding
45907|NCT02998775|hepatic impairment|hepatic impairment
45908|NCT02998775|renal impairment|renal impairment
45909|NCT02998762|major depression|major depression
45910|NCT02998762|major depressive disorder|major depressive disorder
45911|NCT02998762|biomarkers|biomarkers
45912|NCT02998762|MDD|mdd
45913|NCT02998762|long term follow up|long term follow up
45914|NCT02998736|Colon|colon
45915|NCT02998723|Basic Life Support|basic life support
45916|NCT02998723|Education, Medical|education, medical
45917|NCT02998723|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
45918|NCT02998723|Learning|learning
45919|NCT02998697|Systolic Heart Failure|systolic heart failure
45920|NCT02998697|Anemia|anemia
45921|NCT02998697|Iron Deficiency|iron deficiency
45922|NCT02998684|Autism|autism
45923|NCT02998684|Adolescent|adolescent
45924|NCT02998684|Social skills|social skills
45925|NCT02998671|Acne, inflammatory acne, efficacy, safety, PK|acne, inflammatory acne, efficacy, safety, pk
45926|NCT02998658|Laparoscopy|laparoscopy
45927|NCT02998658|Barbed sutures|barbed sutures
45928|NCT02998658|Hysterectomy|hysterectomy
45929|NCT02998645|severe acquired aplastic anemia|severe acquired aplastic anemia
45930|NCT02998645|SAA|saa
45931|NCT02998645|first line|first line
45932|NCT02998645|eltrombopag|eltrombopag
45933|NCT02998645|cyclosporine|cyclosporine
45934|NCT02998645|h-ATG|h-atg
45935|NCT02998645|severe aplastic anemia|severe aplastic anemia
45936|NCT02998645|aplastic anemia|aplastic anemia
45937|NCT02998593|Semen parameters Male infertility oligospermia Traditional Medicine|semen parameters male infertility oligospermia traditional medicine
45938|NCT02998580|late-life depression|late-life depression
45939|NCT02998580|treatment resistance|treatment resistance
45940|NCT02998515|supplemental oxygen|supplemental oxygen
45941|NCT02998515|concentrator|concentrator
45942|NCT02998515|endurance shuttle walk test|endurance shuttle walk test
45943|NCT02998502|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
45944|NCT02998502|Anxiety|anxiety
45945|NCT02998502|Pediatrics|pediatrics
45946|NCT02998489|enteral nutrition|enteral nutrition
45947|NCT02998489|infant,premature|infant,premature
45948|NCT02998489|feeding method|feeding method
45949|NCT02998476|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
45950|NCT02998476|relapsed|relapsed
45951|NCT02998476|refractory|refractory
45952|NCT02998476|non-Hodgkin lymphoma|non-hodgkin lymphoma
45953|NCT02998476|phosphatidylinositol 3-kinase δ (PI3Kδ) inhibitor|phosphatidylinositol 3-kinase δ (pi3kδ) inhibitor
45954|NCT02998476|Bruton's tyrosine kinase (BTK)|bruton's tyrosine kinase (btk)
45955|NCT02998463|Skin-to-skin|skin-to-skin
45956|NCT02998463|Kangaroo Care|kangaroo care
45957|NCT02998463|Kangaroo Mother Care|kangaroo mother care
45958|NCT02998450|Sickle Cell Disease|sickle cell disease
45959|NCT02998450|Sickle Beta 0 Thalassemia|sickle beta 0 thalassemia
45960|NCT02998424|propofol|propofol
45961|NCT02998424|pupillary diameter|pupillary diameter
45962|NCT02998411|anti-infectives|anti-infectives
45963|NCT02998411|adults|adults
45964|NCT02998411|pharmacokinetic|pharmacokinetic
45965|NCT02998411|pharmacodynamic end-points|pharmacodynamic end-points
45966|NCT02998411|clinical cure|clinical cure
45967|NCT02998398|Biosimilar|biosimilar
45968|NCT02998385|salivary glands|salivary glands
45969|NCT02998385|sinus carcinoma|sinus carcinoma
45970|NCT02998385|radiochemotherapy concomitant|radiochemotherapy concomitant
45971|NCT02998385|cisplatin|cisplatin
45972|NCT02998346|Nutrition|nutrition
45973|NCT02998346|CRRT|crrt
45974|NCT02998346|CVVH|cvvh
45975|NCT02998346|citrate|citrate
45976|NCT02998346|anticoagulation|anticoagulation
45977|NCT02998346|caloric uptake|caloric uptake
45978|NCT02998333|Instability|instability
45979|NCT02998333|Ankle|ankle
45980|NCT02998333|Surgical stabilization|surgical stabilization
45981|NCT02998281|cerebral palsy|cerebral palsy
45982|NCT02998281|inspiratory muscle training|inspiratory muscle training
45983|NCT02998255|PEG|peg
45984|NCT02998255|Bowel preparation|bowel preparation
45985|NCT02998255|Colonoscopy|colonoscopy
45986|NCT02998203|organic diet|organic diet
45987|NCT02998203|health|health
45988|NCT02998203|pesticides|pesticides
45989|NCT02998203|inflammation biomarkers|inflammation biomarkers
45990|NCT02998203|oxidative stress biomarkers|oxidative stress biomarkers
45991|NCT02998177|Postoperative pain|postoperative pain
45992|NCT02998177|Rebound pain|rebound pain
45993|NCT02998177|Gut microbiome|gut microbiome
45994|NCT02998177|Gut microbiota|gut microbiota
45995|NCT02998177|Peripheral nerve block|peripheral nerve block
45996|NCT02998177|Axillary brachial plexus block|axillary brachial plexus block
45997|NCT02998138|Chronic Pain|chronic pain
45998|NCT02998138|Pain, Postoperative|pain, postoperative
45999|NCT02998112|fecal microbiota transplantation|fecal microbiota transplantation
46000|NCT02998112|Ulcerative colitis|ulcerative colitis
46001|NCT02998099|Healthy Volunteers|healthy volunteers
46002|NCT02998099|Rivipansel|rivipansel
46003|NCT02998060|Robot|robot
46004|NCT02998060|Spinal Fusion|spinal fusion
46005|NCT02998060|Spine|spine
46006|NCT02998060|Navigation|navigation
46007|NCT02998060|Freehand|freehand
46008|NCT02998008|Exercise Therapy|exercise therapy
46009|NCT02998008|Heart Function Tests|heart function tests
46010|NCT02998008|Heart/physiology|heart/physiology
46011|NCT02998008|Echocardiography|echocardiography
46012|NCT02997995|T2-T4 Breast cancer|t2-t4 breast cancer
46013|NCT02997995|Estrogen Receptor Positive Tumor|estrogen receptor positive tumor
46014|NCT02997995|PD-1|pd-1
46015|NCT02997995|Neoadjuvant|neoadjuvant
46016|NCT02997995|Immune-attractants|immune-attractants
46017|NCT02997995|lymphocytes activation|lymphocytes activation
46018|NCT02997982|Alzheimer's Disease|alzheimer's disease
46019|NCT02997982|Herpes Simplex Virus|herpes simplex virus
46021|NCT02997982|Antiviral Drugs|antiviral drugs
46022|NCT02997969|HIV|hiv
46023|NCT02997943|Obesity|obesity
46024|NCT02997943|Weight Loss|weight loss
46025|NCT02997943|Diet|diet
46026|NCT02997943|Physical Activity|physical activity
46027|NCT02997943|Mobile Health|mobile health
46028|NCT02997904|lice comb|lice comb
46029|NCT02997904|human head lice infestations|human head lice infestations
46030|NCT02997904|combing solution|combing solution
46031|NCT02997891|cognition|cognition
46032|NCT02997891|hip replacement|hip replacement
46033|NCT02997891|physical activity|physical activity
46034|NCT02997891|quality of life|quality of life
46035|NCT02997891|psychological distress|psychological distress
46036|NCT02997878|autoimmune|autoimmune
46037|NCT02997878|AiH|aih
46038|NCT02997878|PSC|psc
46039|NCT02997878|liver disease|liver disease
46040|NCT02997878|cholangitis|cholangitis
46041|NCT02997865|heart failure|heart failure
46042|NCT02997865|depressive disorder, major|depressive disorder, major
46043|NCT02997865|cognitive therapy|cognitive therapy
46044|NCT02997865|antidepressive agents|antidepressive agents
46045|NCT02997865|self-care|self-care
46046|NCT02997852|human-animal interaction|human-animal interaction
46047|NCT02997787|adenomyosis|adenomyosis
46048|NCT02997787|leiomyoma|leiomyoma
46049|NCT02997787|neutrophil to lymphocyte ratio|neutrophil to lymphocyte ratio
46050|NCT02997787|platelet to lymphocyte ratio|platelet to lymphocyte ratio
46051|NCT02997748|acute kidney injury|acute kidney injury
46052|NCT02997748|cardiac surgery|cardiac surgery
46053|NCT02997748|Remote ischemic preconditioning|remote ischemic preconditioning
46054|NCT02997748|[TIMP-2]*[IGFBP7]|[timp-2]*[igfbp7]
46055|NCT02997735|Secondhand Smoke|secondhand smoke
46056|NCT02997735|Nicotine Replacement Therapy|nicotine replacement therapy
46057|NCT02997735|Clinical Decision Support|clinical decision support
46058|NCT02997735|Tobacco quitline|tobacco quitline
46059|NCT02997722|ketamine|ketamine
46060|NCT02997722|suicide|suicide
46061|NCT02997709|Prostate Cancer|prostate cancer
46062|NCT02997709|Circulating Tumor Cells|circulating tumor cells
46063|NCT02997709|CTCs|ctcs
46064|NCT02997709|Androgen Deprivation Therapy|androgen deprivation therapy
46065|NCT02997709|ADT|adt
46066|NCT02997670|Cardiac resynchronization pacing therapy|cardiac resynchronization pacing therapy
46067|NCT02997644|patient education|patient education
46068|NCT02997644|orthopaedic surgery|orthopaedic surgery
46069|NCT02997644|post-surgical pain|post-surgical pain
46070|NCT02997644|chronic opioid use|chronic opioid use
46071|NCT02997631|Pain Management|pain management
46072|NCT02997631|Distraction Therapy|distraction therapy
46073|NCT02997631|Robot Based Distraction|robot based distraction
46074|NCT02997631|MEDi|medi
46075|NCT02997605|low disease activity|low disease activity
46076|NCT02997605|remission|remission
46077|NCT02997566|Autonomic Nervous System|autonomic nervous system
46078|NCT02997566|Sympathetic Nervous System|sympathetic nervous system
46079|NCT02997566|Heart Rate|heart rate
46080|NCT02997553|Indocyanine green (ICG)|indocyanine green (icg)
46081|NCT02997553|Sentinel lymph node biopsy|sentinel lymph node biopsy
46082|NCT02997553|Technetium99|technetium99
46083|NCT02997553|Tumors|tumors
46084|NCT02997553|Optonuclear probe|optonuclear probe
46085|NCT02997553|Surgery|surgery
46086|NCT02997540|female breast lesion|female breast lesion
46087|NCT02997540|ultrasound examination|ultrasound examination
46088|NCT02997514|Solution focused coaching|solution focused coaching
46089|NCT02997514|Self determination|self determination
46090|NCT02997488|videolaryngoscope|videolaryngoscope
46091|NCT02997475|Bulimia Nervosa|bulimia nervosa
46092|NCT02997475|Bulimia|bulimia
46093|NCT02997475|fMRI|fmri
46094|NCT02997475|Emotion Regulation|emotion regulation
46095|NCT02997475|Response Inhibition|response inhibition
46096|NCT02997462|Monocyte|monocyte
46097|NCT02997462|Oxidative Stress|oxidative stress
46098|NCT02997462|Endothelial Function|endothelial function
46101|NCT02997449|Stereotactic ablative radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
51571|NCT02963064|BMT|bmt
37789|NCT03049696|Obesity|obesity
623464|NCT00673413|Emotions|emotions
46102|NCT02997449|Intrathoracic nodal staging|intrathoracic nodal staging
46108|NCT02997371|Traumatic brain injury|traumatic brain injury
46109|NCT02997371|Microdialysis|microdialysis
46110|NCT02997371|Interleukin-1 receptor antagonist|interleukin-1 receptor antagonist
46111|NCT02997371|Magnetic Resonance Imaging|magnetic resonance imaging
46112|NCT02997371|Positron Emission Tomography|positron emission tomography
46113|NCT02997345|PPROM|pprom
46114|NCT02997319|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
46115|NCT02997319|Insulin Resistance|insulin resistance
46116|NCT02997319|Shift Work|shift work
46117|NCT02997319|Circadian Rhythms|circadian rhythms
46118|NCT02997319|MTNR1B|mtnr1b
46119|NCT02997306|Moh's Surgery|moh's surgery
46120|NCT02997306|Erythema|erythema
46121|NCT02997306|Face|face
46122|NCT02997306|Simple Interrupted Sutures|simple interrupted sutures
46123|NCT02997306|Running Sutures|running sutures
46124|NCT02997306|Image Processing|image processing
46125|NCT02997280|acute graft-versus-host disease|acute graft-versus-host disease
46126|NCT02997280|chronic graft-versus-host disease|chronic graft-versus-host disease
46127|NCT02997280|Steroid-refractory GVHD|steroid-refractory gvhd
46128|NCT02997280|ruxolitinib|ruxolitinib
46129|NCT02997280|JAK inhibitors|jak inhibitors
46130|NCT02997254|atrial fibrillation|atrial fibrillation
46131|NCT02997254|ablation|ablation
46132|NCT02997254|abnormal heart rhythm|abnormal heart rhythm
46133|NCT02997241|Colonic Neoplasms|colonic neoplasms
46134|NCT02997241|recurrence|recurrence
46135|NCT02997215|intravenous lidocaine|intravenous lidocaine
46136|NCT02997215|postoperative pain management|postoperative pain management
46137|NCT02997202|Gilteritinib|gilteritinib
46138|NCT02997202|ASP2215|asp2215
46139|NCT02997202|Safety and Efficacy|safety and efficacy
46140|NCT02997202|Acute Myeloid Leukemia|acute myeloid leukemia
46141|NCT02997150|Idiopathic nephrotic syndrome-child-steroid dependant-IL2|idiopathic nephrotic syndrome-child-steroid dependant-il2
46142|NCT02997150|Safety|safety
46143|NCT02997150|Efficacy|efficacy
46144|NCT02997137|Chronic psychological distress|chronic psychological distress
46145|NCT02997137|Chronic exhaustion conditions|chronic exhaustion conditions
46146|NCT02997137|Perceived Stress Questionnaire 30 (PSQ30)|perceived stress questionnaire 30 (psq30)
46147|NCT02997137|Stress management|stress management
46148|NCT02997137|Dietary supplement|dietary supplement
46149|NCT02997124|Alveolar bone grafting|alveolar bone grafting
46150|NCT02997124|delirium|delirium
46151|NCT02997124|early ambulation|early ambulation
46152|NCT02997098|Hepatectomy|hepatectomy
46153|NCT02997085|Pain|pain
46154|NCT02997085|Virtual Reality|virtual reality
46155|NCT02997085|Opioid|opioid
46156|NCT02997085|Prescription pain reliever|prescription pain reliever
46157|NCT02997085|Treatment|treatment
46158|NCT02997072|electrical impedance tomography|electrical impedance tomography
46159|NCT02997072|high frequency jet ventilation|high frequency jet ventilation
46160|NCT02997072|drive pressure|drive pressure
46161|NCT02997059|Crohn disease|crohn disease
46162|NCT02997059|Candida|candida
46163|NCT02997059|ASCA|asca
46164|NCT02997046|Ferumoxytol|ferumoxytol
46165|NCT02997046|MRI|mri
46166|NCT02997046|fistula|fistula
46167|NCT02997046|graft|graft
46168|NCT02997046|kidney transplant|kidney transplant
46169|NCT02997046|angiography|angiography
46170|NCT02997046|arteriovenous|arteriovenous
46171|NCT02997033|Bone|bone
46172|NCT02997033|Sex steroids|sex steroids
46173|NCT02997033|Body composition|body composition
46174|NCT02997033|Men|men
46175|NCT02997007|tDCS|tdcs
46176|NCT02997007|Mild Cognitive Impairment|mild cognitive impairment
46177|NCT02997007|fMRI|fmri
46178|NCT02997007|Healthy ageing|healthy ageing
46179|NCT02996955|Low Back Pain|low back pain
46180|NCT02996955|Social Support|social support
46181|NCT02996955|Illness Perceptions|illness perceptions
46182|NCT02996955|Activity Advice|activity advice
46183|NCT02996942|haemophilia, joint disease, quality of life|haemophilia, joint disease, quality of life
46184|NCT02996903|Cardiac Computed Tomography (CT) Angiography (CCTA)|cardiac computed tomography (ct) angiography (ccta)
46185|NCT02996903|coronary artery disease|coronary artery disease
46186|NCT02996903|malignancy induction|malignancy induction
46187|NCT02996903|radiation dose|radiation dose
46188|NCT02996903|dose saving techniques|dose saving techniques
46189|NCT02996903|effective dose|effective dose
46190|NCT02996864|college students|college students
46191|NCT02996864|physical activity|physical activity
46192|NCT02996864|sleep behaviors|sleep behaviors
46193|NCT02996864|diet|diet
46194|NCT02996851|Fibrinolytic Agents|fibrinolytic agents
46195|NCT02996851|Adverse effects|adverse effects
46196|NCT02996851|Norway|norway
46197|NCT02996851|Registries|registries
46198|NCT02996812|Post-bariatric hypoglycemia|post-bariatric hypoglycemia
402902|NCT01229241|epidural continuous infusion|epidural continuous infusion
46199|NCT02996812|Non-insulinoma pancreatogenous hypoglycemia syndrome|non-insulinoma pancreatogenous hypoglycemia syndrome
46200|NCT02996812|Late dumping syndrome|late dumping syndrome
46201|NCT02996773|high-risk malignancies|high-risk malignancies
46202|NCT02996773|Lymphoma|lymphoma
46203|NCT02996773|Haploidentical|haploidentical
46204|NCT02996773|Bone Marrow Transplant (BMT)|bone marrow transplant (bmt)
46205|NCT02996773|Post-transplant|post-transplant
46206|NCT02996773|myeloablative (MAC)|myeloablative (mac)
46207|NCT02996773|reduced intensity conditioning (RIC)|reduced intensity conditioning (ric)
46208|NCT02996773|haploidentical hematopoietic cell transplantation (HHCT)|haploidentical hematopoietic cell transplantation (hhct)
46209|NCT02996773|Leukemia|leukemia
46210|NCT02996747|bone tumors|bone tumors
46211|NCT02996747|chondroma|chondroma
46212|NCT02996747|chondrosarcoma|chondrosarcoma
46213|NCT02996734|bone tumors|bone tumors
46214|NCT02996734|giant cell tumor|giant cell tumor
46215|NCT02996734|treatment|treatment
46216|NCT02996708|Telemedicine|telemedicine
46217|NCT02996708|Health economics|health economics
46218|NCT02996695|Chemoprophylaxis|chemoprophylaxis
46219|NCT02996695|Chloroquine|chloroquine
46220|NCT02996695|Cryopreserved|cryopreserved
46221|NCT02996695|Malaria|malaria
46222|NCT02996695|Plasmodium|plasmodium
46223|NCT02996695|Sporozoites|sporozoites
46224|NCT02996682|Communicable Diseases|communicable diseases
46225|NCT02996682|Hepatitis|hepatitis
46226|NCT02996682|Hepatitis C|hepatitis c
46227|NCT02996682|Virus Diseases|virus diseases
46228|NCT02996682|Liver Diseases|liver diseases
46229|NCT02996682|Digestive System Diseases|digestive system diseases
46230|NCT02996682|Hepatitis, Viral, Human|hepatitis, viral, human
46231|NCT02996682|Velpatasvir|velpatasvir
46232|NCT02996682|Flaviviridae Infections|flaviviridae infections
46233|NCT02996682|RNA Virus Infections|rna virus infections
46234|NCT02996682|Ribavirin|ribavirin
46235|NCT02996682|Sofosbuvir|sofosbuvir
46236|NCT02996682|Antiviral Agents|antiviral agents
46237|NCT02996682|Antimetabolites|antimetabolites
46238|NCT02996682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
46239|NCT02996682|Anti-Infective Agents|anti-infective agents
46240|NCT02996682|Decompensated Cirrhosis|decompensated cirrhosis
46241|NCT02996643|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
46242|NCT02996643|Brace Treatment|brace treatment
46243|NCT02996643|Ultrasound Imaging|ultrasound imaging
46245|NCT02996630|Fallot|fallot
46246|NCT02996630|Great Arteries Transposition|great arteries transposition
46247|NCT02996617|Lymphomas Non-Hodgkin's B-Cell|lymphomas non-hodgkin's b-cell
46248|NCT02996617|Lymphomas Non-Hodgkin's T-Cell|lymphomas non-hodgkin's t-cell
46249|NCT02996617|PEG-rhG-CSF|peg-rhg-csf
46250|NCT02996617|Neutropenia|neutropenia
46251|NCT02996604|acupuncture|acupuncture
46252|NCT02996604|functional dyspepsia|functional dyspepsia
46253|NCT02996604|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
46254|NCT02996591|Nerve Block|nerve block
46255|NCT02996591|General Anesthesia|general anesthesia
46256|NCT02996591|Spinal Anesthesia|spinal anesthesia
46257|NCT02996591|Pain|pain
46258|NCT02996591|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
46259|NCT02996578|Cognition|cognition
46260|NCT02996578|Cacao|cacao
46261|NCT02996578|Flavan-3-ols|flavan-3-ols
46262|NCT02996578|Blood Pressure|blood pressure
46263|NCT02996578|hemoglobin A1c protein, human|hemoglobin a1c protein, human
46264|NCT02996578|Memory|memory
46265|NCT02996565|Clinic care|clinic care
46266|NCT02996565|Team-based care|team-based care
46267|NCT02996565|Medication Therapy Management (MTM)|medication therapy management (mtm)
46268|NCT02996565|Telehealth|telehealth
46269|NCT02996565|Cluster-randomized|cluster-randomized
46270|NCT02996565|Home blood pressure monitoring|home blood pressure monitoring
46271|NCT02996565|Pharmacist|pharmacist
46272|NCT02996552|Tricuspid annulus dilation|tricuspid annulus dilation
46273|NCT02996552|mitral valve regurgitation|mitral valve regurgitation
46274|NCT02996526|vocal cord palsy dysfunction thoracic surgery complication|vocal cord palsy dysfunction thoracic surgery complication
46275|NCT02996513|Vitamin A status|vitamin a status
46276|NCT02996513|Retinol Isotope Dilution|retinol isotope dilution
46277|NCT02996513|Nigeria|nigeria
46278|NCT02996513|Preschool children|preschool children
46279|NCT02996513|Malaria|malaria
46280|NCT02996513|Inflammation|inflammation
46281|NCT02996474|Pembrolizumab|pembrolizumab
46282|NCT02996474|Decitabine|decitabine
46283|NCT02996474|AML (Acute Myelogenous Leukemia)|aml (acute myelogenous leukemia)
46284|NCT02996461|Zika Infection|zika infection
46285|NCT02996461|Immune Response|immune response
46286|NCT02996461|Flavivirus|flavivirus
46287|NCT02996461|Arthropod-Borne Virus|arthropod-borne virus
46288|NCT02996448|AD-HIES|ad-hies
46289|NCT02996448|Anti-rAls3 Antibody|anti-rals3 antibody
46290|NCT02996448|Staphylococcus Aureus|staphylococcus aureus
46291|NCT02996448|Candida Albicans|candida albicans
46292|NCT02996448|RNA Transcriptome|rna transcriptome
46293|NCT02996396|AAA, Aortoiliac Aneurysm|aaa, aortoiliac aneurysm
46294|NCT02996383|arthroplasty|arthroplasty
46295|NCT02996370|esthetic|esthetic
46296|NCT02996370|inter-implant papilla|inter-implant papilla
46297|NCT02996370|soft tissue tickness|soft tissue tickness
623465|NCT00673413|Adaptation|adaptation
46298|NCT02996370|crestal bone loss|crestal bone loss
46299|NCT02996370|second stage surgery|second stage surgery
46300|NCT02996357|Incontinence-associated dermatitis|incontinence-associated dermatitis
46301|NCT02996357|Risk factor|risk factor
46302|NCT02996357|Intensive care unit|intensive care unit
46303|NCT02996357|Prevention|prevention
46304|NCT02996292|Crowding|crowding
46305|NCT02996292|Self ligating|self ligating
46306|NCT02996292|CBCT|cbct
46307|NCT02996292|RCT|rct
46308|NCT02996279|Neonate|neonate
46309|NCT02996279|Chorioamnionitis|chorioamnionitis
46310|NCT02996279|S100A12|s100a12
46311|NCT02996266|Targeted Temperature Management|targeted temperature management
46312|NCT02996175|Behavior|behavior
46313|NCT02996175|Sleep|sleep
46314|NCT02996175|Problems|problems
46315|NCT02996175|Intervention|intervention
46316|NCT02996162|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
46317|NCT02996162|Chronic Lung Disease|chronic lung disease
46318|NCT02996162|Prematurity|prematurity
46319|NCT02996084|Imaging research|imaging research
46320|NCT02995980|breast cancer screening|breast cancer screening
46321|NCT02995980|dense breasts|dense breasts
46322|NCT02995980|dual-energy contrast-enhanced digital mammography|dual-energy contrast-enhanced digital mammography
46323|NCT02995954|Combination therapy|combination therapy
46324|NCT02995954|ACE inhibitor Calcium Antagonist|ace inhibitor calcium antagonist
46325|NCT02995941|reliability|reliability
46326|NCT02995941|validity|validity
46327|NCT02995941|classification|classification
46328|NCT02995941|irritability|irritability
46330|NCT02995941|intensity|intensity
46331|NCT02995941|intervention|intervention
46332|NCT02995928|Subarachnoid Hemorrhage|subarachnoid hemorrhage
46333|NCT02995928|Decompressive Craniectomy|decompressive craniectomy
46334|NCT02995928|Cerebral Aneurysm|cerebral aneurysm
46335|NCT02995837|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
46336|NCT02995837|Cerebral Blood Flow|cerebral blood flow
46337|NCT02995837|Neurocognition|neurocognition
46338|NCT02995824|Liver transplantation|liver transplantation
46339|NCT02995824|HIV infection|hiv infection
46340|NCT02995824|Antiretroviral therapy|antiretroviral therapy
46341|NCT02995824|Raltegravir|raltegravir
46342|NCT02995785|Simulation|simulation
46343|NCT02995707|Thalidomide NTDT|thalidomide ntdt
46344|NCT02995681|COPD|copd
46345|NCT02995681|Falls|falls
46346|NCT02995681|Balance training|balance training
46347|NCT02995642|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
46348|NCT02995642|Carotid Stenosis|carotid stenosis
46349|NCT02995642|Atherosclerosis|atherosclerosis
46350|NCT02995642|Angiogenesis|angiogenesis
46351|NCT02995642|Inflammation|inflammation
46352|NCT02995642|Macrophages|macrophages
46353|NCT02995642|Positron-Emission Tomography|positron-emission tomography
46354|NCT02995642|Computerized tomography|computerized tomography
46355|NCT02995642|Magnetic Resonance Imaging|magnetic resonance imaging
46356|NCT02995642|(18F)FPP(RGD)2|(18f)fpp(rgd)2
46357|NCT02995616|Robot-Assisted Gait Training|robot-assisted gait training
46358|NCT02995616|Guidance force|guidance force
46359|NCT02995616|Stroke|stroke
46360|NCT02995616|Energy Consumption|energy consumption
46361|NCT02995616|Cardiorespiratory Load|cardiorespiratory load
46362|NCT02994771|Lymphedema, Breast cancer|lymphedema, breast cancer
46363|NCT02994758|Prostate|prostate
46364|NCT02994758|bladder|bladder
46365|NCT02994758|renal|renal
46366|NCT02994758|NGS|ngs
46367|NCT02994758|DSRT|dsrt
46368|NCT02994758|drug screening|drug screening
46369|NCT02994758|sequencing|sequencing
46370|NCT02994758|personalised medicine|personalised medicine
46371|NCT02994680|Air Pollution|air pollution
46372|NCT02994680|Liquefied Petroleum Gas|liquefied petroleum gas
46373|NCT02994680|Cookstove|cookstove
46374|NCT02994680|Behavioral Intervention|behavioral intervention
46375|NCT02994680|Propane Stove|propane stove
46376|NCT02994667|Electrophysiology|electrophysiology
46377|NCT02995564|Social Skills|social skills
46378|NCT02995564|Asperger's|asperger's
46379|NCT02995564|High-functioning autism|high-functioning autism
46380|NCT02995564|Young adults|young adults
46381|NCT02995551|Menisci, Tibial|menisci, tibial
46382|NCT02995551|Knee Injuries|knee injuries
46383|NCT02995551|Arthroscopy|arthroscopy
46384|NCT02995551|Exercise|exercise
46385|NCT02995551|Young adults|young adults
46386|NCT02995551|Treatment Outcome|treatment outcome
46387|NCT02995551|Humans|humans
46388|NCT02995512|myocardial infarction|myocardial infarction
46389|NCT02995512|colchicine|colchicine
46390|NCT02995512|anti-inflammatory|anti-inflammatory
46391|NCT02995499|ASA-PS classification|asa-ps classification
46392|NCT02995499|inter-rater reliability|inter-rater reliability
46393|NCT02995499|general surgery|general surgery
46394|NCT02995473|Psoriasis|psoriasis
51940|NCT02960646|CML|cml
46398|NCT02995434|Virtual Reality|virtual reality
46399|NCT02995434|Cancer Survivorship|cancer survivorship
46400|NCT02995434|Pain Management|pain management
46401|NCT02995434|Cancer Pain Management|cancer pain management
46402|NCT02995434|Chronic Pain Management|chronic pain management
46403|NCT02995434|Adjunctive Pain Management|adjunctive pain management
46404|NCT02995408|resiliency training|resiliency training
46406|NCT02995408|Autism Spectrum Disorders|autism spectrum disorders
46407|NCT02995369|Sealants|sealants
46408|NCT02995369|Dryshield|dryshield
46409|NCT02995369|Cotton roll|cotton roll
46410|NCT02995369|Isolation|isolation
46411|NCT02995369|Efficiency|efficiency
46412|NCT02995369|Preference|preference
46413|NCT02995356|Ectopic pregnancy|ectopic pregnancy
46414|NCT02995356|Axonemal Dynein Heavy Chain 5|axonemal dynein heavy chain 5
46415|NCT02995356|Creatine Kinase|creatine kinase
46416|NCT02995356|Cervical fluid|cervical fluid
46417|NCT02995330|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
46418|NCT02995330|Bone Marrow Transplantation|bone marrow transplantation
46419|NCT02995317|Aged|aged
46420|NCT02995317|Gait|gait
46421|NCT02995317|Postural Balance|postural balance
46422|NCT02995317|Accelerometry|accelerometry
46432|NCT02995174|fixation stability|fixation stability
46433|NCT02995174|perceptual learning|perceptual learning
46434|NCT02995083|osteoarthritis|osteoarthritis
46435|NCT02995057|Microneedles|microneedles
46436|NCT02995057|Biocompatibility|biocompatibility
46437|NCT02995057|Allergy|allergy
46438|NCT02995057|Metal|metal
46439|NCT02995057|Nickel|nickel
46440|NCT02995057|Contact dermatitis|contact dermatitis
46441|NCT02995005|mother to child transmission|mother to child transmission
46442|NCT02995005|hepatitis B|hepatitis b
46443|NCT02995005|tenofovir|tenofovir
46448|NCT02994927|ANCA-associated vasculitis|anca-associated vasculitis
46449|NCT02994927|complement|complement
46450|NCT02994927|vasculitis|vasculitis
46451|NCT02994927|C5aR|c5ar
46452|NCT02994927|avacopan|avacopan
46453|NCT02994927|CCX168|ccx168
46455|NCT02994927|GPA|gpa
46456|NCT02994914|Breast Cancer|breast cancer
46457|NCT02994914|Onco Geriatric Evaluation|onco geriatric evaluation
46458|NCT02994914|Radiotherapy|radiotherapy
46459|NCT02994914|Hypo fractionated radiotherapy|hypo fractionated radiotherapy
46460|NCT02994914|Normo fractionated radiotherapy|normo fractionated radiotherapy
46461|NCT02994914|Large hypo fractionated radiotherapy|large hypo fractionated radiotherapy
46462|NCT02994901|Sarcopenia|sarcopenia
46463|NCT02994901|Geriatrics|geriatrics
46464|NCT02994901|Biomarker|biomarker
46465|NCT02994836|Crohn's Disease|crohn's disease
46466|NCT02994836|Inflammatory bowel disease|inflammatory bowel disease
46467|NCT02994836|Anti-TNF discontinuation|anti-tnf discontinuation
46468|NCT02994836|Ulcerative colitis|ulcerative colitis
46469|NCT02994810|Breastfeeding|breastfeeding
46470|NCT02994810|Orientation|orientation
46471|NCT02994797|salivary glands|salivary glands
46472|NCT02994797|ultrasonography|ultrasonography
46473|NCT02994797|elastometry|elastometry
46474|NCT02994797|elastography|elastography
46475|NCT02994641|critical care|critical care
46476|NCT02994641|patient discharge|patient discharge
46477|NCT02994641|costs and cost analysis|costs and cost analysis
46478|NCT02994641|length of stay|length of stay
46479|NCT02994641|hospital mortality|hospital mortality
46480|NCT02994628|oxidative stress|oxidative stress
46481|NCT02994628|immune function|immune function
46482|NCT02994628|muscle damage|muscle damage
46483|NCT02994628|carbohydrate|carbohydrate
46484|NCT02994628|polyphenols|polyphenols
46485|NCT02994628|cycling|cycling
46486|NCT02994615|Index of Microvascular Resistance|index of microvascular resistance
46487|NCT02994615|Microvascular dysfunction|microvascular dysfunction
46488|NCT02994602|Healthy Men|healthy men
46489|NCT02994602|Male Contraception|male contraception
46490|NCT02994602|Healthy Women|healthy women
46491|NCT02994602|Transfer|transfer
46492|NCT02994602|Transference|transference
46493|NCT02994602|Gel|gel
46494|NCT02994602|Nestorone|nestorone
46495|NCT02994602|Testosterone|testosterone
46496|NCT02994550|FSH|fsh
46497|NCT02994550|LH|lh
46498|NCT02994550|IVF|ivf
46499|NCT02994511|Circulating tumour DNA|circulating tumour dna
46501|NCT02994420|Obesity|obesity
46502|NCT02994420|Menstrual Cycle|menstrual cycle
46503|NCT02994420|Gonadal Steroid Hormones|gonadal steroid hormones
46504|NCT02994420|Satiety Response|satiety response
46505|NCT02994420|Glucagon-Like Peptide 1|glucagon-like peptide 1
46506|NCT02994420|Cholecystokinin|cholecystokinin
46507|NCT02994420|Magnetic Resonance Imaging|magnetic resonance imaging
46508|NCT02994381|Healthy Male Adults|healthy male adults
46509|NCT02994381|14C|14c
46510|NCT02994381|RPC1063|rpc1063
623466|NCT00673413|Estomia|estomia
46511|NCT02994368|retinal degeneration|retinal degeneration
46512|NCT02994368|eye|eye
46513|NCT02994368|REP-1 gene|rep-1 gene
46514|NCT02994355|Family planning clinics|family planning clinics
46515|NCT02994355|Implementation Science|implementation science
38275|NCT03046563|acupressure|acupressure
46516|NCT02994355|Systems Analysis and Improvement Approach (SAIA)|systems analysis and improvement approach (saia)
46517|NCT02994342|vaginal dryness|vaginal dryness
46518|NCT02994342|vaginal gel|vaginal gel
46519|NCT02994342|colostrum|colostrum
46520|NCT02994342|vaginal atrophy|vaginal atrophy
46521|NCT02994329|HIV testing|hiv testing
46522|NCT02994329|Linkage to care|linkage to care
46523|NCT02994303|Fabry disease|fabry disease
46524|NCT02994303|Fabry nephropathy|fabry nephropathy
46525|NCT02994303|end-stage renal disease|end-stage renal disease
46526|NCT02994303|Anderson-Fabry disease|anderson-fabry disease
46527|NCT02994303|Fabry's disease|fabry's disease
46528|NCT02994277|"Artificial Pancreas"|"artificial pancreas"
46529|NCT02994277|"control System"|"control system"
46530|NCT02994277|"Closed loop"|"closed loop"
46531|NCT02994277|diabetes|diabetes
46532|NCT02994277|"T1DM"|"t1dm"
46533|NCT02994277|"pump"|"pump"
46534|NCT02994277|algorithm|algorithm
46535|NCT02994277|CGM|cgm
46536|NCT02994199|Active video gaming|active video gaming
46537|NCT02994199|Energy expenditure|energy expenditure
46538|NCT02994186|cognitive function|cognitive function
46539|NCT02994186|obesity|obesity
46540|NCT02994186|bariatric surgery|bariatric surgery
46541|NCT02994186|metabolic surgery|metabolic surgery
46542|NCT02994160|peripheral nerve|peripheral nerve
46543|NCT02994160|intraneural electrode|intraneural electrode
46544|NCT02994160|hand amputation|hand amputation
46545|NCT02994108|Human Papillomavirus|human papillomavirus
46546|NCT02994108|Men Who Have Sex with Men|men who have sex with men
46547|NCT02994082|Rural health|rural health
46548|NCT02994082|Veterans|veterans
46549|NCT02994082|Smokeless tobacco cessation|smokeless tobacco cessation
46550|NCT02994069|Cisplatin|cisplatin
46551|NCT02994069|Squamous Cell|squamous cell
46552|NCT02994069|Carcinoma|carcinoma
46553|NCT02994030|neuromuscular disorder|neuromuscular disorder
46554|NCT02994017|cystic fibrosis|cystic fibrosis
46555|NCT02994017|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
46556|NCT02994017|prognostic|prognostic
46557|NCT02994004|Hospital, medical decision-making, role conflict, f-MRI|hospital, medical decision-making, role conflict, f-mri
46558|NCT02993978|Pediatric radiotherapy|pediatric radiotherapy
46559|NCT02993926|Drug Therapy|drug therapy
46560|NCT02993887|Caregiver|caregiver
46561|NCT02993887|Technology Dependent Children|technology dependent children
46562|NCT02993887|Resourcefulness|resourcefulness
46563|NCT02993887|Mindfulness|mindfulness
46564|NCT02993874|Ergonemic resources|ergonemic resources
46565|NCT02993874|Walking capacity|walking capacity
46566|NCT02993874|Peripheral artery disease|peripheral artery disease
46567|NCT02993848|Scapula|scapula
46568|NCT02993848|Fracture|fracture
46569|NCT02993796|Krabbe disease|krabbe disease
46570|NCT02993796|globoid cell leukodystrophy|globoid cell leukodystrophy
46571|NCT02993796|galactosylceramide lipidosis|galactosylceramide lipidosis
46572|NCT02993796|sphingolipidosis|sphingolipidosis
46573|NCT02993783|Drug Therapy|drug therapy
46574|NCT02993757|Dengue Fever|dengue fever
46575|NCT02993757|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
46576|NCT02993757|Human Papillomavirus Disease|human papillomavirus disease
46577|NCT02993757|CYD Dengue Vaccine|cyd dengue vaccine
46578|NCT02993757|Dengvaxia®|dengvaxia®
46579|NCT02993757|Gardasil®|gardasil®
46580|NCT02993744|preterm birth|preterm birth
46581|NCT02993744|corticosteroids|corticosteroids
46582|NCT02993744|inflammatory parameters|inflammatory parameters
46583|NCT02993744|betamethasone|betamethasone
46584|NCT02993744|leukocytes|leukocytes
46585|NCT02993731|Neoplasms|neoplasms
46586|NCT02993731|Neoplasms by Site|neoplasms by site
46587|NCT02993731|Digestive System Neoplasms|digestive system neoplasms
46588|NCT02993731|Endocrine Gland Neoplasms|endocrine gland neoplasms
46589|NCT02993731|Pancreatic Neoplasms|pancreatic neoplasms
46590|NCT02993731|Adenocarcinoma|adenocarcinoma
46591|NCT02993731|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
46592|NCT02993731|Neoplasms by Histologic Type|neoplasms by histologic type
46593|NCT02993731|Digestive System Diseases|digestive system diseases
46594|NCT02993731|Pancreatic Diseases|pancreatic diseases
46595|NCT02993731|Endocrine System Diseases|endocrine system diseases
46596|NCT02993731|Albumin-Bound Paclitaxel|albumin-bound paclitaxel
46597|NCT02993731|Gemcitabine|gemcitabine
46598|NCT02993692|direct laryngoscopy|direct laryngoscopy
46599|NCT02993692|fiberopitc bronchoscopy|fiberopitc bronchoscopy
46600|NCT02993692|nasotracheal intubation|nasotracheal intubation
46601|NCT02993640|vasopressin|vasopressin
46602|NCT02993640|nitroglycerine|nitroglycerine
46603|NCT02993640|portal pressure|portal pressure
46604|NCT02993640|portal flow|portal flow
46605|NCT02993627|obesity|obesity
46606|NCT02993627|BMI|bmi
46607|NCT02993627|body weight|body weight
623467|NCT00673426|enoxaparin|enoxaparin
46608|NCT02993601|Heart Failure|heart failure
46609|NCT02993601|Edema|edema
46610|NCT02993601|Oedema|oedema
52191|NCT02959463|MPM|mpm
38272|NCT03046641|Exercise|exercise
38273|NCT03046641|Men|men
38274|NCT03046615|EEG electrodes|eeg electrodes
38276|NCT03046563|abdominal massage|abdominal massage
38277|NCT03046563|constipation|constipation
46611|NCT02993601|Decompensated Heartfailure|decompensated heartfailure
46612|NCT02993588|Melatonin|melatonin
46613|NCT02993588|IVF/ICSI|ivf/icsi
46614|NCT02993588|Poor ovarian response|poor ovarian response
46615|NCT02993575|Pharmacokinetics|pharmacokinetics
46616|NCT02993575|Flucloxacillin|flucloxacillin
46617|NCT02993575|Continuous infusion|continuous infusion
46618|NCT02993575|Intensive Care Unit|intensive care unit
46619|NCT02993562|Food intake|food intake
46620|NCT02993562|Resting Energy Expenditure|resting energy expenditure
46621|NCT02993562|Gall Bladder emptying|gall bladder emptying
46622|NCT02993562|Insulin response|insulin response
46623|NCT02993562|Body Composition|body composition
46624|NCT02993523|Azacitidine|azacitidine
46625|NCT02993523|Acute Myeloid Leukemia|acute myeloid leukemia
46626|NCT02993523|Venetoclax|venetoclax
46627|NCT02993523|Treatment Naïve|treatment naïve
46628|NCT02993510|microfracture|microfracture
46629|NCT02993510|enhanced marrow stimulation|enhanced marrow stimulation
46630|NCT02993510|articular cartilage|articular cartilage
46631|NCT02993510|Autologous Matrix-Induced Chondrogenesis|autologous matrix-induced chondrogenesis
46632|NCT02993510|Chondro-Gide®|chondro-gide®
46633|NCT02993510|knee surgery|knee surgery
46634|NCT02993510|AMIC|amic
46635|NCT02993458|dietary patterns|dietary patterns
46636|NCT02993458|blood pressure|blood pressure
46637|NCT02993458|adolescents|adolescents
46638|NCT02993458|dietary sodium|dietary sodium
46639|NCT02993393|Simulation Training [I02.903.847]|simulation training [i02.903.847]
46640|NCT02993393|Problem-Based Learning [F02.463.425.720]|problem-based learning [f02.463.425.720]
46641|NCT02993380|Olive oil|olive oil
46642|NCT02993380|Erythrocyte membrane fatty acid contents|erythrocyte membrane fatty acid contents
46643|NCT02993380|Oleic acid|oleic acid
46644|NCT02993367|Butylphthalide Soft Capsules|butylphthalide soft capsules
46645|NCT02993367|VCIND|vcind
46646|NCT02993367|fMRI|fmri
46647|NCT02993302|vitamin D|vitamin d
46648|NCT02993302|graves' disease|graves' disease
46649|NCT02993302|dendritic cells|dendritic cells
46650|NCT02993224|thalassemia|thalassemia
46651|NCT02993224|TDT|tdt
46652|NCT02993224|transfusion-dependent|transfusion-dependent
46653|NCT02993224|non-transfusion-dependent|non-transfusion-dependent
46654|NCT02993224|NTDT|ntdt
46655|NCT02993211|Bladder cancer|bladder cancer
46656|NCT02993211|Transurethral resection|transurethral resection
46657|NCT02993211|En bloc resection|en bloc resection
46658|NCT02993211|TURBT|turbt
46659|NCT02993185|pregnancy|pregnancy
46660|NCT02993185|adolescents|adolescents
46661|NCT02993185|sexually transmitted diseases|sexually transmitted diseases
46662|NCT02993185|decision making|decision making
46663|NCT02993185|prevention education|prevention education
46664|NCT02993107|AR101|ar101
46665|NCT02993107|Characterized Peanut Allergen|characterized peanut allergen
46666|NCT02993107|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
46667|NCT02993107|OIT (oral immunotherapy)|oit (oral immunotherapy)
46668|NCT02993107|Peanut Allergy|peanut allergy
46669|NCT02993107|Allergy|allergy
46670|NCT02993107|Peanut-Allergic Children|peanut-allergic children
46671|NCT02993107|Peanut-Allergic Adults|peanut-allergic adults
46672|NCT02993107|Desensitization|desensitization
46673|NCT02993107|PALISADE|palisade
46674|NCT02993094|breast cancer|breast cancer
46675|NCT02993094|advanced triple negative|advanced triple negative
46676|NCT02993094|ixazomib|ixazomib
46677|NCT02993094|carboplatin|carboplatin
46678|NCT02993094|CARIXA|carixa
46679|NCT02993094|Study Group of Medical Tumor Therapy (AGMT)|study group of medical tumor therapy (agmt)
46680|NCT02993081|YAG laser|yag laser
46681|NCT02993068|Genetic testing|genetic testing
46682|NCT02993068|Genetic educational video|genetic educational video
46683|NCT02993068|Genetic counseling|genetic counseling
46684|NCT02993068|Online genetic test results|online genetic test results
46685|NCT02993068|Telephone genetic counseling|telephone genetic counseling
46686|NCT02993068|Saliva test|saliva test
46687|NCT02993068|Questionnaires|questionnaires
46688|NCT02993068|Surveys|surveys
46689|NCT02993042|Rehabilitation|rehabilitation
46690|NCT02993042|Robot-assisted gait training|robot-assisted gait training
46691|NCT02993029|99Tc-MDP|99tc-mdp
46692|NCT02993029|osteoarthritis|osteoarthritis
46693|NCT02993029|celecoxib|celecoxib
46694|NCT02992977|Vaccine, neoantigen|vaccine, neoantigen
46695|NCT02992951|Infection|infection
46696|NCT02992951|Surgical Site Infection|surgical site infection
46697|NCT02992951|Dialkylcarbamoylchloride|dialkylcarbamoylchloride
46698|NCT02992938|Opioid hyperalgesia|opioid hyperalgesia
46699|NCT02992938|Acetazolamide|acetazolamide
46700|NCT02992938|Remifentanil|remifentanil
46701|NCT02992925|Haemophilus influenza type b|haemophilus influenza type b
46702|NCT02992925|Adsorbed Diphteria-purified Pertussis-Tetanus-Inactivate poliovirus combined vaccine|adsorbed diphteria-purified pertussis-tetanus-inactivate poliovirus combined vaccine
46703|NCT02992925|Hib|hib
46704|NCT02992925|DPT-IPV|dpt-ipv
46705|NCT02992899|stress disorders, post-traumatic|stress disorders, post-traumatic
46706|NCT02992899|posttraumatic stress disorder|posttraumatic stress disorder
46707|NCT02992899|PTSD|ptsd
46708|NCT02992899|vagal nerve|vagal nerve
46709|NCT02992886|elderly patients|elderly patients
46710|NCT02992886|rectal cancer|rectal cancer
46711|NCT02992886|preoperative chemoradiotherapy|preoperative chemoradiotherapy
46712|NCT02992886|comprehensive geriatric assessment|comprehensive geriatric assessment
46713|NCT02992860|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
46714|NCT02992860|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
46715|NCT02992860|hypomethylating agent (HMA) treatment|hypomethylating agent (hma) treatment
46716|NCT02992860|leukemic stem cell|leukemic stem cell
46717|NCT02992860|CD123|cd123
46718|NCT02992860|immunotherapy|immunotherapy
46719|NCT02992847|Multiple sclerosis|multiple sclerosis
46720|NCT02992847|Gadolinium based contrast agent|gadolinium based contrast agent
46722|NCT02992847|Dentate nucleus|dentate nucleus
46723|NCT02992821|Hand-held|hand-held
46724|NCT02992821|Ultrasound|ultrasound
46725|NCT02992821|Diagnosis|diagnosis
46726|NCT02992821|Carotid artery stenosis|carotid artery stenosis
46727|NCT02992808|IVF|ivf
46728|NCT02992808|Ovarian stimulation|ovarian stimulation
46729|NCT02992808|Androgenic profile|androgenic profile
46730|NCT02992808|Follicular fluid|follicular fluid
46731|NCT02992808|Recombinant gonadotropins|recombinant gonadotropins
46732|NCT02992808|human menopausal gonadotropin|human menopausal gonadotropin
46733|NCT02992769|Breast Cancer|breast cancer
46734|NCT02992769|Nomogram|nomogram
46735|NCT02992769|Ultrasound|ultrasound
46736|NCT02992769|Axillary Metastases|axillary metastases
46737|NCT02992743|Sarcoma|sarcoma
46738|NCT02992743|Cell Therapy|cell therapy
46739|NCT02992743|T Cell Therapy|t cell therapy
46740|NCT02992743|NY-ESO-1|ny-eso-1
46741|NCT02992743|Immuno-oncology|immuno-oncology
46742|NCT02992743|Metastatic|metastatic
46743|NCT02992743|Previously treated|previously treated
46744|NCT02992743|T Cell Receptor|t cell receptor
46745|NCT02992730|Medication Adherence|medication adherence
46746|NCT02992665|Calcium ionophore|calcium ionophore
46747|NCT02992665|Fertilization|fertilization
46748|NCT02992665|Sperm|sperm
46749|NCT02992665|Oocyte|oocyte
46750|NCT02992665|ICSI|icsi
46751|NCT02992639|High visceral fat|high visceral fat
46752|NCT02992639|Liver enzymes|liver enzymes
46753|NCT02992639|Aminotransferase|aminotransferase
46754|NCT02992639|Mild calorie restriction|mild calorie restriction
46755|NCT02992600|non-cardiac surgery|non-cardiac surgery
46756|NCT02992600|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
46757|NCT02992574|Post-Mastectomy Radiation|post-mastectomy radiation
46758|NCT02992574|Node Negative|node negative
46759|NCT02992574|Early breast Cancer|early breast cancer
46760|NCT02992561|Aggression|aggression
46761|NCT02992561|Violence|violence
46762|NCT02992561|Post-conflict reconstruction|post-conflict reconstruction
46763|NCT02992561|Demobilization|demobilization
46764|NCT02992561|Traumatized offenders|traumatized offenders
46765|NCT02992548|chronic kidney disease|chronic kidney disease
46766|NCT02992548|pravastatin|pravastatin
46767|NCT02992548|erythrocyte membrane fatty acid|erythrocyte membrane fatty acid
46768|NCT02992483|multiple myeloma|multiple myeloma
46769|NCT02992483|lymphoma|lymphoma
46770|NCT02992483|dlbcl|dlbcl
46771|NCT02992431|patient care planning|patient care planning
46772|NCT02992431|primary health care|primary health care
46773|NCT02992431|comorbidity|comorbidity
46774|NCT02992418|Dengue Fever|dengue fever
46775|NCT02992418|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
46776|NCT02992418|CYD Dengue Vaccine|cyd dengue vaccine
46777|NCT02992418|Degavaxia®|degavaxia®
46778|NCT02992392|Tear film|tear film
46779|NCT02992392|Lipid layer|lipid layer
46780|NCT02992392|Liposic|liposic
46781|NCT02992392|Tears Naturale Forte|tears naturale forte
46782|NCT02992379|Anterior disc displacement|anterior disc displacement
46783|NCT02992379|Stabilizing splint|stabilizing splint
46784|NCT02992366|socket shield|socket shield
46785|NCT02992366|volumetric tissue alteration|volumetric tissue alteration
46786|NCT02992366|immediate implant|immediate implant
46787|NCT02992353|VATS|vats
46788|NCT02992353|NSCLC|nsclc
46789|NCT02992353|recurrence rate|recurrence rate
46790|NCT02992288|Chronic Heart Failure|chronic heart failure
46791|NCT02992288|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
46792|NCT02992275|Hip|hip
46793|NCT02992275|Muscle|muscle
46794|NCT02992275|Skeletal/physiopathology|skeletal/physiopathology
46896|NCT02991690|Hypothermia|hypothermia
46800|NCT02992223|Autologous stem cell transplant|autologous stem cell transplant
46801|NCT02992223|BEAM|beam
46802|NCT02992223|Recurrent|recurrent
46803|NCT02992210|CAR|car
46804|NCT02992210|chimeric antigen receptor|chimeric antigen receptor
46805|NCT02992210|adoptive T cell transfer|adoptive t cell transfer
46806|NCT02992197|Rotavirus|rotavirus
46807|NCT02992197|Oral vaccines|oral vaccines
46808|NCT02992197|Vaccine underperformance|vaccine underperformance
46809|NCT02992197|Vaccine shedding|vaccine shedding
46810|NCT02992184|HCV|hcv
46811|NCT02992184|Genedrive|genedrive
46812|NCT02992184|Point of Care|point of care
46813|NCT02992119|safety|safety
46814|NCT02992119|immunogenicity|immunogenicity
46815|NCT02992106|Maternal Obesity|maternal obesity
46816|NCT02992106|Endothelial Dysfunction|endothelial dysfunction
46817|NCT02992106|Childhood Obesity|childhood obesity
46818|NCT02992093|Polycystic ovary syndrome|polycystic ovary syndrome
46819|NCT02992093|Metabonomics|metabonomics
46820|NCT02992093|Traditional Chinese medicine syndromes|traditional chinese medicine syndromes
46821|NCT02992080|Patient with Cystic Fibrosis|patient with cystic fibrosis
46822|NCT02992080|Patient without Cystic fibrosis|patient without cystic fibrosis
46823|NCT02992067|lymph node metastasis|lymph node metastasis
46824|NCT02992067|breast cancer|breast cancer
46825|NCT02992067|CK19|ck19
46826|NCT02992067|contrast-enhanced ultrasonography|contrast-enhanced ultrasonography
46827|NCT02992028|Rotator cuff repair|rotator cuff repair
46828|NCT02992028|Vitamin C|vitamin c
46829|NCT02992028|postoperative pain|postoperative pain
46830|NCT02991989|Home-based exercise|home-based exercise
46831|NCT02991989|Exercise snacking|exercise snacking
46832|NCT02991989|Protein|protein
46833|NCT02991989|Yogurt|yogurt
46834|NCT02991976|Normobaric hyperoxia|normobaric hyperoxia
46835|NCT02991976|Cerebral oxygenation|cerebral oxygenation
46836|NCT02991976|Near-infrared spectroscopy|near-infrared spectroscopy
46837|NCT02991976|Carotid endarterectomy|carotid endarterectomy
46838|NCT02991976|TIVA|tiva
46839|NCT02991924|endobronchial ultrasound|endobronchial ultrasound
46840|NCT02991924|EBUS-TBNA|ebus-tbna
46841|NCT02991924|lung cancer|lung cancer
46842|NCT02991924|staging|staging
46843|NCT02991911|metastatic, prostate cancer|metastatic, prostate cancer
46844|NCT02991898|CML|cml
46845|NCT02991898|MDS|mds
46846|NCT02991898|CLL|cll
46847|NCT02991898|ALL|all
46848|NCT02991898|AML|aml
46849|NCT02991872|Persistence|persistence
46850|NCT02991872|Purified chicken-embryo cell rabies vaccine|purified chicken-embryo cell rabies vaccine
46851|NCT02991872|Rabies Virus Neutralizing Antibody (RVNA)|rabies virus neutralizing antibody (rvna)
46852|NCT02991872|Immunogenicity|immunogenicity
46853|NCT02991872|Post-Exposure Prophylaxis (PEP)|post-exposure prophylaxis (pep)
46854|NCT02991872|Rabipur|rabipur
46860|NCT02991846|chronic graft-versus-host disease cGVHD|chronic graft-versus-host disease cgvhd
46861|NCT02991846|Hematopoietic stem cell transplantation HSCT|hematopoietic stem cell transplantation hsct
46862|NCT02991846|NIH consensus criteria|nih consensus criteria
46863|NCT02991846|GITMO|gitmo
46864|NCT02991833|urinary incontinence|urinary incontinence
46865|NCT02991833|care product|care product
46866|NCT02991833|bowel incontinence|bowel incontinence
46867|NCT02991807|PTEN|pten
46868|NCT02991807|PTEN Gene Mutation|pten gene mutation
46869|NCT02991807|PTEN Hamartoma Tumor Syndrome|pten hamartoma tumor syndrome
46870|NCT02991807|Autism|autism
46871|NCT02991807|Intellectual Disability|intellectual disability
46872|NCT02991807|Neurocognition|neurocognition
46873|NCT02991807|Afinitor|afinitor
46874|NCT02991807|Everolimus|everolimus
46875|NCT02991807|RAD001|rad001
46876|NCT02991794|prostatectomy|prostatectomy
46877|NCT02991794|laparoscopy|laparoscopy
46878|NCT02991794|3D visualization|3d visualization
46879|NCT02991794|learning curve|learning curve
46880|NCT02991794|anastomosis|anastomosis
46881|NCT02991742|nephropathy|nephropathy
46882|NCT02991742|catheterization|catheterization
46883|NCT02991742|contrast media|contrast media
46884|NCT02991742|ioxaglate|ioxaglate
46885|NCT02991742|iodixanol|iodixanol
46886|NCT02991742|high risk|high risk
46887|NCT02991742|prevention|prevention
46888|NCT02991729|Decision aid|decision aid
46889|NCT02991703|Arterial stiffness|arterial stiffness
46890|NCT02991703|pulse wave velocity|pulse wave velocity
46891|NCT02991703|Sphygmocor|sphygmocor
46892|NCT02991703|applanation tonometry|applanation tonometry
46893|NCT02991703|pOpmètre|popmètre
46894|NCT02991703|children|children
46895|NCT02991703|EPIPAGE cohort|epipage cohort
46897|NCT02991690|Cervical Spinal Cord Injury|cervical spinal cord injury
46899|NCT02991677|exercise|exercise
46900|NCT02991677|neuropathy|neuropathy
46901|NCT02991664|glass ionomer cement|glass ionomer cement
46902|NCT02991664|composite resin|composite resin
46903|NCT02991651|RXR agonist IRX4204 erlotinib|rxr agonist irx4204 erlotinib
46904|NCT02991599|Hepatitis B, Vaccine|hepatitis b, vaccine
46905|NCT02991599|Immunogenicity|immunogenicity
46906|NCT02991599|methadone maintenance treatment|methadone maintenance treatment
46907|NCT02991599|Randomized Controlled Trial|randomized controlled trial
46908|NCT02991586|Emotional Instability|emotional instability
46909|NCT02991586|Family Therapy|family therapy
46910|NCT02991586|BPD|bpd
46911|NCT02991586|DBT|dbt
46912|NCT02991560|physiotherapy|physiotherapy
46920|NCT02991534|Physicians, Women [M01.526.485.810.820]|physicians, women [m01.526.485.810.820]
46921|NCT02991534|Health Educators [M01.526.485.410]|health educators [m01.526.485.410]
46922|NCT02991534|Cardiovascular Diseases [C14]|cardiovascular diseases [c14]
46923|NCT02991534|Hypertension [C14.907.489]|hypertension [c14.907.489]
47127|NCT02990442|rTMS|rtms
46924|NCT02991534|Hyperlipidemias [C18.452.584.500.500]|hyperlipidemias [c18.452.584.500.500]
46925|NCT02991534|Dyslipidemias [C18.452.584.500]|dyslipidemias [c18.452.584.500]
46926|NCT02991534|Obesity [C18.654.726.500]|obesity [c18.654.726.500]
46927|NCT02991534|Diabetes Mellitus [C18.452.394.750]|diabetes mellitus [c18.452.394.750]
46928|NCT02991534|Tobacco Use Disorder [C25.775.912]|tobacco use disorder [c25.775.912]
46929|NCT02991534|Overweight [C23.888.144.699]|overweight [c23.888.144.699]
46930|NCT02991508|Adrecizumab|adrecizumab
46931|NCT02991508|Phase 1 clinical trial|phase 1 clinical trial
46932|NCT02991508|Adrenomedullin|adrenomedullin
46933|NCT02991508|Healthy volunteers|healthy volunteers
46934|NCT02991508|Monoclonal recombinant antibody|monoclonal recombinant antibody
46935|NCT02991495|epidemic response|epidemic response
46948|NCT02991430|migraine headache, episodic|migraine headache, episodic
46949|NCT02991378|preschool children|preschool children
46950|NCT02991378|emotional disorders/problems|emotional disorders/problems
46951|NCT02991378|stress related disorders/problems|stress related disorders/problems
46952|NCT02991378|early intervention|early intervention
46953|NCT02991352|Vascular Malformations|vascular malformations
46954|NCT02991352|Image Guidance|image guidance
46955|NCT02991339|Dexamethasone|dexamethasone
46956|NCT02991339|Liver Dysfunction|liver dysfunction
46957|NCT02991339|Hepatectomy|hepatectomy
46958|NCT02991339|Bilirubinaemia|bilirubinaemia
46959|NCT02991339|Jaundice|jaundice
46960|NCT02991326|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
46961|NCT02991326|Temporomandibular Disorder|temporomandibular disorder
46962|NCT02991300|focal defect|focal defect
46963|NCT02991300|focal lesion|focal lesion
46964|NCT02991300|chondral lesion|chondral lesion
46965|NCT02991300|osteochondral lesion|osteochondral lesion
46966|NCT02991274|T790M|t790m
46967|NCT02991274|EGFR (Epidermal Growth Factor Receptor) mutation|egfr (epidermal growth factor receptor) mutation
46968|NCT02991274|NSCLC|nsclc
46969|NCT02991196|Advanced colorectal cancer|advanced colorectal cancer
46970|NCT02991196|DNA mismatch repair (MMR)|dna mismatch repair (mmr)
46971|NCT02991196|MMR-proficient Subjects|mmr-proficient subjects
46972|NCT02991196|TRAIL-R2 (DR5) Antibody|trail-r2 (dr5) antibody
46973|NCT02991183|Caregivers|caregivers
46974|NCT02991183|Acceptance and Commitment Therapy|acceptance and commitment therapy
46975|NCT02991170|myocardial infarction|myocardial infarction
46976|NCT02991170|ventricular arrhythmia|ventricular arrhythmia
46977|NCT02991170|radiofrequency ablation|radiofrequency ablation
46978|NCT02991170|Coronary Artery Bypass Grafts|coronary artery bypass grafts
46979|NCT02991157|cerebral vasospasm|cerebral vasospasm
46980|NCT02991157|nimodipine|nimodipine
46981|NCT02991144|Gene Transfer|gene transfer
46982|NCT02991144|OTC Deficiency|otc deficiency
46983|NCT02991144|Urea Cycle Disorder|urea cycle disorder
46984|NCT02991131|Acute bacterial skin infection|acute bacterial skin infection
46985|NCT02991131|Acute Bacterial Skin and Skin Structure Infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
46986|NCT02991131|Abscess|abscess
46987|NCT02991131|Cellulitis|cellulitis
46988|NCT02991131|Erysipelas|erysipelas
46989|NCT02991131|Wound infection|wound infection
46990|NCT02991131|Methicillin resistant Staphylococcus aureus (MRSA)|methicillin resistant staphylococcus aureus (mrsa)
46991|NCT02991118|hyperlipidemia|hyperlipidemia
46992|NCT02991118|cholesterol|cholesterol
46993|NCT02991118|familial hypercholesterolemia|familial hypercholesterolemia
46994|NCT02991118|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
46996|NCT02991118|HeFH|hefh
46997|NCT02991118|LDL|ldl
46998|NCT02991105|Malignancy|malignancy
46999|NCT02991105|Cancer|cancer
47000|NCT02991105|Organ Transplantation|organ transplantation
47001|NCT02991092|colon carcinoma|colon carcinoma
47002|NCT02991092|liquid treatment|liquid treatment
47003|NCT02991092|fast-track surgery|fast-track surgery
47004|NCT02991079|Food Habits|food habits
47005|NCT02991079|Health education|health education
47006|NCT02991079|Physical activity|physical activity
47007|NCT02991079|Information and Communication Technologies|information and communication technologies
47008|NCT02991066|Acute promyelocytic leukemia|acute promyelocytic leukemia
47009|NCT02991066|Coagulopathy|coagulopathy
47010|NCT02991066|Microparticles|microparticles
47011|NCT02991066|Mechanism|mechanism
47012|NCT02991053|Intra-operative anesthesia|intra-operative anesthesia
47013|NCT02991053|Pediatric patient|pediatric patient
38680|NCT03043911|sepsis|sepsis
47014|NCT02991053|Transversus Abdominis Plane Block|transversus abdominis plane block
47015|NCT02991053|ilioinguinal / iliohypogastric nerve block|ilioinguinal / iliohypogastric nerve block
47016|NCT02989987|PTSD|ptsd
47017|NCT02989987|Shame|shame
47018|NCT02989987|Narrative Exposure Therapy|narrative exposure therapy
47019|NCT02989987|Sexual and gender based violence (SGBV)|sexual and gender based violence (sgbv)
47020|NCT02989987|DR Congo|dr congo
47021|NCT02989974|Survivorship Care|survivorship care
47022|NCT02989974|Caregiving|caregiving
47023|NCT02989948|Endovascular|endovascular
47024|NCT02989935|respiratory muscle|respiratory muscle
47025|NCT02989935|bronchodilator|bronchodilator
47026|NCT02989896|Perfusion index|perfusion index
47324|NCT02988947|Knee Arthroplasty|knee arthroplasty
47027|NCT02989896|Peripheral nerve block success|peripheral nerve block success
47028|NCT02989896|older age|older age
47029|NCT02989883|achalasia|achalasia
47030|NCT02989883|POEM|poem
47031|NCT02989883|outcome|outcome
47032|NCT02989870|Liver Disease|liver disease
47033|NCT02989870|Child-Pugh Class A|child-pugh class a
47034|NCT02989870|Child-Pugh Class B7|child-pugh class b7
47035|NCT02989857|IDH1|idh1
47036|NCT02989831|diabetic neuropathy|diabetic neuropathy
47037|NCT02989831|foot ulcers|foot ulcers
47038|NCT02989831|random vibration|random vibration
47039|NCT02989831|vibration perception threshold|vibration perception threshold
47040|NCT02989831|mechanical noise|mechanical noise
47041|NCT02991027|no known ocular pathology|no known ocular pathology
47042|NCT02991014|music intervention|music intervention
47043|NCT02991014|heart rate variability|heart rate variability
47044|NCT02991014|frequency modulation|frequency modulation
47045|NCT02991014|pain perception|pain perception
47046|NCT02991014|cold pressor test (CPT)|cold pressor test (cpt)
47047|NCT02991001|Hydrodissection|hydrodissection
47048|NCT02990988|Blood donation|blood donation
47049|NCT02990988|Iron repletion|iron repletion
47050|NCT02990988|Transfusion|transfusion
47051|NCT02990975|Intra-operative anesthesia|intra-operative anesthesia
47052|NCT02990975|Pediatric patient|pediatric patient
47053|NCT02990975|Transversus Abdominis Plane Block|transversus abdominis plane block
47054|NCT02990962|perineural injection|perineural injection
47055|NCT02990962|ultrasound-guided|ultrasound-guided
47056|NCT02990962|dextrose|dextrose
47057|NCT02990962|steroid|steroid
47058|NCT02990936|Oropharynx squamous cell carcinoma|oropharynx squamous cell carcinoma
47059|NCT02990936|tumor growth|tumor growth
47060|NCT02990936|predictive markers|predictive markers
47061|NCT02990936|tumoral kinetics|tumoral kinetics
47062|NCT02990910|respiratory adverse events|respiratory adverse events
47063|NCT02990910|adenotonsillectomy|adenotonsillectomy
47064|NCT02990910|opioid analgesia|opioid analgesia
47065|NCT02990910|children|children
47066|NCT02990897|Medical informatics|medical informatics
47067|NCT02990897|Quality of care|quality of care
47068|NCT02990897|Referral|referral
47069|NCT02990884|Intra-operative anesthesia and analgesia|intra-operative anesthesia and analgesia
47070|NCT02990884|ilioinguinal / iliohyogogastric nerve block|ilioinguinal / iliohyogogastric nerve block
47071|NCT02990884|Pediatric patient|pediatric patient
47072|NCT02990819|Immunodeficiencies|immunodeficiencies
47073|NCT02990819|Immune dysregulation syndromes|immune dysregulation syndromes
47074|NCT02990793|PTSD|ptsd
47075|NCT02990793|Concussion|concussion
47077|NCT02990793|TMS|tms
47078|NCT02990741|atrial fibrillation|atrial fibrillation
47079|NCT02990741|automated ECG system|automated ecg system
47080|NCT02990728|Endometrial Cancer.Mirena®|endometrial cancer.mirena®
47081|NCT02990715|average risk CRC screening|average risk crc screening
47082|NCT02990715|Non compliant patients for CRC screening|non compliant patients for crc screening
47083|NCT02990715|Counterindicated patients for colonoscopy|counterindicated patients for colonoscopy
47084|NCT02990702|Infraclavicular block|infraclavicular block
47085|NCT02990702|Retroclavicular block|retroclavicular block
47086|NCT02990702|Ultrasound|ultrasound
47087|NCT02990676|Cognition|cognition
47088|NCT02990676|Computerised cognitive training|computerised cognitive training
47089|NCT02990676|Feasibility study|feasibility study
47090|NCT02990676|Huntington's disease|huntington's disease
47091|NCT02990676|Translational|translational
47092|NCT02990663|Pragmatic|pragmatic
47093|NCT02990663|Primary Care|primary care
47094|NCT02990663|Chronotherapy|chronotherapy
47095|NCT02990663|Administrative Data|administrative data
47097|NCT02990663|Myocardial Infarction|myocardial infarction
623579|NCT00675298|Frequency|frequency
47098|NCT02990663|Congestive Heart Failure|congestive heart failure
47099|NCT02990663|Glaucoma|glaucoma
47100|NCT02990663|Dementia|dementia
47101|NCT02990663|Hip Fracture|hip fracture
47102|NCT02990637|Olive leaf extract|olive leaf extract
47103|NCT02990637|Cardiovascular health|cardiovascular health
47104|NCT02990637|Cholesterol|cholesterol
47105|NCT02990624|psoriasis|psoriasis
47106|NCT02990624|photochemotherapy|photochemotherapy
47107|NCT02990624|atherosclerosis|atherosclerosis
38782|NCT03043352|SAM|sam
47108|NCT02990624|metabolic syndrome|metabolic syndrome
47109|NCT02990624|cardiovascular risk|cardiovascular risk
47110|NCT02990598|Hydroxyurea|hydroxyurea
47111|NCT02990572|Amish|amish
47112|NCT02990572|Mennonite|mennonite
47113|NCT02990559|Iron repletion|iron repletion
47114|NCT02990559|Blood donation|blood donation
47115|NCT02990559|Transfusion|transfusion
47116|NCT02990507|mobility impairment|mobility impairment
47117|NCT02990507|virtual environment|virtual environment
47118|NCT02990507|exercise|exercise
47119|NCT02990507|physical activity|physical activity
47120|NCT02990468|Mucositis|mucositis
47121|NCT02990468|Xerostomia|xerostomia
47122|NCT02990455|alcohol|alcohol
47123|NCT02990455|drinking|drinking
47124|NCT02990455|smoking|smoking
47125|NCT02990455|cigarette|cigarette
47126|NCT02990455|nicotine|nicotine
47128|NCT02990442|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
47129|NCT02990442|Brain Stimulation|brain stimulation
47130|NCT02990429|hypothermia|hypothermia
47131|NCT02990429|Shivering|shivering
47132|NCT02990429|Gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
47133|NCT02990429|Warming|warming
47134|NCT02990429|General anesthesia|general anesthesia
47135|NCT02990377|Opioid Analgesics|opioid analgesics
47136|NCT02990377|Opioid Safety|opioid safety
47137|NCT02990377|Emergency Department|emergency department
47138|NCT02990377|Motivational Enhancement|motivational enhancement
47139|NCT02990377|Interactive Voice Response|interactive voice response
47140|NCT02990377|Reinforcement Learning|reinforcement learning
47141|NCT02990377|mHealth|mhealth
47142|NCT02990364|Circumcision|circumcision
47143|NCT02990364|Analgesia|analgesia
47144|NCT02990364|Controlled Clinical Trial|controlled clinical trial
47145|NCT02990325|ABX464, HIV infection|abx464, hiv infection
47146|NCT02990299|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
47147|NCT02990299|Medication Adherence|medication adherence
47148|NCT02990299|Telemedicine|telemedicine
47149|NCT02990299|Community Health Workers|community health workers
47150|NCT02990299|Pharmacists|pharmacists
47151|NCT02990299|Mobile Health|mobile health
47152|NCT02990286|Non specific intertitial pneumonia|non specific intertitial pneumonia
47153|NCT02990286|interstitial pneumonia with autoimmune feature|interstitial pneumonia with autoimmune feature
47154|NCT02990286|connective tissue disease|connective tissue disease
47155|NCT02990286|rituximab|rituximab
47156|NCT02990286|Mycophenolate Mofetil|mycophenolate mofetil
47157|NCT02990286|pulmonary fibrosis|pulmonary fibrosis
47158|NCT02990247|Asthma|asthma
47159|NCT02990247|Exacerbations|exacerbations
47160|NCT02990247|Telemonitoring|telemonitoring
47161|NCT02990247|Biomarkers|biomarkers
47162|NCT02990234|Capsular Repair|capsular repair
47163|NCT02990234|FAI|fai
47164|NCT02990234|Hip|hip
47165|NCT02990221|Field Cancerization|field cancerization
47166|NCT02990208|Diaphragmatic Breathing|diaphragmatic breathing
47167|NCT02990208|Virtual Reality Exposure Therapy|virtual reality exposure therapy
47168|NCT02990182|Yellow Fever Vaccine|yellow fever vaccine
47169|NCT02990182|Immunity, Humoral|immunity, humoral
47170|NCT02990182|Immunity, Cellular|immunity, cellular
47171|NCT02990182|children|children
47172|NCT02990156|Coils|coils
47173|NCT02990091|TBI|tbi
47174|NCT02990091|DHA|dha
47175|NCT02990091|omega-3 highly unsaturated fatty acids|omega-3 highly unsaturated fatty acids
47176|NCT02990091|synaptamide|synaptamide
47177|NCT02990078|TBI|tbi
47178|NCT02990078|CVR|cvr
47179|NCT02990078|Hypercapnia|hypercapnia
47180|NCT02990078|fNIRS|fnirs
47181|NCT02990065|PROTEIN SUPPLEMENTATION|protein supplementation
47182|NCT02990065|NUTRITIONAL STATUS|nutritional status
47183|NCT02990039|physical activity|physical activity
47184|NCT02990039|sedentary time|sedentary time
47185|NCT02990039|feasibility study|feasibility study
47186|NCT02990039|accelerometer|accelerometer
47187|NCT02989805|Emergency Medicine|emergency medicine
47188|NCT02989805|Psychiatry|psychiatry
47189|NCT02989805|Health Promotion|health promotion
47190|NCT02989805|Public Health|public health
47191|NCT02989792|pain|pain
47192|NCT02989753|Prevention|prevention
47193|NCT02989740|Diabetes Mellitus|diabetes mellitus
47194|NCT02989740|Thincap fibroatheroma|thincap fibroatheroma
47195|NCT02989740|Optical Coherence Tomography|optical coherence tomography
47196|NCT02989740|Fractional Flow Reserve|fractional flow reserve
47197|NCT02989701|Plerixafor|plerixafor
47198|NCT02989675|pediatric|pediatric
47199|NCT02989675|critical illness|critical illness
47200|NCT02989675|Malawi|malawi
47201|NCT02989649|Drug Therapy|drug therapy
47202|NCT02989584|bladder cancer|bladder cancer
47203|NCT02989584|metastatic bladder cancer|metastatic bladder cancer
47204|NCT02989584|atezolizumab|atezolizumab
47205|NCT02989584|urothelial carcinoma|urothelial carcinoma
47206|NCT02989519|preterm labor|preterm labor
47207|NCT02989519|progesterone efficacy|progesterone efficacy
47208|NCT02989519|threatened preterm labor|threatened preterm labor
47209|NCT02989493|Alcoholism|alcoholism
47210|NCT02989493|Stress|stress
47211|NCT02989493|Norepinephrine|norepinephrine
47212|NCT02989493|Doxazosin|doxazosin
47213|NCT02989493|Anxiety|anxiety
47214|NCT02989493|Startle Potentiation|startle potentiation
47215|NCT02989493|Relapse|relapse
47216|NCT02989493|Adrenergic Antagonists|adrenergic antagonists
47217|NCT02989493|Surrogate Endpoint|surrogate endpoint
47218|NCT02989480|Cardiomyopathy|cardiomyopathy
47219|NCT02989441|Perfusion Index|perfusion index
47220|NCT02989441|Hemodynamics|hemodynamics
47221|NCT02989441|Anesthesia|anesthesia
47222|NCT02989441|Stroke Volume|stroke volume
47223|NCT02989415|Anesthesia|anesthesia
47224|NCT02989415|Mechanical Ventilation|mechanical ventilation
47225|NCT02989415|Robotic Surgery|robotic surgery
47226|NCT02989415|Postoperative Pulmonary Complications|postoperative pulmonary complications
47227|NCT02989402|Alzheimer, Rivastigmine|alzheimer, rivastigmine
47228|NCT02989363|deep brain surgery and complex back surgery|deep brain surgery and complex back surgery
47229|NCT02989337|Hyperemesis Gravidarum|hyperemesis gravidarum
47230|NCT02989337|Inflammatory adhesion molecules|inflammatory adhesion molecules
47231|NCT02989337|Dehydration|dehydration
47232|NCT02989311|Iron absorption|iron absorption
47233|NCT02989311|Iron deficiency|iron deficiency
47234|NCT02989311|Hepcidin|hepcidin
47235|NCT02989311|Stable isotopes|stable isotopes
47236|NCT02989311|Anemia|anemia
47237|NCT02989311|Infants|infants
47238|NCT02989298|Peritoneal Dialysis (PD)|peritoneal dialysis (pd)
47239|NCT02989298|Residual renal function|residual renal function
47241|NCT02989298|Peritonitis rate|peritonitis rate
47242|NCT02989298|Technical survival|technical survival
47243|NCT02989298|Patient survival|patient survival
47244|NCT02989285|HIV|hiv
47245|NCT02989285|HIV-associated neurocognitive disorder (HAND)|hiv-associated neurocognitive disorder (hand)
47246|NCT02989285|Neurology|neurology
47247|NCT02989285|Latent HIV|latent hiv
47248|NCT02989285|HIV Reservoirs|hiv reservoirs
47249|NCT02989259|apatinib|apatinib
47250|NCT02989259|advanced head and neck cancer|advanced head and neck cancer
47251|NCT02989259|non-squamous|non-squamous
47252|NCT02989246|pediatrics|pediatrics
47253|NCT02989246|ventilator weaning|ventilator weaning
47254|NCT02989220|Miscarriage|miscarriage
47255|NCT02989207|Glaucoma|glaucoma
47256|NCT02989207|Trabeculectomy|trabeculectomy
47257|NCT02989207|Glaucoma drainage implant|glaucoma drainage implant
47258|NCT02989207|Africa and Africa-Caribbean|africa and africa-caribbean
47259|NCT02989168|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
47260|NCT02989168|hypoxemia|hypoxemia
47261|NCT02989168|oxygen|oxygen
47262|NCT02989142|interpregnancy|interpregnancy
47263|NCT02989142|pregnancy-induced hypertension|pregnancy-induced hypertension
47264|NCT02989142|gestational diabetes mellitus|gestational diabetes mellitus
47265|NCT02989142|caesarean section|caesarean section
47266|NCT02989142|large-for-gestational-age|large-for-gestational-age
47267|NCT02989129|Polyneuropathies and Other Disorders of the Peripheral Nervous System|polyneuropathies and other disorders of the peripheral nervous system
47268|NCT02989129|Chemotherapy Induced Neuropathic Pain|chemotherapy induced neuropathic pain
47269|NCT02989129|CINP|cinp
47270|NCT02989129|Quercetin|quercetin
47271|NCT02989129|Questionnaires|questionnaires
47272|NCT02989129|Surveys|surveys
47273|NCT02989116|Learning|learning
47274|NCT02989116|Executive functions|executive functions
47275|NCT02989116|Cognitive control|cognitive control
47276|NCT02989116|Prefrontal Cortex|prefrontal cortex
47277|NCT02989116|Typically developing children|typically developing children
47278|NCT02989116|Genotype|genotype
47279|NCT02989116|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
47280|NCT02989116|Structural Magnetic Resonance Imaging|structural magnetic resonance imaging
47281|NCT02989116|Inhibition|inhibition
47282|NCT02989116|Working Memory|working memory
47283|NCT02989116|Metacognition|metacognition
47284|NCT02989116|Mindfulness|mindfulness
47285|NCT02989116|Preterm children|preterm children
47286|NCT02989116|Developmental Psychology|developmental psychology
47287|NCT02989116|Developmental cognitive neuroscience|developmental cognitive neuroscience
47288|NCT02989116|Touch screen tablet|touch screen tablet
47289|NCT02989116|Adaptive training|adaptive training
47290|NCT02989103|Hyperthyroidism|hyperthyroidism
47291|NCT02989103|Radiation|radiation
47292|NCT02989103|Mortality|mortality
47293|NCT02989090|Patient Engagement|patient engagement
47294|NCT02989090|Defibrillators|defibrillators
47295|NCT02989090|Health Records, Personal|health records, personal
47296|NCT02989090|Patient Portal|patient portal
47297|NCT02989077|combined coronary and cerebral ischemia|combined coronary and cerebral ischemia
47298|NCT02989064|Cell Therapy|cell therapy
47299|NCT02989064|T Cell Therapy|t cell therapy
47300|NCT02989064|SPEAR T Cell|spear t cell
47301|NCT02989064|MAGE-A10|mage-a10
47302|NCT02989064|Immuno-oncology|immuno-oncology
47303|NCT02989064|Metastatic|metastatic
47304|NCT02989064|Urothelial Cancer|urothelial cancer
47305|NCT02989064|Previously Treated|previously treated
47306|NCT02989064|T Cell Receptor|t cell receptor
47307|NCT02989038|smoker|smoker
47308|NCT02989038|young adult|young adult
47431|NCT02988414|Non-invasive|non-invasive
47309|NCT02988999|D-allulose or erythritol|d-allulose or erythritol
47310|NCT02988986|mTOR|mtor
47311|NCT02988986|Tamoxifen|tamoxifen
47312|NCT02988986|Breast Cancer|breast cancer
47313|NCT02988973|Roxadustat|roxadustat
47314|NCT02988973|Anemia|anemia
47315|NCT02988973|Non-dialysis chronic kidney disease|non-dialysis chronic kidney disease
47316|NCT02988973|ASP1517|asp1517
47317|NCT02988960|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
47318|NCT02988960|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
47319|NCT02988960|Squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
47320|NCT02988960|Nivolumab|nivolumab
47321|NCT02988960|Cutaneous melanoma|cutaneous melanoma
47322|NCT02988960|Advanced solid tumor|advanced solid tumor
47323|NCT02988960|Cancer|cancer
47325|NCT02988947|Hypnosis|hypnosis
47326|NCT02988947|Pain Neuroscience Education|pain neuroscience education
47327|NCT02988947|Pain|pain
47328|NCT02988947|Catastrophizing|catastrophizing
47329|NCT02988947|Optimism|optimism
47330|NCT02988947|Distress|distress
47331|NCT02988947|Hope|hope
47332|NCT02988947|Self-Efficacy|self-efficacy
47333|NCT02988895|Brachytherapy|brachytherapy
47334|NCT02988895|Wet AMD|wet amd
47335|NCT02988869|COPD|copd
47337|NCT02988869|Formoterol|formoterol
47339|NCT02988830|Subcutaneous stimulation|subcutaneous stimulation
47340|NCT02988804|endoscopic endonasal transsphenoidal surgery|endoscopic endonasal transsphenoidal surgery
47341|NCT02988804|laryngeal mask|laryngeal mask
47342|NCT02988765|vulvar cancer|vulvar cancer
47343|NCT02988765|inguinal lymph node|inguinal lymph node
47344|NCT02988765|lymph node status|lymph node status
47345|NCT02988765|cytology|cytology
47346|NCT02988765|core biopsy|core biopsy
47347|NCT02988726|Neurofibroma|neurofibroma
47348|NCT02988726|Schwannoma|schwannoma
47349|NCT02988713|stimulation|stimulation
47350|NCT02988713|chronic pain|chronic pain
47351|NCT02988713|back pain|back pain
47352|NCT02988713|leg pain|leg pain
47353|NCT02988687|fatigue|fatigue
47354|NCT02988687|quality of life|quality of life
47355|NCT02988687|depression|depression
47356|NCT02988687|cognitive function|cognitive function
47357|NCT02988687|growth hormone|growth hormone
47358|NCT02988687|traumatic brain injury|traumatic brain injury
47359|NCT02988674|Ankylosing spondylitis|ankylosing spondylitis
47360|NCT02988674|Humira®|humira®
47361|NCT02988674|Adalimumab|adalimumab
47362|NCT02988674|Spondylarthritis|spondylarthritis
47363|NCT02988674|Psoriatic arthritis|psoriatic arthritis
47364|NCT02988661|Autoimmunity|autoimmunity
47365|NCT02988661|Immune System Disorders|immune system disorders
47366|NCT02988648|Metastatic Breast Cancer|metastatic breast cancer
47367|NCT02988635|Early Palliative Care|early palliative care
47368|NCT02988635|Simultaneous Care|simultaneous care
47369|NCT02988635|Chemotherapy|chemotherapy
47370|NCT02988635|Quality of Life|quality of life
47371|NCT02988596|Concussion|concussion
47372|NCT02988596|Rehabilitation|rehabilitation
47373|NCT02988583|silicone oil|silicone oil
47374|NCT02988583|emulsification|emulsification
47375|NCT02988583|retinal detachment surgery|retinal detachment surgery
47376|NCT02988557|cerebral palsy|cerebral palsy
47377|NCT02988557|gait|gait
47378|NCT02988557|slope|slope
47379|NCT02988557|electromyography|electromyography
47380|NCT02988531|PET|pet
47381|NCT02988531|MRI|mri
47382|NCT02988531|Attenuation|attenuation
47383|NCT02988531|Correction|correction
47384|NCT02988531|Cardiovascular|cardiovascular
47385|NCT02988531|coronary|coronary
47386|NCT02988531|disease|disease
47387|NCT02988518|Psychiatry|psychiatry
47388|NCT02988518|Bipolar disorder|bipolar disorder
47389|NCT02988518|Memory complaints|memory complaints
47390|NCT02988518|Global functioning|global functioning
47391|NCT02988518|Cognitive remediation|cognitive remediation
47392|NCT02988518|Working memory|working memory
47393|NCT02988466|Acute Leukemias|acute leukemias
47394|NCT02988466|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
583412|NCT00511641|Ovarian Cancer|ovarian cancer
47395|NCT02988466|Acute lymphoblastic leukemia (ALL)/lymphoma|acute lymphoblastic leukemia (all)/lymphoma
47396|NCT02988466|Biphenotypic/Undifferentiated/Prolymphocytic Leukemias|biphenotypic/undifferentiated/prolymphocytic leukemias
47397|NCT02988466|Myelodysplastic syndrome|myelodysplastic syndrome
47398|NCT02988466|Chronic myelogenous leukemia|chronic myelogenous leukemia
47399|NCT02988466|Minimal Residual Disease (MRD) positive leukemia|minimal residual disease (mrd) positive leukemia
47400|NCT02988466|Leukemia or Myelodysplastic Syndromes (MDS) in aplasia|leukemia or myelodysplastic syndromes (mds) in aplasia
47401|NCT02988466|Myeloproliferative neoplasms/myelofibrosis|myeloproliferative neoplasms/myelofibrosis
39058|NCT03041831|obesity|obesity
47402|NCT02988466|Relapsed large-cell lymphoma, mantle-cell lymphoma and Hodgkin lymphoma|relapsed large-cell lymphoma, mantle-cell lymphoma and hodgkin lymphoma
47403|NCT02988466|Burkitt's lymphoma|burkitt's lymphoma
47404|NCT02988466|Relapsed T-cell lymphoma|relapsed t-cell lymphoma
47405|NCT02988466|Natural Killer cell malignancies|natural killer cell malignancies
47406|NCT02988466|Relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), marginal zone B-cell lymphoma, follicular lymphoma|relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma (cll/sll), marginal zone b-cell lymphoma, follicular lymphoma
47407|NCT02988466|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
47408|NCT02988466|Relapsed multiple myeloma|relapsed multiple myeloma
47409|NCT02988466|Bone marrow failure syndromes|bone marrow failure syndromes
47410|NCT02988453|mentalization-based treatment|mentalization-based treatment
47411|NCT02988453|conduct disorder|conduct disorder
47412|NCT02988453|adolescents|adolescents
47414|NCT02988440|Hepatocellular carcinoma|hepatocellular carcinoma
47415|NCT02988440|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
47416|NCT02988440|PDR001|pdr001
47417|NCT02988440|liver cancer|liver cancer
47418|NCT02988440|immunotherapy liver|immunotherapy liver
47419|NCT02988440|malignant hepatoma|malignant hepatoma
47420|NCT02988440|Hepatocellular cancer|hepatocellular cancer
47421|NCT02988440|advanced hepatocellular carcinoma (HCC)|advanced hepatocellular carcinoma (hcc)
47422|NCT02988440|advanced liver cancer|advanced liver cancer
47423|NCT02988440|liver cancer progression|liver cancer progression
47424|NCT02988440|sorafenib|sorafenib
47425|NCT02988440|anti-PD1|anti-pd1
47426|NCT02988440|first line|first line
47427|NCT02988414|Sepsis|sepsis
47428|NCT02988414|Infection|infection
47430|NCT02988414|Sequencing|sequencing
47432|NCT02988414|NGS|ngs
47433|NCT02988375|insomnia|insomnia
47434|NCT02988375|depression|depression
47435|NCT02988375|digital CBTI|digital cbti
47436|NCT02988375|online CBTI|online cbti
47437|NCT02988336|difficult intubation|difficult intubation
47438|NCT02988336|thyromental height|thyromental height
47439|NCT02988323|sport concussion|sport concussion
47440|NCT02988323|cervical spine|cervical spine
47441|NCT02988323|vestibular rehabilitation|vestibular rehabilitation
47442|NCT02988323|exercise|exercise
47443|NCT02988323|rehabilitation|rehabilitation
47444|NCT02988323|children|children
47445|NCT02988323|youth|youth
47446|NCT02988310|Limb Loss|limb loss
47447|NCT02988310|Gait Characteristics|gait characteristics
47448|NCT02988284|Gait variability|gait variability
47449|NCT02988271|Meditation|meditation
47450|NCT02988271|Anxiety|anxiety
47451|NCT02988271|Psychosocial distress|psychosocial distress
47452|NCT02988271|Depression|depression
47453|NCT02988271|Questionnaires|questionnaires
47454|NCT02988271|Surveys|surveys
47455|NCT02988271|Meditation Video|meditation video
47456|NCT02988271|Meditation app|meditation app
47457|NCT02988258|Ex vivo gene therapy|ex vivo gene therapy
47458|NCT02988258|T cell receptor transduction|t cell receptor transduction
47459|NCT02988258|Immunotherapy|immunotherapy
47460|NCT02988258|Allogeneic Haematopoietic Stem Cell Transplantation|allogeneic haematopoietic stem cell transplantation
47461|NCT02988258|CMV|cmv
47462|NCT02988232|Work Related Chronic Low Back Pain|work related chronic low back pain
47463|NCT02988232|Korean Medicine|korean medicine
47464|NCT02988232|Sogyeonghwalhyeol-tang|sogyeonghwalhyeol-tang
47465|NCT02988219|cardiac arrhythmia|cardiac arrhythmia
47466|NCT02988219|epidural anesthesia|epidural anesthesia
47467|NCT02988219|combined anesthesia|combined anesthesia
47468|NCT02988219|general anesthesia|general anesthesia
47469|NCT02988219|NSS|nss
47470|NCT02988219|radical nephrectomy|radical nephrectomy
47471|NCT02988219|extraperitoneal|extraperitoneal
47472|NCT02988193|clinical reasoning artificial intelligence|clinical reasoning artificial intelligence
47473|NCT02988193|poorly controlled hypertension|poorly controlled hypertension
47474|NCT02988167|Spontaneous Breathing Trial (SBT)|spontaneous breathing trial (sbt)
47475|NCT02988167|Extubation Decision Support Tool|extubation decision support tool
47476|NCT02988167|Extubation|extubation
47477|NCT02988167|Extubation Readiness|extubation readiness
47478|NCT02988154|Medical education|medical education
47479|NCT02988154|simulation|simulation
47480|NCT02988154|neurosurgical education|neurosurgical education
47481|NCT02988154|Simulation laboratory|simulation laboratory
47482|NCT02988154|Ventricular drain|ventricular drain
47483|NCT02988128|Embolization Device|embolization device
47484|NCT02988128|Flow Diverter|flow diverter
47485|NCT02988128|Intra saccular device|intra saccular device
47486|NCT02988128|Vascular Reconstruction Device|vascular reconstruction device
47487|NCT02988128|Ruptured Intracranial Aneurysm|ruptured intracranial aneurysm
47488|NCT02988128|Unruptured Intracranial Aneurysm|unruptured intracranial aneurysm
47489|NCT02988115|hyperlipidemia|hyperlipidemia
47490|NCT02988115|cholesterol|cholesterol
47491|NCT02988115|familial hypercholesterolemia|familial hypercholesterolemia
47492|NCT02988115|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
39155|NCT03041142|Obesity|obesity
39156|NCT03041142|Cardiovascular risk factors|cardiovascular risk factors
39159|NCT03041116|PKAN|pkan
47493|NCT02988115|ASCVD|ascvd
47494|NCT02988115|HeFH|hefh
47495|NCT02988115|LDL|ldl
47496|NCT02988115|statin intolerence|statin intolerence
47497|NCT02988102|S100B, NSE|s100b, nse
47498|NCT02988102|moderate brain trauma|moderate brain trauma
47499|NCT02988102|mild brain trauma|mild brain trauma
47500|NCT02988089|Helicobacter Pylori Infection|helicobacter pylori infection
47501|NCT02988089|Antimicrobial susceptibility testing (AST)|antimicrobial susceptibility testing (ast)
47502|NCT02988063|Varithena|varithena
47503|NCT02988063|Polidocanol Endovenous Microfoam|polidocanol endovenous microfoam
47504|NCT02988050|Epilepsy Surgery|epilepsy surgery
47505|NCT02988050|Conscious sedation|conscious sedation
47506|NCT02988011|type 2 diabetes|type 2 diabetes
47507|NCT02988011|gastric by-pass surgery|gastric by-pass surgery
47508|NCT02988011|low calorie diet|low calorie diet
47509|NCT02988011|glucose metabolism|glucose metabolism
47510|NCT02987998|Pembrolizumab|pembrolizumab
47511|NCT02987998|Chemoradiation|chemoradiation
47512|NCT02987985|Opioid-sparing|opioid-sparing
47513|NCT02987985|Opioid-free|opioid-free
47514|NCT02987959|TAK-228|tak-228
47515|NCT02987959|MLN0128|mln0128
47516|NCT02987959|mTOR|mtor
47517|NCT02987933|Chronic Pain|chronic pain
47518|NCT02987933|fMRI|fmri
47519|NCT02987933|DTI|dti
47520|NCT02987894|TAVI|tavi
47521|NCT02987894|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
47522|NCT02987894|Transcatheter Aortic Valve Implant|transcatheter aortic valve implant
47523|NCT02987894|Transfemoral access|transfemoral access
47524|NCT02987894|Aortic valve regurgitation|aortic valve regurgitation
47525|NCT02987868|Somatostatin|somatostatin
49476|NCT02976376|mHealth|mhealth
47526|NCT02987868|Thyroid Hormone|thyroid hormone
47527|NCT02987868|Growth Hormone|growth hormone
47528|NCT02987842|Mild cognitive impairment|mild cognitive impairment
47529|NCT02987842|Alzhiemer's disease|alzhiemer's disease
47530|NCT02987842|Neurofeedback|neurofeedback
47532|NCT02987803|Patient Engagement|patient engagement
47533|NCT02987803|Public Reporting|public reporting
47534|NCT02987803|Quality Measurement|quality measurement
47535|NCT02987790|Intensive care|intensive care
47536|NCT02987790|Sepsis|sepsis
47537|NCT02987790|Biomarkers|biomarkers
47538|NCT02987790|C-reactive Protein|c-reactive protein
47539|NCT02987790|Antimicrobial|antimicrobial
47540|NCT02987790|Systemic infection|systemic infection
47541|NCT02987764|Premature|premature
47542|NCT02987764|Birth weight|birth weight
47543|NCT02987725|Adolescence|adolescence
47544|NCT02987725|Autonomic Nervous System|autonomic nervous system
47545|NCT02987725|Hypnosis|hypnosis
47546|NCT02987725|Pain|pain
47547|NCT02987725|Sickle Cell Disease|sickle cell disease
47548|NCT02987712|Thromboelastography|thromboelastography
47549|NCT02987699|Hepatocellular Carcinoma|hepatocellular carcinoma
47550|NCT02987699|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
47551|NCT02987699|optimal dose|optimal dose
47552|NCT02987686|Topical Infliximab|topical infliximab
47553|NCT02987686|Cornea|cornea
47554|NCT02987686|Keratolysis|keratolysis
47555|NCT02987673|Mini/One anastomosis gastric bypass|mini/one anastomosis gastric bypass
47556|NCT02987673|Sleeve Gastrectomy|sleeve gastrectomy
47557|NCT02987673|Gastro-esophageal sphincter function|gastro-esophageal sphincter function
47558|NCT02987634|gingivitis|gingivitis
47559|NCT02987634|dental implant|dental implant
47560|NCT02987634|mouthwash|mouthwash
47561|NCT02987595|intervention|intervention
47562|NCT02987595|lignans|lignans
47563|NCT02987595|whole-grain|whole-grain
47564|NCT02987582|mental health|mental health
47565|NCT02987582|mindfulness|mindfulness
47566|NCT02987582|shame|shame
47567|NCT02987569|Home Parenteral Nutrition|home parenteral nutrition
47568|NCT02987569|HPN|hpn
47569|NCT02987569|Total Parenteral Nutrition|total parenteral nutrition
47570|NCT02987569|TPN|tpn
47571|NCT02987569|mConnect|mconnect
47572|NCT02987569|SBS|sbs
47573|NCT02987569|short bowel disorder|short bowel disorder
47574|NCT02987569|telehealth|telehealth
47575|NCT02987569|telemedicine|telemedicine
47576|NCT02987543|metastatic castration-resistant prostate cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
47577|NCT02987543|homologous recombination repair (HRR)|homologous recombination repair (hrr)
47578|NCT02987530|primary infection|primary infection
47579|NCT02987517|running|running
47580|NCT02987517|vertical load rates|vertical load rates
47581|NCT02987517|cadence|cadence
47582|NCT02987517|footstrike|footstrike
47583|NCT02987504|Cancer|cancer
47584|NCT02987504|Solid tumor|solid tumor
47585|NCT02987504|Phase 1|phase 1
47586|NCT02987491|exercise|exercise
47587|NCT02987478|Vitamin D following intra cytoplasmic sperm injection|vitamin d following intra cytoplasmic sperm injection
47588|NCT02987452|exercise|exercise
47589|NCT02987452|resistant hypertension|resistant hypertension
47590|NCT02987452|blood pressure|blood pressure
47591|NCT02987439|COPD|copd
47592|NCT02987439|Exacerbation|exacerbation
47593|NCT02987439|Rehabilitation|rehabilitation
47594|NCT02987413|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
47595|NCT02987400|DLBCL|dlbcl
47596|NCT02987400|GA-101|ga-101
47597|NCT02987400|ABT-199|abt-199
47598|NCT02987400|relapsed DLBCL|relapsed dlbcl
47599|NCT02987400|refractory DLBCL|refractory dlbcl
47600|NCT02987400|AGMT|agmt
47601|NCT02987400|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
47602|NCT02987400|window of opportunity|window of opportunity
47603|NCT02987387|Tetralogy of Fallot|tetralogy of fallot
47604|NCT02987387|Aortic Valve Defect/Disease Resulting in Ross Procedure|aortic valve defect/disease resulting in ross procedure
47605|NCT02987387|Transcatheter pulmonary valve implantation|transcatheter pulmonary valve implantation
47606|NCT02987387|Transcatheter pulmonary valve replacement|transcatheter pulmonary valve replacement
47607|NCT02987387|Pulmonary Atresia|pulmonary atresia
47608|NCT02987387|Pulmonary Stenosis|pulmonary stenosis
47609|NCT02987374|Influenza Vaccine|influenza vaccine
47610|NCT02987348|type 2 diabetes|type 2 diabetes
47611|NCT02987309|indirect calorimetry|indirect calorimetry
47612|NCT02987309|method comparison|method comparison
47613|NCT02987296|Colorectal Cancer|colorectal cancer
47614|NCT02987296|Surgery|surgery
47615|NCT02987296|Arginine depletion|arginine depletion
47703|NCT02986685|Rabeprazole|rabeprazole
47616|NCT02987296|Immune system dysfunction|immune system dysfunction
47617|NCT02987296|Arginine Supplementation|arginine supplementation
47618|NCT02987270|mass screen and treat|mass screen and treat
47619|NCT02987270|malaria|malaria
47620|NCT02987270|asymptomatic infections|asymptomatic infections
47621|NCT02987270|transmission reduction|transmission reduction
47622|NCT02987270|infectious reservoir|infectious reservoir
47623|NCT02987270|kenya|kenya
47624|NCT02987257|Therapeutics|therapeutics
47625|NCT02987257|Management|management
47626|NCT02987257|Cyclosporine|cyclosporine
47627|NCT02987257|Etanercept|etanercept
47628|NCT02987257|Supportive Care|supportive care
47629|NCT02987257|Immunopathogenesis|immunopathogenesis
47630|NCT02987257|Genetics|genetics
47631|NCT02987257|Adverse Drug Reaction|adverse drug reaction
47632|NCT02987244|Chidamide, T Cell Non-Hodgkin's Lymphoma|chidamide, t cell non-hodgkin's lymphoma
47633|NCT02987218|POCD|pocd
47634|NCT02987218|subarachnoid hemorrhage|subarachnoid hemorrhage
47635|NCT02987218|Propofol|propofol
47636|NCT02987218|Desflurane|desflurane
47637|NCT02987192|spinal anesthesia|spinal anesthesia
47638|NCT02987192|anticoagulation|anticoagulation
47639|NCT02987192|minimally invasive|minimally invasive
47640|NCT02987192|Cesarean Section|cesarean section
47641|NCT02987192|Maternal|maternal
47642|NCT02987166|immunotherapy|immunotherapy
47643|NCT02987166|pembrolizumab|pembrolizumab
47644|NCT02987166|MK-3475|mk-3475
47645|NCT02987166|High-dose conformal radiation therapy|high-dose conformal radiation therapy
47646|NCT02987166|HDCRT|hdcrt
47647|NCT02987166|advanced solid tumor|advanced solid tumor
47648|NCT02987153|Kyphoplasty|kyphoplasty
47649|NCT02987153|Spinal metastases|spinal metastases
47650|NCT02987153|IORT|iort
47651|NCT02987153|Intraoperative radiation therapy|intraoperative radiation therapy
47652|NCT02987153|Pain management|pain management
47653|NCT02987140|Parkinson's disease|parkinson's disease
47654|NCT02987140|freezing of gait|freezing of gait
47655|NCT02987140|context-dependency|context-dependency
47656|NCT02987140|transcranial magnetic stimulation|transcranial magnetic stimulation
47657|NCT02987140|visual cues|visual cues
47658|NCT02987062|Atrial Fibrillation|atrial fibrillation
47659|NCT02987062|Non-vitamin K Oral Anticoagulants|non-vitamin k oral anticoagulants
47660|NCT02987062|Vitamin K Antagonists|vitamin k antagonists
47661|NCT02987062|ROCKET-AF|rocket-af
47662|NCT02987062|RE-LY|re-ly
47663|NCT02987062|ARISTOTLE|aristotle
47664|NCT02987049|heart disease, cardiac rehabilitation|heart disease, cardiac rehabilitation
47665|NCT02987036|nebulizer technologies, lung mechanics, beta-agonistic drug|nebulizer technologies, lung mechanics, beta-agonistic drug
47666|NCT02987023|infertility, uterus, transplantation|infertility, uterus, transplantation
47667|NCT02986997|epidural anesthesia|epidural anesthesia
47668|NCT02986997|prone position|prone position
47669|NCT02986997|percutaneous nephrolithotomy|percutaneous nephrolithotomy
47670|NCT02986984|Diabetes|diabetes
47671|NCT02986984|Chronic kidney disease|chronic kidney disease
47672|NCT02986984|Progression|progression
47673|NCT02986984|Genomics|genomics
47674|NCT02986984|Transcriptomics|transcriptomics
47675|NCT02986971|Contraceptive implant|contraceptive implant
47676|NCT02986945|Depressive symptoms|depressive symptoms
47677|NCT02986945|resiliency|resiliency
47678|NCT02986945|Health Promotion|health promotion
47679|NCT02986945|minority health|minority health
47680|NCT02986945|text-messaging app|text-messaging app
47681|NCT02986945|participatory technology development|participatory technology development
39350|NCT03039855|Mitral|mitral
39351|NCT03039855|Regurgitation|regurgitation
39352|NCT03039855|Heart valve|heart valve
39353|NCT03039855|Transcatheter|transcatheter
39354|NCT03039855|Transapical|transapical
39355|NCT03039855|Functional|functional
39356|NCT03039855|Degenerative|degenerative
39357|NCT03039855|TMVR|tmvr
39360|NCT03039686|muscular dystrophy|muscular dystrophy
47682|NCT02986932|Blood-Brain Barrier|blood-brain barrier
47683|NCT02986919|Malignant peripheral Nerve Sheath Tumors (MPNST); Neurofibromatosis sarcoma|malignant peripheral nerve sheath tumors (mpnst); neurofibromatosis sarcoma
47684|NCT02986906|ulnar neuropathy at elbow|ulnar neuropathy at elbow
47685|NCT02986906|Dextrose|dextrose
47686|NCT02986906|perineural injection|perineural injection
47687|NCT02986893|Multiple Sclerosis|multiple sclerosis
47688|NCT02986893|Diet|diet
47689|NCT02986893|Clinical Trial|clinical trial
47690|NCT02986854|Meningococcal disease|meningococcal disease
47691|NCT02986854|Booster vaccination|booster vaccination
47692|NCT02986854|Meningitis|meningitis
47693|NCT02986854|Antibody persistence|antibody persistence
47694|NCT02986828|platelet rich plasma|platelet rich plasma
47695|NCT02986828|Hydrodissection|hydrodissection
47696|NCT02986737|TAVI|tavi
47697|NCT02986737|Aortic Stenosis|aortic stenosis
47698|NCT02986737|Transcatether Aortic Valve Implantation|transcatether aortic valve implantation
47699|NCT02986724|Drug therapy|drug therapy
47700|NCT02986698|intrauterine transfusion|intrauterine transfusion
47701|NCT02986698|in utero human stem cell transplantation|in utero human stem cell transplantation
47702|NCT02986685|Refractory reflux esophagitis|refractory reflux esophagitis
47704|NCT02986685|trimebutine maleate|trimebutine maleate
47705|NCT02986672|ADHD|adhd
47706|NCT02986672|omega 3|omega 3
47707|NCT02986672|children|children
47708|NCT02986672|nutrition|nutrition
47709|NCT02986672|MUFA|mufa
47710|NCT02986672|ADD|add
47711|NCT02986672|PUFA|pufa
47712|NCT02986672|Calanus|calanus
47713|NCT02986672|learning difficulties|learning difficulties
47714|NCT02986633|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
47715|NCT02986633|Echocardiography|echocardiography
47716|NCT02986633|Biventricular Pacing|biventricular pacing
47717|NCT02986568|Ontogenetic surgery|ontogenetic surgery
47718|NCT02986568|TMMR|tmmr
47719|NCT02986568|PMMR|pmmr
47720|NCT02986568|LEER|leer
47721|NCT02986555|Stress|stress
47722|NCT02986555|Virtual Reality|virtual reality
47723|NCT02986555|Motion sickness|motion sickness
47724|NCT02986555|Visual Fatigue|visual fatigue
47725|NCT02986555|Biofeedback|biofeedback
47726|NCT02986542|newborns,femoral artery, catheterization|newborns,femoral artery, catheterization
47727|NCT02986490|Mental disorders|mental disorders
47728|NCT02986490|Antipsychotic agents|antipsychotic agents
47729|NCT02986490|Magnesium|magnesium
47730|NCT02986490|Cardiovascular risk factor|cardiovascular risk factor
47731|NCT02986490|Metabolic syndrome|metabolic syndrome
47732|NCT02986464|Virtual reality|virtual reality
47733|NCT02986464|Immersive distraction|immersive distraction
47734|NCT02986464|Virtual world|virtual world
47735|NCT02986464|Virtual environment|virtual environment
47736|NCT02986464|Procedural pain|procedural pain
47737|NCT02986464|Acute pain|acute pain
47738|NCT02986464|Pain Management|pain management
47739|NCT02986464|Children, Child|children, child
47740|NCT02986464|Kid, Kids|kid, kids
47741|NCT02986464|Pediatric, Pediatrics|pediatric, pediatrics
47742|NCT02986464|Young children|young children
47743|NCT02986464|Burns|burns
47744|NCT02986464|Burn injuries|burn injuries
47745|NCT02986464|Burn unit|burn unit
47746|NCT02986464|Hydrotherapy|hydrotherapy
47747|NCT02986464|Burn dressing|burn dressing
47748|NCT02986464|Non-pharmacological|non-pharmacological
47749|NCT02986464|Clinical Research|clinical research
47750|NCT02986464|Nursing Practice|nursing practice
47751|NCT02986438|Cocaine|cocaine
47752|NCT02986438|Addiction|addiction
47753|NCT02986438|rTMS|rtms
47754|NCT02986438|fMRI|fmri
47755|NCT02986425|Drug Utilization Review|drug utilization review
47756|NCT02986425|Older people|older people
47757|NCT02986399|fast track|fast track
47758|NCT02986386|Dental Occlusion|dental occlusion
47759|NCT02986386|Oral Health|oral health
47760|NCT02986386|Mastication|mastication
47761|NCT02986386|Dementia|dementia
47762|NCT02986386|Psychological health|psychological health
47763|NCT02986373|ABBV-066|abbv-066
47764|NCT02986373|BI655066|bi655066
47765|NCT02986373|risankizumab|risankizumab
47766|NCT02986334|chronic|chronic
53722|NCT02950051|CLL|cll
47767|NCT02986334|low back|low back
47768|NCT02986334|back|back
47769|NCT02986334|pain|pain
47770|NCT02986334|brain|brain
47771|NCT02986334|MRI|mri
47772|NCT02986321|anti-inflammatory respiratory drug|anti-inflammatory respiratory drug
47773|NCT02986321|PDE4 inhibitor|pde4 inhibitor
47774|NCT02986308|Metabolomics|metabolomics
47775|NCT02986308|Intestinal Polyps|intestinal polyps
47776|NCT02986308|TCM Syndromes|tcm syndromes
47777|NCT02986308|TCM Constitution Types|tcm constitution types
583401|NCT00511615|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
47778|NCT02986295|BioMime, Ultimaster, Ischemic heart disease, DES|biomime, ultimaster, ischemic heart disease, des
47779|NCT02986282|ankle - brachial index|ankle - brachial index
47780|NCT02986269|Respiratory Function|respiratory function
47781|NCT02986269|Patient Positioning|patient positioning
47782|NCT02986269|anesthesia|anesthesia
47783|NCT02986256|telemedicine|telemedicine
47784|NCT02986230|Cancer prevention|cancer prevention
47785|NCT02986230|Clinical Decision Support|clinical decision support
47786|NCT02986230|Rural Health|rural health
47787|NCT02986230|Shared Decision Making|shared decision making
47788|NCT02986204|implant removal|implant removal
47789|NCT02986204|Nexplanon|nexplanon
47790|NCT02986204|Implanon|implanon
47791|NCT02986204|contraception|contraception
47792|NCT02986204|ENG|eng
47793|NCT02986191|gingival graft|gingival graft
47794|NCT02986191|free gingival graft|free gingival graft
47795|NCT02986191|coronally advanced flap|coronally advanced flap
47796|NCT02986191|reduced keratinized gingiva|reduced keratinized gingiva
47797|NCT02986178|Glioblastoma|glioblastoma
47798|NCT02986178|Glioma|glioma
47799|NCT02986178|PVSRIPO|pvsripo
47800|NCT02986178|Duke|duke
47801|NCT02986178|Pro00077024|pro00077024
47802|NCT02986178|Peters|peters
47803|NCT02986178|Brain tumor|brain tumor
47804|NCT02986178|Bigner|bigner
47805|NCT02986165|Platelet Aggregation|platelet aggregation
47806|NCT02986152|PTSD|ptsd
47807|NCT02986152|anxiety|anxiety
47808|NCT02986152|depression|depression
47809|NCT02986152|distress|distress
47810|NCT02986152|fear|fear
47811|NCT02986152|coping|coping
47812|NCT02986152|support|support
47813|NCT02986152|caregiver|caregiver
47814|NCT02986152|oncology|oncology
47815|NCT02986152|app|app
47816|NCT02986152|mobile app|mobile app
47817|NCT02986126|Depression|depression
47818|NCT02986126|Resilience|resilience
47819|NCT02986126|Minority health|minority health
47820|NCT02986126|Community-based participatory research|community-based participatory research
47821|NCT02986126|Lesbian, gay, bisexual, transgender, and intersex (LGBTI) health|lesbian, gay, bisexual, transgender, and intersex (lgbti) health
47822|NCT02986126|Racial / ethnic health disparities|racial / ethnic health disparities
47823|NCT02986126|Patient-centered outcomes research|patient-centered outcomes research
47824|NCT02986126|Comparative-effectiveness research|comparative-effectiveness research
47825|NCT02986100|rucaparib|rucaparib
47826|NCT02986100|CO-338|co-338
47827|NCT02986100|Clovis|clovis
47828|NCT02986100|Clovis Oncology|clovis oncology
47829|NCT02986100|PARP inhibitor|parp inhibitor
47830|NCT02986100|Absorption|absorption
47831|NCT02986100|Metabolism|metabolism
47832|NCT02986100|Excretion|excretion
47833|NCT02986048|proton beam|proton beam
47834|NCT02986048|registry|registry
47835|NCT02986048|radiation|radiation
47836|NCT02986048|cancer|cancer
47837|NCT02986022|Self-efficacy|self-efficacy
47838|NCT02986022|optimism|optimism
47839|NCT02986022|altruism|altruism
47840|NCT02986022|goal setting|goal setting
47841|NCT02986009|emotion management|emotion management
47842|NCT02986009|positive and negative affect|positive and negative affect
47843|NCT02986009|satisfaction with parent-child relationship|satisfaction with parent-child relationship
47844|NCT02986009|subjective happiness|subjective happiness
47845|NCT02986009|family harmony|family harmony
47846|NCT02985996|Preventative Medicine|preventative medicine
47847|NCT02985996|Infectious Diseases|infectious diseases
47848|NCT02985996|Sexually Transmitted Diseases|sexually transmitted diseases
47849|NCT02985983|Brodalumab|brodalumab
47850|NCT02985983|KHK4827|khk4827
47851|NCT02985983|Axial Spondyloarthritis|axial spondyloarthritis
47852|NCT02985970|crush induction, RSI|crush induction, rsi
47853|NCT02985944|colorectal cancer|colorectal cancer
47854|NCT02985944|Colon polyp|colon polyp
47855|NCT02985944|Colonoscopy|colonoscopy
47856|NCT02985944|Adenoma detection rate|adenoma detection rate
47857|NCT02985905|Zinc supplementation|zinc supplementation
47858|NCT02985905|Thiol|thiol
47859|NCT02985905|Glutathione peroxidase|glutathione peroxidase
47860|NCT02985905|Sulfhydryl oxidase|sulfhydryl oxidase
47861|NCT02985892|Physical therapy|physical therapy
47862|NCT02985892|Muscle Stretching Exercises|muscle stretching exercises
47863|NCT02985892|Low Back pain|low back pain
47864|NCT02985879|tauopathy|tauopathy
402903|NCT01229202|trabeculectomy|trabeculectomy
53826|NCT02949427|Virome|virome
39615|NCT03038061|EIT|eit
47865|NCT02985879|Steele-Richardson-Olszewski syndrome|steele-richardson-olszewski syndrome
47866|NCT02985879|PSP|psp
47867|NCT02985866|Artificial Pancreas|artificial pancreas
47868|NCT02985866|Closed Loop Control|closed loop control
47869|NCT02985866|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
47870|NCT02985840|ondansetron|ondansetron
47871|NCT02985840|dexamethasone|dexamethasone
47872|NCT02985814|COPD Asthma Overlap|copd asthma overlap
47873|NCT02985775|CMV-specific T cell|cmv-specific t cell
47874|NCT02985775|haploidentical stem cell transplantation|haploidentical stem cell transplantation
47875|NCT02985775|immunologic response|immunologic response
47876|NCT02985775|acute GVHD|acute gvhd
47877|NCT02985762|bupivacaine|bupivacaine
47878|NCT02985762|exparel|exparel
47879|NCT02985762|analgesic|analgesic
47880|NCT02985762|lumbar spine|lumbar spine
47881|NCT02985749|Autism Spectrum Disorders|autism spectrum disorders
47882|NCT02985749|Pervasive Developmental Disorder|pervasive developmental disorder
47883|NCT02985749|ASD|asd
47884|NCT02985749|PDD|pdd
47885|NCT02985749|Oxytocin|oxytocin
47886|NCT02985749|Syntocinon|syntocinon
47887|NCT02985749|Social Impairment|social impairment
47888|NCT02985749|Treatment|treatment
47889|NCT02985671|Postural Low Back Pain|postural low back pain
47890|NCT02985671|Mechanical Low Back Pain|mechanical low back pain
47891|NCT02985671|Low Back Pain|low back pain
47892|NCT02985671|acetaminophen|acetaminophen
47893|NCT02985671|caffeine|caffeine
47894|NCT02985671|orphenadrine|orphenadrine
47895|NCT02985671|diclofenac sodium|diclofenac sodium
47896|NCT02985645|CGF|cgf
47897|NCT02985645|sinus augmentation|sinus augmentation
47898|NCT02985645|DIVA|diva
47899|NCT02985645|Platelet-Rich Plasma|platelet-rich plasma
47900|NCT02985554|hematologic malignancies|hematologic malignancies
47901|NCT02985554|allogeneic stem cell transplantation (allo-SCT)|allogeneic stem cell transplantation (allo-sct)
47902|NCT02985541|Birth Control|birth control
47903|NCT02985541|Heavy menstrual bleeding|heavy menstrual bleeding
47904|NCT02985515|Anosmia|anosmia
47905|NCT02985515|Olfactory Neuroplasticity|olfactory neuroplasticity
48190|NCT02983578|Durvalumab|durvalumab
47906|NCT02985515|Intranasal Steroid Irrigation|intranasal steroid irrigation
47907|NCT02985502|Quality of Life|quality of life
47908|NCT02985502|Diabetes Mellitus|diabetes mellitus
47909|NCT02985502|Pancreatectomy|pancreatectomy
47910|NCT02985476|Electronic health records|electronic health records
47911|NCT02985476|Health records personal|health records personal
47912|NCT02985437|wound healing|wound healing
47913|NCT02985437|Bovine Lung Surfactant|bovine lung surfactant
47914|NCT02985437|SATOSU|satosu
47915|NCT02985385|Congenital Lethal Malformations|congenital lethal malformations
47916|NCT02985359|Program impact evaluation|program impact evaluation
47917|NCT02985359|Malawi|malawi
47918|NCT02985359|Lipid-based nutrient supplements|lipid-based nutrient supplements
47919|NCT02985359|Social behavior change communication|social behavior change communication
47920|NCT02985359|Childhood stunting|childhood stunting
47921|NCT02985346|Idiopathic pulmonary hemosiderosis|idiopathic pulmonary hemosiderosis
47922|NCT02985346|Bone marrow mesenchymal stem cells|bone marrow mesenchymal stem cells
47923|NCT02985333|paclitaxe,cyclophosphamide,dexamethasone, Multiple Myeloma|paclitaxe,cyclophosphamide,dexamethasone, multiple myeloma
47924|NCT02985320|Sabin strain|sabin strain
47925|NCT02985320|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
47926|NCT02985320|poliomyelitis|poliomyelitis
47928|NCT02985320|immunogenicity|immunogenicity
47929|NCT02985320|infant|infant
47930|NCT02985294|Neuropathic pain|neuropathic pain
47931|NCT02985294|Quantitative Sensory Testing|quantitative sensory testing
47932|NCT02985294|Multiple Excitability Measures|multiple excitability measures
47933|NCT02985294|Threshold Tracking|threshold tracking
47934|NCT02985281|direct acting antiviral drugs, chronic hepatitis C virus infection|direct acting antiviral drugs, chronic hepatitis c virus infection
47935|NCT02985268|MitraClip|mitraclip
47936|NCT02985268|Cardiovascular resynchronization therapy|cardiovascular resynchronization therapy
47937|NCT02985268|Six minute walk test|six minute walk test
47938|NCT02985268|Mitral regurgitation|mitral regurgitation
47939|NCT02985268|CRT-D|crt-d
47940|NCT02985255|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
47941|NCT02985255|Tongue Malignancy|tongue malignancy
47942|NCT02985255|Squamous Cell Carcinoma|squamous cell carcinoma
47943|NCT02985203|lung cancer|lung cancer
47944|NCT02985203|vinorelbine|vinorelbine
47945|NCT02985203|metronomic chemotherapy|metronomic chemotherapy
47946|NCT02985190|Azacitidine|azacitidine
47947|NCT02985190|MDS|mds
47948|NCT02985190|Systemic auto-immune and inflammatory disorders|systemic auto-immune and inflammatory disorders
47949|NCT02985177|Children|children
47950|NCT02985177|Musculoskeletal injury|musculoskeletal injury
47951|NCT02985177|Emergency department|emergency department
47952|NCT02985177|Analgesia|analgesia
47953|NCT02985177|Opioids|opioids
47954|NCT02985164|Anesthesiology( H02.403.066 )|anesthesiology( h02.403.066 )
39640|NCT03037827|endovenous laser ablation|endovenous laser ablation
39641|NCT03037827|radial fiber|radial fiber
39642|NCT03037827|linear endovenous energy density|linear endovenous energy density
47955|NCT02985164|Radiation Protection( N06.850.810.425)|radiation protection( n06.850.810.425)
47956|NCT02985164|Cholangiopancreatography, Endoscopic Retrograde(D002760 )|cholangiopancreatography, endoscopic retrograde(d002760 )
47957|NCT02985151|Scar|scar
47958|NCT02985151|Carbon Dioxide Laser|carbon dioxide laser
47959|NCT02985151|Laser Ablation|laser ablation
47960|NCT02985125|Pancreas|pancreas
47961|NCT02985125|5-FU|5-fu
47962|NCT02985125|Gemcitabine|gemcitabine
47963|NCT02985125|LEE011|lee011
47964|NCT02985125|Everolimus|everolimus
47965|NCT02985125|Refractory|refractory
47966|NCT02985125|Chemotherapy|chemotherapy
401962|NCT01232582|Lower back pain, Facets joints Osteoarthritis|lower back pain, facets joints osteoarthritis
623672|NCT00675649|Injections|injections
47967|NCT02985086|term premature rupture of membranes, antibiotic prophylaxis, chorioamnionitis, endometritis, neonatal infection|term premature rupture of membranes, antibiotic prophylaxis, chorioamnionitis, endometritis, neonatal infection
47968|NCT02985060|Therapeutic hypothermia|therapeutic hypothermia
47969|NCT02985047|Brief admission|brief admission
47970|NCT02985047|admission|admission
47971|NCT02985047|deliberate self-harm|deliberate self-harm
47972|NCT02985047|self-harm|self-harm
47973|NCT02985034|HCC|hcc
47974|NCT02985034|RFA|rfa
47975|NCT02985034|Liver tumor|liver tumor
47976|NCT02985008|Shock, IVBP, ECMO, In hospital death|shock, ivbp, ecmo, in hospital death
47977|NCT02984995|FLT3-ITD|flt3-itd
47978|NCT02984995|Positive refractory or relapsed acute myeloid leukemia|positive refractory or relapsed acute myeloid leukemia
47979|NCT02984995|Hematology malignancy|hematology malignancy
47980|NCT02984995|Developmental Phase II|developmental phase ii
47981|NCT02984956|Hypotension|hypotension
47982|NCT02984956|Pleth variability index|pleth variability index
47983|NCT02984956|Hip Fracture|hip fracture
47984|NCT02984956|Spinal anesthesia|spinal anesthesia
47985|NCT02984943|Rheumatoid Arthritis|rheumatoid arthritis
47986|NCT02984943|Hyperbaric Oxygen|hyperbaric oxygen
47987|NCT02984917|anterior transversalis fascia repair; preperitoneal repair|anterior transversalis fascia repair; preperitoneal repair
47988|NCT02984904|Fusarium Infection|fusarium infection
47989|NCT02984904|Corneal ulcer|corneal ulcer
47990|NCT02984904|Spain|spain
47991|NCT02984904|Epidemiology|epidemiology
47992|NCT02984891|Intravascular ultrasound|intravascular ultrasound
47993|NCT02984891|Optical coherence tomography|optical coherence tomography
47994|NCT02984865|transversus plane block|transversus plane block
47995|NCT02984865|opioid|opioid
47996|NCT02984865|nalbuphine|nalbuphine
47997|NCT02984865|gastrointestinal surgery|gastrointestinal surgery
47998|NCT02984865|elderly patient|elderly patient
47999|NCT02984839|intra-abdominal surgery|intra-abdominal surgery
48000|NCT02984839|neuromuscular blocking agent|neuromuscular blocking agent
48001|NCT02984839|post-anesthesia care unit|post-anesthesia care unit
48002|NCT02984787|Gastric Cancer|gastric cancer
48003|NCT02984787|3D|3d
48004|NCT02984787|2D|2d
48005|NCT02984774|Endometriosis|endometriosis
48006|NCT02984774|Infertility|infertility
48007|NCT02984774|Telomerase activity|telomerase activity
48008|NCT02984761|Carcinoma, Non-Small Cell Lung|carcinoma, non-small cell lung
48009|NCT02984761|Respiratory Tract Neoplasms|respiratory tract neoplasms
48010|NCT02984761|Thoracic Neoplasms|thoracic neoplasms
48011|NCT02984761|Neoplasms by Site|neoplasms by site
48012|NCT02984761|Neoplasms|neoplasms
48013|NCT02984761|Lung Diseases|lung diseases
48014|NCT02984761|Respiratory Tract Diseases|respiratory tract diseases
48015|NCT02984761|Carcinoma, Bronchogenic|carcinoma, bronchogenic
48016|NCT02984761|Bronchial Neoplasms|bronchial neoplasms
48017|NCT02984761|Radiosurgery|radiosurgery
48018|NCT02984761|Radiotherapy|radiotherapy
48019|NCT02984761|Radiotherapy, Image-Guided|radiotherapy, image-guided
48020|NCT02984761|Lung Neoplasms|lung neoplasms
48021|NCT02984748|cochlear implants|cochlear implants
48022|NCT02984748|hearing loss|hearing loss
48023|NCT02984735|chewing|chewing
48024|NCT02984735|cerebral palsy|cerebral palsy
48025|NCT02984735|chewing disorders|chewing disorders
48026|NCT02984735|gross motor function|gross motor function
48027|NCT02984722|PCOS|pcos
48028|NCT02984722|metformin|metformin
48029|NCT02984670|Cognitive therapy|cognitive therapy
48030|NCT02984670|Behavior therapy|behavior therapy
48031|NCT02984670|Moderation|moderation
48032|NCT02984670|Mediation|mediation
48033|NCT02984657|Hypoxemia|hypoxemia
48034|NCT02984657|Reverse Trendelenburg|reverse trendelenburg
48035|NCT02984592|premature ejaculation|premature ejaculation
48036|NCT02984592|intravaginal ejaculatory latency time|intravaginal ejaculatory latency time
48037|NCT02984592|premature ejaculation diagnostic tools|premature ejaculation diagnostic tools
48038|NCT02984566|Primary liver cancer|primary liver cancer
48039|NCT02984566|Secondary liver cancer|secondary liver cancer
48040|NCT02984566|Kilovoltage Intrafraction Monitoring|kilovoltage intrafraction monitoring
48041|NCT02984566|Stereotactic Ablative Body Radiation|stereotactic ablative body radiation
48042|NCT02984553|accelerometry|accelerometry
48043|NCT02984553|aerobic fitness|aerobic fitness
48044|NCT02984553|metabolic thresholds|metabolic thresholds
48045|NCT02984553|moderate to vigorous physical activity|moderate to vigorous physical activity
48046|NCT02984501|radiochemotherapy|radiochemotherapy
48047|NCT02984501|neoadjuvant therapy|neoadjuvant therapy
48048|NCT02984488|necrotic teeth|necrotic teeth
48049|NCT02984488|single visit|single visit
48050|NCT02984488|multiple visits|multiple visits
48051|NCT02984488|protaper next|protaper next
48052|NCT02984475|Beta Thalassemia|beta thalassemia
48053|NCT02984475|Metformin|metformin
48054|NCT02984475|Oxidative stress|oxidative stress
48055|NCT02984475|Iron overload|iron overload
48056|NCT02984475|Liver function|liver function
48057|NCT02984462|percutaneous|percutaneous
48058|NCT02984462|non-fixed|non-fixed
48059|NCT02984462|Akin ;|akin ;
48060|NCT02984462|osteotomy|osteotomy
48061|NCT02984449|cardiac rehabilitation|cardiac rehabilitation
48062|NCT02984449|surgical complications|surgical complications
48063|NCT02984449|quality of life|quality of life
48064|NCT02984449|preoperative|preoperative
48065|NCT02984449|cardiac surgery|cardiac surgery
48066|NCT02984423|Ovarian Cancer|ovarian cancer
48067|NCT02984423|BRCA mutations|brca mutations
48068|NCT02984410|T1-T2, N0 oropharyngeal carcinoma|t1-t2, n0 oropharyngeal carcinoma
48070|NCT02984397|ketotifen|ketotifen
48071|NCT02984397|pediatric|pediatric
48072|NCT02984397|mast cell|mast cell
48073|NCT02984384|Trauma|trauma
48074|NCT02984384|Blood clot|blood clot
48075|NCT02984384|Venous Thromboembolism|venous thromboembolism
48076|NCT02984384|Pulmonary Embolism|pulmonary embolism
48077|NCT02984384|Deep Vein Thrombosis|deep vein thrombosis
48078|NCT02984384|Thromboprophylaxis|thromboprophylaxis
48079|NCT02984384|Blood clot prevention|blood clot prevention
48080|NCT02984384|trauma patients|trauma patients
48081|NCT02984371|atrial fibrillation|atrial fibrillation
48082|NCT02984371|ganglionated plexi|ganglionated plexi
48083|NCT02984371|ischemic heart disease|ischemic heart disease
48084|NCT02984293|Atorvastatin|atorvastatin
48085|NCT02984293|LILRB5|lilrb5
48086|NCT02984293|Statin intolerance|statin intolerance
48087|NCT02984254|knee|knee
48088|NCT02984254|knee osteoarthritis|knee osteoarthritis
48089|NCT02984254|Bracing|bracing
48191|NCT02983565|Long-term oxygen therapy|long-term oxygen therapy
48090|NCT02984254|patellofemoral osteoarthritis|patellofemoral osteoarthritis
48091|NCT02984189|Physical Exercise|physical exercise
48092|NCT02984189|Physical Therapy|physical therapy
48093|NCT02984189|Physical Performance|physical performance
48094|NCT02984189|Critical Power|critical power
48095|NCT02984189|Respiratory Muscle|respiratory muscle
48096|NCT02984176|Simethicone|simethicone
48097|NCT02984176|Laparoscopies|laparoscopies
48098|NCT02984176|Pain|pain
48099|NCT02984163|cancer|cancer
48100|NCT02984163|exercise|exercise
48101|NCT02984137|Lewy body disease|lewy body disease
48102|NCT02984137|REM Sleep Behavior Disorder|rem sleep behavior disorder
48103|NCT02984137|Parkinson disease|parkinson disease
48104|NCT02984137|Imaging|imaging
48105|NCT02984137|Bio-markers|bio-markers
48106|NCT02984137|Prospective cohort|prospective cohort
48107|NCT02984111|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
48108|NCT02984111|Erythropoietin|erythropoietin
48109|NCT02984111|Cardioprotective|cardioprotective
48110|NCT02984098|procedural pain, 40% Dextrose, heel lance|procedural pain, 40% dextrose, heel lance
48111|NCT02984085|RDEB|rdeb
48112|NCT02984085|Stem cells|stem cells
48113|NCT02984085|Gene therapy|gene therapy
48114|NCT02984046|Acute bronchiolitis|acute bronchiolitis
48115|NCT02984046|RSV|rsv
48116|NCT02984046|CC16|cc16
48117|NCT02984046|SP-D|sp-d
48118|NCT02984046|sRAGE|srage
48119|NCT02984046|Severity|severity
48120|NCT02984046|Biomarkers|biomarkers
48121|NCT02983994|asthma, devices|asthma, devices
48122|NCT02983968|Oncology|oncology
48123|NCT02983968|Hepatology|hepatology
48124|NCT02983968|Public Health|public health
48125|NCT02983968|Liver|liver
48126|NCT02983942|ketogenic diet|ketogenic diet
48127|NCT02983942|Primary Central Nervous System Lymphoma|primary central nervous system lymphoma
48128|NCT02983942|chemotherapy|chemotherapy
48129|NCT02983916|Adhesions|adhesions
48130|NCT02983916|Adhesiolysis|adhesiolysis
48131|NCT02983916|chronic pain|chronic pain
48132|NCT02983916|post-operative complications|post-operative complications
48133|NCT02983916|anti-adhesion barrier|anti-adhesion barrier
48134|NCT02983916|cine-MRI|cine-mri
48135|NCT02983916|shared decision making|shared decision making
48136|NCT02983851|Noninvasive mechanical ventilation|noninvasive mechanical ventilation
48137|NCT02983851|Invasive mechanical ventilation|invasive mechanical ventilation
48138|NCT02983838|Amyloid|amyloid
48139|NCT02983838|BDNF|bdnf
48140|NCT02983838|major depressive disorder|major depressive disorder
48141|NCT02983838|cognitive decline|cognitive decline
48142|NCT02983825|CPAP|cpap
48143|NCT02983825|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
48144|NCT02983825|Ventilator Induced Lung Injury|ventilator induced lung injury
48145|NCT02983825|V/Q mismatch|v/q mismatch
48146|NCT02983799|BRCA, ovarian, platinum, chemotherapy|brca, ovarian, platinum, chemotherapy
48147|NCT02983760|Pulmonary embolism|pulmonary embolism
48148|NCT02983747|Platelet Rich Plasma|platelet rich plasma
48149|NCT02983747|Intervertebral Disk Injection Therapy|intervertebral disk injection therapy
48150|NCT02983747|Low Back Pain|low back pain
48151|NCT02983747|Ultrasound Guided|ultrasound guided
48152|NCT02983747|Degenerative Spinal Disease|degenerative spinal disease
48153|NCT02983734|Gulf War|gulf war
48154|NCT02983734|D-cycloserine|d-cycloserine
48155|NCT02983734|Neuroinflammation|neuroinflammation
48156|NCT02983734|Cognition|cognition
48157|NCT02983734|Memory|memory
48158|NCT02983708|Neuroregeneration|neuroregeneration
48159|NCT02983708|G-CSF|g-csf
48160|NCT02983708|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
48161|NCT02983708|Cerebral palsy|cerebral palsy
48162|NCT02983682|Anesthetics, Local|anesthetics, local
48163|NCT02983682|Lidocaine|lidocaine
48164|NCT02983682|Pediatrics|pediatrics
48165|NCT02983682|Children|children
48166|NCT02983682|Adolescents|adolescents
48167|NCT02983669|Thymus Plant|thymus plant
48168|NCT02983669|Multiflotriol [Supplementary Concept]|multiflotriol [supplementary concept]
48169|NCT02983669|Zataria multiflora|zataria multiflora
48170|NCT02983669|Complementary Therapies|complementary therapies
48171|NCT02983669|Herbal Medicine|herbal medicine
48172|NCT02983669|Medicine, traditional|medicine, traditional
48173|NCT02983656|Vaccine Safety|vaccine safety
48174|NCT02983643|Skeletal Muscle Index|skeletal muscle index
48175|NCT02983643|Visceral Adipose Tissue|visceral adipose tissue
48176|NCT02983643|Metabolic Syndrome|metabolic syndrome
48177|NCT02983604|Exemestane|exemestane
48178|NCT02983604|Aromasin|aromasin
48179|NCT02983604|Fulvestrant|fulvestrant
48180|NCT02983604|Faslodex|faslodex
48181|NCT02983604|Breast Cancer,|breast cancer,
48182|NCT02983604|HER 2-|her 2-
48183|NCT02983604|Estrogen receptor positive|estrogen receptor positive
48184|NCT02983578|Pancreatic cancer|pancreatic cancer
48185|NCT02983578|Mismatch deficient colorectal cancer|mismatch deficient colorectal cancer
48186|NCT02983578|Non-small cell lung cancer|non-small cell lung cancer
48187|NCT02983578|NSCLC|nsclc
48188|NCT02983578|AZD9150|azd9150
48189|NCT02983578|MEDI4736|medi4736
48192|NCT02983565|Intelligent oxygen therapy system|intelligent oxygen therapy system
48193|NCT02983565|Auto-titrating oxygen system|auto-titrating oxygen system
48194|NCT02983552|Amblyopia|amblyopia
48195|NCT02983539|sarcomas|sarcomas
48196|NCT02983539|immunocytochemistry|immunocytochemistry
48197|NCT02983539|circulating tumor cells|circulating tumor cells
48198|NCT02983526|short stem|short stem
48199|NCT02983513|Early intervention|early intervention
48200|NCT02983513|Brain Development|brain development
48201|NCT02983513|Neurodevelopment|neurodevelopment
48202|NCT02983500|Patient Reported Outcome (PRO)|patient reported outcome (pro)
48203|NCT02983487|Bordetella Pertussis|bordetella pertussis
48204|NCT02983487|Whooping Cough|whooping cough
48205|NCT02983487|vaccine|vaccine
48206|NCT02983461|urinary incontinence|urinary incontinence
48207|NCT02983461|pelvic floor dysfunction|pelvic floor dysfunction
48208|NCT02983435|Osteopathic Treatment|osteopathic treatment
48209|NCT02983435|Postural control|postural control
48210|NCT02983435|Neuromuscular activation|neuromuscular activation
48211|NCT02983435|Physiotherapy|physiotherapy
48212|NCT02983409|computerized tomography|computerized tomography
48213|NCT02983409|Urinary Calculi|urinary calculi
48214|NCT02983409|Patient admission|patient admission
48215|NCT02983409|Pain|pain
48216|NCT02983396|RELF method|relf method
48217|NCT02983396|Medical device|medical device
48218|NCT02983396|Admission delay|admission delay
48219|NCT02983383|Varicocele|varicocele
48220|NCT02983383|TAP block|tap block
48221|NCT02983383|spinal anesthesia|spinal anesthesia
48222|NCT02983357|Shoulder Arthroplasty|shoulder arthroplasty
48223|NCT02983357|glenohumeral arthritis|glenohumeral arthritis
48224|NCT02983344|fascia iliaca compartment block|fascia iliaca compartment block
48225|NCT02983344|fentanyl|fentanyl
48226|NCT02983266|Hyperadrenergia|hyperadrenergia
48227|NCT02983266|Inflammatory stress|inflammatory stress
48228|NCT02983214|Cilostazol|cilostazol
48229|NCT02983214|Clopidogrel|clopidogrel
48230|NCT02983214|Peripheral Artery Disease|peripheral artery disease
48231|NCT02983201|Orthopedic Pain Syndromes|orthopedic pain syndromes
48232|NCT02983201|Thumbtack Intra-dermal Needle|thumbtack intra-dermal needle
48233|NCT02983201|Filiform needle|filiform needle
48234|NCT02983201|Acupuncture|acupuncture
48235|NCT02983188|Schizophrenia|schizophrenia
48236|NCT02983188|Berberine|berberine
48237|NCT02983188|Metabolic Syndrome|metabolic syndrome
48238|NCT02983188|Chinese medicine|chinese medicine
48239|NCT02983188|Herbal medicine|herbal medicine
48240|NCT02983175|ultrasonogaphy|ultrasonogaphy
48241|NCT02983175|full stomach|full stomach
48242|NCT02983175|pulmonary aspiration|pulmonary aspiration
48243|NCT02983175|anaesthesia|anaesthesia
48244|NCT02983136|Hand Hygiene|hand hygiene
48245|NCT02983136|Implementation|implementation
48246|NCT02983136|Partnership|partnership
48247|NCT02983136|Surgery|surgery
48248|NCT02983123|Acute MI|acute mi
48249|NCT02983123|Acute myocardial infarction cardiac troponin|acute myocardial infarction cardiac troponin
48250|NCT02983123|High-sensitivity cardiac troponin T|high-sensitivity cardiac troponin t
48251|NCT02983123|0/1-hour algorithm|0/1-hour algorithm
48252|NCT02983123|Outpatient clinic|outpatient clinic
48253|NCT02983123|Cardiac troponin|cardiac troponin
48254|NCT02983123|Chest pain|chest pain
48255|NCT02983110|Hormones, Transgender|hormones, transgender
48256|NCT02983097|lymphoma|lymphoma
48257|NCT02983097|relapse|relapse
48258|NCT02983097|recurrence|recurrence
48259|NCT02983097|progress|progress
48260|NCT02983097|progressive|progressive
48261|NCT02983097|b-cell lymphoma|b-cell lymphoma
48262|NCT02983097|chemotherapy|chemotherapy
48263|NCT02983097|immunotherapy|immunotherapy
48264|NCT02983097|IMiD|imid
48265|NCT02983097|Salvage chemotherapy|salvage chemotherapy
48266|NCT02983097|peripheral stem cell mobilization|peripheral stem cell mobilization
48267|NCT02983097|lenalidomide|lenalidomide
48268|NCT02983097|Rituximab|rituximab
48269|NCT02983097|CD20|cd20
48270|NCT02983097|Cytarabine|cytarabine
48271|NCT02983097|Ara-C|ara-c
48272|NCT02983097|platinum-based chemotherapy|platinum-based chemotherapy
48273|NCT02983097|Cisplatin|cisplatin
48274|NCT02983097|Carboplatin|carboplatin
48275|NCT02983097|Cisplatinum|cisplatinum
48276|NCT02983097|Carboplatinum|carboplatinum
48277|NCT02983097|Dexamethasone|dexamethasone
48278|NCT02983084|Orthodontic wires|orthodontic wires
48279|NCT02983084|Root resorption|root resorption
48280|NCT02983071|Breast Cancer|breast cancer
48281|NCT02983071|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
48282|NCT02983071|HER2-Negative|her2-negative
48283|NCT02983071|HR-Positive|hr-positive
48285|NCT02983071|HER2-|her2-
48286|NCT02983071|HER2 -ve|her2 -ve
48287|NCT02983071|HER2 +ve|her2 +ve
48288|NCT02983032|Caregivers|caregivers
48289|NCT02983032|Insomnia|insomnia
48290|NCT02983019|influenza|influenza
48291|NCT02983019|flu|flu
48292|NCT02983019|acute respiratory viral infection|acute respiratory viral infection
48293|NCT02983019|ARVI|arvi
48294|NCT02983019|acute upper respiratory infection|acute upper respiratory infection
48295|NCT02983019|AURI|auri
48296|NCT02983006|TRAIL-DR5|trail-dr5
48297|NCT02983006|DS-8273a|ds-8273a
48298|NCT02983006|Immunoglobulin gamma-1 (IgG1)|immunoglobulin gamma-1 (igg1)
48299|NCT02983006|Cell mediated cytotoxicity (ADCC)|cell mediated cytotoxicity (adcc)
48300|NCT02983006|Complement dependent cytotoxicity (CDC)|complement dependent cytotoxicity (cdc)
48301|NCT02983006|DR5|dr5
48302|NCT02983006|Immunoglobulin G4 (IgG4)|immunoglobulin g4 (igg4)
48303|NCT02983006|Monoclonal antibody|monoclonal antibody
48304|NCT02983006|Programmed Cell Death 1 (PD-1)|programmed cell death 1 (pd-1)
48305|NCT02982993|hepatitis C virus|hepatitis c virus
48306|NCT02982993|linkage-to-care|linkage-to-care
48307|NCT02982993|World Trade Center Health Program cohort|world trade center health program cohort
48308|NCT02982993|Baby Boomer|baby boomer
48309|NCT02982993|risk factors for hepatitis C virus infection|risk factors for hepatitis c virus infection
48310|NCT02982967|child|child
48311|NCT02982967|physical activity|physical activity
48312|NCT02982967|irisin|irisin
48313|NCT02982967|EPCs|epcs
48323|NCT02982928|Acetaminophen|acetaminophen
48324|NCT02982928|robot-assisted or laparoscopic bariatric surgery|robot-assisted or laparoscopic bariatric surgery
48325|NCT02982928|Pharmacokinetics|pharmacokinetics
48326|NCT02982902|Immunotherapy|immunotherapy
48327|NCT02982902|T-Cell Therapy|t-cell therapy
48328|NCT02982902|Lymphoproliferative Disorder|lymphoproliferative disorder
48329|NCT02982889|Analytical, Diagnostic,Therapeutic Technique and Equipment|analytical, diagnostic,therapeutic technique and equipment
48330|NCT02982889|Anesthesia and Analgesia|anesthesia and analgesia
48331|NCT02982876|Silicone Airway stent|silicone airway stent
48332|NCT02982876|Metallic Airway stent|metallic airway stent
48333|NCT02982850|Atrial Fibrillation|atrial fibrillation
48334|NCT02982850|Valvular Insufficiency|valvular insufficiency
48335|NCT02982850|Valvular Stenosis|valvular stenosis
48336|NCT02982824|Children|children
48337|NCT02982824|IQ|iq
48338|NCT02982824|Idiopathic epilepsy|idiopathic epilepsy
48339|NCT02982824|Magnesium supplementation|magnesium supplementation
48340|NCT02982824|Seizure control|seizure control
48341|NCT02982824|Chalfont score|chalfont score
48342|NCT02982811|Activity-based|activity-based
48343|NCT02982811|Client-centred|client-centred
40042|NCT03035162|lower limb functions|lower limb functions
40043|NCT03035149|Obesity|obesity
40044|NCT03035149|Metabolic Syndrome|metabolic syndrome
40045|NCT03035149|Dyspnea|dyspnea
40046|NCT03035149|Pulmonary Function|pulmonary function
40047|NCT03035149|Exercise Capacity|exercise capacity
40048|NCT03035136|polyps|polyps
40049|NCT03035123|Heart Failure|heart failure
40050|NCT03035123|Therapeutic education|therapeutic education
40051|NCT03035123|Quality of life|quality of life
48344|NCT02982811|Rehabilitation|rehabilitation
48345|NCT02982811|Quality of life|quality of life
48346|NCT02982772|Nicotine Replacement|nicotine replacement
48347|NCT02982772|Smoking|smoking
48348|NCT02982772|HIV|hiv
48349|NCT02982746|Head and neck cancer|head and neck cancer
48350|NCT02982746|Person Centred Care|person centred care
48351|NCT02982746|Health related quality of life|health related quality of life
48352|NCT02982746|EORTC QLQ-C30|eortc qlq-c30
48353|NCT02982746|EORTC QLQ-C35|eortc qlq-c35
48354|NCT02982720|cholangiocarcinoma|cholangiocarcinoma
48355|NCT02982720|Pembrolizumab|pembrolizumab
48356|NCT02982720|MK-3475|mk-3475
48357|NCT02982720|Sylatron|sylatron
48358|NCT02982720|peginterferon alfa-2b|peginterferon alfa-2b
48359|NCT02982694|MSI|msi
48360|NCT02982694|colorectal|colorectal
48361|NCT02982694|chemotherapy|chemotherapy
48362|NCT02982694|Bevacizumab|bevacizumab
48363|NCT02982694|Atezolizumab|atezolizumab
48364|NCT02982681|Periodontal disease|periodontal disease
48365|NCT02982681|Platelet rich fibrin|platelet rich fibrin
48366|NCT02982668|severe stroke|severe stroke
48367|NCT02982668|Acute Stroke|acute stroke
48368|NCT02982668|Enteral Feeding|enteral feeding
48369|NCT02982668|Mortality|mortality
48370|NCT02982668|Disability|disability
48371|NCT02982668|Clinical trial|clinical trial
48372|NCT02982655|Severe Stroke|severe stroke
48373|NCT02982655|Acute Stroke|acute stroke
48374|NCT02982655|Antihypertension|antihypertension
48375|NCT02982655|mortality|mortality
48376|NCT02982655|disability|disability
48377|NCT02982655|clinical trial|clinical trial
48378|NCT02982629|Glaucoma|glaucoma
48379|NCT02982629|Eye Care|eye care
48380|NCT02982629|Community Outreach|community outreach
48381|NCT02982577|Xerostomia|xerostomia
48382|NCT02982577|Pilocarpine|pilocarpine
48383|NCT02982577|Quality of life|quality of life
48384|NCT02982564|Exercise|exercise
48385|NCT02982564|Physical Functioning|physical functioning
48386|NCT02982564|Hispanic|hispanic
48387|NCT02982538|posttraumatic stress symptoms|posttraumatic stress symptoms
48388|NCT02982538|implementation|implementation
48389|NCT02982538|dissemination|dissemination
48390|NCT02982538|PTSD|ptsd
48391|NCT02982525|Mussels|mussels
48392|NCT02982525|Dietary Intervention|dietary intervention
48393|NCT02982525|Long-term intervention|long-term intervention
48394|NCT02982525|Vitamin D status|vitamin d status
48395|NCT02982525|Selenium|selenium
48396|NCT02982525|Iodine|iodine
48397|NCT02982525|Vitamin B12|vitamin b12
48398|NCT02982525|Omega-3 index|omega-3 index
48399|NCT02982512|Potential local fields|potential local fields
48400|NCT02982512|Subthalamic neuronal activity|subthalamic neuronal activity
48401|NCT02982499|glaucoma|glaucoma
48402|NCT02982499|Leber optic neuropathy|leber optic neuropathy
48403|NCT02982499|anterior ischemic optic neuropathy|anterior ischemic optic neuropathy
48404|NCT02982486|nivolumab|nivolumab
48405|NCT02982486|ipilimumab|ipilimumab
48406|NCT02982486|immunotherapy|immunotherapy
48407|NCT02982486|PD-1 inhibitor|pd-1 inhibitor
48409|NCT02982460|Rotator cuff tendinopathy|rotator cuff tendinopathy
48410|NCT02982460|Eccentric exercise|eccentric exercise
48411|NCT02982460|Isoinertial training|isoinertial training
48412|NCT02982447|blue laser imaging,detection,randomized trial|blue laser imaging,detection,randomized trial
48413|NCT02982434|atrial fibrillation|atrial fibrillation
48414|NCT02982434|botulinum toxin|botulinum toxin
48415|NCT02982434|ischemic heart disease|ischemic heart disease
48416|NCT02982395|Nanoxel M|nanoxel m
48417|NCT02982395|Docetaxel PM|docetaxel pm
48418|NCT02982395|Docetaxel|docetaxel
48419|NCT02982395|Mitomycin C|mitomycin c
48420|NCT02982395|BCG|bcg
48421|NCT02982395|BCG refractory|bcg refractory
48422|NCT02982395|Non muscle invasive bladder cancer|non muscle invasive bladder cancer
48423|NCT02982395|intravesical|intravesical
48424|NCT02982395|superficial bladder cancer|superficial bladder cancer
48425|NCT02982395|Urothelial carcinoma|urothelial carcinoma
48426|NCT02982395|Transitional cell carcinoma|transitional cell carcinoma
40145|NCT03034850|thromboelastometry|thromboelastometry
40146|NCT03034824|diode laser|diode laser
40147|NCT03034824|Er,Cr:YSGG laser|er,cr:ysgg laser
40148|NCT03034824|Aggressive Periodontitis|aggressive periodontitis
40149|NCT03034824|Clinical periodontal parameters|clinical periodontal parameters
40150|NCT03034824|Gingival crevicular fluid cytokines levels|gingival crevicular fluid cytokines levels
40158|NCT03034772|wet|wet
48427|NCT02982382|Low Back Pain|low back pain
48428|NCT02982382|Musculoskeletal Manipulations|musculoskeletal manipulations
48429|NCT02982382|Neurophysiology|neurophysiology
48430|NCT02982382|Education|education
48431|NCT02982317|Neuraxial anesthesia|neuraxial anesthesia
48432|NCT02982317|Obstetrics|obstetrics
48433|NCT02982317|Ultrasound|ultrasound
48434|NCT02982252|Power mobility|power mobility
48435|NCT02982252|Wheelchair skills training|wheelchair skills training
48436|NCT02982252|Older adults|older adults
48437|NCT02982226|Plantar Fasciitis|plantar fasciitis
48438|NCT02982226|Jogger's Heel|jogger's heel
48439|NCT02982226|ReNu|renu
48440|NCT02982213|Newest Vital Sign|newest vital sign
48441|NCT02982213|Anxiety|anxiety
48442|NCT02982213|Health literacy|health literacy
48443|NCT02982213|Neuraxial Analgesia|neuraxial analgesia
48444|NCT02982213|Epidural catheter placement|epidural catheter placement
48445|NCT02982213|Pregnancy|pregnancy
48446|NCT02982213|Parturients|parturients
48447|NCT02982213|Pain Catastrophizing Scale|pain catastrophizing scale
48448|NCT02982213|STAI questionnaire|stai questionnaire
48449|NCT02982213|Companion|companion
48450|NCT02982200|Embolization Device|embolization device
48451|NCT02982200|Medina|medina
48452|NCT02982200|Rupture Intracranial Aneurysm|rupture intracranial aneurysm
48453|NCT02982200|Unrupture Intracranial Aneurysm|unrupture intracranial aneurysm
48454|NCT02982187|HANDIHALER|handihaler
48455|NCT02982187|ELLIPTA|ellipta
48456|NCT02982187|TURBUHALER|turbuhaler
48457|NCT02982187|DISKUS|diskus
48458|NCT02982187|COPD|copd
48459|NCT02982187|critical error|critical error
48460|NCT02982187|inhaler preference|inhaler preference
48461|NCT02982174|no known ocular pathology|no known ocular pathology
48462|NCT02982161|Third Molar Tooth Extraction|third molar tooth extraction
48463|NCT02982148|sentinel lymph node biopsy|sentinel lymph node biopsy
48464|NCT02982148|methylene blue|methylene blue
48465|NCT02982148|intradermal injection|intradermal injection
48466|NCT02982148|subcutaneous injection|subcutaneous injection
48467|NCT02982135|hemorrhagic moyamoya disease|hemorrhagic moyamoya disease
48468|NCT02982135|bypass|bypass
48469|NCT02982135|indirect bypass|indirect bypass
48477|NCT02982031|Ultrasound-guided lumbar plexus blockade|ultrasound-guided lumbar plexus blockade
48478|NCT02982031|Shamrock technique|shamrock technique
48479|NCT02982031|Paramedian transverse scan|paramedian transverse scan
48481|NCT02982031|USGRA|usgra
48482|NCT02982005|KHK4827 (brodalumab)|khk4827 (brodalumab)
48483|NCT02981979|Takayasu Arteritis|takayasu arteritis
48484|NCT02981979|Leflunomide|leflunomide
48485|NCT02981953|Valtech Cardio|valtech cardio
48486|NCT02981953|Cardioband|cardioband
48487|NCT02981953|Tricuspid|tricuspid
48488|NCT02981940|Brain Tumor|brain tumor
48489|NCT02981914|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
48490|NCT02981914|B-cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
48491|NCT02981914|Acute Myeloid Leukemia|acute myeloid leukemia
48492|NCT02981914|Myelodysplastic Syndromes|myelodysplastic syndromes
48493|NCT02981914|pembrolizumab|pembrolizumab
48494|NCT02981875|reading eye movement|reading eye movement
48495|NCT02981862|HPV infection|hpv infection
48496|NCT02981862|Blood sample|blood sample
48497|NCT02981862|Biopsy|biopsy
48498|NCT02981836|live attenuated varicella vaccine|live attenuated varicella vaccine
48499|NCT02981836|protective effect|protective effect
48500|NCT02981836|safety|safety
48501|NCT02981836|immunogenicity|immunogenicity
48502|NCT02981836|child|child
48503|NCT02981810|TONSILLAR COBLATION|tonsillar coblation
48504|NCT02981797|symptomatic bone metastasis|symptomatic bone metastasis
48505|NCT02981797|metastatic|metastatic
48506|NCT02981797|castration resistant|castration resistant
48507|NCT02981784|chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
48508|NCT02981784|Philadelphia-positive (Ph+)|philadelphia-positive (ph+)
48509|NCT02981784|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
48510|NCT02981732|Osteoporosis|osteoporosis
48511|NCT02981732|kidney yin deficiency syndrome|kidney yin deficiency syndrome
48512|NCT02981732|liuwei dihuang pill|liuwei dihuang pill
48513|NCT02981706|Arteriovenous Fistula (AVF)|arteriovenous fistula (avf)
48514|NCT02981706|Arteriovenous Graft (AVG)|arteriovenous graft (avg)
402904|NCT01229202|glaucoma surgery|glaucoma surgery
48515|NCT02981680|remote ischemic preconditioning; transient limb ischemia; acute kidney injury; coronary artery bypass graft surgery|remote ischemic preconditioning; transient limb ischemia; acute kidney injury; coronary artery bypass graft surgery
48516|NCT02981641|Pancreatic cancer|pancreatic cancer
48517|NCT02981641|Intraoperative radiotherapy (IORT)|intraoperative radiotherapy (iort)
48518|NCT02981641|Concurrent Chemoradiotherapy (CCRT)|concurrent chemoradiotherapy (ccrt)
48520|NCT02981602|Chronic|chronic
48521|NCT02981602|HBV|hbv
48522|NCT02981576|Spinal Cord Injury|spinal cord injury
48523|NCT02981576|Mesenchymal Stem Cells|mesenchymal stem cells
48524|NCT02981563|engagement|engagement
48525|NCT02981563|psychiatric in-patient care|psychiatric in-patient care
48526|NCT02981563|mental health nursing|mental health nursing
48527|NCT02981563|quality interactions|quality interactions
48528|NCT02981550|Infection|infection
48529|NCT02981524|Colorectal Neoplasms|colorectal neoplasms
48530|NCT02981524|Gastrointestinal Neoplasms|gastrointestinal neoplasms
48531|NCT02981524|Digestive System Neoplasms|digestive system neoplasms
48532|NCT02981524|Neoplasms by Site|neoplasms by site
48533|NCT02981524|Neoplasms|neoplasms
48534|NCT02981524|Digestive System Diseases|digestive system diseases
48535|NCT02981524|Gastrointestinal Diseases|gastrointestinal diseases
48536|NCT02981524|Intestinal Diseases|intestinal diseases
48537|NCT02981524|Rectal Diseases|rectal diseases
48538|NCT02981524|Colonic Diseases|colonic diseases
48539|NCT02981498|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
48540|NCT02981498|Sorafenib|sorafenib
48541|NCT02981485|Fat Grafting, Breast Cancer Lymphedema|fat grafting, breast cancer lymphedema
48542|NCT02981459|bladder pain|bladder pain
48543|NCT02981459|urinary frequency|urinary frequency
48544|NCT02981459|urinary urgency|urinary urgency
48545|NCT02981459|mirabegron|mirabegron
48546|NCT02981407|Red Blood Cell Transfusion|red blood cell transfusion
48547|NCT02981407|Anemia|anemia
48548|NCT02981407|Heart Disease|heart disease
48549|NCT02981407|Cardiovascular Disease|cardiovascular disease
48560|NCT02981368|Diagnostic|diagnostic
48561|NCT02981368|Imaging|imaging
48562|NCT02981368|2301|2301
48563|NCT02981368|PET/CT|pet/ct
48564|NCT02981368|PyL|pyl
48565|NCT02981368|PSMA|psma
48566|NCT02981368|radical prostatectomy|radical prostatectomy
48567|NCT02981368|metastatic prostate cancer|metastatic prostate cancer
48568|NCT02981368|recurrent prostate cancer|recurrent prostate cancer
48569|NCT02981355|BST-CarGel|bst-cargel
48570|NCT02981355|Microfracture|microfracture
48571|NCT02981355|Cartilage Lesion, Chondral Lesion|cartilage lesion, chondral lesion
48572|NCT02981355|Femoral condyle|femoral condyle
48573|NCT02981355|Bone Marrow Stimulation|bone marrow stimulation
48574|NCT02981355|Cartilage Repair|cartilage repair
48575|NCT02981355|Tear of Articular Cartilage of Knee, Current|tear of articular cartilage of knee, current
48576|NCT02981342|pancreatic cancer|pancreatic cancer
48577|NCT02981329|Metformin|metformin
48578|NCT02981329|Sickle Cell Anemia|sickle cell anemia
48579|NCT02981329|Sickle Cell Disease|sickle cell disease
48580|NCT02981329|Hemoglobinopathies|hemoglobinopathies
48581|NCT02981329|Hemoglobin Disorder|hemoglobin disorder
48582|NCT02981329|Blood Disease|blood disease
48583|NCT02981329|Hemoglobin Disease; Sickle-Cell, Thalassemia|hemoglobin disease; sickle-cell, thalassemia
48584|NCT02981329|Hemoglobin Disease|hemoglobin disease
48585|NCT02981277|Bronchoscopy|bronchoscopy
48586|NCT02981277|Lignocaine|lignocaine
48587|NCT02981264|Bronchoscopy|bronchoscopy
48588|NCT02981264|Lignocaine|lignocaine
48589|NCT02981264|Endobronchial Ultrasound|endobronchial ultrasound
48590|NCT02981251|Hypertension|hypertension
48591|NCT02981251|Uncontrolled blood pressure|uncontrolled blood pressure
48592|NCT02981251|Health education|health education
48593|NCT02981251|Community based|community based
48594|NCT02981199|microtransplantation|microtransplantation
48595|NCT02981199|multiple myeloma|multiple myeloma
48596|NCT02981186|Intraocular Lens|intraocular lens
48597|NCT02981186|trifocal|trifocal
48598|NCT02981186|cataract|cataract
48599|NCT02981186|PhysIOL|physiol
48600|NCT02981147|cough|cough
48601|NCT02981147|thyme|thyme
48602|NCT02981147|Cisti|cisti
48603|NCT02981147|Ivy Leaves|ivy leaves
48604|NCT02981134|bioabsorbable scaffold|bioabsorbable scaffold
48605|NCT02981134|computed tomography|computed tomography
48606|NCT02981121|Diabetes Prevention|diabetes prevention
48607|NCT02981082|Systemic Sclerosis, Scleroderma, PAH, Pulmonary Hypertension|systemic sclerosis, scleroderma, pah, pulmonary hypertension
48608|NCT02981056|Skincare regimens|skincare regimens
48609|NCT02981056|Skin moisturization|skin moisturization
48610|NCT02981056|Skin barrier|skin barrier
48611|NCT02981056|Skin development|skin development
48612|NCT02981017|Chronic sinusitis|chronic sinusitis
48613|NCT02981017|Frontal sinusitis|frontal sinusitis
48614|NCT02981017|Skull base neoplasm|skull base neoplasm
50557|NCT02969980|MDS|mds
48615|NCT02981004|Aortic valve disease, patient prosthesis mismatch|aortic valve disease, patient prosthesis mismatch
48616|NCT02980965|breast cancer|breast cancer
402905|NCT01229202|bevacizumab|bevacizumab
48617|NCT02980965|neoadjuvant chemotherapy|neoadjuvant chemotherapy
48618|NCT02980965|endocrine therapy|endocrine therapy
48619|NCT02980965|concurrent|concurrent
48620|NCT02980887|Pulmonary arterial hypertension|pulmonary arterial hypertension
48621|NCT02980874|RVO|rvo
48622|NCT02980874|ME|me
48623|NCT02980874|Central Subfield Thickness|central subfield thickness
48624|NCT02980874|OCT|oct
48625|NCT02980874|Optical Coherence Tomography|optical coherence tomography
48626|NCT02980874|Cystoid Macular Edema|cystoid macular edema
48627|NCT02980874|Subretinal Fluid|subretinal fluid
48628|NCT02980874|Eylea|eylea
48629|NCT02980874|Aflibercept|aflibercept
48630|NCT02980874|Anti-VEGF|anti-vegf
48631|NCT02980874|Suprachoroidal|suprachoroidal
48632|NCT02980861|Gastric Cancer|gastric cancer
48633|NCT02980861|Splenic Hilum Lymph Nodes Dissection|splenic hilum lymph nodes dissection
48634|NCT02980861|Gastrectomy|gastrectomy
48635|NCT02980848|digital mammography|digital mammography
48636|NCT02980848|digital breast tomosynthesis|digital breast tomosynthesis
48637|NCT02980848|breast magnetic resonance imaging|breast magnetic resonance imaging
48638|NCT02980848|screening|screening
48639|NCT02980848|breast density|breast density
48640|NCT02980848|breast imaging|breast imaging
48641|NCT02980848|pre-operative magnetic resonance imaging|pre-operative magnetic resonance imaging
48642|NCT02980796|Brain|brain
48643|NCT02980796|MRI|mri
48644|NCT02980796|Exercise|exercise
48645|NCT02980796|Rehabilitation|rehabilitation
48646|NCT02980796|TMS|tms
48647|NCT02980770|Obstructive Sleep Apnea|obstructive sleep apnea
48648|NCT02980770|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
48649|NCT02980770|Hypercapnia|hypercapnia
48650|NCT02980770|Post-Op Complication|post-op complication
48651|NCT02980770|Acid-Base Imbalance|acid-base imbalance
48652|NCT02980744|Stroke|stroke
48653|NCT02980744|Sedentary behaviour|sedentary behaviour
48654|NCT02980744|Intervention|intervention
48655|NCT02980731|Duration of overall response (Dor)|duration of overall response (dor)
48656|NCT02980731|Complete remission rate (CR + CRi)|complete remission rate (cr + cri)
48657|NCT02980731|B-Cell receptor inhibitor (BCRi)|b-cell receptor inhibitor (bcri)
48658|NCT02980731|TP53 gene|tp53 gene
48659|NCT02980731|Progression-free survival (PFS)|progression-free survival (pfs)
48757|NCT02980315|EBV related cancers|ebv related cancers
48950|NCT02978976|RDS|rds
401963|NCT01232556|inotuzumab ozogamicin|inotuzumab ozogamicin
401964|NCT01232556|aggressive Non-Hodgkin lymphoma|aggressive non-hodgkin lymphoma
623777|NCT00676026|menses|menses
48660|NCT02980731|European Organization of Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30)|european organization of research and treatment of cancer quality of life core questionnaire (eortc qlq-c30)
48661|NCT02980731|Refractory CLL|refractory cll
48662|NCT02980731|Overall response rate (ORR)|overall response rate (orr)
48663|NCT02980731|Overall survival (OS)|overall survival (os)
48664|NCT02980731|Relapsed CLL|relapsed cll
48665|NCT02980731|17p deletion|17p deletion
48666|NCT02980718|Olfaction training|olfaction training
48667|NCT02980718|Smell|smell
48668|NCT02980653|Phase II study|phase ii study
48669|NCT02980653|Critical body weight loss|critical body weight loss
48670|NCT02980653|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
48671|NCT02980653|Megestrol acetate|megestrol acetate
48672|NCT02980653|Head and neck cancer|head and neck cancer
48673|NCT02980640|Multiple Sclerosis|multiple sclerosis
48674|NCT02980640|Treatment|treatment
48675|NCT02980640|Quality of Life|quality of life
48676|NCT02980640|Symptoms|symptoms
48677|NCT02980627|Eating Disorders|eating disorders
48678|NCT02980627|Diabulimia|diabulimia
48679|NCT02980627|ED-T1DM|ed-t1dm
48680|NCT02980627|Type 1 Diabetes|type 1 diabetes
48681|NCT02980627|Mobile Technology|mobile technology
48682|NCT02980627|Acceptance and Commitment Therapy|acceptance and commitment therapy
48683|NCT02980614|phase-contrast MRI|phase-contrast mri
48684|NCT02980614|blood flow|blood flow
48685|NCT02980614|velocity mapping|velocity mapping
48686|NCT02980614|Quantitative MRI|quantitative mri
48687|NCT02980614|Cardiac imaging|cardiac imaging
48688|NCT02980614|Tetralogy of Fallot|tetralogy of fallot
48689|NCT02980601|Traumatic Defect|traumatic defect
48690|NCT02980601|Chronic Wounds|chronic wounds
48691|NCT02980575|COPD|copd
48692|NCT02980575|Music|music
48693|NCT02980575|Exercise|exercise
48694|NCT02980562|Bowel preparation|bowel preparation
48695|NCT02980562|Ascorbic acid|ascorbic acid
48696|NCT02980562|Bisacodyl|bisacodyl
48697|NCT02980562|Polyethylene glycol|polyethylene glycol
48698|NCT02980536|NSCLC|nsclc
48699|NCT02980536|TKI|tki
48700|NCT02980536|Mutation|mutation
48701|NCT02980536|Liquid Biopsy|liquid biopsy
48702|NCT02980497|mouthrinse|mouthrinse
48703|NCT02980497|plaque|plaque
48704|NCT02980497|gingivitis|gingivitis
48705|NCT02980497|gum bleeding|gum bleeding
48706|NCT02980484|rTMS|rtms
48707|NCT02980458|Healthy|healthy
48708|NCT02980458|Bioequivalence|bioequivalence
48709|NCT02980458|Deferiprone|deferiprone
40439|NCT03032731|Diet|diet
40440|NCT03032731|Health Behavior|health behavior
40441|NCT03032705|Restorations|restorations
40442|NCT03032705|Composite|composite
40443|NCT03032679|pain, acute, chronic, knee arthroplasty|pain, acute, chronic, knee arthroplasty
40444|NCT03032666|Thalassemia|thalassemia
40445|NCT03032666|HCV|hcv
40446|NCT03032666|Sofosbuvir|sofosbuvir
40447|NCT03032666|Ledipasvir|ledipasvir
40448|NCT03032653|ankle, fracture, rehabilitation, weightbearing, early, late|ankle, fracture, rehabilitation, weightbearing, early, late
40449|NCT03032640|Glucose|glucose
48710|NCT02980445|Myopia|myopia
48711|NCT02980445|Outdoor time|outdoor time
48712|NCT02980445|Children|children
48713|NCT02980445|Intervention|intervention
48714|NCT02980445|Prevention|prevention
48715|NCT02980432|vestibular|vestibular
48716|NCT02980432|spatial orientation|spatial orientation
48717|NCT02980432|vision|vision
48718|NCT02980432|optokinetic|optokinetic
48719|NCT02980406|FODMAP|fodmap
48720|NCT02980406|Irritable bowel syndrome|irritable bowel syndrome
48721|NCT02980406|Gastric accommodation|gastric accommodation
48722|NCT02980406|Gastric motility|gastric motility
48723|NCT02980406|brain-gut axis|brain-gut axis
48724|NCT02980393|congenital heart disease|congenital heart disease
48725|NCT02980393|smart mobile technology|smart mobile technology
48726|NCT02980393|children|children
48727|NCT02980393|adolescents|adolescents
48728|NCT02980393|lifestyle counselling|lifestyle counselling
48729|NCT02980393|nutrition|nutrition
48730|NCT02980393|physical activity|physical activity
48731|NCT02980380|non-invasive brain computer interface|non-invasive brain computer interface
48732|NCT02980380|communication|communication
48733|NCT02980380|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
48734|NCT02980380|complete locked-in state|complete locked-in state
48735|NCT02980367|Anterior Cruciate Ligament|anterior cruciate ligament
48737|NCT02980367|Anterior Cruciate Ligament deficiency|anterior cruciate ligament deficiency
48738|NCT02980367|ACL deficiency|acl deficiency
48739|NCT02980367|ACLD|acld
48740|NCT02980367|Anterior Cruciate Ligament reconstruction|anterior cruciate ligament reconstruction
48741|NCT02980367|ACL reconstruction|acl reconstruction
48742|NCT02980367|Anterior Cruciate Ligament physiotherapy|anterior cruciate ligament physiotherapy
48743|NCT02980367|Anterior Cruciate Ligament rehabilitation|anterior cruciate ligament rehabilitation
48744|NCT02980367|ACL physiotherapy|acl physiotherapy
48745|NCT02980367|ACL rehabilitation|acl rehabilitation
48746|NCT02980367|Anterior Cruciate Ligament management|anterior cruciate ligament management
48747|NCT02980367|ACL management|acl management
48748|NCT02980354|endothelial progenitor cells, ischaemic stroke, aging|endothelial progenitor cells, ischaemic stroke, aging
48749|NCT02980341|Oncology|oncology
48750|NCT02980341|HER3|her3
48751|NCT02980341|Antibody drug conjugate|antibody drug conjugate
48752|NCT02980341|Developmental Phase I/II|developmental phase i/ii
48753|NCT02980328|Overactive bladder|overactive bladder
48754|NCT02980328|Urinary incontinence|urinary incontinence
48755|NCT02980328|Low-level light therapy|low-level light therapy
48756|NCT02980315|nasopharyngeal carcinoma|nasopharyngeal carcinoma
48758|NCT02980302|Mental retardation MR|mental retardation mr
48759|NCT02980302|IQ|iq
48760|NCT02980302|Mutation|mutation
48761|NCT02980302|Gene MYT1L|gene myt1l
48762|NCT02980276|Gestational Diabetes|gestational diabetes
48763|NCT02980276|Diabetes|diabetes
48764|NCT02980276|Pregnancy|pregnancy
48765|NCT02980263|Kawasaki disease|kawasaki disease
48766|NCT02980263|Coronary artery aneurysm|coronary artery aneurysm
48767|NCT02980263|mucocutaneous lymph node syndrome|mucocutaneous lymph node syndrome
48768|NCT02980263|lymph node syndrome|lymph node syndrome
48769|NCT02980263|canakinumab|canakinumab
48770|NCT02980263|intravenous immunoglobulin naïve (IVIG-naïve)|intravenous immunoglobulin naïve (ivig-naïve)
48771|NCT02980263|intravenous immunoglobulin refractory (IVIG-refractory)|intravenous immunoglobulin refractory (ivig-refractory)
48772|NCT02980263|pediatric|pediatric
48773|NCT02980250|feeding intolerance|feeding intolerance
48774|NCT02980250|premature infant|premature infant
48775|NCT02980250|domperidone|domperidone
48776|NCT02980237|Office workers|office workers
48777|NCT02980237|Quality of life|quality of life
48778|NCT02980237|e-Learning|e-learning
48779|NCT02980237|Occupational health|occupational health
48780|NCT02980211|Alveolar Bone|alveolar bone
48781|NCT02980211|Alveolar Ridge|alveolar ridge
48782|NCT02980211|Bone Resorption|bone resorption
48783|NCT02980211|Bone Grafting|bone grafting
48784|NCT02980211|Barrier Membrane|barrier membrane
48785|NCT02980172|triage|triage
48786|NCT02980120|Eating Disorders|eating disorders
48787|NCT02980120|Anorexia Nervosa|anorexia nervosa
48788|NCT02980120|Bulimia Nervosa|bulimia nervosa
48789|NCT02980094|aging|aging
48790|NCT02980094|nutrients|nutrients
48791|NCT02980094|milk|milk
48792|NCT02980094|dietary supplementation|dietary supplementation
48793|NCT02980055|connective tissue graft|connective tissue graft
48794|NCT02980055|transplantation|transplantation
48795|NCT02980055|collagen|collagen
48796|NCT02980055|autologous|autologous
48797|NCT02980055|gingiva|gingiva
48798|NCT02980003|contrast media|contrast media
48799|NCT02980003|contrast-induced acute kidney injury (AKI)|contrast-induced acute kidney injury (aki)
48800|NCT02980003|contrast-induced nephropathy (CIN)|contrast-induced nephropathy (cin)
48801|NCT02979990|infertility|infertility
48802|NCT02979990|education|education
48803|NCT02979951|Observational Study|observational study
48804|NCT02979951|Non-Interventional Study|non-interventional study
48805|NCT02979951|Registries|registries
48810|NCT02979951|Fosfomycin|fosfomycin
48811|NCT02979951|Infectofos|infectofos
48812|NCT02979951|Fomicyt|fomicyt
48813|NCT02979951|Bacterial Infections|bacterial infections
48814|NCT02979951|Gram-Negative Bacterial Infections|gram-negative bacterial infections
48815|NCT02979951|Gram-Positive Bacterial Infections|gram-positive bacterial infections
48816|NCT02979951|Bone Diseases, Infectious|bone diseases, infectious
48817|NCT02979951|Osteomyelitis|osteomyelitis
48818|NCT02979951|Central Nervous System Bacterial Infections|central nervous system bacterial infections
48819|NCT02979951|Meningitis, Bacterial|meningitis, bacterial
48820|NCT02979951|Encephalitis|encephalitis
48821|NCT02979951|Brain Abscess|brain abscess
48822|NCT02979951|Urinary Tract Infections|urinary tract infections
48823|NCT02979951|Respiratory Tract Infections|respiratory tract infections
48824|NCT02979951|Pneumonia, Bacterial|pneumonia, bacterial
48825|NCT02979951|Skin Diseases, Bacterial|skin diseases, bacterial
48826|NCT02979951|Soft Tissue Infections|soft tissue infections
48827|NCT02979951|Intraabdominal Infections|intraabdominal infections
48828|NCT02979951|Sepsis|sepsis
48829|NCT02979951|Bacteremia|bacteremia
48830|NCT02979951|Endocarditis, Bacterial|endocarditis, bacterial
48831|NCT02979951|Treatment Outcome|treatment outcome
48832|NCT02979951|Clinical Efficacy|clinical efficacy
48833|NCT02979951|Microbiological Efficacy|microbiological efficacy
48834|NCT02979951|Safety|safety
48835|NCT02979925|neuropathic pain|neuropathic pain
48836|NCT02979925|TMS|tms
48837|NCT02979925|nerve injury|nerve injury
48838|NCT02979925|transcutaneous magnetic stimulation|transcutaneous magnetic stimulation
48839|NCT02979912|Persistent corneal epithelial defect|persistent corneal epithelial defect
48840|NCT02979912|Platelet Lysate|platelet lysate
48841|NCT02979899|angiosarcoma|angiosarcoma
48842|NCT02979886|single nucleotide polymorphism,GnRH receptor, IVF|single nucleotide polymorphism,gnrh receptor, ivf
48843|NCT02979873|Rapamycin|rapamycin
48844|NCT02979873|Relapse Prevention|relapse prevention
48845|NCT02979873|Immune Tolerance|immune tolerance
48846|NCT02979847|persistent atrial fibrillation|persistent atrial fibrillation
48847|NCT02979847|catheter ablation|catheter ablation
48848|NCT02979847|hybrid|hybrid
48849|NCT02979834|fetal movement|fetal movement
48850|NCT02979834|placenta site|placenta site
48851|NCT02979834|body mass index|body mass index
623778|NCT00676026|women|women
48856|NCT02979782|minimal invasive coronary artery bypass graft (Endo-CABG)|minimal invasive coronary artery bypass graft (endo-cabg)
48857|NCT02979769|Open-label extension study|open-label extension study
48858|NCT02979769|Clinical trial Phase 2|clinical trial phase 2
48859|NCT02979769|Efficacy and safety|efficacy and safety
48860|NCT02979769|Heterotopic ossification|heterotopic ossification
48861|NCT02979769|Flare-up|flare-up
48862|NCT02979769|Palovarotene|palovarotene
48863|NCT02979769|Retinoic acide receptor agonist|retinoic acide receptor agonist
48864|NCT02979769|Retinoic acide receptor gamma agonist|retinoic acide receptor gamma agonist
48865|NCT02979769|Clementia|clementia
48866|NCT02979769|Myositis Ossificans|myositis ossificans
48867|NCT02979769|Munchmeyer's Disease|munchmeyer's disease
48868|NCT02979769|FOP|fop
48869|NCT02979717|satiety|satiety
48870|NCT02979717|protein|protein
48871|NCT02979717|fiber|fiber
48872|NCT02979678|Breast cancer, quality of life|breast cancer, quality of life
48873|NCT02979639|Herpes Zoster|herpes zoster
48874|NCT02979639|Reactogenicity|reactogenicity
48875|NCT02979639|Quality of life|quality of life
48876|NCT02979639|Shingles|shingles
48877|NCT02979626|hospitalization|hospitalization
48878|NCT02979626|intensive care unit|intensive care unit
48879|NCT02979626|school absenteeism|school absenteeism
48880|NCT02979626|work absenteeism|work absenteeism
48881|NCT02979600|Oral immunotherapy|oral immunotherapy
48882|NCT02979600|Oral tolerance induction|oral tolerance induction
48888|NCT02979561|Dabigatran etexilate|dabigatran etexilate
48889|NCT02979561|Recurrence of DVT|recurrence of dvt
48890|NCT02979561|Pulmonary Embolism|pulmonary embolism
48891|NCT02979561|Warfarin|warfarin
48892|NCT02979548|Aprepitant|aprepitant
48893|NCT02979535|Dengue Fever|dengue fever
48894|NCT02979535|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
48895|NCT02979535|Human Papillomavirus Disease|human papillomavirus disease
48896|NCT02979535|CYD Dengue Vaccine|cyd dengue vaccine
48897|NCT02979535|Dengvaxia®|dengvaxia®
48898|NCT02979535|Cervarix®|cervarix®
48899|NCT02979522|Drug therapy, pediatric Hodgkin disease, frontline Hodgkin disease, advanced stage Hodgkin disease, pediatric lymphoma|drug therapy, pediatric hodgkin disease, frontline hodgkin disease, advanced stage hodgkin disease, pediatric lymphoma
48900|NCT02979496|immune|immune
48901|NCT02979496|citrus|citrus
48902|NCT02979470|advanced colon cancer|advanced colon cancer
50844|NCT02967848|Radiotherapy|radiotherapy
48903|NCT02979470|advanced rectum cancer|advanced rectum cancer
48904|NCT02979470|circulating tumor cells|circulating tumor cells
48905|NCT02979470|immune response|immune response
48906|NCT02979470|mutations|mutations
48907|NCT02979457|telephone consultation, patient involvement|telephone consultation, patient involvement
48908|NCT02979418|Water insecurity|water insecurity
48909|NCT02979340|Cystic Fibrosis Liver Disease|cystic fibrosis liver disease
48910|NCT02979340|Pancreatic Insufficiency|pancreatic insufficiency
48911|NCT02979275|acute kidney injury|acute kidney injury
48912|NCT02979275|cardiopulmonary bypass|cardiopulmonary bypass
48913|NCT02979275|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
48914|NCT02979275|tissue hypoxia|tissue hypoxia
48915|NCT02979249|Interventional|interventional
48916|NCT02979249|open-label|open-label
48917|NCT02979249|EPP|epp
48918|NCT02979249|XLP|xlp
48919|NCT02979249|porphyria|porphyria
48920|NCT02979197|High blood pressure|high blood pressure
48921|NCT02979197|Systolic blood pressure|systolic blood pressure
48922|NCT02979197|Diastolic blood pressure|diastolic blood pressure
48923|NCT02979197|Antihypertensive|antihypertensive
48924|NCT02979184|Lymphedema, Obstructive Sleep Apnea , Intensive Decongestive Physiotherapy|lymphedema, obstructive sleep apnea , intensive decongestive physiotherapy
48925|NCT02979119|Hemophilia|hemophilia
48926|NCT02979119|Children, ,|children, ,
48927|NCT02979119|Inhibitors,|inhibitors,
48928|NCT02979119|Prophylaxis|prophylaxis
48929|NCT02979119|Long-term outcome|long-term outcome
48930|NCT02979119|Congenital|congenital
48931|NCT02979093|maternal drug addiction|maternal drug addiction
48932|NCT02979093|mother-infant attachment|mother-infant attachment
48933|NCT02979093|intranasal oxytocin|intranasal oxytocin
48934|NCT02979093|unresolved trauma|unresolved trauma
48935|NCT02979093|maternal brain responses|maternal brain responses
48936|NCT02979093|mother-infant synchrony|mother-infant synchrony
48937|NCT02979067|Apnoea time, preoxygenation, difficult airway, emergency|apnoea time, preoxygenation, difficult airway, emergency
48938|NCT02979041|neck pain|neck pain
48939|NCT02979041|Virtual reality|virtual reality
48940|NCT02979041|Range of motion|range of motion
48941|NCT02979041|physiotherapy|physiotherapy
48942|NCT02979041|Air force|air force
48943|NCT02979041|kinematics|kinematics
48945|NCT02979028|complication|complication
48946|NCT02978989|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
48947|NCT02978989|Solo surgery|solo surgery
48948|NCT02978989|Camera holder|camera holder
48949|NCT02978989|Cholecystitis|cholecystitis
48951|NCT02978976|Doppler on fetal pulmonary artery|doppler on fetal pulmonary artery
48952|NCT02978963|Excessive worry|excessive worry
48953|NCT02978963|Worry|worry
48954|NCT02978963|Adolescents|adolescents
48955|NCT02978963|Intolerance of uncertainty|intolerance of uncertainty
48956|NCT02978950|duplex ultrasound|duplex ultrasound
48957|NCT02978950|trauma|trauma
48958|NCT02978950|venous thromboembolism|venous thromboembolism
48959|NCT02978950|prevention|prevention
48960|NCT02978924|spinal cord|spinal cord
48961|NCT02978924|tsDCS|tsdcs
48962|NCT02978924|3D motion capture|3d motion capture
48963|NCT02978924|EMG|emg
48964|NCT02978911|RMI|rmi
48965|NCT02978898|Follicular Lymphoma|follicular lymphoma
48966|NCT02978898|flow cytometry|flow cytometry
48967|NCT02978898|CD180|cd180
48968|NCT02978898|Toll-like receptor|toll-like receptor
48969|NCT02978898|lymphoproliferative disease|lymphoproliferative disease
48970|NCT02978885|Acute lung injury|acute lung injury
48971|NCT02978885|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
48972|NCT02978885|Whipple procedures|whipple procedures
48973|NCT02978885|pancreatico-duodenectomies|pancreatico-duodenectomies
48974|NCT02978872|Cardiac surgery|cardiac surgery
48975|NCT02978872|Quantra|quantra
48976|NCT02978872|Viscoelastic testing|viscoelastic testing
48977|NCT02978872|Coagulation|coagulation
48978|NCT02978859|MGCD516|mgcd516
48979|NCT02978859|Sarcoma|sarcoma
48980|NCT02978859|liposarcoma|liposarcoma
48981|NCT02978859|Unresectable Liposarcoma|unresectable liposarcoma
48982|NCT02978859|Metastatic Liposarcoma|metastatic liposarcoma
48983|NCT02978833|Gluteus Medius Tendinosis|gluteus medius tendinosis
48984|NCT02978820|scientific exercise approach to scoliosis|scientific exercise approach to scoliosis
48985|NCT02978820|core stabilization training|core stabilization training
48986|NCT02978820|bracing|bracing
48987|NCT02978820|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
48988|NCT02978794|stroke, clinical pathway, medical care|stroke, clinical pathway, medical care
48989|NCT02978781|Tremor|tremor
48990|NCT02978768|dementia|dementia
48991|NCT02978768|Tai Chi|tai chi
48992|NCT02978768|mental training|mental training
48993|NCT02978768|cognitive rehabilitation|cognitive rehabilitation
48994|NCT02978742|Eating Disorders|eating disorders
48995|NCT02978742|Bulimia Nervosa|bulimia nervosa
48996|NCT02978742|Binge Eating Disorder|binge eating disorder
48997|NCT02978742|App|app
48998|NCT02978742|Smartphone|smartphone
48999|NCT02978742|Self-Help|self-help
49000|NCT02978742|Coaching|coaching
49001|NCT02978742|Recovery Record|recovery record
49002|NCT02978742|Mobile Phone|mobile phone
49009|NCT02978677|brain tumors|brain tumors
49010|NCT02978677|proton radiotherapy|proton radiotherapy
49011|NCT02978677|photon radiotherapy|photon radiotherapy
49012|NCT02978664|colonoscopy|colonoscopy
49013|NCT02978664|water exchange|water exchange
49014|NCT02978664|adenoma detection rate|adenoma detection rate
49015|NCT02978664|distraction|distraction
49016|NCT02978651|EDS|eds
49017|NCT02978651|OSA|osa
49018|NCT02978638|Spinal cord injury|spinal cord injury
49019|NCT02978638|Bladder capacity|bladder capacity
49020|NCT02978638|Electrical stimulation|electrical stimulation
49021|NCT02978638|Continence|continence
49022|NCT02978638|Urodynamics|urodynamics
49023|NCT02978612|Colorectal Neoplasms|colorectal neoplasms
49024|NCT02978586|PSMA|psma
49025|NCT02978586|PET/MRI|pet/mri
49026|NCT02978573|First MTP Joint|first mtp joint
49027|NCT02978573|Hallux Rigidus|hallux rigidus
49028|NCT02978573|Hallux Limitus|hallux limitus
49029|NCT02978573|Cartilage Replacement|cartilage replacement
49030|NCT02978573|Osteoarthritis|osteoarthritis
49031|NCT02978573|First MTP Joint Osteoarthritis|first mtp joint osteoarthritis
49032|NCT02978573|Big Toe Pain|big toe pain
49033|NCT02978547|Resectable pancreatic ductal adenocarcinoma|resectable pancreatic ductal adenocarcinoma
49034|NCT02978547|PDAC|pdac
49035|NCT02978547|Metformin|metformin
49036|NCT02978534|pregnant|pregnant
49037|NCT02978534|quetiapine|quetiapine
49038|NCT02978534|bipolar|bipolar
49039|NCT02978534|women|women
49040|NCT02978534|female|female
49041|NCT02978534|postpartum|postpartum
49042|NCT02978534|seroquel|seroquel
49043|NCT02978534|perinatal|perinatal
49044|NCT02978534|manic-depressive|manic-depressive
49045|NCT02978469|Habitual Physical Activity (HPA); Sedentary Behavior;|habitual physical activity (hpa); sedentary behavior;
49046|NCT02978456|IVUS guided PCI|ivus guided pci
49047|NCT02978456|QCA guided PCI|qca guided pci
49048|NCT02978443|Melanoma|melanoma
49049|NCT02978443|Mucosal|mucosal
49050|NCT02978443|Acral Lentiginous|acral lentiginous
49051|NCT02978443|Ipilimumab|ipilimumab
49052|NCT02978443|Nivolumab|nivolumab
49053|NCT02978443|Anti-tumor|anti-tumor
49054|NCT02978443|Potential Predictors|potential predictors
49055|NCT02978443|Opdivo|opdivo
49056|NCT02978443|Yervoy|yervoy
49057|NCT02978430|Fluid therapy|fluid therapy
49058|NCT02978430|Anesthesiology|anesthesiology
49059|NCT02978430|Major surgery|major surgery
49060|NCT02978430|Goal-directed fluid therapy|goal-directed fluid therapy
49061|NCT02978430|Fluid responsiveness|fluid responsiveness
49062|NCT02978430|Closed-loop system|closed-loop system
49063|NCT02978417|Medication-assisted treatment|medication-assisted treatment
49064|NCT02978417|Drug Court|drug court
49065|NCT02978417|Pilot study|pilot study
49066|NCT02978417|Opioid dependence|opioid dependence
49067|NCT02978417|Criminal justice|criminal justice
49068|NCT02978404|radiosurgery|radiosurgery
49069|NCT02978404|PD-1|pd-1
49070|NCT02978404|Nivolumab|nivolumab
49071|NCT02978326|Postpartum Care|postpartum care
49072|NCT02978287|Calcium sensing receptor|calcium sensing receptor
49073|NCT02978287|Parathyroid cell viability|parathyroid cell viability
49074|NCT02978287|Parathyroid allotransplantation|parathyroid allotransplantation
49075|NCT02978287|Transporting solution|transporting solution
49076|NCT02978235|Multiple Myeloma|multiple myeloma
49077|NCT02978235|Relapsed/Refractory|relapsed/refractory
49078|NCT02978235|Lymphoma|lymphoma
49079|NCT02978235|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
49080|NCT02978235|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
49081|NCT02978235|DLBCL|dlbcl
49082|NCT02978235|Mantle Cell Lymphoma|mantle cell lymphoma
49083|NCT02978235|MCL|mcl
49084|NCT02978235|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
49085|NCT02978235|PTCL|ptcl
49086|NCT02978235|TAS4464|tas4464
49087|NCT02978235|NEDD8|nedd8
49088|NCT02978235|NAE inhibitor|nae inhibitor
49089|NCT02978235|Neoplasms|neoplasms
49090|NCT02978235|Hematologic Diseases|hematologic diseases
49091|NCT02978235|Myeloma|myeloma
49092|NCT02978170|Bronchoscopy|bronchoscopy
49093|NCT02978170|Lung lesions|lung lesions
49094|NCT02978170|Cone Beam Computed Tomography|cone beam computed tomography
49095|NCT02978170|CBCT|cbct
49096|NCT02978170|Cone Beam CT|cone beam ct
49097|NCT02978157|Helicobacter pylori|helicobacter pylori
49098|NCT02978157|Eradication rate|eradication rate
49099|NCT02978157|Rescue treatment|rescue treatment
49100|NCT02978144|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
49101|NCT02978131|TUBERCULOSIS|tuberculosis
49102|NCT02978131|Sensitivity and Specificity|sensitivity and specificity
49103|NCT02978131|Polymerase Chain Reaction|polymerase chain reaction
49104|NCT02978131|Immunohistochemistry|immunohistochemistry
49105|NCT02978131|Histochemistry|histochemistry
49106|NCT02978131|Paraformaldehyde and paraffin embedded tissues|paraformaldehyde and paraffin embedded tissues
49107|NCT02978053|Bright light|bright light
49108|NCT02978053|Sleepiness|sleepiness
49109|NCT02978053|Sleep|sleep
49110|NCT02978053|Psychomotor vigilance|psychomotor vigilance
49111|NCT02978040|Antiplatelet therapy|antiplatelet therapy
49112|NCT02978040|Cangrelor|cangrelor
49113|NCT02978040|Tirofiban|tirofiban
49114|NCT02978040|Prasugrel|prasugrel
49115|NCT02978040|Acute Myocardial Infarction|acute myocardial infarction
49116|NCT02978040|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
49117|NCT02978040|Pharmacokinetic/Pharmacodynamic|pharmacokinetic/pharmacodynamic
49118|NCT02978027|motivational interviewing|motivational interviewing
49119|NCT02978027|brief alcohol intervention in primary care|brief alcohol intervention in primary care
49120|NCT02978014|Prostate|prostate
49121|NCT02978014|Radiotherapy|radiotherapy
49122|NCT02978014|Obturator|obturator
49123|NCT02978014|Toxicity|toxicity
49124|NCT02978014|Bowel|bowel
49125|NCT02978014|Urinary|urinary
49126|NCT02978014|Sexual|sexual
49127|NCT02978014|PROM|prom
49128|NCT02978014|EPIC|epic
49129|NCT02977988|Mindfulness|mindfulness
49130|NCT02977988|Women|women
49131|NCT02977988|Relapse prevention|relapse prevention
49132|NCT02977988|Clinical trial|clinical trial
49133|NCT02977988|Substance use disorder|substance use disorder
49134|NCT02977988|Ethnically diverse|ethnically diverse
49135|NCT02977988|Underserved|underserved
49136|NCT02977988|Health disparities|health disparities
49137|NCT02977988|Stress|stress
49138|NCT02977988|Addiction|addiction
49139|NCT02977988|Latina/Hispanic|latina/hispanic
49140|NCT02977988|African American|african american
49141|NCT02977988|Treatment retention|treatment retention
49142|NCT02977988|Residential treatment|residential treatment
49143|NCT02977988|Brain Imaging|brain imaging
49144|NCT02977975|Irritable bowel syndrome|irritable bowel syndrome
49145|NCT02977975|The human microbiome|the human microbiome
49146|NCT02977975|Microbiota|microbiota
49147|NCT02977975|Gut microbiota|gut microbiota
49148|NCT02977975|Probiotics|probiotics
49149|NCT02977975|Sauerkraut|sauerkraut
49150|NCT02977949|SERM|serm
49151|NCT02977949|Season|season
49152|NCT02977949|Variation|variation
49153|NCT02977949|Vitamin D|vitamin d
49154|NCT02977923|Virtual reality|virtual reality
49454|NCT02976480|Irrigation|irrigation
49155|NCT02977923|Immersive distraction|immersive distraction
49156|NCT02977923|Oculus rift|oculus rift
49157|NCT02977923|Virtual world|virtual world
49158|NCT02977923|Virtual environment|virtual environment
49159|NCT02977923|Procedural pain|procedural pain
49160|NCT02977923|Procedural anxiety|procedural anxiety
49161|NCT02977923|Acute pain|acute pain
49162|NCT02977923|Pain management|pain management
49163|NCT02977923|Anxiety|anxiety
49164|NCT02977923|Children, Child|children, child
49165|NCT02977923|Kid, Kids|kid, kids
49166|NCT02977923|Pediatric, Pediatrics|pediatric, pediatrics
49167|NCT02977923|Young children|young children
49168|NCT02977923|Burns|burns
49169|NCT02977923|Burn injuries|burn injuries
49170|NCT02977923|Burn unit|burn unit
49171|NCT02977923|Physiotherapy|physiotherapy
49172|NCT02977923|Physical therapy|physical therapy
49173|NCT02977923|Burn dressing|burn dressing
49174|NCT02977923|Dressing change|dressing change
49175|NCT02977923|Non-pharmacological, nonpharmacological|non-pharmacological, nonpharmacological
49176|NCT02977923|Clinical Research|clinical research
49177|NCT02977923|Nursing Practice|nursing practice
49178|NCT02977897|Diarrhea|diarrhea
49179|NCT02977897|Immunosuppression|immunosuppression
49180|NCT02977897|Post-transplantation|post-transplantation
49181|NCT02977897|Octreotide|octreotide
49182|NCT02977897|Mycophenolate Mofetil|mycophenolate mofetil
49183|NCT02977897|Fecal Calprotectin|fecal calprotectin
49184|NCT02977884|nutrition|nutrition
49185|NCT02977884|exercise|exercise
49186|NCT02977884|stress|stress
49187|NCT02977884|cardiovascular disease|cardiovascular disease
49188|NCT02977884|diabetes|diabetes
49189|NCT02977884|hypertension|hypertension
49190|NCT02977884|dyslipidemia|dyslipidemia
49191|NCT02977884|cholesterol|cholesterol
49192|NCT02977884|overweight|overweight
49193|NCT02977884|obesity|obesity
49194|NCT02977884|lifestyle|lifestyle
40925|NCT03029494|oxidative stress|oxidative stress
40926|NCT03029494|saliva|saliva
49195|NCT02977871|Cesarean section|cesarean section
49196|NCT02977871|operating time|operating time
49197|NCT02977871|bladder|bladder
49198|NCT02977871|urinary retention|urinary retention
49199|NCT02977845|dypsnea|dypsnea
49200|NCT02977845|fatigue|fatigue
49201|NCT02977845|anxiety|anxiety
49207|NCT02977832|medical therapy|medical therapy
49208|NCT02977780|Glioblastoma|glioblastoma
49209|NCT02977728|MTBI|mtbi
49210|NCT02977728|olfaction|olfaction
49211|NCT02977728|acute|acute
49212|NCT02977715|Democratic Republic of the Congo|democratic republic of the congo
49213|NCT02977715|IMVAMUNE|imvamune
49214|NCT02977715|Modified Vaccinia Ankara (MVA)|modified vaccinia ankara (mva)
49215|NCT02977715|Monkeypox|monkeypox
49216|NCT02977715|Orthopoxvirus|orthopoxvirus
49217|NCT02977715|Vaccine|vaccine
49218|NCT02977715|Vaccinia virus|vaccinia virus
49219|NCT02977689|Isocitrate dehydrogenase (IDH)|isocitrate dehydrogenase (idh)
49220|NCT02977689|R-2-Hydroxyglutarate (2-HG)|r-2-hydroxyglutarate (2-hg)
49221|NCT02977689|Gene encoding UDP-glucuronosyltransferase (UGT1A1)|gene encoding udp-glucuronosyltransferase (ugt1a1)
49222|NCT02977689|Glioblastoma (GBM)|glioblastoma (gbm)
49223|NCT02977689|IDH305|idh305
49224|NCT02977689|IDHR132 mutations|idhr132 mutations
49225|NCT02977689|Astrocytoma|astrocytoma
49226|NCT02977689|Oligodendroglioma|oligodendroglioma
49227|NCT02977689|Oligoastrocytoma|oligoastrocytoma
49228|NCT02977689|IDH1 R132H|idh1 r132h
49229|NCT02977689|IDH1|idh1
49230|NCT02977637|hht|hht
49231|NCT02977637|hereditary|hereditary
49232|NCT02977637|hemorrhagic|hemorrhagic
49233|NCT02977637|telangiectasia|telangiectasia
49234|NCT02977637|feraheme|feraheme
49235|NCT02977585|continous positive airway pressure|continous positive airway pressure
49236|NCT02977585|helmet|helmet
49237|NCT02977585|non invasive|non invasive
49238|NCT02977585|positive end expiratory pressure|positive end expiratory pressure
49239|NCT02977585|severe bronchiolitis|severe bronchiolitis
49240|NCT02977585|pediatric intensive care unit|pediatric intensive care unit
49241|NCT02977572|Non-invasive ventilation,|non-invasive ventilation,
49242|NCT02977572|continuous positive airway pressure|continuous positive airway pressure
49243|NCT02977572|cardiogenic pulmonary oedema,|cardiogenic pulmonary oedema,
49244|NCT02977572|acute respiratory failure|acute respiratory failure
49245|NCT02977559|Laryngeal Tube Suction Ambu AuraGain Leak Pressure|laryngeal tube suction ambu auragain leak pressure
49246|NCT02977546|Hemodynamics|hemodynamics
49247|NCT02977546|Noninvasive|noninvasive
49248|NCT02977546|Pulse contour analysis|pulse contour analysis
49249|NCT02977546|Heart failure|heart failure
49250|NCT02977546|Swan Ganz Catheterization|swan ganz catheterization
49251|NCT02977546|Pulmonary artery Catheter|pulmonary artery catheter
49252|NCT02977468|triple negative breast cancer|triple negative breast cancer
49253|NCT02977468|Pembrolizumab|pembrolizumab
49254|NCT02977468|IORT|iort
49255|NCT02977468|tumor microenvironment|tumor microenvironment
49256|NCT02977442|Mitochondrial Dynamics|mitochondrial dynamics
49257|NCT02977442|Insulin Resistance|insulin resistance
49258|NCT02977442|Exercise and Diabetes|exercise and diabetes
49260|NCT02977429|Abdominal infection|abdominal infection
49261|NCT02977429|Hemodynamics|hemodynamics
49262|NCT02977429|Pcv-aCO2|pcv-aco2
49263|NCT02977429|Early Goal-directed Therapy (EGDT)|early goal-directed therapy (egdt)
49264|NCT02977416|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
49265|NCT02977416|fat oxidation|fat oxidation
49266|NCT02977416|exercise|exercise
49267|NCT02977403|Binge Eating|binge eating
49268|NCT02977403|Eating Behavior|eating behavior
49269|NCT02977403|Children|children
49270|NCT02977403|Magnetoencephalography|magnetoencephalography
49271|NCT02977403|Loss of Control|loss of control
49272|NCT02977351|Periodontopathogenic microorganisms|periodontopathogenic microorganisms
49273|NCT02977351|Non-surgical periodontal treatment|non-surgical periodontal treatment
49274|NCT02977325|Physical activity level|physical activity level
49275|NCT02977325|Personal efficacy|personal efficacy
49276|NCT02977325|Knee osteoarthritis|knee osteoarthritis
49277|NCT02977325|Self-management|self-management
49278|NCT02977325|Self-care|self-care
49279|NCT02977325|Education and exercise in knee osteoarthritis|education and exercise in knee osteoarthritis
49280|NCT02977273|Meal size|meal size
49281|NCT02977260|Meal size|meal size
49282|NCT02977247|SoftVue|softvue
49283|NCT02977247|Dense Breast Tissue|dense breast tissue
49284|NCT02977247|Breast Screening|breast screening
49285|NCT02977247|Abnormal Breast|abnormal breast
49286|NCT02977247|Normal Breast|normal breast
49287|NCT02977247|Breast Imaging|breast imaging
49288|NCT02977247|Breast Biopsy|breast biopsy
49289|NCT02977247|Mammography|mammography
49290|NCT02977247|Tomosynthesis|tomosynthesis
49291|NCT02977247|Automated Breast Ultrasound|automated breast ultrasound
49292|NCT02977247|Breast Cancer|breast cancer
49293|NCT02977247|Breast Carcinoma|breast carcinoma
41029|NCT03028870|Pain|pain
49294|NCT02977247|Breast Tumors|breast tumors
49295|NCT02977247|Mammary Carcinoma|mammary carcinoma
49312|NCT02977247|Dense Breasts|dense breasts
49313|NCT02977247|Breast Density|breast density
49314|NCT02977247|Dense Parenchyma|dense parenchyma
49315|NCT02977247|Asymptomatic|asymptomatic
49316|NCT02977247|Delphinus|delphinus
49317|NCT02977247|Delphinus Medical Technologies|delphinus medical technologies
49318|NCT02977247|Diagnostic Breast Imaging|diagnostic breast imaging
49319|NCT02977221|corticotomy|corticotomy
49320|NCT02977221|piezocision|piezocision
49321|NCT02977221|piezosurgery|piezosurgery
49322|NCT02977221|acceleration of tooth movement|acceleration of tooth movement
49323|NCT02977221|crowded anterior teeth|crowded anterior teeth
49324|NCT02977208|Gabapentin|gabapentin
49325|NCT02977208|OCT2|oct2
49326|NCT02977208|OCTN1|octn1
49327|NCT02977208|Pharmacogenetics|pharmacogenetics
49328|NCT02977208|Pharmacokinetics|pharmacokinetics
49329|NCT02977208|Polymorphisms|polymorphisms
49330|NCT02977195|First in Human|first in human
49331|NCT02977195|monoclonal antibody|monoclonal antibody
49332|NCT02977195|Netrin-1|netrin-1
49333|NCT02977156|Injectable lesion|injectable lesion
49334|NCT02977156|Intra-tumoral injection|intra-tumoral injection
49335|NCT02977143|fluid responsiveness|fluid responsiveness
49336|NCT02977143|central venous pressure|central venous pressure
49337|NCT02977143|positive end-expiratory pressure|positive end-expiratory pressure
49338|NCT02977143|robot surgery|robot surgery
49339|NCT02977117|magnesium|magnesium
49340|NCT02977117|ectopic calcification|ectopic calcification
49341|NCT02977117|chronic kidney disease - mineral and bone disorder|chronic kidney disease - mineral and bone disorder
49342|NCT02977117|serum calcification propensity|serum calcification propensity
49343|NCT02977091|short stature|short stature
49344|NCT02977091|fitness|fitness
49345|NCT02977091|children|children
49346|NCT02977078|Inhaler|inhaler
49347|NCT02977065|Dyslipidemia|dyslipidemia
49348|NCT02977065|CETP Inhibitors|cetp inhibitors
49349|NCT02977065|Hyperlipidemia|hyperlipidemia
49350|NCT02977052|Melanoma|melanoma
49351|NCT02977052|Ipilimumab|ipilimumab
49352|NCT02977052|Nivolumab|nivolumab
49353|NCT02977052|Neo-adjuvant|neo-adjuvant
49354|NCT02976987|Colvir|colvir
49355|NCT02976987|high grade squamous intraepithelial lesions|high grade squamous intraepithelial lesions
49356|NCT02976987|cervix|cervix
49357|NCT02976974|chronic pain|chronic pain
49358|NCT02976974|central sensitization|central sensitization
49359|NCT02976974|function|function
49361|NCT02976974|ultrasonography|ultrasonography
49362|NCT02976961|Information|information
49363|NCT02976961|Empowerment|empowerment
49364|NCT02976922|RAS|ras
49365|NCT02976922|microbiome|microbiome
49366|NCT02976922|probiotics|probiotics
49367|NCT02976883|Hypoxia|hypoxia
49368|NCT02976883|HX4|hx4
49369|NCT02976883|PET CT|pet ct
49370|NCT02976883|Radiotherapy|radiotherapy
49371|NCT02976870|Hydronephrosis|hydronephrosis
49372|NCT02976870|Anterior Lumbar Interbody Fusion|anterior lumbar interbody fusion
49373|NCT02976857|refractory diffuse large B-cell lymphoma|refractory diffuse large b-cell lymphoma
49374|NCT02976857|anti-CD19 chimeric antigen receptor T-cell|anti-cd19 chimeric antigen receptor t-cell
49375|NCT02976844|optimal balloon volume|optimal balloon volume
49376|NCT02976844|positive end-expiratory pressure|positive end-expiratory pressure
49377|NCT02976831|Plaque psoriasis vulgaris|plaque psoriasis vulgaris
49378|NCT02976792|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
49379|NCT02976792|Acute Kidney Injury|acute kidney injury
49380|NCT02976792|early acute kidney injury detection|early acute kidney injury detection
49381|NCT02976792|Nephrocheck™|nephrocheck™
49382|NCT02976792|Renal Resistive Index|renal resistive index
49384|NCT02976766|Clinical trial|clinical trial
49385|NCT02976766|Traditional Chinese medicine|traditional chinese medicine
49386|NCT02976766|Axonal loss|axonal loss
49387|NCT02976766|Jiaogulan|jiaogulan
49388|NCT02976766|Gynostemma pentaphyllum|gynostemma pentaphyllum
49389|NCT02976766|Optical coherence tomography|optical coherence tomography
49390|NCT02976753|Blood Coagulation Disorders|blood coagulation disorders
49391|NCT02976753|Hematologic Diseases|hematologic diseases
49392|NCT02976753|Coagulation Protein Disorders|coagulation protein disorders
49393|NCT02976753|Hemorrhagic Disorders|hemorrhagic disorders
49394|NCT02976753|Genetic Diseases, Inborn|genetic diseases, inborn
49395|NCT02976740|lung cancer|lung cancer
49396|NCT02976740|SBRT|sbrt
49397|NCT02976740|rhGM-CSF|rhgm-csf
49398|NCT02976740|Thymosin Alpha 1|thymosin alpha 1
49399|NCT02976727|Vitamin D|vitamin d
49400|NCT02976727|Calcipotriol|calcipotriol
49401|NCT02976727|Ablative fractional laser|ablative fractional laser
49402|NCT02976727|Actinic keratosis|actinic keratosis
49403|NCT02976727|Photodynamic therapy|photodynamic therapy
49404|NCT02976714|Cystic Fibrosis|cystic fibrosis
49405|NCT02976714|Lung disease|lung disease
49406|NCT02976714|DNA methylation|dna methylation
41235|NCT03027687|EMA|ema
49407|NCT02976714|Predictive biomarkers|predictive biomarkers
49408|NCT02976701|STEMI|stemi
50035|NCT02973295|Silymarin|silymarin
49409|NCT02976701|acute coronary syndrome|acute coronary syndrome
49410|NCT02976701|DLBS1033|dlbs1033
49411|NCT02976701|microvascular resistance index|microvascular resistance index
49412|NCT02976701|Left ventricular function|left ventricular function
49413|NCT02976688|Endstage renal Disease|endstage renal disease
49414|NCT02976688|Hemodialysis|hemodialysis
49415|NCT02976649|Morbid obesity|morbid obesity
49416|NCT02976649|Bariatric surgery|bariatric surgery
49417|NCT02976649|Multi-dimensional score|multi-dimensional score
49418|NCT02976636|Obesity treatment|obesity treatment
49419|NCT02976636|Parenting training|parenting training
49420|NCT02976636|Parenting style|parenting style
49421|NCT02976636|Family-based behavioral therapy|family-based behavioral therapy
49422|NCT02976623|metrics|metrics
49423|NCT02976623|feedback|feedback
49424|NCT02976623|ultrasound-guided|ultrasound-guided
49425|NCT02976623|procedural skills|procedural skills
49426|NCT02976610|hemolysis|hemolysis
49427|NCT02976597|Abdominal surgery, pain, local, transversus abdominus block.|abdominal surgery, pain, local, transversus abdominus block.
49428|NCT02976584|EEG|eeg
49429|NCT02976584|Cardiac Surgery|cardiac surgery
49430|NCT02976584|Seizure|seizure
49431|NCT02976584|Tranexamic acid|tranexamic acid
49432|NCT02976558|CAM|cam
49433|NCT02976558|allogenic Stem Cell Transplantation|allogenic stem cell transplantation
49434|NCT02976558|Graft-Versus-Host Disease|graft-versus-host disease
49435|NCT02976558|Depression|depression
49436|NCT02976558|Quality of Life|quality of life
49437|NCT02976558|Acupuncture|acupuncture
49438|NCT02976558|Traditional chinese Medicine|traditional chinese medicine
49439|NCT02976558|Integrative medicine|integrative medicine
49440|NCT02976558|Complementary and Alternative Medicine|complementary and alternative medicine
49441|NCT02976558|Music therapy TaKeTiNa|music therapy taketina
49442|NCT02976558|Clown theatrical performance|clown theatrical performance
49443|NCT02976558|Humour|humour
623879|NCT00676455|MeVis™|mevis™
49444|NCT02976558|Chemotherapy side effects|chemotherapy side effects
49445|NCT02976558|Psycho neuro immune system|psycho neuro immune system
49446|NCT02976558|GvHD|gvhd
49447|NCT02976558|PNEIS|pneis
49448|NCT02976558|CMV|cmv
49449|NCT02976558|EBV|ebv
49450|NCT02976558|holistic medicine|holistic medicine
49451|NCT02976532|Electromagnetic tracking|electromagnetic tracking
49452|NCT02976532|Internal rotation gait|internal rotation gait
49453|NCT02976532|Femoral derotation osteotomy|femoral derotation osteotomy
49455|NCT02976454|Obesity treatment|obesity treatment
49456|NCT02976454|Primary care|primary care
49457|NCT02976454|Guided Self-Help|guided self-help
49458|NCT02976428|knee soft tissue balancing|knee soft tissue balancing
49459|NCT02976428|sensor-guided|sensor-guided
49460|NCT02976428|range of motion|range of motion
49461|NCT02976415|Cardiac Surgery|cardiac surgery
49462|NCT02976415|Physiotherapy|physiotherapy
49463|NCT02976415|In-Bed Cycling|in-bed cycling
49464|NCT02976415|Mechanical Ventilation|mechanical ventilation
49465|NCT02976415|Cycle Ergometry|cycle ergometry
49466|NCT02976415|Early Mobilization|early mobilization
49467|NCT02976415|Rehabilitation|rehabilitation
49468|NCT02976415|Critical Care|critical care
49469|NCT02976415|Intensive Care Unit|intensive care unit
49470|NCT02976389|Supplemental Nutrition Assistance Program|supplemental nutrition assistance program
49471|NCT02976389|Food insecurity|food insecurity
49472|NCT02976389|fruit and vegetable|fruit and vegetable
49473|NCT02976389|healthy diet|healthy diet
49474|NCT02976376|Myocardial infarction|myocardial infarction
49475|NCT02976376|e-Health|e-health
49477|NCT02976376|mobile phones|mobile phones
49478|NCT02976376|smartphone|smartphone
49479|NCT02976376|follow-up|follow-up
49480|NCT02976363|Radiotherapy|radiotherapy
49481|NCT02976363|Respiratory muscles|respiratory muscles
49482|NCT02976363|Neoplasms|neoplasms
49483|NCT02976363|Breast|breast
49484|NCT02976350|Heart failure|heart failure
49485|NCT02976350|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
49486|NCT02976350|GH deficiency|gh deficiency
49487|NCT02976350|Testosterone deficiency|testosterone deficiency
49488|NCT02976350|Low- T3 syndrome|low- t3 syndrome
49489|NCT02976350|Multiple Hormone Deficiencies|multiple hormone deficiencies
49490|NCT02976337|Central sensitization|central sensitization
49491|NCT02976337|Endogenous opioids|endogenous opioids
49492|NCT02976337|Humans|humans
49493|NCT02976337|Latent sensitization|latent sensitization
49494|NCT02976337|Mandibular third molar extraction|mandibular third molar extraction
49495|NCT02976337|Naloxone|naloxone
49496|NCT02976337|Pain|pain
49497|NCT02976337|Pressure algometry|pressure algometry
49498|NCT02976337|Randomized controlled trial|randomized controlled trial
49499|NCT02976337|Secondary hyperalgesia|secondary hyperalgesia
49500|NCT02976337|Target controlled infusion|target controlled infusion
49501|NCT02976311|inflammatory reaction|inflammatory reaction
55986|NCT02935088|FFR|ffr
49502|NCT02976311|IL-6|il-6
49503|NCT02976311|TNF|tnf
49504|NCT02976311|Misgav Ladach technique|misgav ladach technique
49505|NCT02976311|Pfannenstiel-Kerr technique|pfannenstiel-kerr technique
50753|NCT02968589|Exercise|exercise
49506|NCT02976311|cesarean delivery|cesarean delivery
49507|NCT02976311|cesarean technique|cesarean technique
49508|NCT02976298|cerebellum|cerebellum
49509|NCT02976298|supplementary motor area|supplementary motor area
49510|NCT02976285|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
49511|NCT02976285|patch augmentation|patch augmentation
49512|NCT02976272|Bortezomib regimen|bortezomib regimen
49513|NCT02976272|patients with multiple myeloma|patients with multiple myeloma
49514|NCT02976233|Acute Respiratory Failure|acute respiratory failure
49515|NCT02976233|Non Invasive Ventilation|non invasive ventilation
49516|NCT02976233|Ultrasound|ultrasound
49517|NCT02976233|Diaphragm Thickening|diaphragm thickening
49518|NCT02976168|Cognitive functioning|cognitive functioning
49519|NCT02976168|Brain tissue oxygenation|brain tissue oxygenation
49520|NCT02976168|cerebral perfusion|cerebral perfusion
49521|NCT02976168|head down tilt|head down tilt
49522|NCT02976155|critically ill, intensive care, enteral nutrition|critically ill, intensive care, enteral nutrition
49523|NCT02976142|gastric cancer, metastatic|gastric cancer, metastatic
49524|NCT02976142|positive wash cytology|positive wash cytology
49525|NCT02976142|neoadjuvant intraperitoneal immunotherapy|neoadjuvant intraperitoneal immunotherapy
49526|NCT02976116|Fruquintinib|fruquintinib
49527|NCT02976116|NSCLC|nsclc
49528|NCT02976116|1st line|1st line
49529|NCT02976103|recovery|recovery
49530|NCT02976103|pain|pain
49531|NCT02976103|surgical drains|surgical drains
49532|NCT02976077|social cognition|social cognition
49533|NCT02976077|cognitive remediation|cognitive remediation
49534|NCT02976077|emotions|emotions
49535|NCT02976077|theory of mind|theory of mind
49536|NCT02976077|attributions|attributions
49537|NCT02976077|social perception|social perception
49538|NCT02976064|physical activity|physical activity
49539|NCT02976064|lifestyle|lifestyle
49540|NCT02976064|adaptive case management|adaptive case management
49541|NCT02976064|telemedicine|telemedicine
49542|NCT02976064|integrated care|integrated care
49543|NCT02976064|collaborative self-management|collaborative self-management
49544|NCT02976038|Primary Mitochondrial Disease|primary mitochondrial disease
49545|NCT02976038|Stealth|stealth
49546|NCT02976038|elamipretide|elamipretide
49547|NCT02976012|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
49548|NCT02976012|Aflibercept|aflibercept
49549|NCT02976012|Vitreous Hemorrhage|vitreous hemorrhage
49654|NCT02975336|Safety|safety
49550|NCT02975986|acidic, urine, nephrolithiasis, free fatty acid.|acidic, urine, nephrolithiasis, free fatty acid.
49551|NCT02975973|tDCS|tdcs
49552|NCT02975973|cognitive control|cognitive control
49553|NCT02975973|EEG|eeg
49554|NCT02975973|gamma oscillations|gamma oscillations
49555|NCT02975960|systemic sclerosis|systemic sclerosis
49556|NCT02975960|adipose derived stem cell|adipose derived stem cell
49557|NCT02975960|stromal vascular fraction|stromal vascular fraction
49558|NCT02975960|digital ulcer|digital ulcer
49559|NCT02975960|gangrene|gangrene
49560|NCT02975934|CRPC|crpc
49561|NCT02975934|PARP inhibitor|parp inhibitor
49562|NCT02975934|PARPi|parpi
49563|NCT02975934|BRCA|brca
49564|NCT02975934|ATM|atm
49565|NCT02975934|HRD|hrd
49566|NCT02975934|TRITON|triton
49567|NCT02975934|homologous recombination|homologous recombination
49568|NCT02975934|DNA repair|dna repair
49569|NCT02975934|DNA defect|dna defect
49570|NCT02975934|DNA anomaly|dna anomaly
49571|NCT02975934|germline|germline
49572|NCT02975934|somatic|somatic
49573|NCT02975921|Pleural Effusion|pleural effusion
49574|NCT02975921|Thoracentesis|thoracentesis
49575|NCT02975921|Pleural Cavity|pleural cavity
49576|NCT02975921|Pleurodesis|pleurodesis
49577|NCT02975921|Tunneled Pleural Catheter|tunneled pleural catheter
49578|NCT02975908|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
49579|NCT02975908|epidemiology|epidemiology
49580|NCT02975908|clinical features|clinical features
49581|NCT02975908|management|management
49582|NCT02975908|prognosis|prognosis
49583|NCT02975869|Leukemia|leukemia
49584|NCT02975869|Acute Myeloid Leukemia|acute myeloid leukemia
49585|NCT02975856|Anthocyanins|anthocyanins
49586|NCT02975856|Bioavailability|bioavailability
49587|NCT02975856|Flavonoids|flavonoids
49588|NCT02975856|Port wine|port wine
49589|NCT02975856|Red wine|red wine
49590|NCT02975817|pediatric, intraoperative, neurosurgery, inadvertent|pediatric, intraoperative, neurosurgery, inadvertent
49591|NCT02975804|cerebral palsy|cerebral palsy
49592|NCT02975804|video games|video games
49593|NCT02975804|postural control|postural control
49594|NCT02975804|balance|balance
49595|NCT02975804|children|children
49596|NCT02975791|Airway Obstruction|airway obstruction
49597|NCT02975778|80 years old|80 years old
49598|NCT02975765|corticotomy|corticotomy
49599|NCT02975765|minimally invasive|minimally invasive
49600|NCT02975765|piezosurgery|piezosurgery
49601|NCT02975765|piezocision|piezocision
49602|NCT02975765|pain|pain
49603|NCT02975765|discomfort|discomfort
49604|NCT02975739|Intratumoral|intratumoral
49605|NCT02975739|Tongue|tongue
49606|NCT02975739|Microspheres|microspheres
49607|NCT02975726|Liver Cirrhosis|liver cirrhosis
49608|NCT02975726|Refractory ascites|refractory ascites
49609|NCT02975726|PD catheter|pd catheter
49610|NCT02975713|P4,ART,IVF,FSH,LH,AMH|p4,art,ivf,fsh,lh,amh
49611|NCT02975700|PLX3397|plx3397
49612|NCT02975700|Kit-mutant Melanoma|kit-mutant melanoma
49613|NCT02975700|Unresectable or Metastatic KIT-mutated Melanoma|unresectable or metastatic kit-mutated melanoma
49614|NCT02975700|Developmental Phase I/II|developmental phase i/ii
49615|NCT02975687|Acute|acute
49616|NCT02975687|Leukemia|leukemia
49617|NCT02975687|Lymphoid|lymphoid
49618|NCT02975687|CD19|cd19
49619|NCT02975687|Refractory|refractory
49620|NCT02975635|Patients' Preferences|patients' preferences
49621|NCT02975596|educational intervention|educational intervention
49622|NCT02975583|Atherosclerosis|atherosclerosis
49623|NCT02975557|Brimonidine|brimonidine
49624|NCT02975557|Dry Eye|dry eye
49625|NCT02975557|oGVHD|ogvhd
49626|NCT02975557|MGD|mgd
49627|NCT02975544|social and emotional competence|social and emotional competence
49628|NCT02975544|healthy lifestyles|healthy lifestyles
49629|NCT02975544|children|children
49630|NCT02975544|educational programme|educational programme
49631|NCT02975531|Pompage|pompage
49632|NCT02975479|Hay fever|hay fever
49633|NCT02975479|Pollen allergy|pollen allergy
49634|NCT02975479|Allergic rhinitis|allergic rhinitis
49635|NCT02975440|Vilaprisan|vilaprisan
49636|NCT02975440|PK|pk
49637|NCT02975440|rifampicin|rifampicin
49638|NCT02975440|midazolam,|midazolam,
49639|NCT02975440|CYP3A4 induction|cyp3a4 induction
49640|NCT02975440|drug-drug interaction|drug-drug interaction
49641|NCT02975427|Diet|diet
583413|NCT00511641|Cancer Screening|cancer screening
49642|NCT02975427|Abdominal bioelectrical impedance analysis|abdominal bioelectrical impedance analysis
49643|NCT02975427|Anthropometry|anthropometry
49644|NCT02975427|Insulin resistance|insulin resistance
49645|NCT02975362|Acupuncture Treatment; Motor Dysfunction; Stroke Patients|acupuncture treatment; motor dysfunction; stroke patients
49646|NCT02975349|M2951|m2951
49647|NCT02975349|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
49648|NCT02975349|Bruton's Tyrosine Kinase inhibitor|bruton's tyrosine kinase inhibitor
49649|NCT02975336|Systemic Lupus Erythematosus|systemic lupus erythematosus
49650|NCT02975336|M2951|m2951
49651|NCT02975336|Placebo|placebo
49652|NCT02975336|Dose response|dose response
49653|NCT02975336|Oral Corticosteroids|oral corticosteroids
49655|NCT02975336|Efficacy|efficacy
49656|NCT02975336|Autoimmune And Inflammatory Disorders|autoimmune and inflammatory disorders
49657|NCT02975323|hepatic venous pressure gradient|hepatic venous pressure gradient
49658|NCT02975323|liver disease|liver disease
49659|NCT02975323|US Doppler waveform|us doppler waveform
49660|NCT02975323|Cirrhosis|cirrhosis
49661|NCT02975297|smoking|smoking
49662|NCT02975297|pre-diabetes|pre-diabetes
49663|NCT02975297|overweight|overweight
49664|NCT02975297|exenatide|exenatide
49665|NCT02975297|GLP-1 agonists|glp-1 agonists
49666|NCT02975284|bronchial thermoplasty|bronchial thermoplasty
49667|NCT02975284|long term|long term
49668|NCT02975284|interventional bronchoscopy|interventional bronchoscopy
49669|NCT02975258|HIV|hiv
49670|NCT02975258|Asthma|asthma
49671|NCT02975258|Adiposity|adiposity
49672|NCT02975258|Lung disease|lung disease
49673|NCT02975258|Weight|weight
49674|NCT02975258|Fat|fat
49675|NCT02975258|Obese|obese
49676|NCT02975245|Male infertility|male infertility
49677|NCT02975245|Germ cells|germ cells
49678|NCT02975245|Chemotherapy|chemotherapy
49679|NCT02975245|Sperm|sperm
49680|NCT02975232|nutrition disparities|nutrition disparities
49681|NCT02975232|SNAP population|snap population
49682|NCT02975232|behavioral economics|behavioral economics
49683|NCT02975232|retail setting|retail setting
49684|NCT02975232|point of purchase education|point of purchase education
49685|NCT02975232|pediatric obesity|pediatric obesity
49686|NCT02975232|rural population|rural population
49687|NCT02975232|fruit and vegetable purchases|fruit and vegetable purchases
49688|NCT02975232|fruit and vegetable consumption|fruit and vegetable consumption
49689|NCT02975193|Parkinsons Disease|parkinsons disease
49691|NCT02975167|Induction of labor|induction of labor
49692|NCT02975167|mechanical cervical ripening|mechanical cervical ripening
49693|NCT02975167|patient satisfaction|patient satisfaction
49694|NCT02975167|outpatient|outpatient
49695|NCT02975167|cost savings|cost savings
49696|NCT02975154|osteoarthritis|osteoarthritis
49697|NCT02975154|microcurrent|microcurrent
49698|NCT02975154|knee|knee
49699|NCT02975154|electrotherapy|electrotherapy
41445|NCT03026517|BRAF|braf
49700|NCT02975141|Palliative Chemotherapy|palliative chemotherapy
49701|NCT02975141|Afatinib|afatinib
49702|NCT02975141|Gemcitabine|gemcitabine
49703|NCT02975141|nab-paclitaxel|nab-paclitaxel
49704|NCT02975141|pancreatic cancer|pancreatic cancer
49705|NCT02975128|Minimal invasive|minimal invasive
49706|NCT02975128|Biopsy|biopsy
49707|NCT02975089|Frailty|frailty
51420|NCT02964039|gait|gait
49708|NCT02975089|nutrition education|nutrition education
49709|NCT02975089|designed dishware|designed dishware
49710|NCT02975089|balanced diet|balanced diet
49711|NCT02975089|multiple dietary components|multiple dietary components
49712|NCT02975076|Sanchitongshu|sanchitongshu
49713|NCT02975076|Acute Minor Stroke|acute minor stroke
49714|NCT02975076|Transient Ischemic Attack|transient ischemic attack
49715|NCT02975063|Exclusive breastfeeding|exclusive breastfeeding
49716|NCT02975024|mandibular vestibuloplasty|mandibular vestibuloplasty
49717|NCT02975024|wound healing|wound healing
49718|NCT02975024|microcirculation|microcirculation
49719|NCT02975024|Laser Speckle Contrast Imager|laser speckle contrast imager
49720|NCT02975024|Mucograft|mucograft
49721|NCT02975024|strip gingival graft|strip gingival graft
49722|NCT02975011|Magnetic Resonance Imaging|magnetic resonance imaging
49723|NCT02975011|Patient Satisfaction|patient satisfaction
49724|NCT02975011|Numeric Rating Scale|numeric rating scale
49725|NCT02974998|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
49726|NCT02974998|HIV Testing and Counseling (HTC)|hiv testing and counseling (htc)
49727|NCT02974998|Sexually Transmitted Infections (STIs)|sexually transmitted infections (stis)
49728|NCT02974998|Substance Abuse|substance abuse
49729|NCT02974998|Gender Based Violence|gender based violence
49730|NCT02974998|Gang Violence|gang violence
49731|NCT02974998|Victimization|victimization
49732|NCT02974998|Linkage to Care|linkage to care
49733|NCT02974998|Sexual Risk|sexual risk
49734|NCT02974998|Out-of-school Adolescents|out-of-school adolescents
49735|NCT02974998|Young Women|young women
49736|NCT02974985|Facelift|facelift
49737|NCT02974985|HA Filler|ha filler
49738|NCT02974985|Hyaluronic acid|hyaluronic acid
624083|NCT00677261|Nerve|nerve
49744|NCT02974933|apatinib|apatinib
49745|NCT02974933|pemetrexed|pemetrexed
49746|NCT02974933|NSCLC|nsclc
49747|NCT02974907|Dry Eye Syndrome|dry eye syndrome
49748|NCT02974907|Dry Eye|dry eye
49749|NCT02974907|DES|des
49750|NCT02974868|Phase 2|phase 2
49751|NCT02974868|randomized|randomized
49752|NCT02974868|double-blind|double-blind
49753|NCT02974868|placebo|placebo
49754|NCT02974868|alopecia areata|alopecia areata
49755|NCT02974868|safety|safety
49756|NCT02974868|efficacy|efficacy
49757|NCT02974868|JAK|jak
49758|NCT02974868|janus kinase|janus kinase
49759|NCT02974868|moderate|moderate
49760|NCT02974868|severe|severe
49761|NCT02974855|hemophilia|hemophilia
49762|NCT02974829|Chronic Hepatitis B|chronic hepatitis b
49763|NCT02974816|Glooko|glooko
49764|NCT02974816|Mobile health application|mobile health application
49765|NCT02974816|Insulin treated|insulin treated
49766|NCT02974816|Type 2 Diabetes|type 2 diabetes
49767|NCT02974816|Remote patient monitoring|remote patient monitoring
49768|NCT02974816|Certified diabetes educator|certified diabetes educator
49769|NCT02974816|mHealth Advantage|mhealth advantage
49770|NCT02974816|Population health|population health
49771|NCT02974790|echocardiography|echocardiography
49772|NCT02974790|training|training
49773|NCT02974790|emergency department|emergency department
49774|NCT02974790|circulatory failure|circulatory failure
49775|NCT02974725|NSCLC|nsclc
49776|NCT02974725|KRAS|kras
49777|NCT02974725|BRAF|braf
49778|NCT02974725|LXH254|lxh254
49779|NCT02974725|LTT462|ltt462
49780|NCT02974725|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
49781|NCT02974725|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
49782|NCT02974725|lung cancer|lung cancer
49783|NCT02974725|lung adenocarcinoma|lung adenocarcinoma
49784|NCT02974725|Large-cell lung carcinoma|large-cell lung carcinoma
49785|NCT02974725|Non small cell lung carcinoma|non small cell lung carcinoma
49787|NCT02974725|Large cell lung carcinoma|large cell lung carcinoma
49788|NCT02974725|Large cell lung cancer|large cell lung cancer
49789|NCT02974725|squamous cell lung carcinoma|squamous cell lung carcinoma
49790|NCT02974712|Arterial blood gases|arterial blood gases
49792|NCT02974712|HR|hr
49793|NCT02974673|Spinal Cord Injury|spinal cord injury
49794|NCT02974673|Genito sexuals disorders|genito sexuals disorders
49795|NCT02974673|Ejaculatory test|ejaculatory test
49796|NCT02974647|Ruxolitinib|ruxolitinib
49797|NCT02974647|T or NK Cell|t or nk cell
49798|NCT02974647|Relapsed|relapsed
49799|NCT02974647|Refractory|refractory
49800|NCT02974634|Ileostomy|ileostomy
49801|NCT02974608|Placental|placental
49802|NCT02974608|Fetal Loss|fetal loss
49803|NCT02974608|Observational|observational
49804|NCT02974608|Antenatal|antenatal
49805|NCT02974608|Infection|infection
49806|NCT02974608|Malaria|malaria
49807|NCT02974595|Autoinflammation|autoinflammation
49808|NCT02974595|Pediatric Syndromes|pediatric syndromes
49809|NCT02974595|Immune Dysregulation|immune dysregulation
49810|NCT02974595|IL-1 Mediated Diseases|il-1 mediated diseases
49811|NCT02974595|Interferonopathies|interferonopathies
49812|NCT02974582|Marketing|marketing
49813|NCT02974582|Smoking|smoking
49814|NCT02974582|Cigarette|cigarette
49815|NCT02974582|Young Adult|young adult
49816|NCT02974582|Socioeconomic Status|socioeconomic status
49817|NCT02974569|adolescents|adolescents
49818|NCT02974569|young adults|young adults
49819|NCT02974543|tinnitus|tinnitus
49820|NCT02974517|time-lapes|time-lapes
49821|NCT02974517|IVF/ICSI|ivf/icsi
49822|NCT02974517|pregnancy outcome|pregnancy outcome
49823|NCT02974491|hemodialysis|hemodialysis
49824|NCT02974491|diabetes mellitus|diabetes mellitus
49825|NCT02974491|apple juice|apple juice
49826|NCT02974491|potassium|potassium
49827|NCT02974478|orange juice consumption|orange juice consumption
49828|NCT02974478|glucose homeostasis|glucose homeostasis
49829|NCT02974478|antioxidative status|antioxidative status
49830|NCT02974465|Brain injuries|brain injuries
49831|NCT02974465|upper extremity|upper extremity
49832|NCT02974465|biofeedback|biofeedback
49833|NCT02974465|electromyography|electromyography
49834|NCT02974465|recovery of function|recovery of function
49835|NCT02974400|internet-based intervention|internet-based intervention
49836|NCT02974400|e-mental health|e-mental health
49837|NCT02974400|cognitive behavioural intervention|cognitive behavioural intervention
49845|NCT02974309|Diabetes Management|diabetes management
49847|NCT02974283|Normobaric hyperoxia|normobaric hyperoxia
49848|NCT02974283|r-tPA thrombolytic therapy|r-tpa thrombolytic therapy
49849|NCT02974257|cardiac arrest|cardiac arrest
49850|NCT02974257|thiamine|thiamine
49851|NCT02974257|oxygen consumption|oxygen consumption
49852|NCT02974257|lactate|lactate
49853|NCT02974257|shock|shock
49854|NCT02974244|Type 2 diabetes|type 2 diabetes
49855|NCT02974192|Ischemic stroke|ischemic stroke
49856|NCT02974192|Soluble CD40 Ligand|soluble cd40 ligand
49857|NCT02974192|Neopetrin|neopetrin
49858|NCT02974192|stroke risk factors|stroke risk factors
49859|NCT02974192|functional outcome|functional outcome
49860|NCT02974166|Temporomandibular Disorder|temporomandibular disorder
49861|NCT02974166|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
49862|NCT02974166|Rigid Splint|rigid splint
49863|NCT02974166|Speech Therapy|speech therapy
49864|NCT02974127|intracranial benign meningioma|intracranial benign meningioma
49865|NCT02974127|radiosurgery|radiosurgery
49866|NCT02974127|large meningioma|large meningioma
49867|NCT02974127|critical site|critical site
49868|NCT02974127|multisession radiosurgery|multisession radiosurgery
49869|NCT02974101|Spinal cord stimulation|spinal cord stimulation
49870|NCT02974101|AdaptiveStim|adaptivestim
49871|NCT02974062|Position sense|position sense
49872|NCT02974062|Lumbar stabilization exercise|lumbar stabilization exercise
49873|NCT02974049|Ivermectin|ivermectin
49874|NCT02974049|Albendazole|albendazole
49875|NCT02974049|Diethylcarbamazine|diethylcarbamazine
49876|NCT02974036|Patient education|patient education
49877|NCT02974036|Osteoarthritis|osteoarthritis
49878|NCT02974036|Primary health care|primary health care
49879|NCT02974010|d-cycloserine|d-cycloserine
49880|NCT02974010|lurasidone|lurasidone
49881|NCT02974010|ketamine|ketamine
49882|NCT02974010|randomized controlled trial|randomized controlled trial
49883|NCT02973984|Anticoagulant Treatments|anticoagulant treatments
49884|NCT02973984|Multidimensional Prognostic Index (MPI)|multidimensional prognostic index (mpi)
49885|NCT02973984|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
49886|NCT02973984|Frailty|frailty
49887|NCT02973984|Elderly|elderly
49888|NCT02973984|Atrial Fibrillation|atrial fibrillation
49889|NCT02973971|Blood cell biomarkers, peripheral circulating biomarkers|blood cell biomarkers, peripheral circulating biomarkers
49890|NCT02973958|Penis|penis
49891|NCT02973958|Pain|pain
49910|NCT02971852|Hypnosis|hypnosis
49911|NCT02971852|Anesthesia|anesthesia
49912|NCT02971852|Suggestion|suggestion
49913|NCT02971852|Thermography|thermography
49914|NCT02971826|Stroke|stroke
49915|NCT02971826|thrombectomy|thrombectomy
49916|NCT02971826|REVIVETM SE|revivetm se
49917|NCT02971826|MRI|mri
49918|NCT02971826|Computed Tomography|computed tomography
49919|NCT02971813|cardiac rehabilitation|cardiac rehabilitation
49920|NCT02971813|social media|social media
49921|NCT02971813|adherence|adherence
49922|NCT02971813|motivation|motivation
49923|NCT02971800|sodium fluorescein|sodium fluorescein
49924|NCT02971800|ureteral efflux|ureteral efflux
49925|NCT02971800|laparoscopic hysterectomy|laparoscopic hysterectomy
49926|NCT02971774|stroke|stroke
49927|NCT02971774|botulinum toxin injection|botulinum toxin injection
49928|NCT02971774|daily life|daily life
402906|NCT01229202|Vascular Endothelial Growth Inhibitor|vascular endothelial growth inhibitor
41646|NCT03025321|Cocaine|cocaine
49929|NCT02971748|hormone receptor-positive localized inflammatory breast cancer|hormone receptor-positive localized inflammatory breast cancer
49930|NCT02971748|Hormonal therapy|hormonal therapy
49931|NCT02971748|IBC|ibc
49932|NCT02971748|standard adjuvant hormonal therapy|standard adjuvant hormonal therapy
49933|NCT02971748|maintenance therapy|maintenance therapy
49934|NCT02971748|immune related biomarkers|immune related biomarkers
49935|NCT02971748|PD-L1 expression|pd-l1 expression
49936|NCT02971748|HR positive|hr positive
49937|NCT02971748|HR-positive localized IBC|hr-positive localized ibc
49938|NCT02971735|cognitive style|cognitive style
49939|NCT02971735|e-learning|e-learning
49940|NCT02971735|mobile technology|mobile technology
49941|NCT02971735|randomized controlled trial|randomized controlled trial
49942|NCT02971735|otolaryngology-head and neck surgery|otolaryngology-head and neck surgery
49943|NCT02971722|GLP-1 receptor agonist|glp-1 receptor agonist
49944|NCT02973815|family meals|family meals
49945|NCT02973815|home food availability|home food availability
49946|NCT02973802|Graves Disease|graves disease
49947|NCT02973802|Phase 1|phase 1
49948|NCT02973789|Non-Small Cell Lung Cancer|non-small cell lung cancer
49949|NCT02973789|NSCLC|nsclc
49950|NCT02973789|Treatment|treatment
49951|NCT02973789|Minimal Toxicity|minimal toxicity
49952|NCT02973789|TTFields|ttfields
49954|NCT02973789|Tumor Treating Fields|tumor treating fields
49955|NCT02973789|Novocure|novocure
49956|NCT02973789|Docetaxel|docetaxel
49957|NCT02973789|PD-1 inhibitor|pd-1 inhibitor
49958|NCT02973750|high-grade serous cancer|high-grade serous cancer
49959|NCT02973750|stage III cancer|stage iii cancer
49960|NCT02973750|stage IV cancer|stage iv cancer
49961|NCT02973724|Extubation|extubation
49962|NCT02973724|Remifentanil|remifentanil
49963|NCT02973724|Laryngomicrosurgery|laryngomicrosurgery
49964|NCT02973685|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
49965|NCT02973685|Transarterial Chemoembolization|transarterial chemoembolization
49966|NCT02973685|BCLC A/B|bclc a/b
49967|NCT02973672|Fluorescence|fluorescence
49968|NCT02973672|Surgery|surgery
49969|NCT02973672|Cancer|cancer
49970|NCT02973672|SGM-101|sgm-101
51945|NCT02960646|SLL|sll
49971|NCT02973672|Near Infrared|near infrared
49972|NCT02973672|Immunophotodetection|immunophotodetection
49973|NCT02973646|chronic hepatitis b|chronic hepatitis b
49974|NCT02973646|peginterferon alfa-2b|peginterferon alfa-2b
49975|NCT02973646|interferon gene mutation|interferon gene mutation
49976|NCT02973646|interferon receptor|interferon receptor
49977|NCT02973633|Heart Failure|heart failure
49978|NCT02973633|Remodeling|remodeling
49979|NCT02973633|Myocardial Infarction|myocardial infarction
49980|NCT02973633|Left Ventricular Hypertrophy|left ventricular hypertrophy
49981|NCT02973633|Diffusion Tensor MRI|diffusion tensor mri
49982|NCT02973594|left ventricular reverse remodeling|left ventricular reverse remodeling
49983|NCT02973594|beta-1 adrenergic receptor signaling|beta-1 adrenergic receptor signaling
49984|NCT02973594|idiopathic dilated cardiomyopathy|idiopathic dilated cardiomyopathy
49985|NCT02973594|HCN4 inhibition|hcn4 inhibition
49986|NCT02973594|beta-1 adrenergic receptor blocker|beta-1 adrenergic receptor blocker
49987|NCT02973594|gene expression|gene expression
49988|NCT02973581|Surgical Pleth Index (SPI)|surgical pleth index (spi)
49989|NCT02973581|General Anaesthesia (GA),|general anaesthesia (ga),
49990|NCT02973581|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
49991|NCT02973581|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
49992|NCT02973581|Peribulbar Block (PBB)|peribulbar block (pbb)
49993|NCT02973581|Topical Analgesia (TA)|topical analgesia (ta)
49994|NCT02973581|Oculocardiac reflex (OCR)|oculocardiac reflex (ocr)
49995|NCT02973581|Postoperative nausea nad vomitting (PONV)|postoperative nausea nad vomitting (ponv)
49997|NCT02973542|Ethosuximide|ethosuximide
49998|NCT02973542|Pain|pain
49999|NCT02973529|Percutaneous intervention (PCI)|percutaneous intervention (pci)
50000|NCT02973529|Optical coherence tomography (OCT)|optical coherence tomography (oct)
50001|NCT02973529|Bifurcation lesion|bifurcation lesion
50002|NCT02973529|Bioresorbable stents (BRS)|bioresorbable stents (brs)
50003|NCT02973503|Hepatitis C|hepatitis c
50004|NCT02973503|Genotype 1B|genotype 1b
50005|NCT02973503|Non Severe Fibrosis|non severe fibrosis
50006|NCT02973503|Treatment Naïve|treatment naïve
50007|NCT02973503|8 Weeks of Treatment|8 weeks of treatment
50008|NCT02973503|Elbasvir/Grazoprevir Combination|elbasvir/grazoprevir combination
50009|NCT02973490|ESD;Transanal Tube Drainage;Colorectal Tumor|esd;transanal tube drainage;colorectal tumor
50010|NCT02973438|Spinal Cord Injuries|spinal cord injuries
50011|NCT02973438|Obesity|obesity
50012|NCT02973438|Insulin Resistance|insulin resistance
50013|NCT02973438|Intermittent hypoxia|intermittent hypoxia
50014|NCT02973425|mHealth, Smoking cessation,|mhealth, smoking cessation,
50016|NCT02973399|Leukemia, Chronic Lymphocytic|leukemia, chronic lymphocytic
50017|NCT02973399|Hsp90|hsp90
50018|NCT02973399|Ibrutinib|ibrutinib
50019|NCT02973386|Local advanced|local advanced
50020|NCT02973386|High Risk|high risk
50021|NCT02973386|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
50022|NCT02973373|MRI|mri
50023|NCT02973373|Chest|chest
50024|NCT02973373|Apnea|apnea
50025|NCT02973347|Enteral Feeding|enteral feeding
50026|NCT02973347|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
50027|NCT02973347|Mechanical Ventilation|mechanical ventilation
50028|NCT02973347|Pediatric Intensive Care Unit|pediatric intensive care unit
50029|NCT02973347|Critical Illness|critical illness
50030|NCT02973334|sweeteners|sweeteners
50031|NCT02973334|sugar|sugar
50032|NCT02973334|stress response|stress response
50033|NCT02973295|NAFLD;|nafld;
50034|NCT02973295|Fibroscan|fibroscan
50036|NCT02973256|Meningioma grade II|meningioma grade ii
50037|NCT02973256|Meningioma grade III|meningioma grade iii
50038|NCT02973243|early warning scoring|early warning scoring
50039|NCT02973243|respiration rate|respiration rate
50040|NCT02973243|acute care teams|acute care teams
50041|NCT02973243|NEWS|news
50042|NCT02973243|CREWS|crews
50043|NCT02973230|Pregnancy, Ectopic|pregnancy, ectopic
50044|NCT02973230|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
50045|NCT02973230|Pregnancy, Tubal|pregnancy, tubal
50046|NCT02973217|Hyperthermia, Induced|hyperthermia, induced
50047|NCT02973217|Laser Coagulation|laser coagulation
50048|NCT02973217|Laser Therapy|laser therapy
50049|NCT02973204|tumor DNA|tumor dna
50050|NCT02973204|circulating tumor cells|circulating tumor cells
50051|NCT02973204|biopsy|biopsy
50052|NCT02973191|Leukemia|leukemia
50053|NCT02973191|B-Cell Acute Lymphoblastic Leukemia|b-cell acute lymphoblastic leukemia
50054|NCT02973191|JCAR015|jcar015
50055|NCT02973152|Type I Thyroplasty|type i thyroplasty
50056|NCT02973152|Reinnervation|reinnervation
50057|NCT02973113|Nivolumab|nivolumab
50058|NCT02973113|Hodgkin Lymphoma|hodgkin lymphoma
50059|NCT02973113|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
50060|NCT02973113|Lymphoproliferative Disorders|lymphoproliferative disorders
50061|NCT02973113|EBV-specific T Cells|ebv-specific t cells
50062|NCT02973074|iron deficiency|iron deficiency
50063|NCT02973074|patient blood management|patient blood management
50064|NCT02973074|anemia|anemia
50065|NCT02973048|Cesarean delivery|cesarean delivery
50066|NCT02973048|Spinal anesthesia|spinal anesthesia
50067|NCT02973048|Local anesthetics|local anesthetics
50068|NCT02973009|The Sleeve Gastrectomy (SG)|the sleeve gastrectomy (sg)
50069|NCT02973009|bariatric surgery|bariatric surgery
50070|NCT02973009|laparoscopy|laparoscopy
50071|NCT02973009|systematic closure of the epigastric|systematic closure of the epigastric
50072|NCT02972983|Staphylococcus aureus|staphylococcus aureus
50073|NCT02972983|Bacteremia|bacteremia
50074|NCT02972983|Daptomycin|daptomycin
50075|NCT02972957|intranasal|intranasal
50076|NCT02972957|flu vaccine|flu vaccine
50077|NCT02972957|Gambian children|gambian children
50078|NCT02972931|HIV infection|hiv infection
50079|NCT02972931|low HIV reservoir|low hiv reservoir
50080|NCT02972931|functional cure|functional cure
50081|NCT02972905|pharmacokinetics|pharmacokinetics
50082|NCT02972905|GSK2269557|gsk2269557
50083|NCT02972905|Dry powder Inhaler (DPI)|dry powder inhaler (dpi)
50084|NCT02972905|tolerability|tolerability
50085|NCT02972905|safety|safety
50086|NCT02972905|ELLIPTA|ellipta
50087|NCT02971657|Staphylococcus aureus phenotypic characterization|staphylococcus aureus phenotypic characterization
50088|NCT02971657|Antibiotic resistance|antibiotic resistance
50089|NCT02971657|Orthopedic device related infections|orthopedic device related infections
50090|NCT02971657|Phenotypic characterization|phenotypic characterization
50091|NCT02972879|trigger finger|trigger finger
50092|NCT02972879|Therapeutic Modalities|therapeutic modalities
50093|NCT02972879|Corticosteroid Injection|corticosteroid injection
50094|NCT02972879|non-surgical treatment|non-surgical treatment
50095|NCT02972879|physical therapy|physical therapy
50096|NCT02972840|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
50098|NCT02972840|ACP-196|acp-196
50099|NCT02972840|Mantle Cell Lymphoma|mantle cell lymphoma
50100|NCT02972840|acalabrutinib|acalabrutinib
50101|NCT02972840|ACE-LY-308|ace-ly-308
50102|NCT02972840|Treatment naive|treatment naive
50103|NCT02972840|Lymphoma|lymphoma
50104|NCT02972840|non-Hodgkins|non-hodgkins
50105|NCT02972814|Troponin|troponin
50106|NCT02972814|Point of care test|point of care test
50107|NCT02972814|myocardial infarction|myocardial infarction
50108|NCT02972801|Spermatogonial stem cells|spermatogonial stem cells
50109|NCT02972801|Testis|testis
50110|NCT02972801|Fertility|fertility
50111|NCT02972801|Infertility|infertility
50112|NCT02972801|Oncofertility|oncofertility
50113|NCT02972762|depth of anesthesia\postoperation delirium|depth of anesthesia\postoperation delirium
50114|NCT02972736|Radiation dose|radiation dose
50115|NCT02972736|percutaneous coronary intervention|percutaneous coronary intervention
50116|NCT02972736|Coronary|coronary
50117|NCT02972736|Interventional radiology|interventional radiology
50118|NCT02972736|Electrophysiology|electrophysiology
50119|NCT02972723|Metformin Therapy in HCV|metformin therapy in hcv
50120|NCT02972684|Cardiopulmonary Bypass|cardiopulmonary bypass
50121|NCT02972684|Hemorrhage|hemorrhage
50122|NCT02972684|blood transfusion|blood transfusion
50123|NCT02972684|Point-of-care test|point-of-care test
50124|NCT02972684|health economics|health economics
50125|NCT02972671|MiStent|mistent
50126|NCT02972658|Alzheimer's Disease|alzheimer's disease
50127|NCT02972658|Dementia|dementia
50128|NCT02972658|Brain Diseases|brain diseases
50129|NCT02972658|Neurodegenerative Diseases|neurodegenerative diseases
50130|NCT02972658|Central Nervous System Diseases|central nervous system diseases
50131|NCT02972658|Nervous System Diseases|nervous system diseases
50132|NCT02972658|Mental Disorders|mental disorders
51539|NCT02963181|Melatonin|melatonin
50133|NCT02972658|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
50134|NCT02972658|Tauopathies|tauopathies
50135|NCT02972658|Memory|memory
50136|NCT02972658|Amyloid|amyloid
50137|NCT02972632|Drug Therapy|drug therapy
50138|NCT02972619|Blood Pressure|blood pressure
50139|NCT02972619|Lipids|lipids
50140|NCT02972619|Cardiovascular|cardiovascular
50141|NCT02972619|Health Services|health services
50142|NCT02972619|Hypertension|hypertension
50143|NCT02972606|HIV|hiv
50144|NCT02972606|Peripheral Neuropathy|peripheral neuropathy
50145|NCT02972606|Chronic Pain|chronic pain
50146|NCT02972606|Qualitative Research|qualitative research
50147|NCT02972567|probiotics|probiotics
50148|NCT02972567|metabolic syndrome|metabolic syndrome
50149|NCT02972567|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
50150|NCT02972528|DFU|dfu
50151|NCT02972528|Diabetic Foot Ulcer|diabetic foot ulcer
50152|NCT02972528|Diabetes|diabetes
50153|NCT02972528|Platelet Rich Plasma|platelet rich plasma
50154|NCT02972515|Smoking|smoking
50155|NCT02972515|Smoking cessation|smoking cessation
50156|NCT02972515|Multiple behaviors|multiple behaviors
50157|NCT02972515|mHealth|mhealth
50158|NCT02972515|Mobile Application|mobile application
50159|NCT02972502|Metoclopramide (Reglan)|metoclopramide (reglan)
50160|NCT02972502|Haloperidol (Haldol)|haloperidol (haldol)
50161|NCT02972476|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
50162|NCT02972463|Gastrointestinal|gastrointestinal
50163|NCT02972463|Microbiome|microbiome
50164|NCT02972463|Inflammation|inflammation
50165|NCT02972437|GAS in oral cavity|gas in oral cavity
50166|NCT02972424|pelvic fracture|pelvic fracture
50167|NCT02972424|healing|healing
50168|NCT02972424|teriparatide|teriparatide
50169|NCT02972398|treatment resistant depression|treatment resistant depression
50170|NCT02972398|N-Acetyl Cysteine|n-acetyl cysteine
50171|NCT02972398|inflammation mediators|inflammation mediators
50172|NCT02972398|oxidative stress|oxidative stress
50173|NCT02972398|brain imaging|brain imaging
50174|NCT02972385|warfarin|warfarin
50175|NCT02972385|blood clotting|blood clotting
50176|NCT02972372|esophageal cancer|esophageal cancer
50177|NCT02972372|chemoradiation|chemoradiation
50178|NCT02972372|esophagectomy|esophagectomy
50179|NCT02972359|Neridronic Acid|neridronic acid
50180|NCT02972359|Neridronate|neridronate
50181|NCT02972359|CRPS|crps
50307|NCT02971228|Bionic Pancreas|bionic pancreas
50182|NCT02972359|RSD (reflex sympathetic dystrophy)|rsd (reflex sympathetic dystrophy)
50183|NCT02972294|iron isomaltoside|iron isomaltoside
50184|NCT02972294|tranexamic acid|tranexamic acid
50185|NCT02972203|Mindfulness|mindfulness
50186|NCT02972203|primary care|primary care
50187|NCT02972203|self-control|self-control
50188|NCT02972203|self-regulation|self-regulation
50189|NCT02972203|adherence|adherence
50190|NCT02972177|Lung cancer|lung cancer
50191|NCT02972177|Transbronchial ablation|transbronchial ablation
50192|NCT02972177|Radiofrequency ablation|radiofrequency ablation
50193|NCT02972177|Microwave ablation|microwave ablation
50194|NCT02972164|Childhood obesity|childhood obesity
50195|NCT02972164|Lifestyle|lifestyle
50196|NCT02972164|Prevention|prevention
50197|NCT02972164|Intervention|intervention
50198|NCT02972164|Behavioural psychology|behavioural psychology
50199|NCT02972138|Sickle-cells Disease|sickle-cells disease
50200|NCT02972138|bisphosphonates|bisphosphonates
50201|NCT02972138|Vitamine D|vitamine d
50202|NCT02972125|Lacosamide|lacosamide
50203|NCT02972125|Bioequivalence|bioequivalence
50204|NCT02972125|Dry Syrup|dry syrup
50205|NCT02972073|Low back pain|low back pain
50206|NCT02972073|Neuromuscular control|neuromuscular control
50207|NCT02972060|Hormone Naive Prostate Cancer|hormone naive prostate cancer
50208|NCT02972047|Reflux|reflux
50209|NCT02972021|respiratory insufficiency|respiratory insufficiency
50210|NCT02972021|High-flow nasal cannula|high-flow nasal cannula
50211|NCT02972008|Aortic stenosis|aortic stenosis
50212|NCT02972008|Transaortic valve replacement|transaortic valve replacement
50213|NCT02972008|stroke|stroke
50214|NCT02972008|Epigenetic|epigenetic
50215|NCT02971969|gene therapy|gene therapy
50216|NCT02971969|Hemophilia B|hemophilia b
50217|NCT02971956|Esophageal Cancer|esophageal cancer
50218|NCT02971917|Chest radiography|chest radiography
50219|NCT02971917|Image improvements|image improvements
50220|NCT02971917|Image Reconstruction|image reconstruction
50221|NCT02971917|Preprocessing|preprocessing
50222|NCT02971917|MTF|mtf
50223|NCT02971904|newborn|newborn
50224|NCT02971904|prematurity|prematurity
50225|NCT02971904|preterm|preterm
50226|NCT02971904|human milk|human milk
50227|NCT02971904|human milk analyzer|human milk analyzer
50228|NCT02971904|neonatology|neonatology
50229|NCT02971904|neonatal intensive care unit|neonatal intensive care unit
50230|NCT02971904|low birth weight|low birth weight
50231|NCT02971865|Cognitive Behavior Therapy|cognitive behavior therapy
50232|NCT02971865|Chiropractic|chiropractic
50233|NCT02971865|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
50234|NCT02971865|Primary care shared visit|primary care shared visit
50235|NCT02971631|Dumping syndrome|dumping syndrome
50236|NCT02971631|Gastrectomy|gastrectomy
50238|NCT02971631|Insulin|insulin
50239|NCT02971618|dapagliflozin,|dapagliflozin,
50240|NCT02971618|Russia,|russia,
50241|NCT02971618|retrospective study,|retrospective study,
50242|NCT02971618|diabetes mellitus type 2|diabetes mellitus type 2
50243|NCT02971579|ERCP|ercp
50244|NCT02971579|biliary diseases|biliary diseases
50245|NCT02971579|Pancreatic diseases|pancreatic diseases
50246|NCT02971579|outcome|outcome
50247|NCT02971579|Quality|quality
50248|NCT02971579|Training|training
50249|NCT02971566|feeding intolerance|feeding intolerance
50250|NCT02971566|preterm infants|preterm infants
50251|NCT02971566|near infrared spectroscopy|near infrared spectroscopy
50252|NCT02971566|abnormal antenatal Doppler|abnormal antenatal doppler
50354|NCT02971072|modeling|modeling
50253|NCT02971540|Surgical Pleth Index (SPI)|surgical pleth index (spi)
50254|NCT02971540|General Anaesthesia (GA),|general anaesthesia (ga),
50255|NCT02971540|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
50256|NCT02971540|Adequacy of Anaesthesia (AoA|adequacy of anaesthesia (aoa
50257|NCT02971540|Spectral Entropy (SE)|spectral entropy (se)
50258|NCT02971540|Local Anesthetic (LA)|local anesthetic (la)
50259|NCT02971488|Hepatitis C|hepatitis c
50260|NCT02971488|PWID|pwid
50261|NCT02971488|Linkage-to-care|linkage-to-care
50262|NCT02971475|Extracorporeal Shock Wave lithotripsy(ESWL)|extracorporeal shock wave lithotripsy(eswl)
50263|NCT02971475|Endoscopic Retrograde Cholangiopancreatography(ERCP)|endoscopic retrograde cholangiopancreatography(ercp)
50268|NCT02971462|remote ischemic conditioning|remote ischemic conditioning
50269|NCT02971449|Village Healthcare Team|village healthcare team
50270|NCT02971449|mHealth|mhealth
50271|NCT02971449|Telemedicine|telemedicine
50272|NCT02971423|infection|infection
50273|NCT02971423|gram-negative bacterium|gram-negative bacterium
50274|NCT02971345|Hepatocellular carcinoma|hepatocellular carcinoma
50275|NCT02971345|main portal vein tumor thrombus|main portal vein tumor thrombus
50276|NCT02971345|endovascular brachytherapy|endovascular brachytherapy
50277|NCT02971345|stent|stent
50278|NCT02971345|chemoembolization|chemoembolization
50279|NCT02971306|alcoholic hepatitis|alcoholic hepatitis
50280|NCT02971306|alcoholic liver disease|alcoholic liver disease
50281|NCT02971306|jaundice|jaundice
50282|NCT02971306|ascites|ascites
50283|NCT02971306|regeneration|regeneration
50284|NCT02971293|AZD8871|azd8871
50285|NCT02971293|long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
50286|NCT02971293|long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
50287|NCT02971293|inhaled long-acting bronchodilator|inhaled long-acting bronchodilator
50288|NCT02971293|pharmacokinetics|pharmacokinetics
50289|NCT02971293|safety|safety
50290|NCT02971293|tolerability|tolerability
50291|NCT02971293|efficacy|efficacy
50292|NCT02971293|Phase IIa|phase iia
50293|NCT02971293|Muscarinic receptor antagonist β2 adrenoceptor agonist (MABA)|muscarinic receptor antagonist β2 adrenoceptor agonist (maba)
50294|NCT02971267|heart failure|heart failure
50295|NCT02971267|cardiomyopathy|cardiomyopathy
50296|NCT02971267|myocarditis|myocarditis
50297|NCT02971254|cognitive functions|cognitive functions
50298|NCT02971254|anaesthesia recovery|anaesthesia recovery
50299|NCT02971254|sevoflurane|sevoflurane
50300|NCT02971254|desflurane|desflurane
50301|NCT02971241|Integeneration|integeneration
50302|NCT02971241|Mobile technology|mobile technology
50303|NCT02971241|Chronic disease management|chronic disease management
50304|NCT02971241|Diabetes self-management|diabetes self-management
50305|NCT02971228|glucagon|glucagon
50306|NCT02971228|T1DM|t1dm
50308|NCT02971228|diabetes|diabetes
50309|NCT02971228|iLet|ilet
50310|NCT02971228|iPhone|iphone
50311|NCT02971228|Beta Bionics|beta bionics
50312|NCT02971228|Anti-hypoglycemia|anti-hypoglycemia
50313|NCT02971228|Glucagon Analog|glucagon analog
50314|NCT02971202|o-glcnacylation|o-glcnacylation
50315|NCT02971202|hexosamine|hexosamine
50316|NCT02971163|Syncope|syncope
50317|NCT02971163|Shared Decision-Making|shared decision-making
50318|NCT02971163|Emergency Medicine|emergency medicine
50319|NCT02971163|Decision Aid|decision aid
50320|NCT02971137|Smoking|smoking
50321|NCT02971137|Cigarette Smoking|cigarette smoking
50322|NCT02971137|Veterans|veterans
50323|NCT02971137|Tobacco Use|tobacco use
50324|NCT02971137|Pain|pain
50325|NCT02971124|Cognitive Performance|cognitive performance
50326|NCT02971124|Meaningful Play|meaningful play
50327|NCT02971124|Screening test|screening test
50328|NCT02971124|Dementia|dementia
50329|NCT02971085|low-risk prostate cancer|low-risk prostate cancer
50330|NCT02971085|active surveillance|active surveillance
50331|NCT02971085|pathologic reclassification|pathologic reclassification
50332|NCT02971072|address|address
50333|NCT02971072|atrophic|atrophic
50334|NCT02971072|base|base
50335|NCT02971072|clinical|clinical
50336|NCT02971072|cost|cost
50337|NCT02971072|data|data
50338|NCT02971072|disability|disability
50339|NCT02971072|effectiveness|effectiveness
50340|NCT02971072|attention|attention
50341|NCT02971072|biofeedback|biofeedback
50342|NCT02971072|electrical stimulation|electrical stimulation
50343|NCT02971072|electromyography|electromyography
50344|NCT02971072|exercise|exercise
50345|NCT02971072|exertion|exertion
50346|NCT02971072|health care service utilization|health care service utilization
50347|NCT02971072|improved|improved
50348|NCT02971072|injection of therapeutic agent|injection of therapeutic agent
50349|NCT02971072|innovation|innovation
50350|NCT02971072|intervention|intervention
50351|NCT02971072|knowledge|knowledge
50352|NCT02971072|local anesthetics|local anesthetics
50353|NCT02971072|measures|measures
50364|NCT02971072|patients|patients
50365|NCT02971072|pattern|pattern
50366|NCT02971072|programs|programs
50367|NCT02971072|public health relevance|public health relevance
50368|NCT02971072|rehabilitation strategy|rehabilitation strategy
50369|NCT02971072|relating to nervous system|relating to nervous system
50370|NCT02971072|reporting|reporting
50371|NCT02971072|research|research
50372|NCT02971072|rotator cuff|rotator cuff
50373|NCT02971072|shoulder|shoulder
50375|NCT02971072|strength training|strength training
50376|NCT02971072|success|success
50377|NCT02971072|systematic review|systematic review
50378|NCT02971072|techniques|techniques
50379|NCT02971072|testing|testing
50380|NCT02971072|time|time
50381|NCT02971072|training|training
50382|NCT02971072|treatment strategy|treatment strategy
50383|NCT02971072|United States|united states
50384|NCT02971072|work|work
50385|NCT02971059|Elderly|elderly
50386|NCT02971059|Phenylalanine|phenylalanine
50387|NCT02971059|Healthy|healthy
50388|NCT02971046|healthy children|healthy children
50389|NCT02971046|protein|protein
50390|NCT02971046|glutathione|glutathione
50391|NCT02971046|protein requirement|protein requirement
50392|NCT02971033|hepatitis C virus|hepatitis c virus
50393|NCT02971033|antiviral treatment|antiviral treatment
50394|NCT02971033|viral entry inhibitor|viral entry inhibitor
50395|NCT02971033|mathematical modeling|mathematical modeling
50396|NCT02970994|Linear growth and neurodevelopment outcome|linear growth and neurodevelopment outcome
50397|NCT02970994|< 34 weeks|< 34 weeks
50398|NCT02970981|Monoclonal antibody|monoclonal antibody
50399|NCT02970981|Programmed Death-1 (PD-1)|programmed death-1 (pd-1)
50400|NCT02970981|Programmed Death-Ligand 1 (PD-L1)|programmed death-ligand 1 (pd-l1)
50401|NCT02970981|Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)|cytotoxic t lymphocyte-associated antigen 4 (ctla-4)
50402|NCT02970981|Antigen|antigen
50403|NCT02970929|Schizophrenia|schizophrenia
50404|NCT02970916|metastatic colorectal cancer|metastatic colorectal cancer
50405|NCT02970916|FOLFIRI|folfiri
50406|NCT02970916|aflibercept|aflibercept
50407|NCT02970916|oxaliplatin|oxaliplatin
50408|NCT02970916|ACE polymorphisms|ace polymorphisms
50409|NCT02970890|Total Hip Arthroplasty (THA)|total hip arthroplasty (tha)
50410|NCT02970890|Phototherapy|phototherapy
50411|NCT02970890|Low-level laser therapy|low-level laser therapy
50412|NCT02970890|Light-emitting diodes|light-emitting diodes
50421|NCT02970864|Nerve regeneration|nerve regeneration
50422|NCT02970864|Peripheral nerve injury|peripheral nerve injury
50423|NCT02970864|Nerve conduits|nerve conduits
50424|NCT02970864|Sensory nerve transection|sensory nerve transection
50425|NCT02970851|Endothelin receptor antagonist (ERA)|endothelin receptor antagonist (era)
50426|NCT02970851|pulmonary artery hypertension (PAH),|pulmonary artery hypertension (pah),
50427|NCT02970851|18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT)|18f-2-fluoro-2-deoxy-d-glucose (18f-fdg) positron emission tomography/computed tomography (pet/ct)
50428|NCT02970851|Rubidium-82 (82Rb) PET/CT|rubidium-82 (82rb) pet/ct
50429|NCT02970838|Formula diet|formula diet
50430|NCT02970825|exercise medicine|exercise medicine
50431|NCT02970825|youth|youth
50432|NCT02970825|adolescents|adolescents
50433|NCT02970825|students|students
50434|NCT02970695|insomnia|insomnia
50435|NCT02970695|older people|older people
50436|NCT02970695|auriculotherapy|auriculotherapy
50437|NCT02970669|Heart failure with reduced left ventricular ejection fraction (LVEF)|heart failure with reduced left ventricular ejection fraction (lvef)
50438|NCT02970669|Cardiac dysfunction|cardiac dysfunction
50439|NCT02970669|Heart muscle dysfunction|heart muscle dysfunction
624084|NCT00677261|Block|block
50440|NCT02970669|Left ventricular (LV) dilation|left ventricular (lv) dilation
50441|NCT02970669|Left ventricular hypertrophy|left ventricular hypertrophy
50444|NCT02970669|CHF|chf
50445|NCT02970669|acute heart failure|acute heart failure
50446|NCT02970669|chronic heart failure|chronic heart failure
50447|NCT02970669|congestive heart failure|congestive heart failure
50448|NCT02970669|congestive cardiac failure|congestive cardiac failure
50449|NCT02970669|Heart failure|heart failure
50450|NCT02970669|HReEF|hreef
50451|NCT02970669|Physical Activity|physical activity
50452|NCT02970669|Actigraphy|actigraphy
50453|NCT02970669|Home sleep test|home sleep test
50454|NCT02970669|wake|wake
50455|NCT02970643|Olanzapine|olanzapine
50456|NCT02970643|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
50457|NCT02970643|Moderate risk|moderate risk
50458|NCT02970630|prophylaxis|prophylaxis
50459|NCT02970591|FODMAPS|fodmaps
50460|NCT02970591|carbohydrates|carbohydrates
50461|NCT02970591|metabolomics|metabolomics
50462|NCT02970591|microbiota|microbiota
50463|NCT02970565|Family Nurture Intervention|family nurture intervention
50464|NCT02970565|Martha G. Welch MD|martha g. welch md
50465|NCT02970565|Randomized Control Trial|randomized control trial
50466|NCT02970565|Pre-school Intervention|pre-school intervention
50467|NCT02970565|Preschool Intervention|preschool intervention
50468|NCT02970565|Multiple Family Group Intervention|multiple family group intervention
50469|NCT02970565|Emotional Connection|emotional connection
50470|NCT02970565|Co-regulation|co-regulation
50471|NCT02970552|PreTerm Birth|preterm birth
50472|NCT02970552|HIV|hiv
50473|NCT02970552|Vaginal Progesterone|vaginal progesterone
50474|NCT02970552|ART|art
50475|NCT02970526|Colorectal cancer survivors|colorectal cancer survivors
50476|NCT02970513|Escherichia coli|escherichia coli
50477|NCT02970513|Microbiota|microbiota
50478|NCT02970513|Colorectal cancer|colorectal cancer
50479|NCT02970513|Psychiatric disorders|psychiatric disorders
50480|NCT02970513|Personality traits|personality traits
50481|NCT02970500|Cognitive impairment|cognitive impairment
50482|NCT02970500|Methylphenidate|methylphenidate
50483|NCT02970500|Cancer-related cognitive impairment|cancer-related cognitive impairment
50484|NCT02970500|Mixed method|mixed method
50485|NCT02970500|Phase II study|phase ii study
50486|NCT02970500|Breast cancer|breast cancer
50487|NCT02970487|cataract|cataract
50488|NCT02970461|personal health record|personal health record
50489|NCT02970461|gamification|gamification
50490|NCT02970461|chronic patient care|chronic patient care
50491|NCT02970448|LITT|litt
50492|NCT02970448|Brain Tumor|brain tumor
50493|NCT02970448|Temozolomide|temozolomide
50494|NCT02970435|surgery|surgery
50495|NCT02970435|video discharge instructions|video discharge instructions
50496|NCT02970422|Survey|survey
50497|NCT02970422|Priorities|priorities
50498|NCT02970422|Activities|activities
50499|NCT02970422|Participation|participation
50500|NCT02970357|Evaluation|evaluation
50501|NCT02970357|Therapeutic education|therapeutic education
50502|NCT02970357|Type 1 Diabetes|type 1 diabetes
50503|NCT02970357|Children|children
50504|NCT02970344|Coping Skills Training|coping skills training
50505|NCT02970344|Diabetes Education|diabetes education
50506|NCT02970318|CLL|cll
50507|NCT02970318|BTK|btk
50508|NCT02970318|Bruton Tyrosine Kinase|bruton tyrosine kinase
50509|NCT02970318|acalabrutinib|acalabrutinib
50510|NCT02970318|ACP-196|acp-196
50511|NCT02970279|Behavioural activation|behavioural activation
50512|NCT02970279|Psychotherapy, group|psychotherapy, group
50513|NCT02970279|Depression|depression
50514|NCT02970279|Depressive disorder|depressive disorder
50515|NCT02970266|Leber Congenital Amaurosis|leber congenital amaurosis
50516|NCT02970266|Genetic Decryption|genetic decryption
50517|NCT02970266|The genotype-phenotype correlations|the genotype-phenotype correlations
50518|NCT02970266|Ethnicity families|ethnicity families
50519|NCT02970240|cardiopulmonary exercise testing|cardiopulmonary exercise testing
50520|NCT02970240|inflammation|inflammation
50521|NCT02970240|oxidative status|oxidative status
50522|NCT02970227|heart failure|heart failure
50523|NCT02970227|cardiomyopathies|cardiomyopathies
50524|NCT02970227|myocarditis|myocarditis
50525|NCT02970214|heart failure|heart failure
50526|NCT02970214|heart disease|heart disease
50527|NCT02970214|cardiovascular disease|cardiovascular disease
50528|NCT02970214|metabolic risk|metabolic risk
50529|NCT02970214|comorbidities|comorbidities
50530|NCT02970201|eHealth|ehealth
50531|NCT02970201|mHealth|mhealth
50532|NCT02970201|Hemodialysis|hemodialysis
50533|NCT02970201|Adherence|adherence
50534|NCT02970201|Electronic intervention|electronic intervention
50535|NCT02970201|ESRD|esrd
50536|NCT02970201|Nephrology|nephrology
50537|NCT02970188|time restricted feeding|time restricted feeding
50538|NCT02970188|endothelial function|endothelial function
50540|NCT02970188|intermittent fasting|intermittent fasting
50542|NCT02970162|LEMS|lems
50543|NCT02970136|Increased Screening Uptake|increased screening uptake
50544|NCT02970136|Community Health Worker|community health worker
50545|NCT02970136|Medically Underserved|medically underserved
50546|NCT02970097|infraclavicular brachial plexus block|infraclavicular brachial plexus block
50547|NCT02970097|wrist arthroscopy|wrist arthroscopy
50548|NCT02970097|quality of recovery score|quality of recovery score
50549|NCT02970097|pain score|pain score
50550|NCT02970097|modified sleep quality assessment|modified sleep quality assessment
50551|NCT02970071|Spatio-Temporal Image Correlation|spatio-temporal image correlation
50944|NCT02967068|GPA|gpa
50552|NCT02970071|Complicated congenital heart disease|complicated congenital heart disease
50553|NCT02970071|Echocardiography|echocardiography
50554|NCT02970006|spinal cord stimulation|spinal cord stimulation
50555|NCT02970006|virtual reality|virtual reality
50556|NCT02970006|full body illusion|full body illusion
50558|NCT02969980|AML progressed from MDS|aml progressed from mds
50559|NCT02969980|CMML|cmml
50560|NCT02969967|rehabilitation|rehabilitation
50561|NCT02969967|upper extremity|upper extremity
50562|NCT02969967|orthosis|orthosis
50563|NCT02969967|SaeboFlex|saeboflex
50564|NCT02969941|Parkinson Disease|parkinson disease
50565|NCT02969941|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
50566|NCT02969941|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
50567|NCT02969928|Full-mouth ultrasonic debridement|full-mouth ultrasonic debridement
50568|NCT02969928|Clarithromycin|clarithromycin
50569|NCT02969928|Amoxicillin|amoxicillin
50570|NCT02969928|Metronidazole|metronidazole
50571|NCT02969915|people who inject drugs|people who inject drugs
50572|NCT02969915|men who have sex with men|men who have sex with men
50573|NCT02969915|HIV|hiv
50574|NCT02969915|India|india
50575|NCT02969902|Procedural pain|procedural pain
50576|NCT02969902|Phlebotomy|phlebotomy
50577|NCT02969902|Distraction|distraction
50578|NCT02969902|Hand-held computer|hand-held computer
50579|NCT02969902|Children|children
50580|NCT02969889|Airtraq|airtraq
50581|NCT02969889|Intubating laryngeal mask airway|intubating laryngeal mask airway
50582|NCT02969889|BMI>35|bmi>35
50583|NCT02969863|bionic pancreas|bionic pancreas
50584|NCT02969850|vitamin D supplementation|vitamin d supplementation
50585|NCT02969850|calcium supplementation|calcium supplementation
50586|NCT02969837|Multiple Myeloma|multiple myeloma
50587|NCT02969837|Elotuzumab|elotuzumab
50588|NCT02969837|Carfilzomib (Kyprolis)|carfilzomib (kyprolis)
50589|NCT02969837|Lenalidomide (Revlimid)|lenalidomide (revlimid)
50590|NCT02969837|Dexamethasone (E-KRd)|dexamethasone (e-krd)
50591|NCT02969824|Sport Injury|sport injury
50592|NCT02969824|Concussion|concussion
50593|NCT02969824|Active Recovery|active recovery
50594|NCT02969785|Postural control|postural control
50595|NCT02969785|Physiotherapy|physiotherapy
50596|NCT02969785|Sports injuries|sports injuries
50597|NCT02969785|Low back pain|low back pain
50598|NCT02969785|training|training
50599|NCT02969759|Bioenergetics|bioenergetics
50600|NCT02969759|Protein Metabolism|protein metabolism
50601|NCT02969759|Sporadic Amyotrophic Lateral Sclerosis|sporadic amyotrophic lateral sclerosis
50602|NCT02969746|activated charcoal, direct oral anticoagulant|activated charcoal, direct oral anticoagulant
50603|NCT02969733|postoperative analgesia|postoperative analgesia
50604|NCT02969733|PainMatcher|painmatcher
50605|NCT02969707|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
50606|NCT02969707|functional MRI|functional mri
50607|NCT02969707|Fibromyalgia|fibromyalgia
50608|NCT02969707|Hypnosis|hypnosis
50609|NCT02969707|Pain Assessment|pain assessment
50610|NCT02969694|addiction|addiction
50611|NCT02969694|hypersexuality|hypersexuality
50612|NCT02969694|psychostimulants|psychostimulants
50613|NCT02969668|opioid substitution treatment|opioid substitution treatment
50614|NCT02969668|interferon-free direct acting antivirals|interferon-free direct acting antivirals
50615|NCT02969668|hepatitis c therapy|hepatitis c therapy
50616|NCT02969655|Safety|safety
50617|NCT02969655|Efficacy|efficacy
50618|NCT02969655|Daprodustat|daprodustat
50619|NCT02969655|Chronic kidney disease|chronic kidney disease
50620|NCT02969616|lumbar, fusion, DDD, Trinity Elite|lumbar, fusion, ddd, trinity elite
50621|NCT02969603|PET/MRI|pet/mri
50622|NCT02969603|muscular activity|muscular activity
50623|NCT02969603|11C-acetate|11c-acetate
50624|NCT02969590|Contraception|contraception
50625|NCT02969590|Mucus|mucus
50626|NCT02969590|Cervix|cervix
50627|NCT02969590|progestin|progestin
50628|NCT02969590|hormones|hormones
50629|NCT02969577|Androgen deprivation therapy|androgen deprivation therapy
50630|NCT02969577|ADT|adt
50631|NCT02969564|prostate cancer|prostate cancer
50632|NCT02969564|bone metastases|bone metastases
50633|NCT02969564|PET/MRI|pet/mri
50638|NCT02969512|Advanced hip osteoarthritis|advanced hip osteoarthritis
50639|NCT02969512|Online education|online education
50640|NCT02969512|Computer-assisted instruction|computer-assisted instruction
50641|NCT02969512|e-learning|e-learning
50642|NCT02969512|Older adult|older adult
50643|NCT02969499|Electroconvulsive Therapy|electroconvulsive therapy
50644|NCT02969499|Dementia|dementia
50645|NCT02969473|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
50646|NCT02969473|concurrent chemoradiotherapy|concurrent chemoradiotherapy
50647|NCT02969473|docetaxel|docetaxel
50648|NCT02969473|cisplatin|cisplatin
50649|NCT02969473|5-fluorouracil|5-fluorouracil
50650|NCT02969447|Retained Placenta|retained placenta
50651|NCT02969447|Second trimester medical termination|second trimester medical termination
50652|NCT02969447|Third stage labor|third stage labor
50653|NCT02969447|Oxytocin|oxytocin
50654|NCT02969395|3T|3t
50655|NCT02969395|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
50656|NCT02969395|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
50657|NCT02969395|Implantable Pulse Generator (IPG)|implantable pulse generator (ipg)
51540|NCT02963181|Yohimbine|yohimbine
50658|NCT02969395|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
50659|NCT02969395|Cardiac Implantable Electronic Device (CIED)|cardiac implantable electronic device (cied)
50660|NCT02969382|Schizophrenia|schizophrenia
50661|NCT02969369|Parkinson's Disease Psychosis|parkinson's disease psychosis
50662|NCT02969304|Tecfidera|tecfidera
50663|NCT02969304|Off-label|off-label
50664|NCT02969304|Utilization|utilization
50665|NCT02969278|vulvar cancer|vulvar cancer
50666|NCT02969278|sentinel node biopsy|sentinel node biopsy
50667|NCT02969278|inguino-femoral lymphadenectomy|inguino-femoral lymphadenectomy
50668|NCT02969278|18F FDG- PET/TC|18f fdg- pet/tc
50669|NCT02969278|guidelines|guidelines
50670|NCT02969278|preoperative imaging|preoperative imaging
50671|NCT02969265|Drug therapy|drug therapy
50672|NCT02969226|mechanical ventilation|mechanical ventilation
50673|NCT02969226|weaning|weaning
50674|NCT02969226|critically ill|critically ill
50675|NCT02969226|spontaneous breathing trial|spontaneous breathing trial
50676|NCT02969226|screening|screening
50677|NCT02969226|invasive ventilation|invasive ventilation
50678|NCT02969226|SBT technique|sbt technique
754065|NCT01178788|Micronized Progesterone|micronized progesterone
50679|NCT02969213|Electronic management of epilepsy|electronic management of epilepsy
50680|NCT02969213|biological etiology|biological etiology
50681|NCT02969213|Chinese children|chinese children
50682|NCT02969200|Fabry Disease|fabry disease
50683|NCT02969200|Nephropathy|nephropathy
50684|NCT02969200|Measured GFR|measured gfr
50685|NCT02969200|Enzyme replacement therapy|enzyme replacement therapy
50686|NCT02969161|PMTCT (Prevention of Mother-to-Child Transmission)|pmtct (prevention of mother-to-child transmission)
50687|NCT02969161|HIV (Human Immunodeficiency Virus)|hiv (human immunodeficiency virus)
50688|NCT02969161|Loss to follow-up (LTF)|loss to follow-up (ltf)
50689|NCT02969161|Option B+ (B+)|option b+ (b+)
50690|NCT02969161|ART (antiretroviral therapy)|art (antiretroviral therapy)
50691|NCT02969148|Laparoscopic|laparoscopic
50692|NCT02969148|Bursectomy|bursectomy
50693|NCT02969148|D2 lymphadenectomy|d2 lymphadenectomy
50694|NCT02969148|Gastric Cancer|gastric cancer
50695|NCT02969122|gastric cancer|gastric cancer
50696|NCT02969122|peritoneal cytology|peritoneal cytology
50697|NCT02969083|UTUC|utuc
50698|NCT02969083|Upper Tract Urothelial Carcinoma|upper tract urothelial carcinoma
50699|NCT02969083|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
50700|NCT02969083|Adjuvant chemotherapy|adjuvant chemotherapy
50701|NCT02969083|Radical nephroureterectomy|radical nephroureterectomy
50702|NCT02969057|Lipidemic Response|lipidemic response
50703|NCT02969031|communication|communication
50704|NCT02969018|plaque psoriasis|plaque psoriasis
50705|NCT02969005|radiopaque localizer grid|radiopaque localizer grid
50706|NCT02969005|methylene blue|methylene blue
50707|NCT02969005|reduce radiation exposure|reduce radiation exposure
50708|NCT02968979|cachexia|cachexia
50709|NCT02968979|Non-Small Cell Lung cancer|non-small cell lung cancer
50710|NCT02968979|anorexia|anorexia
50711|NCT02968979|malnutrition|malnutrition
50712|NCT02968940|Programmed cell death protein 1 (PD-1)|programmed cell death protein 1 (pd-1)
50713|NCT02968940|Programmed death-ligand 1 (PD-L1)|programmed death-ligand 1 (pd-l1)
50714|NCT02968940|Immunotherapy|immunotherapy
50715|NCT02968940|Hypofractionated Radiotherapy (HFRT)|hypofractionated radiotherapy (hfrt)
50716|NCT02968940|Isocitrate dehydrogenase (IDH)|isocitrate dehydrogenase (idh)
50717|NCT02968940|Glioma|glioma
50718|NCT02968914|Asthma|asthma
50719|NCT02968914|Chronic Obstructive pulmonary Disease|chronic obstructive pulmonary disease
50720|NCT02968914|Pharmacokinetics|pharmacokinetics
50721|NCT02968914|Healthy volunteers|healthy volunteers
50722|NCT02968875|endurance training|endurance training
50723|NCT02968875|BDNF analysis|bdnf analysis
50724|NCT02968875|cognitive function|cognitive function
50725|NCT02968875|physiological abilities|physiological abilities
50726|NCT02968849|HIV|hiv
50727|NCT02968823|Postoperative Pain|postoperative pain
50728|NCT02968823|Anesthesia|anesthesia
50729|NCT02968823|Oral Surgery|oral surgery
50730|NCT02968784|Prostate Cancer|prostate cancer
50731|NCT02968784|MRgFUS|mrgfus
50732|NCT02968784|ExAblate|exablate
50733|NCT02968784|Focused Ultrasound|focused ultrasound
50734|NCT02968771|Coronary artery disease|coronary artery disease
50735|NCT02968771|Cardiac perfusion SPECT|cardiac perfusion spect
50736|NCT02968771|Metabolomics|metabolomics
50737|NCT02968745|Rheumatoid arthritis|rheumatoid arthritis
50738|NCT02968745|human activity|human activity
50739|NCT02968745|Canadian Occupational Performance Measure|canadian occupational performance measure
50740|NCT02968706|High Flow Nasal Cannula|high flow nasal cannula
50741|NCT02968706|Colonoscopy|colonoscopy
50742|NCT02968706|Obesity|obesity
50743|NCT02968654|Blood Transfusion|blood transfusion
50744|NCT02968654|Brain Injury|brain injury
50745|NCT02968654|Outcome|outcome
50746|NCT02968654|Hemoglobin|hemoglobin
50747|NCT02968615|fiber|fiber
50748|NCT02968615|lean protein|lean protein
50749|NCT02968615|loss weight|loss weight
50750|NCT02968589|Tele-rehabilitation|tele-rehabilitation
50751|NCT02968589|Function|function
50752|NCT02968589|Quality of life|quality of life
50754|NCT02968589|Occupational Therapy|occupational therapy
50755|NCT02968589|Physiotherapy|physiotherapy
50756|NCT02968589|Caregiver burden|caregiver burden
50757|NCT02968576|healthy volunteers|healthy volunteers
50758|NCT02968576|pharmacokinetics|pharmacokinetics
50759|NCT02968537|Alcohol use disorders|alcohol use disorders
50760|NCT02968537|inhibition|inhibition
50761|NCT02968537|EEG|eeg
50762|NCT02968537|cortisol|cortisol
50763|NCT02968537|Training|training
50764|NCT02968537|clinical outcome measures|clinical outcome measures
50765|NCT02968498|Blood glucose level|blood glucose level
50766|NCT02968498|Oral intake|oral intake
50767|NCT02968498|Lactulose|lactulose
50768|NCT02968498|Healthy volunteers|healthy volunteers
50769|NCT02968485|advanced solid tumor|advanced solid tumor
50770|NCT02968485|Protein Kinase MEK inhibitor (MEKi)|protein kinase mek inhibitor (meki)
50771|NCT02968485|Safety|safety
50772|NCT02968485|Pharmacokinetics|pharmacokinetics
50773|NCT02968472|4s CAR-T19|4s car-t19
50774|NCT02968472|B cell leukemia|b cell leukemia
50775|NCT02968472|B-ALL|b-all
50776|NCT02968459|Mesenchyme Stem Cells|mesenchyme stem cells
50777|NCT02968459|Cesarean Section|cesarean section
50778|NCT02968459|Uterine Scar|uterine scar
50779|NCT02968446|Valchlor|valchlor
50780|NCT02968446|Vitamin D|vitamin d
50781|NCT02968446|Healthy Volunteer|healthy volunteer
50782|NCT02968433|Young Male Plasma|young male plasma
50783|NCT02968381|tobacco|tobacco
50784|NCT02968381|smoking|smoking
50785|NCT02968381|imagery|imagery
50786|NCT02968342|Hypoactive sexual desire disorder|hypoactive sexual desire disorder
50787|NCT02968212|Mycobacterium avium Complex|mycobacterium avium complex
50788|NCT02968212|Clofazimine|clofazimine
50789|NCT02968186|Mass Screening|mass screening
50790|NCT02968186|Counseling|counseling
50791|NCT02968186|Primary Health Care|primary health care
50792|NCT02968173|Bronchopulmonary dysplasia (BPD)|bronchopulmonary dysplasia (bpd)
50793|NCT02968173|RSV hospitalization|rsv hospitalization
50794|NCT02968173|Palivizumab|palivizumab
50795|NCT02968173|Immunoprophylaxis|immunoprophylaxis
50796|NCT02968173|Chronic lung disease (CLD) of prematurity|chronic lung disease (cld) of prematurity
50797|NCT02968147|atrial fibrillation|atrial fibrillation
50798|NCT02968147|catheter ablation|catheter ablation
50799|NCT02968147|general anaesthesia|general anaesthesia
50800|NCT02968082|MVD|mvd
50801|NCT02968082|Scopolamine|scopolamine
50802|NCT02968082|Microvascular Decompression|microvascular decompression
50803|NCT02968056|atrial fibrillation|atrial fibrillation
50804|NCT02968056|radiofrequency ablation|radiofrequency ablation
50805|NCT02968043|physiotherapeutic scoliosis specific exercise|physiotherapeutic scoliosis specific exercise
50806|NCT02968030|Aged|aged
50807|NCT02968030|Postural balance|postural balance
50808|NCT02968030|Muscle strength|muscle strength
50809|NCT02967991|EUS|eus
50810|NCT02967991|Biopsy|biopsy
50811|NCT02967991|Liver|liver
50812|NCT02967991|FNA|fna
50813|NCT02967991|FNB|fnb
50814|NCT02967978|risk factors|risk factors
50815|NCT02967978|Calcium isotopes|calcium isotopes
50816|NCT02967978|calcium turnover|calcium turnover
50817|NCT02967978|DXA|dxa
50818|NCT02967965|clinical confounders|clinical confounders
50819|NCT02967965|myocardial infarction size|myocardial infarction size
50820|NCT02967965|determinants of myocardial infarct injury|determinants of myocardial infarct injury
50821|NCT02967952|out-of-hospital cardiac arrest (OHCA)|out-of-hospital cardiac arrest (ohca)
50822|NCT02967952|supraglottic airway (SGA)|supraglottic airway (sga)
50823|NCT02967952|endotracheal intubation (ETI)|endotracheal intubation (eti)
50824|NCT02967952|emergency medical system (EMS)|emergency medical system (ems)
583414|NCT00511641|Quality of Life|quality of life
50825|NCT02967952|Supraglottic Airway Versus Endotracheal tube (SAVE)|supraglottic airway versus endotracheal tube (save)
50826|NCT02967926|common bile duct stone|common bile duct stone
50827|NCT02967926|cholangioscopy|cholangioscopy
50828|NCT02967926|SpyGlass|spyglass
50829|NCT02967926|non-fluoroscopic|non-fluoroscopic
50830|NCT02967913|Cesarean delivery|cesarean delivery
50831|NCT02967913|Obstetrical delivery|obstetrical delivery
50833|NCT02967913|UDI-6|udi-6
50834|NCT02967913|Bladder flap|bladder flap
50835|NCT02967874|Adipose -Derived Stromal Vascular Fraction Cells|adipose -derived stromal vascular fraction cells
50836|NCT02967874|Knee Osteoarthritis|knee osteoarthritis
50837|NCT02967874|Intra-articular Administration|intra-articular administration
50838|NCT02967874|Liposuction|liposuction
50839|NCT02967861|chronic periodontitis|chronic periodontitis
50840|NCT02967861|Nuclear factor-kappa B|nuclear factor-kappa b
50841|NCT02967861|Pranayama|pranayama
50842|NCT02967861|Peroxisome proliferator - activated receptor gamma|peroxisome proliferator - activated receptor gamma
50847|NCT02967848|Cancer|cancer
50848|NCT02967848|SPECT|spect
50849|NCT02967770|Metastatic|metastatic
50850|NCT02967770|Pancreas|pancreas
50851|NCT02967770|Cancer|cancer
50852|NCT02967692|PDR001|pdr001
50853|NCT02967692|dabrafenib|dabrafenib
50854|NCT02967692|trametinib|trametinib
50855|NCT02967692|melanoma|melanoma
50856|NCT02967692|immunotherapy|immunotherapy
50857|NCT02967692|PD 1 inhibitor|pd 1 inhibitor
50858|NCT02967692|anti PD1|anti pd1
50859|NCT02967692|PD-1|pd-1
50860|NCT02967692|anti-PD-1|anti-pd-1
50861|NCT02967692|combination treatment|combination treatment
50862|NCT02967692|malignant skin cancer|malignant skin cancer
50863|NCT02967692|skin cancer|skin cancer
50864|NCT02967692|BRAF V600|braf v600
50865|NCT02967692|unresectable BRAF V600 mutated melanoma|unresectable braf v600 mutated melanoma
50866|NCT02967692|metastatic BRAF V600 mutated melanoma|metastatic braf v600 mutated melanoma
50867|NCT02967679|Neuropathy|neuropathy
50868|NCT02967679|Demyelinating polyradiculoneuropathy|demyelinating polyradiculoneuropathy
50869|NCT02967640|Ketamine|ketamine
50870|NCT02967640|Analgesics|analgesics
50871|NCT02967640|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists
50872|NCT02967640|Receptors, Glutamate|receptors, glutamate
50873|NCT02967640|Shoulder|shoulder
50874|NCT02967601|shivering, cesarean section, anxiety, STAI|shivering, cesarean section, anxiety, stai
50875|NCT02967588|Medication adherence|medication adherence
50876|NCT02967588|Behavioural intervention|behavioural intervention
50877|NCT02967588|Acute coronary syndrome|acute coronary syndrome
50878|NCT02967588|Medication beliefs|medication beliefs
50879|NCT02967588|Implementation intentions|implementation intentions
50880|NCT02967575|cervical total disc replacement (cTDR)|cervical total disc replacement (ctdr)
50881|NCT02967536|cognitive function|cognitive function
50882|NCT02967536|microglia|microglia
50883|NCT02967536|neuroinflammation|neuroinflammation
50884|NCT02967523|Hepatocellular carcinoma|hepatocellular carcinoma
50885|NCT02967523|DEB-TACE|deb-tace
50886|NCT02967497|Chemotherapy|chemotherapy
50887|NCT02967497|Herbal medicine|herbal medicine
50888|NCT02967497|Lung cancer|lung cancer
50889|NCT02967484|Acupuncture|acupuncture
50890|NCT02967484|Hypertension|hypertension
50891|NCT02967484|Second prevention of Stroke|second prevention of stroke
50892|NCT02967484|Efficacy|efficacy
50893|NCT02967484|RCT|rct
50894|NCT02967484|Study protocol|study protocol
50895|NCT02967471|ARDS|ards
50896|NCT02967458|prostate cancer|prostate cancer
50897|NCT02967458|prostate ultrasound|prostate ultrasound
50898|NCT02967458|subharmonic imaging|subharmonic imaging
50899|NCT02967458|prostate biopsy|prostate biopsy
50900|NCT02967432|Staphylococcus aureus|staphylococcus aureus
50901|NCT02967432|Staphylococcal colonization|staphylococcal colonization
50902|NCT02967432|Staphylococcal infection|staphylococcal infection
50903|NCT02967432|Mupirocin|mupirocin
50904|NCT02967432|Mupirocin-resistance|mupirocin-resistance
50905|NCT02967419|Repeated Implantation Failure; TWEAK;Fn14;JAK/STAT3;Indoleamine 2,3-dioxygenase|repeated implantation failure; tweak;fn14;jak/stat3;indoleamine 2,3-dioxygenase
50906|NCT02967406|Lifestyle modification|lifestyle modification
50907|NCT02967406|Primary prevention|primary prevention
50908|NCT02967406|Community-based intervention|community-based intervention
50909|NCT02967406|Randomized control trial|randomized control trial
50910|NCT02967328|Reticulated Platelets|reticulated platelets
50911|NCT02967328|Immune Thrombocytopenia|immune thrombocytopenia
50912|NCT02967302|knee arthritis, morphine, local injection, pain|knee arthritis, morphine, local injection, pain
50913|NCT02967289|colon|colon
50914|NCT02967289|cancer|cancer
50915|NCT02967289|stage 3|stage 3
50916|NCT02967289|high-risk|high-risk
50917|NCT02967289|mFolfirinox|mfolfirinox
50918|NCT02967289|mFolfox6|mfolfox6
50919|NCT02967289|adjuvant|adjuvant
50920|NCT02967276|Metformin|metformin
50921|NCT02967276|Dexamethasone|dexamethasone
50922|NCT02967276|Multiple Myeloma|multiple myeloma
50927|NCT02967198|Fusion|fusion
50928|NCT02967198|Ablation|ablation
50929|NCT02967198|Percutaneous biopsy|percutaneous biopsy
50930|NCT02967198|Shear wave elastography|shear wave elastography
402907|NCT01229202|glaucoma|glaucoma
50931|NCT02967159|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
50932|NCT02967159|asthma|asthma
50933|NCT02967107|adenoma|adenoma
50934|NCT02967107|colorectal cancer|colorectal cancer
50935|NCT02967107|polypectomy|polypectomy
50936|NCT02967107|colonoscopy|colonoscopy
50937|NCT02967081|Pulpitis|pulpitis
50938|NCT02967081|Biomarker|biomarker
50939|NCT02967081|Diagnostic|diagnostic
50940|NCT02967081|Dentinal fluid|dentinal fluid
50942|NCT02967068|EGPA|egpa
50943|NCT02967068|GCA|gca
50945|NCT02967068|MPA|mpa
50946|NCT02967068|PAN|pan
50947|NCT02967068|TAK|tak
50948|NCT02967068|HSP|hsp
50949|NCT02966951|osteoarthrosis|osteoarthrosis
50950|NCT02966951|knee|knee
50951|NCT02966951|adipose tissue|adipose tissue
50952|NCT02966951|stem cells|stem cells
50953|NCT02966951|cell therapy|cell therapy
50954|NCT02966925|Vulvovaginal dryness|vulvovaginal dryness
50955|NCT02966886|Surgical Management|surgical management
50956|NCT02966873|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
50957|NCT02966873|Addiction|addiction
50958|NCT02966873|Alcohol Use Disorder|alcohol use disorder
50959|NCT02966873|Cognitive Behavioral Therapy|cognitive behavioral therapy
50960|NCT02966873|N-acetylcysteine (NAC)|n-acetylcysteine (nac)
50961|NCT02966847|Video assisted thoracoscopy|video assisted thoracoscopy
50962|NCT02966847|Cone beam computed tomography|cone beam computed tomography
50963|NCT02966834|PBC|pbc
50964|NCT02966834|itch|itch
50965|NCT02966834|GSK2330672|gsk2330672
50966|NCT02966834|GLIMMER|glimmer
50967|NCT02966834|primary biliary cholangitis|primary biliary cholangitis
50968|NCT02966834|pruritus|pruritus
50969|NCT02966821|Sulfatinib|sulfatinib
50970|NCT02966821|Biliary Tract Cancer|biliary tract cancer
50971|NCT02966821|Second-line|second-line
50972|NCT02966795|sofosbuvir (SOF)|sofosbuvir (sof)
50973|NCT02966795|ribavirin (RBV)|ribavirin (rbv)
50974|NCT02966795|pegylated interferon (pegIFN)|pegylated interferon (pegifn)
50975|NCT02966795|interferon (IFN)|interferon (ifn)
50976|NCT02966795|pegylated-interferon (pegIFN)|pegylated-interferon (pegifn)
50977|NCT02966795|non-cirrhotic|non-cirrhotic
50978|NCT02966795|glecaprevir|glecaprevir
50979|NCT02966795|compensated cirrhosis|compensated cirrhosis
50980|NCT02966795|pibrentasvir|pibrentasvir
50981|NCT02966795|Sustained Virologic Response 12 weeks post dosing (SVR12)|sustained virologic response 12 weeks post dosing (svr12)
50982|NCT02966782|Azacitidine|azacitidine
50983|NCT02966782|Venetoclax|venetoclax
50984|NCT02966782|Higher-Risk (HR) Myelodysplastic Syndromes (MDS)|higher-risk (hr) myelodysplastic syndromes (mds)
50985|NCT02966782|International Prognostic Scoring System (IPSS)|international prognostic scoring system (ipss)
50986|NCT02966782|Hypomethylating Agent-Failure (HMA)|hypomethylating agent-failure (hma)
50987|NCT02966756|Relapsed chronic lymphocytic leukemia (CLL)|relapsed chronic lymphocytic leukemia (cll)
50988|NCT02966756|Leukemia|leukemia
50989|NCT02966756|17p deletion|17p deletion
50990|NCT02966756|Refractory chronic lymphocytic leukemia (CLL)|refractory chronic lymphocytic leukemia (cll)
50991|NCT02966756|Lymphoproliferative Disorders|lymphoproliferative disorders
50992|NCT02966756|venetoclax|venetoclax
50993|NCT02966730|follicular lymphoma|follicular lymphoma
50994|NCT02966730|Ibrutinib|ibrutinib
50995|NCT02966730|FLIPP|flipp
50996|NCT02966730|16-396|16-396
50997|NCT02966717|Rituximab|rituximab
50998|NCT02966717|Mesenchymal stem cells|mesenchymal stem cells
50999|NCT02966717|primary nephrotic syndrome|primary nephrotic syndrome
51000|NCT02966717|chronic kidney disease|chronic kidney disease
51001|NCT02966678|Glaucoma, Dychromatopsia|glaucoma, dychromatopsia
51002|NCT02966652|Male|male
51003|NCT02966652|Hypogonadism|hypogonadism
51004|NCT02966652|Primary|primary
51005|NCT02966652|Secondary|secondary
51006|NCT02966652|Androgen deficiency|androgen deficiency
51007|NCT02966626|Pragmatic, Sodium-Glucose Transporter 2 inhibitor, Malaysia|pragmatic, sodium-glucose transporter 2 inhibitor, malaysia
51008|NCT02966574|Whole body MRI|whole body mri
51009|NCT02966574|Breastcancer|breastcancer
51010|NCT02966561|Pulmonary Rehabilitation|pulmonary rehabilitation
51011|NCT02966561|Physical Activity|physical activity
51012|NCT02966561|Behaviour Change|behaviour change
51013|NCT02966561|Pedometer|pedometer
51014|NCT02966522|Thalidoide|thalidoide
51015|NCT02966483|Rectal cancer|rectal cancer
51016|NCT02966483|Laparoscopic surgery|laparoscopic surgery
51017|NCT02966483|Total mesorectal excision|total mesorectal excision
51018|NCT02966483|Transanal|transanal
51019|NCT02966483|Multicentre randomised clinical trial|multicentre randomised clinical trial
51020|NCT02966470|surgical outcomes|surgical outcomes
51021|NCT02966457|hematological infection, decolonization|hematological infection, decolonization
51022|NCT02966418|Cerebrovascular Disease|cerebrovascular disease
51023|NCT02966418|Mild Hypoxia preconditioning|mild hypoxia preconditioning
51024|NCT02966418|Ischemia, Brain|ischemia, brain
51025|NCT02966418|Brain Injury, Acute|brain injury, acute
51026|NCT02966392|Cuff pressure|cuff pressure
51027|NCT02966392|Ventilator associated pneumonia|ventilator associated pneumonia
51028|NCT02966392|Respiratory tract infections|respiratory tract infections
51029|NCT02966379|Electroacoustic stimulation|electroacoustic stimulation
51030|NCT02966353|Ruxolitinib|ruxolitinib
51031|NCT02966353|anemia|anemia
51032|NCT02966353|Primary Myelofibrosis|primary myelofibrosis
51033|NCT02966353|PMF|pmf
51034|NCT02966353|Post-Polycythemia Vera-Myelofibrosis|post-polycythemia vera-myelofibrosis
51035|NCT02966353|PPV-MF|ppv-mf
51036|NCT02966353|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
51037|NCT02966353|PET-MF|pet-mf
51038|NCT02966340|Alcoholism|alcoholism
51039|NCT02966340|Prazosin|prazosin
51048|NCT02966301|c GvHD|c gvhd
51049|NCT02966301|Arsenic Trioxyde|arsenic trioxyde
51050|NCT02966301|Hematology|hematology
51051|NCT02966275|glucagon|glucagon
51052|NCT02966275|continuous glucose monitorering (CGM)|continuous glucose monitorering (cgm)
51053|NCT02966275|artificial pancreas|artificial pancreas
51054|NCT02966275|hypoglycemia|hypoglycemia
51055|NCT02966275|post-bariatric hypoglycemia|post-bariatric hypoglycemia
51056|NCT02966275|bionic pancreas|bionic pancreas
51057|NCT02966275|bariatric surgery|bariatric surgery
51058|NCT02966249|dexmetomidine, intrathecally, intavenously,anesthesia|dexmetomidine, intrathecally, intavenously,anesthesia
51059|NCT02966236|percutaneous nephrolithotomy|percutaneous nephrolithotomy
51060|NCT02966171|Advanced Solid Malignancies|advanced solid malignancies
51061|NCT02966158|Aerobic Interval Training|aerobic interval training
51062|NCT02966158|Fitness|fitness
51063|NCT02966158|Endothelial Function|endothelial function
51064|NCT02966158|Cognition|cognition
51065|NCT02966145|CBD|cbd
51066|NCT02966145|CBS|cbs
51067|NCT02966145|CBGD|cbgd
51068|NCT02966145|PSP|psp
51069|NCT02966145|nfvPPA|nfvppa
51070|NCT02966145|oPSP|opsp
51071|NCT02966145|vPSP|vpsp
51072|NCT02966145|o/vPSP|o/vpsp
51073|NCT02966145|Corticobasal Degeneration|corticobasal degeneration
51074|NCT02966145|Corticobasal Syndrome|corticobasal syndrome
51075|NCT02966145|Cortocal-basal Ganglionic Degeneration|cortocal-basal ganglionic degeneration
51076|NCT02966145|Progressive Supranuclear Palsy|progressive supranuclear palsy
51077|NCT02966145|Nonfluent Variant Primary Progressive Aphasia|nonfluent variant primary progressive aphasia
51078|NCT02966145|Oligosymptomatic Progressive Supranuclear Palsy|oligosymptomatic progressive supranuclear palsy
51079|NCT02966145|Variant Progressive Supranuclear Palsy|variant progressive supranuclear palsy
51080|NCT02966145|Biomarker|biomarker
51081|NCT02966145|Neuroimaging|neuroimaging
51082|NCT02966145|MRI|mri
51083|NCT02966145|PET|pet
51084|NCT02966145|Tau|tau
51086|NCT02966145|Retinal Imaging|retinal imaging
51087|NCT02966132|Asian American|asian american
51088|NCT02966132|Immigrant Health|immigrant health
51089|NCT02966132|Digital Health Intervention|digital health intervention
51090|NCT02966132|Federally Qualified Health Centers|federally qualified health centers
51091|NCT02966119|stroke|stroke
51092|NCT02966119|intracranial hemorrhage|intracranial hemorrhage
51093|NCT02966119|intracerebral hemorrhage|intracerebral hemorrhage
51094|NCT02966119|antithrombotic drugs|antithrombotic drugs
51095|NCT02966119|brain microbleeds|brain microbleeds
51096|NCT02966093|Differentiated thyroid cancer|differentiated thyroid cancer
51097|NCT02966093|Chinese participants|chinese participants
51098|NCT02966093|Phase 3|phase 3
51099|NCT02966093|Lenvatinib|lenvatinib
51100|NCT02966093|E7080|e7080
51101|NCT02966080|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
51102|NCT02966080|intravenous heparin|intravenous heparin
51103|NCT02966067|Microneedles|microneedles
51104|NCT02966067|Dental Anaesthesia|dental anaesthesia
51105|NCT02966041|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
51106|NCT02966041|PONV|ponv
51107|NCT02966041|CSICU|csicu
51108|NCT02966041|post-cardiac surgery|post-cardiac surgery
51109|NCT02966041|cardiac intensive care unit|cardiac intensive care unit
51119|NCT02965989|nursery care|nursery care
51120|NCT02965989|nursery infection|nursery infection
51121|NCT02965989|online learning|online learning
51122|NCT02965950|breast cancer|breast cancer
51123|NCT02965950|TP53|tp53
51124|NCT02965950|cyclophosphamide|cyclophosphamide
51125|NCT02965937|Attentively embracing story|attentively embracing story
51126|NCT02965937|story-centred care|story-centred care
51127|NCT02965937|heart rate variability|heart rate variability
51128|NCT02965937|cognitive function|cognitive function
51129|NCT02965911|UDCA, Fenofibrate|udca, fenofibrate
51130|NCT02965898|chronic pancreatitis|chronic pancreatitis
51131|NCT02965898|vitamin d|vitamin d
51132|NCT02965898|pancreatitis|pancreatitis
51133|NCT02965898|Pancreatic stellate cell|pancreatic stellate cell
51134|NCT02965898|rct|rct
51135|NCT02965885|Phase I|phase i
51143|NCT02965885|HER2 positive MBC|her2 positive mbc
51144|NCT02965885|NSCLC EGFR T790M Positive|nsclc egfr t790m positive
51145|NCT02965885|NSCLC EGFR T790M Negative|nsclc egfr t790m negative
51146|NCT02965872|Postural Balance|postural balance
51147|NCT02965859|Chronic Hepatitis B|chronic hepatitis b
51149|NCT02965846|evaporative dry eye|evaporative dry eye
58040|NCT02922790|DNA|dna
51150|NCT02965833|Contact lens induced dryness|contact lens induced dryness
51151|NCT02965820|Contact lens induced dryness|contact lens induced dryness
51152|NCT02965807|Bronchial Thermoplasty|bronchial thermoplasty
51153|NCT02965807|moderate asthma|moderate asthma
51154|NCT02965807|China|china
51155|NCT02965794|surgery|surgery
51156|NCT02965794|bowel|bowel
51157|NCT02965794|rectum|rectum
51158|NCT02965794|cancer|cancer
51159|NCT02965794|nutrition|nutrition
51160|NCT02965755|Metastatic Breast Cancer|metastatic breast cancer
51161|NCT02965755|Breast Cancer|breast cancer
51162|NCT02965755|Molecular profiling|molecular profiling
51163|NCT02965755|Personalized medicine|personalized medicine
51164|NCT02965742|DXA|dxa
51165|NCT02965742|DMS|dms
51166|NCT02965742|STRATOS|stratos
51167|NCT02965729|behavior goals|behavior goals
51168|NCT02965729|self-monitoring|self-monitoring
51169|NCT02965729|pedometer|pedometer
51170|NCT02965729|physical activity|physical activity
51171|NCT02965690|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
51172|NCT02965690|TKR|tkr
51173|NCT02965690|Knee kinematics|knee kinematics
51174|NCT02965690|Dynamic RSA|dynamic rsa
51175|NCT02965690|Fluoroscopy|fluoroscopy
51176|NCT02965690|Roentgen Fluoroscopic Stereophotogrammetric Analysis|roentgen fluoroscopic stereophotogrammetric analysis
51177|NCT02965677|drug eluting balloon|drug eluting balloon
51849|NCT02961166|ECMO|ecmo
51178|NCT02965677|Femoral Popliteal Artery|femoral popliteal artery
51179|NCT02965651|embodied conversational agent|embodied conversational agent
51180|NCT02965651|virtual patient agent|virtual patient agent
51181|NCT02965651|meditation|meditation
51182|NCT02965651|mindfulness based stress reduction|mindfulness based stress reduction
51183|NCT02965651|nutrition|nutrition
51185|NCT02965612|Grass Allergy|grass allergy
51186|NCT02965612|Allergic Rhinitis|allergic rhinitis
51187|NCT02965612|Allergic Asthma|allergic asthma
51188|NCT02965612|Paediatric|paediatric
51196|NCT02965547|Ischemic Preconditioning|ischemic preconditioning
51197|NCT02965547|dynamic cerebral autoregulation|dynamic cerebral autoregulation
51198|NCT02965534|night vision|night vision
51199|NCT02965534|mesopic visual acuity|mesopic visual acuity
51200|NCT02965534|aberrometry|aberrometry
51201|NCT02965534|mesopic spectacle correction|mesopic spectacle correction
51202|NCT02965534|night myopia|night myopia
51203|NCT02965508|Home-bound|home-bound
51204|NCT02965508|home-based primary care|home-based primary care
51205|NCT02965495|Osteoarthritis|osteoarthritis
51206|NCT02965482|methacholine, airway hyperresponsiveness|methacholine, airway hyperresponsiveness
51207|NCT02965417|Resistance to anti-EGFR monoclonal antibodies|resistance to anti-egfr monoclonal antibodies
51208|NCT02965417|Mutation of ECD-EGFR|mutation of ecd-egfr
51209|NCT02965404|live attenuated varicella vaccine|live attenuated varicella vaccine
51211|NCT02965404|adult|adult
51212|NCT02965404|adolescent|adolescent
51213|NCT02965404|child|child
51214|NCT02965391|Circulating Tumor DNA|circulating tumor dna
51215|NCT02965391|Half time|half time
51216|NCT02965391|Lung cancer|lung cancer
51217|NCT02965391|Surgery|surgery
51218|NCT02965391|Surveillance|surveillance
51219|NCT02965339|Vasoplegia|vasoplegia
51220|NCT02965339|endothelial dysfunction|endothelial dysfunction
51221|NCT02965339|extracorporeal circulation|extracorporeal circulation
51222|NCT02965339|cardiac surgery|cardiac surgery
51223|NCT02965300|Pulmonary lesion|pulmonary lesion
51224|NCT02965300|Volatile Organic Compositions(VOCs)|volatile organic compositions(vocs)
51225|NCT02965248|Locally advanced colorectal cancer|locally advanced colorectal cancer
51226|NCT02965248|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
51227|NCT02965222|blastocyst|blastocyst
51228|NCT02965222|pregnancy rate|pregnancy rate
51229|NCT02965209|endoscopy|endoscopy
51230|NCT02965209|small bowel endoscopy|small bowel endoscopy
51231|NCT02965209|motorized spiral endoscopy|motorized spiral endoscopy
51232|NCT02965209|spiral endoscopy|spiral endoscopy
51233|NCT02965144|long-term survivors, high-grade glioma|long-term survivors, high-grade glioma
51236|NCT02965079|COPD and ARDS|copd and ards
51237|NCT02965079|CEDIT on behalf of APHP|cedit on behalf of aphp
51238|NCT02965040|ASP1517|asp1517
51239|NCT02965040|Normal renal function|normal renal function
51240|NCT02965040|Dialysis|dialysis
51245|NCT02965027|Chronic Headache|chronic headache
51246|NCT02965027|Post-Traumatic Stress Disorder|post-traumatic stress disorder
51247|NCT02965027|Iraq/Afghanistan Veteran|iraq/afghanistan veteran
51248|NCT02965014|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
51249|NCT02965014|Sexually transmitted infections (STI)|sexually transmitted infections (sti)
51250|NCT02965014|mHealth|mhealth
51251|NCT02965014|Substance abuse|substance abuse
51252|NCT02965014|Violence|violence
51253|NCT02965014|Victimization|victimization
51254|NCT02965014|Linkage to care|linkage to care
51255|NCT02965014|Sexual Risk|sexual risk
51256|NCT02965001|Molecular Imaging|molecular imaging
51257|NCT02965001|uPAR-PET/CT|upar-pet/ct
51258|NCT02965001|Head and neck cancer|head and neck cancer
51259|NCT02965001|curative intended radiotherapy|curative intended radiotherapy
51260|NCT02964949|Nonvalvular Atrial Fibrillation|nonvalvular atrial fibrillation
51261|NCT02964949|High Creatinine Clearance|high creatinine clearance
51262|NCT02964949|Developmental Phase III|developmental phase iii
51263|NCT02964949|Anticoagulant Naïve|anticoagulant naïve
51264|NCT02964936|Anemia|anemia
51265|NCT02964936|Non-dialysis chronic kidney disease|non-dialysis chronic kidney disease
51266|NCT02964936|Roxadustat|roxadustat
51267|NCT02964936|ASP1517|asp1517
51268|NCT02964923|Genetic polymorphism|genetic polymorphism
51269|NCT02964923|Metabolic side effects of drugs|metabolic side effects of drugs
51270|NCT02964923|schizophrenia|schizophrenia
51271|NCT02964923|Second-Generation Antipsychotic|second-generation antipsychotic
51272|NCT02964923|Cannabinoid Receptor Type 1|cannabinoid receptor type 1
51273|NCT02964910|Hepatitis E|hepatitis e
51274|NCT02964897|justice involvement|justice involvement
51275|NCT02964897|Homeless|homeless
51276|NCT02964897|Vulnerable Populations|vulnerable populations
51277|NCT02964897|Linkage to care|linkage to care
51278|NCT02964897|Veterans|veterans
51279|NCT02964871|Long-term care facility|long-term care facility
51280|NCT02964871|Elderly|elderly
51281|NCT02964858|Radiation Dose|radiation dose
51282|NCT02964858|Optimization|optimization
51283|NCT02964858|NHL|nhl
51284|NCT02964858|DLBCL|dlbcl
51285|NCT02964858|R-CHOP|r-chop
51286|NCT02964832|Basic Cardiac Life Support, Education, Feedback|basic cardiac life support, education, feedback
51850|NCT02961140|Outcome|outcome
51287|NCT02964793|Fetal Growth Restriction|fetal growth restriction
51288|NCT02964793|Customised Fetal Weight Reference|customised fetal weight reference
51289|NCT02964793|Estimated fetal Weight|estimated fetal weight
51290|NCT02964793|Symphysis Fundal Height|symphysis fundal height
51291|NCT02964767|HIV|hiv
51292|NCT02964767|HIV-Tb co infection|hiv-tb co infection
51293|NCT02964767|CD4 Cell|cd4 cell
51294|NCT02964741|Episodic Migraine|episodic migraine
51295|NCT02964741|Headache|headache
51296|NCT02964741|Opioid|opioid
51297|NCT02964689|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
51298|NCT02964689|KRAS mutations|kras mutations
51299|NCT02964689|Binimetinib|binimetinib
51300|NCT02964689|Pemetrexed|pemetrexed
51301|NCT02964689|Cisplatin|cisplatin
51302|NCT02964689|Phase IB trial|phase ib trial
51303|NCT02964624|Osteoarthritis|osteoarthritis
51304|NCT02964624|biomarkers|biomarkers
51305|NCT02964624|HMGB1|hmgb1
51306|NCT02964624|knee|knee
51307|NCT02964598|Adolescent|adolescent
51308|NCT02964598|Population-based|population-based
51309|NCT02964598|Social jetlag|social jetlag
51310|NCT02964598|Intervention|intervention
51311|NCT02964598|Bright light|bright light
51312|NCT02964598|Motivation|motivation
51313|NCT02964598|Circadian regulation|circadian regulation
51314|NCT02964598|Behavioral change|behavioral change
51315|NCT02964585|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
51316|NCT02964585|Endothelial Cells|endothelial cells
51317|NCT02964585|Cellular Biomarker|cellular biomarker
51318|NCT02964585|Endothelial Dysfunction|endothelial dysfunction
51319|NCT02964585|CD34+|cd34+
51320|NCT02964585|Impaired renal function|impaired renal function
51321|NCT02964546|direct oral anticoagulants|direct oral anticoagulants
51322|NCT02964546|atrial fibrillation|atrial fibrillation
51323|NCT02964546|renal function|renal function
51324|NCT02964546|ckd-epi|ckd-epi
51325|NCT02964546|plasmatic concentration|plasmatic concentration
51326|NCT02964520|trait anxiety|trait anxiety
51327|NCT02964520|A/T neurofeedback|a/t neurofeedback
51328|NCT02964520|EEG biofeedback|eeg biofeedback
51329|NCT02964520|randomized|randomized
51338|NCT02964468|Rectal Cancer|rectal cancer
51339|NCT02964468|IMRT|imrt
51340|NCT02964468|Radiation Dose Escalation|radiation dose escalation
624085|NCT00677261|Regional|regional
51360|NCT02964351|MicroRNA|microrna
51361|NCT02964351|Prostate Carcinoma|prostate carcinoma
51369|NCT02964299|Gastrointestinal endoscopy|gastrointestinal endoscopy
51370|NCT02964299|Moderate sedation|moderate sedation
51371|NCT02964299|Airway management|airway management
51372|NCT02964286|Cancer|cancer
51373|NCT02964286|Acupressure|acupressure
51374|NCT02964286|Hematopoietic Cell Growth Factors|hematopoietic cell growth factors
51375|NCT02964273|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
51376|NCT02964273|ADPKD|adpkd
51377|NCT02964273|Tolvaptan|tolvaptan
51378|NCT02964273|Renal cysts|renal cysts
51379|NCT02964273|Chronic Kidney Disease|chronic kidney disease
51380|NCT02964273|Genetic Kidney Disease|genetic kidney disease
51381|NCT02964260|Hepatocellular Carcinoma; Embolization; Ablation; simultaneously; sequentially|hepatocellular carcinoma; embolization; ablation; simultaneously; sequentially
51382|NCT02964234|Mammography Screening|mammography screening
51383|NCT02964234|Latinas|latinas
51384|NCT02964234|Breast cancer disparities|breast cancer disparities
51385|NCT02964208|Atrial Fibrillation|atrial fibrillation
51386|NCT02964208|Thromboembolism|thromboembolism
51387|NCT02964208|Stroke|stroke
51388|NCT02964208|ACP|acp
402908|NCT01229189|Vitamin D|vitamin d
51389|NCT02964208|Left Atrial Appendage|left atrial appendage
51390|NCT02964208|Cardiac Plug|cardiac plug
51391|NCT02964182|Mental and Behavioral Disorders Due to Use of Tobacco|mental and behavioral disorders due to use of tobacco
51392|NCT02964182|Carbon monoxide Testing|carbon monoxide testing
51393|NCT02964182|CO|co
51394|NCT02964182|Questionnaires|questionnaires
51395|NCT02964182|Surveys|surveys
51396|NCT02964182|Smartphone assessments|smartphone assessments
51397|NCT02964182|Electronic assessments|electronic assessments
51398|NCT02964182|Usual brand cigarettes|usual brand cigarettes
51399|NCT02964182|UB|ub
51400|NCT02964182|Very Low Nicotine Content Cigarettes|very low nicotine content cigarettes
51401|NCT02964182|VLNCC|vlncc
51402|NCT02964182|E-cigarettes|e-cigarettes
51403|NCT02964182|ECIG|ecig
51404|NCT02964156|RA|ra
51405|NCT02964156|Insole|insole
51406|NCT02964156|Forefoot|forefoot
51407|NCT02964156|Walking Ability|walking ability
51408|NCT02964156|Pain|pain
51409|NCT02964117|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
51410|NCT02964091|Hepatitis C Virus|hepatitis c virus
51411|NCT02964091|sofosbuvir/ledipasvir|sofosbuvir/ledipasvir
51412|NCT02964091|Efficacy|efficacy
51413|NCT02964078|Kidney Disease|kidney disease
51414|NCT02964078|Metastatic|metastatic
51415|NCT02964078|Antibody|antibody
51416|NCT02964065|Influenza Vaccines|influenza vaccines
51417|NCT02964065|LAIV|laiv
51418|NCT02964039|stroke|stroke
51419|NCT02964039|rehabilitation|rehabilitation
51421|NCT02964026|pulmonary artery catheter|pulmonary artery catheter
51422|NCT02964026|Swan-Ganz catheter|swan-ganz catheter
51430|NCT02964000|Pain|pain
51431|NCT02964000|Low level laser therapy|low level laser therapy
51432|NCT02964000|Sham|sham
51433|NCT02964000|Chronic Pain|chronic pain
51434|NCT02964000|Opioid|opioid
51435|NCT02964000|Physical activity|physical activity
51436|NCT02964000|Quality of sleep|quality of sleep
51437|NCT02963974|cochlear implant|cochlear implant
51438|NCT02963961|Delirium|delirium
51439|NCT02963961|Cognition|cognition
51440|NCT02963961|Prehabilitation|prehabilitation
51449|NCT02963896|vestibular rehabilitation|vestibular rehabilitation
51450|NCT02963883|ScVO2|scvo2
51451|NCT02963883|Post operative red cell transfusion|post operative red cell transfusion
51452|NCT02963870|Cognitive behavioral|cognitive behavioral
51453|NCT02963870|security plan|security plan
51454|NCT02963870|suicidal Recidivism in adolescents|suicidal recidivism in adolescents
51455|NCT02963857|breast surgery|breast surgery
51456|NCT02963857|acute pain|acute pain
51457|NCT02963857|regional anesthesia|regional anesthesia
51458|NCT02963831|Oncos-102|oncos-102
51459|NCT02963831|Durvalumab|durvalumab
51460|NCT02963831|Peritoneal|peritoneal
51461|NCT02963831|Cyclophosphamide|cyclophosphamide
51462|NCT02963818|Brief intervention|brief intervention
51463|NCT02963818|Harm reduction|harm reduction
51464|NCT02963818|Young adult|young adult
51465|NCT02963818|College Student|college student
51466|NCT02963805|Children|children
51467|NCT02963805|Physical activity|physical activity
51468|NCT02963805|Physical competence|physical competence
51469|NCT02963805|Obesity|obesity
51472|NCT02963805|Fundamental movement skills|fundamental movement skills
51474|NCT02963792|Burnout prevention|burnout prevention
51475|NCT02963792|Resiliency|resiliency
51476|NCT02963792|Student education|student education
51477|NCT02963766|Pediatrics|pediatrics
51478|NCT02963753|Hyperemesis gravidarum|hyperemesis gravidarum
51479|NCT02963753|gestational diabetes mellitus|gestational diabetes mellitus
51480|NCT02963753|oral glucose tolerance test|oral glucose tolerance test
51481|NCT02963740|breast cancer survivor|breast cancer survivor
51482|NCT02963740|weight loss program|weight loss program
51483|NCT02963727|osteoarthrosis|osteoarthrosis
51484|NCT02963727|Knee|knee
51485|NCT02963727|Wharton Jelly|wharton jelly
51486|NCT02963714|Hepatitis B, Vaccine|hepatitis b, vaccine
51487|NCT02963714|Randomized Controlled Trial|randomized controlled trial
51488|NCT02963714|Hemodialysis|hemodialysis
51489|NCT02963714|Immunogenicity|immunogenicity
51490|NCT02963662|obesity|obesity
51491|NCT02963662|bariatric surgery|bariatric surgery
51492|NCT02963662|gut hormones|gut hormones
51493|NCT02963662|inflammatory adipokine|inflammatory adipokine
51494|NCT02963649|Drug-eluting angioplasty balloon, Drug coated angioplasty balloon, Experimental, percutaneous transluminal angioplasty (PTA)|drug-eluting angioplasty balloon, drug coated angioplasty balloon, experimental, percutaneous transluminal angioplasty (pta)
51495|NCT02963636|family medicine group|family medicine group
51496|NCT02963636|pharmacists|pharmacists
51497|NCT02963636|primary health care|primary health care
51498|NCT02963636|pharmaceutical services|pharmaceutical services
51499|NCT02963636|interprofessional relations|interprofessional relations
51500|NCT02963623|fibtem|fibtem
51501|NCT02963623|total knee replacement|total knee replacement
51502|NCT02963584|chronic total occlusion|chronic total occlusion
51503|NCT02963584|decision aid|decision aid
51507|NCT02963493|relapsed refractory multiple myeloma|relapsed refractory multiple myeloma
51508|NCT02963467|multiple inert gas elimination technique|multiple inert gas elimination technique
51509|NCT02963467|smoking|smoking
51510|NCT02963467|pulmonary disorder|pulmonary disorder
51511|NCT02963441|Diabetic Retinopathy|diabetic retinopathy
51512|NCT02963441|Macular Edema|macular edema
51513|NCT02963415|Subjective memory complaint|subjective memory complaint
51514|NCT02963363|Breast cancer|breast cancer
51515|NCT02963363|HER2+|her2+
51516|NCT02963363|Adapted physical activity|adapted physical activity
51517|NCT02963363|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
51518|NCT02963337|remifentanil|remifentanil
51519|NCT02963337|combined spinal-epidural analgesia|combined spinal-epidural analgesia
51520|NCT02963337|multiparous|multiparous
51521|NCT02963272|Heart failure|heart failure
51522|NCT02963272|ST2|st2
51523|NCT02963272|fibrosis|fibrosis
51524|NCT02963246|mindfulness|mindfulness
51525|NCT02963246|quality of life|quality of life
51526|NCT02963246|Bowel Disease|bowel disease
51527|NCT02963207|colorectal polyp|colorectal polyp
51528|NCT02963207|colorectal lesion|colorectal lesion
51529|NCT02963207|Modified Sano's Classification|modified sano's classification
51530|NCT02963207|NICE classification|nice classification
51531|NCT02963207|NBI|nbi
51532|NCT02963207|PIVI guidelines|pivi guidelines
51533|NCT02963207|SSA/P|ssa/p
51534|NCT02963207|sessile serrated adenoma|sessile serrated adenoma
51535|NCT02963207|sessile serrated polyp|sessile serrated polyp
51536|NCT02963194|self-processing|self-processing
51537|NCT02963194|endowment effect|endowment effect
51538|NCT02963194|neuroimage|neuroimage
51541|NCT02963181|Anti-hypertensive agents|anti-hypertensive agents
51542|NCT02963155|prostate, metastatic|prostate, metastatic
51543|NCT02963142|Intensive care|intensive care
51544|NCT02963142|Extra-corporeal membrane oxygenation (ECMO)|extra-corporeal membrane oxygenation (ecmo)
51545|NCT02963142|Severe Respiratory Infections|severe respiratory infections
51546|NCT02963142|Sequencing|sequencing
51547|NCT02963142|Metagenome|metagenome
51548|NCT02963142|Diagnosis|diagnosis
51549|NCT02963129|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
51550|NCT02963129|Epistaxis|epistaxis
51551|NCT02963116|Pharmacokinetics (PK)|pharmacokinetics (pk)
51552|NCT02963116|Bioavailability (BA)|bioavailability (ba)
51553|NCT02963116|Safety|safety
51554|NCT02963116|Tolerability|tolerability
51555|NCT02963116|Healthy Volunteers|healthy volunteers
51556|NCT02963103|Tacrolimus|tacrolimus
51557|NCT02963103|Kidney transplantation|kidney transplantation
51558|NCT02963090|SCLC|sclc
51559|NCT02963090|small cell lung cancer|small cell lung cancer
51560|NCT02963090|lung cancer|lung cancer
51561|NCT02963090|topotecan|topotecan
51562|NCT02963090|pembrolizumab|pembrolizumab
51563|NCT02963064|Immunodeficiency|immunodeficiency
51564|NCT02963064|Pediatric|pediatric
51565|NCT02963064|SCID|scid
51566|NCT02963064|Bone Marrow Transplantation|bone marrow transplantation
51567|NCT02963064|GVHD|gvhd
51568|NCT02963064|Stem Cells|stem cells
51569|NCT02963064|Chimerism|chimerism
51570|NCT02963064|Transplant|transplant
51572|NCT02963051|metastatic castrate-resistant prostate cancer (mCRPC)|metastatic castrate-resistant prostate cancer (mcrpc)
51573|NCT02963051|neuroendocrine prostate cancer (NEPC)|neuroendocrine prostate cancer (nepc)
51574|NCT02963051|adenocarcinoma castrate-resistant prostate cancer (CRPC)|adenocarcinoma castrate-resistant prostate cancer (crpc)
51575|NCT02963051|Copper|copper
51576|NCT02963051|Disulfiram|disulfiram
51577|NCT02962999|Ketamine|ketamine
51578|NCT02962999|One lung ventilation|one lung ventilation
51579|NCT02962999|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
51580|NCT02962986|vasopressor|vasopressor
51581|NCT02962986|blood pressure|blood pressure
51582|NCT02962986|cesarean section|cesarean section
51583|NCT02962986|spinal anesthesia|spinal anesthesia
51584|NCT02962973|Advanced heart failure|advanced heart failure
51585|NCT02962973|Total artificial heart|total artificial heart
51586|NCT02962947|Melanoma|melanoma
51587|NCT02962947|Propanolol|propanolol
51588|NCT02962947|Betablockers|betablockers
51589|NCT02962908|broad|broad
51590|NCT02962908|universal|universal
51591|NCT02962908|vaccine|vaccine
51592|NCT02962908|influenza|influenza
51593|NCT02962908|peptide|peptide
51594|NCT02962908|Tcell|tcell
51595|NCT02962908|UNISEC|unisec
51596|NCT02962843|Behavior Problem|behavior problem
51597|NCT02962843|Social Competence|social competence
51598|NCT02962843|Student|student
51599|NCT02962843|Children|children
51600|NCT02962830|fetal pain|fetal pain
51601|NCT02962830|fetal analgesia|fetal analgesia
51602|NCT02962804|kidney|kidney
51603|NCT02962804|renal cell|renal cell
51604|NCT02962804|cancer|cancer
51605|NCT02962804|metastatic|metastatic
51606|NCT02962804|recurrent|recurrent
51607|NCT02962791|symptomatic heart failure|symptomatic heart failure
43263|NCT03015012|BMI|bmi
51608|NCT02962778|treatment-resistant|treatment-resistant
51609|NCT02962739|healthy volunteers|healthy volunteers
51610|NCT02962726|Anorexia|anorexia
51611|NCT02962726|Depression|depression
51612|NCT02962726|Microbiome|microbiome
51613|NCT02962713|Atraumatic Restorative Treatment|atraumatic restorative treatment
51614|NCT02962713|glass ionomer cement|glass ionomer cement
51615|NCT02962713|primary teeth|primary teeth
51616|NCT02962713|dental caries.|dental caries.
51617|NCT02962700|continuous haemofiltration|continuous haemofiltration
51618|NCT02962700|intermittent haemodialysis|intermittent haemodialysis
51619|NCT02962687|Veterans|veterans
51620|NCT02962687|Cognitive impairments|cognitive impairments
51621|NCT02962687|Nursing care management|nursing care management
51622|NCT02962687|Videoconferencing|videoconferencing
51623|NCT02962674|BPH|bph
51624|NCT02962661|Other forms of heart disease|other forms of heart disease
51625|NCT02962661|Left ventricular dysfunction|left ventricular dysfunction
51626|NCT02962661|LV|lv
51627|NCT02962661|Heart failure secondary to chemotherapy with anthracyclines|heart failure secondary to chemotherapy with anthracyclines
51628|NCT02962661|Human mesenchymal stem cells|human mesenchymal stem cells
51629|NCT02962661|hMSCs|hmscs
51630|NCT02962661|Mesenchymal Stromal Cells|mesenchymal stromal cells
51631|NCT02962661|MSCs|mscs
51632|NCT02962661|Intravenous infusion|intravenous infusion
51633|NCT02962661|Transendocardial injection|transendocardial injection
51634|NCT02962661|Standard of care drugs for heart failure|standard of care drugs for heart failure
51635|NCT02962648|IDA|ida
51636|NCT02962622|Neurocognition|neurocognition
51637|NCT02962622|Exercise|exercise
51638|NCT02962622|Metabolism|metabolism
51639|NCT02962622|Hispanic women|hispanic women
51640|NCT02962609|Feeding|feeding
51641|NCT02962609|preterm infant|preterm infant
51642|NCT02962609|physiological characteristics|physiological characteristics
51643|NCT02962609|position|position
51644|NCT02962609|ESL|esl
51645|NCT02962609|ESU|esu
51646|NCT02962557|ventilatory depression|ventilatory depression
51647|NCT02962544|Femtosecond|femtosecond
51648|NCT02962544|Small incision lenticule extraction|small incision lenticule extraction
51649|NCT02962544|Lenticule extraction|lenticule extraction
51650|NCT02962544|LASIK|lasik
51651|NCT02962544|Myopia|myopia
51652|NCT02962518|Pressure Device|pressure device
51653|NCT02962518|Clip|clip
51654|NCT02962518|Triamcinolone|triamcinolone
51655|NCT02962518|Fillet Technique|fillet technique
51656|NCT02962492|Dapagliflozin|dapagliflozin
51657|NCT02962492|Ketogenesis|ketogenesis
51658|NCT02962492|Type 1 Diabetes|type 1 diabetes
51659|NCT02962492|DKA|dka
51660|NCT02962492|ketones|ketones
51661|NCT02962492|exenatide/Bydureon|exenatide/bydureon
51662|NCT02962414|Everolimus|everolimus
51663|NCT02962414|Tuberous sclerosis complex|tuberous sclerosis complex
51664|NCT02962414|TSC|tsc
51665|NCT02962414|Refractory seizure|refractory seizure
51666|NCT02962414|Roll over study|roll over study
51667|NCT02962414|Long term safety|long term safety
51668|NCT02962414|PASS|pass
51669|NCT02962388|efficacy|efficacy
51670|NCT02962388|safety|safety
51671|NCT02962375|orange pomace fiber|orange pomace fiber
51672|NCT02962375|glycemic response|glycemic response
51673|NCT02962297|Vitamin E, Non Diabetic|vitamin e, non diabetic
51674|NCT02962271|Musculoskeletal Ultrasound|musculoskeletal ultrasound
51675|NCT02962271|Psoriatic Arthritis|psoriatic arthritis
51676|NCT02962271|Enthesopathy|enthesopathy
51677|NCT02962245|Ulcerative Colitis|ulcerative colitis
51678|NCT02962245|Berberine|berberine
51679|NCT02962232|drug eluting balloon|drug eluting balloon
51680|NCT02962232|arterial vasculature below the knee|arterial vasculature below the knee
51681|NCT02962219|oesophagectomy|oesophagectomy
51682|NCT02962193|ADL|adl
51683|NCT02962193|Bariatric surgery|bariatric surgery
51684|NCT02962193|Daily participation|daily participation
51685|NCT02962180|derma-rolling system, vitiligo|derma-rolling system, vitiligo
51686|NCT02962167|measles virus|measles virus
51687|NCT02962167|recurrent medulloblastoma|recurrent medulloblastoma
51688|NCT02962167|recurrent ATRT|recurrent atrt
51689|NCT02962154|Invasive Coronary Angiography|invasive coronary angiography
51690|NCT02962154|Myocardial Infarction|myocardial infarction
51691|NCT02962154|Major Depressive Disorder|major depressive disorder
51692|NCT02962154|Bipolar I Disorder|bipolar i disorder
51693|NCT02962154|Bipolar II Disorder|bipolar ii disorder
51694|NCT02962154|Mental Stress|mental stress
51695|NCT02962141|drug eluting balloon, Arteriovenous Fistulae|drug eluting balloon, arteriovenous fistulae
51696|NCT02962089|Protein-energy wasting|protein-energy wasting
51697|NCT02962089|Hemodialysis patients|hemodialysis patients
51698|NCT02962089|Microbiota|microbiota
51699|NCT02962089|Branched chain amino acids|branched chain amino acids
51700|NCT02962089|Undernutrition|undernutrition
51701|NCT02962089|Malnutrition|malnutrition
51702|NCT02962089|Renal failure|renal failure
51703|NCT02962089|Dialysis|dialysis
51704|NCT02962089|Protein|protein
51705|NCT02962089|Appetite|appetite
51706|NCT02962089|Body composition|body composition
51707|NCT02962089|Energy expenditure|energy expenditure
51708|NCT02962063|Durvalumab|durvalumab
51709|NCT02962063|Anti-PD-L1 Antibody|anti-pd-l1 antibody
51710|NCT02962063|16-1405|16-1405
51711|NCT02962011|Cesarean, incision, suture,|cesarean, incision, suture,
51712|NCT02961998|hepatocellular carcinoma|hepatocellular carcinoma
51713|NCT02961998|sorafenib|sorafenib
51714|NCT02961998|celecoxib|celecoxib
51715|NCT02961972|vegetarianism|vegetarianism
51716|NCT02961972|Hyperhomocysteinemia|hyperhomocysteinemia
51717|NCT02961972|vegan vegetarian|vegan vegetarian
51718|NCT02961933|hypoxemia|hypoxemia
51719|NCT02961933|intubation|intubation
51720|NCT02961933|apneic oxygenation|apneic oxygenation
51721|NCT02961907|periconceptional habits|periconceptional habits
51722|NCT02961907|Pregnancy|pregnancy
51723|NCT02961907|Infertility|infertility
51724|NCT02961868|Renal Artery Obstruction|renal artery obstruction
51725|NCT02961868|Carotid Artery Diseases|carotid artery diseases
51726|NCT02961868|Genetic Association Studies|genetic association studies
51727|NCT02961829|Dendritic Cell vaccination using|dendritic cell vaccination using
51728|NCT02961829|antiretroviral intensification|antiretroviral intensification
51729|NCT02961829|Auranofin|auranofin
51730|NCT02961829|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
51731|NCT02961829|residual viral replication|residual viral replication
51732|NCT02961829|HIV sanctuaries|hiv sanctuaries
51733|NCT02961829|HIV latency|hiv latency
51734|NCT02961816|Lymphoma|lymphoma
51735|NCT02961816|Refractory/Relapsed Lymphoma|refractory/relapsed lymphoma
51736|NCT02961816|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
51737|NCT02961816|Hodgkin's lymphoma|hodgkin's lymphoma
51738|NCT02961816|T-cell Lymphoma|t-cell lymphoma
51739|NCT02961816|Palifermin|palifermin
51740|NCT02961816|Kepivance|kepivance
51741|NCT02961816|Panobinostat|panobinostat
51742|NCT02961816|LBH589B|lbh589b
51743|NCT02961816|Gemcitabine|gemcitabine
51744|NCT02961816|Gemcitabine Hydrochloride|gemcitabine hydrochloride
51745|NCT02961816|Gemzar|gemzar
51746|NCT02961816|Busulfan|busulfan
51747|NCT02961816|Busulfex|busulfex
51748|NCT02961816|Myleran|myleran
51749|NCT02961816|Melphalan|melphalan
51750|NCT02961816|Alkeran|alkeran
51751|NCT02961816|Rituximab|rituximab
51752|NCT02961816|Rituxan|rituxan
51753|NCT02961816|Dexamethasone|dexamethasone
51754|NCT02961816|Decadron|decadron
51755|NCT02961816|Caphosol|caphosol
51756|NCT02961816|Glutamine|glutamine
51757|NCT02961816|Enterex|enterex
51758|NCT02961816|Glutapak-10|glutapak-10
51759|NCT02961816|NutreStore|nutrestore
51760|NCT02961816|Resource|resource
51761|NCT02961816|GlutaSolve|glutasolve
51762|NCT02961816|Sympt-X G.I.|sympt-x g.i.
51763|NCT02961816|Sympt-X|sympt-x
51764|NCT02961816|Pyridoxine|pyridoxine
51765|NCT02961816|G-CSF|g-csf
51766|NCT02961816|Filgrastim|filgrastim
51767|NCT02961816|Neupogen|neupogen
51768|NCT02961816|Stem cell transplant|stem cell transplant
51771|NCT02961803|Adrenomyeloneuropathy|adrenomyeloneuropathy
51772|NCT02961803|ALD|ald
51773|NCT02961803|Adrenoleukodystrophy|adrenoleukodystrophy
51774|NCT02961803|Biotin|biotin
51775|NCT02961803|2MWT|2mwt
51776|NCT02961803|Two-minute walk test|two-minute walk test
51777|NCT02961803|TW25|tw25
51778|NCT02961803|Timed 25-Foot Walk|timed 25-foot walk
51779|NCT02961764|Critical Pathways|critical pathways
51780|NCT02961764|Health Facilities|health facilities
51781|NCT02961764|Clinical Protocols|clinical protocols
51782|NCT02961764|Patient Satisfaction|patient satisfaction
51783|NCT02961764|Absenteeism|absenteeism
51784|NCT02961764|Anti-Bacterial Agents|anti-bacterial agents
51785|NCT02961764|Quality of Life|quality of life
51786|NCT02961764|Economics, Medical|economics, medical
51787|NCT02961764|Health Resources|health resources
51788|NCT02961764|Health resource utilization|health resource utilization
51789|NCT02961764|Acute bacterial skin and skin structure infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
51790|NCT02961751|Ciprofloxacin-susceptibility|ciprofloxacin-susceptibility
51791|NCT02961751|Gyrase A Assay|gyrase a assay
51792|NCT02961751|Neisseria gonorrhoeae|neisseria gonorrhoeae
51793|NCT02961647|Hemodynamic stress test|hemodynamic stress test
51794|NCT02961647|Surgical intervention|surgical intervention
51795|NCT02961634|onychomycosis|onychomycosis
51796|NCT02961634|nail|nail
51797|NCT02961595|Oral polio vaccine|oral polio vaccine
51798|NCT02961595|Inactivated polio vaccine|inactivated polio vaccine
51799|NCT02961595|Enterovirus|enterovirus
51800|NCT02961595|Type 1 diabetes|type 1 diabetes
51801|NCT02961595|Autoantibody|autoantibody
51802|NCT02961582|Sacral neuromodulation|sacral neuromodulation
51803|NCT02961582|Constipation|constipation
51804|NCT02961582|Slow-transit constipation|slow-transit constipation
51805|NCT02961582|Surgery|surgery
51806|NCT02961582|Colorectal surgery|colorectal surgery
51807|NCT02961582|Cost-effectiveness|cost-effectiveness
51808|NCT02961582|Quality of life|quality of life
51809|NCT02961556|AJG555|ajg555
51810|NCT02961556|Constipation|constipation
51811|NCT02961556|Phase 3|phase 3
51812|NCT02961556|Pediatric participants|pediatric participants
51813|NCT02961491|MIBG|mibg
51814|NCT02961491|Azedra|azedra
51815|NCT02961491|Rare neuroendocrine tumors|rare neuroendocrine tumors
51816|NCT02961491|Iobenguane I 131|iobenguane i 131
51817|NCT02961491|Progenics|progenics
51818|NCT02961465|Sacral neuromodulation|sacral neuromodulation
51819|NCT02961465|Constipation|constipation
51820|NCT02961465|Slow-transit constipation|slow-transit constipation
51821|NCT02961465|Surgery|surgery
51822|NCT02961465|Colorectal surgery|colorectal surgery
51823|NCT02961465|Cost-effectiveness|cost-effectiveness
51824|NCT02961465|Quality of life|quality of life
51825|NCT02961387|Tracheal stenosis, Hydrogen generator, Hydrogen-oxygen, Dyspnea.|tracheal stenosis, hydrogen generator, hydrogen-oxygen, dyspnea.
51826|NCT02961361|dexmedetomidine|dexmedetomidine
51827|NCT02961361|coracoid|coracoid
51828|NCT02961361|brachial plexus block|brachial plexus block
51829|NCT02961348|Oral anticoagulants (NOAC)|oral anticoagulants (noac)
51830|NCT02961309|THC|thc
51831|NCT02961309|marijuana|marijuana
51832|NCT02961309|tobacco cigarette|tobacco cigarette
51833|NCT02961309|smoking|smoking
51834|NCT02961296|Helicobacter Pylori|helicobacter pylori
51835|NCT02961283|BRAF Kinases|braf kinases
51836|NCT02961283|PIK3CA protein, human|pik3ca protein, human
51837|NCT02961244|Surgical Site Infection|surgical site infection
51838|NCT02961244|normothermia|normothermia
51839|NCT02961244|hypothermia|hypothermia
51840|NCT02961244|prewarming|prewarming
51841|NCT02961231|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
51842|NCT02961231|Herd immunity|herd immunity
51843|NCT02961231|Reduced dosing schedule|reduced dosing schedule
51844|NCT02961218|Sickle cell disease|sickle cell disease
51845|NCT02961218|hemoglobinopathy|hemoglobinopathy
51848|NCT02961166|ARDS|ards
51851|NCT02961127|tissue factor pathway inhibitor|tissue factor pathway inhibitor
51852|NCT02961114|Prostatitis, Chronic|prostatitis, chronic
51853|NCT02961114|Nocturia|nocturia
51854|NCT02961114|BPH With Urinary Obstruction|bph with urinary obstruction
51855|NCT02961101|relapsed or refractory|relapsed or refractory
51856|NCT02961101|malignancies|malignancies
51857|NCT02961101|decitabine|decitabine
51858|NCT02961101|anti-PD-1 antibody|anti-pd-1 antibody
51859|NCT02961088|Systematic review and meta-analysis|systematic review and meta-analysis
51860|NCT02961088|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
51861|NCT02961088|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
51862|NCT02961088|Clinical practice guidelines|clinical practice guidelines
51863|NCT02961088|Glycemic index|glycemic index
51864|NCT02961088|Pasta|pasta
51865|NCT02961088|Glycemic load|glycemic load
51866|NCT02961088|Body weight|body weight
51867|NCT02961088|Cardiovascular risk factors|cardiovascular risk factors
51868|NCT02961088|Cardiovascular disease|cardiovascular disease
51869|NCT02961062|ocular pain|ocular pain
51870|NCT02961062|photorefractive keratectomy (PRK)|photorefractive keratectomy (prk)
51871|NCT02961062|SAF312|saf312
51872|NCT02961062|corneal epithelial defect|corneal epithelial defect
51873|NCT02961036|Surveys and Questionnaires|surveys and questionnaires
51874|NCT02961010|school based prevention, child sexual and domestic abuse|school based prevention, child sexual and domestic abuse
51876|NCT02960958|Rheumatoid arthritis|rheumatoid arthritis
51877|NCT02960958|Metabolomics|metabolomics
51878|NCT02960958|urine|urine
51879|NCT02960932|Hemiplegic|hemiplegic
51880|NCT02960932|Child|child
51881|NCT02960932|Elastography|elastography
51882|NCT02960932|paralysis|paralysis
51883|NCT02960893|Ataxia|ataxia
51884|NCT02960893|SCA|sca
51885|NCT02960893|Spinocerebellar Ataxia|spinocerebellar ataxia
51886|NCT02960880|Rivaroxaban, Phenprocoumon, retrospective cohort study, Non-Valvular Atrial fibrillation, NVAF|rivaroxaban, phenprocoumon, retrospective cohort study, non-valvular atrial fibrillation, nvaf
51887|NCT02960867|paediatric|paediatric
51888|NCT02960867|kidney|kidney
51889|NCT02960815|influenza vaccine|influenza vaccine
51890|NCT02960815|Transplantation|transplantation
51891|NCT02960815|imiquimod|imiquimod
51892|NCT02960815|HIV infection|hiv infection
51893|NCT02960815|immunogenicity|immunogenicity
51894|NCT02960802|kidney transplant|kidney transplant
51895|NCT02960802|renal blood flow|renal blood flow
51896|NCT02960789|Dehydration|dehydration
51897|NCT02960789|Children|children
51898|NCT02960789|Measurement|measurement
51899|NCT02960776|Body Weight|body weight
51900|NCT02960776|Habitual sleep|habitual sleep
51901|NCT02960763|Comparative Effectiveness Research|comparative effectiveness research
51902|NCT02960763|Pragmatic Clinical Trials|pragmatic clinical trials
51903|NCT02960763|Patient-Centered Outcomes Research|patient-centered outcomes research
51904|NCT02960750|workplace|workplace
51905|NCT02960750|sedentary behavior|sedentary behavior
51906|NCT02960750|physical activity|physical activity
51907|NCT02960750|physical risk factors|physical risk factors
51908|NCT02960750|mental well-being|mental well-being
51909|NCT02960750|presenteeism|presenteeism
51910|NCT02960750|work productivity|work productivity
51911|NCT02960750|activity-related energy expenditures|activity-related energy expenditures
51912|NCT02960737|Dysphagia|dysphagia
51913|NCT02960737|Stroke|stroke
51914|NCT02960737|Intervention|intervention
51915|NCT02960737|Oral screen|oral screen
51916|NCT02960737|Incidence|incidence
51917|NCT02960724|Uroplasminogen Plasminogen Activator Receptor|uroplasminogen plasminogen activator receptor
51918|NCT02960724|Oropharyngeal cancer|oropharyngeal cancer
51919|NCT02960724|oral cancer|oral cancer
51920|NCT02960724|Positron Emission Tomography|positron emission tomography
51921|NCT02960698|cognitive impulsivity|cognitive impulsivity
51922|NCT02960698|IRM|irm
51923|NCT02960698|Tourette Syndrome|tourette syndrome
51924|NCT02960672|KL-6|kl-6
51925|NCT02960672|disease progression|disease progression
51926|NCT02960672|predict|predict
51927|NCT02960672|biomarkers|biomarkers
51928|NCT02960672|MMP-7|mmp-7
51929|NCT02960659|Metformin|metformin
51930|NCT02960659|Glucose|glucose
51931|NCT02960646|Leukemia|leukemia
51932|NCT02960646|Blood And Marrow Transplantation|blood and marrow transplantation
51933|NCT02960646|Acute lymphocytic leukemia|acute lymphocytic leukemia
51934|NCT02960646|ALL|all
51935|NCT02960646|Acute myeloid leukemia|acute myeloid leukemia
51936|NCT02960646|AML|aml
51937|NCT02960646|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
51938|NCT02960646|CLL|cll
51939|NCT02960646|Chronic myeloid leukemia|chronic myeloid leukemia
51941|NCT02960646|Hodgkin's disease|hodgkin's disease
51942|NCT02960646|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
51943|NCT02960646|NHL|nhl
51944|NCT02960646|Small lymphocytic lymphoma|small lymphocytic lymphoma
51965|NCT02960620|Humanitarian Device Exemption|humanitarian device exemption
51967|NCT02960620|HDE #980006|hde #980006
51977|NCT02960568|primaquine|primaquine
51978|NCT02960568|metabolism|metabolism
51979|NCT02960568|malaria|malaria
51980|NCT02960568|hypnozoite|hypnozoite
51981|NCT02960568|vivax|vivax
51982|NCT02960568|CYP2D6|cyp2d6
51983|NCT02960555|Myeloma|myeloma
51984|NCT02960555|Smoldering Multiple Myeloma|smoldering multiple myeloma
51985|NCT02960555|SMM|smm
51986|NCT02960555|Intermediate or high risk|intermediate or high risk
51987|NCT02960555|SAR650984|sar650984
51988|NCT02960555|Diphenhydramine|diphenhydramine
51989|NCT02960555|Benadryl|benadryl
51990|NCT02960555|Ranitidine|ranitidine
51991|NCT02960555|Ranitidine Hydrochloride|ranitidine hydrochloride
51992|NCT02960555|Zantac|zantac
51993|NCT02960555|Methylprednisolone|methylprednisolone
51994|NCT02960555|Depo-Medrol|depo-medrol
51995|NCT02960555|Medrol|medrol
51996|NCT02960555|Solu-Medrol|solu-medrol
51997|NCT02960542|lifestyle intervention|lifestyle intervention
51998|NCT02960542|weight-loss|weight-loss
51999|NCT02960503|sickle cell disease|sickle cell disease
52000|NCT02960503|pulmonary complications|pulmonary complications
52001|NCT02960503|reduced FEV1|reduced fev1
52002|NCT02960503|azithromycin|azithromycin
52003|NCT02960503|lung function|lung function
52004|NCT02960490|E6011|e6011
52005|NCT02960490|rheumatoid arthritis|rheumatoid arthritis
52006|NCT02960477|Shoulder pain|shoulder pain
52007|NCT02960477|Shoulder surgery|shoulder surgery
52008|NCT02960477|Pain neuroscience education|pain neuroscience education
52009|NCT02960477|Chronic pain|chronic pain
52010|NCT02960464|Parkinson Disease|parkinson disease
52011|NCT02960464|Depression|depression
52012|NCT02960464|Transcranial Direct Current Stimulation|transcranial direct current stimulation
52013|NCT02960464|Neuromodulation|neuromodulation
52014|NCT02960451|prodrome|prodrome
52015|NCT02960451|cognitive behavioral therapy|cognitive behavioral therapy
52016|NCT02960451|family focused therapy|family focused therapy
52017|NCT02960438|E6011|e6011
52018|NCT02960438|rheumatoid arthritis|rheumatoid arthritis
52019|NCT02960373|Dried fruit|dried fruit
52020|NCT02960373|Glycemic Index|glycemic index
52021|NCT02960373|Catalytic dose|catalytic dose
52022|NCT02960373|Glycemic response|glycemic response
52023|NCT02960373|Fructose|fructose
52024|NCT02960373|Postprandial|postprandial
52025|NCT02960373|Randomized clinical trial|randomized clinical trial
52026|NCT02960373|Carbohydrate metabolism|carbohydrate metabolism
52037|NCT02960321|myocardial injury|myocardial injury
52038|NCT02960321|high-sensitivity troponin I|high-sensitivity troponin i
52039|NCT02960321|periprocedural myocardial infarction|periprocedural myocardial infarction
52040|NCT02960269|rural health|rural health
52041|NCT02960269|telehealth|telehealth
52042|NCT02960269|physiotherapy|physiotherapy
52043|NCT02960269|interprofessional|interprofessional
52044|NCT02960243|Deep Brain Stimulation|deep brain stimulation
52045|NCT02960243|Laryngeal Motor Cortex|laryngeal motor cortex
52240|NCT02959112|papilla|papilla
52046|NCT02960243|Essential Voice Tremor|essential voice tremor
52047|NCT02960243|Essential Tremor|essential tremor
52048|NCT02960230|peptide vaccine|peptide vaccine
52049|NCT02960230|immunotherapy|immunotherapy
52050|NCT02960230|DIPG|dipg
52051|NCT02960230|vaccine|vaccine
52052|NCT02960204|cirrhosis|cirrhosis
52053|NCT02960204|Portal Hypertension|portal hypertension
52054|NCT02960204|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
52055|NCT02960204|Liver cirrhosis|liver cirrhosis
52056|NCT02960152|periodontitis|periodontitis
52057|NCT02960113|cesarean section|cesarean section
52058|NCT02960113|acupressure point p6|acupressure point p6
52059|NCT02960113|scopolamine patch|scopolamine patch
52060|NCT02960100|Cancer prevention|cancer prevention
52061|NCT02960100|HPV|hpv
52062|NCT02960100|Human papillomavirus vaccine|human papillomavirus vaccine
52063|NCT02960074|Allergy, Peanut|allergy, peanut
52064|NCT02960074|Hypersensitivity Peanut|hypersensitivity peanut
52065|NCT02960074|Peanut Allergy|peanut allergy
52066|NCT02960074|Donor Feces Infusion|donor feces infusion
52067|NCT02960074|Fecal Transplant|fecal transplant
52068|NCT02960074|Fecal Transplantation|fecal transplantation
52069|NCT02960074|Intestinal Microbiota Transfer|intestinal microbiota transfer
52070|NCT02960074|Fecal Microbiota Transplantation|fecal microbiota transplantation
52071|NCT02960074|Food allergy|food allergy
52072|NCT02960061|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
52073|NCT02960061|gastric cancer|gastric cancer
52074|NCT02960061|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
52075|NCT02960048|Anterior disc displacement|anterior disc displacement
52076|NCT02960048|TMD therapy|tmd therapy
52077|NCT02960048|internal derangement|internal derangement
52078|NCT02960048|occlusal splint|occlusal splint
52079|NCT02960048|anterior repositioning splint|anterior repositioning splint
52080|NCT02960035|Mardird sonographic enthesis index|mardird sonographic enthesis index
52081|NCT02960035|Spondyloarthropathy|spondyloarthropathy
52082|NCT02960035|Ultrasonics|ultrasonics
52083|NCT02960035|Etanercept|etanercept
52084|NCT02960022|prostate cancer|prostate cancer
52085|NCT02960022|prednisone|prednisone
52086|NCT02960022|MDV3100|mdv3100
52087|NCT02960022|enzalutamide|enzalutamide
52088|NCT02960022|Xtandi|xtandi
52089|NCT02960022|abiraterone acetate|abiraterone acetate
52090|NCT02959944|chronic graft versus host disease|chronic graft versus host disease
52091|NCT02959944|PCYC1140|pcyc1140
52092|NCT02959944|PCYC1140IM|pcyc1140im
52093|NCT02959944|1140|1140
52094|NCT02959944|Ibrutinib|ibrutinib
52095|NCT02959944|GVHD|gvhd
52096|NCT02959944|Steroid dependent|steroid dependent
52097|NCT02959944|refractory|refractory
52098|NCT02959944|chronic|chronic
52099|NCT02959944|PCI32765|pci32765
52100|NCT02959944|IMBRUVICA|imbruvica
52101|NCT02959944|Pharmacyclics|pharmacyclics
52102|NCT02959944|PCYC|pcyc
52103|NCT02959944|graft versus host disease|graft versus host disease
52104|NCT02959944|immunology|immunology
52105|NCT02959944|new onset graft versus host disease|new onset graft versus host disease
52106|NCT02959944|INTEGRATE|integrate
52107|NCT02959944|Corticosteroids|corticosteroids
52108|NCT02959944|prednisone|prednisone
52109|NCT02959931|Dietary Potassium|dietary potassium
52115|NCT02959827|Hypothyroidism,|hypothyroidism,
52116|NCT02959827|children,|children,
52117|NCT02959827|iodinated contrast agents,|iodinated contrast agents,
52118|NCT02959827|retrospective cohort,|retrospective cohort,
52119|NCT02959827|database|database
52120|NCT02959814|Fractional Flow Reserve|fractional flow reserve
52121|NCT02959814|Quantitative Coronary Analysis|quantitative coronary analysis
52122|NCT02959814|Stable coronary artery disease|stable coronary artery disease
52123|NCT02959814|Angina pectoris|angina pectoris
52124|NCT02959801|Deep Venous Thrombosis|deep venous thrombosis
52125|NCT02959801|Percutaneous Mechanical Thrombectomy|percutaneous mechanical thrombectomy
52126|NCT02959788|Heart rate variability|heart rate variability
52127|NCT02959775|Hepatitis B vaccination|hepatitis b vaccination
52128|NCT02959775|Immunogenicity|immunogenicity
52129|NCT02959775|Randomized controlled trial|randomized controlled trial
52130|NCT02959775|Drug abuse|drug abuse
52131|NCT02959762|G01 [Biological Sciences]|g01 [biological sciences]
52132|NCT02959762|G02.513 [Nutrition]|g02.513 [nutrition]
52133|NCT02959762|G06.696.259 [Child Nutrition]|g06.696.259 [child nutrition]
52134|NCT02959762|G07.553.481.398.571 [Obesity]|g07.553.481.398.571 [obesity]
52135|NCT02959762|G06 [Biochemical Phenomena, Metabolism, and Nutrition]|g06 [biochemical phenomena, metabolism, and nutrition]
52136|NCT02959762|G12.392.617 [Insulin Resistance]|g12.392.617 [insulin resistance]
52137|NCT02959762|G06.696.259.500 [Adolescent Nutrition]|g06.696.259.500 [adolescent nutrition]
52138|NCT02959762|A06 [Endocrine System]|a06 [endocrine system]
52139|NCT02959762|A07 [Cardiovascular System]|a07 [cardiovascular system]
52140|NCT02959762|C18.452.297.681 [Obesity in Diabetes]|c18.452.297.681 [obesity in diabetes]
52241|NCT02959112|rectal indomethacin|rectal indomethacin
52141|NCT02959762|C18.452.555 [Insulin Resistance]|c18.452.555 [insulin resistance]
52142|NCT02959762|C18 [Nutritional and Metabolic Diseases]|c18 [nutritional and metabolic diseases]
52143|NCT02959762|C18.452.494 [Hyperlipidemia]|c18.452.494 [hyperlipidemia]
43720|NCT03012256|DIVERT Scale|divert scale
43721|NCT03012256|Frail Elderly|frail elderly
43722|NCT03012256|Interprofessional Care|interprofessional care
43723|NCT03012256|Pragmatic Trial|pragmatic trial
43724|NCT03012256|Targeted Intervention|targeted intervention
43725|NCT03012256|Home Care|home care
52144|NCT02959762|C18.452.460 [Hyperglycemia]|c18.452.460 [hyperglycemia]
52145|NCT02959762|C14 [Cardiovascular Diseases]|c14 [cardiovascular diseases]
52146|NCT02959762|D11.786.875.844 [Vitamin K 2]|d11.786.875.844 [vitamin k 2]
52147|NCT02959762|D02.806.550.750 [Vitamin K 2]|d02.806.550.750 [vitamin k 2]
52148|NCT02959762|E02.293 [Diet Therapy]|e02.293 [diet therapy]
52149|NCT02959762|E02 [Therapeutics]|e02 [therapeutics]
52150|NCT02959762|F04.096.544.215.508.428 [Primary Prevention]|f04.096.544.215.508.428 [primary prevention]
52151|NCT02959762|N01.224.425.525 [Nutritional Status]|n01.224.425.525 [nutritional status]
52152|NCT02959749|Osimertinib|osimertinib
52153|NCT02959749|EGFR T790M Resistant Mutation|egfr t790m resistant mutation
52154|NCT02959749|Docetaxel|docetaxel
52155|NCT02959749|Bevacizumab|bevacizumab
52156|NCT02959749|Non Small Cell Lung|non small cell lung
52157|NCT02959736|Vegetative State|vegetative state
52158|NCT02959736|Minimally Conscious State|minimally conscious state
52159|NCT02959736|Brain Injuries|brain injuries
52160|NCT02959723|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
52161|NCT02959723|BMPR2|bmpr2
52162|NCT02959723|Inflammation|inflammation
52163|NCT02959710|Healthy volunteers|healthy volunteers
52164|NCT02959710|AC-1202|ac-1202
52165|NCT02959710|AC-1204|ac-1204
52166|NCT02959710|Pharmacokinetic|pharmacokinetic
52167|NCT02959710|ketone body|ketone body
52168|NCT02959697|Blepharoptosis|blepharoptosis
52169|NCT02959697|Ptosis|ptosis
52170|NCT02959697|Surgery|surgery
52171|NCT02959697|Pain Reduction|pain reduction
52172|NCT02959697|Anesthetic|anesthetic
52173|NCT02959697|Local Anesthetic|local anesthetic
52174|NCT02959697|Subconjunctival|subconjunctival
52175|NCT02959593|Primary open-angle glaucoma|primary open-angle glaucoma
52176|NCT02959593|retinal capillary blood flow|retinal capillary blood flow
52177|NCT02959593|visual stimulation|visual stimulation
52178|NCT02959580|Granulomatous|granulomatous
52179|NCT02959580|Mastitis|mastitis
52180|NCT02959580|topical steroids|topical steroids
52181|NCT02959567|cervix|cervix
52182|NCT02959567|cervical dilation|cervical dilation
52183|NCT02959567|balloon catheter|balloon catheter
52184|NCT02959554|Advanced|advanced
52185|NCT02959554|Metastatic|metastatic
52186|NCT02959554|RCC|rcc
52187|NCT02959541|Leukovorin|leukovorin
52188|NCT02959476|Postoperative pain|postoperative pain
52189|NCT02959476|Postsurgical pain|postsurgical pain
52190|NCT02959463|Malignant pleural mesothelioma|malignant pleural mesothelioma
52192|NCT02959463|Non-metastatic|non-metastatic
52193|NCT02959463|Pembrolizumab|pembrolizumab
52194|NCT02959463|Keytruda|keytruda
52195|NCT02959463|MK-3475|mk-3475
52196|NCT02959463|SCH-900475|sch-900475
52197|NCT02959463|Radiation therapy|radiation therapy
52198|NCT02959463|Radiation treatment|radiation treatment
52208|NCT02959437|CRC|crc
52209|NCT02959359|Chronic hepatitis C|chronic hepatitis c
52210|NCT02959359|Hepatocellular Carcinoma|hepatocellular carcinoma
52211|NCT02959359|Direct-acting antiviral (DAA)|direct-acting antiviral (daa)
52212|NCT02959359|Recurrence|recurrence
52213|NCT02959346|Minimal invasive thoracoscopic surgery|minimal invasive thoracoscopic surgery
52214|NCT02959346|Pain control|pain control
52215|NCT02959346|Acupuncture|acupuncture
52216|NCT02959346|Randomized controlled trial|randomized controlled trial
52217|NCT02959307|Depression|depression
52218|NCT02959307|Major Depressive Disorder|major depressive disorder
52219|NCT02959307|Major Depressive Episode|major depressive episode
52220|NCT02959294|TBI|tbi
52221|NCT02959294|mTBI|mtbi
52222|NCT02959294|Concussion, Brain|concussion, brain
52223|NCT02959294|Loss Consciousness, Traumatic|loss consciousness, traumatic
52224|NCT02959294|Headaches|headaches
52225|NCT02959242|glaucoma, follow-up intervals, treatment efficiency|glaucoma, follow-up intervals, treatment efficiency
52226|NCT02959229|Late onset sepsis|late onset sepsis
52227|NCT02959229|Bovine Lactoferrin|bovine lactoferrin
52228|NCT02959203|Central Venous Catheter|central venous catheter
52229|NCT02959203|Ultrasound|ultrasound
52230|NCT02959203|Chest X-ray|chest x-ray
52231|NCT02959203|Pneumothorax|pneumothorax
52232|NCT02959190|prevention|prevention
52233|NCT02959190|prophylaxis|prophylaxis
52234|NCT02959190|headache|headache
52235|NCT02959177|prevention|prevention
52236|NCT02959177|prophylaxis|prophylaxis
52237|NCT02959177|headache|headache
52238|NCT02959112|pancreatitis after ERCP|pancreatitis after ercp
52239|NCT02959112|epinephrine|epinephrine
43842|NCT03011372|8p11|8p11
52242|NCT02959099|Acute myocardial infarction|acute myocardial infarction
52243|NCT02959099|ST elevation myocardial infarction|st elevation myocardial infarction
52244|NCT02959099|Non ST elevation myocardial infarction|non st elevation myocardial infarction
52245|NCT02959099|Unstable angina|unstable angina
52246|NCT02959099|Coronary computed tomography angiography|coronary computed tomography angiography
52252|NCT02959073|Symptom recording|symptom recording
52253|NCT02959047|MRI|mri
52254|NCT02959047|PCSK9 inhibition|pcsk9 inhibition
52255|NCT02959047|LDL cholesterol|ldl cholesterol
52256|NCT02959021|weight loss|weight loss
52257|NCT02959021|behavioral|behavioral
52258|NCT02959021|primary care|primary care
52259|NCT02959021|lifestyle|lifestyle
52260|NCT02958995|Drug Therapy|drug therapy
52261|NCT02958982|RP3128|rp3128
52262|NCT02958982|Phase 1|phase 1
52263|NCT02958982|Healthy volunteers|healthy volunteers
52264|NCT02958969|venous thromboembolism|venous thromboembolism
52265|NCT02958969|multiple myeloma|multiple myeloma
52266|NCT02958969|anticoagulation|anticoagulation
52267|NCT02958956|Drug Therapy|drug therapy
52268|NCT02958943|atrial fibrillation|atrial fibrillation
52269|NCT02958943|stroke|stroke
52270|NCT02958943|computerized decision support|computerized decision support
52271|NCT02958904|Sexuality|sexuality
52272|NCT02958904|Spinal cord injuries|spinal cord injuries
52273|NCT02958904|Erectile dysfunction|erectile dysfunction
52274|NCT02958904|depression|depression
52275|NCT02958865|Mayo score|mayo score
52276|NCT02958852|Breast Cancer|breast cancer
52277|NCT02958852|Endocrine Treatment|endocrine treatment
52278|NCT02958852|Atorvastatin|atorvastatin
52279|NCT02958852|Mechanisms of Resistance|mechanisms of resistance
52280|NCT02958852|Statins|statins
52281|NCT02958852|Fulvestrant|fulvestrant
52282|NCT02958852|Circulating Tumor Cells|circulating tumor cells
52283|NCT02958852|Statins and Endocrine Treatment|statins and endocrine treatment
52284|NCT02958852|Tumor Marker Expression|tumor marker expression
52285|NCT02958852|ER+ Metastatic Breast Cancer|er+ metastatic breast cancer
52286|NCT02958852|Circulating Tumor DNA|circulating tumor dna
52287|NCT02958852|Cholesterol|cholesterol
52288|NCT02958839|Atrial fibrillation|atrial fibrillation
52289|NCT02958839|Fibroblast Growth factor 23|fibroblast growth factor 23
52290|NCT02958800|Deprescribing|deprescribing
52291|NCT02958800|Single patient open label trial|single patient open label trial
52292|NCT02958800|Long-term care|long-term care
52293|NCT02958761|knee arthrosis|knee arthrosis
52294|NCT02958761|platelet-derived growth factors|platelet-derived growth factors
52295|NCT02958735|exercise|exercise
52296|NCT02958735|cognition|cognition
52297|NCT02958735|brain-derived neurotrophic factor|brain-derived neurotrophic factor
624086|NCT00677261|Anesthesia|anesthesia
52300|NCT02958683|Optoelectronic plethysmography|optoelectronic plethysmography
52301|NCT02958683|Structure light plethysmography|structure light plethysmography
54148|NCT02947399|Thyroid|thyroid
52302|NCT02958683|Respiratory Function Tests|respiratory function tests
52304|NCT02958657|Autonomic Nervous System|autonomic nervous system
52305|NCT02958657|Multiplate® (Multiple Electrode Aggregometry - MEA)|multiplate® (multiple electrode aggregometry - mea)
52306|NCT02958657|VerifyNow®|verifynow®
52307|NCT02958644|prebiotic|prebiotic
52308|NCT02958644|obesity|obesity
52309|NCT02958644|body mass index|body mass index
52310|NCT02958644|microbiota|microbiota
52311|NCT02958605|Children|children
52312|NCT02958605|resuscitation|resuscitation
52313|NCT02958605|smartphone|smartphone
52314|NCT02958592|shear-wave elastography|shear-wave elastography
52315|NCT02958592|hepatic fibrosis|hepatic fibrosis
52316|NCT02958592|liver tumor|liver tumor
52317|NCT02958566|Pain control|pain control
52318|NCT02958566|Post-operative pain|post-operative pain
52319|NCT02958566|Narcotic|narcotic
52320|NCT02958566|Non-narcotic|non-narcotic
52321|NCT02958566|Side effect|side effect
52322|NCT02958566|Toxicity|toxicity
52323|NCT02958553|Lower Extremity Limb Loss|lower extremity limb loss
52324|NCT02958553|Prosthesis Use|prosthesis use
52325|NCT02958540|Prophylaxis|prophylaxis
52329|NCT02958514|IPL|ipl
52330|NCT02958514|MGD|mgd
52331|NCT02958501|Vitamin D|vitamin d
52332|NCT02958501|Inflammatory Bowel Diseases|inflammatory bowel diseases
52333|NCT02958488|34 to 36 Weeks Preterm Neonates|34 to 36 weeks preterm neonates
52334|NCT02958488|Respiratory Distress Syndrom|respiratory distress syndrom
52335|NCT02958488|High Flow Nasal Cannula|high flow nasal cannula
52336|NCT02958436|Safety|safety
52337|NCT02958436|Tolerability|tolerability
52338|NCT02958436|Pharmacokinetics|pharmacokinetics
52339|NCT02958436|REGN3500|regn3500
52340|NCT02958410|CD30|cd30
52341|NCT02958410|CAR-T|car-t
52346|NCT02958384|CAR-T|car-t
52347|NCT02958384|LeY|ley
52348|NCT02958371|Functional magnetic resonance imaging|functional magnetic resonance imaging
52349|NCT02958371|Taste|taste
52350|NCT02958371|Feeding behavior|feeding behavior
52351|NCT02958371|Choice behavior|choice behavior
43910|NCT03010943|virtual reality|virtual reality
43911|NCT03010943|glioma surgery|glioma surgery
43912|NCT03010943|awake craniotomy|awake craniotomy
43914|NCT03010943|glioma|glioma
52352|NCT02958358|pulmonary hypertension|pulmonary hypertension
52353|NCT02958358|ambrisentan|ambrisentan
52354|NCT02958358|PET imaging|pet imaging
52355|NCT02958358|CT/PET|ct/pet
52356|NCT02958332|video games|video games
52357|NCT02958306|cleft lip repair|cleft lip repair
52358|NCT02958306|cheiloplasty|cheiloplasty
52359|NCT02958306|PRP|prp
52360|NCT02958306|platelet rich plasma|platelet rich plasma
52361|NCT02958280|Exercise|exercise
52362|NCT02958280|Smartphone|smartphone
52363|NCT02958267|knee osteoarthritis|knee osteoarthritis
52364|NCT02958267|regenerative medicine|regenerative medicine
52365|NCT02958267|orthobiologics|orthobiologics
52366|NCT02958267|cellular therapy|cellular therapy
52367|NCT02958254|hamstring|hamstring
52368|NCT02958254|ultrasonography|ultrasonography
52369|NCT02958254|validation|validation
52370|NCT02958254|magnetic resonance imaging|magnetic resonance imaging
52371|NCT02958254|muscle thickness|muscle thickness
52372|NCT02958241|spondylolisthesis|spondylolisthesis
52373|NCT02958241|Lumbar spine|lumbar spine
52374|NCT02958241|MRI|mri
52375|NCT02958228|Positive Affect|positive affect
52376|NCT02958228|Mental Imagery|mental imagery
52377|NCT02958228|Cognitive Bias Modification|cognitive bias modification
52378|NCT02958228|Cognitive Control Training|cognitive control training
52379|NCT02958215|Orthostatic|orthostatic
52380|NCT02958215|Cesarean section|cesarean section
52381|NCT02958215|Pregnant|pregnant
52382|NCT02958215|Phenyephrine|phenyephrine
52383|NCT02958215|Hypotension|hypotension
52384|NCT02958202|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
52385|NCT02958202|DMD|dmd
52386|NCT02958202|Dystrophin|dystrophin
52387|NCT02958202|BMN 044|bmn 044
52388|NCT02958202|PRO044|pro044
52389|NCT02958202|BioMarin|biomarin
52390|NCT02958189|Twitter|twitter
52391|NCT02958189|social support|social support
52392|NCT02958189|internet intervention|internet intervention
52393|NCT02958189|sedentary lifestyle|sedentary lifestyle
52394|NCT02958189|walking|walking
52395|NCT02958189|behavior change|behavior change
52396|NCT02958163|Hepatocellular cancer|hepatocellular cancer
52397|NCT02958163|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
52398|NCT02958163|Chemoembolization, Therapeutic|chemoembolization, therapeutic
52399|NCT02958111|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
52400|NCT02958111|Adjuvant chemotherapy|adjuvant chemotherapy
52401|NCT02958111|Capecitabine|capecitabine
52402|NCT02958098|myocardial infarction|myocardial infarction
52403|NCT02958098|stroke|stroke
52406|NCT02958098|atrial fibrillation|atrial fibrillation
52407|NCT02958098|aortic dissection|aortic dissection
52408|NCT02958098|wearable devices|wearable devices
52409|NCT02958098|genomic sequencing|genomic sequencing
52410|NCT02958072|Malleoli ulcers|malleoli ulcers
52411|NCT02958072|Diabetes|diabetes
52413|NCT02958072|Dressing|dressing
52414|NCT02958072|LeucoPatch|leucopatch
52415|NCT02958059|ERCP|ercp
52416|NCT02958059|prophylaxis|prophylaxis
52417|NCT02958059|antibiotics|antibiotics
52420|NCT02958020|cohort, osteoporosis, bone mineral density, Chinese|cohort, osteoporosis, bone mineral density, chinese
52422|NCT02957981|BRCA2|brca2
52423|NCT02957981|Men|men
52424|NCT02957981|Hereditary Cancer|hereditary cancer
52425|NCT02957981|Prostate Cancer|prostate cancer
52426|NCT02957981|Male Breast Cancer|male breast cancer
52430|NCT02957955|Heart failure|heart failure
52434|NCT02957877|Anticoagulation|anticoagulation
52435|NCT02957877|Anti-Xa activity|anti-xa activity
52436|NCT02957877|Low-molecular weight heparin|low-molecular weight heparin
52437|NCT02957877|Unfractionated heparin|unfractionated heparin
52438|NCT02957838|Transferrin Receptor|transferrin receptor
52439|NCT02957838|Type 2 Diabetes|type 2 diabetes
52440|NCT02957838|Stearic Acid (C18:0)|stearic acid (c18:0)
52441|NCT02957838|Mitochondrial Morphology|mitochondrial morphology
52442|NCT02957838|Crossover Study|crossover study
52443|NCT02957812|Gait|gait
52444|NCT02957812|Balance Control|balance control
52445|NCT02957812|Orthotics|orthotics
52446|NCT02957799|Pregnancy|pregnancy
52447|NCT02957799|Home Healthcare Visits|home healthcare visits
52448|NCT02957799|Community Health Workers|community health workers
52449|NCT02957799|Infants|infants
52450|NCT02957786|cytisine|cytisine
52451|NCT02957786|varenicline|varenicline
52452|NCT02957786|smoking cessation|smoking cessation
52453|NCT02957786|indigenous|indigenous
52454|NCT02957747|Women Veterans|women veterans
52455|NCT02957747|Sexual Trauma|sexual trauma
52456|NCT02957734|Vertical dimension of occlusion|vertical dimension of occlusion
52457|NCT02957734|Direct composite restorations|direct composite restorations
52458|NCT02957734|Indirect composite restorations|indirect composite restorations
52459|NCT02957734|Tooth wear|tooth wear
52460|NCT02957734|Failure|failure
52461|NCT02957734|Quality of Life|quality of life
52462|NCT02957695|frontal brain lesions|frontal brain lesions
52463|NCT02957695|neurofeedback|neurofeedback
52464|NCT02957695|cognitive functions|cognitive functions
52465|NCT02957682|Hyperlipidemias|hyperlipidemias
52466|NCT02957682|Dyslipidemias|dyslipidemias
52467|NCT02957682|Lipid Metabolism Disorders|lipid metabolism disorders
52468|NCT02957630|Estetrol (E4)|estetrol (e4)
52469|NCT02957630|Drospirenone (DRSP)|drospirenone (drsp)
52470|NCT02957630|Ethinylestradiol (EE)|ethinylestradiol (ee)
52471|NCT02957630|Levonorgestrel (LNG)|levonorgestrel (lng)
52472|NCT02957630|Oral contraceptive|oral contraceptive
52473|NCT02957630|Prevention of pregnancy|prevention of pregnancy
52474|NCT02957630|Hemostasis|hemostasis
52475|NCT02957630|Metabolism|metabolism
52476|NCT02957617|Neuropathic Pain From Lumbosacral Radiculopathy, PLSR|neuropathic pain from lumbosacral radiculopathy, plsr
52477|NCT02957604|Pregnancy; Cardiovascular Diseases; High serum cholesterol|pregnancy; cardiovascular diseases; high serum cholesterol
52478|NCT02957591|Depression|depression
52479|NCT02957591|probiotic supplementation|probiotic supplementation
52480|NCT02957591|Adjuvant Therapy|adjuvant therapy
52481|NCT02957591|Gut microbiome|gut microbiome
52482|NCT02957591|Psychological functioning|psychological functioning
52483|NCT02957591|Brain imaging|brain imaging
52484|NCT02957591|Brain-Gut interactions|brain-gut interactions
52485|NCT02957591|Sleep|sleep
52486|NCT02957578|Tympanostomy Tube|tympanostomy tube
52487|NCT02957578|Ventilation Tube|ventilation tube
52488|NCT02957578|Grommet|grommet
52489|NCT02957578|Otitis Media|otitis media
52490|NCT02957578|Middle Ear Effusion|middle ear effusion
52491|NCT02957565|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
52492|NCT02957565|Questionnaires|questionnaires
52493|NCT02957565|Surveys|surveys
52494|NCT02957565|Videos|videos
52495|NCT02957565|Advanced Cancer|advanced cancer
52496|NCT02957539|motivation|motivation
52497|NCT02957539|patient incentives|patient incentives
52498|NCT02957513|Diabetes|diabetes
52499|NCT02957513|Uncontrolled|uncontrolled
52500|NCT02957513|Chronic Disease|chronic disease
52501|NCT02957513|Chronic Conditions|chronic conditions
52502|NCT02957513|Medically Underserved Areas|medically underserved areas
52503|NCT02957513|African Americans|african americans
52504|NCT02957513|Health Coaching|health coaching
52505|NCT02957513|Health Education|health education
52506|NCT02957513|Text Messaging|text messaging
52507|NCT02957513|Text Messages|text messages
52508|NCT02957513|Mobile Health|mobile health
52509|NCT02957474|Healthy Volunteers|healthy volunteers
52510|NCT02957474|Pharmacokinetics|pharmacokinetics
52511|NCT02957474|Food Effect|food effect
52512|NCT02957474|Proton Pump|proton pump
52513|NCT02957474|GED-0301|ged-0301
52514|NCT02957474|Mongersen|mongersen
52515|NCT02957422|neurodegeneration|neurodegeneration
52516|NCT02957422|cognitive decline|cognitive decline
52517|NCT02957422|cognition|cognition
52518|NCT02957422|age-related disease|age-related disease
52519|NCT02957422|dairy|dairy
52520|NCT02957422|dairy intake|dairy intake
52521|NCT02957409|Heart failure|heart failure
52522|NCT02957409|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
52523|NCT02957409|HFrEF|hfref
52524|NCT02957383|Sleep, Melatonin|sleep, melatonin
52525|NCT02957383|Circadian Rhythm|circadian rhythm
52526|NCT02957383|Temperature|temperature
52527|NCT02957383|screen illumination|screen illumination
52528|NCT02957344|health communication|health communication
52529|NCT02957344|Zika virus|zika virus
52530|NCT02957344|legislation|legislation
52531|NCT02957344|vaccination|vaccination
52532|NCT02957344|Child Care|child care
52533|NCT02957305|misoprostol|misoprostol
52534|NCT02957305|miscarriage|miscarriage
52535|NCT02957279|sepsis|sepsis
52536|NCT02957279|exosomes|exosomes
52537|NCT02957279|dendritic cell|dendritic cell
52538|NCT02957266|cervical cancer|cervical cancer
52539|NCT02957266|interstitial brachytherapy|interstitial brachytherapy
52540|NCT02957266|gemcitabine|gemcitabine
52541|NCT02957266|volumetric arc therapy|volumetric arc therapy
52542|NCT02957253|Quality of care|quality of care
52543|NCT02957253|Health related quality of life|health related quality of life
52544|NCT02957253|Nurse-led clinic|nurse-led clinic
52545|NCT02957253|Health economics|health economics
52546|NCT02957240|Forearm [A01.378.800.585]|forearm [a01.378.800.585]
52547|NCT02957240|Radius [A02.835.232.087.090.700]|radius [a02.835.232.087.090.700]
52548|NCT02957240|Motor Skills [F02.808.260]|motor skills [f02.808.260]
52549|NCT02957240|Task Performance and Analysis [F02.808.600]|task performance and analysis [f02.808.600]
52550|NCT02957240|Casts, Surgical [E07.858.442.660.430.500]|casts, surgical [e07.858.442.660.430.500]
52551|NCT02957240|Splints [E07.858.690.725.430.750]|splints [e07.858.690.725.430.750]
52552|NCT02957240|motor representation techniques|motor representation techniques
52553|NCT02957240|mirror therapy|mirror therapy
52554|NCT02957240|Women [M01.975]|women [m01.975]
52555|NCT02957227|Alzheimer's disease|alzheimer's disease
52556|NCT02957227|Frontotemporal Dementia|frontotemporal dementia
52557|NCT02957227|Lewy Body Dementia|lewy body dementia
52558|NCT02957227|Diagnosis|diagnosis
52559|NCT02957188|Eicosapentaenoic acid|eicosapentaenoic acid
52560|NCT02957188|Arachidonic acid|arachidonic acid
52561|NCT02957188|Metabolism|metabolism
52562|NCT02957188|Healthy aging|healthy aging
52563|NCT02957175|Immunophenotyping|immunophenotyping
52564|NCT02957175|Perioperative Care|perioperative care
52565|NCT02957175|Innate Immunity|innate immunity
52566|NCT02957175|Cardiac Surgical Procedures|cardiac surgical procedures
52567|NCT02957136|Respiratory Tract Infections|respiratory tract infections
52568|NCT02957136|Influenza, Human|influenza, human
52569|NCT02957136|Common Cold|common cold
52570|NCT02957136|Viral Infection|viral infection
52571|NCT02957136|Pathology, Molecular|pathology, molecular
52572|NCT02957136|Molecular Diagnostics|molecular diagnostics
52573|NCT02957136|Diagnostic Testing|diagnostic testing
52574|NCT02957136|Clinical Microbiology|clinical microbiology
52575|NCT02957136|Polymerase Chain Reaction|polymerase chain reaction
52576|NCT02957136|Antibiotic Stewardship|antibiotic stewardship
52577|NCT02957136|Antimicrobial Use|antimicrobial use
52578|NCT02957136|Emergency Department|emergency department
52579|NCT02957136|Emergency Room|emergency room
52580|NCT02957123|macrophages M2 type|macrophages m2 type
52581|NCT02957123|cytokines|cytokines
52582|NCT02957123|intranasal administration|intranasal administration
52583|NCT02957123|neuroprotection|neuroprotection
52584|NCT02957123|neuroregeneration|neuroregeneration
52585|NCT02957123|organic brain syndrome|organic brain syndrome
52586|NCT02957123|neurocognitive disorders|neurocognitive disorders
52587|NCT02957097|Gabapentin|gabapentin
52588|NCT02957097|acute pain|acute pain
52589|NCT02957084|difficult laryngoscopy|difficult laryngoscopy
52590|NCT02957084|neck circumference|neck circumference
52591|NCT02957084|sternomental distance|sternomental distance
52592|NCT02957084|thyromental distance|thyromental distance
52593|NCT02957084|hyomental distance|hyomental distance
52594|NCT02957084|thyrosternal distance|thyrosternal distance
52595|NCT02957058|Colonoscopy|colonoscopy
52596|NCT02957058|Endoscopic Mucosal Resection|endoscopic mucosal resection
52597|NCT02957058|Adenoma Recurrence|adenoma recurrence
52598|NCT02957058|EMR defect thermal ablation|emr defect thermal ablation
52599|NCT02956993|peripheral artery disease|peripheral artery disease
52600|NCT02956993|PAD|pad
52601|NCT02956993|vonapanitase|vonapanitase
52602|NCT02956993|critical limb ischemia|critical limb ischemia
52603|NCT02956993|CLI|cli
52604|NCT02956993|tibial artery|tibial artery
52605|NCT02956993|stenosis|stenosis
52606|NCT02956993|distal popliteal artery|distal popliteal artery
52607|NCT02956993|peroneal artery|peroneal artery
52608|NCT02956993|below the knee|below the knee
52609|NCT02956993|BTK|btk
52610|NCT02956993|elastase|elastase
52611|NCT02956993|chymotrypsin-like elastase 1|chymotrypsin-like elastase 1
52612|NCT02956993|CELA1|cela1
52613|NCT02956993|PRT-201|prt-201
52614|NCT02956980|type 1 interferons|type 1 interferons
52615|NCT02956980|children|children
52616|NCT02956980|gender|gender
52617|NCT02956980|pubertal status|pubertal status
52618|NCT02956980|sex difference|sex difference
52619|NCT02956967|Non-Interventional Study|non-interventional study
52620|NCT02956954|Enzyme replacement therapy|enzyme replacement therapy
52621|NCT02956941|Academic performance|academic performance
52622|NCT02956941|Behaviour change communication|behaviour change communication
52623|NCT02956941|Nutritional status|nutritional status
52624|NCT02956941|School children|school children
52625|NCT02956941|Ethiopia|ethiopia
52626|NCT02956915|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
52627|NCT02956915|SAPIEN-3 prostheses|sapien-3 prostheses
52628|NCT02956915|Length of stay|length of stay
52629|NCT02956915|Aortic stenosis|aortic stenosis
52630|NCT02956889|Carcinoma, Basal Cell|carcinoma, basal cell
52631|NCT02956889|Vismodegib|vismodegib
52632|NCT02956889|Radiotherapy|radiotherapy
52633|NCT02956837|Vaccines|vaccines
52634|NCT02956837|Respiratory Syncytial Viruses|respiratory syncytial viruses
52635|NCT02956837|Safety|safety
52636|NCT02956837|Reactogenicity|reactogenicity
52637|NCT02956837|Ranking of Formulations|ranking of formulations
52638|NCT02956837|Immunogenicity|immunogenicity
52639|NCT02956824|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
53538|NCT02951026|knee|knee
52640|NCT02956824|Sacro-iliac joints|sacro-iliac joints
52641|NCT02956824|Pelvis|pelvis
52642|NCT02956824|Erosion|erosion
52643|NCT02956824|Fat deposit|fat deposit
52644|NCT02956824|Subchondral sclerosis|subchondral sclerosis
52645|NCT02956824|Bone marrow edema|bone marrow edema
52646|NCT02956824|Axial spondyloarthritis|axial spondyloarthritis
52647|NCT02956811|Type 2 Diabetes|type 2 diabetes
52648|NCT02956811|Left Ventricular Hypertrophy|left ventricular hypertrophy
52649|NCT02956811|Dapagliflozin|dapagliflozin
52650|NCT02956785|Propess|propess
52651|NCT02956759|diabetic retinopathy|diabetic retinopathy
52652|NCT02956759|Pan-retinal photocoagulation|pan-retinal photocoagulation
52653|NCT02956759|proliferative|proliferative
52654|NCT02956759|non-proliferative|non-proliferative
52655|NCT02956733|inexpensive, fasciotomy|inexpensive, fasciotomy
52656|NCT02956707|neonates|neonates
52657|NCT02956707|cardiopulmonary bypass|cardiopulmonary bypass
52658|NCT02956707|adrenal insufficiency|adrenal insufficiency
52659|NCT02956707|congenital heart disease|congenital heart disease
52660|NCT02956694|Aged|aged
52661|NCT02956694|Cognitive impairment|cognitive impairment
52662|NCT02956694|Neurocognitive Disorders|neurocognitive disorders
52663|NCT02956694|Shared decision making|shared decision making
52664|NCT02956694|Distance learning|distance learning
52665|NCT02956694|Primary care|primary care
52666|NCT02956694|Decision support tool|decision support tool
52667|NCT02956694|Patient decision aid|patient decision aid
52668|NCT02956668|tDCS|tdcs
52669|NCT02956668|Visual field|visual field
52670|NCT02956668|Stroke|stroke
52671|NCT02956616|Enhanced Recovery|enhanced recovery
52672|NCT02956590|dyslipidemia|dyslipidemia
52673|NCT02956590|obesity|obesity
52674|NCT02956590|pitavastatin|pitavastatin
52675|NCT02956590|lipids|lipids
52676|NCT02956577|Global Longitudinal Strain (GLS)|global longitudinal strain (gls)
52677|NCT02956577|Coronary Flow Velocity Reserve (CFVR)|coronary flow velocity reserve (cfvr)
52678|NCT02956577|Cardiac dysfunction|cardiac dysfunction
52679|NCT02956577|Microcirculation|microcirculation
52680|NCT02956577|Coronary Computed Tomography Angiography (CCTA)|coronary computed tomography angiography (ccta)
52681|NCT02956577|Type 1 Diabetes|type 1 diabetes
52682|NCT02956577|Type 2 Diabetes|type 2 diabetes
52683|NCT02956551|advanced non-small cell lung cancer|advanced non-small cell lung cancer
52684|NCT02956551|cell based therapy|cell based therapy
52685|NCT02956551|safety|safety
52686|NCT02956551|clinical efficacy|clinical efficacy
52687|NCT02956486|elenbecestat|elenbecestat
52688|NCT02956486|E2609|e2609
52689|NCT02956486|Alzheimer's Disease|alzheimer's disease
52690|NCT02956486|Early Alzheimer's Disease|early alzheimer's disease
52691|NCT02956486|Prodromal Alzheimer's Disease|prodromal alzheimer's disease
52692|NCT02956486|Dementia|dementia
52693|NCT02956486|Dementia, Alzheimer's type|dementia, alzheimer's type
52694|NCT02956486|mild cognitive impairment|mild cognitive impairment
52695|NCT02956486|MissionAD1|missionad1
52696|NCT02956473|Breast Cancer|breast cancer
52702|NCT02956395|adaptive case management approach|adaptive case management approach
52703|NCT02956395|Transitional Care|transitional care
52704|NCT02956395|multimorbidity|multimorbidity
52711|NCT02956343|Atrial fibrillation|atrial fibrillation
52712|NCT02956343|cardiovascular App|cardiovascular app
52713|NCT02956343|Rhythm monitoring|rhythm monitoring
52714|NCT02956343|Stroke prevention|stroke prevention
52715|NCT02956330|RVO|rvo
52716|NCT02956330|ME|me
52717|NCT02956330|Central Subfield Thickness|central subfield thickness
52718|NCT02956330|OCT|oct
52719|NCT02956330|Optical Coherence Tomography|optical coherence tomography
52720|NCT02956330|Cystoid Macular Edema|cystoid macular edema
54352|NCT02945969|albuminuria|albuminuria
52721|NCT02956330|Subretinal Fluid|subretinal fluid
52722|NCT02956330|Eylea|eylea
52723|NCT02956330|Aflibercept|aflibercept
52724|NCT02956330|Anti-VEGF|anti-vegf
52726|NCT02956291|brain tumor|brain tumor
52727|NCT02956291|brain metastasis|brain metastasis
52728|NCT02956278|allopurinol|allopurinol
52729|NCT02956252|cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
52730|NCT02956252|spinal anesthesia|spinal anesthesia
52731|NCT02956252|general anesthesia|general anesthesia
52732|NCT02956252|cholecystectomy|cholecystectomy
52733|NCT02956239|cervical precancer|cervical precancer
52734|NCT02956239|screening|screening
52735|NCT02956239|treatment|treatment
52736|NCT02956239|thermo-coagulation|thermo-coagulation
52737|NCT02956239|thermal ablation|thermal ablation
52738|NCT02956239|Reducing overtreatment|reducing overtreatment
52739|NCT02956213|COPD|copd
52740|NCT02956213|air filter|air filter
52741|NCT02956213|indoor air quality|indoor air quality
52742|NCT02956213|respiratory symptoms|respiratory symptoms
52743|NCT02956213|emphysema|emphysema
52744|NCT02956213|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
52745|NCT02956213|tobacco use|tobacco use
52746|NCT02956200|Fingolimod Hydrochloride|fingolimod hydrochloride
52747|NCT02956200|Intravenous thrombolysis|intravenous thrombolysis
52748|NCT02956200|Mechanical thrombectomy|mechanical thrombectomy
52749|NCT02956200|Acute ischemic stroke|acute ischemic stroke
52750|NCT02956161|Sleep|sleep
52751|NCT02956161|Auditory stimulations|auditory stimulations
52752|NCT02956161|Slow oscillations|slow oscillations
52753|NCT02956096|tDCS|tdcs
52754|NCT02956096|Stroke|stroke
52755|NCT02956096|Autonomic Modulation|autonomic modulation
52756|NCT02956070|dental bleaching|dental bleaching
52757|NCT02956070|antiinflammatory|antiinflammatory
59853|NCT02911974|EUS|eus
52758|NCT02956070|tooth sensitivity|tooth sensitivity
52759|NCT02956031|cancer prevention|cancer prevention
52760|NCT02956031|cervical screening|cervical screening
52761|NCT02956031|cervical cancer|cervical cancer
52762|NCT02956031|cervical disease|cervical disease
52763|NCT02956031|cervical neoplasm|cervical neoplasm
52764|NCT02956031|HPV testing|hpv testing
52765|NCT02956031|immunocytochemistry|immunocytochemistry
52766|NCT02956031|triage techniques|triage techniques
52767|NCT02956018|children|children
52768|NCT02955979|acute renal insufficiency|acute renal insufficiency
52769|NCT02955979|Iodinated Contrast Agents|iodinated contrast agents
52770|NCT02955979|pediatric|pediatric
52771|NCT02955966|Aspergillosis|aspergillosis
52772|NCT02955966|Haematological malignancy|haematological malignancy
52773|NCT02955966|18F-FDG PET/CT|18f-fdg pet/ct
52774|NCT02955966|Biomarkers|biomarkers
52775|NCT02955940|Solid tumors|solid tumors
52776|NCT02955940|ruxolitinib|ruxolitinib
52777|NCT02955940|regorafenib|regorafenib
52778|NCT02955940|capecitabine|capecitabine
52779|NCT02955927|Myopia control,ortho-k, atropine eye drops, children|myopia control,ortho-k, atropine eye drops, children
52780|NCT02955914|Optimism|optimism
52781|NCT02955914|Pessimism|pessimism
52782|NCT02955914|Recovery|recovery
52783|NCT02955914|Elective Cardiac surgery|elective cardiac surgery
52784|NCT02955901|Randomized controlled trial|randomized controlled trial
52785|NCT02955901|Colonoscopy|colonoscopy
52786|NCT02955901|Colon Disease|colon disease
52787|NCT02955901|Low residue diet|low residue diet
52788|NCT02955901|Colon preparation|colon preparation
52789|NCT02955875|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
52790|NCT02955875|Pharmaceutical Services|pharmaceutical services
52791|NCT02955862|Cryptococcal antigenemia|cryptococcal antigenemia
52792|NCT02955862|Cryptococcal meningitis|cryptococcal meningitis
52793|NCT02955862|HIV/AIDS|hiv/aids
52794|NCT02955849|glaucoma|glaucoma
52795|NCT02955849|rural|rural
52796|NCT02955849|China|china
52797|NCT02955849|SLT|slt
52798|NCT02955836|Patient Safety|patient safety
52799|NCT02955836|Quality indicator|quality indicator
52800|NCT02955836|Information system|information system
52801|NCT02955836|Nursing|nursing
52802|NCT02955836|Healthcare Quality|healthcare quality
52803|NCT02955836|Quality measurement|quality measurement
52804|NCT02955823|B cell Lymphoma|b cell lymphoma
52805|NCT02955823|non-Hodgkin Lymphoma|non-hodgkin lymphoma
52806|NCT02955823|Elderly patients|elderly patients
52807|NCT02955810|Newly Diagnosed|newly diagnosed
52808|NCT02955810|Treatment Naiive|treatment naiive
52809|NCT02955797|Meningitis|meningitis
52810|NCT02955797|Meningococcal Meningitis|meningococcal meningitis
52811|NCT02955797|MenACYW conjugate vaccine|menacyw conjugate vaccine
52812|NCT02955797|Nimenrix®|nimenrix®
52813|NCT02955797|Menjugate®|menjugate®
52814|NCT02955771|photodynamic therapy(PDT)|photodynamic therapy(pdt)
52815|NCT02955771|stenting|stenting
52816|NCT02955771|Hilar Cholangiocarcinoma|hilar cholangiocarcinoma
52817|NCT02955771|Deuteporfin|deuteporfin
52818|NCT02955719|Collaborative Care|collaborative care
52819|NCT02955719|Depression|depression
52820|NCT02955719|Anxiety|anxiety
52821|NCT02955719|Mild Cognitive Impairment|mild cognitive impairment
52822|NCT02955719|Integrated Care Pathway|integrated care pathway
52823|NCT02955693|Pharmacokinetics|pharmacokinetics
54653|NCT02944136|stress|stress
52824|NCT02955693|Healthy volunteers|healthy volunteers
52825|NCT02955693|Monomethylfumarate|monomethylfumarate
52826|NCT02955693|Dimethyl fumarate|dimethyl fumarate
52827|NCT02955693|Fumaderm®|fumaderm®
52828|NCT02955693|Ethyl fumarate|ethyl fumarate
52829|NCT02955680|emergence delirium|emergence delirium
52830|NCT02955680|emergence time|emergence time
52831|NCT02955680|bispectral index|bispectral index
52832|NCT02955667|invivo microscopy|invivo microscopy
52833|NCT02955667|colposcopy|colposcopy
52834|NCT02955667|cervical precancer and cancer|cervical precancer and cancer
52835|NCT02955641|Laser peripheral iridotomy|laser peripheral iridotomy
52836|NCT02955641|topical anti-inflammatory drops|topical anti-inflammatory drops
52837|NCT02955602|PBC|pbc
52838|NCT02955602|Primary Biliary Cholangitis (PBC)|primary biliary cholangitis (pbc)
52839|NCT02955576|Psoriasis|psoriasis
52840|NCT02955563|decision making for incapacitated patients|decision making for incapacitated patients
52841|NCT02955563|intensive care|intensive care
52842|NCT02955563|surrogate decision making|surrogate decision making
52843|NCT02955563|patient centered care|patient centered care
52844|NCT02955563|Palliative Care|palliative care
52845|NCT02955563|End of Life|end of life
52846|NCT02955563|Quality of Communication|quality of communication
52847|NCT02955550|Multiple Myeloma|multiple myeloma
52848|NCT02955550|Plasma Cell Myeloma|plasma cell myeloma
52849|NCT02955550|Plasma Cell Neoplasm|plasma cell neoplasm
52850|NCT02955550|Relapsed/refractory Myeloma|relapsed/refractory myeloma
52851|NCT02955550|PNK-007|pnk-007
52852|NCT02955550|Recombinant Human IL-2 (RHIL-2)|recombinant human il-2 (rhil-2)
59980|NCT02910804|GBM|gbm
52853|NCT02955550|Human IL-2|human il-2
52854|NCT02955550|Bone Marrow Transplant|bone marrow transplant
52855|NCT02955537|Hypertension|hypertension
52856|NCT02955537|mHealth|mhealth
52857|NCT02955485|Ankle|ankle
52858|NCT02955485|Instability|instability
52859|NCT02955485|Prediction|prediction
52860|NCT02955472|Neuralgia, Postherpetic|neuralgia, postherpetic
52861|NCT02955472|Postherpetic Neuralgia|postherpetic neuralgia
52862|NCT02955472|Diabetic Neuropathies|diabetic neuropathies
52863|NCT02955472|Diabetic Neuralgia|diabetic neuralgia
52864|NCT02955472|Diabetic Polyneuropathy|diabetic polyneuropathy
52865|NCT02955472|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
52866|NCT02955472|Neuralgia|neuralgia
52867|NCT02955472|Neuropathic Pain|neuropathic pain
52868|NCT02955472|Pregabalin|pregabalin
52869|NCT02955472|Pharmacokinetics|pharmacokinetics
52870|NCT02955472|Bioequivalent|bioequivalent
52871|NCT02955459|Healthy volunteers|healthy volunteers
52872|NCT02955459|Pharmacokinetics|pharmacokinetics
52873|NCT02955446|Refractory Tumors|refractory tumors
52874|NCT02955446|Advanced Solid Tumors|advanced solid tumors
52875|NCT02955433|Rideshare|rideshare
52876|NCT02955433|Digital transportation network|digital transportation network
52877|NCT02955433|Missed appointment|missed appointment
52878|NCT02955420|Autoantibodies|autoantibodies
52879|NCT02955420|Heart Failure|heart failure
52880|NCT02955420|Fatigue Syndrome, Chronic|fatigue syndrome, chronic
52881|NCT02955420|Idiopathic Pulmonary Hypertension|idiopathic pulmonary hypertension
52882|NCT02955420|Cardiomyopathies|cardiomyopathies
52883|NCT02955394|ER+/Her2 - breast cancer|er+/her2 - breast cancer
52884|NCT02955394|Preoperative Fulvestrant|preoperative fulvestrant
52885|NCT02955394|Enzalutamide|enzalutamide
52886|NCT02955368|DP-R212|dp-r212
52887|NCT02955303|Cognitive training|cognitive training
52888|NCT02955303|Tablet computers|tablet computers
52889|NCT02955277|Cognitive training|cognitive training
52890|NCT02955277|Tablet computers|tablet computers
52891|NCT02955264|Glycosylation|glycosylation
52892|NCT02955264|Glucose Metabolic Disorder|glucose metabolic disorder
52893|NCT02955264|Galactose|galactose
52894|NCT02955251|Non-squamous NSCLC|non-squamous nsclc
52895|NCT02955251|Advanced solid tumor|advanced solid tumor
52896|NCT02955251|Ovarian cancer|ovarian cancer
52897|NCT02955251|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
52898|NCT02955251|Cancer|cancer
52899|NCT02955251|Neoplasm|neoplasm
52900|NCT02955251|Nivolumab|nivolumab
52901|NCT02955238|Intervention|intervention
52902|NCT02955238|Cardiovascular Disease|cardiovascular disease
52903|NCT02955238|CVD|cvd
52904|NCT02955238|Diabetes|diabetes
52905|NCT02955238|Latinos|latinos
52906|NCT02955238|CIMT|cimt
52907|NCT02955238|Medication Adherence|medication adherence
52908|NCT02955238|Risk Factors|risk factors
52909|NCT02955238|T2D|t2d
52910|NCT02955225|Knee loads|knee loads
52911|NCT02955225|Knee adduction moment|knee adduction moment
52912|NCT02955225|Biomechanical intervention|biomechanical intervention
52913|NCT02955225|Insole|insole
52914|NCT02955225|Shoe|shoe
52915|NCT02955212|Rheumatoid Arthritis|rheumatoid arthritis
52916|NCT02955212|Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)|conventional synthetic disease-modifying anti-rheumatic drugs (csdmards)
52917|NCT02955212|ABT-494|abt-494
52918|NCT02955134|central blinded histological assessment|central blinded histological assessment
52919|NCT02955134|traditional Chinese medicine intervention|traditional chinese medicine intervention
52920|NCT02955134|long-term follow-up study|long-term follow-up study
52921|NCT02955134|biological specimen banks|biological specimen banks
52922|NCT02955121|Cytochrome P-450 CYP2C19|cytochrome p-450 cyp2c19
52923|NCT02955121|Pharmacogenetics|pharmacogenetics
52924|NCT02955121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
52925|NCT02955121|Percutaneous Coronary Intervention|percutaneous coronary intervention
52926|NCT02955069|Advanced or metastatic|advanced or metastatic
52927|NCT02955069|NET|net
52928|NCT02955069|pNET|pnet
52929|NCT02955069|GI NET|gi net
52930|NCT02955069|thoracic NET|thoracic net
52931|NCT02955069|GEP-NEC|gep-nec
52932|NCT02955056|Weber B|weber b
52933|NCT02955043|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
52934|NCT02955043|Fatigue|fatigue
52935|NCT02955043|Insomnia|insomnia
52936|NCT02955043|Depression|depression
52937|NCT02955043|Behavioral Intervention|behavioral intervention
52938|NCT02955017|obesity|obesity
52939|NCT02955017|children|children
52940|NCT02955017|adolescents|adolescents
52941|NCT02955017|new technology|new technology
52942|NCT02955017|mobile health|mobile health
52943|NCT02955017|chronic disease|chronic disease
52944|NCT02955004|silent brain embolism|silent brain embolism
52945|NCT02955004|atrial fibrillation|atrial fibrillation
52946|NCT02955004|cardioversion|cardioversion
52947|NCT02954965|graduate student|graduate student
52948|NCT02954965|burnout|burnout
52949|NCT02954965|stress|stress
52950|NCT02954965|mood|mood
52951|NCT02954939|lupus nephritis|lupus nephritis
52952|NCT02954939|lymphocyte subsets|lymphocyte subsets
52953|NCT02954939|cytokines|cytokines
52954|NCT02954939|mycophenolate mofetil|mycophenolate mofetil
52955|NCT02954939|cyclophosphamide|cyclophosphamide
52956|NCT02954900|Breast Cancer Prevention|breast cancer prevention
52957|NCT02954900|Risk Assessment|risk assessment
52958|NCT02954900|Chemoprevention|chemoprevention
52959|NCT02954900|Decision Making|decision making
52960|NCT02954887|GWP42003-P|gwp42003-p
52961|NCT02954887|Cannabidiol|cannabidiol
52962|NCT02954809|fatigue|fatigue
52963|NCT02954809|sleep disturbances|sleep disturbances
52964|NCT02954809|circadian activity rhythms|circadian activity rhythms
52965|NCT02954783|Prostate cancer|prostate cancer
52966|NCT02954783|Localized|localized
52967|NCT02954783|Exercise|exercise
52968|NCT02954783|Physical activity|physical activity
52969|NCT02954783|Natural killer cells|natural killer cells
52970|NCT02954783|Immune cells|immune cells
52971|NCT02954757|uterine adenomyosis|uterine adenomyosis
52972|NCT02954744|uterine fibroid|uterine fibroid
52973|NCT02954731|Cognitive Behavior Therapy|cognitive behavior therapy
52974|NCT02954731|Negative Affect|negative affect
52975|NCT02954731|Unified Protocol|unified protocol
52976|NCT02954731|Session Tracking|session tracking
52977|NCT02954731|Mechanisms of Change in Psychotherapy|mechanisms of change in psychotherapy
52978|NCT02954718|activity performance|activity performance
52979|NCT02954718|juvenile idiopathic arthritis|juvenile idiopathic arthritis
52980|NCT02954718|virtual reality|virtual reality
52981|NCT02954679|Psychoactive Substances Consumption|psychoactive substances consumption
52982|NCT02954679|Substance-related Disorder|substance-related disorder
52983|NCT02954679|Off label-use|off label-use
52984|NCT02954679|Cognitive Enhancement|cognitive enhancement
52985|NCT02954679|Students|students
52986|NCT02954679|Doping|doping
52987|NCT02954679|Stimulants|stimulants
52988|NCT02954679|Drug abuse|drug abuse
52989|NCT02954679|Methylphenidate|methylphenidate
52990|NCT02954679|Addictovigilance|addictovigilance
52991|NCT02954679|CEIP|ceip
52992|NCT02954666|cardio-neuromodulation|cardio-neuromodulation
52993|NCT02954666|cardio-neuroablation|cardio-neuroablation
52994|NCT02954666|ablation|ablation
52995|NCT02954666|ganglionated plexi|ganglionated plexi
52996|NCT02954666|anterior right ganglionated plexus|anterior right ganglionated plexus
52997|NCT02954666|syncope|syncope
52998|NCT02954653|relapsed|relapsed
52999|NCT02954653|refractory|refractory
53000|NCT02954653|acute myeloid leukemia|acute myeloid leukemia
53001|NCT02954653|AML|aml
53002|NCT02954627|Osteoarthritis|osteoarthritis
53003|NCT02954627|Obesity|obesity
53004|NCT02954627|Liraglutide 3 mg|liraglutide 3 mg
53005|NCT02954627|Liraglutide|liraglutide
53006|NCT02954627|Ultrasound|ultrasound
53007|NCT02954601|Oral Insulin|oral insulin
53008|NCT02954601|DM T2 (Diabetes Mellitus Type 2)|dm t2 (diabetes mellitus type 2)
53009|NCT02954562|anxiety|anxiety
53010|NCT02954562|fMRI|fmri
53011|NCT02954562|emotion regulation|emotion regulation
53012|NCT02954549|vitamin D deficiency, genomics, vitamin D supplementation|vitamin d deficiency, genomics, vitamin d supplementation
53013|NCT02954536|pembrolizumab|pembrolizumab
53014|NCT02954536|trastuzumab|trastuzumab
53015|NCT02954536|capecitabine|capecitabine
53016|NCT02954536|cisplatin|cisplatin
53017|NCT02954536|Stage IV|stage iv
53018|NCT02954536|HER2-positive|her2-positive
53019|NCT02954536|esophagogastric cancer|esophagogastric cancer
53020|NCT02954536|16-937|16-937
53021|NCT02954536|Oxaliplatin|oxaliplatin
53022|NCT02954536|5-Fluorouracil (5-FU)|5-fluorouracil (5-fu)
53023|NCT02954523|NSCLC|nsclc
53024|NCT02954523|Non-small cell|non-small cell
53025|NCT02954523|Lung Cancer|lung cancer
53026|NCT02954523|Dasatinib|dasatinib
53027|NCT02954523|Osimertinib|osimertinib
53028|NCT02954523|AZD9291|azd9291
53029|NCT02954523|EGFR Mutations|egfr mutations
53030|NCT02954523|Epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
53031|NCT02954445|BCMA|bcma
53032|NCT02954445|CAR-T|car-t
53033|NCT02954432|transcranial Direct Current Stimulation|transcranial direct current stimulation
53034|NCT02954432|Transcranial Ultrasound|transcranial ultrasound
53035|NCT02954432|non-invasive brain stimulation|non-invasive brain stimulation
53036|NCT02954419|IgA Nephropathy|iga nephropathy
53037|NCT02954419|Biomarker|biomarker
53038|NCT02954406|Drug Therapy|drug therapy
53636|NCT02950467|HIV/AIDS|hiv/aids
53039|NCT02954393|Periodontal disease|periodontal disease
53040|NCT02954393|Metronidazole|metronidazole
53041|NCT02954393|Amoxicillin|amoxicillin
53042|NCT02954393|Scaling and root planing|scaling and root planing
53043|NCT02954393|Healing phase|healing phase
53044|NCT02954354|Flu|flu
53045|NCT02954354|S-033188|s-033188
53046|NCT02954354|Oseltamivir|oseltamivir
53047|NCT02954354|Tamiflu®|tamiflu®
53048|NCT02954302|Delayed gastric emptying|delayed gastric emptying
53049|NCT02954302|pancreaticoduodenectomy|pancreaticoduodenectomy
60261|NCT02909153|FPC|fpc
53050|NCT02954289|modifiable risk factors|modifiable risk factors
53051|NCT02954289|lifestyle|lifestyle
53052|NCT02954289|nutrition|nutrition
53053|NCT02954289|weight control|weight control
53054|NCT02954289|dietary intervention|dietary intervention
53055|NCT02954289|health promotion|health promotion
53056|NCT02954289|patient-partner outcomes|patient-partner outcomes
53057|NCT02954289|survivorship|survivorship
53058|NCT02954289|prostate cancer outcomes|prostate cancer outcomes
53059|NCT02954276|safety|safety
53060|NCT02954263|Multiple ascending dose (MAD)|multiple ascending dose (mad)
53061|NCT02954237|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
53062|NCT02954237|Anticoagulant|anticoagulant
53063|NCT02954237|Warfarin|warfarin
53064|NCT02954237|Stroke|stroke
53065|NCT02954224|sleep apnea, delirium|sleep apnea, delirium
53066|NCT02954211|rTMS|rtms
53067|NCT02954211|noninvasive brain stimulation|noninvasive brain stimulation
53068|NCT02954211|physical therapy|physical therapy
53069|NCT02954185|Shoulder Pain|shoulder pain
53070|NCT02954146|Veterans|veterans
53071|NCT02954146|Posttraumatic Stress Disorder|posttraumatic stress disorder
53072|NCT02954146|Anger|anger
53073|NCT02954146|Behavioral Health|behavioral health
53074|NCT02954146|Mobile Health Technology|mobile health technology
53075|NCT02954133|Alignment phase|alignment phase
53076|NCT02954133|Photobiomodulation|photobiomodulation
53077|NCT02954133|Orthodontic treatment|orthodontic treatment
53078|NCT02954133|Malocclusion|malocclusion
53079|NCT02954133|OrthoPulse™|orthopulse™
53080|NCT02954133|Invisalign|invisalign
53081|NCT02954120|8- hydroxy -2´- deoxyguanosine|8- hydroxy -2´- deoxyguanosine
53082|NCT02954120|Malondialdehyde|malondialdehyde
53083|NCT02954120|Total antioxidant status|total antioxidant status
53084|NCT02954120|Oxidative stres|oxidative stres
53085|NCT02954068|Oxytocin|oxytocin
53086|NCT02954055|locally advanced|locally advanced
53087|NCT02954055|metastatic|metastatic
53088|NCT02954055|breast cancer|breast cancer
53089|NCT02954055|ER-positive|er-positive
53090|NCT02954055|HER2-negative|her2-negative
53091|NCT02954055|Stage IV|stage iv
53092|NCT02954042|Incontinence|incontinence
53094|NCT02954016|Weight Loss|weight loss
53095|NCT02954016|Hypertension|hypertension
53096|NCT02954016|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
53097|NCT02954016|Hyperlipidemia|hyperlipidemia
53098|NCT02954003|Obesity|obesity
53099|NCT02954003|Weight Loss|weight loss
53100|NCT02953990|Pregnancy|pregnancy
53101|NCT02953990|Self-Management|self-management
53102|NCT02953990|Yoga|yoga
53103|NCT02953951|blood transfusion|blood transfusion
53104|NCT02953951|free hemoglobin|free hemoglobin
53105|NCT02953951|nitric oxide|nitric oxide
53106|NCT02953951|endothelium-dependent vasodilatation|endothelium-dependent vasodilatation
53107|NCT02953951|peripheral artery tonometry|peripheral artery tonometry
53108|NCT02953951|cardiac surgery.|cardiac surgery.
53109|NCT02953938|Ranibizumab|ranibizumab
53110|NCT02953938|Grid&Direct short pulse laser photocoagulation|grid&direct short pulse laser photocoagulation
53111|NCT02953938|Macular edema,|macular edema,
53112|NCT02953938|Branch retinal vein occlusion (BRVO)|branch retinal vein occlusion (brvo)
53113|NCT02953938|BCVA|bcva
53114|NCT02953938|CSFT|csft
53115|NCT02953938|pro re nata|pro re nata
53116|NCT02953925|primary health care|primary health care
53117|NCT02953925|village doctor|village doctor
53118|NCT02953925|township hospital|township hospital
53119|NCT02953925|community health center|community health center
53120|NCT02953912|Rotation|rotation
53121|NCT02953912|Reciprocation|reciprocation
53122|NCT02953912|single file|single file
53123|NCT02953912|postoperative pain|postoperative pain
53124|NCT02953912|Reciproc|reciproc
53125|NCT02953912|One Shape|one shape
53126|NCT02953912|Symptomatic irreversible pulpitis|symptomatic irreversible pulpitis
53127|NCT02953899|Internet|internet
53128|NCT02953899|Contingency Management|contingency management
53129|NCT02953899|Gambling Disorder|gambling disorder
53131|NCT02953886|Caries|caries
53132|NCT02953886|Cavity|cavity
53133|NCT02953886|Silver Diamine Fluoride (SDF)|silver diamine fluoride (sdf)
53134|NCT02953886|HOMINGS|homings
53135|NCT02953860|Advanced Breast Cancer|advanced breast cancer
53136|NCT02953860|ER+/Her2 Advanced Breast Cancer|er+/her2 advanced breast cancer
53137|NCT02953834|insulin regulation in pregnancy|insulin regulation in pregnancy
53138|NCT02953834|kisspeptin|kisspeptin
53139|NCT02953808|GSK2315698|gsk2315698
53140|NCT02953808|Dose-ascending|dose-ascending
53141|NCT02953808|Systemic amyloidosis|systemic amyloidosis
53142|NCT02953782|Colorectal Neoplasms, Hu5F9-G4, CD47, cetuximab|colorectal neoplasms, hu5f9-g4, cd47, cetuximab
53143|NCT02953756|Brain metastases|brain metastases
53144|NCT02953756|Cognition|cognition
53145|NCT02953756|Radiosurgery|radiosurgery
53146|NCT02953756|Stereotactic radiosurgery|stereotactic radiosurgery
53147|NCT02953756|Gamma Knife Radiosurgery|gamma knife radiosurgery
60415|NCT02908256|PVI|pvi
53148|NCT02953756|Quality of Life|quality of life
53150|NCT02953756|Anxiety|anxiety
53151|NCT02953756|Depression|depression
53152|NCT02953743|E7080|e7080
53153|NCT02953743|Lenvatinib|lenvatinib
53154|NCT02953743|Pharmacokinetic study|pharmacokinetic study
53155|NCT02953743|Chinese participants|chinese participants
53156|NCT02953743|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
53157|NCT02953717|Brain metastases|brain metastases
53158|NCT02953717|Cognition|cognition
53159|NCT02953717|Radiosurgery|radiosurgery
53160|NCT02953717|Gamma Knife Radiosurgery|gamma knife radiosurgery
53161|NCT02953717|Stereotactic radiosurgery|stereotactic radiosurgery
53162|NCT02953717|Whole Brain Radiation Therapy|whole brain radiation therapy
53163|NCT02953717|Quality of Life|quality of life
53164|NCT02953717|Fatigue|fatigue
53165|NCT02953717|Anxiety|anxiety
53166|NCT02953717|Depression|depression
53167|NCT02953704|Myelofibrosis|myelofibrosis
53168|NCT02953704|essential thrombocythemia|essential thrombocythemia
53169|NCT02953704|clinical characteristics|clinical characteristics
53170|NCT02953704|disease burden|disease burden
53171|NCT02953704|patient-reported outcomes|patient-reported outcomes
53172|NCT02953691|perioperative|perioperative
53173|NCT02953691|surgery|surgery
53174|NCT02953691|pain|pain
53175|NCT02953691|anxiety|anxiety
53176|NCT02953691|post operative cognitive dysfunction|post operative cognitive dysfunction
53177|NCT02953691|cognition|cognition
53178|NCT02953678|Graft-versus-host disease (GVHD)|graft-versus-host disease (gvhd)
53179|NCT02953678|acute GVHD|acute gvhd
53180|NCT02953678|steroid-refractory|steroid-refractory
53181|NCT02953678|ruxolitinib|ruxolitinib
53182|NCT02953678|Janus kinase inhibitor|janus kinase inhibitor
53183|NCT02953665|Parkinson's Disease, Liraglutide|parkinson's disease, liraglutide
53184|NCT02953665|Antidiabetic agents|antidiabetic agents
53185|NCT02953665|GLP-1 agonists|glp-1 agonists
53186|NCT02953665|Insulin resistance|insulin resistance
53187|NCT02953626|pilot RCT|pilot rct
53188|NCT02953626|waitlist-controlled RCT|waitlist-controlled rct
53189|NCT02953626|postpartum depression|postpartum depression
53190|NCT02953613|Cardiac Catheterization|cardiac catheterization
53191|NCT02953613|Cardiac intervention|cardiac intervention
53192|NCT02953613|coronary angiogram|coronary angiogram
53193|NCT02953613|coronary artery disease|coronary artery disease
53194|NCT02953613|atherosclerosis|atherosclerosis
53195|NCT02953587|Obesity|obesity
53196|NCT02953587|Bariatric Surgery|bariatric surgery
53197|NCT02953574|geriatric nursing|geriatric nursing
53198|NCT02953561|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
53199|NCT02953561|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
53200|NCT02953561|Acute Myeloid Leukemia|acute myeloid leukemia
53201|NCT02953561|AML|aml
53202|NCT02953561|Avelumab|avelumab
53203|NCT02953561|antiPDL1|antipdl1
53204|NCT02953561|5-azacytidine|5-azacytidine
53205|NCT02953561|Azacitidine|azacitidine
53206|NCT02953561|5-aza|5-aza
53207|NCT02953561|Vidaza|vidaza
53208|NCT02953561|5-AZC|5-azc
53209|NCT02953561|AZA-CR|aza-cr
53210|NCT02953561|Ladakamycin|ladakamycin
53211|NCT02953561|NSC-102816|nsc-102816
53212|NCT02953561|Azacytidine|azacytidine
53213|NCT02953548|GWP42003-P|gwp42003-p
53214|NCT02953548|Cannabidiol|cannabidiol
53215|NCT02953522|Polymorphism|polymorphism
53216|NCT02953522|Folate|folate
53217|NCT02953522|Oxidative stress|oxidative stress
53218|NCT02953522|Overweight and Obesity|overweight and obesity
53219|NCT02953509|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
54456|NCT02945332|behavior|behavior
53220|NCT02953509|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
53221|NCT02953509|indolent lymphoma|indolent lymphoma
53222|NCT02953509|Hu5F9-G4|hu5f9-g4
53223|NCT02953509|CD47|cd47
53227|NCT02953496|claudication|claudication
53228|NCT02953496|superficial femoral artery|superficial femoral artery
53230|NCT02953496|popliteal artery|popliteal artery
53231|NCT02953496|stenosis|stenosis
53232|NCT02953496|elastase|elastase
53233|NCT02953496|chymotrypsin-like elastase 1|chymotrypsin-like elastase 1
53234|NCT02953496|CELA1|cela1
53235|NCT02953496|PRT-201|prt-201
53236|NCT02953483|Ex Vivo lung perfusion|ex vivo lung perfusion
53237|NCT02953470|chronic pain|chronic pain
53238|NCT02953470|community-dwelling|community-dwelling
53239|NCT02953470|older adults|older adults
53240|NCT02953470|physical activity|physical activity
53241|NCT02953470|physiotherapy|physiotherapy
53242|NCT02953470|behavioural medicine|behavioural medicine
53243|NCT02953470|biopsychosocial|biopsychosocial
53244|NCT02953470|exercise|exercise
53245|NCT02953470|independency|independency
53246|NCT02953470|everyday activities|everyday activities
53247|NCT02953470|self-efficacy|self-efficacy
53248|NCT02953470|quality of life|quality of life
53249|NCT02953470|pain-related beliefs|pain-related beliefs
53250|NCT02953470|pain-related disability|pain-related disability
53251|NCT02953431|Asthma|asthma
53252|NCT02953431|Obesity|obesity
53253|NCT02953353|Obesity|obesity
53254|NCT02953353|Feeding behavior|feeding behavior
53255|NCT02953353|Transcranial direct current stimulation|transcranial direct current stimulation
53256|NCT02953353|Weight loss|weight loss
53257|NCT02953340|Neutropenia|neutropenia
53258|NCT02953340|Breast Cancer|breast cancer
53259|NCT02953340|Long-acting Myeloid Growth Factor|long-acting myeloid growth factor
53260|NCT02953340|Early Stage Breast Cancer|early stage breast cancer
53261|NCT02953340|Docetaxel + Cyclophosphamide (TC) chemotherapy|docetaxel + cyclophosphamide (tc) chemotherapy
53262|NCT02953327|Non-Specific Effect of Vaccine|non-specific effect of vaccine
53263|NCT02953327|Middle aged|middle aged
53264|NCT02953327|Immunity, heterologous|immunity, heterologous
53265|NCT02953301|Cutaneous T-Cell Lymphoma (CTLC)|cutaneous t-cell lymphoma (ctlc)
53266|NCT02953301|Maintenance|maintenance
53267|NCT02953301|resminostat|resminostat
53269|NCT02953301|HDAC|hdac
53270|NCT02953301|Mycosis Fungoides|mycosis fungoides
53271|NCT02953301|Sézary Syndrome|sézary syndrome
53272|NCT02953262|Diabetes Mellitus|diabetes mellitus
53273|NCT02953262|Personal Health Records|personal health records
53274|NCT02953262|Patient Outcome Assessment|patient outcome assessment
53275|NCT02953262|Mental Health|mental health
53276|NCT02953184|neoadjuvant chemotherapy|neoadjuvant chemotherapy
53277|NCT02953184|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
53278|NCT02953184|breast cancer|breast cancer
53279|NCT02953171|Irritable Bowel Syndrome|irritable bowel syndrome
53280|NCT02953171|The human microbiome|the human microbiome
53281|NCT02953171|Microbiota|microbiota
53282|NCT02953171|Gut microbiota|gut microbiota
53283|NCT02953171|Probiotics|probiotics
53284|NCT02953171|Sauerkraut|sauerkraut
53285|NCT02953106|Asthma|asthma
53286|NCT02953106|Rhinitis|rhinitis
53287|NCT02953106|Dymista|dymista
53288|NCT02953106|allergy|allergy
53289|NCT02953093|acarbose|acarbose
53290|NCT02953093|aging|aging
53291|NCT02953054|Pain|pain
53292|NCT02953054|Bunionectomy|bunionectomy
624195|NCT00677664|copaxone|copaxone
53293|NCT02953054|Dexmedetomidine|dexmedetomidine
53294|NCT02953054|Transdermal|transdermal
53295|NCT02953054|Patch|patch
53296|NCT02953054|Postoperative|postoperative
53297|NCT02953054|DMTS|dmts
53298|NCT02953028|Continuous Positive Airway Pressure|continuous positive airway pressure
53299|NCT02953028|Mandibular Advancing Splint|mandibular advancing splint
53300|NCT02953028|Efficacy|efficacy
53301|NCT02953028|Compliance|compliance
53302|NCT02953028|Health related quality of life|health related quality of life
53303|NCT02953028|Randomized Controlled Trial|randomized controlled trial
53304|NCT02953028|Snoring|snoring
53305|NCT02953028|Mandibular Advancing Appliance|mandibular advancing appliance
53306|NCT02953028|Mandibular Advancing Device|mandibular advancing device
53307|NCT02953028|Humans|humans
53308|NCT02953028|Quality of Life|quality of life
53309|NCT02953028|Sleep Apnea, Obstructive|sleep apnea, obstructive
53310|NCT02953015|Chronic Migraine|chronic migraine
53311|NCT02953015|Manipulative treatments|manipulative treatments
53312|NCT02953015|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
53313|NCT02952976|open abdomen|open abdomen
53314|NCT02952976|Damage control|damage control
53315|NCT02952976|Abdominal Compartment Syndrome|abdominal compartment syndrome
53316|NCT02952950|Intra Oral Vacuum|intra oral vacuum
53317|NCT02952950|protein content breastmilk|protein content breastmilk
53318|NCT02952937|Neuralgia, Postherpetic|neuralgia, postherpetic
53319|NCT02952937|Postherpetic Neuralgia|postherpetic neuralgia
53324|NCT02952937|Neuralgia|neuralgia
53325|NCT02952937|Neuropathic Pain|neuropathic pain
53326|NCT02952937|Pregabalin|pregabalin
53327|NCT02952937|Pharmacokinetics|pharmacokinetics
53328|NCT02952937|Bioequivalent|bioequivalent
53329|NCT02952898|solar keratoses|solar keratoses
53330|NCT02952872|Computerized Brief Intervention|computerized brief intervention
53331|NCT02952833|Inactivated|inactivated
53332|NCT02952833|Phase I|phase i
53333|NCT02952833|placebo-controlled|placebo-controlled
53334|NCT02952833|Vaccine|vaccine
53335|NCT02952833|ZIKA|zika
53336|NCT02952820|insomnia|insomnia
53337|NCT02952794|endoscopic submucosal dissection (ESD)|endoscopic submucosal dissection (esd)
53338|NCT02952794|endoscopic mucosal band ligation (EMBL)|endoscopic mucosal band ligation (embl)
53339|NCT02952781|ECG Monitoring|ecg monitoring
53340|NCT02952781|Palpitations|palpitations
53341|NCT02952716|carbon monoxide poisoning|carbon monoxide poisoning
53342|NCT02952716|delayed encephalopathy|delayed encephalopathy
53343|NCT02952638|Lipids|lipids
53344|NCT02952638|lysophosphatidic acid|lysophosphatidic acid
53345|NCT02952638|Lysophospholipids|lysophospholipids
53346|NCT02952638|phosphatidylcholine|phosphatidylcholine
53347|NCT02952638|lysophosphatidylcholine|lysophosphatidylcholine
53348|NCT02952638|autotaxin|autotaxin
53349|NCT02952638|dietary|dietary
53350|NCT02952625|PET/MRI|pet/mri
53351|NCT02952599|Non-interventional Study|non-interventional study
53352|NCT02952599|Real World Evidence|real world evidence
60652|NCT02906696|CML|cml
53353|NCT02952599|Patients with Acute VTE treated with Edoxaban|patients with acute vte treated with edoxaban
53354|NCT02952599|Efficacy/Safety|efficacy/safety
53355|NCT02952560|Ultrasound|ultrasound
53356|NCT02952560|Computed Tomography|computed tomography
53357|NCT02952560|Oral cavity size|oral cavity size
53358|NCT02952560|The Mallampati classification|the mallampati classification
53359|NCT02952534|CRPC|crpc
53360|NCT02952534|PARP inhibitor|parp inhibitor
53361|NCT02952534|PARPi|parpi
53362|NCT02952534|BRCA|brca
53363|NCT02952534|ATM|atm
53364|NCT02952534|HRD|hrd
53365|NCT02952534|TRITON|triton
53366|NCT02952534|homologous recombination|homologous recombination
53367|NCT02952534|DNA repair|dna repair
53368|NCT02952534|DNA defect|dna defect
53369|NCT02952534|DNA anomaly|dna anomaly
53370|NCT02952534|BARD1|bard1
53371|NCT02952534|BRIP1|brip1
53372|NCT02952534|CDK12|cdk12
53373|NCT02952534|CHEK2|chek2
53374|NCT02952534|FANCA|fanca
53375|NCT02952534|NBN|nbn
53376|NCT02952534|PALB2|palb2
53377|NCT02952534|RAD51|rad51
53378|NCT02952534|RAD51B|rad51b
53379|NCT02952534|RAD51C|rad51c
53380|NCT02952534|RAD51D|rad51d
53381|NCT02952534|RAD54L|rad54l
53382|NCT02952534|germline|germline
53383|NCT02952534|somatic|somatic
53384|NCT02952495|Alcohol Consumption|alcohol consumption
53385|NCT02952495|Older Adults|older adults
53386|NCT02952482|adrenoleukodystrophy|adrenoleukodystrophy
53387|NCT02952482|C26:0-lyso-PC|c26:0-lyso-pc
53388|NCT02952469|Positron-Emission Tomography|positron-emission tomography
53389|NCT02952469|(68Ga)Glu-urea-Lys(Ahx)-HBED-CC|(68ga)glu-urea-lys(ahx)-hbed-cc
53390|NCT02952469|(68Ga)PSMA-HBED-CC|(68ga)psma-hbed-cc
53391|NCT02952456|SUDEP|sudep
53392|NCT02952456|Epilepsy|epilepsy
53393|NCT02952456|Qualitative research|qualitative research
53394|NCT02952456|Risks associated with epilepsy|risks associated with epilepsy
53395|NCT02952456|Epilepsy-related deaths|epilepsy-related deaths
53396|NCT02952391|cognition|cognition
53397|NCT02952391|cholinergic system|cholinergic system
53398|NCT02952365|LASIK, Ingrowth, Tissue sealant|lasik, ingrowth, tissue sealant
53399|NCT02952300|irreversible pulpitis|irreversible pulpitis
53400|NCT02952300|reciprocation|reciprocation
53401|NCT02952300|rotation|rotation
53402|NCT02952300|single file|single file
53403|NCT02952300|wave one|wave one
53404|NCT02952300|neolix|neolix
53405|NCT02952209|Alveolar Ridge Preservation|alveolar ridge preservation
53406|NCT02952209|Xenograft bone graft|xenograft bone graft
53407|NCT02952209|Collagen membrane|collagen membrane
53408|NCT02952196|Amphetamine|amphetamine
53409|NCT02952196|Stress|stress
53410|NCT02952196|Craving|craving
53411|NCT02952196|CBD|cbd
53412|NCT02952183|Autonomic nerve monitoring|autonomic nerve monitoring
53413|NCT02952183|Nerve-sparing surgery|nerve-sparing surgery
53414|NCT02952131|IBD,Crohn's,Ulcerative Bowel; Diverticulitis;IBS;UC|ibd,crohn's,ulcerative bowel; diverticulitis;ibs;uc
53415|NCT02952105|cardiac arrest|cardiac arrest
53416|NCT02952105|identify of electrocardiac rhythm|identify of electrocardiac rhythm
53417|NCT02952105|ventricuar fibrillation|ventricuar fibrillation
53418|NCT02952105|defibrillation|defibrillation
53419|NCT02952092|ASP1517|asp1517
53420|NCT02952092|Renal anemia|renal anemia
53421|NCT02952092|Hemodialysis|hemodialysis
53422|NCT02952092|Roxadustat|roxadustat
53423|NCT02952053|Myofascial Trigger Points|myofascial trigger points
53424|NCT02952053|Dry needling|dry needling
53425|NCT02952053|Myotonometry|myotonometry
53426|NCT02952040|ASP1517|asp1517
53427|NCT02952040|Pharmacokinetics|pharmacokinetics
53428|NCT02952040|Drug-drug interaction|drug-drug interaction
53429|NCT02952001|Uveitis|uveitis
53430|NCT02952001|UME|ume
53431|NCT02952001|Posterior Uveitis|posterior uveitis
53432|NCT02952001|Anterior Uveitis|anterior uveitis
53433|NCT02952001|Intermediate Uveitis|intermediate uveitis
53434|NCT02952001|Panuveitis|panuveitis
53435|NCT02952001|Non-infectious Uveitis|non-infectious uveitis
53436|NCT02952001|Triamcinolone|triamcinolone
53437|NCT02952001|Choroid|choroid
53438|NCT02952001|Choroidal Injection|choroidal injection
53439|NCT02952001|Suprachoroidal|suprachoroidal
53440|NCT02952001|Microneedle|microneedle
53441|NCT02952001|Microinjection|microinjection
53442|NCT02951949|atherosclerosis, endogenous estrogens, age|atherosclerosis, endogenous estrogens, age
54343|NCT02946034|HCV|hcv
53443|NCT02951897|circulating tumor cells|circulating tumor cells
53444|NCT02951897|lung adenocarcinoma|lung adenocarcinoma
53445|NCT02951897|treatment|treatment
53446|NCT02951897|early diagnosis|early diagnosis
53568|NCT02950909|Therapeutic exercise|therapeutic exercise
53447|NCT02951871|Follicular lymphoma; death, rituximab, treatment related toxicity|follicular lymphoma; death, rituximab, treatment related toxicity
53448|NCT02951858|Alcohol,Smoking,and Substance Use Involvement Screening Test|alcohol,smoking,and substance use involvement screening test
53449|NCT02951858|Brief Intervention|brief intervention
53450|NCT02951858|Substance Use|substance use
60758|NCT02906059|RAS|ras
53451|NCT02951858|Primary Medical and Health Care Institution|primary medical and health care institution
53452|NCT02951793|intensive care unit|intensive care unit
53453|NCT02951793|delirium|delirium
53454|NCT02951793|substance withdrawal|substance withdrawal
53455|NCT02951767|anti-PD-L1|anti-pd-l1
53456|NCT02951767|PD-L1|pd-l1
53457|NCT02951767|MPDL3280A|mpdl3280a
53458|NCT02951767|PD-1|pd-1
53459|NCT02951767|bladder cancer|bladder cancer
53460|NCT02951767|atezolizumab|atezolizumab
53461|NCT02951767|Tecentriq|tecentriq
53462|NCT02951754|ADHD|adhd
53463|NCT02951754|Adults|adults
53464|NCT02951754|treatment|treatment
53465|NCT02951754|Methylphenidate|methylphenidate
53466|NCT02951650|vagus nerve stimulation|vagus nerve stimulation
53467|NCT02951637|Adenocarcinoma, EGFR, Gefitinib, Pemetrexed, Carboplatin|adenocarcinoma, egfr, gefitinib, pemetrexed, carboplatin
53468|NCT02951624|Exercise|exercise
53469|NCT02951624|Breaking prolonged sitting|breaking prolonged sitting
53470|NCT02951624|physical activity|physical activity
53471|NCT02951572|Noninvasive Ventilation|noninvasive ventilation
53472|NCT02951572|Physical activity|physical activity
53473|NCT02951520|Patients|patients
53474|NCT02951481|Clostridium difficile.|clostridium difficile.
53475|NCT02951481|Antimicrobial Stewardship.|antimicrobial stewardship.
53476|NCT02951481|Enterocolitis, Pseudomembranous|enterocolitis, pseudomembranous
53477|NCT02951442|Arterial stiffness|arterial stiffness
53478|NCT02951442|Klotho-FGF23|klotho-fgf23
53479|NCT02951403|elbow arthroscopy|elbow arthroscopy
53480|NCT02951403|DASH|dash
53481|NCT02951403|elbow locking|elbow locking
53482|NCT02951403|elbow osteoarthritis|elbow osteoarthritis
53483|NCT02951390|Surveillance|surveillance
53484|NCT02951390|Colorectal cancer|colorectal cancer
53485|NCT02951390|Colonoscopy|colonoscopy
53486|NCT02951390|Adenoma|adenoma
53487|NCT02951390|Chromoendoscopy|chromoendoscopy
624701|NCT00680043|Hb|hb
53488|NCT02951377|mechanical diagnosis therapy (MDT)|mechanical diagnosis therapy (mdt)
53489|NCT02951377|physical therapy|physical therapy
53490|NCT02951377|steroid injection|steroid injection
53491|NCT02951377|exercise|exercise
53492|NCT02951364|observational|observational
53493|NCT02951338|Physical activity|physical activity
53494|NCT02951338|Exercise|exercise
53495|NCT02951338|Behaviour change|behaviour change
53496|NCT02951338|Rehabilitation|rehabilitation
53497|NCT02951338|Self-management|self-management
53498|NCT02951338|Education|education
53499|NCT02951325|adjuvant RT|adjuvant rt
53500|NCT02951312|Emphysema|emphysema
53501|NCT02951312|Chronic bronchitis|chronic bronchitis
53502|NCT02951312|COPD|copd
53503|NCT02951312|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
53504|NCT02951286|Skeletal openbite|skeletal openbite
53505|NCT02951286|Molar intrusion|molar intrusion
53506|NCT02951286|high pull headgear|high pull headgear
53507|NCT02951273|abdominal surgery|abdominal surgery
53508|NCT02951273|blood pressure|blood pressure
53509|NCT02951273|cardiac output|cardiac output
53510|NCT02951273|cerebral blood flow|cerebral blood flow
53511|NCT02951273|cerebral oxygenation|cerebral oxygenation
53512|NCT02951273|CO2 reactivity|co2 reactivity
53513|NCT02951273|duplex ultrasound|duplex ultrasound
53514|NCT02951273|general anaesthesia|general anaesthesia
53515|NCT02951273|mesenteric traction syndrome|mesenteric traction syndrome
53516|NCT02951273|near-infrared spectroscopy|near-infrared spectroscopy
53517|NCT02951273|upper gastrointestinal cancer surgery|upper gastrointestinal cancer surgery
53518|NCT02951234|coronary artery lesions|coronary artery lesions
53519|NCT02951234|intravenous immunoglobulin|intravenous immunoglobulin
53520|NCT02951234|Kawasaki disease|kawasaki disease
53521|NCT02951234|randomized clinical trial|randomized clinical trial
53523|NCT02951130|CDH|cdh
53524|NCT02951130|PPHN|pphn
53525|NCT02951130|HRF|hrf
53526|NCT02951117|lymphoid malignancies|lymphoid malignancies
53527|NCT02951117|Next generation sequencing|next generation sequencing
53528|NCT02951117|Refractory Multiple Myeloma|refractory multiple myeloma
53529|NCT02951117|Relapsed Multiple Myeloma|relapsed multiple myeloma
53530|NCT02951052|Long-acting cabotegravir|long-acting cabotegravir
53531|NCT02951052|Virologic failure|virologic failure
53532|NCT02951052|long-acting rilpivirine|long-acting rilpivirine
53533|NCT02951052|Antiretroviral|antiretroviral
53534|NCT02951039|Non valvular Atrial Fibrillation|non valvular atrial fibrillation
53535|NCT02951039|Non-interventional Study|non-interventional study
53536|NCT02951039|Efficacy/Safety|efficacy/safety
53537|NCT02951039|Real World Evidence|real world evidence
53539|NCT02951026|osteoarthritis|osteoarthritis
53540|NCT02951026|intra-articular injection|intra-articular injection
53541|NCT02951026|SM04690|sm04690
53542|NCT02951000|thyroidectomy|thyroidectomy
53543|NCT02951000|postoperative pain|postoperative pain
53544|NCT02951000|wound healing|wound healing
53545|NCT02950987|Li-Fraumeni Syndrome (LFS)|li-fraumeni syndrome (lfs)
53546|NCT02950987|Cancer Predisposition Syndromes|cancer predisposition syndromes
53547|NCT02950987|LFS|lfs
53548|NCT02950974|sterofundin|sterofundin
53549|NCT02950974|resuscitation|resuscitation
53550|NCT02950974|normal saline|normal saline
53551|NCT02950974|chloride|chloride
53552|NCT02950974|fluid|fluid
53553|NCT02950974|SID|sid
53554|NCT02950974|pH|ph
53555|NCT02950974|osmolality|osmolality
53556|NCT02950974|urine|urine
53557|NCT02950961|Anxiety [F01.470.132]|anxiety [f01.470.132]
53558|NCT02950961|Depression [F01.145.126.350]|depression [f01.145.126.350]
53559|NCT02950961|Stress Disorders, Post-Traumatic [F03.950.750.500]|stress disorders, post-traumatic [f03.950.750.500]
53560|NCT02950961|Primary Health Care [N04.590.233.727]|primary health care [n04.590.233.727]
53561|NCT02950961|Mental Health [F02.418]|mental health [f02.418]
53562|NCT02950961|Patient Participation [N05.300.150.600.620]|patient participation [n05.300.150.600.620]
53563|NCT02950961|Patient Satisfaction [N05.300.150.600.630]|patient satisfaction [n05.300.150.600.630]
53564|NCT02950961|Patient Preference [N05.300.150.600.630.500]|patient preference [n05.300.150.600.630.500]
53565|NCT02950961|Physicians, Primary Care [M01.526.485.810.800]|physicians, primary care [m01.526.485.810.800]
53566|NCT02950961|Physicians, Women [M01.526.485.810.820]|physicians, women [m01.526.485.810.820]
53567|NCT02950961|Health Behavior [F01.145.488]|health behavior [f01.145.488]
53569|NCT02950909|Chronic pain|chronic pain
53570|NCT02950909|Neck extensors|neck extensors
53571|NCT02950883|Cystic Fibrosis|cystic fibrosis
53572|NCT02950883|Hypertonic Saline|hypertonic saline
53573|NCT02950883|Inhaled Saline|inhaled saline
53574|NCT02950883|Digestive System Diseases|digestive system diseases
53575|NCT02950883|Genetic Diseases, Inborn|genetic diseases, inborn
53576|NCT02950883|Lung Diseases|lung diseases
53577|NCT02950883|Pancreatic Diseases|pancreatic diseases
53578|NCT02950883|Pathologic Processes|pathologic processes
53579|NCT02950883|Respiratory Tract Diseases|respiratory tract diseases
53580|NCT02950883|Computed Tomography (CT)|computed tomography (ct)
53581|NCT02950844|Atrial fibrillation|atrial fibrillation
53582|NCT02950844|Electrogram|electrogram
53583|NCT02950844|Ablation|ablation
53584|NCT02950844|Drivers|drivers
53585|NCT02950831|Chronic Pain|chronic pain
53586|NCT02950831|BurstDR|burstdr
53587|NCT02950831|spinal cord stimulation|spinal cord stimulation
53588|NCT02950831|Accelerometry|accelerometry
53589|NCT02950818|self-care|self-care
53590|NCT02950818|health education|health education
53591|NCT02950818|chronic disease|chronic disease
53592|NCT02950818|heart diseases|heart diseases
53593|NCT02950818|risk factors for heart disease|risk factors for heart disease
53594|NCT02950805|AZD5634|azd5634
53595|NCT02950805|Mucociliary Clearance|mucociliary clearance
53596|NCT02950805|Safety|safety
53597|NCT02950805|Tolerability|tolerability
53598|NCT02950805|Pharmacokinetic|pharmacokinetic
53599|NCT02950805|Cystic Fibrosis|cystic fibrosis
53600|NCT02950805|Cross-Over Study|cross-over study
53601|NCT02950792|Non-Small Cell Lung Cancer|non-small cell lung cancer
53602|NCT02950792|NSCLC|nsclc
53603|NCT02950766|Kidney Cancer|kidney cancer
53604|NCT02950753|Elevated Serum Lactate|elevated serum lactate
53605|NCT02950753|Serum lactate|serum lactate
53606|NCT02950753|Ringer's Lactate|ringer's lactate
53607|NCT02950753|Lactated Ringer's|lactated ringer's
53608|NCT02950753|Hyperlactatemia|hyperlactatemia
53609|NCT02950740|malnutrition|malnutrition
53610|NCT02950727|orthognathic surgery|orthognathic surgery
53613|NCT02950675|Burn patient|burn patient
53614|NCT02950675|Developmental Disabilities|developmental disabilities
53615|NCT02950675|Body function|body function
53616|NCT02950675|Participation|participation
53617|NCT02950675|Quality of Life|quality of life
53618|NCT02950675|longitudinal study|longitudinal study
53619|NCT02950636|Epilepsy|epilepsy
53620|NCT02950610|Electronic nose|electronic nose
53621|NCT02950610|Non invasive diagnosis of NAFLD|non invasive diagnosis of nafld
53622|NCT02950610|NAFLD|nafld
53623|NCT02950610|exhaled breath analysis|exhaled breath analysis
53624|NCT02950610|Volatile organic compounds|volatile organic compounds
53625|NCT02950545|astigmatism, contact lens, driving|astigmatism, contact lens, driving
53626|NCT02950532|Posterior ligamentous complex|posterior ligamentous complex
53627|NCT02950532|Thoracolumbar fractures|thoracolumbar fractures
53628|NCT02950532|Interspinous distance|interspinous distance
53629|NCT02950532|Local kyphosis|local kyphosis
53630|NCT02950506|Interictal|interictal
53631|NCT02950506|Cognitive|cognitive
53632|NCT02950506|Dysfunction|dysfunction
53633|NCT02950506|tDCS|tdcs
53634|NCT02950506|transcranial direct current stimulation|transcranial direct current stimulation
53635|NCT02950480|Mastectomy|mastectomy
53637|NCT02950467|Demoralization|demoralization
53638|NCT02950467|Psilocybin|psilocybin
53639|NCT02950467|Group therapy|group therapy
53640|NCT02950454|Progressive Multiple Sclerosis|progressive multiple sclerosis
53641|NCT02950454|Rehabilitation|rehabilitation
53642|NCT02950454|Exercise|exercise
53643|NCT02950441|Nicotinamide Riboside|nicotinamide riboside
53644|NCT02950441|Nicotinamide Adenine Dinucleotide|nicotinamide adenine dinucleotide
53645|NCT02950441|Skeletal muscle|skeletal muscle
53646|NCT02950441|Metabolism|metabolism
53647|NCT02950428|TAVI|tavi
53648|NCT02950428|Aortic Stenosis|aortic stenosis
53649|NCT02950428|transcatether Aortic Valve Implantation|transcatether aortic valve implantation
53650|NCT02950389|PMMA|pmma
53651|NCT02950389|on-line HFR|on-line hfr
53652|NCT02950389|free light chains|free light chains
53653|NCT02950389|toxins|toxins
53654|NCT02950389|removal|removal
53655|NCT02950389|hemodialysis|hemodialysis
53656|NCT02950376|synthetic drugs|synthetic drugs
53657|NCT02950376|virtual reality|virtual reality
53658|NCT02950376|addiction evaluation|addiction evaluation
53659|NCT02950376|physiological data|physiological data
53660|NCT02950376|eye movement index|eye movement index
53661|NCT02950363|Depression|depression
53662|NCT02950363|Suicide|suicide
53663|NCT02950363|Anxiety disorder|anxiety disorder
53664|NCT02950363|Burn out|burn out
53665|NCT02950363|Sleep quality|sleep quality
53666|NCT02950363|Stress|stress
53667|NCT02950350|Cervical cancer|cervical cancer
53668|NCT02950350|Precision medicine|precision medicine
53669|NCT02950350|Individualized treatment|individualized treatment
53670|NCT02950350|Surgical staging|surgical staging
53671|NCT02950337|Unbiopsied Early Stage Non Small Cell Lung Cancer|unbiopsied early stage non small cell lung cancer
53672|NCT02950324|Prehabilitation|prehabilitation
53673|NCT02950324|Oesophago-gastric|oesophago-gastric
53674|NCT02950324|Cancer|cancer
53675|NCT02950324|Neo-adjuvant|neo-adjuvant
53676|NCT02950324|Exercise|exercise
53677|NCT02950324|Cardiopulmonary exercise test|cardiopulmonary exercise test
53678|NCT02950324|Insulin resistance|insulin resistance
53679|NCT02950298|Pompe|pompe
53680|NCT02950298|Glycogen Storage Disease II|glycogen storage disease ii
53681|NCT02950298|Telemedicine|telemedicine
53682|NCT02950298|Duke University Medical Center|duke university medical center
53683|NCT02950259|Breast Cancer|breast cancer
53684|NCT02950259|Early Stage Breast Cancer|early stage breast cancer
53685|NCT02950259|Male breast cancer|male breast cancer
53686|NCT02950259|IRX-2|irx-2
53687|NCT02950259|Immunotherapy|immunotherapy
53688|NCT02950233|postoperative pain|postoperative pain
53689|NCT02950233|VATS|vats
53690|NCT02950233|activities of daily living|activities of daily living
53691|NCT02950233|quality of life|quality of life
53692|NCT02950194|mesh|mesh
53693|NCT02950194|rectus diastasis|rectus diastasis
53694|NCT02950194|panniculectomy|panniculectomy
53695|NCT02950194|abdominoplasty|abdominoplasty
53696|NCT02950168|Diagnostic procedures|diagnostic procedures
53697|NCT02950168|Interventional procedures|interventional procedures
53698|NCT02950168|Planned or unplanned|planned or unplanned
53699|NCT02950168|Edoxaban-treated population|edoxaban-treated population
53700|NCT02950142|order sets|order sets
53701|NCT02950142|decision support|decision support
53702|NCT02950142|laboratory test|laboratory test
53703|NCT02950142|primary care|primary care
53704|NCT02950129|pelvic girdle dysfunction|pelvic girdle dysfunction
53705|NCT02950103|solid tumor|solid tumor
53706|NCT02950103|phase II|phase ii
53707|NCT02950103|phosphoethanolamine|phosphoethanolamine
53708|NCT02950090|Knee symptoms|knee symptoms
55546|NCT02938169|low back pain|low back pain
53709|NCT02950090|physical activity|physical activity
53710|NCT02950090|Fitbit|fitbit
53711|NCT02950090|Accelerometer|accelerometer
53712|NCT02950090|remote coaching|remote coaching
53713|NCT02950064|BRCA|brca
53714|NCT02950064|BRCA1|brca1
53715|NCT02950064|BRCA2|brca2
53716|NCT02950064|Pancreatic cancer|pancreatic cancer
53717|NCT02950064|Ovarian cancer|ovarian cancer
53718|NCT02950064|Castrate resistant prostate cancer|castrate resistant prostate cancer
53719|NCT02950064|Triple negative breast cancer|triple negative breast cancer
53720|NCT02950064|Breast cancer|breast cancer
53721|NCT02950064|DNA repair mutation-positive solid tumors|dna repair mutation-positive solid tumors
53723|NCT02950038|Lung Cancer, Nonsmall Cell|lung cancer, nonsmall cell
53724|NCT02950038|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
53725|NCT02950038|NSCLC|nsclc
53726|NCT02950038|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
53727|NCT02950038|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
53728|NCT02950038|Ibrutinib|ibrutinib
53729|NCT02950038|PCI-32765|pci-32765
53730|NCT02950038|Imbruvica|imbruvica
53731|NCT02950038|Nivolumab|nivolumab
53732|NCT02950038|BMS-936558|bms-936558
53733|NCT02950038|Opdivo|opdivo
53734|NCT02950012|Healthy|healthy
53735|NCT02950012|Bloating|bloating
53736|NCT02950012|Abdominal Discomfort|abdominal discomfort
53737|NCT02950012|Gas|gas
53738|NCT02950012|Probiotic|probiotic
53739|NCT02950012|Bacillus Subtillis|bacillus subtillis
53740|NCT02949999|Calcineurin inhibitor|calcineurin inhibitor
53741|NCT02949999|Voclosporin|voclosporin
53742|NCT02949973|lupus nephritis|lupus nephritis
53743|NCT02949973|calcineurin inhibitors|calcineurin inhibitors
53744|NCT02949973|voclosporin|voclosporin
53745|NCT02949960|Eczema|eczema
45310|NCT03002090|BaZhen KeLi|bazhen keli
45311|NCT03002064|Esophagus squamous carcinoma|esophagus squamous carcinoma
45312|NCT03002064|First-line chemotherapy|first-line chemotherapy
45313|NCT03002064|Docetaxel|docetaxel
45314|NCT03002064|Cisplatin|cisplatin
45315|NCT03002064|5-fluorouracil|5-fluorouracil
45332|NCT03001986|safety|safety
53746|NCT02949960|Dermatitis|dermatitis
53747|NCT02949960|Skin Diseases|skin diseases
53748|NCT02949960|Skin Diseases, Genetic|skin diseases, genetic
53749|NCT02949960|Dermatitis, Atopic|dermatitis, atopic
53750|NCT02949960|Skin Diseases, Eczematous|skin diseases, eczematous
53751|NCT02949960|Hypersensitivity|hypersensitivity
53752|NCT02949960|Immune System Diseases|immune system diseases
53753|NCT02949947|Malignant Neoplasms of Mesothelial and Soft Tissue|malignant neoplasms of mesothelial and soft tissue
53754|NCT02949947|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
53755|NCT02949947|GIST|gist
53756|NCT02949947|Iron-deficiency anemia|iron-deficiency anemia
53757|NCT02949947|Ferric Carboxymaltose|ferric carboxymaltose
53758|NCT02949947|Injectafer|injectafer
53759|NCT02949947|Iron supplement|iron supplement
53760|NCT02949947|Health Questionnaire|health questionnaire
53761|NCT02949947|Survey|survey
53762|NCT02949908|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
53763|NCT02949908|Rebif|rebif
53764|NCT02949908|Treatment Satisfaction Questionnaire for Medication Version II|treatment satisfaction questionnaire for medication version ii
53765|NCT02949908|Multiple Sclerosis International Quality of Life Questionnaire|multiple sclerosis international quality of life questionnaire
53766|NCT02949882|Diarrhea|diarrhea
53767|NCT02949882|Constipation|constipation
53768|NCT02949882|Elderly|elderly
53769|NCT02949882|Nursing Homes|nursing homes
53770|NCT02949882|Probiotics|probiotics
53771|NCT02949882|Bowel Habits|bowel habits
53772|NCT02949830|RNAi therapeutic|rnai therapeutic
53773|NCT02949830|Porphyria|porphyria
53774|NCT02949830|AIP|aip
53775|NCT02949830|Heme/Haem Arginate|heme/haem arginate
53776|NCT02949791|cisplatin|cisplatin
53777|NCT02949791|HIPEC|hipec
53778|NCT02949791|Intra abdominal pressure|intra abdominal pressure
53779|NCT02949791|tissue drug concentration|tissue drug concentration
53780|NCT02949713|HIV|hiv
53781|NCT02949713|infant feeding|infant feeding
53782|NCT02949713|mHealth|mhealth
53783|NCT02949713|behavioural intervention|behavioural intervention
53784|NCT02949700|metformin|metformin
53785|NCT02949700|head and neck cancer|head and neck cancer
53786|NCT02949687|ileal interposition|ileal interposition
53787|NCT02949687|metabolic surgery|metabolic surgery
53788|NCT02949687|diabetes|diabetes
53789|NCT02949687|intra abdominal selective denervation|intra abdominal selective denervation
53790|NCT02949648|Electronic cigarette|electronic cigarette
53791|NCT02949635|Aged|aged
53792|NCT02949635|Patient readmission|patient readmission
53793|NCT02949635|Geriatric Assessment|geriatric assessment
53794|NCT02949635|Mortality|mortality
53795|NCT02949622|Metabolic syndrome|metabolic syndrome
53796|NCT02949622|Mediterranean diet|mediterranean diet
53797|NCT02949622|Stress|stress
53798|NCT02949622|quality of life|quality of life
53799|NCT02949622|psychological factors|psychological factors
53800|NCT02949609|stroke|stroke
53801|NCT02949609|mirror therapy|mirror therapy
53802|NCT02949609|neurorehabilitation|neurorehabilitation
53803|NCT02949596|quality of sexual life|quality of sexual life
53804|NCT02949596|intensity-modulated radiotherapy|intensity-modulated radiotherapy
53805|NCT02949596|concurrent chemoradiotherapy|concurrent chemoradiotherapy
53806|NCT02949583|DENTAL PLAQUE|dental plaque
53807|NCT02949583|MEDICINAL PLANTS|medicinal plants
53808|NCT02949583|GINGIVITIS|gingivitis
53809|NCT02949505|Prehabilitation|prehabilitation
53810|NCT02949505|liver transplant|liver transplant
53811|NCT02949505|functional capacity|functional capacity
53812|NCT02949505|exercise|exercise
53813|NCT02949492|Liver|liver
53814|NCT02949492|Transplant|transplant
53815|NCT02949492|Immunosuppression|immunosuppression
53816|NCT02949479|sex offenses|sex offenses
53817|NCT02949466|knee osteoarthritis|knee osteoarthritis
53818|NCT02949466|triamcinolone|triamcinolone
53819|NCT02949466|therapeutic effects|therapeutic effects
53820|NCT02949453|suicide|suicide
53821|NCT02949453|prevention|prevention
53822|NCT02949440|Laparoscopic right Hemicolectomy|laparoscopic right hemicolectomy
53823|NCT02949440|Caudal-to-cranial Approach|caudal-to-cranial approach
53824|NCT02949427|Microbiome|microbiome
53825|NCT02949427|Mycobiome|mycobiome
53827|NCT02949427|Pediatric leukemia|pediatric leukemia
53828|NCT02949427|Pediatric bone marrow transplantation|pediatric bone marrow transplantation
53829|NCT02949414|Malacia|malacia
53830|NCT02949414|Stenosis|stenosis
53831|NCT02949414|Trachea|trachea
53832|NCT02949414|Transplant|transplant
53833|NCT02949349|Systemic Lupus Erythematosus|systemic lupus erythematosus
53834|NCT02949349|Lupus Nephritis|lupus nephritis
53835|NCT02949349|Mycophenolate Mofetil|mycophenolate mofetil
53836|NCT02949349|Azathioprine|azathioprine
53837|NCT02949349|Maintenance Therapy|maintenance therapy
53838|NCT02949349|Prednisolone|prednisolone
53839|NCT02949349|Serum albumin|serum albumin
53840|NCT02949349|Serum creatinine|serum creatinine
53841|NCT02949349|Spot urine protein/creatinine ratio|spot urine protein/creatinine ratio
53842|NCT02949323|children|children
53843|NCT02949323|renal stone|renal stone
53844|NCT02949323|metabolic evaluation|metabolic evaluation
53845|NCT02949323|Mutational analysis|mutational analysis
53846|NCT02949297|abdominal|abdominal
53847|NCT02949297|aortic|aortic
53848|NCT02949297|aneurysm|aneurysm
53849|NCT02949271|epidural analgesia|epidural analgesia
53850|NCT02949258|gastric cancer|gastric cancer
53851|NCT02949258|Borrmann type 4|borrmann type 4
53852|NCT02949258|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
53853|NCT02949258|Intra-arterial administration|intra-arterial administration
53854|NCT02949245|Spine|spine
53855|NCT02949245|Surgery|surgery
53856|NCT02949245|Prospective Studies|prospective studies
53857|NCT02949245|Deformity|deformity
53858|NCT02949245|Neurologic deficit|neurologic deficit
53859|NCT02949180|Atrial fibrillation|atrial fibrillation
53860|NCT02949180|Rhythm monitoring|rhythm monitoring
53861|NCT02949180|Cardiovascular App|cardiovascular app
53862|NCT02949180|m-health|m-health
53863|NCT02949167|Nurse-led follow-up after breast cancer|nurse-led follow-up after breast cancer
53864|NCT02949115|Red beetroot|red beetroot
53865|NCT02949115|Dietary Nitrate|dietary nitrate
53866|NCT02949115|Polyphenols|polyphenols
53867|NCT02949115|Endothelial Function|endothelial function
53868|NCT02949115|High-Fat Meal|high-fat meal
53869|NCT02949115|Overweight|overweight
53870|NCT02949115|Obesity|obesity
53871|NCT02949115|Aging|aging
53872|NCT02949115|Cardiometabolic|cardiometabolic
53873|NCT02949089|safety|safety
53874|NCT02949089|tolerability|tolerability
53875|NCT02949089|rising multiple doses|rising multiple doses
53876|NCT02949089|ACH04|ach04
53877|NCT02949089|adult|adult
53878|NCT02949089|male|male
53879|NCT02949063|school lunch|school lunch
53880|NCT02949063|occupational therapy|occupational therapy
53881|NCT02949024|Diabetes mellitus|diabetes mellitus
53882|NCT02949024|Diabetic retinopathy|diabetic retinopathy
53883|NCT02949024|Microneedle|microneedle
53884|NCT02949024|Microinjection|microinjection
53885|NCT02949024|Triamcinolone|triamcinolone
53886|NCT02949024|Choroid|choroid
53887|NCT02949024|Choroid Injection|choroid injection
53888|NCT02949024|Aflibercept|aflibercept
53889|NCT02949024|Suprachoroidal|suprachoroidal
53890|NCT02949011|Tamiflu®|tamiflu®
53891|NCT02949011|Influenza|influenza
53892|NCT02949011|Oseltamivir|oseltamivir
53893|NCT02949011|Flu|flu
53894|NCT02949011|S-033188|s-033188
53895|NCT02948985|Metastatic colorectal cancer|metastatic colorectal cancer
53896|NCT02948985|Cetuximab|cetuximab
53897|NCT02948985|CTCs|ctcs
53898|NCT02948985|ct DNA|ct dna
53899|NCT02948972|deep infiltrating endometriosis|deep infiltrating endometriosis
53900|NCT02948972|endometriosis surgery|endometriosis surgery
53901|NCT02948972|In vitro fertilization|in vitro fertilization
53902|NCT02948946|lung cancer|lung cancer
53903|NCT02948946|pancreatic cancer|pancreatic cancer
53904|NCT02948933|Dengue Fever|dengue fever
53905|NCT02948933|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
53906|NCT02948933|Dengvaxia®|dengvaxia®
53907|NCT02948920|ephedrine|ephedrine
53908|NCT02948920|core temperature|core temperature
53909|NCT02948920|tympanic temperature|tympanic temperature
53910|NCT02948920|heat loss|heat loss
53911|NCT02948920|spinal anesthesia|spinal anesthesia
53912|NCT02948920|neuraxial|neuraxial
53913|NCT02948920|hypothermia|hypothermia
53914|NCT02948920|shivering|shivering
53915|NCT02948881|Osteoporosis|osteoporosis
53916|NCT02948881|bisphosphonates|bisphosphonates
53918|NCT02948868|Methamphetamine|methamphetamine
53919|NCT02948868|MRI|mri
53920|NCT02948868|South Africa|south africa
53921|NCT02948868|Contingency Management|contingency management
53922|NCT02948855|Long non-coding RNA（LncRNA）|long non-coding rna（lncrna）
53923|NCT02948855|Thymoma|thymoma
53924|NCT02948855|Autoimmune disease|autoimmune disease
54872|NCT02942823|nutrition|nutrition
53925|NCT02948855|Notch2 Signaling pathway|notch2 signaling pathway
53926|NCT02948855|Regulatory B cell（Breg）|regulatory b cell（breg）
53927|NCT02948829|Drug therapy|drug therapy
53928|NCT02948803|intervention|intervention
53929|NCT02948803|mHealth|mhealth
53930|NCT02948803|physical activity|physical activity
53931|NCT02948803|active transport|active transport
53932|NCT02948803|smartphone|smartphone
53933|NCT02948803|application|application
53934|NCT02948764|breast cancer|breast cancer
61401|NCT02901951|HBV|hbv
45523|NCT03000777|zinc|zinc
53935|NCT02948764|vacuum-assisted biopsy|vacuum-assisted biopsy
53936|NCT02948764|pathological complete response|pathological complete response
53937|NCT02947724|chocolate cyst|chocolate cyst
53938|NCT02947724|laparoscopy|laparoscopy
53939|NCT02947724|surgicel|surgicel
53940|NCT02947711|E2027|e2027
53941|NCT02947711|Healthy participants|healthy participants
53942|NCT02947711|Pharmacokinetics|pharmacokinetics
53943|NCT02947698|acute kidney injury|acute kidney injury
53944|NCT02947698|weekend admission|weekend admission
53945|NCT02947698|mortality|mortality
53946|NCT02947685|breast cancer|breast cancer
53947|NCT02947685|malignant tumor of the breast|malignant tumor of the breast
53948|NCT02947685|HER2+|her2+
53949|NCT02947685|HR+|hr+
53950|NCT02947685|metastatic breast cancer|metastatic breast cancer
53951|NCT02947659|Body mass index|body mass index
53952|NCT02947659|Academic stress|academic stress
53953|NCT02947659|Musculoskeletal disorders|musculoskeletal disorders
53954|NCT02947607|Human gut microbiome|human gut microbiome
53955|NCT02947607|Colorectal cancer|colorectal cancer
53956|NCT02947607|Colorectal adenoma|colorectal adenoma
53957|NCT02947607|Gut bacteria|gut bacteria
53958|NCT02947607|Metagenomics|metagenomics
53959|NCT02947607|Metatranscriptomics|metatranscriptomics
53960|NCT02947581|subarachnoid neurocysticercosis|subarachnoid neurocysticercosis
53961|NCT02947581|albendazole|albendazole
53962|NCT02947581|praziquantel|praziquantel
53963|NCT02947568|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
53964|NCT02947568|Chronic Kidney Disease|chronic kidney disease
53965|NCT02947568|Diabetes Mellitus|diabetes mellitus
53966|NCT02947568|Cross-sectional|cross-sectional
53967|NCT02947555|diabetes mellitus|diabetes mellitus
53968|NCT02947555|atherosclerosis|atherosclerosis
53969|NCT02947555|AGE|age
53970|NCT02947555|lens autofluorescence|lens autofluorescence
53971|NCT02948712|distress|distress
53972|NCT02948712|survivorship|survivorship
53973|NCT02948712|transition period|transition period
53974|NCT02948699|nasopharyngeal carcinoma|nasopharyngeal carcinoma
53975|NCT02948699|intensity-modulated radiotherapy|intensity-modulated radiotherapy
53976|NCT02948699|nutrition support|nutrition support
53977|NCT02948699|nutrition assessment|nutrition assessment
53978|NCT02948686|dentin bonding agents|dentin bonding agents
53979|NCT02948686|tooth sensitivity|tooth sensitivity
53980|NCT02948686|composite resin restoration|composite resin restoration
53981|NCT02948673|type 2 diabetes|type 2 diabetes
53982|NCT02948673|mitochondrial reactive oxygen species production|mitochondrial reactive oxygen species production
53983|NCT02948673|oxidative stress|oxidative stress
53988|NCT02948621|Quality of life|quality of life
53989|NCT02948608|spondyloarthropathy|spondyloarthropathy
53990|NCT02948608|ankylosing spondylitis|ankylosing spondylitis
53991|NCT02948608|spinal diseases|spinal diseases
53992|NCT02948608|spondylitis|spondylitis
53993|NCT02948608|spondylarthritis|spondylarthritis
53994|NCT02948608|psoriasis|psoriasis
53995|NCT02948608|uveitis|uveitis
53996|NCT02948608|joint diseases|joint diseases
53997|NCT02948582|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
53998|NCT02948582|COPD|copd
53999|NCT02948582|Emphysema|emphysema
54000|NCT02948582|Chronic bronchitis|chronic bronchitis
54001|NCT02948569|Obesity|obesity
54002|NCT02948569|Hyperlipidemia|hyperlipidemia
54003|NCT02948569|Impaired fasting glucose|impaired fasting glucose
54004|NCT02948569|Insulin resistance|insulin resistance
54005|NCT02948569|Hypertension|hypertension
54006|NCT02948504|Unruptured Intracranial Aneurysm|unruptured intracranial aneurysm
54007|NCT02948504|Small aneurysms|small aneurysms
54008|NCT02948504|Risk of rupture|risk of rupture
54009|NCT02948504|Natural history|natural history
54010|NCT02948504|Endovascular Coiling|endovascular coiling
54011|NCT02948504|Surgical clipping|surgical clipping
54012|NCT02948491|Complementary Therapies|complementary therapies
54013|NCT02948491|Neonate Intensive Care Units (NICU)|neonate intensive care units (nicu)
54014|NCT02948491|Child Development|child development
54015|NCT02948491|Infants Premature|infants premature
54016|NCT02948478|precariousness|precariousness
54017|NCT02948478|care pathways|care pathways
54018|NCT02948465|Neutrophil Extracellular Traps|neutrophil extracellular traps
54019|NCT02948452|anorexia nervosa|anorexia nervosa
54020|NCT02948452|anxiety|anxiety
54021|NCT02948452|reward|reward
54022|NCT02948452|recurrence|recurrence
54023|NCT02948452|magnetic resonance imaging|magnetic resonance imaging
54024|NCT02948439|pregnancy|pregnancy
54025|NCT02948439|cardiovascular|cardiovascular
54026|NCT02948439|nervous system|nervous system
54027|NCT02948439|exercise|exercise
54028|NCT02948426|Immunotherapy|immunotherapy
54029|NCT02948426|Adoptive Cell Therapy|adoptive cell therapy
54030|NCT02948426|Carcinomatosis|carcinomatosis
54031|NCT02948426|CA125|ca125
54032|NCT02948413|Traumatic Stress|traumatic stress
61544|NCT02900924|PAD|pad
45599|NCT03000387|Nicotine Patch|nicotine patch
45600|NCT03000387|Abstinence|abstinence
54033|NCT02948413|Oncology|oncology
54034|NCT02948413|Lymphoma|lymphoma
54035|NCT02948335|Microbial communities|microbial communities
54036|NCT02948335|Hospital environment|hospital environment
54037|NCT02948335|Disinfection|disinfection
54038|NCT02948335|Adenosine triphosphate measures|adenosine triphosphate measures
54039|NCT02948335|Bioburden|bioburden
54040|NCT02948322|Acromegaly,|acromegaly,
54041|NCT02948322|water retention|water retention
54046|NCT02948309|Relapse|relapse
54056|NCT02948205|Infertility, TU-LESS, 3D laparoscopy|infertility, tu-less, 3d laparoscopy
54057|NCT02948192|Preterm Delivery|preterm delivery
54058|NCT02948192|Preterm Birth|preterm birth
54059|NCT02948192|Vaginal Microbiome|vaginal microbiome
54060|NCT02948192|Microbiome|microbiome
54061|NCT02948192|Gut Microbiome|gut microbiome
54062|NCT02948192|African American|african american
54063|NCT02948192|Metabolomics|metabolomics
54064|NCT02948192|Pregnancy|pregnancy
54065|NCT02948166|remote endarterectomy|remote endarterectomy
54066|NCT02948166|Angioplasty with stenting of the superficial femoral artery|angioplasty with stenting of the superficial femoral artery
54067|NCT02948140|Subdiaphragmatic infarction|subdiaphragmatic infarction
54068|NCT02948101|Malignant Neoplasm of Female Genital Organs|malignant neoplasm of female genital organs
54069|NCT02948101|Epithelial ovarian cancer|epithelial ovarian cancer
54070|NCT02948101|Fallopian tube cancer|fallopian tube cancer
54071|NCT02948101|Primary peritoneal cancer|primary peritoneal cancer
54072|NCT02948101|PD 0360324|pd 0360324
54073|NCT02948101|Cyclophosphamide|cyclophosphamide
54074|NCT02948101|Cytoxan|cytoxan
54075|NCT02948101|Neosar|neosar
54076|NCT02948101|Pharmacokinetic testing|pharmacokinetic testing
54078|NCT02948101|Pharmacodynamic testing|pharmacodynamic testing
54079|NCT02948101|PD|pd
54080|NCT02948088|Tenosynovial Giant Cell Tumors|tenosynovial giant cell tumors
54081|NCT02948088|Disease registry|disease registry
54082|NCT02948088|Routine clinical practice|routine clinical practice
54083|NCT02948088|Real World Evidence|real world evidence
54084|NCT02948062|ALD|ald
54085|NCT02948062|Newborn Screening|newborn screening
54086|NCT02948049|Accelerometer|accelerometer
54087|NCT02948049|Spinal Cord Stimulator|spinal cord stimulator
54088|NCT02948049|Peripheral Nerve Stimulator|peripheral nerve stimulator
54089|NCT02948049|Physical Function|physical function
54090|NCT02947997|Healthy Volunteers|healthy volunteers
54091|NCT02947984|sphenoid region|sphenoid region
54092|NCT02947984|parasellar area|parasellar area
54093|NCT02947984|photon radiation therapy|photon radiation therapy
54094|NCT02947984|proton radiation therapy|proton radiation therapy
54095|NCT02947958|teleconsultation|teleconsultation
54096|NCT02947958|urology|urology
54097|NCT02947958|primary care|primary care
54098|NCT02947958|tertiary care|tertiary care
54099|NCT02947932|acute pancreatitis|acute pancreatitis
54100|NCT02947932|post-ERCP|post-ercp
54101|NCT02947932|endoscopy|endoscopy
54102|NCT02947919|Perioperative Period|perioperative period
54103|NCT02947919|Music|music
54104|NCT02947906|Gait|gait
54105|NCT02947906|Loading|loading
54106|NCT02947906|Multiple Sclerosis|multiple sclerosis
54107|NCT02947906|Plantar Pressure|plantar pressure
54108|NCT02947893|Nilotinib in Alzheimer's disease|nilotinib in alzheimer's disease
54109|NCT02947880|autism, Bumetanide|autism, bumetanide
54110|NCT02947854|Vaccine|vaccine
54111|NCT02947854|Photochemical Internalisation|photochemical internalisation
54112|NCT02947854|Immune Response|immune response
54113|NCT02947854|Peptide vaccine|peptide vaccine
54114|NCT02947854|Anti cancer vaccine|anti cancer vaccine
54115|NCT02947828|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
54116|NCT02947828|Polyneuropathies, Diabetic|polyneuropathies, diabetic
54117|NCT02947750|Hypertension|hypertension
54118|NCT02947750|Kidney Disorder|kidney disorder
54119|NCT02947750|Nephrology|nephrology
54120|NCT02947750|Physiology|physiology
54121|NCT02947737|Skin graft|skin graft
54122|NCT02947529|Hemiarthroplasty|hemiarthroplasty
54123|NCT02947529|Intramedullary nail|intramedullary nail
54124|NCT02947529|Tranexamic acid|tranexamic acid
54125|NCT02947529|Transfusion|transfusion
54126|NCT02947516|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
54127|NCT02947516|liver|liver
54129|NCT02947516|pain|pain
54130|NCT02947503|Gestational Diabetes|gestational diabetes
54131|NCT02947503|Insulin Resistance|insulin resistance
54132|NCT02947503|Metformin|metformin
54133|NCT02947503|Hyperinsulinaemia|hyperinsulinaemia
54134|NCT02947503|Prevention of Complications|prevention of complications
54135|NCT02947503|Long Term Study|long term study
54136|NCT02947503|Mother and Child|mother and child
54137|NCT02947503|Health Benefits|health benefits
54138|NCT02947490|Blood pressure monitoring|blood pressure monitoring
54144|NCT02947412|sleeve gastrectomy|sleeve gastrectomy
54145|NCT02947412|long-term follow-up|long-term follow-up
54146|NCT02947412|gastroesophageal reflux disease after sleeve|gastroesophageal reflux disease after sleeve
54147|NCT02947412|revisional surgery|revisional surgery
54149|NCT02947399|I-124|i-124
54150|NCT02947399|Thyroid hormone Withdrawal|thyroid hormone withdrawal
54151|NCT02947373|brain tumor|brain tumor
54152|NCT02947373|children|children
54153|NCT02947321|Radiofrequency ablation|radiofrequency ablation
54154|NCT02947308|Anxiety|anxiety
54155|NCT02947308|Depression|depression
54156|NCT02947243|Virtual reality|virtual reality
54157|NCT02947243|Immersive distraction|immersive distraction
54158|NCT02947243|Oculus rift|oculus rift
54159|NCT02947243|Virtual world|virtual world
54160|NCT02947243|Virtual environment|virtual environment
54161|NCT02947243|Procedural pain|procedural pain
54162|NCT02947243|Procedural anxiety|procedural anxiety
54163|NCT02947243|Acute pain|acute pain
54164|NCT02947243|Pain management|pain management
54165|NCT02947243|Anxiety|anxiety
54166|NCT02947243|Children, Child|children, child
54167|NCT02947243|Kid, Kids|kid, kids
54168|NCT02947243|Pediatric, Pediatrics|pediatric, pediatrics
54169|NCT02947243|Young children|young children
54170|NCT02947243|Burns|burns
54171|NCT02947243|Burn injuries|burn injuries
54172|NCT02947243|Burn unit|burn unit
54173|NCT02947243|Physiotherapy|physiotherapy
54174|NCT02947243|Physical therapy|physical therapy
54175|NCT02947243|Burn dressing|burn dressing
54176|NCT02947243|Dressing change|dressing change
54177|NCT02947243|Non-pharmacological, nonpharmacological|non-pharmacological, nonpharmacological
54178|NCT02947243|Clinical Research|clinical research
54179|NCT02947243|Nursing Practice|nursing practice
54180|NCT02947230|Mobility|mobility
54181|NCT02947230|Aging|aging
54182|NCT02947230|Knowledge Translation|knowledge translation
54183|NCT02947230|Physical Activity|physical activity
54184|NCT02947217|Immunology|immunology
54185|NCT02947217|Pregnancy|pregnancy
54186|NCT02947217|Implantation Rate|implantation rate
54187|NCT02947217|Fertilization in Vitro|fertilization in vitro
54188|NCT02947204|Bronchiolitis|bronchiolitis
54189|NCT02947204|Length of Hospital Stay|length of hospital stay
54190|NCT02947204|Clinical Trial|clinical trial
54191|NCT02947204|Oxygen Saturation Monitoring|oxygen saturation monitoring
54199|NCT02947126|cystic fibrosis|cystic fibrosis
54200|NCT02947126|mucociliary clearance|mucociliary clearance
54201|NCT02947126|CFTR|cftr
54202|NCT02947113|cancer|cancer
54203|NCT02947100|Sickle Cell Disease|sickle cell disease
54204|NCT02947100|omega-3 fatty acids|omega-3 fatty acids
54205|NCT02947100|Docosahexaenoic Acid (DHA)|docosahexaenoic acid (dha)
54206|NCT02947100|Eicosapentaenoic Acid (EPA)|eicosapentaenoic acid (epa)
54207|NCT02947087|Islet autotransplantation|islet autotransplantation
54208|NCT02947087|Alpha1 anti trypsin|alpha1 anti trypsin
54209|NCT02947074|Yoga|yoga
54210|NCT02947074|Meditation|meditation
54211|NCT02947074|Glutathione|glutathione
54212|NCT02947074|Catecholamine|catecholamine
54213|NCT02947074|polysomnography|polysomnography
54214|NCT02947061|Advanced Breast Cancer,first treatment, S1, Capecitabine|advanced breast cancer,first treatment, s1, capecitabine
54215|NCT02947035|thyroid cancer|thyroid cancer
54216|NCT02947035|thyroid nodule|thyroid nodule
54217|NCT02947035|thyroidectomy|thyroidectomy
54218|NCT02947035|personalized medicine|personalized medicine
54219|NCT02947022|gadolinium|gadolinium
54220|NCT02947022|deposition|deposition
54221|NCT02947022|GBCA|gbca
54222|NCT02947022|Extremity Pain|extremity pain
54223|NCT02947022|Skin Pain|skin pain
54224|NCT02947022|Chest Wall Pain|chest wall pain
54225|NCT02946944|Pulmonary Embolism|pulmonary embolism
54226|NCT02946944|sildenafil|sildenafil
54227|NCT02946944|oral anticoagulation therapy|oral anticoagulation therapy
54228|NCT02946918|levothyroxine|levothyroxine
54229|NCT02946853|Atrial Fibrillation|atrial fibrillation
54230|NCT02946853|CRT|crt
54231|NCT02946853|AV Junction Ablation|av junction ablation
54232|NCT02946853|LVESV|lvesv
54233|NCT02946827|FODMAPs diet|fodmaps diet
54234|NCT02946827|micro-macro nutrients intake|micro-macro nutrients intake
54235|NCT02946827|IBS (Irritable Bowel Syndrome)|ibs (irritable bowel syndrome)
54236|NCT02946814|essential oils|essential oils
54237|NCT02946814|microscope, colfocal|microscope, colfocal
54238|NCT02946814|dental plaque|dental plaque
54239|NCT02946801|Biofilms|biofilms
54240|NCT02946801|essential oils|essential oils
54241|NCT02946801|alcohol|alcohol
54242|NCT02946801|microscopy, confocal|microscopy, confocal
54243|NCT02946801|mouthwashes|mouthwashes
54244|NCT02946775|septicemia|septicemia
54245|NCT02946775|bacteremia|bacteremia
54246|NCT02946775|pneumonia|pneumonia
54247|NCT02946775|meningitis|meningitis
54248|NCT02946762|HIV|hiv
54249|NCT02946762|TB|tb
54250|NCT02946762|Antiretroviral Treatment|antiretroviral treatment
54251|NCT02946762|Anti-tuberculosis Treatment|anti-tuberculosis treatment
54252|NCT02946762|HIV Counselling and Testing|hiv counselling and testing
45801|NCT02999282|Rehabilitation|rehabilitation
45802|NCT02999269|electroconvulsive therapy|electroconvulsive therapy
45803|NCT02999269|MRI|mri
45805|NCT02999256|Tart Cherry Juice|tart cherry juice
54253|NCT02946762|Treatment as Prevention|treatment as prevention
54254|NCT02946749|Scar pregnancy|scar pregnancy
54255|NCT02946749|Placenta planting abnormal disease|placenta planting abnormal disease
54256|NCT02946749|Early diagnosis|early diagnosis
54257|NCT02946749|Individualized treatment|individualized treatment
54258|NCT02946736|Sleep|sleep
54259|NCT02946736|Physical Health|physical health
54260|NCT02946736|Psychological Health|psychological health
54261|NCT02946736|Well-Being|well-being
54262|NCT02946736|Employee|employee
54263|NCT02946736|Actigraphy|actigraphy
54264|NCT02946710|Alzheimer disease|alzheimer disease
54265|NCT02946710|Alzheimer's disease, biomarkers|alzheimer's disease, biomarkers
54266|NCT02946710|p75NTR-ECD|p75ntr-ecd
54267|NCT02946697|Chinese|chinese
54268|NCT02946697|cancer survivors|cancer survivors
54269|NCT02946697|Quality of Life|quality of life
54270|NCT02946697|Social Support|social support
54271|NCT02946658|COPD, Emphysema|copd, emphysema
54272|NCT02946619|Chinese breast cancer survivors|chinese breast cancer survivors
54273|NCT02946619|expressive writing|expressive writing
54274|NCT02946554|Acute-On-Chronic Liver Failure|acute-on-chronic liver failure
54275|NCT02946554|ACLF|aclf
54276|NCT02946541|DA-1229|da-1229
54277|NCT02946541|evogliptin|evogliptin
54278|NCT02946541|DPP-IV inhibitor|dpp-iv inhibitor
54279|NCT02946541|Suganon|suganon
54280|NCT02946541|DPP-4 inhibitor|dpp-4 inhibitor
54281|NCT02946515|Pediatrics|pediatrics
54282|NCT02946489|cannabis|cannabis
54283|NCT02946489|mindfulness based relapse prevention|mindfulness based relapse prevention
54284|NCT02946489|motivational enhancement therapy|motivational enhancement therapy
54285|NCT02946437|severe SAH|severe sah
54286|NCT02946437|prevention of vasospasm and/ or brain oedema|prevention of vasospasm and/ or brain oedema
54287|NCT02946437|Sevoflurane|sevoflurane
54288|NCT02946437|Postconditioning|postconditioning
54289|NCT02946411|Hyperglycemia|hyperglycemia
54290|NCT02946385|meningococcal disease|meningococcal disease
54291|NCT02946385|meningitis|meningitis
54292|NCT02946385|booster|booster
54293|NCT02946385|antibody persistence|antibody persistence
54294|NCT02946372|retina surgery|retina surgery
54295|NCT02946372|macula|macula
54296|NCT02946372|macular hole|macular hole
54297|NCT02946372|internal limiting membrane (ILM)|internal limiting membrane (ilm)
54298|NCT02946372|vitrectomy|vitrectomy
54299|NCT02946372|autologous transplantation|autologous transplantation
54300|NCT02946346|Human papillomaviruses|human papillomaviruses
54301|NCT02946346|Clearance|clearance
54302|NCT02946346|Kinetics|kinetics
54303|NCT02946346|Ecology|ecology
54304|NCT02946346|Bacterial vaginosis|bacterial vaginosis
54305|NCT02946346|Immune response|immune response
54306|NCT02946346|Microbiota|microbiota
54307|NCT02946333|Multiple Myeloma|multiple myeloma
54308|NCT02946333|autologous stem cell transplant (ASCT)|autologous stem cell transplant (asct)
54309|NCT02946333|QoLMMBuS|qolmmbus
54310|NCT02946333|healthcare costs|healthcare costs
54311|NCT02946320|PCI, bioabsorbable scaffold|pci, bioabsorbable scaffold
54312|NCT02946281|self-management|self-management
54313|NCT02946281|health behavior|health behavior
54314|NCT02946281|cardiac disease|cardiac disease
54315|NCT02946281|habits|habits
54316|NCT02946281|lifestyle|lifestyle
54317|NCT02946255|Psychosis|psychosis
54318|NCT02946255|Psychosis NOS|psychosis nos
54319|NCT02946255|Schizophrenia|schizophrenia
54320|NCT02946255|Hospital discharge|hospital discharge
54321|NCT02946255|Inpatient psychiatry|inpatient psychiatry
54322|NCT02946190|Acellular pertussis vaccines Genetically-detoxified pertussis toxin Adolescents|acellular pertussis vaccines genetically-detoxified pertussis toxin adolescents
54323|NCT02946177|Immunology|immunology
54324|NCT02946177|Pregnancy|pregnancy
54325|NCT02946177|Implantation Rate|implantation rate
54326|NCT02946177|Fertilization in Vitro|fertilization in vitro
54327|NCT02946177|Oocyte donor egg recipient|oocyte donor egg recipient
54328|NCT02946151|Epilepsy|epilepsy
54329|NCT02946151|Seizure monitoring|seizure monitoring
54330|NCT02946151|Electroencephalography|electroencephalography
54331|NCT02946138|Hepatocellular Carcinoma|hepatocellular carcinoma
54332|NCT02946138|carbon-ion radiotherapy|carbon-ion radiotherapy
54333|NCT02946138|GM-CSF|gm-csf
54334|NCT02946138|immunotherapy|immunotherapy
54335|NCT02946086|motor skill learning, visuo-spatial attention|motor skill learning, visuo-spatial attention
54336|NCT02946047|HIV|hiv
54337|NCT02946047|ART|art
54338|NCT02946047|Antiretroviral|antiretroviral
54339|NCT02946047|Therapy|therapy
54340|NCT02946047|Reservoir|reservoir
54341|NCT02946047|Cure|cure
54342|NCT02946034|CKD|ckd
54347|NCT02946021|Neck Cancer|neck cancer
54348|NCT02945982|Portal Hypertension|portal hypertension
54349|NCT02945982|Fuzheng Huayu|fuzheng huayu
54350|NCT02945982|Hepatitis B|hepatitis b
54351|NCT02945969|dietary sodium|dietary sodium
54353|NCT02945969|chronic kidney disease|chronic kidney disease
54354|NCT02945956|Portal Hypertension|portal hypertension
54355|NCT02945956|Fuzheng Huayu|fuzheng huayu
54356|NCT02945956|Hepatitis B|hepatitis b
54357|NCT02945930|Enbucrilate|enbucrilate
54358|NCT02945930|Esophageal and Gastric Varices|esophageal and gastric varices
54359|NCT02945930|Endoscopy|endoscopy
54360|NCT02945930|Safety|safety
54361|NCT02945930|Efficacy|efficacy
54362|NCT02945891|mass screening|mass screening
54363|NCT02945891|coverage|coverage
54364|NCT02945891|self-sampling|self-sampling
54365|NCT02945891|clinical validity|clinical validity
54366|NCT02945878|radiotherapy, oral mucositis,oral mucosa protection|radiotherapy, oral mucositis,oral mucosa protection
54367|NCT02945839|Migraine|migraine
54368|NCT02945839|emergency department|emergency department
54369|NCT02945826|urokinase plasminogen activator receptor|urokinase plasminogen activator receptor
54370|NCT02945826|positron emission tomography|positron emission tomography
54371|NCT02945826|glioblastoma multiforme|glioblastoma multiforme
54372|NCT02945813|Prostate Cancer|prostate cancer
54373|NCT02945813|Prostate Cancer after Prostatectomy|prostate cancer after prostatectomy
54374|NCT02945813|Phase II Trial|phase ii trial
54375|NCT02945813|Salvage Radiotherapy|salvage radiotherapy
54376|NCT02945813|Metformin|metformin
54377|NCT02945800|relapsed|relapsed
54378|NCT02945800|refractory|refractory
54379|NCT02945800|soft tissue|soft tissue
54380|NCT02945800|bones and joints|bones and joints
54381|NCT02945800|non-rhabdomyosarcoma soft tissue sarcoma|non-rhabdomyosarcoma soft tissue sarcoma
54382|NCT02945800|pediatric|pediatric
54383|NCT02945787|Spanish speaking|spanish speaking
54384|NCT02945787|self-help|self-help
54385|NCT02945787|tobacco abstinence|tobacco abstinence
54386|NCT02945787|public health|public health
54387|NCT02945787|Forever Free|forever free
54388|NCT02945787|Stop Smoking for Good|stop smoking for good
54389|NCT02945774|PET|pet
54390|NCT02945774|MRI|mri
54391|NCT02945774|Inflammation|inflammation
54392|NCT02945774|Microglia|microglia
54393|NCT02945774|FEPPA|feppa
54394|NCT02945748|pediatric|pediatric
54395|NCT02945748|cardiac output|cardiac output
54396|NCT02945748|fluid responsiveness|fluid responsiveness
54397|NCT02945748|critically ill|critically ill
54398|NCT02945748|hemodynamic monitoring|hemodynamic monitoring
54399|NCT02945735|depression|depression
54400|NCT02945735|cognitive bias modification|cognitive bias modification
54401|NCT02945735|MDD|mdd
54402|NCT02945735|major depressive disorder|major depressive disorder
54403|NCT02945735|attention bias modification treatment|attention bias modification treatment
54404|NCT02945722|Hemodialysis|hemodialysis
54405|NCT02945722|S. Aureus|s. aureus
54406|NCT02945722|Decolonization|decolonization
54407|NCT02945722|Persistent carriage|persistent carriage
54408|NCT02945709|PTSD|ptsd
54409|NCT02945709|attention training|attention training
54410|NCT02945709|cognitive bias modification|cognitive bias modification
54411|NCT02945696|nerve block|nerve block
54412|NCT02945696|laparoscopy|laparoscopy
54413|NCT02945696|anesthesia|anesthesia
54414|NCT02945683|atopic dermatitis, probiotics, vitamin D3, L. reuteri|atopic dermatitis, probiotics, vitamin d3, l. reuteri
54415|NCT02945644|obstructive sleep apnea|obstructive sleep apnea
54416|NCT02945644|trazodone|trazodone
54417|NCT02945644|positive airway pressure|positive airway pressure
54418|NCT02945644|adherence|adherence
54419|NCT02945631|HPV|hpv
54420|NCT02945631|Induction Chemotherapy|induction chemotherapy
54421|NCT02945631|De-Intensified Chemoradiotherapy|de-intensified chemoradiotherapy
54422|NCT02945631|Oropharynx Cancer|oropharynx cancer
54425|NCT02945592|Hemispatial Neglect|hemispatial neglect
54426|NCT02945592|cueing|cueing
54427|NCT02945592|egocentric-allocentric|egocentric-allocentric
54428|NCT02945592|early rehabilitation|early rehabilitation
54429|NCT02945592|parietal tDCS|parietal tdcs
54430|NCT02945579|Breast Cancer|breast cancer
54431|NCT02945579|Surveillance|surveillance
54432|NCT02945579|Breast biopsy|breast biopsy
54433|NCT02945579|Questionnaires|questionnaires
54434|NCT02945579|Surveys|surveys
54435|NCT02945540|Gestational diabetes|gestational diabetes
54436|NCT02945540|Patient education|patient education
54437|NCT02945540|Patient Satisfaction|patient satisfaction
54438|NCT02945514|Healthy|healthy
54439|NCT02945514|Diet|diet
54440|NCT02945514|Microbiome|microbiome
54441|NCT02945514|Personalized|personalized
54442|NCT02945514|Custom|custom
54443|NCT02945475|functional magnetic resonance imaging|functional magnetic resonance imaging
54444|NCT02945475|eating behavior|eating behavior
54445|NCT02945475|sugar|sugar
54446|NCT02945475|fructose|fructose
54447|NCT02945449|Wharton jelly mesenchymal stem cells|wharton jelly mesenchymal stem cells
54448|NCT02945449|Erectile Dysfunction|erectile dysfunction
54450|NCT02945397|Return to work|return to work
54451|NCT02945397|Work rehabilitation|work rehabilitation
54452|NCT02945397|Sick-leave|sick-leave
54453|NCT02945384|family well-being|family well-being
54454|NCT02945332|exercise|exercise
54455|NCT02945332|activity|activity
54457|NCT02945306|Sleep Disordered Breathing|sleep disordered breathing
54458|NCT02945306|Adenotonsillectomy|adenotonsillectomy
54459|NCT02945306|Child|child
54460|NCT02945293|Pain|pain
54461|NCT02945293|Elderly|elderly
54462|NCT02945293|Aged|aged
54463|NCT02945293|Opioid|opioid
54464|NCT02945293|Cognition|cognition
54465|NCT02945293|Side-effects|side-effects
54466|NCT02945293|Alcohol|alcohol
54467|NCT02945293|Alcohol Use Disorder (AUD)|alcohol use disorder (aud)
54468|NCT02945293|Older|older
54469|NCT02945280|apixaban|apixaban
54470|NCT02945280|factor Xa inhibitors|factor xa inhibitors
54471|NCT02945280|antithrombotic agent|antithrombotic agent
54472|NCT02945280|deep vein thrombosis|deep vein thrombosis
54473|NCT02945280|upper extremity|upper extremity
54474|NCT02945267|Pancreatic Cancer|pancreatic cancer
54475|NCT02945267|Unresectable|unresectable
54476|NCT02945267|Maintenance Treatment|maintenance treatment
54477|NCT02945254|sleep onset latency|sleep onset latency
54478|NCT02945254|sleep quality|sleep quality
54479|NCT02945254|insomnia|insomnia
54480|NCT02945228|Paritaprevir|paritaprevir
54481|NCT02945228|Genotype 2|genotype 2
54482|NCT02945228|Ombitasvir|ombitasvir
54483|NCT02945228|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
54484|NCT02945228|Ritonavir|ritonavir
54485|NCT02945189|Pregnancy|pregnancy
54486|NCT02945176|Boston Keratoprosthesis|boston keratoprosthesis
54487|NCT02945150|hemodialysis|hemodialysis
54488|NCT02945150|peritoneal dialysis|peritoneal dialysis
54489|NCT02945150|renal failure|renal failure
54490|NCT02945150|kidney transplant|kidney transplant
54491|NCT02945085|older adults|older adults
54492|NCT02945085|family caregivers|family caregivers
54493|NCT02945085|Medicare Advantage beneficiaries|medicare advantage beneficiaries
54494|NCT02945072|Child Behavior|child behavior
54495|NCT02945072|Problem Behavior|problem behavior
54496|NCT02945072|postoperative behaviour problems|postoperative behaviour problems
54497|NCT02945059|Liver regeneration|liver regeneration
54498|NCT02945059|portal vein embolization|portal vein embolization
54499|NCT02945059|gelatin powder|gelatin powder
54500|NCT02945059|liver surgery|liver surgery
54501|NCT02945059|hepatectomy|hepatectomy
54502|NCT02945033|Pi3k mutation|pi3k mutation
54503|NCT02945033|Aspirin|aspirin
54504|NCT02944968|Interventional|interventional
54505|NCT02944968|Radiofrequency Ablation|radiofrequency ablation
54506|NCT02944968|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
54507|NCT02944929|Spastic hemiparesis|spastic hemiparesis
54508|NCT02944929|Stroke|stroke
54509|NCT02944929|Self-rehabilitation|self-rehabilitation
54510|NCT02944929|Botulinum Toxin Injections|botulinum toxin injections
54511|NCT02944903|audit|audit
54512|NCT02944903|Lung cancer|lung cancer
54513|NCT02944903|screening practice|screening practice
54514|NCT02944903|Egypt|egypt
54515|NCT02944851|Blood donors|blood donors
54516|NCT02944851|blood donation|blood donation
54517|NCT02944851|traumatic blood loss|traumatic blood loss
54518|NCT02944851|Trauma|trauma
54519|NCT02944838|older adults|older adults
54520|NCT02944838|physical activity|physical activity
54521|NCT02944838|built environment|built environment
54522|NCT02944825|Urolithiasis|urolithiasis
54523|NCT02944825|UTI|uti
54524|NCT02944786|Chronic pain|chronic pain
54525|NCT02944786|Adolescents|adolescents
54526|NCT02944786|School nurse|school nurse
54527|NCT02944773|newborn|newborn
54528|NCT02944773|facilitated tucking|facilitated tucking
54529|NCT02944773|position|position
54530|NCT02944773|weight|weight
54531|NCT02944773|stress|stress
54532|NCT02944747|Gestational age, Preterm birth, LMP, Bangladesh|gestational age, preterm birth, lmp, bangladesh
54533|NCT02944734|Candesartan|candesartan
54534|NCT02944734|Amlodipine|amlodipine
54535|NCT02944734|Hypertension|hypertension
54536|NCT02944734|Vascular Diseases|vascular diseases
54537|NCT02944734|Cardiovascular Diseases|cardiovascular diseases
54538|NCT02944734|Antihypertensive Agents|antihypertensive agents
54539|NCT02944734|Vasodilator Agents|vasodilator agents
54540|NCT02944734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
54541|NCT02944734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists
54542|NCT02944734|Calcium Channel Blockers|calcium channel blockers
54543|NCT02944721|Neuropathic Pain|neuropathic pain
54544|NCT02944708|maintenance chemotherapy|maintenance chemotherapy
54545|NCT02944695|audit|audit
54546|NCT02944695|infection control|infection control
54651|NCT02944136|depression|depression
54547|NCT02944695|bronchoscopy unit|bronchoscopy unit
54548|NCT02944695|Egypt|egypt
54549|NCT02944682|Obstetrics|obstetrics
56359|NCT02932774|SAR|sar
54551|NCT02944682|Pediatrics|pediatrics
54552|NCT02944682|Atherosclerosis|atherosclerosis
54553|NCT02944682|Cancer|cancer
54554|NCT02944682|Cardiovascular Disease|cardiovascular disease
54555|NCT02944682|Public Health|public health
54556|NCT02944682|Environmental Air Pollutants|environmental air pollutants
54557|NCT02944656|Perioperative pain|perioperative pain
54558|NCT02944656|Outpatient surgery|outpatient surgery
54559|NCT02944656|Obstetrics/gynecology|obstetrics/gynecology
54560|NCT02944656|Pain management|pain management
54561|NCT02944630|quality of life|quality of life
54562|NCT02944630|psychotherapy|psychotherapy
54563|NCT02944630|psoriasis|psoriasis
54564|NCT02944630|treatments|treatments
54565|NCT02944578|Cancer|cancer
54566|NCT02944578|HIV|hiv
54567|NCT02944578|Oncology|oncology
54568|NCT02944578|Infectious Diseases|infectious diseases
54569|NCT02944578|HPV|hpv
54570|NCT02944578|Preventive Medicine|preventive medicine
54571|NCT02944539|Mitochondrial DNA copy number|mitochondrial dna copy number
54572|NCT02944539|Gastric cancer|gastric cancer
54573|NCT02944526|suprascapular nerve|suprascapular nerve
54574|NCT02944500|Brain|brain
54575|NCT02944500|Liraglutide|liraglutide
54576|NCT02944500|MRI|mri
54577|NCT02944487|safety|safety
54578|NCT02944487|pharmacokinetics|pharmacokinetics
54579|NCT02944474|Pharmacokinetics|pharmacokinetics
54580|NCT02944474|Safety|safety
54581|NCT02944448|Osteoarthritis|osteoarthritis
54582|NCT02944448|Hip|hip
54583|NCT02944448|Knee|knee
54584|NCT02944448|CR485|cr485
54585|NCT02944448|Analgesic|analgesic
54586|NCT02944448|Kappa opioid|kappa opioid
54587|NCT02944435|Glutaminase Inhibitor|glutaminase inhibitor
54588|NCT02944435|Glutaminase|glutaminase
54589|NCT02944435|CB-839|cb-839
54590|NCT02944396|Poly (ADP) ribose polymerase (PARP)|poly (adp) ribose polymerase (parp)
54591|NCT02944396|paclitaxel|paclitaxel
54592|NCT02944396|nivolumab|nivolumab
54593|NCT02944396|metastatic|metastatic
54594|NCT02944396|pemetrexed|pemetrexed
54595|NCT02944396|Eastern Cooperative Oncology Group (ECOG)|eastern cooperative oncology group (ecog)
54596|NCT02944396|carboplatin|carboplatin
54597|NCT02944396|Common Terminology Criteria for Adverse Events (CTCAE)|common terminology criteria for adverse events (ctcae)
54598|NCT02944396|Immuno Oncology|immuno oncology
54599|NCT02944396|veliparib|veliparib
54600|NCT02944396|non-small cell lung cancer|non-small cell lung cancer
54601|NCT02944396|Platinum Doublet Chemotherapy|platinum doublet chemotherapy
54602|NCT02944396|Response Evaluation Criteria In Solid Tumors (RECIST)|response evaluation criteria in solid tumors (recist)
54603|NCT02944383|Hypertriglycerides|hypertriglycerides
54604|NCT02944344|breast cancer|breast cancer
54605|NCT02944344|stage 4|stage 4
54606|NCT02944344|metastatic|metastatic
54607|NCT02944344|hospice|hospice
54608|NCT02944344|palliative care|palliative care
54609|NCT02944344|end of life|end of life
54610|NCT02944344|advance directive|advance directive
54611|NCT02944344|oncology|oncology
54612|NCT02944344|caregiver|caregiver
54613|NCT02944344|provider|provider
54614|NCT02944344|coping|coping
54615|NCT02944344|support|support
54616|NCT02944344|online|online
54617|NCT02944331|Steam ablation|steam ablation
54618|NCT02944331|Endothermal ablation|endothermal ablation
54619|NCT02944331|Varicose vein treatment|varicose vein treatment
54620|NCT02944331|Venous insufficiency|venous insufficiency
54621|NCT02944331|Saphenous vein reflux|saphenous vein reflux
54622|NCT02944331|Recurrent varicosity|recurrent varicosity
54623|NCT02944318|Physical Activity|physical activity
54624|NCT02944318|Healthy Lifestyle|healthy lifestyle
54625|NCT02944318|Academic performance|academic performance
54626|NCT02944292|Intra-abdominal pressure|intra-abdominal pressure
54627|NCT02944292|Intra-abdominal hypertension|intra-abdominal hypertension
54628|NCT02944266|post general anaesthesia induced|post general anaesthesia induced
54629|NCT02944253|Diet, Reducing|diet, reducing
54630|NCT02944253|Hunger|hunger
54631|NCT02944253|Appetite Regulation|appetite regulation
54632|NCT02944253|Ketogenic Diet|ketogenic diet
54633|NCT02944253|Caloric Restriction|caloric restriction
54634|NCT02944253|Weight Loss|weight loss
54635|NCT02944253|Ketosis|ketosis
54636|NCT02944214|Hyperuricemia|hyperuricemia
54637|NCT02944214|Renal Function|renal function
54638|NCT02944214|Chronic kidney disease|chronic kidney disease
54639|NCT02944214|Febuxostat|febuxostat
54640|NCT02944214|Benzbromarone|benzbromarone
54641|NCT02944201|carvedilol|carvedilol
54642|NCT02944201|biomarkers|biomarkers
54643|NCT02944201|autonomic nerves|autonomic nerves
54644|NCT02944188|enhanced recovery after surgery|enhanced recovery after surgery
54645|NCT02944188|right hemicolectomy|right hemicolectomy
54646|NCT02944162|AML|aml
54647|NCT02944162|CD33|cd33
54648|NCT02944162|CAR-NK|car-nk
54649|NCT02944136|cancer|cancer
54650|NCT02944136|stepped collaborative care intervention|stepped collaborative care intervention
54652|NCT02944136|quality of life|quality of life
54654|NCT02944136|dyadic function|dyadic function
54655|NCT02944136|spousal or intimate caregiver|spousal or intimate caregiver
54656|NCT02944123|Half dose|half dose
54657|NCT02944123|Newer oral P2Y12 receptor inhibitors|newer oral p2y12 receptor inhibitors
54658|NCT02944123|Acute coronary syndrome|acute coronary syndrome
54659|NCT02944097|Bioavailability|bioavailability
54660|NCT02944097|Pharmacokinetics|pharmacokinetics
54661|NCT02944097|trans-resveratrol|trans-resveratrol
54662|NCT02944097|trans-epsilon-viniferin|trans-epsilon-viniferin
54663|NCT02944097|Vineatrol 30|vineatrol 30
54664|NCT02944084|Bioavailability|bioavailability
54665|NCT02944084|Pharmacokinetics|pharmacokinetics
54666|NCT02944084|Rice bran extract|rice bran extract
54667|NCT02944084|Vitamin E|vitamin e
54668|NCT02944084|Gamma-oryzanol|gamma-oryzanol
54669|NCT02944084|Ferulic acid|ferulic acid
54670|NCT02944071|femoropopliteal artery lesions|femoropopliteal artery lesions
54671|NCT02944071|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
54672|NCT02944071|Peripheral Artery Disease|peripheral artery disease
54673|NCT02944071|Drug-coated Balloon|drug-coated balloon
54674|NCT02944058|Multiloc|multiloc
54676|NCT02944058|Locking plate|locking plate
54677|NCT02944058|Straight nail|straight nail
54678|NCT02944058|Randomized controlled trial|randomized controlled trial
54679|NCT02944058|3 and 4 part fractures|3 and 4 part fractures
54680|NCT02944019|Nonvalvular Atrial Fibrillation|nonvalvular atrial fibrillation
54681|NCT02944019|Post Authorisation Safety Study|post authorisation safety study
54682|NCT02944019|Safety|safety
54683|NCT02944019|Real World Evidence|real world evidence
54684|NCT02944006|MRI|mri
54685|NCT02943993|Post-Authorisation Safety Study|post-authorisation safety study
54686|NCT02943993|Real World Evidence|real world evidence
54687|NCT02943993|Edoxaban|edoxaban
54688|NCT02943993|Efficacy/Safety|efficacy/safety
54689|NCT02943980|Intraoperative nerve monitoring, airway management|intraoperative nerve monitoring, airway management
54690|NCT02943967|Refractive Surgical Procedures|refractive surgical procedures
54691|NCT02943967|Photorefractive Keratectomy|photorefractive keratectomy
54692|NCT02943967|Aberrometry|aberrometry
54693|NCT02943954|Fractional Flow Reserve|fractional flow reserve
54694|NCT02943915|Spinal Cord|spinal cord
54695|NCT02943915|Injury|injury
54696|NCT02943915|Exoskeleton|exoskeleton
54697|NCT02943915|Ekso|ekso
54698|NCT02943915|Rehabilitation|rehabilitation
54699|NCT02943902|immunogenicity|immunogenicity
54700|NCT02943889|Mesenchymal stem cells|mesenchymal stem cells
54701|NCT02943889|Liver cirrhosis|liver cirrhosis
54702|NCT02943889|Stem cell therapy|stem cell therapy
54703|NCT02943876|risk prediction|risk prediction
54704|NCT02943876|risk score|risk score
624702|NCT00680043|Hgb|hgb
54705|NCT02943876|accuracy of risk perception|accuracy of risk perception
54706|NCT02943876|self-help|self-help
54707|NCT02943876|psychological distress|psychological distress
54708|NCT02943850|stem cells|stem cells
54709|NCT02943850|growth factor|growth factor
54710|NCT02943850|ALS|als
54711|NCT02943824|brachytherapy|brachytherapy
54712|NCT02943824|machine learning|machine learning
54713|NCT02943824|treatment planning|treatment planning
54714|NCT02943824|Low-Dose-Rate brachytherapy|low-dose-rate brachytherapy
54715|NCT02943811|endometrial cancer|endometrial cancer
54716|NCT02943811|survival|survival
54717|NCT02943811|uterine manipulator|uterine manipulator
54718|NCT02943798|Pulmonary Large Cell Neuroendocrine Carcinoma,chemotherapy|pulmonary large cell neuroendocrine carcinoma,chemotherapy
54719|NCT02943785|Transcatheter Aortic Valve Implantation -- TAVI|transcatheter aortic valve implantation -- tavi
54720|NCT02943785|Anticoagulation|anticoagulation
54721|NCT02943785|Atrial Fibrillation|atrial fibrillation
54722|NCT02943785|ENVISAGE-TAVI-AF|envisage-tavi-af
54723|NCT02943746|Standard Protein Diet|standard protein diet
54724|NCT02943746|High Protein Diet|high protein diet
54725|NCT02943746|Growth|growth
54726|NCT02943746|Body Composition|body composition
54727|NCT02943746|Extremely Low Birth Weight|extremely low birth weight
54728|NCT02943746|Human Milk Derived Fortifier|human milk derived fortifier
54729|NCT02943746|Protein|protein
54730|NCT02943746|Targeted Fortification|targeted fortification
54731|NCT02943746|Human Milk Diet|human milk diet
54732|NCT02943746|Prematurity|prematurity
54733|NCT02943733|Pancreatic neuroendocrine tumors (pNETs)|pancreatic neuroendocrine tumors (pnets)
54734|NCT02943733|Pancreatic neuroendocrine tumors|pancreatic neuroendocrine tumors
54735|NCT02943733|pNETs|pnets
54736|NCT02943733|NETs|nets
54737|NCT02943707|liver diseases|liver diseases
54738|NCT02943707|Bone Marrow Cell Transplantation|bone marrow cell transplantation
54739|NCT02943694|TaTME|tatme
54740|NCT02943694|Complications|complications
54741|NCT02943694|Instrument|instrument
54742|NCT02943642|MF|mf
54743|NCT02943642|CTCL|ctcl
54744|NCT02943642|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
54745|NCT02943616|Absorb GT1 BVS|absorb gt1 bvs
54746|NCT02943616|BVS|bvs
54747|NCT02943616|Bioabsorbable|bioabsorbable
54748|NCT02943616|Myocardial ischemia|myocardial ischemia
54749|NCT02943616|Stent thrombosis|stent thrombosis
54750|NCT02943616|Stents|stents
54751|NCT02943603|mFOLFOX6|mfolfox6
54752|NCT02943603|pembrolizumab|pembrolizumab
54753|NCT02943590|Cancer Treatment Related to Heart Failure|cancer treatment related to heart failure
54754|NCT02943551|Pediatrics|pediatrics
54755|NCT02943551|Respiratory disease|respiratory disease
54756|NCT02943551|antibiotic use|antibiotic use
54757|NCT02943538|Crohn's Disease|crohn's disease
54758|NCT02943538|Colitis, Ulcerative|colitis, ulcerative
54759|NCT02943538|Telemedicine|telemedicine
54760|NCT02943525|vaginal packing|vaginal packing
54761|NCT02943525|pelvic organ prolapse|pelvic organ prolapse
54762|NCT02943525|pain and satisfaction|pain and satisfaction
54763|NCT02943486|Mesenchymal stromal cells|mesenchymal stromal cells
54764|NCT02943486|Fitostimoline|fitostimoline
54765|NCT02943486|MSC derivatives|msc derivatives
54766|NCT02943486|Diabetes|diabetes
54767|NCT02943473|Smoldering multiple myeloma|smoldering multiple myeloma
54768|NCT02943473|myeloma|myeloma
54769|NCT02943473|smoldering|smoldering
54770|NCT02943473|ibrutinib|ibrutinib
54771|NCT02943408|Veterans|veterans
54772|NCT02943408|mental health|mental health
54773|NCT02943408|Patient-Centered Care|patient-centered care
54774|NCT02943382|MGD|mgd
54775|NCT02943382|Autologous Serum|autologous serum
54776|NCT02943382|Meibomian gland dysfunction|meibomian gland dysfunction
54777|NCT02943382|Dry eye disease|dry eye disease
54778|NCT02943382|FAB|fab
54779|NCT02943382|Fingerprick autologous blood|fingerprick autologous blood
54780|NCT02943369|cangrelor|cangrelor
54781|NCT02943369|ticagrelor|ticagrelor
54782|NCT02943369|P2Y12 receptor antagonist|p2y12 receptor antagonist
54783|NCT02943369|acute myocardial infarction|acute myocardial infarction
54784|NCT02943330|Depression|depression
54785|NCT02943330|Cytokines|cytokines
54786|NCT02943330|Hemodialysis|hemodialysis
54787|NCT02943330|Interferon treatment|interferon treatment
54788|NCT02943330|Hepatitis C|hepatitis c
54789|NCT02943304|Pregnancy|pregnancy
54790|NCT02943304|Fetal Development|fetal development
54791|NCT02943304|Child Development|child development
54792|NCT02943304|Developmental Disabilities|developmental disabilities
54793|NCT02943304|Zika Virus Infection|zika virus infection
54794|NCT02943291|Exercise therapy|exercise therapy
54795|NCT02943291|Adipose tissue|adipose tissue
54796|NCT02943291|Mitochondria|mitochondria
54797|NCT02943291|Oxidative Phosphorylation|oxidative phosphorylation
54798|NCT02943265|Care Coordination|care coordination
54799|NCT02943252|apatinib|apatinib
54800|NCT02943252|S1|s1
54801|NCT02943252|advanced head and neck cancer|advanced head and neck cancer
54802|NCT02943252|non-squamous|non-squamous
54803|NCT02943213|Chlorpromazine|chlorpromazine
54804|NCT02943213|Hydrochloride|hydrochloride
54805|NCT02943213|Chlorpromazine Hydrochloride|chlorpromazine hydrochloride
54806|NCT02943213|Bioavailability|bioavailability
54807|NCT02943213|Variability|variability
54808|NCT02943213|Variable|variable
54809|NCT02943213|Absorption|absorption
54810|NCT02943213|USL Pharma|usl pharma
54811|NCT02943213|USL|usl
54812|NCT02943213|Healthy|healthy
54813|NCT02943213|South Africa|south africa
54814|NCT02943213|Cycle|cycle
54815|NCT02943213|Anti-Psychotic|anti-psychotic
54816|NCT02943161|Obesity|obesity
54817|NCT02943161|L-citrulline|l-citrulline
54818|NCT02943109|patient portal|patient portal
54819|NCT02943109|Health Information Technology|health information technology
54820|NCT02943109|Electronic Health Records|electronic health records
54821|NCT02943109|Inpatient Care|inpatient care
54822|NCT02943109|Outpatient Care|outpatient care
54823|NCT02943109|Patient Engagement|patient engagement
54824|NCT02943070|Rezum|rezum
54825|NCT02943070|Water Vapor Ablation|water vapor ablation
54826|NCT02943031|bile duct tumor|bile duct tumor
54827|NCT02943031|individualized precise treatment programs|individualized precise treatment programs
54828|NCT02943018|ultrasound anovaginal distance, observer variation|ultrasound anovaginal distance, observer variation
54829|NCT02942979|Facilitation|facilitation
54830|NCT02942979|Implementation|implementation
54831|NCT02942979|Homelessness|homelessness
54832|NCT02942979|Substance Use Disorder|substance use disorder
54833|NCT02942979|Mental Illness|mental illness
54834|NCT02942979|Co-Occurring Disorders|co-occurring disorders
54835|NCT02942979|Veterans|veterans
54836|NCT02942979|Primary Care|primary care
54837|NCT02942966|Angioplasty|angioplasty
54838|NCT02942966|Below the Knee|below the knee
54839|NCT02942966|PAD|pad
54840|NCT02942966|Critical Limb Ischemia|critical limb ischemia
54841|NCT02942966|Lesion|lesion
54842|NCT02942966|Claudication|claudication
54843|NCT02942953|Pacemaker, Artificial|pacemaker, artificial
54844|NCT02942953|Diaphragmatic pacing|diaphragmatic pacing
54845|NCT02942927|Polypharmacy|polypharmacy
54846|NCT02942927|Multimorbidity|multimorbidity
54847|NCT02942927|Randomized Control Trial|randomized control trial
54848|NCT02942927|Drug Discontinuation|drug discontinuation
54849|NCT02942927|Patient Preference|patient preference
54850|NCT02942927|eHealth|ehealth
54851|NCT02942901|PET-CT|pet-ct
54852|NCT02942901|pulmonary metstasectomy|pulmonary metstasectomy
54859|NCT02942875|mirror therapy|mirror therapy
54860|NCT02942875|rehabilitation|rehabilitation
54861|NCT02942875|subacute|subacute
54862|NCT02942849|Bemfola|bemfola
54863|NCT02942849|r-hFSH|r-hfsh
54864|NCT02942849|Oocytes|oocytes
54865|NCT02942849|Pregnancy|pregnancy
54866|NCT02942849|OHSS|ohss
54867|NCT02942836|Respiration Rate Detection|respiration rate detection
54868|NCT02942823|obesity|obesity
54869|NCT02942823|child|child
54870|NCT02942823|primary prevention|primary prevention
54871|NCT02942823|serious game|serious game
54873|NCT02942823|physical activity|physical activity
54874|NCT02942823|psychosocial|psychosocial
54875|NCT02942823|stress|stress
54876|NCT02942823|knowledge|knowledge
54877|NCT02942823|diet|diet
54878|NCT02942823|energy density|energy density
54879|NCT02942823|beverages|beverages
54880|NCT02942823|food pyramide|food pyramide
54881|NCT02942732|Vitamin D|vitamin d
54882|NCT02942732|Glucose|glucose
54883|NCT02942732|HbA1C|hba1c
54884|NCT02942732|Insulin resistance|insulin resistance
54885|NCT02942732|Blood lipids|blood lipids
54886|NCT02942693|Apatinib|apatinib
54887|NCT02942693|Particle therapy|particle therapy
54888|NCT02942680|coronary artery bypass grafting|coronary artery bypass grafting
54889|NCT02942641|Urethral catheter|urethral catheter
54890|NCT02942641|clean intermittent catheterization|clean intermittent catheterization
54891|NCT02942641|UTI|uti
54892|NCT02942641|pain|pain
54893|NCT02942641|quality of life|quality of life
54894|NCT02942641|hematuria|hematuria
54895|NCT02942641|cloudy urine|cloudy urine
54896|NCT02942589|Portion Size|portion size
54897|NCT02942498|behavior, cognitive|behavior, cognitive
54898|NCT02942472|clinical pregnancy rate after embryo transfer|clinical pregnancy rate after embryo transfer
54899|NCT02942459|music therapy|music therapy
54900|NCT02942459|double-blinded|double-blinded
54901|NCT02942459|Randomized Controlled study (RCT)|randomized controlled study (rct)
54902|NCT02942459|Schizophrenia, negative symptoms|schizophrenia, negative symptoms
54903|NCT02942407|Renal dialysis|renal dialysis
54904|NCT02942329|humanized anti-PD-1 monoclonal antibody|humanized anti-pd-1 monoclonal antibody
54905|NCT02942329|apatinib|apatinib
54906|NCT02942329|Gastric Neoplasms|gastric neoplasms
54907|NCT02942329|Gastric Cancer|gastric cancer
54908|NCT02942329|Cancer of Stomach|cancer of stomach
54909|NCT02942329|Hepatocellular Carcinoma|hepatocellular carcinoma
54910|NCT02942329|Liver Cancer, Adult|liver cancer, adult
54911|NCT02942329|Liver Cell Carcinoma|liver cell carcinoma
54912|NCT02942316|Heart Rate|heart rate
54913|NCT02942316|Reflex, Pupillary|reflex, pupillary
54914|NCT02942316|Monitoring, Intraoperative|monitoring, intraoperative
54915|NCT02942303|Botulinum Toxin, Rejuvenation, Brow lift, Eyebrow.|botulinum toxin, rejuvenation, brow lift, eyebrow.
54916|NCT02942290|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
54917|NCT02942290|Azacitidine|azacitidine
54918|NCT02942290|Higher-Risk (HR) Myelodysplastic Syndromes (MDS)|higher-risk (hr) myelodysplastic syndromes (mds)
54919|NCT02942290|Venetoclax|venetoclax
54920|NCT02942290|Acute Myelogenous Leukemia|acute myelogenous leukemia
54921|NCT02942290|Pharmacokinetic|pharmacokinetic
54922|NCT02942277|Malaria|malaria
54923|NCT02942277|Reactogenicity|reactogenicity
54924|NCT02942277|Antibody|antibody
54925|NCT02942277|Direct Skin Feed|direct skin feed
54926|NCT02942277|Mosquito|mosquito
54927|NCT02942264|Brain Tumor|brain tumor
54928|NCT02942264|Glioblastoma|glioblastoma
54929|NCT02942264|Relapse|relapse
54930|NCT02942264|Randomized|randomized
54931|NCT02942264|temodar|temodar
54932|NCT02942251|MDD|mdd
54933|NCT02942251|big data analytics|big data analytics
54934|NCT02942238|CME|cme
54935|NCT02942238|Right hemi Colon cancer|right hemi colon cancer
54936|NCT02942238|D3|d3
54937|NCT02942238|laparoscopy|laparoscopy
54938|NCT02942225|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
54939|NCT02942225|metabolomics|metabolomics
54940|NCT02942225|neuropsychological deficits|neuropsychological deficits
54941|NCT02942225|pathway analysis|pathway analysis
54942|NCT02942212|Smoking Cessation|smoking cessation
54943|NCT02942212|Nicotine patch|nicotine patch
54944|NCT02942212|Nicoderm Committed Quitters|nicoderm committed quitters
54945|NCT02942212|CQ|cq
54946|NCT02942212|Nicoderm CQ|nicoderm cq
54947|NCT02942212|Questionnaires|questionnaires
54948|NCT02942212|Surveys|surveys
54949|NCT02942212|Interviews|interviews
54950|NCT02942212|Breath tests|breath tests
54951|NCT02942173|CD45RA-depletion|cd45ra-depletion
54952|NCT02942173|TCR-alpha/beta depletion|tcr-alpha/beta depletion
54953|NCT02942173|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
54954|NCT02942121|surgery education|surgery education
54955|NCT02942121|radical cystectomy|radical cystectomy
54956|NCT02942121|cystectomy|cystectomy
54957|NCT02942121|muscle-invasive bladder cancer|muscle-invasive bladder cancer
54958|NCT02942108|piezolectric surgery|piezolectric surgery
54959|NCT02942108|conventional surgery|conventional surgery
54960|NCT02942108|lower third molars|lower third molars
54961|NCT02942095|Advanced Solid Tumors|advanced solid tumors
54962|NCT02942095|Metastatic cancer|metastatic cancer
54963|NCT02942095|Ixazomib|ixazomib
54964|NCT02942095|MLN9708|mln9708
54965|NCT02942095|Erlotinib|erlotinib
54966|NCT02942095|Erlotinib hydrochloride|erlotinib hydrochloride
54967|NCT02942095|OSI-774|osi-774
54968|NCT02942095|CP358774|cp358774
54969|NCT02942095|Tarceva|tarceva
54970|NCT02942043|Malignant pleural effusion|malignant pleural effusion
54971|NCT02942043|Bevacizumab|bevacizumab
54972|NCT02941991|Stargardt's Macular Dystrophy|stargardt's macular dystrophy
54973|NCT02941991|Retinal Diseases|retinal diseases
54974|NCT02941991|Macular Degeneration|macular degeneration
54975|NCT02941991|fundus flavimaculatus|fundus flavimaculatus
54976|NCT02941991|hESC-RPE|hesc-rpe
54977|NCT02941991|juvenile macular dystrophy|juvenile macular dystrophy
54978|NCT02941991|SMD|smd
54979|NCT02941939|high intensity interval training|high intensity interval training
54980|NCT02941939|hyperbaric oxygen|hyperbaric oxygen
54981|NCT02941926|HR-positive HER2-negative|hr-positive her2-negative
54982|NCT02941926|advanced breast cancer|advanced breast cancer
54983|NCT02941926|LEE011|lee011
54984|NCT02941926|ribociclib|ribociclib
54985|NCT02941926|letrozole|letrozole
54986|NCT02941926|goserelin|goserelin
54987|NCT02941926|CDK|cdk
54988|NCT02941926|CDK4|cdk4
54989|NCT02941926|CDK6|cdk6
54990|NCT02941926|CDK4/6|cdk4/6
54991|NCT02941926|Phase IIIb|phase iiib
54992|NCT02941926|ER-positive|er-positive
54993|NCT02941926|PR-positive|pr-positive
54994|NCT02941926|premenopausal|premenopausal
54995|NCT02941926|postmenopausal|postmenopausal
54996|NCT02941926|men with advanced breast cancer|men with advanced breast cancer
54997|NCT02941900|Genetic Testing|genetic testing
54998|NCT02941900|16-1243|16-1243
54999|NCT02941887|Social behavior|social behavior
55000|NCT02941887|Gingivitis|gingivitis
55001|NCT02941887|Periodontitis|periodontitis
55002|NCT02941887|Down's Syndrome|down's syndrome
55003|NCT02941874|IRAP|irap
55004|NCT02941874|Insulin Regulated Amino Peptidase|insulin regulated amino peptidase
55005|NCT02941874|Diagnostic biomarker|diagnostic biomarker
55006|NCT02941874|Type 2 diabetes|type 2 diabetes
55007|NCT02941861|Hepatocellular carcinoma|hepatocellular carcinoma
55008|NCT02941861|Cholangiocarcinoma|cholangiocarcinoma
55009|NCT02941861|Recurrence|recurrence
55010|NCT02941835|pre-operative radiotherapy|pre-operative radiotherapy
55011|NCT02941783|Kovaltry|kovaltry
55012|NCT02941783|hemophilia A|hemophilia a
55013|NCT02941783|Japan|japan
55014|NCT02941783|Post-marketing surveillance|post-marketing surveillance
55015|NCT02941770|Adolescents|adolescents
55016|NCT02941770|Overweight|overweight
55017|NCT02941770|Obesity|obesity
55018|NCT02941770|Weight Loss|weight loss
55019|NCT02941770|Physical activity consultation|physical activity consultation
55020|NCT02941770|Cardiorespiratory fitness|cardiorespiratory fitness
55021|NCT02941770|Endothelial structure|endothelial structure
55022|NCT02941770|Endothelial function|endothelial function
55023|NCT02941757|Mediterranean Diet|mediterranean diet
55024|NCT02941757|Firefighters|firefighters
55025|NCT02941757|workplace|workplace
55026|NCT02941757|Intervention|intervention
55027|NCT02941757|obesity|obesity
55028|NCT02941757|Randomized Control Trial|randomized control trial
55029|NCT02941744|nivolumab|nivolumab
55030|NCT02941744|ipilimumab|ipilimumab
55031|NCT02941744|low fixed dose|low fixed dose
55032|NCT02941744|adjuvant therapy|adjuvant therapy
55033|NCT02941744|Melanoma|melanoma
55034|NCT02941718|Smoking|smoking
55035|NCT02941718|Smoking cessation|smoking cessation
55036|NCT02941718|Nicotine|nicotine
55037|NCT02941705|stem cell research|stem cell research
55038|NCT02941640|Laparoscopic appendectomy|laparoscopic appendectomy
55039|NCT02941640|Endoloop|endoloop
55040|NCT02941640|Stapler|stapler
55041|NCT02941640|Hem-o-lok clip|hem-o-lok clip
55042|NCT02941640|DS clip|ds clip
55043|NCT02941601|Thoracic Neoplasms|thoracic neoplasms
55044|NCT02941601|Lung Diseases|lung diseases
55045|NCT02941601|Lung Cancer|lung cancer
55046|NCT02941601|Respiratory Tract Diseases|respiratory tract diseases
55047|NCT02941601|Respiratory Tract Neoplasms|respiratory tract neoplasms
55048|NCT02941601|Antineoplastic Agents|antineoplastic agents
55049|NCT02941601|Monoclonal Antibodies|monoclonal antibodies
55050|NCT02941562|rectal cancer, radiotherapy|rectal cancer, radiotherapy
55051|NCT02941536|Circulating Tumor Cells|circulating tumor cells
55052|NCT02941536|Stereotactic Radiosurgery|stereotactic radiosurgery
55053|NCT02941497|Stress, Psychological|stress, psychological
55055|NCT02941497|Physical Activity|physical activity
55056|NCT02941497|Fruit|fruit
55057|NCT02941497|Vegetables|vegetables
55058|NCT02941497|Social Marketing|social marketing
55059|NCT02941497|Peer Influence|peer influence
55060|NCT02941497|Community-Based Participatory Research|community-based participatory research
55061|NCT02941471|Constipation|constipation
55062|NCT02941471|Neuromodulation|neuromodulation
55063|NCT02941471|Interferential|interferential
55064|NCT02941471|Transabdominal|transabdominal
55065|NCT02941445|DPP4-inhibitors|dpp4-inhibitors
55066|NCT02941419|Platelet lysate|platelet lysate
55067|NCT02941419|Critical limb ischemia|critical limb ischemia
55068|NCT02941419|Peripheral arterial disease|peripheral arterial disease
55069|NCT02941406|Retina|retina
55070|NCT02941406|Perimetry|perimetry
55071|NCT02941393|internal tocodynamometry, external tocodynamometry, cesarean section, labor, newborn, vacuum extraction, dystocia|internal tocodynamometry, external tocodynamometry, cesarean section, labor, newborn, vacuum extraction, dystocia
55072|NCT02941380|coronary artery bypass grafting|coronary artery bypass grafting
55073|NCT02941380|cardiopulmonary bypass|cardiopulmonary bypass
55074|NCT02941380|Cerebral oxidative stress|cerebral oxidative stress
55075|NCT02941380|Cerebral inflammatory stress|cerebral inflammatory stress
55076|NCT02941380|Cerebral hemodynamics|cerebral hemodynamics
55077|NCT02941380|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
55078|NCT02941341|Bemfola|bemfola
55079|NCT02941341|r-hFSH|r-hfsh
55080|NCT02941341|ART|art
55081|NCT02941341|Oocytes|oocytes
55082|NCT02941341|OHSS|ohss
55083|NCT02941341|Pregnancy|pregnancy
55084|NCT02941328|SMA, SMN1, Kugelberg-Welander|sma, smn1, kugelberg-welander
55085|NCT02941315|Cardiomyopathy|cardiomyopathy
55086|NCT02941315|Heart Failure|heart failure
55087|NCT02941315|Cardiac Magnetic Resonance|cardiac magnetic resonance
55088|NCT02941302|gliomas|gliomas
55089|NCT02941302|biological boundary|biological boundary
55090|NCT02941302|imaging border|imaging border
55091|NCT02941302|operation|operation
55092|NCT02941263|AMD|amd
55093|NCT02941263|Georgraphic Atrophy|georgraphic atrophy
55094|NCT02941263|Macular Degeneration|macular degeneration
55095|NCT02941237|Pulse oximetry|pulse oximetry
55096|NCT02941237|Children|children
55097|NCT02941211|cervix|cervix
55098|NCT02941211|cervical dilation|cervical dilation
55099|NCT02941211|balloon catheter|balloon catheter
55100|NCT02941172|Brown adipose tissue|brown adipose tissue
55101|NCT02941172|Cannabinoid receptor|cannabinoid receptor
55102|NCT02941172|PET imaging|pet imaging
55103|NCT02941172|Metabolism|metabolism
55104|NCT02941120|Cartilage defect|cartilage defect
55105|NCT02941120|Knee|knee
55106|NCT02941120|ACT (Autologous chondrocyte implantation)|act (autologous chondrocyte implantation)
55107|NCT02941120|NOVOCART® Inject|novocart® inject
55108|NCT02941107|Aboriginal|aboriginal
55109|NCT02941107|Rotavirus|rotavirus
55110|NCT02941107|Vaccine|vaccine
55111|NCT02941107|Diarrhoea|diarrhoea
55112|NCT02941081|iron supplement|iron supplement
55113|NCT02941068|severe sepsis|severe sepsis
55114|NCT02941068|intra-abdominal perforation|intra-abdominal perforation
55115|NCT02941068|surgical intensive care unit|surgical intensive care unit
55116|NCT02941068|fungal infection|fungal infection
55117|NCT02941068|prophylactic anti-fungal treatment|prophylactic anti-fungal treatment
55118|NCT02941055|Diet|diet
55119|NCT02941055|Inflammation|inflammation
55120|NCT02941055|Metabolomics|metabolomics
55121|NCT02941029|Radiation|radiation
55122|NCT02941029|Chemotherapy|chemotherapy
55123|NCT02941003|Early stage lung adenocarcinoma|early stage lung adenocarcinoma
55124|NCT02941003|Intraoperative frozen section|intraoperative frozen section
55125|NCT02941003|Diagnostic criteria|diagnostic criteria
55126|NCT02940977|Circulating tumor cell|circulating tumor cell
55127|NCT02940977|Epithelial to mesenchymal transition|epithelial to mesenchymal transition
55128|NCT02940977|Prostate specific antigen (PSA)|prostate specific antigen (psa)
55129|NCT02940977|Partin table|partin table
55130|NCT02940925|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
55131|NCT02940925|induction chemotherapy|induction chemotherapy
55132|NCT02940912|Parkinson disease|parkinson disease
55133|NCT02940912|Insomnia|insomnia
55134|NCT02940912|Sleep disorders|sleep disorders
55135|NCT02940912|Polysomnography|polysomnography
55136|NCT02940912|Apomorphine|apomorphine
55137|NCT02940912|Multiple sleep latency test|multiple sleep latency test
55138|NCT02940912|Parkinson Disease Sleep Scale 2 (PDSS-2)|parkinson disease sleep scale 2 (pdss-2)
55139|NCT02940873|severe hypoglycemia|severe hypoglycemia
55140|NCT02940873|impaired awareness of hypoglycemia|impaired awareness of hypoglycemia
55141|NCT02940873|type 1 diabetes mellitus|type 1 diabetes mellitus
55142|NCT02940873|cognitive behavioral therapy|cognitive behavioral therapy
55143|NCT02940873|structured education|structured education
55144|NCT02940847|ultrasound-guided technique|ultrasound-guided technique
55145|NCT02940847|blind technique|blind technique
55146|NCT02940847|medial brachial cutaneous nerve block|medial brachial cutaneous nerve block
55147|NCT02940847|intercostobrachial nerve block|intercostobrachial nerve block
55148|NCT02940821|Tooth Whitening|tooth whitening
55149|NCT02940808|Caffeine|caffeine
55249|NCT02940184|Physiology|physiology
55154|NCT02940808|Emotional Stroop|emotional stroop
46721|NCT02992847|MRI|mri
55155|NCT02940808|Global/local congruency|global/local congruency
55156|NCT02940808|N-Back|n-back
55157|NCT02940808|Prefrontal Cortex|prefrontal cortex
55158|NCT02940795|breast feeding|breast feeding
55159|NCT02940795|fructose|fructose
55160|NCT02940769|depression, insomnia. light, cortisol, melatonin|depression, insomnia. light, cortisol, melatonin
55161|NCT02940756|Malaria, efficacy, safety, ACT, DR Congo|malaria, efficacy, safety, act, dr congo
55162|NCT02940743|Hemodialysis|hemodialysis
55163|NCT02940704|Reciproc|reciproc
55164|NCT02940704|One Shape|one shape
55165|NCT02940704|reciprocation|reciprocation
55166|NCT02940704|continuous rotation|continuous rotation
55167|NCT02940704|irreversible pulpitis|irreversible pulpitis
55168|NCT02940704|postoperative pain|postoperative pain
55169|NCT02940678|Trauma|trauma
55170|NCT02940678|Clinical prediction models|clinical prediction models
55171|NCT02940678|Transferability studies|transferability studies
55172|NCT02940678|Sweden|sweden
55173|NCT02940652|Laryngeal mask,MRI|laryngeal mask,mri
55177|NCT02940613|Rapid response|rapid response
55178|NCT02940613|Eating Disorders|eating disorders
55179|NCT02940613|Cognitive Behavior Therapy|cognitive behavior therapy
55180|NCT02940613|Bulimia Nervosa|bulimia nervosa
55181|NCT02940613|Binge Eating Disorder|binge eating disorder
55182|NCT02940613|Purging Disorder|purging disorder
55183|NCT02940600|normothermic perfusion|normothermic perfusion
55184|NCT02940600|old donors|old donors
55185|NCT02940600|extended criteria grafts|extended criteria grafts
55186|NCT02940600|reconditioning|reconditioning
55187|NCT02940587|Non Healing Wound|non healing wound
55188|NCT02940574|Oxytocin|oxytocin
55189|NCT02940574|Autism Spectrum Disorders|autism spectrum disorders
55190|NCT02940548|non-dipper hypertension|non-dipper hypertension
55191|NCT02940548|young|young
55192|NCT02940548|middle-aged|middle-aged
55193|NCT02940548|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
55194|NCT02940548|arterial stiffness|arterial stiffness
55195|NCT02940548|nifedipine gastrointestinal therapeutic system (GITS)|nifedipine gastrointestinal therapeutic system (gits)
55196|NCT02940496|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
55197|NCT02940496|Advanced liver cancer|advanced liver cancer
55198|NCT02940496|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
55199|NCT02940496|Pembrolizumab|pembrolizumab
55200|NCT02940496|Keytruda|keytruda
55201|NCT02940496|MK-3475|mk-3475
55202|NCT02940496|SCH-900475|sch-900475
55203|NCT02940496|Biomarkers|biomarkers
55204|NCT02940483|Ependymoma|ependymoma
55205|NCT02940457|tDCS|tdcs
55206|NCT02940457|MCI|mci
55207|NCT02940457|Working Memory|working memory
55208|NCT02940457|fNIRS|fnirs
55209|NCT02940418|Diabetes Mellitus|diabetes mellitus
55210|NCT02940418|Type 1|type 1
55211|NCT02940418|Adipose derived mesenchymal stem cells|adipose derived mesenchymal stem cells
55212|NCT02940405|Ketorolac Premedication|ketorolac premedication
55213|NCT02940405|Anesthetic Efficiency|anesthetic efficiency
55214|NCT02940405|Post-Endodontic Pain|post-endodontic pain
55215|NCT02940405|Post-operative pain|post-operative pain
55216|NCT02940405|Irreversible Pulpitis|irreversible pulpitis
55217|NCT02940405|Oral premedication|oral premedication
55218|NCT02940392|Rezum|rezum
55219|NCT02940340|infective endocarditis|infective endocarditis
55220|NCT02940340|systemic microcirculation|systemic microcirculation
55221|NCT02940327|ECMO|ecmo
55222|NCT02940327|PPHN|pphn
55223|NCT02940327|Pulmonary Hypertension of the Newborn|pulmonary hypertension of the newborn
55224|NCT02940327|Markers of inflammation|markers of inflammation
55225|NCT02940327|Mi-Ecmo|mi-ecmo
55226|NCT02940249|Polyphenol|polyphenol
55227|NCT02940249|Apple|apple
55228|NCT02940249|Fruit|fruit
55229|NCT02940249|Hyperglycaemia|hyperglycaemia
55230|NCT02940249|Metabolic|metabolic
55231|NCT02940223|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
55232|NCT02940223|Cancer-related fatigue|cancer-related fatigue
55233|NCT02940223|Regorafenib|regorafenib
55234|NCT02940223|Stivarga|stivarga
55235|NCT02940223|Fish oil|fish oil
55236|NCT02940223|Icosapent ethyl|icosapent ethyl
55237|NCT02940223|Quality of life questionnaire|quality of life questionnaire
55238|NCT02940223|Symptom questionnaire|symptom questionnaire
55239|NCT02940223|Walk test|walk test
55240|NCT02940223|Chair/stand test|chair/stand test
55241|NCT02940223|Placebo|placebo
55242|NCT02940223|Resistance exercises|resistance exercises
55243|NCT02940223|Walking program|walking program
55244|NCT02940223|Resistance training|resistance training
55245|NCT02940223|Stretching exercises|stretching exercises
55246|NCT02940223|Advanced cancer|advanced cancer
55247|NCT02940197|overweight|overweight
55248|NCT02940197|Caloric Restriction|caloric restriction
55256|NCT02940158|glycemia|glycemia
55257|NCT02940158|insulin|insulin
55258|NCT02940158|glucose|glucose
55259|NCT02940145|inflammatory biomarkers|inflammatory biomarkers
55260|NCT02940145|Interleukines|interleukines
55261|NCT02940145|resistance training|resistance training
55262|NCT02940145|phase angle|phase angle
55263|NCT02940145|oxidative stress|oxidative stress
55264|NCT02940106|oocyte cryopreservation|oocyte cryopreservation
55265|NCT02940106|closed vitrification|closed vitrification
55266|NCT02940106|open vitrification|open vitrification
55267|NCT02940067|prehabilitation|prehabilitation
55268|NCT02940067|pancreatectomy|pancreatectomy
55269|NCT02940067|nutrition|nutrition
55270|NCT02940067|exercise|exercise
55271|NCT02940054|Early diagnosis|early diagnosis
55272|NCT02940041|Diagnosis|diagnosis
55273|NCT02940041|Sonography|sonography
55274|NCT02940041|Magnetic Ressonance|magnetic ressonance
55275|NCT02940015|Quality Control|quality control
55276|NCT02940015|Urine|urine
55277|NCT02940015|Tissue|tissue
55278|NCT02940015|Normal|normal
55279|NCT02940002|Plaque form psoriasis vulgaris|plaque form psoriasis vulgaris
55280|NCT02939989|Virologic failure|virologic failure
55281|NCT02939989|Compensated Cirrhosis|compensated cirrhosis
55282|NCT02939989|HCV Genotype 3 (HCV GT3)|hcv genotype 3 (hcv gt3)
55283|NCT02939989|HCV Genotype 5 (HCV GT5)|hcv genotype 5 (hcv gt5)
55284|NCT02939989|Chronic Hepatitis C (HCV)|chronic hepatitis c (hcv)
55285|NCT02939989|HCV Genotype 4 (HCV GT4)|hcv genotype 4 (hcv gt4)
55286|NCT02939989|HCV Genotype 2 (HCV GT2)|hcv genotype 2 (hcv gt2)
55287|NCT02939989|HCV Genotype 1 (HCV GT1)|hcv genotype 1 (hcv gt1)
55288|NCT02939989|HCV Genotype 6 (HCV GT6)|hcv genotype 6 (hcv gt6)
55289|NCT02939989|Non-cirrhotics|non-cirrhotics
55290|NCT02939976|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
55296|NCT02939911|Residual neuromuscular blockade|residual neuromuscular blockade
55297|NCT02939872|DAPT|dapt
55298|NCT02939872|BVS|bvs
55299|NCT02939872|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
55300|NCT02939872|Dual Antiplatelet Therapy|dual antiplatelet therapy
55301|NCT02939859|Multiple Sclerosis|multiple sclerosis
55302|NCT02939859|Demyelinating Diseases|demyelinating diseases
55303|NCT02939859|Nervous System Diseases|nervous system diseases
55304|NCT02939859|Autoimmune Disorders|autoimmune disorders
55305|NCT02939846|Safety|safety
55306|NCT02939846|Solid tumor|solid tumor
55307|NCT02939846|Trametinib|trametinib
55308|NCT02939846|Pharmacokinetics|pharmacokinetics
55309|NCT02939820|RNAi therapeutic|rnai therapeutic
55310|NCT02939820|FAP|fap
624703|NCT00680043|Omontys|omontys
55311|NCT02939820|Familial Amyloid Polyneuropathies|familial amyloid polyneuropathies
55312|NCT02939820|TTR|ttr
55313|NCT02939820|Transthyretin|transthyretin
55314|NCT02939820|Amyloidosis|amyloidosis
55315|NCT02939807|Yeliva™|yeliva™
55316|NCT02939807|hepatocellular carcinoma|hepatocellular carcinoma
55317|NCT02939807|ABC294640|abc294640
55318|NCT02939807|hepatic neoplasms|hepatic neoplasms
55319|NCT02939807|liver neoplasms|liver neoplasms
55320|NCT02939807|hepatic cancer|hepatic cancer
55321|NCT02939794|cardiac surgery|cardiac surgery
55322|NCT02939794|hemoglobin|hemoglobin
55323|NCT02939794|iron|iron
55324|NCT02939755|Collaborative care intervention|collaborative care intervention
55325|NCT02939755|Cancer|cancer
55326|NCT02939755|Depression|depression
55327|NCT02939755|Palliative care|palliative care
55328|NCT02939755|Quality of life|quality of life
55329|NCT02939755|Fatigue|fatigue
55330|NCT02939755|Pain|pain
55331|NCT02939742|preterm premature rupture of membranes|preterm premature rupture of membranes
55332|NCT02939742|complications of prematurity|complications of prematurity
55333|NCT02939742|neonatal morbidity|neonatal morbidity
55334|NCT02939742|respiratory distress syndrome|respiratory distress syndrome
55335|NCT02939742|antenatal corticosteroids|antenatal corticosteroids
55336|NCT02939742|betamethasone|betamethasone
55337|NCT02939729|prehabilitation|prehabilitation
55338|NCT02939729|physiotherapy|physiotherapy
55339|NCT02939729|cardiac|cardiac
55340|NCT02939729|thoracic|thoracic
55341|NCT02939729|preoperative|preoperative
55342|NCT02939716|small bowel|small bowel
55343|NCT02939716|bloating|bloating
55344|NCT02939716|flow|flow
55345|NCT02939703|Adipose tissue|adipose tissue
55346|NCT02939703|calorimetry|calorimetry
55347|NCT02939703|energy expenditure|energy expenditure
55348|NCT02939703|microbiome|microbiome
55349|NCT02939690|Catheter|catheter
55350|NCT02939690|Umbilical vein|umbilical vein
55351|NCT02939690|Neonate|neonate
55838|NCT02936180|Flu vaccine|flu vaccine
55352|NCT02939664|banded gastric bypass|banded gastric bypass
55353|NCT02939664|weight loss|weight loss
55354|NCT02939651|Metastatic|metastatic
55355|NCT02939651|High grade|high grade
55356|NCT02939638|Plant-based diet|plant-based diet
55357|NCT02939638|Obesity|obesity
55358|NCT02939638|Insulin sensitivity|insulin sensitivity
55359|NCT02939638|Intracellular lipid|intracellular lipid
55360|NCT02939638|Postprandial metabolism|postprandial metabolism
55361|NCT02939638|Vegan diet|vegan diet
55362|NCT02939612|Stress management|stress management
55366|NCT02939599|Increased blood pressure in the pulmonary vein|increased blood pressure in the pulmonary vein
46913|NCT02991560|taping|taping
46914|NCT02991560|conservative treatment|conservative treatment
46915|NCT02991534|Patient Participation [N05.300.150.600.620]|patient participation [n05.300.150.600.620]
46916|NCT02991534|Health Behavior [F01.145.488]|health behavior [f01.145.488]
46917|NCT02991534|Women [M01.975]|women [m01.975]
46918|NCT02991534|Patient Satisfaction [N05.715.360.600]|patient satisfaction [n05.715.360.600]
46919|NCT02991534|Physicians, Primary Care [M01.526.485.810.800]|physicians, primary care [m01.526.485.810.800]
55367|NCT02939599|Increased blood pressure in the lung vasculature|increased blood pressure in the lung vasculature
55369|NCT02939599|Dizziness|dizziness
55370|NCT02939599|Fainting|fainting
55371|NCT02939599|Leg swelling|leg swelling
55372|NCT02939599|Cough|cough
55373|NCT02939599|Angina pector|angina pector
55374|NCT02939586|Sleep, Sleep apnoea, Haemodialysis, Haemodiafiltration, end stage kidney disease|sleep, sleep apnoea, haemodialysis, haemodiafiltration, end stage kidney disease
55375|NCT02939560|Autism Spectrum Disorder|autism spectrum disorder
55376|NCT02939560|Autism|autism
55377|NCT02939560|Depressive|depressive
55378|NCT02939560|Depression|depression
55379|NCT02939547|intravenous|intravenous
55380|NCT02939547|cyclodextrin|cyclodextrin
55381|NCT02939547|compassionate|compassionate
55382|NCT02939547|Trappsol|trappsol
55383|NCT02939534|Parkinson's disease|parkinson's disease
55384|NCT02939534|autoimmunity|autoimmunity
55385|NCT02939521|Pincer Nail|pincer nail
55386|NCT02939521|Surgery|surgery
55387|NCT02939508|Acute lower gastrointestinal dysfunction|acute lower gastrointestinal dysfunction
55388|NCT02939508|Colon-originated lesions|colon-originated lesions
55389|NCT02939508|Critical patient|critical patient
55390|NCT02939508|Colonoscopic decompression|colonoscopic decompression
55391|NCT02939508|Anticholinergic drugs|anticholinergic drugs
55392|NCT02939495|Premature Ejaculation|premature ejaculation
55393|NCT02939495|Erectile Dysfunction|erectile dysfunction
55394|NCT02939495|DAP-SPEED|dap-speed
55395|NCT02939495|Dapoxetine|dapoxetine
55396|NCT02939495|Sildenafil|sildenafil
55397|NCT02939469|Sympathetic Nerve Activity|sympathetic nerve activity
55398|NCT02939469|Skin Sympathetic Nerve Activity|skin sympathetic nerve activity
55399|NCT02939456|prostate|prostate
55400|NCT02939456|cancer|cancer
55401|NCT02939456|MRI|mri
55402|NCT02939417|Laminate veneers|laminate veneers
55403|NCT02939417|Grape seed extract|grape seed extract
55404|NCT02939417|Emax|emax
55405|NCT02939417|collagen cross-linking agent|collagen cross-linking agent
55406|NCT02939404|Energy Intake|energy intake
55407|NCT02939404|Energy Expenditure|energy expenditure
55408|NCT02939404|Eating Behavior|eating behavior
55409|NCT02939404|Cold Exposure|cold exposure
55410|NCT02939378|ketogenic diet|ketogenic diet
55411|NCT02939378|recurrent glioblastoma|recurrent glioblastoma
55412|NCT02939378|chemotherapy|chemotherapy
55413|NCT02939352|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
55414|NCT02939352|Magnetic Resonance Imaging|magnetic resonance imaging
55415|NCT02939352|MRI, Functional|mri, functional
55416|NCT02939339|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
55417|NCT02939313|alcohol|alcohol
55418|NCT02939313|addiction|addiction
55419|NCT02939313|cTBS|ctbs
55420|NCT02939300|Melanoma|melanoma
55421|NCT02939300|Leptomeningeal Metastases|leptomeningeal metastases
55422|NCT02939287|autologous|autologous
55423|NCT02939287|myeloma|myeloma
55424|NCT02939287|transplant|transplant
55425|NCT02939209|Rotator cuff repair|rotator cuff repair
55426|NCT02939209|Interscalene block|interscalene block
55427|NCT02939209|Hydromorphone|hydromorphone
55428|NCT02939209|Pain|pain
55429|NCT02939209|Rebound pain|rebound pain
55430|NCT02939183|Multiple Myeloma|multiple myeloma
55431|NCT02939157|Diagnostic Ultrasound|diagnostic ultrasound
55432|NCT02939157|Primary Care|primary care
55433|NCT02939131|Cognitive Behavioral Therapy|cognitive behavioral therapy
55434|NCT02939131|Medication Management|medication management
55435|NCT02938351|Intervention|intervention
55436|NCT02938351|dialysis|dialysis
55437|NCT02938325|Electroencephalogram|electroencephalogram
55438|NCT02938325|awareness|awareness
55439|NCT02938286|Fractional laser|fractional laser
55440|NCT02938286|Topical anesthesia|topical anesthesia
55441|NCT02938286|Drug delivery|drug delivery
55442|NCT02938286|CO2 laser|co2 laser
55443|NCT02938286|Er:YAG laser|er:yag laser
55444|NCT02938247|Malnutrition|malnutrition
55445|NCT02938247|Geriatric subjects|geriatric subjects
55446|NCT02938247|Nursing home|nursing home
55447|NCT02938234|Malnutrition|malnutrition
55448|NCT02938234|Geriatric subjects|geriatric subjects
55449|NCT02938234|Nursing home|nursing home
55839|NCT02936180|Influenza|influenza
55450|NCT02939092|Gingival Bleeding on probing|gingival bleeding on probing
55451|NCT02939079|Multiple Sclerosis|multiple sclerosis
55452|NCT02939079|Fingolimod|fingolimod
55453|NCT02939079|Fish Oil|fish oil
55454|NCT02939053|Bioimpedance spectroscopy|bioimpedance spectroscopy
55455|NCT02939040|positive activities intervention|positive activities intervention
55456|NCT02939040|peri-operative|peri-operative
55457|NCT02939014|Drug therapy|drug therapy
55458|NCT02938988|Periodontal Diseases|periodontal diseases
55459|NCT02938988|Down Syndrome|down syndrome
55460|NCT02938975|malaria|malaria
55461|NCT02938975|personal protection|personal protection
55462|NCT02938975|permethrin treated clothing|permethrin treated clothing
55463|NCT02938975|insect repellents|insect repellents
55464|NCT02938975|army personnel|army personnel
55465|NCT02938975|cluster randomised trial|cluster randomised trial
55466|NCT02938949|Myocardial Infarction|myocardial infarction
55467|NCT02938949|Low Density Lipoprotein Cholesterol|low density lipoprotein cholesterol
55468|NCT02938949|proprotein convertase subtilisin kexin 9, human|proprotein convertase subtilisin kexin 9, human
55469|NCT02938949|alirocumab|alirocumab
55470|NCT02938910|Primary hyperaldosteronism|primary hyperaldosteronism
55471|NCT02938910|Secondary hyperaldosteronism|secondary hyperaldosteronism
55472|NCT02938910|Cardiac fibrosis|cardiac fibrosis
55473|NCT02938910|magnetic resonance imaging|magnetic resonance imaging
55474|NCT02938897|Telehealth|telehealth
55475|NCT02938897|Weight loss|weight loss
55476|NCT02938897|Diet quality|diet quality
55477|NCT02938897|Behavioral counseling|behavioral counseling
55478|NCT02938871|synbiotic|synbiotic
55479|NCT02938871|infections|infections
55480|NCT02938871|probiotics|probiotics
55481|NCT02938871|liver transplantation|liver transplantation
55482|NCT02938832|cardiovascular disease, diet, diabetes|cardiovascular disease, diet, diabetes
55483|NCT02938819|upper limbs|upper limbs
55484|NCT02938819|physiotherapy|physiotherapy
55485|NCT02938793|cancer, malignancy|cancer, malignancy
55486|NCT02938780|Behavioral economics|behavioral economics
55487|NCT02938780|Breast cancer survivors|breast cancer survivors
55488|NCT02938780|nutrition|nutrition
55489|NCT02938780|physical activity|physical activity
55490|NCT02938767|peritoneal dialysis|peritoneal dialysis
55491|NCT02938767|carotid intima-media thickness|carotid intima-media thickness
55492|NCT02938767|coronary flow reserve|coronary flow reserve
55493|NCT02938767|cardiovascular mortality|cardiovascular mortality
55494|NCT02938754|Hemiparesis|hemiparesis
55495|NCT02938754|Functional independence|functional independence
55496|NCT02938754|Virtual Rehabilitation|virtual rehabilitation
55497|NCT02938741|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
55498|NCT02938741|lymphoblastic lymphoma|lymphoblastic lymphoma
55499|NCT02938741|stem-cell transplant|stem-cell transplant
55500|NCT02938741|T-cell lymphoma|t-cell lymphoma
55501|NCT02938741|ATG|atg
55502|NCT02938728|AntiPD1|antipd1
55503|NCT02938702|Active surveillance|active surveillance
55504|NCT02938650|nitrolipid|nitrolipid
55505|NCT02938650|microbiome|microbiome
55506|NCT02938650|inflammation|inflammation
55507|NCT02938650|cytokine|cytokine
55508|NCT02938598|maternal depression|maternal depression
55509|NCT02938598|pediatric-based maternal depression screening|pediatric-based maternal depression screening
55510|NCT02938598|maternal health services|maternal health services
55511|NCT02938546|Non-small-cell lung cancer|non-small-cell lung cancer
55512|NCT02938546|18F-FDG PET/CT|18f-fdg pet/ct
55513|NCT02938546|treatment response assessment|treatment response assessment
55514|NCT02938520|Antiretroviral agent|antiretroviral agent
55515|NCT02938520|Maintenance|maintenance
55516|NCT02938520|rilpivirine|rilpivirine
55517|NCT02938520|dolutegravir|dolutegravir
55518|NCT02938520|TMC278|tmc278
55519|NCT02938520|Triumeq|triumeq
55520|NCT02938520|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
55521|NCT02938520|once monthly, every 4 weeks, once daily|once monthly, every 4 weeks, once daily
55522|NCT02938520|GSK1265744|gsk1265744
55523|NCT02938520|CAB|cab
55524|NCT02938520|Tivicay|tivicay
55525|NCT02938520|Long-Acting Intramuscular rilpivirine|long-acting intramuscular rilpivirine
55526|NCT02938520|lamivudine|lamivudine
55527|NCT02938520|integrase inhibitor|integrase inhibitor
55528|NCT02938520|Long-Acting Intramuscular Cabotegravir|long-acting intramuscular cabotegravir
55529|NCT02938520|ART naïve|art naïve
55530|NCT02938520|cabotegravir|cabotegravir
55531|NCT02938520|abacavir|abacavir
55532|NCT02938507|Overactive bladder, Incontinence|overactive bladder, incontinence
55533|NCT02938481|colon cancer, lymph node, extent of bowel resection|colon cancer, lymph node, extent of bowel resection
55534|NCT02938455|Hyperalgesia|hyperalgesia
55535|NCT02938455|Opioids|opioids
55536|NCT02938455|Postoperative pain|postoperative pain
55537|NCT02938455|DNA methylation|dna methylation
55538|NCT02938429|congenital|congenital
55539|NCT02938390|Nipple Sparing Mastectomy|nipple sparing mastectomy
63415|NCT02888652|PCI|pci
55540|NCT02938390|Ultrasound|ultrasound
55541|NCT02938221|TeleStroke|telestroke
55542|NCT02938221|HINTS|hints
55543|NCT02938221|Diagnosis|diagnosis
55544|NCT02938221|Telemedicine|telemedicine
55841|NCT02936167|Plasmalyte|plasmalyte
55547|NCT02938169|surface EMG|surface emg
55548|NCT02938169|exercise|exercise
55549|NCT02938156|Hemophilia|hemophilia
55550|NCT02938143|Jumpers knee|jumpers knee
55551|NCT02938143|Patellar Tendinopathy|patellar tendinopathy
55553|NCT02938143|UTE MRI|ute mri
55554|NCT02938143|Exercise Therapy|exercise therapy
55555|NCT02938143|NBA|nba
55556|NCT02938117|obesity|obesity
55557|NCT02938117|eccentric exercise|eccentric exercise
55558|NCT02938117|body composition|body composition
55559|NCT02938117|training program|training program
55560|NCT02938091|Hispanics|hispanics
55561|NCT02938091|Single nucleotide polymorphism|single nucleotide polymorphism
55562|NCT02938091|Hepatic lipase|hepatic lipase
55563|NCT02938052|Heart Failure|heart failure
55564|NCT02938052|Positive Psychology|positive psychology
55565|NCT02938052|Adherence to Health Behaviors|adherence to health behaviors
55566|NCT02938039|laryngeal airways|laryngeal airways
55567|NCT02938039|infants|infants
55568|NCT02938039|neonates|neonates
55569|NCT02938039|children|children
55570|NCT02938039|anesthetized|anesthetized
55571|NCT02938000|aerobic training|aerobic training
55572|NCT02938000|stroke|stroke
55573|NCT02938000|exercise|exercise
55574|NCT02938000|stroke recovery|stroke recovery
55575|NCT02937974|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
55576|NCT02937974|Xuebijing|xuebijing
55577|NCT02937948|Locally advanced|locally advanced
55578|NCT02937922|Exercise|exercise
55579|NCT02937922|Endothelium|endothelium
55580|NCT02937922|Hypertension|hypertension
55581|NCT02937922|Endothelial progenitor cell|endothelial progenitor cell
55582|NCT02937922|Endothelial microparticle|endothelial microparticle
55583|NCT02937909|woundcare community nursing competence|woundcare community nursing competence
55584|NCT02937883|Daily Activities|daily activities
55585|NCT02937818|Platinum Refractory Extensive-Stage Carcinoma, Small Cell Lung|platinum refractory extensive-stage carcinoma, small cell lung
55586|NCT02937818|Platinum Refractory Extensive-Stage Oat Cell Carcinoma of Lung|platinum refractory extensive-stage oat cell carcinoma of lung
55587|NCT02937818|Platinum Refractory Extensive-Stage Oat Cell Lung Cancer|platinum refractory extensive-stage oat cell lung cancer
55588|NCT02937818|Platinum Refractory Extensive-Stage Small Cell Cancer Of The Lung|platinum refractory extensive-stage small cell cancer of the lung
55589|NCT02937818|Platinum Refractory Extensive-Stage Small Cell Lung Cancer|platinum refractory extensive-stage small cell lung cancer
55590|NCT02937740|Hypogonadism|hypogonadism
55591|NCT02937714|Teachers|teachers
55592|NCT02937714|mental health literacy|mental health literacy
55593|NCT02937714|school mental health promotion|school mental health promotion
55596|NCT02937675|small molecule inhibitor of protein translation|small molecule inhibitor of protein translation
55597|NCT02937675|immunomodulator|immunomodulator
55598|NCT02937675|phase 1 dose escalation|phase 1 dose escalation
55599|NCT02937649|Obesity|obesity
55600|NCT02937649|Bariatric surgery|bariatric surgery
55601|NCT02937649|Sleeve gastrectomy|sleeve gastrectomy
55602|NCT02937649|Staple-line Leak|staple-line leak
55603|NCT02937649|Bougie|bougie
55604|NCT02937649|Calibration|calibration
55605|NCT02937597|proficiency based progression|proficiency based progression
55606|NCT02937597|feedback|feedback
55607|NCT02937597|computer based assessment|computer based assessment
55608|NCT02937597|non technical skills|non technical skills
55609|NCT02937597|deteriorating patient|deteriorating patient
55610|NCT02937597|ISBAR|isbar
55611|NCT02937571|Carfilzomib|carfilzomib
55612|NCT02937571|Lenalidomide|lenalidomide
55613|NCT02937571|Dexamethasone|dexamethasone
55614|NCT02937571|15-326|15-326
55615|NCT02937558|hypoglycemia|hypoglycemia
55616|NCT02937532|Fear of falling|fear of falling
55617|NCT02937532|Fear avoidance behavior|fear avoidance behavior
55618|NCT02937532|cognitive behavioral therapy|cognitive behavioral therapy
55619|NCT02937532|Rehabilitation|rehabilitation
55620|NCT02937519|Chronomodulated Chemotherapy|chronomodulated chemotherapy
55621|NCT02937519|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
55622|NCT02937519|Advanced Nasopharyngeal Cancer|advanced nasopharyngeal cancer
55623|NCT02937506|propofol|propofol
55624|NCT02937506|colonoscopy|colonoscopy
55625|NCT02937506|patient satisfaction|patient satisfaction
55626|NCT02937480|stroke|stroke
55627|NCT02937480|physical activity|physical activity
55628|NCT02937480|task performance|task performance
55629|NCT02937480|clinical protocol|clinical protocol
55630|NCT02937467|SWE|swe
55631|NCT02937467|diagnosis|diagnosis
55632|NCT02937454|Acute Heart Failure|acute heart failure
55633|NCT02937454|Iron Deficiency|iron deficiency
55634|NCT02937441|C10.228.140.187|c10.228.140.187
55635|NCT02937428|vaccination|vaccination
55636|NCT02937428|pain|pain
55637|NCT02937428|fear|fear
55638|NCT02937428|psychological intervention|psychological intervention
55639|NCT02937415|carbon monoxide|carbon monoxide
55640|NCT02937415|oxidative stress|oxidative stress
55641|NCT02937415|waterpipe smoking|waterpipe smoking
55642|NCT02937415|cigarette smoking|cigarette smoking
55643|NCT02937415|pulmonary function test|pulmonary function test
55644|NCT02937350|chronic kidney disease|chronic kidney disease
55645|NCT02937350|vitamin d catabolism|vitamin d catabolism
55646|NCT02937311|Taping, stroke|taping, stroke
55647|NCT02937311|rehabilitation|rehabilitation
55648|NCT02937311|shoulder pain|shoulder pain
55649|NCT02937311|electrical stimulation|electrical stimulation
55650|NCT02937298|Diet Induced Thermogenesis|diet induced thermogenesis
55651|NCT02937298|Obesity|obesity
55652|NCT02937298|Energy balance|energy balance
55653|NCT02937298|Energy expenditure|energy expenditure
55654|NCT02937298|berries|berries
55655|NCT02937298|Sea Buckthorn|sea buckthorn
55656|NCT02937298|Wild garlic|wild garlic
55657|NCT02937272|TGF Beta|tgf beta
55658|NCT02937233|Zika|zika
55659|NCT02937233|Vaccine|vaccine
55660|NCT02937233|ZPIV|zpiv
55661|NCT02937207|Bronchial Asthma|bronchial asthma
55662|NCT02937207|Traditional Chinese Medicine|traditional chinese medicine
55663|NCT02937194|Early childhood caries (ECC)|early childhood caries (ecc)
55664|NCT02937194|Oral health promotion|oral health promotion
55665|NCT02937194|Randomized controlled trial|randomized controlled trial
55666|NCT02937142|Behavior Therapy|behavior therapy
55667|NCT02937142|Cognitive Therapy|cognitive therapy
55668|NCT02937142|Adolescents|adolescents
55669|NCT02937142|Psychotherapy, Group|psychotherapy, group
55670|NCT02937129|Infrared tympanic thermometer|infrared tympanic thermometer
55671|NCT02937129|Axillary thermometer|axillary thermometer
55672|NCT02937129|Mercury glass thermometer|mercury glass thermometer
55673|NCT02937129|Adult emergency department|adult emergency department
55674|NCT02937103|Leukemia|leukemia
55675|NCT02937103|Myeloid|myeloid
55676|NCT02937103|CD123|cd123
55677|NCT02937103|CAR-T|car-t
55678|NCT02937090|Polycystic Ovary Syndrome|polycystic ovary syndrome
55679|NCT02937090|Intestinal Microbiota|intestinal microbiota
55680|NCT02937077|etiology|etiology
55681|NCT02937038|Urine Biomarkers|urine biomarkers
55682|NCT02937038|Child Nutrition|child nutrition
55683|NCT02937038|Hydration|hydration
55684|NCT02937038|Parent Nutrition Habits|parent nutrition habits
55685|NCT02937025|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
55686|NCT02937025|Stroke|stroke
55687|NCT02937025|Left Atrial Appendage Closure|left atrial appendage closure
55688|NCT02937025|Intervention|intervention
55689|NCT02937012|Primary Biliary Cirrhosis|primary biliary cirrhosis
55690|NCT02937012|Primary Biliary Cholangitis|primary biliary cholangitis
55691|NCT02937012|Bezafibrate|bezafibrate
55692|NCT02937012|Ursodeoxycholic acid|ursodeoxycholic acid
55693|NCT02936973|simple obesity|simple obesity
55694|NCT02936973|catgut implantation|catgut implantation
55695|NCT02936934|Adverse Drug Reaction|adverse drug reaction
55696|NCT02936934|Morphine|morphine
55697|NCT02936934|Oxycodone|oxycodone
55698|NCT02936934|Abdominal hysterectomy|abdominal hysterectomy
55699|NCT02936921|Toxoplasma gondii|toxoplasma gondii
55700|NCT02936921|Toxoplasmosis|toxoplasmosis
55701|NCT02936921|congenital|congenital
55702|NCT02936921|prenatal|prenatal
55703|NCT02936921|screening|screening
55704|NCT02936921|treatment|treatment
55705|NCT02936921|diagnosis|diagnosis
55706|NCT02936908|Neuromuscular Diseases|neuromuscular diseases
55707|NCT02936908|Muscular dystrophy|muscular dystrophy
55708|NCT02936908|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
55709|NCT02936908|Acute respiratory failure|acute respiratory failure
55710|NCT02936908|respiratory care|respiratory care
55711|NCT02936908|mechanical ventilation|mechanical ventilation
55712|NCT02936908|weaning|weaning
55713|NCT02936908|Intensive Care Unit|intensive care unit
55714|NCT02936908|Critical Care|critical care
55715|NCT02936908|Survival|survival
55716|NCT02936882|ultrasonography|ultrasonography
55717|NCT02936882|aspiration|aspiration
55718|NCT02936882|emergency|emergency
55719|NCT02936882|children|children
55720|NCT02936882|antrum|antrum
55721|NCT02936843|Pain|pain
55722|NCT02936843|Inflammation|inflammation
55723|NCT02936843|Diabetes Mellitus|diabetes mellitus
55724|NCT02936843|Adult|adult
55725|NCT02936843|Neuropathy|neuropathy
55726|NCT02936817|HRCT|hrct
55727|NCT02936817|High Resolution Computed Tomography scans|high resolution computed tomography scans
55728|NCT02936817|Functional Respiratory Imaging|functional respiratory imaging
55729|NCT02936817|CT scan|ct scan
55730|NCT02936817|Computed Tomography|computed tomography
55731|NCT02936817|COPD|copd
55732|NCT02936817|sputum producing COPD patients|sputum producing copd patients
55733|NCT02936817|Aerobika® device|aerobika® device
55734|NCT02936804|early stage lung cancer|early stage lung cancer
55735|NCT02936804|LDCT screening|ldct screening
47338|NCT02988843|GCT|gct
55736|NCT02936804|lung resection|lung resection
55737|NCT02936804|electromagnetic navigation bronchoscopy|electromagnetic navigation bronchoscopy
55738|NCT02936804|peripheral biomarker|peripheral biomarker
55840|NCT02936167|Ringer Lactate|ringer lactate
55739|NCT02936791|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
55740|NCT02936791|ADPKD|adpkd
55741|NCT02936791|PKD biomarkers|pkd biomarkers
55742|NCT02936791|Kidney Institute|kidney institute
55743|NCT02936791|University of Kansas Medical Center|university of kansas medical center
55744|NCT02936778|Short-term medical and psychosocial functioning|short-term medical and psychosocial functioning
55745|NCT02936713|flatulence|flatulence
55746|NCT02936713|gas|gas
55747|NCT02936713|probiotics|probiotics
55748|NCT02936713|fermented milk|fermented milk
55749|NCT02936713|diet|diet
55750|NCT02936713|functional gastrointestinal disorders|functional gastrointestinal disorders
55751|NCT02936700|Psychiatry|psychiatry
55752|NCT02936700|Suicide|suicide
55753|NCT02936700|Randomized controlled trial|randomized controlled trial
55754|NCT02936700|ACT|act
55755|NCT02936700|fMRI|fmri
55756|NCT02936687|blood flow|blood flow
55757|NCT02936687|magnetic resonance imaging|magnetic resonance imaging
55758|NCT02936687|insulin|insulin
55759|NCT02936687|vasodilation|vasodilation
55760|NCT02936661|postpartum hemorrhage， cesarean section， tranexamic acid|postpartum hemorrhage， cesarean section， tranexamic acid
55761|NCT02936648|Hepatitis C|hepatitis c
55762|NCT02936635|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
55763|NCT02936635|ALS|als
55764|NCT02936635|tirasemtiv|tirasemtiv
55765|NCT02936609|healthcare access|healthcare access
55766|NCT02936609|healthcare utilization|healthcare utilization
55767|NCT02936609|preventive services|preventive services
55768|NCT02936609|cancer survivors|cancer survivors
55769|NCT02936531|evoked response potential|evoked response potential
55770|NCT02936531|ERP|erp
55771|NCT02936531|Brain Network Activation|brain network activation
55772|NCT02936531|BNA|bna
55773|NCT02936531|Biomarker|biomarker
55774|NCT02936518|ankyloglossia|ankyloglossia
55775|NCT02936518|breastfeeding|breastfeeding
55776|NCT02936518|lip tie|lip tie
55777|NCT02936505|chronic lung allograft dysfunction|chronic lung allograft dysfunction
55778|NCT02936505|cyclosporin|cyclosporin
55779|NCT02936505|tacrolimus|tacrolimus
55780|NCT02936505|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
55781|NCT02936505|Restrictive Allograft Syndrome|restrictive allograft syndrome
55782|NCT02936505|CLAD|clad
55783|NCT02936492|Phase I|phase i
55784|NCT02936492|Healthy volunteers|healthy volunteers
55785|NCT02936466|Psychiatry|psychiatry
55786|NCT02936466|Randomized controlled trial|randomized controlled trial
55787|NCT02936466|Bipolar disorder|bipolar disorder
55788|NCT02936466|Serious game|serious game
55789|NCT02936466|Compliance|compliance
55790|NCT02936466|Psychoeducation|psychoeducation
55791|NCT02936453|Spinal Cord Injury|spinal cord injury
55792|NCT02936453|Epidural Electrical Stimulation|epidural electrical stimulation
55793|NCT02936453|Robot-assisted|robot-assisted
55794|NCT02936440|acute kidney injury|acute kidney injury
55795|NCT02936440|intensive care unit|intensive care unit
55801|NCT02936414|Schizophrenia|schizophrenia
55802|NCT02936388|uveal melanoma|uveal melanoma
55803|NCT02936388|liver metastasis|liver metastasis
55804|NCT02936388|chemoembolisation|chemoembolisation
55805|NCT02936388|radioembolisation|radioembolisation
55806|NCT02936375|lupus|lupus
55807|NCT02936375|nephritis|nephritis
55808|NCT02936375|iguratimod|iguratimod
55809|NCT02936362|Bread|bread
55810|NCT02936362|Microbiome|microbiome
55811|NCT02936362|Blood tests|blood tests
55812|NCT02936362|Sourdough bread|sourdough bread
55813|NCT02936362|Dietary intervention|dietary intervention
55814|NCT02936349|Hereditary Hemorrhagic Telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
55815|NCT02936349|Pulmonary Arteriovenous Malformation (PAVM)|pulmonary arteriovenous malformation (pavm)
55816|NCT02936349|Transthoracic Contrast Echocardiogram (TTCE)|transthoracic contrast echocardiogram (ttce)
55817|NCT02936323|SCLC small cell lung cancer neuroendocrine NET|sclc small cell lung cancer neuroendocrine net
55818|NCT02936310|stress|stress
55819|NCT02936310|mindfulness|mindfulness
55820|NCT02936310|Mindful Living With Stress Intervention|mindful living with stress intervention
55821|NCT02936310|nurse|nurse
55822|NCT02936310|HIV/AIDS|hiv/aids
55823|NCT02936271|Radiofrequency Ablation|radiofrequency ablation
55824|NCT02936271|Sclerotherapy|sclerotherapy
55825|NCT02936271|Vasculera|vasculera
55826|NCT02936219|complementary feeding|complementary feeding
55827|NCT02936219|breast milk|breast milk
55828|NCT02936219|formula feeding|formula feeding
55829|NCT02936219|combined feeding|combined feeding
55830|NCT02936219|preterm infants|preterm infants
55831|NCT02936219|body composition|body composition
55832|NCT02936206|proliferation Index|proliferation index
55833|NCT02936206|Tamoxifen|tamoxifen
55834|NCT02936206|Fulvestrant|fulvestrant
55835|NCT02936206|cyclinD1|cyclind1
55836|NCT02936206|Breast cancer|breast cancer
55837|NCT02936180|Rheumatoid arthritis|rheumatoid arthritis
55842|NCT02936167|Perioperative Period|perioperative period
55843|NCT02936141|homeless, mental disorders, attendance|homeless, mental disorders, attendance
55844|NCT02936102|Phase I|phase i
55845|NCT02936102|FAZ053|faz053
55846|NCT02936102|PDR001|pdr001
55847|NCT02936102|Checkpoint inhibitor|checkpoint inhibitor
55848|NCT02936102|PD-L1|pd-l1
55849|NCT02936102|PD-1|pd-1
55850|NCT02936063|Head and neck surgery|head and neck surgery
55851|NCT02936063|Scar cosmesis|scar cosmesis
55852|NCT02936063|Surgical staples|surgical staples
55853|NCT02936063|Sutures|sutures
55854|NCT02936063|Patient satisfaction|patient satisfaction
55855|NCT02936050|Echocardiography|echocardiography
55856|NCT02936050|Telemedicine|telemedicine
55857|NCT02936050|Nurses|nurses
55858|NCT02936050|Decision support|decision support
55859|NCT02936050|eHealth|ehealth
55865|NCT02935998|schizophrenia|schizophrenia
55866|NCT02935998|agitation|agitation
55867|NCT02935998|ziprasidone|ziprasidone
55868|NCT02935985|spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
55869|NCT02935985|point-of-care bio-markers|point-of-care bio-markers
55870|NCT02935985|multicenter|multicenter
55871|NCT02935985|Emergency Department|emergency department
55872|NCT02935985|Romania|romania
55873|NCT02935972|prostate biopsy, analgesia, anesthesia, pain, prostate cancer|prostate biopsy, analgesia, anesthesia, pain, prostate cancer
55874|NCT02935946|pharyngeal swallow, NICU, intervention, thickening|pharyngeal swallow, nicu, intervention, thickening
55875|NCT02935920|PRO, follow up|pro, follow up
55876|NCT02935894|oxygenated lipids|oxygenated lipids
55877|NCT02935894|metabolic profiling|metabolic profiling
55878|NCT02935894|sphingoid bases|sphingoid bases
55879|NCT02935894|ceramides|ceramides
55880|NCT02935894|endocannabinoids|endocannabinoids
55881|NCT02935894|non-invasive sampling|non-invasive sampling
55882|NCT02935868|Saliva|saliva
55883|NCT02935855|Diabetic patients|diabetic patients
55884|NCT02935855|nondiabetic patients|nondiabetic patients
55885|NCT02935842|Parkinson's Disease|parkinson's disease
55886|NCT02935842|Word Retrieval|word retrieval
55887|NCT02935842|Apraxia Symptoms|apraxia symptoms
55888|NCT02935842|Dysarthria|dysarthria
55889|NCT02935829|energy intake|energy intake
55890|NCT02935829|blood glucose|blood glucose
55891|NCT02935829|carob flour|carob flour
55892|NCT02935790|unresectable|unresectable
55893|NCT02935790|melanoma|melanoma
55894|NCT02935777|Pomegranate extract|pomegranate extract
55895|NCT02935777|cognitive function|cognitive function
55896|NCT02935777|cognition|cognition
55897|NCT02935777|polyphenols|polyphenols
55898|NCT02935777|memory|memory
625696|NCT00682799|RC|rc
55899|NCT02935738|prednisolone|prednisolone
55900|NCT02935738|anti-sperm antibodies|anti-sperm antibodies
55901|NCT02935738|sperm penetration assay|sperm penetration assay
55902|NCT02935712|Safety|safety
55903|NCT02935712|Tolerability|tolerability
55904|NCT02935712|AZD8601|azd8601
55905|NCT02935712|Type II Diabetes|type ii diabetes
55906|NCT02935582|Topical|topical
55907|NCT02935582|Real-world|real-world
55908|NCT02935582|Local standard of care|local standard of care
55909|NCT02935582|Non-interventional|non-interventional
55910|NCT02935582|Calcipotriol|calcipotriol
55911|NCT02935569|Alopecia|alopecia
55912|NCT02935569|Radiotherapy|radiotherapy
55913|NCT02935556|Post Partum Pre-eclampsia|post partum pre-eclampsia
55914|NCT02935517|Color vision deficiency|color vision deficiency
55915|NCT02935517|Color vision defects|color vision defects
55916|NCT02935517|Vision disorders|vision disorders
55917|NCT02935517|Sensation disorders|sensation disorders
55918|NCT02935517|Neurologic manifestations|neurologic manifestations
55919|NCT02935517|Nervous system diseases|nervous system diseases
55920|NCT02935517|Eye diseases|eye diseases
55921|NCT02935517|Signs and symptoms|signs and symptoms
55922|NCT02935504|Depression|depression
55923|NCT02935504|Pregnancy|pregnancy
55924|NCT02935504|Postpartum|postpartum
55925|NCT02935491|TAVI|tavi
55926|NCT02935491|Aortic stenosis|aortic stenosis
55927|NCT02935491|aortic stiffness|aortic stiffness
55928|NCT02935491|calcifications|calcifications
55929|NCT02935491|CT-scan|ct-scan
55930|NCT02935491|Vascular impedance|vascular impedance
55931|NCT02935478|bariatric surgery|bariatric surgery
55932|NCT02935478|minimally invasive|minimally invasive
55933|NCT02935478|Embolization|embolization
55934|NCT02935478|ghrelin|ghrelin
55935|NCT02935478|gastric artery embolization|gastric artery embolization
55936|NCT02935452|Self-management|self-management
55937|NCT02935452|Supportive self-management|supportive self-management
55938|NCT02935452|Normalisation process theory|normalisation process theory
55939|NCT02935452|Social networks|social networks
55940|NCT02935439|Mobile Phone|mobile phone
55941|NCT02935439|Self-efficacy|self-efficacy
55942|NCT02935439|Quality of Life|quality of life
55943|NCT02935439|Knowledge|knowledge
55944|NCT02935439|Feasibility|feasibility
55945|NCT02935426|cyanoacrylate|cyanoacrylate
55946|NCT02935426|sutures|sutures
55947|NCT02935400|porphyria|porphyria
55948|NCT02935400|biomarkers|biomarkers
55949|NCT02935387|Very early rheumatoid arthritis|very early rheumatoid arthritis
55950|NCT02935374|children|children
55951|NCT02935374|intestinal microbiome|intestinal microbiome
55952|NCT02935374|microbiota|microbiota
55953|NCT02935374|antimicrobial course|antimicrobial course
55954|NCT02935374|amoxicillin|amoxicillin
55955|NCT02935374|amoxicillin-clavulanate|amoxicillin-clavulanate
55956|NCT02935374|macrolide|macrolide
55957|NCT02935322|Prevention|prevention
55958|NCT02935309|rectum|rectum
55959|NCT02935309|transrectal|transrectal
55960|NCT02935309|carcinoma|carcinoma
55961|NCT02935270|Stroke|stroke
55966|NCT02935231|proactive|proactive
55967|NCT02935231|nicotine replacement therapy|nicotine replacement therapy
55968|NCT02935231|smoking hotspots|smoking hotspots
55969|NCT02935192|seasonal influenza|seasonal influenza
55970|NCT02935192|vaccine|vaccine
55971|NCT02935153|CD22|cd22
55972|NCT02935153|CAR-T|car-t
55973|NCT02935153|Leukemia|leukemia
55974|NCT02935153|Lymphoma|lymphoma
55975|NCT02935127|absorbable sutures|absorbable sutures
55976|NCT02935114|Tooth Bleaching|tooth bleaching
55977|NCT02935114|Tooth Bleaching Agents|tooth bleaching agents
55978|NCT02935114|Tooth Whitening|tooth whitening
55979|NCT02935114|Hydrogen Peroxide|hydrogen peroxide
55980|NCT02935114|Carbamide Peroxide|carbamide peroxide
55981|NCT02935101|glucocorticoids|glucocorticoids
55982|NCT02935101|craving|craving
55983|NCT02935101|Heroin|heroin
55984|NCT02935101|Cocaine|cocaine
55985|NCT02935101|dependency|dependency
55987|NCT02935088|Percutaneous coronary intervention|percutaneous coronary intervention
55988|NCT02935062|Speech|speech
55989|NCT02935062|Speech Therapy|speech therapy
55990|NCT02935062|Speech Sound Disorders|speech sound disorders
55991|NCT02935062|Phonological Disorders|phonological disorders
55992|NCT02935062|Auditory Perception|auditory perception
55993|NCT02935010|Helicobacter pylori|helicobacter pylori
55994|NCT02935010|Bismuth quadruple therapy|bismuth quadruple therapy
55995|NCT02935010|Tailored therapy|tailored therapy
55996|NCT02935010|Empiric therapy|empiric therapy
55997|NCT02935010|clarithromycin susceptibility|clarithromycin susceptibility
55998|NCT02934997|sepsis|sepsis
55999|NCT02934997|septic shock|septic shock
56000|NCT02934997|cholesterol|cholesterol
56001|NCT02934997|high density lipoprotein|high density lipoprotein
56002|NCT02934984|Pancreatic Cancer|pancreatic cancer
56003|NCT02934984|recurrence|recurrence
56005|NCT02934958|Colon Cancer Screening|colon cancer screening
56006|NCT02934945|Budesonide/formoterol|budesonide/formoterol
56007|NCT02934945|Typical asthma|typical asthma
56008|NCT02934945|Cough variant asthma|cough variant asthma
56009|NCT02934919|Nalmefene|nalmefene
56010|NCT02934919|Impulse control disorders|impulse control disorders
56011|NCT02934919|Parkinson's disease|parkinson's disease
56012|NCT02934919|Tolerance|tolerance
56013|NCT02934919|Efficacy|efficacy
56014|NCT02934906|Neonatal Alloimmune Thrombocytopenia|neonatal alloimmune thrombocytopenia
56015|NCT02934906|pregnancy|pregnancy
56016|NCT02934906|human platelet allogantigen|human platelet allogantigen
56017|NCT02934906|asian|asian
56018|NCT02934906|Chinese|chinese
56019|NCT02934880|adapted physical activity, cognitive functions|adapted physical activity, cognitive functions
56020|NCT02934854|GAMT deficiency|gamt deficiency
56021|NCT02934854|GAMT and AGAT deficiencies|gamt and agat deficiencies
56022|NCT02934854|Creatine Transporter Deficiency|creatine transporter deficiency
56023|NCT02934854|Brain Creatine Transporter Deficiency|brain creatine transporter deficiency
56024|NCT02934815|psychological intervention|psychological intervention
56025|NCT02934815|breast cancer|breast cancer
56026|NCT02934815|supportive-expressive group therapy|supportive-expressive group therapy
56027|NCT02934815|emotion regulation|emotion regulation
56028|NCT02934815|social support|social support
56029|NCT02934815|attachment|attachment
56030|NCT02934815|quality of life|quality of life
56031|NCT02934789|submucosal fibroids|submucosal fibroids
56032|NCT02934789|heavy menstrual bleeding|heavy menstrual bleeding
56033|NCT02934789|quality of life|quality of life
56035|NCT02934776|prostate cancer|prostate cancer
56036|NCT02934776|MRI|mri
56037|NCT02934750|pursed lip breathing|pursed lip breathing
56038|NCT02934750|interstitial lund disease|interstitial lund disease
56039|NCT02934750|exercise physiology|exercise physiology
56040|NCT02934737|Obesity|obesity
56041|NCT02934737|Diabetes Mellitus|diabetes mellitus
56042|NCT02934724|HPV vaccines|hpv vaccines
56043|NCT02934724|HPV-6|hpv-6
56044|NCT02934724|HPV-11|hpv-11
56045|NCT02934724|HPV-16|hpv-16
56046|NCT02934724|HPV-18|hpv-18
56047|NCT02934724|Gardasil|gardasil
56048|NCT02934711|Multimorbidity|multimorbidity
56049|NCT02934711|Exercise coordinated groups (GECO)|exercise coordinated groups (geco)
56050|NCT02934711|Caregivers|caregivers
56051|NCT02934685|Prostatic Neoplasms|prostatic neoplasms
56052|NCT02934685|radiotherapy|radiotherapy
56053|NCT02934646|Robotics|robotics
56054|NCT02934646|Upper Extremity|upper extremity
56055|NCT02934633|injury|injury
56056|NCT02934633|child|child
56057|NCT02934633|cars|cars
56058|NCT02934633|pedestrians|pedestrians
56059|NCT02934633|child safety|child safety
56060|NCT02934633|interactive|interactive
56061|NCT02934633|computer|computer
56062|NCT02934633|prevention|prevention
56063|NCT02934633|internet|internet
56064|NCT02934633|CD-ROM|cd-rom
56065|NCT02934620|pregnancy|pregnancy
56066|NCT02934620|condom|condom
56068|NCT02934620|sexually transmitted infections|sexually transmitted infections
56069|NCT02934607|Asthma|asthma
56070|NCT02934607|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
56071|NCT02934607|Spacer device|spacer device
56072|NCT02934607|Symbicort|symbicort
56073|NCT02934607|Pressurized metered-dose inhaler|pressurized metered-dose inhaler
56074|NCT02934607|Relative bioavailability|relative bioavailability
56075|NCT02934607|Crossover|crossover
56076|NCT02934607|AstraZeneca|astrazeneca
56077|NCT02934607|Safety|safety
56078|NCT02934607|Activated charcoal|activated charcoal
56079|NCT02934607|AeroChamber Plus Flow-Vu spacer device|aerochamber plus flow-vu spacer device
56080|NCT02934568|Ribociclib|ribociclib
56081|NCT02934568|LEE011|lee011
56082|NCT02934542|Laparoscope holder|laparoscope holder
56083|NCT02934542|Colon resection|colon resection
56084|NCT02934542|Right hemicolectomy|right hemicolectomy
56085|NCT02934542|Left hemicolectomy|left hemicolectomy
56086|NCT02934542|Sigmoid resection|sigmoid resection
56087|NCT02934542|Anti-reflux|anti-reflux
56088|NCT02934542|Hiatal hernia|hiatal hernia
56089|NCT02934516|Obstructed labor|obstructed labor
56090|NCT02934516|C section. push method|c section. push method
56091|NCT02934516|reverse breech|reverse breech
56092|NCT02934503|Chemotherapy|chemotherapy
56093|NCT02934503|PD-L1|pd-l1
56094|NCT02934503|Thoracic radiotherapy|thoracic radiotherapy
56095|NCT02934503|PD-1|pd-1
56096|NCT02934503|MK-3475|mk-3475
56097|NCT02934477|Myelofibrosis|myelofibrosis
56098|NCT02934477|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
56099|NCT02934477|Medicare|medicare
56100|NCT02934438|nitric oxide|nitric oxide
56101|NCT02934438|Neo40 supplement,|neo40 supplement,
56102|NCT02934438|exercise tolerance|exercise tolerance
56103|NCT02934425|Pork|pork
56104|NCT02934425|Refined carbohydrates|refined carbohydrates
56105|NCT02934425|Satiety|satiety
56106|NCT02934425|Glucose|glucose
56107|NCT02934425|Insulin|insulin
56108|NCT02934425|Breakfast|breakfast
56109|NCT02934425|Lipoprotein lipids|lipoprotein lipids
56110|NCT02934399|dynamic hormone diagnostics|dynamic hormone diagnostics
56111|NCT02934399|adrenal insufficiency|adrenal insufficiency
56112|NCT02934399|congenital adrenal hyperplasia|congenital adrenal hyperplasia
56113|NCT02934399|primary hyperaldosteronism|primary hyperaldosteronism
56114|NCT02934399|cushing syndrome|cushing syndrome
56115|NCT02934399|growth hormone deficiency|growth hormone deficiency
56116|NCT02934399|acromegaly|acromegaly
56117|NCT02934360|Lung Cancer|lung cancer
56118|NCT02934360|Breast Cancer|breast cancer
56119|NCT02934360|cell free DNA|cell free dna
56120|NCT02934360|biomarker|biomarker
56121|NCT02934347|Intubation, Back-up position; Glottis, View|intubation, back-up position; glottis, view
56122|NCT02934334|major depression|major depression
56123|NCT02934334|major depressive episode|major depressive episode
56124|NCT02934334|biomarkers|biomarkers
56125|NCT02934334|relapse|relapse
56126|NCT02934334|near term relapse|near term relapse
56127|NCT02934334|m-health|m-health
56128|NCT02934321|Erythritol|erythritol
56129|NCT02934321|Satiety Response|satiety response
56130|NCT02934321|Ghrelin|ghrelin
56131|NCT02934295|Rubeola|rubeola
56132|NCT02934269|Healthy subjects|healthy subjects
56133|NCT02934269|Safety|safety
56134|NCT02934269|CC-90006|cc-90006
56135|NCT02934269|Phase 1|phase 1
56136|NCT02934269|Tolerability|tolerability
56137|NCT02934256|Neurofibromatosis Type 2|neurofibromatosis type 2
56138|NCT02934256|Vestibular Schwannoma|vestibular schwannoma
56139|NCT02934256|Other NF2-related tumors|other nf2-related tumors
56140|NCT02934243|Laryngeal Masks|laryngeal masks
56141|NCT02934243|Ventilation|ventilation
56142|NCT02934243|Risk factors|risk factors
56143|NCT02934204|PCNSL|pcnsl
56144|NCT02934204|DLBCL|dlbcl
56145|NCT02934204|methotrexate|methotrexate
56146|NCT02934204|temozolomide|temozolomide
56147|NCT02934191|Tonsillectomy|tonsillectomy
56148|NCT02934191|Post-operative complications|post-operative complications
56149|NCT02934191|Post-operative pain|post-operative pain
56150|NCT02934178|shigellosis|shigellosis
56151|NCT02934178|Enterobacteriaceae Infections|enterobacteriaceae infections
56152|NCT02934178|Gram-Negative Bacterial Infections|gram-negative bacterial infections
56153|NCT02934178|Bacterial Infections|bacterial infections
56154|NCT02934178|Gastroenteritis|gastroenteritis
56155|NCT02934178|Gastrointestinal Diseases|gastrointestinal diseases
56156|NCT02934178|Digestive System Diseases|digestive system diseases
56157|NCT02934178|Intestinal Diseases|intestinal diseases
56158|NCT02934165|child safety|child safety
56159|NCT02934165|injury|injury
56160|NCT02934165|computer|computer
56161|NCT02934165|prevention|prevention
56162|NCT02934165|internet|internet
56163|NCT02934152|Gastroesophageal reflux disease|gastroesophageal reflux disease
56164|NCT02934152|Helicobacter pylori|helicobacter pylori
56166|NCT02934139|Cavosonstat|cavosonstat
56167|NCT02934139|Healthy Volunteer|healthy volunteer
56168|NCT02934113|weight loss|weight loss
56169|NCT02934113|text messaging|text messaging
56170|NCT02934113|workplace|workplace
56171|NCT02934113|participatory approach|participatory approach
56172|NCT02934113|health care workers|health care workers
56173|NCT02934100|Calcaneal spur|calcaneal spur
56174|NCT02934100|Heel spur|heel spur
56175|NCT02934100|ESWT|eswt
56176|NCT02934100|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
56177|NCT02934100|ultrasound therapy|ultrasound therapy
56178|NCT02934100|electric field diathermy|electric field diathermy
56179|NCT02934100|skanlab 25 bodywave|skanlab 25 bodywave
56180|NCT02934100|sham laser therapy|sham laser therapy
56181|NCT02934087|snare technique|snare technique
56182|NCT02934087|cannulation of contralateral gate|cannulation of contralateral gate
56183|NCT02934087|endovascular|endovascular
56184|NCT02934087|aneurysm|aneurysm
56185|NCT02934087|AAA|aaa
56186|NCT02934087|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
56187|NCT02934074|Limb Loss|limb loss
56188|NCT02934074|Gait Variability|gait variability
56189|NCT02934074|Phantom Sensation|phantom sensation
56190|NCT02934074|Phantom Pain|phantom pain
56191|NCT02934074|Peripheral Sensation|peripheral sensation
56192|NCT02934061|Acute low back pain|acute low back pain
56193|NCT02934022|Maraviroc|maraviroc
56194|NCT02934022|HAART regimen|haart regimen
56195|NCT02934022|Immunologic response|immunologic response
56196|NCT02933996|immunosuppression|immunosuppression
56197|NCT02933996|cardiac sugery|cardiac sugery
56198|NCT02933996|Transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
56199|NCT02933996|postoperative|postoperative
56200|NCT02933957|Vascular Evaluation|vascular evaluation
56201|NCT02933957|influencing factor|influencing factor
56202|NCT02933957|She Minority population|she minority population
56203|NCT02933944|locally recurrent|locally recurrent
56204|NCT02933918|Probiotics|probiotics
56205|NCT02933918|Nasal Irrigation|nasal irrigation
56206|NCT02933918|Healthy Volunteers|healthy volunteers
56207|NCT02933801|metastatic castration resistant prostate cancer (mCRPC)|metastatic castration resistant prostate cancer (mcrpc)
56208|NCT02933801|Prostate Cancer|prostate cancer
56209|NCT02933801|phase II trial|phase ii trial
56210|NCT02933801|ODM-201|odm-201
56211|NCT02933801|maintenance therapy|maintenance therapy
56212|NCT02933788|cardiovascular disease|cardiovascular disease
56213|NCT02933788|atherosclerosis|atherosclerosis
56214|NCT02933723|influenza vaccine|influenza vaccine
56215|NCT02933723|nursing home|nursing home
56216|NCT02933723|influenza|influenza
56217|NCT02933723|vaccination|vaccination
56218|NCT02933723|immunity|immunity
56219|NCT02933723|cell-mediated immunity|cell-mediated immunity
56220|NCT02933723|humoral immunity|humoral immunity
56221|NCT02933710|Japanese encephalitis|japanese encephalitis
56222|NCT02933710|IMOJEV®|imojev®
56223|NCT02933710|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
56224|NCT02933697|Atrial Fibrillation|atrial fibrillation
56225|NCT02933697|Kidney disease|kidney disease
56226|NCT02933697|Anticoagulation|anticoagulation
56227|NCT02933671|suprainguinal fascia iliaca (SIFI)|suprainguinal fascia iliaca (sifi)
56228|NCT02933671|nerve block|nerve block
56229|NCT02933645|Insulin|insulin
56230|NCT02933645|Intranasal|intranasal
56231|NCT02933645|Glucose/metabolism|glucose/metabolism
56232|NCT02933645|Glucose homeostasis|glucose homeostasis
56233|NCT02933632|Osteoarthritis|osteoarthritis
56234|NCT02933632|Physiotherapy|physiotherapy
56235|NCT02933632|Rehabilitation|rehabilitation
56236|NCT02933632|Clinical Trials|clinical trials
56237|NCT02933632|Accelerated rehabilitation|accelerated rehabilitation
56238|NCT02933632|Hip Replacement Arthroplasty|hip replacement arthroplasty
56239|NCT02933554|bariatric surgery|bariatric surgery
56240|NCT02933554|minimally invasive|minimally invasive
56241|NCT02933554|Embolization|embolization
56242|NCT02933554|NASH|nash
56243|NCT02933554|ghrelin|ghrelin
56244|NCT02933554|gastric artery embolization|gastric artery embolization
56245|NCT02933515|yoga|yoga
56246|NCT02933515|occupational therapy|occupational therapy
56247|NCT02933515|stroke|stroke
56248|NCT02933463|children with high caries risk|children with high caries risk
56249|NCT02933437|Brugada syndrome|brugada syndrome
56250|NCT02933437|SCN5A|scn5a
56251|NCT02933437|SCN10A|scn10a
56252|NCT02933437|Ajmaline|ajmaline
56253|NCT02933411|Bleeding Disorders|bleeding disorders
56254|NCT02933411|Heavy Menstrual Bleeding|heavy menstrual bleeding
56255|NCT02933359|cranial vault|cranial vault
56256|NCT02933359|calvarial trauma|calvarial trauma
56257|NCT02933359|calvarial reconstruction|calvarial reconstruction
56258|NCT02933320|Indolent B-cell Lymphoma|indolent b-cell lymphoma
56259|NCT02933320|Chronic Lymphocytic Leukaemia|chronic lymphocytic leukaemia
56260|NCT02933320|Waldenström Macroglobulinaemia|waldenström macroglobulinaemia
56261|NCT02933320|BI-1206|bi-1206
56262|NCT02933320|CD32b|cd32b
56263|NCT02933294|uniportal|uniportal
56264|NCT02933294|lung cancer|lung cancer
56265|NCT02933294|VATS|vats
56266|NCT02933268|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
56267|NCT02933268|Polycystic Kidney Disease|polycystic kidney disease
56268|NCT02933268|ADPKD|adpkd
56269|NCT02933268|Water|water
56270|NCT02933268|Vasopressin|vasopressin
56271|NCT02933268|Dietary|dietary
56272|NCT02933255|Safety|safety
56273|NCT02933255|Neoadjuvant|neoadjuvant
56274|NCT02933255|Prostatectomy|prostatectomy
56275|NCT02933255|Immunotherapy|immunotherapy
56276|NCT02933255|Vaccine|vaccine
56277|NCT02933242|Cancer|cancer
56278|NCT02933216|Cesarean Scar Diverticula|cesarean scar diverticula
56279|NCT02933177|Dementia|dementia
56280|NCT02933177|Alzheimer disease|alzheimer disease
56281|NCT02933177|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
56282|NCT02933177|non-drug intervention|non-drug intervention
56283|NCT02933138|Lipoprotein Lipase|lipoprotein lipase
56284|NCT02933138|Hypertriglyceridemia|hypertriglyceridemia
56285|NCT02933138|Triglycerides|triglycerides
56286|NCT02933138|Lipolysis|lipolysis
56287|NCT02933138|Multifactorial Chylomicronemia|multifactorial chylomicronemia
56288|NCT02933125|substance abuse|substance abuse
56289|NCT02933125|group psychotherapy|group psychotherapy
56290|NCT02933125|family therapy|family therapy
56291|NCT02933125|longitudinal study|longitudinal study
56292|NCT02933125|child and adolescent|child and adolescent
56293|NCT02933112|Oral appliance therapy|oral appliance therapy
56294|NCT02933086|Pregnant|pregnant
56295|NCT02933086|Low Back Pain|low back pain
56296|NCT02933086|Postural Control|postural control
56297|NCT02933060|intravenous fluid|intravenous fluid
56298|NCT02933060|headache|headache
56299|NCT02933047|Hysterectomy|hysterectomy
56300|NCT02933047|Patient satisfaction|patient satisfaction
56301|NCT02933047|Rehabilitation|rehabilitation
56302|NCT02933047|Laparoscopy|laparoscopy
56303|NCT02933047|Return to work|return to work
56304|NCT02933047|Exercise|exercise
56305|NCT02933034|ISCHEMIC OR CORONARY HEART DISEASE|ischemic or coronary heart disease
56306|NCT02933034|MYOCARDIAL INFARCTION|myocardial infarction
56307|NCT02933034|MAGNETIC RESONANCE IMAGING|magnetic resonance imaging
56308|NCT02933034|DELAYED GADOLINIUM ENHANCEMENT MRI|delayed gadolinium enhancement mri
56309|NCT02933034|MANGANESE-ENHANCED MRI|manganese-enhanced mri
56310|NCT02933034|INFARCT VOLUME/SIZE|infarct volume/size
56311|NCT02933034|ALL CAUSE MORTALITY|all cause mortality
56312|NCT02933034|VENTRICULAR ARRHYTHMIAS|ventricular arrhythmias
56313|NCT02933021|MGUS|mgus
56315|NCT02933008|biofeedback|biofeedback
56316|NCT02933008|injury prevention|injury prevention
56317|NCT02933008|virtual reality|virtual reality
56318|NCT02932995|Optical Coherence Tomography|optical coherence tomography
56319|NCT02932995|Drug-Eluting Stent|drug-eluting stent
56320|NCT02932982|primary care|primary care
56321|NCT02932982|chest pain|chest pain
56322|NCT02932982|dyspnea|dyspnea
56323|NCT02932956|GPC3-Positive Solid Tumors|gpc3-positive solid tumors
56324|NCT02932956|GPC3-CAR T cells|gpc3-car t cells
56325|NCT02932956|GPC3|gpc3
56326|NCT02932956|Glypican|glypican
56327|NCT02932930|QLB|qlb
56328|NCT02932930|Abdominoplasty|abdominoplasty
56329|NCT02932930|Quadratus lumborum block|quadratus lumborum block
56330|NCT02932904|Drug therapy|drug therapy
56331|NCT02932865|azoospermia|azoospermia
56332|NCT02932865|male fertility|male fertility
56333|NCT02932865|MD-TESE|md-tese
56334|NCT02932865|miRNA|mirna
56335|NCT02932865|piRNA|pirna
56336|NCT02932865|male infertility|male infertility
56337|NCT02932852|stem cell|stem cell
56338|NCT02932852|mesenchymal|mesenchymal
56339|NCT02932852|ADASc|adasc
56340|NCT02932852|transplantation|transplantation
56341|NCT02932852|cornea|cornea
56342|NCT02932852|corneal defects|corneal defects
56343|NCT02932852|keratoconus|keratoconus
56344|NCT02932852|scaffold|scaffold
56345|NCT02932852|lamina|lamina
56346|NCT02932839|Epilepsy surgery|epilepsy surgery
56347|NCT02932839|Micro-electrode arrays|micro-electrode arrays
56348|NCT02932839|Single-neuron recordings|single-neuron recordings
56349|NCT02932839|Electrocorticography|electrocorticography
56350|NCT02932826|Autoimmune Diabetes|autoimmune diabetes
56351|NCT02932826|Umbilical Cord Blood Cell|umbilical cord blood cell
56352|NCT02932826|Regulatory T Lymphocyte|regulatory t lymphocyte
56353|NCT02932826|Cell Therapy|cell therapy
56354|NCT02932800|Catheters|catheters
64389|NCT02882126|PAH|pah
56355|NCT02932800|Vascular Access Devices|vascular access devices
56356|NCT02932800|Suture Techniques|suture techniques
56357|NCT02932800|microbiota|microbiota
56358|NCT02932800|Blood Circulation|blood circulation
56360|NCT02932774|seasonal allergic rhinitis|seasonal allergic rhinitis
56361|NCT02932774|hay fever|hay fever
56362|NCT02932774|seasonal allergic rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
56363|NCT02932761|cesarean scar diverticula|cesarean scar diverticula
56364|NCT02932761|vaginal repair|vaginal repair
56365|NCT02932761|GnRHa|gnrha
56366|NCT02932722|Propofol|propofol
56369|NCT02932709|Emergency|emergency
56370|NCT02932709|follow-up|follow-up
56371|NCT02932709|nurse|nurse
56372|NCT02932709|phone|phone
56373|NCT02932709|suicide attempts|suicide attempts
56374|NCT02932683|Resuscitation|resuscitation
56375|NCT02932683|Neonatal|neonatal
56376|NCT02932683|Education|education
56377|NCT02932644|Rheumatoid Arthritis|rheumatoid arthritis
56378|NCT02932644|Cardiovascular event|cardiovascular event
56379|NCT02932644|Cardiovascular mortality|cardiovascular mortality
56380|NCT02932644|Vitamin D|vitamin d
56381|NCT02932631|hemiparesis|hemiparesis
56382|NCT02932631|STROKE|stroke
56383|NCT02932631|neural plasticity|neural plasticity
56384|NCT02932631|PHYSICAL THERAPY|physical therapy
56385|NCT02932605|Schizophrenia|schizophrenia
56386|NCT02932605|Cannabidiol|cannabidiol
56387|NCT02932605|Positron Emission Tomography (PET)|positron emission tomography (pet)
56388|NCT02932605|Microglia|microglia
56389|NCT02932566|Heart failure|heart failure
56390|NCT02932566|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
56391|NCT02932566|Myocardial fibrosis|myocardial fibrosis
56392|NCT02932566|Extracellular volume fraction (ECV)|extracellular volume fraction (ecv)
56393|NCT02932566|Interstitial fibrosis|interstitial fibrosis
56394|NCT02932553|bioresorbable vascular scaffold|bioresorbable vascular scaffold
56395|NCT02932553|variant angina|variant angina
56396|NCT02932553|moderate coronary artery disease|moderate coronary artery disease
56397|NCT02932553|vasospastic angina|vasospastic angina
56398|NCT02932527|cannabis|cannabis
56399|NCT02932501|Bisphosphonate|bisphosphonate
56400|NCT02932501|Jaw|jaw
56401|NCT02932501|Osteonecrosis|osteonecrosis
56402|NCT02932501|Antiresorptive drugs|antiresorptive drugs
56403|NCT02932501|Denosumab|denosumab
56404|NCT02932488|PET-MR|pet-mr
56405|NCT02932488|5-HT1B receptor|5-ht1b receptor
56406|NCT02932488|Sumatriptan|sumatriptan
56407|NCT02932488|phMRI|phmri
56408|NCT02932488|[11C]AZ10419369|[11c]az10419369
56409|NCT02932436|empagliflozin|empagliflozin
56410|NCT02932436|diastolic function|diastolic function
56411|NCT02932436|poorly controlled type 2 diabetes mellitus|poorly controlled type 2 diabetes mellitus
56412|NCT02932423|Sugar-sweetened beverage|sugar-sweetened beverage
56413|NCT02932423|Overweight|overweight
56414|NCT02932423|Obese|obese
56415|NCT02932423|Sugar|sugar
56416|NCT02932423|Water|water
56417|NCT02932397|Ambulatory surgery|ambulatory surgery
56418|NCT02932397|Perioperative outcomes|perioperative outcomes
56419|NCT02932397|General anesthesia under desflurane|general anesthesia under desflurane
56420|NCT02932397|Prevention of coughing|prevention of coughing
56421|NCT02932397|Propofol|propofol
56422|NCT02932384|HIV|hiv
56423|NCT02932384|Black/African American|black/african american
56424|NCT02932384|Men|men
56425|NCT02932384|Gay/bisexual|gay/bisexual
56426|NCT02932384|Los Angeles|los angeles
56427|NCT02932371|Cardiac output|cardiac output
56428|NCT02932358|Intensive care units|intensive care units
56429|NCT02932358|Delirium|delirium
56430|NCT02932358|Cross infection|cross infection
56431|NCT02932358|Mortality|mortality
56432|NCT02932358|Length of stay|length of stay
56433|NCT02932358|Burnout, Professional|burnout, professional
56434|NCT02932358|Depression|depression
56435|NCT02932358|Anxiety|anxiety
56436|NCT02932345|EGFR mutation; non-small-cell lung cancer;|egfr mutation; non-small-cell lung cancer;
56437|NCT02932332|shortness of breath|shortness of breath
56438|NCT02932332|oxygen|oxygen
56439|NCT02932332|breathing therapies|breathing therapies
56440|NCT02932319|induction of labour|induction of labour
56441|NCT02932319|nulliparous|nulliparous
56442|NCT02932319|prolonged pregnancy|prolonged pregnancy
56443|NCT02932319|foley catheter|foley catheter
56444|NCT02932319|vaginal birth|vaginal birth
56445|NCT02932280|Recurrent|recurrent
56446|NCT02932280|Refractory Disease|refractory disease
56447|NCT02932280|Neratinib|neratinib
56448|NCT02932280|16-878|16-878
56449|NCT02932267|Acne|acne
56450|NCT02932267|Dark skin|dark skin
56451|NCT02932254|Physiological Effects of Drugs|physiological effects of drugs
56452|NCT02932254|Rocuronium|rocuronium
56453|NCT02932254|Sugammadex sodium|sugammadex sodium
56454|NCT02932254|Magnesium|magnesium
56553|NCT02931721|MRI|mri
56455|NCT02932254|Neuromuscular block, antagonism|neuromuscular block, antagonism
56456|NCT02932215|mobile health device|mobile health device
56457|NCT02932215|substance abuse treatment|substance abuse treatment
56458|NCT02932215|quality of life|quality of life
56459|NCT02932215|lorcaserin|lorcaserin
56460|NCT02932202|Obesity|obesity
56461|NCT02932202|Pregnancy|pregnancy
56462|NCT02932202|Weight Gain|weight gain
56463|NCT02932189|Mechanical Ventilator Weaning|mechanical ventilator weaning
56464|NCT02932189|Respiratory Muscle Training|respiratory muscle training
56465|NCT02932189|Mortality Rate|mortality rate
56466|NCT02932176|Arteries|arteries
56467|NCT02932163|Chronic low back pain|chronic low back pain
56469|NCT02932163|endurance|endurance
56470|NCT02932150|CHB|chb
56471|NCT02932150|HBV|hbv
56472|NCT02932137|SLE,IL-2|sle,il-2
56473|NCT02932124|German Resuscitation Registry|german resuscitation registry
56474|NCT02932124|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
56475|NCT02932124|cardiopulmonary resuscitation|cardiopulmonary resuscitation
56476|NCT02932124|mechanical chest compression devices|mechanical chest compression devices
56477|NCT02932111|IBS|ibs
56478|NCT02932111|Osteopathic manipulative treatment|osteopathic manipulative treatment
56479|NCT02932111|pain|pain
56480|NCT02932085|Transcranial magnetic stimulation|transcranial magnetic stimulation
56481|NCT02932085|Magnetic resonance imaging|magnetic resonance imaging
56482|NCT02932085|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
56483|NCT02932059|Metamemory|metamemory
56484|NCT02932059|Schizophrenia|schizophrenia
56485|NCT02932059|Aging|aging
56486|NCT02932059|Learning|learning
56487|NCT02932059|Judgement of learning|judgement of learning
56488|NCT02932059|Sentence construction strategy|sentence construction strategy
56489|NCT02932046|eating disorders|eating disorders
56490|NCT02932046|anorexia nervosa|anorexia nervosa
56491|NCT02932046|appetite|appetite
56492|NCT02932020|disc herniation|disc herniation
56493|NCT02932020|spinal stenosis|spinal stenosis
56494|NCT02932007|persistent|persistent
56495|NCT02932007|longstanding persistent|longstanding persistent
56496|NCT02931994|dental floss|dental floss
56497|NCT02931994|gingival embrasure|gingival embrasure
56498|NCT02931994|oral hygiene|oral hygiene
56499|NCT02931981|DKK4|dkk4
56500|NCT02931981|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
56501|NCT02931981|Biomarker|biomarker
56502|NCT02931968|Monolithic Zirconia|monolithic zirconia
56503|NCT02931968|Implant supported prosthesis|implant supported prosthesis
56504|NCT02931968|Fixed partial denture|fixed partial denture
56505|NCT02931955|allergy|allergy
56506|NCT02931955|insect venom|insect venom
56507|NCT02931955|pollen|pollen
56508|NCT02931955|systems biology|systems biology
56509|NCT02931942|AA|aa
56510|NCT02931916|smart-phone|smart-phone
56511|NCT02931916|assessment|assessment
56512|NCT02931916|chronic ankle instability|chronic ankle instability
56513|NCT02931903|implant supported restorations|implant supported restorations
56514|NCT02931903|IPS Emax (lithium disilicate glass-ceramic)|ips emax (lithium disilicate glass-ceramic)
56515|NCT02931903|Vita Enamic (hybrid dental ceramic)|vita enamic (hybrid dental ceramic)
56516|NCT02931903|implant survival|implant survival
56517|NCT02931903|peri-implant tissue response|peri-implant tissue response
56518|NCT02931890|gastric cancer|gastric cancer
56519|NCT02931890|radiotherapy|radiotherapy
56520|NCT02931890|chemoradiotherapy|chemoradiotherapy
56521|NCT02931877|Sevoflurane|sevoflurane
56522|NCT02931877|Propofol|propofol
56523|NCT02931877|Cardiac valvular surgery|cardiac valvular surgery
56524|NCT02931877|Cardiopulmonary bypass|cardiopulmonary bypass
56525|NCT02931877|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
56526|NCT02931825|high risk|high risk
56527|NCT02931825|surveillance|surveillance
56528|NCT02931825|screening|screening
56529|NCT02931825|colonoscopy|colonoscopy
56530|NCT02931812|cirrhosis|cirrhosis
56531|NCT02931812|reward system|reward system
56532|NCT02931812|taste sensitivity|taste sensitivity
56533|NCT02931812|chronic renal failure|chronic renal failure
56534|NCT02931799|Colitis, Ulcerative|colitis, ulcerative
56535|NCT02931799|Crohn Disease|crohn disease
56536|NCT02931799|Inflammatory Bowel Diseases|inflammatory bowel diseases
56537|NCT02931799|Gastroenterology|gastroenterology
56538|NCT02931799|Quality Improvement|quality improvement
56539|NCT02931799|Post-Discharge|post-discharge
56540|NCT02931786|core body temperature|core body temperature
56541|NCT02931786|magnetic resonance imaging|magnetic resonance imaging
56542|NCT02931786|propofol|propofol
56543|NCT02931786|ketofol|ketofol
56544|NCT02931773|Diabetes Autonomic Cardiovascular|diabetes autonomic cardiovascular
56545|NCT02931747|Bacopa Monnieri|bacopa monnieri
56546|NCT02931747|Working memory|working memory
56547|NCT02931747|Cognitive processing|cognitive processing
56548|NCT02931747|Student|student
56549|NCT02931721|Azospermia|azospermia
56550|NCT02931721|Micro Dissection Testicular Sperm Extraction|micro dissection testicular sperm extraction
56551|NCT02931721|Male infertility|male infertility
56552|NCT02931721|Testis|testis
56554|NCT02931708|Heart Failure|heart failure
48069|NCT02984397|pain|pain
56555|NCT02931708|Diaphragm|diaphragm
56556|NCT02931708|Electrical Stimulation|electrical stimulation
56557|NCT02931695|post partum|post partum
56558|NCT02931682|Creatine transporter|creatine transporter
56559|NCT02931682|developmental delay|developmental delay
56560|NCT02931682|intellectual disability|intellectual disability
56561|NCT02931682|X-linked|x-linked
56562|NCT02931682|language|language
56563|NCT02931682|seizure|seizure
56564|NCT02931682|observational|observational
56565|NCT02931682|brain spectroscopy|brain spectroscopy
56566|NCT02931656|Gestational Diabetes|gestational diabetes
56567|NCT02931643|Spices|spices
56568|NCT02931643|Functional food|functional food
56569|NCT02931643|Cardiometabolic risk|cardiometabolic risk
56570|NCT02931643|Metabolic syndrome|metabolic syndrome
56571|NCT02931643|Inflammation|inflammation
56572|NCT02931643|Peripheral blood mononuclear cell|peripheral blood mononuclear cell
56573|NCT02931643|Acute|acute
56574|NCT02931643|miRNA|mirna
56575|NCT02931630|Whey protein|whey protein
56576|NCT02931630|Dietary fibers|dietary fibers
56577|NCT02931630|Wheat bran|wheat bran
56578|NCT02931630|Arabinoxylan|arabinoxylan
56579|NCT02931630|Postprandial lipaemia|postprandial lipaemia
56580|NCT02931630|Body composition|body composition
56581|NCT02931630|Blood pressure|blood pressure
56582|NCT02931630|Metabolic rate|metabolic rate
56583|NCT02931630|Insulin sensitivity|insulin sensitivity
56584|NCT02931630|Metabolic syndrome|metabolic syndrome
56585|NCT02931604|sinus wash|sinus wash
56586|NCT02931604|sinus lavage|sinus lavage
56587|NCT02931604|Sinusitis|sinusitis
56588|NCT02931591|Small for gestational age|small for gestational age
56589|NCT02931591|insulin sensitivity|insulin sensitivity
56590|NCT02931591|IGF-1 response|igf-1 response
56591|NCT02931591|growth hormone treatment|growth hormone treatment
56592|NCT02931578|glycemic index|glycemic index
56593|NCT02931552|Breast cancer|breast cancer
56594|NCT02931552|Latinas|latinas
56595|NCT02931552|Peer support counselor|peer support counselor
56596|NCT02931552|Spanish speaking|spanish speaking
56597|NCT02931552|Community based|community based
56598|NCT02931552|Rural|rural
56599|NCT02931526|Tigecycline|tigecycline
583415|NCT00511641|Questionnaire|questionnaire
56600|NCT02931526|Continuous Renal Replacement Therapy|continuous renal replacement therapy
56601|NCT02931526|Pharmacokinetics|pharmacokinetics
56602|NCT02931500|machine learning|machine learning
56603|NCT02931500|cohort study|cohort study
56604|NCT02931474|Growth Hormone|growth hormone
56605|NCT02931474|Traumatic Brain Injury|traumatic brain injury
56606|NCT02931474|Insomnia|insomnia
56607|NCT02931474|Polysomnography|polysomnography
56608|NCT02931474|NREM Sleep|nrem sleep
56609|NCT02931461|endobronchial transbronchial needle aspiration lung cancer procore|endobronchial transbronchial needle aspiration lung cancer procore
56610|NCT02931448|Device assessment|device assessment
56611|NCT02931435|Genicular Radiofrequency Ablation|genicular radiofrequency ablation
56612|NCT02931435|Knee Arthroplasty, Total|knee arthroplasty, total
56613|NCT02931422|HIV|hiv
56614|NCT02931422|financial incentive|financial incentive
56615|NCT02931422|pediatric HIV testing|pediatric hiv testing
56616|NCT02931409|Positive end-expiratory pressure|positive end-expiratory pressure
56617|NCT02931409|Static pulmonary compliance|static pulmonary compliance
56618|NCT02931409|Lung Protective Ventilation|lung protective ventilation
56619|NCT02931409|Radical cystectomy and urinary diversion|radical cystectomy and urinary diversion
56620|NCT02931409|Postoperative pulmonary complications|postoperative pulmonary complications
56621|NCT02931409|Procalcitonin|procalcitonin
56622|NCT02931383|Liraglutide|liraglutide
56623|NCT02931383|Liraglutide 3 mg|liraglutide 3 mg
56624|NCT02931383|Osteoarthritis|osteoarthritis
56625|NCT02931383|Obesity|obesity
56626|NCT02931383|Ultrasound|ultrasound
56627|NCT02931370|Osteoarthritis|osteoarthritis
56628|NCT02931370|Obesity|obesity
56629|NCT02931370|Ultrasound|ultrasound
56630|NCT02931370|Liraglutide|liraglutide
56631|NCT02931370|Liraglutide 3mg|liraglutide 3mg
56632|NCT02931357|Treatment of teething in infants|treatment of teething in infants
56633|NCT02931344|Osteoarthrtis|osteoarthrtis
56634|NCT02931344|Obesity|obesity
56635|NCT02931344|Liraglutide 3 mg|liraglutide 3 mg
56636|NCT02931344|Liraglutide|liraglutide
56637|NCT02931344|Biomarkers|biomarkers
56638|NCT02931318|Organ donation|organ donation
56639|NCT02931318|brain death|brain death
56640|NCT02931318|public opinion|public opinion
56641|NCT02931305|Epimedium prenylflavonoids|epimedium prenylflavonoids
56642|NCT02931305|Osteoporosis|osteoporosis
56643|NCT02931305|Cardiovascular diseases|cardiovascular diseases
56644|NCT02931305|Phase 1|phase 1
56645|NCT02931305|safety|safety
56646|NCT02931305|tolerability|tolerability
56647|NCT02931292|sleeve gastrectomy|sleeve gastrectomy
56648|NCT02931292|laparoscopy|laparoscopy
56649|NCT02931292|bariatric surgery|bariatric surgery
56650|NCT02931292|obesity surgery|obesity surgery
56651|NCT02931292|metabolic surgery|metabolic surgery
56652|NCT02931214|Healthy Subjects|healthy subjects
56653|NCT02931214|Pharmacokinetics|pharmacokinetics
56654|NCT02931214|Pharmacodynamics|pharmacodynamics
56655|NCT02931201|Positron-Emission Tomography|positron-emission tomography
56656|NCT02931201|Prognosis|prognosis
56657|NCT02931188|Vascular Diseases|vascular diseases
56658|NCT02931188|Lipids|lipids
56659|NCT02931188|Cholesteryl Ester Transfer Protein (CETP) Inhibition|cholesteryl ester transfer protein (cetp) inhibition
56660|NCT02931188|Anacetrapib|anacetrapib
56661|NCT02931188|Cardiovascular Disease|cardiovascular disease
56662|NCT02931188|Cholesterol|cholesterol
56663|NCT02931175|ACTH gel|acth gel
56667|NCT02931175|Intermediate Uveitis|intermediate uveitis
56668|NCT02931175|Pan Uveitis|pan uveitis
56669|NCT02931175|Uveitis|uveitis
56670|NCT02931149|platelet-rich plasma|platelet-rich plasma
56671|NCT02931149|endoscopic mucosal resection|endoscopic mucosal resection
56672|NCT02931149|endoscopic submucosal dissection|endoscopic submucosal dissection
56673|NCT02931110|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
56674|NCT02931110|follicular lymphoma (FL)|follicular lymphoma (fl)
56675|NCT02931110|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
56676|NCT02931110|Hodgkin lymphoma (HL)|hodgkin lymphoma (hl)
56677|NCT02931097|Parkinson's disease|parkinson's disease
56678|NCT02931097|Deep brain stimulation|deep brain stimulation
56679|NCT02931097|Mesencephalic locomotor region|mesencephalic locomotor region
56680|NCT02931058|Knee-extension exercise|knee-extension exercise
56681|NCT02931058|Quadriceps exercise|quadriceps exercise
56682|NCT02931058|Knee osteoarthritis|knee osteoarthritis
56683|NCT02931058|Exercise adherence|exercise adherence
56684|NCT02931058|Dose-response relationship|dose-response relationship
56685|NCT02931058|Prehabilitation|prehabilitation
56686|NCT02931045|extracellular vesicles|extracellular vesicles
56687|NCT02931045|inflammation|inflammation
56688|NCT02931045|thrombosis|thrombosis
56689|NCT02931045|antiplatelet drugs|antiplatelet drugs
56690|NCT02931032|nano receptor|nano receptor
56691|NCT02931032|oral microbiology|oral microbiology
56692|NCT02931032|dental caries|dental caries
56693|NCT02931032|periodontal disease|periodontal disease
56694|NCT02931019|fiberoptic|fiberoptic
56695|NCT02931019|intubation|intubation
56696|NCT02931019|posture|posture
56697|NCT02930954|NSCLC, EGFR, Bim, mutation abundance|nsclc, egfr, bim, mutation abundance
56698|NCT02930941|tranexamic acid|tranexamic acid
56699|NCT02930941|epistaxis|epistaxis
56700|NCT02930941|emergency medicine|emergency medicine
56701|NCT02930941|intranasal|intranasal
56703|NCT02930928|Anaesthesia|anaesthesia
56704|NCT02930928|Anthropometry|anthropometry
56705|NCT02930928|Body weight and measures|body weight and measures
56706|NCT02930928|Development|development
56707|NCT02930928|Emergency treatment|emergency treatment
56708|NCT02930928|Patient safety|patient safety
56709|NCT02930915|Head and Neck Cancer|head and neck cancer
56710|NCT02930915|Radiotherapy|radiotherapy
56711|NCT02930902|Pancreatic Cancer|pancreatic cancer
56712|NCT02930902|Pembrolizumab|pembrolizumab
56713|NCT02930902|MK3475|mk3475
56714|NCT02930902|Paricalcitol|paricalcitol
56715|NCT02930902|Zemplar|zemplar
56716|NCT02930902|Gemcitabine|gemcitabine
56717|NCT02930902|Hydrochloride Gemzar|hydrochloride gemzar
56718|NCT02930902|Nab-paclitaxel|nab-paclitaxel
56719|NCT02930902|Paclitaxel|paclitaxel
56720|NCT02930902|Abraxane|abraxane
56721|NCT02930902|ABI-007|abi-007
56722|NCT02930902|Resectable Pancreatic Cancer|resectable pancreatic cancer
56723|NCT02930889|Therapeutic Embolization|therapeutic embolization
56724|NCT02930889|Prostatic Artery Embolization|prostatic artery embolization
56725|NCT02930876|sarcopenia|sarcopenia
56726|NCT02930876|cancer|cancer
56727|NCT02930876|chemotherapy|chemotherapy
56728|NCT02930876|palliative care|palliative care
56729|NCT02930876|resistance training|resistance training
56730|NCT02929797|pancreatic cancer|pancreatic cancer
56731|NCT02929784|Hemiplegic Shoulder Pain|hemiplegic shoulder pain
56732|NCT02929784|transcranial Direct Current Stimulation|transcranial direct current stimulation
56733|NCT02929784|Stroke|stroke
56734|NCT02929771|Virtual Reality|virtual reality
56735|NCT02929771|Subcutaneous Port Sampling|subcutaneous port sampling
56736|NCT02929771|Pain|pain
56737|NCT02929771|Children|children
56738|NCT02929745|immunology, genetics|immunology, genetics
56739|NCT02929667|Fluoxetine|fluoxetine
56740|NCT02929641|Optical Enhancement technology|optical enhancement technology
56741|NCT02929641|coloractal polyp prediction|coloractal polyp prediction
56742|NCT02930733|Postoperative Analgesia|postoperative analgesia
56743|NCT02930733|Ultrasound guided serratus plane block|ultrasound guided serratus plane block
56744|NCT02930720|TAUS|taus
56745|NCT02930720|breathing protocols and cough|breathing protocols and cough
56746|NCT02930720|pelvic floor displacement|pelvic floor displacement
56747|NCT02930720|women|women
56748|NCT02930720|SUI|sui
56749|NCT02930707|magnesium sulfate|magnesium sulfate
56750|NCT02930707|postoperative pain|postoperative pain
56751|NCT02930707|TAP block|tap block
56758|NCT02930642|Delay discounting|delay discounting
56759|NCT02930629|Recovery Period, Anesthesia|recovery period, anesthesia
56760|NCT02930629|Neuromuscular Monitoring|neuromuscular monitoring
56761|NCT02930603|Developmental Disabilities|developmental disabilities
56762|NCT02930603|Body function and body structure|body function and body structure
56763|NCT02930603|Participation|participation
56764|NCT02930603|Life activities|life activities
56765|NCT02930603|Quality of Life|quality of life
56766|NCT02930577|treatment adherence|treatment adherence
56767|NCT02930577|outpatient treatment|outpatient treatment
56768|NCT02930577|drug dependence|drug dependence
56769|NCT02930525|apnea|apnea
56770|NCT02930525|children|children
56771|NCT02930525|hypercarbia|hypercarbia
56772|NCT02930525|procedural sedation|procedural sedation
56773|NCT02930525|HFNC|hfnc
56774|NCT02930512|Bone mineral density|bone mineral density
56775|NCT02930512|Osteoporosis|osteoporosis
56776|NCT02930512|Parkinson's disease|parkinson's disease
56777|NCT02930512|Bone turnover markers|bone turnover markers
56778|NCT02930486|Syndesmosis|syndesmosis
56779|NCT02930486|Injury|injury
56780|NCT02930486|Ankle|ankle
56781|NCT02930486|Fracture|fracture
56782|NCT02930486|Weber C|weber c
56783|NCT02930473|Psychotherapy|psychotherapy
56784|NCT02930473|Nursing|nursing
56785|NCT02930473|Nursing Care|nursing care
56786|NCT02930473|Nursing Model|nursing model
56787|NCT02930473|Randomised Controlled Trial|randomised controlled trial
56788|NCT02930434|Vitamin D|vitamin d
56789|NCT02930434|cholecalciferol|cholecalciferol
56790|NCT02930434|Antarctica|antarctica
56791|NCT02930434|Chile|chile
56792|NCT02930434|cathelicidin|cathelicidin
56793|NCT02930434|bone metabolism|bone metabolism
56794|NCT02930434|cardiovascular risk|cardiovascular risk
56795|NCT02930421|mild COPD|mild copd
56796|NCT02930421|Exercise training|exercise training
56797|NCT02930421|Six minute walking distance|six minute walking distance
56798|NCT02930421|Quality of life|quality of life
56799|NCT02930421|Saint George Respiratory Questionnaire (SGRQ)|saint george respiratory questionnaire (sgrq)
56800|NCT02930395|Concussion|concussion
56801|NCT02930395|Professional rugby players|professional rugby players
56809|NCT02930304|tennis elbow|tennis elbow
56810|NCT02930304|pain|pain
56811|NCT02930304|shock wave|shock wave
56812|NCT02930304|kinesio taping|kinesio taping
56813|NCT02930252|Self-expandable metal stent|self-expandable metal stent
56814|NCT02930252|strictures|strictures
56815|NCT02930252|biliary|biliary
56816|NCT02930239|ACL-reconstruction|acl-reconstruction
56817|NCT02930239|Gait rehabilitation|gait rehabilitation
56818|NCT02930239|Anti Gravity treadmill|anti gravity treadmill
56819|NCT02930239|ACL-rehabilitation|acl-rehabilitation
56820|NCT02930213|unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
56821|NCT02930213|minimally conscious state|minimally conscious state
56822|NCT02930213|circadian rhythms|circadian rhythms
56823|NCT02930213|free-running period|free-running period
56824|NCT02930200|Smoking Cessation|smoking cessation
56825|NCT02930200|Smartphone Based Smoking Cessation|smartphone based smoking cessation
56826|NCT02930187|Rheumatoid arthritis, remission, ultrasound|rheumatoid arthritis, remission, ultrasound
56827|NCT02930161|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
56828|NCT02930161|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
56829|NCT02930161|Methionine|methionine
56830|NCT02930161|Succinic acid|succinic acid
56831|NCT02930148|mHealth|mhealth
56832|NCT02930148|adolescents|adolescents
56833|NCT02930148|quasi-experimental study|quasi-experimental study
56834|NCT02930148|apps|apps
56835|NCT02930148|lifestyles|lifestyles
56836|NCT02930148|lifestyles knowledge|lifestyles knowledge
56837|NCT02930148|dietary behaviour|dietary behaviour
56838|NCT02930148|physical activity|physical activity
56839|NCT02930148|sleeping behaviour|sleeping behaviour
56840|NCT02930135|Indirect Pulp Capping, Young Permanent Molars|indirect pulp capping, young permanent molars
56841|NCT02930070|sepsis|sepsis
56842|NCT02930070|qSOFA|qsofa
56843|NCT02930070|SOFA|sofa
56844|NCT02930070|diagnostic accuracy|diagnostic accuracy
56845|NCT02930057|lumbar dorsal root ganglion|lumbar dorsal root ganglion
56846|NCT02930057|transforaminal epidural steroid injection|transforaminal epidural steroid injection
56847|NCT02930057|chronic lumbosacral radicular pain|chronic lumbosacral radicular pain
56848|NCT02930057|pulsed radiofrequency treatment|pulsed radiofrequency treatment
56849|NCT02930057|betamethasone|betamethasone
56948|NCT02929212|Glucose|glucose
56850|NCT02930057|dorsal root ganglion|dorsal root ganglion
56851|NCT02930044|Emergency department|emergency department
56852|NCT02930044|Insulin|insulin
56853|NCT02930044|Adult|adult
56854|NCT02930031|muscle injury|muscle injury
56855|NCT02930031|exercise|exercise
56856|NCT02930031|redox status|redox status
56857|NCT02930031|immune cells|immune cells
56858|NCT02930018|Acute Ischemic Stroke|acute ischemic stroke
56859|NCT02930018|Endovascular Thrombectomy|endovascular thrombectomy
56860|NCT02930018|Neuroprotection|neuroprotection
56861|NCT02930018|Tat-NR2B9c|tat-nr2b9c
56862|NCT02930018|NA-1|na-1
56863|NCT02930005|Psychotic|psychotic
56864|NCT02930005|Schizophrenia|schizophrenia
56865|NCT02930005|Schizoaffective|schizoaffective
56866|NCT02930005|Bipolar|bipolar
56867|NCT02929979|PTSD|ptsd
56868|NCT02929979|Alcohol Use Disorder|alcohol use disorder
56869|NCT02929979|Cognitive Training|cognitive training
56870|NCT02929979|Veterans|veterans
56871|NCT02929953|premature birth|premature birth
56872|NCT02929953|risk factor|risk factor
56873|NCT02929953|type 1 diabetes mellitus|type 1 diabetes mellitus
56874|NCT02929953|seasonality|seasonality
56875|NCT02929953|prevalence|prevalence
56876|NCT02929953|enteral feeding|enteral feeding
56877|NCT02929953|immunomodulating medications|immunomodulating medications
56878|NCT02929953|early onset|early onset
56880|NCT02929914|Carious dentin|carious dentin
56881|NCT02929914|Photodynamic Therapy|photodynamic therapy
56882|NCT02929888|ST-segment elevacion myocardial infarction, platelets|st-segment elevacion myocardial infarction, platelets
56883|NCT02929836|Ablation Linear Lesions|ablation linear lesions
56884|NCT02929602|prescribing|prescribing
56885|NCT02929602|effectiveness|effectiveness
56886|NCT02929602|dental|dental
56887|NCT02929602|opioid|opioid
56888|NCT02929602|analgesic|analgesic
56889|NCT02929576|metastatic|metastatic
56890|NCT02929576|triple negative|triple negative
56891|NCT02929550|Cardiovascular disease|cardiovascular disease
56892|NCT02929550|Costs|costs
56893|NCT02929550|Guidelines|guidelines
56894|NCT02929550|Lipids|lipids
56895|NCT02929550|Myocardial infarction|myocardial infarction
56896|NCT02929537|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
56897|NCT02929537|registration research|registration research
56898|NCT02929537|Medicine, Chinese Traditional|medicine, chinese traditional
56899|NCT02929524|Ketamine|ketamine
56900|NCT02929524|Intranasal administration|intranasal administration
56901|NCT02929524|Pediatric nursing|pediatric nursing
56902|NCT02929498|GSK2879552|gsk2879552
56903|NCT02929498|Revised International Prognostic Scoring System (IPSS-R)|revised international prognostic scoring system (ipss-r)
56904|NCT02929498|azacitidine|azacitidine
56905|NCT02929498|hypomethylating agents|hypomethylating agents
56906|NCT02929498|myelodysplastic syndrome|myelodysplastic syndrome
56907|NCT02929472|Physical Activity|physical activity
56908|NCT02929472|Physical Fitness|physical fitness
56909|NCT02929472|Intervention|intervention
56910|NCT02929472|Children and Adolescents|children and adolescents
56911|NCT02929459|Gut Microbiota|gut microbiota
56912|NCT02929459|Riboflavin|riboflavin
56913|NCT02929459|Vitamin B2|vitamin b2
56914|NCT02929459|oGTT|ogtt
56915|NCT02929459|Faecalibacterium prausnitzii|faecalibacterium prausnitzii
56916|NCT02929446|mobilisation|mobilisation
56917|NCT02929446|physiotherapy|physiotherapy
56918|NCT02929433|disability|disability
56919|NCT02929433|pain|pain
56920|NCT02929433|Rotator Cuff Tear|rotator cuff tear
56921|NCT02929433|rehabilitation|rehabilitation
56922|NCT02929433|range of motion (ROM)|range of motion (rom)
56923|NCT02929420|Multicenter|multicenter
56924|NCT02929420|randomized|randomized
56925|NCT02929420|open|open
56926|NCT02929420|parallel controlled|parallel controlled
56927|NCT02929394|Histologically proven locally advanced or metastatic high grade STS (excluding histologies insensitive to chemotherapy such as ASPS, PECOMA subtypes)|histologically proven locally advanced or metastatic high grade sts (excluding histologies insensitive to chemotherapy such as asps, pecoma subtypes)
56928|NCT02929381|Narrow Band Imaging|narrow band imaging
56929|NCT02929381|Colorectal Cancer Screening|colorectal cancer screening
56930|NCT02929381|Colonoscopy|colonoscopy
56931|NCT02929381|Responsive Insertion Technology|responsive insertion technology
56932|NCT02929381|Near Focus|near focus
56933|NCT02929368|PICC-Line|picc-line
56934|NCT02929355|Carotid atherosclerosis|carotid atherosclerosis
56935|NCT02929355|duplex ultrasonography|duplex ultrasonography
56936|NCT02929355|diabetes|diabetes
56937|NCT02929355|vascular events|vascular events
56938|NCT02929277|farm children|farm children
56939|NCT02929277|non-farm children|non-farm children
56940|NCT02929264|Healthy volunteer|healthy volunteer
56941|NCT02929264|Experimental hyperalgesia|experimental hyperalgesia
56942|NCT02929264|fMRI|fmri
56943|NCT02929225|bacterial translocation;micro-inflammation;hemodialysis|bacterial translocation;micro-inflammation;hemodialysis
56944|NCT02929212|Gastric Bypass|gastric bypass
56945|NCT02929212|Meal Texture|meal texture
56946|NCT02929212|Meal Number|meal number
56947|NCT02929212|GLP-1|glp-1
56949|NCT02929134|Lymphedema|lymphedema
56950|NCT02929134|Lymphatic Filariasis|lymphatic filariasis
56951|NCT02929134|Filariasis|filariasis
56952|NCT02929134|Doxycycline|doxycycline
56953|NCT02929121|Lymphedema|lymphedema
56954|NCT02929121|Lymphatic Filariasis|lymphatic filariasis
56955|NCT02929121|Filariasis|filariasis
56956|NCT02929121|Doxycycline|doxycycline
56957|NCT02929108|hospice|hospice
56958|NCT02929108|caregiver|caregiver
56959|NCT02929082|magnetic resonance force|magnetic resonance force
56960|NCT02929069|Minority Stress|minority stress
56961|NCT02929017|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
56962|NCT02929017|Fibrosis|fibrosis
56964|NCT02929017|Caregivers|caregivers
56965|NCT02929017|Pulmonary|pulmonary
56966|NCT02929017|Palliative|palliative
56967|NCT02929017|end of life|end of life
56968|NCT02929017|Idiopathic|idiopathic
56969|NCT02929004|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
56986|NCT02928965|psychosis|psychosis
56987|NCT02928965|schizophrenia|schizophrenia
56988|NCT02928965|negative symptoms|negative symptoms
56989|NCT02928965|minocycline|minocycline
56990|NCT02928952|Mindfulness|mindfulness
56991|NCT02928939|multimorbidity|multimorbidity
56992|NCT02928939|multiple chronic conditions|multiple chronic conditions
56993|NCT02928939|drug-drug interactions|drug-drug interactions
56994|NCT02928939|drug-disease interactions|drug-disease interactions
56995|NCT02928939|polypharmacy|polypharmacy
56996|NCT02928939|Oral anticoagulants|oral anticoagulants
56997|NCT02928939|Steroids|steroids
56998|NCT02928913|sedentary|sedentary
56999|NCT02928913|non-sedentary|non-sedentary
57000|NCT02928913|populations|populations
57001|NCT02928900|Adolescents|adolescents
57002|NCT02928900|Clinical training|clinical training
57003|NCT02928900|HIV care and treatment|hiv care and treatment
57004|NCT02928900|Africa|africa
57005|NCT02928861|Positron-Emission Tomography|positron-emission tomography
57006|NCT02928861|Prognosis|prognosis
57007|NCT02928835|Total knee arthroplasty|total knee arthroplasty
57008|NCT02928835|Knee flexion|knee flexion
57009|NCT02928835|Dynamic orthosis|dynamic orthosis
57010|NCT02928822|stroke|stroke
57011|NCT02928822|broca's aphasia|broca's aphasia
57012|NCT02928822|priming|priming
57013|NCT02928822|Intensive language-action therapy|intensive language-action therapy
57014|NCT02928822|Rehabilitation gaming system|rehabilitation gaming system
57015|NCT02928809|temporomandibular joint|temporomandibular joint
57016|NCT02928809|temporomandibular disorder|temporomandibular disorder
57017|NCT02928809|muscle fatigue|muscle fatigue
57018|NCT02928809|low-level laser therapy|low-level laser therapy
57019|NCT02928796|Attentional capacity|attentional capacity
57020|NCT02928796|Working memory|working memory
57021|NCT02928796|Simulation-based training|simulation-based training
57022|NCT02928796|Eye-tracking|eye-tracking
57023|NCT02928796|Visual attention|visual attention
57024|NCT02928796|Psychophysiological measurement|psychophysiological measurement
57025|NCT02928796|Surgical simulation|surgical simulation
57026|NCT02928796|Computer-based simulation|computer-based simulation
57027|NCT02928783|Home-based cardiac rehabilitation|home-based cardiac rehabilitation
57028|NCT02928783|Quality of Medical Care|quality of medical care
57029|NCT02928783|Heart Failure|heart failure
57030|NCT02928757|Care coordination|care coordination
57031|NCT02928757|Complex care kids Ontario|complex care kids ontario
57032|NCT02928757|Technology-dependent|technology-dependent
57033|NCT02928757|Quality of life|quality of life
57034|NCT02928744|Resistance|resistance
57035|NCT02928744|Forced oscillations|forced oscillations
57036|NCT02928744|Dyspnea|dyspnea
57037|NCT02928731|Cancer|cancer
57038|NCT02928731|Quality of life|quality of life
57039|NCT02928731|Child|child
57040|NCT02928718|Post-ERCP pancreatitis|post-ercp pancreatitis
57041|NCT02928718|Genetic variation|genetic variation
57042|NCT02928705|analgesia|analgesia
57043|NCT02928705|prehospital|prehospital
57044|NCT02928705|telemedicine|telemedicine
57045|NCT02928705|ambulance|ambulance
57046|NCT02928705|opioids|opioids
57047|NCT02928705|teleconsultation|teleconsultation
57048|NCT02928705|tele-emergency medical services|tele-emergency medical services
57049|NCT02928705|adverse events|adverse events
57050|NCT02928705|prehospital emergency medical service physician|prehospital emergency medical service physician
57051|NCT02928692|Minocycline|minocycline
57052|NCT02928692|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
57053|NCT02928692|Postoperative delirium|postoperative delirium
57054|NCT02928679|Magnetic resonance imaging|magnetic resonance imaging
57055|NCT02928679|Dynamic contrast enhanced MRI|dynamic contrast enhanced mri
57056|NCT02928679|Liraglutide 3 mg|liraglutide 3 mg
57057|NCT02928679|Liraglutide|liraglutide
57058|NCT02928679|Obesity|obesity
57059|NCT02928679|Osteoarthritis|osteoarthritis
57060|NCT02928666|decision-support|decision-support
57061|NCT02928666|ontology|ontology
57062|NCT02928666|computer-interpretable guidelines|computer-interpretable guidelines
57063|NCT02928666|comorbidities|comorbidities
57064|NCT02928653|energy intake|energy intake
57065|NCT02928653|energy expenditure|energy expenditure
57066|NCT02928653|appetite|appetite
57067|NCT02928614|Osteoarthritis|osteoarthritis
57068|NCT02928614|Obesity|obesity
57069|NCT02928614|Liraglutide 3 mg|liraglutide 3 mg
57070|NCT02928614|Liraglutide|liraglutide
57071|NCT02928614|Biomarkers|biomarkers
57072|NCT02928575|Glioblastoma|glioblastoma
57073|NCT02928575|Sunitinib|sunitinib
57074|NCT02928575|Temozolomide|temozolomide
57075|NCT02928575|Radiation Therapy,|radiation therapy,
57076|NCT02928575|MGMT|mgmt
57077|NCT02928575|Biomarkers|biomarkers
57078|NCT02928549|interviews|interviews
57079|NCT02928549|16-1378|16-1378
57080|NCT02928523|Autologous Fecal Microbiota Transplantation|autologous fecal microbiota transplantation
57081|NCT02928497|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
57082|NCT02928497|Left atrial appendage|left atrial appendage
57083|NCT02928484|Functional dyspepsia|functional dyspepsia
57084|NCT02928484|Abdominal pain|abdominal pain
57085|NCT02928484|Flatulence|flatulence
57086|NCT02928484|Probiotics|probiotics
57087|NCT02928484|Bifidobacterium|bifidobacterium
57088|NCT02928484|Lactobacillus|lactobacillus
57089|NCT02928471|Liraglutide|liraglutide
57090|NCT02928471|Liraglutide 3 mg|liraglutide 3 mg
57091|NCT02928471|Osteoarthritis|osteoarthritis
57092|NCT02928471|Obesity|obesity
57093|NCT02928471|Magnetic resonance imaging|magnetic resonance imaging
57094|NCT02928471|Computed tomography|computed tomography
57097|NCT02928445|dementia|dementia
57098|NCT02928445|RVT-101|rvt-101
57099|NCT02928445|intepirdine|intepirdine
57100|NCT02928445|Lewy bodies|lewy bodies
57101|NCT02928432|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
57102|NCT02928432|Abiraterone acetate|abiraterone acetate
57103|NCT02928432|Steroids Switch|steroids switch
57104|NCT02928354|Asthma|asthma
57105|NCT02928354|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
57106|NCT02928354|Healthy volunteers|healthy volunteers
57107|NCT02928354|Pharmacokinetics (PK)|pharmacokinetics (pk)
57108|NCT02928354|Bioavailability|bioavailability
57109|NCT02928354|AZD7594|azd7594
57110|NCT02928354|Safety|safety
57111|NCT02928354|Tolerability|tolerability
57112|NCT02928328|craniofacial pain|craniofacial pain
57113|NCT02928328|masticatory muscle|masticatory muscle
57114|NCT02928328|burning mouth syndrome|burning mouth syndrome
57115|NCT02928328|temporomandibular disorders|temporomandibular disorders
57116|NCT02928276|Rheumakit|rheumakit
57117|NCT02928276|Rheumatoid Arthritis|rheumatoid arthritis
57118|NCT02928276|anti-TNF|anti-tnf
57119|NCT02928237|tDCS|tdcs
57120|NCT02928237|cancer liver|cancer liver
57121|NCT02928237|chronic abdominal pain|chronic abdominal pain
57123|NCT02928237|VDS|vds
57124|NCT02928237|HAM-D|ham-d
57125|NCT02928237|BPI|bpi
57126|NCT02928237|analgesia|analgesia
57127|NCT02928224|Colorectal cancer|colorectal cancer
57128|NCT02928224|BRAF|braf
57129|NCT02928224|BRAFV600E|brafv600e
57130|NCT02928198|Tomography, Optical Coherence|tomography, optical coherence
57131|NCT02928198|Percutaneous Coronary Intervention|percutaneous coronary intervention
57132|NCT02928198|Cardiac Catheterization|cardiac catheterization
57133|NCT02928198|Coronary Biovascular Scaffold|coronary biovascular scaffold
57134|NCT02928185|training manuals|training manuals
57135|NCT02928185|patients and caregivers|patients and caregivers
57136|NCT02928185|16-1334|16-1334
57137|NCT02928172|q-CON|q-con
57138|NCT02928172|q-NOX|q-nox
57139|NCT02928172|BIS|bis
57140|NCT02928172|Electroencephalograms (EEG)|electroencephalograms (eeg)
57141|NCT02928172|Laryngeal Mask Airway (LMA)|laryngeal mask airway (lma)
57142|NCT02928172|Sedation|sedation
57143|NCT02928172|General Anesthesia|general anesthesia
57144|NCT02928159|Low Pulse Amplitude Seizure Therapy|low pulse amplitude seizure therapy
57145|NCT02928159|Electroconvulsive Therapy|electroconvulsive therapy
57146|NCT02928159|Low Pulse Amplitude Electroconvulsive Therapy|low pulse amplitude electroconvulsive therapy
57147|NCT02928159|Low Pulse Amplitude ECT|low pulse amplitude ect
57148|NCT02928159|LAP|lap
57149|NCT02928159|LAP-ST|lap-st
57150|NCT02928159|ECT|ect
57151|NCT02928159|Mood disorders|mood disorders
57152|NCT02928159|Psychotic disorders|psychotic disorders
57153|NCT02928146|TAPP|tapp
57154|NCT02928146|TEP|tep
57155|NCT02928146|Lichtenstein|lichtenstein
57157|NCT02928146|hernioplasty|hernioplasty
57158|NCT02928133|Non-vitamin K antagonist oral anticoagulant (NOAC)|non-vitamin k antagonist oral anticoagulant (noac)
57159|NCT02928133|Congenital heart disease|congenital heart disease
57160|NCT02928133|Atrial fibrillation|atrial fibrillation
57161|NCT02928133|Atrial tachyarrhythmia|atrial tachyarrhythmia
57162|NCT02928133|Thromboembolism|thromboembolism
57163|NCT02928094|refractory angina|refractory angina
57164|NCT02928094|myocardial ischemia|myocardial ischemia
57165|NCT02928094|angiogenesis|angiogenesis
57166|NCT02928068|telehealth|telehealth
57167|NCT02928055|Stroke|stroke
57168|NCT02928055|Shoulder Pain|shoulder pain
57169|NCT02928055|Electrical stimulation|electrical stimulation
57170|NCT02928055|Neuromuscular stimulation|neuromuscular stimulation
57171|NCT02928055|Intramuscular stimulation|intramuscular stimulation
57172|NCT02928029|Radium-223 dichloride|radium-223 dichloride
57173|NCT02928029|bortezomib|bortezomib
57174|NCT02928029|dexamethasone|dexamethasone
57175|NCT02928029|early relapsed multiple myeloma|early relapsed multiple myeloma
402909|NCT01229189|Effectiveness|effectiveness
57176|NCT02928029|combination therapy multiple myeloma|combination therapy multiple myeloma
57177|NCT02928016|carbohydrate counting method|carbohydrate counting method
57178|NCT02928016|protein|protein
57179|NCT02928016|fat|fat
57180|NCT02928016|glucose|glucose
57181|NCT02928016|type 1 diabetes|type 1 diabetes
57182|NCT02928003|Lung surgery|lung surgery
57183|NCT02927977|dry needling|dry needling
57184|NCT02927977|exercise|exercise
57185|NCT02927977|manual therapy|manual therapy
57186|NCT02927951|Diabetes Mellitus|diabetes mellitus
57187|NCT02927951|Peripheral Neuropathy|peripheral neuropathy
57188|NCT02927951|Diabetic Pain|diabetic pain
57189|NCT02927899|Tomato-Soy-Arugula|tomato-soy-arugula
57199|NCT02927821|Adult Day Care Centers|adult day care centers
57201|NCT02927808|Motivational Interviewing|motivational interviewing
57202|NCT02927808|LDL-C|ldl-c
57203|NCT02927808|LDL target|ldl target
57204|NCT02927808|Medication adherence|medication adherence
57205|NCT02927782|Cerebrospinal Fluid Leak|cerebrospinal fluid leak
57206|NCT02927782|Lumbar|lumbar
57207|NCT02927756|Non-Hodgkin Lymphoma Transformed Recurrent|non-hodgkin lymphoma transformed recurrent
57208|NCT02927756|Discordant Lymphomas|discordant lymphomas
57209|NCT02927756|Composite Lymphomas|composite lymphomas
57210|NCT02927756|Follicular Lymphoma|follicular lymphoma
57211|NCT02927756|Aggressive Lymphoma|aggressive lymphoma
57212|NCT02927730|Retained placenta, surgical hysteroscopy, residua|retained placenta, surgical hysteroscopy, residua
57213|NCT02927717|Grade 3b Follicular Lymphoma|grade 3b follicular lymphoma
57214|NCT02927717|2016 WHO Criteria|2016 who criteria
57215|NCT02927717|Front-line treatment|front-line treatment
57216|NCT02927717|Rituximab|rituximab
57217|NCT02927704|Aggressive Periodontitis|aggressive periodontitis
57218|NCT02927704|monocyte chemoattractant protein-1|monocyte chemoattractant protein-1
57219|NCT02927704|gingival crevicular fluid|gingival crevicular fluid
57220|NCT02927704|enzyme-linked immunosorbent assay|enzyme-linked immunosorbent assay
57221|NCT02927691|Rehabilitation|rehabilitation
57222|NCT02927691|Parkinson's disease|parkinson's disease
57223|NCT02927691|Swallowing|swallowing
57224|NCT02927691|Cough|cough
57225|NCT02927691|Dysphagia|dysphagia
57226|NCT02927691|Dystussia|dystussia
57227|NCT02927678|Diabetic foot|diabetic foot
57228|NCT02927678|Osteomyelitis|osteomyelitis
57229|NCT02927678|Antibiotic treatment|antibiotic treatment
57230|NCT02927678|White Blood Cell SPECT/CT|white blood cell spect/ct
57231|NCT02927665|Weight Loss|weight loss
57232|NCT02927613|Home mechanical ventilation|home mechanical ventilation
57233|NCT02927613|Mortality|mortality
57234|NCT02927613|Complications|complications
57235|NCT02927613|Developing country|developing country
57236|NCT02927600|Glycemic response|glycemic response
57237|NCT02927600|Glycemic index|glycemic index
57238|NCT02927600|Meal intervention|meal intervention
57239|NCT02927600|Chinese population|chinese population
57240|NCT02927587|TCI|tci
57241|NCT02927587|fiberoptic bronchoscopy|fiberoptic bronchoscopy
57242|NCT02927587|sedation|sedation
57243|NCT02927574|drug-coated balloon angioplasty|drug-coated balloon angioplasty
57244|NCT02927574|angioplasty|angioplasty
57245|NCT02927574|plain old balloon angioplasty|plain old balloon angioplasty
57246|NCT02927574|peripheral arterial disease|peripheral arterial disease
57247|NCT02927574|intermittent claudication|intermittent claudication
57253|NCT02927522|Hip replacement|hip replacement
57254|NCT02927522|Knee replacement|knee replacement
57255|NCT02927496|Lymphedema|lymphedema
57256|NCT02927496|Lymphatic Filariasis|lymphatic filariasis
57257|NCT02927496|Filariasis|filariasis
57258|NCT02927496|Doxycycline|doxycycline
57259|NCT02927483|Venous Insufficiency|venous insufficiency
57260|NCT02927470|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
57261|NCT02927457|Cutaneous Lupus Erythematosus-CLE|cutaneous lupus erythematosus-cle
57262|NCT02927457|Spleen Tyrosine Kinase-SYK|spleen tyrosine kinase-syk
57263|NCT02927457|Photoprovocation-PV|photoprovocation-pv
57264|NCT02927457|GSK2646264|gsk2646264
57265|NCT02927431|Anti-inflammatory|anti-inflammatory
57267|NCT02927431|Influenza|influenza
57268|NCT02927431|Hospitalized patients|hospitalized patients
57269|NCT02927405|gabapentin|gabapentin
57270|NCT02927405|TAP block|tap block
57271|NCT02927366|Pulmonary hypertension (PH),|pulmonary hypertension (ph),
57272|NCT02927366|Increase blood pressure in the pulmonary artery|increase blood pressure in the pulmonary artery
57273|NCT02927366|Increased blood pressure in the pulmonary vein|increased blood pressure in the pulmonary vein
57274|NCT02927366|Increased blood pressure in the lung vasculature|increased blood pressure in the lung vasculature
57275|NCT02927366|Shortness of breath|shortness of breath
57276|NCT02927366|Dizziness|dizziness
57277|NCT02927366|Fainting|fainting
57278|NCT02927366|Leg swelling|leg swelling
57279|NCT02927366|Cough|cough
57280|NCT02927366|Angina pector|angina pector
57281|NCT02927353|Bioequivalence, Biosimilarity, Pharmacokinetics, adalimumab|bioequivalence, biosimilarity, pharmacokinetics, adalimumab
57282|NCT02927340|Lung Cancer|lung cancer
57283|NCT02927288|PTSD, mTBI|ptsd, mtbi
57284|NCT02927262|Acute myeloid leukemia|acute myeloid leukemia
57285|NCT02927262|First Complete Remission|first complete remission
57286|NCT02927262|FLT3/ITD|flt3/itd
57287|NCT02927262|AML|aml
57288|NCT02927262|ASP2215|asp2215
57289|NCT02927236|Non-Invasive Brain Stimulation|non-invasive brain stimulation
583416|NCT00511641|Screening|screening
583417|NCT00511641|Survey|survey
57294|NCT02927210|Dimethandrolone|dimethandrolone
57300|NCT02927132|Drinking, Alcohol|drinking, alcohol
57301|NCT02927119|thyroglobulin|thyroglobulin
57302|NCT02927119|iodine|iodine
57303|NCT02927119|pregnancy|pregnancy
57304|NCT02927106|leukemia|leukemia
57305|NCT02927106|myeloid|myeloid
57306|NCT02927106|genomics|genomics
57307|NCT02927080|FSHD|fshd
57308|NCT02927041|hemodynamic transesophageal echocardiography|hemodynamic transesophageal echocardiography
57309|NCT02927028|energy availability|energy availability
57310|NCT02927028|walnuts|walnuts
57311|NCT02926989|Isotonic|isotonic
57312|NCT02926989|Hypotonic|hypotonic
57313|NCT02926989|Intravenous fluids|intravenous fluids
57314|NCT02926976|Schizophrenia|schizophrenia
57315|NCT02926963|Chronic Granulomatous Disease, Nox2, p22phox, iPS cells|chronic granulomatous disease, nox2, p22phox, ips cells
57316|NCT02926911|Ductal Carcinoma|ductal carcinoma
57322|NCT02926885|liver|liver
57323|NCT02926885|laparoscopy|laparoscopy
57324|NCT02926885|Bariatric Surgery|bariatric surgery
57325|NCT02926885|Esophagogastric Junction|esophagogastric junction
57326|NCT02926885|obesity|obesity
57327|NCT02926872|Screening|screening
57328|NCT02926872|Hepatic Injury|hepatic injury
57329|NCT02926872|Pediatric Patients|pediatric patients
57330|NCT02926846|Peritoneal dialysis|peritoneal dialysis
57331|NCT02926846|Lavage|lavage
57332|NCT02926820|Huntington disease|huntington disease
57333|NCT02926820|cognitive rehabilitation|cognitive rehabilitation
57334|NCT02926820|cognitive dysfunction|cognitive dysfunction
57335|NCT02926807|Atopic Dermatitis|atopic dermatitis
57336|NCT02926807|Vascular Inflammation|vascular inflammation
57337|NCT02926807|Coronary Atherosclerosis|coronary atherosclerosis
57338|NCT02926807|Ascending aorta|ascending aorta
57339|NCT02926807|Pet scan|pet scan
57340|NCT02926768|Cancer|cancer
57341|NCT02926768|Non Small Cell Lung Cancer|non small cell lung cancer
57342|NCT02926768|EGFR sensitivity mutation|egfr sensitivity mutation
57343|NCT02926768|T790M|t790m
57344|NCT02926768|NSCLC|nsclc
57345|NCT02926768|epidermal growth factor receptor|epidermal growth factor receptor
57346|NCT02926768|EGFR|egfr
57347|NCT02926768|EGFR inhibitor|egfr inhibitor
57348|NCT02926768|Solid Tumors|solid tumors
57349|NCT02926755|Intra Venous Ultrasound (IVUS)|intra venous ultrasound (ivus)
57350|NCT02926755|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
57351|NCT02926755|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
57352|NCT02926755|Acute Myocardial Infarction|acute myocardial infarction
57353|NCT02926755|Coronary Artery Disease (CAD)|coronary artery disease (cad)
57354|NCT02926755|Angiography|angiography
57355|NCT02926742|Thrombolysis|thrombolysis
57356|NCT02926742|Ultrasound Thrombolysis|ultrasound thrombolysis
57357|NCT02926742|Pulmonary Embolism|pulmonary embolism
57358|NCT02926742|Saddle PE|saddle pe
57359|NCT02926742|Submassive PE|submassive pe
57360|NCT02926742|Massive PE|massive pe
57361|NCT02926742|Bilateral PE|bilateral pe
57362|NCT02926729|Breast Cancer|breast cancer
57363|NCT02926716|Stomach neoplasm|stomach neoplasm
57364|NCT02926716|Endoscopy|endoscopy
57365|NCT02926716|Narrow band imaging|narrow band imaging
57366|NCT02926703|seizure|seizure
57367|NCT02926703|lactate|lactate
57368|NCT02926703|creatine kinase|creatine kinase
57369|NCT02926677|PTSD|ptsd
57370|NCT02926677|Child Trauma|child trauma
57371|NCT02926677|Cue-Centered Treatment|cue-centered treatment
57372|NCT02926677|Trauma-Focused Cognitive-Behavioral Therapy|trauma-focused cognitive-behavioral therapy
57373|NCT02926677|fNIRs|fnirs
57374|NCT02926677|CCT|cct
57375|NCT02926677|TF-CBT|tf-cbt
57376|NCT02926677|Posttraumatic stress|posttraumatic stress
57377|NCT02926677|NIRX|nirx
57378|NCT02926625|Unspecific fever|unspecific fever
57379|NCT02926625|Ethiopia|ethiopia
57380|NCT02926625|iCCM|iccm
57381|NCT02926625|CHW|chw
57382|NCT02926625|HEW|hew
57383|NCT02926599|High Fidelity Simulation|high fidelity simulation
57384|NCT02926586|RUNX1-RUNX1T1|runx1-runx1t1
57385|NCT02926586|CBFβ-MYH11|cbfβ-myh11
57386|NCT02926586|fludarabine|fludarabine
57387|NCT02926586|cytarabine|cytarabine
57388|NCT02926573|oral cavity|oral cavity
57389|NCT02926573|oropharynx|oropharynx
57390|NCT02926573|hypopharynx and larynx|hypopharynx and larynx
57391|NCT02926560|Chronic inflammatory rheumatism|chronic inflammatory rheumatism
57392|NCT02926547|proteomics|proteomics
57393|NCT02926534|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
57394|NCT02926534|smoking|smoking
57395|NCT02926534|prevalence|prevalence
57396|NCT02926534|cross-sectional study|cross-sectional study
57397|NCT02926534|Kazakhstan|kazakhstan
48852|NCT02979834|maternal education|maternal education
48853|NCT02979821|pan-HER inhibitor|pan-her inhibitor
48854|NCT02979782|cardiac surgery|cardiac surgery
48855|NCT02979782|neurological outcome|neurological outcome
57398|NCT02926521|nerve block catheter|nerve block catheter
57399|NCT02926521|catheter fixation|catheter fixation
57400|NCT02926521|catheter dressing|catheter dressing
57401|NCT02926508|Reading|reading
57402|NCT02926508|Learning|learning
57403|NCT02926508|Cognition|cognition
57404|NCT02926482|Evidence-based practice implementation|evidence-based practice implementation
57405|NCT02926482|Buprenorphine|buprenorphine
57406|NCT02926482|Addiction treatment|addiction treatment
57407|NCT02926469|Virtual Reality|virtual reality
57408|NCT02926469|Analgesia|analgesia
57409|NCT02926469|Immersive Virtual Reality|immersive virtual reality
57410|NCT02926469|VR|vr
57411|NCT02926469|Labor|labor
57412|NCT02926469|Pain|pain
57413|NCT02926443|Shoulder|shoulder
57414|NCT02926443|Motor control|motor control
57415|NCT02926443|Proprioception|proprioception
57416|NCT02926443|Usual physiotherapy care|usual physiotherapy care
57417|NCT02926443|Supervised exercise program|supervised exercise program
57418|NCT02926404|Sagittal alignment|sagittal alignment
57419|NCT02926404|Surgical planning|surgical planning
57420|NCT02926404|Patient-specific|patient-specific
57421|NCT02926404|Adult Spinal Deformity|adult spinal deformity
57422|NCT02926352|LLLT|lllt
57423|NCT02926352|LLLS|llls
57424|NCT02926352|Low-Level Laser Stimulation|low-level laser stimulation
57425|NCT02926352|Low-Level Laser Therapy|low-level laser therapy
57426|NCT02926352|Low-Level Light Therapy|low-level light therapy
57427|NCT02926352|Transcranial infrared light stimulation|transcranial infrared light stimulation
57428|NCT02926352|Near-infrared light|near-infrared light
57429|NCT02926352|Photobiomodulation|photobiomodulation
57430|NCT02926352|Fear Extinction|fear extinction
57431|NCT02926352|Exposure Therapy|exposure therapy
57432|NCT02926352|Claustrophobia|claustrophobia
57433|NCT02926352|Fear of enclosed spaces|fear of enclosed spaces
57434|NCT02926352|Fear of contamination|fear of contamination
57435|NCT02926352|Fear of public speaking|fear of public speaking
57436|NCT02926352|Anxiety sensitivity|anxiety sensitivity
57437|NCT02926352|Cytochrome oxidase|cytochrome oxidase
57438|NCT02926352|Memory consolidation|memory consolidation
57439|NCT02926352|Cognitive enhancer|cognitive enhancer
57440|NCT02926326|Healthy Male volunteers|healthy male volunteers
57441|NCT02926313|RCT|rct
57442|NCT02926313|Specialized seating|specialized seating
57443|NCT02926313|Pressure ulcers|pressure ulcers
57444|NCT02926300|crohn's disease|crohn's disease
57445|NCT02926300|stem cell therapy|stem cell therapy
57446|NCT02926300|inflammatory bowel disease|inflammatory bowel disease
57447|NCT02926300|hUCB-MSC|hucb-msc
57449|NCT02926300|Umbilical cord Blood|umbilical cord blood
57450|NCT02926287|prolapse surgery|prolapse surgery
57451|NCT02926287|ambulatory surgery|ambulatory surgery
57452|NCT02926274|whole blood|whole blood
57453|NCT02926274|trauma|trauma
57454|NCT02926274|transfusion|transfusion
57455|NCT02926274|coagulopathy|coagulopathy
57456|NCT02926248|Arthrofibrosis|arthrofibrosis
57457|NCT02926235|Total Knee Arthroplasty|total knee arthroplasty
57458|NCT02926209|colonoscopy|colonoscopy
57459|NCT02926209|adenoma|adenoma
57460|NCT02926209|polyp|polyp
57461|NCT02926209|crc screening|crc screening
57462|NCT02926196|ER-Negative|er-negative
57463|NCT02926196|PR-Negative|pr-negative
57464|NCT02926196|HER2-Negative|her2-negative
57465|NCT02926144|Intratracheal intubation|intratracheal intubation
57466|NCT02926144|videolaryngoscope|videolaryngoscope
57467|NCT02926144|McGrath MAC|mcgrath mac
57468|NCT02926131|stick test|stick test
57469|NCT02926118|Glucose|glucose
57470|NCT02926118|Continuous glucose monitor|continuous glucose monitor
57471|NCT02926118|Glycemic load|glycemic load
57472|NCT02926118|Dietary intervention|dietary intervention
57473|NCT02926066|Aromatic L-amino acid decarboxylase (AADC)|aromatic l-amino acid decarboxylase (aadc)
57474|NCT02926014|Dysphagia|dysphagia
57475|NCT02926014|Lingual Tonsil Hypertrophy|lingual tonsil hypertrophy
57476|NCT02926014|Lingual Tonsil Enlargement|lingual tonsil enlargement
57477|NCT02926001|Taxes|taxes
57478|NCT02926001|Beverages/economics|beverages/economics
57479|NCT02926001|Carbonated Beverages/economics|carbonated beverages/economics
57480|NCT02926001|Diet, Food and Nutrition/economics|diet, food and nutrition/economics
57481|NCT02926001|Economics|economics
57482|NCT02926001|Energy Intake|energy intake
57483|NCT02926001|Risk Factors|risk factors
57484|NCT02925988|Critically ill|critically ill
57485|NCT02925988|High risk neonates|high risk neonates
57486|NCT02925949|Treatment|treatment
57487|NCT02925949|Adherence|adherence
57488|NCT02925949|Intervention|intervention
57489|NCT02925949|MSM Couples|msm couples
57490|NCT02925936|Radiography|radiography
57491|NCT02925936|Radiation|radiation
57492|NCT02925936|Diagnostic imaging|diagnostic imaging
57493|NCT02925871|stroke|stroke
57494|NCT02925871|rehabilitation|rehabilitation
57495|NCT02925871|interdisciplinary health team|interdisciplinary health team
57496|NCT02925871|patient-centered care|patient-centered care
57497|NCT02925871|care transition|care transition
57498|NCT02925858|Ketamine|ketamine
57499|NCT02925858|Cardiac surgery|cardiac surgery
57500|NCT02925858|Pain|pain
57501|NCT02925832|Deep topical fornix nerve block Anesthesia|deep topical fornix nerve block anesthesia
57502|NCT02925832|Ropivacaine|ropivacaine
57503|NCT02925832|Bupivacaine|bupivacaine
57504|NCT02925832|Anaesthesia|anaesthesia
57505|NCT02925832|Eye surgery blocks|eye surgery blocks
57506|NCT02925832|Phacoemulsification|phacoemulsification
57507|NCT02925819|Mitral regurgitation|mitral regurgitation
57508|NCT02925819|Mitral stenosis|mitral stenosis
57509|NCT02925819|Mitral valve repair deterioration|mitral valve repair deterioration
57510|NCT02925819|Bioprosthesis degeneration|bioprosthesis degeneration
57511|NCT02925780|Enamel defects|enamel defects
57512|NCT02925780|Fluorosis|fluorosis
57513|NCT02925741|bed linens|bed linens
57514|NCT02925728|Finger-Food|finger-food
57515|NCT02925663|executive functioning|executive functioning
57516|NCT02925650|Alzheimer's Disease|alzheimer's disease
57517|NCT02925650|SILK™|silk™
57518|NCT02925650|Pharmacodynamics|pharmacodynamics
57519|NCT02925650|Safety|safety
57520|NCT02925650|Pharmacokinetics|pharmacokinetics
57521|NCT02925624|ablation index|ablation index
57522|NCT02925624|pulmonary vein isolation|pulmonary vein isolation
57523|NCT02925624|implantable loop recorder|implantable loop recorder
57524|NCT02925611|Postoperative delirium|postoperative delirium
57525|NCT02925611|spine surgery|spine surgery
57526|NCT02925611|isoflurane|isoflurane
57527|NCT02925611|desflurane|desflurane
57528|NCT02925598|Laringeal masks|laringeal masks
57529|NCT02925598|Cholecystectomy, Laparascopic|cholecystectomy, laparascopic
57530|NCT02925598|Intubation, intratracheal|intubation, intratracheal
57531|NCT02925572|pediatric obesity|pediatric obesity
57532|NCT02925572|eccentric exercise|eccentric exercise
57533|NCT02925572|body composition|body composition
57534|NCT02925572|training program|training program
57535|NCT02925559|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
57536|NCT02925559|Glycemic Variability|glycemic variability
57537|NCT02925559|Dapagliflozin|dapagliflozin
57538|NCT02925559|Gliclazide MR|gliclazide mr
57539|NCT02925559|Continuous Glucose Monitoring|continuous glucose monitoring
57540|NCT02925559|Mean Amplitude of Glycemic Excursions|mean amplitude of glycemic excursions
57541|NCT02925559|MAGE|mage
57542|NCT02925546|Healthy|healthy
57543|NCT02925546|Pharmacokinetics|pharmacokinetics
57544|NCT02925546|Phase I|phase i
57545|NCT02925546|GSK2798745|gsk2798745
57546|NCT02925546|Tablet|tablet
57547|NCT02925533|Bladder Cancer|bladder cancer
57548|NCT02925533|Urothelial Cancer|urothelial cancer
57549|NCT02925520|Cholestasis|cholestasis
57550|NCT02925494|Elagolix plus Norethindrone Acetate|elagolix plus norethindrone acetate
57551|NCT02925494|Uterine Fibroids|uterine fibroids
57552|NCT02925494|Elagolix Sodium|elagolix sodium
57553|NCT02925494|Heavy Menstrual Bleeding|heavy menstrual bleeding
57554|NCT02925494|Elagolix|elagolix
57555|NCT02925481|Yoga|yoga
57556|NCT02925481|PTSD|ptsd
57557|NCT02925481|mental health|mental health
57558|NCT02925481|stillbirth|stillbirth
57559|NCT02925468|orthodontics|orthodontics
57560|NCT02925455|Hemiplegia|hemiplegia
58284|NCT02921724|oral drug|oral drug
57561|NCT02925455|Functional Electrical Stimulation|functional electrical stimulation
57562|NCT02925455|Video Games|video games
57563|NCT02925455|Occupational Therapy|occupational therapy
57564|NCT02925442|Unilateral Knee Arthroplasty|unilateral knee arthroplasty
57565|NCT02925442|Radiofrequency Ablation|radiofrequency ablation
57566|NCT02925442|Genicular|genicular
57567|NCT02925442|RFA|rfa
57568|NCT02925442|C-RFA|c-rfa
57569|NCT02925442|t-RFA|t-rfa
57570|NCT02925442|total knee replacement|total knee replacement
57571|NCT02925364|magnetic resonance imaging|magnetic resonance imaging
57572|NCT02925364|central pain processing|central pain processing
57573|NCT02925364|anatomical MRI|anatomical mri
57574|NCT02925364|fMRI|fmri
57575|NCT02925325|Major depressive disorder|major depressive disorder
57576|NCT02925325|Music therapy|music therapy
57577|NCT02925325|Residual symptoms|residual symptoms
57578|NCT02925286|gambling prevention|gambling prevention
57579|NCT02925286|workplace policy|workplace policy
57580|NCT02925273|dementia|dementia
57581|NCT02925234|Molecular tumor profile|molecular tumor profile
57582|NCT02925234|Multidisciplinary tumor board|multidisciplinary tumor board
57583|NCT02925234|Antitumor drugs|antitumor drugs
57584|NCT02925234|Molecular Targeted Therapy|molecular targeted therapy
57585|NCT02925234|Drug Repositioning|drug repositioning
57586|NCT02925234|Off-Label Use|off-label use
57587|NCT02925234|Sequence Analysis, DNA|sequence analysis, dna
57588|NCT02925221|Kidney Disease|kidney disease
57589|NCT02925221|ADPKD-Related Outcome|adpkd-related outcome
57590|NCT02925221|Quality of Life|quality of life
57591|NCT02925195|Vitamin D|vitamin d
57592|NCT02925195|cardiovascular disease|cardiovascular disease
57593|NCT02925195|MESA|mesa
57594|NCT02925195|genetics|genetics
57602|NCT02925156|Obesity|obesity
57603|NCT02925156|Diabetes|diabetes
57604|NCT02925156|Cardiovascular Disease|cardiovascular disease
57605|NCT02925156|Adiponectin|adiponectin
57606|NCT02925156|Leptin|leptin
57607|NCT02925156|Ghrelin|ghrelin
57608|NCT02925143|Residual nerve blockade|residual nerve blockade
57609|NCT02925143|Neuromuscular monitoring|neuromuscular monitoring
57610|NCT02925143|Residual curarization|residual curarization
57611|NCT02925143|Neuromuscular blocking agents|neuromuscular blocking agents
57612|NCT02925143|E-learning|e-learning
57613|NCT02925143|Web based learning|web based learning
57614|NCT02925117|ABT-494|abt-494
57615|NCT02925117|Atopic Dermatitis|atopic dermatitis
57616|NCT02925104|cMET, INC280, food,|cmet, inc280, food,
57617|NCT02925065|Parkinson's|parkinson's
57618|NCT02925065|Non-traditional guitar instruction|non-traditional guitar instruction
57619|NCT02925065|Guitar therapy|guitar therapy
57620|NCT02925065|Upper extremity motor function|upper extremity motor function
57621|NCT02925065|Hand dexterity|hand dexterity
57622|NCT02925039|Rehabilitation|rehabilitation
57623|NCT02925039|Geriatric|geriatric
57624|NCT02925013|Omega 3|omega 3
57625|NCT02925013|Lipids|lipids
57626|NCT02925013|Pregnancy|pregnancy
57627|NCT02925000|Advanced Malignancy|advanced malignancy
57628|NCT02925000|lymphoma|lymphoma
57629|NCT02925000|TLC178|tlc178
57630|NCT02924948|Endoscopic ultrasonography|endoscopic ultrasonography
57631|NCT02924922|renal cell carcinoma|renal cell carcinoma
57632|NCT02924922|laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
57633|NCT02924922|robot-assisted partial nephrectomy|robot-assisted partial nephrectomy
57634|NCT02924922|nephron sparing surgery|nephron sparing surgery
57635|NCT02924922|warm ischemia time|warm ischemia time
57636|NCT02924922|renal function loss|renal function loss
57637|NCT02924870|health education|health education
57638|NCT02924792|Intraosseous access|intraosseous access
57639|NCT02924740|stress urinary incontinence|stress urinary incontinence
57640|NCT02924740|quality of life|quality of life
57641|NCT02924740|pelvic floor muscle training|pelvic floor muscle training
57642|NCT02924740|pelvic floor muscle exercises|pelvic floor muscle exercises
57643|NCT02924740|vaginal tampon training|vaginal tampon training
57644|NCT02924727|Spontaneous AMI|spontaneous ami
57645|NCT02924727|HF hospitalization|hf hospitalization
57646|NCT02924727|outpatient HF|outpatient hf
57835|NCT02923869|Bupivacaine|bupivacaine
57647|NCT02924727|LV systolic dysfunction|lv systolic dysfunction
57648|NCT02924727|pulmonary congestion|pulmonary congestion
57649|NCT02924727|STEMI|stemi
57650|NCT02924727|NSTEMI|nstemi
57651|NCT02924727|randomized clinical trial|randomized clinical trial
57652|NCT02924727|LCZ696|lcz696
57653|NCT02924727|ramipril|ramipril
57654|NCT02924714|GIST|gist
57655|NCT02924701|prognosis|prognosis
57664|NCT02924675|neuropathic pain, ent cancer, pregabalin|neuropathic pain, ent cancer, pregabalin
57665|NCT02924649|Brain injury|brain injury
57666|NCT02924649|Early mobilisation|early mobilisation
57667|NCT02924649|Consciousness|consciousness
57668|NCT02924649|Cerebral blood flow|cerebral blood flow
57669|NCT02924649|Blood pressure|blood pressure
57670|NCT02924636|C-section|c-section
57671|NCT02924636|Instrumental delivery|instrumental delivery
57672|NCT02924636|Pregnancy complications|pregnancy complications
57673|NCT02924636|Macrosomia|macrosomia
57674|NCT02924636|Neonatal complications|neonatal complications
57675|NCT02924584|hormonal receptor positive, human epidermal growth factor receptor 2 negative, breast cancer, aromatse inhibitor, overall survival, prevalence|hormonal receptor positive, human epidermal growth factor receptor 2 negative, breast cancer, aromatse inhibitor, overall survival, prevalence
57677|NCT02924558|Protein|protein
57678|NCT02924558|Unsaturated fatty acids|unsaturated fatty acids
57679|NCT02924558|Triglycerides|triglycerides
57680|NCT02924558|Insulin sensitivity|insulin sensitivity
57681|NCT02924558|Lipid triad|lipid triad
57682|NCT02924506|cervical arthroplasty|cervical arthroplasty
57683|NCT02924493|Endometriosis|endometriosis
57684|NCT02924493|IBS|ibs
57685|NCT02924493|Irritable bowel syndrome|irritable bowel syndrome
57686|NCT02924493|low FODMAP diet|low fodmap diet
57687|NCT02924493|FODMAPs|fodmaps
57688|NCT02924493|visceral syndrome|visceral syndrome
57689|NCT02924493|fermentable carbohydrates|fermentable carbohydrates
57690|NCT02924493|visceral hypersensitivity|visceral hypersensitivity
57691|NCT02924493|cross organ effect|cross organ effect
57692|NCT02924480|invasive bladder cancer|invasive bladder cancer
57693|NCT02924480|cystectomy|cystectomy
57694|NCT02924480|high grade bladder cancer|high grade bladder cancer
57695|NCT02924467|reminder systems|reminder systems
57696|NCT02924467|Influenza vaccines|influenza vaccines
57697|NCT02924454|metoprolol|metoprolol
57698|NCT02924454|lipid emulsion|lipid emulsion
57699|NCT02924454|pharmacodynamics|pharmacodynamics
57700|NCT02924454|pharmacokinetics|pharmacokinetics
57701|NCT02924441|Mammogram|mammogram
57702|NCT02924441|Pain Management|pain management
57703|NCT02924441|Lidocaine|lidocaine
57705|NCT02924402|NHL|nhl
57706|NCT02924402|B-cell Prolymphocytic Leukemia|b-cell prolymphocytic leukemia
57707|NCT02924402|Transformed Lymphoma|transformed lymphoma
57708|NCT02924402|Burkitt's Lymphoma|burkitt's lymphoma
57709|NCT02924402|Mantle Cell Lymphoma|mantle cell lymphoma
57710|NCT02924402|Hairy Cell Leukemia|hairy cell leukemia
57711|NCT02924402|Splenic Marginal Zone Lymphoma|splenic marginal zone lymphoma
57712|NCT02924402|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
57713|NCT02924402|Variant Hairy Cell Leukemia|variant hairy cell leukemia
57714|NCT02924402|Splenic B-cell Lymphoma/Leukemia|splenic b-cell lymphoma/leukemia
57715|NCT02924402|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
57716|NCT02924402|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT)|extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (malt)
57717|NCT02924402|MALT Lymphoma|malt lymphoma
57718|NCT02924402|Nodal Marginal Zone Lymphoma|nodal marginal zone lymphoma
57719|NCT02924402|Follicular Lymphoma|follicular lymphoma
57720|NCT02924402|In Situ Follicular Neoplasia|in situ follicular neoplasia
57721|NCT02924402|Duodenal-type Follicular Lymphoma|duodenal-type follicular lymphoma
57722|NCT02924402|Large B-cell Lymphoma with IRF4 rearrangement|large b-cell lymphoma with irf4 rearrangement
57846|NCT02923804|steatosis|steatosis
57723|NCT02924402|Primary Cutaneous Follicle Center Lymphoma|primary cutaneous follicle center lymphoma
57724|NCT02924402|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
57725|NCT02924402|DLBCL|dlbcl
57726|NCT02924402|T-cell/Histiocyte-Rich Large B-cell Lymphoma|t-cell/histiocyte-rich large b-cell lymphoma
57727|NCT02924402|Primary Cutaneous DLBCL, leg type|primary cutaneous dlbcl, leg type
57728|NCT02924402|EBV-positive DLBCL, NOS|ebv-positive dlbcl, nos
57729|NCT02924402|EBV-positive Mucocutaneous Ulcer|ebv-positive mucocutaneous ulcer
57730|NCT02924402|DLBCL Associated with Chronic Inflammation|dlbcl associated with chronic inflammation
57731|NCT02924402|Lymphomatoid Granulomatosis|lymphomatoid granulomatosis
57732|NCT02924402|Primary Mediastinal (Thymic) Large B-cell Lymphoma|primary mediastinal (thymic) large b-cell lymphoma
57733|NCT02924402|Intravascular Large B-cell Lymphoma|intravascular large b-cell lymphoma
57836|NCT02923869|Nerve Block|nerve block
57734|NCT02924402|ALK+ Large B-cell Lymphoma|alk+ large b-cell lymphoma
57735|NCT02924402|Plasmablastic Lymphoma|plasmablastic lymphoma
57736|NCT02924402|Primary Effusion Lymphoma|primary effusion lymphoma
57737|NCT02924402|HHV8+ DLBCL|hhv8+ dlbcl
57738|NCT02924402|Burkitt-like Lymphoma with 11q Aberration|burkitt-like lymphoma with 11q aberration
57739|NCT02924402|High-grade B-cell Lymphoma|high-grade b-cell lymphoma
57740|NCT02924402|B-cell Lymphoma, unclassifiable|b-cell lymphoma, unclassifiable
57741|NCT02924402|Post-transplant Lymphoproliferative Disorder|post-transplant lymphoproliferative disorder
57742|NCT02924402|PTLD|ptld
57743|NCT02924402|CLL|cll
57744|NCT02924402|SLL|sll
57745|NCT02924402|High-grade Lymphoma|high-grade lymphoma
57746|NCT02924402|Richter's Transformation|richter's transformation
57747|NCT02924376|Cholangiocarcinoma|cholangiocarcinoma
57748|NCT02924376|fibroblast growth factor (FGF)|fibroblast growth factor (fgf)
57749|NCT02924376|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
57750|NCT02924376|FGF/FGFR alterations|fgf/fgfr alterations
57751|NCT02924363|Cardiac Magnetic Resonance|cardiac magnetic resonance
57752|NCT02924363|Mitra Clip|mitra clip
57753|NCT02924363|Mitral Valve|mitral valve
57754|NCT02924337|QT/QTC interval|qt/qtc interval
57755|NCT02924337|Hypoglycemic Agents|hypoglycemic agents
57756|NCT02924337|Imeglimin|imeglimin
57757|NCT02924337|Healthy Volunteers|healthy volunteers
57758|NCT02924324|local Injection|local injection
58285|NCT02921724|sunitinib|sunitinib
57759|NCT02924324|pain Medication|pain medication
57760|NCT02924324|propofol|propofol
57761|NCT02924324|ropivacaine|ropivacaine
57762|NCT02924324|16-1417|16-1417
57763|NCT02924311|Diabetic Macular Edema|diabetic macular edema
57764|NCT02924272|Drug Therapy|drug therapy
57765|NCT02924259|muscle soreness|muscle soreness
57766|NCT02924259|pain|pain
57767|NCT02924259|myofascial release|myofascial release
57768|NCT02924246|immunity|immunity
57769|NCT02924246|vaccination|vaccination
57770|NCT02924246|milk|milk
57771|NCT02924233|Squamous|squamous
57772|NCT02924233|Non-Small Cell Lung Cancer|non-small cell lung cancer
57773|NCT02924233|NSCLC|nsclc
57774|NCT02924207|diabetes mellitus|diabetes mellitus
57777|NCT02924142|Kennedy classification for edentulous ridge|kennedy classification for edentulous ridge
57778|NCT02924129|Chronic Pain|chronic pain
57779|NCT02924129|Back Pain|back pain
57780|NCT02924129|Leg Pain|leg pain
57782|NCT02924129|Neurologic Manifestations|neurologic manifestations
57783|NCT02924129|Nervous System Diseases|nervous system diseases
57784|NCT02924129|Signs and Symptoms|signs and symptoms
57785|NCT02924129|SCS|scs
57786|NCT02924129|Closed Loop|closed loop
57787|NCT02924116|insomnia|insomnia
57788|NCT02924116|sleep|sleep
57789|NCT02924116|Bioboosti|bioboosti
66134|NCT02870777|MRD|mrd
57790|NCT02924116|Biomobie|biomobie
57791|NCT02924116|device|device
57792|NCT02924103|acute rhinosinusitis|acute rhinosinusitis
57793|NCT02924103|staphylococcus aureus|staphylococcus aureus
57794|NCT02924103|nasal vestibule|nasal vestibule
57795|NCT02924103|contamination|contamination
57796|NCT02924090|Major depressive disorder|major depressive disorder
57797|NCT02924090|Etomidate|etomidate
57798|NCT02924090|Ketamine|ketamine
57799|NCT02924090|Hyperventilation|hyperventilation
57800|NCT02924090|Electroconvulsive therapy|electroconvulsive therapy
57801|NCT02924090|Depression|depression
57802|NCT02924090|Anesthesia|anesthesia
57803|NCT02924090|Nervous System Diseases|nervous system diseases
57804|NCT02924090|Mental Disorders|mental disorders
57805|NCT02924090|Electroencephalography|electroencephalography
57806|NCT02924090|Cerebral Metabolism|cerebral metabolism
57807|NCT02924038|low-grade glioma|low-grade glioma
57808|NCT02924038|glioma|glioma
57809|NCT02924038|immunotherapy|immunotherapy
57810|NCT02924038|vaccine|vaccine
57811|NCT02924038|WHO grade II|who grade ii
57812|NCT02924012|post exercise hypotension|post exercise hypotension
57813|NCT02924012|exercise|exercise
57814|NCT02924012|video games|video games
57815|NCT02923999|HIV|hiv
57816|NCT02923999|MAB|mab
57817|NCT02923999|PLANT|plant
57818|NCT02923986|Liposomal Grb-2 treatment of Ph+ CML|liposomal grb-2 treatment of ph+ cml
57819|NCT02923986|Liposomal Grb-2 with Das for Ph+ CML|liposomal grb-2 with das for ph+ cml
57820|NCT02923947|Pharmacokinetics,|pharmacokinetics,
57821|NCT02923947|Renal impairment,|renal impairment,
57822|NCT02923947|Safety assessments,|safety assessments,
57823|NCT02923947|Solid tumours,|solid tumours,
57824|NCT02923947|EGFRm+|egfrm+
57825|NCT02923947|EGFRm+/T790M+ inhibitor|egfrm+/t790m+ inhibitor
57826|NCT02923908|Palatability|palatability
57827|NCT02923908|Pediatrics|pediatrics
57828|NCT02923908|Facial Recognition|facial recognition
57829|NCT02923908|Taste|taste
57830|NCT02923908|Facial Expressions|facial expressions
57831|NCT02923882|Low-birth-weight|low-birth-weight
57832|NCT02923882|Model kitchen|model kitchen
57833|NCT02923882|Improved cookstove|improved cookstove
57834|NCT02923869|Levobupivacaine|levobupivacaine
57841|NCT02923843|frailty|frailty
57842|NCT02923843|comprehensive geriatric assessment|comprehensive geriatric assessment
57843|NCT02923817|spinal cord injury|spinal cord injury
57844|NCT02923817|autologous transplants|autologous transplants
57845|NCT02923817|bone marrow derived mononuclear cells|bone marrow derived mononuclear cells
57847|NCT02923804|NAFL|nafl
57848|NCT02923804|NAFLD|nafld
57849|NCT02923804|Polyunsaturated fatty acids|polyunsaturated fatty acids
57850|NCT02923804|omega-3|omega-3
57851|NCT02923804|EPA|epa
57852|NCT02923804|DHA|dha
57853|NCT02923804|fish oil|fish oil
57854|NCT02923739|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
57855|NCT02923739|Ovarian Cancer|ovarian cancer
57856|NCT02923739|Fallopian Tube Cancer|fallopian tube cancer
57857|NCT02923739|Primary Peritoneal Cancer|primary peritoneal cancer
57858|NCT02923739|relapsed/refractory|relapsed/refractory
57859|NCT02923739|Platinum-resistant disease|platinum-resistant disease
57860|NCT02923739|Paclitaxel|paclitaxel
57861|NCT02923739|Taxol|taxol
57862|NCT02923739|Bevacizumab|bevacizumab
57863|NCT02923739|Avastin|avastin
57864|NCT02923739|rhuMAb-VEGF|rhumab-vegf
57865|NCT02923739|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
57866|NCT02923739|Emactuzumab|emactuzumab
57867|NCT02923739|RO5509554|ro5509554
57871|NCT02923700|platelet rich plasma|platelet rich plasma
57872|NCT02923700|intra-articular injection|intra-articular injection
57873|NCT02923700|leukocytes|leukocytes
57874|NCT02923687|Ketorolac|ketorolac
57875|NCT02923687|Root canal treatment|root canal treatment
57876|NCT02923687|Pain|pain
57877|NCT02923687|Premedication|premedication
57878|NCT02923661|single implant|single implant
57879|NCT02923635|Oncoplastic breast surgery|oncoplastic breast surgery
57880|NCT02923635|Standard Wide Local Excision|standard wide local excision
57881|NCT02923596|Keloid|keloid
583418|NCT00511654|depression|depression
57888|NCT02923518|Heart Screening|heart screening
57889|NCT02923518|Master Athletes|master athletes
57890|NCT02923518|Cardiovascular Disease|cardiovascular disease
57891|NCT02923479|Rehabilitation|rehabilitation
57892|NCT02923479|Robotics|robotics
57893|NCT02923466|refractory solid tumor|refractory solid tumor
57894|NCT02923427|laryngeal mask Supreme|laryngeal mask supreme
57895|NCT02923427|i-gel|i-gel
57896|NCT02923427|laparoscopic gynecological surgery|laparoscopic gynecological surgery
57897|NCT02923414|Cardioversion|cardioversion
57898|NCT02923401|Exercise|exercise
57899|NCT02923401|Biomarkers|biomarkers
57900|NCT02923401|Breast cancer high risk|breast cancer high risk
57901|NCT02923401|Treadmill|treadmill
57902|NCT02923401|Stationary bicycle|stationary bicycle
57903|NCT02923401|Questionnaires|questionnaires
57904|NCT02923401|Surveys|surveys
57905|NCT02923401|Motivational sessions|motivational sessions
57906|NCT02923401|Phone calls|phone calls
57907|NCT02923401|Printed materials|printed materials
57908|NCT02923362|GERD|gerd
57909|NCT02923362|Reflux|reflux
57910|NCT02923362|Acid Reflux|acid reflux
57911|NCT02923362|Heartburn|heartburn
57912|NCT02923362|Regurgitation|regurgitation
57913|NCT02923362|Laryngopharyngeal Reflux|laryngopharyngeal reflux
57914|NCT02923362|Hiatal Hernia|hiatal hernia
57916|NCT02923362|LINX|linx
57917|NCT02923362|Magnetic Sphincter Augmentation|magnetic sphincter augmentation
57918|NCT02923362|Antireflux Surgery|antireflux surgery
57919|NCT02923362|Nissen|nissen
57920|NCT02923349|Solid tumor|solid tumor
57921|NCT02923349|adenocarcinoma of the endometrium|adenocarcinoma of the endometrium
57922|NCT02923349|ovarian cancer|ovarian cancer
57923|NCT02923349|renal cell carcinoma|renal cell carcinoma
57924|NCT02923349|melanoma|melanoma
57925|NCT02923349|non-small cell lung cancer|non-small cell lung cancer
57926|NCT02923349|OX40|ox40
57927|NCT02923349|immunoglobulin G monoclonal antibody|immunoglobulin g monoclonal antibody
57928|NCT02923336|liver cirrhosis|liver cirrhosis
57929|NCT02923336|variceal bleeding|variceal bleeding
57930|NCT02923336|non selective beta blockers|non selective beta blockers
57931|NCT02923323|Neurocognitive Function|neurocognitive function
57932|NCT02923323|MRI|mri
57933|NCT02923323|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
57934|NCT02923323|Sleep|sleep
57935|NCT02923297|parkinson|parkinson
57936|NCT02923297|alpha-synuclein|alpha-synuclein
57937|NCT02923297|GALIG|galig
57938|NCT02923297|quantitative PCR (polymerase chain reaction)|quantitative pcr (polymerase chain reaction)
57939|NCT02923271|Driving|driving
57940|NCT02923271|Teens|teens
57941|NCT02923271|Texting|texting
57942|NCT02923271|Cellphone|cellphone
57943|NCT02923271|DriveID|driveid
57944|NCT02923271|Motor vehicle accident|motor vehicle accident
57945|NCT02923258|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
57946|NCT02923258|concurrent chemotherapy|concurrent chemotherapy
57947|NCT02923258|High-Risk|high-risk
57948|NCT02923232|Contact lens; Accommodation; Visual performance|contact lens; accommodation; visual performance
57949|NCT02923219|Facial Rejuvenation|facial rejuvenation
57950|NCT02923219|Adipose-Derived Stem Cells|adipose-derived stem cells
57951|NCT02923206|apheresis|apheresis
57952|NCT02923206|pregnancy|pregnancy
57953|NCT02923206|pre-eclampsia|pre-eclampsia
57954|NCT02923206|PE|pe
57955|NCT02923206|sFlt-1|sflt-1
57956|NCT02923206|Pre-term|pre-term
57961|NCT02923154|NASH|nash
57962|NCT02923141|substance use|substance use
57963|NCT02923141|trauma|trauma
57964|NCT02923141|HIV|hiv
57965|NCT02923141|viral load|viral load
57966|NCT02923141|women|women
57967|NCT02923115|Venous thromboembolism|venous thromboembolism
57968|NCT02923115|VTE|vte
57969|NCT02923115|Pulmonary embolism|pulmonary embolism
57970|NCT02923115|PE|pe
57971|NCT02923115|Acute Submassive Pulmonary Embolism|acute submassive pulmonary embolism
57972|NCT02923102|Recovery|recovery
57973|NCT02923102|Muscle soreness|muscle soreness
57974|NCT02923102|Lemon Verbena|lemon verbena
57975|NCT02923089|Diabetes|diabetes
57976|NCT02923089|Lentils|lentils
57977|NCT02923089|Pulses|pulses
57978|NCT02923089|Postprandial glycemia|postprandial glycemia
57979|NCT02923076|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
57980|NCT02923063|Chronic Kidney Disease|chronic kidney disease
57981|NCT02923063|Mitochondrial Metabolism|mitochondrial metabolism
57982|NCT02923063|Physical Performance|physical performance
57983|NCT02923063|Exercise Intolerance|exercise intolerance
57984|NCT02923063|Muscle Fatigue|muscle fatigue
57985|NCT02922998|CD64 antigens|cd64 antigens
57986|NCT02922998|Biomarkers|biomarkers
58684|NCT02919163|respiration|respiration
57987|NCT02922998|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
57988|NCT02922998|Interleukin-4|interleukin-4
57989|NCT02922998|Interferon-gamma|interferon-gamma
57990|NCT02922998|C-reactive protein|c-reactive protein
57991|NCT02922998|lipopolysaccharide-binding protein|lipopolysaccharide-binding protein
57992|NCT02922998|procalcitonin|procalcitonin
57993|NCT02922998|Cytokines|cytokines
57994|NCT02922998|Patients|patients
57995|NCT02922998|Human|human
57996|NCT02922998|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
57997|NCT02922998|Sepsis|sepsis
57998|NCT02922998|Infection|infection
57999|NCT02922998|Antibiotics|antibiotics
58000|NCT02922998|Intensive Care Units|intensive care units
58001|NCT02922998|Point-of-Care Systems|point-of-care systems
58002|NCT02922998|Bedside Testing|bedside testing
58003|NCT02922985|Cesarean delivery|cesarean delivery
58004|NCT02922985|Multimodal pain management|multimodal pain management
58006|NCT02922972|Wound healing|wound healing
58007|NCT02922972|Platelet-Rich Plasma|platelet-rich plasma
58008|NCT02922972|RegenLab|regenlab
58009|NCT02922959|Opioid Substitution Treatment|opioid substitution treatment
58010|NCT02922959|Telephone intervention|telephone intervention
58011|NCT02922959|secondary prevention|secondary prevention
58012|NCT02922959|naloxone|naloxone
58013|NCT02922946|entinostat|entinostat
58014|NCT02922946|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
58015|NCT02922946|HDAC|hdac
58016|NCT02922933|entinostat|entinostat
58017|NCT02922933|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
58018|NCT02922933|HDAC|hdac
58019|NCT02922868|Cystoscopy|cystoscopy
58020|NCT02922868|EndoSheath|endosheath
58021|NCT02922868|Infection Control|infection control
58022|NCT02922868|Bacteriuria|bacteriuria
58023|NCT02922842|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
58024|NCT02922829|Food Insecurity|food insecurity
58025|NCT02922829|Nutrition|nutrition
58026|NCT02922816|Carbapenem-resistant Enterobacteriaceae (CRE)|carbapenem-resistant enterobacteriaceae (cre)
58027|NCT02922816|Vancomycin-resistant Enterococcus (VRE)|vancomycin-resistant enterococcus (vre)
58028|NCT02922816|Multidrug Resistant Organism (MDRO)|multidrug resistant organism (mdro)
58029|NCT02922816|Fecal Microbiota Transplant (FMT)|fecal microbiota transplant (fmt)
58030|NCT02922816|Renal Transplant|renal transplant
58031|NCT02922816|Colonization|colonization
58032|NCT02922816|Infection|infection
58033|NCT02922816|Antibiotic Resistance|antibiotic resistance
58034|NCT02922816|Resistome|resistome
58035|NCT02922816|Multidrug Resistant (MDR) Pseudomonas|multidrug resistant (mdr) pseudomonas
58036|NCT02922790|smoker|smoker
58037|NCT02922790|smoking|smoking
58038|NCT02922790|cigarette|cigarette
58039|NCT02922790|cessation|cessation
58041|NCT02922790|DNA damage|dna damage
58042|NCT02922790|blood draw|blood draw
58043|NCT02922790|feedback|feedback
58044|NCT02922790|cellular|cellular
58046|NCT02922790|tobacco smoke|tobacco smoke
58047|NCT02922764|Solid malignancy|solid malignancy
58048|NCT02922764|Lymphoma|lymphoma
58049|NCT02922764|Solid tumor|solid tumor
58050|NCT02922764|Melanoma|melanoma
58051|NCT02922764|Non-small cell lung cancer|non-small cell lung cancer
58052|NCT02922764|Epithelial ovarian carcinoma|epithelial ovarian carcinoma
58053|NCT02922764|Breast cancer|breast cancer
58054|NCT02922764|NSCLC|nsclc
58055|NCT02922764|EOC|eoc
58056|NCT02922764|BC|bc
58057|NCT02922764|LXR|lxr
58058|NCT02922764|ApoE|apoe
58059|NCT02922764|mBC|mbc
58060|NCT02922751|transient elastography|transient elastography
58061|NCT02922751|pediatric liver disease|pediatric liver disease
58062|NCT02922751|biliary atresia|biliary atresia
58063|NCT02922751|Alagille Syndrome|alagille syndrome
58064|NCT02922751|Alpha1 Anti-Trypsin Deficiency|alpha1 anti-trypsin deficiency
58065|NCT02922751|liver fibrosis|liver fibrosis
58066|NCT02922751|cholestasis|cholestasis
58067|NCT02922738|Clinical Knowledge Systems, Decision support, Dermatology|clinical knowledge systems, decision support, dermatology
58068|NCT02922738|Technology Assessment|technology assessment
58069|NCT02922673|human endotoxemia|human endotoxemia
58070|NCT02922673|LPS|lps
58071|NCT02922673|acetylsalicylic acid|acetylsalicylic acid
58072|NCT02922673|placebo|placebo
58073|NCT02922673|endotoxin tolerance|endotoxin tolerance
58074|NCT02922660|Ambulatory surgery|ambulatory surgery
58075|NCT02922660|Ophthalmic|ophthalmic
58076|NCT02922660|Inhalation anesthesia|inhalation anesthesia
58077|NCT02922660|Desflurane|desflurane
58078|NCT02922660|Total intravenous anesthesia|total intravenous anesthesia
58079|NCT02922634|postoperative health outcomes|postoperative health outcomes
58080|NCT02922634|older surgical patients|older surgical patients
58081|NCT02921581|Dose painting|dose painting
58082|NCT02921581|18F-FDG|18f-fdg
58083|NCT02921581|Positron emission tomography|positron emission tomography
58084|NCT02921581|Radiotherapy|radiotherapy
58085|NCT02922608|Education, Medical|education, medical
58086|NCT02922543|Multiple Myeloma|multiple myeloma
58087|NCT02922543|Teratogenicity|teratogenicity
59602|NCT02913924|Treatment|treatment
58088|NCT02922543|Thrombocytopenia and haemorrhage|thrombocytopenia and haemorrhage
58089|NCT02922543|Neutropenia and infection|neutropenia and infection
58090|NCT02922543|Venous thromboembolism|venous thromboembolism
58091|NCT02922543|Allergic reactions|allergic reactions
58092|NCT02922543|Diarrhoea or constipation|diarrhoea or constipation
58093|NCT02922543|Peripheral neuropathy|peripheral neuropathy
58094|NCT02922543|Cardiac failure|cardiac failure
58095|NCT02922543|Arrhythmia|arrhythmia
58096|NCT02922543|Renal failure|renal failure
58097|NCT02922543|Myocardial infarction|myocardial infarction
58098|NCT02922543|Interstitial lung disease|interstitial lung disease
58099|NCT02922543|Tumour lysis syndrome|tumour lysis syndrome
58100|NCT02922517|biomarkers|biomarkers
58101|NCT02922517|echocardiography|echocardiography
58102|NCT02922517|MRI imaging|mri imaging
58103|NCT02922517|nuclear medicine|nuclear medicine
59815|NCT02912312|RNI|rni
58104|NCT02922504|First trimester abortion|first trimester abortion
58105|NCT02922504|Surgical abortion|surgical abortion
58106|NCT02922504|Music intervention|music intervention
58107|NCT02922504|Local anesthesia|local anesthesia
58108|NCT02922504|Pain|pain
66521|NCT02868021|Elderly|elderly
58109|NCT02922439|chronic disease|chronic disease
58110|NCT02922439|multimorbidity|multimorbidity
58111|NCT02922439|chronic disease self-management|chronic disease self-management
58112|NCT02922439|tailored information|tailored information
58113|NCT02922439|mobile applications|mobile applications
58114|NCT02922426|ALKS 3831|alks 3831
58115|NCT02922426|Samidorphan|samidorphan
58116|NCT02922426|Olanzapine|olanzapine
58117|NCT02922413|Porphyria|porphyria
58118|NCT02922413|Heme|heme
58119|NCT02922400|Autism|autism
58120|NCT02922400|Traumatic Brain Injury|traumatic brain injury
58121|NCT02922400|Schizophrenia|schizophrenia
58122|NCT02922400|Virtual-Reality Social Cognition Training|virtual-reality social cognition training
58123|NCT02922387|varenicline|varenicline
58124|NCT02922387|COPD|copd
58125|NCT02922387|asthma|asthma
58126|NCT02922387|pneumonia|pneumonia
58127|NCT02922387|smoking cessation|smoking cessation
58128|NCT02922374|acute severe colitis|acute severe colitis
58129|NCT02922374|corticosteroids|corticosteroids
58130|NCT02922374|UCEIS|uceis
58131|NCT02922374|fecal calprotectin|fecal calprotectin
58132|NCT02922348|premature ovarian failure|premature ovarian failure
58133|NCT02922348|hormone replacement|hormone replacement
58134|NCT02922335|Antisocial Behavior|antisocial behavior
58135|NCT02922335|Mental Illness|mental illness
58136|NCT02922335|Emerging Adulthood|emerging adulthood
58137|NCT02922335|Criminal Behavior|criminal behavior
58138|NCT02922335|Serious Mental Illness|serious mental illness
58139|NCT02922322|Mat Pilates|mat pilates
58140|NCT02922322|Chronic Nonspecific low back pain|chronic nonspecific low back pain
58141|NCT02922322|Quality of life|quality of life
58142|NCT02922322|Disability|disability
58143|NCT02922322|transverse abdominal muscle|transverse abdominal muscle
58144|NCT02922283|T cell response|t cell response
58145|NCT02922283|Interleukin 2|interleukin 2
58146|NCT02922283|PET scan|pet scan
58147|NCT02922283|Ipilimumab|ipilimumab
58148|NCT02922283|Pembrolizumab|pembrolizumab
58149|NCT02922283|Nivolumab|nivolumab
58150|NCT02922270|peritoneal dialysis: outcome|peritoneal dialysis: outcome
58151|NCT02922270|peritoneal dialysis: complications|peritoneal dialysis: complications
58152|NCT02922270|peritoneal dialysis: technique|peritoneal dialysis: technique
58153|NCT02922270|peritoneal dialysis: peritonitis|peritoneal dialysis: peritonitis
58154|NCT02922244|herbal products|herbal products
58155|NCT02922244|reduction of radiation-induced dermatitis|reduction of radiation-induced dermatitis
58156|NCT02922244|breast cancer|breast cancer
58157|NCT02922244|radiotherapy|radiotherapy
58158|NCT02922192|Anti-inflammatory|anti-inflammatory
58159|NCT02922192|Biologics|biologics
58160|NCT02922192|Biologic and Biosimilars Collective Intelligence Consortium|biologic and biosimilars collective intelligence consortium
58161|NCT02922192|BBCIC|bbcic
58162|NCT02922179|Insulin|insulin
58163|NCT02922179|Diabetes|diabetes
58164|NCT02922179|Biologic and Biosimilars Collective Intelligence Consortium|biologic and biosimilars collective intelligence consortium
58165|NCT02922179|BBCIC|bbcic
58166|NCT02922179|Descriptive analysis|descriptive analysis
58167|NCT02922153|CryoAnalgesia|cryoanalgesia
58168|NCT02922153|Thoracotomy|thoracotomy
58169|NCT02922153|FEV1|fev1
58170|NCT02922153|VAS|vas
58171|NCT02922140|pharmaceutical care service, clinical pharmacist|pharmaceutical care service, clinical pharmacist
58172|NCT02922140|Cardiac rehabilitation unit|cardiac rehabilitation unit
58173|NCT02922140|Acute coronary syndrome|acute coronary syndrome
58174|NCT02922140|patient education and counselling|patient education and counselling
58175|NCT02922127|Ulipristal Acetate (UPA)|ulipristal acetate (upa)
58176|NCT02922127|Breast Cancer|breast cancer
58177|NCT02922127|Combined Oral Contraceptive (COC)|combined oral contraceptive (coc)
58178|NCT02922114|Ultrasonography|ultrasonography
58179|NCT02922114|Clinical assesment|clinical assesment
58180|NCT02922114|joint abnormalities|joint abnormalities
58181|NCT02922088|Vein Graft Failure|vein graft failure
58182|NCT02922088|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
58183|NCT02922088|Vascular Grafts|vascular grafts
58184|NCT02922088|Saphenous Vein Grafts|saphenous vein grafts
58185|NCT02922088|Vein Graft Disease|vein graft disease
58186|NCT02922088|Vein Graft Treatment|vein graft treatment
58187|NCT02922088|Vein Graft Handling|vein graft handling
58188|NCT02922075|gingival recession|gingival recession
58189|NCT02922075|immediate implant and provisional placement|immediate implant and provisional placement
58190|NCT02922075|bone graft|bone graft
58191|NCT02922075|connective tissue graft|connective tissue graft
58192|NCT02922075|collagen matrix|collagen matrix
58193|NCT02922062|lipids|lipids
58194|NCT02922062|saturated fat|saturated fat
58195|NCT02922062|palm oil|palm oil
58196|NCT02922049|Probe Based Confocal Laser Endomicroscopy (pCLE)|probe based confocal laser endomicroscopy (pcle)
58197|NCT02922049|Barrett's esophagus|barrett's esophagus
58198|NCT02922049|BORN|born
58199|NCT02922049|Intestinal metaplasia|intestinal metaplasia
58201|NCT02921997|A/H7N9|a/h7n9
58202|NCT02921997|ASO3 Adjuvant|aso3 adjuvant
58203|NCT02921997|influenza|influenza
58204|NCT02921997|monovalent|monovalent
58205|NCT02921997|pH1N1|ph1n1
58206|NCT02921997|vaccines|vaccines
58207|NCT02921984|Salivary Gland Tumors|salivary gland tumors
58208|NCT02921984|Head and Neck Cancer|head and neck cancer
58209|NCT02921984|concurrent chemotherapy|concurrent chemotherapy
58210|NCT02921984|genetic testing|genetic testing
58211|NCT02921958|Parents of children with disabilities|parents of children with disabilities
58212|NCT02921932|Physiotherapy|physiotherapy
58213|NCT02921932|Inspiratory Muscle Training|inspiratory muscle training
58214|NCT02921932|Perioperative Medicine|perioperative medicine
58215|NCT02921932|Postoperative outcomes|postoperative outcomes
58216|NCT02921932|Preoperative nutrition|preoperative nutrition
58217|NCT02921932|Elderly, frail|elderly, frail
58218|NCT02921906|Insulin|insulin
58219|NCT02921906|Glucose|glucose
58220|NCT02921906|Incretin|incretin
58221|NCT02921906|GLP-1|glp-1
58222|NCT02921906|Food|food
58223|NCT02921867|ultrasound|ultrasound
58224|NCT02921867|radiology|radiology
58225|NCT02921867|simulation|simulation
58226|NCT02921867|abdominal ultrasound|abdominal ultrasound
58227|NCT02921867|medical education|medical education
58228|NCT02921841|Adolescents|adolescents
58229|NCT02921841|HIV prevention|hiv prevention
58230|NCT02921841|computerized intervention|computerized intervention
58231|NCT02921841|mental health treatment|mental health treatment
58232|NCT02921828|Pomalyst|pomalyst
58233|NCT02921828|Teratogenicity|teratogenicity
58234|NCT02921828|bone marrow suppression|bone marrow suppression
58235|NCT02921828|thromboembolism|thromboembolism
58237|NCT02921828|infection|infection
58238|NCT02921828|tumour lysis syndrome|tumour lysis syndrome
58239|NCT02921828|somnolence|somnolence
58240|NCT02921828|depressed level of consciousness|depressed level of consciousness
58241|NCT02921828|confusion|confusion
58242|NCT02921828|fatigue|fatigue
58243|NCT02921828|dizziness|dizziness
58244|NCT02921828|acute renal failure|acute renal failure
58245|NCT02921828|heart failure|heart failure
58246|NCT02921828|arrhythmia|arrhythmia
58247|NCT02921828|interstitial pneumonia|interstitial pneumonia
58248|NCT02921828|hypersensitivity|hypersensitivity
58249|NCT02921828|hepatic function disorder|hepatic function disorder
58250|NCT02921828|jaundice|jaundice
58251|NCT02921815|Leukemia|leukemia
58252|NCT02921815|Acute Myeloid Leukemia|acute myeloid leukemia
58253|NCT02921815|Revlimid|revlimid
58254|NCT02921802|Teratogenicity|teratogenicity
58255|NCT02921802|Thrombocytopenia and haemorrhage|thrombocytopenia and haemorrhage
58256|NCT02921802|Neutropenia and infection|neutropenia and infection
58257|NCT02921802|Venous thromboembolism|venous thromboembolism
58258|NCT02921802|Allergic reactions|allergic reactions
58259|NCT02921802|Diarrhoea or constipation|diarrhoea or constipation
58260|NCT02921802|Peripheral neuropathy|peripheral neuropathy
58261|NCT02921802|Cardiac failure|cardiac failure
58262|NCT02921802|Arrhythmia|arrhythmia
58263|NCT02921802|Renal failure|renal failure
58264|NCT02921802|Myocardial infarction|myocardial infarction
58265|NCT02921802|Interstitial lung disease|interstitial lung disease
58266|NCT02921802|Tumour lysis syndrome|tumour lysis syndrome
58267|NCT02921802|Transformation from myelodysplastic syndrome to acute myeloid leukemia|transformation from myelodysplastic syndrome to acute myeloid leukemia
58268|NCT02921789|Bleselumab|bleselumab
58269|NCT02921789|ASKP1240|askp1240
58270|NCT02921789|Efficacy and Safety|efficacy and safety
58271|NCT02921776|Vidatalk|vidatalk
58272|NCT02921776|App|app
58273|NCT02921776|Augmentative and Alternative Communication|augmentative and alternative communication
58274|NCT02921776|iPad|ipad
58275|NCT02921776|Android|android
58276|NCT02921776|Mechanical ventilation|mechanical ventilation
58277|NCT02921776|Patient Communication|patient communication
58278|NCT02921776|Critical Illness|critical illness
58280|NCT02921737|metastatic|metastatic
58281|NCT02921737|pancreatic|pancreatic
58282|NCT02921737|adenocarcinoma|adenocarcinoma
58283|NCT02921724|cancer|cancer
58286|NCT02921724|capecitabine|capecitabine
58287|NCT02921724|mobile app|mobile app
58288|NCT02921659|nicotinamide riboside|nicotinamide riboside
58289|NCT02921659|aging|aging
58290|NCT02921659|arterial stiffness|arterial stiffness
58291|NCT02921659|endothelial dysfunction|endothelial dysfunction
58292|NCT02921646|energetic expenditure|energetic expenditure
58293|NCT02921633|Immunization|immunization
58294|NCT02921633|Behavioural insights|behavioural insights
58295|NCT02921633|Children|children
58296|NCT02921620|Gastrointestinal symptoms|gastrointestinal symptoms
58297|NCT02921620|Diarrhea|diarrhea
58298|NCT02921620|Abdominal pain|abdominal pain
58299|NCT02921555|RCT (randomized controlled trial)|rct (randomized controlled trial)
58300|NCT02921529|Postoperative recovery|postoperative recovery
58301|NCT02921529|colon surgery|colon surgery
58302|NCT02921516|Adolescence|adolescence
49739|NCT02974985|Facial Rejuvenation|facial rejuvenation
49740|NCT02974985|Aging Face|aging face
49741|NCT02974985|WIZDOM|wizdom
49742|NCT02974985|Midface lift|midface lift
49743|NCT02974985|Midface augmentation|midface augmentation
58303|NCT02921516|Adherence|adherence
58304|NCT02921438|Cardiovascular Diseases|cardiovascular diseases
58305|NCT02921438|Heart Diseases|heart diseases
58306|NCT02921438|Myocardial Ischemia|myocardial ischemia
58307|NCT02921438|NSTE ACS|nste acs
58308|NCT02921438|NSTEMI|nstemi
58309|NCT02921438|Unstable Angina Pectoris|unstable angina pectoris
58310|NCT02921438|Coronary Artery Disease|coronary artery disease
58311|NCT02921425|lifestyle|lifestyle
58312|NCT02921425|patient health record|patient health record
58313|NCT02921425|Veterans|veterans
58314|NCT02921425|prediabetes|prediabetes
58315|NCT02921373|perfluorocarbon imaging|perfluorocarbon imaging
58316|NCT02921373|peripheral blood mononuclear cells|peripheral blood mononuclear cells
58317|NCT02921373|cancer immunotherapy|cancer immunotherapy
58318|NCT02921373|prostate cancer|prostate cancer
58319|NCT02921373|MRI|mri
58320|NCT02921360|thrombolytic therapy|thrombolytic therapy
58321|NCT02921360|tissue plasminogen activator|tissue plasminogen activator
58322|NCT02921360|aspirin|aspirin
58323|NCT02921321|MRI|mri
58324|NCT02921321|Muscular Dystrophy|muscular dystrophy
58325|NCT02921321|Cardiac|cardiac
58326|NCT02921321|Late gadolinium enhancement|late gadolinium enhancement
58327|NCT02921308|Prematurity|prematurity
58328|NCT02921308|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
58329|NCT02921308|MRI|mri
58330|NCT02921308|PFT|pft
58331|NCT02921308|Emphysema|emphysema
58332|NCT02921282|genes|genes
58333|NCT02921282|cues|cues
58334|NCT02921282|reward|reward
58335|NCT02921282|smoking|smoking
58336|NCT02921230|atherosclerosis|atherosclerosis
58337|NCT02921230|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
58338|NCT02921230|Proximal Popliteal Artery (PPA)|proximal popliteal artery (ppa)
58339|NCT02921230|stenting|stenting
58340|NCT02921230|paclitaxel|paclitaxel
58341|NCT02921217|Cardiovascular diseases|cardiovascular diseases
58342|NCT02921217|abdominal visceral fat|abdominal visceral fat
58343|NCT02921217|subcutaneous body fat|subcutaneous body fat
58344|NCT02921217|body weight|body weight
58345|NCT02921217|waist circumference|waist circumference
58346|NCT02921217|lipid profile|lipid profile
58347|NCT02921217|insulin resistance|insulin resistance
58348|NCT02921217|glucose metabolism|glucose metabolism
58349|NCT02921217|blood pressure|blood pressure
58350|NCT02921217|inflammation|inflammation
58351|NCT02921217|adiponectin|adiponectin
58352|NCT02921217|leptin|leptin
58353|NCT02921217|metabolomics|metabolomics
58354|NCT02921217|cardiovascular risk factor|cardiovascular risk factor
58355|NCT02921204|Vitamin D|vitamin d
58356|NCT02921204|Calcium|calcium
58357|NCT02921204|Phytic Acid|phytic acid
58358|NCT02921204|body weight|body weight
58359|NCT02921191|recombinant human granulocyte colony-stimulating factors|recombinant human granulocyte colony-stimulating factors
58360|NCT02921191|G-CSFs|g-csfs
58361|NCT02921191|biosimilar|biosimilar
58362|NCT02921191|biologics|biologics
58363|NCT02921191|High Neutropenia Risk Chemotherapy|high neutropenia risk chemotherapy
58364|NCT02921191|Biologic and Biosimilars Collective Intelligence Consortium|biologic and biosimilars collective intelligence consortium
58365|NCT02921191|bbcic|bbcic
58366|NCT02921165|tooth extraction|tooth extraction
58367|NCT02921165|tooth socket healing|tooth socket healing
58368|NCT02921165|hypertension|hypertension
58369|NCT02921165|rinses|rinses
58370|NCT02921139|Hepatocellular Carcinoma|hepatocellular carcinoma
58371|NCT02921139|Transcatheter Arterial Chemoembolization (TACE)|transcatheter arterial chemoembolization (tace)
58372|NCT02921139|Stereotactic ablative radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
58373|NCT02921113|suPAR|supar
58374|NCT02921113|Acute Kidney Injury|acute kidney injury
58375|NCT02921113|On-Pump Cardiac Surgery|on-pump cardiac surgery
58376|NCT02921113|Biomarker|biomarker
58377|NCT02921048|Eicosapentaenoic Acid|eicosapentaenoic acid
58378|NCT02921048|Docosahexaenoic Acid|docosahexaenoic acid
58379|NCT02921048|Ambient Air Pollution|ambient air pollution
58588|NCT02919605|pentamidine isothionate|pentamidine isothionate
58380|NCT02921035|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
58381|NCT02921035|Interferon beta-1a|interferon beta-1a
58383|NCT02921035|Morisky Medication Adherence Scale|morisky medication adherence scale
58384|NCT02921022|Gemcitabine|gemcitabine
58385|NCT02921022|Nab-paclitaxel|nab-paclitaxel
58386|NCT02921022|PEGPH20|pegph20
58387|NCT02921022|Rivaroxaban|rivaroxaban
58388|NCT02921022|thromboembolic event (TE)|thromboembolic event (te)
58389|NCT02921022|16-1066|16-1066
58390|NCT02920996|NSCLC|nsclc
58391|NCT02920996|MET|met
58392|NCT02920996|Non-small cell lung cancer|non-small cell lung cancer
49844|NCT02974309|Youth|youth
49846|NCT02974309|Sleep|sleep
58393|NCT02920996|MET mutation|met mutation
58394|NCT02920996|NTRK rearrangement|ntrk rearrangement
58395|NCT02920996|NTRK|ntrk
58396|NCT02920996|targeted therapy|targeted therapy
58397|NCT02920996|MET exon 14|met exon 14
58398|NCT02920996|NTRK1|ntrk1
58399|NCT02920996|NTRK2|ntrk2
58400|NCT02920996|NTRK3|ntrk3
58401|NCT02920996|merestinib|merestinib
58402|NCT02920996|LY2801653|ly2801653
58403|NCT02920918|Systolic Heart Failure|systolic heart failure
58404|NCT02920918|Canagliflozin|canagliflozin
58405|NCT02920918|Sitagliptin Phosphate|sitagliptin phosphate
58406|NCT02920918|Type 2 Diabetes|type 2 diabetes
58407|NCT02920918|SGLT2 inhibitor|sglt2 inhibitor
58408|NCT02920918|DPPIV inhibitor|dppiv inhibitor
58409|NCT02920866|Functional strength integration|functional strength integration
58410|NCT02920866|Rehabilitation|rehabilitation
58411|NCT02920866|Hip arthroplasty|hip arthroplasty
58412|NCT02920866|Physical function|physical function
58413|NCT02920866|Muscle performance|muscle performance
58414|NCT02920866|Movement compensations|movement compensations
58415|NCT02920853|chronic pain|chronic pain
58416|NCT02920827|HIV Infections|hiv infections
58417|NCT02920827|HIV seronegativity|hiv seronegativity
58418|NCT02920801|saxagliptin|saxagliptin
58419|NCT02920801|endothelial progenitor cell|endothelial progenitor cell
58420|NCT02920801|flow-mediated dilation|flow-mediated dilation
58421|NCT02920788|Rehabilitation|rehabilitation
58422|NCT02920788|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
58423|NCT02920749|anaesthesia|anaesthesia
58425|NCT02920749|recovery profiles|recovery profiles
58426|NCT02920723|Sleep Apnea Syndromes|sleep apnea syndromes
58427|NCT02920723|Sleep Apnea, Obstructives|sleep apnea, obstructives
58428|NCT02920723|Training|training
58429|NCT02920684|Early rehabilitation|early rehabilitation
58430|NCT02920684|Mechanical ventilation|mechanical ventilation
58431|NCT02920684|Physiotherapy|physiotherapy
58432|NCT02920658|NAVS Naphthalan|navs naphthalan
58433|NCT02920658|Betamethasone dipropionate|betamethasone dipropionate
58434|NCT02920658|Topical treatment|topical treatment
58435|NCT02920645|ICH|ich
58436|NCT02920645|AVM|avm
58437|NCT02920645|intracerebral hemorrhage|intracerebral hemorrhage
58438|NCT02920645|arterio-venous malformation|arterio-venous malformation
58439|NCT02920645|AVICH|avich
58440|NCT02920632|Parkinson|parkinson
58441|NCT02920632|Cognitive training|cognitive training
58442|NCT02920632|Cognitive rehabilitation|cognitive rehabilitation
58443|NCT02920632|Brain networks|brain networks
58444|NCT02920619|ultrasound|ultrasound
58445|NCT02920619|muscle|muscle
58446|NCT02920606|pulpotomy|pulpotomy
58447|NCT02920606|pulpitis|pulpitis
58448|NCT02920606|mature tooth|mature tooth
58449|NCT02920606|tricalcium silicate|tricalcium silicate
58450|NCT02920593|Vitamin D; hypertensive disorders of pregnancy|vitamin d; hypertensive disorders of pregnancy
58451|NCT02920580|Subarachnoid hemorrhage|subarachnoid hemorrhage
58452|NCT02920580|Spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
58453|NCT02920580|Global cerebral anoxia/cardiac arrest|global cerebral anoxia/cardiac arrest
58454|NCT02920580|Meningitis/Encephalitis/Cerebral abscess|meningitis/encephalitis/cerebral abscess
58455|NCT02920580|Seizure|seizure
58456|NCT02920580|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
58457|NCT02920580|Ischemic Stroke|ischemic stroke
58458|NCT02920580|Brain tumor|brain tumor
58459|NCT02920554|gallbladder cancer|gallbladder cancer
58460|NCT02920554|bisegmentectomy|bisegmentectomy
58461|NCT02920515|epidemiology|epidemiology
58462|NCT02920515|treatment|treatment
58463|NCT02920515|molecular pathological mechanism|molecular pathological mechanism
58464|NCT02920515|environmental disrupting chemicals|environmental disrupting chemicals
58465|NCT02920489|severity of labor pain|severity of labor pain
58466|NCT02920489|individualized administration|individualized administration
58467|NCT02920489|neuraxial labor analgesia|neuraxial labor analgesia
58468|NCT02920476|lung|lung
58469|NCT02920476|metastatic|metastatic
58470|NCT02920476|carcinoma|carcinoma
58471|NCT02920463|Anti-Infective agents|anti-infective agents
58472|NCT02920463|Antimicrobial stewardship|antimicrobial stewardship
58473|NCT02920463|Empirical antibiotic therapy|empirical antibiotic therapy
58474|NCT02920463|De-escalation|de-escalation
58475|NCT02920463|Critical care|critical care
58476|NCT02920450|lung|lung
58477|NCT02920450|carcinoma|carcinoma
58478|NCT02920437|dietary salt|dietary salt
58479|NCT02920437|24 hour urinary sodium excretion|24 hour urinary sodium excretion
58480|NCT02920437|blood pressure|blood pressure
58481|NCT02920437|hypertension|hypertension
58482|NCT02920346|Neonatal Systemic lupus erythematosus|neonatal systemic lupus erythematosus
58483|NCT02920346|Sjogren's syndrome|sjogren's syndrome
58484|NCT02920346|Fetal Atrioventricular Block|fetal atrioventricular block
58485|NCT02920346|Fetal Heart Block|fetal heart block
58486|NCT02920333|stroke|stroke
58487|NCT02920333|transcraniel direct current stimulation|transcraniel direct current stimulation
58488|NCT02920333|repetitive transcraniel magnetic stimulation|repetitive transcraniel magnetic stimulation
58489|NCT02920333|rehabilitation|rehabilitation
58490|NCT02920333|lower extremeties|lower extremeties
58491|NCT02920307|laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
58492|NCT02920307|total extraperitoneoscopic hernia repair|total extraperitoneoscopic hernia repair
58493|NCT02920307|transabdominal preperitoneal hernia repair|transabdominal preperitoneal hernia repair
58494|NCT02920307|inguinal hernia|inguinal hernia
58495|NCT02920307|laparoscopy|laparoscopy
60269|NCT02909101|HIV|hiv
58501|NCT02920268|yoga|yoga
58502|NCT02920268|adolescents|adolescents
58503|NCT02920268|recurrent abdominal pain|recurrent abdominal pain
58504|NCT02920242|Travelers|travelers
58505|NCT02920242|diarrhea|diarrhea
58506|NCT02920242|rifaximin|rifaximin
58507|NCT02920242|equivalence|equivalence
58508|NCT02920229|68Ga-PSMA|68ga-psma
58509|NCT02920229|HBED-PET/CT|hbed-pet/ct
58510|NCT02920229|biochemical relapse|biochemical relapse
58511|NCT02920229|prostate cancer|prostate cancer
58512|NCT02920229|radically treated|radically treated
58513|NCT02920216|Head and Neck Neoplasms|head and neck neoplasms
58514|NCT02920216|Recurrence|recurrence
58515|NCT02920216|Indocyanine Green|indocyanine green
58516|NCT02920216|Salvage surgery|salvage surgery
58517|NCT02920203|Sudden unexpected death|sudden unexpected death
58518|NCT02920203|young subjects|young subjects
58519|NCT02920203|molecular genetic autopsy|molecular genetic autopsy
58520|NCT02920203|sequencing|sequencing
58521|NCT02920138|Obesity|obesity
58522|NCT02920138|intraabdominal pressure|intraabdominal pressure
58523|NCT02920138|cerebral oxymeter|cerebral oxymeter
58524|NCT02920138|sleeve gastrectomy|sleeve gastrectomy
58525|NCT02920138|laparoscopy|laparoscopy
58526|NCT02920125|Vascular disease|vascular disease
58527|NCT02920112|Obesity|obesity
58528|NCT02920112|Bariatric Surgery|bariatric surgery
58529|NCT02920112|Bariatrics|bariatrics
58530|NCT02920112|Cognitive Therapy|cognitive therapy
58534|NCT02920073|anorexia nervosa|anorexia nervosa
58535|NCT02920073|under nutrition|under nutrition
58537|NCT02920073|enteral nutrition|enteral nutrition
58539|NCT02920047|Fimasartan|fimasartan
58540|NCT02920008|AML, acute myeloid leukemia, guadecitabine, SGI-110, Phase 3|aml, acute myeloid leukemia, guadecitabine, sgi-110, phase 3
58541|NCT02919982|Anticoagulant|anticoagulant
58542|NCT02919982|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
58543|NCT02919982|Registries|registries
58544|NCT02919969|Anal Cancer|anal cancer
58545|NCT02919956|Single Ventricle|single ventricle
58546|NCT02919956|Fontan|fontan
58547|NCT02919904|prostate cancer|prostate cancer
58548|NCT02919904|sleep|sleep
58549|NCT02919904|androgen deprivation therapy|androgen deprivation therapy
58550|NCT02919891|intra-epidermal nerve fibre density|intra-epidermal nerve fibre density
58551|NCT02919891|IENFD|ienfd
58552|NCT02919891|Chronic Pain|chronic pain
58553|NCT02919891|Post-mastectomy|post-mastectomy
58554|NCT02919891|Post-mastectomy pain syndrome|post-mastectomy pain syndrome
58555|NCT02919891|PMPS|pmps
58556|NCT02919891|Chronic Post-Surgical Pain|chronic post-surgical pain
58557|NCT02919891|CPSP|cpsp
58558|NCT02919891|Mastectomy|mastectomy
58559|NCT02919813|mindfulness group therapy|mindfulness group therapy
58560|NCT02919813|vulvodynia|vulvodynia
58561|NCT02919813|vulvar pain|vulvar pain
58562|NCT02919787|Neoadjuvant treatment|neoadjuvant treatment
58563|NCT02919761|persistant disease activity|persistant disease activity
58564|NCT02919748|dementia|dementia
58565|NCT02919748|cognitive decline|cognitive decline
58566|NCT02919748|choral singing|choral singing
58567|NCT02919748|health education program|health education program
58568|NCT02919748|randomized controlled trial|randomized controlled trial
58573|NCT02919722|Music therapy|music therapy
58574|NCT02919722|sensorimotor cortex|sensorimotor cortex
58575|NCT02919722|brain injury|brain injury
58576|NCT02919696|CDK4/6 Inhibitor|cdk4/6 inhibitor
58577|NCT02919683|Head and Neck Cancer|head and neck cancer
58578|NCT02919670|Stem Cell Transplant|stem cell transplant
58579|NCT02919644|vaccination|vaccination
58580|NCT02919644|autologous dendritic cells|autologous dendritic cells
58581|NCT02919644|autologous tumour homogenate|autologous tumour homogenate
58582|NCT02919644|curative resection|curative resection
58583|NCT02919644|stage IV colorectal cancer|stage iv colorectal cancer
58584|NCT02919618|Ventricular Tachycardia|ventricular tachycardia
58585|NCT02919618|Ablation|ablation
58586|NCT02919618|Noninvasive|noninvasive
58587|NCT02919605|Cutaneous Leishmaniasis|cutaneous leishmaniasis
58589|NCT02919605|treatment|treatment
58590|NCT02919553|endoscopic ultrasound|endoscopic ultrasound
58591|NCT02919553|wet-suction technique|wet-suction technique
58592|NCT02919553|capillary technique|capillary technique
58593|NCT02919553|fine needle aspiration|fine needle aspiration
58594|NCT02919553|fine needle biopsy|fine needle biopsy
50097|NCT02972840|Btk|btk
58595|NCT02919514|fall prevention|fall prevention
58596|NCT02919514|Aging|aging
58597|NCT02919514|surfaces|surfaces
58598|NCT02919475|JTE-051|jte-051
58599|NCT02919475|Active Rheumatoid Arthritis|active rheumatoid arthritis
58601|NCT02919475|Safety|safety
58602|NCT02919475|Tolerability|tolerability
58603|NCT02919475|Rheumatoid Arthritis|rheumatoid arthritis
58604|NCT02919462|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
58605|NCT02919462|advanced stage IIIB|advanced stage iiib
58606|NCT02919462|high Thymidylate Synthase expression|high thymidylate synthase expression
58607|NCT02919462|Treatment|treatment
58608|NCT02919462|Chemotherapy Naïve Patients|chemotherapy naïve patients
58609|NCT02919462|stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer|stage iiib-iv non-squamous non-small cell lung cancer
58610|NCT02919462|Cisplatin and Pemetrexed|cisplatin and pemetrexed
58611|NCT02919462|Cisplatin and Oral Vinorelbine|cisplatin and oral vinorelbine
58612|NCT02919449|Lung Cancer Measles Nivolumab Opdivo|lung cancer measles nivolumab opdivo
58613|NCT02918656|Cochrane|cochrane
58614|NCT02918656|Abstract|abstract
58615|NCT02918656|Infographics|infographics
58616|NCT02918656|Understanding|understanding
58617|NCT02918643|Elderly|elderly
58618|NCT02918643|Potentially Inappropriate Medications|potentially inappropriate medications
58619|NCT02918630|E-cigarettes|e-cigarettes
58620|NCT02918630|Schizophrenia|schizophrenia
58621|NCT02918617|dentin hypersensitivity|dentin hypersensitivity
58622|NCT02918617|nanohydroxyapatite|nanohydroxyapatite
58623|NCT02918617|calcium sodium phosphosilicate|calcium sodium phosphosilicate
58624|NCT02918617|toothpaste|toothpaste
58625|NCT02918617|tooth cream|tooth cream
58626|NCT02918604|peripheral vein access|peripheral vein access
58627|NCT02918604|infrared|infrared
58628|NCT02918604|pediatric|pediatric
58629|NCT02918578|Physical Inactivity|physical inactivity
58630|NCT02918578|Behavior Change|behavior change
58631|NCT02918526|Laryngeal masks|laryngeal masks
58632|NCT02918513|Wellness|wellness
58633|NCT02918513|Mental Wellness|mental wellness
58634|NCT02918513|Well-Being|well-being
58635|NCT02919384|Embryonic development|embryonic development
58636|NCT02919384|blastocyst stage|blastocyst stage
58637|NCT02919345|Dapagliflozin|dapagliflozin
58638|NCT02919345|Glibenclamide|glibenclamide
58639|NCT02919345|Endothelial Function|endothelial function
58640|NCT02919345|Vascular Endothelial Cells|vascular endothelial cells
58641|NCT02919345|Flow Mediated Dilation|flow mediated dilation
58642|NCT02919267|One lung ventilation|one lung ventilation
58643|NCT02919267|Lung collapse|lung collapse
58644|NCT02919267|Bronchial blocker|bronchial blocker
58645|NCT02919267|Double lumen tube|double lumen tube
58646|NCT02919267|video assisted thoracoscopic surgery|video assisted thoracoscopic surgery
58647|NCT02919267|VATS|vats
58648|NCT02919267|DLT|dlt
58649|NCT02919267|Thoracic surgery|thoracic surgery
58650|NCT02919267|Video-assisted|video-assisted
58651|NCT02919241|dental anxiety|dental anxiety
58652|NCT02919241|cognitive therapy|cognitive therapy
58653|NCT02919228|cerebral oxygen metabolism|cerebral oxygen metabolism
58654|NCT02919228|functional near-infrared spectroscopy|functional near-infrared spectroscopy
58655|NCT02919228|partial pressure of carbon dioxide|partial pressure of carbon dioxide
58656|NCT02919228|heart rate variability|heart rate variability
58657|NCT02919228|blood pressure|blood pressure
58658|NCT02919228|affect|affect
58659|NCT02919228|mood|mood
58660|NCT02919228|respiration|respiration
58661|NCT02919228|systematic randomized cross-over study|systematic randomized cross-over study
58662|NCT02919228|systemic physiology|systemic physiology
58663|NCT02919228|electro-dermal activity|electro-dermal activity
58664|NCT02919228|pulse-respiratory quotient|pulse-respiratory quotient
58665|NCT02919189|cerebral oxygen metabolism|cerebral oxygen metabolism
58666|NCT02919189|functional near-infrared spectroscopy|functional near-infrared spectroscopy
58667|NCT02919189|partial pressure of carbon dioxide|partial pressure of carbon dioxide
58668|NCT02919189|heart rate variability|heart rate variability
58669|NCT02919189|blood pressure|blood pressure
58670|NCT02919189|affect|affect
58671|NCT02919189|mood|mood
58672|NCT02919189|respiration|respiration
58673|NCT02919189|systematic randomized cross-over study|systematic randomized cross-over study
58674|NCT02919189|systemic physiology|systemic physiology
58675|NCT02919189|electro-dermal activity|electro-dermal activity
58676|NCT02919189|pulse-respiratory quotient|pulse-respiratory quotient
58677|NCT02919163|cerebral oxygen metabolism|cerebral oxygen metabolism
58678|NCT02919163|functional near-infrared spectroscopy|functional near-infrared spectroscopy
58679|NCT02919163|partial pressure of carbon dioxide|partial pressure of carbon dioxide
58680|NCT02919163|heart rate variability|heart rate variability
58681|NCT02919163|blood pressure|blood pressure
58682|NCT02919163|affect|affect
58683|NCT02919163|mood|mood
58685|NCT02919163|systematic randomized cross-over study|systematic randomized cross-over study
58686|NCT02919163|systemic physiology|systemic physiology
58687|NCT02919163|electro-dermal activity|electro-dermal activity
58688|NCT02919163|pulse-respiratory quotient|pulse-respiratory quotient
58689|NCT02919150|Myofascial Trigger Points|myofascial trigger points
58690|NCT02919150|Myotonometry|myotonometry
58691|NCT02919150|Isokinetic Dynamometry|isokinetic dynamometry
58693|NCT02919150|Reliability|reliability
58694|NCT02919137|cerebral oxygen metabolism|cerebral oxygen metabolism
58695|NCT02919137|functional near-infrared spectroscopy|functional near-infrared spectroscopy
58696|NCT02919137|partial pressure of carbon dioxide|partial pressure of carbon dioxide
58697|NCT02919137|heart rate variability|heart rate variability
58698|NCT02919137|blood pressure|blood pressure
58699|NCT02919137|affect|affect
58700|NCT02919137|mood|mood
58701|NCT02919137|respiration|respiration
58702|NCT02919137|systematic randomized cross-over study|systematic randomized cross-over study
58703|NCT02919137|systemic physiology|systemic physiology
58704|NCT02919137|electro-dermal activity|electro-dermal activity
58705|NCT02919137|pulse-respiratory quotient|pulse-respiratory quotient
58706|NCT02919124|Coronary artery bypass grafting|coronary artery bypass grafting
58707|NCT02919124|Anastomosis|anastomosis
58708|NCT02919124|Ultrasonography|ultrasonography
58709|NCT02919059|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
58710|NCT02919059|DM|dm
58711|NCT02919046|neuroblastoma|neuroblastoma
58712|NCT02919046|CAR-T|car-t
58713|NCT02919033|randomized controlled trial|randomized controlled trial
58714|NCT02919033|telemedicine|telemedicine
58715|NCT02919033|hypertension|hypertension
58716|NCT02919033|primary care|primary care
58717|NCT02919033|medication adherence|medication adherence
58718|NCT02919020|Proprioceptive Neuromuscular Facilitation (PNF )|proprioceptive neuromuscular facilitation (pnf )
58719|NCT02919020|resistance exercise|resistance exercise
58720|NCT02918968|enzalutamide|enzalutamide
58721|NCT02918968|Xtandi|xtandi
58722|NCT02918968|Prostate Cancer|prostate cancer
58723|NCT02918955|head and neck cancer|head and neck cancer
58724|NCT02918955|radiotherapy|radiotherapy
58725|NCT02918955|chemotherapy|chemotherapy
58726|NCT02918955|neck dissection|neck dissection
58727|NCT02918955|surgery|surgery
58728|NCT02918955|quality of life|quality of life
58729|NCT02918955|toxicity|toxicity
58730|NCT02918955|oropharyngeal cancer|oropharyngeal cancer
58731|NCT02918955|laryngeal cancer|laryngeal cancer
58732|NCT02918955|hypopharyngeal cancer|hypopharyngeal cancer
58733|NCT02918929|First-in-human|first-in-human
58734|NCT02918929|Single Ascending Dose|single ascending dose
58735|NCT02918929|Multiple Ascending Dose|multiple ascending dose
58736|NCT02918890|Pediatric|pediatric
58737|NCT02918890|HABIT|habit
58738|NCT02918890|CIMT|cimt
58739|NCT02918890|Cerebral Palsy|cerebral palsy
58740|NCT02918890|Hemiplegia|hemiplegia
58741|NCT02918890|Children|children
58742|NCT02918890|Therapy|therapy
58743|NCT02918877|Volatile Anesthetics|volatile anesthetics
58744|NCT02918877|Intravenous Anesthetics|intravenous anesthetics
58745|NCT02918877|Inflammatory Lung Injury|inflammatory lung injury
58746|NCT02918877|Postoperative Pulmonary Complications|postoperative pulmonary complications
58747|NCT02918877|Cardiac Surgery|cardiac surgery
58748|NCT02918877|Cardiopulmonary Bypass|cardiopulmonary bypass
58749|NCT02918864|Autism Spectrum Disorder|autism spectrum disorder
58750|NCT02918864|Oxytocin|oxytocin
58751|NCT02918864|Social Skills|social skills
58752|NCT02918864|Social cognitive skills|social cognitive skills
58753|NCT02918864|Cognitive Behavioral Intervention|cognitive behavioral intervention
58754|NCT02918864|Combination treatment|combination treatment
58755|NCT02918864|Syntocinon|syntocinon
58756|NCT02918864|NETT (Nonverbal communication, Emotion recognition, Theory of mind Training)|nett (nonverbal communication, emotion recognition, theory of mind training)
58757|NCT02918864|emotion recognition|emotion recognition
58758|NCT02918864|theory of mind|theory of mind
58759|NCT02918838|HIV|hiv
58760|NCT02918838|Antiretroviral (ARV)|antiretroviral (arv)
58761|NCT02918838|co-trimoxazole|co-trimoxazole
58762|NCT02918838|SMS|sms
58763|NCT02918838|Lottery incentive|lottery incentive
58764|NCT02918838|mobile health|mobile health
58765|NCT02918838|Uganda|uganda
58766|NCT02918838|Youth|youth
58767|NCT02918825|schizophrenia|schizophrenia
58768|NCT02918825|clinical trial|clinical trial
58769|NCT02918825|olanzapine|olanzapine
58770|NCT02918825|paliperidone|paliperidone
58771|NCT02918812|Hysterosalpingography|hysterosalpingography
58772|NCT02918812|Pain relief|pain relief
58773|NCT02918812|Infertility|infertility
58774|NCT02918812|Intracervical block|intracervical block
58775|NCT02918812|Diclofenac|diclofenac
58776|NCT02918786|oxygen therapy|oxygen therapy
58777|NCT02918786|continuous positive airway pressure|continuous positive airway pressure
58778|NCT02918786|extubation|extubation
58779|NCT02918773|Pediatrics|pediatrics
58780|NCT02918773|Emergency Medicine|emergency medicine
58781|NCT02918773|Ear infection|ear infection
58782|NCT02918760|Gabapentin, chronic pelvic pain.|gabapentin, chronic pelvic pain.
58783|NCT02918734|Anterior Cruciate Ligament|anterior cruciate ligament
50237|NCT02971631|GLP-1|glp-1
58784|NCT02918734|Bone-Patellar Tendon-Bone Grafting|bone-patellar tendon-bone grafting
58785|NCT02918721|Hyaluronic Acid, Nasolabial Fold, Lidocaine|hyaluronic acid, nasolabial fold, lidocaine
58786|NCT02918708|vaccination|vaccination
60571|NCT02907281|MS|ms
58788|NCT02918708|pneumococcal|pneumococcal
58789|NCT02918708|conjugate|conjugate
58790|NCT02918695|Geriatric assessment|geriatric assessment
58791|NCT02918695|Fit and frail elderly|fit and frail elderly
58792|NCT02918695|Geriatric oncology|geriatric oncology
58793|NCT02918500|Coronary Artery Bypass Surgery (CABG)|coronary artery bypass surgery (cabg)
58794|NCT02918500|Nicotine Replacement Therapy (NRT)|nicotine replacement therapy (nrt)
58795|NCT02918474|Contralateral prophylactic breast cancer|contralateral prophylactic breast cancer
58796|NCT02918474|CPM|cpm
58797|NCT02918474|Breast cancer surgery|breast cancer surgery
58798|NCT02918474|Breast Cancer|breast cancer
58799|NCT02918474|Questionnaire|questionnaire
58800|NCT02918474|Survey|survey
58801|NCT02918474|Decision tool|decision tool
58802|NCT02918474|Contralateral Prophylactic Mastectomy|contralateral prophylactic mastectomy
58803|NCT02918422|Diet Intervention|diet intervention
58804|NCT02918422|Metabolic Syndrome|metabolic syndrome
58805|NCT02918422|Feeding Study|feeding study
58806|NCT02918422|Prediabetes|prediabetes
58807|NCT02918396|Atrial Fibrillation|atrial fibrillation
58808|NCT02918396|Atrial Fibrosis|atrial fibrosis
58809|NCT02918396|Late Gadolinium Enhancement Magnetic Resonance Imaging|late gadolinium enhancement magnetic resonance imaging
58810|NCT02918396|Computational Modeling|computational modeling
58811|NCT02918396|Rotor Anchor Sites|rotor anchor sites
58812|NCT02918370|Alcohol Use Disorder|alcohol use disorder
58813|NCT02918370|Bipolar Disorder|bipolar disorder
58814|NCT02918370|Mood|mood
58815|NCT02918370|Alcohol Craving|alcohol craving
58816|NCT02918370|Aripiprazole|aripiprazole
58817|NCT02918344|calcium phosphate paste|calcium phosphate paste
58818|NCT02918305|denervation|denervation
58840|NCT02918201|Bandages|bandages
58841|NCT02918201|Occlusive Dressings|occlusive dressings
58842|NCT02918175|mHealth|mhealth
58843|NCT02918162|pembrolizumab|pembrolizumab
58844|NCT02918162|adenocarcinoma|adenocarcinoma
58845|NCT02918162|gastric cancer|gastric cancer
58846|NCT02918162|Locoregional gastric adenocarcinoma|locoregional gastric adenocarcinoma
58847|NCT02918162|Locoregional GE junction adenocarcinoma|locoregional ge junction adenocarcinoma
58848|NCT02918149|Ultrasonography|ultrasonography
58849|NCT02918149|Infant|infant
58850|NCT02918149|Newborn|newborn
58851|NCT02918149|Lumbar puncture|lumbar puncture
58852|NCT02918149|Spinal puncture|spinal puncture
58853|NCT02918149|Cerebrospinal fluid|cerebrospinal fluid
58854|NCT02918123|Psoriasis|psoriasis
58855|NCT02918123|Plaque psoriasis|plaque psoriasis
58856|NCT02918123|Stem cell|stem cell
58857|NCT02918123|Cell therapy|cell therapy
58858|NCT02918123|Furestem|furestem
58859|NCT02918123|Mesenchymal stem cell|mesenchymal stem cell
58860|NCT02918123|MSC|msc
58861|NCT02918123|Umbilical cord blood|umbilical cord blood
58862|NCT02918123|hUCB-MSC|hucb-msc
58863|NCT02918123|UCB-MSC|ucb-msc
58864|NCT02918097|Cost effectiveness|cost effectiveness
58865|NCT02918097|Bipolar disorder|bipolar disorder
58866|NCT02918097|Depressive episodes|depressive episodes
58867|NCT02918097|Quality of Life|quality of life
58868|NCT02918084|sequential administration chemiotherapy|sequential administration chemiotherapy
58869|NCT02918084|early breast cancer|early breast cancer
58870|NCT02918084|breast cancer|breast cancer
58871|NCT02918084|aromatase inhibitor|aromatase inhibitor
58872|NCT02918084|adjuvant|adjuvant
58873|NCT02918084|post menopausal|post menopausal
58874|NCT02918071|Asthma,|asthma,
58875|NCT02918071|Bronchial Diseases,|bronchial diseases,
58876|NCT02918071|Respiratory Tract Diseases,|respiratory tract diseases,
58877|NCT02918071|Lung Diseases,|lung diseases,
58878|NCT02918071|Obstructive Lung Diseases,|obstructive lung diseases,
58879|NCT02918071|Benralizumab|benralizumab
58880|NCT02918058|Frailty|frailty
58881|NCT02918058|Deprescription|deprescription
58882|NCT02918045|Tooth Extraction|tooth extraction
58883|NCT02918045|Surgical Hemostasis|surgical hemostasis
58884|NCT02918045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
58885|NCT02918045|Chitosan|chitosan
58886|NCT02918032|Jordans anomaly|jordans anomaly
58887|NCT02918032|neutral lipid storage disease|neutral lipid storage disease
58888|NCT02918032|triglyceride deposit cardiovasculopathy|triglyceride deposit cardiovasculopathy
58889|NCT02918032|ATGL gene|atgl gene
58890|NCT02918032|CGI-58 gene|cgi-58 gene
58891|NCT02918032|primary triglyceride deposit cardiomyovasculopathy (TGCV)|primary triglyceride deposit cardiomyovasculopathy (tgcv)
58892|NCT02918032|neutral lipid storage disease with myopathy (NLSD-M)|neutral lipid storage disease with myopathy (nlsd-m)
58893|NCT02917993|non-small cell lung cancer|non-small cell lung cancer
58894|NCT02917993|locally advanced|locally advanced
58895|NCT02917993|metastatic|metastatic
58896|NCT02917993|epidermal growth factor receptor (EGFR) inhibition|epidermal growth factor receptor (egfr) inhibition
67550|NCT02861794|RSA|rsa
59603|NCT02913911|feedback|feedback
58897|NCT02917993|Janus kinase inhibition|janus kinase inhibition
58898|NCT02917980|structural Heart Diseases|structural heart diseases
58899|NCT02917980|surgical treatment|surgical treatment
58900|NCT02917980|interventional treatment|interventional treatment
58901|NCT02917980|hybrid treatment|hybrid treatment
58912|NCT02917928|carnosine, type 2 diabetes, cardiovascular factors|carnosine, type 2 diabetes, cardiovascular factors
58914|NCT02917915|Emphysema|emphysema
58915|NCT02917915|Chronic Bronchitis|chronic bronchitis
58916|NCT02917915|Pulmonary rehabilitation|pulmonary rehabilitation
58917|NCT02917915|Lung Diseases, Obstructive|lung diseases, obstructive
58918|NCT02917902|student-run free clinic|student-run free clinic
58919|NCT02917902|food supply|food supply
58920|NCT02917902|food insecure|food insecure
58921|NCT02917902|medically uninsured|medically uninsured
58922|NCT02917902|medically underserved|medically underserved
58923|NCT02917889|Caffeine|caffeine
58924|NCT02917889|Autonomic Nervous System|autonomic nervous system
58925|NCT02917889|Recovery|recovery
58926|NCT02917889|Aerobic exercise|aerobic exercise
58927|NCT02917876|Obstructive Sleep Apnea|obstructive sleep apnea
58928|NCT02917876|Pregnancy|pregnancy
58929|NCT02917876|Obesity|obesity
58930|NCT02917876|Fluid shifts|fluid shifts
58931|NCT02917876|Body composition|body composition
58932|NCT02917876|Sleep|sleep
58933|NCT02917863|Hypothyroidism|hypothyroidism
58934|NCT02917863|Microbiota|microbiota
58935|NCT02917863|Thyroid hormone|thyroid hormone
58936|NCT02917863|L-Thyroxine|l-thyroxine
58937|NCT02917863|Celiac disease|celiac disease
58938|NCT02917850|stroke|stroke
58939|NCT02917850|gait|gait
58940|NCT02917850|hip flexors|hip flexors
58941|NCT02917850|paresis|paresis
58942|NCT02917850|hemiplegia|hemiplegia
58943|NCT02917798|Genetic Testing|genetic testing
58944|NCT02917798|16-919|16-919
58945|NCT02917772|tailored immuno therapy|tailored immuno therapy
58946|NCT02917772|Nivolumab|nivolumab
58947|NCT02917772|Ipilimumab|ipilimumab
58948|NCT02917772|boost|boost
58949|NCT02917759|liver cancer|liver cancer
58950|NCT02917759|biliary tract cancer|biliary tract cancer
58951|NCT02917759|cholangiocarcinoma|cholangiocarcinoma
58952|NCT02917759|hepatocellular carcinoma|hepatocellular carcinoma
58953|NCT02917759|liver tumor|liver tumor
58954|NCT02917759|biliary tumor|biliary tumor
58955|NCT02917759|hepatoma|hepatoma
58956|NCT02917759|liver mass|liver mass
58957|NCT02917746|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
58958|NCT02917746|Imiquimod|imiquimod
58959|NCT02917746|Treatment|treatment
58960|NCT02917746|Predictive biomarkers|predictive biomarkers
58961|NCT02917720|TKI discontinuation|tki discontinuation
58962|NCT02917707|CRC|crc
58963|NCT02917707|liver metastasis|liver metastasis
58964|NCT02917681|ALS|als
58965|NCT02917681|mesenchymal stem cells|mesenchymal stem cells
58966|NCT02917681|intrathecal|intrathecal
58967|NCT02917668|Obesity|obesity
58968|NCT02917668|Hyperoxia|hyperoxia
58969|NCT02917668|Hypercapnia|hypercapnia
58970|NCT02917668|Postoperative complications|postoperative complications
58971|NCT02917668|Cardiac surgical procedures|cardiac surgical procedures
58972|NCT02917655|Education|education
58973|NCT02917655|Quality of Life|quality of life
58974|NCT02917655|Osteoarthritis|osteoarthritis
58975|NCT02917655|Metabolic Syndrome|metabolic syndrome
58976|NCT02917642|bacterial infection|bacterial infection
58977|NCT02917642|endotoxin|endotoxin
58978|NCT02917642|passive ultrasonic irrigation|passive ultrasonic irrigation
58979|NCT02917642|root canal treatment|root canal treatment
58980|NCT02917590|Spinal cord injury|spinal cord injury
58981|NCT02917590|dual-task obstacle crossing|dual-task obstacle crossing
58982|NCT02917564|Choroidal effusions|choroidal effusions
58983|NCT02917564|Trabeculectomy|trabeculectomy
58984|NCT02917551|Bacteremia, duration, non-critically ill, non-ICU|bacteremia, duration, non-critically ill, non-icu
58985|NCT02917525|Calcium metabolism|calcium metabolism
58986|NCT02917525|Matrix Gla Protein|matrix gla protein
58987|NCT02917525|Vitamin K2|vitamin k2
58988|NCT02917486|ExtraCorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
58989|NCT02917486|patient in intensive care|patient in intensive care
58990|NCT02917486|pharmacokinetic modeling|pharmacokinetic modeling
58991|NCT02917473|Medical skin examination|medical skin examination
58992|NCT02917473|Skin Self Examination|skin self examination
58993|NCT02917473|Sun protection|sun protection
58994|NCT02917460|Rady|rady
58995|NCT02917460|Pediatric|pediatric
58996|NCT02917460|Genomic|genomic
58997|NCT02917460|Precision medicine|precision medicine
58998|NCT02917460|Biorepository|biorepository
58999|NCT02917447|PTSD|ptsd
59000|NCT02917447|Women Veterans|women veterans
59001|NCT02917447|Online intervention|online intervention
59002|NCT02917434|Obesity|obesity
59003|NCT02917434|Psoriatic arthritis|psoriatic arthritis
59004|NCT02917434|Psoriasis|psoriasis
59005|NCT02917434|Metabolic syndrome|metabolic syndrome
67625|NCT02861417|Myleran|myleran
50443|NCT02970669|AHF|ahf
59006|NCT02917434|Cardiovascular disease|cardiovascular disease
59604|NCT02913898|learning|learning
59007|NCT02917395|hypertrophic cardiomyopathy, disopyramide,|hypertrophic cardiomyopathy, disopyramide,
59008|NCT02917369|LCLC; Integrative Analysis; Metastasis|lclc; integrative analysis; metastasis
59009|NCT02917356|Healing touch|healing touch
59010|NCT02917356|Faith Healing|faith healing
59011|NCT02917356|Pain|pain
60729|NCT02906215|mHealth|mhealth
59017|NCT02917291|Trauma Spinal Cord|trauma spinal cord
59018|NCT02917291|Thoracic Acute Spinal Cord Injury|thoracic acute spinal cord injury
59019|NCT02917291|Neurosurgery|neurosurgery
59020|NCT02917291|Cell Therapy|cell therapy
59022|NCT02917291|HC016 adipose mesenchymal stem cell|hc016 adipose mesenchymal stem cell
59023|NCT02917291|SPINE|spine
59024|NCT02917213|acute myocardial infarction|acute myocardial infarction
59025|NCT02917213|cardiac embolism|cardiac embolism
59026|NCT02917213|intracardiac fluid dynamics|intracardiac fluid dynamics
59027|NCT02917213|silent brain infarct|silent brain infarct
59028|NCT02917213|intracardiac blood stasis|intracardiac blood stasis
59029|NCT02917174|asthma|asthma
59030|NCT02917174|m-health|m-health
59031|NCT02917174|asthma control|asthma control
59032|NCT02917174|self-management|self-management
59033|NCT02917161|Prostate|prostate
59034|NCT02917161|Prostatic Neoplams|prostatic neoplams
59035|NCT02917161|Therapeutic Embolization|therapeutic embolization
59036|NCT02917161|Prostatectomy|prostatectomy
59037|NCT02917122|Parkinson disease|parkinson disease
59038|NCT02917122|transcranial direct current stimulation|transcranial direct current stimulation
59039|NCT02917122|depression|depression
59040|NCT02917122|dopamine transporter|dopamine transporter
59041|NCT02917122|single photon emission computerized tomography|single photon emission computerized tomography
59042|NCT02917083|chimeric antigen receptors|chimeric antigen receptors
59043|NCT02917083|immunotherapy|immunotherapy
59044|NCT02917083|CAR T-cells|car t-cells
59045|NCT02917083|lymphoma|lymphoma
59046|NCT02917083|Cyclophosphamide|cyclophosphamide
59047|NCT02917083|fludarabine|fludarabine
59048|NCT02917070|Consanguinity-associated kidney diseases|consanguinity-associated kidney diseases
59049|NCT02917070|Turkey population|turkey population
59050|NCT02917031|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
59051|NCT02917031|Heart Failure|heart failure
59052|NCT02917031|Saxagliptin|saxagliptin
59053|NCT02917031|Sitagliptin|sitagliptin
59054|NCT02917018|Dexmedetomidine|dexmedetomidine
59055|NCT02917018|Stress response|stress response
59056|NCT02917018|Emergence agitation|emergence agitation
59057|NCT02917005|breast cancer|breast cancer
59058|NCT02917005|hormone receptor positive, HER2 negative|hormone receptor positive, her2 negative
59059|NCT02917005|palbociclib|palbociclib
59060|NCT02917005|premenopausal|premenopausal
59061|NCT02916992|spontaneous pneumothorax|spontaneous pneumothorax
59062|NCT02916992|familial pneumothorax|familial pneumothorax
59063|NCT02916992|Birt-Hogg-Dube syndrome|birt-hogg-dube syndrome
59064|NCT02916992|prevalence|prevalence
59065|NCT02916992|FLCN mutation|flcn mutation
59066|NCT02916992|Lung cysts|lung cysts
59067|NCT02916992|BHD|bhd
59068|NCT02916992|inherited disease|inherited disease
59069|NCT02916992|genetic disease|genetic disease
59070|NCT02916992|primary pneumothorax|primary pneumothorax
59071|NCT02916992|CAT scan|cat scan
59072|NCT02916992|CT scan|ct scan
59073|NCT02916940|sprains of the proximal interphalangeal joints of the long fingers|sprains of the proximal interphalangeal joints of the long fingers
59074|NCT02916940|Diprophos|diprophos
59075|NCT02916927|ketamine|ketamine
59076|NCT02916927|emergency department|emergency department
59077|NCT02916914|preterm|preterm
59078|NCT02916914|feeding|feeding
59079|NCT02916914|oral transition|oral transition
59080|NCT02916901|Dyslipidemia|dyslipidemia
59081|NCT02916901|CKD-519|ckd-519
59082|NCT02916901|CETP inhibitor|cetp inhibitor
59083|NCT02916901|ABPM|abpm
59084|NCT02916888|Atopic dermatitis|atopic dermatitis
59085|NCT02916888|Topical corticosteroid|topical corticosteroid
59086|NCT02916888|Pediatric|pediatric
59087|NCT02916888|Eczema|eczema
59088|NCT02916888|Quality of life|quality of life
59089|NCT02916875|Shared decision Making|shared decision making
59090|NCT02916875|Follow-up|follow-up
59091|NCT02916862|fiber|fiber
59092|NCT02916862|calcium absorption|calcium absorption
59093|NCT02916862|bone mass|bone mass
59094|NCT02916862|adolescents|adolescents
59095|NCT02916849|Accidental Falls|accidental falls
59096|NCT02916849|Prevention & Control|prevention & control
59097|NCT02916849|Exercise|exercise
59098|NCT02916849|Exercise therapy/methods*|exercise therapy/methods*
59099|NCT02916849|Aged|aged
59100|NCT02916849|Aged 80 and over|aged 80 and over
59101|NCT02916849|Smartphone|smartphone
59102|NCT02916849|Computers|computers
59103|NCT02916849|Computers handheld|computers handheld
59104|NCT02916849|Motivation|motivation
59105|NCT02916849|Postural balance|postural balance
50539|NCT02970188|arterial stiffness|arterial stiffness
50541|NCT02970175|Terlipressin|terlipressin
59106|NCT02916849|Health behaviour|health behaviour
59107|NCT02916849|mHealth|mhealth
59108|NCT02916849|eHealth|ehealth
59605|NCT02913872|Spirometry|spirometry
59109|NCT02916810|transcranial magnetic stimulation|transcranial magnetic stimulation
59110|NCT02916810|schizophrenia|schizophrenia
59112|NCT02916797|Feedback|feedback
59113|NCT02916797|Physical Therapy|physical therapy
59114|NCT02916784|Sit-to-stand|sit-to-stand
59115|NCT02916784|Walking devices|walking devices
59116|NCT02916771|Smoldering Multiple Myeloma|smoldering multiple myeloma
59117|NCT02916758|older adults|older adults
59118|NCT02916758|community mobility|community mobility
59119|NCT02916758|wellness|wellness
59120|NCT02916758|isolation|isolation
59121|NCT02916745|Non-small cell lung cancer|non-small cell lung cancer
59122|NCT02916745|NSCLC|nsclc
59123|NCT02916745|lung cancer|lung cancer
59124|NCT02916745|lung carcinoma|lung carcinoma
59125|NCT02916745|lung metastasis|lung metastasis
59126|NCT02916732|asymptomatics|asymptomatics
59127|NCT02916732|microcephaly|microcephaly
59128|NCT02916732|abnormalities|abnormalities
59129|NCT02916719|neo-adjuvant radiotherapy|neo-adjuvant radiotherapy
59130|NCT02916719|breast cancer|breast cancer
59131|NCT02916719|MRI|mri
59132|NCT02916693|Mirabegron|mirabegron
59133|NCT02916693|Overactive Bladder|overactive bladder
59134|NCT02916693|Erectile Dysfunction|erectile dysfunction
59135|NCT02916693|Beta 3 agonist|beta 3 agonist
59136|NCT02916680|Pancreatic islet transplantation|pancreatic islet transplantation
59137|NCT02916641|Fuzhenghuayu|fuzhenghuayu
59138|NCT02916628|smoking cessation|smoking cessation
59139|NCT02916628|group counseling|group counseling
59140|NCT02916628|acupressure|acupressure
59141|NCT02916628|serotonin|serotonin
59142|NCT02916628|depressive symptoms|depressive symptoms
59143|NCT02916628|resilience|resilience
59144|NCT02916537|prostate cancer|prostate cancer
59145|NCT02916537|prostate specific membrane antigen|prostate specific membrane antigen
59146|NCT02916537|prostate neoplasms|prostate neoplasms
59147|NCT02916537|metastatic prostate cancer|metastatic prostate cancer
59148|NCT02916537|prostatic hyperplasia|prostatic hyperplasia
59149|NCT02916524|Aphasia|aphasia
59150|NCT02916524|Bilingualism|bilingualism
59151|NCT02916524|Language therapy|language therapy
59152|NCT02916524|Rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
59153|NCT02916524|Speech-language pathology|speech-language pathology
59154|NCT02916498|chronic neuropathic pain in the low back and legs|chronic neuropathic pain in the low back and legs
59155|NCT02916498|subperception spinal cord stimulation|subperception spinal cord stimulation
59156|NCT02916485|bioresorbable scaffold|bioresorbable scaffold
59157|NCT02916485|vascular restoration therapy|vascular restoration therapy
59158|NCT02916472|AYA|aya
59159|NCT02916472|exercise|exercise
59160|NCT02916472|cancer|cancer
59161|NCT02916472|cybercycling|cybercycling
59162|NCT02916407|Anesthesia|anesthesia
59163|NCT02916407|Agitation|agitation
59164|NCT02916407|Extubation|extubation
59165|NCT02916316|Lymphoma|lymphoma
59166|NCT02916316|Large B-Cell|large b-cell
59167|NCT02916316|Cardiotoxicity|cardiotoxicity
59168|NCT02916303|Schizophrenia|schizophrenia
59169|NCT02916303|Psychosis|psychosis
59170|NCT02916303|Effectiveness|effectiveness
59171|NCT02916290|Fuzhenghuayu|fuzhenghuayu
59172|NCT02916264|scalp block, surgical peth index|scalp block, surgical peth index
59173|NCT02916160|Chronic Heart failure|chronic heart failure
59174|NCT02916160|Sleep Apnea Syndrome|sleep apnea syndrome
59175|NCT02916160|Continuous Positive Airways Pressure|continuous positive airways pressure
59176|NCT02916160|SACUBITRIL - VALSARTAN|sacubitril - valsartan
59177|NCT02916108|Concussion|concussion
59178|NCT02916108|Mild traumatic brain injury|mild traumatic brain injury
59179|NCT02916108|EEG|eeg
59180|NCT02916082|Cervical length|cervical length
59181|NCT02916082|Prolonged pregnancy|prolonged pregnancy
59182|NCT02916082|Vaginal birth|vaginal birth
59183|NCT02916069|Spectroscopy|spectroscopy
59184|NCT02916069|Transcranial Doppler|transcranial doppler
59185|NCT02916069|Bispectral index|bispectral index
59186|NCT02916069|Cardiac surgery|cardiac surgery
59187|NCT02916056|Alzheimer's disease|alzheimer's disease
59188|NCT02916056|RAGE|rage
59189|NCT02916056|ADAS-cog|adas-cog
59190|NCT02916056|CDR-sb|cdr-sb
59191|NCT02916043|acute kidney injury|acute kidney injury
59192|NCT02916043|cardiovascular surgery|cardiovascular surgery
59193|NCT02916043|mortality|mortality
59194|NCT02916030|Vitamin D|vitamin d
59195|NCT02916030|Stroke|stroke
59196|NCT02916030|Parathormone|parathormone
59197|NCT02916017|Non-infectious Intermediate-, Posterior-, or Pan-uveitis|non-infectious intermediate-, posterior-, or pan-uveitis
59198|NCT02916017|Adalimumab|adalimumab
59199|NCT02916017|Humira|humira
59200|NCT02916004|Analgesia|analgesia
59201|NCT02916004|Pain measurement|pain measurement
50637|NCT02969512|Patient education|patient education
59202|NCT02916004|Nociception|nociception
59203|NCT02916004|Electromyography|electromyography
59204|NCT02916004|Electrical stimulation|electrical stimulation
59205|NCT02916004|Pupillometry|pupillometry
59206|NCT02916004|Critical care|critical care
59207|NCT02916004|Sedation|sedation
59797|NCT02912442|infertility|infertility
59208|NCT02915991|Coronary catheterization|coronary catheterization
59209|NCT02915991|Instantaneous wave free ratio (iFR)|instantaneous wave free ratio (ifr)
59210|NCT02915991|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
59211|NCT02915991|automated co-registration|automated co-registration
59212|NCT02915939|Family caregiving|family caregiving
59311|NCT02915432|Anti PD-1|anti pd-1
59213|NCT02915939|Institutionalization|institutionalization
59214|NCT02915939|Residential long-term care|residential long-term care
59215|NCT02915939|Placement|placement
59216|NCT02915939|Psychosocial support|psychosocial support
59217|NCT02915939|Dementia|dementia
59218|NCT02915939|Caregivers|caregivers
59219|NCT02915939|Nursing homes|nursing homes
59220|NCT02915939|Assisted Living Facilities|assisted living facilities
59221|NCT02915939|Long-Term Care|long-term care
59222|NCT02915939|Intervention Study|intervention study
59223|NCT02915939|Psychosocial Support Systems|psychosocial support systems
59224|NCT02915939|Social Support|social support
59225|NCT02915939|Coping|coping
59226|NCT02915900|In vitro fertilization|in vitro fertilization
59227|NCT02915887|neck pain|neck pain
59228|NCT02915887|chronic|chronic
59229|NCT02915887|taping|taping
59230|NCT02915887|kinematics|kinematics
59231|NCT02915887|motion analysis|motion analysis
59232|NCT02915887|physiotherapy|physiotherapy
59233|NCT02915861|immune responses|immune responses
59234|NCT02915861|vaccines|vaccines
59235|NCT02915848|deep brain stimulation|deep brain stimulation
59236|NCT02915848|local field potential|local field potential
59237|NCT02915848|kinematic analysis|kinematic analysis
59238|NCT02915835|Scleroderma|scleroderma
59239|NCT02915835|Digital Ulcer|digital ulcer
59240|NCT02915809|Influenza Vaccines|influenza vaccines
59241|NCT02915796|Endothelial progenitor cell|endothelial progenitor cell
59242|NCT02915796|Percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
59243|NCT02915783|unresectable advanced|unresectable advanced
59244|NCT02915783|metastatic|metastatic
59245|NCT02915770|Moderate dilatation of common bile duct|moderate dilatation of common bile duct
59246|NCT02915757|Depression|depression
59247|NCT02915757|EDOR test|edor test
59248|NCT02915757|Electrodermal hyporeactivity|electrodermal hyporeactivity
59249|NCT02915744|Breast Cancer Brain Metastases (BCBM)|breast cancer brain metastases (bcbm)
59250|NCT02915744|Carcinoma|carcinoma
59251|NCT02915731|Vitamin A stores|vitamin a stores
59252|NCT02915731|Stable isotope dilution|stable isotope dilution
59253|NCT02915731|Multiple vitamin A interventions|multiple vitamin a interventions
59254|NCT02915718|dilated cardiomyopathy|dilated cardiomyopathy
59255|NCT02915718|immunoadsorption|immunoadsorption
59256|NCT02915692|Foley|foley
59257|NCT02915692|CAUTI|cauti
59258|NCT02915692|ERASE CAUTI|erase cauti
59259|NCT02915679|Suicidal behavior|suicidal behavior
59260|NCT02915679|psychological and social pain|psychological and social pain
59261|NCT02915679|physical pain|physical pain
59262|NCT02915679|pain perception|pain perception
59263|NCT02915666|Melanoma, skin|melanoma, skin
59264|NCT02915627|Antishock Garment|antishock garment
59265|NCT02915614|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
59266|NCT02915614|pulmonary rehabilitation|pulmonary rehabilitation
59267|NCT02915614|exercise training|exercise training
59268|NCT02915614|skeletal muscle biopsy|skeletal muscle biopsy
59269|NCT02915562|rehabilitation|rehabilitation
59270|NCT02915562|exercise|exercise
59271|NCT02915562|outcome measurement|outcome measurement
59272|NCT02915549|premature infant|premature infant
59273|NCT02915549|early progressive feeding|early progressive feeding
59274|NCT02915536|iodine excess|iodine excess
59275|NCT02915536|thyroid disease|thyroid disease
59276|NCT02915536|children|children
59277|NCT02915536|tolerable upper intake level|tolerable upper intake level
59278|NCT02915523|Ovarian Cancer|ovarian cancer
59279|NCT02915523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
59280|NCT02915523|Entinostat|entinostat
59281|NCT02915523|Solid tumor|solid tumor
59282|NCT02915523|Avelumab|avelumab
59283|NCT02915523|SNDX-275|sndx-275
59284|NCT02915523|Ovarian Neoplasms|ovarian neoplasms
59285|NCT02915523|Ovarian Diseases|ovarian diseases
59286|NCT02915523|Fallopian Tube Cancer|fallopian tube cancer
59287|NCT02915523|Peritoneal Cancer|peritoneal cancer
59288|NCT02915497|Prolonged Exposure Therapy|prolonged exposure therapy
59289|NCT02915484|Transcranial Direct Current Stimulation|transcranial direct current stimulation
59290|NCT02915484|Apathy|apathy
59291|NCT02915484|Stroke|stroke
59292|NCT02915484|Empathy|empathy
59293|NCT02915484|Electric Stimulation Therapy|electric stimulation therapy
59294|NCT02915484|Depression|depression
59295|NCT02915484|Anhedonia|anhedonia
59296|NCT02915484|Prefrontal Cortex|prefrontal cortex
59297|NCT02915484|Electroencephalography|electroencephalography
59298|NCT02915484|Cognition|cognition
59299|NCT02915484|Emotions|emotions
59300|NCT02915484|Neurological Rehabilitation|neurological rehabilitation
59301|NCT02915484|Brain Diseases|brain diseases
59302|NCT02915484|Cerebrovascular Disorders|cerebrovascular disorders
59303|NCT02915471|Adolescent|adolescent
59304|NCT02915471|Online Peer Support|online peer support
59305|NCT02915471|Managing Cancer|managing cancer
59306|NCT02915471|Mentor|mentor
59307|NCT02915458|Weaning|weaning
59308|NCT02915458|Mechanical ventilation|mechanical ventilation
59309|NCT02915458|synchrosqueezing transform|synchrosqueezing transform
59310|NCT02915445|EpCAM CAR-T, solid tumors, cancer immunotherapy|epcam car-t, solid tumors, cancer immunotherapy
59312|NCT02915432|JS001|js001
59313|NCT02915432|Gastric Adenocarcinoma|gastric adenocarcinoma
59314|NCT02915432|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
59315|NCT02915432|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
59316|NCT02915432|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
59317|NCT02915432|Simon's Two Stage|simon's two stage
59318|NCT02915432|ORR|orr
59319|NCT02915393|Chronic Gastritis|chronic gastritis
59320|NCT02915393|Qi Deficiency Constitution|qi deficiency constitution
59321|NCT02915393|Next Generation Sequencing|next generation sequencing
59322|NCT02915393|Proteomics|proteomics
59323|NCT02915393|Metabonomics|metabonomics
59324|NCT02915367|HIV/AIDS|hiv/aids
59325|NCT02915367|adherence|adherence
59326|NCT02915367|women|women
59327|NCT02915367|real time monitoring|real time monitoring
59328|NCT02915367|risk|risk
59329|NCT02915367|SMS|sms
59330|NCT02915367|mHealth|mhealth
59331|NCT02915315|blood pressure|blood pressure
59332|NCT02915315|Hypertrophy|hypertrophy
59333|NCT02915315|Left Ventricular|left ventricular
59334|NCT02915315|arterial Stiffness|arterial stiffness
59335|NCT02915315|Proteinuria|proteinuria
59336|NCT02915315|baPWV|bapwv
59337|NCT02915315|ambulatory Blood Pressure|ambulatory blood pressure
59338|NCT02915302|Influenza|influenza
59339|NCT02915302|Influenza virus vaccine|influenza virus vaccine
59340|NCT02915302|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
59341|NCT02915289|Caesarean section|caesarean section
59342|NCT02915289|Chlorhexidine gluconate|chlorhexidine gluconate
59343|NCT02915276|Blastocyst|blastocyst
59344|NCT02915276|Human|human
59345|NCT02915276|DNA|dna
59346|NCT02915276|Blastocentesis|blastocentesis
59347|NCT02915263|Diabetes Complications|diabetes complications
59348|NCT02915263|Diabetes Mellitus|diabetes mellitus
59349|NCT02915263|Diabetic Neuropathies|diabetic neuropathies
59350|NCT02915263|IGIV-C|igiv-c
59351|NCT02915263|Immune Globulin Injection (Human), 10% Caprylate/Chromatography|immune globulin injection (human), 10% caprylate/chromatography
59352|NCT02915263|Gamunex-C|gamunex-c
59353|NCT02915237|Veterans|veterans
59354|NCT02915237|Gulf War Illness|gulf war illness
59355|NCT02915237|Gulf War Veterans's Illness|gulf war veterans's illness
59356|NCT02915237|Gulf War Veterans' Medically Unexplained Illnesses|gulf war veterans' medically unexplained illnesses
59357|NCT02915211|Epilepsy|epilepsy
59358|NCT02915211|Glut|glut
59359|NCT02915211|Ketogenic|ketogenic
59360|NCT02915211|Glucose|glucose
59361|NCT02915198|Metformin|metformin
59362|NCT02915198|Atherosclerosis|atherosclerosis
59363|NCT02915198|Prediabetic State|prediabetic state
59364|NCT02915198|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
59365|NCT02915198|Coronary Artery Disease|coronary artery disease
59366|NCT02915198|Peripheral Arterial Disease|peripheral arterial disease
59367|NCT02915198|Cerebrovascular Disorders|cerebrovascular disorders
59368|NCT02915185|exercise|exercise
59369|NCT02915185|rehabilitation|rehabilitation
59370|NCT02915185|recovery of function|recovery of function
59371|NCT02915185|transcranial magnetic stimulation|transcranial magnetic stimulation
59372|NCT02915185|transcranial direct-current stimulation|transcranial direct-current stimulation
59373|NCT02915172|Advanced Cancer|advanced cancer
583419|NCT00511654|NK1 receptor antagonists,|nk1 receptor antagonists,
59374|NCT02915172|Malignant neoplasm of breast|malignant neoplasm of breast
59375|NCT02915172|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
59376|NCT02915172|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
59377|NCT02915172|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
59378|NCT02915172|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
59379|NCT02915172|Malignant neoplasms of ill-defined secondary and unspecified sites|malignant neoplasms of ill-defined secondary and unspecified sites
59380|NCT02915172|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
59381|NCT02915172|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
59382|NCT02915172|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
68147|NCT02857985|MRI|mri
50832|NCT02967913|PFDI-20|pfdi-20
59383|NCT02915172|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
59384|NCT02915172|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
59385|NCT02915172|Malignant neoplasms of thyroid and other endocrine glands|malignant neoplasms of thyroid and other endocrine glands
59386|NCT02915172|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
59387|NCT02915172|Lenvatinib|lenvatinib
59389|NCT02915172|Lenvima|lenvima
60299|NCT02908971|overweight|overweight
59390|NCT02915172|Capecitabine|capecitabine
59391|NCT02915172|Xeloda|xeloda
59392|NCT02915146|eczema|eczema
59393|NCT02915146|phototherapy|phototherapy
59394|NCT02915146|uva1|uva1
59396|NCT02915146|adults|adults
59397|NCT02915146|children|children
59398|NCT02915133|high myopia|high myopia
59399|NCT02915133|myopia foveoschisis|myopia foveoschisis
59400|NCT02915133|macular buckling|macular buckling
59401|NCT02915120|Knee pain|knee pain
59402|NCT02915120|osteoarthritis|osteoarthritis
59403|NCT02915120|genicular nerve|genicular nerve
59404|NCT02915120|ultrasonography|ultrasonography
59405|NCT02915120|pulsed radiofrequency|pulsed radiofrequency
59406|NCT02915107|drug eluting stents|drug eluting stents
59407|NCT02915107|coronary vascular healing|coronary vascular healing
59408|NCT02915068|patient-provider communication|patient-provider communication
59409|NCT02915068|Electronic Health Records|electronic health records
59410|NCT02915068|Provider education|provider education
59411|NCT02915055|Analgesic efficacy|analgesic efficacy
59412|NCT02915055|knee arthroplasty|knee arthroplasty
59413|NCT02915055|Opioid consumption|opioid consumption
59414|NCT02915055|Pain Medicine|pain medicine
59415|NCT02915055|Narcotics|narcotics
59416|NCT02915055|Multimodal Analgesia|multimodal analgesia
59417|NCT02915042|Pain|pain
59418|NCT02915042|dexmedetomidine|dexmedetomidine
59419|NCT02915042|postoperative|postoperative
59420|NCT02915029|Native American|native american
59421|NCT02915029|Community Health Representative|community health representative
59422|NCT02915029|Home base|home base
59423|NCT02915029|Diabetes|diabetes
59424|NCT02915029|Point of care testing|point of care testing
59425|NCT02915029|Patient Activation Measure|patient activation measure
59426|NCT02915029|Patient preferences|patient preferences
59427|NCT02915003|health care navigation|health care navigation
59428|NCT02915003|health literacy|health literacy
59429|NCT02915003|Affordable Care Act|affordable care act
59430|NCT02914977|Relapsed|relapsed
59431|NCT02914977|Refractory|refractory
59432|NCT02914964|Fatigue|fatigue
59433|NCT02914964|Quality of Life|quality of life
59434|NCT02914964|Diet|diet
59435|NCT02914951|Autism|autism
59436|NCT02914951|Irritability|irritability
59437|NCT02914951|Disruptive Behavior|disruptive behavior
59438|NCT02914951|Aggression|aggression
59439|NCT02914951|Behavior Therapy|behavior therapy
59440|NCT02914951|Cognitive Behavioral Therapy|cognitive behavioral therapy
59441|NCT02914951|Intellectual Disability|intellectual disability
59442|NCT02914951|Cognitive Impairment|cognitive impairment
59443|NCT02914925|CIT|cit
59444|NCT02914925|ArmeoSpring|armeospring
59445|NCT02914925|TMS|tms
59446|NCT02914899|Chinese Taxi Drivers|chinese taxi drivers
59447|NCT02914899|16-949|16-949
59448|NCT02914886|Diabetes|diabetes
59449|NCT02914886|Lipoatrophy|lipoatrophy
59450|NCT02914886|children|children
59451|NCT02914886|adolescents|adolescents
59452|NCT02914886|adults|adults
59453|NCT02914886|insulin therapy|insulin therapy
59454|NCT02914873|prostate cancer|prostate cancer
59455|NCT02914873|active surveillance|active surveillance
59456|NCT02914873|standardised treatment triggers|standardised treatment triggers
59457|NCT02914873|MRI|mri
59458|NCT02914873|randomized|randomized
59459|NCT02914821|consumption|consumption
59460|NCT02914821|decision making|decision making
59461|NCT02914821|policy|policy
59462|NCT02914821|sweetened beverages|sweetened beverages
59463|NCT02914821|taxes|taxes
59464|NCT02914821|Diet, Food, and Nutrition|diet, food, and nutrition
59465|NCT02914769|Depression|depression
59466|NCT02914769|Ayahuasca|ayahuasca
59467|NCT02914769|Psychedelics|psychedelics
59468|NCT02914743|Oral health|oral health
59469|NCT02914743|Diabetes|diabetes
59470|NCT02914743|Interprofessionalism|interprofessionalism
59471|NCT02914743|Periodontal disease|periodontal disease
59472|NCT02914730|diabetes|diabetes
59474|NCT02914730|medication adherence|medication adherence
59475|NCT02914717|golimumab|golimumab
59476|NCT02914691|Type 2 diabetes|type 2 diabetes
59477|NCT02914691|Diabetic Nephropathy|diabetic nephropathy
59478|NCT02914691|Proteomics|proteomics
59479|NCT02914691|Albuminuria|albuminuria
59480|NCT02914691|SGLT2 inhibitor|sglt2 inhibitor
59481|NCT02914678|Emergency Medical Services|emergency medical services
59482|NCT02914678|Analgesics|analgesics
59483|NCT02914665|Heart failure|heart failure
59484|NCT02914665|diuresis|diuresis
50941|NCT02967068|CSS|css
59485|NCT02914665|dropsy|dropsy
59486|NCT02914665|congestion|congestion
59487|NCT02914665|elamipretide|elamipretide
59488|NCT02914665|MTP-131|mtp-131
59489|NCT02914665|Bendavia™|bendavia™
59490|NCT02914652|Congenital Heart Disease|congenital heart disease
59491|NCT02914652|Ventricular Septal Defect|ventricular septal defect
59492|NCT02914652|Beta-2-agonists|beta-2-agonists
59493|NCT02914652|Surgery|surgery
59494|NCT02914652|Follow-up|follow-up
59495|NCT02914626|Glaucoma, Neovascular|glaucoma, neovascular
59500|NCT02914483|Myocardial Infarction|myocardial infarction
59501|NCT02914483|Women|women
59502|NCT02914483|Stress Management|stress management
59503|NCT02914470|advanced|advanced
59504|NCT02914431|Personalized Titanium Plate|personalized titanium plate
59505|NCT02914431|Orthognathic Surgery|orthognathic surgery
59506|NCT02914431|Maxilla Repositioning|maxilla repositioning
59507|NCT02914431|Accuracy|accuracy
59508|NCT02914431|Computer-aided Design and Manufacturing|computer-aided design and manufacturing
59509|NCT02914418|transcranial magnetic stimulation|transcranial magnetic stimulation
59510|NCT02914418|Spinal Cord Injuries|spinal cord injuries
59511|NCT02914418|Muscle Spasticity|muscle spasticity
59512|NCT02914418|Pain|pain
59513|NCT02914418|Spinal Cord|spinal cord
59514|NCT02914418|Spinal Cord Diseases|spinal cord diseases
59515|NCT02914405|131-I-mIBG therapy|131-i-mibg therapy
59516|NCT02914405|ch14.18/CHO|ch14.18/cho
59517|NCT02914405|Nivolumab|nivolumab
59518|NCT02914392|case control study|case control study
59519|NCT02914392|Environmental Factors|environmental factors
59520|NCT02914392|Fetal Congenital Heart Disease|fetal congenital heart disease
59521|NCT02914366|Ambroxol|ambroxol
59522|NCT02914366|Dementia|dementia
59523|NCT02914366|Parkinson's disease|parkinson's disease
59524|NCT02914366|Disease modifying treatment|disease modifying treatment
59525|NCT02914366|Pharmacological Chaperone|pharmacological chaperone
59526|NCT02914366|GBA1|gba1
59527|NCT02914353|Factor X!a|factor x!a
59528|NCT02914353|anticoagulant|anticoagulant
59529|NCT02914353|thromboembolism|thromboembolism
59530|NCT02914353|venous thromboembolism|venous thromboembolism
59531|NCT02914353|embolism and thrombosis|embolism and thrombosis
59532|NCT02914353|enzyme inhibitors|enzyme inhibitors
59533|NCT02914353|hematologic agent|hematologic agent
59534|NCT02914327|CLL|cll
59535|NCT02914327|Leukemia, Chronic Lymphocytic|leukemia, chronic lymphocytic
59536|NCT02914327|Hsp90|hsp90
59537|NCT02914327|BTK|btk
59538|NCT02914327|Ibrutinib|ibrutinib
59539|NCT02914314|epilepsy|epilepsy
59540|NCT02914314|refractory partial seizures|refractory partial seizures
59541|NCT02914249|Orange juice|orange juice
59542|NCT02914249|Low-calorie diet|low-calorie diet
59543|NCT02914249|Body composition|body composition
59544|NCT02914249|Weight-loss|weight-loss
59545|NCT02914249|Metabolic biomarkers|metabolic biomarkers
59546|NCT02914249|Obese|obese
59547|NCT02914236|Nasal valve|nasal valve
59548|NCT02914236|Nasal airway obstruction|nasal airway obstruction
59549|NCT02914210|TKR|tkr
59550|NCT02914210|TKA|tka
59551|NCT02914210|Knee|knee
59552|NCT02914210|Surgery|surgery
59553|NCT02914210|Replacement|replacement
59554|NCT02914210|Rehabilitation|rehabilitation
59555|NCT02914210|Virtual|virtual
59556|NCT02914210|Physical Therapy|physical therapy
59557|NCT02914210|Telerehabilitation|telerehabilitation
59558|NCT02914197|Decision|decision
59559|NCT02914197|Mammography|mammography
59560|NCT02914197|Informed Choice|informed choice
59561|NCT02914197|Full Information|full information
59562|NCT02914197|Decision Aid|decision aid
59563|NCT02914197|Self-efficacy|self-efficacy
59564|NCT02914197|Shared decision making|shared decision making
59565|NCT02914197|Over-detection|over-detection
59566|NCT02914197|Over-diagnosis|over-diagnosis
59567|NCT02914184|Safety|safety
59568|NCT02914184|Healthy infants|healthy infants
59569|NCT02914184|Immunogenicity|immunogenicity
59570|NCT02914184|Human Rotavirus (HRV)|human rotavirus (hrv)
59571|NCT02914171|Myopathic right ventricle|myopathic right ventricle
59572|NCT02914158|breast cancer|breast cancer
59573|NCT02914158|ovarian function suppression (OFS)|ovarian function suppression (ofs)
59574|NCT02914158|aromatase inhibitors（AIs）|aromatase inhibitors（ais）
59575|NCT02914158|tamoxifen（TAM）|tamoxifen（tam）
59576|NCT02914119|Residual nerve blockade|residual nerve blockade
59577|NCT02914119|Neuromuscular monitoring|neuromuscular monitoring
59578|NCT02914119|Residual curarization|residual curarization
59579|NCT02914119|Neuromuscular blocking agents|neuromuscular blocking agents
59580|NCT02914106|Neuroactive steroids|neuroactive steroids
59581|NCT02914106|Acute Ischemic Stroke|acute ischemic stroke
59582|NCT02914106|Patients|patients
59583|NCT02914093|Hypercapnia|hypercapnia
59584|NCT02914093|Physiotherapy|physiotherapy
59585|NCT02914093|Inspiratory Muscle Training|inspiratory muscle training
59586|NCT02914067|Pediatric brain tumors|pediatric brain tumors
59587|NCT02914067|Cognitive deficits|cognitive deficits
59588|NCT02914067|Resting state functional connectivity|resting state functional connectivity
59589|NCT02914067|NIH toolbox|nih toolbox
59590|NCT02914054|ITP|itp
59591|NCT02914041|Kyphosis|kyphosis
61318|NCT02902510|yoga|yoga
59592|NCT02914041|Kyphosis wall distance|kyphosis wall distance
59593|NCT02914041|elderly|elderly
59594|NCT02914028|TAP block|tap block
59595|NCT02914028|subacute pain|subacute pain
59596|NCT02914028|inguinal herniography|inguinal herniography
59597|NCT02913937|ultrasonic irrigation|ultrasonic irrigation
59598|NCT02913937|pain|pain
59599|NCT02913937|healing|healing
59600|NCT02913937|apical periodontitis|apical periodontitis
59601|NCT02913924|Marijuana|marijuana
59606|NCT02913872|Exhaled Nitric Oxide|exhaled nitric oxide
59607|NCT02913872|Primary Care|primary care
59608|NCT02913859|prostate cancer|prostate cancer
59609|NCT02913859|hormone-sensitive|hormone-sensitive
59610|NCT02913859|metastasis|metastasis
59611|NCT02913846|denutrition|denutrition
59612|NCT02913846|hospital length of stay|hospital length of stay
59613|NCT02913846|patient's autonomy|patient's autonomy
59614|NCT02913833|Pain|pain
59615|NCT02913833|Hospital length of stay|hospital length of stay
59616|NCT02913833|Revalidation unit|revalidation unit
59617|NCT02913781|Polar body removal|polar body removal
59618|NCT02913781|ICSI|icsi
59619|NCT02913781|Fertilization failure|fertilization failure
59620|NCT02913742|Intraoperative Neurophysiological Monitoring|intraoperative neurophysiological monitoring
59621|NCT02913729|breast cancer|breast cancer
59622|NCT02913703|Ghrelin|ghrelin
59623|NCT02913690|Hemodialysis|hemodialysis
59624|NCT02913690|Tocotrienol|tocotrienol
59625|NCT02913690|Vitamin E|vitamin e
59626|NCT02913677|feeding intolerance|feeding intolerance
59627|NCT02913677|minimal enteral nutrition|minimal enteral nutrition
59628|NCT02913677|very low birth weight|very low birth weight
59629|NCT02913677|preterm infant|preterm infant
59630|NCT02913664|Dementia|dementia
59631|NCT02913664|Alzheimer's Disease|alzheimer's disease
59632|NCT02913664|Cognitive Function|cognitive function
59633|NCT02913664|Blood Pressure|blood pressure
59634|NCT02913664|Cholesterol|cholesterol
59635|NCT02913664|Physical Activity|physical activity
59636|NCT02913664|Exercise|exercise
59637|NCT02913664|Magnetic Resonance Imaging|magnetic resonance imaging
59638|NCT02913651|Idiopathic hypersomnia|idiopathic hypersomnia
59639|NCT02913651|heart rate variability|heart rate variability
59640|NCT02913651|parasympathetic activity|parasympathetic activity
59641|NCT02913651|autonomic arousal response|autonomic arousal response
59642|NCT02913625|Brachial plexus|brachial plexus
59643|NCT02913625|Regional anesthesia|regional anesthesia
59644|NCT02913625|Infraclavicular|infraclavicular
59645|NCT02913625|Retroclavicular|retroclavicular
59646|NCT02913625|Parasagittal|parasagittal
59647|NCT02913625|Upper limb surgery|upper limb surgery
59648|NCT02913625|Ultrasound guided block|ultrasound guided block
59649|NCT02913625|Coracoid|coracoid
59650|NCT02913612|Hemangioma|hemangioma
59651|NCT02913612|Infantile Hemangioma|infantile hemangioma
59652|NCT02913612|Pharmacokinetics|pharmacokinetics
59653|NCT02913508|Drug therapy|drug therapy
59654|NCT02913495|Progesterone|progesterone
59655|NCT02913495|Prevention of preterm birth|prevention of preterm birth
59656|NCT02913469|Morphine，Ticagrelor，STEMI，PCI|morphine，ticagrelor，stemi，pci
59657|NCT02913417|uveal melanoma|uveal melanoma
59658|NCT02913417|liver metastases|liver metastases
59659|NCT02913391|noninvasive ventilation|noninvasive ventilation
59660|NCT02913391|myocardial revascularization|myocardial revascularization
59661|NCT02913391|pulmonary atelectasis|pulmonary atelectasis
59662|NCT02913391|anoxia|anoxia
59663|NCT02913391|hypoxia|hypoxia
59664|NCT02913391|positive end expiratory pressure|positive end expiratory pressure
59665|NCT02913365|Haemoptysis|haemoptysis
59666|NCT02913365|Hemoptysis|hemoptysis
59667|NCT02913365|Airway bleeding|airway bleeding
59668|NCT02913365|Pulmonary hemorrhage|pulmonary hemorrhage
59669|NCT02913339|screening|screening
59670|NCT02913339|telemedicine|telemedicine
59671|NCT02913339|risk assessment|risk assessment
59672|NCT02913339|prevention|prevention
59673|NCT02913300|Lignocaine|lignocaine
59674|NCT02913261|GvHD (Graft versus Host Disease)|gvhd (graft versus host disease)
59675|NCT02913261|INC424|inc424
59676|NCT02913261|ruxolitinib|ruxolitinib
59677|NCT02913261|best available therapy (BAT)|best available therapy (bat)
59678|NCT02913261|corticosteroid-refractory acute graft vs. host disease|corticosteroid-refractory acute graft vs. host disease
59679|NCT02913261|allogeneic stem cell transplantation|allogeneic stem cell transplantation
59680|NCT02913261|steroid refractory acute graft vs. host disease|steroid refractory acute graft vs. host disease
59681|NCT02913261|Janus Kinase (JAK) inhibitor|janus kinase (jak) inhibitor
59682|NCT02913248|periodontitis|periodontitis
59683|NCT02913248|saliva|saliva
51136|NCT02965885|Solid Tumors|solid tumors
51137|NCT02965885|Pharmacokinetics|pharmacokinetics
51138|NCT02965885|Pharmacodynamics|pharmacodynamics
51139|NCT02965885|MTD|mtd
51140|NCT02965885|TAS116|tas116
51141|NCT02965885|HSP90 Inhibitor|hsp90 inhibitor
51142|NCT02965885|Neoplasms|neoplasms
51148|NCT02965846|EDE|ede
59684|NCT02913248|bacteria|bacteria
59685|NCT02913235|biofilm|biofilm
59686|NCT02913235|saliva|saliva
59687|NCT02913235|bacteria|bacteria
59688|NCT02913235|oral hygiene|oral hygiene
59689|NCT02913222|femoroacetabular impingement|femoroacetabular impingement
59690|NCT02913222|labral tear|labral tear
59692|NCT02913183|acute stroke|acute stroke
59693|NCT02913183|young health plasma|young health plasma
59694|NCT02913183|efficacy|efficacy
59695|NCT02913183|safety|safety
59696|NCT02913105|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
59697|NCT02913105|NASH|nash
60300|NCT02908971|adrenarche,|adrenarche,
59698|NCT02913105|Fatty liver disease|fatty liver disease
59699|NCT02913014|Antiarrhythmic Agents|antiarrhythmic agents
59700|NCT02913014|Catheter Ablation, electric|catheter ablation, electric
59701|NCT02913014|Cardiac Arrhythmias|cardiac arrhythmias
59702|NCT02913014|Anti-Arrhythmia Drugs|anti-arrhythmia drugs
59703|NCT02913001|Diet|diet
59704|NCT02913001|glycemic index|glycemic index
59705|NCT02913001|glycemic load|glycemic load
59706|NCT02913001|Acne Vulgaris|acne vulgaris
59707|NCT02912988|Subfertility|subfertility
59708|NCT02912988|In-vitro fertilization|in-vitro fertilization
59709|NCT02912988|Letrozole|letrozole
59710|NCT02912949|Bispecific Antibody IgG1, HER2, HER3|bispecific antibody igg1, her2, her3
59711|NCT02912949|First-in-human|first-in-human
59712|NCT02912949|MCLA-128|mcla-128
59713|NCT02912949|Antibodies, Bispecific|antibodies, bispecific
59714|NCT02912949|Immunologic Factors|immunologic factors
59715|NCT02912949|Cytokines|cytokines
59716|NCT02912936|medium chain triglyceride|medium chain triglyceride
59718|NCT02912936|coconut oil|coconut oil
59719|NCT02912936|MRI|mri
59720|NCT02912936|PET|pet
59721|NCT02912936|ketones|ketones
59722|NCT02912923|Stroke|stroke
59723|NCT02912923|Rehabilitation Robotics|rehabilitation robotics
59724|NCT02912923|Bimanual|bimanual
59725|NCT02912923|Compensatory Movements|compensatory movements
59726|NCT02912923|Hemiplegia|hemiplegia
59727|NCT02912923|Kinematics|kinematics
59728|NCT02912923|Reaching|reaching
59729|NCT02912923|Trunk|trunk
59730|NCT02912897|EBV-CTL|ebv-ctl
59731|NCT02912897|Multiple sclerosis|multiple sclerosis
59732|NCT02912897|cellular therapy|cellular therapy
59733|NCT02912897|clinically isolated syndrome|clinically isolated syndrome
59734|NCT02912871|subthalamotomy|subthalamotomy
59735|NCT02912871|motor features|motor features
59736|NCT02912871|deep brain stimulation|deep brain stimulation
59737|NCT02912832|Diagnosis|diagnosis
59738|NCT02912806|Knee Arthroplasty|knee arthroplasty
59739|NCT02912806|Total knee replacement|total knee replacement
59740|NCT02912806|Knee osteoarthritis|knee osteoarthritis
59741|NCT02912806|Patient-Outcomes Measurement Program|patient-outcomes measurement program
59742|NCT02912806|Surgical Registries|surgical registries
59743|NCT02912806|Shared Decision Making|shared decision making
59744|NCT02912806|Patient Reported Outcomes|patient reported outcomes
59745|NCT02912806|Patient Experience|patient experience
59746|NCT02912806|Cohort Studies|cohort studies
59747|NCT02912767|lower-extremity lymphedema|lower-extremity lymphedema
59748|NCT02912767|16-1001|16-1001
59749|NCT02912702|Pegaspargase|pegaspargase
59750|NCT02912702|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
59751|NCT02912702|Epstein Barr virus|epstein barr virus
59752|NCT02912702|initial treatment|initial treatment
59753|NCT02912689|COPD|copd
59754|NCT02912689|Non-invasive ventilation|non-invasive ventilation
59755|NCT02912689|NAVA|nava
59756|NCT02912676|Cancer|cancer
59757|NCT02912676|Thioguanine|thioguanine
59758|NCT02912676|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
59759|NCT02912676|6 Mercaptopurine|6 mercaptopurine
59760|NCT02912676|Maintenance Therapy of Leukemia|maintenance therapy of leukemia
59761|NCT02912676|Denmark|denmark
59762|NCT02912676|Lymphoblastic Lymphoma|lymphoblastic lymphoma
59763|NCT02912650|ibuprofen|ibuprofen
59764|NCT02912650|acetaminophen|acetaminophen
59765|NCT02912650|pain|pain
59766|NCT02912650|molar extraction|molar extraction
59767|NCT02912624|Physical Examination|physical examination
59768|NCT02912624|Diagnostic Imaging|diagnostic imaging
59769|NCT02912624|Ultrasonography|ultrasonography
59770|NCT02912624|Hemodynamics|hemodynamics
59771|NCT02912624|Patient Outcome Assessment|patient outcome assessment
59772|NCT02912624|Mortality|mortality
51234|NCT02965079|extracorporeal CO2 removal|extracorporeal co2 removal
51235|NCT02965079|registry|registry
59773|NCT02912585|colostrum|colostrum
59774|NCT02912572|Endometrial Cancer|endometrial cancer
59775|NCT02912546|Stroke, Acute|stroke, acute
59776|NCT02911805|Exercise|exercise
59777|NCT02911805|Retinal Degeneration|retinal degeneration
59778|NCT02911805|Neuropharmacology|neuropharmacology
59779|NCT02911805|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
59780|NCT02911805|Biometry|biometry
59781|NCT02911805|Immunochemistry|immunochemistry
59782|NCT02911805|Molecular Biology|molecular biology
59783|NCT02911805|Neurosciences|neurosciences
59784|NCT02911805|Ophthalmology|ophthalmology
59785|NCT02911792|hyperfiltering|hyperfiltering
59786|NCT02911792|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
59787|NCT02911766|Periodontal Index|periodontal index
59788|NCT02911727|Cesarean section|cesarean section
59789|NCT02911727|Postnatal Care|postnatal care
59790|NCT02911714|Kidney Transplantation|kidney transplantation
59791|NCT02911714|Delayed Graft Function|delayed graft function
59792|NCT02911714|Acute Allograft Rejection|acute allograft rejection
59793|NCT02911714|Acute Kidney Injury|acute kidney injury
59794|NCT02912455|Post-Bariatric Surgery|post-bariatric surgery
59795|NCT02912455|hemoglobin A1c protein, human|hemoglobin a1c protein, human
59796|NCT02912442|thyroid|thyroid
59798|NCT02912442|autoimmunity|autoimmunity
59799|NCT02912442|pregnancy loss|pregnancy loss
59800|NCT02912442|autoantibodies|autoantibodies
59801|NCT02912364|Eslicarbazepine|eslicarbazepine
59802|NCT02912364|Carbamazepine|carbamazepine
59803|NCT02912364|cognition|cognition
59804|NCT02912351|Total Knee Arthroplasty|total knee arthroplasty
59805|NCT02912351|Total Knee Replacement|total knee replacement
59806|NCT02912351|Revision Knee Arthroplasty|revision knee arthroplasty
59910|NCT02911155|Radiation|radiation
59807|NCT02912338|Sarcopenic obesity|sarcopenic obesity
59808|NCT02912338|Body composition|body composition
59809|NCT02912338|Physical function|physical function
59810|NCT02912338|quality of life|quality of life
59811|NCT02912338|long term care|long term care
59812|NCT02912312|Malignant neoplasm of breast|malignant neoplasm of breast
59813|NCT02912312|Lymphedema|lymphedema
59814|NCT02912312|Standard regional nodal irradiation|standard regional nodal irradiation
59816|NCT02912312|Shortened regional nodal irradiation|shortened regional nodal irradiation
59817|NCT02912312|Radiation therapy|radiation therapy
59818|NCT02912312|XRT|xrt
59819|NCT02912312|Arm swelling|arm swelling
59820|NCT02912312|Questionnaires|questionnaires
59821|NCT02912312|Surveys|surveys
59822|NCT02912273|Geriatric assessment|geriatric assessment
59823|NCT02912247|tumor necrosis factor-a blocker|tumor necrosis factor-a blocker
59824|NCT02912247|pharmacokinetics|pharmacokinetics
59825|NCT02912247|safety|safety
59826|NCT02912169|Alzheimer's Disease|alzheimer's disease
59827|NCT02912169|Alzheimer's|alzheimer's
59828|NCT02912169|Stem cell|stem cell
59829|NCT02912169|Adipose-derived stem cells|adipose-derived stem cells
59830|NCT02912169|ASC|asc
59831|NCT02912169|ADSC|adsc
59832|NCT02912156|Pharmacokinetic|pharmacokinetic
59833|NCT02912130|Exercise|exercise
59834|NCT02912130|Nutrition|nutrition
59835|NCT02912130|Sarcopenia|sarcopenia
59836|NCT02912130|Healthy Ageing|healthy ageing
59837|NCT02912130|Elderly|elderly
59838|NCT02912130|Muscular Hypertrophy|muscular hypertrophy
59839|NCT02912104|primary ovarian insufficiency|primary ovarian insufficiency
59840|NCT02912104|premature ovarian failure|premature ovarian failure
59841|NCT02912104|Infertility|infertility
59842|NCT02912104|human amniotic epithelial cells transplantation|human amniotic epithelial cells transplantation
59843|NCT02912052|Perioperative Chemotherapy|perioperative chemotherapy
59844|NCT02912052|Postoperative Chemotherapy|postoperative chemotherapy
59845|NCT02912052|Colon Cancer|colon cancer
59846|NCT02912052|Resectable Liver Metastasis|resectable liver metastasis
59847|NCT02912000|Dental Health Services|dental health services
59848|NCT02912000|Sugar-Sweetened Beverages|sugar-sweetened beverages
59849|NCT02912000|Tobacco control|tobacco control
59850|NCT02912000|Pediatrics|pediatrics
59851|NCT02912000|Parents|parents
59852|NCT02911974|fine needle biopsy|fine needle biopsy
59854|NCT02911974|solid pancreatic mass|solid pancreatic mass
59855|NCT02911896|physical function|physical function
59856|NCT02911896|critical care|critical care
59857|NCT02911857|Canakinumab,|canakinumab,
59858|NCT02911857|interleukin-1|interleukin-1
59859|NCT02911857|Periodic Fevers Syndrome|periodic fevers syndrome
59860|NCT02911857|TRAPS|traps
59861|NCT02911857|HIDS|hids
59862|NCT02911857|crFMF|crfmf
625698|NCT00682799|MDS|mds
59863|NCT02911857|auto-inflammatory diseases|auto-inflammatory diseases
59864|NCT02911857|extension study|extension study
59865|NCT02911597|Ketamine|ketamine
59866|NCT02911597|Naltrexone|naltrexone
51441|NCT02963961|Neuroplasticity|neuroplasticity
51355|NCT02964377|Pediatric|pediatric
51356|NCT02964377|muscle disease|muscle disease
51357|NCT02964377|Duchenne muscular dystrophy|duchenne muscular dystrophy
51358|NCT02964377|cardiomyopathy|cardiomyopathy
51359|NCT02964364|TAKAYASU ARTERITIS|takayasu arteritis
59867|NCT02911597|Treatment-Resistant|treatment-resistant
59869|NCT02911545|Atrial fibrillation|atrial fibrillation
59870|NCT02911545|Anticoagulation|anticoagulation
59871|NCT02911545|Cardioversion|cardioversion
59872|NCT02911532|pterygium|pterygium
59873|NCT02911532|tissue engineering|tissue engineering
59874|NCT02911532|atretoblepharia|atretoblepharia
59875|NCT02911519|Schizophrenia|schizophrenia
59876|NCT02911519|Patient Education|patient education
59877|NCT02911493|sedentary time|sedentary time
59878|NCT02911493|number of steps/day|number of steps/day
59879|NCT02911493|mobility|mobility
59880|NCT02911493|disability|disability
59881|NCT02911428|Ebola|ebola
59882|NCT02911428|Ebola Virus Vaccines|ebola virus vaccines
59883|NCT02911428|Haemorrhagic Fever|haemorrhagic fever
59884|NCT02911428|Ebola Infection|ebola infection
59885|NCT02911428|GP protein, Ebola virus|gp protein, ebola virus
59886|NCT02911415|Ebola|ebola
59887|NCT02911415|Ebola Virus Vaccines|ebola virus vaccines
59888|NCT02911415|Haemorrhagic Fever|haemorrhagic fever
59889|NCT02911415|Ebola Infection|ebola infection
59890|NCT02911415|GP protein, Ebola virus|gp protein, ebola virus
59891|NCT02911311|conbercept|conbercept
59892|NCT02911311|anti-VEGF agent|anti-vegf agent
59893|NCT02911311|panretinal photocoagulation|panretinal photocoagulation
59899|NCT02911272|Best action line|best action line
59900|NCT02911272|Prolonged labour prevention|prolonged labour prevention
59901|NCT02911207|chronic ill patients|chronic ill patients
59902|NCT02911207|Emotion management skill|emotion management skill
59903|NCT02911207|Quality of Life|quality of life
59904|NCT02911181|BIVA measurement|biva measurement
59905|NCT02911181|SNAQ score|snaq score
59906|NCT02911168|NERVE BLOCK|nerve block
59907|NCT02911168|ANESTHESIA RECOVERY PERIOD|anesthesia recovery period
59908|NCT02911168|PAIN MANAGEMENT|pain management
59909|NCT02911155|Cohort Study|cohort study
59911|NCT02911155|Occupation|occupation
59912|NCT02911142|Treatment Naive|treatment naive
59913|NCT02911142|Immune Modulatory|immune modulatory
59914|NCT02911142|Chemotherapy|chemotherapy
59915|NCT02911142|AIDS-Related Lymphoma|aids-related lymphoma
59916|NCT02911142|PEL|pel
59917|NCT02911129|Chronic Stroke|chronic stroke
59918|NCT02911129|Neglect|neglect
59919|NCT02911129|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
59920|NCT02911129|Visual and Motor Integration|visual and motor integration
59921|NCT02911129|Visual Fields|visual fields
59922|NCT02911116|Panuveitis|panuveitis
59923|NCT02911116|Intermediate Uveitis|intermediate uveitis
59924|NCT02911116|Uveitis|uveitis
59925|NCT02911103|Electrophysiology|electrophysiology
59926|NCT02911103|Neurosurgery|neurosurgery
59927|NCT02911103|Dystonia|dystonia
59928|NCT02911103|Deep Brain Stimulation|deep brain stimulation
59929|NCT02911090|Endometriosis|endometriosis
59930|NCT02911090|Chronic pelvic pain|chronic pelvic pain
59931|NCT02911090|Dyspareunia|dyspareunia
59932|NCT02911077|Bacteria|bacteria
59933|NCT02911064|Questionnaires|questionnaires
59934|NCT02911064|Surveys|surveys
59935|NCT02911064|Benign neoplasms|benign neoplasms
59936|NCT02911064|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
59937|NCT02911064|Inpatient rehabilitation therapy|inpatient rehabilitation therapy
59938|NCT02911038|Complete denture|complete denture
59939|NCT02911038|PMMA|pmma
59940|NCT02911038|Stereolithography|stereolithography
59941|NCT02911025|epilepsy|epilepsy
59942|NCT02911025|sleep|sleep
59943|NCT02911025|antiepileptic drugs|antiepileptic drugs
59944|NCT02910986|Mammography|mammography
59945|NCT02910986|Breast Density|breast density
59946|NCT02910986|Hispanic|hispanic
59947|NCT02910973|Inflammation, Vagus Nerve Stimulation|inflammation, vagus nerve stimulation
59948|NCT02910960|fine needle biopsy|fine needle biopsy
59949|NCT02910960|EUS|eus
59950|NCT02910960|solid pancreatic mass|solid pancreatic mass
59951|NCT02910934|Indoor Residual Spray|indoor residual spray
59952|NCT02910934|IRS|irs
59953|NCT02910934|Insecticide Treated Net|insecticide treated net
59954|NCT02910934|LLIN|llin
59955|NCT02910934|ITN|itn
59956|NCT02910921|Migraine|migraine
59957|NCT02910921|Prediction|prediction
59958|NCT02910921|Forecast|forecast
59959|NCT02910921|App|app
59960|NCT02910921|Fitbit|fitbit
59961|NCT02910921|Individual|individual
59962|NCT02910921|Algorithm|algorithm
59963|NCT02910921|Machine Learning|machine learning
51470|NCT02963805|School|school
51471|NCT02963805|Health|health
51473|NCT02963792|Professionalism|professionalism
59964|NCT02910921|Mayo Clinic|mayo clinic
59965|NCT02910921|Allergan|allergan
59966|NCT02910921|Second Opinion|second opinion
59967|NCT02910908|Elderly|elderly
59968|NCT02910908|ESRD prognosis|esrd prognosis
59969|NCT02910908|help decision making dialysis therapeutic project|help decision making dialysis therapeutic project
59970|NCT02910882|Pancreas Cancer|pancreas cancer
59971|NCT02910882|Unresectable|unresectable
59972|NCT02910882|Chemoradiation|chemoradiation
59973|NCT02910882|PEGPH20|pegph20
59974|NCT02910843|rectal cancer|rectal cancer
59975|NCT02910843|Neoadjuvant treatment|neoadjuvant treatment
59976|NCT02910843|Regorafenib|regorafenib
59977|NCT02910843|Capecitabine|capecitabine
59978|NCT02910843|locally advanced rectal cancer|locally advanced rectal cancer
59979|NCT02910843|Phase Ib trial|phase ib trial
59981|NCT02910804|GRPR|grpr
59982|NCT02910804|IRDye800|irdye800
59983|NCT02910804|NIRF|nirf
59984|NCT02910804|surgery|surgery
59985|NCT02910726|indocyanine green fluorescent dye|indocyanine green fluorescent dye
59986|NCT02910726|Technetium lymphoscintigraphy|technetium lymphoscintigraphy
59987|NCT02910726|sentinel lymph node biopsy|sentinel lymph node biopsy
59988|NCT02910726|16-1003|16-1003
59989|NCT02910700|Melanoma|melanoma
59990|NCT02910700|Metastatic Melanoma|metastatic melanoma
59991|NCT02910700|BRAF- mutated metastatic melanoma|braf- mutated metastatic melanoma
59992|NCT02910700|BRAF-wild type metastatic melanoma|braf-wild type metastatic melanoma
59993|NCT02910700|Nivolumab|nivolumab
59994|NCT02910700|BMS-936558|bms-936558
59995|NCT02910700|Opdivo|opdivo
59996|NCT02910700|Dabrafenib|dabrafenib
59997|NCT02910700|Tafinlar|tafinlar
59998|NCT02910700|GSK2118436|gsk2118436
59999|NCT02910700|Trametinib|trametinib
60000|NCT02910700|GSK1120212|gsk1120212
60097|NCT02910180|Tissue Repository|tissue repository
60001|NCT02910687|Non ST Elevation Myocardial Infarction (NSTEMI)|non st elevation myocardial infarction (nstemi)
60002|NCT02910687|Elderly|elderly
60003|NCT02910687|Frailty|frailty
60004|NCT02910687|Prognostic value|prognostic value
60005|NCT02910661|Kidney Transplantation|kidney transplantation
60006|NCT02910648|healthy|healthy
60008|NCT02910648|weight loss|weight loss
60009|NCT02910648|sleep|sleep
60010|NCT02910648|healthy sleeper|healthy sleeper
60011|NCT02910648|overweight|overweight
60012|NCT02910648|obese|obese
60013|NCT02910635|Thorough QTc, Therapeutic dose, supra therapeutic dose|thorough qtc, therapeutic dose, supra therapeutic dose
60014|NCT02910622|breast|breast
60015|NCT02910622|ovarian|ovarian
60016|NCT02910622|cancer|cancer
60017|NCT02910609|preterm|preterm
60018|NCT02910609|patent ductus arterioles|patent ductus arterioles
60019|NCT02910609|treatment|treatment
60020|NCT02910557|CTCAE - Common Terminology Criteria for Adverse Events|ctcae - common terminology criteria for adverse events
60021|NCT02910557|eCRF - electronic case report form|ecrf - electronic case report form
60022|NCT02910557|ECOG - Eastern Cooperative Oncology Group|ecog - eastern cooperative oncology group
60023|NCT02910557|EDC - electronic data capture|edc - electronic data capture
60024|NCT02910557|GM-CSF - human granulocyte macrophage colony-stimulating factor|gm-csf - human granulocyte macrophage colony-stimulating factor
60025|NCT02910557|HCP - health care provider|hcp - health care provider
60026|NCT02910557|HSV-1 - herpes simplex virus type 1|hsv-1 - herpes simplex virus type 1
60027|NCT02910557|ICF - informed consent form|icf - informed consent form
60028|NCT02910557|ICP - infected cell protein|icp - infected cell protein
60029|NCT02910557|IEC - Independent Ethics Committee|iec - independent ethics committee
60030|NCT02910557|IRB - Institutional Review Board|irb - institutional review board
60031|NCT02910557|MedDRA - Medical Dictionary for Regulatory Activities|meddra - medical dictionary for regulatory activities
60032|NCT02910557|PFU - plaque-forming unit|pfu - plaque-forming unit
60033|NCT02910557|qPCR - quantitative polymerase chain reaction|qpcr - quantitative polymerase chain reaction
60034|NCT02910557|SmPC - Summary of Product Characteristics|smpc - summary of product characteristics
60035|NCT02910557|USPI - United States Prescribing Information|uspi - united states prescribing information
60036|NCT02910531|Cystinuria|cystinuria
60037|NCT02910531|Kidney stone|kidney stone
60038|NCT02910531|Alpha lipoic acid|alpha lipoic acid
60039|NCT02910479|Body Temperature|body temperature
60040|NCT02910479|Thermometers|thermometers
60041|NCT02910453|Pulmonary lobectomy|pulmonary lobectomy
60042|NCT02910453|Video-Assisted Thoracic Surgery|video-assisted thoracic surgery
60043|NCT02910453|Opto-electronic plethysmography|opto-electronic plethysmography
60044|NCT02910453|Posterolateral thoracotomy|posterolateral thoracotomy
60045|NCT02910427|stroke|stroke
60046|NCT02910427|potassium and magnesium-enriched salt|potassium and magnesium-enriched salt
60047|NCT02910427|neurological performance|neurological performance
60048|NCT02910388|conization|conization
60049|NCT02910388|LLETZ|lletz
60050|NCT02910388|loop excision|loop excision
60051|NCT02910388|randomized controlled trial|randomized controlled trial
60052|NCT02910388|colposcopy|colposcopy
60053|NCT02910388|direct colposcopic vision|direct colposcopic vision
60054|NCT02910388|intraoperative colposcopy|intraoperative colposcopy
60055|NCT02910375|golimumab|golimumab
60056|NCT02910375|drug monitoring|drug monitoring
60057|NCT02910375|home based care|home based care
60058|NCT02910349|valvular hear disease|valvular hear disease
60059|NCT02910349|echocardiography|echocardiography
60060|NCT02910349|magnetic resonance|magnetic resonance
60061|NCT02910349|global longitudinal strain|global longitudinal strain
60062|NCT02910349|T1 relaxation time|t1 relaxation time
60063|NCT02910310|Uterine Balloon Tamponade|uterine balloon tamponade
60064|NCT02910297|cannabidiol|cannabidiol
60065|NCT02910297|Dravet Syndrome|dravet syndrome
60066|NCT02910297|Lennox Gastaut Syndrome|lennox gastaut syndrome
60068|NCT02910284|Herpes|herpes
60069|NCT02910284|Genital Herpes|genital herpes
60070|NCT02910258|myelofibrosis|myelofibrosis
60071|NCT02910258|pegylated interferon|pegylated interferon
60072|NCT02910245|Therapeutic Drug Monitoring|therapeutic drug monitoring
60073|NCT02910245|Mercaptopurine (6-MP)|mercaptopurine (6-mp)
60074|NCT02910245|Thiopurine|thiopurine
60075|NCT02910245|Efficacy|efficacy
60076|NCT02910232|Rice starch|rice starch
60077|NCT02910232|Porous composite|porous composite
60078|NCT02910232|Biomaterial|biomaterial
60079|NCT02910232|Bone regeneration|bone regeneration
60080|NCT02910232|Clinical trial|clinical trial
60081|NCT02910232|Hydroxyapatite|hydroxyapatite
60082|NCT02910219|HER2|her2
60083|NCT02910219|pertuzumab|pertuzumab
60084|NCT02910219|trastuzumab|trastuzumab
60085|NCT02910219|docetaxel|docetaxel
60086|NCT02910219|paclitaxel|paclitaxel
60087|NCT02910219|carboplatin|carboplatin
60088|NCT02910219|crofelemer|crofelemer
60089|NCT02910219|chemotherapy induced diarrhea|chemotherapy induced diarrhea
60090|NCT02910206|etomidate|etomidate
60092|NCT02910193|alcoholism|alcoholism
60093|NCT02910193|genetics|genetics
60094|NCT02910193|functional MRI|functional mri
60095|NCT02910193|structural MRI|structural mri
60096|NCT02910193|first-degree relatives|first-degree relatives
60098|NCT02910180|Cerebrovascular Diseases|cerebrovascular diseases
60099|NCT02910180|Stroke|stroke
60100|NCT02910180|Aneurysm|aneurysm
60101|NCT02910180|Arteriovenous malformation|arteriovenous malformation
60102|NCT02910180|Fistula|fistula
60103|NCT02910180|Intracranial Stenosis|intracranial stenosis
60104|NCT02910180|Treatment|treatment
60105|NCT02910180|Registry|registry
60106|NCT02910180|Outcomes|outcomes
60107|NCT02910141|Type 2 diabetes|type 2 diabetes
60108|NCT02910141|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
60109|NCT02910141|Meta-analysis|meta-analysis
60110|NCT02910141|Insulin pump therapy|insulin pump therapy
60111|NCT02910141|Multiple daily insulin injections|multiple daily insulin injections
60112|NCT02910102|RVT-101|rvt-101
60113|NCT02910102|intepirdine|intepirdine
60114|NCT02910102|Alzheimer's disease|alzheimer's disease
60115|NCT02910102|Dementia with Lewy bodies|dementia with lewy bodies
60116|NCT02910102|Lewy body dementia|lewy body dementia
60117|NCT02910102|Parkinson's Disease Dementia|parkinson's disease dementia
60118|NCT02910089|Diabetes Mellitus Type 2|diabetes mellitus type 2
60119|NCT02910063|Relapsed/Refractory Aggressive B-Cell Non Hodgkin Lymphoma|relapsed/refractory aggressive b-cell non hodgkin lymphoma
60120|NCT02910063|Blinatumomab|blinatumomab
60121|NCT02910063|Leukemia|leukemia
60122|NCT02910063|Standard of Care|standard of care
60123|NCT02910063|SOC|soc
60124|NCT02910063|Cancer|cancer
60125|NCT02910063|Chemotherapy|chemotherapy
60126|NCT02910050|androgen receptor|androgen receptor
60127|NCT02910050|bicalutamide|bicalutamide
60128|NCT02910050|aromatase inhibitors|aromatase inhibitors
60129|NCT02910050|advanced breast cancer|advanced breast cancer
60130|NCT02910050|letrozole|letrozole
60131|NCT02910050|anastrozole|anastrozole
60132|NCT02910050|exemestane|exemestane
60133|NCT02909998|Biomarkers|biomarkers
60134|NCT02909998|Genetic|genetic
60135|NCT02909998|Chronic arthritis|chronic arthritis
60136|NCT02909998|Treatment|treatment
60137|NCT02909985|Infrared|infrared
60138|NCT02909985|Dark Adaptation|dark adaptation
60139|NCT02909985|Vision|vision
60140|NCT02909985|Scotopic Threshold Response|scotopic threshold response
60141|NCT02909985|Transient Receptor Potential (TRP) Channels|transient receptor potential (trp) channels
60142|NCT02909985|Human|human
60143|NCT02909959|sulforaphane|sulforaphane
60144|NCT02909959|glucoraphanin|glucoraphanin
60145|NCT02909959|physiologic effects of drugs|physiologic effects of drugs
60146|NCT02909946|multidrug-resistant organisms|multidrug-resistant organisms
60147|NCT02909946|nursing home|nursing home
60148|NCT02909946|post-acute care|post-acute care
60149|NCT02909946|long-term care|long-term care
60150|NCT02909946|infection control|infection control
60151|NCT02909920|Telerehabilitation|telerehabilitation
60152|NCT02909920|Physiotherapy|physiotherapy
60153|NCT02909920|Surgery|surgery
60154|NCT02909920|Telemedicine|telemedicine
60155|NCT02909894|Sedentary behaviour|sedentary behaviour
60156|NCT02909894|Postprandial glycaemic response|postprandial glycaemic response
60157|NCT02909881|polysaccharide|polysaccharide
60158|NCT02909881|oxidation|oxidation
60159|NCT02909881|endurance exercise|endurance exercise
60160|NCT02909855|children|children
60161|NCT02909855|psychological predictors|psychological predictors
60162|NCT02909855|side-effects|side-effects
60163|NCT02909855|vaccination|vaccination
60164|NCT02909842|influenza|influenza
60165|NCT02909842|vaccine|vaccine
60166|NCT02909842|probiotic|probiotic
60167|NCT02909842|immune response|immune response
60168|NCT02909829|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
60169|NCT02909829|Artificial Pancreas|artificial pancreas
60170|NCT02909829|Closed-Loop Delivery|closed-loop delivery
60171|NCT02909829|Insulin|insulin
60172|NCT02909829|Adolescent|adolescent
60173|NCT02909829|Missed Bolus|missed bolus
60174|NCT02909803|glucose|glucose
60175|NCT02909803|glycemic index|glycemic index
60176|NCT02909803|lentil|lentil
60177|NCT02909803|polyphenols|polyphenols
60178|NCT02909803|metabolites|metabolites
60179|NCT02909803|bioavailability|bioavailability
60180|NCT02909777|Lymphoma|lymphoma
60181|NCT02909777|Neuroblastoma|neuroblastoma
60182|NCT02909777|Brain Tumor|brain tumor
60183|NCT02909777|Solid Tumor|solid tumor
60184|NCT02909764|Salty taste|salty taste
60185|NCT02909764|Psychophysics|psychophysics
60186|NCT02909764|Genetics|genetics
60187|NCT02909764|Diet|diet
60188|NCT02909764|Age|age
60189|NCT02909725|Physical activity|physical activity
60190|NCT02909725|Sedentary time|sedentary time
60191|NCT02909725|Pregnancy|pregnancy
60192|NCT02909725|Pregnant women|pregnant women
60193|NCT02909725|Weight gain|weight gain
60194|NCT02909712|sub-Saharan|sub-saharan
60195|NCT02909712|dihydroartemisinin|dihydroartemisinin
60196|NCT02909712|piperaquine|piperaquine
60197|NCT02909712|sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
60198|NCT02909712|antimalarials|antimalarials
60199|NCT02909686|Gulf War Syndrome|gulf war syndrome
60200|NCT02909686|Chronic Multisymptom Illnesses|chronic multisymptom illnesses
60201|NCT02909686|Medically Unexplained Illnesses|medically unexplained illnesses
60202|NCT02909673|adolescent behavior|adolescent behavior
60203|NCT02909673|intimate partner violence|intimate partner violence
60204|NCT02909673|youth risk behavior|youth risk behavior
60205|NCT02909673|violence prevention|violence prevention
60206|NCT02909673|teen dating violence|teen dating violence
60207|NCT02909621|OsteoArthritis; FLEXOFYTOL®; Curcuma; biomarkers|osteoarthritis; flexofytol®; curcuma; biomarkers
60208|NCT02909556|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
60209|NCT02909556|TAVI|tavi
60210|NCT02909556|Transcatheter Aortic Valve Implant|transcatheter aortic valve implant
60211|NCT02909556|Transfemoral access|transfemoral access
60212|NCT02909530|Endoscopic ultrasound-guided fine needle biopsy|endoscopic ultrasound-guided fine needle biopsy
60213|NCT02909530|Olympus EZ Shot 3Plus|olympus ez shot 3plus
60214|NCT02909530|Olympus EZ Shot 2|olympus ez shot 2
60215|NCT02909452|entinostat|entinostat
60216|NCT02909452|pembrolizumab|pembrolizumab
60217|NCT02909452|solid tumor|solid tumor
60218|NCT02909452|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
60219|NCT02909426|Screening|screening
60220|NCT02909426|Digital mammography|digital mammography
60221|NCT02909426|Ultrasonography|ultrasonography
60222|NCT02909426|Sensitivity|sensitivity
60223|NCT02909426|Specificity|specificity
60224|NCT02909413|desflurane|desflurane
60225|NCT02909413|sevoflurane|sevoflurane
60226|NCT02909400|mitochondrial|mitochondrial
60227|NCT02909400|oxidative phosphorylation (oxphos)|oxidative phosphorylation (oxphos)
60228|NCT02909400|MELAS|melas
60229|NCT02909400|MIDD|midd
60230|NCT02909400|KH176|kh176
60231|NCT02909400|Proof of Concept|proof of concept
60232|NCT02909387|Epilepsy|epilepsy
60233|NCT02909387|Seizure Disorder|seizure disorder
60234|NCT02909374|Implementation|implementation
60235|NCT02909374|fall prevention|fall prevention
60236|NCT02909374|balance training|balance training
60237|NCT02909348|Neoplasms|neoplasms
60238|NCT02909348|Melanoma|melanoma
60239|NCT02909348|Immunotherapy|immunotherapy
60240|NCT02909348|Biomarkers|biomarkers
60241|NCT02909309|Propofol|propofol
60242|NCT02909309|Deep Sedation|deep sedation
60243|NCT02909309|Anoxia|anoxia
60244|NCT02909309|Hypercapnia|hypercapnia
60245|NCT02909231|Patient Outcome Assessment|patient outcome assessment
60246|NCT02909218|HIV/AIDS, Swaziland|hiv/aids, swaziland
60247|NCT02909205|child|child
60248|NCT02909205|gastrostomy|gastrostomy
60249|NCT02909205|supportive care|supportive care
60250|NCT02909205|educational program|educational program
60251|NCT02909192|Parkinson's Disease|parkinson's disease
60252|NCT02909192|Excessive Daytime Sleepiness|excessive daytime sleepiness
60253|NCT02909192|Circadian Rhythms|circadian rhythms
60254|NCT02909192|Light Therapy|light therapy
51769|NCT02961803|AMN|amn
60255|NCT02909179|Community Health Workers, mHealth, mobile phones, ANC, PNC, essential newborn care|community health workers, mhealth, mobile phones, anc, pnc, essential newborn care
60256|NCT02909153|Triferic|triferic
60257|NCT02909153|ferric pyrophosphate citrate|ferric pyrophosphate citrate
60258|NCT02909153|peritoneal dialysis|peritoneal dialysis
60259|NCT02909153|anemia|anemia
60260|NCT02909153|chronic kidney disease|chronic kidney disease
60262|NCT02909127|deglutition|deglutition
60263|NCT02909127|deglutition disorders|deglutition disorders
60264|NCT02909127|pediatric dysphagia|pediatric dysphagia
60265|NCT02909127|swallowing|swallowing
60266|NCT02909114|stereotactic boday radiotherapy, oligometastases|stereotactic boday radiotherapy, oligometastases
60267|NCT02909101|Working memory|working memory
60268|NCT02909101|cognitive training|cognitive training
60270|NCT02909101|substance abuse|substance abuse
60271|NCT02909088|stuttering|stuttering
60272|NCT02909088|childhood onset fluency disorder|childhood onset fluency disorder
60273|NCT02909088|ecopipam|ecopipam
60274|NCT02909075|PET/CT|pet/ct
60275|NCT02909075|MRI|mri
60276|NCT02909075|Assess Thymic Function|assess thymic function
60277|NCT02909075|16-1244|16-1244
60278|NCT02909062|Electronic Activity Monitoring (EAM)|electronic activity monitoring (eam)
60279|NCT02909062|16-493|16-493
60280|NCT02909049|Prostate Biopsy|prostate biopsy
60281|NCT02909049|Local Anesthesia|local anesthesia
60282|NCT02909049|Pain|pain
60283|NCT02909049|Biopsy of prostate|biopsy of prostate
60284|NCT02909036|Melphalan|melphalan
60285|NCT02909036|Autologous Hematopoietic Progenitor Cell Transplant|autologous hematopoietic progenitor cell transplant
60286|NCT02909036|High Dose Therapy|high dose therapy
60287|NCT02909036|16-875|16-875
60288|NCT02909023|Hepatitis B Virus|hepatitis b virus
60289|NCT02909023|Elispot test|elispot test
60290|NCT02909023|T cellular immune response|t cellular immune response
60291|NCT02908984|unilateral headache|unilateral headache
60292|NCT02908984|cervical pain|cervical pain
60293|NCT02908984|neck pain|neck pain
60294|NCT02908984|voxel based morphometry|voxel based morphometry
60295|NCT02908984|diffusion tensor imaging|diffusion tensor imaging
60296|NCT02908984|structural brain changes|structural brain changes
60297|NCT02908984|rehabilitation|rehabilitation
60298|NCT02908971|soy based formula|soy based formula
60301|NCT02908971|gonadarache|gonadarache
60302|NCT02908945|Ketamine|ketamine
60303|NCT02908945|Anesthesia|anesthesia
60304|NCT02908945|EEG|eeg
60305|NCT02908945|NeuroSENSE|neurosense
60306|NCT02908945|Pain|pain
60307|NCT02908919|Colonoscopy|colonoscopy
60308|NCT02908919|Picosulfate sodium|picosulfate sodium
60309|NCT02908919|Polyethylene glycol|polyethylene glycol
60310|NCT02908919|Magnesium citrate|magnesium citrate
60311|NCT02908919|Ascorbic acid|ascorbic acid
60608|NCT02906995|pharmacokinetics|pharmacokinetics
60315|NCT02908867|Sexuality|sexuality
60316|NCT02908867|Spinal cord injuries|spinal cord injuries
60317|NCT02908867|Complementary Therapies|complementary therapies
60318|NCT02908867|Medicinal plants|medicinal plants
60319|NCT02908854|Spices|spices
60320|NCT02908854|Herbs|herbs
60321|NCT02908854|Vegetables|vegetables
60322|NCT02908854|National School Lunch Program|national school lunch program
60323|NCT02908854|High school|high school
60324|NCT02908828|Biological Products/therapeutic use|biological products/therapeutic use
60325|NCT02908828|Copepoda|copepoda
60326|NCT02908828|Dietary Supplements|dietary supplements
60327|NCT02908828|Fish Oils|fish oils
60328|NCT02908828|Fatty Acids, Omega-3|fatty acids, omega-3
60329|NCT02908828|Oxygen Consumption|oxygen consumption
60330|NCT02908828|Calanus|calanus
60331|NCT02908828|Maximal oxygen uptake|maximal oxygen uptake
60332|NCT02908828|Zooplankton|zooplankton
60333|NCT02908789|Photochemotherapy|photochemotherapy
60334|NCT02908763|Chronic Hepatitis B|chronic hepatitis b
60335|NCT02908763|Peginterferon Alpha|peginterferon alpha
60336|NCT02908750|oncology|oncology
60337|NCT02908750|cancer|cancer
60338|NCT02908750|non small cell lung cancer|non small cell lung cancer
60339|NCT02908750|anticancer drug|anticancer drug
60340|NCT02908750|lung neoplasms|lung neoplasms
60341|NCT02908750|pharmacokinetics|pharmacokinetics
60342|NCT02908750|AZD9291|azd9291
60343|NCT02908750|osimertinib|osimertinib
60344|NCT02908750|fexofenadine|fexofenadine
60345|NCT02908750|TAGRISSO™|tagrisso™
60346|NCT02908750|EGFR genes|egfr genes
60347|NCT02908724|Familial cardiomyopathies|familial cardiomyopathies
60348|NCT02908724|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
60349|NCT02908724|Left ventricular hypertrophy|left ventricular hypertrophy
60350|NCT02908659|intensive care unit|intensive care unit
60351|NCT02908659|patient's monitoring|patient's monitoring
60352|NCT02908659|respiratory rate|respiratory rate
60353|NCT02908633|open angle glaucoma|open angle glaucoma
60354|NCT02908633|canaloplasty|canaloplasty
60355|NCT02908633|migs|migs
60356|NCT02908633|abic|abic
60357|NCT02908594|Nursing|nursing
60358|NCT02908594|ESRD|esrd
60359|NCT02908594|hemodialysis|hemodialysis
60360|NCT02908594|intradialytic exercise|intradialytic exercise
60361|NCT02908594|depression|depression
60362|NCT02908594|fatigue|fatigue
60363|NCT02908594|Quality Of Life|quality of life
60364|NCT02908594|self-efficacy|self-efficacy
60365|NCT02908594|resilience|resilience
60366|NCT02908568|mandibular stretching, trigeminocardiac reflex|mandibular stretching, trigeminocardiac reflex
60367|NCT02908555|type 1 diabetes|type 1 diabetes
60368|NCT02908555|adolescents|adolescents
60369|NCT02908555|sleep|sleep
60370|NCT02908490|Arthritis, Rheumatoid|arthritis, rheumatoid
60371|NCT02908490|Atherosclerosis|atherosclerosis
60372|NCT02908464|Cardiac Surgery|cardiac surgery
60373|NCT02908464|Delirium|delirium
60374|NCT02908464|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
60382|NCT02908412|Nerve Block|nerve block
60383|NCT02908412|Spectrophotometry|spectrophotometry
60384|NCT02908412|Bupivacaine|bupivacaine
60385|NCT02908412|Spinal Surgery|spinal surgery
60386|NCT02908412|Blood Loss, Surgical|blood loss, surgical
60387|NCT02908386|Head and neck tumors|head and neck tumors
60388|NCT02908386|Proton|proton
60389|NCT02908386|Photon|photon
60390|NCT02908386|replanning timing|replanning timing
60391|NCT02908373|risk management|risk management
60392|NCT02908373|nursing home|nursing home
60393|NCT02908373|elderly|elderly
60394|NCT02908373|care|care
60395|NCT02908360|Double positive lymphocyte T F prausnitzii|double positive lymphocyte t f prausnitzii
60396|NCT02908347|Plaque psoriasis|plaque psoriasis
60397|NCT02908347|chronic|chronic
60398|NCT02908347|moderate|moderate
60399|NCT02908347|severe|severe
60400|NCT02908347|Plaque|plaque
60401|NCT02908308|Induced hypothermia|induced hypothermia
60402|NCT02908308|Mild induced hypothermia|mild induced hypothermia
60403|NCT02908308|Therapeutic hypothermia|therapeutic hypothermia
60404|NCT02908308|Cardiac arrest|cardiac arrest
60405|NCT02908308|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
60406|NCT02908308|Mortality|mortality
60407|NCT02908308|Neurological function|neurological function
60408|NCT02908308|Randomised clinical trial|randomised clinical trial
60409|NCT02908282|tear film|tear film
60410|NCT02908282|omega-3 fatty acids|omega-3 fatty acids
60411|NCT02908282|eye drops|eye drops
60412|NCT02908269|Influenza|influenza
60807|NCT02905708|hypothermia|hypothermia
60413|NCT02908269|Fluzone® Quadrivalent, Influenza Vaccine (2016-2017 formulation)|fluzone® quadrivalent, influenza vaccine (2016-2017 formulation)
60414|NCT02908269|Fluzone® High Dose, Influenza Vaccine (2016-2017 formulation)|fluzone® high dose, influenza vaccine (2016-2017 formulation)
60416|NCT02908256|delta PP|delta pp
60417|NCT02908256|vascular filling|vascular filling
60418|NCT02908243|Hemophilia|hemophilia
60419|NCT02908243|Primary prophylaxis|primary prophylaxis
60420|NCT02908243|Pettersson Score|pettersson score
60421|NCT02908243|Joint function study|joint function study
60422|NCT02908243|Comorbidity|comorbidity
60423|NCT02908217|Polymyalgia Rheumatica|polymyalgia rheumatica
60424|NCT02908217|Tocilizumab|tocilizumab
60425|NCT02908217|Glucocorticoid|glucocorticoid
60426|NCT02908204|superficial esophageal squamous cell carcinoma|superficial esophageal squamous cell carcinoma
60427|NCT02908204|efficacy|efficacy
60428|NCT02908204|survival|survival
60429|NCT02908178|ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
60430|NCT02908178|sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
60431|NCT02908087|Diabetes Type 1|diabetes type 1
60432|NCT02908087|Diabetes, Insulin-Dependent|diabetes, insulin-dependent
60433|NCT02908087|Liraglutide|liraglutide
60434|NCT02908087|GLP-1 Analogue|glp-1 analogue
60435|NCT02908087|Early diagnosis|early diagnosis
60436|NCT02908074|Hypogonadotropic|hypogonadotropic
60437|NCT02908074|hypogonadism|hypogonadism
60438|NCT02908074|testosterone|testosterone
60439|NCT02908061|Mesh Placement|mesh placement
60440|NCT02908061|Radical Cystectomy|radical cystectomy
60441|NCT02908061|16-1285|16-1285
60442|NCT02908048|liver cancer|liver cancer
60443|NCT02908048|cholangiocarcinoma (CCA)|cholangiocarcinoma (cca)
60444|NCT02908048|cirrhosis|cirrhosis
60445|NCT02908048|hepatitis|hepatitis
60446|NCT02908048|bile duct cancer|bile duct cancer
60447|NCT02908048|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
60448|NCT02908048|hepatobiliary carcinoma|hepatobiliary carcinoma
60449|NCT02908048|hepatoma|hepatoma
60450|NCT02908048|liver mass|liver mass
60451|NCT02907983|Menopause|menopause
60452|NCT02907983|Post-menopausal|post-menopausal
60453|NCT02907970|Cervical cancer|cervical cancer
60454|NCT02907970|Screening|screening
60455|NCT02907970|Barriers|barriers
60456|NCT02907931|hemodynamics|hemodynamics
60457|NCT02907931|ultrasonography|ultrasonography
60458|NCT02907879|Subarachnoid Hemorrhage|subarachnoid hemorrhage
60459|NCT02907879|Ultrasound perfusion imaging|ultrasound perfusion imaging
60460|NCT02907879|cerebral hypoperfusion|cerebral hypoperfusion
60461|NCT02907879|vasospasm|vasospasm
60462|NCT02907879|DIND|dind
60463|NCT02907879|infarction|infarction
60464|NCT02907827|complete remission|complete remission
60465|NCT02907827|cfDNA|cfdna
60466|NCT02907827|DW-MRI|dw-mri
60467|NCT02907827|surveillance|surveillance
60468|NCT02907814|Uveitis|uveitis
625699|NCT00682799|SCT|sct
60470|NCT02907801|congenital muscular torticollis|congenital muscular torticollis
60472|NCT02907801|perception-action approach|perception-action approach
60473|NCT02907788|Cystic fibrosis|cystic fibrosis
60474|NCT02907788|Neutrophils|neutrophils
60475|NCT02907788|PMN|pmn
60476|NCT02907788|Inflammation|inflammation
60477|NCT02907788|Lung disease|lung disease
60478|NCT02907788|PRAGMA|pragma
60479|NCT02907762|Endovascular|endovascular
60480|NCT02907762|EVAR|evar
60481|NCT02907762|Neck Angulation|neck angulation
60482|NCT02907710|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
60483|NCT02907710|endostar|endostar
60484|NCT02907710|chemoradiotherapy|chemoradiotherapy
60485|NCT02907697|HIV/AIDS|hiv/aids
60486|NCT02907697|adherence|adherence
60487|NCT02907697|substance use|substance use
60488|NCT02907697|HIV care continuum|hiv care continuum
60489|NCT02907684|Cardiovascular disease|cardiovascular disease
60490|NCT02907684|Non alcoholic fatty liver|non alcoholic fatty liver
60491|NCT02907684|Diabetes|diabetes
60492|NCT02907684|Almonds|almonds
60493|NCT02907684|Endothelium-dependent vasodilation|endothelium-dependent vasodilation
60494|NCT02907684|Fecal short chain fatty acids (SCFAs)|fecal short chain fatty acids (scfas)
60495|NCT02907684|Snacking|snacking
60496|NCT02907671|carpal tunnel injection|carpal tunnel injection
60497|NCT02907671|corticosteroid|corticosteroid
60498|NCT02907671|ultrasound-guided|ultrasound-guided
60499|NCT02907671|musculoskeletal ultrasound|musculoskeletal ultrasound
60500|NCT02907658|Internet Use Disorder|internet use disorder
60501|NCT02907658|Internet Gaming Disorder|internet gaming disorder
60502|NCT02907658|Cognitive-Behavioral Intervention|cognitive-behavioral intervention
60503|NCT02907658|Indicated Prevention|indicated prevention
60504|NCT02907658|Adolescents|adolescents
60505|NCT02907658|Internet Addiction|internet addiction
60506|NCT02907632|Metoclopramide|metoclopramide
60507|NCT02907632|Pro kinetic|pro kinetic
60508|NCT02907632|Gastroesophageal Reflux|gastroesophageal reflux
60509|NCT02907632|Premature Infant|premature infant
60510|NCT02907632|Low Birth Weight|low birth weight
60511|NCT02907632|Kangaroo Mother Care Method|kangaroo mother care method
60513|NCT02907606|Non-small-cell Lung Cancer|non-small-cell lung cancer
60514|NCT02907606|circulating tumor DNA|circulating tumor dna
60515|NCT02907606|urine|urine
60516|NCT02907593|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
60517|NCT02907593|Pulmonary|pulmonary
60518|NCT02907593|Surfactant|surfactant
60519|NCT02907593|Steroids|steroids
60520|NCT02907593|Extremely low gestational age|extremely low gestational age
60521|NCT02907580|influenza|influenza
60522|NCT02907580|vaccination|vaccination
60523|NCT02907554|Preconditioning|preconditioning
60524|NCT02907554|Tissue and organ procurement|tissue and organ procurement
60525|NCT02907554|Cyclosporine A|cyclosporine a
60526|NCT02907554|Kidney transplantation|kidney transplantation
60527|NCT02907554|Delayed graft function|delayed graft function
60528|NCT02907541|eLearning|elearning
60529|NCT02907541|Quality Improvement Methods|quality improvement methods
60530|NCT02907541|Knowledge Transfer|knowledge transfer
60531|NCT02907541|Impact of learning|impact of learning
60532|NCT02907515|single implant retained mandibular overdenture|single implant retained mandibular overdenture
60533|NCT02907489|post operative pain|post operative pain
60534|NCT02907489|triple antibiotic paste|triple antibiotic paste
60535|NCT02907489|intracanal medication|intracanal medication
60536|NCT02907463|Aortic Valve Replacement|aortic valve replacement
60537|NCT02907463|Aortic Stenosis|aortic stenosis
60538|NCT02907463|EDWARDS INTUITY Elite|edwards intuity elite
60539|NCT02907463|Rapid deployment valves|rapid deployment valves
60540|NCT02907437|Minocycline|minocycline
60541|NCT02907437|Negative symptoms|negative symptoms
60542|NCT02907437|Cognitive symptoms|cognitive symptoms
60543|NCT02907437|Inflammation|inflammation
60544|NCT02907411|Quadrivas|quadrivas
60545|NCT02907411|Veins|veins
60546|NCT02907411|Lipedema|lipedema
60547|NCT02907411|Lymphedema|lymphedema
60548|NCT02907398|Neurostimulation|neurostimulation
60549|NCT02907398|Hypoglossal nerve|hypoglossal nerve
60550|NCT02907398|Tongue|tongue
60551|NCT02907398|Upper airway stimulation|upper airway stimulation
60552|NCT02907398|Surgery|surgery
60553|NCT02907385|Rectal Cancer|rectal cancer
60554|NCT02907385|Low Anterior Resection|low anterior resection
60555|NCT02907385|LifeSeal|lifeseal
60556|NCT02907385|Surgical Sealant|surgical sealant
60557|NCT02907372|cognitive dysfunctions|cognitive dysfunctions
60558|NCT02907372|cognitive complaints|cognitive complaints
60559|NCT02907372|metastatic prostate cancer|metastatic prostate cancer
60560|NCT02907372|new generations of hormone-therapy|new generations of hormone-therapy
60561|NCT02907333|Condom use|condom use
60562|NCT02907333|Human Papillomavirus|human papillomavirus
60563|NCT02907333|Conization|conization
60564|NCT02907307|LactiSal|lactisal
60565|NCT02907307|Vaginal therapy|vaginal therapy
60566|NCT02907294|PDE10 inhibitor|pde10 inhibitor
60567|NCT02907294|phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
60568|NCT02907294|Huntington's disease|huntington's disease
60569|NCT02907294|psychiatric disorders|psychiatric disorders
60570|NCT02907281|Multiple sclerosis|multiple sclerosis
60572|NCT02907281|Optical coherence tomography|optical coherence tomography
60573|NCT02907281|OCT|oct
60574|NCT02907281|RRMS|rrms
60575|NCT02907268|botulinum toxin type A, intradermal|botulinum toxin type a, intradermal
60576|NCT02907255|Pulse oximetry|pulse oximetry
60577|NCT02907255|vital signs monitoring|vital signs monitoring
60578|NCT02907255|wireless notification of clinicians|wireless notification of clinicians
60579|NCT02907255|respiratory monitoring system|respiratory monitoring system
60580|NCT02907242|stillbirth|stillbirth
60581|NCT02907242|cerebroplacental ratio|cerebroplacental ratio
60582|NCT02907242|fetal growth restriction|fetal growth restriction
60583|NCT02907216|Healthy Japanese infants|healthy japanese infants
60584|NCT02907216|Safety|safety
60585|NCT02907216|Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) vaccine|diphtheria, tetanus, pertussis and inactivated poliovirus (dpt-ipv) vaccine
60586|NCT02907216|Vaccination|vaccination
60587|NCT02907216|Oral HRV liquid vaccine|oral hrv liquid vaccine
60588|NCT02907216|Immunogenicity|immunogenicity
60589|NCT02907190|pulses|pulses
60590|NCT02907190|beans|beans
60591|NCT02907190|blood glucose|blood glucose
60592|NCT02907190|insulin|insulin
60593|NCT02907112|meat intake|meat intake
60594|NCT02907112|meat analogues|meat analogues
60595|NCT02907112|LDL Cholesterol|ldl cholesterol
60596|NCT02907112|HDL Cholesterol|hdl cholesterol
60597|NCT02907099|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
60598|NCT02907099|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
60599|NCT02907099|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
60600|NCT02907099|BL-8040|bl-8040
60601|NCT02907099|Pembrolizumab|pembrolizumab
60602|NCT02907099|Keytruda|keytruda
60603|NCT02907099|MK-3475|mk-3475
60604|NCT02907099|SCH-900475|sch-900475
60606|NCT02907060|prolonged pregnancy|prolonged pregnancy
60607|NCT02907060|mechanical cervical ripening|mechanical cervical ripening
60610|NCT02906982|Periodontal diseases|periodontal diseases
60611|NCT02906982|Periodontitis|periodontitis
60612|NCT02906982|Gingivitis|gingivitis
60613|NCT02906982|Teeth Whitening|teeth whitening
60614|NCT02906982|Dental Plaque Index|dental plaque index
60615|NCT02906982|Periodontal Index|periodontal index
60616|NCT02906982|Teeth Whitening Agents|teeth whitening agents
60617|NCT02906982|Tooth Discoloration|tooth discoloration
60618|NCT02906982|Mean Probing Depth|mean probing depth
60619|NCT02906982|Pocket Depth|pocket depth
60620|NCT02906943|Molecular Profiling|molecular profiling
60621|NCT02906943|Advanced Cancer|advanced cancer
60622|NCT02906943|Advanced Solid Tumors|advanced solid tumors
60623|NCT02906943|Phase I Clinical Trial Candidates|phase i clinical trial candidates
60624|NCT02906943|Next Generation Sequencing|next generation sequencing
60625|NCT02906878|Intensive Care|intensive care
60626|NCT02906878|Haematology|haematology
60627|NCT02906878|Platelets prophylactic transfusion|platelets prophylactic transfusion
60628|NCT02906839|cardiovascular risk|cardiovascular risk
60629|NCT02906839|risk of atrial fibrillation recurrence|risk of atrial fibrillation recurrence
60630|NCT02906839|sleep apnea syndrome|sleep apnea syndrome
60631|NCT02906839|atrial fibrillation|atrial fibrillation
60632|NCT02906826|Airway clearance technique|airway clearance technique
60633|NCT02906826|Positive expiratory pressure technique|positive expiratory pressure technique
60634|NCT02906826|Adherence|adherence
60635|NCT02906813|Drug Therapy|drug therapy
60636|NCT02906800|cisplatin|cisplatin
60637|NCT02906800|head and neck cancer|head and neck cancer
60638|NCT02906800|digoxin|digoxin
60639|NCT02906787|Smoking Cessation|smoking cessation
60640|NCT02906787|Weight Loss|weight loss
60641|NCT02906761|asthma, aspirin|asthma, aspirin
60642|NCT02906748|parathyroid autografting|parathyroid autografting
60643|NCT02906748|thyroidectomy|thyroidectomy
60644|NCT02906748|survival rate|survival rate
60645|NCT02906748|hypoparathyroidism|hypoparathyroidism
60646|NCT02906722|Nebulized colistin|nebulized colistin
60647|NCT02906722|Intravenous colistin|intravenous colistin
60648|NCT02906722|ventilator-associated pneumonia|ventilator-associated pneumonia
60649|NCT02906722|multidrug resistance|multidrug resistance
60650|NCT02906722|Gram-negative bacteria|gram-negative bacteria
60651|NCT02906696|Chronic myelogenous leukemia|chronic myelogenous leukemia
60653|NCT02906696|Chronic phase post frontline TKI failure|chronic phase post frontline tki failure
60654|NCT02906696|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
60655|NCT02906696|TKI|tki
60656|NCT02906696|Bosutinib|bosutinib
60657|NCT02906696|SKI-606|ski-606
60658|NCT02906696|Phone calls|phone calls
60659|NCT02906696|Questionnaires|questionnaires
60660|NCT02906696|Surveys|surveys
52199|NCT02959463|XRT|xrt
52200|NCT02959463|Intensity modulated radiation therapy|intensity modulated radiation therapy
52201|NCT02959463|IMRT|imrt
52202|NCT02959463|Proton beam therapy|proton beam therapy
60661|NCT02906683|Urinary Incontinence|urinary incontinence
60662|NCT02906683|Urinary Incontinence, Stress|urinary incontinence, stress
60663|NCT02906683|Lower Urinary Tract Symptoms|lower urinary tract symptoms
60665|NCT02906657|Medication Reconciliation|medication reconciliation
60666|NCT02906657|Adverse Drug Event|adverse drug event
60667|NCT02906657|Elderly|elderly
60668|NCT02906657|patient pharmaceutical record|patient pharmaceutical record
60669|NCT02906644|Nicotine addiction|nicotine addiction
60670|NCT02906644|Cigarette smoking|cigarette smoking
60671|NCT02906644|Smoking cessation|smoking cessation
60672|NCT02906644|lorcaserin|lorcaserin
60673|NCT02906644|Belviq|belviq
60674|NCT02906644|Nicotine patches|nicotine patches
60675|NCT02906631|encephalitis,|encephalitis,
60676|NCT02906631|neurologic outcomes of all-cause encephalitis in intensive care unit|neurologic outcomes of all-cause encephalitis in intensive care unit
60677|NCT02906631|outcome, intensive care unit|outcome, intensive care unit
60678|NCT02906553|Nitric Oxide|nitric oxide
60679|NCT02906553|Cognition|cognition
60680|NCT02906527|Cardiology|cardiology
60681|NCT02906527|Oral anticoagulants|oral anticoagulants
60682|NCT02906527|Risk and Benefit analysis|risk and benefit analysis
60683|NCT02906527|Health insurance databases|health insurance databases
60684|NCT02906527|Safety|safety
60685|NCT02906527|Elderly|elderly
60686|NCT02906514|Hydroxyethyl Starch|hydroxyethyl starch
60687|NCT02906514|Cardiac surgery|cardiac surgery
60688|NCT02906514|Priming of cardiopulmonary bypass|priming of cardiopulmonary bypass
60689|NCT02906501|Risperidone|risperidone
60690|NCT02906501|ADHD|adhd
60691|NCT02906501|DBD|dbd
60692|NCT02906501|IGT|igt
60693|NCT02906501|CNP|cnp
60694|NCT02906501|Executive functions|executive functions
60695|NCT02906488|Quality of life|quality of life
60696|NCT02906475|Dermatitis, atopic|dermatitis, atopic
60697|NCT02906475|prevention and control|prevention and control
60698|NCT02906475|Infant|infant
60699|NCT02906475|Skin care|skin care
60700|NCT02906475|randomized controlled trial|randomized controlled trial
60701|NCT02906462|Leonetti French law|leonetti french law
60702|NCT02906462|Palliative care|palliative care
60703|NCT02906449|concussion, mild head injury, mindfulness|concussion, mild head injury, mindfulness
60711|NCT02906384|functional MRI|functional mri
60712|NCT02906384|hopkins Verbal Learning Test|hopkins verbal learning test
60713|NCT02906384|prophylactic cranial irradiation|prophylactic cranial irradiation
60714|NCT02906345|Septic shock|septic shock
62771|NCT02892487|Oropharynx|oropharynx
60715|NCT02906345|Fresh frozen plasma|fresh frozen plasma
60716|NCT02906306|Older adults|older adults
60717|NCT02906306|Occupational Therapy|occupational therapy
60718|NCT02906306|Self-Efficacy|self-efficacy
60719|NCT02906306|Psychological Well-being|psychological well-being
60720|NCT02906280|EBUS-TBNA|ebus-tbna
60721|NCT02906241|African Americans|african americans
60722|NCT02906241|prostate cancer|prostate cancer
60723|NCT02906241|Minority|minority
60724|NCT02906241|Racial /Ethnic disparity|racial /ethnic disparity
60725|NCT02906241|Cancer care|cancer care
60726|NCT02906241|patient-physician communication|patient-physician communication
60727|NCT02906241|cancer clinical trial accrual|cancer clinical trial accrual
60728|NCT02906228|non-ionizing radiation|non-ionizing radiation
60730|NCT02906215|implementation|implementation
60731|NCT02906163|EGFR mutation positive|egfr mutation positive
60732|NCT02906163|Thymosin Alpha 1|thymosin alpha 1
60733|NCT02906163|Tyrosine Kinase inhibitor|tyrosine kinase inhibitor
60734|NCT02906163|Thymalfasin|thymalfasin
60735|NCT02906163|Non Small Cell Lung Cancer|non small cell lung cancer
60736|NCT02906150|EGFR Wild Type|egfr wild type
60737|NCT02906150|Thymosin Alpha 1|thymosin alpha 1
60738|NCT02906150|Non-Small Cell Lung Cancer|non-small cell lung cancer
60739|NCT02906150|Thymalfasin|thymalfasin
60740|NCT02906124|hypercholesterolaemia|hypercholesterolaemia
60741|NCT02906124|Lipid lowering therapies|lipid lowering therapies
60742|NCT02906124|Pregnancy|pregnancy
60743|NCT02906111|Estriol|estriol
60744|NCT02906111|Prolapse|prolapse
60745|NCT02906111|Quality of life|quality of life
60746|NCT02906111|Vaginal health|vaginal health
60747|NCT02906111|Vaginal surgery|vaginal surgery
60748|NCT02906098|Gingivitis|gingivitis
60749|NCT02906098|Adolescents|adolescents
60750|NCT02906098|Oral hygiene|oral hygiene
60751|NCT02906098|Oral health behavior|oral health behavior
60752|NCT02906098|Periodontal infection control|periodontal infection control
60753|NCT02906085|[C10.228.140.546.399.750.250]|[c10.228.140.546.399.750.250]
60754|NCT02906072|Obesity|obesity
60755|NCT02906072|Body fat|body fat
60756|NCT02906072|Plant-based diet|plant-based diet
52298|NCT02958735|insulin-like growth factor 1|insulin-like growth factor 1
52299|NCT02958735|cortisol|cortisol
52303|NCT02958657|Platelet function|platelet function
60757|NCT02906072|Plant-based meal replacement|plant-based meal replacement
60759|NCT02906059|KRAS|kras
60760|NCT02906059|NRAS|nras
60761|NCT02906059|BRAF|braf
60762|NCT02906059|Mutated|mutated
60763|NCT02906059|Wee1 inhibitor|wee1 inhibitor
60764|NCT02906046|SCA 3|sca 3
60765|NCT02906046|Ataxic Gait|ataxic gait
60766|NCT02906033|Surgical Procedures, Operative|surgical procedures, operative
60767|NCT02906033|Operating Rooms|operating rooms
60768|NCT02906033|Quality of Life|quality of life
60769|NCT02906033|Surgery-related anxiety|surgery-related anxiety
60770|NCT02905994|Leukemia|leukemia
60771|NCT02905981|IRIDA|irida
60772|NCT02905981|Triferic|triferic
60773|NCT02905981|soluble ferric pyrophosphate|soluble ferric pyrophosphate
60774|NCT02905981|Shohl's solution|shohl's solution
60775|NCT02905968|Anastomotic leak|anastomotic leak
60776|NCT02905968|Low rectal cancer|low rectal cancer
60777|NCT02905929|sedentary behavior|sedentary behavior
60778|NCT02905929|standing|standing
60779|NCT02905929|sitting|sitting
60780|NCT02905929|inclinometer|inclinometer
60781|NCT02905864|Liraglutide|liraglutide
60782|NCT02905864|Liraglutide 3 mg|liraglutide 3 mg
60783|NCT02905864|Osteoarthritis|osteoarthritis
60784|NCT02905864|Obesity|obesity
60785|NCT02905799|Osteoarthritis|osteoarthritis
60786|NCT02905799|Knee|knee
60787|NCT02905799|Resveratrol|resveratrol
60788|NCT02905799|Oral Treatment|oral treatment
60789|NCT02905799|Pain|pain
60790|NCT02905799|Trial|trial
60791|NCT02905786|General Practice|general practice
60792|NCT02905786|Nurse practitioner|nurse practitioner
60793|NCT02905786|Natriuretic peptides|natriuretic peptides
60794|NCT02905786|Clinical audit|clinical audit
60795|NCT02905773|Intensity|intensity
60796|NCT02905760|Acute Myocardial Infarction|acute myocardial infarction
62509|NCT02894073|obese patients|obese patients
60797|NCT02905760|Right ventricular infarction|right ventricular infarction
60799|NCT02905760|Fluid Expansion|fluid expansion
60800|NCT02905747|Exercise Therapy|exercise therapy
60801|NCT02905747|Musculoskeletal Pain|musculoskeletal pain
60802|NCT02905747|Knee osteoarthritis|knee osteoarthritis
60803|NCT02905747|Physical Therapy Modalities|physical therapy modalities
60804|NCT02905734|Nicotine replacement therapy|nicotine replacement therapy
60805|NCT02905734|Tobacco|tobacco
60806|NCT02905708|normothermia|normothermia
60813|NCT02905669|esophagus|esophagus
60814|NCT02905669|esophago-gastric junction|esophago-gastric junction
60815|NCT02905669|pylorus|pylorus
60816|NCT02905656|quitline|quitline
60817|NCT02905656|nicotine replacement therapy|nicotine replacement therapy
60818|NCT02905656|tobacco intervention|tobacco intervention
60819|NCT02905656|smokers not ready to quit|smokers not ready to quit
60820|NCT02905643|Pseudoprogression|pseudoprogression
60821|NCT02905643|Brain Cancer|brain cancer
60822|NCT02905630|coronary flow reserve|coronary flow reserve
60823|NCT02905630|angina|angina
60824|NCT02905630|exercise training|exercise training
60825|NCT02905617|Breast Augmentation|breast augmentation
60826|NCT02905617|Breast Revision-Augmentation|breast revision-augmentation
60827|NCT02905604|rTMS|rtms
60828|NCT02905604|negative symptoms|negative symptoms
60829|NCT02905604|intermittent theta burst|intermittent theta burst
60830|NCT02905604|iTBS|itbs
60831|NCT02905604|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
60832|NCT02905604|dorsomedial prefrontal cortex|dorsomedial prefrontal cortex
60833|NCT02905604|dmPFC|dmpfc
60834|NCT02905604|NIRS|nirs
60835|NCT02905591|pharmacological ascorbate|pharmacological ascorbate
60836|NCT02905591|ascorbic acid|ascorbic acid
60837|NCT02905591|radiation|radiation
60838|NCT02905591|chemotherapy|chemotherapy
60839|NCT02905591|carboplatin|carboplatin
60840|NCT02905591|paclitaxel|paclitaxel
60841|NCT02905565|Multicenter|multicenter
60842|NCT02905565|Randomized|randomized
60843|NCT02905565|Double-Blind|double-blind
60844|NCT02905565|Placebo-Controlled|placebo-controlled
60845|NCT02905565|Add-On to Standard-of-Care|add-on to standard-of-care
60846|NCT02905565|Safety|safety
60847|NCT02905565|Efficacy|efficacy
60848|NCT02905552|Myelodysplastic syndrome (myelodysplasia)|myelodysplastic syndrome (myelodysplasia)
60849|NCT02905552|Infection|infection
60850|NCT02905552|Risk Factors|risk factors
60851|NCT02905539|Iron|iron
60852|NCT02905539|anemia|anemia
60853|NCT02905539|phosphorus|phosphorus
60854|NCT02905539|FGF-23|fgf-23
60855|NCT02905526|Reproductive health|reproductive health
60856|NCT02905513|Reproductive health|reproductive health
60857|NCT02905500|Disability-Adjusted Life Years|disability-adjusted life years
60858|NCT02905500|Epidemiology|epidemiology
52404|NCT02958098|dilated cardiomyopathy|dilated cardiomyopathy
52405|NCT02958098|systolic heart failure|systolic heart failure
52412|NCT02958072|Healing|healing
60859|NCT02905500|Public Health|public health
60860|NCT02905487|Gestational Diabetes Mellitus|gestational diabetes mellitus
60861|NCT02905487|Obesity|obesity
60862|NCT02905487|Adipocytokin|adipocytokin
60863|NCT02905474|chronic kidney disease, mobile applications, mHealth, medication reconciliation, self-management|chronic kidney disease, mobile applications, mhealth, medication reconciliation, self-management
60864|NCT02905461|Reproductive health|reproductive health
60868|NCT02905448|Insulin resistance|insulin resistance
60869|NCT02905448|Hyperuricemia|hyperuricemia
60876|NCT02905422|physical activity|physical activity
60877|NCT02905422|sleep|sleep
60878|NCT02905422|nutrition|nutrition
60879|NCT02905422|Soldier|soldier
60880|NCT02905422|prevention|prevention
60881|NCT02905422|remote monitoring|remote monitoring
60882|NCT02905422|mobile technology|mobile technology
60883|NCT02905396|small fiber neuropathy|small fiber neuropathy
60884|NCT02905396|spinal cord stimulation|spinal cord stimulation
60885|NCT02905396|treatment|treatment
60886|NCT02905396|pain|pain
60887|NCT02905370|Home Health|home health
60888|NCT02905370|Rehabilitation|rehabilitation
60889|NCT02905370|High Intensity|high intensity
60890|NCT02905370|Hospital Associated Deconditioning|hospital associated deconditioning
60891|NCT02905370|Functional Mobility|functional mobility
60892|NCT02905370|Physical Function|physical function
60893|NCT02905357|Myocardial Infarction|myocardial infarction
60894|NCT02905357|Women|women
60895|NCT02905357|Imaging|imaging
60896|NCT02905305|cochlear implants|cochlear implants
60897|NCT02905305|Dexamethasone|dexamethasone
60898|NCT02905305|combined device|combined device
60899|NCT02905279|spider phobia|spider phobia
60900|NCT02905279|animal phobia|animal phobia
60901|NCT02905279|exposure therapy|exposure therapy
60902|NCT02905279|biofeedback|biofeedback
60903|NCT02905279|relaxation training|relaxation training
60904|NCT02905240|Autologous Protein Solution|autologous protein solution
60905|NCT02905240|APS|aps
60906|NCT02905240|intra-articular injection|intra-articular injection
60907|NCT02905240|osteoarthritis|osteoarthritis
60908|NCT02905227|Adult smokers|adult smokers
60909|NCT02905227|Asthma|asthma
60910|NCT02905227|Healthy volunteers|healthy volunteers
60913|NCT02905188|GPC3-positive hepatocellular carcinoma|gpc3-positive hepatocellular carcinoma
60915|NCT02905175|Porphyromonas gingivalis|porphyromonas gingivalis
60916|NCT02905149|Oncological|oncological
60917|NCT02905149|Surgery|surgery
60918|NCT02905149|Breast|breast
60919|NCT02905149|Reconstruction|reconstruction
60920|NCT02905136|autoantibodies|autoantibodies
60921|NCT02905136|neuronal synaptic receptors|neuronal synaptic receptors
60922|NCT02905136|autoimmune encephalitis|autoimmune encephalitis
60923|NCT02905110|Malignant Neoplasms, Brain|malignant neoplasms, brain
60924|NCT02905097|Knee arthroplasty, Total|knee arthroplasty, total
60925|NCT02905097|Knee replacement, Total|knee replacement, total
60926|NCT02905097|Survival rate|survival rate
60927|NCT02905097|Osseointegration|osseointegration
60928|NCT02905097|Gait|gait
60929|NCT02905071|mental health|mental health
60930|NCT02905071|well-being at work|well-being at work
60931|NCT02905071|screening|screening
60932|NCT02905071|psychosocial risk|psychosocial risk
60933|NCT02905071|psychometrics|psychometrics
60934|NCT02905071|questionnaire|questionnaire
60935|NCT02905071|job stress|job stress
60936|NCT02905032|Afib|afib
60937|NCT02905032|Atrial fib|atrial fib
60938|NCT02905032|Shared|shared
60939|NCT02905032|Decision|decision
60940|NCT02905032|Making|making
60941|NCT02905032|Aid|aid
60942|NCT02905032|AF|af
60946|NCT02904980|Quiet eye training|quiet eye training
60947|NCT02904980|Visual Attention|visual attention
60948|NCT02904954|Lung neoplasms|lung neoplasms
60949|NCT02904954|Bronchial Neoplasms|bronchial neoplasms
60950|NCT02904954|Carcinoma, bronchogenic|carcinoma, bronchogenic
60951|NCT02904954|Neoplasms|neoplasms
60952|NCT02904954|Neoplasms by site|neoplasms by site
60953|NCT02904954|Respiratory Tract Diseases|respiratory tract diseases
60954|NCT02904954|Respiratory Tract Neoplasms|respiratory tract neoplasms
60955|NCT02904954|Thoracic Neoplasms|thoracic neoplasms
60956|NCT02904941|Children|children
60957|NCT02904941|Skin Transplantation|skin transplantation
60958|NCT02904941|Amniotic Membrane|amniotic membrane
60959|NCT02904902|adalimumab|adalimumab
60960|NCT02904902|japanese participants|japanese participants
60961|NCT02904902|efficacy|efficacy
60962|NCT02904902|safety|safety
60963|NCT02904850|Non-small cell lung cancer|non-small cell lung cancer
60964|NCT02904850|locally advanced or metastatic|locally advanced or metastatic
60965|NCT02904850|erlotinib monotherapy|erlotinib monotherapy
60966|NCT02904837|Randomized clinical trial|randomized clinical trial
60967|NCT02904837|Parkinson's disease|parkinson's disease
60968|NCT02904837|Mental practice|mental practice
60969|NCT02904837|Gait|gait
60970|NCT02904824|adipose tissue|adipose tissue
60971|NCT02904824|adult stem cells|adult stem cells
625700|NCT00682825|Anesthesia|anesthesia
60972|NCT02904824|vocal cord paralysis|vocal cord paralysis
60973|NCT02904811|Chlamydia trachomatis|chlamydia trachomatis
60974|NCT02904811|Pelvic inflammatory disease|pelvic inflammatory disease
60975|NCT02904798|sunscreen|sunscreen
60976|NCT02904798|photoprotection|photoprotection
60977|NCT02904798|visible light|visible light
60978|NCT02904746|follow-up|follow-up
60979|NCT02904746|mental health appointment|mental health appointment
60980|NCT02904720|Vitamin D; Pregnancy|vitamin d; pregnancy
60981|NCT02904707|Skin Graft|skin graft
60982|NCT02904668|chronic pain|chronic pain
60983|NCT02904642|SMS reminder|sms reminder
60984|NCT02904642|incentive|incentive
60985|NCT02904642|mobile phone|mobile phone
60986|NCT02904642|Immunization|immunization
60987|NCT02904590|IBD|ibd
60988|NCT02904590|Infection|infection
60989|NCT02904577|Indolent B-Cell Lymphomas|indolent b-cell lymphomas
60990|NCT02904577|prospective collection|prospective collection
60991|NCT02904564|drug delivery|drug delivery
60992|NCT02904564|Idiopathic Guttate Hypomelanosis|idiopathic guttate hypomelanosis
60993|NCT02904551|prospective study|prospective study
60994|NCT02904551|free gingival graft|free gingival graft
60995|NCT02904551|keratinized gingiva|keratinized gingiva
60996|NCT02904551|dental implant|dental implant
60997|NCT02904538|Dexamethasone|dexamethasone
60998|NCT02904538|Regional anesthesia|regional anesthesia
60999|NCT02904538|Front foot surgery|front foot surgery
61000|NCT02904538|Metacarpal osteotomy|metacarpal osteotomy
61001|NCT02904525|newly diagnosed|newly diagnosed
61002|NCT02904525|MRI|mri
61003|NCT02904499|Atrial Fibrillation|atrial fibrillation
61004|NCT02904499|Anticoagulants|anticoagulants
61005|NCT02904499|Pharmacoepidemiology|pharmacoepidemiology
61006|NCT02904447|hemicap|hemicap
61007|NCT02904447|hallux rigidus|hallux rigidus
61008|NCT02904434|voriconazole|voriconazole
61009|NCT02904434|absorption|absorption
61010|NCT02904434|pharmacokinetic|pharmacokinetic
61012|NCT02904434|bioavailability|bioavailability
61013|NCT02904434|intestinal first-pass metabolism|intestinal first-pass metabolism
61014|NCT02904434|pharmacokinetics|pharmacokinetics
61015|NCT02904434|intestinal|intestinal
61016|NCT02904421|scoliosis|scoliosis
61017|NCT02904421|spinal deformity|spinal deformity
61018|NCT02904421|vitamin D|vitamin d
61019|NCT02904421|bone health|bone health
61020|NCT02904408|quality of life|quality of life
61021|NCT02904408|psychotherapy|psychotherapy
61022|NCT02904408|hidradenitis|hidradenitis
61023|NCT02904408|treatments|treatments
61024|NCT02904356|OCD|ocd
61025|NCT02904356|TMS|tms
61026|NCT02904356|Neuromodulation|neuromodulation
61027|NCT02904356|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
61028|NCT02904356|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
61029|NCT02904356|Imaging|imaging
61030|NCT02904343|hemodialysis machine|hemodialysis machine
61031|NCT02904343|quality|quality
61032|NCT02904343|safety|safety
61033|NCT02904343|domestic|domestic
61034|NCT02904304|Flu|flu
61035|NCT02904304|Treatment|treatment
61036|NCT02904291|Bariatric surgery|bariatric surgery
62772|NCT02892487|Hypopharynx|hypopharynx
61037|NCT02904291|Gastrointestinal tract|gastrointestinal tract
61038|NCT02904291|Biological availability|biological availability
61039|NCT02904291|Pharmacokinetics|pharmacokinetics
61040|NCT02904278|Pediatric Heart Transplant Recipient|pediatric heart transplant recipient
61041|NCT02904278|Medication Adherence|medication adherence
61042|NCT02904265|continuous spike wave in sleep|continuous spike wave in sleep
61043|NCT02904265|Landau-Kleffner syndrome|landau-kleffner syndrome
61044|NCT02904265|acetazolamide|acetazolamide
61045|NCT02904265|diazepam|diazepam
61046|NCT02904252|Transient elastography|transient elastography
61047|NCT02904252|Fibrotest|fibrotest
61048|NCT02904239|Contrast Media|contrast media
61049|NCT02904239|Multidetector Computed Tomography|multidetector computed tomography
61050|NCT02904239|Individualized Medicine|individualized medicine
61051|NCT02904239|Radiation Dosage|radiation dosage
61052|NCT02904239|Incidental cardiac findings|incidental cardiac findings
61053|NCT02904239|Thoracic high-pitch Computed Tomography|thoracic high-pitch computed tomography
61054|NCT02904226|ICOS|icos
61055|NCT02904226|ICOS agonist monoclonal antibody|icos agonist monoclonal antibody
61056|NCT02904226|JTX-2011|jtx-2011
61057|NCT02904226|Anti-PD-1|anti-pd-1
61058|NCT02904226|Nivolumab|nivolumab
61059|NCT02904226|ICONIC|iconic
61060|NCT02904226|Immunotherapy|immunotherapy
61061|NCT02904226|Immuno-oncology|immuno-oncology
61062|NCT02904226|Cancer|cancer
61063|NCT02904226|Solid Tumor|solid tumor
61064|NCT02904226|Dose Escalation|dose escalation
61065|NCT02904226|Dose Expansion|dose expansion
61066|NCT02904213|vaccine|vaccine
61067|NCT02904213|ComBe Five|combe five
61068|NCT02904213|Vietnam|vietnam
61069|NCT02904213|pentavalent|pentavalent
61070|NCT02904135|Circulating Tumor Cells|circulating tumor cells
61071|NCT02904070|Threat of|threat of
61072|NCT02904044|School|school
61073|NCT02904044|Sport|sport
61074|NCT02904044|Injuries|injuries
61076|NCT02904005|Prediction|prediction
61077|NCT02904005|Prospective study|prospective study
61078|NCT02904005|Suicide attempt|suicide attempt
61079|NCT02904005|Risk management|risk management
61080|NCT02903992|Frail Elderly|frail elderly
61081|NCT02903992|sarcopenia|sarcopenia
61082|NCT02903966|Tolerability|tolerability
61083|NCT02903966|GSK2982772|gsk2982772
61084|NCT02903966|Safety|safety
61085|NCT02903966|Pharmacokinetics|pharmacokinetics
61086|NCT02903966|RIP1 kinase inhibitor|rip1 kinase inhibitor
61087|NCT02903966|Ulcerative colitis|ulcerative colitis
61088|NCT02903966|Pharmacodynamics|pharmacodynamics
61089|NCT02903914|Immuno-Oncology|immuno-oncology
61090|NCT02903914|Checkpoint Inhibitors|checkpoint inhibitors
61091|NCT02903914|Tumor Metabolism|tumor metabolism
61092|NCT02903914|PD-1 inhibitor|pd-1 inhibitor
61093|NCT02903914|PD-L1 inhibitor|pd-l1 inhibitor
61094|NCT02903914|Solid Tumors|solid tumors
61095|NCT02903914|RCC|rcc
61096|NCT02903914|MEL|mel
61097|NCT02903914|NSCLC|nsclc
61098|NCT02903914|Arginase|arginase
61099|NCT02903914|Arginase Inhibitor|arginase inhibitor
61100|NCT02903914|CB-1158|cb-1158
61101|NCT02903914|SCCHN|scchn
61102|NCT02903914|GEJ|gej
61103|NCT02903901|Delirium|delirium
61104|NCT02903862|Caregivers|caregivers
61105|NCT02903862|Case Management|case management
61106|NCT02903862|Alzheimer's Disease|alzheimer's disease
61107|NCT02903862|Cognition|cognition
61108|NCT02903862|Caregiver Burden|caregiver burden
61109|NCT02903862|Depression|depression
61110|NCT02903823|spinal cord injury|spinal cord injury
61111|NCT02903823|cerebral palsy|cerebral palsy
61112|NCT02903823|stroke|stroke
61113|NCT02903797|Endometrial hyperplasia|endometrial hyperplasia
61114|NCT02903797|Irisin|irisin
61115|NCT02903797|fibronectin type III domain containing 5|fibronectin type iii domain containing 5
61615|NCT02900378|accelerometry|accelerometry
61120|NCT02903719|Nerve block|nerve block
61121|NCT02903719|Postoperative shoulder pain|postoperative shoulder pain
61122|NCT02903719|Liver resection|liver resection
61123|NCT02903706|gold miners|gold miners
61124|NCT02903706|plasmodium carriers|plasmodium carriers
61125|NCT02903706|artemisinine resistance|artemisinine resistance
61126|NCT02903680|Relapse Prevention|relapse prevention
61127|NCT02903680|Children|children
61128|NCT02903667|bone grafting|bone grafting
61129|NCT02903667|implantology|implantology
61130|NCT02903667|oral surgery|oral surgery
61132|NCT02903615|glucose|glucose
61133|NCT02903615|inflammation|inflammation
61134|NCT02903602|sharing histories|sharing histories
61135|NCT02903602|autobiographical memory|autobiographical memory
61136|NCT02903602|health behavior|health behavior
61137|NCT02903602|narrative communication|narrative communication
61138|NCT02903602|community health workers|community health workers
61139|NCT02903602|global health|global health
61140|NCT02903602|maternal and child health|maternal and child health
61141|NCT02903602|stunting|stunting
61142|NCT02903537|Multiple Sclerosis|multiple sclerosis
61143|NCT02903537|Dendritic Cells|dendritic cells
61144|NCT02903537|Immune Tolerance|immune tolerance
61145|NCT02903537|Myelin Proteins|myelin proteins
61146|NCT02903537|Tolerogenic dendritic cells|tolerogenic dendritic cells
61147|NCT02903511|Metformin|metformin
61148|NCT02903511|total kidney volume|total kidney volume
61149|NCT02903511|glomerular filtration rate|glomerular filtration rate
61150|NCT02903498|disease control survival|disease control survival
61151|NCT02903472|SCI|sci
61152|NCT02903472|microbiome|microbiome
61153|NCT02903472|metabolome|metabolome
61154|NCT02903472|GI|gi
61155|NCT02903472|UTI|uti
61156|NCT02903472|DNA|dna
61157|NCT02903472|genomics|genomics
61158|NCT02903472|infections|infections
61159|NCT02903472|tetraplegic|tetraplegic
61160|NCT02903472|paraplegic|paraplegic
61161|NCT02903459|Central Fat|central fat
61162|NCT02903459|Subcutaneous Fat|subcutaneous fat
61163|NCT02903459|Lumbar Lordosis Degree|lumbar lordosis degree
61164|NCT02903459|Cellulite|cellulite
61165|NCT02903433|Avocado|avocado
61166|NCT02903433|Cardiovascular disease|cardiovascular disease
61167|NCT02903407|Ventilators, Mechanical|ventilators, mechanical
61168|NCT02903407|Intensive Care Units|intensive care units
61169|NCT02903407|Deep Sedation|deep sedation
61170|NCT02903381|Smoldering Multiple Myeloma|smoldering multiple myeloma
61171|NCT02903368|Prostate Cancer|prostate cancer
61172|NCT02903342|Fever|fever
61173|NCT02903342|Febrile illness|febrile illness
61174|NCT02903342|Children|children
61175|NCT02903316|Fluid responsiveness|fluid responsiveness
61176|NCT02903316|Perioperative|perioperative
61177|NCT02903316|Extra systoles|extra systoles
61178|NCT02903316|Coronary artery bypass|coronary artery bypass
52697|NCT02956447|Kisspeptin|kisspeptin
52698|NCT02956447|Hyperprolactinemia|hyperprolactinemia
52699|NCT02956408|Obesity|obesity
52700|NCT02956408|Pediatrics|pediatrics
52701|NCT02956408|Vitamin D deficiency|vitamin d deficiency
61179|NCT02903316|Systolic arterial pressure|systolic arterial pressure
61180|NCT02903264|Gestational Diabetes Mellitus|gestational diabetes mellitus
61181|NCT02903264|Obesity|obesity
61182|NCT02903264|Periodontal Disease|periodontal disease
61183|NCT02903251|Oxytocin|oxytocin
61184|NCT02903251|Administration, Intranasal|administration, intranasal
61185|NCT02903251|Ethanol|ethanol
61186|NCT02903238|placebo|placebo
61187|NCT02903238|pain|pain
61188|NCT02903238|osteoarthritis|osteoarthritis
61189|NCT02903225|Heart rate variability|heart rate variability
61190|NCT02903225|Systolic heart failure|systolic heart failure
61191|NCT02903225|Physical exercise|physical exercise
61192|NCT02903225|Parasympathetic indexes|parasympathetic indexes
61193|NCT02903212|Apoptotic cells|apoptotic cells
61194|NCT02903199|Whey Protein|whey protein
61195|NCT02903199|Postprandial Glycaemia|postprandial glycaemia
61196|NCT02903199|Appetite Response|appetite response
61197|NCT02903186|infants|infants
61198|NCT02903186|minorities|minorities
61199|NCT02903186|overfeeding|overfeeding
61200|NCT02903186|WIC program|wic program
61201|NCT02903186|feeding practices|feeding practices
61202|NCT02903186|breastfeeding|breastfeeding
61203|NCT02903173|respiratory depression|respiratory depression
61204|NCT02903173|postpartum|postpartum
61205|NCT02903173|neuraxial morphine|neuraxial morphine
61206|NCT02903173|cesarean delivery|cesarean delivery
61207|NCT02903160|Castration resistant|castration resistant
61208|NCT02903160|Prostate cancer|prostate cancer
61209|NCT02903160|Metastatic|metastatic
61210|NCT02903160|First-line|first-line
61211|NCT02903160|Treatment naive|treatment naive
61212|NCT02903160|Rapidly cycling|rapidly cycling
61213|NCT02903160|Non-cross resistant|non-cross resistant
62899|NCT02891811|maintenance|maintenance
61214|NCT02903147|IVDR; driving behavior patterns; Meta-Cognitive Intervention|ivdr; driving behavior patterns; meta-cognitive intervention
61215|NCT02903121|Unscheduled bleeding|unscheduled bleeding
61216|NCT02903121|Long acting contraception|long acting contraception
61217|NCT02903095|Single ascending dose|single ascending dose
61218|NCT02903082|Myeloid-Derivated suppressive cell|myeloid-derivated suppressive cell
61219|NCT02903082|Sepsis|sepsis
61220|NCT02903082|Inflammatory Response Syndrome, Systemic|inflammatory response syndrome, systemic
61221|NCT02903069|newly diagnosed|newly diagnosed
61222|NCT02903069|malignant glioma|malignant glioma
61223|NCT02903069|WHO Grade 4|who grade 4
61224|NCT02903069|WHO Grade IV|who grade iv
61225|NCT02903069|Marizomib|marizomib
61227|NCT02903069|TMZ|tmz
61228|NCT02903069|RT|rt
61229|NCT02903069|brain cancer|brain cancer
61230|NCT02903069|proteasome inhibitor|proteasome inhibitor
61231|NCT02903069|radiation|radiation
61232|NCT02903069|temozolomide|temozolomide
61233|NCT02903069|temodar|temodar
61234|NCT02903069|chemotherapy|chemotherapy
61235|NCT02903069|concurrent|concurrent
61236|NCT02903069|adjuvant|adjuvant
61237|NCT02903056|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
61238|NCT02903056|Diffusion Spectrum Imaging|diffusion spectrum imaging
61239|NCT02903056|Susceptibility weighted imaging|susceptibility weighted imaging
61240|NCT02903056|Magnetic Resonance Imaging|magnetic resonance imaging
61241|NCT02903043|MicroRNAs|micrornas
61242|NCT02903043|Angiogenesis|angiogenesis
61243|NCT02903043|Skeletal muscle|skeletal muscle
61244|NCT02903043|COPD|copd
61245|NCT02903030|Gastrointestinal Microbiome|gastrointestinal microbiome
61246|NCT02902991|liquid biopsy, breast cancer,circulating tumor biomarker|liquid biopsy, breast cancer,circulating tumor biomarker
61247|NCT02902978|E6130|e6130
61248|NCT02902978|Japanese healthy adult male participants|japanese healthy adult male participants
61249|NCT02902978|Phase 1|phase 1
61250|NCT02902978|Pharmacokinetics|pharmacokinetics
61251|NCT02902965|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
61252|NCT02902965|Bortezomib|bortezomib
61253|NCT02902965|Dexamethasone|dexamethasone
61254|NCT02902965|Ibrutinib|ibrutinib
61255|NCT02902939|Immune Suppression, Inflammatory Response, Cardiac Surgery|immune suppression, inflammatory response, cardiac surgery
61256|NCT02902913|platelet reactivity|platelet reactivity
61257|NCT02902913|phenolic|phenolic
61258|NCT02902913|extra virgin olive oil|extra virgin olive oil
61259|NCT02902913|cyclooxygenase|cyclooxygenase
61260|NCT02902913|oleocanthal|oleocanthal
61261|NCT02902913|oxylipin|oxylipin
61262|NCT02902900|Multiple Myeloma|multiple myeloma
61263|NCT02902900|Pomalidomide|pomalidomide
61264|NCT02902900|Efficacy|efficacy
61265|NCT02902835|Buprenorphine treatment|buprenorphine treatment
61266|NCT02902835|Incarceration|incarceration
61267|NCT02902835|Linkage Intervention|linkage intervention
61268|NCT02902835|Opioid use disorder|opioid use disorder
61269|NCT02902822|melanoma|melanoma
61270|NCT02902822|non-melanoma skin cancer|non-melanoma skin cancer
61271|NCT02902822|mole|mole
61272|NCT02902822|app|app
61273|NCT02902822|cliccailneo|cliccailneo
61274|NCT02902809|open-label study|open-label study
61275|NCT02902809|tralokinumab|tralokinumab
61276|NCT02902809|subcutaneous|subcutaneous
61277|NCT02902809|inadequately controlled asthma|inadequately controlled asthma
61279|NCT02902809|medium to high-dose of inhaled corticosteroid|medium to high-dose of inhaled corticosteroid
61280|NCT02902809|long-acting β2-agonist|long-acting β2-agonist
61281|NCT02902770|Pain|pain
61282|NCT02902770|Lidocaine|lidocaine
61283|NCT02902770|Ketorolac|ketorolac
61284|NCT02902757|FDG|fdg
61285|NCT02902757|PET/CT very early response (48 hrs)|pet/ct very early response (48 hrs)
61286|NCT02902705|White adipose tissue|white adipose tissue
61287|NCT02902705|chronic kidney disease|chronic kidney disease
61288|NCT02902705|uremia|uremia
61289|NCT02902705|adipocytes|adipocytes
61290|NCT02902692|brief|brief
61291|NCT02902692|mindfulness|mindfulness
61292|NCT02902666|Bioequivalence|bioequivalence
61293|NCT02902666|Paracetamol 1000 mg/codeine 30 mg|paracetamol 1000 mg/codeine 30 mg
61294|NCT02902666|Co-efferalgan 500 mg/30 mg|co-efferalgan 500 mg/30 mg
61295|NCT02902653|misoprostol|misoprostol
61296|NCT02902653|dinoprostonal|dinoprostonal
61297|NCT02902653|induction|induction
61298|NCT02902614|embryo biopsy|embryo biopsy
61299|NCT02902614|preimplantation genetic testing|preimplantation genetic testing
61300|NCT02902614|animal pole|animal pole
61301|NCT02902614|vegetal pole|vegetal pole
61302|NCT02902614|day 3 embryo biopsy|day 3 embryo biopsy
61303|NCT02902614|embryo implantation|embryo implantation
61304|NCT02902614|Blastomeres|blastomeres
61305|NCT02902588|Blood-Brain Barrier|blood-brain barrier
61306|NCT02902588|Magnetic Resonance Imaging|magnetic resonance imaging
61307|NCT02902588|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
61308|NCT02902588|Indocyanine green|indocyanine green
61309|NCT02902575|Stomach Neoplasms|stomach neoplasms
61310|NCT02902575|Laparoscopy|laparoscopy
61311|NCT02902575|Advanced Gastric Cancer|advanced gastric cancer
61312|NCT02902575|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
61313|NCT02902549|Optical Coherence Tomography|optical coherence tomography
61314|NCT02902549|Fluorescence Imaging|fluorescence imaging
61315|NCT02902549|Sidestream Darkfield Microscopy|sidestream darkfield microscopy
61320|NCT02902510|Parkinson's disease|parkinson's disease
61321|NCT02902510|gait|gait
61322|NCT02902510|balance|balance
61323|NCT02902458|implantable cardioverter defibrillator|implantable cardioverter defibrillator
61324|NCT02902458|primary prevention|primary prevention
61325|NCT02902458|psychological follow-up|psychological follow-up
61326|NCT02902458|anxiety|anxiety
61327|NCT02902458|depression|depression
61328|NCT02902458|quality of life|quality of life
61329|NCT02902445|Vaccine|vaccine
61330|NCT02902445|Polymorphism|polymorphism
61331|NCT02902432|endostar|endostar
61332|NCT02902432|cisplatin|cisplatin
61333|NCT02902393|Fibrinolysis|fibrinolysis
61334|NCT02902393|tPA|tpa
61335|NCT02902367|mobility|mobility
61336|NCT02902367|exercise|exercise
61337|NCT02902367|walking capacity|walking capacity
61338|NCT02902367|fat mass|fat mass
61339|NCT02902367|muscles|muscles
61340|NCT02902341|Nutrition Therapy|nutrition therapy
61341|NCT02902315|Muscle soreness|muscle soreness
61342|NCT02902315|Free radicals|free radicals
61343|NCT02902315|Ascorbic acid|ascorbic acid
61344|NCT02902315|Alpha-Tocopherol|alpha-tocopherol
61345|NCT02902315|Cryotherapy|cryotherapy
61346|NCT02902315|Exercise tolerance|exercise tolerance
61347|NCT02902315|Resistance training|resistance training
61348|NCT02902302|Bioequivalence|bioequivalence
61349|NCT02902302|Ibuprofen 400 mg/5 ml|ibuprofen 400 mg/5 ml
61350|NCT02902302|Moment 400 mg coated tablet|moment 400 mg coated tablet
61351|NCT02902302|Oral Suspension|oral suspension
61352|NCT02902289|Bioequivalence|bioequivalence
61353|NCT02902289|Ibuprofen 200 mg/5 ml|ibuprofen 200 mg/5 ml
61354|NCT02902289|Moment 200 mg coated tablet|moment 200 mg coated tablet
61355|NCT02902289|Oral Suspension|oral suspension
61356|NCT02902276|plasma citrulline|plasma citrulline
61357|NCT02902276|lipopolysaccharide|lipopolysaccharide
61358|NCT02902276|critically ill|critically ill
61359|NCT02902276|Hospitalization in an Intensive Care Unit|hospitalization in an intensive care unit
61360|NCT02902263|Telemedecine|telemedecine
61361|NCT02902263|Thrombolysis|thrombolysis
61362|NCT02902250|Vertebroplasty|vertebroplasty
61363|NCT02902250|Core decompression|core decompression
61364|NCT02902250|Osteoporosis|osteoporosis
61365|NCT02902211|ankle foot orthosis|ankle foot orthosis
61366|NCT02902211|biomechanics|biomechanics
61367|NCT02902211|mobility|mobility
61368|NCT02902185|Chidamide|chidamide
61369|NCT02902185|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
61370|NCT02902185|HIV-1 Reservoir|hiv-1 reservoir
61371|NCT02902185|Chronic HIV infections|chronic hiv infections
61372|NCT02902185|HIV Eradication|hiv eradication
61373|NCT02902185|Antiretroviral Therapy|antiretroviral therapy
61374|NCT02902159|Stress|stress
61375|NCT02902159|Low Mood|low mood
61376|NCT02902159|Mental Health|mental health
61377|NCT02902159|Peer Support|peer support
61378|NCT02902159|Online|online
61379|NCT02902133|cerebrospinal fluid leak|cerebrospinal fluid leak
61380|NCT02902107|Low Dose Rate Brachytherapy|low dose rate brachytherapy
61381|NCT02902107|CivaSheet|civasheet
61382|NCT02902107|16-605|16-605
61383|NCT02902042|Unresectable or metastatic BRAF V600 mutant melanoma|unresectable or metastatic braf v600 mutant melanoma
61384|NCT02902042|Encorafenib, binimetinib, pembrolizumab|encorafenib, binimetinib, pembrolizumab
61385|NCT02902029|unresectable stage IIIB, IIIC, IV melanoma|unresectable stage iiib, iiic, iv melanoma
61386|NCT02902016|PPARgamma|ppargamma
61387|NCT02902016|Lactose intolerance|lactose intolerance
61388|NCT02902016|Lactase|lactase
61389|NCT02901990|mumps|mumps
61390|NCT02901990|immunity|immunity
61391|NCT02901990|cohort study|cohort study
61392|NCT02901990|children|children
61393|NCT02901990|vaccine|vaccine
61394|NCT02901977|Hypertension|hypertension
61395|NCT02901977|Blood pressure|blood pressure
61396|NCT02901977|Hemostasis|hemostasis
61397|NCT02901977|Endothelial function|endothelial function
61398|NCT02901951|adult subjects|adult subjects
61399|NCT02901951|Hepatitis B antibody|hepatitis b antibody
61400|NCT02901951|Hepatitis B|hepatitis b
61402|NCT02901925|ABY-029|aby-029
61403|NCT02901925|Affibody|affibody
61404|NCT02901925|Molecular Fluorescence-Guided Surgery|molecular fluorescence-guided surgery
61405|NCT02901925|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
61406|NCT02901912|physical activity|physical activity
61407|NCT02901912|sedentarism|sedentarism
61408|NCT02901912|fecal enzymatic activity|fecal enzymatic activity
61413|NCT02901808|NOMI|nomi
61414|NCT02901808|Angiography|angiography
61415|NCT02901808|Digital Subtraction Angiography (DSA)|digital subtraction angiography (dsa)
61416|NCT02901782|Knee|knee
61417|NCT02901782|Titanium Plate|titanium plate
61418|NCT02901730|laser peripheral iridoplasty|laser peripheral iridoplasty
61419|NCT02901730|treatment|treatment
61420|NCT02901678|skelatal open bite, posterior intrusion|skelatal open bite, posterior intrusion
61421|NCT02901626|Short cervix|short cervix
61422|NCT02901626|Preterm delivery|preterm delivery
61423|NCT02901626|Singletons|singletons
61424|NCT02901626|Pregnancy|pregnancy
61425|NCT02901626|Pessary|pessary
61426|NCT02901600|DMBT1 expression|dmbt1 expression
61427|NCT02901600|Colorectal cancer|colorectal cancer
61428|NCT02901548|BCG refractory CIS|bcg refractory cis
61429|NCT02901548|Urothelial CIS of bladder|urothelial cis of bladder
61430|NCT02901548|Carcinoma in situ (CIS)|carcinoma in situ (cis)
61431|NCT02901548|Bacillus Calmette-Guérin (BCG)|bacillus calmette-guérin (bcg)
61432|NCT02901548|Medi4736|medi4736
61433|NCT02901548|Durvalumab|durvalumab
61434|NCT02901548|CIS of the bladder|cis of the bladder
61435|NCT02901548|Bladder cancer|bladder cancer
61436|NCT02901548|BCG Vaccine|bcg vaccine
61437|NCT02901548|Bladder diseases|bladder diseases
61438|NCT02901548|Urothelial diseases|urothelial diseases
61439|NCT02901535|telemedicine|telemedicine
61440|NCT02901535|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
61441|NCT02901535|Primary Health care|primary health care
61442|NCT02901535|spirometry|spirometry
61443|NCT02901522|telemedicine|telemedicine
61444|NCT02901522|asthma control test|asthma control test
61445|NCT02901522|Primary Health care|primary health care
61446|NCT02901522|spirometry|spirometry
61447|NCT02901509|Chikungunya|chikungunya
61448|NCT02901509|Quality of Life|quality of life
61449|NCT02901483|Head and Neck|head and neck
61450|NCT02901457|Body Image|body image
61451|NCT02901418|chronic hepatitis B|chronic hepatitis b
61452|NCT02901418|mother to child transmission|mother to child transmission
61453|NCT02901418|interruption|interruption
61454|NCT02901418|hepatitis B immunoglobulin|hepatitis b immunoglobulin
61455|NCT02901418|pregnancy|pregnancy
61456|NCT02901418|HBsAg|hbsag
61457|NCT02901418|newborns|newborns
61458|NCT02901405|sarcoma|sarcoma
61459|NCT02901405|infection|infection
61460|NCT02901405|negative pressure|negative pressure
61461|NCT02901392|Male Urethral Slings|male urethral slings
61462|NCT02901392|Artificial Urinary Sphincter|artificial urinary sphincter
61463|NCT02901392|Prostatectomy|prostatectomy
61464|NCT02901392|Radiotherapy|radiotherapy
61465|NCT02901379|atorvastatin|atorvastatin
61466|NCT02901379|myocardial edema|myocardial edema
61467|NCT02901379|Follistatin-like 1|follistatin-like 1
61468|NCT02901379|FSTL1|fstl1
61469|NCT02901379|atorvastatin 80mg|atorvastatin 80mg
61470|NCT02901379|coronary artery bypass surgery|coronary artery bypass surgery
61471|NCT02901366|Mass balance|mass balance
61472|NCT02901340|Borderline idiopathic isolated oligohydramnios|borderline idiopathic isolated oligohydramnios
61473|NCT02901340|Fetal renal artery doppler indices|fetal renal artery doppler indices
61474|NCT02901340|neonatal outcomes|neonatal outcomes
61475|NCT02901340|Maternal hydration|maternal hydration
61476|NCT02901327|Lumbar Stabilisation Exercise|lumbar stabilisation exercise
61477|NCT02901327|Treadmill Walk|treadmill walk
61478|NCT02901327|Multifidus Muscle Activation|multifidus muscle activation
61479|NCT02901327|Pain Intensity|pain intensity
61480|NCT02901327|Functional Disability|functional disability
61481|NCT02901288|pulmonary tuberculosis|pulmonary tuberculosis
61482|NCT02901288|shortened regimen|shortened regimen
61483|NCT02901288|clinical trial|clinical trial
61484|NCT02901275|Clinical Trial, Phase II|clinical trial, phase ii
61485|NCT02901275|Analgesia|analgesia
61486|NCT02901262|continuous EEG|continuous eeg
61487|NCT02901249|Cost effectiveness|cost effectiveness
61488|NCT02901249|Unipolar Depression|unipolar depression
61489|NCT02901249|Major Depression Disorder|major depression disorder
61490|NCT02901249|Quality of life disorder|quality of life disorder
61491|NCT02901236|trabeculectomy|trabeculectomy
61492|NCT02901236|glaucoma|glaucoma
61493|NCT02901236|filtration surgery|filtration surgery
61494|NCT02901236|wound healing|wound healing
61495|NCT02901236|angiogenesis|angiogenesis
61496|NCT02901236|mitomycin|mitomycin
61497|NCT02901236|vascular endothelial growth factor inhibition|vascular endothelial growth factor inhibition
61498|NCT02901223|Oncoplastic breast surgery|oncoplastic breast surgery
61499|NCT02901223|oncological safety|oncological safety
61500|NCT02901223|patient satisfaction|patient satisfaction
61501|NCT02901210|Recta prolapse|recta prolapse
61502|NCT02901210|Intraoperative bleeding|intraoperative bleeding
61503|NCT02901210|mucosal cauterization|mucosal cauterization
61504|NCT02901197|capnography|capnography
61505|NCT02901171|Smoking cessation|smoking cessation
61506|NCT02901171|Acceptance and Commitment Therapy|acceptance and commitment therapy
61507|NCT02901171|Smartphone|smartphone
61508|NCT02901158|esophageal pressure|esophageal pressure
61509|NCT02901158|chest wall elastance|chest wall elastance
61510|NCT02901158|lung elastance|lung elastance
61511|NCT02901158|transpulmonary pressure|transpulmonary pressure
61512|NCT02901145|immunotherapy,solid tumor,pediatric|immunotherapy,solid tumor,pediatric
61616|NCT02900365|trauma|trauma
61513|NCT02901106|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
61514|NCT02901106|Dimethyl fumarate|dimethyl fumarate
61515|NCT02901093|Stapes surgery|stapes surgery
61516|NCT02901093|Sensorineural complications|sensorineural complications
61518|NCT02901093|Imaging|imaging
61519|NCT02901093|Cone Beam CT|cone beam ct
61520|NCT02901067|Fibrinolysis|fibrinolysis
61521|NCT02901015|schizophrenia|schizophrenia
61522|NCT02901002|Complex Regional Pain Syndromes|complex regional pain syndromes
61523|NCT02901002|Pain|pain
61524|NCT02901002|Spontaneous sensations|spontaneous sensations
61525|NCT02901002|interoception|interoception
61526|NCT02900989|Psychiatry|psychiatry
61527|NCT02900989|Pediatrics|pediatrics
61528|NCT02900989|Suicide|suicide
61529|NCT02900976|Organ Transplantation|organ transplantation
61530|NCT02900963|Nutrition|nutrition
61531|NCT02900963|Head and Neck Cancer|head and neck cancer
61532|NCT02900950|cancer|cancer
61533|NCT02900950|resection margin|resection margin
61534|NCT02900950|pathology|pathology
61535|NCT02900950|pancreas|pancreas
61536|NCT02900937|Stents|stents
61537|NCT02900937|Angioplasty|angioplasty
61538|NCT02900937|Coronary Vessels|coronary vessels
61539|NCT02900937|Coronary Artery Disease|coronary artery disease
61540|NCT02900937|Angina Pectoris|angina pectoris
61541|NCT02900937|Myocardial Ischemia|myocardial ischemia
61542|NCT02900937|Myocardial Infarction|myocardial infarction
61543|NCT02900937|Myocardial Revascularization|myocardial revascularization
61545|NCT02900924|PVD|pvd
61546|NCT02900924|SFA stent|sfa stent
61547|NCT02900911|head and neck cancer|head and neck cancer
61548|NCT02900911|dysphagia|dysphagia
61549|NCT02900911|rehabilitation|rehabilitation
62773|NCT02892487|Larynx|larynx
61550|NCT02900911|radiation therapy|radiation therapy
61551|NCT02900820|Anti-Bacterial Agents|anti-bacterial agents
61552|NCT02900820|Primary Health Care|primary health care
61553|NCT02900820|Drug Resistance, Microbial|drug resistance, microbial
61554|NCT02900820|Respiratory Tract Infections|respiratory tract infections
61555|NCT02900781|Arthroplasty|arthroplasty
61556|NCT02900781|Physical Therapy|physical therapy
61557|NCT02900768|Bone Marrow Transplantation|bone marrow transplantation
61558|NCT02900768|Exercise|exercise
61559|NCT02900768|Rehabilitation|rehabilitation
61560|NCT02900768|Cancer|cancer
61561|NCT02900755|Electroencephalography|electroencephalography
61562|NCT02900755|Perampanel|perampanel
61563|NCT02900742|lung cancer|lung cancer
61564|NCT02900742|traditional Chinese medicine|traditional chinese medicine
61565|NCT02900742|maintenance therapy|maintenance therapy
61566|NCT02900742|chemotherapy|chemotherapy
61567|NCT02900677|Pancreatic Cancer|pancreatic cancer
61568|NCT02900677|Fatigue|fatigue
61569|NCT02900677|Nutrition|nutrition
53093|NCT02954016|Obesity|obesity
61570|NCT02900677|Quality of Life|quality of life
61571|NCT02900664|CRC|crc
61572|NCT02900664|TNBC|tnbc
61573|NCT02900664|NSCLC (adenocarcinoma)|nsclc (adenocarcinoma)
61574|NCT02900664|Immunomodulation|immunomodulation
61575|NCT02900664|Biomarkers|biomarkers
61576|NCT02900664|Bayesian logistic regression model|bayesian logistic regression model
61577|NCT02900664|PDR001|pdr001
61578|NCT02900664|Immunotherapy|immunotherapy
61579|NCT02900651|MAK683, advanced malignancies, DLBCL, EED - Embryonic ectoderm development, EZH2 - Enhancer of zeste homolog 2|mak683, advanced malignancies, dlbcl, eed - embryonic ectoderm development, ezh2 - enhancer of zeste homolog 2
61580|NCT02900638|mentoring|mentoring
61581|NCT02900638|children|children
61582|NCT02900638|cardiovascular health|cardiovascular health
61583|NCT02900612|dyslipidemias,|dyslipidemias,
61584|NCT02900612|aging|aging
61585|NCT02900612|water aerobics training|water aerobics training
61586|NCT02900612|resistance aquatic training|resistance aquatic training
61587|NCT02900612|lipid profile|lipid profile
61588|NCT02900599|HIV|hiv
61589|NCT02900599|Behavior|behavior
61590|NCT02900547|Systolic Heart Failure|systolic heart failure
61591|NCT02900547|medical algorithm decision support system|medical algorithm decision support system
61592|NCT02900534|grief|grief
61593|NCT02900534|depression|depression
61594|NCT02900534|bereavement|bereavement
61595|NCT02900534|divorce|divorce
61596|NCT02900534|online self-help|online self-help
61597|NCT02900495|Nocturnal Enuresis|nocturnal enuresis
61598|NCT02900495|Bedwetting|bedwetting
61599|NCT02900495|TENS|tens
61600|NCT02900469|RANK|rank
61601|NCT02900469|RANKL|rankl
61602|NCT02900456|Intra-aortic Balloon Pumps|intra-aortic balloon pumps
61603|NCT02900456|Registry|registry
61604|NCT02900417|type 2 diabetes|type 2 diabetes
61605|NCT02900417|gut microbiota|gut microbiota
61606|NCT02900417|sitagliptin|sitagliptin
61607|NCT02900378|physical activity|physical activity
61608|NCT02900378|actigraphy|actigraphy
61609|NCT02900378|sleep|sleep
61610|NCT02900378|sacubitril/valsartan|sacubitril/valsartan
61611|NCT02900378|enalapril|enalapril
61612|NCT02900378|heart failure|heart failure
61613|NCT02900378|reduced ejection fraction|reduced ejection fraction
61614|NCT02900378|randomized controlled trial|randomized controlled trial
61617|NCT02900365|cataract|cataract
61618|NCT02900365|lensectomy|lensectomy
61619|NCT02900365|time|time
61620|NCT02900365|early|early
61621|NCT02900365|late|late
63316|NCT02889315|PAH|pah
61624|NCT02900352|Alcohol Dependence|alcohol dependence
61625|NCT02900352|Zonisamide|zonisamide
61626|NCT02900352|Alcohol Intoxication|alcohol intoxication
61627|NCT02900352|Drinking Behaviors|drinking behaviors
61628|NCT02900352|Anticonvulsants|anticonvulsants
61629|NCT02900339|MRI|mri
61630|NCT02900339|Sequence optimization|sequence optimization
61631|NCT02900339|Healthy volunteers|healthy volunteers
61632|NCT02900326|Exercise capacity|exercise capacity
61633|NCT02900326|Mindfulness|mindfulness
61634|NCT02900326|Quality of life|quality of life
61635|NCT02900313|acute kidney injury|acute kidney injury
61636|NCT02900313|cardiac surgery|cardiac surgery
61637|NCT02900313|cardiac surgery associated acute kidney injury|cardiac surgery associated acute kidney injury
61638|NCT02900313|renal replacement therapy|renal replacement therapy
61639|NCT02900313|renal recovery|renal recovery
61640|NCT02900313|serum hyperphosphatemia|serum hyperphosphatemia
61641|NCT02900287|Survival|survival
61642|NCT02900287|Cancer|cancer
61643|NCT02900248|Biomarkers|biomarkers
61644|NCT02900248|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
61645|NCT02900248|Neoplasms|neoplasms
61646|NCT02900248|Myelodysplastic Syndromes|myelodysplastic syndromes
61647|NCT02900235|Healthy|healthy
61648|NCT02900209|Influenza|influenza
61649|NCT02900209|Exacerbations|exacerbations
61650|NCT02900196|Probiotics|probiotics
61651|NCT02900196|Antibiotic Associated Diarrhea|antibiotic associated diarrhea
61652|NCT02900196|Gastro-Intestinal disorders|gastro-intestinal disorders
62874|NCT02891915|Pneumonia|pneumonia
61653|NCT02900196|Helicobacter pylori|helicobacter pylori
61654|NCT02900170|Rivaroxaban, Acute Kidney Injury|rivaroxaban, acute kidney injury
61655|NCT02900157|Advanced Solid Tumor|advanced solid tumor
61656|NCT02900157|Immunotherapy|immunotherapy
61657|NCT02900157|MEDI9090|medi9090
61658|NCT02900157|MEDI4736|medi4736
61659|NCT02900157|Durvalumab|durvalumab
61660|NCT02900118|Bone metastasis|bone metastasis
61661|NCT02900118|PET-CT|pet-ct
61662|NCT02900118|whole-body MRI|whole-body mri
61663|NCT02900092|postmenopausal|postmenopausal
61664|NCT02900092|women|women
61665|NCT02900092|depression|depression
61666|NCT02900079|malaria|malaria
61667|NCT02900079|rapid diagnostic test|rapid diagnostic test
61668|NCT02900079|travel|travel
61669|NCT02900079|fever|fever
61670|NCT02900079|self care|self care
61671|NCT02900066|fever|fever
61672|NCT02900066|traveler|traveler
61673|NCT02900066|arbovirus|arbovirus
61674|NCT02900066|rickettsia|rickettsia
61675|NCT02900066|malaria|malaria
61676|NCT02900066|filter paper|filter paper
61677|NCT02900066|diagnosis|diagnosis
61678|NCT02900001|myocardial infarction|myocardial infarction
61679|NCT02900001|invasive strategy|invasive strategy
61680|NCT02900001|elderly|elderly
61681|NCT02900001|delayed|delayed
61682|NCT02899988|IL-23|il-23
61683|NCT02899988|dermatology|dermatology
61684|NCT02899975|Validation|validation
61685|NCT02899975|Information and Fitness Software|information and fitness software
61686|NCT02899975|Elderly|elderly
61687|NCT02899975|WeTakeCare|wetakecare
61688|NCT02899949|dapagliflozin|dapagliflozin
61689|NCT02899949|type 2 diabetes|type 2 diabetes
61690|NCT02899949|real-world data|real-world data
61691|NCT02899936|Mass drug administration|mass drug administration
61692|NCT02899936|Safety Data|safety data
61693|NCT02899897|echocardiography|echocardiography
61694|NCT02899884|Drug Therapy|drug therapy
61695|NCT02899871|joint pain|joint pain
61696|NCT02899858|Thoracic spinal cord injury|thoracic spinal cord injury
61697|NCT02899858|Paralysis|paralysis
61698|NCT02899858|ASIA A|asia a
61699|NCT02899858|Device|device
61700|NCT02899832|children|children
61701|NCT02899832|spasms|spasms
61702|NCT02899819|pesticides|pesticides
61703|NCT02899819|exposure|exposure
61704|NCT02899819|in utero|in utero
61705|NCT02899806|Video Information|video information
61706|NCT02899806|Satisfaction|satisfaction
61707|NCT02899806|Anxiety|anxiety
61708|NCT02899806|Epidural Analgesia|epidural analgesia
61709|NCT02899806|Comprehension|comprehension
61710|NCT02899806|delivery|delivery
61711|NCT02899767|transfusion dependency|transfusion dependency
61712|NCT02899767|transfusion intensity|transfusion intensity
61713|NCT02899767|prognosis|prognosis
61714|NCT02899767|chemotherapy|chemotherapy
61715|NCT02899754|lung cancer|lung cancer
61716|NCT02899754|decision support|decision support
61717|NCT02899754|implementation|implementation
61718|NCT02899741|Medically intractable epilepsy, Omega-3|medically intractable epilepsy, omega-3
61719|NCT02899689|Labor|labor
61720|NCT02899689|Foley|foley
61721|NCT02899689|Dilapan|dilapan
61722|NCT02899689|Cervical Dilators|cervical dilators
61723|NCT02899689|Induction|induction
61724|NCT02899650|Delayed Onset Muscle Soreness|delayed onset muscle soreness
61728|NCT02899637|Rehabilitation|rehabilitation
61729|NCT02899637|Non-invasive brain stimulation|non-invasive brain stimulation
61730|NCT02899637|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
61732|NCT02899585|Palliative care|palliative care
61733|NCT02899546|Peripherally Inserted Central Catheter|peripherally inserted central catheter
61734|NCT02899546|Infections|infections
61735|NCT02899546|Radiology|radiology
61736|NCT02899533|PAH|pah
61737|NCT02899533|Pulmonary hypertension|pulmonary hypertension
61738|NCT02899507|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
61739|NCT02899507|Prophylactic antibiotics|prophylactic antibiotics
61740|NCT02899468|TBI|tbi
61741|NCT02899468|Virtual Reality|virtual reality
61742|NCT02899455|Hypertension|hypertension
61743|NCT02899455|Hyperlipidemia|hyperlipidemia
61744|NCT02899442|cardiovascular risk|cardiovascular risk
61745|NCT02899442|Occupational Health|occupational health
61746|NCT02899442|night work|night work
61747|NCT02899442|Public Health|public health
61748|NCT02899442|Preventive Health Services|preventive health services
61749|NCT02899416|cardiovascular risk|cardiovascular risk
61750|NCT02899416|young adulthood|young adulthood
61751|NCT02899403|Cognitive Tasks|cognitive tasks
61752|NCT02899403|Mild Cognitive Impairment|mild cognitive impairment
61753|NCT02899403|Neurophysiological Correlates|neurophysiological correlates
61754|NCT02899403|Healthy Volunteers|healthy volunteers
61755|NCT02899377|PET/CT|pet/ct
61756|NCT02899377|Primary Sjögren's Syndrome|primary sjögren's syndrome
61757|NCT02899377|Magnetic resonance imaging|magnetic resonance imaging
61758|NCT02899377|11^C-MET|11^c-met
61759|NCT02899377|18^F-FDG|18^f-fdg
61760|NCT02899364|Sodium thiosulfate|sodium thiosulfate
61761|NCT02899364|STEMI|stemi
61762|NCT02899364|Infarct size|infarct size
61763|NCT02899364|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
61764|NCT02899364|Hydrogen sulfide|hydrogen sulfide
61765|NCT02899286|Acute myeloid leukemia|acute myeloid leukemia
61766|NCT02899286|AML|aml
61767|NCT02899286|pegylated recombinant human arginase|pegylated recombinant human arginase
61768|NCT02899286|PEG-BCT-100|peg-bct-100
61769|NCT02899273|Early Childhood Caries|early childhood caries
61770|NCT02899273|eye-tracking|eye-tracking
61771|NCT02899273|children|children
61772|NCT02899273|dentistry|dentistry
61773|NCT02899273|face perception|face perception
61774|NCT02899247|composite resin|composite resin
61775|NCT02899247|surface sealant|surface sealant
61776|NCT02899234|Nicotine|nicotine
61777|NCT02899234|Electronic Cigarette|electronic cigarette
61781|NCT02899169|Acute promyelocytic leukemia|acute promyelocytic leukemia
61782|NCT02899169|Realgar-Indigo Naturalis Formula|realgar-indigo naturalis formula
61783|NCT02899169|All-trans Retinoic Acid|all-trans retinoic acid
61784|NCT02899091|Alzheimer's disease|alzheimer's disease
61785|NCT02899091|Mesenchymal Stem cells|mesenchymal stem cells
61786|NCT02899052|Refractory myeloma|refractory myeloma
61787|NCT02899052|Multiple Myeloma|multiple myeloma
61788|NCT02899052|Relapsed myeloma|relapsed myeloma
61789|NCT02899026|Glucocorticosteroids|glucocorticosteroids
61790|NCT02899026|Sirukumab|sirukumab
61791|NCT02899026|Prednisone|prednisone
61792|NCT02899026|Polymyalgia Rheumatica|polymyalgia rheumatica
61793|NCT02899013|Perianal Lesions|perianal lesions
61794|NCT02898987|HIV|hiv
61795|NCT02898987|Hepatitis C|hepatitis c
61796|NCT02898987|Comorbidities|comorbidities
61797|NCT02898987|AIDS|aids
61798|NCT02898948|procalcitonin|procalcitonin
61799|NCT02898948|bacterial infection|bacterial infection
61800|NCT02898909|femtosecond laser-assisted cataract surgery|femtosecond laser-assisted cataract surgery
61801|NCT02898909|nuclear lens fragmentation|nuclear lens fragmentation
61802|NCT02898844|dieting|dieting
61803|NCT02898844|dyads|dyads
61804|NCT02898844|psychological well-being|psychological well-being
61805|NCT02898844|weight loss|weight loss
61806|NCT02898844|cortisol|cortisol
61807|NCT02898792|sensitivity, opioid|sensitivity, opioid
61808|NCT02898753|GSD-II|gsd-ii
61809|NCT02898753|Pompe Disease|pompe disease
61810|NCT02898753|Glycogen Storage Diseases|glycogen storage diseases
61811|NCT02898753|GAA|gaa
61812|NCT02898740|Parkinson's disease|parkinson's disease
61813|NCT02898740|exercise therapy|exercise therapy
61814|NCT02898740|quality of life|quality of life
61815|NCT02898701|Motor Learning|motor learning
61816|NCT02898701|Dose of Motor Practice|dose of motor practice
61817|NCT02898701|Postural Control|postural control
61818|NCT02898701|Serial Reaction Time Task|serial reaction time task
61819|NCT02898701|Retention|retention
61820|NCT02898701|Transfer|transfer
61821|NCT02898701|Overpractice|overpractice
61822|NCT02898701|Overtraining|overtraining
61823|NCT02898701|Overlearning|overlearning
61824|NCT02898688|Influenza vaccine|influenza vaccine
61825|NCT02898688|Pertussis vaccine|pertussis vaccine
61826|NCT02898688|Perinatal vaccination|perinatal vaccination
61827|NCT02898688|Infant vaccination|infant vaccination
61828|NCT02898662|inhaled|inhaled
61829|NCT02898662|TLR9 agonist|tlr9 agonist
61830|NCT02898662|withdrawal design|withdrawal design
61832|NCT02898532|Children, ADHD, target shooting sport|children, adhd, target shooting sport
61833|NCT02898506|Diabetes Type 1|diabetes type 1
61834|NCT02898506|Diabetes, Insulin-Dependent|diabetes, insulin-dependent
61835|NCT02898506|Liraglutide|liraglutide
61836|NCT02898506|Preclinical Type 1 Diabetes|preclinical type 1 diabetes
61837|NCT02898506|GLP-1 Analogue|glp-1 analogue
61838|NCT02898506|Dysglycemia|dysglycemia
61839|NCT02898506|Prevention|prevention
61840|NCT02898493|Validation of questionnaire|validation of questionnaire
61841|NCT02898493|Quality of life|quality of life
61842|NCT02898441|lung cancer screening|lung cancer screening
61843|NCT02898441|low-dose CT|low-dose ct
61844|NCT02898441|high-risk population|high-risk population
61845|NCT02898415|HCC|hcc
61846|NCT02898415|Liver Transplantation|liver transplantation
61847|NCT02898415|AFP|afp
61848|NCT02898415|Mortality|mortality
61849|NCT02898415|Competing risk|competing risk
61850|NCT02898415|Selection criteria|selection criteria
61851|NCT02898415|Recurrence|recurrence
61852|NCT02898376|spa care|spa care
61853|NCT02898376|randomised controlled trial|randomised controlled trial
61854|NCT02898376|pentoxifylline/tocopherol combination|pentoxifylline/tocopherol combination
61855|NCT02898376|late sequelae|late sequelae
61856|NCT02898376|radiotherapy|radiotherapy
61857|NCT02898363|Care of disabled population|care of disabled population
61858|NCT02898363|Mental retardation|mental retardation
61859|NCT02898363|Cancer screening|cancer screening
61860|NCT02898363|Cancer prevention|cancer prevention
61861|NCT02898324|Bullying|bullying
61862|NCT02898324|KiVa program|kiva program
61863|NCT02898324|Primary school students|primary school students
61864|NCT02898311|CAD-CAM|cad-cam
61865|NCT02898311|composite dental resin|composite dental resin
61963|NCT02897622|severe and enduring|severe and enduring
61866|NCT02898311|Immediate dental implant loading|immediate dental implant loading
61867|NCT02898259|Lenalidomide|lenalidomide
61868|NCT02898259|Ixazomib|ixazomib
61869|NCT02898259|Rituximab|rituximab
61870|NCT02898246|heart failure|heart failure
61871|NCT02898246|fear of physical activity|fear of physical activity
61872|NCT02898246|motor activity|motor activity
61873|NCT02898233|depression|depression
61874|NCT02898233|internet-based|internet-based
61875|NCT02898233|treatment|treatment
61876|NCT02898233|low-level light therapy|low-level light therapy
61877|NCT02898233|LLLT|lllt
61878|NCT02898233|deprexis|deprexis
61879|NCT02898194|Surrogate Decision-making|surrogate decision-making
61880|NCT02898194|Health Care|health care
61881|NCT02898194|Medical Decisions|medical decisions
61882|NCT02898194|End of Life Care|end of life care
61883|NCT02898168|stroke|stroke
61884|NCT02898168|Rehabilitation|rehabilitation
61885|NCT02898168|WalkAide (WA)|walkaide (wa)
61886|NCT02898168|Functional Electrical Stimulation (FES)|functional electrical stimulation (fes)
61887|NCT02898155|Avoidable hospitalizations|avoidable hospitalizations
61888|NCT02898155|primary care|primary care
61889|NCT02898155|geographicvariation|geographicvariation
61890|NCT02898142|Postprandial test|postprandial test
61891|NCT02898142|Metabolic syndrime|metabolic syndrime
61892|NCT02898142|HTG|htg
61893|NCT02898129|chronic respiratory diseases|chronic respiratory diseases
61894|NCT02898129|housing|housing
61895|NCT02898129|lung function test|lung function test
61896|NCT02898116|ALK-rearranged|alk-rearranged
61897|NCT02898116|ALK-positive|alk-positive
61898|NCT02898116|ALK Inhibitor|alk inhibitor
61899|NCT02898116|Ensartinib|ensartinib
61900|NCT02898116|X-396|x-396
61901|NCT02898116|anti-PD-L1|anti-pd-l1
61902|NCT02898116|Durvalumab|durvalumab
61903|NCT02898116|MEDI4736|medi4736
61904|NCT02898116|ALK|alk
61905|NCT02898090|Quality indicators|quality indicators
61906|NCT02898090|Appropriateness|appropriateness
61907|NCT02898090|Oral anticoagulant prescriptions|oral anticoagulant prescriptions
61908|NCT02898090|Development and validation|development and validation
61909|NCT02898090|Hospital information system|hospital information system
61910|NCT02898090|Information Storage and Retrieval|information storage and retrieval
61911|NCT02898090|Natural Language Processing|natural language processing
61912|NCT02898077|Second line|second line
61913|NCT02898077|Angiogenesis|angiogenesis
61914|NCT02898077|Vascular endothelial growth factor receptor 2|vascular endothelial growth factor receptor 2
61915|NCT02898051|heparin low-molecular-weight;pharmacokinetics|heparin low-molecular-weight;pharmacokinetics
61916|NCT02898012|Glioblastoma Multiforme|glioblastoma multiforme
61917|NCT02898012|temozolomide|temozolomide
61918|NCT02898012|bevacizumab|bevacizumab
61919|NCT02897973|Spinal loads|spinal loads
61920|NCT02897973|Trunk muscle force|trunk muscle force
61921|NCT02897973|Computational modeling|computational modeling
62116|NCT02896504|Chemobrain|chemobrain
61922|NCT02897973|Unilateral lower limb amputation|unilateral lower limb amputation
61923|NCT02897960|wheezing|wheezing
61924|NCT02897960|bronchiolitis|bronchiolitis
61925|NCT02897960|respiratory sound algorithm|respiratory sound algorithm
61926|NCT02897947|Lumbosacral Region|lumbosacral region
61928|NCT02897947|Registries|registries
61929|NCT02897895|Lung transplantation in end-stage lung diseases|lung transplantation in end-stage lung diseases
61930|NCT02897843|Electroconvulsive Therapy|electroconvulsive therapy
61931|NCT02897843|Transcranial Direct Current Stimulation|transcranial direct current stimulation
61932|NCT02897843|cognition|cognition
61933|NCT02897817|Methotrexate|methotrexate
61934|NCT02897817|Treatment adherence|treatment adherence
61935|NCT02897804|multiphase optimization strategy|multiphase optimization strategy
61936|NCT02897804|college students|college students
61937|NCT02897778|entinostat|entinostat
61938|NCT02897778|solid tumor|solid tumor
61939|NCT02897778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
61940|NCT02897765|Checkpoint Inhibitor|checkpoint inhibitor
61941|NCT02897765|Immunotherapy|immunotherapy
61942|NCT02897765|Personalized Vaccine|personalized vaccine
61943|NCT02897765|Neoantigen|neoantigen
61944|NCT02897765|Poly-ICLC|poly-iclc
61945|NCT02897765|Peptide|peptide
61946|NCT02897752|stroke|stroke
61947|NCT02897752|Rehabilitation|rehabilitation
61948|NCT02897752|WalkAide (WA)|walkaide (wa)
61949|NCT02897752|Functional Electrical Stimulation (FES)|functional electrical stimulation (fes)
61950|NCT02897713|mechanical ventilation|mechanical ventilation
61951|NCT02897713|enteral nutrition|enteral nutrition
61952|NCT02897713|feeding intolerance|feeding intolerance
61953|NCT02897700|Chemotherapy|chemotherapy
61954|NCT02897700|Safety|safety
61955|NCT02897700|Tolerability|tolerability
61956|NCT02897700|Efficacy|efficacy
61957|NCT02897687|Autism Spectrum Disorder|autism spectrum disorder
61958|NCT02897687|Social Skills|social skills
61959|NCT02897687|Social Media|social media
61960|NCT02897661|fecal microbiota transplantation|fecal microbiota transplantation
61961|NCT02897661|enteral nutrition|enteral nutrition
61962|NCT02897622|Eating disorders|eating disorders
61964|NCT02897622|quality of life|quality of life
61965|NCT02897622|case management|case management
61966|NCT02897609|Beta-lactamine|beta-lactamine
61967|NCT02897609|β-lactamine|β-lactamine
61968|NCT02897570|ghrelin|ghrelin
61969|NCT02897570|breakfast meal|breakfast meal
61970|NCT02897570|P-300|p-300
61971|NCT02897531|Ileocolic, stapled, laparoscopy, right hemicolectomy|ileocolic, stapled, laparoscopy, right hemicolectomy
61972|NCT02897518|Videolaryngoscopes|videolaryngoscopes
61973|NCT02897518|Intubation|intubation
61974|NCT02897505|post traumatic stress disorder (PTSD)|post traumatic stress disorder (ptsd)
61975|NCT02897466|ventilator-associated pneumonia|ventilator-associated pneumonia
61976|NCT02897466|Multidrug-resistant bacteria|multidrug-resistant bacteria
61977|NCT02897440|Femoral Neck Fracture|femoral neck fracture
61978|NCT02897440|Hip Arthroplasty|hip arthroplasty
61979|NCT02897440|Repairing of soft tissue|repairing of soft tissue
61980|NCT02897427|Oropharyngeal cancer|oropharyngeal cancer
61981|NCT02897427|Anal cancer|anal cancer
61982|NCT02897427|Penile cancer|penile cancer
61983|NCT02897427|Human papillomavirus|human papillomavirus
61984|NCT02897427|HPV|hpv
61985|NCT02897427|HPV 16 E antigens|hpv 16 e antigens
61986|NCT02897427|Oropharyngeal cancer screening|oropharyngeal cancer screening
61987|NCT02897427|Dysplasia|dysplasia
61988|NCT02897427|Ultrasound scans of throat and the lymph nodes in neck|ultrasound scans of throat and the lymph nodes in neck
61989|NCT02897427|Anal cancer screening|anal cancer screening
61990|NCT02897427|Anal pap test|anal pap test
61991|NCT02897427|High-resolution anoscopy|high-resolution anoscopy
61992|NCT02897427|HRA|hra
61993|NCT02897427|Penile cancer screening|penile cancer screening
61994|NCT02897401|urinary N'Nitrosonornicotine|urinary n'nitrosonornicotine
61995|NCT02897401|nicotine|nicotine
61996|NCT02897401|electronic cigarette|electronic cigarette
61997|NCT02897401|nicotine remplacement treatment|nicotine remplacement treatment
61998|NCT02897362|ADHD|adhd
61999|NCT02897362|Sleep|sleep
62000|NCT02897362|Adolescents|adolescents
62001|NCT02897362|Neurocognition|neurocognition
62002|NCT02897362|Polysomnography|polysomnography
62003|NCT02897310|critically ill patients|critically ill patients
62004|NCT02897310|acute kidney injury|acute kidney injury
62005|NCT02897310|renal replacement therapy|renal replacement therapy
62006|NCT02897310|long term outcome|long term outcome
62007|NCT02897284|Mindfulness-based|mindfulness-based
62008|NCT02897284|Self-care|self-care
62009|NCT02897284|Health workers|health workers
62010|NCT02897284|Epigenetics|epigenetics
62011|NCT02897271|Eosinophilic Gastrointestinal Disorders|eosinophilic gastrointestinal disorders
62012|NCT02897258|Dialysis|dialysis
62013|NCT02897258|Thrombosis|thrombosis
62014|NCT02897258|Haemorrhage|haemorrhage
62015|NCT02897245|Myelogenous|myelogenous
62016|NCT02897245|Chronic|chronic
62017|NCT02897245|BCR-ABL Positive|bcr-abl positive
62018|NCT02897232|Human Papillomavirus Vaccine|human papillomavirus vaccine
62019|NCT02897232|HPV|hpv
62020|NCT02897232|Patient Acceptance|patient acceptance
62021|NCT02897232|Physician Comfort|physician comfort
62022|NCT02897232|Male Vaccination|male vaccination
62023|NCT02897232|HPV Associated Cancers|hpv associated cancers
62024|NCT02897219|SGLT2 inhibitor|sglt2 inhibitor
62025|NCT02897219|ASP1941|asp1941
62026|NCT02897219|type 1 diabetes mellitus|type 1 diabetes mellitus
62027|NCT02897206|Acute pancreatitis|acute pancreatitis
62028|NCT02897206|Antibiotic prophylaxis|antibiotic prophylaxis
62029|NCT02897206|Imipenem-cilastatin|imipenem-cilastatin
62030|NCT02897206|Infected pancreatic necrosis|infected pancreatic necrosis
62031|NCT02897206|Infection|infection
62032|NCT02897206|Organ failure|organ failure
62033|NCT02897180|tuberculosis|tuberculosis
62034|NCT02897180|latent tuberculosis infection|latent tuberculosis infection
62035|NCT02897180|Food supplement|food supplement
62036|NCT02897180|Mycobacterium manresensis|mycobacterium manresensis
62037|NCT02897180|Nyaditum resae|nyaditum resae
62038|NCT02897180|Efficacy trial|efficacy trial
62039|NCT02897167|Psychosis|psychosis
62040|NCT02897167|Antipsychotic Agents|antipsychotic agents
62041|NCT02897167|Immunology|immunology
62042|NCT02897167|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
62043|NCT02897141|HIV|hiv
62044|NCT02897141|Health Management App|health management app
62045|NCT02897141|HIV symptoms|hiv symptoms
62046|NCT02897128|Sarcoma|sarcoma
62047|NCT02897128|Radiation|radiation
62048|NCT02897128|Wound healing|wound healing
62049|NCT02897115|Humira|humira
62050|NCT02897115|Axial Spondyloarthritis|axial spondyloarthritis
62051|NCT02897089|universal adhesive|universal adhesive
62052|NCT02897089|fissure sealants|fissure sealants
62053|NCT02897089|retention|retention
62054|NCT02897063|midodrine|midodrine
62055|NCT02897063|droxidopa|droxidopa
62056|NCT02897063|splanchnic circulation|splanchnic circulation
62057|NCT02897037|Bivalirudin|bivalirudin
62058|NCT02897037|Acute myocardial infarction|acute myocardial infarction
62059|NCT02897037|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
62060|NCT02897024|Cerebral Palsy|cerebral palsy
62061|NCT02897024|Motor Impairments|motor impairments
62062|NCT02896985|C-Reactive Protein (CRP)|c-reactive protein (crp)
62063|NCT02896985|Anti-Adalimumab Antibody (AAA)|anti-adalimumab antibody (aaa)
62064|NCT02896985|Therapeutic Drug Monitoring (TDM)|therapeutic drug monitoring (tdm)
62065|NCT02896985|Patient Reported Outcome 2 (PRO 2)|patient reported outcome 2 (pro 2)
62066|NCT02896985|Adalimumab|adalimumab
62067|NCT02896985|Harvey Bradshaw Index (HBI)|harvey bradshaw index (hbi)
62068|NCT02896972|vitrectomy|vitrectomy
62069|NCT02896972|macular hole retinal detachment|macular hole retinal detachment
62070|NCT02896972|high myopia|high myopia
62071|NCT02896920|Humira®|humira®
62072|NCT02896920|Hidradenitis Suppurativa (HS)|hidradenitis suppurativa (hs)
62073|NCT02896920|Canada|canada
62074|NCT02896816|Parkinson's|parkinson's
62075|NCT02896803|Pancreatic Cancer|pancreatic cancer
62076|NCT02896803|Chemotherapy|chemotherapy
62077|NCT02896790|Cancer|cancer
62078|NCT02896790|Oral Therapy|oral therapy
62079|NCT02896790|Compliance|compliance
62080|NCT02896790|Anthropology|anthropology
62081|NCT02896790|Psychology|psychology
62082|NCT02896777|pH|ph
62083|NCT02896777|IVF|ivf
62084|NCT02896777|live birth rate|live birth rate
62085|NCT02896751|CPAP|cpap
62086|NCT02896751|Noninvasive Ventilation Mask|noninvasive ventilation mask
62087|NCT02896725|Venous leg ulcer|venous leg ulcer
62088|NCT02896725|Acellular skin substitutes|acellular skin substitutes
62089|NCT02896725|Keratin dressings|keratin dressings
62090|NCT02896699|Pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
62091|NCT02896699|diffusion of innovation|diffusion of innovation
62092|NCT02896699|men who have sex with men|men who have sex with men
62093|NCT02896699|LGBT|lgbt
62094|NCT02896699|African American|african american
62095|NCT02896699|Black|black
62096|NCT02896699|HIV|hiv
62097|NCT02896699|network analysis|network analysis
62098|NCT02896699|network intervention|network intervention
62099|NCT02896686|Ileostomy closure|ileostomy closure
62100|NCT02896686|Polypropylene Mesh|polypropylene mesh
62101|NCT02896686|Incisional hernia|incisional hernia
62102|NCT02896673|positive expiratory pressure (PEP)|positive expiratory pressure (pep)
62103|NCT02896673|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
62104|NCT02896673|electrical impedance tomography (EIT)|electrical impedance tomography (eit)
62105|NCT02896673|tidal volume (TV)|tidal volume (tv)
62106|NCT02896673|transpulmonary pressure (TPP)|transpulmonary pressure (tpp)
62107|NCT02896621|Sleep Apnea|sleep apnea
62108|NCT02896621|Hypertension|hypertension
62109|NCT02896621|Chlortalidone|chlortalidone
62110|NCT02896621|Diastolic function|diastolic function
62111|NCT02896569|resurfacing|resurfacing
62112|NCT02896569|ablation|ablation
62113|NCT02896556|image analysis|image analysis
62114|NCT02896543|dendritic cells|dendritic cells
62115|NCT02896543|P-selectin|p-selectin
62117|NCT02896504|Chemotherapy|chemotherapy
62118|NCT02896504|Hormonal Therapy|hormonal therapy
62119|NCT02896504|Neuroimaging|neuroimaging
62120|NCT02896465|Children|children
62121|NCT02896465|Diarrhea|diarrhea
62122|NCT02896465|Human milk oligosaccharides|human milk oligosaccharides
62123|NCT02896439|Traumatic|traumatic
62124|NCT02896439|Acetabular|acetabular
62125|NCT02896426|Parent training|parent training
62126|NCT02896426|Preschoolers|preschoolers
62127|NCT02896426|Behavior problems|behavior problems
62128|NCT02896426|Oppositional Defiant Disorder|oppositional defiant disorder
62129|NCT02896426|ODD|odd
62130|NCT02896426|Conduct Disorder|conduct disorder
62131|NCT02896426|CD|cd
62132|NCT02896426|Children|children
62133|NCT02896426|Parenting|parenting
62134|NCT02896426|Collaborative Problem Solving|collaborative problem solving
62135|NCT02896426|CPS|cps
62136|NCT02896426|Disruptive behavior|disruptive behavior
62137|NCT02896348|Hemiparesis|hemiparesis
62138|NCT02896348|Stroke|stroke
62139|NCT02896348|Rehabilitation|rehabilitation
62140|NCT02896348|Home-based|home-based
62141|NCT02896335|Recurrent Brain metastases|recurrent brain metastases
62142|NCT02896283|wound healing|wound healing
62143|NCT02896283|low-level laser therapy|low-level laser therapy
62144|NCT02896283|gingival recession|gingival recession
62145|NCT02896270|idiopathic podocytopathies|idiopathic podocytopathies
62146|NCT02896270|Neprology|neprology
62147|NCT02896257|Quality Improvement|quality improvement
62148|NCT02896257|Quality Enhancement Research Initiatives|quality enhancement research initiatives
62149|NCT02896257|QuERI|queri
62150|NCT02896257|Interventional|interventional
62151|NCT02896257|Multicenter|multicenter
62152|NCT02896257|Inhaled corticosteroids|inhaled corticosteroids
62153|NCT02896257|Pneumonia|pneumonia
62154|NCT02896257|Safety|safety
62155|NCT02896257|De-implementation|de-implementation
62156|NCT02896257|Respiratory Tract Diseases|respiratory tract diseases
62157|NCT02896257|Lung Diseases|lung diseases
62158|NCT02896257|Lung Diseases, Obstructive|lung diseases, obstructive
62159|NCT02896257|Pulmonary Diseases, Chronic Obstructive COPD|pulmonary diseases, chronic obstructive copd
62160|NCT02896244|Clostridium difficile|clostridium difficile
62161|NCT02896244|Clostridium difficile infection|clostridium difficile infection
62162|NCT02896244|antibiotics|antibiotics
62163|NCT02896244|antibiotics associated diarrhea|antibiotics associated diarrhea
62164|NCT02896244|microbiome|microbiome
62165|NCT02896244|microbiota|microbiota
62166|NCT02896218|Vancomycin|vancomycin
62167|NCT02896218|Critically Ill|critically ill
62168|NCT02896218|Pharmacist|pharmacist
62169|NCT02896218|Population Pharmacokinetic|population pharmacokinetic
62170|NCT02896218|Bayesian Methods|bayesian methods
62171|NCT02896192|POMC deficiency obesity|pomc deficiency obesity
62172|NCT02896192|PCSK1 deficiency obesity|pcsk1 deficiency obesity
62173|NCT02896179|Multiple sclerosis|multiple sclerosis
62174|NCT02896179|Gait rehabilitation|gait rehabilitation
62175|NCT02896179|Quality of life|quality of life
62176|NCT02896179|Virtual reality|virtual reality
62177|NCT02896179|Cognitive deficit|cognitive deficit
62178|NCT02896179|Robot assisted gait training|robot assisted gait training
62179|NCT02896166|nsclc and stage I and microwave ablation|nsclc and stage i and microwave ablation
62180|NCT02896140|Type 2 diabetes|type 2 diabetes
62181|NCT02896140|Obesity|obesity
62182|NCT02896140|Nutrition|nutrition
62183|NCT02896140|Dairy|dairy
62184|NCT02896127|Ankylosing Spondyloarthritis|ankylosing spondyloarthritis
62185|NCT02896127|Axial spondyloarthritis|axial spondyloarthritis
62186|NCT02896101|Mild to moderate|mild to moderate
62187|NCT02896075|delayed onset muscle soreness|delayed onset muscle soreness
62188|NCT02896075|laughter|laughter
62189|NCT02896049|neoplasms|neoplasms
62190|NCT02896049|hyperthermia|hyperthermia
62191|NCT02896036|Laparoscopic Entry|laparoscopic entry
62192|NCT02896036|Veress Needle|veress needle
62193|NCT02896036|Intraperitoneal insufflation|intraperitoneal insufflation
62194|NCT02896036|Time|time
62195|NCT02896036|Complications|complications
62196|NCT02896023|predictors|predictors
62197|NCT02896023|ovarian reserve|ovarian reserve
62198|NCT02896023|infertile women|infertile women
62199|NCT02896010|Mobile Health|mobile health
62200|NCT02895997|mental fatigue|mental fatigue
62201|NCT02895997|critical care|critical care
62202|NCT02895984|Social network analysis|social network analysis
62203|NCT02895984|Brief Motivational Interviewing|brief motivational interviewing
62204|NCT02895984|College Students|college students
62205|NCT02895971|Venous Thromboembolism|venous thromboembolism
62206|NCT02895971|professional Practices|professional practices
62207|NCT02895906|22q11.2 DS|22q11.2 ds
62208|NCT02895880|Communication Tool|communication tool
62209|NCT02895880|Cancer Survivors|cancer survivors
62210|NCT02895880|Increase Statin|increase statin
62211|NCT02895880|16-1128|16-1128
62212|NCT02895854|Low risk prostate cancer|low risk prostate cancer
62213|NCT02895854|Intermediate risk prostate cancer|intermediate risk prostate cancer
62214|NCT02895854|Low dose-rate brachytherapy|low dose-rate brachytherapy
62215|NCT02895854|Hypofractionated|hypofractionated
62216|NCT02895854|Robotic external beam radiation|robotic external beam radiation
62217|NCT02895854|Quality of life|quality of life
62218|NCT02895841|oncology|oncology
62219|NCT02895841|bone marrow transplant|bone marrow transplant
62220|NCT02895841|sickle cell disease|sickle cell disease
62221|NCT02895802|down syndrome|down syndrome
62222|NCT02895789|spinal muscular atrophy|spinal muscular atrophy
62223|NCT02895789|oxidative capacity|oxidative capacity
62224|NCT02895789|exercise tolerance|exercise tolerance
62225|NCT02895789|mitochondrial myopathy|mitochondrial myopathy
62226|NCT02895789|SMA|sma
62227|NCT02895789|six minute walk test|six minute walk test
62228|NCT02895789|neuromuscular disease|neuromuscular disease
62229|NCT02895789|ambulation|ambulation
62230|NCT02895789|exercise|exercise
62231|NCT02895789|mitochondria|mitochondria
62232|NCT02895789|cycle ergometry|cycle ergometry
62233|NCT02895789|near infrared spectroscopy|near infrared spectroscopy
62234|NCT02895763|QUALITY OF LIFE|quality of life
62235|NCT02895763|NEUROMUSCULAR DISEASES|neuromuscular diseases
62236|NCT02895750|diabetes type 2|diabetes type 2
62237|NCT02895750|Metformin|metformin
62238|NCT02895750|chronic kidney disease|chronic kidney disease
62239|NCT02895750|CKD|ckd
62240|NCT02895737|aortic stenosis, transcatheter aortic valve replacement, stroke, ischemic infarction, cerebral embolic protection device|aortic stenosis, transcatheter aortic valve replacement, stroke, ischemic infarction, cerebral embolic protection device
62241|NCT02895724|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
62242|NCT02895724|secondary lymphedema|secondary lymphedema
62243|NCT02895698|Cupping|cupping
62244|NCT02895698|Dry cupping|dry cupping
62245|NCT02895698|Myofascial trigger points|myofascial trigger points
62246|NCT02895685|Simulation|simulation
62247|NCT02895685|Self-regulated training|self-regulated training
62248|NCT02895685|Education|education
62249|NCT02895685|Open surgery|open surgery
62250|NCT02895685|Dyad training|dyad training
62251|NCT02895659|fluid management|fluid management
62252|NCT02895659|critical illness|critical illness
62253|NCT02895659|hemodynamics|hemodynamics
62254|NCT02895659|buffered infusates|buffered infusates
62255|NCT02895633|MR imaging|mr imaging
62256|NCT02895633|Diffusion weighted imaging|diffusion weighted imaging
62257|NCT02895633|MR proton spectroscopy|mr proton spectroscopy
62258|NCT02895633|CT perfusion|ct perfusion
62259|NCT02895633|Contrast enhanced ultrasound|contrast enhanced ultrasound
62260|NCT02895568|Antimalarial drug|antimalarial drug
62261|NCT02895568|Resistance|resistance
62262|NCT02895568|Republic of Chard|republic of chard
62263|NCT02895555|ODI|odi
62264|NCT02895503|Stage IA Non-Small Cell Lung Carcinoma|stage ia non-small cell lung carcinoma
62265|NCT02895503|Stage IB Non-Small Cell Lung Carcinoma|stage ib non-small cell lung carcinoma
62266|NCT02895503|Stage IIA Non-Small Cell Lung Carcinoma|stage iia non-small cell lung carcinoma
62267|NCT02895503|Stage IIB Non-Small Cell Lung Carcinoma|stage iib non-small cell lung carcinoma
62268|NCT02895503|Stage IIIA Non-Small Cell Lung Cancer|stage iiia non-small cell lung cancer
62269|NCT02895503|Stage IIIB Non-Small Cell Lung Cancer|stage iiib non-small cell lung cancer
62270|NCT02895503|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
62271|NCT02895451|Exercise-based cardiac rehabilitation|exercise-based cardiac rehabilitation
62272|NCT02895451|Physical capacity|physical capacity
62273|NCT02895451|Adherence|adherence
62274|NCT02895451|Behavioral medicine|behavioral medicine
62275|NCT02895438|Gluten-Sensitive|gluten-sensitive
62276|NCT02895438|Diet, Gluten-Free|diet, gluten-free
62277|NCT02895438|Irritable Bowel Syndrome|irritable bowel syndrome
62278|NCT02895438|non Coeliac Gluten sensitivity|non coeliac gluten sensitivity
62279|NCT02895438|children|children
62280|NCT02895425|Renal Transplant|renal transplant
62281|NCT02895386|Hypertension|hypertension
62282|NCT02895386|High Blood Pressure|high blood pressure
62283|NCT02895386|Systolic Blood Pressure|systolic blood pressure
62284|NCT02895373|platelet inhibition|platelet inhibition
62285|NCT02895373|alprostadil|alprostadil
62286|NCT02895373|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
62287|NCT02895373|bleeding|bleeding
62288|NCT02895373|thromboembolic|thromboembolic
62290|NCT02895334|Congenital Heart Disease|congenital heart disease
62291|NCT02895321|nano-hydroxyapatite|nano-hydroxyapatite
62292|NCT02895321|potassium nitrate|potassium nitrate
62293|NCT02895308|compliance|compliance
62294|NCT02895295|Medicare Part D|medicare part d
62295|NCT02895295|decision support|decision support
62296|NCT02895295|prescription drugs|prescription drugs
62297|NCT02895295|expert recommendation|expert recommendation
62298|NCT02895295|health insurance choice|health insurance choice
62299|NCT02895282|Obesity|obesity
62300|NCT02895282|Chronobiology|chronobiology
62301|NCT02895282|Circadian|circadian
62302|NCT02895269|Complementary Alternative Providers|complementary alternative providers
62303|NCT02895269|Collaborative Shared Care|collaborative shared care
62304|NCT02895269|Primary Health Care Providers|primary health care providers
62305|NCT02895269|Psychosis|psychosis
62306|NCT02895230|Androgen-deprivation therapy|androgen-deprivation therapy
62307|NCT02895230|Prostate cancer|prostate cancer
62705|NCT02892929|Life Style|life style
62308|NCT02895230|Nationwide population-based cohort|nationwide population-based cohort
62309|NCT02895230|Myocardial infarction|myocardial infarction
62310|NCT02895230|Ischemic stroke|ischemic stroke
62311|NCT02895217|Energy expenditure|energy expenditure
62312|NCT02895217|Food intake|food intake
62313|NCT02895217|Women|women
62317|NCT02895204|Immune function|immune function
62318|NCT02895204|Pre-albumin|pre-albumin
62319|NCT02895204|Interleukin-12|interleukin-12
62320|NCT02895178|Breast cancer|breast cancer
62321|NCT02895178|Survivors|survivors
62322|NCT02895178|Exercise|exercise
62323|NCT02895165|breast neoplasms|breast neoplasms
62324|NCT02895165|fertility preservation|fertility preservation
62325|NCT02895165|pregnancy|pregnancy
62326|NCT02895152|COPD|copd
62327|NCT02895152|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
62328|NCT02895152|Pulmonary Rehabilitation|pulmonary rehabilitation
62329|NCT02895152|Activity Monitors|activity monitors
62330|NCT02895152|Fitbit|fitbit
62331|NCT02895152|Fitness Tracker|fitness tracker
62332|NCT02895139|Additive Manufacture|additive manufacture
62333|NCT02895139|Orthotic Insole|orthotic insole
62334|NCT02895113|Aspirin|aspirin
62335|NCT02895113|Diabetes|diabetes
62336|NCT02895113|Renal function|renal function
62337|NCT02895113|Thromboxane|thromboxane
62338|NCT02895100|ulcerative colitis|ulcerative colitis
62339|NCT02895100|inflammatory bowel disease|inflammatory bowel disease
62340|NCT02895100|PROPEL|propel
62341|NCT02895100|Propel Study|propel study
62342|NCT02895087|diurnal variation|diurnal variation
62343|NCT02895087|stress|stress
62344|NCT02895074|femtosecond laser-assisted cataract surgery (FLACS)|femtosecond laser-assisted cataract surgery (flacs)
62345|NCT02895074|subfoveal choroidal thickness (SFCT)|subfoveal choroidal thickness (sfct)
62346|NCT02895074|conventional phacoemulsification surgery (CPS)|conventional phacoemulsification surgery (cps)
62347|NCT02895009|Coronary Disease|coronary disease
62348|NCT02895009|Radial artery occlusion|radial artery occlusion
62349|NCT02895009|transradial coronary intervention|transradial coronary intervention
62350|NCT02894996|pediatric|pediatric
62351|NCT02894996|anesthesia|anesthesia
62352|NCT02894996|fluid responsiveness|fluid responsiveness
62353|NCT02894996|hemodynamic|hemodynamic
62354|NCT02894983|wrist fracture|wrist fracture
62355|NCT02894983|colles fracture|colles fracture
62356|NCT02894983|non-operative|non-operative
62357|NCT02894983|rehabilitation|rehabilitation
62358|NCT02894944|Pancreatic cancer|pancreatic cancer
62359|NCT02894944|Adenovirus|adenovirus
62360|NCT02894944|Gene therapy|gene therapy
62361|NCT02894931|macrophage atherogenicity|macrophage atherogenicity
62362|NCT02894931|dietary interventions|dietary interventions
62363|NCT02894931|sugars|sugars
62364|NCT02894931|amino acids|amino acids
62365|NCT02894931|artificial sweeteners|artificial sweeteners
62366|NCT02894931|atherosclerosis|atherosclerosis
62367|NCT02894892|Electron Microscopy|electron microscopy
62368|NCT02894892|Helicobacter pylori|helicobacter pylori
62369|NCT02894892|Bismuth|bismuth
62370|NCT02894879|Postoperative pulmonary complications|postoperative pulmonary complications
62371|NCT02894866|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
62372|NCT02894866|hyperbaric oxygen therapy|hyperbaric oxygen therapy
62373|NCT02894840|GPO Tri Fluvac Vaccine|gpo tri fluvac vaccine
62374|NCT02894840|Tri Fluvac Vaccine|tri fluvac vaccine
62375|NCT02894814|Self administration|self administration
62376|NCT02894814|Medication|medication
62377|NCT02894814|Inpatient|inpatient
62378|NCT02894814|Self-care|self-care
62379|NCT02894814|Self-management|self-management
62380|NCT02894814|Medical patients|medical patients
62381|NCT02894749|hybrid rooms|hybrid rooms
62382|NCT02894749|cone-beam computed tomography|cone-beam computed tomography
62383|NCT02894723|Hypertension,|hypertension,
62384|NCT02894723|Nitric Oxide|nitric oxide
62385|NCT02894723|L-Arginine|l-arginine
62386|NCT02894723|Arterial Stiffness|arterial stiffness
62387|NCT02894723|Ambulatory blood pressure measurement|ambulatory blood pressure measurement
62388|NCT02894710|postoperative pain|postoperative pain
62389|NCT02894710|intravenous lidocaine|intravenous lidocaine
62390|NCT02894710|chronic post-surgical pain|chronic post-surgical pain
62391|NCT02894710|remifentanil|remifentanil
62392|NCT02894710|patient controlled analgesia|patient controlled analgesia
62393|NCT02894710|morphine consumption|morphine consumption
62394|NCT02894710|ENT surgery|ent surgery
62395|NCT02894632|MRI|mri
62396|NCT02894632|Motion|motion
62397|NCT02894632|Respiratory movement|respiratory movement
62398|NCT02894632|Artifacts correction|artifacts correction
62399|NCT02894619|urinary incontinence|urinary incontinence
62400|NCT02894619|anal incontinence|anal incontinence
62401|NCT02894619|sexuality|sexuality
62402|NCT02894619|quality of life|quality of life
62403|NCT02894606|Kidney Transplant|kidney transplant
62404|NCT02894606|Immunology|immunology
62405|NCT02894593|Antiplaque agents|antiplaque agents
62406|NCT02894593|chemical plaque control|chemical plaque control
62407|NCT02894593|oral hygiene|oral hygiene
62408|NCT02894593|essential oils|essential oils
62410|NCT02894593|mouthwash|mouthwash
62411|NCT02894541|Dyslipidemia|dyslipidemia
62412|NCT02894541|CKD-519|ckd-519
62413|NCT02894541|CETP inhibitor|cetp inhibitor
62414|NCT02894541|Food Drug Interaction|food drug interaction
62415|NCT02894528|Alveolar ridge|alveolar ridge
62416|NCT02894528|guided bone regeneration|guided bone regeneration
62417|NCT02894528|bone grafts|bone grafts
62418|NCT02894502|Self-care|self-care
62419|NCT02894502|Motivational interviewing|motivational interviewing
62420|NCT02894502|Heart failure|heart failure
62421|NCT02894502|Caregivers|caregivers
62422|NCT02894476|satisfaction with care|satisfaction with care
62423|NCT02894476|outpatient care|outpatient care
62424|NCT02894476|self-reported health status|self-reported health status
62425|NCT02894476|alcohol dependence|alcohol dependence
62426|NCT02894476|opioid dependence|opioid dependence
62427|NCT02894463|dental care|dental care
62428|NCT02894463|emeno|emeno
62429|NCT02894463|abuse|abuse
62430|NCT02894450|Atrial fibrillation|atrial fibrillation
62431|NCT02894450|oral anticoagulant|oral anticoagulant
62432|NCT02894450|bioassay|bioassay
62433|NCT02894450|elderly subject|elderly subject
62434|NCT02894437|prevention|prevention
62435|NCT02894437|organization|organization
62436|NCT02894437|pressure ulcers|pressure ulcers
62437|NCT02894424|Inner limiting membrane|inner limiting membrane
62438|NCT02894424|Microperimetry|microperimetry
62439|NCT02894424|surgical's dye|surgical's dye
62440|NCT02894411|MRI|mri
62441|NCT02894411|Excyclotorsion|excyclotorsion
62442|NCT02894398|HR+|hr+
62443|NCT02894398|HER2-|her2-
62444|NCT02894398|Locally advanced (inoperable or metastatic) Breast Cancer|locally advanced (inoperable or metastatic) breast cancer
62445|NCT02894398|Palbociclib|palbociclib
62446|NCT02894398|Aromatase inhibitor or fulvestrant|aromatase inhibitor or fulvestrant
62447|NCT02894398|Pre-/perimenopausal receiving LHRH agonist / ovarian ablation|pre-/perimenopausal receiving lhrh agonist / ovarian ablation
62448|NCT02894398|Postmenopausal|postmenopausal
62449|NCT02894372|Oral spray|oral spray
62450|NCT02894372|Topical sprays|topical sprays
62451|NCT02894372|Faringomoss|faringomoss
62452|NCT02894372|Local phytotherapy|local phytotherapy
62453|NCT02894359|Cervical spine|cervical spine
62454|NCT02894359|Musculoskeletal imagery|musculoskeletal imagery
62455|NCT02894359|computer modelling of cervical spine|computer modelling of cervical spine
62456|NCT02894359|ConeBeam.|conebeam.
62457|NCT02894346|Motivation|motivation
62458|NCT02894346|Teachers|teachers
62459|NCT02894346|Physical activity|physical activity
53984|NCT02948673|antioxidant treatment|antioxidant treatment
53985|NCT02948673|glutathione supplementation|glutathione supplementation
53986|NCT02948621|Endoscopic sleeve gastroplasty|endoscopic sleeve gastroplasty
53987|NCT02948621|Excess weight loss|excess weight loss
62460|NCT02894346|School|school
62461|NCT02894333|Parkinson's disease|parkinson's disease
62462|NCT02894333|Action-effect prediction|action-effect prediction
62463|NCT02894333|Sensory attenuation|sensory attenuation
62464|NCT02894333|Voluntary action|voluntary action
62465|NCT02894320|Parkinson's disease|parkinson's disease
62466|NCT02894320|Voluntary action|voluntary action
62467|NCT02894320|Action-effect preactivation|action-effect preactivation
62468|NCT02894320|Action-effect prediction|action-effect prediction
62469|NCT02894307|MEchanical valves|mechanical valves
62470|NCT02894307|Rivaroxaban|rivaroxaban
62471|NCT02894294|malaria|malaria
62472|NCT02894294|chemoprevention|chemoprevention
62473|NCT02894294|season|season
62474|NCT02894294|anemia|anemia
62475|NCT02894294|impact|impact
62476|NCT02894294|coverage|coverage
62477|NCT02894294|children|children
62478|NCT02894281|Pupillary light reflex|pupillary light reflex
62479|NCT02894281|Multiple sclerosis|multiple sclerosis
62480|NCT02894190|Non Invasive Ventilation (NIV)|non invasive ventilation (niv)
62481|NCT02894190|Adherence|adherence
62482|NCT02894190|Beliefs|beliefs
62483|NCT02894190|Development|development
62484|NCT02894190|Validation|validation
62485|NCT02894177|E02.880.820.950|e02.880.820.950
62486|NCT02894164|Cystatin C|cystatin c
62487|NCT02894164|Creatinine|creatinine
62488|NCT02894164|Glomerular Filtration Rate|glomerular filtration rate
62489|NCT02894125|Chronic Low Back Pain|chronic low back pain
62490|NCT02894125|Old subject|old subject
62491|NCT02894125|SPA Therapy|spa therapy
62492|NCT02894125|Pain|pain
62493|NCT02894125|Function|function
62494|NCT02894125|Expectations|expectations
62495|NCT02894125|Fears|fears
62496|NCT02894112|endothelial dependent vasodilation|endothelial dependent vasodilation
62497|NCT02894112|blood flow|blood flow
62498|NCT02894112|blood glucose|blood glucose
62499|NCT02894112|triglycerides|triglycerides
62500|NCT02894112|non-fat milk|non-fat milk
62501|NCT02894112|dairy|dairy
62502|NCT02894099|Aged|aged
62503|NCT02894099|Sedentary Behaviour|sedentary behaviour
62504|NCT02894099|Blood Glucose|blood glucose
62505|NCT02894099|Insulin|insulin
62506|NCT02894099|Inflammatory markers|inflammatory markers
62507|NCT02894086|acute appendicitis|acute appendicitis
62508|NCT02894086|ambulatory appendicectomy|ambulatory appendicectomy
62516|NCT02894034|prognostic|prognostic
62517|NCT02894021|padding|padding
62518|NCT02894021|lymphoceles|lymphoceles
62519|NCT02894021|prevention|prevention
62521|NCT02893995|Subcutaneous Treprostinil|subcutaneous treprostinil
62522|NCT02893995|Remodulin|remodulin
62523|NCT02893995|6 Minute Walk Test|6 minute walk test
62524|NCT02893969|Physical Activity|physical activity
62525|NCT02893969|Rest|rest
62526|NCT02893956|Echocardiography|echocardiography
62527|NCT02893956|postural support|postural support
62528|NCT02893956|preterm neonate|preterm neonate
62529|NCT02893904|Propofol|propofol
62530|NCT02893904|Sevoflurane|sevoflurane
62531|NCT02893904|Bispectral Index|bispectral index
62532|NCT02893904|Children|children
62533|NCT02893904|Electroencephalographic signs|electroencephalographic signs
62534|NCT02893891|Obesity|obesity
62535|NCT02893891|Bariatric medicine|bariatric medicine
62536|NCT02893891|Sleeve gastric resection|sleeve gastric resection
62537|NCT02893891|Gastric plication|gastric plication
62538|NCT02893891|Intragastric ballon|intragastric ballon
62539|NCT02893891|Body composition|body composition
62540|NCT02893891|Adipokines|adipokines
62541|NCT02893891|Ghrelin|ghrelin
62542|NCT02893891|Bone mineral density|bone mineral density
62543|NCT02893891|Quality of life|quality of life
62544|NCT02893878|Seasonal influenza vaccines|seasonal influenza vaccines
62545|NCT02893878|Passive Enhanced Safety surveillance|passive enhanced safety surveillance
62546|NCT02893878|England|england
62547|NCT02893878|Pilot study|pilot study
62548|NCT02893865|Apnea syndrome|apnea syndrome
62549|NCT02893865|Coronary artery disease|coronary artery disease
62550|NCT02893865|Oxidative stress|oxidative stress
62551|NCT02893865|Continuous positive airway pressure|continuous positive airway pressure
62552|NCT02893865|Endothelial dysfunction|endothelial dysfunction
62553|NCT02893839|Allergy|allergy
62554|NCT02893839|cross-reactivity|cross-reactivity
62555|NCT02893839|oral allergy syndrome|oral allergy syndrome
62556|NCT02893839|potato|potato
62557|NCT02893839|sensitization|sensitization
62558|NCT02893826|Aneurysm|aneurysm
62559|NCT02893826|Ruptured|ruptured
62560|NCT02893826|nimodipine|nimodipine
62561|NCT02893826|subarachnoid hemorrhage|subarachnoid hemorrhage
62567|NCT02893787|Speckle Tracking|speckle tracking
62568|NCT02893787|Anthracyclines|anthracyclines
62569|NCT02893787|Chilhood cancers|chilhood cancers
62570|NCT02893787|Myocardial function|myocardial function
62571|NCT02893787|Echocardiography|echocardiography
62572|NCT02893761|breast cancer|breast cancer
62573|NCT02893761|survival|survival
62574|NCT02893761|prognosis factors|prognosis factors
62575|NCT02893748|colon|colon
62576|NCT02893748|polyps|polyps
62577|NCT02893748|cancer|cancer
62578|NCT02893748|screening|screening
62579|NCT02893735|Clinical Trial|clinical trial
62580|NCT02893735|Composite resin|composite resin
62581|NCT02893722|ivf ,atosiban,repeated implantation failure,RCT|ivf ,atosiban,repeated implantation failure,rct
62585|NCT02893657|MELD score|meld score
62586|NCT02893657|hemodynamics|hemodynamics
62587|NCT02893657|liver abnormalities|liver abnormalities
62588|NCT02893566|overweight|overweight
62589|NCT02893566|body mass index|body mass index
62590|NCT02893566|university students|university students
62591|NCT02893566|physical activity|physical activity
62592|NCT02893566|sedentary behavior|sedentary behavior
62593|NCT02893566|body composition|body composition
62594|NCT02893566|Mi Band|mi band
62595|NCT02893514|Drug Use|drug use
62596|NCT02893488|dolutegravir|dolutegravir
62597|NCT02893488|abacavir|abacavir
62598|NCT02893488|relative bioavailability|relative bioavailability
62599|NCT02893488|palatability|palatability
62600|NCT02893488|GSK2619619|gsk2619619
62601|NCT02893488|palatability questionnaire|palatability questionnaire
62602|NCT02893488|lamivudine|lamivudine
62603|NCT02893488|pediatric|pediatric
62604|NCT02893488|calcium|calcium
62605|NCT02893488|dispersible tablet|dispersible tablet
62606|NCT02893462|data warehousing|data warehousing
62607|NCT02893462|data aggregation|data aggregation
62608|NCT02893462|data mining|data mining
62609|NCT02893449|Parkinson|parkinson
62610|NCT02893449|SAS-SR|sas-sr
62611|NCT02893449|Social adaptation|social adaptation
62612|NCT02893449|Patients suffering from Parkinson's disease|patients suffering from parkinson's disease
62613|NCT02893423|Ropivacaine|ropivacaine
62614|NCT02893423|C-Section Analgesia|c-section analgesia
62615|NCT02893423|Tap Block|tap block
62616|NCT02893358|Allisartan Isoproxil|allisartan isoproxil
62617|NCT02893358|left ventricular hypertrophy|left ventricular hypertrophy
62618|NCT02893358|large arterial stiffness|large arterial stiffness
62619|NCT02893358|microalbuminuria|microalbuminuria
62620|NCT02893345|Self Care (Rehabilitation)|self care (rehabilitation)
62621|NCT02893345|Community Participation|community participation
62622|NCT02893345|Patient-Centered Outcomes Research|patient-centered outcomes research
62623|NCT02893345|Informatics, Clinical|informatics, clinical
62624|NCT02893319|Infant Feeding|infant feeding
62625|NCT02893319|Infant Growth|infant growth
62626|NCT02893306|Type1 Diabetes Mellitus|type1 diabetes mellitus
62627|NCT02893306|Multipotent stromal cell|multipotent stromal cell
62628|NCT02893306|Mesenchymal stem cell|mesenchymal stem cell
62629|NCT02893306|Insulin|insulin
62630|NCT02893306|Pancreatic reserve|pancreatic reserve
62631|NCT02893306|Disease progression|disease progression
62632|NCT02893267|Stroke|stroke
62633|NCT02893267|Shoulder Pain|shoulder pain
62634|NCT02893267|Electrical stimulation|electrical stimulation
62635|NCT02893267|Neuromuscular stimulation|neuromuscular stimulation
62636|NCT02893267|Intramuscular stimulation|intramuscular stimulation
62637|NCT02893267|Physical Therapy|physical therapy
62638|NCT02893254|ankylosing spondylitis, tumor necrosis factor-α inhibitors|ankylosing spondylitis, tumor necrosis factor-α inhibitors
62639|NCT02893228|forced expiratory volume in 1 second|forced expiratory volume in 1 second
62640|NCT02893228|forced vital capacity|forced vital capacity
62641|NCT02893228|peak expiratory flow rate|peak expiratory flow rate
62642|NCT02893228|interscalene block|interscalene block
62643|NCT02893228|diaphragmatic paresis|diaphragmatic paresis
62644|NCT02893202|PTSD|ptsd
62645|NCT02893202|Equine assisted activities|equine assisted activities
62646|NCT02893202|quality of life|quality of life
62647|NCT02893189|CD19+|cd19+
62648|NCT02893189|allogeneic transplant|allogeneic transplant
62649|NCT02893189|relapse|relapse
62650|NCT02893176|Lung Transplant|lung transplant
62651|NCT02893176|Macitentan|macitentan
62652|NCT02893176|CLAD|clad
62654|NCT02893176|bronchiolitis obliterans|bronchiolitis obliterans
62655|NCT02893176|chronic lung allograft dysfunction|chronic lung allograft dysfunction
62656|NCT02893176|Organ Rejection|organ rejection
62657|NCT02893163|Metabolic Syndrome|metabolic syndrome
62658|NCT02893163|Cancer Risk|cancer risk
62659|NCT02893163|Lifestyle Interventions|lifestyle interventions
62660|NCT02893163|Primary Care|primary care
62661|NCT02893163|Behavioural Change|behavioural change
62662|NCT02893150|Mindful Eating|mindful eating
62663|NCT02893150|Overweight|overweight
62664|NCT02893150|Primary Care|primary care
62665|NCT02893150|Randomized Clinical Trial|randomized clinical trial
62666|NCT02893137|Tumour treating fields|tumour treating fields
62667|NCT02893137|Optune|optune
62668|NCT02893137|Craniectomy|craniectomy
62669|NCT02893137|TTFields|ttfields
62670|NCT02893124|chronic hepatitis B|chronic hepatitis b
62671|NCT02893111|neuromyelitis optica spectrum disorders|neuromyelitis optica spectrum disorders
62672|NCT02893111|Bortezomib|bortezomib
62673|NCT02893111|Velcade|velcade
62674|NCT02893111|Proteasome inhibitor|proteasome inhibitor
62675|NCT02893072|Diabetes, Gestational|diabetes, gestational
625701|NCT00682825|Awareness|awareness
62676|NCT02893072|Nutrition Therapy|nutrition therapy
62677|NCT02893046|care pathway|care pathway
62678|NCT02893046|hospital- private network|hospital- private network
62679|NCT02893046|early consultation|early consultation
62680|NCT02893033|Dysphagia|dysphagia
62681|NCT02893033|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
62682|NCT02893033|Stroke|stroke
62683|NCT02893020|Emotional experience and burnout in physicians|emotional experience and burnout in physicians
62684|NCT02892994|therapeutic ultrasound|therapeutic ultrasound
62685|NCT02892968|Regional Anesthesia Ultrasound guided|regional anesthesia ultrasound guided
62686|NCT02892968|Emergency Department|emergency department
62687|NCT02892968|Knowledge to Practice Intervention|knowledge to practice intervention
62688|NCT02892955|Heart Failure|heart failure
62689|NCT02892955|LVAS|lvas
62690|NCT02892955|Ventricular Dysfunction|ventricular dysfunction
62691|NCT02892955|Cardiomyopathy|cardiomyopathy
62692|NCT02892955|Heart Disease|heart disease
62693|NCT02892955|Cardiovascular Disease|cardiovascular disease
62694|NCT02892955|Heart-assist devices|heart-assist devices
62695|NCT02892955|Thoratec Corporation|thoratec corporation
62696|NCT02892942|Controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
62697|NCT02892942|Estradiol|estradiol
62698|NCT02892942|Embryo implantation|embryo implantation
62699|NCT02892942|Endometrial receptivity|endometrial receptivity
62700|NCT02892942|Fertility preservation|fertility preservation
62701|NCT02892929|Motivational Interviewing|motivational interviewing
62702|NCT02892929|Hypertension|hypertension
62703|NCT02892929|Nursing|nursing
62704|NCT02892929|Randomized Controlled Trial|randomized controlled trial
62712|NCT02892877|Complete Hydatidiform mole|complete hydatidiform mole
62713|NCT02892877|Partial Hydatidiform mole|partial hydatidiform mole
62714|NCT02892877|Invasive mole|invasive mole
62715|NCT02892877|Choriocarcinoma|choriocarcinoma
62716|NCT02892877|Post-molar neoplasia|post-molar neoplasia
62717|NCT02892877|Placental Site Trophoblastic Tumor (PSTT)|placental site trophoblastic tumor (pstt)
62718|NCT02892877|Epithelioid Trophoblastic Tumor (ETT)|epithelioid trophoblastic tumor (ett)
62719|NCT02892877|hCG follow-up|hcg follow-up
62720|NCT02892864|Bell's Palsy|bell's palsy
62721|NCT02892864|Peripheral facial palsy|peripheral facial palsy
62723|NCT02892851|Craving|craving
62724|NCT02892851|Cocaine addiction|cocaine addiction
62725|NCT02892838|mobile bearing knee prosthesis|mobile bearing knee prosthesis
62726|NCT02892825|Music|music
62727|NCT02892825|cataract surgery|cataract surgery
62728|NCT02892825|topical anaesthesia|topical anaesthesia
62729|NCT02892825|anxiety|anxiety
62730|NCT02892825|hypertension|hypertension
62731|NCT02892786|circulating tumor cell|circulating tumor cell
62732|NCT02892786|CellSearch™ method|cellsearch™ method
62733|NCT02892786|RT-PCR|rt-pcr
62734|NCT02892773|electrical impedance tomography|electrical impedance tomography
62735|NCT02892773|incentive spirometry|incentive spirometry
62736|NCT02892773|EzPAP|ezpap
62737|NCT02892773|lung volume|lung volume
62738|NCT02892773|atelectasis|atelectasis
62739|NCT02892773|positive airway pressure|positive airway pressure
62740|NCT02892773|pulmonary complication|pulmonary complication
62741|NCT02892773|abdominal surgery|abdominal surgery
62742|NCT02892773|end-expiratory lung volume|end-expiratory lung volume
62743|NCT02892747|Chronic Heart Failure (CHF)|chronic heart failure (chf)
62744|NCT02892747|Dietetics education|dietetics education
62745|NCT02892747|Malnutrition|malnutrition
62746|NCT02892721|CT Colonography|ct colonography
62747|NCT02892721|Virtual colonoscopy|virtual colonoscopy
62748|NCT02892721|Colorectal cancer|colorectal cancer
62749|NCT02892721|Colon cancer|colon cancer
62750|NCT02892721|Training|training
62751|NCT02892708|supratentorial gliomas|supratentorial gliomas
62752|NCT02892708|surgery|surgery
62753|NCT02892708|magnetic resonance spectroscopy|magnetic resonance spectroscopy
62754|NCT02892708|elderly|elderly
62755|NCT02892630|Immune Thrombocytopenia|immune thrombocytopenia
62756|NCT02892630|Pregnancy|pregnancy
62757|NCT02892617|Modic 1|modic 1
62758|NCT02892617|low back pain|low back pain
62759|NCT02892604|Type 1 diabetes|type 1 diabetes
62760|NCT02892604|artificial pancreas|artificial pancreas
62761|NCT02892604|closed-loop insulin infusion|closed-loop insulin infusion
62762|NCT02892565|systemic lupus erythematosus|systemic lupus erythematosus
62763|NCT02892565|antiphospholipid syndrome|antiphospholipid syndrome
62764|NCT02892565|antiphospholipid antibodies|antiphospholipid antibodies
62765|NCT02892513|Colorectal Surgery|colorectal surgery
62766|NCT02892513|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
62767|NCT02892487|Quality of life|quality of life
62768|NCT02892487|Radiotherapy|radiotherapy
62769|NCT02892487|Dysphagia|dysphagia
62770|NCT02892487|Oral cavity|oral cavity
62774|NCT02892487|Swallowing rehabilitation|swallowing rehabilitation
62775|NCT02892487|Toxicity|toxicity
62776|NCT02892474|Coronary Arteriosclerosis|coronary arteriosclerosis
62777|NCT02892474|Hybrid Coronary Revascularization|hybrid coronary revascularization
62778|NCT02892474|Coronary Artery Bypass Grafting|coronary artery bypass grafting
62779|NCT02892461|Anemia, Iron-Deficiency|anemia, iron-deficiency
62780|NCT02892461|Cesarean Section|cesarean section
62781|NCT02892461|Umbilical Cord Milking|umbilical cord milking
62782|NCT02892461|Randomized Controlled Trial|randomized controlled trial
62783|NCT02892409|Drug Therapy|drug therapy
62784|NCT02892344|Phase III, blinded, QMF149, Mometasone furoate (MF), mild asthma, Adolescent, adult|phase iii, blinded, qmf149, mometasone furoate (mf), mild asthma, adolescent, adult
62785|NCT02892331|exercise|exercise
62786|NCT02892331|insulin resistance|insulin resistance
62787|NCT02892331|mitochondrial function|mitochondrial function
62788|NCT02892331|arterial stiffness|arterial stiffness
62789|NCT02892331|exercise intensity|exercise intensity
62790|NCT02892331|fitness|fitness
62791|NCT02892305|Pancreaticoduodenectomy|pancreaticoduodenectomy
62792|NCT02892305|Hepatectomy|hepatectomy
62793|NCT02892305|Liver ablation|liver ablation
62794|NCT02892279|Microneurography|microneurography
62795|NCT02892279|Air pollution|air pollution
62796|NCT02892266|Transplant recipients|transplant recipients
62797|NCT02892266|Adolescents|adolescents
62798|NCT02892266|Post-Traumatic Stress Symptoms (PTSS)|post-traumatic stress symptoms (ptss)
62799|NCT02892266|Transplant Recipient and Family Impact(s)|transplant recipient and family impact(s)
62800|NCT02892253|postoperative hypocalcemia|postoperative hypocalcemia
62801|NCT02892253|near infrared imaging|near infrared imaging
62802|NCT02892253|parathyroid autofluorescence|parathyroid autofluorescence
62803|NCT02892227|bedside echography|bedside echography
62804|NCT02892162|atrial fibrillation|atrial fibrillation
62805|NCT02892162|catheter ablation|catheter ablation
62806|NCT02892149|AKB-6548|akb-6548
62807|NCT02892149|Chronic kidney disease|chronic kidney disease
62808|NCT02892149|anemia|anemia
62809|NCT02892149|CKD|ckd
62810|NCT02892149|chronic renal insufficiency|chronic renal insufficiency
62811|NCT02892149|renal impairment|renal impairment
62812|NCT02892149|erythropoietin|erythropoietin
62813|NCT02892149|kidney|kidney
62814|NCT02892149|renal|renal
62815|NCT02892149|oral anemia treatment|oral anemia treatment
62816|NCT02892149|hemoglobin|hemoglobin
62817|NCT02892149|hypoxia-inducible factor|hypoxia-inducible factor
62818|NCT02892149|HIF|hif
62819|NCT02892149|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
62820|NCT02892149|HIF-PHI|hif-phi
62821|NCT02892149|efficacy|efficacy
62822|NCT02892149|safety|safety
62823|NCT02892149|Phase 3|phase 3
62824|NCT02892149|cardiovascular|cardiovascular
62825|NCT02892149|DD-CKD|dd-ckd
62826|NCT02892123|HER2|her2
62830|NCT02892123|gastric cancer|gastric cancer
62831|NCT02892123|gastroesophageal cancer|gastroesophageal cancer
62832|NCT02892123|ovarian cancer|ovarian cancer
62833|NCT02892123|non-small cell lung cancer|non-small cell lung cancer
62834|NCT02892110|Marijuana use|marijuana use
62835|NCT02892110|Varenicline/Chantix|varenicline/chantix
62836|NCT02892110|Motivational enhancement therapy|motivational enhancement therapy
62837|NCT02892097|tDCS|tdcs
62838|NCT02892097|neglect|neglect
62839|NCT02892097|paresis|paresis
62840|NCT02892097|transcranial direct current stimulation|transcranial direct current stimulation
62841|NCT02892097|rehabilitation|rehabilitation
62842|NCT02892084|Chronic Stroke ( > 6 months)|chronic stroke ( > 6 months)
62843|NCT02892084|non-invasive brain stimulation|non-invasive brain stimulation
62844|NCT02892084|rehabilitation|rehabilitation
62845|NCT02892084|walking|walking
62846|NCT02892084|kinetics|kinetics
62847|NCT02892045|neuromuscular block|neuromuscular block
62848|NCT02892045|monitoring|monitoring
62849|NCT02892019|indacaterol acetate, asthma, GINA 2015, pediatrics|indacaterol acetate, asthma, gina 2015, pediatrics
62850|NCT02891993|Cancer Care|cancer care
62851|NCT02891980|Ad26|ad26
62852|NCT02891980|Ebola|ebola
62853|NCT02891980|immunogenicity response|immunogenicity response
62854|NCT02891980|MVA-Multi Filo|mva-multi filo
62855|NCT02891980|Omics|omics
62856|NCT02891980|Zaire|zaire
62857|NCT02891954|Glucosuria|glucosuria
62858|NCT02891954|SGLT2 inhibitors|sglt2 inhibitors
62859|NCT02891954|Canagliflozin|canagliflozin
62860|NCT02891954|FGF23|fgf23
62861|NCT02891954|Parathyroid hormone|parathyroid hormone
62862|NCT02891954|1,25-Dihydroxyvitamin D|1,25-dihydroxyvitamin d
62863|NCT02891954|Glucagon|glucagon
62864|NCT02891954|Ketone bodies|ketone bodies
62865|NCT02891954|Uric acid|uric acid
72608|NCT02829879|RCT|rct
62866|NCT02891954|Pharmacogenomics|pharmacogenomics
62867|NCT02891928|Type 2 diabetes|type 2 diabetes
62868|NCT02891928|Diabetic neuropathy|diabetic neuropathy
62869|NCT02891928|Disorders of equilibrium|disorders of equilibrium
62870|NCT02891928|"Rocker sole shoes"|"rocker sole shoes"
62871|NCT02891928|Walking|walking
62872|NCT02891915|Antimicrobial|antimicrobial
62873|NCT02891915|Beta-Lactam|beta-lactam
62875|NCT02891915|Short Course|short course
62876|NCT02891915|Standard Course|standard course
62877|NCT02891915|Therapy|therapy
62878|NCT02891876|direct pulp capping, biodentine|direct pulp capping, biodentine
62879|NCT02891863|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
62880|NCT02891837|L-citrulline|l-citrulline
62881|NCT02891837|pediatric|pediatric
62882|NCT02891837|Lung Injury|lung injury
62883|NCT02891837|Bypass|bypass
62884|NCT02891837|Heart Defects|heart defects
62885|NCT02891837|Clinical Sequelae|clinical sequelae
62886|NCT02891824|PD-L1|pd-l1
62887|NCT02891824|Atezolizumab|atezolizumab
62888|NCT02891824|Randomized, double blinded|randomized, double blinded
62889|NCT02891824|first or second late relapse|first or second late relapse
62890|NCT02891824|progressive non-mucinous epithelial ovarian cancer, primary peritoneal adenocarcinoma and / or fallopian-tube adenocarcinoma|progressive non-mucinous epithelial ovarian cancer, primary peritoneal adenocarcinoma and / or fallopian-tube adenocarcinoma
62891|NCT02891824|progression-free survival|progression-free survival
62892|NCT02891811|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
62893|NCT02891811|carfilzomib|carfilzomib
62894|NCT02891811|thalidomide|thalidomide
62895|NCT02891811|lenalidomide|lenalidomide
62896|NCT02891811|dexamethasone|dexamethasone
62897|NCT02891811|transplant ineligible|transplant ineligible
62898|NCT02891811|induction therapy|induction therapy
62903|NCT02891798|clonidine|clonidine
62904|NCT02891798|dexamethasone|dexamethasone
62905|NCT02891798|bupivacaine|bupivacaine
62906|NCT02891798|nerve block|nerve block
62907|NCT02891733|Expression of the Neurotensin|expression of the neurotensin
62908|NCT02891733|Neurotensin|neurotensin
62909|NCT02891668|Basal Metabolic rate|basal metabolic rate
62910|NCT02891668|Quality of life|quality of life
62911|NCT02891668|Resting energy expenditure|resting energy expenditure
62912|NCT02891668|Insulin resistance|insulin resistance
62913|NCT02891668|Cognitive Function|cognitive function
62914|NCT02891668|Body Composition|body composition
62915|NCT02891642|malignancy|malignancy
62916|NCT02891642|Pleural Effusion|pleural effusion
62917|NCT02891642|Pleural Neoplasms|pleural neoplasms
62918|NCT02891642|Ascites|ascites
62919|NCT02891616|Melanoma|melanoma
62920|NCT02891616|18F-FLT|18f-flt
62921|NCT02891616|18F-FDG|18f-fdg
62922|NCT02891616|PET/CT|pet/ct
62923|NCT02891616|PET/MR|pet/mr
62924|NCT02891577|intra abdominal hypertension|intra abdominal hypertension
62925|NCT02891577|shock|shock
62926|NCT02891577|critically ill|critically ill
64615|NCT02880748|Polyps|polyps
62927|NCT02891564|therapeutic video games, mobile interventions|therapeutic video games, mobile interventions
62928|NCT02891551|Leukemia|leukemia
62929|NCT02891551|Chronic|chronic
62930|NCT02891551|Acute|acute
62931|NCT02891551|Observational|observational
62932|NCT02891551|Non-interventional|non-interventional
62933|NCT02891551|OCEAN|ocean
62934|NCT02891551|Netherlands|netherlands
62935|NCT02891551|azacitidine|azacitidine
62936|NCT02891538|EGCG|egcg
62937|NCT02891538|Green Tea|green tea
62938|NCT02891538|Colon Cancer|colon cancer
62939|NCT02891512|Magnetic Fields|magnetic fields
62940|NCT02891512|Pain|pain
62941|NCT02891512|Paresthesia|paresthesia
62942|NCT02891512|Visual Analogue Scale|visual analogue scale
62943|NCT02891499|Miniscrews|miniscrews
62944|NCT02891499|Mini-implants|mini-implants
62945|NCT02891499|Temporal anchorage devices|temporal anchorage devices
62946|NCT02891499|Bone screws|bone screws
62947|NCT02891499|Stability|stability
62948|NCT02891499|Displacement|displacement
62949|NCT02891499|Low-level laser therapy|low-level laser therapy
62950|NCT02891499|Cone-beam computed tomography|cone-beam computed tomography
62951|NCT02891499|Resonance frequency analysis|resonance frequency analysis
62952|NCT02891499|Orthodontic|orthodontic
62953|NCT02891499|Orthodontic miniscrew implant|orthodontic miniscrew implant
62954|NCT02891486|spinal surgery, surgical site infection|spinal surgery, surgical site infection
62955|NCT02891473|Posture|posture
62956|NCT02891473|Pain|pain
62957|NCT02891473|Muscle stretching|muscle stretching
62958|NCT02891473|Mézières method|mézières method
62959|NCT02891473|Camptocormia|camptocormia
62960|NCT02891473|Trunk control|trunk control
62961|NCT02891460|Mitomycin C|mitomycin c
62962|NCT02891460|MMC|mmc
62963|NCT02891460|NMIBC|nmibc
62964|NCT02891460|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
62965|NCT02891460|Hydrogel Reverse thermal gelation|hydrogel reverse thermal gelation
72667|NCT02829736|pain|pain
62966|NCT02891460|Drug retention|drug retention
62967|NCT02891460|Urinary Bladder Neoplasms|urinary bladder neoplasms
62968|NCT02891460|Urologic Neoplasms|urologic neoplasms
62969|NCT02891460|Urinary Bladder Diseases|urinary bladder diseases
62970|NCT02891460|Urologic Diseases|urologic diseases
62971|NCT02891434|Duchenne muscular dystrophy|duchenne muscular dystrophy
62972|NCT02891434|motor learning|motor learning
62973|NCT02891434|motor abilities|motor abilities
62974|NCT02891395|allogeneic stem cell transplantation|allogeneic stem cell transplantation
62975|NCT02891395|imatinib Mesylate|imatinib mesylate
62976|NCT02891395|Nilotinib|nilotinib
62981|NCT02891356|Adiponectin|adiponectin
62982|NCT02891356|Bone remodelling markers|bone remodelling markers
62983|NCT02891343|Cognitive Function|cognitive function
62984|NCT02891343|Hypoxia|hypoxia
62985|NCT02891343|Neurophysiological Function|neurophysiological function
62986|NCT02891343|Effect of Alzheimer Disease symptomatic drugs|effect of alzheimer disease symptomatic drugs
62987|NCT02891343|Healthy Subjects|healthy subjects
62988|NCT02891330|Roux-en-Y Gastric ByPass|roux-en-y gastric bypass
62989|NCT02891304|esophagogastroduodenoscopy|esophagogastroduodenoscopy
62990|NCT02891291|optical coherence tomography|optical coherence tomography
62991|NCT02891278|leukemia|leukemia
62992|NCT02891239|laser treatment|laser treatment
62993|NCT02891226|inflammatory bowel disease|inflammatory bowel disease
62994|NCT02891226|IL-23|il-23
62995|NCT02891226|biologic|biologic
62996|NCT02891187|Postoperative Care|postoperative care
62997|NCT02891187|Telephone follow-up|telephone follow-up
63301|NCT02889458|Chinese|chinese
62998|NCT02891187|Healthcare Value|healthcare value
62999|NCT02891174|ibuprofen|ibuprofen
63000|NCT02891174|acetaminophen|acetaminophen
63001|NCT02891174|blood pressure|blood pressure
63002|NCT02891174|post-partum|post-partum
63003|NCT02891174|pain control|pain control
63004|NCT02891174|pre-eclampsia|pre-eclampsia
63005|NCT02891174|gestational hypertension|gestational hypertension
63006|NCT02891161|durvalumab|durvalumab
63007|NCT02891161|MEDI4736|medi4736
63008|NCT02891161|anti-PD-L1|anti-pd-l1
63009|NCT02891096|respiratory complications|respiratory complications
63010|NCT02891096|respiratory muscle strength|respiratory muscle strength
63011|NCT02891096|discriminator|discriminator
63012|NCT02891083|adjuvant chemotherapy|adjuvant chemotherapy
63013|NCT02891083|adjuvant radiotherapy|adjuvant radiotherapy
63014|NCT02891083|lymph node metastasis|lymph node metastasis
63015|NCT02891083|surgery|surgery
63016|NCT02891083|squamous cell carcinoma|squamous cell carcinoma
63017|NCT02891070|Cranial Surgery|cranial surgery
63018|NCT02891070|Cerebrospinal Fluid Leak|cerebrospinal fluid leak
63019|NCT02891070|Tisseel|tisseel
63020|NCT02891031|Rhus|rhus
63021|NCT02891031|Medicine, Traditional|medicine, traditional
63022|NCT02891031|Herbal medicine|herbal medicine
63023|NCT02891031|Uric acid|uric acid
63024|NCT02890966|SHR4640 pharmacokinetics pharmacodynamics|shr4640 pharmacokinetics pharmacodynamics
63025|NCT02890927|Geriatric Nursing|geriatric nursing
63026|NCT02890927|Geriatric co-management|geriatric co-management
63027|NCT02890927|Geriatric team|geriatric team
63028|NCT02890901|Escherichia coli|escherichia coli
63029|NCT02890901|Bloodstream infections|bloodstream infections
63031|NCT02890901|Score|score
63032|NCT02890901|Host factors|host factors
63033|NCT02890901|Microbiology|microbiology
63034|NCT02890888|small vessel disease of the brain|small vessel disease of the brain
63035|NCT02890888|hyperbaric oxygen|hyperbaric oxygen
63036|NCT02890888|functional connectivity MRI|functional connectivity mri
63037|NCT02890875|ethanol lock|ethanol lock
63038|NCT02890875|parenteral nutrition|parenteral nutrition
63039|NCT02890862|Kinematics|kinematics
63040|NCT02890862|Activity of Daily living|activity of daily living
63041|NCT02890862|3D motion analysis|3d motion analysis
63042|NCT02890836|Blood pressure|blood pressure
63043|NCT02890836|Hypertension|hypertension
63044|NCT02890836|White coat hypertension|white coat hypertension
63045|NCT02890836|Preeclampsia|preeclampsia
63046|NCT02890836|Anti-hypertensiva|anti-hypertensiva
63047|NCT02890823|Antiepileptic Drugs|antiepileptic drugs
63048|NCT02890823|Vitamin D Deficiency|vitamin d deficiency
63049|NCT02890823|Asian|asian
63050|NCT02890810|Acupuncture|acupuncture
63051|NCT02890810|Back Pain|back pain
63052|NCT02890810|Chronic Pain|chronic pain
63053|NCT02890797|Child|child
63054|NCT02890771|Turmeric|turmeric
63055|NCT02890771|Chronic periodontitis|chronic periodontitis
63056|NCT02890758|Natural Killer Cell|natural killer cell
63057|NCT02890758|ALT-803|alt-803
63058|NCT02890745|Empagliflozin|empagliflozin
63059|NCT02890745|Oxidative stress|oxidative stress
63060|NCT02890745|Oxidative nucleic acid modifications|oxidative nucleic acid modifications
63061|NCT02890745|8-oxo-7,8-dihydro-2'-deoxyguanosine|8-oxo-7,8-dihydro-2'-deoxyguanosine
63062|NCT02890745|8-oxo-7,8-dihydroguanosine|8-oxo-7,8-dihydroguanosine
63063|NCT02890706|Pulmonary embolism (PE)|pulmonary embolism (pe)
63064|NCT02890706|Dual-Energy CT (DECT)|dual-energy ct (dect)
63065|NCT02890706|Subtraction imaging|subtraction imaging
63066|NCT02890693|gestational diabetes mellitus|gestational diabetes mellitus
63067|NCT02890693|randomized controlled trial|randomized controlled trial
63068|NCT02890693|lifestyle intervention|lifestyle intervention
63069|NCT02890693|cardiovascular|cardiovascular
63070|NCT02890693|metabolic|metabolic
63071|NCT02890693|mental health|mental health
63072|NCT02890693|depression|depression
63073|NCT02890693|physical activity|physical activity
63074|NCT02890693|dietary intervention|dietary intervention
63075|NCT02890680|platelet-rich fibrin|platelet-rich fibrin
63076|NCT02890680|third molar|third molar
63077|NCT02890680|bone regeneration|bone regeneration
63078|NCT02890667|Cancer|cancer
63079|NCT02890667|incidence|incidence
63080|NCT02890667|health insurance data|health insurance data
63081|NCT02890667|algorithms|algorithms
63082|NCT02890654|Teenagers|teenagers
63083|NCT02890654|Multidisciplinary approach|multidisciplinary approach
63084|NCT02890654|Pain|pain
63085|NCT02890654|Surgery|surgery
63086|NCT02890628|Thai-Myanmar border|thai-myanmar border
63087|NCT02890615|Survivors|survivors
63088|NCT02890615|Self Care|self care
63089|NCT02890589|Acute coronary syndrome|acute coronary syndrome
63090|NCT02890589|ST (Software Test) -elevation|st (software test) -elevation
63091|NCT02890576|cochlear implant|cochlear implant
63092|NCT02890576|telemedicine|telemedicine
63093|NCT02890576|new organization of patient monitoring|new organization of patient monitoring
63094|NCT02890563|Varicose veins|varicose veins
63095|NCT02890563|Compression stockings|compression stockings
63096|NCT02890563|Sclerotherapy|sclerotherapy
63097|NCT02890563|Radiofrequency ablation|radiofrequency ablation
63098|NCT02890550|Ciliopathy|ciliopathy
63099|NCT02890550|Retinitis pigmentosa|retinitis pigmentosa
63100|NCT02890550|ALMS1 gene|alms1 gene
63101|NCT02890537|Osteonecrosis|osteonecrosis
63102|NCT02890537|Femoral Head|femoral head
63103|NCT02890537|Hip|hip
63104|NCT02890537|Orthopedics|orthopedics
63105|NCT02890537|Bone|bone
63106|NCT02890537|Musculoskeletal Disorders|musculoskeletal disorders
63107|NCT02890524|aphthous stomatitis|aphthous stomatitis
63108|NCT02890524|night guard|night guard
63109|NCT02890524|inflammatory cytokine|inflammatory cytokine
63110|NCT02890459|HIV|hiv
63111|NCT02890459|incentives|incentives
63112|NCT02890459|behavioral economics|behavioral economics
63113|NCT02890446|attentional focus|attentional focus
63114|NCT02890446|upper extremity|upper extremity
63115|NCT02890446|hemiparesis|hemiparesis
63116|NCT02890446|stroke|stroke
63117|NCT02890394|Neck Pain|neck pain
63118|NCT02890394|Suboccipital inhibition|suboccipital inhibition
63119|NCT02890394|Physical Therapy|physical therapy
63120|NCT02890368|CD47|cd47
63121|NCT02890368|SIRPa|sirpa
63122|NCT02890368|Immunotherapy|immunotherapy
63123|NCT02890368|Checkpoint inhibitor|checkpoint inhibitor
63124|NCT02890342|Propionic Acidemia|propionic acidemia
63125|NCT02890342|Inborn Error of Metabolism|inborn error of metabolism
63126|NCT02890342|Genetics|genetics
63127|NCT02890342|Pccb|pccb
63128|NCT02890342|Pcca|pcca
63129|NCT02890290|Frail Elderly|frail elderly
63130|NCT02890290|Diet, Food, and Nutrition|diet, food, and nutrition
63131|NCT02890290|physical function|physical function
63132|NCT02890290|marine protein hydrolysates|marine protein hydrolysates
63133|NCT02890290|protein intake|protein intake
63134|NCT02890290|seafood intake|seafood intake
63135|NCT02890290|municipal home care service|municipal home care service
63136|NCT02890290|ageing|ageing
63137|NCT02890290|old|old
63138|NCT02890290|nutrition|nutrition
63139|NCT02890290|frail|frail
63140|NCT02890264|End stage renal disease|end stage renal disease
63141|NCT02890264|Dialysis|dialysis
63142|NCT02890251|Infant|infant
63143|NCT02890251|Premature|premature
63144|NCT02890251|Diseases|diseases
63145|NCT02890238|Sildenafil Citrate|sildenafil citrate
63146|NCT02890238|Induction of Ovulation|induction of ovulation
63147|NCT02890238|Pregnancy Rate|pregnancy rate
63148|NCT02890225|renal residual stones|renal residual stones
63149|NCT02890225|external physical vibration lithecbole|external physical vibration lithecbole
63150|NCT02890225|stone free rate|stone free rate
63151|NCT02890225|complications|complications
63152|NCT02890212|Major depression, selenium, placebo, sertraline|major depression, selenium, placebo, sertraline
63153|NCT02890186|narcotrend|narcotrend
63154|NCT02890186|propofol|propofol
63155|NCT02890186|remifentanil|remifentanil
63156|NCT02890186|closed-loop of target controlled infusion|closed-loop of target controlled infusion
63157|NCT02890173|Essential hypertension|essential hypertension
63158|NCT02890173|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
63159|NCT02890173|Esaxerenone|esaxerenone
63160|NCT02890173|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
63161|NCT02890160|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
63162|NCT02890147|SADs|sads
63163|NCT02890147|Healthy Volunteers|healthy volunteers
63164|NCT02890147|Molecular profiles|molecular profiles
63165|NCT02890147|Omics Techniques|omics techniques
63166|NCT02890134|SADs|sads
63167|NCT02890134|Molecular Reclassification|molecular reclassification
63168|NCT02890121|SADs|sads
63169|NCT02890121|Molecular Reclassification|molecular reclassification
63170|NCT02890108|High-Intensity Sweeteners|high-intensity sweeteners
63171|NCT02890108|Non-Nutritive Sweeteners|non-nutritive sweeteners
63172|NCT02890108|Artificial sweeteners|artificial sweeteners
63173|NCT02890108|Glucose intolerance|glucose intolerance
63174|NCT02890082|Breast cancer|breast cancer
63175|NCT02890082|fertility|fertility
63176|NCT02890082|chemotherapy|chemotherapy
63177|NCT02890069|PDR001|pdr001
63179|NCT02890069|TNBC|tnbc
63180|NCT02890069|NSCLC|nsclc
63181|NCT02890069|Immunomodulation|immunomodulation
63182|NCT02890069|Biomarkers|biomarkers
63183|NCT02890069|Bayesian logistic regression model|bayesian logistic regression model
63184|NCT02890056|sugar-sweetened beverage consumption|sugar-sweetened beverage consumption
63185|NCT02890056|water consumption|water consumption
63186|NCT02890056|dietary behaviors|dietary behaviors
63187|NCT02890056|youth|youth
63188|NCT02890043|spine|spine
63189|NCT02890043|robot-assisted surgery|robot-assisted surgery
63190|NCT02890043|pedicle screw|pedicle screw
63191|NCT02890030|Cisplatin-based therapy|cisplatin-based therapy
63192|NCT02890030|Ototoxicity|ototoxicity
63193|NCT02890030|Neurotoxicity|neurotoxicity
63194|NCT02890017|outpatient surgery|outpatient surgery
63195|NCT02890017|urology medico-economic|urology medico-economic
63196|NCT02890017|hotel|hotel
63197|NCT02890004|Subarachnoid Hemorrhage|subarachnoid hemorrhage
63505|NCT02887963|Gestation|gestation
63198|NCT02890004|Neurointensive care|neurointensive care
63199|NCT02890004|Observational registry|observational registry
63200|NCT02889991|Myofascial pain.|myofascial pain.
63201|NCT02889991|Myofascial trigger point.|myofascial trigger point.
63202|NCT02889991|Infraspinatus muscle.|infraspinatus muscle.
63203|NCT02889991|Deep dry needling.|deep dry needling.
63204|NCT02889991|Local twitch response.|local twitch response.
63205|NCT02889991|Fascial mechanotransduction.|fascial mechanotransduction.
63206|NCT02889991|Needle grasp.|needle grasp.
63207|NCT02889991|Myofascial fibrosis.|myofascial fibrosis.
63208|NCT02889991|Elastography.|elastography.
63209|NCT02889978|Cancer Screening|cancer screening
63210|NCT02889978|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
63211|NCT02889978|Deep Sequencing|deep sequencing
63212|NCT02889978|Circulating cell-free tumor DNA|circulating cell-free tumor dna
63213|NCT02889965|Multiple sclerosis|multiple sclerosis
63214|NCT02889965|Pharmacoepidemiology|pharmacoepidemiology
63215|NCT02889965|Disease modifying drugs|disease modifying drugs
63216|NCT02889965|Neuro-myelitis optica|neuro-myelitis optica
63217|NCT02889952|postoperative hypocalcemia|postoperative hypocalcemia
63218|NCT02889952|near infrared imaging|near infrared imaging
63219|NCT02889952|parathyroid autofluorescence|parathyroid autofluorescence
63220|NCT02889939|rehabilitation|rehabilitation
63221|NCT02889939|recovery of function|recovery of function
63222|NCT02889939|environment|environment
63223|NCT02889900|ovarian cancer|ovarian cancer
63224|NCT02889887|Preterm|preterm
63225|NCT02889887|Sensory Processing|sensory processing
63226|NCT02889887|Motor Development|motor development
63227|NCT02889874|Radiation therapy|radiation therapy
63228|NCT02889874|omission|omission
63229|NCT02889874|non-inferiority|non-inferiority
63230|NCT02889874|breast cancer|breast cancer
63231|NCT02889861|Uveal melanoma|uveal melanoma
63232|NCT02889861|Cutaneous melanoma|cutaneous melanoma
63233|NCT02889835|Class II|class ii
63234|NCT02889835|molar and premolar|molar and premolar
63235|NCT02889835|resin composite|resin composite
63236|NCT02889835|adult|adult
63237|NCT02889835|restoration|restoration
63238|NCT02889809|Growth Velocity|growth velocity
63239|NCT02889809|Prepubertal|prepubertal
63240|NCT02889809|Asthma|asthma
63241|NCT02889809|Paediatric|paediatric
63242|NCT02889783|urodynamics|urodynamics
63243|NCT02889783|urethral sensation|urethral sensation
63244|NCT02889783|urethral pain|urethral pain
63245|NCT02889757|tuberculosis|tuberculosis
63246|NCT02889757|acetylcysteine|acetylcysteine
63247|NCT02889757|hepatotoxicity|hepatotoxicity
63248|NCT02889744|Temperature|temperature
63249|NCT02889744|Hypothermia|hypothermia
63250|NCT02889744|Brain|brain
63251|NCT02889744|Oxygen|oxygen
63252|NCT02889744|Prognosis|prognosis
63253|NCT02889731|Suicide|suicide
63254|NCT02889731|Heights|heights
63255|NCT02889731|Suicide hot spots|suicide hot spots
63256|NCT02889731|Bridges|bridges
63257|NCT02889705|Ultrasonography|ultrasonography
63258|NCT02889705|echotexture|echotexture
63259|NCT02889705|K value|k value
63260|NCT02889705|SCM muscles|scm muscles
63261|NCT02889705|CMT infants|cmt infants
63262|NCT02889692|lung cancer|lung cancer
63263|NCT02889692|traditional Chinese medicine|traditional chinese medicine
63264|NCT02889692|maintenance therapy|maintenance therapy
63265|NCT02889692|targeted therapy|targeted therapy
63266|NCT02889679|Colonoscopy|colonoscopy
63267|NCT02889679|Polypectomy|polypectomy
63268|NCT02889666|relapsed|relapsed
63269|NCT02889666|non-small cell lung cancer|non-small cell lung cancer
63270|NCT02889666|cisplatin|cisplatin
63271|NCT02889666|carboplatin|carboplatin
63272|NCT02889666|oxaliplatin|oxaliplatin
63273|NCT02889666|docetaxel|docetaxel
63274|NCT02889666|gemcitabine|gemcitabine
63275|NCT02889627|Fecal Microbiota Transplantation|fecal microbiota transplantation
63276|NCT02889627|Gut microbiota|gut microbiota
63277|NCT02889627|Brain-gut axis|brain-gut axis
63278|NCT02889627|Epilepsy|epilepsy
63279|NCT02889588|Refractive Surgery|refractive surgery
63280|NCT02889588|higher order aberrations|higher order aberrations
63281|NCT02889562|apixaban|apixaban
63282|NCT02889562|anticoagulant|anticoagulant
63283|NCT02889562|CABG|cabg
63284|NCT02889562|thrombosis|thrombosis
63285|NCT02889562|fibrillation|fibrillation
63286|NCT02889536|parastomal hernia|parastomal hernia
63287|NCT02889536|ostomy|ostomy
63288|NCT02889536|qualitative|qualitative
63289|NCT02889536|phenomenological-hermeneutic research|phenomenological-hermeneutic research
63290|NCT02889536|symptoms|symptoms
63291|NCT02889536|parastomal bulging|parastomal bulging
63292|NCT02889523|Front line therapy|front line therapy
63293|NCT02889523|Age-adjusted International Prognostic Index (aa-IPI) >1|age-adjusted international prognostic index (aa-ipi) >1
63294|NCT02889523|60 to 80 years|60 to 80 years
63295|NCT02889510|diabetes|diabetes
63296|NCT02889510|liraglutide|liraglutide
63297|NCT02889510|lung function|lung function
63298|NCT02889497|vaccine|vaccine
63299|NCT02889497|safety|safety
63300|NCT02889497|immunogenicity|immunogenicity
63302|NCT02889458|Breast Cancer|breast cancer
63303|NCT02889458|Women|women
63304|NCT02889419|Multiple Sclerosis|multiple sclerosis
63305|NCT02889419|Disability|disability
63306|NCT02889419|Underwear|underwear
63307|NCT02889419|Urinary catheter|urinary catheter
63308|NCT02889419|Self-catheterisation|self-catheterisation
63309|NCT02889380|Infertility|infertility
63310|NCT02889380|Cetrotide|cetrotide
63311|NCT02889380|Assisted reproductive technology (ART)|assisted reproductive technology (art)
63312|NCT02889341|Docosahexanoic Acid,|docosahexanoic acid,
63313|NCT02889341|DNA fragmentation|dna fragmentation
63314|NCT02889341|male fertility|male fertility
63315|NCT02889341|Sperm parameters improvements|sperm parameters improvements
63317|NCT02889315|treprostinil|treprostinil
63318|NCT02889315|LenusPro|lenuspro
63319|NCT02889315|implantable device|implantable device
63320|NCT02889315|quality of life|quality of life
63321|NCT02888340|Acupuncture|acupuncture
63322|NCT02888340|Emergency Department|emergency department
63323|NCT02888340|Pain|pain
63324|NCT02888314|mHealth|mhealth
63325|NCT02888314|Pokemon Go|pokemon go
63326|NCT02889289|traumatic brain injury|traumatic brain injury
63327|NCT02889289|virtual reality|virtual reality
63328|NCT02889289|Xbox kinect|xbox kinect
63329|NCT02889289|balance|balance
63330|NCT02889250|geriatric|geriatric
63331|NCT02889250|depression|depression
63332|NCT02889250|deep brain stimulation|deep brain stimulation
63333|NCT02889250|subcallosal cingulate|subcallosal cingulate
63334|NCT02889237|Fracture healing|fracture healing
63335|NCT02889237|Calcium supplementation|calcium supplementation
63336|NCT02889237|Vitamin D supplementation|vitamin d supplementation
63338|NCT02889224|Obesity|obesity
63339|NCT02889224|Cortisol|cortisol
63340|NCT02889224|Hydrocortisone|hydrocortisone
63341|NCT02889224|Endocannabinoïds|endocannabinoïds
63342|NCT02889198|web-based tool|web-based tool
63343|NCT02889198|child, preschool|child, preschool
63344|NCT02889198|nutrition|nutrition
63345|NCT02889198|implementation|implementation
63346|NCT02889198|child care|child care
63347|NCT02889185|Optical Coherence Tomography|optical coherence tomography
63348|NCT02889185|Retinal camera|retinal camera
63349|NCT02889159|photoaging|photoaging
63350|NCT02889146|Intensive Care Units|intensive care units
63351|NCT02889146|Physical Therapy Specialty|physical therapy specialty
63352|NCT02889146|Critical illness|critical illness
63353|NCT02889146|Muscle weakness|muscle weakness
63354|NCT02889146|Bed rest|bed rest
63355|NCT02889133|Iron deficiency|iron deficiency
63356|NCT02889133|Transfusion|transfusion
63357|NCT02889133|Blood donation|blood donation
63358|NCT02889120|Drug advice by phone|drug advice by phone
63359|NCT02889120|Teleprescription|teleprescription
63360|NCT02889120|Medical call centre|medical call centre
63361|NCT02889120|Out of hours call|out of hours call
63362|NCT02889081|birth cohort|birth cohort
63363|NCT02889081|prenatal|prenatal
63364|NCT02889081|skin barrier|skin barrier
63365|NCT02889081|atopic dermatitis|atopic dermatitis
63366|NCT02889081|key nutritional factors|key nutritional factors
63367|NCT02889016|PANS|pans
63368|NCT02889016|PANDAS|pandas
63369|NCT02888951|Diabetes|diabetes
63370|NCT02888951|Diabetes Mellitus|diabetes mellitus
63371|NCT02888951|Gastric Ultrasound|gastric ultrasound
63372|NCT02888951|Preoperative fasting|preoperative fasting
63373|NCT02888951|Empty Stomach|empty stomach
63374|NCT02888951|Gastric Diabetes|gastric diabetes
63375|NCT02888912|glass ionomer cement|glass ionomer cement
63376|NCT02888912|composite resin|composite resin
63377|NCT02888886|systemic inflammation|systemic inflammation
63378|NCT02888873|composite resin|composite resin
63379|NCT02888873|Clinical trial|clinical trial
63380|NCT02888873|FDI (World Dental Federation) criteria|fdi (world dental federation) criteria
63381|NCT02888860|genetic susceptibility|genetic susceptibility
63382|NCT02888860|candida infection|candida infection
63383|NCT02888860|colonization|colonization
63384|NCT02888847|post bleaching teeth sensitivity|post bleaching teeth sensitivity
63386|NCT02888834|adverse drug reactions|adverse drug reactions
64214|NCT02882906|Pain|pain
63387|NCT02888834|hospitalized subjects|hospitalized subjects
63388|NCT02888834|community-dwelling|community-dwelling
63389|NCT02888808|gastroesophageal reflux disease|gastroesophageal reflux disease
63390|NCT02888808|women|women
63391|NCT02888808|Nigeria|nigeria
63392|NCT02888808|obesity|obesity
63393|NCT02888795|hypertonic dextrose prolotherapy|hypertonic dextrose prolotherapy
63394|NCT02888795|osteoarthritis|osteoarthritis
63395|NCT02888769|Coronary artery disease|coronary artery disease
63396|NCT02888769|Text messages|text messages
63397|NCT02888769|Blood pressure|blood pressure
63398|NCT02888769|Lifestyle|lifestyle
63399|NCT02888769|Risk factors|risk factors
63400|NCT02888756|Immunotherapy|immunotherapy
63401|NCT02888756|mRNA|mrna
63402|NCT02888756|Lentivirus infection|lentivirus infection
63403|NCT02888756|Virus disease|virus disease
63405|NCT02888756|Immunodeficiency syndrome|immunodeficiency syndrome
63406|NCT02888730|cystic fibrosis|cystic fibrosis
63407|NCT02888730|chronic rhinosinusitis|chronic rhinosinusitis
63408|NCT02888730|Lung Diseases|lung diseases
63409|NCT02888730|tobramycin|tobramycin
63410|NCT02888730|nebulized sonic aerosol therapy|nebulized sonic aerosol therapy
63411|NCT02888704|Atopic dermatitis|atopic dermatitis
63412|NCT02888704|Mesenchymal stem cells|mesenchymal stem cells
63413|NCT02888678|ASPIRES|aspires
63414|NCT02888652|Coronary Heart Disease|coronary heart disease
63416|NCT02888652|Anti-Platelet Agents|anti-platelet agents
63417|NCT02888613|mini-lumbotomy|mini-lumbotomy
63418|NCT02888613|mini-laparotomy|mini-laparotomy
63419|NCT02888613|retroperitoneal approach|retroperitoneal approach
63420|NCT02888613|transperitoneal approach|transperitoneal approach
63421|NCT02888613|abdominal aortic surgery|abdominal aortic surgery
63422|NCT02888535|primary immunodeficiency|primary immunodeficiency
63423|NCT02888535|secondary immunodeficiency|secondary immunodeficiency
63424|NCT02888535|intensive care unit|intensive care unit
63425|NCT02888535|infection|infection
63426|NCT02888535|adult|adult
63427|NCT02888509|depression|depression
63428|NCT02888509|anxiety disorder|anxiety disorder
63429|NCT02888509|bipolar disorder|bipolar disorder
63430|NCT02888509|Magnetic Resonance Imaging|magnetic resonance imaging
63431|NCT02888483|physical activity|physical activity
63432|NCT02888483|energy expenditure|energy expenditure
63433|NCT02888457|nasopharyngeal carriage|nasopharyngeal carriage
63434|NCT02888457|Streptococcus pneumoniae|streptococcus pneumoniae
65101|NCT02877342|Injury|injury
63435|NCT02888457|acute otitis media|acute otitis media
63436|NCT02888457|day-care centers|day-care centers
63437|NCT02888431|pH|ph
63438|NCT02888431|base deficit|base deficit
63439|NCT02888431|lactate values|lactate values
63440|NCT02888431|venous blood samples|venous blood samples
63441|NCT02888431|arterial blood samples|arterial blood samples
63442|NCT02888418|vaccine|vaccine
63443|NCT02888418|safety|safety
63444|NCT02888418|immunogenicity|immunogenicity
63445|NCT02888405|Body Composition|body composition
63446|NCT02888366|breast cancer|breast cancer
63447|NCT02888366|breath test|breath test
63448|NCT02888366|Menssana|menssana
63449|NCT02888366|Ancillary|ancillary
63450|NCT02888366|Mammography|mammography
63451|NCT02888366|Rapid Point-of-care|rapid point-of-care
63452|NCT02888366|Inflatable Bag|inflatable bag
63453|NCT02888353|Magnetic Resonance Imaging and Pacemakers ICD|magnetic resonance imaging and pacemakers icd
63454|NCT02888288|adolescent|adolescent
63455|NCT02888288|adolescence|adolescence
63456|NCT02888288|HIV/AIDS|hiv/aids
63457|NCT02888288|mental health|mental health
63458|NCT02888288|cognitive behavioral therapy|cognitive behavioral therapy
63459|NCT02888262|Bipolar disorder|bipolar disorder
63460|NCT02888262|Blood|blood
63461|NCT02888262|Smartphone|smartphone
63462|NCT02888262|Brain imaging|brain imaging
63463|NCT02888262|Cognition|cognition
63464|NCT02888262|Neuropsychology|neuropsychology
63465|NCT02888249|Tobacco withdrawal|tobacco withdrawal
63466|NCT02888249|Autonomic Agents|autonomic agents
63467|NCT02888236|Psoriasis|psoriasis
63468|NCT02888080|pulmonary sarcoidosis|pulmonary sarcoidosis
63469|NCT02888080|sarcoidosis|sarcoidosis
63470|NCT02888080|canakinumab|canakinumab
63471|NCT02888080|autoimmune diseases|autoimmune diseases
63472|NCT02888080|granulomas|granulomas
63473|NCT02888080|inflammation|inflammation
63474|NCT02888080|lung function testing|lung function testing
63475|NCT02888080|immunosuppressive agents|immunosuppressive agents
63476|NCT02888080|interleukin|interleukin
63477|NCT02888080|interleukin-1Beta|interleukin-1beta
63478|NCT02888080|[F-18]FDG-PET/CT|[f-18]fdg-pet/ct
63479|NCT02888080|respiratory|respiratory
63480|NCT02888080|pulmonary|pulmonary
63481|NCT02888080|steroids|steroids
63482|NCT02888080|corticosteroids|corticosteroids
63483|NCT02888080|lung diseases|lung diseases
63485|NCT02888041|Cervical ripening|cervical ripening
63486|NCT02888041|Pregnancy|pregnancy
63487|NCT02888041|Vaginal Administration|vaginal administration
63488|NCT02888028|Remote ICD follow-up|remote icd follow-up
63489|NCT02888028|HRQoL|hrqol
64215|NCT02882906|Shoulder|shoulder
63490|NCT02888028|Health related Quality of Life|health related quality of life
63491|NCT02888028|Depression|depression
63492|NCT02888028|anxiety|anxiety
63493|NCT02888028|device acceptance|device acceptance
63494|NCT02888028|telemedicine|telemedicine
63495|NCT02888028|telemonitoring|telemonitoring
63496|NCT02887989|Virtual Reality|virtual reality
63497|NCT02887989|Non-Opioid Pain Management|non-opioid pain management
63498|NCT02887976|Prostate Cancer|prostate cancer
63499|NCT02887976|Castrate Resistant Prostate Cancer (CRPC)|castrate resistant prostate cancer (crpc)
63500|NCT02887976|metastatic|metastatic
63501|NCT02887976|castrate resistant|castrate resistant
63502|NCT02887963|Iron Deficiency|iron deficiency
63503|NCT02887963|Iron Deficiency Anemia|iron deficiency anemia
63504|NCT02887963|Pregnant Women|pregnant women
63507|NCT02887963|Epidemiology|epidemiology
63508|NCT02887872|stroke|stroke
63509|NCT02887872|upper extremity function|upper extremity function
63510|NCT02887872|rehabilitation|rehabilitation
63511|NCT02887820|ECMO|ecmo
63512|NCT02887820|TEG|teg
63513|NCT02887807|Cardiac arrest|cardiac arrest
63514|NCT02887807|Shockable|shockable
63515|NCT02887807|Cyclosporine|cyclosporine
63516|NCT02887794|pitch discrimination|pitch discrimination
63517|NCT02887794|auditory processing disorders|auditory processing disorders
63518|NCT02887794|auditory perception|auditory perception
63519|NCT02887794|auditory-verbal hallucinations|auditory-verbal hallucinations
63520|NCT02887794|theory of mind|theory of mind
63521|NCT02887729|Polycystic disease|polycystic disease
63522|NCT02887703|ataxia|ataxia
63523|NCT02887703|balance training|balance training
63524|NCT02887703|vibrotactile biofeedback|vibrotactile biofeedback
63525|NCT02887703|sensory augmentation|sensory augmentation
63526|NCT02887703|cerebellar ataxia|cerebellar ataxia
63527|NCT02887690|MPL|mpl
63528|NCT02887690|prosthetic limb|prosthetic limb
63529|NCT02887690|upper extremity|upper extremity
63530|NCT02887690|prosthesis|prosthesis
63531|NCT02887677|Dapagliflozin|dapagliflozin
63532|NCT02887677|Arterial Stiffness|arterial stiffness
63533|NCT02887677|Aortic Pressure|aortic pressure
63534|NCT02887651|cerebrale metastases|cerebrale metastases
63535|NCT02887651|radiotherapy|radiotherapy
63536|NCT02887651|surgery|surgery
63537|NCT02887651|complete surgical resection|complete surgical resection
63538|NCT02887651|resection|resection
63539|NCT02887651|cavity boost radiation therapy|cavity boost radiation therapy
63540|NCT02887651|observation|observation
63542|NCT02887586|Mechanism Study|mechanism study
63543|NCT02887586|Anorexia|anorexia
63544|NCT02887586|Cancer|cancer
63545|NCT02887573|Bowel preparation|bowel preparation
63546|NCT02887573|Colorectal polyps|colorectal polyps
63547|NCT02887573|Colon capsule endoscopy|colon capsule endoscopy
63548|NCT02887560|Right ventricle|right ventricle
63549|NCT02887560|Pulmonary transplantation|pulmonary transplantation
63550|NCT02887560|Strain|strain
63551|NCT02887560|isovolumic acceleration (IVA)|isovolumic acceleration (iva)
63552|NCT02887495|scleroderma|scleroderma
63553|NCT02887495|biorepository|biorepository
63554|NCT02887482|DNA|dna
63555|NCT02887482|Vaccine|vaccine
63556|NCT02887469|Hyponatremia|hyponatremia
63557|NCT02887469|Hypertonic saline|hypertonic saline
63558|NCT02887469|Treatment|treatment
63559|NCT02887469|Osmotic demyelination syndrome|osmotic demyelination syndrome
63560|NCT02887430|foot reflexology|foot reflexology
63561|NCT02887430|pain intensity|pain intensity
63562|NCT02887430|health-related quality of life|health-related quality of life
63563|NCT02887417|platelet activation|platelet activation
63564|NCT02887391|hemodialysis|hemodialysis
63565|NCT02887391|nutritional status|nutritional status
63566|NCT02887378|bronchial biopsy|bronchial biopsy
63567|NCT02887365|colon cancer|colon cancer
63568|NCT02887365|MSI-L|msi-l
63569|NCT02887365|MSS|mss
63570|NCT02887365|Tegafur-Uracil|tegafur-uracil
63571|NCT02887365|Low-Level Microsatellite-Instability|low-level microsatellite-instability
63572|NCT02887339|Informed Consent|informed consent
63573|NCT02887339|Research donation request|research donation request
63574|NCT02887339|Effective Communication|effective communication
63575|NCT02887313|Rectal cancer|rectal cancer
63576|NCT02887313|Neoadjuvant chemoradiation therapy|neoadjuvant chemoradiation therapy
63577|NCT02887300|Quality of Health Care|quality of health care
63578|NCT02887300|Psychological Stress|psychological stress
63579|NCT02887300|Burnout|burnout
63580|NCT02887300|Health Care Professional|health care professional
63581|NCT02887300|Mantra Meditation|mantra meditation
63582|NCT02887300|Health Care Economics|health care economics
63583|NCT02887274|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
63584|NCT02887274|Sepsis|sepsis
63585|NCT02887274|Severe Sepsis|severe sepsis
63586|NCT02887274|Septic shock|septic shock
63587|NCT02887274|Multiple organ failure|multiple organ failure
63588|NCT02887261|Power Port|power port
63589|NCT02887248|nab-paclitaxel|nab-paclitaxel
63590|NCT02887248|gemcitabine|gemcitabine
63591|NCT02887222|Epidural|epidural
63592|NCT02887222|Labor analgesia|labor analgesia
63593|NCT02887222|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
63594|NCT02887196|Breast Cancer|breast cancer
63595|NCT02887183|Heart failure|heart failure
63596|NCT02887183|Reduced left ventricular ejection fraction|reduced left ventricular ejection fraction
63597|NCT02887183|HFrEF|hfref
63598|NCT02887183|NT-proBNP|nt-probnp
63599|NCT02887183|Cardiac remodeling|cardiac remodeling
63600|NCT02887170|Adolescent|adolescent
63601|NCT02887170|Lost to contact|lost to contact
63602|NCT02887170|Recurrence|recurrence
63603|NCT02887170|Long-term outcome|long-term outcome
63604|NCT02887131|Subtalar arthritis|subtalar arthritis
63605|NCT02887131|Subtalar instability|subtalar instability
63606|NCT02887118|Erythrocytes|erythrocytes
63607|NCT02887118|Sickle Cell Disease|sickle cell disease
63608|NCT02887092|health determinants|health determinants
63609|NCT02887092|epidemiology|epidemiology
63610|NCT02887092|maintaining autonomy|maintaining autonomy
63611|NCT02887092|psychology|psychology
63612|NCT02887092|osteoarthritis|osteoarthritis
63613|NCT02887092|perceived health|perceived health
63614|NCT02887053|MRI|mri
63615|NCT02887053|Healthy subjects|healthy subjects
63616|NCT02887040|Diffuse, intrinsic brain stem glioma|diffuse, intrinsic brain stem glioma
63617|NCT02887040|Antineoplaston therapy|antineoplaston therapy
63618|NCT02887040|Radiation|radiation
63619|NCT02887014|bowel preparation|bowel preparation
63620|NCT02887014|colonoscopy|colonoscopy
63621|NCT02887014|inpatients|inpatients
63622|NCT02887014|cathartics|cathartics
63623|NCT02887001|cost study|cost study
63624|NCT02887001|clinical pharmacist|clinical pharmacist
63625|NCT02886988|Botulinum toxin type A, scar|botulinum toxin type a, scar
63626|NCT02886975|Renal Insufficiency, Chronic|renal insufficiency, chronic
63627|NCT02886975|Diet, Protein-Restricted|diet, protein-restricted
63628|NCT02886936|transtibial amputees|transtibial amputees
63629|NCT02886910|Chorioamnionitis|chorioamnionitis
63630|NCT02886910|Early onset neonatal sepsis|early onset neonatal sepsis
63631|NCT02886910|Antibiotics|antibiotics
63632|NCT02886910|Clinical observation|clinical observation
63633|NCT02886897|Refractory solid tumors|refractory solid tumors
63634|NCT02886897|Dendritic and Cytokine-induced killer cell|dendritic and cytokine-induced killer cell
63635|NCT02886897|Anti-PD-1 antibody|anti-pd-1 antibody
63636|NCT02886897|Combination immunotherapy|combination immunotherapy
63637|NCT02886884|Diabetes|diabetes
63642|NCT02886858|electroconvulsive therapy|electroconvulsive therapy
63643|NCT02886845|SNP,Breast Neoplasms|snp,breast neoplasms
63644|NCT02886832|Prostate Health|prostate health
63645|NCT02886819|Whole body vibration|whole body vibration
63646|NCT02886819|Tonic vibration reflex|tonic vibration reflex
63647|NCT02886819|Bone myoregulation reflex|bone myoregulation reflex
63648|NCT02886806|closed loop|closed loop
63649|NCT02886806|remifentanil|remifentanil
63650|NCT02886806|propofol|propofol
63651|NCT02886767|skin to skin contact|skin to skin contact
63652|NCT02886754|Clinical Communication|clinical communication
63653|NCT02886754|ISBAR|isbar
63654|NCT02886754|Simulation|simulation
63655|NCT02886754|Performance|performance
63656|NCT02886754|Non technical skills|non technical skills
63657|NCT02886754|Proficiency|proficiency
63658|NCT02886741|campaign|campaign
63659|NCT02886741|surgical site infection|surgical site infection
63660|NCT02886741|orthopedic surgery|orthopedic surgery
63661|NCT02886741|quality improvement|quality improvement
63662|NCT02886741|infection control|infection control
63663|NCT02886650|Paediatrics|paediatrics
63664|NCT02886650|epilepsy surgery|epilepsy surgery
63665|NCT02886650|genetic mutation|genetic mutation
63666|NCT02886650|focal seizures|focal seizures
63667|NCT02886637|A baumannii infection|a baumannii infection
63668|NCT02886637|Immunosuppression|immunosuppression
63669|NCT02886637|prognosis|prognosis
63670|NCT02886637|immune function|immune function
63671|NCT02886585|Brain Metastases|brain metastases
63672|NCT02886559|demethylating agent|demethylating agent
63673|NCT02886559|chidamide|chidamide
63674|NCT02886533|Major haemorrhage|major haemorrhage
63675|NCT02886533|Oral anticoagulation|oral anticoagulation
625702|NCT00682825|Bispectral|bispectral
63676|NCT02886533|Antiplatelet drugs|antiplatelet drugs
63677|NCT02886533|Gastrointestinal bleeding|gastrointestinal bleeding
63678|NCT02886533|Intracranial haemorrhage|intracranial haemorrhage
63679|NCT02886520|Urinary incontinence|urinary incontinence
63680|NCT02886520|Materials|materials
63681|NCT02886520|Surgery|surgery
63682|NCT02886520|Transobturator tape|transobturator tape
63683|NCT02886520|Polyvinylidene fluoride|polyvinylidene fluoride
63684|NCT02886520|Polypropylene|polypropylene
63685|NCT02886481|thyroidectomy|thyroidectomy
63686|NCT02886481|Electrophysiologic|electrophysiologic
63687|NCT02886481|vocal cord movement|vocal cord movement
63688|NCT02886429|dexmedetomidine|dexmedetomidine
63689|NCT02886429|bupivacaine|bupivacaine
63690|NCT02886429|Ultrasound guided paravertebral block|ultrasound guided paravertebral block
63691|NCT02886429|pain|pain
63692|NCT02886429|post-thoracotomy|post-thoracotomy
63693|NCT02886416|HIV infection|hiv infection
63694|NCT02886390|remote ischemic conditioning|remote ischemic conditioning
63695|NCT02886390|r-tPA thrombolytic therapy|r-tpa thrombolytic therapy
63696|NCT02886351|Moderate Sedation|moderate sedation
63697|NCT02886351|Pediatric Dentistry|pediatric dentistry
63698|NCT02886351|Anxiety|anxiety
63699|NCT02886325|Receipt of Preventive Cancer Screening|receipt of preventive cancer screening
63700|NCT02886299|Fibrates|fibrates
63701|NCT02886299|Statins|statins
63702|NCT02886299|Hemodialysis|hemodialysis
63703|NCT02886299|Dyslipidemia|dyslipidemia
63704|NCT02886299|Improved Oxidative Stress|improved oxidative stress
63705|NCT02886299|Egypt|egypt
63706|NCT02886273|Sudden Cardiac Arrest|sudden cardiac arrest
63707|NCT02886273|Out-of-hospital|out-of-hospital
63708|NCT02886273|Ventricular fibrillation|ventricular fibrillation
63709|NCT02886273|Classification|classification
63710|NCT02886273|Mechanisms|mechanisms
63711|NCT02886273|Biomarkers|biomarkers
63712|NCT02886234|HIV|hiv
63713|NCT02886234|Mindfulness|mindfulness
63714|NCT02886234|Adherence behaviors|adherence behaviors
63715|NCT02886234|Stress|stress
63716|NCT02886234|Depression|depression
63717|NCT02886221|Hallux Valgus|hallux valgus
63718|NCT02886221|Reverdin-Isham Osteotomy|reverdin-isham osteotomy
63719|NCT02886221|Minimally Invasive Surgery|minimally invasive surgery
63720|NCT02886221|Percutaneous Distal Osteotomy|percutaneous distal osteotomy
63721|NCT02886221|First Ray|first ray
63722|NCT02886221|Forefoot|forefoot
63723|NCT02886182|chronic hepatitis B|chronic hepatitis b
63724|NCT02886182|pregnancy|pregnancy
63725|NCT02886182|Cellular immune response|cellular immune response
63726|NCT02886182|Clinical implications|clinical implications
63727|NCT02886169|Sacha Inchi|sacha inchi
63728|NCT02886169|High-fat meal|high-fat meal
63729|NCT02886169|Postprandial inflammatory responses|postprandial inflammatory responses
63730|NCT02886156|OSA|osa
63731|NCT02886156|CPAP|cpap
63732|NCT02886156|cognitive function|cognitive function
63733|NCT02886156|gut microbiota|gut microbiota
63734|NCT02886156|metabolomics|metabolomics
63736|NCT02886130|Volleyball|volleyball
63737|NCT02886130|Athletes|athletes
63738|NCT02886130|Executive functions|executive functions
63739|NCT02886130|Vertical jump|vertical jump
63740|NCT02886130|Peak power|peak power
63741|NCT02886104|synchronous|synchronous
63742|NCT02886104|metachronous|metachronous
63743|NCT02886104|colorectal liver metastasis|colorectal liver metastasis
63744|NCT02886104|resection|resection
63745|NCT02886104|ablation|ablation
63746|NCT02886091|Keloids|keloids
63747|NCT02886091|Shaving|shaving
63748|NCT02886091|Ears|ears
63749|NCT02886091|Cryosurgery|cryosurgery
63750|NCT02886091|Hypertrophic scars|hypertrophic scars
63751|NCT02886065|Myeloma|myeloma
63752|NCT02886052|Cognitive behavior therapy|cognitive behavior therapy
63753|NCT02886052|Internet treatment|internet treatment
63754|NCT02886052|Self-help treatment|self-help treatment
63755|NCT02886052|Insomnia|insomnia
63756|NCT02886052|ICBT|icbt
63757|NCT02886052|CBT-i|cbt-i
63758|NCT02886052|Bereavement|bereavement
63759|NCT02886039|Cardiorespiratory arrest|cardiorespiratory arrest
63760|NCT02886039|Neurologic outcome|neurologic outcome
63761|NCT02886039|Electroencephalogram|electroencephalogram
63762|NCT02886039|Somatosensory evoked potential|somatosensory evoked potential
63763|NCT02886039|Synek classification|synek classification
63764|NCT02886039|Cerebral performance category|cerebral performance category
63765|NCT02886039|Hypothermia|hypothermia
63766|NCT02886026|Laser|laser
63767|NCT02886026|Bladder cancer|bladder cancer
63768|NCT02886026|Treatment|treatment
63769|NCT02886026|Outpatient|outpatient
63770|NCT02886026|TUR-BT|tur-bt
63771|NCT02886013|prevalence|prevalence
63772|NCT02885974|Celecoxib|celecoxib
63773|NCT02885974|Bladder Cancer|bladder cancer
63774|NCT02885909|type 2 diabetes|type 2 diabetes
63775|NCT02885909|inpatient|inpatient
63776|NCT02885909|glucose control|glucose control
63777|NCT02885909|continue glucose monitor|continue glucose monitor
63778|NCT02885896|Call center|call center
63779|NCT02885896|nurses|nurses
63780|NCT02885896|pediatrics|pediatrics
63781|NCT02885896|standardized messages|standardized messages
63782|NCT02885896|family counseling|family counseling
63783|NCT02885870|biomarker|biomarker
63784|NCT02885870|spinal cord disease|spinal cord disease
63785|NCT02885870|resonance imaging|resonance imaging
63786|NCT02885870|electrophysiology|electrophysiology
63787|NCT02885831|Abduction splint|abduction splint
63788|NCT02885831|Pubo-femoral distance|pubo-femoral distance
63789|NCT02885792|Schizophrenia|schizophrenia
63790|NCT02885792|Cardiovascular disease|cardiovascular disease
63791|NCT02885792|Premature mortality|premature mortality
63792|NCT02885792|Arteriosclerosis|arteriosclerosis
63793|NCT02885792|Risk factor|risk factor
63794|NCT02885792|Intervention|intervention
63795|NCT02885792|Treatment|treatment
63796|NCT02885792|Somatic morbidity|somatic morbidity
63797|NCT02885766|CML|cml
63798|NCT02885766|Myeloid leukaemia chronic|myeloid leukaemia chronic
63799|NCT02885766|CML progression|cml progression
63800|NCT02885766|Chronic phase chronic myeloid leukemia|chronic phase chronic myeloid leukemia
63801|NCT02885766|PF-114|pf-114
63802|NCT02885766|Cytogenetic response CCyR|cytogenetic response ccyr
63803|NCT02885766|Major molecular response MMR|major molecular response mmr
63804|NCT02885766|Complete molecular response CMR|complete molecular response cmr
63805|NCT02885766|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
63908|NCT02884986|Postoperative pain|postoperative pain
63806|NCT02885766|2-nd generation Bcr-Abl inhibitors resistant|2-nd generation bcr-abl inhibitors resistant
63807|NCT02885753|colorectal|colorectal
63808|NCT02885753|cancer|cancer
63809|NCT02885753|metastasis|metastasis
63810|NCT02885753|hepatic|hepatic
63811|NCT02885701|postoperative dressing|postoperative dressing
63812|NCT02885701|postoperative splint|postoperative splint
63813|NCT02885701|mini-open carpal tunnel release|mini-open carpal tunnel release
63814|NCT02885688|Septic Shock|septic shock
63815|NCT02885688|Sepsis|sepsis
63816|NCT02885688|Standard of care|standard of care
63817|NCT02885688|Liquid nutrition|liquid nutrition
63818|NCT02885688|Metabolic support|metabolic support
63819|NCT02885688|Enteral nutrition|enteral nutrition
63820|NCT02885688|Insulin Drip|insulin drip
63821|NCT02885688|Glucose Drip|glucose drip
63822|NCT02885662|Primary aldosteronism|primary aldosteronism
63823|NCT02885662|Hypertension|hypertension
63824|NCT02885662|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
63825|NCT02885662|Developmental Phase III|developmental phase iii
63826|NCT02885636|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
63827|NCT02885636|Pulmonary Hypertension|pulmonary hypertension
63828|NCT02885597|Juanbi Pill|juanbi pill
63829|NCT02885597|Methotrexate|methotrexate
63830|NCT02885597|Active|active
63831|NCT02885597|Rheumatoid Arthritis|rheumatoid arthritis
63832|NCT02885584|Mechanical ventilation|mechanical ventilation
63833|NCT02885558|Receptors, Calcium Channel Blocker|receptors, calcium channel blocker
63835|NCT02885519|Vocational Rehabilitation|vocational rehabilitation
63836|NCT02885519|Common Mental Disorders|common mental disorders
63837|NCT02885519|Return to Work|return to work
63838|NCT02885519|Mental Health Services|mental health services
63839|NCT02885519|Psychological Stress|psychological stress
63840|NCT02885519|Adjustment Disorder|adjustment disorder
63841|NCT02885519|Burnout|burnout
63842|NCT02885519|Integration|integration
63843|NCT02885519|Cognitive Behavior Therapy|cognitive behavior therapy
63844|NCT02885493|Parkinson march|parkinson march
63845|NCT02885467|Total Knee Arthroplasty|total knee arthroplasty
63846|NCT02885441|Inflammation|inflammation
63847|NCT02885389|Infantile spasms|infantile spasms
63848|NCT02885389|West syndrome|west syndrome
63849|NCT02885389|variant|variant
63850|NCT02885389|mutation|mutation
63851|NCT02885389|CNV|cnv
63852|NCT02885389|sequencing|sequencing
63853|NCT02885376|Mucositis|mucositis
63854|NCT02885337|Frail Elderly|frail elderly
63855|NCT02885337|Arthroplasty|arthroplasty
63856|NCT02885337|Frailty|frailty
63857|NCT02885324|High Grade Glioma|high grade glioma
63858|NCT02885324|Cabozantinib|cabozantinib
63859|NCT02885324|GBM|gbm
63860|NCT02885324|Children|children
63861|NCT02885324|AA|aa
63862|NCT02885311|Drinking|drinking
63863|NCT02885311|Excessive drinking|excessive drinking
63864|NCT02885311|Alcohol use disorders|alcohol use disorders
63865|NCT02885311|Primary Care|primary care
63866|NCT02885285|Parkinson's disease|parkinson's disease
63867|NCT02885285|fatigue|fatigue
63868|NCT02885285|anxiety|anxiety
63869|NCT02885285|depression|depression
63870|NCT02885285|exercise|exercise
63871|NCT02885272|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
63872|NCT02885272|Glioblastoma|glioblastoma
63873|NCT02885272|FDG PET|fdg pet
63874|NCT02885272|CT|ct
63875|NCT02885272|MRI|mri
63876|NCT02885246|Panama|panama
63877|NCT02885246|Influenza B|influenza b
63878|NCT02885246|Influenza A|influenza a
63879|NCT02885246|Strain circulation|strain circulation
63880|NCT02885246|Database|database
63881|NCT02885233|Fall Prevention|fall prevention
63882|NCT02885233|Multiple Sclerosis|multiple sclerosis
63883|NCT02885233|Web-based education|web-based education
63884|NCT02885233|Self-efficacy|self-efficacy
63885|NCT02885207|Limbic encephalitis|limbic encephalitis
63886|NCT02885207|anti-neuronal antibodies|anti-neuronal antibodies
63887|NCT02885194|Parkinson Disease|parkinson disease
63888|NCT02885194|Pain|pain
63889|NCT02885194|Deep Brain Stimulation|deep brain stimulation
63890|NCT02885194|Laser-Evoked Potentials|laser-evoked potentials
63891|NCT02885168|vasoreactivity|vasoreactivity
63892|NCT02885168|recombinant activated protein C|recombinant activated protein c
63893|NCT02885116|NHF|nhf
63894|NCT02885116|pulmonary hypertension|pulmonary hypertension
63895|NCT02885103|NHF|nhf
63896|NCT02885103|nasal highflow|nasal highflow
63897|NCT02885038|Platelet Transfusion|platelet transfusion
64216|NCT02882867|Prospective|prospective
63898|NCT02885025|hypersensitivity|hypersensitivity
63899|NCT02885025|antioxidants|antioxidants
63900|NCT02884999|trauma|trauma
63901|NCT02884999|bleeding|bleeding
63902|NCT02884999|coagulopathy|coagulopathy
63903|NCT02884999|guidelines compliance|guidelines compliance
63904|NCT02884999|recommendation|recommendation
63905|NCT02884999|transfusion|transfusion
63906|NCT02884986|Etoricoxib|etoricoxib
63907|NCT02884986|Spinal anaesthesia|spinal anaesthesia
64110|NCT02883686|depression|depression
63909|NCT02884973|congenital heart|congenital heart
63910|NCT02884973|NIRS|nirs
63911|NCT02884960|Uterine Fibroids|uterine fibroids
63912|NCT02884960|Embolization|embolization
63913|NCT02884947|Brain Neoplasms|brain neoplasms
63914|NCT02884947|Magnetic Resonance Imaging|magnetic resonance imaging
63915|NCT02884947|Neurosurgery|neurosurgery
63916|NCT02884934|venous thromboembolism|venous thromboembolism
63917|NCT02884934|recurrent venous thromboembolism|recurrent venous thromboembolism
63918|NCT02884934|anticoagulant-related bleeding|anticoagulant-related bleeding
63919|NCT02884921|Postoperative pain|postoperative pain
63920|NCT02884921|Dental treatment|dental treatment
63921|NCT02884921|Paracetamol|paracetamol
63922|NCT02884895|Intubating Laryngeal Tube Suction|intubating laryngeal tube suction
63923|NCT02884895|Blind intubation|blind intubation
63924|NCT02884882|Stroke Basal Ganglia|stroke basal ganglia
63925|NCT02884882|Emotional change|emotional change
63926|NCT02884869|Blind intubation,|blind intubation,
63927|NCT02884869|Laryngeal Mask Airway|laryngeal mask airway
63928|NCT02884856|color|color
63929|NCT02884856|dentistry|dentistry
63930|NCT02884856|gender|gender
63931|NCT02884843|Laryngeal Tube|laryngeal tube
63932|NCT02884843|blind intubation|blind intubation
63933|NCT02884843|fiberoptic|fiberoptic
63934|NCT02884804|Postpartum Hemorrhage|postpartum hemorrhage
63935|NCT02884804|Immature platelet|immature platelet
63936|NCT02884791|FGF21|fgf21
63937|NCT02884791|Fibroblast growth factor|fibroblast growth factor
63938|NCT02884791|fructose|fructose
63939|NCT02884778|pain|pain
63940|NCT02884778|monitoring|monitoring
63941|NCT02884778|anesthesia|anesthesia
63942|NCT02884765|mandibular condyle|mandibular condyle
63943|NCT02884765|subcondylar|subcondylar
63944|NCT02884765|mandible|mandible
63945|NCT02884765|fracture|fracture
63946|NCT02884700|Legionella|legionella
63947|NCT02884700|Legionnaires' disease|legionnaires' disease
63948|NCT02884700|Diagnosis|diagnosis
63949|NCT02884700|Prognosis|prognosis
63950|NCT02884674|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
63951|NCT02884674|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
63952|NCT02884648|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
63953|NCT02884648|Ovarian Cancer|ovarian cancer
63954|NCT02884648|Fallopian tube cancer|fallopian tube cancer
63955|NCT02884648|Primary peritoneal cancer|primary peritoneal cancer
63956|NCT02884648|Bevacizumab|bevacizumab
63957|NCT02884648|Avastin|avastin
63958|NCT02884648|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
63959|NCT02884648|rhuMab-VEGF|rhumab-vegf
63960|NCT02884635|Methotrexate|methotrexate
63961|NCT02884635|ASP1707|asp1707
63962|NCT02884635|Rheumatoid arthritis|rheumatoid arthritis
63963|NCT02884622|Lung disease|lung disease
63964|NCT02884622|Epigenetics|epigenetics
63965|NCT02884622|DNA methylation|dna methylation
63966|NCT02884622|Modifier genes|modifier genes
63967|NCT02884596|Inferior alveolar nerve block|inferior alveolar nerve block
63968|NCT02884596|irreversible pulpitis|irreversible pulpitis
63969|NCT02884596|selective serotonin reuptake inhibitor antidepressants|selective serotonin reuptake inhibitor antidepressants
63970|NCT02884583|Food allergy|food allergy
63971|NCT02884583|asthma|asthma
63972|NCT02884583|Predictive factor|predictive factor
63973|NCT02884583|Exacerbation|exacerbation
63974|NCT02884583|Prevalence|prevalence
63975|NCT02884570|Tracheotomy|tracheotomy
63976|NCT02884570|Anxiety|anxiety
63977|NCT02884570|Depression|depression
63978|NCT02884570|Back Home|back home
63979|NCT02884518|dopamine receptor occupancy|dopamine receptor occupancy
63980|NCT02884518|antipsychotics|antipsychotics
63981|NCT02884518|positron emission tomography|positron emission tomography
63982|NCT02884492|inflammation|inflammation
63983|NCT02884492|aging|aging
63984|NCT02884492|mild cognitive impairment|mild cognitive impairment
63985|NCT02884453|gastrooesophageal carcinoma|gastrooesophageal carcinoma
63986|NCT02884427|Direct current|direct current
63987|NCT02884427|Dynamometry|dynamometry
63988|NCT02884427|Hand strength|hand strength
63989|NCT02884427|Electrotherapy|electrotherapy
63990|NCT02884427|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
63991|NCT02884414|Knee Pathology|knee pathology
63992|NCT02884375|Elderly|elderly
63993|NCT02884375|Cancer|cancer
63994|NCT02884375|Geriatric assessment|geriatric assessment
63995|NCT02884375|Treatment|treatment
63996|NCT02884375|Epidemiology|epidemiology
63997|NCT02884362|melanoma clinical biological database|melanoma clinical biological database
63998|NCT02884349|Computer aided orthopaedic surgery|computer aided orthopaedic surgery
63999|NCT02884349|Implant orientation|implant orientation
64000|NCT02884349|Range of motion|range of motion
64001|NCT02884310|Remifentanil|remifentanil
64002|NCT02884310|Heart Rate Variability|heart rate variability
64003|NCT02884310|Pupil dilation|pupil dilation
64004|NCT02884310|SPI|spi
64005|NCT02884284|breast cancer|breast cancer
64006|NCT02884284|database|database
64007|NCT02884271|CPR|cpr
64008|NCT02884271|cardiac arrest|cardiac arrest
64009|NCT02884271|operating room|operating room
64010|NCT02884258|Assisted Reproductive Technology|assisted reproductive technology
64011|NCT02884258|Obesity|obesity
64012|NCT02884258|Bariatric Surgery|bariatric surgery
64013|NCT02884258|Infertility|infertility
64014|NCT02884258|Fertility Preservation|fertility preservation
64015|NCT02884245|Fertility|fertility
64016|NCT02884245|Reproductive processes|reproductive processes
64017|NCT02884245|In vitro fertilization|in vitro fertilization
64018|NCT02884245|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
64019|NCT02884245|Estrogens|estrogens
64020|NCT02884245|Follicule Stimulating Hormon|follicule stimulating hormon
64021|NCT02884219|Early treatment|early treatment
64022|NCT02884219|Expectative treatment|expectative treatment
64023|NCT02884219|Patent ductus arteriosus|patent ductus arteriosus
64024|NCT02884219|Preterm|preterm
64025|NCT02884206|heart failure|heart failure
64026|NCT02884206|cognition|cognition
64027|NCT02884206|positron emission tomography|positron emission tomography
64028|NCT02884206|magnetic resonance imaging|magnetic resonance imaging
64029|NCT02884206|LCZ696|lcz696
64030|NCT02884206|valsartan|valsartan
64031|NCT02884193|Cooling|cooling
64032|NCT02884193|Cryotherapy|cryotherapy
64033|NCT02884193|isometric Force|isometric force
64034|NCT02884193|Palmar Grip|palmar grip
64035|NCT02884193|Dynamometry|dynamometry
64036|NCT02884180|Dexamethasone|dexamethasone
64039|NCT02884154|Endoscopic ultrasonography|endoscopic ultrasonography
64040|NCT02884154|Biopsy|biopsy
64041|NCT02884154|Gastrointestinal tract|gastrointestinal tract
64042|NCT02884154|Subepithelial tumor|subepithelial tumor
64043|NCT02884141|Renal Artery Obstruction|renal artery obstruction
64044|NCT02884141|Carotid Artery Diseases|carotid artery diseases
64045|NCT02884141|Genetic Association Studies|genetic association studies
64046|NCT02884102|genetic sequencing|genetic sequencing
64047|NCT02884102|relapsed|relapsed
64048|NCT02884076|Hemorrhoids|hemorrhoids
64049|NCT02884076|Sodergren score|sodergren score
64050|NCT02884076|Validation|validation
64051|NCT02884063|PGS|pgs
64052|NCT02884063|PGD|pgd
64053|NCT02884063|free embryo DNA|free embryo dna
64054|NCT02884063|NGS|ngs
64055|NCT02884037|NAFLD|nafld
64056|NCT02884037|Rifaximin|rifaximin
64057|NCT02884037|Endotoxin and Homeostatic Model Assessment|endotoxin and homeostatic model assessment
64058|NCT02884024|obesity|obesity
64059|NCT02884024|inflammation|inflammation
64060|NCT02884024|cancer risk|cancer risk
64061|NCT02884011|Chronic antihypertensives|chronic antihypertensives
64062|NCT02884011|Septic shock|septic shock
64063|NCT02884011|Vasopressor|vasopressor
64064|NCT02884011|Vasopressor dosing|vasopressor dosing
64065|NCT02883998|home-based physical therapy|home-based physical therapy
64066|NCT02883998|outpatient physical therapy|outpatient physical therapy
64067|NCT02883998|unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
64068|NCT02883998|PT (Physical Therapy)|pt (physical therapy)
64069|NCT02883998|osteoarthritis|osteoarthritis
64070|NCT02883972|Immunization|immunization
64071|NCT02883972|Behavioural insights|behavioural insights
64072|NCT02883972|Children|children
64073|NCT02883959|critically ill|critically ill
64074|NCT02883959|mechanical ventilation|mechanical ventilation
64075|NCT02883959|pain|pain
64076|NCT02883959|nursing|nursing
64080|NCT02883842|Text messages|text messages
64081|NCT02883777|Kidney Transplantation|kidney transplantation
64082|NCT02883777|Low Glycemic Index|low glycemic index
64083|NCT02883777|High Protein|high protein
64084|NCT02883764|eicosapentaenoic acid|eicosapentaenoic acid
64085|NCT02883764|EPA|epa
64086|NCT02883764|docosahexaenoic acid|docosahexaenoic acid
64087|NCT02883764|DHA|dha
64088|NCT02883764|omega-3 index|omega-3 index
64089|NCT02883751|diabetes mellitus|diabetes mellitus
64090|NCT02883751|amputation stumps|amputation stumps
64091|NCT02883751|diabetic foot|diabetic foot
64092|NCT02883751|phototherapy|phototherapy
64093|NCT02883751|clinical trial|clinical trial
64094|NCT02883725|Esophageal atresia|esophageal atresia
64095|NCT02883712|epilepsy|epilepsy
64096|NCT02883712|pharmacoresistant|pharmacoresistant
64097|NCT02883712|antiepileptic drug|antiepileptic drug
64098|NCT02883712|pharmacokinetic|pharmacokinetic
64099|NCT02883712|pharmacodynamic|pharmacodynamic
64100|NCT02883712|pharmacogenetic|pharmacogenetic
64101|NCT02883699|Breast cancer|breast cancer
64102|NCT02883699|Prostate cancer|prostate cancer
64103|NCT02883699|Exercise prescription|exercise prescription
64104|NCT02883699|High intensity interval training|high intensity interval training
64105|NCT02883699|Daily undulating periodization training|daily undulating periodization training
64106|NCT02883699|Aerobic training|aerobic training
64107|NCT02883699|Resistance training|resistance training
64108|NCT02883699|Physical fitness|physical fitness
64109|NCT02883699|Exercise|exercise
64114|NCT02883686|effectiveness|effectiveness
64115|NCT02883673|Postpartum Hemorrhage|postpartum hemorrhage
64116|NCT02883660|genetics|genetics
64117|NCT02883660|Antidepressants|antidepressants
64118|NCT02883647|chronic hepatitis b, nucleos(t)ide analog|chronic hepatitis b, nucleos(t)ide analog
64119|NCT02883634|Back pain|back pain
64120|NCT02883634|spinal manipulation|spinal manipulation
64121|NCT02883621|upper endoscopy|upper endoscopy
64122|NCT02883621|cap assisted endoscopy|cap assisted endoscopy
64123|NCT02883621|esophagus|esophagus
64124|NCT02883608|Papilla|papilla
64125|NCT02883608|major duodenal papilla|major duodenal papilla
64126|NCT02883608|ampulla of vater|ampulla of vater
64127|NCT02883595|thymosin alpha 1; sepsis; monocyte; pharmacokinetics|thymosin alpha 1; sepsis; monocyte; pharmacokinetics
64128|NCT02883582|asthma ,hydrogen|asthma ,hydrogen
64129|NCT02883569|Low back pain|low back pain
64130|NCT02883569|Intervertebral Disc Degeneration|intervertebral disc degeneration
64131|NCT02883569|Spinal stenosis|spinal stenosis
64132|NCT02883569|Comparative Effectiveness Research|comparative effectiveness research
64133|NCT02883569|Cost-Benefit Analysis|cost-benefit analysis
64134|NCT02883556|Carcinoma|carcinoma
64135|NCT02883556|Squamous Cell|squamous cell
64136|NCT02883556|Skin|skin
64137|NCT02883556|pembrolizumab|pembrolizumab
64138|NCT02883556|Programmed Cell Death 1 Ligand 1|programmed cell death 1 ligand 1
64139|NCT02883517|cell-free circulating DNA;|cell-free circulating dna;
64141|NCT02883517|liquid biopsy|liquid biopsy
64142|NCT02883504|E/e' ratio|e/e' ratio
64143|NCT02883504|Doppler echocardiography, filling pressure|doppler echocardiography, filling pressure
64144|NCT02883504|Left Ventricular end-Diastolic Pressure|left ventricular end-diastolic pressure
64145|NCT02883465|diaphragmatic dysfunction|diaphragmatic dysfunction
64146|NCT02883465|mechanical ventilation weaning|mechanical ventilation weaning
64147|NCT02883465|failure extubation rate|failure extubation rate
64148|NCT02883439|MP29-02|mp29-02
64149|NCT02883426|H3N2v Influenza Viruses|h3n2v influenza viruses
64153|NCT02883387|DIEP flap|diep flap
64154|NCT02883387|Deep inferior epigastric artery perforator flap|deep inferior epigastric artery perforator flap
64157|NCT02883309|Hemodialysis|hemodialysis
64158|NCT02883309|Skeletal muscle|skeletal muscle
64159|NCT02883309|Exercise|exercise
64160|NCT02883309|Rehabilitation|rehabilitation
64161|NCT02883309|Disability Evaluation|disability evaluation
64162|NCT02883257|Major Depression|major depression
64163|NCT02883257|Major Depressive Disorder|major depressive disorder
64164|NCT02883257|Persistent Depressive Disorder|persistent depressive disorder
64165|NCT02883257|Cognitive Behavioral Therapy|cognitive behavioral therapy
64166|NCT02883257|Biomarkers|biomarkers
64167|NCT02883218|immunosuppression|immunosuppression
64168|NCT02883218|community-acquired sepsis|community-acquired sepsis
64169|NCT02883218|mortality|mortality
64170|NCT02883192|Cesarean section|cesarean section
64171|NCT02883192|spinal anesthesia|spinal anesthesia
64172|NCT02883192|hypotension|hypotension
64173|NCT02883192|ondansetron|ondansetron
64174|NCT02883153|Zirconium-89|zirconium-89
64175|NCT02883153|PET/CT|pet/ct
64176|NCT02883153|imaging|imaging
64177|NCT02883153|girentuximab|girentuximab
64178|NCT02883140|Sialography|sialography
64179|NCT02883140|Cone-beam CT|cone-beam ct
64180|NCT02883140|MRI sialography|mri sialography
64181|NCT02883140|non tumor salivary symptoms|non tumor salivary symptoms
64182|NCT02883127|Motivational Interviewing|motivational interviewing
64183|NCT02883127|Diet|diet
64184|NCT02883127|Carbohydrates|carbohydrates
64185|NCT02883127|Psychosocial factors|psychosocial factors
64186|NCT02883114|PF-06648671|pf-06648671
64188|NCT02883114|CYP3A|cyp3a
64189|NCT02883114|drug interaction|drug interaction
64190|NCT02883088|Optical coherence tomograhpy|optical coherence tomograhpy
64191|NCT02883088|registry|registry
64192|NCT02883088|Coronary artery disease|coronary artery disease
64193|NCT02883036|tigecycline|tigecycline
64194|NCT02883036|treatment|treatment
64195|NCT02883036|mitochondrial biogenesis|mitochondrial biogenesis
64196|NCT02883036|metabolic characteristics|metabolic characteristics
64197|NCT02883023|Bleomycin|bleomycin
64198|NCT02883023|Electroporation|electroporation
64199|NCT02883010|Surgical incision|surgical incision
64200|NCT02883010|surgical complication|surgical complication
64201|NCT02883010|NPWT|npwt
64202|NCT02883010|negative pressure|negative pressure
64203|NCT02883010|colorectal surgery|colorectal surgery
64204|NCT02883010|dehisced|dehisced
64205|NCT02882971|chronic pain|chronic pain
64206|NCT02882971|rating scale|rating scale
64208|NCT02882932|peritonitis|peritonitis
64209|NCT02882932|solutions|solutions
64210|NCT02882932|normal saline|normal saline
64211|NCT02882932|infection|infection
64212|NCT02882932|peritoneal lavage|peritoneal lavage
64213|NCT02882906|Stroke|stroke
64217|NCT02882867|Epidemiology|epidemiology
64218|NCT02882867|Track and Field|track and field
64219|NCT02882841|AIEC (Adherent and Invasive Escherichia Coli)|aiec (adherent and invasive escherichia coli)
64220|NCT02882841|Mucosal Healing|mucosal healing
64221|NCT02882841|Non-invasive biomarkers|non-invasive biomarkers
64222|NCT02882815|IrisFIT PFO|irisfit pfo
64223|NCT02882802|anger|anger
64224|NCT02882802|aggression|aggression
64225|NCT02882763|Early intervention|early intervention
64226|NCT02882763|ECCE|ecce
64227|NCT02882763|Intervention study|intervention study
64228|NCT02882763|Child development|child development
64229|NCT02882763|At-risk families|at-risk families
64230|NCT02882763|Psychosocial stress|psychosocial stress
64231|NCT02882763|Prevention|prevention
64232|NCT02882763|Educational opportunities|educational opportunities
64233|NCT02882763|Randomized controlled trial|randomized controlled trial
64234|NCT02882763|Evaluation|evaluation
64235|NCT02882763|Parenting|parenting
64236|NCT02882763|Parent-child interaction|parent-child interaction
64237|NCT02882750|Lung Cancer|lung cancer
64238|NCT02882750|Quality of Life|quality of life
64239|NCT02882750|VATS|vats
64240|NCT02882750|SABR|sabr
64241|NCT02882698|Down syndrome|down syndrome
64242|NCT02882698|motor skills|motor skills
64243|NCT02882698|physiotherapy|physiotherapy
64244|NCT02882698|mobile telephone|mobile telephone
64245|NCT02882698|exposure to virtual reality therapy|exposure to virtual reality therapy
65893|NCT02872181|Maternal Position|maternal position
64246|NCT02882685|Roux-en-Y gastric bypass|roux-en-y gastric bypass
64247|NCT02882685|Mini-gastric bypass|mini-gastric bypass
64248|NCT02882685|Single anastomosis gastric bypass|single anastomosis gastric bypass
64249|NCT02882659|Clinical Trial, Phase I|clinical trial, phase i
64250|NCT02882646|stroke|stroke
64251|NCT02882646|cerebral palsy|cerebral palsy
64252|NCT02882646|rehabilitation|rehabilitation
64253|NCT02882646|robotics|robotics
64254|NCT02882646|therapy|therapy
64255|NCT02882646|bilateral|bilateral
64256|NCT02882633|lumbar plexus block|lumbar plexus block
64257|NCT02882633|fascia iliac block|fascia iliac block
64258|NCT02882633|quality of recovery score|quality of recovery score
64259|NCT02882633|pain score|pain score
64260|NCT02882620|Colorectal neoplasm|colorectal neoplasm
64261|NCT02882620|Screening|screening
64262|NCT02882620|Patient navigation|patient navigation
64263|NCT02882620|Randomized controlled trial|randomized controlled trial
64264|NCT02882620|Cost-benefit analysis|cost-benefit analysis
64265|NCT02882620|Health behavior|health behavior
64266|NCT02882620|Health equity|health equity
64267|NCT02882620|American Indians|american indians
64268|NCT02882620|Community-based participatory research|community-based participatory research
64269|NCT02882620|Fecal occult blood test|fecal occult blood test
64270|NCT02882607|HIV|hiv
64271|NCT02882607|Prevention|prevention
64272|NCT02882607|unintended pregnancy|unintended pregnancy
64273|NCT02882607|Malawi|malawi
64274|NCT02882607|adolescent women|adolescent women
64275|NCT02882607|community|community
64276|NCT02882607|rural|rural
64277|NCT02882581|Metformin|metformin
64278|NCT02882581|Pharmacokinetics|pharmacokinetics
64279|NCT02882581|Organic cation transporter|organic cation transporter
64280|NCT02882581|Multidrug and toxin extrusion|multidrug and toxin extrusion
64281|NCT02882581|Pharmacogenetics|pharmacogenetics
64282|NCT02882581|positron emission tomography|positron emission tomography
64283|NCT02882542|cerebral oxygen metabolism|cerebral oxygen metabolism
55796|NCT02936440|bioelectrical impedance analysis|bioelectrical impedance analysis
55797|NCT02936414|Berberine|berberine
55798|NCT02936414|Cytokine|cytokine
55799|NCT02936414|CRP|crp
55800|NCT02936414|Metabolism|metabolism
64284|NCT02882542|functional near-infrared spectroscopy|functional near-infrared spectroscopy
64285|NCT02882542|partial pressure of carbon dioxide|partial pressure of carbon dioxide
64286|NCT02882542|heart rate variability|heart rate variability
64287|NCT02882542|blood pressure|blood pressure
64288|NCT02882542|affect|affect
64289|NCT02882542|mood|mood
64290|NCT02882542|respiration|respiration
64291|NCT02882542|systematic randomized cross-over study|systematic randomized cross-over study
64292|NCT02882542|systemic physiology|systemic physiology
64293|NCT02882542|electro-dermal activity|electro-dermal activity
64294|NCT02882542|pulse-respiratory quotient|pulse-respiratory quotient
64295|NCT02882529|cerebral oxygen metabolism|cerebral oxygen metabolism
64296|NCT02882529|functional near-infrared spectroscopy|functional near-infrared spectroscopy
64297|NCT02882529|partial pressure of carbon dioxide|partial pressure of carbon dioxide
64298|NCT02882529|heart rate variability|heart rate variability
64299|NCT02882529|blood pressure|blood pressure
64300|NCT02882529|affect|affect
64301|NCT02882529|mood|mood
64302|NCT02882529|respiration|respiration
64303|NCT02882529|systematic randomized cross-over study|systematic randomized cross-over study
64304|NCT02882529|systemic physiology|systemic physiology
64305|NCT02882529|electro-dermal activity|electro-dermal activity
64504|NCT02881346|Plaque|plaque
64306|NCT02882529|pulse-respiratory quotient|pulse-respiratory quotient
64505|NCT02881346|Topical|topical
64307|NCT02882516|cerebral oxygen metabolism|cerebral oxygen metabolism
64308|NCT02882516|functional near-infrared spectroscopy|functional near-infrared spectroscopy
64309|NCT02882516|partial pressure of carbon dioxide|partial pressure of carbon dioxide
64310|NCT02882516|heart rate variability|heart rate variability
64311|NCT02882516|blood pressure|blood pressure
64312|NCT02882516|affect|affect
64313|NCT02882516|mood|mood
64314|NCT02882516|respiration|respiration
64315|NCT02882516|systematic randomized cross-over study|systematic randomized cross-over study
64316|NCT02882516|systemic physiology|systemic physiology
64317|NCT02882516|electro-dermal activity|electro-dermal activity
64318|NCT02882516|pulse-respiratory quotient|pulse-respiratory quotient
64319|NCT02882503|Endoscopic ultrasound|endoscopic ultrasound
64320|NCT02882503|Radiofrequency ablation|radiofrequency ablation
64321|NCT02882503|Pancreas|pancreas
64322|NCT02882490|Tourette syndrome|tourette syndrome
64323|NCT02882464|gingival recession|gingival recession
64324|NCT02882464|mucogingival surgery|mucogingival surgery
64325|NCT02882451|bile duct|bile duct
64326|NCT02882451|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
64327|NCT02882451|pinaverium bromide|pinaverium bromide
64328|NCT02882425|selexipag|selexipag
64329|NCT02882425|bioavailability|bioavailability
64330|NCT02882412|effectiveness|effectiveness
64331|NCT02882412|buprenorphine/naloxone|buprenorphine/naloxone
64332|NCT02882412|iatrogenic opioid dependence|iatrogenic opioid dependence
64333|NCT02882399|athletes|athletes
64334|NCT02882373|Hypertensive diseases|hypertensive diseases
64335|NCT02882373|Renal failure|renal failure
64336|NCT02882373|High blood pressure|high blood pressure
64337|NCT02882373|Proteinuria|proteinuria
64338|NCT02882373|L-Arginine|l-arginine
64339|NCT02882373|Placebo|placebo
64341|NCT02882334|Focal Dystonia|focal dystonia
64342|NCT02882334|Writer's cramp|writer's cramp
64343|NCT02882321|Malignant Tumor of Lymphoid Hemopoietic and Related Tissue|malignant tumor of lymphoid hemopoietic and related tissue
64344|NCT02882321|Acute myeloid leukemia|acute myeloid leukemia
64345|NCT02882321|AML|aml
64346|NCT02882321|Relapsed/Refractory|relapsed/refractory
64347|NCT02882321|IACS-010759|iacs-010759
64348|NCT02882321|Phone Call follow up|phone call follow up
64349|NCT02882282|Diseases of oral cavity salivary glands and jaws|diseases of oral cavity salivary glands and jaws
64350|NCT02882282|High risk oral intra-epithelial neoplasias|high risk oral intra-epithelial neoplasias
64351|NCT02882282|IEN|ien
64352|NCT02882282|Oral pre-malignant lesion(s)|oral pre-malignant lesion(s)
64353|NCT02882282|History of invasive oral cancer|history of invasive oral cancer
64354|NCT02882282|Pembrolizumab|pembrolizumab
64355|NCT02882282|Keytruda|keytruda
64356|NCT02882282|MK-3475|mk-3475
64357|NCT02882282|SCH-900475|sch-900475
64358|NCT02882282|Observation only|observation only
64359|NCT02882269|locally advanced colon cancer|locally advanced colon cancer
64360|NCT02882269|neoadjuvant chemotherapy|neoadjuvant chemotherapy
64361|NCT02882256|laceration|laceration
64362|NCT02882256|urinary tract infection|urinary tract infection
64363|NCT02882256|minor head injury|minor head injury
64364|NCT02882256|concussion|concussion
64365|NCT02882217|Double-blind|double-blind
64366|NCT02882217|Randomized|randomized
64367|NCT02882217|Dose-escalating|dose-escalating
64368|NCT02882217|Placebo-controlled|placebo-controlled
64369|NCT02882217|Phase I|phase i
625703|NCT00682825|BIS|bis
64370|NCT02882217|Healthy volunteers|healthy volunteers
64371|NCT02882217|Bronchial asthma|bronchial asthma
64372|NCT02882217|Histamine glutarimide|histamine glutarimide
64373|NCT02882217|EURRUS|eurrus
64374|NCT02882191|contraception|contraception
64375|NCT02882178|Prostate cancer|prostate cancer
64376|NCT02882178|cabazitaxel|cabazitaxel
64377|NCT02882178|consensus|consensus
64378|NCT02882178|conformity|conformity
64379|NCT02882178|prescription|prescription
64380|NCT02882178|conditions of use|conditions of use
64381|NCT02882165|COPD|copd
64382|NCT02882165|Early Intervention|early intervention
64383|NCT02882165|Risk|risk
64384|NCT02882165|Stratification|stratification
64385|NCT02882152|Analgesia|analgesia
64386|NCT02882152|Nerve Block|nerve block
64387|NCT02882152|Pain, Postoperative|pain, postoperative
64388|NCT02882139|Electrical storm|electrical storm
64390|NCT02882126|Subcutaneous Treprostinil|subcutaneous treprostinil
64391|NCT02882126|Remodulin|remodulin
64392|NCT02882126|6 Minute Walk Test|6 minute walk test
64393|NCT02882100|influenza|influenza
64394|NCT02882100|vaccine|vaccine
64395|NCT02882100|vaccination|vaccination
64396|NCT02882100|nursing home|nursing home
64397|NCT02882100|cluster randomized trial|cluster randomized trial
64398|NCT02882100|respiratory-related hospitalization|respiratory-related hospitalization
64399|NCT02882061|neck pain|neck pain
64400|NCT02882061|physical examination|physical examination
64401|NCT02882061|thoracic manipulation|thoracic manipulation
64402|NCT02882048|Opioid addiction|opioid addiction
64403|NCT02882048|Opioid weaning|opioid weaning
64404|NCT02882035|pain|pain
64405|NCT02882035|patient comfort|patient comfort
65316|NCT02876211|Klotho|klotho
64406|NCT02882022|Eustachian tube dysfunction|eustachian tube dysfunction
64407|NCT02882022|Audiometry|audiometry
64408|NCT02881996|appendicitis|appendicitis
64409|NCT02881996|pain|pain
64410|NCT02881996|perforation|perforation
64411|NCT02881983|alcohol use disorder|alcohol use disorder
64412|NCT02881983|emotion processing|emotion processing
64413|NCT02881983|abstinence|abstinence
64414|NCT02881983|sympathetic system|sympathetic system
64415|NCT02881983|parasympathetic system|parasympathetic system
64416|NCT02881957|critical illness|critical illness
64417|NCT02881957|craniocerebral trauma|craniocerebral trauma
64418|NCT02881957|intracranial aneurysm|intracranial aneurysm
64419|NCT02881957|spinal cord injuries|spinal cord injuries
64420|NCT02881957|seizures|seizures
64421|NCT02881957|meningitis|meningitis
64422|NCT02881957|stroke|stroke
64423|NCT02881957|vitamin d deficiency|vitamin d deficiency
64424|NCT02881957|cholecalciferol|cholecalciferol
64425|NCT02881957|intracranial hemorrhages|intracranial hemorrhages
64426|NCT02881944|Gulf War Illness|gulf war illness
64427|NCT02881944|Diet|diet
64428|NCT02881944|IBS|ibs
64429|NCT02881944|FODMAP|fodmap
64430|NCT02881931|Huntington's disease|huntington's disease
64431|NCT02881931|functional rating scale|functional rating scale
64432|NCT02881931|cognitive pre-testing|cognitive pre-testing
64433|NCT02881931|patient reported outcome (PRO)|patient reported outcome (pro)
64434|NCT02881931|HDGEC participant at Pre-Manifest stage|hdgec participant at pre-manifest stage
64435|NCT02881931|HDGEC participant at Early-Manifest stage|hdgec participant at early-manifest stage
64436|NCT02881931|Corresponding HDGEC participant companion|corresponding hdgec participant companion
64437|NCT02881892|CAPD|capd
66093|NCT02871050|CD|cd
64438|NCT02881892|Peritoneal solute transport rate|peritoneal solute transport rate
64439|NCT02881892|Dialysis adequacy|dialysis adequacy
64440|NCT02881866|Air hunger|air hunger
64441|NCT02881866|Work/effort|work/effort
64442|NCT02881866|Aerosolized|aerosolized
64443|NCT02881866|Hypercapnia|hypercapnia
64444|NCT02881866|Resistive load|resistive load
64445|NCT02881866|Nebulised|nebulised
64447|NCT02881853|atopic|atopic
64448|NCT02881827|Saliva|saliva
64449|NCT02881827|Low-level laser therapy|low-level laser therapy
64450|NCT02881827|Masseter muscle|masseter muscle
64451|NCT02881827|Salivary glands|salivary glands
64452|NCT02881814|Lung ultrasound|lung ultrasound
64453|NCT02881814|Chest physiotherapy|chest physiotherapy
64454|NCT02881814|Decision-making process|decision-making process
64455|NCT02881814|Diagnostic|diagnostic
64456|NCT02881801|accelerometry|accelerometry
64457|NCT02881775|TMS|tms
64458|NCT02881775|rTMS|rtms
64459|NCT02881775|corticospinal|corticospinal
64460|NCT02881775|quadriceps|quadriceps
64461|NCT02881762|hepatitis C virus (HCV)|hepatitis c virus (hcv)
64462|NCT02881762|Maraviroc|maraviroc
64463|NCT02881762|Human immunodeficiency virus (HCV)|human immunodeficiency virus (hcv)
64464|NCT02881671|genetic|genetic
64465|NCT02881671|congenital atrioventricular block|congenital atrioventricular block
64466|NCT02881671|progressive Cardiac Conduction Disease|progressive cardiac conduction disease
64467|NCT02881658|Plant sterols|plant sterols
74550|NCT02817698|smoking|smoking
56004|NCT02934984|DNA|dna
64468|NCT02881658|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
64469|NCT02881658|Phytosterols|phytosterols
64470|NCT02881658|Soya Beverage|soya beverage
64471|NCT02881645|Intensive care units|intensive care units
64472|NCT02881645|Nursing Care|nursing care
64473|NCT02881645|Critical incidents|critical incidents
64474|NCT02881645|Best practices|best practices
64475|NCT02881619|Tooth bleaching|tooth bleaching
64476|NCT02881593|Operating in Minimally Invasive|operating in minimally invasive
64477|NCT02881567|Multiple Sclerosis|multiple sclerosis
64478|NCT02881567|Daclizumab|daclizumab
64479|NCT02881567|Tysabri-Switch|tysabri-switch
64480|NCT02881528|Type 1 Diabetes|type 1 diabetes
64481|NCT02881528|Juvenile Diabetes|juvenile diabetes
64482|NCT02881502|granulocyte activation|granulocyte activation
64484|NCT02881502|severe asthma|severe asthma
64485|NCT02881437|Primary Immunodeficiency|primary immunodeficiency
64486|NCT02881437|SubCutaneous Immunoglobulins|subcutaneous immunoglobulins
64487|NCT02881424|Familiarity|familiarity
64488|NCT02881424|Recollection|recollection
64489|NCT02881424|Face Recognition|face recognition
64490|NCT02881424|Alcohol dependence|alcohol dependence
64491|NCT02881424|Social cognition|social cognition
64492|NCT02881411|self-soft tissue therapy|self-soft tissue therapy
64493|NCT02881411|trigger points|trigger points
64494|NCT02881411|feasibility study|feasibility study
64495|NCT02881398|Mobile Health|mobile health
64496|NCT02881398|Telemedicine|telemedicine
64497|NCT02881398|Pocket-Echocardiography|pocket-echocardiography
64498|NCT02881385|Synchrony|synchrony
64499|NCT02881385|Pressure Support Ventilation|pressure support ventilation
64500|NCT02881372|oral food desensitization|oral food desensitization
64501|NCT02881372|food elimination|food elimination
64502|NCT02881372|food reintroduction|food reintroduction
64503|NCT02881346|Psoriasis vulgaris|psoriasis vulgaris
64506|NCT02881346|Calcipotriol|calcipotriol
64507|NCT02881346|Foam|foam
64508|NCT02881346|Spray|spray
64509|NCT02881307|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
64510|NCT02881307|Musculoskeletal Ultrasound (MSUS)|musculoskeletal ultrasound (msus)
64511|NCT02881255|implantable cardioverter defibrillator|implantable cardioverter defibrillator
64512|NCT02881255|subcutaneous ICD|subcutaneous icd
64513|NCT02881255|transvenous ICD|transvenous icd
64514|NCT02881255|inherited arrhythmia syndrome|inherited arrhythmia syndrome
64515|NCT02881203|breast cancer|breast cancer
64516|NCT02881203|radiation|radiation
64517|NCT02881203|DIBH|dibh
64518|NCT02881203|cardiac toxicity|cardiac toxicity
64519|NCT02881177|oxytocin|oxytocin
64520|NCT02881177|tolerability|tolerability
64521|NCT02881177|HIV|hiv
64522|NCT02881177|men who have sex with men (MSM)|men who have sex with men (msm)
64523|NCT02881177|addiction|addiction
64524|NCT02881164|Glycemia|glycemia
64525|NCT02881164|Satiety|satiety
64526|NCT02881164|Insulin|insulin
64527|NCT02881164|Breakfast|breakfast
64528|NCT02881164|Low glycemic index|low glycemic index
64529|NCT02881164|High glycemic index|high glycemic index
64530|NCT02881151|Deep brain stimulation|deep brain stimulation
64531|NCT02881151|DBS|dbs
64532|NCT02881151|Central thalamus|central thalamus
64533|NCT02881151|TBI|tbi
64534|NCT02881151|Traumatic brain injury|traumatic brain injury
64535|NCT02881086|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
64536|NCT02881086|Lymphoblastic lymphoma|lymphoblastic lymphoma
64537|NCT02881086|Nelarabine|nelarabine
64538|NCT02881086|BCR-ABL|bcr-abl
64539|NCT02881086|MRD|mrd
64540|NCT02881086|PEG-Asparaginase|peg-asparaginase
64541|NCT02881086|Rituximab|rituximab
64542|NCT02881073|Placental Growth Factor|placental growth factor
64543|NCT02881073|Maternal Morbidity|maternal morbidity
64544|NCT02881073|Neonatal Morbidity|neonatal morbidity
64545|NCT02881073|Pre-eclampsia|pre-eclampsia
64546|NCT02881073|Heath Economics|heath economics
64547|NCT02881060|Glucagon|glucagon
64548|NCT02881060|Ethanol|ethanol
64549|NCT02881034|Anemia|anemia
64550|NCT02881034|Antiviral Agents|antiviral agents
64551|NCT02881034|Glomerular Filtration Rate|glomerular filtration rate
64552|NCT02881034|Hepatitis C|hepatitis c
64553|NCT02881034|Ribavirin|ribavirin
64554|NCT02881034|Telaprevir|telaprevir
64555|NCT02881021|elastic tape|elastic tape
64556|NCT02881021|kinesiology taping|kinesiology taping
64557|NCT02881021|physiotherapy|physiotherapy
64558|NCT02881021|rotator cuff|rotator cuff
64559|NCT02881021|shoulder pain|shoulder pain
64560|NCT02881021|tendon injuries|tendon injuries
64561|NCT02880995|dopamine receptor occupancy|dopamine receptor occupancy
64562|NCT02880995|antipsychotics|antipsychotics
64563|NCT02880995|positron emission tomography|positron emission tomography
64565|NCT02880956|Nervous system diseases|nervous system diseases
64566|NCT02880956|Memory loss|memory loss
64567|NCT02880956|Mild Alzheimer's Disease (AD)|mild alzheimer's disease (ad)
64568|NCT02880956|Early Alzheimer's Disease|early alzheimer's disease
64569|NCT02880956|Early dementia|early dementia
64570|NCT02880956|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
64571|NCT02880956|AD|ad
64572|NCT02880956|Tauopathies|tauopathies
64573|NCT02880956|Neurodegenerative diseases|neurodegenerative diseases
64574|NCT02880930|vitamin D|vitamin d
64575|NCT02880917|Attention|attention
64576|NCT02880917|Memory (short and long-term)|memory (short and long-term)
64577|NCT02880917|Conflict monitoring tasks|conflict monitoring tasks
64578|NCT02880917|Verbal fluency|verbal fluency
64579|NCT02880878|Subcortical Intracerebral Hemorrhage|subcortical intracerebral hemorrhage
64580|NCT02880878|Intracerebral Hemorrhage|intracerebral hemorrhage
64581|NCT02880878|Intracranial Hemorrhages|intracranial hemorrhages
64582|NCT02880878|ICH|ich
64583|NCT02880878|Hemorrhage|hemorrhage
64584|NCT02880878|Cerebrovascular Disorders|cerebrovascular disorders
64585|NCT02880878|Brain Diseases|brain diseases
64586|NCT02880878|Central Nervous System Diseases|central nervous system diseases
64587|NCT02880878|Nervous System Diseases|nervous system diseases
64588|NCT02880878|Vascular Diseases|vascular diseases
64589|NCT02880878|Cardiovascular Diseases|cardiovascular diseases
64590|NCT02880878|Pathologic Processes|pathologic processes
64591|NCT02880878|MIPS|mips
64592|NCT02880878|Minimally Invasive Parafascicular Surgery|minimally invasive parafascicular surgery
64593|NCT02880878|Neurosurgery|neurosurgery
64594|NCT02880878|Medical Economic|medical economic
64595|NCT02880878|Hospital Economics|hospital economics
64596|NCT02880865|vaccine|vaccine
64597|NCT02880852|Systemic Lupus Erythematosus|systemic lupus erythematosus
64598|NCT02880852|Belimumab|belimumab
64599|NCT02880852|Pharmacodynamics|pharmacodynamics
64600|NCT02880852|safety tolerability|safety tolerability
64601|NCT02880852|Pharmacokinetics|pharmacokinetics
64602|NCT02880852|Chinese subjects|chinese subjects
64603|NCT02880800|Analgesia, Patient-Controlled|analgesia, patient-controlled
64604|NCT02880800|Analgesics, Opioid|analgesics, opioid
64606|NCT02880774|Temporomandibular Joint Disorders|temporomandibular joint disorders
64607|NCT02880774|Mandibular Movement|mandibular movement
64608|NCT02880774|Músculoesqueléticas Manipulations|músculoesqueléticas manipulations
64609|NCT02880774|Modalities of Physiotherapy.|modalities of physiotherapy.
64610|NCT02880761|hemodialysis|hemodialysis
64611|NCT02880761|chronic renal failure|chronic renal failure
64612|NCT02880761|arteriovenous fistulae|arteriovenous fistulae
64613|NCT02880748|Water exchange colonoscopy|water exchange colonoscopy
64614|NCT02880748|Adenoma miss rate|adenoma miss rate
64616|NCT02880735|Myotonic Dystrophy|myotonic dystrophy
64617|NCT02880735|Noninvasive Ventilation|noninvasive ventilation
64618|NCT02880735|Respiratory Failure|respiratory failure
64619|NCT02880722|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
64620|NCT02880722|Experience Sampling Method (ESM)|experience sampling method (esm)
64621|NCT02880722|Ecological Momentary Assessment (EMA)|ecological momentary assessment (ema)
64622|NCT02880722|Abdominal pain|abdominal pain
64623|NCT02880696|Time Perception|time perception
64624|NCT02880696|Tactile Perception|tactile perception
64625|NCT02880696|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
64626|NCT02880683|Electrical Stimulation Therapy|electrical stimulation therapy
64627|NCT02880683|Parasympathetic Nervous System|parasympathetic nervous system
64628|NCT02880683|Sympathetic Fibers|sympathetic fibers
64629|NCT02880683|Post Ganglionic|post ganglionic
64630|NCT02880683|Congestive Heart Failure|congestive heart failure
64631|NCT02880683|Heart Failure|heart failure
64632|NCT02880670|Rheumatoid|rheumatoid
64633|NCT02880657|superoxide dismutase|superoxide dismutase
64634|NCT02880657|melon concentrate|melon concentrate
64635|NCT02880657|oxidative stress|oxidative stress
64636|NCT02880657|physical training|physical training
64637|NCT02880644|Central retinal vein occlusion|central retinal vein occlusion
64639|NCT02880644|CRVO|crvo
64640|NCT02880618|Heart Failure|heart failure
64641|NCT02880618|Reduced ejection fraction|reduced ejection fraction
64642|NCT02880540|Adolescent|adolescent
64643|NCT02880540|Bariatric|bariatric
64644|NCT02880540|Obesity|obesity
64645|NCT02880540|Pain|pain
64646|NCT02880540|Opiate-sparing|opiate-sparing
64647|NCT02880475|Moderate to severe chronic non-malignant pain|moderate to severe chronic non-malignant pain
64648|NCT02880462|schizophrenia|schizophrenia
64649|NCT02880462|sulforaphane|sulforaphane
64650|NCT02880423|salpingectomy|salpingectomy
64651|NCT02880423|cesarean section|cesarean section
64652|NCT02880423|tubal ligation|tubal ligation
64653|NCT02880423|morbidity|morbidity
64654|NCT02880410|Glioblastoma|glioblastoma
64655|NCT02880410|NeuroBlate|neuroblate
64656|NCT02880410|LITT|litt
64657|NCT02880410|Quality of Life|quality of life
64659|NCT02880371|Advanced Solid Tumors|advanced solid tumors
64660|NCT02880371|Pembrolizumab|pembrolizumab
64661|NCT02880371|ARRY-382|arry-382
64662|NCT02880332|Chronic pain|chronic pain
64663|NCT02880332|Endogenous Pain Processing|endogenous pain processing
64664|NCT02880332|Central sensitization|central sensitization
64665|NCT02880332|Pain neuroscience education|pain neuroscience education
64666|NCT02880319|Bone Cancer|bone cancer
64667|NCT02880293|transplant conditioning|transplant conditioning
64668|NCT02880293|KIR/HLA based haploidentical donor selection|kir/hla based haploidentical donor selection
64669|NCT02880293|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
64670|NCT02880254|body mass index change|body mass index change
64671|NCT02880254|weight loss|weight loss
64672|NCT02880254|patient compliance|patient compliance
64673|NCT02880202|Massage Therapy|massage therapy
64674|NCT02880202|Hospice|hospice
64675|NCT02880202|Integrative Medicine|integrative medicine
64676|NCT02880202|Palliative Care|palliative care
64677|NCT02880202|Caregivers|caregivers
64678|NCT02880189|Obesity NOS|obesity nos
64679|NCT02880189|NASH|nash
64680|NCT02880189|NASH with Fibrosis|nash with fibrosis
64681|NCT02880189|Intragastric Balloon|intragastric balloon
64682|NCT02880189|ORBERA|orbera
64683|NCT02880189|ORBERA Intragastric Balloon|orbera intragastric balloon
64684|NCT02880176|Behavioral Economics|behavioral economics
64685|NCT02880176|Financial Incentives|financial incentives
64686|NCT02880176|Bladder Cancer|bladder cancer
64687|NCT02880176|Ambulation|ambulation
64688|NCT02880176|Surgical Co-Morbidity|surgical co-morbidity
64689|NCT02880176|Fitbit|fitbit
64690|NCT02880176|Mobile Health|mobile health
64691|NCT02880176|Radical Cystectomy|radical cystectomy
64692|NCT02880150|elite climbers|elite climbers
64693|NCT02880150|near infrared spectroscopy|near infrared spectroscopy
64694|NCT02880124|Isotope Labeling, Stable|isotope labeling, stable
64695|NCT02880124|Exercise, Physical|exercise, physical
64696|NCT02880124|Calorimetry, Indirect|calorimetry, indirect
64697|NCT02880124|Athletic Performance|athletic performance
64698|NCT02880124|Sugar Maple|sugar maple
64699|NCT02880111|Malignant Brain Tumor|malignant brain tumor
64700|NCT02880111|patient sputum|patient sputum
64701|NCT02880098|Neonatology|neonatology
64702|NCT02880098|Troponin T|troponin t
64703|NCT02880098|Standards|standards
64704|NCT02880059|Sleep Apnea, Aneurysm, Subarachnoid Hemorrhage, Blood Pressure.|sleep apnea, aneurysm, subarachnoid hemorrhage, blood pressure.
64705|NCT02880046|immune response|immune response
64706|NCT02880046|T lymphocyte|t lymphocyte
64707|NCT02880046|PD-1/PDL-1 pathway|pd-1/pdl-1 pathway
64708|NCT02880033|Parkinson's disease|parkinson's disease
64709|NCT02880033|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
64710|NCT02880033|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
64711|NCT02880033|ex vivo model for oxidative stress|ex vivo model for oxidative stress
64712|NCT02880033|iron metabolism and chelation|iron metabolism and chelation
64713|NCT02880007|Pulsed dose-rate brachytherapy|pulsed dose-rate brachytherapy
64714|NCT02880007|3D dosimetry|3d dosimetry
64715|NCT02880007|Prospective Studies|prospective studies
64716|NCT02880007|Radiotherapy Dosage|radiotherapy dosage
64717|NCT02880007|Uterine Cervical Neoplasms/radiotherapy|uterine cervical neoplasms/radiotherapy
64718|NCT02880007|Brachytherapy/methods|brachytherapy/methods
64719|NCT02879968|serum squamous cell carcinoma antigen|serum squamous cell carcinoma antigen
64720|NCT02879968|tumor volume|tumor volume
64721|NCT02879968|Head and Neck Cancer|head and neck cancer
64722|NCT02879955|Glucagon-Like Peptide 1|glucagon-like peptide 1
64723|NCT02879955|Carbohydrates|carbohydrates
64724|NCT02879955|Gastric bypass|gastric bypass
64725|NCT02879955|Bariatric Surgery|bariatric surgery
64726|NCT02879955|Overweight|overweight
64727|NCT02879942|Placental volume|placental volume
64728|NCT02879942|First-trimester screening|first-trimester screening
64729|NCT02879942|Ultrasound|ultrasound
64730|NCT02879942|Preeclampsia|preeclampsia
64731|NCT02879942|Intrauterine growth restriction|intrauterine growth restriction
66384|NCT02869035|MDD|mdd
64732|NCT02879942|Biochemical markers|biochemical markers
64733|NCT02879942|Uterine artery doppler|uterine artery doppler
64734|NCT02879929|chronic nasal dysfunction|chronic nasal dysfunction
64735|NCT02879929|Quality of life|quality of life
64737|NCT02879929|self-reporting questionnaire|self-reporting questionnaire
64738|NCT02879929|development|development
64739|NCT02879929|validation|validation
64740|NCT02879903|Porphyromonas gingivalis|porphyromonas gingivalis
64741|NCT02879903|Periodontal treatment|periodontal treatment
64742|NCT02879903|Smokers|smokers
64743|NCT02879877|First in human|first in human
64744|NCT02879877|subjects|subjects
64745|NCT02879864|fatigue|fatigue
64746|NCT02879864|tiredness|tiredness
64747|NCT02879864|luxo therapy|luxo therapy
64748|NCT02879864|therapy by light|therapy by light
64749|NCT02879851|ultrasound|ultrasound
64750|NCT02879851|Koelis system|koelis system
64751|NCT02879851|MRI|mri
64752|NCT02879851|gold grain|gold grain
64753|NCT02879825|Ventricular Premature Complexes|ventricular premature complexes
64754|NCT02879812|Transplantation Surgery|transplantation surgery
64755|NCT02879812|Nephrology|nephrology
64756|NCT02879812|Organ and Tissue Transplantation|organ and tissue transplantation
74950|NCT02815293|EDE|ede
56314|NCT02933008|ACL|acl
64757|NCT02879799|Family-centered care|family-centered care
64758|NCT02879799|Family-integrated care|family-integrated care
64759|NCT02879799|Neonatal intensive care unit|neonatal intensive care unit
64760|NCT02879799|Premature|premature
64761|NCT02879799|Infant|infant
64762|NCT02879773|Respiratory Function Tests|respiratory function tests
64763|NCT02879773|Computed tomography|computed tomography
64764|NCT02879773|Thoracic surgical procedures|thoracic surgical procedures
64765|NCT02879773|Diagnosis|diagnosis
64766|NCT02879760|Lung|lung
64767|NCT02879760|Cancer|cancer
64768|NCT02879760|Chemotherapy|chemotherapy
64769|NCT02879760|Oncolytic virus|oncolytic virus
64770|NCT02879760|Immunotherapy|immunotherapy
64771|NCT02879760|Pembrolizumab|pembrolizumab
64772|NCT02879760|Keytruda|keytruda
64773|NCT02879747|treatment|treatment
64774|NCT02879747|growth hormone|growth hormone
64775|NCT02879747|childhood|childhood
64776|NCT02879747|short stature|short stature
64777|NCT02879734|peritoneal dialysis|peritoneal dialysis
64778|NCT02879734|laparoscopy|laparoscopy
64779|NCT02879734|omentum|omentum
64780|NCT02879721|Gastrointestinal|gastrointestinal
64781|NCT02879708|Social Accountability|social accountability
64782|NCT02879708|Healthcare Quality|healthcare quality
64783|NCT02879708|Health System Strengthening|health system strengthening
64784|NCT02879708|Child Health|child health
64785|NCT02879708|Childhood pneumonia|childhood pneumonia
64786|NCT02879708|Childhood diarrhea|childhood diarrhea
64787|NCT02879682|glioma|glioma
64788|NCT02879682|brain metastases|brain metastases
64789|NCT02879682|nTMS|ntms
64790|NCT02879630|pharmacokinetics|pharmacokinetics
64791|NCT02879630|acyclovir|acyclovir
64792|NCT02879552|Upper blepharoplasty|upper blepharoplasty
64793|NCT02879552|brassiere sutures|brassiere sutures
64794|NCT02879552|tarsal platform show|tarsal platform show
64795|NCT02879552|eyeshadow space|eyeshadow space
64796|NCT02879552|brow fat span|brow fat span
64797|NCT02879539|cochlear implants, power consumption,|cochlear implants, power consumption,
64798|NCT02879526|Relapse/Refratory Peripheral T Cell Lymphoma|relapse/refratory peripheral t cell lymphoma
64799|NCT02879526|Chidamide|chidamide
64903|NCT02878720|non-invasive vagus nerve stimulation|non-invasive vagus nerve stimulation
64800|NCT02879526|Cyclophosphamide、Prednisone、Thalidomide(CPT)|cyclophosphamide、prednisone、thalidomide(cpt)
64801|NCT02879500|Systematic review and meta-analysis|systematic review and meta-analysis
64802|NCT02879500|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
64803|NCT02879500|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
64804|NCT02879500|Clinical practice guidelines|clinical practice guidelines
64805|NCT02879500|Randomized controlled trials|randomized controlled trials
64806|NCT02879500|Prospective cohort studies|prospective cohort studies
64807|NCT02879500|Body weight|body weight
64808|NCT02879500|Body mass index|body mass index
64809|NCT02879500|Adiposity|adiposity
64810|NCT02879500|Overweight|overweight
64811|NCT02879500|Obesity|obesity
64812|NCT02879461|SURGERY|surgery
64813|NCT02879461|REHABILITATION|rehabilitation
64814|NCT02879448|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
64815|NCT02879448|Left Atrial Appendage|left atrial appendage
64816|NCT02879409|HbA1c variability|hba1c variability
64817|NCT02879409|Diabetes Mellitus Type 2|diabetes mellitus type 2
64818|NCT02879409|Diabetes microvascular complications|diabetes microvascular complications
64819|NCT02879409|Diabetes macrovascular complications|diabetes macrovascular complications
64820|NCT02879396|Older adults|older adults
64821|NCT02879396|Avoidable admissions|avoidable admissions
64822|NCT02879396|Assisted living home|assisted living home
64823|NCT02879396|Emergency service calls|emergency service calls
64824|NCT02879396|Heading Assisted Living Facilities|heading assisted living facilities
64825|NCT02879383|Type 2 Diabetes|type 2 diabetes
64826|NCT02879370|Anastomotic Leak|anastomotic leak
64827|NCT02879370|Rectal cancer|rectal cancer
64831|NCT02879357|advanced care planning|advanced care planning
64832|NCT02879357|palliative care|palliative care
64833|NCT02879331|pulmonary emphysema|pulmonary emphysema
64834|NCT02879331|coils|coils
64835|NCT02879331|cycloergometry|cycloergometry
64836|NCT02879331|lung volume reduction|lung volume reduction
64837|NCT02879305|erythropoiesis stimulating agents|erythropoiesis stimulating agents
64838|NCT02879305|GSK1278863|gsk1278863
64839|NCT02879305|daprodustat|daprodustat
64840|NCT02879305|anemia|anemia
64841|NCT02879305|chronic kidney disease|chronic kidney disease
64842|NCT02879305|hemoglobin|hemoglobin
64843|NCT02879305|recombinant human erythropoietin|recombinant human erythropoietin
64844|NCT02879292|Pyloric stenosis spinal anesthesia postoperative pain|pyloric stenosis spinal anesthesia postoperative pain
64845|NCT02879279|Stroke|stroke
64846|NCT02879279|Upper limb|upper limb
64847|NCT02879279|Robotic rehabilitation|robotic rehabilitation
64848|NCT02879266|Dengue Vaccine|dengue vaccine
64849|NCT02879188|degenerative joint disease|degenerative joint disease
64850|NCT02879188|total knee arthroplasty|total knee arthroplasty
64851|NCT02879188|physical therapy|physical therapy
64852|NCT02879188|arthroplasty, replacement, knee|arthroplasty, replacement, knee
64853|NCT02879149|Ankle Fusions|ankle fusions
64854|NCT02879149|AUGMENT® Bone Graft|augment® bone graft
64855|NCT02879149|Autologous Bone Graft|autologous bone graft
64856|NCT02879149|arthritis|arthritis
64857|NCT02879149|ankle pain|ankle pain
64858|NCT02879149|foot pain|foot pain
64859|NCT02879149|hindfoot fracture|hindfoot fracture
64860|NCT02879149|ankle fracture|ankle fracture
64861|NCT02879136|Gait|gait
64862|NCT02879136|Balance|balance
64864|NCT02879110|Sulforaphane|sulforaphane
64865|NCT02879110|clinic trial|clinic trial
64866|NCT02879110|Autism Spectrum Disorder|autism spectrum disorder
64867|NCT02879110|Efficacy|efficacy
64868|NCT02879110|Safety|safety
64869|NCT02879110|Mechanism|mechanism
64870|NCT02879032|Treadmill Scores|treadmill scores
64871|NCT02879032|Coronary Angiogram|coronary angiogram
64872|NCT02879032|Coronary Artery Disease|coronary artery disease
64873|NCT02879006|Chinese herbal therapy|chinese herbal therapy
64874|NCT02879006|Oral immunotherapy|oral immunotherapy
64875|NCT02879006|Food allergy|food allergy
64876|NCT02879006|Omalizumab|omalizumab
64877|NCT02878928|Pharmacogenetic testing|pharmacogenetic testing
64879|NCT02878928|Depression|depression
64880|NCT02878928|Neuropsychiatric diseases|neuropsychiatric diseases
64881|NCT02878928|IDgenetix|idgenetix
64882|NCT02878928|AltheaDx|altheadx
64883|NCT02878902|emergency|emergency
64884|NCT02878902|coordination|coordination
64885|NCT02878902|dialysis|dialysis
64886|NCT02878824|Neurophysiology|neurophysiology
64887|NCT02878824|Autonomic|autonomic
64888|NCT02878824|Sensory|sensory
64889|NCT02878824|Child|child
64890|NCT02878824|Ethnicity|ethnicity
64891|NCT02878824|Environment|environment
64892|NCT02878811|heart failure|heart failure
64893|NCT02878811|prospective|prospective
64894|NCT02878811|cohort|cohort
64895|NCT02878785|AML|aml
64896|NCT02878746|Mirror therapy|mirror therapy
64897|NCT02878746|Proprioception|proprioception
64898|NCT02878746|Rehabilitation|rehabilitation
64899|NCT02878746|Stroke|stroke
64900|NCT02878746|Hemiplegia|hemiplegia
64901|NCT02878720|ischemic stroke|ischemic stroke
64902|NCT02878720|hemorrhagic chronic|hemorrhagic chronic
65315|NCT02876211|Iron|iron
64904|NCT02878720|robot-assisted rehabilitation|robot-assisted rehabilitation
64905|NCT02878681|Diabetic Macular Edema.|diabetic macular edema.
64906|NCT02878668|procalcitonin|procalcitonin
64907|NCT02878668|post-operative|post-operative
64908|NCT02878668|complication|complication
64909|NCT02878668|CRP|crp
64910|NCT02878655|N0 clinical and radiological|n0 clinical and radiological
64911|NCT02878655|dissection IIb sector|dissection iib sector
64912|NCT02878564|Schistosomiasis mansoni|schistosomiasis mansoni
64913|NCT02878564|HIV susceptibility|hiv susceptibility
64914|NCT02878564|Genital immunology|genital immunology
64915|NCT02878564|Mucosal immunology|mucosal immunology
64916|NCT02878564|HIV entry assay|hiv entry assay
64917|NCT02878564|Adult women|adult women
64918|NCT02878512|Segmental Epidural|segmental epidural
64919|NCT02878512|Regional Anesthesia for PCNL|regional anesthesia for pcnl
64920|NCT02878499|autism|autism
64921|NCT02878499|autism spectrum disorder|autism spectrum disorder
64922|NCT02878499|ASD|asd
64923|NCT02878499|sleep|sleep
64924|NCT02878499|Circadian|circadian
64925|NCT02878499|Biological rhythms|biological rhythms
64926|NCT02878499|melatonin|melatonin
64927|NCT02878499|Cognition|cognition
64928|NCT02878499|Behavior|behavior
64930|NCT02878499|Longitudinal accelerated design|longitudinal accelerated design
64931|NCT02878486|Physical activity|physical activity
64932|NCT02878486|Alzheimer's disease|alzheimer's disease
64933|NCT02878486|cognitive impairment|cognitive impairment
64934|NCT02878486|sedentary behavior|sedentary behavior
64935|NCT02878486|insulin sensitivity|insulin sensitivity
64936|NCT02878447|Haemoptysis|haemoptysis
64937|NCT02878447|Radiotherapy|radiotherapy
64938|NCT02878447|Tuberculosis|tuberculosis
64939|NCT02878447|Aspergilloma|aspergilloma
64940|NCT02878447|Bronchiectasis|bronchiectasis
64941|NCT02878434|Cancer|cancer
64942|NCT02878434|Fertility|fertility
64943|NCT02878434|Pregnancy|pregnancy
64944|NCT02878434|Chemotherapy|chemotherapy
64945|NCT02878434|Radiotherapy|radiotherapy
64946|NCT02878434|Long term|long term
64947|NCT02878434|Follow up|follow up
64948|NCT02878395|genomics|genomics
64949|NCT02878395|epigenomics|epigenomics
64950|NCT02878395|recurrence|recurrence
64951|NCT02878382|PDT|pdt
64952|NCT02878382|skin cancer|skin cancer
64953|NCT02878382|calcipotriol|calcipotriol
64954|NCT02878369|fluid replacement|fluid replacement
64955|NCT02878356|Motivational Interviewing, Clinical supervision, Education|motivational interviewing, clinical supervision, education
64956|NCT02878330|Respiratory Syncytial Virus, RSV|respiratory syncytial virus, rsv
64957|NCT02878330|Preterm Infants|preterm infants
64958|NCT02878330|Lower Respiratory Tract Infection|lower respiratory tract infection
64962|NCT02878304|Prognosis|prognosis
64963|NCT02878304|Hand function|hand function
64964|NCT02878304|Rehabilitation|rehabilitation
64965|NCT02878304|Spasticity|spasticity
64966|NCT02878304|MRI|mri
64967|NCT02878278|Chidamide|chidamide
64968|NCT02878278|Administration method|administration method
64969|NCT02878265|malaria|malaria
64970|NCT02878265|vitamin A|vitamin a
64971|NCT02878265|Zinc|zinc
64972|NCT02878265|Multivitamin|multivitamin
64973|NCT02878252|COPD, Asthma, ACOS|copd, asthma, acos
64974|NCT02878239|knee osteoarthritis|knee osteoarthritis
64975|NCT02878239|gait|gait
64976|NCT02878239|Kellgren-Lawrence Scores|kellgren-lawrence scores
64977|NCT02878161|rheumatoid arthritis|rheumatoid arthritis
64978|NCT02878161|tumor necrosis factor α inhibitor|tumor necrosis factor α inhibitor
64979|NCT02878161|predictive|predictive
64980|NCT02878161|iTRAQ|itraq
64981|NCT02878161|signal pathway|signal pathway
64982|NCT02878148|Nephrolithiasis|nephrolithiasis
64983|NCT02878148|Ureteral stone|ureteral stone
64984|NCT02878148|Acute renal colic|acute renal colic
64985|NCT02878148|Ultrasonography|ultrasonography
64986|NCT02878148|Computed tomography|computed tomography
64987|NCT02878148|Diagnosis|diagnosis
64988|NCT02878122|ovarian cancer|ovarian cancer
64989|NCT02878122|chemo resistance|chemo resistance
64990|NCT02878122|predictive factors|predictive factors
64991|NCT02878122|cohort study|cohort study
64992|NCT02878122|bio bank|bio bank
64993|NCT02878109|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
64994|NCT02878109|Transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
64995|NCT02878096|nocturnal polyuria|nocturnal polyuria
64996|NCT02878083|vedolizumab,|vedolizumab,
64997|NCT02878083|confocal endomicroscopy|confocal endomicroscopy
64998|NCT02878083|biomarker|biomarker
64999|NCT02878083|ULCERATIVE COLITIS|ulcerative colitis
65000|NCT02878070|Spinal Cord Injuries|spinal cord injuries
65001|NCT02878070|Telemedicine|telemedicine
65002|NCT02878070|Health Behaviors|health behaviors
65003|NCT02878057|Apatinib|apatinib
65004|NCT02878057|HER-2 Negative|her-2 negative
65005|NCT02878057|Chest wall Metastasis|chest wall metastasis
65006|NCT02878057|Multicenter Phase II Study|multicenter phase ii study
65007|NCT02878057|Breast cancer|breast cancer
65008|NCT02878044|Shared Decision Making, Decision Aid|shared decision making, decision aid
65009|NCT02878031|Integrated Community Case Management|integrated community case management
65010|NCT02878031|Community Health Worker|community health worker
65011|NCT02878031|Nigeria|nigeria
65012|NCT02878018|Cohort Study|cohort study
65013|NCT02878018|Children|children
65014|NCT02878018|Henoch-Schonlein Purpura Nephritis|henoch-schonlein purpura nephritis
65015|NCT02878018|Diagnosis and Treatment of Traditional Chinese Medicine|diagnosis and treatment of traditional chinese medicine
65016|NCT02878005|Intubating Laryngeal Tube|intubating laryngeal tube
65017|NCT02878005|blind intubation|blind intubation
65018|NCT02878005|fiberoptic|fiberoptic
65019|NCT02877992|Infertility|infertility
65020|NCT02877992|Tachykinin|tachykinin
65021|NCT02877992|Kisspeptin|kisspeptin
65022|NCT02877940|ProSeal LMA|proseal lma
65023|NCT02877940|LTS-D|lts-d
65024|NCT02877940|i-gel|i-gel
65025|NCT02877914|heart failure, retrospective|heart failure, retrospective
65026|NCT02877888|cost effectiveness|cost effectiveness
65027|NCT02877888|fluoride varnish|fluoride varnish
65028|NCT02877888|dental caries|dental caries
65029|NCT02877875|anxiety|anxiety
65030|NCT02877875|depression|depression
65031|NCT02877875|trauma|trauma
65032|NCT02877875|behavior problems|behavior problems
65033|NCT02877875|evidence-based treatments|evidence-based treatments
65034|NCT02877875|manualized treatments|manualized treatments
65035|NCT02877875|cognitive-behavioral therapy|cognitive-behavioral therapy
65036|NCT02877875|youth|youth
65037|NCT02877875|mental health|mental health
65038|NCT02877849|fMRI|fmri
65039|NCT02877849|brain networks|brain networks
65040|NCT02877849|biomarker|biomarker
65041|NCT02877849|relapse|relapse
65042|NCT02877849|alcohol|alcohol
65043|NCT02877836|Dystonia|dystonia
65044|NCT02877836|fMRI|fmri
65045|NCT02877836|DTI|dti
65046|NCT02877836|DBS|dbs
65047|NCT02877823|Pediatric Antipsychotic Treatment|pediatric antipsychotic treatment
65048|NCT02877823|Pediatric healthy lifestyle intervention|pediatric healthy lifestyle intervention
65049|NCT02877823|Parent peer support|parent peer support
65054|NCT02877758|cutaneous aging|cutaneous aging
65055|NCT02877758|skin rejuvenation|skin rejuvenation
65056|NCT02877758|wrinkles|wrinkles
65057|NCT02877732|Concussion|concussion
65058|NCT02877732|Athletes|athletes
65059|NCT02877732|Eye-tracking|eye-tracking
65060|NCT02877732|Vision|vision
65061|NCT02877706|Register|register
65062|NCT02877693|ICD|icd
65063|NCT02877693|Thoracic MRI Scan|thoracic mri scan
65064|NCT02877693|tachycardia|tachycardia
65065|NCT02877680|Strengths-based|strengths-based
65066|NCT02877680|Mobile Health (mHealth)|mobile health (mhealth)
65067|NCT02877680|Adolescence|adolescence
65068|NCT02877680|Resilience|resilience
65069|NCT02877680|Family|family
65070|NCT02877667|tattoo|tattoo
65071|NCT02877667|laser|laser
65072|NCT02877654|Plasmatic zonulin|plasmatic zonulin
65073|NCT02877654|Irritable Bowel Syndrome|irritable bowel syndrome
65074|NCT02877654|Intestinal permeability|intestinal permeability
65075|NCT02877641|Current Smoker|current smoker
65076|NCT02877641|Former Smoker|former smoker
65077|NCT02877628|pharmacokinetic|pharmacokinetic
65078|NCT02877628|pharmacodynamic|pharmacodynamic
65079|NCT02877628|tacrolimus|tacrolimus
65080|NCT02877628|CYP3A5|cyp3a5
65081|NCT02877628|liver transplantation|liver transplantation
65082|NCT02877563|peripheral artery disease|peripheral artery disease
65083|NCT02877563|contrast enhanced ultrasound|contrast enhanced ultrasound
65084|NCT02877550|untreated Follicular lymphoma|untreated follicular lymphoma
65085|NCT02877550|non-Hodgkin lymphoma|non-hodgkin lymphoma
65086|NCT02877550|Obinutuzumab|obinutuzumab
65087|NCT02877550|Gazyva|gazyva
65088|NCT02877550|Gazyvaro|gazyvaro
65089|NCT02877550|Venetoclax|venetoclax
65090|NCT02877550|Venclexta|venclexta
65091|NCT02877446|Left ventricular assist device (LVAD)|left ventricular assist device (lvad)
65092|NCT02877446|Terminal heart failure|terminal heart failure
65093|NCT02877446|Ventricular assist device (VAD)|ventricular assist device (vad)
65094|NCT02877433|Small diameter implant|small diameter implant
65095|NCT02877433|Cross-arch prostheses|cross-arch prostheses
65096|NCT02877420|Endoscopy|endoscopy
65097|NCT02877420|Simulation Training|simulation training
65098|NCT02877420|Non-technical Skills|non-technical skills
65099|NCT02877381|Tranexamic Acid|tranexamic acid
65100|NCT02877381|Blood Transfusion|blood transfusion
65102|NCT02877342|Injuries|injuries
65103|NCT02877342|Triage|triage
65104|NCT02877329|psychological effects|psychological effects
65105|NCT02877303|Leukemia|leukemia
65106|NCT02877303|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
65107|NCT02877303|ALL|all
65108|NCT02877303|Newly diagnosed B-Cell Lineage Acute lymphoblastic leukemia|newly diagnosed b-cell lineage acute lymphoblastic leukemia
65109|NCT02877303|Blinatumomab|blinatumomab
65110|NCT02877303|Blincyto|blincyto
65111|NCT02877303|G-CSF|g-csf
65112|NCT02877303|Filgrastim|filgrastim
65113|NCT02877303|Neupogen|neupogen
65114|NCT02877303|Pegfilgrastim|pegfilgrastim
65115|NCT02877303|Neulasta|neulasta
65116|NCT02877303|PEG-G-CSF|peg-g-csf
65117|NCT02877303|Cyclophosphamide|cyclophosphamide
65118|NCT02877303|Cytoxan|cytoxan
65119|NCT02877303|Neosar|neosar
65120|NCT02877303|Revimmune|revimmune
65121|NCT02877303|Clafen|clafen
65122|NCT02877303|Mesna|mesna
65123|NCT02877303|Mesnex|mesnex
65124|NCT02877303|Dexamethasone|dexamethasone
65125|NCT02877303|Decadron|decadron
65126|NCT02877303|Ofatumumab|ofatumumab
65127|NCT02877303|Arzerra|arzerra
65128|NCT02877303|Methotrexate|methotrexate
65129|NCT02877303|MTX|mtx
65130|NCT02877303|Doxorubicin|doxorubicin
65131|NCT02877303|Doxorubicin Hydrochloride|doxorubicin hydrochloride
65132|NCT02877303|Adriamycin PFS|adriamycin pfs
65133|NCT02877303|Adriamycin RDF|adriamycin rdf
65134|NCT02877303|Adriamycin|adriamycin
65135|NCT02877303|Rubex|rubex
65136|NCT02877303|Vincristine|vincristine
65137|NCT02877303|Oncovin|oncovin
65138|NCT02877303|Vincasar PFS|vincasar pfs
65139|NCT02877303|Vincristine Sulfate|vincristine sulfate
65140|NCT02877303|LCR|lcr
65141|NCT02877303|VCR|vcr
65142|NCT02877303|Cytarabine|cytarabine
65143|NCT02877303|ARA-C|ara-c
65144|NCT02877303|Cytosar|cytosar
65146|NCT02877303|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
65147|NCT02877303|Arabino Sylcytosine|arabino sylcytosine
65148|NCT02877303|Cytosine Arabinoside|cytosine arabinoside
65149|NCT02877303|Rituximab|rituximab
65150|NCT02877303|Rituxan|rituxan
65151|NCT02877303|Leucovorin|leucovorin
65152|NCT02877303|Citrovorum|citrovorum
65153|NCT02877303|Wellcovorin|wellcovorin
65154|NCT02877303|6-Mercaptopurine|6-mercaptopurine
65155|NCT02877303|Mercaptopurine|mercaptopurine
65156|NCT02877303|Purinethol|purinethol
65157|NCT02877303|6-MP|6-mp
65158|NCT02877303|Prednisone|prednisone
65159|NCT02877303|Deltasone|deltasone
65160|NCT02877303|Orasone|orasone
65161|NCT02877303|Prednicen-M|prednicen-m
65162|NCT02877290|COPD|copd
65163|NCT02877290|NIRS|nirs
65164|NCT02877290|NIV|niv
65165|NCT02877290|Exercise|exercise
65166|NCT02877264|Vapendavir|vapendavir
65167|NCT02877264|Bioavailability|bioavailability
625704|NCT00682825|Recall|recall
65168|NCT02877264|Biological Availability|biological availability
65169|NCT02877264|Volunteers|volunteers
65170|NCT02877251|Venous Thromboembolism|venous thromboembolism
65171|NCT02877251|Venous Thrombosis|venous thrombosis
65172|NCT02877251|Pulmonary Thromboembolism|pulmonary thromboembolism
65173|NCT02877251|National Registry|national registry
65174|NCT02877251|Mexico|mexico
65175|NCT02877251|Major Adverse Cardiovascular Events|major adverse cardiovascular events
65176|NCT02877238|remote ischemic preconditioning|remote ischemic preconditioning
65177|NCT02877238|sevoflurane|sevoflurane
65178|NCT02877238|total intravenous anesthetic|total intravenous anesthetic
65179|NCT02877212|ITP|itp
65180|NCT02877212|Eltrombopag|eltrombopag
65181|NCT02877212|Steroid refractory|steroid refractory
65182|NCT02877212|Fc Receptor|fc receptor
65183|NCT02877199|Hepatitis C|hepatitis c
65184|NCT02877199|anti-E1E2 antibodies|anti-e1e2 antibodies
65185|NCT02877199|cirrhosis|cirrhosis
65186|NCT02877199|triple therapy|triple therapy
65187|NCT02877173|Arteriosclerosis Obliterans|arteriosclerosis obliterans
65188|NCT02877173|Atherosclerotic Occlusive Disease of the Lower Extremities|atherosclerotic occlusive disease of the lower extremities
65189|NCT02877173|Intermittent Claudication|intermittent claudication
65190|NCT02877121|interstitial lung disease|interstitial lung disease
65191|NCT02877121|Respiratory Muscle Function|respiratory muscle function
65192|NCT02877121|Neural Respiratory Drive|neural respiratory drive
65193|NCT02877056|Colorectal adenocarcinoma|colorectal adenocarcinoma
65194|NCT02877056|Neoadjuvant therapy|neoadjuvant therapy
65195|NCT02877056|Endoscopy|endoscopy
65196|NCT02877056|Endoscopic biopsy|endoscopic biopsy
65197|NCT02877056|Biomarkers|biomarkers
65198|NCT02877056|Genes|genes
65199|NCT02876991|choline positron emission tomography|choline positron emission tomography
65200|NCT02876991|occult recurrence|occult recurrence
65201|NCT02876991|prostatic adenocarcinoma|prostatic adenocarcinoma
65202|NCT02876991|sodium fluoride positron emission tomography|sodium fluoride positron emission tomography
65203|NCT02876952|Cardio-respiratory fitness|cardio-respiratory fitness
65204|NCT02876952|high intensity exercise training|high intensity exercise training
65205|NCT02876939|Hereditary Sensory Neuropathy|hereditary sensory neuropathy
65206|NCT02876939|Autonomic Neuropathy|autonomic neuropathy
65207|NCT02876939|Familial Dysautonomia|familial dysautonomia
65208|NCT02876939|proprioception|proprioception
65209|NCT02876939|motor control|motor control
65210|NCT02876939|sensory nervous system.|sensory nervous system.
65211|NCT02876939|HSAN III|hsan iii
65212|NCT02876939|IKBKAP gene mutation|ikbkap gene mutation
65213|NCT02876926|HIV testing|hiv testing
65214|NCT02876926|Self-testing|self-testing
65215|NCT02876926|Counseling|counseling
65216|NCT02876926|Referral|referral
65217|NCT02876874|Rheumatoid Arthritis|rheumatoid arthritis
65218|NCT02876874|lymph nodes morphology|lymph nodes morphology
65219|NCT02876874|drainage of lymphatic vessels|drainage of lymphatic vessels
65220|NCT02876848|Administrative Claims, Healthcare|administrative claims, healthcare
65221|NCT02876848|Aromatase Inhibitors|aromatase inhibitors
65222|NCT02876848|Breast Neoplasms|breast neoplasms
65223|NCT02876848|Health Services for the Aged|health services for the aged
65224|NCT02876848|Medical Informatics Applications|medical informatics applications
65225|NCT02876848|Medication Adherence|medication adherence
65226|NCT02876848|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
65227|NCT02876848|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
65228|NCT02876848|Telemedicine|telemedicine
65229|NCT02876835|hemoglobin|hemoglobin
65230|NCT02876835|anemia|anemia
65231|NCT02876835|non-dialysis|non-dialysis
65232|NCT02876835|GSK1278863|gsk1278863
65233|NCT02876835|erythropoiesis stimulating agents|erythropoiesis stimulating agents
65234|NCT02876835|daprodustat|daprodustat
65235|NCT02876835|chronic kidney disease|chronic kidney disease
65236|NCT02876809|centenarians|centenarians
65237|NCT02876809|geriatric|geriatric
65238|NCT02876809|telomere length|telomere length
65239|NCT02876809|progerin|progerin
65240|NCT02876809|metagenome|metagenome
65241|NCT02876809|metabolome|metabolome
65242|NCT02876796|fractional de novo lipogenesis|fractional de novo lipogenesis
65243|NCT02876796|DNL|dnl
65244|NCT02876796|pharmacodynamic|pharmacodynamic
65245|NCT02876796|pharmacokinetic|pharmacokinetic
65246|NCT02876705|Patterns|patterns
65247|NCT02876705|Pain|pain
65248|NCT02876705|Cycling|cycling
65249|NCT02876705|Running|running
65250|NCT02876705|Exhaustion|exhaustion
65251|NCT02876679|Hematopoietic Stem Cell|hematopoietic stem cell
65252|NCT02876679|Transplantation|transplantation
65253|NCT02876679|Graft vs Host Disease|graft vs host disease
65254|NCT02876679|Cyclophosphamide|cyclophosphamide
65255|NCT02876679|Anti-Thymocyte Globulin|anti-thymocyte globulin
65256|NCT02876679|GVHD prophylaxis|gvhd prophylaxis
65257|NCT02876666|Spinal Cord Injuries|spinal cord injuries
65258|NCT02876666|Health Behavior|health behavior
65259|NCT02876653|Obstructive sleep apnea|obstructive sleep apnea
65260|NCT02876653|Aging|aging
65261|NCT02876653|Telomere length|telomere length
65262|NCT02876614|radionuclide cisternography|radionuclide cisternography
65263|NCT02876614|CSF leak|csf leak
65264|NCT02876614|imaging|imaging
65265|NCT02876601|Coagulation|coagulation
65266|NCT02876601|Inflammation|inflammation
65267|NCT02876601|Defibrotide|defibrotide
75593|NCT02811809|IHT|iht
56802|NCT02930395|S100B|s100b
65268|NCT02876601|Fibrinolysis|fibrinolysis
65269|NCT02876588|Wrong-Patient Errors|wrong-patient errors
65270|NCT02876588|Retract-and-Reorder Tool|retract-and-reorder tool
65271|NCT02876562|Gingival Recession Coverage|gingival recession coverage
65272|NCT02876549|G6PD|g6pd
65273|NCT02876549|Primaquine|primaquine
65274|NCT02876510|Ovarian Cancer|ovarian cancer
65275|NCT02876510|Esophageal Cancer|esophageal cancer
65276|NCT02876510|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
65277|NCT02876510|Squamous non-small cell lung cancer|squamous non-small cell lung cancer
65278|NCT02876458|Coronary angiogram|coronary angiogram
65279|NCT02876458|Survival rate|survival rate
65280|NCT02876458|Neurological sequel|neurological sequel
65281|NCT02876445|Huntington's disease|huntington's disease
65282|NCT02876445|Caregiver|caregiver
65283|NCT02876445|ZARIT burden scale|zarit burden scale
65284|NCT02876419|nucleic acid polymer REP 2139 HBsAg hepatitis B hepatitis D|nucleic acid polymer rep 2139 hbsag hepatitis b hepatitis d
65285|NCT02876367|Epidemiology|epidemiology
65286|NCT02876354|Hemodialysis|hemodialysis
65287|NCT02876354|Vitamin k2|vitamin k2
65288|NCT02876354|Vascular calcifications|vascular calcifications
65289|NCT02876341|Chronic antihypertensives|chronic antihypertensives
65290|NCT02876341|New onset atrial fibrillation|new onset atrial fibrillation
65291|NCT02876341|Septic shock|septic shock
65292|NCT02876328|Ebola Vaccine|ebola vaccine
65293|NCT02876315|innate immunity|innate immunity
65294|NCT02876315|elderly adults|elderly adults
65295|NCT02876315|multivitamin supplement|multivitamin supplement
65296|NCT02876315|vitamin D|vitamin d
65297|NCT02876315|vitamin C|vitamin c
65298|NCT02876315|zinc|zinc
65299|NCT02876302|Inflammatory Breast Cancer|inflammatory breast cancer
65300|NCT02876302|Breast Cancer|breast cancer
65301|NCT02876302|Triple Negative Breast Cancer|triple negative breast cancer
65302|NCT02876263|aortic diseases|aortic diseases
65303|NCT02876263|aortic aneurysm|aortic aneurysm
65304|NCT02876263|electroencephalography|electroencephalography
65305|NCT02876263|Near-Infrared spectroscopy|near-infrared spectroscopy
65306|NCT02876263|Transcranial Doppler ultrasonography|transcranial doppler ultrasonography
65307|NCT02876263|Cardiopulmonary arrest|cardiopulmonary arrest
65308|NCT02876263|Hypothermia, Induced|hypothermia, induced
65309|NCT02876250|Lung transplantation|lung transplantation
65310|NCT02876250|Cyclosporine|cyclosporine
65311|NCT02876250|Postconditioning|postconditioning
65312|NCT02876211|Renal disease|renal disease
65313|NCT02876211|Erythropoiesis|erythropoiesis
65314|NCT02876211|Erythropoietin stimulating agent|erythropoietin stimulating agent
65317|NCT02876211|Selective vitamin D receptor activation|selective vitamin d receptor activation
65318|NCT02876198|Retinal neovascularization|retinal neovascularization
65319|NCT02876198|Anti-VEGF|anti-vegf
65320|NCT02876198|Retinal Nerve Fiber Layer (RNFL)|retinal nerve fiber layer (rnfl)
65321|NCT02876185|Glaucoma surveillance|glaucoma surveillance
65322|NCT02876185|Orthoptist|orthoptist
65323|NCT02876172|PTSD|ptsd
65324|NCT02876172|psychotherapy|psychotherapy
65325|NCT02876172|MDMA|mdma
65326|NCT02876172|dyad|dyad
65327|NCT02876172|cognitive behavioral therapy|cognitive behavioral therapy
65328|NCT02876159|Vaccination|vaccination
65329|NCT02876146|Albendazole|albendazole
65330|NCT02876146|Benzimidazole|benzimidazole
65331|NCT02876146|Echinococcus multilocularis|echinococcus multilocularis
65332|NCT02876146|Alveolar echinococcosis|alveolar echinococcosis
65333|NCT02876146|Liver Diseases|liver diseases
65334|NCT02876107|Malignant neoplasm of breast|malignant neoplasm of breast
65335|NCT02876107|Breast cancer|breast cancer
754066|NCT01178788|17 alpha hydroxy P|17 alpha hydroxy p
754067|NCT01178788|Preterm Delivery|preterm delivery
65336|NCT02876107|Newly diagnosed primary triple-negative inflammatory breast cancer|newly diagnosed primary triple-negative inflammatory breast cancer
65337|NCT02876107|Inflammatory breast cancer|inflammatory breast cancer
65339|NCT02876107|TN-IBC|tn-ibc
65340|NCT02876107|Breast biopsy|breast biopsy
65341|NCT02876107|Mammogram|mammogram
65342|NCT02876107|Ultrasound|ultrasound
65343|NCT02876107|Paclitaxel|paclitaxel
65344|NCT02876107|Taxol|taxol
65345|NCT02876107|Carboplatin|carboplatin
65346|NCT02876107|Paraplatin|paraplatin
65347|NCT02876107|Panitumumab|panitumumab
65348|NCT02876107|Vectibix|vectibix
65349|NCT02876107|Doxorubicin|doxorubicin
65350|NCT02876107|Doxorubicin Hydrochloride|doxorubicin hydrochloride
65351|NCT02876107|Adriamycin PFS|adriamycin pfs
65352|NCT02876107|Adriamycin RDF|adriamycin rdf
65353|NCT02876107|Adriamycin|adriamycin
65354|NCT02876107|Rubex|rubex
65355|NCT02876107|Cyclophosphamide|cyclophosphamide
65356|NCT02876107|Cytoxan|cytoxan
65357|NCT02876107|Neosar|neosar
65361|NCT02876055|Brachial Plexus/ultrasonography|brachial plexus/ultrasonography
65362|NCT02876055|Shoulder Pain/prevention & control|shoulder pain/prevention & control
75680|NCT02811107|anxiety|anxiety
56963|NCT02929017|IPF|ipf
65363|NCT02876042|Heart Failure|heart failure
65364|NCT02876042|Preserved Ejection Fraction|preserved ejection fraction
65365|NCT02875938|left middle cerebral artery|left middle cerebral artery
65366|NCT02875938|cerebrovascular accident (CVA)|cerebrovascular accident (cva)
65367|NCT02875938|stroke|stroke
65368|NCT02875925|blood coagulation|blood coagulation
65369|NCT02875912|Family|family
65370|NCT02875912|Care Rituals|care rituals
65371|NCT02875912|End of Life|end of life
65372|NCT02875912|Discordance of care|discordance of care
65374|NCT02875860|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
65375|NCT02875860|Fetal Tracheal Occlusion|fetal tracheal occlusion
65376|NCT02875860|FETO|feto
65377|NCT02875860|plug-unplug|plug-unplug
65378|NCT02875860|GoldBal2|goldbal2
65379|NCT02875860|Balloon|balloon
65380|NCT02875860|Goldvalve Balloon|goldvalve balloon
65381|NCT02875860|TOTAL|total
65382|NCT02875795|linguistic|linguistic
65383|NCT02875795|quality of life|quality of life
65384|NCT02875782|Smoking Cessation|smoking cessation
65385|NCT02875769|cetylpyridinium chloride|cetylpyridinium chloride
65386|NCT02875769|chlorhexidine|chlorhexidine
65387|NCT02875769|oral aerosol|oral aerosol
65388|NCT02875769|oral splatter|oral splatter
65389|NCT02875769|mouthwash|mouthwash
65390|NCT02875769|microbiology|microbiology
65391|NCT02875704|DR|dr
65392|NCT02875704|AMD|amd
65393|NCT02875691|disease activity|disease activity
65394|NCT02875652|circulation tumor DNA|circulation tumor dna
65395|NCT02875652|choroidal melanoma|choroidal melanoma
65396|NCT02875639|Ischemic Heart Failure|ischemic heart failure
65397|NCT02875639|coronary artery disease|coronary artery disease
65398|NCT02875639|qi deficiency and blood stasis|qi deficiency and blood stasis
65402|NCT02875613|Epstein-barr virus|epstein-barr virus
65403|NCT02875600|chronic gastro-intestinal ischemia|chronic gastro-intestinal ischemia
65404|NCT02875600|oxygen deficiency of the gastro-intestinal tract|oxygen deficiency of the gastro-intestinal tract
65406|NCT02875587|Infertility|infertility
65407|NCT02875587|Cabergoline|cabergoline
65408|NCT02875587|Calcium gluconate|calcium gluconate
65409|NCT02875587|IVF-ET|ivf-et
65410|NCT02875574|Isoniazid|isoniazid
65411|NCT02875574|Drug Resistance|drug resistance
65412|NCT02875535|Evidence-based|evidence-based
65413|NCT02875535|lesbian, gay, bisexual, transgender, intersex, and queer|lesbian, gay, bisexual, transgender, intersex, and queer
65414|NCT02875535|adolescent|adolescent
65415|NCT02875535|Suicide prevention|suicide prevention
65416|NCT02875535|Implementation study|implementation study
65417|NCT02875522|COPD|copd
65418|NCT02875522|Exercise Training|exercise training
65419|NCT02875522|Flow-Mediated Dilation|flow-mediated dilation
65420|NCT02875522|Arterial Stiffness|arterial stiffness
65421|NCT02875522|Echocardiography|echocardiography
65422|NCT02875522|Cerebrovascular Physiology|cerebrovascular physiology
65423|NCT02875470|non-surgical periodontal debridement|non-surgical periodontal debridement
65424|NCT02875470|root planing/instrumentation|root planing/instrumentation
65425|NCT02875470|cytokine(s)|cytokine(s)
65426|NCT02875470|dental plaque|dental plaque
65427|NCT02875470|microscopy, electron, scanning|microscopy, electron, scanning
65428|NCT02875457|small cell lung cancer; apatinib; etoposide; cisplatin|small cell lung cancer; apatinib; etoposide; cisplatin
65429|NCT02875405|postoperative|postoperative
65430|NCT02875405|pericardiotomy|pericardiotomy
65431|NCT02875405|prevention|prevention
65432|NCT02875405|cardiac surgery|cardiac surgery
65433|NCT02875405|left|left
65434|NCT02875405|posterior|posterior
65435|NCT02875379|Noninvasive Ventilation|noninvasive ventilation
65436|NCT02875379|Mechanical Ventilation|mechanical ventilation
65437|NCT02875353|Post-Polypectomy|post-polypectomy
65438|NCT02875353|Colon bleeding|colon bleeding
65439|NCT02875353|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
65440|NCT02875327|SEER|seer
65441|NCT02875327|Medicaid|medicaid
65449|NCT02875262|intracranial aneurysm|intracranial aneurysm
65450|NCT02875262|subarachnoid hemorrhage|subarachnoid hemorrhage
65451|NCT02875262|stroke|stroke
65452|NCT02875262|chelator|chelator
65453|NCT02875249|post-antibiotic diarrhea|post-antibiotic diarrhea
65454|NCT02875249|intestinal microbiome|intestinal microbiome
65459|NCT02875210|Anterior Cruciate Ligament|anterior cruciate ligament
65460|NCT02875210|A02.835.583.512.100|a02.835.583.512.100
65461|NCT02875197|Kinetics|kinetics
65462|NCT02875197|Biomechanics|biomechanics
65463|NCT02875197|Amputation|amputation
65464|NCT02875197|Prosthesis|prosthesis
65465|NCT02875197|Transtibial|transtibial
65466|NCT02875184|Psoriatic Arthritis|psoriatic arthritis
65467|NCT02875184|Apremilast|apremilast
65468|NCT02875184|CC-10004|cc-10004
65469|NCT02875171|Anthracyclines; Cardiotoxicity; 2-D Echocardiography|anthracyclines; cardiotoxicity; 2-d echocardiography
65470|NCT02875145|Corneal Transplantation|corneal transplantation
65471|NCT02875145|Graft Survival|graft survival
65472|NCT02875106|Sinus rhythm|sinus rhythm
65473|NCT02875041|rehabilitation|rehabilitation
65475|NCT02875028|Coagulations|coagulations
65476|NCT02875028|Platelets|platelets
65477|NCT02875028|Inflammation|inflammation
65478|NCT02875028|endotoxemia|endotoxemia
65479|NCT02875028|vorapaxar|vorapaxar
65480|NCT02875015|Anesthetics|anesthetics
65481|NCT02875015|Anesthetic Effects|anesthetic effects
65482|NCT02875015|Mid-urethral sling|mid-urethral sling
65483|NCT02874976|sedentary lifestyle|sedentary lifestyle
65484|NCT02874963|Diabetes|diabetes
65485|NCT02874963|Oral Hygiene|oral hygiene
65486|NCT02874963|Periodontal Surgery|periodontal surgery
65487|NCT02874963|Periodontal Medicine|periodontal medicine
65488|NCT02874950|Exercise|exercise
65489|NCT02874937|Syncope|syncope
65490|NCT02874937|Vasovagal|vasovagal
65491|NCT02874937|Atomoxetine|atomoxetine
65492|NCT02874924|Geriatrics|geriatrics
65493|NCT02874911|Exergaming|exergaming
65494|NCT02874911|Neurodegenerative diseases|neurodegenerative diseases
65495|NCT02874911|Rare disease|rare disease
65496|NCT02874911|Motor exercises|motor exercises
65497|NCT02874911|Training|training
65498|NCT02874911|Spinocerebellar ataxia|spinocerebellar ataxia
65499|NCT02874885|Locally-advanced rectal cancer|locally-advanced rectal cancer
65500|NCT02874885|LARC|larc
65501|NCT02874885|Colorectal cancer|colorectal cancer
65502|NCT02874885|CRC|crc
65503|NCT02874885|Rectosigmoid cancer|rectosigmoid cancer
65504|NCT02874885|No known diagnosis of colorectal cancer|no known diagnosis of colorectal cancer
65505|NCT02874885|Blood draws|blood draws
65506|NCT02874885|Blood samples|blood samples
65507|NCT02874885|Circulating tumor cells (CTC)|circulating tumor cells (ctc)
65508|NCT02874885|CTC|ctc
65509|NCT02874872|Nursing homes|nursing homes
65510|NCT02874872|Antibiotic Stewardship|antibiotic stewardship
65511|NCT02874872|Antibiotic Resistance|antibiotic resistance
65512|NCT02874859|DIABETIC RETINOPATHY|diabetic retinopathy
65513|NCT02874859|Intravitreal aflibercept|intravitreal aflibercept
65514|NCT02874833|Depression|depression
65515|NCT02874833|Unipolar depression|unipolar depression
65516|NCT02874833|Bipolar affective disorder|bipolar affective disorder
65517|NCT02874833|Exercise|exercise
65518|NCT02874833|Internet-based intervention|internet-based intervention
65519|NCT02874820|Imidazoline Receptor 2|imidazoline receptor 2
65520|NCT02874820|(4,5-dihydro-1H-imidazol-2-yl)-1-methyl-1H-indole|(4,5-dihydro-1h-imidazol-2-yl)-1-methyl-1h-indole
65521|NCT02874820|BU99008|bu99008
65522|NCT02874820|[11C]-BU99008|[11c]-bu99008
65523|NCT02874820|Radionuclide Imaging|radionuclide imaging
65524|NCT02874820|Molecular Imaging|molecular imaging
65525|NCT02874807|Hyponatremia|hyponatremia
65526|NCT02874807|SGLT2 inhibitor|sglt2 inhibitor
65527|NCT02874794|Heart Failure|heart failure
65528|NCT02874794|Reduced Ejection Fraction|reduced ejection fraction
65529|NCT02874794|Central Aortic Stiffness|central aortic stiffness
65530|NCT02874794|Vascular|vascular
65531|NCT02874794|Echocardiogram|echocardiogram
65633|NCT02874001|psychology|psychology
65532|NCT02874755|Quality of Care|quality of care
65533|NCT02874755|Standardized Patients|standardized patients
65534|NCT02874729|Biomarkers, Tumor|biomarkers, tumor
65535|NCT02874729|Biological Assay|biological assay
65536|NCT02874716|Quality of Care|quality of care
65537|NCT02874716|Standardized Patients|standardized patients
65538|NCT02874677|Multiple sclerosis|multiple sclerosis
65539|NCT02874677|Ventilatory threshold|ventilatory threshold
65540|NCT02874677|Effort Reeducation|effort reeducation
65541|NCT02874651|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
65542|NCT02874651|EB Virus|eb virus
65543|NCT02874651|DNA|dna
65544|NCT02874651|vascular endothecial growth factor receptor inhibitor|vascular endothecial growth factor receptor inhibitor
65545|NCT02874651|Apatinib|apatinib
65546|NCT02874612|Young Adults|young adults
65552|NCT02874560|Functional remission|functional remission
65553|NCT02874560|Observational study|observational study
65554|NCT02874560|FROGS|frogs
65555|NCT02874560|PSP|psp
65556|NCT02874560|Functioning|functioning
65557|NCT02874560|Schizophrenia|schizophrenia
65558|NCT02874508|leukocyte subpopulations|leukocyte subpopulations
65559|NCT02874508|perioperative myocardial infarction|perioperative myocardial infarction
65560|NCT02874508|non-cardiac surgery|non-cardiac surgery
65561|NCT02874508|perioperative cardiovascular risk|perioperative cardiovascular risk
65562|NCT02874495|Crohn's disease|crohn's disease
65563|NCT02874495|Rectal Distension|rectal distension
65564|NCT02874495|Remission|remission
65565|NCT02874495|Anticipation|anticipation
65566|NCT02874495|Painful|painful
65567|NCT02874482|Schizophrenia|schizophrenia
65568|NCT02874482|Change blindness|change blindness
65569|NCT02874482|Eye tracking|eye tracking
65570|NCT02874482|Implicit response|implicit response
65571|NCT02874469|sudden death|sudden death
65572|NCT02874469|post-traumatic stress disorder|post-traumatic stress disorder
65573|NCT02874469|psychological distress|psychological distress
65574|NCT02874469|diary|diary
65575|NCT02874469|resuscitation|resuscitation
75981|NCT02809443|DNA|dna
57095|NCT02928471|Dynamic contrast enhanced MRI|dynamic contrast enhanced mri
57096|NCT02928445|Dementia with Lewy bodies|dementia with lewy bodies
65576|NCT02874456|Zyca virus|zyca virus
65577|NCT02874352|intensive care|intensive care
65578|NCT02874352|tracheostomy|tracheostomy
65579|NCT02874339|Acute cardiogenic pulmonary|acute cardiogenic pulmonary
65580|NCT02874339|Respiratory failure|respiratory failure
65581|NCT02874339|Hypercapnia|hypercapnia
65582|NCT02874339|High flow nasal oxygen|high flow nasal oxygen
65583|NCT02874339|Non invasive ventilation|non invasive ventilation
65584|NCT02874339|Emergency department|emergency department
65585|NCT02874326|Sandostatin LAR|sandostatin lar
65586|NCT02874326|Somatostatin|somatostatin
65587|NCT02874326|Octreotide|octreotide
65588|NCT02874313|CPAP|cpap
65589|NCT02874313|Sleep apnea|sleep apnea
65590|NCT02874313|Diabetes|diabetes
65591|NCT02874313|Diabetic retinopathy|diabetic retinopathy
65592|NCT02874287|Coronary Artery Disease|coronary artery disease
65593|NCT02874287|Hydroxychloroquine|hydroxychloroquine
65594|NCT02874287|Cross-Over Study|cross-over study
65595|NCT02874274|Corticobasal syndrome|corticobasal syndrome
65596|NCT02874274|Dementia with Lewy Bodies|dementia with lewy bodies
65597|NCT02874274|Home Visit Program (HVP)|home visit program (hvp)
65598|NCT02874274|Multidimensional Caregiver Strain Index|multidimensional caregiver strain index
65599|NCT02874274|Parkinson's Disease Dementia|parkinson's disease dementia
65600|NCT02874274|Progressive Supranuclear Palsy|progressive supranuclear palsy
65601|NCT02874222|aromatase inhibitors|aromatase inhibitors
65602|NCT02874183|Heart Failure|heart failure
65604|NCT02874183|CHF|chf
65605|NCT02874183|RCT|rct
65606|NCT02874183|Self-efficacy|self-efficacy
65607|NCT02874183|Pharmacy|pharmacy
65608|NCT02874183|Pharmacist|pharmacist
65609|NCT02874183|Transition of Care|transition of care
65610|NCT02874183|Readmission|readmission
65611|NCT02874131|Posttraumatic Stress Disorder|posttraumatic stress disorder
65612|NCT02874131|Major Depressive Disorder|major depressive disorder
65613|NCT02874131|Behavioral Activation|behavioral activation
65614|NCT02874131|Cognitive Processing Therapy|cognitive processing therapy
65615|NCT02874131|Comorbidity|comorbidity
65616|NCT02874131|Military|military
65617|NCT02874105|Medical treatment|medical treatment
65618|NCT02874105|physiotherapy|physiotherapy
65619|NCT02874092|Methotrexate (MTX)|methotrexate (mtx)
65620|NCT02874092|Ticagrelor|ticagrelor
65621|NCT02874066|Hepatitis C virus|hepatitis c virus
65622|NCT02874066|Hemodialysis|hemodialysis
65623|NCT02874066|Direct acting antiviral agents|direct acting antiviral agents
65624|NCT02874053|Risk Perceptions|risk perceptions
65625|NCT02874053|Medical Tradeoffs|medical tradeoffs
65626|NCT02874053|Regulatory Focus|regulatory focus
65627|NCT02874053|Integral Affect|integral affect
65628|NCT02874027|gut microbiota|gut microbiota
65629|NCT02874027|depression|depression
65630|NCT02874027|gut-brain axis|gut-brain axis
65631|NCT02874027|circadian rhythm|circadian rhythm
65632|NCT02874027|Traumatic Brain Injury|traumatic brain injury
65634|NCT02874001|caregiver support time|caregiver support time
65635|NCT02873975|Advanced Cancers|advanced cancers
65636|NCT02873975|Solid tumors|solid tumors
65637|NCT02873975|MYC amplification|myc amplification
65638|NCT02873975|CCNE1 amplification|ccne1 amplification
65639|NCT02873975|Rb loss|rb loss
65640|NCT02873975|FBXW7 mutation|fbxw7 mutation
65641|NCT02873975|BRCA1 mutation|brca1 mutation
65642|NCT02873975|BRCA2 mutation|brca2 mutation
65644|NCT02873975|RAD51C mutation|rad51c mutation
65645|NCT02873975|RAD51D mutation|rad51d mutation
65646|NCT02873975|ATR mutation|atr mutation
65647|NCT02873975|ATM mutation|atm mutation
65648|NCT02873975|CHK2 mutation|chk2 mutation
65649|NCT02873975|Fanconi anemia|fanconi anemia
65650|NCT02873962|Relapsed Ovarian Cancer|relapsed ovarian cancer
65651|NCT02873949|immunology factors|immunology factors
65652|NCT02873949|TREM|trem
65653|NCT02873949|stress|stress
65654|NCT02873923|clinical trial|clinical trial
65655|NCT02873923|surrogate endpoints|surrogate endpoints
65656|NCT02873923|meta analysis|meta analysis
65657|NCT02873897|elderly|elderly
65658|NCT02873858|elderly|elderly
65659|NCT02873780|Pulmonary rehabilitation|pulmonary rehabilitation
65660|NCT02873780|COPD|copd
65661|NCT02873780|Evaluation|evaluation
65662|NCT02873780|oxygen desaturation|oxygen desaturation
65663|NCT02873780|exercise capacity|exercise capacity
65664|NCT02873767|First in human|first in human
65665|NCT02873767|Healthy volunteers|healthy volunteers
65666|NCT02873741|Sexually Transmitted Diseases (STDs)|sexually transmitted diseases (stds)
65667|NCT02873741|Cancer|cancer
65668|NCT02873741|AIDS|aids
65669|NCT02873728|chronic ulcer|chronic ulcer
65670|NCT02873728|diabetic ulcer|diabetic ulcer
57196|NCT02927860|sleep|sleep
57197|NCT02927860|exercise|exercise
57198|NCT02927860|activity|activity
57200|NCT02927821|Caregivers|caregivers
65671|NCT02873728|venous ulcer|venous ulcer
65672|NCT02873728|remote ischemic conditioning|remote ischemic conditioning
65673|NCT02873715|Childhood weight control|childhood weight control
65674|NCT02873702|Drug therapy|drug therapy
65675|NCT02873689|Drug therapy|drug therapy
65676|NCT02873676|prevalence; lifestyle modification; clinical outcomes|prevalence; lifestyle modification; clinical outcomes
65677|NCT02873650|Hepatic impairment|hepatic impairment
65678|NCT02873650|Healthy volunteers|healthy volunteers
65679|NCT02873650|Clinical pharmacology study|clinical pharmacology study
65680|NCT02873650|DRB436|drb436
65681|NCT02873650|dabrafenib|dabrafenib
65682|NCT02873650|normal hepatic function|normal hepatic function
65683|NCT02873650|impaired hepatic function|impaired hepatic function
65684|NCT02873637|total knee replacement|total knee replacement
65685|NCT02873637|anesthesia|anesthesia
65686|NCT02873637|catheter|catheter
65687|NCT02873624|Acute Kidney Injury , Laparoscopic Cholecystectomy|acute kidney injury , laparoscopic cholecystectomy
65688|NCT02873598|Induction Chemotherapy|induction chemotherapy
65689|NCT02873598|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
65690|NCT02873598|Dose Escalation|dose escalation
65691|NCT02873598|Locally Advanced Pancreatic Cancer (LAPC)|locally advanced pancreatic cancer (lapc)
65692|NCT02873598|Maximum Tolerated Dose (MTD)|maximum tolerated dose (mtd)
65693|NCT02873572|Online poker|online poker
65694|NCT02873572|Casino|casino
65695|NCT02873572|Massively Multiplayer Online Role-Playing Game (MMORPG)|massively multiplayer online role-playing game (mmorpg)
65696|NCT02873572|Iowa Gambling Task (IGT)|iowa gambling task (igt)
65697|NCT02873572|High Resolution Electroencephalography (HR-EEG)|high resolution electroencephalography (hr-eeg)
65698|NCT02873559|older|older
65699|NCT02873559|frail|frail
65700|NCT02873559|men|men
65701|NCT02873559|progressive muscle training|progressive muscle training
65702|NCT02873559|muscle training|muscle training
65703|NCT02873559|exercise|exercise
65704|NCT02873559|testosterone|testosterone
65705|NCT02873520|Precision Cell Immunotherapy|precision cell immunotherapy
65706|NCT02873520|Chemotherapy|chemotherapy
65707|NCT02873520|Advanced Gastric Cancer|advanced gastric cancer
65708|NCT02873507|transplantation, liver|transplantation, liver
65709|NCT02873494|Hemodynamic monitoring|hemodynamic monitoring
65710|NCT02873494|cardiac output|cardiac output
65711|NCT02873494|Transthoracic echocardiography|transthoracic echocardiography
65712|NCT02873494|Impedance cardiography|impedance cardiography
65713|NCT02873494|Child|child
65714|NCT02873494|Physioflow|physioflow
65715|NCT02873494|pediatric intensive care unit|pediatric intensive care unit
65716|NCT02873442|Precision Cell Immunotherapy|precision cell immunotherapy
65717|NCT02873442|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
65718|NCT02873442|Advanced Liver Cancer|advanced liver cancer
65719|NCT02873416|Precision Cell Immunotherapy|precision cell immunotherapy
65720|NCT02873416|Chemotherapy|chemotherapy
65721|NCT02873416|Advanced Lung Cancer|advanced lung cancer
65722|NCT02873390|PD-1 Antibody|pd-1 antibody
65723|NCT02873390|CAR-T Cells|car-t cells
65724|NCT02873390|EGFR family|egfr family
65725|NCT02873390|Advanced Malignancies|advanced malignancies
65726|NCT02873377|Hispanics|hispanics
66226|NCT02870114|Pain|pain
65727|NCT02873377|Construction workers|construction workers
65728|NCT02873377|Tobacco Quitline|tobacco quitline
65729|NCT02873377|Nicotine replacement therapy|nicotine replacement therapy
65730|NCT02873351|L-DOPA|l-dopa
65731|NCT02873351|GPR143|gpr143
65732|NCT02873351|PEDF|pedf
65733|NCT02873351|VEGF|vegf
65734|NCT02873325|ADV|adv
65735|NCT02873325|CMV|cmv
65736|NCT02873325|HSCT|hsct
65737|NCT02873299|PTSD, Post Traumatic Stress Disorder|ptsd, post traumatic stress disorder
65738|NCT02873286|RSV Vaccines|rsv vaccines
65739|NCT02873286|Respiratory Syncytial Virus Vaccines|respiratory syncytial virus vaccines
65740|NCT02873260|Dengue Vaccine|dengue vaccine
65741|NCT02873234|Telemedicine|telemedicine
65742|NCT02873234|Chinese Medicine syndrome differentiation|chinese medicine syndrome differentiation
65743|NCT02873234|Long-term study|long-term study
65744|NCT02873234|Relapse rate|relapse rate
65745|NCT02873234|Suicide rate|suicide rate
65746|NCT02873234|Antidepressants|antidepressants
65747|NCT02873208|Alkermes|alkermes
65748|NCT02873208|ALKS 3831|alks 3831
65749|NCT02873208|Samidorphan|samidorphan
65750|NCT02873208|Schizophrenia|schizophrenia
65751|NCT02873208|Safety|safety
625796|NCT00683111|famotidine|famotidine
65752|NCT02873182|Intraoperative monitoring|intraoperative monitoring
65753|NCT02873182|Intraoperative neuromonitoring|intraoperative neuromonitoring
65754|NCT02873182|Autonomic nervous system|autonomic nervous system
65755|NCT02873182|Spine surgery|spine surgery
65756|NCT02873182|Pelvic surgery|pelvic surgery
76193|NCT02807883|ALL|all
57290|NCT02927236|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
57291|NCT02927210|Healthy Men|healthy men
57292|NCT02927210|Male Contraception|male contraception
57293|NCT02927210|Androgen|androgen
65757|NCT02873182|Sexual function|sexual function
65758|NCT02873182|Bowel function|bowel function
65759|NCT02873182|Bladder function|bladder function
65760|NCT02873169|Left ventricular assist device|left ventricular assist device
65761|NCT02873169|Ventricular Arrhythmias|ventricular arrhythmias
65762|NCT02873169|Implantable Cardioverter-defibrillator|implantable cardioverter-defibrillator
65763|NCT02873156|E2027|e2027
65764|NCT02873156|Healthy participants|healthy participants
65765|NCT02873156|Pharmacokinetics|pharmacokinetics
65766|NCT02873156|Pharmacodynamics|pharmacodynamics
65767|NCT02873117|Benign prostate hyperplasia|benign prostate hyperplasia
65768|NCT02873117|5 alpha reductase inhibitor|5 alpha reductase inhibitor
65769|NCT02873117|prostate cancer|prostate cancer
65770|NCT02873117|Symptomatic|symptomatic
65771|NCT02873117|treated|treated
65772|NCT02873013|prostate cancer|prostate cancer
65773|NCT02873013|observational study|observational study
65774|NCT02873000|incentive spirometry|incentive spirometry
65775|NCT02873000|outcome|outcome
65776|NCT02873000|length of stay,|length of stay,
65777|NCT02873000|hospital complication|hospital complication
65778|NCT02873000|general internal medicine|general internal medicine
65779|NCT02873000|hospital medicine|hospital medicine
65780|NCT02873000|non-critically-ill|non-critically-ill
65781|NCT02872974|Cardiovascular diseases|cardiovascular diseases
65782|NCT02872974|Gestational diabetes mellitus|gestational diabetes mellitus
65783|NCT02872974|Pediatrics|pediatrics
65784|NCT02872974|Fetal programming|fetal programming
65785|NCT02872974|Cohort study|cohort study
65786|NCT02872948|Non invasive prenatal testing|non invasive prenatal testing
65787|NCT02872948|Down Syndrome|down syndrome
65788|NCT02872948|Digital PCR|digital pcr
65789|NCT02872922|Endothelial function|endothelial function
65790|NCT02872922|Ultrasonic Therapy|ultrasonic therapy
65792|NCT02872922|Nitric oxide|nitric oxide
65794|NCT02872883|Prelabour rupture of membranes|prelabour rupture of membranes
65795|NCT02872883|term pregnancy|term pregnancy
65796|NCT02872883|management|management
65797|NCT02872883|vaginal examination|vaginal examination
65798|NCT02872883|induction of labour|induction of labour
65799|NCT02872883|expectant management|expectant management
65800|NCT02872870|language disorders|language disorders
65801|NCT02872870|developmental disorders of oral and written language|developmental disorders of oral and written language
65802|NCT02872831|Fine needle aspiration|fine needle aspiration
65803|NCT02872818|Apoptotic signal pathway|apoptotic signal pathway
65804|NCT02872818|Survivin|survivin
65805|NCT02872818|Bcl-2|bcl-2
65806|NCT02872818|Bax|bax
65807|NCT02872818|c-Myc|c-myc
65808|NCT02872818|Caspase-9|caspase-9
65809|NCT02872818|endometrial hyperplasia|endometrial hyperplasia
65810|NCT02872818|endometrium cancer|endometrium cancer
65812|NCT02872753|Platelet Rich Plasma|platelet rich plasma
65813|NCT02872753|meniscectomy|meniscectomy
65814|NCT02872753|randomized controlled trial|randomized controlled trial
65815|NCT02872753|intra-op injection|intra-op injection
65816|NCT02872714|Urothelial carcinoma|urothelial carcinoma
65817|NCT02872714|fibroblast growth factor (FGF)|fibroblast growth factor (fgf)
65818|NCT02872714|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
65819|NCT02872714|FGF/FGFR alterations|fgf/fgfr alterations
65820|NCT02872675|Asthma|asthma
65821|NCT02872675|Exercise-Induced Asthma|exercise-induced asthma
65822|NCT02872675|Gut Bacteria|gut bacteria
65823|NCT02872675|Bimuno® Galactooligosaccharide|bimuno® galactooligosaccharide
65824|NCT02872675|Pulmonary Function|pulmonary function
65825|NCT02872675|Prebiotics|prebiotics
65826|NCT02872675|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
65827|NCT02872675|Gut Microbiota|gut microbiota
65828|NCT02872675|Nutritional Intervention|nutritional intervention
65829|NCT02872675|Eucapnic Voluntary Hyperpnoea|eucapnic voluntary hyperpnoea
65830|NCT02872675|Systemic Inflammation|systemic inflammation
65831|NCT02872675|Systemic Immune Function|systemic immune function
65832|NCT02872675|Regulatory T Cells|regulatory t cells
65833|NCT02872675|TH1 Cells|th1 cells
65834|NCT02872675|TH2 Cells|th2 cells
65835|NCT02872675|Short-Chain Fatty Acids|short-chain fatty acids
65836|NCT02872675|Acetate|acetate
65837|NCT02872675|Propionate|propionate
65838|NCT02872675|Butyrate|butyrate
65839|NCT02872675|Metagenomics|metagenomics
65840|NCT02872675|Metabolomics|metabolomics
65841|NCT02872675|Airway Inflammation|airway inflammation
65842|NCT02872610|suicidal thoughts|suicidal thoughts
65843|NCT02872610|suicidal ideation|suicidal ideation
65844|NCT02872610|Internet intervention|internet intervention
65845|NCT02872610|self-help|self-help
65846|NCT02872571|islet of Langerhans|islet of langerhans
65847|NCT02872571|transplantation|transplantation
65848|NCT02872571|muscle|muscle
65849|NCT02872506|Quality of life|quality of life
65850|NCT02872506|Crohn's disease|crohn's disease
65851|NCT02872506|Ileocecal resection|ileocecal resection
65852|NCT02872506|Anti TNF|anti tnf
65853|NCT02872493|obesity|obesity
65854|NCT02872493|bariatric surgery|bariatric surgery
65855|NCT02872493|bowel length|bowel length
65856|NCT02872480|Concussion|concussion
65857|NCT02872480|Exercise|exercise
65858|NCT02872467|Cocaine|cocaine
65859|NCT02872467|Mothers|mothers
65860|NCT02872467|Pregnant women|pregnant women
65861|NCT02872467|Postpartum women|postpartum women
65862|NCT02872467|Oxytocin|oxytocin
65863|NCT02872467|Substance use disorders|substance use disorders
65864|NCT02872467|Substance abuse|substance abuse
65865|NCT02872467|Prenatal substance use|prenatal substance use
65866|NCT02872467|stress|stress
65867|NCT02872454|Major Depression|major depression
65868|NCT02872454|Text Messaging|text messaging
65869|NCT02872454|Guided Self-Help|guided self-help
65870|NCT02872402|gestational diabetes|gestational diabetes
65871|NCT02872402|dietary modification|dietary modification
65872|NCT02872402|weight loss|weight loss
65873|NCT02872402|physical activity|physical activity
65874|NCT02872402|breastfeeding|breastfeeding
65875|NCT02872376|Anemia|anemia
65876|NCT02872376|Crohn's disease|crohn's disease
65877|NCT02872376|Ulcerative colitis|ulcerative colitis
65878|NCT02872363|breast screening|breast screening
65879|NCT02872363|breast cancer|breast cancer
65880|NCT02872363|mammogram|mammogram
65881|NCT02872363|uptake|uptake
65882|NCT02872363|reminder|reminder
65883|NCT02872363|text message|text message
65884|NCT02872363|SMS|sms
65885|NCT02872311|Vaccine|vaccine
65886|NCT02872311|Influenza|influenza
65887|NCT02872311|High Dose|high dose
65888|NCT02872311|Adjuvanted|adjuvanted
65889|NCT02872298|Severe|severe
65890|NCT02872298|Refractory|refractory
65992|NCT02871674|Behavioural interventions|behavioural interventions
65894|NCT02872181|Tilt|tilt
65895|NCT02872181|Left Uterine Displacement|left uterine displacement
65896|NCT02872181|Cesarean Delivery|cesarean delivery
65897|NCT02872181|Cesarean Section|cesarean section
65898|NCT02872155|contrast-induced nephropathy|contrast-induced nephropathy
65899|NCT02872155|renal insufficiency|renal insufficiency
65900|NCT02872155|computed tomography|computed tomography
65901|NCT02872129|Fibromyalgia|fibromyalgia
65902|NCT02872129|chronic widespread pain|chronic widespread pain
65903|NCT02872129|follow-up|follow-up
65904|NCT02872129|pain|pain
65905|NCT02872129|fatigue|fatigue
65906|NCT02872129|symptoms|symptoms
65907|NCT02872129|workability|workability
65908|NCT02872129|physical function|physical function
65909|NCT02872090|COPD|copd
65910|NCT02872090|bronchodilatators|bronchodilatators
65911|NCT02872090|autonomic nervous system|autonomic nervous system
65912|NCT02872090|cardiovascular system|cardiovascular system
65913|NCT02872077|AA for NAS|aa for nas
65914|NCT02872064|Early breast cancer|early breast cancer
65915|NCT02872064|Photodynamic therapy|photodynamic therapy
65916|NCT02872064|PDT|pdt
65917|NCT02872064|Visudyne|visudyne
65918|NCT02872064|Verteporfin|verteporfin
65919|NCT02872051|Vocational Rehabilitation|vocational rehabilitation
65920|NCT02872051|Anxiety|anxiety
65921|NCT02872051|Depression|depression
65922|NCT02872051|Common Mental Disorders|common mental disorders
65923|NCT02872051|Cognitive Behavior Therapy|cognitive behavior therapy
65924|NCT02872051|Return to Work|return to work
65925|NCT02872051|Mental Health Services|mental health services
65926|NCT02872051|Integration|integration
65927|NCT02871999|Acupuncture Therapy|acupuncture therapy
65928|NCT02871999|Pain degree after surgery|pain degree after surgery
65929|NCT02871973|parenting|parenting
65930|NCT02871973|child development|child development
65931|NCT02871973|language|language
65932|NCT02871947|severe asthma|severe asthma
65933|NCT02871934|Pharmacogenetics|pharmacogenetics
65934|NCT02871934|SLCO1B1 protein, human|slco1b1 protein, human
65935|NCT02871934|OATP1B1 protein, human|oatp1b1 protein, human
65936|NCT02871934|Simvastatin|simvastatin
65937|NCT02871934|Cardiovascular disease|cardiovascular disease
65938|NCT02871934|Cholesterol|cholesterol
65939|NCT02871934|Statin-related myotoxicity|statin-related myotoxicity
65940|NCT02871934|Veterans|veterans
65941|NCT02871934|Point-of-care|point-of-care
65942|NCT02871921|Behavioral prevention|behavioral prevention
65943|NCT02871921|social interaction|social interaction
65944|NCT02871921|dementia|dementia
65945|NCT02871921|MRI|mri
65946|NCT02871895|sepsis|sepsis
65947|NCT02871895|severe sepsis|severe sepsis
65948|NCT02871895|septic shock|septic shock
65949|NCT02871895|multiple organ failure|multiple organ failure
65950|NCT02871869|Cinobufacini Tablets|cinobufacini tablets
65951|NCT02871869|CHOP protocol|chop protocol
65952|NCT02871856|Screening|screening
65953|NCT02871856|Computed tomography|computed tomography
65954|NCT02871856|Lung cancer|lung cancer
65955|NCT02871830|Physical activity|physical activity
65956|NCT02871830|Walking|walking
65957|NCT02871830|Intervention|intervention
65958|NCT02871830|Adolescent girls|adolescent girls
65959|NCT02871830|Randomised trial|randomised trial
65960|NCT02871817|Near Corrected Visual Acuity|near corrected visual acuity
65961|NCT02871817|Early Treatment Diabetes Retinopathy Study|early treatment diabetes retinopathy study
65962|NCT02871817|Amsler Grid|amsler grid
65963|NCT02871817|Home Monitoring|home monitoring
65964|NCT02871791|Her2-negative metastatic breast cancer|her2-negative metastatic breast cancer
65965|NCT02871791|Hormone receptor (HR)-positive breast cancer|hormone receptor (hr)-positive breast cancer
65966|NCT02871765|Patient education|patient education
65967|NCT02871765|Knowledge|knowledge
65968|NCT02871765|Life distress|life distress
65969|NCT02871765|Quality of life|quality of life
65970|NCT02871752|prostate cancer|prostate cancer
65971|NCT02871752|active surveillance|active surveillance
65972|NCT02871752|MBSR|mbsr
65973|NCT02871752|couples|couples
65974|NCT02871752|health promotion|health promotion
65975|NCT02871752|quality of life|quality of life
65976|NCT02871739|Communication skills training|communication skills training
65977|NCT02871739|Shared Decision Making|shared decision making
65978|NCT02871739|Decision making|decision making
65979|NCT02871739|Decision Aids|decision aids
65980|NCT02871739|lung cancer screening|lung cancer screening
65981|NCT02871726|Prostate Cancer Detection|prostate cancer detection
65982|NCT02871726|Prostate Biopsy|prostate biopsy
65983|NCT02871726|Prostate Cancer|prostate cancer
65984|NCT02871726|Transrectal Ultrasound|transrectal ultrasound
65985|NCT02871713|quadratus lumborum block|quadratus lumborum block
65986|NCT02871700|stroke|stroke
65987|NCT02871700|translational rehabilitation|translational rehabilitation
65988|NCT02871700|mirror neuron system|mirror neuron system
65989|NCT02871700|action observation|action observation
65990|NCT02871700|mirror therapy|mirror therapy
65991|NCT02871700|MEG|meg
65993|NCT02871674|Sleep difficulties|sleep difficulties
65994|NCT02871674|Children|children
65995|NCT02871674|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
65996|NCT02871674|Randomised controlled trial|randomised controlled trial
65997|NCT02871674|Saudi Arabia|saudi arabia
65998|NCT02871674|Behavioural Insomnia|behavioural insomnia
65999|NCT02871661|vulvodynia|vulvodynia
66000|NCT02871661|pelvic floor muscles|pelvic floor muscles
66001|NCT02871661|kinesiotherapy|kinesiotherapy
66002|NCT02871661|electrical therapy|electrical therapy
66003|NCT02871661|physical therapy|physical therapy
66004|NCT02871661|amitriptyline|amitriptyline
66005|NCT02871661|female sexual dysfunction.|female sexual dysfunction.
66006|NCT02871648|Healthy|healthy
66007|NCT02871609|Biofilm|biofilm
66008|NCT02871609|Morbidity|morbidity
66009|NCT02871609|Ureteral Catheterization|ureteral catheterization
66010|NCT02871570|Hepatic Impairment|hepatic impairment
66011|NCT02871570|Rivipansel|rivipansel
66012|NCT02871544|BNP|bnp
66013|NCT02871544|NGAL|ngal
66014|NCT02871544|Sepsis|sepsis
66015|NCT02871544|Mortality|mortality
66016|NCT02871531|retinal detachment|retinal detachment
66017|NCT02871531|pneumatic retinopexy|pneumatic retinopexy
66018|NCT02871531|vitrectomy|vitrectomy
66019|NCT02871479|Atopic Dermatitis|atopic dermatitis
66020|NCT02871479|Eczema|eczema
66021|NCT02871453|Ischemic Stroke|ischemic stroke
66022|NCT02871453|Motor Dysfunction|motor dysfunction
66023|NCT02871453|Scalp Acupuncture|scalp acupuncture
66024|NCT02871427|Lewy body dementia|lewy body dementia
66025|NCT02871427|Dementia with Lewy bodies|dementia with lewy bodies
66026|NCT02871427|Parkinson's disease dementia|parkinson's disease dementia
66520|NCT02868034|Exercise|exercise
66027|NCT02871427|Visual hallucinations|visual hallucinations
66028|NCT02871427|REM sleep behavior disorder|rem sleep behavior disorder
66029|NCT02871401|IPF|ipf
66030|NCT02871401|Herpesvirus|herpesvirus
66031|NCT02871401|Valganciclovir|valganciclovir
66032|NCT02871388|Physical activity|physical activity
66033|NCT02871388|Diet|diet
66034|NCT02871388|Nutrition|nutrition
66035|NCT02871388|Breast cancer prevention|breast cancer prevention
66036|NCT02871388|Mammography screening|mammography screening
66037|NCT02871375|myopia|myopia
66038|NCT02871375|presbyopia|presbyopia
66039|NCT02871349|Autism|autism
66040|NCT02871349|ASD|asd
66041|NCT02871336|Cata collection|cata collection
66042|NCT02871336|Pancreatic cancer surgery|pancreatic cancer surgery
66043|NCT02871323|Myelofibrosis Transformation in Essential Thrombocythemia|myelofibrosis transformation in essential thrombocythemia
66044|NCT02871297|adolescent|adolescent
66046|NCT02871284|cancer|cancer
66047|NCT02871284|anticancer treatment|anticancer treatment
66048|NCT02871284|exercise|exercise
66049|NCT02871284|physical activity|physical activity
57595|NCT02925195|pharmacogenetics|pharmacogenetics
57596|NCT02925195|blood pressure|blood pressure
57597|NCT02925195|biomarkers|biomarkers
57598|NCT02925169|Subglottis, cricoid, airway shape, CT imaging|subglottis, cricoid, airway shape, ct imaging
57599|NCT02925156|Activity Energy Expenditure|activity energy expenditure
57600|NCT02925156|Doubly Labeled Water|doubly labeled water
57601|NCT02925156|Physical Activity|physical activity
57676|NCT02924558|Egg|egg
66050|NCT02871284|sensorimotor training|sensorimotor training
66051|NCT02871284|chemotherapy-induced polyneuropathy|chemotherapy-induced polyneuropathy
66052|NCT02871245|Acupuncture Therapy|acupuncture therapy
66053|NCT02871245|Laparoscopic Surgery|laparoscopic surgery
66054|NCT02871245|Gastrointestinal Tract Recovery of Function|gastrointestinal tract recovery of function
66055|NCT02871219|Follicular lymphoma|follicular lymphoma
66056|NCT02871219|Obinutuzumab|obinutuzumab
66057|NCT02871219|GA101|ga101
66058|NCT02871219|Gazyva|gazyva
66059|NCT02871219|Lenalidomide|lenalidomide
66060|NCT02871219|CC-5013|cc-5013
66061|NCT02871219|Revlimid|revlimid
66062|NCT02871193|paravertebral block|paravertebral block
66063|NCT02871193|patient controlled analgesia|patient controlled analgesia
66064|NCT02871193|ropivacaine|ropivacaine
66065|NCT02871193|dexamethasone|dexamethasone
66066|NCT02871180|Hypoglycemia|hypoglycemia
66067|NCT02871180|Type 1 diabetes|type 1 diabetes
66068|NCT02871167|oocyte/embryo cryopreservation|oocyte/embryo cryopreservation
66069|NCT02871128|Hemoglobin|hemoglobin
66070|NCT02871128|serum iron|serum iron
66071|NCT02871128|serum ferritin|serum ferritin
66072|NCT02871128|Hematocrit|hematocrit
66073|NCT02871128|antioxidant|antioxidant
66074|NCT02871115|Cancer Care|cancer care
66075|NCT02871102|mechanical ventilation|mechanical ventilation
66076|NCT02871102|respiratory mechanics|respiratory mechanics
66077|NCT02871102|acute respiratory distress syndrome|acute respiratory distress syndrome
66078|NCT02871102|positive end-expiratory pressure|positive end-expiratory pressure
66079|NCT02871102|tidal volume|tidal volume
66080|NCT02871089|Type 1 Diabetes|type 1 diabetes
66081|NCT02871089|Closed-loop glucose control|closed-loop glucose control
66082|NCT02871089|Artificial Pancreas|artificial pancreas
66083|NCT02871089|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
66084|NCT02871089|Multiple daily injection therapy|multiple daily injection therapy
66085|NCT02871089|New onset type 1 diabetes|new onset type 1 diabetes
66086|NCT02871089|Residual C-Peptide secretion|residual c-peptide secretion
66087|NCT02871089|Beta-cell function preservation|beta-cell function preservation
66088|NCT02871089|Continuous glucose monitoring|continuous glucose monitoring
66089|NCT02871050|Biobank|biobank
66090|NCT02871050|biorepository|biorepository
66091|NCT02871050|Castlebank|castlebank
66092|NCT02871050|Castleman Disease|castleman disease
66094|NCT02871050|MCD|mcd
66095|NCT02871050|iMCD|imcd
66096|NCT02871050|Castleman|castleman
66097|NCT02871050|Castleman's Disease|castleman's disease
66098|NCT02871050|multicentric Castleman's disease|multicentric castleman's disease
66099|NCT02871050|multicentric Castleman disease|multicentric castleman disease
66100|NCT02871050|Angiofollicular Lymph Hyperplasia|angiofollicular lymph hyperplasia
66101|NCT02871024|Polymyxin B|polymyxin b
66102|NCT02871024|Pneumonia|pneumonia
66103|NCT02871024|Sepsis|sepsis
66104|NCT02871024|Urinary tract infection|urinary tract infection
66105|NCT02871011|Tinea Bronchodilator Agents|tinea bronchodilator agents
66106|NCT02871011|Tinea Pedis|tinea pedis
66107|NCT02871011|Nitric Oxide|nitric oxide
66108|NCT02871011|Dermatomycoses|dermatomycoses
66109|NCT02871011|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors
66110|NCT02871011|Infectious|infectious
66111|NCT02871011|Infection|infection
66112|NCT02871011|Mycoses|mycoses
66113|NCT02871011|Skin Diseases|skin diseases
66114|NCT02871011|Foot Dermatoses|foot dermatoses
66115|NCT02871011|Foot Diseases|foot diseases
66116|NCT02871011|Pruritus|pruritus
66117|NCT02871011|Skin Manifestations Signs and Symptoms|skin manifestations signs and symptoms
66364|NCT02869035|MRI|mri
66118|NCT02870946|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
66119|NCT02870946|Cardiogenic Shock|cardiogenic shock
66120|NCT02870946|Renal Replacement Therapy|renal replacement therapy
66121|NCT02870933|CD 133+|cd 133+
66122|NCT02870933|Transepicardial with Transseptal Implantation|transepicardial with transseptal implantation
66123|NCT02870933|CABG|cabg
66124|NCT02870907|primary enucleation|primary enucleation
66125|NCT02870907|retinoblastoma|retinoblastoma
66126|NCT02870868|slow breathing|slow breathing
66127|NCT02870868|yoga|yoga
66128|NCT02870868|mind-body practicers|mind-body practicers
66129|NCT02870842|ultrasonography|ultrasonography
66130|NCT02870842|child|child
66131|NCT02870842|perioperative period|perioperative period
66132|NCT02870842|general anesthesia|general anesthesia
66133|NCT02870842|lung|lung
66135|NCT02870777|Acute myeloid leukemia|acute myeloid leukemia
66136|NCT02870764|Danshenduofensuanyan|danshenduofensuanyan
66137|NCT02870764|Lp-PLA2|lp-pla2
66138|NCT02870764|coronary artery disease|coronary artery disease
66139|NCT02870764|Salvia miltiorrhiza|salvia miltiorrhiza
66140|NCT02870751|ETEC|etec
66141|NCT02870751|human challenge study|human challenge study
66142|NCT02870751|heat stable toxin|heat stable toxin
66148|NCT02870712|suture|suture
66149|NCT02870699|chemotherapy neoadjuvant|chemotherapy neoadjuvant
66150|NCT02870686|ERCP|ercp
66151|NCT02870686|EUS guided ERCP without fluoroscopy|eus guided ercp without fluoroscopy
66152|NCT02870673|acupuncture|acupuncture
66153|NCT02870673|electrical stimulation|electrical stimulation
66154|NCT02870673|carpal tunnel syndrome|carpal tunnel syndrome
66155|NCT02870608|Elastography|elastography
66156|NCT02870556|cervical epidural, laryngectomy, pharyngocutaneous fistula|cervical epidural, laryngectomy, pharyngocutaneous fistula
66157|NCT02870543|Bruxism|bruxism
66158|NCT02870543|Sleep bruxism|sleep bruxism
66159|NCT02870543|Sleep related bruxism|sleep related bruxism
66160|NCT02870543|Homeopathy|homeopathy
66161|NCT02870504|laser peripheral iridoplasty|laser peripheral iridoplasty
66162|NCT02870504|treatment|treatment
66163|NCT02870491|Child Diarrhea|child diarrhea
66164|NCT02870491|Cluster Randomized Controlled Trial|cluster randomized controlled trial
66165|NCT02870491|Oral Rehydration|oral rehydration
66166|NCT02870491|ORS|ors
66167|NCT02870491|Zinc|zinc
66168|NCT02870491|Brac|brac
66169|NCT02870491|Community Health Workers|community health workers
66170|NCT02870491|Uganda|uganda
66171|NCT02870465|outpatient versus operating room|outpatient versus operating room
66172|NCT02870465|k wire infection|k wire infection
66173|NCT02870465|closed reduction internal fixation|closed reduction internal fixation
66174|NCT02870452|Haemophilia|haemophilia
66175|NCT02870452|RCT|rct
66176|NCT02870452|Pain|pain
66177|NCT02870452|Hemarthrosis|hemarthrosis
66178|NCT02870452|Hypnosis|hypnosis
66179|NCT02870452|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
66180|NCT02870452|Quality of Life|quality of life
66181|NCT02870452|Distress|distress
66182|NCT02870452|Cytokines|cytokines
66183|NCT02870426|Olfactory ensheathing cells|olfactory ensheathing cells
66184|NCT02870413|telehealth|telehealth
66185|NCT02870387|chronic illness|chronic illness
66186|NCT02870387|children|children
66187|NCT02870387|children with medical complexity|children with medical complexity
66188|NCT02870387|medical home|medical home
66189|NCT02870387|inpatient consultation|inpatient consultation
66190|NCT02870335|low back|low back
66191|NCT02870335|manual therapy|manual therapy
66192|NCT02870335|stretching|stretching
66193|NCT02870322|overweight|overweight
66194|NCT02870322|obesity|obesity
66195|NCT02870322|lifestyle prescription|lifestyle prescription
66196|NCT02870322|prevention|prevention
66197|NCT02870322|physical activity|physical activity
66198|NCT02870322|healthy eating|healthy eating
66199|NCT02870283|Cost effectiveness|cost effectiveness
66200|NCT02870283|Bipolar disorder|bipolar disorder
66201|NCT02870283|Mixed episodes|mixed episodes
66202|NCT02870283|Quality of life|quality of life
66203|NCT02870270|saliva|saliva
66204|NCT02870270|microflora|microflora
66205|NCT02870270|diet|diet
66206|NCT02870270|quality of life|quality of life
66207|NCT02870270|oral cancer|oral cancer
66208|NCT02870244|Melanoma|melanoma
66209|NCT02870244|Gene Therapy|gene therapy
66210|NCT02870244|Adoptive T-Cell Transfer|adoptive t-cell transfer
66211|NCT02870244|IL-2|il-2
66212|NCT02870192|Rectal Prolapse|rectal prolapse
66213|NCT02870179|Pulse Oximetry|pulse oximetry
66214|NCT02870179|Temperature|temperature
66215|NCT02870179|Respiratory Rate|respiratory rate
66216|NCT02870179|Respiratory Gases|respiratory gases
66217|NCT02870179|This study determines the measurement accuracy of the physiological parameters|this study determines the measurement accuracy of the physiological parameters
66218|NCT02870140|CAD|cad
66219|NCT02870140|ACS|acs
66220|NCT02870140|All comers|all comers
66221|NCT02870140|PCI|pci
66222|NCT02870114|Haemophilia|haemophilia
66223|NCT02870114|Quality of Life|quality of life
66224|NCT02870114|Distress|distress
66225|NCT02870114|Hemarthrosis|hemarthrosis
66227|NCT02870101|Nucleic acid amplification tests|nucleic acid amplification tests
66228|NCT02870101|Neisseria gonorrhoeae infection|neisseria gonorrhoeae infection
66229|NCT02870101|Chlamydia trachomatis infection|chlamydia trachomatis infection
66230|NCT02870101|Sexually transmitted diseases|sexually transmitted diseases
66231|NCT02870101|Pharynx|pharynx
66232|NCT02870101|Rectum|rectum
66233|NCT02870101|Gram-Negative Bacterial Infections|gram-negative bacterial infections
57775|NCT02924181|pulmonary vein isolation|pulmonary vein isolation
57776|NCT02924181|contact force sensing catheter|contact force sensing catheter
57781|NCT02924129|Pain|pain
66234|NCT02870101|Bacterial Infections|bacterial infections
66235|NCT02870101|Genital Diseases, Male|genital diseases, male
66236|NCT02870101|Genital Diseases, Female|genital diseases, female
66238|NCT02870062|Critical patient|critical patient
66239|NCT02870062|Healthcare associated infections|healthcare associated infections
66240|NCT02870062|Critical care environment|critical care environment
66241|NCT02870062|Patient colonization|patient colonization
66242|NCT02870049|early detection|early detection
66243|NCT02869971|Prostatic artery embolization|prostatic artery embolization
66244|NCT02869971|Combined Therapy|combined therapy
66246|NCT02869958|Asthma|asthma
66247|NCT02869958|Exacerbation|exacerbation
66248|NCT02869958|Treatment|treatment
66249|NCT02869958|Internet|internet
66250|NCT02869958|Emergency care|emergency care
66251|NCT02869945|de novo untreated Parkinson Disease|de novo untreated parkinson disease
66252|NCT02869945|genetic|genetic
66253|NCT02869945|COMT Polymorphism|comt polymorphism
66254|NCT02869945|gene|gene
66255|NCT02869945|brain MRI|brain mri
66256|NCT02869945|brain MPET|brain mpet
66257|NCT02869841|laparotomy|laparotomy
66258|NCT02869841|pain|pain
66259|NCT02869841|rectus sheath block|rectus sheath block
66260|NCT02869815|Methylene blue|methylene blue
66261|NCT02869815|Indocyanine green|indocyanine green
66262|NCT02869815|Neoadjuvant Therapy|neoadjuvant therapy
66263|NCT02869815|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
66264|NCT02869815|Breast Neoplasms|breast neoplasms
66265|NCT02869802|Cancer|cancer
66266|NCT02869802|Pancreatic Cancer|pancreatic cancer
66267|NCT02869802|Advanced Pancreatic Ductal Adenocarcinoma|advanced pancreatic ductal adenocarcinoma
66268|NCT02869802|PDAC|pdac
66269|NCT02869802|Genomic Analysis|genomic analysis
66270|NCT02869802|Molecular subtyping|molecular subtyping
66271|NCT02869763|Ethanol|ethanol
66272|NCT02869763|Steroid profile|steroid profile
66273|NCT02869763|Pharmacokinetics|pharmacokinetics
66274|NCT02869737|Point of Care Device; post traumatic coagulopathy|point of care device; post traumatic coagulopathy
66275|NCT02869724|IMV : voluntary drug intoxications|imv : voluntary drug intoxications
66276|NCT02869724|Drug|drug
66277|NCT02869724|Divided prescription|divided prescription
66278|NCT02869672|safety|safety
66279|NCT02869672|immunogenicity|immunogenicity
66280|NCT02869672|vaccine|vaccine
66281|NCT02869659|obesity|obesity
66282|NCT02869659|pre-diabetes|pre-diabetes
66283|NCT02869659|overweight|overweight
66284|NCT02869659|lifestyle change|lifestyle change
66285|NCT02869659|glucose|glucose
66286|NCT02869646|PTSD|ptsd
66287|NCT02869646|acupuncture|acupuncture
66288|NCT02869646|integrative medicine|integrative medicine
66289|NCT02869464|Aneurysm|aneurysm
66290|NCT02869464|Intracranial Aneurysm|intracranial aneurysm
66291|NCT02869464|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
66292|NCT02869438|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
66293|NCT02869399|head and neck cancer, nutritional intervention|head and neck cancer, nutritional intervention
66294|NCT02869386|stroke|stroke
66295|NCT02869386|prehospital|prehospital
66296|NCT02869386|telemedicine|telemedicine
66297|NCT02869386|thrombolysis|thrombolysis
66298|NCT02869386|thrombectomy|thrombectomy
66299|NCT02869386|endovascular treatment|endovascular treatment
66300|NCT02869386|functional outcome|functional outcome
66301|NCT02869347|recombinant C1 esterase inhibitor|recombinant c1 esterase inhibitor
66302|NCT02869347|acute kidney injury|acute kidney injury
66303|NCT02869347|coronary angiography|coronary angiography
66304|NCT02869347|contrast media|contrast media
66305|NCT02869347|Conestat alfa|conestat alfa
66306|NCT02869347|inflammation|inflammation
66307|NCT02869308|Cardiomyopathy|cardiomyopathy
66308|NCT02869308|Chemotherapy|chemotherapy
66309|NCT02869308|Left ventricular ejection fraction|left ventricular ejection fraction
66310|NCT02869295|Metastatic Solid Tumors|metastatic solid tumors
66311|NCT02869295|Locally Advanced Solid Tumors|locally advanced solid tumors
66312|NCT02869256|chronic myeloid leukemia|chronic myeloid leukemia
66313|NCT02869256|practices evaluation|practices evaluation
66314|NCT02869243|A malignant growing astrocytoma of central nervous system|a malignant growing astrocytoma of central nervous system
66315|NCT02869230|Breast cancer|breast cancer
66316|NCT02869230|Non palpable breast lesions|non palpable breast lesions
66317|NCT02869230|radioguided occult lesion localization|radioguided occult lesion localization
66418|NCT02868788|insulin resistance|insulin resistance
66318|NCT02869217|NY-ESO-1 expressing solid tumors in HLA-A2 positive patients|ny-eso-1 expressing solid tumors in hla-a2 positive patients
66319|NCT02869165|Postmenopausal|postmenopausal
66320|NCT02869152|sentinel lymph node|sentinel lymph node
57885|NCT02923544|Uterine Manipulator|uterine manipulator
57886|NCT02923544|Yukio's Uterine Manipulating Instrument (YUMI)|yukio's uterine manipulating instrument (yumi)
57887|NCT02923544|16-1397|16-1397
66321|NCT02869152|lymphatic mapping|lymphatic mapping
66322|NCT02869152|rectal tumor|rectal tumor
66323|NCT02869152|rectal cancer|rectal cancer
66324|NCT02869152|early stage|early stage
66325|NCT02869139|Thirst|thirst
66327|NCT02869139|Menthol|menthol
66328|NCT02869139|Perioperative Nursing.|perioperative nursing.
66329|NCT02869139|Recovery Room|recovery room
66330|NCT02869126|99mTc-Sestamibi|99mtc-sestamibi
66334|NCT02869100|sodium fluoride positron emission tomography|sodium fluoride positron emission tomography
66335|NCT02869074|von Willebrand disease (VWD)|von willebrand disease (vwd)
66336|NCT02869074|von Willebrand factor (VWF)|von willebrand factor (vwf)
66337|NCT02869074|von Willebrand factor gene|von willebrand factor gene
66338|NCT02869074|next generation sequencing|next generation sequencing
66340|NCT02869074|VWD Spanish Cohort|vwd spanish cohort
66341|NCT02869061|Bladder neck obstruction|bladder neck obstruction
66342|NCT02869061|Bladder outlet obstruction|bladder outlet obstruction
66343|NCT02869061|Benign prostatic hyperplasia|benign prostatic hyperplasia
66344|NCT02869061|Urinary bladder neck obstruction|urinary bladder neck obstruction
66345|NCT02869061|Bladder neck contracture|bladder neck contracture
66346|NCT02869061|Bladder neck stricture|bladder neck stricture
66347|NCT02869061|Bladder neck stenosis|bladder neck stenosis
66348|NCT02869061|Transurethral resection of the prostate|transurethral resection of the prostate
66349|NCT02869061|Prostatectomy|prostatectomy
66350|NCT02869061|Stromal vascular fraction (SVF)|stromal vascular fraction (svf)
66351|NCT02869061|Adipose-derived regenerative cells (ADRC)|adipose-derived regenerative cells (adrc)
66352|NCT02869061|Adipose tissue|adipose tissue
66353|NCT02869061|Stem cells|stem cells
66354|NCT02869048|Biological Specimen Banks|biological specimen banks
66355|NCT02869048|Innate Immunity|innate immunity
66356|NCT02869048|Clinical Study|clinical study
66357|NCT02869048|Complement system proteins|complement system proteins
66358|NCT02869048|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
66359|NCT02869048|Neurodegenerative disease|neurodegenerative disease
66360|NCT02869048|Motor neuron disease|motor neuron disease
66361|NCT02869035|PET|pet
66362|NCT02869035|Serotonin|serotonin
66363|NCT02869035|5-HT4R|5-ht4r
66365|NCT02869035|fMRI|fmri
66366|NCT02869035|EEG|eeg
66367|NCT02869035|Cortisol awakening response|cortisol awakening response
66368|NCT02869035|Oxidative stress|oxidative stress
66369|NCT02869035|Mental health|mental health
66370|NCT02869035|Prediction of treatment response|prediction of treatment response
66371|NCT02869035|Inflammation|inflammation
66372|NCT02869035|5-HTTLPR|5-httlpr
66373|NCT02869035|Brain imaging|brain imaging
66374|NCT02869035|Early life stress|early life stress
66375|NCT02869035|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
66376|NCT02869035|Escitalopram|escitalopram
66377|NCT02869035|Psychometrics|psychometrics
66378|NCT02869035|Moderate depression|moderate depression
66379|NCT02869035|Severe depression|severe depression
66380|NCT02869035|ERP|erp
66381|NCT02869035|rsfMRI|rsfmri
66382|NCT02869035|11C-SB207145|11c-sb207145
66383|NCT02869035|Sexual function|sexual function
66385|NCT02869035|Affective cognition|affective cognition
66386|NCT02869035|Cold cognition|cold cognition
66387|NCT02869035|Social cognition|social cognition
66388|NCT02869035|Anxiety|anxiety
66389|NCT02869009|stroke|stroke
66390|NCT02869009|clopidogrel|clopidogrel
66391|NCT02869009|antiplatelets|antiplatelets
66392|NCT02868957|CAD|cad
66393|NCT02868957|Digital imaging|digital imaging
66394|NCT02868957|Prosthetic Dentistry|prosthetic dentistry
66395|NCT02868931|self-management|self-management
66396|NCT02868931|empowerment|empowerment
66397|NCT02868931|treatment and education program|treatment and education program
66398|NCT02868931|insulin pump|insulin pump
66399|NCT02868931|diabetes education|diabetes education
66400|NCT02868866|physical activity|physical activity
66401|NCT02868866|nutrition|nutrition
66402|NCT02868866|fruits and vegetables|fruits and vegetables
66403|NCT02868866|faith-based|faith-based
66404|NCT02868866|churches|churches
66405|NCT02868853|diet|diet
66406|NCT02868853|weight loss|weight loss
66407|NCT02868853|tracking|tracking
66408|NCT02868853|mobile|mobile
66409|NCT02868853|calories|calories
66410|NCT02868840|stroke|stroke
66411|NCT02868840|Tai ji|tai ji
66412|NCT02868840|postural balance|postural balance
66413|NCT02868840|cognition|cognition
66414|NCT02868827|cholecalciferol and critical illness|cholecalciferol and critical illness
66415|NCT02868827|Mortality and cholecalciferol supplementation|mortality and cholecalciferol supplementation
66416|NCT02868801|Pregabalin|pregabalin
66417|NCT02868788|inflammation|inflammation
77076|NCT02802449|HTN|htn
66419|NCT02868788|type 2 diabetes|type 2 diabetes
66420|NCT02868788|obesity|obesity
66421|NCT02868762|neck pain, voice disorder|neck pain, voice disorder
66422|NCT02868749|Hyaluronic Acid|hyaluronic acid
66423|NCT02868749|histology|histology
66424|NCT02868749|ultrasound|ultrasound
66425|NCT02868749|subcutaneous|subcutaneous
66426|NCT02868749|adipose tissue|adipose tissue
66427|NCT02868723|cerebrovascular disease|cerebrovascular disease
66429|NCT02868723|stroke management|stroke management
66430|NCT02868723|prognosis|prognosis
66431|NCT02868723|3D Carotid Doppler Imaging|3d carotid doppler imaging
66432|NCT02868723|Randomization|randomization
66433|NCT02868710|primary prevention|primary prevention
66434|NCT02868671|mild TBI|mild tbi
66435|NCT02868671|Post-traumatic Stress Disorders|post-traumatic stress disorders
66436|NCT02868671|Acupuncture|acupuncture
66437|NCT02868658|Influenza|influenza
66438|NCT02868658|health care workers|health care workers
66439|NCT02868658|nosocomial|nosocomial
66440|NCT02868658|asymptomatic|asymptomatic
66441|NCT02868658|France|france
66442|NCT02868632|Unresectable|unresectable
66443|NCT02868632|Locally Advanced|locally advanced
66444|NCT02868632|Non-Metastatic|non-metastatic
66445|NCT02868619|fMRI|fmri
66446|NCT02868619|Deep brain stimulation|deep brain stimulation
66447|NCT02868619|Food|food
66448|NCT02868619|Eating|eating
66449|NCT02868619|Reward|reward
66451|NCT02868580|Antiretroviral Therapy, Triumeq|antiretroviral therapy, triumeq
66452|NCT02868541|microorganisms|microorganisms
66453|NCT02868541|pilgrim|pilgrim
66454|NCT02868541|hajj|hajj
66455|NCT02868528|advanced age women|advanced age women
66456|NCT02868528|blastocyst culture|blastocyst culture
66457|NCT02868528|PGS|pgs
66458|NCT02868528|live birth rate|live birth rate
66459|NCT02868502|Glaucoma|glaucoma
66460|NCT02868502|Open Angle Glaucoma|open angle glaucoma
66461|NCT02868502|Intra Ocular Pressure|intra ocular pressure
66462|NCT02868502|Ocular Hypotensive Drops|ocular hypotensive drops
66463|NCT02868502|Trabeculectomy|trabeculectomy
66464|NCT02868502|Cyclophotocoagulation|cyclophotocoagulation
66465|NCT02868502|Glaucoma Drainage Device|glaucoma drainage device
66466|NCT02868489|Microbiota|microbiota
66467|NCT02868463|oxygen tension|oxygen tension
66468|NCT02868463|Female Urinary Microbiome|female urinary microbiome
66469|NCT02868463|Urinary Tract Symptoms|urinary tract symptoms
66470|NCT02868463|Urine Oxygen Level|urine oxygen level
66471|NCT02868398|Ulcerative Colitis|ulcerative colitis
66472|NCT02868398|Golimumab|golimumab
66473|NCT02868398|Deep and prolonged remission|deep and prolonged remission
66474|NCT02868385|Schistosomiasis|schistosomiasis
66475|NCT02868385|Schistosoma mansoni|schistosoma mansoni
66476|NCT02868385|Bilharzia|bilharzia
66477|NCT02868372|Cesarean section|cesarean section
66478|NCT02868372|Betadine|betadine
66479|NCT02868372|Wound infection|wound infection
66480|NCT02868320|SMS|sms
66481|NCT02868320|text messaging|text messaging
66482|NCT02868320|diabetes self management|diabetes self management
66483|NCT02868320|glycemic control|glycemic control
66484|NCT02868320|mHealth|mhealth
66485|NCT02868320|mobile health|mobile health
66486|NCT02868320|diabetes education|diabetes education
66487|NCT02868281|Cluster Randomization|cluster randomization
66488|NCT02868281|Peak Expiratory Flow|peak expiratory flow
66489|NCT02868281|Forced Expiratory Volume|forced expiratory volume
66490|NCT02868281|Standardized Asthma Quality of Life Questionnaire|standardized asthma quality of life questionnaire
66491|NCT02868281|Asthma Control Test|asthma control test
66492|NCT02868268|Neuroblastoma|neuroblastoma
66493|NCT02868255|Biobank analyses|biobank analyses
66494|NCT02868255|Effect evaluation of the drug|effect evaluation of the drug
66495|NCT02868255|patient-derived cells|patient-derived cells
66496|NCT02868255|SIRPα/CD47 expression|sirpα/cd47 expression
66497|NCT02868242|HCV genotype 1 or 4 (GT-1 or GT-4)|hcv genotype 1 or 4 (gt-1 or gt-4)
66498|NCT02868242|Direct Acting Antiviral|direct acting antiviral
66499|NCT02868242|Combination Therapy|combination therapy
66500|NCT02868242|Hepatitis C, Chronic|hepatitis c, chronic
66501|NCT02868242|Liver Diseases|liver diseases
66502|NCT02868242|Virus Diseases|virus diseases
66503|NCT02868177|Prevention|prevention
66504|NCT02868151|Oral mucositis, chemo radiotherapy, vitamin c,|oral mucositis, chemo radiotherapy, vitamin c,
66505|NCT02868138|Sickle cell disease|sickle cell disease
66506|NCT02868138|Hydroxyurea|hydroxyurea
66507|NCT02868138|Compliance|compliance
66508|NCT02868125|pertrochanteric|pertrochanteric
66509|NCT02868125|radiography|radiography
66510|NCT02868112|Cancer Care|cancer care
66511|NCT02868112|Palliative Care|palliative care
66512|NCT02868112|Geriatrics|geriatrics
66513|NCT02868112|Quality of Life|quality of life
66514|NCT02868086|Age-related macular degeneration|age-related macular degeneration
66515|NCT02868086|Optical coherence tomography angiography|optical coherence tomography angiography
66516|NCT02868047|chronic pancreatitis|chronic pancreatitis
66517|NCT02868047|endoscopic ultrasound|endoscopic ultrasound
66518|NCT02868034|Low Back Pain|low back pain
66519|NCT02868034|Spinal Manipulation|spinal manipulation
66522|NCT02868021|Exercise|exercise
66523|NCT02868008|multimodal imaging|multimodal imaging
66524|NCT02868008|surgical risk|surgical risk
66525|NCT02868008|arteriovenous malformations|arteriovenous malformations
66526|NCT02867982|platform switching|platform switching
66528|NCT02867982|soft tissue thickness|soft tissue thickness
66529|NCT02867982|dental implant|dental implant
66530|NCT02867969|Spinocerebellar ataxia|spinocerebellar ataxia
66531|NCT02867969|Exergaming|exergaming
66532|NCT02867969|Neurodegenerative diseases|neurodegenerative diseases
66533|NCT02867969|Rare disease|rare disease
66534|NCT02867969|Motor exercises|motor exercises
66535|NCT02867969|Premanifest stage|premanifest stage
66536|NCT02867969|Training|training
66537|NCT02867956|Ovarian cancer|ovarian cancer
66538|NCT02867956|Apatinib|apatinib
66539|NCT02867956|Etoposide|etoposide
66540|NCT02867956|Chemotherapy|chemotherapy
66541|NCT02867943|sepsis, shock,Lactate,volume controlled ventilation|sepsis, shock,lactate,volume controlled ventilation
66542|NCT02867930|Echocardiography|echocardiography
66543|NCT02867930|Transesophageal|transesophageal
66544|NCT02867930|Dexmedetomidine|dexmedetomidine
66545|NCT02867930|Ketamine|ketamine
66546|NCT02867930|Propofol|propofol
66547|NCT02867917|Fibers|fibers
66548|NCT02867917|Constipation|constipation
66549|NCT02867891|FLT3-ITD|flt3-itd
66550|NCT02867891|AML|aml
66551|NCT02867891|allo-HSCT|allo-hsct
66552|NCT02867839|Gastric cancer|gastric cancer
66553|NCT02867839|Adjuvant chemotherapy|adjuvant chemotherapy
66554|NCT02867839|S1|s1
66555|NCT02867839|Oxaliplatin|oxaliplatin
66556|NCT02867826|Endoscopy|endoscopy
66557|NCT02867826|Ampulla of Vater|ampulla of vater
66558|NCT02867826|Duodenoscopy|duodenoscopy
66559|NCT02867813|High Cholesterol|high cholesterol
66560|NCT02867813|Treatment for high cholesterol|treatment for high cholesterol
66561|NCT02867813|Lowering cholesterol|lowering cholesterol
66562|NCT02867813|Lowering high cholesterol|lowering high cholesterol
66563|NCT02867813|Hypercholesterolemia|hypercholesterolemia
66564|NCT02867800|Sickle Cell Disease|sickle cell disease
66565|NCT02867800|Graft Versus Host Disease|graft versus host disease
66566|NCT02867800|Abatacept|abatacept
66567|NCT02867800|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
66568|NCT02867787|Shoulder Joint|shoulder joint
66569|NCT02867787|A02.835.583.748|a02.835.583.748
66570|NCT02867774|chronic pelvic pain|chronic pelvic pain
66571|NCT02867774|central pain amplification|central pain amplification
66572|NCT02867774|exercise|exercise
66573|NCT02867774|physical activity|physical activity
66574|NCT02867761|COPD|copd
66575|NCT02867761|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
66576|NCT02867761|Pulmonary Function Tests|pulmonary function tests
66577|NCT02867761|Current Smoker|current smoker
66578|NCT02867761|Former Smoker|former smoker
66579|NCT02867761|Chronic Obstructive Airway Disease|chronic obstructive airway disease
66580|NCT02867761|Respiratory Symptoms|respiratory symptoms
66581|NCT02867748|tvt abbrevo , Serasis|tvt abbrevo , serasis
66582|NCT02867735|Macular Edema|macular edema
66583|NCT02867735|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
66979|NCT02865226|thoracotomy|thoracotomy
66586|NCT02867696|Bariatric Surgery|bariatric surgery
66587|NCT02867696|Physical Activity|physical activity
66588|NCT02867696|Weight Management|weight management
66589|NCT02867696|Weight Loss|weight loss
66593|NCT02867670|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
66594|NCT02867644|conversational hypnosis|conversational hypnosis
66595|NCT02867644|imaging|imaging
66596|NCT02867644|care|care
66597|NCT02867644|breast neoplasia|breast neoplasia
66598|NCT02867644|anxiety|anxiety
66599|NCT02867644|pain|pain
66600|NCT02867631|Intervention study|intervention study
66601|NCT02867631|Maternal obesity|maternal obesity
66602|NCT02867631|Nutrition|nutrition
66603|NCT02867631|Maternal child health|maternal child health
66604|NCT02867514|tobacco|tobacco
66605|NCT02867514|craving|craving
66606|NCT02867514|tDCS|tdcs
66607|NCT02867514|attentional tasks|attentional tasks
66608|NCT02867501|venous distension|venous distension
66609|NCT02867501|venous reflux|venous reflux
66610|NCT02867488|carotenoids|carotenoids
66611|NCT02867488|phylloquinone|phylloquinone
66612|NCT02867488|tocopherols|tocopherols
66613|NCT02867488|vitamin A|vitamin a
66614|NCT02867384|Graft vs. Host Disease|graft vs. host disease
66615|NCT02867358|acute uncomplicated influenza|acute uncomplicated influenza
66616|NCT02867319|safety|safety
66617|NCT02867319|vaccine|vaccine
66618|NCT02867306|methotrexate (MTX)|methotrexate (mtx)
66619|NCT02867306|Pharmacokinetics|pharmacokinetics
66620|NCT02867306|ASP1707|asp1707
66621|NCT02867306|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
66622|NCT02867280|Sorafenib|sorafenib
66623|NCT02867280|Microvascular invasion|microvascular invasion
66624|NCT02867280|adjuvant therapy|adjuvant therapy
66625|NCT02867280|hepatocellular carcinoma|hepatocellular carcinoma
66626|NCT02867267|thymosin alpha 1; thymalfasin; sepsis; immunodepression|thymosin alpha 1; thymalfasin; sepsis; immunodepression
66627|NCT02867254|candida|candida
66628|NCT02867254|endodontic lesion|endodontic lesion
66629|NCT02867254|diabetes|diabetes
66630|NCT02867202|intrauterine balloon|intrauterine balloon
66631|NCT02867202|intrauterine contraceptive device|intrauterine contraceptive device
66632|NCT02867202|Asherman Syndrome|asherman syndrome
66633|NCT02867189|anterior chamber flare|anterior chamber flare
66634|NCT02867189|cataract|cataract
66635|NCT02867189|intraocular pressure|intraocular pressure
66636|NCT02867189|micro-instrument|micro-instrument
66637|NCT02867189|photograph-based atlas|photograph-based atlas
66639|NCT02867189|training nurse|training nurse
66640|NCT02867111|sperm selection|sperm selection
66641|NCT02867111|ICSI|icsi
66642|NCT02867111|Assisted Reproductive Techniques|assisted reproductive techniques
66643|NCT02867098|healthy|healthy
66644|NCT02867098|volunteer|volunteer
66645|NCT02867085|MDS|mds
66646|NCT02867085|Myelodysplastic Syndromes|myelodysplastic syndromes
66647|NCT02867033|desmoid tumour|desmoid tumour
66648|NCT02867020|apalutamide|apalutamide
66649|NCT02867020|abiraterone|abiraterone
66650|NCT02867020|prostate cancer|prostate cancer
66651|NCT02867007|KW-0761|kw-0761
66652|NCT02867007|KHK2455|khk2455
66653|NCT02867007|Metastatic Solid Tumors|metastatic solid tumors
66654|NCT02867007|Locally Advanced Solid Tumors|locally advanced solid tumors
66655|NCT02867007|Mogamulizumab|mogamulizumab
66656|NCT02867007|Oncology|oncology
66657|NCT02867007|Anti-Tumor|anti-tumor
66658|NCT02866994|Women|women
66659|NCT02866981|Brain Metastases|brain metastases
66660|NCT02866955|aromatase inhibitors|aromatase inhibitors
66661|NCT02866955|Metastases|metastases
66662|NCT02866929|orthodontics|orthodontics
66663|NCT02866929|periodontics|periodontics
66664|NCT02866929|piezosurgery|piezosurgery
66665|NCT02866929|accelerated orthodontics|accelerated orthodontics
66666|NCT02866929|Surgically Accelerated Orthodontic Treatment|surgically accelerated orthodontic treatment
66667|NCT02866903|Peritoneal carcinosis|peritoneal carcinosis
66668|NCT02866903|intraperitoneal (IP) OXAliplatin|intraperitoneal (ip) oxaliplatin
66669|NCT02866903|Phase I/II dose escalation trial|phase i/ii dose escalation trial
66670|NCT02866903|FOLFIRI Bevacizumab chemotherapy|folfiri bevacizumab chemotherapy
66671|NCT02866890|Laryngeal Tube Suction|laryngeal tube suction
66672|NCT02866890|seal pressure|seal pressure
66673|NCT02866890|mechanical ventilation|mechanical ventilation
66674|NCT02866877|augmented renal clearance|augmented renal clearance
66675|NCT02866864|Allergen|allergen
66676|NCT02866864|Veterinary|veterinary
66677|NCT02866864|Allergy|allergy
66678|NCT02866864|Animals|animals
66679|NCT02866838|Tranexamic acid|tranexamic acid
66680|NCT02866838|NOAC|noac
66681|NCT02866838|Direct Oral Anticoagulant (DOAC)|direct oral anticoagulant (doac)
66682|NCT02866838|Direct oral anticoagulants|direct oral anticoagulants
66683|NCT02866838|Non-Vitamin K antagonist oral anticoagulants|non-vitamin k antagonist oral anticoagulants
66684|NCT02866825|Inflammation|inflammation
66685|NCT02866825|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
66686|NCT02866825|Pathologic Processes|pathologic processes
66687|NCT02866825|Organ Dysfunction|organ dysfunction
66688|NCT02866799|Multimorbidity|multimorbidity
66689|NCT02866799|Primary Health Care|primary health care
66690|NCT02866799|Polypharmacy|polypharmacy
66691|NCT02866799|Comorbidity|comorbidity
66692|NCT02866799|Medication Adherence|medication adherence
66693|NCT02866799|Medication Appropriateness Index|medication appropriateness index
66694|NCT02866799|Patient-Centered Care|patient-centered care
66695|NCT02866773|Family|family
66696|NCT02866773|well-being|well-being
66697|NCT02866773|Physical activity|physical activity
66698|NCT02866773|Diet|diet
66699|NCT02866760|Smoking Cessation|smoking cessation
66700|NCT02866734|Diabetic Retinopathy|diabetic retinopathy
66701|NCT02866734|Screening|screening
66702|NCT02866734|Fee for screening|fee for screening
66703|NCT02866734|Private practice|private practice
66704|NCT02866721|Human Mesenchymal Stem Cells|human mesenchymal stem cells
66705|NCT02866695|Actinic Keratosis|actinic keratosis
66706|NCT02866695|lung transplant|lung transplant
66707|NCT02866695|kidney transplant|kidney transplant
66708|NCT02866643|contraceptive implant|contraceptive implant
66709|NCT02866643|postpartum contraception|postpartum contraception
66710|NCT02866643|breastfeeding and contraception|breastfeeding and contraception
66711|NCT02866630|Sevoflurane|sevoflurane
66712|NCT02866630|Desflurane|desflurane
66713|NCT02866630|Coronary Sinus|coronary sinus
66714|NCT02866630|Oxygenator Exhaust|oxygenator exhaust
66715|NCT02866630|Lactate|lactate
66716|NCT02866630|Cardiopulmonary bypass|cardiopulmonary bypass
66717|NCT02866617|Quality of Life|quality of life
77455|NCT02800356|Lasers|lasers
66718|NCT02866617|Vacuum formed thermoplastic retainer|vacuum formed thermoplastic retainer
66719|NCT02866617|Orthodontic study model|orthodontic study model
66720|NCT02866617|3D reconstructed study model|3d reconstructed study model
66721|NCT02866604|Traumatic brain injury|traumatic brain injury
66722|NCT02866604|isotonic balanced fluid|isotonic balanced fluid
66723|NCT02866591|mammography|mammography
66724|NCT02866591|pain|pain
66725|NCT02866591|quality of life|quality of life
66727|NCT02866591|image quality|image quality
66728|NCT02866591|radiology|radiology
66729|NCT02866526|adolescents|adolescents
66730|NCT02866526|young adults|young adults
66731|NCT02866448|Cardiovascular disease|cardiovascular disease
66732|NCT02866448|Flavonoid|flavonoid
66733|NCT02866448|Isoquercetin|isoquercetin
66734|NCT02866448|Aspirin|aspirin
625996|NCT00683891|FazaClo|fazaclo
66735|NCT02866448|Platelet function|platelet function
66736|NCT02866448|Vascular function|vascular function
66737|NCT02866448|Blood pressure|blood pressure
66738|NCT02866435|MRI|mri
66739|NCT02866422|OCD|ocd
66740|NCT02866409|dexmedetomidine|dexmedetomidine
66741|NCT02866409|nerve block|nerve block
66742|NCT02866409|anesthesia infiltration|anesthesia infiltration
66743|NCT02866396|chronic pain|chronic pain
66744|NCT02866396|oxycodone|oxycodone
66745|NCT02866396|pregabalin|pregabalin
66746|NCT02866396|lumbar spine surgery|lumbar spine surgery
66747|NCT02866396|multimodal analgesia|multimodal analgesia
66748|NCT02866344|Microwave ablation|microwave ablation
66749|NCT02866344|Ablation techniques|ablation techniques
66750|NCT02866344|Operative surgical procedures|operative surgical procedures
66751|NCT02866344|Hepatic resection|hepatic resection
66752|NCT02866344|Surgery|surgery
66753|NCT02866344|Outcomes assessment|outcomes assessment
66754|NCT02866305|primary spontaneous pneumothorax|primary spontaneous pneumothorax
66755|NCT02866305|epidemiology|epidemiology
66756|NCT02866305|genetics|genetics
66757|NCT02866305|risk factors|risk factors
66758|NCT02866292|Pelvic Floor|pelvic floor
66759|NCT02866292|Pregnancy|pregnancy
66760|NCT02866292|Physical Therapy Specialty|physical therapy specialty
66761|NCT02866253|Dehydroepiandrosterone（DHEA）|dehydroepiandrosterone（dhea）
66762|NCT02866253|DOR（Diminished Ovarian Reserve)|dor（diminished ovarian reserve)
66763|NCT02866253|IVF(In vitro fertilization)|ivf(in vitro fertilization)
66764|NCT02866253|BMP-15(Bone Morphogenetic Protein 15)|bmp-15(bone morphogenetic protein 15)
66765|NCT02866227|Bacterial|bacterial
66766|NCT02866227|Candidiasis|candidiasis
66767|NCT02866227|Gel|gel
66768|NCT02866227|Insert|insert
66769|NCT02866227|TOL-463|tol-463
66770|NCT02866227|Vaginal|vaginal
66771|NCT02866227|Vaginitis|vaginitis
66772|NCT02866227|Vaginoses|vaginoses
66773|NCT02866227|Vulvovaginal|vulvovaginal
66774|NCT02866201|Turista|turista
66775|NCT02866175|percutaneous intervention|percutaneous intervention
66776|NCT02866175|vitamin K antagonist|vitamin k antagonist
66777|NCT02866149|Cancer|cancer
66778|NCT02866149|circulating tumor biomarkers|circulating tumor biomarkers
66779|NCT02866149|circulating tumor DNA|circulating tumor dna
66780|NCT02866149|Circulating tumor Cell (CTC)|circulating tumor cell (ctc)
66882|NCT02865590|Bone Substitutes|bone substitutes
66781|NCT02866097|integrated community case management|integrated community case management
66782|NCT02866097|Mobile Health (mHealth)|mobile health (mhealth)
66783|NCT02866097|rapid diagnostic test|rapid diagnostic test
66784|NCT02866097|artemether-lumefantrine|artemether-lumefantrine
66785|NCT02866097|amoxicillin|amoxicillin
66786|NCT02866097|zinc|zinc
66787|NCT02866097|oral rehydration solution (ORS)|oral rehydration solution (ors)
66788|NCT02866097|District Health Information System 2 (DHIS2)|district health information system 2 (dhis2)
66789|NCT02866097|iCCM-DHIS2|iccm-dhis2
66790|NCT02866097|ZCAHRD|zcahrd
66791|NCT02866084|vestibular migraines|vestibular migraines
66792|NCT02866084|dizziness|dizziness
66793|NCT02866084|migraine headache|migraine headache
66794|NCT02866045|Subepithelial lesions|subepithelial lesions
66795|NCT02866045|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
66796|NCT02866006|HPV|hpv
66797|NCT02866006|Type 16, 18|type 16, 18
66798|NCT02866006|E6E7|e6e7
66799|NCT02866006|Immune therapeutic vaccine|immune therapeutic vaccine
66800|NCT02865993|cesarean section|cesarean section
66801|NCT02865993|cesarean section complications|cesarean section complications
66802|NCT02865993|betadine irrigation|betadine irrigation
66803|NCT02865980|inflammation, infection|inflammation, infection
66804|NCT02865967|Decision Support Techniques|decision support techniques
66805|NCT02865967|Delayed Diagnosis|delayed diagnosis
66806|NCT02865967|Natural Language Processing|natural language processing
66807|NCT02865967|Geographic Information Systems|geographic information systems
66808|NCT02865941|Target Fortification|target fortification
66809|NCT02865941|Breast milk analysis|breast milk analysis
66810|NCT02865941|Nutrition|nutrition
66811|NCT02865941|Macronutrient intake|macronutrient intake
58382|NCT02921035|Rebif®|rebif®
66812|NCT02865941|Protein accretion|protein accretion
66813|NCT02865915|Acne|acne
66814|NCT02865915|Hirsutism|hirsutism
66815|NCT02865915|Menstrual Irregularity|menstrual irregularity
66816|NCT02865915|Alopecia|alopecia
66817|NCT02865902|Low level laser therapy|low level laser therapy
66818|NCT02865902|wound healing|wound healing
66819|NCT02865902|periodontology|periodontology
66820|NCT02865889|laparoscopic surgery|laparoscopic surgery
66821|NCT02865889|Uterine Neoplasms|uterine neoplasms
66822|NCT02865876|Infectious keratitis|infectious keratitis
66823|NCT02865876|Cross-linking|cross-linking
66824|NCT02865863|Multivitamin|multivitamin
66825|NCT02865863|Eurycomalongifoliawater extract|eurycomalongifoliawater extract
66826|NCT02865863|Quality of Life|quality of life
66828|NCT02865850|vadadustat|vadadustat
66829|NCT02865850|AKB-6548|akb-6548
66830|NCT02865850|anemia|anemia
66831|NCT02865850|chronic kidney disease|chronic kidney disease
66832|NCT02865850|CKD|ckd
66833|NCT02865850|chronic renal insufficiency|chronic renal insufficiency
66834|NCT02865850|renal impairment|renal impairment
66835|NCT02865850|erythropoietin|erythropoietin
66836|NCT02865850|kidney|kidney
66837|NCT02865850|renal|renal
66838|NCT02865850|oral anemia treatment|oral anemia treatment
66839|NCT02865850|hemoglobin|hemoglobin
66840|NCT02865850|hypoxia-inducible factor|hypoxia-inducible factor
66841|NCT02865850|HIF|hif
66842|NCT02865850|efficacy|efficacy
66843|NCT02865850|safety|safety
66844|NCT02865850|phase 3|phase 3
66845|NCT02865850|cardiovascular|cardiovascular
66846|NCT02865837|Brachytherapy|brachytherapy
66847|NCT02865837|Organs at Risk|organs at risk
66848|NCT02865837|Bladder volume|bladder volume
66849|NCT02865837|Cervical cancer|cervical cancer
66850|NCT02865824|Colonoscopy|colonoscopy
66851|NCT02865811|Ovarian Cancer|ovarian cancer
66852|NCT02865798|Heart Valve Diseases|heart valve diseases
66853|NCT02865798|Cardiovascular Diseases|cardiovascular diseases
66854|NCT02865798|Heart Disease|heart disease
66855|NCT02865798|Valvular Heart Diseases|valvular heart diseases
66856|NCT02865785|recurrent implantation failure|recurrent implantation failure
66857|NCT02865785|intralipid|intralipid
66858|NCT02865785|uterine natural killer cells|uterine natural killer cells
66859|NCT02865746|Steroids|steroids
66860|NCT02865746|Pain measurement|pain measurement
66861|NCT02865733|Remodulin®|remodulin®
66862|NCT02865733|pulmonary vascular resistance|pulmonary vascular resistance
66863|NCT02865733|univentricular physiology|univentricular physiology
66864|NCT02865707|ulcerative colitis|ulcerative colitis
66865|NCT02865707|prebiotics|prebiotics
66866|NCT02865707|b-fructans|b-fructans
66867|NCT02865707|inulin|inulin
66868|NCT02865707|oligofructose|oligofructose
66869|NCT02865707|intestinal microbiota|intestinal microbiota
66870|NCT02865681|Infertility|infertility
66871|NCT02865681|Gonadotropins|gonadotropins
66872|NCT02865681|Menopur|menopur
66873|NCT02865681|Ovarian stimulation|ovarian stimulation
66874|NCT02865642|Stroke|stroke
66875|NCT02865642|Serotonin|serotonin
66876|NCT02865642|Hand Paresis|hand paresis
66877|NCT02865616|CDI|cdi
66878|NCT02865616|recurrent infection|recurrent infection
66879|NCT02865616|MET-2|met-2
66880|NCT02865616|C. difficile|c. difficile
66881|NCT02865590|Maxillary Sinus/surgery|maxillary sinus/surgery
66883|NCT02865590|Radiography, Panoramic|radiography, panoramic
66884|NCT02865564|Probiotics|probiotics
66885|NCT02865564|Anti-Bacterial Agents|anti-bacterial agents
66886|NCT02865564|Infant, Newborn|infant, newborn
66887|NCT02865564|Gastrointestinal Microbiome|gastrointestinal microbiome
66889|NCT02865564|Gastrointestinal Diseases|gastrointestinal diseases
66890|NCT02865564|Body Composition|body composition
66891|NCT02865564|Bone Density|bone density
66892|NCT02865564|Randomized Controlled Trial|randomized controlled trial
66893|NCT02865564|Lactobacillus reuteri|lactobacillus reuteri
66894|NCT02865564|Pediatrics|pediatrics
66895|NCT02865564|Feces|feces
66896|NCT02865564|ultrasonography|ultrasonography
66897|NCT02865564|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
66898|NCT02865564|Electric Impedance|electric impedance
66899|NCT02865564|Surveys and Questionnaires|surveys and questionnaires
66900|NCT02865538|Hot flashes|hot flashes
66901|NCT02865538|Post-menopausal|post-menopausal
66902|NCT02865525|Surveys and Questionnaires|surveys and questionnaires
66903|NCT02865525|Patient Education as Topic|patient education as topic
66904|NCT02865525|Medication Adherence|medication adherence
66905|NCT02865525|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
66906|NCT02865525|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
66907|NCT02865525|Heart failure|heart failure
66908|NCT02865512|thoracic epidural injection|thoracic epidural injection
66909|NCT02865512|patient position|patient position
66910|NCT02865486|Gastric emptying|gastric emptying
66911|NCT02865486|MRI|mri
66912|NCT02865486|lipid emulsions|lipid emulsions
66913|NCT02865486|breath test|breath test
77693|NCT02798952|Safety|safety
58538|NCT02920060|RSE|rse
66914|NCT02865486|GI peptide hormones|gi peptide hormones
66915|NCT02865473|Schlemm's canal lumen area|schlemm's canal lumen area
66916|NCT02865473|PEX|pex
66917|NCT02865460|Chronic Pain|chronic pain
66918|NCT02865460|Cognitive Disorders|cognitive disorders
66919|NCT02865460|Inflammation|inflammation
66920|NCT02865460|Neurologic manifestations|neurologic manifestations
66921|NCT02865460|Dementia|dementia
66922|NCT02865460|Mental Disorders|mental disorders
66923|NCT02865460|Ubiquinol/ubiquinone|ubiquinol/ubiquinone
66924|NCT02865460|Pathologic Processes|pathologic processes
66939|NCT02865447|bone mineral density|bone mineral density
66941|NCT02865447|osteoarthritis|osteoarthritis
66942|NCT02865447|THA|tha
66943|NCT02865447|musculoskeletal disease|musculoskeletal disease
66944|NCT02865408|Amino acids|amino acids
66945|NCT02865408|critically-ill|critically-ill
66946|NCT02865408|catabolic|catabolic
66947|NCT02865408|nutrition|nutrition
66948|NCT02865408|anabolic|anabolic
66949|NCT02865395|Belladonna and Opium Suppositories|belladonna and opium suppositories
66950|NCT02865382|Adenoma detection rate|adenoma detection rate
66951|NCT02865382|Optical Enhancement Technonogy|optical enhancement technonogy
66952|NCT02865382|Colonoscopy|colonoscopy
66953|NCT02865369|chronic hepatitis C|chronic hepatitis c
66954|NCT02865369|Daclatasvir|daclatasvir
66955|NCT02865369|Asunaprevir|asunaprevir
66956|NCT02865369|fibrosis|fibrosis
66957|NCT02865369|transient elastography|transient elastography
66958|NCT02865356|atopic dermatitis|atopic dermatitis
66959|NCT02865356|eczema|eczema
66960|NCT02865356|children|children
66961|NCT02865356|skin|skin
66962|NCT02865356|topical|topical
66963|NCT02865356|cyclosporine|cyclosporine
66964|NCT02865343|Functional Electrical Stimulation (FES)-Rowing|functional electrical stimulation (fes)-rowing
66965|NCT02865330|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
66966|NCT02865330|Low Risk Prostate Cancer|low risk prostate cancer
66967|NCT02865330|Active Surveillance|active surveillance
66968|NCT02865304|metastatic breast cancer|metastatic breast cancer
66969|NCT02865304|HER-2-negative|her-2-negative
66970|NCT02865304|endostar|endostar
66971|NCT02865252|manual therapy|manual therapy
66972|NCT02865252|mobilization with movement|mobilization with movement
66973|NCT02865239|Imaging, Three-Dimensional|imaging, three-dimensional
66974|NCT02865239|Magnetic Resonance Imaging/methods*|magnetic resonance imaging/methods*
66975|NCT02865239|Breast Neoplasms/diagnosis*|breast neoplasms/diagnosis*
66976|NCT02865239|Prone Position|prone position
66977|NCT02865239|Prospective Studies|prospective studies
66978|NCT02865226|thoracic surgery|thoracic surgery
66980|NCT02865213|Open bite|open bite
66981|NCT02865213|Molar intrusion|molar intrusion
66982|NCT02865213|Temporary anchorage devices|temporary anchorage devices
66983|NCT02865200|Nutrition|nutrition
66984|NCT02865200|Public Health|public health
66992|NCT02865174|Thrombin-gelatin matrix|thrombin-gelatin matrix
66993|NCT02865174|Floseal|floseal
66994|NCT02865174|Tranexamic Acid|tranexamic acid
66995|NCT02865174|Total Knee Arthroplasty|total knee arthroplasty
66996|NCT02865135|HPV Related Head and Neck|hpv related head and neck
66997|NCT02865135|Cervical|cervical
66998|NCT02865135|Anal Cancer|anal cancer
66999|NCT02865109|Spinal Muscular Atrophy|spinal muscular atrophy
67000|NCT02865109|SMA|sma
67001|NCT02865109|SMN|smn
67002|NCT02865109|SMNRx|smnrx
67003|NCT02865109|ISIS-SMNRx|isis-smnrx
67004|NCT02865109|ISIS-SMN Rx|isis-smn rx
67005|NCT02865109|ISIS 396443|isis 396443
67006|NCT02865109|ISIS-396443|isis-396443
67007|NCT02865109|ENDEAR|endear
67008|NCT02865109|IONIS-SMNRx|ionis-smnrx
67009|NCT02865109|IONIS-SMN Rx|ionis-smn rx
67010|NCT02865109|EMBRACE|embrace
67011|NCT02865109|NURTURE|nurture
67012|NCT02865109|IONIS|ionis
67013|NCT02865109|BIOGEN|biogen
67014|NCT02865109|SHINE|shine
67015|NCT02865109|Nusinersen|nusinersen
67016|NCT02865070|premature|premature
67017|NCT02865070|wireless vitals|wireless vitals
67018|NCT02865070|vitals monitor|vitals monitor
67019|NCT02865044|Fatty Acids|fatty acids
67020|NCT02865044|Fish Oil|fish oil
67021|NCT02865044|Marine Copepod|marine copepod
67022|NCT02865044|Fatty Acid Absorption|fatty acid absorption
67023|NCT02865018|Neuromyelitis Optica|neuromyelitis optica
67024|NCT02865018|Cetirizine|cetirizine
67025|NCT02864992|lung|lung
67026|NCT02864992|neoplasm|neoplasm
67027|NCT02864992|cancer|cancer
67028|NCT02864992|tumor|tumor
67029|NCT02864992|adenocarcinoma|adenocarcinoma
67030|NCT02864992|MET exon 14|met exon 14
67031|NCT02864992|METex14|metex14
67032|NCT02864992|pulmonary|pulmonary
67033|NCT02864992|stage III|stage iii
67034|NCT02864992|stage IV|stage iv
67035|NCT02864992|c-Met|c-met
67037|NCT02864992|NSCLC|nsclc
67038|NCT02864992|advanced non-small cell lung cancer|advanced non-small cell lung cancer
67039|NCT02864966|Safety study|safety study
67040|NCT02864966|new product|new product
67041|NCT02864966|normal healthy skin.|normal healthy skin.
67042|NCT02864940|Memory|memory
67043|NCT02864940|aneurysm|aneurysm
67044|NCT02864940|deficits|deficits
67045|NCT02864940|trouble|trouble
67046|NCT02864940|forgetful|forgetful
67047|NCT02864940|ruptured|ruptured
67048|NCT02864940|subarachnoid|subarachnoid
67049|NCT02864940|hemorrhage|hemorrhage
67050|NCT02864927|Meningitis|meningitis
67051|NCT02864927|Meningococcal Meningitis|meningococcal meningitis
67052|NCT02864927|Meningococcal Infections|meningococcal infections
67053|NCT02864927|Menactra®|menactra®
67054|NCT02864927|Meningococcal Vaccine|meningococcal vaccine
67055|NCT02864888|Diffuse, intrinsic brain stem glioma|diffuse, intrinsic brain stem glioma
67056|NCT02864888|QT/QTc interval|qt/qtc interval
67057|NCT02864888|Radiation|radiation
67058|NCT02864888|Antineoplaston therapy|antineoplaston therapy
67059|NCT02864875|Fibrinogen|fibrinogen
67060|NCT02864875|Tromboelastography|tromboelastography
67061|NCT02864849|Rectal cancer|rectal cancer
67062|NCT02864849|neoadjuvant|neoadjuvant
67063|NCT02864849|radiotherapy|radiotherapy
67064|NCT02864849|chemotherapy|chemotherapy
67065|NCT02864849|toxicity|toxicity
67066|NCT02864836|Copper|copper
67067|NCT02864836|isotopic distribution|isotopic distribution
67068|NCT02864836|cancer|cancer
67069|NCT02864823|Scleromalacia perforans|scleromalacia perforans
67070|NCT02864823|Necrotizing Scleritis|necrotizing scleritis
67071|NCT02864823|Perichondrium|perichondrium
67072|NCT02864797|Health related quality of life|health related quality of life
67073|NCT02864797|patient reported outcomes|patient reported outcomes
67074|NCT02864797|cohort|cohort
67075|NCT02864797|e-health|e-health
67076|NCT02864771|Ventricular Arrhythmias|ventricular arrhythmias
67077|NCT02864771|ICD|icd
67078|NCT02864771|Biological markers|biological markers
67079|NCT02864745|early rehabilitation|early rehabilitation
67080|NCT02864745|critically ill|critically ill
67081|NCT02864745|muscle weakness|muscle weakness
67082|NCT02864745|neuromuscular stimulation|neuromuscular stimulation
67083|NCT02864745|functional electrical stimulation-assisted cycle ergometry|functional electrical stimulation-assisted cycle ergometry
67084|NCT02864745|ICUAW|icuaw
67085|NCT02864732|Low back pain|low back pain
67086|NCT02864732|stabilization exercises|stabilization exercises
67087|NCT02864732|neuromuscular electrical stimulation|neuromuscular electrical stimulation
67088|NCT02864719|Heart arrest|heart arrest
67089|NCT02864719|Cardiac arrest|cardiac arrest
67091|NCT02864693|Microprocessor Controlled Ankle|microprocessor controlled ankle
67092|NCT02864693|Transtibial Amputee|transtibial amputee
67093|NCT02864693|Pacifica LP|pacifica lp
67094|NCT02864693|Kinnex|kinnex
67095|NCT02864680|cannabis|cannabis
67096|NCT02864680|magnocellular pathway|magnocellular pathway
67097|NCT02864654|Critical lower limb ischemia|critical lower limb ischemia
67098|NCT02864654|Atherosclerosis obliterans|atherosclerosis obliterans
67099|NCT02864654|Diabetic angiopathies|diabetic angiopathies
67100|NCT02864654|Thromboangiitis obliterans|thromboangiitis obliterans
67101|NCT02864654|Ischemic ulcers|ischemic ulcers
67102|NCT02864654|Peripheral arterial disease|peripheral arterial disease
67103|NCT02864654|Indirect revascularisation|indirect revascularisation
67104|NCT02864654|Intramuscular injection|intramuscular injection
67105|NCT02864654|Ankle-brachial index|ankle-brachial index
67106|NCT02864654|Transcutaneous oxygen tension|transcutaneous oxygen tension
67107|NCT02864654|Stromal vascular fraction (SVF)|stromal vascular fraction (svf)
67108|NCT02864654|Adipose-derived regenerative cells (ADRC)|adipose-derived regenerative cells (adrc)
67109|NCT02864654|Adipose tissue|adipose tissue
67110|NCT02864654|Stem cells|stem cells
67111|NCT02864641|chronic kidney disease|chronic kidney disease
67112|NCT02864641|adolescents|adolescents
67113|NCT02864641|renal disease|renal disease
67114|NCT02864641|CKD|ckd
67115|NCT02864628|RSV Vaccines|rsv vaccines
67116|NCT02864628|Respiratory Syncytial Virus Vaccines|respiratory syncytial virus vaccines
67117|NCT02864615|renal cell carcinoma|renal cell carcinoma
67118|NCT02864615|metastasis|metastasis
67119|NCT02864615|stereotactic body radiation therapy|stereotactic body radiation therapy
67120|NCT02864615|targted therapy|targted therapy
67121|NCT02864615|immune checkpoint inhibitors|immune checkpoint inhibitors
67122|NCT02864602|Regional anesthesia|regional anesthesia
67123|NCT02864602|Adjuvant|adjuvant
67124|NCT02864602|Dexamethasone|dexamethasone
67125|NCT02864589|Tourette, Tic, Tics|tourette, tic, tics
67126|NCT02864550|Men who have sex with men|men who have sex with men
67127|NCT02864550|Human immunodeficiency virus|human immunodeficiency virus
67128|NCT02864550|Doxycycline|doxycycline
67129|NCT02864550|Tetracycline|tetracycline
67130|NCT02864537|warfarin|warfarin
67131|NCT02864537|self-management|self-management
67132|NCT02864537|Conventional management|conventional management
67135|NCT02864537|Complications|complications
67136|NCT02864537|Quality of life|quality of life
67137|NCT02864524|Physical Therapy Modalities|physical therapy modalities
67138|NCT02864524|Exercises|exercises
67139|NCT02864524|Musculoskeletal Manipulations|musculoskeletal manipulations
67140|NCT02864485|Live donor liver transplantation|live donor liver transplantation
67141|NCT02864459|Ultrasonography|ultrasonography
67142|NCT02864459|Weaning|weaning
67143|NCT02864433|cholera|cholera
67144|NCT02864433|oral cholera vaccine|oral cholera vaccine
67145|NCT02864433|diarrhea|diarrhea
67146|NCT02864420|home hospital|home hospital
67147|NCT02864420|acute care home|acute care home
67148|NCT02864420|care redesign|care redesign
67149|NCT02864420|delivery innovation|delivery innovation
67150|NCT02864420|heart failure|heart failure
67151|NCT02864420|pneumonia|pneumonia
67152|NCT02864420|cellulitis|cellulitis
67153|NCT02864420|urinary tract infections|urinary tract infections
67154|NCT02864342|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
67155|NCT02864342|COPD|copd
67156|NCT02864342|Respiratory|respiratory
67157|NCT02864342|adherence|adherence
67158|NCT02864342|medication reminders|medication reminders
67159|NCT02864329|Male Infertility|male infertility
67160|NCT02864329|micro RNAs|micro rnas
67161|NCT02864329|small interfering RNAs|small interfering rnas
67162|NCT02864329|miRNA|mirna
67163|NCT02864329|siRNA|sirna
67164|NCT02864316|radiation-induced solid tumors|radiation-induced solid tumors
67165|NCT02864316|Nivolumab|nivolumab
67166|NCT02864316|Phase 2 study|phase 2 study
67167|NCT02864303|Alzheimer's disease|alzheimer's disease
67168|NCT02864303|Mild Cognitive Impairment|mild cognitive impairment
67169|NCT02864303|Saliva|saliva
67170|NCT02864303|Amyloid peptides|amyloid peptides
67171|NCT02864303|Diagnosis|diagnosis
67172|NCT02864290|Pharmacokinetics of AGS62P1|pharmacokinetics of ags62p1
67173|NCT02864290|AGS62P1|ags62p1
67174|NCT02864290|AML|aml
67175|NCT02864290|Acute Myeloid Leukemia|acute myeloid leukemia
67176|NCT02864277|Gynecology|gynecology
67177|NCT02864277|Cancer|cancer
67178|NCT02864277|General Surgery|general surgery
67179|NCT02864277|Recovery Quality|recovery quality
67180|NCT02864277|Length of hospital stay|length of hospital stay
67181|NCT02864238|electronic milestone pathway|electronic milestone pathway
67182|NCT02864238|cardiac valve surgery|cardiac valve surgery
67183|NCT02864186|Pain|pain
67184|NCT02864186|Quality of life|quality of life
67187|NCT02864173|Postoperative cognitive decline|postoperative cognitive decline
67188|NCT02864173|Postoperative delirium|postoperative delirium
67189|NCT02864173|Cognitive outcome|cognitive outcome
67191|NCT02864173|Genetics|genetics
67192|NCT02864160|Language Concordance|language concordance
67193|NCT02864160|Diabetes Self-Management|diabetes self-management
67194|NCT02864160|Health Coaching|health coaching
67195|NCT02864160|Latinos|latinos
67196|NCT02864134|Optic neuritis|optic neuritis
67197|NCT02864134|ganglion cell layer|ganglion cell layer
67198|NCT02864121|High-risk human papillomavirus|high-risk human papillomavirus
67199|NCT02864121|Integration of HR-HPV DNA|integration of hr-hpv dna
67200|NCT02864121|biomarker of severity|biomarker of severity
67201|NCT02864121|biomarker of evolution|biomarker of evolution
67202|NCT02864095|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
67203|NCT02864095|Epinephrine|epinephrine
67204|NCT02864095|Tranexamic acid|tranexamic acid
67205|NCT02864082|X-linked, lamellar|x-linked, lamellar
67210|NCT02864030|Eribulin mesylate|eribulin mesylate
67211|NCT02864030|Halaven|halaven
67212|NCT02864030|Polymorphisms|polymorphisms
67213|NCT02864030|Tolerability|tolerability
67214|NCT02864004|Parkinson disease|parkinson disease
67215|NCT02864004|Quality of Life|quality of life
67216|NCT02864004|Apomorphine infusion|apomorphine infusion
67217|NCT02863978|Sepsis|sepsis
67218|NCT02863978|Neonates|neonates
67219|NCT02863978|Cardio-respiratory maturation|cardio-respiratory maturation
67220|NCT02863978|Neurobehavioral maturation|neurobehavioral maturation
67221|NCT02863926|BKA|bka
67222|NCT02863926|amputation|amputation
67223|NCT02863926|MarrowStim|marrowstim
67224|NCT02863926|below knee amputation|below knee amputation
67225|NCT02863926|wound complication|wound complication
67226|NCT02863926|vascular disease|vascular disease
67227|NCT02863926|critical limb ischemia|critical limb ischemia
67228|NCT02863926|peripheral artery disease|peripheral artery disease
67229|NCT02863926|AKA|aka
67230|NCT02863926|stem cells|stem cells
67231|NCT02863926|bone marrow|bone marrow
67232|NCT02863887|Weight Loss|weight loss
67233|NCT02863887|African American|african american
67234|NCT02863887|Community Based|community based
67235|NCT02863887|Mobile technology|mobile technology
67236|NCT02863887|Translational science|translational science
67237|NCT02863874|Perineal tear|perineal tear
67238|NCT02863874|Labor|labor
67239|NCT02863874|Triclosan|triclosan
67240|NCT02863861|Sedation|sedation
67241|NCT02863861|Pediatric Patients|pediatric patients
67243|NCT02863822|Low FODMAP|low fodmap
67244|NCT02863822|Dietary Modification|dietary modification
67245|NCT02863809|Keratolysis|keratolysis
67246|NCT02863809|Corneal Melting|corneal melting
67247|NCT02863809|Boston KPro|boston kpro
78064|NCT02797119|Plasmin|plasmin
67248|NCT02863809|Keratoprosthesis|keratoprosthesis
67249|NCT02863770|endosonography|endosonography
67250|NCT02863744|mmp-8|mmp-8
67251|NCT02863744|early stages of wound healing|early stages of wound healing
67252|NCT02863744|wound healing marker|wound healing marker
67253|NCT02863731|postural changes|postural changes
67254|NCT02863731|alternating postures|alternating postures
67255|NCT02863731|Cognitive performance|cognitive performance
67256|NCT02863731|Height-adjustable desk|height-adjustable desk
67257|NCT02863731|Worksite|worksite
67258|NCT02863718|CLL|cll
67259|NCT02863692|CLL|cll
67260|NCT02863692|B-PLL|b-pll
67261|NCT02863692|T-PLL|t-pll
67262|NCT02863692|SLL|sll
67263|NCT02863692|T-NK-LGL|t-nk-lgl
67264|NCT02863692|HCL|hcl
67265|NCT02863692|Richter´s Transformation|richter´s transformation
67266|NCT02863679|tetracaine hydrochloride gel|tetracaine hydrochloride gel
67267|NCT02863679|analgesia|analgesia
67268|NCT02863679|intrauterine balloon|intrauterine balloon
67269|NCT02863679|hysteroscope operation|hysteroscope operation
67270|NCT02863666|Cariopulmonary, cardiac arrest|cariopulmonary, cardiac arrest
67271|NCT02863653|social participation|social participation
67272|NCT02863653|International Classification of Functioning|international classification of functioning
67273|NCT02863640|Senile macular degeneration|senile macular degeneration
67274|NCT02863640|Parkinson's disease|parkinson's disease
67275|NCT02863627|Emergencies|emergencies
67276|NCT02863627|newborn|newborn
67277|NCT02863627|care|care
67278|NCT02863601|Buprenorphine|buprenorphine
67279|NCT02863601|Opiate Substitution Treatment|opiate substitution treatment
67280|NCT02863575|third molar extraction|third molar extraction
67281|NCT02863575|ibuprofen|ibuprofen
67282|NCT02863575|ibuprofen/caffeine|ibuprofen/caffeine
67283|NCT02863575|post-surgical dental pain|post-surgical dental pain
67284|NCT02863536|Recurrence of Bacterial Vaginosis|recurrence of bacterial vaginosis
67683|NCT02860975|Safety|safety
67288|NCT02863510|Chronic kidney disease|chronic kidney disease
67290|NCT02863471|Adenocarcinoma|adenocarcinoma
67291|NCT02863471|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
67292|NCT02863471|HIPEC|hipec
67293|NCT02863471|Pancreatic surgery|pancreatic surgery
67294|NCT02863471|Gemcitabine|gemcitabine
67295|NCT02863458|MDS|mds
67296|NCT02863458|AML|aml
67297|NCT02863458|hypomethylating agents (HMA)|hypomethylating agents (hma)
67298|NCT02863458|Surveillance Epidemiology and End Results (SEER)|surveillance epidemiology and end results (seer)
67304|NCT02862392|Scoliosis|scoliosis
67305|NCT02862392|Adolescent|adolescent
67306|NCT02862392|Idiopathic scoliosis|idiopathic scoliosis
67307|NCT02862392|Predictive factors|predictive factors
67308|NCT02862366|myeloproliferative neoplasms|myeloproliferative neoplasms
67309|NCT02862366|Circulating Procoagulants Microparticles|circulating procoagulants microparticles
67310|NCT02862353|Validation new test|validation new test
67311|NCT02862327|anaesthetic techniques|anaesthetic techniques
67312|NCT02862327|regional anesthesia|regional anesthesia
67313|NCT02862327|brachial plexus block|brachial plexus block
67314|NCT02862327|Local Anesthetic|local anesthetic
67315|NCT02862327|ropivacaine|ropivacaine
67316|NCT02862327|analgesia|analgesia
67317|NCT02862327|steroid|steroid
67318|NCT02862327|dexamethasone|dexamethasone
67319|NCT02862327|placebo|placebo
67320|NCT02862327|adjuvant|adjuvant
67321|NCT02862327|ultrasound guided|ultrasound guided
67322|NCT02862314|Procalcitonin|procalcitonin
67323|NCT02862301|Histone Deacetylases|histone deacetylases
67324|NCT02862301|Histone Acetyltransferases|histone acetyltransferases
67325|NCT02863406|Dust rate|dust rate
67326|NCT02863406|Microscopic analysis|microscopic analysis
67327|NCT02863380|Individualized Medicine|individualized medicine
67328|NCT02863380|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
67329|NCT02863380|Transcranial Direct Current Stimulation Monocentric|transcranial direct current stimulation monocentric
67330|NCT02863380|Compariative Cross-Over 3 Arms Study Randomized, Single-Blind Method|compariative cross-over 3 arms study randomized, single-blind method
67331|NCT02863380|Functional Neuroimaging|functional neuroimaging
67332|NCT02863302|Acute Myeloid Leukemia, Reflexology|acute myeloid leukemia, reflexology
67333|NCT02863263|foam dressing|foam dressing
67334|NCT02863263|MedifoamⓇ|medifoamⓡ
67335|NCT02863263|BetafoamⓇ|betafoamⓡ
67336|NCT02863263|povidone iodine|povidone iodine
67337|NCT02863237|brain injury|brain injury
67338|NCT02863237|mechanical ventilation|mechanical ventilation
67339|NCT02863237|weaning|weaning
67340|NCT02863198|unexplained infertility|unexplained infertility
67341|NCT02863198|endometrial injury|endometrial injury
67342|NCT02863198|pregnancy|pregnancy
67343|NCT02863185|chronic kidney disease|chronic kidney disease
67344|NCT02863185|pitavastatin|pitavastatin
67350|NCT02863172|Saliva sample|saliva sample
67351|NCT02863146|locally advanced breast cancer|locally advanced breast cancer
67352|NCT02863146|alopecia|alopecia
67353|NCT02863146|eribulin|eribulin
67354|NCT02863120|Bupivacaine|bupivacaine
67355|NCT02863120|Osteoarthritis|osteoarthritis
67356|NCT02863120|Arthritis|arthritis
67357|NCT02863120|Joint Diseases|joint diseases
67358|NCT02863120|Ropivacaine|ropivacaine
67359|NCT02863120|Anesthetics, Local|anesthetics, local
67360|NCT02863120|Anesthetics|anesthetics
67361|NCT02863107|Colon Cancer|colon cancer
67362|NCT02863107|Rectal Cancer|rectal cancer
67363|NCT02863107|Questionnaires|questionnaires
67364|NCT02863107|Surveys|surveys
67365|NCT02863107|Blood draw|blood draw
67366|NCT02863094|schizophrenia|schizophrenia
67367|NCT02863094|auditory hallucinations|auditory hallucinations
67368|NCT02863094|functional magnetic resonance imaging|functional magnetic resonance imaging
67369|NCT02863094|transcranial magnetic stimulation|transcranial magnetic stimulation
67370|NCT02863068|Sickle cell disease|sickle cell disease
67371|NCT02863068|sodium nitrite|sodium nitrite
67774|NCT02860455|CO-oximetry|co-oximetry
67372|NCT02863068|wound healing|wound healing
67373|NCT02863068|Ulcer|ulcer
67374|NCT02863055|MPM|mpm
67375|NCT02863055|Unresectable|unresectable
67376|NCT02863055|Phase II|phase ii
67377|NCT02863055|Randomized|randomized
67378|NCT02863055|Maintenance|maintenance
67379|NCT02863029|Intestinal stem cells|intestinal stem cells
67380|NCT02863016|dialysis|dialysis
67381|NCT02863016|hemodiafiltration|hemodiafiltration
67382|NCT02862990|Breast cancer|breast cancer
67383|NCT02862990|Fertility|fertility
67384|NCT02862964|back pain|back pain
67385|NCT02862951|pregnancy|pregnancy
67386|NCT02862925|fetal monitoring|fetal monitoring
67387|NCT02862925|cesarean delivery|cesarean delivery
67388|NCT02862925|obstetrics|obstetrics
67389|NCT02862925|midwifery|midwifery
67390|NCT02862925|developing countries|developing countries
67391|NCT02862912|Chloroprocaine|chloroprocaine
67392|NCT02862912|cervical cerclage|cervical cerclage
67393|NCT02862912|spinal anesthesia|spinal anesthesia
67394|NCT02862912|Bupivacaine|bupivacaine
67395|NCT02862873|Spinal anaesthesia|spinal anaesthesia
67396|NCT02862821|biomarkers of psychiatric disorder|biomarkers of psychiatric disorder
67397|NCT02862821|gambling addiction|gambling addiction
67398|NCT02862821|high resolution-ElectroEncephaloGraphy (HR-EEG)|high resolution-electroencephalography (hr-eeg)
67399|NCT02862808|Whole exome sequencing|whole exome sequencing
67400|NCT02862808|Molecular diagnostic|molecular diagnostic
67401|NCT02862808|Genetic counselling|genetic counselling
67402|NCT02862795|colonoscopy|colonoscopy
67403|NCT02862730|diabetes|diabetes
67404|NCT02862730|closed-loop|closed-loop
67405|NCT02862730|dual hormone|dual hormone
67406|NCT02862730|exercise|exercise
67407|NCT02862717|Cost effectiveness|cost effectiveness
67408|NCT02862717|cost utility|cost utility
67409|NCT02862717|ESRD|esrd
67410|NCT02862717|hemodialysis|hemodialysis
67411|NCT02862717|ICER|icer
67412|NCT02862717|Markov model|markov model
67413|NCT02862717|peritoneal dialysis|peritoneal dialysis
67414|NCT02862691|toothache|toothache
67415|NCT02862626|Diabetic children|diabetic children
67416|NCT02862626|Mothers|mothers
67417|NCT02862613|Precision Cells|precision cells
67418|NCT02862613|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
67419|NCT02862613|Advanced Liver Cancer|advanced liver cancer
67420|NCT02862600|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
67421|NCT02862600|heart failure|heart failure
67422|NCT02862600|cardiopulmonary exercise testing|cardiopulmonary exercise testing
67423|NCT02862600|6 minute walk test|6 minute walk test
67424|NCT02862600|perhexiline|perhexiline
67425|NCT02862600|carnitine palmitoyltransferase|carnitine palmitoyltransferase
67426|NCT02862600|mixed ion channel effects|mixed ion channel effects
67427|NCT02862600|late sodium current inhibitor|late sodium current inhibitor
67428|NCT02862600|calcium channel inhibition|calcium channel inhibition
67429|NCT02862587|Precision Cells|precision cells
67430|NCT02862587|Chemotherapy|chemotherapy
67431|NCT02862587|Advanced Lung Cancer|advanced lung cancer
67432|NCT02862574|Rheumatoid Arthritis|rheumatoid arthritis
67433|NCT02862574|Tumor Necrosis Factor Inhibitor|tumor necrosis factor inhibitor
67434|NCT02862574|TNF-IR|tnf-ir
67435|NCT02862574|Methotrexate|methotrexate
67436|NCT02862561|Precision Cell Immunotherapy|precision cell immunotherapy
67437|NCT02862561|Chemotherapy|chemotherapy
67438|NCT02862561|Advanced Malignancies|advanced malignancies
67439|NCT02862522|uric acid|uric acid
67440|NCT02862522|microvascular dysfunction|microvascular dysfunction
67441|NCT02862522|inflammation|inflammation
67442|NCT02862509|Post-frontal sinus operation chronic rhinosinusitis patients|post-frontal sinus operation chronic rhinosinusitis patients
67443|NCT02862509|Budesonide nasal instillation|budesonide nasal instillation
67444|NCT02862509|Vertex to floor position|vertex to floor position
67445|NCT02862496|Hyperemesis Gravidarum|hyperemesis gravidarum
67446|NCT02862496|Bone Health|bone health
67447|NCT02862496|Urine N-telopeptide|urine n-telopeptide
67448|NCT02862496|Serum calcium|serum calcium
67449|NCT02862496|Serum parathormone|serum parathormone
67450|NCT02862496|Serum vit D|serum vit d
67451|NCT02862470|Lovastatin|lovastatin
67452|NCT02862470|Vildagliptin|vildagliptin
67453|NCT02862470|Exosome|exosome
67454|NCT02862470|Anaplastic thyroid cancer|anaplastic thyroid cancer
67455|NCT02862470|Proteomics|proteomics
67456|NCT02862470|Urine|urine
67457|NCT02862470|Biological marker|biological marker
67458|NCT02862457|Advanced Solid Tumors|advanced solid tumors
67459|NCT02862418|MRI|mri
67460|NCT02862418|UTE MRI|ute mri
67461|NCT02862418|Pulmonary|pulmonary
67462|NCT02862405|Vision loss|vision loss
67463|NCT02862405|Object recognition|object recognition
67464|NCT02862405|Space recognition|space recognition
67465|NCT02862223|Coagulation|coagulation
67466|NCT02862223|Circulatory Function|circulatory function
67467|NCT02862223|Blood Pressure|blood pressure
67468|NCT02862223|Inflammatory response|inflammatory response
67469|NCT02862223|Blood Glucose|blood glucose
67470|NCT02862223|Healthy vascular function|healthy vascular function
67471|NCT02862210|Lithium|lithium
67472|NCT02862210|Lithium Carbonate|lithium carbonate
67473|NCT02862145|Biosy accessible melanoma|biosy accessible melanoma
67474|NCT02862132|VDZ: Vedolizumab|vdz: vedolizumab
67475|NCT02862132|UC: Ulcerative colitis|uc: ulcerative colitis
67476|NCT02862132|CD: Crohn's disease|cd: crohn's disease
67477|NCT02862132|TDM: Therapeutic drug monitoring|tdm: therapeutic drug monitoring
67478|NCT02862119|percutaneous coronary intervention|percutaneous coronary intervention
67479|NCT02862119|fractional flow reserve|fractional flow reserve
67480|NCT02862119|all cause mortality|all cause mortality
67481|NCT02862119|myocardial infarction|myocardial infarction
67482|NCT02862119|registry-based randomized clinical trial|registry-based randomized clinical trial
67483|NCT02862106|Chronic Hepatitis B|chronic hepatitis b
67484|NCT02862106|HBeAg positive|hbeag positive
67485|NCT02862106|Therapeutic HBV Vaccine|therapeutic hbv vaccine
67486|NCT02862106|HBV-specific Cytotoxic T Lymphocyte|hbv-specific cytotoxic t lymphocyte
67487|NCT02862067|SGLT2|sglt2
67488|NCT02862067|type 2 diabetes mellitus|type 2 diabetes mellitus
67489|NCT02862067|systolic heart failure|systolic heart failure
67490|NCT02862067|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
67491|NCT02862054|haemophagocytic lymphohistiocytosis|haemophagocytic lymphohistiocytosis
67492|NCT02862054|splenectomy|splenectomy
67493|NCT02862054|unknown etiology|unknown etiology
67494|NCT02862028|PD-1 antibody|pd-1 antibody
67495|NCT02862028|CAR-T cells|car-t cells
67496|NCT02862028|EGFR family|egfr family
67497|NCT02862028|advanced solid tumor|advanced solid tumor
67498|NCT02862002|opioid therapy|opioid therapy
67499|NCT02862002|medical oncology.|medical oncology.
67500|NCT02861989|osteoporosis|osteoporosis
67501|NCT02861989|prevention|prevention
67502|NCT02861989|care management|care management
67503|NCT02861989|focus groups|focus groups
67504|NCT02861963|Femoral Allogenic Vein Valve Conduit|femoral allogenic vein valve conduit
67505|NCT02861963|Rehabilitation of native pulmonary arteries|rehabilitation of native pulmonary arteries
67506|NCT02861950|hypospadias|hypospadias
67507|NCT02861950|caudal|caudal
67508|NCT02861950|urethrocutaneous fistula|urethrocutaneous fistula
67509|NCT02861950|penile nerve block|penile nerve block
67510|NCT02861911|Muscle function|muscle function
67511|NCT02861911|Oxidative stress|oxidative stress
67512|NCT02861911|Quality of life|quality of life
67513|NCT02861911|Physical activities|physical activities
67514|NCT02861898|EGFR|egfr
67515|NCT02861898|Epidermal Growth Factor Receptor|epidermal growth factor receptor
67516|NCT02861898|EGFRvIII|egfrviii
67517|NCT02861885|Colonoscopy|colonoscopy
67518|NCT02861885|sessile serrated lesions|sessile serrated lesions
67519|NCT02861885|chromoendoscopy|chromoendoscopy
67520|NCT02861885|narrow band imaging|narrow band imaging
67521|NCT02861885|Indigo Carmin®|indigo carmin®
67522|NCT02861885|Pit pattern|pit pattern
67523|NCT02861885|Kudo classification|kudo classification
67524|NCT02861885|NICE classification|nice classification
67525|NCT02861885|neoplasms by histologic type|neoplasms by histologic type
67526|NCT02861872|Ovarian|ovarian
67527|NCT02861872|Ovarian cancer|ovarian cancer
67528|NCT02861872|Chemotherapy|chemotherapy
67529|NCT02861872|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
67530|NCT02861872|pharmacokinetics|pharmacokinetics
67531|NCT02861859|Breast cancer|breast cancer
67532|NCT02861859|Breast Carcinoma|breast carcinoma
67533|NCT02861859|Breast Tumors|breast tumors
67534|NCT02861859|Chemotherapy|chemotherapy
67535|NCT02861859|Antiemetic effects|antiemetic effects
67536|NCT02861859|Antiemetic drugs|antiemetic drugs
67537|NCT02861859|Drug Therapy|drug therapy
67538|NCT02861846|epilepsy|epilepsy
67539|NCT02861846|Alzheimer|alzheimer
67540|NCT02861846|biomarkers|biomarkers
67541|NCT02861846|predictive value|predictive value
67543|NCT02861820|brain networks|brain networks
67544|NCT02861820|biomarker|biomarker
67545|NCT02861820|relapse|relapse
67546|NCT02861820|stimulants|stimulants
67547|NCT02861794|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
67548|NCT02861794|Total Knee Replacement (TKR)|total knee replacement (tkr)
67549|NCT02861794|Kinematics|kinematics
67551|NCT02861794|Knee arthroplasty|knee arthroplasty
67552|NCT02861794|Implant stability|implant stability
67553|NCT02861781|Bariatric surgery|bariatric surgery
67554|NCT02861755|Depression|depression
67555|NCT02861755|Depressive Disorder|depressive disorder
67556|NCT02861755|Psychological Stress|psychological stress
67557|NCT02861755|Behavioral Symptoms|behavioral symptoms
67558|NCT02861755|Mental Disorders|mental disorders
67559|NCT02861755|Mood Disorders|mood disorders
67560|NCT02861729|Partial coverage restoration|partial coverage restoration
67561|NCT02861729|Crown|crown
67562|NCT02861729|Posterior teeth|posterior teeth
67563|NCT02861729|All ceramic|all ceramic
67564|NCT02861729|Zirconia reinforced lithium silicate|zirconia reinforced lithium silicate
67565|NCT02861729|Lithium disilicate|lithium disilicate
67566|NCT02861729|CAD/CAM|cad/cam
67567|NCT02861690|Esophageal Cancer|esophageal cancer
67568|NCT02861690|nedaplatin|nedaplatin
67569|NCT02861690|Liposomal Paclitaxel|liposomal paclitaxel
67570|NCT02861638|Total hip replacement|total hip replacement
67571|NCT02861638|Action observation treatment|action observation treatment
67572|NCT02861638|Rehabilitation|rehabilitation
67573|NCT02861638|Arthroplasty|arthroplasty
67574|NCT02861612|peripheral nerves|peripheral nerves
67575|NCT02861612|quadriplegia|quadriplegia
67576|NCT02861612|nerve transfer|nerve transfer
69378|NCT02849756|Future|future
67577|NCT02861612|surgical procedures, operative|surgical procedures, operative
67578|NCT02861612|hand|hand
67579|NCT02861612|upper extremity|upper extremity
67580|NCT02861612|quality of life|quality of life
67581|NCT02861586|Chikungunya, infectious disease|chikungunya, infectious disease
67582|NCT02861573|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
67583|NCT02861573|mCRPC|mcrpc
67584|NCT02861573|PD1|pd1
67585|NCT02861573|PD-1|pd-1
67586|NCT02861573|PDL1|pdl1
67587|NCT02861573|PD-L1|pd-l1
67588|NCT02861508|Ultrasonography|ultrasonography
67589|NCT02861495|upper extremity fracture|upper extremity fracture
67590|NCT02861482|PPH, Bakri Ballon|pph, bakri ballon
67591|NCT02861469|qualitative study, end of life, ethics, palliative care|qualitative study, end of life, ethics, palliative care
67592|NCT02861456|Adolescent|adolescent
67593|NCT02861456|Low Back Pain|low back pain
67594|NCT02861456|Athlete|athlete
67595|NCT02861430|colon cancer|colon cancer
67596|NCT02861430|sentinel node|sentinel node
67597|NCT02861417|Other diseases of blood and blood-forming organs|other diseases of blood and blood-forming organs
67598|NCT02861417|Acute myeloid leukemia|acute myeloid leukemia
67599|NCT02861417|AML|aml
67600|NCT02861417|Acute lymphocytic leukemia|acute lymphocytic leukemia
67601|NCT02861417|ALL|all
67602|NCT02861417|Chronic myeloid leukemia|chronic myeloid leukemia
67603|NCT02861417|CML|cml
67604|NCT02861417|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
67605|NCT02861417|CLL|cll
67606|NCT02861417|Myelodysplastic syndrome|myelodysplastic syndrome
67607|NCT02861417|MDS|mds
67608|NCT02861417|Myeloproliferative syndrome|myeloproliferative syndrome
67609|NCT02861417|Non-Hodgkins lymphoma|non-hodgkins lymphoma
67610|NCT02861417|NHL|nhl
67611|NCT02861417|Hodgkins lymphoma|hodgkins lymphoma
67612|NCT02861417|HL|hl
67613|NCT02861417|Multiple myeloma|multiple myeloma
67614|NCT02861417|MM|mm
67615|NCT02861417|Stem cell infusion|stem cell infusion
67616|NCT02861417|Stem cell transplant|stem cell transplant
67617|NCT02861417|Haploidentical donor|haploidentical donor
67618|NCT02861417|Matched donor|matched donor
67619|NCT02861417|Thiotepa|thiotepa
67620|NCT02861417|Mycophenolate Mofetil|mycophenolate mofetil
67621|NCT02861417|MMF|mmf
67622|NCT02861417|CellCept|cellcept
67623|NCT02861417|Busulfan|busulfan
67624|NCT02861417|Busulfex|busulfex
67626|NCT02861417|Fludarabine|fludarabine
67627|NCT02861417|Fludarabine phosphate|fludarabine phosphate
67628|NCT02861417|Fludara|fludara
67629|NCT02861417|Mesna|mesna
67630|NCT02861417|Mesnex|mesnex
67631|NCT02861417|Cyclophosphamide|cyclophosphamide
67632|NCT02861417|Cytoxan|cytoxan
67633|NCT02861417|Neosar|neosar
67634|NCT02861417|Tacrolimus|tacrolimus
67635|NCT02861417|Prograf|prograf
67636|NCT02861417|G-CSF|g-csf
67637|NCT02861417|Filgrastim|filgrastim
67638|NCT02861417|Neupogen|neupogen
67639|NCT02861404|HPV|hpv
67640|NCT02861378|anaesthesia, dental|anaesthesia, dental
67641|NCT02861378|lidocaine|lidocaine
67642|NCT02861352|Zinc|zinc
67643|NCT02861352|DNA Integrity|dna integrity
67644|NCT02861352|Gene Expression|gene expression
67645|NCT02861352|diet zinc|diet zinc
67646|NCT02861352|nutrition requirements|nutrition requirements
67647|NCT02861326|chronic periodontitis, dental scaling, periodontal pockets|chronic periodontitis, dental scaling, periodontal pockets
67648|NCT02861300|CB-839|cb-839
67649|NCT02861300|PIK3CA|pik3ca
67650|NCT02861300|capecitabine|capecitabine
67651|NCT02861248|Burn Scar|burn scar
67652|NCT02861248|Micro-plasma Radiofrequency Therapy|micro-plasma radiofrequency therapy
67653|NCT02861183|sodium hyaluronate|sodium hyaluronate
67654|NCT02861183|OVT|ovt
67655|NCT02861183|hyaluronic acid|hyaluronic acid
67656|NCT02861170|Mindfulness|mindfulness
67657|NCT02861170|Chronic Pain|chronic pain
67658|NCT02861170|Chronic Hip Pain|chronic hip pain
67659|NCT02861170|Total Hip Arthroplasty|total hip arthroplasty
67660|NCT02861170|Disability|disability
67661|NCT02861170|Quality of Life|quality of life
67662|NCT02861157|Type 1 Diabetes|type 1 diabetes
67663|NCT02861157|Adolescents|adolescents
67664|NCT02861157|T1D|t1d
67665|NCT02861131|Sugammadex|sugammadex
67666|NCT02861131|Neuromuscular Blockade|neuromuscular blockade
67667|NCT02861118|Drug Therapy|drug therapy
67668|NCT02861092|Serious adverse event|serious adverse event
67669|NCT02861092|bone and joint infection|bone and joint infection
67670|NCT02861092|obesity|obesity
67671|NCT02861092|dose adjustment|dose adjustment
67672|NCT02861066|Mindfulness-based Intervention|mindfulness-based intervention
67673|NCT02861066|Wellbeing|wellbeing
67674|NCT02861066|Treatment|treatment
67675|NCT02861027|Osteoarthritis|osteoarthritis
67676|NCT02861027|Total hip arthroplasty|total hip arthroplasty
67677|NCT02861027|Physiotherapy|physiotherapy
67678|NCT02861027|Functional Electrical Stimulation|functional electrical stimulation
67679|NCT02861001|tracheotomy|tracheotomy
67680|NCT02861001|bronchoscopy|bronchoscopy
67681|NCT02861001|critical care|critical care
67682|NCT02860975|Prolonged Hypoxia|prolonged hypoxia
67684|NCT02860975|Mitochondrial function|mitochondrial function
67685|NCT02860949|Local anesthetic infiltration|local anesthetic infiltration
67686|NCT02860949|Posterior capsular infiltration|posterior capsular infiltration
67687|NCT02860949|Multimodal anesthesia|multimodal anesthesia
67688|NCT02860949|Knee arthroplasty|knee arthroplasty
67689|NCT02860949|Pain control|pain control
67690|NCT02860949|Osteoarthritis, Knee|osteoarthritis, knee
67691|NCT02860923|glucagon-like peptide-1|glucagon-like peptide-1
67692|NCT02860923|exenatide|exenatide
67693|NCT02860923|placebo|placebo
67694|NCT02860923|multicenter trial|multicenter trial
67695|NCT02860910|hot flashes|hot flashes
67696|NCT02860910|postmenopause|postmenopause
67697|NCT02860910|perimenopause|perimenopause
67698|NCT02860832|Cyberbullying|cyberbullying
67699|NCT02860832|Traditional bullying|traditional bullying
67700|NCT02860832|Depression|depression
67701|NCT02860819|Multiple relapsed/refractory testicular germ cell tumors|multiple relapsed/refractory testicular germ cell tumors
67702|NCT02860819|PARP inhibition|parp inhibition
67703|NCT02860819|Chemotherapy|chemotherapy
67704|NCT02860819|Gemcitabine|gemcitabine
67705|NCT02860819|Carboplatin|carboplatin
67706|NCT02860793|PTK7|ptk7
67707|NCT02860793|Acute Myeloid Leukemia|acute myeloid leukemia
67708|NCT02860767|Prosthesis-Related Infections|prosthesis-related infections
67709|NCT02860767|Antibiotic dosing|antibiotic dosing
67710|NCT02860767|Reimplantation|reimplantation
67711|NCT02860767|Knee-prothesis|knee-prothesis
67712|NCT02860767|Hip-prothesis|hip-prothesis
67713|NCT02860741|Sub-Clinical Depression|sub-clinical depression
67714|NCT02860728|COPD|copd
67715|NCT02860728|Resistance Training|resistance training
67716|NCT02860728|Exercise Training|exercise training
67717|NCT02860728|Dyspnea|dyspnea
67718|NCT02860715|Safety|safety
67719|NCT02860715|Pharmacodynamics|pharmacodynamics
67720|NCT02860715|Dose-Limiting Toxicity (DLT)|dose-limiting toxicity (dlt)
67721|NCT02860715|Immunogenicity|immunogenicity
67722|NCT02860715|Pharmacokinetics|pharmacokinetics
67723|NCT02860702|Single Ventricle|single ventricle
67724|NCT02860702|Congenital Heart Defect|congenital heart defect
67725|NCT02860689|Sexuality|sexuality
67726|NCT02860689|Spinal cord injuries|spinal cord injuries
67727|NCT02860689|Penile erection|penile erection
67728|NCT02860689|erectile dysfunction|erectile dysfunction
67729|NCT02860689|Psychological Sexual Dysfunctions|psychological sexual dysfunctions
67730|NCT02860676|CLL|cll
67731|NCT02860676|cancer|cancer
67732|NCT02860676|UC-961|uc-961
67733|NCT02860676|cirmtuzumab|cirmtuzumab
67734|NCT02860637|Sexuality|sexuality
67735|NCT02860637|Spinal cord injuries|spinal cord injuries
67736|NCT02860637|Penile erection|penile erection
67737|NCT02860637|erectile dysfunction|erectile dysfunction
67738|NCT02860624|GERD|gerd
67739|NCT02860611|Type 1 diabetes|type 1 diabetes
67740|NCT02860611|Type 2 diabetes|type 2 diabetes
67741|NCT02860611|T helper 1 cytokines|t helper 1 cytokines
67742|NCT02860598|ESAs|esas
67743|NCT02860598|erythropoietin|erythropoietin
67744|NCT02860598|AML|aml
67745|NCT02860598|HSCT|hsct
67746|NCT02860585|Metastatic breast cancer|metastatic breast cancer
67747|NCT02860585|high-dose chemotherapy|high-dose chemotherapy
67748|NCT02860585|autologous haematopoietic progenitor cell transplantation|autologous haematopoietic progenitor cell transplantation
67749|NCT02860572|fluid therapy|fluid therapy
67750|NCT02860572|oliguria|oliguria
67751|NCT02860572|endothelial injury|endothelial injury
67752|NCT02860559|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
67753|NCT02860559|Severe Combined Immunodeficiency|severe combined immunodeficiency
67754|NCT02860546|Refractory|refractory
67755|NCT02860546|Metastatic|metastatic
67756|NCT02860546|Colorectal cancer|colorectal cancer
67757|NCT02860546|TAS-102|tas-102
67758|NCT02860546|Nivolumab|nivolumab
67759|NCT02860546|Microsatellite Stable|microsatellite stable
67760|NCT02860546|Programmed cell death protein1 (PD 1)|programmed cell death protein1 (pd 1)
67761|NCT02860533|Blood pressure|blood pressure
67762|NCT02860533|smartphone App|smartphone app
67763|NCT02860533|Hypertension|hypertension
67764|NCT02860533|Stress testing|stress testing
67765|NCT02860533|Prevention|prevention
67766|NCT02860533|Cardiovascular risk factors|cardiovascular risk factors
67767|NCT02860520|Retinitis pigmentosa:|retinitis pigmentosa:
67768|NCT02860494|Tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
67769|NCT02860494|topical everolimus|topical everolimus
67770|NCT02860494|seamless design|seamless design
67771|NCT02860494|dose-escalation study|dose-escalation study
67772|NCT02860494|m-TOR inhibitor|m-tor inhibitor
67773|NCT02860455|CO poisoning|co poisoning
67775|NCT02860455|Pulse oximetry|pulse oximetry
67776|NCT02860455|Carbon monoxide saturation (SpCO)|carbon monoxide saturation (spco)
67777|NCT02860455|Emergency Department|emergency department
67778|NCT02860455|Sensitivity|sensitivity
67779|NCT02860455|Specificity|specificity
67780|NCT02860442|Alcohol misuse|alcohol misuse
67781|NCT02860442|Smartphone app|smartphone app
69774|NCT02847715|Aftercare|aftercare
67782|NCT02860442|Screening, Brief Intervention, Referral to Treatment (SBIRT)|screening, brief intervention, referral to treatment (sbirt)
67783|NCT02860416|Neurology|neurology
67784|NCT02860403|Cervical spinal cord injury|cervical spinal cord injury
67785|NCT02860403|Motor imagery|motor imagery
67786|NCT02860403|Magnetoencephalography|magnetoencephalography
67787|NCT02860377|emergence agitation|emergence agitation
67788|NCT02860377|emergence time|emergence time
67789|NCT02860377|pediatric|pediatric
67790|NCT02860351|subclavian vein|subclavian vein
67791|NCT02860338|Psuedobulbar affect, PBA|psuedobulbar affect, pba
67792|NCT02860299|patients|patients
67793|NCT02860273|Pulmonary Rehabilitation|pulmonary rehabilitation
67794|NCT02860273|COPD|copd
67795|NCT02860273|High Flow Nasal Cannula|high flow nasal cannula
67796|NCT02860273|HFNC|hfnc
67797|NCT02860273|Aerobic capacity|aerobic capacity
67798|NCT02860260|BDNF|bdnf
67799|NCT02860247|antibiotic|antibiotic
67800|NCT02860247|MALDI-TOF MS|maldi-tof ms
67801|NCT02860247|susceptibility testing|susceptibility testing
67802|NCT02860234|Rectal cancer|rectal cancer
67803|NCT02860234|neoadjuvant|neoadjuvant
67804|NCT02860234|radiotherapy|radiotherapy
67805|NCT02860234|chemotherapy|chemotherapy
67806|NCT02860234|organ preservation|organ preservation
67807|NCT02860221|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
67808|NCT02860221|Epinephrine|epinephrine
67809|NCT02860221|Tranexamic acid|tranexamic acid
67810|NCT02860208|Peri-Implantitis|peri-implantitis
67811|NCT02860208|Surgical therapy|surgical therapy
67812|NCT02860208|Follow-up|follow-up
67813|NCT02860208|Supportive peri-implant therapy|supportive peri-implant therapy
67814|NCT02860130|Regional Citrate Anticoagulation (RCA)|regional citrate anticoagulation (rca)
67815|NCT02860130|Continuous Renal Replacement Therapy (CRRT)|continuous renal replacement therapy (crrt)
67816|NCT02860130|Acute Kidney Injury|acute kidney injury
67817|NCT02860117|ketamine|ketamine
67818|NCT02860117|continuous infusion|continuous infusion
67819|NCT02860117|severe burned patients|severe burned patients
67820|NCT02860104|microwave ablation|microwave ablation
67821|NCT02860104|breast|breast
67822|NCT02860104|multicenter|multicenter
67823|NCT02860091|ropivacaine infusion|ropivacaine infusion
67824|NCT02860091|regional anesthesia|regional anesthesia
67825|NCT02860091|paravertebral block|paravertebral block
67826|NCT02860078|pain|pain
67827|NCT02860078|epidural|epidural
67828|NCT02860078|ultrasound|ultrasound
67829|NCT02860013|Telemedicine|telemedicine
67830|NCT02860013|Effectiveness|effectiveness
67831|NCT02860013|Cost-effectiveness|cost-effectiveness
67833|NCT02859987|Nursing Services|nursing services
67834|NCT02859974|Paradoxical vocal fold motion disorder (PVFMD)|paradoxical vocal fold motion disorder (pvfmd)
67835|NCT02859974|vocal cord dysfunction (VCD)|vocal cord dysfunction (vcd)
67836|NCT02859974|Respiratory retraining|respiratory retraining
67837|NCT02859974|Respiratory disorders|respiratory disorders
67839|NCT02859935|HIV|hiv
67847|NCT02859727|APDS; PASLI; PI3Kdelta; p110delta-activating mutation causing senescent T cells, lymphadenopathy and immunodeficiency; Activated PI3Kdelta Syndrome;|apds; pasli; pi3kdelta; p110delta-activating mutation causing senescent t cells, lymphadenopathy and immunodeficiency; activated pi3kdelta syndrome;
67848|NCT02859662|abdominal compartment syndrome|abdominal compartment syndrome
67849|NCT02859662|abdominal aortic aneurysm|abdominal aortic aneurysm
67851|NCT02859649|working memory|working memory
59395|NCT02915146|uvb|uvb
67852|NCT02859649|short term memory|short term memory
67853|NCT02859649|gesture|gesture
67854|NCT02859584|Acute hepatitis|acute hepatitis
67855|NCT02859584|acute liver failure|acute liver failure
67856|NCT02859584|adrenal dysfunction|adrenal dysfunction
67857|NCT02859584|salivary cortisol|salivary cortisol
67858|NCT02859584|serum free cortisol|serum free cortisol
67859|NCT02859545|chronic pain|chronic pain
67860|NCT02859545|pain|pain
67861|NCT02859545|validation|validation
67862|NCT02859545|couples|couples
67863|NCT02859545|romantic relationships|romantic relationships
67864|NCT02859545|emotional validation|emotional validation
67865|NCT02859532|blood coagulation|blood coagulation
67866|NCT02859532|Endogenous Thrombin Potential|endogenous thrombin potential
67867|NCT02859532|rotational thromboelastometry|rotational thromboelastometry
67868|NCT02859480|Rosuvastatin Calcium|rosuvastatin calcium
67869|NCT02859480|Percutaneous Coronary Intervention|percutaneous coronary intervention
67870|NCT02859480|Drug-Eluting Stents|drug-eluting stents
67871|NCT02859480|Patient Outcome Assessment|patient outcome assessment
67872|NCT02859480|Biomarkers|biomarkers
67873|NCT02859480|Hyperlipidemias|hyperlipidemias
67874|NCT02859480|Dyslipidemias|dyslipidemias
67879|NCT02859480|Lipid Regulating Agents|lipid regulating agents
67880|NCT02859467|Physical Therapy Modalities|physical therapy modalities
67881|NCT02859467|Exercise|exercise
67882|NCT02859467|Electrical Stimulation Therapy|electrical stimulation therapy
67883|NCT02859467|Bandages|bandages
67884|NCT02859454|PD-L1 Expression|pd-l1 expression
67885|NCT02859454|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
67886|NCT02859454|Juvenile-onset Disease|juvenile-onset disease
67887|NCT02859454|Papillomatous Lesions|papillomatous lesions
67888|NCT02859454|Monoclonal Antibody|monoclonal antibody
67889|NCT02859441|Intravitreal Injection|intravitreal injection
67890|NCT02859441|Retinal Capillary Hemangioma|retinal capillary hemangioma
67891|NCT02859428|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
67892|NCT02859415|Metastatic Colorectal Cancer|metastatic colorectal cancer
67893|NCT02859415|Metastatic Renal Cell Cancer|metastatic renal cell cancer
67894|NCT02859415|Sarcoma|sarcoma
67895|NCT02859415|ABCB4 Liver Toxicity|abcb4 liver toxicity
67896|NCT02859415|ABCB11 Heptatoxicity|abcb11 heptatoxicity
67897|NCT02859402|T-cell Non-Hodgkin Lymphoma|t-cell non-hodgkin lymphoma
67898|NCT02859402|NK/T-cell Non-Hodgkin Lymphoma|nk/t-cell non-hodgkin lymphoma
67899|NCT02859402|Relapsed, refractory|relapsed, refractory
67900|NCT02859402|Conditioning|conditioning
67901|NCT02859402|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
67902|NCT02859389|Leukemia|leukemia
67903|NCT02859389|Down Syndrome|down syndrome
67904|NCT02859389|Neurocognitive|neurocognitive
67905|NCT02859389|Survivorship|survivorship
67906|NCT02859389|Attention|attention
67907|NCT02859389|Executive function|executive function
67908|NCT02859389|Late effects|late effects
67909|NCT02859376|Preterm infants|preterm infants
67910|NCT02859376|Pain|pain
67911|NCT02859376|Sucrose|sucrose
67912|NCT02859350|Plasmodium falciparum|plasmodium falciparum
67913|NCT02859350|PfSPZ Vaccine|pfspz vaccine
67914|NCT02859350|PfSPZ Challenge (NF54)|pfspz challenge (nf54)
67915|NCT02859350|CHMI|chmi
67916|NCT02859350|Chloroquine|chloroquine
67917|NCT02859350|Chemoprophylaxis|chemoprophylaxis
67918|NCT02859350|PfSPZ-CVac|pfspz-cvac
67925|NCT02859324|CC-122|cc-122
67926|NCT02859324|Nivolumab|nivolumab
67927|NCT02859324|Hepatocellular Carcinoma|hepatocellular carcinoma
67928|NCT02859324|Phase 1/2|phase 1/2
67929|NCT02859324|Safety|safety
67930|NCT02859311|Recovery|recovery
67931|NCT02859298|Premature Delivery|premature delivery
67932|NCT02859298|Polarimetric Imaging|polarimetric imaging
67933|NCT02859298|Polarimetric colposcope|polarimetric colposcope
67935|NCT02859285|Arousal|arousal
67936|NCT02859285|Orgasm|orgasm
67937|NCT02859285|Clitoral|clitoral
67938|NCT02859285|Estradiol|estradiol
67939|NCT02859285|Post Menopausal|post menopausal
67940|NCT02859272|Suspension, benign hysterectomy, post operative prolapse|suspension, benign hysterectomy, post operative prolapse
67941|NCT02859233|Spinal Puncture|spinal puncture
67942|NCT02859233|Dural puncture|dural puncture
67943|NCT02859233|Nursing|nursing
67944|NCT02859220|hemodialysis|hemodialysis
67945|NCT02859220|PTH|pth
67946|NCT02859207|Early Alzheimer's disease|early alzheimer's disease
67947|NCT02859207|E2609|e2609
67948|NCT02859207|Mild and Moderate Hepatic Impairment|mild and moderate hepatic impairment
67949|NCT02859181|Increased Metabolic Requirement|increased metabolic requirement
67950|NCT02859168|Neck|neck
67951|NCT02859168|Shoulder|shoulder
67952|NCT02859168|Manual Therapies|manual therapies
67953|NCT02859142|Varenicline|varenicline
67954|NCT02859129|Epanova|epanova
67955|NCT02859129|omega-3 carboxylic acids|omega-3 carboxylic acids
67956|NCT02859129|Vascepa|vascepa
67957|NCT02859129|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester
67958|NCT02859129|Crestor|crestor
59473|NCT02914730|insulin|insulin
67959|NCT02859129|rosuvastatin|rosuvastatin
67960|NCT02859116|Metabolic diseases|metabolic diseases
67961|NCT02859077|NSCLC|nsclc
67962|NCT02859077|BIM|bim
67963|NCT02859077|EGFR mutation|egfr mutation
67964|NCT02859064|radioembolization|radioembolization
67965|NCT02859064|somatostatin analogs|somatostatin analogs
67966|NCT02859064|carcinoid|carcinoid
67967|NCT02859064|neuroendocrine|neuroendocrine
67968|NCT02859064|liver-directed therapy|liver-directed therapy
67969|NCT02859051|Cognitive Behavioral Support provided by Robot|cognitive behavioral support provided by robot
67970|NCT02859025|Alveolar cleft|alveolar cleft
67971|NCT02859025|Osteoplasty|osteoplasty
67972|NCT02859025|Tissue engineering|tissue engineering
67973|NCT02859025|Stem cells|stem cells
67975|NCT02859025|Bone|bone
67976|NCT02859025|Lateral ramus|lateral ramus
67977|NCT02858999|primary plasma cell leukaemia|primary plasma cell leukaemia
67978|NCT02858999|treatment|treatment
67979|NCT02858960|High Flow Nasal Cannula|high flow nasal cannula
67980|NCT02858960|COPD|copd
67981|NCT02858960|Pulmonary rehabilitation|pulmonary rehabilitation
67982|NCT02858960|HFNC|hfnc
67983|NCT02858960|Oxygen|oxygen
67984|NCT02858947|composite resin|composite resin
67985|NCT02858947|bulk-fill|bulk-fill
67986|NCT02858947|teeth endodontically-treated|teeth endodontically-treated
67987|NCT02858934|Short preoperative tomotherapy|short preoperative tomotherapy
67988|NCT02858934|Radiotherapy|radiotherapy
67989|NCT02858921|Neoadjuvant Therapy|neoadjuvant therapy
67990|NCT02858921|Pembrolizumab|pembrolizumab
67991|NCT02858921|Dabrafenib|dabrafenib
67992|NCT02858921|Trametinib|trametinib
67993|NCT02858921|Pathological response|pathological response
67994|NCT02858921|RECIST|recist
67995|NCT02858921|Immune response|immune response
67996|NCT02858921|BRAF|braf
67997|NCT02858921|Randomised|randomised
67998|NCT02858921|Stage IIIB/C|stage iiib/c
67999|NCT02858921|Biomarkers, Tumour|biomarkers, tumour
68000|NCT02858921|Biomarkers, Drug response|biomarkers, drug response
68001|NCT02858921|Metabolic Response|metabolic response
68002|NCT02858895|High grade glioma|high grade glioma
68003|NCT02858895|malignant glioma|malignant glioma
68004|NCT02858895|recurrent glioblastoma|recurrent glioblastoma
68005|NCT02858895|recurrent GBM|recurrent gbm
68006|NCT02858895|recurrent GB|recurrent gb
68007|NCT02858895|glioblastoma (GB)|glioblastoma (gb)
68008|NCT02858895|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
68009|NCT02858895|progressive glioblastoma|progressive glioblastoma
68010|NCT02858895|Brain tumor|brain tumor
68011|NCT02858895|Brain cancer|brain cancer
68012|NCT02858895|immunotherapy|immunotherapy
68013|NCT02858895|targeted|targeted
68014|NCT02858895|IL4R|il4r
68015|NCT02858843|genetics|genetics
68016|NCT02858830|FPL|fpl
68017|NCT02858830|adipose tissue|adipose tissue
68018|NCT02858830|diabetes|diabetes
68019|NCT02858830|dyslipidemia|dyslipidemia
68020|NCT02858830|metabolic|metabolic
68021|NCT02858830|hyperinsulinemia|hyperinsulinemia
68022|NCT02858804|mantle cell lymphoma|mantle cell lymphoma
68023|NCT02858804|EDOCH|edoch
68024|NCT02858804|DHAP|dhap
68025|NCT02858804|maintenance therapy|maintenance therapy
68026|NCT02858778|Palliative Care|palliative care
68027|NCT02858778|Emergency Department|emergency department
68028|NCT02858752|Attention|attention
68029|NCT02858752|Short-term memory|short-term memory
68030|NCT02858752|Aural Memory|aural memory
68031|NCT02858752|Visual Memory|visual memory
68032|NCT02858752|Child|child
68033|NCT02858752|EEG|eeg
68034|NCT02858726|Hemodialysis|hemodialysis
68035|NCT02858726|CR845|cr845
68036|NCT02858726|Kappa opioid|kappa opioid
68037|NCT02858726|Anti-itch|anti-itch
583420|NCT00511693|fragility fracture|fragility fracture
68039|NCT02858700|neonatal bacterial infection|neonatal bacterial infection
68040|NCT02858700|procalcitonin|procalcitonin
68041|NCT02858635|Suicidal behaviour|suicidal behaviour
68043|NCT02858635|Genetics|genetics
68044|NCT02858635|Serotonin|serotonin
68045|NCT02858622|pediatric|pediatric
68046|NCT02858622|renal transplant|renal transplant
68047|NCT02858622|pain|pain
68048|NCT02858622|dual TAB|dual tab
68049|NCT02858570|Meningococcal Vaccines|meningococcal vaccines
68050|NCT02858570|Immunogenicity, Reactogenicity and Safety of Vaccine|immunogenicity, reactogenicity and safety of vaccine
68051|NCT02858544|Mild traumatic brain injury|mild traumatic brain injury
68052|NCT02858518|anticoagulant|anticoagulant
68053|NCT02858492|efficacy|efficacy
68054|NCT02858492|safety|safety
68055|NCT02858492|pharmacokinetics|pharmacokinetics
68056|NCT02858492|pharmacodynamics|pharmacodynamics
68057|NCT02858492|Rheumatoid Arthritis|rheumatoid arthritis
68058|NCT02858492|autoimmune|autoimmune
68059|NCT02858453|Interstitial cystitis|interstitial cystitis
68060|NCT02858453|Bladder pain syndrome|bladder pain syndrome
68061|NCT02858453|Painful bladder syndrome|painful bladder syndrome
68062|NCT02858453|Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)|interstitial cystitis/bladder pain syndrome (ic/bps)
68063|NCT02858453|AQX-1125|aqx-1125
68064|NCT02858453|SHIP1|ship1
68065|NCT02858453|Chronic interstitial cystitis|chronic interstitial cystitis
68066|NCT02858440|Primary dose|primary dose
68067|NCT02858440|Reactogenicity|reactogenicity
68068|NCT02858440|Immunogenicity|immunogenicity
68069|NCT02858440|Booster dose|booster dose
68070|NCT02858440|Combined vaccine|combined vaccine
68071|NCT02858440|Russian Infants|russian infants
68072|NCT02858440|Infanrix®-IPV/Hib|infanrix®-ipv/hib
68073|NCT02858427|cognitive inhibition|cognitive inhibition
68074|NCT02858427|elderly|elderly
68075|NCT02858427|suicide attempt|suicide attempt
68076|NCT02858427|depression|depression
68081|NCT02858375|provoked vulvodynia|provoked vulvodynia
68082|NCT02858362|DMD|dmd
68083|NCT02858362|Muscular Dystrophy|muscular dystrophy
68084|NCT02858362|Utrophin|utrophin
68085|NCT02858362|Duchenne|duchenne
68086|NCT02858362|PhaseOut DMD|phaseout dmd
68087|NCT02858336|Luteinizing Hormone (LH)|luteinizing hormone (lh)
68088|NCT02858336|Functional Hypothalamic Amenorrhea (HA)|functional hypothalamic amenorrhea (ha)
68089|NCT02858336|Energy Deficiency|energy deficiency
68090|NCT02858336|Gonadotropin-Releasing Hormone|gonadotropin-releasing hormone
68091|NCT02858336|Leptin|leptin
68092|NCT02858323|Alloimmunization|alloimmunization
68093|NCT02858323|Refractoriness|refractoriness
68094|NCT02858323|Corrected Count Increment|corrected count increment
68095|NCT02858323|HLA-Compatible|hla-compatible
68101|NCT02858297|Oral lichen planus|oral lichen planus
68102|NCT02858297|Glucosamine|glucosamine
68103|NCT02858297|IL-8|il-8
68104|NCT02858258|MCL|mcl
68105|NCT02858245|MitraClip|mitraclip
68106|NCT02858245|Structural Heart Failure|structural heart failure
68107|NCT02858245|Degenerative Mitral Regurgitation (DMR)|degenerative mitral regurgitation (dmr)
68108|NCT02858245|Actigraphy|actigraphy
68109|NCT02858232|MASCT-I|masct-i
68110|NCT02858232|Solid Tumors|solid tumors
68111|NCT02858219|Botulinum toxin|botulinum toxin
68112|NCT02858219|Pain improvement|pain improvement
68113|NCT02858206|Locally advanced esophageal cancer|locally advanced esophageal cancer
68114|NCT02858206|Radiotherapy and nimotuzumab|radiotherapy and nimotuzumab
68115|NCT02858206|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
68116|NCT02858154|OSA|osa
68117|NCT02858154|obstructive sleep apnea|obstructive sleep apnea
68118|NCT02858154|infants|infants
68119|NCT02858154|high flow nasal cannula|high flow nasal cannula
68120|NCT02858154|HFNC|hfnc
68121|NCT02858141|oncogeriatric evaluation|oncogeriatric evaluation
68122|NCT02858141|pancreatic cancer|pancreatic cancer
68123|NCT02858141|Database|database
68124|NCT02858102|Schizophrenia|schizophrenia
68125|NCT02858102|Psychosis|psychosis
68126|NCT02858102|Obesity|obesity
68127|NCT02858102|Neurocognition|neurocognition
68128|NCT02858102|Depression|depression
68129|NCT02858102|Bipolar disorder|bipolar disorder
68130|NCT02858102|Metabolomics|metabolomics
68131|NCT02858102|Biomarkers|biomarkers
68132|NCT02858102|Hypertension|hypertension
68133|NCT02858102|Dyslipidemia|dyslipidemia
68134|NCT02858102|Hyperglycemia|hyperglycemia
68135|NCT02858102|Hypertriglyceridemia|hypertriglyceridemia
68136|NCT02858076|Anti-VEGF|anti-vegf
68137|NCT02858076|Vitrectomy|vitrectomy
68138|NCT02858063|Breast cancer|breast cancer
68139|NCT02858063|Quality Of Life|quality of life
68140|NCT02858063|Women|women
68141|NCT02858063|Partner|partner
68142|NCT02858011|behavior change communication|behavior change communication
68143|NCT02858011|cash transfer|cash transfer
68144|NCT02858011|household welfare|household welfare
68145|NCT02858011|child nutrition status|child nutrition status
68146|NCT02857985|Myocardial Infarction|myocardial infarction
68148|NCT02857985|rotational angiography|rotational angiography
68149|NCT02857972|Menstruation, Female Barrier, Sanitary pads|menstruation, female barrier, sanitary pads
68150|NCT02857933|cerebral palsy|cerebral palsy
68151|NCT02857933|motor impairments|motor impairments
68152|NCT02857920|Vascular Endothelial Growth Factor (VEGF) antibody|vascular endothelial growth factor (vegf) antibody
68153|NCT02857920|solid tumor|solid tumor
68154|NCT02857920|NK Immunotherapy|nk immunotherapy
68155|NCT02857907|Kidney transplantation|kidney transplantation
68156|NCT02857907|Immunosuppressive treatment|immunosuppressive treatment
68157|NCT02857894|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
68158|NCT02857881|keratoconus|keratoconus
68159|NCT02857881|photokeratectomy|photokeratectomy
68160|NCT02857881|de-epithelization|de-epithelization
68161|NCT02857868|Hepatic Impairment|hepatic impairment
68163|NCT02857868|Child-Pugh|child-pugh
68164|NCT02857868|healthy subjects with normal hepatic function|healthy subjects with normal hepatic function
68165|NCT02857855|liver transplantation|liver transplantation
68166|NCT02857855|postoperative infection|postoperative infection
68167|NCT02857855|biliary complications|biliary complications
59717|NCT02912936|MCT|mct
68168|NCT02857855|patient survival|patient survival
68169|NCT02857855|graft survival|graft survival
68170|NCT02857855|supplemental oxygen|supplemental oxygen
68171|NCT02857829|Cognition|cognition
68172|NCT02857829|working memory|working memory
68173|NCT02857829|nootropic|nootropic
68174|NCT02857829|reaction time|reaction time
68175|NCT02857829|healthy individuals|healthy individuals
68176|NCT02857829|cognitive enhancement|cognitive enhancement
68177|NCT02857803|Virtual Reality|virtual reality
68178|NCT02857803|Cognitive Rehabilitation|cognitive rehabilitation
68179|NCT02857803|Motor Rehabilitation|motor rehabilitation
68180|NCT02857803|Ecological validity|ecological validity
68181|NCT02857803|Personalisation|personalisation
68182|NCT02857790|Rotablation|rotablation
68183|NCT02857790|High speed rotational atherectomy|high speed rotational atherectomy
68184|NCT02857790|Type IV myocardial infarction|type iv myocardial infarction
68185|NCT02857790|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
68186|NCT02857790|CMR|cmr
68187|NCT02857790|Percutaneous Coronary Intervention|percutaneous coronary intervention
68188|NCT02857751|depression|depression
68189|NCT02857751|PTSD|ptsd
68190|NCT02857751|anxiety|anxiety
68191|NCT02857751|surf therapy|surf therapy
68192|NCT02857699|Quality of life|quality of life
68193|NCT02857699|Phase I trials|phase i trials
68194|NCT02857673|Children with Special Health Care Needs|children with special health care needs
68195|NCT02857673|Violence Prevention|violence prevention
68196|NCT02857660|Sarcopenia|sarcopenia
68197|NCT02857660|Obesity|obesity
68198|NCT02857660|Whole-Body Electromyostimulation|whole-body electromyostimulation
68199|NCT02857660|Protein Supplementation|protein supplementation
68200|NCT02857660|community dwelling men|community dwelling men
68201|NCT02857647|Bariatric surgery|bariatric surgery
68202|NCT02857647|Anxiety|anxiety
68203|NCT02857647|Nutrition knowledge|nutrition knowledge
68204|NCT02857647|Weight loss expectations|weight loss expectations
68205|NCT02857634|Urinary Bladder cancer|urinary bladder cancer
68206|NCT02857634|diagnosis|diagnosis
68207|NCT02857634|Cellvizio Dual Band|cellvizio dual band
68208|NCT02857582|Antibiotic-induced diarrhea|antibiotic-induced diarrhea
68209|NCT02857582|Clostridium-difficile toxin|clostridium-difficile toxin
68210|NCT02857582|Pseudomembranous colitis|pseudomembranous colitis
68211|NCT02857504|double lumen tube|double lumen tube
68212|NCT02857504|hook|hook
68213|NCT02857439|Trauma of the shoulder|trauma of the shoulder
68214|NCT02857413|Xerostomia|xerostomia
68215|NCT02857413|Radiotherapy|radiotherapy
68216|NCT02857348|decision making|decision making
68217|NCT02857348|heuristics|heuristics
68218|NCT02857283|Air pollution|air pollution
68219|NCT02857283|Air pollutant exposure|air pollutant exposure
68220|NCT02857283|Ozone|ozone
68221|NCT02857270|MAPK|mapk
68222|NCT02857270|RAS|ras
68223|NCT02857270|BRAF|braf
68224|NCT02857257|IBS|ibs
68225|NCT02857257|Microbiota|microbiota
68226|NCT02857244|Freezing of Gait|freezing of gait
68227|NCT02857231|Bioimpedance spectroscopy|bioimpedance spectroscopy
68228|NCT02857205|Hirschsprung Associated EnteroColitis (HAEC)|hirschsprung associated enterocolitis (haec)
68229|NCT02857179|bariatric surgery|bariatric surgery
68230|NCT02857179|follow-up|follow-up
68231|NCT02857179|weight loss|weight loss
68232|NCT02857179|complications|complications
68233|NCT02857179|comorbidities evolution|comorbidities evolution
68234|NCT02857166|JS001|js001
68235|NCT02857166|solid tumors|solid tumors
68236|NCT02857153|MAP|map
68237|NCT02857153|Blood loss|blood loss
68238|NCT02857153|Postoperative delirium|postoperative delirium
68239|NCT02857153|Elderly patients|elderly patients
68240|NCT02857153|Noncardiothoracic surgery|noncardiothoracic surgery
68241|NCT02857127|Low income population|low income population
68242|NCT02857127|Motor Activity|motor activity
68243|NCT02857127|Primary Health Care|primary health care
68244|NCT02857088|depression|depression
68245|NCT02857088|emotional reactivity|emotional reactivity
68257|NCT02856971|rotating hinge prosthesis|rotating hinge prosthesis
68258|NCT02856971|hinge knee arthroplasty|hinge knee arthroplasty
68259|NCT02856945|fracture|fracture
68260|NCT02856945|children|children
68261|NCT02856945|knee|knee
68262|NCT02856945|clinical criteria|clinical criteria
68263|NCT02856945|decision making|decision making
68264|NCT02856906|Orofacial Pain|orofacial pain
68265|NCT02856906|Electromyography|electromyography
68266|NCT02856906|dental occlusion|dental occlusion
68267|NCT02856893|AZD9291|azd9291
68268|NCT02856893|Osimertinib|osimertinib
68269|NCT02856893|Gefitinib|gefitinib
68270|NCT02856893|NSCLC|nsclc
68271|NCT02856841|epithelial ovarian cancer|epithelial ovarian cancer
68272|NCT02856841|optimum cytoreduction|optimum cytoreduction
68273|NCT02856815|Immuncell-LC|immuncell-lc
68274|NCT02856815|Transarterial Chemoembolization|transarterial chemoembolization
68275|NCT02856789|Fibrin structure|fibrin structure
68276|NCT02856789|Thromboelastography|thromboelastography
79402|NCT02789332|pCR|pcr
68277|NCT02856789|Fibrin formation|fibrin formation
68278|NCT02856789|Fibrinolysis|fibrinolysis
68279|NCT02856789|TEG 5000|teg 5000
68281|NCT02856789|Coagulo-lytic balance|coagulo-lytic balance
68282|NCT02856789|Normal range|normal range
68283|NCT02856776|Vitamin D|vitamin d
68284|NCT02856776|Metabolomics|metabolomics
68285|NCT02856776|Microbiota|microbiota
68286|NCT02856776|Gene Expression|gene expression
68287|NCT02856711|Group Prenatal Visits,CenteringPregnancy|group prenatal visits,centeringpregnancy
68288|NCT02856698|Acute heart failure|acute heart failure
68289|NCT02856698|morphine|morphine
68290|NCT02856698|midazolam|midazolam
68291|NCT02856698|in-hospital mortality|in-hospital mortality
68292|NCT02856672|Laryngeal Tube Supreme Laryngeal Mask Airway Leak Pressure|laryngeal tube supreme laryngeal mask airway leak pressure
68293|NCT02856620|cardiac mechanics|cardiac mechanics
68294|NCT02856620|circulating biomarkers|circulating biomarkers
68295|NCT02856620|frailty|frailty
68296|NCT02856542|Psoriasis vulgaris, scalp, topical, applicator, device|psoriasis vulgaris, scalp, topical, applicator, device
68297|NCT02856503|DCIS|dcis
68298|NCT02856503|IBC|ibc
68299|NCT02856503|Breast Cancer|breast cancer
68300|NCT02856503|Invasive Breast Carcinoma|invasive breast carcinoma
68301|NCT02856503|High Grade Ductal Carcinoma in-situ|high grade ductal carcinoma in-situ
68302|NCT02855424|stroke|stroke
68303|NCT02855424|exercise capacity|exercise capacity
68304|NCT02855385|Rectal bleeding, , ,|rectal bleeding, , ,
68305|NCT02855385|Attitude|attitude
68306|NCT02855385|Health seeking behaviour|health seeking behaviour
68307|NCT02855385|Nigeria|nigeria
68308|NCT02855385|Screening|screening
68309|NCT02855385|high risk patients|high risk patients
68310|NCT02856412|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
68311|NCT02856412|Exercise|exercise
68312|NCT02856412|Mindfulness|mindfulness
68313|NCT02856399|methadone|methadone
68314|NCT02856399|cancer pain|cancer pain
68315|NCT02856399|long term effect|long term effect
68316|NCT02856373|Denervation|denervation
68317|NCT02856373|Renal Artery|renal artery
68318|NCT02856360|Football|football
68319|NCT02856360|Cleats|cleats
68320|NCT02856360|Stiffness|stiffness
68321|NCT02856347|Medullary Thyroid Cancer|medullary thyroid cancer
68322|NCT02856347|PET F-DOPA|pet f-dopa
68323|NCT02856347|18-FDOPA|18-fdopa
68324|NCT02856334|chronic pelvic pain|chronic pelvic pain
68325|NCT02856334|vulvodynia|vulvodynia
68326|NCT02856334|pelvic pain|pelvic pain
68327|NCT02856334|psychosocial factors|psychosocial factors
68328|NCT02856334|central sensitization|central sensitization
68329|NCT02856295|postpartum venous thromboembolism|postpartum venous thromboembolism
68330|NCT02856295|prophylactic dose of low molecular weight heparin|prophylactic dose of low molecular weight heparin
68331|NCT02856295|anti 10a|anti 10a
68332|NCT02856269|Zinc|zinc
68333|NCT02856256|Energy drink|energy drink
68334|NCT02856256|Choroid|choroid
68335|NCT02856230|Critical limb ischemia|critical limb ischemia
68336|NCT02856230|bellow-the-knee angioplasty|bellow-the-knee angioplasty
68337|NCT02856230|drug-eluting balloon|drug-eluting balloon
68339|NCT02856165|oxygen therapy|oxygen therapy
68340|NCT02856165|High flow nasal canula oxygen therapy|high flow nasal canula oxygen therapy
68341|NCT02856165|Bronchiolitis|bronchiolitis
68342|NCT02856152|Healthy Volunteer|healthy volunteer
68343|NCT02856139|ultra-widefield fluorescein angiography|ultra-widefield fluorescein angiography
68344|NCT02856139|peripheral retina|peripheral retina
68345|NCT02856139|normal eyes|normal eyes
68346|NCT02856126|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
68347|NCT02856126|Transarterial Chemoembolization|transarterial chemoembolization
68348|NCT02856113|Drug therapy|drug therapy
68349|NCT02856087|acute pain|acute pain
68350|NCT02856087|postoperative|postoperative
68351|NCT02856087|surgery|surgery
68352|NCT02856048|GnRH agonist|gnrh agonist
68353|NCT02856048|Ovarian reserve|ovarian reserve
68354|NCT02856048|Fertility Preservation|fertility preservation
68355|NCT02856048|Alkylating Agents|alkylating agents
68356|NCT02856035|chronic stroke|chronic stroke
68357|NCT02856035|functional MRI|functional mri
68358|NCT02856035|functional NIRS|functional nirs
68359|NCT02856035|motor learning|motor learning
68360|NCT02856035|FES|fes
68361|NCT02856035|upper extremity|upper extremity
68362|NCT02856035|neural feedback|neural feedback
68363|NCT02856035|arm/hand functional training|arm/hand functional training
68364|NCT02856022|electrical ilioinguinal nerve stimulation|electrical ilioinguinal nerve stimulation
68365|NCT02856022|bladder pain syndrome|bladder pain syndrome
68366|NCT02856022|intravesical irrigation|intravesical irrigation
68367|NCT02855996|fatherhood|fatherhood
68368|NCT02855996|father involvement|father involvement
68369|NCT02855996|economic stability|economic stability
68370|NCT02855996|co-parenting|co-parenting
68371|NCT02855996|healthy relationships|healthy relationships
68372|NCT02855996|father-child engagement|father-child engagement
59868|NCT02911597|TRD|trd
68373|NCT02855957|Alpha-Hemoglobin Stabilizing Protein|alpha-hemoglobin stabilizing protein
68374|NCT02855957|alpha-Hb pool|alpha-hb pool
68375|NCT02855957|thalassemias|thalassemias
68376|NCT02855957|diagnostic method|diagnostic method
68377|NCT02855957|biomarker|biomarker
68378|NCT02855944|ovarian cancer|ovarian cancer
68379|NCT02855944|fallopian tube cancer|fallopian tube cancer
68380|NCT02855944|primary peritoneal cancer|primary peritoneal cancer
68381|NCT02855944|peritoneal cancer|peritoneal cancer
68382|NCT02855944|platinum sensitive|platinum sensitive
68383|NCT02855944|relapsed disease|relapsed disease
68384|NCT02855944|PARP Inhibitor|parp inhibitor
68385|NCT02855944|PARP|parp
68386|NCT02855944|rucaparib|rucaparib
68387|NCT02855944|ruca|ruca
68388|NCT02855944|homologous recombination|homologous recombination
68389|NCT02855944|homologous recombination deficiency|homologous recombination deficiency
68390|NCT02855944|genomic scarring|genomic scarring
68391|NCT02855944|loss of heterozygosity|loss of heterozygosity
68392|NCT02855944|CO-338|co-338
68393|NCT02855944|PF-01367338|pf-01367338
68394|NCT02855944|PF 01367338|pf 01367338
68395|NCT02855944|CO-338-043|co-338-043
68396|NCT02855944|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
68397|NCT02855944|platinum sensitive fallopian tube cancer|platinum sensitive fallopian tube cancer
68398|NCT02855944|platinum sensitive primary peritoneal cancer|platinum sensitive primary peritoneal cancer
68399|NCT02855944|platinum sensitive peritoneal cancer|platinum sensitive peritoneal cancer
68400|NCT02855944|gynecological cancer|gynecological cancer
68401|NCT02855944|Clovis|clovis
68402|NCT02855944|Clovis oncology|clovis oncology
68403|NCT02855944|ARIEL2|ariel2
68404|NCT02855944|ARIEL 2|ariel 2
68405|NCT02855944|ARIEL-2|ariel-2
68406|NCT02855944|ARIEL-3|ariel-3
68407|NCT02855944|ARIEL 3|ariel 3
68408|NCT02855944|ARIEL3|ariel3
68409|NCT02855944|ARIEL4|ariel4
68410|NCT02855944|ARIEL-4|ariel-4
68411|NCT02855944|ARIEL 4|ariel 4
68412|NCT02855944|A4|a4
68413|NCT02855944|advanced OC|advanced oc
68414|NCT02855944|platinum resistant ovarian cancer|platinum resistant ovarian cancer
68415|NCT02855944|platinum resistant primary ovarian cancer|platinum resistant primary ovarian cancer
68416|NCT02855944|Rubraca|rubraca
68417|NCT02855918|Psychiatry|psychiatry
68418|NCT02855918|Depressive disorder|depressive disorder
68419|NCT02855918|Suicidal behavior|suicidal behavior
68420|NCT02855918|Genetics|genetics
68421|NCT02855905|Exercise|exercise
68422|NCT02855905|Cold Temperature|cold temperature
68423|NCT02855892|GV1001|gv1001
68424|NCT02855892|BPH|bph
68425|NCT02855892|Benign prostatic hyperplasia|benign prostatic hyperplasia
68426|NCT02855788|gastric cancer|gastric cancer
68427|NCT02855788|gastroesophageal cancer|gastroesophageal cancer
68428|NCT02855788|metastatic|metastatic
68429|NCT02855788|advanced|advanced
68430|NCT02855736|Suicidal inpatients|suicidal inpatients
68431|NCT02855736|Positive Psychology|positive psychology
68432|NCT02855736|Gratitude|gratitude
68433|NCT02855736|Psychological pain|psychological pain
68434|NCT02855723|Squamous carcinoma of oral cavity and oropharynx|squamous carcinoma of oral cavity and oropharynx
68435|NCT02855723|Sentinel lymph node|sentinel lymph node
68436|NCT02855723|Lymph node dissection|lymph node dissection
68437|NCT02855723|Equivalence|equivalence
68438|NCT02855671|microcirculation|microcirculation
68439|NCT02855671|thermal|thermal
68440|NCT02855671|temperature|temperature
68441|NCT02855658|Sjögren's syndrome|sjögren's syndrome
68442|NCT02855658|Gan-Lu-Yin|gan-lu-yin
68443|NCT02855658|Sang-Ju-Yin|sang-ju-yin
68444|NCT02855658|Xuefu-Zhuyu-Decoction|xuefu-zhuyu-decoction
68445|NCT02855658|Oxidative stress|oxidative stress
68446|NCT02855658|Immune regulation|immune regulation
68447|NCT02855658|Gene modulation|gene modulation
68448|NCT02855658|SS-1|ss-1
68449|NCT02855645|Trichosanthes root|trichosanthes root
68450|NCT02855645|Traditional Chinese Medicine|traditional chinese medicine
68451|NCT02855645|Clinical trial|clinical trial
68452|NCT02855632|G-CSF|g-csf
68453|NCT02855632|adhesion reformation|adhesion reformation
68454|NCT02855632|Asherman syndrome|asherman syndrome
68455|NCT02855619|inspiratory muscles training programs|inspiratory muscles training programs
68456|NCT02855619|Ventilator-induced diaphragmatic dysfunction|ventilator-induced diaphragmatic dysfunction
68457|NCT02855619|Weaning|weaning
68458|NCT02855619|Intensive care unit|intensive care unit
68459|NCT02855606|Oral PrEP|oral prep
68460|NCT02855606|TGW|tgw
68461|NCT02855606|Thai MSM|thai msm
68462|NCT02855593|acupuncture|acupuncture
68463|NCT02855580|Pharmacogenomic|pharmacogenomic
68464|NCT02855580|child|child
68465|NCT02855580|psychiatry|psychiatry
68466|NCT02855580|Obsessive Compulsive Disorder|obsessive compulsive disorder
68467|NCT02855580|Depression|depression
68468|NCT02855580|Anxiety|anxiety
68469|NCT02855580|CYP2D6|cyp2d6
68470|NCT02855580|CYP2C19|cyp2c19
68471|NCT02855580|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
79648|NCT02787811|IUI|iui
60007|NCT02910648|BMI|bmi
68472|NCT02855580|SSRI|ssri
68473|NCT02855567|surgery|surgery
68474|NCT02855567|acupuncture|acupuncture
68475|NCT02855567|gynecology|gynecology
68476|NCT02855567|pain|pain
68477|NCT02855567|narcotics|narcotics
68478|NCT02855554|myocardial tissue characterization|myocardial tissue characterization
68479|NCT02855541|Blood Glucose|blood glucose
68480|NCT02855541|Physical Fitness|physical fitness
68481|NCT02855541|Body Composition|body composition
68482|NCT02855541|Lipids|lipids
68483|NCT02855528|Tin Filter|tin filter
68484|NCT02855528|Coronary Artery Calcium Scoring|coronary artery calcium scoring
68485|NCT02855528|Radiation dose reduction|radiation dose reduction
68486|NCT02855515|drug-induced sleep endoscopy|drug-induced sleep endoscopy
68487|NCT02855515|obstructive sleep apnoea|obstructive sleep apnoea
68488|NCT02855515|VOTE classification|vote classification
68489|NCT02855515|AHI|ahi
68490|NCT02855515|BMI|bmi
68491|NCT02855489|Condom Use|condom use
68492|NCT02855489|HIV/STD|hiv/std
68493|NCT02855489|Intervention|intervention
68494|NCT02855489|Theory of Planned Behavior|theory of planned behavior
68495|NCT02855489|Dismantling Study Design|dismantling study design
68496|NCT02855463|Giant virus|giant virus
68497|NCT02855463|Amoeba|amoeba
68498|NCT02855359|Antibodies, Monoclonal|antibodies, monoclonal
68499|NCT02855359|SGN-19A|sgn-19a
68500|NCT02855359|Denintuzumab Mafodotin|denintuzumab mafodotin
68501|NCT02855359|DLBCL|dlbcl
68502|NCT02855359|Antibody-Drug Conjugate|antibody-drug conjugate
68503|NCT02855359|Antigens, CD19|antigens, cd19
68504|NCT02855359|Hematologic Diseases|hematologic diseases
68505|NCT02855359|Immune System Diseases|immune system diseases
68506|NCT02855359|Immunoproliferative Disorders|immunoproliferative disorders
68507|NCT02855359|Immunotherapy|immunotherapy
68508|NCT02855359|Lymphatic Diseases|lymphatic diseases
68509|NCT02855359|Lymphoma|lymphoma
68510|NCT02855359|Lymphoma, B-Cell|lymphoma, b-cell
68511|NCT02855359|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
68512|NCT02855359|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
68513|NCT02855359|Monomethyl auristatin F|monomethyl auristatin f
68514|NCT02855359|Neoplasms|neoplasms
68515|NCT02855359|Neoplasms by Histologic Type|neoplasms by histologic type
68516|NCT02855359|Transformed Lymphoma / DLBCL|transformed lymphoma / dlbcl
68517|NCT02855359|Cyclophosphamide|cyclophosphamide
68518|NCT02855359|Doxorubicin|doxorubicin
68519|NCT02855359|Liposomal doxorubicin|liposomal doxorubicin
68520|NCT02855359|Prednisone|prednisone
68521|NCT02855359|Rituximab|rituximab
68522|NCT02855359|Vincristine|vincristine
68523|NCT02855359|Alkylating Agents|alkylating agents
68524|NCT02855359|Anti-Inflammatory Agents|anti-inflammatory agents
68525|NCT02855359|Antibiotic, Antineoplastic|antibiotic, antineoplastic
68526|NCT02855359|Antimitotic Agents|antimitotic agents
68527|NCT02855359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
68528|NCT02855359|Antineoplastic Agents|antineoplastic agents
68529|NCT02855359|Phytogenic Antirheumatic Agents|phytogenic antirheumatic agents
68530|NCT02855359|Glucocorticoids|glucocorticoids
68531|NCT02855359|Drug Therapy|drug therapy
68532|NCT02855359|Follicular Lymphoma Grade 3b|follicular lymphoma grade 3b
68533|NCT02855359|immunosuppressive agents|immunosuppressive agents
68534|NCT02855333|Merendino procedure|merendino procedure
68535|NCT02855333|Feasibility, Safety and QoL of the Merendino procedure|feasibility, safety and qol of the merendino procedure
68537|NCT02855320|Rheumatoid arthritis|rheumatoid arthritis
68538|NCT02855320|Spondyloarthritis|spondyloarthritis
68539|NCT02855320|patient education|patient education
68540|NCT02855320|self-management|self-management
68541|NCT02855307|Closed-loop system|closed-loop system
68542|NCT02855307|Artificial pancreas|artificial pancreas
68543|NCT02855307|Exercise|exercise
68544|NCT02855307|Hypoglycemia|hypoglycemia
68545|NCT02855307|Insulin|insulin
68546|NCT02855307|Type 1 diabetes|type 1 diabetes
68547|NCT02855294|oral contraceptive pills|oral contraceptive pills
68548|NCT02855294|Joint stability|joint stability
68549|NCT02855268|Kidney disease, nephritis|kidney disease, nephritis
68550|NCT02855229|Translational|translational
68551|NCT02855229|Electrophysiology|electrophysiology
68552|NCT02855216|Physiotherapy|physiotherapy
68553|NCT02855216|Range of motion|range of motion
68554|NCT02855216|Inhibition sub-occipital techniques|inhibition sub-occipital techniques
68555|NCT02855190|Ga68-citrate|ga68-citrate
68556|NCT02855190|FDG|fdg
68557|NCT02855190|PET/MR and PET/CT|pet/mr and pet/ct
68558|NCT02855190|Periprosthetic joint infection|periprosthetic joint infection
68559|NCT02855177|Hyperlipidemia|hyperlipidemia
68560|NCT02855164|LJN452|ljn452
68561|NCT02855164|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
68562|NCT02855164|NASH|nash
68563|NCT02855164|phase 2|phase 2
68564|NCT02855164|adaptive design|adaptive design
68565|NCT02855164|randomized|randomized
68566|NCT02855151|EUS|eus
68567|NCT02855138|isotretinoin|isotretinoin
60067|NCT02910284|HSV|hsv
68568|NCT02855138|PCOS|pcos
68569|NCT02855138|acne vulgaris|acne vulgaris
68570|NCT02855125|NSCLC|nsclc
68571|NCT02855125|phase 2 study|phase 2 study
68572|NCT02855125|TAS-114|tas-114
68573|NCT02855125|S-1|s-1
68574|NCT02855073|adipose-derived mesenchymal progenitor cells|adipose-derived mesenchymal progenitor cells
68575|NCT02855073|Artz|artz
68576|NCT02855034|child and infant|child and infant
68577|NCT02855034|Blood samples|blood samples
68578|NCT02855021|Dementia|dementia
68579|NCT02855021|Cerebral metabolism|cerebral metabolism
68580|NCT02855021|PET scan|pet scan
68581|NCT02855008|Social Problem-Solving|social problem-solving
68582|NCT02855008|Intellectual Disability|intellectual disability
68583|NCT02855008|Problem Behaviors|problem behaviors
68584|NCT02855008|Community based intervention|community based intervention
68585|NCT02855008|Prevention|prevention
68586|NCT02854956|phenotype|phenotype
68587|NCT02854956|X-linked mental retardation|x-linked mental retardation
68588|NCT02854956|neuronal networks|neuronal networks
68589|NCT02854956|cognitive processes|cognitive processes
68590|NCT02854930|Clinical death|clinical death
68591|NCT02854930|state of consciousness|state of consciousness
68592|NCT02854904|Immunomodulatory|immunomodulatory
68593|NCT02854904|dexmedetomidine|dexmedetomidine
68594|NCT02854904|anesthesia|anesthesia
68595|NCT02854904|alpha-2 agonist|alpha-2 agonist
68596|NCT02854904|arthrodesis|arthrodesis
68597|NCT02854904|spinal fusion|spinal fusion
68598|NCT02854904|Immune effect|immune effect
68599|NCT02854904|double randomized clinical trials|double randomized clinical trials
68601|NCT02854891|Heat|heat
68602|NCT02854891|Light|light
68603|NCT02854826|Frail Older Adults, Interprofessional Team|frail older adults, interprofessional team
68604|NCT02854813|overactive bladder|overactive bladder
68605|NCT02854813|coronary artery disease|coronary artery disease
68606|NCT02854813|gensini score|gensini score
68607|NCT02854800|varenicline|varenicline
68608|NCT02854800|buprenorphine|buprenorphine
69145|NCT02851329|EGFR TKIs|egfr tkis
68609|NCT02854787|Spinal anesthesia|spinal anesthesia
68610|NCT02854787|cesarean|cesarean
68611|NCT02854787|blood pressure|blood pressure
68612|NCT02854787|Norepinephrine|norepinephrine
68613|NCT02854787|Phenylephrine|phenylephrine
68614|NCT02854735|Head and Neck Neoplasms|head and neck neoplasms
68615|NCT02854735|Total body composition|total body composition
68616|NCT02854735|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
68617|NCT02854735|Malnutrition|malnutrition
68618|NCT02854735|Muscle quantification|muscle quantification
68619|NCT02854722|deferasirox|deferasirox
68620|NCT02854722|iron accumulation|iron accumulation
68621|NCT02854696|Islet cell Transplantation|islet cell transplantation
68622|NCT02854696|cost-effectiveness analysis|cost-effectiveness analysis
68623|NCT02854696|Cost-utility analysis|cost-utility analysis
68624|NCT02854696|Type 1 Diabetes|type 1 diabetes
68625|NCT02854683|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
68626|NCT02854683|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
68627|NCT02854683|Postural Tachycardia Syndrome (POTS)|postural tachycardia syndrome (pots)
68628|NCT02854683|Neurally Mediated Syncope (NMS)|neurally mediated syncope (nms)
68629|NCT02854683|Systemic Exertion Intolerance Disease (SEID)|systemic exertion intolerance disease (seid)
68630|NCT02854683|Orthostatic Intolerance (OI)|orthostatic intolerance (oi)
68631|NCT02854683|Oral Rehydration Solution (ORS)|oral rehydration solution (ors)
583421|NCT00511693|management of osteoporosis|management of osteoporosis
68632|NCT02854683|Lower Body Negative Pressure (LBNP)|lower body negative pressure (lbnp)
68633|NCT02854670|capsaicin|capsaicin
68634|NCT02854670|pain improvement|pain improvement
68635|NCT02854670|provoked vulvodynia|provoked vulvodynia
68636|NCT02854657|melanoma|melanoma
68637|NCT02854657|skin self-examination|skin self-examination
68638|NCT02854631|Cirrhosis|cirrhosis
68639|NCT02854631|Prednisone|prednisone
68640|NCT02854631|Jaundice|jaundice
68641|NCT02854605|Non-alcoholic fatty liver disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
68642|NCT02854605|Fibrosis|fibrosis
68643|NCT02854605|GS-9674|gs-9674
68644|NCT02854592|rtPA|rtpa
68645|NCT02854592|urokinase|urokinase
68646|NCT02854579|Hypoxic-Ischemic Encephalopathy|hypoxic-ischemic encephalopathy
68647|NCT02854579|progenitor cell|progenitor cell
68648|NCT02854579|paracrine factor|paracrine factor
68649|NCT02854579|adipose mesenchymal stem cell|adipose mesenchymal stem cell
68650|NCT02854579|neonate|neonate
68651|NCT02854566|periprosthetic fracture of the femur|periprosthetic fracture of the femur
68652|NCT02854566|hip prosthesis|hip prosthesis
68653|NCT02854540|hyperhidrosis|hyperhidrosis
68654|NCT02854540|palmar|palmar
68655|NCT02854540|sweating|sweating
68656|NCT02854540|iontophoresis|iontophoresis
68657|NCT02854540|sweat gland diseases|sweat gland diseases
68658|NCT02854540|skin diseases|skin diseases
68659|NCT02854514|endometrial -cytokines|endometrial -cytokines
68660|NCT02854501|Homocysteine|homocysteine
68661|NCT02854501|Preeclampsia|preeclampsia
68662|NCT02854501|poor placentation|poor placentation
68663|NCT02854475|skin parameters|skin parameters
68664|NCT02854475|cholesterol|cholesterol
68665|NCT02854475|Raman spectroscopy|raman spectroscopy
68666|NCT02854462|Language Development|language development
68667|NCT02854462|Shared Picture Book reading|shared picture book reading
68668|NCT02854462|Preschoolers|preschoolers
68669|NCT02854462|Inference making|inference making
68670|NCT02854449|Immune Marker|immune marker
68671|NCT02854449|Immunologic Marker|immunologic marker
68680|NCT02854436|DNA anomalies|dna anomalies
68682|NCT02854436|PARP inhibitor|parp inhibitor
68683|NCT02854436|PARPi|parpi
68684|NCT02854410|dietary sodium nitrate|dietary sodium nitrate
68685|NCT02854410|radiotherapy|radiotherapy
68686|NCT02854410|nasopharyngeal carcinoma|nasopharyngeal carcinoma
68687|NCT02854384|Epilepsy|epilepsy
68688|NCT02854384|Mobile phone|mobile phone
68689|NCT02854371|gadoxetic acid|gadoxetic acid
68690|NCT02854371|T1 map|t1 map
68692|NCT02854345|CZT camera|czt camera
68693|NCT02854345|pinhole|pinhole
68694|NCT02854332|Pain|pain
68695|NCT02854332|Analgesic|analgesic
68696|NCT02854332|Stimulation|stimulation
68697|NCT02854332|Motor Cortex|motor cortex
68698|NCT02854306|Bariatric surgery|bariatric surgery
68699|NCT02854306|Mindfulness|mindfulness
68700|NCT02854306|Obese|obese
68701|NCT02854293|palliative care|palliative care
68702|NCT02854293|cancer|cancer
68703|NCT02854293|quality of life|quality of life
68704|NCT02854280|Hypoxia|hypoxia
68705|NCT02854280|Brain|brain
68706|NCT02854280|Effort|effort
68707|NCT02854267|organ procurement|organ procurement
68708|NCT02854267|brain death|brain death
68709|NCT02854267|organ donation|organ donation
68710|NCT02854267|next of kins|next of kins
68711|NCT02854254|phlebitis|phlebitis
68712|NCT02854254|catheter|catheter
68713|NCT02854254|congestive heart failure|congestive heart failure
68714|NCT02854254|dobutamine|dobutamine
68715|NCT02854241|MRI|mri
68716|NCT02854241|HCC|hcc
68717|NCT02854241|surveillance|surveillance
68718|NCT02854228|Pituitary tumor|pituitary tumor
68719|NCT02854228|pituitary carcinoma|pituitary carcinoma
68720|NCT02854228|acromegaly|acromegaly
68721|NCT02854228|cushing|cushing
68722|NCT02854228|prolactinoma|prolactinoma
68723|NCT02854163|Secukinumab|secukinumab
68724|NCT02854163|Neutrophils|neutrophils
68725|NCT02854163|Vitamin D|vitamin d
68726|NCT02854124|Melanoma|melanoma
68727|NCT02854124|Dissemination|dissemination
68728|NCT02854124|Initiating stem cells|initiating stem cells
68729|NCT02854098|BHJS, constipation|bhjs, constipation
68730|NCT02854085|Prevention of Cognitive Decline|prevention of cognitive decline
68731|NCT02854085|Art Therapy|art therapy
68732|NCT02854085|Music Reminiscence Activity|music reminiscence activity
68733|NCT02854085|Elderly|elderly
68734|NCT02854072|GV1001|gv1001
68735|NCT02854059|Asymptomatic antibody-mediated TTP|asymptomatic antibody-mediated ttp
68736|NCT02854046|calcific uremic arteriolopathy|calcific uremic arteriolopathy
68737|NCT02854046|case-control study|case-control study
68738|NCT02854046|cohort study|cohort study
68749|NCT02854020|Aircraft|aircraft
68750|NCT02854020|Emergency|emergency
68751|NCT02854020|First aid|first aid
68752|NCT02854020|Cabin crew|cabin crew
68753|NCT02854020|Burn|burn
68754|NCT02854020|Cardiac arrest|cardiac arrest
68755|NCT02854007|Coronary artery disease|coronary artery disease
68756|NCT02854007|Angioplasty|angioplasty
68758|NCT02854007|QALY (Quality-Adjusted Life Years)|qaly (quality-adjusted life years)
68760|NCT02853994|DEB|deb
68761|NCT02853994|Sirolimus|sirolimus
68762|NCT02853994|PCI|pci
68763|NCT02853994|ISR|isr
68764|NCT02853994|SVD|svd
68765|NCT02853994|Restenosis|restenosis
68766|NCT02853994|Bifurcation|bifurcation
68767|NCT02853994|CAD|cad
68768|NCT02853994|Coronary artery|coronary artery
68769|NCT02853968|Unlock the Cell|unlock the cell
68770|NCT02853968|Castleman's Disease|castleman's disease
68771|NCT02853968|CD|cd
68772|NCT02853968|Castleman Disease|castleman disease
68773|NCT02853968|MCD|mcd
68774|NCT02853968|iMCD|imcd
68775|NCT02853968|Angiofollicular Lymph Hyperplasia|angiofollicular lymph hyperplasia
68776|NCT02853968|multicentric Castleman's disease|multicentric castleman's disease
68777|NCT02853968|multicentric Castleman disease|multicentric castleman disease
68778|NCT02853968|idiopathic multicentric Castleman disease|idiopathic multicentric castleman disease
68779|NCT02853929|Pertussis|pertussis
68780|NCT02853929|Immunogenicity|immunogenicity
68781|NCT02853929|Poliomyelitis|poliomyelitis
68782|NCT02853929|Tetanus|tetanus
68783|NCT02853929|Hepatitis B|hepatitis b
68784|NCT02853929|Diptheria|diptheria
68785|NCT02853903|solid tumor|solid tumor
68786|NCT02853903|NK immunotherapy|nk immunotherapy
68787|NCT02853890|Birth|birth
68788|NCT02853890|obstetric analgesia|obstetric analgesia
68789|NCT02853890|obstetric anesthesia|obstetric anesthesia
68790|NCT02853864|Gender|gender
68791|NCT02853864|Propofol|propofol
68792|NCT02853864|Dexmedetomidine|dexmedetomidine
68793|NCT02853864|Interaction|interaction
68794|NCT02853851|Stress factors,|stress factors,
68795|NCT02853851|intensive care units,|intensive care units,
68796|NCT02853851|scale,|scale,
68797|NCT02853851|quality of care|quality of care
68798|NCT02853838|acute viral bronchiolitis|acute viral bronchiolitis
68799|NCT02853838|respiratory syncytial virus|respiratory syncytial virus
68800|NCT02853838|chest physiotherapy|chest physiotherapy
68801|NCT02853812|tinnitus|tinnitus
68802|NCT02853812|residual inhibition|residual inhibition
68803|NCT02853786|cochlear implant|cochlear implant
68804|NCT02853786|language environment|language environment
68805|NCT02853786|speech therapy assessment|speech therapy assessment
68806|NCT02853786|LENA technology|lena technology
68807|NCT02853773|sweeteners|sweeteners
68808|NCT02853773|sugar|sugar
68809|NCT02853773|EEG|eeg
68810|NCT02853773|food viewing|food viewing
68811|NCT02853773|food intake|food intake
68812|NCT02853747|arterial stiffness|arterial stiffness
68813|NCT02853747|retinal vessels|retinal vessels
68814|NCT02853747|physical activity|physical activity
68815|NCT02853747|children|children
68816|NCT02853708|E. coli|e. coli
68817|NCT02853708|extended-spectrum beta-lactamase|extended-spectrum beta-lactamase
68818|NCT02853708|molecular epidemiology|molecular epidemiology
68819|NCT02853708|risk factors|risk factors
68820|NCT02853695|Hysteroscopy|hysteroscopy
68821|NCT02853695|Diffusion|diffusion
68822|NCT02853695|Implementation|implementation
68823|NCT02853695|Diagnostic hysteroscopy|diagnostic hysteroscopy
68824|NCT02853695|Operative hysteroscopy|operative hysteroscopy
68825|NCT02853682|glycocalyx|glycocalyx
68826|NCT02853682|capillary leak syndrome|capillary leak syndrome
68827|NCT02853656|preterm birth|preterm birth
68828|NCT02853656|gestation|gestation
68829|NCT02853617|S. pneumoniae|s. pneumoniae
68830|NCT02853617|N. meningitidis|n. meningitidis
68831|NCT02853617|H. influenza|h. influenza
68832|NCT02853617|B. pertussis|b. pertussis
68833|NCT02853617|C. tetani|c. tetani
68834|NCT02853617|MRSA|mrsa
68835|NCT02853591|laparoscopy|laparoscopy
68836|NCT02853591|hysterectomy|hysterectomy
68837|NCT02853500|Liver Cancer|liver cancer
68838|NCT02853487|Cluster headache|cluster headache
68839|NCT02853487|actigraphy|actigraphy
68840|NCT02853487|circadian rhythm|circadian rhythm
68841|NCT02853461|biofilm|biofilm
68842|NCT02853461|periprosthetic joint infection|periprosthetic joint infection
68843|NCT02853461|hip|hip
68844|NCT02853461|endoprothesis|endoprothesis
68845|NCT02853461|ceramic|ceramic
68846|NCT02853461|bearing components|bearing components
68847|NCT02853461|sonication|sonication
68848|NCT02853461|low grade infection|low grade infection
68849|NCT02853461|joint aspiration|joint aspiration
68850|NCT02853448|Plasma|plasma
68851|NCT02853448|Serum|serum
68852|NCT02853448|Effective Blood Draws|effective blood draws
68853|NCT02853435|Cross-over|cross-over
68854|NCT02853435|Gepotidacin|gepotidacin
68855|NCT02853435|Pharmacokinetics|pharmacokinetics
68856|NCT02853435|Relative Bioavailability|relative bioavailability
68857|NCT02853435|non-compartmental PK analysis|non-compartmental pk analysis
68858|NCT02853435|High shear wet granulation|high shear wet granulation
68859|NCT02853396|internalised stigma|internalised stigma
68860|NCT02853396|self stigma|self stigma
68861|NCT02853396|inpatients|inpatients
68863|NCT02853396|Cognitive therapy|cognitive therapy
68864|NCT02853383|Chronic Obstructive Pulmonary Diseases, COPD|chronic obstructive pulmonary diseases, copd
68865|NCT02853357|Thoracic manipulation|thoracic manipulation
68866|NCT02853357|Low back pain|low back pain
68867|NCT02853357|Core strengthening|core strengthening
68868|NCT02853357|Thoracic spine thrust manipulation|thoracic spine thrust manipulation
68869|NCT02853344|PD1|pd1
68870|NCT02853344|PD-1|pd-1
68871|NCT02853344|PDL1|pdl1
68872|NCT02853344|PD-L1|pd-l1
68873|NCT02853331|PD1|pd1
68874|NCT02853331|PD-1|pd-1
68875|NCT02853331|PDL1|pdl1
68876|NCT02853331|PD-L1|pd-l1
68877|NCT02853331|VEGFR TKI|vegfr tki
68878|NCT02853305|PD1|pd1
68879|NCT02853305|PD-1|pd-1
68880|NCT02853305|PDL1|pdl1
68881|NCT02853305|PD-L1|pd-l1
68882|NCT02853266|Kawasaki disease|kawasaki disease
68883|NCT02853266|non-cruzi-related antibody (NCRA)|non-cruzi-related antibody (ncra)
68884|NCT02853253|Preterm neonates|preterm neonates
68885|NCT02853240|Cerebral palsy|cerebral palsy
68886|NCT02853240|children|children
68887|NCT02853240|muscle spasticity|muscle spasticity
68888|NCT02853240|botulinum toxin injection|botulinum toxin injection
68889|NCT02853227|Telemark score, reliability|telemark score, reliability
68890|NCT02853214|Dysglobulinemia|dysglobulinemia
68891|NCT02853214|Multiple Myeloma|multiple myeloma
68893|NCT02853214|Waldenström|waldenström
68894|NCT02853214|genetic factors|genetic factors
68895|NCT02853214|Sequencing|sequencing
68896|NCT02853201|Extubation|extubation
68897|NCT02853201|Intercostal Muscles|intercostal muscles
68898|NCT02853201|Diaphragm|diaphragm
68899|NCT02853201|Sternocleidomastoid Muscle|sternocleidomastoid muscle
68900|NCT02853162|Stereotactic body radiotherapy|stereotactic body radiotherapy
68901|NCT02853162|MRI|mri
68902|NCT02853162|Renal cell carcinoma|renal cell carcinoma
68903|NCT02853149|Spinal Cord Injury|spinal cord injury
68904|NCT02853149|disability|disability
68905|NCT02853149|obesity|obesity
68906|NCT02853149|cardiometabolic|cardiometabolic
68907|NCT02853149|Caregiver|caregiver
68908|NCT02853110|MRI, stereotactic body radiotherapy, hypofractionation|mri, stereotactic body radiotherapy, hypofractionation
68909|NCT02853084|Auto-inflammatory diseases|auto-inflammatory diseases
68910|NCT02853084|IL-1 inhibitors|il-1 inhibitors
68911|NCT02853084|HL2351|hl2351
68912|NCT02853084|Cryopyrin‑Associated Periodic Syndromes (CAPS)|cryopyrin‑associated periodic syndromes (caps)
68913|NCT02853084|Neonatal Onset Multisystem Inflammatory Disease (NOMID)|neonatal onset multisystem inflammatory disease (nomid)
68914|NCT02853084|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
68915|NCT02853084|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
68916|NCT02853058|stillbirth|stillbirth
68917|NCT02853058|hemorrhage|hemorrhage
68918|NCT02853019|Emotion|emotion
68919|NCT02853019|motivation|motivation
68920|NCT02853019|cognition|cognition
68921|NCT02853019|schizophrenia|schizophrenia
68922|NCT02853006|Cancer lung|cancer lung
68923|NCT02853006|Fluids|fluids
68924|NCT02853006|LungCancerTest|lungcancertest
68925|NCT02853006|radiological anomalies|radiological anomalies
68926|NCT02853006|non-cancerous|non-cancerous
68927|NCT02853006|carriers|carriers
68928|NCT02853006|Patient reference|patient reference
68929|NCT02852993|Erythrocyte Transfusion|erythrocyte transfusion
68930|NCT02852993|Survival|survival
68931|NCT02852967|Skin Diseases|skin diseases
68932|NCT02852967|Auto-Immune Diseases|auto-immune diseases
68933|NCT02852967|Plaque|plaque
68934|NCT02852967|Dermatology|dermatology
68935|NCT02852954|Progesterone Induced Blocking Factor|progesterone induced blocking factor
68936|NCT02852954|Endometrial Cancer|endometrial cancer
68937|NCT02852941|Impedance|impedance
68938|NCT02852941|Kidney Transplantation|kidney transplantation
68939|NCT02852928|ILD; chILD|ild; child
68940|NCT02852915|Colonic Neoplasms|colonic neoplasms
68941|NCT02852915|Laparoscopic Surgery|laparoscopic surgery
68942|NCT02852915|T4|t4
68943|NCT02852902|Bloodstream infections caused by MDR Enterobacteriaceae|bloodstream infections caused by mdr enterobacteriaceae
68944|NCT02852902|Extended-spectrum β-lactamase-producers|extended-spectrum β-lactamase-producers
68945|NCT02852902|Carbapenemase-producing organisms|carbapenemase-producing organisms
68946|NCT02852902|Solid Organ Transplantation|solid organ transplantation
68947|NCT02852902|Multidrug-resistant Enterobacteriaceae|multidrug-resistant enterobacteriaceae
68948|NCT02852902|Anti-Infective Agents|anti-infective agents
68949|NCT02852889|internal jugular vein distensibility,haemodynamics|internal jugular vein distensibility,haemodynamics
68950|NCT02852876|Safety of ASP2151|safety of asp2151
68951|NCT02852876|Phase 1|phase 1
68952|NCT02852876|Pharmacokinetics|pharmacokinetics
68953|NCT02852876|Healthy male subjects|healthy male subjects
68954|NCT02852876|Tolerability|tolerability
68955|NCT02852876|Food effect of ASP2151|food effect of asp2151
68956|NCT02852811|Climacteric|climacteric
68957|NCT02852811|Education|education
68958|NCT02852811|Mental health|mental health
68959|NCT02852811|Menopause|menopause
68960|NCT02852772|Cognitive impairment|cognitive impairment
68961|NCT02852772|HIV|hiv
68962|NCT02852772|Microalbuminuria|microalbuminuria
68963|NCT02852772|Chronic kidney disease|chronic kidney disease
68964|NCT02852720|Pharmacokinetics|pharmacokinetics
68965|NCT02852720|levobupivacaine|levobupivacaine
68966|NCT02852720|Pregnancy|pregnancy
68967|NCT02852720|Cesarean section|cesarean section
68968|NCT02852720|Electrocardiography|electrocardiography
68969|NCT02852668|elderly|elderly
68970|NCT02852668|strength training|strength training
68971|NCT02852668|power training|power training
68972|NCT02852668|functional capacity|functional capacity
68973|NCT02852668|gait biomechanics|gait biomechanics
68974|NCT02852655|Brain Tumor|brain tumor
68975|NCT02852642|power training|power training
68976|NCT02852642|plyometric training|plyometric training
68977|NCT02852642|functional capacity|functional capacity
68978|NCT02852629|decision-support sheet|decision-support sheet
68979|NCT02852616|Course|course
68980|NCT02852616|Posttraumatic Stress Disorder|posttraumatic stress disorder
68981|NCT02852616|Narrative Exposure Therapy|narrative exposure therapy
68982|NCT02852603|dissection|dissection
68983|NCT02852603|aneurysm|aneurysm
68984|NCT02852603|thoracic aorta|thoracic aorta
68985|NCT02852590|Observational|observational
68986|NCT02852590|Pediatric|pediatric
68987|NCT02852590|Off-Label Use|off-label use
68988|NCT02852590|Unlicensed drug use|unlicensed drug use
68989|NCT02852590|Adverse Drug Reaction|adverse drug reaction
68990|NCT02852590|Hospitalized Children|hospitalized children
68991|NCT02852590|Pediatric inpatients|pediatric inpatients
60469|NCT02907814|Optical Coherence Tomography|optical coherence tomography
60471|NCT02907801|infants|infants
68992|NCT02852577|panic disorder|panic disorder
68993|NCT02852577|agoraphobia|agoraphobia
68994|NCT02852577|clonazepam|clonazepam
68995|NCT02852577|paroxetine|paroxetine
68996|NCT02852564|Non-Muscle|non-muscle
68997|NCT02852564|Invasive|invasive
68998|NCT02852564|Bladder|bladder
68999|NCT02852564|Cancer|cancer
69000|NCT02852564|Muscle|muscle
69001|NCT02852564|Surgery|surgery
69002|NCT02852564|Transurethral|transurethral
69003|NCT02852564|Resection|resection
69004|NCT02852564|Tumor|tumor
69005|NCT02852564|Ethacrynic|ethacrynic
69006|NCT02852564|Acid|acid
69007|NCT02852564|Mitomycin|mitomycin
69008|NCT02852564|Urine|urine
69009|NCT02852564|NMIBC|nmibc
69010|NCT02852512|Laparoscopic Sacrocolpopexy|laparoscopic sacrocolpopexy
69011|NCT02852512|Robotic Assisted Sacrocolpopexy|robotic assisted sacrocolpopexy
69012|NCT02852512|Pelvic Organ Prolapse|pelvic organ prolapse
69013|NCT02852499|environmental epidemiology|environmental epidemiology
69014|NCT02852499|cohort|cohort
69015|NCT02852499|atmospheric pollutant|atmospheric pollutant
69016|NCT02852499|chemical pollutant|chemical pollutant
69017|NCT02852499|growth, neuro-development, respiratory health|growth, neuro-development, respiratory health
69018|NCT02852499|big data|big data
69019|NCT02852499|biological samples (RNA, DNA, urines ...)|biological samples (rna, dna, urines ...)
69020|NCT02852499|e-dohad and exposome|e-dohad and exposome
69021|NCT02852486|BCR-ABL Positive|bcr-abl positive
69022|NCT02852486|Leukemia, Chronic Myeloid|leukemia, chronic myeloid
69023|NCT02852486|Imatinib|imatinib
69024|NCT02852486|Pioglitazone|pioglitazone
69025|NCT02852473|Continuous Positive Airway Pressure|continuous positive airway pressure
69026|NCT02852473|Radiotherapy|radiotherapy
69027|NCT02852473|Proton Therapy|proton therapy
69028|NCT02852382|scalp block|scalp block
69029|NCT02852382|local infiltration|local infiltration
69030|NCT02852330|Voltage tomography|voltage tomography
69031|NCT02852304|liver|liver
69032|NCT02852304|transplant|transplant
69033|NCT02852304|Lysosomal Acid Lipase|lysosomal acid lipase
69034|NCT02852278|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
69035|NCT02852278|ALS|als
69036|NCT02852278|motor neuron diseases|motor neuron diseases
69144|NCT02851329|stage IV EGFR-mutant|stage iv egfr-mutant
69037|NCT02852278|Progressive Muscular Atrophy|progressive muscular atrophy
69038|NCT02852278|Primary Lateral Sclerosis|primary lateral sclerosis
69039|NCT02852278|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
69040|NCT02852265|oral contraceptive|oral contraceptive
69041|NCT02852265|contraceptive implant|contraceptive implant
69042|NCT02852265|contraception|contraception
69043|NCT02852265|adherence|adherence
69044|NCT02852265|adverse event|adverse event
69045|NCT02852239|Renal impairment|renal impairment
69046|NCT02852239|Healthy volunteers|healthy volunteers
69047|NCT02852239|Clinical pharmacology study|clinical pharmacology study
69048|NCT02852239|DRB436|drb436
69049|NCT02852239|dabrafenib|dabrafenib
69050|NCT02852239|normal renal function|normal renal function
69051|NCT02852239|impaired renal function|impaired renal function
69052|NCT02852213|AADC|aadc
69053|NCT02852213|gene therapy|gene therapy
69054|NCT02852187|Intervertebral Disc Degeneration|intervertebral disc degeneration
69055|NCT02852187|Lumbar Spinal Disease|lumbar spinal disease
69056|NCT02852148|Wound|wound
69057|NCT02852148|Pressure Ulcer|pressure ulcer
69058|NCT02852148|Diabetic Foot Ulcer|diabetic foot ulcer
69059|NCT02852148|Venous Leg Ulcer|venous leg ulcer
69060|NCT02852148|Burn|burn
69061|NCT02852148|Quality of Life|quality of life
69062|NCT02852135|Laryngeal Mask Airway|laryngeal mask airway
69063|NCT02852135|lateral position|lateral position
69064|NCT02852135|laparoscopic surgery|laparoscopic surgery
69065|NCT02852122|prostate cancer|prostate cancer
69066|NCT02852122|C11 Choline PET/MR|c11 choline pet/mr
69068|NCT02852122|biochemical failure|biochemical failure
69069|NCT02852096|gastric cancer|gastric cancer
69070|NCT02852096|Her2/neu|her2/neu
69071|NCT02852096|dual paraffin blocks|dual paraffin blocks
69072|NCT02852096|trastuzumab|trastuzumab
69073|NCT02852070|bronchoalveolar lavage|bronchoalveolar lavage
69074|NCT02852070|lower respiratory tract infections|lower respiratory tract infections
69075|NCT02851979|premature newborns|premature newborns
69076|NCT02851979|apneas prevention|apneas prevention
69077|NCT02851979|olfactory stimulation|olfactory stimulation
69078|NCT02851979|latin square design|latin square design
69079|NCT02851966|Non-obstructive Azoospermia|non-obstructive azoospermia
69080|NCT02851966|Sperm Retrieval|sperm retrieval
69081|NCT02851966|Infertility, Male|infertility, male
69082|NCT02851966|Semen|semen
69083|NCT02851966|Biomarkers|biomarkers
69084|NCT02851966|Proteomics|proteomics
69090|NCT02851940|Band Ligation|band ligation
69091|NCT02851940|hypertonic saline sclerotherapy|hypertonic saline sclerotherapy
69092|NCT02851836|attachment|attachment
69093|NCT02851836|adolescent|adolescent
69094|NCT02851836|picture|picture
69095|NCT02851823|Er-YAG lasers|er-yag lasers
69096|NCT02851823|Nd-YAG lasers|nd-yag lasers
69097|NCT02851823|chronic periodontitis|chronic periodontitis
69098|NCT02851823|nonsurgical periodontal debridement|nonsurgical periodontal debridement
69099|NCT02851810|attachment|attachment
69100|NCT02851810|oculomotor marker|oculomotor marker
69101|NCT02851810|emotion regulation|emotion regulation
69102|NCT02851784|hepatocellular carcinoma|hepatocellular carcinoma
69103|NCT02851784|ablation|ablation
69104|NCT02851784|immunotherapy|immunotherapy
69105|NCT02851784|cytokine induced kill cell|cytokine induced kill cell
69106|NCT02851732|Quality Improvement|quality improvement
69107|NCT02851732|Cluster Analysis|cluster analysis
69108|NCT02851719|Urinary Incontinence, Stress|urinary incontinence, stress
69109|NCT02851719|Pelvic Floor|pelvic floor
69110|NCT02851719|Exercise|exercise
69111|NCT02851719|Patient Compliance|patient compliance
69112|NCT02851706|Brain Tumor|brain tumor
69113|NCT02851706|Glioma|glioma
69114|NCT02851706|Astrocytoma|astrocytoma
69115|NCT02851706|Brain Cancer|brain cancer
69116|NCT02851706|Spine Cander|spine cander
69117|NCT02851615|Anemia, Sickle Cell|anemia, sickle cell
69118|NCT02851615|Self Care|self care
69119|NCT02851615|Adolescent|adolescent
69120|NCT02851615|Young Adult|young adult
69121|NCT02851615|Disease Management|disease management
69122|NCT02851615|Behavioral Activation|behavioral activation
69123|NCT02851615|Peer Communication|peer communication
69124|NCT02851576|Adenovirus|adenovirus
69125|NCT02851550|liver|liver
69126|NCT02851550|transplant|transplant
69127|NCT02851550|Lysosomal Acid Lipase|lysosomal acid lipase
69128|NCT02851472|TRAGI (transfusion related acute gut injury)|tragi (transfusion related acute gut injury)
69129|NCT02851472|inhaled nitric oxide (iNO)|inhaled nitric oxide (ino)
69130|NCT02851472|prematurity|prematurity
69131|NCT02851472|PRBC transfusion|prbc transfusion
69132|NCT02851472|NEC (necrotizing enterocolitis)|nec (necrotizing enterocolitis)
69133|NCT02851472|NIRS (near infrared spectroscopy)|nirs (near infrared spectroscopy)
69134|NCT02851472|ELGAN (extremely low gestational age neonate)|elgan (extremely low gestational age neonate)
69135|NCT02851459|Vaccines|vaccines
69263|NCT02850497|endothelization|endothelization
69140|NCT02851368|Indocyanine Green|indocyanine green
69141|NCT02851368|Fluorescence Imaging|fluorescence imaging
69142|NCT02851342|Cognition|cognition
69143|NCT02851342|MEG|meg
69146|NCT02851329|progression-free survival|progression-free survival
69147|NCT02851329|prognosis|prognosis
69148|NCT02851329|computed tomography|computed tomography
69149|NCT02851290|Hypospadias|hypospadias
69150|NCT02851290|Caudal block|caudal block
69151|NCT02851290|Dorsal penile nerve block|dorsal penile nerve block
69152|NCT02851290|Anesthesia|anesthesia
69153|NCT02851290|Urethrocutaneous fistula|urethrocutaneous fistula
69154|NCT02851290|Urethral stricture|urethral stricture
69155|NCT02851290|Meatal stenosis|meatal stenosis
69156|NCT02851290|Glanular dehiscence|glanular dehiscence
69157|NCT02851277|Peanut Allergy|peanut allergy
69158|NCT02851277|ASP0892|asp0892
69159|NCT02851264|Early Esophageal Squamous Neoplasia|early esophageal squamous neoplasia
69160|NCT02851264|optical enhancement technology|optical enhancement technology
69161|NCT02851264|virtual chromoendoscopy|virtual chromoendoscopy
69162|NCT02851251|eye disease|eye disease
69163|NCT02851251|neonatal eye disease|neonatal eye disease
69165|NCT02851251|screening|screening
69166|NCT02851251|multicenter|multicenter
69167|NCT02851134|genetic|genetic
69168|NCT02851121|Neurophysiological|neurophysiological
69169|NCT02851121|Perception-action|perception-action
69170|NCT02851121|Link|link
69171|NCT02851108|falciparum malaria|falciparum malaria
69173|NCT02851108|africa|africa
69174|NCT02851108|elimination disorder|elimination disorder
69175|NCT02851082|Training Program|training program
69176|NCT02851082|Endurance|endurance
69177|NCT02851082|Von Willebrand factor|von willebrand factor
69178|NCT02851069|Observational Study|observational study
69179|NCT02851069|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
69180|NCT02851069|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
69181|NCT02851069|Chronic Hepatitis C|chronic hepatitis c
69182|NCT02851069|Sustained Virological Response|sustained virological response
69183|NCT02851056|Myeloma|myeloma
69184|NCT02851056|Vaccine|vaccine
69185|NCT02851056|Dendritic cell|dendritic cell
69186|NCT02851056|autologous hematopoietic cell transplant|autologous hematopoietic cell transplant
69187|NCT02851056|HCT|hct
69188|NCT02851030|Child, Preschool|child, preschool
69189|NCT02851030|Child Care|child care
69190|NCT02850991|Esophageal cancer, radiation, chemotherapy|esophageal cancer, radiation, chemotherapy
69191|NCT02850939|Breast cancer|breast cancer
69192|NCT02850939|Endocrine hormonal therapy|endocrine hormonal therapy
69193|NCT02850939|mHealth|mhealth
69194|NCT02850926|Concussion|concussion
69195|NCT02850926|Soccer|soccer
69196|NCT02850926|Adolescent|adolescent
69197|NCT02850874|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
69198|NCT02850874|perioperative systemic chemotherapy|perioperative systemic chemotherapy
69199|NCT02850874|peritoneal disease|peritoneal disease
69200|NCT02850848|Pharmacokinetic|pharmacokinetic
69201|NCT02850835|Decision Aid|decision aid
69202|NCT02850835|Pelvic Organ Prolapse (POP)|pelvic organ prolapse (pop)
69203|NCT02850822|decitabine|decitabine
69204|NCT02850822|chemotherapy|chemotherapy
69205|NCT02850809|radiofrequency ablation|radiofrequency ablation
69206|NCT02850809|complications|complications
69207|NCT02850796|Mindfulness|mindfulness
69208|NCT02850796|self-compassion|self-compassion
69209|NCT02850796|Acceptance and Commitment Therapy|acceptance and commitment therapy
69210|NCT02850796|weight self-stigma|weight self-stigma
69211|NCT02850796|quality-of-life|quality-of-life
69212|NCT02850783|colon cancer|colon cancer
69213|NCT02850757|Modified William's airway|modified william's airway
69214|NCT02850757|fiberoptic bronchoscope|fiberoptic bronchoscope
69215|NCT02850757|U shape Guedls airway|u shape guedls airway
69216|NCT02850757|oral airways|oral airways
69217|NCT02850757|efficacy and safety|efficacy and safety
69218|NCT02850705|Neuromyelitis Optica|neuromyelitis optica
69219|NCT02850705|Myelitis|myelitis
69220|NCT02850705|Optic Neuritis|optic neuritis
69221|NCT02850705|autoantibody|autoantibody
69222|NCT02850705|demyelination|demyelination
69223|NCT02850679|Atrial Fibrillation|atrial fibrillation
69224|NCT02850679|Cardioversion|cardioversion
69225|NCT02850666|social skills|social skills
69226|NCT02850666|child|child
69227|NCT02850666|theory of mind|theory of mind
69228|NCT02850666|drama|drama
69229|NCT02850666|occupational therapy|occupational therapy
69230|NCT02850666|Speech-language pathology|speech-language pathology
69231|NCT02850653|Acute Endophthalmitis.|acute endophthalmitis.
69232|NCT02850653|PCR|pcr
69233|NCT02850653|Ocular sampling|ocular sampling
69234|NCT02850627|acute coronary syndrome|acute coronary syndrome
69235|NCT02850627|Tongguan capsule|tongguan capsule
69236|NCT02850627|miRNAs|mirnas
69237|NCT02850601|Oral lichen planus|oral lichen planus
69238|NCT02850601|Dexamethasone solution|dexamethasone solution
69239|NCT02850562|body composition,|body composition,
69240|NCT02850562|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
69241|NCT02850562|sarcopenia|sarcopenia
69242|NCT02850562|peripheral quantitative computed tomography|peripheral quantitative computed tomography
69243|NCT02850562|muscle density|muscle density
69244|NCT02850562|elderly|elderly
69245|NCT02850549|neck pain|neck pain
69246|NCT02850549|cervical|cervical
69247|NCT02850549|classification|classification
69248|NCT02850549|outcomes|outcomes
69249|NCT02850549|physical therapy|physical therapy
69250|NCT02850536|Colorectal Cancer|colorectal cancer
69251|NCT02850536|Liver Metastases|liver metastases
69252|NCT02850536|Breast Cancer|breast cancer
69253|NCT02850536|Gastric Cancer|gastric cancer
69254|NCT02850536|Pancreas Cancer|pancreas cancer
69255|NCT02850536|Carcinoembryonic antigen|carcinoembryonic antigen
69256|NCT02850536|CAR-T|car-t
69257|NCT02850536|Immunotherapy|immunotherapy
69258|NCT02850510|Harsh discipline|harsh discipline
69259|NCT02850510|parental competence|parental competence
69260|NCT02850510|positive parenting|positive parenting
69261|NCT02850497|optical coherence tomography|optical coherence tomography
69262|NCT02850497|malapposition|malapposition
69264|NCT02850471|Postoperative pulmonary complications|postoperative pulmonary complications
69265|NCT02850471|Transcutaneous electric acupoint stimulation|transcutaneous electric acupoint stimulation
69266|NCT02850471|pulmonary protection|pulmonary protection
69267|NCT02850432|Magnetic resonance imaging|magnetic resonance imaging
69268|NCT02850432|Extracellular volume matrix fraction|extracellular volume matrix fraction
69269|NCT02850432|Peripheral artery disease|peripheral artery disease
69270|NCT02850432|Blood-oxygen level dependent|blood-oxygen level dependent
69271|NCT02850432|Cardiac function|cardiac function
69272|NCT02850393|suppression mnemonic|suppression mnemonic
69273|NCT02850393|emotional response|emotional response
69274|NCT02850393|inhibitory control of failures|inhibitory control of failures
69275|NCT02850393|neurological alterations|neurological alterations
69276|NCT02850341|Physical Activity|physical activity
69277|NCT02850341|Mental Health|mental health
69278|NCT02850341|Health Behavior|health behavior
69279|NCT02850341|Walking|walking
69280|NCT02850341|Physical Exercise|physical exercise
69281|NCT02850341|Mental disorder|mental disorder
69282|NCT02850315|optimal coherence tomography|optimal coherence tomography
69283|NCT02850315|myocardial reperfusion|myocardial reperfusion
69284|NCT02850276|HIV disease|hiv disease
69285|NCT02850276|gastrointestinal problems|gastrointestinal problems
69286|NCT02850263|Diabetic Retinopathy|diabetic retinopathy
69287|NCT02850263|Diabetic Macular Oedema|diabetic macular oedema
69288|NCT02850263|Diabetic Macular Edema|diabetic macular edema
69289|NCT02850263|Aflibercept|aflibercept
69290|NCT02850250|Observational|observational
69291|NCT02850250|pharmacokinetic|pharmacokinetic
69292|NCT02850250|cardiac|cardiac
69293|NCT02850250|Cefuroxime|cefuroxime
69294|NCT02850250|Paediatric|paediatric
69295|NCT02850237|cerebral saturation|cerebral saturation
69296|NCT02850237|capnography|capnography
69297|NCT02850237|pre-hospital|pre-hospital
69298|NCT02850198|ischemic stroke|ischemic stroke
69299|NCT02850185|COPD|copd
69300|NCT02850185|hydrogen|hydrogen
69301|NCT02850172|nutrition|nutrition
69302|NCT02850172|exercise|exercise
69303|NCT02850172|inspiratory muscle training|inspiratory muscle training
69305|NCT02850146|cognition|cognition
69306|NCT02850146|longitudinal|longitudinal
69307|NCT02850146|cognitive decline|cognitive decline
69308|NCT02850146|observational|observational
69309|NCT02850146|imaging|imaging
69310|NCT02850120|surgical mesh|surgical mesh
69311|NCT02850120|observational study|observational study
69312|NCT02850120|intraoperative complications|intraoperative complications
69313|NCT02850120|postoperative complications|postoperative complications
69314|NCT02850107|Atherectomy, Drug-Coated Balloon|atherectomy, drug-coated balloon
69315|NCT02850094|Physical activity|physical activity
69316|NCT02850094|Exercise|exercise
69317|NCT02850094|Financial Incentives|financial incentives
69318|NCT02850081|Carotid endarterectomy|carotid endarterectomy
69319|NCT02850081|CEA|cea
69320|NCT02850081|stroke|stroke
69321|NCT02850081|asymptomatic stenosis|asymptomatic stenosis
69322|NCT02850055|physiotherapy, Temporomandibular Joint Disorder, tinnitus.|physiotherapy, temporomandibular joint disorder, tinnitus.
69323|NCT02850042|motor recovery|motor recovery
69324|NCT02850042|human|human
69325|NCT02850042|occupation-based practice|occupation-based practice
69326|NCT02850042|motor training|motor training
69327|NCT02850042|transcranial magnetic stimulation|transcranial magnetic stimulation
69328|NCT02850029|antimicrobial|antimicrobial
69329|NCT02850029|intensive care units|intensive care units
69330|NCT02850016|Romidepsin|romidepsin
69331|NCT02850016|3BNC117|3bnc117
69332|NCT02850016|Broadly neutralizing antibody|broadly neutralizing antibody
69333|NCT02849977|POMC|pomc
69334|NCT02849977|PCSK1|pcsk1
69335|NCT02849977|Pro-opiomelanocortin|pro-opiomelanocortin
69336|NCT02849964|Incidence|incidence
69337|NCT02849964|Renal Replacement Therapy|renal replacement therapy
69338|NCT02849964|Socioeconomic Factors|socioeconomic factors
69339|NCT02849964|Clinical Practice Pattern|clinical practice pattern
69340|NCT02849951|Colitis|colitis
69341|NCT02849951|Colitis, Ulcerative|colitis, ulcerative
69342|NCT02849951|Ulcer|ulcer
69343|NCT02849951|Colonic Diseases|colonic diseases
69344|NCT02849951|Digestive System Diseases|digestive system diseases
69345|NCT02849951|Gastroenteritis|gastroenteritis
69346|NCT02849951|Gastrointestinal Diseases|gastrointestinal diseases
69347|NCT02849951|Inflammatory Bowel Diseases|inflammatory bowel diseases
69348|NCT02849951|Intestinal Diseases|intestinal diseases
69349|NCT02849951|Pathologic Processes|pathologic processes
69350|NCT02849951|Mesalamine|mesalamine
69351|NCT02849938|children with medical complexity|children with medical complexity
69352|NCT02849938|Telemedicine|telemedicine
69353|NCT02849938|Tracheostomy|tracheostomy
69354|NCT02849925|Pit and Fissure Sealants|pit and fissure sealants
69355|NCT02849925|Caries|caries
69356|NCT02849925|Glass ionomer|glass ionomer
69357|NCT02849925|Resin|resin
69358|NCT02849886|GvHD|gvhd
69359|NCT02849886|Suicide gene|suicide gene
69360|NCT02849886|Dimerizer drug AP1903|dimerizer drug ap1903
69361|NCT02849886|Hematological stem cell transplantation|hematological stem cell transplantation
69362|NCT02849834|Neuropathic Pain|neuropathic pain
69363|NCT02849834|Stimulation of the Motor Cortex (SCM)|stimulation of the motor cortex (scm)
69364|NCT02849834|Pharmacoresistant|pharmacoresistant
69365|NCT02849834|rTMS|rtms
69366|NCT02849808|Corneal Transplantation|corneal transplantation
69367|NCT02849795|Obesity, Abdominal|obesity, abdominal
69368|NCT02849795|Adipokines|adipokines
69369|NCT02849795|Risk of cardiovascular diseases|risk of cardiovascular diseases
69370|NCT02849782|Gait analysis|gait analysis
69371|NCT02849782|Fampridine|fampridine
69373|NCT02849782|Daily activity|daily activity
69374|NCT02849782|Cognition|cognition
69375|NCT02849756|Intensive care|intensive care
69376|NCT02849756|elderly|elderly
69377|NCT02849756|autonomy|autonomy
69379|NCT02849756|older patients|older patients
69380|NCT02849756|intensive care unit|intensive care unit
69381|NCT02849743|oxytocin|oxytocin
69382|NCT02849743|hypothalamic obesity|hypothalamic obesity
69383|NCT02849743|craniopharyngioma|craniopharyngioma
69384|NCT02849743|metabolism|metabolism
69385|NCT02849730|Epi-PCA|epi-pca
69386|NCT02849730|Patient controlled analgesia|patient controlled analgesia
69387|NCT02849730|Epidural patient controlled analgesia|epidural patient controlled analgesia
69388|NCT02849730|Elderly patient|elderly patient
69389|NCT02849730|Side effect|side effect
69390|NCT02849730|Postoperative pain|postoperative pain
60865|NCT02905448|Obesity|obesity
60866|NCT02905448|Body composition|body composition
60867|NCT02905448|Atherosclerosis|atherosclerosis
69391|NCT02849704|Chronic Pancreatitis|chronic pancreatitis
69392|NCT02849704|Pancreatic Function|pancreatic function
69393|NCT02849704|Reduced Exocrine Pancreatic Function|reduced exocrine pancreatic function
69394|NCT02849704|Pancreatic Insufficiency|pancreatic insufficiency
69395|NCT02849678|Postoperative Pain|postoperative pain
69396|NCT02849678|Bowel Surgery|bowel surgery
69397|NCT02849678|Regional Anesthesia|regional anesthesia
69398|NCT02849665|Kangaroo-Mother Care Method; child development|kangaroo-mother care method; child development
69399|NCT02849652|Smoking cessation|smoking cessation
69400|NCT02849652|Nicotine dependence|nicotine dependence
69401|NCT02849652|Organizational change|organizational change
69402|NCT02849652|Mental Healthcare|mental healthcare
69403|NCT02849626|Partial-Onset Seizures|partial-onset seizures
69404|NCT02849626|Primary Generalized Tonic-Clonic Seizures|primary generalized tonic-clonic seizures
69405|NCT02849626|Adjunctive Therapy|adjunctive therapy
69406|NCT02849626|Epilepsy|epilepsy
69407|NCT02849613|cell therapy|cell therapy
69408|NCT02849613|stem cell|stem cell
69409|NCT02849613|transplantation|transplantation
69410|NCT02849613|graft|graft
69411|NCT02849613|recovery|recovery
69412|NCT02849613|repair|repair
69413|NCT02849613|stroke|stroke
69414|NCT02849613|mesenchymal stem cell|mesenchymal stem cell
69415|NCT02849613|regenerative|regenerative
69416|NCT02849600|Vital pulp therapy,Young permanent tooth,Treatment outcome|vital pulp therapy,young permanent tooth,treatment outcome
69417|NCT02849587|Driving Under the Influence|driving under the influence
69418|NCT02849587|Memory Impairment|memory impairment
69419|NCT02849587|Reaction Time|reaction time
69420|NCT02849587|Time Perception|time perception
69421|NCT02849561|Pupillary light reflex|pupillary light reflex
69422|NCT02849561|Cardio respiratory arrest|cardio respiratory arrest
69423|NCT02849535|Oral chemotherapy|oral chemotherapy
69424|NCT02849535|Relative dose intensity|relative dose intensity
69425|NCT02849535|Health related program|health related program
69426|NCT02849535|Secured drug intake|secured drug intake
69427|NCT02849522|Lower Urinary Tract Symptoms caused by Benign Prostatic Enlargement (LUTS BPE)|lower urinary tract symptoms caused by benign prostatic enlargement (luts bpe)
69428|NCT02849522|Prostate Artery Embolisation (PAE)|prostate artery embolisation (pae)
69429|NCT02849522|Transurethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
69430|NCT02849522|Open prostatectomy|open prostatectomy
69431|NCT02849522|Laser enucleation or ablation of the prostate (Green Light, KTP, HoLEP)|laser enucleation or ablation of the prostate (green light, ktp, holep)
69432|NCT02849522|IPSS Score|ipss score
69433|NCT02849522|IIEF Score|iief score
69434|NCT02849522|Complications|complications
69435|NCT02849522|Quality of Life|quality of life
69436|NCT02849483|PONV|ponv
69437|NCT02849483|digestive signs and symptoms|digestive signs and symptoms
69438|NCT02849483|vomiting|vomiting
69439|NCT02849483|antiemetics|antiemetics
69440|NCT02849483|nausea|nausea
69441|NCT02849483|ramosetron|ramosetron
69442|NCT02849470|Adipose Stem/Stromal Cells|adipose stem/stromal cells
69443|NCT02849470|PRP|prp
69444|NCT02849470|SVF|svf
69445|NCT02849470|Cell Therapy|cell therapy
69446|NCT02849470|Alopecia|alopecia
69447|NCT02849470|GF|gf
69448|NCT02849444|renal function|renal function
69449|NCT02849444|Relapsed Multiple myeloma|relapsed multiple myeloma
69450|NCT02849444|anti-MM therapy|anti-mm therapy
69451|NCT02849431|mindfulness|mindfulness
69452|NCT02849418|Botulinum toxin type A|botulinum toxin type a
69453|NCT02849418|Urinary Incontinence|urinary incontinence
69454|NCT02849418|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
69455|NCT02849392|Pistachio|pistachio
69456|NCT02849392|Body composition|body composition
69457|NCT02849392|Erythrocyte membrane incorporation of fatty acids|erythrocyte membrane incorporation of fatty acids
69458|NCT02849392|Dietary quality/micronutrient quality|dietary quality/micronutrient quality
69459|NCT02849392|Blood lipids|blood lipids
69460|NCT02849392|Inflammatory markers|inflammatory markers
69461|NCT02849392|Bone density|bone density
69462|NCT02849392|Bone turnover markers|bone turnover markers
69463|NCT02849392|Satiety|satiety
69464|NCT02849379|tongue cancer|tongue cancer
69465|NCT02849379|cryosurgery|cryosurgery
69466|NCT02849379|NK immunotherapy|nk immunotherapy
69467|NCT02849366|Sarcoma|sarcoma
69468|NCT02849366|Cryosurgery|cryosurgery
69469|NCT02849366|NK Immunotherapy|nk immunotherapy
69470|NCT02849353|Ovarian Cancer|ovarian cancer
69471|NCT02849353|cryosurgery|cryosurgery
69472|NCT02849353|NK immunotherapy|nk immunotherapy
69473|NCT02849340|Cervical Cancer|cervical cancer
69474|NCT02849340|cryosurgery|cryosurgery
69475|NCT02849340|NK immunotherapy|nk immunotherapy
69476|NCT02849327|Pharyngeal cancer|pharyngeal cancer
69477|NCT02849327|Cryosurgery|cryosurgery
69478|NCT02849327|NK immunotherapy|nk immunotherapy
69479|NCT02849314|laryngeal cancer|laryngeal cancer
69480|NCT02849314|cryosurgery|cryosurgery
69481|NCT02849314|NK immunotherapy|nk immunotherapy
69482|NCT02849249|allergy|allergy
69483|NCT02849249|Immunotherapy|immunotherapy
69484|NCT02849249|SCIT|scit
69485|NCT02849236|PECS block,|pecs block,
69486|NCT02849236|pectoral block,|pectoral block,
69487|NCT02849236|breast augmentation|breast augmentation
69488|NCT02849223|Mild Traumatic Brain Injury|mild traumatic brain injury
69489|NCT02849223|Transcranial Direct Current Stimulation|transcranial direct current stimulation
69490|NCT02849223|Working Memory|working memory
69491|NCT02849197|pilonidal sinus|pilonidal sinus
69492|NCT02849197|complication|complication
69493|NCT02849197|recurrence|recurrence
69494|NCT02849171|18F-fluorocholine (18F-FCH) PET|18f-fluorocholine (18f-fch) pet
69495|NCT02849171|16-676|16-676
69496|NCT02849171|High-grade Gliomas|high-grade gliomas
69497|NCT02849158|Rectoscopy|rectoscopy
69498|NCT02849158|Proctectomy|proctectomy
69499|NCT02849158|Fibroblasts|fibroblasts
69500|NCT02849145|Circulating tumor DNA|circulating tumor dna
69501|NCT02849119|Robot; Laparoscopic|robot; laparoscopic
69502|NCT02849119|Partial nephrectomy|partial nephrectomy
69503|NCT02849119|Transperitoneal|transperitoneal
69504|NCT02849119|Retroperitoneal|retroperitoneal
69505|NCT02849119|Laparoscopic Surgery|laparoscopic surgery
69506|NCT02849119|Surgical Procedures, Robotic|surgical procedures, robotic
69507|NCT02849119|Nephrectomy|nephrectomy
69508|NCT02849106|3D culture|3d culture
69509|NCT02849106|chemogram|chemogram
69510|NCT02849106|FOLFOX|folfox
69511|NCT02849106|FOLFIRI|folfiri
69512|NCT02849093|Optical coherence tomography|optical coherence tomography
69513|NCT02849093|imaging of ocular structures|imaging of ocular structures
69514|NCT02849067|ischaemic heart disease|ischaemic heart disease
69515|NCT02849067|comedy session|comedy session
69516|NCT02849067|laughter therapy|laughter therapy
69517|NCT02849041|Circulating Tumor Cells|circulating tumor cells
69518|NCT02849041|Lung|lung
69519|NCT02849028|gut microbiota|gut microbiota
69520|NCT02849028|sleep disorder|sleep disorder
69521|NCT02849028|gut-brain axis|gut-brain axis
69522|NCT02849028|circadian rhythm|circadian rhythm
69523|NCT02849028|Traumatic Brain Injury|traumatic brain injury
69524|NCT02849015|liver tumor|liver tumor
69525|NCT02849015|cryosurgery|cryosurgery
69526|NCT02849015|NK immunotherapy|nk immunotherapy
69527|NCT02849002|Concussion|concussion
69528|NCT02848989|Breast Cancer Surgery Pain|breast cancer surgery pain
69529|NCT02848989|Breast Cancer|breast cancer
69530|NCT02848950|Metformin|metformin
69531|NCT02848950|fecundability|fecundability
69532|NCT02848950|uterine doppler|uterine doppler
69533|NCT02848937|calcium balance|calcium balance
69534|NCT02848937|dialysis|dialysis
69535|NCT02848937|concentrate with citrate|concentrate with citrate
69536|NCT02848924|prevalence|prevalence
69537|NCT02848924|surgery|surgery
69538|NCT02848924|Treatments|treatments
69648|NCT02848157|dexmedetomidine|dexmedetomidine
69539|NCT02848911|acute lymphoblastic leukemia|acute lymphoblastic leukemia
69540|NCT02848898|Focal Vibrations|focal vibrations
69541|NCT02848898|Neurorehabilitation|neurorehabilitation
69542|NCT02848898|Spasticity|spasticity
69543|NCT02848898|Multiple Sclerosis|multiple sclerosis
69544|NCT02848885|Magnetic resonance imaging|magnetic resonance imaging
69545|NCT02848885|Anosognosia|anosognosia
69546|NCT02848885|Electrical stimulation of the brain|electrical stimulation of the brain
583422|NCT00511693|osteoporosis coordinator|osteoporosis coordinator
69547|NCT02848872|Tumor-infiltrating lymphocytes (TILs)|tumor-infiltrating lymphocytes (tils)
69548|NCT02848859|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
69549|NCT02848859|randomized controlled trial|randomized controlled trial
69550|NCT02848846|Amputees|amputees
69551|NCT02848820|Appendicitis|appendicitis
69552|NCT02848820|Appendectomy|appendectomy
69553|NCT02848820|Antibiotics|antibiotics
69554|NCT02848781|Sudden Cardiac Death|sudden cardiac death
69555|NCT02848781|ICD Therapy|icd therapy
69556|NCT02848781|VT Ablation|vt ablation
69557|NCT02848690|Sodium restriction|sodium restriction
69558|NCT02848690|Dietary sodium restriction questionnaire (DSRQ)|dietary sodium restriction questionnaire (dsrq)
69559|NCT02848690|Low-sodium diet|low-sodium diet
69560|NCT02848690|Adherence|adherence
69561|NCT02848690|Educational intervention|educational intervention
69562|NCT02848677|advanced glycation end-products|advanced glycation end-products
69563|NCT02848677|Cardiovascular disease|cardiovascular disease
69564|NCT02848677|Low Sodium Diet|low sodium diet
69565|NCT02848677|vascular inflammation|vascular inflammation
69566|NCT02848638|PET, Yttrium-90|pet, yttrium-90
69567|NCT02848625|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
69568|NCT02848625|Yoga|yoga
69569|NCT02848625|Quality of life|quality of life
69570|NCT02848612|anticoagulation|anticoagulation
69571|NCT02848612|aneurysmal subarachnoid haemorrhage|aneurysmal subarachnoid haemorrhage
69581|NCT02848560|orkambi|orkambi
69582|NCT02848560|129Xe MRI|129xe mri
61075|NCT02904005|Suicide|suicide
69583|NCT02848560|hyperpolarized xenon|hyperpolarized xenon
69585|NCT02848560|CFTR modulator therapy|cftr modulator therapy
69586|NCT02848534|fever|fever
69587|NCT02848534|hyperthermia|hyperthermia
69588|NCT02848534|inflammatory syndrome|inflammatory syndrome
69589|NCT02848521|ADPKD|adpkd
69590|NCT02848521|CKD|ckd
69591|NCT02848521|Rapid progressor|rapid progressor
69592|NCT02848521|quality of life|quality of life
69593|NCT02848521|DCE|dce
69594|NCT02848508|Metformin|metformin
69595|NCT02848508|moderate renal failure|moderate renal failure
69596|NCT02848508|severe renal failure|severe renal failure
69597|NCT02848508|chronic kidney disease|chronic kidney disease
69598|NCT02848508|hyperlactatemia|hyperlactatemia
69599|NCT02848508|lactic acidosis|lactic acidosis
69600|NCT02848495|Aneurysm|aneurysm
69601|NCT02848495|Biocollection|biocollection
69602|NCT02848495|Familial Form|familial form
69603|NCT02848482|Photodynamic therapy|photodynamic therapy
69604|NCT02848456|Manipulation, Spinal|manipulation, spinal
69605|NCT02848456|H-Reflex|h-reflex
69606|NCT02848456|Muscle Contraction|muscle contraction
69607|NCT02848456|Muscle Strength Dynamometer|muscle strength dynamometer
69608|NCT02848443|metastatic|metastatic
69609|NCT02848443|colorectal|colorectal
69610|NCT02848443|cancer|cancer
69611|NCT02848443|oxaliplatin|oxaliplatin
69612|NCT02848443|dose-escalation|dose-escalation
69613|NCT02848443|Lonsurf|lonsurf
69614|NCT02848443|nivolumab|nivolumab
69615|NCT02848443|bevacizumab|bevacizumab
69616|NCT02848430|Humulus lupulus|humulus lupulus
69617|NCT02848404|Mild cognitive impairment|mild cognitive impairment
69618|NCT02848404|Cognitive rehabilitation|cognitive rehabilitation
69619|NCT02848404|Cognitive therapy|cognitive therapy
69620|NCT02848404|Alzheimer's disease|alzheimer's disease
69621|NCT02848404|Memory enhancement|memory enhancement
69622|NCT02848404|Categorical language fluency|categorical language fluency
69623|NCT02848378|Advanced Oxidation Protein Products|advanced oxidation protein products
69624|NCT02848378|Gingival crevicular fluid|gingival crevicular fluid
69625|NCT02848378|Monocyte chemoattractant protein-1|monocyte chemoattractant protein-1
69626|NCT02848378|Periodontal Disease|periodontal disease
69627|NCT02848365|Measurement|measurement
69634|NCT02848235|Prevention of Mother to Child Transmission|prevention of mother to child transmission
69889|NCT02847013|Postcesarean Section|postcesarean section
69635|NCT02848235|Antenatal Care for HIV positive women|antenatal care for hiv positive women
69636|NCT02848235|Kenya|kenya
69637|NCT02848222|contact lens discomfort|contact lens discomfort
69638|NCT02848222|dry eye disease|dry eye disease
69639|NCT02848222|meibomian gland dysfunction|meibomian gland dysfunction
69640|NCT02848222|Bruder mask|bruder mask
69641|NCT02848209|Peeling|peeling
69642|NCT02848209|Histological skin changes|histological skin changes
69643|NCT02848209|Trichloroacetic acid peel|trichloroacetic acid peel
69644|NCT02848209|phenol/croton oil peel|phenol/croton oil peel
69645|NCT02848170|essential hypertension|essential hypertension
69646|NCT02848170|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
69647|NCT02848170|Developmental Phase III|developmental phase iii
69649|NCT02848157|pudendal block|pudendal block
69650|NCT02848157|hypospadias|hypospadias
69651|NCT02848144|Immunoparalysis|immunoparalysis
69652|NCT02848144|immune response|immune response
69653|NCT02848144|sepsis|sepsis
69654|NCT02848144|toxic shock syndrome|toxic shock syndrome
69655|NCT02848118|Hypoventilation|hypoventilation
69656|NCT02848118|capnography|capnography
69657|NCT02848118|bronchoscopy|bronchoscopy
69658|NCT02848105|aGVHD|agvhd
69659|NCT02848105|valproic acid|valproic acid
69660|NCT02848092|Visual Attention|visual attention
69661|NCT02848092|Automobile Driving|automobile driving
69666|NCT02847988|muscle strength|muscle strength
69667|NCT02847988|muscle function|muscle function
69668|NCT02847988|functional status|functional status
69669|NCT02847975|Becker|becker
69670|NCT02847975|dystrophy|dystrophy
69671|NCT02847975|sympatholysis|sympatholysis
69672|NCT02847962|Fortified-blended foods|fortified-blended foods
69673|NCT02847962|Extrusion|extrusion
69674|NCT02847962|Sorghum|sorghum
69675|NCT02847962|Cowpea|cowpea
69676|NCT02847962|Vitamin A|vitamin a
69677|NCT02847962|Iron|iron
69678|NCT02847962|Protein|protein
69679|NCT02847962|Food Aid|food aid
69680|NCT02847962|Anemia, Iron-Deficiency|anemia, iron-deficiency
69681|NCT02847962|Deficiency, Vitamin A|deficiency, vitamin a
69682|NCT02847962|Growth Velocity|growth velocity
69683|NCT02847962|Stunting|stunting
69684|NCT02847962|Wasting|wasting
69685|NCT02847962|Protein-Energy Malnutrition|protein-energy malnutrition
69686|NCT02847962|Complementary Feeding|complementary feeding
69687|NCT02847962|Corn|corn
69689|NCT02847962|Fortified Foods|fortified foods
69690|NCT02847962|Food assistance|food assistance
69691|NCT02847936|triclosan|triclosan
69692|NCT02847936|sutures|sutures
69693|NCT02847936|infection|infection
69694|NCT02847923|Mobile Devices|mobile devices
69695|NCT02847923|Augmentative and Alternative Communication|augmentative and alternative communication
69696|NCT02847923|Cerebral Palsy|cerebral palsy
69697|NCT02847910|tissue suction tube|tissue suction tube
69698|NCT02847910|disposable instrument|disposable instrument
69699|NCT02847910|induced abortion|induced abortion
69700|NCT02847884|IBD|ibd
69701|NCT02847884|Crohn's disease|crohn's disease
69702|NCT02847884|Remicade|remicade
69703|NCT02847884|Infliximab|infliximab
69704|NCT02847884|Level|level
69705|NCT02847884|Drug Level|drug level
69706|NCT02847884|Children|children
69707|NCT02847871|mobility|mobility
69708|NCT02847871|exercise|exercise
69709|NCT02847871|nutrition|nutrition
69710|NCT02847871|primary care|primary care
69711|NCT02847871|prevention|prevention
69712|NCT02847871|care pathway|care pathway
69713|NCT02847871|elderly patient|elderly patient
69714|NCT02847858|unsafe sex|unsafe sex
69715|NCT02847858|unprotected sex|unprotected sex
69716|NCT02847858|adolescents|adolescents
69717|NCT02847858|Latinas|latinas
69718|NCT02847858|Hispanic|hispanic
69719|NCT02847858|mobile health applications|mobile health applications
69720|NCT02847858|unintended pregnancy|unintended pregnancy
69721|NCT02847858|teen pregnancy prevention|teen pregnancy prevention
69722|NCT02847858|school-based health centers|school-based health centers
69723|NCT02847845|chronic fatigue syndrome|chronic fatigue syndrome
69724|NCT02847845|idiopathic chronic fatigue|idiopathic chronic fatigue
69725|NCT02847845|red ginseng|red ginseng
69726|NCT02847845|cortisol|cortisol
69727|NCT02847845|anti-oxidant|anti-oxidant
69728|NCT02847832|Adnexal Diseases|adnexal diseases
69729|NCT02847832|Ovary|ovary
69730|NCT02847832|Ovarian Neoplasms|ovarian neoplasms
69731|NCT02847832|Ovarian Cysts|ovarian cysts
69732|NCT02847832|Ovarian Diseases|ovarian diseases
69733|NCT02847832|Ultrasonography|ultrasonography
69734|NCT02847832|Ultrasonography, Doppler|ultrasonography, doppler
69735|NCT02847832|Diagnosis|diagnosis
69736|NCT02847832|Early Diagnosis|early diagnosis
69737|NCT02847832|Early Detection of Cancer|early detection of cancer
69738|NCT02847832|Genital Neoplasms, Female|genital neoplasms, female
69739|NCT02847832|Genital Diseases, Female|genital diseases, female
69740|NCT02847832|Urogenital Neoplasms|urogenital neoplasms
69741|NCT02847832|Cysts|cysts
69742|NCT02847832|Endocrine System Diseases|endocrine system diseases
69743|NCT02847832|Gonadal Disorders|gonadal disorders
69744|NCT02847832|Neoplasms|neoplasms
69745|NCT02847832|Endocrine Gland Neoplasms|endocrine gland neoplasms
69746|NCT02847832|International Ovarian Tumor Analysis|international ovarian tumor analysis
69747|NCT02847832|Simple Rules|simple rules
69748|NCT02847832|Preoperative evaluation|preoperative evaluation
69749|NCT02847832|Prediction Models|prediction models
69750|NCT02847832|Logistic Regression Models|logistic regression models
69751|NCT02847832|Mathematical Models|mathematical models
69752|NCT02847832|Adnexal Masses|adnexal masses
69753|NCT02847832|Ovarian Tumors|ovarian tumors
69754|NCT02847832|Risk of Malignancy|risk of malignancy
69755|NCT02847793|Attentional Bias Modification (ABM)|attentional bias modification (abm)
69756|NCT02847793|Cognitive Bias Modification (CBM)|cognitive bias modification (cbm)
69757|NCT02847793|Depression|depression
69758|NCT02847793|Dysphoria|dysphoria
69759|NCT02847793|Gaze patterns|gaze patterns
69760|NCT02847793|Eye-tracking|eye-tracking
69761|NCT02847767|Liver Perfusion|liver perfusion
69890|NCT02847013|Postoperative|postoperative
69763|NCT02847767|Dynamic Contrast-Enhanced Computed Tomography|dynamic contrast-enhanced computed tomography
69765|NCT02847754|physical exercise|physical exercise
69766|NCT02847741|Depression|depression
69767|NCT02847741|Cholesterol|cholesterol
69768|NCT02847741|Suicidal behavior|suicidal behavior
69769|NCT02847741|Predictive factor|predictive factor
69770|NCT02847715|PRO|pro
69771|NCT02847715|PROM|prom
69772|NCT02847715|Adverse event|adverse event
69773|NCT02847715|QTool|qtool
69775|NCT02847702|Osteoarthritis|osteoarthritis
69776|NCT02847702|Pain|pain
69777|NCT02847702|Osteoarthritis, knee|osteoarthritis, knee
69778|NCT02847689|Premature Birth|premature birth
69779|NCT02847689|Obstetric Labor, Premature|obstetric labor, premature
69780|NCT02847689|Obstetric Labor Complications|obstetric labor complications
69781|NCT02847689|Pregnancy Complications|pregnancy complications
69782|NCT02847676|Peritoneal adhesions|peritoneal adhesions
69783|NCT02847676|Stem cells|stem cells
69785|NCT02847663|Cold|cold
69786|NCT02847663|recovery|recovery
69789|NCT02847637|Hemophilia A|hemophilia a
69790|NCT02847637|Emicizumab|emicizumab
69791|NCT02847611|Dynamometer mechanic|dynamometer mechanic
69792|NCT02847611|Strength of prehension|strength of prehension
69793|NCT02847611|Comparison|comparison
69794|NCT02847611|Device|device
69795|NCT02847611|Diagnosis|diagnosis
69796|NCT02847611|Healthy Volunteers|healthy volunteers
61278|NCT02902809|asthma|asthma
69797|NCT02847598|CLE, SLE, Cutaneous Lupus Erythematosus, Systemic Lupus Erythematosus, Lupus|cle, sle, cutaneous lupus erythematosus, systemic lupus erythematosus, lupus
69798|NCT02847585|water-soluble ubiquinol supplementation|water-soluble ubiquinol supplementation
69799|NCT02847585|pediatric cardiomyopathy|pediatric cardiomyopathy
69800|NCT02847585|antioxidant|antioxidant
69801|NCT02847585|inflammation|inflammation
69802|NCT02847585|complementary therapy|complementary therapy
69803|NCT02847533|resistant depression|resistant depression
69804|NCT02847533|inflammation|inflammation
69805|NCT02847520|Disorders related to gaming and gambling; poker|disorders related to gaming and gambling; poker
69806|NCT02847507|HIV|hiv
69807|NCT02847507|Hepatitis E|hepatitis e
69808|NCT02847481|Fecal Microbiota Transplantation|fecal microbiota transplantation
69809|NCT02847455|Ilaprazole|ilaprazole
69810|NCT02847455|Proton pump inhibitor|proton pump inhibitor
69811|NCT02847455|Duodenal ulcer|duodenal ulcer
69812|NCT02847455|Acid suppression|acid suppression
69813|NCT02847455|Randomized trial|randomized trial
69814|NCT02847442|Ongentys|ongentys
69815|NCT02847403|dysglycemia|dysglycemia
69816|NCT02847403|MCI|mci
69817|NCT02847403|exenatide LAR|exenatide lar
69818|NCT02847403|GLP-1|glp-1
69819|NCT02847390|diabetes mellitus|diabetes mellitus
69820|NCT02847390|physician education|physician education
69821|NCT02847390|nursing education|nursing education
69822|NCT02847390|hyperglycemia|hyperglycemia
69823|NCT02847390|hypoglycemia|hypoglycemia
69824|NCT02847390|inpatient|inpatient
69825|NCT02847390|hospital|hospital
69826|NCT02847390|glycemic control|glycemic control
69827|NCT02847364|chewing gum|chewing gum
69828|NCT02847364|prevention|prevention
69829|NCT02847351|arabinoxylan, HOMA index, glycemic control, obesity.|arabinoxylan, homa index, glycemic control, obesity.
69830|NCT02847338|Hypertension|hypertension
69831|NCT02847312|Oat|oat
69832|NCT02847312|Phenolic acid|phenolic acid
69833|NCT02847312|Avenanthramide|avenanthramide
69834|NCT02847312|FMD|fmd
69835|NCT02847312|LDI|ldi
69836|NCT02847312|Gut microbiota|gut microbiota
69837|NCT02847312|Blood Pressure|blood pressure
69838|NCT02847312|Renin Angiotensin|renin angiotensin
69839|NCT02847312|Nitric Oxide|nitric oxide
69840|NCT02847299|cough help|cough help
69841|NCT02847299|mechanical insufflation|mechanical insufflation
69842|NCT02847299|mechanical ventilation|mechanical ventilation
69843|NCT02847299|neuromuscular diseases|neuromuscular diseases
69844|NCT02847299|peak cough flow|peak cough flow
69845|NCT02847273|NIRS|nirs
69846|NCT02847273|Regional oxygen saturation|regional oxygen saturation
69847|NCT02847273|cardiac surgery with bypass|cardiac surgery with bypass
69848|NCT02847247|healthy|healthy
69849|NCT02847234|Cervical necrotizing fasciitis|cervical necrotizing fasciitis
69850|NCT02847234|mediastinitis|mediastinitis
69851|NCT02847221|cough peak flow|cough peak flow
69852|NCT02847221|scheduled weaning trial|scheduled weaning trial
69853|NCT02847221|scheduled extubation|scheduled extubation
69854|NCT02847221|prognosis|prognosis
69855|NCT02847208|cystic fibrosis|cystic fibrosis
69856|NCT02847208|contraception|contraception
69857|NCT02847208|gynaecological follow-up|gynaecological follow-up
69858|NCT02847208|screening|screening
69859|NCT02847208|Pap smear|pap smear
69860|NCT02847208|counselling|counselling
69861|NCT02847195|pediatric intensive care|pediatric intensive care
69862|NCT02847195|pain assessment|pain assessment
69863|NCT02847195|tracheal aspiration|tracheal aspiration
69864|NCT02847195|sedation|sedation
69865|NCT02847195|pupillometer|pupillometer
69866|NCT02847156|cystic fibrosis|cystic fibrosis
69867|NCT02847156|viruses|viruses
69868|NCT02847156|respiratory viral infection|respiratory viral infection
69869|NCT02847156|children|children
69870|NCT02847143|Attachement|attachement
69871|NCT02847143|Oxytocin|oxytocin
69872|NCT02847143|fMRI|fmri
69873|NCT02847117|Natural Mastiha, Bioavailability|natural mastiha, bioavailability
69874|NCT02847091|Ipragliflozin|ipragliflozin
69875|NCT02847091|SGLT2 inhibitor|sglt2 inhibitor
69876|NCT02847091|Type 2 diabetes mellitus|type 2 diabetes mellitus
69877|NCT02847091|ASP1941|asp1941
69878|NCT02847078|Coronary Disease|coronary disease
69879|NCT02847078|percutaneous coronary intervention|percutaneous coronary intervention
69880|NCT02847078|secondary prevention|secondary prevention
69881|NCT02847078|smart phone app|smart phone app
69882|NCT02847026|inactivated poliovirus vaccine|inactivated poliovirus vaccine
69883|NCT02847026|fractional inactivated poliovirus vaccine|fractional inactivated poliovirus vaccine
69884|NCT02847026|Rotavirus|rotavirus
69885|NCT02847026|Rotarix|rotarix
69894|NCT02846987|Abemaciclib i|abemaciclib i
69895|NCT02846987|LY2835219|ly2835219
69896|NCT02846987|16-376|16-376
69897|NCT02846974|Pulse Oximetry|pulse oximetry
69898|NCT02846974|Free and Open Source|free and open source
69899|NCT02846961|inflammatory bowel disease|inflammatory bowel disease
69900|NCT02846961|biosimilar|biosimilar
69901|NCT02846961|anti-drug antibody|anti-drug antibody
69902|NCT02846961|trough drug concentration|trough drug concentration
69903|NCT02846948|sepsis|sepsis
69904|NCT02846948|echocardiography|echocardiography
69905|NCT02846948|urgent|urgent
69906|NCT02846948|abdominal surgery|abdominal surgery
69907|NCT02846935|p16/CDKN2A|p16/cdkn2a
69908|NCT02846935|TP53|tp53
69909|NCT02846935|THU|thu
69910|NCT02846935|Decitabine|decitabine
69911|NCT02846935|Tetrahydrouridine|tetrahydrouridine
69912|NCT02846935|DEC|dec
69913|NCT02846883|aneurysms|aneurysms
69914|NCT02846857|Closed-loop system|closed-loop system
69915|NCT02846857|Artificial pancreas|artificial pancreas
69916|NCT02846857|Type 1 diabetes|type 1 diabetes
69917|NCT02846857|Hypoglycemia|hypoglycemia
69918|NCT02846857|Insulin|insulin
69919|NCT02846857|Glucagon|glucagon
69920|NCT02846831|Type 1 diabetes|type 1 diabetes
69921|NCT02846831|Artificial pancreas|artificial pancreas
69922|NCT02846831|Closed-loop system|closed-loop system
69923|NCT02846831|Hypoglycemia|hypoglycemia
69924|NCT02846831|Glucagon|glucagon
69925|NCT02846831|Insulin|insulin
69926|NCT02846818|Microdialysis|microdialysis
69927|NCT02846818|Cardiac surgery|cardiac surgery
69928|NCT02846818|Lactate to pyruvate ratio|lactate to pyruvate ratio
69929|NCT02846818|Cardiopulmonary bypass|cardiopulmonary bypass
69930|NCT02846818|Neurological complications|neurological complications
69931|NCT02846779|Insulin persistence|insulin persistence
69932|NCT02846779|Telepharmacy|telepharmacy
69933|NCT02846766|advanced cancer|advanced cancer
69934|NCT02846766|FGF|fgf
69935|NCT02846766|FGFR|fgfr
69936|NCT02846766|Fibroblast Growth Factor Receptor|fibroblast growth factor receptor
69937|NCT02846740|cranial electric stimulation|cranial electric stimulation
69938|NCT02846740|suicide|suicide
69939|NCT02846740|psychiatric inpatients|psychiatric inpatients
69940|NCT02846727|Hypoperfusion|hypoperfusion
69941|NCT02846727|Sepsis|sepsis
69942|NCT02846714|Education|education
69943|NCT02846714|Prevention and Control|prevention and control
69944|NCT02846714|Behavioral Research|behavioral research
69945|NCT02846701|Neuropathic pain|neuropathic pain
69946|NCT02846701|Antidepressant|antidepressant
69947|NCT02846701|Duloxetine|duloxetine
69948|NCT02846701|Liquid Chromatography|liquid chromatography
69949|NCT02846701|Mass Spectrometry|mass spectrometry
69950|NCT02846675|SVF|svf
69951|NCT02846675|Stromal Vascular Fraction|stromal vascular fraction
69952|NCT02846675|osteoarthritis(OA)|osteoarthritis(oa)
69953|NCT02846675|knee|knee
69954|NCT02846675|adipose|adipose
69955|NCT02846662|depression|depression
69956|NCT02846662|mobile technology|mobile technology
69957|NCT02846662|community trial|community trial
69958|NCT02846623|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
69959|NCT02846623|CLL|cll
69960|NCT02846623|Relapsed, Refractory|relapsed, refractory
69961|NCT02846623|High-risk Untreated|high-risk untreated
69962|NCT02846623|High-risk molecular features|high-risk molecular features
69963|NCT02846623|Genetic mutation|genetic mutation
69964|NCT02846623|17p/TP53 deletion|17p/tp53 deletion
69965|NCT02846623|Obinutuzumab|obinutuzumab
69966|NCT02846623|GA101|ga101
69967|NCT02846623|Gazyva|gazyva
69968|NCT02846623|Atezolizumab|atezolizumab
69969|NCT02846623|MPDL3280A|mpdl3280a
69970|NCT02846623|Tencentriq|tencentriq
69971|NCT02846623|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
69972|NCT02846623|SLL|sll
69973|NCT02846610|anesthesia|anesthesia
69974|NCT02846610|continuous regional anesthesia|continuous regional anesthesia
69975|NCT02846610|complications|complications
69976|NCT02846610|epidural analgesia|epidural analgesia
69977|NCT02846610|antibiotics|antibiotics
69978|NCT02846597|Respiratory distress syndrome|respiratory distress syndrome
69979|NCT02846597|Sustained lung inflation|sustained lung inflation
69980|NCT02846597|Delivery room|delivery room
69981|NCT02846584|CAR T|car t
70001|NCT02846467|Mobile applications|mobile applications
70002|NCT02846441|posthepatectomy liver failure|posthepatectomy liver failure
70003|NCT02846441|ALPPS|alpps
70004|NCT02846441|hepatobiliary scintigraphy|hepatobiliary scintigraphy
70005|NCT02846441|SPECT|spect
70006|NCT02846441|mebrofenin|mebrofenin
70007|NCT02846415|Dementia|dementia
70008|NCT02846415|Play and Playthings|play and playthings
70009|NCT02846415|Cognition|cognition
70010|NCT02846415|Memory|memory
70011|NCT02846402|HIV testing|hiv testing
70012|NCT02846402|Female sex workers|female sex workers
70013|NCT02846402|HIV self-testing|hiv self-testing
70014|NCT02846389|Radiation therapy for Breast Cancer|radiation therapy for breast cancer
70015|NCT02846363|stroke|stroke
70016|NCT02846363|public awareness campaign|public awareness campaign
70017|NCT02846363|call to EMS|call to ems
70018|NCT02846337|cardio-renal syndrome|cardio-renal syndrome
70019|NCT02846337|hemodialysis|hemodialysis
70020|NCT02846337|peritoneal dialysis|peritoneal dialysis
70021|NCT02846337|hemofiltration|hemofiltration
70022|NCT02846337|composite endpoint|composite endpoint
70023|NCT02846311|test|test
70024|NCT02846311|winter|winter
70025|NCT02846311|season|season
70026|NCT02846298|Drug Monitoring|drug monitoring
70027|NCT02846298|ICU|icu
70028|NCT02846298|Pharmacokinetic|pharmacokinetic
70029|NCT02846298|Pharmacodynamic|pharmacodynamic
70030|NCT02846298|antibiotic|antibiotic
70031|NCT02846298|Glycopeptides|glycopeptides
70032|NCT02846298|β-lactam-aminoglycoside|β-lactam-aminoglycoside
70033|NCT02846285|Bleeding|bleeding
70034|NCT02846259|intracranial aneurysm|intracranial aneurysm
70035|NCT02846259|cerebral ischemia|cerebral ischemia
70036|NCT02846259|aspirin|aspirin
70037|NCT02846246|aged care|aged care
70038|NCT02846246|health|health
70039|NCT02846246|home care services|home care services
70040|NCT02846246|person-centred care|person-centred care
70041|NCT02846220|Medication Adherence|medication adherence
70042|NCT02846220|Middle Aged 45-64|middle aged 45-64
70043|NCT02846220|Aged 65-79|aged 65-79
70044|NCT02846220|Aged, 80 and over|aged, 80 and over
70045|NCT02846207|cerebral infarction|cerebral infarction
70046|NCT02846207|syndrome of qi deficiency and blood stasis|syndrome of qi deficiency and blood stasis
70047|NCT02846207|Buyanghuanwu decoction|buyanghuanwu decoction
70048|NCT02846207|clinical effects and mechanisms|clinical effects and mechanisms
70049|NCT02846194|Fibromyalgia|fibromyalgia
70050|NCT02846194|Guided Imagery|guided imagery
70051|NCT02846194|chronic pain|chronic pain
70052|NCT02846155|preparation|preparation
70053|NCT02846155|capsule endoscopy|capsule endoscopy
70054|NCT02846129|multiple gestation|multiple gestation
70055|NCT02846129|complications|complications
70056|NCT02846129|cesarean delivery|cesarean delivery
70057|NCT02846116|all ceramic crown|all ceramic crown
70058|NCT02846116|Lithium disilicate|lithium disilicate
70059|NCT02846116|e-max|e-max
70060|NCT02846116|vita suprinity|vita suprinity
70061|NCT02846077|sleep|sleep
70062|NCT02846077|social networks|social networks
70063|NCT02846077|undergraduates|undergraduates
70064|NCT02846077|mood|mood
70065|NCT02846077|circadian rhythms|circadian rhythms
70066|NCT02846051|varicose vein|varicose vein
70067|NCT02846051|physical activity|physical activity
70068|NCT02846038|Pediatric cancer|pediatric cancer
70069|NCT02846038|Childhood cancer|childhood cancer
70070|NCT02846038|High-risk disease|high-risk disease
70071|NCT02846038|Prognosis|prognosis
70072|NCT02846038|Communication|communication
70073|NCT02846038|Bad news|bad news
70074|NCT02846038|Pediatric oncologist|pediatric oncologist
70075|NCT02846038|Parent|parent
70076|NCT02846038|Relapse|relapse
70077|NCT02846038|Progression|progression
70078|NCT02845999|natural killer cells|natural killer cells
70079|NCT02845999|adoptive transfer|adoptive transfer
70080|NCT02845999|allogenic immunotherapy|allogenic immunotherapy
70081|NCT02845999|gastrointestinal cancer EGFR+|gastrointestinal cancer egfr+
70082|NCT02845986|Stomach Neoplasms|stomach neoplasms
70083|NCT02845986|Laparoscopy|laparoscopy
70084|NCT02845986|Spleen-Preserving|spleen-preserving
70085|NCT02845986|No.10 Lymph Node Dissection|no.10 lymph node dissection
70086|NCT02845973|gut microbiota|gut microbiota
70087|NCT02845921|Propofol|propofol
70088|NCT02845921|Hypotension|hypotension
70089|NCT02845921|Induction of anaesthesia|induction of anaesthesia
70090|NCT02845921|Leg elevation|leg elevation
70091|NCT02845921|Leg wrapping|leg wrapping
70092|NCT02845895|Screening for nutritional disorder|screening for nutritional disorder
70093|NCT02845895|Comparison of two organizations|comparison of two organizations
70094|NCT02845895|Indicator IPAQSS|indicator ipaqss
70095|NCT02845856|recurrent lung cancer|recurrent lung cancer
70096|NCT02845856|EGFR mutation|egfr mutation
70097|NCT02845856|Cetuximab|cetuximab
70098|NCT02845856|NK immunotherapy|nk immunotherapy
70099|NCT02845843|Middle East Respiratory Syndrome Coronavirus|middle east respiratory syndrome coronavirus
70100|NCT02845843|MERS-CoV|mers-cov
70101|NCT02845843|Clinical trial|clinical trial
70102|NCT02845843|Lopinavir|lopinavir
70103|NCT02845843|Ritonavir|ritonavir
70104|NCT02845843|Interferon beta|interferon beta
70105|NCT02845830|dementia|dementia
70106|NCT02845830|elderly|elderly
70107|NCT02845830|quality of life|quality of life
70108|NCT02845830|assessment|assessment
70109|NCT02845830|factor|factor
70112|NCT02845830|early stage|early stage
70113|NCT02845804|coronary artery disease|coronary artery disease
70114|NCT02845804|percutaneous coronary intervention|percutaneous coronary intervention
70115|NCT02845804|everolimus-eluting stents|everolimus-eluting stents
70116|NCT02845778|melatonin|melatonin
70117|NCT02845778|pharmacokinetics|pharmacokinetics
70118|NCT02845765|Erectile Dysfunction|erectile dysfunction
70119|NCT02845765|ED|ed
70120|NCT02845765|Fundus Oculi|fundus oculi
70121|NCT02845765|Retinal Vascularization|retinal vascularization
70122|NCT02845765|International Index of Erectile Function Questionnaire|international index of erectile function questionnaire
70123|NCT02845765|IIEF|iief
70124|NCT02845765|Dynamic Vessel Analyzer|dynamic vessel analyzer
70125|NCT02845765|DVA|dva
70126|NCT02845765|Phosphodiesterase type 5 Inhibitor|phosphodiesterase type 5 inhibitor
70127|NCT02845765|PDE5Is|pde5is
70128|NCT02845739|kidney transplantation|kidney transplantation
70129|NCT02845739|human papillomavirus|human papillomavirus
70130|NCT02845687|nicotine addiction|nicotine addiction
70131|NCT02845687|cigarette smoking|cigarette smoking
70132|NCT02845661|Narcotrend index|narcotrend index
70133|NCT02845661|OAA/S scale|oaa/s scale
70134|NCT02845661|Dexmedetomidine|dexmedetomidine
70135|NCT02845661|Sedation|sedation
70136|NCT02845648|anticholinergics|anticholinergics
70137|NCT02845648|awakener|awakener
70138|NCT02845622|Hazelnut|hazelnut
70139|NCT02845622|Cocoa|cocoa
70140|NCT02845622|Flavonoid|flavonoid
70141|NCT02845622|Lipids|lipids
70142|NCT02845622|Vascular Reactivity|vascular reactivity
70143|NCT02845609|Congenital macrothrombocytopenia|congenital macrothrombocytopenia
70144|NCT02845609|Sialic acid|sialic acid
70145|NCT02845609|Bleeding|bleeding
70146|NCT02845583|Nursing|nursing
70147|NCT02845583|Diagnosis Related Group|diagnosis related group
70148|NCT02845583|Activity based costing|activity based costing
70149|NCT02845557|Youth|youth
70150|NCT02845557|Type 2 Diabetes|type 2 diabetes
70151|NCT02845557|glucose homeostasis|glucose homeostasis
70152|NCT02845557|incretin effect|incretin effect
70153|NCT02845544|Postural Balance|postural balance
70154|NCT02845531|Variant angina|variant angina
70155|NCT02845531|Aborted sudden cardiac death|aborted sudden cardiac death
70156|NCT02845531|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
70157|NCT02845531|Optimal Medical Therapy|optimal medical therapy
70158|NCT02845531|ICD|icd
70159|NCT02845505|intravascular ultrasonography|intravascular ultrasonography
70160|NCT02845505|Computed Tomography|computed tomography
70161|NCT02845492|Exercise|exercise
70162|NCT02845492|Qigong|qigong
70163|NCT02845492|Mind-Body|mind-body
70164|NCT02845492|Fatigue|fatigue
70165|NCT02845492|Cancer|cancer
70166|NCT02845492|EEG|eeg
70167|NCT02845492|HRV|hrv
70168|NCT02845466|Venous Leg Ulcer|venous leg ulcer
70169|NCT02845466|Diabetic Foot Ulcer|diabetic foot ulcer
70170|NCT02845466|Wound Healing|wound healing
70171|NCT02845466|Growth Factor|growth factor
70172|NCT02845466|Protease Inhibitor|protease inhibitor
70173|NCT02845453|youth|youth
70174|NCT02845453|adolescent|adolescent
70175|NCT02845453|young adult|young adult
70176|NCT02845453|substance use disorder|substance use disorder
70177|NCT02845453|bipolar disorder|bipolar disorder
70178|NCT02845453|quetiapine|quetiapine
70179|NCT02845440|Pragmatic Trial|pragmatic trial
70180|NCT02845440|Community Health Workers|community health workers
70181|NCT02845440|Academic Detailing|academic detailing
70182|NCT02845427|Closed Suction Drain|closed suction drain
70183|NCT02845427|Wound Hematoma|wound hematoma
70184|NCT02845388|IVF|ivf
70185|NCT02845362|Neuromuscular|neuromuscular
70186|NCT02845362|dysphagia|dysphagia
70187|NCT02845362|Swallowing disorders|swallowing disorders
70188|NCT02845362|Questionnaire|questionnaire
70189|NCT02845362|Assessment|assessment
70190|NCT02845284|adolescent|adolescent
70191|NCT02845284|reproductive health|reproductive health
70192|NCT02845245|Comminuted intra-articular distal tibia fractures|comminuted intra-articular distal tibia fractures
70193|NCT02845245|3D printing|3d printing
70194|NCT02845245|pre-operative planning|pre-operative planning
70195|NCT02845232|Acute myeloid leukemia|acute myeloid leukemia
70196|NCT02845232|Therapy|therapy
70197|NCT02845232|Blood transfusion|blood transfusion
70198|NCT02845232|Cost-effectiveness|cost-effectiveness
70199|NCT02845232|Prognosis|prognosis
70200|NCT02845206|Total Knee Replacement|total knee replacement
70201|NCT02845206|Patient Specific Instrumentation|patient specific instrumentation
70202|NCT02845180|lipectomy|lipectomy
70203|NCT02845180|panniculectomy|panniculectomy
70204|NCT02845154|Ischemia reperfusion|ischemia reperfusion
70205|NCT02845154|post-reperfusion syndrome|post-reperfusion syndrome
70206|NCT02845154|living donor liver transplantation|living donor liver transplantation
70207|NCT02845154|patient outcome|patient outcome
70208|NCT02845141|ACL|acl
70209|NCT02845141|Revision surgery|revision surgery
70210|NCT02845141|tunnel enlargement|tunnel enlargement
70211|NCT02845141|bone substitute material|bone substitute material
70213|NCT02845115|Middle Ear Implant|middle ear implant
70214|NCT02845115|laser velocimetry|laser velocimetry
70215|NCT02845102|Chronic Illness|chronic illness
70216|NCT02845102|Chronic Pain|chronic pain
70217|NCT02845102|Depression|depression
70218|NCT02845102|Comorbid Depression|comorbid depression
70219|NCT02845102|Cognitive Behavioral Therapy|cognitive behavioral therapy
70220|NCT02845102|Relational Agent Technology|relational agent technology
70221|NCT02845102|CBT|cbt
70222|NCT02845102|Virtual Counselor|virtual counselor
70223|NCT02845076|Noninvasive ventilation|noninvasive ventilation
70224|NCT02845076|Respiratory insufficiency|respiratory insufficiency
70225|NCT02845076|Hypercapnia|hypercapnia
70226|NCT02845076|ventilator weaning|ventilator weaning
70227|NCT02845063|muscle plasticity|muscle plasticity
70228|NCT02845063|exercise|exercise
70229|NCT02845063|rehabilitation|rehabilitation
70230|NCT02845063|perfusion|perfusion
70231|NCT02845063|ACE|ace
70232|NCT02845063|genotype|genotype
70233|NCT02845063|hypertension|hypertension
70234|NCT02845063|molecular biology|molecular biology
70235|NCT02845050|neo-adjuvant|neo-adjuvant
70236|NCT02845050|vinflunine|vinflunine
70237|NCT02845050|cisplatin|cisplatin
70238|NCT02845050|radical cystectomy|radical cystectomy
70239|NCT02845050|muscle-invasive bladder cancer|muscle-invasive bladder cancer
70240|NCT02845050|JaNEO|janeo
70241|NCT02845011|Cardio first angle|cardio first angle
70242|NCT02845011|CPR|cpr
70243|NCT02845011|Cardiopulmonary Arrest|cardiopulmonary arrest
70244|NCT02845011|Clinical trial|clinical trial
70245|NCT02844998|intravaginal ejaculatory latency time|intravaginal ejaculatory latency time
70246|NCT02844998|international physical activity questionnaire|international physical activity questionnaire
70247|NCT02844998|premature ejaculation diagnostic tool|premature ejaculation diagnostic tool
70248|NCT02844985|Sexual Addiction|sexual addiction
70249|NCT02844985|Genomics|genomics
70250|NCT02844985|Personality|personality
70251|NCT02844985|Polymorphism|polymorphism
70252|NCT02844972|arrest or limitation of active treatment|arrest or limitation of active treatment
70253|NCT02844972|emergency treatment|emergency treatment
70254|NCT02844959|Atrial Fibrillation|atrial fibrillation
70255|NCT02844959|Biomarkers|biomarkers
70256|NCT02844959|Inflammatory Response|inflammatory response
70257|NCT02844959|C-reactive protein|c-reactive protein
70258|NCT02844959|FGF2|fgf2
70259|NCT02844959|MMP8|mmp8
70260|NCT02844959|troponin I|troponin i
70261|NCT02844959|body temperature|body temperature
70262|NCT02844946|Acceptance and Commitment Therapy|acceptance and commitment therapy
70263|NCT02844946|mild Traumatic Brain Injury|mild traumatic brain injury
70264|NCT02844946|Veterans|veterans
70265|NCT02844946|Post Traumatic Stress Disorder|post traumatic stress disorder
70266|NCT02844907|Incretins|incretins
70267|NCT02844907|GLP-1|glp-1
70268|NCT02844894|intubation, ischemia modified albumine, dexmedetomidine, esmolol|intubation, ischemia modified albumine, dexmedetomidine, esmolol
70269|NCT02844868|stroke|stroke
70270|NCT02844868|hemiplegia|hemiplegia
70525|NCT02843438|Uveitis|uveitis
70271|NCT02844868|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
70272|NCT02844868|rehabilitation|rehabilitation
70273|NCT02844868|lower extremity|lower extremity
70274|NCT02844868|gait training|gait training
70275|NCT02844855|Alzheimer|alzheimer
70276|NCT02844855|Parkinson|parkinson
70277|NCT02844855|Action memory|action memory
70278|NCT02844842|mild or moderate|mild or moderate
70279|NCT02844829|Prostate Cancer|prostate cancer
70280|NCT02844829|Magnetic Resonance Imaging|magnetic resonance imaging
70281|NCT02844777|topical ointment|topical ointment
70282|NCT02844777|skin|skin
70283|NCT02844777|hexokinase|hexokinase
626196|NCT00678262|ECG|ecg
70293|NCT02844699|Ad5|ad5
70294|NCT02844686|Myocardial perfusion imaging|myocardial perfusion imaging
70295|NCT02844686|Single-Photon Emission Computer-Assisted Tomography|single-photon emission computer-assisted tomography
70296|NCT02844673|Sickle cell disease|sickle cell disease
70297|NCT02844673|Hydroxyurea|hydroxyurea
70298|NCT02844673|Adherence|adherence
70299|NCT02844673|randomized trial|randomized trial
70300|NCT02844673|medication possession ratio|medication possession ratio
70301|NCT02844660|Diabetes Mellitus|diabetes mellitus
70302|NCT02844660|Foot Diseases|foot diseases
70303|NCT02844660|Foot Ulcer|foot ulcer
70304|NCT02844634|pre-exposure prophylaxis|pre-exposure prophylaxis
70632|NCT02842814|Stable|stable
70305|NCT02844634|men who have sex with men|men who have sex with men
70306|NCT02844634|HIV prevention|hiv prevention
70307|NCT02844634|sexually transmitted infection|sexually transmitted infection
70308|NCT02844634|syphilis|syphilis
70309|NCT02844608|Health-related quality of life|health-related quality of life
70310|NCT02844608|Oncology clinical practice|oncology clinical practice
70311|NCT02844608|Electronic collection|electronic collection
70312|NCT02844595|Smoking, psychological treatment, depression|smoking, psychological treatment, depression
70318|NCT02844543|concussion, eye-tracking, athletes, vision|concussion, eye-tracking, athletes, vision
70319|NCT02844530|adults|adults
70328|NCT02844478|Caregiving|caregiving
70329|NCT02844478|Family caregiving|family caregiving
70330|NCT02844478|Stress|stress
70331|NCT02844478|dementia caregiving|dementia caregiving
70332|NCT02844478|Hispanics|hispanics
70333|NCT02844478|Spanish|spanish
70334|NCT02844478|Telomere|telomere
70335|NCT02844465|epilepsy|epilepsy
70336|NCT02844465|laser ablation|laser ablation
70337|NCT02844465|Visualase|visualase
70338|NCT02844465|laser interstitial thermal therapy|laser interstitial thermal therapy
70339|NCT02844452|Atopic Dermatitis|atopic dermatitis
70340|NCT02844452|acupuncture|acupuncture
70341|NCT02844452|visit frequency|visit frequency
70342|NCT02844452|adult patient with AD|adult patient with ad
70343|NCT02844426|synbiotic|synbiotic
70344|NCT02844426|soluble dietary fiber|soluble dietary fiber
70345|NCT02844426|slow transit constipation|slow transit constipation
70346|NCT02844426|microbiota|microbiota
70347|NCT02844387|cancer|cancer
70348|NCT02844387|brain|brain
70349|NCT02844387|arginine|arginine
70350|NCT02844387|radiation|radiation
70351|NCT02844374|Epilepsy|epilepsy
70352|NCT02844374|Surgery candidate|surgery candidate
70353|NCT02844374|EEG's Signal|eeg's signal
70354|NCT02844361|high-risk|high-risk
70355|NCT02844361|ASCT|asct
70356|NCT02844348|Pain|pain
70357|NCT02844348|Hypnosis|hypnosis
70358|NCT02844348|Chronic Dialysis|chronic dialysis
70359|NCT02844348|Arterial Disease|arterial disease
70360|NCT02844335|Breast Cancer|breast cancer
70361|NCT02844335|Cryosurgery|cryosurgery
70362|NCT02844335|NK Immunotherapy|nk immunotherapy
70363|NCT02844296|short-bout exercise|short-bout exercise
70364|NCT02844296|craving|craving
70365|NCT02844296|handgrip|handgrip
70366|NCT02844296|smoking cessation|smoking cessation
70367|NCT02844296|RCT|rct
70368|NCT02844283|HGF,myocardial infarction|hgf,myocardial infarction
70369|NCT02844257|Acute myeloid leukaemia|acute myeloid leukaemia
70370|NCT02844257|Transfusion dependency|transfusion dependency
70371|NCT02844257|Transfusion intensity|transfusion intensity
70372|NCT02844257|Prognosis|prognosis
70373|NCT02844257|Chemotherapy|chemotherapy
70374|NCT02844244|family well-being|family well-being
70375|NCT02844244|positive psychology|positive psychology
70376|NCT02844218|Acute myeloid leukemia|acute myeloid leukemia
70377|NCT02844218|Chemotherapy|chemotherapy
70378|NCT02844218|Low-intensity therapy|low-intensity therapy
70379|NCT02844218|Older patients|older patients
70380|NCT02844218|Prognosis|prognosis
70381|NCT02844218|Supportive care|supportive care
70382|NCT02844205|nursing care|nursing care
70383|NCT02844205|observational scale|observational scale
70384|NCT02844205|neonate|neonate
70385|NCT02844205|premature infant|premature infant
70386|NCT02844205|developmental care|developmental care
70387|NCT02844192|Vancomycin|vancomycin
70388|NCT02844192|under dosage|under dosage
70389|NCT02844192|intensive care unit|intensive care unit
70390|NCT02844192|pharmacokinetics|pharmacokinetics
70391|NCT02844153|Metformin|metformin
70392|NCT02844153|type 2 diabetes|type 2 diabetes
70393|NCT02844153|chronic kidney disease|chronic kidney disease
70394|NCT02844153|antidiabetic medications|antidiabetic medications
70395|NCT02844153|lactic acidosis|lactic acidosis
70396|NCT02844114|Ganoderma Lucidum Spore|ganoderma lucidum spore
70397|NCT02844114|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
70398|NCT02844114|Chemotherapy|chemotherapy
70399|NCT02844114|Gemcitabine|gemcitabine
70400|NCT02844114|Cisplatin|cisplatin
70401|NCT02844088|meningococcus C|meningococcus c
70402|NCT02844075|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
70403|NCT02844075|pembrolizumab|pembrolizumab
70404|NCT02844075|PD-1|pd-1
70405|NCT02844075|neoadjuvant|neoadjuvant
70406|NCT02844075|chemoradiation|chemoradiation
70407|NCT02844049|Deep Brain Stimulation|deep brain stimulation
70408|NCT02844049|Quality of Life|quality of life
70409|NCT02844036|Distal Lesions|distal lesions
70410|NCT02844036|Post-embolic HTP|post-embolic htp
70411|NCT02844036|Angioplasty|angioplasty
70412|NCT02844023|Arteritis|arteritis
70413|NCT02844023|Biomarker|biomarker
70414|NCT02844023|Horton disease|horton disease
70415|NCT02843997|Bipolar disorder|bipolar disorder
70416|NCT02843997|Endophenotype|endophenotype
70417|NCT02843997|Family|family
70418|NCT02843997|Autosomal dominant expression|autosomal dominant expression
70419|NCT02843997|Sequencing|sequencing
70420|NCT02843997|Heritability|heritability
70421|NCT02843984|Amniocentesis|amniocentesis
70422|NCT02843971|Water Drinking Test|water drinking test
70423|NCT02843971|Intraocular Pressure|intraocular pressure
70424|NCT02843971|Sensimed Triggerfish|sensimed triggerfish
70425|NCT02843958|Medical device|medical device
70426|NCT02843958|Hemoptic|hemoptic
70427|NCT02843958|Vitamin K antagonist|vitamin k antagonist
70428|NCT02843958|Diagnostic in vitro|diagnostic in vitro
70429|NCT02843945|brachytherapy|brachytherapy
70430|NCT02843945|CivaSheet|civasheet
70431|NCT02843945|CivaTech|civatech
70432|NCT02843945|whipple|whipple
70433|NCT02843945|radiation|radiation
70434|NCT02843945|borderline resectable|borderline resectable
70435|NCT02843945|locally advanced|locally advanced
70436|NCT02843945|Pd-103|pd-103
70437|NCT02843945|intraoperative radiation|intraoperative radiation
70438|NCT02843932|Somatoform|somatoform
70439|NCT02843932|Psychogenic|psychogenic
70440|NCT02843919|Electrocardiography|electrocardiography
70441|NCT02843919|Electroencephalography|electroencephalography
70442|NCT02843919|Neural Correlates|neural correlates
70443|NCT02843919|Mental Workload|mental workload
70444|NCT02843906|alzheimer disease|alzheimer disease
70445|NCT02843906|bipolar disorders|bipolar disorders
70446|NCT02843906|mild cognitive impairement|mild cognitive impairement
70447|NCT02843893|Pupillary|pupillary
70448|NCT02843893|Reflexes|reflexes
70449|NCT02843893|Analgesia|analgesia
70450|NCT02843893|Sedation|sedation
70451|NCT02843880|CMV reactivation|cmv reactivation
70452|NCT02843880|CMV disease|cmv disease
70453|NCT02843880|Predictive factors|predictive factors
70454|NCT02843880|Critically ill patients|critically ill patients
70455|NCT02843880|Septic shock|septic shock
70456|NCT02843867|Transplantation|transplantation
70457|NCT02843867|Immunology|immunology
70458|NCT02843867|Atherosclerosis|atherosclerosis
70459|NCT02843828|Exoskeleton Device|exoskeleton device
70460|NCT02843828|elderly|elderly
70461|NCT02843828|stroke|stroke
70462|NCT02843828|gait rehabilitation|gait rehabilitation
70463|NCT02843815|Non-small cell lung cancer|non-small cell lung cancer
70464|NCT02843815|Cryosurgery|cryosurgery
70465|NCT02843815|NK Immunotherapy|nk immunotherapy
70466|NCT02843802|Metastatic liver cancer|metastatic liver cancer
70467|NCT02843802|Cryosurgery|cryosurgery
70468|NCT02843802|NK Immunotherapy|nk immunotherapy
70469|NCT02843789|Adipokines|adipokines
70470|NCT02843789|Tocilizumab|tocilizumab
70471|NCT02843776|Palliative Care|palliative care
70472|NCT02843776|Euthanasia|euthanasia
70473|NCT02843776|Epidemiologic Studies|epidemiologic studies
70474|NCT02843750|Rehabilitation|rehabilitation
70475|NCT02843750|Inspiratory Muscle Training|inspiratory muscle training
70476|NCT02843724|Uncontrolled Type 2 Diabetes|uncontrolled type 2 diabetes
70477|NCT02843724|HbA1c >7.0%|hba1c >7.0%
70478|NCT02843711|Lungcarta Panel|lungcarta panel
70479|NCT02843711|lung adenocarcinoma|lung adenocarcinoma
70480|NCT02843672|metatarsalgia|metatarsalgia
70481|NCT02843672|surgery|surgery
70482|NCT02843672|weil|weil
70483|NCT02843672|MIS|mis
70484|NCT02843672|percutaneous|percutaneous
70485|NCT02843672|DMMO|dmmo
70486|NCT02843646|gait training|gait training
70487|NCT02843646|stepping|stepping
70488|NCT02843633|Acute Coronary Syndrome|acute coronary syndrome
70489|NCT02843633|Percutaneous Coronary Intervention|percutaneous coronary intervention
70490|NCT02843633|Drug Coated Stent|drug coated stent
70491|NCT02843633|Drug Eluting Stent|drug eluting stent
70493|NCT02843620|Joint|joint
70494|NCT02843620|Joint Discomfort|joint discomfort
70495|NCT02843607|Kidney Cancer|kidney cancer
70496|NCT02843607|Cryosurgery|cryosurgery
70497|NCT02843607|NK Immunotherapy|nk immunotherapy
70498|NCT02843581|Esophageal Cancer|esophageal cancer
70499|NCT02843581|NK immunotherapy|nk immunotherapy
70500|NCT02843581|Safety|safety
70501|NCT02843581|Efficacy|efficacy
70502|NCT02843555|Leukodystrophy|leukodystrophy
70503|NCT02843555|Myelin Gene|myelin gene
70504|NCT02843555|Myelin Protein|myelin protein
70505|NCT02843555|Sural Nerve Biopsy|sural nerve biopsy
70506|NCT02843555|Undiagnosed Disease|undiagnosed disease
70507|NCT02843555|Schwann Cell|schwann cell
70508|NCT02843555|White Matter Pathology|white matter pathology
70509|NCT02843555|Motor Delay|motor delay
70510|NCT02843555|Cognitive Regression|cognitive regression
70511|NCT02843555|Motor Deterioration|motor deterioration
70512|NCT02843555|Unknown Disease|unknown disease
70513|NCT02843542|Positron emission tomography-magnetic resonance imaging (PET-MR)|positron emission tomography-magnetic resonance imaging (pet-mr)
70514|NCT02843542|Hyperthyroidism|hyperthyroidism
70515|NCT02843542|Positron emission tomography-computed tomography (PET-CT)|positron emission tomography-computed tomography (pet-ct)
70516|NCT02843529|biomarkers|biomarkers
70517|NCT02843529|CSF|csf
70518|NCT02843529|EEG|eeg
70519|NCT02843529|MRI|mri
70520|NCT02843490|neovascular age-related macular edema|neovascular age-related macular edema
70521|NCT02843490|biomarker|biomarker
70522|NCT02843490|ranibizumab|ranibizumab
70523|NCT02843490|lucentis|lucentis
70524|NCT02843438|Toxoplasmosis|toxoplasmosis
70529|NCT02843425|Precancerous colorectal polyps|precancerous colorectal polyps
70530|NCT02843425|Canned beans|canned beans
70531|NCT02843425|Questionnaires|questionnaires
70532|NCT02843425|Surveys|surveys
70533|NCT02843425|Stool samples|stool samples
70534|NCT02843412|Gastric cancer|gastric cancer
70535|NCT02843412|Her2/neu|her2/neu
70536|NCT02843412|Dual paraffin blocks|dual paraffin blocks
70537|NCT02843412|Trastuzumab|trastuzumab
70538|NCT02843412|Clinical Prospective Multicenter Cohort Study|clinical prospective multicenter cohort study
70539|NCT02843399|Diabetes Mellitus Type 2|diabetes mellitus type 2
70540|NCT02843386|Uveal melanoma|uveal melanoma
70541|NCT02843386|High risk of metastasis|high risk of metastasis
70542|NCT02843386|Genomic high risk signature|genomic high risk signature
70543|NCT02843386|Adjuvant chemotherapy|adjuvant chemotherapy
70544|NCT02843360|public health|public health
70545|NCT02843347|Biorepository|biorepository
70546|NCT02843347|Genetics|genetics
70547|NCT02843334|Fabry disease|fabry disease
70548|NCT02843334|End Stage Renal Disease|end stage renal disease
70549|NCT02843334|chronic dialysis|chronic dialysis
70550|NCT02843334|alpha galactosidase A|alpha galactosidase a
70551|NCT02843334|Lyso-GB3|lyso-gb3
70552|NCT02843334|GLA mutation|gla mutation
70553|NCT02843334|Prevalence|prevalence
70554|NCT02843321|infection|infection
70555|NCT02843308|hoarding disorder|hoarding disorder
70556|NCT02843308|hoarding|hoarding
70557|NCT02843308|clutter|clutter
70558|NCT02843295|renal transplantation|renal transplantation
70559|NCT02843295|immunology|immunology
70560|NCT02843295|rejection|rejection
70561|NCT02843269|RCT|rct
70562|NCT02843269|Multi-component intervention|multi-component intervention
70563|NCT02843269|Health personnel|health personnel
70564|NCT02843269|Physical exercise training|physical exercise training
70566|NCT02843204|solid tumor|solid tumor
70567|NCT02843204|anti-PD-L1|anti-pd-l1
70568|NCT02843204|NK immunotherapy|nk immunotherapy
70569|NCT02843191|Rectal Cancer|rectal cancer
70570|NCT02843191|Consolidation Chemotherapy|consolidation chemotherapy
70571|NCT02843178|nutrition|nutrition
70572|NCT02843178|food security|food security
70573|NCT02843178|behavioral economics|behavioral economics
70574|NCT02843165|stereotactic body radiation therapy|stereotactic body radiation therapy
70575|NCT02843165|checkpoint blockade immunotherapy|checkpoint blockade immunotherapy
70576|NCT02843139|Circulating microRNA|circulating microrna
70577|NCT02843139|Childhood obesity|childhood obesity
70578|NCT02843139|Adulthood diabetes|adulthood diabetes
70579|NCT02843126|recurrent breast cancer|recurrent breast cancer
70580|NCT02843126|Her-2 positive|her-2 positive
70581|NCT02843126|Trastuzumab|trastuzumab
70582|NCT02843126|NK immunotherapy|nk immunotherapy
70583|NCT02843113|single father|single father
70584|NCT02843113|parenting behavior|parenting behavior
70585|NCT02843100|Crohn's Disease|crohn's disease
70587|NCT02843100|Exclusive Enteral Nutrition|exclusive enteral nutrition
70589|NCT02843100|Microbiome|microbiome
70590|NCT02843087|Breastfeeding|breastfeeding
70591|NCT02843087|Microbiome|microbiome
70592|NCT02843087|BEACH|beach
70593|NCT02843087|Human milk|human milk
70594|NCT02843087|Pediatric Obesity|pediatric obesity
70595|NCT02843074|B-cell tumors|b-cell tumors
70596|NCT02843074|autologous stem cell transplantation|autologous stem cell transplantation
70597|NCT02843074|blood cancers|blood cancers
70598|NCT02843061|B lymphoma|b lymphoma
70599|NCT02843061|Rituximab|rituximab
70600|NCT02843061|NK immunotherapy|nk immunotherapy
70601|NCT02843048|Osteoporosis|osteoporosis
70602|NCT02843048|Bariatric Surgery|bariatric surgery
70603|NCT02843048|Physical exercise|physical exercise
70604|NCT02843048|Obesity|obesity
70605|NCT02843022|postpartum|postpartum
70606|NCT02843022|nursing|nursing
70607|NCT02843022|follow-up|follow-up
70608|NCT02842983|Esmolol|esmolol
70609|NCT02842983|Hypotension|hypotension
70610|NCT02842983|Shock, Septic|shock, septic
70611|NCT02842983|Sepsis|sepsis
70612|NCT02842983|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
70613|NCT02842983|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists
70614|NCT02842983|Adrenergic Antagonists|adrenergic antagonists
70615|NCT02842983|Pharmacologic Actions|pharmacologic actions
70616|NCT02842983|Physiological Effects of Drugs|physiological effects of drugs
70617|NCT02842931|DLBCL, R-DA-EPOCH-21, R-mNHL-BFM-90, auto-SCT|dlbcl, r-da-epoch-21, r-mnhl-bfm-90, auto-sct
70618|NCT02842918|Thoracic Spine Manipulation|thoracic spine manipulation
70619|NCT02842918|Neurodynamics|neurodynamics
70620|NCT02842918|Sham|sham
70621|NCT02842866|Meningitis|meningitis
70622|NCT02842866|Meningococcal Meningitis|meningococcal meningitis
70623|NCT02842866|Meningococcal Infections|meningococcal infections
70624|NCT02842866|MenACYW conjugate vaccine|menacyw conjugate vaccine
70628|NCT02842853|Meningococcal Infections|meningococcal infections
70629|NCT02842853|MenACYW conjugate vaccine|menacyw conjugate vaccine
70630|NCT02842853|Licensed MCV4 vaccine|licensed mcv4 vaccine
70631|NCT02842814|Systemic Lupus Erythematosus|systemic lupus erythematosus
70633|NCT02842814|Relapse Risk|relapse risk
70634|NCT02842814|Glucocorticoid Withdrawal|glucocorticoid withdrawal
70635|NCT02842788|prone position|prone position
70636|NCT02842788|acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
70637|NCT02842788|mechanical ventilation|mechanical ventilation
70638|NCT02842788|ICU|icu
70639|NCT02842788|prevalence|prevalence
70640|NCT02842775|rehabilitation|rehabilitation
70641|NCT02842762|Echocardiography, Three-dimensional|echocardiography, three-dimensional
70642|NCT02842762|Cardiac Surgical Procedures|cardiac surgical procedures
70643|NCT02842762|Cardiac Pacing, Artificial|cardiac pacing, artificial
70644|NCT02842762|Anesthesia|anesthesia
70645|NCT02842736|heavy menstrual bleeding|heavy menstrual bleeding
70646|NCT02842736|endometrial ablation|endometrial ablation
70647|NCT02842723|craniopharyngioma|craniopharyngioma
70648|NCT02842723|protontherapy|protontherapy
70774|NCT02841787|Aging|aging
70649|NCT02842697|clinically significant portal hypertension|clinically significant portal hypertension
82229|NCT02773394|Brazil|brazil
70650|NCT02842697|hepatic venous pressure gradient|hepatic venous pressure gradient
70651|NCT02842697|computed tomographic angiography|computed tomographic angiography
70654|NCT02842658|Chemotherapy|chemotherapy
70655|NCT02842658|Exercise|exercise
70656|NCT02842645|Foetal Exposure During Pregnancy|foetal exposure during pregnancy
70657|NCT02842645|Health|health
70658|NCT02842645|Growth|growth
70659|NCT02842580|colorectal|colorectal
70660|NCT02842580|cancer|cancer
70661|NCT02842580|metastasis|metastasis
70662|NCT02842554|PDN|pdn
70663|NCT02842554|Painful Diabetic Neuropathy|painful diabetic neuropathy
70664|NCT02842554|Diabetes|diabetes
70665|NCT02842502|Skin Substitutes|skin substitutes
70666|NCT02842489|colonoscopy insertion|colonoscopy insertion
70667|NCT02842489|tilt-down position|tilt-down position
70668|NCT02842476|pulse oximetry|pulse oximetry
70669|NCT02842437|dexmedetomidine|dexmedetomidine
70670|NCT02842437|sepsis|sepsis
70671|NCT02842437|respiration|respiration
70672|NCT02842424|Ramipril|ramipril
70673|NCT02842424|Angiotensin-converting enzyme|angiotensin-converting enzyme
70674|NCT02842424|Claudication|claudication
70675|NCT02842424|Myopathy|myopathy
70676|NCT02842424|Peripheral Arterial Disease|peripheral arterial disease
70677|NCT02842411|bowel preparation|bowel preparation
70678|NCT02842411|chronic constipation|chronic constipation
70679|NCT02842411|risk factor|risk factor
70680|NCT02842398|gait|gait
70681|NCT02842398|balance|balance
70682|NCT02842398|street-crossing|street-crossing
70683|NCT02842385|soft tissue thickness|soft tissue thickness
70684|NCT02842385|dental implant|dental implant
70685|NCT02842385|crestal bone loss|crestal bone loss
70686|NCT02842372|Acute Graft Versus Host Disease in Skin|acute graft versus host disease in skin
70687|NCT02842372|GvHD|gvhd
70688|NCT02842372|Ectoin|ectoin
70689|NCT02842372|Dermatitis|dermatitis
70690|NCT02842372|Inflammation of the skin|inflammation of the skin
70691|NCT02842372|Topical therapy skin GvHD|topical therapy skin gvhd
70692|NCT02842346|Ultrasound; umbilical Doppler; resistance index; fetal growth|ultrasound; umbilical doppler; resistance index; fetal growth
70693|NCT02842307|Acupuncture|acupuncture
70694|NCT02842307|Expertise-based randomized controlled trial|expertise-based randomized controlled trial
70695|NCT02842307|Nausea|nausea
70696|NCT02842307|Vomiting|vomiting
70697|NCT02842307|Cancer|cancer
70698|NCT02842294|bevacizumab|bevacizumab
70699|NCT02842294|health related quality of life|health related quality of life
70700|NCT02842255|Sleep apnea|sleep apnea
70701|NCT02842255|Oximeter|oximeter
70702|NCT02842255|Calibration|calibration
70703|NCT02842255|Oxygen partial pressure|oxygen partial pressure
70704|NCT02842229|Myelodysplastic Syndromes|myelodysplastic syndromes
70705|NCT02842229|Leukemia Myeloid Acute|leukemia myeloid acute
70706|NCT02842229|Multiple Myeloma|multiple myeloma
70707|NCT02842229|Leukemia, Lymphocytic, Chronic|leukemia, lymphocytic, chronic
70708|NCT02842229|Elderly Patients|elderly patients
70709|NCT02842229|Haematological malignancy|haematological malignancy
70710|NCT02842229|Elderly|elderly
70711|NCT02842229|Health Status|health status
70712|NCT02842229|Scale validation|scale validation
70713|NCT02842229|Retrospective|retrospective
70714|NCT02842216|Pharmaceutical preparations|pharmaceutical preparations
70715|NCT02842216|Dietary supplements|dietary supplements
70716|NCT02842203|colorectal cancer|colorectal cancer
70717|NCT02842190|Neonatal|neonatal
70718|NCT02842190|NIPPV|nippv
70720|NCT02842190|Extubation failure|extubation failure
70721|NCT02842151|IOL|iol
70722|NCT02842125|Colorectal|colorectal
70723|NCT02842125|solid tumors|solid tumors
70724|NCT02842125|hepatocellular|hepatocellular
70725|NCT02842125|Ad-P53|ad-p53
70726|NCT02842125|metastatic|metastatic
70727|NCT02842125|capecitabine|capecitabine
70728|NCT02842112|Acute myeloid leukemia|acute myeloid leukemia
70729|NCT02842112|prognosis|prognosis
70730|NCT02842112|stem cell harvest|stem cell harvest
70731|NCT02842112|autologous transplant|autologous transplant
70732|NCT02842112|leukemia stem cell|leukemia stem cell
70733|NCT02842060|Prevention & Control|prevention & control
70734|NCT02842060|Young Adult|young adult
70735|NCT02842060|Internet|internet
70736|NCT02842047|caregiver|caregiver
70737|NCT02842047|end of life|end of life
70738|NCT02842034|schizophrenia|schizophrenia
70739|NCT02842034|rTMS|rtms
70740|NCT02842008|Exercise Therapy|exercise therapy
70741|NCT02842008|Shoulder pain|shoulder pain
70742|NCT02842008|Shoulder injuries|shoulder injuries
70743|NCT02842008|Shoulder function|shoulder function
70744|NCT02842008|Prevention|prevention
70745|NCT02842008|Wheelchair users|wheelchair users
70746|NCT02841995|cGVHD|cgvhd
70747|NCT02841995|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
70748|NCT02841995|Immune System Diseases|immune system diseases
70749|NCT02841995|Steroid refractory chronic graft vs host disease (cGVHD)|steroid refractory chronic graft vs host disease (cgvhd)
70750|NCT02841995|Bone Marrow Transplantation|bone marrow transplantation
70751|NCT02841995|Anti-Inflammatory Agents|anti-inflammatory agents
70752|NCT02841995|Glucocorticoids|glucocorticoids
70753|NCT02841995|Corticosteroids|corticosteroids
70754|NCT02841969|Ulcer|ulcer
70755|NCT02841969|Electrolysed|electrolysed
70756|NCT02841969|Water|water
70757|NCT02841943|Fluid responsiveness|fluid responsiveness
70758|NCT02841943|Near-infrared spectroscopy|near-infrared spectroscopy
70759|NCT02841943|Thoracic surgery|thoracic surgery
70760|NCT02841943|Hypovolemia|hypovolemia
70761|NCT02841943|veno-arterial carbon dioxide gradient|veno-arterial carbon dioxide gradient
70762|NCT02841943|arterio-venous oxygen gradient|arterio-venous oxygen gradient
70763|NCT02841943|hypercarbia|hypercarbia
70764|NCT02841943|Carotid artery|carotid artery
70765|NCT02841943|ultrasonography|ultrasonography
70766|NCT02841943|Doppler|doppler
70767|NCT02841930|Healthcare Access|healthcare access
70768|NCT02841930|Undocumented Immigrants|undocumented immigrants
70769|NCT02841930|Primary Prevention|primary prevention
70770|NCT02841800|radiofrequency ablation|radiofrequency ablation
70771|NCT02841800|malignant biliary stenosis|malignant biliary stenosis
70772|NCT02841787|Depression|depression
70773|NCT02841787|Web-based intervention|web-based intervention
70775|NCT02841787|Geriatrics|geriatrics
70776|NCT02841787|Social network|social network
70777|NCT02841787|Older adults|older adults
70778|NCT02841748|Pembrolizumab|pembrolizumab
70779|NCT02841748|HNSCC|hnscc
70780|NCT02841735|brief intervention|brief intervention
70781|NCT02841735|web-based interventions|web-based interventions
70782|NCT02841735|harm reduction|harm reduction
70783|NCT02841735|young adult|young adult
70784|NCT02841735|college student|college student
70785|NCT02841709|insomnia|insomnia
70786|NCT02841709|elderly|elderly
70787|NCT02841709|Polysomnography|polysomnography
70788|NCT02841696|Heart failure|heart failure
70789|NCT02841696|Systolic dysfunction|systolic dysfunction
70790|NCT02841696|GLS|gls
70791|NCT02841696|Arterial stiffness|arterial stiffness
70792|NCT02841696|Left ventricular hypertrophy|left ventricular hypertrophy
70793|NCT02841657|3 Dimensional Laparoscopy|3 dimensional laparoscopy
70794|NCT02841657|Visual work load|visual work load
70795|NCT02841657|Nasa Task Load Index|nasa task load index
70796|NCT02841657|Simulator Sickness Questionnaire|simulator sickness questionnaire
70797|NCT02841553|Endoplasmic Reticulum Stress|endoplasmic reticulum stress
70798|NCT02841540|Myelodysplastic Syndromes|myelodysplastic syndromes
70799|NCT02841540|Acute Myeloid Leukemia|acute myeloid leukemia
70800|NCT02841540|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
70801|NCT02841540|H3B-8800|h3b-8800
70802|NCT02841501|Gene Expression Profiling|gene expression profiling
70803|NCT02841501|Genome-Wide Association Study|genome-wide association study
70804|NCT02841501|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
70805|NCT02841501|Drug Resistance, Fungal|drug resistance, fungal
70806|NCT02841475|Atrial Fibrillation , Comorbidities|atrial fibrillation , comorbidities
70807|NCT02841462|thermal ablation|thermal ablation
70808|NCT02841462|recurrent Bursitis|recurrent bursitis
70809|NCT02841462|chronic Bursitis|chronic bursitis
70810|NCT02841462|olecranon|olecranon
70811|NCT02841462|intra-bursal perfusion|intra-bursal perfusion
70812|NCT02841449|Hydration|hydration
70813|NCT02841449|Glycemic control|glycemic control
70814|NCT02841449|Appetite|appetite
70815|NCT02841449|Endocrinology|endocrinology
70816|NCT02841436|irreversible electroporation|irreversible electroporation
70817|NCT02841436|pancreatic cancer|pancreatic cancer
70818|NCT02841423|physical status I-III;|physical status i-iii;
70819|NCT02841423|age > 55 yr)|age > 55 yr)
70820|NCT02841423|undergoing surgery (duration, > 1 h)|undergoing surgery (duration, > 1 h)
70821|NCT02841410|Food|food
70822|NCT02841410|Emotion|emotion
70823|NCT02841410|Health|health
70824|NCT02841410|Nutrition|nutrition
70825|NCT02841410|Heuristic|heuristic
70826|NCT02841410|Reasoning|reasoning
70827|NCT02841410|Magnetic Resonance Imaging|magnetic resonance imaging
70828|NCT02841384|patellofemoral pain syndrome|patellofemoral pain syndrome
70829|NCT02841384|postural balance|postural balance
70830|NCT02841384|knee|knee
70831|NCT02841384|physiotherapy|physiotherapy
70832|NCT02841371|estimated glomerular filtration rate|estimated glomerular filtration rate
70833|NCT02841371|serum creatinine|serum creatinine
70834|NCT02841371|serum cystatin C|serum cystatin c
70835|NCT02841371|chronic kidney disease|chronic kidney disease
70836|NCT02841358|Niemann-Pick Disease, Type C|niemann-pick disease, type c
70837|NCT02841358|Psychiatric|psychiatric
70838|NCT02841358|Psychotic disorders|psychotic disorders
70839|NCT02841345|emotional processing|emotional processing
70840|NCT02841345|action|action
70841|NCT02841332|Recurrent Glioblastoma|recurrent glioblastoma
70842|NCT02841332|Positron emission tomography|positron emission tomography
70843|NCT02841332|Fluoro misonidazole|fluoro misonidazole
70844|NCT02841332|MRI multimodal|mri multimodal
70845|NCT02841319|Virtual reality|virtual reality
82513|NCT02771782|BCG|bcg
62289|NCT02895334|CHD|chd
70846|NCT02841319|Hemiplegic|hemiplegic
70847|NCT02841319|Cerebral Palsy|cerebral palsy
70848|NCT02841319|upper extremity|upper extremity
70849|NCT02841319|hand function|hand function
70850|NCT02841293|Anorectal cancer|anorectal cancer
70851|NCT02841293|perineal morbidity|perineal morbidity
70852|NCT02841293|cost-utility analysis|cost-utility analysis
70853|NCT02841293|biological meshes|biological meshes
70854|NCT02841241|esmolol|esmolol
70855|NCT02841241|adrenergic storm|adrenergic storm
70856|NCT02841241|septic shock|septic shock
70857|NCT02841228|SIB-IMRT|sib-imrt
70858|NCT02841228|NSCLC|nsclc
70859|NCT02841228|Radiochemothearpy|radiochemothearpy
70860|NCT02841215|Gale|gale
70861|NCT02841215|Severe forms of scabies|severe forms of scabies
70862|NCT02841215|Oral parasitic drug|oral parasitic drug
70863|NCT02841215|Ivermectin|ivermectin
70864|NCT02841202|optical coherence tomography|optical coherence tomography
70865|NCT02841202|oral contraceptive pills|oral contraceptive pills
70866|NCT02841163|Magnetic Resonance Imaging|magnetic resonance imaging
70867|NCT02841163|Patient Satisfaction|patient satisfaction
70868|NCT02841163|Numeric Rating Scale|numeric rating scale
70869|NCT02841124|Decision making|decision making
70870|NCT02841098|Carotid stenosis,stroke,endarterectomy,medical therapy|carotid stenosis,stroke,endarterectomy,medical therapy
70871|NCT02841085|Genetic|genetic
70872|NCT02841085|Thrombophilia|thrombophilia
70873|NCT02841059|quality of life|quality of life
70874|NCT02841059|urinary incontinence|urinary incontinence
70876|NCT02841046|stroke volume variation|stroke volume variation
70877|NCT02841046|cardiac index|cardiac index
70878|NCT02841046|non-severe patients|non-severe patients
70879|NCT02841046|gastrointestinal surgery|gastrointestinal surgery
70880|NCT02840955|Atopic dermatitis|atopic dermatitis
70881|NCT02840955|Staphylococcus aureus|staphylococcus aureus
70882|NCT02840955|Microbiome|microbiome
70883|NCT02840955|Staphefekt|staphefekt
70884|NCT02840942|intravenous line|intravenous line
70885|NCT02840942|robot|robot
70886|NCT02840916|Laser acupuncture|laser acupuncture
70887|NCT02840916|Postpartum weight retention|postpartum weight retention
70888|NCT02840916|Obesity|obesity
70889|NCT02840903|CTA|cta
70890|NCT02840903|Computed Tomographic Angiography|computed tomographic angiography
70891|NCT02840877|tuberculosis culture|tuberculosis culture
70892|NCT02840877|alcohol use|alcohol use
70893|NCT02840851|Magnetic Resonance Imaging|magnetic resonance imaging
70894|NCT02840851|Transcranial Doppler Ultrasound|transcranial doppler ultrasound
70895|NCT02840851|Hypercapnia|hypercapnia
70896|NCT02840799|Heart Failure|heart failure
70897|NCT02840799|Exercise Intolerance|exercise intolerance
70898|NCT02840799|Ejection Fraction|ejection fraction
70899|NCT02840786|stents|stents
70900|NCT02840786|atherectomy|atherectomy
70901|NCT02840786|femoral artery|femoral artery
70902|NCT02840786|popliteal artery|popliteal artery
70903|NCT02840773|RANKL|rankl
70904|NCT02840773|OPG|opg
70905|NCT02840773|Peri-implant crevicular fluid|peri-implant crevicular fluid
70906|NCT02840760|tardive dyskinesia.|tardive dyskinesia.
70907|NCT02840760|rTMS|rtms
70908|NCT02840747|Lymphomatoid Papulosis|lymphomatoid papulosis
70909|NCT02840747|Sézary Syndrome|sézary syndrome
70910|NCT02840747|T-Cell Lymphoma|t-cell lymphoma
70911|NCT02840734|Kinesio taping|kinesio taping
70912|NCT02840734|Obese adults|obese adults
70913|NCT02840734|Muscular function|muscular function
70914|NCT02840734|Fatigue|fatigue
70915|NCT02840682|resource limited setting|resource limited setting
70916|NCT02840682|Thailand-Myanmar border|thailand-myanmar border
70917|NCT02840669|Cardiomyopathy|cardiomyopathy
70918|NCT02840643|hemispherectomy|hemispherectomy
70920|NCT02840643|hand function|hand function
70921|NCT02840630|n3 LC-PUFA|n3 lc-pufa
70922|NCT02840630|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
70923|NCT02840630|South Asian|south asian
70924|NCT02840630|HbA1c|hba1c
70925|NCT02840630|Omega 3 status|omega 3 status
70926|NCT02840617|ICG|icg
70927|NCT02840617|prostate cancer|prostate cancer
70928|NCT02840591|Citicoline, Ramelteon, Rozerem|citicoline, ramelteon, rozerem
70929|NCT02840539|Mantle cell lymphoma|mantle cell lymphoma
70930|NCT02840539|Bortezomib|bortezomib
70931|NCT02840539|Cytarabine|cytarabine
70932|NCT02840526|PVB|pvb
70933|NCT02840526|PCA|pca
70934|NCT02840526|nephrectomy|nephrectomy
70935|NCT02840526|postoperative pain|postoperative pain
70936|NCT02840513|Smartphone app|smartphone app
70937|NCT02840513|CO self-monitoring|co self-monitoring
70938|NCT02840500|Breakthrough Cancer Pain|breakthrough cancer pain
70939|NCT02840500|Quality of life|quality of life
70940|NCT02840500|Palliative Care Units|palliative care units
70941|NCT02840487|Zika Infection|zika infection
70942|NCT02840487|Flavivirus|flavivirus
70943|NCT02840487|Vaccine-Mediated Protection|vaccine-mediated protection
70944|NCT02840487|Immune Response|immune response
70945|NCT02840487|Arthropod-Borne Virus|arthropod-borne virus
70946|NCT02840474|HIV Viral Load|hiv viral load
70947|NCT02840474|Antiviral|antiviral
70948|NCT02840474|CD4 Count|cd4 count
70949|NCT02840474|HIV-1 Infection|hiv-1 infection
70950|NCT02840448|Williams Syndrome|williams syndrome
70951|NCT02840448|Blood Flow|blood flow
70952|NCT02840448|Brain|brain
70953|NCT02840448|Arterial Stiffness|arterial stiffness
70954|NCT02840435|Nicotine addiction|nicotine addiction
70955|NCT02840435|Cigarette smoking|cigarette smoking
70956|NCT02840422|Hyaluronic acid|hyaluronic acid
70957|NCT02840422|Knee osteoarthritis|knee osteoarthritis
70958|NCT02840422|Quality of life|quality of life
70959|NCT02840396|language|language
70960|NCT02840396|DLPFC|dlpfc
70961|NCT02840396|rTMS|rtms
70962|NCT02840396|Executive Functions|executive functions
70963|NCT02840370|transcranial direct current stimulation|transcranial direct current stimulation
70964|NCT02840370|aphasia|aphasia
70965|NCT02840370|language production|language production
70966|NCT02840370|prefrontal cortex|prefrontal cortex
70967|NCT02840357|Chronic inflammation|chronic inflammation
70968|NCT02840357|Adults|adults
70969|NCT02840357|overweight|overweight
70970|NCT02840357|obese|obese
70971|NCT02840344|Couple Functioning|couple functioning
70972|NCT02840344|Stress Reduction|stress reduction
70973|NCT02840331|Gastric carcinoma|gastric carcinoma
70974|NCT02840331|Peritoneal carcinomatosis|peritoneal carcinomatosis
70975|NCT02840331|Photodynamic diagnosis|photodynamic diagnosis
70976|NCT02840331|Photodynamic therapy|photodynamic therapy
70977|NCT02840331|St. John's Wort|st. john's wort
70978|NCT02840331|Peritoneal metastasis|peritoneal metastasis
70979|NCT02840318|Terminal care|terminal care
70980|NCT02840318|Residential facilities|residential facilities
70981|NCT02840318|Integrated health care systems|integrated health care systems
70982|NCT02840318|Interdisciplinary health team|interdisciplinary health team
70983|NCT02840318|Palliative care|palliative care
70984|NCT02840305|Natural scenes|natural scenes
70985|NCT02840305|Brain bases|brain bases
70986|NCT02840305|Visual perception|visual perception
70987|NCT02840305|MRI|mri
70988|NCT02840292|Late Preterms|late preterms
70989|NCT02840292|Neurobehavioral Assessment of Preterm Infants (NAPI)|neurobehavioral assessment of preterm infants (napi)
70990|NCT02840279|cognition|cognition
70991|NCT02840279|dementia|dementia
70992|NCT02840279|phosphodiesterase type 4D|phosphodiesterase type 4d
70993|NCT02840279|PDE4D|pde4d
70994|NCT02840227|Cancer|cancer
70995|NCT02840227|General anesthesia|general anesthesia
70996|NCT02840227|Epidural anesthesia|epidural anesthesia
70997|NCT02840201|biomarkers|biomarkers
70998|NCT02840188|goalkeeper's fracture|goalkeeper's fracture
70999|NCT02840175|Treatment tapering|treatment tapering
71000|NCT02840175|Oligoarticular|oligoarticular
71001|NCT02840175|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
71002|NCT02840175|Inactive disease|inactive disease
71003|NCT02840175|Biologic therapy|biologic therapy
71004|NCT02840162|prostate cancer|prostate cancer
71005|NCT02840162|NSAIDs|nsaids
71006|NCT02840162|chemoprevention|chemoprevention
71007|NCT02840162|celecoxib|celecoxib
71008|NCT02840162|COX-2 inhibitors|cox-2 inhibitors
71009|NCT02840149|68Ga-DOTA-TATE, PET/CT|68ga-dota-tate, pet/ct
71010|NCT02840136|Respiratory infection|respiratory infection
71011|NCT02840136|Antibiotic therapy|antibiotic therapy
71012|NCT02840136|LC-MS/MS|lc-ms/ms
71013|NCT02840136|Sputum antibiotic concentrations|sputum antibiotic concentrations
71014|NCT02840097|Brain injuries|brain injuries
71015|NCT02840097|Wounds and injuries|wounds and injuries
71016|NCT02840097|Hemorrhage|hemorrhage
71017|NCT02840097|Tranexamic acid|tranexamic acid
71018|NCT02840097|Child|child
71019|NCT02840084|breast implant capsular contracture|breast implant capsular contracture
71020|NCT02840045|electroencephalography (EEG)|electroencephalography (eeg)
71021|NCT02840019|Fetal MRI|fetal mri
71022|NCT02840019|Pregnancy|pregnancy
71023|NCT02840019|Pregnant Women|pregnant women
71024|NCT02840019|MRI Coil|mri coil
71025|NCT02840019|MRI Sequence Development/Testing|mri sequence development/testing
71026|NCT02840019|Abnormal Fetuses|abnormal fetuses
71027|NCT02840019|Typically Developing Fetuses|typically developing fetuses
71028|NCT02840019|Fetal MRI Technology Development|fetal mri technology development
71029|NCT02840006|Vasoconstrictor Agents|vasoconstrictor agents
71030|NCT02840006|Vasodilator Agents|vasodilator agents
71031|NCT02839993|tDCS effects|tdcs effects
71032|NCT02839993|associative learning|associative learning
71033|NCT02839980|oropharyngeal colonization|oropharyngeal colonization
71034|NCT02839915|Language Impairment|language impairment
71035|NCT02839850|Arthroplasty|arthroplasty
71036|NCT02839850|replacement|replacement
71037|NCT02839850|Knee|knee
71038|NCT02839850|function|function
71039|NCT02839850|radiographic|radiographic
71040|NCT02839850|survivorship|survivorship
71041|NCT02839837|Depression|depression
71042|NCT02839837|Depressive Disorder|depressive disorder
71043|NCT02839837|Exercise|exercise
71044|NCT02839837|Neuroplasticity|neuroplasticity
71045|NCT02839837|Non-invasive brain stimulation|non-invasive brain stimulation
71046|NCT02839837|Healthy Control|healthy control
71047|NCT02839824|bowel cleansing|bowel cleansing
71048|NCT02839824|bowel preparation|bowel preparation
71049|NCT02839811|Betalactams|betalactams
71050|NCT02839811|In vitro diagnosis|in vitro diagnosis
71051|NCT02839798|sTMS|stms
71052|NCT02839798|NEST|nest
71053|NCT02839798|NeoSync|neosync
71054|NCT02839798|synchronous|synchronous
71055|NCT02839798|non-invasive neuromodulation|non-invasive neuromodulation
71056|NCT02839798|TMS|tms
71057|NCT02839798|transcranial magnetic stimulation|transcranial magnetic stimulation
71058|NCT02839798|EEG|eeg
71059|NCT02839798|bipolar|bipolar
71060|NCT02839798|depression|depression
71061|NCT02839785|Cerebral palsy|cerebral palsy
71062|NCT02839785|Physiotherapy|physiotherapy
71063|NCT02839785|Children|children
71064|NCT02839785|Ibuprofen|ibuprofen
71065|NCT02839785|Pain|pain
71066|NCT02839785|Anxiety|anxiety
71067|NCT02839772|podoconiosis|podoconiosis
71068|NCT02839772|glycerine|glycerine
71069|NCT02839772|RCT|rct
71070|NCT02839772|SBF|sbf
71071|NCT02839772|TEWL|tewl
71072|NCT02839772|SC hydration|sc hydration
71073|NCT02839759|Hearing loss|hearing loss
71074|NCT02839759|Presbycusis|presbycusis
71075|NCT02839759|Aging|aging
71076|NCT02839759|Teleaudiology|teleaudiology
71077|NCT02839733|Brain Imaging|brain imaging
71078|NCT02839733|Adult|adult
71079|NCT02839733|DNA Testing|dna testing
71080|NCT02839733|Children|children
71081|NCT02839694|Lung Resection|lung resection
71082|NCT02839694|Surgery|surgery
71083|NCT02839694|Bilateral Lung Metastases|bilateral lung metastases
71084|NCT02839681|Lung Adenocarcinoma|lung adenocarcinoma
71085|NCT02839681|Immunotoxin|immunotoxin
71086|NCT02839681|Immunotherapy|immunotherapy
71087|NCT02839668|breast cancer|breast cancer
71088|NCT02839668|angiogenesis|angiogenesis
71089|NCT02839668|VEGF|vegf
71090|NCT02839603|Visceral leishmaniasis|visceral leishmaniasis
71091|NCT02839603|HIV co-infection|hiv co-infection
71092|NCT02839603|Asymptomatic|asymptomatic
71093|NCT02839590|Glaucoma|glaucoma
71094|NCT02839590|Ocular hypertension|ocular hypertension
71095|NCT02839590|Aqueous dynamics|aqueous dynamics
71096|NCT02839564|chronic abdominal pain|chronic abdominal pain
71097|NCT02839564|laparoscopic adhesiolysis|laparoscopic adhesiolysis
71098|NCT02839564|placebo|placebo
71099|NCT02839551|Betalactams|betalactams
71100|NCT02839551|Drug hypersensitivity|drug hypersensitivity
71101|NCT02839551|Drug provocation test|drug provocation test
71102|NCT02839551|Reactive dose|reactive dose
71103|NCT02839538|infiltration|infiltration
71104|NCT02839538|hemorrhoidectomy|hemorrhoidectomy
71105|NCT02839538|postoperative pain|postoperative pain
71106|NCT02839525|Eccentric exercise|eccentric exercise
71107|NCT02839525|Dietary supplement|dietary supplement
71108|NCT02839525|Muscle damage|muscle damage
71109|NCT02839499|seniors|seniors
71110|NCT02839499|mixed food|mixed food
71111|NCT02839499|normal texture food|normal texture food
71112|NCT02839486|antibiotic prophylaxis|antibiotic prophylaxis
71113|NCT02839486|pharmacokinetics|pharmacokinetics
71114|NCT02839486|cardiopulmonary bypass|cardiopulmonary bypass
71115|NCT02839447|semen|semen
71116|NCT02839447|sperm|sperm
71117|NCT02839447|oxidative stress|oxidative stress
71118|NCT02839447|reactive oxygen species|reactive oxygen species
71119|NCT02839447|idiopathic male infertility|idiopathic male infertility
71120|NCT02839408|periodontitis|periodontitis
71121|NCT02839408|azithromycin|azithromycin
71122|NCT02839408|probiotic|probiotic
71123|NCT02839395|screen illumination|screen illumination
71125|NCT02839395|body temperature|body temperature
71126|NCT02839395|cognitive functioning|cognitive functioning
71127|NCT02839395|light pollution|light pollution
71128|NCT02839369|walking performance|walking performance
71129|NCT02839369|Cerebral Palsy, Typically Developed|cerebral palsy, typically developed
71130|NCT02839330|Influenza|influenza
71131|NCT02839330|Vaccine|vaccine
71133|NCT02839330|Avian|avian
71134|NCT02839330|Pandemic|pandemic
71135|NCT02839330|H5N1|h5n1
71136|NCT02839330|MF59|mf59
71137|NCT02839317|Dysbiosis|dysbiosis
71138|NCT02839317|Crohn's disease|crohn's disease
71139|NCT02839317|Age|age
71140|NCT02839278|Immunomodulation|immunomodulation
71141|NCT02839226|ulcers|ulcers
71142|NCT02839226|wounds|wounds
71143|NCT02839226|diabetes|diabetes
71144|NCT02839226|venous ulcers|venous ulcers
71145|NCT02839226|arterial ulcers|arterial ulcers
71146|NCT02839226|granulation tissue|granulation tissue
71147|NCT02839226|protein kinase c|protein kinase c
71148|NCT02839200|Insomnia|insomnia
71149|NCT02839200|Polysomnography|polysomnography
71150|NCT02839174|low carbohydrate diet|low carbohydrate diet
71151|NCT02839161|Hookworm|hookworm
71152|NCT02839161|Vaccine|vaccine
71153|NCT02839161|Na-GST-1|na-gst-1
71154|NCT02839161|Na-APR-1|na-apr-1
71155|NCT02839161|Necator americanus|necator americanus
71156|NCT02839148|Appetite, Stunting, Satiety, Children|appetite, stunting, satiety, children
71157|NCT02839122|Dutasteride|dutasteride
71158|NCT02839122|Tadalafil|tadalafil
71159|NCT02839070|Sleep|sleep
71160|NCT02839070|Learning|learning
71161|NCT02839070|Circadian Rhythms|circadian rhythms
71162|NCT02839057|Axis fractures|axis fractures
71163|NCT02839057|Elderly|elderly
71164|NCT02839057|Mortality|mortality
71165|NCT02839057|Surgical treatment|surgical treatment
71166|NCT02839031|diabetes mellitus|diabetes mellitus
71167|NCT02839031|glycaemia|glycaemia
71168|NCT02839031|cognitive-behavioral treatment|cognitive-behavioral treatment
71169|NCT02839031|coping|coping
71170|NCT02839031|parents|parents
71171|NCT02839031|children|children
71172|NCT02839005|Wound Closure Thechnical|wound closure thechnical
71173|NCT02839005|Wound Healing|wound healing
71174|NCT02838992|Cyclophosphamide|cyclophosphamide
71175|NCT02838992|Umbilical Cord Blood|umbilical cord blood
71176|NCT02838992|ATG|atg
71177|NCT02838979|Glutamine|glutamine
71178|NCT02838979|Chronic Kidney Disease|chronic kidney disease
71179|NCT02838966|immunomodulation|immunomodulation
71180|NCT02838966|immunonutrition|immunonutrition
71181|NCT02838953|Ultrasonography|ultrasonography
71182|NCT02838953|Respiratory Function Tests|respiratory function tests
71183|NCT02838953|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
71184|NCT02838953|Rehabilitation|rehabilitation
71185|NCT02838927|Hypoparathyroidism|hypoparathyroidism
71186|NCT02838927|Epidemiology|epidemiology
71187|NCT02838927|Medication Therapy Management|medication therapy management
71188|NCT02838914|Right atrium|right atrium
71189|NCT02838914|Echocardiography|echocardiography
71190|NCT02838914|Remodeling|remodeling
71191|NCT02838888|Adenoma|adenoma
71192|NCT02838888|computer|computer
71193|NCT02838888|automatic|automatic
71194|NCT02838888|polyp|polyp
71195|NCT02838888|detection|detection
71196|NCT02838862|Neuroendocrine Tumors|neuroendocrine tumors
71197|NCT02838862|MALDI-MS|maldi-ms
71198|NCT02838862|Proteomics|proteomics
71199|NCT02838862|Biomarkers, Tumor|biomarkers, tumor
71200|NCT02838862|Precision Medicine|precision medicine
71201|NCT02838836|Cancer|cancer
71202|NCT02838836|Circulating tumor cells (CTCs)|circulating tumor cells (ctcs)
71203|NCT02838836|Disseminated tumor cells (DTCs)|disseminated tumor cells (dtcs)
71204|NCT02838836|Circulating tumor DNA (ctDNA)|circulating tumor dna (ctdna)
71205|NCT02838823|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
71206|NCT02838823|triple negative breast cancer|triple negative breast cancer
71207|NCT02838823|safety|safety
71208|NCT02838810|peginterferon alfa|peginterferon alfa
71209|NCT02838810|Chronic Hepatitis B|chronic hepatitis b
71210|NCT02838797|Parkinson's disease|parkinson's disease
71211|NCT02838797|Gastroparesis|gastroparesis
71212|NCT02838797|Constipation|constipation
71213|NCT02838797|Prokinetic|prokinetic
71214|NCT02838797|5-HT4-receptor partial agonist|5-ht4-receptor partial agonist
71215|NCT02838771|Swallowing Disorder|swallowing disorder
71216|NCT02838771|Dysphagia|dysphagia
71217|NCT02838758|Morton's neuroma|morton's neuroma
71218|NCT02838758|Intermetatarsal neuroma|intermetatarsal neuroma
71219|NCT02838758|forefoot pain|forefoot pain
71220|NCT02838758|ultrasound guided cryoablation|ultrasound guided cryoablation
71221|NCT02838758|ultrasound guided perineural lidocaine injection|ultrasound guided perineural lidocaine injection
71222|NCT02838706|postoperative anemia|postoperative anemia
71223|NCT02838706|perfusion index|perfusion index
71224|NCT02838680|aortic stenosis|aortic stenosis
71225|NCT02838680|transcatheter aortic valve replacement (TAVR)|transcatheter aortic valve replacement (tavr)
71226|NCT02838654|cervical epidural space|cervical epidural space
71227|NCT02838654|wave form analysis|wave form analysis
71228|NCT02838615|spinal stenosis|spinal stenosis
71229|NCT02838615|epidural steroid injection|epidural steroid injection
71230|NCT02838602|carbon ions therapy|carbon ions therapy
71231|NCT02838602|radiotherapy|radiotherapy
71232|NCT02838602|radioresistant tumors|radioresistant tumors
71233|NCT02838602|cancer|cancer
71234|NCT02838602|randomized trial|randomized trial
71235|NCT02838589|Cerebrovascular Stroke|cerebrovascular stroke
71236|NCT02838589|Ischemic Stroke|ischemic stroke
71237|NCT02838589|Glucagon like peptide - 1|glucagon like peptide - 1
71238|NCT02838563|Dementia|dementia
71239|NCT02838563|Alzheimer|alzheimer
71240|NCT02838563|Well-Being|well-being
71241|NCT02838550|Physical Activity|physical activity
71242|NCT02838550|Motivational Online Intervention|motivational online intervention
71243|NCT02838550|Pedometers|pedometers
71244|NCT02838537|Triptan|triptan
71245|NCT02838537|Drug utilization|drug utilization
71246|NCT02838537|Elderly|elderly
71247|NCT02838537|Drug abuse|drug abuse
71248|NCT02838537|Cardiovascular disease|cardiovascular disease
71249|NCT02838524|Spontaneous Breathing Trial|spontaneous breathing trial
71250|NCT02838524|Inspiratory Effort|inspiratory effort
71251|NCT02838524|Mechanical Ventilation|mechanical ventilation
71252|NCT02838524|Respiratory muscle load-capacity balance|respiratory muscle load-capacity balance
71253|NCT02838498|ERCP|ercp
71254|NCT02838498|EMS|ems
71255|NCT02838498|Cannulation|cannulation
71256|NCT02838498|Successful rate|successful rate
71257|NCT02838498|Trainee|trainee
71258|NCT02838407|Chronic lower respiratory tract infection|chronic lower respiratory tract infection
71259|NCT02838407|Bonchoalveolar lavage|bonchoalveolar lavage
71260|NCT02838407|Nasopharyngeal swabs|nasopharyngeal swabs
71261|NCT02838290|Burnout|burnout
71262|NCT02838290|Psychiatric morbidity|psychiatric morbidity
71263|NCT02838290|Anxiety|anxiety
71264|NCT02838290|Grief|grief
71265|NCT02838290|Alcohol and drug use|alcohol and drug use
71266|NCT02838277|lymphatic vessels|lymphatic vessels
71267|NCT02838277|leaky vessels|leaky vessels
71268|NCT02838277|hypertrophic adipocyte|hypertrophic adipocyte
71269|NCT02838212|adverse drug reaction|adverse drug reaction
71270|NCT02838212|hospital mortality|hospital mortality
71271|NCT02838212|incidence|incidence
71272|NCT02838199|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
71273|NCT02838199|TAVR|tavr
71274|NCT02838199|TAVI|tavi
71275|NCT02838199|SAVR|savr
71276|NCT02838186|colonoscopy|colonoscopy
71277|NCT02838186|right colon retroflexion|right colon retroflexion
71278|NCT02838186|adenoma detection rate|adenoma detection rate
71279|NCT02838186|feasibility|feasibility
71280|NCT02838186|surveillance interval|surveillance interval
71281|NCT02838160|educational strategies|educational strategies
71283|NCT02838160|psychological and clinical outcomes|psychological and clinical outcomes
71284|NCT02838160|intensive care unit|intensive care unit
71285|NCT02838160|follow-up study|follow-up study
71286|NCT02838160|RCT|rct
71287|NCT02838134|Laparoscopic donor nephrectomy|laparoscopic donor nephrectomy
71288|NCT02838134|Early quality of recovery|early quality of recovery
71289|NCT02838121|bisphosphonate|bisphosphonate
71290|NCT02838121|Total hip replacement|total hip replacement
71291|NCT02838121|functional outcomes|functional outcomes
71292|NCT02838121|bone mineral density|bone mineral density
71293|NCT02838095|nap|nap
71294|NCT02838095|sleep restriction|sleep restriction
71295|NCT02838095|recovery sleep|recovery sleep
71296|NCT02838095|cognitive performance|cognitive performance
71297|NCT02838095|subjective sleepiness|subjective sleepiness
71298|NCT02838095|mood|mood
71299|NCT02838095|neurobehavioural functions|neurobehavioural functions
71300|NCT02838082|traumatic brain injury|traumatic brain injury
71301|NCT02838082|sleep-wake cycle disturbance|sleep-wake cycle disturbance
71302|NCT02838082|circadian disruption|circadian disruption
71303|NCT02838056|anesthesia, epidural|anesthesia, epidural
71304|NCT02838056|skin temperature|skin temperature
71305|NCT02838030|Preeclampsia|preeclampsia
71306|NCT02838030|L-arginine|l-arginine
71307|NCT02838004|Refractive lens exchange (RLE) or cataract surgery|refractive lens exchange (rle) or cataract surgery
71308|NCT02837991|Kidney Cancer|kidney cancer
71309|NCT02837991|Celldex|celldex
71310|NCT02837991|Dose Escalation|dose escalation
71311|NCT02837978|Arthritis, Rheumatoid|arthritis, rheumatoid
71312|NCT02837978|Tacrolimus|tacrolimus
71313|NCT02837978|Treatment outcome|treatment outcome
71314|NCT02837978|Safety|safety
71315|NCT02837952|Ibuprofen, acetaminophen, pain, molar extraction|ibuprofen, acetaminophen, pain, molar extraction
71316|NCT02837913|Perioperative Warming|perioperative warming
71317|NCT02837887|Cancer|cancer
71318|NCT02837887|Depression|depression
71319|NCT02837874|Gastric cancer|gastric cancer
71320|NCT02837874|gastrojejunostomy|gastrojejunostomy
71321|NCT02837874|isoperistaltic|isoperistaltic
71322|NCT02837874|antiperistaltic|antiperistaltic
71323|NCT02837861|Metabolic Support|metabolic support
71324|NCT02837861|Nutritional Support|nutritional support
71325|NCT02837861|Neuro-endocrine Event|neuro-endocrine event
71326|NCT02837861|Enteral feedings|enteral feedings
71327|NCT02837861|Parenteral feeding|parenteral feeding
71328|NCT02837848|Rotator Cuff Tendinopathy|rotator cuff tendinopathy
71329|NCT02837848|Exercises|exercises
71330|NCT02837848|Coactivation|coactivation
71331|NCT02837848|Strengthening|strengthening
71332|NCT02837822|Spinal Cord Stimulation|spinal cord stimulation
71333|NCT02837822|Quantitative Sensory Testing|quantitative sensory testing
71334|NCT02837809|low-dose computed tomography|low-dose computed tomography
71335|NCT02837809|lung|lung
71336|NCT02837809|randomized controlled trial|randomized controlled trial
71337|NCT02837809|neoplasms|neoplasms
71338|NCT02837809|screening|screening
71339|NCT02837809|smoking|smoking
71340|NCT02837770|pain|pain
71341|NCT02837770|intravitreal injection|intravitreal injection
71342|NCT02837770|anti-VEGF|anti-vegf
71343|NCT02837770|diclofenac eye drops|diclofenac eye drops
71344|NCT02837770|oral diclofenac|oral diclofenac
71345|NCT02837770|Short Form of McGill Pain Questionnaire|short form of mcgill pain questionnaire
71346|NCT02837653|cardiovascular Risk|cardiovascular risk
83110|NCT02767908|Tobacco|tobacco
71347|NCT02837640|Retinitis Pigmentosa|retinitis pigmentosa
71348|NCT02837640|Levodopa|levodopa
71349|NCT02837627|gastroesophageal reflux|gastroesophageal reflux
71350|NCT02837627|tube enteral feeding|tube enteral feeding
71351|NCT02837627|preterm infants|preterm infants
71352|NCT02837601|Laparoscopic surgical procedures|laparoscopic surgical procedures
71353|NCT02837601|Shoulder Pain|shoulder pain
71354|NCT02837601|Abdominal Pain|abdominal pain
71355|NCT02837601|Pediatrics|pediatrics
71356|NCT02837588|chronic pelvic pain|chronic pelvic pain
71357|NCT02837588|trigger points|trigger points
71358|NCT02837588|hiperthermy|hiperthermy
71359|NCT02837575|HSV-2|hsv-2
71360|NCT02837575|Genital Herpes|genital herpes
71361|NCT02837575|Herpes|herpes
71362|NCT02837575|Herpes Simplex Virus, Type 2|herpes simplex virus, type 2
71363|NCT02837562|Radiation exposure|radiation exposure
71364|NCT02837562|Cardiac catheterization|cardiac catheterization
71365|NCT02837523|Lysosomal Storage Diseases|lysosomal storage diseases
71366|NCT02837497|pediatric|pediatric
71367|NCT02837497|heart arrest|heart arrest
71368|NCT02837471|Pedometer usability|pedometer usability
71369|NCT02837471|Usability and feasibility|usability and feasibility
71370|NCT02837471|web application|web application
71371|NCT02837458|Electric current|electric current
71372|NCT02837458|Nerve block|nerve block
71373|NCT02837458|somatosensory evaluation|somatosensory evaluation
71374|NCT02837432|Depression|depression
71375|NCT02837432|Cortisol|cortisol
71376|NCT02837432|Sadness|sadness
71377|NCT02837432|Genetics|genetics
71378|NCT02837432|Stress|stress
71379|NCT02837419|extracorporeal life support|extracorporeal life support
71380|NCT02837419|health related quality of life|health related quality of life
71381|NCT02837380|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
71382|NCT02837380|Long-acting beta2 agonist|long-acting beta2 agonist
71383|NCT02837380|Dry powder inhaler|dry powder inhaler
71384|NCT02837380|Inhaled corticosteroid|inhaled corticosteroid
71385|NCT02837367|nutrigenetics|nutrigenetics
71386|NCT02837367|medical foods|medical foods
71387|NCT02837367|obesity|obesity
71388|NCT02837367|children|children
71389|NCT02837367|adults|adults
71390|NCT02837354|Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy|cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
72179|NCT02832401|psychosis|psychosis
71391|NCT02837341|medical device|medical device
71392|NCT02837328|Magnesium Supplementation|magnesium supplementation
71393|NCT02837328|Magnesium|magnesium
71394|NCT02837328|Dietary Supplement|dietary supplement
71395|NCT02837328|Arrhythmia|arrhythmia
71396|NCT02837302|Liver cirrhosis|liver cirrhosis
71397|NCT02837302|Branched chain amino acid|branched chain amino acid
71398|NCT02837302|End-Stage Liver Disease score|end-stage liver disease score
71399|NCT02837289|patellofemoral pain syndrome|patellofemoral pain syndrome
71400|NCT02837289|therapy taping|therapy taping
71401|NCT02837289|knee|knee
71402|NCT02837289|physical therapy|physical therapy
71403|NCT02837289|runners|runners
71404|NCT02837276|Intermittent Hypoxemia|intermittent hypoxemia
71405|NCT02837276|Acute Kidney Injury|acute kidney injury
71406|NCT02837276|Preterm infant|preterm infant
71407|NCT02837250|HIV|hiv
71408|NCT02837250|Substance Use|substance use
71409|NCT02837224|retained surgical sponge|retained surgical sponge
71410|NCT02837224|adverse event|adverse event
71411|NCT02837185|Cervical dystonia|cervical dystonia
71412|NCT02837185|Transcranial magnetic stimulation|transcranial magnetic stimulation
71413|NCT02837185|Electromyography|electromyography
71414|NCT02837185|TMS|tms
71415|NCT02837185|EMG|emg
71416|NCT02837159|colorectal cancer|colorectal cancer
71417|NCT02837159|Health Life Style Habits|health life style habits
71418|NCT02837159|Health|health
71419|NCT02837146|RA|ra
71420|NCT02837120|retrospective study|retrospective study
71421|NCT02837120|acute myocardial infarction|acute myocardial infarction
71422|NCT02837120|acute aortic dissection|acute aortic dissection
71423|NCT02837120|pulmonary embolism|pulmonary embolism
71424|NCT02837120|unstable angina|unstable angina
71425|NCT02837068|Hemiplegia|hemiplegia
71426|NCT02837068|shoulder pain|shoulder pain
71427|NCT02837068|wheelchair|wheelchair
71429|NCT02837068|rehabilitation|rehabilitation
71430|NCT02837055|intubation, intratracheal|intubation, intratracheal
71431|NCT02837055|critical care|critical care
71432|NCT02837042|penile cancer|penile cancer
71433|NCT02837042|Pembrolizumab|pembrolizumab
71434|NCT02837042|penile squamous cell carcinoma|penile squamous cell carcinoma
71435|NCT02837042|squamous cell cancer|squamous cell cancer
71436|NCT02837016|Self-Control|self-control
71437|NCT02837016|Biofeedback|biofeedback
71438|NCT02837016|Respiration|respiration
71439|NCT02837003|Drug-Eluting Stent|drug-eluting stent
71440|NCT02836977|tegafur-uracil|tegafur-uracil
71441|NCT02836925|hepatitis C|hepatitis c
71442|NCT02836925|NHL|nhl
71443|NCT02836925|Indolent B-cell lymphoma|indolent b-cell lymphoma
71444|NCT02836912|Rehabilitation|rehabilitation
71445|NCT02836899|acute kidney injury; nitric oxide; cardiopulmonary bypass; endothelial dysfunction; cardiac surgery|acute kidney injury; nitric oxide; cardiopulmonary bypass; endothelial dysfunction; cardiac surgery
71446|NCT02836834|immunotherapy|immunotherapy
71447|NCT02836834|check point inhibitor|check point inhibitor
71448|NCT02836834|PD-1 antibody|pd-1 antibody
71449|NCT02836834|solid tumor|solid tumor
71450|NCT02836834|lymphoma|lymphoma
71451|NCT02836834|phase 1 trial|phase 1 trial
71452|NCT02836808|Multidisciplinary interventions|multidisciplinary interventions
71453|NCT02836808|Long term control|long term control
71454|NCT02836808|Empowerment|empowerment
71455|NCT02836795|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
71456|NCT02836795|advanced solid tumors|advanced solid tumors
71457|NCT02836795|safety|safety
71458|NCT02836782|HIV/HCV|hiv/hcv
71459|NCT02836782|Antiretroviral therapy|antiretroviral therapy
71460|NCT02836782|HIV-DNA|hiv-dna
71461|NCT02836782|Direct acting antiviral|direct acting antiviral
71462|NCT02836769|Rehabilitation|rehabilitation
71463|NCT02836769|Head and neck cancer|head and neck cancer
71464|NCT02836769|Quality of life|quality of life
71465|NCT02836769|self-efficacy|self-efficacy
71466|NCT02836743|REM sleep behavior disorder|rem sleep behavior disorder
71467|NCT02836743|Melatonin|melatonin
71468|NCT02836717|sacral nerve modulation|sacral nerve modulation
71469|NCT02836717|quality of life|quality of life
71470|NCT02836717|stimulator maintenance|stimulator maintenance
71475|NCT02836691|Stress|stress
71476|NCT02836665|Emergency Room|emergency room
71477|NCT02836665|Manchester Triage System|manchester triage system
71478|NCT02836665|Telemedicine|telemedicine
71479|NCT02836665|Patients|patients
71480|NCT02836652|HeartMate II (HMII)|heartmate ii (hmii)
71481|NCT02836652|Left Ventricular Assist Device (LVAD)|left ventricular assist device (lvad)
71482|NCT02836600|notch inhibitor|notch inhibitor
71483|NCT02836548|advanced melanoma|advanced melanoma
71484|NCT02836548|BRAF V600 mutation|braf v600 mutation
71485|NCT02836548|vorinostat|vorinostat
71486|NCT02836548|HDAC inhibitor|hdac inhibitor
71487|NCT02836535|complications|complications
71488|NCT02836535|surgery|surgery
71489|NCT02836522|Health-Related Symptom Index|health-related symptom index
71490|NCT02836522|ANCHOR( ANal Cancer HSIL (high grade squamous intraepithelial lesions) Outcomes Research study)|anchor( anal cancer hsil (high grade squamous intraepithelial lesions) outcomes research study)
71491|NCT02836509|Low Back Pain|low back pain
71492|NCT02836509|Ibuprofen|ibuprofen
71493|NCT02836509|Paracetamol|paracetamol
71494|NCT02836509|Emergency Medicine|emergency medicine
71500|NCT02836470|Post-operative Ileus|post-operative ileus
71501|NCT02836470|Post-Operative Abdominal Adhesions|post-operative abdominal adhesions
71502|NCT02836470|Return of Gastrointestinal Function|return of gastrointestinal function
71503|NCT02836470|Anastomosis|anastomosis
71504|NCT02836470|Enterotomy|enterotomy
71505|NCT02836470|Enterostomy|enterostomy
71506|NCT02836470|Colorectal Surgery|colorectal surgery
71507|NCT02836470|Intestines Surgery|intestines surgery
71508|NCT02836431|Pediatric|pediatric
71509|NCT02836431|Sedation|sedation
71510|NCT02836431|Dexmedetomidine|dexmedetomidine
71511|NCT02836418|FSHD|fshd
71512|NCT02836418|LGMD|lgmd
71513|NCT02836405|Autism|autism
71514|NCT02836405|ASD|asd
71515|NCT02836405|Autistic Disorder|autistic disorder
71516|NCT02836405|Pervasive Development Disorders|pervasive development disorders
71517|NCT02836405|Pervasive Child Development Disorders|pervasive child development disorders
71518|NCT02836405|Asperger's Syndrome|asperger's syndrome
71519|NCT02836405|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
71520|NCT02836405|TMS|tms
71521|NCT02836405|Autism Spectrum Disorder|autism spectrum disorder
71522|NCT02836379|Breakthrough Cancer Pain|breakthrough cancer pain
71523|NCT02836379|Quality of life|quality of life
71524|NCT02836379|Radiotherapy|radiotherapy
71525|NCT02836366|Proximal humerus|proximal humerus
71526|NCT02836366|Fracture|fracture
71527|NCT02836366|Nailing|nailing
71529|NCT02836327|MRI|mri
71530|NCT02836327|Multiple Sclerosis|multiple sclerosis
71531|NCT02836327|Neuromyelitis Optica Spectrum Disorders|neuromyelitis optica spectrum disorders
71532|NCT02836327|Multimodel|multimodel
71533|NCT02836314|Anorganic bovine bone mineral;|anorganic bovine bone mineral;
71534|NCT02836314|Graft|graft
71535|NCT02836314|Intrabony periodontal defect|intrabony periodontal defect
71536|NCT02836314|platelet rich fibrin|platelet rich fibrin
71537|NCT02836288|Ketamine|ketamine
71538|NCT02836288|Treatment of Depression|treatment of depression
71539|NCT02836275|Adnexal Diseases|adnexal diseases
71540|NCT02836275|Ovary|ovary
71541|NCT02836275|Ovarian Neoplasms|ovarian neoplasms
71542|NCT02836275|Ovarian Cysts|ovarian cysts
71543|NCT02836275|Ovarian Diseases|ovarian diseases
71544|NCT02836275|Ultrasonography|ultrasonography
71545|NCT02836275|Ultrasonography, Doppler|ultrasonography, doppler
71546|NCT02836275|Magnetic Resonance Imaging|magnetic resonance imaging
71547|NCT02836275|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
71548|NCT02836275|Diagnosis|diagnosis
71549|NCT02836275|Early Diagnosis|early diagnosis
71550|NCT02836275|Early Detection of Cancer|early detection of cancer
71551|NCT02836275|Genital Neoplasms, Female|genital neoplasms, female
71552|NCT02836275|Genital Diseases, Female|genital diseases, female
71553|NCT02836275|Urogenital Neoplasms|urogenital neoplasms
71554|NCT02836275|Cysts|cysts
71555|NCT02836275|Endocrine System Diseases|endocrine system diseases
71556|NCT02836275|Gonadal Disorders|gonadal disorders
71557|NCT02836275|Neoplasms|neoplasms
71558|NCT02836275|Endocrine Gland Neoplasms|endocrine gland neoplasms
71559|NCT02836275|International Ovarian Tumor Analysis|international ovarian tumor analysis
71560|NCT02836275|Simple Rules|simple rules
71561|NCT02836275|Preoperative Evaluation|preoperative evaluation
71562|NCT02836275|Perfusion -and Diffusion-weighted Imaging|perfusion -and diffusion-weighted imaging
71563|NCT02836275|Adnexal Masses|adnexal masses
71564|NCT02836275|Ovarian Tumors|ovarian tumors
71565|NCT02836249|Hepatitis|hepatitis
71566|NCT02836249|Tenofovir|tenofovir
71567|NCT02836249|Viread|viread
71568|NCT02836236|Hepatitis|hepatitis
71569|NCT02836236|Tenofovir|tenofovir
71570|NCT02836236|Viread|viread
71571|NCT02836210|27-gauge Pars plana vitrectomy|27-gauge pars plana vitrectomy
71572|NCT02836197|Uncertainty;hope;cancer;communication skills training;physicians|uncertainty;hope;cancer;communication skills training;physicians
71573|NCT02836184|Hemodialysis,Hyperphosphatemia,Nicotinic Acids|hemodialysis,hyperphosphatemia,nicotinic acids
71574|NCT02836119|Gut Microbiota|gut microbiota
71575|NCT02836119|Gut Microbiome|gut microbiome
71576|NCT02836119|Sleep|sleep
71577|NCT02836119|Infancy|infancy
71578|NCT02836119|Development|development
71579|NCT02836106|Healthy Volunteers|healthy volunteers
71580|NCT02836106|Obese Volunteers|obese volunteers
71581|NCT02836093|Exercise|exercise
71582|NCT02836093|Radiation Treatment|radiation treatment
71583|NCT02836093|16-941|16-941
71584|NCT02836080|Mental Health|mental health
71585|NCT02836080|Randomized|randomized
71586|NCT02836080|Pragmatic|pragmatic
71593|NCT02836054|Alzheimer's disease|alzheimer's disease
71594|NCT02836054|bipolar disorder|bipolar disorder
71595|NCT02836054|cognitive functions|cognitive functions
71596|NCT02836041|assess sleep|assess sleep
71597|NCT02836041|Sleep Deprivation|sleep deprivation
71598|NCT02836041|16-866|16-866
71599|NCT02836015|Shared Medical Visits|shared medical visits
71600|NCT02836015|Spanish-speaking|spanish-speaking
71606|NCT02835963|acute heart failure|acute heart failure
71607|NCT02835963|dyspnea|dyspnea
71608|NCT02835963|predictive value|predictive value
71609|NCT02835924|regorafenib|regorafenib
71610|NCT02835924|metastatic colorectal cancer|metastatic colorectal cancer
71611|NCT02835872|fiber|fiber
71612|NCT02835872|cholesterol|cholesterol
71613|NCT02835859|Obesity, sweet taste receptors|obesity, sweet taste receptors
71614|NCT02835846|Overactive Bladder Syndrome|overactive bladder syndrome
71615|NCT02835846|Female Urinary Microbiome|female urinary microbiome
71616|NCT02835846|Urinary Urgency|urinary urgency
71617|NCT02835846|Estrogen|estrogen
71618|NCT02835846|Nocturia|nocturia
71619|NCT02835846|Incontinence|incontinence
71620|NCT02835833|advanced solid tumors|advanced solid tumors
71621|NCT02835833|Nintedanib|nintedanib
71622|NCT02835833|Bevacizumab|bevacizumab
71623|NCT02835833|dose escalation|dose escalation
71624|NCT02835820|HIV|hiv
71625|NCT02835820|Neurocognitive|neurocognitive
71626|NCT02835820|Ketogenic Diet|ketogenic diet
71627|NCT02835807|skin cancer|skin cancer
71628|NCT02835794|Myelodysplastic Syndromes|myelodysplastic syndromes
71629|NCT02835781|Breast Implants|breast implants
71630|NCT02835781|Acellular Dermal Matrix|acellular dermal matrix
71631|NCT02835729|AML|aml
71632|NCT02835716|Phosphodiesterase type 4 inhibitor|phosphodiesterase type 4 inhibitor
71633|NCT02835716|ustekinumab|ustekinumab
71634|NCT02835716|secukinumab|secukinumab
71635|NCT02835716|P40 subunit|p40 subunit
71636|NCT02835716|Interleukin IL-12|interleukin il-12
71637|NCT02835716|Interleukin IL-23|interleukin il-23
71638|NCT02835716|Apoprotein e4|apoprotein e4
71639|NCT02835716|Interleukin IL-17A|interleukin il-17a
71640|NCT02835703|Congenital heart disease|congenital heart disease
71641|NCT02835703|Coarctation of aorta|coarctation of aorta
71642|NCT02835703|Aortic arch hypoplasia|aortic arch hypoplasia
71643|NCT02835703|Cerebral selective antegrade perfusion|cerebral selective antegrade perfusion
71644|NCT02835703|Double arterial cannulation|double arterial cannulation
71645|NCT02835690|PD1|pd1
71646|NCT02835690|PD-1|pd-1
71647|NCT02835690|PDL1|pdl1
71648|NCT02835690|PD-L1|pd-l1
71649|NCT02835677|Caregivers|caregivers
71650|NCT02835677|Activities of Daily Living|activities of daily living
71651|NCT02835664|Nicotinamide Riboside|nicotinamide riboside
71652|NCT02835664|Obesity|obesity
71653|NCT02835664|Metabolic health|metabolic health
71654|NCT02835664|Insulin resistance|insulin resistance
71655|NCT02835664|Mitochondrial function|mitochondrial function
71656|NCT02835664|Brown adipose tissue|brown adipose tissue
71657|NCT02835664|Energy expenditure|energy expenditure
71658|NCT02835664|Ectopic lipid accumulation|ectopic lipid accumulation
71659|NCT02835664|Cardiovascular risk|cardiovascular risk
71660|NCT02835664|Acetylcarnitine|acetylcarnitine
71661|NCT02835651|Palmitic acid|palmitic acid
71662|NCT02835651|Stearic acid|stearic acid
71663|NCT02835651|HDL-metabolism|hdl-metabolism
71664|NCT02835651|Human intervention study|human intervention study
71665|NCT02835625|Diagnostic Imaging|diagnostic imaging
71666|NCT02835625|Mammography|mammography
71667|NCT02835625|Randomized Controlled Trial|randomized controlled trial
71668|NCT02835625|Tomosynthesis|tomosynthesis
71669|NCT02835625|Early performance measures|early performance measures
71670|NCT02835625|Recall|recall
71671|NCT02835625|Radiation dose|radiation dose
71672|NCT02835625|Cancer detection|cancer detection
71673|NCT02835625|Sensitivity|sensitivity
71674|NCT02835625|Specificity|specificity
71675|NCT02835625|Cost|cost
71676|NCT02835625|Economy|economy
71677|NCT02835586|paclitaxel|paclitaxel
71678|NCT02835586|critical ischemia|critical ischemia
71679|NCT02835586|restenosis|restenosis
71680|NCT02835586|femoropopliteal artery lesions TASC C and D|femoropopliteal artery lesions tasc c and d
71681|NCT02835547|cardiovascular event|cardiovascular event
71682|NCT02835547|risk factors|risk factors
71683|NCT02835547|inflammatory diseases and acquired dysimmune|inflammatory diseases and acquired dysimmune
71684|NCT02835534|acute ST elevation myocardial infarction|acute st elevation myocardial infarction
71686|NCT02835456|Biofilm|biofilm
71687|NCT02835456|Urinary tract infections|urinary tract infections
71688|NCT02835456|micropattern|micropattern
71689|NCT02835456|Catheter|catheter
71690|NCT02835443|Ischemic Stroke|ischemic stroke
71691|NCT02835443|Deep Brain Stimulation|deep brain stimulation
71692|NCT02835443|DBS|dbs
71693|NCT02835443|Physical Therapy|physical therapy
71694|NCT02835443|Rehab|rehab
71695|NCT02835430|Coronally advanced flap|coronally advanced flap
71696|NCT02835430|Gingival recession|gingival recession
71697|NCT02835430|Bone, demineralized|bone, demineralized
71698|NCT02835430|Bone, freeze-dried|bone, freeze-dried
71699|NCT02835430|platelet-rich fibrin|platelet-rich fibrin
71700|NCT02835430|root coverage procedures|root coverage procedures
71701|NCT02835417|fetal heart rate variability|fetal heart rate variability
71702|NCT02835417|entropy|entropy
71703|NCT02835417|multifractal analysis|multifractal analysis
71704|NCT02835417|scattering transform|scattering transform
71705|NCT02835417|sparse vector machine|sparse vector machine
71706|NCT02835417|acidosis|acidosis
71707|NCT02835378|bilateral upper limb amputation|bilateral upper limb amputation
71708|NCT02835378|prosthetic fitting|prosthetic fitting
71709|NCT02835378|epidemiology|epidemiology
71710|NCT02835378|clinical practices|clinical practices
71711|NCT02835378|totally non-functional hand|totally non-functional hand
71712|NCT02835365|baclofen|baclofen
71713|NCT02835365|alcohol|alcohol
71714|NCT02835365|withdrawal|withdrawal
71715|NCT02835352|anxiety|anxiety
71716|NCT02835326|Older Adults|older adults
71717|NCT02835326|Weight Loss|weight loss
71718|NCT02835326|Exercise|exercise
71719|NCT02835326|Knee pain|knee pain
71720|NCT02835300|Asthma|asthma
71721|NCT02835300|Adolescents|adolescents
71722|NCT02835300|e-Health|e-health
71723|NCT02835300|Intervention|intervention
71724|NCT02835274|parkinson disease|parkinson disease
71725|NCT02835274|deep brain stimulation|deep brain stimulation
71726|NCT02835274|directional stimulation|directional stimulation
71727|NCT02835261|Obesity|obesity
71728|NCT02835261|Metabolic Disorders|metabolic disorders
71729|NCT02835209|spontaneous breathing test|spontaneous breathing test
71730|NCT02835209|premature infant|premature infant
71731|NCT02835209|work of breathing|work of breathing
71732|NCT02835170|Immunoglobulin G|immunoglobulin g
71733|NCT02835170|Treatment|treatment
71734|NCT02835157|Normal saline|normal saline
71735|NCT02835157|Balanced saline|balanced saline
71736|NCT02835157|Septic shock|septic shock
71737|NCT02835157|Children|children
71738|NCT02835157|Hyperchloremia|hyperchloremia
71739|NCT02835157|Acute kidney injury|acute kidney injury
71740|NCT02835131|hyperinsulinemia|hyperinsulinemia
71741|NCT02835131|hypoglycemia|hypoglycemia
71742|NCT02835131|somatostatin|somatostatin
71743|NCT02835131|pasireotide|pasireotide
71744|NCT02835131|congenital|congenital
71745|NCT02835079|Duchenne Tamoxifen|duchenne tamoxifen
71747|NCT02835066|Stage II|stage ii
71748|NCT02835066|Stage IIIA|stage iiia
71749|NCT02835066|Stage IIIB|stage iiib
71750|NCT02835066|Stage IV|stage iv
71751|NCT02835066|Non-Small Cell|non-small cell
71752|NCT02835040|Corticosteroid|corticosteroid
71753|NCT02835040|Antibiotic|antibiotic
71754|NCT02835040|Early mobilization|early mobilization
71755|NCT02835040|Malnutrition|malnutrition
71756|NCT02835027|Acute limb ischaemia(ALI)|acute limb ischaemia(ali)
71757|NCT02835027|Acute ischaemia of the lower extremity|acute ischaemia of the lower extremity
71758|NCT02835027|Thrombosis|thrombosis
63178|NCT02890069|CRC|crc
71759|NCT02835027|Emboli|emboli
71760|NCT02835027|Endovascular surgery|endovascular surgery
71761|NCT02835027|Surgery|surgery
71762|NCT02835027|Amputation free survival|amputation free survival
71763|NCT02835027|Long time survival|long time survival
71764|NCT02835027|Demographics|demographics
71765|NCT02835014|Diabetes Mellitus Type I|diabetes mellitus type i
71766|NCT02835014|Adolescents|adolescents
71767|NCT02835014|Mental Health|mental health
71768|NCT02835014|Self efficacy|self efficacy
71769|NCT02835014|parenting styles|parenting styles
71770|NCT02834988|Endometrial Cancer|endometrial cancer
71771|NCT02834988|Sentinel Lymph Node Dissection|sentinel lymph node dissection
71772|NCT02834988|SLND|slnd
71773|NCT02834975|Fallopian Tube Carcinoma|fallopian tube carcinoma
71774|NCT02834975|Peritoneal Carcinoma|peritoneal carcinoma
71775|NCT02834975|Epithelial Ovarian Cancer|epithelial ovarian cancer
71776|NCT02834962|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
71777|NCT02834897|EOS imagery|eos imagery
71778|NCT02834884|rare cancer|rare cancer
71779|NCT02834884|biomarker|biomarker
71780|NCT02834884|screening|screening
71781|NCT02834858|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
71782|NCT02834819|bronchiolitis|bronchiolitis
71783|NCT02834819|hypoxia|hypoxia
71784|NCT02834819|hypertonic saline|hypertonic saline
71785|NCT02834793|Lennox-Gastaut Syndrome (LGS)|lennox-gastaut syndrome (lgs)
71786|NCT02834793|Inadequately controlled seizures|inadequately controlled seizures
71787|NCT02834780|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
71788|NCT02834780|H3B-6527|h3b-6527
71790|NCT02834715|Diabetes|diabetes
71791|NCT02834715|Stevia|stevia
71792|NCT02834715|insulin secretion|insulin secretion
71793|NCT02834715|insulin sensitivity|insulin sensitivity
71794|NCT02834715|Sweetener|sweetener
71795|NCT02834702|sinew acupuncture|sinew acupuncture
71796|NCT02834702|neck pain|neck pain
71797|NCT02834702|chronic pain|chronic pain
71798|NCT02834676|DiscoGel(R)|discogel(r)
71799|NCT02834676|gelified ethanol|gelified ethanol
71800|NCT02834676|percutaneous treatment|percutaneous treatment
71801|NCT02834676|Oswestry Disability Index (ODI)|oswestry disability index (odi)
71802|NCT02834676|Visual analog Scale (VAS)|visual analog scale (vas)
71803|NCT02834676|Neuropathic Pain Questionnaire (DN-4)|neuropathic pain questionnaire (dn-4)
71804|NCT02834676|cervical|cervical
71806|NCT02834637|cervical cancer|cervical cancer
71807|NCT02834637|vaccines|vaccines
71808|NCT02834637|HPV vaccine|hpv vaccine
71809|NCT02834637|dose reduction|dose reduction
71810|NCT02834637|Human papilloma virus vaccine schedules|human papilloma virus vaccine schedules
71811|NCT02834624|surfactant|surfactant
71812|NCT02834624|respiratory distress syndrome|respiratory distress syndrome
71813|NCT02834624|inflammation|inflammation
71814|NCT02834624|c-reactive protein|c-reactive protein
71815|NCT02834624|lipid peroxidation|lipid peroxidation
71816|NCT02834546|Hepatocellular Carcinoma|hepatocellular carcinoma
71817|NCT02834546|Sorafenib|sorafenib
71818|NCT02834546|Toxicity|toxicity
71819|NCT02834546|Plasmatic concentration|plasmatic concentration
71820|NCT02834533|Lokomat;|lokomat;
71821|NCT02834533|robotic rehabilitation.|robotic rehabilitation.
71822|NCT02834533|Multiple Sclerosis;|multiple sclerosis;
71823|NCT02834533|Virtual reality|virtual reality
71824|NCT02834494|locally advanced breast cancer|locally advanced breast cancer
71825|NCT02834494|neoadjuvant chemotherapy|neoadjuvant chemotherapy
71826|NCT02834481|Pain Care|pain care
71827|NCT02834481|Pediatric and Neonatal Intensive Care Units|pediatric and neonatal intensive care units
71828|NCT02834468|Dexamethasone|dexamethasone
71829|NCT02834468|Rituximab|rituximab
71830|NCT02834468|Cyclosporin|cyclosporin
71831|NCT02834468|Intravenous Immunoglobulin|intravenous immunoglobulin
71833|NCT02834403|breast cancer|breast cancer
71834|NCT02834403|nitric oxide synthase|nitric oxide synthase
71835|NCT02834403|docetaxel|docetaxel
71836|NCT02834403|L-NMMA|l-nmma
71837|NCT02834390|AML|aml
71838|NCT02834390|phase 1|phase 1
71839|NCT02834390|hematology|hematology
71841|NCT02834390|newly diagnosed|newly diagnosed
71842|NCT02834377|Cardiac Output|cardiac output
71843|NCT02834377|Hemodynamics|hemodynamics
71844|NCT02834377|Perioperative Care|perioperative care
71845|NCT02834338|activity tracking|activity tracking
71846|NCT02834338|postoperative recovery|postoperative recovery
71847|NCT02834338|ERAS|eras
71848|NCT02834338|fast-track surgery|fast-track surgery
71849|NCT02834325|high flow nasal cannula|high flow nasal cannula
71850|NCT02834325|success|success
71851|NCT02834325|failure|failure
71852|NCT02834325|ROX index|rox index
71853|NCT02834312|Estetrol|estetrol
71854|NCT02834312|Vasomotor symptoms|vasomotor symptoms
71855|NCT02834312|Menopause|menopause
71856|NCT02834260|absorbable implant|absorbable implant
71857|NCT02834260|subconjunctival|subconjunctival
71858|NCT02834260|immune rejection|immune rejection
71859|NCT02834260|safety profile|safety profile
71860|NCT02834260|dexamethasone|dexamethasone
71861|NCT02834234|mesothelioma|mesothelioma
71862|NCT02834234|peritoneum|peritoneum
71863|NCT02834234|genomic|genomic
71864|NCT02834234|CGH arrays|cgh arrays
71865|NCT02834221|Femoral vein puncture|femoral vein puncture
71866|NCT02834195|Cerebral palsy|cerebral palsy
71867|NCT02834195|reliability|reliability
71868|NCT02834195|upper limb and hand patterns|upper limb and hand patterns
71869|NCT02834195|classification|classification
71870|NCT02834169|Rare peritoneal surface malignancies|rare peritoneal surface malignancies
71871|NCT02834169|pseudomyxoma peritonei|pseudomyxoma peritonei
71872|NCT02834169|peritoneal mesothelioma|peritoneal mesothelioma
71873|NCT02834169|desmoplastic small round cell tumor|desmoplastic small round cell tumor
71874|NCT02834169|psammocarcinoma|psammocarcinoma
626781|NCT00687232|Japanese|japanese
71881|NCT02834143|Limb Ischemia|limb ischemia
71882|NCT02834117|Ovulation Induction|ovulation induction
71883|NCT02834117|quality of life|quality of life
71884|NCT02834117|Reproductive Physiological Processes|reproductive physiological processes
71886|NCT02834078|HbA1c|hba1c
71887|NCT02834078|Pre Diabetes|pre diabetes
71888|NCT02834078|Berberine|berberine
71889|NCT02834065|Postoperative Cognitive Decline|postoperative cognitive decline
71890|NCT02834065|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
71891|NCT02834065|Cardiovascular Surgical Procedures|cardiovascular surgical procedures
71892|NCT02834065|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
71893|NCT02834065|Small Ubiquitin-Related Modifier Proteins|small ubiquitin-related modifier proteins
71894|NCT02834052|Immunotherapy|immunotherapy
71895|NCT02834052|Anti-programmed death 1 (PD-1) inhibitor|anti-programmed death 1 (pd-1) inhibitor
71896|NCT02834052|Immunostimulant|immunostimulant
71897|NCT02834052|monoclonal antibody|monoclonal antibody
71898|NCT02834052|TLR3 agonist|tlr3 agonist
71899|NCT02834052|Immunologic factors|immunologic factors
71900|NCT02834039|Tidal volume|tidal volume
71901|NCT02834039|renal transplant|renal transplant
71902|NCT02834039|donor|donor
71903|NCT02834039|nephrectomy|nephrectomy
71904|NCT02834039|ventilation|ventilation
71905|NCT02834039|Living renal transplant donor patient|living renal transplant donor patient
71906|NCT02834026|Muscle Strength|muscle strength
71907|NCT02834026|Muscle Strength Dynamometer|muscle strength dynamometer
71908|NCT02834026|Chronic Renal Disease|chronic renal disease
71909|NCT02834026|Exercise|exercise
71910|NCT02834026|Physical therapy modalities|physical therapy modalities
71911|NCT02833987|Direct oral anticoagulants|direct oral anticoagulants
71912|NCT02833987|Safety|safety
71913|NCT02833987|Major bleed|major bleed
71914|NCT02833987|Adverse events|adverse events
71915|NCT02833974|GSK2245035|gsk2245035
71916|NCT02833974|TLR7 agonist|tlr7 agonist
71917|NCT02833974|allergic asthma|allergic asthma
71918|NCT02833974|FEV1|fev1
71919|NCT02833948|Heart Valve Disease|heart valve disease
71920|NCT02833948|Randomized Controlled Trial|randomized controlled trial
71921|NCT02833948|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
71922|NCT02833948|TAVR|tavr
71923|NCT02833948|Valve Thrombosis|valve thrombosis
71924|NCT02833935|spinal cord injury|spinal cord injury
71925|NCT02833935|physical activity|physical activity
71926|NCT02833935|self-determination theory|self-determination theory
71927|NCT02833935|life satisfaction|life satisfaction
71928|NCT02833883|Enzalutamide|enzalutamide
71929|NCT02833883|CC-115|cc-115
71930|NCT02833883|16-074|16-074
71931|NCT02833857|Secondary Hyperparathyroidism, chronic kidney disease, hemodialysis|secondary hyperparathyroidism, chronic kidney disease, hemodialysis
71939|NCT02833805|immunosuppression|immunosuppression
71940|NCT02833805|nonmyeloablative|nonmyeloablative
71941|NCT02833805|non-myeloablative|non-myeloablative
71942|NCT02833805|allogeneic|allogeneic
71943|NCT02833805|tacrolimus|tacrolimus
71944|NCT02833805|bone marrow|bone marrow
71945|NCT02833805|bone marrow transplant|bone marrow transplant
71946|NCT02833805|cyclophosphamide|cyclophosphamide
71947|NCT02833805|thymoglobulin|thymoglobulin
71949|NCT02833805|fludarabine|fludarabine
71950|NCT02833766|Breast Cancer|breast cancer
71951|NCT02833766|advanced triple Negative, EGFR positive breast cancer|advanced triple negative, egfr positive breast cancer
71953|NCT02833766|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
71954|NCT02833740|Mid-Upper Arm Circumference (MUAC)|mid-upper arm circumference (muac)
71955|NCT02833740|Mother MUAC|mother muac
71956|NCT02833740|Community screening for acute malnutrition|community screening for acute malnutrition
71957|NCT02833727|asthma; smoking; Eosinophils; health care costs|asthma; smoking; eosinophils; health care costs
71958|NCT02833675|angioedema|angioedema
71959|NCT02833675|C1Inhibitor|c1inhibitor
71960|NCT02833675|bradykinin|bradykinin
71961|NCT02833675|Histamin|histamin
71962|NCT02833662|Hypoxia|hypoxia
71963|NCT02833662|Perioperative outcomes|perioperative outcomes
71964|NCT02833649|Keratoconus|keratoconus
71965|NCT02833649|Crosslinking|crosslinking
71966|NCT02833649|Toric ICL|toric icl
626782|NCT00687232|inhalation|inhalation
63385|NCT02888834|elderly|elderly
71967|NCT02833623|Helicobacter Pylori eradication rate|helicobacter pylori eradication rate
71968|NCT02833623|Efficacy of Short-message-based Re-education (SMRE)|efficacy of short-message-based re-education (smre)
71970|NCT02833597|peripheral artery disease|peripheral artery disease
71971|NCT02833597|transcutaneous oxygen pressure|transcutaneous oxygen pressure
71973|NCT02833597|rowing ergometer|rowing ergometer
71974|NCT02833584|Paracetamol|paracetamol
71975|NCT02833558|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
71976|NCT02833558|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
71977|NCT02833558|Bleeding|bleeding
71978|NCT02833519|pregnant women|pregnant women
71979|NCT02833519|exercise|exercise
71980|NCT02833519|depression|depression
71981|NCT02833519|anxiety|anxiety
71986|NCT02833467|Circulating Tumor DNA|circulating tumor dna
71987|NCT02833467|Heterogeneous|heterogeneous
71988|NCT02833467|Multiple primary lung cancer|multiple primary lung cancer
71989|NCT02833454|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
71990|NCT02833454|Direct Insertion of Anterior Cruciate Ligament|direct insertion of anterior cruciate ligament
71991|NCT02833415|Visceral|visceral
71992|NCT02833415|Obesity|obesity
71993|NCT02833415|Adipose|adipose
71994|NCT02833415|Diabetes|diabetes
71999|NCT02833376|microbiota|microbiota
72000|NCT02833376|ethanol|ethanol
72001|NCT02833376|chlorhexidine|chlorhexidine
72002|NCT02833363|gastric microbiota|gastric microbiota
72003|NCT02833363|Helicobacter pylori|helicobacter pylori
72004|NCT02833363|Non-atrophic Gasrititis|non-atrophic gasrititis
72005|NCT02833363|Atrophic gastritis|atrophic gastritis
72006|NCT02833363|Intestinal metaplasia|intestinal metaplasia
72007|NCT02833363|intraepithelial neoplasia|intraepithelial neoplasia
72008|NCT02833363|Gastric cancer|gastric cancer
72009|NCT02833337|Bone|bone
72010|NCT02833337|Maxilla|maxilla
72011|NCT02833337|Cone-Beam Computed Tomography|cone-beam computed tomography
72012|NCT02833337|Regeneration|regeneration
72013|NCT02833324|Postoperative Period|postoperative period
72014|NCT02833324|Colorectal Surgery|colorectal surgery
72015|NCT02833324|Surgery|surgery
72016|NCT02833311|Neuromusculoskeletal condition|neuromusculoskeletal condition
72017|NCT02833298|Sustained Virological Response|sustained virological response
72018|NCT02833298|SVR|svr
72019|NCT02833298|patient navigation|patient navigation
72020|NCT02833298|screening|screening
72021|NCT02833298|HCC|hcc
72022|NCT02833298|HCV|hcv
72023|NCT02833272|benzodiazepines|benzodiazepines
72024|NCT02833272|Z-drugs|z-drugs
72025|NCT02833259|Pneumonia|pneumonia
72026|NCT02833259|Patient readmission|patient readmission
72027|NCT02833259|Community-acquired infections|community-acquired infections
72028|NCT02833259|Observational study|observational study
72029|NCT02833259|Quality of health care|quality of health care
72030|NCT02833259|Models, Statistical|models, statistical
72031|NCT02833246|texting|texting
72032|NCT02833246|Adherence to Oral Anticancer Medications|adherence to oral anticancer medications
72033|NCT02833246|16-810|16-810
72034|NCT02833233|Early stage|early stage
72035|NCT02833233|Resectable|resectable
72036|NCT02833233|Ipilimumab|ipilimumab
72037|NCT02833233|Nivolumab|nivolumab
72038|NCT02833233|Cryoablation|cryoablation
72039|NCT02833233|16-495|16-495
72040|NCT02833220|blood pressure|blood pressure
72041|NCT02833207|blood flow|blood flow
72042|NCT02833207|vasodilation|vasodilation
72043|NCT02833207|skeletal muscle|skeletal muscle
72044|NCT02833207|Doppler Ultrasound|doppler ultrasound
72045|NCT02833207|diabetes prevention program|diabetes prevention program
72046|NCT02833207|endothelium dependent dilation|endothelium dependent dilation
72047|NCT02833168|Neuromuscular disorders|neuromuscular disorders
72048|NCT02833168|Sleep disordered breathing|sleep disordered breathing
72049|NCT02833168|Dyspnea|dyspnea
72050|NCT02833155|entinostat|entinostat
72051|NCT02833155|breast cancer|breast cancer
72052|NCT02833142|Healthy Volunteer|healthy volunteer
72053|NCT02833142|opicinumab|opicinumab
72054|NCT02833116|radiculalgia|radiculalgia
72055|NCT02833116|chronic pain|chronic pain
72056|NCT02833116|quality of life|quality of life
72057|NCT02833103|Pinaverium Bromide|pinaverium bromide
72058|NCT02833103|cholecystectomy|cholecystectomy
72059|NCT02833103|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
72060|NCT02833012|Healthy volunteers|healthy volunteers
72061|NCT02833012|Caprylic triglyceride oil|caprylic triglyceride oil
72062|NCT02833012|AC-1202|ac-1202
72063|NCT02833012|AC-1204|ac-1204
72064|NCT02833012|Pharmacokinetic|pharmacokinetic
72065|NCT02833012|ketone body|ketone body
72066|NCT02833012|Axona|axona
72067|NCT02832999|Diabetes|diabetes
72068|NCT02832999|GLP-1|glp-1
72069|NCT02832999|Insulin secretion|insulin secretion
72070|NCT02832999|insulin sensitivity|insulin sensitivity
72071|NCT02832999|Africa|africa
72072|NCT02832999|Liraglutide|liraglutide
72073|NCT02832999|Vildaglipin|vildaglipin
626783|NCT00687245|children|children
72074|NCT02832986|Frailty consultation|frailty consultation
72075|NCT02832973|Hypertension Resistant to Conventional Therapy|hypertension resistant to conventional therapy
72076|NCT02832973|Natriuretic Agents|natriuretic agents
72516|NCT02830256|Intubation|intubation
72077|NCT02832973|Renin-Angiotensin System|renin-angiotensin system
72078|NCT02832973|Bisoprolol|bisoprolol
72079|NCT02832960|Thyroid Dysfunction|thyroid dysfunction
72080|NCT02832960|Atherosclerosis|atherosclerosis
72081|NCT02832960|Heart Failure|heart failure
72082|NCT02832960|Cardiovascular imaging|cardiovascular imaging
72083|NCT02832960|Randomized Controlled Trial|randomized controlled trial
72084|NCT02832934|Thyroid Dysfunction|thyroid dysfunction
72085|NCT02832934|Atherosclerosis|atherosclerosis
72086|NCT02832934|Heart Failure|heart failure
72087|NCT02832934|Cardiovascular Imaging|cardiovascular imaging
72088|NCT02832934|Randomized Controlled Trial|randomized controlled trial
72089|NCT02832921|Alzheimer's disease|alzheimer's disease
72090|NCT02832921|virtual reality|virtual reality
72091|NCT02832921|cognitive training|cognitive training
72092|NCT02832895|Adults|adults
72093|NCT02832895|Frontal bone window|frontal bone window
72094|NCT02832895|Transcranial doppler|transcranial doppler
72095|NCT02832882|HCC|hcc
72096|NCT02832882|RFA|rfa
72097|NCT02832869|Polyp detection rate|polyp detection rate
72098|NCT02832869|Adenoma detection rate|adenoma detection rate
72099|NCT02832869|Boston Bowel Preparation Scale|boston bowel preparation scale
72100|NCT02832830|bony metastases|bony metastases
72101|NCT02832830|palliative radiotherapy|palliative radiotherapy
72102|NCT02832817|Oxygen therapy|oxygen therapy
72103|NCT02832817|Pulse oximeter|pulse oximeter
72104|NCT02832817|Hypoxia|hypoxia
72105|NCT02832817|Hypoxemia|hypoxemia
72106|NCT02832817|Arterial blood gas|arterial blood gas
72107|NCT02832791|ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION|anterior cruciate ligament reconstruction
72108|NCT02832791|QUADRICEPS TENDON|quadriceps tendon
72109|NCT02832791|HAMSTRING TENDON|hamstring tendon
72110|NCT02832765|Palliative radiotherapy|palliative radiotherapy
72111|NCT02832765|Bone metastases|bone metastases
72112|NCT02832739|Technology acceptance|technology acceptance
72113|NCT02832739|Usability|usability
72114|NCT02832739|eHealth|ehealth
72115|NCT02832739|self-management support in chronic illness|self-management support in chronic illness
72116|NCT02832739|prevention|prevention
72117|NCT02832739|Special Orthopaedic Co-Morbidity after hip/knee replacement|special orthopaedic co-morbidity after hip/knee replacement
72118|NCT02832726|absorption of Vitamin B12|absorption of vitamin b12
72119|NCT02832713|Knee osteoarthritis|knee osteoarthritis
72120|NCT02832713|Intra-articular botulinum toxin|intra-articular botulinum toxin
72121|NCT02832713|Hyaluronic acid|hyaluronic acid
72122|NCT02832713|Pain|pain
72123|NCT02832713|Function|function
72124|NCT02832700|glycopeptides|glycopeptides
72125|NCT02832700|dietary proteins|dietary proteins
72126|NCT02832700|whey protein|whey protein
72127|NCT02832700|caseinomacropeptide|caseinomacropeptide
72128|NCT02832700|antiinflammatories|antiinflammatories
72129|NCT02832700|human microbiome|human microbiome
72130|NCT02832661|renal allograft|renal allograft
72131|NCT02832661|graft injuries|graft injuries
72132|NCT02832661|biopsy|biopsy
72133|NCT02832661|biomarkers|biomarkers
72134|NCT02832661|omics approach|omics approach
72135|NCT02832635|brain metastasis|brain metastasis
72136|NCT02832635|whole-brain radiotherapy|whole-brain radiotherapy
72137|NCT02832635|TMZ|tmz
72138|NCT02832635|avoidance of hippocampus|avoidance of hippocampus
72139|NCT02832622|MultiPoint Pacing|multipoint pacing
72140|NCT02832622|Heart Failure|heart failure
72141|NCT02832622|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
72142|NCT02832622|SJM Quadripolar Biventricular Pacing|sjm quadripolar biventricular pacing
72143|NCT02832609|closing volume|closing volume
72144|NCT02832609|expiratory flow limitation|expiratory flow limitation
72145|NCT02832609|obesity|obesity
72146|NCT02832609|orthopnea|orthopnea
72147|NCT02832596|Anesthesia|anesthesia
72148|NCT02832596|Blood pressure|blood pressure
72149|NCT02832596|Plasma Volume|plasma volume
72150|NCT02832596|Vasopressor agents|vasopressor agents
72151|NCT02832596|Coronary artery bypass|coronary artery bypass
72152|NCT02832596|Glycocalyx|glycocalyx
72153|NCT02832596|ANP|anp
72154|NCT02832596|Coagulation|coagulation
72280|NCT02831764|HIV 1|hiv 1
72155|NCT02832583|PRP, hyaluronic acid, mesotherapy, skin wrinkle, skin rejuvenation|prp, hyaluronic acid, mesotherapy, skin wrinkle, skin rejuvenation
72156|NCT02832557|Autism|autism
72157|NCT02832557|Asperger's Syndrome|asperger's syndrome
72158|NCT02832557|microRNA|microrna
72159|NCT02832557|epigenetic|epigenetic
72160|NCT02832557|biomarker|biomarker
72161|NCT02832544|atrial fibrillation|atrial fibrillation
72162|NCT02832544|stroke|stroke
72163|NCT02832531|atrial fibrillation|atrial fibrillation
72164|NCT02832531|stroke|stroke
72165|NCT02832492|disorders of consciousness|disorders of consciousness
72166|NCT02832492|unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
72167|NCT02832492|pupil near response|pupil near response
72168|NCT02832492|prognosis of consciousness recovery|prognosis of consciousness recovery
72169|NCT02832453|High intensity physical exercise|high intensity physical exercise
72170|NCT02832453|Primary health care|primary health care
72171|NCT02832453|Behaviour change interventions|behaviour change interventions
72172|NCT02832427|Coronary artery bypass grafting|coronary artery bypass grafting
72173|NCT02832427|Heart valve surgery|heart valve surgery
72174|NCT02832427|Postoperative morbidity|postoperative morbidity
72175|NCT02832427|Operative mortality|operative mortality
72176|NCT02832401|event-related potentials|event-related potentials
72178|NCT02832401|caffeine|caffeine
72183|NCT02832336|Neurological disorder|neurological disorder
72184|NCT02832336|Excessive daytime sleepiness|excessive daytime sleepiness
72185|NCT02832336|Orexin|orexin
72186|NCT02832336|adenosine antagonist|adenosine antagonist
72187|NCT02832323|hemodialysis|hemodialysis
72188|NCT02832323|EPO|epo
72189|NCT02832323|MIRCERA|mircera
72190|NCT02832310|valsalva|valsalva
72191|NCT02832258|Enterobacteria|enterobacteria
72192|NCT02832258|Children|children
72193|NCT02832258|Febrile urinary tract infection|febrile urinary tract infection
72194|NCT02832258|Cystitis|cystitis
72195|NCT02832258|Extended-spectrum beta-lactamase-producing Enterobacteriaceae|extended-spectrum beta-lactamase-producing enterobacteriaceae
72199|NCT02832219|Overweight|overweight
72200|NCT02832219|Molecular hydrogen|molecular hydrogen
72201|NCT02832219|Insulin|insulin
72202|NCT02832206|Atrial fibrillation|atrial fibrillation
72203|NCT02832206|Hybrid ablation|hybrid ablation
72204|NCT02832180|Rheumatoid|rheumatoid
72205|NCT02832141|Skin blood flow|skin blood flow
72206|NCT02832141|Skin redness|skin redness
72207|NCT02832141|Sympathetic nervous system|sympathetic nervous system
72208|NCT02832141|Regional Blood Flow|regional blood flow
72209|NCT02832128|Cochlear Implant|cochlear implant
72210|NCT02832115|Radial Artery Spasm|radial artery spasm
72211|NCT02832115|Cardiac Catheterization|cardiac catheterization
72212|NCT02832115|Vascular Access Site Complications|vascular access site complications
72213|NCT02832115|Vasodilator|vasodilator
72214|NCT02832115|Nitroglycerine|nitroglycerine
72215|NCT02832115|Lidocaine|lidocaine
72216|NCT02832102|prognostic modelling|prognostic modelling
72217|NCT02832102|radiomics|radiomics
72218|NCT02832102|clinical decision support system|clinical decision support system
72219|NCT02832102|big data analysis|big data analysis
72220|NCT02832102|multiscale prognostic signatures|multiscale prognostic signatures
72221|NCT02832102|patient-clinician co-decision tools|patient-clinician co-decision tools
72222|NCT02832089|atrial fibrillation|atrial fibrillation
72223|NCT02832089|rate reduction|rate reduction
72224|NCT02832050|play|play
72225|NCT02832050|therapy|therapy
72226|NCT02832024|stents|stents
72227|NCT02832024|atherectomy|atherectomy
72228|NCT02832024|femoral artery|femoral artery
72229|NCT02832024|popliteal artery|popliteal artery
72230|NCT02832024|In-stent Restenosis|in-stent restenosis
72231|NCT02831985|Child|child
72232|NCT02831985|Middle ear ventilation|middle ear ventilation
72233|NCT02831985|Follow-up studies|follow-up studies
72234|NCT02831985|General practitioners|general practitioners
72235|NCT02831972|Healthy Volunteers|healthy volunteers
72236|NCT02831959|Non-Small Cell Lung Cancer|non-small cell lung cancer
72237|NCT02831959|NSCLC|nsclc
72238|NCT02831959|Brain metastases|brain metastases
72239|NCT02831959|Treatment|treatment
72240|NCT02831959|Minimal toxicity|minimal toxicity
72241|NCT02831959|TTFields|ttfields
72242|NCT02831959|TTF|ttf
72243|NCT02831959|Tumor Treating Fields|tumor treating fields
72244|NCT02831959|Novocure|novocure
72245|NCT02831959|SRS|srs
72246|NCT02831959|Stereotactic radiosurgery|stereotactic radiosurgery
72247|NCT02831946|skin closure|skin closure
72248|NCT02831946|intracuticular suture|intracuticular suture
72249|NCT02831946|glue (dermabond)|glue (dermabond)
72250|NCT02831933|lung cancer|lung cancer
72251|NCT02831933|metastatic|metastatic
72252|NCT02831933|gene therapy|gene therapy
72253|NCT02831933|immunotherapy|immunotherapy
72254|NCT02831920|Prostate Cancer|prostate cancer
72255|NCT02831920|MRI|mri
72256|NCT02831920|CEUS|ceus
72257|NCT02831920|Contrast Ultrasound|contrast ultrasound
72258|NCT02831920|Fusion|fusion
72259|NCT02831920|targeted biopsy|targeted biopsy
72260|NCT02831907|Ultrasonography|ultrasonography
72261|NCT02831907|Portal vein Doppler|portal vein doppler
72262|NCT02831907|Renal Doppler|renal doppler
72263|NCT02831907|Cardio-Intestinal syndrome|cardio-intestinal syndrome
72265|NCT02831907|Renal congestion|renal congestion
72266|NCT02831907|Intra-renal hemodynamics|intra-renal hemodynamics
72267|NCT02831894|insomnia|insomnia
72268|NCT02831894|sedative hypnotics|sedative hypnotics
72269|NCT02831894|hypnotic tapering|hypnotic tapering
72270|NCT02831855|Rheumatoid Arthritis|rheumatoid arthritis
72271|NCT02831855|Tofacitinib|tofacitinib
72272|NCT02831855|CP-690,550|cp-690,550
72273|NCT02831855|Xeljanz|xeljanz
72274|NCT02831855|methotrexate withdrawal|methotrexate withdrawal
72288|NCT02831751|RNA Virus Infections|rna virus infections
72289|NCT02831751|Immulogic|immulogic
72290|NCT02831751|Immunogenic Factors|immunogenic factors
72291|NCT02831751|Physiological Effects of Drug|physiological effects of drug
72292|NCT02831751|Virus Diseases|virus diseases
72293|NCT02831751|Orthomyxoviridae Infections|orthomyxoviridae infections
72294|NCT02831751|Infection|infection
72295|NCT02831738|Fiber|fiber
72296|NCT02831738|Polydextrose|polydextrose
72297|NCT02831738|Glycemic Index|glycemic index
72298|NCT02831712|NTBI|ntbi
72299|NCT02831712|Iron status|iron status
72300|NCT02831712|Iron supplement|iron supplement
72301|NCT02831699|Zika|zika
72302|NCT02831699|Guillain Barré|guillain barré
72315|NCT02831634|Breast cancer|breast cancer
72316|NCT02831634|cutaneous melanoma|cutaneous melanoma
72317|NCT02831621|overweight|overweight
72318|NCT02831621|ectopic fat|ectopic fat
72319|NCT02831621|exercise|exercise
72320|NCT02831621|diet|diet
72321|NCT02831582|Breast Cancer|breast cancer
72322|NCT02831582|Postmenopausal|postmenopausal
72323|NCT02831582|Stage IA|stage ia
72324|NCT02831582|Stage IB|stage ib
72325|NCT02831582|Stage IIA|stage iia
72326|NCT02831582|Stage IIB|stage iib
72327|NCT02831582|Stage IIIA|stage iiia
72328|NCT02831582|Stage IIIB|stage iiib
72329|NCT02831582|Stage IIIC|stage iiic
72330|NCT02831556|Ultrasound|ultrasound
72331|NCT02831556|Abdomen|abdomen
72332|NCT02831556|Pelvis|pelvis
72333|NCT02831556|3D|3d
72334|NCT02831504|Myotonic Dystrophy type 1|myotonic dystrophy type 1
72335|NCT02831504|DM1|dm1
72336|NCT02831504|Muscular Dystrophy|muscular dystrophy
72337|NCT02831504|Neuromuscular Diseases|neuromuscular diseases
72338|NCT02831491|metastatic|metastatic
72339|NCT02831465|Dynamic hyperinflation|dynamic hyperinflation
72340|NCT02831465|Maximal Voluntary Ventilation|maximal voluntary ventilation
72341|NCT02831465|Inspiratory capacity|inspiratory capacity
72342|NCT02831465|healthy subjects|healthy subjects
72343|NCT02831452|pelvic floor muscles|pelvic floor muscles
72344|NCT02831452|evaluation|evaluation
72345|NCT02831452|dynamometer|dynamometer
72346|NCT02831452|perineometer|perineometer
72347|NCT02831439|Choosing Wisely|choosing wisely
72348|NCT02831439|Breast cancer|breast cancer
72349|NCT02831439|Controlled trial|controlled trial
72350|NCT02831439|High-value health care|high-value health care
72351|NCT02831439|Health services research|health services research
72352|NCT02831348|Asthma|asthma
72353|NCT02831348|Allergic rhinitis|allergic rhinitis
72354|NCT02831348|Rhinitis|rhinitis
72355|NCT02831348|Pneumonia|pneumonia
72356|NCT02831348|Cystic fibrosis|cystic fibrosis
72357|NCT02831322|Transradial|transradial
72358|NCT02831322|ﬂow-mediated vasodilation|ﬂow-mediated vasodilation
72359|NCT02831309|physical activity|physical activity
72360|NCT02831296|SMA|sma
72361|NCT02831296|Werdnig-Hoffmann disease|werdnig-hoffmann disease
72362|NCT02831296|Kugelberg-Welander disease|kugelberg-welander disease
72363|NCT02831283|inflammation|inflammation
72364|NCT02831283|aging|aging
72365|NCT02831283|mild cognitive impairment|mild cognitive impairment
72366|NCT02831270|cardiac surgery|cardiac surgery
72367|NCT02831270|acute normovolemic hemodilution|acute normovolemic hemodilution
72368|NCT02831257|Neurofibromatosis 2|neurofibromatosis 2
72369|NCT02831218|bioresorbable vascular scaffold|bioresorbable vascular scaffold
72370|NCT02831218|coronary artery disease|coronary artery disease
72371|NCT02831205|bioresorbable vascular scaffold|bioresorbable vascular scaffold
72372|NCT02831205|coronary artery disease|coronary artery disease
72373|NCT02831166|Vascular closure devices|vascular closure devices
72374|NCT02831166|Transradial approach|transradial approach
72375|NCT02831166|Transfemoral approach|transfemoral approach
72376|NCT02831140|Fast track|fast track
72377|NCT02831140|rehabilitation|rehabilitation
72378|NCT02831140|post operative complications|post operative complications
72379|NCT02831127|short message service; adherence; stent exchange; ERCP|short message service; adherence; stent exchange; ercp
72380|NCT02831101|BIS|bis
72381|NCT02831101|Elderly|elderly
72382|NCT02831101|Propofol|propofol
72383|NCT02831101|Sufentanil|sufentanil
72384|NCT02831101|Loss of consciousness|loss of consciousness
72385|NCT02831088|Neu2000KWL|neu2000kwl
72386|NCT02831088|Neuroprotection|neuroprotection
72387|NCT02831088|endovascular therapy|endovascular therapy
72388|NCT02831088|glutamate|glutamate
72395|NCT02830971|standardized learning curve|standardized learning curve
72396|NCT02830971|Nurse|nurse
72397|NCT02830971|intensive care unit|intensive care unit
72398|NCT02830971|Mastery|mastery
72399|NCT02830971|Training|training
72400|NCT02830971|Developing|developing
72401|NCT02830971|Skills|skills
72402|NCT02830919|Osteoarthritis of knee|osteoarthritis of knee
72403|NCT02830919|Glucosamine sulfate|glucosamine sulfate
72404|NCT02830919|Chondroitin sulfate|chondroitin sulfate
72405|NCT02830906|Total Knee Arthroplasty|total knee arthroplasty
72406|NCT02830906|Intrathecal Morphine|intrathecal morphine
72407|NCT02830906|Ramosetron|ramosetron
72408|NCT02830906|Ondansetron|ondansetron
72535|NCT02830113|diabetes|diabetes
72409|NCT02830906|postoperative nausea and vomiting|postoperative nausea and vomiting
72410|NCT02830880|Imaging|imaging
72411|NCT02830880|Nuclear medicine|nuclear medicine
72412|NCT02830880|Oncology|oncology
72413|NCT02830880|Radiology|radiology
72414|NCT02830880|Urogenital disorders|urogenital disorders
72415|NCT02830867|glutathione|glutathione
73128|NCT02826629|TMS|tms
72416|NCT02830867|glutathione synthetase deficiency|glutathione synthetase deficiency
72417|NCT02830867|autosomal inheritance|autosomal inheritance
72418|NCT02830867|recessive|recessive
72419|NCT02830841|RIPC|ripc
72420|NCT02830841|hepatic ischemic and reperfusion injury|hepatic ischemic and reperfusion injury
72421|NCT02830841|pediatric living donor liver transplantation|pediatric living donor liver transplantation
72422|NCT02830815|Broadband click stimulus testing|broadband click stimulus testing
72423|NCT02830815|General Anesthesia|general anesthesia
72424|NCT02830815|Sevoflurane|sevoflurane
72425|NCT02830815|Propofol|propofol
72426|NCT02830815|Amplitude latency|amplitude latency
72427|NCT02830815|Wave V|wave v
72428|NCT02830776|dermatochalasis|dermatochalasis
72429|NCT02830776|bimatoprost|bimatoprost
72430|NCT02830776|blepharoplasty|blepharoplasty
72431|NCT02830763|neutral lipid storage disease|neutral lipid storage disease
72432|NCT02830763|CNT-02|cnt-02
72433|NCT02830763|primary triglyceride deposit cardiomyovasculopathy (TGCV)|primary triglyceride deposit cardiomyovasculopathy (tgcv)
72434|NCT02830763|neutral lipid storage disease with myopathy (NLSD-M)|neutral lipid storage disease with myopathy (nlsd-m)
72435|NCT02830737|Small Hepatocellular Carcinoma|small hepatocellular carcinoma
72436|NCT02830737|No-touch RFA|no-touch rfa
72437|NCT02830737|Traditional RFA|traditional rfa
72438|NCT02830737|Recurrence rate|recurrence rate
72439|NCT02830724|Metastatic Solid Cancers|metastatic solid cancers
72440|NCT02830724|Renal Cell Cancer|renal cell cancer
72441|NCT02830724|Cell Therapy|cell therapy
72442|NCT02830724|CAR T Cells|car t cells
72443|NCT02830711|happiness|happiness
72444|NCT02830711|anger|anger
72445|NCT02830711|sadness|sadness
72446|NCT02830711|anticipation|anticipation
72447|NCT02830698|Nervous System|nervous system
72448|NCT02830698|Hypnosis|hypnosis
72449|NCT02830698|Electrocardiography, Ambulatory|electrocardiography, ambulatory
72450|NCT02830685|pre-pectoral breast reconstruction|pre-pectoral breast reconstruction
72451|NCT02830685|subcutaneous breast reconstruction|subcutaneous breast reconstruction
72452|NCT02830633|laparoscopy|laparoscopy
72453|NCT02830633|rectal cancer|rectal cancer
72454|NCT02830633|pelvic autonomic nerve|pelvic autonomic nerve
72455|NCT02830568|Kidney transplantation|kidney transplantation
72456|NCT02830568|Surgical procedures|surgical procedures
72457|NCT02830568|Kidney living donors|kidney living donors
72458|NCT02830568|Quality of life|quality of life
72459|NCT02830542|Clostridium difficile|clostridium difficile
72460|NCT02830542|C Diff|c diff
72461|NCT02830542|CDI|cdi
72462|NCT02830529|Mindfulness|mindfulness
72463|NCT02830529|African American|african american
72464|NCT02830529|fMRI|fmri
72465|NCT02830477|Previously treated patients|previously treated patients
72466|NCT02830451|Registry|registry
72467|NCT02830451|Spine|spine
72468|NCT02830451|Surgery|surgery
72469|NCT02830451|Medical Oncology|medical oncology
72470|NCT02830451|Radiation Oncology|radiation oncology
72471|NCT02830451|Neoplasms|neoplasms
72472|NCT02830451|Metastasis|metastasis
72473|NCT02830451|Chemotherapy|chemotherapy
72474|NCT02830451|Radiation Therapy|radiation therapy
72475|NCT02830451|Tumor Markers|tumor markers
72476|NCT02830438|kidney disease|kidney disease
72477|NCT02830438|fibrosis|fibrosis
72478|NCT02830438|ultrasound|ultrasound
72479|NCT02830438|elastography|elastography
72480|NCT02830425|Multimorbidity|multimorbidity
72481|NCT02830425|Polypharmacy|polypharmacy
72482|NCT02830425|Appropriateness|appropriateness
72484|NCT02830425|START|start
72485|NCT02830399|treatment-resistant-depression|treatment-resistant-depression
72486|NCT02830399|rTMS|rtms
72487|NCT02830399|ECT|ect
72488|NCT02830399|Augmentation strategy|augmentation strategy
72489|NCT02830373|LVIS stents|lvis stents
72490|NCT02830373|Intracranial aneurysm|intracranial aneurysm
72491|NCT02830373|Unruptured aneurysm|unruptured aneurysm
72492|NCT02830373|Wide-necked aneurysm|wide-necked aneurysm
72493|NCT02830360|Antiarrhythmic drug therapy|antiarrhythmic drug therapy
72494|NCT02830360|VT Catheter ablation|vt catheter ablation
72495|NCT02830360|ICD Therapy|icd therapy
72496|NCT02830360|Ischemic Heart Disease|ischemic heart disease
72497|NCT02830347|antibiotic resistance|antibiotic resistance
72498|NCT02830347|oral microbiome|oral microbiome
72499|NCT02830334|Suicide|suicide
72500|NCT02830334|Youth Suicide|youth suicide
72501|NCT02830308|Hormones|hormones
72502|NCT02830308|Endocrine|endocrine
72503|NCT02830308|Hypercortisolism|hypercortisolism
72504|NCT02830308|Bone|bone
72505|NCT02830308|Hypothalamic-Pituitary Dysfunction|hypothalamic-pituitary dysfunction
72506|NCT02830295|body awareness therapy|body awareness therapy
72507|NCT02830295|physical therapy|physical therapy
72508|NCT02830295|movement therapy|movement therapy
72509|NCT02830269|Neuro-ICU|neuro-icu
72510|NCT02830269|Third ventricle|third ventricle
72511|NCT02830269|Computer Tomography|computer tomography
72512|NCT02830269|Transcranial Doppler ultrasonography|transcranial doppler ultrasonography
72513|NCT02830256|Intensive care unit|intensive care unit
72514|NCT02830256|Neuro-ICU|neuro-icu
72515|NCT02830256|Pain|pain
72517|NCT02830256|critical care|critical care
72518|NCT02830256|patients|patients
72519|NCT02830217|STEMI|stemi
72520|NCT02830217|primary PCI|primary pci
72521|NCT02830217|sST2|sst2
72522|NCT02830217|prognosis|prognosis
72523|NCT02830204|mitral valve regurgitation|mitral valve regurgitation
72524|NCT02830204|mitral valve stenosis|mitral valve stenosis
72525|NCT02830191|Cyclosporine, Dried blood spot|cyclosporine, dried blood spot
72526|NCT02830152|Stroke|stroke
72527|NCT02830152|intracerebral hemorrhage|intracerebral hemorrhage
72528|NCT02830152|left atrial appendage occlusion|left atrial appendage occlusion
72529|NCT02830152|atrial fibrillation|atrial fibrillation
72530|NCT02830152|oral anticoagulation|oral anticoagulation
72531|NCT02830152|preventive therapy|preventive therapy
72532|NCT02830126|Outcomes|outcomes
72533|NCT02830126|Information technology|information technology
72534|NCT02830113|periodontitis|periodontitis
72536|NCT02830113|prevention|prevention
72537|NCT02830113|impaired glucose tolerance|impaired glucose tolerance
72538|NCT02830113|insulin resistance|insulin resistance
72539|NCT02830100|Intern speech|intern speech
72540|NCT02830100|Speech and visual imaging|speech and visual imaging
72541|NCT02830100|Mind and oral drift|mind and oral drift
72542|NCT02830100|Cognitive performance|cognitive performance
72543|NCT02830100|Magnetic Resonance Imaging|magnetic resonance imaging
72544|NCT02830087|randomized controlled trial|randomized controlled trial
72545|NCT02830087|tourniquet|tourniquet
72546|NCT02830087|tourniquet cuff pressure|tourniquet cuff pressure
72547|NCT02830087|total knee arthroplasty|total knee arthroplasty
72548|NCT02830087|total knee replacement|total knee replacement
72549|NCT02830087|pain, postoperative|pain, postoperative
72550|NCT02830087|range of motion, articular|range of motion, articular
72551|NCT02830087|blood loss, surgical|blood loss, surgical
72552|NCT02830087|muscle strength, quadriceps|muscle strength, quadriceps
72553|NCT02830087|walking|walking
72554|NCT02830087|manipulation, orthopedic/therapeutic use|manipulation, orthopedic/therapeutic use
72555|NCT02830087|wound healing/surgery|wound healing/surgery
72556|NCT02830074|Sleep Apnea Syndromes|sleep apnea syndromes
72557|NCT02830074|Spinal Cord Injuries|spinal cord injuries
72558|NCT02830074|Sleep|sleep
72559|NCT02830074|Quality of life|quality of life
72560|NCT02830061|Cancer|cancer
72561|NCT02830061|Teenage|teenage
72562|NCT02830061|Young Adult|young adult
72563|NCT02830061|Fertility|fertility
72564|NCT02830061|Cryopreservation|cryopreservation
72565|NCT02830061|Experience|experience
72566|NCT02830048|diabetes|diabetes
72567|NCT02830048|glibenclamide|glibenclamide
72568|NCT02830048|glucagon|glucagon
72569|NCT02830035|ultrasound guided|ultrasound guided
72570|NCT02830035|spinal anesthesia|spinal anesthesia
72571|NCT02830035|neuraxial block|neuraxial block
72572|NCT02830035|paramedian|paramedian
72573|NCT02830022|autism spectrum disorder|autism spectrum disorder
72574|NCT02829996|glaucoma|glaucoma
72575|NCT02829996|primary open-angle glaucoma|primary open-angle glaucoma
72576|NCT02829996|ocular hypertension|ocular hypertension
72577|NCT02829996|adenosine agonist|adenosine agonist
72578|NCT02829996|eye drop|eye drop
72579|NCT02829996|trabodenoson|trabodenoson
72580|NCT02829996|trabecular meshwork|trabecular meshwork
72581|NCT02829983|clarithromycin|clarithromycin
72582|NCT02829983|periodontal debridement|periodontal debridement
72583|NCT02829983|aggressive periodontitis|aggressive periodontitis
72584|NCT02829970|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
72692|NCT02829619|Food Timing|food timing
72585|NCT02829970|Alcohol-Related Disorders|alcohol-related disorders
72586|NCT02829970|Substance-Related Disorders|substance-related disorders
72587|NCT02829970|Motivational Interviewing|motivational interviewing
72588|NCT02829970|Behavior Therapy|behavior therapy
72589|NCT02829944|Cesarean section|cesarean section
72590|NCT02829931|recurrent glioma|recurrent glioma
72591|NCT02829931|high grade glioma|high grade glioma
72592|NCT02829931|head and neck disease|head and neck disease
72593|NCT02829931|grade III glioma|grade iii glioma
72594|NCT02829931|grade IV glioma|grade iv glioma
72595|NCT02829931|radiation therapy|radiation therapy
72596|NCT02829918|advanced biliary tract cancer|advanced biliary tract cancer
72597|NCT02829918|refractory biliary tract cancer|refractory biliary tract cancer
72598|NCT02829918|digestive diseases|digestive diseases
72599|NCT02829918|immunotherapy|immunotherapy
72600|NCT02829905|mass screening|mass screening
72601|NCT02829905|patient satisfaction|patient satisfaction
72602|NCT02829905|radiography|radiography
72603|NCT02829905|mammography|mammography
72604|NCT02829879|Dentin Sensitivity|dentin sensitivity
72605|NCT02829879|Arginin|arginin
72606|NCT02829879|Potassium Nitrate|potassium nitrate
72607|NCT02829879|Dentifrice|dentifrice
72609|NCT02829853|SARCOIDOSIS|sarcoidosis
72610|NCT02829853|GRANULOMA DISEASES|granuloma diseases
72611|NCT02829853|GENETICS|genetics
72612|NCT02829853|PREDISPOSITION|predisposition
72613|NCT02829853|EXOME (WES-NGS)|exome (wes-ngs)
72614|NCT02829840|Leukemia|leukemia
72615|NCT02829840|FLT3-Mutated Acute Myeloid Leukemia|flt3-mutated acute myeloid leukemia
72616|NCT02829840|FLT3-Mutated High-Risk Myelodysplastic Syndrome|flt3-mutated high-risk myelodysplastic syndrome
72617|NCT02829840|Acute Myeloid Leukemia|acute myeloid leukemia
72618|NCT02829840|AML|aml
72619|NCT02829840|Myelodysplastic Syndrome|myelodysplastic syndrome
72620|NCT02829840|MDS|mds
72621|NCT02829840|Ponatinib|ponatinib
72622|NCT02829840|Iclusig|iclusig
72623|NCT02829840|AP24534|ap24534
72624|NCT02829840|5-azacytidine|5-azacytidine
72625|NCT02829840|Azacitidine|azacitidine
72626|NCT02829840|5-aza|5-aza
72627|NCT02829840|Vidaza|vidaza
72628|NCT02829840|5-AZC|5-azc
72629|NCT02829840|AZA-CR|aza-cr
72630|NCT02829840|Ladakamycin|ladakamycin
72631|NCT02829840|NSC-102816|nsc-102816
72632|NCT02829840|Azacytidine|azacytidine
72633|NCT02829827|Radiprodil|radiprodil
72634|NCT02829827|Infantile spasms|infantile spasms
72635|NCT02829827|IS|is
72636|NCT02829827|Infantile|infantile
72637|NCT02829827|Spasms|spasms
72638|NCT02829827|Epilepsy|epilepsy
72639|NCT02829827|Paediatrics|paediatrics
72640|NCT02829827|Drug-resistant|drug-resistant
72641|NCT02829827|West Syndrome|west syndrome
72642|NCT02829827|Hypsarrhythmia|hypsarrhythmia
72643|NCT02829814|Pain|pain
72644|NCT02829814|Sleep|sleep
72645|NCT02829814|Fibromyalgia|fibromyalgia
72646|NCT02829814|FM|fm
72647|NCT02829801|animal assisted therapy|animal assisted therapy
72648|NCT02829801|well-being|well-being
72649|NCT02829801|Alzheimer's Disease|alzheimer's disease
72650|NCT02829788|Digestive peritoneal carcinomatosis|digestive peritoneal carcinomatosis
72651|NCT02829788|laparoscopy|laparoscopy
72652|NCT02829788|laparotomy|laparotomy
72653|NCT02829788|peritoneal cancer index (PCI)|peritoneal cancer index (pci)
72654|NCT02829788|staging|staging
72655|NCT02829762|isolated|isolated
72656|NCT02829762|at risk of isolation|at risk of isolation
72657|NCT02829762|patients|patients
72658|NCT02829749|Heart Valve Diseases|heart valve diseases
72659|NCT02829749|Heart failure|heart failure
72660|NCT02829749|Heart diseases|heart diseases
72661|NCT02829749|Mitral valve insufficiency|mitral valve insufficiency
72662|NCT02829736|lung neoplasm|lung neoplasm
72663|NCT02829736|lung metastasis|lung metastasis
72664|NCT02829736|enhanced recovery after surgery|enhanced recovery after surgery
72665|NCT02829736|fast-track surgery|fast-track surgery
72666|NCT02829736|intraoperative chest tube removal|intraoperative chest tube removal
72668|NCT02829736|lung function|lung function
72669|NCT02829736|reasons for admission|reasons for admission
72670|NCT02829723|Phase I/II|phase i/ii
72671|NCT02829723|BLZ945|blz945
72672|NCT02829723|PDR001|pdr001
72673|NCT02829723|CSF-1R|csf-1r
72674|NCT02829723|PD-1|pd-1
72675|NCT02829710|Analgesia|analgesia
72676|NCT02829710|intensive care units|intensive care units
72677|NCT02829710|clinical protocol|clinical protocol
72678|NCT02829710|deep sedation|deep sedation
72679|NCT02829710|nursing assessment|nursing assessment
72680|NCT02829697|Regional anaesthesia|regional anaesthesia
72681|NCT02829671|Loneliness|loneliness
72682|NCT02829671|Suicidal behavior|suicidal behavior
72683|NCT02829671|Depression|depression
72684|NCT02829645|eating disoders|eating disoders
72685|NCT02829645|neuropsychology|neuropsychology
72686|NCT02829645|pronostic|pronostic
72687|NCT02829632|mobile technology|mobile technology
72688|NCT02829632|feedback message|feedback message
72690|NCT02829619|Obesity|obesity
72691|NCT02829619|Nutrigenetics|nutrigenetics
72693|NCT02829619|Weight loss|weight loss
72694|NCT02829606|Age-related Macular Degeneration|age-related macular degeneration
72695|NCT02829606|Central Scotoma|central scotoma
72696|NCT02829606|Head Mounted Display|head mounted display
72697|NCT02829580|endothelial function|endothelial function
72698|NCT02829580|flow-mediated dilation|flow-mediated dilation
72699|NCT02829580|vascular elastic properties|vascular elastic properties
72700|NCT02829554|Emotion|emotion
72701|NCT02829554|Judgment|judgment
72702|NCT02829554|Decision Making|decision making
72703|NCT02829541|Single Ascending Dose (SAD), Healthy Volunteers|single ascending dose (sad), healthy volunteers
72704|NCT02829502|Cerebrovascular disease|cerebrovascular disease
72705|NCT02829502|Glucagon like peptide 1|glucagon like peptide 1
72706|NCT02829489|nutrition|nutrition
72707|NCT02829489|foregut tumors|foregut tumors
72708|NCT02829489|patient related outcomes|patient related outcomes
84743|NCT02758210|Tablet|tablet
64077|NCT02883959|music|music
64078|NCT02883842|Coronary artery disease|coronary artery disease
64079|NCT02883842|Diabetes|diabetes
72709|NCT02829489|audit|audit
72710|NCT02829476|Adolescent idiopathic Scoliosis|adolescent idiopathic scoliosis
72711|NCT02829476|Ghrelin|ghrelin
72712|NCT02829450|peritoneal ultrafiltration|peritoneal ultrafiltration
72713|NCT02829450|congestive heart failure|congestive heart failure
72714|NCT02829450|chronic kidney disease|chronic kidney disease
72715|NCT02829398|cerebral ischemia|cerebral ischemia
72716|NCT02829385|Apatinib|apatinib
72717|NCT02829385|XELOX Regimen|xelox regimen
72718|NCT02829385|metastatic colorectal cancer|metastatic colorectal cancer
72719|NCT02829346|Tranexamic acid|tranexamic acid
72720|NCT02829346|Peri-articular injection|peri-articular injection
72721|NCT02829346|Total knee arthroplasty|total knee arthroplasty
72722|NCT02829346|Blood loss|blood loss
72723|NCT02829346|Osteoarthritis, Knee|osteoarthritis, knee
72724|NCT02829333|analgesia|analgesia
72725|NCT02829333|anesthesia|anesthesia
72726|NCT02829333|leiomyomas|leiomyomas
72727|NCT02829333|tumor|tumor
72728|NCT02829333|vascular endothelial growth factor|vascular endothelial growth factor
72729|NCT02829333|anesthesia technique on tumor|anesthesia technique on tumor
72730|NCT02829320|efficacy|efficacy
72731|NCT02829320|hemodialysis (HD)|hemodialysis (hd)
72732|NCT02829320|hemoglobin (Hgb)|hemoglobin (hgb)
72733|NCT02829320|erythropoiesis-stimulating agents (ESAs)|erythropoiesis-stimulating agents (esas)
72734|NCT02829320|GSK1278863|gsk1278863
72735|NCT02829307|89Zirconium|89zirconium
72736|NCT02829307|Open label|open label
72737|NCT02829307|Pharmacokinetics|pharmacokinetics
72738|NCT02829307|Radioactive|radioactive
72739|NCT02829307|Clearance|clearance
72740|NCT02829307|Biodistribution|biodistribution
72741|NCT02829281|knee osteoarthritis|knee osteoarthritis
72742|NCT02829281|Intra-articular injection|intra-articular injection
72743|NCT02829281|Botulinum Toxin Type A|botulinum toxin type a
72744|NCT02829281|Corticosteroid|corticosteroid
72745|NCT02829268|Wolfram syndrome|wolfram syndrome
72746|NCT02829268|Diabetes Mellitus|diabetes mellitus
72747|NCT02829268|Optic Nerve Atrophy|optic nerve atrophy
72748|NCT02829268|Ataxia|ataxia
72749|NCT02829268|Endoplasmic Reticulum Stress|endoplasmic reticulum stress
72750|NCT02829255|High altitude|high altitude
72751|NCT02829255|Cerebral autoregulation|cerebral autoregulation
72752|NCT02829255|Transfer function analysis|transfer function analysis
72753|NCT02829242|Near Infrared Spectroscopy|near infrared spectroscopy
72754|NCT02829242|Somatic Saturation|somatic saturation
72755|NCT02829242|Well Leg Compartment Syndrome|well leg compartment syndrome
72756|NCT02829242|Robotic Assisted Laparoscopic Surgery|robotic assisted laparoscopic surgery
72757|NCT02829242|Trendelenburg Position|trendelenburg position
72758|NCT02829216|myelosuppression|myelosuppression
72759|NCT02829216|mesenchymal stromal cells|mesenchymal stromal cells
72760|NCT02829203|Frailty|frailty
72761|NCT02829203|Surgery|surgery
72762|NCT02829190|External carotid artery|external carotid artery
72763|NCT02829190|Facial artery|facial artery
72764|NCT02829190|Lingual artery|lingual artery
72765|NCT02829190|Superior thyroid artery|superior thyroid artery
72766|NCT02829190|Internal maxillary artery|internal maxillary artery
72767|NCT02829190|Phase-contrast MRI|phase-contrast mri
72768|NCT02829190|Rate of flow|rate of flow
72769|NCT02829190|Superficial temporal artery|superficial temporal artery
72770|NCT02829177|Type 1 diabetes|type 1 diabetes
72771|NCT02829177|Diabetic nephropathy|diabetic nephropathy
72772|NCT02829177|Albuminuria|albuminuria
72773|NCT02829177|Allopurinol|allopurinol
72774|NCT02829164|Tonsillectomy|tonsillectomy
72775|NCT02829164|primary IgA nephropathy|primary iga nephropathy
72776|NCT02829164|primary nephropathy|primary nephropathy
72777|NCT02829164|IgA|iga
72778|NCT02829164|Berger's disease|berger's disease
72779|NCT02829164|Purpura rheumatoid|purpura rheumatoid
626784|NCT00687245|reflux|reflux
72780|NCT02829164|kidney failure|kidney failure
72781|NCT02829151|Peripheral artery disease|peripheral artery disease
72782|NCT02829151|Critical limb ischemia|critical limb ischemia
72783|NCT02829151|Angioplasty|angioplasty
72784|NCT02829151|Antiplatelet therapy|antiplatelet therapy
72785|NCT02829125|Early rehabilitation|early rehabilitation
72786|NCT02829125|abdominal surgery|abdominal surgery
72788|NCT02829112|Shulman|shulman
72789|NCT02829112|fasciitis|fasciitis
72790|NCT02829112|Shulman fasciitis|shulman fasciitis
72791|NCT02829112|eosinophilic fasciitis|eosinophilic fasciitis
72792|NCT02829112|inflammatory disease|inflammatory disease
72793|NCT02829112|prevalence|prevalence
72794|NCT02829073|Tinnitus|tinnitus
72795|NCT02829073|Double-blind|double-blind
72796|NCT02829073|Neuromonic Tinnitus Treatment Program|neuromonic tinnitus treatment program
72797|NCT02829073|Oasis™|oasis™
72798|NCT02829060|nephrolithiasis|nephrolithiasis
72799|NCT02829060|percutaneous nephrolithiasis|percutaneous nephrolithiasis
72800|NCT02829060|urinary tract infection (UTI)|urinary tract infection (uti)
72801|NCT02829060|Sepsis|sepsis
72802|NCT02829034|pulmonary hypertension|pulmonary hypertension
72803|NCT02829034|right ventricular function|right ventricular function
72804|NCT02829034|ranolazine|ranolazine
72805|NCT02829021|Sensitivity|sensitivity
72806|NCT02829021|Specificity|specificity
72807|NCT02829021|Breast cancer|breast cancer
72808|NCT02829021|Mammography|mammography
72809|NCT02829021|Thermography|thermography
72810|NCT02829021|Infrared|infrared
72811|NCT02829021|Dynamic|dynamic
72812|NCT02829021|Diagnostic accuracy|diagnostic accuracy
72813|NCT02829021|Diagnostic odds ratio|diagnostic odds ratio
72814|NCT02829008|HER2 negative breast cancer|her2 negative breast cancer
72815|NCT02829008|low-dose bevacizumab|low-dose bevacizumab
72816|NCT02829008|pemetrexed|pemetrexed
72817|NCT02828995|Diabetes Mellitus|diabetes mellitus
72818|NCT02828995|Stigma|stigma
72819|NCT02828995|Social Determinants of Health|social determinants of health
72820|NCT02828982|powered ankle prosthesis|powered ankle prosthesis
72821|NCT02828982|activity monitoring|activity monitoring
72822|NCT02828982|muscle fatigue|muscle fatigue
72823|NCT02828982|below knee amputation|below knee amputation
72824|NCT02828969|Trajectory|trajectory
72825|NCT02828969|Emergency room|emergency room
72826|NCT02828969|Conduct disorder|conduct disorder
72827|NCT02828969|Care management|care management
72828|NCT02828956|eating disorders|eating disorders
72829|NCT02828956|ANSOCQ|ansocq
72830|NCT02828956|anorexia nervosa|anorexia nervosa
72831|NCT02828878|Apoptosis|apoptosis
72832|NCT02828878|FAS Ligand|fas ligand
72833|NCT02828878|Bone marrow transplantation|bone marrow transplantation
72834|NCT02828878|GvHD|gvhd
72835|NCT02828878|Stem cells|stem cells
72836|NCT02828865|Hepatocellular Carcinoma|hepatocellular carcinoma
72837|NCT02828865|irreversible electroporation|irreversible electroporation
72838|NCT02828865|liver cancer|liver cancer
72839|NCT02828852|pregnancy|pregnancy
72840|NCT02828852|platelets|platelets
72841|NCT02828839|Transperineal|transperineal
72842|NCT02828839|Transrectal|transrectal
72843|NCT02828839|Needle Guide|needle guide
72844|NCT02828839|Biopsy|biopsy
72845|NCT02828761|chest pain|chest pain
72846|NCT02828761|calcium score|calcium score
72847|NCT02828761|coronary calcium score|coronary calcium score
72848|NCT02828761|coronary calcium scoring|coronary calcium scoring
72849|NCT02828761|calcium scoring|calcium scoring
72850|NCT02828761|cacs|cacs
72851|NCT02828761|ccs|ccs
72852|NCT02828748|cannabinoids|cannabinoids
72853|NCT02828748|inflammatory bowel disease|inflammatory bowel disease
72854|NCT02828722|Circadian rhythm|circadian rhythm
72855|NCT02828722|Critical Illness|critical illness
72856|NCT02828722|Mechanical ventilation|mechanical ventilation
72857|NCT02828722|Environmental modulation|environmental modulation
72858|NCT02828696|CAD-CAM composites|cad-cam composites
72859|NCT02828696|Worn dentition|worn dentition
72860|NCT02828696|minimally invasive treatment|minimally invasive treatment
72861|NCT02828683|DES|des
72862|NCT02828683|PCI|pci
72863|NCT02828683|STEMI|stemi
72864|NCT02828683|Interventional Cardiology|interventional cardiology
72865|NCT02828657|ORBERA|orbera
72866|NCT02828644|ADHD|adhd
72867|NCT02828592|SAA|saa
72868|NCT02828579|obesity|obesity
72869|NCT02828579|bariatric surgery|bariatric surgery
72870|NCT02828579|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
72871|NCT02828553|Wearable device|wearable device
72872|NCT02828553|Fitbit|fitbit
72873|NCT02828553|Inpatient|inpatient
72874|NCT02828540|HT047|ht047
72875|NCT02828540|Pueraria lobata|pueraria lobata
72876|NCT02828540|Scutellaria baicalensis|scutellaria baicalensis
72877|NCT02828501|Pain Threshold|pain threshold
72878|NCT02828436|Hypertension|hypertension
72879|NCT02828436|High Blood Pressure|high blood pressure
72880|NCT02828423|periodontal regeneration|periodontal regeneration
72881|NCT02828410|serum bovine immunoglobulin protein isolate|serum bovine immunoglobulin protein isolate
72882|NCT02828410|IPAA|ipaa
72883|NCT02828410|quality of life|quality of life
72884|NCT02828384|fodmap diet|fodmap diet
72885|NCT02828332|Autism Spectrum Disorders|autism spectrum disorders
72886|NCT02828332|Cohort|cohort
72887|NCT02828306|stroke|stroke
72888|NCT02828306|head trauma|head trauma
72889|NCT02828306|Patient Specific Implant|patient specific implant
72890|NCT02828306|skull defect|skull defect
72891|NCT02828267|Tanzania|tanzania
72892|NCT02828267|Alcohol Use|alcohol use
72893|NCT02828267|Brief Intervention|brief intervention
72894|NCT02828228|obesity|obesity
72895|NCT02828228|weight loss|weight loss
72896|NCT02828228|vitamin D deficiency|vitamin d deficiency
72897|NCT02828228|body composition|body composition
72898|NCT02828202|Melanoma|melanoma
72899|NCT02828202|Skin|skin
72900|NCT02828202|Biobank|biobank
72901|NCT02828189|Physical Therapy Modalities|physical therapy modalities
72902|NCT02828189|Breast Cancer Treatment|breast cancer treatment
72903|NCT02828189|Exercise Therapy|exercise therapy
72904|NCT02828189|Dyspnea|dyspnea
72905|NCT02828176|cardiometry|cardiometry
72906|NCT02828176|uterine displacement|uterine displacement
72907|NCT02828111|Gorlin Syndrome|gorlin syndrome
72908|NCT02828111|Basal Cell Nevus Syndrome BCNS|basal cell nevus syndrome bcns
72909|NCT02828111|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
72910|NCT02828111|Basal cell carcinoma|basal cell carcinoma
72911|NCT02828111|Hedgehog inhibitor|hedgehog inhibitor
72912|NCT02828111|Surgically Eligible Basal Cell Carcinomas|surgically eligible basal cell carcinomas
72913|NCT02828098|aggressive solid tumors|aggressive solid tumors
72914|NCT02828059|Caesarean section|caesarean section
72915|NCT02828007|EIT|eit
72916|NCT02828007|NIV|niv
72917|NCT02827968|PDL-1|pdl-1
72918|NCT02827942|pylori|pylori
72919|NCT02827903|Metformin|metformin
72920|NCT02827903|Rosuvastatin|rosuvastatin
72921|NCT02827903|type 2 diabetes|type 2 diabetes
72922|NCT02827903|dyslipidemia|dyslipidemia
72923|NCT02827864|Mirror therapy|mirror therapy
72924|NCT02827864|transcranial direct current stimulation|transcranial direct current stimulation
72925|NCT02827864|stroke|stroke
72926|NCT02827864|neurorehabilitation|neurorehabilitation
72927|NCT02827851|Damage of articular cartilage|damage of articular cartilage
72928|NCT02827851|Cartilage degeneration|cartilage degeneration
72929|NCT02827851|Intraarticular injection|intraarticular injection
72930|NCT02827851|SVF|svf
72931|NCT02827851|Stromal vascular fraction|stromal vascular fraction
72932|NCT02827851|Adipose-derived regenerative cells (ADRC)|adipose-derived regenerative cells (adrc)
72933|NCT02827851|Adipose tissue|adipose tissue
72934|NCT02827851|Stem cells|stem cells
72935|NCT02827825|Neurosurgical|neurosurgical
72936|NCT02827825|Intensive Care|intensive care
72937|NCT02827799|heart failure|heart failure
72938|NCT02827799|insomnia|insomnia
72939|NCT02827799|sleep disorders|sleep disorders
72940|NCT02827799|actigraphy|actigraphy
72941|NCT02827799|cardiomyopathy|cardiomyopathy
72942|NCT02827799|depression|depression
72943|NCT02827799|sleepiness|sleepiness
72944|NCT02827799|anxiety|anxiety
72945|NCT02827799|fatigue|fatigue
72946|NCT02827786|hepatic tumours|hepatic tumours
72947|NCT02827773|Literacy|literacy
72948|NCT02827747|Keratoconus progression|keratoconus progression
72949|NCT02827747|Vitamins and keratoconus|vitamins and keratoconus
72950|NCT02827747|Vitamin supplementation|vitamin supplementation
72951|NCT02827682|IoC|ioc
72952|NCT02827682|monitor|monitor
72953|NCT02827682|elderly|elderly
72954|NCT02827682|postoperative effectiveness|postoperative effectiveness
72955|NCT02827656|Fertilization in vitro|fertilization in vitro
72956|NCT02827656|Luteal Phase|luteal phase
72957|NCT02827656|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
72958|NCT02827617|Ibrutinib|ibrutinib
72959|NCT02827617|TP53|tp53
72960|NCT02827617|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
72961|NCT02827604|Caesarean section|caesarean section
72962|NCT02827604|lower uterine segment|lower uterine segment
72963|NCT02827604|sonography|sonography
72964|NCT02827591|repeat cesarean section|repeat cesarean section
72965|NCT02827591|lower uterine segment|lower uterine segment
72966|NCT02827591|quantitative sonography|quantitative sonography
72967|NCT02827565|colorectal cancer|colorectal cancer
72968|NCT02827565|Kras mutation|kras mutation
72969|NCT02827565|Nras mutation|nras mutation
72970|NCT02827565|Braf mutation|braf mutation
72971|NCT02827552|pediatric oncology|pediatric oncology
72972|NCT02827552|radiotherapy|radiotherapy
72973|NCT02827552|radiosensitivity|radiosensitivity
72974|NCT02827513|Centanafadine|centanafadine
72975|NCT02827513|Adult attention-deficit hyperactivity disorder|adult attention-deficit hyperactivity disorder
72976|NCT02827513|Healthy participants|healthy participants
72977|NCT02827448|Left Ventricular Assist Device|left ventricular assist device
72978|NCT02827448|Heart transplantation|heart transplantation
72979|NCT02827448|Perioperative|perioperative
72980|NCT02827448|Acute Kidney Injury|acute kidney injury
72981|NCT02827448|Renal|renal
72982|NCT02827448|Kidney|kidney
72983|NCT02827448|Total Artificial Heart|total artificial heart
72984|NCT02827422|therapeutic hypothermia|therapeutic hypothermia
72985|NCT02827409|Delayed cord clamping|delayed cord clamping
72986|NCT02827396|Disability|disability
72987|NCT02827396|children|children
72988|NCT02827396|parents|parents
72989|NCT02827396|depression|depression
72990|NCT02827396|knowledge|knowledge
72991|NCT02827396|psychosocial intervention|psychosocial intervention
72992|NCT02827344|PD-1/PD-L1|pd-1/pd-l1
73297|NCT02825602|health|health
72993|NCT02827344|Immune checkpoints|immune checkpoints
72994|NCT02827344|Immunotherapy|immunotherapy
72995|NCT02827344|lung cancer|lung cancer
72996|NCT02827344|circulating tumor cells|circulating tumor cells
72997|NCT02827344|immunocytochemistry|immunocytochemistry
72998|NCT02827344|ISET|iset
72999|NCT02827344|MDSC|mdsc
73000|NCT02827344|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
73001|NCT02827331|Benzodiazepines|benzodiazepines
73002|NCT02827331|Fracture|fracture
73003|NCT02827318|Blood glucose|blood glucose
73004|NCT02827305|antiplaque|antiplaque
73005|NCT02827305|antigingivitis|antigingivitis
73006|NCT02827292|music|music
73007|NCT02827292|inflammation|inflammation
73008|NCT02827279|Autism Spectrum Disorder|autism spectrum disorder
73009|NCT02827279|Emotion|emotion
73010|NCT02827253|brain|brain
73011|NCT02827253|haemodialysis|haemodialysis
73012|NCT02827253|intradialytic hypotension|intradialytic hypotension
73013|NCT02827240|Female sex workers|female sex workers
73014|NCT02827240|HIV testing|hiv testing
73015|NCT02827240|HIV self-test|hiv self-test
73016|NCT02827227|HIV-infected patients|hiv-infected patients
73017|NCT02827227|cART|cart
73018|NCT02827227|immune restoration|immune restoration
73019|NCT02827227|markers|markers
73020|NCT02827214|Thoracolumbar spine|thoracolumbar spine
73021|NCT02827214|Burst fractures|burst fractures
73022|NCT02827214|Conservative treatment|conservative treatment
73023|NCT02827214|Surgical treatment|surgical treatment
73024|NCT02827214|Thoracic or lumbar vertebrae|thoracic or lumbar vertebrae
73025|NCT02827201|pancreatic cancer|pancreatic cancer
73026|NCT02827162|Dengue Fever|dengue fever
73027|NCT02827162|Dengue Haemorrhagic Fever|dengue haemorrhagic fever
73028|NCT02827162|Tetravalent Dengue Vaccine|tetravalent dengue vaccine
73029|NCT02827149|HSCT|hsct
73030|NCT02827149|high resolution HLA typing|high resolution hla typing
73031|NCT02827149|unrelated donor|unrelated donor
73032|NCT02827084|electromyography|electromyography
73033|NCT02827084|torque|torque
73034|NCT02827084|quadriceps muscle|quadriceps muscle
73035|NCT02827058|Delivery, obstetric|delivery, obstetric
73036|NCT02827058|Analgesia, Epidural|analgesia, epidural
73037|NCT02827058|Injections, Epidural|injections, epidural
73038|NCT02827058|Needles|needles
73039|NCT02827058|Cesarean Section|cesarean section
73040|NCT02827032|Hypertension|hypertension
73041|NCT02827006|Bone graft|bone graft
73042|NCT02827006|Calcium phosphate bone cement|calcium phosphate bone cement
73044|NCT02827006|Xray|xray
73045|NCT02827006|CT|ct
73046|NCT02826993|PillCAM2|pillcam2
73047|NCT02826967|Hydro-San Plus colonic irrigation system|hydro-san plus colonic irrigation system
73048|NCT02826967|Screening colonoscopy|screening colonoscopy
73049|NCT02826954|Paranasal Sinus Diseases|paranasal sinus diseases
73050|NCT02826954|Nasal Obstruction|nasal obstruction
73051|NCT02826941|hypothermia treatment|hypothermia treatment
73052|NCT02826915|newborn|newborn
73053|NCT02826915|infant|infant
73054|NCT02826915|child|child
73055|NCT02826915|EEG|eeg
73056|NCT02826915|NIRS|nirs
73057|NCT02826902|Total intravenous anesthesia|total intravenous anesthesia
73058|NCT02826902|desflurane|desflurane
73059|NCT02826902|QoR-40|qor-40
73060|NCT02826902|cosmetic lower limb lengthening|cosmetic lower limb lengthening
73061|NCT02826889|Fluid responsiveness|fluid responsiveness
73062|NCT02826889|pulse pressure variation|pulse pressure variation
73063|NCT02826889|pleth variability index|pleth variability index
73064|NCT02826889|prone position|prone position
73065|NCT02826876|Laparoscopic surgery|laparoscopic surgery
73066|NCT02826863|seizure|seizure
73067|NCT02826863|tonic-atonic|tonic-atonic
73068|NCT02826863|epilepsy|epilepsy
73069|NCT02826863|myoclonic|myoclonic
73070|NCT02826863|encephalopathy|encephalopathy
73071|NCT02826850|Osteoarthritis, Knee|osteoarthritis, knee
73072|NCT02826850|Pulsed Radiofrequency Treatment|pulsed radiofrequency treatment
73073|NCT02826850|Ultrasonography, Interventional|ultrasonography, interventional
73074|NCT02826837|Advanced Colorectal Cancer|advanced colorectal cancer
73075|NCT02826824|corpus callosum agenesis|corpus callosum agenesis
73076|NCT02826824|agenesis|agenesis
73077|NCT02826824|corpus callosum|corpus callosum
73078|NCT02826811|Graft dysfunction|graft dysfunction
73079|NCT02826811|Graft loss|graft loss
73080|NCT02826811|kidney|kidney
73085|NCT02826811|Immunosuppression|immunosuppression
73086|NCT02826811|Prognostic markers|prognostic markers
73088|NCT02826798|VBI-1501|vbi-1501
73089|NCT02826798|prophylactic vaccine|prophylactic vaccine
73090|NCT02826798|virus diseases|virus diseases
73091|NCT02826798|cytomegalovirus|cytomegalovirus
73092|NCT02826798|CMV|cmv
73093|NCT02826798|cytomegalovirus infections|cytomegalovirus infections
73094|NCT02826798|cytomegalovirus vaccines|cytomegalovirus vaccines
73095|NCT02826798|Herpesviridae Infections|herpesviridae infections
73096|NCT02826798|Phase 1|phase 1
73097|NCT02826798|Human Herpesvirus 5|human herpesvirus 5
73098|NCT02826798|HHV5|hhv5
73099|NCT02826798|Vaccines, virus-like particle|vaccines, virus-like particle
73101|NCT02826798|enveloped virus-like particle|enveloped virus-like particle
73102|NCT02826798|eVLP|evlp
73103|NCT02826759|sphingolipid|sphingolipid
73104|NCT02826759|diabetes mellitus|diabetes mellitus
73105|NCT02826759|biomarker|biomarker
64483|NCT02881502|HDAC2|hdac2
73106|NCT02826759|obesity|obesity
73107|NCT02826759|insulin resistance|insulin resistance
73108|NCT02826733|preterm infants|preterm infants
73109|NCT02826733|term infants|term infants
73110|NCT02826733|hemispheric dominance|hemispheric dominance
73111|NCT02826720|HDL cholesterol|hdl cholesterol
73112|NCT02826720|Hyperlipidemia|hyperlipidemia
73113|NCT02826720|LDL cholesterol|ldl cholesterol
73114|NCT02826720|Periodontal disease|periodontal disease
73115|NCT02826720|Triglyceride|triglyceride
73116|NCT02826655|WF-OCT|wf-oct
73117|NCT02826655|OCT|oct
73118|NCT02826655|diabetic retinopathy|diabetic retinopathy
73119|NCT02826655|diabetic macular edema|diabetic macular edema
73120|NCT02826642|newly diagnosed acute myeloid leukemia|newly diagnosed acute myeloid leukemia
73121|NCT02826642|AML|aml
73122|NCT02826642|myeloid dysplastic syndrome|myeloid dysplastic syndrome
73123|NCT02826642|MDS|mds
73124|NCT02826642|IDH305|idh305
73125|NCT02826642|standard of care in IDH1 mutant acute myeloid leukemia|standard of care in idh1 mutant acute myeloid leukemia
73126|NCT02826629|Sensorimotor Integration|sensorimotor integration
73127|NCT02826629|Schizophrenia|schizophrenia
73129|NCT02826629|Oculomotor|oculomotor
73130|NCT02826629|Motor Control|motor control
73131|NCT02826616|Trimetazidine|trimetazidine
73132|NCT02826616|ST-segment elevation myocardial|st-segment elevation myocardial
73133|NCT02826616|Reperfusion injury|reperfusion injury
73134|NCT02826616|Percutaneous coronary intervention|percutaneous coronary intervention
73135|NCT02826603|Plaque psoriasis,|plaque psoriasis,
73136|NCT02826603|secukinumab,|secukinumab,
73137|NCT02826603|ustekinumab|ustekinumab
73138|NCT02826564|radiotherapy|radiotherapy
73139|NCT02826564|immunotherapy|immunotherapy
73140|NCT02826512|BRCA1-like|brca1-like
73141|NCT02826512|HER2 negative|her2 negative
73142|NCT02826499|Pediguard|pediguard
73143|NCT02826499|Pedicular screws|pedicular screws
73144|NCT02826499|Fluoroscopy|fluoroscopy
73149|NCT02826460|Transplant|transplant
73150|NCT02826460|Adherence|adherence
73151|NCT02826434|Breast Cancer|breast cancer
73152|NCT02826434|vaccine|vaccine
73153|NCT02826434|immunotherapy|immunotherapy
73154|NCT02826434|PD-L1 Inhibitor|pd-l1 inhibitor
73155|NCT02826434|triple negative breast cancer|triple negative breast cancer
73156|NCT02826421|Intraocular lens|intraocular lens
73157|NCT02826395|Prostate cancer|prostate cancer
73158|NCT02826395|diagnostic|diagnostic
73159|NCT02826395|imaging|imaging
73160|NCT02826395|PET/CT|pet/ct
73161|NCT02826395|Acetate carbon-11|acetate carbon-11
73162|NCT02826369|Algorithms|algorithms
73163|NCT02826369|Image Processing, Computer-Assisted/methods*|image processing, computer-assisted/methods*
73164|NCT02826369|Magnetic Resonance Imaging/methods*|magnetic resonance imaging/methods*
73165|NCT02826369|Data Compression|data compression
73166|NCT02826369|Breast Neoplasms|breast neoplasms
73167|NCT02826356|Angioedema|angioedema
73168|NCT02826356|Emergency treatment|emergency treatment
73169|NCT02826356|Treatment availability|treatment availability
73170|NCT02826356|Health Equity|health equity
73171|NCT02826343|COPD|copd
73172|NCT02826330|Crohn's Disease|crohn's disease
73173|NCT02826330|Healthy relatives|healthy relatives
73174|NCT02826330|Dysbiosis|dysbiosis
73175|NCT02826330|Biomarkers|biomarkers
73176|NCT02826304|Vaginal Hysterectomy|vaginal hysterectomy
73177|NCT02826304|Laparoscopic assisted vaginal hysterectomy|laparoscopic assisted vaginal hysterectomy
73178|NCT02826304|Large uteri|large uteri
73179|NCT02826291|OSNA|osna
73180|NCT02826291|sentinel|sentinel
73181|NCT02826291|lymph|lymph
73182|NCT02826291|node|node
73183|NCT02826291|endometrial|endometrial
73184|NCT02826291|cancer|cancer
73185|NCT02826278|Newborn genitalia|newborn genitalia
73186|NCT02826278|reference charts|reference charts
73187|NCT02826252|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
73188|NCT02826213|Renal infusion|renal infusion
73189|NCT02826213|Renal infusion device|renal infusion device
73190|NCT02826200|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
73191|NCT02826200|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
73192|NCT02826200|Prosthetic Cardiac Valve Thrombosis|prosthetic cardiac valve thrombosis
73193|NCT02826200|Cerebrovascular Accident|cerebrovascular accident
73194|NCT02826200|Prosthetic Valve Malfunction|prosthetic valve malfunction
73195|NCT02826200|Four-dimensional volume rendered cardiac CT|four-dimensional volume rendered cardiac ct
73196|NCT02826200|Transesophageal echocardiography|transesophageal echocardiography
73197|NCT02826200|Transthoracic echocardiography|transthoracic echocardiography
73198|NCT02826200|Brain MRI|brain mri
73199|NCT02826187|Acetabular implant|acetabular implant
73200|NCT02826161|Neoplasms|neoplasms
73201|NCT02826161|Neoplasms by Site|neoplasms by site
73202|NCT02826161|Lung Neoplasms|lung neoplasms
73203|NCT02826161|Thoracic Neoplasms|thoracic neoplasms
73204|NCT02826161|Respiratory Tract Neoplasms|respiratory tract neoplasms
73205|NCT02826161|Bronchial Neoplasms|bronchial neoplasms
73206|NCT02826096|Psychiatry|psychiatry
73207|NCT02826096|psychological|psychological
73208|NCT02826096|psychotherapy|psychotherapy
73209|NCT02826096|randomize|randomize
73210|NCT02826096|Biofeedback|biofeedback
73211|NCT02826070|Chronic Hepatitis B|chronic hepatitis b
73212|NCT02826031|Sodium Hyaluronate|sodium hyaluronate
73213|NCT02826031|mild to moderate knee osteoarthritis|mild to moderate knee osteoarthritis
73214|NCT02826018|RNAi therapeutic|rnai therapeutic
73215|NCT02826018|Hepatitis B|hepatitis b
73216|NCT02826018|Chronic Hepatitis B|chronic hepatitis b
73217|NCT02826018|Hepatitis B, Chronic|hepatitis b, chronic
73218|NCT02826018|Hepatitis B Infection|hepatitis b infection
73220|NCT02825927|Dysphagia|dysphagia
73221|NCT02825927|Oral screen|oral screen
73222|NCT02825927|Intervention|intervention
73223|NCT02825927|Oral Health|oral health
73224|NCT02825927|Food Intake|food intake
73225|NCT02825927|Quality of life|quality of life
73226|NCT02825927|Elderly|elderly
73227|NCT02825927|Short-term care facilities|short-term care facilities
73228|NCT02825914|glycopeptides|glycopeptides
73229|NCT02825914|human microbiome|human microbiome
73230|NCT02825914|caseinomacropeptide|caseinomacropeptide
73231|NCT02825914|whey protein|whey protein
73232|NCT02825914|dietary proteins|dietary proteins
73233|NCT02825849|endometrium|endometrium
73234|NCT02825849|thin uterine lining|thin uterine lining
73235|NCT02825849|uterine scarring|uterine scarring
73236|NCT02825836|M7583|m7583
73237|NCT02825836|Bruton's Tyrosine Kinase Inhibitor|bruton's tyrosine kinase inhibitor
73238|NCT02825836|Lymphoma|lymphoma
73239|NCT02825836|Open|open
73240|NCT02825836|Phase I|phase i
73241|NCT02825810|breast cancer|breast cancer
73242|NCT02825810|long-term survival|long-term survival
73243|NCT02825810|motor control|motor control
73244|NCT02825810|cervical pain|cervical pain
73245|NCT02825797|Broadly neutralizing antibody|broadly neutralizing antibody
73246|NCT02825797|3BNC117|3bnc117
73247|NCT02825797|10-1074|10-1074
73248|NCT02825784|potassium chronic kidney disease CKD children|potassium chronic kidney disease ckd children
73249|NCT02825758|Micronutrients|micronutrients
73250|NCT02825758|restricted|restricted
73251|NCT02825758|ketogenic|ketogenic
73252|NCT02825758|diet|diet
73253|NCT02825758|acceptability|acceptability
73254|NCT02825732|Alzheimer's disease or related disorder|alzheimer's disease or related disorder
73255|NCT02825732|Comorbidity|comorbidity
73256|NCT02825732|Charlson comorbidity index|charlson comorbidity index
73257|NCT02825732|Caregiver burden|caregiver burden
73258|NCT02825732|Cohort|cohort
73259|NCT02825732|Dementia|dementia
73260|NCT02825732|Behavioral disorders|behavioral disorders
73261|NCT02825732|Functional dependency|functional dependency
73262|NCT02825719|Fibroid|fibroid
73263|NCT02825719|Ulipristal|ulipristal
73264|NCT02825719|Selective progesterone receptor modulator|selective progesterone receptor modulator
73265|NCT02825719|Chinese|chinese
73266|NCT02825706|Hemophilia|hemophilia
73267|NCT02825706|Educational Physiotherapy|educational physiotherapy
73268|NCT02825706|Pain|pain
73269|NCT02825706|Quality of life|quality of life
73270|NCT02825706|Illness Behaviour|illness behaviour
73271|NCT02825706|Elbow|elbow
73272|NCT02825680|Weight Loss|weight loss
73273|NCT02825680|Body Weight Maintenance|body weight maintenance
73274|NCT02825680|Quality Improvement|quality improvement
73275|NCT02825667|Haemophilia|haemophilia
73276|NCT02825667|Ankle|ankle
73277|NCT02825667|Arthropathy|arthropathy
73278|NCT02825667|Pain|pain
73279|NCT02825667|Range of motion|range of motion
73280|NCT02825667|Myofascial techniques|myofascial techniques
73284|NCT02825654|Epidemiologic|epidemiologic
73285|NCT02825654|Observational|observational
73286|NCT02825654|Interview or questionnaire|interview or questionnaire
73287|NCT02825654|Deployment related|deployment related
73288|NCT02825654|Enduring Freedom|enduring freedom
73289|NCT02825654|Iraqi Freedom|iraqi freedom
73290|NCT02825615|radial artery cannulation|radial artery cannulation
73291|NCT02825615|ultrasound guided|ultrasound guided
73292|NCT02825615|first success rate|first success rate
73293|NCT02825615|systolic blood pressure|systolic blood pressure
73294|NCT02825615|shock|shock
73295|NCT02825602|Vietnam veteran|vietnam veteran
73296|NCT02825602|aging|aging
73299|NCT02825602|Conventional Warfare|conventional warfare
73300|NCT02825602|Toxic Effect|toxic effect
73301|NCT02825602|Chemical|chemical
73305|NCT02825550|Hepatoma|hepatoma
73306|NCT02825550|Transcatheter Arterial chemo-embolization|transcatheter arterial chemo-embolization
73308|NCT02825511|basal cell carcinoma, histological diagnosis, prognostic impact|basal cell carcinoma, histological diagnosis, prognostic impact
73309|NCT02825472|Congenital Heart Disease|congenital heart disease
73310|NCT02825472|Sport|sport
73311|NCT02825472|Exercise training|exercise training
73312|NCT02825459|abstinence|abstinence
73313|NCT02825459|abuse liability|abuse liability
73314|NCT02825459|electronic cigarette|electronic cigarette
73315|NCT02825459|e-cigarette|e-cigarette
73316|NCT02825459|electronic nicotine delivery device|electronic nicotine delivery device
73317|NCT02825459|harm reduction|harm reduction
73318|NCT02825459|nicotine|nicotine
73319|NCT02825459|nicotine dependence|nicotine dependence
73320|NCT02825459|smoking|smoking
73321|NCT02825459|smoking cessation|smoking cessation
73322|NCT02825459|tobacco|tobacco
73323|NCT02825459|vape|vape
73324|NCT02825459|vaping|vaping
73325|NCT02825459|withdrawal|withdrawal
73326|NCT02825446|radio frequency denervation|radio frequency denervation
73327|NCT02825446|tibial arteries|tibial arteries
73328|NCT02825446|atherosclerosis of the peripheral arteries|atherosclerosis of the peripheral arteries
73329|NCT02825381|Arthroplasty|arthroplasty
73330|NCT02825381|Hip|hip
73331|NCT02825355|robotic surgery procedure|robotic surgery procedure
73332|NCT02825355|indocyanine green|indocyanine green
73333|NCT02825355|sentinel lymph node mapping|sentinel lymph node mapping
73334|NCT02825342|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
73335|NCT02825342|Proton Pump Inhibitor (PPI)|proton pump inhibitor (ppi)
73336|NCT02825316|Crohn's disease|crohn's disease
73337|NCT02825316|inflammatory bowel diseases|inflammatory bowel diseases
73338|NCT02825316|Mediterranean diet|mediterranean diet
73339|NCT02825316|microbiome|microbiome
73340|NCT02825303|postural changes|postural changes
73341|NCT02825303|Height adjustable desk|height adjustable desk
73342|NCT02825303|Prolonged sitting|prolonged sitting
73343|NCT02825303|Cognitive performance|cognitive performance
73344|NCT02825290|Frozen-thawed embryo transfer (FET)|frozen-thawed embryo transfer (fet)
73345|NCT02825290|Luteal support|luteal support
73346|NCT02825290|Progesterone|progesterone
73347|NCT02825290|Natural cycle|natural cycle
73348|NCT02825290|Cryopreservation|cryopreservation
73349|NCT02825290|IVF|ivf
73350|NCT02825290|hCG|hcg
73351|NCT02825290|GnRH-Agonist|gnrh-agonist
73352|NCT02825290|Pregnancy rate|pregnancy rate
73353|NCT02825277|3D Power Doppler|3d power doppler
73354|NCT02825277|uteroplacental vascularization|uteroplacental vascularization
73355|NCT02825277|preeclampsia|preeclampsia
73356|NCT02825277|intra-uterine growth restriction|intra-uterine growth restriction
73357|NCT02825277|placental morphology|placental morphology
73358|NCT02825264|Glaucoma Drainage Device|glaucoma drainage device
73359|NCT02825264|STARflo|starflo
73360|NCT02825238|exercise|exercise
73361|NCT02825238|osteoarthritis|osteoarthritis
73362|NCT02825238|knee|knee
73363|NCT02825238|patellofemoral pain|patellofemoral pain
73364|NCT02825225|Prostatic Neoplasms|prostatic neoplasms
73365|NCT02825225|Biopsy|biopsy
73366|NCT02825225|Anesthesia|anesthesia
73367|NCT02825225|Detection|detection
73368|NCT02825212|Hepatitis C|hepatitis c
73369|NCT02825212|Cryoglobulinemia|cryoglobulinemia
73370|NCT02825160|Iloprost|iloprost
73371|NCT02825160|Ventavis|ventavis
73372|NCT02825160|Prostacycline analogue|prostacycline analogue
73373|NCT02825160|Pulmonary arterial hypertension|pulmonary arterial hypertension
73374|NCT02825160|Japan|japan
73375|NCT02825160|Post-marketing surveillance|post-marketing surveillance
73376|NCT02825147|pegaspargase,methotrexate|pegaspargase,methotrexate
73377|NCT02825134|heart valve disease|heart valve disease
73378|NCT02825134|valvular bioprosthesis|valvular bioprosthesis
73379|NCT02825134|aortic valve replacement|aortic valve replacement
73380|NCT02825134|Randomized clinical trial|randomized clinical trial
73381|NCT02825108|human chorionic gonadotropin (hCG), implantation rate intrauterine hCG clinical pregnancy rate frozen embryo transfer cycles|human chorionic gonadotropin (hcg), implantation rate intrauterine hcg clinical pregnancy rate frozen embryo transfer cycles
73382|NCT02825095|malignant pleural effusion,talc pleurodesis,quality of life|malignant pleural effusion,talc pleurodesis,quality of life
73383|NCT02825082|Emergency general surgery|emergency general surgery
73384|NCT02825082|Geriatric|geriatric
73385|NCT02825082|Outcomes|outcomes
73386|NCT02825082|Frailty|frailty
73387|NCT02825043|COPD|copd
73388|NCT02825004|Burnout|burnout
73389|NCT02825004|Health Care Workers|health care workers
73390|NCT02825004|Coping Skills|coping skills
73391|NCT02825004|Clinical Trial|clinical trial
73392|NCT02824952|Tagrisso|tagrisso
73393|NCT02824952|AZD9291|azd9291
73394|NCT02824952|EGFRm|egfrm
73395|NCT02824952|NSCLC|nsclc
73396|NCT02824900|Vibration Stimuli|vibration stimuli
73397|NCT02824900|Contraversive Pusher Syndrome|contraversive pusher syndrome
73398|NCT02824887|Electroacupuncture|electroacupuncture
73399|NCT02824887|Deep needling|deep needling
73400|NCT02824887|Lumbar disc herniation five points|lumbar disc herniation five points
73401|NCT02824887|Long term effect|long term effect
73402|NCT02824887|Prospective cohort study|prospective cohort study
73403|NCT02824848|congenital muscular torticollis|congenital muscular torticollis
73404|NCT02824848|infants|infants
73405|NCT02824848|passive stretching|passive stretching
73406|NCT02824848|perception-action approach|perception-action approach
73407|NCT02824822|Sudden Unexpected Death in Epilepsy|sudden unexpected death in epilepsy
73408|NCT02824822|SUDEP|sudep
73409|NCT02824822|Sudden Cardiac Arrest|sudden cardiac arrest
73410|NCT02824822|Sudden Cardiac Death|sudden cardiac death
73411|NCT02824822|Sleep|sleep
73412|NCT02824822|Ion channel disease|ion channel disease
73413|NCT02824822|Long QT syndrome|long qt syndrome
73414|NCT02824822|Brugada|brugada
73415|NCT02824822|Catecholaminergic Polymorphic Ventricular Tachycardia|catecholaminergic polymorphic ventricular tachycardia
73416|NCT02824809|hypogonadism|hypogonadism
73417|NCT02824809|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
73418|NCT02824809|Severity of Illness Index|severity of illness index
73419|NCT02824809|Testosterone|testosterone
73420|NCT02824796|ADHD|adhd
73421|NCT02824783|colorectal surgery|colorectal surgery
73422|NCT02824783|enhanced recovery|enhanced recovery
73423|NCT02824757|interstitial lung disease|interstitial lung disease
73424|NCT02824757|glucocorticcoid|glucocorticcoid
73425|NCT02824757|glucose|glucose
73426|NCT02824757|continuous glucose monitor|continuous glucose monitor
73427|NCT02824744|Bronchiolitis|bronchiolitis
73428|NCT02824744|High flow nasal canula|high flow nasal canula
73429|NCT02824731|brain tumors|brain tumors
73430|NCT02824731|proton radiotherapy|proton radiotherapy
73431|NCT02824731|photon radiotherapy|photon radiotherapy
73432|NCT02824718|Hypoparathyroidism|hypoparathyroidism
73433|NCT02824718|PTH(1-34)|pth(1-34)
73434|NCT02824718|Thiazides|thiazides
73435|NCT02824718|Hypercalciuria|hypercalciuria
73436|NCT02824718|Calcium sensing receptor|calcium sensing receptor
73437|NCT02824705|Heart|heart
73438|NCT02824705|Abnormality|abnormality
73439|NCT02824705|Thoracic Aorta|thoracic aorta
73440|NCT02824705|Pericardium|pericardium
73441|NCT02824679|Normal labour|normal labour
73442|NCT02824679|Augmentation of labour|augmentation of labour
73443|NCT02824679|Hyoscine butylbromide|hyoscine butylbromide
73444|NCT02824653|acute GVHD|acute gvhd
73445|NCT02824653|chronic GVHD|chronic gvhd
73446|NCT02824653|steroid-refractory|steroid-refractory
73447|NCT02824653|Mesenchymal Stem Cells|mesenchymal stem cells
73448|NCT02824640|Addiction|addiction
73449|NCT02824640|Adherence|adherence
73450|NCT02824640|Adverse Effects|adverse effects
73451|NCT02824640|Direct Acting Antiviral Agent|direct acting antiviral agent
73452|NCT02824640|Chronic Hepatitis C|chronic hepatitis c
73453|NCT02824640|Resistance Development|resistance development
73454|NCT02824640|Methadone Clinic|methadone clinic
73455|NCT02824640|Primary Care|primary care
73456|NCT02824640|Directly Observed Therapy|directly observed therapy
73457|NCT02824640|Randomized Controlled Trial|randomized controlled trial
73458|NCT02824640|Resistance|resistance
73459|NCT02824640|Reinfection|reinfection
73460|NCT02824640|Treatment Outcome|treatment outcome
73461|NCT02824640|Patient Navigation|patient navigation
73462|NCT02824640|Multi-Site|multi-site
73463|NCT02824640|Liver Disease|liver disease
73464|NCT02824640|Intervention|intervention
73465|NCT02824640|Sustained Viral Response|sustained viral response
73466|NCT02824588|Pain|pain
73467|NCT02824588|Working memory|working memory
73468|NCT02824575|breast cancer|breast cancer
73469|NCT02824575|chemotherapy|chemotherapy
73470|NCT02824575|metastasis|metastasis
73471|NCT02824575|tumor micro-environment|tumor micro-environment
73472|NCT02824549|Flash glucose monitoring|flash glucose monitoring
73473|NCT02824549|skin reactions|skin reactions
73474|NCT02824549|usability|usability
73475|NCT02824549|accuracy|accuracy
73477|NCT02824536|10-1074|10-1074
73478|NCT02824536|Broadly neutralizing antibody|broadly neutralizing antibody
73479|NCT02824536|HIV Prevention|hiv prevention
73480|NCT02824523|asthma|asthma
73481|NCT02824523|nasal polyps|nasal polyps
73482|NCT02824523|aspirin sensitivity|aspirin sensitivity
73483|NCT02824523|AERD|aerd
73484|NCT02824484|Guided written disclosure protocol|guided written disclosure protocol
73485|NCT02824484|Emotional disclosure|emotional disclosure
73486|NCT02824484|Meaning|meaning
73487|NCT02824484|Post-Traumatic Growth|post-traumatic growth
73488|NCT02824484|Cancer|cancer
73489|NCT02824471|Sickle Cell Disease|sickle cell disease
73490|NCT02824471|Biofluidic Chip Technology|biofluidic chip technology
73491|NCT02824458|EGFR tyrosine kinase inhibitors|egfr tyrosine kinase inhibitors
73492|NCT02824458|VEGFR inhibitor|vegfr inhibitor
73493|NCT02824458|NSCLC|nsclc
73494|NCT02824406|Sickle Cell Anemia|sickle cell anemia
73495|NCT02824406|Cerebrovascular Reserve|cerebrovascular reserve
73496|NCT02824406|Perfusion|perfusion
73497|NCT02824406|Vasculopathy|vasculopathy
73498|NCT02824406|Magnetic Resonance Imaging|magnetic resonance imaging
73499|NCT02824393|Mesenchymal stem cell|mesenchymal stem cell
73500|NCT02824393|Chronic autoimmune urticaria|chronic autoimmune urticaria
73501|NCT02824367|Parkinson|parkinson
73502|NCT02824367|Perfectionism|perfectionism
73503|NCT02824341|Parkinson 's disease|parkinson 's disease
73504|NCT02824341|REM sleep behavior disorder|rem sleep behavior disorder
73505|NCT02824341|Reward system|reward system
73506|NCT02824341|Functional MRI|functional mri
73507|NCT02824289|skin cancer|skin cancer
64863|NCT02879136|PD|pd
73508|NCT02824289|prevention|prevention
73509|NCT02824289|worksite|worksite
73510|NCT02824289|policy|policy
73511|NCT02824263|obstructive sleep apnea|obstructive sleep apnea
73512|NCT02824263|CPAP|cpap
73513|NCT02824263|metabolism|metabolism
73514|NCT02824250|Migraine|migraine
73515|NCT02824250|Mindfulness|mindfulness
73516|NCT02824250|MBSR|mbsr
73517|NCT02824224|levonorgestrel|levonorgestrel
73518|NCT02824224|breakthrough bleeding|breakthrough bleeding
73519|NCT02824198|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
73520|NCT02824198|Dengue Virus|dengue virus
73521|NCT02824198|CYD Dengue Vaccine|cyd dengue vaccine
73522|NCT02824185|FCH-PET/MRI|fch-pet/mri
73523|NCT02824185|primary HCC|primary hcc
73524|NCT02824185|curative treatment|curative treatment
73525|NCT02824185|resection|resection
73526|NCT02824185|thermo-ablation|thermo-ablation
73527|NCT02824185|transplantation|transplantation
73528|NCT02824172|Cast immobilization|cast immobilization
73529|NCT02824172|Complete rest|complete rest
73530|NCT02824172|Osgood Schlatter|osgood schlatter
73531|NCT02824159|ibrutinib|ibrutinib
73532|NCT02824159|idelalisib|idelalisib
73533|NCT02824159|side effect|side effect
73534|NCT02824159|pharmacokinetic|pharmacokinetic
73535|NCT02824159|plasma balance mean concentration|plasma balance mean concentration
73536|NCT02824146|atelectasis|atelectasis
73537|NCT02824146|children|children
73538|NCT02824146|lung ultrasound|lung ultrasound
73539|NCT02824146|lung recruitment|lung recruitment
73540|NCT02824133|Glioma grade III|glioma grade iii
73541|NCT02824133|Glioma grade IV|glioma grade iv
73542|NCT02824133|Glioma recurrent|glioma recurrent
73543|NCT02824133|IDHwt|idhwt
73544|NCT02824133|FGFR-TACC fusion|fgfr-tacc fusion
73545|NCT02824120|ischemic heart disease|ischemic heart disease
73546|NCT02824120|laugh therapy|laugh therapy
73547|NCT02824094|Expanded Access Protocol|expanded access protocol
73548|NCT02824094|crizotinib|crizotinib
73549|NCT02824094|Xalkori|xalkori
73550|NCT02824094|ROS1|ros1
73551|NCT02824094|Japanese|japanese
73552|NCT02824094|A8081064|a8081064
73553|NCT02824081|Psychiatry|psychiatry
73554|NCT02824081|Depressive disorder|depressive disorder
73555|NCT02824081|Suicide|suicide
73556|NCT02824081|Inflammation|inflammation
73557|NCT02824042|Phase 1|phase 1
73558|NCT02824042|Solid tumors|solid tumors
73559|NCT02824042|Mesothelin|mesothelin
73560|NCT02824042|Itraconazole|itraconazole
73561|NCT02824042|PK DDI|pk ddi
73562|NCT02824042|ECG thorough QTC|ecg thorough qtc
73563|NCT02823977|ketamine|ketamine
73564|NCT02823977|dexmedetomidine|dexmedetomidine
73565|NCT02823977|alcohol|alcohol
73566|NCT02823964|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
73567|NCT02823964|cystic fibrosis|cystic fibrosis
73568|NCT02823964|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
73569|NCT02823912|Capsaicin|capsaicin
73570|NCT02823912|Dyslipidemia|dyslipidemia
73571|NCT02823912|Inflammatory cytokines|inflammatory cytokines
73572|NCT02823899|cholera vaccine|cholera vaccine
73573|NCT02823899|hikojima serotype|hikojima serotype
73574|NCT02823899|randomized trial|randomized trial
73575|NCT02823899|immunogenicity|immunogenicity
73576|NCT02823886|myocardial infarction|myocardial infarction
73577|NCT02823886|MRI|mri
73578|NCT02823886|inflammatory biomarkers|inflammatory biomarkers
73579|NCT02823873|Hypertension|hypertension
73580|NCT02823873|Pregnant|pregnant
73581|NCT02823873|Preeclampsia|preeclampsia
73582|NCT02823873|Gestational Hypertension|gestational hypertension
73583|NCT02823873|Blood Pressure|blood pressure
73584|NCT02823873|Pregnant Women|pregnant women
73585|NCT02823873|Postpartum Women|postpartum women
73586|NCT02823860|Peritoneal carcinomatosis|peritoneal carcinomatosis
73587|NCT02823860|Biobanking|biobanking
73588|NCT02823860|Biospecimen research|biospecimen research
73589|NCT02823860|Prospective clinical database|prospective clinical database
73590|NCT02823860|Tissue banking|tissue banking
73591|NCT02823860|Quality of Life|quality of life
73592|NCT02823860|various histological subtypes|various histological subtypes
73593|NCT02823847|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
73594|NCT02823847|Human immunodeficiency virus|human immunodeficiency virus
74492|NCT02818010|stage 4|stage 4
73596|NCT02823847|Carbon monoxide test|carbon monoxide test
73597|NCT02823847|Self-help materials|self-help materials
73598|NCT02823847|Visual Oral Screening Examination|visual oral screening examination
73599|NCT02823847|Direct Fluorescent Oral Visualization Examination|direct fluorescent oral visualization examination
73600|NCT02823847|Oral Biopsy|oral biopsy
73601|NCT02823834|osteoarthritis|osteoarthritis
73602|NCT02823834|avascular necrosis|avascular necrosis
73603|NCT02823834|ankylosis|ankylosis
73607|NCT02823834|correction of functional deformity|correction of functional deformity
73608|NCT02823821|End-Stage Kidney Disease|end-stage kidney disease
73609|NCT02823821|Hemodialysis|hemodialysis
64959|NCT02878317|Glycosylation End Products, Advanced|glycosylation end products, advanced
64960|NCT02878317|Skin autofluorescence|skin autofluorescence
64961|NCT02878317|Renal Dialysis|renal dialysis
73610|NCT02823821|Dialysate|dialysate
73612|NCT02823821|Cluster-randomisation|cluster-randomisation
73613|NCT02823795|Patient participation|patient participation
73614|NCT02823795|Empowerment|empowerment
73615|NCT02823795|Medication management|medication management
73616|NCT02823795|Symptom management|symptom management
73617|NCT02823795|Self determination theory|self determination theory
73618|NCT02823795|Motivational Interviewing|motivational interviewing
73619|NCT02823782|Laminar HP|laminar hp
73620|NCT02823782|Complex HP|complex hp
73621|NCT02823769|clinical study|clinical study
73622|NCT02823769|dental fillings|dental fillings
73623|NCT02823743|recurrent pregnancy loss, Habitual abortion|recurrent pregnancy loss, habitual abortion
73624|NCT02823704|Sepsis|sepsis
73625|NCT02823704|Chest pain|chest pain
73626|NCT02823704|Abdominal pain|abdominal pain
73627|NCT02823704|Electrolyte disturbances|electrolyte disturbances
73628|NCT02823704|Stroke|stroke
73629|NCT02823704|Triage|triage
73630|NCT02823704|Risk for death|risk for death
73631|NCT02823691|NETs|nets
73632|NCT02823665|gastric bypass surgery|gastric bypass surgery
73633|NCT02823665|Hypoglycemia|hypoglycemia
73634|NCT02823665|sleeve gastrectomy|sleeve gastrectomy
73635|NCT02823665|glucose tolerance|glucose tolerance
73636|NCT02823613|ENaC|enac
73637|NCT02823613|Exosomes|exosomes
73638|NCT02823613|Urinary biomarker|urinary biomarker
73639|NCT02823613|Salt regulation|salt regulation
73640|NCT02823600|retinal screening|retinal screening
73641|NCT02823600|outpatient dialysis|outpatient dialysis
73642|NCT02823587|Bronchiectasis|bronchiectasis
73643|NCT02823587|Mucociliary clearance|mucociliary clearance
73644|NCT02823587|Exercise|exercise
73645|NCT02823587|Inflammation|inflammation
73646|NCT02823535|military|military
73647|NCT02823444|Magnetic Resonance Imaging|magnetic resonance imaging
73648|NCT02823444|Magnetic Resonance Angiography|magnetic resonance angiography
73649|NCT02823431|voiding efficiency|voiding efficiency
73650|NCT02823431|detrusor underactivity|detrusor underactivity
73651|NCT02823431|urodynamics|urodynamics
73652|NCT02823418|primipara|primipara
73653|NCT02823418|childbirth|childbirth
73654|NCT02823418|neuraxial labor analgesia|neuraxial labor analgesia
73655|NCT02823418|postpartum depression|postpartum depression
73656|NCT02823405|Advance malignancy|advance malignancy
73657|NCT02823392|unexpected difficult bag mask ventilation|unexpected difficult bag mask ventilation
73658|NCT02823392|difficult intubation|difficult intubation
73659|NCT02823392|predictors|predictors
73660|NCT02823392|pediatric anesthesia|pediatric anesthesia
73661|NCT02823379|physical activity|physical activity
73662|NCT02823379|overweight|overweight
73663|NCT02823379|obese|obese
73664|NCT02823379|exercise|exercise
73665|NCT02823379|women|women
73666|NCT02823379|African American|african american
73667|NCT02823379|Smartphone|smartphone
73668|NCT02823379|cardiovascular disease risk|cardiovascular disease risk
73669|NCT02823366|PBC|pbc
73670|NCT02823366|UDCA|udca
73671|NCT02823366|Fenofibrate|fenofibrate
73672|NCT02823353|PBC|pbc
73673|NCT02823353|UDCA|udca
73674|NCT02823353|Fenofibrate|fenofibrate
73675|NCT02823288|intimate partner violence|intimate partner violence
73676|NCT02823288|masculinity|masculinity
73677|NCT02823288|community mobilization|community mobilization
73678|NCT02823288|social intervention|social intervention
73680|NCT02823262|Breast Cancer|breast cancer
73681|NCT02823262|Estrogen Receptor Positive Breast Cancer|estrogen receptor positive breast cancer
73682|NCT02823262|Node-negative Breast Cancer|node-negative breast cancer
73683|NCT02823262|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|human epidermal growth factor 2 negative carcinoma of breast
73684|NCT02823236|Keloid|keloid
73685|NCT02823236|Scar|scar
73686|NCT02823223|Endobronchial Valve|endobronchial valve
73687|NCT02823197|determinants|determinants
73688|NCT02823197|active transport|active transport
73689|NCT02823197|intervention|intervention
73690|NCT02823197|adolescents|adolescents
73691|NCT02823184|Myeloproliferative neoplasms|myeloproliferative neoplasms
73692|NCT02823184|Endoplasmic reticulum stress|endoplasmic reticulum stress
73693|NCT02823171|Bioequivalence Study|bioequivalence study
73694|NCT02823171|Healthy subjects|healthy subjects
73695|NCT02823158|Parkinson Disease|parkinson disease
73696|NCT02823158|Morbus Parkinson|morbus parkinson
73697|NCT02823158|Basal Ganglia|basal ganglia
73698|NCT02823158|Pallidal Stimulation|pallidal stimulation
73699|NCT02823145|seizure|seizure
73700|NCT02823145|tonic clonic|tonic clonic
75186|NCT02813889|infant|infant
73702|NCT02823145|myoclonic|myoclonic
73703|NCT02823145|encephalopathy|encephalopathy
73704|NCT02823119|Mini-hysteroscopy|mini-hysteroscopy
73705|NCT02823119|Office hysteroscopy|office hysteroscopy
73706|NCT02823119|Pain|pain
73707|NCT02823093|vascular calcification|vascular calcification
73708|NCT02823093|aortic calcification|aortic calcification
73709|NCT02823093|vitamin K antagonist|vitamin k antagonist
73710|NCT02823093|fluindione|fluindione
73711|NCT02823093|warfarin|warfarin
73712|NCT02823093|matrix gla protein|matrix gla protein
73713|NCT02823067|Pemphigoid|pemphigoid
73714|NCT02823067|Bullous pemphigoid|bullous pemphigoid
73715|NCT02823067|Pruritus|pruritus
73716|NCT02823067|Senile pruritus|senile pruritus
73717|NCT02823067|Neuropsychiatric symptoms|neuropsychiatric symptoms
73718|NCT02823054|elective surgery|elective surgery
73719|NCT02823054|CABG|cabg
73720|NCT02823054|One-lung ventilation|one-lung ventilation
73721|NCT02823054|EZ Blockers|ez blockers
73722|NCT02823054|pleural effusion|pleural effusion
73723|NCT02823041|cognitive training|cognitive training
73724|NCT02823041|aerobic exercise|aerobic exercise
73725|NCT02823041|neurotrophic factors|neurotrophic factors
73726|NCT02823041|randomized controlled trial|randomized controlled trial
73727|NCT02823041|functional outcome|functional outcome
73728|NCT02823028|Smoking|smoking
73729|NCT02823028|Social Media|social media
73730|NCT02823028|Twitter|twitter
73731|NCT02823028|Behavior Change|behavior change
73732|NCT02823028|Social Support|social support
73733|NCT02822989|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
73734|NCT02822989|Musculoskeletal Pain|musculoskeletal pain
73735|NCT02822989|Inflammation|inflammation
73736|NCT02822963|Transurethral resection of the prostate|transurethral resection of the prostate
73737|NCT02822963|Anticoagulants|anticoagulants
73738|NCT02822963|Platelet aggregation inhibitors|platelet aggregation inhibitors
73739|NCT02822911|elderly|elderly
73740|NCT02822911|chronic alcoholism|chronic alcoholism
73937|NCT02821377|immunology|immunology
73741|NCT02822911|Carbohydrate Deficient Transferrin|carbohydrate deficient transferrin
73742|NCT02822911|Biological Detection / Diagnosis|biological detection / diagnosis
73743|NCT02822898|Maintenance|maintenance
73744|NCT02822898|Intravenous solutions|intravenous solutions
73745|NCT02822898|Intravenous fluids|intravenous fluids
73746|NCT02822898|Tonicity|tonicity
73747|NCT02822898|Potassium|potassium
73748|NCT02822898|Sodium|sodium
73749|NCT02822898|Fluid retention|fluid retention
73750|NCT02822872|infertility|infertility
73751|NCT02822872|stress|stress
73752|NCT02822872|scalp hair|scalp hair
73753|NCT02822872|cortisol|cortisol
73754|NCT02822846|Lung ultrasound|lung ultrasound
73755|NCT02822846|Sliding lung|sliding lung
73756|NCT02822846|Probe position|probe position
73757|NCT02822755|Exercise|exercise
73758|NCT02822755|Adherence|adherence
73759|NCT02822755|Physical Therapy|physical therapy
73760|NCT02822703|smoking cessation|smoking cessation
73761|NCT02822703|tobacco use disorder|tobacco use disorder
73762|NCT02822703|delay discounting|delay discounting
73763|NCT02822703|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
73764|NCT02822703|relapse prevention|relapse prevention
73765|NCT02822690|palliative care|palliative care
73766|NCT02822690|Quality of dying|quality of dying
73767|NCT02822664|Brain, pedophilia, neuroimaging|brain, pedophilia, neuroimaging
73768|NCT02822638|Myocardial infarction|myocardial infarction
73769|NCT02822638|biomarkers|biomarkers
73770|NCT02822638|STEMI|stemi
73771|NCT02822625|Capsaicin|capsaicin
73772|NCT02822625|QUTENZA®|qutenza®
73773|NCT02822625|Hypnosis|hypnosis
73774|NCT02822625|Peripheral Neuropathic|peripheral neuropathic
73775|NCT02822612|optical coherence tomography|optical coherence tomography
73776|NCT02822612|optical imaging|optical imaging
73777|NCT02822612|retinal imaging|retinal imaging
73778|NCT02822599|CBP, congenital heart defects, cardiopulmonary bypass|cbp, congenital heart defects, cardiopulmonary bypass
73779|NCT02822586|CD30-positive|cd30-positive
73780|NCT02822586|Stage IB to Stage IVA|stage ib to stage iva
73781|NCT02822560|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
73782|NCT02822560|percutaneous EVAR (pEVAR)|percutaneous evar (pevar)
73783|NCT02822560|cost analysis|cost analysis
73784|NCT02822560|procedure time|procedure time
73785|NCT02822521|Rheumatoid Arthritis|rheumatoid arthritis
73786|NCT02822521|Mobile Health|mobile health
73787|NCT02822521|Pain|pain
73788|NCT02822521|Arthritis|arthritis
73789|NCT02822495|Lymphoproliferative Disorders|lymphoproliferative disorders
73790|NCT02822495|Epstein-Barr Virus|epstein-barr virus
73791|NCT02822495|Epstein-Barr Viremia|epstein-barr viremia
73887|NCT02821702|placenta accreta|placenta accreta
73792|NCT02822495|Post Transplant Lymphoproliferative Disorder|post transplant lymphoproliferative disorder
73793|NCT02822495|EBV-PTLD|ebv-ptld
73794|NCT02822495|Solid Organ Transplant|solid organ transplant
73795|NCT02822495|Hematopoietic Cell Transplant|hematopoietic cell transplant
75287|NCT02813421|CGM|cgm
73796|NCT02822495|primary immunodeficiency|primary immunodeficiency
73797|NCT02822495|acquired immunodeficiency|acquired immunodeficiency
73798|NCT02822495|Epstein-Barr Virus Lymphoma|epstein-barr virus lymphoma
73799|NCT02822469|TMD Infrared Thermography Physical Therapy Modalities|tmd infrared thermography physical therapy modalities
73800|NCT02822456|dysphagia|dysphagia
73801|NCT02822456|intermittent tube|intermittent tube
73802|NCT02822456|individual 3D printed guiding tube|individual 3d printed guiding tube
73803|NCT02822430|Pain|pain
73804|NCT02822430|Psychiatric disorders|psychiatric disorders
73805|NCT02822417|Recover time|recover time
73806|NCT02822404|kidney toxicity|kidney toxicity
73807|NCT02822378|Postmenopausal Osteoporosis|postmenopausal osteoporosis
73808|NCT02822378|Human|human
73809|NCT02822378|Female|female
73810|NCT02822378|Non-pharmacologic therapy|non-pharmacologic therapy
73811|NCT02822326|Leukemia|leukemia
73812|NCT02822326|CART CD19|cart cd19
73813|NCT02822326|Chemotherapy Resistant|chemotherapy resistant
73814|NCT02822326|Chemotherapy Refractory|chemotherapy refractory
73815|NCT02822326|CD19 +|cd19 +
73816|NCT02822326|Lymphoma|lymphoma
73817|NCT02822235|Drug Therapy|drug therapy
73818|NCT02822222|essential hypertension|essential hypertension
73819|NCT02822222|hypertension|hypertension
73820|NCT02822222|high blood pressure|high blood pressure
73821|NCT02822222|cardiovascular diseases|cardiovascular diseases
73822|NCT02822222|RMJH-111b|rmjh-111b
73823|NCT02822222|magnesium|magnesium
73824|NCT02822222|magnesium citrate|magnesium citrate
73825|NCT02822222|calcium channel blockers|calcium channel blockers
73826|NCT02822222|vasodilators|vasodilators
73827|NCT02822222|antihypertensive agents|antihypertensive agents
73828|NCT02822209|coordinating nurse of thoracic oncology|coordinating nurse of thoracic oncology
73829|NCT02822209|quality of care in thoracic oncology|quality of care in thoracic oncology
73830|NCT02822209|lung cancer quality of life|lung cancer quality of life
73831|NCT02822144|ischemic stroke|ischemic stroke
73832|NCT02822144|thrombectomy|thrombectomy
73833|NCT02822144|anesthesia|anesthesia
73834|NCT02822144|sedation|sedation
73835|NCT02822118|IBS-D; Chang'an I Recipe; Placebo|ibs-d; chang'an i recipe; placebo
73836|NCT02822066|Effectivity|effectivity
73837|NCT02822066|safety|safety
73838|NCT02822066|irreversible electroporation|irreversible electroporation
73839|NCT02822066|liver|liver
73840|NCT02822066|pancreas|pancreas
73841|NCT02822053|Ultrasonography-guided Laser Ablation|ultrasonography-guided laser ablation
73842|NCT02822040|Root Resorption|root resorption
73843|NCT02822040|Panoramic Radiograph|panoramic radiograph
73844|NCT02822001|Sugammadex|sugammadex
73845|NCT02821975|Depression|depression
73846|NCT02821975|Cognitive function|cognitive function
73847|NCT02821975|Work|work
73848|NCT02821962|Sedentary behaviour|sedentary behaviour
73849|NCT02821949|Non Small Cells Lung Cancer|non small cells lung cancer
73850|NCT02821949|Procalcitonin|procalcitonin
73851|NCT02821936|positron emission tomography|positron emission tomography
73852|NCT02821936|parametric imaging|parametric imaging
73853|NCT02821936|lung cancer|lung cancer
73854|NCT02821884|Stroke|stroke
73855|NCT02821884|Transcranial direct current stimulation|transcranial direct current stimulation
73856|NCT02821884|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
73857|NCT02821884|upper extremity motor recovery|upper extremity motor recovery
73858|NCT02821832|Tuberculosis|tuberculosis
73859|NCT02821832|PET/CT Scanning|pet/ct scanning
73860|NCT02821832|Immunological Markers|immunological markers
73861|NCT02821832|4-Month Treatment Completion|4-month treatment completion
73862|NCT02821819|ovarian stimulation|ovarian stimulation
73863|NCT02821819|random|random
73864|NCT02821819|egg donation|egg donation
73865|NCT02821819|antagonist|antagonist
73866|NCT02821819|gnrh agonist trigger|gnrh agonist trigger
73867|NCT02821806|Normal Volunteer|normal volunteer
73868|NCT02821806|Donation|donation
73869|NCT02821806|Adoptive T Cell Therapy|adoptive t cell therapy
73870|NCT02821806|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
73871|NCT02821780|Biospecimen Procurement|biospecimen procurement
73872|NCT02821780|Laboratory Research Specimens|laboratory research specimens
73873|NCT02821767|Pathogenesis|pathogenesis
73874|NCT02821767|Ocular Disorders|ocular disorders
73875|NCT02821767|Eye|eye
73876|NCT02821767|Eye Diseases|eye diseases
73877|NCT02821754|PDL1-Mediated Adaptive Resistance|pdl1-mediated adaptive resistance
73878|NCT02821754|Monoclonal Antibody|monoclonal antibody
73879|NCT02821754|CTLA-4|ctla-4
73880|NCT02821754|Ablative Therapy|ablative therapy
73881|NCT02821754|Combination of Tremelimumab and Durvalumab|combination of tremelimumab and durvalumab
73882|NCT02821741|Sensory Stimulation|sensory stimulation
73883|NCT02821728|Prostate|prostate
73884|NCT02821728|Sulphate|sulphate
73885|NCT02821728|ATP|atp
73886|NCT02821728|PTEN|pten
73888|NCT02821702|cesarean section|cesarean section
73889|NCT02821702|artery embolization|artery embolization
73890|NCT02821689|Dermatopolymyositis|dermatopolymyositis
73891|NCT02821689|Interstitial lung disease|interstitial lung disease
73892|NCT02821689|Pirfenidone|pirfenidone
73894|NCT02821637|effort rehabilitation|effort rehabilitation
73895|NCT02821637|quality of life|quality of life
73897|NCT02821637|physical skills assessment|physical skills assessment
73898|NCT02821611|Student Stress|student stress
73899|NCT02821611|Meditation|meditation
73900|NCT02821611|Sleep Quality|sleep quality
73901|NCT02821611|Blood Pressure|blood pressure
73902|NCT02821559|Colorectal cancer|colorectal cancer
73903|NCT02821559|raltitrexed|raltitrexed
73904|NCT02821559|oxaliplatin|oxaliplatin
73905|NCT02821559|bevacizumab|bevacizumab
73906|NCT02821559|biweekly|biweekly
73907|NCT02821559|triweekly|triweekly
73908|NCT02821520|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
73909|NCT02821520|Photodynamic Therapy|photodynamic therapy
73910|NCT02821520|Conbercept|conbercept
73911|NCT02821520|Efficacy|efficacy
73912|NCT02821520|Safety|safety
73913|NCT02821520|vascular endothelial growth factor|vascular endothelial growth factor
73914|NCT02821494|HPV|hpv
73915|NCT02821494|Vaccination|vaccination
73916|NCT02821494|Immunotherapy|immunotherapy
73917|NCT02821481|Neuromuscular|neuromuscular
73918|NCT02821481|Supplementation|supplementation
73919|NCT02821481|Elderly|elderly
73920|NCT02821455|Isoflurane|isoflurane
73921|NCT02821455|Sevoflurane|sevoflurane
73922|NCT02821455|Bispectral Index|bispectral index
73923|NCT02821455|Pulmonary Surgical Procedures|pulmonary surgical procedures
73924|NCT02821442|Electroacupuncture|electroacupuncture
73925|NCT02821442|Neuropathic Pain|neuropathic pain
73926|NCT02821442|Chemotherapy Induced Peripheral Neuropathy|chemotherapy induced peripheral neuropathy
73927|NCT02821429|Respiratory weaning|respiratory weaning
73928|NCT02821429|Pulmonary ventilation|pulmonary ventilation
73929|NCT02821416|asthma|asthma
73930|NCT02821390|intravitreal injection|intravitreal injection
73931|NCT02821390|pain|pain
73932|NCT02821390|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
73933|NCT02821390|anti-VEGF|anti-vegf
73934|NCT02821390|nepafenac|nepafenac
73935|NCT02821377|cirrhosis|cirrhosis
73936|NCT02821377|ascites|ascites
73938|NCT02821377|inflammation|inflammation
73939|NCT02821377|nutrition|nutrition
73940|NCT02821351|Afib|afib
73941|NCT02821338|Bioequivalence|bioequivalence
73942|NCT02821338|Lamotrigine Extended Release|lamotrigine extended release
73943|NCT02821338|Generic|generic
73944|NCT02821338|Pharmacokinetic|pharmacokinetic
73945|NCT02821299|Laryngeal transplantation|laryngeal transplantation
73946|NCT02821299|Laryngeal function|laryngeal function
73947|NCT02821299|Swallowing|swallowing
73948|NCT02821299|Voice production|voice production
73949|NCT02821299|Respiration|respiration
73950|NCT02821299|Quality of life|quality of life
73951|NCT02821247|Treatment Naïve Patients|treatment naïve patients
73952|NCT02821234|Insomnia|insomnia
73953|NCT02821234|Hyperarousal|hyperarousal
73954|NCT02821208|Psychogenic nonepileptic seizure, quality of life|psychogenic nonepileptic seizure, quality of life
73955|NCT02821169|sinus surgery|sinus surgery
73956|NCT02821169|sphenopalatin ganglion|sphenopalatin ganglion
73957|NCT02821169|ropivacaine|ropivacaine
73958|NCT02821169|local anesthesia|local anesthesia
73959|NCT02821143|Telemedicine|telemedicine
73960|NCT02821143|Nursing Home|nursing home
73961|NCT02821143|Hospitalization|hospitalization
73962|NCT02821130|Dyspnea|dyspnea
73963|NCT02821130|Exercise|exercise
73964|NCT02821130|Cystic Fibrosis|cystic fibrosis
73965|NCT02821117|Diabetes Mellitus, Paediatric|diabetes mellitus, paediatric
73966|NCT02821117|Sensing Technology|sensing technology
73967|NCT02821104|Complement|complement
73968|NCT02821104|endothelial function|endothelial function
73969|NCT02821104|insulin sensitivity|insulin sensitivity
73970|NCT02821104|adolescents|adolescents
73971|NCT02821104|inflammation|inflammation
73972|NCT02821078|phase-contrast MRI|phase-contrast mri
73973|NCT02821078|blood flow|blood flow
73974|NCT02821078|velocity mapping|velocity mapping
73975|NCT02821078|abdominal imaging|abdominal imaging
73976|NCT02821078|Quantitative MRI|quantitative mri
73977|NCT02821039|Idiopathic Pulmonary Fibrosis, Usual Interstitial Pneumonia|idiopathic pulmonary fibrosis, usual interstitial pneumonia
73978|NCT02821000|PD1|pd1
73979|NCT02821000|PD-1|pd-1
73980|NCT02821000|PDL1|pdl1
73981|NCT02821000|PD-L1|pd-l1
73982|NCT02820987|Septic shock, Beta Lactams, Extended infusion, PK/PD|septic shock, beta lactams, extended infusion, pk/pd
73983|NCT02820961|Breast Neoplasms|breast neoplasms
73984|NCT02820961|Breast Diseases|breast diseases
73985|NCT02820961|Exemestane|exemestane
73986|NCT02820961|Protein Kinase Inhibitors|protein kinase inhibitors
73987|NCT02820961|Aromatase Inhibitors|aromatase inhibitors
73988|NCT02820961|entinostat|entinostat
73993|NCT02820961|ER+ Breast Cancer|er+ breast cancer
73994|NCT02820961|Breast Tumor|breast tumor
73995|NCT02820935|Cytochrome P450|cytochrome p450
73996|NCT02820935|Pharmacokinetics|pharmacokinetics
73997|NCT02820935|CC-220|cc-220
73998|NCT02820935|Healthy Subjects|healthy subjects
74001|NCT02820922|general anesthesia|general anesthesia
65358|NCT02876055|Nerve Block/methods|nerve block/methods
65359|NCT02876055|Pain, Postoperative/prevention & control|pain, postoperative/prevention & control
65360|NCT02876055|Anesthetics, Local/administration & dosage|anesthetics, local/administration & dosage
65373|NCT02875860|CDH|cdh
74002|NCT02820922|regional anesthesia|regional anesthesia
74003|NCT02820909|ultrasound guidance|ultrasound guidance
74004|NCT02820909|emergency wards|emergency wards
74005|NCT02820909|arterial and venous catheters|arterial and venous catheters
74006|NCT02820909|femoral|femoral
74007|NCT02820909|complications|complications
74008|NCT02820870|Cardiovascular Disease|cardiovascular disease
74009|NCT02820870|Quality Improvement|quality improvement
74010|NCT02820870|Decision Support Tool|decision support tool
74011|NCT02820870|Performance Measurement|performance measurement
74012|NCT02820870|Primary Prevention|primary prevention
74013|NCT02820857|Gastroentero-pancreatic neuroendocrine carcinomas|gastroentero-pancreatic neuroendocrine carcinomas
74014|NCT02820857|Second-line treatment|second-line treatment
74015|NCT02820857|Bevacizumab|bevacizumab
74016|NCT02820857|Folfiri|folfiri
74017|NCT02820844|Overactive bladder|overactive bladder
74018|NCT02820844|Botulinum toxin type A|botulinum toxin type a
74019|NCT02820844|Urinary incontinence|urinary incontinence
74020|NCT02820831|Frail Elderly|frail elderly
74021|NCT02820831|Peripheral Vascular Surgery|peripheral vascular surgery
74022|NCT02820831|Risk Assessment|risk assessment
74023|NCT02820831|Functional status|functional status
74024|NCT02820818|thoracic magnetic resonance imaging|thoracic magnetic resonance imaging
74025|NCT02820818|pulmonary function test|pulmonary function test
74026|NCT02820805|children|children
74027|NCT02820805|dietary carbohydrates|dietary carbohydrates
74028|NCT02820805|solanum tuberosum|solanum tuberosum
74029|NCT02820805|cognition|cognition
74030|NCT02820805|memory|memory
74031|NCT02820805|emotions|emotions
74032|NCT02820805|blood glucose|blood glucose
74033|NCT02820779|Willis|willis
74034|NCT02820779|Intracranial aneurysms|intracranial aneurysms
74035|NCT02820766|Posterior Stabilized Knee|posterior stabilized knee
74036|NCT02820766|Total Knee Arthroscopy|total knee arthroscopy
74037|NCT02820766|Journey II BCS|journey ii bcs
74038|NCT02820753|Universal Medication Schedule|universal medication schedule
74039|NCT02820753|Health Literacy|health literacy
74040|NCT02820753|Medication adherence|medication adherence
74047|NCT02820701|Osteopathic Manipulation|osteopathic manipulation
74048|NCT02820701|Somatic Dysfunction|somatic dysfunction
74049|NCT02820701|Musculoskeletal Ultrasound|musculoskeletal ultrasound
74050|NCT02820688|Local Anesthtetics|local anesthtetics
74051|NCT02820688|Nerve Block|nerve block
74052|NCT02820688|Bupivacaine|bupivacaine
74053|NCT02820688|Prilocaine|prilocaine
74054|NCT02820675|quality improvement|quality improvement
74055|NCT02820675|routine data|routine data
74056|NCT02820675|risk adjustment|risk adjustment
74057|NCT02820675|sepsis, severe sepsis, septic shock|sepsis, severe sepsis, septic shock
74058|NCT02820675|quality of coding|quality of coding
74059|NCT02820649|Exercise training|exercise training
74060|NCT02820649|Endothelial function|endothelial function
74061|NCT02820623|implementation|implementation
74062|NCT02820623|fidelity|fidelity
74063|NCT02820623|cognitive behavioral therapy|cognitive behavioral therapy
74064|NCT02820558|Neuropeptide|neuropeptide
74065|NCT02820558|Therapy|therapy
74066|NCT02820558|Onset|onset
74067|NCT02820545|patient safety culture|patient safety culture
74068|NCT02820545|hospital|hospital
74069|NCT02820545|patient perception|patient perception
626785|NCT00687245|GERD|gerd
74070|NCT02820545|healthcare professional perception|healthcare professional perception
74071|NCT02820545|sociological|sociological
74072|NCT02820545|qualitative|qualitative
74073|NCT02820545|questionnaire construct|questionnaire construct
74074|NCT02820545|psychometrics|psychometrics
74075|NCT02820519|Neuropathic pain|neuropathic pain
74076|NCT02820519|Loxapine|loxapine
74077|NCT02820519|Antipsychotics|antipsychotics
74078|NCT02820519|Co-Analgesics|co-analgesics
74079|NCT02820519|Tolerability|tolerability
74080|NCT02820519|Analgesic efficacy|analgesic efficacy
74081|NCT02820506|robotic surgery procedures|robotic surgery procedures
74082|NCT02820506|indocyanine green|indocyanine green
74083|NCT02820506|sentinel lymph node mapping|sentinel lymph node mapping
74084|NCT02820480|stroke|stroke
74085|NCT02820480|rehabilitation|rehabilitation
74086|NCT02820480|robotics|robotics
74087|NCT02820480|cerebral palsy|cerebral palsy
74088|NCT02820480|therapy|therapy
74089|NCT02820467|Indocyanine|indocyanine
74090|NCT02820467|Angiography|angiography
74091|NCT02820467|Ischemia|ischemia
74092|NCT02820454|AGuIX|aguix
74093|NCT02820454|polysiloxane gadolinium-chelates based nanoparticles|polysiloxane gadolinium-chelates based nanoparticles
65474|NCT02875041|balance|balance
74094|NCT02820415|aneuploidy|aneuploidy
74095|NCT02820415|next generation sequencing|next generation sequencing
74096|NCT02820415|oocyte vitrification|oocyte vitrification
74097|NCT02820415|preimplantation genetic diagnosis|preimplantation genetic diagnosis
74098|NCT02820415|preimplantation genetic screening|preimplantation genetic screening
74099|NCT02820402|Pregnancy|pregnancy
74100|NCT02820402|Obesity|obesity
74101|NCT02820402|Diet|diet
74102|NCT02820402|Maternal/child health|maternal/child health
74103|NCT02820402|Asthma/allergy|asthma/allergy
74104|NCT02820402|Air pollution|air pollution
74105|NCT02820402|Epigenetics|epigenetics
74106|NCT02820402|Cognition/behavior|cognition/behavior
74107|NCT02820376|4D computed tomography|4d computed tomography
74108|NCT02820376|Kidney function tests|kidney function tests
74109|NCT02820376|Living Donors|living donors
74110|NCT02820363|wound|wound
74111|NCT02820363|open fracture|open fracture
74112|NCT02820363|fracture|fracture
74113|NCT02820363|tibial|tibial
74114|NCT02820350|Acute Renal Failure|acute renal failure
74115|NCT02820350|Acute kidney injury|acute kidney injury
74116|NCT02820350|Continuous Renal Replacement Therapy|continuous renal replacement therapy
74117|NCT02820350|Selective cytopheretic device|selective cytopheretic device
74118|NCT02820350|Pediatric|pediatric
74119|NCT02820311|Thorough QT (TQT)|thorough qt (tqt)
74120|NCT02820311|cardiac safety|cardiac safety
74121|NCT02820272|Cold water|cold water
74122|NCT02820272|Negative pressure wound therapy|negative pressure wound therapy
74123|NCT02820272|pain|pain
74124|NCT02820246|nutrition assessment|nutrition assessment
74125|NCT02820246|nutrition therapy|nutrition therapy
74126|NCT02820246|nutrition surveys|nutrition surveys
74127|NCT02820246|patient outcome assessment|patient outcome assessment
74128|NCT02820246|outcome and process assessment|outcome and process assessment
74129|NCT02820246|benchmarking|benchmarking
74130|NCT02820246|risk assessment|risk assessment
74131|NCT02820246|scoring system|scoring system
74132|NCT02820220|Knowledge|knowledge
74133|NCT02820220|Programs|programs
74134|NCT02820220|Patients|patients
74135|NCT02820220|Students|students
74136|NCT02820220|Nurses|nurses
74137|NCT02820207|Carotid Artery Plaque|carotid artery plaque
74138|NCT02820207|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
74139|NCT02820207|Plague Histopathology|plague histopathology
74140|NCT02820181|tracheostomy ties|tracheostomy ties
74141|NCT02820168|Designing|designing
74142|NCT02820168|Patient-Oriented|patient-oriented
74143|NCT02820168|Prescriptions|prescriptions
74144|NCT02820155|Alzheimer's disease,cognitive function|alzheimer's disease,cognitive function
74145|NCT02820142|biomarker|biomarker
74146|NCT02820142|Renal Function|renal function
74147|NCT02820129|polypharmacy|polypharmacy
74148|NCT02820129|wallet card|wallet card
74149|NCT02820129|medication|medication
74150|NCT02820129|self-efficacy|self-efficacy
74151|NCT02820129|patient enablement|patient enablement
74152|NCT02820103|Patient delay|patient delay
74153|NCT02820103|Behaviour change|behaviour change
74154|NCT02820103|Intervention Modelling Experiment|intervention modelling experiment
74155|NCT02820090|Inflammatory Factor|inflammatory factor
74156|NCT02820090|Mechanical Ventilation|mechanical ventilation
74157|NCT02820077|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
74158|NCT02820051|bronchoscopy|bronchoscopy
74159|NCT02820051|conscious sedation|conscious sedation
74160|NCT02820051|midazolam|midazolam
74161|NCT02820051|patient comfort|patient comfort
74162|NCT02820051|propofol|propofol
74163|NCT02820012|Scoliosis|scoliosis
74164|NCT02820012|ST2R|st2r
74165|NCT02819986|occupational functioning|occupational functioning
74166|NCT02819986|Worries|worries
74167|NCT02819986|Pain|pain
74168|NCT02819986|Disability|disability
74169|NCT02819973|Patient Education|patient education
74170|NCT02819973|ICD|icd
74171|NCT02819973|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
74172|NCT02819973|Video|video
74173|NCT02819973|Decision|decision
74174|NCT02819973|Decision making|decision making
74175|NCT02819960|probiotics|probiotics
74176|NCT02819960|irinotecan|irinotecan
74177|NCT02819960|diarrhea|diarrhea
74178|NCT02819960|Lactobacillus rhamnosus|lactobacillus rhamnosus
74179|NCT02819960|Bifidobacterium animalis|bifidobacterium animalis
74180|NCT02819960|prevention|prevention
74181|NCT02819960|chemotherapy|chemotherapy
74182|NCT02819947|systemic sclerosis|systemic sclerosis
74183|NCT02819947|cohort|cohort
74184|NCT02819947|Korean|korean
74185|NCT02819921|Hot Flashes|hot flashes
74186|NCT02819921|Breast Neoplasms|breast neoplasms
74187|NCT02819921|Tamoxifen|tamoxifen
74188|NCT02819921|Desvenlafaxine Succinate|desvenlafaxine succinate
74189|NCT02819895|Phone Appointment Reminder|phone appointment reminder
74190|NCT02819895|Immunization Rates|immunization rates
74191|NCT02819895|mHealth|mhealth
74192|NCT02819882|Unresectable|unresectable
74193|NCT02819882|locally|locally
74194|NCT02819882|advanced|advanced
74195|NCT02819882|metastatic disease|metastatic disease
74196|NCT02819843|T-VEC (Talimogene Laherparepvec)|t-vec (talimogene laherparepvec)
74197|NCT02819843|Radiotherapy|radiotherapy
74198|NCT02819843|16-224|16-224
74199|NCT02819830|Aerobic exercise|aerobic exercise
74200|NCT02819830|Strength training|strength training
74201|NCT02819830|Inflammation|inflammation
74202|NCT02819830|cardiovascular disease|cardiovascular disease
74203|NCT02819817|Aloe Vera, wound, healing|aloe vera, wound, healing
74204|NCT02819791|Cardiovascular|cardiovascular
74205|NCT02819791|therapeutic education|therapeutic education
74206|NCT02819778|Diagnosis|diagnosis
74207|NCT02819778|Craniocerebral Trauma|craniocerebral trauma
74208|NCT02819778|Pediatrics|pediatrics
74209|NCT02819778|S100B|s100b
74210|NCT02819778|mild traumatic brain injury|mild traumatic brain injury
74211|NCT02819752|squamous cell carcinoma|squamous cell carcinoma
74212|NCT02819752|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
74213|NCT02819713|Prostate Biopsy|prostate biopsy
74214|NCT02819713|NRS-score|nrs-score
74215|NCT02819713|instillagel|instillagel
74216|NCT02819713|ultrasound conductive gel|ultrasound conductive gel
74217|NCT02819700|behavioural disorders|behavioural disorders
74218|NCT02819687|Phase I|phase i
74219|NCT02819687|Healthy|healthy
74220|NCT02819687|Pharmacokinetics|pharmacokinetics
74221|NCT02819687|Pharmacodynamics|pharmacodynamics
74222|NCT02819674|hypertension|hypertension
74223|NCT02819674|early onset|early onset
74224|NCT02819674|target organ damage|target organ damage
74225|NCT02819661|Elective Caesarean Section|elective caesarean section
74226|NCT02819661|obese women|obese women
74227|NCT02819661|BMI≥30|bmi≥30
74228|NCT02819661|spinal anesthesia combined with intrathecal morphine|spinal anesthesia combined with intrathecal morphine
74229|NCT02819648|symptomatic|symptomatic
74230|NCT02819648|irreversible|irreversible
74231|NCT02819635|ABT-494|abt-494
74232|NCT02819635|Moderately to Severely Active UC|moderately to severely active uc
74233|NCT02819570|early-onset neonatal sepsis|early-onset neonatal sepsis
74234|NCT02819570|Prophylactic antibiotics|prophylactic antibiotics
74235|NCT02819570|Pregnancy|pregnancy
74236|NCT02819570|PPROM|pprom
74237|NCT02819570|EOS|eos
74238|NCT02819544|Digestive System|digestive system
74239|NCT02819531|Coronary Atherectomy|coronary atherectomy
74240|NCT02819531|percutaneous coronary intervention|percutaneous coronary intervention
74241|NCT02819518|PD1|pd1
74242|NCT02819518|PD-1|pd-1
74243|NCT02819518|PDL1|pdl1
74244|NCT02819518|PD-L1|pd-l1
74245|NCT02819505|beta-alanine|beta-alanine
74246|NCT02819505|carnosine|carnosine
74247|NCT02819505|neuromuscular|neuromuscular
74248|NCT02819505|stimulation|stimulation
74249|NCT02819505|skeletal muscle|skeletal muscle
74250|NCT02819492|Adenoma|adenoma
74251|NCT02819492|Colonoscopy|colonoscopy
74252|NCT02819492|Withdrawal|withdrawal
74253|NCT02819492|Proximal|proximal
74254|NCT02819492|Observation Time|observation time
74255|NCT02819479|Radiation necrosis|radiation necrosis
74256|NCT02819479|Radiation adverse event|radiation adverse event
74257|NCT02819479|Intra-arterial chemotherapy|intra-arterial chemotherapy
74258|NCT02819479|Bevacizumab|bevacizumab
74259|NCT02819479|Blood brain barrier disruption|blood brain barrier disruption
74260|NCT02819479|Blood brain barrier breakdown|blood brain barrier breakdown
74261|NCT02819466|intragastric volume|intragastric volume
74262|NCT02819466|stomach|stomach
74263|NCT02819466|fasting|fasting
74264|NCT02819453|Corticosteroid|corticosteroid
74265|NCT02819427|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
74266|NCT02819427|Electroencephalography|electroencephalography
74267|NCT02819427|children|children
626786|NCT00687245|pediatric|pediatric
74268|NCT02819388|randomized control trial; contraception; inequalities|randomized control trial; contraception; inequalities
74269|NCT02819375|propofol|propofol
74270|NCT02819375|ketamine|ketamine
74271|NCT02819375|remifentanil|remifentanil
74272|NCT02819349|Relapse Prevention|relapse prevention
74273|NCT02819349|People with Schizophrenia|people with schizophrenia
74274|NCT02819349|Text-Messaging|text-messaging
74275|NCT02819349|Assertive Community Treatment (ACT)|assertive community treatment (act)
74276|NCT02819336|urinary incontinence|urinary incontinence
74277|NCT02819336|electroacupuncture|electroacupuncture
74278|NCT02819336|stroke|stroke
74279|NCT02819336|complications|complications
74280|NCT02819336|randomized controlled trial|randomized controlled trial
74281|NCT02819336|pilot projects|pilot projects
74282|NCT02819284|Ocular Discomfort|ocular discomfort
74283|NCT02819284|Pain|pain
74284|NCT02819284|Corticosteroid|corticosteroid
74285|NCT02819284|Hyperemia|hyperemia
74286|NCT02819284|Dry Eye|dry eye
74287|NCT02819219|Dietary Supplements|dietary supplements
74288|NCT02819219|Exercise|exercise
74289|NCT02819193|Breastfeeding|breastfeeding
74290|NCT02819193|mother's milk|mother's milk
74291|NCT02819193|breast milk|breast milk
74292|NCT02819193|raw milk|raw milk
74293|NCT02819193|neonate|neonate
74294|NCT02819193|Neonatal intensive care unit (NICU)|neonatal intensive care unit (nicu)
74295|NCT02819180|Influenza|influenza
74296|NCT02819167|ischemic stroke|ischemic stroke
74297|NCT02819167|brain reserve|brain reserve
74298|NCT02819167|cognitive reserve|cognitive reserve
74299|NCT02819167|cognitive prognosis|cognitive prognosis
74300|NCT02819115|Influenza|influenza
754068|NCT01178788|Cervical shortening|cervical shortening
74302|NCT02819089|ACDF|acdf
74303|NCT02819089|Dexmedetomidine|dexmedetomidine
74304|NCT02819089|Anesthesia|anesthesia
74305|NCT02819089|Agitation|agitation
74306|NCT02819089|Riker sedation agitation scores|riker sedation agitation scores
74307|NCT02819050|CPAP|cpap
74308|NCT02819050|Extremely Low Birth Weight Infant (ELBW)|extremely low birth weight infant (elbw)
74309|NCT02819050|Non-invasive respiratory support|non-invasive respiratory support
74310|NCT02819050|Premature infants|premature infants
74311|NCT02819050|Non invasive ventilation weaning|non invasive ventilation weaning
74312|NCT02819037|Gastric bypass|gastric bypass
74313|NCT02819037|Intestinal Bacterial Overgrowth Syndrome|intestinal bacterial overgrowth syndrome
74314|NCT02819037|Gas chromatography|gas chromatography
74315|NCT02819011|Ankle Foot Orthoses|ankle foot orthoses
74316|NCT02819011|falls|falls
74317|NCT02819011|Fall Prevention|fall prevention
74318|NCT02819011|Frailty|frailty
74319|NCT02819011|Concern for falls|concern for falls
74320|NCT02819011|Footwear|footwear
74321|NCT02819011|Mobility|mobility
74322|NCT02818998|Diabetic macular edema|diabetic macular edema
74323|NCT02818998|DME|dme
74324|NCT02818959|Aortic Valve Disease|aortic valve disease
74325|NCT02818959|Aortic Valve Replacement|aortic valve replacement
74326|NCT02818959|Transcatheter|transcatheter
74327|NCT02818959|Transfemoral|transfemoral
74328|NCT02818959|Aortic Stenosis|aortic stenosis
74329|NCT02818946|MRI|mri
74330|NCT02818946|Spontaneous Nipple Discharge|spontaneous nipple discharge
74331|NCT02818946|Breast Cancer|breast cancer
74332|NCT02818933|24-hour diet recall|24-hour diet recall
74333|NCT02818933|Adolescents|adolescents
74334|NCT02818933|Web-based diet recall|web-based diet recall
74335|NCT02818920|Pembrolizumab|pembrolizumab
74336|NCT02818920|Neoadjuvant|neoadjuvant
74337|NCT02818920|Tumor Infiltrating Lymphocytes (TILs)|tumor infiltrating lymphocytes (tils)
74338|NCT02818894|THA, Hip Replacement, Spinal Anesthesia|tha, hip replacement, spinal anesthesia
74339|NCT02818894|Total hip arthroplasty|total hip arthroplasty
74340|NCT02818894|anterior total hip replacement|anterior total hip replacement
74341|NCT02818881|aerobic|aerobic
74342|NCT02818881|muscle activity|muscle activity
74343|NCT02818881|energy expenditure|energy expenditure
74344|NCT02818855|Root coverage|root coverage
74345|NCT02818855|Gingival recession|gingival recession
74346|NCT02818855|Plastic surgery|plastic surgery
74347|NCT02818855|Connective tissue graft|connective tissue graft
74348|NCT02818855|Mucograft|mucograft
74349|NCT02818842|Database|database
74350|NCT02818842|Birth defects|birth defects
74351|NCT02818842|Neonatal pathologies|neonatal pathologies
74352|NCT02818829|Adenocarcinoma|adenocarcinoma
74353|NCT02818829|Endoscopic ultrasonography|endoscopic ultrasonography
74354|NCT02818829|Fine-needle aspiration|fine-needle aspiration
74355|NCT02818829|Biomarkers|biomarkers
74356|NCT02818829|Epidemiology|epidemiology
74357|NCT02818829|DNA tumors|dna tumors
74358|NCT02818816|Brimonidine tartrate|brimonidine tartrate
74359|NCT02818816|Intraocular pressure|intraocular pressure
74360|NCT02818816|Prostate Cancer|prostate cancer
74361|NCT02818816|Prostatectomy|prostatectomy
74362|NCT02818803|propolis|propolis
74363|NCT02818803|therapeutic|therapeutic
74364|NCT02818803|miconazole|miconazole
74365|NCT02818803|denture stomatitis|denture stomatitis
74366|NCT02818790|mHealth|mhealth
74367|NCT02818790|Motivational Interviewing|motivational interviewing
74368|NCT02818790|Obesity|obesity
74369|NCT02818790|Prevention|prevention
74370|NCT02818790|Diet|diet
74371|NCT02818790|Physical Activity|physical activity
74372|NCT02818790|Health Preventive System|health preventive system
74373|NCT02818777|Parkinson's Disease|parkinson's disease
74374|NCT02818777|Tremor|tremor
74375|NCT02818777|tolerability|tolerability
74376|NCT02818777|safety|safety
74377|NCT02818777|cognition|cognition
74378|NCT02818777|anxiety|anxiety
74379|NCT02818777|psychosis|psychosis
74380|NCT02818777|mood|mood
74381|NCT02818777|dyskinesia|dyskinesia
74382|NCT02818777|cannabidiol|cannabidiol
74383|NCT02818777|cannabis|cannabis
74384|NCT02818777|efficacy|efficacy
74385|NCT02818777|sleep|sleep
74386|NCT02818777|motor symptoms|motor symptoms
74387|NCT02818777|non-motor symptoms|non-motor symptoms
74388|NCT02818777|quality of life|quality of life
74389|NCT02818777|marijuana|marijuana
74390|NCT02818764|serum biomarkers|serum biomarkers
74391|NCT02818764|cerebral blood flow|cerebral blood flow
74491|NCT02818010|stage 3|stage 3
74392|NCT02818764|modified Blessed Dementia Rating scale|modified blessed dementia rating scale
74393|NCT02818764|Confusion Assessment Method|confusion assessment method
74394|NCT02818764|Delirium Rating Scale-98|delirium rating scale-98
74395|NCT02818751|Anxiety|anxiety
74396|NCT02818751|Adolescents with Anxiety|adolescents with anxiety
74397|NCT02818738|Idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
74398|NCT02818738|Steroid sensitive nephrotic syndrome|steroid sensitive nephrotic syndrome
74401|NCT02818738|Children|children
74402|NCT02818686|Ulcerative Colitis, Active Moderate and Severe|ulcerative colitis, active moderate and severe
74403|NCT02818673|diagnostic performances|diagnostic performances
74404|NCT02818673|ascites|ascites
74405|NCT02818647|tonsillectomy|tonsillectomy
74406|NCT02818647|electrocautery|electrocautery
74407|NCT02818647|postoperative pain|postoperative pain
74408|NCT02818647|visual analogue scale|visual analogue scale
74409|NCT02818608|Cerebrovascular Accident|cerebrovascular accident
74410|NCT02818608|Cerebrovascular Stroke|cerebrovascular stroke
74411|NCT02818608|Cerebral Stroke|cerebral stroke
74412|NCT02818595|voice recognition|voice recognition
74413|NCT02818582|Liberia|liberia
74414|NCT02818582|EBV|ebv
74415|NCT02818582|Semen|semen
74416|NCT02818504|obesity|obesity
74417|NCT02818504|dysglycemia|dysglycemia
74418|NCT02818504|hypercholesterolemia|hypercholesterolemia
74419|NCT02818504|lifestyle|lifestyle
74420|NCT02818504|smoking|smoking
74421|NCT02818504|physical activity|physical activity
74422|NCT02818439|Old person|old person
74423|NCT02818426|cancer immunotherapy|cancer immunotherapy
74424|NCT02818426|CD4 T lymphocyte helper|cd4 t lymphocyte helper
74425|NCT02818426|telomerase|telomerase
74426|NCT02818413|Stool microbiome|stool microbiome
74427|NCT02818413|Stool metabolome|stool metabolome
74428|NCT02818413|Single nucleotide polymorphisms|single nucleotide polymorphisms
74429|NCT02818400|maxillofacial surgery|maxillofacial surgery
74430|NCT02818400|face graft|face graft
74431|NCT02818400|composite tissue|composite tissue
74432|NCT02818400|stem cell infusion|stem cell infusion
74433|NCT02818400|allotransplantation|allotransplantation
74434|NCT02818400|microsurgery|microsurgery
74435|NCT02818387|propofol|propofol
74436|NCT02818387|midazolam|midazolam
74437|NCT02818387|remifentanil|remifentanil
74438|NCT02818387|combination|combination
74439|NCT02818387|synergic|synergic
74440|NCT02818387|pharmacodynamics|pharmacodynamics
74441|NCT02818387|Loss of consciousness|loss of consciousness
74442|NCT02818361|Rheumatoid Arthritis|rheumatoid arthritis
74443|NCT02818361|Tripterygium wilfordii Hook F|tripterygium wilfordii hook f
74444|NCT02818361|double-blinded|double-blinded
74445|NCT02818361|randomized controlled trial|randomized controlled trial
74546|NCT02817711|infection|infection
74446|NCT02818361|Tripterygium|tripterygium
74447|NCT02818361|Administration|administration
74448|NCT02818361|Topical|topical
74449|NCT02818348|HIV infection|hiv infection
74450|NCT02818348|Darunavir/cobicistat|darunavir/cobicistat
74451|NCT02818348|Etravirine, drug-drug interactions|etravirine, drug-drug interactions
74452|NCT02818348|Population PK analysis|population pk analysis
74453|NCT02818296|Intolerance of uncertainty|intolerance of uncertainty
74454|NCT02818296|Anxiety|anxiety
74455|NCT02818283|Human Immunodeficiency Virus|human immunodeficiency virus
74456|NCT02818283|hypercholesterolemia|hypercholesterolemia
74457|NCT02818283|pretzels|pretzels
74458|NCT02818283|nutritional study|nutritional study
74459|NCT02818283|dietary soy|dietary soy
74460|NCT02818283|antiretroviral therapy|antiretroviral therapy
74461|NCT02818244|commercial heart monitors|commercial heart monitors
74462|NCT02818244|accuracy|accuracy
74463|NCT02818244|EKG|ekg
74464|NCT02818244|varying degrees of exertion|varying degrees of exertion
626787|NCT00687258|Anemia|anemia
74465|NCT02818166|magnetic resonance|magnetic resonance
74466|NCT02818166|right mini-thoracotomy|right mini-thoracotomy
74467|NCT02818153|Allergic rhinitis|allergic rhinitis
74468|NCT02818140|Postoperative pain|postoperative pain
74469|NCT02818140|Transmuscular quadratus lumborum block|transmuscular quadratus lumborum block
74470|NCT02818140|Block|block
74471|NCT02818140|Ropivacaine|ropivacaine
74472|NCT02818140|TQL|tql
74473|NCT02818140|percutaneous nephrolithotomy|percutaneous nephrolithotomy
74474|NCT02818140|PNL|pnl
74475|NCT02818140|Ultrasound-guided|ultrasound-guided
74476|NCT02818114|PTSD|ptsd
74477|NCT02818114|Prolonged Exposure|prolonged exposure
74478|NCT02818114|Peer Support|peer support
74479|NCT02818075|Peer support|peer support
74480|NCT02818075|Postpartum Depression|postpartum depression
74481|NCT02818075|Adolescent Pregnancy|adolescent pregnancy
74482|NCT02818062|Endophthalmitis|endophthalmitis
74483|NCT02818062|Cytokines|cytokines
74484|NCT02818062|Chemokines|chemokines
74485|NCT02818062|Inflammation|inflammation
74486|NCT02818062|Regulation|regulation
74487|NCT02818049|Bronchioalveolar Lavage|bronchioalveolar lavage
74488|NCT02818010|physical activity|physical activity
74489|NCT02818010|chronic kidney disease|chronic kidney disease
74490|NCT02818010|nephrology|nephrology
74493|NCT02818010|stage 5|stage 5
74494|NCT02817997|patient registry|patient registry
74495|NCT02817997|ACCELERATE study|accelerate study
74496|NCT02817997|CD|cd
74497|NCT02817997|MCD|mcd
74498|NCT02817997|iMCD|imcd
74499|NCT02817997|Castleman|castleman
76004|NCT02809261|Dextrose|dextrose
74501|NCT02817997|Angiofollicular Lymph Hyperplasia|angiofollicular lymph hyperplasia
74502|NCT02817997|multicentric Castleman's disease|multicentric castleman's disease
74503|NCT02817997|multicentric Castleman disease|multicentric castleman disease
74504|NCT02817984|Abdominoplasty|abdominoplasty
74505|NCT02817971|feedback|feedback
74506|NCT02817971|pneumonia|pneumonia
74507|NCT02817971|quality of care|quality of care
74508|NCT02817958|inguinal lymph nodes|inguinal lymph nodes
74509|NCT02817958|penile cancer|penile cancer
74510|NCT02817958|squamous|squamous
74511|NCT02817958|TIP chemotherapy|tip chemotherapy
74512|NCT02817945|TATE-RGD|tate-rgd
74513|NCT02817945|SSTR2|sstr2
74514|NCT02817945|integrin αvβ3|integrin αvβ3
74515|NCT02817919|Pharmacovigilance|pharmacovigilance
74516|NCT02817919|Africa|africa
74517|NCT02817893|∆POP: variation of the plethysmographic waveform of pulse oximetry|∆pop: variation of the plethysmographic waveform of pulse oximetry
74518|NCT02817893|∆PP: pulse pressure variation|∆pp: pulse pressure variation
74519|NCT02817893|pulse oximetry plethysmographic|pulse oximetry plethysmographic
74520|NCT02817893|abdominal surgery|abdominal surgery
74521|NCT02817880|rTMS, tDCS, tsDCS, pain, algoneurodystrophy , neurostimulation|rtms, tdcs, tsdcs, pain, algoneurodystrophy , neurostimulation
74522|NCT02817841|Estetrol|estetrol
74523|NCT02817841|Drospirenone|drospirenone
74524|NCT02817841|Prevention of pregnancy|prevention of pregnancy
74525|NCT02817841|Oral contraception|oral contraception
74526|NCT02817828|Estetrol|estetrol
74527|NCT02817815|Atrial fibrillation, blood platelet|atrial fibrillation, blood platelet
74528|NCT02817802|Registry|registry
74529|NCT02817802|Magmaris|magmaris
74530|NCT02817802|Coronary Artery Disease|coronary artery disease
74531|NCT02817802|PCI|pci
74532|NCT02817789|TAVI|tavi
74533|NCT02817789|Antiplatelet agent|antiplatelet agent
74534|NCT02817789|Ticagrelor|ticagrelor
74535|NCT02817789|Cerebrovascular events|cerebrovascular events
74536|NCT02817776|Interventional|interventional
74537|NCT02817776|Radiofrequency Ablation|radiofrequency ablation
74538|NCT02817776|Persistent Atrial Fibrillation|persistent atrial fibrillation
74539|NCT02817750|volunteers|volunteers
74540|NCT02817750|Pharmacokinetics|pharmacokinetics
74541|NCT02817724|Breast Neoplasms|breast neoplasms
74542|NCT02817724|survivor|survivor
74543|NCT02817724|occupational therapy|occupational therapy
74544|NCT02817724|mobile applications|mobile applications
74545|NCT02817724|Quality of Life|quality of life
74547|NCT02817711|bone and joint infection|bone and joint infection
74548|NCT02817711|relapse|relapse
74549|NCT02817711|adverse event|adverse event
74551|NCT02817698|cannabis|cannabis
74552|NCT02817698|cocaine|cocaine
74553|NCT02817685|surveillance|surveillance
74554|NCT02817685|hepatocellular carcinoma|hepatocellular carcinoma
74555|NCT02817685|ultrasound|ultrasound
74556|NCT02817685|cirrhosis|cirrhosis
74557|NCT02817685|chronic hepatitis B|chronic hepatitis b
74558|NCT02817672|Human|human
74559|NCT02817672|Mental Disorders|mental disorders
74560|NCT02817672|intervention|intervention
74561|NCT02817672|digital health|digital health
74562|NCT02817659|Glucagon|glucagon
74563|NCT02817646|Intensive Care Unit|intensive care unit
74564|NCT02817646|Critical Illness|critical illness
74565|NCT02817646|Body composition|body composition
74566|NCT02817646|Protein nutrition|protein nutrition
74567|NCT02817633|Anitibodies|anitibodies
74568|NCT02817633|TSR-022|tsr-022
74569|NCT02817633|Advanced solid tumors|advanced solid tumors
74570|NCT02817633|Metastatic solid tumors|metastatic solid tumors
74571|NCT02817633|Immunotherapy|immunotherapy
74572|NCT02817633|PD-1|pd-1
74573|NCT02817633|Anti-PD-1|anti-pd-1
74574|NCT02817633|colorectal cancer|colorectal cancer
74575|NCT02817633|non-small cell lung cancer|non-small cell lung cancer
74576|NCT02817633|Melanoma|melanoma
74577|NCT02817607|Sensation|sensation
74578|NCT02817594|Sustained Virological Response|sustained virological response
74579|NCT02817594|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
74580|NCT02817594|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
74581|NCT02817594|Observational Study|observational study
74582|NCT02817594|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
74583|NCT02817594|Chronic Hepatitis C|chronic hepatitis c
74584|NCT02817581|National Early Warning Score (NEWS)|national early warning score (news)
74585|NCT02817581|Lactate|lactate
74586|NCT02817581|Emergency Department|emergency department
74587|NCT02817568|Aggressive Periodontitis|aggressive periodontitis
74588|NCT02817568|C-C chemokine receptor 2|c-c chemokine receptor 2
74589|NCT02817568|Gene expression|gene expression
87143|NCT02743351|ALL|all
74590|NCT02817568|monocyte chemoattractant protein-1,|monocyte chemoattractant protein-1,
74684|NCT02816892|diagnosis|diagnosis
74591|NCT02817568|restriction fragment length polymorphism|restriction fragment length polymorphism
74592|NCT02817555|Anemia|anemia
74593|NCT02817555|Hemodialysis|hemodialysis
74594|NCT02817555|Erythropoiesis Stimulating Agent|erythropoiesis stimulating agent
74596|NCT02817516|Drug Therapy|drug therapy
74597|NCT02817503|hypertension|hypertension
74598|NCT02817503|BP titration|bp titration
74599|NCT02817503|intensive blood pressure control|intensive blood pressure control
74600|NCT02817503|primary prevention|primary prevention
74601|NCT02817503|China|china
74602|NCT02817503|H-type Hypertension|h-type hypertension
74603|NCT02817490|hypermobility|hypermobility
74604|NCT02817490|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
74605|NCT02817490|patient education program|patient education program
74606|NCT02817477|Intranasal Ketamine, Analgesia, Trauma, Morphine, Mass Casualty|intranasal ketamine, analgesia, trauma, morphine, mass casualty
74607|NCT02817451|Diphtheria|diphtheria
74608|NCT02817451|Tetanus|tetanus
74609|NCT02817451|Pertussis|pertussis
74610|NCT02817451|Hepatitis B|hepatitis b
74611|NCT02817451|DTaP IPV HB PRP-T Combined Vaccine|dtap ipv hb prp-t combined vaccine
74612|NCT02817451|Human Immunodeficiency Virus|human immunodeficiency virus
74613|NCT02817425|S-1|s-1
74614|NCT02817425|Adjuvant Chemotherapy|adjuvant chemotherapy
74615|NCT02817425|TEGAFOX|tegafox
74616|NCT02817412|binge eating|binge eating
74617|NCT02817412|obesity|obesity
74618|NCT02817412|overeating|overeating
74619|NCT02817399|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
74620|NCT02817399|Functional Electrical stimulation|functional electrical stimulation
74621|NCT02817399|Gait analysis|gait analysis
74622|NCT02817399|Physical therapy|physical therapy
74623|NCT02817386|postoperative delirium|postoperative delirium
74624|NCT02817386|microRNA|microrna
74625|NCT02817373|IVF|ivf
74626|NCT02817373|embryo transfer|embryo transfer
74627|NCT02817373|ultrasound|ultrasound
74628|NCT02817373|implantation|implantation
74629|NCT02817334|Near-infrared fluorescence|near-infrared fluorescence
74630|NCT02817334|Indocyanine green, ICG|indocyanine green, icg
74631|NCT02817334|breast cancer|breast cancer
74632|NCT02817308|Antigen, CA-19-9|antigen, ca-19-9
74633|NCT02817308|Salivas|salivas
74634|NCT02817308|body fluids|body fluids
74635|NCT02817269|Shoulder pain|shoulder pain
74636|NCT02817269|Trigger points|trigger points
74637|NCT02817269|Referred pain|referred pain
74638|NCT02817269|Visual analogue scale|visual analogue scale
74639|NCT02817191|age-related cataract|age-related cataract
74640|NCT02817191|Holy-Comod|holy-comod
74641|NCT02817191|Tears Naturale Forte|tears naturale forte
74642|NCT02817191|phacoemulsification|phacoemulsification
74643|NCT02817191|inflammatory mediators|inflammatory mediators
74748|NCT02816515|Non interventional study|non interventional study
74644|NCT02817165|Probiotics, diarrhea, antibiotic, children, hospital|probiotics, diarrhea, antibiotic, children, hospital
74645|NCT02817152|periodontal treatment|periodontal treatment
74646|NCT02817152|low-level light therapy|low-level light therapy
74647|NCT02817126|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
74648|NCT02817126|Robotic Surgical Procedures|robotic surgical procedures
74649|NCT02817126|Laparoscopic Surgical Procedures|laparoscopic surgical procedures
74650|NCT02817126|Rectal Cancer|rectal cancer
74651|NCT02817126|Intraoperative Complications|intraoperative complications
74652|NCT02817126|Postoperative Complications|postoperative complications
74653|NCT02817126|Recovery of Function|recovery of function
74654|NCT02817126|Recurrence|recurrence
74655|NCT02817126|Disease Progression|disease progression
74656|NCT02817126|Survival|survival
74657|NCT02817087|Stroke|stroke
74658|NCT02817061|no keywords for disease type and/or category|no keywords for disease type and/or category
74659|NCT02817035|interstitial lung disease|interstitial lung disease
74660|NCT02817035|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
74661|NCT02817035|mechanical ventilation|mechanical ventilation
74662|NCT02817035|expiratory delay|expiratory delay
74663|NCT02817035|neural inspiratory time|neural inspiratory time
74664|NCT02817022|Developmentally Supportive Care|developmentally supportive care
74665|NCT02817009|Behavioral Health Intervention|behavioral health intervention
74666|NCT02817009|Randomized Control Trial|randomized control trial
74667|NCT02817009|Family Intervention|family intervention
74668|NCT02817009|Nutrition|nutrition
74669|NCT02817009|Weight Management|weight management
74670|NCT02817009|Multidisciplinary Program|multidisciplinary program
74671|NCT02816944|Endoscopic ultrasonography|endoscopic ultrasonography
74672|NCT02816944|Laser ablation|laser ablation
74673|NCT02816931|Treatment|treatment
74674|NCT02816931|Drug Monitoring|drug monitoring
74675|NCT02816931|Minimum Inhibitory Concentration|minimum inhibitory concentration
74676|NCT02816931|Dried Blood Spot Method|dried blood spot method
74677|NCT02816931|Pharmacokinetics|pharmacokinetics
74678|NCT02816931|Pharmacodynamics|pharmacodynamics
87338|NCT02742090|CLL|cll
74679|NCT02816905|intraocular pressure|intraocular pressure
74680|NCT02816905|topical steroids|topical steroids
74681|NCT02816905|strabismus|strabismus
74682|NCT02816892|aortic dissection|aortic dissection
74683|NCT02816892|biomarkers|biomarkers
74685|NCT02816866|childhood cancer|childhood cancer
74686|NCT02816866|survivorship care|survivorship care
74687|NCT02816866|health services|health services
74688|NCT02816866|barriers|barriers
74696|NCT02816814|Omega-3 fatty acids|omega-3 fatty acids
74697|NCT02816788|PTSD|ptsd
74698|NCT02816788|Equine Assisted Therapy|equine assisted therapy
74699|NCT02816775|hemodynamics|hemodynamics
74700|NCT02816775|QT interval|qt interval
74701|NCT02816762|CPAP|cpap
74702|NCT02816762|Sleep apnea|sleep apnea
74703|NCT02816762|Diabetes|diabetes
74704|NCT02816762|Nephropathy|nephropathy
74705|NCT02816762|Albuminuria|albuminuria
74706|NCT02816749|Diabetic Foot|diabetic foot
74707|NCT02816749|Wound Healing|wound healing
74708|NCT02816749|Larva|larva
74709|NCT02816749|Occlusive Dressings|occlusive dressings
74710|NCT02816736|Heart Failure|heart failure
74711|NCT02816736|Heart Diseases|heart diseases
74712|NCT02816736|Cardiovascular Diseases|cardiovascular diseases
74713|NCT02816736|Valsartan|valsartan
74714|NCT02816736|Entresto|entresto
74715|NCT02816723|mindfulness|mindfulness
74716|NCT02816723|aging|aging
74717|NCT02816723|Veterans|veterans
74718|NCT02816697|Smoking Habits|smoking habits
74719|NCT02816684|phobic disorders|phobic disorders
74720|NCT02816684|anxiety disorders|anxiety disorders
74721|NCT02816645|Parkinson's Disease|parkinson's disease
74722|NCT02816645|Biomarker|biomarker
74723|NCT02816645|Iron|iron
74724|NCT02816645|R2*|r2*
74725|NCT02816645|MRI|mri
74726|NCT02816645|Patients|patients
74727|NCT02816645|UK Parkinson's Disease Society Brain Bank|uk parkinson's disease society brain bank
74728|NCT02816632|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
74729|NCT02816632|Galvanic Vestibular Stimulation|galvanic vestibular stimulation
74730|NCT02816632|Feedback Processing|feedback processing
74731|NCT02816632|Reward, Social, Vestibular System|reward, social, vestibular system
74732|NCT02816632|Cingulate Cortex|cingulate cortex
74733|NCT02816632|Decision-making|decision-making
74734|NCT02816619|Parkinson's disease|parkinson's disease
74735|NCT02816619|Physical activity|physical activity
74736|NCT02816619|Physical exercise|physical exercise
74737|NCT02816606|ACL reconstruction|acl reconstruction
74738|NCT02816593|carbamide peroxide|carbamide peroxide
74739|NCT02816593|Hydrogen peroxide|hydrogen peroxide
74740|NCT02816593|Quality of life|quality of life
74741|NCT02816554|Japanese Encephalitis|japanese encephalitis
74742|NCT02816554|JECEVAX|jecevax
74743|NCT02816554|Vietnam|vietnam
74744|NCT02816528|Antibiotics|antibiotics
74745|NCT02816528|Primary care|primary care
74746|NCT02816528|Stewardship|stewardship
74747|NCT02816528|General practitioners|general practitioners
74749|NCT02816515|Ectoin|ectoin
74750|NCT02816515|Mouth wash|mouth wash
74751|NCT02816515|Mucositis|mucositis
74752|NCT02816515|Chemotherapy|chemotherapy
74753|NCT02816515|Radiotherapy|radiotherapy
74754|NCT02816502|childhood|childhood
74755|NCT02816502|adversity|adversity
74756|NCT02816450|Water|water
74757|NCT02816450|Children|children
74758|NCT02816450|Cognition|cognition
74759|NCT02816450|Hydration|hydration
74760|NCT02816424|Screening and Brief Intervention|screening and brief intervention
74761|NCT02816424|Motivational Interviewing|motivational interviewing
74762|NCT02816424|Teen Pregnancy Prevention|teen pregnancy prevention
74763|NCT02816385|PV-loops (pressure-volume loops)|pv-loops (pressure-volume loops)
74764|NCT02816385|Myocardial contractility|myocardial contractility
74765|NCT02816385|Cardioplegia|cardioplegia
74766|NCT02816385|Induced|induced
74767|NCT02816359|Position patient|position patient
74768|NCT02816359|Esophageal pressure|esophageal pressure
74769|NCT02816346|shigella|shigella
74770|NCT02816320|hospital mortality|hospital mortality
74771|NCT02816320|standardized mortality ratios|standardized mortality ratios
74772|NCT02816320|patient safety|patient safety
74773|NCT02816320|healthcare quality|healthcare quality
74774|NCT02816320|hospital performance|hospital performance
74775|NCT02816320|administrative data|administrative data
74776|NCT02816281|Surgical case cancellation|surgical case cancellation
74777|NCT02816281|Pre-operative assessment clinic|pre-operative assessment clinic
74778|NCT02816242|Concept Map|concept map
74779|NCT02816242|critical thinking|critical thinking
74780|NCT02816242|medical student teaching|medical student teaching
74781|NCT02816229|Haemoptysis|haemoptysis
74782|NCT02816229|Aspergillus|aspergillus
74783|NCT02816229|Endobronchial valve|endobronchial valve
74784|NCT02816229|Interventional pulmonology|interventional pulmonology
74785|NCT02816229|Tuberculosis|tuberculosis
74786|NCT02816138|Geriatrics|geriatrics
74787|NCT02816138|Depression|depression
74788|NCT02816138|Elderly|elderly
74789|NCT02816138|Cognition|cognition
74790|NCT02816138|Memory|memory
74791|NCT02816125|breast cancer|breast cancer
74792|NCT02816125|fatty acids|fatty acids
74793|NCT02816125|omega-3|omega-3
74794|NCT02816060|pain measurement|pain measurement
74795|NCT02816047|wearable cardioverter defibrillator|wearable cardioverter defibrillator
74796|NCT02816047|LifeVest|lifevest
74797|NCT02816047|sudden death|sudden death
74798|NCT02816047|defibrillator|defibrillator
74799|NCT02816034|Learning|learning
74800|NCT02816034|Cerebellum|cerebellum
74801|NCT02816021|Melanoma and other malignant neoplasms of skin|melanoma and other malignant neoplasms of skin
74802|NCT02816021|Metastatic melanoma|metastatic melanoma
74803|NCT02816021|Advanced melanoma|advanced melanoma
74804|NCT02816021|Azacitidine|azacitidine
74805|NCT02816021|5-azacytidine|5-azacytidine
74806|NCT02816021|5-aza|5-aza
74807|NCT02816021|Vidaza|vidaza
74808|NCT02816021|5-AZC|5-azc
74809|NCT02816021|Ladakamycin|ladakamycin
74810|NCT02816021|NSC-102816|nsc-102816
74811|NCT02816021|Azacytidine|azacytidine
74812|NCT02816021|Pembrolizumab|pembrolizumab
74813|NCT02816021|Keytruda|keytruda
74814|NCT02816021|MK-3475|mk-3475
74815|NCT02816021|SCH-900475|sch-900475
74816|NCT02816008|cognitive rehabilitation|cognitive rehabilitation
74817|NCT02816008|memory|memory
74818|NCT02816008|attention|attention
74819|NCT02816008|spatial neglect|spatial neglect
74820|NCT02816008|executive dysfunctioning|executive dysfunctioning
74821|NCT02815995|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
74822|NCT02815995|Multiple sarcoma subtypes|multiple sarcoma subtypes
74823|NCT02815995|Advanced and/or metastatic sarcoma|advanced and/or metastatic sarcoma
74824|NCT02815995|Adipocytic tumors|adipocytic tumors
74825|NCT02815995|Vascular tumors|vascular tumors
74826|NCT02815995|Leiomyosarcoma|leiomyosarcoma
74827|NCT02815995|Angiosarcoma|angiosarcoma
74828|NCT02815995|Epithelioid hemangioendothelioma|epithelioid hemangioendothelioma
74829|NCT02815995|Undifferentiated pleomorphic sarcoma|undifferentiated pleomorphic sarcoma
74830|NCT02815995|Synovial sarcoma|synovial sarcoma
74831|NCT02815995|Osteosarcoma|osteosarcoma
74832|NCT02815995|Other sarcoma histologies|other sarcoma histologies
74833|NCT02815995|Durvalumab|durvalumab
74834|NCT02815995|Tremelimumab|tremelimumab
74835|NCT02815969|neuroendocrine tumors|neuroendocrine tumors
74836|NCT02815969|indol profile|indol profile
74837|NCT02815969|catecholamines|catecholamines
74838|NCT02815969|LC-MS/MS|lc-ms/ms
74839|NCT02815956|percutaneous tibial nerve stimulation|percutaneous tibial nerve stimulation
74840|NCT02815956|randomized|randomized
74841|NCT02815956|controlled study|controlled study
74842|NCT02815930|High cost user (HCU)|high cost user (hcu)
74843|NCT02815930|Healthcare utilization|healthcare utilization
74844|NCT02815930|Healthcare expenditures|healthcare expenditures
74845|NCT02815930|Medication use|medication use
74846|NCT02815930|Medication expenditures|medication expenditures
74847|NCT02815930|Multimorbidity|multimorbidity
74848|NCT02815930|Observational study|observational study
74849|NCT02815904|Neonates|neonates
74850|NCT02815904|physical therapy|physical therapy
74851|NCT02815904|neonatal intensive care units|neonatal intensive care units
74852|NCT02815904|yakson touch|yakson touch
74853|NCT02815904|kinesthetic stimulation|kinesthetic stimulation
74854|NCT02815865|Primiparous|primiparous
74855|NCT02815865|Foley catheter|foley catheter
74856|NCT02815865|Dinoprostone|dinoprostone
74857|NCT02815865|Induction|induction
74858|NCT02815852|breast cancer in women under 40 years old|breast cancer in women under 40 years old
74859|NCT02815852|biopsy|biopsy
74860|NCT02815852|ultrasonography|ultrasonography
74861|NCT02815852|Magnetic Resonance Imaging|magnetic resonance imaging
74862|NCT02815839|urate transporter 1|urate transporter 1
74863|NCT02815839|SHR4640|shr4640
74864|NCT02815839|single ascending dose|single ascending dose
74865|NCT02815839|pharmacokinetics|pharmacokinetics
74866|NCT02815839|pharmacodynamics|pharmacodynamics
74867|NCT02815813|Serious Mental Illness|serious mental illness
74868|NCT02815813|Young Adults|young adults
74869|NCT02815813|Obesity|obesity
74870|NCT02815813|Cardiometabolic Risk|cardiometabolic risk
74871|NCT02815813|Physical Activity|physical activity
74872|NCT02815813|Weight Loss|weight loss
74873|NCT02815813|Fitness|fitness
74874|NCT02815813|Peer Support|peer support
74875|NCT02815813|Smartphone|smartphone
74876|NCT02815813|Mobile Technology|mobile technology
74877|NCT02815813|mHealth|mhealth
74878|NCT02815813|Social Media|social media
74879|NCT02815813|Facebook|facebook
74880|NCT02815800|Treatment|treatment
74881|NCT02815800|Motor signs|motor signs
74882|NCT02815800|Non motor signs|non motor signs
74883|NCT02815800|Fluctuations|fluctuations
74884|NCT02815800|Open labelled|open labelled
74885|NCT02815787|SP2086|sp2086
74886|NCT02815787|Glyburide|glyburide
74902|NCT02815657|SP2086|sp2086
66326|NCT02869139|Ice|ice
74903|NCT02815657|Valsartan|valsartan
74904|NCT02815657|Drug-drug Interaction|drug-drug interaction
74905|NCT02815631|fractional flow reserve|fractional flow reserve
74906|NCT02815631|cardiogoniometry|cardiogoniometry
74907|NCT02815618|Time-resolved spectroscopy|time-resolved spectroscopy
74908|NCT02815618|Diffuse correlation spectroscopy|diffuse correlation spectroscopy
74909|NCT02815618|Neonatology|neonatology
74911|NCT02815579|Food insecurity|food insecurity
74912|NCT02815579|Microcredit loan|microcredit loan
74913|NCT02815579|Agriculture|agriculture
74914|NCT02815579|Livelihoods|livelihoods
74915|NCT02815566|kidney, antiretroviral agent, tenofovir, osteoporosis, women|kidney, antiretroviral agent, tenofovir, osteoporosis, women
74916|NCT02815527|enteral nutrition|enteral nutrition
74917|NCT02815527|intensive care unit|intensive care unit
74918|NCT02815527|whey|whey
74919|NCT02815527|protein|protein
74920|NCT02815527|muscle mass|muscle mass
74921|NCT02815527|leucin|leucin
74922|NCT02815527|energy expenditure|energy expenditure
74923|NCT02815514|aortic valve stenosis|aortic valve stenosis
74924|NCT02815514|aortic valve insufficiency|aortic valve insufficiency
74925|NCT02815514|transapical aortic valve implantation|transapical aortic valve implantation
74926|NCT02815514|aortic valve replacement|aortic valve replacement
74927|NCT02815514|percutaneous aortic valve replacement|percutaneous aortic valve replacement
74928|NCT02815514|aortic valve valvuloplasty|aortic valve valvuloplasty
74929|NCT02815501|Thyroid dysfunction|thyroid dysfunction
74930|NCT02815501|obstetric complications|obstetric complications
74931|NCT02815462|Frequent hospital admissions|frequent hospital admissions
74932|NCT02815462|Risk stratification|risk stratification
74933|NCT02815462|Readmissions|readmissions
74934|NCT02815449|Iron fortification|iron fortification
74935|NCT02815449|Bioavailability|bioavailability
74936|NCT02815449|Nigeria|nigeria
74937|NCT02815449|Women|women
74938|NCT02815449|Bouillon cubes|bouillon cubes
74939|NCT02815410|Glioblastoma Multiforme|glioblastoma multiforme
74940|NCT02815410|Levetiracetam|levetiracetam
74941|NCT02815410|Temozolomide|temozolomide
74942|NCT02815410|Survival outcome|survival outcome
74943|NCT02815397|Double Hit DLBCL|double hit dlbcl
74944|NCT02815319|Dexamethasone|dexamethasone
74945|NCT02815319|Chemotherapy|chemotherapy
74946|NCT02815306|Congenital idiopathic clubfoot|congenital idiopathic clubfoot
74947|NCT02815306|Pirani score|pirani score
74948|NCT02815306|infant|infant
74949|NCT02815306|polyaxial brace|polyaxial brace
74951|NCT02815293|evaporative dry eye|evaporative dry eye
74952|NCT02815280|acne|acne
74953|NCT02815267|acne|acne
74954|NCT02815254|Physiotherapy|physiotherapy
74955|NCT02815254|hip fracture|hip fracture
74956|NCT02815254|rehabilitation|rehabilitation
74957|NCT02815254|high dose exercise|high dose exercise
74958|NCT02815254|low dose exercise|low dose exercise
74959|NCT02815215|congenital clubfoot|congenital clubfoot
74960|NCT02815189|pain|pain
74961|NCT02815176|Plasminogen activator inhibitor-1|plasminogen activator inhibitor-1
74962|NCT02815176|Wide angle fluorescein angiography|wide angle fluorescein angiography
74963|NCT02815176|Choroid|choroid
74964|NCT02815137|Digital PCR|digital pcr
74965|NCT02815137|classical|classical
74966|NCT02815137|Hodgkin Lymphoma|hodgkin lymphoma
74967|NCT02815137|mutation|mutation
74968|NCT02815085|heart failure|heart failure
74969|NCT02815085|mHealth|mhealth
74970|NCT02815072|Fontan palliation|fontan palliation
74971|NCT02815072|Marfan's syndrome|marfan's syndrome
74972|NCT02815046|urgency urinary incontinence|urgency urinary incontinence
74974|NCT02815046|Botulinum toxin A|botulinum toxin a
74976|NCT02815033|Hormono-Sensitive prostate cancer|hormono-sensitive prostate cancer
74977|NCT02815033|Enzalutamide|enzalutamide
74978|NCT02815033|Imaging|imaging
74979|NCT02815033|PET/CT|pet/ct
74980|NCT02815033|Whole body MRI|whole body mri
74981|NCT02815033|Circulating tumour cells|circulating tumour cells
74982|NCT02815033|Cell-free tumour DNA|cell-free tumour dna
74983|NCT02815020|Primary care|primary care
74984|NCT02815020|Self-management support|self-management support
74985|NCT02815020|Care coordination|care coordination
74986|NCT02815020|Practice-based research network|practice-based research network
74987|NCT02814994|Mechanical Ventilation|mechanical ventilation
74988|NCT02814994|ARDS|ards
74989|NCT02814994|Ventilator Strategy|ventilator strategy
74990|NCT02814994|Outcome|outcome
74991|NCT02814981|hydroxyzine|hydroxyzine
74992|NCT02814981|Long QT|long qt
74993|NCT02814968|Castration-resistant prostate cancer|castration-resistant prostate cancer
74994|NCT02814968|Enzalutamide|enzalutamide
74995|NCT02814968|Imaging|imaging
74996|NCT02814968|PET/CT|pet/ct
74997|NCT02814968|Whole body MRI|whole body mri
74998|NCT02814968|Circulating tumour cells|circulating tumour cells
74999|NCT02814968|Cell-free tumour DNA|cell-free tumour dna
75000|NCT02814955|atrial fibrillation|atrial fibrillation
75001|NCT02814955|pulmonary veins|pulmonary veins
75002|NCT02814955|oral anticoagulant|oral anticoagulant
75003|NCT02814955|electrophysiology|electrophysiology
75004|NCT02814955|anticoagulant drugs|anticoagulant drugs
75005|NCT02814929|ROP|rop
75006|NCT02814929|Risk factors|risk factors
75007|NCT02814929|Incidence|incidence
75008|NCT02814929|Turkey|turkey
75009|NCT02814916|Acute Bacterial Skin and Skin Structure Infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
75010|NCT02814903|aldosterone|aldosterone
75011|NCT02814903|cardiac surgery|cardiac surgery
75012|NCT02814903|atrial fibrillation|atrial fibrillation
75013|NCT02814903|galectin-3|galectin-3
75014|NCT02814903|mitochondria|mitochondria
75015|NCT02814903|ngal|ngal
75016|NCT02814903|acute kidney failure|acute kidney failure
75017|NCT02814903|epicardial fat|epicardial fat
75018|NCT02814903|right atrial sample|right atrial sample
75019|NCT02814890|Thoracic paravertebral block|thoracic paravertebral block
75020|NCT02814890|Dexmedetomidine|dexmedetomidine
75021|NCT02814890|Video-assisted Pneumonectomy|video-assisted pneumonectomy
75022|NCT02814890|Ropivacaine|ropivacaine
75023|NCT02814890|Pain, Postoperative|pain, postoperative
75024|NCT02814877|Antibiotic stewardship|antibiotic stewardship
75025|NCT02814877|cost-effectiveness evaluation|cost-effectiveness evaluation
75026|NCT02814877|Antibiotic use|antibiotic use
75027|NCT02814864|Hematology|hematology
75028|NCT02814864|Mesenchymal Stromal Cell|mesenchymal stromal cell
75029|NCT02814864|radiotherapy|radiotherapy
75030|NCT02814864|gastro-intestinal complications|gastro-intestinal complications
75031|NCT02814864|lower digestive tract cancers|lower digestive tract cancers
75032|NCT02814864|colitis|colitis
75033|NCT02814864|bleeding|bleeding
75034|NCT02814864|diarrhea|diarrhea
75035|NCT02814864|pelvic radiation disease|pelvic radiation disease
75036|NCT02814851|Left atrium appendage (LAA) occlusion|left atrium appendage (laa) occlusion
75037|NCT02814851|Transesophageal echocardiography|transesophageal echocardiography
75038|NCT02814851|Cardiac output hemodynamic measurement|cardiac output hemodynamic measurement
75039|NCT02814851|Leycom Pressure/Volume Combination Catheter|leycom pressure/volume combination catheter
75040|NCT02814838|Diabetes mellitus Type 1|diabetes mellitus type 1
75041|NCT02814838|Beta cells function|beta cells function
75042|NCT02814825|ViviGen|vivigen
75043|NCT02814825|ACDF|acdf
75044|NCT02814825|Cervical|cervical
75045|NCT02814760|acute ischemic stroke|acute ischemic stroke
75046|NCT02814760|stepped-wedge|stepped-wedge
75047|NCT02814760|interactive training|interactive training
75048|NCT02814760|implementation|implementation
75049|NCT02814760|emergency department|emergency department
75050|NCT02814734|Intra-Abdominal Hypertension|intra-abdominal hypertension
75051|NCT02814734|Abdominal Compartment Syndrome|abdominal compartment syndrome
75052|NCT02814734|Round Belly Sign|round belly sign
75053|NCT02814734|Radiology|radiology
75054|NCT02814734|CT findings|ct findings
75055|NCT02814734|Intensive Care|intensive care
75056|NCT02814708|Sepsis|sepsis
75057|NCT02814708|Vaccination|vaccination
75058|NCT02814695|Male infertility|male infertility
75059|NCT02814695|oxidative stress|oxidative stress
75060|NCT02814695|antioxidants|antioxidants
75061|NCT02814695|probiotics|probiotics
75062|NCT02814695|Vitamin E|vitamin e
75063|NCT02814695|Baker's Yeast|baker's yeast
75064|NCT02814682|palliative care|palliative care
75065|NCT02814682|quality|quality
75066|NCT02814682|indicator|indicator
75067|NCT02814682|multi-dimensional|multi-dimensional
200979|NCT02112708|Psychotherapy, Rational-Emotive|psychotherapy, rational-emotive
75068|NCT02814656|muscarinic receptor antagonist and β2 adrenoceptor agonist [MABA]|muscarinic receptor antagonist and β2 adrenoceptor agonist [maba]
75069|NCT02814656|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
75070|NCT02814656|Asthma (in combination with an inhaled corticosteroid [ICS]|asthma (in combination with an inhaled corticosteroid [ics]
75071|NCT02814656|alpha-lactose monohydrate|alpha-lactose monohydrate
75072|NCT02814656|dry powder inhaler|dry powder inhaler
75073|NCT02814656|long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
75074|NCT02814656|long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
75075|NCT02814656|fixed-dose combination (FDC)|fixed-dose combination (fdc)
75076|NCT02814643|Male and female adolescent patients|male and female adolescent patients
75077|NCT02814643|severe asthma|severe asthma
75078|NCT02814604|Front-of-Pack Labelling|front-of-pack labelling
75079|NCT02814604|Star rating system|star rating system
75080|NCT02814604|Traffic light rating system|traffic light rating system
75081|NCT02814604|Consumer Behavior|consumer behavior
75082|NCT02814604|Health Literacy|health literacy
75083|NCT02814604|Mobile Apps|mobile apps
75084|NCT02814604|Nutrition Labeling|nutrition labeling
75085|NCT02814604|Healthy food choices|healthy food choices
75086|NCT02814578|OCT|oct
75087|NCT02814578|IVUS|ivus
75088|NCT02814578|BVS|bvs
75089|NCT02814565|Drug therapy|drug therapy
75090|NCT02814513|Children|children
75091|NCT02814513|Adolescents|adolescents
75092|NCT02814487|DAM|dam
75093|NCT02814487|multiple sclerosis|multiple sclerosis
75094|NCT02814487|MSFC|msfc
87797|NCT02738788|airway|airway
66450|NCT02868580|ALS|als
75095|NCT02814487|application|application
75096|NCT02814487|smartphone|smartphone
75097|NCT02814474|PET/CT|pet/ct
75098|NCT02814474|Heart failure|heart failure
75099|NCT02814474|hydroxybutyrate|hydroxybutyrate
75100|NCT02814435|Retina|retina
75101|NCT02814435|Retinal Degeneration|retinal degeneration
75102|NCT02814435|Quality of Life Measures|quality of life measures
75103|NCT02814422|Triglyceride-rich lipoprotein|triglyceride-rich lipoprotein
75104|NCT02814422|dementia|dementia
75105|NCT02814422|Alzheimer's disease|alzheimer's disease
75106|NCT02814422|mild cognition impairment|mild cognition impairment
75107|NCT02814422|amyloid-beta|amyloid-beta
75108|NCT02814396|Ventricular|ventricular
75109|NCT02814396|CVD|cvd
75110|NCT02814396|Ventricular arrhythmias|ventricular arrhythmias
75111|NCT02814383|Prematurity|prematurity
75112|NCT02814383|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
75113|NCT02814383|Cerebral Perfusion|cerebral perfusion
75114|NCT02814383|Cerebral Autoregulation|cerebral autoregulation
75115|NCT02814357|Blood glucose, serum insulin|blood glucose, serum insulin
75116|NCT02814344|labour|labour
75117|NCT02814331|Video-EEG|video-eeg
75118|NCT02814331|near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
75119|NCT02814318|Vancomycin|vancomycin
75120|NCT02814318|Penicillin|penicillin
75121|NCT02814318|Clindamycin|clindamycin
75122|NCT02814318|Group B streptococcal infection|group b streptococcal infection
75123|NCT02814318|Rectovaginal GBS colonization|rectovaginal gbs colonization
75124|NCT02814318|Vaginal GBS colonization|vaginal gbs colonization
75125|NCT02814318|Intrapartum|intrapartum
75126|NCT02814318|Prophylaxis|prophylaxis
75127|NCT02814227|obstructive sleep apnea screening device|obstructive sleep apnea screening device
75128|NCT02814201|Motor slowing|motor slowing
75129|NCT02814201|Computerized mental chronometry paradigm|computerized mental chronometry paradigm
75130|NCT02814188|Exercise|exercise
75131|NCT02814175|Psoriatic Arthritis|psoriatic arthritis
75132|NCT02814162|Subarachnoid Hemorrhage, Aneurysmal|subarachnoid hemorrhage, aneurysmal
75133|NCT02814162|Predictive|predictive
75134|NCT02814162|Adiponectin|adiponectin
75135|NCT02814149|delayed implant|delayed implant
75136|NCT02814149|esthetics|esthetics
75137|NCT02814149|immediate implant|immediate implant
75138|NCT02814149|bone augmentation|bone augmentation
75139|NCT02814123|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
75140|NCT02814123|Pramlintide|pramlintide
75141|NCT02814123|Artificial Pancreas|artificial pancreas
75142|NCT02814123|Closed-Loop System|closed-loop system
75143|NCT02814123|Insulin|insulin
75144|NCT02814110|Granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
75145|NCT02814110|muscular dystrophy|muscular dystrophy
75146|NCT02814110|muscle strength|muscle strength
75147|NCT02814110|children|children
75149|NCT02814097|Heart Failure|heart failure
75150|NCT02814097|HFpEF|hfpef
75151|NCT02814097|elamipretide|elamipretide
75152|NCT02814097|MTP-131|mtp-131
75153|NCT02814097|Bendavia™|bendavia™
75154|NCT02814071|Early Feeding|early feeding
75155|NCT02814071|Acute Pancreatitis|acute pancreatitis
75156|NCT02814071|Pediatric|pediatric
75157|NCT02814058|pharmacokinetics|pharmacokinetics
75158|NCT02814058|Healthy Volunteers|healthy volunteers
75159|NCT02814045|biomarkers, sleep fragmentation, intermittent hypoxia|biomarkers, sleep fragmentation, intermittent hypoxia
75160|NCT02814032|proteomic|proteomic
75161|NCT02814032|cervical lymph node metastasis|cervical lymph node metastasis
75162|NCT02814019|respiratory function in DMD|respiratory function in dmd
75163|NCT02814006|marital relationship|marital relationship
75164|NCT02813993|infertility|infertility
75165|NCT02813993|fertility awareness|fertility awareness
75166|NCT02813993|preconceptional care|preconceptional care
75167|NCT02813993|health interventions|health interventions
75168|NCT02813993|couples|couples
75169|NCT02813980|SUDEP|sudep
75170|NCT02813980|Sudden cardiac death|sudden cardiac death
75171|NCT02813980|Sudden unexpected death in epilepsy|sudden unexpected death in epilepsy
75172|NCT02813980|Sleep|sleep
75173|NCT02813980|Polysomnography|polysomnography
75174|NCT02813980|Autonomic|autonomic
75175|NCT02813980|Cardiovascular|cardiovascular
75176|NCT02813941|Randomized controlled trial|randomized controlled trial
75177|NCT02813941|Systematic review|systematic review
75178|NCT02813941|Summary of finding tables|summary of finding tables
75179|NCT02813941|GRADE|grade
75180|NCT02813941|AHRQ|ahrq
75181|NCT02813928|ColoRectal Cancer|colorectal cancer
75182|NCT02813928|Cancerology|cancerology
75183|NCT02813928|Translational Research|translational research
75184|NCT02813928|ccfDNA|ccfdna
75188|NCT02813889|developmental delay|developmental delay
75189|NCT02813889|robotics|robotics
75190|NCT02813889|cerebral palsy|cerebral palsy
75191|NCT02813850|sickle cell disease|sickle cell disease
75192|NCT02813850|oxygen therapy|oxygen therapy
75193|NCT02813850|pregnancy|pregnancy
75194|NCT02813850|pregnancy in sickle cell disease|pregnancy in sickle cell disease
75195|NCT02813837|relapsed|relapsed
75196|NCT02813837|refractory|refractory
75197|NCT02813837|CD19+|cd19+
75198|NCT02813837|leukemia|leukemia
75199|NCT02813837|lymphoma|lymphoma
75200|NCT02813811|Temperature-controlled Laminar Airflow|temperature-controlled laminar airflow
75201|NCT02813811|Exacerbation frequency|exacerbation frequency
75203|NCT02813772|infants|infants
75204|NCT02813772|colic|colic
75205|NCT02813759|GLYCEMIA|glycemia
75206|NCT02813759|SATIETY|satiety
75207|NCT02813759|C PEPTIDE|c peptide
75208|NCT02813759|PRELOAD|preload
75209|NCT02813759|INSULIN|insulin
75210|NCT02813746|Obesity|obesity
75211|NCT02813746|Tobacco|tobacco
75212|NCT02813746|Epigenetic|epigenetic
75213|NCT02813746|Transcriptomic|transcriptomic
75214|NCT02813746|microRNAs|micrornas
75215|NCT02813746|miRNAs|mirnas
75216|NCT02813733|thyroid surgery|thyroid surgery
75217|NCT02813733|surgical outcomes|surgical outcomes
75218|NCT02813733|patient safety|patient safety
75219|NCT02813733|healthcare quality|healthcare quality
75220|NCT02813733|surgeons performance|surgeons performance
75221|NCT02813720|Erosions|erosions
75222|NCT02813720|Onycholysis|onycholysis
75223|NCT02813720|HR-pQCT|hr-pqct
75224|NCT02813720|Psoriatic arthritis|psoriatic arthritis
75225|NCT02813707|Vitamins|vitamins
75226|NCT02813707|Mineral|mineral
75227|NCT02813707|Surgery|surgery
75228|NCT02813694|Pneumonia|pneumonia
75229|NCT02813694|CABP|cabp
75230|NCT02813694|CAP|cap
75231|NCT02813694|Community acquired bacterial pneumonia|community acquired bacterial pneumonia
75232|NCT02813681|Acute Pain|acute pain
75233|NCT02813681|ultrasonography|ultrasonography
75234|NCT02813668|Nutrition|nutrition
75235|NCT02813668|Occupational Health|occupational health
75236|NCT02813655|tetracosactide|tetracosactide
75237|NCT02813655|Synacthène®|synacthène®
75238|NCT02813655|cosyntropin|cosyntropin
75239|NCT02813655|post-dural syndrom|post-dural syndrom
75240|NCT02813655|post-dural puncture headache|post-dural puncture headache
75241|NCT02813642|chronic kidney disease starting dialysis|chronic kidney disease starting dialysis
75242|NCT02813642|cardiovascular risk|cardiovascular risk
75243|NCT02813642|bone mineral metabolism markers|bone mineral metabolism markers
75244|NCT02813629|transcranial Direct Current Stimulation|transcranial direct current stimulation
75245|NCT02813629|Peripheral Electrical Stimulation|peripheral electrical stimulation
75246|NCT02813629|Sickle Cell Disease|sickle cell disease
75247|NCT02813629|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
75248|NCT02813629|quantitative Electroencephalography|quantitative electroencephalography
75249|NCT02813603|EBUS-TBNA|ebus-tbna
75250|NCT02813603|staging|staging
75251|NCT02813603|lymph node metastases|lymph node metastases
75253|NCT02813577|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
75254|NCT02813577|Experimental|experimental
75255|NCT02813577|Standard Angioplasty Balloon|standard angioplasty balloon
75260|NCT02813551|Preeclampsia, puerperium|preeclampsia, puerperium
75261|NCT02813538|Thrombelastography|thrombelastography
75262|NCT02813538|Antithrombin proteins|antithrombin proteins
75263|NCT02813538|Liver surgery|liver surgery
75264|NCT02813538|Liver function tests|liver function tests
75265|NCT02813525|Aortic Isthmus|aortic isthmus
75266|NCT02813525|Isthmic Systolic Index|isthmic systolic index
75267|NCT02813525|feasibility|feasibility
75268|NCT02813525|reproducibility|reproducibility
75269|NCT02813525|mortality|mortality
75270|NCT02813525|delivery|delivery
75271|NCT02813499|Acute Coronary Syndrome|acute coronary syndrome
75272|NCT02813473|SYNTAX Score II|syntax score ii
75273|NCT02813473|Multi Slice Computed Tomography|multi slice computed tomography
75274|NCT02813473|MSCT|msct
75275|NCT02813473|Heart Team|heart team
75276|NCT02813473|Fractional Flow Reserve Computed Tomography|fractional flow reserve computed tomography
75278|NCT02813473|FFR MSCT|ffr msct
75279|NCT02813473|PCI|pci
75280|NCT02813473|CABG|cabg
75281|NCT02813473|Percutaneous Coronary Intervention|percutaneous coronary intervention
75282|NCT02813473|Coronary Artery Bypass Graft|coronary artery bypass graft
75283|NCT02813434|Cerebral amyloid imaging|cerebral amyloid imaging
75284|NCT02813434|Florbetapir|florbetapir
75285|NCT02813434|18F-AV-45|18f-av-45
75286|NCT02813434|poststroke|poststroke
75288|NCT02813382|bupivacaine|bupivacaine
75289|NCT02813382|prilocaine|prilocaine
75290|NCT02813382|2-chloroprocaine|2-chloroprocaine
75291|NCT02813330|Women|women
75292|NCT02813330|severe|severe
75293|NCT02813330|low back ache|low back ache
75294|NCT02813330|labor|labor
75295|NCT02813317|Surgery|surgery
75296|NCT02813317|Breast cancer|breast cancer
75297|NCT02813317|Quality of life|quality of life
75298|NCT02813317|Care pathway|care pathway
75299|NCT02813317|Economic evaluation|economic evaluation
75300|NCT02813304|Acute|acute
75301|NCT02813304|rotator cuff tendinopathy|rotator cuff tendinopathy
75302|NCT02813304|exercise|exercise
75303|NCT02813304|loading|loading
75304|NCT02813304|ice|ice
75305|NCT02813304|cryotherapy|cryotherapy
75306|NCT02813304|randomised control trial|randomised control trial
75307|NCT02813291|Motor imagery|motor imagery
75308|NCT02813291|transcranial direct current stimulation|transcranial direct current stimulation
75309|NCT02813291|motor learning|motor learning
75310|NCT02813291|aging|aging
75311|NCT02813265|Ocular Discomfort|ocular discomfort
75312|NCT02813265|Pain|pain
75313|NCT02813265|Corticosteroid|corticosteroid
75314|NCT02813265|Hyperemia|hyperemia
75315|NCT02813265|Dry Eye|dry eye
75316|NCT02813252|long-term follow-up|long-term follow-up
75317|NCT02813252|chimeric antigen receptor (CAR) T cells|chimeric antigen receptor (car) t cells
75318|NCT02813252|JCAR015|jcar015
75319|NCT02813239|IVF|ivf
75320|NCT02813239|Dual trigger|dual trigger
75321|NCT02813239|GnRH agonist|gnrh agonist
75322|NCT02813239|hCG|hcg
75323|NCT02813239|mature oocytes|mature oocytes
75324|NCT02813226|castration-resistant|castration-resistant
75325|NCT02813226|molecular imaging|molecular imaging
75326|NCT02813226|abiraterone acetate|abiraterone acetate
75327|NCT02813226|enzalutamide|enzalutamide
75328|NCT02813226|metabolic response|metabolic response
75329|NCT02813213|skin transplantation|skin transplantation
75330|NCT02813213|grafting skin|grafting skin
75331|NCT02813200|COPD, inhaler device, handling|copd, inhaler device, handling
75332|NCT02813187|venous leg ulcer|venous leg ulcer
75333|NCT02813187|venous|venous
75334|NCT02813187|QCDR|qcdr
75335|NCT02813187|quality measure|quality measure
75336|NCT02813187|wound|wound
75337|NCT02813187|Outcome|outcome
75338|NCT02813161|diabetic foot ulcer|diabetic foot ulcer
75339|NCT02813161|diabetes|diabetes
75340|NCT02813161|arterial disease|arterial disease
75341|NCT02813161|neuropathy|neuropathy
75342|NCT02813161|amputation|amputation
75343|NCT02813161|QCDR|qcdr
75344|NCT02813161|quality measure|quality measure
75345|NCT02813161|wound|wound
75346|NCT02813096|HCC|hcc
75347|NCT02813096|PVTT|pvtt
75348|NCT02813096|Folofox4|folofox4
75349|NCT02813096|Early Recurrence|early recurrence
75350|NCT02813044|anesthesia|anesthesia
75351|NCT02813044|intravenous|intravenous
75352|NCT02813044|neurosurgery|neurosurgery
75353|NCT02813044|pituitary neoplasm|pituitary neoplasm
75354|NCT02813044|postoperative period|postoperative period
75355|NCT02813031|functional meat products|functional meat products
75356|NCT02813031|hypocaloric fats|hypocaloric fats
75357|NCT02813031|diglyceride|diglyceride
75358|NCT02813031|obesity|obesity
75359|NCT02813018|child|child
75360|NCT02813018|analgesia|analgesia
75361|NCT02813018|epidural|epidural
75362|NCT02813018|pain|pain
75363|NCT02813018|postoperative|postoperative
75364|NCT02813018|orthopedics|orthopedics
75365|NCT02813005|High frequency jet ventilation|high frequency jet ventilation
75366|NCT02812966|peripheral arterial disease|peripheral arterial disease
75367|NCT02812966|drug coated balloon|drug coated balloon
75368|NCT02812927|Glycemic lability index|glycemic lability index
75369|NCT02812927|Continuous glucose monitoring system|continuous glucose monitoring system
75370|NCT02812927|intensive care|intensive care
75371|NCT02812927|Insulin|insulin
75372|NCT02812888|Hyperthyroidism|hyperthyroidism
75373|NCT02812888|Betatrophin|betatrophin
75374|NCT02812836|anorectal manometry|anorectal manometry
75375|NCT02812836|children|children
75376|NCT02812836|constipation|constipation
75377|NCT02812823|manometry|manometry
75378|NCT02812823|children|children
75379|NCT02812823|constipation|constipation
75380|NCT02812823|functional disorders|functional disorders
75381|NCT02812797|Adipokines|adipokines
75382|NCT02812797|Chronic Heart Failure|chronic heart failure
75383|NCT02812797|Prognosis|prognosis
75384|NCT02812784|Nephrocheck™|nephrocheck™
75385|NCT02812784|acute kidney injury|acute kidney injury
75386|NCT02812758|sedation depth|sedation depth
75387|NCT02812758|indices of preload dependence|indices of preload dependence
75388|NCT02812745|anaesthesia|anaesthesia
75389|NCT02812732|HPV vaccination|hpv vaccination
75390|NCT02812732|provider education|provider education
75391|NCT02812667|Metastatic|metastatic
75392|NCT02812667|NSCLC|nsclc
75393|NCT02812667|nivolumab|nivolumab
75394|NCT02812667|plinabulin|plinabulin
75395|NCT02812667|BPI-2358|bpi-2358
75396|NCT02812667|opdivo|opdivo
75397|NCT02812667|Non-Small Cell Lung Cancer|non-small cell lung cancer
75398|NCT02812667|cancer|cancer
75399|NCT02812654|Sarcoma|sarcoma
75400|NCT02812654|soft tissue sarcoma|soft tissue sarcoma
75401|NCT02812654|neoadjuvant chemotherapy|neoadjuvant chemotherapy
75402|NCT02812654|neoadjuvant radiotherapy|neoadjuvant radiotherapy
75403|NCT02812654|hypofractionated radiotherapy|hypofractionated radiotherapy
75404|NCT02812641|Concurrent chemoradiation|concurrent chemoradiation
75405|NCT02812641|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
75406|NCT02812641|Vascular endothelial growth factor|vascular endothelial growth factor
75407|NCT02812628|laparoscopic surgery|laparoscopic surgery
75408|NCT02812628|abdominoperineal resection|abdominoperineal resection
75409|NCT02812628|rectal cancer|rectal cancer
75410|NCT02812628|individualized surgery|individualized surgery
75411|NCT02812628|levator muscle|levator muscle
75412|NCT02812615|Environmental Enteric Dysfunction|environmental enteric dysfunction
75413|NCT02812602|Total Knee Replacement|total knee replacement
75414|NCT02812602|Stitch|stitch
75415|NCT02812602|Removal|removal
75416|NCT02812602|Pain|pain
75418|NCT02812576|Group B streptococcus|group b streptococcus
75419|NCT02812576|Infants|infants
75420|NCT02812576|China|china
75421|NCT02812550|full-spectrum endoscopy|full-spectrum endoscopy
75422|NCT02812550|polyp detection rate|polyp detection rate
75423|NCT02812550|colorectal cancer|colorectal cancer
75424|NCT02812550|colorectal screening|colorectal screening
75425|NCT02812550|adenoma detection rate|adenoma detection rate
75426|NCT02812550|endoscopic innovations|endoscopic innovations
75427|NCT02812537|Trajectories|trajectories
75428|NCT02812537|emergency room|emergency room
75429|NCT02812537|conduct disorder|conduct disorder
75430|NCT02812537|care management|care management
75431|NCT02812524|Immunotherapy|immunotherapy
75432|NCT02812524|Yervoy|yervoy
75433|NCT02812524|Head and neck cancer|head and neck cancer
75434|NCT02812524|Pre-operative|pre-operative
75435|NCT02812498|teleconsultation|teleconsultation
75436|NCT02812498|insulin therapy|insulin therapy
75437|NCT02812498|HbA1c|hba1c
75438|NCT02812459|Electrical Stimulation Therapy|electrical stimulation therapy
75439|NCT02812459|Kinesio taping|kinesio taping
75440|NCT02812459|Exercise|exercise
75441|NCT02812446|biofilm|biofilm
75442|NCT02812446|staphylokinase|staphylokinase
75443|NCT02812446|Staphylococcus aureus|staphylococcus aureus
75444|NCT02812446|microarrays|microarrays
75445|NCT02812446|bone binding sialoprotein|bone binding sialoprotein
75446|NCT02812446|bone and joint infection|bone and joint infection
75447|NCT02812446|blood group|blood group
75448|NCT02812433|birth asphyxia|birth asphyxia
75449|NCT02812433|brain|brain
75450|NCT02812433|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
75451|NCT02812433|neonate|neonate
75452|NCT02812433|neuroprotection|neuroprotection
75453|NCT02812433|neurorestoration|neurorestoration
75454|NCT02812433|newborn|newborn
75455|NCT02812433|sildenafil|sildenafil
75456|NCT02812420|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
75457|NCT02812420|Urothelial Carcinoma|urothelial carcinoma
75458|NCT02812420|Muscle-invasive, high-risk bladder cancer|muscle-invasive, high-risk bladder cancer
583423|NCT00511693|small volume hospitals|small volume hospitals
75459|NCT02812420|Ineligible for neoadjuvant cisplatin-containing chemotherapies|ineligible for neoadjuvant cisplatin-containing chemotherapies
75460|NCT02812420|Bladder cancer|bladder cancer
75461|NCT02812420|Cystectomy|cystectomy
75462|NCT02812420|Bladder cancer surgery|bladder cancer surgery
75463|NCT02812420|Durvalumab|durvalumab
75464|NCT02812420|MEDI4736|medi4736
75465|NCT02812420|Tremelimumab|tremelimumab
75466|NCT02812420|Phone calls|phone calls
75467|NCT02812394|Parkinson's disease|parkinson's disease
75468|NCT02812394|Episodic motor fluctuations (OFF periods)|episodic motor fluctuations (off periods)
75469|NCT02812381|Trigger Points, movement|trigger points, movement
75470|NCT02812355|off-pump|off-pump
75471|NCT02812355|coronary artery bypass|coronary artery bypass
75472|NCT02812355|heparinization|heparinization
75473|NCT02812342|Alopecia|alopecia
75474|NCT02812316|Myopia|myopia
75475|NCT02812316|Scleral lens|scleral lens
75476|NCT02812316|Astigmatism|astigmatism
75477|NCT02812316|Presbyopia|presbyopia
75578|NCT02811861|Lenvatinib|lenvatinib
75478|NCT02812290|antibody mediated rejection, T cell mediated rejection|antibody mediated rejection, t cell mediated rejection
75479|NCT02812277|anastrozole|anastrozole
75481|NCT02812277|postmenopausal patients|postmenopausal patients
75482|NCT02812238|Inflammasome|inflammasome
75483|NCT02812238|Sirt3|sirt3
75484|NCT02812238|Nicotinamide Riboside|nicotinamide riboside
75485|NCT02812238|Fasting|fasting
75486|NCT02812212|ureteropelvic junction obstruction|ureteropelvic junction obstruction
75487|NCT02812212|cortical transit time|cortical transit time
75488|NCT02812186|Neuromuscular blockade|neuromuscular blockade
75489|NCT02812173|urinary drainage|urinary drainage
75490|NCT02812173|urethral catheter|urethral catheter
75491|NCT02812173|suprapubic tube|suprapubic tube
75492|NCT02812173|pain|pain
75493|NCT02812173|discomfort|discomfort
75494|NCT02812173|radical prostatectomy|radical prostatectomy
75495|NCT02812173|robotic surgery|robotic surgery
75496|NCT02812173|urinary infection|urinary infection
75497|NCT02812147|L-dihydoxyphenylserine|l-dihydoxyphenylserine
75498|NCT02812147|L-DOPS|l-dops
75499|NCT02812147|Northera|northera
75500|NCT02812134|phosphorus supplementation|phosphorus supplementation
75501|NCT02812134|FGF23|fgf23
75502|NCT02812134|anorexic|anorexic
75503|NCT02812134|adolescents|adolescents
75504|NCT02812134|undernutrition|undernutrition
88290|NCT02735551|IUD|iud
75505|NCT02812108|intracranial aneurysm|intracranial aneurysm
75506|NCT02812108|endovascular treatment|endovascular treatment
75507|NCT02812108|recanalization|recanalization
75508|NCT02812108|outcome|outcome
75509|NCT02812108|hemodynamics|hemodynamics
75510|NCT02812108|computational fluid dynamic|computational fluid dynamic
75511|NCT02812108|stent|stent
75512|NCT02812108|flow diversion|flow diversion
75513|NCT02812082|Web-based|web-based
75514|NCT02812082|patient education application|patient education application
75515|NCT02812082|16-769|16-769
75516|NCT02812056|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
75517|NCT02812056|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
75518|NCT02812056|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
75519|NCT02812056|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
75520|NCT02812056|Human papilloma virus associated malignancies|human papilloma virus associated malignancies
75521|NCT02812056|HPV|hpv
75522|NCT02812056|Alisertib|alisertib
75523|NCT02812056|MLN8237|mln8237
75524|NCT02812056|TAK-228|tak-228
75525|NCT02812056|MLN0128|mln0128
75526|NCT02812043|onychomycosis|onychomycosis
75527|NCT02812043|amorolfine|amorolfine
75528|NCT02812043|long-pulsed Nd:YAG|long-pulsed nd:yag
75529|NCT02812043|fungal infection|fungal infection
75530|NCT02812030|Observational Study|observational study
75531|NCT02812030|aflibercept|aflibercept
75532|NCT02812030|Diabetic Retinopathy|diabetic retinopathy
75533|NCT02812030|Visual Acuity|visual acuity
75534|NCT02812017|educational intervention|educational intervention
75535|NCT02812017|language development|language development
75536|NCT02812017|postpartum|postpartum
75537|NCT02812017|parental attachment|parental attachment
75538|NCT02812017|achievement gap|achievement gap
75539|NCT02812017|language gap|language gap
75540|NCT02812017|school readiness|school readiness
75541|NCT02812004|Vitreous Floaters|vitreous floaters
75542|NCT02812004|Mouches Voulantes|mouches voulantes
75543|NCT02811991|paracetamol|paracetamol
75544|NCT02811991|post-operative analgesia|post-operative analgesia
75545|NCT02811965|heel|heel
75546|NCT02811965|pressure ulcer|pressure ulcer
75547|NCT02811965|pressure mapping|pressure mapping
75548|NCT02811952|bladder cancer|bladder cancer
75549|NCT02811939|Cannabis|cannabis
75550|NCT02811939|Marijuana|marijuana
75551|NCT02811939|THC|thc
75552|NCT02811939|Dronabinol|dronabinol
75553|NCT02811939|Pregnenolone|pregnenolone
75554|NCT02811939|PREG|preg
75555|NCT02811939|Psychotic Disorders|psychotic disorders
75556|NCT02811926|parastomal bulging|parastomal bulging
75557|NCT02811926|peristomal bulging|peristomal bulging
75558|NCT02811926|ileostomy|ileostomy
75559|NCT02811926|colostomy|colostomy
75560|NCT02811926|enterostomy|enterostomy
75561|NCT02811926|incidence|incidence
75562|NCT02811926|risk factor|risk factor
75563|NCT02811913|sensory impairment|sensory impairment
75564|NCT02811913|sensory deficit|sensory deficit
75565|NCT02811913|upper limb|upper limb
75566|NCT02811913|transcranial magnetic stimulation|transcranial magnetic stimulation
75567|NCT02811913|brain stimulation|brain stimulation
75568|NCT02811913|rehabilitation|rehabilitation
75569|NCT02811900|obesity surgery|obesity surgery
75570|NCT02811900|Roux en Y gastric bypass|roux en y gastric bypass
75571|NCT02811900|sleeve gastrectomy|sleeve gastrectomy
75572|NCT02811900|excess weight loss|excess weight loss
75573|NCT02811900|quality of life|quality of life
75574|NCT02811874|diabetes education|diabetes education
75575|NCT02811874|community health workers|community health workers
75576|NCT02811874|diabetes control|diabetes control
75577|NCT02811861|Renal Cell Carcinoma (RCC)|renal cell carcinoma (rcc)
75579|NCT02811861|First-line RCC|first-line rcc
75580|NCT02811861|Treatment-naive RCC|treatment-naive rcc
75581|NCT02811861|Everolimus|everolimus
75582|NCT02811861|Pembrolizumab|pembrolizumab
75583|NCT02811861|Sunitinib|sunitinib
75584|NCT02811861|Phase 3 RCC|phase 3 rcc
75585|NCT02811861|Phase 3 first-line RCC|phase 3 first-line rcc
75586|NCT02811861|Phase 3 treatment-naive RCC|phase 3 treatment-naive rcc
75587|NCT02811822|GMI-1271|gmi-1271
75588|NCT02811822|bortezomib|bortezomib
75589|NCT02811822|carfilzomib|carfilzomib
75590|NCT02811822|multiple myeloma|multiple myeloma
75591|NCT02811809|Prostate cancer|prostate cancer
75592|NCT02811809|Apalutamide|apalutamide
75594|NCT02811809|BCR|bcr
75595|NCT02811809|Biochemical recurrence|biochemical recurrence
75597|NCT02811796|drug eluting stents|drug eluting stents
75598|NCT02811796|flow fractional reserve|flow fractional reserve
75600|NCT02811796|angio-based FFR|angio-based ffr
75601|NCT02811783|Pruritus|pruritus
75602|NCT02811783|Mycosis Fungoides|mycosis fungoides
75603|NCT02811783|CTCL|ctcl
75604|NCT02811783|naloxone|naloxone
75605|NCT02811783|opiate antagonist|opiate antagonist
75606|NCT02811718|Stress Management|stress management
66929|NCT02865460|Therapeutic Uses|therapeutic uses
66930|NCT02865460|Physiological Effects of Drugs|physiological effects of drugs
66931|NCT02865460|Gulf war illness|gulf war illness
66932|NCT02865460|Chronic fatigue|chronic fatigue
66933|NCT02865447|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
66934|NCT02865447|DEXA|dexa
75607|NCT02811718|Resiliency|resiliency
75608|NCT02811718|Skype|skype
75609|NCT02811692|Database|database
75610|NCT02811692|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
75611|NCT02811692|Wet Age-related Macular Degeneration (wAMD)|wet age-related macular degeneration (wamd)
75612|NCT02811692|Retinal Diseases|retinal diseases
75613|NCT02811692|Optic Nerve Diseases|optic nerve diseases
75614|NCT02811692|Corneal Diseases|corneal diseases
75615|NCT02811692|Vision Disorders|vision disorders
75616|NCT02811679|Lymphoma|lymphoma
75617|NCT02811653|Motor slowing|motor slowing
75618|NCT02811640|Intra-Abdominal Pressure|intra-abdominal pressure
75619|NCT02811640|Stryker Pressure Monitor|stryker pressure monitor
75620|NCT02811627|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
75621|NCT02811627|Memantine|memantine
75622|NCT02811627|Treatment prediction biomarker|treatment prediction biomarker
75623|NCT02811614|intracerebral hemorrhage,hypertensive|intracerebral hemorrhage,hypertensive
75624|NCT02811614|minimally invasive surgery|minimally invasive surgery
75625|NCT02811614|neuroendoscopic surgery|neuroendoscopic surgery
75626|NCT02811614|stereotactic aspiration|stereotactic aspiration
75627|NCT02811601|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
75628|NCT02811575|Coloscopy|coloscopy
75629|NCT02811549|Cochlear Implant|cochlear implant
75630|NCT02811549|HiRes™ 90K Advantage Implant|hires™ 90k advantage implant
75631|NCT02811549|HiFocus™ Mid-Scala electrode|hifocus™ mid-scala electrode
75632|NCT02811549|HiFocus™ 1J electrode|hifocus™ 1j electrode
75633|NCT02811549|HiFocus Helix™ electrode|hifocus helix™ electrode
75634|NCT02811549|Cochlear Implantation|cochlear implantation
75635|NCT02811549|Listening Benefits|listening benefits
75636|NCT02811549|Adults|adults
75637|NCT02811549|Cochlear Implant Benefit|cochlear implant benefit
75638|NCT02811549|Electrical Stimulation|electrical stimulation
75639|NCT02811484|Obesity|obesity
75640|NCT02811458|Panic Disorder|panic disorder
75641|NCT02811458|Agoraphobia|agoraphobia
75642|NCT02811458|Social Anxiety Disorder|social anxiety disorder
75643|NCT02811458|Generalized Anxiety Disorder|generalized anxiety disorder
75644|NCT02811458|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
75645|NCT02811445|microbiome, metabolome, aging, lean mass, physical function|microbiome, metabolome, aging, lean mass, physical function
75646|NCT02811432|Kangaroo mother care|kangaroo mother care
75647|NCT02811432|Neonates|neonates
75648|NCT02811432|Low birth weight|low birth weight
75649|NCT02811432|Unstable|unstable
75650|NCT02811393|Bariatric surgery, sarcopenia|bariatric surgery, sarcopenia
75651|NCT02811380|CVC|cvc
75652|NCT02811380|Healthcare associated infections (HAI)|healthcare associated infections (hai)
75653|NCT02811380|CLABSI|clabsi
627168|NCT00681993|concurrent|concurrent
75657|NCT02811276|High-protein diet|high-protein diet
75658|NCT02811276|Energy metabolism|energy metabolism
75659|NCT02811276|Substrate oxidation|substrate oxidation
75660|NCT02811250|Renal cancer|renal cancer
75661|NCT02811250|Stereotactic radiotherapy|stereotactic radiotherapy
75662|NCT02811185|PET|pet
75663|NCT02811185|CT|ct
75664|NCT02811185|PET/CT|pet/ct
75665|NCT02811172|Biological multi-paradigm model|biological multi-paradigm model
75666|NCT02811172|Biomarkers|biomarkers
75667|NCT02811172|Triglycerides|triglycerides
75668|NCT02811172|Cholesterol|cholesterol
75669|NCT02811172|Prolactin|prolactin
75670|NCT02811172|Glucose|glucose
75671|NCT02811146|Heart Failure|heart failure
75672|NCT02811146|Noninvasive Ventilation|noninvasive ventilation
75673|NCT02811146|Positive- Pressure Respiration|positive- pressure respiration
75674|NCT02811133|inositol|inositol
75675|NCT02811120|meningococcal|meningococcal
75676|NCT02811120|conjugate|conjugate
75677|NCT02811120|vaccine|vaccine
75678|NCT02811120|quadrivalent|quadrivalent
75679|NCT02811120|meningococcal quadrivalent conjugate vaccine|meningococcal quadrivalent conjugate vaccine
75681|NCT02811107|pain|pain
75682|NCT02811107|preoperative area|preoperative area
75683|NCT02811107|premedication|premedication
75684|NCT02811068|HPV|hpv
75685|NCT02811068|vaccine|vaccine
75686|NCT02811068|Human Papillomavirus Virus Vaccine|human papillomavirus virus vaccine
75689|NCT02811016|High Altitude|high altitude
75690|NCT02811016|budesonide|budesonide
75691|NCT02811016|hypoxia|hypoxia
75692|NCT02811003|Insertional Achilles|insertional achilles
75695|NCT02810977|gastric volume|gastric volume
88524|NCT02734082|stroke|stroke
67036|NCT02864992|cMET|cmet
75696|NCT02810977|gastric content|gastric content
75697|NCT02810977|ultrasound|ultrasound
75698|NCT02810977|perioperative fasting|perioperative fasting
75699|NCT02810964|Schizophrenia|schizophrenia
75700|NCT02810964|Schizoaffective Disorder|schizoaffective disorder
75701|NCT02810964|Sulforaphane|sulforaphane
75702|NCT02810964|Sulforaphane supplement|sulforaphane supplement
75703|NCT02810951|RDEB|rdeb
75704|NCT02810938|Ablation|ablation
75705|NCT02810938|Mifi technology|mifi technology
75706|NCT02810938|maximum voltage-guided ablation|maximum voltage-guided ablation
75707|NCT02810899|child|child
75708|NCT02810899|craniotomy|craniotomy
75709|NCT02810899|intelligence tests|intelligence tests
75710|NCT02810899|dexmedetomidine|dexmedetomidine
75711|NCT02810899|Disruption|disruption
75712|NCT02810899|Dehiscence|dehiscence
75713|NCT02810899|Mild Cognitive Disorder|mild cognitive disorder
75714|NCT02810886|Prostate Cancer|prostate cancer
75715|NCT02810860|laparoscopic cholecystectomy|laparoscopic cholecystectomy
75716|NCT02810847|Amblyopia|amblyopia
75717|NCT02810847|strabismus|strabismus
75718|NCT02810847|virtual reality|virtual reality
75719|NCT02810847|computer games|computer games
75722|NCT02810821|Gonadal hormones|gonadal hormones
75723|NCT02810821|Gonadotropins|gonadotropins
75724|NCT02810821|Cardiovascular diseases|cardiovascular diseases
75725|NCT02810821|Lipids|lipids
75726|NCT02810821|Obesity|obesity
75727|NCT02810821|Atherosclerosis|atherosclerosis
75728|NCT02810821|Glucose metabolism disorders|glucose metabolism disorders
75729|NCT02810821|Metabolic syndrome|metabolic syndrome
75730|NCT02810821|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
75731|NCT02810808|Neovascular Age-related Macular Degeneration|neovascular age-related macular degeneration
75732|NCT02810808|Ranibizumab|ranibizumab
75733|NCT02810808|Pro Re Nata|pro re nata
75734|NCT02810795|Coronary|coronary
75735|NCT02810795|Artery|artery
75736|NCT02810795|Computed tomography|computed tomography
75737|NCT02810795|FFR|ffr
75738|NCT02810795|CT myocardial perfusion|ct myocardial perfusion
75739|NCT02810795|Dynamic|dynamic
75740|NCT02810782|opiate dependence|opiate dependence
75741|NCT02810782|withdrawal|withdrawal
75742|NCT02810782|newborn|newborn
75743|NCT02810730|pancreas|pancreas
75744|NCT02810730|adenocarcinoma|adenocarcinoma
75745|NCT02810704|Anticoagulant|anticoagulant
75746|NCT02810704|Venous Thromboembolism|venous thromboembolism
75747|NCT02810704|Pulmonary Embolism|pulmonary embolism
75748|NCT02810704|Total Knee Arthroplasty|total knee arthroplasty
75749|NCT02810704|Total Hip Arthroplasty|total hip arthroplasty
75750|NCT02810691|Diabetes|diabetes
75751|NCT02810691|Fiber|fiber
75752|NCT02810691|Supplementation|supplementation
75753|NCT02810691|Soluble fiber|soluble fiber
75754|NCT02810691|Post-prandial blood glucose|post-prandial blood glucose
75755|NCT02810691|Nutrition|nutrition
75756|NCT02810678|Tuberculosis|tuberculosis
75757|NCT02810665|Repeatability|repeatability
75758|NCT02810665|Concordance|concordance
75759|NCT02810665|Agreement|agreement
75760|NCT02810665|ETDRS visual acuity chart|etdrs visual acuity chart
75761|NCT02810665|numeric|numeric
75762|NCT02810665|Landolt C|landolt c
75763|NCT02810665|Roman alphabet|roman alphabet
75764|NCT02810652|Cancer Surgery Care|cancer surgery care
75765|NCT02810639|pain|pain
75766|NCT02810587|Endophthalmitis|endophthalmitis
75767|NCT02810587|Intravitreous injection|intravitreous injection
75768|NCT02810587|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
75769|NCT02810587|topical antibiotics|topical antibiotics
75770|NCT02810561|Troponin|troponin
75771|NCT02810535|Local IgE|local ige
75772|NCT02810535|Non-allergic rhinitis|non-allergic rhinitis
75773|NCT02810535|Allergic rhinitis to house dust mite|allergic rhinitis to house dust mite
75774|NCT02810509|Wafarin|wafarin
75775|NCT02810509|Cardioembolic (CE) stroke|cardioembolic (ce) stroke
75776|NCT02810509|ischemic stroke|ischemic stroke
75777|NCT02810483|Prader-Willi|prader-willi
75778|NCT02810483|SPW|spw
75779|NCT02810483|impulsivity|impulsivity
75780|NCT02810483|eating disorders|eating disorders
75781|NCT02810483|topiramate|topiramate
75782|NCT02810457|Cancer|cancer
75783|NCT02810457|Bevacizumab|bevacizumab
75784|NCT02810457|Carboplatin|carboplatin
75785|NCT02810457|Paclitaxel|paclitaxel
75786|NCT02810431|Transfer Protocol|transfer protocol
75787|NCT02810431|Long-Term Storage|long-term storage
75788|NCT02810431|Sample Retention|sample retention
75789|NCT02810418|Immunotoxin|immunotoxin
75790|NCT02810418|Mesothelin|mesothelin
75791|NCT02810418|Antibody-based Therapeutics|antibody-based therapeutics
75792|NCT02810418|Advanced Cancer|advanced cancer
75794|NCT02810405|Storage|storage
75795|NCT02810405|Molecular Profiling|molecular profiling
75796|NCT02810405|Biopsy|biopsy
75797|NCT02810405|Repository|repository
75798|NCT02810379|informed consent|informed consent
67134|NCT02864537|TTR|ttr
75799|NCT02810379|ERCP|ercp
75800|NCT02810379|video|video
75801|NCT02810366|Verbal Autopsy|verbal autopsy
75802|NCT02810366|Physician-coded verbal autopsy|physician-coded verbal autopsy
75803|NCT02810366|Computer-coded verbal autopsy|computer-coded verbal autopsy
75804|NCT02810366|InterVA|interva
75805|NCT02810366|Naive Bayes Classifier (NBC)|naive bayes classifier (nbc)
75806|NCT02810366|Tariff|tariff
75807|NCT02810366|InSilicoVA|insilicova
75808|NCT02810366|Randomised Control Trial|randomised control trial
75809|NCT02810366|SmartVA|smartva
75810|NCT02810366|King-Lu|king-lu
75811|NCT02810327|Alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
75812|NCT02810327|AATD|aatd
75813|NCT02810327|Alpha-1|alpha-1
75814|NCT02810327|SERPINA1|serpina1
75815|NCT02810327|MZ|mz
75816|NCT02810327|Carrier|carrier
75817|NCT02810327|Heterozygote|heterozygote
75818|NCT02810327|Smoking|smoking
75819|NCT02810327|COPD|copd
75820|NCT02810327|Emphysema|emphysema
75821|NCT02810327|Sequencing|sequencing
75822|NCT02810301|gluten|gluten
75823|NCT02810301|non-celiac|non-celiac
75824|NCT02810301|gluten sensitivity|gluten sensitivity
75825|NCT02810288|Airway anatomy|airway anatomy
75826|NCT02810288|difficult intubation|difficult intubation
75827|NCT02810288|congenital syndromes|congenital syndromes
75828|NCT02810262|Lung cancer|lung cancer
75829|NCT02810262|Bone metastases|bone metastases
75830|NCT02810262|EGFR|egfr
75831|NCT02810262|KRAS|kras
75832|NCT02810262|Bone biomarkers|bone biomarkers
75833|NCT02810262|Metabolic parameters|metabolic parameters
75834|NCT02810249|African American YMSM|african american ymsm
75835|NCT02810249|PrEP|prep
75836|NCT02810249|HIV Pre-Exposure Prophylaxis|hiv pre-exposure prophylaxis
75837|NCT02810249|Common Sense Model|common sense model
75838|NCT02810249|Healthcare|healthcare
75839|NCT02810249|HIV Prevention|hiv prevention
75840|NCT02810236|Focal breast pain|focal breast pain
75841|NCT02810236|Directed Ultrasound|directed ultrasound
75842|NCT02810236|Reassurance|reassurance
75843|NCT02810236|Anxiety|anxiety
75844|NCT02810210|Zika|zika
75845|NCT02810210|microcephaly|microcephaly
75846|NCT02810210|congenital abnormalities|congenital abnormalities
75847|NCT02810210|new-born|new-born
75848|NCT02810210|infant|infant
75849|NCT02810184|bone augmentation|bone augmentation
75850|NCT02810184|long-term bone volume changes|long-term bone volume changes
75851|NCT02810184|immediate provisional implant|immediate provisional implant
75852|NCT02810171|anxiety|anxiety
75853|NCT02810171|social anxiety disorder|social anxiety disorder
75854|NCT02810171|generalized anxiety disorder|generalized anxiety disorder
75855|NCT02810171|phobias|phobias
75856|NCT02810171|fears|fears
75857|NCT02810171|worry|worry
75858|NCT02810145|traumatic brain injury|traumatic brain injury
75859|NCT02810145|cerebral desaturation|cerebral desaturation
75860|NCT02810145|intensive care|intensive care
75861|NCT02810145|hemodynamics|hemodynamics
75862|NCT02810145|Loss|loss
75863|NCT02810145|Consciousness|consciousness
75864|NCT02810106|Spect|spect
75865|NCT02810106|Stress Test|stress test
75866|NCT02810106|Myocardial Perfusion CT|myocardial perfusion ct
75867|NCT02810106|CT angiography|ct angiography
75868|NCT02810093|Breast cancer|breast cancer
75869|NCT02810093|Text mining|text mining
75870|NCT02810093|Big Data|big data
75871|NCT02810093|Machine Learning|machine learning
75872|NCT02810054|regeneration|regeneration
75873|NCT02810054|intrabony defects|intrabony defects
75874|NCT02810054|enamel matrix derivative|enamel matrix derivative
75875|NCT02810054|MIST|mist
75876|NCT02810028|Limb girdle muscular dystrophy|limb girdle muscular dystrophy
75877|NCT02810028|Becker's muscular dystrophy|becker's muscular dystrophy
75878|NCT02810028|Facioscapulohumeral muscular dystrophy|facioscapulohumeral muscular dystrophy
75879|NCT02810028|Inclusion-body myositis|inclusion-body myositis
75880|NCT02810028|Acceptance and Commitment Therapy|acceptance and commitment therapy
75881|NCT02810028|ACT|act
75882|NCT02809950|postoperative nausea and vomiting, oral carbohydrate beverage|postoperative nausea and vomiting, oral carbohydrate beverage
75883|NCT02809937|aged|aged
75884|NCT02809937|surgical procedures, operative|surgical procedures, operative
75885|NCT02809937|delirium|delirium
75886|NCT02809937|dexmedetomidine|dexmedetomidine
75887|NCT02809937|long-term outcome|long-term outcome
75888|NCT02809924|endotracheal intubation|endotracheal intubation
75889|NCT02809924|teaching|teaching
75890|NCT02809924|just-in-time|just-in-time
75891|NCT02809898|Biomarkers, Neoplasms|biomarkers, neoplasms
75892|NCT02809885|Hepatitis E|hepatitis e
75893|NCT02809885|Pediatric|pediatric
75894|NCT02809885|Transplantation|transplantation
75895|NCT02809885|Prevalence|prevalence
75896|NCT02808806|stroke|stroke
75898|NCT02808806|brain infarction|brain infarction
75899|NCT02808806|ischemic stroke|ischemic stroke
75900|NCT02808806|treatment|treatment
75902|NCT02808806|intraarterial thrombectomy|intraarterial thrombectomy
75903|NCT02808806|delay|delay
75904|NCT02808806|total system delay|total system delay
75905|NCT02808806|pre-hospital delay|pre-hospital delay
75906|NCT02808806|in-hospital delay|in-hospital delay
75907|NCT02808806|feedback|feedback
75908|NCT02808806|real-time feedback|real-time feedback
75909|NCT02808806|visual feedback|visual feedback
75910|NCT02808793|ISM|ism
75911|NCT02808793|Mastocytosis|mastocytosis
75912|NCT02808793|Indolent Mastocytosis|indolent mastocytosis
75913|NCT02808780|Ulcerative Colitis|ulcerative colitis
75914|NCT02808780|Simponi (Golimumab)|simponi (golimumab)
75915|NCT02808780|Thiopurines|thiopurines
75916|NCT02808780|Lymphoma|lymphoma
75917|NCT02808780|Malignancies|malignancies
75918|NCT02808767|Acute myocardial infarction|acute myocardial infarction
75919|NCT02808767|Primary coronary intervention|primary coronary intervention
75920|NCT02808767|Antiplatelet therapy|antiplatelet therapy
75921|NCT02808728|Total Knee Arthroplasty|total knee arthroplasty
75922|NCT02808728|Total Knee Replacement|total knee replacement
75923|NCT02808728|Exparel|exparel
75924|NCT02808728|Liposomal Bupivacaine|liposomal bupivacaine
75925|NCT02808728|Ropivacaine|ropivacaine
75926|NCT02808728|Postoperative Pain Management|postoperative pain management
75927|NCT02808702|Attention|attention
75928|NCT02808702|Cognitive behavioral therapy|cognitive behavioral therapy
75929|NCT02808702|Neuroimaging|neuroimaging
75930|NCT02808689|Moderate|moderate
75931|NCT02808689|Severe|severe
75932|NCT02809820|ACS|acs
75933|NCT02809820|Beta Blockers|beta blockers
75934|NCT02809820|platelet aggregation|platelet aggregation
75935|NCT02809820|light transmission aggregometry|light transmission aggregometry
75936|NCT02809820|Beta-Adrenergic Blockers|beta-adrenergic blockers
75937|NCT02809807|Work of Breathing; Hypoxemia; Respiratory Acidosis; Respiratory effort; COPD|work of breathing; hypoxemia; respiratory acidosis; respiratory effort; copd
75938|NCT02809781|ankylosing spondylitis|ankylosing spondylitis
75939|NCT02809781|mesenchymal stem cell|mesenchymal stem cell
75940|NCT02809781|etanercept|etanercept
75941|NCT02809768|Healthy participants|healthy participants
75942|NCT02809768|Pharmacokinetic Drug-Drug Interaction|pharmacokinetic drug-drug interaction
75943|NCT02809768|Avatrombopag|avatrombopag
75944|NCT02809755|Obesity|obesity
75945|NCT02809755|laparoscopic gastric banding|laparoscopic gastric banding
75946|NCT02809755|band revision|band revision
75947|NCT02809755|laparoscopic gastric banding sleeve gastrectomy|laparoscopic gastric banding sleeve gastrectomy
75948|NCT02809742|Pregnant|pregnant
75949|NCT02809742|Labor|labor
75950|NCT02809742|Epidural|epidural
75951|NCT02809742|Analgesia|analgesia
75952|NCT02809742|Intermittent|intermittent
75953|NCT02809651|Infrascanner|infrascanner
75954|NCT02809651|Intracranial hemorrhage|intracranial hemorrhage
75955|NCT02809625|Dynamic contrast -enhanced MRI|dynamic contrast -enhanced mri
75956|NCT02809625|brucella spondylitis|brucella spondylitis
75957|NCT02809599|vertigo|vertigo
75958|NCT02809599|dizziness|dizziness
75959|NCT02809586|Alcohol|alcohol
75960|NCT02809586|Teens|teens
75961|NCT02809586|Young Adults|young adults
75962|NCT02809586|Social Media|social media
75963|NCT02809573|peripheral T-cell lymphoma|peripheral t-cell lymphoma
75964|NCT02809573|PTCL|ptcl
75965|NCT02809573|chidamide|chidamide
75966|NCT02809573|CHOP|chop
75967|NCT02809573|phase Ib|phase ib
75968|NCT02809560|Lymphocytes Th2|lymphocytes th2
75969|NCT02809560|Cav1 channels|cav1 channels
75970|NCT02809534|Anlotinib|anlotinib
75971|NCT02809534|AL3818|al3818
75972|NCT02809508|Omega-3|omega-3
75973|NCT02809508|Child nutrition|child nutrition
75974|NCT02809508|Dietary recommendations|dietary recommendations
75975|NCT02809508|Cardiovascular risk markers|cardiovascular risk markers
75976|NCT02809508|Cognitive function|cognitive function
75977|NCT02809508|Mental health|mental health
75979|NCT02809443|Zika|zika
75980|NCT02809443|Vaccine|vaccine
75982|NCT02809391|Postural Balance|postural balance
75983|NCT02809391|Gait|gait
75984|NCT02809391|Foot Orthotic|foot orthotic
75985|NCT02809391|Proprioception|proprioception
75986|NCT02809391|Somatosensory|somatosensory
75987|NCT02809365|insulin treated|insulin treated
75988|NCT02809339|Chemotherapy|chemotherapy
75989|NCT02809339|ovarian cancer|ovarian cancer
75990|NCT02809339|Patient reported outcome|patient reported outcome
75991|NCT02809339|Quality of Care|quality of care
75992|NCT02809326|efficiency|efficiency
75993|NCT02809326|exposure therapy|exposure therapy
75994|NCT02809326|PTSD|ptsd
75995|NCT02809326|combat|combat
75996|NCT02809326|veterans|veterans
75997|NCT02809313|gingivitis|gingivitis
75998|NCT02809313|probiotic|probiotic
75999|NCT02809313|non- surgical treatment|non- surgical treatment
76000|NCT02809274|iron deficiency|iron deficiency
76011|NCT02809222|Ascorbic acid|ascorbic acid
76012|NCT02809222|Oxidative stress|oxidative stress
76013|NCT02809222|Preleukemia|preleukemia
76014|NCT02809196|Food Habits|food habits
76015|NCT02809196|Adolescents|adolescents
76016|NCT02809196|Digital Communication|digital communication
76017|NCT02809183|metabolic acidosis|metabolic acidosis
76018|NCT02809183|serum bicarbonate|serum bicarbonate
76019|NCT02809183|kidney disease|kidney disease
76020|NCT02809131|CIED infection|cied infection
76021|NCT02809118|Deafness|deafness
76022|NCT02809118|Hearing Loss|hearing loss
76023|NCT02809118|Hearing Loss, Sensorineural|hearing loss, sensorineural
76024|NCT02809118|Ear Diseases|ear diseases
76025|NCT02809118|Hearing Disorders|hearing disorders
76026|NCT02809118|Nervous System Diseases|nervous system diseases
76027|NCT02809118|Neurologic Manifestations|neurologic manifestations
76028|NCT02809118|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
76029|NCT02809118|Sensation Disorders|sensation disorders
76030|NCT02809118|Signs and Symptoms|signs and symptoms
76031|NCT02809118|Hearing and Speech Impairment|hearing and speech impairment
76032|NCT02809118|Hearing Loss, Unilateral|hearing loss, unilateral
76033|NCT02809105|Chronic constipation|chronic constipation
76034|NCT02809105|Linaclotide|linaclotide
76035|NCT02809105|ASP0456|asp0456
76036|NCT02809092|Acute Myeloid Leukemia, Natural Killer Cells|acute myeloid leukemia, natural killer cells
76037|NCT02809066|premenstrual syndrome|premenstrual syndrome
76038|NCT02809066|calcium|calcium
76039|NCT02809066|quality of life|quality of life
76040|NCT02809053|low tumor burden follicular lymphoma (LTBFL)|low tumor burden follicular lymphoma (ltbfl)
76041|NCT02809014|Fluoride|fluoride
76042|NCT02809014|Dental caries|dental caries
76043|NCT02809014|Dentifrice|dentifrice
76044|NCT02809001|Fat grafting|fat grafting
76045|NCT02809001|Expansion-related complications|expansion-related complications
76046|NCT02808988|Bisphosphonate|bisphosphonate
76047|NCT02808988|osteoporosis|osteoporosis
76048|NCT02808988|RANKL|rankl
76049|NCT02808988|OPG|opg
76050|NCT02808988|periodontitis|periodontitis
76051|NCT02808975|Hurley Stage I, II, or III|hurley stage i, ii, or iii
76052|NCT02808975|adalimumab|adalimumab
76053|NCT02808975|inguinal region|inguinal region
76054|NCT02808975|secondary intention|secondary intention
76055|NCT02808975|Hidradenitis Suppurativa|hidradenitis suppurativa
76056|NCT02808975|axilla|axilla
76057|NCT02808975|abcess and inflammatory nodule (AN) count|abcess and inflammatory nodule (an) count
76061|NCT02808936|remote ischemic conditioning|remote ischemic conditioning
76062|NCT02808936|orthopedic surgery|orthopedic surgery
76063|NCT02808936|ischemic heart disease|ischemic heart disease
76064|NCT02808910|behavior|behavior
76065|NCT02808910|food intake|food intake
76066|NCT02808910|salt|salt
76067|NCT02808910|vegetables|vegetables
76068|NCT02808910|portion size|portion size
76069|NCT02808910|weight loss|weight loss
76070|NCT02808910|habits|habits
76071|NCT02808897|Chest tubes|chest tubes
76072|NCT02808897|Atrial fibrillation|atrial fibrillation
76073|NCT02808897|Thoracic surgery|thoracic surgery
76074|NCT02808897|Critical care|critical care
76075|NCT02808858|MDS|mds
76076|NCT02808858|Myelodisplastic Syndrome|myelodisplastic syndrome
76077|NCT02808845|coronary angiography|coronary angiography
76078|NCT02808845|contrast-induced acute kidney injury|contrast-induced acute kidney injury
76079|NCT02808845|microalbuminuria|microalbuminuria
76080|NCT02808832|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
76081|NCT02808832|Cervical cancer screening|cervical cancer screening
76082|NCT02808832|Provider intervention|provider intervention
76083|NCT02808819|Asthma|asthma
76084|NCT02808819|Bronchial Diseases|bronchial diseases
76085|NCT02808819|Respiratory Tract Diseases|respiratory tract diseases
76086|NCT02808819|Lung Diseases|lung diseases
76087|NCT02808819|Obstructive Lung Diseases|obstructive lung diseases
76088|NCT02808676|Cognitive training|cognitive training
76089|NCT02808676|Vitamin D|vitamin d
76090|NCT02808676|Exercise|exercise
76091|NCT02808637|Pain management|pain management
76092|NCT02808637|vaccination|vaccination
76093|NCT02808637|manual pressure|manual pressure
76094|NCT02808637|needle aspiration|needle aspiration
76095|NCT02808624|Oxaliplatin, peripheral neuropathy, L-CARNOSINE|oxaliplatin, peripheral neuropathy, l-carnosine
76096|NCT02808598|Clinical Trials|clinical trials
76097|NCT02808598|Education|education
76098|NCT02808598|Hispanic Americans|hispanic americans
76099|NCT02808598|African Americans|african americans
76100|NCT02808598|Health Disparities|health disparities
76101|NCT02808598|Patient Participation|patient participation
76103|NCT02808572|chronic kidney disease|chronic kidney disease
76104|NCT02808572|vascular calcifications|vascular calcifications
76105|NCT02808572|cardiovascular risk|cardiovascular risk
76440|NCT02806609|cryotherapy|cryotherapy
76106|NCT02808546|Gallbladder stone|gallbladder stone
76107|NCT02808546|Risk factor|risk factor
76108|NCT02808546|Case-control study|case-control study
76109|NCT02808546|Obesity|obesity
76110|NCT02808546|Hypertension|hypertension
76111|NCT02808546|Alcohol consumption|alcohol consumption
76112|NCT02808520|Social participation|social participation
76113|NCT02808520|Children and adolescents with cancer|children and adolescents with cancer
89027|NCT02731118|Salovum|salovum
76114|NCT02808520|Quality of life with hodgkin-lymphoma|quality of life with hodgkin-lymphoma
76115|NCT02808520|Social inequalities and cancer|social inequalities and cancer
76116|NCT02808494|Preeclampsia|preeclampsia
76117|NCT02808494|Fetal Growth Restriction|fetal growth restriction
76118|NCT02808481|systemic sclerosis|systemic sclerosis
76119|NCT02808481|cardiac disease|cardiac disease
76120|NCT02808481|Heart transplantation|heart transplantation
76121|NCT02808481|primitive cardiac damage|primitive cardiac damage
76122|NCT02808468|Sexual assault|sexual assault
76123|NCT02808468|Posttraumatic Stress Disorder|posttraumatic stress disorder
76124|NCT02808468|Alcohol use|alcohol use
76125|NCT02808468|Cognitive therapy|cognitive therapy
76126|NCT02808429|Atacicept|atacicept
76127|NCT02808429|IgA Nephropathy|iga nephropathy
76128|NCT02808429|Berger´s disease|berger´s disease
76129|NCT02808429|Glomerulonephritis|glomerulonephritis
76130|NCT02808429|Proteinuria|proteinuria
76131|NCT02808416|Solid tumors|solid tumors
76132|NCT02808416|Brain metastases|brain metastases
76133|NCT02808416|DC vaccine|dc vaccine
76134|NCT02808416|Personalized vaccine|personalized vaccine
76135|NCT02808416|Tumor antigens|tumor antigens
76136|NCT02808416|PBMCs|pbmcs
76137|NCT02808364|Recurrent glioblastoma|recurrent glioblastoma
76138|NCT02808364|DC vaccine|dc vaccine
76139|NCT02808364|tumor antigen|tumor antigen
76140|NCT02808364|personalized vaccine|personalized vaccine
76141|NCT02808299|statin|statin
76142|NCT02808299|hepatitis B virus|hepatitis b virus
76143|NCT02808273|Bemiparine|bemiparine
76144|NCT02808273|Antithrombotic microsurgery protocol|antithrombotic microsurgery protocol
76145|NCT02808273|Comparative study|comparative study
76146|NCT02808273|Anticoagulant microsurgery protocol|anticoagulant microsurgery protocol
76147|NCT02808260|sub-clinical atrial fibrillation|sub-clinical atrial fibrillation
76148|NCT02808260|biomarkers|biomarkers
76149|NCT02808260|implanted pacemaker or defibrillator|implanted pacemaker or defibrillator
76150|NCT02808247|advanced metastatic soft tissue sarcoma|advanced metastatic soft tissue sarcoma
76151|NCT02808221|Heart failure|heart failure
76152|NCT02808221|heart disease|heart disease
76153|NCT02808221|left ventricular|left ventricular
76154|NCT02808195|Cerebral Palsy|cerebral palsy
76155|NCT02808195|Neurological Rehabilitation|neurological rehabilitation
76156|NCT02808195|Upper Extremity|upper extremity
76157|NCT02808156|Cerebral Palsy,|cerebral palsy,
76158|NCT02808156|Upper limb neurorehabilitation|upper limb neurorehabilitation
76159|NCT02808156|Upper Extremity|upper extremity
76160|NCT02808156|Neurological Rehabilitation|neurological rehabilitation
76161|NCT02808130|hyperlipidemia, periodontal disease, oxidative stress,|hyperlipidemia, periodontal disease, oxidative stress,
76162|NCT02808117|microfinance institution|microfinance institution
76163|NCT02808117|MFI|mfi
76164|NCT02808078|Instrumented treadmill|instrumented treadmill
76165|NCT02808078|Augmented reality|augmented reality
76166|NCT02808078|Neurorehabilitation|neurorehabilitation
76167|NCT02808078|Gait disorders|gait disorders
76168|NCT02808065|Kidney transplant|kidney transplant
76169|NCT02808065|Kidney transplantation|kidney transplantation
76170|NCT02808065|Renal transplant|renal transplant
76171|NCT02808065|Renal transplantation|renal transplantation
76172|NCT02808052|Bacterial infections|bacterial infections
76173|NCT02808026|severe hypertension|severe hypertension
76174|NCT02808026|grade III hypertension|grade iii hypertension
76175|NCT02808026|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
76176|NCT02807987|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
76177|NCT02807987|Moderate renal impairment|moderate renal impairment
76178|NCT02807987|Hypertension|hypertension
76179|NCT02807974|Hypertension with Type 2 Diabetes and Albuminuria|hypertension with type 2 diabetes and albuminuria
76180|NCT02807974|Diabetic nephropathy|diabetic nephropathy
76181|NCT02807974|Diabetic renal disease|diabetic renal disease
76182|NCT02807974|Albuminuria|albuminuria
76183|NCT02807974|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
76312|NCT02807428|post-surgical pain|post-surgical pain
76185|NCT02807948|MRI Scan, pacemakers, ICD, CRT|mri scan, pacemakers, icd, crt
76186|NCT02807922|Palliative Care|palliative care
76187|NCT02807922|zopiclone|zopiclone
76188|NCT02807896|biomarker|biomarker
76195|NCT02807883|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
76197|NCT02807883|Blincyto|blincyto
76198|NCT02807883|Post allogeneic stem cell transplant|post allogeneic stem cell transplant
76199|NCT02807870|Parental training|parental training
76200|NCT02807870|Preschool age|preschool age
76201|NCT02807870|Attention Deficit/Hyperactivity Disorder (ADHD)|attention deficit/hyperactivity disorder (adhd)
76441|NCT02806609|balance|balance
76202|NCT02807857|low-interventional observational study,|low-interventional observational study,
76204|NCT02807857|heart failure,|heart failure,
76205|NCT02807857|primary care,|primary care,
76206|NCT02807857|ESC guidelines,|esc guidelines,
76207|NCT02807857|Europe,|europe,
76208|NCT02807857|NT-proBNP,|nt-probnp,
76209|NCT02807857|reduced ventricular ejection fraction (EF),|reduced ventricular ejection fraction (ef),
76210|NCT02807844|Triple negative breast cancer|triple negative breast cancer
76211|NCT02807844|Pancreatic carcinoma|pancreatic carcinoma
76212|NCT02807844|Melanoma|melanoma
76213|NCT02807844|Endometrial Carcinoma|endometrial carcinoma
76214|NCT02807844|Immuno oncology|immuno oncology
76215|NCT02807844|Monoclonal antibody|monoclonal antibody
76216|NCT02807844|PDR001|pdr001
76217|NCT02807844|MCS110|mcs110
76218|NCT02807831|Executive Function|executive function
76219|NCT02807831|Language|language
76220|NCT02807831|Preschool child|preschool child
76221|NCT02807831|Development|development
76222|NCT02807818|Child development|child development
76223|NCT02807818|Infant|infant
76224|NCT02807818|Mother-Child Relations|mother-child relations
76225|NCT02807805|castration resistant prostate cancer|castration resistant prostate cancer
76226|NCT02807792|Perianal surgery|perianal surgery
76227|NCT02807779|angioplasty|angioplasty
76228|NCT02807779|peripheral artery disease|peripheral artery disease
76229|NCT02807779|peripheral vascular disease|peripheral vascular disease
76230|NCT02807779|atherosclerosis|atherosclerosis
76231|NCT02807779|balloon angioplasty|balloon angioplasty
76232|NCT02807779|dexamethasone|dexamethasone
76233|NCT02807779|drug coated balloon|drug coated balloon
76234|NCT02807779|paclitaxel|paclitaxel
76235|NCT02807779|walking|walking
76236|NCT02807779|claudication|claudication
76237|NCT02807766|autism|autism
76238|NCT02807766|Brain Plasticity|brain plasticity
76239|NCT02807766|Behavioral Intervention|behavioral intervention
76240|NCT02807766|Magnetic Resonance Imaging|magnetic resonance imaging
76241|NCT02807753|Hemophilia|hemophilia
76242|NCT02807753|Arthropathy|arthropathy
76243|NCT02807753|Pediatric|pediatric
76244|NCT02807740|Virtual Reality|virtual reality
76245|NCT02807740|Rehabilitation|rehabilitation
76246|NCT02807740|Cardiocirculatory system|cardiocirculatory system
76247|NCT02807740|Parkinson Disease|parkinson disease
76248|NCT02807688|health promotion|health promotion
76249|NCT02807688|lifestyles|lifestyles
76250|NCT02807688|physical comorbidity|physical comorbidity
76251|NCT02807688|risk factors|risk factors
76252|NCT02807688|behavioural change|behavioural change
76253|NCT02807662|posttraumatic stress disorder|posttraumatic stress disorder
76254|NCT02807662|prenatal care|prenatal care
76255|NCT02807636|Urothelial carcinoma|urothelial carcinoma
76256|NCT02807636|Bladder cancer|bladder cancer
76257|NCT02807636|Anti-PD-L1|anti-pd-l1
76258|NCT02807636|Transitional carcinoma|transitional carcinoma
76259|NCT02807636|Tecentriq|tecentriq
76260|NCT02807636|Atezolizumab|atezolizumab
76261|NCT02807636|IMvigor130|imvigor130
76262|NCT02807610|Etomidate lipuro|etomidate lipuro
76263|NCT02807610|Induction characteristics|induction characteristics
76264|NCT02807584|Wound|wound
76265|NCT02807584|burns|burns
76266|NCT02807584|acute|acute
76267|NCT02807584|chronic|chronic
76268|NCT02807584|foam|foam
76269|NCT02807584|adhesive|adhesive
76270|NCT02807584|dressing|dressing
76271|NCT02807571|Hand|hand
76272|NCT02807558|AML|aml
76273|NCT02807558|MDS|mds
76274|NCT02807545|Scoliosis-Specific Exercises|scoliosis-specific exercises
76275|NCT02807545|Schroth|schroth
76276|NCT02807519|Oral health|oral health
76277|NCT02807519|Saliva|saliva
76278|NCT02807519|Biomarker|biomarker
76279|NCT02807519|Cytokines|cytokines
76280|NCT02807519|Cancer|cancer
76281|NCT02807519|children|children
76282|NCT02807506|elders|elders
76283|NCT02807506|robotics|robotics
76306|NCT02807454|FUSION MM-003|fusion mm-003
76307|NCT02807454|PD-L1|pd-l1
76308|NCT02807441|Bleeding|bleeding
76309|NCT02807441|Aspirin|aspirin
76310|NCT02807441|Spine|spine
76311|NCT02807441|Surgery|surgery
76313|NCT02807428|total knee arthroplasty|total knee arthroplasty
76314|NCT02807428|total knee replacement|total knee replacement
76315|NCT02807415|cystic fibrosis|cystic fibrosis
76316|NCT02807415|CFTR|cftr
76317|NCT02807415|CFTR modulation|cftr modulation
76318|NCT02807415|sweat test|sweat test
76319|NCT02807415|intestinal current measurement, ICM|intestinal current measurement, icm
76320|NCT02807415|nasal transepithelial potential difference measurement, NPD|nasal transepithelial potential difference measurement, npd
76321|NCT02807402|Ombitasvir|ombitasvir
76322|NCT02807402|Dasabuvir|dasabuvir
76323|NCT02807402|Paritaprevir|paritaprevir
76324|NCT02807402|HCV|hcv
76325|NCT02807402|Chronic Hepatitis C|chronic hepatitis c
76326|NCT02807363|endometriosis|endometriosis
76327|NCT02807363|gonadotropin-releasing hormone agonist|gonadotropin-releasing hormone agonist
76328|NCT02807363|healthy volunteers|healthy volunteers
76329|NCT02807363|leuprolide oral tablet|leuprolide oral tablet
76330|NCT02807350|Intermittent Exotropia|intermittent exotropia
76331|NCT02807350|IXT|ixt
76332|NCT02807350|overminus|overminus
76333|NCT02807337|Oral mucositis|oral mucositis
76334|NCT02807311|Malnutrition|malnutrition
76335|NCT02807311|Undernutrition|undernutrition
76336|NCT02807311|lung transplantation|lung transplantation
76337|NCT02807311|artificial nutrition|artificial nutrition
76338|NCT02807311|nutritional supplements|nutritional supplements
76339|NCT02807311|enteral nutrition|enteral nutrition
76340|NCT02807298|Intarligamentary|intarligamentary
76341|NCT02807298|Articaine|articaine
76342|NCT02807298|Lidocaine|lidocaine
76343|NCT02807246|Probiotic|probiotic
76344|NCT02807246|Neonatal Hyperbilirubinemia|neonatal hyperbilirubinemia
76345|NCT02807220|Imuneks|imuneks
76346|NCT02807207|To Study pharmacokinetics and Cardiac safety pacritinib study|to study pharmacokinetics and cardiac safety pacritinib study
76347|NCT02807155|Transitional Care|transitional care
76348|NCT02807155|Young Adult|young adult
76349|NCT02807155|Guided Imagery|guided imagery
76350|NCT02807116|Drug-Interaction Study|drug-interaction study
76351|NCT02807103|Rituximab|rituximab
76352|NCT02807103|remission induction|remission induction
76353|NCT02807103|eosinophilic granulomatosis with polyangiitis|eosinophilic granulomatosis with polyangiitis
76354|NCT02807090|Low Back Pain|low back pain
76355|NCT02807090|Exercise|exercise
76356|NCT02807090|Dance Therapy|dance therapy
76357|NCT02807090|Physical Therapy|physical therapy
76358|NCT02807077|Healthy subjects|healthy subjects
76359|NCT02807038|Respiratory Function Tests|respiratory function tests
76360|NCT02807038|Air pollution|air pollution
76361|NCT02807038|Pregnancy|pregnancy
76362|NCT02807038|Spirometry|spirometry
76363|NCT02807012|Home care services|home care services
76364|NCT02807012|Nursing|nursing
76365|NCT02807012|Clinical trial|clinical trial
76366|NCT02807012|Geriatric nursing|geriatric nursing
76367|NCT02807012|Family caregiver|family caregiver
76368|NCT02807012|Aged|aged
76369|NCT02806999|Heart disease|heart disease
76370|NCT02806999|Postoperative period|postoperative period
76371|NCT02806999|Hyperglycemia|hyperglycemia
76372|NCT02806999|Berberine|berberine
76373|NCT02806999|Insulin|insulin
200980|NCT02112708|Depression|depression
76382|NCT02806921|Scleral Contact Lens|scleral contact lens
76383|NCT02806921|Tear Proteases|tear proteases
76384|NCT02806921|Tear Cytokines|tear cytokines
76385|NCT02806908|Driving|driving
76386|NCT02806895|Driving|driving
76387|NCT02806856|Middle Cerebral Artery Stroke|middle cerebral artery stroke
76388|NCT02806856|tDCS|tdcs
76389|NCT02806856|Acute|acute
76390|NCT02806843|stroke|stroke
76391|NCT02806843|hemiplegia|hemiplegia
76392|NCT02806843|healthy|healthy
76393|NCT02806843|robotics|robotics
76394|NCT02806843|rehabilitation|rehabilitation
76395|NCT02806843|therapy|therapy
76396|NCT02806830|Intravitreal injection|intravitreal injection
76397|NCT02806830|AMD|amd
76398|NCT02806830|Diabetic Retinopathy|diabetic retinopathy
76699|NCT02804789|Prevention|prevention
76399|NCT02806830|Retinal Artery Occlusion|retinal artery occlusion
76400|NCT02806830|Myopia, Degenerative|myopia, degenerative
76401|NCT02806830|eye drops|eye drops
76402|NCT02806804|vaccine|vaccine
76403|NCT02806804|safety|safety
76404|NCT02806804|immunogenicity|immunogenicity
76405|NCT02806791|Patients|patients
76406|NCT02806778|cardiac arrest|cardiac arrest
76407|NCT02806778|jugular venous oximetry|jugular venous oximetry
76408|NCT02806778|hypoxic brain injury|hypoxic brain injury
76409|NCT02806765|Dynamic Stability|dynamic stability
76410|NCT02806765|Postural Stability|postural stability
76411|NCT02806765|Gait Speed|gait speed
76412|NCT02806765|Hand Grip Strength|hand grip strength
76413|NCT02806765|Timed Get-up and Go|timed get-up and go
76414|NCT02806765|Older Adults|older adults
76415|NCT02806752|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
76416|NCT02806739|Soy protein|soy protein
76417|NCT02806739|isoflavones|isoflavones
76418|NCT02806739|gestational diabetes|gestational diabetes
76419|NCT02806700|Diabetes|diabetes
76420|NCT02806700|Social Media|social media
76421|NCT02806687|Locally advanced pancreatic adenocarcinoma|locally advanced pancreatic adenocarcinoma
76422|NCT02806687|gene therapy|gene therapy
76423|NCT02806687|gemcitabine|gemcitabine
76424|NCT02806687|chemosensitization|chemosensitization
76425|NCT02806674|Helicobacter pylori|helicobacter pylori
76426|NCT02806674|Antibiotic resistance|antibiotic resistance
76427|NCT02806674|Sequencing|sequencing
76428|NCT02806661|Robotic surgery|robotic surgery
76429|NCT02806661|Vagus nerve preserving|vagus nerve preserving
76430|NCT02806635|Relationship Distress|relationship distress
76431|NCT02806635|Relationship Satisfaction|relationship satisfaction
76432|NCT02806635|Marriage|marriage
76433|NCT02806635|Web-based|web-based
76434|NCT02806635|Internet|internet
76435|NCT02806622|Sports|sports
76436|NCT02806622|University|university
76437|NCT02806622|Lower Extremity|lower extremity
76438|NCT02806622|Hip Joint|hip joint
76439|NCT02806609|football|football
76442|NCT02806609|electromyography|electromyography
76443|NCT02806557|Neoplasms|neoplasms
76444|NCT02806557|Neutropenia|neutropenia
76445|NCT02806557|drug therapy|drug therapy
76446|NCT02806557|Hematologic tests|hematologic tests
76447|NCT02806557|Point-of-care Systems|point-of-care systems
76448|NCT02806557|Febrile neutropenia|febrile neutropenia
76449|NCT02806544|Breast neoplasms|breast neoplasms
76450|NCT02806544|Breast cancer|breast cancer
76451|NCT02806544|Locally advanced breast cancer|locally advanced breast cancer
76452|NCT02806544|Neoadjuvant endocrine therapy|neoadjuvant endocrine therapy
76453|NCT02806544|Tamoxifen|tamoxifen
76454|NCT02806544|Low and middle income country|low and middle income country
76455|NCT02806531|vaccine|vaccine
76456|NCT02806531|safety|safety
76457|NCT02806518|DIEP|diep
76458|NCT02806518|Computed Tomography|computed tomography
76459|NCT02806518|Doppler|doppler
76460|NCT02806518|Thermography|thermography
76461|NCT02806440|Low dose naltrexone|low dose naltrexone
76462|NCT02806440|Pain|pain
76463|NCT02806375|Myelofibrosis|myelofibrosis
76464|NCT02806375|Ruxolitinib|ruxolitinib
76465|NCT02806375|Cyclophosphamide|cyclophosphamide
76466|NCT02806375|Immunosuppressive Agents|immunosuppressive agents
76467|NCT02806375|Immune System Diseases|immune system diseases
76468|NCT02806375|Busulfan|busulfan
76469|NCT02806375|Fludarabine|fludarabine
76470|NCT02806375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
76471|NCT02806375|Myeloablative Agonists|myeloablative agonists
76472|NCT02806375|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
76473|NCT02806375|Allogeneic|allogeneic
76474|NCT02806362|Non-cirrhotic|non-cirrhotic
76475|NCT02806362|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
76476|NCT02806362|moderate fibrosis|moderate fibrosis
76477|NCT02806362|Chronic Hepatitis C Virus ( HCV)|chronic hepatitis c virus ( hcv)
76478|NCT02806362|Chronic Hepatitis C Genotype 1b|chronic hepatitis c genotype 1b
76479|NCT02806349|American ginseng|american ginseng
76480|NCT02806349|Konjac glucomannan fiber|konjac glucomannan fiber
76481|NCT02806336|exercise training|exercise training
76482|NCT02806336|assistive device|assistive device
76483|NCT02806336|weight loss|weight loss
76484|NCT02806336|function|function
76485|NCT02806336|mobility|mobility
76486|NCT02806310|Aortic Valve|aortic valve
76487|NCT02806310|Bicuspid|bicuspid
76488|NCT02806297|cholecystectomy|cholecystectomy
76489|NCT02806284|vaccination|vaccination
76490|NCT02806284|Streptococcus pneumoniae|streptococcus pneumoniae
76491|NCT02806271|Worry Postponement|worry postponement
76492|NCT02806271|Stimulus Control|stimulus control
76493|NCT02806245|Congenital Heart Disease (CHD)|congenital heart disease (chd)
76494|NCT02806245|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
76495|NCT02806245|Cardiac Index|cardiac index
76496|NCT02806245|Hemodynamics|hemodynamics
76497|NCT02806245|Pediatrics|pediatrics
76498|NCT02806232|Praziquantel ODT formulation|praziquantel odt formulation
76516|NCT02806141|Aerosolized colistin|aerosolized colistin
76517|NCT02806141|Intravenous colistin|intravenous colistin
76519|NCT02806128|kallikrein|kallikrein
76520|NCT02806128|KLK|klk
76521|NCT02806089|chronic kidney disease|chronic kidney disease
76522|NCT02806089|malnutrition inflammation atherogenesis syndrome|malnutrition inflammation atherogenesis syndrome
76523|NCT02806089|muscle strength|muscle strength
76524|NCT02806089|muscle mass|muscle mass
76525|NCT02806089|lean body mass|lean body mass
76526|NCT02806089|physical activity|physical activity
76527|NCT02806076|HCC|hcc
76528|NCT02806076|RFA|rfa
76529|NCT02806063|Prosthesis|prosthesis
76530|NCT02806063|joint infection|joint infection
76531|NCT02806063|perioperative samples|perioperative samples
76532|NCT02806050|FES PET|fes pet
76533|NCT02806050|Palbociclib|palbociclib
76534|NCT02805985|Degenerative Disc Disease|degenerative disc disease
76535|NCT02805985|Spondylolisthesis|spondylolisthesis
76536|NCT02805985|Retrolisthesis|retrolisthesis
76537|NCT02805972|Obesity|obesity
76538|NCT02805972|Binge eating|binge eating
76539|NCT02805868|Severe|severe
76540|NCT02805868|Anemia|anemia
76541|NCT02805868|Aplastic|aplastic
76542|NCT02805868|Post-Polycythemic|post-polycythemic
76543|NCT02805868|Transformation|transformation
76544|NCT02805868|Thrombocythemia|thrombocythemia
76545|NCT02805868|Essential|essential
76546|NCT02805842|non adherence|non adherence
76547|NCT02805842|Tacrolimus|tacrolimus
76548|NCT02805842|Advagraf|advagraf
76549|NCT02805829|NK cells|nk cells
76550|NCT02805829|Trastuzumab|trastuzumab
76551|NCT02805816|Celiac disease|celiac disease
76552|NCT02805816|Tissue transglutaminase|tissue transglutaminase
76553|NCT02805816|Histology|histology
76554|NCT02805790|Primary Mitochondrial Disease|primary mitochondrial disease
76555|NCT02805790|Mitochondrial Myopathy|mitochondrial myopathy
76556|NCT02805790|Elamipretide|elamipretide
76557|NCT02805790|MTP-131|mtp-131
76558|NCT02805790|Bendavia™|bendavia™
76559|NCT02805751|Achilles|achilles
76560|NCT02805751|Tendon|tendon
76561|NCT02805751|Loading|loading
76562|NCT02805751|Rehabilitation|rehabilitation
67838|NCT02859948|AML|aml
76563|NCT02805738|Chronic Hepatitis B|chronic hepatitis b
76564|NCT02805738|tenofovir|tenofovir
76565|NCT02805738|CKD-390|ckd-390
76566|NCT02805725|Advanced solid tumor|advanced solid tumor
76567|NCT02805725|Advanced pretreated soft tissue sarcomas|advanced pretreated soft tissue sarcomas
76568|NCT02805725|Phase I/II trial|phase i/ii trial
76569|NCT02805725|Dose escalation|dose escalation
76570|NCT02805725|PK study|pk study
76571|NCT02805712|Heart Failure|heart failure
76572|NCT02805712|Palliative Care|palliative care
76576|NCT02805686|Toxicity, Drug|toxicity, drug
76577|NCT02805673|Osteopathy|osteopathy
76578|NCT02805673|Support|support
76579|NCT02805673|Treatment|treatment
76580|NCT02805673|Pain|pain
76581|NCT02805673|Quality of Life|quality of life
76594|NCT02805647|25-Hydroxy-vitamin D, children, bone fractures, vitamin D receptor polymorphism|25-hydroxy-vitamin d, children, bone fractures, vitamin d receptor polymorphism
76595|NCT02805634|nine holes peg|nine holes peg
76596|NCT02805634|triple stimulation|triple stimulation
76597|NCT02805634|multiple sclerosis|multiple sclerosis
76598|NCT02805582|Peripheral Nerve Block|peripheral nerve block
76599|NCT02805569|videolaryngoscope|videolaryngoscope
76600|NCT02805569|intubation stylet|intubation stylet
76601|NCT02805569|articulating stylet|articulating stylet
76602|NCT02805569|difficult airway|difficult airway
76603|NCT02805530|oligometastatic disease, radical treatment|oligometastatic disease, radical treatment
76800|NCT02804178|ATR-101|atr-101
76605|NCT02805517|Transplant Donors|transplant donors
76606|NCT02805504|Bupivacaine|bupivacaine
76607|NCT02805504|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
76608|NCT02805491|Hypospadias|hypospadias
76609|NCT02805491|newborns|newborns
76610|NCT02805491|pesticide|pesticide
76611|NCT02805491|Picardie|picardie
76612|NCT02805465|Heart Failure|heart failure
76613|NCT02805465|Atrial Fibrillation|atrial fibrillation
76614|NCT02805465|CRT|crt
76615|NCT02805465|BiVP|bivp
76616|NCT02805465|HBP|hbp
76617|NCT02805387|labor dystocia|labor dystocia
76624|NCT02805335|Central Venous Catheter|central venous catheter
76625|NCT02805335|Catheter Bloodstream Related Infection|catheter bloodstream related infection
76626|NCT02805335|Economic evaluation|economic evaluation
76627|NCT02805309|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
76628|NCT02805309|Exercise|exercise
76629|NCT02805309|Frailty|frailty
76630|NCT02805309|Functional Outcomes|functional outcomes
76631|NCT02805309|Cognitive Behavioral Intervention|cognitive behavioral intervention
76633|NCT02805270|adverse drug events, preventable, potential, counselling, medication reconciliation|adverse drug events, preventable, potential, counselling, medication reconciliation
76634|NCT02805244|JTZ-951|jtz-951
76635|NCT02805244|Pharmacokinetics|pharmacokinetics
76636|NCT02805244|14C-JTZ-951|14c-jtz-951
76637|NCT02805244|Mass balance|mass balance
76638|NCT02805244|Time course|time course
76639|NCT02805205|PEG-rhG-CSF neutropenia|peg-rhg-csf neutropenia
76640|NCT02805192|Emergency Department|emergency department
76641|NCT02805192|Estimation of age and weight|estimation of age and weight
76642|NCT02805192|Size measurement|size measurement
76643|NCT02805166|PEG-rhG-CSF|peg-rhg-csf
76644|NCT02805153|PEG-rhG-CSF|peg-rhg-csf
76645|NCT02805140|mother|mother
76646|NCT02805140|social support|social support
76647|NCT02805140|mobile app|mobile app
76648|NCT02805140|videoconference|videoconference
76649|NCT02805140|sedentary|sedentary
76650|NCT02805140|physical activity|physical activity
76651|NCT02805127|Asthma|asthma
76652|NCT02805127|COPD|copd
76653|NCT02805127|Capnography|capnography
76654|NCT02805114|Asthma|asthma
76655|NCT02805114|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
76656|NCT02805114|Capnography|capnography
76657|NCT02805062|Trapped Lung|trapped lung
76658|NCT02805036|alveolar recruitment|alveolar recruitment
76659|NCT02805036|stroke volume/physiology|stroke volume/physiology
76660|NCT02805036|cardiac output/physiology|cardiac output/physiology
76661|NCT02804997|non-invasive ventilation|non-invasive ventilation
76662|NCT02804997|cardiac surgery|cardiac surgery
76663|NCT02804984|idiopathic cytopenia of undetermined significance (ICUS)|idiopathic cytopenia of undetermined significance (icus)
76664|NCT02804984|molecular defects|molecular defects
76665|NCT02804958|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
76666|NCT02804958|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
76667|NCT02804958|Clinical outcomes|clinical outcomes
76668|NCT02804945|Blood And Marrow Transplantation|blood and marrow transplantation
76669|NCT02804945|Adult Respiratory Distress Syndrome|adult respiratory distress syndrome
76670|NCT02804945|ARDS|ards
76671|NCT02804945|Allogeneic human mesenchymal stem cells|allogeneic human mesenchymal stem cells
76672|NCT02804945|hMSCs|hmscs
76673|NCT02804945|Placebo|placebo
76674|NCT02804945|Plasma-Lyte A solution|plasma-lyte a solution
76675|NCT02804945|Standard of Care|standard of care
76676|NCT02804945|Recent onset pulmonary toxicity|recent onset pulmonary toxicity
76777|NCT02804347|Electroconvulsive Therapy|electroconvulsive therapy
76677|NCT02804893|Lung cancer, video-assisted thoracoscopic surgery, robotic-assisted thoracoscopic surgery|lung cancer, video-assisted thoracoscopic surgery, robotic-assisted thoracoscopic surgery
76678|NCT02804880|Smoking cessation|smoking cessation
76679|NCT02804880|Quit to Win|quit to win
76680|NCT02804880|Brief intervention|brief intervention
76681|NCT02804880|Personalized active referral|personalized active referral
76682|NCT02804880|Instant messaging|instant messaging
76683|NCT02804880|SMS|sms
76684|NCT02804880|Smoking Cessation Intervention|smoking cessation intervention
76685|NCT02804841|Vitamin D supplementation|vitamin d supplementation
76686|NCT02804841|Cognitive function|cognitive function
76687|NCT02804841|Physical function|physical function
76688|NCT02804841|Successful ageing|successful ageing
76689|NCT02804841|Prevention|prevention
76690|NCT02804841|Cholecalciferol|cholecalciferol
76691|NCT02804841|Dementia|dementia
76692|NCT02804841|Muscle mass|muscle mass
76693|NCT02804815|Aspirin|aspirin
76694|NCT02804815|prostate|prostate
76695|NCT02804815|colorectal|colorectal
76696|NCT02804815|breast|breast
76697|NCT02804815|gastro-oesophageal|gastro-oesophageal
76698|NCT02804815|recurrence|recurrence
76700|NCT02804763|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
627268|NCT00688818|Randomized|randomized
76701|NCT02804763|Dapirolizumab Pegol (DZP)|dapirolizumab pegol (dzp)
76702|NCT02804750|Cushing's Syndrome|cushing's syndrome
76703|NCT02804750|Cushing's Disease|cushing's disease
76704|NCT02804750|Cushings|cushings
76705|NCT02804750|Hypercortisolemia|hypercortisolemia
76706|NCT02804750|Cushingoid|cushingoid
76707|NCT02804750|Type 2 Diabetes|type 2 diabetes
76708|NCT02804750|Impaired Glucose Intolerance|impaired glucose intolerance
76709|NCT02804750|Hypertension|hypertension
76710|NCT02804750|Adrenal Corticotrophic Hormone (ACTH)|adrenal corticotrophic hormone (acth)
76711|NCT02804750|Adrenocortical Carcinoma|adrenocortical carcinoma
76712|NCT02804750|Primary Pigmented Nodular Adrenal Disease (PPNAD)|primary pigmented nodular adrenal disease (ppnad)
76713|NCT02804750|Moon Facies|moon facies
76714|NCT02804750|Dorsocervical Fat Pad|dorsocervical fat pad
76715|NCT02804750|Adrenal Adenoma|adrenal adenoma
76716|NCT02804750|Adrenal Carcinoma|adrenal carcinoma
76717|NCT02804750|Adrenal Autonomy|adrenal autonomy
76718|NCT02804750|Cortisol|cortisol
76720|NCT02804724|Human immunodeficiency virus|human immunodeficiency virus
76721|NCT02804724|Late diagnosis|late diagnosis
76722|NCT02804672|Cardiovascular health|cardiovascular health
76723|NCT02804672|Diet|diet
76724|NCT02804672|Functional limitations|functional limitations
76725|NCT02804672|Frailty|frailty
76726|NCT02804672|Older adults|older adults
76727|NCT02804659|micro-RNA|micro-rna
76728|NCT02804646|Recombinant human endostatin(Endostar)|recombinant human endostatin(endostar)
76729|NCT02804646|Durative transfusion|durative transfusion
76730|NCT02804646|adenocarcinoma of lung|adenocarcinoma of lung
76731|NCT02804633|IV acetaminophen|iv acetaminophen
76732|NCT02804633|Colorectal Surgery|colorectal surgery
76733|NCT02804633|Enhance Recovery|enhance recovery
76734|NCT02804633|Opioid Consumption|opioid consumption
76735|NCT02804633|Pain Management|pain management
76736|NCT02804607|burn|burn
76737|NCT02804607|child|child
76738|NCT02804607|graft|graft
76739|NCT02804607|development|development
76740|NCT02804607|complications|complications
76741|NCT02804607|autonomy|autonomy
76742|NCT02804568|Schizophrenia|schizophrenia
76743|NCT02804568|Alkermes|alkermes
76744|NCT02804568|ALK 3831|alk 3831
76745|NCT02804568|Samidorphan|samidorphan
76746|NCT02804555|reactive oxygen species|reactive oxygen species
76747|NCT02804555|elective cesarean section|elective cesarean section
76748|NCT02804555|oxygen therapy|oxygen therapy
76749|NCT02804555|newborn|newborn
76750|NCT02804542|fascia iliaca blocks|fascia iliaca blocks
76751|NCT02804529|Laparoscopic entry|laparoscopic entry
76752|NCT02804529|Meng's point|meng's point
76753|NCT02804529|Veress needle|veress needle
76754|NCT02804477|adherence|adherence
76755|NCT02804477|opioid|opioid
76756|NCT02804477|MMAS 8, morisky medication adherence scale|mmas 8, morisky medication adherence scale
76757|NCT02804477|validation|validation
76758|NCT02804425|Medical Education|medical education
76759|NCT02804425|Simulation|simulation
76760|NCT02804425|Anesthesia crisis management|anesthesia crisis management
76761|NCT02804425|Learning outcomes|learning outcomes
76762|NCT02804412|communication disorders|communication disorders
76763|NCT02804412|language and speech disorder rehabilitation|language and speech disorder rehabilitation
76764|NCT02804412|stroke|stroke
76765|NCT02804399|rifampin|rifampin
76766|NCT02804399|pharmacokinetics|pharmacokinetics
76767|NCT02804399|PF-06463922|pf-06463922
76768|NCT02804399|drug interaction|drug interaction
76769|NCT02804386|HCV|hcv
76770|NCT02804386|safety|safety
76771|NCT02804386|efficacy|efficacy
76772|NCT02804386|EVR|evr
76773|NCT02804386|SVR|svr
76774|NCT02804373|oxytocin|oxytocin
76775|NCT02804373|adults|adults
76776|NCT02804347|Olfactory Dysfunction|olfactory dysfunction
77074|NCT02802449|Vitamin D|vitamin d
76778|NCT02804347|Theta Burst Stimulation|theta burst stimulation
76779|NCT02804321|catheter ablation|catheter ablation
76780|NCT02804321|galectin 3|galectin 3
76781|NCT02804321|ngal|ngal
76782|NCT02804321|aldosterone|aldosterone
76783|NCT02804321|atrial fibrillation|atrial fibrillation
76784|NCT02804308|Combined Training|combined training
76785|NCT02804308|Breast Cancer|breast cancer
76786|NCT02804308|Body Composition|body composition
76787|NCT02804308|Postmenopausal Women|postmenopausal women
76788|NCT02804308|Aromatase Inhibitors|aromatase inhibitors
76789|NCT02804308|Quality of life|quality of life
76790|NCT02804295|Prescription Drug|prescription drug
76791|NCT02804295|Misuse|misuse
76792|NCT02804269|Healthy Volunteer|healthy volunteer
76793|NCT02804269|Dilated cardiomyopathy|dilated cardiomyopathy
76794|NCT02804269|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
76795|NCT02804269|ischemic heart disease|ischemic heart disease
76796|NCT02804269|Cardiovascular Magnetic Resonance Imaging|cardiovascular magnetic resonance imaging
76797|NCT02804243|nasal high flow therapy|nasal high flow therapy
627572|NCT00690547|During|during
76798|NCT02804243|rehabilitation|rehabilitation
76799|NCT02804243|exercise endurance|exercise endurance
76801|NCT02804178|classic congenital adrenal hyperplasia|classic congenital adrenal hyperplasia
76802|NCT02804178|21-hydroxylase deficiency|21-hydroxylase deficiency
76803|NCT02804178|CAH|cah
76804|NCT02804165|Type 1 diabetes|type 1 diabetes
76805|NCT02804165|Enterovirus|enterovirus
76806|NCT02804165|Genetics|genetics
76807|NCT02804165|Gene-Virus interaction|gene-virus interaction
76808|NCT02804152|pregnancy|pregnancy
76809|NCT02804152|pain|pain
76810|NCT02804152|prescription opioid|prescription opioid
76811|NCT02804139|Cesarean Section|cesarean section
76812|NCT02804139|Postpartum issues|postpartum issues
76813|NCT02804126|acute pain|acute pain
76814|NCT02804126|transversus abdominis plane block|transversus abdominis plane block
76815|NCT02804126|quadratus lumborum block|quadratus lumborum block
76816|NCT02804126|neuropathic pain|neuropathic pain
76817|NCT02804100|Circulating Tumor DNA|circulating tumor dna
76818|NCT02804100|Lung cancer|lung cancer
76819|NCT02804100|Plasma DNA|plasma dna
76820|NCT02804061|nutrition|nutrition
76821|NCT02804061|exercise|exercise
76822|NCT02804061|behavior change|behavior change
76823|NCT02804061|adherence|adherence
76824|NCT02804048|Dyspareunia|dyspareunia
76825|NCT02804048|Pelvic floor muscles|pelvic floor muscles
76826|NCT02804048|Women|women
76827|NCT02804022|Respiratory Depression|respiratory depression
76828|NCT02804009|anxiety|anxiety
76829|NCT02804009|coronary angiography|coronary angiography
76830|NCT02803957|Degenerative|degenerative
76831|NCT02803957|Mitral Regurgitation|mitral regurgitation
76832|NCT02803944|azithromycin|azithromycin
76833|NCT02803944|cystic fibrosis|cystic fibrosis
76834|NCT02803944|pulmonary function|pulmonary function
76835|NCT02803931|Cardiogoniometry|cardiogoniometry
76836|NCT02803931|Electrocardiography|electrocardiography
76837|NCT02803879|cardiac resynchronisation therapy|cardiac resynchronisation therapy
76838|NCT02803879|cardiogoniometry|cardiogoniometry
76839|NCT02803866|Parenting Self-efficacy|parenting self-efficacy
76840|NCT02803866|Parent training program|parent training program
76841|NCT02803866|Perceived self-efficacy tool|perceived self-efficacy tool
76842|NCT02803853|Native American|native american
76843|NCT02803853|Obesity|obesity
76844|NCT02803853|Multi level|multi level
76845|NCT02803853|Policy|policy
76846|NCT02803853|Schools|schools
76847|NCT02803853|Worksite|worksite
76848|NCT02803853|Social Media|social media
76849|NCT02803853|Food Store|food store
76850|NCT02803840|Large B-Cell|large b-cell
76851|NCT02803840|Diffuse|diffuse
76852|NCT02803827|diarrhoea|diarrhoea
76853|NCT02803827|gastroenteritis|gastroenteritis
76854|NCT02803827|rapid diagnostics|rapid diagnostics
76855|NCT02803827|probiotics|probiotics
76856|NCT02803814|Pancreatoduodenectomy|pancreatoduodenectomy
76857|NCT02803814|Pancreatic tumors|pancreatic tumors
76858|NCT02803814|Periampullary tumors|periampullary tumors
76859|NCT02803801|Parents' ability to guide their child|parents' ability to guide their child
76860|NCT02803801|Parent perception of competence|parent perception of competence
76861|NCT02803801|Parent understanding of their child's unique learning style|parent understanding of their child's unique learning style
76862|NCT02803788|ramosetron, ondansetron, dexamethasone,|ramosetron, ondansetron, dexamethasone,
76863|NCT02803762|ADME|adme
76864|NCT02803762|Pacritinib|pacritinib
76865|NCT02803671|preterm neonates|preterm neonates
76866|NCT02803671|EEG-NIRS|eeg-nirs
76867|NCT02803658|smoking|smoking
76868|NCT02803645|healthy subjects|healthy subjects
76869|NCT02803645|cardiovascular risk factors|cardiovascular risk factors
76870|NCT02803645|markers of arterial inflammation|markers of arterial inflammation
76871|NCT02803645|markers of oxidative stress|markers of oxidative stress
89901|NCT02725762|AMD|amd
68162|NCT02857868|ABL001|abl001
76872|NCT02803632|young|young
76873|NCT02803632|disruptive mood dysregulation disorder|disruptive mood dysregulation disorder
76874|NCT02803632|actigraphic profile|actigraphic profile
76875|NCT02803619|Non-small cell lung cancer|non-small cell lung cancer
76876|NCT02803619|leptomeningeal metastasis|leptomeningeal metastasis
76877|NCT02803619|EGFR sensitive mutations|egfr sensitive mutations
76878|NCT02803606|hypothermia|hypothermia
76879|NCT02803606|routine care|routine care
76880|NCT02803606|preterm neonates|preterm neonates
76881|NCT02803593|a technology-based intervention|a technology-based intervention
76882|NCT02803593|Asian American|asian american
76883|NCT02803593|survivorship|survivorship
76884|NCT02803541|chronic kidney disease|chronic kidney disease
76885|NCT02803541|exercise|exercise
76886|NCT02803541|pediatrics|pediatrics
76887|NCT02803541|summer camp|summer camp
76888|NCT02803515|intra peritonal chemo hyperthermia|intra peritonal chemo hyperthermia
76889|NCT02803515|peritoneal carcinomatosis|peritoneal carcinomatosis
76890|NCT02803515|ovarian cancer|ovarian cancer
76891|NCT02803502|thrombin generation test|thrombin generation test
76892|NCT02803502|factor VIII|factor viii
76893|NCT02803502|hemophilia|hemophilia
76894|NCT02803489|chronic heart failure|chronic heart failure
76895|NCT02803489|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
76896|NCT02803489|diabetes|diabetes
76897|NCT02803476|PCO|pco
76898|NCT02803476|Vitamin D|vitamin d
76899|NCT02803476|Insulin resistance|insulin resistance
76900|NCT02803463|peritoneal closure|peritoneal closure
76901|NCT02803463|appendectomy|appendectomy
76902|NCT02803463|postoperative pain|postoperative pain
76903|NCT02803463|life quality|life quality
76904|NCT02803450|Effects of; Anesthesia|effects of; anesthesia
76905|NCT02803450|spinal and epidural|spinal and epidural
76906|NCT02803437|Castration-resistant prostate cancer|castration-resistant prostate cancer
76907|NCT02803424|robot-assisted laparoscopic radical prostatectomy|robot-assisted laparoscopic radical prostatectomy
76908|NCT02803424|Autoflow|autoflow
76909|NCT02803424|trendelenburg position|trendelenburg position
76910|NCT02803424|pneumoperitoneum|pneumoperitoneum
76911|NCT02803411|Coronary Heart Disease|coronary heart disease
76912|NCT02803411|Coronary Computed Tomography Angiography (CCTA)|coronary computed tomography angiography (ccta)
76913|NCT02803411|Coronary Atherosclerotic Plaque|coronary atherosclerotic plaque
76914|NCT02803411|coronary atherosclerosis|coronary atherosclerosis
76915|NCT02803398|Compression bandages|compression bandages
76916|NCT02803385|Patient Controlled Epidural Analgesia|patient controlled epidural analgesia
76917|NCT02803385|Continous Epidural Infusion Analgesia|continous epidural infusion analgesia
76918|NCT02803372|partial nephrectomy|partial nephrectomy
76919|NCT02803372|acute kidney injury|acute kidney injury
76920|NCT02803372|LiDCOrapid|lidcorapid
76921|NCT02803372|circulatory management|circulatory management
76922|NCT02803359|Laryngeal evoked brainstem response (LEBR)|laryngeal evoked brainstem response (lebr)
76923|NCT02803359|laryngopharyngeal sensory discrimination testing (LPSDT)|laryngopharyngeal sensory discrimination testing (lpsdt)
76924|NCT02803359|brainstem activity|brainstem activity
76925|NCT02803346|sepsis|sepsis
76926|NCT02803346|septic shock|septic shock
76927|NCT02803346|immunosuppression|immunosuppression
76928|NCT02803346|HLA-DR|hla-dr
76929|NCT02803346|lymphopenia|lymphopenia
76930|NCT02803333|NSCLC|nsclc
76931|NCT02803333|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
76932|NCT02803333|Lung Diseases|lung diseases
76933|NCT02803333|Thoracic Neoplasms|thoracic neoplasms
76934|NCT02803320|Sunscreen active|sunscreen active
76935|NCT02803307|osteoarthritis of the knee|osteoarthritis of the knee
76936|NCT02803307|TLC599|tlc599
76937|NCT02803307|Dexamethasone|dexamethasone
76938|NCT02803307|DSP|dsp
76939|NCT02803255|Injuries|injuries
76940|NCT02803255|Spinal Cord|spinal cord
76941|NCT02803242|copd|copd
76942|NCT02803242|emphysema|emphysema
76943|NCT02803242|bronchitis|bronchitis
76944|NCT02803242|bronchiectasis|bronchiectasis
76945|NCT02803203|Osimertinib|osimertinib
76946|NCT02803203|bevacizumab|bevacizumab
76947|NCT02803203|metastatic|metastatic
76948|NCT02803203|16-033|16-033
76949|NCT02803190|Spine curve|spine curve
76950|NCT02803190|Posture|posture
76951|NCT02803190|Fracture|fracture
76952|NCT02803190|sarcopenia|sarcopenia
76953|NCT02803190|Exercise|exercise
76954|NCT02803177|large bone defect|large bone defect
76955|NCT02803177|bone marrow-derived mononuclear cells|bone marrow-derived mononuclear cells
76956|NCT02803151|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
76957|NCT02803151|Lymph node metastasis|lymph node metastasis
76958|NCT02803151|T cell immunity|t cell immunity
76959|NCT02803151|cell-free DNA|cell-free dna
76960|NCT02803138|Sustained Virological Response|sustained virological response
76961|NCT02803138|Observational Study|observational study
76962|NCT02803138|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
76963|NCT02803138|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
76964|NCT02803138|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
76965|NCT02803138|Chronic Hepatitis C|chronic hepatitis c
76966|NCT02803125|PTSD|ptsd
76967|NCT02803125|Aging|aging
76968|NCT02803125|Veteran|veteran
76969|NCT02803125|Intervention|intervention
77383|NCT02800772|ERCP|ercp
76970|NCT02803086|Prostate cancer|prostate cancer
76971|NCT02803086|Radiotherapy|radiotherapy
76972|NCT02803086|Hematopoietic stem cells|hematopoietic stem cells
76973|NCT02803086|Radiotoxicity|radiotoxicity
76974|NCT02802982|Thrombocytopenia|thrombocytopenia
76975|NCT02802982|Neonates|neonates
76976|NCT02802956|Life participation|life participation
76977|NCT02802943|CLL, Peptid Vaccination|cll, peptid vaccination
76978|NCT02802917|Eye stinging potential|eye stinging potential
76979|NCT02802904|Healthy subjects|healthy subjects
76980|NCT02802891|Asthma|asthma
76981|NCT02802891|Allergy|allergy
76982|NCT02802891|Diagnosis|diagnosis
76983|NCT02802891|Endocrine disruptors|endocrine disruptors
76984|NCT02802891|Children|children
76985|NCT02802839|Virtual Reality|virtual reality
76986|NCT02802839|venipuncture|venipuncture
76987|NCT02802826|Exercise|exercise
76988|NCT02802826|Chemotherapy|chemotherapy
627573|NCT00690547|After|after
76989|NCT02802826|Physical Activity|physical activity
76990|NCT02802826|Breast Cancer|breast cancer
76991|NCT02802813|Single-blinded controlled trial|single-blinded controlled trial
76992|NCT02802813|Primaquine|primaquine
76993|NCT02802787|Quality of life|quality of life
76994|NCT02802787|Occupation|occupation
76995|NCT02802787|Pain|pain
76996|NCT02802787|Fatigue|fatigue
76997|NCT02802774|Post-operative treatment|post-operative treatment
76998|NCT02802748|Early Breast Cancer|early breast cancer
76999|NCT02802748|Hormone Receptor-positive|hormone receptor-positive
77000|NCT02802748|Window-of-opportunity|window-of-opportunity
77001|NCT02802748|PAM50|pam50
77002|NCT02802748|Luminal A|luminal a
77003|NCT02802748|Luminal B|luminal b
77004|NCT02802748|proliferation signature|proliferation signature
77005|NCT02802748|metronomic vinorelbine|metronomic vinorelbine
77006|NCT02802748|letrozole|letrozole
77007|NCT02802735|Pharmacokinetics|pharmacokinetics
77008|NCT02802735|Apremilast|apremilast
77009|NCT02802735|Healthy Adult Male|healthy adult male
77010|NCT02802735|Korean Subjects|korean subjects
77011|NCT02802722|convalescence|convalescence
77012|NCT02802722|inflammation|inflammation
77013|NCT02802722|resolution|resolution
77014|NCT02802722|vitamin D|vitamin d
77015|NCT02802709|knee|knee
77016|NCT02802696|Transfusion|transfusion
77017|NCT02802696|Transfusion Medicine|transfusion medicine
77018|NCT02802696|Diuretic|diuretic
77019|NCT02802683|Hypotension|hypotension
77020|NCT02802683|cesarean section|cesarean section
77021|NCT02802657|Age-related Macular Degeneration|age-related macular degeneration
77022|NCT02802657|Conbercept|conbercept
77023|NCT02802657|Treat-and-Extend Regimen|treat-and-extend regimen
77024|NCT02802657|Pro Re Nata|pro re nata
77025|NCT02802631|Bacterial infections|bacterial infections
77026|NCT02802618|Validity|validity
77027|NCT02802618|Reliability|reliability
77028|NCT02802618|Rehabilitation|rehabilitation
77029|NCT02802618|Translation|translation
77030|NCT02802618|Education|education
77031|NCT02802579|obesity|obesity
77032|NCT02802579|dual source CT|dual source ct
77033|NCT02802579|coronary CT angiography|coronary ct angiography
77034|NCT02802579|prognosis|prognosis
77035|NCT02802579|bariatric surgery|bariatric surgery
77036|NCT02802579|gastric bypass surgery|gastric bypass surgery
77037|NCT02802579|coronary arterial disease|coronary arterial disease
77038|NCT02802579|major adverse coronary event|major adverse coronary event
77039|NCT02802566|Maternal Obesity|maternal obesity
77040|NCT02802566|Inflammation|inflammation
77041|NCT02802553|SmartGoggles|smartgoggles
77042|NCT02802553|sentinel lymph nodes|sentinel lymph nodes
77043|NCT02802553|indocyanine green|indocyanine green
77044|NCT02802553|Cardio-Green|cardio-green
77045|NCT02802553|Spy Elite|spy elite
77046|NCT02802540|nabilone|nabilone
77047|NCT02802540|anorexia|anorexia
77048|NCT02802540|Non-Small Cell Lung Cancer|non-small cell lung cancer
77049|NCT02802514|Gastrointestinal|gastrointestinal
77050|NCT02802514|Glucagon like peptide|glucagon like peptide
77051|NCT02802514|Nausea|nausea
77052|NCT02802514|Magnetic resonance imaging|magnetic resonance imaging
77053|NCT02802501|Safety|safety
77054|NCT02802501|Artemisinin Combination Therapy|artemisinin combination therapy
77055|NCT02802501|Efficacy|efficacy
77056|NCT02802501|Tafenoquine|tafenoquine
77057|NCT02802501|Superiority|superiority
77058|NCT02802501|Primaquine|primaquine
77059|NCT02802501|Radical cure|radical cure
77060|NCT02802501|Vivax|vivax
77062|NCT02802501|Plasmodium vivax malaria|plasmodium vivax malaria
77063|NCT02802501|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
77064|NCT02802488|D-dimers|d-dimers
77065|NCT02802488|Atrial fibrillation|atrial fibrillation
77066|NCT02802475|antibodies|antibodies
77067|NCT02802475|auto-immune encephalitis|auto-immune encephalitis
77068|NCT02802475|epilepsy|epilepsy
77069|NCT02802475|limbic encephalitis|limbic encephalitis
77070|NCT02802462|endothelial progenitor cell|endothelial progenitor cell
77071|NCT02802462|hemodynamic|hemodynamic
77072|NCT02802462|Exercise|exercise
77073|NCT02802462|HIIT|hiit
77075|NCT02802449|Hypovitaminosis D|hypovitaminosis d
77077|NCT02802423|TNBC|tnbc
77078|NCT02802423|Breast cancer|breast cancer
77079|NCT02802423|Triple negative|triple negative
77080|NCT02802397|Early ovarian reserve decreased|early ovarian reserve decreased
77081|NCT02802384|Paget's Disease of Bone|paget's disease of bone
77082|NCT02802384|Healthy controls|healthy controls
77083|NCT02802371|caregiver burden|caregiver burden
77084|NCT02802371|Alzheimer disease and related disorders|alzheimer disease and related disorders
77085|NCT02802371|elderly|elderly
77086|NCT02802371|pharmaceutical care|pharmaceutical care
77087|NCT02802371|optimization of drug prescribing|optimization of drug prescribing
77088|NCT02802371|psychosocial intervention|psychosocial intervention
77089|NCT02802358|Falls|falls
77090|NCT02802358|Functionality|functionality
77091|NCT02802332|neonatal|neonatal
77092|NCT02802332|preterm|preterm
77093|NCT02802332|Nepal|nepal
77094|NCT02802332|family-initiated identification|family-initiated identification
77095|NCT02802332|basic newborn care|basic newborn care
77096|NCT02802306|Angioplasty|angioplasty
77097|NCT02802306|Peripheral Artery Disease|peripheral artery disease
77098|NCT02802306|PAD|pad
77099|NCT02802306|Lesion|lesion
77100|NCT02802306|Claudication|claudication
77101|NCT02802293|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
77102|NCT02802293|Major Depressive Disorder|major depressive disorder
77103|NCT02802280|endothelial dysfunction|endothelial dysfunction
77104|NCT02802254|physical activity|physical activity
77105|NCT02802254|patient feedback|patient feedback
77106|NCT02802254|risk perception|risk perception
77107|NCT02802254|pedometer|pedometer
77108|NCT02802215|Diabetes Mellitus|diabetes mellitus
77109|NCT02802215|Pregnancy|pregnancy
77110|NCT02802202|Palpation|palpation
77111|NCT02802202|Chronic Pain|chronic pain
77112|NCT02802202|Muscle|muscle
77113|NCT02802189|Chronic Mechanical Neck Pain|chronic mechanical neck pain
77114|NCT02802189|exercise|exercise
77115|NCT02802189|Integrated Neuromuscular Inhibition Technique|integrated neuromuscular inhibition technique
77116|NCT02802163|untreated multiple myeloma|untreated multiple myeloma
77117|NCT02802163|newly diagnosed myeloma|newly diagnosed myeloma
77118|NCT02802163|transplant eligible|transplant eligible
77119|NCT02802150|Zanthoxylum schinifolium seed Oil|zanthoxylum schinifolium seed oil
77120|NCT02802150|soy bean oil|soy bean oil
77121|NCT02802150|omega-3 fatty acid|omega-3 fatty acid
77122|NCT02802150|dry eye disease|dry eye disease
77123|NCT02802137|tafluprost|tafluprost
77124|NCT02802137|dorzolamide|dorzolamide
77125|NCT02802137|timolol|timolol
77127|NCT02802124|hepatocellular carcinoma|hepatocellular carcinoma
77128|NCT02802124|carbon-ion radiotherapy|carbon-ion radiotherapy
77129|NCT02802124|toxicity|toxicity
77130|NCT02802124|efficacy|efficacy
77131|NCT02802111|Beta Agonists|beta agonists
77132|NCT02802111|Asthma|asthma
77133|NCT02802111|Albuterol|albuterol
77134|NCT02802111|Levalbuterol|levalbuterol
77135|NCT02802098|Metastatic breast cancer|metastatic breast cancer
77136|NCT02802098|bevacizumab maintenance|bevacizumab maintenance
77137|NCT02802098|Durvalumab|durvalumab
77138|NCT02802085|Total Knee Arthroplasty|total knee arthroplasty
77139|NCT02802085|Total Knee Replacement|total knee replacement
77140|NCT02802085|TKA|tka
77141|NCT02802085|TKR|tkr
77142|NCT02802085|Stiffness of Knee|stiffness of knee
77143|NCT02802085|Deformity|deformity
77144|NCT02802085|Knee Joint|knee joint
77145|NCT02802085|Instability|instability
77146|NCT02802085|Post-traumatic|post-traumatic
77147|NCT02802085|Arthrosis|arthrosis
77148|NCT02802046|FFRCT|ffrct
77149|NCT02802046|Angina pectoris grade|angina pectoris grade
77150|NCT02802046|Fractional flow reserve|fractional flow reserve
77151|NCT02802046|CCTA|ccta
77152|NCT02802033|Registry|registry
77153|NCT02802033|Spine|spine
77154|NCT02802033|Osteobiologics|osteobiologics
77155|NCT02802033|Spinal Fusion|spinal fusion
77156|NCT02801994|Patient-ventilator interaction|patient-ventilator interaction
77157|NCT02801994|Inspiratory muscles|inspiratory muscles
77158|NCT02801994|Electromyogram|electromyogram
77159|NCT02801994|Mechanical ventilation|mechanical ventilation
77160|NCT02801994|Proportional Assist Ventilation|proportional assist ventilation
77161|NCT02801981|tolerability|tolerability
77162|NCT02801981|healthy volunteers|healthy volunteers
77163|NCT02801981|Cholestasis|cholestasis
77164|NCT02801981|safety|safety
77165|NCT02801955|gastric adenocarcinoma|gastric adenocarcinoma
77166|NCT02801955|tumor markers|tumor markers
77167|NCT02801955|peritoneal cytology|peritoneal cytology
77168|NCT02801942|Biomarker|biomarker
77169|NCT02801942|Immune Profile|immune profile
77170|NCT02801942|Biopsy|biopsy
77171|NCT02801942|Leukocyte subsets|leukocyte subsets
77172|NCT02801942|Inguinal lymph nodes|inguinal lymph nodes
77173|NCT02801942|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
77174|NCT02801916|Humans|humans
77175|NCT02801916|Glycemic response|glycemic response
77176|NCT02801916|Oat beta-glucan|oat beta-glucan
77177|NCT02801877|Depression|depression
77178|NCT02801877|Anxiety|anxiety
77179|NCT02801877|Behavior Therapy|behavior therapy
77180|NCT02801877|Technology Assisted|technology assisted
77181|NCT02801877|Mobile Phone|mobile phone
77182|NCT02801877|Cellular Phone|cellular phone
77183|NCT02801877|Smartphone|smartphone
77184|NCT02801877|App|app
77185|NCT02801877|Coach|coach
77186|NCT02801864|tDCS|tdcs
77187|NCT02801864|transcranial direct current stimulation|transcranial direct current stimulation
77188|NCT02801864|intensive speech therapy|intensive speech therapy
77189|NCT02801864|chronic|chronic
77190|NCT02801864|post stroke|post stroke
77191|NCT02801864|aphasia|aphasia
77192|NCT02801864|production|production
77193|NCT02801864|language|language
77194|NCT02801851|Delirium|delirium
77195|NCT02801838|Inspiratory muscles|inspiratory muscles
77196|NCT02801838|Patient-ventilator interaction|patient-ventilator interaction
77197|NCT02801838|Electromyogram|electromyogram
77198|NCT02801838|Mechanical ventilation|mechanical ventilation
77199|NCT02801825|axillay artery|axillay artery
77200|NCT02801825|cannulation|cannulation
77201|NCT02801825|femoral artery|femoral artery
77202|NCT02801812|Nailfold Capillaroscopy|nailfold capillaroscopy
77203|NCT02801799|Anaesthesia|anaesthesia
77204|NCT02801799|Analgesia|analgesia
77205|NCT02801799|Nerve blocks|nerve blocks
77206|NCT02801799|Peripheral nerve blocks|peripheral nerve blocks
77207|NCT02801799|Regional anaesthesia|regional anaesthesia
77208|NCT02801799|therapeutic techniques|therapeutic techniques
77209|NCT02801799|ropivacaine|ropivacaine
77210|NCT02801799|nerve block duration|nerve block duration
77211|NCT02801799|lower limb|lower limb
77212|NCT02801799|Postoperative pain|postoperative pain
77213|NCT02801786|Mammography|mammography
77214|NCT02801786|Premedication|premedication
77215|NCT02801786|Pain|pain
77216|NCT02801786|Discomfort|discomfort
77217|NCT02801786|Breast|breast
77218|NCT02801773|gingivitis|gingivitis
77219|NCT02801773|probiotic|probiotic
77220|NCT02801773|non- surgical treatment|non- surgical treatment
77222|NCT02801760|Self-Consent|self-consent
77223|NCT02801760|PrEP|prep
77224|NCT02801760|Autonomous Research Consent|autonomous research consent
77225|NCT02801760|Participation-associated Outcomes|participation-associated outcomes
77226|NCT02801747|HIV care continuum|hiv care continuum
77227|NCT02801747|antiretroviral therapy|antiretroviral therapy
77228|NCT02801747|engagement in HIV care|engagement in hiv care
77229|NCT02801747|Multiphase Optimization Strategy (MOST)|multiphase optimization strategy (most)
77230|NCT02801708|Embolic stroke of undetermined source|embolic stroke of undetermined source
77231|NCT02801708|Atrial fibrillation|atrial fibrillation
77232|NCT02801695|pre-eclampsia|pre-eclampsia
77233|NCT02801695|citrulline|citrulline
77234|NCT02801695|pregnancy|pregnancy
77235|NCT02801669|anticoagulants|anticoagulants
77236|NCT02801669|DU-176b|du-176b
77237|NCT02801669|edoxaban|edoxaban
77238|NCT02801669|factor Xa|factor xa
77239|NCT02801669|oral|oral
77240|NCT02801669|prevention|prevention
77241|NCT02801669|atrial fibrillation|atrial fibrillation
77242|NCT02801643|PET|pet
77243|NCT02801643|dopamine|dopamine
77244|NCT02801643|fMRI|fmri
77245|NCT02801643|reward|reward
77246|NCT02801617|Latanoprost|latanoprost
77247|NCT02801617|Glaucoma|glaucoma
77248|NCT02801617|Ocular hypertension|ocular hypertension
77249|NCT02801617|Crossover study|crossover study
77250|NCT02801578|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
77251|NCT02801578|CLL|cll
77252|NCT02801578|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
77253|NCT02801578|Ibrutinib|ibrutinib
77254|NCT02801578|PCI-32765|pci-32765
77255|NCT02801578|Imbruvica|imbruvica
77256|NCT02801578|Pharmacodynamics|pharmacodynamics
77257|NCT02801552|regenerative endodontic treatment|regenerative endodontic treatment
77258|NCT02801552|platelet-rich fibrin|platelet-rich fibrin
77259|NCT02801552|Immature permanent tooth|immature permanent tooth
77260|NCT02801552|apical periodontitis|apical periodontitis
77261|NCT02801513|mindfulness|mindfulness
77262|NCT02801513|EEG|eeg
77263|NCT02801513|error-related negativity|error-related negativity
77264|NCT02801513|late positive potential|late positive potential
77265|NCT02801513|long-range temporal correlations|long-range temporal correlations
77266|NCT02801500|bilioenteric anastomosis|bilioenteric anastomosis
77267|NCT02801487|Carbon Ion Therapy|carbon ion therapy
77268|NCT02801487|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
90488|NCT02722668|AML|aml
77269|NCT02801435|EGFR inhibitor|egfr inhibitor
77270|NCT02801435|topical agent|topical agent
77271|NCT02801435|psoriasis|psoriasis
77272|NCT02801435|phase 1|phase 1
77273|NCT02801422|cannabis|cannabis
77274|NCT02801422|fMRI|fmri
77275|NCT02801422|addiction|addiction
77276|NCT02801422|relapse|relapse
77277|NCT02801409|Lung Cancer|lung cancer
77278|NCT02801409|Surgical Resection|surgical resection
77279|NCT02801409|Epidural Anesthesia and Analgesia|epidural anesthesia and analgesia
77280|NCT02801409|Long-Term Outcome|long-term outcome
77384|NCT02800772|acetic acid|acetic acid
77281|NCT02801357|substance withdrawal syndrome|substance withdrawal syndrome
77282|NCT02801357|opiate addiction|opiate addiction
77283|NCT02801357|opiate dependence|opiate dependence
77284|NCT02801357|opioid withdrawal syndrome|opioid withdrawal syndrome
77285|NCT02801357|buprenorphine|buprenorphine
77286|NCT02801344|exercise|exercise
77287|NCT02801344|performance|performance
77288|NCT02801344|recovery|recovery
77289|NCT02801344|muscle|muscle
77290|NCT02801344|protein|protein
77291|NCT02801331|Stochastic Resonance|stochastic resonance
77292|NCT02801331|Fetus/Newborn Infant|fetus/newborn infant
77293|NCT02801331|Drug Withdrawal|drug withdrawal
77294|NCT02801331|Substance Abuse|substance abuse
77296|NCT02801305|Scleroderma|scleroderma
77297|NCT02801305|Diltiazem|diltiazem
77298|NCT02801305|Nitroglycerin|nitroglycerin
77299|NCT02801305|Topical|topical
77300|NCT02801279|Cerebral Palsy|cerebral palsy
77301|NCT02801279|Occupational Therapy|occupational therapy
77302|NCT02801279|Upper Limb Motor Training|upper limb motor training
77303|NCT02801266|Contraception|contraception
77304|NCT02801266|Reproductive and Sexual Health|reproductive and sexual health
77305|NCT02801266|Counseling|counseling
77306|NCT02801266|Contraceptive Counseling|contraceptive counseling
77307|NCT02801240|Inflammatory Bowel Disease|inflammatory bowel disease
77308|NCT02801227|premature rupture of membrane|premature rupture of membrane
77309|NCT02801227|primipara|primipara
77310|NCT02801227|term|term
77311|NCT02801227|bishop|bishop
77312|NCT02801214|cannabis|cannabis
77313|NCT02801214|fMRI|fmri
77314|NCT02801214|emotion|emotion
77315|NCT02801201|sedation|sedation
77316|NCT02801201|spinal anesthesia|spinal anesthesia
77317|NCT02801162|arterial blood gas|arterial blood gas
77318|NCT02801123|Complimentary Cancer Therapies|complimentary cancer therapies
77319|NCT02801123|Psychosocial Oncology|psychosocial oncology
77320|NCT02801123|Behavioural Medicine|behavioural medicine
77321|NCT02801123|Mindfulness Based Cancer Recovery|mindfulness based cancer recovery
77322|NCT02801123|Tai Chi|tai chi
77323|NCT02801123|Qigong|qigong
77324|NCT02801123|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
77325|NCT02801123|Yoga|yoga
77326|NCT02801123|Preference-based trial|preference-based trial
77327|NCT02801084|Reduced|reduced
77328|NCT02801084|Environmental|environmental
77329|NCT02801084|Stimulation|stimulation
77330|NCT02801071|Post-Polio Syndrome|post-polio syndrome
77331|NCT02801071|PPS|pps
77332|NCT02801058|Osteopathic manipulative treatment|osteopathic manipulative treatment
77333|NCT02801058|Abdominal Diaphragm mobility|abdominal diaphragm mobility
77334|NCT02801058|Thoracic Ultrasounds|thoracic ultrasounds
77335|NCT02800980|lymphocele|lymphocele
77336|NCT02800980|sclerotherapy|sclerotherapy
77337|NCT02800980|drainage|drainage
77338|NCT02800980|percutaneous|percutaneous
77339|NCT02800967|platelet activation|platelet activation
77340|NCT02800967|platelet aggregation|platelet aggregation
77341|NCT02800967|Aronia|aronia
77342|NCT02800967|flow cytometry|flow cytometry
77343|NCT02800967|polyphenols|polyphenols
77344|NCT02800967|cardiovascular disease risk|cardiovascular disease risk
77345|NCT02800954|Multiple Myeloma|multiple myeloma
77346|NCT02800954|bone lesions|bone lesions
77347|NCT02800954|Macrophage-Colony Stimulating Factor|macrophage-colony stimulating factor
77348|NCT02800941|Pulmonary Arterial hypertension|pulmonary arterial hypertension
77349|NCT02800941|Oral anticoagulants|oral anticoagulants
77350|NCT02800941|Major bleedings|major bleedings
77351|NCT02800915|Spinal Cord Injury|spinal cord injury
77352|NCT02800915|Pressure Ulcer|pressure ulcer
77353|NCT02800915|Health Related Quality of Life|health related quality of life
77354|NCT02800915|Telemedicine|telemedicine
77355|NCT02800915|Service Innovation|service innovation
77356|NCT02800915|Rehabilitation|rehabilitation
77357|NCT02800915|Interdisciplinary collaboration|interdisciplinary collaboration
77358|NCT02800915|User- participation|user- participation
77359|NCT02800915|Activity and participation|activity and participation
77360|NCT02800915|Health economics|health economics
77361|NCT02800889|relapsed|relapsed
77362|NCT02800889|refractory|refractory
77363|NCT02800889|solid tumors|solid tumors
77364|NCT02800850|Dementia|dementia
77365|NCT02800850|Depression|depression
77366|NCT02800850|Agitation|agitation
77367|NCT02800850|Bright Light|bright light
77368|NCT02800837|left main|left main
68691|NCT02854371|MRI|mri
77369|NCT02800837|stent|stent
77370|NCT02800837|self-expandable|self-expandable
77371|NCT02800837|DES|des
77372|NCT02800837|Stentys|stentys
77373|NCT02800811|FR104|fr104
77374|NCT02800811|CD28|cd28
77375|NCT02800811|immunomodulation|immunomodulation
77376|NCT02800811|T regulatory cell|t regulatory cell
77377|NCT02800811|Pegylated monovalent anti-CD28 Fab antibody|pegylated monovalent anti-cd28 fab antibody
77378|NCT02800798|Obstructive sleep apnea|obstructive sleep apnea
77379|NCT02800798|Preeclampsia|preeclampsia
77380|NCT02800798|Pregnancy|pregnancy
77381|NCT02800798|Stopbang|stopbang
77382|NCT02800772|pancreatic duct|pancreatic duct
77385|NCT02800746|Prognathic surgery|prognathic surgery
77386|NCT02800746|intravenous iron|intravenous iron
77387|NCT02800720|Fibromyalgia Syndromey|fibromyalgia syndromey
77388|NCT02800681|Asperger Syndrome|asperger syndrome
77389|NCT02800681|Autism Spectrum Disorder|autism spectrum disorder
77390|NCT02800681|Schizotypal disorder|schizotypal disorder
77391|NCT02800681|Schizophrenia Spectrum Disorder|schizophrenia spectrum disorder
77392|NCT02800681|Psychopathology|psychopathology
77393|NCT02800681|Examination of Anomalous Self Disorder|examination of anomalous self disorder
77394|NCT02800681|Autism Diagnostic Observation Schedule|autism diagnostic observation schedule
77395|NCT02800681|Phenomenology|phenomenology
77396|NCT02800681|Differential diagnosis|differential diagnosis
77397|NCT02800681|Young Adult|young adult
77398|NCT02800668|Duodenal Jejunal Bypass Liner|duodenal jejunal bypass liner
77400|NCT02800668|weight loss therapy|weight loss therapy
77401|NCT02800655|ARV treatment Naive|arv treatment naive
77402|NCT02800655|Medication Adherence|medication adherence
77403|NCT02800655|Digital Health Feedback System|digital health feedback system
77404|NCT02800655|Proteus Digital Health|proteus digital health
77406|NCT02800642|Aflibercept|aflibercept
77407|NCT02800642|Eylea|eylea
77408|NCT02800642|Intravitreal,|intravitreal,
77409|NCT02800616|Academic Achievement|academic achievement
77410|NCT02800616|Accelerometry|accelerometry
77411|NCT02800616|Children|children
77412|NCT02800616|Primary school Intervention|primary school intervention
77413|NCT02800616|Nutrition|nutrition
77414|NCT02800616|Obesity|obesity
77415|NCT02800616|Physical Activity|physical activity
77416|NCT02800616|Prevention|prevention
77417|NCT02800616|School Health|school health
77418|NCT02800603|preschool mental health|preschool mental health
77419|NCT02800603|emotional and behaviour problems|emotional and behaviour problems
77420|NCT02800590|Adult participants|adult participants
77421|NCT02800590|Sedation|sedation
77422|NCT02800590|elective|elective
77423|NCT02800525|Benign pigmented lesions|benign pigmented lesions
77424|NCT02800525|Picosecond laser|picosecond laser
77425|NCT02800525|Q-switched laser|q-switched laser
77426|NCT02800512|pelvic organ prolapse|pelvic organ prolapse
77427|NCT02800512|cystocele|cystocele
77428|NCT02800512|rectocele|rectocele
77429|NCT02800512|enterocele|enterocele
77430|NCT02800473|Bladder cancer|bladder cancer
77431|NCT02800473|Hexvix|hexvix
77432|NCT02800473|Bimodal Endoscopic Imager|bimodal endoscopic imager
77433|NCT02800473|Cystoscopy|cystoscopy
77434|NCT02800460|Subthalamic nucleus|subthalamic nucleus
77435|NCT02800460|Basal ganglia|basal ganglia
77436|NCT02800460|Parkinson disease|parkinson disease
77437|NCT02800460|Magnetic Resonance Imaging|magnetic resonance imaging
77438|NCT02800460|Susceptibility-Weighted Imaging|susceptibility-weighted imaging
77439|NCT02800434|allograft|allograft
77440|NCT02800434|hands|hands
77441|NCT02800434|immunosuppression|immunosuppression
77442|NCT02800434|fMRI|fmri
77443|NCT02800395|Alzheimer|alzheimer
77444|NCT02800395|oxydative stress|oxydative stress
77445|NCT02800395|nutrition|nutrition
77446|NCT02800395|biomarkers|biomarkers
77447|NCT02800382|paraoxonase|paraoxonase
77448|NCT02800382|lung diseases|lung diseases
77449|NCT02800369|Human papillomavirus|human papillomavirus
77450|NCT02800369|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
77451|NCT02800369|zinc finger nuclease|zinc finger nuclease
77452|NCT02800356|Age-Related Macular Degeneration|age-related macular degeneration
77453|NCT02800356|Geographic Atrophy|geographic atrophy
77454|NCT02800356|Reticular pseudodrusen|reticular pseudodrusen
77456|NCT02800356|PASCAL 577|pascal 577
77457|NCT02800304|malnutrition|malnutrition
77458|NCT02800304|food intake|food intake
77459|NCT02800304|frailty|frailty
77460|NCT02800291|food intake|food intake
77461|NCT02800265|healthy volunteer|healthy volunteer
77462|NCT02800265|healthy|healthy
77463|NCT02800265|cancer prevention|cancer prevention
77464|NCT02800265|prevention|prevention
77465|NCT02800252|fatty acids|fatty acids
77466|NCT02800252|aspirin|aspirin
77467|NCT02800252|diabetes mellitus|diabetes mellitus
77468|NCT02800252|chronic periodontitis|chronic periodontitis
77469|NCT02800252|periodontal debridement|periodontal debridement
90679|NCT02721381|RCT|rct
68759|NCT02853994|DCB|dcb
77470|NCT02800200|platelet rich plasma|platelet rich plasma
77471|NCT02800200|extracorporeal shock wave|extracorporeal shock wave
77472|NCT02800122|acute dyspnea|acute dyspnea
77473|NCT02800122|emergency|emergency
77474|NCT02800122|acute heart failure|acute heart failure
77475|NCT02800109|Fetal growth|fetal growth
77476|NCT02800109|Newborn growth|newborn growth
77477|NCT02800070|autologous stem cell transplant|autologous stem cell transplant
77478|NCT02800070|gene therapy|gene therapy
77479|NCT02800070|Fabry disease|fabry disease
77480|NCT02800070|lentivirus|lentivirus
77481|NCT02800070|haematopoietic stem cell transplant|haematopoietic stem cell transplant
77482|NCT02800018|hypothermia therapy|hypothermia therapy
77483|NCT02800018|perinatal asphyxia|perinatal asphyxia
77484|NCT02800005|gastric cancer|gastric cancer
77485|NCT02800005|gastrectomy|gastrectomy
77486|NCT02800005|laparotomy|laparotomy
77487|NCT02800005|surgical outcome|surgical outcome
77488|NCT02800005|survival|survival
77489|NCT02800005|abdominal fat area|abdominal fat area
77490|NCT02800005|Body Mass Index|body mass index
77491|NCT02799953|diabetes mellitus and hypertension|diabetes mellitus and hypertension
77492|NCT02799953|consumer health information technology|consumer health information technology
77493|NCT02799953|self-monitoring|self-monitoring
77494|NCT02799953|randomized controlled trial|randomized controlled trial
77495|NCT02799927|Indirect Pulp Treatment|indirect pulp treatment
77496|NCT02799927|Primary Teeth|primary teeth
77497|NCT02799927|Biodentine|biodentine
77498|NCT02799927|Calcium Hydroxide|calcium hydroxide
77499|NCT02799927|Split-Mouth design|split-mouth design
77500|NCT02799901|advanced melanoma|advanced melanoma
77501|NCT02799901|high dose radiotherapy|high dose radiotherapy
77502|NCT02799901|Nivolumab|nivolumab
77503|NCT02799888|Graft-versus-host Disease|graft-versus-host disease
77504|NCT02799888|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
77505|NCT02799888|Acute Leukemia|acute leukemia
77506|NCT02799888|Myelodysplastic syndrome|myelodysplastic syndrome
77507|NCT02799888|Lymphoma|lymphoma
77508|NCT02799875|respiratory distress syndrome|respiratory distress syndrome
77509|NCT02799875|permissive hypercapnia|permissive hypercapnia
77510|NCT02799875|ventilator strategy|ventilator strategy
77511|NCT02799862|metastatic|metastatic
77512|NCT02799862|locally advanced|locally advanced
77513|NCT02799862|unresectable|unresectable
77515|NCT02799849|narcolepsy|narcolepsy
77516|NCT02799849|metabolism|metabolism
77517|NCT02799823|aortic stenosis|aortic stenosis
77518|NCT02799823|transcatheter aortic valve replacement|transcatheter aortic valve replacement
77519|NCT02799810|lung transplantation|lung transplantation
77520|NCT02799810|psychosocial functioning|psychosocial functioning
77521|NCT02799810|longitudinal|longitudinal
77522|NCT02799810|TERS|ters
77523|NCT02799810|adherence|adherence
77524|NCT02799810|Quality of life|quality of life
77525|NCT02799797|adductor canal block|adductor canal block
77526|NCT02799784|tiotropium|tiotropium
77527|NCT02799784|COPD|copd
77528|NCT02799784|olodaterol|olodaterol
77529|NCT02799784|Umeclidinium bromide|umeclidinium bromide
77530|NCT02799784|efficacy|efficacy
77531|NCT02799784|vilanterol|vilanterol
77532|NCT02799771|Pulmonary arterial hypertension|pulmonary arterial hypertension
77533|NCT02799771|Interstitial lung disease at HRCT|interstitial lung disease at hrct
77534|NCT02799745|Therapeutic Cancer Progression|therapeutic cancer progression
77535|NCT02799745|Pathological Cancer Progression|pathological cancer progression
77536|NCT02799745|Enzalutamide|enzalutamide
77537|NCT02799745|Prostate Cancer|prostate cancer
77538|NCT02799745|Active surveillance|active surveillance
77539|NCT02799732|Feasibility Study|feasibility study
77540|NCT02799732|HPV vaccine|hpv vaccine
77541|NCT02799732|1Dose Trial|1dose trial
77542|NCT02799719|Fat mass|fat mass
77543|NCT02799719|hemodialysis patients|hemodialysis patients
77544|NCT02799719|inflammation|inflammation
77545|NCT02799719|adipocytokines|adipocytokines
77546|NCT02799719|bioimpedance spectroscopy|bioimpedance spectroscopy
77547|NCT02799706|Prostate cancer|prostate cancer
77548|NCT02799706|GnRH antagonist|gnrh antagonist
77549|NCT02799706|GnRH agonist|gnrh agonist
77550|NCT02799706|radiation therapy|radiation therapy
77551|NCT02799706|very high risk localized prostate cancer|very high risk localized prostate cancer
77552|NCT02799706|locally advanced prostate cancer|locally advanced prostate cancer
77553|NCT02799693|Catheter Ablation|catheter ablation
77554|NCT02799693|Ventricular Tachycardia|ventricular tachycardia
77555|NCT02799693|Intramural Needle Catheter|intramural needle catheter
77556|NCT02799680|CART|cart
77558|NCT02799667|negative pressure wound therapy|negative pressure wound therapy
77559|NCT02799667|cesarean delivery|cesarean delivery
77560|NCT02799654|Total Hip Arthroplasty|total hip arthroplasty
77561|NCT02799641|Contraception|contraception
77562|NCT02799641|IUD|iud
77563|NCT02799641|levonorgestrel releasing intrauterine device|levonorgestrel releasing intrauterine device
90840|NCT02720237|HIV|hiv
68862|NCT02853396|CBT|cbt
77564|NCT02799641|lidocaine|lidocaine
77565|NCT02799641|valium|valium
77566|NCT02799641|diazepam|diazepam
77567|NCT02799641|pain|pain
77568|NCT02799641|VAS|vas
77569|NCT02799641|visual analog scale|visual analog scale
77570|NCT02799628|Trust|trust
77571|NCT02799628|Low Back Pain|low back pain
77572|NCT02799628|Treatment Outcome|treatment outcome
77573|NCT02799602|Metastatic hormone sensitive prostate cancer|metastatic hormone sensitive prostate cancer
77574|NCT02799576|Ultrasound|ultrasound
77575|NCT02799576|Regional blockade|regional blockade
77576|NCT02799576|Infraclavicular brachial plexus|infraclavicular brachial plexus
77577|NCT02799550|CART|cart
77578|NCT02799550|ALL|all
77579|NCT02799550|elderly|elderly
77580|NCT02799550|Relapsed|relapsed
77581|NCT02799550|Refractory|refractory
77582|NCT02799550|CD19+|cd19+
77583|NCT02799511|biological markers|biological markers
77584|NCT02799498|etanercept|etanercept
77585|NCT02799498|healthy subject|healthy subject
77586|NCT02799498|open-label|open-label
77587|NCT02799498|randomized|randomized
77588|NCT02799498|PK|pk
77589|NCT02799498|auto-injection|auto-injection
77590|NCT02799498|pharmacokinetic|pharmacokinetic
77591|NCT02799472|GSK3196165|gsk3196165
77592|NCT02799472|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
77593|NCT02799472|disease-modifying antirheumatic drugs (DMARDs)|disease-modifying antirheumatic drugs (dmards)
77594|NCT02799472|granulocyte-macrophage colony stimulating factor (GM-CSF)|granulocyte-macrophage colony stimulating factor (gm-csf)
77595|NCT02799472|Rheumatoid Arthritis|rheumatoid arthritis
77596|NCT02799472|Methotrexate|methotrexate
77597|NCT02799459|Hypnoanesthesia|hypnoanesthesia
77598|NCT02799459|Hypnosis|hypnosis
77599|NCT02799459|conization|conization
77600|NCT02799446|sinusitis, rhinitis, rhinosinusitis, chronic|sinusitis, rhinitis, rhinosinusitis, chronic
77601|NCT02799433|Water|water
77602|NCT02799433|Physical activity|physical activity
77603|NCT02799433|Child care|child care
77604|NCT02799433|Weight change|weight change
77615|NCT02799303|screening|screening
77616|NCT02799303|biopsy|biopsy
77617|NCT02799303|magnetic resonance imaging|magnetic resonance imaging
77618|NCT02799303|prostate specific antigen|prostate specific antigen
77619|NCT02799264|fasted|fasted
77620|NCT02799264|healthy volunteers|healthy volunteers
77621|NCT02799264|cabotegravir|cabotegravir
77622|NCT02799264|high fat|high fat
77623|NCT02799264|pharmacokinetics|pharmacokinetics
77624|NCT02799264|randomized|randomized
77625|NCT02799264|Phase I|phase i
200981|NCT02112708|Social Work|social work
77626|NCT02799264|two way crossover|two way crossover
77627|NCT02799251|lymphopenia|lymphopenia
77628|NCT02799251|postoperative infection|postoperative infection
77629|NCT02799251|thoracic cancer surgery|thoracic cancer surgery
77630|NCT02799251|digestive cancer surgery|digestive cancer surgery
77632|NCT02799225|carbapenems|carbapenems
77633|NCT02799212|Hepatocellular carcinoma|hepatocellular carcinoma
77634|NCT02799212|Hepatectomy|hepatectomy
77635|NCT02799212|Ascites|ascites
77636|NCT02799212|Somatostatin|somatostatin
77637|NCT02799186|Spontaneous Coronary Artery Dissection|spontaneous coronary artery dissection
77638|NCT02799186|haematoma|haematoma
77639|NCT02799186|Fibromuscular Dysplasia|fibromuscular dysplasia
77640|NCT02799186|genetic analysis|genetic analysis
77641|NCT02799186|Acute Coronary Syndrome|acute coronary syndrome
77642|NCT02799173|cardiovascular calcification|cardiovascular calcification
77643|NCT02799173|RANK: Receptor Activator of Nuclear Factor kappa B|rank: receptor activator of nuclear factor kappa b
77644|NCT02799173|RANKL: Receptor Activator of Nuclear Factor kappa B Ligand|rankl: receptor activator of nuclear factor kappa b ligand
77645|NCT02799173|OPG: Osteoprotegerin|opg: osteoprotegerin
77646|NCT02799173|SLE: Systemic lupus erythematosus|sle: systemic lupus erythematosus
77647|NCT02799147|Allogeneic Transplantation|allogeneic transplantation
77648|NCT02799147|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
77649|NCT02799147|Leukemia, Acute Lymphoblastic|leukemia, acute lymphoblastic
77650|NCT02799147|Acute Myeloid Leukemia|acute myeloid leukemia
77651|NCT02799147|Mixed-Lineage Acute Leukemias|mixed-lineage acute leukemias
77652|NCT02799147|Immune System Diseases|immune system diseases
77653|NCT02799147|Immunosuppressive Agents|immunosuppressive agents
77654|NCT02799147|Myeloablative Agonists|myeloablative agonists
77655|NCT02799147|Busulfan|busulfan
77656|NCT02799147|Fludarabine|fludarabine
77657|NCT02799147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
77658|NCT02799147|Bendamustine Hydrochloride|bendamustine hydrochloride
77659|NCT02799134|Cortisol Awakening Response suppression|cortisol awakening response suppression
77660|NCT02799134|Dexamethasone Suppression Test|dexamethasone suppression test
77661|NCT02799134|high-order cognition|high-order cognition
77662|NCT02799134|social cognition|social cognition
77663|NCT02799108|children|children
77664|NCT02799108|language|language
77665|NCT02799108|NIRS|nirs
77666|NCT02799095|Immunotherapy|immunotherapy
77667|NCT02799095|IL-2|il-2
77668|NCT02799095|Interleukin-2|interleukin-2
77669|NCT02799095|Solid tumors|solid tumors
77670|NCT02799056|Airway Extubation|airway extubation
77671|NCT02799056|Ultrasonography|ultrasonography
77672|NCT02799056|Ventilator Weaning|ventilator weaning
77673|NCT02799043|FIRMap, Rotor, FIRM-guided procedure|firmap, rotor, firm-guided procedure
77674|NCT02799017|Aphasia|aphasia
77675|NCT02799017|Reading|reading
77676|NCT02799017|Writing|writing
77677|NCT02799017|Naming|naming
77678|NCT02799017|Language|language
77679|NCT02799017|Chronic post stroke|chronic post stroke
77680|NCT02799017|Phonology|phonology
77681|NCT02799017|Semantic Feature Analysis|semantic feature analysis
77682|NCT02799017|Recovery|recovery
77683|NCT02798991|REarranged during Transfection Growth Factor Receptor Tyrosine Kinase Inhibitor|rearranged during transfection growth factor receptor tyrosine kinase inhibitor
77684|NCT02798978|pharmacokinetics|pharmacokinetics
77685|NCT02798978|TLR4 agonist|tlr4 agonist
77686|NCT02798978|cancer|cancer
77687|NCT02798978|tolerability|tolerability
77688|NCT02798978|GSK1795091|gsk1795091
77689|NCT02798978|pharmacodynamics|pharmacodynamics
77690|NCT02798978|safety|safety
77691|NCT02798965|parvovirus genome|parvovirus genome
77692|NCT02798952|Hepatitis B antibodies|hepatitis b antibodies
77694|NCT02798952|Challenge dose|challenge dose
77695|NCT02798952|Persistence|persistence
77696|NCT02798952|Engerix B Kinder|engerix b kinder
77697|NCT02798952|Infanrix hexa|infanrix hexa
77698|NCT02798952|Immunogenicity|immunogenicity
77699|NCT02798952|Adolescents|adolescents
77700|NCT02798939|spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
77701|NCT02798939|lactoferrin|lactoferrin
77702|NCT02798939|procalcitonin|procalcitonin
77703|NCT02798939|Aution® urine dipsticks|aution® urine dipsticks
77704|NCT02798926|hypothermia|hypothermia
77705|NCT02798926|central venous catheter placement|central venous catheter placement
77706|NCT02798926|Polyethylene bag|polyethylene bag
77707|NCT02798913|dual antiplatelet therapy|dual antiplatelet therapy
77708|NCT02798913|peripheral transluminal angioplasty|peripheral transluminal angioplasty
77709|NCT02798900|Task-specific exercise|task-specific exercise
77710|NCT02798900|Ultrasonic Waves|ultrasonic waves
77711|NCT02798900|Biomechanics|biomechanics
77712|NCT02798900|Gait|gait
77713|NCT02798900|Rehabilitation|rehabilitation
77714|NCT02798900|Exercise therapy|exercise therapy
77715|NCT02798887|Regeneration|regeneration
77716|NCT02798887|Bone regeneration|bone regeneration
77717|NCT02798887|Grafting, Bone|grafting, bone
77718|NCT02798887|Allograft|allograft
77719|NCT02798887|Xenograft|xenograft
77720|NCT02798874|Ticagrelor|ticagrelor
77721|NCT02798874|No-reflow|no-reflow
77722|NCT02798874|Acute ST-segment elevation myocardial|acute st-segment elevation myocardial
77723|NCT02798874|Reperfusion injury|reperfusion injury
77724|NCT02798874|Percutaneous coronary intervention|percutaneous coronary intervention
77725|NCT02798796|breast cancer|breast cancer
77726|NCT02798796|conservative surgery|conservative surgery
77728|NCT02798783|Vestibular Aqueduct|vestibular aqueduct
77729|NCT02798783|SLC26A4|slc26a4
77730|NCT02798783|FOXI1|foxi1
77731|NCT02798783|Temporal Bone|temporal bone
77732|NCT02798731|Heart transplant|heart transplant
77733|NCT02798731|Microvascular dysfunction|microvascular dysfunction
77734|NCT02798731|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
77735|NCT02798731|Fractional flow reserve|fractional flow reserve
77736|NCT02798731|Coronary flow reserve|coronary flow reserve
77737|NCT02798731|Index of microvascular resistance|index of microvascular resistance
77738|NCT02798705|Cardiac amyloidosis|cardiac amyloidosis
77739|NCT02798705|Fractional flow reserve|fractional flow reserve
77740|NCT02798705|Microvascular dysfunction|microvascular dysfunction
77741|NCT02798705|Coronary flow reserve|coronary flow reserve
77742|NCT02798705|Index of microcirculatory resistance|index of microcirculatory resistance
77743|NCT02798692|Prevention|prevention
77744|NCT02798666|Physical fitness|physical fitness
77745|NCT02798666|Respiratory exchange ratio|respiratory exchange ratio
77746|NCT02798666|Insulin sensitivity|insulin sensitivity
77747|NCT02798666|High intensity interval training|high intensity interval training
77748|NCT02798666|Continuous exercise training|continuous exercise training
77749|NCT02798601|Cerebral edema|cerebral edema
77750|NCT02798601|Hypernatremia|hypernatremia
77751|NCT02798601|Extended Glasgow Outcome Scale|extended glasgow outcome scale
77752|NCT02798601|Intracranial pressure|intracranial pressure
77753|NCT02798601|Mannitol|mannitol
77754|NCT02798601|Hypertonic saline|hypertonic saline
77755|NCT02798601|Mortality|mortality
77756|NCT02798588|coma|coma
77757|NCT02798588|prognosis|prognosis
77758|NCT02798588|comparative study|comparative study
77759|NCT02798588|functional imaging|functional imaging
77760|NCT02798588|PET-MRI|pet-mri
77761|NCT02798588|electrophysiology|electrophysiology
77762|NCT02798575|COPD|copd
77763|NCT02798575|invasive ventilation|invasive ventilation
77764|NCT02798575|exacerbation|exacerbation
77765|NCT02798575|home care|home care
77766|NCT02798575|mechanical ventilation|mechanical ventilation
77767|NCT02798575|unsuccessful weaning|unsuccessful weaning
77768|NCT02798575|ventilatory parameters|ventilatory parameters
77769|NCT02798562|low dose CT|low dose ct
77770|NCT02798562|contrast-enhanced|contrast-enhanced
77771|NCT02798562|breast cancer screening|breast cancer screening
77772|NCT02798562|computer tomography|computer tomography
77773|NCT02798549|HBV|hbv
77774|NCT02798549|liver|liver
77775|NCT02798536|Immunotoxin|immunotoxin
77776|NCT02798536|Mesothelin|mesothelin
77777|NCT02798536|Targeted Therapy|targeted therapy
77778|NCT02798523|Methylprednisolone|methylprednisolone
77779|NCT02798523|Immunologic|immunologic
77780|NCT02798523|Infusion|infusion
77781|NCT02798523|Topical|topical
77782|NCT02798523|Intravenous|intravenous
77783|NCT02798510|Gallbladder Carcinoma|gallbladder carcinoma
77784|NCT02798510|Extrahepatic Cholangiocarcinoma|extrahepatic cholangiocarcinoma
77785|NCT02798510|Chemoradiotherapy|chemoradiotherapy
77786|NCT02798497|PVL|pvl
77787|NCT02798497|Pneumonias|pneumonias
77788|NCT02798497|Staphylococcus aureus|staphylococcus aureus
77789|NCT02798484|Diffusion Weighted Magnetic Resonance Imaging|diffusion weighted magnetic resonance imaging
77790|NCT02798484|Breast cancer|breast cancer
77791|NCT02798484|Neo-adjuvant therapy|neo-adjuvant therapy
77792|NCT02798471|Pediatric|pediatric
77793|NCT02798471|Venous thrombolism|venous thrombolism
77804|NCT02798432|Cemented|cemented
77805|NCT02798432|Fixation|fixation
77806|NCT02798406|brain|brain
77807|NCT02798406|Central Nervous System (CNS) diseases|central nervous system (cns) diseases
77808|NCT02798406|Central Nervous System (CNS) neoplasms|central nervous system (cns) neoplasms
77809|NCT02798406|CNS|cns
77810|NCT02798406|conditionally replicative adenovirus|conditionally replicative adenovirus
77811|NCT02798406|DNX-2401|dnx-2401
77812|NCT02798406|pembrolizumab|pembrolizumab
77813|NCT02798406|KEYTRUDA|keytruda
77814|NCT02798406|MK-3475|mk-3475
77815|NCT02798406|SCH 900475|sch 900475
77816|NCT02798406|lambrolizumab|lambrolizumab
77817|NCT02798406|neoplasm, germ cell and embryonal|neoplasm, germ cell and embryonal
77818|NCT02798406|neoplasm, granular and epithelial|neoplasm, granular and epithelial
77819|NCT02798406|Alcyone|alcyone
77820|NCT02798406|Alcyone Lifesciences|alcyone lifesciences
77821|NCT02798406|AMC|amc
77822|NCT02798406|cannula|cannula
77823|NCT02798406|MEMS cannula|mems cannula
77824|NCT02798406|DNX-2401 + pembrolizumab|dnx-2401 + pembrolizumab
77825|NCT02798406|Delta-24|delta-24
77826|NCT02798406|Delta-24-RGD|delta-24-rgd
77827|NCT02798406|Checkpoint inhibitor|checkpoint inhibitor
77828|NCT02798406|anti-PD1/PD-L1|anti-pd1/pd-l1
77829|NCT02798406|immunotherapy|immunotherapy
77830|NCT02798406|monoclonal antibody|monoclonal antibody
77831|NCT02798406|KEYNOTE-192|keynote-192
77832|NCT02798367|insomnia|insomnia
77833|NCT02798367|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
77834|NCT02798367|melatonin|melatonin
77842|NCT02798315|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
77843|NCT02798315|Sustained Virological Response|sustained virological response
77844|NCT02798315|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
77845|NCT02798315|Observational Study|observational study
77846|NCT02798315|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
77847|NCT02798315|Chronic Hepatitis C|chronic hepatitis c
77848|NCT02798250|Type 1 diabetes|type 1 diabetes
77849|NCT02798250|Artificial pancreas|artificial pancreas
77850|NCT02798250|Closed-loop system|closed-loop system
77851|NCT02798250|Postprandial glucose control|postprandial glucose control
77852|NCT02798250|Hypoglycemia|hypoglycemia
77854|NCT02798250|Glucagon|glucagon
77855|NCT02798237|exercise|exercise
77856|NCT02798237|walking|walking
77857|NCT02798237|health|health
77858|NCT02798224|Colorectal Cancer Screening|colorectal cancer screening
77859|NCT02798224|CRC Screening|crc screening
77860|NCT02798224|Rectum|rectum
77861|NCT02798224|Colon|colon
77862|NCT02798224|Screening|screening
77863|NCT02798224|Populations at Risk|populations at risk
77864|NCT02798224|CRC|crc
77865|NCT02798224|colorectal cancer (CRC)|colorectal cancer (crc)
77867|NCT02798159|Sexual Dysfunction|sexual dysfunction
77868|NCT02798159|Physiological Sexual Dysfunctions|physiological sexual dysfunctions
77869|NCT02798159|Psychological Sexual and Gender Disorders|psychological sexual and gender disorders
77870|NCT02798159|Sildenafil|sildenafil
77871|NCT02798146|in-vitro fertilization|in-vitro fertilization
77872|NCT02798146|luteal phase|luteal phase
77873|NCT02798081|augmentative and alternative communication|augmentative and alternative communication
77874|NCT02798081|social inclusion|social inclusion
77875|NCT02798081|serious games|serious games
77876|NCT02798081|Information and communication technologies|information and communication technologies
77877|NCT02798068|Steroids|steroids
77878|NCT02798068|Cardiac surgery|cardiac surgery
77879|NCT02798068|Endothelial dysfunction|endothelial dysfunction
69164|NCT02851251|newborn|newborn
77880|NCT02798068|Glycocalyx|glycocalyx
77881|NCT02798068|Flow mediated vasodilation|flow mediated vasodilation
77882|NCT02798029|Brain Metastases|brain metastases
77883|NCT02798029|Parenchymal Brain Metastases|parenchymal brain metastases
77884|NCT02798029|Oligometastatic brain metastases|oligometastatic brain metastases
77885|NCT02798029|Frameless Fractionated Stereotactic Radiation Therapy|frameless fractionated stereotactic radiation therapy
77886|NCT02798029|FFSRT|ffsrt
77887|NCT02798003|Cachexia|cachexia
77888|NCT02798003|Food reward|food reward
77889|NCT02797990|[G08.686.785.760.769.500]|[g08.686.785.760.769.500]
77890|NCT02797990|[G08.686.785.760.769]|[g08.686.785.760.769]
77891|NCT02797990|[N02.360]|[n02.360]
77909|NCT02797977|Next-Generation Sequencing|next-generation sequencing
77910|NCT02797977|Genetic biomarkers|genetic biomarkers
77925|NCT02797951|cluster headache|cluster headache
77926|NCT02797951|headache|headache
77927|NCT02797951|brain diseases|brain diseases
77928|NCT02797951|central nervous system diseases|central nervous system diseases
77929|NCT02797951|headache disorders|headache disorders
77930|NCT02797951|headache disorders, primary|headache disorders, primary
77931|NCT02797951|nervous system diseases|nervous system diseases
77932|NCT02797951|neurologic manifestations|neurologic manifestations
77933|NCT02797951|pain|pain
77934|NCT02797951|trigeminal autonomic cephalalgias|trigeminal autonomic cephalalgias
77935|NCT02797925|Achilles tendon|achilles tendon
77936|NCT02797925|Patella tendon|patella tendon
77937|NCT02797925|Inflammation|inflammation
77938|NCT02797925|Edema|edema
77939|NCT02797925|Clinical|clinical
77940|NCT02797925|Structural|structural
77941|NCT02797912|pulmonary function|pulmonary function
77942|NCT02797912|respiratory muscle function|respiratory muscle function
77943|NCT02797912|body composition|body composition
77944|NCT02797912|exercise tolerance|exercise tolerance
77945|NCT02797886|Hemiplegia|hemiplegia
77946|NCT02797886|Drop foot|drop foot
77947|NCT02797886|Foot drop|foot drop
77948|NCT02797860|Transabdominal cervicoisthmic cerclage|transabdominal cervicoisthmic cerclage
77949|NCT02797860|Rocuronium|rocuronium
77950|NCT02797860|Pregnant Women|pregnant women
77951|NCT02797847|TTR-mediated Amyloidosis|ttr-mediated amyloidosis
77952|NCT02797847|Amyloidosis, Hereditary|amyloidosis, hereditary
77953|NCT02797847|Amyloid Neuropathies, Familial|amyloid neuropathies, familial
77954|NCT02797847|Familial Amyloid Polyneuropathies|familial amyloid polyneuropathies
77955|NCT02797847|Amyloid Neuropathies|amyloid neuropathies
77956|NCT02797847|Amyloidosis, Hereditary, Transthyretin-Related|amyloidosis, hereditary, transthyretin-related
77957|NCT02797847|Familial Amyloidosis|familial amyloidosis
77958|NCT02797847|RNAi therapeutic|rnai therapeutic
77959|NCT02797834|Extracellular vesicles|extracellular vesicles
77960|NCT02797834|Endometrial fluid|endometrial fluid
77961|NCT02797834|Menstrual cycle|menstrual cycle
77968|NCT02797743|Healthy Volunteers|healthy volunteers
77969|NCT02797730|Art Therapy|art therapy
77970|NCT02797730|Caregiver's|caregiver's
77971|NCT02797691|Cognitive Behavior Therapy|cognitive behavior therapy
77972|NCT02797691|Depression|depression
77973|NCT02797691|Anxiety|anxiety
77974|NCT02797691|Pashto|pashto
77975|NCT02797691|Pakistani|pakistani
77976|NCT02797691|Afghan|afghan
77977|NCT02797652|Breast cancer|breast cancer
77978|NCT02797652|ctDNA|ctdna
77979|NCT02797652|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
77980|NCT02797652|Adjuvant chemotherapy|adjuvant chemotherapy
77981|NCT02797639|Intellectual Disability|intellectual disability
77982|NCT02797639|Collaborative Consultation|collaborative consultation
77983|NCT02797639|Participation|participation
77984|NCT02797600|Appalachia|appalachia
77985|NCT02797587|Alcohol Use|alcohol use
77986|NCT02797587|Tobacco Use|tobacco use
77987|NCT02797587|Smoking|smoking
77988|NCT02797587|Inflammation|inflammation
77989|NCT02797587|Coronary Heart Disease|coronary heart disease
77991|NCT02797587|Varenicline|varenicline
77992|NCT02797587|Cytisine|cytisine
77993|NCT02797587|Nicotine Replacement Therapy|nicotine replacement therapy
77994|NCT02797587|Partial Agonist Therapy|partial agonist therapy
77995|NCT02797587|HIV|hiv
77996|NCT02797587|Reynolds risk score|reynolds risk score
77997|NCT02797587|VACS index|vacs index
77998|NCT02797561|Fractional flow reserve|fractional flow reserve
77999|NCT02797561|Tandem|tandem
78000|NCT02797561|Percutaneous Coronary Intervention|percutaneous coronary intervention
78001|NCT02797548|drug-eluting stent|drug-eluting stent
78002|NCT02797548|antiplatelet therapy|antiplatelet therapy
78003|NCT02797548|noncardiac surgery|noncardiac surgery
78004|NCT02797509|Intensive Care Unit|intensive care unit
78005|NCT02797496|Parkinson's disease|parkinson's disease
78006|NCT02797496|Mild to moderate stage|mild to moderate stage
78007|NCT02797496|Asymmetric Motor Strengthening|asymmetric motor strengthening
78008|NCT02797496|Rehabilitation|rehabilitation
78009|NCT02797457|Bilateral amputation of the forearms|bilateral amputation of the forearms
78010|NCT02797457|Bilateral allograft|bilateral allograft
78011|NCT02797457|Prosthetic forehands|prosthetic forehands
78012|NCT02797457|Medical economic evaluation|medical economic evaluation
78013|NCT02797418|Attentional disorders, intellectual deficiency|attentional disorders, intellectual deficiency
78014|NCT02797405|radiation therapy|radiation therapy
78015|NCT02797405|radiosensitivity|radiosensitivity
78016|NCT02797405|in vitro diagnostic medical devices|in vitro diagnostic medical devices
78017|NCT02797405|Adverse Event post radiotherapy|adverse event post radiotherapy
78018|NCT02797392|Tailored lifestyle intervention|tailored lifestyle intervention
78019|NCT02797392|Selective prevention|selective prevention
78020|NCT02797392|Primary care|primary care
78021|NCT02797392|Web based health risk assessment|web based health risk assessment
78022|NCT02797392|Patient-centered health information system|patient-centered health information system
78023|NCT02797392|Lifestyle intervention|lifestyle intervention
78024|NCT02797392|preventive treatment|preventive treatment
78025|NCT02797379|Psychoeducation|psychoeducation
78026|NCT02797379|Self-help|self-help
78027|NCT02797327|Molecular signature|molecular signature
78028|NCT02797327|Thailand-Myanmar border|thailand-myanmar border
78029|NCT02797314|Type 2 diabetes|type 2 diabetes
78030|NCT02797314|Bone quality|bone quality
78031|NCT02797314|Bone biopsies|bone biopsies
78032|NCT02797314|Vertebral fractures|vertebral fractures
78033|NCT02797314|Osteodensitometry|osteodensitometry
78034|NCT02797314|Trabecular Bone Score|trabecular bone score
78035|NCT02797301|early reading skills|early reading skills
78036|NCT02797249|preeclampsia|preeclampsia
78037|NCT02797249|low dose aspirin|low dose aspirin
78038|NCT02797249|prevention|prevention
78039|NCT02797236|Phase I|phase i
78040|NCT02797236|conjugate vaccine|conjugate vaccine
78041|NCT02797236|Shigella flexneri 2a|shigella flexneri 2a
78042|NCT02797236|safety|safety
78043|NCT02797236|Immunogenicity|immunogenicity
78044|NCT02797236|Healthy adults|healthy adults
78045|NCT02797223|alopecia|alopecia
78046|NCT02797223|chemotherapy|chemotherapy
78047|NCT02797223|breast cancer|breast cancer
78048|NCT02797158|TAVI|tavi
78049|NCT02797158|Aortic stenosis|aortic stenosis
78050|NCT02797158|Coronary artery disease|coronary artery disease
78051|NCT02797158|Coronary angiography|coronary angiography
78052|NCT02797158|Percutaneous Coronary Intervention|percutaneous coronary intervention
78053|NCT02797158|Myocardial ischemia|myocardial ischemia
78054|NCT02797158|SPECT|spect
78055|NCT02797158|Coronary revascularization|coronary revascularization
78056|NCT02797145|Digoxin|digoxin
78057|NCT02797132|CF|cf
78059|NCT02797119|Fibrinolysis|fibrinolysis
78060|NCT02797119|Cesarean section|cesarean section
78061|NCT02797119|Pharmacokinetics|pharmacokinetics
78062|NCT02797119|D dimers|d dimers
78063|NCT02797119|Fibrinogen|fibrinogen
78065|NCT02797119|Transfusion|transfusion
78066|NCT02797106|Drooling|drooling
78067|NCT02797106|Cerebral palsy|cerebral palsy
78068|NCT02797106|Botulinium toxin|botulinium toxin
78069|NCT02797106|Practice survey of health professionals|practice survey of health professionals
78070|NCT02797106|Children|children
78071|NCT02797093|anti-retroviral therapy|anti-retroviral therapy
78072|NCT02797080|ACTIMMUNE|actimmune
78073|NCT02797080|interferon y-1b|interferon y-1b
78074|NCT02797067|Extracorporeal Shock Wave lithotripsy(ESWL)|extracorporeal shock wave lithotripsy(eswl)
78075|NCT02797067|Prophylaxis|prophylaxis
78076|NCT02797067|Indomethacin|indomethacin
78077|NCT02797067|Chronic pancreatitis|chronic pancreatitis
78078|NCT02797054|HPV vaccination|hpv vaccination
78079|NCT02797054|Vaccination decision-making|vaccination decision-making
78080|NCT02797054|Tailored health messaging|tailored health messaging
78081|NCT02797054|Barriers to vaccination|barriers to vaccination
78082|NCT02797054|Attitudes|attitudes
78083|NCT02797041|Multiple myeloma|multiple myeloma
78084|NCT02797041|Bortezomib|bortezomib
78085|NCT02797041|Relapsed multiple myeloma|relapsed multiple myeloma
78086|NCT02797041|Rechallenge|rechallenge
78087|NCT02797028|Hyperuricemia|hyperuricemia
78088|NCT02797028|endothelial function|endothelial function
78089|NCT02797028|anthocyanidins|anthocyanidins
78090|NCT02797015|MS|ms
78091|NCT02797015|RMS|rms
78092|NCT02797015|Multiple Sclerosis|multiple sclerosis
78093|NCT02797015|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
78094|NCT02796976|arterial stiffness|arterial stiffness
78095|NCT02796976|retinal vessels|retinal vessels
78096|NCT02796976|physical activity|physical activity
78097|NCT02796976|ageing|ageing
78098|NCT02796963|HIV|hiv
78099|NCT02796963|MSM|msm
78100|NCT02796963|test uptake|test uptake
78101|NCT02796963|crowdsourcing|crowdsourcing
78102|NCT02796950|Acipimox|acipimox
78103|NCT02796950|GLP-1|glp-1
78104|NCT02796950|Insulin secretion|insulin secretion
78105|NCT02796937|Pulmonary Emphysema|pulmonary emphysema
78106|NCT02796937|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
78107|NCT02796937|AATD|aatd
78108|NCT02796937|Alpha-1 PI Deficiency|alpha-1 pi deficiency
78109|NCT02796937|Alpha-1 Proteinase Inhibitor|alpha-1 proteinase inhibitor
78110|NCT02796924|Psychogenic Non-Epileptic Seizure|psychogenic non-epileptic seizure
78111|NCT02796924|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
78112|NCT02796924|Brain Stimulation|brain stimulation
78113|NCT02796898|Prostate Cancer|prostate cancer
78114|NCT02796898|PSA|psa
78115|NCT02796898|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
78116|NCT02796859|Inflammation|inflammation
78117|NCT02796859|Psychosis|psychosis
78118|NCT02796859|Schizophrenia|schizophrenia
78119|NCT02796846|CPAP (continuous positive airway pressure)|cpap (continuous positive airway pressure)
78120|NCT02796846|OSA (Obstructive sleep apnea)|osa (obstructive sleep apnea)
78121|NCT02796833|Home parenteral nutrition|home parenteral nutrition
78122|NCT02796833|Liver injury|liver injury
78123|NCT02796833|Intravenous Lipid Emulsions|intravenous lipid emulsions
78124|NCT02796833|Catheter-related infections|catheter-related infections
78125|NCT02796833|Safety|safety
78126|NCT02796820|Huaier Granule|huaier granule
78127|NCT02796820|After radical surgery|after radical surgery
583424|NCT00511745|Interactions|interactions
78128|NCT02796820|Prevention of Recurrence and Metastasis|prevention of recurrence and metastasis
78129|NCT02796820|Efficacy and safety|efficacy and safety
78130|NCT02796794|Enteral nutrition|enteral nutrition
78131|NCT02796794|Genistein|genistein
78132|NCT02796794|Cytokine|cytokine
78133|NCT02796755|Central Nervous System (CNS) Glutamate|central nervous system (cns) glutamate
78134|NCT02796755|Breast Cancer Treatment|breast cancer treatment
78135|NCT02796755|Fatigue|fatigue
78136|NCT02796755|Cognitive Dysfunction|cognitive dysfunction
78137|NCT02796755|Behavioral|behavioral
78138|NCT02796755|Psychometrics|psychometrics
78139|NCT02796755|Imaging Technology|imaging technology
78140|NCT02796755|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
78141|NCT02796742|SSTIs|sstis
78142|NCT02796742|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
78143|NCT02796742|Methicillin susceptible Staphylococcus aureus (MSSA)|methicillin susceptible staphylococcus aureus (mssa)
78144|NCT02796742|the toxin Panton-Valentine Leukocidin (PVL)|the toxin panton-valentine leukocidin (pvl)
78145|NCT02796742|Emergency Departments|emergency departments
78146|NCT02796716|Wounded warriors|wounded warriors
78147|NCT02796716|Battlefield infection|battlefield infection
78148|NCT02796716|ESBL|esbl
78149|NCT02796716|MRSA|mrsa
78151|NCT02796690|nasal carriage|nasal carriage
78152|NCT02796690|Staphylococcus aureus|staphylococcus aureus
78153|NCT02796690|good hygiene practices|good hygiene practices
78157|NCT02796677|Formoterol fumarate|formoterol fumarate
78158|NCT02796677|Tiotropium|tiotropium
78159|NCT02796677|Bronchodilation|bronchodilation
78160|NCT02796677|COPD|copd
78161|NCT02796664|Ginseng|ginseng
78162|NCT02796664|Stroke|stroke
78163|NCT02796664|Quantitative MR flow analysis|quantitative mr flow analysis
78164|NCT02796651|Perforomist|perforomist
78165|NCT02796651|Pressair|pressair
78166|NCT02796651|COPD|copd
78167|NCT02796651|Cigarette smoking|cigarette smoking
78168|NCT02796651|Formoterol fumarate|formoterol fumarate
78169|NCT02796651|long-acting β2-adrenergic agonists (LABA)|long-acting β2-adrenergic agonists (laba)
78170|NCT02796651|long-acting muscarinic antagonists (LAMA)|long-acting muscarinic antagonists (lama)
78171|NCT02796638|Acute Heart Failure|acute heart failure
78172|NCT02796638|Positive-Pressure Ventilation|positive-pressure ventilation
78173|NCT02796638|Adaptive Servo-Ventilation|adaptive servo-ventilation
78174|NCT02796625|EEG|eeg
78175|NCT02796625|healthy subjects|healthy subjects
78176|NCT02796612|anxiety|anxiety
78177|NCT02796612|breast cancer, suspected|breast cancer, suspected
78178|NCT02796612|breast biopsy|breast biopsy
78179|NCT02796612|empathy|empathy
78180|NCT02796612|standardized and structured information|standardized and structured information
78181|NCT02796612|anxiety reduction|anxiety reduction
78182|NCT02796586|Refugee Health|refugee health
78183|NCT02796586|Resettled Refugee|resettled refugee
78190|NCT02796573|B-CBT|b-cbt
78191|NCT02796573|depression|depression
78192|NCT02796560|Drugs, Generic|drugs, generic
78193|NCT02796560|Generic Equivalency|generic equivalency
78194|NCT02796547|Episiotomy|episiotomy
78195|NCT02796547|Levobupivacaine|levobupivacaine
78196|NCT02796534|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
78197|NCT02796521|malnutrition|malnutrition
78198|NCT02796521|aging|aging
78199|NCT02796521|diet therapy|diet therapy
78200|NCT02796508|Healthy aging|healthy aging
78201|NCT02796508|Cognitive training|cognitive training
78202|NCT02796508|Video-games|video-games
78203|NCT02796508|Attention|attention
78204|NCT02796508|Working memory|working memory
78205|NCT02796508|Wellbeing|wellbeing
78206|NCT02796495|Neuroplasticity|neuroplasticity
78207|NCT02796495|Sensory Feedback|sensory feedback
78208|NCT02796495|Nerve stimulation|nerve stimulation
78209|NCT02796495|Robotic Hand|robotic hand
78210|NCT02796456|apelin|apelin
78211|NCT02796456|colostrum|colostrum
78212|NCT02796456|plasma|plasma
78213|NCT02796456|glycemic markers|glycemic markers
91536|NCT02716012|RNA|rna
78214|NCT02796456|lipidic markers|lipidic markers
78215|NCT02796456|pregnancy|pregnancy
78216|NCT02796456|postpartum|postpartum
78217|NCT02796443|acute cholecystitis|acute cholecystitis
78218|NCT02796443|early versus delayed surgery|early versus delayed surgery
78219|NCT02796430|Indirect calorimetry|indirect calorimetry
78220|NCT02796430|critical care|critical care
78221|NCT02796430|mechanical ventilation|mechanical ventilation
78222|NCT02796430|energy expenditure|energy expenditure
78223|NCT02796430|ICALIC study|icalic study
78224|NCT02796404|home monitoring|home monitoring
78225|NCT02796404|cardiac monitoring|cardiac monitoring
78229|NCT02796378|physical activity|physical activity
78230|NCT02796378|statin therapy|statin therapy
78231|NCT02796378|diabetes mellitus|diabetes mellitus
78232|NCT02796378|cardiovascular disease|cardiovascular disease
78233|NCT02796378|Q10-supplementation|q10-supplementation
78235|NCT02796365|Cancer|cancer
78236|NCT02796365|Cardiotoxicity|cardiotoxicity
78237|NCT02796365|Cardiomyopathy|cardiomyopathy
78238|NCT02796365|Cardiac Rehabilitation|cardiac rehabilitation
78242|NCT02796326|tracheal stenosis|tracheal stenosis
78243|NCT02796326|tracheal dilatation|tracheal dilatation
78244|NCT02796326|ventilation|ventilation
78245|NCT02796300|bioflo|bioflo
78246|NCT02796300|Duramax catheter|duramax catheter
78247|NCT02796300|dialysis|dialysis
78248|NCT02796287|Amnesia|amnesia
78249|NCT02796287|transient global amnesia|transient global amnesia
78250|NCT02796261|Anaplastic Astrocytoma|anaplastic astrocytoma
78251|NCT02796261|Grade 3 Glioma|grade 3 glioma
78252|NCT02796261|Glioma|glioma
78253|NCT02796261|Eflornithine|eflornithine
78254|NCT02796261|Brain Cancer|brain cancer
78255|NCT02796261|Brain Tumor|brain tumor
78256|NCT02796261|Neuro-oncology|neuro-oncology
78257|NCT02796261|Progressive Anaplastic Astrocytoma|progressive anaplastic astrocytoma
78258|NCT02796261|Recurrent Anaplastic Astrocytoma|recurrent anaplastic astrocytoma
78259|NCT02796261|Progressive Glioma|progressive glioma
78260|NCT02796261|Recurrent Glioma|recurrent glioma
78261|NCT02796261|Malignant Glioma|malignant glioma
78262|NCT02796261|Progressive Brain Tumor|progressive brain tumor
78263|NCT02796261|Recurrent Brain Tumor|recurrent brain tumor
78264|NCT02796248|type 1 diabetes|type 1 diabetes
78265|NCT02796248|glucose control|glucose control
78267|NCT02796248|youth|youth
78268|NCT02796222|Hemophilia|hemophilia
78269|NCT02796222|Recombinant factor VIII|recombinant factor viii
78270|NCT02796222|Recombinant factor VIII Fc|recombinant factor viii fc
78271|NCT02796222|Recombinant factor IX|recombinant factor ix
78272|NCT02796222|Patient-reported outcomes|patient-reported outcomes
78273|NCT02796222|Recombinant factor IX Fc|recombinant factor ix fc
78274|NCT02796209|atomoxetine|atomoxetine
78275|NCT02796209|autonomic failure|autonomic failure
78276|NCT02796196|Hematopoietic|hematopoietic
78277|NCT02796196|Recipient|recipient
78278|NCT02796170|SGLT-2 inhibitor|sglt-2 inhibitor
78279|NCT02796170|urinary angiotensinogen|urinary angiotensinogen
78280|NCT02796157|bioresorbable vascular scaffold, drug eluting stent, coronary artery disease|bioresorbable vascular scaffold, drug eluting stent, coronary artery disease
78281|NCT02796144|schizophrenia|schizophrenia
78282|NCT02796144|schizoaffective disorder|schizoaffective disorder
78283|NCT02796144|overweight|overweight
78284|NCT02796144|obesity|obesity
78285|NCT02796144|weight loss|weight loss
78286|NCT02796144|metformin|metformin
78287|NCT02796144|lorcaserin|lorcaserin
78288|NCT02796131|Phase I|phase i
78289|NCT02796131|Healthy|healthy
78290|NCT02796131|Pharmacodynamics|pharmacodynamics
78291|NCT02796118|Pharmacokinetics|pharmacokinetics
78292|NCT02796118|Healthy non-elderly and elderly subjects|healthy non-elderly and elderly subjects
78293|NCT02796118|ASP2151|asp2151
78294|NCT02796118|Safety|safety
78295|NCT02796092|Pelvic Congestion Syndrome|pelvic congestion syndrome
78296|NCT02796092|Pelvic Venous Insufficiency|pelvic venous insufficiency
78297|NCT02796092|Chronic pelvic pain|chronic pelvic pain
78298|NCT02796066|Acne, topical, SCD-1 inhibitor, moderate, severe|acne, topical, scd-1 inhibitor, moderate, severe
78299|NCT02796040|Parkinson's disease|parkinson's disease
78300|NCT02796040|Impulse control disorders|impulse control disorders
78301|NCT02796040|Diffusion tensor imaging|diffusion tensor imaging
78302|NCT02796040|MRI|mri
78303|NCT02796040|Mesocorticolimbic pathway|mesocorticolimbic pathway
78304|NCT02796027|Health Services Research|health services research
78306|NCT02795962|Endovascular Procedures|endovascular procedures
78307|NCT02795962|Emergency Medical Services|emergency medical services
78308|NCT02795949|Enterobacteriaceae|enterobacteriaceae
78309|NCT02795949|Bacteremia|bacteremia
78310|NCT02795949|Escalation|escalation
78311|NCT02795949|Bacterial resistance|bacterial resistance
78312|NCT02795949|Bloodstream infection|bloodstream infection
78313|NCT02795949|Recurrence|recurrence
78314|NCT02795936|rehabilitation|rehabilitation
78315|NCT02795936|exercise|exercise
78316|NCT02795897|genetics|genetics
78317|NCT02795897|genomics|genomics
69584|NCT02848560|LCI|lci
78318|NCT02795897|amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
78319|NCT02795897|primary lateral sclerosis (PLS)|primary lateral sclerosis (pls)
78320|NCT02795897|progressive muscular atrophy (PMA)|progressive muscular atrophy (pma)
78321|NCT02795897|motor neuron disease|motor neuron disease
78322|NCT02795884|Lung cancer|lung cancer
78323|NCT02795884|NSCLC|nsclc
78324|NCT02795884|adjuvant treatment|adjuvant treatment
78325|NCT02795871|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
78326|NCT02795871|Prenatal treatment|prenatal treatment
78327|NCT02795871|Dexamethasone|dexamethasone
78328|NCT02795871|Neuropsychological assessment|neuropsychological assessment
78329|NCT02795871|Cognitive development|cognitive development
78330|NCT02795858|Carcinoid Tumors|carcinoid tumors
78331|NCT02795806|Address|address
78334|NCT02795793|children|children
78335|NCT02795793|pediatric|pediatric
78336|NCT02795754|GSK2838232|gsk2838232
78337|NCT02795754|HIV|hiv
78338|NCT02795754|repeated dose escalation|repeated dose escalation
78339|NCT02795754|immediate release tablet|immediate release tablet
78340|NCT02795754|single dose escalation|single dose escalation
78341|NCT02795715|tDCS|tdcs
78342|NCT02795702|tDCS|tdcs
78343|NCT02795676|Glomerular filtration rate|glomerular filtration rate
78344|NCT02795676|Proteinuria|proteinuria
78345|NCT02795663|Near-InfraRed Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
78346|NCT02795663|Deep brain stimulation of SubThalamic Nucleus (DBS)|deep brain stimulation of subthalamic nucleus (dbs)
78347|NCT02795650|Metastatic|metastatic
78348|NCT02795650|Pancreas|pancreas
78349|NCT02795637|Attention deficit hyperactivity disorder (ADHD),|attention deficit hyperactivity disorder (adhd),
78350|NCT02795637|Binge-Eating Disorder (BED)|binge-eating disorder (bed)
78351|NCT02795611|Family-centered|family-centered
78352|NCT02795611|Autism spectrum disorder|autism spectrum disorder
78353|NCT02795611|Occupational therapy|occupational therapy
78354|NCT02795611|Participation|participation
78355|NCT02795611|Play|play
78356|NCT02795585|Fractional Flow Reserve|fractional flow reserve
78357|NCT02795585|Coronary Artery Disease|coronary artery disease
78358|NCT02795572|Breast Neoplasms|breast neoplasms
78359|NCT02795572|Peripheral Neuropathies|peripheral neuropathies
78360|NCT02795559|Nutrition|nutrition
78361|NCT02795559|Humans|humans
78362|NCT02795559|Obesity|obesity
78363|NCT02795559|Blood glucose|blood glucose
78364|NCT02795559|Dietary fiber|dietary fiber
78365|NCT02795559|Appetite|appetite
78366|NCT02795559|Short chain fatty acids|short chain fatty acids
78367|NCT02795546|periodontal regeneration|periodontal regeneration
78368|NCT02795533|Cognitive function|cognitive function
78369|NCT02795533|Quality of Life|quality of life
78372|NCT02795468|Peripheral|peripheral
78373|NCT02795468|Arterial|arterial
78374|NCT02795468|Catheterization|catheterization
78375|NCT02795455|Eating Disorders|eating disorders
78376|NCT02795455|Food Avoidance|food avoidance
78377|NCT02795455|Reward Learning|reward learning
78378|NCT02795455|Reward System|reward system
78379|NCT02795455|Family-based treatment|family-based treatment
78380|NCT02795455|interoceptive exposure|interoceptive exposure
78381|NCT02795455|insula-amygdala-ventral striatum subcircuits|insula-amygdala-ventral striatum subcircuits
78382|NCT02795429|Phase Ib/II|phase ib/ii
78383|NCT02795429|INC280|inc280
78384|NCT02795429|PDR001|pdr001
78385|NCT02795429|checkpoint inhibitor|checkpoint inhibitor
78386|NCT02795429|PD-1|pd-1
78387|NCT02795416|Moderate to severe plaque psoriasis, PASI, secukinumab, monoclonal antibody, Turkish population|moderate to severe plaque psoriasis, pasi, secukinumab, monoclonal antibody, turkish population
78388|NCT02795403|HCV, liver|hcv, liver
78389|NCT02795390|Chinese herbal medicine formula|chinese herbal medicine formula
78390|NCT02795390|MaZiRenWan|mazirenwan
78391|NCT02795390|Randomized controlled trial|randomized controlled trial
78392|NCT02795390|Constipation|constipation
78393|NCT02795390|Palliative care in cancer|palliative care in cancer
78394|NCT02795377|arterial hypertension|arterial hypertension
78395|NCT02795377|microparticle|microparticle
78396|NCT02795377|endothelial function|endothelial function
78397|NCT02795364|High Grade Glioma|high grade glioma
78398|NCT02795364|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
78399|NCT02795364|Surgical resection|surgical resection
78400|NCT02795364|Prognosis|prognosis
78401|NCT02795325|Primary Hyperoxaluria Type 1|primary hyperoxaluria type 1
78402|NCT02795325|PH1|ph1
78403|NCT02795325|Calcium Oxalate Stones|calcium oxalate stones
78404|NCT02795325|Kidney Stones|kidney stones
78405|NCT02795325|Liver Enzyme Deficiency|liver enzyme deficiency
78406|NCT02795325|Genetic Diseases|genetic diseases
78407|NCT02795325|Inborn Kidney Diseases|inborn kidney diseases
78408|NCT02795325|Metabolic Diseases|metabolic diseases
78409|NCT02795325|Inborn Errors|inborn errors
78410|NCT02795325|Urological Diseases|urological diseases
78411|NCT02795325|Carbohydrate Metabolism|carbohydrate metabolism
78412|NCT02795325|Hyperoxaluria|hyperoxaluria
78413|NCT02795325|AGT|agt
78414|NCT02795325|RNAi|rnai
69688|NCT02847962|Soy|soy
78415|NCT02795325|siRNA|sirna
78416|NCT02795325|DCR-PH1|dcr-ph1
78417|NCT02795312|Cigarette Smoking|cigarette smoking
78418|NCT02795286|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
78419|NCT02795286|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
78420|NCT02795286|Chronic Hemodialysis|chronic hemodialysis
78421|NCT02795286|In-center HD|in-center hd
78422|NCT02795286|Sodium|sodium
78423|NCT02795286|Isotonic Dialysis|isotonic dialysis
78424|NCT02795273|Rhinitis|rhinitis
78425|NCT02795273|Conjunctivitis|conjunctivitis
78426|NCT02795273|Grass|grass
78427|NCT02795273|Allergy|allergy
78431|NCT02795260|diagnostic test|diagnostic test
78432|NCT02795195|re-irradiation|re-irradiation
78433|NCT02795195|carbon ion therapy|carbon ion therapy
78434|NCT02795182|Relapsed|relapsed
78435|NCT02795182|Refractory|refractory
78436|NCT02795156|regorafenib|regorafenib
78437|NCT02795156|afatinib|afatinib
78438|NCT02795156|targeted therapy|targeted therapy
78440|NCT02795104|RISE|rise
78441|NCT02795091|clean supplies|clean supplies
78442|NCT02795091|ICU floor|icu floor
78443|NCT02795091|bacteria colony|bacteria colony
78444|NCT02795091|catheter associated with infection|catheter associated with infection
78445|NCT02795078|Atherosclerotic Intracranial Arterial Stenosis|atherosclerotic intracranial arterial stenosis
78446|NCT02795078|Intracranial Aneurysms|intracranial aneurysms
78447|NCT02795052|Neurologic Disease|neurologic disease
78448|NCT02795052|Cerebral Vascular Accident|cerebral vascular accident
78449|NCT02795052|Stroke|stroke
78450|NCT02795052|Traumatic Brain Injury|traumatic brain injury
78451|NCT02795052|Multiple Sclerosis|multiple sclerosis
78452|NCT02795052|Parkinsons Disease|parkinsons disease
78453|NCT02795052|Neuropathy|neuropathy
78454|NCT02795052|Neurodegeneration|neurodegeneration
78455|NCT02795052|Diabetic Neuropathy|diabetic neuropathy
78456|NCT02795052|Cerebral Ischemia|cerebral ischemia
78457|NCT02795026|dry needling|dry needling
78458|NCT02795026|vulvodynia|vulvodynia
78459|NCT02795026|pelvic pain chronic|pelvic pain chronic
78460|NCT02795013|Genetic studies|genetic studies
78461|NCT02795013|Pediatric|pediatric
78462|NCT02795000|Primary Ovarian Insufficiency|primary ovarian insufficiency
78463|NCT02795000|nomogram|nomogram
78464|NCT02794987|Bile duct|bile duct
78465|NCT02794987|indeterminate stricture|indeterminate stricture
78466|NCT02794987|cholangioscopy|cholangioscopy
78467|NCT02794987|Spyglass|spyglass
200982|NCT02112708|Primary Health Care|primary health care
78468|NCT02794948|primary ovarian insufficiency|primary ovarian insufficiency
78469|NCT02794948|TCM intervention|tcm intervention
78470|NCT02794935|inspiratory muscle training|inspiratory muscle training
78471|NCT02794935|heart failure|heart failure
78472|NCT02794935|obstructive sleep apnea|obstructive sleep apnea
78474|NCT02794922|Temporomandibular joint disorder|temporomandibular joint disorder
78475|NCT02794922|trpv1|trpv1
78476|NCT02794909|Point-of-care ultrasound|point-of-care ultrasound
78477|NCT02794909|ED|ed
78478|NCT02794909|Low and middle-income country|low and middle-income country
78479|NCT02794909|Echocardiography|echocardiography
78480|NCT02794909|Lung ultrasound|lung ultrasound
78481|NCT02794909|Resuscitation|resuscitation
78482|NCT02794857|ALS|als
78483|NCT02794857|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
78484|NCT02794857|Motor Neuron Disease|motor neuron disease
78485|NCT02794857|Central Nervous System Diseases|central nervous system diseases
78486|NCT02794857|Nervous System Diseases|nervous system diseases
78487|NCT02794857|Neurodegenerative Diseases|neurodegenerative diseases
78488|NCT02794857|Neuromuscular Diseases|neuromuscular diseases
78489|NCT02794857|Inflammation|inflammation
78490|NCT02794857|C-Reactive Protein|c-reactive protein
78491|NCT02794831|NSAIDs|nsaids
78492|NCT02794831|Bacterial Infections|bacterial infections
78493|NCT02794831|Severity|severity
78494|NCT02794831|Self Medication|self medication
78495|NCT02794818|Prevention|prevention
78496|NCT02794818|Nutrition|nutrition
78500|NCT02794779|cesarean section|cesarean section
78501|NCT02794779|labor|labor
78502|NCT02794779|oxytocin|oxytocin
78503|NCT02794753|Trichotillomania|trichotillomania
78504|NCT02794753|Hair-pulling Disorder|hair-pulling disorder
78505|NCT02794753|Cognitive Training|cognitive training
78506|NCT02794753|Neuroplasticity|neuroplasticity
78507|NCT02794753|Working Memory|working memory
78508|NCT02794740|Osteoarthritis|osteoarthritis
78509|NCT02794714|Laparoscopic Gynecologic Surgeries|laparoscopic gynecologic surgeries
78510|NCT02794688|Non-lactating|non-lactating
78511|NCT02794688|idiopathic granulomatous mastitis|idiopathic granulomatous mastitis
78512|NCT02794688|periductal mastitis|periductal mastitis
78513|NCT02794688|ductal lavage|ductal lavage
78514|NCT02794675|resectable|resectable
78515|NCT02794675|Cesium 131|cesium 131
78516|NCT02794675|brachytherapy|brachytherapy
78517|NCT02794662|Oxygen Delivery System, Nasal Cannula|oxygen delivery system, nasal cannula
69762|NCT02847767|Hepatocellular Carcinoma|hepatocellular carcinoma
69764|NCT02847754|bony metastases|bony metastases
78518|NCT02794662|Oxygen Delivery System, Incubator|oxygen delivery system, incubator
78519|NCT02794623|cochlear implants|cochlear implants
78520|NCT02794623|hearing loss|hearing loss
78521|NCT02794610|Tacrolimus|tacrolimus
78522|NCT02794610|Ocular penetration|ocular penetration
78523|NCT02794610|Topical|topical
78524|NCT02794597|Unplanned Pregnancy, LARC|unplanned pregnancy, larc
78525|NCT02794558|Breast Cancer, MRgFus, Focused Ultrasound|breast cancer, mrgfus, focused ultrasound
78526|NCT02794519|Asthma Control Questionnaire|asthma control questionnaire
78527|NCT02794519|interleukin-6|interleukin-6
78528|NCT02794519|Sirukumab|sirukumab
78529|NCT02794519|severe, poorly controlled asthma|severe, poorly controlled asthma
78530|NCT02794519|asthma|asthma
78531|NCT02794519|ACQ|acq
78532|NCT02794506|Diabetes mellitus|diabetes mellitus
78533|NCT02794506|Chronic periodontitis|chronic periodontitis
78534|NCT02794506|Propolis|propolis
78535|NCT02794480|ELLIPTA|ellipta
78536|NCT02794480|metered dose inhaler|metered dose inhaler
78537|NCT02794480|Dry powder inhaler|dry powder inhaler
78538|NCT02794467|Heavy menstrual bleeding|heavy menstrual bleeding
78539|NCT02794467|Adenomyosis|adenomyosis
78540|NCT02794467|Safety|safety
78541|NCT02794467|Epelsiban|epelsiban
78542|NCT02794467|Tolerability|tolerability
78543|NCT02794467|Proof of concept|proof of concept
78544|NCT02794428|Gastric adenocarcinoma|gastric adenocarcinoma
78545|NCT02794428|Gastric intestinal metaplasia|gastric intestinal metaplasia
78546|NCT02794428|Atrophic gastritis|atrophic gastritis
78547|NCT02794428|Gastric premalignant lesion|gastric premalignant lesion
78548|NCT02794415|HIV|hiv
78549|NCT02794415|disability|disability
78550|NCT02794415|rehabilitation|rehabilitation
78551|NCT02794415|exercise|exercise
78552|NCT02794389|Acetylcysteine|acetylcysteine
78553|NCT02794376|IBS|ibs
78554|NCT02794350|RBANS-H|rbans-h
78555|NCT02794350|Cochlear implantation|cochlear implantation
78556|NCT02794350|Cognition|cognition
78557|NCT02794350|Older adults|older adults
78558|NCT02794350|RBANS|rbans
78559|NCT02794285|Lupus Erythematosus, Systemic Autoimmune Diseases, Connective Tissue Diseases,Immune System Diseases|lupus erythematosus, systemic autoimmune diseases, connective tissue diseases,immune system diseases
78560|NCT02794272|GABA concentration|gaba concentration
78561|NCT02794272|tDCS|tdcs
78562|NCT02794259|GABA concentration|gaba concentration
78563|NCT02794259|tDCS|tdcs
78564|NCT02794233|Deep Brain Stimulation|deep brain stimulation
78565|NCT02794233|Electric Impedance|electric impedance
78566|NCT02794233|Parkinson disease|parkinson disease
78567|NCT02794220|E-cigarette|e-cigarette
78568|NCT02794220|healthy volunteer study|healthy volunteer study
78569|NCT02794220|Pharmacokinetics|pharmacokinetics
78570|NCT02794220|Nicorette|nicorette
78571|NCT02794207|Pediatric|pediatric
78572|NCT02794207|Cancer|cancer
78574|NCT02794207|Qualitative Interview|qualitative interview
78575|NCT02794194|Chronic Ankle Instability|chronic ankle instability
78576|NCT02794194|Whole Body Vibration|whole body vibration
78577|NCT02794194|Proprioception|proprioception
78578|NCT02794181|Transfusion-Transmitted Infections|transfusion-transmitted infections
78579|NCT02794181|Dengue Virus|dengue virus
78681|NCT02793713|Prediction|prediction
78580|NCT02794181|Chikungunya Virus|chikungunya virus
78581|NCT02794181|Natural History|natural history
78582|NCT02794181|Blood Transfusion|blood transfusion
78583|NCT02794142|hemodialysis|hemodialysis
78584|NCT02794142|muscle dysfunction|muscle dysfunction
78585|NCT02794142|mitochondria|mitochondria
78586|NCT02794142|oxidative stress|oxidative stress
78587|NCT02794142|inflammation|inflammation
78588|NCT02794142|renal transplantation|renal transplantation
78589|NCT02794103|Virtual reality|virtual reality
78590|NCT02794103|Immersive distraction|immersive distraction
78591|NCT02794103|Virtual world|virtual world
78592|NCT02794103|Virtual environment|virtual environment
78593|NCT02794103|Procedural pain|procedural pain
78594|NCT02794103|Procedural anxiety|procedural anxiety
78595|NCT02794103|Acute pain|acute pain
78596|NCT02794103|Pain management|pain management
78597|NCT02794103|Anxiety|anxiety
78598|NCT02794103|Children, Child|children, child
78599|NCT02794103|Kid, Kids|kid, kids
78600|NCT02794103|Pediatric, Pediatrics|pediatric, pediatrics
78601|NCT02794103|Young children|young children
78602|NCT02794103|Burns|burns
78603|NCT02794103|Burn injuries|burn injuries
78604|NCT02794103|Burn unit|burn unit
78605|NCT02794103|Hydrotherapy|hydrotherapy
78606|NCT02794103|Burn dressing|burn dressing
78607|NCT02794103|Non-pharmacological|non-pharmacological
78608|NCT02794103|Clinical Research|clinical research
78609|NCT02794103|Nursing Practice|nursing practice
78610|NCT02794090|Behavioral treatment|behavioral treatment
78611|NCT02794090|Telephone coaching|telephone coaching
78612|NCT02794090|Outpatient clinic|outpatient clinic
78613|NCT02794077|Nasopharyngeal undifferentiated carcinoma|nasopharyngeal undifferentiated carcinoma
78614|NCT02793947|Peri-incisional injection|peri-incisional injection
78615|NCT02793947|Multimodal analgesia|multimodal analgesia
78616|NCT02793947|Femur fracture|femur fracture
78617|NCT02793934|Rehabilitation|rehabilitation
78618|NCT02793934|ICF|icf
78619|NCT02793934|Pilot project|pilot project
78620|NCT02793934|Stroke|stroke
78621|NCT02793934|Acute myocardial infarction|acute myocardial infarction
78622|NCT02793934|Total hip replacement|total hip replacement
78623|NCT02793921|Alteration|alteration
78624|NCT02793921|Cognitive Function|cognitive function
78625|NCT02793921|Exercise|exercise
78626|NCT02793908|Endometriosis|endometriosis
78627|NCT02793908|Subcutaneous progesterone|subcutaneous progesterone
78628|NCT02793908|luteal phase|luteal phase
78629|NCT02793895|Atrial fibrillation/flutter|atrial fibrillation/flutter
78630|NCT02793895|Postoperative atrial arrhythmia|postoperative atrial arrhythmia
78631|NCT02793895|Cardiac surgery|cardiac surgery
78632|NCT02793895|Stroke prevention|stroke prevention
78633|NCT02793895|Oral anticoagulation|oral anticoagulation
78634|NCT02793895|Cardiac rhythm monitoring|cardiac rhythm monitoring
78635|NCT02793869|congenital cataract;anterior segment characteristics|congenital cataract;anterior segment characteristics
78636|NCT02793856|lung cancer|lung cancer
78637|NCT02793856|immune checkpoint|immune checkpoint
78639|NCT02793856|CRISPER|crisper
78640|NCT02793856|autologous cell infusion|autologous cell infusion
78641|NCT02793830|medication adherence|medication adherence
78642|NCT02793830|mHealth|mhealth
78643|NCT02793830|China|china
78644|NCT02793830|heart disease|heart disease
78645|NCT02793817|postsurgical|postsurgical
78646|NCT02793817|postoperative|postoperative
78647|NCT02793817|ocular|ocular
78648|NCT02793817|cataract|cataract
78649|NCT02793817|inflammation|inflammation
78650|NCT02793817|pain|pain
78651|NCT02793817|corticosteroid|corticosteroid
78652|NCT02793804|HIV self-testing|hiv self-testing
78653|NCT02793804|HIV|hiv
78654|NCT02793804|Zambia|zambia
78655|NCT02793791|high grade dysplastic nodule (HGDN)|high grade dysplastic nodule (hgdn)
78656|NCT02793791|low grade dysplastic nodule (LGDN)|low grade dysplastic nodule (lgdn)
78657|NCT02793778|Crohn's Disease|crohn's disease
78658|NCT02793778|Digestive System Diseases|digestive system diseases
78659|NCT02793778|Gastrointestinal Diseases|gastrointestinal diseases
78660|NCT02793778|Intestinal Diseases|intestinal diseases
78661|NCT02793778|mucosal healing|mucosal healing
78662|NCT02793778|inflammatory bowel disease|inflammatory bowel disease
78663|NCT02793778|Medical Food|medical food
78664|NCT02793778|Nutritional intervention|nutritional intervention
78665|NCT02793765|Advanced Prostate Cancer|advanced prostate cancer
80123|NCT02785302|HIV|hiv
78666|NCT02793765|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
78667|NCT02793765|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
78668|NCT02793765|Metastatic disease|metastatic disease
78669|NCT02793765|CRPC|crpc
78670|NCT02793752|IVF|ivf
78671|NCT02793752|In vitro fertilization|in vitro fertilization
78672|NCT02793752|Cumulus Cells|cumulus cells
78673|NCT02793752|Oocyte|oocyte
78674|NCT02793752|Embryo|embryo
78675|NCT02793752|Fertility|fertility
78676|NCT02793739|Safety|safety
78677|NCT02793739|Efficacy|efficacy
78678|NCT02793739|Longevity|longevity
78679|NCT02793726|Hip Prosthesis|hip prosthesis
78680|NCT02793713|EBUS|ebus
78682|NCT02793713|malignancy|malignancy
78683|NCT02793713|lymph nodes|lymph nodes
78684|NCT02793713|lung cancer|lung cancer
78685|NCT02793713|Diagnostic Techniques, Respiratory System|diagnostic techniques, respiratory system
78686|NCT02793700|Betamethasone|betamethasone
78687|NCT02793674|effort of breathing|effort of breathing
78688|NCT02793674|high flow nasal cannula|high flow nasal cannula
78689|NCT02793674|respiratory distress|respiratory distress
78690|NCT02793648|Depression|depression
78691|NCT02793648|Elderly|elderly
78692|NCT02793635|Paraplegia|paraplegia
78693|NCT02793635|Gait|gait
78694|NCT02793635|Exoskeleton|exoskeleton
78695|NCT02793622|Chemoprevention|chemoprevention
78696|NCT02793622|Malaria|malaria
78697|NCT02793622|Sulfadoxine-Pyrimethamine|sulfadoxine-pyrimethamine
78698|NCT02793622|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
78699|NCT02793609|induction of labor|induction of labor
78700|NCT02793609|double balloon catheter|double balloon catheter
78701|NCT02793609|mechanical ripening|mechanical ripening
78702|NCT02793505|metformin|metformin
78703|NCT02793505|pregnancy outcomes|pregnancy outcomes
78704|NCT02793505|birth defects|birth defects
78705|NCT02793505|spontaneous abortion|spontaneous abortion
78706|NCT02793505|pharmacoepidemiology|pharmacoepidemiology
78707|NCT02793466|Durvalumab|durvalumab
78708|NCT02793466|solid tumors|solid tumors
78709|NCT02793466|Immunotherapy|immunotherapy
78710|NCT02793466|Check Point Inhibitor|check point inhibitor
78711|NCT02793466|pediatrics|pediatrics
78712|NCT02793466|children|children
78713|NCT02793401|High Intensity Laser|high intensity laser
78714|NCT02793401|Ultrasound|ultrasound
78715|NCT02793401|Chronic Shoulder Pain|chronic shoulder pain
78716|NCT02793375|Montelukast|montelukast
78717|NCT02793375|Tonsillectomy|tonsillectomy
78718|NCT02793349|angioplasty|angioplasty
78719|NCT02793349|stents|stents
78720|NCT02793349|polymers|polymers
78721|NCT02793349|absorbable implants|absorbable implants
78722|NCT02793271|Depression|depression
78723|NCT02793271|Primary Health Care|primary health care
78724|NCT02793271|Social Stigma|social stigma
78725|NCT02793271|Stereotyping|stereotyping
78726|NCT02793271|Health Care Quality|health care quality
78727|NCT02793271|Access|access
78728|NCT02793271|Evaluation|evaluation
78729|NCT02793258|tDCS|tdcs
78730|NCT02793258|neuromodulation|neuromodulation
78731|NCT02793258|depression|depression
78732|NCT02793258|cognition|cognition
78733|NCT02793232|Safety|safety
78734|NCT02793232|Tolerability|tolerability
78735|NCT02793232|Pharmacokinetics|pharmacokinetics
78736|NCT02793232|Alzheimer's disease|alzheimer's disease
78737|NCT02793219|Advanced Prostate Cancer|advanced prostate cancer
78738|NCT02793219|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
78739|NCT02793219|CRPC|crpc
78740|NCT02793219|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
78741|NCT02793219|Metastatic disease|metastatic disease
78742|NCT02793206|Drusen|drusen
78743|NCT02793206|SD-OCT|sd-oct
78744|NCT02793167|acute kidney injury|acute kidney injury
78745|NCT02793167|medication alert systems|medication alert systems
78746|NCT02793154|gastric emptying|gastric emptying
78747|NCT02793154|albiglutide|albiglutide
78748|NCT02793154|GMA|gma
78749|NCT02793154|exenatide|exenatide
78750|NCT02793154|type 2 diabetes mellitus|type 2 diabetes mellitus
78751|NCT02793141|Pneumonia|pneumonia
78752|NCT02793141|Intensive Care Unit|intensive care unit
78753|NCT02793141|Nosocomial pneumonia|nosocomial pneumonia
78754|NCT02793141|Hospital-acquired pneumonia|hospital-acquired pneumonia
78755|NCT02793141|Ventilator-associated pneumonia|ventilator-associated pneumonia
78756|NCT02793141|ICU|icu
78757|NCT02793141|HAP|hap
78758|NCT02793141|VAP|vap
78759|NCT02793141|Critical Care|critical care
78760|NCT02793128|TC-3|tc-3
78761|NCT02793128|Mitogel|mitogel
78762|NCT02793128|UTUC|utuc
78763|NCT02793128|Ureteral|ureteral
78764|NCT02793128|Upper Tract|upper tract
78765|NCT02793128|Carcinoma|carcinoma
78766|NCT02793128|Kidney|kidney
78767|NCT02793128|Renal|renal
78768|NCT02793128|Gel|gel
78769|NCT02793128|Local|local
78770|NCT02793128|Mitomycin C|mitomycin c
78771|NCT02793128|Prolonged Release|prolonged release
78772|NCT02793128|Slow Release|slow release
78773|NCT02793128|Kidney Sparing|kidney sparing
78774|NCT02793128|T1|t1
78776|NCT02793128|Low Grade|low grade
78777|NCT02793102|mental anorexia|mental anorexia
78778|NCT02793102|sensory workshops|sensory workshops
78779|NCT02793102|BMI|bmi
78780|NCT02793076|Posture|posture
78781|NCT02793076|Body image|body image
78782|NCT02793076|Dancing|dancing
78783|NCT02793076|Group|group
78784|NCT02793076|Survivors|survivors
78785|NCT02793063|Brittle Bone|brittle bone
78786|NCT02793063|Osteogenesis Imperfecta|osteogenesis imperfecta
78787|NCT02793063|BBD|bbd
78788|NCT02793063|OI|oi
78789|NCT02793063|Congenital Abnormalities|congenital abnormalities
78790|NCT02793063|Congenital Bone Disorder|congenital bone disorder
78791|NCT02793063|Lobstein Syndrome|lobstein syndrome
78792|NCT02793050|Trabectedin|trabectedin
78793|NCT02793050|Soft Tissue Sarcoma|soft tissue sarcoma
78794|NCT02793050|Observational|observational
78795|NCT02793037|zirconia|zirconia
78796|NCT02793037|resin bonded bridge|resin bonded bridge
78797|NCT02793024|food shopping intervention|food shopping intervention
78798|NCT02792972|Analgesic|analgesic
78799|NCT02792972|Medicinal plants|medicinal plants
78800|NCT02792972|Skin|skin
78801|NCT02792972|Antimicrobial agents|antimicrobial agents
78802|NCT02792972|Pain Measurement|pain measurement
78803|NCT02792907|Foot Surgery|foot surgery
78804|NCT02792907|Compliance|compliance
78805|NCT02792907|Compressive Stockings|compressive stockings
78806|NCT02792894|cluster randomized trial|cluster randomized trial
78807|NCT02792894|developmental delays|developmental delays
78808|NCT02792894|neurodevelopmental disorders|neurodevelopmental disorders
78809|NCT02792894|autism|autism
78810|NCT02792894|intellectual disability|intellectual disability
78811|NCT02792894|low resource settings|low resource settings
78812|NCT02792894|family volunteers|family volunteers
78813|NCT02792881|Stomach Neoplasms|stomach neoplasms
78814|NCT02792881|Laparoscopy|laparoscopy
78815|NCT02792881|Remnant gastric cancer|remnant gastric cancer
78816|NCT02792855|Snifﬁng Position|snifﬁng position
78817|NCT02792855|Simple Head Extension|simple head extension
78942|NCT02792114|CAR T cells|car t cells
92307|NCT02711605|fat|fat
78818|NCT02792829|Bioavailability of Lenvatinib suspension|bioavailability of lenvatinib suspension
78819|NCT02792829|Palatability of Lenvatinib suspension|palatability of lenvatinib suspension
78820|NCT02792829|Lenvatinib|lenvatinib
78821|NCT02792829|Lenvima|lenvima
78822|NCT02792829|E7080|e7080
78823|NCT02792829|Capsule formulation|capsule formulation
78824|NCT02792829|Healthy volunteers|healthy volunteers
78825|NCT02792803|POAG|poag
78826|NCT02792803|Primary open angle glaucoma|primary open angle glaucoma
78827|NCT02792803|Ocular Hypertension|ocular hypertension
78828|NCT02792803|Xalatan|xalatan
78829|NCT02792803|Latanoprost|latanoprost
78830|NCT02792803|Ocular Hyperemia|ocular hyperemia
78832|NCT02792803|Intraocular Pressure|intraocular pressure
78833|NCT02792803|Allergan|allergan
78834|NCT02792803|prostaglandin|prostaglandin
78835|NCT02792790|Amyloidosis|amyloidosis
78836|NCT02792790|Carpal tunnel syndrome|carpal tunnel syndrome
78837|NCT02792777|Concept Mapping|concept mapping
78838|NCT02792777|VOICe|voice
78839|NCT02792777|Interviews|interviews
78840|NCT02792777|Patient-Centered Research|patient-centered research
78841|NCT02792764|port|port
78842|NCT02792764|peripheral intravenous lines|peripheral intravenous lines
78843|NCT02792764|oncology|oncology
78844|NCT02792751|Depth of anesthesia|depth of anesthesia
78845|NCT02792751|BIS|bis
78846|NCT02792751|ERCP|ercp
78847|NCT02792751|Positive Regulation|positive regulation
78848|NCT02792712|Acute myocardial infarction|acute myocardial infarction
78849|NCT02792712|Antiplatelet agents|antiplatelet agents
78850|NCT02792712|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
78851|NCT02792686|Healthy Volunteers|healthy volunteers
78852|NCT02792673|Embryo transfer media|embryo transfer media
78853|NCT02792673|improvement of embryo transfer technique|improvement of embryo transfer technique
78854|NCT02792673|improvement of implantation|improvement of implantation
78855|NCT02792673|"Hyaluronan-enriched media Embryo Glue®"|"hyaluronan-enriched media embryo glue®"
78856|NCT02792673|"30% Protein-supplemented Culture Medium Global Total®"|"30% protein-supplemented culture medium global total®"
78857|NCT02792673|Autologous Follicular Fluid as embryo transfer medium|autologous follicular fluid as embryo transfer medium
78858|NCT02792634|Bariatric surgery|bariatric surgery
78859|NCT02792634|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
78860|NCT02792634|Obesity|obesity
78861|NCT02792608|Mindfulness-based Therapy|mindfulness-based therapy
78862|NCT02792608|Brain Tumour Survivors|brain tumour survivors
78863|NCT02792608|Depressive Symptoms|depressive symptoms
78864|NCT02792608|Quality of Life|quality of life
78865|NCT02792608|Perceived Stress|perceived stress
78866|NCT02792608|Wellbeing|wellbeing
78867|NCT02792608|Treatment|treatment
78868|NCT02792582|Brain tumor|brain tumor
78869|NCT02792582|Pediatrics|pediatrics
78870|NCT02792582|Radiation therapy|radiation therapy
78871|NCT02792582|Proton therapy|proton therapy
78872|NCT02792582|Surgery|surgery
78873|NCT02792569|IVA|iva
78874|NCT02792569|Hippo Pathway|hippo pathway
78875|NCT02792569|Follicle activation|follicle activation
78876|NCT02792569|Low Responder|low responder
78877|NCT02792569|POI|poi
78878|NCT02792569|Poor Ovarian Reserve|poor ovarian reserve
78879|NCT02792569|Poor Ovarian Response|poor ovarian response
78880|NCT02792569|Salvador/Warts/Hippo pathway|salvador/warts/hippo pathway
78881|NCT02792556|drug abortion|drug abortion
78882|NCT02792556|urine pregnancy test|urine pregnancy test
78883|NCT02792556|negative predictive value|negative predictive value
78884|NCT02792556|check Top test|check top test
78885|NCT02792556|transvaginal ultrasound|transvaginal ultrasound
78886|NCT02792543|nutrition|nutrition
78887|NCT02792543|double enterostomy|double enterostomy
78888|NCT02792543|chyme reinfusion|chyme reinfusion
78889|NCT02792543|randomized controlled trial|randomized controlled trial
78890|NCT02792439|Fitness|fitness
78891|NCT02792439|Health kit|health kit
78892|NCT02792439|Researchkit|researchkit
78893|NCT02792439|Walking|walking
78894|NCT02792426|Smoking Cessation|smoking cessation
78895|NCT02792426|Nicotine Dependence|nicotine dependence
78896|NCT02792426|Tobacco Dependence|tobacco dependence
78897|NCT02792413|osteoporosis|osteoporosis
78898|NCT02792413|chronic kidney disease|chronic kidney disease
78899|NCT02792413|anti-RANK ligand antibody|anti-rank ligand antibody
78900|NCT02792413|bone mineral density|bone mineral density
78901|NCT02792413|vascular calcifications|vascular calcifications
78902|NCT02792387|cardio-renal syndrome|cardio-renal syndrome
78903|NCT02792387|right heart dysfunction|right heart dysfunction
78904|NCT02792387|central venous pressure|central venous pressure
78905|NCT02792387|eGFR|egfr
78906|NCT02792387|low-flow theory|low-flow theory
78907|NCT02792374|Dental patients|dental patients
78908|NCT02792374|Psychological Profile|psychological profile
78909|NCT02792361|Post-Operative Pterional Craniotomy|post-operative pterional craniotomy
78910|NCT02792361|Suction Drain|suction drain
78911|NCT02792361|Benefits|benefits
78912|NCT02792348|congenital urine flow impairment|congenital urine flow impairment
78913|NCT02792348|urinary metabolomics profile|urinary metabolomics profile
78914|NCT02792348|Nuclear Magnetic Resonance|nuclear magnetic resonance
78915|NCT02792322|Cancer|cancer
78916|NCT02792322|Oropharynx|oropharynx
78917|NCT02792270|Surgery|surgery
78918|NCT02792231|Relapsing multiple sclerosis|relapsing multiple sclerosis
78919|NCT02792231|Ofatumumab|ofatumumab
78920|NCT02792218|Relapsing multiple sclerosis|relapsing multiple sclerosis
78921|NCT02792218|Ofatumumab|ofatumumab
78922|NCT02792205|Willebrand factor deficiency|willebrand factor deficiency
78923|NCT02792205|hematology|hematology
78924|NCT02792205|Willebrand:Collagen-binding|willebrand:collagen-binding
78925|NCT02792166|Morbid obesity|morbid obesity
78926|NCT02792166|Metabolic syndrome|metabolic syndrome
78927|NCT02792166|Metabolic surgery|metabolic surgery
78928|NCT02792166|Bariatric surgery|bariatric surgery
78929|NCT02792166|SADI|sadi
78930|NCT02792166|BPD-DS|bpd-ds
78931|NCT02792153|estrogen|estrogen
78932|NCT02792153|anxiety|anxiety
78933|NCT02792153|amenorrhea|amenorrhea
78934|NCT02792153|eating disorders|eating disorders
78935|NCT02792140|Psychology|psychology
78936|NCT02792140|Dreams|dreams
78937|NCT02792127|Social Anxiety|social anxiety
78938|NCT02792127|Cognitive Behaviour Therapy|cognitive behaviour therapy
78939|NCT02792127|Online Program|online program
78940|NCT02792114|T-Cell|t-cell
78941|NCT02792114|Chimeric antigen receptor (CAR)|chimeric antigen receptor (car)
78943|NCT02792114|Triple-negative breast cancer|triple-negative breast cancer
78944|NCT02792114|Immunotherapy T-cell therapy|immunotherapy t-cell therapy
78945|NCT02792114|16-040|16-040
78946|NCT02792114|immunotherapy|immunotherapy
78947|NCT02792114|CAR|car
78948|NCT02792088|HBV|hbv
78949|NCT02792075|Coronary Stenosis|coronary stenosis
78950|NCT02792075|Intracoronary Imaging|intracoronary imaging
78951|NCT02792075|VH-IVUS|vh-ivus
78952|NCT02792075|OCT|oct
78953|NCT02792075|NIRS|nirs
78954|NCT02792075|gray scale IVUS|gray scale ivus
78955|NCT02792023|Colorectal cancer|colorectal cancer
78956|NCT02792023|Immunochemical occult blood test|immunochemical occult blood test
78957|NCT02792010|T1rho MRI|t1rho mri
78958|NCT02792010|hip|hip
78959|NCT02792010|cartilage|cartilage
78960|NCT02792010|Healthy participants|healthy participants
78961|NCT02791997|Audition|audition
78962|NCT02791997|Stroke|stroke
78963|NCT02791997|Migraine|migraine
78964|NCT02791997|Attention|attention
78965|NCT02791997|Short-term memory,|short-term memory,
78966|NCT02791997|Emotions|emotions
78967|NCT02791997|EEG|eeg
78968|NCT02791997|MEG|meg
78969|NCT02791984|Suprasternal|suprasternal
78970|NCT02791984|echography|echography
78971|NCT02791984|fluid responsiveness|fluid responsiveness
78972|NCT02791971|Contraception|contraception
78973|NCT02791971|Birth control|birth control
78974|NCT02791971|Social communication|social communication
78975|NCT02791971|Adolescent|adolescent
78976|NCT02791971|Social network|social network
78977|NCT02791971|Health education|health education
78978|NCT02791971|Reproductive health|reproductive health
78979|NCT02791945|TBI|tbi
78980|NCT02791945|hazardous and harmful alcohol use|hazardous and harmful alcohol use
78981|NCT02791945|Veterans|veterans
78982|NCT02791945|co-occurring disorders|co-occurring disorders
78983|NCT02791945|pharmacotherapy|pharmacotherapy
78984|NCT02791932|Pregnancy|pregnancy
78985|NCT02791932|Postpartum period|postpartum period
78986|NCT02791932|Depression|depression
78987|NCT02791906|Chronic Kidney Diseases|chronic kidney diseases
78988|NCT02791906|Chronic Kidney Insufficiency|chronic kidney insufficiency
78989|NCT02791906|Chronic Renal Diseases|chronic renal diseases
79091|NCT02791360|Brain|brain
78990|NCT02791906|Chronic Renal Insufficiency|chronic renal insufficiency
78991|NCT02791906|Kidney Insufficiency, Chronic|kidney insufficiency, chronic
78992|NCT02791906|Cardiac Failure|cardiac failure
78993|NCT02791906|Congestive Heart Failure|congestive heart failure
78994|NCT02791906|Heart Decompensation|heart decompensation
78995|NCT02791906|Heart Failure, Congestive|heart failure, congestive
78996|NCT02791906|Myocardial Failure|myocardial failure
78997|NCT02791880|acute kidney injury|acute kidney injury
78998|NCT02791880|transcatheter aortic valve replacement|transcatheter aortic valve replacement
78999|NCT02791880|genomics|genomics
79000|NCT02791880|biomarker|biomarker
79001|NCT02791841|Reading|reading
79002|NCT02791841|Developmental Dyslexia,|developmental dyslexia,
79003|NCT02791841|Music|music
79004|NCT02791841|Rhythm|rhythm
79005|NCT02791841|Action Video Games|action video games
79006|NCT02791841|Hemisphere-Specific Stimulation|hemisphere-specific stimulation
79007|NCT02791815|selexipag|selexipag
79008|NCT02791815|pharmacokinetics|pharmacokinetics
79009|NCT02791815|midazolam|midazolam
79010|NCT02791802|Lipoprotein(a)|lipoprotein(a)
79011|NCT02791802|lipoprotein/lipid apheresis|lipoprotein/lipid apheresis
79012|NCT02791802|CV disease|cv disease
92553|NCT02710279|Suicide|suicide
70284|NCT02844777|precancerous conditions|precancerous conditions
70285|NCT02844777|carcinoma, squamous cell|carcinoma, squamous cell
70286|NCT02844712|Drug hypersensitivity|drug hypersensitivity
70287|NCT02844712|Betalactam|betalactam
70288|NCT02844712|Drug provocation test|drug provocation test
70289|NCT02844699|prostate cancer|prostate cancer
70290|NCT02844699|adenovirus|adenovirus
70292|NCT02844699|immunotherapy|immunotherapy
79013|NCT02791789|Autism Spectrum Disorder|autism spectrum disorder
79014|NCT02791789|SEMATIC|sematic
79015|NCT02791789|software|software
79016|NCT02791776|scoliosis|scoliosis
79017|NCT02791763|Renal Anemia|renal anemia
79018|NCT02791763|Japanese|japanese
79019|NCT02791763|chronic kidney disease|chronic kidney disease
79020|NCT02791763|Peritoneal dialysis|peritoneal dialysis
79021|NCT02791763|GSK1278863|gsk1278863
79022|NCT02791763|Non-dialysis|non-dialysis
79023|NCT02791750|hormone replacement therapy|hormone replacement therapy
79024|NCT02791750|breast cancer|breast cancer
79025|NCT02791750|follow up|follow up
79026|NCT02791737|Hematologic Malignancy|hematologic malignancy
79027|NCT02791737|Exercise|exercise
79028|NCT02791737|Decreased Physical Activity|decreased physical activity
79029|NCT02791711|Bronchiolitis|bronchiolitis
79030|NCT02791711|Continuous Positive Airway Pressure|continuous positive airway pressure
79031|NCT02791711|HFNC|hfnc
79032|NCT02791698|cortisol|cortisol
79033|NCT02791698|hair|hair
79034|NCT02791698|urinary|urinary
79035|NCT02791685|Cardiac Rehabilitation|cardiac rehabilitation
79036|NCT02791672|Perioperative Care|perioperative care
79037|NCT02791672|Breast Reconstruction|breast reconstruction
79038|NCT02791659|radiation exposure|radiation exposure
79039|NCT02791659|ERCP|ercp
79040|NCT02791659|prone|prone
79041|NCT02791659|left lateral decubitus|left lateral decubitus
79042|NCT02791607|Circulating tumor cells|circulating tumor cells
79043|NCT02791607|Head and neck cancer|head and neck cancer
79044|NCT02791607|Survival Prognosis|survival prognosis
79045|NCT02791607|P16Ink4A|p16ink4a
79046|NCT02791607|HPV|hpv
79047|NCT02791555|pradaxa|pradaxa
79048|NCT02791555|warfarin|warfarin
79049|NCT02791542|Asthma|asthma
79050|NCT02791516|Osteoporosis.|osteoporosis.
79051|NCT02791516|Osteoporosis-Postmenopausal.|osteoporosis-postmenopausal.
79052|NCT02791516|Bone Diseases-Metabolic.|bone diseases-metabolic.
79053|NCT02791516|Bone Diseases.|bone diseases.
79054|NCT02791516|Musculoskeletal Diseases.|musculoskeletal diseases.
79055|NCT02791503|Irreversible electroporation (IRE|irreversible electroporation (ire
79056|NCT02791503|Stereotactic ablative radiotherapy (SABR|stereotactic ablative radiotherapy (sabr
79057|NCT02791503|Efficacy|efficacy
79058|NCT02791503|Tumor ablation|tumor ablation
79059|NCT02791503|Chemotherapy|chemotherapy
79060|NCT02791503|Locally advanced pancreatic cancer (LAPC)|locally advanced pancreatic cancer (lapc)
79061|NCT02791477|Attune|attune
79062|NCT02791464|Meditation|meditation
79063|NCT02791464|TM|tm
79064|NCT02791464|PTSD|ptsd
79065|NCT02791464|Trauma|trauma
79066|NCT02791464|Female Prisoners|female prisoners
79067|NCT02791451|COPD|copd
79068|NCT02791451|telemonitoring|telemonitoring
79069|NCT02791451|exacerbation|exacerbation
79070|NCT02791425|Brain-Computer Interface|brain-computer interface
79071|NCT02791425|Intratracheal intubation|intratracheal intubation
79072|NCT02791425|Mechanical ventilation|mechanical ventilation
79073|NCT02791425|Nonverbal communication|nonverbal communication
79074|NCT02791425|Critical illness|critical illness
79075|NCT02791425|Electroencephalography|electroencephalography
79076|NCT02791425|Visual Evoked Potential|visual evoked potential
79077|NCT02791412|left main|left main
79078|NCT02791412|unprotected|unprotected
79079|NCT02791412|percutaneous coronary intervention|percutaneous coronary intervention
79080|NCT02791412|coronary-artery bypass graft|coronary-artery bypass graft
79081|NCT02791399|opioid safety|opioid safety
79082|NCT02791399|opioid misuse|opioid misuse
79083|NCT02791399|opioid abuse|opioid abuse
79084|NCT02791399|patient-centered|patient-centered
79085|NCT02791399|opioid|opioid
79086|NCT02791399|opiate|opiate
79087|NCT02791399|chronic pain|chronic pain
79088|NCT02791399|primary care|primary care
79089|NCT02791399|Veteran|veteran
79090|NCT02791399|clinical care|clinical care
79092|NCT02791360|Radiotherapy|radiotherapy
79093|NCT02791360|MRI|mri
79094|NCT02791360|Sequelae|sequelae
79095|NCT02791334|PDL1|pdl1
79096|NCT02791334|PD-L1|pd-l1
79097|NCT02791295|Type 2 diabetes|type 2 diabetes
79098|NCT02791295|lifestyle intervention|lifestyle intervention
79099|NCT02791295|insulin pump treatment|insulin pump treatment
79100|NCT02791295|body weight|body weight
79101|NCT02791295|body composition|body composition
79102|NCT02791282|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
79103|NCT02791282|MRI|mri
79104|NCT02791282|SPECT|spect
79105|NCT02791230|amyloidosis|amyloidosis
79106|NCT02791230|amyloid|amyloid
79107|NCT02791230|transthyretin|transthyretin
79108|NCT02791230|TTR|ttr
79109|NCT02791191|BACE inhibitor|bace inhibitor
79110|NCT02791100|height|height
79111|NCT02791100|weight|weight
79112|NCT02791100|diet|diet
79113|NCT02791100|complementary foods|complementary foods
79114|NCT02791100|protein|protein
79115|NCT02791100|calcium|calcium
79116|NCT02791009|HF|hf
79117|NCT02791009|HFrEF|hfref
79118|NCT02791009|HFpEF|hfpef
79119|NCT02791009|MRI|mri
79120|NCT02791009|biomarker|biomarker
79121|NCT02790996|sepsis|sepsis
79122|NCT02790996|neonate|neonate
79123|NCT02790996|vancomycin|vancomycin
79124|NCT02790983|Registry|registry
79125|NCT02790983|Spine|spine
79126|NCT02790983|Surgery|surgery
79127|NCT02790983|Medical Oncology|medical oncology
79128|NCT02790983|Radiation Oncology|radiation oncology
79129|NCT02790983|Neoplasms|neoplasms
79130|NCT02790944|Germline|germline
79131|NCT02790944|Pancreatic|pancreatic
79132|NCT02790944|Genetic Testing|genetic testing
79136|NCT02790931|preventive care|preventive care
79137|NCT02790931|rehabilitation|rehabilitation
79138|NCT02790931|Diabetic Neuropathy|diabetic neuropathy
79139|NCT02790918|Pulmonary Hypertension|pulmonary hypertension
79140|NCT02790918|MRI|mri
79141|NCT02790905|pregnant and post-partum women|pregnant and post-partum women
79142|NCT02790905|Validation questionnaires|validation questionnaires
79143|NCT02790905|Thai-Myanmar border|thai-myanmar border
79144|NCT02790892|type 1 diabetes|type 1 diabetes
79145|NCT02790892|type 2 diabetes|type 2 diabetes
79146|NCT02790892|children|children
79147|NCT02790892|adolescents|adolescents
79148|NCT02790892|young adults|young adults
79149|NCT02790892|youth|youth
79150|NCT02790892|transition|transition
79151|NCT02790892|art therapy|art therapy
79152|NCT02790892|behavioral therapy|behavioral therapy
79153|NCT02790879|Transitional care|transitional care
79154|NCT02790879|teenagers|teenagers
79155|NCT02790879|cystic fibrosis|cystic fibrosis
79156|NCT02790879|pulmonary function|pulmonary function
79157|NCT02790879|nutritional function|nutritional function
79158|NCT02790879|Patients who experiment a transition pediatric - adult care|patients who experiment a transition pediatric - adult care
79159|NCT02790866|Decision Aid|decision aid
79160|NCT02790866|Informed Decision Making|informed decision making
79161|NCT02790866|Shared Decision making|shared decision making
79162|NCT02790866|Screening|screening
79163|NCT02790853|Cancer of Head and Neck|cancer of head and neck
79164|NCT02790853|Oral Potentially Malignant Disorders|oral potentially malignant disorders
79165|NCT02790853|OPMD|opmd
79166|NCT02790853|Multimodal Imaging|multimodal imaging
79167|NCT02790853|Suspicious oral mucosal lesion|suspicious oral mucosal lesion
79168|NCT02790853|Pathologic diagnosis of dysplasia|pathologic diagnosis of dysplasia
79169|NCT02790853|History of resected oral cancer|history of resected oral cancer
79170|NCT02790853|White Light Examination|white light examination
79171|NCT02790853|WL|wl
79172|NCT02790853|Wide-field auto-fluorescence imaging device PS2.1/PS3|wide-field auto-fluorescence imaging device ps2.1/ps3
79173|NCT02790853|Proflavine Hemisulfate|proflavine hemisulfate
79174|NCT02790853|High-Resolution Optical System|high-resolution optical system
79175|NCT02790853|HRME|hrme
79176|NCT02790853|Brush Biopsy|brush biopsy
79177|NCT02790853|Tissue Biopsy|tissue biopsy
79178|NCT02790840|Volunteers|volunteers
79179|NCT02790801|chronic heart failure|chronic heart failure
79180|NCT02790801|atrial fibrillation|atrial fibrillation
79181|NCT02790801|anticoagulant|anticoagulant
79182|NCT02790762|stem cells|stem cells
79183|NCT02790762|Mesenchymal Stem Cells|mesenchymal stem cells
79184|NCT02790762|Umbilical Cord-Mesenchymal Stem Cells|umbilical cord-mesenchymal stem cells
79185|NCT02790762|Pneumoconiosis|pneumoconiosis
79186|NCT02790749|Developmental hip dysplasia|developmental hip dysplasia
79187|NCT02790749|Intra-articular pathology|intra-articular pathology
79188|NCT02790749|Adult hip dysplasia|adult hip dysplasia
79189|NCT02790749|Labral tear, hip|labral tear, hip
79190|NCT02790749|Chondromalacia, hip|chondromalacia, hip
79191|NCT02790736|propranolol|propranolol
79192|NCT02790736|public speaking anxiety|public speaking anxiety
79193|NCT02790710|propanolol|propanolol
79194|NCT02790710|obsessive-compulsive disorder|obsessive-compulsive disorder
79195|NCT02790697|Indirect calorimetry|indirect calorimetry
79196|NCT02790697|ICALIC Study|icalic study
79197|NCT02790697|Energy expenditure|energy expenditure
79198|NCT02790697|VO2|vo2
79199|NCT02790697|VCO2|vco2
79200|NCT02790697|Respiratory quotient|respiratory quotient
79201|NCT02790658|Grumixama|grumixama
92784|NCT02708472|Anxiety|anxiety
79202|NCT02790658|Urolithins|urolithins
79203|NCT02790658|Anthocyanins|anthocyanins
79204|NCT02790658|Metabolomic Approach|metabolomic approach
79205|NCT02790658|Ellagitannins|ellagitannins
79206|NCT02790658|Subjects|subjects
79207|NCT02790645|Type 1 diabetes|type 1 diabetes
79208|NCT02790645|Health technologies|health technologies
79209|NCT02790645|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
79210|NCT02790645|Telemedicine|telemedicine
79211|NCT02790645|Glycemic variability|glycemic variability
79212|NCT02790645|Inflammatory markers,|inflammatory markers,
79213|NCT02790645|Oxidative stress|oxidative stress
79214|NCT02790645|Depression|depression
79215|NCT02790645|Quality of life|quality of life
79216|NCT02790645|Cost-effectiveness|cost-effectiveness
79220|NCT02790567|diagnostic performance|diagnostic performance
79221|NCT02790567|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
79222|NCT02790567|rapid immunological diagnostic method|rapid immunological diagnostic method
79223|NCT02790567|immunoassay|immunoassay
79224|NCT02790567|pretest scoring systems|pretest scoring systems
79225|NCT02790567|4Ts score|4ts score
79226|NCT02790567|HEP score|hep score
79228|NCT02790541|HBOT|hbot
79229|NCT02790541|reverse|reverse
79230|NCT02790541|angiogenesis|angiogenesis
79231|NCT02790541|elderly|elderly
79232|NCT02790541|mitochohndria|mitochohndria
79233|NCT02790528|statin|statin
79234|NCT02790528|vasospastic angina|vasospastic angina
79235|NCT02790476|Safe|safe
79236|NCT02790476|Prescribing|prescribing
79237|NCT02790476|Opioids|opioids
79238|NCT02790463|Allopurinol|allopurinol
79239|NCT02790398|Transdiagnostic treatment protocol|transdiagnostic treatment protocol
79240|NCT02790398|Transdiagnostic treatment protocol + PA component|transdiagnostic treatment protocol + pa component
79241|NCT02790372|Nursing homes|nursing homes
79242|NCT02790372|Norway|norway
79243|NCT02790359|Carbon dioxide|carbon dioxide
79244|NCT02790359|Air|air
79245|NCT02790359|Colonoscopy|colonoscopy
79246|NCT02790346|hemiparesis|hemiparesis
79247|NCT02790346|deformity of the foot and ankle|deformity of the foot and ankle
79248|NCT02790320|Eribulin mesylate|eribulin mesylate
79249|NCT02790320|Halaven|halaven
79250|NCT02790320|Breast cancer|breast cancer
79251|NCT02790307|multiple sclerosis|multiple sclerosis
79252|NCT02790307|overactive bladder|overactive bladder
79253|NCT02790307|urinary incontinence|urinary incontinence
79254|NCT02790307|tibial nerve stimulation|tibial nerve stimulation
79255|NCT02790294|magnetic resonance imaging|magnetic resonance imaging
79256|NCT02790268|Cionni Ring|cionni ring
79257|NCT02790268|Ultrasound Biomicroscopy|ultrasound biomicroscopy
79258|NCT02790242|Mechanical Circulatory Support Device (MCSD)|mechanical circulatory support device (mcsd)
79259|NCT02790242|ventricular Assist Device (VAD)|ventricular assist device (vad)
79260|NCT02790229|rehabilitation, anti-gravity treadmill|rehabilitation, anti-gravity treadmill
79261|NCT02790216|Image guided brachytherapy|image guided brachytherapy
79262|NCT02790151|working memory, recollection training, transfer|working memory, recollection training, transfer
79263|NCT02790138|Drug Therapy|drug therapy
79264|NCT02790112|Body Mass Index|body mass index
79265|NCT02790112|Body Composition|body composition
79266|NCT02790112|Glucose Metabolism Disorders|glucose metabolism disorders
79267|NCT02790112|Bone Development|bone development
79268|NCT02790112|Gonadal Disorders|gonadal disorders
79269|NCT02790112|Fertility|fertility
79270|NCT02790112|Overweight|overweight
79271|NCT02790112|Obesity|obesity
79272|NCT02790112|Menarche|menarche
79273|NCT02790099|Pain|pain
79274|NCT02790099|Postoperative pain control|postoperative pain control
79275|NCT02790099|Rectus sheath block|rectus sheath block
79276|NCT02790099|Intrathecal morphine|intrathecal morphine
79277|NCT02790099|Caesarean section|caesarean section
79278|NCT02790086|hypothermia|hypothermia
79279|NCT02790086|prevalence|prevalence
79280|NCT02790086|perioperative|perioperative
79281|NCT02790086|anemia|anemia
79282|NCT02790086|myocardial injury|myocardial injury
79283|NCT02790086|troponin T|troponin t
79284|NCT02790086|noncardiac surgery|noncardiac surgery
79285|NCT02790073|Calciphylaxis|calciphylaxis
79286|NCT02790073|Calcific Uremic Arteriolopathy|calcific uremic arteriolopathy
79287|NCT02790073|Dialysis|dialysis
79288|NCT02790073|End Stage Renal Disease|end stage renal disease
79289|NCT02790073|Rare disease (ORPHA280062)|rare disease (orpha280062)
79290|NCT02790073|Calcification|calcification
79291|NCT02790073|Calcium Metabolism Disorders|calcium metabolism disorders
79292|NCT02790073|Calcinosis|calcinosis
79293|NCT02790073|Metabolic Diseases|metabolic diseases
79294|NCT02790060|diabetes|diabetes
79295|NCT02790047|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
79296|NCT02790047|Exercise Therapy|exercise therapy
79297|NCT02790047|Positive Expiratory Pressure|positive expiratory pressure
79298|NCT02790047|Physical Fitness|physical fitness
79299|NCT02790047|Quality of Life|quality of life
70586|NCT02843100|Pediatric|pediatric
70588|NCT02843100|Diet|diet
79300|NCT02790008|echocardiography|echocardiography
79301|NCT02790008|magnetic resonance imaging|magnetic resonance imaging
79302|NCT02790008|cardiopulmonary exercise test|cardiopulmonary exercise test
79303|NCT02789995|Intensive Care Unit - Acquired Weakness (ICU-AW)|intensive care unit - acquired weakness (icu-aw)
79304|NCT02789982|PTSD|ptsd
79305|NCT02789982|Trauma related disorders|trauma related disorders
79306|NCT02789982|Reconsolidation blockade|reconsolidation blockade
79307|NCT02789982|Paris attacks|paris attacks
79308|NCT02789956|Internal connection|internal connection
79309|NCT02789956|Cobalt/Chrome|cobalt/chrome
79310|NCT02789956|Cad-cam Framework|cad-cam framework
79311|NCT02789956|marginal bone level|marginal bone level
79312|NCT02789943|IHD Normal EF|ihd normal ef
79313|NCT02789930|Weight estimation|weight estimation
79314|NCT02789930|Patient safety|patient safety
79315|NCT02789917|ACS|acs
79316|NCT02789917|Triple-Therapy|triple-therapy
79317|NCT02789917|AF|af
79318|NCT02789917|oral anticoagulation (OAC)|oral anticoagulation (oac)
79319|NCT02789917|non-vitamin-K oral anticoagulant (NOAC)|non-vitamin-k oral anticoagulant (noac)
79320|NCT02789878|Neoadjuvant therapy|neoadjuvant therapy
79321|NCT02789878|High-risk Prostate Cancer|high-risk prostate cancer
79322|NCT02789865|Acute appendicitis|acute appendicitis
79323|NCT02789865|Endoscopic retrograde appendicitis therapy|endoscopic retrograde appendicitis therapy
79324|NCT02789865|Endoscopic retrograde appendicography|endoscopic retrograde appendicography
79325|NCT02789865|Endoscopic therapy|endoscopic therapy
79326|NCT02789865|Appendectomy|appendectomy
79327|NCT02789865|Antibiotic Therapy|antibiotic therapy
79328|NCT02789787|Cleft Lip|cleft lip
79329|NCT02789787|Palate|palate
79330|NCT02789787|Class III|class iii
79331|NCT02789787|Malocclusion|malocclusion
79332|NCT02789787|Protraction|protraction
79333|NCT02789761|Flow-mediated dilatation (FMD)|flow-mediated dilatation (fmd)
79334|NCT02789761|Vascular function|vascular function
79335|NCT02789761|cognitive function|cognitive function
79336|NCT02789735|Pregnancy|pregnancy
79337|NCT02789735|laser therapy|laser therapy
79338|NCT02789735|persistent pain|persistent pain
79339|NCT02789735|pelvic pain|pelvic pain
79340|NCT02789722|Mate|mate
79341|NCT02789722|Vascular protection|vascular protection
79342|NCT02789722|Endothelial function|endothelial function
79343|NCT02789722|Ilex paraguariensis|ilex paraguariensis
79344|NCT02789657|neoadjuvant breast cancer|neoadjuvant breast cancer
79345|NCT02789657|stage I-III breast cancer|stage i-iii breast cancer
79346|NCT02789657|HER 2 positive breast cancer|her 2 positive breast cancer
79347|NCT02789644|Ursodeoxycholic acid|ursodeoxycholic acid
79348|NCT02789644|Metabolomics/biomarker|metabolomics/biomarker
79349|NCT02789644|Pharmacokinetics|pharmacokinetics
79350|NCT02789605|Aphthous Stomatitis [C07.465.864.750]|aphthous stomatitis [c07.465.864.750]
79351|NCT02789592|REM Sleep Behavior Disorder|rem sleep behavior disorder
79352|NCT02789592|Parkinson Disease|parkinson disease
79353|NCT02789592|Randomized Controlled Trial|randomized controlled trial
79354|NCT02789592|Clinical Trial|clinical trial
79355|NCT02789592|Melatonin|melatonin
79356|NCT02789592|Clonazepam|clonazepam
79357|NCT02789579|prophylactic|prophylactic
79358|NCT02789579|Urinary Tract Infections|urinary tract infections
79359|NCT02789579|Minimally invasive upper tract lithotomy|minimally invasive upper tract lithotomy
79360|NCT02789566|Primaquine|primaquine
79361|NCT02789566|Pharmacokinetic|pharmacokinetic
79362|NCT02789553|Glucose digestion|glucose digestion
79363|NCT02789553|Bypass surgery|bypass surgery
79364|NCT02789553|C13-glucose tracer|c13-glucose tracer
79365|NCT02789553|Insulin secretion|insulin secretion
79366|NCT02789540|COPD symptoms|copd symptoms
79367|NCT02789527|healthy volunteers|healthy volunteers
79368|NCT02789514|esophagogastroduodenoscopy|esophagogastroduodenoscopy
79369|NCT02789514|paediatric|paediatric
79370|NCT02789501|Catheter|catheter
79371|NCT02789501|Dysfunctions|dysfunctions
79372|NCT02789501|Blood Stream Infections|blood stream infections
79373|NCT02789501|Haemodialysis|haemodialysis
79374|NCT02789501|Taurolidine|taurolidine
79375|NCT02789501|Tunneled|tunneled
79376|NCT02789436|halitosis|halitosis
79377|NCT02789436|chronic periodontitis|chronic periodontitis
79378|NCT02789436|probiotic|probiotic
79379|NCT02789410|Cesarean delivery|cesarean delivery
79380|NCT02789410|Analgesia|analgesia
79381|NCT02789410|Intrathecal opioids|intrathecal opioids
79382|NCT02789397|Granulomatous and lymphocytic interstitial lung disease|granulomatous and lymphocytic interstitial lung disease
79383|NCT02789397|common variable immunodeficiency|common variable immunodeficiency
79384|NCT02789397|Rituximab|rituximab
79385|NCT02789397|Azathioprine|azathioprine
79386|NCT02789397|primary immunodeficiency|primary immunodeficiency
79387|NCT02789397|GLIILD|gliild
79388|NCT02789397|CVID|cvid
79389|NCT02789384|soft-tissue sarcomas|soft-tissue sarcomas
79390|NCT02789384|CINSARC|cinsarc
93038|NCT02706886|PH1|ph1
79391|NCT02789384|biomarker|biomarker
79392|NCT02789384|efficacy|efficacy
79393|NCT02789384|pronostic|pronostic
79394|NCT02789371|EUS-FNA|eus-fna
79395|NCT02789371|modified wet suction technique|modified wet suction technique
79396|NCT02789371|dry suction technique|dry suction technique
79397|NCT02789358|cryotherapy|cryotherapy
79398|NCT02789345|T790M|t790m
79399|NCT02789345|epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
79400|NCT02789332|carboplatin|carboplatin
79401|NCT02789332|olaparib|olaparib
79403|NCT02789332|neoadjuvant|neoadjuvant
79404|NCT02789332|triple-negative|triple-negative
79405|NCT02789332|hormonreceptor-positive|hormonreceptor-positive
79406|NCT02789332|BRCA1/2|brca1/2
79407|NCT02789332|HRD, homologous recominant deficient|hrd, homologous recominant deficient
79408|NCT02789332|breast cancer|breast cancer
79409|NCT02789332|genetic testing (somatic and germline mutations)|genetic testing (somatic and germline mutations)
79410|NCT02789319|Blood Glucose Monitoring System|blood glucose monitoring system
79411|NCT02789319|BGMS|bgms
79412|NCT02789319|Diabetes|diabetes
79413|NCT02789319|Patient Use|patient use
79414|NCT02789306|Preventive therapy|preventive therapy
627574|NCT00690547|Active|active
79415|NCT02789306|Dental implants|dental implants
79416|NCT02789293|Glaucoma|glaucoma
79417|NCT02789293|Ultrasound|ultrasound
79418|NCT02789293|Ciliary body|ciliary body
79419|NCT02789267|Head and Neck Cancer|head and neck cancer
79420|NCT02789267|Quality of Life|quality of life
79421|NCT02789267|Dietary support|dietary support
79422|NCT02789254|acute myeloid leukemia|acute myeloid leukemia
79423|NCT02789254|Fms-like receptor tyrosine kinase (FLT3)|fms-like receptor tyrosine kinase (flt3)
79424|NCT02789254|stem cell transplantation|stem cell transplantation
79425|NCT02789254|complete remission|complete remission
79427|NCT02789254|antibodies|antibodies
79428|NCT02789254|Leukemia|leukemia
79430|NCT02789254|Fc-optimized|fc-optimized
79431|NCT02789241|Endotoxin|endotoxin
79432|NCT02789241|healthy|healthy
79433|NCT02789241|volunteers|volunteers
79434|NCT02789241|males|males
79435|NCT02789241|females|females
79436|NCT02789215|Child care food costs|child care food costs
79437|NCT02789215|Meal participation rates|meal participation rates
79438|NCT02789215|Child and Adult Care Food Program|child and adult care food program
79439|NCT02789202|dental caries|dental caries
79440|NCT02789202|deciduous tooth|deciduous tooth
79441|NCT02789176|Phenobarbital|phenobarbital
79442|NCT02789176|EEG|eeg
79443|NCT02789176|family impact|family impact
79444|NCT02789176|neurodevelopment|neurodevelopment
79445|NCT02789163|breast|breast
79446|NCT02789163|ultrasound|ultrasound
79447|NCT02789163|diagnostic exam|diagnostic exam
79448|NCT02789163|automated volume breast scanner|automated volume breast scanner
79449|NCT02789137|metastatic renal cell carcinoma|metastatic renal cell carcinoma
79450|NCT02789124|fluid responsiveness|fluid responsiveness
79451|NCT02789124|carotid artery flow time|carotid artery flow time
79452|NCT02789124|passive leg raise|passive leg raise
79453|NCT02789098|ST Elevation Myocardial Infarction|st elevation myocardial infarction
79454|NCT02789098|Ventricular remodeling|ventricular remodeling
79455|NCT02789098|Biomarkers|biomarkers
79456|NCT02789098|Coronary endothelial function|coronary endothelial function
79457|NCT02789098|Positron Emission Tomography|positron emission tomography
79458|NCT02789085|TENS|tens
79459|NCT02789085|ULF-TENS|ulf-tens
79460|NCT02789085|ANS|ans
79461|NCT02789085|Dentistry|dentistry
79462|NCT02789085|TMD|tmd
79463|NCT02789059|Becker muscular dystrophy|becker muscular dystrophy
79464|NCT02789059|Facioscapulohumeral dystrophy|facioscapulohumeral dystrophy
79465|NCT02789059|congenital myopathy|congenital myopathy
79466|NCT02789059|motor neurone diseases|motor neurone diseases
79467|NCT02789046|adult|adult
79468|NCT02789046|vascular access|vascular access
79469|NCT02789046|preoperative period|preoperative period
79470|NCT02789046|peripheral venous catheterization|peripheral venous catheterization
79471|NCT02789033|diabetic foot ulcers|diabetic foot ulcers
79472|NCT02789033|chitosan|chitosan
79473|NCT02789033|isosorbide dinitrate spray|isosorbide dinitrate spray
79474|NCT02788981|triple-negative breast cancer|triple-negative breast cancer
79475|NCT02788981|advanced breast cancer|advanced breast cancer
79476|NCT02788981|nab-paclitaxel|nab-paclitaxel
79477|NCT02788981|mifepristone|mifepristone
79478|NCT02788981|glucocorticoid receptor-positive breast cancer|glucocorticoid receptor-positive breast cancer
79479|NCT02788968|Psychology and Cognitive Neuroscience of development|psychology and cognitive neuroscience of development
79482|NCT02788968|Conflict detection|conflict detection
79483|NCT02788968|Reasoning|reasoning
79484|NCT02788955|Protein|protein
79485|NCT02788955|Diet intervention|diet intervention
79486|NCT02788955|Muscle|muscle
79491|NCT02788929|Percutaneous Transluminal Coronary Intervention|percutaneous transluminal coronary intervention
79493|NCT02788929|Fitbit Charge HR|fitbit charge hr
79494|NCT02788916|Drug Therapy|drug therapy
79495|NCT02788903|Obesity Counseling|obesity counseling
79496|NCT02788864|Forest ranger|forest ranger
79497|NCT02788864|P.falciparum|p.falciparum
79498|NCT02788864|P.vivax|p.vivax
79499|NCT02788864|Dihydroartemisinine-piperaquine (DP)|dihydroartemisinine-piperaquine (dp)
79500|NCT02788864|Primaquine|primaquine
79506|NCT02788838|Magnetic Resonance Imaging|magnetic resonance imaging
79507|NCT02788838|Energy Intake|energy intake
79508|NCT02788838|Commercials|commercials
79509|NCT02788838|Children|children
79510|NCT02788799|ST Elevation|st elevation
79511|NCT02788799|LCX Artery|lcx artery
79512|NCT02788786|chlorhexidine|chlorhexidine
79513|NCT02788786|cetylpyridinium chloride|cetylpyridinium chloride
79514|NCT02788786|gingival crevicular fluid|gingival crevicular fluid
79515|NCT02788734|carpal tunnel syndrome|carpal tunnel syndrome
79517|NCT02788734|inherited peripheral neuropathy|inherited peripheral neuropathy
79518|NCT02788734|Charcot-Marie-Tooth disease|charcot-marie-tooth disease
79521|NCT02788734|CMT|cmt
79522|NCT02788734|HNPP|hnpp
79523|NCT02788708|paclitaxel|paclitaxel
79524|NCT02788708|lenvatinib|lenvatinib
79525|NCT02788695|Visual Nonspecific|visual nonspecific
79526|NCT02788682|VDBP|vdbp
79527|NCT02788682|single nucleotide polymorphisms (SNPs)|single nucleotide polymorphisms (snps)
79528|NCT02788682|interferon based therapy|interferon based therapy
79529|NCT02788682|Egypt|egypt
79530|NCT02788656|heart failure|heart failure
79531|NCT02788656|neprilysin|neprilysin
79532|NCT02788656|implantable hemodynamic monitor|implantable hemodynamic monitor
79533|NCT02788656|angiotensin-receptor blocker|angiotensin-receptor blocker
79534|NCT02788656|angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
79535|NCT02788604|psychosocial screening, quality of life|psychosocial screening, quality of life
79536|NCT02788552|Neurological|neurological
79537|NCT02788552|Diet and Nutrition|diet and nutrition
79538|NCT02788552|Mental Health|mental health
79539|NCT02788539|Chronic Pain|chronic pain
79540|NCT02788539|mhealth|mhealth
79541|NCT02788539|Integrative Medicine|integrative medicine
79542|NCT02788539|MBSR|mbsr
79543|NCT02788539|Mindfulness Based Stress Reduction|mindfulness based stress reduction
79544|NCT02788539|Web based|web based
79545|NCT02788539|Internet Based|internet based
79546|NCT02788526|Carcinoma,Hepatocellular|carcinoma,hepatocellular
79547|NCT02788526|Chemoembolization|chemoembolization
79548|NCT02788526|Adjuvant therapy|adjuvant therapy
79549|NCT02788526|Hepatocellular|hepatocellular
79550|NCT02788526|Microvessels invasion|microvessels invasion
79551|NCT02788500|Epidemiology|epidemiology
79552|NCT02788500|Sports medicine|sports medicine
79553|NCT02788500|Research protocol|research protocol
79554|NCT02788500|Athletic injuries|athletic injuries
79555|NCT02788500|Sports for persons with disabilities|sports for persons with disabilities
79556|NCT02788448|Percutaneous vascular closure device|percutaneous vascular closure device
79557|NCT02788448|Large hole closure device|large hole closure device
79558|NCT02788396|STEMI|stemi
79559|NCT02788396|PPCI|ppci
79560|NCT02788396|post-dilatation|post-dilatation
79561|NCT02788396|coronary microcirculation|coronary microcirculation
79562|NCT02788370|Positive expiratory pressure|positive expiratory pressure
79563|NCT02788370|Cardiopulmonary responses|cardiopulmonary responses
79564|NCT02788370|Exercise|exercise
79565|NCT02788370|Older people|older people
79566|NCT02788357|motor training|motor training
79567|NCT02788357|motor recovery|motor recovery
79568|NCT02788357|human|human
79569|NCT02788357|neuroplasticity|neuroplasticity
79976|NCT02786329|lidocaine|lidocaine
79570|NCT02788357|transcranial magnetic stimulation|transcranial magnetic stimulation
79571|NCT02788344|Observational study|observational study
79572|NCT02788344|Myocardial revascularization|myocardial revascularization
79573|NCT02788344|Thrombolytic therapy|thrombolytic therapy
79574|NCT02788344|Hospital mortality|hospital mortality
79575|NCT02788344|Hemorrhage|hemorrhage
79576|NCT02788344|Quality of health care|quality of health care
79577|NCT02788344|Angioplasty|angioplasty
79578|NCT02788318|Epilepsy|epilepsy
79579|NCT02788318|SUDEP|sudep
79580|NCT02788318|Serotonin|serotonin
79581|NCT02788292|acetylcysteine|acetylcysteine
79582|NCT02788292|three-dimensional reconstruction|three-dimensional reconstruction
79583|NCT02788292|autologous fat grafting|autologous fat grafting
79585|NCT02788266|Cervical lesion|cervical lesion
79586|NCT02788266|gingival recession|gingival recession
79587|NCT02788266|restorative materials|restorative materials
79588|NCT02788253|Mallampati|mallampati
79589|NCT02788253|Intubation difficult|intubation difficult
79590|NCT02788253|Mask ventilation difficult|mask ventilation difficult
79591|NCT02788227|Ebola Vaccine|ebola vaccine
79592|NCT02788214|Gastric Cancer|gastric cancer
79593|NCT02788214|Bacterial Risk Factors|bacterial risk factors
79594|NCT02788214|DNA Methylation|dna methylation
79595|NCT02788214|DNA Sequencing|dna sequencing
79598|NCT02788201|Bladder Cancer|bladder cancer
79599|NCT02788201|Molecular Profiles|molecular profiles
79600|NCT02788201|Algorithm|algorithm
79601|NCT02788201|Biomarkers|biomarkers
70875|NCT02841059|POP|pop
79602|NCT02788188|First in Human|first in human
79603|NCT02788188|Middle East Respiratory Syndrome (MERS)|middle east respiratory syndrome (mers)
79604|NCT02788188|Tc Bovine-Derived|tc bovine-derived
79605|NCT02788188|Transchromosomic Cattle|transchromosomic cattle
79606|NCT02788175|HIV Immune Therapy|hiv immune therapy
79607|NCT02788175|Monoclonal Antibody|monoclonal antibody
79608|NCT02788175|Integrin|integrin
79609|NCT02788149|Ultrasonography|ultrasonography
79610|NCT02788149|Submental|submental
79611|NCT02788149|Lateral Parapharyngeal wall|lateral parapharyngeal wall
79612|NCT02788149|Tongue base thickness|tongue base thickness
79613|NCT02788149|Polysomnography|polysomnography
79614|NCT02788123|De-Nol|de-nol
79615|NCT02788123|NSAID-induced gastropathy|nsaid-induced gastropathy
79616|NCT02788123|Pantoprazole|pantoprazole
79617|NCT02788123|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate
79618|NCT02788123|Russia|russia
79619|NCT02788097|blastocysts|blastocysts
79620|NCT02788097|progesterone|progesterone
79621|NCT02788097|implantation|implantation
79622|NCT02788097|artificial frozen embryo transfer|artificial frozen embryo transfer
79623|NCT02788084|Next Generation Sequencing|next generation sequencing
79624|NCT02788084|Cell free DNA|cell free dna
79625|NCT02788071|Irritable Bowel Syndrome|irritable bowel syndrome
79626|NCT02788071|Fecal Microbiota Transplantation|fecal microbiota transplantation
79627|NCT02788071|Microbiota|microbiota
79628|NCT02788058|Hypofractionated Radiotherapy|hypofractionated radiotherapy
79629|NCT02788058|EGFR Positive|egfr positive
79630|NCT02788058|Lung Adenocarcinoma|lung adenocarcinoma
79631|NCT02788058|Limited Metastases|limited metastases
79632|NCT02788019|Adductor canal block, nerve block|adductor canal block, nerve block
79633|NCT02787941|acute coronary syndrome|acute coronary syndrome
79634|NCT02787941|medication adherence|medication adherence
79635|NCT02787941|pharmacist-led interventions|pharmacist-led interventions
79636|NCT02787941|Vietnam|vietnam
79637|NCT02787915|dendritic cells|dendritic cells
79638|NCT02787915|cytotoxic T lymphocyte|cytotoxic t lymphocyte
79639|NCT02787915|DC vaccine|dc vaccine
79640|NCT02787863|Pneumococcal vaccine|pneumococcal vaccine
79641|NCT02787863|Polioxidonium|polioxidonium
79642|NCT02787837|Prognostic|prognostic
79643|NCT02787837|Castration|castration
79644|NCT02787837|Resistant|resistant
79645|NCT02787837|Abiraterone|abiraterone
79646|NCT02787824|iron deficiency|iron deficiency
79647|NCT02787824|hemodialysis|hemodialysis
79649|NCT02787811|Pregnancy rate|pregnancy rate
79650|NCT02787811|predictors|predictors
79651|NCT02787798|Nervous System|nervous system
79652|NCT02787798|Cardiac disease|cardiac disease
79653|NCT02787785|Subcutaneous|subcutaneous
79654|NCT02787785|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
79655|NCT02787785|MADIT|madit
79656|NCT02787785|Diabetes|diabetes
79657|NCT02787785|Myocardial Infarction|myocardial infarction
79658|NCT02787759|stroke|stroke
79659|NCT02787759|walking|walking
79660|NCT02787759|balance|balance
79661|NCT02787759|exercise|exercise
79662|NCT02787746|AD|ad
79663|NCT02787746|Donepezil|donepezil
79664|NCT02787746|Safety|safety
79665|NCT02787733|performance|performance
79666|NCT02787733|recovery|recovery
79667|NCT02787720|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
79668|NCT02787720|Pulmonary Rehabilitation|pulmonary rehabilitation
79669|NCT02787720|Rehabilitation Plan|rehabilitation plan
79670|NCT02787720|Rehabilitation Techniques|rehabilitation techniques
79671|NCT02787720|Survivor|survivor
79672|NCT02787720|Randomized Controlled Trial|randomized controlled trial
79673|NCT02787707|Breast cancer|breast cancer
79674|NCT02787707|Traditional medicine|traditional medicine
79675|NCT02787707|Chemotherapy Induced Nausea and Vomiting|chemotherapy induced nausea and vomiting
79676|NCT02787707|Bunium Persicum|bunium persicum
79677|NCT02787707|Rhus Coriaria|rhus coriaria
79678|NCT02787694|stroke|stroke
79679|NCT02787694|walking|walking
79680|NCT02787694|balance|balance
79681|NCT02787694|exercise|exercise
79682|NCT02787668|childhood obesity|childhood obesity
79683|NCT02787668|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
79689|NCT02787629|D007440|d007440
79690|NCT02787590|Neurology|neurology
79691|NCT02787577|Sleep Duration|sleep duration
79692|NCT02787577|Sleep Quality|sleep quality
79693|NCT02787577|Body Composition|body composition
79694|NCT02787577|Energy Intake|energy intake
79695|NCT02787577|Energy Expenditure|energy expenditure
79696|NCT02787577|Energy Balance|energy balance
79697|NCT02787577|Cardiovascular Risk|cardiovascular risk
79698|NCT02787564|fruit, vegetables|fruit, vegetables
79699|NCT02787538|Rheumatoid Arthritis|rheumatoid arthritis
79700|NCT02787538|Decision Aids|decision aids
79702|NCT02787512|ERCP|ercp
79703|NCT02787512|stent|stent
79704|NCT02787512|preoperative biliary drainage|preoperative biliary drainage
79705|NCT02787499|Drug resistance|drug resistance
79706|NCT02787499|Standard of care|standard of care
79707|NCT02787499|sub-saharan africa|sub-saharan africa
79708|NCT02787499|antiretroviral therapy|antiretroviral therapy
79709|NCT02787499|diagnostics|diagnostics
79710|NCT02787499|implementation|implementation
79711|NCT02787486|Down syndrome|down syndrome
79712|NCT02787486|Edwards syndrome|edwards syndrome
79713|NCT02787486|Patau syndrome|patau syndrome
79714|NCT02787486|Klinefelter syndrome|klinefelter syndrome
79715|NCT02787486|DiGeorge syndrome|digeorge syndrome
79716|NCT02787486|Chromosome Deletion|chromosome deletion
79717|NCT02787486|Aneuploidy|aneuploidy
79718|NCT02787473|Squamous cell lung cancer|squamous cell lung cancer
79719|NCT02787473|Pemetrexed|pemetrexed
79720|NCT02787473|Radiosensitivity|radiosensitivity
79721|NCT02787460|Parenting|parenting
79722|NCT02787460|Family Relations|family relations
79723|NCT02787460|Marriage|marriage
79724|NCT02787460|Relationships|relationships
79725|NCT02787447|Hypofractionated Radiotherapy|hypofractionated radiotherapy
79726|NCT02787447|Thymosin Alpha 1|thymosin alpha 1
79727|NCT02787447|Lung Adenocarcinoma|lung adenocarcinoma
79728|NCT02787447|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
79729|NCT02787434|African american men|african american men
79730|NCT02787434|prostate cancer screening|prostate cancer screening
79731|NCT02787434|web-based decision aid|web-based decision aid
79732|NCT02787434|informed decision making|informed decision making
79733|NCT02787434|shared decision-making|shared decision-making
79734|NCT02787421|Reconstructive Surgery|reconstructive surgery
79735|NCT02787421|Rhinoplasty|rhinoplasty
79736|NCT02787382|cytomegalovirus|cytomegalovirus
79737|NCT02787382|TORCH|torch
79738|NCT02787382|prenatal diagnosis|prenatal diagnosis
79739|NCT02787382|congenital infections|congenital infections
79740|NCT02787382|fetal abnormalities|fetal abnormalities
79741|NCT02787382|echocardiography|echocardiography
79742|NCT02787382|myocardial deformation|myocardial deformation
79743|NCT02787369|Refractory Leukemia|refractory leukemia
79744|NCT02787369|Leukemia|leukemia
79745|NCT02787356|Skin Diseases, Erythema|skin diseases, erythema
79746|NCT02787330|pediatric cancer|pediatric cancer
79747|NCT02787330|psychosocial|psychosocial
79748|NCT02787330|siblings|siblings
79749|NCT02787317|bivalirudin|bivalirudin
79750|NCT02787317|myocardial injure|myocardial injure
79751|NCT02787304|NAFLD activity score|nafld activity score
79752|NCT02787304|ASBTi|asbti
79753|NCT02787304|MRI PDFF|mri pdff
79755|NCT02787304|NAFLD|nafld
79756|NCT02787304|liver disease|liver disease
79757|NCT02787304|ASBT|asbt
79758|NCT02787304|MRI proton density fat fraction|mri proton density fat fraction
79759|NCT02787304|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
79760|NCT02787304|apical sodium dependent bile acid transporter inhibitor|apical sodium dependent bile acid transporter inhibitor
79761|NCT02787304|fatty liver|fatty liver
79762|NCT02787304|NASH|nash
79763|NCT02787278|rtPA|rtpa
79764|NCT02787278|Intracranial hemorrhage|intracranial hemorrhage
79765|NCT02787265|High density spinal cord stimulation|high density spinal cord stimulation
79766|NCT02787265|Virtual expert registry|virtual expert registry
79767|NCT02787226|liposomal bupivacaine|liposomal bupivacaine
79768|NCT02787226|analgesia for total shoulder arthroplasty|analgesia for total shoulder arthroplasty
79769|NCT02787226|peripheral nerve blocks for total shoulder arthroplasty|peripheral nerve blocks for total shoulder arthroplasty
79770|NCT02787213|proteomics|proteomics
79771|NCT02787213|pregnancy|pregnancy
79772|NCT02787213|biomarkers|biomarkers
79773|NCT02787213|preterm birth|preterm birth
79774|NCT02787200|electroencephalogram (EEG),Human brain,Brain-Computer Interface|electroencephalogram (eeg),human brain,brain-computer interface
79775|NCT02787187|Standard lymphadenectomy|standard lymphadenectomy
80186|NCT02784912|Galectin-3|galectin-3
79776|NCT02787187|extended lymphadenectomy|extended lymphadenectomy
79777|NCT02787187|pancreaticoduodenectomy|pancreaticoduodenectomy
79778|NCT02787174|Asthma|asthma
79779|NCT02787174|Medication adherence|medication adherence
79780|NCT02787174|Intervention study|intervention study
79781|NCT02787161|Chronic Kidney Disease|chronic kidney disease
79782|NCT02787161|Hemodialysis|hemodialysis
79783|NCT02787161|Hemodiafiltration|hemodiafiltration
79784|NCT02787161|Renal Replacement Therapy|renal replacement therapy
79785|NCT02787161|Physical Activity|physical activity
79786|NCT02787161|Accelerometer|accelerometer
79787|NCT02787148|cognitive behavioral therapy|cognitive behavioral therapy
79788|NCT02787148|psychotherapy|psychotherapy
79789|NCT02787148|cardiovascular health|cardiovascular health
79790|NCT02787148|psychoneuroimmunology|psychoneuroimmunology
79791|NCT02787135|Delusions|delusions
79792|NCT02787135|Schizophrenia|schizophrenia
79793|NCT02787135|Cognitive Behavior Therapy|cognitive behavior therapy
79794|NCT02787135|Emotion|emotion
79795|NCT02787135|Emotion regulation|emotion regulation
79796|NCT02787135|self-esteem|self-esteem
79797|NCT02787135|sleep quality|sleep quality
79798|NCT02787135|Efficacy of change|efficacy of change
79799|NCT02787122|Schizophrenia|schizophrenia
79800|NCT02787122|psychotic disorders|psychotic disorders
79801|NCT02787122|Cognitive Behavior Therapy|cognitive behavior therapy
71132|NCT02839330|Flu|flu
79802|NCT02787122|emotion regulation|emotion regulation
79803|NCT02787122|self-esteem|self-esteem
79804|NCT02787122|randomized-controlled trial|randomized-controlled trial
79805|NCT02787109|Safety|safety
79806|NCT02787109|Immunogenicity|immunogenicity
79807|NCT02787109|Phase I|phase i
79808|NCT02787096|dynamic knee laxity measurement|dynamic knee laxity measurement
79809|NCT02787096|laxi-MRI|laxi-mri
79810|NCT02787096|partial anterior cruciate ligament tear|partial anterior cruciate ligament tear
79811|NCT02787083|Interstitial Cystitis|interstitial cystitis
79812|NCT02787044|influenza vaccine|influenza vaccine
79813|NCT02787044|cardiopulmonary hospitalization|cardiopulmonary hospitalization
79814|NCT02787044|heart failure|heart failure
79815|NCT02787044|myocardial infarction|myocardial infarction
79816|NCT02787044|clinical trial|clinical trial
79817|NCT02787031|hip fracture|hip fracture
79818|NCT02787031|geriatric|geriatric
79819|NCT02787031|epidemiology|epidemiology
79820|NCT02787031|practice variation|practice variation
79821|NCT02787031|anesthesia|anesthesia
79822|NCT02787018|Brachial plexus block|brachial plexus block
79823|NCT02787018|Ropivacaine|ropivacaine
79824|NCT02787018|Dexmedetomidine|dexmedetomidine
79825|NCT02787018|Dexamethasone|dexamethasone
79826|NCT02787018|Adjuvants, anesthesia|adjuvants, anesthesia
79827|NCT02787005|PD1|pd1
79828|NCT02787005|PD-1|pd-1
79829|NCT02787005|PDL1|pdl1
79830|NCT02787005|PD-L1|pd-l1
79831|NCT02786992|Misoprostol|misoprostol
79832|NCT02786992|Oxytocin|oxytocin
79833|NCT02786992|Carbetocin|carbetocin
79834|NCT02786992|Prevention|prevention
79835|NCT02786992|Post-partum hemorrhage|post-partum hemorrhage
79836|NCT02786979|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
79837|NCT02786979|Arteriosclerosis|arteriosclerosis
79838|NCT02786979|beraprost|beraprost
79839|NCT02786979|Aspirin|aspirin
79840|NCT02786966|Cervical spine injuries|cervical spine injuries
79841|NCT02786966|Canadian C-spine Rule|canadian c-spine rule
79842|NCT02786966|Emergency Medical Services|emergency medical services
79843|NCT02786966|Paramedic|paramedic
79844|NCT02786966|Cervical spine fracture|cervical spine fracture
79845|NCT02786953|Sleep|sleep
79846|NCT02786953|Adherence|adherence
79847|NCT02786953|Diabetes Management|diabetes management
79848|NCT02786953|Adolescent|adolescent
79849|NCT02786940|remote|remote
79850|NCT02786940|cardiac monitoring|cardiac monitoring
79851|NCT02786940|mortality|mortality
79852|NCT02786927|HANDIHALER|handihaler
79853|NCT02786927|Dry Powder Inhaler|dry powder inhaler
79854|NCT02786927|COPD|copd
79855|NCT02786927|ELLIPTA|ellipta
79856|NCT02786927|Inhaler preference attributes|inhaler preference attributes
79857|NCT02786875|lifestyle|lifestyle
79858|NCT02786875|low glycemic index diet|low glycemic index diet
79859|NCT02786875|exercise|exercise
79860|NCT02786875|vitamin D|vitamin d
79861|NCT02786875|breast cancer|breast cancer
79862|NCT02786875|Mediterranean diet|mediterranean diet
79863|NCT02786862|mechanical ventilation|mechanical ventilation
79864|NCT02786862|independent ventilation|independent ventilation
79865|NCT02786862|ventilation/perfusion mismatch|ventilation/perfusion mismatch
79866|NCT02786862|thoracic anesthesia|thoracic anesthesia
79867|NCT02786849|Electric Stimulation|electric stimulation
79868|NCT02786849|Electric Stimulation Therapy|electric stimulation therapy
79869|NCT02786836|acute liver failure|acute liver failure
79870|NCT02786836|methacetin|methacetin
79871|NCT02786836|breath test|breath test
79872|NCT02786836|severe acute liver injury|severe acute liver injury
79873|NCT02786836|hepatic encephalopathy|hepatic encephalopathy
79874|NCT02786836|ALFSG Registry|alfsg registry
79875|NCT02786836|acetaminophen toxicity|acetaminophen toxicity
79876|NCT02786797|breast cancer|breast cancer
79877|NCT02786797|mindfulness-based stress reduction|mindfulness-based stress reduction
79878|NCT02786797|cognitive impairment|cognitive impairment
79879|NCT02786771|Stress Management|stress management
79880|NCT02786771|Mindfulness|mindfulness
79881|NCT02786771|Meditation|meditation
79882|NCT02786771|Stress Resilience|stress resilience
79883|NCT02786732|Psoriasis|psoriasis
79884|NCT02786719|Sargramostim|sargramostim
79885|NCT02786719|Cyclophosphamide|cyclophosphamide
79886|NCT02786719|Topotecan|topotecan
79887|NCT02786719|Cisplatin|cisplatin
79888|NCT02786719|Dexrazoxane|dexrazoxane
79889|NCT02786719|Doxorubicin|doxorubicin
79890|NCT02786719|Etoposide|etoposide
79891|NCT02786719|Filgrastim|filgrastim
79892|NCT02786719|Vincristine|vincristine
79893|NCT02786719|Mesna|mesna
79894|NCT02786706|Traumatic Brain Injury|traumatic brain injury
79895|NCT02786706|Intracranial Pressure|intracranial pressure
79896|NCT02786706|Ultrasonography|ultrasonography
79897|NCT02786706|Computer-Assisted Image Analysis|computer-assisted image analysis
79898|NCT02786706|Intracranial Hypertension|intracranial hypertension
79899|NCT02786706|Acute brain injuries|acute brain injuries
79900|NCT02786693|TEP-scan|tep-scan
79901|NCT02786654|Acute myocardial infarction|acute myocardial infarction
79902|NCT02786654|mortality|mortality
79903|NCT02786654|evidence-based care|evidence-based care
79904|NCT02786654|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
79905|NCT02786654|β blockers|β blockers
79906|NCT02786641|nasopharyngeal carcinoma|nasopharyngeal carcinoma
79907|NCT02786641|induction chemotherapy|induction chemotherapy
79908|NCT02786641|concurrent chemotherapy|concurrent chemotherapy
79909|NCT02786641|docetaxel|docetaxel
79910|NCT02786641|cisplatin|cisplatin
79911|NCT02786641|xeloda|xeloda
79912|NCT02786641|nomogram|nomogram
79913|NCT02786615|men who have sex with men (MSM)|men who have sex with men (msm)
79914|NCT02786589|Lung cancer Immunotherapy|lung cancer immunotherapy
79915|NCT02786589|Plasmodium vivax|plasmodium vivax
79916|NCT02786589|Immunotherapy|immunotherapy
79917|NCT02786576|Moderate to Severe Hidradenitis Suppurativa|moderate to severe hidradenitis suppurativa
79918|NCT02786576|Adalimumab|adalimumab
79919|NCT02786563|ultrasonographic (US)|ultrasonographic (us)
79920|NCT02786563|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
79921|NCT02786563|C-reactive protein (CRP)|c-reactive protein (crp)
79922|NCT02786563|power doppler (PD)|power doppler (pd)
79923|NCT02786563|disease activity scale (DAS)|disease activity scale (das)
79924|NCT02786550|Lower blepharoplasty, Botulinum toxin, Scar|lower blepharoplasty, botulinum toxin, scar
79925|NCT02786537|Hepatitis C|hepatitis c
79926|NCT02786524|Palliative Care|palliative care
79927|NCT02786524|Triage|triage
79928|NCT02786524|Symptom Evaluation|symptom evaluation
79929|NCT02786524|Chemotherapy|chemotherapy
79930|NCT02786524|Patient Distress|patient distress
79931|NCT02786498|Tibial Shaft|tibial shaft
79932|NCT02786498|Tibia|tibia
79933|NCT02786498|Femoral Shaft|femoral shaft
79934|NCT02786498|Femur|femur
79935|NCT02786498|Vitamin D|vitamin d
79936|NCT02786498|Fracture Healing|fracture healing
79937|NCT02786485|BPX-501|bpx-501
79938|NCT02786485|Rimiducid|rimiducid
79939|NCT02786485|AP1903|ap1903
79940|NCT02786485|Hematological malignancies|hematological malignancies
79941|NCT02786485|Hematologic diseases|hematologic diseases
79942|NCT02786485|Leukemias and Myelodysplastic Syndromes|leukemias and myelodysplastic syndromes
79943|NCT02786485|Lymphomas|lymphomas
79944|NCT02786485|Multiple myeloma|multiple myeloma
79945|NCT02786472|Bystander behaviors|bystander behaviors
79946|NCT02786472|Incoming students|incoming students
79947|NCT02786472|CampusSave|campussave
79948|NCT02786472|Prevention|prevention
79949|NCT02786472|Sexual Assault|sexual assault
79950|NCT02786472|Incapacitation|incapacitation
79951|NCT02786459|Prostate|prostate
79952|NCT02786459|Local Recurrence|local recurrence
79953|NCT02786459|Radical Prostatectomy|radical prostatectomy
79954|NCT02786446|Lidocaine gel|lidocaine gel
79955|NCT02786446|Extracorporeal shockwave lithotripsy|extracorporeal shockwave lithotripsy
79956|NCT02786446|Naproxen sodium|naproxen sodium
79957|NCT02786446|Pain score|pain score
79958|NCT02786420|pregnancy|pregnancy
79959|NCT02786420|magnetic resonance imaging|magnetic resonance imaging
79960|NCT02786420|environmental air pollutants|environmental air pollutants
79961|NCT02786407|overactive bladder|overactive bladder
79962|NCT02786407|Botulinum Toxin Type A for Injection|botulinum toxin type a for injection
79963|NCT02786368|Food Production|food production
79964|NCT02786368|Inadequacy|inadequacy
79965|NCT02786368|Dietary zinc|dietary zinc
79966|NCT02786368|Iron|iron
79967|NCT02786368|vitamin A|vitamin a
79968|NCT02786342|Hepatocellular Carcinoma|hepatocellular carcinoma
79969|NCT02786342|Sorafenib|sorafenib
79970|NCT02786342|HCC|hcc
79971|NCT02786342|Angiogenesis|angiogenesis
79972|NCT02786342|Polymorphisms|polymorphisms
79973|NCT02786329|colorectal cancer|colorectal cancer
79974|NCT02786329|TIVA|tiva
79975|NCT02786329|sevoflurane|sevoflurane
79977|NCT02786264|transcatheter aortic valve replacement|transcatheter aortic valve replacement
79978|NCT02786264|anesthesia|anesthesia
79979|NCT02786264|conscious sedation|conscious sedation
79980|NCT02786264|managed anesthesia care|managed anesthesia care
79981|NCT02786199|Hepatocellular Carcinoma(HCC)|hepatocellular carcinoma(hcc)
79982|NCT02786199|Ultrasound|ultrasound
79983|NCT02786199|Backscatter|backscatter
79984|NCT02786199|Differentiation grade|differentiation grade
79985|NCT02786199|Survival|survival
79986|NCT02786186|Psoriasis|psoriasis
79987|NCT02786186|Plaque Psoriasis|plaque psoriasis
79988|NCT02786186|Chronic Plaque Psoriasis|chronic plaque psoriasis
79990|NCT02786186|Secukinumab|secukinumab
79991|NCT02786186|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
79992|NCT02786186|PURE registry|pure registry
79993|NCT02786186|Registry|registry
79994|NCT02786173|PRIME|prime
79995|NCT02786173|PAD|pad
79996|NCT02786173|PVD|pvd
79997|NCT02786173|Observational|observational
79998|NCT02786173|CLI|cli
79999|NCT02786173|PRIME Registry|prime registry
80000|NCT02786147|Breast Cancer|breast cancer
71282|NCT02838160|KAP|kap
80001|NCT02786147|Ovarian Cancer|ovarian cancer
80002|NCT02786147|B-RST|b-rst
80003|NCT02786121|hip replacement,|hip replacement,
80004|NCT02786121|rehabilitation,|rehabilitation,
80005|NCT02786121|early ambulation,|early ambulation,
80006|NCT02786108|left gastric artery|left gastric artery
80007|NCT02786108|embolization|embolization
80008|NCT02786108|obesity|obesity
80009|NCT02786095|Atrial fibrillation|atrial fibrillation
80010|NCT02786095|anti arrhythmic drug|anti arrhythmic drug
80011|NCT02786095|NOAC|noac
80012|NCT02786095|warfarin|warfarin
80013|NCT02786095|coumadin|coumadin
80014|NCT02786056|Respiratory Function Tests|respiratory function tests
80015|NCT02786056|Lung|lung
80016|NCT02785965|electroacupuncture|electroacupuncture
80017|NCT02785965|lifestyle modification|lifestyle modification
80018|NCT02785965|diet|diet
80019|NCT02785965|exercise|exercise
80020|NCT02785965|Dai Meridian|dai meridian
80021|NCT02785926|pesticide exposure|pesticide exposure
80022|NCT02785926|respiratory control|respiratory control
80023|NCT02785926|sleep|sleep
80024|NCT02785900|Antibodies, monoclonal|antibodies, monoclonal
80025|NCT02785900|Antibody drug conjugate|antibody drug conjugate
80026|NCT02785900|Antigens, cluster of differentiation 33 (CD33)|antigens, cluster of differentiation 33 (cd33)
80027|NCT02785900|Drug therapy|drug therapy
80028|NCT02785900|Immunotherapy|immunotherapy
80029|NCT02785887|Breast cancer|breast cancer
80030|NCT02785887|lung cancer|lung cancer
80031|NCT02785887|Gastrointestinal Cancer|gastrointestinal cancer
80032|NCT02785887|Ovarian cancer|ovarian cancer
80033|NCT02785887|Prostate cancer|prostate cancer
80034|NCT02785887|bladder cancer|bladder cancer
80035|NCT02785861|hormonal therapy|hormonal therapy
80036|NCT02785861|walking|walking
80037|NCT02785861|fatigue|fatigue
80038|NCT02785822|Reproductive Techniques, Assisted|reproductive techniques, assisted
80039|NCT02785809|Oral contraceptives|oral contraceptives
80040|NCT02785809|long-term use|long-term use
80041|NCT02785809|AMH|amh
80042|NCT02785809|Ovarian reserve parameters|ovarian reserve parameters
80043|NCT02785783|EndoRings™|endorings™
80044|NCT02785757|adenocarcinoma|adenocarcinoma
80045|NCT02785757|venous thromboembolism|venous thromboembolism
80046|NCT02785757|thrombin generation assay|thrombin generation assay
80047|NCT02785731|pelvic mass|pelvic mass
80048|NCT02785731|ovarian cancer|ovarian cancer
80049|NCT02785731|gynecological cancer|gynecological cancer
80050|NCT02785731|risk prediction|risk prediction
80051|NCT02785718|Contact system|contact system
80052|NCT02785718|Factor XI deficiency|factor xi deficiency
80053|NCT02785718|Factor XII deficiency|factor xii deficiency
80054|NCT02785718|Global haemostasis assays|global haemostasis assays
80055|NCT02785705|immunization|immunization
80056|NCT02785705|vaccine schedule|vaccine schedule
80057|NCT02785705|poliomyelitis|poliomyelitis
80058|NCT02785705|polio|polio
80059|NCT02785705|oral polio vaccine|oral polio vaccine
80060|NCT02785705|inactivated polio vaccine|inactivated polio vaccine
80061|NCT02785692|soft tissue sarcoma|soft tissue sarcoma
80062|NCT02785692|IMRT and sarcoma|imrt and sarcoma
80063|NCT02785692|preoperative highly conformal radiation therapy|preoperative highly conformal radiation therapy
80064|NCT02785692|soft tissue sarcoma and wound healing|soft tissue sarcoma and wound healing
80065|NCT02785692|postoperative complications|postoperative complications
80066|NCT02785692|treatment tolerance of soft tissue IMRT|treatment tolerance of soft tissue imrt
80067|NCT02785679|Allergy|allergy
80068|NCT02785679|Cow's milk|cow's milk
80069|NCT02785679|breast feeding|breast feeding
80070|NCT02785679|Cow's milk formula|cow's milk formula
80071|NCT02785679|prevention|prevention
80072|NCT02785666|Men who have sex with men|men who have sex with men
80073|NCT02785666|Elimination|elimination
80074|NCT02785653|sevoflurane|sevoflurane
80075|NCT02785653|rocuronium|rocuronium
80076|NCT02785653|intubation|intubation
80077|NCT02785627|Bone health|bone health
80078|NCT02785627|Bone microarchitecture|bone microarchitecture
80079|NCT02785627|Androgen deprivation therapy (ADT)|androgen deprivation therapy (adt)
80080|NCT02785588|MRI Scanner|mri scanner
80081|NCT02785588|NICU|nicu
80190|NCT02784912|hs-TnT|hs-tnt
80082|NCT02785562|PDL1 expression : Protein Death Ligand 1 expression .|pdl1 expression : protein death ligand 1 expression .
80083|NCT02785549|Acute diverticulitis|acute diverticulitis
80084|NCT02785549|Antibiotic|antibiotic
80085|NCT02785549|Outpatient treatment|outpatient treatment
80086|NCT02785536|minority health|minority health
80087|NCT02785536|social class|social class
80088|NCT02785536|healthcare disparities|healthcare disparities
80089|NCT02785536|tobacco use disorder|tobacco use disorder
80090|NCT02785497|Electrical stimulation|electrical stimulation
80091|NCT02785497|wound healing|wound healing
80092|NCT02785497|Polarity current|polarity current
80093|NCT02785497|Burn|burn
80094|NCT02785497|Chronic ulcer|chronic ulcer
80095|NCT02785484|Cigarette smoking|cigarette smoking
80096|NCT02785484|Smoking|smoking
80097|NCT02785484|Tobacco use|tobacco use
80098|NCT02785471|Suicide prevention|suicide prevention
80099|NCT02785471|men's mental health|men's mental health
80100|NCT02785471|depression|depression
80101|NCT02785471|suicide ideation and behaviors|suicide ideation and behaviors
80102|NCT02785419|Rehabilitation|rehabilitation
80103|NCT02785419|Upper Extremity|upper extremity
80104|NCT02785419|Physical Therapy|physical therapy
80105|NCT02785406|cocaine|cocaine
80106|NCT02785406|sleep|sleep
80107|NCT02785406|anxiety|anxiety
80108|NCT02785406|craving|craving
80109|NCT02785406|addiction|addiction
80110|NCT02785406|orexin|orexin
80111|NCT02785406|cue reactivity|cue reactivity
80112|NCT02785406|suvorexant|suvorexant
80113|NCT02785406|Belsomra|belsomra
80114|NCT02785393|Methamphetamine|methamphetamine
80115|NCT02785393|Dependence|dependence
80116|NCT02785341|adapted physical activity|adapted physical activity
80118|NCT02785328|sleep|sleep
80119|NCT02785328|narcolepsy|narcolepsy
80120|NCT02785328|apnea|apnea
80121|NCT02785328|epilepsy|epilepsy
80122|NCT02785302|Pediatric|pediatric
80124|NCT02785302|Transition|transition
80125|NCT02785302|Adult Care|adult care
80126|NCT02785263|Anal cancer|anal cancer
80127|NCT02785263|Shared decision making|shared decision making
80128|NCT02785250|vaccine|vaccine
80129|NCT02785250|immunotherapy|immunotherapy
80130|NCT02785250|IDO1 inhibitor|ido1 inhibitor
80131|NCT02785250|ovarian|ovarian
80132|NCT02785250|fallopian tube|fallopian tube
80133|NCT02785250|peritoneal|peritoneal
80134|NCT02785250|cancer|cancer
80135|NCT02785250|recurrent|recurrent
80136|NCT02785250|tumor|tumor
80137|NCT02785250|measurable|measurable
80138|NCT02785237|Drug-eluting stent|drug-eluting stent
80139|NCT02785237|OCT|oct
80140|NCT02785237|Re-endothelialization|re-endothelialization
80141|NCT02785146|Huaier Granule|huaier granule
80142|NCT02785146|After radical surgery|after radical surgery
80143|NCT02785146|Prevention of recurrence and metastasis|prevention of recurrence and metastasis
80144|NCT02785146|Efficacy and safety|efficacy and safety
80145|NCT02785120|Phase 2|phase 2
80146|NCT02785120|Efficacy|efficacy
80147|NCT02785120|Safety|safety
80148|NCT02785120|Ischemic Stroke|ischemic stroke
80149|NCT02785107|Exercise|exercise
80150|NCT02785107|Habit|habit
80151|NCT02785107|MVPA|mvpa
80152|NCT02785107|M-PAC|m-pac
80153|NCT02785107|Automaticity|automaticity
80154|NCT02785107|Physical Activity|physical activity
80155|NCT02785094|Caesarean Section Rate|caesarean section rate
80156|NCT02785094|Primigravida|primigravida
80157|NCT02785081|Thoracic epidural|thoracic epidural
80158|NCT02785081|Magnetic Resonance Imaging|magnetic resonance imaging
80159|NCT02785081|Children|children
80160|NCT02785068|Phase I|phase i
80161|NCT02785068|Cancer|cancer
80162|NCT02785068|EGFR|egfr
80163|NCT02785068|Metastatic Colorectal Cancer|metastatic colorectal cancer
80164|NCT02785068|Oncology|oncology
80165|NCT02785068|RAS/RAF Wild-Type|ras/raf wild-type
80166|NCT02785068|Nal-IRI|nal-iri
80167|NCT02785068|EGFR Inhibitor|egfr inhibitor
80168|NCT02785068|Oligoclonal Antibody|oligoclonal antibody
80169|NCT02785068|Nanoliposome|nanoliposome
80170|NCT02785068|Nanoliposomal Irinotecan|nanoliposomal irinotecan
80171|NCT02785016|Stress Urinary Incontinence|stress urinary incontinence
80172|NCT02785016|Suburethral Sling|suburethral sling
80173|NCT02785003|Colorectal Surgery|colorectal surgery
80174|NCT02785003|Acute Pain|acute pain
80175|NCT02785003|Pain|pain
80176|NCT02785003|post-operative pain|post-operative pain
80177|NCT02785003|ketamine|ketamine
80178|NCT02784938|Employment|employment
80179|NCT02784938|Mental Illness|mental illness
80180|NCT02784938|Photovoice|photovoice
80181|NCT02784912|Biomarkers|biomarkers
80182|NCT02784912|Ventricular Dysfunction|ventricular dysfunction
80183|NCT02784912|Ventricular Tachycardia|ventricular tachycardia
80184|NCT02784912|Electrical Storm|electrical storm
80185|NCT02784912|ST2|st2
80187|NCT02784912|NT-proBNP|nt-probnp
80188|NCT02784912|Iron Deficiency|iron deficiency
80189|NCT02784912|hs-CRP|hs-crp
80191|NCT02784886|Placenta accreta|placenta accreta
80192|NCT02784886|previous caesarean|previous caesarean
80193|NCT02784886|placenta praevia|placenta praevia
80194|NCT02784886|Cell-free fetal DNA|cell-free fetal dna
80195|NCT02784886|Biological markers|biological markers
80196|NCT02784873|High intensity interval training|high intensity interval training
80197|NCT02784873|Coronary heart disease|coronary heart disease
80198|NCT02784873|Exercise training|exercise training
80199|NCT02784873|Cardiac rehabilitation|cardiac rehabilitation
80200|NCT02784873|Interval training|interval training
80202|NCT02784860|lidocaine|lidocaine
80203|NCT02784860|propofol|propofol
80204|NCT02784860|sedation|sedation
80205|NCT02784834|CLL|cll
80206|NCT02784834|cancer|cancer
80207|NCT02784834|DMF|dmf
80208|NCT02784834|SLL|sll
80209|NCT02784834|dimethylfumarate|dimethylfumarate
71471|NCT02836717|SNM|snm
71472|NCT02836691|Autonomic nervous system|autonomic nervous system
71473|NCT02836691|Uncontrolled severe asthma|uncontrolled severe asthma
71474|NCT02836691|Paucigranulocitic asthma phenotype|paucigranulocitic asthma phenotype
80210|NCT02784834|relapsed|relapsed
80211|NCT02784834|refractory|refractory
80212|NCT02784795|Notch Inhibitor|notch inhibitor
80213|NCT02784782|Spinal|spinal
80214|NCT02784782|Vertebral|vertebral
80215|NCT02784782|Burstfracture|burstfracture
80216|NCT02784782|Orthesis|orthesis
80217|NCT02784782|Brace|brace
80218|NCT02784782|Thoracolumbar|thoracolumbar
80219|NCT02784756|Quantiferon-CMV|quantiferon-cmv
80220|NCT02784756|solid organ transplant|solid organ transplant
80221|NCT02784756|CMV Disease|cmv disease
80222|NCT02784743|Wuchereria bancrofti|wuchereria bancrofti
80223|NCT02784743|Anopheles|anopheles
80224|NCT02784743|Albendazole|albendazole
80225|NCT02784743|Ivermectin|ivermectin
80227|NCT02784730|breast cancer|breast cancer
80228|NCT02784730|chemotherapy|chemotherapy
80229|NCT02784730|peripherally inserted central catheter|peripherally inserted central catheter
80230|NCT02784730|implantable device|implantable device
80231|NCT02784730|randomized controlled trial|randomized controlled trial
80232|NCT02784730|iterative placement|iterative placement
80233|NCT02784730|Catheterization, Central Venous|catheterization, central venous
80234|NCT02784717|rivaroxaban,|rivaroxaban,
80235|NCT02784717|non-interventional,|non-interventional,
80236|NCT02784717|atrial fibrillation,|atrial fibrillation,
80237|NCT02784717|stroke prevention,|stroke prevention,
80238|NCT02784665|CSC|csc
80239|NCT02784665|Micropulse Laser|micropulse laser
80240|NCT02784665|Traditional Laser|traditional laser
80241|NCT02784639|KRAS/BRAF mutational status|kras/braf mutational status
80242|NCT02784626|Dexmedetomidine|dexmedetomidine
80243|NCT02784626|Propofol|propofol
80244|NCT02784626|Pain, Postoperative|pain, postoperative
80245|NCT02784600|Partial-thickness|partial-thickness
80246|NCT02784600|Full-thickness|full-thickness
80247|NCT02784587|stellate ganglion block|stellate ganglion block
80248|NCT02784587|cardiac surgery|cardiac surgery
80249|NCT02784574|Rehabilitation|rehabilitation
80250|NCT02784574|Aftercare|aftercare
80251|NCT02784561|allogeneic peripheral blood stem cell transplantation|allogeneic peripheral blood stem cell transplantation
80252|NCT02784561|conditioning regimen|conditioning regimen
80253|NCT02784561|acute leukemia|acute leukemia
80254|NCT02784561|relapsed/refractory|relapsed/refractory
80255|NCT02784509|Physical Activity|physical activity
80256|NCT02784509|Sedentary Behavior|sedentary behavior
80257|NCT02784509|Cardiometabolic Risk Factors|cardiometabolic risk factors
80258|NCT02784509|Childhood and Adolescence|childhood and adolescence
80259|NCT02784496|Myelofibrosis|myelofibrosis
80260|NCT02784496|Primary Myelofibrosis|primary myelofibrosis
80261|NCT02784496|PMF|pmf
80262|NCT02784496|Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis|post polycythemia vera/essential thrombocythemia myelofibrosis
80263|NCT02784496|Post-PV/ET MF|post-pv/et mf
80264|NCT02784496|Ruxolitinib|ruxolitinib
80265|NCT02784496|Jakafi|jakafi
80266|NCT02784496|INCB018424|incb018424
80267|NCT02784496|INC424|inc424
80268|NCT02784496|Questionnaires|questionnaires
80269|NCT02784496|Surveys|surveys
80270|NCT02784444|NASH|nash
80271|NCT02784405|percutaneous coronary intervention|percutaneous coronary intervention
80272|NCT02784405|stent implantation|stent implantation
80273|NCT02784379|Mastalgia|mastalgia
80274|NCT02784379|electromyography|electromyography
80275|NCT02784379|Pectoral|pectoral
80276|NCT02784366|Cancer immunotherapy|cancer immunotherapy
80277|NCT02784366|Ipilimumab|ipilimumab
80278|NCT02784353|Rehabilitation|rehabilitation
80279|NCT02784353|Quality of life|quality of life
80280|NCT02784353|Surgery|surgery
80281|NCT02784353|Hepatic neoplasms|hepatic neoplasms
80282|NCT02784353|Biliary tract neoplasms|biliary tract neoplasms
80283|NCT02784353|Pancreatic neoplasms|pancreatic neoplasms
80284|NCT02784340|Postoperative pain|postoperative pain
80285|NCT02784340|dexamethasone|dexamethasone
80286|NCT02784340|cesarean section|cesarean section
80287|NCT02784314|Clinically localized prostate cancer|clinically localized prostate cancer
80288|NCT02784314|Robotic-assisted prostatectomy|robotic-assisted prostatectomy
80289|NCT02784314|Laparoscopic prostatectomy|laparoscopic prostatectomy
80290|NCT02784314|Erectile function ;|erectile function ;
80586|NCT02782793|Resection|resection
80291|NCT02784314|Cost efficacy study|cost efficacy study
80292|NCT02784288|head and neck neoplasms|head and neck neoplasms
80293|NCT02784288|HPV|hpv
80294|NCT02784288|human papilloma virus|human papilloma virus
80295|NCT02784288|de-escalation|de-escalation
80296|NCT02784288|low-risk|low-risk
80297|NCT02784288|oropharyngeal cancer|oropharyngeal cancer
81767|NCT02776189|MRI|mri
80298|NCT02784262|Botulinum Toxin Type A|botulinum toxin type a
80299|NCT02784262|Block|block
80300|NCT02784262|Sphenopalatine Ganglion|sphenopalatine ganglion
80301|NCT02784249|Glaucoma|glaucoma
80302|NCT02784249|glaucoma surgery|glaucoma surgery
80303|NCT02784249|ab interno|ab interno
80304|NCT02784223|F18-choline|f18-choline
80305|NCT02784223|Surgery|surgery
80306|NCT02784223|Indeterminate|indeterminate
80307|NCT02784223|Thyroid node|thyroid node
80308|NCT02784210|Multiple Sclerosis|multiple sclerosis
80309|NCT02784210|Corticosteroids|corticosteroids
80310|NCT02784184|Hypothalamic-pituitary-gonadal axis|hypothalamic-pituitary-gonadal axis
80311|NCT02784158|Non-small cell lung cancer|non-small cell lung cancer
80312|NCT02784158|Non-small cell lung carcinoma|non-small cell lung carcinoma
80313|NCT02784158|Epithelial lung cancer|epithelial lung cancer
80314|NCT02784158|Squamous cell carcinoma|squamous cell carcinoma
80315|NCT02784158|Large cell carcinoma|large cell carcinoma
80316|NCT02784158|Adenocarcinoma|adenocarcinoma
80317|NCT02784158|Anaplastic lymphoma kinase (ALK)|anaplastic lymphoma kinase (alk)
80318|NCT02784158|Carcinoma|carcinoma
80319|NCT02784158|Advanced Cancers|advanced cancers
80320|NCT02784158|Brigatinib|brigatinib
80322|NCT02784119|temporary porto-caval shunt|temporary porto-caval shunt
80323|NCT02784119|liver graft|liver graft
80324|NCT02784119|extended criteria donor|extended criteria donor
80325|NCT02784106|Rheumatoid Arthritis|rheumatoid arthritis
80326|NCT02784106|M2951|m2951
80327|NCT02784106|Bruton's Tyrosine Kinase (BTK)|bruton's tyrosine kinase (btk)
80328|NCT02784093|Chronic Constipation|chronic constipation
80329|NCT02784093|Fecal impaction|fecal impaction
80330|NCT02784093|Gastrografin|gastrografin
80331|NCT02784093|Randomized Controlled Trial|randomized controlled trial
80332|NCT02784080|Liver Transplantation|liver transplantation
80333|NCT02784080|HLA alloantibodies|hla alloantibodies
80334|NCT02784080|donor specific antibodies|donor specific antibodies
80335|NCT02784080|Mortality|mortality
80336|NCT02784080|Re-transplantation|re-transplantation
80337|NCT02784080|Rejection|rejection
80338|NCT02784080|Acute rejection|acute rejection
80339|NCT02784080|Chronic rejection|chronic rejection
80340|NCT02784080|Biliary complications|biliary complications
80341|NCT02784080|Biliary stricture|biliary stricture
80342|NCT02784080|Arterial thrombosis|arterial thrombosis
80343|NCT02784080|Arterial stenosis|arterial stenosis
80344|NCT02784080|Portal vein thrombosis|portal vein thrombosis
80345|NCT02784080|Fibrosis|fibrosis
80346|NCT02784080|Single antigen bead|single antigen bead
80347|NCT02784080|Cross-match|cross-match
80348|NCT02784041|knee arthroplasty|knee arthroplasty
80349|NCT02784041|adductor canal block|adductor canal block
80350|NCT02784041|periarticular infiltration|periarticular infiltration
80351|NCT02784028|Peritoneal Carcinomatosis|peritoneal carcinomatosis
80352|NCT02784028|SGM-101|sgm-101
80353|NCT02783989|Endothelial function|endothelial function
80354|NCT02783989|Inflammation|inflammation
80355|NCT02783989|Genes related to vascular risk|genes related to vascular risk
80356|NCT02783963|Coronary Artery Disease|coronary artery disease
80357|NCT02783963|Coronary Thrombosis|coronary thrombosis
80358|NCT02783963|Coronary Stenosis|coronary stenosis
80359|NCT02783963|Tomography, Optical Coherence|tomography, optical coherence
80360|NCT02783963|Magnetic Resonance Imaging|magnetic resonance imaging
80361|NCT02783950|Genomics|genomics
80362|NCT02783950|Adjuvant Treatment|adjuvant treatment
80363|NCT02783937|Premature|premature
80364|NCT02783937|Ovarian|ovarian
80365|NCT02783937|Failure|failure
80366|NCT02783937|Filgrastim|filgrastim
80367|NCT02783924|vitamin D|vitamin d
80368|NCT02783924|genomics|genomics
80369|NCT02783924|proteomics|proteomics
80370|NCT02783924|metabolomics|metabolomics
80371|NCT02783924|adipose tissue|adipose tissue
80372|NCT02783911|Clinical and Radiograph|clinical and radiograph
80373|NCT02783898|pre syncope, palpitations|pre syncope, palpitations
80374|NCT02783859|Children|children
80375|NCT02783859|Anti-Bacterial Agents|anti-bacterial agents
80376|NCT02783859|Indigenous Population|indigenous population
80377|NCT02783859|Hospitals|hospitals
80378|NCT02783846|Propofol|propofol
80379|NCT02783846|Dexmedetomidine|dexmedetomidine
80380|NCT02783846|Dose|dose
80381|NCT02783846|Bispectral index monitor|bispectral index monitor
80382|NCT02783833|malaria, induced blood stage model challenge|malaria, induced blood stage model challenge
80483|NCT02783404|dentistry|dentistry
80383|NCT02783820|malaria, single ascending dose,|malaria, single ascending dose,
80384|NCT02783794|BP-C1|bp-c1
80385|NCT02783794|CDBPA|cdbpa
80386|NCT02783794|Cis-coordinated complexes of platinum(II) with polymer of benzene polycarboxylic acids derived from lignin|cis-coordinated complexes of platinum(ii) with polymer of benzene polycarboxylic acids derived from lignin
80587|NCT02782780|insomnia|insomnia
80387|NCT02783794|Benzene polycarboxylic acids complex with cis-diammineplatinum(II)|benzene polycarboxylic acids complex with cis-diammineplatinum(ii)
80388|NCT02783794|Metastatic Breast Cancer|metastatic breast cancer
80389|NCT02783794|Platinum analogue|platinum analogue
80390|NCT02783794|Metronomic chemotherapy|metronomic chemotherapy
94281|NCT02698904|Anxiety|anxiety
71685|NCT02835456|CAUTI|cauti
80391|NCT02783794|Breast cancer|breast cancer
80392|NCT02783794|Cisplatin|cisplatin
80395|NCT02783781|Preoperative biological variables|preoperative biological variables
80396|NCT02783781|EuroSCORE II|euroscore ii
80397|NCT02783781|Risk prediction|risk prediction
80398|NCT02783768|E-cigarettes|e-cigarettes
80400|NCT02783755|pain|pain
80401|NCT02783755|coping|coping
80402|NCT02783755|mhealth|mhealth
80403|NCT02783755|Breast cancer|breast cancer
80404|NCT02783742|provider-patient communication|provider-patient communication
80405|NCT02783742|coaching|coaching
80406|NCT02783742|feedback|feedback
80407|NCT02783742|burnout|burnout
80408|NCT02783729|E2006|e2006
80409|NCT02783729|Lemborexant|lemborexant
80410|NCT02783729|zolpidem tartrate|zolpidem tartrate
80411|NCT02783729|Ambien CR|ambien cr
80412|NCT02783729|Insomnia|insomnia
80413|NCT02783703|Insulin resistance|insulin resistance
80414|NCT02783664|Breast Cancer|breast cancer
80416|NCT02783664|BRCA2|brca2
80417|NCT02783664|stress|stress
80418|NCT02783664|gene testing|gene testing
80419|NCT02783664|genetic screening|genetic screening
80420|NCT02783664|psychological support|psychological support
80421|NCT02783664|State-Trait Anxiety Inventory|state-trait anxiety inventory
80422|NCT02783664|Cancer Worry Scale|cancer worry scale
80423|NCT02783664|Health Anxiety Inventory|health anxiety inventory
80424|NCT02783664|gene mutations|gene mutations
80425|NCT02783625|Duvelisib|duvelisib
80426|NCT02783625|Romidepsin|romidepsin
80427|NCT02783625|Bortezomib|bortezomib
80428|NCT02783625|16-042|16-042
80429|NCT02783573|dementia|dementia
80430|NCT02783573|brain diseases|brain diseases
80431|NCT02783573|neurodegenerative diseases|neurodegenerative diseases
80432|NCT02783573|central nervous system diseases|central nervous system diseases
80433|NCT02783573|nervous system diseases|nervous system diseases
80434|NCT02783573|mental disorders|mental disorders
80435|NCT02783573|delirium, dementia, amnestic, cognitive|delirium, dementia, amnestic, cognitive
80436|NCT02783573|tauopathies|tauopathies
80437|NCT02783573|memory|memory
80438|NCT02783573|amyloid|amyloid
80439|NCT02783560|Sleep|sleep
80440|NCT02783560|Electrodermal Activity|electrodermal activity
80441|NCT02783560|Mealtimes|mealtimes
80442|NCT02783534|Acupuncture|acupuncture
80443|NCT02783534|Primary Dysmenorrhea|primary dysmenorrhea
80444|NCT02783534|Randomized Controlled Trial|randomized controlled trial
80445|NCT02783534|Placebo Effect|placebo effect
80446|NCT02783521|Hispanic men|hispanic men
80447|NCT02783521|Weight loss|weight loss
80448|NCT02783521|Diet|diet
80449|NCT02783521|Physical activity|physical activity
80450|NCT02783521|Intervention|intervention
80451|NCT02783508|Labor analgesia|labor analgesia
80452|NCT02783508|Nitrous Oxide|nitrous oxide
80453|NCT02783508|Meperidine|meperidine
80454|NCT02783508|Multiparous|multiparous
80455|NCT02783508|Visual analogue scale|visual analogue scale
80456|NCT02783495|glioma|glioma
80457|NCT02783495|neurocognitive|neurocognitive
80458|NCT02783495|quality of life|quality of life
80459|NCT02783456|renal hemodynamic|renal hemodynamic
80460|NCT02783456|central hemodynamic|central hemodynamic
80461|NCT02783456|pilot study|pilot study
80462|NCT02783456|flight noise|flight noise
80463|NCT02783456|healthy participant|healthy participant
80464|NCT02783456|renal plasma flow|renal plasma flow
80465|NCT02783456|filtration fraction|filtration fraction
80466|NCT02783456|renal vascular resistance|renal vascular resistance
80467|NCT02783456|calculated intra glomerular pressure|calculated intra glomerular pressure
80468|NCT02783443|Anesthesia, glycocalyx, perfused boundary region|anesthesia, glycocalyx, perfused boundary region
80469|NCT02783430|Ketamine|ketamine
80470|NCT02783430|Palliative care|palliative care
80471|NCT02783430|Supportive care|supportive care
80472|NCT02783430|Early palliative care|early palliative care
80473|NCT02783430|Fast acting antidepressant|fast acting antidepressant
80474|NCT02783430|End of life care|end of life care
80475|NCT02783430|Cancer|cancer
80476|NCT02783430|psychological distress|psychological distress
80477|NCT02783430|antidepressant|antidepressant
80478|NCT02783430|serotonin norepinephrine reuptake inhibitors|serotonin norepinephrine reuptake inhibitors
80479|NCT02783417|Visceral fat|visceral fat
80480|NCT02783404|bacteraemia|bacteraemia
80481|NCT02783404|endocarditis|endocarditis
80482|NCT02783404|antibiotic prophylaxis|antibiotic prophylaxis
80484|NCT02783378|impedance metry|impedance metry
80485|NCT02783378|gaviscon|gaviscon
80588|NCT02782780|insomnia disorder|insomnia disorder
80486|NCT02783339|Next Generation Neuroform Stent System|next generation neuroform stent system
80487|NCT02783339|Intracranial|intracranial
80488|NCT02783339|Stent system|stent system
80489|NCT02783339|Saccular aneurysm|saccular aneurysm
80490|NCT02783339|Stent assisted coiling|stent assisted coiling
80491|NCT02783326|Chronic Disease Obstructive Pulmonary|chronic disease obstructive pulmonary
80493|NCT02783326|Physical Therapy|physical therapy
80494|NCT02783313|pathogen inactivation|pathogen inactivation
80495|NCT02783313|platelets|platelets
80496|NCT02783300|GSK3326595|gsk3326595
80497|NCT02783300|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
80498|NCT02783300|Solid tumor|solid tumor
80499|NCT02783300|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
80500|NCT02783300|breast cancer|breast cancer
80501|NCT02783300|bladder cancer|bladder cancer
80502|NCT02783300|dose escalation|dose escalation
80503|NCT02783287|Exercise adherence|exercise adherence
80504|NCT02783287|Medication adherence|medication adherence
80505|NCT02783287|Mobile health|mobile health
80506|NCT02783287|Cardiac rehabilitation|cardiac rehabilitation
80507|NCT02783261|radioembolization|radioembolization
80508|NCT02783261|hypertrophy|hypertrophy
80509|NCT02783261|Y90|y90
80510|NCT02783248|Percutaneous mitral commissurotomy|percutaneous mitral commissurotomy
80511|NCT02783248|Mitral Stenosis|mitral stenosis
80512|NCT02783235|VIA|via
80513|NCT02783235|Cervical Cancer|cervical cancer
80514|NCT02783235|Training|training
80515|NCT02783222|breast cancer|breast cancer
80516|NCT02783222|elderly patients|elderly patients
80517|NCT02783170|Tdap vaccine|tdap vaccine
80518|NCT02783170|Flu vaccine|flu vaccine
80519|NCT02783170|vaccines in pregnancy|vaccines in pregnancy
80520|NCT02783170|immunizations in pregnancy|immunizations in pregnancy
80521|NCT02783170|Whooping Cough|whooping cough
80522|NCT02783170|Pertussis|pertussis
80523|NCT02783170|Influenza|influenza
80524|NCT02783157|Autonomic|autonomic
80525|NCT02783157|Vagal nerve stimulation|vagal nerve stimulation
80526|NCT02783157|Postoperative atrial fibrillation|postoperative atrial fibrillation
80527|NCT02783144|Analgesia|analgesia
80528|NCT02783144|Dexamethasone|dexamethasone
80529|NCT02783144|Levobupivacaine|levobupivacaine
80530|NCT02783144|Ultrasound-guided|ultrasound-guided
80531|NCT02783144|Tranversus Abdominis|tranversus abdominis
80532|NCT02783131|inventions|inventions
80533|NCT02783131|Simulation Training|simulation training
80534|NCT02783131|Postpartum Haemorrhage|postpartum haemorrhage
80535|NCT02783131|Non Technical Skills|non technical skills
80536|NCT02783131|teamwork|teamwork
80537|NCT02783131|Crew Resource Management, Healthcare|crew resource management, healthcare
80538|NCT02783118|Depression|depression
80539|NCT02783118|Prevention|prevention
80540|NCT02783118|CBT|cbt
80541|NCT02783118|Smartphone app|smartphone app
80542|NCT02783105|Music therapy|music therapy
80543|NCT02783105|Paroxysmal sympathetic hyperactivity|paroxysmal sympathetic hyperactivity
80544|NCT02783105|Traumatic brain injury|traumatic brain injury
80545|NCT02783079|Breast Cancer|breast cancer
80546|NCT02783079|Prostate Cancer|prostate cancer
80547|NCT02783079|Colon Cancer|colon cancer
80548|NCT02783079|Lung Cancer|lung cancer
80549|NCT02783079|Gynecologic Cancer|gynecologic cancer
80550|NCT02783014|overactive bladder|overactive bladder
80551|NCT02782988|Olfaction|olfaction
80552|NCT02782988|CMV|cmv
80553|NCT02782962|nystagmus|nystagmus
80554|NCT02782962|vertigo|vertigo
80555|NCT02782962|unsteadiness|unsteadiness
80556|NCT02782962|emergency duplex ultrasonography|emergency duplex ultrasonography
80557|NCT02782936|Work of Breathing; Hypoxemia; Respiratory Acidosis; Respiratory effort|work of breathing; hypoxemia; respiratory acidosis; respiratory effort
80558|NCT02782923|Cervical Spine Surgery|cervical spine surgery
80559|NCT02782923|Simulation|simulation
80560|NCT02782897|intravenous immunoglobulin|intravenous immunoglobulin
80561|NCT02782897|intracerebral hemorrhage|intracerebral hemorrhage
80562|NCT02782897|perihematomal edema|perihematomal edema
80563|NCT02782884|post-operative pain|post-operative pain
80564|NCT02782871|Transfer|transfer
80565|NCT02782871|Intra-hospital|intra-hospital
80566|NCT02782871|Ventilator|ventilator
80567|NCT02782871|Manual ventilation|manual ventilation
80568|NCT02782871|Head and neck surgery|head and neck surgery
80569|NCT02782858|Multiple Sclerosis|multiple sclerosis
80570|NCT02782858|Multiple Sclerosis Relapsing-Remitting|multiple sclerosis relapsing-remitting
80571|NCT02782858|GNbAC1|gnbac1
80572|NCT02782858|MRI|mri
80573|NCT02782858|Monoclonal antibody|monoclonal antibody
80574|NCT02782858|Multiple Sclerosis associated retrovirus MSRV|multiple sclerosis associated retrovirus msrv
80575|NCT02782858|MS|ms
80576|NCT02782858|RRMS|rrms
80577|NCT02782858|HERV-W|herv-w
80578|NCT02782832|Neuromuscular|neuromuscular
80579|NCT02782832|Blockade|blockade
80580|NCT02782832|Surgery|surgery
80581|NCT02782819|Shock resuscitation|shock resuscitation
80582|NCT02782819|colloid|colloid
80583|NCT02782819|crystalloid|crystalloid
80584|NCT02782793|Endoscopic|endoscopic
80585|NCT02782793|Mucosal|mucosal
80589|NCT02782780|Gulf War Illness|gulf war illness
80590|NCT02782780|Chronic Multisymptom Illness|chronic multisymptom illness
80591|NCT02782728|intimate partner violence|intimate partner violence
80592|NCT02782728|reproductive coercion|reproductive coercion
71875|NCT02834169|primary peritoneal serous carcinoma|primary peritoneal serous carcinoma
71876|NCT02834169|diffuse peritoneal leiomyomatosis|diffuse peritoneal leiomyomatosis
71877|NCT02834169|appendiceal mucinous neoplasms|appendiceal mucinous neoplasms
71878|NCT02834169|registry|registry
71879|NCT02834169|population-based database|population-based database
71880|NCT02834143|vascular|vascular
71885|NCT02834117|fertility|fertility
80593|NCT02782728|women's health|women's health
80594|NCT02782728|relationship abuse|relationship abuse
80595|NCT02782702|Botulism Toxin|botulism toxin
80596|NCT02782663|Crohn's Disease|crohn's disease
80597|NCT02782663|Tolerability|tolerability
80599|NCT02782663|Efficacy|efficacy
80600|NCT02782663|Safety|safety
80601|NCT02782650|Limits|limits
80602|NCT02782650|Prenatal Counseling|prenatal counseling
80603|NCT02782650|Decision-making|decision-making
80604|NCT02782650|Foetal Complications|foetal complications
80605|NCT02782650|Counseling|counseling
80606|NCT02782650|Viability|viability
80607|NCT02782637|limits of viability|limits of viability
80608|NCT02782637|Prenatal Counseling|prenatal counseling
80609|NCT02782637|Decision-making|decision-making
80610|NCT02782637|Viability|viability
80611|NCT02782637|Counseling|counseling
80612|NCT02782611|Happiness|happiness
80613|NCT02782611|Subjective Well-Being|subjective well-being
80614|NCT02782611|Psychological Flourishing|psychological flourishing
80615|NCT02782611|Well-Being|well-being
80616|NCT02782611|Health|health
80617|NCT02782611|Behavioral Change|behavioral change
80618|NCT02782611|Life Satisfaction|life satisfaction
80619|NCT02782611|Affect|affect
80620|NCT02782611|Emotion|emotion
80621|NCT02782611|Goals|goals
80622|NCT02782611|Meaning in Life|meaning in life
80623|NCT02782598|Negative|negative
80624|NCT02782598|Atrioventricular|atrioventricular
80625|NCT02782598|Hysteresis|hysteresis
80626|NCT02782598|Cardiac Resynchronization|cardiac resynchronization
80627|NCT02782598|MultiPoint|multipoint
80628|NCT02782585|neck pain|neck pain
80629|NCT02782585|Manual therapy|manual therapy
80630|NCT02782585|psychological interaction|psychological interaction
80631|NCT02782572|Exercise|exercise
80632|NCT02782572|Cardiac Rehabilitation|cardiac rehabilitation
80633|NCT02782572|Non-invasive ventilation|non-invasive ventilation
80634|NCT02782520|Cardiopulmonary bypass|cardiopulmonary bypass
80635|NCT02782520|Swan Ganz|swan ganz
80636|NCT02782520|Fluid expansion|fluid expansion
80637|NCT02782520|hypertonic saline solution|hypertonic saline solution
80638|NCT02782507|pilot study|pilot study
80639|NCT02782507|CBT trial|cbt trial
80640|NCT02782494|Latent tuberculosis infection, dialysis|latent tuberculosis infection, dialysis
80641|NCT02782468|Drug Therapy|drug therapy
80642|NCT02782429|ketamine|ketamine
80643|NCT02782429|Cardiac Surgery|cardiac surgery
80644|NCT02782429|Neurocognitive Disorders|neurocognitive disorders
80645|NCT02782416|Renal|renal
80646|NCT02782416|Latent|latent
80647|NCT02782416|Tuberculosis|tuberculosis
80648|NCT02782403|Leukemia|leukemia
80649|NCT02782403|Chronic Myeloid Leukemia|chronic myeloid leukemia
80651|NCT02782403|Chronic Myeloid Leukemia, Chronic Phase|chronic myeloid leukemia, chronic phase
80652|NCT02782403|CML-CP|cml-cp
80653|NCT02782403|Chronic Myeloid Leukemia in Accelerated Phase|chronic myeloid leukemia in accelerated phase
80654|NCT02782403|CML-AP|cml-ap
80655|NCT02782403|Chronic Myeloid Leukemia in Blast Phase|chronic myeloid leukemia in blast phase
80656|NCT02782403|CML-BP|cml-bp
80657|NCT02782403|Axitinib|axitinib
80658|NCT02782403|AG-013736|ag-013736
80659|NCT02782403|Inlyta|inlyta
80660|NCT02782403|Bosutinib|bosutinib
80661|NCT02782403|SKI-606|ski-606
80662|NCT02782390|Stainless dental crown|stainless dental crown
80663|NCT02782390|Composite Resin|composite resin
80664|NCT02782390|Primary teeth|primary teeth
80665|NCT02782377|Faecal Incontinence|faecal incontinence
80666|NCT02782377|Obstructive Defaecation|obstructive defaecation
80667|NCT02782377|Rectal Prolapse|rectal prolapse
80668|NCT02782364|Faecal Incontinence|faecal incontinence
80669|NCT02782338|warfarin|warfarin
80670|NCT02782338|Voltaren eye drops|voltaren eye drops
80671|NCT02782338|INR|inr
80672|NCT02782312|Bronchiectasis|bronchiectasis
80673|NCT02782312|ICS+LABA|ics+laba
80674|NCT02782299|Decision aid|decision aid
80675|NCT02782299|Shared decision making|shared decision making
80676|NCT02782299|Older adult patients|older adult patients
80677|NCT02782299|Distal radius fracture|distal radius fracture
80678|NCT02782286|ketorolac|ketorolac
80679|NCT02782286|pain relieve|pain relieve
80680|NCT02782286|morphine|morphine
71972|NCT02833597|claudication|claudication
80681|NCT02782273|ketorolac|ketorolac
80682|NCT02782273|pain relieve|pain relieve
80683|NCT02782273|morphine|morphine
80684|NCT02782221|lipolysis|lipolysis
80685|NCT02782221|ATGL|atgl
80686|NCT02782182|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
80687|NCT02782182|FOLFIRINOX|folfirinox
80688|NCT02782182|resectable pancreatic cancer|resectable pancreatic cancer
80689|NCT02782156|Process Evaluation|process evaluation
80690|NCT02782156|alcohol withdrawal syndrome|alcohol withdrawal syndrome
80691|NCT02782143|delirium detection|delirium detection
80692|NCT02782130|HIV|hiv
80693|NCT02782130|YMSM|ymsm
80694|NCT02782130|Trans women|trans women
80695|NCT02782130|ART Adherence|art adherence
80696|NCT02782130|Intervention|intervention
80697|NCT02782104|Depressive Disorder, Treatment-Resistant|depressive disorder, treatment-resistant
80698|NCT02782104|Esketamine|esketamine
80699|NCT02782104|JNJ-54135419|jnj-54135419
80700|NCT02782091|MET|met
80701|NCT02782091|Prognosis|prognosis
80702|NCT02782091|Cognition|cognition
80703|NCT02782091|Ecological|ecological
80704|NCT02782091|Executive function|executive function
80705|NCT02782078|osteoarticular infection|osteoarticular infection
80706|NCT02782078|rifampicin|rifampicin
80707|NCT02782078|clindamycin|clindamycin
80708|NCT02782078|enzymatic induction|enzymatic induction
80709|NCT02782078|antibiotherapy resistance|antibiotherapy resistance
80710|NCT02782065|validation|validation
80711|NCT02782065|pediatrics|pediatrics
80712|NCT02782065|asthma severity|asthma severity
80713|NCT02782052|pulmonary arterial hypertension|pulmonary arterial hypertension
80714|NCT02782052|spirometry|spirometry
80715|NCT02782052|dynamic lung hyperinflation|dynamic lung hyperinflation
80716|NCT02782052|bronchodilator|bronchodilator
80717|NCT02782052|dyspnoea|dyspnoea
80718|NCT02782052|Idiopathic|idiopathic
80719|NCT02782052|heritable|heritable
80720|NCT02782052|PAH|pah
80721|NCT02782026|pulmonary hypertension|pulmonary hypertension
80722|NCT02782026|early detection|early detection
80723|NCT02782013|community acquired pneumonia|community acquired pneumonia
80724|NCT02782013|CAP|cap
80725|NCT02782013|disease progression|disease progression
80726|NCT02782000|dementia,early recognition|dementia,early recognition
80727|NCT02782000|early recognition|early recognition
80728|NCT02782000|general practitioner|general practitioner
80729|NCT02782000|training|training
80730|NCT02781935|unresectable colorectal liver metastasis|unresectable colorectal liver metastasis
80731|NCT02781935|diffusion weighted MRI|diffusion weighted mri
80732|NCT02781935|disappearing liver metastasis|disappearing liver metastasis
80733|NCT02781922|cardiac stem/progenitor cells|cardiac stem/progenitor cells
80734|NCT02781922|autologous cell therapy|autologous cell therapy
80735|NCT02781922|functional single ventricle|functional single ventricle
80736|NCT02781922|congenital heart disease|congenital heart disease
80737|NCT02781909|NSAIDS|nsaids
80738|NCT02781909|tuberculosis treatment|tuberculosis treatment
80739|NCT02781909|anti-inflammatories|anti-inflammatories
80740|NCT02781909|Host-directed therapies|host-directed therapies
80741|NCT02781909|TB|tb
80742|NCT02781896|TAVI|tavi
80743|NCT02781896|aortic valve bioprothesis|aortic valve bioprothesis
80744|NCT02781896|TAVI simplification|tavi simplification
80745|NCT02781896|aortic stenosis|aortic stenosis
80746|NCT02781896|rapid left ventricular pacing|rapid left ventricular pacing
80747|NCT02781896|TAVR|tavr
80748|NCT02781883|Liposomal Grb-2 treatment of AML|liposomal grb-2 treatment of aml
80749|NCT02781883|Liposomal Grb-2 with LDAC for AML|liposomal grb-2 with ldac for aml
80750|NCT02781857|Exhaled Breath|exhaled breath
80751|NCT02781857|Mass Spectrometry|mass spectrometry
80752|NCT02781857|Fingerprinting|fingerprinting
80753|NCT02781818|hidradenitis|hidradenitis
80754|NCT02781818|intralesional|intralesional
80755|NCT02781818|triamcinolone|triamcinolone
80756|NCT02781779|Cardiac Implantable Electronic Device|cardiac implantable electronic device
80757|NCT02781779|Implant|implant
80758|NCT02781766|Haemophilia A|haemophilia a
80759|NCT02781766|prophylaxis|prophylaxis
80760|NCT02781766|thrombin generation assay|thrombin generation assay
80761|NCT02781766|factor VIII|factor viii
80762|NCT02781766|prophylactic therapy|prophylactic therapy
80763|NCT02781740|Continous Positive Airway Pressure|continous positive airway pressure
80764|NCT02781740|CPAP|cpap
80765|NCT02781740|Sham CPAP|sham cpap
80766|NCT02781740|CPAP withdrawal|cpap withdrawal
80767|NCT02781740|suboptimal CPAP|suboptimal cpap
80768|NCT02781727|Human Growth Hormone|human growth hormone
80769|NCT02781727|hGH|hgh
80770|NCT02781727|GHD|ghd
80771|NCT02781727|rHGH|rhgh
80772|NCT02781727|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
80773|NCT02781727|Long Acting Growth Hormone|long acting growth hormone
80774|NCT02781727|Somatropin|somatropin
80775|NCT02781727|Prodrug|prodrug
80776|NCT02781727|Growth Failure|growth failure
80777|NCT02781727|Growth Hormone Replacement Therapy|growth hormone replacement therapy
80778|NCT02781727|Sustained Release|sustained release
80779|NCT02781727|Sustained Release Growth Hormone|sustained release growth hormone
80780|NCT02781727|Growth Hormone Deficiency|growth hormone deficiency
80781|NCT02781714|contraception|contraception
80782|NCT02781714|postpartum period|postpartum period
80783|NCT02781714|mobile health|mobile health
80784|NCT02781714|mHealth|mhealth
80785|NCT02781714|Kenya|kenya
80786|NCT02781714|couples|couples
80787|NCT02781675|Diet|diet
80788|NCT02781675|Mediterranean|mediterranean
80789|NCT02781675|Cholesterol|cholesterol
80790|NCT02781675|Inflammation|inflammation
80791|NCT02781662|Safety|safety
80792|NCT02781662|Hospitalization|hospitalization
80997|NCT02780739|Cognition|cognition
80793|NCT02781662|Older Persons|older persons
80794|NCT02781662|High-Risk|high-risk
80795|NCT02781649|Renal|renal
80796|NCT02781649|Transplants|transplants
80797|NCT02781649|Hepatitis C|hepatitis c
80798|NCT02781649|HCV-negative|hcv-negative
80799|NCT02781649|Infected|infected
80800|NCT02781649|Donors|donors
80801|NCT02781636|Efficacy|efficacy
80802|NCT02781636|Implantable|implantable
80803|NCT02781636|Wireless|wireless
80804|NCT02781636|Neuromodulation|neuromodulation
80805|NCT02781636|Device|device
80806|NCT02781636|Tibial|tibial
80807|NCT02781623|Quadriceps|quadriceps
80808|NCT02781623|Tibial Plateau|tibial plateau
80809|NCT02781623|Fracture|fracture
80810|NCT02781610|Cystic fibrosis|cystic fibrosis
80811|NCT02781610|Pulmonary exacerbation|pulmonary exacerbation
80812|NCT02781610|Antibiotic|antibiotic
80813|NCT02781610|Treatment duration|treatment duration
80814|NCT02781610|Lung infection|lung infection
80815|NCT02781610|Cystic Fibrosis Foundation|cystic fibrosis foundation
80816|NCT02781610|Cystic Fibrosis Foundation National Patient Registry|cystic fibrosis foundation national patient registry
80817|NCT02781597|Hemoptysis|hemoptysis
80818|NCT02781597|Tranexamic acid|tranexamic acid
80819|NCT02781597|VAS score|vas score
80820|NCT02781545|Child Development|child development
80821|NCT02781545|Psychomotor Performance|psychomotor performance
80822|NCT02781545|Newborns|newborns
80823|NCT02781545|Surgery|surgery
80824|NCT02781493|Prucalopride|prucalopride
80825|NCT02781493|Polyethylene Glycol|polyethylene glycol
80826|NCT02781493|bowel preparation|bowel preparation
80827|NCT02781467|Acute Myeloid|acute myeloid
80828|NCT02781467|Leukemia|leukemia
80829|NCT02781467|PNK-007|pnk-007
80830|NCT02781467|Human IL-2|human il-2
80831|NCT02781467|RHIL-2|rhil-2
80832|NCT02781467|Fludarabine|fludarabine
80833|NCT02781467|Cyclophosphamide|cyclophosphamide
80834|NCT02781454|SALS|sals
80835|NCT02781454|Mexiletine|mexiletine
80836|NCT02781454|TMS|tms
80837|NCT02781454|NCS|ncs
80838|NCT02781402|Overweight BMI Individuals|overweight bmi individuals
80839|NCT02781402|Normal BMI Individuals|normal bmi individuals
80840|NCT02781389|Basal cell carcinoma (BCC)|basal cell carcinoma (bcc)
80841|NCT02781389|advanced BCC (aBCC)|advanced bcc (abcc)
80842|NCT02781389|metastatic BCC (mBCC)|metastatic bcc (mbcc)
80843|NCT02781376|Primary Care|primary care
80844|NCT02781376|Computer Decision Support System|computer decision support system
80845|NCT02781376|Guidelines|guidelines
80846|NCT02781376|Snoring|snoring
80847|NCT02781363|thoracic ultrasound|thoracic ultrasound
80848|NCT02781363|children|children
80849|NCT02781363|efficacy|efficacy
80850|NCT02781363|emergency service|emergency service
80851|NCT02781350|high fat diet|high fat diet
80852|NCT02781350|insulinogenesis|insulinogenesis
80853|NCT02781350|Fiber|fiber
80854|NCT02781350|inflammation|inflammation
80855|NCT02781324|Ultrasonic Bone Scalpel|ultrasonic bone scalpel
80856|NCT02781324|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
80857|NCT02781324|Posterior Spinal Fusion|posterior spinal fusion
80858|NCT02781324|Estimated Blood Loss|estimated blood loss
80859|NCT02781272|pelvic mass|pelvic mass
80860|NCT02781272|ovarian cancer|ovarian cancer
80861|NCT02781272|gynecological cancer|gynecological cancer
80862|NCT02781272|risk prediction|risk prediction
80863|NCT02781259|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
80864|NCT02781259|Fluorescence|fluorescence
80865|NCT02781259|Breast Neoplasms|breast neoplasms
80866|NCT02781259|Indocyanine Green|indocyanine green
80867|NCT02781220|MCI|mci
80868|NCT02781220|Dementia|dementia
80869|NCT02781220|amyloid PET|amyloid pet
80870|NCT02781220|physician diagnosis|physician diagnosis
80871|NCT02781220|Alzheimer's disease|alzheimer's disease
80872|NCT02781220|AD|ad
80873|NCT02781220|PET imaging|pet imaging
80874|NCT02781220|Appropriate Use Criteria|appropriate use criteria
80875|NCT02781220|patient-reported outcomes|patient-reported outcomes
80876|NCT02781220|patient adherence|patient adherence
80877|NCT02781207|syncope|syncope
80878|NCT02781207|point-of-care ultrasound|point-of-care ultrasound
80879|NCT02781181|Stenting|stenting
80880|NCT02781181|Protection device|protection device
72177|NCT02832401|EEG|eeg
80881|NCT02781181|EPD usage|epd usage
80882|NCT02781168|Premature newborn|premature newborn
80883|NCT02781168|Cortisol|cortisol
80884|NCT02781168|Stress|stress
80885|NCT02781155|Health related quality of life|health related quality of life
80886|NCT02781155|Moxibustion|moxibustion
80887|NCT02781155|Cancer|cancer
80888|NCT02781155|Chemotherapy|chemotherapy
80889|NCT02781155|Neutropenia|neutropenia
80890|NCT02781155|Anaemia|anaemia
80891|NCT02781155|Thrombocytopenia|thrombocytopenia
80892|NCT02781155|Self management|self management
80893|NCT02781155|Wellbeing|wellbeing
80894|NCT02781129|Memory|memory
80895|NCT02781129|Responsive Neurostimulator System|responsive neurostimulator system
80896|NCT02781090|HIV|hiv
80897|NCT02781090|Tobacco|tobacco
80898|NCT02781090|Cigarette|cigarette
80899|NCT02781090|Smoking|smoking
80900|NCT02781090|Social Network|social network
80901|NCT02781090|Internet|internet
80902|NCT02781090|Cessation|cessation
80903|NCT02781077|Stroke|stroke
80905|NCT02781077|Task-oriented exercise program|task-oriented exercise program
80906|NCT02781077|Exercise intensity|exercise intensity
80907|NCT02781012|Pancreatic Disease|pancreatic disease
80908|NCT02781012|Pancreas|pancreas
80909|NCT02781012|Borderline Resectable|borderline resectable
80910|NCT02781012|Pancreatic Cancer|pancreatic cancer
80911|NCT02781012|Pancreatitis|pancreatitis
80912|NCT02781012|Family history of pancreatic cancer|family history of pancreatic cancer
80913|NCT02781012|Healthy|healthy
80914|NCT02781012|Healthy at risk|healthy at risk
80915|NCT02780999|Osteoarthritis|osteoarthritis
80916|NCT02780999|hand|hand
80917|NCT02780999|orthotic|orthotic
80918|NCT02780999|rehabilitation|rehabilitation
80919|NCT02780986|female entertainment worker|female entertainment worker
80920|NCT02780986|heterosexual men|heterosexual men
80921|NCT02780986|entertainment establishment|entertainment establishment
80922|NCT02780986|condom use|condom use
80923|NCT02780986|sexually transmitted infection|sexually transmitted infection
80924|NCT02780986|Singapore|singapore
80925|NCT02780947|Ventricular tachycardia|ventricular tachycardia
80926|NCT02780947|Ablation|ablation
80927|NCT02780947|Myocardial Infarction|myocardial infarction
80928|NCT02780947|Heart Failure|heart failure
80929|NCT02780934|Pressure Dressing|pressure dressing
80930|NCT02780934|Post-operative Care|post-operative care
80931|NCT02780934|Simple Adhesive Dressing|simple adhesive dressing
80932|NCT02780934|Mohs|mohs
80933|NCT02780921|Prehabilitation|prehabilitation
80934|NCT02780921|Oesophageal cancer|oesophageal cancer
80935|NCT02780921|Gastric cancer|gastric cancer
80936|NCT02780921|Fitness|fitness
80937|NCT02780921|Preconditionning|preconditionning
80938|NCT02780921|two parallel arms|two parallel arms
80939|NCT02780895|Parkinson Disease|parkinson disease
80940|NCT02780895|stereotactic surgery|stereotactic surgery
80941|NCT02780895|human allogeneic fetal derived stem cells|human allogeneic fetal derived stem cells
80942|NCT02780882|Pasireotide|pasireotide
80943|NCT02780882|Ectopic ACTH|ectopic acth
80944|NCT02780882|SOM230|som230
80945|NCT02780882|ectopic ACTH-dependent Cushing's syndrome|ectopic acth-dependent cushing's syndrome
80946|NCT02780856|Caries Activity Demineralisation|caries activity demineralisation
80947|NCT02780856|Demineralisation|demineralisation
80948|NCT02780843|Stroke|stroke
80949|NCT02780843|Tomography, X-Ray Computed|tomography, x-ray computed
80950|NCT02780843|Magnetic Resonance Imaging|magnetic resonance imaging
80951|NCT02780843|Thrombolytic Therapy|thrombolytic therapy
80952|NCT02780830|Lymphoma|lymphoma
80953|NCT02780830|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
80954|NCT02780830|non-GCB Diffuse Large B-Cell Lymphoma|non-gcb diffuse large b-cell lymphoma
80955|NCT02780830|Relapsed or Refractory non-GCB Diffuse Large B-Cell Lymphoma|relapsed or refractory non-gcb diffuse large b-cell lymphoma
80956|NCT02780830|Vistusertib|vistusertib
80957|NCT02780830|AZD2014|azd2014
80958|NCT02780830|Ibrutinib|ibrutinib
80959|NCT02780830|Imbruvica|imbruvica
80960|NCT02780791|Infertility|infertility
80961|NCT02780791|Ovarian Failure, Premature|ovarian failure, premature
80962|NCT02780791|Ovarian Follicle|ovarian follicle
80963|NCT02780791|Ovary|ovary
80964|NCT02780791|Tissue Transplantation|tissue transplantation
80965|NCT02780791|Cryopreservation|cryopreservation
80966|NCT02780791|Pelvis|pelvis
80967|NCT02780791|Chemotherapy|chemotherapy
80968|NCT02780791|Pregnancy Rate|pregnancy rate
80969|NCT02780791|Folliculogenesis|folliculogenesis
80970|NCT02780791|Endometrium|endometrium
80971|NCT02780791|Estrogens|estrogens
80972|NCT02780791|Progestins|progestins
80973|NCT02780791|Follicle Stimulating Hormone|follicle stimulating hormone
80974|NCT02780791|Estradiol|estradiol
80975|NCT02780791|Progesterone|progesterone
80976|NCT02780791|Hormones|hormones
80977|NCT02780791|Maturation of Follicles|maturation of follicles
80978|NCT02780791|Pregnant Women|pregnant women
80979|NCT02780791|Premature Menopause|premature menopause
72275|NCT02831855|withdrawal study|withdrawal study
72276|NCT02831829|cardiac rehabilitation|cardiac rehabilitation
72277|NCT02831829|coronary artery disease|coronary artery disease
72278|NCT02831777|non-invasive blood pressure|non-invasive blood pressure
72279|NCT02831764|tolerability|tolerability
72281|NCT02831764|efficacy|efficacy
72282|NCT02831764|treatment naïve|treatment naïve
72287|NCT02831751|Human|human
80980|NCT02780791|Ovarian Insufficiency|ovarian insufficiency
81088|NCT02780297|PH type 1|ph type 1
80981|NCT02780791|Ovarian Insufficiency, Premature|ovarian insufficiency, premature
80982|NCT02780791|Cytotoxic therapy|cytotoxic therapy
80983|NCT02780791|Fertility Protection|fertility protection
80984|NCT02780791|Reproductive Medicine|reproductive medicine
80985|NCT02780791|Reproductive Techniques|reproductive techniques
80986|NCT02780791|Reproductive Technology|reproductive technology
80987|NCT02780791|Cryotherapy|cryotherapy
80988|NCT02780791|Pregnancy|pregnancy
80989|NCT02780739|Psychological Tests|psychological tests
80990|NCT02780739|Neuropsychological Tests|neuropsychological tests
80991|NCT02780739|Transcranial Direct Current Stimulation|transcranial direct current stimulation
80992|NCT02780739|Exercise|exercise
80993|NCT02780739|Circuit-Based Exercise|circuit-based exercise
80994|NCT02780739|Video Games|video games
80995|NCT02780739|Magnetic Resonance Imaging|magnetic resonance imaging
80996|NCT02780739|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
81002|NCT02780739|Decision Making|decision making
81003|NCT02780739|Brain|brain
81004|NCT02780739|Gray Matter|gray matter
81005|NCT02780739|White Matter|white matter
81006|NCT02780726|Peritoneal dialysis|peritoneal dialysis
81007|NCT02780726|Roxadustat|roxadustat
81008|NCT02780726|Renal anemia|renal anemia
81009|NCT02780726|ASP1517|asp1517
81010|NCT02780713|Breast cancer|breast cancer
81011|NCT02780713|Healthy volunteers|healthy volunteers
81012|NCT02780713|Pharmacokinetics|pharmacokinetics
81013|NCT02780713|AZD9496|azd9496
81014|NCT02780713|Safety|safety
81015|NCT02780713|Tolerability|tolerability
401965|NCT01232556|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
81016|NCT02780674|Polymyositis, dermatomyositis, Sjogren's syndrome, SLE, SSc|polymyositis, dermatomyositis, sjogren's syndrome, sle, ssc
81017|NCT02780648|stereotactic radiotherapy|stereotactic radiotherapy
81018|NCT02780648|pancreatic adenocarcinoma|pancreatic adenocarcinoma
81019|NCT02780635|family, caregiving, ptsd, couples|family, caregiving, ptsd, couples
81020|NCT02780609|autologous hematopoietic cell transplantation (HCT)|autologous hematopoietic cell transplantation (hct)
81021|NCT02780609|high-dose melphalan|high-dose melphalan
81022|NCT02780609|selinexor|selinexor
81023|NCT02780596|Infant|infant
81024|NCT02780596|Toddler|toddler
81025|NCT02780596|Primary Care|primary care
81026|NCT02780570|SVPE|svpe
81027|NCT02780570|intravenous immunoglobulin|intravenous immunoglobulin
81028|NCT02780570|plasmapheresis|plasmapheresis
81029|NCT02780557|Vocabulary|vocabulary
81030|NCT02780557|Book reading|book reading
81031|NCT02780557|Infancy|infancy
81032|NCT02780557|Parenting|parenting
81033|NCT02780544|Infant, premature|infant, premature
81034|NCT02780544|Pain|pain
81035|NCT02780544|Stress, physiological|stress, physiological
81036|NCT02780544|Stress, psychological|stress, psychological
81037|NCT02780544|skin-to-skin contact|skin-to-skin contact
81038|NCT02780518|oxygen|oxygen
81039|NCT02780518|carbon dioxide|carbon dioxide
81040|NCT02780492|Duchenne muscular dystrophy|duchenne muscular dystrophy
81041|NCT02780492|Natural history|natural history
81042|NCT02780492|Outcome measures|outcome measures
81043|NCT02780492|North Star Ambulatory Assessment (NSAA)|north star ambulatory assessment (nsaa)
81044|NCT02780492|6 minute walk distance (6MWD)|6 minute walk distance (6mwd)
81045|NCT02780492|Myoset|myoset
81046|NCT02780492|Exon skipping|exon skipping
81051|NCT02780466|Septic shock|septic shock
81052|NCT02780466|Endotracheal intubation|endotracheal intubation
81053|NCT02780466|Outcome|outcome
81054|NCT02780440|Post Stroke Recovery|post stroke recovery
81055|NCT02780440|Mirror Therapy|mirror therapy
81056|NCT02780440|Unimanual mirror therapy|unimanual mirror therapy
81057|NCT02780440|Bimanual mirror therapy|bimanual mirror therapy
81058|NCT02780440|Stroke|stroke
81059|NCT02780427|Dose-Response Relationship, Drug|dose-response relationship, drug
81060|NCT02780414|Hypertension|hypertension
81061|NCT02780414|Proteinuria|proteinuria
81062|NCT02780414|Thrombocytopenia|thrombocytopenia
81063|NCT02780414|Renal Insufficiency|renal insufficiency
81064|NCT02780414|Impaired Liver Function|impaired liver function
81065|NCT02780414|Pulmonary Edema|pulmonary edema
81066|NCT02780401|Stage I|stage i
81067|NCT02780401|Stage II|stage ii
81068|NCT02780401|Stage III|stage iii
81069|NCT02780388|MEDI4920, CD40L, RA, rheumatoid arthritis|medi4920, cd40l, ra, rheumatoid arthritis
81070|NCT02780375|Transcriptional Responses|transcriptional responses
81071|NCT02780375|Radiation|radiation
81072|NCT02780323|Celecoxib|celecoxib
81073|NCT02780323|CELBESTA|celbesta
81074|NCT02780310|Lenvatinib|lenvatinib
81075|NCT02780310|15-327|15-327
81076|NCT02780297|primary hyperoxaluria|primary hyperoxaluria
81077|NCT02780297|Dent Disease|dent disease
81078|NCT02780297|enteric hyperoxaluria|enteric hyperoxaluria
81079|NCT02780297|cystinuria|cystinuria
81080|NCT02780297|Lowe Syndrome|lowe syndrome
81081|NCT02780297|Adenine phosphoribosyltransferase deficiency|adenine phosphoribosyltransferase deficiency
81082|NCT02780297|PH|ph
81083|NCT02780297|APRTd|aprtd
81084|NCT02780297|APRT|aprt
81085|NCT02780297|hyperoxaluria|hyperoxaluria
81086|NCT02780297|oxalate|oxalate
81087|NCT02780297|oxalosis|oxalosis
81089|NCT02780297|PH type 2|ph type 2
81090|NCT02780297|PH type 3|ph type 3
81091|NCT02780297|Dents|dents
81092|NCT02780297|Dent|dent
81093|NCT02780297|Dent 1|dent 1
81094|NCT02780297|Dent 2|dent 2
81095|NCT02780297|APRT deficiency|aprt deficiency
81096|NCT02780284|Gut Microbiota|gut microbiota
81097|NCT02780284|Butyrate|butyrate
81098|NCT02780284|Physical activity|physical activity
81099|NCT02780271|Breast Cancer|breast cancer
81100|NCT02780271|Cancer survivor|cancer survivor
81101|NCT02780271|e-communication|e-communication
81102|NCT02780271|diet and physical activity|diet and physical activity
81103|NCT02780271|fruits/vegetables daily servings|fruits/vegetables daily servings
81104|NCT02780271|energy density|energy density
81105|NCT02780245|Caesarean Section|caesarean section
81106|NCT02780245|Tranexamic Acid|tranexamic acid
81107|NCT02780245|Postpartum Hemorrhage|postpartum hemorrhage
81108|NCT02780245|Ecbolics|ecbolics
81109|NCT02780232|Depression|depression
81110|NCT02780232|Adolescence|adolescence
81111|NCT02780232|Prevention|prevention
81112|NCT02780232|Early intervention|early intervention
81113|NCT02780232|E-Mental Health|e-mental health
81114|NCT02780180|Aminopeptidase A inhibitor|aminopeptidase a inhibitor
81115|NCT02780180|Heart Failure|heart failure
81116|NCT02780180|Up-titration|up-titration
81117|NCT02780180|Dose-Response Relationship, Drug|dose-response relationship, drug
81118|NCT02780180|Pharmacokinetics|pharmacokinetics
627575|NCT00690547|Extension|extension
81119|NCT02780180|Patient Safety|patient safety
81120|NCT02780180|Treatment Efficacy|treatment efficacy
81121|NCT02780167|Phase 2|phase 2
81122|NCT02780167|randomized|randomized
81123|NCT02780167|double-blind|double-blind
81124|NCT02780167|placebo|placebo
81125|NCT02780167|atopic dermatitis|atopic dermatitis
81126|NCT02780167|safety|safety
81127|NCT02780167|efficacy|efficacy
81128|NCT02780167|JAK|jak
81129|NCT02780167|janus kinase|janus kinase
81130|NCT02780167|moderate|moderate
81131|NCT02780167|severe|severe
81132|NCT02780154|7G8 clone|7g8 clone
81133|NCT02780154|NF54 strain|nf54 strain
81134|NCT02780154|Non-immune|non-immune
81135|NCT02780154|PCR|pcr
81136|NCT02780154|PfSPZ Challenge|pfspz challenge
81137|NCT02780154|Plasmodium falciparum|plasmodium falciparum
81138|NCT02780154|qPCR|qpcr
81139|NCT02780154|Sporozoites|sporozoites
81140|NCT02780141|Renal anemia|renal anemia
81141|NCT02780141|ASP1517|asp1517
81142|NCT02780141|Hemodialysis|hemodialysis
81143|NCT02780128|neuroblastoma|neuroblastoma
81144|NCT02780128|cancer|cancer
81145|NCT02780128|genetic profiling|genetic profiling
81146|NCT02780128|ceritinib|ceritinib
81147|NCT02780128|ribociclib|ribociclib
81148|NCT02780128|trametinib|trametinib
81149|NCT02780128|HDM201|hdm201
81150|NCT02780102|ADHD|adhd
81151|NCT02780102|Cognitive-motor rehabilitation|cognitive-motor rehabilitation
81152|NCT02780102|Active Control Group|active control group
81153|NCT02780102|Stimulant Medication|stimulant medication
81154|NCT02780089|Metastatic|metastatic
81155|NCT02780089|Unresectable|unresectable
81156|NCT02780063|Dilation|dilation
81157|NCT02780063|Intraocular|intraocular
81158|NCT02780063|Ophthalmology|ophthalmology
81159|NCT02780050|cardiopulmonary resuscitation|cardiopulmonary resuscitation
81160|NCT02780050|manikins|manikins
81161|NCT02780050|physical fitness|physical fitness
81162|NCT02780024|Neo-Adjuvant Metformin|neo-adjuvant metformin
81163|NCT02780024|Neo-Adjuvant Temozolomide|neo-adjuvant temozolomide
81164|NCT02780024|Temozolomide and accelerated hypofractionation|temozolomide and accelerated hypofractionation
81165|NCT02780024|Metformin and accelerated hypofractionation|metformin and accelerated hypofractionation
81166|NCT02780024|Adjuvant Temozolomide|adjuvant temozolomide
81167|NCT02780024|Adjuvant Metformin|adjuvant metformin
81168|NCT02780011|CD30+|cd30+
81169|NCT02780011|Relapsed|relapsed
81170|NCT02780011|Refractory|refractory
81171|NCT02780011|ALCL|alcl
95282|NCT02693379|VIA|via
81172|NCT02779985|Lycium Barbarum|lycium barbarum
81173|NCT02779985|Energy expenditure|energy expenditure
81174|NCT02779985|Postprandial metabolism|postprandial metabolism
81175|NCT02779972|Cardiac Physiology|cardiac physiology
81176|NCT02779972|Physiology|physiology
81177|NCT02779933|Hospital-acquired Pneumonia|hospital-acquired pneumonia
81178|NCT02779933|Epidemiology|epidemiology
81179|NCT02779933|Risk Factors|risk factors
81180|NCT02779920|refractory gastroparesis|refractory gastroparesis
81181|NCT02779920|per oral pyloromyotomy|per oral pyloromyotomy
81182|NCT02779907|Paediatric|paediatric
81183|NCT02779907|Malawi|malawi
81184|NCT02779894|Sleep Apnea|sleep apnea
81185|NCT02779894|Communication Based Technology|communication based technology
81186|NCT02779894|ICT|ict
81187|NCT02779868|body composition|body composition
81188|NCT02779868|functional capacity|functional capacity
81189|NCT02779868|quality of life|quality of life
81190|NCT02779855|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
81191|NCT02779855|estrogen receptor|estrogen receptor
81192|NCT02779855|progesterone receptor|progesterone receptor
81193|NCT02779855|invasive ductal carcinoma|invasive ductal carcinoma
81194|NCT02779855|breast cancer tumors|breast cancer tumors
81195|NCT02779790|Systematic Review and Meta-Analysis|systematic review and meta-analysis
81196|NCT02779790|Evidence-Based Medicine|evidence-based medicine
81197|NCT02779790|Evidence-Based Nutrition|evidence-based nutrition
81198|NCT02779790|Clinical Practice Guidelines|clinical practice guidelines
81199|NCT02779790|Liquid Meal Replacements|liquid meal replacements
81200|NCT02779790|Body Weight|body weight
81201|NCT02779790|Systolic Blood Pressure|systolic blood pressure
81202|NCT02779790|Diastolic Blood Pressure|diastolic blood pressure
81203|NCT02779790|Fasting Blood Glucose|fasting blood glucose
81204|NCT02779790|Fasting Blood Insulin|fasting blood insulin
81205|NCT02779790|HbA1c|hba1c
81206|NCT02779790|Total Cholesterol|total cholesterol
81207|NCT02779790|Triglycerides|triglycerides
81208|NCT02779790|LDL-C|ldl-c
81209|NCT02779790|HDL-C|hdl-c
81210|NCT02779790|Controlled Feeding Trials|controlled feeding trials
81211|NCT02779764|Hemodialysis|hemodialysis
81212|NCT02779764|ASP1517|asp1517
81213|NCT02779764|Renal anemia|renal anemia
81214|NCT02779725|Symptom Management|symptom management
81215|NCT02779712|Remote ischaemic conditioning|remote ischaemic conditioning
81216|NCT02779686|Macular Degeneration|macular degeneration
81217|NCT02779686|Genetic testing|genetic testing
81218|NCT02779686|Age-Related Macular degeneration|age-related macular degeneration
81219|NCT02779686|Age-Related Maculopathies|age-related maculopathies
81220|NCT02779660|Atrial Fibrillation|atrial fibrillation
81221|NCT02779647|Overweight, obesity, play, physical activity, accelerometry.|overweight, obesity, play, physical activity, accelerometry.
81222|NCT02779608|malignant ascites|malignant ascites
81223|NCT02779582|Progesterone|progesterone
81224|NCT02779582|Menstrual Flow|menstrual flow
81225|NCT02779556|Health Literacy|health literacy
81226|NCT02779556|Diabetes|diabetes
81227|NCT02779543|In lab sleep studies|in lab sleep studies
81228|NCT02779517|upper extremity|upper extremity
81229|NCT02779517|stroke|stroke
81230|NCT02779517|rehabilitation|rehabilitation
81231|NCT02779517|robotics|robotics
81232|NCT02779517|telepresence|telepresence
81233|NCT02779517|elderly|elderly
81234|NCT02779517|aged|aged
81235|NCT02779517|Housing for the elderly|housing for the elderly
81236|NCT02779517|retirement|retirement
81237|NCT02779517|homes for the aged|homes for the aged
81238|NCT02779491|fruit and vegetables|fruit and vegetables
81239|NCT02779491|food intake|food intake
81240|NCT02779491|knowledge|knowledge
81241|NCT02779478|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
81242|NCT02779478|cavitary|cavitary
81243|NCT02779478|nodular bronchiectatic disease|nodular bronchiectatic disease
81245|NCT02779465|vitamin D treatment|vitamin d treatment
81246|NCT02779465|chronic hepatitis B|chronic hepatitis b
81247|NCT02779452|neurodevelopment|neurodevelopment
81248|NCT02779452|electroencephalography|electroencephalography
81249|NCT02779452|gestational diabetes mellitus|gestational diabetes mellitus
81250|NCT02779452|omega 3 polyunsaturated fatty acids|omega 3 polyunsaturated fatty acids
81251|NCT02779426|Atopic dermatitis|atopic dermatitis
81252|NCT02779426|Text Messages|text messages
81253|NCT02779426|Health literacy|health literacy
81255|NCT02779400|coagulation|coagulation
81256|NCT02779400|vitamin K antagonist|vitamin k antagonist
81257|NCT02779387|GnRH-a|gnrh-a
81258|NCT02779387|endometriosis|endometriosis
81259|NCT02779387|efficiency|efficiency
81260|NCT02779374|ovarian insufficiency Bone Marrow|ovarian insufficiency bone marrow
81261|NCT02779361|green tea|green tea
81262|NCT02779361|steroid profile|steroid profile
81263|NCT02779348|Nebicapone|nebicapone
81264|NCT02779348|Warfarin|warfarin
81265|NCT02779335|tube-fed|tube-fed
81266|NCT02779335|Formula Tolerance|formula tolerance
81267|NCT02779335|Pediatric Patients|pediatric patients
81268|NCT02779322|gastric bypass|gastric bypass
81269|NCT02779322|hospital charges|hospital charges
81270|NCT02779322|mini gastric bypass|mini gastric bypass
81271|NCT02779309|Frail Older Adults|frail older adults
81272|NCT02779309|Mortality|mortality
81273|NCT02779309|Home Care|home care
81274|NCT02779309|Survival Analysis|survival analysis
81275|NCT02779309|Clinical Prediction Rule|clinical prediction rule
81276|NCT02779296|Cyanoacrylates|cyanoacrylates
81277|NCT02779296|Mammaplasty|mammaplasty
81278|NCT02779296|Mastectomy|mastectomy
81279|NCT02779257|hypoglycemia|hypoglycemia
81280|NCT02779244|Orthopedic|orthopedic
81281|NCT02779244|Post-operative|post-operative
81282|NCT02779244|Weight bearing|weight bearing
81283|NCT02779244|Range of motion|range of motion
81284|NCT02779218|Hemiplegia|hemiplegia
81285|NCT02779205|Cell therapy|cell therapy
81286|NCT02779205|Stromal Cells|stromal cells
81287|NCT02779205|Stem cells|stem cells
81288|NCT02779205|Adipose tissue|adipose tissue
81289|NCT02779205|Children|children
81290|NCT02779166|hip arthroscopy|hip arthroscopy
81291|NCT02779153|SLE|sle
81292|NCT02779153|H.P. Acthar Gel|h.p. acthar gel
81293|NCT02779140|BoNT|bont
81294|NCT02779140|botulinum|botulinum
81295|NCT02779140|Botulism|botulism
81296|NCT02779140|Clostridium|clostridium
81297|NCT02779140|Neurotoxin|neurotoxin
81298|NCT02779140|NTM-1632|ntm-1632
81299|NCT02779127|Smoking|smoking
81300|NCT02779127|Endothelium|endothelium
81301|NCT02779127|Passive smoking|passive smoking
81302|NCT02779114|Rheumatoid Arthritis|rheumatoid arthritis
81303|NCT02779114|Remission|remission
81304|NCT02779114|Dose reduction|dose reduction
81305|NCT02779101|Central nervous system lymphoma|central nervous system lymphoma
81306|NCT02779101|Pembrolizumab|pembrolizumab
81307|NCT02779075|Sleeve Gastrectomy|sleeve gastrectomy
81308|NCT02779075|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
81309|NCT02779036|Stroke|stroke
81310|NCT02779036|task-oriented home exercise|task-oriented home exercise
81311|NCT02779036|walking competency|walking competency
81318|NCT02778984|facial mask|facial mask
81319|NCT02778971|MCI|mci
81320|NCT02778971|Dementia|dementia
81321|NCT02778971|amyloid PET|amyloid pet
81322|NCT02778971|physician diagnosis|physician diagnosis
81323|NCT02778971|Alzheimer's disease|alzheimer's disease
81324|NCT02778971|AD|ad
81325|NCT02778971|PET imaging|pet imaging
81326|NCT02778971|Appropriate Use Criteria|appropriate use criteria
81327|NCT02778971|patient-reported outcomes|patient-reported outcomes
81328|NCT02778958|bariatric surgery|bariatric surgery
81329|NCT02778958|morbid obesity|morbid obesity
81330|NCT02778958|nonopioid analgesics|nonopioid analgesics
81331|NCT02778945|spinal surgery|spinal surgery
81332|NCT02778945|sugammadex|sugammadex
81333|NCT02778945|deep neuromuscular block|deep neuromuscular block
81334|NCT02778945|shear wave elastography|shear wave elastography
81335|NCT02778945|neuromuscular monitoring|neuromuscular monitoring
81336|NCT02778919|Endometriosis|endometriosis
81337|NCT02778906|Abatacept|abatacept
81338|NCT02778893|Conmana|conmana
81339|NCT02778893|Thalidomide|thalidomide
81340|NCT02778893|NSCLC|nsclc
81341|NCT02778893|EGFR mutation|egfr mutation
81342|NCT02778854|NSCLC|nsclc
81343|NCT02778854|liquid biopsy|liquid biopsy
81344|NCT02778854|driver mutation|driver mutation
81345|NCT02778828|linezolide|linezolide
81346|NCT02778828|tuberculosis|tuberculosis
81347|NCT02778828|MDR-TB|mdr-tb
81348|NCT02778802|Pulmonary Hypertension|pulmonary hypertension
81349|NCT02778802|Emphysema|emphysema
81350|NCT02778802|COPD|copd
81351|NCT02778776|Metformin|metformin
81352|NCT02778776|Agave Inulin|agave inulin
81353|NCT02778776|METS|mets
81354|NCT02778776|Inflammation parameters|inflammation parameters
81355|NCT02778776|Urodynamic parameters|urodynamic parameters
81356|NCT02778776|Prostate hyperplasia|prostate hyperplasia
81357|NCT02778763|Breast cancer|breast cancer
81358|NCT02778763|TLR2|tlr2
81359|NCT02778763|Neutropenia|neutropenia
81360|NCT02778750|Cystic Fibrosis (CF)|cystic fibrosis (cf)
81361|NCT02778737|ACT, CBT, Randomized controlled trial, Chronic Pain|act, cbt, randomized controlled trial, chronic pain
81362|NCT02778711|anti-IL-17|anti-il-17
81363|NCT02778711|secukinumab|secukinumab
81364|NCT02778672|bacterial pneumonia|bacterial pneumonia
81365|NCT02778672|children|children
81366|NCT02778672|diagnosing pneumonia|diagnosing pneumonia
81367|NCT02778672|thermal imaging|thermal imaging
81368|NCT02778633|Volume responsiveness mean systemic filling pressure|volume responsiveness mean systemic filling pressure
81369|NCT02778620|Volume responsiveness mean systemic filling pressure|volume responsiveness mean systemic filling pressure
81370|NCT02778607|Atypical Parkinsonism Syndrome (APS)|atypical parkinsonism syndrome (aps)
81371|NCT02778581|Cognitive Impairment, Alzheimer's Disease, Vegetal Oil|cognitive impairment, alzheimer's disease, vegetal oil
81372|NCT02778542|Automated Hovering|automated hovering
81373|NCT02778542|Remote Monitoring|remote monitoring
81374|NCT02778542|Bidirectional Text Messaging|bidirectional text messaging
81375|NCT02778529|stroke|stroke
81376|NCT02778529|amputees|amputees
81377|NCT02778529|spinal cord injuries|spinal cord injuries
81378|NCT02778529|cerebral palsy|cerebral palsy
81379|NCT02778529|robotics|robotics
81380|NCT02778529|rehabilitation|rehabilitation
81381|NCT02778503|Tooth, Deciduous|tooth, deciduous
81382|NCT02778503|Dentition, Permanent|dentition, permanent
81383|NCT02778503|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
81384|NCT02778503|Glass Ionomer Cements|glass ionomer cements
81385|NCT02778503|Dental Caries|dental caries
81386|NCT02778490|sleeve gastrectomy, bariatric surgery|sleeve gastrectomy, bariatric surgery
81387|NCT02778464|Inflammatory Bowel Disease|inflammatory bowel disease
81388|NCT02778464|Pregnancy|pregnancy
81389|NCT02778464|Stool markers|stool markers
81390|NCT02778464|Calprotectin|calprotectin
81391|NCT02778464|Faecal S100A12 (f-SA12)|faecal s100a12 (f-sa12)
81392|NCT02778464|Faecal calprotectin (f-Cp)|faecal calprotectin (f-cp)
81393|NCT02778425|partial splenic embolization|partial splenic embolization
81394|NCT02778412|Thyroid cancer|thyroid cancer
81395|NCT02778412|Thyroid nodules|thyroid nodules
81396|NCT02778412|Thyroid neoplasia|thyroid neoplasia
81397|NCT02778412|Thyroiditis|thyroiditis
81398|NCT02778399|Pelvic Pain|pelvic pain
81399|NCT02778399|Endometriosis|endometriosis
81400|NCT02778399|Dysmenorrhea|dysmenorrhea
81401|NCT02778399|Dyspareunia|dyspareunia
81402|NCT02778360|Attention deficit|attention deficit
81403|NCT02778360|Neurofeedback|neurofeedback
81404|NCT02778360|ADHD|adhd
81405|NCT02778360|Methylphenidate|methylphenidate
81407|NCT02778347|Need assessment|need assessment
81408|NCT02778347|Tools|tools
81409|NCT02778347|Validity|validity
81410|NCT02778347|Quality of care|quality of care
81411|NCT02778308|Gallbladder cancer, adjuvant chemotherapy, gemcitabine|gallbladder cancer, adjuvant chemotherapy, gemcitabine
81412|NCT02778269|ECG|ecg
81413|NCT02778269|CGM|cgm
81414|NCT02778269|Hypoglycaemia|hypoglycaemia
81415|NCT02778269|Sudden Cardiac Death|sudden cardiac death
81416|NCT02778256|depression, bipolar disorder|depression, bipolar disorder
81417|NCT02778230|fiber|fiber
81418|NCT02778230|gastrointestinal|gastrointestinal
81419|NCT02778230|microbiota|microbiota
81420|NCT02778191|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
81421|NCT02778191|cisplatin|cisplatin
81422|NCT02778191|carboplatin|carboplatin
81423|NCT02778191|5-fluorouracil|5-fluorouracil
81424|NCT02778087|motor recovery|motor recovery
81425|NCT02778087|mirror therapy|mirror therapy
81426|NCT02778087|upper extremity|upper extremity
81427|NCT02778074|Internet Cognitive Behavioural Therapy|internet cognitive behavioural therapy
81428|NCT02778061|Intra Uterine Ball|intra uterine ball
81429|NCT02778061|IUD|iud
81430|NCT02778061|copper|copper
81431|NCT02778061|contraception|contraception
81432|NCT02778022|Child behavior disorders|child behavior disorders
81433|NCT02778022|Parent child relationship|parent child relationship
81434|NCT02778022|Primary care|primary care
81435|NCT02778009|Medical student|medical student
81436|NCT02778009|Activity Monitor|activity monitor
81437|NCT02778009|Medical school|medical school
81438|NCT02778009|Fitness|fitness
81439|NCT02777996|screening|screening
81440|NCT02777983|patient education|patient education
81441|NCT02777983|low back pain|low back pain
81442|NCT02777983|technology|technology
81443|NCT02777970|Acute pain|acute pain
81444|NCT02777970|Acute moderate to severe pain|acute moderate to severe pain
81445|NCT02777970|Postoperative pain|postoperative pain
81446|NCT02777970|Dexketoprofen Tramadol|dexketoprofen tramadol
81447|NCT02777970|Dexketoprofen trometamol|dexketoprofen trometamol
81448|NCT02777970|Tramadol hydrochloride|tramadol hydrochloride
81449|NCT02777970|Multimodal analgesia|multimodal analgesia
81450|NCT02777970|Third molar extraction|third molar extraction
81451|NCT02777970|Fixed drug combination|fixed drug combination
81452|NCT02777970|Paracetamol|paracetamol
81453|NCT02777970|Analgesics|analgesics
81454|NCT02777957|Echocardiography|echocardiography
81455|NCT02777957|Lung Transplantation|lung transplantation
81456|NCT02777944|motivation|motivation
81457|NCT02777944|attendance|attendance
81458|NCT02777918|food intake|food intake
81459|NCT02777905|late life|late life
81460|NCT02777905|mindfulness meditation|mindfulness meditation
81461|NCT02777879|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
81462|NCT02777853|tea|tea
81463|NCT02777853|cardiovascular|cardiovascular
81464|NCT02777853|vascular|vascular
81465|NCT02777853|metabolism|metabolism
81466|NCT02777853|microcirculation|microcirculation
81467|NCT02777853|physical inactivity|physical inactivity
81468|NCT02777853|polyphenols|polyphenols
81469|NCT02777853|conduit artery|conduit artery
81470|NCT02777853|endothelial function|endothelial function
81471|NCT02777853|cerebrovascular|cerebrovascular
81472|NCT02777853|insulin sensitivity|insulin sensitivity
81473|NCT02777827|Abediterol|abediterol
81474|NCT02777827|Dry powder inhaler|dry powder inhaler
72787|NCT02829125|ERAS|eras
81475|NCT02777827|Pressured metered-dose inhaler|pressured metered-dose inhaler
81476|NCT02777827|Pharmacokinetic|pharmacokinetic
81477|NCT02777827|Pharmacodynamic|pharmacodynamic
81478|NCT02777827|Safety|safety
81479|NCT02777814|colorectal cancer|colorectal cancer
81480|NCT02777814|Entecavir|entecavir
81481|NCT02777814|Hepatitis B Carrier|hepatitis b carrier
81482|NCT02777801|gastric cancer|gastric cancer
81483|NCT02777801|hepatitis B carrier|hepatitis b carrier
81484|NCT02777801|entecavir|entecavir
81485|NCT02777788|Chinese Traditional Medicine|chinese traditional medicine
81486|NCT02777775|NF1|nf1
81487|NCT02777775|CNF|cnf
81488|NCT02777775|PNF|pnf
81489|NCT02777775|Skin Tumors|skin tumors
81490|NCT02777736|Lymphoma, B cell|lymphoma, b cell
81491|NCT02777736|Central nervous system relapse|central nervous system relapse
81492|NCT02777736|Methotrexate|methotrexate
81493|NCT02777736|Intrathecal chemotherapy|intrathecal chemotherapy
81494|NCT02777723|Dry Eye Syndrome|dry eye syndrome
81495|NCT02777723|Sodium Hyaluronate|sodium hyaluronate
81496|NCT02777723|CKD-350|ckd-350
81497|NCT02777697|cancer treatment protocols|cancer treatment protocols
81498|NCT02777697|chronic cancer pain|chronic cancer pain
81499|NCT02777697|cognitive function|cognitive function
81805|NCT02776033|GSK2982772|gsk2982772
81500|NCT02777697|quality of life|quality of life
81501|NCT02777697|anxiety|anxiety
81502|NCT02777697|depression|depression
81503|NCT02777684|Physical activity|physical activity
81504|NCT02777684|Knee osteoarthritis|knee osteoarthritis
81505|NCT02777684|Non pharmacological treatment|non pharmacological treatment
81506|NCT02777684|Qualitative study|qualitative study
81509|NCT02777619|Dexmedetomidine|dexmedetomidine
81510|NCT02777619|Propofol|propofol
81511|NCT02777619|Target-controlled Infusion Intravenous Anesthesia|target-controlled infusion intravenous anesthesia
81512|NCT02777606|Severe Sepsis|severe sepsis
81513|NCT02777606|Sini Decoction|sini decoction
81514|NCT02777606|Immune Function|immune function
81515|NCT02777606|Mortality|mortality
81516|NCT02777580|Thrombolytic Therapy|thrombolytic therapy
81517|NCT02777580|Primary PCI|primary pci
81518|NCT02777554|Healthy Subjects|healthy subjects
81519|NCT02777554|Apremilast|apremilast
81520|NCT02777554|Pharmacokinetic|pharmacokinetic
81521|NCT02777541|early enteral nutrition|early enteral nutrition
81522|NCT02777541|children|children
81523|NCT02777541|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
81524|NCT02777515|electronic cigarette|electronic cigarette
81526|NCT02777489|perindopril|perindopril
81527|NCT02777489|carboxypeptidase D|carboxypeptidase d
81528|NCT02777489|genotyping|genotyping
81529|NCT02777489|theranostic|theranostic
81530|NCT02777450|low back pain|low back pain
81531|NCT02777450|physical examination|physical examination
81532|NCT02777450|local anesthesia|local anesthesia
81533|NCT02777437|Colonic Neoplasms|colonic neoplasms
81534|NCT02777437|Laparoscopic Surgery|laparoscopic surgery
81535|NCT02777437|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
81537|NCT02777411|Vaccines|vaccines
81538|NCT02777411|Hand, Foot and Mouth Disease|hand, foot and mouth disease
81539|NCT02777411|EV71 enteroviruses vaccine|ev71 enteroviruses vaccine
81540|NCT02777398|Intra-spinal Canal|intra-spinal canal
81541|NCT02777398|Tumor|tumor
81542|NCT02777398|Minimal Invasive Surgery|minimal invasive surgery
81543|NCT02777398|Clinical Trial|clinical trial
81544|NCT02777398|Quadrant Channel|quadrant channel
81545|NCT02777385|Head and Neck|head and neck
81546|NCT02777385|Locally Advanced|locally advanced
81547|NCT02777385|Squamous Cell Carcinoma|squamous cell carcinoma
81548|NCT02777385|SCCHN|scchn
81549|NCT02777385|Untreated|untreated
81550|NCT02777385|High Risk|high risk
81551|NCT02777385|Intermediate Risk|intermediate risk
81552|NCT02777385|Radiation Therapy|radiation therapy
81553|NCT02777385|Cisplatin|cisplatin
81554|NCT02777372|Zoloft|zoloft
81555|NCT02777372|PMS|pms
81556|NCT02777372|Menses|menses
81557|NCT02777359|patent foramen ovale|patent foramen ovale
81558|NCT02777359|migraine|migraine
81559|NCT02777359|treatment|treatment
81560|NCT02777346|WOUNDS, PENETRATING|wounds, penetrating
81561|NCT02777346|CHILD, PRESCHOOL|child, preschool
81562|NCT02777346|CHILD|child
81563|NCT02777346|INFANT|infant
81564|NCT02777346|ADOLESCENT|adolescent
81565|NCT02777346|SUTURES|sutures
81566|NCT02777346|POLYGLACTIN 910|polyglactin 910
81567|NCT02777346|POLYPROPYLENES|polypropylenes
81568|NCT02777333|Simulation|simulation
81569|NCT02777333|Arthroscopy|arthroscopy
81570|NCT02777333|Motion analysis|motion analysis
81571|NCT02777320|Sciatica|sciatica
81572|NCT02777320|Ibuprofen|ibuprofen
81573|NCT02777320|Paracetamol|paracetamol
81574|NCT02777320|Emergency Medicine|emergency medicine
81575|NCT02777307|Laparoscopic|laparoscopic
81576|NCT02777307|Cholecistectomy|cholecistectomy
81577|NCT02777307|Collection|collection
81578|NCT02777307|Bleeding|bleeding
81579|NCT02777307|reoperation|reoperation
81580|NCT02777281|Shoulder Pain|shoulder pain
81581|NCT02777281|Wheelchair|wheelchair
81582|NCT02777281|Spinal Cord injury|spinal cord injury
81583|NCT02777242|Hypogonadism|hypogonadism
81584|NCT02777242|Testosterone enanthate|testosterone enanthate
81585|NCT02777216|RDN|rdn
81586|NCT02777203|morcellation|morcellation
81587|NCT02777203|myomectomy|myomectomy
81588|NCT02777203|hysterectomy|hysterectomy
81589|NCT02777190|misoprostol|misoprostol
81590|NCT02777190|cytotec|cytotec
81591|NCT02777190|cervical ripening|cervical ripening
81592|NCT02777190|labor, induced|labor, induced
81593|NCT02777190|active labor|active labor
81594|NCT02777138|Adipose tissue|adipose tissue
81595|NCT02777138|Inflammation|inflammation
81596|NCT02777138|Age Comparison|age comparison
81597|NCT02777138|Macrophages|macrophages
81598|NCT02777138|T-lymphocytes|t-lymphocytes
81599|NCT02777138|Adipose Progenitors|adipose progenitors
81600|NCT02777125|pediatrics|pediatrics
81601|NCT02777125|metered dose inhalers|metered dose inhalers
81602|NCT02777125|breath actuated nebulizers|breath actuated nebulizers
81603|NCT02777112|high-risk|high-risk
81605|NCT02777112|productivity|productivity
81606|NCT02777112|return on investment|return on investment
81607|NCT02777112|workplace|workplace
81608|NCT02777112|e-mental health program|e-mental health program
81609|NCT02777112|job coach|job coach
81610|NCT02777099|remote ischemic postconditioning|remote ischemic postconditioning
81611|NCT02777099|autonomic function|autonomic function
81612|NCT02777099|heart rate variability|heart rate variability
81613|NCT02777099|acute ischemic stroke|acute ischemic stroke
81614|NCT02777099|prognosis|prognosis
81615|NCT02777086|HIV|hiv
81616|NCT02777086|Risk Behaviors|risk behaviors
81617|NCT02777086|Decision-making|decision-making
81618|NCT02777073|Diabetic ketoacidosis|diabetic ketoacidosis
81619|NCT02777073|Insulin|insulin
81620|NCT02777073|Type 1 Diabetes|type 1 diabetes
81621|NCT02777073|glucose (sugar) control|glucose (sugar) control
81622|NCT02777073|SGLT-2 inhibitors|sglt-2 inhibitors
81623|NCT02777060|virtual reality|virtual reality
81624|NCT02777060|sensor-based balance training|sensor-based balance training
81625|NCT02777060|gait|gait
81626|NCT02777060|balance|balance
81627|NCT02777047|Thromboembolism|thromboembolism
81628|NCT02777047|Medication Safety|medication safety
81629|NCT02777047|Hospital-community collaboration|hospital-community collaboration
81630|NCT02777047|Pilot RCT|pilot rct
81631|NCT02777047|Telehealth|telehealth
81632|NCT02777034|Laparoscopy|laparoscopy
81633|NCT02777034|Enhanced Recovery|enhanced recovery
81634|NCT02777034|Fast-track|fast-track
81635|NCT02777021|Pediatric|pediatric
81636|NCT02777021|Acute Myeloid Leukemia|acute myeloid leukemia
81637|NCT02777021|Quality of Life|quality of life
81638|NCT02777021|Neutropenia Management|neutropenia management
81639|NCT02777021|Patient Centered Outcomes|patient centered outcomes
81640|NCT02777021|Chemotherapy|chemotherapy
81641|NCT02776982|Gastroesophageal reflux disease|gastroesophageal reflux disease
81642|NCT02776982|GERD|gerd
81643|NCT02776982|Barrett's Esophagus|barrett's esophagus
81644|NCT02776982|Esophageal adenocarcinoma|esophageal adenocarcinoma
81645|NCT02776969|Papillary Carcinoma|papillary carcinoma
81646|NCT02776969|Gene Hunting|gene hunting
81647|NCT02776969|Familial|familial
81648|NCT02776956|atrial fibrillation;left atrial function|atrial fibrillation;left atrial function
81649|NCT02776930|Injury Prediction|injury prediction
81650|NCT02776930|Return to Work|return to work
81651|NCT02776930|Injury Prevention|injury prevention
81652|NCT02776917|metastatic breast cancer|metastatic breast cancer
81653|NCT02776917|locally advanced, unresectable breast cancer|locally advanced, unresectable breast cancer
81654|NCT02776917|HER2/NEU negative|her2/neu negative
81655|NCT02776904|Concussion|concussion
81656|NCT02776904|Football player|football player
81657|NCT02776904|Movement assessment|movement assessment
81658|NCT02776904|Soccer player|soccer player
81659|NCT02776891|lymphoma|lymphoma
81660|NCT02776891|gallium citrate|gallium citrate
81661|NCT02776891|PET|pet
81662|NCT02776865|suprascapular nerve block|suprascapular nerve block
81663|NCT02776813|CD20+|cd20+
81664|NCT02776813|B-cell|b-cell
81665|NCT02776813|ACTR087|actr087
81666|NCT02776813|Relapsed|relapsed
81667|NCT02776813|Refractory|refractory
81668|NCT02776800|Wound|wound
81669|NCT02776800|Surgical Wound|surgical wound
81670|NCT02776800|Trauma Wound|trauma wound
81671|NCT02776800|Home Health Care|home health care
81672|NCT02776800|Home Health Nurse|home health nurse
81673|NCT02776800|Pressure Ulcer|pressure ulcer
81674|NCT02776800|Diabetic Foot Ulcer|diabetic foot ulcer
81675|NCT02776800|Venous Leg Ulcer|venous leg ulcer
81676|NCT02776800|Arterial Ulcer|arterial ulcer
81677|NCT02776800|Wound Dehiscence|wound dehiscence
81678|NCT02776800|Open Wound|open wound
81679|NCT02776774|spine|spine
81680|NCT02776748|Tenofovir disoproxil|tenofovir disoproxil
81681|NCT02776748|Pre-exposure prophylaxis|pre-exposure prophylaxis
81682|NCT02776748|Breastfeeding|breastfeeding
81683|NCT02776748|Emtricitabine|emtricitabine
81684|NCT02776748|Tenofovir|tenofovir
81685|NCT02776748|Post-partum|post-partum
81686|NCT02776748|HIV prevention|hiv prevention
81687|NCT02776748|Women|women
81688|NCT02776748|Pharmacokinetics|pharmacokinetics
81689|NCT02776722|Systematic Review and Meta-analysis|systematic review and meta-analysis
81690|NCT02776722|randomized controlled trial|randomized controlled trial
81691|NCT02776722|Evidence-Based Medicine|evidence-based medicine
81692|NCT02776722|carbohydrate metabolism|carbohydrate metabolism
81693|NCT02776722|postprandial|postprandial
81694|NCT02776722|glycemic response|glycemic response
81695|NCT02776722|glycemic control|glycemic control
81696|NCT02776722|insulin sensitivity|insulin sensitivity
81697|NCT02776722|beta-cell function|beta-cell function
81698|NCT02776722|sugars|sugars
81699|NCT02776722|fructose|fructose
81700|NCT02776722|allulose|allulose
81701|NCT02776722|tagatose|tagatose
81702|NCT02776722|sorbose|sorbose
81703|NCT02776696|Closed Loop|closed loop
81704|NCT02776696|Artificial Pancreas|artificial pancreas
81710|NCT02776644|interferon alpha|interferon alpha
81711|NCT02776644|interleukin 2|interleukin 2
81712|NCT02776592|Healthy Children|healthy children
81713|NCT02776579|Resistance Training; Muscle Strength|resistance training; muscle strength
81714|NCT02776566|Anticoagulation|anticoagulation
81715|NCT02776566|Anticoagulation Management|anticoagulation management
81716|NCT02776566|Self-Testing|self-testing
81717|NCT02776566|Self-Management|self-management
81718|NCT02776566|Warfarin|warfarin
81719|NCT02776566|Thromboembolism|thromboembolism
81720|NCT02776566|Blood Coagulation Disorders|blood coagulation disorders
81721|NCT02776566|Health Disparities|health disparities
81722|NCT02776566|Minorities|minorities
81723|NCT02776566|African American|african american
81724|NCT02776566|Hispanic|hispanic
81725|NCT02776566|Cardiovascular Disease|cardiovascular disease
81726|NCT02776566|Models of Anticoagulation Care|models of anticoagulation care
81727|NCT02776566|Tele-Health|tele-health
81728|NCT02776566|Home Self-Testing|home self-testing
81729|NCT02776527|Gastric cancer|gastric cancer
81730|NCT02776527|D2 Lymphadenectomy|d2 lymphadenectomy
81731|NCT02776527|postoprative adjuvant chemotherapy|postoprative adjuvant chemotherapy
81732|NCT02776527|Apatinib|apatinib
81733|NCT02776527|disease free survival|disease free survival
81734|NCT02776488|brain trauma, metabolic therapy|brain trauma, metabolic therapy
81735|NCT02776462|Eye Tracking|eye tracking
81736|NCT02776462|Concussion|concussion
81737|NCT02776462|Outcome Measures|outcome measures
81738|NCT02776410|sustainable healthy eating|sustainable healthy eating
81739|NCT02776410|consumer behaviour|consumer behaviour
81740|NCT02776410|consumer attitudes|consumer attitudes
81741|NCT02776384|Heart Failure|heart failure
81742|NCT02776384|Biomarkers|biomarkers
81743|NCT02776384|Echocardiography|echocardiography
81744|NCT02776384|Cardiopulmonary Function Tests|cardiopulmonary function tests
81745|NCT02776371|Helicobacter pylori|helicobacter pylori
81746|NCT02776371|Sequential therapy|sequential therapy
81747|NCT02776371|Modified non-clarithromycin triple therapy|modified non-clarithromycin triple therapy
81748|NCT02776345|calcific tendonitis|calcific tendonitis
81749|NCT02776345|rotator cuff calcific tendonitis|rotator cuff calcific tendonitis
81750|NCT02776332|breastfeeding|breastfeeding
81751|NCT02776332|premature infants|premature infants
81752|NCT02776332|manual expression|manual expression
81753|NCT02776319|Non-invasive brain stimulation|non-invasive brain stimulation
81754|NCT02776319|tobacco use disorder|tobacco use disorder
81756|NCT02776280|water|water
81757|NCT02776280|salt|salt
81758|NCT02776280|oral fluids|oral fluids
81759|NCT02776280|plaque|plaque
81760|NCT02776280|dental caries|dental caries
81761|NCT02776254|anti-retroviral therapy|anti-retroviral therapy
81762|NCT02776254|differentiated care|differentiated care
81763|NCT02776241|ADPKD|adpkd
81764|NCT02776241|total kidney volume|total kidney volume
81765|NCT02776241|kidney disease|kidney disease
81766|NCT02776189|Anaesthesia|anaesthesia
81768|NCT02776189|Brain|brain
81769|NCT02776176|enhanced recovery after surgery|enhanced recovery after surgery
81770|NCT02776176|hirschsprung disease|hirschsprung disease
81771|NCT02776163|Salivary Gland Tumors|salivary gland tumors
81772|NCT02776163|Head-an-Neck cancer|head-an-neck cancer
81773|NCT02776163|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
81774|NCT02776163|High-Risk|high-risk
81775|NCT02776163|Cisplatin|cisplatin
81776|NCT02776163|Docetaxel|docetaxel
81777|NCT02776150|probe melting curve|probe melting curve
81778|NCT02776150|Drug resistance|drug resistance
81779|NCT02776150|Tuberculosis, Pulmonary|tuberculosis, pulmonary
81780|NCT02776137|Docetaxel|docetaxel
81781|NCT02776137|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
81782|NCT02776137|High-Risk|high-risk
81783|NCT02776137|Squamous Cell Carcinoma|squamous cell carcinoma
81784|NCT02776137|Head-and-Neck Cancer|head-and-neck cancer
81785|NCT02776124|Nutritional status|nutritional status
73081|NCT02826811|Transplantation|transplantation
73082|NCT02826811|BKV|bkv
73083|NCT02826811|Anti-BKV|anti-bkv
73084|NCT02826811|Nephropathy|nephropathy
73087|NCT02826798|VBI-1501A|vbi-1501a
81786|NCT02776124|nasopharyngeal carcinoma|nasopharyngeal carcinoma
81787|NCT02776124|Nutritional Counseling|nutritional counseling
81788|NCT02776124|concurrent chemoradiotherapy|concurrent chemoradiotherapy
81789|NCT02776124|oral nutritional supplements|oral nutritional supplements
81790|NCT02776111|Kidney Transplant|kidney transplant
81791|NCT02776098|Cystic Fibrosis|cystic fibrosis
81792|NCT02776098|Glucose Intolerance|glucose intolerance
81793|NCT02776098|Muscle Accrual|muscle accrual
81794|NCT02776098|Cystic Fibrosis-related Diabetes|cystic fibrosis-related diabetes
81795|NCT02776085|optic nerve sheath diameter|optic nerve sheath diameter
81796|NCT02776085|ultrasound|ultrasound
81797|NCT02776085|shunt failure|shunt failure
81798|NCT02776072|Tecfidera, DMF, dimethyl fumarate, Fingolimod, Glatiramer acetate, Teriflunomide, Gilenya, Copaxone, Aubagio|tecfidera, dmf, dimethyl fumarate, fingolimod, glatiramer acetate, teriflunomide, gilenya, copaxone, aubagio
81800|NCT02776059|pegfilgrastim|pegfilgrastim
81801|NCT02776059|cirrhosis, alcoholic|cirrhosis, alcoholic
81898|NCT02775578|biomarkers|biomarkers
81899|NCT02775578|Percutaneous Coronary Intervention, PCI|percutaneous coronary intervention, pci
81802|NCT02776046|Oxygen, surgical site infection, postoperative complication, recruitment maneuvers, open lung strategy|oxygen, surgical site infection, postoperative complication, recruitment maneuvers, open lung strategy
81803|NCT02776033|tolerability|tolerability
81804|NCT02776033|safety|safety
81806|NCT02776033|RIP1 kinase inhibitor|rip1 kinase inhibitor
81807|NCT02776033|psoriasis|psoriasis
81808|NCT02776007|Continuous Glucose Monitoring System|continuous glucose monitoring system
81809|NCT02775955|Pharmacokinetics|pharmacokinetics
81810|NCT02775929|Tenofovir disoproxil|tenofovir disoproxil
81811|NCT02775929|Emtricitabine|emtricitabine
81812|NCT02775929|Pre-exposure Prophylaxis|pre-exposure prophylaxis
81813|NCT02775929|Antiretroviral Therapy|antiretroviral therapy
81814|NCT02775929|HIV Prevention|hiv prevention
81815|NCT02775929|FTC TDF|ftc tdf
81816|NCT02775929|PrEP|prep
81817|NCT02775929|HIV Infected Partners|hiv infected partners
81818|NCT02775929|HIV Uninfected Partners|hiv uninfected partners
81819|NCT02775903|MEDI4736|medi4736
81820|NCT02775903|Durvalumab|durvalumab
81821|NCT02775903|Myelodysplastic Syndromes|myelodysplastic syndromes
81822|NCT02775903|Acute Myeloid Leukemia|acute myeloid leukemia
81823|NCT02775903|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
81824|NCT02775903|Azacitidine|azacitidine
81825|NCT02775903|Safety|safety
81826|NCT02775903|Efficacy|efficacy
81827|NCT02775903|PD-L1|pd-l1
81828|NCT02775877|PCOS|pcos
81829|NCT02775877|letrozole|letrozole
81830|NCT02775877|clomiphene|clomiphene
81831|NCT02775786|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
81832|NCT02775786|Pancreatic Cancer|pancreatic cancer
81833|NCT02775773|TXA|txa
81834|NCT02775773|PPH|pph
81835|NCT02775760|brain|brain
81836|NCT02775760|brain mapping|brain mapping
81837|NCT02775760|cognition|cognition
81838|NCT02775760|exercise|exercise
81839|NCT02775760|physical activity|physical activity
81840|NCT02775760|hippocampus|hippocampus
81841|NCT02775760|entorhinal cortex|entorhinal cortex
81842|NCT02775760|spatial navigation|spatial navigation
81843|NCT02775760|learning|learning
81844|NCT02775760|memory|memory
81845|NCT02775760|magnetic resonance imaging|magnetic resonance imaging
81846|NCT02775760|functional neuroimaging|functional neuroimaging
81847|NCT02775760|physical endurance|physical endurance
81848|NCT02775760|physical fitness|physical fitness
81849|NCT02775760|resistance training|resistance training
81850|NCT02775760|walking|walking
81851|NCT02775760|muscle stretching exercises|muscle stretching exercises
81852|NCT02775760|exercise test|exercise test
81853|NCT02775760|neuropsychological tests|neuropsychological tests
81854|NCT02775760|executive function|executive function
81855|NCT02775760|attention|attention
81856|NCT02775760|body composition|body composition
81857|NCT02775734|Polycystic Ovary Syndrome|polycystic ovary syndrome
81858|NCT02775734|N-acetyl-cysteine|n-acetyl-cysteine
81859|NCT02775734|Clomiphene citrate|clomiphene citrate
81860|NCT02775734|Clomiphene citrate resistant|clomiphene citrate resistant
81861|NCT02775734|Laparoscopic ovarian drilling|laparoscopic ovarian drilling
81862|NCT02775734|therapy|therapy
81863|NCT02775721|Nursing Education|nursing education
81864|NCT02775721|Weight Loss|weight loss
81865|NCT02775721|Gastrostomy Tube Care|gastrostomy tube care
81866|NCT02775695|pancreatic cancer|pancreatic cancer
81867|NCT02775695|Resectable Pancreatic Cancer|resectable pancreatic cancer
81868|NCT02775695|Doxycycline|doxycycline
81869|NCT02775695|Metakaryote cells|metakaryote cells
81870|NCT02775695|Eukaryotic cells|eukaryotic cells
81871|NCT02775695|Cancer Stem Cells|cancer stem cells
81872|NCT02775695|Targeted Cancer Stem Cell Therapy|targeted cancer stem cell therapy
81873|NCT02775695|Multi-metakaryocide therapy|multi-metakaryocide therapy
81874|NCT02775695|Doxycycline Hyclate|doxycycline hyclate
81875|NCT02775695|Tetracycline|tetracycline
81876|NCT02775682|epilepsy, dynamic cerebral autoregulation|epilepsy, dynamic cerebral autoregulation
81877|NCT02775669|noninvasive ICP monitoring|noninvasive icp monitoring
81878|NCT02775656|Cimzia®|cimzia®
81879|NCT02775656|CZP|czp
81880|NCT02775656|Pregnancy Follow up study|pregnancy follow up study
81881|NCT02775656|Autoimmune diseases|autoimmune diseases
81882|NCT02775656|Pregnancy outcomes|pregnancy outcomes
81883|NCT02775656|major congenital malformations|major congenital malformations
81884|NCT02775656|birth outcomes|birth outcomes
81885|NCT02775656|malformation|malformation
81886|NCT02775656|birth defect|birth defect
81887|NCT02775643|Melanoma|melanoma
81888|NCT02775643|Spitzoid Melanoma|spitzoid melanoma
81889|NCT02775643|Congenital Melanoma|congenital melanoma
81890|NCT02775643|Melanoma Arising in Giant Nevi|melanoma arising in giant nevi
81891|NCT02775643|Melanocytic lesions with indeterminate biological behavior|melanocytic lesions with indeterminate biological behavior
81892|NCT02775643|Pigment synthesizing melanomas|pigment synthesizing melanomas
81893|NCT02775604|fall risks at home|fall risks at home
81894|NCT02775604|video technology|video technology
81895|NCT02775604|home assessment|home assessment
81896|NCT02775578|heart failure|heart failure
81897|NCT02775578|coronary artery disease|coronary artery disease
81902|NCT02775552|Breastfeeding|breastfeeding
81903|NCT02775552|Complementary Feeding|complementary feeding
81904|NCT02775552|Infant and Young Child Feeding|infant and young child feeding
81905|NCT02775552|Social and Behavior Change Communication|social and behavior change communication
81907|NCT02775539|Pulmonary hypertension|pulmonary hypertension
81908|NCT02775539|Mirabegron|mirabegron
81909|NCT02775539|Heart failure|heart failure
81910|NCT02775539|B3 adrenergic|b3 adrenergic
627671|NCT00690950|BPH|bph
81911|NCT02775526|Mixed urinary incontinence|mixed urinary incontinence
81912|NCT02775526|Transobturator tape (TOT)|transobturator tape (tot)
81913|NCT02775526|Tension-Free Vaginal Tape (TVT)|tension-free vaginal tape (tvt)
81914|NCT02775526|Burch colposuspension|burch colposuspension
81915|NCT02775526|Urinary incontinence|urinary incontinence
81916|NCT02775500|pregnancy|pregnancy
81917|NCT02775500|apremilast|apremilast
81918|NCT02775500|Otezla|otezla
81919|NCT02775500|autoimmune disease|autoimmune disease
81920|NCT02775500|psoriatic arthritis|psoriatic arthritis
81921|NCT02775500|psoriasis|psoriasis
81922|NCT02775500|TNF|tnf
81923|NCT02775500|tumor necrosis factor|tumor necrosis factor
81924|NCT02775500|birth outcome|birth outcome
81925|NCT02775500|birth defect|birth defect
81926|NCT02775487|COPD|copd
81927|NCT02775487|Air quality|air quality
81928|NCT02775474|Methadone|methadone
81929|NCT02775474|Pain, Postoperative|pain, postoperative
81930|NCT02775474|Chronic Pain|chronic pain
81931|NCT02775474|Bariatric Surgery|bariatric surgery
81932|NCT02775461|Pancreas Cancer|pancreas cancer
81933|NCT02775461|Chronic Pancreatitis|chronic pancreatitis
81934|NCT02775461|Pancreatic Cyst|pancreatic cyst
81935|NCT02775461|BRCA1|brca1
81936|NCT02775461|BRCA2|brca2
81937|NCT02775461|Lynch Syndrome|lynch syndrome
81938|NCT02775461|Peutz-Jeghers syndrome|peutz-jeghers syndrome
81939|NCT02775461|ATM mutation|atm mutation
81940|NCT02775461|FAMMM Syndrome|fammm syndrome
81941|NCT02775461|Pancreatitis|pancreatitis
81942|NCT02775461|Family History of Pancreas Cancer|family history of pancreas cancer
81943|NCT02775461|Family History of Cancer|family history of cancer
81944|NCT02775448|Homeopathy|homeopathy
81945|NCT02775448|Carduus marianus|carduus marianus
81946|NCT02775448|Dyslipidemia|dyslipidemia
81947|NCT02775448|Climacteric|climacteric
81948|NCT02775448|Obesity|obesity
81949|NCT02775448|Triglycerides|triglycerides
81950|NCT02775448|Cholesterol|cholesterol
81951|NCT02775448|Insulin resistance|insulin resistance
81952|NCT02775448|LDL-cholesterol|ldl-cholesterol
81953|NCT02775448|HDL-cholesterol|hdl-cholesterol
81958|NCT02775383|National MDS Study|national mds study
81959|NCT02775383|MDS|mds
81960|NCT02775383|Idiopathic|idiopathic
81961|NCT02775383|cytopenia|cytopenia
81962|NCT02775383|cytopenias|cytopenias
81963|NCT02775383|ICUS|icus
81964|NCT02775383|MDS/MPN|mds/mpn
81965|NCT02775383|Myeloproliferative Neoplasm|myeloproliferative neoplasm
81966|NCT02775383|Biorepository|biorepository
81967|NCT02775344|Laparoscopy|laparoscopy
81968|NCT02775344|ovarian cystectomy|ovarian cystectomy
81969|NCT02775344|three dimension laparoscopy|three dimension laparoscopy
81970|NCT02775331|shift scheduling|shift scheduling
81971|NCT02775331|work-life interaction|work-life interaction
81972|NCT02775331|working time control|working time control
81973|NCT02775331|public sector|public sector
81974|NCT02775318|Stellate Ganglion|stellate ganglion
73281|NCT02825654|Pulmonary|pulmonary
73282|NCT02825654|Lung|lung
73283|NCT02825654|Military and environmental exposures|military and environmental exposures
81975|NCT02775318|Digital Subtraction Angiography|digital subtraction angiography
81976|NCT02775318|Transcranial Doppler Ultrasonography|transcranial doppler ultrasonography
81977|NCT02775279|acute coronary syndrome, telomere length, predictive factor|acute coronary syndrome, telomere length, predictive factor
81978|NCT02775253|Brown adipose tissue|brown adipose tissue
81979|NCT02775253|Subcutaneous white adipose tissue|subcutaneous white adipose tissue
81980|NCT02775253|White adipose tissue|white adipose tissue
81981|NCT02775240|Maribavir|maribavir
81982|NCT02775214|Storz C-MAC|storz c-mac
81983|NCT02775214|direct laryngoscopy|direct laryngoscopy
81984|NCT02775214|pyloromyotomy|pyloromyotomy
81985|NCT02775214|rapid sequence|rapid sequence
81986|NCT02775201|plantaris|plantaris
81987|NCT02775201|Tendinopathy|tendinopathy
81988|NCT02775201|Achilles|achilles
81989|NCT02775201|Release|release
81990|NCT02775175|Ramadan|ramadan
81991|NCT02775175|Fasting|fasting
81992|NCT02775175|Nutrition|nutrition
81993|NCT02775175|Quality of Life|quality of life
81994|NCT02775136|brain injuries|brain injuries
81995|NCT02775136|neurological monitoring|neurological monitoring
81996|NCT02775084|n-3|n-3
81997|NCT02775084|Polyunsaturated|polyunsaturated
81998|NCT02775084|Fatty acids|fatty acids
81999|NCT02775084|Antigens|antigens
82000|NCT02775084|Cognition|cognition
82002|NCT02775045|EoE|eoe
82003|NCT02775032|advance care planning|advance care planning
82004|NCT02775032|general practice|general practice
82005|NCT02775032|family practice|family practice
82006|NCT02775032|palliative care|palliative care
82007|NCT02775032|end-of-life care|end-of-life care
82008|NCT02774967|root coverage|root coverage
82009|NCT02774967|gingival recession|gingival recession
82010|NCT02774967|periodontal surgery|periodontal surgery
82011|NCT02774954|Change the cycle|change the cycle
82012|NCT02774954|social learning theory|social learning theory
82013|NCT02774954|people who inject drugs|people who inject drugs
82014|NCT02774954|injection drug use|injection drug use
627829|NCT00691314|Stents|stents
82015|NCT02774954|Information, Motivation, Behavior Skills Model|information, motivation, behavior skills model
82016|NCT02774954|Longitudinal cohort study|longitudinal cohort study
82017|NCT02774928|Pulmonary Hypertension|pulmonary hypertension
82018|NCT02774928|COPD|copd
82019|NCT02774928|ILD|ild
82020|NCT02774928|OSA|osa
82021|NCT02774902|Drug Therapy|drug therapy
82022|NCT02774889|Falls Prevention|falls prevention
82023|NCT02774889|Stepping On|stepping on
82024|NCT02774889|Health Promotion|health promotion
82025|NCT02774889|Implementation|implementation
82026|NCT02774889|Health Maintenance|health maintenance
82027|NCT02774876|Closed-loop system|closed-loop system
82028|NCT02774876|Artificial pancreas|artificial pancreas
82029|NCT02774876|Glucose control|glucose control
82030|NCT02774876|Meal|meal
82031|NCT02774850|Pediatric|pediatric
82032|NCT02774850|Neutropenia Management|neutropenia management
82033|NCT02774850|Acute Myeloid Leukemia|acute myeloid leukemia
82034|NCT02774850|Chart Abstraction|chart abstraction
82035|NCT02774850|Chemotherapy|chemotherapy
82036|NCT02774837|nucleoside analogues|nucleoside analogues
82037|NCT02774837|tenofovir|tenofovir
82038|NCT02774837|telbivudine|telbivudine
82039|NCT02774837|quantitative HBsAg|quantitative hbsag
82040|NCT02774837|combination therapy|combination therapy
82041|NCT02774798|Rectal Prolapse|rectal prolapse
82042|NCT02774798|Rectal Intussuception|rectal intussuception
82043|NCT02774759|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
82044|NCT02774759|Endometrial cancer survivors|endometrial cancer survivors
82045|NCT02774759|Obese|obese
82046|NCT02774759|Weight loss intervention|weight loss intervention
82047|NCT02774759|Resistance training|resistance training
82048|NCT02774759|Aerobic exercise|aerobic exercise
82049|NCT02774759|Questionnaires|questionnaires
82050|NCT02774759|Surveys|surveys
82051|NCT02774759|Accelerometer|accelerometer
82052|NCT02774759|Fitness Test|fitness test
82053|NCT02774759|Telephone Coaching|telephone coaching
82054|NCT02774759|Video Chat Sessions|video chat sessions
82055|NCT02774707|Dry eye|dry eye
82056|NCT02774694|nociceptive flexion reflex|nociceptive flexion reflex
82057|NCT02774694|interventional pain management|interventional pain management
82058|NCT02774668|gender|gender
82059|NCT02774668|arterial stiffness|arterial stiffness
82060|NCT02774668|blood pressure|blood pressure
82061|NCT02774668|weight loss|weight loss
82062|NCT02774668|uric acid|uric acid
82063|NCT02774655|healthy volunteers|healthy volunteers
82064|NCT02774655|patient compliance|patient compliance
82065|NCT02774655|exercise|exercise
82066|NCT02774655|motivation|motivation
82067|NCT02774642|PTSD|ptsd
82068|NCT02774642|insomnia|insomnia
82069|NCT02774642|CBT-I|cbt-i
82070|NCT02774642|Prolonged Exposure|prolonged exposure
82071|NCT02774642|Veteran|veteran
82072|NCT02774629|food allergy|food allergy
82073|NCT02774629|skin prick test|skin prick test
82074|NCT02774629|atopy patch test|atopy patch test
82075|NCT02774590|Acne vulgaris|acne vulgaris
82076|NCT02774590|Rosacea|rosacea
82077|NCT02774577|Oxygen Consumption|oxygen consumption
82078|NCT02774577|Aged|aged
82079|NCT02774577|Whole Body Vibration|whole body vibration
82080|NCT02774551|Body composition|body composition
82081|NCT02774551|Muscle strength|muscle strength
82082|NCT02774551|Health related quality of life|health related quality of life
82083|NCT02774538|Cervical HPV infection|cervical hpv infection
82084|NCT02774538|Oral HPV infection|oral hpv infection
82085|NCT02774538|Sexually transmitted infection|sexually transmitted infection
82086|NCT02774525|child welfare system|child welfare system
82087|NCT02774525|parental substance use problem|parental substance use problem
82088|NCT02774525|child maltreatment|child maltreatment
82089|NCT02774525|parenting|parenting
82090|NCT02774473|Metastatic|metastatic
82091|NCT02774473|Rb+|rb+
82092|NCT02774473|Breast Cancer|breast cancer
82093|NCT02774408|backup ventilation|backup ventilation
82094|NCT02774408|preterm infants|preterm infants
82224|NCT02773407|Efficacy|efficacy
82095|NCT02774408|functional residual capacity|functional residual capacity
82096|NCT02774408|chronic lung disease|chronic lung disease
83516|NCT02765360|EIT|eit
82098|NCT02774382|Infection|infection
82099|NCT02774369|cancer|cancer
82100|NCT02774369|insomnia|insomnia
82101|NCT02774369|sleep|sleep
82102|NCT02774369|physical exercise|physical exercise
82103|NCT02774369|aerobic|aerobic
82104|NCT02774369|cognitive-behavioral therapy|cognitive-behavioral therapy
82105|NCT02774369|self-help|self-help
82106|NCT02774369|RCT|rct
82107|NCT02774356|Brainstem|brainstem
82108|NCT02774356|Encoding|encoding
82109|NCT02774356|Pitch|pitch
82110|NCT02774304|elastance|elastance
82111|NCT02774304|fluid responsiveness|fluid responsiveness
82112|NCT02774265|Fracture|fracture
82113|NCT02774265|Prophylaxis|prophylaxis
82114|NCT02774226|Flow-Mediated Dilation|flow-mediated dilation
82115|NCT02774226|Kuvan|kuvan
82116|NCT02774226|Antioxidant|antioxidant
82117|NCT02774226|FEV1|fev1
82118|NCT02774187|Hepatocellular Carcinoma|hepatocellular carcinoma
82119|NCT02774187|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
82120|NCT02774187|Sorafenib|sorafenib
82121|NCT02774174|Proximal Humerus|proximal humerus
82122|NCT02774109|low back pain|low back pain
82123|NCT02774109|fish oil|fish oil
82124|NCT02774109|omega 3|omega 3
82125|NCT02774096|Aortic dissection|aortic dissection
82126|NCT02774096|Cerebral and Spinal Protection|cerebral and spinal protection
82127|NCT02774096|Post-conditioning|post-conditioning
82128|NCT02774083|older people|older people
82129|NCT02774083|cognitive training|cognitive training
82130|NCT02774070|AAJ RA MRI synovitis|aaj ra mri synovitis
82131|NCT02774057|Captafer®|captafer®
82132|NCT02774057|Iron Sulfate|iron sulfate
82133|NCT02774057|Iron deficiency anemia|iron deficiency anemia
82134|NCT02774057|inflammatory bowel disease|inflammatory bowel disease
82135|NCT02774044|preterm neonates, surfactant|preterm neonates, surfactant
82136|NCT02774031|Anesthesia, Inhalation|anesthesia, inhalation
82137|NCT02774031|Laparoscopy|laparoscopy
82138|NCT02774031|Prostatectomy|prostatectomy
82139|NCT02774031|Cystectomy|cystectomy
82140|NCT02774031|Gynecologic Surgical Procedures|gynecologic surgical procedures
82141|NCT02774018|Mindfulness|mindfulness
82142|NCT02774018|Elderly|elderly
82143|NCT02774018|Psychopathology|psychopathology
82144|NCT02773992|Solitary Pulmonary Nodule|solitary pulmonary nodule
82145|NCT02773992|Itos|itos
82146|NCT02773992|lung cancer|lung cancer
82147|NCT02773979|challenge|challenge
82148|NCT02773979|malaria|malaria
82149|NCT02773979|P. falciparum|p. falciparum
82150|NCT02773979|PfSPZ|pfspz
82151|NCT02773979|sporozoites|sporozoites
82152|NCT02773979|vaccine|vaccine
82153|NCT02773953|CPAP|cpap
82154|NCT02773953|Telemonitoring|telemonitoring
82155|NCT02773927|Agave inulin|agave inulin
82156|NCT02773927|Adiponectin|adiponectin
82157|NCT02773927|Metabolic syndrome|metabolic syndrome
82158|NCT02773927|Metformin|metformin
82159|NCT02773927|Insulin resistance|insulin resistance
82160|NCT02773914|Activity of Daily Living (ADL)|activity of daily living (adl)
82161|NCT02773914|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
82162|NCT02773914|Elderly|elderly
82163|NCT02773914|Frailty|frailty
82164|NCT02773914|Randomized controlled study|randomized controlled study
82165|NCT02773901|intracranial pressure|intracranial pressure
82166|NCT02773901|noninvasive monitoring|noninvasive monitoring
82167|NCT02773901|lumbar puncture|lumbar puncture
82168|NCT02773888|intracranial pressure|intracranial pressure
82169|NCT02773888|noninvasive monitoring|noninvasive monitoring
82170|NCT02773875|artificial pancreas|artificial pancreas
73476|NCT02824536|3BNC117|3bnc117
82171|NCT02773862|brain injuries|brain injuries
82172|NCT02773862|noninvasive monitoring|noninvasive monitoring
82173|NCT02773862|intracranial pressure|intracranial pressure
82174|NCT02773849|IFN|ifn
82175|NCT02773849|BCG-unresponsive|bcg-unresponsive
82176|NCT02773849|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
82177|NCT02773836|tobacco use|tobacco use
82178|NCT02773836|e-cigarettes|e-cigarettes
82179|NCT02773836|public policy|public policy
82180|NCT02773836|ITC|itc
82181|NCT02773823|obesity|obesity
82182|NCT02773823|children|children
82183|NCT02773823|cardiovascular health|cardiovascular health
82184|NCT02773823|intervention study|intervention study
82185|NCT02773797|Sedation|sedation
82186|NCT02773797|Dexmedetomidine|dexmedetomidine
82187|NCT02773771|Muscle Atrophy|muscle atrophy
82188|NCT02773771|Critical Illness|critical illness
82189|NCT02773771|Ultrasound|ultrasound
82190|NCT02773771|beta-hydroxy-beta-methylbutyrate|beta-hydroxy-beta-methylbutyrate
82191|NCT02773771|ICU|icu
82192|NCT02773680|respiration|respiration
82193|NCT02773680|monitoring, physiologic|monitoring, physiologic
82194|NCT02773680|diagnostic techniques, respiratory system|diagnostic techniques, respiratory system
82195|NCT02773654|shoulder|shoulder
82196|NCT02773654|motion|motion
82197|NCT02773654|measurement|measurement
82198|NCT02773654|healthy shoulder|healthy shoulder
82199|NCT02773654|shoulder motion|shoulder motion
82200|NCT02773602|Analgesia|analgesia
82201|NCT02773602|caudal analgesia|caudal analgesia
82202|NCT02773602|ropivacaine|ropivacaine
82203|NCT02773602|clonidine|clonidine
82204|NCT02773602|dexamethasone|dexamethasone
82205|NCT02773550|Multiple Myeloma|multiple myeloma
82206|NCT02773524|Metastatic|metastatic
82207|NCT02773524|Locally recurrent|locally recurrent
82208|NCT02773524|Oesophago-gastric junction|oesophago-gastric junction
82209|NCT02773524|Stomach|stomach
82210|NCT02773524|Adenocarcinoma|adenocarcinoma
82211|NCT02773524|Undifferentiated Carcinoma|undifferentiated carcinoma
82212|NCT02773472|colorectal|colorectal
82213|NCT02773472|electroacupuncture|electroacupuncture
82214|NCT02773472|laparoscopic surgery|laparoscopic surgery
82215|NCT02773446|ETEC|etec
82216|NCT02773446|Escherichia coli|escherichia coli
82217|NCT02773446|enteritis|enteritis
82218|NCT02773446|Challenge|challenge
82219|NCT02773446|CS6|cs6
82220|NCT02773446|Enterotoxigenic|enterotoxigenic
82221|NCT02773407|Undifferentiated febrile illness|undifferentiated febrile illness
82222|NCT02773407|Azithromycin|azithromycin
82223|NCT02773407|Cotrimoxazole|cotrimoxazole
82225|NCT02773407|Enteric fever|enteric fever
82226|NCT02773407|Fever clearance time|fever clearance time
82227|NCT02773394|Hepatitis C Virus|hepatitis c virus
82228|NCT02773394|Observational|observational
82230|NCT02773342|Invasive Pulmonal Aspergillosis|invasive pulmonal aspergillosis
82231|NCT02773342|Neutropenic Patients|neutropenic patients
82232|NCT02773342|Haematological Malignancies|haematological malignancies
82233|NCT02773342|Chest Computed Tomography|chest computed tomography
82234|NCT02773329|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
82235|NCT02773329|Cancer|cancer
82236|NCT02773329|game-based exercise|game-based exercise
82237|NCT02773329|exercise|exercise
82238|NCT02773329|wearable sensors|wearable sensors
82239|NCT02773329|balance|balance
82240|NCT02773329|falls|falls
82241|NCT02773329|virtual reality|virtual reality
82242|NCT02773303|Neurofeedback|neurofeedback
82243|NCT02773303|balance, postural|balance, postural
82244|NCT02773303|postural equilibrium|postural equilibrium
82245|NCT02773303|EEG|eeg
82246|NCT02773290|Aplastic Anemia|aplastic anemia
82247|NCT02773251|Postoperative adhesion|postoperative adhesion
82248|NCT02773251|Laparoscopy|laparoscopy
82249|NCT02773251|Adhesion barrier|adhesion barrier
82250|NCT02773225|non severe Aplastic Anemia,|non severe aplastic anemia,
82251|NCT02773186|postoperative|postoperative
82252|NCT02773186|behavioral changes|behavioral changes
82253|NCT02773173|Colorectal Laparoscopic Surgery|colorectal laparoscopic surgery
82254|NCT02773134|Post-operative Bracing|post-operative bracing
82255|NCT02773134|Rigid Lumbosacral Orthosis|rigid lumbosacral orthosis
82256|NCT02773134|Posterior Spine Fusion|posterior spine fusion
82257|NCT02773134|Quality of Life|quality of life
82258|NCT02773134|Lumbar Degenerative Conditions|lumbar degenerative conditions
82259|NCT02773121|Cognition|cognition
82260|NCT02773121|Learning|learning
82261|NCT02773121|Memory|memory
82262|NCT02773121|Executive Function|executive function
82263|NCT02773121|Attention|attention
82264|NCT02773121|Neuropsychological Tests|neuropsychological tests
82265|NCT02773121|Physical Activity|physical activity
82266|NCT02773121|Physical Fitness|physical fitness
82267|NCT02773121|Exercise|exercise
82268|NCT02773121|Resistance Training|resistance training
82269|NCT02773121|Walking|walking
82270|NCT02773121|Muscle Stretching Exercises|muscle stretching exercises
73595|NCT02823847|HIV|hiv
82271|NCT02773121|Exercise Test|exercise test
82272|NCT02773121|Balance|balance
82273|NCT02773121|Flexibility|flexibility
82274|NCT02773121|Body Composition|body composition
82275|NCT02773082|Treatment-Resistant|treatment-resistant
82276|NCT02773082|Anxiety|anxiety
82277|NCT02773056|transfemoral|transfemoral
82278|NCT02773056|amputation|amputation
82279|NCT02773056|perspiration|perspiration
82280|NCT02773056|socket|socket
82281|NCT02773056|socket comfort|socket comfort
82282|NCT02773030|Multiple Myeloma|multiple myeloma
82283|NCT02773030|Relapsed|relapsed
82284|NCT02773030|Refractory|refractory
82285|NCT02773030|Pharmacokinetics|pharmacokinetics
82286|NCT02773030|Safety|safety
82287|NCT02773030|Efficacy|efficacy
82288|NCT02773030|CC-220|cc-220
82289|NCT02773030|Relapsed and refractory multiple myeloma|relapsed and refractory multiple myeloma
82290|NCT02773017|sedation|sedation
82291|NCT02773017|age|age
82292|NCT02773017|dexmedetomidine|dexmedetomidine
82293|NCT02773004|Genomic test|genomic test
82294|NCT02773004|Chemotherapy decision|chemotherapy decision
82295|NCT02772978|decision making|decision making
82296|NCT02772978|impulsivity|impulsivity
82297|NCT02772926|Benfotiamine|benfotiamine
82298|NCT02772926|Advanced glycation end products|advanced glycation end products
82299|NCT02772926|Soluble receptor for AGEs|soluble receptor for ages
82300|NCT02772926|Endogenous secretory receptor for AGEs|endogenous secretory receptor for ages
82301|NCT02772900|Aging|aging
82302|NCT02772900|Beetroot|beetroot
82303|NCT02772900|Dietary Nitrate|dietary nitrate
82304|NCT02772900|Functional Food|functional food
82306|NCT02772887|pregnancy|pregnancy
82307|NCT02772887|type 2 diabetes|type 2 diabetes
82308|NCT02772887|asymmetric dimethylarginine|asymmetric dimethylarginine
82309|NCT02772887|L-arginine|l-arginine
82310|NCT02772887|L-citrulline|l-citrulline
82414|NCT02772406|colonoscopy|colonoscopy
82311|NCT02772887|placental growth factor (PlGF)|placental growth factor (plgf)
82312|NCT02772887|blood pressure|blood pressure
82313|NCT02772874|fecal incontinence|fecal incontinence
82314|NCT02772874|severity|severity
82315|NCT02772874|ultrasound|ultrasound
82316|NCT02772874|anorectal manometry|anorectal manometry
82317|NCT02772874|classification|classification
82318|NCT02772835|nCPAP|ncpap
82319|NCT02772835|nHFOV|nhfov
82320|NCT02772835|Preterm|preterm
82321|NCT02772835|RDS|rds
82322|NCT02772835|CO2 Elimination|co2 elimination
82323|NCT02772809|stroke|stroke
82324|NCT02772809|hemiplegia|hemiplegia
82325|NCT02772809|rehabilitation|rehabilitation
82326|NCT02772809|robotics|robotics
82327|NCT02772809|neuroplasticity|neuroplasticity
82328|NCT02772796|Pharmacokinetics|pharmacokinetics
82329|NCT02772796|Healthy Volunteer Study|healthy volunteer study
82330|NCT02772783|brain|brain
82331|NCT02772783|fMRI|fmri
82332|NCT02772783|carbohydrate|carbohydrate
82333|NCT02772783|insulin clamp|insulin clamp
82334|NCT02772783|intake regulation|intake regulation
82335|NCT02772783|overweight|overweight
82336|NCT02772783|glycemic index|glycemic index
82337|NCT02772757|hearing loss|hearing loss
82338|NCT02772757|hearing aids|hearing aids
82339|NCT02772757|outcome assessment|outcome assessment
82340|NCT02772744|Hepatitis C virus genotype 4|hepatitis c virus genotype 4
82341|NCT02772744|Antiviral|antiviral
82342|NCT02772744|Virologic Response|virologic response
82343|NCT02772731|mastectomy|mastectomy
82344|NCT02772718|Hypoglycemia|hypoglycemia
82345|NCT02772705|Standardized Uptake Value|standardized uptake value
82346|NCT02772705|Diagnosis|diagnosis
82347|NCT02772679|Diabetes|diabetes
82348|NCT02772679|Treg|treg
82349|NCT02772679|Proluekin|proluekin
82350|NCT02772666|Relative afferent pupillary defect (RAPD)|relative afferent pupillary defect (rapd)
82351|NCT02772666|Multiple sclerosis|multiple sclerosis
82352|NCT02772666|Glaucoma|glaucoma
82353|NCT02772653|Microcirculation|microcirculation
82354|NCT02772653|Videomicroscopy|videomicroscopy
82355|NCT02772653|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
82356|NCT02772653|B-Type Natriuretic Peptide|b-type natriuretic peptide
82357|NCT02772653|Thromboelastometry|thromboelastometry
82358|NCT02772653|Trauma|trauma
82359|NCT02772653|Resuscitation|resuscitation
82360|NCT02772653|Hypovolemic shock|hypovolemic shock
82361|NCT02772640|Hypercholesterolemia|hypercholesterolemia
82362|NCT02772640|Rosuvastatin|rosuvastatin
82363|NCT02772640|Statin|statin
82364|NCT02772640|Ezetimibe|ezetimibe
82365|NCT02772640|Compliance|compliance
82366|NCT02772640|Cholesterol|cholesterol
82367|NCT02772640|Secondary prevention|secondary prevention
82368|NCT02772640|Coronary artery disease|coronary artery disease
82369|NCT02772640|Cholesterol absorption inhibitor|cholesterol absorption inhibitor
82370|NCT02772627|Parkinson's disease, Nebicapone|parkinson's disease, nebicapone
82371|NCT02772614|Nebicapone, Parkinson's disease|nebicapone, parkinson's disease
82372|NCT02772601|ABBV-066|abbv-066
73679|NCT02823288|rape|rape
82373|NCT02772601|BI 655066|bi 655066
82374|NCT02772601|risankizumab|risankizumab
82375|NCT02772588|ARN-509|arn-509
82376|NCT02772588|Abiraterone|abiraterone
82377|NCT02772588|Leuprolide|leuprolide
82378|NCT02772588|Intensity-Modulated and Image-Guided Radiation Therapy|intensity-modulated and image-guided radiation therapy
82379|NCT02772588|15-334|15-334
82380|NCT02772588|apalutamide,|apalutamide,
82381|NCT02772588|JNJ-56021927|jnj-56021927
82382|NCT02772575|MOLECULAR PREDICTORS|molecular predictors
82383|NCT02772575|Hepatic trans-arterial embolization (TAE)|hepatic trans-arterial embolization (tae)
82384|NCT02772575|16-385|16-385
82385|NCT02772562|prostate cancer|prostate cancer
82386|NCT02772549|Diagnosis|diagnosis
82387|NCT02772536|Chronic Tinnitus Tinted Light Change in Perception|chronic tinnitus tinted light change in perception
82388|NCT02772523|Primary Prevention|primary prevention
82389|NCT02772510|Stroke|stroke
82390|NCT02772510|Rehabilitation|rehabilitation
82391|NCT02772510|Hand|hand
82392|NCT02772510|Game|game
82393|NCT02772510|Functional electrical stimulation|functional electrical stimulation
82394|NCT02772510|Virtual reality|virtual reality
82395|NCT02772497|DME|dme
82396|NCT02772497|Anti VEGF|anti vegf
82397|NCT02772497|VEGF trap|vegf trap
82398|NCT02772497|Diabetes|diabetes
82399|NCT02772497|Diabetic retinopathy|diabetic retinopathy
82400|NCT02772497|ZALTRAP|zaltrap
82401|NCT02772497|Ziv aflibercept|ziv aflibercept
82402|NCT02772484|noninvasive monitoring|noninvasive monitoring
82403|NCT02772471|intracranial pressure|intracranial pressure
82404|NCT02772471|noninvasive monitoring|noninvasive monitoring
82405|NCT02772458|Crohn's Disease|crohn's disease
82406|NCT02772458|gut brain axis|gut brain axis
82407|NCT02772458|reduced appetite|reduced appetite
82409|NCT02772445|Caregiver|caregiver
82410|NCT02772432|resiliency training|resiliency training
82411|NCT02772432|parenting|parenting
82412|NCT02772432|special learning disability|special learning disability
82413|NCT02772406|ulcerative colitis|ulcerative colitis
82417|NCT02772367|cardiotoxicity|cardiotoxicity
82418|NCT02772367|16-025|16-025
82419|NCT02772354|Pediatric population, ablation|pediatric population, ablation
82420|NCT02772341|Asthma|asthma
82421|NCT02772341|Halotherapy|halotherapy
82422|NCT02772341|Airway hyper-reactivity|airway hyper-reactivity
82423|NCT02772341|Metacholine|metacholine
82424|NCT02772328|Testing|testing
82425|NCT02772328|Access|access
82426|NCT02772315|genomics|genomics
82427|NCT02772315|proteomics|proteomics
82428|NCT02772315|metabolomics|metabolomics
82429|NCT02772315|endocrine hypertension|endocrine hypertension
82430|NCT02772315|primary aldosteronism|primary aldosteronism
82431|NCT02772315|Cushing syndrom|cushing syndrom
82432|NCT02772315|pheochromocytoma|pheochromocytoma
82433|NCT02772289|Mesenchyme Stem Cells|mesenchyme stem cells
82434|NCT02772289|Cesarean Section|cesarean section
82435|NCT02772289|Scars|scars
82437|NCT02772263|Paramedicine|paramedicine
82438|NCT02772263|Community Paramedic|community paramedic
82439|NCT02772263|Elderly|elderly
82440|NCT02772250|bowel preparation|bowel preparation
82441|NCT02772250|polyethylene glycol|polyethylene glycol
82442|NCT02772250|face-to-face re-education|face-to-face re-education
82443|NCT02772250|telephone re-education|telephone re-education
82444|NCT02772250|Boston Bowel Preparation Scale|boston bowel preparation scale
82445|NCT02772237|concussion|concussion
82446|NCT02772237|sports-related concussion|sports-related concussion
82447|NCT02772237|mTBI|mtbi
82448|NCT02772237|Riboflavin|riboflavin
82449|NCT02772237|Vitamin B2|vitamin b2
82450|NCT02772159|COPD|copd
82451|NCT02772159|ADME|adme
82452|NCT02772159|Healthy Normal Males|healthy normal males
82453|NCT02772159|Phase 1|phase 1
82454|NCT02772120|Infertility|infertility
82455|NCT02772120|In vitro fertilization|in vitro fertilization
82456|NCT02772120|Embryo transfer|embryo transfer
82457|NCT02772120|Blastocyst|blastocyst
82458|NCT02772120|Progesterone|progesterone
82459|NCT02772120|Crinone|crinone
82460|NCT02772107|Small Cell Lung Carcinoma|small cell lung carcinoma
82461|NCT02772094|glioblastoma multiforme|glioblastoma multiforme
82462|NCT02772094|glioblastoma|glioblastoma
82463|NCT02772094|newly diagnosed glioblastoma|newly diagnosed glioblastoma
82464|NCT02772094|immunotherapy|immunotherapy
82465|NCT02772094|dendritic cells|dendritic cells
82466|NCT02772094|grade IV astrocytoma|grade iv astrocytoma
82467|NCT02772094|oncology|oncology
82468|NCT02772094|neurology|neurology
82469|NCT02772094|glioma|glioma
82470|NCT02772094|brain tumor|brain tumor
82471|NCT02772094|ADCTA-G|adcta-g
82472|NCT02772055|Moxa smoke|moxa smoke
82473|NCT02772055|Moxibustion|moxibustion
82474|NCT02772055|Knee osteoarthritis|knee osteoarthritis
82475|NCT02772042|Manual Therapy|manual therapy
82476|NCT02772042|Physiotherapy|physiotherapy
82477|NCT02772042|Manipulation|manipulation
82478|NCT02772003|Chronic HCV|chronic hcv
82479|NCT02772003|Immunotherapy|immunotherapy
96932|NCT02683538|RFA|rfa
82480|NCT02772003|DNA Vaccine|dna vaccine
82481|NCT02772003|Electroporation|electroporation
82482|NCT02771990|Back Pain|back pain
82483|NCT02771964|outcome assessment|outcome assessment
82484|NCT02771964|postoperative period|postoperative period
82485|NCT02771951|Childhood|childhood
82486|NCT02771951|Obesity|obesity
82487|NCT02771938|radiotherapy, breast cancer, DIEP flap|radiotherapy, breast cancer, diep flap
82488|NCT02771925|Gabapentin|gabapentin
82489|NCT02771925|Alcohol Dependence|alcohol dependence
82490|NCT02771899|Imaging, Three-Dimensional|imaging, three-dimensional
82491|NCT02771899|Spine|spine
82492|NCT02771899|Scoliosis|scoliosis
82493|NCT02771886|mindfulness|mindfulness
82494|NCT02771886|urges|urges
82495|NCT02771886|adolescents|adolescents
82496|NCT02771886|risk behaviors|risk behaviors
82497|NCT02771886|therapy intervention|therapy intervention
82498|NCT02771860|denosumab|denosumab
82499|NCT02771860|RANKL-blockade|rankl-blockade
82500|NCT02771834|Postural balance|postural balance
82501|NCT02771834|Osteoporosis|osteoporosis
82502|NCT02771834|Postmenopause|postmenopause
82503|NCT02771834|Vitamin D|vitamin d
82504|NCT02771834|Kyfhosis|kyfhosis
82505|NCT02771834|Muscle strength|muscle strength
82506|NCT02771808|CABG|cabg
82507|NCT02771795|HER2|her2
82508|NCT02771795|Trastuzumab|trastuzumab
82509|NCT02771795|Biosimilar|biosimilar
82510|NCT02771795|Cancer|cancer
82511|NCT02771795|Breast|breast
82512|NCT02771795|Positive|positive
82514|NCT02771782|TDaP-IPV|tdap-ipv
82515|NCT02771782|DPT Vaccine|dpt vaccine
82516|NCT02771769|cell-free DNA|cell-free dna
82517|NCT02771769|copy number instability|copy number instability
82519|NCT02771769|cancer|cancer
82520|NCT02771756|Breast cancer|breast cancer
82521|NCT02771756|Lung cancer|lung cancer
82522|NCT02771756|Nutritional support|nutritional support
82523|NCT02771756|Safety|safety
82524|NCT02771756|Effectiveness|effectiveness
82525|NCT02771743|Neuroblastoma|neuroblastoma
82526|NCT02771743|High risk|high risk
82527|NCT02771743|Tandem high dose chemotherapy|tandem high dose chemotherapy
82528|NCT02771691|Adolescent|adolescent
82529|NCT02771652|Multiple Sclerosis|multiple sclerosis
82530|NCT02771652|Quality of Life|quality of life
82531|NCT02771652|exercise|exercise
82532|NCT02771652|internet|internet
82950|NCT02768987|exercise|exercise
82533|NCT02771639|Hip arthroplasty|hip arthroplasty
82534|NCT02771639|periprosthetic joint infection|periprosthetic joint infection
82535|NCT02771639|outcome|outcome
82536|NCT02771626|RCC|rcc
82537|NCT02771626|MEL|mel
82538|NCT02771626|NSCLC|nsclc
82539|NCT02771626|Immuno-Oncology|immuno-oncology
82540|NCT02771626|Tumor Metabolism|tumor metabolism
82541|NCT02771626|Glutaminase|glutaminase
82542|NCT02771626|Glutaminase Inhibitor|glutaminase inhibitor
82543|NCT02771613|Morbidity Mortality Review|morbidity mortality review
82544|NCT02771613|medical simulation|medical simulation
82545|NCT02771613|in situ simulation|in situ simulation
82546|NCT02771613|multi professional simulation|multi professional simulation
82547|NCT02771613|hospital adverse event|hospital adverse event
82548|NCT02771600|Procedural pain|procedural pain
82549|NCT02771600|Procedural anxiety|procedural anxiety
82550|NCT02771600|Pediatrics|pediatrics
82551|NCT02771600|Needle-related procedures|needle-related procedures
82552|NCT02771587|alcohol|alcohol
82553|NCT02771587|energy drink|energy drink
82554|NCT02771587|coagulability|coagulability
82555|NCT02771587|caffeine|caffeine
82556|NCT02771587|taurine|taurine
82557|NCT02771587|driving performance|driving performance
82558|NCT02771574|Bariatric surgery complications|bariatric surgery complications
82559|NCT02771574|Glucose Metabolism Disorders|glucose metabolism disorders
82560|NCT02771574|Exendin (9-39)|exendin (9-39)
82561|NCT02771574|GLP-1|glp-1
82562|NCT02771561|Patent Foramen Ovale|patent foramen ovale
82563|NCT02771561|Obstructive Sleep Apnea|obstructive sleep apnea
82564|NCT02771561|Apnea-Hypopnea Index|apnea-hypopnea index
82565|NCT02771561|Oxygen Desaturation Index|oxygen desaturation index
82566|NCT02771561|Epworth Sleepiness Scale|epworth sleepiness scale
82567|NCT02771561|Quality of life|quality of life
82568|NCT02771561|Continuous Positive Airway Pressure|continuous positive airway pressure
82569|NCT02771561|Obstructive Sleep Apnea-Hypopnea Syndrome|obstructive sleep apnea-hypopnea syndrome
82570|NCT02771561|Gore™ septal occluder device|gore™ septal occluder device
82571|NCT02771548|Knee injuries|knee injuries
82572|NCT02771548|Rehabilitation|rehabilitation
82573|NCT02771548|Return to sport|return to sport
82574|NCT02771548|Biomechanics|biomechanics
82575|NCT02771522|Caries, Acitivity, Demineralsiation|caries, acitivity, demineralsiation
82576|NCT02771509|CPB|cpb
82577|NCT02771509|Cardiac Surgery|cardiac surgery
82578|NCT02771509|Acute Kidney Injury|acute kidney injury
82579|NCT02771470|Gut microflora|gut microflora
82580|NCT02771470|Lung cancer|lung cancer
82581|NCT02771470|Chemotherapy|chemotherapy
82582|NCT02771470|Immunity|immunity
82583|NCT02771470|Nutrition|nutrition
82584|NCT02771457|Influximab|influximab
82585|NCT02771457|IFX|ifx
82586|NCT02771457|Remicade|remicade
82587|NCT02771418|Carotid endarterectomy|carotid endarterectomy
82588|NCT02771418|postoperative cognitive dysfunction|postoperative cognitive dysfunction
82589|NCT02771405|HCV-HCC-DAAs|hcv-hcc-daas
82590|NCT02771366|neuroinflammation|neuroinflammation
82591|NCT02771366|cognitive function|cognitive function
82592|NCT02771366|aging adults|aging adults
82593|NCT02771314|NSCLC|nsclc
82594|NCT02771314|AZD9291|azd9291
82595|NCT02771314|>= 2nd line|>= 2nd line
82596|NCT02771314|liquid biopsy|liquid biopsy
82597|NCT02771314|EGFR TKIs|egfr tkis
82598|NCT02771314|EGFR mutant|egfr mutant
82599|NCT02771301|IDH1R132H Dendritic cell glioma|idh1r132h dendritic cell glioma
82600|NCT02771288|Kawasaki disease|kawasaki disease
82601|NCT02771288|optical coherence tomography|optical coherence tomography
82602|NCT02771288|multislice computed tomography|multislice computed tomography
82603|NCT02771249|Latent Tuberculosis Infection (LTBI)|latent tuberculosis infection (ltbi)
82604|NCT02771249|Antiretrovirals (ARVs)|antiretrovirals (arvs)
82605|NCT02771249|HIV|hiv
82606|NCT02771249|UGT1A1|ugt1a1
82607|NCT02771249|Drug-Drug Interaction (DDI)|drug-drug interaction (ddi)
82608|NCT02771236|Inherited Eye Disease|inherited eye disease
82609|NCT02771210|Active psoriatic arthritis|active psoriatic arthritis
82610|NCT02771210|Axial spondyloarthritides|axial spondyloarthritides
82611|NCT02771210|Subcutaneous|subcutaneous
82612|NCT02771210|Secukinumab in prefilled syringe|secukinumab in prefilled syringe
82613|NCT02771210|Enthesitis|enthesitis
82614|NCT02771210|Achilles tendon|achilles tendon
82615|NCT02771197|AML|aml
200983|NCT02112695|endurance sportswomen|endurance sportswomen
82623|NCT02771041|Hip prothesis|hip prothesis
82624|NCT02771002|critically ill patients|critically ill patients
82625|NCT02771002|septic shock|septic shock
82626|NCT02771002|peripheral perfusion index|peripheral perfusion index
82627|NCT02771002|capillary refill time|capillary refill time
82628|NCT02771002|mottling score|mottling score
82629|NCT02771002|microcirculation|microcirculation
82630|NCT02770989|Cardiac Ablation|cardiac ablation
82631|NCT02770989|Safety|safety
82632|NCT02770989|Performance|performance
82633|NCT02770989|Laser|laser
82634|NCT02770963|discogenic|discogenic
82635|NCT02770963|Acupuncture Therapy|acupuncture therapy
82636|NCT02770963|randomized controlled trial|randomized controlled trial
82637|NCT02770950|Knee Osteoarthritis|knee osteoarthritis
82638|NCT02770937|laparoscopy, simulator|laparoscopy, simulator
82639|NCT02770924|cataract|cataract
82640|NCT02770924|phacoemulsification|phacoemulsification
82641|NCT02770924|AT LISA TRI TORIC|at lisa tri toric
82642|NCT02770924|IOL|iol
82643|NCT02770911|Rectal Carcinoma|rectal carcinoma
82644|NCT02770911|Laparoscopy|laparoscopy
82645|NCT02770911|Anastomotic Leak|anastomotic leak
82646|NCT02770911|Double-stapling technique|double-stapling technique
82647|NCT02770898|probation|probation
82648|NCT02770898|evidence-based|evidence-based
82649|NCT02770898|well-being|well-being
82650|NCT02770898|physical exercise|physical exercise
82651|NCT02770898|family well-being|family well-being
82652|NCT02770872|serum amyloid a|serum amyloid a
82653|NCT02770872|lipoprotein|lipoprotein
82654|NCT02770872|insulin resistance|insulin resistance
82655|NCT02770872|dyslipidemia|dyslipidemia
82656|NCT02770859|Achalasia|achalasia
82657|NCT02770833|Proteins (seafood and meat)|proteins (seafood and meat)
82658|NCT02770833|GI|gi
82659|NCT02770833|Energy expenditure|energy expenditure
82660|NCT02770833|Energy balance|energy balance
82661|NCT02770833|Thermogenesis (DIT)|thermogenesis (dit)
82662|NCT02770833|Appetite regulating hormones|appetite regulating hormones
82663|NCT02770833|Appetite sensations|appetite sensations
82664|NCT02770833|Glucose allostatis|glucose allostatis
82665|NCT02770833|Amino acid metabolism|amino acid metabolism
82666|NCT02770833|Satiety|satiety
82667|NCT02770833|Food preferences|food preferences
82668|NCT02770807|Ataxia Teleangiectasia|ataxia teleangiectasia
82669|NCT02770807|AT|at
82670|NCT02770807|EryDex system|erydex system
82671|NCT02770807|Dexamethasone|dexamethasone
82672|NCT02770807|Dexamethasone sodium phosphate|dexamethasone sodium phosphate
82673|NCT02770781|survivors|survivors
82674|NCT02770781|physical fitness|physical fitness
82675|NCT02770768|HSDD (Hypoactive Sexual Desire Disorder)|hsdd (hypoactive sexual desire disorder)
82676|NCT02770768|EEG (Electroencephalogram)|eeg (electroencephalogram)
82677|NCT02770742|patient satisfaction|patient satisfaction
82678|NCT02770742|unsedated colonoscopy|unsedated colonoscopy
82679|NCT02770742|intestinal diseases|intestinal diseases
82680|NCT02770729|intracameral moxifloxacin|intracameral moxifloxacin
82681|NCT02770729|endophthalmitis|endophthalmitis
82682|NCT02770729|Vigamox|vigamox
82683|NCT02770729|endothelial cell density|endothelial cell density
82684|NCT02770677|Yoga|yoga
82685|NCT02770677|COPD|copd
82686|NCT02770677|rehabilitation|rehabilitation
82687|NCT02770651|optical coherence tomography|optical coherence tomography
82688|NCT02770651|everolimus-eluting stent|everolimus-eluting stent
82689|NCT02770651|zotarolimus-eluting stent|zotarolimus-eluting stent
82690|NCT02770638|Healthy|healthy
82691|NCT02770638|Sport|sport
82692|NCT02770638|Athlete|athlete
82693|NCT02770638|Male|male
82694|NCT02770638|University|university
82695|NCT02770638|Adults|adults
82696|NCT02770638|Rugby Football Union|rugby football union
82697|NCT02770638|Professional|professional
82698|NCT02770638|Competitive sport|competitive sport
82699|NCT02770638|Scoop Stretcher|scoop stretcher
82700|NCT02770638|Ferno Scoop Stretcher|ferno scoop stretcher
82701|NCT02770638|Long back spinal board|long back spinal board
82702|NCT02770638|Emergency Medical Services|emergency medical services
82703|NCT02770638|Long backboard|long backboard
82704|NCT02770638|Patient Extrication|patient extrication
82705|NCT02770638|Triple Immobilisation|triple immobilisation
82706|NCT02770638|Pre hospital Medicine|pre hospital medicine
200984|NCT02112695|addiction|addiction
82707|NCT02770638|Rigid Cervical Collar|rigid cervical collar
82708|NCT02770638|Pressure Testing|pressure testing
82709|NCT02770638|Tissue Pressure Testing|tissue pressure testing
82710|NCT02770638|Visual Analogue Scale|visual analogue scale
82711|NCT02770638|Pressure Sores|pressure sores
82712|NCT02770638|Pressure area damage|pressure area damage
82713|NCT02770638|Tissue Viability|tissue viability
82714|NCT02770638|Tissue Interface Pressure|tissue interface pressure
82715|NCT02770638|Comfort|comfort
82716|NCT02770638|Pain|pain
82717|NCT02770625|Type I Gaucher|type i gaucher
82718|NCT02770625|ISU302|isu302
82719|NCT02770625|Imiglucerase|imiglucerase
82720|NCT02770599|IBD|ibd
82721|NCT02770599|HRQoL|hrqol
82722|NCT02770599|QoC|qoc
82723|NCT02770599|Adherence|adherence
82724|NCT02770599|IBD nurse|ibd nurse
82725|NCT02770599|MDT|mdt
82726|NCT02770573|nano-hydroxyapatite|nano-hydroxyapatite
82727|NCT02770508|antiretroviral naive|antiretroviral naive
82730|NCT02770482|biomarkers|biomarkers
82731|NCT02770482|cerebrospinal fluid|cerebrospinal fluid
82732|NCT02770469|Breast Cancer|breast cancer
82733|NCT02770469|Korean Americans|korean americans
82734|NCT02770469|Survivorship|survivorship
82735|NCT02770469|Quality of Life|quality of life
82736|NCT02770469|Coping Skills|coping skills
82737|NCT02770469|Perceived Stress|perceived stress
82738|NCT02770456|fish oil, preterm birth, pregnancy, China, prevention|fish oil, preterm birth, pregnancy, china, prevention
82739|NCT02770443|Recovered LVEF|recovered lvef
82741|NCT02770391|HSD3B1 Genotype|hsd3b1 genotype
82742|NCT02770391|Steroid Metabolism|steroid metabolism
82743|NCT02770391|High-risk Prostate Cancer|high-risk prostate cancer
82744|NCT02770391|ARN-509|arn-509
82745|NCT02770378|Temozolomide|temozolomide
82746|NCT02770378|Recurrent Glioblastoma|recurrent glioblastoma
82747|NCT02770352|retrospective chart review|retrospective chart review
82748|NCT02770352|prospective chart review|prospective chart review
82749|NCT02770352|fistula formation and repair|fistula formation and repair
82750|NCT02770352|database|database
82751|NCT02770352|demographics of women with fistulas|demographics of women with fistulas
82752|NCT02770352|internationally accepted risks factors for fistula formation|internationally accepted risks factors for fistula formation
82753|NCT02770339|Pharmacogenomics|pharmacogenomics
82754|NCT02770339|Psychiatric crisis|psychiatric crisis
82755|NCT02770339|Drug overdose|drug overdose
82756|NCT02770339|Psychotropic medications|psychotropic medications
82757|NCT02770326|Safety of Stool Transplant|safety of stool transplant
82758|NCT02770326|Fecal Microbiota Transplantation (FMT)|fecal microbiota transplantation (fmt)
82759|NCT02770326|15-337|15-337
82760|NCT02770300|automatic|automatic
82761|NCT02770300|personalized|personalized
82762|NCT02770300|robotic therapy|robotic therapy
82763|NCT02770261|DP-R208|dp-r208
82764|NCT02770222|Pharmacokinetics|pharmacokinetics
82765|NCT02770196|Community-Supported Agriculture|community-supported agriculture
82766|NCT02770196|Local Food System|local food system
82767|NCT02770196|Vegetable|vegetable
82768|NCT02770196|Fruit|fruit
82769|NCT02770196|Childhood Obesity|childhood obesity
82770|NCT02770183|Myocardial stunning|myocardial stunning
82771|NCT02770183|Echocardiography, Transesophageal|echocardiography, transesophageal
82772|NCT02770183|Extracorporeal Circulation|extracorporeal circulation
82773|NCT02770144|Child Quality of Life|child quality of life
82774|NCT02770144|Financial Coaching|financial coaching
82775|NCT02770144|Socioeconomic Status|socioeconomic status
82776|NCT02770144|Social Determinants of Health|social determinants of health
82779|NCT02770118|sleep restriction|sleep restriction
82780|NCT02770118|obesity|obesity
82781|NCT02770118|brown adipose tissue|brown adipose tissue
82782|NCT02770105|L-theanine|l-theanine
82783|NCT02770105|caffeine|caffeine
82784|NCT02770105|selective attention|selective attention
82785|NCT02770105|fMRI|fmri
82786|NCT02770105|RVRT|rvrt
82787|NCT02770079|Insulin sensitivity|insulin sensitivity
82788|NCT02770053|Foraminal enlargement|foraminal enlargement
82789|NCT02770053|Root canal treatment|root canal treatment
82790|NCT02770040|Acute Severe Ulcerative Colitis|acute severe ulcerative colitis
82791|NCT02770040|Steroid Refractory Ulcerative Colitis|steroid refractory ulcerative colitis
82792|NCT02770027|Colon Surgery|colon surgery
82793|NCT02770027|blood viscosity|blood viscosity
82794|NCT02770014|Non-Small Cell Lung Cancer|non-small cell lung cancer
82795|NCT02770014|Epidermal Growth Factor Receptor|epidermal growth factor receptor
82796|NCT02770001|Admixture|admixture
82797|NCT02770001|African American|african american
82798|NCT02770001|African American Genetics|african american genetics
82799|NCT02769988|Adolescents|adolescents
82800|NCT02769988|Health Information Literacy|health information literacy
82801|NCT02769988|Health Education|health education
82802|NCT02769975|Endocrinology|endocrinology
82803|NCT02769975|Obesity|obesity
82804|NCT02769975|Pediatric|pediatric
82805|NCT02769975|Growth Disorder|growth disorder
82806|NCT02769975|Pubertal Development|pubertal development
82807|NCT02769962|PARP Inhibitor|parp inhibitor
82808|NCT02769962|Topoisomerase I (Top1)|topoisomerase i (top1)
82810|NCT02769962|Nanoparticle Drug Conjugate|nanoparticle drug conjugate
82811|NCT02769949|Genetics|genetics
82812|NCT02769949|Metabolic|metabolic
82813|NCT02769949|Dysmorphic Syndromes|dysmorphic syndromes
82814|NCT02769949|Developmental Delay|developmental delay
82815|NCT02769949|Genetic Counseling|genetic counseling
82816|NCT02769936|Receptors|receptors
82817|NCT02769936|N-Methyl-D-Aspartate|n-methyl-d-aspartate
82818|NCT02769923|WestPharma ID-adapter|westpharma id-adapter
82819|NCT02769923|Star ID syringe|star id syringe
627830|NCT00691314|Stenosis|stenosis
82820|NCT02769923|BCG needle syringe|bcg needle syringe
82826|NCT02769884|artificial pancreas|artificial pancreas
82828|NCT02769832|Albumin-bound Paclitaxel|albumin-bound paclitaxel
82829|NCT02769832|SCLC|sclc
82830|NCT02769832|Gemzar|gemzar
82831|NCT02769819|Flexible fiberscope|flexible fiberscope
82832|NCT02769754|LIVER|liver
82833|NCT02769754|RESECTION|resection
82834|NCT02769754|SURGERY|surgery
82835|NCT02769741|Cashew|cashew
82836|NCT02769741|Lipoprotein|lipoprotein
82837|NCT02769715|Removable partial dentures|removable partial dentures
82838|NCT02769715|partial edentulism|partial edentulism
82839|NCT02769702|Uveitis|uveitis
82840|NCT02769689|Multiple sclerosis|multiple sclerosis
82841|NCT02769689|Natalizumab|natalizumab
82842|NCT02769689|Fingolimod|fingolimod
82843|NCT02769689|Methylprednisolone|methylprednisolone
82844|NCT02769650|Coronary stenosis|coronary stenosis
82845|NCT02769650|Drug-eluting stent|drug-eluting stent
82846|NCT02769650|Coronary angioplasty with stenting|coronary angioplasty with stenting
82847|NCT02769650|Ischemic Heart Disease|ischemic heart disease
82848|NCT02769650|Chronic total occlusion|chronic total occlusion
82849|NCT02769650|Right coronary artery|right coronary artery
82850|NCT02769650|Stress-MRI|stress-mri
82851|NCT02769637|upper gastrointestinal tract|upper gastrointestinal tract
82852|NCT02769637|lung microbiota and inflammation|lung microbiota and inflammation
82853|NCT02769624|Congenital heart disease|congenital heart disease
82854|NCT02769598|Pain|pain
82855|NCT02769598|Nociception|nociception
82856|NCT02769598|Pediatric intensive care|pediatric intensive care
82857|NCT02769598|Pain assessment scale|pain assessment scale
82858|NCT02769598|ANI index|ani index
82859|NCT02769585|Obesity|obesity
82860|NCT02769585|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
82861|NCT02769585|weight reduction|weight reduction
82862|NCT02769572|Knee osteoarthritis|knee osteoarthritis
82863|NCT02769572|moxibustion|moxibustion
82864|NCT02769572|diclofenac sodium gel|diclofenac sodium gel
82865|NCT02769520|squamous cell carcinoma head and neck|squamous cell carcinoma head and neck
82866|NCT02769520|pembrolizumab|pembrolizumab
82867|NCT02769494|Oral ulcer|oral ulcer
82868|NCT02769494|Crohn's disease|crohn's disease
82869|NCT02769468|Temperature-Probe Placement-preterm infant-case room|temperature-probe placement-preterm infant-case room
82870|NCT02769455|Food Labelling|food labelling
82871|NCT02769442|Intravenous|intravenous
82872|NCT02769442|Catheter|catheter
82873|NCT02769442|Puncture|puncture
82874|NCT02769442|Peripheral Catheterization|peripheral catheterization
82875|NCT02769442|First Stick Success|first stick success
82876|NCT02769442|Contamination|contamination
82877|NCT02769442|Terumo|terumo
82878|NCT02769442|SurFlash|surflash
82879|NCT02769416|spinal cord injury|spinal cord injury
82880|NCT02769416|traumatic brain injury|traumatic brain injury
82881|NCT02769403|Job Satisfaction|job satisfaction
82882|NCT02769403|Job Performance|job performance
82883|NCT02769403|Primary Care|primary care
82884|NCT02769390|Analgesia|analgesia
82885|NCT02769390|Bupivacaine|bupivacaine
82886|NCT02769390|Clonidine|clonidine
82887|NCT02769377|diabetes, glucometer, mobile-phone|diabetes, glucometer, mobile-phone
82888|NCT02769364|Advanced or Metastatic Breast Cancer|advanced or metastatic breast cancer
82889|NCT02769364|Eribulin|eribulin
82890|NCT02769351|volume overload|volume overload
82891|NCT02769351|heart failure|heart failure
97467|NCT02680067|ICG|icg
82892|NCT02769351|cardiac decompensation|cardiac decompensation
82893|NCT02769351|ultrafiltration|ultrafiltration
82894|NCT02769338|Implementation|implementation
82895|NCT02769338|Quality Improvement|quality improvement
82896|NCT02769338|Stroke|stroke
82897|NCT02769338|Transient Ischemic Attack|transient ischemic attack
82898|NCT02769338|TIA|tia
82899|NCT02769338|System Redesign|system redesign
82900|NCT02769338|QI Intervention|qi intervention
82901|NCT02769325|atropine|atropine
82902|NCT02769325|pain, postoperative|pain, postoperative
82907|NCT02769260|pyrosequencing|pyrosequencing
82908|NCT02769260|16S DNA gene|16s dna gene
82909|NCT02769260|Confocal Laser Scanning Microscope|confocal laser scanning microscope
82910|NCT02769260|bacterial viability|bacterial viability
82911|NCT02769260|bacterial diversity|bacterial diversity
82912|NCT02769247|naproxen|naproxen
82913|NCT02769247|lidocaine|lidocaine
82914|NCT02769247|intrauterine device|intrauterine device
82915|NCT02769247|IUD|iud
82916|NCT02769247|pain|pain
82917|NCT02769234|EEG|eeg
82918|NCT02769234|ERP|erp
82919|NCT02769234|Event-related Potentials|event-related potentials
82920|NCT02769234|Alzheimer's|alzheimer's
82921|NCT02769234|P300|p300
82922|NCT02769208|Air Pollution|air pollution
82923|NCT02769208|Air Filtration|air filtration
82924|NCT02769208|Exposure Assessment|exposure assessment
82925|NCT02769208|HEPA Filter|hepa filter
82926|NCT02769208|Electrostatic Precipitator|electrostatic precipitator
82927|NCT02769208|Cardiovascular Disease Biomarkers|cardiovascular disease biomarkers
82928|NCT02769208|Respiratory Disease Biomarkers|respiratory disease biomarkers
82929|NCT02769182|Older adults|older adults
82930|NCT02769182|falls|falls
82931|NCT02769182|cognition|cognition
82932|NCT02769182|smart phone|smart phone
82933|NCT02769169|Ranibizumab, regression of the polyps|ranibizumab, regression of the polyps
82934|NCT02769143|Postmenopausal|postmenopausal
82935|NCT02769143|Bone Density|bone density
82936|NCT02769143|Exercise|exercise
82937|NCT02769104|aromatase inhibitors|aromatase inhibitors
82938|NCT02769104|chemotherapy|chemotherapy
82939|NCT02769104|neoadjuvant|neoadjuvant
82940|NCT02769104|postmenopausal|postmenopausal
82941|NCT02769104|breast cancer|breast cancer
82942|NCT02769078|Anticoagulation|anticoagulation
82943|NCT02769065|Drug Therapy|drug therapy
82944|NCT02769052|endometriosis|endometriosis
82945|NCT02769052|dyspareunia|dyspareunia
82946|NCT02769052|physical therapy|physical therapy
82947|NCT02769052|sexuality|sexuality
82948|NCT02769052|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
82949|NCT02769013|Schistosoma haematobium plasmodium falciparum transmission|schistosoma haematobium plasmodium falciparum transmission
82951|NCT02768987|physical activity|physical activity
82952|NCT02768987|behavior modification|behavior modification
82953|NCT02768987|coping skills|coping skills
82954|NCT02768987|self management|self management
82955|NCT02768987|glycemic control|glycemic control
82956|NCT02768987|overweight|overweight
82957|NCT02768987|obesity|obesity
82958|NCT02768987|body composition|body composition
82959|NCT02768987|adherence|adherence
82960|NCT02768961|sofosbuvir|sofosbuvir
82961|NCT02768961|ledipasvir|ledipasvir
82962|NCT02768961|ribavirin|ribavirin
82963|NCT02768961|prisoner|prisoner
82964|NCT02768961|hepatitis c|hepatitis c
82965|NCT02768961|prevalence|prevalence
82966|NCT02768961|hepatitis b|hepatitis b
82967|NCT02768922|Telemedicine|telemedicine
82968|NCT02768922|Telerehabilitation|telerehabilitation
82969|NCT02768922|Speech and language therapy|speech and language therapy
82970|NCT02768883|Childhood asthma|childhood asthma
82971|NCT02768883|Latino|latino
82972|NCT02768844|Stochastic Resonance|stochastic resonance
82973|NCT02768844|Fetus/Newborn Infant|fetus/newborn infant
82974|NCT02768844|Drug Withdrawal|drug withdrawal
82975|NCT02768844|Substance Abuse|substance abuse
82976|NCT02768818|Maternal Obesity Complicating Pregnancy|maternal obesity complicating pregnancy
82977|NCT02768805|Influenza|influenza
82978|NCT02768805|Human|human
82979|NCT02768805|RNA Virus Infections|rna virus infections
82980|NCT02768805|Immunologic|immunologic
82981|NCT02768805|Immunogenic Factors|immunogenic factors
82982|NCT02768805|Physiological Effects of Drug|physiological effects of drug
82983|NCT02768805|Virus Diseases|virus diseases
82984|NCT02768805|Orthomyxoviridae Infections|orthomyxoviridae infections
82985|NCT02768805|Infection|infection
82986|NCT02768779|hair|hair
82987|NCT02768766|MEK inhibitor|mek inhibitor
82988|NCT02768766|Selumetinib|selumetinib
82989|NCT02768766|hyd-sulfate AZD6244|hyd-sulfate azd6244
82990|NCT02768766|Uveal melanoma|uveal melanoma
82991|NCT02768766|Melanoma|melanoma
82992|NCT02768753|Robotic thyroidectomy|robotic thyroidectomy
82993|NCT02768753|Robotic central neck dissection|robotic central neck dissection
82994|NCT02768753|Axillary bilateral-breast approach|axillary bilateral-breast approach
82995|NCT02768753|Bilateral axillo-breast approach|bilateral axillo-breast approach
82996|NCT02768727|neurocognitive function|neurocognitive function
82997|NCT02768727|neural inertia|neural inertia
82998|NCT02768727|xenon gas|xenon gas
82999|NCT02768714|Breast Cancer High risk Stage II or Stage III / IV|breast cancer high risk stage ii or stage iii / iv
83000|NCT02768701|Pembrolizumab|pembrolizumab
83001|NCT02768701|cyclophosphamide|cyclophosphamide
83002|NCT02768688|Human Brain|human brain
83003|NCT02768688|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
83004|NCT02768688|Dexmedetomidine|dexmedetomidine
83005|NCT02768688|Cerebral blood flow|cerebral blood flow
83006|NCT02768675|Kyphotic|kyphotic
83007|NCT02768675|Corrective Surgery|corrective surgery
83008|NCT02768675|Spinal fractures|spinal fractures
83009|NCT02768636|Omega-3, ANS, HRV, SDNN|omega-3, ans, hrv, sdnn
83010|NCT02768610|dexmedetomidine|dexmedetomidine
83011|NCT02768584|severe mental illness|severe mental illness
83012|NCT02768584|nursing|nursing
83013|NCT02768584|therapeutic alliance|therapeutic alliance
83014|NCT02768584|psychiatric diseases|psychiatric diseases
83015|NCT02768571|cerebrolysin, stroke, motor function|cerebrolysin, stroke, motor function
83016|NCT02768558|Lung Cancer|lung cancer
83017|NCT02768558|NSCLC|nsclc
83018|NCT02768558|Nivolumab|nivolumab
83019|NCT02768545|Hepatitis C|hepatitis c
83020|NCT02768545|Ezetimibe|ezetimibe
83021|NCT02768545|Cholesterol|cholesterol
83028|NCT02768532|Clinical response|clinical response
83029|NCT02768532|Clinical remission|clinical remission
83030|NCT02768519|Participants|participants
83031|NCT02768506|obesity, malabsorption, gastric bypass, SADI-S|obesity, malabsorption, gastric bypass, sadi-s
83032|NCT02768480|Diabetes|diabetes
83033|NCT02768480|phone calls|phone calls
83034|NCT02768480|glycemic control|glycemic control
83035|NCT02768467|Alloderm graft|alloderm graft
83036|NCT02768467|Allograft|allograft
83037|NCT02768467|Buccal Mucosa|buccal mucosa
83038|NCT02768454|broad-spectrum antimicrobial|broad-spectrum antimicrobial
83039|NCT02768454|antibiotics pharmacist|antibiotics pharmacist
83040|NCT02768428|Knowledge [K01.468]|knowledge [k01.468]
83041|NCT02768428|Video-Audio Media [V01.255.500]|video-audio media [v01.255.500]
83042|NCT02768428|Handbooks [V02.520]|handbooks [v02.520]
83043|NCT02768402|Mitral Valve Regurgitation|mitral valve regurgitation
83044|NCT02768402|Primary MR|primary mr
83045|NCT02768402|Secondary MR|secondary mr
83046|NCT02768402|MR|mr
83047|NCT02768402|Heart Failure|heart failure
83048|NCT02768402|Structural Heart|structural heart
83049|NCT02768402|Secondary Mitral Valve Regurgitation|secondary mitral valve regurgitation
83050|NCT02768402|Primary Mitral Valve Regurgitation|primary mitral valve regurgitation
83051|NCT02768389|Modified Atkins Diet|modified atkins diet
83052|NCT02768389|MAD|mad
83053|NCT02768389|Brain Tumor|brain tumor
83054|NCT02768389|Glioblastoma|glioblastoma
83061|NCT02768350|lung collapse|lung collapse
83062|NCT02768350|ventilator hyper inflation|ventilator hyper inflation
83063|NCT02768350|hemodynamic responses|hemodynamic responses
83064|NCT02768350|ventilatory responses|ventilatory responses
83065|NCT02768350|trauma patients|trauma patients
83066|NCT02768337|brain metastasis|brain metastasis
83067|NCT02768337|operable brain metastasis|operable brain metastasis
83068|NCT02768324|sepsis|sepsis
83069|NCT02768324|Gastrointestinal Microbiome|gastrointestinal microbiome
83070|NCT02768324|Gut microbiota|gut microbiota
83071|NCT02768324|Gut Flora|gut flora
83072|NCT02768324|Intestinal Flora|intestinal flora
83073|NCT02768311|Instrumentation Post-operative pain Root canal preparation|instrumentation post-operative pain root canal preparation
83074|NCT02768298|Heart failure|heart failure
83075|NCT02768298|systolic heart failure|systolic heart failure
83076|NCT02768298|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
83077|NCT02768298|exercise capacity|exercise capacity
83078|NCT02768285|apical patency|apical patency
83079|NCT02768285|root canal treatment|root canal treatment
83080|NCT02768233|Medication-overuse Headache|medication-overuse headache
83081|NCT02768233|Educational Programme|educational programme
83082|NCT02768233|Personality Profiles|personality profiles
83083|NCT02768181|nutrition-specific behaviour change communication|nutrition-specific behaviour change communication
83084|NCT02768181|dietary supplements|dietary supplements
83085|NCT02768168|Dezocine|dezocine
83086|NCT02768168|Dexamethasone 21-phosphate|dexamethasone 21-phosphate
83087|NCT02768168|Pain|pain
83088|NCT02768168|Pruritus|pruritus
83089|NCT02768155|OA, Osteoarthritis, Knee|oa, osteoarthritis, knee
83090|NCT02768116|Active Transfer of Plaque|active transfer of plaque
83091|NCT02768103|upper extremity|upper extremity
83092|NCT02768103|spinal cord injury|spinal cord injury
83093|NCT02768103|surgical reconstruction|surgical reconstruction
83094|NCT02768103|MRI, functional|mri, functional
83095|NCT02768103|rehabilitation|rehabilitation
83096|NCT02768077|melatonin|melatonin
83097|NCT02768077|sleep disturbances|sleep disturbances
83098|NCT02768025|smoking cessation|smoking cessation
83099|NCT02768025|tobacco control|tobacco control
83100|NCT02768025|acupuncture|acupuncture
83101|NCT02768025|Korean Medicine|korean medicine
83102|NCT02768025|Traditional & Complementary Medicine|traditional & complementary medicine
83103|NCT02767999|Acute ischemic stroke|acute ischemic stroke
83104|NCT02767986|Hispanic|hispanic
83105|NCT02767986|Health Belief Model|health belief model
83106|NCT02767986|Cultural Consensus Theory|cultural consensus theory
83107|NCT02767986|Cancer Genetics|cancer genetics
83108|NCT02767986|Qualitative|qualitative
83109|NCT02767960|Tenascin-C|tenascin-c
83111|NCT02767908|Smoking Cessation|smoking cessation
83112|NCT02767869|Metabolic syndrome|metabolic syndrome
83113|NCT02767869|central obesity|central obesity
83114|NCT02767869|Banaba|banaba
83115|NCT02767869|insulin secretion|insulin secretion
83116|NCT02767869|insulin sensitivity|insulin sensitivity
83117|NCT02767804|ALK-positive NSCLC|alk-positive nsclc
83118|NCT02767778|Acute ischemic stroke|acute ischemic stroke
83119|NCT02767778|Neuroprotection|neuroprotection
83120|NCT02767778|Extremely low frequency magnetic fields|extremely low frequency magnetic fields
83121|NCT02767752|Resectable pancreatic cancer|resectable pancreatic cancer
83122|NCT02767752|Adjuvant|adjuvant
83123|NCT02767713|Cognition Disorders|cognition disorders
83124|NCT02767713|Cardiac Surgical Procedures|cardiac surgical procedures
83125|NCT02767713|dexamethasone|dexamethasone
83126|NCT02767687|Postoperative Care|postoperative care
83127|NCT02767687|Postoperative Period|postoperative period
83128|NCT02767687|Heart Surgery|heart surgery
83130|NCT02767674|R-miniCHOP|r-minichop
83131|NCT02767674|elderly patients with diffuse large B cell lymphoma|elderly patients with diffuse large b cell lymphoma
83132|NCT02767661|metronomic capecitabine|metronomic capecitabine
83133|NCT02767661|aromatase inhibitor|aromatase inhibitor
83134|NCT02767661|first line treatment|first line treatment
83135|NCT02767661|metastatic breast cancer|metastatic breast cancer
83136|NCT02767648|cholestasis|cholestasis
83137|NCT02767648|neonatal|neonatal
83138|NCT02767648|infant|infant
83139|NCT02767596|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
83140|NCT02767596|treatment|treatment
83141|NCT02767596|GLP-1|glp-1
83142|NCT02767583|Neuropathology|neuropathology
83143|NCT02767570|Osteoarthritis, Knee|osteoarthritis, knee
83144|NCT02767570|Arthritis|arthritis
83145|NCT02767570|Joint Diseases|joint diseases
83146|NCT02767570|Musculoskeletal Diseases|musculoskeletal diseases
83147|NCT02767570|Rheumatic Diseases|rheumatic diseases
83148|NCT02767544|laparoscopic hysterectomy|laparoscopic hysterectomy
83149|NCT02767544|postoperative pain|postoperative pain
83150|NCT02767544|local analgesia|local analgesia
83151|NCT02767544|vaginal wound|vaginal wound
83152|NCT02767479|eradication rates|eradication rates
83153|NCT02767479|rabeprazole|rabeprazole
83154|NCT02767479|esomeprazole|esomeprazole
83155|NCT02767453|Shoulder arthroplasty|shoulder arthroplasty
83156|NCT02767453|Closed suction drainage|closed suction drainage
83157|NCT02767453|Glenohumeral|glenohumeral
83158|NCT02767453|Drainage tube|drainage tube
83159|NCT02767427|Infection Control|infection control
83160|NCT02767427|Preoperative Care|preoperative care
83161|NCT02767427|Chlorhexidine|chlorhexidine
83162|NCT02767427|Pre-Surgical Wash|pre-surgical wash
83163|NCT02767427|Spine Surgery|spine surgery
83164|NCT02767427|Surgical site infections|surgical site infections
83165|NCT02767427|Cutaneous bacterial load on skin|cutaneous bacterial load on skin
83166|NCT02767401|PET-CT|pet-ct
83167|NCT02767401|Cardiac magnetic resonance (CMR) imaging|cardiac magnetic resonance (cmr) imaging
83168|NCT02767401|Major adverse cardiac events (MACEs)|major adverse cardiac events (maces)
83169|NCT02767401|coronary artery disease|coronary artery disease
83170|NCT02767375|Hepatocellular Carcinoma|hepatocellular carcinoma
83171|NCT02767375|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
83172|NCT02767362|atorvastatin|atorvastatin
83173|NCT02767362|endometrium|endometrium
83174|NCT02767362|endometrial cancer|endometrial cancer
83175|NCT02767310|Bioequivalence|bioequivalence
83176|NCT02767310|two rosuvastatin-containing products|two rosuvastatin-containing products
83177|NCT02767284|Contrast Sensitivity|contrast sensitivity
83178|NCT02767284|Diagnostic Techniques, Ophthalmological|diagnostic techniques, ophthalmological
83179|NCT02767258|Dry eye|dry eye
83180|NCT02767258|Diseases of the eye and adnexa|diseases of the eye and adnexa
83181|NCT02767245|Thiamine|thiamine
83182|NCT02767245|Congestive heart failure|congestive heart failure
83183|NCT02767245|Atrial fibrillation|atrial fibrillation
83184|NCT02767245|Graves' disease|graves' disease
83185|NCT02767232|PHLO|phlo
83186|NCT02767232|deep vein thrombosis|deep vein thrombosis
83187|NCT02767232|deep venous thrombosis|deep venous thrombosis
83188|NCT02767232|blood clot|blood clot
83189|NCT02767232|catheter-directed thrombolysis|catheter-directed thrombolysis
83190|NCT02767232|thrombolysis|thrombolysis
83191|NCT02767232|post-thrombotic syndrome|post-thrombotic syndrome
83193|NCT02767232|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
83194|NCT02767232|rt-PA|rt-pa
83195|NCT02767232|Activase|activase
83196|NCT02767232|Alteplase|alteplase
83197|NCT02767219|Ophthalmology|ophthalmology
83198|NCT02767206|Transnasal endoscopy|transnasal endoscopy
83199|NCT02767206|ultrathin endoscopes|ultrathin endoscopes
83200|NCT02767206|esophageal varices|esophageal varices
83201|NCT02767206|gastric varices|gastric varices
83202|NCT02767167|Cow's milk|cow's milk
83203|NCT02767167|Iodine|iodine
83204|NCT02767167|Selenium|selenium
83205|NCT02767167|Women|women
83206|NCT02767167|Child-bearing age|child-bearing age
83207|NCT02767154|extracorporeal circulation|extracorporeal circulation
83208|NCT02767141|Hunger|hunger
83209|NCT02767141|food insecurity|food insecurity
83210|NCT02767141|behaviors|behaviors
83211|NCT02767128|pharmacokinetics|pharmacokinetics
83212|NCT02767128|healthy adult volunteer|healthy adult volunteer
83213|NCT02767102|Mediterranean diet|mediterranean diet
83214|NCT02767102|indoleamine|indoleamine
83219|NCT02767076|paramedian spinal anesthesia|paramedian spinal anesthesia
83220|NCT02767076|real time|real time
83221|NCT02767076|ultrasound|ultrasound
83222|NCT02767076|knee surgeries|knee surgeries
83223|NCT02767076|conventional|conventional
83224|NCT02767050|DENTAL CARIES|dental caries
83225|NCT02767050|TOBACCO USERS|tobacco users
83226|NCT02767050|SMOKERS|smokers
83227|NCT02767050|SMOKELESS TOBACCO CHEWERS|smokeless tobacco chewers
83228|NCT02767011|surgical site infection|surgical site infection
83229|NCT02766985|FSHD|fshd
83230|NCT02766985|muscular dystrophy|muscular dystrophy
83231|NCT02766972|Intracranial Aneurysm|intracranial aneurysm
83232|NCT02766972|Surgical Clipping|surgical clipping
83233|NCT02766972|Rapid Ventricular Pacing|rapid ventricular pacing
83234|NCT02766959|chronic rhinosinusitis|chronic rhinosinusitis
83235|NCT02766959|airway physiology|airway physiology
83236|NCT02766959|taste receptors|taste receptors
83237|NCT02766959|tas2r|tas2r
83238|NCT02766959|epithelial biology|epithelial biology
83239|NCT02766959|upper respiratory disease|upper respiratory disease
83240|NCT02766946|Mechanical Ventilation|mechanical ventilation
83241|NCT02766933|tenofovir|tenofovir
83242|NCT02766933|hepatocellular carcinoma|hepatocellular carcinoma
83243|NCT02766933|cirrhosis|cirrhosis
83244|NCT02766881|Ductal Carcinoma in Situ|ductal carcinoma in situ
83246|NCT02766881|Breast Conserving Surgery|breast conserving surgery
83247|NCT02766855|cysteamine|cysteamine
83248|NCT02766855|nephropathic cystinosis|nephropathic cystinosis
83249|NCT02766855|cystine crystals|cystine crystals
83250|NCT02766842|SharkCore|sharkcore
83251|NCT02766842|ProCore|procore
83252|NCT02766829|spinal|spinal
83253|NCT02766829|anesthesia|anesthesia
83254|NCT02766829|sitting|sitting
83255|NCT02766829|cross leg|cross leg
83256|NCT02766829|spinal-bone contact|spinal-bone contact
83257|NCT02766738|residential aged care|residential aged care
83258|NCT02766738|mobility|mobility
83259|NCT02766738|social participation|social participation
83260|NCT02766738|functional capability|functional capability
83261|NCT02766712|catheter ablation|catheter ablation
83871|NCT02763189|Training|training
83262|NCT02766712|atrial fibrillation|atrial fibrillation
83263|NCT02766699|Astrocytoma, Grade IV|astrocytoma, grade iv
83264|NCT02766699|Doxorubicin|doxorubicin
83265|NCT02766699|Glioblastoma|glioblastoma
83266|NCT02766699|Neoplasms|neoplasms
83267|NCT02766699|Neoplasms by Site|neoplasms by site
83268|NCT02766699|Antineoplastic Agents|antineoplastic agents
83269|NCT02766699|Drug Delivery Systems|drug delivery systems
83270|NCT02766699|Molecular Targeted Therapy|molecular targeted therapy
83271|NCT02766699|Nanoparticles|nanoparticles
83272|NCT02766699|Disease Progression|disease progression
83273|NCT02766699|Recurrence|recurrence
83274|NCT02766699|Brain Neoplasms|brain neoplasms
83275|NCT02766699|Immunotherapy|immunotherapy
83276|NCT02766699|Receptor, Epidermal Growth Factor|receptor, epidermal growth factor
83277|NCT02766699|Antibodies, Bispecific|antibodies, bispecific
83278|NCT02766686|Prostate cancer|prostate cancer
83279|NCT02766686|proton radiotherapy|proton radiotherapy
83280|NCT02766686|photon radiotherapy|photon radiotherapy
83281|NCT02766660|Thyroid ophthalmopathy|thyroid ophthalmopathy
83282|NCT02766660|optical coherence tomography|optical coherence tomography
83283|NCT02766647|Filgrastim|filgrastim
83284|NCT02766634|filgrastim|filgrastim
83285|NCT02766621|First in human, Phase 1, Healthy volunteers|first in human, phase 1, healthy volunteers
83286|NCT02766608|COPD|copd
83287|NCT02766582|Ovarian|ovarian
83288|NCT02766582|platinum|platinum
83289|NCT02766582|pembrolizumab|pembrolizumab
83290|NCT02766569|IRFACODE II, ASD closure, ASD device, erosion, arrhythmia|irfacode ii, asd closure, asd device, erosion, arrhythmia
83291|NCT02766543|prostate cancer|prostate cancer
83292|NCT02766543|high intensity transurethral ultrasound ablation|high intensity transurethral ultrasound ablation
83293|NCT02766543|MRI-guided|mri-guided
83294|NCT02766543|minimally invasive|minimally invasive
83295|NCT02766543|real-time temperature feedback control|real-time temperature feedback control
83296|NCT02766491|Stretching|stretching
83302|NCT02766400|Stroke|stroke
83303|NCT02766400|Rehabilitation|rehabilitation
97986|NCT02676544|PAE|pae
83304|NCT02766400|Cognition|cognition
83305|NCT02766400|Disability|disability
83306|NCT02766400|Intervention|intervention
83307|NCT02766374|Asthma|asthma
83308|NCT02766374|Biofeedback|biofeedback
83309|NCT02766374|Heart rate variability biofeedback|heart rate variability biofeedback
83310|NCT02766374|Inhaled corticosteroids|inhaled corticosteroids
83311|NCT02766361|Bipolar disorder|bipolar disorder
83312|NCT02766361|Psychotherapy|psychotherapy
83313|NCT02766361|Cognitive rehabilitation|cognitive rehabilitation
83314|NCT02766348|DC-CTL, NSCLC|dc-ctl, nsclc
83315|NCT02766322|Alcohol metabolism|alcohol metabolism
83316|NCT02766322|Bariatric surgery|bariatric surgery
83317|NCT02766322|Effects of alcohol on driving|effects of alcohol on driving
83318|NCT02766309|Self-assessment of health, Sf12-v2|self-assessment of health, sf12-v2
83320|NCT02766296|trauma|trauma
83321|NCT02766296|working memory|working memory
83322|NCT02766296|working memory training|working memory training
83323|NCT02766283|Children|children
83324|NCT02766283|Iodinated contrast agents|iodinated contrast agents
83325|NCT02766270|Grade II/III Glioma|grade ii/iii glioma
83326|NCT02766270|IDH|idh
83327|NCT02766270|TERT|tert
83328|NCT02766270|Chemoradiotherapy|chemoradiotherapy
83329|NCT02766270|Temozolomide|temozolomide
83330|NCT02766218|toddler obesity|toddler obesity
83331|NCT02766218|responsive feeding|responsive feeding
83332|NCT02766218|behavioral weight control|behavioral weight control
83333|NCT02766218|pregnancy weight gain|pregnancy weight gain
83334|NCT02766218|early life risk factors|early life risk factors
83335|NCT02766205|Embolic Stroke of Undetermined Source|embolic stroke of undetermined source
83336|NCT02766205|Atrial fibrillation|atrial fibrillation
83337|NCT02766205|prognostic score|prognostic score
83338|NCT02766192|ketamine|ketamine
83339|NCT02766192|mindfulness based cognitive therapy|mindfulness based cognitive therapy
83340|NCT02766192|PTSD|ptsd
83341|NCT02766192|trauma memory|trauma memory
83342|NCT02766192|memory extinction|memory extinction
83343|NCT02766192|memory re-consolidation|memory re-consolidation
83344|NCT02766192|metabolomics|metabolomics
83345|NCT02766192|TIMBER (Trauma Intervention using Mindfulness Based Extinction and Re-consolidation of trauma memories)|timber (trauma intervention using mindfulness based extinction and re-consolidation of trauma memories)
83346|NCT02766127|radiotherapy|radiotherapy
83347|NCT02766114|CTS|cts
83348|NCT02766114|Carpal tunnel syndrome|carpal tunnel syndrome
83349|NCT02766114|Carpal tunnel release|carpal tunnel release
83350|NCT02766114|Mini incision of carpal tunnel release|mini incision of carpal tunnel release
83351|NCT02766114|Cosmetic surgery of carpal tunnel syndrome|cosmetic surgery of carpal tunnel syndrome
83481|NCT02765529|Biomarkers|biomarkers
83352|NCT02766114|endoscopic carpal tunnel surgery|endoscopic carpal tunnel surgery
83353|NCT02766114|Carpal Tunnel Release Through Mini Transverse Approach|carpal tunnel release through mini transverse approach
83354|NCT02766114|Dr. Sayed Issa's Approach|dr. sayed issa's approach
83355|NCT02766114|CTRMTA|ctrmta
83356|NCT02766114|OCTR|octr
83357|NCT02766114|ECTR|ectr
83358|NCT02766114|Open Carpal Tunnel Release|open carpal tunnel release
83359|NCT02766114|Endoscopic Carpal Tunnel Release|endoscopic carpal tunnel release
83360|NCT02766114|Syria|syria
83361|NCT02766114|Cosmetic|cosmetic
83362|NCT02766114|Safety|safety
83363|NCT02766114|Rehabilitation,|rehabilitation,
83364|NCT02766114|Complications|complications
83365|NCT02766114|Surgery|surgery
83366|NCT02766114|Satisfaction|satisfaction
83367|NCT02766088|Dengue|dengue
83368|NCT02766088|Household|household
83369|NCT02766088|Southeast Asia|southeast asia
83370|NCT02766088|Latin America|latin america
83371|NCT02766088|Surveillance|surveillance
83372|NCT02766075|Transcatheter Aortic Valve Disease|transcatheter aortic valve disease
83373|NCT02766075|Supervised TAVR Exercise Program|supervised tavr exercise program
83374|NCT02766062|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
83375|NCT02766062|metabolic syndrome|metabolic syndrome
83376|NCT02766062|propofol|propofol
83377|NCT02766062|sevoflurane|sevoflurane
83378|NCT02766049|HIV|hiv
83379|NCT02766049|immunotherapy|immunotherapy
83380|NCT02766049|clinical trial|clinical trial
83381|NCT02766049|dendritic cell|dendritic cell
83382|NCT02766036|Proteinuria|proteinuria
83383|NCT02766036|Propolis|propolis
83384|NCT02766023|CTV-05|ctv-05
83385|NCT02766023|LACTIN-V|lactin-v
83386|NCT02766023|Lactobacillus|lactobacillus
83387|NCT02766023|MetroGel®|metrogel®
83388|NCT02766023|Vaginitis|vaginitis
83389|NCT02765997|AML|aml
83390|NCT02765997|ALL|all
83391|NCT02765997|MDS|mds
83392|NCT02765984|implantation site|implantation site
83393|NCT02765984|placental site|placental site
83394|NCT02765984|Doppler|doppler
83395|NCT02765971|chewing gums|chewing gums
83396|NCT02765971|laxatives|laxatives
83397|NCT02765971|bowel function|bowel function
83398|NCT02765945|Exercise|exercise
83399|NCT02765945|Osteoporosis|osteoporosis
83400|NCT02765945|Cytokines|cytokines
83401|NCT02765932|Hip|hip
83402|NCT02765932|Knee|knee
83403|NCT02765932|replacement|replacement
83404|NCT02765932|surgery|surgery
83405|NCT02765919|Carcinoma cervix|carcinoma cervix
83406|NCT02765919|RCT(randomised controlled trial)|rct(randomised controlled trial)
83407|NCT02765919|9 Gray|9 gray
83408|NCT02765919|Brachytherapy|brachytherapy
83409|NCT02765906|video|video
83410|NCT02765906|educational tool|educational tool
83411|NCT02765906|preeclampsia|preeclampsia
83412|NCT02765906|hypertension|hypertension
83413|NCT02765906|pregnancy|pregnancy
83414|NCT02765906|patient education|patient education
83415|NCT02765906|graphic card|graphic card
83416|NCT02765906|eclampsia|eclampsia
83417|NCT02765906|HELLP|hellp
83418|NCT02765906|anxiety|anxiety
83419|NCT02765906|anxiety assessment|anxiety assessment
83420|NCT02765906|STAI 6|stai 6
83421|NCT02765841|HoFH|hofh
83422|NCT02765815|TKA|tka
83423|NCT02765815|Knee replacement|knee replacement
83424|NCT02765815|Arthritis|arthritis
83425|NCT02765815|Knee|knee
83426|NCT02765776|Anti-HIV Drugs|anti-hiv drugs
83427|NCT02765776|Raltegravir Potassium|raltegravir potassium
83428|NCT02765776|Aged|aged
83429|NCT02765776|Retrospective Study|retrospective study
83430|NCT02765776|Medical Records|medical records
83431|NCT02765750|Emergence agitation|emergence agitation
83432|NCT02765711|ticagrelor|ticagrelor
83433|NCT02765711|acute coronary syndrome|acute coronary syndrome
83434|NCT02765698|Magnetic Resonance Imaging|magnetic resonance imaging
83435|NCT02765672|Combat Veterans|combat veterans
83436|NCT02765672|Automobile Driving|automobile driving
83437|NCT02765672|Fitness to Drive|fitness to drive
83439|NCT02765659|Prevention|prevention
83440|NCT02765659|Implementation|implementation
83441|NCT02765659|Community based participatory research|community based participatory research
83442|NCT02765620|Positron-Emission Tomography|positron-emission tomography
83443|NCT02765620|Response Criteria|response criteria
83444|NCT02765620|solid tumor|solid tumor
83445|NCT02765607|Blood circulation|blood circulation
83446|NCT02765607|Cardiac surgical procedures|cardiac surgical procedures
83447|NCT02765607|Homeostasis|homeostasis
83448|NCT02765594|Glomerulonephritis, IGA|glomerulonephritis, iga
83449|NCT02765594|Kidney Diseases|kidney diseases
83450|NCT02765594|Autoimmune Diseases|autoimmune diseases
83451|NCT02765594|Glomerulonephritis|glomerulonephritis
83452|NCT02765594|Nephritis|nephritis
83453|NCT02765594|Immune System Diseases|immune system diseases
83454|NCT02765594|Urologic Diseases|urologic diseases
83455|NCT02765594|Hydroxychloroquine|hydroxychloroquine
83456|NCT02765594|Anti-Infective Agents|anti-infective agents
83457|NCT02765594|Antimalarials|antimalarials
83458|NCT02765594|Antiparasitic Agents|antiparasitic agents
83459|NCT02765594|Antiprotozoal Agents|antiprotozoal agents
83460|NCT02765594|Antirheumatic Agents|antirheumatic agents
83461|NCT02765594|Enzyme Inhibitors|enzyme inhibitors
83462|NCT02765594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
83463|NCT02765594|Pharmacologic Actions|pharmacologic actions
83464|NCT02765594|Therapeutic Uses|therapeutic uses
84076|NCT02761902|Children|children
83465|NCT02765594|interleukin-6|interleukin-6
83466|NCT02765594|interferon-alpha|interferon-alpha
83467|NCT02765594|tumor necrosis factor-alpha|tumor necrosis factor-alpha
83468|NCT02765581|Acupuncture|acupuncture
83469|NCT02765581|Migraine|migraine
83470|NCT02765581|Randomized Controlled Trial|randomized controlled trial
83471|NCT02765581|Placebo Effect|placebo effect
83472|NCT02765568|Coronary Artery Disease|coronary artery disease
83473|NCT02765568|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
83474|NCT02765542|Depression|depression
83475|NCT02765542|mHealth|mhealth
83476|NCT02765542|Interactive Voice Response|interactive voice response
83477|NCT02765542|Bolivia|bolivia
83478|NCT02765542|Mental health|mental health
83479|NCT02765529|Environmental Pollution|environmental pollution
83480|NCT02765529|Fine particles|fine particles
83482|NCT02765529|Elderly|elderly
83483|NCT02765490|Hepatitis C, Chronic|hepatitis c, chronic
83484|NCT02765490|AL-335|al-335
83485|NCT02765490|Odalasvir|odalasvir
83486|NCT02765490|Simeprevir|simeprevir
83487|NCT02765490|ODV|odv
83488|NCT02765490|SMV|smv
83489|NCT02765490|ACH-3102|ach-3102
83490|NCT02765490|ACH-0143102|ach-0143102
83491|NCT02765490|TMC435|tmc435
83492|NCT02765477|Acute myocardial infarction|acute myocardial infarction
83493|NCT02765477|ST Elevation Myocardial Infarction|st elevation myocardial infarction
83494|NCT02765477|Acute Coronary Occlusion|acute coronary occlusion
83495|NCT02765477|Electrocardiogram|electrocardiogram
83496|NCT02765477|Ventricular Paced Rhythm|ventricular paced rhythm
83497|NCT02765477|Modified Sgarbossa Criteria|modified sgarbossa criteria
83498|NCT02765451|non-academic|non-academic
83499|NCT02765451|health institution|health institution
83500|NCT02765451|development|development
83501|NCT02765451|clinical research|clinical research
83502|NCT02765451|cancer|cancer
83503|NCT02765451|private hospital|private hospital
83504|NCT02765451|public hospital|public hospital
83505|NCT02765451|northwestern france|northwestern france
83506|NCT02765451|france|france
83507|NCT02765451|hospitals|hospitals
83508|NCT02765412|decision support|decision support
83509|NCT02765412|patient preferences|patient preferences
83510|NCT02765412|risk adjustment|risk adjustment
83511|NCT02765386|Cochlear implants|cochlear implants
83512|NCT02765386|Hybrid fittings|hybrid fittings
83513|NCT02765386|Cross-over frequency|cross-over frequency
83514|NCT02765373|aromatase inhibitors|aromatase inhibitors
83515|NCT02765373|lipid levels|lipid levels
83517|NCT02765360|NIV|niv
83518|NCT02765308|Uveitis|uveitis
83519|NCT02765308|Glaucoma|glaucoma
83520|NCT02765308|Aqueous humor dynamics|aqueous humor dynamics
83521|NCT02765295|Hydrogen|hydrogen
83522|NCT02765295|Inhalation|inhalation
83523|NCT02765295|bronchiectasis|bronchiectasis
83524|NCT02765282|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
83525|NCT02765282|Kinesia|kinesia
83526|NCT02765269|cancer pain|cancer pain
83527|NCT02765269|mobile applications|mobile applications
83528|NCT02765243|neuroblastoma|neuroblastoma
83529|NCT02765243|GD2|gd2
83530|NCT02765243|Chimeric antigen receptor|chimeric antigen receptor
83531|NCT02765243|Immunotherapy|immunotherapy
83532|NCT02765243|Cyclophosphamide|cyclophosphamide
83533|NCT02765243|Fludarabine|fludarabine
83534|NCT02765217|Antibiotic associated diarrhea|antibiotic associated diarrhea
84922|NCT02757209|DPI|dpi
83535|NCT02765217|Children|children
83536|NCT02765217|Prevention|prevention
83537|NCT02765217|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
83538|NCT02765217|Probiotic|probiotic
83539|NCT02765191|Magnetic Resonance Imaging|magnetic resonance imaging
83540|NCT02765191|Norepinephrine|norepinephrine
83541|NCT02765191|Fluid Therapy|fluid therapy
83542|NCT02765191|Renal Circulation|renal circulation
83543|NCT02765165|Phase 1|phase 1
83544|NCT02765165|Phase 2|phase 2
83545|NCT02765165|Glioblastoma Multiforme|glioblastoma multiforme
83546|NCT02765165|Glioblastoma|glioblastoma
83547|NCT02765165|GBM|gbm
83548|NCT02765165|Brain Tumor|brain tumor
83549|NCT02765165|Brain Cancer|brain cancer
83550|NCT02765165|Tumor|tumor
83551|NCT02765165|Solid Tumor|solid tumor
83552|NCT02765165|Tumour|tumour
83553|NCT02765165|Lomustine|lomustine
83554|NCT02765165|CCNU|ccnu
83555|NCT02765165|CXCR4|cxcr4
83556|NCT02765165|Phase 1 Clinical Trial|phase 1 clinical trial
83557|NCT02765165|Phase 2 Clinical Trial|phase 2 clinical trial
83558|NCT02765152|exercise|exercise
83559|NCT02765152|rhythmic movement|rhythmic movement
83560|NCT02765152|discrete movement|discrete movement
83561|NCT02765100|Bipolar Disorder|bipolar disorder
83562|NCT02765100|Obesity|obesity
83563|NCT02765100|Depression|depression
83564|NCT02765074|subcutaneous tocilizumab|subcutaneous tocilizumab
83565|NCT02765074|High Resolution peripheral QCT (HR-pQCT)|high resolution peripheral qct (hr-pqct)
83566|NCT02765074|bone erosion|bone erosion
83567|NCT02765074|bone microarchitecture|bone microarchitecture
83568|NCT02765074|rheumatoid arthritis|rheumatoid arthritis
83569|NCT02765048|Adolescent girls|adolescent girls
83570|NCT02765048|Child welfare|child welfare
83571|NCT02765048|Trauma treatment|trauma treatment
83572|NCT02765048|PTSD|ptsd
83573|NCT02765048|Depression|depression
83574|NCT02765048|Social problem-solving|social problem-solving
83575|NCT02765009|Fluid overload|fluid overload
83576|NCT02765009|Multiple organ failure|multiple organ failure
83577|NCT02765009|Diuretics|diuretics
83578|NCT02765009|Fluid restriction|fluid restriction
83579|NCT02765009|Body weight|body weight
83580|NCT02764983|Combat Veterans|combat veterans
83581|NCT02764983|Automobile Driving|automobile driving
83582|NCT02764983|Fitness to Drive|fitness to drive
83583|NCT02764905|Diabetes|diabetes
83584|NCT02764905|Cognitive-physical rehabilitation|cognitive-physical rehabilitation
83585|NCT02764905|Self care management|self care management
83586|NCT02764879|Omega 3 fatty acids|omega 3 fatty acids
83587|NCT02764879|Root planning|root planning
83588|NCT02764879|chronic periodontitis|chronic periodontitis
83589|NCT02764866|Lung cancer|lung cancer
83590|NCT02764866|Sleep apnea|sleep apnea
83591|NCT02764866|Sleep disordered breathing|sleep disordered breathing
83592|NCT02764853|HIV|hiv
83593|NCT02764853|Black|black
83594|NCT02764853|African American|african american
83595|NCT02764853|Women|women
83596|NCT02764853|Cognitive Behavioral Therapy|cognitive behavioral therapy
83597|NCT02764853|Racism|racism
83598|NCT02764853|Stigma|stigma
83599|NCT02764853|Discrimination|discrimination
83600|NCT02764853|Gender related stressors|gender related stressors
83601|NCT02764853|Resilience|resilience
83602|NCT02764853|Behavioral Medicine|behavioral medicine
83603|NCT02764827|skin prick test|skin prick test
83604|NCT02764827|grass and weed pollens|grass and weed pollens
83605|NCT02764788|Auriculotherapy|auriculotherapy
83606|NCT02764762|Drug Therapy|drug therapy
83607|NCT02764749|vascular function|vascular function
83608|NCT02764749|endothelial function|endothelial function
83609|NCT02764749|polyphenols|polyphenols
83610|NCT02764697|Glaucoma associated with uveitis|glaucoma associated with uveitis
83611|NCT02764671|recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
83612|NCT02764671|safety|safety
83613|NCT02764671|immunogenicity|immunogenicity
83614|NCT02764645|Cardiopulmonary Bypass|cardiopulmonary bypass
83615|NCT02764619|Upstream therapy, spironolactone|upstream therapy, spironolactone
83616|NCT02764619|Atrial remodelling|atrial remodelling
83617|NCT02764619|Modified look-locker inversion recover (MOLLI) sequences|modified look-locker inversion recover (molli) sequences
83618|NCT02764619|T1 mapping|t1 mapping
83619|NCT02764619|Diffuse myocardial fibrosis|diffuse myocardial fibrosis
83620|NCT02764606|Lung Cancer|lung cancer
83621|NCT02764606|Biomarkers|biomarkers
83622|NCT02764606|Bone|bone
83623|NCT02764606|Metastases|metastases
83624|NCT02764593|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
83625|NCT02764593|HNSCC|hnscc
83626|NCT02764593|Nivolumab|nivolumab
83628|NCT02763540|Pathology|pathology
83629|NCT02763540|diagnosis|diagnosis
83630|NCT02763540|lung biopsy|lung biopsy
83631|NCT02763527|smoking cessation|smoking cessation
83632|NCT02763501|bariatric surgery|bariatric surgery
83633|NCT02763501|gastric bypass|gastric bypass
83634|NCT02763501|intestinal obstruction|intestinal obstruction
83635|NCT02763501|postoperative complication|postoperative complication
83636|NCT02763501|methods|methods
83637|NCT02763501|laparoscopy|laparoscopy
83638|NCT02763488|blood flow restriction training|blood flow restriction training
83639|NCT02763488|occlusion training|occlusion training
83640|NCT02763488|total knee arthroplasty|total knee arthroplasty
83641|NCT02763488|post-operative rehabilitation|post-operative rehabilitation
83642|NCT02763475|Killer Cells, Natural|killer cells, natural
83643|NCT02763475|Consolidation treatment|consolidation treatment
83644|NCT02763475|cytologic remission|cytologic remission
83645|NCT02763475|Haploidentical NK Cells|haploidentical nk cells
83646|NCT02763475|allogeneic|allogeneic
83647|NCT02763475|IL-2 Expanded NK Cells|il-2 expanded nk cells
83648|NCT02764554|Post-Marketing Surveillance|post-marketing surveillance
83649|NCT02764554|Lenvima|lenvima
83650|NCT02764554|Lenvatinib|lenvatinib
83651|NCT02764554|E7080|e7080
83652|NCT02764554|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
83653|NCT02764554|Refractory to radioactive iodine|refractory to radioactive iodine
83654|NCT02764554|Progressive|progressive
83655|NCT02764554|locally recurrent|locally recurrent
83656|NCT02764554|metastatic|metastatic
83657|NCT02764541|Breast Cancer|breast cancer
83658|NCT02764541|Invasive Lobular Carcinoma|invasive lobular carcinoma
83659|NCT02764515|Kunxian Capsule|kunxian capsule
83660|NCT02764515|efficacy|efficacy
83661|NCT02764515|rheumatoid arthritis|rheumatoid arthritis
83662|NCT02764515|Methotrexate|methotrexate
83663|NCT02764502|Epidural Identification pressure gauge|epidural identification pressure gauge
83664|NCT02764476|psychogenic|psychogenic
83665|NCT02764476|non-epileptic seizures|non-epileptic seizures
83666|NCT02764476|functional neurological symptom disorder|functional neurological symptom disorder
83667|NCT02764476|PNES|pnes
83668|NCT02764476|PMD|pmd
83669|NCT02764476|virtual reality|virtual reality
83670|NCT02764476|3D augmented reality|3d augmented reality
83671|NCT02764476|mirror therapy|mirror therapy
83672|NCT02764463|Fiber Reinforced Composites|fiber reinforced composites
83673|NCT02764463|Resin cements|resin cements
83674|NCT02764463|Survival|survival
83675|NCT02764450|composite|composite
83676|NCT02764450|restoration|restoration
83677|NCT02764450|polymerization|polymerization
83678|NCT02764424|Newborn|newborn
83679|NCT02764424|Heart Rate Variability (HRV)|heart rate variability (hrv)
83680|NCT02764424|Analgesic Nociception Index (ANI)|analgesic nociception index (ani)
83681|NCT02764424|Autonomous Nervous System (ANS)|autonomous nervous system (ans)
83682|NCT02764411|Capillary malformations|capillary malformations
83683|NCT02764411|Onrealtea|onrealtea
83684|NCT02764411|port-wine stain|port-wine stain
83685|NCT02764411|treatment|treatment
83686|NCT02764411|topical|topical
83687|NCT02764372|Arm rehabilitation|arm rehabilitation
83688|NCT02764372|Serious games|serious games
83689|NCT02764372|stroke|stroke
83690|NCT02764372|Multiple sclerosis|multiple sclerosis
83691|NCT02764346|Arthritis|arthritis
83692|NCT02764346|Self-management|self-management
83693|NCT02764346|Pain|pain
83694|NCT02764333|TPIV200/huFR-1|tpiv200/hufr-1
83695|NCT02764333|Anti-PD-L1|anti-pd-l1
83696|NCT02764333|vaccine|vaccine
83697|NCT02764333|16-011|16-011
83698|NCT02764294|anxiety|anxiety
83699|NCT02764294|pain|pain
83700|NCT02764294|satisfaction|satisfaction
83701|NCT02764294|cystoscopy|cystoscopy
83702|NCT02764294|distraction methods|distraction methods
83703|NCT02764268|Gastric Cancer|gastric cancer
83704|NCT02764268|Pharmacokinetics|pharmacokinetics
83705|NCT02764268|Dose titration|dose titration
98489|NCT02673255|Td|td
83706|NCT02764242|insect sting allergy|insect sting allergy
83707|NCT02764242|recombinant venom allergen|recombinant venom allergen
83708|NCT02764203|Dark Chocolate|dark chocolate
83709|NCT02764203|Blood Pressure|blood pressure
83710|NCT02764203|Wearable Devices|wearable devices
83711|NCT02764203|Digital Health|digital health
83712|NCT02764164|TDCS|tdcs
83713|NCT02764151|GBM|gbm
83714|NCT02764151|malignant glioma|malignant glioma
83715|NCT02764151|glioma|glioma
83716|NCT02764151|anaplastic glioma|anaplastic glioma
83717|NCT02764151|astrocytoma|astrocytoma
83718|NCT02764151|IDO|ido
83719|NCT02764151|IDO1|ido1
83720|NCT02764151|PF-06840003|pf-06840003
83721|NCT02764138|poverty|poverty
83722|NCT02764138|discrimination|discrimination
83723|NCT02764125|Parkinson's Disease|parkinson's disease
83724|NCT02764125|Wearing-off|wearing-off
83725|NCT02764112|warfarin|warfarin
83726|NCT02764073|Heart failure|heart failure
83727|NCT02764073|Bioimpedance|bioimpedance
83728|NCT02764073|Lung ultrasonography|lung ultrasonography
83729|NCT02764060|Periodontitis|periodontitis
83730|NCT02764060|Tongue coating|tongue coating
83731|NCT02764060|Tongue cleaning|tongue cleaning
83732|NCT02764060|Bacterial load|bacterial load
83733|NCT02764047|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
83734|NCT02764047|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
83735|NCT02764047|NAFLD|nafld
83736|NCT02764047|NASH|nash
83737|NCT02764034|Low level Laser|low level laser
83738|NCT02764034|Tissue culture|tissue culture
83739|NCT02764034|Endometrial receptivity|endometrial receptivity
83740|NCT02764021|HbA1c|hba1c
83741|NCT02764021|Diabetes-Releated Complications|diabetes-releated complications
83742|NCT02764021|Diet, Low Carbohydrate|diet, low carbohydrate
83743|NCT02764021|Carbohydrate-Restricted Diet|carbohydrate-restricted diet
83744|NCT02764021|Diabetes Mellitus|diabetes mellitus
83745|NCT02764021|Metabolic Disorder|metabolic disorder
83746|NCT02764021|Glucose Metabolism Disorders|glucose metabolism disorders
83747|NCT02764021|Endocrine System Diseases|endocrine system diseases
83748|NCT02764008|Postoperative Analgesia|postoperative analgesia
83749|NCT02764008|Peritubal infiltration|peritubal infiltration
83750|NCT02764008|Ultrasound guided low thoracic paravertebral block|ultrasound guided low thoracic paravertebral block
83751|NCT02764008|Percutaneous Nephrolithotomy pain|percutaneous nephrolithotomy pain
83753|NCT02763995|pharmaceutical care|pharmaceutical care
83754|NCT02763995|older patients|older patients
83755|NCT02763995|cardiovascular risk|cardiovascular risk
83756|NCT02763995|pharmacotherapy follow up|pharmacotherapy follow up
83757|NCT02763982|left ventricular ejection fraction|left ventricular ejection fraction
83758|NCT02763982|peak oxygen uptake|peak oxygen uptake
83759|NCT02763982|respiratory muscles|respiratory muscles
83760|NCT02763982|quality of life|quality of life
83761|NCT02763956|Gelstix, Hydrogel|gelstix, hydrogel
83762|NCT02763930|Cardiovascular disease|cardiovascular disease
83763|NCT02763930|Blood pressure|blood pressure
83764|NCT02763930|Hypertension|hypertension
83765|NCT02763930|Dairy products|dairy products
83766|NCT02763930|Milk|milk
83767|NCT02763930|Cheese|cheese
83768|NCT02763891|Balance|balance
83769|NCT02763891|Mobility|mobility
83770|NCT02763891|Trunk control|trunk control
83771|NCT02763878|Uncut Roux-en-Y|uncut roux-en-y
83772|NCT02763878|Billroth II anastomosis|billroth ii anastomosis
83773|NCT02763878|Distal gastric cancer|distal gastric cancer
83774|NCT02763878|Nutrition status|nutrition status
83775|NCT02763878|Postoperative complications|postoperative complications
83776|NCT02763852|Parkinson's Disease|parkinson's disease
83777|NCT02763852|Nebicapone|nebicapone
83778|NCT02763839|Parkinson's disease|parkinson's disease
83779|NCT02763839|Nebicapone|nebicapone
83780|NCT02763826|Transcranial Direct Current Stimulation|transcranial direct current stimulation
83781|NCT02763826|tDCS|tdcs
83782|NCT02763800|Parkinson's disease|parkinson's disease
83783|NCT02763800|Nebicapone|nebicapone
83784|NCT02763774|coronary artery bypass|coronary artery bypass
83785|NCT02763774|sistemic inflammatory response syndrome|sistemic inflammatory response syndrome
83786|NCT02763774|left ventricular dysfunction|left ventricular dysfunction
83787|NCT02763774|postoperative complications|postoperative complications
83788|NCT02763774|physical fitness|physical fitness
83789|NCT02763735|Pulmonary arterial hypertension|pulmonary arterial hypertension
83790|NCT02763735|Right ventricle|right ventricle
83791|NCT02763735|Right ventricular function|right ventricular function
83792|NCT02763735|Metabolism|metabolism
83793|NCT02763735|Non-invasive imaging|non-invasive imaging
83794|NCT02763735|Healthy Subjects|healthy subjects
83795|NCT02763722|atopic dermatitis|atopic dermatitis
83796|NCT02763722|allergic contact dermatitis|allergic contact dermatitis
83797|NCT02763722|cosmetics|cosmetics
83798|NCT02763722|transepidermal water loos|transepidermal water loos
83799|NCT02763696|Metagenomics|metagenomics
83800|NCT02763696|Vaginal microflora|vaginal microflora
83801|NCT02763696|High-throughput sequencing|high-throughput sequencing
83802|NCT02763683|Parkinsons Disease|parkinsons disease
83803|NCT02763683|PET Imaging|pet imaging
83804|NCT02763683|PIB|pib
83805|NCT02763683|VAT|vat
83806|NCT02763683|Dementia|dementia
83807|NCT02763670|Heart failure|heart failure
83808|NCT02763670|patient education as topic|patient education as topic
83809|NCT02763670|patient care management|patient care management
83810|NCT02763657|fMRI|fmri
83811|NCT02763657|reasoning|reasoning
83812|NCT02763657|development|development
83813|NCT02763644|transplant associated microangiopathy|transplant associated microangiopathy
83814|NCT02763618|Neurofeedback|neurofeedback
83815|NCT02763618|theta/beta ratio|theta/beta ratio
83913|NCT02762864|clopidogrel|clopidogrel
83816|NCT02763618|multiple baseline|multiple baseline
83817|NCT02763605|Acanthamoeba Keratitis|acanthamoeba keratitis
83818|NCT02763605|in vivo confocal microscopic|in vivo confocal microscopic
83819|NCT02763592|Localized Neuropathic pain|localized neuropathic pain
83820|NCT02763592|5% lidocaine medicated plaster|5% lidocaine medicated plaster
83821|NCT02763592|Knee surgery|knee surgery
83822|NCT02763566|Hormone Receptor-Positive|hormone receptor-positive
83823|NCT02763566|HER2-Negative|her2-negative
83825|NCT02763566|CDK6|cdk6
83826|NCT02763553|Ketone Bodies|ketone bodies
83827|NCT02763553|Enteral Nutrition|enteral nutrition
83828|NCT02763553|Ketogenic Diet|ketogenic diet
83829|NCT02763462|Acute Febrile Illness|acute febrile illness
83830|NCT02763436|term infant, neonatal transition, cord clamping, NIRS, arterial oxygen saturation, regional cerebral oxygen saturation, cerebral blood volume|term infant, neonatal transition, cord clamping, nirs, arterial oxygen saturation, regional cerebral oxygen saturation, cerebral blood volume
83831|NCT02763423|umbilical cord stem cell|umbilical cord stem cell
83833|NCT02763371|high GI lunch|high gi lunch
83834|NCT02763371|low GI lunch|low gi lunch
83836|NCT02763358|weight loss|weight loss
83837|NCT02763332|Fibromyalgia|fibromyalgia
83838|NCT02763332|Efficacy|efficacy
83839|NCT02763332|Taping|taping
83840|NCT02763319|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
83841|NCT02763319|bendamustine|bendamustine
83842|NCT02763319|rituximab|rituximab
83843|NCT02763319|combination therapy|combination therapy
83844|NCT02763319|CD19 monoclonal antibody|cd19 monoclonal antibody
83845|NCT02763319|transplant ineligible|transplant ineligible
83846|NCT02763293|pain|pain
83847|NCT02763293|effectiveness|effectiveness
83848|NCT02763293|manual therapy|manual therapy
83849|NCT02763267|Insulin sensitivity|insulin sensitivity
83850|NCT02763267|Insulin secretion|insulin secretion
83851|NCT02763267|Pregnancy|pregnancy
83852|NCT02763267|Placental proteins|placental proteins
83853|NCT02763254|Epstein-Barr Virus|epstein-barr virus
83854|NCT02763254|DLBCL|dlbcl
83855|NCT02763254|PTLD|ptld
83856|NCT02763254|EBV|ebv
83857|NCT02763254|CIVIC|civic
83858|NCT02763254|HL|hl
83859|NCT02763254|T cell|t cell
83860|NCT02763241|rhinitis|rhinitis
83861|NCT02763228|Physical Activity|physical activity
83862|NCT02763228|Breast Cancer|breast cancer
83863|NCT02763228|minority|minority
83864|NCT02763228|African American|african american
83865|NCT02763202|transition of care|transition of care
83866|NCT02763202|pragmatic clinical trial|pragmatic clinical trial
83867|NCT02763202|telemedicine|telemedicine
83868|NCT02763202|emergency medical technician|emergency medical technician
83869|NCT02763189|Mentoring|mentoring
83870|NCT02763189|Endotracheal Tube Exchange|endotracheal tube exchange
83872|NCT02763176|hCG testing, multi-level pregnancy test|hcg testing, multi-level pregnancy test
83873|NCT02763150|Gestational Diabetes Prevention|gestational diabetes prevention
83874|NCT02763124|Pseudophakic|pseudophakic
83875|NCT02763111|ankylosing spondylitis|ankylosing spondylitis
83876|NCT02763111|interleukin 17|interleukin 17
83877|NCT02763111|monoclonal antibody|monoclonal antibody
83878|NCT02763098|cardiovascular responses|cardiovascular responses
83879|NCT02763098|analgesics opioid|analgesics opioid
83880|NCT02763098|remifentanil|remifentanil
83881|NCT02763046|Ankylosing Spondylitis|ankylosing spondylitis
83882|NCT02763046|NSAID|nsaid
83883|NCT02763046|ASAS|asas
83884|NCT02763046|Secukinumab|secukinumab
83885|NCT02763046|Subcutaneous|subcutaneous
83886|NCT02763020|high glycemic index, polyphenols, blood glucose, satiety|high glycemic index, polyphenols, blood glucose, satiety
83887|NCT02762994|interleukin 17|interleukin 17
83888|NCT02762994|monoclonal antibody|monoclonal antibody
83889|NCT02762994|psoriasis|psoriasis
83890|NCT02762981|CORT125134|cort125134
83891|NCT02762981|nabpaclitaxel|nabpaclitaxel
83892|NCT02762981|Triple-Negative Breast Cancer|triple-negative breast cancer
83893|NCT02762981|Ovarian Epithelial Cancer|ovarian epithelial cancer
83894|NCT02762981|GR Antagonist|gr antagonist
83895|NCT02762981|Glucocorticoid Receptor Antagonist|glucocorticoid receptor antagonist
83896|NCT02762955|adalimumab|adalimumab
83897|NCT02762955|biosimilar|biosimilar
83898|NCT02762955|BCD-057|bcd-057
83899|NCT02762955|psoriasis|psoriasis
98715|NCT02671617|Aged|aged
75148|NCT02814110|adolescents|adolescents
83900|NCT02762955|tumor necrosis factor|tumor necrosis factor
83901|NCT02762955|monoclonal antibody|monoclonal antibody
83902|NCT02762942|cervical ripening|cervical ripening
83903|NCT02762942|misoprostol|misoprostol
83904|NCT02762942|supracervical balloon|supracervical balloon
83905|NCT02762942|Foley catheter|foley catheter
83906|NCT02762929|Analgesia|analgesia
83907|NCT02762929|Bunionectomy|bunionectomy
83908|NCT02762903|Shoulder arthroplasty|shoulder arthroplasty
83909|NCT02762903|Lesser Tuberosity Osteotomy|lesser tuberosity osteotomy
83910|NCT02762903|Subscapularis tenotomy|subscapularis tenotomy
83911|NCT02762864|aspirin|aspirin
83912|NCT02762864|ticagrelor|ticagrelor
83914|NCT02762851|Influenza|influenza
83915|NCT02762851|Vaccine|vaccine
83916|NCT02762851|Heart failure|heart failure
83917|NCT02762851|Vascular|vascular
83918|NCT02762799|neutrophil count|neutrophil count
83919|NCT02762799|filgrastim|filgrastim
83920|NCT02762799|granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
83921|NCT02762747|Hernia, Inguinal|hernia, inguinal
83922|NCT02762747|Extraperitoneal Hernioplasty|extraperitoneal hernioplasty
83923|NCT02762747|Drain|drain
83924|NCT02762747|Mesh Repair|mesh repair
83925|NCT02762747|Laparoscopic|laparoscopic
83926|NCT02762734|adolescent|adolescent
83927|NCT02762734|suicide|suicide
83928|NCT02762721|FGFR2 fusion|fgfr2 fusion
83929|NCT02762721|iCCA|icca
83930|NCT02762721|mixed HCC-CCA|mixed hcc-cca
83931|NCT02762721|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
83932|NCT02762721|Mixed Hepatocellular Cholangiocarcinoma|mixed hepatocellular cholangiocarcinoma
83934|NCT02762721|ArQule|arqule
83935|NCT02762708|Bariatric Surgery|bariatric surgery
83936|NCT02762708|Weight loss|weight loss
83937|NCT02762695|Hypertension|hypertension
83938|NCT02762695|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
83939|NCT02762695|Case Management|case management
83940|NCT02762669|Uterine contraction|uterine contraction
83941|NCT02762669|Oxytocin desensitization|oxytocin desensitization
83942|NCT02762643|DP-R213|dp-r213
83943|NCT02762617|Healthy Volunteers|healthy volunteers
83944|NCT02762617|Women's Health|women's health
83945|NCT02762552|Stroke|stroke
83946|NCT02762552|Etiology|etiology
83947|NCT02762552|Recurrence|recurrence
83948|NCT02762552|Transcranial holter|transcranial holter
83949|NCT02762552|Microembolic signals|microembolic signals
83950|NCT02762526|lipectomy|lipectomy
83951|NCT02762526|abdominoplasty|abdominoplasty
83952|NCT02762526|plethysmography optoelectronics|plethysmography optoelectronics
83953|NCT02762526|diaphragmatic mobility|diaphragmatic mobility
83954|NCT02762526|lung function|lung function
83955|NCT02762526|respiratory muscles|respiratory muscles
83956|NCT02762474|nab-paclitaxel|nab-paclitaxel
83957|NCT02762474|IMRT|imrt
83958|NCT02762474|esophageal cancer|esophageal cancer
83959|NCT02762461|Fertilization in Vitro|fertilization in vitro
83960|NCT02762461|Sperm Injections, Intracytoplasmic|sperm injections, intracytoplasmic
83961|NCT02762461|Endometriosis|endometriosis
83962|NCT02762422|endothelial function|endothelial function
83963|NCT02762422|iron stores|iron stores
83964|NCT02762422|red blood cell|red blood cell
83965|NCT02762422|blood donation|blood donation
83966|NCT02762409|critical care|critical care
83967|NCT02762409|reduction of depression syndrome|reduction of depression syndrome
83968|NCT02762409|anxiety|anxiety
83969|NCT02762409|quality of life|quality of life
83970|NCT02762409|post traumatic stress|post traumatic stress
83971|NCT02762409|discomforts|discomforts
83972|NCT02762396|Young ischemic stroke|young ischemic stroke
83973|NCT02762396|Risk factors|risk factors
83974|NCT02762396|Causes|causes
83975|NCT02762396|Consequences|consequences
83976|NCT02762370|Osteoarthritis|osteoarthritis
83977|NCT02762370|Knee|knee
83978|NCT02762370|Pain|pain
83979|NCT02762370|Diabetes|diabetes
83980|NCT02762370|Intra-articular|intra-articular
83981|NCT02762370|Injection|injection
83982|NCT02762357|Novosyn Quick|novosyn quick
83983|NCT02762357|Episiotomy|episiotomy
83984|NCT02762331|Vitamin C|vitamin c
83985|NCT02762331|Coronary Artery Bypass Grafting|coronary artery bypass grafting
83986|NCT02762331|Atrial Fibrillation|atrial fibrillation
83987|NCT02762331|Cardiac Valve Repair|cardiac valve repair
83988|NCT02762305|fall risk|fall risk
83989|NCT02762305|RSVP bone builders|rsvp bone builders
83990|NCT02762305|Group Exercise|group exercise
83991|NCT02762305|Older adults|older adults
83992|NCT02762305|Balance confidence|balance confidence
83993|NCT02762305|life satisfaction|life satisfaction
83994|NCT02762305|balance|balance
83995|NCT02762292|Mechanical ventilation|mechanical ventilation
83996|NCT02762292|Children|children
83997|NCT02762292|Work of breathing|work of breathing
83998|NCT02762279|Mechanical ventilation|mechanical ventilation
83999|NCT02762279|Children|children
75252|NCT02813577|Legs|legs
84000|NCT02762279|Esophageal Pressure|esophageal pressure
84001|NCT02762279|Pleural Pressure|pleural pressure
84002|NCT02762240|Accreditation|accreditation
84003|NCT02762240|Certification|certification
84004|NCT02762240|General Practice|general practice
84005|NCT02762240|Family Medicine|family medicine
84006|NCT02762240|Randomized Controlled Trial|randomized controlled trial
84007|NCT02762227|CEUS|ceus
84008|NCT02762227|CT|ct
84009|NCT02762227|gallbladder cholesterol polyps|gallbladder cholesterol polyps
84010|NCT02762227|adenoma|adenoma
84011|NCT02762227|gallbladder cancer|gallbladder cancer
84012|NCT02762214|Uterin manipulator|uterin manipulator
84013|NCT02762214|Endometrial Cancer|endometrial cancer
84014|NCT02762214|Laparoscopy|laparoscopy
84015|NCT02762214|Robotic|robotic
84016|NCT02762188|wet ARMD|wet armd
84017|NCT02762188|VEGF|vegf
84018|NCT02762188|intra vitreal injections|intra vitreal injections
84019|NCT02762175|maxillomandibular advancement|maxillomandibular advancement
84020|NCT02762175|obstructive sleep apnea|obstructive sleep apnea
84021|NCT02762175|apnea-hypopnea index|apnea-hypopnea index
84022|NCT02762175|quality of life|quality of life
84023|NCT02762162|antiplatelet|antiplatelet
84024|NCT02762162|stent thrombosis|stent thrombosis
84025|NCT02762149|Tsui Test|tsui test
84027|NCT02762149|Epidural catheter|epidural catheter
84028|NCT02762097|polyps|polyps
84029|NCT02762097|saline sonography|saline sonography
84030|NCT02762097|infertility|infertility
84031|NCT02762084|Gorlin Syndrome|gorlin syndrome
84032|NCT02762084|Basal Cell|basal cell
84033|NCT02762084|Nevus Syndrome|nevus syndrome
84034|NCT02762084|BCNS|bcns
84035|NCT02762084|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
84036|NCT02762084|Basal cell carcinoma|basal cell carcinoma
84037|NCT02762084|Hedgehog|hedgehog
84038|NCT02762084|Surgically Eligible Basal Cell Carcinomas|surgically eligible basal cell carcinomas
84039|NCT02762058|Acquired Brain Injury|acquired brain injury
84040|NCT02762058|Stroke Rehabilitation|stroke rehabilitation
84041|NCT02762045|Therapeutic Vaccine HIV Adenovirus type 5 vector|therapeutic vaccine hiv adenovirus type 5 vector
84042|NCT02762032|Skin Biopsy|skin biopsy
84043|NCT02762032|PrimaVie|primavie
84044|NCT02762032|Herbal Supplement|herbal supplement
84045|NCT02762019|Stomatitis|stomatitis
84046|NCT02762019|Laser|laser
84047|NCT02762019|Children|children
84048|NCT02762019|Chemotherapy|chemotherapy
84049|NCT02762019|Treatment|treatment
84050|NCT02762006|durvalumab|durvalumab
84051|NCT02762006|tremelimumab|tremelimumab
84052|NCT02762006|Phase Ib|phase ib
84053|NCT02762006|Locally Advanced|locally advanced
84054|NCT02761980|ibuprofen; acetaminophen; induced fever; fever|ibuprofen; acetaminophen; induced fever; fever
84055|NCT02761967|Physical activity|physical activity
84056|NCT02761967|Pregnancy|pregnancy
84057|NCT02761967|Childbirth|childbirth
84058|NCT02761967|Postpartum period|postpartum period
84059|NCT02761967|Exercise|exercise
84060|NCT02761954|regional anesthesia|regional anesthesia
84061|NCT02761954|caudal block|caudal block
84062|NCT02761928|Facet Joint|facet joint
84063|NCT02761928|Sacroiliac Joint|sacroiliac joint
84064|NCT02761928|Myofascial Trigger Point Pain|myofascial trigger point pain
84065|NCT02761928|Injectables|injectables
84066|NCT02761915|Neuroblastoma|neuroblastoma
84067|NCT02761915|Immunotherapy|immunotherapy
84068|NCT02761915|1RG-CART|1rg-cart
84069|NCT02761915|Cyclophosphamide|cyclophosphamide
84070|NCT02761915|Fludarabine|fludarabine
84071|NCT02761915|CAR T-cells|car t-cells
84072|NCT02761915|Anti-GD2|anti-gd2
84073|NCT02761915|GD2|gd2
84074|NCT02761915|CAR|car
84075|NCT02761915|Chimeric Antigen Receptor|chimeric antigen receptor
84077|NCT02761902|Polysomnography|polysomnography
84078|NCT02761902|sleep|sleep
84079|NCT02761902|obstructive sleep apnea;|obstructive sleep apnea;
84080|NCT02761902|Chinese|chinese
84081|NCT02761863|Mesothelioma|mesothelioma
84082|NCT02761863|CD 74|cd 74
84083|NCT02761863|VEGF|vegf
84084|NCT02761824|Quality of Life|quality of life
84085|NCT02761824|Occupation|occupation
84086|NCT02761772|Preimplantation Factor|preimplantation factor
84087|NCT02761746|HIV|hiv
84088|NCT02761746|Adherence|adherence
84089|NCT02761746|Health Outcomes|health outcomes
84090|NCT02761733|Shared Decision Making|shared decision making
84091|NCT02761733|Case Management|case management
84092|NCT02761733|Decision Aid|decision aid
84093|NCT02761694|AKT1|akt1
84094|NCT02761694|AKT2|akt2
84095|NCT02761694|AKT3|akt3
84096|NCT02761694|PI3K|pi3k
84097|NCT02761694|PTEN-null|pten-null
84098|NCT02761694|solid tumors|solid tumors
84099|NCT02761694|cancer|cancer
84100|NCT02761694|ARQ 751|arq 751
84101|NCT02761694|ArQule|arqule
84102|NCT02761694|PTEN|pten
84103|NCT02761681|Acceptance and Commitment Therapy|acceptance and commitment therapy
84104|NCT02761681|Mindfulness|mindfulness
84105|NCT02761681|Guided self-help|guided self-help
84106|NCT02761681|College students|college students
84107|NCT02761681|Focused Interviews|focused interviews
84108|NCT02761681|RCT Control Condition|rct control condition
84109|NCT02761681|RCT ACT-CL Condition|rct act-cl condition
84110|NCT02761668|Pathological tooth migration|pathological tooth migration
84111|NCT02761668|periodontal regenerative surgery|periodontal regenerative surgery
84112|NCT02761668|vertical infrabony defects|vertical infrabony defects
84113|NCT02761668|xenogeneic bone graft|xenogeneic bone graft
84114|NCT02761668|orthodontic therapy|orthodontic therapy
84115|NCT02761655|Dementia|dementia
84116|NCT02761655|Medication Adherence|medication adherence
84117|NCT02761655|Perspective Memory|perspective memory
84118|NCT02761590|intermuscular fat|intermuscular fat
84119|NCT02761590|circuit training|circuit training
84120|NCT02761590|adipokines|adipokines
84129|NCT02761564|Blood transfusion|blood transfusion
84130|NCT02761564|ScvO2|scvo2
84131|NCT02761538|obesity|obesity
84132|NCT02761538|Overweight|overweight
84133|NCT02761538|ICTs|icts
84134|NCT02761538|Cost-effectiveness|cost-effectiveness
84135|NCT02761525|silver nanoparticles antimicrobial activity|silver nanoparticles antimicrobial activity
84141|NCT02761447|Motor control Laterality|motor control laterality
84142|NCT02761447|Pain Perception|pain perception
84143|NCT02761447|Lower Extremity|lower extremity
84144|NCT02761447|Complementary Therapies|complementary therapies
84145|NCT02761447|Physical Therapy Modalities|physical therapy modalities
84146|NCT02761434|copeptin|copeptin
84147|NCT02761434|vasopressin|vasopressin
84148|NCT02761434|dehydration|dehydration
84149|NCT02761434|insulin resistance|insulin resistance
84150|NCT02761434|Diabetes|diabetes
84151|NCT02761434|Glucose regulation|glucose regulation
84152|NCT02761421|IOPD|iopd
84153|NCT02761408|Head and neck cancer|head and neck cancer
84154|NCT02761408|Asian|asian
84155|NCT02761408|ALDH2|aldh2
84156|NCT02761369|food addiction|food addiction
84157|NCT02761369|obesity|obesity
84158|NCT02761369|deep TMS|deep tms
84159|NCT02761369|PAS|pas
84160|NCT02761369|Food Stroop|food stroop
84161|NCT02761369|brain laterality|brain laterality
84162|NCT02761369|EEG|eeg
84163|NCT02761369|INP|inp
84164|NCT02761343|cardiac arrhythmia|cardiac arrhythmia
84165|NCT02761343|cardiac ablation|cardiac ablation
84166|NCT02761343|congenital cardiac disease|congenital cardiac disease
84167|NCT02761343|cardiac ablation lesions under Magnetic Resonance imaging|cardiac ablation lesions under magnetic resonance imaging
84168|NCT02761330|Anesthesia|anesthesia
84169|NCT02761330|Electroconvulsive therapy|electroconvulsive therapy
84170|NCT02761330|Delirium|delirium
84171|NCT02761330|Electroencephalography|electroencephalography
84172|NCT02761330|Seizures|seizures
84173|NCT02761330|Depression|depression
84174|NCT02761330|Ketamine|ketamine
84175|NCT02761330|Etomidate|etomidate
84176|NCT02761330|Physiological Effects of Drugs|physiological effects of drugs
84177|NCT02761330|Pharmacologic Actions|pharmacologic actions
84178|NCT02761330|Confusion|confusion
84179|NCT02761330|Mental Disorders|mental disorders
84180|NCT02761330|Neurobehavioral Manifestations|neurobehavioral manifestations
84181|NCT02761330|Signs and Symptoms|signs and symptoms
84182|NCT02761330|Neurologic Manifestations|neurologic manifestations
84183|NCT02761330|Cognitive Disorders|cognitive disorders
84184|NCT02761317|bowel preparation|bowel preparation
84185|NCT02761317|bisacodyl|bisacodyl
84186|NCT02761317|polyethyleneglycol|polyethyleneglycol
84187|NCT02761317|colorectal surgery|colorectal surgery
84188|NCT02761291|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
84189|NCT02761291|EB virus|eb virus
84190|NCT02761291|metastasis|metastasis
84191|NCT02761291|recurrence|recurrence
84192|NCT02761291|cytolytic viral activation therapy|cytolytic viral activation therapy
84193|NCT02761291|gemcitabine|gemcitabine
84194|NCT02761291|valproic acid|valproic acid
84195|NCT02761291|ganciclovir|ganciclovir
84196|NCT02761291|valganciclovir|valganciclovir
84197|NCT02761265|Degenerative Adult Scoliosis|degenerative adult scoliosis
84198|NCT02761265|Gait Analysis|gait analysis
84199|NCT02761265|Balance Analysis|balance analysis
84200|NCT02761265|Biomechanics|biomechanics
84201|NCT02761265|Neuromuscular Control|neuromuscular control
84202|NCT02761265|Thoracolumbar Deformity|thoracolumbar deformity
84203|NCT02761252|Bilastine|bilastine
84204|NCT02761252|Montelukast|montelukast
84205|NCT02761252|total symptom score|total symptom score
84206|NCT02761252|AQLQ|aqlq
84207|NCT02761239|cricopharyngeal muscle|cricopharyngeal muscle
84208|NCT02761239|innervation by EBSLN|innervation by ebsln
84209|NCT02761239|A prospective case-controlled study|a prospective case-controlled study
84210|NCT02761226|platform switching|platform switching
84211|NCT02761226|dental implant|dental implant
84212|NCT02761226|crestal bone level|crestal bone level
84213|NCT02761226|implant stability|implant stability
84214|NCT02761226|postoperative complication|postoperative complication
84215|NCT02761187|Drug Therapy|drug therapy
84216|NCT02761174|Vascular lesions|vascular lesions
84217|NCT02761174|inflammation|inflammation
84218|NCT02761174|IPL|ipl
84224|NCT02761148|white matter hyperintensity|white matter hyperintensity
84225|NCT02761148|brain network|brain network
84226|NCT02761148|MRI|mri
84227|NCT02761148|cognition|cognition
84228|NCT02761148|emotion|emotion
84229|NCT02761135|Biopsy technique|biopsy technique
84230|NCT02761135|Transrectal ultrasonography probe|transrectal ultrasonography probe
84231|NCT02761135|Side-fire|side-fire
84232|NCT02761135|Prostate cancer|prostate cancer
84233|NCT02761135|End-fire|end-fire
84234|NCT02761083|Eye surgery|eye surgery
84235|NCT02761083|Suture material|suture material
84236|NCT02761083|Novosyn Quick|novosyn quick
84237|NCT02761083|Vicryl Rapid|vicryl rapid
84238|NCT02761070|glioblastoma|glioblastoma
84239|NCT02761070|recurrent|recurrent
84240|NCT02761070|dose-dense temozolomide|dose-dense temozolomide
84241|NCT02761070|bevacizumab|bevacizumab
84242|NCT02761031|Heart rate variability|heart rate variability
84243|NCT02761031|Electrocardiography|electrocardiography
84244|NCT02761031|Observational study|observational study
84367|NCT02760342|Metformin|metformin
84245|NCT02761031|Non-interventional study|non-interventional study
84246|NCT02761031|Risk assessment|risk assessment
84247|NCT02761031|Perioperative|perioperative
84248|NCT02761005|Eradication therapy|eradication therapy
84249|NCT02761005|Mutation of 23S rRNA of H. pylori|mutation of 23s rrna of h. pylori
84250|NCT02761005|Personalized therapy|personalized therapy
84251|NCT02760979|knee arthroplasty|knee arthroplasty
84252|NCT02760940|Inflammatory bowel diseases|inflammatory bowel diseases
84253|NCT02760940|Anemia|anemia
84254|NCT02760940|Crohn's disease|crohn's disease
84255|NCT02760940|Ulcerative colitis|ulcerative colitis
84256|NCT02760940|Oral iron|oral iron
84257|NCT02760940|Quality of life|quality of life
84258|NCT02760914|adipose tissue|adipose tissue
84259|NCT02760914|inflammatory mediators|inflammatory mediators
84260|NCT02760914|gene expression|gene expression
84261|NCT02760875|Achilles Tendon Rupture|achilles tendon rupture
84262|NCT02760875|Conservative treatment|conservative treatment
84263|NCT02760875|early weight bearing|early weight bearing
84264|NCT02760875|Achilles Tendon Length|achilles tendon length
84265|NCT02760875|Ultrasound|ultrasound
84266|NCT02760875|Foot Pressure Mapping|foot pressure mapping
84267|NCT02760875|ATRA|atra
84268|NCT02760875|Heel Raise Work|heel raise work
84269|NCT02760849|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
84270|NCT02760849|HBOC|hboc
84271|NCT02760849|Deleterious mutation in ovarian cancer genes|deleterious mutation in ovarian cancer genes
84272|NCT02760849|Changes in female sexual function|changes in female sexual function
84273|NCT02760849|Salpingectomy with delayed oophorectomy|salpingectomy with delayed oophorectomy
84274|NCT02760849|ISDO|isdo
84275|NCT02760849|Risk-reducing salpingo-oophorectomy (RRSO)|risk-reducing salpingo-oophorectomy (rrso)
84276|NCT02760849|RRSO|rrso
84277|NCT02760849|Questionnaires|questionnaires
84278|NCT02760849|Surveys|surveys
84279|NCT02760836|Crohn's disease|crohn's disease
84280|NCT02760836|disease outcomes|disease outcomes
84281|NCT02760784|Achilles Tendon Rupture|achilles tendon rupture
84282|NCT02760784|Conservative treatment|conservative treatment
84283|NCT02760784|early weight bearing|early weight bearing
84284|NCT02760784|Dynamic|dynamic
84285|NCT02760784|ATRS|atrs
84286|NCT02760784|ATRA|atra
84287|NCT02760784|Heel Raise Work|heel raise work
84288|NCT02760771|THV (trans-catheter heart valve)|thv (trans-catheter heart valve)
84289|NCT02760771|severe aortic stenosis|severe aortic stenosis
84290|NCT02760771|pre-dilation|pre-dilation
84291|NCT02760771|rapid pacing|rapid pacing
84292|NCT02760771|BAV (balloon artery valvuloplasty|bav (balloon artery valvuloplasty
84293|NCT02760758|non-nucleoside inhibitor|non-nucleoside inhibitor
84295|NCT02760758|HCV|hcv
84296|NCT02760758|DAA|daa
84297|NCT02760745|fever|fever
84298|NCT02760745|shivering|shivering
84299|NCT02760745|chills|chills
84300|NCT02760745|rigors|rigors
84301|NCT02760745|severe bacterial infection|severe bacterial infection
84302|NCT02760719|3% hypertonic solution|3% hypertonic solution
84303|NCT02760719|duration of hospitalisation|duration of hospitalisation
84304|NCT02760693|bipolar disorder, naturalistic cohort study,|bipolar disorder, naturalistic cohort study,
84305|NCT02760693|defined catchment area,long term treatment|defined catchment area,long term treatment
84306|NCT02760680|Chronic Heart Failure|chronic heart failure
84307|NCT02760680|Sleep-Disordered Breathing|sleep-disordered breathing
84308|NCT02760680|Peripheral Arterial Tone|peripheral arterial tone
84309|NCT02760667|Oropharyngeal cancer|oropharyngeal cancer
84310|NCT02760667|Laryngeal cancer|laryngeal cancer
84311|NCT02760641|obesity|obesity
84312|NCT02760641|low carbohydrate diet|low carbohydrate diet
84313|NCT02760641|metabolism|metabolism
84314|NCT02760641|body composition|body composition
84315|NCT02760641|visceral fat|visceral fat
84316|NCT02760641|older adults|older adults
84317|NCT02760641|insulin sensitivity|insulin sensitivity
84318|NCT02760615|Drug therapy|drug therapy
84319|NCT02760602|anti-amyloid|anti-amyloid
84320|NCT02760602|monoclonal antibody|monoclonal antibody
84321|NCT02760589|ACL tear|acl tear
84322|NCT02760589|ACL lesion|acl lesion
84323|NCT02760589|ACL reconstruction|acl reconstruction
84324|NCT02760589|InternalBrace|internalbrace
84325|NCT02760589|functional performance test|functional performance test
84326|NCT02760589|anterior cruciate ligament|anterior cruciate ligament
84327|NCT02760537|Liver Neoplasms|liver neoplasms
84328|NCT02760537|Hepatitis B|hepatitis b
84329|NCT02760537|Hepatitis B vaccination|hepatitis b vaccination
84330|NCT02760537|Asian Americans|asian americans
84331|NCT02760537|Lay health workers|lay health workers
84332|NCT02760537|Community health workers|community health workers
84333|NCT02760511|Randomized Controlled Trial|randomized controlled trial
84334|NCT02760511|Anthocyanin|anthocyanin
84335|NCT02760511|Antioxidants|antioxidants
84336|NCT02760485|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
84337|NCT02760485|Relapsed Diffuse large B-cell lymphoma|relapsed diffuse large b-cell lymphoma
84338|NCT02760485|Refractory Diffuse large B-cell lymphoma|refractory diffuse large b-cell lymphoma
84339|NCT02760485|activated B cell|activated b cell
84340|NCT02760485|germinal center B-cell|germinal center b-cell
84341|NCT02760485|non-Hodgkin lymphoma|non-hodgkin lymphoma
84342|NCT02760485|JAK1 inhibitor|jak1 inhibitor
84343|NCT02760485|Bruton's tyrosine kinase (BTK) inhibitor|bruton's tyrosine kinase (btk) inhibitor
84344|NCT02760472|Retinopathy of Prematurity|retinopathy of prematurity
84345|NCT02760472|Preterm|preterm
84346|NCT02760472|Fatty acids|fatty acids
84347|NCT02760433|moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
84348|NCT02760433|severe Rheumatoid Arthritis|severe rheumatoid arthritis
84349|NCT02760433|Olokizumab|olokizumab
84350|NCT02760407|moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
84351|NCT02760407|severe Rheumatoid Arthritis|severe rheumatoid arthritis
84352|NCT02760407|subcutaneous|subcutaneous
84353|NCT02760407|Olokizumab|olokizumab
84354|NCT02760394|chronic ischemic heart disease|chronic ischemic heart disease
84355|NCT02760394|coronary bypass|coronary bypass
84356|NCT02760394|refractory stable angina|refractory stable angina
84357|NCT02760394|HBOT|hbot
84358|NCT02760394|reperfusion|reperfusion
84359|NCT02760394|neoangiogenesis|neoangiogenesis
84360|NCT02760394|microvascular|microvascular
84361|NCT02760394|myocardial perfusion|myocardial perfusion
84362|NCT02760368|moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
84363|NCT02760368|severe Rheumatoid Arthritis|severe rheumatoid arthritis
84364|NCT02760368|subcutaneous|subcutaneous
84365|NCT02760368|Olokizumab|olokizumab
84366|NCT02760342|Pharmacokinetics|pharmacokinetics
84368|NCT02760342|Drug-drug interaction|drug-drug interaction
84369|NCT02760342|ASP015K|asp015k
84370|NCT02760329|asthma|asthma
84371|NCT02760329|COPD|copd
84372|NCT02760329|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
84373|NCT02760329|lung disease|lung disease
84374|NCT02760329|chronic airways disease|chronic airways disease
84375|NCT02760329|obstructive lung disease|obstructive lung disease
84376|NCT02760316|Healthy Volunteers|healthy volunteers
84377|NCT02760316|Obese|obese
84378|NCT02760316|Insulin Resistant Subjects|insulin resistant subjects
84379|NCT02760316|Rheumatoid Arthritis|rheumatoid arthritis
84380|NCT02760303|insulin dependent diabetes mellitus|insulin dependent diabetes mellitus
84381|NCT02760303|adolescents and young adults|adolescents and young adults
84382|NCT02760303|stress reduction|stress reduction
84383|NCT02760303|metabolic control|metabolic control
84384|NCT02760290|Forced Expiratory Volume in 1 second|forced expiratory volume in 1 second
84385|NCT02760290|Forced expiratory vital capacity|forced expiratory vital capacity
84386|NCT02760290|Peak expiratory flow|peak expiratory flow
84387|NCT02760277|Duchenne muscular dystrophy|duchenne muscular dystrophy
84388|NCT02760277|vamorolone|vamorolone
84389|NCT02760264|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
84390|NCT02760264|vamorolone|vamorolone
84391|NCT02760251|immunomodulation|immunomodulation
84392|NCT02760238|myeloproliferative neoplasm|myeloproliferative neoplasm
84393|NCT02760238|myelodysplastic syndrome|myelodysplastic syndrome
84394|NCT02760238|registry|registry
84395|NCT02760238|leukemia|leukemia
84396|NCT02760238|Bone Marrow Diseases|bone marrow diseases
84397|NCT02760238|Hematologic Diseases|hematologic diseases
84398|NCT02760238|Neoplasms|neoplasms
84399|NCT02760225|Pembrolizumab|pembrolizumab
84400|NCT02760225|PET imaging|pet imaging
84401|NCT02760225|Melanoma|melanoma
84402|NCT02760225|Non-small cell lung cancer|non-small cell lung cancer
84403|NCT02760212|Shockwave therapy|shockwave therapy
84404|NCT02760212|fMRI|fmri
84405|NCT02760212|blood biomarkers|blood biomarkers
84406|NCT02760173|verticality perception|verticality perception
84407|NCT02760147|Pressure Support Ventilation|pressure support ventilation
84408|NCT02760134|Super-Mini Percutaneous Nephrolithotomy(SMP)|super-mini percutaneous nephrolithotomy(smp)
75654|NCT02811380|Noble metal alloy coating|noble metal alloy coating
75655|NCT02811380|CVC related thrombosis|cvc related thrombosis
75656|NCT02811341|Scopolamine butylbromide PCLE|scopolamine butylbromide pcle
84409|NCT02760134|Renal Pelvic Pressure|renal pelvic pressure
84410|NCT02760121|Acetazolamide|acetazolamide
84411|NCT02760121|Methazolamide|methazolamide
84412|NCT02760121|Control of breathing|control of breathing
84413|NCT02760121|Hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
84706|NCT02758379|lithotripsy|lithotripsy
84414|NCT02760108|Early onset Parkinson's disease|early onset parkinson's disease
84415|NCT02760108|Familial Parkinson's disease|familial parkinson's disease
84416|NCT02760108|Parkinson's disease|parkinson's disease
84417|NCT02760108|Genetics|genetics
84418|NCT02760095|environmental enteric dysfunction|environmental enteric dysfunction
84419|NCT02760095|environmental enteropathy|environmental enteropathy
84420|NCT02760095|zinc|zinc
84421|NCT02760095|vitamin A|vitamin a
84422|NCT02760095|Bangladesh|bangladesh
84423|NCT02760082|Multiple Sclerosis|multiple sclerosis
84424|NCT02760082|Qualitative study|qualitative study
84425|NCT02760082|Motivation|motivation
84426|NCT02760056|Thyroid hormone|thyroid hormone
84427|NCT02760056|Remyelination|remyelination
84428|NCT02760004|Depression|depression
84429|NCT02759991|Hepatitis E virus|hepatitis e virus
84430|NCT02759991|Viral Hepatitis Vaccines|viral hepatitis vaccines
84431|NCT02759978|Imaging|imaging
84432|NCT02759978|Computed Tomography|computed tomography
84433|NCT02759978|Magnetic Resonance Imaging|magnetic resonance imaging
84434|NCT02759978|Positron Emission Tomography|positron emission tomography
84435|NCT02759978|Leukocyte Scintigraphy|leukocyte scintigraphy
84436|NCT02759978|Microbiological diagnostics|microbiological diagnostics
84437|NCT02759978|Sonication|sonication
84438|NCT02759978|Drug Monitoring|drug monitoring
84439|NCT02759978|Cardiac Surgery|cardiac surgery
84440|NCT02759952|retinitis pigmentosa|retinitis pigmentosa
84441|NCT02759952|PDE6A|pde6a
84442|NCT02759952|gene therapy trial|gene therapy trial
84443|NCT02759939|Shared Decision-Making|shared decision-making
84444|NCT02759939|Patient-Provider Communication|patient-provider communication
84445|NCT02759926|Healthy volunteers|healthy volunteers
84446|NCT02759926|Obesity|obesity
84447|NCT02759926|Bitter|bitter
84448|NCT02759913|neuromuscular diseases|neuromuscular diseases
84449|NCT02759848|COPD, tuberculosis, mortality|copd, tuberculosis, mortality
84450|NCT02759835|EGFR Tyrosine Kinase Inhibitors|egfr tyrosine kinase inhibitors
84451|NCT02759835|T790M Mutation|t790m mutation
84452|NCT02759835|Local Ablative Therapies|local ablative therapies
84453|NCT02759835|Oligoprogressive Disease|oligoprogressive disease
84454|NCT02759835|Acquired Resistance|acquired resistance
84455|NCT02759822|Haploidentical Hematopoietic Stem Cell Transplantation|haploidentical hematopoietic stem cell transplantation
84456|NCT02759822|Partially Matched Hematopoietic Stem Cell Transplantation|partially matched hematopoietic stem cell transplantation
84457|NCT02759822|Post-transplant Cyclophosphamide|post-transplant cyclophosphamide
84458|NCT02759822|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
84459|NCT02759783|Radiotherapy|radiotherapy
84460|NCT02759783|oligometastases|oligometastases
84461|NCT02759783|SBRT|sbrt
84462|NCT02759757|Kinesio Taping|kinesio taping
84463|NCT02759757|Low back Pain|low back pain
84464|NCT02759757|Electromyographic|electromyographic
84465|NCT02759757|EMG|emg
84466|NCT02759744|Thermal Ablation|thermal ablation
84467|NCT02759744|Localized Prostate Cancer|localized prostate cancer
84468|NCT02759744|Medtronic-Visualase|medtronic-visualase
84469|NCT02759744|Thermal Damage|thermal damage
84470|NCT02759744|PSA Levels|psa levels
84471|NCT02759731|Murine Models|murine models
84472|NCT02759731|Rheumatoid Arthritis|rheumatoid arthritis
84473|NCT02759731|Corticosteroids|corticosteroids
84474|NCT02759731|Systemic Therapy|systemic therapy
84475|NCT02759731|Inflammatory Cytokines|inflammatory cytokines
84476|NCT02759718|pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
84477|NCT02759718|chromogranin A|chromogranin a
84478|NCT02759705|fertility|fertility
84479|NCT02759705|sexuality|sexuality
84480|NCT02759705|male|male
84481|NCT02759705|exstrophy-epispadias complex|exstrophy-epispadias complex
84482|NCT02759705|bladder exstrophy|bladder exstrophy
84483|NCT02759705|epispadias|epispadias
84484|NCT02759666|PARP|parp
84485|NCT02759666|advanced solid tumor|advanced solid tumor
84486|NCT02759640|c-Met kinase inhibitor|c-met kinase inhibitor
84487|NCT02759640|Advanced solid tumors|advanced solid tumors
84488|NCT02759627|Rehabilitation|rehabilitation
84489|NCT02759627|Gait|gait
84490|NCT02759627|Ambulation|ambulation
84491|NCT02759627|Exercise Therapy|exercise therapy
84492|NCT02759627|Physical Exertion|physical exertion
84493|NCT02759627|Motor Skills|motor skills
84494|NCT02759601|HDAC Inhibitor|hdac inhibitor
84495|NCT02759601|Tefinostat|tefinostat
84496|NCT02759601|Inflammation|inflammation
84497|NCT02759601|Hepatocellular Carcinoma|hepatocellular carcinoma
84498|NCT02759601|Cancer associated Inflammation in Hepatocellular Carcinoma|cancer associated inflammation in hepatocellular carcinoma
84499|NCT02759588|GL-ONC1|gl-onc1
84500|NCT02759588|oncolytic virus|oncolytic virus
84501|NCT02759588|virotherapy|virotherapy
84502|NCT02759588|Viral therapy|viral therapy
84503|NCT02759588|immunotherapy|immunotherapy
84504|NCT02759588|immune therapy|immune therapy
84505|NCT02759588|vaccinia|vaccinia
84506|NCT02759588|vaccinia virus|vaccinia virus
84507|NCT02759588|Genelux|genelux
84508|NCT02759588|ovarian cancer|ovarian cancer
84509|NCT02759588|platinum resistant|platinum resistant
85118|NCT02755922|Treatment|treatment
84510|NCT02759588|platinum refractory|platinum refractory
84511|NCT02759588|peritoneal carcinomatosis|peritoneal carcinomatosis
84512|NCT02759588|fallopian cancer|fallopian cancer
84513|NCT02759588|cancer|cancer
84514|NCT02759588|abdominal cancer|abdominal cancer
84515|NCT02759588|imaging|imaging
84516|NCT02759588|carcinoma|carcinoma
84517|NCT02759588|DNA virus|dna virus
84518|NCT02759588|neoplasms|neoplasms
84519|NCT02759588|neoplasms by histological type|neoplasms by histological type
84520|NCT02759588|neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
84521|NCT02759588|Poxviridae infections|poxviridae infections
84522|NCT02759588|Virus diseases|virus diseases
84523|NCT02759588|recurrent ovarian cancer|recurrent ovarian cancer
84524|NCT02759588|intermediate platinum-sensitive|intermediate platinum-sensitive
84525|NCT02759549|Radiation Therapy|radiation therapy
84526|NCT02759523|Magnetic Resonance Imaging|magnetic resonance imaging
84527|NCT02759523|Portion Size|portion size
84528|NCT02759523|Energy Intake|energy intake
84529|NCT02759510|cardiac output|cardiac output
84530|NCT02759510|norepinephrin|norepinephrin
84531|NCT02759510|cesarean section|cesarean section
84532|NCT02759484|CHWs|chws
84533|NCT02759484|Health Education|health education
84534|NCT02759484|Disease Self Management|disease self management
84535|NCT02759445|alcohol induced cardiomyopathy|alcohol induced cardiomyopathy
84536|NCT02759445|myocardial deformation imaging|myocardial deformation imaging
84537|NCT02759432|high-intensity interval training|high-intensity interval training
84538|NCT02759432|adolescents|adolescents
84540|NCT02759432|quality of life|quality of life
84541|NCT02759432|school-based intervention|school-based intervention
84542|NCT02759367|Nutrition|nutrition
84543|NCT02759367|Potassium|potassium
84544|NCT02759354|Immune response|immune response
84545|NCT02759328|Stroke|stroke
84546|NCT02759328|Rehabilitation|rehabilitation
84547|NCT02759328|Serious games|serious games
84548|NCT02759328|Virtual reality|virtual reality
84549|NCT02759328|Xbox Kinect™|xbox kinect™
84550|NCT02759302|MRI|mri
84551|NCT02759302|LGMD|lgmd
84552|NCT02759302|POMT2|pomt2
84553|NCT02759289|Arsenic|arsenic
84554|NCT02759276|Nailfold Videocapillaroscopy|nailfold videocapillaroscopy
84555|NCT02759276|Venous Occlusion Plethysmography|venous occlusion plethysmography
84556|NCT02759276|Endothelial Function|endothelial function
84557|NCT02759276|Microcirculation|microcirculation
84558|NCT02759276|Inflammatory Biomarkers|inflammatory biomarkers
84559|NCT02759185|PTSD|ptsd
84560|NCT02759185|marijuana|marijuana
84561|NCT02759185|cannabis|cannabis
84562|NCT02759185|sleep|sleep
84563|NCT02759185|THC|thc
84564|NCT02759185|CBD|cbd
84565|NCT02759172|Suicide prevention|suicide prevention
84566|NCT02759172|Jail|jail
84567|NCT02759120|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
84568|NCT02759120|IPF|ipf
84569|NCT02759120|pulmonary fibrosis|pulmonary fibrosis
84570|NCT02759120|antimicrobial therapy|antimicrobial therapy
84571|NCT02759120|doxycycline|doxycycline
84572|NCT02759120|co-trimoxazole|co-trimoxazole
84573|NCT02759094|GERD|gerd
84574|NCT02759094|Implantable medical device|implantable medical device
84575|NCT02759094|RefluxStop|refluxstop
84576|NCT02759094|Reflux|reflux
84577|NCT02759094|Gastroesophageal Reflux|gastroesophageal reflux
84578|NCT02759094|Laparoscopy|laparoscopy
84579|NCT02759094|pH-Monitoring|ph-monitoring
84580|NCT02759094|PPI proton pump inhibitors|ppi proton pump inhibitors
84581|NCT02759068|vegetative state|vegetative state
84582|NCT02759068|minimally conscious state|minimally conscious state
84583|NCT02759068|music|music
84584|NCT02759068|preference|preference
84585|NCT02758990|Food|food
84586|NCT02758990|Nutrigenomics|nutrigenomics
84587|NCT02758990|Precision Medicine|precision medicine
84588|NCT02758990|Pharmacogenetics|pharmacogenetics
84589|NCT02758990|Lifestyle|lifestyle
84590|NCT02758977|Colorectal liver metastases|colorectal liver metastases
84591|NCT02758977|Liver Surgery|liver surgery
84592|NCT02758977|ALPPS|alpps
84593|NCT02758977|Two Stage Hepatectomy|two stage hepatectomy
84594|NCT02758977|Surgical Oncology|surgical oncology
84595|NCT02758977|Hepatectomy|hepatectomy
84596|NCT02758964|TAVR|tavr
99563|NCT02665975|CBT|cbt
84597|NCT02758964|TAVI|tavi
84598|NCT02758964|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
84599|NCT02758964|Intracranial Embolism|intracranial embolism
84600|NCT02758951|Induction Chemotherapy|induction chemotherapy
84601|NCT02758951|Chemotherapy, Adjuvant|chemotherapy, adjuvant
84602|NCT02758951|Molecular Targeted Therapy|molecular targeted therapy
84603|NCT02758951|Colorectal Surgery|colorectal surgery
84604|NCT02758951|Cytoreductive Surgery|cytoreductive surgery
84605|NCT02758951|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
84606|NCT02758951|Peritoneum|peritoneum
84607|NCT02758951|Peritoneal Lavage|peritoneal lavage
84608|NCT02758951|Peritoneal Cavity|peritoneal cavity
84609|NCT02758951|Ascitic Fluid|ascitic fluid
84707|NCT02758366|glioblastoma multiforme|glioblastoma multiforme
84610|NCT02758951|Chemotherapy, Cancer, Regional Perfusion|chemotherapy, cancer, regional perfusion
84611|NCT02758951|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
84612|NCT02758951|Drug Therapy, Combination|drug therapy, combination
84613|NCT02758951|Drug Therapy|drug therapy
84614|NCT02758951|Morbidity|morbidity
84615|NCT02758951|Mortality|mortality
84616|NCT02758951|Hospital Mortality|hospital mortality
84617|NCT02758951|Chemically-Induced Disorders|chemically-induced disorders
84618|NCT02758951|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
84619|NCT02758951|Laparotomy|laparotomy
84620|NCT02758899|Anterior cervical discectomy|anterior cervical discectomy
84621|NCT02758899|Anterior cervical fusion|anterior cervical fusion
84622|NCT02758860|Colonoscopy|colonoscopy
84623|NCT02758860|Diverticular disease of the colon|diverticular disease of the colon
84624|NCT02758860|Classification|classification
84625|NCT02758847|critical lower limb ischemia with tissue loss|critical lower limb ischemia with tissue loss
84626|NCT02758834|Preterm Infants|preterm infants
84627|NCT02758834|Phytosterols|phytosterols
84628|NCT02758834|Parenteral Nutrition|parenteral nutrition
84629|NCT02758821|C-reactive protein|c-reactive protein
84630|NCT02758821|antibiotic|antibiotic
84631|NCT02758795|protein|protein
84632|NCT02758795|inflammation|inflammation
627918|NCT00691626|sleep|sleep
84633|NCT02758795|anti-inflammatory agents|anti-inflammatory agents
84634|NCT02758743|smoking|smoking
84635|NCT02758743|tobacco|tobacco
84636|NCT02758743|smoking cessation|smoking cessation
84637|NCT02758730|GBA mutation|gba mutation
84638|NCT02758704|Intubation|intubation
84639|NCT02758704|Neonatal|neonatal
84640|NCT02758704|Teaching|teaching
84641|NCT02758704|Stress|stress
84642|NCT02758704|Simulation|simulation
84643|NCT02758691|memory|memory
84644|NCT02758691|insulin|insulin
84645|NCT02758678|P-selectin|p-selectin
84646|NCT02758678|Lung Cancer|lung cancer
84647|NCT02758678|Raman Spectroscopy|raman spectroscopy
84648|NCT02758665|CLL|cll
84649|NCT02758665|chronic lymphocytic leukemia|chronic lymphocytic leukemia
84650|NCT02758665|ibrutinib|ibrutinib
84651|NCT02758665|venetoclax|venetoclax
84652|NCT02758665|obinutuzumab|obinutuzumab
84653|NCT02758665|TP53 Deletion|tp53 deletion
84654|NCT02758652|chemoresistance|chemoresistance
84655|NCT02758652|miRNA|mirna
84656|NCT02758652|microRNA|microrna
84657|NCT02758639|parental cancer|parental cancer
84658|NCT02758639|children psychosocial adjustment|children psychosocial adjustment
84659|NCT02758639|psychosocial intervention|psychosocial intervention
84660|NCT02758574|acute pulmonary embolism|acute pulmonary embolism
84661|NCT02758574|submassive pulmonary embolism|submassive pulmonary embolism
84662|NCT02758574|thrombolysis|thrombolysis
84663|NCT02758574|catheter directed thrombolysis|catheter directed thrombolysis
84664|NCT02758574|ultrasound assisted thrombolysis|ultrasound assisted thrombolysis
84665|NCT02758561|decisional aid|decisional aid
84666|NCT02758561|workshops|workshops
84667|NCT02758561|urinary incontinence|urinary incontinence
84668|NCT02758561|pelvic organ prolapse|pelvic organ prolapse
84669|NCT02758561|pelvic floor dysfunction|pelvic floor dysfunction
84670|NCT02758561|decisional conflict|decisional conflict
84671|NCT02758548|Total IgE measurement|total ige measurement
84672|NCT02758548|Novel Point-of-care test device|novel point-of-care test device
84673|NCT02758548|atopic conditions|atopic conditions
84674|NCT02758548|in vitro diagnostic test|in vitro diagnostic test
84675|NCT02758522|Diabetes Mellitus|diabetes mellitus
84676|NCT02758522|Hospital Hyperglycemia|hospital hyperglycemia
84677|NCT02758496|Autism, chart review, transcranial magnetic stimulation (TMS)|autism, chart review, transcranial magnetic stimulation (tms)
84678|NCT02758470|Muscle Fatigue|muscle fatigue
84679|NCT02758470|Acetazolamide|acetazolamide
84680|NCT02758470|Methazolamide|methazolamide
84681|NCT02758457|cad/cam|cad/cam
84682|NCT02758457|dental porcelain|dental porcelain
84683|NCT02758457|zirconia|zirconia
84684|NCT02758457|press on metal|press on metal
84685|NCT02758444|environmental enteric dysfunction|environmental enteric dysfunction
84686|NCT02758444|environmental enteropathy|environmental enteropathy
99689|NCT02665104|TCD|tcd
84687|NCT02758444|zinc absorption|zinc absorption
84688|NCT02758444|Bangladesh|bangladesh
84689|NCT02758444|toddlers|toddlers
84690|NCT02758444|zinc isotope|zinc isotope
84691|NCT02758431|testosterone|testosterone
84692|NCT02758418|Adjustment disorders online|adjustment disorders online
84693|NCT02758418|Psychological Treatments|psychological treatments
84694|NCT02758418|Information and Communication Technologies|information and communication technologies
84695|NCT02758418|Internet|internet
84696|NCT02758418|Bibliotherapy|bibliotherapy
84697|NCT02758405|Epidural|epidural
84698|NCT02758405|Labor analgesia|labor analgesia
84699|NCT02758405|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
84700|NCT02758392|Healthy|healthy
84701|NCT02758392|JNJ-61178104|jnj-61178104
84702|NCT02758392|Placebo|placebo
84703|NCT02758392|Safety|safety
84704|NCT02758379|coronary artery disease|coronary artery disease
84705|NCT02758379|calcified lesions|calcified lesions
84708|NCT02758366|high grade glioma|high grade glioma
84709|NCT02758366|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
84710|NCT02758366|DIPG|dipg
84711|NCT02758366|doxorubicin|doxorubicin
84712|NCT02758366|temozolomide|temozolomide
84713|NCT02758366|malignant glioma|malignant glioma
84714|NCT02758353|Malaria in Pregnancy|malaria in pregnancy
84715|NCT02758353|Nigeria|nigeria
84716|NCT02758353|Sulfadoxine-Pyrimethamine|sulfadoxine-pyrimethamine
84717|NCT02758353|Scale up|scale up
84718|NCT02758353|Primary Health Care|primary health care
84719|NCT02758340|induction of labor|induction of labor
84720|NCT02758340|misoprostol|misoprostol
84721|NCT02758340|foley's balloon catheter|foley's balloon catheter
84722|NCT02758327|Tear Osmolarity|tear osmolarity
84723|NCT02758327|Keratitis Sicca|keratitis sicca
84724|NCT02758327|Ocular Surface Disease|ocular surface disease
84725|NCT02758327|TheraTears|theratears
84726|NCT02758314|PD-1|pd-1
84727|NCT02758314|PD-L1|pd-l1
84728|NCT02758314|NSCLC|nsclc
84729|NCT02758288|Kidney transplant|kidney transplant
84730|NCT02758288|BK Viremia|bk viremia
84731|NCT02758288|BK Nephropathy|bk nephropathy
84732|NCT02758275|Medication adherence|medication adherence
629407|NCT00700310|perampanel|perampanel
84738|NCT02758275|Teaching|teaching
84739|NCT02758275|Randomized controlled trial|randomized controlled trial
84740|NCT02758210|Bradycardia|bradycardia
84741|NCT02758210|Atrial Tachyarrhythmia|atrial tachyarrhythmia
84742|NCT02758210|Smart Phone|smart phone
84744|NCT02758197|Mindfulness|mindfulness
84745|NCT02758197|Chronic Pain|chronic pain
84746|NCT02758197|Quality of Life|quality of life
84747|NCT02758197|Immune Function|immune function
84748|NCT02758197|Cancer survivors|cancer survivors
84749|NCT02758197|Disability|disability
84750|NCT02758132|Castrate-resistant prostate cancer with bone metastases|castrate-resistant prostate cancer with bone metastases
84751|NCT02758106|chest wall oscillation|chest wall oscillation
84752|NCT02758106|acute respiratory failure|acute respiratory failure
84753|NCT02758106|airway secretion|airway secretion
84754|NCT02758080|Personalized medicine|personalized medicine
84755|NCT02758080|Next generation sequencing|next generation sequencing
84756|NCT02758041|Acne|acne
84757|NCT02758028|Youth|youth
84758|NCT02758015|betaine|betaine
84759|NCT02758015|betaine hydrochloride|betaine hydrochloride
84760|NCT02758015|healthy volunteer|healthy volunteer
84761|NCT02758015|gastric pH|gastric ph
84762|NCT02758002|atrial fibrillation ablation|atrial fibrillation ablation
84763|NCT02758002|ablation|ablation
84764|NCT02758002|atrial fibrillation rotors|atrial fibrillation rotors
84765|NCT02757989|Low risk MDS|low risk mds
84766|NCT02757989|Transplantation|transplantation
84767|NCT02757963|Screening tool|screening tool
84768|NCT02757963|International Prostate Symptom Score|international prostate symptom score
84769|NCT02757963|Lower urinary tract symptoms|lower urinary tract symptoms
84770|NCT02757963|BPO|bpo
84771|NCT02757963|BPE|bpe
84772|NCT02757963|Benign prostatic enlargement|benign prostatic enlargement
84773|NCT02757963|Benign prostatic obstruction|benign prostatic obstruction
84774|NCT02757963|LUTS|luts
84775|NCT02757963|Benign prostatic hyperplasia|benign prostatic hyperplasia
84776|NCT02757963|IPSS|ipss
84777|NCT02757963|BPH|bph
84778|NCT02757950|exposed and unexposed cohorts|exposed and unexposed cohorts
84779|NCT02757950|post-marketing, maternal immunization|post-marketing, maternal immunization
84780|NCT02757950|neonate related Adverse Events|neonate related adverse events
84998|NCT02756702|All-Poly|all-poly
84781|NCT02757950|Congenital anomaly|congenital anomaly
84782|NCT02757950|RefortrixTM|refortrixtm
84783|NCT02757950|Pregnancy related Adverse Events|pregnancy related adverse events
84789|NCT02757911|XCGD|xcgd
84790|NCT02757898|Red Blood Cell (RBC) transfusion|red blood cell (rbc) transfusion
84791|NCT02757898|Biotin labeled red blood cells|biotin labeled red blood cells
84792|NCT02757885|bone marrow transplant|bone marrow transplant
84793|NCT02757872|Hypertension|hypertension
84794|NCT02757872|Kidney Diseases|kidney diseases
84795|NCT02757872|Vitamin D|vitamin d
84796|NCT02757872|Omega 3 fatty acids|omega 3 fatty acids
84797|NCT02757846|Radiomics|radiomics
84798|NCT02757846|prognosis|prognosis
84799|NCT02757846|medical images|medical images
84800|NCT02757846|Hepatocellular carcinoma|hepatocellular carcinoma
84801|NCT02757820|anesthesia; airway; laryngeal mask airway; I-gel; Air-Q|anesthesia; airway; laryngeal mask airway; i-gel; air-q
84802|NCT02757807|Erectile Dysfunction|erectile dysfunction
84803|NCT02757781|Patient empowerment|patient empowerment
84804|NCT02757781|Patient involvement|patient involvement
84805|NCT02757781|Patient participation|patient participation
85015|NCT02756663|carfilzomib|carfilzomib
84806|NCT02757781|Healthcare professional attitudes|healthcare professional attitudes
84807|NCT02757781|Chronic diseases|chronic diseases
84808|NCT02757768|Myrbetriq|myrbetriq
84809|NCT02757768|Lower Urinary Tract Symptoms|lower urinary tract symptoms
84810|NCT02757768|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
84811|NCT02757768|Overactive Bladder|overactive bladder
84812|NCT02757768|Betmiga|betmiga
84813|NCT02757768|Mirabegron|mirabegron
84814|NCT02757768|Tamsulosin Hydrochloride|tamsulosin hydrochloride
84815|NCT02757742|sudden cardiac death|sudden cardiac death
84816|NCT02757742|ventricular arrhythmias|ventricular arrhythmias
84817|NCT02757742|cardiopathy|cardiopathy
84818|NCT02757742|late gadolinium enhancement|late gadolinium enhancement
84819|NCT02757716|addiction remission|addiction remission
84820|NCT02757716|addiction transfer|addiction transfer
84821|NCT02757703|somatostatin|somatostatin
84822|NCT02757703|variceal bleeding|variceal bleeding
84823|NCT02757703|terlipressin|terlipressin
84824|NCT02757664|achilles|achilles
84825|NCT02757664|tendinopathy|tendinopathy
84826|NCT02757664|Physical Therapy Modalities|physical therapy modalities
84829|NCT02757586|chronic lymphocytic leukemia|chronic lymphocytic leukemia
84830|NCT02757586|XPO1|xpo1
84831|NCT02757586|in vitro|in vitro
84832|NCT02757586|in vivo|in vivo
84833|NCT02757560|saturated fat|saturated fat
84834|NCT02757560|acute insulin resistance|acute insulin resistance
84835|NCT02757560|insulin suppression test|insulin suppression test
84836|NCT02757560|dietary fatty acids|dietary fatty acids
84837|NCT02757521|Bipolar Depressive Disorder|bipolar depressive disorder
84838|NCT02757521|Treatment- Resistant Bipolar Disorder|treatment- resistant bipolar disorder
84839|NCT02757521|Nitrous Oxide|nitrous oxide
84840|NCT02757495|sevoflurane emergence agitation|sevoflurane emergence agitation
84841|NCT02757495|caudal dexmedetomidine|caudal dexmedetomidine
84842|NCT02757482|Patient training|patient training
84844|NCT02757482|International Normalized Ratio|international normalized ratio
84845|NCT02757482|Nursing|nursing
84846|NCT02757456|exercise|exercise
84847|NCT02757456|hemodialysis|hemodialysis
84848|NCT02757456|pulse wave velocity|pulse wave velocity
84849|NCT02757456|micro RNAs|micro rnas
84850|NCT02757443|Phosphocreatine|phosphocreatine
84851|NCT02757443|Creatine Phosphate|creatine phosphate
84852|NCT02757443|Neoton|neoton
84853|NCT02757443|Phosphate, Creatine|phosphate, creatine
84854|NCT02757443|Phosphorylcreatine|phosphorylcreatine
84855|NCT02757404|botulinum toxin|botulinum toxin
84856|NCT02757404|spasticity|spasticity
84857|NCT02757404|injection technique|injection technique
84858|NCT02757404|neuronox|neuronox
84859|NCT02757404|meditoxin|meditoxin
84860|NCT02757391|Advanced gastrointestinal malignancies|advanced gastrointestinal malignancies
84861|NCT02757391|Metastatic gastrointestinal tumor|metastatic gastrointestinal tumor
84862|NCT02757391|Adoptive T cell infusion|adoptive t cell infusion
84863|NCT02757391|Cyclophosphamide|cyclophosphamide
84864|NCT02757391|Cytoxan|cytoxan
84865|NCT02757391|Neosar|neosar
84866|NCT02757391|IL-2|il-2
84867|NCT02757391|Aldesleukin|aldesleukin
84868|NCT02757391|Interleukin-2|interleukin-2
84869|NCT02757391|Proleukin|proleukin
84870|NCT02757391|Pembrolizumab|pembrolizumab
84871|NCT02757391|Keytruda|keytruda
84872|NCT02757391|MK-3475|mk-3475
84873|NCT02757391|SCH-900475|sch-900475
84874|NCT02757391|Phone calls|phone calls
84875|NCT02757378|Pain|pain
84876|NCT02757378|Brain|brain
84877|NCT02757378|Plasticity|plasticity
84878|NCT02757378|Education|education
84879|NCT02757378|Manual Therapy|manual therapy
84880|NCT02757378|Straight Leg Raise|straight leg raise
84881|NCT02757378|Remapping|remapping
84882|NCT02757365|aspirin|aspirin
84883|NCT02757352|ankylosing|ankylosing
84884|NCT02757352|nonradiographic spondyloarthritis|nonradiographic spondyloarthritis
84888|NCT02757326|sphingosine kinase 2 inhibitor|sphingosine kinase 2 inhibitor
86044|NCT02749942|Diabetes|diabetes
84889|NCT02757326|sphingosine kinase 2|sphingosine kinase 2
84890|NCT02757326|SK2 inhibitor|sk2 inhibitor
84891|NCT02757326|SK2|sk2
84892|NCT02757313|marijuana|marijuana
84893|NCT02757313|driving|driving
84894|NCT02757313|THC|thc
84895|NCT02757313|cannabis|cannabis
84896|NCT02757313|intoxication|intoxication
84897|NCT02757313|MRI|mri
84898|NCT02757287|Ovarian stimulation|ovarian stimulation
84899|NCT02757287|LH inhibition|lh inhibition
99941|NCT02663713|MI|mi
84900|NCT02757274|Urologic Surgical Procedure|urologic surgical procedure
84901|NCT02757274|Male|male
84902|NCT02757261|Bruxism|bruxism
84903|NCT02757261|Child|child
84904|NCT02757261|Occlusal splint|occlusal splint
84905|NCT02757261|Bite force|bite force
84906|NCT02757261|Acunpuncture|acunpuncture
84907|NCT02757261|Laser|laser
84908|NCT02757261|Muscle actvity|muscle actvity
84909|NCT02757261|Salivary Cortisol|salivary cortisol
84910|NCT02757235|chronic subdural hematoma|chronic subdural hematoma
84911|NCT02757235|irrigation|irrigation
84912|NCT02757235|recurrence|recurrence
84913|NCT02757235|burr hole evacuation|burr hole evacuation
84914|NCT02757235|temperature|temperature
84915|NCT02757209|ASTHMA|asthma
84916|NCT02757209|COPD|copd
84917|NCT02757209|budesonide|budesonide
84918|NCT02757209|formoterol|formoterol
84919|NCT02757209|Salmeterol|salmeterol
84920|NCT02757209|Fluticasone|fluticasone
84921|NCT02757209|Spiromax|spiromax
84923|NCT02757209|Diskus|diskus
84924|NCT02757196|Immune Thrombocytopenia|immune thrombocytopenia
84925|NCT02757196|Rituximab|rituximab
84926|NCT02757196|methylprednisolone|methylprednisolone
84927|NCT02757157|Hydrotherapy|hydrotherapy
84928|NCT02757157|Walking|walking
84929|NCT02757131|Mobility|mobility
84930|NCT02757131|Elderly|elderly
84931|NCT02757131|Hospitalized patient|hospitalized patient
84932|NCT02757118|Cardiac Surgery, blood viscosity|cardiac surgery, blood viscosity
84933|NCT02757092|Pulmonary rehabilitation|pulmonary rehabilitation
84934|NCT02757092|lung cancer|lung cancer
84935|NCT02757092|Thoracoscopy|thoracoscopy
84936|NCT02757079|Melatonin|melatonin
84937|NCT02757079|NPC-15|npc-15
84938|NCT02757079|Sleep disorders|sleep disorders
84939|NCT02757079|Neurodevelopmental disorder|neurodevelopmental disorder
84940|NCT02757079|Sleep latency|sleep latency
84941|NCT02757079|DSM-5|dsm-5
84942|NCT02757066|Melatonin|melatonin
84943|NCT02757066|NPC-15|npc-15
84944|NCT02757066|Sleep disorders|sleep disorders
84945|NCT02757066|Autism spectrum disorders|autism spectrum disorders
84946|NCT02757066|DSM-5|dsm-5
84947|NCT02757053|Brain Concussion|brain concussion
84948|NCT02757053|Brain Injuries|brain injuries
84949|NCT02757053|Diffuse Axonal Injury|diffuse axonal injury
84950|NCT02757053|Football|football
84951|NCT02757053|Head Protective Devices|head protective devices
84952|NCT02757053|Magnetic Resonance Imaging|magnetic resonance imaging
84953|NCT02757053|Helmet|helmet
84954|NCT02757053|Third party add-on|third party add-on
84955|NCT02757040|chronic lymphocytic leukemia|chronic lymphocytic leukemia
84957|NCT02757040|arsenic trioxide|arsenic trioxide
84958|NCT02757040|phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
84959|NCT02757027|CABG surgery|cabg surgery
84960|NCT02757027|blood viscosity|blood viscosity
84961|NCT02757001|Retrievable Inferior Vena Cava Filters|retrievable inferior vena cava filters
84962|NCT02757001|Pulmonary Embolism|pulmonary embolism
84963|NCT02756923|Male Infertility|male infertility
84964|NCT02756923|Spermatogonial stem cell|spermatogonial stem cell
84965|NCT02756910|open abdominal surgery|open abdominal surgery
84966|NCT02756910|anesthesia, general|anesthesia, general
84967|NCT02756897|Leukemia|leukemia
84968|NCT02756897|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
84969|NCT02756897|CLL|cll
84970|NCT02756897|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
84971|NCT02756897|SLL|sll
84972|NCT02756897|Refractory and/or relapsed|refractory and/or relapsed
84973|NCT02756897|Ibrutinib|ibrutinib
84974|NCT02756897|PCI-32765|pci-32765
84975|NCT02756897|Imbruvica|imbruvica
84976|NCT02756897|Venetoclax|venetoclax
84977|NCT02756897|ABT-199|abt-199
84978|NCT02756897|GDC-0199|gdc-0199
84979|NCT02756845|Non CNS Tumor|non cns tumor
84980|NCT02756832|Drug Therapy|drug therapy
84981|NCT02756819|Drug Therapy|drug therapy
84982|NCT02756806|Tattoo removal, Picosecond Laser, Q-switched Laser|tattoo removal, picosecond laser, q-switched laser
84983|NCT02756780|Remission|remission
84984|NCT02756780|Carer|carer
84985|NCT02756780|Psychological|psychological
84986|NCT02756780|Bereaved|bereaved
84987|NCT02756780|Cancer|cancer
84988|NCT02756780|Breast|breast
84989|NCT02756780|Prostate|prostate
84990|NCT02756780|Colorectal|colorectal
84991|NCT02756780|Music|music
84992|NCT02756741|Cirrhosis|cirrhosis
84993|NCT02756741|hepatitis B virus|hepatitis b virus
84994|NCT02756741|Alcohol|alcohol
84995|NCT02756741|varices|varices
84996|NCT02756702|TKA|tka
84997|NCT02756702|TKR|tkr
84999|NCT02756702|posterior stabilized|posterior stabilized
85000|NCT02756689|Mechanical cervical ripening|mechanical cervical ripening
85001|NCT02756689|Transcervical catheter|transcervical catheter
85002|NCT02756689|Foley catheter for labor induction|foley catheter for labor induction
85003|NCT02756689|Cervical ripening|cervical ripening
85004|NCT02756689|Induction of labor|induction of labor
85005|NCT02756676|Parkinson Disease|parkinson disease
85006|NCT02756676|Quality of Life|quality of life
85007|NCT02756676|Rehabilitation|rehabilitation
85008|NCT02756663|multiple myeloma|multiple myeloma
85009|NCT02756663|MM|mm
85010|NCT02756663|relapsed|relapsed
85011|NCT02756663|relapsed and refractory|relapsed and refractory
85012|NCT02756663|panobinostat|panobinostat
85013|NCT02756663|LBH589|lbh589
85014|NCT02756663|histone deacetylase inhibitor|histone deacetylase inhibitor
85016|NCT02756663|proteasome inhibitor|proteasome inhibitor
85017|NCT02756650|Behcet Disease|behcet disease
85018|NCT02756650|Inflammation|inflammation
85019|NCT02756650|Immune system|immune system
85020|NCT02756650|Arthritis|arthritis
85021|NCT02756611|Oncology|oncology
85022|NCT02756611|TP53 Mutation|tp53 mutation
85023|NCT02756611|Refractory|refractory
85024|NCT02756611|Relapsed|relapsed
85025|NCT02756611|B-Cell receptor inhibitor|b-cell receptor inhibitor
85026|NCT02756611|17p Deletion|17p deletion
85027|NCT02756611|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
85028|NCT02756598|sufentanil|sufentanil
85029|NCT02756598|propofol|propofol
85030|NCT02756598|personality/stress test|personality/stress test
85031|NCT02756598|fast-track|fast-track
85032|NCT02756585|computed tomography|computed tomography
85033|NCT02756585|perfusion imaging|perfusion imaging
85034|NCT02756585|brain death|brain death
85035|NCT02756585|traumatic brain injury|traumatic brain injury
85036|NCT02756559|sepsis|sepsis
85037|NCT02756559|microRNAs|micrornas
85040|NCT02756520|diet, protein-restricted|diet, protein-restricted
85041|NCT02756520|renal function|renal function
85042|NCT02756507|anxiety symptoms|anxiety symptoms
85043|NCT02756507|depression symptoms|depression symptoms
85044|NCT02756507|internalizing symptoms|internalizing symptoms
85045|NCT02756468|pancreatic cancer|pancreatic cancer
85046|NCT02756468|procalcitonin|procalcitonin
85047|NCT02756455|gastric cancer|gastric cancer
85048|NCT02756455|procalcitonin|procalcitonin
85049|NCT02756429|atrial fibrillation|atrial fibrillation
85051|NCT02756429|thromboembolism|thromboembolism
85052|NCT02756429|inflammation|inflammation
85053|NCT02756416|Reversible Cerebral Vasoconstriction Syndrome (RCVS)|reversible cerebral vasoconstriction syndrome (rcvs)
85054|NCT02756416|Arterial spin labeling (ASL) MRI|arterial spin labeling (asl) mri
85055|NCT02756390|Insomnia cancer Survivor|insomnia cancer survivor
85056|NCT02756364|Drug Therapy|drug therapy
85057|NCT02756325|Azoospermia, IVF, MRI|azoospermia, ivf, mri
85058|NCT02756299|Sleep Apnea|sleep apnea
86418|NCT02747667|Eye|eye
85059|NCT02756299|Positive Airway Pressure|positive airway pressure
85060|NCT02756299|Patient Education|patient education
85061|NCT02756286|Electroencephalography|electroencephalography
85063|NCT02756273|ileostomy|ileostomy
85064|NCT02756273|morbidity|morbidity
85065|NCT02756273|colorectal surgery|colorectal surgery
85070|NCT02756221|symptoms|symptoms
85071|NCT02756208|vaccine|vaccine
85072|NCT02756208|healthy volunteer|healthy volunteer
85073|NCT02756195|Patient safety|patient safety
85074|NCT02756195|adverse events|adverse events
85075|NCT02756195|pediatric surgery|pediatric surgery
85076|NCT02756195|quality improvement|quality improvement
85077|NCT02756195|health systems|health systems
85078|NCT02756195|observational study|observational study
85079|NCT02756195|non-routine event|non-routine event
85080|NCT02756195|National Surgical Improvement Program|national surgical improvement program
85081|NCT02756169|Obesity|obesity
85082|NCT02756169|Breastfeeding|breastfeeding
85083|NCT02756169|Grow up|grow up
85084|NCT02756169|Milk composition|milk composition
85085|NCT02756169|Mexico|mexico
85086|NCT02756156|interscalene|interscalene
85087|NCT02756156|infraclavicular|infraclavicular
85088|NCT02756156|humerus surgery|humerus surgery
85089|NCT02756143|fetal heart|fetal heart
85090|NCT02756143|cesarean section|cesarean section
85091|NCT02756143|exercise|exercise
85092|NCT02756143|pregnancy|pregnancy
85093|NCT02756091|Intracranial Artery Dissection|intracranial artery dissection
85094|NCT02756091|IAD|iad
85095|NCT02756091|Stroke|stroke
85096|NCT02756091|Observational Study|observational study
85097|NCT02756065|Bipolar|bipolar
85098|NCT02756065|schizophrenia|schizophrenia
85099|NCT02756065|schizoaffective|schizoaffective
85100|NCT02756026|Breast milk|breast milk
85101|NCT02756026|mineral|mineral
85102|NCT02756026|vitamin|vitamin
85103|NCT02756013|chemotherapy dosing|chemotherapy dosing
85104|NCT02756013|Body surface area|body surface area
85105|NCT02756013|BSA|bsa
85106|NCT02756013|paclitaxel|paclitaxel
85107|NCT02756013|carboplatin|carboplatin
85108|NCT02756013|dose dense|dose dense
86150|NCT02749292|remission|remission
85109|NCT02756000|myocardial infarction|myocardial infarction
85110|NCT02756000|percutaneous coronary intervention|percutaneous coronary intervention
85111|NCT02756000|multivessel coronary artery disease|multivessel coronary artery disease
85112|NCT02756000|dobutamine stress echocardiography|dobutamine stress echocardiography
85113|NCT02755961|End-stage renal disease|end-stage renal disease
85114|NCT02755961|Phosphate binders|phosphate binders
85115|NCT02755961|Hyperphosphatemia|hyperphosphatemia
85116|NCT02755961|Dietary education|dietary education
85117|NCT02755922|Mesenchymal Stem Cells|mesenchymal stem cells
85119|NCT02755909|Cardiac surgery, anxiety, education|cardiac surgery, anxiety, education
85120|NCT02755883|Physical activity|physical activity
85121|NCT02755883|non-small lung cancer|non-small lung cancer
85122|NCT02755883|positive affect|positive affect
85123|NCT02755857|Prophylaxis|prophylaxis
85124|NCT02755857|Bioavailability|bioavailability
85125|NCT02755857|Pharmacokinetics|pharmacokinetics
85126|NCT02755844|endometrial carcinomas|endometrial carcinomas
85127|NCT02755844|metronomic cyclophosphamide|metronomic cyclophosphamide
85128|NCT02755844|metformin|metformin
85129|NCT02755844|olaparib|olaparib
85130|NCT02755844|dose-escalation study|dose-escalation study
85131|NCT02755818|high density lipoprotein (HDL)|high density lipoprotein (hdl)
85132|NCT02755818|lipid|lipid
85133|NCT02755818|insulin resistance|insulin resistance
85134|NCT02755818|glomerular filtration rate (GFR)|glomerular filtration rate (gfr)
85135|NCT02755818|obesity|obesity
85136|NCT02755805|Stroke|stroke
85137|NCT02755805|Rehabilitation|rehabilitation
85143|NCT02755792|Calligraphy|calligraphy
85144|NCT02755792|Emotional calmness|emotional calmness
85145|NCT02755792|Working memory|working memory
85146|NCT02755753|Rebamipide|rebamipide
85147|NCT02755740|female|female
85148|NCT02755688|atrial fibrillation|atrial fibrillation
85149|NCT02755688|catheter ablation|catheter ablation
85150|NCT02755688|thoracoscopic surgical ablation|thoracoscopic surgical ablation
85151|NCT02755688|long standing persistent atrial fibrillation|long standing persistent atrial fibrillation
85152|NCT02755662|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
85153|NCT02755662|mandibular repositioning device|mandibular repositioning device
85154|NCT02755636|Health Behavior Change|health behavior change
85155|NCT02755636|Primary Health Care|primary health care
85156|NCT02755636|Patient Participation|patient participation
85157|NCT02755636|Provider-Patient Communication|provider-patient communication
85158|NCT02755636|Cluster-Randomized Trial|cluster-randomized trial
85159|NCT02755636|Mobile Health|mobile health
85160|NCT02755610|Peritoneal Dialysis|peritoneal dialysis
85161|NCT02755610|Checklist|checklist
85166|NCT02755584|Aging|aging
85167|NCT02755584|Senescent Cells|senescent cells
85168|NCT02755532|Pharmacokinetics|pharmacokinetics
85169|NCT02755532|Bupivacaine|bupivacaine
85170|NCT02755532|Axillary brachial plexus block|axillary brachial plexus block
85171|NCT02755519|primary aldosteronism|primary aldosteronism
85174|NCT02755506|Ultrasound elastography|ultrasound elastography
85175|NCT02755506|Thoracic lesions|thoracic lesions
85176|NCT02755506|EBUS-TBNA|ebus-tbna
85177|NCT02755480|bone marrow transplant|bone marrow transplant
85178|NCT02755480|infection|infection
85179|NCT02755480|computed tomography|computed tomography
85180|NCT02755480|radiation dose|radiation dose
85181|NCT02755441|Diagnosis|diagnosis
85182|NCT02755441|Prognosis|prognosis
85183|NCT02755441|Biomarker|biomarker
85184|NCT02755415|Rehabilitation|rehabilitation
85185|NCT02755415|Robotic|robotic
85186|NCT02755415|Gait|gait
85187|NCT02755415|Quality of Life|quality of life
85188|NCT02755389|Tracheal intubation|tracheal intubation
85189|NCT02755389|High flow nasal oxygen|high flow nasal oxygen
85190|NCT02755389|Airway management|airway management
85191|NCT02755389|Apneic oxygenation|apneic oxygenation
85192|NCT02755363|COPD|copd
85193|NCT02755363|residual volume|residual volume
85194|NCT02755363|osteopathy|osteopathy
85195|NCT02755363|hyperinflation|hyperinflation
85196|NCT02755350|PrEP|prep
85197|NCT02755350|HIV Prevention|hiv prevention
85198|NCT02755350|combination prevention|combination prevention
85199|NCT02755350|demonstration project|demonstration project
85200|NCT02755337|adenocarcinoma|adenocarcinoma
85201|NCT02755337|non-adenocarcinoma|non-adenocarcinoma
85202|NCT02755298|Treatment Outcome|treatment outcome
85203|NCT02755298|Acetazolamide|acetazolamide
85204|NCT02755272|Triple Negative Breast Cancer|triple negative breast cancer
85205|NCT02755259|Acetazolamide|acetazolamide
85206|NCT02755259|Hemodynamics|hemodynamics
85207|NCT02755246|subjective cognitive decline|subjective cognitive decline
85208|NCT02755246|dementia|dementia
85209|NCT02755246|lifestyle|lifestyle
85210|NCT02755246|polyamine|polyamine
85211|NCT02755246|memory|memory
85212|NCT02755246|elderly|elderly
85213|NCT02755246|prevention|prevention
85214|NCT02755246|treatment|treatment
85215|NCT02755246|dietary supplement|dietary supplement
85216|NCT02755246|Polyamine-enriched diet|polyamine-enriched diet
85217|NCT02755194|pharmacokinetics|pharmacokinetics
85218|NCT02755194|Drug-in-milk|drug-in-milk
85219|NCT02755194|breastfeeding|breastfeeding
85220|NCT02755194|drug safety|drug safety
85221|NCT02755194|population pharmacokinetics|population pharmacokinetics
85222|NCT02755155|acute circulatory failure requiring norepinephrine|acute circulatory failure requiring norepinephrine
85223|NCT02755155|SIRS|sirs
85224|NCT02755155|Albumin, therapeutic|albumin, therapeutic
85225|NCT02755116|Nausea|nausea
85226|NCT02755116|Vomiting|vomiting
85227|NCT02755103|Mindfulness|mindfulness
85228|NCT02755103|Comorbid PTSD and SUD|comorbid ptsd and sud
85229|NCT02755103|Meditation|meditation
85230|NCT02755090|nitrous|nitrous
85231|NCT02755090|pain|pain
85232|NCT02755077|Anesthesia induction|anesthesia induction
85233|NCT02755077|Airway|airway
85234|NCT02755077|Mask ventilation|mask ventilation
85235|NCT02755038|postmenopausal women|postmenopausal women
85236|NCT02755038|scalp hair|scalp hair
85237|NCT02755038|estrogen|estrogen
85238|NCT02755038|progesterone|progesterone
85239|NCT02755025|Sepsis|sepsis
85240|NCT02755025|SOFA score|sofa score
85241|NCT02755025|Automated calculation|automated calculation
85242|NCT02755012|Maternal Health|maternal health
85243|NCT02755012|Guatemala|guatemala
85244|NCT02755012|Indigenous Population|indigenous population
85245|NCT02755012|Stunting|stunting
85246|NCT02755012|Food Insecurity|food insecurity
85247|NCT02755012|Poverty|poverty
85248|NCT02755012|Social Support|social support
85249|NCT02755012|Maternal Autonomy|maternal autonomy
85250|NCT02755012|Paternal Support|paternal support
85251|NCT02755012|Cortisol Rhythm|cortisol rhythm
85252|NCT02754986|heart rate variability|heart rate variability
85253|NCT02754960|Gastrointestinal bleeding|gastrointestinal bleeding
85254|NCT02754960|Vascular malformation|vascular malformation
85255|NCT02754960|Angiodysplasia|angiodysplasia
85256|NCT02754960|Thalidomide|thalidomide
85257|NCT02754947|Assessment and Consultation Team (ACT)|assessment and consultation team (act)
85258|NCT02754947|Rapid Response Team (RRT)|rapid response team (rrt)
85259|NCT02754947|Perioperative complications|perioperative complications
85260|NCT02754947|Respiratory insufficiency|respiratory insufficiency
85261|NCT02754947|ASA status|asa status
85262|NCT02754934|chronic|chronic
85263|NCT02754895|acute coronary syndrome|acute coronary syndrome
85264|NCT02754895|health behavior|health behavior
85265|NCT02754895|factorial design|factorial design
85266|NCT02754895|positive psychology|positive psychology
85267|NCT02754882|NSCLC|nsclc
85268|NCT02754882|bevacizumab|bevacizumab
85269|NCT02754882|avastin|avastin
85270|NCT02754856|Colorectal Cancer|colorectal cancer
85271|NCT02754856|Liver Metastases|liver metastases
85272|NCT02754856|Resectable liver metastases|resectable liver metastases
85274|NCT02754856|Fluorouracil|fluorouracil
85275|NCT02754856|5-Fluorouracil|5-fluorouracil
85276|NCT02754856|5-FU|5-fu
85277|NCT02754856|Adrucil|adrucil
85278|NCT02754856|Efudex|efudex
85279|NCT02754856|Leucovorin|leucovorin
85280|NCT02754856|Citrovorum|citrovorum
85281|NCT02754856|Wellcovorin|wellcovorin
85282|NCT02754856|Oxaliplatin|oxaliplatin
85283|NCT02754856|Eloxatin|eloxatin
85284|NCT02754856|Bevacizumab|bevacizumab
85285|NCT02754856|Avastin|avastin
85286|NCT02754856|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
85287|NCT02754856|MEDI4736|medi4736
85288|NCT02754856|Durvalumab|durvalumab
85289|NCT02754778|arterial stiffness|arterial stiffness
85290|NCT02754778|preeclampsia|preeclampsia
85291|NCT02754778|HELLP-syndrome|hellp-syndrome
85292|NCT02754778|pulse wave velocity|pulse wave velocity
85293|NCT02754778|advanced glycation endproducts|advanced glycation endproducts
85294|NCT02754778|skin autofluorescence|skin autofluorescence
85295|NCT02754778|conditional workout|conditional workout
85296|NCT02754778|postpartum|postpartum
85297|NCT02754778|cardiovascular risk|cardiovascular risk
85298|NCT02754778|pregnancy|pregnancy
85299|NCT02754778|vicorder|vicorder
85300|NCT02754778|age reader|age reader
85301|NCT02754752|Malignant neoplasm of breast|malignant neoplasm of breast
85302|NCT02754752|Electro-acupuncture|electro-acupuncture
85303|NCT02754752|Questionnaires|questionnaires
85304|NCT02754752|Surveys|surveys
85305|NCT02754752|Standard of care|standard of care
85306|NCT02754752|Chronic Pain|chronic pain
85307|NCT02754739|Pravastatin|pravastatin
85308|NCT02754739|Insulin Resistance|insulin resistance
85309|NCT02754700|Anterior Cruciate Ligament|anterior cruciate ligament
85310|NCT02754687|male contraception|male contraception
85311|NCT02754687|healthy men|healthy men
85312|NCT02754687|androgen|androgen
85313|NCT02754687|Nortestosterone|nortestosterone
85314|NCT02754687|Dodecylcarbonate|dodecylcarbonate
85315|NCT02754687|11-Beta|11-beta
85316|NCT02754687|11β|11β
85317|NCT02754687|contraception|contraception
85318|NCT02754661|Polyps; Capsule endoscopy; CT Colonography; Colonoscopy; Average risk patients for colorectal cancer screening|polyps; capsule endoscopy; ct colonography; colonoscopy; average risk patients for colorectal cancer screening
85416|NCT02754089|Body mass index|body mass index
85320|NCT02754635|maternal and perinatal morbidity/mortality|maternal and perinatal morbidity/mortality
85321|NCT02754622|Rehabilitation|rehabilitation
85322|NCT02754609|Celiac Disease|celiac disease
85323|NCT02754609|Necator americanus|necator americanus
85324|NCT02754609|Helminths|helminths
85325|NCT02754609|Autoimmunity|autoimmunity
85326|NCT02754609|Clinical Trials, Phase I|clinical trials, phase i
85327|NCT02754609|Randomized Controlled Trial|randomized controlled trial
85328|NCT02754583|trachoma|trachoma
85329|NCT02754583|soil transmitted helminths|soil transmitted helminths
85330|NCT02754583|sanitation|sanitation
85331|NCT02754583|face washing|face washing
85332|NCT02754583|antibiotics|antibiotics
85333|NCT02754570|Open-angle glaucoma|open-angle glaucoma
85334|NCT02754570|Ocular hypertension|ocular hypertension
85335|NCT02754570|Latanoprost|latanoprost
85336|NCT02754570|Pilocarpine|pilocarpine
85337|NCT02754544|Brain tumor|brain tumor
85338|NCT02754544|Metastatic brain tumor|metastatic brain tumor
85339|NCT02754544|Neurosurgery|neurosurgery
85340|NCT02754544|Electrocorticogram|electrocorticogram
85341|NCT02754544|ECoG|ecog
85342|NCT02754544|Transcranial magnetic stimulation|transcranial magnetic stimulation
85344|NCT02754544|Direct electrical stimulation|direct electrical stimulation
85345|NCT02754544|DES|des
85346|NCT02754544|Functional MRI|functional mri
85347|NCT02754544|fMRI|fmri
85348|NCT02754544|PMT High-Resolution Grids|pmt high-resolution grids
85349|NCT02754544|CorTec High-Resolution Hybrid Grids|cortec high-resolution hybrid grids
85350|NCT02754544|Digital glove|digital glove
85351|NCT02754544|Neurological exam|neurological exam
85352|NCT02754544|Ad-Tech Grids|ad-tech grids
85353|NCT02754544|Grip Sensor|grip sensor
85354|NCT02754531|Cole formula|cole formula
85355|NCT02754531|Pediatric patients|pediatric patients
85356|NCT02754531|intubation|intubation
85357|NCT02754531|Ultrasonography|ultrasonography
85358|NCT02754531|Endotracheal tube|endotracheal tube
85359|NCT02754531|uncuffed|uncuffed
85360|NCT02754531|pediatric|pediatric
85361|NCT02754505|Keywords: intensive care, muscle wasting, discharge, neuromuscular weakness, mobilization|keywords: intensive care, muscle wasting, discharge, neuromuscular weakness, mobilization
85362|NCT02754453|Weight Regain|weight regain
85363|NCT02754453|Group Treatment|group treatment
85364|NCT02754453|Weight Loss|weight loss
85365|NCT02754427|Surveillance|surveillance
85366|NCT02754427|Physiotherapy|physiotherapy
85367|NCT02754427|Arm morbidity|arm morbidity
85368|NCT02754414|platelets|platelets
85369|NCT02754414|transfusion|transfusion
85370|NCT02754414|cold storage|cold storage
85371|NCT02754414|apheresis|apheresis
85372|NCT02754401|public health|public health
85373|NCT02754401|periodontitis|periodontitis
85374|NCT02754401|self-reported questionnaire|self-reported questionnaire
85375|NCT02754388|LDCT, screening, health behavior, psychological factors|ldct, screening, health behavior, psychological factors
85376|NCT02754375|biological markers|biological markers
85377|NCT02754375|rTMS|rtms
85380|NCT02754349|pulse wave velocity|pulse wave velocity
85381|NCT02754349|augmentation index|augmentation index
85382|NCT02754349|central pulse pressure|central pulse pressure
85383|NCT02754310|Education, medical|education, medical
85384|NCT02754310|Simulation Training|simulation training
85385|NCT02754297|Neuroendocrine tumors|neuroendocrine tumors
85386|NCT02754297|Personalized|personalized
85387|NCT02754297|Peptide receptor radionuclide therapy|peptide receptor radionuclide therapy
85388|NCT02754297|PRRT|prrt
85389|NCT02754297|177Lu-DOTATATE|177lu-dotatate
85390|NCT02754297|177Lu-octreotate|177lu-octreotate
85391|NCT02754245|multicenter study|multicenter study
85392|NCT02754245|emergency department|emergency department
85393|NCT02754245|overcrowding status|overcrowding status
85394|NCT02754245|estimation tool|estimation tool
85395|NCT02754245|validation|validation
85396|NCT02754232|Physical training|physical training
85397|NCT02754232|Telemedicine|telemedicine
85398|NCT02754232|Daily activities|daily activities
85399|NCT02754232|Cross sectoral|cross sectoral
85400|NCT02754219|Diabetes Mellitus, Type II|diabetes mellitus, type ii
85401|NCT02754193|Venous-Arterial ExtraCorporeal Membrane Oxygenation|venous-arterial extracorporeal membrane oxygenation
85402|NCT02754180|adjuvant|adjuvant
85403|NCT02754180|pancreatic cancer|pancreatic cancer
85404|NCT02754180|R1 resection|r1 resection
85405|NCT02754180|positive lymph nodes|positive lymph nodes
85406|NCT02754167|Hepcidin|hepcidin
85407|NCT02754167|hemoglobin|hemoglobin
85408|NCT02754167|iron|iron
85409|NCT02754167|anemia of chronic disease|anemia of chronic disease
85410|NCT02754089|Body weight changes|body weight changes
85411|NCT02754089|Medicine, Traditional|medicine, traditional
85412|NCT02754089|Herbal medicine|herbal medicine
85413|NCT02754089|Rhus|rhus
85414|NCT02754089|Waist Circumference|waist circumference
85415|NCT02754089|Waist-Hip Ratio|waist-hip ratio
85419|NCT02754011|HER2 negative|her2 negative
85420|NCT02754011|Locally advanced or metastatic|locally advanced or metastatic
85421|NCT02753998|Stenosis of arteriovenous fistula|stenosis of arteriovenous fistula
85422|NCT02753998|Angioplasty|angioplasty
85423|NCT02753998|Paclitaxel-Coated Balloon Angioplasty|paclitaxel-coated balloon angioplasty
86360|NCT02747979|insomnia|insomnia
85424|NCT02753920|voiding trial|voiding trial
85425|NCT02753920|prolapse|prolapse
85426|NCT02753894|Dose-finding|dose-finding
85427|NCT02753894|Hemodialysis|hemodialysis
100597|NCT02660268|Hip|hip
85428|NCT02753894|ASP1585|asp1585
85429|NCT02753894|Chronic kidney disease|chronic kidney disease
85430|NCT02753868|Intradialytic exercise|intradialytic exercise
85431|NCT02753868|Cardiac and arterial function|cardiac and arterial function
85432|NCT02753842|Sexually Transmitted Infections|sexually transmitted infections
85433|NCT02753842|Condoms|condoms
85434|NCT02753842|Contraceptive Devices|contraceptive devices
85436|NCT02753816|Tranexamic Acid|tranexamic acid
85437|NCT02753816|Burn|burn
85439|NCT02753816|Tangential|tangential
85440|NCT02753816|Excision|excision
85441|NCT02753790|Brain|brain
85442|NCT02753790|Metastasis|metastasis
85443|NCT02753790|IMRT|imrt
85444|NCT02753790|Radiation|radiation
85445|NCT02753790|Cancer|cancer
85446|NCT02753790|Hippocampus|hippocampus
85447|NCT02753790|Intensity modulated radiotherapy|intensity modulated radiotherapy
85448|NCT02753790|Quality of life|quality of life
85449|NCT02753790|QOL|qol
85450|NCT02753712|Small airway disease|small airway disease
85451|NCT02753712|asthma|asthma
85452|NCT02753699|Chronic hepatitis C|chronic hepatitis c
85453|NCT02753686|HR+ HER2|hr+ her2
85454|NCT02753686|postmenopausal|postmenopausal
85455|NCT02753686|advanced breast cancer|advanced breast cancer
85456|NCT02753686|non steroidal aromatase inhibitor (NSAI) exposure|non steroidal aromatase inhibitor (nsai) exposure
85457|NCT02753686|metastatic|metastatic
85458|NCT02753686|endocrine therapy|endocrine therapy
85459|NCT02753686|targeted therapy|targeted therapy
85460|NCT02753686|prospective|prospective
85461|NCT02753686|observational|observational
85462|NCT02753686|registry|registry
85463|NCT02753686|real world setting|real world setting
85464|NCT02753686|non-interventional|non-interventional
85465|NCT02753686|Canadian|canadian
85466|NCT02753673|Breast Conserving Therapy|breast conserving therapy
85467|NCT02753673|Reported Outcomes Instrument|reported outcomes instrument
85468|NCT02753673|16-325|16-325
85469|NCT02753660|spinal, anesthesia, pendant, spinal-bone contact, puncture|spinal, anesthesia, pendant, spinal-bone contact, puncture
85470|NCT02753608|exhaled breath condensate|exhaled breath condensate
85471|NCT02753608|volatile organic compounds|volatile organic compounds
85472|NCT02753595|PEGylated Recombinant Human Hyaluronidase|pegylated recombinant human hyaluronidase
85473|NCT02753595|Eribulin Mesylate|eribulin mesylate
85474|NCT02753595|E7389|e7389
85475|NCT02753595|PEGPH20|pegph20
200985|NCT02112695|undernutrition|undernutrition
85476|NCT02753595|Human Epidermal Growth Factor Receptor 2-Negative|human epidermal growth factor receptor 2-negative
85478|NCT02753582|Elderly, pre-frail, SOD|elderly, pre-frail, sod
85479|NCT02753569|Magnetic Resonance Imaging|magnetic resonance imaging
85480|NCT02753569|PET/CT|pet/ct
85481|NCT02753569|non-small cell lung cancer|non-small cell lung cancer
85482|NCT02753556|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
85483|NCT02753556|COPD|copd
85484|NCT02753556|ScreenFlow|screenflow
85485|NCT02753556|Screening|screening
85486|NCT02753556|Lung Disease|lung disease
85487|NCT02753556|Mobile Health|mobile health
85488|NCT02753556|Peak Flow Meter|peak flow meter
85489|NCT02753556|Usability|usability
85490|NCT02753517|hepatobiliary scintigraphy|hepatobiliary scintigraphy
85491|NCT02753517|extended hepatectomy|extended hepatectomy
85492|NCT02753517|volumetry|volumetry
85493|NCT02753504|Dyslipidemia|dyslipidemia
85494|NCT02753491|short interview, diabetes, lifestyle changes, primary care|short interview, diabetes, lifestyle changes, primary care
85495|NCT02753478|hypothermia|hypothermia
85496|NCT02753465|Rectal Neoplasms|rectal neoplasms
85497|NCT02753465|anastomosis|anastomosis
85498|NCT02753465|OS|os
85499|NCT02753465|DFS|dfs
85500|NCT02753465|LCA|lca
85501|NCT02753465|laparoscopic surgery|laparoscopic surgery
85502|NCT02753452|youth|youth
85503|NCT02753452|disability|disability
85504|NCT02753452|transition|transition
85505|NCT02753452|life skills|life skills
85506|NCT02753452|adolescence|adolescence
85507|NCT02753413|Vaccine|vaccine
85508|NCT02753413|Safety|safety
85509|NCT02753413|Reactogenicity|reactogenicity
85510|NCT02753413|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
85511|NCT02753387|mouthwash|mouthwash
85512|NCT02753387|head and neck cancer|head and neck cancer
85513|NCT02753387|chlorhexidine|chlorhexidine
85514|NCT02753387|pathogens germs|pathogens germs
85515|NCT02753374|cystic fibrosis, Chinese, children|cystic fibrosis, chinese, children
85516|NCT02753361|Ultrasound|ultrasound
85517|NCT02753361|regional blockade|regional blockade
85518|NCT02753361|lipoma|lipoma
85519|NCT02753335|CRPS, graded motor imagery, desensitization, fMRI, DMN|crps, graded motor imagery, desensitization, fmri, dmn
85520|NCT02753322|Dual task training|dual task training
85521|NCT02753322|Dual task interference|dual task interference
85522|NCT02753322|Sub-acute stroke|sub-acute stroke
85523|NCT02753322|Physiotherapy training|physiotherapy training
86456|NCT02747316|Hepcidin|hepcidin
85524|NCT02753322|Community ambulation|community ambulation
85525|NCT02753322|Balance|balance
85526|NCT02753309|BCG|bcg
100707|NCT02659631|CRC|crc
85527|NCT02753309|Rapamycin|rapamycin
85528|NCT02753296|Cancer|cancer
85529|NCT02753296|Fertility Preservation|fertility preservation
85530|NCT02753296|Patient Decision Aid|patient decision aid
85531|NCT02753283|Bone loss|bone loss
85532|NCT02753283|Frail Geriatric Patients|frail geriatric patients
85533|NCT02753283|Nursing Home Patients|nursing home patients
85534|NCT02753283|Long-term Care Patients|long-term care patients
85535|NCT02753283|Osteoporosis|osteoporosis
85536|NCT02753283|Osteoporotic Fractures|osteoporotic fractures
85537|NCT02753257|stroke|stroke
85538|NCT02753257|stroke mimic|stroke mimic
85539|NCT02753244|Cognitive VideoGames|cognitive videogames
85540|NCT02753179|Bilateral vestibular hypofunction|bilateral vestibular hypofunction
85541|NCT02753179|Video Head Impulse Test|video head impulse test
85542|NCT02753179|Covert-saccades|covert-saccades
85543|NCT02753179|Quality of life|quality of life
85544|NCT02753179|Dynamic visual acuity|dynamic visual acuity
85545|NCT02753166|PTSD (Post Traumatic Stress Disorder)|ptsd (post traumatic stress disorder)
85546|NCT02753166|Emergency Department|emergency department
85547|NCT02753127|Colorectal Neoplasms|colorectal neoplasms
85548|NCT02753127|Colonic Diseases|colonic diseases
85549|NCT02753127|Digestive System Diseases|digestive system diseases
85550|NCT02753127|Digestive System Neoplasms|digestive system neoplasms
85551|NCT02753127|Gastrointestinal Diseases|gastrointestinal diseases
85552|NCT02753127|Gastrointestinal Neoplasms|gastrointestinal neoplasms
85553|NCT02753127|Intestinal Diseases|intestinal diseases
85554|NCT02753127|Intestinal Neoplasms|intestinal neoplasms
85555|NCT02753127|Neoplasms|neoplasms
85556|NCT02753127|Neoplasms by Histologic Type|neoplasms by histologic type
85557|NCT02753127|Neoplasms by Site|neoplasms by site
85558|NCT02753127|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
85559|NCT02753127|Rectal Diseases|rectal diseases
85560|NCT02753114|Ketamine|ketamine
85561|NCT02753114|Intranasal|intranasal
85562|NCT02753114|Emergency Medical Services|emergency medical services
85563|NCT02753114|Pain|pain
85564|NCT02753114|Analgesia|analgesia
85565|NCT02753101|Positron Emission Tomography|positron emission tomography
85566|NCT02753101|Magnetic Resonance Imaging|magnetic resonance imaging
85567|NCT02753101|PET/MRI|pet/mri
85568|NCT02753101|sigma-1 receptor|sigma-1 receptor
85569|NCT02753101|radiopharmaceutical|radiopharmaceutical
85570|NCT02753101|complex regional pain syndrome|complex regional pain syndrome
85571|NCT02753101|sciatica|sciatica
85572|NCT02753101|chronic pain|chronic pain
85573|NCT02753088|Equivalence|equivalence
85574|NCT02753088|BCD-063|bcd-063
85575|NCT02753088|Copaxone-Teva|copaxone-teva
85576|NCT02753049|HIV|hiv
85577|NCT02753049|AIDS|aids
85578|NCT02753049|Adolescent|adolescent
85579|NCT02753049|Adherence|adherence
85580|NCT02753049|Retention|retention
85581|NCT02753049|mHealth|mhealth
85582|NCT02753036|cognition|cognition
85583|NCT02753036|chemotherapy|chemotherapy
85584|NCT02753036|polyneuropathy|polyneuropathy
85585|NCT02753036|paclitaxel|paclitaxel
85586|NCT02753036|cancer|cancer
85587|NCT02753036|chemobrain|chemobrain
85588|NCT02752984|Peripherally inserted central venous catheter|peripherally inserted central venous catheter
85589|NCT02752932|Head and neck cancer|head and neck cancer
85590|NCT02752932|Patient derived Xenograft|patient derived xenograft
85591|NCT02752932|Chemotherapy|chemotherapy
85592|NCT02752932|Metastases|metastases
85593|NCT02752906|Meningitis|meningitis
85594|NCT02752906|Meningococcal Meningitis|meningococcal meningitis
85595|NCT02752906|Meningococcal Infections|meningococcal infections
85596|NCT02752906|MenACYW conjugate vaccine|menacyw conjugate vaccine
85597|NCT02752906|Licensed Meningococcal Conjugate Vaccine (MCV4)|licensed meningococcal conjugate vaccine (mcv4)
85598|NCT02752893|estrogen|estrogen
85599|NCT02752893|estrogen receptor|estrogen receptor
85600|NCT02752893|ER+|er+
85601|NCT02752893|HER2|her2
85602|NCT02752893|HER2-|her2-
85603|NCT02752893|HER2-negative|her2-negative
85604|NCT02752893|xenograft|xenograft
85605|NCT02752893|co-clinical|co-clinical
85606|NCT02752893|mice|mice
85607|NCT02752893|patient-derived xenograft|patient-derived xenograft
85608|NCT02752893|patient-derived|patient-derived
85609|NCT02752893|breast cancer|breast cancer
85610|NCT02752893|precision medicine|precision medicine
85611|NCT02752893|personalized medicine|personalized medicine
85612|NCT02752867|traditional Chinese medicine granules|traditional chinese medicine granules
85613|NCT02752867|Cognitive Impairment|cognitive impairment
85614|NCT02752867|Acute cerebral infraction|acute cerebral infraction
85615|NCT02752867|treatment|treatment
85616|NCT02752854|pain scores|pain scores
85617|NCT02752854|pressure algometer|pressure algometer
85618|NCT02752854|healthy volunteer adults|healthy volunteer adults
85619|NCT02752802|Contrast Media|contrast media
85620|NCT02752802|Angiography|angiography
85621|NCT02752789|alloantibodies|alloantibodies
86660|NCT02745795|overweight|overweight
85622|NCT02752789|donor specific antibodies (DSA)-preformed, de novo|donor specific antibodies (dsa)-preformed, de novo
85623|NCT02752789|self-antigens|self-antigens
85624|NCT02752789|chronic allograft function|chronic allograft function
85625|NCT02752776|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
85626|NCT02752763|Dry eye|dry eye
85627|NCT02752763|isotretinoin, AS|isotretinoin, as
85628|NCT02752763|Autologous serum|autologous serum
85629|NCT02752724|major depressive disorder|major depressive disorder
85630|NCT02752724|electroconvulsive therapy|electroconvulsive therapy
85631|NCT02752724|metabolomics|metabolomics
85632|NCT02752724|treatment resistant depression|treatment resistant depression
85633|NCT02752724|anesthesiology|anesthesiology
85634|NCT02752724|ketamine|ketamine
85635|NCT02752724|prospective randomized clinical trial|prospective randomized clinical trial
85636|NCT02752711|Minor head trauma|minor head trauma
85637|NCT02752711|Children|children
85638|NCT02752711|Clinical decision rule|clinical decision rule
85639|NCT02752685|Nab-Paclitaxel|nab-paclitaxel
85640|NCT02752685|Abraxane|abraxane
85641|NCT02752685|MK-3475|mk-3475
85642|NCT02752672|dithranol|dithranol
85643|NCT02752672|therapeutic mechanisms|therapeutic mechanisms
85644|NCT02752659|Monitoring|monitoring
85645|NCT02752646|cataract|cataract
85646|NCT02752633|Xanthine dehydrogenase inhibitor treatment, pharmacotherapy|xanthine dehydrogenase inhibitor treatment, pharmacotherapy
85647|NCT02752620|osteopathic manipulative treatment|osteopathic manipulative treatment
85648|NCT02752620|Chronic nonspecific low back pain|chronic nonspecific low back pain
85649|NCT02752620|low back pain|low back pain
85650|NCT02752594|probiotic|probiotic
85651|NCT02752594|mutans streptococci|mutans streptococci
85652|NCT02752594|bacillus coagulans|bacillus coagulans
85653|NCT02752594|caries|caries
85654|NCT02752581|suction drain|suction drain
85655|NCT02752581|knee arthroscopy|knee arthroscopy
85656|NCT02752581|knee pain|knee pain
85657|NCT02752555|Oligoasthenoteratozoospermia|oligoasthenoteratozoospermia
85658|NCT02752555|Male factor managment|male factor managment
85659|NCT02752555|Intacytoplasmic sperm injection|intacytoplasmic sperm injection
85660|NCT02752529|Liver Transplantation|liver transplantation
85661|NCT02752529|Individualized Therapy|individualized therapy
85662|NCT02752529|Polymorphism|polymorphism
85663|NCT02752477|Opioid-sparing|opioid-sparing
85664|NCT02752464|Weight Loss|weight loss
85665|NCT02752464|Health Status Disparities|health status disparities
85666|NCT02752438|high frequency oscillatory ventilation|high frequency oscillatory ventilation
85667|NCT02752438|rescue|rescue
85668|NCT02752438|newborn|newborn
85669|NCT02752425|Speech disorders|speech disorders
85670|NCT02752425|Speech therapy|speech therapy
85671|NCT02752425|Visual feedback|visual feedback
85672|NCT02752425|Buccopharyngeal surgery|buccopharyngeal surgery
85673|NCT02752425|Central nervous system damage|central nervous system damage
85674|NCT02752373|GTC Seizures|gtc seizures
85675|NCT02752360|intestinal reconstruction|intestinal reconstruction
85676|NCT02752360|end to end anastomosis|end to end anastomosis
85677|NCT02752321|patient discharge|patient discharge
85678|NCT02752321|patient engagement|patient engagement
85679|NCT02752321|patient satisfaction|patient satisfaction
85680|NCT02752321|continuity of patient care|continuity of patient care
85681|NCT02752321|hospital discharge|hospital discharge
85682|NCT02752321|health technology|health technology
85683|NCT02752321|eDischarge|edischarge
85684|NCT02752321|multimedia|multimedia
85685|NCT02752321|mobile applications|mobile applications
85686|NCT02752321|software applications|software applications
85687|NCT02752321|portable electronic applications|portable electronic applications
85688|NCT02752282|Family Planning|family planning
85689|NCT02752282|LNG-IUS|lng-ius
85690|NCT02752282|Health Education|health education
85691|NCT02752256|tissue plasminogen activator|tissue plasminogen activator
85692|NCT02752243|acute leukemia|acute leukemia
85693|NCT02752243|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
85694|NCT02752243|Stem Cell Transplantation|stem cell transplantation
85695|NCT02752230|Post operative pain|post operative pain
85696|NCT02752230|Bariatric Surgery|bariatric surgery
85697|NCT02752204|Relapsed|relapsed
85698|NCT02752204|Refractory|refractory
85699|NCT02752204|Lymphoma|lymphoma
85700|NCT02752191|ferumoxytol|ferumoxytol
85701|NCT02752178|Depression|depression
85702|NCT02752178|Major depressive disorder|major depressive disorder
85703|NCT02752178|MDD|mdd
85704|NCT02752152|Counseling|counseling
85705|NCT02752139|Sleep Disorders|sleep disorders
85706|NCT02752139|Cerebral Hemodynamics|cerebral hemodynamics
85707|NCT02752139|Dynamic Cerebral Auto-Regulation|dynamic cerebral auto-regulation
85708|NCT02752139|Stroke|stroke
85811|NCT02751502|Arm|arm
85709|NCT02752126|Esophageal sparing|esophageal sparing
85710|NCT02752126|Conventional radiotherapy|conventional radiotherapy
85711|NCT02752126|Palliative radiation|palliative radiation
85712|NCT02752126|Central lung tumors|central lung tumors
85713|NCT02752113|diabetes mellitus type 2|diabetes mellitus type 2
77061|NCT02802501|ACT|act
85714|NCT02752113|Metformin|metformin
86762|NCT02745158|Joint|joint
85715|NCT02752113|Micro- and macrocirculation|micro- and macrocirculation
85716|NCT02752113|HbA1c >= 7%|hba1c >= 7%
85717|NCT02752100|Lower Extremity Arterial Occlusive Disease|lower extremity arterial occlusive disease
85718|NCT02752100|Interventional Therapy|interventional therapy
85719|NCT02752074|Melanoma|melanoma
85720|NCT02752074|Metastatic Melanoma|metastatic melanoma
85721|NCT02752035|AML|aml
85722|NCT02752035|ASP2215|asp2215
85723|NCT02752035|Newly Diagnosed AML|newly diagnosed aml
85724|NCT02752035|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
85725|NCT02752035|FLT3|flt3
85726|NCT02752022|e-cigarettes|e-cigarettes
85727|NCT02752022|nitrosamines|nitrosamines
85728|NCT02752022|smoking cessation|smoking cessation
85729|NCT02752009|Breast Cancer|breast cancer
85730|NCT02752009|Armpit lymph nodes Cancer|armpit lymph nodes cancer
85731|NCT02751996|Chronic Hepatitis|chronic hepatitis
85732|NCT02751996|HBV|hbv
85733|NCT02751996|Double blind|double blind
85734|NCT02751983|Suicide|suicide
85735|NCT02751983|Psychiatric Rehabilitation|psychiatric rehabilitation
85736|NCT02751983|Acceptance and Commitment Therapy|acceptance and commitment therapy
85737|NCT02751983|Brief Psychotherapy|brief psychotherapy
85738|NCT02751983|Inpatients|inpatients
85739|NCT02751970|Dental adhesive|dental adhesive
85740|NCT02751970|adhesive systems|adhesive systems
85741|NCT02751970|Dental Restoration Failure|dental restoration failure
85742|NCT02751944|exercise-induced|exercise-induced
85743|NCT02751944|joint pain|joint pain
85744|NCT02751944|joint stiffness|joint stiffness
85745|NCT02751944|post-menopausal|post-menopausal
85746|NCT02751944|women|women
85747|NCT02751944|cartilage turnover|cartilage turnover
85748|NCT02751944|CTX-II|ctx-ii
85749|NCT02751931|Pediatrics|pediatrics
85750|NCT02751931|Urodynamics|urodynamics
85751|NCT02751931|Mirabegron|mirabegron
85752|NCT02751931|Phase 3|phase 3
85753|NCT02751931|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
85754|NCT02751918|Mesothelin-expressing platinum-resistant cancer|mesothelin-expressing platinum-resistant cancer
85755|NCT02751814|Childcare Center Regulations|childcare center regulations
85756|NCT02751814|Physical Activity|physical activity
85757|NCT02751814|Sedentary Behavior|sedentary behavior
85758|NCT02751814|Screen-time Behavior|screen-time behavior
85759|NCT02751788|childcare center regulations|childcare center regulations
85760|NCT02751788|physical activity|physical activity
85761|NCT02751788|sedentary behavior|sedentary behavior
85762|NCT02751788|screen-time behavior|screen-time behavior
85763|NCT02751775|Childcare center regulations|childcare center regulations
85764|NCT02751775|Physical Activity|physical activity
85765|NCT02751775|Sedentary Behavior|sedentary behavior
85766|NCT02751775|Screen-Time Behavior|screen-time behavior
85767|NCT02751775|Focus groups|focus groups
85768|NCT02751723|cancer disease|cancer disease
85769|NCT02751723|palliative care|palliative care
85770|NCT02751723|palliative therapy|palliative therapy
85771|NCT02751723|cancer|cancer
85772|NCT02751723|patient´s needs|patient´s needs
85773|NCT02751723|patient care|patient care
85774|NCT02751723|disease burden|disease burden
85775|NCT02751684|Rapid Sequence Induction|rapid sequence induction
85776|NCT02751684|European|european
85777|NCT02751684|Evaluation|evaluation
85778|NCT02751684|EUROpE RSI|europe rsi
85779|NCT02751684|Standards|standards
85780|NCT02751684|RSI|rsi
85781|NCT02751645|Pediatric|pediatric
85782|NCT02751645|Cardiac|cardiac
85783|NCT02751645|Surgery|surgery
85784|NCT02751632|Ultra High Risk of Psychosis|ultra high risk of psychosis
85785|NCT02751632|Prodrome|prodrome
85786|NCT02751619|Pre-emptive analgesia|pre-emptive analgesia
85787|NCT02751619|Post-thoracotomy pain|post-thoracotomy pain
85788|NCT02751619|Lidocaine patch|lidocaine patch
85789|NCT02751606|Ferumoxtran|ferumoxtran
85790|NCT02751606|MRI Scans|mri scans
85791|NCT02751593|pregnancy|pregnancy
85792|NCT02751593|Immune Thrombocytopenia|immune thrombocytopenia
85793|NCT02751593|dexamethasone|dexamethasone
85794|NCT02751554|124I-PU-AD|124i-pu-ad
85795|NCT02751554|PET Imaging|pet imaging
85796|NCT02751554|16-004|16-004
85797|NCT02751528|Breast Cancer|breast cancer
85798|NCT02751528|Breast Cancer male|breast cancer male
85799|NCT02751528|Breast Neoplasms|breast neoplasms
85800|NCT02751528|Breast Neoplasms male|breast neoplasms male
85801|NCT02751528|Vaccine|vaccine
85802|NCT02751528|HER2|her2
85803|NCT02751528|Metastatic|metastatic
85804|NCT02751528|Locally Advanced|locally advanced
85805|NCT02751528|Unresectable|unresectable
85806|NCT02751528|Solid Tumor|solid tumor
85807|NCT02751528|Phase 1|phase 1
85808|NCT02751528|Cancer Vaccine|cancer vaccine
85809|NCT02751502|Children|children
85810|NCT02751502|Pediatrics|pediatrics
85812|NCT02751502|Upper limb|upper limb
85813|NCT02751502|bimanual training|bimanual training
85814|NCT02751502|physical training|physical training
85815|NCT02751437|preterm|preterm
85816|NCT02751437|arginine|arginine
85817|NCT02751437|immune function|immune function
85818|NCT02751437|nutrition|nutrition
85819|NCT02751424|Multidrug-resistant|multidrug-resistant
85820|NCT02751424|Gram negative bacterial infection|gram negative bacterial infection
85821|NCT02751424|Safety|safety
85822|NCT02751424|Pharmacokinetic|pharmacokinetic
85823|NCT02751333|Esophageal stricture|esophageal stricture
85824|NCT02751333|Esophageal leak|esophageal leak
85825|NCT02751333|Esophageal perforation|esophageal perforation
85826|NCT02751333|Esophageal fistula|esophageal fistula
85827|NCT02751333|Endostitch|endostitch
85828|NCT02751333|Esophageal stent|esophageal stent
85841|NCT02751268|infratrochlear nerve block|infratrochlear nerve block
85842|NCT02751268|septorhinoplasty|septorhinoplasty
85843|NCT02751268|general anesthesia|general anesthesia
85844|NCT02751268|postoperative analgesia|postoperative analgesia
85845|NCT02751242|Diuretic Resistance|diuretic resistance
85846|NCT02751242|Emergency Medicine|emergency medicine
85847|NCT02751229|Mental illness|mental illness
85848|NCT02751229|adolescents|adolescents
85849|NCT02751229|intervention|intervention
85850|NCT02751229|stigma|stigma
85851|NCT02751229|disclosure|disclosure
85852|NCT02751229|secrecy|secrecy
85853|NCT02751216|high frequency / high density spinal cord stimulation|high frequency / high density spinal cord stimulation
85854|NCT02751216|EEG|eeg
85855|NCT02751216|conditioned pain modulation|conditioned pain modulation
85856|NCT02751177|KRAS gene mutation|kras gene mutation
85857|NCT02751177|NRAS gene mutation|nras gene mutation
85858|NCT02751177|BRAF gene mutation|braf gene mutation
85859|NCT02751138|Immune phenotype|immune phenotype
85860|NCT02751138|Cytokines|cytokines
85861|NCT02751138|Genetic aberration|genetic aberration
85862|NCT02751138|Overall survival|overall survival
85863|NCT02751138|Progression free survival|progression free survival
85864|NCT02751125|Mesenchymal stem cells|mesenchymal stem cells
85865|NCT02751125|bone augmentation|bone augmentation
85866|NCT02751125|bone regeneration|bone regeneration
85867|NCT02751086|minimally invasive surgery|minimally invasive surgery
85868|NCT02751086|gastrectomy|gastrectomy
85869|NCT02751086|robotic surgery|robotic surgery
85870|NCT02751086|laparoscopic surgery|laparoscopic surgery
85871|NCT02751086|laparoscopy|laparoscopy
85872|NCT02751086|robot-assisted|robot-assisted
85873|NCT02751086|robotic|robotic
85874|NCT02751086|robotic gastrectomy|robotic gastrectomy
85875|NCT02751086|laparoscopic gastrectomy|laparoscopic gastrectomy
85876|NCT02751086|minimally invasive gastrectomy|minimally invasive gastrectomy
85877|NCT02751073|Microbiota|microbiota
85878|NCT02751073|Proteome|proteome
85879|NCT02751034|Wrinkle Severity Rating Scale|wrinkle severity rating scale
85880|NCT02751034|Global Aesthetic Improvement Scale|global aesthetic improvement scale
85881|NCT02751034|Hyaluronic acid filler|hyaluronic acid filler
85882|NCT02751034|filler|filler
85883|NCT02751034|Nasolabial Fold|nasolabial fold
85897|NCT02750969|tinnitus|tinnitus
85898|NCT02750969|lidocain patch|lidocain patch
85899|NCT02750956|endocan protein|endocan protein
85900|NCT02750956|VEGF A|vegf a
85901|NCT02750956|TNF-alpha|tnf-alpha
85902|NCT02750956|after treatment|after treatment
85903|NCT02750930|Extension|extension
85904|NCT02750930|Long-term Safety|long-term safety
85905|NCT02750930|Pharmacodynamics|pharmacodynamics
85906|NCT02750930|Albiglutide|albiglutide
85907|NCT02750930|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
85908|NCT02750917|postoperative pain|postoperative pain
85909|NCT02750917|lornoxicam|lornoxicam
85910|NCT02750917|etoricoxib|etoricoxib
85911|NCT02750917|total knee arthroplasty|total knee arthroplasty
85912|NCT02750904|Smoking Cessation|smoking cessation
86016|NCT02750241|support group|support group
85913|NCT02750904|Acceptance & Commitment Therapy|acceptance & commitment therapy
85914|NCT02750904|Cognitive Behavioral Therapy|cognitive behavioral therapy
85915|NCT02750904|Bipolar Disorder|bipolar disorder
85916|NCT02750891|high grade glioma|high grade glioma
85918|NCT02750891|DIPG|dipg
85919|NCT02750878|Urinary Incontinence, Stress [C13.351.968.934.814.500]|urinary incontinence, stress [c13.351.968.934.814.500]
85920|NCT02750865|biomedical technology|biomedical technology
85921|NCT02750865|palliative care|palliative care
85922|NCT02750800|Patient related outcomes|patient related outcomes
85923|NCT02750800|Psoriatic arthritis|psoriatic arthritis
85924|NCT02750800|Rheumatoid arthritis|rheumatoid arthritis
85925|NCT02750800|Patient support program|patient support program
632618|NCT00712582|ifosfamide|ifosfamide
85926|NCT02750800|Ankylosing spondylitis|ankylosing spondylitis
85927|NCT02750800|Quality of life|quality of life
85928|NCT02750800|Psoriasis|psoriasis
85929|NCT02750800|Observational study|observational study
85930|NCT02750800|Ulcerative colitis|ulcerative colitis
85931|NCT02750800|Crohn's disease|crohn's disease
85932|NCT02750722|Exercise|exercise
85933|NCT02750722|Lung diffusion capacity|lung diffusion capacity
85934|NCT02750722|Sputum viscoelasticity|sputum viscoelasticity
85935|NCT02750722|Lung disease|lung disease
85936|NCT02750709|HT-1|ht-1
85937|NCT02750709|Tyrosinemia|tyrosinemia
85938|NCT02750709|Nitisinone|nitisinone
85939|NCT02750709|Bioequivalence|bioequivalence
85940|NCT02750709|Healthy Volunteer|healthy volunteer
85941|NCT02750709|Orfadin|orfadin
85942|NCT02750696|Acetaminophen|acetaminophen
85943|NCT02750696|Analgesia|analgesia
85944|NCT02750696|Codeine|codeine
85945|NCT02750696|Drug Combinations|drug combinations
85946|NCT02750696|Endodontics|endodontics
85947|NCT02750696|Periapical abscess|periapical abscess
85948|NCT02750696|Randomized Controlled Trial|randomized controlled trial
85949|NCT02750696|Tramadol|tramadol
85950|NCT02750696|Visual analog scale|visual analog scale
85951|NCT02750683|inotropic effect, norepinephrine, septic shock,|inotropic effect, norepinephrine, septic shock,
85952|NCT02750670|Lymphoma|lymphoma
85953|NCT02750670|Non-Hodgkin's|non-hodgkin's
85954|NCT02750670|CD20+|cd20+
85955|NCT02750670|Obinutuzumab|obinutuzumab
85956|NCT02750670|GDP Chemotherapy|gdp chemotherapy
85957|NCT02750670|Refractory and aggressive non-Hodgkin lymphoma|refractory and aggressive non-hodgkin lymphoma
85958|NCT02750631|depression|depression
85959|NCT02750631|melatonin|melatonin
85960|NCT02750631|light therapy|light therapy
85961|NCT02750631|Wake Therapy|wake therapy
85962|NCT02750631|chronobiology|chronobiology
85963|NCT02750592|Ankylosing Spondylitis|ankylosing spondylitis
85964|NCT02750540|Tenofovir enema|tenofovir enema
85965|NCT02750423|Cardiology|cardiology
85966|NCT02750423|Surgery|surgery
85967|NCT02750397|HIV|hiv
85968|NCT02750397|Kidney Transplant|kidney transplant
85969|NCT02750397|Liver Transplant|liver transplant
85970|NCT02750397|Transplant|transplant
85971|NCT02750371|Cavernous sinus meningioma|cavernous sinus meningioma
85972|NCT02750371|Pituitary adenoma|pituitary adenoma
85973|NCT02750371|Hippocampus|hippocampus
85974|NCT02750371|Irradiation|irradiation
85975|NCT02750371|Autobiographical memory|autobiographical memory
85976|NCT02750358|Enzalutamide|enzalutamide
85977|NCT02750358|15-307|15-307
85978|NCT02750345|HT-1|ht-1
85979|NCT02750345|Tyrosinemia|tyrosinemia
85980|NCT02750345|Nitisinone|nitisinone
85981|NCT02750345|Bioavailability|bioavailability
85982|NCT02750345|Healthy Volunteer|healthy volunteer
85983|NCT02750345|Food-Effect|food-effect
85984|NCT02750332|HT-1|ht-1
85985|NCT02750332|Tyrosinemia|tyrosinemia
85986|NCT02750332|Nitisinone|nitisinone
85987|NCT02750332|Bioavailability|bioavailability
85988|NCT02750332|Healthy Volunteer|healthy volunteer
85989|NCT02750332|Food-Effect|food-effect
85990|NCT02750319|Amiodarone|amiodarone
85991|NCT02750319|N-Acetylcysteine|n-acetylcysteine
85992|NCT02750319|16-307|16-307
85993|NCT02750293|vitamin D|vitamin d
85994|NCT02750293|blood pressure|blood pressure
85995|NCT02750293|serum lipids|serum lipids
85996|NCT02750293|glucose metabolism|glucose metabolism
85997|NCT02750293|muscle function|muscle function
85998|NCT02750293|arterial stiffness|arterial stiffness
85999|NCT02750293|depression|depression
86000|NCT02750293|psoriasis|psoriasis
86001|NCT02750293|sleep|sleep
86002|NCT02750293|bone density|bone density
86003|NCT02750267|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
86004|NCT02750267|Artificial Pancreas Project (APP)|artificial pancreas project (app)
86005|NCT02750267|Diabetes Assistant (DiAs)|diabetes assistant (dias)
86006|NCT02750267|Closed-Loop Control (CLC)|closed-loop control (clc)
86007|NCT02750267|Continuous Glucose Monitor|continuous glucose monitor
86008|NCT02750267|Pediatric|pediatric
86009|NCT02750267|Insulin Pump|insulin pump
86010|NCT02750241|active video game|active video game
86011|NCT02750241|mHealth|mhealth
86012|NCT02750241|cancer survivor|cancer survivor
86013|NCT02750241|women's health|women's health
86014|NCT02750241|breast cancer|breast cancer
86015|NCT02750241|physical activity|physical activity
86017|NCT02750241|survivorship|survivorship
86018|NCT02750215|MET exon 14 skipping|met exon 14 skipping
86019|NCT02750215|Stage IV non-small cell lung cancer NSCLC|stage iv non-small cell lung cancer nsclc
86020|NCT02750202|Genital warts|genital warts
86021|NCT02750202|HPV types|hpv types
86022|NCT02750202|HPV vaccine|hpv vaccine
86023|NCT02750202|Cervical cytology|cervical cytology
86024|NCT02750202|Therapeutic vaccine|therapeutic vaccine
86025|NCT02750202|Quadrivalent HPV vaccine|quadrivalent hpv vaccine
86026|NCT02750176|Rehabilitation|rehabilitation
86027|NCT02750176|Closed chain exercises|closed chain exercises
86028|NCT02750137|Tetracaine|tetracaine
86029|NCT02750124|participation|participation
86030|NCT02750124|self sampling|self sampling
86031|NCT02750124|Screening|screening
86032|NCT02750098|Diabetes Mellitus, Cataract, Aqueous humor|diabetes mellitus, cataract, aqueous humor
86033|NCT02750085|Hemophilia A|hemophilia a
86034|NCT02750085|pharmacokinetics|pharmacokinetics
86035|NCT02750085|myPKFiT|mypkfit
86036|NCT02750020|Telephone survey|telephone survey
86037|NCT02749955|HIV prevention|hiv prevention
86038|NCT02749955|Pre exposure prophylaxis|pre exposure prophylaxis
86039|NCT02749955|Men who have sex with men|men who have sex with men
77295|NCT02801318|Patient|patient
86040|NCT02749955|Partner services|partner services
86041|NCT02749955|Linkage to care|linkage to care
86042|NCT02749955|Seronegative|seronegative
86043|NCT02749955|Sexually transmitted diseases|sexually transmitted diseases
86045|NCT02749942|Remote Ischemic Conditioning|remote ischemic conditioning
86046|NCT02749942|Neuropathy|neuropathy
86047|NCT02749942|Angiopathy|angiopathy
86048|NCT02749929|Distal radius fracture, Low Level Laser Therapy|distal radius fracture, low level laser therapy
86050|NCT02749916|MP-RAGE|mp-rage
86051|NCT02749916|DANTE T1-SPACE|dante t1-space
86052|NCT02749877|Pediatric Cancer|pediatric cancer
86053|NCT02749877|Training|training
86054|NCT02749877|Working Memory|working memory
86055|NCT02749877|Physical Activity|physical activity
86056|NCT02749877|Brain Tumor|brain tumor
86057|NCT02749877|Physical Exercise|physical exercise
86058|NCT02749864|Hepatitis|hepatitis
86059|NCT02749864|Prevalence|prevalence
86060|NCT02749864|Epidemiology|epidemiology
86061|NCT02749864|Infectious diseases|infectious diseases
86062|NCT02749851|pregnancy|pregnancy
86063|NCT02749851|growth restriction|growth restriction
86064|NCT02749838|Cancer|cancer
86065|NCT02749838|Genomic testing|genomic testing
86066|NCT02749838|Genetic testing|genetic testing
86067|NCT02749838|Molecular screening|molecular screening
86068|NCT02749838|Molecular Profiling|molecular profiling
86069|NCT02749838|Biomarker|biomarker
86070|NCT02749838|Biopsy|biopsy
86071|NCT02749838|Tumor sampling|tumor sampling
86072|NCT02749838|Registry|registry
86073|NCT02749825|Prostate|prostate
86074|NCT02749825|Cancer|cancer
86075|NCT02749825|Trelstar|trelstar
86076|NCT02749760|Ulnar collateral ligament|ulnar collateral ligament
86077|NCT02749760|elbow injuries|elbow injuries
86078|NCT02749760|dynamic elbow stabilizers|dynamic elbow stabilizers
86079|NCT02749760|Tommy John's procedure|tommy john's procedure
86080|NCT02749760|elbow injuries in pitchers|elbow injuries in pitchers
86081|NCT02749747|Menopause|menopause
86082|NCT02749747|nonhormonal treatment|nonhormonal treatment
86083|NCT02749747|sulpiride|sulpiride
86084|NCT02749734|Human embryo stem cell derived retinal pigment epitheliums|human embryo stem cell derived retinal pigment epitheliums
86085|NCT02749734|Subretinal transplantation|subretinal transplantation
86086|NCT02749734|Wet Age related Macular degeneration|wet age related macular degeneration
86087|NCT02749734|Stargardt's macular dystrophy|stargardt's macular dystrophy
86088|NCT02749721|depression|depression
86089|NCT02749721|brain network activation|brain network activation
86090|NCT02749721|vortioxetine|vortioxetine
86091|NCT02749708|IRX5183|irx5183
86092|NCT02749708|relapsed/refractory AML|relapsed/refractory aml
86093|NCT02749708|high-risk MDS|high-risk mds
86094|NCT02749695|menopause, climacteric syndrome, insomnia, placental extract|menopause, climacteric syndrome, insomnia, placental extract
86095|NCT02749682|Nyhus classification|nyhus classification
86103|NCT02749656|Scalp psoriasis|scalp psoriasis
86104|NCT02749656|0.25% Desoximetasone cream|0.25% desoximetasone cream
86105|NCT02749591|stroke rehabilitation|stroke rehabilitation
86106|NCT02749591|spasticity|spasticity
86107|NCT02749591|Botulinum toxin type A injection|botulinum toxin type a injection
86108|NCT02749591|robot-assisted therapy|robot-assisted therapy
86109|NCT02749591|mirror therapy|mirror therapy
86110|NCT02749591|randomized controlled trial|randomized controlled trial
86111|NCT02749565|asthma|asthma
86112|NCT02749565|fibrocyte|fibrocyte
86113|NCT02749565|airway remodeling|airway remodeling
86114|NCT02749565|OSA|osa
86115|NCT02749565|hypoxia|hypoxia
86116|NCT02749539|Mastectomy|mastectomy
86117|NCT02749539|Shoulder Pain|shoulder pain
86118|NCT02749539|ROM|rom
86119|NCT02749539|Kinesio Tape|kinesio tape
86120|NCT02749526|Recombinant human endostatin，Endo|recombinant human endostatin，endo
86121|NCT02749500|Motor control|motor control
86122|NCT02749487|Critical Care|critical care
86123|NCT02749487|Neutrophils|neutrophils
86124|NCT02749487|Lymphocytes|lymphocytes
86125|NCT02749461|preterm infants|preterm infants
86126|NCT02749461|pain|pain
86127|NCT02749461|assessment|assessment
86128|NCT02749461|contextual factors|contextual factors
86129|NCT02749461|diagnostic accuracy|diagnostic accuracy
86130|NCT02749435|Digital disease management tool|digital disease management tool
86131|NCT02749435|Type 2 diabetes mellitus/ T2DM|type 2 diabetes mellitus/ t2dm
86132|NCT02749435|HbA1c|hba1c
86133|NCT02749435|Standard care|standard care
86134|NCT02749435|PRO questionnaires|pro questionnaires
86135|NCT02749435|Smart phone/ personal computer with internet access|smart phone/ personal computer with internet access
86136|NCT02749422|cognitive dysfunction|cognitive dysfunction
86137|NCT02749422|memory loss|memory loss
86138|NCT02749422|non-invasive transcranial magnetic stimulation (TMS)|non-invasive transcranial magnetic stimulation (tms)
86139|NCT02749422|rTMS|rtms
86140|NCT02749422|Magstim Rapid2|magstim rapid2
86141|NCT02749357|gait|gait
86142|NCT02749357|robotic orthosis|robotic orthosis
77399|NCT02800668|obesity|obesity
86143|NCT02749344|Frozen Embryo Transfer, Progesterone, Endometrium|frozen embryo transfer, progesterone, endometrium
86144|NCT02749318|Behavior Modification|behavior modification
86145|NCT02749318|Genetic Testing|genetic testing
86146|NCT02749318|Risk Management|risk management
86147|NCT02749318|Oral Health Care|oral health care
86148|NCT02749292|rituximab|rituximab
86149|NCT02749292|maintenance|maintenance
86151|NCT02749266|chiropractic, cognition|chiropractic, cognition
86152|NCT02749253|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
86153|NCT02749253|Sudarshan Kriya Yoga (SKY)|sudarshan kriya yoga (sky)
86154|NCT02749227|Clinically non-functioning pituitary adenomas (CNFAs)|clinically non-functioning pituitary adenomas (cnfas)
86155|NCT02749227|silent corticotroph adenomas|silent corticotroph adenomas
86156|NCT02749201|Obesity|obesity
86157|NCT02749201|sleeve gastrectomy|sleeve gastrectomy
86158|NCT02749188|Urine Specimen Collection/methods|urine specimen collection/methods
86159|NCT02749188|Infant|infant
86160|NCT02749188|Newborn|newborn
86161|NCT02749188|Feasibility Studies|feasibility studies
86162|NCT02749188|Bladder stimulation|bladder stimulation
86163|NCT02749175|cricoid pressure|cricoid pressure
86164|NCT02749149|Cardiac|cardiac
86165|NCT02749149|Surgery|surgery
86166|NCT02749149|Frailty|frailty
86167|NCT02749149|Frail|frail
86168|NCT02749149|Patients|patients
86169|NCT02749149|Recovery|recovery
86170|NCT02749149|Morbidity|morbidity
86171|NCT02749149|Outcomes|outcomes
86172|NCT02749149|Mortality|mortality
86173|NCT02749149|Heart|heart
86174|NCT02749149|Perioperative|perioperative
86175|NCT02749149|Disability|disability
86176|NCT02749149|WHODAS|whodas
86177|NCT02749136|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
86178|NCT02749136|Borderline resectable|borderline resectable
86179|NCT02749136|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
86180|NCT02749136|FOLFIRINOX|folfirinox
86181|NCT02749110|Mass screening|mass screening
86182|NCT02749110|Family medicine|family medicine
86183|NCT02749110|Human Papillomavirus DNA tests|human papillomavirus dna tests
86184|NCT02749110|Papanicolaou test|papanicolaou test
87509|NCT02740686|Inflammation|inflammation
86185|NCT02749110|Early detection of cancer/methods*|early detection of cancer/methods*
86186|NCT02749110|Specimen Handling/methods*|specimen handling/methods*
86187|NCT02749110|Patient compliance|patient compliance
86188|NCT02749110|Adult|adult
86189|NCT02749110|Female|female
86190|NCT02749110|Humans|humans
86191|NCT02749110|Randomized controlled trial|randomized controlled trial
86192|NCT02749084|chronic graft versus host disease|chronic graft versus host disease
86193|NCT02749084|T regulatory cell|t regulatory cell
86194|NCT02749058|capsulectomy|capsulectomy
86195|NCT02749058|capsulotomy|capsulotomy
86196|NCT02749019|BBN-RGD|bbn-rgd
86197|NCT02749019|GRPR|grpr
86198|NCT02749019|integrin αvβ3|integrin αvβ3
86199|NCT02749006|Bipolar-I disorder|bipolar-i disorder
86200|NCT02749006|Depression|depression
86201|NCT02749006|intermittent Theta-Burst Stimulation (rTMS)|intermittent theta-burst stimulation (rtms)
86202|NCT02749006|neuromodulatory technique|neuromodulatory technique
86203|NCT02748967|Healthy|healthy
86204|NCT02748967|ExPEC4V|expec4v
86205|NCT02748967|JNJ-63871860|jnj-63871860
86206|NCT02748967|Safety|safety
86207|NCT02748941|unstable/stable atherosclerotic plaque|unstable/stable atherosclerotic plaque
86208|NCT02748941|HITS|hits
86209|NCT02748941|GSM|gsm
86210|NCT02748941|CEUS|ceus
86211|NCT02748941|HR MRI|hr mri
86212|NCT02748941|mi-RNA|mi-rna
86213|NCT02748915|Cochlear Implant|cochlear implant
86214|NCT02748915|ECAP|ecap
86215|NCT02748915|EABR|eabr
86216|NCT02748915|perceptual levels|perceptual levels
86217|NCT02748915|hearing performances|hearing performances
86218|NCT02748902|Verruca vulgaris|verruca vulgaris
86219|NCT02748902|Common warts|common warts
86220|NCT02748902|Verruca|verruca
86221|NCT02748902|Warts|warts
86222|NCT02748902|Papilloma virus|papilloma virus
86223|NCT02748902|ingenol mebutate 0.05% gel|ingenol mebutate 0.05% gel
86224|NCT02748902|hands|hands
86225|NCT02748889|SCLC|sclc
86226|NCT02748889|Small Cell|small cell
86227|NCT02748889|Lung Cancer|lung cancer
86234|NCT02748824|Age- Related Macular Degeneration; Diabetic Retinopathy; Glaucoma; Cataract|age- related macular degeneration; diabetic retinopathy; glaucoma; cataract
86236|NCT02748811|intervention study|intervention study
86237|NCT02748811|geriatrics|geriatrics
86238|NCT02748811|chemotherapy|chemotherapy
86239|NCT02748772|Anti-angiogenesis Drugs|anti-angiogenesis drugs
86240|NCT02748772|Advanced Colorectal Cancer|advanced colorectal cancer
86241|NCT02748772|Endostar|endostar
86242|NCT02748772|Thalidomide|thalidomide
86243|NCT02748772|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
86244|NCT02748759|Continous Passive Motion|continous passive motion
86245|NCT02748759|Manual Physical Therapy|manual physical therapy
77514|NCT02799862|NSCLC|nsclc
86246|NCT02748759|Range of Motion, Articular|range of motion, articular
86247|NCT02748759|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
86248|NCT02748759|Rehabilitation|rehabilitation
86375|NCT02747875|methadone|methadone
86249|NCT02748759|Kaltenborn Manual Therapy|kaltenborn manual therapy
86250|NCT02748746|Lymphedema|lymphedema
86251|NCT02748746|Electric Impedance|electric impedance
86252|NCT02748746|Breast Cancer|breast cancer
86253|NCT02748733|Adapted APD|adapted apd
86254|NCT02748733|Dialytic Sodium Removal|dialytic sodium removal
86763|NCT02745158|Mobility|mobility
86255|NCT02748733|Ultrafiltration|ultrafiltration
86256|NCT02748733|Clearance rate|clearance rate
86257|NCT02748733|Intraperitoneal pressure|intraperitoneal pressure
86258|NCT02748720|Premature|premature
86259|NCT02748720|Respiratory Function Monitor|respiratory function monitor
86260|NCT02748694|Drug Therapy|drug therapy
86261|NCT02748681|obstructive sleep apnea|obstructive sleep apnea
86262|NCT02748681|CPAP|cpap
86263|NCT02748681|stroke|stroke
86264|NCT02748681|telemedicine|telemedicine
86265|NCT02748681|neurorehabilitation|neurorehabilitation
86266|NCT02748681|systolic blood pressure|systolic blood pressure
86267|NCT02748629|inguinal hernia|inguinal hernia
86268|NCT02748629|mesh|mesh
86269|NCT02748629|lichtenstein|lichtenstein
86270|NCT02748629|hernia repair|hernia repair
86271|NCT02748629|selfgripping mesh|selfgripping mesh
86272|NCT02748616|Colitis|colitis
86273|NCT02748616|Bile|bile
86274|NCT02748577|Migraines|migraines
86275|NCT02748577|Pain responses|pain responses
86276|NCT02748551|Gastric cancer|gastric cancer
86277|NCT02748551|locally advanced gastric cancer|locally advanced gastric cancer
86278|NCT02748551|laparoscopic surgery|laparoscopic surgery
86279|NCT02748551|laparoscopic procedure|laparoscopic procedure
86280|NCT02748551|comparison laparoscopic with open procedure|comparison laparoscopic with open procedure
86281|NCT02748551|multicenter trials|multicenter trials
86282|NCT02748486|schizophrenia|schizophrenia
86283|NCT02748486|randomized controlled trial|randomized controlled trial
86284|NCT02748486|metacognitive training|metacognitive training
86285|NCT02748486|single sessions|single sessions
86286|NCT02748473|Pilates exercises|pilates exercises
86287|NCT02748473|pelvic floor muscle contraction|pelvic floor muscle contraction
86288|NCT02748434|iPro2 Continuous Blood Glucose Recorder|ipro2 continuous blood glucose recorder
86289|NCT02748434|Subclinical|subclinical
86290|NCT02748421|retina surgery|retina surgery
86291|NCT02748421|image guided surgery|image guided surgery
86292|NCT02748421|optical coherence tomography assisted|optical coherence tomography assisted
86300|NCT02748356|Spina Bifida|spina bifida
86301|NCT02748356|Spinal Cord Injury|spinal cord injury
86302|NCT02748317|Spina Bifida|spina bifida
86303|NCT02748317|Spinal Cord Injury|spinal cord injury
86304|NCT02748317|Lower Urinary Tract Symptoms|lower urinary tract symptoms
86305|NCT02748317|Probiotics|probiotics
86306|NCT02748317|Intermittent Catheterization|intermittent catheterization
86307|NCT02748291|Sedentary|sedentary
86308|NCT02748291|Knee osteoarthritis|knee osteoarthritis
86309|NCT02748291|Knee pain|knee pain
86310|NCT02748291|Gonarthritis|gonarthritis
86311|NCT02748291|Arthritis|arthritis
86313|NCT02748291|Pedometer|pedometer
86314|NCT02748291|Physical Activity|physical activity
86315|NCT02748291|Activities of Daily Function|activities of daily function
86316|NCT02748291|Department of Health Physical Activity Guidelines|department of health physical activity guidelines
86317|NCT02748291|Improve pain|improve pain
86318|NCT02748291|Decrease pain|decrease pain
86319|NCT02748291|Improve function|improve function
86320|NCT02748291|Increase function|increase function
86321|NCT02748291|Activity Monitoring|activity monitoring
632619|NCT00712582|etoposide|etoposide
86322|NCT02748291|Monitoring, Ambulatory/instrumentation|monitoring, ambulatory/instrumentation
86323|NCT02748278|subfertility|subfertility
86324|NCT02748278|In-vitro fertilization|in-vitro fertilization
86325|NCT02748239|diabetes self-management education|diabetes self-management education
86326|NCT02748239|insulin therapy|insulin therapy
86327|NCT02748174|Migraine|migraine
86328|NCT02748174|Curelator|curelator
86329|NCT02748161|Hepatocellular carcinoma|hepatocellular carcinoma
86330|NCT02748161|DEB-TACE|deb-tace
86331|NCT02748161|QED|qed
86332|NCT02748148|Medication Therapy Management|medication therapy management
86333|NCT02748148|Pharmacogenomics|pharmacogenomics
86334|NCT02748122|Adolescents|adolescents
86335|NCT02748122|Insulin|insulin
86336|NCT02748122|T2DM|t2dm
86337|NCT02748109|Physical Therapy|physical therapy
86338|NCT02748109|Balance Disorder|balance disorder
86339|NCT02748109|Concussion|concussion
86340|NCT02748109|Mild Traumatic Brain Injury|mild traumatic brain injury
86341|NCT02748096|Unicompartmental Knee Replacement|unicompartmental knee replacement
86342|NCT02748096|Patient Specific Instrumentation|patient specific instrumentation
86343|NCT02748083|tDCS|tdcs
86344|NCT02748083|schizophrenia|schizophrenia
86345|NCT02748083|cognition|cognition
86346|NCT02748083|fMRI|fmri
86347|NCT02748031|Congenital cataracts|congenital cataracts
86348|NCT02748031|Opacity location|opacity location
86349|NCT02748031|Opacity shape|opacity shape
86350|NCT02748031|Classification|classification
86351|NCT02748031|Clinical applicability|clinical applicability
86352|NCT02748005|Fenugreek seed extract|fenugreek seed extract
86353|NCT02748005|testosterone|testosterone
86354|NCT02748005|protodioscin|protodioscin
86355|NCT02748005|hypogonadism|hypogonadism
86356|NCT02747979|hemodialysis|hemodialysis
86357|NCT02747979|hyperparathyroidism|hyperparathyroidism
86358|NCT02747979|refractory pruritus|refractory pruritus
86359|NCT02747979|ostalgia|ostalgia
86361|NCT02747979|CVD incidence|cvd incidence
86362|NCT02747979|life quality|life quality
86363|NCT02747966|access flow|access flow
86364|NCT02747966|access recirculation|access recirculation
86365|NCT02747966|cardiac output|cardiac output
86366|NCT02747966|cardiac index|cardiac index
86367|NCT02747966|hemodialysis|hemodialysis
86368|NCT02747927|Drug therapy|drug therapy
86369|NCT02747901|KINESIOTAPING|kinesiotaping
86370|NCT02747901|COLD THERAPY|cold therapy
86371|NCT02747901|FUNCTIONAL PERFORMANCE|functional performance
86372|NCT02747888|Thyroid|thyroid
86373|NCT02747875|pediatric|pediatric
86374|NCT02747875|cardiac bypass surgery|cardiac bypass surgery
86376|NCT02747875|fentanyl|fentanyl
86377|NCT02747875|morphine|morphine
86378|NCT02747862|Attenuated Familial Adenomatous Polyposis|attenuated familial adenomatous polyposis
86379|NCT02747862|AFAP|afap
86380|NCT02747862|Deleterious Familial Adenomatous Polyposis|deleterious familial adenomatous polyposis
86381|NCT02747862|FAP|fap
86382|NCT02747862|Chart review|chart review
86383|NCT02747797|Advanced Cancer|advanced cancer
86384|NCT02747797|Lucitanib (E3810)|lucitanib (e3810)
86385|NCT02747797|Fibroblast Growth Factor Receptor|fibroblast growth factor receptor
86386|NCT02747797|FGFR|fgfr
86387|NCT02747797|Vascular Endothelial Growth Factor Receptor|vascular endothelial growth factor receptor
86388|NCT02747797|VEGFR|vegfr
86389|NCT02747797|Platelet Derived Growth Factor Receptor|platelet derived growth factor receptor
86390|NCT02747797|PDGFR|pdgfr
86391|NCT02747797|metastatic malignancy|metastatic malignancy
86392|NCT02747784|cognitive dysfunction|cognitive dysfunction
86393|NCT02747784|cognitive training|cognitive training
86394|NCT02747771|effectiveness|effectiveness
86395|NCT02747771|trichotillomania|trichotillomania
86397|NCT02747771|habit reversal training|habit reversal training
86398|NCT02747771|acceptance and commitment therapy|acceptance and commitment therapy
86399|NCT02747771|cognitive behavioral therapy|cognitive behavioral therapy
86400|NCT02747758|neuropathic pain|neuropathic pain
86401|NCT02747758|neuralgia|neuralgia
86402|NCT02747758|tDCS|tdcs
86403|NCT02747758|transcranial direct current stimulation|transcranial direct current stimulation
86404|NCT02747745|Caregivers|caregivers
86405|NCT02747745|Case Management|case management
86406|NCT02747745|Community Dwelling|community dwelling
86407|NCT02747706|peer mentor|peer mentor
86408|NCT02747706|health coach|health coach
86409|NCT02747706|parent support|parent support
86410|NCT02747706|parent mentor|parent mentor
86411|NCT02747680|type 1 diabetes|type 1 diabetes
86412|NCT02747680|hypoglycemia unawareness|hypoglycemia unawareness
86413|NCT02747680|healthy control|healthy control
86414|NCT02747667|iol dislocation|iol dislocation
86415|NCT02747667|iol complication|iol complication
86416|NCT02747667|intraocular lens|intraocular lens
86417|NCT02747667|Implant or Graft|implant or graft
86419|NCT02747654|NAT2 genotype guided dosing|nat2 genotype guided dosing
86420|NCT02747628|Transdermal nicotine|transdermal nicotine
86421|NCT02747628|Transdermal melatonin|transdermal melatonin
86422|NCT02747628|Postoperative pain|postoperative pain
86423|NCT02747628|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
86424|NCT02747615|Preoperative autologous blood donation, allogeneic blood transfusion, parenteral iron, tranexamic acid, revision total hip arthroplasty, hemoglobin, hematocrit|preoperative autologous blood donation, allogeneic blood transfusion, parenteral iron, tranexamic acid, revision total hip arthroplasty, hemoglobin, hematocrit
86425|NCT02747602|Healthy volunteers|healthy volunteers
86426|NCT02747602|Caprylic triglyceride oil|caprylic triglyceride oil
86427|NCT02747602|AC-1204|ac-1204
86428|NCT02747602|Pharmacokinetic|pharmacokinetic
86429|NCT02747602|Ketone body|ketone body
86430|NCT02747576|Childhood Cancer Survivor|childhood cancer survivor
86431|NCT02747576|Social-cognition|social-cognition
86432|NCT02747576|Healthy Volunteers|healthy volunteers
86433|NCT02747563|prostate cancer|prostate cancer
86434|NCT02747563|PSA|psa
86435|NCT02747563|digital rectal examination|digital rectal examination
86436|NCT02747472|GIP|gip
86437|NCT02747472|GIP receptor antagonist|gip receptor antagonist
86438|NCT02747446|fructose, triglyceride, oral glucose tolerance|fructose, triglyceride, oral glucose tolerance
86439|NCT02747433|robot-assisted therapy|robot-assisted therapy
86440|NCT02747433|task-oriented training|task-oriented training
86441|NCT02747433|motor learning|motor learning
86442|NCT02747420|Posterior Tibial Nerve Stimulation, Bladder|posterior tibial nerve stimulation, bladder
86443|NCT02747368|Wet age-related macular degeneration|wet age-related macular degeneration
86444|NCT02747368|Age-related macular degeneration|age-related macular degeneration
86445|NCT02747368|Ocusweep|ocusweep
86446|NCT02747368|Driving health|driving health
86447|NCT02747368|Visual field|visual field
86448|NCT02747368|Contrast sensitivity|contrast sensitivity
86449|NCT02747342|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
86450|NCT02747342|Monotherapy|monotherapy
86451|NCT02747329|BuMA Supreme|buma supreme
86452|NCT02747329|Xience V/Prime|xience v/prime
86453|NCT02747329|OCT|oct
86454|NCT02747329|neointima formation|neointima formation
86455|NCT02747316|Iron bioavailability|iron bioavailability
86457|NCT02747316|Iron absorption|iron absorption
86458|NCT02747303|brain metastases|brain metastases
86459|NCT02747303|Stereotactic Radiosurgery|stereotactic radiosurgery
86460|NCT02747290|BBN-RGD|bbn-rgd
86461|NCT02747290|PET|pet
86462|NCT02747290|integrin αvβ3|integrin αvβ3
86463|NCT02747290|GRPR|grpr
86464|NCT02747264|eRAPID|erapid
86465|NCT02747264|PRO|pro
86466|NCT02747264|PROM|prom
86467|NCT02747264|Adverse event|adverse event
86468|NCT02747264|QTool|qtool
86469|NCT02747264|CTCAE|ctcae
86470|NCT02747251|"Shoulder Impingement Syndrome[Mesh]"|"shoulder impingement syndrome[mesh]"
86471|NCT02747251|"Rehabilitation[Mesh]"|"rehabilitation[mesh]"
86472|NCT02747251|"Exercise[Mesh]"|"exercise[mesh]"
86473|NCT02747251|"Rotator Cuff[Mesh]"|"rotator cuff[mesh]"
86474|NCT02747238|Pregnancy|pregnancy
86475|NCT02747238|Epidural|epidural
86476|NCT02747238|Labor|labor
86477|NCT02747225|electrical properties|electrical properties
86478|NCT02747225|malignant tissues|malignant tissues
86479|NCT02747225|in vivo|in vivo
86480|NCT02747212|electrical properties|electrical properties
86481|NCT02747212|malignant tissues|malignant tissues
86482|NCT02747212|ex vivo|ex vivo
86483|NCT02747199|SYNERGY|synergy
86484|NCT02747199|Neointimal formation|neointimal formation
86485|NCT02747199|OCT|oct
86486|NCT02747199|coronary angioscopy|coronary angioscopy
86487|NCT02747199|coronary artery disease|coronary artery disease
86488|NCT02747186|lidocaine, jaw|lidocaine, jaw
86489|NCT02747173|metastatic, bone metastases|metastatic, bone metastases
86490|NCT02747160|Cancer|cancer
86491|NCT02747160|Anxiety|anxiety
86492|NCT02747160|Cognitive behavior therapy|cognitive behavior therapy
86493|NCT02747160|Elderly|elderly
86494|NCT02747160|Caregivers|caregivers
86495|NCT02747121|External inspections|external inspections
86496|NCT02747108|Veterans|veterans
86497|NCT02747108|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
86498|NCT02747108|Prediabetes|prediabetes
86499|NCT02747108|Decision-making|decision-making
86500|NCT02747108|Motivation|motivation
86501|NCT02747108|Health Promotion|health promotion
86502|NCT02747108|Prevention and Control|prevention and control
86503|NCT02747095|CT|ct
86504|NCT02747095|Spectral Images|spectral images
86505|NCT02747082|endodontic retreatment|endodontic retreatment
86506|NCT02747082|sodium hypochlorite|sodium hypochlorite
86507|NCT02747082|chlorhexidine|chlorhexidine
86508|NCT02747082|calcium hydroxide|calcium hydroxide
86509|NCT02747082|Retreatment|retreatment
86510|NCT02747069|Heart rate|heart rate
86511|NCT02747069|Electronic Stethoscope|electronic stethoscope
86512|NCT02747069|Electrocardiogram|electrocardiogram
86513|NCT02747069|Resuscitation|resuscitation
86514|NCT02747030|Central retinal vein occlusion|central retinal vein occlusion
86515|NCT02747030|Retinal endovascular surgery|retinal endovascular surgery
632620|NCT00712582|carboplatin|carboplatin
86516|NCT02747030|Retinal vein cannulation|retinal vein cannulation
86517|NCT02747030|Ocriplasmin|ocriplasmin
86518|NCT02747017|transplant|transplant
86519|NCT02746965|magnetic seizure therapy|magnetic seizure therapy
86520|NCT02746965|randomized controlled trials|randomized controlled trials
86521|NCT02746965|schizophrenia|schizophrenia
86522|NCT02746965|cognition|cognition
86523|NCT02746939|program evaluation|program evaluation
86524|NCT02746939|health literacy|health literacy
86525|NCT02746939|fitness|fitness
86526|NCT02746939|nutrition|nutrition
86527|NCT02746939|education|education
86528|NCT02746913|Pelvic, Urodynamic, Vaginal Wall|pelvic, urodynamic, vaginal wall
86529|NCT02746874|Total Knee Replacement, Replacement of the knee joint,|total knee replacement, replacement of the knee joint,
86530|NCT02746861|peer mentor|peer mentor
86531|NCT02746861|peer supporter|peer supporter
86532|NCT02746861|peer coach|peer coach
86533|NCT02746861|peer-to-peer mentoring|peer-to-peer mentoring
86534|NCT02746848|cornea epithelium healing Amniotic Membrane Eye Drop|cornea epithelium healing amniotic membrane eye drop
86535|NCT02746835|physical condition|physical condition
86536|NCT02746835|self-efficacy|self-efficacy
86537|NCT02746835|fall risk|fall risk
86538|NCT02746835|exercise program|exercise program
86539|NCT02746822|acute myocardial infarction,|acute myocardial infarction,
77794|NCT02798471|Pulmonary embolism|pulmonary embolism
86540|NCT02746822|thrombus aspiration|thrombus aspiration
86541|NCT02746679|Asherman syndrome|asherman syndrome
86542|NCT02746679|Mindfulness|mindfulness
86543|NCT02746679|Anxiety|anxiety
86544|NCT02746679|Depression|depression
86545|NCT02746679|Quality of Life|quality of life
86546|NCT02746653|Fascia Closure Device, hernia,|fascia closure device, hernia,
86547|NCT02746614|adaptive behavior|adaptive behavior
86548|NCT02746614|motor proficiency|motor proficiency
86549|NCT02746614|psychomotor therapy|psychomotor therapy
86550|NCT02746614|intellectual disability|intellectual disability
86551|NCT02746588|miscarriage|miscarriage
86552|NCT02746588|uterine abnormalities|uterine abnormalities
86553|NCT02746588|Chronic infection|chronic infection
86554|NCT02746562|Assisted reproduction|assisted reproduction
86555|NCT02746562|In vitro fertilisation|in vitro fertilisation
86556|NCT02746562|Frozen embryo transfer (FER)|frozen embryo transfer (fer)
86557|NCT02746536|COPD|copd
86558|NCT02746536|Inspiratory capacity|inspiratory capacity
86559|NCT02746536|Exercise|exercise
86561|NCT02746523|Concussion|concussion
86562|NCT02746523|Biomarkers|biomarkers
86563|NCT02746497|Menopause|menopause
86564|NCT02746497|Hot flushes|hot flushes
86565|NCT02746497|Acupuncture|acupuncture
86566|NCT02746497|Randomized controlled trial|randomized controlled trial
86567|NCT02746458|Blood Flow Restriction|blood flow restriction
86568|NCT02746458|Muscle Weakness|muscle weakness
86569|NCT02746458|Physical therapy techniques|physical therapy techniques
86570|NCT02746458|closed femoral fracture injuries|closed femoral fracture injuries
86571|NCT02746445|Autism|autism
86572|NCT02746445|ASD|asd
86573|NCT02746445|Autism Spectrum Disorder|autism spectrum disorder
86574|NCT02746432|CRC-Insulin|crc-insulin
86575|NCT02746354|Chronic Pain|chronic pain
86576|NCT02746354|Analgesics, Opioid|analgesics, opioid
86577|NCT02746354|Primary Health Care|primary health care
86578|NCT02746276|malnutrition|malnutrition
86579|NCT02746276|antibiotics|antibiotics
86580|NCT02746276|antimicrobial resistance|antimicrobial resistance
86581|NCT02746276|pharmacokinetics|pharmacokinetics
86582|NCT02746263|Elective total knee arthroplasty|elective total knee arthroplasty
86583|NCT02746237|Serotonin|serotonin
86584|NCT02746237|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
86585|NCT02746237|Pharmacokinetics|pharmacokinetics
86586|NCT02746237|Phase 1|phase 1
86587|NCT02746237|Healthy Volunteers|healthy volunteers
86588|NCT02746224|Colorectal cancer|colorectal cancer
86589|NCT02746224|Colorectal surgery|colorectal surgery
86590|NCT02746211|immunology|immunology
86591|NCT02746211|pathogenicity|pathogenicity
86592|NCT02746198|Probiotics, Antibiotics, AAD, Helicobacter p.|probiotics, antibiotics, aad, helicobacter p.
86593|NCT02746185|cancer|cancer
86594|NCT02746185|venous thromboembolism|venous thromboembolism
86595|NCT02746185|low-molecular weight heparin|low-molecular weight heparin
86596|NCT02746185|rivaroxaban|rivaroxaban
86597|NCT02746172|cochlear implants|cochlear implants
86598|NCT02746172|Mapping|mapping
86599|NCT02746172|in-situ audiometry|in-situ audiometry
86600|NCT02746107|shared decision making|shared decision making
86601|NCT02746107|oral anticoagulant|oral anticoagulant
86602|NCT02746107|atrial fibrillation|atrial fibrillation
86603|NCT02746107|stroke|stroke
86604|NCT02746107|decision to treat|decision to treat
86605|NCT02746081|BAY1436032|bay1436032
86609|NCT02746081|Safety|safety
86610|NCT02746081|Tolerability|tolerability
86611|NCT02746081|Pharmacokinetics|pharmacokinetics
86612|NCT02746081|Pharmacodynamics|pharmacodynamics
86613|NCT02746081|Efficacy|efficacy
86614|NCT02746081|Food-effect|food-effect
86615|NCT02746068|Bone Marrow Lesions|bone marrow lesions
86616|NCT02746068|AXS02|axs02
86617|NCT02746068|Axsome|axsome
86618|NCT02746068|Knee OA|knee oa
86619|NCT02746068|Osteoarthritis|osteoarthritis
86620|NCT02746042|chronic rhinosinusitis|chronic rhinosinusitis
86621|NCT02746042|Sinupret extract|sinupret extract
86622|NCT02746042|herbal medicinal product|herbal medicinal product
86623|NCT02746003|drinking water|drinking water
86624|NCT02746003|salinity|salinity
86625|NCT02745990|erythropoietin|erythropoietin
86626|NCT02745990|preterm|preterm
86627|NCT02745990|brain injury|brain injury
86628|NCT02745990|cerebral palsy|cerebral palsy
86629|NCT02745990|PVL|pvl
86630|NCT02745951|cardiopulmonary bypass|cardiopulmonary bypass
86631|NCT02745951|cardioplegia|cardioplegia
86632|NCT02745951|cardioprotection|cardioprotection
86633|NCT02745951|coronary artery bypass graft surgery|coronary artery bypass graft surgery
86634|NCT02745951|heliox|heliox
86635|NCT02745938|Exercise test|exercise test
86636|NCT02745938|GDF-15|gdf-15
86637|NCT02745938|Growth and Differentiation Factor 15|growth and differentiation factor 15
86638|NCT02745925|Iron bioavailability|iron bioavailability
86639|NCT02745925|Inflammation|inflammation
86640|NCT02745925|Hepcidin|hepcidin
86641|NCT02745925|Iron absorption|iron absorption
102085|NCT02651831|ICMs|icms
77965|NCT02797821|HPP|hpp
86642|NCT02745912|Drug Therapy|drug therapy
86643|NCT02745899|asthma|asthma
86644|NCT02745899|cow milk|cow milk
86645|NCT02745899|pulmonary function testing|pulmonary function testing
86646|NCT02745899|children|children
86647|NCT02745899|mucus|mucus
86648|NCT02745860|selexipag|selexipag
86649|NCT02745860|pharmacokinetics|pharmacokinetics
86650|NCT02745821|coronary flow reserve|coronary flow reserve
86651|NCT02745821|fractional flow reserve|fractional flow reserve
86652|NCT02745821|diabetes mellitus|diabetes mellitus
86653|NCT02745821|coronary artery disease|coronary artery disease
86654|NCT02745821|percutaneous coronary intervention|percutaneous coronary intervention
86655|NCT02745821|coronary physiology|coronary physiology
86656|NCT02745821|index of microcirculatory resistance|index of microcirculatory resistance
86657|NCT02745795|Motivational interview|motivational interview
86658|NCT02745795|adolescents|adolescents
86659|NCT02745795|obesity|obesity
86661|NCT02745795|physical activity|physical activity
86662|NCT02745795|diet|diet
86663|NCT02745782|Pulpitis|pulpitis
86664|NCT02745782|Syncope|syncope
86665|NCT02745782|Trigeminal Cardio-Reflex|trigeminal cardio-reflex
86669|NCT02745743|Phase 1|phase 1
86670|NCT02745743|Dose escalation|dose escalation
86671|NCT02745743|Dose expansion|dose expansion
86672|NCT02745743|Positive transcription elongation factor b inhibitor|positive transcription elongation factor b inhibitor
86673|NCT02745743|Cyclin-dependent kinase 9 inhibitor|cyclin-dependent kinase 9 inhibitor
86674|NCT02745717|Severe aplastic anemia|severe aplastic anemia
86675|NCT02745717|immunosuppressive therapy|immunosuppressive therapy
86676|NCT02745717|cord blood transfusion|cord blood transfusion
86677|NCT02745704|chronic hepatitis B|chronic hepatitis b
86678|NCT02745704|peginterferon alfa|peginterferon alfa
86679|NCT02745678|Enema|enema
86680|NCT02745678|Ulcerative Colitis|ulcerative colitis
86681|NCT02745652|median nerve|median nerve
86682|NCT02745652|wrist joint|wrist joint
86683|NCT02745652|carpal tunnel|carpal tunnel
86684|NCT02745639|rectal cancer|rectal cancer
86685|NCT02745639|radiotherapy|radiotherapy
86686|NCT02745639|chemotherapy|chemotherapy
86687|NCT02745639|VMAT|vmat
86688|NCT02745639|toxicity|toxicity
86689|NCT02745600|RFA|rfa
86690|NCT02745600|Liver|liver
86691|NCT02745600|Ablation Techniques|ablation techniques
86692|NCT02745600|Treatment Simulation|treatment simulation
86693|NCT02745600|Computer assisted therapy|computer assisted therapy
86694|NCT02745574|should and upper abdominal pain, post-laparoscopy|should and upper abdominal pain, post-laparoscopy
86695|NCT02745561|Endostatin|endostatin
86696|NCT02745561|Oxaliplatin|oxaliplatin
86697|NCT02745561|Esophageal Cancer|esophageal cancer
86698|NCT02745561|chemoradiotherapy|chemoradiotherapy
86699|NCT02745548|Lung Cancer|lung cancer
86700|NCT02745548|NSCLC (Non Small Cell Lung Cancer)|nsclc (non small cell lung cancer)
86701|NCT02745548|SABR (Stereotactic ablative radiotherapy)|sabr (stereotactic ablative radiotherapy)
86702|NCT02745522|Placebo analgesia|placebo analgesia
86703|NCT02745522|Working memory|working memory
86704|NCT02745509|Extensive Intraoperative Peritoneal Lavage|extensive intraoperative peritoneal lavage
86705|NCT02745509|EIPL|eipl
86706|NCT02745509|Gastric Cancer|gastric cancer
86707|NCT02745496|Image-guided biopsy|image-guided biopsy
86708|NCT02745496|Tumour detection|tumour detection
86709|NCT02745496|Diagnostic|diagnostic
86710|NCT02745496|Biomarkers|biomarkers
86711|NCT02745483|RFA|rfa
86712|NCT02745470|lean/obese diabetes mellitus|lean/obese diabetes mellitus
86713|NCT02745470|functional MRI|functional mri
86714|NCT02745470|GLP-1|glp-1
86715|NCT02745470|appetite|appetite
86716|NCT02745470|activation of brain|activation of brain
86717|NCT02745470|connectivity|connectivity
86718|NCT02745444|Living kidney transplantation|living kidney transplantation
86719|NCT02745444|Chronic kidney disease|chronic kidney disease
86720|NCT02745444|Acute kidney injury|acute kidney injury
86721|NCT02745431|Likeability|likeability
86722|NCT02745431|Being liked|being liked
86723|NCT02745405|Weight Stigma|weight stigma
86724|NCT02745405|Cortisol Reactivity|cortisol reactivity
86725|NCT02745405|Eating Behavior|eating behavior
86726|NCT02745392|migraine|migraine
86727|NCT02745392|migraine headache|migraine headache
86728|NCT02745392|acute migraine|acute migraine
86729|NCT02745392|acute migraine headache|acute migraine headache
86730|NCT02745353|Cancer|cancer
86731|NCT02745353|Constipation|constipation
86732|NCT02745353|Opioid|opioid
86733|NCT02745327|oral vaccination|oral vaccination
86734|NCT02745327|nutrition|nutrition
86735|NCT02745314|Aortic Stenosis, Frailty, Elderly, moertality|aortic stenosis, frailty, elderly, moertality
86736|NCT02745275|Peer Education|peer education
86737|NCT02745275|Health Coaches|health coaches
86738|NCT02745275|Community Dwelling Seniors|community dwelling seniors
86739|NCT02745275|Health Literacy|health literacy
86740|NCT02745275|Health Education|health education
86741|NCT02745275|Healthy Ageing|healthy ageing
86742|NCT02745236|Atrial Fibrillation|atrial fibrillation
86743|NCT02745236|Health Related Quality of Life|health related quality of life
86744|NCT02745236|Nurse Practitioner|nurse practitioner
86745|NCT02745236|Sustainable Models of Healthcare|sustainable models of healthcare
86746|NCT02745236|Patient Satisfaction|patient satisfaction
86747|NCT02745171|Parkinson's disease|parkinson's disease
86748|NCT02745171|Quality of life|quality of life
86749|NCT02745171|Functional mobility|functional mobility
86750|NCT02745171|Follow up|follow up
86751|NCT02745158|Fibrodysplasia ossificans progressiva|fibrodysplasia ossificans progressiva
86752|NCT02745158|FOP|fop
86753|NCT02745158|International FOP Association|international fop association
86754|NCT02745158|Patient Advocacy Group|patient advocacy group
86755|NCT02745158|Patient Registry|patient registry
86756|NCT02745158|Natural History|natural history
86757|NCT02745158|Patient-Reported Outcomes|patient-reported outcomes
86758|NCT02745158|Observational Database|observational database
86759|NCT02745158|Bone Morphogenetic Protein|bone morphogenetic protein
86760|NCT02745158|BMP|bmp
86761|NCT02745158|Bone Growth|bone growth
86764|NCT02745158|Flare-Up|flare-up
86765|NCT02745158|Heterotopic Ossification|heterotopic ossification
86766|NCT02745158|Ectopic Bone|ectopic bone
86767|NCT02745158|Osteochondroma|osteochondroma
86768|NCT02745158|Hallux Valgus|hallux valgus
86769|NCT02745158|ALK2|alk2
86770|NCT02745158|ACVR1|acvr1
86771|NCT02745158|Activin A|activin a
86772|NCT02745158|IFOPA|ifopa
86773|NCT02745158|Activin A Receptor Type I|activin a receptor type i
86774|NCT02745158|Activin Receptor-like Kinase-2|activin receptor-like kinase-2
86775|NCT02745145|Double-Blind Method|double-blind method
86776|NCT02745145|Interstitial Lung Diseases|interstitial lung diseases
86777|NCT02745145|Systemic Scleroderma|systemic scleroderma
86778|NCT02745145|Abituzumab|abituzumab
86779|NCT02745145|Mycophenolate|mycophenolate
86780|NCT02745145|Efficacy, Safety|efficacy, safety
86781|NCT02745132|Chronic, Cognition Disorders|chronic, cognition disorders
86782|NCT02745132|Neurocognition Disorders|neurocognition disorders
86783|NCT02745132|Cognitive Impairments|cognitive impairments
86784|NCT02745132|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
86785|NCT02745132|MRI functional|mri functional
86786|NCT02745132|Verbal fluency|verbal fluency
86787|NCT02745106|Chronic thromboembolic pulmonary hypertension, Navigation system, Ablation|chronic thromboembolic pulmonary hypertension, navigation system, ablation
86788|NCT02745093|Abortion induced|abortion induced
86789|NCT02745093|Patient Acceptance of Healthcare|patient acceptance of healthcare
86790|NCT02745093|safety|safety
86791|NCT02745093|effectiveness|effectiveness
86792|NCT02745093|misoprostol|misoprostol
86793|NCT02745093|mifepristone|mifepristone
86794|NCT02745080|Psoriatic Arthritis|psoriatic arthritis
86795|NCT02745080|secukinumab|secukinumab
86796|NCT02745080|adalimumab|adalimumab
86797|NCT02745080|monoclonal antibody|monoclonal antibody
86798|NCT02745080|CASPAR|caspar
86799|NCT02745054|oral anticoagulants|oral anticoagulants
86800|NCT02745054|bleeding|bleeding
86801|NCT02745054|anticoagulation reversal|anticoagulation reversal
86802|NCT02745041|Fibrinogen|fibrinogen
86803|NCT02745041|Cryoprecipitate|cryoprecipitate
86804|NCT02745028|delayed gastric emptying|delayed gastric emptying
86805|NCT02745028|children|children
86806|NCT02745028|monosodium glutamate|monosodium glutamate
86807|NCT02745015|periodontitis|periodontitis
86808|NCT02745015|diabetes|diabetes
86809|NCT02745015|HbA1c|hba1c
86810|NCT02745015|inflammation|inflammation
86811|NCT02745002|Bronchoscopy|bronchoscopy
86812|NCT02745002|Bronchoscopes|bronchoscopes
86813|NCT02744989|Schizophrenia|schizophrenia
634281|NCT00717379|Kidney|kidney
86814|NCT02744989|Transcranial direct-current stimulation (tDCS)|transcranial direct-current stimulation (tdcs)
86815|NCT02744989|Sham|sham
86816|NCT02744989|Positive and Negative Syndrome Scale (PANSS)|positive and negative syndrome scale (panss)
86817|NCT02744989|Functional Magnetic Resonance Imaging (fRMI)|functional magnetic resonance imaging (frmi)
86818|NCT02744989|Brain-Derived-Neurotrophic Factor (BDNF)|brain-derived-neurotrophic factor (bdnf)
86819|NCT02744976|Coronary artery disease|coronary artery disease
86820|NCT02744976|Atherosclerosis|atherosclerosis
86821|NCT02744976|Prediabetes|prediabetes
86822|NCT02744976|Intravascular ultrasound|intravascular ultrasound
86823|NCT02744976|Insulin resistance|insulin resistance
86824|NCT02744976|Percutaneous coronary intervention|percutaneous coronary intervention
86825|NCT02744976|Metformin|metformin
86826|NCT02744950|pulley|pulley
86827|NCT02744950|scalp defects|scalp defects
86828|NCT02744911|speech problems|speech problems
86829|NCT02744898|uterus|uterus
86830|NCT02744898|gynecological|gynecological
86831|NCT02744872|lung transplantation|lung transplantation
86832|NCT02744872|chronic renal insufficiency|chronic renal insufficiency
102383|NCT02649855|PSA|psa
78150|NCT02796716|KPC|kpc
86833|NCT02744859|Decision Making|decision making
86834|NCT02744859|Consumption|consumption
86835|NCT02744859|Economics|economics
86836|NCT02744846|antibiotics|antibiotics
86837|NCT02744846|children|children
86838|NCT02744846|pediatric|pediatric
86839|NCT02744846|body mass index|body mass index
86840|NCT02744846|Observational Study|observational study
86841|NCT02744846|Comparative Effectiveness Research|comparative effectiveness research
86842|NCT02744846|Obesity|obesity
86843|NCT02744846|Growth Trajectory|growth trajectory
86844|NCT02744846|Cohort Study|cohort study
86845|NCT02744846|Electronic Medical Record|electronic medical record
86846|NCT02744846|Qualitative Research|qualitative research
86848|NCT02744807|intrauterine adhesions|intrauterine adhesions
86849|NCT02744807|Chronic endometritis|chronic endometritis
86850|NCT02744807|infections|infections
86851|NCT02744807|Hysteroscopy|hysteroscopy
86852|NCT02743741|Somatostatin Receptor Positive Neuroendocrine Tumors|somatostatin receptor positive neuroendocrine tumors
86853|NCT02743728|perinatal stroke|perinatal stroke
86854|NCT02743728|transcranial magnetic stimulation|transcranial magnetic stimulation
86855|NCT02743728|magnetic resonance imaging|magnetic resonance imaging
86856|NCT02743728|diffusion tensor imaging|diffusion tensor imaging
86857|NCT02743728|non-invasive brain stimulation|non-invasive brain stimulation
86858|NCT02743728|infant|infant
86859|NCT02743715|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
86860|NCT02743715|Transcranial direct current stimulation|transcranial direct current stimulation
86861|NCT02743715|Neuromodulation|neuromodulation
86862|NCT02743702|Effectiveness|effectiveness
86863|NCT02743702|Physical therapy modalities|physical therapy modalities
86864|NCT02743702|neuromuscular diseases|neuromuscular diseases
86865|NCT02743689|Postoperative|postoperative
86866|NCT02743689|Cardiac surgery|cardiac surgery
86867|NCT02743676|Avian Influenza|avian influenza
86868|NCT02743663|pediatric|pediatric
86869|NCT02743663|lung ventilation inhomogeneity|lung ventilation inhomogeneity
86870|NCT02743663|preschool|preschool
86871|NCT02743663|asthma|asthma
86872|NCT02743663|wheeze|wheeze
86873|NCT02743650|Low Serum Bicarbonate Level|low serum bicarbonate level
86874|NCT02743650|Sodium Bicarbonate|sodium bicarbonate
86875|NCT02743637|Cancer|cancer
86876|NCT02743637|Oncology|oncology
86877|NCT02743637|Solid Tumors|solid tumors
86878|NCT02743637|Phase 1|phase 1
86879|NCT02743637|SDX-7320|sdx-7320
86880|NCT02743637|SynDevRx|syndevrx
86881|NCT02743637|MetAP2|metap2
86882|NCT02743637|Breast|breast
86883|NCT02743637|Post menopausal|post menopausal
86884|NCT02743637|Colorectal|colorectal
86885|NCT02743637|Pancreatic|pancreatic
86886|NCT02743637|Ovarian|ovarian
86887|NCT02743637|Endometrial|endometrial
86888|NCT02743637|Esophageal|esophageal
86889|NCT02743637|Lung|lung
86890|NCT02743637|Renal|renal
86891|NCT02743637|Prostate|prostate
86892|NCT02743637|Liver|liver
86893|NCT02743611|BPX-701|bpx-701
86894|NCT02743611|AP1903|ap1903
86895|NCT02743611|Rimiducid|rimiducid
86897|NCT02743611|MDS|mds
86898|NCT02743611|Primary Refractory AML|primary refractory aml
86899|NCT02743611|Relapsed AML|relapsed aml
86900|NCT02743611|Refractory Myeloid Neoplasms|refractory myeloid neoplasms
86901|NCT02743598|HIV infection|hiv infection
86902|NCT02743598|Diabetes Mellitus type 2|diabetes mellitus type 2
86903|NCT02743598|Obesity|obesity
86904|NCT02743598|Neurocognitive function|neurocognitive function
86905|NCT02743572|premature infant|premature infant
86907|NCT02743572|iron-fortification|iron-fortification
86908|NCT02743572|parenteral nutrition|parenteral nutrition
86909|NCT02743572|randomized controlled trial|randomized controlled trial
86910|NCT02744781|Muscular Atrophy|muscular atrophy
86911|NCT02744781|Asymmetry|asymmetry
86912|NCT02744781|Athletes|athletes
635710|NCT00715130|Overweight|overweight
86913|NCT02744768|Acute Lymphoblastic Leukemia, adult, dasatinib, blinatumomab|acute lymphoblastic leukemia, adult, dasatinib, blinatumomab
86914|NCT02744716|intrauterine balloon|intrauterine balloon
86915|NCT02744716|uterine endometrial repair|uterine endometrial repair
86916|NCT02744716|intrauterine adhesion|intrauterine adhesion
86917|NCT02744716|aspirin|aspirin
86918|NCT02744690|Eye Disease|eye disease
86919|NCT02744690|Intraocular Pressure|intraocular pressure
86920|NCT02744690|Visual Acuity|visual acuity
86921|NCT02744690|Trabeculectomy|trabeculectomy
86922|NCT02744677|Tetralogy of Fallot|tetralogy of fallot
86923|NCT02744677|Aortic Valve Defect/Disease Resulting in Ross Procedure|aortic valve defect/disease resulting in ross procedure
86924|NCT02744677|Pulmonary Atresia|pulmonary atresia
86925|NCT02744677|Pulmonary Stenosis|pulmonary stenosis
86926|NCT02744677|Truncus Arteriosus|truncus arteriosus
86927|NCT02744677|Transposition of the Great Arteries|transposition of the great arteries
86928|NCT02744677|Transcatheter pulmonary valve implantation|transcatheter pulmonary valve implantation
78234|NCT02796365|Exercise|exercise
86929|NCT02744677|Transcatheter pulmonary valve replacement|transcatheter pulmonary valve replacement
86930|NCT02744677|TPV|tpv
86931|NCT02744677|TPVR|tpvr
86932|NCT02744677|TPVI|tpvi
86933|NCT02744664|Lung Neoplasms|lung neoplasms
86934|NCT02744664|EGFR mutation|egfr mutation
86935|NCT02744664|Cryotherapy|cryotherapy
86936|NCT02744664|Icotinib|icotinib
86937|NCT02744638|bacterial vaginosis|bacterial vaginosis
86938|NCT02744638|probiotics|probiotics
86939|NCT02744638|Amsel Score|amsel score
86940|NCT02744638|Nugent Score|nugent score
86941|NCT02744599|Feasibility trial|feasibility trial
86942|NCT02744586|Sexually transmitted infections|sexually transmitted infections
86943|NCT02744586|Neglected tropical diseases|neglected tropical diseases
86944|NCT02744586|Non-communicable diseases|non-communicable diseases
86945|NCT02744534|Prostate Cancer|prostate cancer
86946|NCT02744534|Imaging Technology|imaging technology
86947|NCT02744534|Oncology|oncology
86948|NCT02744534|Prostate Biopsy|prostate biopsy
86949|NCT02744508|palonosetron, dexamethasone, PONV (postoperative nausea and vomiting)|palonosetron, dexamethasone, ponv (postoperative nausea and vomiting)
86950|NCT02744495|cardiac surgery|cardiac surgery
86951|NCT02744495|corticoids|corticoids
86952|NCT02744495|droperidol|droperidol
86953|NCT02744495|antiemetics|antiemetics
86954|NCT02744495|Postoperative Vomiting|postoperative vomiting
86955|NCT02744495|Postoperative Nausea|postoperative nausea
86956|NCT02744495|Postoperative Emesis|postoperative emesis
86957|NCT02744495|prophylaxis|prophylaxis
86958|NCT02744469|Tuberculosis|tuberculosis
86959|NCT02744469|population structure|population structure
86960|NCT02744469|implications|implications
86961|NCT02744469|lineages|lineages
86962|NCT02744469|spoligotyping|spoligotyping
86963|NCT02744469|sputum|sputum
86964|NCT02744469|resistance|resistance
86965|NCT02744469|culture|culture
86966|NCT02744469|diagnostics|diagnostics
86967|NCT02744469|outcome|outcome
86968|NCT02744469|new/retreatment patient|new/retreatment patient
86969|NCT02744456|Hydrochlorothiazide tablet|hydrochlorothiazide tablet
86970|NCT02744456|Norvasc|norvasc
86971|NCT02744456|Cozaar|cozaar
86972|NCT02744456|amlodipine besylate tablets|amlodipine besylate tablets
86973|NCT02744456|losartan potassium tablets|losartan potassium tablets
86974|NCT02744456|Hypertension|hypertension
86975|NCT02744456|High Blood Pressure|high blood pressure
86976|NCT02744430|Medical expulsive therapy|medical expulsive therapy
86977|NCT02744430|ureteral stone|ureteral stone
86978|NCT02744430|stent pain|stent pain
86979|NCT02744417|smoking cessation|smoking cessation
86980|NCT02744417|tobacco|tobacco
86981|NCT02744417|periodontal|periodontal
86982|NCT02744417|subgingival microorganisms|subgingival microorganisms
86983|NCT02744352|infraclavicular brachial plexus block|infraclavicular brachial plexus block
86984|NCT02744352|quality of recovery score|quality of recovery score
86985|NCT02744352|pain score|pain score
86986|NCT02744352|disability assessment of shoulder and hand questionnaire|disability assessment of shoulder and hand questionnaire
86987|NCT02744339|PH-HFpEF|ph-hfpef
200986|NCT02112695|[11C]diprenorphine Pet|[11c]diprenorphine pet
86988|NCT02744300|Gestational diabetes mellitus (GDM) in most recent pregnancy|gestational diabetes mellitus (gdm) in most recent pregnancy
86989|NCT02744287|Non Resectable Pancreatic Cancer|non resectable pancreatic cancer
86991|NCT02744287|AP1903|ap1903
86992|NCT02744287|CAR T|car t
86993|NCT02744287|PSCA-CAR|psca-car
86994|NCT02744274|acupuncture|acupuncture
86995|NCT02744274|chemotherapy|chemotherapy
86996|NCT02744274|peripheral neuropathy|peripheral neuropathy
86997|NCT02744274|randomized clinical trial|randomized clinical trial
86998|NCT02744274|numbness|numbness
86999|NCT02744261|HIV|hiv
87000|NCT02744261|STI|sti
87001|NCT02744261|Primary Prevention|primary prevention
87002|NCT02744261|Topical Microbicides|topical microbicides
87003|NCT02744261|User Experience|user experience
87004|NCT02744261|Drug Delivery Systems|drug delivery systems
87005|NCT02744248|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
87006|NCT02744196|rheumatoid arthritis|rheumatoid arthritis
87010|NCT02744196|biologic therapy|biologic therapy
87011|NCT02744196|monoclonal antibody|monoclonal antibody
87013|NCT02744183|Exercise|exercise
87014|NCT02744183|Fasted|fasted
87015|NCT02744183|Glucose|glucose
87016|NCT02744183|Energy Balance|energy balance
87017|NCT02744170|COPD|copd
87018|NCT02744170|Incremental Shuttle Walk Test|incremental shuttle walk test
87019|NCT02744170|Endurance Shuttle Walk Test|endurance shuttle walk test
87020|NCT02744170|oxygen therapy|oxygen therapy
87021|NCT02744131|PCOS|pcos
87022|NCT02744131|Metformin|metformin
87023|NCT02744131|OCP|ocp
87024|NCT02744131|metabolic parameters|metabolic parameters
87025|NCT02744118|Media Use|media use
87026|NCT02744092|Rivaroxaban (Xarelto)|rivaroxaban (xarelto)
87027|NCT02744092|Apixaban (Eliquis)|apixaban (eliquis)
87028|NCT02744092|Edoxaban (Savaysa)|edoxaban (savaysa)
78332|NCT02795793|appendicitis|appendicitis
78333|NCT02795793|non-operative management|non-operative management
87029|NCT02744092|Dabigatran (Pradaxa)|dabigatran (pradaxa)
87030|NCT02744092|Warfarin (Coumadin)|warfarin (coumadin)
87031|NCT02744092|Low molecular weight heparin (LMWH)|low molecular weight heparin (lmwh)
87032|NCT02744079|diet|diet
87033|NCT02744079|dietary intervention|dietary intervention
87034|NCT02744079|carbohydrate restriction|carbohydrate restriction
87035|NCT02744079|low carbohydrate|low carbohydrate
87036|NCT02744079|fat restriction|fat restriction
87037|NCT02744079|low fat|low fat
87038|NCT02744079|cancer|cancer
87039|NCT02744079|breast cancer|breast cancer
87040|NCT02744079|pre-surgical window|pre-surgical window
87041|NCT02744079|biomarker|biomarker
87042|NCT02744053|Breast Cancer|breast cancer
87043|NCT02744053|Malignant neoplasm of breast|malignant neoplasm of breast
87044|NCT02744053|Triple Negative Breast Cancer|triple negative breast cancer
87045|NCT02744053|TNBC|tnbc
87046|NCT02744053|Tc99m Sestamibi Molecular Breast Imaging|tc99m sestamibi molecular breast imaging
87047|NCT02744053|MBI|mbi
87048|NCT02744053|Dynamic Contrast Enhanced Molecular Resonance Imaging|dynamic contrast enhanced molecular resonance imaging
87049|NCT02744053|DCE-MRI|dce-mri
87050|NCT02744040|HIV reservoir|hiv reservoir
87051|NCT02744040|alcohol|alcohol
87052|NCT02744040|ART|art
87053|NCT02744027|Generalized Lymphatic Anomaly|generalized lymphatic anomaly
87054|NCT02744027|Kaposiform Lymphangiomatosis|kaposiform lymphangiomatosis
87055|NCT02744027|Dynamic Contrast Enhanced Magnetic Resonance Lymphangiogram|dynamic contrast enhanced magnetic resonance lymphangiogram
87056|NCT02744027|Magnetic Resonance Imaging|magnetic resonance imaging
87057|NCT02743988|cerebral oxygenation|cerebral oxygenation
87058|NCT02743988|NIRS|nirs
87059|NCT02743988|near-infrared spectroscopy|near-infrared spectroscopy
87060|NCT02743988|bradycardia|bradycardia
87061|NCT02743988|hypoxemia|hypoxemia
87062|NCT02743988|cerebral perfusion|cerebral perfusion
87063|NCT02743988|cardiac output|cardiac output
87064|NCT02743988|apnea|apnea
87065|NCT02743988|desaturation|desaturation
87066|NCT02743988|oxygen saturation target range|oxygen saturation target range
87067|NCT02743949|Drug therapy|drug therapy
87068|NCT02743910|preoperative|preoperative
87069|NCT02743910|neoadjuvant|neoadjuvant
87070|NCT02743910|plasma tumor DNA|plasma tumor dna
87071|NCT02743910|ptDNA|ptdna
87072|NCT02743897|end-stage renal disease|end-stage renal disease
87073|NCT02743871|FIH, Pharmacokinetics|fih, pharmacokinetics
87074|NCT02743858|Lymphedema|lymphedema
87075|NCT02743858|Surveillance Program|surveillance program
87076|NCT02743858|Axillary Lymph Node Dissection|axillary lymph node dissection
87077|NCT02743858|16-220|16-220
87082|NCT02743832|Surgery, Oral|surgery, oral
87083|NCT02743832|Tumor budding|tumor budding
87084|NCT02743819|Melanoma|melanoma
87085|NCT02743819|Pembrolizumab|pembrolizumab
87086|NCT02743819|Ipilimumab|ipilimumab
87087|NCT02743806|Drug Therapy|drug therapy
87088|NCT02743793|single organ liver or kidney allograft|single organ liver or kidney allograft
87089|NCT02743793|operationally tolerant allograft recipients|operationally tolerant allograft recipients
87090|NCT02743793|longitudinal follow-up|longitudinal follow-up
87091|NCT02743780|Ocular Hypertension|ocular hypertension
87092|NCT02743780|Open-Angle Glaucoma|open-angle glaucoma
87093|NCT02743780|POAG|poag
87094|NCT02743780|Glaucoma|glaucoma
87095|NCT02743767|Airway management|airway management
87096|NCT02743767|General anaesthesia|general anaesthesia
87097|NCT02743767|Critical incidents|critical incidents
87098|NCT02743767|Complications|complications
87099|NCT02743546|B-Cell, Malignancy|b-cell, malignancy
87100|NCT02743546|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
87101|NCT02743546|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
87102|NCT02743546|Lymphoma, Follicular|lymphoma, follicular
87103|NCT02743546|Lymphocytic, Chronic, B-Cell|lymphocytic, chronic, b-cell
87104|NCT02743546|JNJ-64052781|jnj-64052781
87105|NCT02743546|Ibrutinib|ibrutinib
87106|NCT02743533|cardiovascular diseases, prognosis|cardiovascular diseases, prognosis
87107|NCT02743520|sleep apnea|sleep apnea
87108|NCT02743481|Pesticide|pesticide
87109|NCT02743481|Agriculture|agriculture
87111|NCT02743481|Childhood|childhood
87112|NCT02743481|Leukemia|leukemia
87113|NCT02743468|Bronchoscopy|bronchoscopy
87114|NCT02743468|Pollutants|pollutants
87115|NCT02743468|Human Pulmonary Cells|human pulmonary cells
87116|NCT02743468|Cytochrome P450|cytochrome p450
87117|NCT02743468|Soluble Epoxide Hydrolase|soluble epoxide hydrolase
87118|NCT02743455|Fever|fever
87119|NCT02743455|Immunogenicity|immunogenicity
87120|NCT02743455|MVA-BN|mva-bn
87121|NCT02743455|Reactogenicity|reactogenicity
87122|NCT02743455|Vaccine|vaccine
87123|NCT02743455|Yellow|yellow
87124|NCT02743429|ch14.18/CHO|ch14.18/cho
87125|NCT02743429|neuroblastoma|neuroblastoma
87126|NCT02743429|long term infusion|long term infusion
78428|NCT02795260|ESAT6|esat6
78429|NCT02795260|CFP10|cfp10
78430|NCT02795260|skin test|skin test
78439|NCT02795143|TEN|ten
87127|NCT02743416|Screening|screening
87128|NCT02743416|Stroke prevention|stroke prevention
87129|NCT02743416|Cost effectiveness|cost effectiveness
87130|NCT02743390|blood pressure|blood pressure
87131|NCT02743390|inflammation|inflammation
87132|NCT02743390|tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
87133|NCT02743377|GsI+/-|gsi+/-
87134|NCT02743377|Camp|camp
87135|NCT02743377|GNAS|gnas
87136|NCT02743351|Cell Transplants|cell transplants
87137|NCT02743351|Hematopoietic Cell Transplant|hematopoietic cell transplant
87138|NCT02743351|HSCT|hsct
87139|NCT02743351|Hematologic Malignancies|hematologic malignancies
87140|NCT02743351|Hematologic Malignancy|hematologic malignancy
87141|NCT02743351|Acute Myeloid Leukemia|acute myeloid leukemia
87142|NCT02743351|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
87144|NCT02743351|AML|aml
87145|NCT02743351|Myelodysplastic Syndrome|myelodysplastic syndrome
87146|NCT02743351|MDS|mds
87147|NCT02743351|Allogeneic|allogeneic
87148|NCT02743351|CML|cml
87149|NCT02743351|Stem Cell Transplant|stem cell transplant
87150|NCT02743351|Transplant|transplant
87151|NCT02743338|Sleep Restriction|sleep restriction
87152|NCT02743338|Sleep Compression|sleep compression
87153|NCT02743338|Cognitive Behavioral Therapy|cognitive behavioral therapy
87154|NCT02743312|Balance-Based Torso-Weighting|balance-based torso-weighting
87155|NCT02743312|Physical Activity|physical activity
87156|NCT02743312|Neurorehabilitation|neurorehabilitation
87157|NCT02743286|sedentary behavior|sedentary behavior
87158|NCT02743286|sitting|sitting
87159|NCT02743286|feasibility|feasibility
87160|NCT02743286|endothelial function|endothelial function
87161|NCT02743286|metabolism|metabolism
87162|NCT02743260|phenotype|phenotype
87163|NCT02743260|transporter|transporter
87164|NCT02743260|cocktail|cocktail
87165|NCT02743247|Healthy volunteer|healthy volunteer
87166|NCT02743221|metastatic|metastatic
87167|NCT02743221|colorectal|colorectal
87168|NCT02743221|cancer|cancer
87169|NCT02743221|untreated|untreated
87170|NCT02743221|first-line|first-line
87171|NCT02743221|S95005|s95005
87172|NCT02743221|bevacizumab|bevacizumab
87173|NCT02743221|capecitabine|capecitabine
87174|NCT02743208|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
87175|NCT02743208|Surgical Procedures, Operative|surgical procedures, operative
87176|NCT02743208|Hip Prosthesis|hip prosthesis
87177|NCT02743169|Geographic Information Systems|geographic information systems
87178|NCT02743169|Spatial Analysis|spatial analysis
87179|NCT02743169|Emergency Medical Services|emergency medical services
87180|NCT02743156|IVUS|ivus
87181|NCT02743156|Acute Renal Failure|acute renal failure
87182|NCT02743156|Angioplasty|angioplasty
87183|NCT02743156|stent|stent
87184|NCT02743156|contrast|contrast
87185|NCT02743156|percutaneous coronary intervention|percutaneous coronary intervention
87186|NCT02743156|intravascular ultrasound|intravascular ultrasound
87187|NCT02743143|Exercise therapy|exercise therapy
87188|NCT02743143|Cardiovascular disease|cardiovascular disease
87189|NCT02743143|Risk|risk
87190|NCT02743130|Berries|berries
87191|NCT02743130|Blackcurrant (Ribes nigrum)|blackcurrant (ribes nigrum)
87192|NCT02743130|Lingonberry (Vaccinium vitis-idaea)|lingonberry (vaccinium vitis-idaea)
87193|NCT02743130|Sucrose|sucrose
87194|NCT02743130|Inverted sugar|inverted sugar
87195|NCT02743130|Postprandial glucose response|postprandial glucose response
87196|NCT02743130|Postprandial insulin response|postprandial insulin response
87226|NCT02742974|Hemodynamics|hemodynamics
87227|NCT02742974|Operative procedures|operative procedures
87228|NCT02742961|orthopedics|orthopedics
87229|NCT02742961|anesthesiology|anesthesiology
87230|NCT02742961|nerve block|nerve block
87231|NCT02742961|length of stay|length of stay
87232|NCT02742961|Patient readmission|patient readmission
87233|NCT02742948|elective caesarean section|elective caesarean section
87234|NCT02742948|antibiotics|antibiotics
87235|NCT02742948|endometritis|endometritis
87236|NCT02742922|self harm|self harm
87237|NCT02742922|culturally adapted therapy|culturally adapted therapy
87238|NCT02742922|problem solving therapy|problem solving therapy
87239|NCT02742922|low and middle income countries|low and middle income countries
87240|NCT02742896|Erectile dysfunction|erectile dysfunction
87241|NCT02742896|cognitive function|cognitive function
87242|NCT02742870|Diffusion MRI|diffusion mri
87243|NCT02742870|ADC histograms|adc histograms
87244|NCT02742870|Adnexal tumor|adnexal tumor
87245|NCT02742844|phase I/IIa|phase i/iia
87246|NCT02742844|mesenchymal stem cells|mesenchymal stem cells
87247|NCT02742844|ABCB5+|abcb5+
87248|NCT02742844|APZ2|apz2
87249|NCT02742844|chronic venous ulcer|chronic venous ulcer
87250|NCT02742844|varicose ulcer|varicose ulcer
87251|NCT02742844|skin ulcer|skin ulcer
87252|NCT02742844|advanced therapy medicinal product|advanced therapy medicinal product
87253|NCT02742844|APZ2-II-01|apz2-ii-01
87254|NCT02742844|autologous use|autologous use
87255|NCT02742844|somatic cell therapy|somatic cell therapy
87256|NCT02742818|forced-air warming|forced-air warming
87257|NCT02742818|hypothermia|hypothermia
87258|NCT02742818|endovascular surgery|endovascular surgery
87259|NCT02742818|blanket|blanket
87260|NCT02742805|hives|hives
87261|NCT02742792|sleep apnea|sleep apnea
87262|NCT02742792|elderly|elderly
87263|NCT02742792|exercise|exercise
87264|NCT02742766|Dose escalation study|dose escalation study
87265|NCT02742766|Safety|safety
87266|NCT02742766|Pharmacodynamics|pharmacodynamics
87267|NCT02742766|Pharmacokinetics|pharmacokinetics
87268|NCT02742766|GSK3008356|gsk3008356
87269|NCT02742766|Tolerability|tolerability
87270|NCT02742753|Otitis|otitis
87271|NCT02742753|Vaccine|vaccine
87272|NCT02742753|Sweden|sweden
87273|NCT02742753|Database|database
87274|NCT02742675|prostate cancer|prostate cancer
87275|NCT02742675|androgen deprivation therapy|androgen deprivation therapy
87276|NCT02742675|local treatment|local treatment
87282|NCT02742662|Weight Loss|weight loss
87283|NCT02742662|Lifestyle Intervention|lifestyle intervention
87284|NCT02742623|Cancer|cancer
87285|NCT02742623|Deep Venous Thrombosis|deep venous thrombosis
87286|NCT02742623|Pulmonary Embolism|pulmonary embolism
87287|NCT02742584|cough stress test|cough stress test
87288|NCT02742584|urodynamics|urodynamics
87289|NCT02742584|pad test|pad test
87290|NCT02742571|Biological evaluation of denutrition|biological evaluation of denutrition
87291|NCT02742571|Denutrition|denutrition
87292|NCT02742571|PINI score|pini score
87293|NCT02742558|cholera vaccine|cholera vaccine
87294|NCT02742558|randomized trial|randomized trial
87295|NCT02742558|immunogenicity|immunogenicity
87296|NCT02742506|Brain-damaged|brain-damaged
87297|NCT02742506|Disorders of consciousness|disorders of consciousness
87298|NCT02742506|Post-coma|post-coma
87299|NCT02742506|consciousness|consciousness
87300|NCT02742506|coma|coma
87301|NCT02742506|vegetative state|vegetative state
87302|NCT02742506|minimally conscious state|minimally conscious state
87303|NCT02742506|music|music
87304|NCT02742506|P300|p300
87305|NCT02742493|relapse|relapse
87306|NCT02742493|irregularity|irregularity
87307|NCT02742493|recession|recession
87308|NCT02742493|retention|retention
87309|NCT02742480|stroke|stroke
87310|NCT02742480|oral anticoagulants|oral anticoagulants
87311|NCT02742480|cardioembolic|cardioembolic
87508|NCT02740686|Immunity|immunity
87312|NCT02742454|Umbilical Cord Clamping|umbilical cord clamping
87313|NCT02742454|Intraventricular Hemorrhage|intraventricular hemorrhage
87314|NCT02742454|Extremely Preterm Infants|extremely preterm infants
87315|NCT02742337|Epigenetic|epigenetic
87316|NCT02742324|efficacy|efficacy
87317|NCT02742324|safety|safety
87318|NCT02742298|Neuromuscular Ultrasound|neuromuscular ultrasound
87319|NCT02742298|Electrical Impedance Myography|electrical impedance myography
87320|NCT02742285|antimalarials|antimalarials
87321|NCT02742285|blood samples|blood samples
87322|NCT02742285|drug concentrations|drug concentrations
87323|NCT02742285|pharmacokinetics|pharmacokinetics
87324|NCT02742285|lumefantrine|lumefantrine
87325|NCT02742285|healthy volunteers|healthy volunteers
87326|NCT02742233|Diabetes|diabetes
87327|NCT02742233|Wound Healing|wound healing
87328|NCT02742233|Dipeptidyl Peptidase 4 Inhibition|dipeptidyl peptidase 4 inhibition
87329|NCT02742220|intermittent claudication|intermittent claudication
87330|NCT02742220|exercise|exercise
87331|NCT02742220|blood pressure|blood pressure
87332|NCT02742220|cardiovascular system|cardiovascular system
87333|NCT02742194|ginger obesity|ginger obesity
87334|NCT02742194|ginger inflammation|ginger inflammation
87335|NCT02742194|treatment of obesity|treatment of obesity
87336|NCT02742155|Family Research|family research
87337|NCT02742116|Expanded carrier screening|expanded carrier screening
87339|NCT02742025|Coronary Angiography|coronary angiography
87340|NCT02742012|electroencephalogram|electroencephalogram
87341|NCT02742012|hemodynamic monitoring|hemodynamic monitoring
87342|NCT02742012|respiratory monitoring|respiratory monitoring
87343|NCT02741986|risk assessment|risk assessment
87344|NCT02741986|sepsis|sepsis
87345|NCT02741986|acute kidney injury (AKI)|acute kidney injury (aki)
87346|NCT02741973|Yoga|yoga
87347|NCT02741973|Stress|stress
87348|NCT02741973|Adolescents|adolescents
87349|NCT02741973|School|school
87350|NCT02741973|Children|children
87351|NCT02741960|metformin|metformin
87352|NCT02741960|systemic lupus erythematosus|systemic lupus erythematosus
87353|NCT02741947|Parkinson|parkinson
87354|NCT02741947|Therapeutic Equivalence|therapeutic equivalence
87355|NCT02741947|Levodopa|levodopa
87356|NCT02741895|Biosensing Techniques|biosensing techniques
87357|NCT02741895|Patient Readmission|patient readmission
87358|NCT02741882|Microcephaly|microcephaly
102997|NCT02646098|NHL|nhl
78638|NCT02793856|PD-1|pd-1
87359|NCT02741882|zika Virus|zika virus
87360|NCT02741882|Case-control study|case-control study
87361|NCT02741869|Staphylococcus aureus; nare carriage|staphylococcus aureus; nare carriage
87362|NCT02741804|Memory|memory
87363|NCT02741791|AXS-05|axs-05
87364|NCT02741791|Major Depressive Disorder|major depressive disorder
87365|NCT02741791|Treatment Resistant Depression|treatment resistant depression
87366|NCT02741791|TRD|trd
87367|NCT02741791|MDD|mdd
87368|NCT02741791|Axsome|axsome
87369|NCT02741791|NMDA receptor|nmda receptor
87370|NCT02741791|Refractory depression|refractory depression
87371|NCT02741791|Resistant depression|resistant depression
87372|NCT02741791|Depression|depression
87373|NCT02741778|Esophagogastric Junction|esophagogastric junction
87374|NCT02741778|Adenocarcinoma|adenocarcinoma
87376|NCT02741765|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
87377|NCT02741765|Exercise|exercise
87378|NCT02741765|Brain Plasticity|brain plasticity
87379|NCT02741752|histomorphometry|histomorphometry
87380|NCT02741739|Drug concentration|drug concentration
87381|NCT02741739|REGN1033|regn1033
87382|NCT02741739|blood|blood
87383|NCT02741700|Adherence|adherence
87384|NCT02741700|Disparities|disparities
87385|NCT02741700|Patient Outcomes|patient outcomes
87386|NCT02741687|stress hyperglycemia|stress hyperglycemia
87387|NCT02741687|blood glucose|blood glucose
87388|NCT02741674|Observational Study|observational study
87389|NCT02741674|Comparative Effectiveness Research|comparative effectiveness research
87390|NCT02741648|Red Blood Cell Transfusion|red blood cell transfusion
87391|NCT02741648|Digestive tract problems|digestive tract problems
87392|NCT02741648|Extremely Low Birth Weight|extremely low birth weight
87393|NCT02741622|Exercise therapy|exercise therapy
87394|NCT02741609|Borrelia|borrelia
87395|NCT02741609|spirochetes|spirochetes
87396|NCT02741609|culture|culture
87397|NCT02741609|immunostaining|immunostaining
87398|NCT02741596|DX-2930|dx-2930
87399|NCT02741596|Dyax|dyax
87492|NCT02740725|Amblyopia|amblyopia
87400|NCT02741596|Hereditary Angioedema|hereditary angioedema
87401|NCT02741557|Fixed-dose Combination (FDC)|fixed-dose combination (fdc)
87402|NCT02741557|Bioequivalence|bioequivalence
87403|NCT02741557|Dolutegravir|dolutegravir
87404|NCT02741557|Rilpivirine|rilpivirine
87405|NCT02741544|Second primary cancers|second primary cancers
87406|NCT02741544|Cataracts|cataracts
87407|NCT02741544|Newly-diagnosed multiple myeloma|newly-diagnosed multiple myeloma
87408|NCT02741544|Revlimid capsules|revlimid capsules
87409|NCT02741518|obesity|obesity
87410|NCT02741518|FMT|fmt
87411|NCT02741505|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
87412|NCT02741505|sleep|sleep
87609|NCT02740127|Naropin|naropin
87413|NCT02741505|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
87414|NCT02741505|Sleep Disordered Breathing (SDB)|sleep disordered breathing (sdb)
87415|NCT02741505|Period Limb Movement during Sleep (PLMS)|period limb movement during sleep (plms)
87416|NCT02741479|dancers|dancers
87417|NCT02741440|Spinocerebellar Ataxia|spinocerebellar ataxia
87418|NCT02741427|Tooth discoloration|tooth discoloration
87419|NCT02741427|Toothpaste|toothpaste
87420|NCT02741427|Tooth bleaching|tooth bleaching
87421|NCT02741427|Clinical trial|clinical trial
87422|NCT02741414|Helicobacter pylori|helicobacter pylori
87423|NCT02741414|Antibiotic resistance|antibiotic resistance
87424|NCT02741414|Sequencing|sequencing
87425|NCT02741414|Mechanism|mechanism
87426|NCT02741401|Complementary therapies|complementary therapies
87427|NCT02741401|Massage|massage
87428|NCT02741401|Gastrointestinal cancer|gastrointestinal cancer
87429|NCT02741388|selinexor|selinexor
87430|NCT02741388|lymphoma|lymphoma
87431|NCT02741388|inhibitor of nuclear export|inhibitor of nuclear export
87432|NCT02741362|Type III hypersensitivity autoimmune disease|type iii hypersensitivity autoimmune disease
87433|NCT02741349|Atrial fibrillation|atrial fibrillation
87434|NCT02741349|Risk score|risk score
87435|NCT02741297|Spinal Cord Stimulation|spinal cord stimulation
87436|NCT02741297|Chronic Pain|chronic pain
87437|NCT02741232|analgesics, opioids|analgesics, opioids
87438|NCT02741232|pectoral block|pectoral block
87439|NCT02741206|psycho-education|psycho-education
87440|NCT02741206|maternal depression|maternal depression
87441|NCT02741206|Reach Out Stay Strong Essentials|reach out stay strong essentials
87442|NCT02741193|Transcranial magnet stimulation (nTMS)|transcranial magnet stimulation (ntms)
87443|NCT02741193|Brainsight Neuronavigation|brainsight neuronavigation
87444|NCT02741193|Electromyography|electromyography
87445|NCT02741193|EMG|emg
87446|NCT02741167|peritoneal surface malignancies|peritoneal surface malignancies
87447|NCT02741167|cytoreductive surgery|cytoreductive surgery
87448|NCT02741167|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
87449|NCT02741154|aromataze inhibitor, poor responder ,induction|aromataze inhibitor, poor responder ,induction
87450|NCT02741128|Dengue Fever|dengue fever
87451|NCT02741128|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
103131|NCT02645279|MRI|mri
87452|NCT02741128|Human Immunodeficiency Virus|human immunodeficiency virus
87453|NCT02741128|CYD Dengue Vaccine|cyd dengue vaccine
87454|NCT02741115|Fontan|fontan
87455|NCT02741115|Maximal Oxygen Consumption|maximal oxygen consumption
87456|NCT02741115|Vascular Function|vascular function
87457|NCT02741115|EndoPAT|endopat
87458|NCT02741115|Myocardial Performance|myocardial performance
87459|NCT02741102|Infertility|infertility
87460|NCT02741102|AUFI|aufi
87461|NCT02741089|Analgosedation|analgosedation
87462|NCT02741089|Internal Quality Assurance|internal quality assurance
87463|NCT02741063|oxytocin|oxytocin
87464|NCT02741063|attentional bias|attentional bias
87465|NCT02741063|Autism|autism
87466|NCT02741011|Cone-Beam Computed Tomography|cone-beam computed tomography
87467|NCT02741011|Mentally Handicapped|mentally handicapped
87468|NCT02740998|Microbiome|microbiome
87469|NCT02740998|Progestin|progestin
87470|NCT02740998|Long-acting contraception|long-acting contraception
87471|NCT02740985|AZD4635|azd4635
87472|NCT02740985|durvalumab|durvalumab
87473|NCT02740985|non-small cell lung cancer|non-small cell lung cancer
87474|NCT02740985|advanced solid malignancies|advanced solid malignancies
87475|NCT02740933|Brain Tumor Surgery|brain tumor surgery
87476|NCT02740868|Magnetic Resonance Imaging,cystic fibrosis,asthma,healthy|magnetic resonance imaging,cystic fibrosis,asthma,healthy
87477|NCT02740855|sclerotherapy|sclerotherapy
87478|NCT02740855|ethanol|ethanol
87479|NCT02740855|pulmonal hypertension|pulmonal hypertension
87480|NCT02740790|Human papillomavirus|human papillomavirus
87481|NCT02740790|vaccine|vaccine
87482|NCT02740790|cervical infection|cervical infection
87483|NCT02740790|cervical cancer|cervical cancer
87484|NCT02740764|Functional autonomy level|functional autonomy level
87485|NCT02740764|Lawton Instrumental Activities of Daily Living|lawton instrumental activities of daily living
87486|NCT02740764|Cognitive disorders|cognitive disorders
87487|NCT02740764|Potentially inappropriate medication|potentially inappropriate medication
87488|NCT02740764|elderly|elderly
87489|NCT02740764|Optimization of drug prescribing|optimization of drug prescribing
87490|NCT02740738|Knee Arthroplasty|knee arthroplasty
87491|NCT02740738|Hip Arthroplasty|hip arthroplasty
87493|NCT02740725|Interaction Binocular Treatment (I-BiTTM)|interaction binocular treatment (i-bittm)
87494|NCT02740725|Patch Therapy|patch therapy
87495|NCT02740712|rucaparib|rucaparib
87496|NCT02740712|CO-338|co-338
87497|NCT02740712|Clovis|clovis
87498|NCT02740712|Clovis Oncology|clovis oncology
87499|NCT02740712|PARP Inhibitor|parp inhibitor
87500|NCT02740712|Drug-Drug Interaction|drug-drug interaction
87501|NCT02740699|Cholesterol|cholesterol
87502|NCT02740699|Heart Disease|heart disease
87503|NCT02740699|CT Scan|ct scan
87504|NCT02740699|Crestor|crestor
87505|NCT02740699|Lipitor|lipitor
87506|NCT02740686|COPD|copd
87507|NCT02740686|Exercise|exercise
87519|NCT02740595|oxidative stress|oxidative stress
87520|NCT02740569|scleroderma|scleroderma
87521|NCT02740569|sleep apnea|sleep apnea
87522|NCT02740569|pulmonary disease|pulmonary disease
87523|NCT02740556|Hepatitis C|hepatitis c
87524|NCT02740556|Adherence|adherence
87525|NCT02740556|Adheretech|adheretech
87526|NCT02740556|HepCure|hepcure
87527|NCT02740556|Telehealth|telehealth
87528|NCT02740556|Health apps|health apps
87529|NCT02740543|World Trade Center|world trade center
87531|NCT02740543|Induced Sputum|induced sputum
87532|NCT02740543|Exhaled Breath Condensate|exhaled breath condensate
87533|NCT02740504|Respiration rate|respiration rate
87534|NCT02740465|ACE|ace
87535|NCT02740465|Anxiety|anxiety
87536|NCT02740465|COPD|copd
87537|NCT02740452|Rupture|rupture
87538|NCT02740452|Anterior Cruciate Ligament (ACL)|anterior cruciate ligament (acl)
87539|NCT02740452|Laxity knee|laxity knee
87540|NCT02740452|Instability knee|instability knee
87541|NCT02740400|Endobronchial ultrasonography|endobronchial ultrasonography
87542|NCT02740400|guided sheath|guided sheath
87543|NCT02740400|diagnosis|diagnosis
87544|NCT02740400|accuracy|accuracy
87545|NCT02740400|complication|complication
87546|NCT02740374|ROTEM|rotem
87547|NCT02740374|Thromboelastometry|thromboelastometry
87548|NCT02740374|spine surgery|spine surgery
87549|NCT02740374|allogenic blood transfusion|allogenic blood transfusion
87550|NCT02740374|blood loss|blood loss
87551|NCT02740374|red blood cell transfusion|red blood cell transfusion
87552|NCT02740335|anticoagulant reversal|anticoagulant reversal
87553|NCT02740335|urgent surgery|urgent surgery
87554|NCT02740335|invasive procedures|invasive procedures
87555|NCT02740335|vitamin K|vitamin k
87556|NCT02740335|prothrombin complex concentrate|prothrombin complex concentrate
87557|NCT02740335|four-factor prothrombin complex concentrate (4F-PCC)|four-factor prothrombin complex concentrate (4f-pcc)
87558|NCT02740322|Hum Test, Weber test, audiogram|hum test, weber test, audiogram
87559|NCT02740309|inflammatory bowel disease|inflammatory bowel disease
87560|NCT02740309|childhood chronic disease|childhood chronic disease
87561|NCT02740309|adolescent depression|adolescent depression
87562|NCT02740309|adolescent anxiety|adolescent anxiety
87563|NCT02740309|integrated brief behavioral therapy|integrated brief behavioral therapy
87564|NCT02740309|adolescent psychosocial risks|adolescent psychosocial risks
87565|NCT02740309|adolescent chronic disease|adolescent chronic disease
87566|NCT02740309|childhood depression|childhood depression
87567|NCT02740309|childhood anxiety|childhood anxiety
87568|NCT02740309|childhood psychosocial risks|childhood psychosocial risks
87569|NCT02740283|Gestational Diabetes Mellitus|gestational diabetes mellitus
87570|NCT02740283|Oral Glucose Tolerance Test|oral glucose tolerance test
87571|NCT02740270|advanced solid tumors|advanced solid tumors
87572|NCT02740270|lymphomas|lymphomas
87573|NCT02740270|GWN323|gwn323
87574|NCT02740270|PDR001|pdr001
87575|NCT02740270|advanced malignancies|advanced malignancies
87576|NCT02740270|anti-GITR|anti-gitr
87577|NCT02740270|anti-PD-1|anti-pd-1
87578|NCT02740270|adults|adults
87579|NCT02740231|viscosupplement|viscosupplement
87580|NCT02740231|osteoarthritis|osteoarthritis
87581|NCT02740231|knee|knee
87582|NCT02740231|intra-articular injection|intra-articular injection
87583|NCT02740231|arthritis|arthritis
87584|NCT02740231|degenerative|degenerative
87585|NCT02740218|Psoriasis|psoriasis
87586|NCT02740218|Apremilast|apremilast
87587|NCT02740218|APPRECIATE|appreciate
87588|NCT02740218|Dermatology|dermatology
87589|NCT02740218|Retrospective|retrospective
87590|NCT02740218|Observational|observational
87591|NCT02740205|Patients with Enteral Feeding|patients with enteral feeding
87600|NCT02740166|Esophageal Varices; propranolol; banding ligation|esophageal varices; propranolol; banding ligation
87601|NCT02740140|chronic coinfection|chronic coinfection
87602|NCT02740127|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
87603|NCT02740127|Adult Penile Prosthesis Surgery|adult penile prosthesis surgery
87604|NCT02740127|Caudal nerve block|caudal nerve block
87605|NCT02740127|CNB|cnb
87606|NCT02740127|General anesthesia|general anesthesia
87607|NCT02740127|GA|ga
87608|NCT02740127|Ropivacaine|ropivacaine
87610|NCT02740127|Epinephrine|epinephrine
87611|NCT02740127|Decadron|decadron
87612|NCT02740127|Dexamethasone|dexamethasone
87613|NCT02740127|Clonidine|clonidine
87614|NCT02740127|Propofol|propofol
87615|NCT02740127|Diprivan|diprivan
87616|NCT02740114|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
87617|NCT02740114|Open gynecologic surgery|open gynecologic surgery
87618|NCT02740114|Local wound infiltration|local wound infiltration
87619|NCT02740114|Gynecologic cancer|gynecologic cancer
87620|NCT02740114|Bupivacaine|bupivacaine
87621|NCT02740114|Liposomal Bupivacaine|liposomal bupivacaine
87622|NCT02740114|Oxycodone|oxycodone
87623|NCT02740114|ETH-Oxydose [DSC]|eth-oxydose [dsc]
87624|NCT02740114|OxyContin|oxycontin
87625|NCT02740114|OxyIR|oxyir
87626|NCT02740114|Roxicodone|roxicodone
87627|NCT02740114|Questionnaires|questionnaires
87628|NCT02740114|Surveys|surveys
87629|NCT02740114|MD Anderson Symptom Inventory|md anderson symptom inventory
87630|NCT02740114|MDASI|mdasi
87631|NCT02740114|Pill diary|pill diary
87632|NCT02740114|Medication log|medication log
87633|NCT02740101|oxytocin|oxytocin
87634|NCT02740101|social reward|social reward
87635|NCT02740101|social punishment|social punishment
87636|NCT02740075|Mechanical versus hand ventilation|mechanical versus hand ventilation
87637|NCT02740075|Transport ventilation|transport ventilation
87638|NCT02740049|Epithelial Cells|epithelial cells
87639|NCT02740010|MIOL|miol
87640|NCT02740010|extended depth of focus|extended depth of focus
87641|NCT02740010|cataract|cataract
87642|NCT02740010|visual acuity|visual acuity
87643|NCT02740010|halos|halos
87644|NCT02739984|diabetes|diabetes
87645|NCT02739984|type 2 diabetes|type 2 diabetes
87646|NCT02739984|high blood cholesterol|high blood cholesterol
87647|NCT02739984|hypercholesterolemia|hypercholesterolemia
87648|NCT02739984|mixed dyslipidemia|mixed dyslipidemia
87649|NCT02739984|high cholesterol|high cholesterol
87650|NCT02739984|statin intolerant|statin intolerant
87651|NCT02739945|Ulnar Nerve Compression, Cubital Tunnel|ulnar nerve compression, cubital tunnel
87652|NCT02739932|Attenuated Psychotic Symptoms|attenuated psychotic symptoms
87653|NCT02739919|Kidney stones|kidney stones
87654|NCT02739919|Renal Calculi|renal calculi
87655|NCT02739880|Vaginal discomfort|vaginal discomfort
87656|NCT02739880|Vaginal dryness|vaginal dryness
87657|NCT02739867|occult cancer|occult cancer
87658|NCT02739867|venous thromboembolism|venous thromboembolism
87659|NCT02739867|tumor-educated platelets|tumor-educated platelets
87660|NCT02739867|platelet RNA profiling|platelet rna profiling
87661|NCT02739867|early diagnosis|early diagnosis
87662|NCT02739867|screening|screening
87663|NCT02739854|trauma|trauma
87664|NCT02739854|atelectasis|atelectasis
87665|NCT02739841|hemodynamic response|hemodynamic response
87666|NCT02739828|Quality of life|quality of life
87667|NCT02739815|Caesarean Section|caesarean section
87668|NCT02739815|Tranexamic Acid|tranexamic acid
87669|NCT02739815|Postpartum Hemorrhage|postpartum hemorrhage
87670|NCT02739815|Ecbolics|ecbolics
87671|NCT02739789|tDCS rejection affect mood fMRI|tdcs rejection affect mood fmri
87672|NCT02739763|PfSPZ|pfspz
87673|NCT02739763|Semi-immune adults|semi-immune adults
87674|NCT02739763|Kenya|kenya
87675|NCT02739763|challenge|challenge
87676|NCT02739763|CHMI|chmi
87677|NCT02739763|malaria|malaria
87678|NCT02739737|Bias|bias
87679|NCT02739737|Orthopedics|orthopedics
87680|NCT02739737|Peer Review|peer review
87681|NCT02739698|ovarian cancer|ovarian cancer
87682|NCT02739659|prostate carcinoma|prostate carcinoma
87683|NCT02739659|carbon-ion radiotherapy|carbon-ion radiotherapy
87684|NCT02739659|efficacy|efficacy
87685|NCT02739659|toxicity|toxicity
87686|NCT02739633|Chemotherapy|chemotherapy
87687|NCT02739633|Gemcitabine|gemcitabine
87688|NCT02739633|Recurrent and metastatic adenocarcinoma of the pancreas|recurrent and metastatic adenocarcinoma of the pancreas
87689|NCT02739633|Genexol-PM|genexol-pm
87690|NCT02739633|Paclitaxel|paclitaxel
87691|NCT02739607|emotional disorders|emotional disorders
87692|NCT02739607|internet-delivered intervention|internet-delivered intervention
87693|NCT02739607|anxiety|anxiety
87694|NCT02739607|depression|depression
87695|NCT02739607|transdiagnostic|transdiagnostic
87696|NCT02739568|EDS|eds
87697|NCT02739568|OSA|osa
87698|NCT02739555|Osteoid osteoma|osteoid osteoma
87699|NCT02739555|Bisphophonates|bisphophonates
87700|NCT02739542|Radiologically Isolated Syndrome (RIS)|radiologically isolated syndrome (ris)
87701|NCT02739490|physiotherapeutic techniques|physiotherapeutic techniques
87702|NCT02739490|pelvis|pelvis
87703|NCT02739490|Muscle strength|muscle strength
87704|NCT02739477|Favipiravir|favipiravir
87705|NCT02739477|Tolerance|tolerance
87706|NCT02739477|Survivor|survivor
87707|NCT02739477|Ebola Virus|ebola virus
87708|NCT02739477|Genital reservoir|genital reservoir
87709|NCT02739477|Guinea|guinea
87710|NCT02739464|Burn|burn
87711|NCT02739464|Exercise|exercise
87712|NCT02739464|Ergometer|ergometer
87713|NCT02739464|MP-10|mp-10
87714|NCT02739451|immunocompromized patients|immunocompromized patients
87715|NCT02739451|critically ill patients|critically ill patients
87716|NCT02739438|Pulmonary inflammation|pulmonary inflammation
87717|NCT02739438|Endothelial dysfunction|endothelial dysfunction
87718|NCT02739438|Electronic Cigarettes|electronic cigarettes
87719|NCT02739425|Sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
87720|NCT02739425|Superparamagnetic iron oxide (SPIO) tracer|superparamagnetic iron oxide (spio) tracer
87721|NCT02739399|phenylephrine|phenylephrine
87722|NCT02739399|alpha mimetics|alpha mimetics
635711|NCT00715130|Sedentary|sedentary
87723|NCT02739399|pulse pressure variation|pulse pressure variation
87724|NCT02739399|venous return|venous return
87725|NCT02739347|tDCS|tdcs
87726|NCT02739347|cognitive control|cognitive control
87727|NCT02739347|working memory|working memory
87728|NCT02739347|EEG|eeg
87729|NCT02739347|gamma oscillations|gamma oscillations
87730|NCT02739321|Autism|autism
87731|NCT02739321|ASD|asd
87732|NCT02739321|Sleep|sleep
87733|NCT02739321|Mattress|mattress
87734|NCT02739308|proprioception|proprioception
87735|NCT02739308|ankle sprain|ankle sprain
87736|NCT02739308|fencing|fencing
87737|NCT02739269|ovarian response|ovarian response
87738|NCT02739269|anti-Mullerian hormone|anti-mullerian hormone
87739|NCT02739269|antral follicle count|antral follicle count
87740|NCT02739256|voiding trial|voiding trial
87741|NCT02739256|pelvic organ prolapse|pelvic organ prolapse
87742|NCT02739256|post-operative catheterization|post-operative catheterization
87743|NCT02739204|Celecoxib|celecoxib
87744|NCT02739204|Relapse-free OSCC patient|relapse-free oscc patient
87745|NCT02739204|Recurrence|recurrence
87746|NCT02739204|Survival|survival
87747|NCT02739204|Prognosis|prognosis
87748|NCT02739191|NPWT|npwt
87749|NCT02739165|Acute exacerbations|acute exacerbations
87750|NCT02739165|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
87751|NCT02739165|Recombinant human soluble thrombomodulin|recombinant human soluble thrombomodulin
87752|NCT02739165|ART-123|art-123
87753|NCT02739152|Sepsis|sepsis
87754|NCT02739152|Severe sepsis|severe sepsis
87755|NCT02739152|Infections|infections
87756|NCT02739152|Worsening|worsening
87757|NCT02739126|Diagnosis|diagnosis
87758|NCT02739113|OMECs|omecs
87759|NCT02739113|Cornea|cornea
87760|NCT02739113|Amniotic membrane|amniotic membrane
87761|NCT02739113|Collagenase|collagenase
87762|NCT02739100|pharmacokinetics|pharmacokinetics
87763|NCT02739100|bioequivalence|bioequivalence
87764|NCT02739087|radiation free cardiac catheterization|radiation free cardiac catheterization
87765|NCT02739061|pathogenesis|pathogenesis
87766|NCT02739061|cognitive behavioral group therapy|cognitive behavioral group therapy
87767|NCT02738996|Diabetes|diabetes
87768|NCT02738996|Sedentary Lifestyle|sedentary lifestyle
87769|NCT02738983|Non-small cell lung cancer|non-small cell lung cancer
103451|NCT02643303|In Situ|in situ
87770|NCT02738983|epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)|epidermal growth factor receptor tyrosine kinase inhibitor (egfr-tki)
87771|NCT02738983|Radiotherapy|radiotherapy
87772|NCT02738983|wild type|wild type
87773|NCT02738931|dolutegravir|dolutegravir
87774|NCT02738931|lamivudine|lamivudine
87775|NCT02738931|Bioavailability|bioavailability
87776|NCT02738931|fixed dose combinations|fixed dose combinations
87777|NCT02738918|Renal Transplant|renal transplant
87778|NCT02738918|Anti HLA antibodies|anti hla antibodies
87779|NCT02738918|Humoral rejection|humoral rejection
87780|NCT02738892|Pregnancy|pregnancy
87781|NCT02738892|Stillbirth|stillbirth
87782|NCT02738892|Preterm birth|preterm birth
87783|NCT02738866|breast cancer|breast cancer
87784|NCT02738866|Metastatic Breast Cancer|metastatic breast cancer
87785|NCT02738866|palbociclib|palbociclib
87786|NCT02738866|fulvestrant|fulvestrant
87787|NCT02738814|emergence agitation|emergence agitation
87788|NCT02738814|emergence delirium|emergence delirium
87789|NCT02738814|PAED scale|paed scale
87790|NCT02738814|The Modified Aldrete Scoring System|the modified aldrete scoring system
87791|NCT02738814|treatment|treatment
87793|NCT02738814|sevoflurane|sevoflurane
87794|NCT02738801|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
87795|NCT02738801|GLPG1690|glpg1690
87796|NCT02738801|Autotaxin|autotaxin
87798|NCT02738788|airway changes|airway changes
87799|NCT02738788|MMS|mms
87800|NCT02738788|prone position|prone position
87801|NCT02738788|Trendelenburg position|trendelenburg position
87802|NCT02738775|multiple sclerosis|multiple sclerosis
87803|NCT02738762|intensive care|intensive care
87804|NCT02738762|glutamine|glutamine
87805|NCT02738762|length of stay|length of stay
87806|NCT02738749|sudden cardiac death, sodium channel splicing variant|sudden cardiac death, sodium channel splicing variant
87807|NCT02738723|Limited-stage small cell lung cancer|limited-stage small cell lung cancer
87808|NCT02738723|Stereotactic body radiation therapy|stereotactic body radiation therapy
87809|NCT02738723|Intensity modulated radiation therapy|intensity modulated radiation therapy
87810|NCT02738723|Radiation|radiation
87811|NCT02738723|Chemotherapy|chemotherapy
87812|NCT02738697|Carcinoma,Hepatocellular|carcinoma,hepatocellular
87813|NCT02738697|Adjuvant chemotherapy|adjuvant chemotherapy
87814|NCT02738697|Microvessels invasion|microvessels invasion
87815|NCT02738697|Survival|survival
87816|NCT02738697|Recurrence|recurrence
87817|NCT02738684|lung cancer|lung cancer
87818|NCT02738684|adenocarcinoma|adenocarcinoma
87819|NCT02738684|EGFR|egfr
87820|NCT02738684|plasma free nucleic acids|plasma free nucleic acids
87821|NCT02738671|functional MRI|functional mri
87822|NCT02738671|olfactory function|olfactory function
87823|NCT02738671|bariatric surgery|bariatric surgery
87824|NCT02738658|Coronary microcirculatory dysfunction|coronary microcirculatory dysfunction
87825|NCT02738658|Coronary endothelium dysfunction|coronary endothelium dysfunction
87826|NCT02738619|allergic rhinitis|allergic rhinitis
87827|NCT02738619|immunotherapy|immunotherapy
87828|NCT02738619|vitamin D|vitamin d
87829|NCT02738606|Colorectal Cancer|colorectal cancer
87830|NCT02738606|Other diseases of intestines|other diseases of intestines
87831|NCT02738606|Liver and Unresectable Pulmonary Metastases|liver and unresectable pulmonary metastases
87832|NCT02738606|Resectable liver metastases|resectable liver metastases
87833|NCT02738606|Liver resection|liver resection
87834|NCT02738606|Chemotherapy|chemotherapy
87835|NCT02738554|HBV|hbv
87836|NCT02738554|treatment cessation|treatment cessation
87837|NCT02738554|HBsAg|hbsag
87838|NCT02738554|HBcrAg|hbcrag
87839|NCT02738554|nucleoside analogue|nucleoside analogue
87840|NCT02738554|entecavir|entecavir
87841|NCT02738554|tenofovir|tenofovir
87842|NCT02738502|HIV|hiv
87843|NCT02738502|prevention of mother-to-child transmission|prevention of mother-to-child transmission
87844|NCT02738502|Ritonavir boosted darunavir monotherapy|ritonavir boosted darunavir monotherapy
87845|NCT02738489|PD-1/PD-L1 advanced Melanoma immunotherapy|pd-1/pd-l1 advanced melanoma immunotherapy
87846|NCT02738463|ferritin LBW|ferritin lbw
87847|NCT02738450|cognitive decline|cognitive decline
87848|NCT02738437|osteogenesis|osteogenesis
87849|NCT02738437|Positron-Emission Tomography|positron-emission tomography
87850|NCT02738437|Radiostereometric analysis|radiostereometric analysis
87851|NCT02738424|Low Back Pain|low back pain
87852|NCT02738424|MRI|mri
87853|NCT02738372|Chronic Pain|chronic pain
87854|NCT02738372|Biopsychosocial Factors|biopsychosocial factors
87855|NCT02738372|Shoulder pain|shoulder pain
87856|NCT02738372|Prognosis|prognosis
87857|NCT02738372|Central Nervous System Sensitization|central nervous system sensitization
87858|NCT02738359|colon cancer|colon cancer
87859|NCT02738359|rectum cancer|rectum cancer
87860|NCT02738359|colonoscopy|colonoscopy
87861|NCT02738359|fecal immunological test|fecal immunological test
87862|NCT02738359|colon capsule|colon capsule
87863|NCT02738346|Small Cell Lung Cancer|small cell lung cancer
87864|NCT02738346|Topotecan|topotecan
103585|NCT02642393|PD|pd
79133|NCT02790931|diabetic foot|diabetic foot
79134|NCT02790931|therapeutic exercises|therapeutic exercises
79135|NCT02790931|foot|foot
87865|NCT02738346|Etoposide|etoposide
87866|NCT02738307|High Altitude|high altitude
87867|NCT02738307|Attention|attention
87868|NCT02738307|Cognitive Function|cognitive function
87869|NCT02738307|Acclimatization|acclimatization
87870|NCT02738307|Sleep|sleep
87871|NCT02738255|Obstructive sleep apnea|obstructive sleep apnea
87872|NCT02738255|Mouth breathing|mouth breathing
87873|NCT02738255|Apnea-Hypopnea Index (AHI)|apnea-hypopnea index (ahi)
87874|NCT02738242|Functional Electrical Stimulation|functional electrical stimulation
87875|NCT02738242|Upper motor neuron injury or disease|upper motor neuron injury or disease
87876|NCT02738242|Drop foot|drop foot
87877|NCT02738242|Thigh muscle weakness|thigh muscle weakness
87878|NCT02738203|Pain Management|pain management
87879|NCT02738203|IUD insertion|iud insertion
87880|NCT02738203|Endometrial Biopsy|endometrial biopsy
87881|NCT02738190|albumin|albumin
87882|NCT02738190|fresh frozen plasma|fresh frozen plasma
87883|NCT02738190|extracorporeal circulation|extracorporeal circulation
87884|NCT02738190|cardiovascular surgery|cardiovascular surgery
87885|NCT02738190|pediatric population|pediatric population
87886|NCT02738177|misopristol|misopristol
87887|NCT02738177|effox|effox
89226|NCT02729987|CBT|cbt
87888|NCT02738177|cervical ripening|cervical ripening
87890|NCT02738138|Non-cirrhotic|non-cirrhotic
87891|NCT02738138|HCV Genotype 1|hcv genotype 1
87892|NCT02738138|HCV Genotype 6|hcv genotype 6
87893|NCT02738138|Human Immunodeficiency Virus (HIV) Infection|human immunodeficiency virus (hiv) infection
87894|NCT02738138|HCV Genotype 5|hcv genotype 5
87895|NCT02738138|HCV Treatment Naive|hcv treatment naive
87896|NCT02738138|HCV Genotype 4|hcv genotype 4
87897|NCT02738138|HCV Treatment Experienced|hcv treatment experienced
87898|NCT02738138|HCV Genotype 2|hcv genotype 2
87899|NCT02738138|Hepatitis C Virus (HCV) Infection|hepatitis c virus (hcv) infection
87900|NCT02738138|Compensated Cirrhosis|compensated cirrhosis
87901|NCT02738125|SOTHIS|sothis
87902|NCT02738125|Adalimumab|adalimumab
87903|NCT02738125|Ulcerative Colitis|ulcerative colitis
87904|NCT02738125|Effectiveness|effectiveness
87905|NCT02738086|Amputation|amputation
87906|NCT02738086|Physical Activity|physical activity
87907|NCT02738086|Rehabilitation|rehabilitation
87908|NCT02738034|Hypertension|hypertension
87909|NCT02738034|Cognition|cognition
88010|NCT02737410|Hypnosis|hypnosis
88430|NCT02734602|ketamine|ketamine
87910|NCT02738034|Computerized Training|computerized training
87911|NCT02738034|Cogmed|cogmed
87912|NCT02738021|Psychosocial|psychosocial
87913|NCT02738021|Psychotherapy|psychotherapy
87914|NCT02738021|Maternal|maternal
87915|NCT02737995|Iron deficiency|iron deficiency
87916|NCT02737982|coronary heart disease|coronary heart disease
87917|NCT02737982|gender|gender
87918|NCT02737982|platelet|platelet
87919|NCT02737982|microvascular dysfunction|microvascular dysfunction
87920|NCT02737982|sexual hormones|sexual hormones
87921|NCT02737982|cardiac magnetic resonance|cardiac magnetic resonance
87922|NCT02737982|percutaneous coronary interventions|percutaneous coronary interventions
87923|NCT02737969|Transesophageal Echocardiography/angiography (TEE/Angio)|transesophageal echocardiography/angiography (tee/angio)
87924|NCT02737943|Skin graft|skin graft
87926|NCT02737943|MEBO|mebo
87927|NCT02737943|Wound dressing|wound dressing
87928|NCT02737943|Wound care|wound care
87929|NCT02737943|Raw Area|raw area
87930|NCT02737930|Acute ischemic stroke|acute ischemic stroke
87931|NCT02737930|Homonymous hemianopia|homonymous hemianopia
87932|NCT02737930|Homonymous quadrantanopia|homonymous quadrantanopia
87933|NCT02737930|Visual field loss|visual field loss
87934|NCT02737930|Post-stroke recovery|post-stroke recovery
87935|NCT02737930|Fluoxetine|fluoxetine
87936|NCT02737930|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
87937|NCT02737904|Muscle spasticity|muscle spasticity
87938|NCT02737865|Focal nodular hyperplasia|focal nodular hyperplasia
87939|NCT02737865|Ultrasonography|ultrasonography
87940|NCT02737865|Superb-Microvascular imaging|superb-microvascular imaging
87941|NCT02737865|Contrast-enhanced ultrasonography|contrast-enhanced ultrasonography
87942|NCT02737813|isobaric marcaine|isobaric marcaine
87943|NCT02737813|hyperbaric marcaine|hyperbaric marcaine
87944|NCT02737787|Second or Greater Remission|second or greater remission
87945|NCT02737787|WT1 Analog Peptide Vaccine|wt1 analog peptide vaccine
87946|NCT02737787|Montanide|montanide
87947|NCT02737787|GM-CSF|gm-csf
87948|NCT02737787|Nivolumab|nivolumab
87949|NCT02737787|15-247|15-247
87950|NCT02737774|Icotinib|icotinib
87951|NCT02737774|chemotherapy|chemotherapy
87952|NCT02737774|EGFR|egfr
87953|NCT02737761|Heart Failure|heart failure
87954|NCT02737761|Positive Psychology|positive psychology
103768|NCT02641522|T1D|t1d
79227|NCT02790541|aging|aging
87955|NCT02737761|Adherence to Health Behaviors|adherence to health behaviors
87956|NCT02737748|Donor Site Wounds|donor site wounds
87957|NCT02737696|prescription opioid|prescription opioid
87958|NCT02737696|prevention|prevention
87959|NCT02737696|computer-based|computer-based
87960|NCT02737696|adolescent|adolescent
87961|NCT02737683|Disease|disease
87962|NCT02737683|anxiety|anxiety
87963|NCT02737683|depression|depression
87964|NCT02737683|combine|combine
87965|NCT02737683|negative emotional states|negative emotional states
87966|NCT02737683|functional dyspepsia|functional dyspepsia
87967|NCT02737657|Canagliflozin|canagliflozin
87968|NCT02737657|Metformin|metformin
87969|NCT02737657|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
87970|NCT02737657|INVOKANA|invokana
87971|NCT02737657|Sulfonylurea|sulfonylurea
87972|NCT02737644|Congenital Heart Disease|congenital heart disease
87973|NCT02737644|Key Nutritional Factors|key nutritional factors
87974|NCT02737644|conception|conception
87975|NCT02737644|pregnant|pregnant
87976|NCT02737605|Esketamine|esketamine
87977|NCT02737605|Healthy|healthy
87978|NCT02737605|Pharmacokinetics|pharmacokinetics
87979|NCT02737605|Electrocardiogram|electrocardiogram
87980|NCT02737605|Repolarization|repolarization
87981|NCT02737579|cardiac catheterization|cardiac catheterization
87982|NCT02737579|cardiac MRI|cardiac mri
87983|NCT02737566|Smoking Cessation|smoking cessation
87984|NCT02737566|Financial Incentives|financial incentives
87985|NCT02737566|Contingency Management|contingency management
89316|NCT02729298|First in human|first in human
87994|NCT02737501|Non-small cell lung cancer|non-small cell lung cancer
87995|NCT02737501|Non-small cell lung carcinoma|non-small cell lung carcinoma
87996|NCT02737501|Epithelial lung cancer|epithelial lung cancer
87997|NCT02737501|Squamous cell carcinoma|squamous cell carcinoma
87998|NCT02737501|Large cell carcinoma|large cell carcinoma
87999|NCT02737501|Adenocarcinoma|adenocarcinoma
88000|NCT02737501|Carcinoma|carcinoma
88001|NCT02737501|Anaplastic Lymphoma Kinase (ALK)|anaplastic lymphoma kinase (alk)
88002|NCT02737501|Advanced Cancers|advanced cancers
88003|NCT02737501|Brigatinib|brigatinib
88004|NCT02737501|AP26113|ap26113
88005|NCT02737488|Therapy|therapy
88006|NCT02737488|Trauma Systems Therapy|trauma systems therapy
88007|NCT02737410|Resilience|resilience
88008|NCT02737410|Coping|coping
88009|NCT02737410|Psychosomatic|psychosomatic
88011|NCT02737410|Construct Validation|construct validation
88012|NCT02737384|Combined immunodeficiencies|combined immunodeficiencies
88013|NCT02737384|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
88014|NCT02737384|CD45RA|cd45ra
88015|NCT02737384|primitive immunodeficiencies|primitive immunodeficiencies
88016|NCT02737384|pediatric transplantation|pediatric transplantation
88017|NCT02737384|CD45RA depletion|cd45ra depletion
88018|NCT02737358|nicotine|nicotine
88019|NCT02737358|tobacco|tobacco
88020|NCT02737358|smoking|smoking
88021|NCT02737358|cessation|cessation
88022|NCT02737358|N-acetylcysteine|n-acetylcysteine
88023|NCT02737358|NAC|nac
88024|NCT02737358|pharmacotherapy|pharmacotherapy
88025|NCT02737358|relapse|relapse
88026|NCT02737358|tobacco use disorder|tobacco use disorder
88027|NCT02737345|fibrinolysis|fibrinolysis
88028|NCT02737345|liver transplant|liver transplant
88029|NCT02737345|thromboelastometry|thromboelastometry
88030|NCT02737319|Contrast,nephropathy, angioplasty, stable coronary|contrast,nephropathy, angioplasty, stable coronary
88031|NCT02737306|Allogeneic Stem-Cell Transplantation|allogeneic stem-cell transplantation
88032|NCT02737280|infant|infant
88033|NCT02737280|high flow nasal cannulae|high flow nasal cannulae
88034|NCT02737280|oxygen therapy|oxygen therapy
88035|NCT02737280|bronchiolitis|bronchiolitis
88036|NCT02737267|Genetics|genetics
88037|NCT02737267|Polymorphism|polymorphism
88038|NCT02737267|Epigenetics|epigenetics
88039|NCT02737267|Metagenomics|metagenomics
88040|NCT02737267|Metabolomics|metabolomics
88041|NCT02737267|Metabolic syndrome conditions|metabolic syndrome conditions
88042|NCT02737267|Precision nutrition|precision nutrition
88043|NCT02737254|Attachment|attachment
88044|NCT02737254|Oxytocin|oxytocin
88045|NCT02737254|Cognitive bias modification|cognitive bias modification
88046|NCT02737254|Middle childhood|middle childhood
88047|NCT02737241|Prostate|prostate
88048|NCT02737241|Laser|laser
88049|NCT02737241|Enucleation|enucleation
88050|NCT02737202|LAM|lam
88051|NCT02737189|Basilar Artery Occlusion|basilar artery occlusion
88052|NCT02737189|Ischemic Stroke|ischemic stroke
88053|NCT02737189|Mechanical Embolectomy|mechanical embolectomy
88054|NCT02737176|Smoking Cessation|smoking cessation
88055|NCT02737176|Mouth Diseases|mouth diseases
88056|NCT02737176|Periodontal Diseases|periodontal diseases
88057|NCT02737176|Leukoplakia|leukoplakia
88058|NCT02737176|Keratosis|keratosis
88059|NCT02737176|Implant|implant
103834|NCT02641158|HIV|hiv
88060|NCT02737176|Lichen Planus|lichen planus
88061|NCT02737163|Programmable shunts|programmable shunts
88062|NCT02737163|Strata valve|strata valve
88063|NCT02737124|Acetaminophen|acetaminophen
88064|NCT02737124|Surgery|surgery
88065|NCT02737124|Meniscectomy|meniscectomy
88066|NCT02737098|PTSD|ptsd
88067|NCT02737098|virtual care|virtual care
88068|NCT02737098|implementation|implementation
88069|NCT02737098|telepsychiatry|telepsychiatry
88070|NCT02737098|telepsychology|telepsychology
88071|NCT02737085|CD19-targeted CAR-T Cell|cd19-targeted car-t cell
88072|NCT02737085|CD20-targeted CAR-T Cell|cd20-targeted car-t cell
88073|NCT02737085|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
88074|NCT02737072|immuno-oncology|immuno-oncology
88075|NCT02737046|Adult T-cell Leukemia-Lymphoma|adult t-cell leukemia-lymphoma
88076|NCT02737046|ATLL|atll
88077|NCT02737033|ADHD|adhd
88078|NCT02737033|Adults|adults
88079|NCT02737033|Treatment|treatment
88080|NCT02737033|Rhodiola|rhodiola
88082|NCT02737020|Adults|adults
88083|NCT02737020|Treatment|treatment
88084|NCT02737020|Rhodiola rosea|rhodiola rosea
88085|NCT02737007|Malaria|malaria
88086|NCT02737007|Microdose|microdose
88087|NCT02737007|GSK3191607|gsk3191607
88088|NCT02736994|edentulous|edentulous
88089|NCT02736994|patients|patients
88090|NCT02736994|with full|with full
88091|NCT02736981|Obesity|obesity
88092|NCT02736981|Weight Loss|weight loss
88093|NCT02736981|Young Adults|young adults
88094|NCT02736968|Amebic|amebic
88095|NCT02736968|Auranofin|auranofin
88096|NCT02736968|GI Protozoa|gi protozoa
88097|NCT02736968|Giardiasis|giardiasis
88098|NCT02736968|Reprofiled|reprofiled
88099|NCT02736890|Botulinum Toxin A|botulinum toxin a
88100|NCT02736890|Neuropathic pain|neuropathic pain
88101|NCT02736890|Spinal cord injury|spinal cord injury
88102|NCT02736890|Pain management|pain management
88103|NCT02736890|Rehabilitation|rehabilitation
88104|NCT02736877|keratoconus|keratoconus
88105|NCT02736877|bullous keratopathy|bullous keratopathy
88106|NCT02736877|corneal dystrophy|corneal dystrophy
88107|NCT02736851|disability|disability
88108|NCT02736851|home|home
88109|NCT02736851|stretching exercises|stretching exercises
88110|NCT02736838|Pressure|pressure
88111|NCT02736838|Pressure Ulcer|pressure ulcer
88112|NCT02736838|Skin perfusion|skin perfusion
88113|NCT02736838|Skin oxygenation|skin oxygenation
88114|NCT02736812|Randomized controlled trial|randomized controlled trial
88115|NCT02736812|Lyophilized Plasma|lyophilized plasma
88116|NCT02736812|Advanced Trauma Life Support Care|advanced trauma life support care
88117|NCT02736786|proton|proton
88118|NCT02736773|Guided Bone|guided bone
88119|NCT02736773|Pre-implant referred|pre-implant referred
88120|NCT02736773|Regeneration|regeneration
88121|NCT02736747|Stroke|stroke
88122|NCT02736747|Muscle Spasticity|muscle spasticity
88123|NCT02736747|Cryotherapy|cryotherapy
88124|NCT02736747|Gait|gait
88125|NCT02736747|Muscle Weakness|muscle weakness
88126|NCT02736747|Proprioception|proprioception
88127|NCT02736708|Primary sclerosing cholangitis|primary sclerosing cholangitis
88128|NCT02736695|PPA|ppa
88129|NCT02736669|weight loss|weight loss
88130|NCT02736669|body weight|body weight
88131|NCT02736669|behavioral|behavioral
88132|NCT02736643|LDCT, screening|ldct, screening
88133|NCT02736630|general anaesthesia|general anaesthesia
88134|NCT02736630|elective surgery|elective surgery
88135|NCT02736630|national epidemiology|national epidemiology
88136|NCT02736630|turkey|turkey
88137|NCT02736565|metastatic|metastatic
88138|NCT02736565|askin tumor|askin tumor
88139|NCT02736565|neuroectodermal tumor|neuroectodermal tumor
88140|NCT02736565|pNET|pnet
88141|NCT02736565|sarcoma|sarcoma
88142|NCT02736565|soft tissue|soft tissue
88143|NCT02736552|Gastric cancer|gastric cancer
88144|NCT02736552|Adjuvant chemotherapy|adjuvant chemotherapy
88145|NCT02736552|S-1|s-1
88146|NCT02736552|D2 resection|d2 resection
88147|NCT02736526|moderate intermittent exotropia|moderate intermittent exotropia
88148|NCT02736526|surgical treatment|surgical treatment
88149|NCT02736526|observation|observation
88150|NCT02736513|Tagrisso|tagrisso
88151|NCT02736513|AZD9291|azd9291
88152|NCT02736513|EGFRm|egfrm
88153|NCT02736513|brain metastases|brain metastases
88154|NCT02736513|NSCLC|nsclc
88155|NCT02736500|neuroendocrine tumors|neuroendocrine tumors
88156|NCT02736500|gastro entero pancreatic neuroendocrine tumors|gastro entero pancreatic neuroendocrine tumors
88157|NCT02736500|Radioisotope therapy|radioisotope therapy
88158|NCT02736500|177Lu-DOTATATE|177lu-dotatate
88159|NCT02736500|METRONOMIC CAPECITABINE|metronomic capecitabine
88160|NCT02736487|Air Pollution|air pollution
88161|NCT02736487|Exposure Assessment|exposure assessment
88162|NCT02736487|Filtration|filtration
88163|NCT02736487|Cardiovascular Outcomes|cardiovascular outcomes
88164|NCT02736487|Respiratory Outcomes|respiratory outcomes
79426|NCT02789254|CD135|cd135
88165|NCT02736487|Short-term Intervention|short-term intervention
88166|NCT02736461|Orbital fractures|orbital fractures
88167|NCT02736461|Strabismus|strabismus
88168|NCT02736461|Predicting factors|predicting factors
88169|NCT02736461|orbital floor fractures|orbital floor fractures
88170|NCT02736448|GEP-NET tumors|gep-net tumors
88171|NCT02736448|Lu-PRRT|lu-prrt
88172|NCT02736448|177Lutethium - Peptide Receptor Radionuclide Therapy|177lutethium - peptide receptor radionuclide therapy
88173|NCT02736448|gastro-entero-pancreatic neuroendocrine tumors|gastro-entero-pancreatic neuroendocrine tumors
88174|NCT02736448|18-FDG Positron Emission Tomography (PET) positive|18-fdg positron emission tomography (pet) positive
88175|NCT02736448|low dose of capecitabine|low dose of capecitabine
88176|NCT02736435|Magnetic Resonance Guided High Intensity Focused Ultrasound|magnetic resonance guided high intensity focused ultrasound
88177|NCT02736435|MR-HIFU|mr-hifu
88178|NCT02736435|Fibroids|fibroids
88179|NCT02736435|Leuprolide Acetate|leuprolide acetate
88180|NCT02736357|Lymphoma|lymphoma
88181|NCT02736357|Cohort|cohort
88182|NCT02736357|non-Hodgkin|non-hodgkin
88183|NCT02736344|coronary luminal diameter|coronary luminal diameter
88185|NCT02736344|vessels|vessels
88186|NCT02736331|Cognitive performance|cognitive performance
88187|NCT02736331|Metabolic control|metabolic control
88188|NCT02736331|Pharmacokinetic profile|pharmacokinetic profile
88189|NCT02736331|Anthocyanins|anthocyanins
88190|NCT02736305|ovarian|ovarian
88191|NCT02736305|regorafenib|regorafenib
88192|NCT02736305|platinum resistant|platinum resistant
88193|NCT02736305|clear cell|clear cell
88194|NCT02736305|endometrioid|endometrioid
88195|NCT02736266|Muscle-invasive|muscle-invasive
88196|NCT02736266|Urothelial bladder carcinoma|urothelial bladder carcinoma
88197|NCT02736266|Neoadjuvant therapy|neoadjuvant therapy
88198|NCT02736266|Radical cystectomy|radical cystectomy
88199|NCT02736253|foot amputation|foot amputation
88200|NCT02736253|Osteomyelitis|osteomyelitis
88201|NCT02736253|Diabetic Foot|diabetic foot
88202|NCT02736227|liver transplantation|liver transplantation
88203|NCT02736227|immunosuppression|immunosuppression
88204|NCT02736227|everolimus|everolimus
88205|NCT02736227|tacrolimus|tacrolimus
88206|NCT02736227|kidney function|kidney function
88207|NCT02736227|liver function|liver function
88208|NCT02736227|biomarkers|biomarkers
88209|NCT02736188|GNE Myopathy|gne myopathy
88210|NCT02736188|GNEM|gnem
88211|NCT02736188|Nonaka|nonaka
88212|NCT02736188|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
88213|NCT02736188|HIBM|hibm
88214|NCT02736188|DMRV|dmrv
88215|NCT02736188|QSM|qsm
88216|NCT02736162|Perampanel|perampanel
88217|NCT02736162|E2007|e2007
88218|NCT02736162|Phase 4|phase 4
88219|NCT02736162|Fycompa|fycompa
88220|NCT02736136|maternal parenting self-efficacy|maternal parenting self-efficacy
88221|NCT02736136|parental stress|parental stress
88222|NCT02736136|maternal sensitivity|maternal sensitivity
88223|NCT02736136|mother-infant bond|mother-infant bond
88224|NCT02736110|Osteoarthritis, knee|osteoarthritis, knee
88225|NCT02736084|optimism|optimism
88226|NCT02736084|positive affect|positive affect
88227|NCT02736084|adherence|adherence
88228|NCT02736084|health behavior|health behavior
88229|NCT02736084|diabetes|diabetes
88230|NCT02736006|Alveolo-capillar membrane|alveolo-capillar membrane
88231|NCT02736006|decompression illness|decompression illness
88233|NCT02736006|occupational|occupational
88234|NCT02735993|Celution|celution
88235|NCT02735993|ADRC|adrc
88236|NCT02735993|Heart Failure|heart failure
88237|NCT02735993|Device|device
88238|NCT02735980|SCLC|sclc
88239|NCT02735980|LY2606368|ly2606368
88240|NCT02735980|CHK1|chk1
88241|NCT02735915|Immunogenicity|immunogenicity
88242|NCT02735915|Safety|safety
88243|NCT02735915|Long term follow-up|long term follow-up
88244|NCT02735915|Adults|adults
88245|NCT02735915|Herpes zoster|herpes zoster
88246|NCT02735902|antivitamins K|antivitamins k
88247|NCT02735876|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
88248|NCT02735876|Btk|btk
88249|NCT02735876|ACP-196|acp-196
88250|NCT02735876|Mantle Cell Lymphoma|mantle cell lymphoma
88251|NCT02735876|MCL|mcl
88252|NCT02735811|Implantable defibrillator|implantable defibrillator
88253|NCT02735811|Cardiomyopathies|cardiomyopathies
88254|NCT02735720|thoracic endovascular aortic repair|thoracic endovascular aortic repair
88255|NCT02735720|endograft|endograft
88256|NCT02735720|cardiac remodelling|cardiac remodelling
88257|NCT02735720|thoracic aortic aneurysm|thoracic aortic aneurysm
88258|NCT02735720|penetrating aortic ulcer|penetrating aortic ulcer
88259|NCT02735720|MRI|mri
88260|NCT02735694|Sleep apnea|sleep apnea
88261|NCT02735694|Hypoglossal Nerve|hypoglossal nerve
88262|NCT02735694|N-methyl-D-aspartate receptors|n-methyl-d-aspartate receptors
88263|NCT02735694|Cycloserine|cycloserine
88264|NCT02735694|Short-term potentiation|short-term potentiation
88265|NCT02735668|Shoulder Pain|shoulder pain
79519|NCT02788734|Hereditary Neuropathy|hereditary neuropathy
79520|NCT02788734|Pressure Palsies|pressure palsies
88266|NCT02735668|Pattern Motor|pattern motor
88267|NCT02735668|Physical Therapy Modalities|physical therapy modalities
88268|NCT02735668|Breast Cancer Treatment|breast cancer treatment
88269|NCT02735655|endoscopy|endoscopy
88270|NCT02735655|Education|education
88271|NCT02735655|capsule endoscopy|capsule endoscopy
88272|NCT02735655|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
88273|NCT02735655|esophagogastroduodenoscopy|esophagogastroduodenoscopy
88274|NCT02735655|colonoscopy|colonoscopy
88275|NCT02735655|Double-Balloon Enteroscopy|double-balloon enteroscopy
88276|NCT02735655|Global status|global status
88277|NCT02735655|unmet need|unmet need
88278|NCT02735616|heart rate variability|heart rate variability
88279|NCT02735616|stroke|stroke
88280|NCT02735577|Alcohol|alcohol
88281|NCT02735577|Craving|craving
88282|NCT02735577|Functional MRI|functional mri
88283|NCT02735577|Cognitive control|cognitive control
88284|NCT02735577|Risky decision-making|risky decision-making
88285|NCT02735577|Disulfiram|disulfiram
88286|NCT02735564|Weight Loss|weight loss
88287|NCT02735564|Magnetic Resonance Imaging|magnetic resonance imaging
88294|NCT02735525|telemedicine|telemedicine
88296|NCT02735499|onabotulinum toxin A|onabotulinum toxin a
88297|NCT02735499|Urinary bladder|urinary bladder
88298|NCT02735499|EMDA|emda
88299|NCT02735499|iontophoresis|iontophoresis
88300|NCT02735499|electrophoresis|electrophoresis
88301|NCT02735499|Urinary incontinence|urinary incontinence
88302|NCT02735486|Ginger|ginger
88303|NCT02735486|blood pressure|blood pressure
88304|NCT02735486|flow mediated dilatation|flow mediated dilatation
88305|NCT02735434|Health anxiety|health anxiety
88306|NCT02735434|illness anxiety disorder|illness anxiety disorder
88307|NCT02735434|ACT|act
88308|NCT02735434|internet|internet
88309|NCT02735421|acne|acne
88310|NCT02735421|scars|scars
88311|NCT02735395|Periodontal Diseases|periodontal diseases
88312|NCT02735395|Metronidazole|metronidazole
88313|NCT02735395|Amoxicillin|amoxicillin
88314|NCT02735395|Chronic periodontitis|chronic periodontitis
88315|NCT02735395|Root Planing|root planing
88316|NCT02735382|Translational Medical Research|translational medical research
88317|NCT02735382|Clinical Practice Guidelines|clinical practice guidelines
88318|NCT02735382|Electronic Health Records|electronic health records
88319|NCT02735382|Smoking|smoking
88320|NCT02735382|Tobacco|tobacco
88321|NCT02735382|Quitline|quitline
88322|NCT02735330|CCP|ccp
88323|NCT02735317|Nasopharyngeal carcinoma (NPC)|nasopharyngeal carcinoma (npc)
88324|NCT02735317|radiotherapy|radiotherapy
88325|NCT02735317|oral mucositis (OM)|oral mucositis (om)
88326|NCT02735291|Leukemia CAR-T|leukemia car-t
88327|NCT02735265|Rehabilitation|rehabilitation
88328|NCT02735265|Virtual reality|virtual reality
88329|NCT02735252|Castration Resistant|castration resistant
88330|NCT02735252|Metastatic|metastatic
88331|NCT02735239|Oesophageal Cancer|oesophageal cancer
88332|NCT02735239|Oesophageal adenocarcinoma|oesophageal adenocarcinoma
88333|NCT02735239|Oesophageal squamous cell carcinoma|oesophageal squamous cell carcinoma
88334|NCT02735239|Immunotherapy|immunotherapy
88335|NCT02735239|Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)|cytotoxic t-lymphocyte-associated protein 4 (ctla-4)
88336|NCT02735239|Programmed cell death protein 1 (PD-1)|programmed cell death protein 1 (pd-1)
88337|NCT02735239|Programmed death ligand 1 (PD-L1)|programmed death ligand 1 (pd-l1)
88339|NCT02735226|Shanghai Healthcare|shanghai healthcare
88340|NCT02735226|Healthcare Quality, Access, and Evaluation|healthcare quality, access, and evaluation
88341|NCT02735213|Central Serous Choroidopathy|central serous choroidopathy
88342|NCT02735213|Micropulse Laser Treatment|micropulse laser treatment
88343|NCT02735213|Traditional laser Treatment|traditional laser treatment
88344|NCT02735213|optical coherence tomography|optical coherence tomography
88345|NCT02735174|Telehealth|telehealth
88346|NCT02735174|Sensor cap|sensor cap
88347|NCT02735174|School based care|school based care
88348|NCT02735174|Community health|community health
88349|NCT02735174|AsthmaTreatSmart Application|asthmatreatsmart application
88350|NCT02735161|Sarcoidosis|sarcoidosis
88351|NCT02735161|Fatigue|fatigue
88352|NCT02735161|Exercise|exercise
88353|NCT02735148|Postural balance|postural balance
88354|NCT02735148|Accidental falls|accidental falls
88355|NCT02735148|Rehabilitation|rehabilitation
88356|NCT02735148|Cerebrovascular Accident|cerebrovascular accident
88357|NCT02735148|Walking|walking
88358|NCT02735148|Mobility limitation|mobility limitation
88359|NCT02735135|bedridden|bedridden
88360|NCT02735109|VIN|vin
88361|NCT02735096|Bilateral Vestibular Hypofunction|bilateral vestibular hypofunction
88362|NCT02735096|Unilateral Vestibular Hypofunction|unilateral vestibular hypofunction
88363|NCT02735096|Imbalance|imbalance
88364|NCT02735070|Common cold treatment|common cold treatment
88365|NCT02735057|oesophagus cancer|oesophagus cancer
88366|NCT02735031|Glucagon-Like Peptide 1|glucagon-like peptide 1
88367|NCT02735031|Impaired hypoglycemic awareness|impaired hypoglycemic awareness
88368|NCT02734992|Migraines|migraines
88369|NCT02734992|Tension-type Headache|tension-type headache
88370|NCT02734992|Acceptance|acceptance
88371|NCT02734979|lymphedema|lymphedema
88372|NCT02734979|edema|edema
88373|NCT02734966|Drug-Induced|drug-induced
88374|NCT02734966|Acute Liver Injury|acute liver injury
88375|NCT02734953|Inhaled nitric oxide|inhaled nitric oxide
88376|NCT02734953|Exercise|exercise
88377|NCT02734953|6 minute walk test|6 minute walk test
88378|NCT02734953|CardioMems|cardiomems
88379|NCT02734927|schizophrenia|schizophrenia
88380|NCT02734927|motivation|motivation
88381|NCT02734927|executive control|executive control
88382|NCT02734901|polyphenols|polyphenols
88383|NCT02734901|vascular function|vascular function
88384|NCT02734901|endothelial function|endothelial function
88386|NCT02734888|arterial inflammation|arterial inflammation
88387|NCT02734888|electronic cigarettes|electronic cigarettes
88388|NCT02734888|PET scan|pet scan
88389|NCT02734875|anticoagulants|anticoagulants
88390|NCT02734875|NOACs|noacs
88391|NCT02734875|warfarin|warfarin
88392|NCT02734875|randomized designed delay|randomized designed delay
88393|NCT02734875|intervention|intervention
88394|NCT02734875|machine learning algorithm|machine learning algorithm
88395|NCT02734875|primary care|primary care
88396|NCT02734862|mycoses|mycoses
88397|NCT02734810|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
88398|NCT02734810|Cystic Fibrosis|cystic fibrosis
88399|NCT02734810|Liprotamase|liprotamase
88400|NCT02734810|Pancreatic Enzyme Replacement Therapy (PERT)|pancreatic enzyme replacement therapy (pert)
88401|NCT02734771|DLBCL|dlbcl
88402|NCT02734745|diabetes type 1|diabetes type 1
88403|NCT02734745|flash glucose monitoring|flash glucose monitoring
88404|NCT02734732|Prostate|prostate
88405|NCT02734732|Biopsy|biopsy
88406|NCT02734732|Infection|infection
88407|NCT02734732|Prophylaxis|prophylaxis
88408|NCT02734732|Antibiotic|antibiotic
88409|NCT02734693|Attention-Deficit Hyperactivity Disorder (ADHD)|attention-deficit hyperactivity disorder (adhd)
88410|NCT02734680|Pancreatic cancer|pancreatic cancer
88411|NCT02734680|Intraoperative radiotherapy(IORT)|intraoperative radiotherapy(iort)
88412|NCT02734680|Postoperative radiochemotherapy|postoperative radiochemotherapy
88413|NCT02734654|oxidative stress|oxidative stress
88414|NCT02734654|lung lobectomy|lung lobectomy
88415|NCT02734615|LSZ102|lsz102
88416|NCT02734615|ER+ breast cancer|er+ breast cancer
88417|NCT02734615|advanced ER+ breast cancer|advanced er+ breast cancer
88516|NCT02734160|check point inhibitors|check point inhibitors
88418|NCT02734615|metastatic ER+ breast cancer|metastatic er+ breast cancer
88419|NCT02734615|SERD|serd
88420|NCT02734615|SERM|serm
88421|NCT02734615|fulvestrant|fulvestrant
88422|NCT02734615|tamoxifen|tamoxifen
88423|NCT02734615|aromatase inhibitor|aromatase inhibitor
88424|NCT02734615|ESR1|esr1
88425|NCT02734615|estrogen receptor|estrogen receptor
88426|NCT02734615|endocrine therapy|endocrine therapy
88427|NCT02734602|depression|depression
88428|NCT02734602|post-traumatic stress disorder|post-traumatic stress disorder
88429|NCT02734602|sv2a|sv2a
88432|NCT02734589|Ulcerative Colitis|ulcerative colitis
88433|NCT02734589|Nutrition|nutrition
88434|NCT02734589|microbiome|microbiome
88435|NCT02734576|Venous Sinus Stenting|venous sinus stenting
88436|NCT02734576|Dural Sinus Stenting|dural sinus stenting
88437|NCT02734550|Sepsis|sepsis
88438|NCT02734550|Invasive Candida Infection|invasive candida infection
88439|NCT02734550|Biomarker|biomarker
88440|NCT02734550|(1,3)-β-D-glucan|(1,3)-β-d-glucan
88441|NCT02734550|Antifungal therapy|antifungal therapy
88442|NCT02734550|Intensive care medicine|intensive care medicine
88443|NCT02734550|Critically ill|critically ill
88444|NCT02734524|Natural killer cells|natural killer cells
88445|NCT02734524|NSCLC|nsclc
88446|NCT02734524|NCT|nct
88447|NCT02734524|Combined therapy|combined therapy
88448|NCT02734485|Progressive supranuclear palsy|progressive supranuclear palsy
88449|NCT02734485|Deep transcranial magnetic stimulation|deep transcranial magnetic stimulation
88450|NCT02734472|blood pressure|blood pressure
88451|NCT02734472|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
88452|NCT02734472|Vascular Stiffness|vascular stiffness
88453|NCT02734472|Proteinuria|proteinuria
88454|NCT02734472|Carotid Artery Diseases|carotid artery diseases
88455|NCT02734446|Bronchial Inflammation|bronchial inflammation
88456|NCT02734446|Asthma|asthma
88457|NCT02734446|Childhood Asthma Control Test (C-ACT)|childhood asthma control test (c-act)
88458|NCT02734446|Asthma Exacerbations|asthma exacerbations
88459|NCT02734433|Advanced solid tumors|advanced solid tumors
88460|NCT02734433|Asian subjects|asian subjects
88461|NCT02734433|Developmental Phase I|developmental phase i
88462|NCT02734420|Dental caries|dental caries
88463|NCT02734420|PDT|pdt
79754|NCT02787304|NAS|nas
88464|NCT02734420|LLLT|lllt
88465|NCT02734420|pediatric dentistry|pediatric dentistry
88466|NCT02734394|exercise|exercise
88467|NCT02734394|body composition|body composition
88468|NCT02734394|metabolism|metabolism
88469|NCT02734394|nutrition|nutrition
88470|NCT02734381|elderly patients|elderly patients
88471|NCT02734381|prevalence|prevalence
88472|NCT02734381|emergency department use|emergency department use
88473|NCT02734381|main presenting disease|main presenting disease
88474|NCT02734355|atrial fibrillation|atrial fibrillation
88475|NCT02734355|catheter ablation|catheter ablation
88476|NCT02734355|left atrium|left atrium
88477|NCT02734355|mechanical function|mechanical function
88478|NCT02734355|contractility|contractility
88479|NCT02734329|Nephron sparing surgery|nephron sparing surgery
88480|NCT02734329|Zero ischemia|zero ischemia
88481|NCT02734329|Warm ischemia|warm ischemia
88482|NCT02734329|Laparoscopic|laparoscopic
88483|NCT02734329|Radiofrequency ablation|radiofrequency ablation
88484|NCT02734329|Microwave ablation|microwave ablation
88485|NCT02734303|Dietary Radioactivity|dietary radioactivity
88486|NCT02734303|Dietary Assessment|dietary assessment
88487|NCT02734303|Retrospective Recall|retrospective recall
88488|NCT02734303|Focus Group|focus group
88489|NCT02734290|metastatic|metastatic
88490|NCT02734290|Human epidermal growth factor receptor 2 (Her2) negative breast cancer|human epidermal growth factor receptor 2 (her2) negative breast cancer
88491|NCT02734290|Estrogen Receptor (ER) negative breast cancer|estrogen receptor (er) negative breast cancer
88492|NCT02734290|Progesterone Receptor (PR) negative breast cancer|progesterone receptor (pr) negative breast cancer
88493|NCT02734290|Immunotherapy|immunotherapy
88494|NCT02734290|Breast Cancer|breast cancer
88495|NCT02734277|Insulin|insulin
88496|NCT02734277|Glucose Intolerance|glucose intolerance
88497|NCT02734277|Prior ITN027AI Study Participants-NCT00129259|prior itn027ai study participants-nct00129259
88498|NCT02734277|Prior ITN045AI Study Participants-NCT00965458|prior itn045ai study participants-nct00965458
88499|NCT02734251|Healthy mood|healthy mood
88500|NCT02734251|Stress management|stress management
88501|NCT02734251|Relora|relora
88502|NCT02734251|Healthy subjects|healthy subjects
88503|NCT02734225|total knee replacement|total knee replacement
88504|NCT02734225|total knee arthroplasty|total knee arthroplasty
88505|NCT02734225|rehabilitation|rehabilitation
88506|NCT02734225|physical therapy|physical therapy
88507|NCT02734225|balance|balance
88508|NCT02734212|Stigmatization|stigmatization
88509|NCT02734199|Birth Control|birth control
88510|NCT02734199|Contraception|contraception
88511|NCT02734199|IUD|iud
88512|NCT02734186|Filariasis|filariasis
88513|NCT02734186|Schistosoma Mansoni|schistosoma mansoni
88514|NCT02734186|Coinfection|coinfection
635712|NCT00715130|Worksite|worksite
88515|NCT02734160|immunotherapy|immunotherapy
88517|NCT02734160|transforming growth factor (TGF)-beta R1 kinase inhibitor|transforming growth factor (tgf)-beta r1 kinase inhibitor
88518|NCT02734134|Periprosthetic joint infection|periprosthetic joint infection
88519|NCT02734121|breast cancer|breast cancer
88520|NCT02734121|breast reconstruction|breast reconstruction
88521|NCT02734121|shared decision making|shared decision making
88522|NCT02734121|decision support intervention|decision support intervention
88523|NCT02734108|Sever anorexia nervosa|sever anorexia nervosa
88525|NCT02734082|ischemia|ischemia
88526|NCT02734082|Berne|berne
88527|NCT02734069|carboplatin|carboplatin
88528|NCT02734043|bundled payment|bundled payment
88529|NCT02734030|Anterior Knee Pain Syndrome|anterior knee pain syndrome
88530|NCT02734030|Quadriceps Femoris|quadriceps femoris
88531|NCT02734030|Muscle Inhibition|muscle inhibition
88532|NCT02734030|Interpolated Twitch Technique|interpolated twitch technique
88533|NCT02734030|Muscle Architecture|muscle architecture
88534|NCT02734030|Single Leg Squat|single leg squat
88535|NCT02734030|Women Knee Pain|women knee pain
88536|NCT02734004|MEDIOLA|mediola
88537|NCT02734004|Olaparib|olaparib
88538|NCT02734004|MEDI4736|medi4736
88539|NCT02734004|Ovarian cancer|ovarian cancer
88540|NCT02734004|Breast cancer|breast cancer
88541|NCT02734004|Small Cell Lung Cancer|small cell lung cancer
88542|NCT02734004|Gastric Cancer|gastric cancer
88543|NCT02734004|Phase I/II, Adults|phase i/ii, adults
88544|NCT02734004|PDL-1|pdl-1
88545|NCT02733978|Ozone oxygen|ozone oxygen
88546|NCT02733978|ulcer healing|ulcer healing
88547|NCT02733965|clinical pharmacy consultations|clinical pharmacy consultations
88548|NCT02733965|oral anti-cancer therapy|oral anti-cancer therapy
88549|NCT02733965|serious adverse events|serious adverse events
88550|NCT02733965|medication reconciliation|medication reconciliation
88551|NCT02733939|technology|technology
88552|NCT02733939|informal care|informal care
88553|NCT02733939|caregiver burden|caregiver burden
88554|NCT02733913|atrial fibrillation|atrial fibrillation
88555|NCT02733913|pulmonary vein isolation|pulmonary vein isolation
88556|NCT02733913|heart rate turbulence|heart rate turbulence
88557|NCT02733913|baroreflex sensitivity|baroreflex sensitivity
88558|NCT02733900|aseptic osteonecrosis|aseptic osteonecrosis
88559|NCT02733900|femoral head|femoral head
88560|NCT02733900|micro scanner|micro scanner
88561|NCT02733900|Raman spectrometry|raman spectrometry
88562|NCT02733900|MRI|mri
88563|NCT02733861|dental implant|dental implant
88564|NCT02733861|stability|stability
88565|NCT02733861|implant stability quotient|implant stability quotient
88566|NCT02733848|Roux-en-Y gastric bypass|roux-en-y gastric bypass
88567|NCT02733848|Hypoglycemia|hypoglycemia
88568|NCT02733848|Creon|creon
88569|NCT02733822|opiate|opiate
88570|NCT02733822|heroin|heroin
88571|NCT02733822|opioid|opioid
88572|NCT02733822|overdose|overdose
88573|NCT02733822|naloxone|naloxone
88574|NCT02733809|Hepatocellular Carcinoma|hepatocellular carcinoma
88575|NCT02733809|Sorafenib|sorafenib
88576|NCT02733796|zika virus|zika virus
88577|NCT02733796|semen analysis|semen analysis
88578|NCT02733796|sexual transmission|sexual transmission
88579|NCT02733757|Clonidine|clonidine
88580|NCT02733757|Sub-Tenon's and Peribulbar block|sub-tenon's and peribulbar block
88582|NCT02733757|OPP|opp
88583|NCT02733757|OPA|opa
88584|NCT02733744|Stem cell transplant|stem cell transplant
88585|NCT02733744|fecal microbiota transplantation|fecal microbiota transplantation
88586|NCT02733718|Necrotizing enterocolitis|necrotizing enterocolitis
88587|NCT02733718|Transfusion|transfusion
88588|NCT02733718|Mesenteric Oxygenisation|mesenteric oxygenisation
88589|NCT02733705|Pain|pain
88590|NCT02733705|TRUS biopsy|trus biopsy
88591|NCT02733692|HIV|hiv
88592|NCT02733692|STDs|stds
88593|NCT02733692|web-based app|web-based app
88594|NCT02733692|women|women
88595|NCT02733666|Absorbable screw|absorbable screw
88596|NCT02733666|Internal fixation|internal fixation
88597|NCT02733666|Children|children
88598|NCT02733653|Superficial Femoral Artery|superficial femoral artery
88599|NCT02733653|Proximal Popliteal Artery|proximal popliteal artery
88600|NCT02733653|Endovascular therapy|endovascular therapy
88601|NCT02733653|Atherectomy|atherectomy
88602|NCT02733601|breast cancer epidemiology algeria registry|breast cancer epidemiology algeria registry
88603|NCT02733588|hypoglycemia|hypoglycemia
88604|NCT02733588|glucagon|glucagon
88605|NCT02733588|glucose metabolism disorders|glucose metabolism disorders
88606|NCT02733588|hormones|hormones
88607|NCT02733588|gastrointestinal agents|gastrointestinal agents
88608|NCT02733588|bariatric surgery|bariatric surgery
88609|NCT02733588|incretins|incretins
88610|NCT02733536|endotracheal intubation|endotracheal intubation
88611|NCT02733536|trauma|trauma
88612|NCT02733536|paramedic|paramedic
88613|NCT02733510|kidney transplantation|kidney transplantation
88614|NCT02733510|subclinical rejection|subclinical rejection
88615|NCT02733510|steroid pulse therapy|steroid pulse therapy
88616|NCT02733497|sympathectomy, sympathicotomy, heart rate variability,|sympathectomy, sympathicotomy, heart rate variability,
88639|NCT02733341|Primary percutaneous coronary intervention (PPCI)|primary percutaneous coronary intervention (ppci)
88640|NCT02733328|Cardio-pulmonary bypass (CPB)|cardio-pulmonary bypass (cpb)
88641|NCT02733328|renal replacement therapy (RRT)|renal replacement therapy (rrt)
88642|NCT02733328|enzyme-linked immunosorbent assay (ELISA)|enzyme-linked immunosorbent assay (elisa)
88643|NCT02733263|gut microbiota|gut microbiota
88644|NCT02733263|fiber|fiber
88645|NCT02733263|diet quality|diet quality
88646|NCT02733263|immunity|immunity
88647|NCT02733250|NSCLC|nsclc
88648|NCT02733250|Pembrolizumab|pembrolizumab
88649|NCT02733250|Nab-paclitaxel|nab-paclitaxel
88650|NCT02733237|oxytocin|oxytocin
88651|NCT02733237|infidelity|infidelity
88652|NCT02733224|lenalidomide adherence MEMS|lenalidomide adherence mems
88653|NCT02733211|Closed Loop|closed loop
88654|NCT02733185|chelation|chelation
88655|NCT02733172|Vulvodynia|vulvodynia
88656|NCT02733172|Endophenotypes|endophenotypes
88657|NCT02733172|functional MRI|functional mri
88658|NCT02733159|Performance Status 2|performance status 2
88659|NCT02733159|Pembrolizumab|pembrolizumab
88660|NCT02733159|MK-3475|mk-3475
88661|NCT02733133|Testosterone|testosterone
88662|NCT02733133|AndroGel|androgel
88663|NCT02733133|Transference|transference
88664|NCT02733133|Women|women
88665|NCT02733133|Children|children
88666|NCT02733107|Non-small Cell Lung Cancer|non-small cell lung cancer
88667|NCT02733107|Apatinib|apatinib
88668|NCT02733107|Etoposide|etoposide
88669|NCT02733081|Long Acting Reversible Contraception|long acting reversible contraception
88670|NCT02733081|Intrauterine Device (IUD)|intrauterine device (iud)
88671|NCT02733081|Intrauterine Device (IUD) Insertion|intrauterine device (iud) insertion
88672|NCT02733081|Family Planning|family planning
88673|NCT02733081|International Family Planning|international family planning
88674|NCT02733055|Postural Equilibrium|postural equilibrium
88675|NCT02733055|Musculoskeletal Equilibrium|musculoskeletal equilibrium
88676|NCT02733055|Eye Movements|eye movements
88677|NCT02733055|Saccades|saccades
88678|NCT02733055|Pursuit, Smooth|pursuit, smooth
88703|NCT02733003|Implementation Science|implementation science
88704|NCT02733003|HIV|hiv
88705|NCT02733003|Sexual Risk|sexual risk
88706|NCT02733003|Sexually Transmitted Diseases|sexually transmitted diseases
88707|NCT02733003|Substance Abuse|substance abuse
88708|NCT02733003|Violence and Victimization|violence and victimization
88709|NCT02733003|Linkage to care|linkage to care
88710|NCT02733003|Gender-based Violence|gender-based violence
88715|NCT02732990|Cardiac function|cardiac function
88716|NCT02732990|Muscle metaboreflex|muscle metaboreflex
88717|NCT02732964|satisfaction|satisfaction
88718|NCT02732938|CCR2i, nab-paclitaxel, Abraxane, gemcitabine, pancreas|ccr2i, nab-paclitaxel, abraxane, gemcitabine, pancreas
88719|NCT02732925|Vertebral Compression Fracture|vertebral compression fracture
88720|NCT02732925|Balloon Kyphoplasty|balloon kyphoplasty
88721|NCT02732925|Conservative treatment|conservative treatment
88722|NCT02732925|Sham procedure|sham procedure
88723|NCT02732925|VCFs|vcfs
88724|NCT02732925|Multiple Myeloma|multiple myeloma
88725|NCT02732912|falls|falls
88726|NCT02732912|sleep|sleep
88727|NCT02732899|AMD|amd
88728|NCT02732886|foam dressing|foam dressing
88729|NCT02732860|personalized patient-derived xenografts (pPDX)|personalized patient-derived xenografts (ppdx)
88730|NCT02732860|molecular profiling|molecular profiling
88731|NCT02732860|epigenetic analysis|epigenetic analysis
88732|NCT02732860|drug sensitivity testing|drug sensitivity testing
88733|NCT02732860|triple negative|triple negative
88734|NCT02732860|metastatic|metastatic
88735|NCT02732847|Respiratory infections|respiratory infections
88736|NCT02732847|Primary care|primary care
88737|NCT02732847|Antibiotics|antibiotics
88738|NCT02732847|Delayed prescriptions|delayed prescriptions
88739|NCT02732834|Doctor-Patient Communication|doctor-patient communication
88740|NCT02732834|16-001|16-001
88741|NCT02732821|Gastroparesis|gastroparesis
88742|NCT02732821|G-POEM|g-poem
88743|NCT02732821|Gastric Per Oral Endoscopic Myotomy|gastric per oral endoscopic myotomy
88744|NCT02732808|Double stimulations|double stimulations
88745|NCT02732808|luteal-phase ovarian stimulation|luteal-phase ovarian stimulation
88746|NCT02732808|poor ovarian response|poor ovarian response
88747|NCT02732782|Achilles tendon|achilles tendon
88748|NCT02732782|isometric muscle training|isometric muscle training
88749|NCT02732782|competitive sports|competitive sports
88750|NCT02732782|strength training|strength training
88751|NCT02732782|eccentric exercise|eccentric exercise
88752|NCT02732782|isometric exercise|isometric exercise
88753|NCT02732782|chronic condition|chronic condition
88754|NCT02732782|regeneration|regeneration
88755|NCT02732782|tendon|tendon
88756|NCT02732782|tendon properties|tendon properties
88757|NCT02732782|tendinopathy|tendinopathy
88758|NCT02732782|tendinosis|tendinosis
88759|NCT02732782|intervention|intervention
88760|NCT02732782|training load|training load
88761|NCT02732782|high performance sports|high performance sports
88762|NCT02732756|ADHD|adhd
88763|NCT02732756|Sleep|sleep
88764|NCT02732756|Attention|attention
88765|NCT02732756|Adolescence|adolescence
88766|NCT02732743|childhod constipation|childhod constipation
88767|NCT02732730|ART (Antir-retroviral therapy)|art (antir-retroviral therapy)
88768|NCT02732730|PrEP (Pre-Exposure Prophylaxis)|prep (pre-exposure prophylaxis)
88769|NCT02732730|DAIDS (Division of AIDS)|daids (division of aids)
88770|NCT02732730|HPTN (HIV Prevention Trials Network)|hptn (hiv prevention trials network)
88771|NCT02732704|Aortic Valve Disease|aortic valve disease
88772|NCT02732704|Aortic Regurgitation|aortic regurgitation
88773|NCT02732691|Aortic Valve Disease|aortic valve disease
88774|NCT02732691|Aortic Valve Stenosis|aortic valve stenosis
88775|NCT02732613|Laryngeal Mask Airway|laryngeal mask airway
88776|NCT02732613|Body weight|body weight
88777|NCT02732613|Complication|complication
88778|NCT02732600|Veterans|veterans
88779|NCT02732600|Veterans Health|veterans health
88780|NCT02732600|Patient Compliance|patient compliance
88781|NCT02732600|Primary Health Care|primary health care
88782|NCT02732600|Health Care Providers|health care providers
88783|NCT02732600|Health Promotion|health promotion
88784|NCT02732522|misoprostol|misoprostol
88785|NCT02732522|induction of labor|induction of labor
88786|NCT02732522|sublingual|sublingual
88787|NCT02732496|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
88788|NCT02732496|Tourette Syndrome|tourette syndrome
88789|NCT02732496|Working Memory Training|working memory training
88790|NCT02732483|gastric cancer|gastric cancer
88791|NCT02732483|bleeding|bleeding
88792|NCT02732483|gastrointestinal hemorrhage|gastrointestinal hemorrhage
88793|NCT02732470|Systemic Lupus Erythematous|systemic lupus erythematous
88794|NCT02732470|Qi Gong|qi gong
88795|NCT02732470|Quality of life|quality of life
88801|NCT02732444|Erythrocytes Membranes Stability|erythrocytes membranes stability
88802|NCT02732444|Oxidative Stress|oxidative stress
88803|NCT02732444|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
88804|NCT02732444|Advanced Pulmonary Disease (APD)|advanced pulmonary disease (apd)
88805|NCT02732444|Long-Term Home Oxygen Therapy (LTOT)|long-term home oxygen therapy (ltot)
88806|NCT02732418|CI-contraceptive injection|ci-contraceptive injection
88807|NCT02732418|DMPA-Depot medroxyprogesterone acetate|dmpa-depot medroxyprogesterone acetate
88808|NCT02732418|MPA-Medroxyprogesterone Acetate|mpa-medroxyprogesterone acetate
88809|NCT02732418|subQ-subcutaneous|subq-subcutaneous
88810|NCT02732379|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
88811|NCT02732379|Aromatherapy|aromatherapy
88812|NCT02732379|Quality of Health Care|quality of health care
88813|NCT02732366|aged [MeSH term]|aged [mesh term]
88814|NCT02732366|exercise [MeSH term]|exercise [mesh term]
88815|NCT02732340|triple-branched stent graft|triple-branched stent graft
88816|NCT02732340|hemi-arch replace|hemi-arch replace
88817|NCT02732340|the occluded rate of false lumen|the occluded rate of false lumen
88818|NCT02732275|Relapsed non-hodgkin lymphoma.|relapsed non-hodgkin lymphoma.
88819|NCT02732275|phase 1|phase 1
88820|NCT02732275|oncology|oncology
88821|NCT02732262|acute pain|acute pain
88822|NCT02732262|postoperative|postoperative
88823|NCT02732262|surgery|surgery
88824|NCT02732249|Helicobacter pylori|helicobacter pylori
88825|NCT02732249|Clarithromycin|clarithromycin
88826|NCT02732249|Amoxicillin|amoxicillin
88827|NCT02732249|Metronidazole|metronidazole
88828|NCT02732249|Eradication|eradication
88829|NCT02732236|marginal zone lymphoma|marginal zone lymphoma
88830|NCT02732236|Cohort|cohort
88831|NCT02732236|Rituximab|rituximab
88833|NCT02732223|Atherosclerosis|atherosclerosis
88834|NCT02732223|omega 3|omega 3
88835|NCT02732223|plant sterols|plant sterols
88836|NCT02732223|polyphenols|polyphenols
88838|NCT02732184|MDS|mds
88839|NCT02732158|Novel laboratory methods|novel laboratory methods
88840|NCT02732145|Three-Vulvar-Rings|three-vulvar-rings
88841|NCT02732145|Three-Rings-Vulvoscopy|three-rings-vulvoscopy
88842|NCT02732145|N-S-P scheme|n-s-p scheme
88843|NCT02732145|Vulvoscopy Index|vulvoscopy index
88844|NCT02732145|Vulvar Dermatosis|vulvar dermatosis
88845|NCT02732145|Vulvar Lichen Sclerosus|vulvar lichen sclerosus
88846|NCT02732145|Lichen Planus|lichen planus
88847|NCT02732145|Lichen Simplex Chronicus|lichen simplex chronicus
88848|NCT02732145|Vulvodynia|vulvodynia
88849|NCT02732145|Provoked Vestibulodynia|provoked vestibulodynia
88850|NCT02732145|Vulvar Vestibulitis|vulvar vestibulitis
88851|NCT02732145|Vulvar Diseases|vulvar diseases
88852|NCT02732119|HR-positive|hr-positive
88853|NCT02732119|HER2-negative|her2-negative
88854|NCT02732119|Advanced breast cancer|advanced breast cancer
88855|NCT02732119|LEE011|lee011
88856|NCT02732119|ribociclib|ribociclib
88857|NCT02732119|everolimus|everolimus
88858|NCT02732119|Afinitor|afinitor
88859|NCT02732119|exemestane|exemestane
88860|NCT02732119|Aromasin|aromasin
88861|NCT02732119|CDK|cdk
88862|NCT02732119|CDK4|cdk4
88863|NCT02732119|CDK6|cdk6
88864|NCT02732119|CDK4/6|cdk4/6
88865|NCT02732119|CDK4/6 inhibitor|cdk4/6 inhibitor
88866|NCT02732119|Phase III|phase iii
88867|NCT02732119|ER-positive|er-positive
88868|NCT02732119|PR-positive|pr-positive
88869|NCT02732119|Postmenopausal|postmenopausal
88870|NCT02732106|ADRCs, cell characterization|adrcs, cell characterization
88871|NCT02732080|primary percutaneous coronary intervention|primary percutaneous coronary intervention
88872|NCT02732080|microvascular obstruction|microvascular obstruction
88873|NCT02732080|myocardial edema|myocardial edema
88874|NCT02732080|microvascular resistance|microvascular resistance
88875|NCT02732080|acute myocardial infarction|acute myocardial infarction
88876|NCT02732067|Anesthesia|anesthesia
88877|NCT02732054|HBV vaccination, immunity|hbv vaccination, immunity
88878|NCT02732015|Sarcoma|sarcoma
88879|NCT02732015|Locally advanced|locally advanced
88880|NCT02732015|High risk for relapse|high risk for relapse
88881|NCT02732015|Metastatic|metastatic
88882|NCT02732015|Questionnaires|questionnaires
88883|NCT02732015|Surveys|surveys
88884|NCT02732015|Rolapitant|rolapitant
88885|NCT02732015|Fosaprepitant|fosaprepitant
88886|NCT02732015|Dexamethasone|dexamethasone
88887|NCT02732015|Decadron|decadron
88888|NCT02732015|Ondansetron|ondansetron
88889|NCT02732015|Zofran|zofran
88890|NCT02732015|Doxorubicin|doxorubicin
88891|NCT02732015|Adriamycin PFS|adriamycin pfs
88892|NCT02732015|Adriamycin RDF|adriamycin rdf
88893|NCT02732015|Rubex|rubex
88894|NCT02732015|Mesna|mesna
88895|NCT02732015|Mesnex|mesnex
88896|NCT02732015|Ifosfamide|ifosfamide
88897|NCT02732015|Ifex|ifex
88898|NCT02732015|Vincristine|vincristine
88899|NCT02732015|Nausea|nausea
88900|NCT02732015|Vomiting|vomiting
88901|NCT02732002|shoulder|shoulder
88902|NCT02732002|rotator cuff- injury|rotator cuff- injury
88903|NCT02732002|management|management
88904|NCT02732002|rehabilitation model|rehabilitation model
88905|NCT02731976|Gluten-Free diet|gluten-free diet
88906|NCT02731976|Healthy individuals|healthy individuals
88907|NCT02731963|Outcomes|outcomes
88908|NCT02731963|Bowel preparation|bowel preparation
80117|NCT02785328|Memory|memory
88909|NCT02731950|Sternotomy , cardiac surgery , pain|sternotomy , cardiac surgery , pain
88910|NCT02731924|Appendicitis|appendicitis
88911|NCT02731924|Ultrasound|ultrasound
88912|NCT02731924|Emergency Department|emergency department
88913|NCT02731872|COPD|copd
88914|NCT02731872|oxygen treatment|oxygen treatment
88915|NCT02731872|quality of life|quality of life
88916|NCT02731846|Efficacy|efficacy
88917|NCT02731846|Triple therapy|triple therapy
88918|NCT02731846|Parallel|parallel
88919|NCT02731846|Respiratory|respiratory
88920|NCT02731820|potassium citrate|potassium citrate
88921|NCT02731807|TA-65|ta-65
88922|NCT02731807|Telemorase|telemorase
88923|NCT02731807|Dietary Supplement|dietary supplement
88924|NCT02731794|cardiopulmonary bypass|cardiopulmonary bypass
88925|NCT02731794|coronary artery bypass grafting|coronary artery bypass grafting
88926|NCT02731794|inflammatory response|inflammatory response
88927|NCT02731794|cardiac dysfunction|cardiac dysfunction
88928|NCT02731781|OUTCOME|outcome
88929|NCT02731781|PROGNOSIS|prognosis
88930|NCT02731781|PEDIATRIC HEAd injury|pediatric head injury
88931|NCT02731781|CT SCAN|ct scan
88932|NCT02731755|Oats|oats
88933|NCT02731755|Phenolic acid|phenolic acid
88934|NCT02731755|FMD|fmd
88935|NCT02731755|LDI|ldi
88936|NCT02731755|Renin angiotensin|renin angiotensin
88937|NCT02731755|Nitric oxide|nitric oxide
88938|NCT02731729|Ipilimumab|ipilimumab
88939|NCT02731729|Nivolumab|nivolumab
88940|NCT02731729|Stage III-IV Melanoma|stage iii-iv melanoma
88941|NCT02731729|Progressed or Relapsed on PD-1 Inhibitor Therapy|progressed or relapsed on pd-1 inhibitor therapy
88942|NCT02731729|16-043|16-043
88943|NCT02731703|overdenture|overdenture
88944|NCT02731703|overlay|overlay
88945|NCT02731703|implant supported|implant supported
88946|NCT02731703|denture|denture
88947|NCT02731703|dental prosthesis|dental prosthesis
88948|NCT02731703|maxillary|maxillary
88949|NCT02731690|GNE Myopathy|gne myopathy
88950|NCT02731690|Nonaka|nonaka
88951|NCT02731690|GNEM|gnem
88952|NCT02731690|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
88953|NCT02731690|HIBM|hibm
88954|NCT02731690|DMRV|dmrv
88955|NCT02731690|QSM|qsm
88956|NCT02731664|Irritable bowel syndrome|irritable bowel syndrome
88957|NCT02731664|Functional dyspepsia|functional dyspepsia
88958|NCT02731664|Gastric emptying|gastric emptying
88959|NCT02731664|Gastrointestinal peptide hormones|gastrointestinal peptide hormones
88960|NCT02731638|cornea|cornea
88961|NCT02731638|ulcer|ulcer
88962|NCT02731638|fungal|fungal
88963|NCT02731638|keratitis|keratitis
88964|NCT02731625|Kettlebell training|kettlebell training
88965|NCT02731625|High-intensity interval training|high-intensity interval training
88966|NCT02731612|Bipolar Disorder|bipolar disorder
88967|NCT02731612|Cognition|cognition
88968|NCT02731612|Euthymic|euthymic
88969|NCT02731612|Lurasidone|lurasidone
88970|NCT02731599|Parkinson Disease|parkinson disease
88971|NCT02731599|treadmill|treadmill
88972|NCT02731599|Rehabilitation|rehabilitation
88973|NCT02731586|Dental Implants|dental implants
88974|NCT02731586|Allogenic mesenchymal stem cells|allogenic mesenchymal stem cells
88975|NCT02731586|osseointegration|osseointegration
88976|NCT02731586|primary stability|primary stability
88977|NCT02731586|resonance frequency analysis|resonance frequency analysis
88978|NCT02731586|RFA|rfa
88979|NCT02731586|implants and stem cells|implants and stem cells
88980|NCT02731586|use of stem cells|use of stem cells
88981|NCT02731586|stem cells|stem cells
88982|NCT02731573|Mediastenitis|mediastenitis
88983|NCT02731560|Pakistan, Rituximab|pakistan, rituximab
88984|NCT02731560|RA|ra
88985|NCT02731521|MRS Biomarkers|mrs biomarkers
89186|NCT02730130|16-032|16-032
88986|NCT02731508|Transcranial Direct Current Stimulation|transcranial direct current stimulation
88987|NCT02731508|Neuroplasticity|neuroplasticity
88988|NCT02731482|Bronchiectasis|bronchiectasis
88989|NCT02731482|Rehabilitation|rehabilitation
88990|NCT02731482|Quality of Life|quality of life
88991|NCT02731482|Physiotherapy Specialty|physiotherapy specialty
88992|NCT02731456|high altitude|high altitude
88993|NCT02731456|cognition|cognition
88994|NCT02731456|sleep|sleep
88995|NCT02731443|dreaming|dreaming
88996|NCT02731443|epilepsy|epilepsy
88997|NCT02731443|neurosurgery|neurosurgery
88998|NCT02731443|temporal lobectomy|temporal lobectomy
88999|NCT02731378|erythropoietin|erythropoietin
89000|NCT02731378|iron supplementation|iron supplementation
89001|NCT02731378|inadequately responsive|inadequately responsive
89002|NCT02731378|chemotherapy-induced anaemia|chemotherapy-induced anaemia
89003|NCT02731365|Parkinson's Disease|parkinson's disease
89004|NCT02731300|Transcranial direct current stimulation|transcranial direct current stimulation
89005|NCT02731300|Cathodal stimulation|cathodal stimulation
89006|NCT02731300|Childhood Pharmacoresistant epilepsy|childhood pharmacoresistant epilepsy
89007|NCT02731300|Lennox-Gastaut syndrome|lennox-gastaut syndrome
89008|NCT02731235|Stroke|stroke
80226|NCT02784743|MDA|mda
89009|NCT02731235|stroke, acute|stroke, acute
89010|NCT02731235|Cerebral small vessel disease|cerebral small vessel disease
89011|NCT02731222|CEAP classification|ceap classification
89115|NCT02730650|PRT|prt
89012|NCT02731222|CVD: Chronic Venous Disease|cvd: chronic venous disease
89013|NCT02731222|Onychodystrophy|onychodystrophy
89014|NCT02731222|Body Mass Index|body mass index
89015|NCT02731196|exercise|exercise
89016|NCT02731196|lumbar microdiscectomy|lumbar microdiscectomy
89017|NCT02731183|Fecal Microbiota Transplantation|fecal microbiota transplantation
89018|NCT02731183|Chronic intestinal pseudo obstruction|chronic intestinal pseudo obstruction
89019|NCT02731183|Efficacy and safety|efficacy and safety
89020|NCT02731170|Parkinson Disease|parkinson disease
89021|NCT02731170|Advanced Stages|advanced stages
89022|NCT02731170|Rehabilitation|rehabilitation
89023|NCT02731144|Loss of Physical Function|loss of physical function
89024|NCT02731118|glaucoma|glaucoma
89025|NCT02731118|intraocular pressure lowering treatment|intraocular pressure lowering treatment
89026|NCT02731118|antisectory factor (AF)|antisectory factor (af)
89028|NCT02731105|acne|acne
89029|NCT02731105|vulgaris|vulgaris
89030|NCT02731105|Clindamycin|clindamycin
89031|NCT02731105|Tretinoin|tretinoin
89032|NCT02731105|Adapalen|adapalen
89033|NCT02731105|Benzoylperoxid|benzoylperoxid
89034|NCT02731105|Epiduo|epiduo
89035|NCT02731105|Acnatac|acnatac
89036|NCT02731092|lactoferrin|lactoferrin
89037|NCT02731092|very low birth weight infants|very low birth weight infants
89038|NCT02731092|preterm infants|preterm infants
89039|NCT02731079|Sleeve gastrectomy stapler Covidien Ethicon bleeding leak|sleeve gastrectomy stapler covidien ethicon bleeding leak
89040|NCT02731053|Depression|depression
89041|NCT02731053|Prevention|prevention
89042|NCT02731053|Adolescents|adolescents
89043|NCT02731053|School|school
89044|NCT02731053|Effectiveness|effectiveness
89045|NCT02731014|Dry Needling|dry needling
89046|NCT02730975|pharmacokinetics|pharmacokinetics
89047|NCT02730975|food-effect|food-effect
89048|NCT02730975|fat diet|fat diet
89049|NCT02730975|abiraterone acetate|abiraterone acetate
89050|NCT02730949|D-Chiro-Inositol, type 1 diabetes|d-chiro-inositol, type 1 diabetes
89051|NCT02730923|Clinical Trials, Randomized|clinical trials, randomized
89052|NCT02730923|Clinical Trial, Phase I|clinical trial, phase i
89053|NCT02730923|Clinical Trial, Phase II|clinical trial, phase ii
89054|NCT02730923|Multicenter Trials|multicenter trials
89055|NCT02730923|Aromatase Inhibitors|aromatase inhibitors
89056|NCT02730923|mTOR kinase inhibitor|mtor kinase inhibitor
89057|NCT02730910|Bioavailability|bioavailability
89058|NCT02730910|adults|adults
89059|NCT02730897|Surgery|surgery
89060|NCT02730897|Thoracotomy|thoracotomy
89061|NCT02730897|VATS|vats
89062|NCT02730884|Leukemia|leukemia
89063|NCT02730884|Myelofibrosis|myelofibrosis
89064|NCT02730884|MF|mf
89065|NCT02730884|Anemia|anemia
89066|NCT02730884|Splenomegaly|splenomegaly
89067|NCT02730884|Post-polycythemia vera MF|post-polycythemia vera mf
89068|NCT02730884|post-PV|post-pv
89069|NCT02730884|post-essential thrombocythemia MF|post-essential thrombocythemia mf
89070|NCT02730884|post-ET|post-et
89071|NCT02730884|Rigosertib|rigosertib
89072|NCT02730884|ON 01910.Na|on 01910.na
89073|NCT02730884|Questionnaire|questionnaire
89074|NCT02730884|Survey|survey
89075|NCT02730858|Metastatic Breast Cancer|metastatic breast cancer
89076|NCT02730858|Palliative Care|palliative care
89077|NCT02730858|Breast Cancer|breast cancer
89078|NCT02730858|End of life|end of life
89079|NCT02730858|Health service research|health service research
89080|NCT02730845|Elective|elective
89081|NCT02730845|local anesthesia|local anesthesia
89082|NCT02730845|knee arthroscopy|knee arthroscopy
89083|NCT02730845|Dexmedetomidine|dexmedetomidine
89084|NCT02730793|Cystic Fibrosis|cystic fibrosis
89811|NCT02726256|Diabetes|diabetes
89085|NCT02730793|P. aeruginosa (PA)|p. aeruginosa (pa)
89086|NCT02730754|Mood Disorders|mood disorders
89087|NCT02730754|Illness Perception|illness perception
89088|NCT02730754|Primary Care|primary care
89089|NCT02730754|Medication Adherence|medication adherence
89090|NCT02730741|diarrhoea|diarrhoea
89091|NCT02730741|metfomin|metfomin
89092|NCT02730741|type 2 diabetes|type 2 diabetes
89093|NCT02730741|microbiota|microbiota
89094|NCT02730728|adductor canal block|adductor canal block
89095|NCT02730728|tinetti score|tinetti score
89096|NCT02730728|time to up and go test|time to up and go test
89097|NCT02730728|Ambulation distance|ambulation distance
89098|NCT02730728|pain score|pain score
89099|NCT02730728|quality of recovery score|quality of recovery score
89100|NCT02730689|DP-R207|dp-r207
89101|NCT02730689|Rosuvastatin|rosuvastatin
89102|NCT02730689|Ezetimibe|ezetimibe
89103|NCT02730676|electronic cigarettes|electronic cigarettes
89104|NCT02730676|e-cigarette|e-cigarette
89105|NCT02730676|combustible cigarette|combustible cigarette
89106|NCT02730676|cigarette|cigarette
89107|NCT02730676|menthol|menthol
89108|NCT02730676|cig-alike|cig-alike
80321|NCT02784158|AP26113|ap26113
89109|NCT02730676|subjective measures|subjective measures
89110|NCT02730676|pharmacokinetics|pharmacokinetics
89111|NCT02730676|craving|craving
89112|NCT02730663|Endoscopic ultrasound guided transluminal drainage|endoscopic ultrasound guided transluminal drainage
89113|NCT02730650|FACE-Q|face-q
89114|NCT02730650|Platelet Rich Therapy|platelet rich therapy
89116|NCT02730624|piperacillin/tazobactam|piperacillin/tazobactam
89117|NCT02730624|critically ill|critically ill
89118|NCT02730624|severe sepsis|severe sepsis
89119|NCT02730624|septic shock|septic shock
89120|NCT02730611|Vertical sleeve gastrectomy|vertical sleeve gastrectomy
89121|NCT02730611|Metabolic syndrome|metabolic syndrome
89122|NCT02730611|Disorder of Bile Acid and Cholesterol Metabolism|disorder of bile acid and cholesterol metabolism
89123|NCT02730611|Cholangiocarcinoma|cholangiocarcinoma
89124|NCT02730611|Hepatocellular carcinoma|hepatocellular carcinoma
89125|NCT02730585|C-reactive protein|c-reactive protein
89126|NCT02730572|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
89127|NCT02730572|Methylphenidate|methylphenidate
89128|NCT02730559|Motivational Interviewing|motivational interviewing
89129|NCT02730533|endoscopic submucosal dissection|endoscopic submucosal dissection
89130|NCT02730533|proton pump inhibitor|proton pump inhibitor
89131|NCT02730533|bleeding|bleeding
89132|NCT02730520|respiratory disease|respiratory disease
89133|NCT02730520|allergen sensitization|allergen sensitization
89134|NCT02730520|aging|aging
89135|NCT02730520|skin tests|skin tests
89136|NCT02730520|air allergens|air allergens
89138|NCT02730494|Candidiasis|candidiasis
89139|NCT02730494|Lcr35®|lcr35®
89140|NCT02730494|Lcr Regenerans®|lcr regenerans®
89141|NCT02730455|Stroke|stroke
89142|NCT02730351|Fluticasone furoate|fluticasone furoate
89143|NCT02730351|activity monitoring|activity monitoring
89144|NCT02730351|Vilanterol|vilanterol
89145|NCT02730351|Cross-over|cross-over
89146|NCT02730351|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
89147|NCT02730351|exercise challenge|exercise challenge
89148|NCT02730351|double-dummy|double-dummy
89149|NCT02730351|asthma|asthma
89150|NCT02730351|spirometry|spirometry
89151|NCT02730351|fluticasone propionate|fluticasone propionate
89152|NCT02730338|Castrate-Resistant|castrate-resistant
89153|NCT02730325|CDI|cdi
89154|NCT02730325|C. diff|c. diff
89155|NCT02730325|Ulcerative Colitis|ulcerative colitis
89156|NCT02730325|UC|uc
89157|NCT02730325|IBD|ibd
89158|NCT02730325|Inflammatory Bowel Disease|inflammatory bowel disease
89159|NCT02730312|AML|aml
89160|NCT02730312|B-ALL|b-all
89161|NCT02730312|BPDCN|bpdcn
89162|NCT02730312|CML|cml
89163|NCT02730312|Blast Crisis|blast crisis
89164|NCT02730286|human activity|human activity
89165|NCT02730286|International Classification of Functioning|international classification of functioning
89166|NCT02730260|Directive coaching|directive coaching
89167|NCT02730260|Nondirective coaching|nondirective coaching
636773|NCT00727987|CNTO148|cnto148
89168|NCT02730260|smoking cessation quitline|smoking cessation quitline
89169|NCT02730260|social support|social support
89170|NCT02730247|ramucirumab|ramucirumab
89171|NCT02730247|docetaxel|docetaxel
89172|NCT02730221|Administrative workload|administrative workload
89173|NCT02730221|Patient data management system|patient data management system
89174|NCT02730221|Intensive Care Unit|intensive care unit
89175|NCT02730221|Work sampling method|work sampling method
89176|NCT02730221|Nursing Activity Score|nursing activity score
89177|NCT02730182|postural control|postural control
89178|NCT02730182|high altitude|high altitude
89179|NCT02730169|Hypogonadotropic|hypogonadotropic
89180|NCT02730169|hypogonadism|hypogonadism
89181|NCT02730169|testosterone|testosterone
89182|NCT02730143|Altitude|altitude
89183|NCT02730143|Nocturnal breathing pattern|nocturnal breathing pattern
89184|NCT02730130|Pembrolizumab|pembrolizumab
89185|NCT02730130|Radiotherapy|radiotherapy
89187|NCT02730117|Acute kidney injury|acute kidney injury
89188|NCT02730117|Furosemide stress test|furosemide stress test
89189|NCT02730117|critical care|critical care
89190|NCT02730078|Mood Disorders|mood disorders
89191|NCT02730078|Self Care|self care
89192|NCT02730078|Primary Care|primary care
89193|NCT02730065|Cerebral small vessel disease|cerebral small vessel disease
89194|NCT02730065|Lifestyle modification|lifestyle modification
89195|NCT02730065|Physical activity|physical activity
89196|NCT02730065|Primary prevention|primary prevention
89197|NCT02730065|Aerobic dance|aerobic dance
89198|NCT02730065|Cognition|cognition
89199|NCT02730065|Depression|depression
89200|NCT02730065|Activities of daily living|activities of daily living
89201|NCT02730065|Cerebral autoregulation|cerebral autoregulation
89202|NCT02730052|Blood pressure control|blood pressure control
89203|NCT02730052|Hypertension|hypertension
89204|NCT02730052|Office blood pressure|office blood pressure
89205|NCT02730052|Self-measured blood pressure,|self-measured blood pressure,
105206|NCT02633683|RLS|rls
80415|NCT02783664|BRCA1|brca1
89206|NCT02730052|Telemonitoring|telemonitoring
89207|NCT02730039|Cancer Care Providers|cancer care providers
89208|NCT02730039|Psychotherapy|psychotherapy
89209|NCT02730039|15-321|15-321
89210|NCT02730026|Ketofrofen|ketofrofen
89211|NCT02730026|Omeprazole|omeprazole
89212|NCT02730026|Lower Third Molar|lower third molar
89213|NCT02730026|Oral Surgery|oral surgery
89214|NCT02730013|Older adults|older adults
89215|NCT02730013|Square stepping exercise|square stepping exercise
89216|NCT02730013|Mind-motor exercise|mind-motor exercise
89217|NCT02730013|Long-term care|long-term care
89218|NCT02730013|Global cognitive functioning|global cognitive functioning
89219|NCT02730000|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
89220|NCT02730000|Primary Teeth|primary teeth
89221|NCT02730000|Clinical Efficacy|clinical efficacy
89222|NCT02730000|Cost Analysis|cost analysis
89223|NCT02730000|Glass Ionomer Cement|glass ionomer cement
89224|NCT02729987|online|online
89225|NCT02729987|internet|internet
89227|NCT02729987|Stress|stress
89228|NCT02729987|Work|work
89229|NCT02729987|Internet based treatment|internet based treatment
89230|NCT02729974|thromboelastography|thromboelastography
89231|NCT02729935|Parecoxib|parecoxib
89232|NCT02729935|Bladder Discomfort|bladder discomfort
89233|NCT02729909|Drug therapy|drug therapy
89234|NCT02729870|Ketones|ketones
89235|NCT02729870|Gastroenteritis|gastroenteritis
89236|NCT02729844|Incidence|incidence
89237|NCT02729844|Risk factors|risk factors
89238|NCT02729844|Outcome|outcome
89239|NCT02729831|decision making|decision making
89240|NCT02729831|decision aids|decision aids
89241|NCT02729831|decision quality instruments|decision quality instruments
89242|NCT02729831|osteoarthritis|osteoarthritis
89243|NCT02729831|shared decision making|shared decision making
89244|NCT02729818|Retina|retina
89245|NCT02729818|Microperimetry|microperimetry
89246|NCT02729818|Visual Fields|visual fields
89247|NCT02729805|ketamine|ketamine
89248|NCT02729805|chronic pain|chronic pain
89249|NCT02729805|mastectomy|mastectomy
89250|NCT02729805|acute pain|acute pain
89251|NCT02729792|depression|depression
89252|NCT02729792|treatment resistance|treatment resistance
89253|NCT02729792|biomarkers|biomarkers
89254|NCT02729792|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
89255|NCT02729766|Hyponatremia|hyponatremia
89256|NCT02729766|SGLT2 inhibitor|sglt2 inhibitor
89257|NCT02729740|Penumbra Smart coils|penumbra smart coils
89258|NCT02729740|PC 400|pc 400
89259|NCT02729740|AV malformations|av malformations
89260|NCT02729740|AV fistulae|av fistulae
89261|NCT02729688|Venous insufficiency|venous insufficiency
89262|NCT02729688|Compression|compression
89263|NCT02729688|Bandaging|bandaging
89264|NCT02729675|fruit & vegetable, market, education, worksite, food access|fruit & vegetable, market, education, worksite, food access
89265|NCT02729597|neuromuscular disorders|neuromuscular disorders
89267|NCT02729597|white matter|white matter
89269|NCT02729597|myotonic dystrophy|myotonic dystrophy
89270|NCT02729558|brain metastases|brain metastases
89271|NCT02729558|radiotherapy|radiotherapy
89272|NCT02729558|resection|resection
89273|NCT02729545|acupuncture, POCS|acupuncture, pocs
89274|NCT02729532|Extra-pulmonary tuberculosis|extra-pulmonary tuberculosis
89275|NCT02729532|multiple drug resistant tuberculosis|multiple drug resistant tuberculosis
89276|NCT02729532|mycobacterium tuberculosis|mycobacterium tuberculosis
89277|NCT02729532|human immunodeficiency virus|human immunodeficiency virus
89278|NCT02729506|hepatocellular carcinoma|hepatocellular carcinoma
89279|NCT02729506|transarterial radioembolization|transarterial radioembolization
89280|NCT02729506|chemoembolization chemoembolization|chemoembolization chemoembolization
89281|NCT02729506|clinical trial|clinical trial
89282|NCT02729493|Liver Cancer CAR-T|liver cancer car-t
89283|NCT02729467|Healthy|healthy
89284|NCT02729467|JNJ-53718678|jnj-53718678
89285|NCT02729467|Itraconazole|itraconazole
89286|NCT02729467|Rifampicin|rifampicin
89287|NCT02729467|Pharmacokinetics|pharmacokinetics
89288|NCT02729428|Aging|aging
89289|NCT02729428|White Matter Hyperintensity Volume|white matter hyperintensity volume
89290|NCT02729428|Default Mode Network Connectivity|default mode network connectivity
89291|NCT02729428|Cognitive Function|cognitive function
89292|NCT02729428|Cardiorespiratory Fitness|cardiorespiratory fitness
89293|NCT02729428|Magnetic Resonance Imaging|magnetic resonance imaging
89294|NCT02729415|Hair Diseases|hair diseases
89295|NCT02729415|Alopecia|alopecia
89296|NCT02729402|Adults|adults
89297|NCT02729389|Social Status|social status
89298|NCT02729389|Hispanics|hispanics
89299|NCT02729389|Energy Balance|energy balance
89300|NCT02729389|Stress|stress
89301|NCT02729376|Healthy Volunteers|healthy volunteers
89302|NCT02729337|technology|technology
89303|NCT02729337|adolescent|adolescent
89304|NCT02729337|developing country|developing country
89305|NCT02729337|hiv prevention|hiv prevention
89306|NCT02729337|mHealth|mhealth
89307|NCT02729324|nasopharyngeal carcinoma (NPC)|nasopharyngeal carcinoma (npc)
89308|NCT02729324|radiation dermatitis|radiation dermatitis
89309|NCT02729324|intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
89310|NCT02729311|exercise|exercise
89311|NCT02729311|function|function
89312|NCT02729311|quality of life|quality of life
89313|NCT02729311|caregiver|caregiver
89314|NCT02729298|Tolero|tolero
89315|NCT02729298|Phase 1|phase 1
89317|NCT02729298|Solid Tumors|solid tumors
89318|NCT02729298|AXL inhibitor|axl inhibitor
89319|NCT02729298|Advanced Malignancy|advanced malignancy
89320|NCT02729298|Cancer|cancer
89322|NCT02729233|mucosal barrier function|mucosal barrier function
89323|NCT02729220|Aging|aging
89324|NCT02729220|Oxidative stress|oxidative stress
89325|NCT02729220|Proteases|proteases
89326|NCT02729220|Bronchoscopy|bronchoscopy
89327|NCT02729207|NSAID Patch|nsaid patch
89328|NCT02729168|Rabies|rabies
89329|NCT02729168|Vaccine|vaccine
89330|NCT02729168|Safety|safety
89331|NCT02729168|INDIRAB|indirab
89332|NCT02729168|Vietnam|vietnam
89333|NCT02729155|Ischemic Preconditioning|ischemic preconditioning
89334|NCT02729155|Postconditioning|postconditioning
89335|NCT02729155|Angioplasty|angioplasty
89336|NCT02729155|Angiography|angiography
89337|NCT02729155|Contrast-Induced Nephropathy|contrast-induced nephropathy
89338|NCT02729142|HRpQCT|hrpqct
89339|NCT02729142|transplant|transplant
89340|NCT02729142|bone microarchitecture|bone microarchitecture
89341|NCT02729129|Diesel exhaust|diesel exhaust
90622|NCT02721719|UC|uc
89342|NCT02729129|Air pollution|air pollution
89343|NCT02729129|Intervention|intervention
89344|NCT02729129|Plethysmography|plethysmography
89345|NCT02729116|Extended-Spectrum ß-lactamase-producing Escherichia coli|extended-spectrum ß-lactamase-producing escherichia coli
89346|NCT02729116|Extended-Spectrum ß-lactamase-producing Klebsiella pneumoniae|extended-spectrum ß-lactamase-producing klebsiella pneumoniae
89347|NCT02729116|Kidney Transplantation|kidney transplantation
89348|NCT02729116|Urinary Tract Infections|urinary tract infections
89349|NCT02729090|Peripheral Arterial Disease, exercise|peripheral arterial disease, exercise
89350|NCT02729064|Intranasal Insulin|intranasal insulin
89351|NCT02729064|Insulin concentration|insulin concentration
89352|NCT02729064|Blood glucose|blood glucose
89353|NCT02729064|Cerebro Spinal Fluid insulin|cerebro spinal fluid insulin
89354|NCT02729064|Intraoperative blood glucose|intraoperative blood glucose
89355|NCT02729064|Cardiac Surgery|cardiac surgery
89356|NCT02729064|Thoracic Surgery|thoracic surgery
89357|NCT02729051|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
89358|NCT02729051|fluticasone furoate/umeclidinium bromide/vilanterol (FF/UMEC/VI)|fluticasone furoate/umeclidinium bromide/vilanterol (ff/umec/vi)
89359|NCT02729051|Umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
89360|NCT02729051|Closed triple therapy|closed triple therapy
89362|NCT02729051|Open triple therapy|open triple therapy
89363|NCT02729051|fluticasone furoate/vilanterol (FF/VI)|fluticasone furoate/vilanterol (ff/vi)
89364|NCT02729038|Normal Renal Function|normal renal function
89365|NCT02729038|end stage renal disease (ESRD)|end stage renal disease (esrd)
89366|NCT02729038|Pharmacokinetics|pharmacokinetics
89367|NCT02729038|Gepotidacin|gepotidacin
89368|NCT02729038|Renal Impairment|renal impairment
89369|NCT02729025|Hyperlipidemia|hyperlipidemia
89370|NCT02729025|Dyslipidemia|dyslipidemia
89371|NCT02729025|Proprotein convertase subtilisin/kexin type 9 (PCSK9) Inhibition|proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibition
89372|NCT02729025|Arterial Wall Inflamation|arterial wall inflamation
89373|NCT02729025|Elevated lipoprotein a|elevated lipoprotein a
89374|NCT02729012|Children|children
89375|NCT02728999|Trendelenburg position|trendelenburg position
89376|NCT02728999|Robotic assisted gynecologic procedures|robotic assisted gynecologic procedures
89377|NCT02728999|benign gynecologic conditions|benign gynecologic conditions
89378|NCT02728986|Costs and Cost Analysis|costs and cost analysis
89379|NCT02728986|Humans|humans
89380|NCT02728986|Health Care Costs|health care costs
89381|NCT02728986|varicose ulcer|varicose ulcer
89382|NCT02728986|Compression Bandages|compression bandages
89383|NCT02728973|colorectal resection|colorectal resection
89384|NCT02728973|enhanced recovery after surgery|enhanced recovery after surgery
89385|NCT02728973|Postoperative Complications|postoperative complications
89386|NCT02728973|length of hospital stay|length of hospital stay
89387|NCT02728947|Parkinson's Disease|parkinson's disease
89388|NCT02728934|Rheumatoid Arthritis|rheumatoid arthritis
89389|NCT02728934|Golimumab|golimumab
89390|NCT02728934|Infliximab|infliximab
89391|NCT02728895|Drug Therapy|drug therapy
89392|NCT02728882|Lymphoma CAR-T|lymphoma car-t
89393|NCT02728843|Parkinson's disease|parkinson's disease
89394|NCT02728843|Deferiprone|deferiprone
89395|NCT02728830|gynecologic cancers|gynecologic cancers
89396|NCT02728830|mullerian cancers|mullerian cancers
105464|NCT02632266|growth|growth
80650|NCT02782403|CML|cml
89397|NCT02728830|tumoral immunoprofile|tumoral immunoprofile
89398|NCT02728817|Vascular access|vascular access
89399|NCT02728817|Hemodialysis|hemodialysis
89400|NCT02728817|Arteriovenous fistula|arteriovenous fistula
89401|NCT02728817|Stenosis|stenosis
89402|NCT02728817|Failure|failure
89404|NCT02728726|Postoperative respiratory depression|postoperative respiratory depression
89405|NCT02728726|Neuromuscular Agents|neuromuscular agents
89406|NCT02728713|Cranial manipulation|cranial manipulation
89407|NCT02728713|Visual function|visual function
89408|NCT02728687|peripheral neuropathy|peripheral neuropathy
89418|NCT02728648|Pharmacodynamics|pharmacodynamics
89419|NCT02728635|Adipose tissue, epigenetic, abdominal gluteal fat|adipose tissue, epigenetic, abdominal gluteal fat
89420|NCT02728622|ovarian cancer|ovarian cancer
89421|NCT02728622|platinum-resistant|platinum-resistant
89422|NCT02728622|endocrine treatment|endocrine treatment
89423|NCT02728622|chemotherapy|chemotherapy
89424|NCT02728622|tamoxifen|tamoxifen
89425|NCT02728583|Plant sterols|plant sterols
89426|NCT02728583|Fish oil|fish oil
89427|NCT02728583|Blood lipids|blood lipids
89428|NCT02728570|flavonoids|flavonoids
89429|NCT02728570|insulin resistance|insulin resistance
89430|NCT02728570|plasma lipids|plasma lipids
89431|NCT02728570|intestinal microbiome|intestinal microbiome
89432|NCT02728570|intestinal inflammation|intestinal inflammation
89433|NCT02728570|subclinical inflammation|subclinical inflammation
89434|NCT02728557|Therapeutic alliance|therapeutic alliance
89435|NCT02728557|Psychotherapy|psychotherapy
89436|NCT02728557|Psychodynamic psychotherapy|psychodynamic psychotherapy
89437|NCT02728557|supportive-expressive treatment|supportive-expressive treatment
89438|NCT02728557|Process research|process research
89439|NCT02728557|Attachment theory|attachment theory
89440|NCT02728557|Attachment orientation|attachment orientation
89441|NCT02728557|Mechanism of change in psychotherapy|mechanism of change in psychotherapy
89442|NCT02728466|flavanols|flavanols
89443|NCT02728466|cocoa procyanidins|cocoa procyanidins
89444|NCT02728466|vascular function|vascular function
89445|NCT02728466|endothelial function|endothelial function
89446|NCT02728427|Suprapubic Catheterization|suprapubic catheterization
89447|NCT02728427|Transurethral Catheterization|transurethral catheterization
89448|NCT02728427|Rectal Cancer|rectal cancer
89449|NCT02728427|Laparoscopic Surgery|laparoscopic surgery
89450|NCT02728414|Diabetes Mellitus, Type 2, Probiotics, Treatment|diabetes mellitus, type 2, probiotics, treatment
89451|NCT02728401|inflammation|inflammation
89452|NCT02728401|sepsis|sepsis
89453|NCT02728401|pediatric|pediatric
89454|NCT02728401|transcripts|transcripts
89455|NCT02728401|serum proteins|serum proteins
89456|NCT02728401|cardiopulmonary bypass|cardiopulmonary bypass
89457|NCT02728388|NF1|nf1
89458|NCT02728388|Neurofibroma|neurofibroma
89459|NCT02728388|Neurofibromatosis Type 1|neurofibromatosis type 1
89460|NCT02728362|tibial shaft fractures|tibial shaft fractures
89461|NCT02728284|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
89462|NCT02728219|Recurrent Hepatocellular Carcinoma|recurrent hepatocellular carcinoma
636774|NCT00727987|Golimumab|golimumab
89463|NCT02728219|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
89464|NCT02728219|AFP conversion|afp conversion
89465|NCT02728193|treatments|treatments
89466|NCT02728193|hepatocellular carcinoma|hepatocellular carcinoma
89467|NCT02728180|Acute Ischemic Stroke|acute ischemic stroke
89468|NCT02728180|Xingnaojing injection|xingnaojing injection
89469|NCT02728180|Randomized Controlled Trial|randomized controlled trial
89470|NCT02728180|Traditional Chinese Medicine|traditional chinese medicine
89471|NCT02728167|Hepatectomy|hepatectomy
89472|NCT02728167|Liver metastasis|liver metastasis
89473|NCT02728167|High-Intensity Focused Ultrasound|high-intensity focused ultrasound
89474|NCT02728167|Liver metastases (LM) requiring surgery|liver metastases (lm) requiring surgery
89475|NCT02728154|pre-clinical diastolic dysfunction (pre-HFpEF)|pre-clinical diastolic dysfunction (pre-hfpef)
89476|NCT02728128|Milrinone|milrinone
89477|NCT02728115|Huntington's Disease|huntington's disease
89478|NCT02728115|Stem Cell|stem cell
89479|NCT02728115|Dental Pulp Stem Cells|dental pulp stem cells
89488|NCT02728076|Breast Cancer|breast cancer
89489|NCT02728076|Accelerated Partial Breast Irradiation|accelerated partial breast irradiation
90017|NCT02725164|respiration|respiration
89490|NCT02728037|Myofascial Trigger Points|myofascial trigger points
89491|NCT02728037|Myofascial Pain|myofascial pain
89492|NCT02728037|Intramuscular Anesthetic Injection|intramuscular anesthetic injection
89493|NCT02727998|PTSD|ptsd
89494|NCT02727972|depression|depression
89495|NCT02727972|bipolar|bipolar
89496|NCT02727972|post-traumatic stress disorder|post-traumatic stress disorder
89497|NCT02727972|mood disorders|mood disorders
89498|NCT02727972|PET|pet
89499|NCT02727972|mGluRr|mglurr
89500|NCT02727972|glutamate system|glutamate system
89501|NCT02727972|MRI|mri
89502|NCT02727959|UC|uc
89503|NCT02727959|CD|cd
89504|NCT02727959|IBD|ibd
89505|NCT02727894|Screening|screening
89506|NCT02727894|pTNM|ptnm
89507|NCT02727894|Metastasis|metastasis
89508|NCT02727894|Chemotherapy|chemotherapy
89509|NCT02727894|Resection Margins|resection margins
89510|NCT02727881|AMD, CNV, choroidal neovascularization, retinal eye disease|amd, cnv, choroidal neovascularization, retinal eye disease
89511|NCT02727855|Cholera|cholera
89512|NCT02727855|Vaccine|vaccine
89513|NCT02727855|Strategy|strategy
89514|NCT02727803|Acute Myelogenous Leukemia|acute myelogenous leukemia
89515|NCT02727803|AML|aml
89516|NCT02727803|Myelodysplastic syndrome|myelodysplastic syndrome
89517|NCT02727803|MDS|mds
89518|NCT02727803|Multiple myeloma|multiple myeloma
89519|NCT02727803|MM|mm
89520|NCT02727803|Umbilical cord blood transplant|umbilical cord blood transplant
89521|NCT02727803|UCB|ucb
89522|NCT02727803|Natural killer cells|natural killer cells
89523|NCT02727803|NK|nk
89524|NCT02727803|Busulfan|busulfan
89525|NCT02727803|Busulfex|busulfex
89526|NCT02727803|Myleran|myleran
89527|NCT02727803|Fludarabine|fludarabine
89528|NCT02727803|Fludarabine Phosphate|fludarabine phosphate
89529|NCT02727803|Fludara|fludara
89530|NCT02727803|Clofarabine|clofarabine
89531|NCT02727803|Clofarex|clofarex
89532|NCT02727803|Clolar|clolar
89533|NCT02727803|Rabbit ATB|rabbit atb
89534|NCT02727803|ATG (Rabbit)|atg (rabbit)
89535|NCT02727803|Rabbit Antithymocyte Globulin|rabbit antithymocyte globulin
89536|NCT02727803|Rabbit Antilymphocyte Globulin|rabbit antilymphocyte globulin
89537|NCT02727803|rATG Thymoglobulin|ratg thymoglobulin
89538|NCT02727803|Total Body Irradiation|total body irradiation
89539|NCT02727803|TBI|tbi
89540|NCT02727803|Radiation therapy|radiation therapy
89541|NCT02727803|XRT|xrt
89542|NCT02727803|Rituximab|rituximab
89543|NCT02727803|Rituxan|rituxan
89544|NCT02727803|Cyclophosphamide|cyclophosphamide
89545|NCT02727803|Cytoxan|cytoxan
89546|NCT02727803|Neosar|neosar
89547|NCT02727803|Melphalan|melphalan
89548|NCT02727803|Alkeran|alkeran
89549|NCT02727777|Lymphoma|lymphoma
89550|NCT02727777|Relapsed Lymphoma|relapsed lymphoma
89551|NCT02727777|MLN0128|mln0128
89552|NCT02727777|Blood sugar|blood sugar
89553|NCT02727777|Glucometer|glucometer
89554|NCT02727777|TK228|tk228
89555|NCT02727764|Rheumatoid Arthritis|rheumatoid arthritis
89556|NCT02727764|Gene therapy|gene therapy
89557|NCT02727764|Phase Ib|phase ib
89558|NCT02727764|Intra-articular|intra-articular
89559|NCT02727738|Hyperthyroidism|hyperthyroidism
89560|NCT02727738|Methimazole|methimazole
89561|NCT02727738|Selenium|selenium
89562|NCT02727712|coronary artery bypass graft|coronary artery bypass graft
89563|NCT02727712|thoracic paravertebral block|thoracic paravertebral block
89564|NCT02727699|Mild Dementia|mild dementia
89565|NCT02727699|Actinogen|actinogen
89566|NCT02727699|Alzheimer's Disease|alzheimer's disease
89567|NCT02727699|Xanamem|xanamem
89568|NCT02727699|Cortisol|cortisol
89569|NCT02727699|UE2343|ue2343
89570|NCT02727699|XanADu|xanadu
89571|NCT02727686|transsphenoidal pituitary surgery|transsphenoidal pituitary surgery
89572|NCT02727673|cancer stem cells|cancer stem cells
89573|NCT02727660|COPD|copd
89574|NCT02727647|Moderate hemophilia A|moderate hemophilia a
89575|NCT02727647|Severe hemophilia A|severe hemophilia a
89576|NCT02727647|Intermediate dose prophylaxis|intermediate dose prophylaxis
89577|NCT02727647|Low dose prophylaxis|low dose prophylaxis
89578|NCT02727634|Hemodynamics|hemodynamics
89579|NCT02727634|Echocardiography, Doppler, Pulsed|echocardiography, doppler, pulsed
89580|NCT02727621|Dexmedetomidine|dexmedetomidine
89581|NCT02727621|Cardiac|cardiac
89582|NCT02727621|Coronary Artery Bypass Grapht|coronary artery bypass grapht
89583|NCT02727621|Sedation|sedation
89584|NCT02727621|Propofol|propofol
89585|NCT02727621|Intravenous Anesthetics|intravenous anesthetics
89586|NCT02727582|MDR|mdr
89587|NCT02727556|skin conductance response|skin conductance response
89588|NCT02727556|facial muscle activity|facial muscle activity
89589|NCT02727556|heart rate variability|heart rate variability
89590|NCT02727556|eyetracking|eyetracking
89591|NCT02727543|Hypertension|hypertension
89592|NCT02727543|mHealth|mhealth
89593|NCT02727543|Medication Non-adherence|medication non-adherence
89594|NCT02727530|Infant Colic|infant colic
89595|NCT02727530|Manual Therapy|manual therapy
89596|NCT02727530|Effectiveness|effectiveness
89597|NCT02727517|Resuscitation|resuscitation
89598|NCT02727517|Cord clamping|cord clamping
89599|NCT02727504|Aortic valve stenosis|aortic valve stenosis
89600|NCT02727504|low flow|low flow
89601|NCT02727504|dobutamine stress echocardiography|dobutamine stress echocardiography
89602|NCT02727491|opioid analgesics,|opioid analgesics,
89603|NCT02727491|opioid consumption|opioid consumption
89604|NCT02727491|adverse effects|adverse effects
89605|NCT02727491|postoperative pain|postoperative pain
89606|NCT02727491|tonsillectomy|tonsillectomy
89607|NCT02727478|Balance|balance
89608|NCT02727478|Rehabilitation|rehabilitation
89609|NCT02727478|Exercise|exercise
89610|NCT02727478|basal ganglia|basal ganglia
89611|NCT02727478|Gait|gait
89612|NCT02727478|Training|training
89613|NCT02727478|physical activity|physical activity
89614|NCT02727439|microvascular function|microvascular function
89615|NCT02727439|laser Doppler flowmetry|laser doppler flowmetry
89616|NCT02727439|exercise|exercise
89617|NCT02727426|microvascular function|microvascular function
89618|NCT02727426|laser Doppler flowmetry|laser doppler flowmetry
89619|NCT02727426|high salt diet|high salt diet
89620|NCT02727374|Fear to Fall|fear to fall
89621|NCT02727374|Geriatric|geriatric
89622|NCT02727374|Rehabilitation|rehabilitation
89623|NCT02727374|Psychology|psychology
89624|NCT02727361|Dystonia|dystonia
89625|NCT02727361|Binding potential|binding potential
89626|NCT02727361|FEOBV|feobv
89627|NCT02727348|femoral sciatic block spinal diabetic foot haemodynamic pain|femoral sciatic block spinal diabetic foot haemodynamic pain
89628|NCT02727335|Non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
89629|NCT02727335|crizotinib|crizotinib
89630|NCT02727309|Apatinib|apatinib
89631|NCT02727309|Second-line Treatment|second-line treatment
89632|NCT02727309|Hepatocellular Cancer|hepatocellular cancer
89633|NCT02727309|TACE|tace
89634|NCT02727283|Healthy volunteer|healthy volunteer
89635|NCT02727283|Safety|safety
89636|NCT02727283|Pharmacokinetics|pharmacokinetics
89637|NCT02727283|Dose escalation|dose escalation
89638|NCT02727283|GSK3179106|gsk3179106
89639|NCT02727283|Rearranged during Transfection|rearranged during transfection
89640|NCT02727283|Irritable Bowel Syndrome|irritable bowel syndrome
89641|NCT02727283|Adults|adults
89642|NCT02727270|Movement disorders|movement disorders
89643|NCT02727270|Metabolic Stress|metabolic stress
89644|NCT02727257|Parkinson's disease|parkinson's disease
89645|NCT02727257|rehabilitation|rehabilitation
89646|NCT02727257|attention|attention
89647|NCT02727257|executive functions|executive functions
89648|NCT02727244|Pain Catastrophizing Scale|pain catastrophizing scale
89649|NCT02727231|closed loop glucose control|closed loop glucose control
89650|NCT02727231|hypoglycemia|hypoglycemia
89651|NCT02727231|type 1 diabetes|type 1 diabetes
89653|NCT02727166|intestinal gas|intestinal gas
89654|NCT02727166|functional gut symptoms|functional gut symptoms
89655|NCT02727166|intestinal sensitivity|intestinal sensitivity
89656|NCT02727166|intestinal motility|intestinal motility
89657|NCT02727153|Colonic cancer|colonic cancer
89658|NCT02727153|E.R.A.S. programs|e.r.a.s. programs
89659|NCT02727153|Safety|safety
89660|NCT02727114|skin thickness|skin thickness
89661|NCT02727114|high-frequency ultrasound|high-frequency ultrasound
89662|NCT02727101|Focal epilepsy, Perampanel|focal epilepsy, perampanel
89663|NCT02727088|Dental Pulp Disease|dental pulp disease
89664|NCT02727088|Endodontics|endodontics
89665|NCT02727088|Pulp Capping|pulp capping
89666|NCT02727088|Pulpotomy|pulpotomy
89667|NCT02727088|Pulpectomy|pulpectomy
89668|NCT02727075|Occult Gastrointestinal Bleeding|occult gastrointestinal bleeding
89669|NCT02727075|Iron Deficiency Anemia|iron deficiency anemia
89670|NCT02727075|Aged 75 Years and Older|aged 75 years and older
89671|NCT02727062|pain|pain
89676|NCT02727023|Healthy|healthy
89677|NCT02727010|Motor disability|motor disability
89678|NCT02727010|Motor impairment|motor impairment
89679|NCT02727010|Pregnancy|pregnancy
89680|NCT02727010|Parenthood|parenthood
89681|NCT02727010|Child psychology|child psychology
89682|NCT02726997|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
89683|NCT02726997|Ovarian Cancer|ovarian cancer
89684|NCT02726997|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
89685|NCT02726997|Fallopian Tube Cancer|fallopian tube cancer
89686|NCT02726997|High-grade epithelial non-mucinous ovarian cancer|high-grade epithelial non-mucinous ovarian cancer
89687|NCT02726997|Laparoscopy surgery|laparoscopy surgery
89688|NCT02726997|Durvalumab|durvalumab
89689|NCT02726997|MEDI4736|medi4736
89690|NCT02726997|Carboplatin|carboplatin
89691|NCT02726997|Paraplatin|paraplatin
89692|NCT02726997|Paclitaxel|paclitaxel
89693|NCT02726997|Taxol|taxol
89694|NCT02726984|stroke|stroke
89695|NCT02726984|carotid plaque|carotid plaque
89696|NCT02726984|18F-sodium fluoride PET/MR|18f-sodium fluoride pet/mr
89697|NCT02726971|Intrauterine Adhesion|intrauterine adhesion
89698|NCT02726971|Oestrogen Artificial Periodic Therapy|oestrogen artificial periodic therapy
89703|NCT02726932|Peritonitis|peritonitis
89704|NCT02726932|Inflammatory Markers|inflammatory markers
89705|NCT02726932|Patient Outcome Assessment|patient outcome assessment
89706|NCT02726932|Classification|classification
89707|NCT02726932|Multiple Organ Failure|multiple organ failure
89708|NCT02726932|Intraabdominal Infections|intraabdominal infections
89709|NCT02726919|focal epilepsy|focal epilepsy
89714|NCT02726867|refractory status epilepticus|refractory status epilepticus
89716|NCT02726867|lacosamide|lacosamide
89717|NCT02726867|ketamine|ketamine
89718|NCT02726841|Thoracic aorta|thoracic aorta
89719|NCT02726841|Abdominal aorta|abdominal aorta
89720|NCT02726841|Stents|stents
89721|NCT02726789|nucleic acid polymer REP 2139 HBsAg hepatitis B|nucleic acid polymer rep 2139 hbsag hepatitis b
89722|NCT02726763|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
89723|NCT02726763|Cognitive Training|cognitive training
89724|NCT02726763|16-034|16-034
89725|NCT02726750|Monoclonal gammopathy of unknown significance|monoclonal gammopathy of unknown significance
89726|NCT02726750|MGUS|mgus
89727|NCT02726750|Smoldering multiple myeloma|smoldering multiple myeloma
89728|NCT02726750|SMM|smm
89729|NCT02726750|Asymptomatic monoclonal gammopathies|asymptomatic monoclonal gammopathies
89730|NCT02726750|Biomarker testing|biomarker testing
89731|NCT02726750|Blood collection|blood collection
89732|NCT02726750|Blood draw|blood draw
89733|NCT02726737|inferior alveolar nerve block|inferior alveolar nerve block
89734|NCT02726737|irreversible pulpitis|irreversible pulpitis
89735|NCT02726737|local anesthesia|local anesthesia
89736|NCT02726737|sodium bicarbonate|sodium bicarbonate
89737|NCT02726724|Stress-Resident performance-Observers|stress-resident performance-observers
89738|NCT02726685|respiratory training|respiratory training
89739|NCT02726685|functional performance|functional performance
89740|NCT02726672|inspiratory muscles|inspiratory muscles
89741|NCT02726672|multiple sclerosis|multiple sclerosis
89742|NCT02726672|rehabilitation|rehabilitation
89743|NCT02726646|Local Drug Delivery|local drug delivery
89744|NCT02726646|Antibiotics|antibiotics
89745|NCT02726646|Doxycycline|doxycycline
89746|NCT02726646|Smokers|smokers
89747|NCT02726646|Chronic Periodontitis|chronic periodontitis
89748|NCT02726620|Decision support|decision support
89749|NCT02726620|Decision Support Systems, Clinical|decision support systems, clinical
89750|NCT02726620|Decision Support Techniques|decision support techniques
89751|NCT02726620|Hypotension|hypotension
89752|NCT02726620|Intraoperative Hypotension|intraoperative hypotension
89753|NCT02726620|Acute Kidney Injury|acute kidney injury
89754|NCT02726620|Postoperative Myocardial Injury|postoperative myocardial injury
89755|NCT02726620|Postoperative Mortality|postoperative mortality
89756|NCT02726620|Blood Pressure|blood pressure
89757|NCT02726607|Prevention of mother-to-child transmission (PMTCT)|prevention of mother-to-child transmission (pmtct)
89758|NCT02726607|Kenya|kenya
89759|NCT02726607|HITSystem 2.0|hitsystem 2.0
89760|NCT02726607|retention through PMTCT cascade of care|retention through pmtct cascade of care
89761|NCT02726607|Early Infant Diagnosis|early infant diagnosis
89762|NCT02726607|eHealth system-level intervention|ehealth system-level intervention
89763|NCT02726594|Magnetic Resonance Imaging, Patient Satisfaction|magnetic resonance imaging, patient satisfaction
89764|NCT02726568|EGFR-TKI|egfr-tki
89765|NCT02726568|NSCLC|nsclc
89766|NCT02726568|Icotinib|icotinib
89767|NCT02726555|Red yeast rice|red yeast rice
89768|NCT02726555|Atorvastatin|atorvastatin
89769|NCT02726555|Mild cardiovascular disease|mild cardiovascular disease
89770|NCT02726542|obesity|obesity
89771|NCT02726542|adolescence|adolescence
89772|NCT02726542|fatty liver|fatty liver
89773|NCT02726542|growth hormone|growth hormone
89774|NCT02726516|Performance|performance
89775|NCT02726503|anaplastic thyroid cancer, lenvatinib|anaplastic thyroid cancer, lenvatinib
89776|NCT02726490|gestational diabetes, pregnancy, diabetes|gestational diabetes, pregnancy, diabetes
89777|NCT02726464|Platelet-rich Plasma|platelet-rich plasma
89778|NCT02726464|Cell-Derived Microparticles|cell-derived microparticles
89779|NCT02726464|Pain Management|pain management
89780|NCT02726464|Blood Platelets|blood platelets
89781|NCT02726464|Therapeutics|therapeutics
89782|NCT02726464|Inflammation|inflammation
89783|NCT02726464|ThromboLUX|thrombolux
89784|NCT02726464|Dynamic Light Scattering|dynamic light scattering
89785|NCT02726399|Ramucirumab|ramucirumab
89786|NCT02726399|Trastuzumab|trastuzumab
89787|NCT02726399|Capecitabine|capecitabine
89788|NCT02726399|Cisplatin|cisplatin
89789|NCT02726399|HER2-Positive|her2-positive
89790|NCT02726399|15-301|15-301
89797|NCT02726334|Metastatic|metastatic
89798|NCT02726308|Dexamethasone|dexamethasone
89799|NCT02726308|Super-hydration|super-hydration
89800|NCT02726308|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
89801|NCT02726308|Nausea|nausea
89802|NCT02726308|Vomiting|vomiting
89803|NCT02726308|Postoperative|postoperative
89804|NCT02726269|Helicobacter Pylory infections|helicobacter pylory infections
89805|NCT02726269|Levofloxacin|levofloxacin
89806|NCT02726269|Antibiotic resistance|antibiotic resistance
89807|NCT02726269|Clarithromycin|clarithromycin
89808|NCT02726269|Mutations|mutations
89809|NCT02726269|Fluorescence|fluorescence
89810|NCT02726269|Hybridization|hybridization
89812|NCT02726256|DM complication|dm complication
89813|NCT02726243|Inflammatory bowel disease|inflammatory bowel disease
89814|NCT02726243|Crohn's Disease|crohn's disease
89815|NCT02726243|Ulcerative Colitis|ulcerative colitis
89816|NCT02726243|colorectal cancer|colorectal cancer
89817|NCT02726243|primary sclerosing cholangitis|primary sclerosing cholangitis
89818|NCT02726217|CareSmarts|caresmarts
89819|NCT02726217|SMS-based mobile|sms-based mobile
89820|NCT02726178|Apnea|apnea
89821|NCT02726178|bradycardia|bradycardia
89822|NCT02726178|immunization|immunization
89823|NCT02726178|inflammation|inflammation
89824|NCT02726178|preterms|preterms
89825|NCT02726152|Diagnostic laparoscopy|diagnostic laparoscopy
89826|NCT02726152|Acute appendicitis|acute appendicitis
89827|NCT02726152|Appendiceal stump|appendiceal stump
89828|NCT02726139|Factor VIII|factor viii
89829|NCT02726139|inhibitor|inhibitor
89830|NCT02726139|assay|assay
89831|NCT02726126|Transdermal fentanyl|transdermal fentanyl
89832|NCT02726126|Transdermal melatonin|transdermal melatonin
89833|NCT02726126|Postoperative pain|postoperative pain
89834|NCT02726126|lumber laminectomy|lumber laminectomy
89835|NCT02726126|Relief|relief
89836|NCT02726113|prostate cancer|prostate cancer
89837|NCT02726113|vitamin D|vitamin d
89838|NCT02726100|Telemedicine|telemedicine
89839|NCT02726100|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
89840|NCT02726100|Decision Support Systems, Clinical|decision support systems, clinical
89841|NCT02726100|Family Health Promoter|family health promoter
89842|NCT02726100|Primary Health Care|primary health care
89843|NCT02726087|Ministernotomy|ministernotomy
89844|NCT02726087|aortic valve stenosis|aortic valve stenosis
89845|NCT02726087|quality of life|quality of life
89846|NCT02726087|satisfaction|satisfaction
89847|NCT02726087|cardiac surgery|cardiac surgery
89848|NCT02726074|epilepsy|epilepsy
89849|NCT02726074|partial-onset seizures|partial-onset seizures
89850|NCT02726074|secondarily generalized seizures|secondarily generalized seizures
89851|NCT02726035|Self-injurious behavior|self-injurious behavior
89852|NCT02726035|Self mutilation|self mutilation
89853|NCT02726035|naltrexone|naltrexone
89854|NCT02725996|Hepatocellular Carcinoma|hepatocellular carcinoma
89855|NCT02725996|Natural Killer cells|natural killer cells
89856|NCT02725983|Gingivitis|gingivitis
89857|NCT02725983|Oral Hygiene|oral hygiene
89858|NCT02725983|Intra oral camera|intra oral camera
89859|NCT02725983|Self regulation|self regulation
89860|NCT02725983|bleeding|bleeding
89865|NCT02725970|BMI|bmi
89866|NCT02725970|Public Schools|public schools
89867|NCT02725957|Bioblast|bioblast
89868|NCT02725944|Cryptogenic stroke|cryptogenic stroke
89869|NCT02725944|Occult paroxysmal atrial fibrillation|occult paroxysmal atrial fibrillation
89870|NCT02725931|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
89871|NCT02725931|COPD|copd
89872|NCT02725931|Pulmonary rehabilitation|pulmonary rehabilitation
89873|NCT02725931|Physical activity|physical activity
89874|NCT02725931|Exercise|exercise
89875|NCT02725918|NSCLC|nsclc
89876|NCT02725918|EGFR-TKI failure|egfr-tki failure
89877|NCT02725918|chemotherapy|chemotherapy
89878|NCT02725905|Weight Management Counseling|weight management counseling
89879|NCT02725905|Medical School Education|medical school education
89880|NCT02725892|lung cancer epidemiology algeria registry|lung cancer epidemiology algeria registry
89881|NCT02725866|Observational Study|observational study
89882|NCT02725866|Sustained Virological Response|sustained virological response
89883|NCT02725866|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
89884|NCT02725866|Chronic Hepatitis C|chronic hepatitis c
89885|NCT02725866|Paritaprevir/r - Ombitasvir, ± Dasabuvir,|paritaprevir/r - ombitasvir, ± dasabuvir,
89886|NCT02725866|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
89887|NCT02725853|Transcranial Direct Current Stimulation|transcranial direct current stimulation
89888|NCT02725853|Arm Training|arm training
89889|NCT02725853|Virtual Reality Exposure Therapy|virtual reality exposure therapy
89890|NCT02725840|pulmonary vasculature|pulmonary vasculature
89891|NCT02725840|radiation late effects|radiation late effects
89892|NCT02725840|proton therapy|proton therapy
89893|NCT02725814|Sucrose|sucrose
89894|NCT02725814|Effectiveness|effectiveness
89895|NCT02725814|Healthcare Delivery|healthcare delivery
89896|NCT02725814|Neonates|neonates
89897|NCT02725814|Nursing|nursing
89898|NCT02725775|Orange Juice, Polyphenol, Cognition|orange juice, polyphenol, cognition
89899|NCT02725762|Dry AMD|dry amd
89900|NCT02725762|Vision Loss|vision loss
89902|NCT02725749|shoulder|shoulder
89903|NCT02725749|low level laser therapy|low level laser therapy
89904|NCT02725749|exercises|exercises
89905|NCT02725710|uterine aspiration|uterine aspiration
89906|NCT02725658|Neoadjuvant Therapy|neoadjuvant therapy
89907|NCT02725658|Diffuse Optical Spectroscopic Imaging|diffuse optical spectroscopic imaging
89908|NCT02725658|DOSI|dosi
89909|NCT02725658|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
89910|NCT02725645|Surface electromyography|surface electromyography
89911|NCT02725645|children|children
89912|NCT02725645|backpack|backpack
89913|NCT02725632|Sodium channel|sodium channel
89914|NCT02725632|splicing variant|splicing variant
89915|NCT02725632|sleep apnea syndrome|sleep apnea syndrome
89916|NCT02725606|Neutropenia|neutropenia
89917|NCT02725606|Breast Cancer|breast cancer
89918|NCT02725606|GW003|gw003
89919|NCT02725593|Diabetes Mellitus|diabetes mellitus
89920|NCT02725593|Dapagliflozin|dapagliflozin
89921|NCT02725593|Placebo|placebo
89922|NCT02725593|Insulin resistance|insulin resistance
89923|NCT02725593|Metabolic Diseases|metabolic diseases
89924|NCT02725580|Neuronal ceroid lipofuscinosis|neuronal ceroid lipofuscinosis
89925|NCT02725580|NCL|ncl
89926|NCT02725580|Gene Transfer|gene transfer
89927|NCT02725580|Gray Foundation|gray foundation
89928|NCT02725541|HER2 equivocal|her2 equivocal
89929|NCT02725541|Trastuzumab emtansine|trastuzumab emtansine
89930|NCT02725541|Breast cancer|breast cancer
89931|NCT02725502|T1DM|t1dm
89932|NCT02725502|Linagliptin|linagliptin
89933|NCT02725502|mix meal test|mix meal test
89934|NCT02725489|Vigil|vigil
89935|NCT02725489|durvalumab|durvalumab
89936|NCT02725489|MEDI4736|medi4736
89937|NCT02725489|PD-L1|pd-l1
89938|NCT02725489|anti PD-L1|anti pd-l1
89939|NCT02725489|immunotherapy|immunotherapy
89940|NCT02725489|PD-L1 inhibitor|pd-l1 inhibitor
89941|NCT02725489|breast cancer|breast cancer
89942|NCT02725489|ovarian cancer|ovarian cancer
89943|NCT02725489|fallopian tube cancer|fallopian tube cancer
89944|NCT02725489|primary peritoneal cancer|primary peritoneal cancer
89945|NCT02725489|uterine cancer|uterine cancer
89946|NCT02725489|cervical cancer|cervical cancer
89947|NCT02725489|endometrial cancer|endometrial cancer
89948|NCT02725463|vestibular|vestibular
89949|NCT02725463|implant|implant
89950|NCT02725463|prosthesis|prosthesis
89951|NCT02725463|labyrinth|labyrinth
89952|NCT02725463|ototoxicity|ototoxicity
89953|NCT02725463|gentamicin|gentamicin
89954|NCT02725463|oscillopsia|oscillopsia
89955|NCT02725463|disequilibrium|disequilibrium
89956|NCT02725463|dizziness|dizziness
89957|NCT02725463|vestibulopathy|vestibulopathy
89958|NCT02725463|inner ear|inner ear
89959|NCT02725450|Motor Imagery|motor imagery
89960|NCT02725450|Fine motor skills|fine motor skills
89961|NCT02725450|Disabled|disabled
89962|NCT02725411|Chronic low back pain|chronic low back pain
89963|NCT02725411|Chronic pain|chronic pain
89964|NCT02725398|Buscopan|buscopan
89965|NCT02725398|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
89966|NCT02725398|Imaging Quality|imaging quality
89967|NCT02725385|No Evidence of Disease|no evidence of disease
89968|NCT02725372|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
89969|NCT02725372|PAH|pah
89970|NCT02725372|Inhaled Nitric Oxide|inhaled nitric oxide
89971|NCT02725372|iNO|ino
89972|NCT02725372|long term oxygen therapy|long term oxygen therapy
89973|NCT02725372|oxygen therapy|oxygen therapy
89974|NCT02725359|Thyroidectomy pain|thyroidectomy pain
89975|NCT02725359|Tizanidine|tizanidine
89976|NCT02725359|Postoperative analgesia|postoperative analgesia
89977|NCT02725359|Ultrasound guided Superficial cervical plexus block|ultrasound guided superficial cervical plexus block
89978|NCT02725346|Surgical Planning Solution|surgical planning solution
89979|NCT02725346|Acromioplasty|acromioplasty
89980|NCT02725346|Shoulder Surgery|shoulder surgery
89981|NCT02725346|Critical Shoulder Angle|critical shoulder angle
89982|NCT02725333|Glenohumeral stabilization|glenohumeral stabilization
89983|NCT02725333|Computer tomography|computer tomography
89984|NCT02725333|Subtle or minor instability|subtle or minor instability
89985|NCT02725333|Unstable painful shoulder|unstable painful shoulder
89986|NCT02725333|Apprehension|apprehension
89987|NCT02725333|Dislocation|dislocation
89988|NCT02725333|Subluxation|subluxation
89989|NCT02725333|Kinematics modeling|kinematics modeling
89990|NCT02725333|Biomechanics|biomechanics
89991|NCT02725333|Motion capture|motion capture
89992|NCT02725333|3D simulation|3d simulation
89993|NCT02725320|rotator cuff|rotator cuff
89994|NCT02725320|shoulder reconstruction|shoulder reconstruction
89995|NCT02725294|exacerbation|exacerbation
89996|NCT02725294|access to care|access to care
89997|NCT02725294|telemedicine|telemedicine
89998|NCT02725268|Drug Therapy|drug therapy
89999|NCT02725229|Postoperative pain|postoperative pain
90000|NCT02725229|Parasternal block|parasternal block
90001|NCT02725229|Sternotomy|sternotomy
90002|NCT02725229|TENS|tens
90003|NCT02725203|Cardiovascular risk management|cardiovascular risk management
90004|NCT02725203|behaviour change techniques|behaviour change techniques
90005|NCT02725203|self-management|self-management
90006|NCT02725203|physical activity|physical activity
90007|NCT02725203|nurse-led|nurse-led
90008|NCT02725203|behaviour change wheel|behaviour change wheel
90009|NCT02725203|primary care|primary care
90010|NCT02725203|clustered RCT|clustered rct
90011|NCT02725177|Ocular Sarcoidosis|ocular sarcoidosis
90012|NCT02725164|oxygen|oxygen
90013|NCT02725164|nitrous oxide|nitrous oxide
90014|NCT02725164|sevoflurane|sevoflurane
90015|NCT02725164|carbon dioxide|carbon dioxide
90016|NCT02725164|endotracheal tube|endotracheal tube
90018|NCT02725151|inferior vena cava ultrasound|inferior vena cava ultrasound
90019|NCT02725151|acute|acute
90020|NCT02725151|heart failure|heart failure
90021|NCT02725151|management|management
90022|NCT02725151|decompensation|decompensation
90023|NCT02725138|Helicobacter pylori|helicobacter pylori
90024|NCT02725138|probiotic|probiotic
90025|NCT02725138|bacterial density|bacterial density
90026|NCT02725125|Stomach Cancer CAR-T|stomach cancer car-t
90027|NCT02725099|STEMI|stemi
90028|NCT02725060|POTS|pots
90029|NCT02725060|Orthostatic Intolerance|orthostatic intolerance
90030|NCT02725060|Orthostatic Tachycardia|orthostatic tachycardia
90031|NCT02725047|Osteoarthritis, Knee|osteoarthritis, knee
90032|NCT02725047|Cryotherapy|cryotherapy
90033|NCT02725047|Thermotherapy|thermotherapy
90034|NCT02725047|Hypothermia|hypothermia
90035|NCT02725047|Knee|knee
90036|NCT02725047|Physiotherapy|physiotherapy
90037|NCT02725021|tobacco prevention|tobacco prevention
90038|NCT02725008|Asthma|asthma
90039|NCT02725008|Pediatric|pediatric
90040|NCT02725008|Emergency Department|emergency department
90041|NCT02725008|Dexamethasone|dexamethasone
90042|NCT02725008|Steroid|steroid
90043|NCT02724982|Self esteem|self esteem
90044|NCT02724982|Body mass index|body mass index
90045|NCT02724969|text messaging|text messaging
90046|NCT02724969|short message service|short message service
90047|NCT02724943|child obesity|child obesity
90048|NCT02724943|primary prevention|primary prevention
90049|NCT02724943|primary care|primary care
90050|NCT02724943|weight management|weight management
90051|NCT02724943|child overweight|child overweight
90053|NCT02724930|low back pain, chronic pain, cognitive behavior therapy|low back pain, chronic pain, cognitive behavior therapy
90054|NCT02724904|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
90055|NCT02724904|CNS Non-Hodgkin lymphoma|cns non-hodgkin lymphoma
90056|NCT02724891|Pelvic Floor Dysfunction|pelvic floor dysfunction
90057|NCT02724878|Kidney Cancer|kidney cancer
90058|NCT02724865|Oral Appliance Therapy|oral appliance therapy
90059|NCT02724852|MMR|mmr
90060|NCT02724852|vaccination|vaccination
90061|NCT02724852|HIV|hiv
90062|NCT02724852|Serologic response|serologic response
90063|NCT02724826|Expectations|expectations
90064|NCT02724826|Outcomes|outcomes
90065|NCT02724826|Qigong|qigong
90066|NCT02724826|Exercise therapy|exercise therapy
90067|NCT02724826|Disability|disability
90068|NCT02724826|Neck movements,|neck movements,
90069|NCT02724800|Insomnia|insomnia
90070|NCT02724800|Veterans|veterans
90071|NCT02724800|Cognitive Behavioral Therapy for Insomnia|cognitive behavioral therapy for insomnia
90072|NCT02724800|Brief Behavioral Treatment for Insomnia|brief behavioral treatment for insomnia
90073|NCT02724800|Comparative Effectiveness Research|comparative effectiveness research
90074|NCT02724787|Post-traumatic stress disorder|post-traumatic stress disorder
90075|NCT02724787|Veterans|veterans
90076|NCT02724787|Aggression|aggression
90077|NCT02724787|Emotion regulation|emotion regulation
90078|NCT02724774|infants|infants
90079|NCT02724774|mental health|mental health
90080|NCT02724774|postpartum period|postpartum period
90081|NCT02724748|Aggression|aggression
90082|NCT02724748|Mental Health|mental health
90083|NCT02724748|Education, Continuing|education, continuing
90084|NCT02724735|Depression|depression
90085|NCT02724735|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
90086|NCT02724735|Major Depressive Disorder|major depressive disorder
90087|NCT02724735|Neurogenesis|neurogenesis
90088|NCT02724735|Synaptogenesis|synaptogenesis
90089|NCT02724735|NSI-189|nsi-189
90090|NCT02724735|Neuralstem|neuralstem
90091|NCT02724722|melamine|melamine
90092|NCT02724722|phthalate|phthalate
90093|NCT02724709|Automatic Data Processing|automatic data processing
90094|NCT02724709|Three-Dimensional Echocardiography|three-dimensional echocardiography
90095|NCT02724709|Aortic Valve|aortic valve
90096|NCT02724683|ascites|ascites
90097|NCT02724683|drainage|drainage
90098|NCT02724683|catheter|catheter
90099|NCT02724683|symptoms|symptoms
90100|NCT02724683|management|management
90101|NCT02724683|quality of life|quality of life
90102|NCT02724683|malignant|malignant
90103|NCT02724683|cancer|cancer
90104|NCT02724657|Child|child
90105|NCT02724657|Breathing exercises|breathing exercises
90106|NCT02724631|Clogged enteral access devices|clogged enteral access devices
90107|NCT02724631|Occluded enteral access device|occluded enteral access device
90108|NCT02724631|Enteral nutrition|enteral nutrition
90109|NCT02724631|Enteral access device|enteral access device
90110|NCT02724631|Tube Feeding|tube feeding
90111|NCT02724631|Gastric Feeding Tubes|gastric feeding tubes
90112|NCT02724618|Curcumin|curcumin
90113|NCT02724618|Protection, Radiation|protection, radiation
90114|NCT02724618|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
90115|NCT02724618|Radiation Therapy|radiation therapy
90116|NCT02724618|Prostate Cancer|prostate cancer
90117|NCT02724605|RBCS,|rbcs,
90118|NCT02724605|Transfusion,|transfusion,
90119|NCT02724605|Pediatric|pediatric
90120|NCT02724605|Changes|changes
90121|NCT02724566|Type 2 diabetic volunteers|type 2 diabetic volunteers
90122|NCT02724527|Cystic Fibrosis|cystic fibrosis
90123|NCT02724527|N91115|n91115
90124|NCT02724527|Cavosonstat|cavosonstat
90125|NCT02724488|Advanced cancer|advanced cancer
90126|NCT02724488|Advanced solid tumors|advanced solid tumors
90127|NCT02724488|Phase I clinical trial candidates|phase i clinical trial candidates
90128|NCT02724488|Phase II clinical trial candidates|phase ii clinical trial candidates
90129|NCT02724488|Phase III clinical trial candidates|phase iii clinical trial candidates
90130|NCT02724488|Head and Neck|head and neck
90131|NCT02724488|Melanoma|melanoma
90132|NCT02724488|Upper Aerodigestive cancer|upper aerodigestive cancer
90133|NCT02724488|Oral Cavity|oral cavity
90134|NCT02724488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors
90135|NCT02724488|ICIs|icis
90136|NCT02724488|ctDNA|ctdna
90137|NCT02724488|Whole Exome Sequencing|whole exome sequencing
90138|NCT02724488|Molecular Profiling|molecular profiling
90139|NCT02724475|Laser Ablation|laser ablation
90140|NCT02724475|Portal Vein Tumor|portal vein tumor
90141|NCT02724475|Thrombus|thrombus
90142|NCT02724462|smoking cessation|smoking cessation
90143|NCT02724462|app for quitting smoking|app for quitting smoking
90144|NCT02724449|IAD|iad
90145|NCT02724449|Fecal incontinence|fecal incontinence
90146|NCT02724436|Yittrium-90|yittrium-90
90147|NCT02724436|Hepatocellular Carcinoma|hepatocellular carcinoma
90148|NCT02724423|epilepsy|epilepsy
90149|NCT02724423|seizure|seizure
90150|NCT02724410|appendectomy|appendectomy
90151|NCT02724397|Colon cancer|colon cancer
90152|NCT02724397|Diagnosis|diagnosis
90153|NCT02724397|Adenoma|adenoma
90154|NCT02724397|Serrated lesions|serrated lesions
90155|NCT02724358|Carcinoma|carcinoma
90156|NCT02724358|Hepatocellular|hepatocellular
90157|NCT02724358|Notch1|notch1
90158|NCT02724345|Cell keratin 18|cell keratin 18
90159|NCT02724332|Aspartate beta hydroxylase|aspartate beta hydroxylase
90160|NCT02724332|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
90161|NCT02724319|percutaneous coronary intervention|percutaneous coronary intervention
90163|NCT02724319|loss-of-function allele|loss-of-function allele
90164|NCT02724267|131I-chTNT-1/B treatment|131i-chtnt-1/b treatment
90165|NCT02724254|Genital warts|genital warts
90166|NCT02724254|HPV types|hpv types
90167|NCT02724254|Sexually Transmitted Disease|sexually transmitted disease
90168|NCT02724254|Papillomavirus Infections|papillomavirus infections
90169|NCT02724254|Viral Disease|viral disease
90170|NCT02724254|Anogenital warts|anogenital warts
90171|NCT02724254|AGW|agw
90172|NCT02724254|HPV6|hpv6
90173|NCT02724254|HPV11|hpv11
90174|NCT02724254|Human papillomavirus infection|human papillomavirus infection
90175|NCT02724254|HPV|hpv
90176|NCT02724254|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
90177|NCT02724254|Aviragen Therapeutics|aviragen therapeutics
90178|NCT02724254|Aviragen|aviragen
90179|NCT02724241|nicotine|nicotine
90180|NCT02724241|autonomic tone|autonomic tone
90181|NCT02724241|oxidative stress|oxidative stress
90182|NCT02724228|Achondroplasia|achondroplasia
90183|NCT02724228|Dwarfism|dwarfism
90184|NCT02724228|Bone Diseases, Developmental|bone diseases, developmental
90185|NCT02724228|Bone Diseases|bone diseases
90186|NCT02724215|Subarachnoid hemorrhage|subarachnoid hemorrhage
90187|NCT02724215|Sleep Apnea|sleep apnea
90188|NCT02724202|Curcumin|curcumin
90189|NCT02724202|5FU|5fu
90190|NCT02724202|5-fluorouracil|5-fluorouracil
90191|NCT02724202|Adracil|adracil
90192|NCT02724202|5FU Resistant|5fu resistant
90193|NCT02724202|Metastatic Colon Cancer|metastatic colon cancer
90194|NCT02724202|Colon Cancer|colon cancer
90195|NCT02724189|electronic pre-assessment|electronic pre-assessment
90196|NCT02724189|preoperative assessment|preoperative assessment
90197|NCT02724163|Acute Myeloid Leukaemia|acute myeloid leukaemia
90198|NCT02724163|Children|children
90199|NCT02724163|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
90200|NCT02724163|Liposomal daunorubicin|liposomal daunorubicin
90201|NCT02724163|Mitoxantrone|mitoxantrone
90202|NCT02724163|Randomised controlled trial|randomised controlled trial
90203|NCT02724163|Risk stratification|risk stratification
90204|NCT02724163|Minimal residual disease|minimal residual disease
90205|NCT02724163|Stem cell transplant|stem cell transplant
90206|NCT02724150|Gastroduodenal Ulcer|gastroduodenal ulcer
90207|NCT02724150|Marginal Ulcer|marginal ulcer
90208|NCT02724150|Peptic Ulcer Hemorrhage|peptic ulcer hemorrhage
90209|NCT02724150|Peptic Ulcer|peptic ulcer
90210|NCT02724137|Total Knee Replacement|total knee replacement
90211|NCT02724137|Physical Therapy|physical therapy
90212|NCT02724137|Fitbit®|fitbit®
90213|NCT02724124|exercise muscle stretching|exercise muscle stretching
90214|NCT02724124|electromyography|electromyography
90215|NCT02724111|Neuromuscular blockade|neuromuscular blockade
90216|NCT02724111|Surgical rating scale|surgical rating scale
90217|NCT02724111|Rocuronium|rocuronium
90218|NCT02724111|Sugammadex|sugammadex
90219|NCT02724111|Spinal surgery|spinal surgery
90323|NCT02723591|Tacrolimus|tacrolimus
90220|NCT02724111|General anesthesia|general anesthesia
90221|NCT02724098|Palliative Therapy|palliative therapy
90222|NCT02724072|Thoracic Surgery|thoracic surgery
90223|NCT02724072|Aortic Arch|aortic arch
90224|NCT02724072|Frozen Elephant Trunk|frozen elephant trunk
90225|NCT02724072|Performance Goal|performance goal
90226|NCT02724046|Neisseria meningitidis|neisseria meningitidis
90227|NCT02724046|Ciprofloxacin|ciprofloxacin
90228|NCT02724046|Chemoprevention|chemoprevention
90229|NCT02724033|post operative nausea vomiting|post operative nausea vomiting
90230|NCT02724033|Inner ear surgery|inner ear surgery
90231|NCT02724020|Drug Therapy|drug therapy
90232|NCT02724007|Trauma|trauma
90233|NCT02724007|India|india
90234|NCT02724007|ICISS|iciss
90235|NCT02723994|B-cell acute lymphoblastic leukemia (ALL)|b-cell acute lymphoblastic leukemia (all)
90236|NCT02723994|pediatric|pediatric
90237|NCT02723994|multi-agent chemotherapy|multi-agent chemotherapy
90238|NCT02723994|JAK inhibitor|jak inhibitor
90239|NCT02723981|Stent , COMBO Stent, anticoagulation|stent , combo stent, anticoagulation
90240|NCT02723955|ICOS receptor agonist antibody|icos receptor agonist antibody
90241|NCT02723955|Pembrolizumab|pembrolizumab
90242|NCT02723955|KEYNOTE-478|keynote-478
90243|NCT02723955|GSK3359609|gsk3359609
90244|NCT02723955|Dose expansion|dose expansion
90245|NCT02723955|Dose escalation|dose escalation
90246|NCT02723942|glypican-3(GPC3)|glypican-3(gpc3)
90247|NCT02723942|chimeric antigen receptor-modified T cell(CAR-T)|chimeric antigen receptor-modified t cell(car-t)
90248|NCT02723942|hepatocellular carcinoma(HCC)|hepatocellular carcinoma(hcc)
90249|NCT02723929|transcranial direct current stimulation|transcranial direct current stimulation
90250|NCT02723929|transcranial ultrasound|transcranial ultrasound
90251|NCT02723929|non-invasive brain stimulation|non-invasive brain stimulation
90252|NCT02723916|Parents|parents
90253|NCT02723916|Child|child
90254|NCT02723916|Preschool|preschool
90255|NCT02723916|eHealth|ehealth
90256|NCT02723903|somatization symptom score|somatization symptom score
90257|NCT02723903|SSS checklist|sss checklist
90258|NCT02723903|coronary angiography|coronary angiography
90259|NCT02723903|Patient Health Questionnaire|patient health questionnaire
90260|NCT02723903|Generalized Anxiety Disorder 7-items|generalized anxiety disorder 7-items
90261|NCT02723877|TNBC|tnbc
90262|NCT02723864|Pharmacodynamic|pharmacodynamic
90263|NCT02723864|DNA Damage Repair|dna damage repair
90264|NCT02723864|BRCA Null|brca null
90265|NCT02723864|Apoptosis|apoptosis
90266|NCT02723864|Combination Therapy|combination therapy
90267|NCT02723838|Bladder|bladder
90268|NCT02723838|Cancer|cancer
90269|NCT02723838|REOLYSIN®|reolysin®
90270|NCT02723838|Gemcitabine|gemcitabine
90271|NCT02723838|Cisplatin|cisplatin
90272|NCT02723838|Reovirus|reovirus
90273|NCT02723838|Oncolytic virus|oncolytic virus
90274|NCT02723825|Distal tibia|distal tibia
90275|NCT02723825|fractures|fractures
90276|NCT02723825|epiphyses|epiphyses
90277|NCT02723825|children|children
90278|NCT02723812|Influenza|influenza
90280|NCT02723812|vaccine|vaccine
90281|NCT02723812|Vietnam|vietnam
90282|NCT02723799|Hope|hope
90283|NCT02723786|Delayed Graft Function|delayed graft function
90284|NCT02723786|Renal Transplantation|renal transplantation
90285|NCT02723786|Prevention|prevention
90286|NCT02723786|GSK1070806|gsk1070806
90287|NCT02723773|Efficacy|efficacy
90288|NCT02723773|Immunogenicity|immunogenicity
90289|NCT02723773|Safety|safety
90290|NCT02723773|Adults|adults
90291|NCT02723773|Herpes zoster|herpes zoster
90292|NCT02723747|myocardial ischemia|myocardial ischemia
90293|NCT02723747|magnetic resonance imaging|magnetic resonance imaging
90294|NCT02723747|perfusion|perfusion
90295|NCT02723747|software|software
90296|NCT02723734|Decipher®|decipher®
90297|NCT02723734|African-American men|african-american men
90298|NCT02723734|prostate|prostate
90299|NCT02723734|low risk PCa|low risk pca
90300|NCT02723734|intermediate risk PCa|intermediate risk pca
90301|NCT02723734|genomic classifier (GC)|genomic classifier (gc)
90302|NCT02723721|Lentigo maligna|lentigo maligna
90303|NCT02723695|Cochlear implant|cochlear implant
90304|NCT02723695|Perception|perception
90305|NCT02723695|Posture|posture
90306|NCT02723695|Quality of life|quality of life
90307|NCT02723669|Relative Bioavailability|relative bioavailability
90308|NCT02723656|smoking|smoking
90309|NCT02723656|cancer|cancer
90310|NCT02723656|cancer registry|cancer registry
90407|NCT02723136|Internship|internship
90311|NCT02723656|smoking cessation|smoking cessation
90312|NCT02723643|Hypertension|hypertension
90313|NCT02723643|Essential hypertension|essential hypertension
90314|NCT02723643|Blood pressure|blood pressure
90315|NCT02723643|Cardiovascular diseases|cardiovascular diseases
90316|NCT02723630|Bioequivalence|bioequivalence
90317|NCT02723630|Lenvatinib|lenvatinib
90318|NCT02723630|Healthy Volunteers|healthy volunteers
90319|NCT02723630|Lenvima|lenvima
90320|NCT02723630|E7080|e7080
90321|NCT02723591|FK506|fk506
90322|NCT02723591|Kidney Transplantation|kidney transplantation
90324|NCT02723591|Astagraf XL|astagraf xl
90325|NCT02723552|preeclampsia|preeclampsia
90326|NCT02723552|young adult hypertension|young adult hypertension
90327|NCT02723552|preterm birth|preterm birth
90328|NCT02723526|Metastatic Hormone-Sensitive Prostate Cancer；circulating tumor cells；Prognosis；Liquid biopsy|metastatic hormone-sensitive prostate cancer；circulating tumor cells；prognosis；liquid biopsy
90329|NCT02723513|Proton MRI|proton mri
90330|NCT02723513|Noble Gas MRI|noble gas mri
90331|NCT02723513|Pulmonary Function|pulmonary function
90332|NCT02723500|Magnetic Resonance Imaging|magnetic resonance imaging
90333|NCT02723500|Pulmonary Function|pulmonary function
90334|NCT02723487|TAP block|tap block
90335|NCT02723487|pediatric|pediatric
90336|NCT02723487|Laparoscopic|laparoscopic
90337|NCT02723487|postoperative pain|postoperative pain
90338|NCT02723474|Magnetic Resonance Imaging|magnetic resonance imaging
90339|NCT02723474|Pulmonary Function|pulmonary function
90340|NCT02723396|Parkinson's disease|parkinson's disease
90341|NCT02723396|Sleep Benefit|sleep benefit
90342|NCT02723383|alcoholism|alcoholism
90343|NCT02723383|intensive care|intensive care
90344|NCT02723383|Baclofen|baclofen
90345|NCT02723383|restlessness|restlessness
90346|NCT02723383|Delirium tremens|delirium tremens
90347|NCT02723383|Alcohol withdrawal syndrome|alcohol withdrawal syndrome
90348|NCT02723370|Quality of Healthcare|quality of healthcare
90349|NCT02723370|Colorectal neoplasms|colorectal neoplasms
90350|NCT02723370|Health Literacy|health literacy
90351|NCT02723370|Teach-Back Communication|teach-back communication
90352|NCT02723370|Evidence Based Practice|evidence based practice
90353|NCT02723370|Colonoscopy|colonoscopy
90354|NCT02723357|Financial Coaching|financial coaching
90355|NCT02723357|Mental Health|mental health
90356|NCT02723357|Social Determinants|social determinants
90357|NCT02723357|Medical-Financial Partnership|medical-financial partnership
90358|NCT02723357|Toxic Stress|toxic stress
90359|NCT02723344|PTSD|ptsd
90360|NCT02723344|Mild TBI|mild tbi
90361|NCT02723344|Probiotic|probiotic
90362|NCT02723344|Inflammation|inflammation
90363|NCT02723331|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
90364|NCT02723331|Perioperative Therapy|perioperative therapy
90365|NCT02723331|Resectable Pancreas Ductal Adenocarcinoma|resectable pancreas ductal adenocarcinoma
90366|NCT02723331|Borderline Resectable Pancreas Ductal Adenocarcinoma|borderline resectable pancreas ductal adenocarcinoma
90367|NCT02723331|Nab-paclitaxel|nab-paclitaxel
90368|NCT02723331|Abraxane|abraxane
90369|NCT02723331|Gemcitabine|gemcitabine
90370|NCT02723331|Neoadjuvant Therapy|neoadjuvant therapy
90371|NCT02723331|Adjuvant Therapy|adjuvant therapy
90372|NCT02723318|Cognition|cognition
90373|NCT02723318|Financial Coaching|financial coaching
90374|NCT02723318|Social Determinants of Health|social determinants of health
90375|NCT02723318|Socioeconomic Status|socioeconomic status
90376|NCT02723305|Klinefelter syndrome|klinefelter syndrome
90378|NCT02723305|Sex chromosome aneuploidy|sex chromosome aneuploidy
90379|NCT02723305|sex chromosome variation|sex chromosome variation
90380|NCT02723305|hypogonadism|hypogonadism
90381|NCT02723305|cardiometabolic|cardiometabolic
90382|NCT02723305|body composition|body composition
90383|NCT02723305|exercise capacity|exercise capacity
90384|NCT02723279|Urgency-frequency Syndrome|urgency-frequency syndrome
90385|NCT02723279|Electrical Pudendal Nerve Stimulation|electrical pudendal nerve stimulation
90386|NCT02723279|Tolterodine Tartrate|tolterodine tartrate
90387|NCT02723266|American Indian, Alaska Native Adolescents|american indian, alaska native adolescents
90388|NCT02723266|Preconception Counseling|preconception counseling
90389|NCT02723266|Reproductive Health|reproductive health
90390|NCT02723266|Gestational Diabetes Mellitus|gestational diabetes mellitus
90391|NCT02723253|rectal cancer|rectal cancer
90392|NCT02723253|radiotherapy|radiotherapy
90393|NCT02723253|chemotherapy|chemotherapy
90394|NCT02723253|Raltitrexed|raltitrexed
90395|NCT02723253|Oxaliplatin|oxaliplatin
90396|NCT02723240|NUC-3373|nuc-3373
90397|NCT02723240|Dose escalation|dose escalation
90398|NCT02723240|Nucleotide Analogue|nucleotide analogue
90399|NCT02723227|Parenting Stress|parenting stress
90400|NCT02723227|Stress|stress
90401|NCT02723227|Social Determinants|social determinants
90402|NCT02723227|Socioeconomic status|socioeconomic status
90403|NCT02723227|Financial Coaching|financial coaching
90404|NCT02723175|Fibromyalgia|fibromyalgia
90405|NCT02723175|Pain|pain
90406|NCT02723136|Smartphone|smartphone
90408|NCT02723136|Internal Medicine|internal medicine
90409|NCT02723123|CPAP|cpap
90410|NCT02723123|NIPPV|nippv
90411|NCT02723123|Extubation failure|extubation failure
90412|NCT02723123|Cardiorespiratory behaviour|cardiorespiratory behaviour
90413|NCT02723123|NIV-NAVA|niv-nava
90414|NCT02723110|Type 2 Diabetes Risk|type 2 diabetes risk
90415|NCT02723084|Hepatitis C Virus|hepatitis c virus
90416|NCT02723084|Non-cirrhotic|non-cirrhotic
90417|NCT02723084|Hepatitis C Genotype 2|hepatitis c genotype 2
90418|NCT02723084|Chronic Hepatitis C Virus|chronic hepatitis c virus
90419|NCT02723058|Depression|depression
90420|NCT02723058|Homelessness|homelessness
90421|NCT02723058|Primary care|primary care
90422|NCT02723006|Drug Therapy|drug therapy
90423|NCT02722954|malignancy|malignancy
90424|NCT02722954|metastatic|metastatic
90425|NCT02722954|Demcizumab|demcizumab
90426|NCT02722954|Pembrolizumab|pembrolizumab
90427|NCT02722954|Phase 1b|phase 1b
90428|NCT02722941|autologous hematopoietic cell transplant (HCT)|autologous hematopoietic cell transplant (hct)
90429|NCT02722941|autologous|autologous
90430|NCT02722928|Postoperative pneumocephalus|postoperative pneumocephalus
90431|NCT02722928|Fraction of inspired oxygen|fraction of inspired oxygen
90432|NCT02722928|Intracranial surgery|intracranial surgery
90433|NCT02722915|fMRI|fmri
90434|NCT02722915|neurofeedback|neurofeedback
90435|NCT02722915|hallucination|hallucination
90436|NCT02722915|schizophrenia|schizophrenia
90437|NCT02722902|Metabolic flexibility|metabolic flexibility
90438|NCT02722902|Insulin sensitivity|insulin sensitivity
90439|NCT02722889|Ascending aorta|ascending aorta
90440|NCT02722889|Elongation of the aorta|elongation of the aorta
90441|NCT02722889|Type A dissection|type a dissection
90442|NCT02722889|Aortic rupture|aortic rupture
90443|NCT02722889|Aortic length|aortic length
90444|NCT02722876|Rehabilitation|rehabilitation
90445|NCT02722876|Cross-education|cross-education
90446|NCT02722850|breast cancer|breast cancer
90447|NCT02722850|cancer survivorship|cancer survivorship
90448|NCT02722850|dietary intake|dietary intake
90449|NCT02722850|physical activity|physical activity
90450|NCT02722850|quality of life|quality of life
90451|NCT02722824|motor symptoms|motor symptoms
90452|NCT02722811|Etanercept|etanercept
90453|NCT02722811|Osteoarthritis Of Knee|osteoarthritis of knee
90454|NCT02722811|TNF-α|tnf-α
90455|NCT02722811|IL-1α|il-1α
90456|NCT02722811|Subcutaneous Injection|subcutaneous injection
90457|NCT02722785|Exercise training|exercise training
90458|NCT02722785|Surgical complications|surgical complications
90459|NCT02722785|Cancer prognosis|cancer prognosis
90460|NCT02722785|Muscle function|muscle function
90461|NCT02722785|Body composition|body composition
90462|NCT02722785|Pulmonary function|pulmonary function
90464|NCT02722772|Intra-Articular Injection|intra-articular injection
90465|NCT02722772|Etanercept|etanercept
90466|NCT02722772|TNF-α|tnf-α
90467|NCT02722772|IL-1|il-1
90468|NCT02722772|Osteoarthritis of Knee|osteoarthritis of knee
90469|NCT02722746|Epidural Analgesia|epidural analgesia
90470|NCT02722733|Hodgkin's lymphoma|hodgkin's lymphoma
90471|NCT02722733|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
90472|NCT02722733|mobilization|mobilization
90473|NCT02722733|G-CSF|g-csf
90474|NCT02722733|filgrastim|filgrastim
90475|NCT02722733|cytosine arabinoside|cytosine arabinoside
90476|NCT02722733|autologous stem cell transplantation|autologous stem cell transplantation
90477|NCT02722720|Carotid atherosclerosis|carotid atherosclerosis
90478|NCT02722720|Carotid stenosis|carotid stenosis
90479|NCT02722720|Ischemic attack|ischemic attack
90480|NCT02722720|Stroke|stroke
90481|NCT02722720|Carotid stenting|carotid stenting
90482|NCT02722720|Transradial approach|transradial approach
90483|NCT02722720|Transfemoral approach|transfemoral approach
90484|NCT02722720|Bleeding|bleeding
90485|NCT02722720|Thromboembolism|thromboembolism
90486|NCT02722720|Embolism|embolism
90487|NCT02722720|Neurocognitive disorders|neurocognitive disorders
90489|NCT02722668|ALL|all
90490|NCT02722668|CML|cml
90491|NCT02722668|CLL|cll
90492|NCT02722668|SLL|sll
90493|NCT02722655|Pediatrics|pediatrics
90494|NCT02722629|COPD|copd
90495|NCT02722629|Respiratory Aspiration|respiratory aspiration
90496|NCT02722629|COPD acute exacerbation|copd acute exacerbation
90497|NCT02722616|Ultrasound|ultrasound
90498|NCT02722590|Epilepsy|epilepsy
90499|NCT02722590|Partial-onset seizures|partial-onset seizures
90500|NCT02722590|secondarily generalized seizures|secondarily generalized seizures
90501|NCT02722551|Mitral|mitral
90502|NCT02722551|Regurgitation|regurgitation
90503|NCT02722551|Insufficiency|insufficiency
90504|NCT02722551|Degenerative|degenerative
90505|NCT02722551|Functional|functional
90506|NCT02722551|Primary|primary
90507|NCT02722551|Secondary|secondary
90508|NCT02722551|Organic|organic
90509|NCT02722551|Transcatheter|transcatheter
90510|NCT02722551|TMVR|tmvr
90511|NCT02722551|TMVI|tmvi
90512|NCT02722551|Heart valve|heart valve
90513|NCT02722551|Mitral valve|mitral valve
90514|NCT02722551|Transapical|transapical
90515|NCT02722551|Transfemoral|transfemoral
90516|NCT02722551|Trans-septal|trans-septal
90517|NCT02722551|Transeptal|transeptal
90518|NCT02722551|Severe|severe
90519|NCT02722525|ADT|adt
90520|NCT02722525|Prostate cancer|prostate cancer
90521|NCT02722499|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
90522|NCT02722499|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
81755|NCT02776319|craving|craving
90523|NCT02722499|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
90524|NCT02722499|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
90724|NCT02721043|Cancer|cancer
90525|NCT02722499|Diabetes Mellitus, Type II|diabetes mellitus, type ii
90526|NCT02722499|African American|african american
90527|NCT02722499|Blacks|blacks
90528|NCT02722499|non-Hispanic Blacks|non-hispanic blacks
90529|NCT02722499|Randomized Control Trial|randomized control trial
90530|NCT02722499|Controlled Clinical Trial|controlled clinical trial
90531|NCT02722499|Behavioral Research|behavioral research
90532|NCT02722499|Behavioral Medicine|behavioral medicine
90533|NCT02722421|efavirenz|efavirenz
90534|NCT02722421|levonorgestrel|levonorgestrel
90535|NCT02722421|contraceptive implant|contraceptive implant
90536|NCT02722408|LDL-C|ldl-c
90537|NCT02722408|Lipid Regulator|lipid regulator
90538|NCT02722382|Chronic Kidney Disease|chronic kidney disease
90539|NCT02722291|presbyopia|presbyopia
90540|NCT02722265|Essential hypertension|essential hypertension
90541|NCT02722265|Long-term treatment|long-term treatment
90542|NCT02722265|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
90543|NCT02722252|In Vitro Fertilization with ICSI|in vitro fertilization with icsi
90544|NCT02722239|Xigduo;|xigduo;
90545|NCT02722239|bioequivalence;|bioequivalence;
90546|NCT02722239|crossover;|crossover;
90547|NCT02722239|Russia|russia
90548|NCT02722226|High fidelity simulation|high fidelity simulation
90549|NCT02722226|Sedation|sedation
90550|NCT02722226|Medical education|medical education
90551|NCT02722200|fMRI obesity|fmri obesity
90552|NCT02722148|Eosinophilic Esophagitis|eosinophilic esophagitis
90553|NCT02722148|Diet Elimination Therapy|diet elimination therapy
90554|NCT02722122|Cystic Fibrosis|cystic fibrosis
90555|NCT02722122|CF|cf
90556|NCT02722122|AIR DNase™|air dnase™
90557|NCT02722122|Digestive System Diseases|digestive system diseases
90558|NCT02722122|Genetic Diseases, Inborn|genetic diseases, inborn
90559|NCT02722122|Infant, New born, Diseases|infant, new born, diseases
90560|NCT02722122|Lung diseases|lung diseases
90561|NCT02722122|Pancreatic Diseases|pancreatic diseases
90562|NCT02722122|Respiratory Tract Diseases|respiratory tract diseases
90563|NCT02722096|arteriovenous fistula|arteriovenous fistula
90564|NCT02722096|regional anesthesia|regional anesthesia
90565|NCT02722096|local anesthesia|local anesthesia
90566|NCT02722096|early complication|early complication
90567|NCT02722031|intensive care|intensive care
90569|NCT02722031|hypoxemia|hypoxemia
90570|NCT02722031|ARDS|ards
90571|NCT02722005|Health related quality of life|health related quality of life
90572|NCT02722005|Financial Coaching|financial coaching
90573|NCT02722005|Medical Financial Partnership|medical financial partnership
90574|NCT02722005|Social Determinants of Health|social determinants of health
90575|NCT02722005|Socioeconomic status|socioeconomic status
90576|NCT02721966|Assessment of spondyloarthritis international society (ASAS)|assessment of spondyloarthritis international society (asas)
90577|NCT02721966|ASAS|asas
90578|NCT02721966|axial|axial
90579|NCT02721966|Psoriatic Arthritis (PsA)|psoriatic arthritis (psa)
90580|NCT02721966|PsA|psa
90581|NCT02721966|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
90582|NCT02721966|MRI|mri
90583|NCT02721927|refugees|refugees
90584|NCT02721927|Syrian|syrian
90585|NCT02721927|cost|cost
90586|NCT02721927|visit|visit
90587|NCT02721914|low-back pain|low-back pain
90588|NCT02721914|massage therapy|massage therapy
90589|NCT02721914|Gymnastics|gymnastics
90590|NCT02721914|disability|disability
90591|NCT02721901|Gastrointestinal Disorders|gastrointestinal disorders
90592|NCT02721901|Nutrition|nutrition
90593|NCT02721901|Behavioral|behavioral
90594|NCT02721862|gallstones|gallstones
90595|NCT02721862|cholelithiasis|cholelithiasis
90596|NCT02721862|sleeve gastrectomy|sleeve gastrectomy
90597|NCT02721797|hypermobility|hypermobility
90598|NCT02721797|collagen|collagen
90599|NCT02721797|joint|joint
90600|NCT02721797|hyperflexation|hyperflexation
90601|NCT02721784|MRI|mri
90602|NCT02721784|Radiotherapy|radiotherapy
90603|NCT02721758|Motivational Interviewing|motivational interviewing
90604|NCT02721758|Health Behavior|health behavior
90605|NCT02721758|Cardiac Rehabilitation|cardiac rehabilitation
90606|NCT02721732|Advanced Cancers|advanced cancers
90607|NCT02721732|Rare tumors|rare tumors
90608|NCT02721732|Squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
90609|NCT02721732|Anaplastic thyroid cancer|anaplastic thyroid cancer
90610|NCT02721732|Adrenocortical carcinoma|adrenocortical carcinoma
90708|NCT02721173|Tazarotene|tazarotene
90611|NCT02721732|Medullary renal cell carcinoma|medullary renal cell carcinoma
90612|NCT02721732|Carcinoma of unknown primary|carcinoma of unknown primary
90613|NCT02721732|Penile carcinoma|penile carcinoma
90614|NCT02721732|Thymoma|thymoma
90615|NCT02721732|Testicular carcinoma|testicular carcinoma
90616|NCT02721732|Paraganglioma-pheochromocytoma|paraganglioma-pheochromocytoma
90617|NCT02721732|Pembrolizumab|pembrolizumab
90618|NCT02721732|Keytruda|keytruda
90619|NCT02721732|MK-3475|mk-3475
90620|NCT02721732|SCH-900475|sch-900475
90621|NCT02721719|Ulcerative Colitis|ulcerative colitis
90623|NCT02721719|Vedolizumab|vedolizumab
90624|NCT02721719|Entyvio|entyvio
90625|NCT02721719|Inflammatory Bowl Disease|inflammatory bowl disease
90626|NCT02721719|IBD|ibd
90627|NCT02721719|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
90628|NCT02721706|Nutrition assessment|nutrition assessment
90629|NCT02721706|inpatients|inpatients
90630|NCT02721706|cost-benefit analysis|cost-benefit analysis
90631|NCT02721706|quality of life|quality of life
90632|NCT02721706|body composition|body composition
90633|NCT02721706|mass screening|mass screening
90634|NCT02721693|Troponin|troponin
90635|NCT02721693|Exercise|exercise
90636|NCT02721667|Blood pressure|blood pressure
90637|NCT02721667|Telemonitoring|telemonitoring
90638|NCT02721667|Case management|case management
90639|NCT02721667|Seniors|seniors
90640|NCT02721654|Plasma-Lyte|plasma-lyte
90641|NCT02721654|Sodium chloride|sodium chloride
90642|NCT02721654|Saline|saline
90643|NCT02721654|Fluid resuscitation|fluid resuscitation
90644|NCT02721654|Intravenous fluid therapy|intravenous fluid therapy
90645|NCT02721654|Critically ill|critically ill
90646|NCT02721654|Critical care|critical care
90647|NCT02721628|Keratoconus|keratoconus
90648|NCT02721615|intra spinal pressure|intra spinal pressure
90649|NCT02721615|spinal cord perfusion pressure|spinal cord perfusion pressure
90650|NCT02721615|microdialysis|microdialysis
90651|NCT02721615|duroplasty|duroplasty
90652|NCT02721537|Brain Nicotinamide Adenine Dinucleotide (NAD+)|brain nicotinamide adenine dinucleotide (nad+)
90777|NCT02720627|anti-androgen|anti-androgen
90653|NCT02721537|Adenosine Triphosphate (ATP) Depletion|adenosine triphosphate (atp) depletion
90654|NCT02721537|Polyadenosine Diphosphate-Ribosepolymerase (PARP) Activation|polyadenosine diphosphate-ribosepolymerase (parp) activation
90655|NCT02721524|Ring Annuloplasty|ring annuloplasty
90656|NCT02721524|Suture Annuloplasty|suture annuloplasty
90657|NCT02721524|Functional Tricuspid Regurgitation|functional tricuspid regurgitation
90658|NCT02721498|Respiratory Physiotherapy|respiratory physiotherapy
90659|NCT02721498|Airway clearance techniques|airway clearance techniques
90660|NCT02721498|Outcome measures|outcome measures
90661|NCT02721485|Ringer's Lactate|ringer's lactate
90663|NCT02721485|resuscitation fluids|resuscitation fluids
90664|NCT02721485|hypovolemia|hypovolemia
90665|NCT02721459|unresectable melanoma|unresectable melanoma
90666|NCT02721459|stage III melanoma|stage iii melanoma
90667|NCT02721459|stage IV melanoma|stage iv melanoma
90668|NCT02721459|AJCC melanoma staging|ajcc melanoma staging
90669|NCT02721459|American Joint Committee on Cancer (AJCC)|american joint committee on cancer (ajcc)
90670|NCT02721459|BRAF V600 E mutation|braf v600 e mutation
90671|NCT02721459|BRAF V600 K mutation|braf v600 k mutation
90672|NCT02721394|Challenging Behaviour|challenging behaviour
90673|NCT02721394|Functional Communication Training|functional communication training
90674|NCT02721394|Positive Behavioural Support|positive behavioural support
90675|NCT02721394|Family carer training|family carer training
90676|NCT02721381|Autism Spectrum Disorder|autism spectrum disorder
90677|NCT02721381|Parent training|parent training
90678|NCT02721381|Telehealth|telehealth
90680|NCT02721355|Chronic gastritis|chronic gastritis
90681|NCT02721355|Gastric ulcer|gastric ulcer
90682|NCT02721355|Helicobacter pylori|helicobacter pylori
90684|NCT02721342|Chronic proteinuric nephropathies|chronic proteinuric nephropathies
90685|NCT02721329|Obstructive Sleep Apnea|obstructive sleep apnea
90686|NCT02721329|OSA|osa
90687|NCT02721329|Insomnia|insomnia
90688|NCT02721329|CPAP|cpap
90689|NCT02721329|SensAwake|sensawake
90690|NCT02721290|Knee surgery|knee surgery
90691|NCT02721277|Parenteral nutrition, Total|parenteral nutrition, total
90692|NCT02721277|Infant, newborn|infant, newborn
90693|NCT02721277|Cholestasis|cholestasis
90694|NCT02721277|Enterocolitis, Necrotizing|enterocolitis, necrotizing
90695|NCT02721251|exercise|exercise
90696|NCT02721251|weight loss|weight loss
90697|NCT02721251|sleep apnea|sleep apnea
90698|NCT02721212|Robotic|robotic
90699|NCT02721212|Stroke|stroke
90700|NCT02721212|Upper Limb Rehabilitation|upper limb rehabilitation
90701|NCT02721186|Malaria|malaria
90702|NCT02721186|Plasmodium|plasmodium
90703|NCT02721186|Mass drug administration|mass drug administration
90704|NCT02721186|Malaria elimination|malaria elimination
90705|NCT02721186|Zanzibar|zanzibar
90706|NCT02721186|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
90707|NCT02721186|Single low dose Primaquine|single low dose primaquine
90709|NCT02721173|Adapalene|adapalene
90710|NCT02721173|Clindamycin|clindamycin
90711|NCT02721160|performance-based financing|performance-based financing
90712|NCT02721160|malnutrition|malnutrition
90713|NCT02721160|impact evaluation|impact evaluation
90714|NCT02721108|Mindfulness|mindfulness
90715|NCT02721108|Headspace|headspace
90716|NCT02721108|Psychological approaches|psychological approaches
107097|NCT02623517|AF|af
90717|NCT02721108|Progressive muscle relaxation|progressive muscle relaxation
90718|NCT02721082|tobacco treatment|tobacco treatment
90719|NCT02721069|Seizures|seizures
90720|NCT02721069|Epilepsy|epilepsy
90721|NCT02721043|Personalized vaccine|personalized vaccine
90722|NCT02721043|Poly-ICLC|poly-iclc
90723|NCT02721043|Immunotherapy|immunotherapy
90725|NCT02721030|Heartfailure|heartfailure
90726|NCT02721030|1-year mortality|1-year mortality
90727|NCT02721030|heartfailure quality of life|heartfailure quality of life
90728|NCT02721030|sub-Saharan Africa|sub-saharan africa
90729|NCT02721017|Nuss|nuss
90730|NCT02721017|Nuss Procedure|nuss procedure
90731|NCT02721017|pectus excavatum|pectus excavatum
90732|NCT02721017|cryoanalgesia|cryoanalgesia
90733|NCT02721004|Rheumatoid arthritis|rheumatoid arthritis
90734|NCT02721004|RoActemra|roactemra
90735|NCT02721004|Tocilizumab|tocilizumab
90736|NCT02720965|Pain Acute|pain acute
90737|NCT02720965|Orthopedic Surgery|orthopedic surgery
90738|NCT02720965|Satisfaction Nerve Blocks|satisfaction nerve blocks
90739|NCT02720913|Time|time
90740|NCT02720913|COR-KNOT|cor-knot
90741|NCT02720913|Standard|standard
90742|NCT02720913|Cost|cost
90743|NCT02720887|pregnant women|pregnant women
90744|NCT02720887|nanoparticles|nanoparticles
90745|NCT02720887|amniotic fluid|amniotic fluid
90746|NCT02720861|RNF213 rs112735431 Gene|rnf213 rs112735431 gene
90747|NCT02720861|Acute Non-embolic ischemic stroke|acute non-embolic ischemic stroke
90748|NCT02720848|double-balloon enteroscopy|double-balloon enteroscopy
90749|NCT02720809|micronutrients|micronutrients
90750|NCT02720809|blood pressure|blood pressure
90751|NCT02720809|allergy|allergy
90752|NCT02720809|lung function|lung function
90753|NCT02720796|PDX|pdx
90754|NCT02720796|TumorGraft|tumorgraft
90755|NCT02720796|Patient derived xenograft|patient derived xenograft
90756|NCT02720796|sarcoma|sarcoma
90757|NCT02720783|Pharmacokinetics|pharmacokinetics
90758|NCT02720783|Econazole nitrate 150mg|econazole nitrate 150mg
90759|NCT02720783|Benzydamine HCl 6mg|benzydamine hcl 6mg
90760|NCT02720783|Vaginal pessary|vaginal pessary
90761|NCT02720783|Tolerability|tolerability
90762|NCT02720770|growth hormone|growth hormone
200987|NCT02112695|pituitary region|pituitary region
90763|NCT02720718|Gastric Bypass Status for Obesity Complicating Pregnancy, Childbirth and the Puerperium|gastric bypass status for obesity complicating pregnancy, childbirth and the puerperium
90764|NCT02720718|Laparoscopy|laparoscopy
90765|NCT02720718|Suture Techniques|suture techniques
90766|NCT02720718|Sutures|sutures
90767|NCT02720705|sevoflurane emergence agitation|sevoflurane emergence agitation
90768|NCT02720692|Pain|pain
90769|NCT02720692|Analgesia|analgesia
90770|NCT02720692|N1539|n1539
90771|NCT02720692|Phase 3|phase 3
90772|NCT02720679|Genetics|genetics
90773|NCT02720679|Whole genome sequencing|whole genome sequencing
90774|NCT02720679|Pediatrics and hematology|pediatrics and hematology
90775|NCT02720627|acne|acne
90776|NCT02720627|cortexolone|cortexolone
90778|NCT02720614|accelerated hypofractionated radiotherapy|accelerated hypofractionated radiotherapy
90779|NCT02720614|three-dimensional conformal radiation therapy|three-dimensional conformal radiation therapy
90780|NCT02720614|concurrent radiochemotherapy|concurrent radiochemotherapy
90781|NCT02720601|irinotecan|irinotecan
90782|NCT02720601|capecitabine|capecitabine
90783|NCT02720601|gemcitabine|gemcitabine
90784|NCT02720601|biliary tract cancer|biliary tract cancer
90785|NCT02720601|gallbladder cancer|gallbladder cancer
90786|NCT02720601|second-line|second-line
90787|NCT02720575|Vitamin D|vitamin d
90788|NCT02720575|Bioavailability|bioavailability
90789|NCT02720575|Fortified Bread|fortified bread
90790|NCT02720536|Anemia.|anemia.
90791|NCT02720536|Myelodysplastic Syndrome|myelodysplastic syndrome
90792|NCT02720536|Thalassemia|thalassemia
90793|NCT02720536|Film coated tablet|film coated tablet
90794|NCT02720523|rheumatoid arthritis|rheumatoid arthritis
90795|NCT02720523|ABT-494|abt-494
90796|NCT02720523|Antirheumatic agents|antirheumatic agents
90797|NCT02720523|Japanese|japanese
90798|NCT02720510|multiple myeloma|multiple myeloma
90799|NCT02720510|farydak|farydak
90800|NCT02720510|panobinostat|panobinostat
90801|NCT02720510|LBH589|lbh589
90802|NCT02720510|ASCT|asct
90803|NCT02720510|transplant|transplant
90804|NCT02720471|local analgesia|local analgesia
90805|NCT02720471|total hip replacement|total hip replacement
90806|NCT02720471|local infiltrations|local infiltrations
90807|NCT02720458|Hypnotics withdrawal in insomniac patients|hypnotics withdrawal in insomniac patients
90808|NCT02720458|Cognitive-Behavioural Therapy (CBT)|cognitive-behavioural therapy (cbt)
90809|NCT02720458|Internet-delivered self-help program|internet-delivered self-help program
90810|NCT02720458|Sleep restriction|sleep restriction
90811|NCT02720458|Stimulus control|stimulus control
90812|NCT02720458|Half-life benzodiazepine|half-life benzodiazepine
90813|NCT02720458|Z-drug|z-drug
90814|NCT02720445|Alzheimer's Disease|alzheimer's disease
90815|NCT02720445|Nicotine|nicotine
90816|NCT02720445|Transdermal Patch|transdermal patch
90817|NCT02720432|early intervention, infant|early intervention, infant
90818|NCT02720419|drug eluting stent|drug eluting stent
90819|NCT02720419|percutaneous coronary intervention|percutaneous coronary intervention
90820|NCT02720419|real world|real world
90821|NCT02720380|Asthma|asthma
90822|NCT02720380|Physical Therapy Specialty|physical therapy specialty
90823|NCT02720380|Breathing Exercises|breathing exercises
90824|NCT02720380|Child|child
90825|NCT02720380|Clinical Trail|clinical trail
90826|NCT02720302|Overweight|overweight
90827|NCT02720302|Children|children
90828|NCT02720302|Treatment|treatment
90829|NCT02720302|Prevention|prevention
90830|NCT02720302|Lifestyle intervention|lifestyle intervention
90831|NCT02720289|injury prevention|injury prevention
90832|NCT02720276|stroke|stroke
90833|NCT02720276|exercise|exercise
90834|NCT02720276|walking|walking
90835|NCT02720276|mobility|mobility
90836|NCT02720263|Schizophrenia|schizophrenia
90837|NCT02720263|ASP4345|asp4345
90838|NCT02720250|omega-3 fatty acids, microcirculation, laser Doppler flowmetry, lipid profile|omega-3 fatty acids, microcirculation, laser doppler flowmetry, lipid profile
90839|NCT02720237|Alcohol use|alcohol use
90841|NCT02720237|Viral Load|viral load
90843|NCT02720211|headache|headache
90844|NCT02720211|photophobia|photophobia
90845|NCT02720211|migraine|migraine
90846|NCT02720211|light sensitivity|light sensitivity
90847|NCT02720211|tints|tints
90848|NCT02720211|thin films|thin films
90849|NCT02720146|Dry eye|dry eye
90850|NCT02720133|ramadan fasting|ramadan fasting
90851|NCT02720133|variation of biochemical parameters|variation of biochemical parameters
90852|NCT02720133|variation of hematological parameters|variation of hematological parameters
90853|NCT02720133|verify now assay|verify now assay
90854|NCT02720107|fingolimod,|fingolimod,
90855|NCT02720107|Biomarker,|biomarker,
90856|NCT02720107|Multiple sclerosis,|multiple sclerosis,
90857|NCT02720107|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
90858|NCT02720094|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
90859|NCT02720094|PrEP|prep
90860|NCT02720068|PD1|pd1
90861|NCT02720068|PD-1|pd-1
90862|NCT02720068|PDL1|pdl1
90863|NCT02720068|PD-L1|pd-l1
90864|NCT02720055|Distal Radius Fracture|distal radius fracture
90865|NCT02720055|Outcomes|outcomes
90866|NCT02720055|Psychological Intervention|psychological intervention
90867|NCT02720029|aspiration|aspiration
90868|NCT02720029|reflux|reflux
90869|NCT02720016|Post Traumatic Stress Disorder|post traumatic stress disorder
90870|NCT02720016|Marital Therapy|marital therapy
90871|NCT02720016|Veterans|veterans
90872|NCT02720016|Telemedicine|telemedicine
90873|NCT02720003|Atherosclerosis|atherosclerosis
90874|NCT02720003|Superficial Femoral Artery|superficial femoral artery
90875|NCT02720003|Proximal Popliteal Artery|proximal popliteal artery
90876|NCT02719990|VRS-317|vrs-317
90877|NCT02719990|Long Acting Growth Hormone|long acting growth hormone
90878|NCT02719990|Versartis|versartis
90879|NCT02719990|somavaratan|somavaratan
90880|NCT02719990|Growth Hormone Deficiency|growth hormone deficiency
90881|NCT02719990|Adult Growth Hormone Deficiency|adult growth hormone deficiency
90882|NCT02719990|AGHD|aghd
90883|NCT02719990|Growth Hormone Replacement|growth hormone replacement
90884|NCT02719990|Growth Hormone Replacement Therapy|growth hormone replacement therapy
90885|NCT02719990|XTEN|xten
90886|NCT02719964|Cognitive Training|cognitive training
90887|NCT02719964|Traumatic Brain Injury|traumatic brain injury
90888|NCT02719964|Video Games|video games
90889|NCT02719951|autism|autism
90890|NCT02719951|fragile X syndrome (FXS)|fragile x syndrome (fxs)
90891|NCT02719951|PET (Positron Emission Tomography)|pet (positron emission tomography)
90892|NCT02719951|glutamate|glutamate
90893|NCT02719925|magnesium deficiency|magnesium deficiency
90894|NCT02719925|stress psycological|stress psycological
90895|NCT02719925|sleep duration and quality|sleep duration and quality
90896|NCT02719925|mineral water rich in magnesium|mineral water rich in magnesium
90897|NCT02719899|NLRP3 Inflammasome|nlrp3 inflammasome
90898|NCT02719899|Sirtuin 3|sirtuin 3
90899|NCT02719899|T-Cell Polarity|t-cell polarity
90900|NCT02719899|Caloric Restriction|caloric restriction
90901|NCT02719873|obesity , pregnancy , maternal and fetal outcome|obesity , pregnancy , maternal and fetal outcome
90902|NCT02719847|Lung cancer|lung cancer
90903|NCT02719847|Non-Small Cell Lung|non-small cell lung
90904|NCT02719847|NSCLC|nsclc
90905|NCT02719847|Suspected non small cell lung cancer|suspected non small cell lung cancer
90906|NCT02719847|Endobronchial ultrasound-guided transbronchial needle aspiration|endobronchial ultrasound-guided transbronchial needle aspiration
90907|NCT02719847|EBUS-TBNA|ebus-tbna
90908|NCT02719821|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
90909|NCT02719821|Fatigue|fatigue
90910|NCT02719821|Insomnia|insomnia
90911|NCT02719821|Depression|depression
90912|NCT02719821|Behavioral Intervention|behavioral intervention
107351|NCT02621788|3RP|3rp
90913|NCT02719808|Vertical infection transmission|vertical infection transmission
90914|NCT02719808|Tenofovir|tenofovir
90915|NCT02719795|Breast Neoplasms|breast neoplasms
90916|NCT02719795|Nerve block|nerve block
90917|NCT02719795|Anesthesia|anesthesia
90918|NCT02719769|Positive Blood Culture|positive blood culture
90919|NCT02719743|children|children
90920|NCT02719743|H5N1|h5n1
90921|NCT02719743|observer-blind|observer-blind
90922|NCT02719743|Influenza|influenza
90923|NCT02719743|dose-ranging|dose-ranging
90924|NCT02719717|VATS lobectomy|vats lobectomy
90925|NCT02719717|vascular sealing|vascular sealing
90926|NCT02719717|energy|energy
90927|NCT02719717|pulmonary artery|pulmonary artery
90928|NCT02719691|MLN0128|mln0128
90929|NCT02719691|Dual TORC1/2 Inhibitor|dual torc1/2 inhibitor
90930|NCT02719691|MLN8237|mln8237
90931|NCT02719691|Aurora A inhibitor|aurora a inhibitor
90932|NCT02719691|Alisertib|alisertib
90933|NCT02719691|Triple-Negative Breast Cancer|triple-negative breast cancer
90934|NCT02719652|intracranial atherosclerotic disease（ICAD）|intracranial atherosclerotic disease（icad）
90935|NCT02719652|vulnerable plaque|vulnerable plaque
90936|NCT02719652|high-resolution magnetic resonance imaging （HR-MRI）|high-resolution magnetic resonance imaging （hr-mri）
90937|NCT02719626|senior|senior
90938|NCT02719626|nutrition|nutrition
90939|NCT02719626|home delivered meals|home delivered meals
90940|NCT02719626|food safety|food safety
90941|NCT02719626|emergency prep|emergency prep
90942|NCT02719600|Virtual Reality|virtual reality
90943|NCT02719587|saliva|saliva
90944|NCT02719587|omega-3|omega-3
90945|NCT02719574|AML|aml
90946|NCT02719574|MDS|mds
90947|NCT02719574|IDH1|idh1
90948|NCT02719574|IDH|idh
90949|NCT02719535|corneal reshaping therapy|corneal reshaping therapy
90950|NCT02719535|corneal biomechanics|corneal biomechanics
90951|NCT02719483|Children|children
90952|NCT02719483|Spasticity|spasticity
90953|NCT02719483|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
90954|NCT02719483|Cerebral palsy|cerebral palsy
90955|NCT02719483|Gross motor function|gross motor function
90956|NCT02719470|Cognition Impairment|cognition impairment
90957|NCT02719470|Rehabilitation|rehabilitation
90958|NCT02719470|Parkinson's Disease|parkinson's disease
90959|NCT02719457|Exercise testing|exercise testing
90960|NCT02719457|COPD|copd
90961|NCT02719457|Upper and Lower limb exercise|upper and lower limb exercise
90962|NCT02719418|Thromboembolism|thromboembolism
90963|NCT02719418|Venous Thrombosis|venous thrombosis
90964|NCT02719418|Embolism and Thrombosis|embolism and thrombosis
90965|NCT02719418|Chronic Renal Diseases|chronic renal diseases
90966|NCT02719418|Kidney Failure, Chronic|kidney failure, chronic
90967|NCT02719418|Renal Failure, Chronic|renal failure, chronic
90968|NCT02719418|Venous Thromboembolism|venous thromboembolism
90969|NCT02719418|Tinzaparin|tinzaparin
90970|NCT02719418|Innohep|innohep
90971|NCT02719418|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
90972|NCT02719405|milk|milk
90973|NCT02719405|allergy|allergy
90974|NCT02719405|tolerance|tolerance
90975|NCT02719327|Alzheimer's disease|alzheimer's disease
90976|NCT02719327|Cerebrospinal fluid|cerebrospinal fluid
90977|NCT02719327|brain blood flow|brain blood flow
90978|NCT02719327|cognition|cognition
90979|NCT02719327|icosapent ethyl|icosapent ethyl
90980|NCT02719327|Vascepa|vascepa
90981|NCT02719327|omega-3 fatty acids|omega-3 fatty acids
90982|NCT02719327|eicosapentaenoic acid|eicosapentaenoic acid
90983|NCT02719262|Melamine|melamine
90984|NCT02719262|Renal damage|renal damage
90985|NCT02719262|Workplace intervention|workplace intervention
90986|NCT02719249|ESRD|esrd
90987|NCT02719249|Fabry disease|fabry disease
90988|NCT02719236|Coxarthrosis|coxarthrosis
90989|NCT02719236|Hip arthroplasty|hip arthroplasty
90990|NCT02719236|Direct Anterior Approach|direct anterior approach
90991|NCT02719236|Direct Lateral Approach|direct lateral approach
90992|NCT02719223|Intradialytic hypotension|intradialytic hypotension
90993|NCT02719223|hemodynamic parameters|hemodynamic parameters
90994|NCT02719223|Hemodiafiltration|hemodiafiltration
90995|NCT02719223|NICAS device (non-invasive cardiac system)|nicas device (non-invasive cardiac system)
90996|NCT02719158|Acute otitis media with tympanostomy tubes|acute otitis media with tympanostomy tubes
90997|NCT02719158|OTIPRIO|otiprio
90998|NCT02719145|micro RNA|micro rna
90999|NCT02719145|asthma|asthma
91000|NCT02719145|COPD|copd
91001|NCT02719132|Diabetes Mellitus type 2, dapagliflozin, quality of life|diabetes mellitus type 2, dapagliflozin, quality of life
91002|NCT02719106|real world data|real world data
91003|NCT02719106|percutaneous coronary intervention|percutaneous coronary intervention
91004|NCT02719106|drug eluting stent|drug eluting stent
91005|NCT02719093|Infertility Male|infertility male
91006|NCT02719093|Receptors FSH|receptors fsh
91007|NCT02719093|Varicocele|varicocele
91008|NCT02719093|FSH therapy|fsh therapy
91209|NCT02718001|Severe|severe
107547|NCT02620631|TKA|tka
91009|NCT02719080|anaesthetists, surgeons, stress, burnout|anaesthetists, surgeons, stress, burnout
91010|NCT02719067|neuropsychological function|neuropsychological function
91011|NCT02719067|neuroimage|neuroimage
91012|NCT02719067|developmental changes|developmental changes
91013|NCT02719054|Depression|depression
91014|NCT02719054|Child Development|child development
91015|NCT02719054|Stimulation|stimulation
91016|NCT02719054|CBT|cbt
91017|NCT02719054|Bangladesh|bangladesh
91018|NCT02719015|Melanoma|melanoma
91019|NCT02719015|Refractory Metastatic Melanoma|refractory metastatic melanoma
91020|NCT02719015|rAd.CD40L|rad.cd40l
91021|NCT02719015|ISF35|isf35
91022|NCT02719015|Intratumoral|intratumoral
91023|NCT02719015|IT|it
91024|NCT02719015|Pembrolizumab|pembrolizumab
91025|NCT02719015|Keytruda|keytruda
91026|NCT02719015|MK-3475|mk-3475
91027|NCT02719015|SCH-900475|sch-900475
91028|NCT02719015|MM|mm
91029|NCT02718989|H-reflex|h-reflex
91030|NCT02718989|TENS|tens
91031|NCT02718989|Tone|tone
91032|NCT02718976|Hip surgery anesthesia|hip surgery anesthesia
91033|NCT02718976|Perioperative analgesia|perioperative analgesia
91034|NCT02718950|Brown Adipose Tissue|brown adipose tissue
91035|NCT02718950|Hypothalamic Activation|hypothalamic activation
91036|NCT02718950|Non-shivering Thermogenesis|non-shivering thermogenesis
91037|NCT02718950|Basal Metabolic Rate|basal metabolic rate
91038|NCT02718950|Liraglutide|liraglutide
91039|NCT02718950|Victoza|victoza
91040|NCT02718950|Body Composition|body composition
91041|NCT02718950|Body weight|body weight
91042|NCT02718950|Adipose Tissue Biopsy|adipose tissue biopsy
91043|NCT02718937|Viral diseases|viral diseases
91044|NCT02718937|Antiviral|antiviral
91045|NCT02718937|Paramyxoviridae infections|paramyxoviridae infections
91046|NCT02718937|RSV|rsv
91047|NCT02718937|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
91048|NCT02718937|Aviragen Therapeutics|aviragen therapeutics
91049|NCT02718937|Aviragen|aviragen
91050|NCT02718924|Thromboelastometry|thromboelastometry
91051|NCT02718924|pregnancy|pregnancy
91052|NCT02718924|obesity|obesity
91053|NCT02718898|genital|genital
91054|NCT02718885|inulin-type fructans|inulin-type fructans
91055|NCT02718885|hemodialysis|hemodialysis
91056|NCT02718885|gut microbiome|gut microbiome
91057|NCT02718885|mineral and bone disorder|mineral and bone disorder
91058|NCT02718859|advanced pancreatic cancer|advanced pancreatic cancer
91059|NCT02718859|nature killer cell|nature killer cell
91060|NCT02718859|irreversible electroporation|irreversible electroporation
91061|NCT02718833|Multiple Myeloma|multiple myeloma
91063|NCT02718807|Patient Care|patient care
91064|NCT02718807|Education|education
91065|NCT02718794|Simulation Training [I02.903.847]|simulation training [i02.903.847]
91066|NCT02718794|Problem-Based Learning [F02.463.425.720]|problem-based learning [f02.463.425.720]
91067|NCT02718794|Airway Management [E02.041]|airway management [e02.041]
91068|NCT02718755|Hematologic malignancy|hematologic malignancy
91069|NCT02718755|Relapsed and refractory hematologic malignancies|relapsed and refractory hematologic malignancies
91070|NCT02718755|Acute myeloid leukemia|acute myeloid leukemia
91071|NCT02718755|AML|aml
91072|NCT02718755|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
91073|NCT02718755|ALL|all
91074|NCT02718755|Burkitt's leukemia/lymphoma|burkitt's leukemia/lymphoma
91075|NCT02718755|Prolymphocytic leukemia|prolymphocytic leukemia
91076|NCT02718755|Biphenotypic acute leukemia|biphenotypic acute leukemia
91077|NCT02718755|Blast-phase of chronic myeloid leukemia|blast-phase of chronic myeloid leukemia
91078|NCT02718755|CML|cml
91079|NCT02718755|B-cell lymphoma|b-cell lymphoma
91080|NCT02718755|Richter's transformation of chronic lymphocytic leukemia|richter's transformation of chronic lymphocytic leukemia
91081|NCT02718755|CLL|cll
91082|NCT02718755|Fludarabine|fludarabine
91083|NCT02718755|Fludarabine phosphate|fludarabine phosphate
91084|NCT02718755|Fludara|fludara
91085|NCT02718755|Cytarabine|cytarabine
91086|NCT02718755|Ara-C|ara-c
91087|NCT02718755|Cytosar|cytosar
91088|NCT02718755|DepoCyt|depocyt
91089|NCT02718755|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
91090|NCT02718729|Anastomotic leakage|anastomotic leakage
91091|NCT02718729|Rectal cancer|rectal cancer
91092|NCT02718729|Laparoscopic|laparoscopic
91093|NCT02718729|Rectal resection|rectal resection
91095|NCT02718690|H-Reflex|h-reflex
91096|NCT02718690|Current Density|current density
91097|NCT02718690|TENS|tens
91098|NCT02718651|ALK rearrangement|alk rearrangement
91099|NCT02718651|Circulating tumor DNA|circulating tumor dna
91100|NCT02718651|Plasma DNA|plasma dna
91101|NCT02718651|Non-small cell lung cancer|non-small cell lung cancer
91102|NCT02718651|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
91103|NCT02718625|Pressure Ulcers|pressure ulcers
91104|NCT02718625|Bed sores|bed sores
91105|NCT02718625|Long-term care|long-term care
91106|NCT02718625|Nursing home|nursing home
91107|NCT02718612|Uraemic Sarcopenia|uraemic sarcopenia
91108|NCT02718612|Sarcopenic Obesity|sarcopenic obesity
91109|NCT02718586|Myokines|myokines
91110|NCT02718586|Protein Energy Wasting|protein energy wasting
91111|NCT02718586|Hemodialysis|hemodialysis
91112|NCT02718573|Hepatitis C|hepatitis c
91113|NCT02718573|Interferon-free|interferon-free
91114|NCT02718573|DDA's|dda's
91115|NCT02718547|Diabetes mellitus|diabetes mellitus
91116|NCT02718547|Diabetic macular edema|diabetic macular edema
91117|NCT02718547|Intra ocular pressure|intra ocular pressure
91118|NCT02718547|Ocular perfusion pressure|ocular perfusion pressure
91119|NCT02718547|Retinal perfusion|retinal perfusion
91120|NCT02718521|contrast-induced nephropathy|contrast-induced nephropathy
91121|NCT02718521|hydration therapy combined with intravenous infusion of isosorbide|hydration therapy combined with intravenous infusion of isosorbide
91122|NCT02718521|percutaneous coronary intervention|percutaneous coronary intervention
91123|NCT02718469|Ebola|ebola
91124|NCT02718469|VSV|vsv
91125|NCT02718469|Vesicular Stomatitis Virus|vesicular stomatitis virus
91126|NCT02718469|Vaccine|vaccine
91127|NCT02718469|Zaire|zaire
91128|NCT02718417|untreated epithelial ovarian|untreated epithelial ovarian
91129|NCT02718417|fallopian tube|fallopian tube
91130|NCT02718417|primary peritoneal cancer|primary peritoneal cancer
91131|NCT02718404|MR-HIFU|mr-hifu
91132|NCT02718404|bone metastases|bone metastases
91133|NCT02718404|pain treatment|pain treatment
91134|NCT02718391|Intradermal Autologous Dendritic Cell Vaccine|intradermal autologous dendritic cell vaccine
91135|NCT02718391|Malignant Melanoma|malignant melanoma
91136|NCT02718391|Adjuvant|adjuvant
91137|NCT02718391|vaccin|vaccin
91138|NCT02718391|therapy|therapy
91139|NCT02718391|randomized trial|randomized trial
91140|NCT02718391|observation|observation
91141|NCT02718378|safety|safety
91142|NCT02718378|pharmacokinetics|pharmacokinetics
91143|NCT02718378|pharmacodynamics|pharmacodynamics
91144|NCT02718378|randomized|randomized
91145|NCT02718365|Lung Neoplasms|lung neoplasms
91146|NCT02718365|Surgery|surgery
91147|NCT02718365|VATS|vats
91148|NCT02718365|GGO|ggo
91149|NCT02718365|GGN|ggn
91150|NCT02718365|Segmentectomy|segmentectomy
91151|NCT02718365|Wedge Resection|wedge resection
91152|NCT02718365|Prognosis|prognosis
91153|NCT02718313|intraventricular conduction delay|intraventricular conduction delay
91154|NCT02718300|Primary myelofibrosis (PMF)|primary myelofibrosis (pmf)
91155|NCT02718300|post-polycythemia vera myelofibrosis (PPV-MF)|post-polycythemia vera myelofibrosis (ppv-mf)
91156|NCT02718300|post-essential thrombocythemia myelofibrosis (PET-MF)|post-essential thrombocythemia myelofibrosis (pet-mf)
583425|NCT00511745|Adjusted doses|adjusted doses
91157|NCT02718300|myeloproliferative neoplasms (MPNs)|myeloproliferative neoplasms (mpns)
91158|NCT02718300|phosphoinositide 3-kinase (PI3K) inhibitor|phosphoinositide 3-kinase (pi3k) inhibitor
91159|NCT02718300|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
91161|NCT02718287|socio-emotional development|socio-emotional development
91162|NCT02718287|cognitive development|cognitive development
91163|NCT02718287|motor skills|motor skills
91164|NCT02718274|HIV self-testing|hiv self-testing
91165|NCT02718274|Malawi|malawi
91166|NCT02718274|HIV|hiv
91167|NCT02718248|self-harm|self-harm
91168|NCT02718248|problem-solving therapy|problem-solving therapy
91169|NCT02718248|emergency department|emergency department
91170|NCT02718248|e-therapy|e-therapy
91171|NCT02718248|suicide prevention|suicide prevention
91172|NCT02718222|Post-partum intrauterine device (PPIUD)|post-partum intrauterine device (ppiud)
91173|NCT02718157|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
91174|NCT02718157|GBS|gbs
91175|NCT02718157|Streptococcus agalactiae|streptococcus agalactiae
91176|NCT02718157|Antepartum women|antepartum women
91177|NCT02718144|dose-escalation|dose-escalation
91178|NCT02718144|safety|safety
91179|NCT02718144|dose-limiting toxicity|dose-limiting toxicity
91180|NCT02718131|Tibial Pseudarthrosis|tibial pseudarthrosis
91181|NCT02718105|KIR HLA-C|kir hla-c
91182|NCT02718105|ART|art
91183|NCT02718066|HBI-8000|hbi-8000
91184|NCT02718066|nivolumab|nivolumab
91185|NCT02718066|Melanoma|melanoma
91186|NCT02718066|Renal Cell Carcinoma|renal cell carcinoma
91187|NCT02718066|Non-Small Cell Lung Cancer|non-small cell lung cancer
91188|NCT02718027|Hereditary Nephritis|hereditary nephritis
91189|NCT02718027|Nephritis, Familial|nephritis, familial
91190|NCT02718027|Hereditary Familial Congenital Hemorrhagic Nephritis|hereditary familial congenital hemorrhagic nephritis
91191|NCT02718014|Non Surgical Therapy|non surgical therapy
91192|NCT02718001|Mitral|mitral
91193|NCT02718001|Regurgitation|regurgitation
91194|NCT02718001|Insufficiency|insufficiency
91195|NCT02718001|Degenerative|degenerative
91196|NCT02718001|Functional|functional
91197|NCT02718001|Primary|primary
91198|NCT02718001|Secondary|secondary
91199|NCT02718001|Organic|organic
91200|NCT02718001|Transcatheter|transcatheter
91201|NCT02718001|TMVR|tmvr
91202|NCT02718001|TMVI|tmvi
91203|NCT02718001|Heart Valve|heart valve
91204|NCT02718001|Mitral Valve|mitral valve
91205|NCT02718001|Transapical|transapical
91206|NCT02718001|Transseptal|transseptal
91207|NCT02718001|Trans-Septal|trans-septal
91208|NCT02718001|Transeptal|transeptal
91212|NCT02717988|moderately to severely active|moderately to severely active
91213|NCT02717975|Urinary retention|urinary retention
91214|NCT02717975|trial removal of catheter|trial removal of catheter
91215|NCT02717975|valve|valve
91216|NCT02717962|Glioma|glioma
91217|NCT02717962|Glioblastoma|glioblastoma
91218|NCT02717962|Glioblastoma multiforme|glioblastoma multiforme
91219|NCT02717962|GBM|gbm
91220|NCT02717962|brain tumor|brain tumor
91221|NCT02717962|brain cancer|brain cancer
91222|NCT02717962|recurrent brain tumor|recurrent brain tumor
91223|NCT02717962|recurrent brain cancer|recurrent brain cancer
91224|NCT02717962|refractory brain tumor|refractory brain tumor
91225|NCT02717962|refractory brain cancer|refractory brain cancer
91226|NCT02717962|recurrent GBM|recurrent gbm
91227|NCT02717962|refractory GBM|refractory gbm
91228|NCT02717962|recurrent glioma|recurrent glioma
91229|NCT02717962|refractory glioma|refractory glioma
91230|NCT02717962|recurrent glioblastoma|recurrent glioblastoma
91231|NCT02717962|refractory glioblastoma|refractory glioblastoma
91232|NCT02717962|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
91233|NCT02717962|refractory glioblastoma multiforme|refractory glioblastoma multiforme
91234|NCT02717962|failed bevacizumab|failed bevacizumab
91235|NCT02717962|temodar failure|temodar failure
91236|NCT02717962|temozolomide failure|temozolomide failure
91237|NCT02717949|hepatitis C|hepatitis c
91238|NCT02717949|low-grade lymphoma|low-grade lymphoma
91239|NCT02717936|squamous cell carcinoma|squamous cell carcinoma
91240|NCT02717936|dermatosurgery|dermatosurgery
91241|NCT02717936|immunohistochemistry|immunohistochemistry
91242|NCT02717923|metastatic colorectal cancer|metastatic colorectal cancer
91243|NCT02717923|maintenance treatment|maintenance treatment
91244|NCT02717923|cetuximab|cetuximab
91245|NCT02717910|Games|games
91246|NCT02717910|Adolescent|adolescent
91247|NCT02717910|Health education|health education
91248|NCT02717910|Smoking|smoking
91249|NCT02717910|Health literacy|health literacy
91250|NCT02717884|AML|aml
91251|NCT02717884|MDS|mds
91252|NCT02717884|relapsed|relapsed
91253|NCT02717884|trans-retinoic acid ATRA|trans-retinoic acid atra
91254|NCT02717884|epigenetic treatment|epigenetic treatment
91255|NCT02717884|non-M3 AML blasts|non-m3 aml blasts
91256|NCT02717884|tranylcypromine TCP|tranylcypromine tcp
91257|NCT02717884|LSD1|lsd1
91258|NCT02717884|refractory|refractory
91259|NCT02717871|Collagen cross-linking, PACK-CXL, infectious keratitis, CXL.|collagen cross-linking, pack-cxl, infectious keratitis, cxl.
91260|NCT02717845|varus malignment|varus malignment
91261|NCT02717845|osteoarthritis|osteoarthritis
91262|NCT02717845|knee|knee
91263|NCT02717819|Sarcopenia|sarcopenia
91264|NCT02717819|Muscular atrophy|muscular atrophy
91265|NCT02717819|Frailty|frailty
91266|NCT02717819|Acute illness|acute illness
91267|NCT02717819|Ageing|ageing
91268|NCT02717819|Protein supplementation|protein supplementation
91269|NCT02717819|Whey protein|whey protein
91270|NCT02717819|Resistance training|resistance training
91271|NCT02717819|Strength training|strength training
91272|NCT02717767|pneumonia|pneumonia
91273|NCT02717767|diagnosis|diagnosis
91274|NCT02717767|prognosis|prognosis
91275|NCT02717767|tracheal aspirate|tracheal aspirate
91276|NCT02717767|bronchoalveolar lavage|bronchoalveolar lavage
91277|NCT02717663|Reinforcement|reinforcement
91278|NCT02717663|Walking|walking
91279|NCT02717663|Exercise|exercise
91280|NCT02717663|Built Environment|built environment
91281|NCT02717663|Adaptive|adaptive
91282|NCT02717663|Financial incentive|financial incentive
91283|NCT02717663|Walkability|walkability
91284|NCT02717650|Exercise Testing|exercise testing
91285|NCT02717650|Maximal Exercise Testing|maximal exercise testing
91286|NCT02717650|Maximal Exercise Capacity|maximal exercise capacity
91287|NCT02717650|Peak Exercise Capacity|peak exercise capacity
91288|NCT02717650|Adults|adults
91289|NCT02717650|Step Tests|step tests
91290|NCT02717637|oxycodone, caesarean, spinal anesthesia|oxycodone, caesarean, spinal anesthesia
91291|NCT02717624|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
91292|NCT02717624|Btk|btk
91293|NCT02717624|ACP-196|acp-196
91294|NCT02717624|Mantle Cell Lymphoma|mantle cell lymphoma
91295|NCT02717624|MCL|mcl
91296|NCT02717624|acalabrutinib|acalabrutinib
91297|NCT02717624|ACE-LY-106|ace-ly-106
91298|NCT02717611|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
91299|NCT02717611|Ibrutinib Intolerant|ibrutinib intolerant
91302|NCT02717585|Continuous Positive Airway Pressure therapy|continuous positive airway pressure therapy
91303|NCT02717585|Chronic Pain|chronic pain
91304|NCT02717585|Sleep Disturbance|sleep disturbance
91305|NCT02717559|Anterior cruciate ligament / injuries|anterior cruciate ligament / injuries
91306|NCT02717559|Anterior cruciate ligament / surgery|anterior cruciate ligament / surgery
91307|NCT02717559|knee injuries / surgery|knee injuries / surgery
91308|NCT02717559|outcomes research|outcomes research
91309|NCT02717559|prospective studies|prospective studies
91310|NCT02717559|osteoarthritis|osteoarthritis
91311|NCT02717546|Distal Tibia Fracture Screw|distal tibia fracture screw
91312|NCT02717520|glass hybrid|glass hybrid
91313|NCT02717520|composite|composite
91314|NCT02717494|PPV-23|ppv-23
91315|NCT02717494|PCV-10|pcv-10
91316|NCT02717494|HIV|hiv
91317|NCT02717494|Immunization|immunization
91318|NCT02717494|Pregnancy|pregnancy
91319|NCT02717455|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
91320|NCT02717442|Meniere's Disease|meniere's disease
91321|NCT02717442|Vertigo|vertigo
91322|NCT02717416|upper gastrointestinal bleeding|upper gastrointestinal bleeding
91323|NCT02717416|endoscopic hemostasis|endoscopic hemostasis
91324|NCT02717416|hemostatic powder|hemostatic powder
91325|NCT02717403|Chronic Disease Management|chronic disease management
91326|NCT02717403|Rheumatoid Arthritis|rheumatoid arthritis
91327|NCT02717403|Facebook|facebook
91328|NCT02717403|Social networking|social networking
91329|NCT02717403|Internet|internet
91330|NCT02717403|Questionnaires|questionnaires
91331|NCT02717403|Surveys|surveys
91332|NCT02717403|Phone interview|phone interview
91333|NCT02717390|Reading|reading
91334|NCT02717390|Early Childhood development|early childhood development
91335|NCT02717390|Talking|talking
91336|NCT02717390|Playing|playing
91337|NCT02717390|Praising|praising
91338|NCT02717390|Safety|safety
91339|NCT02717390|Injury prevention|injury prevention
91340|NCT02717377|Micro bouts|micro bouts
91341|NCT02717377|Physical Activity|physical activity
91342|NCT02717338|blood donor|blood donor
91343|NCT02717338|retention|retention
91344|NCT02717338|motivation|motivation
91345|NCT02717338|self-determination theory|self-determination theory
91346|NCT02717247|tRNS|trns
91347|NCT02717247|Food addiction,|food addiction,
91348|NCT02717247|Obesity|obesity
91349|NCT02717247|Craving|craving
91350|NCT02717247|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
91351|NCT02717182|self management program|self management program
91352|NCT02717182|patient education|patient education
91353|NCT02717182|self care program|self care program
91354|NCT02717169|health promotion|health promotion
91355|NCT02717169|health action process|health action process
91356|NCT02717169|activity tracker|activity tracker
91357|NCT02717169|sleep regulation|sleep regulation
91358|NCT02717143|Acute myocarditis|acute myocarditis
91359|NCT02717143|Dilated cardiomyopathy|dilated cardiomyopathy
91360|NCT02717143|Magnetic resonance imaging|magnetic resonance imaging
91361|NCT02717117|Motility|motility
91362|NCT02717117|MRI|mri
91363|NCT02717117|Gut peptides|gut peptides
91364|NCT02717117|Feeding|feeding
91365|NCT02717104|femoropopliteal|femoropopliteal
91366|NCT02717078|diet|diet
91367|NCT02717078|carbohydrate|carbohydrate
91368|NCT02717065|Neuromodulation|neuromodulation
91369|NCT02717065|Noninvasive|noninvasive
91370|NCT02717065|Plasticity|plasticity
91371|NCT02717065|Hearing|hearing
91372|NCT02717065|Hyperacusis|hyperacusis
91373|NCT02717013|Muscle|muscle
91374|NCT02717013|Bone|bone
91375|NCT02717013|Fat|fat
91376|NCT02716974|Lupron|lupron
91377|NCT02716974|Bicalutamide|bicalutamide
91378|NCT02716974|Docetaxel|docetaxel
91379|NCT02716896|cystectomy|cystectomy
91380|NCT02716896|radiation|radiation
91381|NCT02716896|chemotherapy|chemotherapy
91382|NCT02716883|keratitis|keratitis
91383|NCT02716883|AMT|amt
91384|NCT02716883|bacterial keratitis|bacterial keratitis
91385|NCT02716883|medication|medication
91386|NCT02716870|Systematic review and meta-analysis|systematic review and meta-analysis
91387|NCT02716870|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
91388|NCT02716870|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
91389|NCT02716870|Clinical practice guidelines|clinical practice guidelines
91390|NCT02716870|Clinical trials|clinical trials
91391|NCT02716870|Dietary sugars|dietary sugars
91392|NCT02716870|Fructose|fructose
91393|NCT02716870|High fructose corn syrup|high fructose corn syrup
91394|NCT02716870|Fruit|fruit
91395|NCT02716870|Isocaloric|isocaloric
91396|NCT02716870|Hypercaloric|hypercaloric
91397|NCT02716870|Cardiometabolic risk factors|cardiometabolic risk factors
91398|NCT02716870|Triglycerides|triglycerides
91399|NCT02716870|Cholesterol|cholesterol
91400|NCT02716870|Glycemic control|glycemic control
91401|NCT02716870|Insulin resistance|insulin resistance
91402|NCT02716870|Body weight|body weight
91403|NCT02716870|Uric acid|uric acid
91404|NCT02716870|Blood pressure|blood pressure
91405|NCT02716870|Fatty liver|fatty liver
91406|NCT02716870|Fasting|fasting
91407|NCT02716870|Postprandial|postprandial
91408|NCT02716844|Osteoporosis|osteoporosis
91409|NCT02716844|Clinic Pilates Exercise|clinic pilates exercise
91410|NCT02716844|Kinesiophobia|kinesiophobia
91411|NCT02716844|Pain|pain
91412|NCT02716831|Bulimia Nervosa|bulimia nervosa
91413|NCT02716831|Eating Disorders|eating disorders
91414|NCT02716831|Binge Eating|binge eating
91415|NCT02716831|Bulimia|bulimia
91416|NCT02716831|Purging|purging
91417|NCT02716818|Glucocorticoid therapy|glucocorticoid therapy
91418|NCT02716805|autologous stem cell transplant|autologous stem cell transplant
91419|NCT02716805|HDT/ASCT|hdt/asct
91420|NCT02716805|CTLA-4|ctla-4
91421|NCT02716805|PD-L1|pd-l1
91422|NCT02716805|peripheral blood mononuclear cells|peripheral blood mononuclear cells
91423|NCT02716805|PBMC|pbmc
91424|NCT02716805|ASCT|asct
91425|NCT02716766|Sorafenib|sorafenib
91426|NCT02716766|Drug Therapy|drug therapy
91427|NCT02716740|Post-obesity surgery|post-obesity surgery
91428|NCT02716740|Leucine-enriched amino acid supplementation|leucine-enriched amino acid supplementation
91429|NCT02716740|Anabolic substance|anabolic substance
91430|NCT02716740|Physical training|physical training
91431|NCT02716740|Muscular mass|muscular mass
91432|NCT02716740|Loss of weight|loss of weight
91433|NCT02716714|Korean|korean
91434|NCT02716701|Exercise|exercise
91435|NCT02716688|Esophageal cancer|esophageal cancer
91436|NCT02716688|Radiotherapy|radiotherapy
91437|NCT02716688|elder|elder
91438|NCT02716688|S-1|s-1
91439|NCT02716675|HIV-1 Infections|hiv-1 infections
91440|NCT02716649|Trauma|trauma
91441|NCT02716649|ICISS|iciss
91442|NCT02716649|India|india
91443|NCT02716649|ICD-10|icd-10
91444|NCT02716597|albumin, septic shock|albumin, septic shock
91445|NCT02716571|Healthy Subjects|healthy subjects
91446|NCT02716571|Healthy Participants|healthy participants
91447|NCT02716545|Gastrointestinal vascular malformation|gastrointestinal vascular malformation
91448|NCT02716545|Endoscopic Therapy|endoscopic therapy
91449|NCT02716519|Diabetes|diabetes
91450|NCT02716519|diabetic foot ulcer|diabetic foot ulcer
91451|NCT02716519|foot sore|foot sore
91452|NCT02716519|type 2 diabetes|type 2 diabetes
91453|NCT02716519|type 1 diabetes|type 1 diabetes
91454|NCT02716519|DFU|dfu
91455|NCT02716519|pressure ulcers|pressure ulcers
91456|NCT02716519|bed sores|bed sores
91457|NCT02716506|POP surgery|pop surgery
91458|NCT02716493|Telerehabilitation|telerehabilitation
91459|NCT02716480|Nutrition|nutrition
91460|NCT02716480|Physical activity|physical activity
91461|NCT02716480|Bariatric surgery|bariatric surgery
91462|NCT02716480|Obesity|obesity
91463|NCT02716480|Health technology|health technology
91464|NCT02716480|Health-connected devices|health-connected devices
91465|NCT02716467|nursing|nursing
91466|NCT02716467|intercessory prayer|intercessory prayer
91469|NCT02716454|Early surgery|early surgery
91470|NCT02716454|Crohn's disease|crohn's disease
91471|NCT02716454|Step-up therapy|step-up therapy
91472|NCT02716415|neonates|neonates
91473|NCT02716415|infants|infants
91474|NCT02716402|Cyanotic congenital heart disease|cyanotic congenital heart disease
91475|NCT02716402|pulmonary thrombosis|pulmonary thrombosis
91480|NCT02716337|human milk target fortification|human milk target fortification
91481|NCT02716324|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
91482|NCT02716324|Shared-Decision Making|shared-decision making
91483|NCT02716324|Care Manager|care manager
91484|NCT02716324|Children|children
91485|NCT02716324|Parents|parents
91486|NCT02716324|Teachers|teachers
91489|NCT02716285|Irritable Bowel Syndrome|irritable bowel syndrome
91490|NCT02716285|Abdominal pain|abdominal pain
91491|NCT02716285|Targeted Delivery|targeted delivery
91492|NCT02716285|Peppermint oil|peppermint oil
91493|NCT02716272|mesothelioma|mesothelioma
91494|NCT02716272|immunotherapy|immunotherapy
91495|NCT02716272|nivolumab|nivolumab
91496|NCT02716272|ipilimumab|ipilimumab
91497|NCT02716259|Periodontitis|periodontitis
91498|NCT02716259|Cardiovascular diseases|cardiovascular diseases
91499|NCT02716259|Bacteremia|bacteremia
91500|NCT02716259|Scaling and root planing|scaling and root planing
91501|NCT02716259|Flow-mediated dilation|flow-mediated dilation
91502|NCT02716259|carotid intima-media thickness|carotid intima-media thickness
91503|NCT02716259|Porphyromonas gingivalis|porphyromonas gingivalis
91504|NCT02716259|Aggregatibacter actinomycetemcomitans|aggregatibacter actinomycetemcomitans
91505|NCT02716246|MPS IIIA|mps iiia
91506|NCT02716220|DREAMS 2G|dreams 2g
91507|NCT02716220|Scaffold|scaffold
91508|NCT02716220|Drug Eluting Absorbable Metal Scaffold|drug eluting absorbable metal scaffold
91509|NCT02716220|Coronary Artery Disease|coronary artery disease
91510|NCT02716207|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
91511|NCT02716207|CyberKnife|cyberknife
91512|NCT02716207|Dose Escalation|dose escalation
91513|NCT02716181|Atopic Dermatitis|atopic dermatitis
91514|NCT02716181|Topical therapy|topical therapy
91515|NCT02716168|Cancer|cancer
91516|NCT02716168|tele-health|tele-health
91517|NCT02716168|Shared care|shared care
91518|NCT02716168|Continuity|continuity
91519|NCT02716116|NSCLC|nsclc
91520|NCT02716116|EGFR|egfr
91521|NCT02716116|HER2|her2
108119|NCT02617082|DCIS|dcis
82728|NCT02770508|dual therapy|dual therapy
82729|NCT02770482|dementia|dementia
82740|NCT02770443|DCM|dcm
91522|NCT02716116|human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
91523|NCT02716116|exon 20 insertions|exon 20 insertions
91524|NCT02716116|exon 19 deletions|exon 19 deletions
91525|NCT02716116|exon 21 substitution|exon 21 substitution
91526|NCT02716116|T790M|t790m
91527|NCT02716116|ErbB-2|erbb-2
91528|NCT02716116|Epidermal Growth Factor Receptor|epidermal growth factor receptor
91529|NCT02716103|AL amyloidosis, systemic primary amyloidosis|al amyloidosis, systemic primary amyloidosis
91530|NCT02716064|chronic conditions, self-management, PHR|chronic conditions, self-management, phr
91531|NCT02716038|Non-Small Cell Lung Cancer|non-small cell lung cancer
91532|NCT02716038|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
91533|NCT02716038|Nonsmall Cell Lung Cancer|nonsmall cell lung cancer
91534|NCT02716038|NSCLC|nsclc
91535|NCT02716012|Oligonucleotide|oligonucleotide
91537|NCT02716012|saRNA|sarna
91538|NCT02716012|Fibrosis|fibrosis
91539|NCT02716012|Cirrhosis|cirrhosis
91541|NCT02715986|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
91542|NCT02715986|fMRI|fmri
91543|NCT02715947|Psoriasis Vulgaris|psoriasis vulgaris
91544|NCT02715947|Methotrexate|methotrexate
91545|NCT02715934|Diabetes Education|diabetes education
91546|NCT02715934|Chronic Disease Management|chronic disease management
91547|NCT02715934|Health Care Delivery|health care delivery
91548|NCT02715934|Patient-Centered Medical Home|patient-centered medical home
91549|NCT02715934|Primary Care|primary care
91550|NCT02715895|Infant|infant
91551|NCT02715895|Growth|growth
91552|NCT02715895|Body Weight Changes|body weight changes
91553|NCT02715895|Infant Formula|infant formula
91554|NCT02715895|Randomized Controlled Trial|randomized controlled trial
91555|NCT02715882|Colorectal cancer|colorectal cancer
91556|NCT02715882|TLR5|tlr5
91557|NCT02715882|Immunotherapy|immunotherapy
91558|NCT02715869|Myocardial Preconditioning, inotropic score|myocardial preconditioning, inotropic score
91559|NCT02715856|Bone metastases|bone metastases
91560|NCT02715856|Intramedullary nailing surgery|intramedullary nailing surgery
91561|NCT02715856|IM|im
91562|NCT02715856|Physical tasks|physical tasks
91563|NCT02715856|Surveys|surveys
91564|NCT02715856|Questionnaires|questionnaires
91565|NCT02715856|Smartphone|smartphone
91566|NCT02715856|Tablet|tablet
91567|NCT02715856|Telemedicine|telemedicine
91568|NCT02715856|Telemonitoring|telemonitoring
91569|NCT02715843|CD20|cd20
91570|NCT02715843|immunotoxin|immunotoxin
91571|NCT02715843|NHL|nhl
91572|NCT02715843|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
91573|NCT02715843|lymphoma|lymphoma
91574|NCT02715843|cancer|cancer
91575|NCT02715843|antibodies|antibodies
91576|NCT02715843|immunotherapy|immunotherapy
91577|NCT02715843|safety|safety
91578|NCT02715843|pharmacokinetics|pharmacokinetics
91579|NCT02715843|MT-3724|mt-3724
91580|NCT02715843|relapsed|relapsed
91581|NCT02715843|refractory|refractory
91582|NCT02715817|Stroke|stroke
91583|NCT02715817|Hemiparesis|hemiparesis
91584|NCT02715817|Physical Therapy|physical therapy
91585|NCT02715817|Virtual Reality Exposure Therapy|virtual reality exposure therapy
91586|NCT02715817|Video Games|video games
91587|NCT02715804|Pancreatic ductal adenocarcinoma (PDA)|pancreatic ductal adenocarcinoma (pda)
91588|NCT02715804|Pancreatic ductal carcinoma|pancreatic ductal carcinoma
91589|NCT02715804|PEGylated Recombinant Human Hyaluronidase (PEGPH20)|pegylated recombinant human hyaluronidase (pegph20)
91590|NCT02715804|Nab-paclitaxel|nab-paclitaxel
91591|NCT02715804|Gemcitabine|gemcitabine
91592|NCT02715804|Metastatic|metastatic
91593|NCT02715804|Stage IV|stage iv
91594|NCT02715791|Self-Management|self-management
91595|NCT02715791|Health Connectors|health connectors
91596|NCT02715791|Volunteers|volunteers
91597|NCT02715791|Technology|technology
91598|NCT02715791|Interprofessional team|interprofessional team
91599|NCT02715791|Chronic disease|chronic disease
91600|NCT02715791|Self-efficacy|self-efficacy
91601|NCT02715791|Patient-centredness|patient-centredness
91602|NCT02715791|Community Engagement|community engagement
91603|NCT02715739|Trauma|trauma
91604|NCT02715739|India|india
91605|NCT02715739|ICISS|iciss
91606|NCT02715713|Autonomic neuropathy, Testosterone Deficiency|autonomic neuropathy, testosterone deficiency
91607|NCT02715661|blood flow|blood flow
91608|NCT02715661|brain health|brain health
91609|NCT02715661|exercise|exercise
91610|NCT02715661|endothelial activation|endothelial activation
91611|NCT02715596|head and neck|head and neck
91612|NCT02715596|eicosapentanoic acid|eicosapentanoic acid
91613|NCT02715596|body composition|body composition
91614|NCT02715570|Aspergillus species|aspergillus species
91615|NCT02715570|Filamentous fungi|filamentous fungi
91616|NCT02715570|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors
91617|NCT02715570|Anti-Infective Agents|anti-infective agents
91618|NCT02715570|Antifungal Agents|antifungal agents
91619|NCT02715570|Enzyme Inhibitors|enzyme inhibitors
91620|NCT02715570|Aspergillosis|aspergillosis
91621|NCT02715570|Allergic Bronchopulmonary|allergic bronchopulmonary
91622|NCT02715570|Asthma|asthma
91623|NCT02715544|Intervention|intervention
91624|NCT02715544|Physical activity|physical activity
91625|NCT02715544|Eating habit|eating habit
91626|NCT02715544|Connectedness to nature|connectedness to nature
91627|NCT02715518|Acute ST-segment elevation myocardial infarction|acute st-segment elevation myocardial infarction
91628|NCT02715518|Acute myocardial infarction|acute myocardial infarction
91629|NCT02715518|Fractional flow reserve|fractional flow reserve
91630|NCT02715518|Percutaneous coronary intervention|percutaneous coronary intervention
91631|NCT02715518|Multivessel disease|multivessel disease
91632|NCT02715518|STEMI|stemi
91633|NCT02715518|NSTEMI|nstemi
91634|NCT02715505|Hurler syndrome, MLD, Krabbe, cALD, Hematopoietic Stem Cell Transplantation (HSCT)|hurler syndrome, mld, krabbe, cald, hematopoietic stem cell transplantation (hsct)
91635|NCT02715453|Frailty|frailty
91636|NCT02715453|Acute myocardial infarction|acute myocardial infarction
91637|NCT02715440|Benzodiazepines|benzodiazepines
91638|NCT02715440|drugs|drugs
91639|NCT02715440|withdrawal|withdrawal
91640|NCT02715440|nursing home|nursing home
91641|NCT02715440|elderly|elderly
91642|NCT02715440|therapy elderly|therapy elderly
91643|NCT02715440|Adverse Effect|adverse effect
91644|NCT02715440|pharmacokinetics|pharmacokinetics
91645|NCT02715440|Decreased Drug Tolerance|decreased drug tolerance
91646|NCT02715375|asthma environment|asthma environment
91647|NCT02715362|immunotherapy GPC3 CAR-T HCC|immunotherapy gpc3 car-t hcc
91648|NCT02715349|schizophrenia|schizophrenia
91649|NCT02715349|psychoeducation|psychoeducation
91650|NCT02715349|Vietnam|vietnam
91651|NCT02715336|In vitro fertilization|in vitro fertilization
91652|NCT02715336|IVF|ivf
91653|NCT02715336|Assisted Reproductive Technologies|assisted reproductive technologies
91654|NCT02715336|ART|art
91655|NCT02715336|OHSS|ohss
91656|NCT02715336|Ovarian hyperstimulation|ovarian hyperstimulation
91657|NCT02715336|dual triggering|dual triggering
91658|NCT02715336|GnRH|gnrh
91659|NCT02715323|dry eye|dry eye
91660|NCT02715323|immunological profile|immunological profile
91661|NCT02715323|autoimmune|autoimmune
91662|NCT02715297|glioblastoma|glioblastoma
91663|NCT02715297|GBM|gbm
91664|NCT02715297|radiotherapy|radiotherapy
91665|NCT02715297|Re-irradiation|re-irradiation
91666|NCT02715297|progression|progression
91667|NCT02715284|Metastatic solid tumors|metastatic solid tumors
91668|NCT02715284|Advanced solid tumors|advanced solid tumors
91669|NCT02715284|anti-PD-1|anti-pd-1
91670|NCT02715284|TSR-042|tsr-042
91671|NCT02715284|Immunotherapy|immunotherapy
91672|NCT02715284|PD-1|pd-1
91673|NCT02715284|Endometrial|endometrial
91674|NCT02715284|Non-small cell lung cancer, NSCLC|non-small cell lung cancer, nsclc
91676|NCT02715245|Primary Health Care|primary health care
91677|NCT02715245|Physiotherapy|physiotherapy
91678|NCT02715245|chronic disease|chronic disease
91679|NCT02715206|rural adolescents, substance use, prevention, adaptation|rural adolescents, substance use, prevention, adaptation
91680|NCT02715154|Epidural Anaesthesia|epidural anaesthesia
91681|NCT02715154|Cesarean Section|cesarean section
91682|NCT02715154|Dexmedetomidine|dexmedetomidine
91683|NCT02715141|surveillance, molecular stool testing|surveillance, molecular stool testing
91684|NCT02715115|Autism|autism
91685|NCT02715115|Rett's syndrome|rett's syndrome
91686|NCT02715115|Rett disorder|rett disorder
91687|NCT02715115|Rett's disorder|rett's disorder
91688|NCT02715115|Ataxia|ataxia
91689|NCT02715102|lung cancer|lung cancer
91690|NCT02715102|lung neoplasms|lung neoplasms
91691|NCT02715102|lung nodules|lung nodules
91692|NCT02715102|screening tests for cancer|screening tests for cancer
91693|NCT02715089|NGS|ngs
91694|NCT02715089|Liver Neoplasms|liver neoplasms
91695|NCT02715089|Biliary Tract Neoplasms|biliary tract neoplasms
91696|NCT02715089|Hepatobiliary Neoplasms|hepatobiliary neoplasms
91697|NCT02715076|Thoracic Surgery|thoracic surgery
91698|NCT02715076|Thoracic surgery, Video assisted|thoracic surgery, video assisted
91699|NCT02715076|Open Abdominal Surgery|open abdominal surgery
91700|NCT02715076|Anesthesia, General|anesthesia, general
91701|NCT02715050|phototherapy|phototherapy
91702|NCT02715050|photobiostimulation|photobiostimulation
91703|NCT02715050|muscle training|muscle training
91704|NCT02715050|muscular adaptation|muscular adaptation
91705|NCT02715037|fusobacterium necrophorum|fusobacterium necrophorum
91706|NCT02715037|acute tonsillitis|acute tonsillitis
91707|NCT02715037|peritonsillar cellulitis|peritonsillar cellulitis
91708|NCT02715037|infectious mononucleosis|infectious mononucleosis
91709|NCT02715037|microbiology|microbiology
91710|NCT02715037|antibody development|antibody development
91711|NCT02715024|Tamsulosin|tamsulosin
91712|NCT02715024|Solifenacin|solifenacin
91713|NCT02715024|Lower urinary tract symptoms|lower urinary tract symptoms
91714|NCT02715024|Overactive bladder|overactive bladder
91715|NCT02715011|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
91716|NCT02715011|JNJ-63709178|jnj-63709178
91717|NCT02714998|ectopic pregnancy|ectopic pregnancy
91718|NCT02714998|ovarian reserve|ovarian reserve
91719|NCT02714998|salpingectomy|salpingectomy
91720|NCT02714998|methotrexate|methotrexate
91721|NCT02714985|chikungunya virus|chikungunya virus
91722|NCT02714985|RT-PCR|rt-pcr
91723|NCT02714985|urine|urine
91724|NCT02714985|diagnosis|diagnosis
91725|NCT02714946|Thyroid Nodule|thyroid nodule
91726|NCT02714946|Percutaneous radiofrequency ablation (RFA)|percutaneous radiofrequency ablation (rfa)
91727|NCT02714946|Percutaneous laser ablation (LA)|percutaneous laser ablation (la)
91728|NCT02714933|pulmonary|pulmonary
91729|NCT02714933|parenchyma|parenchyma
91730|NCT02714933|MRI sequence Advanced ZTE|mri sequence advanced zte
91731|NCT02714933|chest computed tomography|chest computed tomography
91732|NCT02714920|DNA Repair Enzyme Signature|dna repair enzyme signature
91733|NCT02714920|instrinsic radio- or chemo-resistance|instrinsic radio- or chemo-resistance
91734|NCT02714920|treatment-induced radio- or chemo-resistance|treatment-induced radio- or chemo-resistance
91735|NCT02714894|magnetic resonance imaging|magnetic resonance imaging
91736|NCT02714894|magnetic resonance spectroscopy|magnetic resonance spectroscopy
91737|NCT02714868|repeated measures|repeated measures
91738|NCT02714868|matched comparison|matched comparison
91739|NCT02714868|manualized intervention|manualized intervention
91740|NCT02714868|self-determination|self-determination
91741|NCT02714868|participation|participation
91742|NCT02714868|advocacy|advocacy
91743|NCT02714868|problem-solving|problem-solving
91744|NCT02714868|commuinity participation|commuinity participation
91745|NCT02714868|occupational therapy|occupational therapy
91746|NCT02714868|environment|environment
91747|NCT02714829|Injectable Ceramics Bone Graft Substitute Containing rhBMP-2|injectable ceramics bone graft substitute containing rhbmp-2
91748|NCT02714790|Acute Myeloid Leukemia|acute myeloid leukemia
91749|NCT02714790|Minimal Residual Disease|minimal residual disease
91750|NCT02714790|Wilms Tumor|wilms tumor
91751|NCT02714777|General anesthesia|general anesthesia
91752|NCT02714777|Autonomic nervous system|autonomic nervous system
91753|NCT02714777|Children|children
91754|NCT02714764|Alexander Disease|alexander disease
91755|NCT02714738|Brachial plexus block|brachial plexus block
91756|NCT02714738|Regional anesthesia|regional anesthesia
91757|NCT02714738|Ultrasound|ultrasound
91758|NCT02714725|Dexmedetomidine|dexmedetomidine
91759|NCT02714725|Microcirculation|microcirculation
91760|NCT02714725|On Pump|on pump
91761|NCT02714725|CABG|cabg
91762|NCT02714686|Fertility|fertility
91763|NCT02714686|Total Contraception Prevalence Rate|total contraception prevalence rate
91764|NCT02714686|Family planning methods|family planning methods
91765|NCT02714686|Birth Control|birth control
91766|NCT02714686|Mass Media Campaign|mass media campaign
91767|NCT02714686|Demand for contraception|demand for contraception
91768|NCT02714686|Modern Contraception Prevalence Rate|modern contraception prevalence rate
91769|NCT02714686|Birth intervals|birth intervals
91770|NCT02714647|motor learning|motor learning
91771|NCT02714647|attention|attention
91772|NCT02714647|priming|priming
91773|NCT02714647|rehabilitation|rehabilitation
91774|NCT02714621|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
91775|NCT02714621|High Intensity Focused Ultrasound (HIFU)|high intensity focused ultrasound (hifu)
91776|NCT02714621|Focused Ultrasound Surgery|focused ultrasound surgery
91777|NCT02714595|cefiderocol|cefiderocol
91778|NCT02714595|Bloodstream infections (BSI)|bloodstream infections (bsi)
91779|NCT02714595|Complicated urinary tract infection (cUTI)|complicated urinary tract infection (cuti)
91780|NCT02714595|Ventilator associated pneumonia (VAP)|ventilator associated pneumonia (vap)
91781|NCT02714595|Hospital acquired pneumonia (HAP)|hospital acquired pneumonia (hap)
91782|NCT02714595|Sepsis|sepsis
91783|NCT02714595|multi-drug resistant pathogens|multi-drug resistant pathogens
91784|NCT02714595|S-649266|s-649266
91785|NCT02714595|Gram-negative pathogens|gram-negative pathogens
91786|NCT02714595|Healthcare-associated pneumonia (HCAP)|healthcare-associated pneumonia (hcap)
91787|NCT02714595|carbapenem resistant pathogens|carbapenem resistant pathogens
91788|NCT02714582|Shift report|shift report
91789|NCT02714582|Bedside|bedside
91790|NCT02714582|Nursing|nursing
91791|NCT02714582|Matched controlled trial|matched controlled trial
91792|NCT02714582|Mixed method|mixed method
91793|NCT02714582|Patient participation|patient participation
91794|NCT02714556|Lung volume|lung volume
91795|NCT02714556|Lung Clearance Index|lung clearance index
91796|NCT02714556|Functional Residual Capacity|functional residual capacity
91797|NCT02714556|Respiratory function|respiratory function
91798|NCT02714543|OSMF|osmf
91799|NCT02714543|Aloevera|aloevera
91800|NCT02714543|Hydrocortisone|hydrocortisone
91801|NCT02714543|Hyaluronidase|hyaluronidase
91802|NCT02714504|Prophylaxis|prophylaxis
91803|NCT02714465|Hyperbaric Oxygen Therapy; Gamma Knife Radiosurgery|hyperbaric oxygen therapy; gamma knife radiosurgery
91804|NCT02714452|Person-centred care|person-centred care
91805|NCT02714452|Thriving|thriving
91806|NCT02714452|Satisfaction with care|satisfaction with care
91807|NCT02714452|Residential aged care|residential aged care
91808|NCT02714452|Caring environment|caring environment
91809|NCT02714439|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
91810|NCT02714439|Cervical Cancer Prevention|cervical cancer prevention
91811|NCT02714439|Abnormal Pap test|abnormal pap test
91812|NCT02714439|Positive HPV test|positive hpv test
91813|NCT02714439|History of cervical dysplasia|history of cervical dysplasia
91814|NCT02714439|Colposcopy|colposcopy
91815|NCT02714439|Proflavine|proflavine
91816|NCT02714439|Proflavine hemisulfate|proflavine hemisulfate
91817|NCT02714439|High-Resolution Microendoscopy|high-resolution microendoscopy
91818|NCT02714439|HRME|hrme
91819|NCT02714439|Human papillomavirus|human papillomavirus
91820|NCT02714426|Cognitive Aging|cognitive aging
91821|NCT02714426|Attention|attention
91822|NCT02714426|Mindfulness|mindfulness
91823|NCT02714413|D-allulose|d-allulose
91824|NCT02714413|Caucasian|caucasian
91825|NCT02714413|African American|african american
91826|NCT02714400|Obstructive Sleep Apnea|obstructive sleep apnea
91827|NCT02714400|Arousal threshold|arousal threshold
91828|NCT02714400|Venlafaxine|venlafaxine
91829|NCT02714387|Non traumatic acute brain injury|non traumatic acute brain injury
91830|NCT02714374|GL-ONC1|gl-onc1
91831|NCT02714374|Solid Organ Cancer|solid organ cancer
91832|NCT02714374|Cancer|cancer
91833|NCT02714374|Surgery|surgery
91834|NCT02714374|Oncolytic Virus|oncolytic virus
91835|NCT02714374|Soliris|soliris
91836|NCT02714374|Metastatic melanoma|metastatic melanoma
91837|NCT02714374|Esophageal and gastric adenocarcinoma (Stage III/IV)|esophageal and gastric adenocarcinoma (stage iii/iv)
91838|NCT02714374|Cholangiocarcinoma|cholangiocarcinoma
91839|NCT02714374|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
91840|NCT02714374|Gallbladder cancer|gallbladder cancer
91841|NCT02714374|Colorectal cancer (Stage IV)|colorectal cancer (stage iv)
91842|NCT02714374|High-grade mucinous appendix cancer|high-grade mucinous appendix cancer
91843|NCT02714374|High-grade gastrointestinal neuroendocrine cancer|high-grade gastrointestinal neuroendocrine cancer
91844|NCT02714374|Mesothelioma|mesothelioma
91845|NCT02714374|High-grade soft tissue sarcoma|high-grade soft tissue sarcoma
91846|NCT02714374|Stage III or IV|stage iii or iv
91847|NCT02714361|Iron deficiency|iron deficiency
91848|NCT02714361|Vitamin D|vitamin d
91849|NCT02714361|Iron absorption|iron absorption
91850|NCT02714361|Hepcidin|hepcidin
91851|NCT02714348|Helminth infection|helminth infection
91852|NCT02714348|Vaccination|vaccination
91853|NCT02714322|Adalimumab|adalimumab
91854|NCT02714322|Biologics|biologics
91855|NCT02714322|Biosimilar|biosimilar
91856|NCT02714309|Postprandial glycemia|postprandial glycemia
91857|NCT02714309|Metabolic health measures|metabolic health measures
91858|NCT02714296|colon preparation for endoscopy|colon preparation for endoscopy
91859|NCT02714296|enteral feeding|enteral feeding
91860|NCT02714296|sip feeding|sip feeding
91861|NCT02714296|nutridrink|nutridrink
91862|NCT02714296|nutridrink compact protein|nutridrink compact protein
91863|NCT02714283|nontuberculous mycobacteria|nontuberculous mycobacteria
91864|NCT02714283|corticosteroids|corticosteroids
91865|NCT02714283|macrolides|macrolides
91866|NCT02714283|antibiotics|antibiotics
91867|NCT02714205|Hot flash|hot flash
91868|NCT02714153|Lead extraction|lead extraction
91869|NCT02714153|Superior Vena Cava Tear|superior vena cava tear
91870|NCT02714153|Pacemaker/Defibrillator lead extraction|pacemaker/defibrillator lead extraction
91871|NCT02714127|Human Papillomavirus|human papillomavirus
91872|NCT02714127|Biomarker|biomarker
91873|NCT02714127|Self-sampling|self-sampling
91874|NCT02714127|First-void urine|first-void urine
91875|NCT02714127|Cervicovaginal fluid|cervicovaginal fluid
91876|NCT02714127|Colposcopy|colposcopy
91877|NCT02714114|Antibodies|antibodies
91878|NCT02714114|Vaccination|vaccination
91879|NCT02714114|Self-sampling|self-sampling
91880|NCT02714114|First-void urine|first-void urine
91882|NCT02714088|High-intensity interval training|high-intensity interval training
91883|NCT02714088|Functional fitness|functional fitness
91884|NCT02714088|Quality of life|quality of life
91885|NCT02714088|Older adults|older adults
91886|NCT02714062|Adolescent Obesity|adolescent obesity
91887|NCT02714062|Childhood Obesity|childhood obesity
91888|NCT02714062|Qsymia|qsymia
91889|NCT02714062|Pharmacokinetics|pharmacokinetics
91890|NCT02714062|VI-0521|vi-0521
91891|NCT02714049|hypoactive sexual desire disorder|hypoactive sexual desire disorder
91892|NCT02714049|Addyi|addyi
91893|NCT02714049|flibanserin|flibanserin
91894|NCT02714049|low sexual desire|low sexual desire
91895|NCT02714049|HSDD|hsdd
91897|NCT02714010|EGFR-TKI|egfr-tki
91898|NCT02714010|whole brain radiotherapy|whole brain radiotherapy
91899|NCT02714010|brain metastasis|brain metastasis
91900|NCT02714010|non-small cell lung cancer|non-small cell lung cancer
91901|NCT02713984|HER2 CAR-T|her2 car-t
91902|NCT02713984|safety|safety
91903|NCT02713984|efficiency|efficiency
91904|NCT02713984|refractory and relapsed cancer|refractory and relapsed cancer
91905|NCT02713971|Rehabilitation|rehabilitation
91906|NCT02713971|Balance|balance
91907|NCT02713971|Gait|gait
91908|NCT02713971|Biofeedback|biofeedback
91909|NCT02713958|Telerehabilitation|telerehabilitation
91910|NCT02713958|Elbow fractures|elbow fractures
91911|NCT02713958|Arthrolysis|arthrolysis
91912|NCT02713958|MediTouch|meditouch
91913|NCT02713958|Occupational Therapy|occupational therapy
91914|NCT02713958|Active exercises|active exercises
91915|NCT02713945|Simvastatin|simvastatin
91917|NCT02713945|MAPK|mapk
91918|NCT02713932|Aortic valve stenosis|aortic valve stenosis
91919|NCT02713932|Aortic valve regurgitation|aortic valve regurgitation
91920|NCT02713932|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
91921|NCT02713919|Cancer|cancer
91922|NCT02713919|Outpatients|outpatients
91923|NCT02713919|Family Caregivers|family caregivers
91924|NCT02713893|Pharmacokinetics|pharmacokinetics
91925|NCT02713893|Econazole nitrate 1%|econazole nitrate 1%
91926|NCT02713893|Benzydamine HCl 0.12%|benzydamine hcl 0.12%
91927|NCT02713893|Intravaginal cream|intravaginal cream
91928|NCT02713893|Antimycotic|antimycotic
91929|NCT02713893|Tolerability|tolerability
91930|NCT02713880|Peripheral Nervous System Diseases|peripheral nervous system diseases
91931|NCT02713880|Neuromuscular Diseases|neuromuscular diseases
91932|NCT02713880|Metabolism, Inborn Errors|metabolism, inborn errors
91933|NCT02713880|Genetic Diseases, Inborn|genetic diseases, inborn
91934|NCT02713854|Subfertility|subfertility
91935|NCT02713854|In-vitro fertilization|in-vitro fertilization
91936|NCT02713854|BAP-EB|bap-eb
91937|NCT02713854|Endometrial epithelial cells|endometrial epithelial cells
91938|NCT02713854|Repeated implantation failure|repeated implantation failure
91939|NCT02713828|gpNMB-Expressing Squamous Cell Carcinoma of the Lung|gpnmb-expressing squamous cell carcinoma of the lung
91940|NCT02713828|Stage IIIb|stage iiib
91941|NCT02713828|Stage IV|stage iv
91942|NCT02713828|Advanced Squamous Cell Cancer of the Lung|advanced squamous cell cancer of the lung
91943|NCT02713828|Metastatic Squamous Cell Cancer of the Lung|metastatic squamous cell cancer of the lung
91944|NCT02713828|gpNMB-Expressing|gpnmb-expressing
91945|NCT02713828|Glembatumumab Vedotin|glembatumumab vedotin
91946|NCT02713815|Amphetamine-type stimulants|amphetamine-type stimulants
91951|NCT02713789|ED|ed
91952|NCT02713776|High-Output Enterostomy|high-output enterostomy
91953|NCT02713776|Pasireotide|pasireotide
91954|NCT02713776|Somatostatin Analogues|somatostatin analogues
91955|NCT02713763|Sunitinib|sunitinib
91956|NCT02713750|Combined Oral Contraceptives|combined oral contraceptives
91957|NCT02713750|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
91958|NCT02713750|Hormonal Contraception|hormonal contraception
91959|NCT02713750|Human Immunodeficiency Virus|human immunodeficiency virus
91960|NCT02713750|Intrauterine Device|intrauterine device
91961|NCT02713750|Pharmacokinetic|pharmacokinetic
91962|NCT02713750|Sexually Transmitted Diseases|sexually transmitted diseases
91963|NCT02713750|Reproductive Health|reproductive health
91964|NCT02713737|hypoxemia|hypoxemia
91965|NCT02713737|high-flow|high-flow
91966|NCT02713737|atrial fibrillation|atrial fibrillation
91967|NCT02713737|sleep|sleep
91968|NCT02713711|Psoriasis|psoriasis
91969|NCT02713711|balneotherapy|balneotherapy
91970|NCT02713711|phototherapy|phototherapy
91971|NCT02713711|balneophototherapy|balneophototherapy
91972|NCT02713698|Anaesthetics|anaesthetics
91973|NCT02713698|Intravenous|intravenous
91974|NCT02713698|Propofol|propofol
91975|NCT02713698|Pharmacokinetics|pharmacokinetics
91976|NCT02713698|Pharmacodynamics|pharmacodynamics
91977|NCT02713698|Propofol pharmacokinetic-pharmacodynamic model|propofol pharmacokinetic-pharmacodynamic model
91978|NCT02713685|regional anesthesia|regional anesthesia
91979|NCT02713685|lower limb surgery|lower limb surgery
91980|NCT02713685|Bupivacaine|bupivacaine
91981|NCT02713659|Literacy|literacy
91982|NCT02713659|Child Development|child development
91983|NCT02713659|Reading|reading
91984|NCT02713646|MRI|mri
91985|NCT02713646|Virtual Endoscopy|virtual endoscopy
91986|NCT02713646|Pain Measurement|pain measurement
91987|NCT02713620|HBV vaccination, immunity|hbv vaccination, immunity
91988|NCT02713581|Proximal venous thromboembolism|proximal venous thromboembolism
91989|NCT02713568|Macrosomia|macrosomia
91990|NCT02713568|Magnetic Resonance- Estimated Fetal Weight|magnetic resonance- estimated fetal weight
91991|NCT02713568|Ultrasound-Estimated Fetal Weight|ultrasound-estimated fetal weight
91992|NCT02713568|Large-for-date fetus|large-for-date fetus
91997|NCT02713516|Anxiety|anxiety
91998|NCT02713516|OCD|ocd
91999|NCT02713516|Obsessive Compulsive Disorder|obsessive compulsive disorder
92000|NCT02713516|Generalized Anxiety|generalized anxiety
92001|NCT02713516|Social Phobia|social phobia
92002|NCT02713516|Separation Anxiety|separation anxiety
92003|NCT02713516|GAD|gad
83245|NCT02766881|DSC|dsc
92004|NCT02713516|Youth|youth
92005|NCT02713516|Teen|teen
92006|NCT02713516|Therapy|therapy
92007|NCT02713451|Oxygen|oxygen
92008|NCT02713438|Physical activity|physical activity
92009|NCT02713438|Planning|planning
92010|NCT02713438|Implementation intention|implementation intention
92011|NCT02713438|Quality of life|quality of life
92012|NCT02713438|Body weight|body weight
92013|NCT02713425|Anxiety|anxiety
92014|NCT02713425|Social Phobia|social phobia
92015|NCT02713425|Separation Anxiety|separation anxiety
92016|NCT02713425|Generalized Anxiety|generalized anxiety
92017|NCT02713425|GAD|gad
92018|NCT02713425|Phobia|phobia
92019|NCT02713425|video game|video game
92020|NCT02713425|teen|teen
92021|NCT02713425|youth|youth
92022|NCT02713425|child|child
92023|NCT02713425|adolescent|adolescent
92024|NCT02713347|Quality of Life|quality of life
92025|NCT02713347|Symptom Assessment|symptom assessment
92026|NCT02713347|Palliative Care|palliative care
92027|NCT02713347|Disease Management|disease management
92028|NCT02713347|Delivery of Health Care|delivery of health care
92029|NCT02713347|Advance Care Planning|advance care planning
92030|NCT02713334|Decision Making|decision making
92031|NCT02713334|Communication|communication
92032|NCT02713334|16-080|16-080
92033|NCT02713321|diabetes|diabetes
92034|NCT02713321|vulnerable populations|vulnerable populations
92035|NCT02713321|comorbidity|comorbidity
92036|NCT02713321|patient-centered outcomes research|patient-centered outcomes research
92037|NCT02713321|Medicaid reform|medicaid reform
92038|NCT02713321|health disparities|health disparities
92039|NCT02713295|Moderate Plaque Psoriasis|moderate plaque psoriasis
92040|NCT02713295|Plaque Psoriasis|plaque psoriasis
92234|NCT02712047|cross-over|cross-over
92041|NCT02713295|Severe Plaque Psoriasis|severe plaque psoriasis
92042|NCT02713282|Schizophrenia|schizophrenia
92043|NCT02713282|R092670|r092670
92044|NCT02713282|Paliperidone Palmitate|paliperidone palmitate
92045|NCT02713269|Secondary Malignant Neoplasm of Vertebral Column|secondary malignant neoplasm of vertebral column
92046|NCT02713269|Spine Metastases|spine metastases
92047|NCT02713269|Epidural spinal cord compression|epidural spinal cord compression
92048|NCT02713269|Stereotactic spine radiosurgery|stereotactic spine radiosurgery
92049|NCT02713269|SSRS|ssrs
92050|NCT02713269|Thermal ablation|thermal ablation
92051|NCT02713269|Symptom questionnaire|symptom questionnaire
92052|NCT02713269|Surveys|surveys
92053|NCT02713256|Graves' disease|graves' disease
92054|NCT02713256|Hyperthyroidism|hyperthyroidism
92055|NCT02713256|CFZ533|cfz533
92056|NCT02713256|TSH|tsh
92057|NCT02713243|Primary bile acid diarrhea,|primary bile acid diarrhea,
92058|NCT02713243|FXR agonist,|fxr agonist,
92059|NCT02713243|bile acid malabsorption.|bile acid malabsorption.
92060|NCT02713217|depressive disorder|depressive disorder
92061|NCT02713217|alcohol-related disorders|alcohol-related disorders
92062|NCT02713217|telemedicine|telemedicine
92063|NCT02713217|rural health|rural health
92064|NCT02713217|collaborative care|collaborative care
92065|NCT02713191|Bronchoscopy|bronchoscopy
92066|NCT02713191|Sedation|sedation
92067|NCT02713191|Dexmedetomidine|dexmedetomidine
92068|NCT02713165|Gut Microbiota|gut microbiota
92069|NCT02713139|vaginal|vaginal
92070|NCT02713139|discharge|discharge
92072|NCT02713048|Cardiac arrest|cardiac arrest
92073|NCT02713048|Troponin I|troponin i
92074|NCT02713048|coronary anatomy|coronary anatomy
92075|NCT02713022|DEXA Scan|dexa scan
92076|NCT02713022|15-235|15-235
92077|NCT02713009|Maternal body weight|maternal body weight
92078|NCT02713009|Vitamin D|vitamin d
92079|NCT02713009|Pregnancy|pregnancy
92080|NCT02712996|Traumatic Brain Injury|traumatic brain injury
92081|NCT02712996|Attention Deficit|attention deficit
92082|NCT02712996|TBI|tbi
92083|NCT02712996|Vyvanse|vyvanse
92084|NCT02712983|Inhaled tobramycin; tobramycin inhalation powder; bronchiectasis; pulmonary Pseudomonas aeruginosa infection; dose-finding study|inhaled tobramycin; tobramycin inhalation powder; bronchiectasis; pulmonary pseudomonas aeruginosa infection; dose-finding study
92085|NCT02712918|Depression|depression
92086|NCT02712918|Inpatient|inpatient
92087|NCT02712918|Acute|acute
92088|NCT02712918|Brief Behavioral Activation Treatment for Depression|brief behavioral activation treatment for depression
92089|NCT02712905|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
92090|NCT02712905|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
92091|NCT02712905|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
92092|NCT02712905|myelofibrosis (MF)|myelofibrosis (mf)
92093|NCT02712905|solid tumor, lysine-specific demethylase 1 (LSD1) inhibitor|solid tumor, lysine-specific demethylase 1 (lsd1) inhibitor
92094|NCT02712840|Single embryo transfer|single embryo transfer
92095|NCT02712840|Freeze-all|freeze-all
92096|NCT02712840|Fresh|fresh
92097|NCT02712840|Vitrification|vitrification
92098|NCT02712840|Clinical Pregnancy|clinical pregnancy
92099|NCT02712840|Blastocyst|blastocyst
92100|NCT02712827|self-gripping mesh, fibrin glue, total extraperitoneal|self-gripping mesh, fibrin glue, total extraperitoneal
92101|NCT02712801|HIV|hiv
92102|NCT02712801|antiretroviral treatment|antiretroviral treatment
92103|NCT02712801|child|child
92104|NCT02712801|testing|testing
92105|NCT02712788|Subarachnoid Hemorrhage|subarachnoid hemorrhage
92106|NCT02712788|Cerebral Vasospasm|cerebral vasospasm
92107|NCT02712788|Milrinone|milrinone
92108|NCT02712788|Hyperdynamic Therapy|hyperdynamic therapy
92109|NCT02712762|immunological profiles|immunological profiles
92110|NCT02712749|Binaural Beat|binaural beat
92111|NCT02712749|Elderly|elderly
92112|NCT02712749|preoperative medication|preoperative medication
92113|NCT02712736|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
92114|NCT02712723|ER+, HER2-negative breast cancer|er+, her2-negative breast cancer
92115|NCT02712723|Stage II or III|stage ii or iii
92116|NCT02712723|Letrozole|letrozole
92117|NCT02712723|Femara|femara
92118|NCT02712723|Ribociclib|ribociclib
92119|NCT02712723|LEE011|lee011
92120|NCT02712723|Neo-adjuvant|neo-adjuvant
92121|NCT02712710|knee, osteoarthritis, brace|knee, osteoarthritis, brace
92122|NCT02712697|liver-kidney yin deficiency syndrome|liver-kidney yin deficiency syndrome
92123|NCT02712697|primary severe IgA nephropathy|primary severe iga nephropathy
92124|NCT02712697|Lee's grade Ⅲ|lee's grade ⅲ
92125|NCT02712671|Cost-Benefit Analysis|cost-benefit analysis
92126|NCT02712671|Quality of Life|quality of life
92127|NCT02712593|Healthy participants|healthy participants
92128|NCT02712593|Dietary supplement|dietary supplement
92129|NCT02712593|Bioavailability|bioavailability
92130|NCT02712593|Niagen™|niagen™
92131|NCT02712593|Nicotinamide riboside|nicotinamide riboside
92132|NCT02712593|N-methylnicotinamide|n-methylnicotinamide
92133|NCT02712580|pediatric burns|pediatric burns
92134|NCT02712580|deep dermal wounds|deep dermal wounds
92135|NCT02712580|wound healing|wound healing
92136|NCT02712580|ChildPain Measurement|childpain measurement
92137|NCT02712580|Treatment Outcome Wound Healing/physiology|treatment outcome wound healing/physiology
92138|NCT02712580|wireless electric stimulation|wireless electric stimulation
637557|NCT00722293|Sarcoma|sarcoma
92139|NCT02712580|wireless current stimulation|wireless current stimulation
92140|NCT02712580|wireless technology|wireless technology
92141|NCT02712580|children|children
92142|NCT02712580|conservative treatment|conservative treatment
92143|NCT02712580|deep dermal scalds|deep dermal scalds
92144|NCT02712580|humans|humans
92145|NCT02712580|deep dermal burns|deep dermal burns
92146|NCT02712580|burns|burns
92147|NCT02712580|wound healing process|wound healing process
92148|NCT02712554|Pain|pain
92149|NCT02712554|Nausea|nausea
92150|NCT02712554|Vomiting|vomiting
92151|NCT02712541|Caregiver burden Index|caregiver burden index
92152|NCT02712489|HAART-treated participants|haart-treated participants
92153|NCT02712489|Tat|tat
92154|NCT02712489|Therapeutic immunization|therapeutic immunization
92155|NCT02712476|Mannitol|mannitol
92156|NCT02712476|Furosemid|furosemid
92157|NCT02712476|Brain Relaxation|brain relaxation
92158|NCT02712463|Schizophrenia|schizophrenia
92159|NCT02712463|Oral antipsychotics|oral antipsychotics
92160|NCT02712463|Long acting Injectable antipsychotics|long acting injectable antipsychotics
92161|NCT02712450|geriatric|geriatric
92162|NCT02712450|emergency|emergency
92163|NCT02712450|clinical pathway|clinical pathway
92164|NCT02712450|regulation|regulation
92165|NCT02712450|SAMU|samu
92166|NCT02712450|training|training
92167|NCT02712437|Insomnia|insomnia
92168|NCT02712437|Quality of Life|quality of life
92169|NCT02712437|Cognitive behavioral therapy|cognitive behavioral therapy
92170|NCT02712424|Vaccine|vaccine
92171|NCT02712372|AZD4831 oral suspension|azd4831 oral suspension
92172|NCT02712372|Healthy male subjects|healthy male subjects
92173|NCT02712372|Safety|safety
92174|NCT02712372|Tolerability|tolerability
92175|NCT02712372|Pharmacokinetics|pharmacokinetics
92176|NCT02712372|Pharmacodynamics|pharmacodynamics
92177|NCT02712359|Havrix|havrix
92178|NCT02712359|Cross-sectional seroprevalence survey|cross-sectional seroprevalence survey
92179|NCT02712359|Panama|panama
92180|NCT02712359|Long-term persistence|long-term persistence
92181|NCT02712359|Hepatitis|hepatitis
92182|NCT02712346|Sickle Cell Anemia|sickle cell anemia
92183|NCT02712346|Sickle Cell Thalassemia|sickle cell thalassemia
92184|NCT02712346|Sickle Beta Thalassemia|sickle beta thalassemia
92185|NCT02712346|Proteinuria|proteinuria
92186|NCT02712346|Sickle nephropathy|sickle nephropathy
92187|NCT02712333|PM2.5|pm2.5
92188|NCT02712333|air purification|air purification
92189|NCT02712333|randomized controlled trial|randomized controlled trial
92190|NCT02712333|metabolomics|metabolomics
92191|NCT02712333|Metabolites|metabolites
92192|NCT02712333|exhaled nitric oxide|exhaled nitric oxide
92193|NCT02712320|Prostate Neoplasm Cancer Carcinoma|prostate neoplasm cancer carcinoma
92194|NCT02712320|Safety Extension|safety extension
92195|NCT02712294|pulmonary hypertension|pulmonary hypertension
92196|NCT02712294|peripheral muscle electrostimulation|peripheral muscle electrostimulation
92197|NCT02712294|capacity of the exercises|capacity of the exercises
92198|NCT02712294|quality of life|quality of life
92300|NCT02711644|Pregnancy|pregnancy
92199|NCT02712281|Food Selectivity|food selectivity
92200|NCT02712281|Autism MEAL Plan|autism meal plan
92201|NCT02712281|Parent Education|parent education
92202|NCT02712268|Polypharmacy|polypharmacy
92203|NCT02712268|Clinical decision-making|clinical decision-making
92204|NCT02712255|Physical activity|physical activity
92205|NCT02712255|Quality of life|quality of life
92206|NCT02712255|Planning|planning
92207|NCT02712255|Implementation intentions|implementation intentions
92208|NCT02712255|Cardiovascular disease|cardiovascular disease
92209|NCT02712255|Diabetes|diabetes
92210|NCT02712203|Measles vaccine|measles vaccine
92211|NCT02712203|Priorix|priorix
92212|NCT02712203|Priorix-Tetra|priorix-tetra
92213|NCT02712203|Age at vaccination|age at vaccination
92214|NCT02712177|vaccine safety|vaccine safety
92215|NCT02712177|interaction|interaction
92216|NCT02712164|Split-thickness skin graft|split-thickness skin graft
92217|NCT02712164|STSG|stsg
92218|NCT02712164|donor site|donor site
92219|NCT02712164|negative-pressure wound therapy|negative-pressure wound therapy
92220|NCT02712164|NPWT|npwt
92221|NCT02712164|dressing|dressing
92222|NCT02712151|transversus abdominal plane block|transversus abdominal plane block
92223|NCT02712138|Hyperbilirubinemia|hyperbilirubinemia
92224|NCT02712138|Unconjugated Benign Bilirubinemia|unconjugated benign bilirubinemia
92225|NCT02712060|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
92226|NCT02712060|Obstructive Sleep Apnea|obstructive sleep apnea
92227|NCT02712060|Prevalence|prevalence
92228|NCT02712060|Children|children
92229|NCT02712060|Pediatric|pediatric
92230|NCT02712060|Adolescents|adolescents
92231|NCT02712047|Fluticasone furoate/vilanterol|fluticasone furoate/vilanterol
92232|NCT02712047|Asthma|asthma
92233|NCT02712047|fraction of exhaled nitric oxide|fraction of exhaled nitric oxide
637656|NCT00730080|Kuvan|kuvan
92235|NCT02712034|Medication-assisted treatment (MAT)|medication-assisted treatment (mat)
92236|NCT02712034|Buprenorphine|buprenorphine
92237|NCT02712034|Methadone|methadone
92238|NCT02712034|Naltrexone|naltrexone
92239|NCT02712021|Cerebral Palsy|cerebral palsy
92240|NCT02712021|Lycra|lycra
92241|NCT02712021|Motor Function|motor function
92242|NCT02712021|Static Balance|static balance
92243|NCT02711995|botulinum toxin|botulinum toxin
92244|NCT02711995|injection augmentation|injection augmentation
92245|NCT02711995|essential voice tremor|essential voice tremor
92246|NCT02711956|Metastatic Castration-Resistant Prostate Cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
92247|NCT02711956|Phase 1b|phase 1b
92248|NCT02711956|Prostate Cancer|prostate cancer
92249|NCT02711956|Pharmacokinetics (PK)|pharmacokinetics (pk)
92250|NCT02711956|ZEN003694|zen003694
92251|NCT02711956|ZEN-3694|zen-3694
92252|NCT02711956|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
92253|NCT02711956|BET inhibitor (BETi)|bet inhibitor (beti)
92254|NCT02711956|Bromodomain|bromodomain
92255|NCT02711956|Pharmacodynamics (PD)|pharmacodynamics (pd)
92256|NCT02711956|Enzalutamide|enzalutamide
92257|NCT02711956|XTANDI|xtandi
92258|NCT02711956|MDV3100|mdv3100
92259|NCT02711956|Epigenetics|epigenetics
92260|NCT02711930|intra-ocular pressure|intra-ocular pressure
92261|NCT02711930|prone ventilation|prone ventilation
92262|NCT02711917|Propofol|propofol
92263|NCT02711917|Sevoflurane|sevoflurane
92264|NCT02711917|Etomidate|etomidate
92265|NCT02711917|Rocuronium|rocuronium
92266|NCT02711917|BIS|bis
92267|NCT02711917|Closed loop infusion system|closed loop infusion system
92268|NCT02711904|Extubation|extubation
92269|NCT02711904|Cough|cough
92270|NCT02711904|Target Controlled Anesthesia (TACAN)|target controlled anesthesia (tacan)
92271|NCT02711891|fingerstick|fingerstick
92272|NCT02711891|opioid|opioid
92273|NCT02711891|heelstick|heelstick
92274|NCT02711891|loperamide|loperamide
92275|NCT02711891|topical opioid|topical opioid
92276|NCT02711826|graft inflammation|graft inflammation
92277|NCT02711826|Treg|treg
92278|NCT02711826|polyclonally expanded Tregs (polyTregs)|polyclonally expanded tregs (polytregs)
92279|NCT02711826|darTregs|dartregs
92280|NCT02711826|calcineurin inhibitors (CNIs)|calcineurin inhibitors (cnis)
92281|NCT02711826|mTOR inhibitors|mtor inhibitors
92282|NCT02711787|Hand|hand
92283|NCT02711787|Paralysis|paralysis
92284|NCT02711787|Stroke|stroke
92285|NCT02711722|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
92286|NCT02711709|Intra-abdominal sepsis|intra-abdominal sepsis
92287|NCT02711709|Surgical ICU|surgical icu
92288|NCT02711696|Celiac Disease,|celiac disease,
92289|NCT02711696|Gluten Free Diet|gluten free diet
92290|NCT02711696|Gluten contamination|gluten contamination
92291|NCT02711670|nephrolithiasis|nephrolithiasis
92292|NCT02711670|calcium stones|calcium stones
92293|NCT02711670|kidney stones|kidney stones
92294|NCT02711670|hypercalciuria|hypercalciuria
92295|NCT02711670|thiazide|thiazide
92296|NCT02711657|Fibrocytes|fibrocytes
92297|NCT02711657|Interstitial Lung Diseases|interstitial lung diseases
92298|NCT02711657|Rheumatoid Arthritis|rheumatoid arthritis
92299|NCT02711657|Asthma|asthma
92301|NCT02711644|Prenatal|prenatal
92302|NCT02711644|Nutrition|nutrition
92303|NCT02711631|coronary angioplasty|coronary angioplasty
92304|NCT02711631|cardiac rehabilitation|cardiac rehabilitation
92305|NCT02711631|coronary artery bypass graft|coronary artery bypass graft
92306|NCT02711605|ultrasound|ultrasound
92308|NCT02711592|Orthopaedic Pain Management|orthopaedic pain management
92309|NCT02711566|Rehabilitation|rehabilitation
92310|NCT02711566|Robot-assisted therapy|robot-assisted therapy
92311|NCT02711501|post-operative pain|post-operative pain
92312|NCT02711501|diode laser|diode laser
92313|NCT02711488|school-based intervention|school-based intervention
92314|NCT02711488|sedentary behavior|sedentary behavior
92315|NCT02711488|physical activity|physical activity
92316|NCT02711488|sugar sweetened beverages|sugar sweetened beverages
92317|NCT02711462|Healthy Subjects|healthy subjects
92318|NCT02711449|acute surgery|acute surgery
92319|NCT02711449|laparoscopy|laparoscopy
92320|NCT02711371|addiction|addiction
92321|NCT02711371|cannabis|cannabis
92322|NCT02711371|fMRI|fmri
92323|NCT02711345|LTT462|ltt462
92324|NCT02711345|ERK|erk
92325|NCT02711345|MAPK|mapk
92326|NCT02711345|solid tumor|solid tumor
92327|NCT02711267|Open Flow Microperfusion|open flow microperfusion
92328|NCT02711241|Gastroenteritis|gastroenteritis
92329|NCT02711241|Analgesia|analgesia
92330|NCT02711241|Emergency department|emergency department
92331|NCT02711189|Addiction|addiction
92332|NCT02711189|Oxytocin|oxytocin
92333|NCT02711189|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
92334|NCT02711189|Alcohol|alcohol
92335|NCT02711189|Cue Reactivity|cue reactivity
92336|NCT02711137|Solid tumor|solid tumor
92337|NCT02711137|lymphoma|lymphoma
92338|NCT02711137|leukemia|leukemia
92339|NCT02711137|AML|aml
92340|NCT02711137|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
92341|NCT02711137|multiple myeloma|multiple myeloma
92342|NCT02711137|myeloproliferative neoplasm (MPN)|myeloproliferative neoplasm (mpn)
92343|NCT02711137|MDS/MPN|mds/mpn
92344|NCT02711137|myelofibrosis (MF)|myelofibrosis (mf)
92345|NCT02711137|pancreatic cancer|pancreatic cancer
92346|NCT02711137|colorectal cancer|colorectal cancer
92347|NCT02711137|non-small cell lung cancer|non-small cell lung cancer
92348|NCT02711137|prostate cancer|prostate cancer
92349|NCT02711137|breast cancer|breast cancer
92350|NCT02711137|ovarian cancer|ovarian cancer
92351|NCT02711137|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
92352|NCT02711137|NUT midline carcinoma|nut midline carcinoma
92353|NCT02711137|non-Hodgkin lymphoma|non-hodgkin lymphoma
92354|NCT02711137|diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
92355|NCT02711137|double-hit|double-hit
92356|NCT02711137|triple-hit|triple-hit
92357|NCT02711137|myc|myc
92358|NCT02711137|bromodomain and extra-terminal (BET) inhibitor|bromodomain and extra-terminal (bet) inhibitor
92359|NCT02711124|hemoglobin A1c|hemoglobin a1c
92360|NCT02711124|coronary artery bypass grafting|coronary artery bypass grafting
92361|NCT02711124|impedance aggregometry|impedance aggregometry
92362|NCT02711124|platelet reactivity|platelet reactivity
92363|NCT02711124|clinical outcomes|clinical outcomes
92364|NCT02711098|cardiac arrest|cardiac arrest
92365|NCT02711098|hypothermia|hypothermia
92366|NCT02711098|critical care|critical care
92367|NCT02711059|hyperparathyroidism|hyperparathyroidism
92368|NCT02711059|insulin resistance|insulin resistance
92369|NCT02711020|Depressive symptoms|depressive symptoms
92370|NCT02711020|Fibromyalgia|fibromyalgia
92371|NCT02711020|Cognitive Behavioral Therapy|cognitive behavioral therapy
92372|NCT02711020|Personal Constructs Therapy|personal constructs therapy
92373|NCT02711020|Differential Efficacy|differential efficacy
92374|NCT02711007|osteosarcoma|osteosarcoma
92375|NCT02711007|metastasis|metastasis
92376|NCT02711007|advanced|advanced
92377|NCT02711007|apatinib|apatinib
92378|NCT02710994|Immediate release omeprazole|immediate release omeprazole
92379|NCT02710994|Integrated gastric acidity|integrated gastric acidity
92380|NCT02710981|Sildenafil vaginal gel|sildenafil vaginal gel
92381|NCT02710981|endometrium|endometrium
92382|NCT02710981|clomiphene|clomiphene
92383|NCT02710981|anovulation|anovulation
92384|NCT02710968|FETO|feto
92385|NCT02710916|Optical Coherence Tomography|optical coherence tomography
92386|NCT02710916|Intraocular pressure|intraocular pressure
92387|NCT02710916|Optic Nerve Head|optic nerve head
92388|NCT02710916|Nerve fiber layer|nerve fiber layer
92389|NCT02710916|Bruch Membrane Opening -Minimum Rim Width|bruch membrane opening -minimum rim width
92390|NCT02710903|Periodontitis|periodontitis
92392|NCT02710903|Pathogenesis|pathogenesis
92393|NCT02710903|IL29|il29
92394|NCT02710903|IL28B|il28b
92395|NCT02710890|Epilepsy|epilepsy
92396|NCT02710890|pediatric|pediatric
92397|NCT02710890|intravenous|intravenous
92398|NCT02710890|children|children
92399|NCT02710890|Lacosamide|lacosamide
92400|NCT02710890|VIMPAT®|vimpat®
92401|NCT02710890|seizure|seizure
92402|NCT02710877|epidural analgesia|epidural analgesia
92403|NCT02710877|patient controlled analgesia|patient controlled analgesia
92404|NCT02710877|obstetric outcome|obstetric outcome
92405|NCT02710864|Cytomegalovirus|cytomegalovirus
92406|NCT02710851|human papillomavirus vaccine|human papillomavirus vaccine
92407|NCT02710851|condylomata acuminata|condylomata acuminata
92408|NCT02710838|Early gastric cancer|early gastric cancer
92409|NCT02710838|Infrared endoscope|infrared endoscope
92410|NCT02710799|Endocrinology|endocrinology
92411|NCT02710799|Referral list|referral list
92412|NCT02710799|Teleconsultation|teleconsultation
92413|NCT02710799|Telemedicine|telemedicine
92414|NCT02710799|Cluster randomized clinical trial|cluster randomized clinical trial
92415|NCT02710773|Gait|gait
92416|NCT02710773|Randomized controlled trial|randomized controlled trial
92417|NCT02710773|Chronic Stroke|chronic stroke
92418|NCT02710773|Treadmill training|treadmill training
92419|NCT02710760|Biomarkers|biomarkers
92420|NCT02710760|Child Nutrition Sciences|child nutrition sciences
92421|NCT02710760|Economics, Behavioral|economics, behavioral
92422|NCT02710747|warfarin|warfarin
92423|NCT02710747|Chinese patients|chinese patients
92424|NCT02710747|heart valve replacement|heart valve replacement
92425|NCT02710734|Urothelial|urothelial
92426|NCT02710721|Fasting|fasting
92427|NCT02710721|Prostatic Neoplasms|prostatic neoplasms
92428|NCT02710721|Complementary Therapies|complementary therapies
92429|NCT02710721|Urology|urology
92430|NCT02710708|birth control,|birth control,
92431|NCT02710708|contraceptives safety,|contraceptives safety,
92432|NCT02710708|contraceptives efficacy,|contraceptives efficacy,
92433|NCT02710708|moderate acne vulgaris|moderate acne vulgaris
583426|NCT00511745|Duodenal Ulcer|duodenal ulcer
92434|NCT02710682|Lateral Epicondylitis of the elbow|lateral epicondylitis of the elbow
92435|NCT02710682|Tendon Fenestration|tendon fenestration
92729|NCT02708888|Trunk|trunk
92436|NCT02710682|Minimally invasive Surgery|minimally invasive surgery
92437|NCT02710682|Ultrasound-guided procedure|ultrasound-guided procedure
92438|NCT02710682|Ultrasonography|ultrasonography
92439|NCT02710682|Elastography|elastography
92440|NCT02710669|ablation|ablation
92441|NCT02710656|Atherosclerosis|atherosclerosis
92443|NCT02710656|Poplitea|poplitea
92444|NCT02710656|Drug coated balloon|drug coated balloon
92445|NCT02710656|Angioplasty|angioplasty
92446|NCT02710656|Restenosis|restenosis
92447|NCT02710656|Peripheral artery disease (PAD)|peripheral artery disease (pad)
92448|NCT02710643|Follicular|follicular
92449|NCT02710643|Lymphoma|lymphoma
92450|NCT02710643|Grade 1|grade 1
92451|NCT02710643|Grade 2|grade 2
92452|NCT02710604|chronic hepatitis B(CHB)|chronic hepatitis b(chb)
92453|NCT02710591|Rimeporide|rimeporide
92454|NCT02710578|Alcohol impaired driving|alcohol impaired driving
92455|NCT02710578|Driving simulation|driving simulation
92456|NCT02710578|Residual effects of alcohol|residual effects of alcohol
92457|NCT02710578|Acute psychomotor effects of alcohol|acute psychomotor effects of alcohol
92458|NCT02710578|Young drivers|young drivers
92459|NCT02710565|Endo bronchial ultrasound|endo bronchial ultrasound
92460|NCT02710565|Trans bronchial needle aspiration|trans bronchial needle aspiration
92461|NCT02710565|Cell line|cell line
92462|NCT02710565|Lung cancer|lung cancer
92463|NCT02710552|arterial hypertension|arterial hypertension
92464|NCT02710552|antihypertensive drugs|antihypertensive drugs
92465|NCT02710539|arterial hypertension|arterial hypertension
92466|NCT02710539|antihypertensive drugs|antihypertensive drugs
92467|NCT02710513|beta-glucans|beta-glucans
92468|NCT02710513|gut microbiota|gut microbiota
92469|NCT02710513|p-cresyl sulphate (pCS)|p-cresyl sulphate (pcs)
92470|NCT02710513|indoxyl sulphate (IS)|indoxyl sulphate (is)
92471|NCT02710513|short-chain fatty acid (SCFA)|short-chain fatty acid (scfa)
92472|NCT02710500|LGMD2B|lgmd2b
92473|NCT02710500|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
92474|NCT02710500|Miyoshi|miyoshi
92475|NCT02710500|Gene Transfer|gene transfer
92476|NCT02710500|Dysferlin|dysferlin
92477|NCT02710487|Parkinson's disease, Sleep Benefit|parkinson's disease, sleep benefit
92478|NCT02710474|preterm birth|preterm birth
92479|NCT02710474|NICU|nicu
92480|NCT02710474|neonatal|neonatal
92481|NCT02710474|kangaroo care|kangaroo care
92482|NCT02710474|separation stress|separation stress
92483|NCT02710474|family nurture|family nurture
92484|NCT02710474|maternal confidence|maternal confidence
92485|NCT02710474|maternal competence|maternal competence
92486|NCT02710474|calming cycle|calming cycle
92487|NCT02710474|infant neurodevelopment|infant neurodevelopment
92488|NCT02710474|infant psychological development|infant psychological development
92489|NCT02710474|mother-infant co-regulation|mother-infant co-regulation
92490|NCT02710474|post-partum depression|post-partum depression
92491|NCT02710461|Polyphenols|polyphenols
92492|NCT02710461|Grape|grape
92493|NCT02710461|Pomegranate|pomegranate
92494|NCT02710461|Metabolic syndrome|metabolic syndrome
92495|NCT02710461|Abdominal obesity|abdominal obesity
92496|NCT02710461|Postprandial glucose|postprandial glucose
92497|NCT02710461|Insulin resistance|insulin resistance
92498|NCT02710435|Coronary Sinus|coronary sinus
92499|NCT02710435|Reducer|reducer
92500|NCT02710435|Refractory Angina|refractory angina
92501|NCT02710435|Angina Pectoris|angina pectoris
92502|NCT02710435|Angina Pectoris, Stable|angina pectoris, stable
92503|NCT02710435|Chronic Stable Angina|chronic stable angina
92504|NCT02710435|Persistent Angina|persistent angina
92505|NCT02710435|Neovasc Reducer System|neovasc reducer system
92506|NCT02710435|Refractory Angina Pectoris|refractory angina pectoris
92507|NCT02710435|Coronary Sinus Narrowing|coronary sinus narrowing
92508|NCT02710435|Reversible Ischemic Heart Disease|reversible ischemic heart disease
92509|NCT02710435|Chronic Angina|chronic angina
92510|NCT02710435|End Stage Angina|end stage angina
92511|NCT02710435|Coronary Sinus Reduction|coronary sinus reduction
92512|NCT02710435|Coronary Sinus Reducer|coronary sinus reducer
92513|NCT02710435|Chronic Refractory Angina|chronic refractory angina
92514|NCT02710435|Chronic Refractory Angina Pectoris|chronic refractory angina pectoris
92515|NCT02710422|Prostate Cancer|prostate cancer
92516|NCT02710422|Amniotic Membrane Placement|amniotic membrane placement
92517|NCT02710422|Robotic Assisted Radical Prostatectomy|robotic assisted radical prostatectomy
92519|NCT02710422|Human Amniotic Membrane Allograft|human amniotic membrane allograft
92520|NCT02710409|safety, immunogenicity , quadrivalent influenza vaccine|safety, immunogenicity , quadrivalent influenza vaccine
92521|NCT02710396|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
92522|NCT02710396|Non-Small Cell Lung Cancer|non-small cell lung cancer
92523|NCT02710396|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
92524|NCT02710396|Nonsmall Cell Lung Cancer|nonsmall cell lung cancer
92525|NCT02710396|NSCLC|nsclc
92526|NCT02710396|Cancer of Neck|cancer of neck
92527|NCT02710396|Neoplasms, Head and Neck|neoplasms, head and neck
92528|NCT02710396|Cancer of the Head|cancer of the head
92529|NCT02710396|Cancer of the Head and Neck|cancer of the head and neck
92530|NCT02710396|Head, Neck Neoplasms|head, neck neoplasms
92531|NCT02710396|Bladder Cancer|bladder cancer
92532|NCT02710396|Bladder Neoplasms|bladder neoplasms
92533|NCT02710396|Malignant Tumor of Urinary Bladder|malignant tumor of urinary bladder
92534|NCT02710396|Urinary Bladder Cancer|urinary bladder cancer
92535|NCT02710396|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
92536|NCT02710396|Carcinoma, Transitional Cell|carcinoma, transitional cell
92537|NCT02710370|Bariatric Surgery|bariatric surgery
92538|NCT02710370|Gastric Bypass|gastric bypass
92539|NCT02710370|Obesity/surgery|obesity/surgery
92540|NCT02710370|Endoscopy, Digestive System|endoscopy, digestive system
92541|NCT02710370|Blood Glucose/metabolism|blood glucose/metabolism
92542|NCT02710370|Diabetes Mellitus, Experimental/metabolism|diabetes mellitus, experimental/metabolism
92543|NCT02710370|Energy Metabolism|energy metabolism
92544|NCT02710370|Glucose/metabolism|glucose/metabolism
92545|NCT02710370|Jejunum/metabolism|jejunum/metabolism
92546|NCT02710370|Metabolomics|metabolomics
92547|NCT02710370|Gene Expression|gene expression
92548|NCT02710357|Mandibular Prosthesis Implantation|mandibular prosthesis implantation
92549|NCT02710357|Prostheses and Implants|prostheses and implants
92550|NCT02710357|Denture, Complete, Lower|denture, complete, lower
92551|NCT02710279|Psychiatry|psychiatry
92552|NCT02710279|Depressive disorder|depressive disorder
92554|NCT02710266|Synthetic Protease Inhibitor|synthetic protease inhibitor
92555|NCT02710266|Hepatectomy|hepatectomy
92556|NCT02710266|Postoperative Complications|postoperative complications
92557|NCT02710253|Metastatic cancer|metastatic cancer
92558|NCT02710253|Prior treatment with immunotherapy agent|prior treatment with immunotherapy agent
92559|NCT02710253|Salvage radiation therapy|salvage radiation therapy
92560|NCT02710253|Radiation therapy|radiation therapy
92561|NCT02710253|XRT|xrt
92562|NCT02710253|Progressive disease|progressive disease
92563|NCT02710253|PD|pd
92564|NCT02710253|Stereotactic radiation|stereotactic radiation
92565|NCT02710253|External beam radiation|external beam radiation
92566|NCT02710253|Whole brain radiation therapy|whole brain radiation therapy
92567|NCT02710253|WBRT|wbrt
92568|NCT02710214|Hot flash|hot flash
92569|NCT02710214|Estrogen|estrogen
92570|NCT02710214|Women|women
92571|NCT02710149|CAR-T|car-t
92572|NCT02710149|Leukemia|leukemia
92573|NCT02710149|Lymphoma|lymphoma
92574|NCT02710136|Asthma|asthma
92575|NCT02710136|Glycerinated German cockroach allergenic extract|glycerinated german cockroach allergenic extract
92576|NCT02710136|Cockroach Nasal Allergen Challenge|cockroach nasal allergen challenge
92577|NCT02710058|support group|support group
92578|NCT02710058|15-246|15-246
92579|NCT02710058|The Arab American Breast Cancer Education and Referral Program (AMBER)|the arab american breast cancer education and referral program (amber)
92580|NCT02710045|Immunity, Innate|immunity, innate
92581|NCT02710045|Immunity, Non-Specific|immunity, non-specific
92582|NCT02710045|Transcriptome|transcriptome
92583|NCT02710045|Antibodies|antibodies
92584|NCT02710045|Cytokines|cytokines
92585|NCT02710045|Immunity, Cellular|immunity, cellular
92586|NCT02710032|Transgender women|transgender women
92587|NCT02710032|HIV Pre-Exposure Prophylaxis|hiv pre-exposure prophylaxis
92588|NCT02710032|Adherence|adherence
92589|NCT02710032|Peru|peru
92590|NCT02710032|Social Networks|social networks
92591|NCT02710019|substance use|substance use
92592|NCT02710019|psychosis|psychosis
92593|NCT02710019|youth|youth
92594|NCT02710019|video game|video game
92595|NCT02710006|Uterus|uterus
92596|NCT02710006|Ultrasound|ultrasound
92597|NCT02709980|Brain Injury|brain injury
92598|NCT02709980|Insomnia|insomnia
92599|NCT02709980|Sleep|sleep
92600|NCT02709941|Obstructive Sleep Apnea|obstructive sleep apnea
92601|NCT02709941|Inspiratory Muscle Strength Training|inspiratory muscle strength training
92602|NCT02709941|Baroreceptor Sensitivity|baroreceptor sensitivity
92603|NCT02709941|Blood Pressure|blood pressure
92604|NCT02709928|Multiple ascending dose|multiple ascending dose
92605|NCT02709850|ANGPTL-3|angptl-3
92606|NCT02709837|bioavailability|bioavailability
92607|NCT02709837|amino acid|amino acid
92608|NCT02709837|carnosine|carnosine
92609|NCT02709837|lycopene|lycopene
92610|NCT02709837|mastication|mastication
92611|NCT02709837|meat|meat
92612|NCT02709798|Shenfu Injection|shenfu injection
92613|NCT02709798|Reperfusion Injury|reperfusion injury
92614|NCT02709798|Myocardial Protection|myocardial protection
92615|NCT02709798|Percutaneous Coronary Intervention|percutaneous coronary intervention
92616|NCT02709746|paediatric patients|paediatric patients
92617|NCT02709733|Virtual Reality|virtual reality
92618|NCT02709733|Negative Symptoms|negative symptoms
92619|NCT02709720|Lung Cancer|lung cancer
92620|NCT02709720|Cancer Lung Disease|cancer lung disease
92621|NCT02709720|NORA|nora
92622|NCT02709720|GECP 15/02|gecp 15/02
92623|NCT02709720|Metronomic administration|metronomic administration
92624|NCT02709707|Diabetes, Blood Sugar|diabetes, blood sugar
92625|NCT02709681|Sickle Cell Disease|sickle cell disease
92626|NCT02709681|Hydroxyurea|hydroxyurea
92627|NCT02709668|MTHFR depression vitamins Homocysteine|mthfr depression vitamins homocysteine
92628|NCT02709655|paediatric|paediatric
92629|NCT02709616|Glioblastoma|glioblastoma
92630|NCT02709616|DC vaccine|dc vaccine
92631|NCT02709616|tumor antigen|tumor antigen
92632|NCT02709616|personalized vaccine|personalized vaccine
92633|NCT02709551|corporate health management|corporate health management
92634|NCT02709551|hrv|hrv
92635|NCT02709551|mindfulness|mindfulness
92636|NCT02709525|hyaluronic acid|hyaluronic acid
92637|NCT02709525|bone repair|bone repair
92638|NCT02709525|dental socket|dental socket
92639|NCT02709525|cone beam computed tomography|cone beam computed tomography
92640|NCT02709512|Malignant Pleural Mesothelioma with Low Argininosuccinate Synthetase 1 Expression|malignant pleural mesothelioma with low argininosuccinate synthetase 1 expression
92641|NCT02709486|Osteoarthritis, pain, tanezumab.|osteoarthritis, pain, tanezumab.
92642|NCT02709473|propofol|propofol
92643|NCT02709473|remifentanil|remifentanil
92644|NCT02709473|rocuronium|rocuronium
92645|NCT02709460|hematoma|hematoma
92646|NCT02709460|complication|complication
92647|NCT02709460|hysterectomy|hysterectomy
92648|NCT02709447|Intimate Partner Violence|intimate partner violence
92649|NCT02709447|Juvenile Delinquency|juvenile delinquency
92650|NCT02709447|Sexual Behavior|sexual behavior
92651|NCT02709421|post-Endoscopic Retrograde cholangiopancreatography pancreatitis|post-endoscopic retrograde cholangiopancreatography pancreatitis
92652|NCT02709421|Risk factors|risk factors
92653|NCT02709421|Indomethacin|indomethacin
92654|NCT02709408|Carbapenem resistance|carbapenem resistance
92655|NCT02709408|Enterobacteriaceae|enterobacteriaceae
92656|NCT02709408|Acinetobacter baumannii|acinetobacter baumannii
92657|NCT02709408|Bloodstream infections|bloodstream infections
92658|NCT02709408|Intrabdominal infections|intrabdominal infections
92659|NCT02709408|Urinary tract infections|urinary tract infections
92660|NCT02709408|Pneumonia|pneumonia
92661|NCT02709408|Risk factors|risk factors
92662|NCT02709408|Outcome|outcome
92663|NCT02709408|Hospitalised patients|hospitalised patients
92664|NCT02709408|Mortality|mortality
92665|NCT02709408|Clinical response|clinical response
92666|NCT02709408|Length of hospital stay|length of hospital stay
92667|NCT02709369|HIRREM|hirrem
92668|NCT02709369|Neuro-technology|neuro-technology
92669|NCT02709369|Closed-loop|closed-loop
92670|NCT02709369|Acoustic stimulation|acoustic stimulation
92671|NCT02709369|Allostatic|allostatic
92672|NCT02709369|heart rate variability|heart rate variability
92673|NCT02709369|baroreflex sensitivity|baroreflex sensitivity
92674|NCT02709369|traumatic brain injury|traumatic brain injury
92675|NCT02709369|sports concussion|sports concussion
92676|NCT02709369|PTSD|ptsd
92677|NCT02709369|hot flashes|hot flashes
92678|NCT02709369|headache|headache
92679|NCT02709369|insomnia|insomnia
92680|NCT02709304|urinary catheter discomfort|urinary catheter discomfort
92681|NCT02709278|BCG|bcg
92682|NCT02709278|Aerosol|aerosol
92683|NCT02709278|Tuberculosis|tuberculosis
92684|NCT02709278|Challenge|challenge
92685|NCT02709226|Brain Tumor|brain tumor
92686|NCT02709226|Astrocytoma|astrocytoma
92687|NCT02709226|GBM|gbm
92688|NCT02709226|Radiation Therapy|radiation therapy
92689|NCT02709187|DP-R208|dp-r208
92690|NCT02709174|Pulmonary Embolism|pulmonary embolism
92691|NCT02709174|Pregnancy|pregnancy
92692|NCT02709174|D-Dimer|d-dimer
92693|NCT02709161|neurofeedback|neurofeedback
92694|NCT02709161|major depressive disorder|major depressive disorder
92695|NCT02709161|amygdala|amygdala
92696|NCT02709148|Parkinson's Disease|parkinson's disease
92697|NCT02709070|highly-purified CTL|highly-purified ctl
92698|NCT02709044|Acute pancreatitis|acute pancreatitis
92699|NCT02709044|Fluid resuscitation|fluid resuscitation
92700|NCT02709044|Crystalloids|crystalloids
92701|NCT02709031|Cicletanine|cicletanine
92702|NCT02709031|Magnesium|magnesium
92703|NCT02709031|Metabolic disease|metabolic disease
92704|NCT02709018|posttraumatic stress disorder|posttraumatic stress disorder
92705|NCT02709018|losartan|losartan
92706|NCT02709018|angiotensin receptor blocker|angiotensin receptor blocker
92707|NCT02709005|Bacterial Vaginosis|bacterial vaginosis
92708|NCT02709005|Monolaurin Vaginal Gel|monolaurin vaginal gel
92709|NCT02708992|Azithromycin|azithromycin
92710|NCT02708992|Cefixime|cefixime
92711|NCT02708992|Duration|duration
92712|NCT02708992|High-Dose|high-dose
92713|NCT02708992|Neisseria gonorrhoeae|neisseria gonorrhoeae
92714|NCT02708992|Pharmacokinetics|pharmacokinetics
92715|NCT02708992|Susceptibility|susceptibility
92716|NCT02708979|Stress|stress
92717|NCT02708979|Eating|eating
92718|NCT02708966|Gymnema Sylvestre|gymnema sylvestre
92719|NCT02708966|Glycemic control|glycemic control
92720|NCT02708927|social integration|social integration
92721|NCT02708927|cognitive impairment|cognitive impairment
92722|NCT02708927|emotional processing|emotional processing
92723|NCT02708927|quality of life|quality of life
92724|NCT02708901|Autism Spectrum Disorder|autism spectrum disorder
92725|NCT02708901|Probiotic Vivomixx®|probiotic vivomixx®
92726|NCT02708901|Gastrointestinal Symptoms|gastrointestinal symptoms
92727|NCT02708901|Gut-Brain Axis|gut-brain axis
92728|NCT02708901|Endophenotypes|endophenotypes
92730|NCT02708888|Biomechanical Phenomena|biomechanical phenomena
92731|NCT02708888|Gait|gait
92732|NCT02708888|Electromyography|electromyography
92733|NCT02708888|Rehabilitation|rehabilitation
92734|NCT02708888|Balance|balance
92735|NCT02708875|Microvascular|microvascular
92736|NCT02708875|Insulin resistance|insulin resistance
92737|NCT02708875|Mixed Meal|mixed meal
92738|NCT02708875|Glucose tolerance|glucose tolerance
92739|NCT02708823|Postoperative delirium|postoperative delirium
92740|NCT02708823|Risk assessment|risk assessment
92741|NCT02708823|Clinical screening tool|clinical screening tool
92742|NCT02708823|Tablet computer|tablet computer
92743|NCT02708810|radiosurgery (RS)|radiosurgery (rs)
92744|NCT02708810|trigeminal neuralgia (TGN)|trigeminal neuralgia (tgn)
92745|NCT02708797|Cerebral autoregulation|cerebral autoregulation
92746|NCT02708797|MRI|mri
92747|NCT02708797|VBM|vbm
92748|NCT02708797|Doppler Transcranial|doppler transcranial
92749|NCT02708784|Glykogen storage disease type 2)|glykogen storage disease type 2)
92750|NCT02708784|Dystrophia Myotonica|dystrophia myotonica
92751|NCT02708784|Muscular disorders|muscular disorders
92752|NCT02708784|MR-imaging|mr-imaging
92753|NCT02708784|Muscle strength|muscle strength
92754|NCT02708784|Myopathies|myopathies
92755|NCT02708745|communication|communication
92756|NCT02708745|immunization|immunization
92758|NCT02708719|MID|mid
92759|NCT02708719|1-minute sit-to-stand-test|1-minute sit-to-stand-test
92760|NCT02708706|adhesive capsulitis|adhesive capsulitis
92761|NCT02708706|hyaluronic acid|hyaluronic acid
92762|NCT02708667|non-small cell lung cancer|non-small cell lung cancer
92763|NCT02708667|crizotinib|crizotinib
92764|NCT02708667|hepatic toxicity|hepatic toxicity
92765|NCT02708654|Remote monitoring|remote monitoring
92766|NCT02708654|Incentives|incentives
92767|NCT02708628|scar prevention|scar prevention
92768|NCT02708628|sectio|sectio
92769|NCT02708628|extract of allium cepae|extract of allium cepae
92770|NCT02708628|allantoin|allantoin
92771|NCT02708628|heparin|heparin
92772|NCT02708602|β2-adrenergic receptor|β2-adrenergic receptor
92773|NCT02708602|genetic polymorphisms|genetic polymorphisms
92774|NCT02708602|labor progress|labor progress
92775|NCT02708563|meconium|meconium
92776|NCT02708563|neonatal resuscitation|neonatal resuscitation
92777|NCT02708498|Palliative care|palliative care
92778|NCT02708498|Frail elderly|frail elderly
92779|NCT02708498|Comorbidity|comorbidity
92780|NCT02708498|Staff Development|staff development
92781|NCT02708498|Nursing Homes|nursing homes
92782|NCT02708472|Generalized Anxiety Disorder|generalized anxiety disorder
92783|NCT02708472|synchronized Transcranial Magnetic Stimulation|synchronized transcranial magnetic stimulation
92785|NCT02708472|Neurostimulation|neurostimulation
92786|NCT02708472|TMS|tms
92787|NCT02708446|Second Trimester|second trimester
92788|NCT02708446|Abortion|abortion
92789|NCT02708446|Misoprostol|misoprostol
92790|NCT02708446|Sublingual|sublingual
92791|NCT02708446|Buccal|buccal
92792|NCT02708433|lidocaine, jaw|lidocaine, jaw
92793|NCT02708420|Glidescope|glidescope
92794|NCT02708420|Cardiovascular surgery|cardiovascular surgery
92795|NCT02708420|Macintosh Laryngoscope|macintosh laryngoscope
92800|NCT02708381|Oncogeriatric|oncogeriatric
92801|NCT02708381|Senior adult|senior adult
92802|NCT02708368|Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD)|chronic kidney disease - mineral bone disorder (ckd-mbd)
92803|NCT02708329|Coronary stenosis|coronary stenosis
92804|NCT02708329|Drug-eluting stent|drug-eluting stent
92805|NCT02708329|Coronary angioplasty with stenting|coronary angioplasty with stenting
92806|NCT02708329|Ischemic Heart Disease|ischemic heart disease
92807|NCT02708329|Chronic total occlusion|chronic total occlusion
92808|NCT02708329|Bifurcational lesion|bifurcational lesion
92809|NCT02708329|Bifurcational stenting|bifurcational stenting
92810|NCT02708303|Esophageal Reflux|esophageal reflux
92811|NCT02708303|Gastric Acid Reflux|gastric acid reflux
92812|NCT02708303|Gastric Acid Reflux Disease|gastric acid reflux disease
92813|NCT02708303|Gastro-Esophageal Reflux|gastro-esophageal reflux
92814|NCT02708303|Gastro-oesophageal Reflux|gastro-oesophageal reflux
92815|NCT02708303|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
92816|NCT02708303|Reflux, Gastroesophageal|reflux, gastroesophageal
92817|NCT02708303|Esophageal Hernia|esophageal hernia
92818|NCT02708303|Hernia, Esophageal|hernia, esophageal
92819|NCT02708303|Hernia, Paraesophageal|hernia, paraesophageal
92820|NCT02708303|Hiatal Hernia|hiatal hernia
92821|NCT02708303|Sliding Hiatal Hernia|sliding hiatal hernia
92822|NCT02708303|Sliding Esophageal Hernia|sliding esophageal hernia
92823|NCT02708303|Hernia, Hiatus|hernia, hiatus
92824|NCT02708303|Paraesophageal Hiatal Hernia|paraesophageal hiatal hernia
92825|NCT02708303|Questionnaires|questionnaires
92826|NCT02708277|intrauterine contraceptive device|intrauterine contraceptive device
92827|NCT02708277|intrauterine balloon|intrauterine balloon
92828|NCT02708238|Infantile colics|infantile colics
92829|NCT02708199|Drug resistance malaria|drug resistance malaria
92830|NCT02708199|Myanmar Artemisinin Resistance Containment Zone|myanmar artemisinin resistance containment zone
92831|NCT02708199|Asymptomatic malaria|asymptomatic malaria
92832|NCT02708199|Serology|serology
92837|NCT02708173|vaccine|vaccine
92838|NCT02708173|safety|safety
92839|NCT02708134|Chest compressions|chest compressions
92840|NCT02708134|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
92841|NCT02708069|Autism Spectrum Disorder|autism spectrum disorder
92842|NCT02708056|Sugammadex|sugammadex
92843|NCT02708056|Rocuronium|rocuronium
92844|NCT02708056|Infant patients|infant patients
92845|NCT02708017|Subcostal TAP block|subcostal tap block
92846|NCT02708017|Posterior TAP block|posterior tap block
92847|NCT02708017|Ultrasound|ultrasound
92848|NCT02708017|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
92849|NCT02707991|Continuity of Patient Care|continuity of patient care
92850|NCT02707991|Treatment Cascade|treatment cascade
92851|NCT02707978|Dementia|dementia
92852|NCT02707978|Brain Diseases|brain diseases
92853|NCT02707978|Central Nervous System Diseases|central nervous system diseases
92854|NCT02707978|Mild Cognitive Impairment|mild cognitive impairment
92855|NCT02707978|tauopathies|tauopathies
92856|NCT02707978|Neurodegenerative Disease|neurodegenerative disease
92857|NCT02707965|Generic brittle|generic brittle
92858|NCT02707965|Anti-epileptic drug|anti-epileptic drug
94098|NCT02700256|surgery|surgery
92860|NCT02707952|Compensated cirrhosis|compensated cirrhosis
92861|NCT02707952|Hepatitis C Genotype 1|hepatitis c genotype 1
92862|NCT02707952|Hepatitis C Genotype 5|hepatitis c genotype 5
92863|NCT02707952|Non-cirrhotic|non-cirrhotic
92864|NCT02707952|Hepatitis C virus|hepatitis c virus
92865|NCT02707952|Hepatitis C Genotype 6|hepatitis c genotype 6
92866|NCT02707952|Hepatitis C Genotype 3|hepatitis c genotype 3
92867|NCT02707952|Hepatitis C Genotype 4|hepatitis c genotype 4
92868|NCT02707952|Renal impairment|renal impairment
92869|NCT02707952|Hepatitis C Genotype 2|hepatitis c genotype 2
92870|NCT02707952|Chronic Hepatitis C|chronic hepatitis c
92871|NCT02707900|Vorinostat|vorinostat
92872|NCT02707900|AGS-004|ags-004
92873|NCT02707900|HIV virus|hiv virus
92874|NCT02707900|AIDS|aids
92875|NCT02707887|Mental Disorders|mental disorders
92876|NCT02707887|Mood Disorders|mood disorders
92877|NCT02707887|Behavioral Activation|behavioral activation
92878|NCT02707861|HIV|hiv
92879|NCT02707861|Resistant|resistant
92880|NCT02707861|Salvage|salvage
92881|NCT02707861|ibalizumab|ibalizumab
92882|NCT02707861|antibody|antibody
92883|NCT02707861|AIDS|aids
92884|NCT02707835|Edema,taping,ultrasound|edema,taping,ultrasound
92885|NCT02707822|tacrolimus|tacrolimus
92886|NCT02707822|pharmacokinetics|pharmacokinetics
92887|NCT02707822|gene polymorphism|gene polymorphism
92888|NCT02707822|clinical factors|clinical factors
92990|NCT02707172|Cross-Over Studies|cross-over studies
94185|NCT02699515|MSB0011359C|msb0011359c
92889|NCT02707796|oxygen reserve index, partial oxygen pressure, hemicolectomy|oxygen reserve index, partial oxygen pressure, hemicolectomy
92890|NCT02707783|stable and unstable angina|stable and unstable angina
92891|NCT02707783|bioresorbable vascular scaffold|bioresorbable vascular scaffold
92892|NCT02707783|BVS|bvs
92893|NCT02707783|PCI|pci
92894|NCT02707770|COPD, pulmonary rehabilitation, ambulatory oxygen therapy|copd, pulmonary rehabilitation, ambulatory oxygen therapy
92895|NCT02707757|Haemodialysis|haemodialysis
92896|NCT02707757|Anaemia|anaemia
92897|NCT02707757|Iron|iron
92898|NCT02707757|Erythropoeitin stimulating agents|erythropoeitin stimulating agents
92899|NCT02707744|Heart Failure|heart failure
92900|NCT02707744|Atrial Fibrillation|atrial fibrillation
92901|NCT02707744|Ambulatory ECG monitor|ambulatory ecg monitor
92902|NCT02707718|sepsis|sepsis
92903|NCT02707718|biomarker|biomarker
92904|NCT02707718|prognostic|prognostic
92905|NCT02707718|emergency department|emergency department
92906|NCT02707718|diagnosis|diagnosis
92907|NCT02707692|HIV|hiv
92908|NCT02707692|AIDS|aids
92909|NCT02707692|Immune Stimulation|immune stimulation
92910|NCT02707692|HIV Reservoir|hiv reservoir
92911|NCT02707679|Knee|knee
92912|NCT02707679|Mobilization|mobilization
92913|NCT02707679|Taping|taping
92914|NCT02707679|Function|function
92915|NCT02707679|Balance|balance
92916|NCT02707666|resectable malignant pleural mesothelioma|resectable malignant pleural mesothelioma
92917|NCT02707666|Pembrolizumab|pembrolizumab
92918|NCT02707627|Pediatric|pediatric
92919|NCT02707627|Laser|laser
92920|NCT02707627|Burn|burn
92921|NCT02707627|Scar|scar
637657|NCT00730080|cognition|cognition
92922|NCT02707627|Photothermolysis|photothermolysis
92923|NCT02707601|HIV|hiv
92924|NCT02707601|HCV|hcv
92925|NCT02707601|Antiretroviral therapy|antiretroviral therapy
92926|NCT02707601|HCV direct acting antiviral(s) (DAA)|hcv direct acting antiviral(s) (daa)
92927|NCT02707588|Determine the tolerance and efficacy of Pembrolizumab|determine the tolerance and efficacy of pembrolizumab
92928|NCT02707575|Keratin|keratin
92929|NCT02707575|Ranibizumab|ranibizumab
92930|NCT02707562|Cystic fibrosis G551D mutation|cystic fibrosis g551d mutation
92931|NCT02707562|GLPG1837|glpg1837
92932|NCT02707549|crystalloid solutions|crystalloid solutions
92933|NCT02707549|acid-base imbalance|acid-base imbalance
92934|NCT02707549|water-electrolyte Imbalance|water-electrolyte imbalance
92935|NCT02707523|RSV|rsv
92936|NCT02707523|respiratory support|respiratory support
92937|NCT02707523|RSV induced respiratory failure|rsv induced respiratory failure
92938|NCT02707510|logotherapy|logotherapy
92939|NCT02707510|cognitive behavior therapy|cognitive behavior therapy
92940|NCT02707510|metastatic breast cancer|metastatic breast cancer
92941|NCT02707497|sepsis|sepsis
92942|NCT02707497|thrombocytopenia|thrombocytopenia
92943|NCT02707497|recombinant human thrombopoietin|recombinant human thrombopoietin
92944|NCT02707497|platelet|platelet
92945|NCT02707497|28-day mortality|28-day mortality
92946|NCT02707484|Gastrointestinal vascular malformation|gastrointestinal vascular malformation
92947|NCT02707484|thalidomide|thalidomide
92948|NCT02707484|Small intestinal bleeding|small intestinal bleeding
92949|NCT02707458|apolipoprotein E|apolipoprotein e
92950|NCT02707458|Alzheimer|alzheimer
92951|NCT02707458|pre-clinical|pre-clinical
92952|NCT02707458|pre-symptomatic|pre-symptomatic
92953|NCT02707458|dose-finding|dose-finding
92954|NCT02707458|prevention|prevention
92955|NCT02707432|Cardiovascular Diseases|cardiovascular diseases
92956|NCT02707432|Community-Based Participatory Research|community-based participatory research
92957|NCT02707432|African Americans|african americans
92958|NCT02707419|Total knee replacement|total knee replacement
92959|NCT02707419|Action observation treatment|action observation treatment
92960|NCT02707419|Rehabilitation|rehabilitation
92961|NCT02707393|stem cell transplantation|stem cell transplantation
92962|NCT02707393|pediatrics|pediatrics
92963|NCT02707354|GVHD|gvhd
92964|NCT02707354|confocal endomicroscopy|confocal endomicroscopy
92965|NCT02707341|psoriasis|psoriasis
92966|NCT02707341|disease registry|disease registry
92967|NCT02707328|Gemcitabine|gemcitabine
92968|NCT02707328|Gemzar|gemzar
92969|NCT02707328|CyberKnife|cyberknife
92970|NCT02707328|Cyber knife|cyber knife
92971|NCT02707328|CK|ck
92972|NCT02707328|abraxane|abraxane
92973|NCT02707328|nab-paclitaxel|nab-paclitaxel
92974|NCT02707315|Cyber Knife|cyber knife
92975|NCT02707315|CyberKnife|cyberknife
92976|NCT02707315|Stereotactic Radiosurgery|stereotactic radiosurgery
92977|NCT02707315|CK|ck
92978|NCT02707276|Bipolar Depression|bipolar depression
92979|NCT02707276|Geriatric|geriatric
92980|NCT02707276|Low Field Magnetic Stimulation|low field magnetic stimulation
92981|NCT02707263|heparin|heparin
110015|NCT02604602|PPH|pph
92982|NCT02707250|pethidine|pethidine
92983|NCT02707250|laparoscopic cholecystectomy|laparoscopic cholecystectomy
92984|NCT02707250|bupivacaine|bupivacaine
92985|NCT02707224|DP-R208|dp-r208
92986|NCT02707172|Diethylhexyl Phthalate|diethylhexyl phthalate
92987|NCT02707172|Hand hygiene|hand hygiene
92988|NCT02707172|Soaps|soaps
92989|NCT02707172|N-of-1 design|n-of-1 design
92991|NCT02707159|Circulating tumor cells|circulating tumor cells
92992|NCT02707159|Nab-paclitaxel|nab-paclitaxel
92993|NCT02707159|Metastatic pancreatic cancer|metastatic pancreatic cancer
92994|NCT02707159|Gemcitabine|gemcitabine
92995|NCT02707120|PRGF, Neurotrophic Keratitis, platelet rich plasma, PRP|prgf, neurotrophic keratitis, platelet rich plasma, prp
92996|NCT02707094|back|back
92997|NCT02707094|pain|pain
92998|NCT02707094|chronic|chronic
92999|NCT02707068|Quality of Life|quality of life
93000|NCT02707068|Self-help intervention|self-help intervention
93001|NCT02707055|Alcohol Consumption|alcohol consumption
93002|NCT02707055|Alcohol Treatment|alcohol treatment
93003|NCT02707055|Alcoholism|alcoholism
93004|NCT02707055|Ghrelin|ghrelin
93005|NCT02707055|Ghrelin Antagonism|ghrelin antagonism
93006|NCT02707042|Microbiome|microbiome
93007|NCT02707042|Amoxicillin|amoxicillin
93008|NCT02707042|Azithromycin|azithromycin
93009|NCT02707042|Metagenome|metagenome
93010|NCT02707042|Metabolic|metabolic
93011|NCT02707029|Screening Protocol|screening protocol
93012|NCT02707029|Pain|pain
93013|NCT02707029|Phenotypes|phenotypes
93014|NCT02707016|Emergence delirium|emergence delirium
93015|NCT02707016|Sevoflurane|sevoflurane
93016|NCT02707016|Pediatric anesthesia|pediatric anesthesia
93017|NCT02707003|Post-operative respiratory distress|post-operative respiratory distress
93018|NCT02706977|Ophthalmology|ophthalmology
93019|NCT02706964|metastasis|metastasis
93020|NCT02706964|3D imaging|3d imaging
93021|NCT02706964|early detection|early detection
93022|NCT02706951|Musculoskeletal Disease|musculoskeletal disease
93023|NCT02706951|anti-inflammatory agents|anti-inflammatory agents
93024|NCT02706951|Arthritis|arthritis
93025|NCT02706951|Joint Disease|joint disease
93026|NCT02706951|antirheumatic agents|antirheumatic agents
93027|NCT02706938|Gastroesophageal reflux disease|gastroesophageal reflux disease
93028|NCT02706938|Head of bed elevation|head of bed elevation
93029|NCT02706938|Quality of life|quality of life
93030|NCT02706938|Nocturnal symptoms|nocturnal symptoms
93031|NCT02706938|Lifestyle measures|lifestyle measures
93032|NCT02706912|Stroke|stroke
93033|NCT02706912|Hemiparesis|hemiparesis
93034|NCT02706912|Activities of Daily Living|activities of daily living
93035|NCT02706912|Virtual World|virtual world
93036|NCT02706912|Occupational Therapy|occupational therapy
93037|NCT02706899|Antibody-Drug Conjugate CD33 Antigen|antibody-drug conjugate cd33 antigen
93039|NCT02706886|Primary Hyperoxaluria|primary hyperoxaluria
93040|NCT02706886|RNAi therapeutic|rnai therapeutic
93041|NCT02706886|siRNA|sirna
93042|NCT02706886|AGT|agt
93043|NCT02706873|Musculoskeletal disease|musculoskeletal disease
93044|NCT02706873|Arthritis|arthritis
93045|NCT02706873|Anti-inflammatory agents|anti-inflammatory agents
93046|NCT02706873|Joint disease|joint disease
93047|NCT02706873|Antirheumatic agents|antirheumatic agents
93048|NCT02706847|Antirheumatic agents|antirheumatic agents
93049|NCT02706847|Anti-inflammatory agents|anti-inflammatory agents
93050|NCT02706847|Musculoskeletal Disease|musculoskeletal disease
93051|NCT02706847|Joint Disease|joint disease
93052|NCT02706847|Arthritis|arthritis
93053|NCT02706834|Drug therapy|drug therapy
93054|NCT02706821|prediabetes|prediabetes
93055|NCT02706821|blood glucose|blood glucose
93056|NCT02706821|clinical trial|clinical trial
93057|NCT02706808|chronic kidney disease|chronic kidney disease
93058|NCT02706808|hemodialysis|hemodialysis
93059|NCT02706808|conservative treatment|conservative treatment
93060|NCT02706808|resistance starch|resistance starch
93061|NCT02706795|Cervical dystonia|cervical dystonia
93062|NCT02706795|Spasmodic torticollis|spasmodic torticollis
93063|NCT02706704|Intravitreal Adalimumab|intravitreal adalimumab
93064|NCT02706704|Subcutaneous Adalimumab|subcutaneous adalimumab
93065|NCT02706678|FK506|fk506
93066|NCT02706678|Renal transplant recipients|renal transplant recipients
93067|NCT02706678|cyclosporin|cyclosporin
93068|NCT02706665|Anesthetics|anesthetics
93069|NCT02706665|Propofol|propofol
93070|NCT02706665|Electroencephalography|electroencephalography
93071|NCT02706665|SEDline monitor|sedline monitor
93072|NCT02706652|Screening|screening
93073|NCT02706652|Genotype|genotype
93074|NCT02706652|Drug Dosing|drug dosing
93075|NCT02706652|Trial Selection|trial selection
93076|NCT02706639|Biospecimen Procurement|biospecimen procurement
93077|NCT02706639|Laboratory Research Specimens|laboratory research specimens
93078|NCT02706639|Sample Collection|sample collection
93079|NCT02706639|Rare Diseases|rare diseases
93080|NCT02706587|Critical illness polyneuropathy|critical illness polyneuropathy
93081|NCT02706587|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
93082|NCT02706574|Eye Tracking|eye tracking
93083|NCT02706574|Blood-based Biomarkers|blood-based biomarkers
93084|NCT02706574|CSF-based Biomarkers|csf-based biomarkers
93085|NCT02706574|Magnetic Resonance Imaging|magnetic resonance imaging
93086|NCT02706574|Computed Tomography Scan|computed tomography scan
93087|NCT02706574|Outcome Measures|outcome measures
93088|NCT02706561|15-317|15-317
93089|NCT02706548|occupational therapy|occupational therapy
93090|NCT02706548|medication adherence|medication adherence
93091|NCT02706548|intervention studies|intervention studies
93092|NCT02706535|Itraconazole|itraconazole
93093|NCT02706535|Rifampicin|rifampicin
93094|NCT02706535|Pharmacokinetics|pharmacokinetics
93095|NCT02706535|Cross-over|cross-over
93096|NCT02706496|aging of elderly|aging of elderly
93097|NCT02706496|falling prevention|falling prevention
93098|NCT02706496|electroencephalography|electroencephalography
93099|NCT02706496|postural control|postural control
93100|NCT02706496|biomechanics|biomechanics
93101|NCT02706470|recurrent miscarriage; immunology|recurrent miscarriage; immunology
93102|NCT02706457|intensive care|intensive care
93103|NCT02706457|functionality|functionality
93104|NCT02706405|PD-L1|pd-l1
93105|NCT02706405|immunotherapy|immunotherapy
93106|NCT02706405|non-Hodgkin lymphoma|non-hodgkin lymphoma
93107|NCT02706353|Melanoma|melanoma
93108|NCT02706353|Metastatic Melanoma|metastatic melanoma
93109|NCT02706353|Intratumoral APX005M|intratumoral apx005m
93110|NCT02706353|Pembrolizumab|pembrolizumab
93111|NCT02706353|Keytruda|keytruda
93112|NCT02706353|MK-3475|mk-3475
93113|NCT02706353|SCH-900475|sch-900475
93114|NCT02706327|orthotic insoles|orthotic insoles
93115|NCT02706327|pain|pain
93116|NCT02706327|quality of life|quality of life
93117|NCT02706327|athletic performance|athletic performance
93118|NCT02706301|colorectal cancer survivor|colorectal cancer survivor
93119|NCT02706301|cancer pain|cancer pain
93120|NCT02706301|psychological distress|psychological distress
93121|NCT02706301|coping skills training|coping skills training
93122|NCT02706301|symptom management|symptom management
93123|NCT02706301|cancer survivorship|cancer survivorship
93124|NCT02706210|Mild Cognitive Impairment|mild cognitive impairment
93125|NCT02706210|Diffusion Tensor Imaging|diffusion tensor imaging
93126|NCT02706197|Electron Paramagnetic Resonance|electron paramagnetic resonance
93127|NCT02706197|Hypoxia|hypoxia
93128|NCT02706197|OxyChip|oxychip
93129|NCT02706184|gastric cancer|gastric cancer
93130|NCT02706184|colorectal cancer|colorectal cancer
93131|NCT02706184|chemotherapy induced diarrhea|chemotherapy induced diarrhea
93132|NCT02706184|5-Fluoruracil|5-fluoruracil
93133|NCT02706184|chemotherapeutic remedy|chemotherapeutic remedy
93134|NCT02706145|social norms|social norms
93135|NCT02706145|youth violence|youth violence
93136|NCT02706145|media|media
93137|NCT02706132|Mesenchymal stromal cells|mesenchymal stromal cells
93138|NCT02706132|Liver Transplantation|liver transplantation
93139|NCT02706132|ABO blood group|abo blood group
93140|NCT02706119|total parenteral nutrition|total parenteral nutrition
93141|NCT02706119|glargine insulin|glargine insulin
93142|NCT02706119|insulin|insulin
93143|NCT02706080|Antithrombotic agents|antithrombotic agents
93144|NCT02706080|VKA|vka
93145|NCT02706080|Direct Oral Anticoagulant|direct oral anticoagulant
93146|NCT02706080|Antiplatelet|antiplatelet
93147|NCT02706080|Bleeding|bleeding
93148|NCT02706080|Emergency|emergency
93149|NCT02706041|Exploratory Lap (Ex Lap)|exploratory lap (ex lap)
93150|NCT02706041|Damage Control Laparotomy (DCL)|damage control laparotomy (dcl)
93151|NCT02706041|Definitive|definitive
93152|NCT02706028|underwater ultrasound|underwater ultrasound
93153|NCT02706028|rheumatoid arthritis|rheumatoid arthritis
93154|NCT02706015|Headache|headache
93155|NCT02706015|Aura|aura
93156|NCT02706015|Migraine|migraine
93157|NCT02705937|xerostomia, Saliva, iatrogenic oral dryness, dairy product|xerostomia, saliva, iatrogenic oral dryness, dairy product
93158|NCT02705898|alcohol use disorders|alcohol use disorders
93159|NCT02705898|physical activity|physical activity
93160|NCT02705898|women's health|women's health
93161|NCT02705885|IgY|igy
93162|NCT02705885|Periodontitis|periodontitis
93163|NCT02705885|Porphyromonas gingivalis|porphyromonas gingivalis
93164|NCT02705885|gingipains|gingipains
93165|NCT02705885|Efficacy|efficacy
93166|NCT02705872|Epidural|epidural
93167|NCT02705872|Programmed intermittent boluses|programmed intermittent boluses
93168|NCT02705872|Cesarian section|cesarian section
93169|NCT02705872|Instrumented delivery|instrumented delivery
93170|NCT02705846|BRCA1|brca1
93171|NCT02705846|BRCA2|brca2
93172|NCT02705846|Lynch Syndrome|lynch syndrome
93173|NCT02705820|Metastatic, Lung Cancer, Switch, Maintenance, Pembrolizumab.|metastatic, lung cancer, switch, maintenance, pembrolizumab.
93174|NCT02705807|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
93175|NCT02705807|safety|safety
93176|NCT02705807|FLOLAN|flolan
93177|NCT02705807|New Thermostable Formulation|new thermostable formulation
93178|NCT02705807|dose adjustment|dose adjustment
93179|NCT02705807|reformulated diluents|reformulated diluents
93180|NCT02705807|currently marketed diluent|currently marketed diluent
93181|NCT02705794|intubation, laryngoscopy|intubation, laryngoscopy
93182|NCT02705768|Neuron-specific enolase (NSE)|neuron-specific enolase (nse)
93183|NCT02705768|Carbamazepine|carbamazepine
93184|NCT02705768|Oxcarbazepine|oxcarbazepine
93185|NCT02705742|Mesenchymal stem cells|mesenchymal stem cells
93186|NCT02705742|Liver cirrhosis|liver cirrhosis
93187|NCT02705742|Hepatitis C|hepatitis c
93188|NCT02705729|dental caries|dental caries
93189|NCT02705729|proximal surfaces|proximal surfaces
93190|NCT02705729|posterior teeth|posterior teeth
93191|NCT02705729|carious lesions|carious lesions
93192|NCT02705729|tooth diseases|tooth diseases
93193|NCT02705729|dental restorations|dental restorations
93194|NCT02705729|glass-ionomer|glass-ionomer
93195|NCT02705664|Onychomycosis|onychomycosis
93196|NCT02705612|Cervical cancer|cervical cancer
93197|NCT02705612|cisplatin|cisplatin
93198|NCT02705612|nimotuzumab|nimotuzumab
93199|NCT02705599|Ischemic stroke|ischemic stroke
93200|NCT02705599|High resolution MRI|high resolution mri
93201|NCT02705599|Perfusion|perfusion
93202|NCT02705599|Mechanism|mechanism
93203|NCT02705586|Movement disorders|movement disorders
93204|NCT02705586|Metabolic Stress|metabolic stress
93205|NCT02705547|Friedreich Ataxia|friedreich ataxia
93206|NCT02705534|Hepatitis C|hepatitis c
93207|NCT02705534|Cirrhosis|cirrhosis
93208|NCT02705534|Sofosbuvir|sofosbuvir
93209|NCT02705534|Ledipasvir|ledipasvir
93210|NCT02705534|Ribavirin|ribavirin
93211|NCT02705521|shoulder|shoulder
93212|NCT02705521|impingement|impingement
93213|NCT02705521|rehabilitation|rehabilitation
93214|NCT02705521|physiotherapy|physiotherapy
93215|NCT02705521|gamification|gamification
93216|NCT02705521|activation|activation
93217|NCT02705521|engagement|engagement
93218|NCT02705508|extranodal natural killer/T-cell lymphoma|extranodal natural killer/t-cell lymphoma
93222|NCT02705482|Advanced solid tumors|advanced solid tumors
93223|NCT02705482|MEDI0562|medi0562
93224|NCT02705482|durvalumab|durvalumab
93225|NCT02705482|tremelimumab|tremelimumab
93226|NCT02705482|OX40|ox40
93227|NCT02705482|PD-L1|pd-l1
93228|NCT02705482|CTLA-4|ctla-4
93229|NCT02705482|immuno-oncology|immuno-oncology
93230|NCT02705482|Cancer|cancer
93231|NCT02705469|Metastatic Castration-Resistant Prostate Cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
93232|NCT02705469|Phase 1|phase 1
93233|NCT02705469|Prostate Cancer|prostate cancer
93234|NCT02705469|Pharmacokinetics (PK)|pharmacokinetics (pk)
93235|NCT02705469|ZEN003694|zen003694
93236|NCT02705469|ZEN-3694|zen-3694
93237|NCT02705469|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
93238|NCT02705469|BET inhibitor (BETi)|bet inhibitor (beti)
93239|NCT02705469|Bromodomain|bromodomain
93240|NCT02705469|Pharmacodynamics (PD)|pharmacodynamics (pd)
93241|NCT02705469|Epigenetics|epigenetics
93242|NCT02705456|Dental Caries|dental caries
93243|NCT02705456|Tooth Paste|tooth paste
93244|NCT02705456|Orthodontics|orthodontics
93245|NCT02705456|Fluorides|fluorides
93246|NCT02705417|arteriovenous fistula|arteriovenous fistula
93247|NCT02705417|colour Doppler|colour doppler
93248|NCT02705417|physical examination|physical examination
93249|NCT02705417|renal dialysis|renal dialysis
93250|NCT02705417|retrospective studies|retrospective studies
93251|NCT02705404|multifocal|multifocal
93252|NCT02705404|genetic|genetic
93253|NCT02705404|bronchoalveolar carcinoma|bronchoalveolar carcinoma
93254|NCT02705404|adenocarcinoma in situ|adenocarcinoma in situ
93255|NCT02705404|ground glass opacity|ground glass opacity
93256|NCT02705404|next generation sequencing|next generation sequencing
93257|NCT02705378|Intensive care unit|intensive care unit
93258|NCT02705378|ICU|icu
93259|NCT02705378|Critical Illness|critical illness
93260|NCT02705378|Constipation|constipation
93261|NCT02705365|Lung Screening|lung screening
93262|NCT02705365|Low-Dose Computer Tomography|low-dose computer tomography
93263|NCT02705365|Patient Navigation|patient navigation
93264|NCT02705352|Skin graft|skin graft
93265|NCT02705352|5-Fluorouracil|5-fluorouracil
93266|NCT02705352|Periocular reconstruction|periocular reconstruction
93270|NCT02705287|vitamin D|vitamin d
93271|NCT02705287|half life|half life
93272|NCT02705287|kinetics|kinetics
93274|NCT02705261|behavior therapy|behavior therapy
93275|NCT02705261|cognitive therapy|cognitive therapy
93276|NCT02705261|parent|parent
93277|NCT02705261|anxiety|anxiety
93278|NCT02705222|Abnormal uterine bleeding|abnormal uterine bleeding
93279|NCT02705222|Dilatation and curettage|dilatation and curettage
93280|NCT02705222|Hysteroscopy|hysteroscopy
93281|NCT02705196|oncolytic|oncolytic
93282|NCT02705196|adenovirus|adenovirus
93283|NCT02705196|pancreatic|pancreatic
93284|NCT02705196|cancer|cancer
93285|NCT02705196|LOKON|lokon
93286|NCT02705196|LOAd703|load703
93287|NCT02705183|surgical treatment|surgical treatment
93288|NCT02705183|post-operative radiotherapy|post-operative radiotherapy
93289|NCT02705183|quality of life|quality of life
93290|NCT02705183|complications|complications
93291|NCT02705183|survival|survival
93292|NCT02705183|long bones|long bones
94186|NCT02699476|NFL|nfl
93293|NCT02705170|index of microvascular resistance|index of microvascular resistance
93294|NCT02705157|long bones|long bones
93295|NCT02705157|survival|survival
93296|NCT02705157|prognosis|prognosis
93297|NCT02705157|treatment|treatment
93298|NCT02705157|quality of life|quality of life
93299|NCT02705131|Cervical radiculopathy|cervical radiculopathy
93300|NCT02705131|Balance chiropractic therapy|balance chiropractic therapy
93301|NCT02705118|radiofrequency ablation|radiofrequency ablation
93302|NCT02705118|image fusion|image fusion
93303|NCT02705105|Metastatic Solid Tumors|metastatic solid tumors
93304|NCT02705105|Advanced Solid Tumors|advanced solid tumors
93305|NCT02705105|KW-0761|kw-0761
93306|NCT02705105|ONO-4538/BMS-936558|ono-4538/bms-936558
93307|NCT02705105|Anti-tumor|anti-tumor
93308|NCT02705105|Mogamulizumab|mogamulizumab
93309|NCT02705105|Nivolumab|nivolumab
93310|NCT02705105|Oncology|oncology
93311|NCT02705053|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
93312|NCT02705053|Artificial Pancreas|artificial pancreas
93313|NCT02705053|Autoimmune Diseases|autoimmune diseases
93314|NCT02705053|Diabetes Mellitus|diabetes mellitus
93315|NCT02705053|Hyperglycemia|hyperglycemia
93316|NCT02705053|Hypoglycemia|hypoglycemia
93317|NCT02705040|male osteoporosis|male osteoporosis
93318|NCT02705040|miRNA|mirna
93319|NCT02705040|biomarker|biomarker
638043|NCT00733083|paediatric|paediatric
93320|NCT02705014|pituitary stalk interruption syndrome|pituitary stalk interruption syndrome
93321|NCT02705014|pulsatile GnRH therapy|pulsatile gnrh therapy
93322|NCT02705014|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
93323|NCT02705014|hypopituitarism|hypopituitarism
93324|NCT02704975|Dry Needling, Shoulder Stabilization|dry needling, shoulder stabilization
93325|NCT02704962|schizophrenia|schizophrenia
93326|NCT02704962|olanzapine|olanzapine
93327|NCT02704962|trifluoperazine|trifluoperazine
93328|NCT02704962|antipsychotic polypharmacy|antipsychotic polypharmacy
93329|NCT02704949|Urolithiasis|urolithiasis
93330|NCT02704949|Fluoroscopy|fluoroscopy
93331|NCT02704949|Radiation|radiation
93332|NCT02704949|Ureteroscopy|ureteroscopy
93333|NCT02704923|Atropine|atropine
93334|NCT02704923|Pneumonia|pneumonia
93335|NCT02704923|Ventilator|ventilator
93336|NCT02704923|Adults|adults
93337|NCT02704923|Intensive care unit.|intensive care unit.
93338|NCT02704871|SeptiCyte|septicyte
93339|NCT02704858|recurrent glioblastoma|recurrent glioblastoma
93340|NCT02704858|recurrent GBM|recurrent gbm
93341|NCT02704845|Inflammatory back pain|inflammatory back pain
93342|NCT02704845|Ankylosing spondylitis|ankylosing spondylitis
93343|NCT02704845|Non-specific low back pain|non-specific low back pain
93344|NCT02704845|Pain experience|pain experience
93345|NCT02704845|Disability|disability
93346|NCT02704845|Behavioural|behavioural
93347|NCT02704845|Psychological|psychological
93348|NCT02704845|Biopsychosocial|biopsychosocial
93349|NCT02704845|Pain profiles|pain profiles
93350|NCT02704832|Geriatric oncology|geriatric oncology
93351|NCT02704832|Intervention|intervention
93352|NCT02704832|Case management|case management
93353|NCT02704819|Decision Support System|decision support system
93354|NCT02704819|Dizziness|dizziness
93355|NCT02704819|Vertigo|vertigo
93356|NCT02704819|Balance|balance
93357|NCT02704780|Retained placenta|retained placenta
93358|NCT02704780|Misoprostol|misoprostol
93359|NCT02704780|double blind|double blind
93360|NCT02704780|Randomization|randomization
93361|NCT02704780|Haemorrhage|haemorrhage
93362|NCT02704715|postoperative pain|postoperative pain
93363|NCT02704715|general anesthesia|general anesthesia
93364|NCT02704702|Fimasartan|fimasartan
93365|NCT02704676|CA-125|ca-125
93366|NCT02704676|Pre-Eclampsia|pre-eclampsia
93367|NCT02704663|adnexal mass|adnexal mass
93368|NCT02704663|laparoscopy|laparoscopy
93369|NCT02704663|removal route|removal route
93370|NCT02704663|postoperative pain|postoperative pain
93371|NCT02704637|vasospasm|vasospasm
93372|NCT02704624|Crohn Disease|crohn disease
93373|NCT02704624|Fatigue|fatigue
93374|NCT02704624|Osteopenia|osteopenia
93375|NCT02704624|Exercise Tolerance|exercise tolerance
93376|NCT02704624|Vitamin d|vitamin d
93377|NCT02704585|Neonatal resuscitation|neonatal resuscitation
93378|NCT02704585|Pulse oximetry|pulse oximetry
93379|NCT02704572|Herpes zoster vaccine|herpes zoster vaccine
93380|NCT02704572|cell-mediated immunity|cell-mediated immunity
93381|NCT02704533|Plasmodium falciparum|plasmodium falciparum
93382|NCT02704533|PfSPZ Vaccine|pfspz vaccine
93383|NCT02704533|PfSPZ Challenge (NF54)|pfspz challenge (nf54)
93384|NCT02704533|PfSPZ Challenge (7G8)|pfspz challenge (7g8)
93385|NCT02704533|CHMI|chmi
93386|NCT02704520|Rectal Cancer|rectal cancer
93387|NCT02704520|Magnetic Resonance Imaging|magnetic resonance imaging
93388|NCT02704520|Chemoradiotherapy|chemoradiotherapy
93389|NCT02704520|Chemotherapy|chemotherapy
93390|NCT02704520|Diagnostic Imaging|diagnostic imaging
93391|NCT02704507|tretinoin|tretinoin
93392|NCT02704507|topical steroid|topical steroid
93393|NCT02704507|irritation|irritation
93394|NCT02704507|retinoid induced irritation|retinoid induced irritation
93395|NCT02704494|Resveratrol|resveratrol
93396|NCT02704494|Diabetes mellitus|diabetes mellitus
93397|NCT02704494|Diabetes complications|diabetes complications
93398|NCT02704494|Diabetic nephropathies|diabetic nephropathies
93399|NCT02704494|Proteinuria|proteinuria
93400|NCT02704494|Albuminuria|albuminuria
93401|NCT02704494|renal insufficiency|renal insufficiency
93402|NCT02704481|mifepristone|mifepristone
93403|NCT02704481|misoprostol|misoprostol
93404|NCT02704481|medical abortion|medical abortion
93405|NCT02704468|CAVI|cavi
93406|NCT02704468|FGF-21|fgf-21
93407|NCT02704468|arterial stiffness|arterial stiffness
93408|NCT02704468|renal transplant|renal transplant
93409|NCT02704455|children|children
93410|NCT02704442|anesthesiology|anesthesiology
93411|NCT02704442|ophthalmology|ophthalmology
93412|NCT02704416|Ventricular arrhythmias|ventricular arrhythmias
93413|NCT02704416|aborted cardiac arrest|aborted cardiac arrest
93414|NCT02704416|cardiac death|cardiac death
93415|NCT02704403|Elafibranor|elafibranor
93416|NCT02704403|NASH|nash
93417|NCT02704403|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
93418|NCT02704403|Fatty liver disease|fatty liver disease
93419|NCT02704403|Fibrosis|fibrosis
638044|NCT00733083|pain|pain
93420|NCT02704390|ORADUR®-Methylphenidate|oradur®-methylphenidate
93421|NCT02704377|Prostate Cancer Survivor|prostate cancer survivor
93422|NCT02704338|Autoimmune Diseases, Treg|autoimmune diseases, treg
93423|NCT02704325|DMD|dmd
93424|NCT02704325|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
93425|NCT02704273|MTM|mtm
93426|NCT02704273|XLMTM|xlmtm
93427|NCT02704208|Antiretroviral Therapy|antiretroviral therapy
93428|NCT02704208|Medication Adherence|medication adherence
93429|NCT02704208|Technology-based Intervention|technology-based intervention
93430|NCT02704195|Parkinson disease|parkinson disease
93431|NCT02704195|Deep brain stimulation|deep brain stimulation
93432|NCT02704195|Freezing of Gait|freezing of gait
93433|NCT02704182|Arthroplasties, Knee Replacement|arthroplasties, knee replacement
93434|NCT02704169|head and neck cancer|head and neck cancer
93435|NCT02704169|H&N cancer|h&n cancer
93436|NCT02704156|Stereotactic body radiation therapy|stereotactic body radiation therapy
93437|NCT02704156|CyberKnife|cyberknife
93438|NCT02704156|Initial treatment|initial treatment
93439|NCT02704130|Therapeutic Embolization|therapeutic embolization
93440|NCT02704130|Ablation Techniques|ablation techniques
93441|NCT02704130|Transarterial Embolization|transarterial embolization
93442|NCT02704130|TAE|tae
93443|NCT02704130|Microwave Ablation|microwave ablation
93444|NCT02704130|MWA|mwa
93445|NCT02704065|amyloidosis|amyloidosis
93446|NCT02704065|renal transplantation|renal transplantation
93447|NCT02704026|Body composition|body composition
93448|NCT02704026|Nutritional status|nutritional status
93449|NCT02704013|Neurotrophins|neurotrophins
93450|NCT02704013|Nerve Growth Factor|nerve growth factor
93451|NCT02704013|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
93452|NCT02704013|Urinary Biomarkers|urinary biomarkers
93453|NCT02704013|Urodynamics|urodynamics
93454|NCT02704013|Anticholinergics|anticholinergics
93455|NCT02704013|Children|children
93456|NCT02703961|CCRT|ccrt
93457|NCT02703961|adjuvant chemotherapy|adjuvant chemotherapy
93458|NCT02703961|cisplatin and docetaxel|cisplatin and docetaxel
93459|NCT02703909|morbid obesity|morbid obesity
93460|NCT02703909|laparoscopic surgery|laparoscopic surgery
93461|NCT02703909|neuromuscular blockade|neuromuscular blockade
93462|NCT02703896|g a, bile reflux. PPIs, H2RAs, prokinetic agents|g a, bile reflux. ppis, h2ras, prokinetic agents
93463|NCT02703831|adult spine deformity|adult spine deformity
93464|NCT02703831|time-driven activity-based costing|time-driven activity-based costing
93465|NCT02703831|three-column posterior osteotomy|three-column posterior osteotomy
93466|NCT02703805|Community program|community program
93467|NCT02703805|Wellness|wellness
93468|NCT02703805|Exercise|exercise
93469|NCT02703805|Physical Activity|physical activity
93470|NCT02703805|Education|education
93471|NCT02703805|Stroke|stroke
93472|NCT02703805|Self-management|self-management
93473|NCT02703779|Multiple Myeloma|multiple myeloma
93474|NCT02703779|Bortezomib|bortezomib
93475|NCT02703779|Autologous|autologous
93476|NCT02703779|Stem Cell|stem cell
93477|NCT02703779|Purging|purging
93478|NCT02703779|In-vivo purging|in-vivo purging
93479|NCT02703779|Ex-vivo purging|ex-vivo purging
93480|NCT02703779|Leukapheresis|leukapheresis
93481|NCT02703779|Contaminated|contaminated
93482|NCT02703779|Stem Cell Harvest|stem cell harvest
84733|NCT02758275|Patient compliance|patient compliance
84734|NCT02758275|Diabetes mellitus, Type 2|diabetes mellitus, type 2
84735|NCT02758275|Hypertension|hypertension
84736|NCT02758275|Nursing|nursing
84737|NCT02758275|Nursing process|nursing process
93483|NCT02703779|Stem Cell Transplant|stem cell transplant
93484|NCT02703779|Transplantation|transplantation
93485|NCT02703727|polypharmacy|polypharmacy
93486|NCT02703727|polymedication check|polymedication check
93487|NCT02703727|anticoagulation treatment|anticoagulation treatment
93488|NCT02703714|Advanced|advanced
93489|NCT02703714|Locally-advanced|locally-advanced
93490|NCT02703714|Not eligible for resection|not eligible for resection
93491|NCT02703714|Prior chemotherapy treatment|prior chemotherapy treatment
93492|NCT02703701|Patient Satisfaction|patient satisfaction
93493|NCT02703701|Emergency Department efficiency|emergency department efficiency
93494|NCT02703662|Biologic mesh|biologic mesh
93495|NCT02703662|abdominal wall reconstruction|abdominal wall reconstruction
93496|NCT02703649|Aromatase inhibitor|aromatase inhibitor
93497|NCT02703649|induction of ovulation|induction of ovulation
93498|NCT02703636|Alzheimer's disease|alzheimer's disease
93499|NCT02703623|Prostate cancer|prostate cancer
93500|NCT02703623|Metastatic castration-resistant prostate cancer to the bone|metastatic castration-resistant prostate cancer to the bone
93501|NCT02703623|mCRPC|mcrpc
93502|NCT02703623|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
93503|NCT02703623|Biomarkers|biomarkers
93504|NCT02703623|Abiraterone Acetate|abiraterone acetate
93505|NCT02703623|Zytiga|zytiga
93506|NCT02703623|Prednisone|prednisone
93507|NCT02703623|ARN509|arn509
93508|NCT02703623|Ipilimumab|ipilimumab
93509|NCT02703623|Yervoy|yervoy
93510|NCT02703623|BMS-734016|bms-734016
93511|NCT02703623|MDX010|mdx010
93512|NCT02703623|Cabazitaxel|cabazitaxel
93513|NCT02703623|Jevtana|jevtana
93514|NCT02703623|Carboplatin|carboplatin
93515|NCT02703623|Paraplatin|paraplatin
93516|NCT02703610|Pain|pain
93517|NCT02703610|Elderly|elderly
93518|NCT02703597|Cigarette Smoking Behavior|cigarette smoking behavior
93519|NCT02703597|Smoking curiosity|smoking curiosity
93520|NCT02703597|Smoking Cessation|smoking cessation
93521|NCT02703597|Smoking Prevention|smoking prevention
93522|NCT02703597|Health improvement|health improvement
93523|NCT02703597|Smoking prevention interactive experience|smoking prevention interactive experience
93524|NCT02703597|ASPIRE|aspire
93525|NCT02703597|Game-based social activities|game-based social activities
93526|NCT02703597|GSA's|gsa's
93527|NCT02703597|Surveys|surveys
93528|NCT02703597|Questionnaires|questionnaires
93529|NCT02703597|Interviews|interviews
93530|NCT02703584|Double trigger|double trigger
93531|NCT02703571|Trametinib|trametinib
93532|NCT02703571|Ribociclib|ribociclib
93533|NCT02703571|LEE011|lee011
93534|NCT02703571|TMT212|tmt212
93535|NCT02703571|advanced solid tumors|advanced solid tumors
93536|NCT02703571|pancreatic cancer|pancreatic cancer
93537|NCT02703571|KRAS-mutant colorectal cancer|kras-mutant colorectal cancer
93538|NCT02703571|colorectal cancer|colorectal cancer
93539|NCT02703571|advanced pancreatic cancer|advanced pancreatic cancer
93540|NCT02703571|metastatic pancreatic cancer|metastatic pancreatic cancer
93541|NCT02703545|familial pancreas cancer|familial pancreas cancer
93542|NCT02703545|pancreatic cyst|pancreatic cyst
93543|NCT02703532|Therapy|therapy
93544|NCT02703532|Rehabilitation|rehabilitation
93545|NCT02703532|Caregiver|caregiver
93546|NCT02703519|cesarean section, repeat|cesarean section, repeat
93547|NCT02703519|uterine scar tissue|uterine scar tissue
93548|NCT02703519|transvaginal ultrasound|transvaginal ultrasound
93549|NCT02703519|uterine rupture|uterine rupture
93550|NCT02703519|placenta accreta|placenta accreta
93551|NCT02703519|placenta percreta|placenta percreta
93552|NCT02703519|placenta increta|placenta increta
93553|NCT02703467|Exhaled hydrogen sulphide|exhaled hydrogen sulphide
93554|NCT02703428|Abdominal|abdominal
93555|NCT02703428|Aortic|aortic
93556|NCT02703428|Aneurysm|aneurysm
93557|NCT02703415|immune|immune
93558|NCT02703415|interleukin|interleukin
93559|NCT02703415|tramadol|tramadol
93560|NCT02703415|postoperartive analgesia|postoperartive analgesia
93561|NCT02703415|pediatric|pediatric
93562|NCT02703415|caudal bupivacaine|caudal bupivacaine
93563|NCT02703402|low back pain|low back pain
93564|NCT02703402|physical exercise and quality of life|physical exercise and quality of life
93565|NCT02703389|knowledge translation|knowledge translation
93566|NCT02703389|antimicrobial stewardship|antimicrobial stewardship
93567|NCT02703311|Valtech Cardio|valtech cardio
93568|NCT02703311|Cardioband|cardioband
93569|NCT02703311|Mitral Valve|mitral valve
93570|NCT02703298|Advanced Solid Malignancy|advanced solid malignancy
84827|NCT02757664|High-Energy Shock Waves|high-energy shock waves
84828|NCT02757612|laser diode, pain|laser diode, pain
93571|NCT02703298|Safety and Tolerability|safety and tolerability
93572|NCT02703298|Tumor Response|tumor response
93573|NCT02703298|Oncology|oncology
93574|NCT02703272|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
93575|NCT02703272|Ibrutinib|ibrutinib
93576|NCT02703272|JNJ-54179060|jnj-54179060
93577|NCT02703246|Hysterectomy, Vaginal|hysterectomy, vaginal
93578|NCT02703246|Hysterectomy, Abdominal|hysterectomy, abdominal
93579|NCT02703220|sleep apnea|sleep apnea
93580|NCT02703220|chemoresponsiveness|chemoresponsiveness
93581|NCT02703220|cerebrovascular response|cerebrovascular response
93582|NCT02703220|hyperoxia|hyperoxia
93583|NCT02703220|acetazolamide|acetazolamide
93584|NCT02703220|finasteride|finasteride
93585|NCT02703220|apneic threshold|apneic threshold
93586|NCT02703220|carbon-dioxide reserve|carbon-dioxide reserve
93587|NCT02703207|obstructive sleep apnea|obstructive sleep apnea
93588|NCT02703207|COPD|copd
93589|NCT02703207|Overlap syndrome|overlap syndrome
93590|NCT02703207|quality of life|quality of life
93591|NCT02703207|neurocognitive function|neurocognitive function
93592|NCT02703207|sleepiness|sleepiness
93593|NCT02703207|elderly|elderly
93594|NCT02703194|IgG4-related disease|igg4-related disease
94187|NCT02699476|veterans|veterans
93595|NCT02703194|IgG4-related sclerosing cholangitis|igg4-related sclerosing cholangitis
93596|NCT02703194|Mikulicz disease|mikulicz disease
93597|NCT02703194|Pancreatitis|pancreatitis
93598|NCT02703194|Retroperitoneal fibrosis|retroperitoneal fibrosis
93599|NCT02703194|Lymphadenopathy|lymphadenopathy
93600|NCT02703181|Safety|safety
93601|NCT02703181|Dose Escalation|dose escalation
93602|NCT02703181|Repeat Dosing|repeat dosing
93603|NCT02703181|Epelsiban|epelsiban
93604|NCT02703181|Pharmacokinetics|pharmacokinetics
93605|NCT02703181|Healthy Women Volunteers|healthy women volunteers
93606|NCT02703181|Tolerability|tolerability
93607|NCT02703181|Oxytocin|oxytocin
93608|NCT02703168|Dental implants|dental implants
93609|NCT02703142|esophagogastrostomy|esophagogastrostomy
93610|NCT02703142|gastric conduit ischemia|gastric conduit ischemia
93611|NCT02703142|endoscopy|endoscopy
93612|NCT02703129|Migraine|migraine
93613|NCT02703129|Diet quality|diet quality
93614|NCT02703129|Nutritional intervention|nutritional intervention
93615|NCT02703129|Severity of disease|severity of disease
93616|NCT02703129|Depressive symptoms|depressive symptoms
93617|NCT02703116|HIV|hiv
93618|NCT02703116|Substance Use|substance use
93619|NCT02703103|cardiopulmonary resuscitation|cardiopulmonary resuscitation
93620|NCT02703103|chest compression|chest compression
93621|NCT02703103|adult|adult
93622|NCT02703103|simulation|simulation
93623|NCT02703064|Furocyst|furocyst
93624|NCT02703064|PCOS|pcos
93625|NCT02703038|cardiogenic shock|cardiogenic shock
93626|NCT02703038|observatory|observatory
93627|NCT02703025|Obesity, green coffee bean extract, weight management|obesity, green coffee bean extract, weight management
93628|NCT02702973|Characteristic analysis|characteristic analysis
93629|NCT02702960|FL-HCC|fl-hcc
93630|NCT02702960|living donor liver transplant|living donor liver transplant
93631|NCT02702960|HLA matched first degree relative|hla matched first degree relative
93632|NCT02702960|Milan Criteria|milan criteria
93633|NCT02702960|Ephraim Fuchs|ephraim fuchs
93634|NCT02702960|Fibrolamellar Cancer Foundation|fibrolamellar cancer foundation
93635|NCT02702960|fibrolamellar|fibrolamellar
93636|NCT02702960|non-fibrolamellar|non-fibrolamellar
93637|NCT02702947|BPH|bph
93638|NCT02702947|Prunus Domestica extract|prunus domestica extract
93639|NCT02702882|Fenugreek seed extract, hypogonadism, protodioscin, testosterone|fenugreek seed extract, hypogonadism, protodioscin, testosterone
93640|NCT02702869|cleft lip|cleft lip
93641|NCT02702869|cleft palate|cleft palate
93642|NCT02702869|cleft lip and palate|cleft lip and palate
93643|NCT02702869|cleft alveolus|cleft alveolus
93644|NCT02702869|multidisciplinary team|multidisciplinary team
93645|NCT02702869|interdisciplinary team|interdisciplinary team
93646|NCT02702856|Prostate Cancer|prostate cancer
93647|NCT02702856|Gleason Grade|gleason grade
93648|NCT02702856|Prostatic Neoplasms|prostatic neoplasms
93649|NCT02702817|Alzheimer's disease, biomarkers, cognitive decline, pre-clinical|alzheimer's disease, biomarkers, cognitive decline, pre-clinical
93650|NCT02702791|Physical activity|physical activity
93651|NCT02702791|Pulmonary rehabilitation|pulmonary rehabilitation
93652|NCT02702791|COPD|copd
93653|NCT02702778|Polymyalgia Rheumatica (PMR)|polymyalgia rheumatica (pmr)
93654|NCT02702765|sCD163|scd163
93655|NCT02702765|liver cirrhosis|liver cirrhosis
93656|NCT02702765|disease severity|disease severity
93782|NCT02702362|stroke|stroke
93657|NCT02702752|Heart diseases stromal differentiation factor alpha 1|heart diseases stromal differentiation factor alpha 1
93658|NCT02702713|bioactive|bioactive
93659|NCT02702713|enriched foods|enriched foods
93660|NCT02702713|anthocyanins (AC)|anthocyanins (ac)
93661|NCT02702713|beta-glucans (BG)|beta-glucans (bg)
93662|NCT02702713|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
93663|NCT02702687|Asthma|asthma
93664|NCT02702687|Childhood Asthma|childhood asthma
93665|NCT02702687|Bronchial Diseases|bronchial diseases
93666|NCT02702687|Immune System Diseases|immune system diseases
93667|NCT02702687|Lung Diseases|lung diseases
93668|NCT02702687|Lung Diseases, Obstructive|lung diseases, obstructive
93669|NCT02702687|Respiratory Tract Diseases|respiratory tract diseases
93670|NCT02702687|Peak Flow Meter|peak flow meter
93671|NCT02702687|Symptom Perception|symptom perception
93672|NCT02702687|Illness Representation|illness representation
93673|NCT02702661|Fascia Iliaca Block|fascia iliaca block
93674|NCT02702661|Local Anaesthetic Infiltration|local anaesthetic infiltration
93675|NCT02702661|Hip Arthroscopy|hip arthroscopy
93676|NCT02702648|healthy subjects|healthy subjects
93677|NCT02702648|first-in-man|first-in-man
93678|NCT02702648|safety|safety
93679|NCT02702622|bananas|bananas
93680|NCT02702622|biofortified|biofortified
93681|NCT02702622|carotenoids|carotenoids
93682|NCT02702622|vitamin A|vitamin a
93683|NCT02702583|Myelosuppressive Chemotherapy|myelosuppressive chemotherapy
93684|NCT02702583|Febrile Neutropenia|febrile neutropenia
93685|NCT02702583|Solid Tumors|solid tumors
93686|NCT02702583|Dental Infection|dental infection
93687|NCT02702583|Oral Infection|oral infection
93688|NCT02702557|Frail Elderly|frail elderly
93689|NCT02702557|Elastic Band Exercises|elastic band exercises
93690|NCT02702557|Unsupervised Exercises|unsupervised exercises
93691|NCT02702557|Monitoring Technology|monitoring technology
93692|NCT02702557|Bandcizer|bandcizer
93693|NCT02702557|Adherence|adherence
93694|NCT02702557|Feasibility|feasibility
93695|NCT02702531|Laparoscopic Surgery|laparoscopic surgery
93696|NCT02702531|FloShield Defogging and Cleaning System|floshield defogging and cleaning system
93697|NCT02702531|Clearify Defogging and Cleaning System|clearify defogging and cleaning system
93698|NCT02702531|gynecologic|gynecologic
93699|NCT02702518|rhDNase I, Pulmozyme, oGVHD, Dry Eye|rhdnase i, pulmozyme, ogvhd, dry eye
93700|NCT02702505|Pulp|pulp
93701|NCT02702505|pulpotomies|pulpotomies
93702|NCT02702505|mineral trioxide aggregate|mineral trioxide aggregate
93703|NCT02702492|PAK4|pak4
93704|NCT02702492|KPT-9274|kpt-9274
93705|NCT02702492|Karyopharm|karyopharm
93706|NCT02702492|NHL|nhl
93707|NCT02702492|solid tumors|solid tumors
93708|NCT02702479|Systematic review and meta-analysis|systematic review and meta-analysis
93709|NCT02702479|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
93710|NCT02702479|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
93711|NCT02702479|Clinical practice guidelines|clinical practice guidelines
93712|NCT02702479|Clinical trials|clinical trials
93713|NCT02702479|Dietary sugars|dietary sugars
93714|NCT02702479|Fructose|fructose
93715|NCT02702479|High fructose corn syrup|high fructose corn syrup
93716|NCT02702479|Isocaloric|isocaloric
93717|NCT02702479|Hypercaloric|hypercaloric
93718|NCT02702479|Cardiometabolic Risk Factors|cardiometabolic risk factors
93719|NCT02702479|Triglycerides|triglycerides
93720|NCT02702479|Cholesterol|cholesterol
93721|NCT02702479|Glycemic control|glycemic control
93722|NCT02702479|Body weight|body weight
93723|NCT02702479|Uric acid|uric acid
93724|NCT02702479|Blood pressure|blood pressure
93725|NCT02702479|Fatty liver|fatty liver
93726|NCT02702479|Fasting|fasting
93727|NCT02702479|Postprandial|postprandial
93728|NCT02702466|Upper limb musculoskeletal disorders|upper limb musculoskeletal disorders
93729|NCT02702466|Spa treatment|spa treatment
93730|NCT02702466|Randomized controlled trials|randomized controlled trials
93731|NCT02702466|Education|education
93732|NCT02702466|Self- management|self- management
93733|NCT02702466|Self-care|self-care
93734|NCT02702466|Exercise|exercise
93735|NCT02702466|Non pharmacological treatment|non pharmacological treatment
93736|NCT02702440|Systematic review and meta-analysis|systematic review and meta-analysis
93737|NCT02702440|Sugars|sugars
93738|NCT02702440|Liquid calories|liquid calories
93739|NCT02702440|Solid calories|solid calories
93740|NCT02702440|Clinical trials|clinical trials
93741|NCT02702440|Body weight|body weight
93742|NCT02702440|Body Mass Index|body mass index
93743|NCT02702440|Evidence-base nutrition (EBN)|evidence-base nutrition (ebn)
93744|NCT02702440|Evidence-base medicine (EBM)|evidence-base medicine (ebm)
93745|NCT02702440|Clinical practice guidelines|clinical practice guidelines
93746|NCT02702427|viral infections post HSCT, virus-specific T-cells|viral infections post hsct, virus-specific t-cells
93747|NCT02702414|PD1|pd1
93748|NCT02702414|PD-1|pd-1
93749|NCT02702414|PDL1|pdl1
93750|NCT02702414|PD-L1|pd-l1
93751|NCT02702401|PD1|pd1
93752|NCT02702401|PD-1|pd-1
93753|NCT02702401|PDL1|pdl1
93754|NCT02702401|PD-L1|pd-l1
93755|NCT02702388|Lenvatinib|lenvatinib
93756|NCT02702388|E7080|e7080
85038|NCT02756520|chronic kidney disease, pre-dialytic|chronic kidney disease, pre-dialytic
85039|NCT02756520|Ketosteril, keto-acids|ketosteril, keto-acids
85050|NCT02756429|stroke|stroke
93757|NCT02702388|Iodine-131 Refractory Differentiated Thyroid Cancer|iodine-131 refractory differentiated thyroid cancer
93758|NCT02702388|Lenvima|lenvima
93759|NCT02702388|Phase 2|phase 2
93760|NCT02702388|RR-DTC|rr-dtc
93761|NCT02702375|Systematic review and meta-analysis|systematic review and meta-analysis
93762|NCT02702375|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
93763|NCT02702375|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
93764|NCT02702375|Clinical practice guidelines|clinical practice guidelines
93765|NCT02702375|Prospective cohort studies|prospective cohort studies
93766|NCT02702375|Dietary sugars|dietary sugars
93768|NCT02702375|Sucrose|sucrose
93769|NCT02702375|High fructose corn syrup|high fructose corn syrup
93770|NCT02702375|HFCS|hfcs
93771|NCT02702375|Cohort studies|cohort studies
93772|NCT02702375|Prospective studies|prospective studies
93773|NCT02702375|Diabetes Mellitus|diabetes mellitus
93774|NCT02702375|Metabolic syndrome|metabolic syndrome
93775|NCT02702375|Coronary heart disease|coronary heart disease
93776|NCT02702375|Stroke|stroke
93777|NCT02702375|Hypertension|hypertension
93778|NCT02702375|Gout|gout
93779|NCT02702362|disorders of consciousness|disorders of consciousness
93780|NCT02702362|minimally conscious state|minimally conscious state
93781|NCT02702362|traumatic brain injury|traumatic brain injury
93783|NCT02702362|transcranial direct current stimulation|transcranial direct current stimulation
93784|NCT02702323|hepatocellular carcinoma|hepatocellular carcinoma
93785|NCT02702323|pulmonary metastasis|pulmonary metastasis
93786|NCT02702323|Apatinib|apatinib
93787|NCT02702323|efficacy|efficacy
93788|NCT02702323|safety|safety
94378|NCT02698254|Surveys|surveys
93789|NCT02702297|Preterm premature rupture of the membranes|preterm premature rupture of the membranes
93790|NCT02702297|PPROM|pprom
93791|NCT02702297|PROM|prom
93792|NCT02702297|fetal membranes|fetal membranes
93793|NCT02702297|premature rupture|premature rupture
93794|NCT02702297|neonatal early onset sepsis|neonatal early onset sepsis
93795|NCT02702297|amniotic fluid|amniotic fluid
93796|NCT02702297|amniotic infection|amniotic infection
93797|NCT02702297|fetal inflammatory response syndrome|fetal inflammatory response syndrome
93798|NCT02702297|adverse neonatal outcome|adverse neonatal outcome
93799|NCT02702297|FIRS|firs
93800|NCT02702284|Advance Directives|advance directives
93801|NCT02702284|Healthcare power of attorney|healthcare power of attorney
93802|NCT02702258|mindfulness|mindfulness
93803|NCT02702258|blood pressure|blood pressure
638045|NCT00733083|child|child
93804|NCT02702258|hypertension|hypertension
93805|NCT02702258|prehypertension|prehypertension
93806|NCT02702206|Shoulder pain|shoulder pain
93807|NCT02702206|subdeltoid bursitis|subdeltoid bursitis
93808|NCT02702206|subacromial bursitis|subacromial bursitis
93809|NCT02702206|intra-bursa injection|intra-bursa injection
93810|NCT02702167|brain stimulation|brain stimulation
93811|NCT02702167|rTMS|rtms
93812|NCT02702154|brain stimulation|brain stimulation
93813|NCT02702154|rTMS|rtms
93814|NCT02702141|Non-hodgkin lymphoma|non-hodgkin lymphoma
93815|NCT02702141|Antibody-drug conjugate|antibody-drug conjugate
93816|NCT02702141|CD19|cd19
93817|NCT02702141|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
93818|NCT02702141|DLBCL|dlbcl
93819|NCT02702141|Grade 3 follicular lymphoma|grade 3 follicular lymphoma
93820|NCT02702128|Bleeding perioperative|bleeding perioperative
93821|NCT02702128|EXACYL|exacyl
93822|NCT02702128|Oorthognathism surgery|oorthognathism surgery
93823|NCT02702128|Hematoma|hematoma
93824|NCT02702115|gene specific targeted insertion|gene specific targeted insertion
93825|NCT02702076|Apomorphine|apomorphine
93826|NCT02702024|efficacy|efficacy
93827|NCT02702024|double incision technique|double incision technique
93828|NCT02702024|uterus preserving surgery|uterus preserving surgery
93829|NCT02701998|Ischemic Stroke|ischemic stroke
93830|NCT02701998|Transient Ischemic Attack|transient ischemic attack
93831|NCT02701998|Physical Activity|physical activity
93832|NCT02701998|Sedentary Behavior|sedentary behavior
93833|NCT02701998|Lifestyle|lifestyle
93834|NCT02701998|Behavior|behavior
93835|NCT02701959|Nitric oxide|nitric oxide
93836|NCT02701959|Dietary intervention trail|dietary intervention trail
93837|NCT02701946|Blood loss|blood loss
93838|NCT02701946|Total knee arthroplasty|total knee arthroplasty
93839|NCT02701946|Bandage|bandage
93840|NCT02701946|Dressing|dressing
93841|NCT02701920|Premature Birth|premature birth
93842|NCT02701920|Infant|infant
93843|NCT02701920|Heart rate|heart rate
93844|NCT02701881|Femoropopliteal Artery|femoropopliteal artery
93845|NCT02701881|Drug-eluting Stent|drug-eluting stent
93846|NCT02701881|Endovascular Therapy|endovascular therapy
85138|NCT02755805|Cognition|cognition
85139|NCT02755805|Intervention|intervention
85140|NCT02755805|Strategy training|strategy training
85141|NCT02755792|Mild Cognitive Impairment|mild cognitive impairment
85142|NCT02755792|Cognitive training|cognitive training
93847|NCT02701868|Infant Formula|infant formula
93848|NCT02701829|taxi cab drivers|taxi cab drivers
93849|NCT02701829|high blood pressure|high blood pressure
93850|NCT02701829|16-038|16-038
93851|NCT02701816|Peripheral Artery Disease|peripheral artery disease
93852|NCT02701816|Femoropopliteal Artery|femoropopliteal artery
93853|NCT02701816|Nitinol Stent|nitinol stent
93854|NCT02701816|Restenosis|restenosis
93855|NCT02701777|spike timing dependant plasticity|spike timing dependant plasticity
93856|NCT02701764|laser-assisted in situ keratomileusis|laser-assisted in situ keratomileusis
93875|NCT02701673|Glutapak-10|glutapak-10
93876|NCT02701673|NutreStore|nutrestore
93877|NCT02701673|Resource|resource
93878|NCT02701673|GlutaSolve|glutasolve
93879|NCT02701673|Sympt-X-G.I.|sympt-x-g.i.
93880|NCT02701673|Sympt-X|sympt-x
93881|NCT02701673|Pyridoxine|pyridoxine
93882|NCT02701673|Belinostat|belinostat
93883|NCT02701673|Azacitidine|azacitidine
93884|NCT02701673|5-azacytidine|5-azacytidine
93885|NCT02701673|5-aza|5-aza
93886|NCT02701673|Azacytidine|azacytidine
93887|NCT02701673|Vidaza|vidaza
93888|NCT02701673|5-AZC|5-azc
93889|NCT02701673|AZA-CR|aza-cr
93890|NCT02701673|Ladakamycin|ladakamycin
93891|NCT02701673|Gemcitabine|gemcitabine
93892|NCT02701673|Gemcitabine Hydrochloride|gemcitabine hydrochloride
93893|NCT02701673|Gemzar|gemzar
93894|NCT02701673|Stem cell transplant|stem cell transplant
93896|NCT02701673|Melphalan|melphalan
93897|NCT02701673|Alkeran|alkeran
93898|NCT02701660|Pharmaceutical Care|pharmaceutical care
93899|NCT02701660|Adherence|adherence
93900|NCT02701660|Polypharmacy|polypharmacy
93901|NCT02701660|e-Health|e-health
93902|NCT02701660|opioid substitution therapy|opioid substitution therapy
93903|NCT02701647|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
93904|NCT02701634|Chronic Graft Versus Host Disease (cGVHD)|chronic graft versus host disease (cgvhd)
93905|NCT02701634|newly diagnosed cGVHD|newly diagnosed cgvhd
93906|NCT02701634|immune reconstitution|immune reconstitution
93907|NCT02701634|Immune System Diseases|immune system diseases
93908|NCT02701634|allogeneic stem cell transplantation|allogeneic stem cell transplantation
93909|NCT02701634|SYK inhibitor|syk inhibitor
93910|NCT02701621|Parkinson's disease, aquatic therapy, balance, MIRT|parkinson's disease, aquatic therapy, balance, mirt
93911|NCT02701517|conditioning treatment|conditioning treatment
93912|NCT02701517|alemtuzumab|alemtuzumab
93913|NCT02701517|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
93914|NCT02701517|chronic lymphoproliferative disorders|chronic lymphoproliferative disorders
93915|NCT02701504|sleep apnea|sleep apnea
93916|NCT02701504|coronary artery bypass grafting|coronary artery bypass grafting
93917|NCT02701504|outcomes|outcomes
93918|NCT02701465|Shoulder|shoulder
93919|NCT02701465|Exercise therapy|exercise therapy
93920|NCT02701452|GnRH agonist triggering|gnrh agonist triggering
93921|NCT02701426|Macrosomia|macrosomia
93922|NCT02701426|Weight gain|weight gain
93923|NCT02701426|Participation|participation
93924|NCT02701426|Adhesion|adhesion
93925|NCT02701426|Physical activity|physical activity
93926|NCT02701426|Nutrition|nutrition
93927|NCT02701413|Apex M|apex m
93928|NCT02701413|Postpartum|postpartum
93929|NCT02701413|Pelvic Floor rehabilitation|pelvic floor rehabilitation
93930|NCT02701387|bone implant interaction|bone implant interaction
93931|NCT02701387|implant stability|implant stability
93932|NCT02701387|resonance frequency analysis (RFA)|resonance frequency analysis (rfa)
93933|NCT02701387|implant stability quotient (ISQ)|implant stability quotient (isq)
93934|NCT02701374|TRK-700|trk-700
93935|NCT02701374|Post-Herpetic Neuralgia|post-herpetic neuralgia
93936|NCT02701361|mindfulness|mindfulness
93937|NCT02701361|critical illness|critical illness
93938|NCT02701361|intensive care unit|intensive care unit
95173|NCT02693873|Pilot Study|pilot study
93939|NCT02701361|mindfulness-based stress reduction|mindfulness-based stress reduction
93940|NCT02701348|neoadjuvant endocrine|neoadjuvant endocrine
93941|NCT02701335|Osteoarthritis|osteoarthritis
93942|NCT02701335|Hand|hand
93943|NCT02701335|Rehabilitation|rehabilitation
93944|NCT02701322|Velopharyngeal Insufficiency|velopharyngeal insufficiency
93945|NCT02701322|Fluoroscopy|fluoroscopy
93946|NCT02701309|Iron deficiency|iron deficiency
93947|NCT02701309|Child|child
93948|NCT02701309|Infancy|infancy
93949|NCT02701309|Preschool children|preschool children
93950|NCT02701309|iron deficiency anemia|iron deficiency anemia
402910|NCT01229189|Pregnant women and their neonates|pregnant women and their neonates
93951|NCT02701296|Infiltration between popliteal artery and capsule of knee (iPACK)|infiltration between popliteal artery and capsule of knee (ipack)
93952|NCT02701270|Glycemic Index|glycemic index
93953|NCT02701270|Dietary Fiber|dietary fiber
93954|NCT02701257|Bionic Pancreas|bionic pancreas
93955|NCT02701257|Insulin|insulin
93956|NCT02701257|Glucagon|glucagon
93957|NCT02701257|Continuous Glucose Monitor|continuous glucose monitor
93958|NCT02701244|Infiltrating Ductal Carcinoma|infiltrating ductal carcinoma
93959|NCT02701244|Ductal Carcinoma In Situ|ductal carcinoma in situ
93960|NCT02701244|Brachytherapy|brachytherapy
93961|NCT02701244|Breast Neoplasms|breast neoplasms
93962|NCT02701244|Breast Diseases|breast diseases
93963|NCT02701244|Neoplasms|neoplasms
93964|NCT02701244|Neoplasms by Site|neoplasms by site
93965|NCT02701231|lung cancer|lung cancer
93966|NCT02701231|Low-frequency rotating magnetic therapy system|low-frequency rotating magnetic therapy system
93967|NCT02701231|systemic anti-tumor therapy|systemic anti-tumor therapy
93968|NCT02701218|Canalith repositioning procedure (CRP)|canalith repositioning procedure (crp)
93969|NCT02701218|BPPV|bppv
93970|NCT02701205|Plaque Psoriasis|plaque psoriasis
93971|NCT02701205|Skin Disease|skin disease
93972|NCT02701192|coccygodynia|coccygodynia
93973|NCT02701192|coccygectomy|coccygectomy
93974|NCT02701192|coccyx|coccyx
93975|NCT02701179|Lignocaine|lignocaine
93976|NCT02701166|Pruritus|pruritus
93977|NCT02701166|itch|itch
93978|NCT02701166|cholestasis|cholestasis
93979|NCT02701075|peripheral neuropathy|peripheral neuropathy
93980|NCT02701075|traumatic tissue injury|traumatic tissue injury
93981|NCT02701075|radiculopathy|radiculopathy
93982|NCT02701036|sporadic ataxia|sporadic ataxia
93983|NCT02701036|MSAc|msac
93984|NCT02701036|SAOA|saoa
93985|NCT02701036|multiple system atrophy of cerebellar type|multiple system atrophy of cerebellar type
93986|NCT02701036|natural history|natural history
93987|NCT02701010|behavioral therapy|behavioral therapy
93988|NCT02701010|overactive bladder|overactive bladder
93989|NCT02701010|urinary incontinence|urinary incontinence
93990|NCT02700958|Remote ischemic preconditioning|remote ischemic preconditioning
93991|NCT02700958|Contrast-induced Nephropathy|contrast-induced nephropathy
93992|NCT02700958|Stable coronary artery disease|stable coronary artery disease
93993|NCT02700958|Lower extremity arterial disease|lower extremity arterial disease
93994|NCT02700958|Low molecular weight metabolites|low molecular weight metabolites
93995|NCT02700958|Functional properties of arteries|functional properties of arteries
93996|NCT02700932|non-invasive|non-invasive
93997|NCT02700906|Lateral epicondylitis|lateral epicondylitis
93998|NCT02700906|tennis elbow|tennis elbow
93999|NCT02700906|Lidocaine|lidocaine
94000|NCT02700906|corticosteroid|corticosteroid
94001|NCT02700880|wearable cardioverter defibrillator|wearable cardioverter defibrillator
94002|NCT02700880|ischemic cardiomyopathy|ischemic cardiomyopathy
94003|NCT02700880|new onset heart failure|new onset heart failure
94004|NCT02700880|sudden cardiac death|sudden cardiac death
94005|NCT02700867|intraosseous access|intraosseous access
94006|NCT02700867|cardiopulmonary resuscitation|cardiopulmonary resuscitation
94007|NCT02700867|paramedic|paramedic
94008|NCT02700867|simulation|simulation
94009|NCT02700867|cadaver|cadaver
94010|NCT02700854|Hypothermia treatment|hypothermia treatment
94011|NCT02700854|Hypocapnia|hypocapnia
94012|NCT02700854|Inhaled CO2|inhaled co2
94013|NCT02700854|Neuroprotection|neuroprotection
94014|NCT02700828|Hypothermia treatment|hypothermia treatment
94015|NCT02700828|Circulatory failure|circulatory failure
94016|NCT02700828|Neonatal hypotension|neonatal hypotension
94017|NCT02700828|Relative adrenal insufficiency|relative adrenal insufficiency
94018|NCT02700828|Hydrocortisone supplementation|hydrocortisone supplementation
94019|NCT02700802|food insecurity|food insecurity
94020|NCT02700802|informal caregiver health|informal caregiver health
94021|NCT02700802|clinic-to-community linkages|clinic-to-community linkages
94022|NCT02700802|community resources|community resources
94023|NCT02700789|diagnostic accuracy|diagnostic accuracy
94024|NCT02700789|double decidual sac sign|double decidual sac sign
94025|NCT02700789|intrauterine pregnancy|intrauterine pregnancy
94026|NCT02700776|screening mammogram|screening mammogram
94027|NCT02700776|GP88|gp88
94028|NCT02700776|breast cancer|breast cancer
94029|NCT02700763|Brain metastasis|brain metastasis
94030|NCT02700737|cardiovascular modeling|cardiovascular modeling
94031|NCT02700737|aortic coarctation|aortic coarctation
94032|NCT02700737|virtual stenting|virtual stenting
94033|NCT02700698|Mitochondria|mitochondria
94035|NCT02700698|muscle|muscle
94036|NCT02700698|PBMC|pbmc
94037|NCT02700672|Ageing|ageing
94038|NCT02700672|Cognition|cognition
94039|NCT02700672|Executive Function|executive function
94040|NCT02700672|Gait|gait
94041|NCT02700620|emotional eating|emotional eating
94042|NCT02700620|restrictive eating|restrictive eating
94043|NCT02700620|body dissatisfaction|body dissatisfaction
94044|NCT02700607|cerebral aneurysm, coiling embolization, blood viscosity|cerebral aneurysm, coiling embolization, blood viscosity
111378|NCT02596711|NRT|nrt
94045|NCT02700555|colorectal cancer|colorectal cancer
94046|NCT02700555|diabetes|diabetes
94047|NCT02700555|metabolic parameters|metabolic parameters
94048|NCT02700555|Surveillance|surveillance
94049|NCT02700542|asthma|asthma
94050|NCT02700542|pest management|pest management
94051|NCT02700503|Diabetes prevention|diabetes prevention
94052|NCT02700503|type 2 diabetes|type 2 diabetes
94053|NCT02700503|prediabetes|prediabetes
94054|NCT02700503|family|family
94055|NCT02700477|Type-2 Diabetic|type-2 diabetic
94056|NCT02700477|HbA1c|hba1c
94057|NCT02700477|FBS|fbs
94058|NCT02700477|PPBS|ppbs
94059|NCT02700477|C-peptide|c-peptide
94060|NCT02700451|IV acetaminophen|iv acetaminophen
94061|NCT02700451|IV Ketorolac|iv ketorolac
94062|NCT02700451|Post-operative analgesia|post-operative analgesia
94063|NCT02700451|Opioid use|opioid use
94064|NCT02700425|Wide QRS|wide qrs
94065|NCT02700425|Ventricular Dyssynchrony|ventricular dyssynchrony
94066|NCT02700399|Rehabilitation|rehabilitation
94067|NCT02700386|Breast|breast
94068|NCT02700386|Cancer|cancer
94069|NCT02700386|Hypofractionated|hypofractionated
94070|NCT02700386|Node-Positive Breast Cancer|node-positive breast cancer
94071|NCT02700386|Radiation Therapy|radiation therapy
94072|NCT02700386|Comprehensive Radiation Therapy|comprehensive radiation therapy
94073|NCT02700360|EC-18|ec-18
94074|NCT02700360|Hematology|hematology
94075|NCT02700360|Cancer|cancer
94076|NCT02700360|Neutropenia|neutropenia
94077|NCT02700334|Prediabetes|prediabetes
94078|NCT02700334|Impaired fasting glucose|impaired fasting glucose
94079|NCT02700334|Hyperglycemia|hyperglycemia
94080|NCT02700334|Impaired glucose tolerance|impaired glucose tolerance
94081|NCT02700334|Glucose intolerance|glucose intolerance
94082|NCT02700334|Dapagliflozin|dapagliflozin
94083|NCT02700334|Sodium glucose cotransporter 2 inhibitor|sodium glucose cotransporter 2 inhibitor
94084|NCT02700334|SGLT2|sglt2
94184|NCT02699541|Diabetes Type 2|diabetes type 2
94085|NCT02700321|non severely hypoxemic respiratory failure|non severely hypoxemic respiratory failure
94086|NCT02700321|preoxygenation|preoxygenation
94087|NCT02700321|crash induction|crash induction
94088|NCT02700308|Solid tumors|solid tumors
94089|NCT02700308|Spine metastasis|spine metastasis
94090|NCT02700308|Vertebroplasty|vertebroplasty
94091|NCT02700308|kyphoplasty|kyphoplasty
94092|NCT02700308|randomization|randomization
94093|NCT02700295|Orthokeratology|orthokeratology
94094|NCT02700282|Cystic fibrosis|cystic fibrosis
94095|NCT02700282|Backpack carrying|backpack carrying
94096|NCT02700282|Respiratory function|respiratory function
94097|NCT02700282|Children|children
94099|NCT02700256|15-315|15-315
94100|NCT02700243|Cystic Fibrosis|cystic fibrosis
94101|NCT02700243|Exercise|exercise
94102|NCT02700243|Fitbit|fitbit
94103|NCT02700217|Donor Nephrectomy|donor nephrectomy
94104|NCT02700139|Myopia control, aspheric lenses, children|myopia control, aspheric lenses, children
94105|NCT02700126|propofol|propofol
94106|NCT02700126|total intravenous anesthesia|total intravenous anesthesia
94107|NCT02700126|cerebral aneurysm|cerebral aneurysm
94108|NCT02700126|single nucleotide polymorphism|single nucleotide polymorphism
94109|NCT02700087|Laryngomalacia|laryngomalacia
94110|NCT02700061|Induced Constraint Therapy|induced constraint therapy
94111|NCT02700061|Robotic Occupational Therapy|robotic occupational therapy
94112|NCT02700061|Neuroplasticity|neuroplasticity
94113|NCT02700048|type 1 diabetes|type 1 diabetes
94114|NCT02700048|hypoglycemia|hypoglycemia
94115|NCT02700048|hypoglycemia unawareness|hypoglycemia unawareness
94116|NCT02700035|Intervention|intervention
94117|NCT02700035|Prevention|prevention
94118|NCT02700035|Randomized Controlled Trial|randomized controlled trial
94119|NCT02700035|Bii-Zin-Da-De-Dah|bii-zin-da-de-dah
94120|NCT02700022|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
94121|NCT02700022|Alisertib|alisertib
94122|NCT02699905|Sepsis|sepsis
94123|NCT02699905|Septic Shock|septic shock
94124|NCT02699905|Multiple Organ Dysfunction|multiple organ dysfunction
94125|NCT02699905|FFA2|ffa2
94126|NCT02699905|GPR43|gpr43
94127|NCT02699866|Small diameter implant|small diameter implant
94128|NCT02699840|Meningitis|meningitis
94129|NCT02699840|Meningococcal Meningitis|meningococcal meningitis
94130|NCT02699840|Meningococcal Infections|meningococcal infections
94131|NCT02699840|Menactra®|menactra®
94132|NCT02699840|Meningococcal Vaccine|meningococcal vaccine
94236|NCT02699073|regorafenib|regorafenib
94133|NCT02699827|Levobupivacaine|levobupivacaine
94134|NCT02699827|Magnesium|magnesium
94135|NCT02699827|Preeclampsia|preeclampsia
94136|NCT02699827|Epidural|epidural
94137|NCT02699814|Depression|depression
94138|NCT02699814|Children|children
94140|NCT02699775|Botulinum toxin injections|botulinum toxin injections
94141|NCT02699775|Stroke|stroke
94142|NCT02699775|3D motion analysis|3d motion analysis
94143|NCT02699775|Gait pattern|gait pattern
94144|NCT02699762|self rehabilitation|self rehabilitation
94145|NCT02699762|stroke|stroke
85438|NCT02753816|Surgery|surgery
94146|NCT02699762|botulinum toxin injection|botulinum toxin injection
94147|NCT02699762|arm functions|arm functions
94148|NCT02699749|Drug Therapy|drug therapy
94149|NCT02699736|HIV|hiv
94150|NCT02699736|HIV-1|hiv-1
94151|NCT02699736|Hepatitis C|hepatitis c
94152|NCT02699736|HCV|hcv
94153|NCT02699736|prospective|prospective
94154|NCT02699736|cohort|cohort
94155|NCT02699736|coinfection|coinfection
94156|NCT02699671|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
94157|NCT02699671|Routine Clinical Practice|routine clinical practice
94158|NCT02699671|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
94159|NCT02699671|Coronary Artery Disease|coronary artery disease
94160|NCT02699671|drug eluting stent|drug eluting stent
94161|NCT02699671|acute myocardial infarction|acute myocardial infarction
94162|NCT02699658|levofloxacin|levofloxacin
94163|NCT02699658|population pharmacokinetics|population pharmacokinetics
94164|NCT02699658|pharmacodynamics|pharmacodynamics
94165|NCT02699632|Survey|survey
94166|NCT02699619|Undisplaced|undisplaced
94167|NCT02699606|Tumor|tumor
94168|NCT02699606|Fibroblast Growth Factor Receptor (FGFR)|fibroblast growth factor receptor (fgfr)
94169|NCT02699606|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
94170|NCT02699606|Erdafitinib|erdafitinib
94171|NCT02699606|Urothelial Cancer|urothelial cancer
94172|NCT02699606|Esophageal Cancer|esophageal cancer
94173|NCT02699606|Cholangiocarcinoma|cholangiocarcinoma
94174|NCT02699580|Biodegradable collagen implant|biodegradable collagen implant
94175|NCT02699580|scleral thinning|scleral thinning
94176|NCT02699580|strabismus surgery|strabismus surgery
94177|NCT02699567|taste perception|taste perception
94178|NCT02699567|individual differences|individual differences
94179|NCT02699567|fat|fat
94180|NCT02699567|genetics|genetics
94181|NCT02699541|Diabetes Self-Management Education|diabetes self-management education
94182|NCT02699541|Behavioural change theory|behavioural change theory
94183|NCT02699541|IMB model|imb model
94188|NCT02699476|cognitive training|cognitive training
94190|NCT02699476|concussion|concussion
94191|NCT02699437|Preeclampsia|preeclampsia
94192|NCT02699437|Antiphospholipid Antibodies|antiphospholipid antibodies
94193|NCT02699411|ligament anterior cruciate , dry needling, physioterapy, propioception, knee arthroplasty, vastus medialis.|ligament anterior cruciate , dry needling, physioterapy, propioception, knee arthroplasty, vastus medialis.
94194|NCT02699385|Gastroenteritis|gastroenteritis
94195|NCT02699385|Domperidone|domperidone
94196|NCT02699385|Pediatric participants|pediatric participants
94197|NCT02699372|Healthy Volunteers|healthy volunteers
94198|NCT02699359|concussion|concussion
94199|NCT02699359|mild traumatic brain injuries|mild traumatic brain injuries
94200|NCT02699346|concussion|concussion
94201|NCT02699346|mild traumatic brain injuries|mild traumatic brain injuries
94202|NCT02699320|Short bowel syndrome|short bowel syndrome
94203|NCT02699320|Intestinal microbiota|intestinal microbiota
94204|NCT02699320|immune|immune
94205|NCT02699307|physical activity|physical activity
94206|NCT02699294|Pain Threshold|pain threshold
94207|NCT02699294|Pectoralis Minor|pectoralis minor
94208|NCT02699294|Proprioceptive Neuromuscular Facilitation (PNF) Stretching|proprioceptive neuromuscular facilitation (pnf) stretching
94209|NCT02699294|Physiotherapy|physiotherapy
94210|NCT02699294|Rehabilitation|rehabilitation
94211|NCT02699242|Fiberoptic intubation Training Simulation Performance|fiberoptic intubation training simulation performance
94212|NCT02699216|Macular Degeneration|macular degeneration
94213|NCT02699216|Eye Diseases|eye diseases
94214|NCT02699216|Retinal Degeneration|retinal degeneration
94215|NCT02699216|Retinal Diseases|retinal diseases
94216|NCT02699190|Leukodystrophy|leukodystrophy
94217|NCT02699190|White Matter Disease|white matter disease
94218|NCT02699190|Whole Genome Sequencing|whole genome sequencing
94219|NCT02699190|WGS|wgs
94220|NCT02699177|ciliary beat frequency,|ciliary beat frequency,
94221|NCT02699164|non surgical spinal decompression therapy|non surgical spinal decompression therapy
94222|NCT02699164|deep friction massage|deep friction massage
94223|NCT02699164|exercise|exercise
94224|NCT02699099|Children|children
94225|NCT02699099|Infants|infants
94226|NCT02699099|SB257049|sb257049
94227|NCT02699099|Malaria|malaria
94228|NCT02699099|Immunogenicity|immunogenicity
94229|NCT02699099|Surveillance|surveillance
94230|NCT02699099|Efficacy|efficacy
94231|NCT02699099|Safety|safety
94232|NCT02699099|Africa|africa
94233|NCT02699099|Plasmodium falciparum|plasmodium falciparum
94234|NCT02699073|colorectal cancer|colorectal cancer
94237|NCT02699073|CHOI criteria|choi criteria
94238|NCT02699073|RECIST criteria|recist criteria
94239|NCT02699060|GERD|gerd
94240|NCT02699060|Barrett`s esophagus|barrett`s esophagus
94241|NCT02699060|macrophage|macrophage
94242|NCT02699060|FSSG questionnaire|fssg questionnaire
94243|NCT02699047|Gastrointestinal cancer|gastrointestinal cancer
94244|NCT02699047|Fish oil|fish oil
94245|NCT02699047|Oxidative stress|oxidative stress
94246|NCT02699047|Inflammation|inflammation
94247|NCT02699047|Quality of life|quality of life
94248|NCT02699047|Nutritional status|nutritional status
94249|NCT02699047|Colorectal cancer|colorectal cancer
94250|NCT02699047|Stomach cancer|stomach cancer
94251|NCT02699047|Chemotherapy|chemotherapy
94252|NCT02699047|polyunsaturated fatty acids n-3|polyunsaturated fatty acids n-3
94253|NCT02699034|real-time MRI|real-time mri
94254|NCT02699034|electrophysiology study|electrophysiology study
94255|NCT02699034|atrial flutter ablation|atrial flutter ablation
94256|NCT02699034|active tracking|active tracking
94257|NCT02699008|clopidogrel；antiplatelet therapy|clopidogrel；antiplatelet therapy
94258|NCT02698982|elderly|elderly
94259|NCT02698982|postoperative cognitive dysfunction|postoperative cognitive dysfunction
94260|NCT02698982|postoperative delirium|postoperative delirium
94261|NCT02698982|depth of anesthesia|depth of anesthesia
94262|NCT02698982|intraoperative blood pressure monitoring|intraoperative blood pressure monitoring
94263|NCT02698969|Sugammadex|sugammadex
94264|NCT02698969|Post-operative residual curarization|post-operative residual curarization
94265|NCT02698969|Diaphragm Ultrasonography|diaphragm ultrasonography
94266|NCT02698956|SAPIEN 3 THV|sapien 3 thv
94267|NCT02698956|TAVI|tavi
94268|NCT02698956|Transfemoral|transfemoral
94269|NCT02698956|Transaortic|transaortic
94270|NCT02698956|Transapical|transapical
94271|NCT02698956|Aortic valve|aortic valve
94272|NCT02698943|cataract; intraocular lens; posterior capsule opacification; glistening; ENVISTA|cataract; intraocular lens; posterior capsule opacification; glistening; envista
94273|NCT02698930|Infective endocarditis|infective endocarditis
94274|NCT02698930|acute kidney injury|acute kidney injury
94275|NCT02698930|dexmedetomidine|dexmedetomidine
94276|NCT02698917|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
94277|NCT02698917|Resuscitation|resuscitation
94278|NCT02698917|Hypoxia-Ischemia, Brain|hypoxia-ischemia, brain
94279|NCT02698904|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
94280|NCT02698904|Relaxation Technique|relaxation technique
94282|NCT02698891|Early Stage Breast Cancer|early stage breast cancer
94283|NCT02698878|Lupin Protein|lupin protein
94284|NCT02698878|Glucose Metabolism|glucose metabolism
94285|NCT02698878|GLUT4|glut4
94286|NCT02698878|Muscle Unloading|muscle unloading
94287|NCT02698878|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
94288|NCT02698852|Drug eluting stents|drug eluting stents
638046|NCT00733083|opiates|opiates
94289|NCT02698852|Interventional Cardiology|interventional cardiology
94290|NCT02698839|Drug eluting stents|drug eluting stents
94291|NCT02698839|Interventional Cardiology|interventional cardiology
94292|NCT02698826|Cardiac Arrest, Hyperoxia, Ischemia-reperfusion Injury, Reactive Oxygen Species, Oxidative Stress, Neuropsychological Tests|cardiac arrest, hyperoxia, ischemia-reperfusion injury, reactive oxygen species, oxidative stress, neuropsychological tests
94293|NCT02698761|Vaso-Occlusive Crises|vaso-occlusive crises
94294|NCT02698761|Sickle Cell Disease|sickle cell disease
94295|NCT02698761|Decreasing Length of Stay|decreasing length of stay
94296|NCT02698761|Comprehensive Care Plan|comprehensive care plan
94297|NCT02698748|Chloroquine|chloroquine
94298|NCT02698748|Malaria Elimination|malaria elimination
94299|NCT02698748|P.falciparum|p.falciparum
94300|NCT02698748|Clinical Trial|clinical trial
94301|NCT02698748|Mozambique|mozambique
94302|NCT02698748|Adults|adults
94303|NCT02698709|Keratoconus|keratoconus
94304|NCT02698709|Corneal Topography|corneal topography
94305|NCT02698709|Diagnosis|diagnosis
94306|NCT02698709|Keratomileusis, Laser In Situ|keratomileusis, laser in situ
94307|NCT02698696|Cognitive Remediation|cognitive remediation
94308|NCT02698696|Mood disorders|mood disorders
94309|NCT02698696|Neuropsychology|neuropsychology
94310|NCT02698683|Nutrition|nutrition
94311|NCT02698683|Lymphocyte Count|lymphocyte count
94312|NCT02698683|Immunoparalysis|immunoparalysis
94313|NCT02698683|nutritional status of septic patients|nutritional status of septic patients
94314|NCT02698670|Cardiac Arrhythmias|cardiac arrhythmias
94315|NCT02698670|Cardiovascular Disease|cardiovascular disease
94316|NCT02698670|Radiofrequency Ablation|radiofrequency ablation
94317|NCT02698670|Cardiac Mapping|cardiac mapping
94318|NCT02698657|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
94319|NCT02698657|Methotrexate|methotrexate
94320|NCT02698657|ASP5094|asp5094
94321|NCT02698631|Catheter Ablation|catheter ablation
94322|NCT02698631|Radiofrequency|radiofrequency
94323|NCT02698631|Fibrosis|fibrosis
94324|NCT02698631|Late-gadolinium enhanced MRI|late-gadolinium enhanced mri
94325|NCT02698618|Diabetes|diabetes
94326|NCT02698618|IMR|imr
94327|NCT02698618|Microcirculation|microcirculation
94328|NCT02698618|Ticagrelor|ticagrelor
94329|NCT02698618|CFR|cfr
94330|NCT02698618|FFR|ffr
94331|NCT02698618|Coronary microcirculation|coronary microcirculation
94332|NCT02698592|atrial flutter|atrial flutter
94333|NCT02698592|ablation|ablation
94334|NCT02698592|Thermocool SF catheter|thermocool sf catheter
94335|NCT02698579|Adrenoleukodystrophy|adrenoleukodystrophy
94336|NCT02698579|X-linked Adrenoleukodystrophy|x-linked adrenoleukodystrophy
94337|NCT02698579|Hematopoietic Stem Cells|hematopoietic stem cells
94338|NCT02698553|Major depressive disorder|major depressive disorder
94339|NCT02698553|Extended release Bupropion|extended release bupropion
94340|NCT02698527|lidocaine|lidocaine
94341|NCT02698501|Asthma|asthma
94342|NCT02698501|Airway hyperresponsiveness|airway hyperresponsiveness
94343|NCT02698501|TSLP|tslp
94344|NCT02698501|Mast cell|mast cell
94345|NCT02698501|Eosinophil|eosinophil
94346|NCT02698475|Psoriasis|psoriasis
94347|NCT02698475|Ustekinumab|ustekinumab
94348|NCT02698475|STELARA|stelara
94349|NCT02698462|Advanced neoplasia|advanced neoplasia
94350|NCT02698462|Colorectal cancer|colorectal cancer
94351|NCT02698462|Population screening|population screening
94352|NCT02698462|Family history|family history
94353|NCT02698436|Acne|acne
94354|NCT02698371|composite resins|composite resins
94355|NCT02698371|dental restoration|dental restoration
94356|NCT02698371|adhesives|adhesives
94357|NCT02698371|non-carious cervical lesions|non-carious cervical lesions
94358|NCT02698371|clinical effectiveness|clinical effectiveness
94359|NCT02698371|Adhese universal|adhese universal
94360|NCT02698371|Futurabond U|futurabond u
94361|NCT02698371|Futurabond DC|futurabond dc
94362|NCT02698371|self-etch|self-etch
94363|NCT02698371|multimode/universal|multimode/universal
94364|NCT02698371|clinical trial|clinical trial
94365|NCT02698358|Peripheral artery disease, Iliac artery, nitinol stent, restenosis|peripheral artery disease, iliac artery, nitinol stent, restenosis
94366|NCT02698345|Popliteal artery disease, drug-eluting balloon, angioplasty|popliteal artery disease, drug-eluting balloon, angioplasty
94367|NCT02698319|Triage|triage
94368|NCT02698319|Systematic Triage|systematic triage
94369|NCT02698280|Bevacizumab|bevacizumab
94370|NCT02698280|Nimustine|nimustine
94371|NCT02698280|Pathology, Molecular|pathology, molecular
94372|NCT02698254|Brain cancer|brain cancer
94373|NCT02698254|Recurrent brain tumor|recurrent brain tumor
94374|NCT02698254|Prior radiation treatment to brain|prior radiation treatment to brain
94375|NCT02698254|Radiation therapy|radiation therapy
94376|NCT02698254|XRT|xrt
94377|NCT02698254|Questionnaires|questionnaires
94379|NCT02698241|Cardiac Resynchronization Therapy Defibrillator (CRT-D)|cardiac resynchronization therapy defibrillator (crt-d)
94380|NCT02698241|heart failure|heart failure
94381|NCT02698241|integrated diagnostics|integrated diagnostics
94382|NCT02698241|chronic medication management|chronic medication management
94387|NCT02698163|Root Canal Therapy|root canal therapy
94388|NCT02698150|Mitral regurgitation|mitral regurgitation
94389|NCT02698150|Mitraclip|mitraclip
94390|NCT02698150|Remote monitoring|remote monitoring
94391|NCT02698150|Wearables|wearables
94392|NCT02698111|nasopharyngeal carcinoma,donafeinib|nasopharyngeal carcinoma,donafeinib
94393|NCT02698098|Malaysia|malaysia
94394|NCT02698098|Asia|asia
94395|NCT02698098|Southeast Asia|southeast asia
94396|NCT02698098|Compulsory Drug Detention Centers|compulsory drug detention centers
94397|NCT02698098|Compulsory Centers for Drug Users|compulsory centers for drug users
94398|NCT02698098|Methadone|methadone
94399|NCT02698098|Drug Relapse|drug relapse
94400|NCT02698098|Drug and Narcotic Control|drug and narcotic control
94401|NCT02698098|Opiate Substitution Treatment|opiate substitution treatment
94402|NCT02698098|Prisons|prisons
94403|NCT02698085|carpal tunnel syndrome|carpal tunnel syndrome
94404|NCT02698085|physiotherapy|physiotherapy
94405|NCT02698085|manual therapy|manual therapy
94406|NCT02698072|Stiffness|stiffness
94407|NCT02698072|Pain|pain
94408|NCT02698072|Disfunction|disfunction
94409|NCT02698046|Heart failure|heart failure
94410|NCT02698046|Iron|iron
94411|NCT02698046|Anemia|anemia
94412|NCT02698046|Chronic disease|chronic disease
94413|NCT02698033|food allergy|food allergy
94414|NCT02698033|peanut|peanut
94415|NCT02698033|food challenge|food challenge
94416|NCT02698020|Newborn|newborn
94417|NCT02698020|Anesthesia|anesthesia
94418|NCT02698020|Oxygen|oxygen
94419|NCT02698020|Hyperoxia|hyperoxia
94420|NCT02697994|Sterile Water Injection|sterile water injection
94421|NCT02697994|Midwifery|midwifery
94422|NCT02697981|sleeve gastrectomy|sleeve gastrectomy
94423|NCT02697929|Rocuronium|rocuronium
94424|NCT02697916|aspirin|aspirin
94425|NCT02697916|ACSD|acsd
94426|NCT02697916|PCORI|pcori
94427|NCT02697903|Creatine kinase supplementation|creatine kinase supplementation
94428|NCT02697903|C-reactive protein|c-reactive protein
94429|NCT02697903|resistance training|resistance training
94430|NCT02697903|Pomegranate supplementation|pomegranate supplementation
94431|NCT02697903|pomegranate juice|pomegranate juice
94432|NCT02697903|muscle damage response|muscle damage response
94433|NCT02697786|Aortic valve surgery|aortic valve surgery
639340|NCT00735904|gemcitabine|gemcitabine
94438|NCT02697760|cadmium-zinc-telluride，CZT cameras|cadmium-zinc-telluride，czt cameras
94439|NCT02697760|myocardial blood flow，MBF|myocardial blood flow，mbf
94440|NCT02697760|myocardial flow reserve，MFR|myocardial flow reserve，mfr
94441|NCT02697747|Ultrasound|ultrasound
94442|NCT02697747|Palpation|palpation
94443|NCT02697747|Analgesia|analgesia
94444|NCT02697747|Epidural|epidural
94445|NCT02697734|Cushing's disease|cushing's disease
94446|NCT02697734|LCI699|lci699
94447|NCT02697734|osilodrostat|osilodrostat
94448|NCT02697734|Pituitary Gland|pituitary gland
94449|NCT02697734|Adrenocorticotropic|adrenocorticotropic
94450|NCT02697734|Hormone|hormone
94451|NCT02697734|ACTH|acth
94453|NCT02697721|Caregivers|caregivers
94454|NCT02697721|Behavioral symptoms|behavioral symptoms
94455|NCT02697721|Dementia|dementia
94456|NCT02697721|Alzheimer disease|alzheimer disease
94457|NCT02697721|Physical activity|physical activity
94458|NCT02697721|Depressive symptoms|depressive symptoms
94459|NCT02697721|Powerful Tools for Caregivers|powerful tools for caregivers
94460|NCT02697721|Chronic Disease Self-Management Program|chronic disease self-management program
94461|NCT02697695|chronic inflammation|chronic inflammation
94462|NCT02697695|fatty liver index|fatty liver index
94463|NCT02697669|Heart failure|heart failure
94464|NCT02697669|myocardial perfusion|myocardial perfusion
94465|NCT02697669|single-photon emission tomography|single-photon emission tomography
94466|NCT02697643|clinical decision support|clinical decision support
94467|NCT02697643|substance use|substance use
94468|NCT02697643|opioid|opioid
94469|NCT02697630|Uveal melanoma|uveal melanoma
94470|NCT02697591|Solid tumor|solid tumor
94471|NCT02697591|adenocarcinoma of the endometrium|adenocarcinoma of the endometrium
94472|NCT02697591|melanoma, non-small cell lung cancer (NSCLC)|melanoma, non-small cell lung cancer (nsclc)
94473|NCT02697591|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
94474|NCT02697591|glucocorticoid-induced tumor necrosis factor receptor (GITR)|glucocorticoid-induced tumor necrosis factor receptor (gitr)
94475|NCT02697565|childhood obesity|childhood obesity
94476|NCT02697565|obesity|obesity
94477|NCT02697565|prevention|prevention
94478|NCT02697565|nutrition|nutrition
94479|NCT02697565|health|health
94480|NCT02697565|preschool|preschool
94481|NCT02697565|childcare|childcare
94482|NCT02697565|role model|role model
94483|NCT02697565|pediatric obesity|pediatric obesity
94484|NCT02697565|weight|weight
94485|NCT02697565|overweight|overweight
94486|NCT02697565|early childhood|early childhood
94487|NCT02697565|train the trainer|train the trainer
94488|NCT02697526|radial artery|radial artery
94489|NCT02697526|occlusion|occlusion
94490|NCT02697526|functional|functional
94491|NCT02697526|complications|complications
94492|NCT02697526|consequences|consequences
94493|NCT02697487|Depression|depression
94494|NCT02697487|Cohort|cohort
94495|NCT02697474|Hepatitis B|hepatitis b
94496|NCT02697474|DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine|dtap-ipv-hep b-prp-t hexavalent vaccine
94497|NCT02697474|Euvax-B®|euvax-b®
94498|NCT02697474|Hexaxim®|hexaxim®
94499|NCT02697474|Infanrix® hexa|infanrix® hexa
94500|NCT02697435|Chronic Low Back Pain|chronic low back pain
94501|NCT02697435|Aged|aged
94502|NCT02697435|Elderly|elderly
94503|NCT02697435|Primary Care|primary care
94504|NCT02697435|Assessment|assessment
94505|NCT02697435|Lumbar|lumbar
94506|NCT02697435|Spinal Stenosis|spinal stenosis
94507|NCT02697435|Hip Osteoarthritis|hip osteoarthritis
94508|NCT02697435|Myofascial Pain Syndrome|myofascial pain syndrome
94509|NCT02697435|Fibromyalgia|fibromyalgia
94510|NCT02697435|Depression|depression
94511|NCT02697435|Maladaptive Coping|maladaptive coping
94512|NCT02697435|Lumbar Spinal Stenosis|lumbar spinal stenosis
94513|NCT02697435|Insomnia|insomnia
94514|NCT02697435|Sacroiliac Joint Pain|sacroiliac joint pain
94515|NCT02697435|Lateral Hip and Thigh Pain|lateral hip and thigh pain
94516|NCT02697435|Anxiety|anxiety
94517|NCT02697435|Dementia|dementia
94518|NCT02697435|Recent Leg Length Discrepancy|recent leg length discrepancy
94519|NCT02697422|Smoking (tobacco use)|smoking (tobacco use)
94520|NCT02697422|Peer health coach|peer health coach
94521|NCT02697422|Systolic blood pressure|systolic blood pressure
94522|NCT02697422|Framingham Cardiovascular risk score|framingham cardiovascular risk score
94523|NCT02697422|Lipid|lipid
94524|NCT02697422|Health related quality of life|health related quality of life
94525|NCT02697422|Health care utilization|health care utilization
94526|NCT02697422|Medication adherence|medication adherence
94527|NCT02697422|Physical activity|physical activity
94528|NCT02697422|Nutrition|nutrition
94529|NCT02697422|Alcohol use|alcohol use
94530|NCT02697422|Stress management|stress management
94531|NCT02697396|Social Marketing Campaign|social marketing campaign
94532|NCT02697396|Mexican American Children|mexican american children
94533|NCT02697396|16-069|16-069
94534|NCT02697383|Ixazomib (MLN9708)|ixazomib (mln9708)
94535|NCT02697383|Dexamethasone|dexamethasone
94537|NCT02697370|Haemophilia A prophylaxis pharmacokinetic dosing|haemophilia a prophylaxis pharmacokinetic dosing
96506|NCT02685982|Depression|depression
94538|NCT02697357|Emotion Regulation Therapy|emotion regulation therapy
94539|NCT02697357|Distress Among Caregivers|distress among caregivers
94540|NCT02697357|15-219|15-219
85829|NCT02751307|metformin|metformin
85830|NCT02751307|clozapine|clozapine
85831|NCT02751307|schizophrenia|schizophrenia
85832|NCT02751307|metabolic traits|metabolic traits
85833|NCT02751294|Healthy Volunteer|healthy volunteer
85834|NCT02751294|Malaria|malaria
85835|NCT02751294|Pharmacokinetics|pharmacokinetics
85836|NCT02751294|Tafenoquine|tafenoquine
85837|NCT02751281|pneumatic|pneumatic
85838|NCT02751281|ultra-sonic|ultra-sonic
85839|NCT02751281|percutaneous nephrolithotomy|percutaneous nephrolithotomy
85840|NCT02751268|infraorbital nerve block|infraorbital nerve block
94541|NCT02697331|Short cervix, twins, progesterone|short cervix, twins, progesterone
94542|NCT02697305|Insulin response|insulin response
94543|NCT02697305|Incretin effect|incretin effect
94544|NCT02697305|GLP-1|glp-1
94546|NCT02697305|Valine|valine
94547|NCT02697305|Leucine|leucine
94548|NCT02697305|Isoleucine|isoleucine
94549|NCT02697305|Branched chain amino acids|branched chain amino acids
94550|NCT02697292|Intravenous Immunoglobulin|intravenous immunoglobulin
94551|NCT02697292|VGKC|vgkc
94552|NCT02697292|Autoimmune epilepsy|autoimmune epilepsy
94553|NCT02697292|Gamumex-C|gamumex-c
94554|NCT02697279|Abscess|abscess
94555|NCT02697279|Loop|loop
94556|NCT02697279|Drainage|drainage
94557|NCT02697253|Roux-en-Y Bariatric Surgery|roux-en-y bariatric surgery
94558|NCT02697253|Psychosocial Variables|psychosocial variables
94559|NCT02697253|Behavioral Variables|behavioral variables
94560|NCT02697253|Weight Loss|weight loss
94561|NCT02697253|Food Intake|food intake
94562|NCT02697253|GLP-1|glp-1
94563|NCT02697253|Reinforcing Value of Food|reinforcing value of food
94564|NCT02697253|Exendin 9-39|exendin 9-39
94565|NCT02697240|sickle cell disease|sickle cell disease
94566|NCT02697240|citrulline|citrulline
94567|NCT02697227|Smoking cessation|smoking cessation
94568|NCT02697227|Smoking behavior|smoking behavior
94569|NCT02697227|Behavioral Activation Treatment|behavioral activation treatment
94570|NCT02697227|BATS|bats
94571|NCT02697227|Standard Smoking Cessation Counseling|standard smoking cessation counseling
94572|NCT02697227|SC|sc
94573|NCT02697227|Nicotine Replacement Therapy|nicotine replacement therapy
94574|NCT02697227|NRT|nrt
94575|NCT02697227|Nicotine patch|nicotine patch
94576|NCT02697227|Questionnaires|questionnaires
94577|NCT02697227|Surveys|surveys
94578|NCT02697227|CO Level|co level
94579|NCT02697227|Cotinine Level|cotinine level
94580|NCT02697227|Saliva test|saliva test
94581|NCT02697214|commercial heart rate monitors|commercial heart rate monitors
94582|NCT02697214|accuracy|accuracy
94583|NCT02697214|EKG|ekg
94584|NCT02697214|varying degrees of exertion|varying degrees of exertion
94585|NCT02697201|Mitochondrial Dynamics|mitochondrial dynamics
94586|NCT02697201|Insulin Resistance|insulin resistance
94587|NCT02697188|testosterone|testosterone
94588|NCT02697188|male hypogonadism|male hypogonadism
94589|NCT02697188|low testosterone|low testosterone
94590|NCT02697175|live video-colposcopy|live video-colposcopy
94591|NCT02697175|cervical dysplasia|cervical dysplasia
94592|NCT02697175|anxiety|anxiety
94593|NCT02697175|randomized controlled trial|randomized controlled trial
94594|NCT02697175|colposcopy|colposcopy
94595|NCT02697162|Intermittent catheterisation|intermittent catheterisation
94596|NCT02697162|Antiseptic|antiseptic
94597|NCT02697162|Octenidine chloride|octenidine chloride
94598|NCT02697162|Children|children
94599|NCT02697149|ERCP|ercp
94600|NCT02697149|nonradiation-to-endoscopist|nonradiation-to-endoscopist
94601|NCT02697149|gallstones|gallstones
94602|NCT02697136|Low HDL|low hdl
94603|NCT02697136|Low apoA-I|low apoa-i
94604|NCT02697136|ABCA-1 mutations|abca-1 mutations
94605|NCT02697136|ApoA-I mutations|apoa-i mutations
94606|NCT02697123|Venous Thrombosis|venous thrombosis
94607|NCT02697123|Pregnancy|pregnancy
94608|NCT02697123|postpartum|postpartum
94609|NCT02697123|antepartum|antepartum
94610|NCT02697110|Cognition|cognition
94611|NCT02697110|Brain Stimulation|brain stimulation
94612|NCT02697110|Early Child Development|early child development
94613|NCT02697097|Hip Muscle Strength|hip muscle strength
94614|NCT02697097|FAI|fai
94615|NCT02697071|Ketamine|ketamine
94616|NCT02697071|Migraine|migraine
94617|NCT02697071|Headache|headache
94618|NCT02697071|Emergency Department|emergency department
94619|NCT02697045|Schizophrenia|schizophrenia
94620|NCT02697045|Quality of Life|quality of life
94621|NCT02697045|Functionality|functionality
94622|NCT02697045|Long Acting Injectable|long acting injectable
94623|NCT02697045|Aripiprazole|aripiprazole
94624|NCT02697045|Naturalistic|naturalistic
94625|NCT02697045|Open-label|open-label
94626|NCT02697045|Single Arm|single arm
94627|NCT02697045|Uncontrolled Study|uncontrolled study
94628|NCT02697032|FDHT|fdht
94629|NCT02697032|PET|pet
94630|NCT02697032|Breast cancer|breast cancer
94631|NCT02697032|Bicalutamide|bicalutamide
94632|NCT02697019|Nonsuicidal Self-Injury (NSSI), Deliberate Self-Harm (DSH), Self-harm, Self-injury|nonsuicidal self-injury (nssi), deliberate self-harm (dsh), self-harm, self-injury
94633|NCT02696993|Metastatic Brain Cancer|metastatic brain cancer
94634|NCT02696993|Non-small cell lung cancer with brain metastasis|non-small cell lung cancer with brain metastasis
94635|NCT02696993|NSCLC|nsclc
94636|NCT02696993|Intracranial disease|intracranial disease
95925|NCT02689752|14C|14c
94637|NCT02696993|Stereotactic radiosurgery|stereotactic radiosurgery
94638|NCT02696993|SRS|srs
94639|NCT02696993|Whole brain radiation therapy|whole brain radiation therapy
94640|NCT02696993|WBRT|wbrt
94641|NCT02696993|Neurocognitive exam|neurocognitive exam
94642|NCT02696993|Nivolumab|nivolumab
94643|NCT02696993|BMS-936558|bms-936558
94644|NCT02696993|Opdivo|opdivo
94645|NCT02696993|Ipilimumab|ipilimumab
94646|NCT02696993|Yervoy|yervoy
94647|NCT02696993|BMS-734016|bms-734016
94648|NCT02696993|MDX010|mdx010
94649|NCT02696980|obesity|obesity
94650|NCT02696980|asthma|asthma
94651|NCT02696967|Heart Failure|heart failure
94652|NCT02696954|Artemether-lumefantrine|artemether-lumefantrine
94653|NCT02696954|Amodiaquine|amodiaquine
94654|NCT02696954|Primaquine|primaquine
94655|NCT02696902|Pseudomonas aeruginosa, Pneumonia|pseudomonas aeruginosa, pneumonia
94656|NCT02696889|Infertility|infertility
94657|NCT02696889|Premature Ovarian Failure|premature ovarian failure
94658|NCT02696889|Stem Cells|stem cells
94659|NCT02696889|Amenorrhea|amenorrhea
94660|NCT02696876|Cartilage|cartilage
94661|NCT02696876|Mesenchymal stromal cell|mesenchymal stromal cell
94662|NCT02696876|Microfracture|microfracture
94663|NCT02696876|Knee|knee
94664|NCT02696876|Defect|defect
94665|NCT02696876|Injury|injury
94666|NCT02696876|Stem cell|stem cell
94667|NCT02696876|Autologous|autologous
94668|NCT02696876|Minimally manipulated|minimally manipulated
94669|NCT02696850|sinusitis|sinusitis
94670|NCT02696850|rhinosinusitis|rhinosinusitis
94671|NCT02696850|rhinitis|rhinitis
94672|NCT02696850|nasal lavage|nasal lavage
94673|NCT02696811|cancer|cancer
94674|NCT02696811|inflammation|inflammation
94675|NCT02696811|dietary intervention trial|dietary intervention trial
94676|NCT02696798|Ankylosing Spondylitis|ankylosing spondylitis
94677|NCT02696785|Ankylosing Spondylitis|ankylosing spondylitis
94678|NCT02696759|Breast|breast
94679|NCT02696759|Cancer|cancer
94680|NCT02696733|TURBT|turbt
94681|NCT02696733|ultrasound guided|ultrasound guided
94682|NCT02696733|ONB|onb
94683|NCT02696733|interadductor approach|interadductor approach
94684|NCT02696720|lidocaine|lidocaine
94685|NCT02696720|phantom limb pain (PLP)|phantom limb pain (plp)
94686|NCT02696720|Primary/secondary scar hyperalgesia|primary/secondary scar hyperalgesia
94687|NCT02696707|cardiac toxicities|cardiac toxicities
94688|NCT02696668|multisensory exercises|multisensory exercises
94689|NCT02696668|group-based balance exercise programme|group-based balance exercise programme
94690|NCT02696655|transplantation|transplantation
94691|NCT02696642|mesothelin-expressing advanced solid cancers|mesothelin-expressing advanced solid cancers
94692|NCT02696629|Ventilatory control|ventilatory control
94693|NCT02696629|Obstructive sleep apnea|obstructive sleep apnea
94694|NCT02696629|Loop gain|loop gain
94695|NCT02696629|Upper airway|upper airway
94696|NCT02696629|Surgery|surgery
94697|NCT02696603|Health app research|health app research
94698|NCT02696603|mHealth research|mhealth research
94699|NCT02696603|Mobile health research|mobile health research
94700|NCT02696603|Mobile application health research|mobile application health research
94701|NCT02696564|COPD|copd
94702|NCT02696564|emphysema|emphysema
94703|NCT02696564|HRCT|hrct
94704|NCT02696564|losartan|losartan
94705|NCT02696551|Medical education|medical education
94706|NCT02696551|Spondyloarthritis|spondyloarthritis
94707|NCT02696551|Physician action|physician action
94708|NCT02696538|Fall risk|fall risk
94709|NCT02696538|Rehabiliation|rehabiliation
94710|NCT02696538|Physical Therapy|physical therapy
94711|NCT02696538|Functional Gait Assessment|functional gait assessment
94712|NCT02696538|mini-Balance Evaluation Systems Test|mini-balance evaluation systems test
94713|NCT02696538|Berg Balance Scale|berg balance scale
94714|NCT02696538|Psychometric properties|psychometric properties
94715|NCT02696538|Validity|validity
94716|NCT02696538|Inter-rater reliability|inter-rater reliability
94717|NCT02696538|Montreal Cognitive Assessment|montreal cognitive assessment
94718|NCT02696525|Circulating Tumor DNA|circulating tumor dna
94719|NCT02696525|Lung cancer|lung cancer
94720|NCT02696525|lead time|lead time
94721|NCT02696512|Severe Disorders of Consciousness (SDOC)|severe disorders of consciousness (sdoc)
94722|NCT02696512|Coma|coma
94723|NCT02696512|Vegetative State|vegetative state
94724|NCT02696512|Minimally Conscious State|minimally conscious state
94725|NCT02696499|Uremic pruritus|uremic pruritus
94726|NCT02696499|Pruritus|pruritus
94727|NCT02696499|Chronic itch|chronic itch
94728|NCT02696499|Itch|itch
94729|NCT02696499|Hemodialysis|hemodialysis
94730|NCT02696499|End-stage renal disease|end-stage renal disease
94731|NCT02696473|Bioavailability|bioavailability
94732|NCT02696473|Polyacetylenes|polyacetylenes
94733|NCT02696473|Falcarinol|falcarinol
94734|NCT02696473|Falcarindiol|falcarindiol
94735|NCT02696473|Falcarindiol-3-acetate|falcarindiol-3-acetate
94736|NCT02696473|Carrot|carrot
94737|NCT02696473|Biological Availability|biological availability
94738|NCT02696460|debridement|debridement
94739|NCT02696460|analgesia|analgesia
94740|NCT02696447|Radiation therapy|radiation therapy
94741|NCT02696447|Thrombosis|thrombosis
94742|NCT02696434|naltrexone|naltrexone
94743|NCT02696434|VIVITROL|vivitrol
94744|NCT02696434|buprenorphine|buprenorphine
94745|NCT02696434|opioid|opioid
94746|NCT02696434|addiction|addiction
94747|NCT02696408|Mucositis|mucositis
94748|NCT02696408|Low level laser therapy|low level laser therapy
94749|NCT02696408|Autograft|autograft
94750|NCT02696408|Allograft|allograft
94751|NCT02696382|Veterans|veterans
94752|NCT02696382|Progressive High Intensity Physical Therapy|progressive high intensity physical therapy
94753|NCT02696382|Gait Speed|gait speed
94754|NCT02696382|Acute Hospitalization|acute hospitalization
94755|NCT02696382|Hospital Associated Deconditioning|hospital associated deconditioning
94756|NCT02696356|HLA-A*02|hla-a*02
94757|NCT02696343|somatosensory stimulation|somatosensory stimulation
94758|NCT02696343|orocutaneous|orocutaneous
94759|NCT02696343|gene expression|gene expression
94760|NCT02696291|Dengue|dengue
94761|NCT02696291|Arbovirus Infections|arbovirus infections
94762|NCT02696291|Flaviviridae Infections|flaviviridae infections
94763|NCT02696291|Flavivirus Infections|flavivirus infections
94764|NCT02696291|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
94765|NCT02696291|RNA Virus Infections|rna virus infections
94766|NCT02696291|Virus Diseases|virus diseases
94767|NCT02696291|Pharmaceutical Solutions|pharmaceutical solutions
94768|NCT02696291|Pharmacologic Actions|pharmacologic actions
94769|NCT02696291|Therapeutic Uses|therapeutic uses
94770|NCT02696278|gut microbiota|gut microbiota
94771|NCT02696278|obesity|obesity
94772|NCT02696278|toddlers|toddlers
94773|NCT02696278|fiber|fiber
94774|NCT02696278|unsaturated fats|unsaturated fats
94775|NCT02696265|Atrial Fibrillation|atrial fibrillation
94776|NCT02696265|Complex Fractionated Atrial Electrocardiograms|complex fractionated atrial electrocardiograms
94777|NCT02696265|Pulmonary Vein Isolation|pulmonary vein isolation
94778|NCT02696265|Ablation|ablation
94779|NCT02696265|CFAE/spatiotemporal dispersion guided ablation|cfae/spatiotemporal dispersion guided ablation
94780|NCT02696252|Endocrine System Diseases|endocrine system diseases
95028|NCT02694640|Peer mentors|peer mentors
94781|NCT02696252|Glucose Metabolism Disorders|glucose metabolism disorders
94782|NCT02696252|Metabolic Diseases|metabolic diseases
94783|NCT02696239|vaginal cuff closure|vaginal cuff closure
94784|NCT02696239|Robotic Hysterectomy|robotic hysterectomy
94785|NCT02696200|Concussion|concussion
94786|NCT02696187|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
94787|NCT02696187|Feasibility|feasibility
94788|NCT02696187|Health promotion tool|health promotion tool
94789|NCT02696187|Self management|self management
94790|NCT02696187|Evidence based care|evidence based care
94791|NCT02696187|Knowledge transfer|knowledge transfer
94792|NCT02696187|Implementation|implementation
94793|NCT02696161|platelet rich plasma|platelet rich plasma
94794|NCT02696161|Perineural injection therapy|perineural injection therapy
94795|NCT02696135|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
94796|NCT02696135|Heart failure|heart failure
94797|NCT02696135|Stroke|stroke
94798|NCT02696122|Pain, postoperative|pain, postoperative
94799|NCT02696122|Hernia, abdominal|hernia, abdominal
94800|NCT02696122|Anesthesia, spinal|anesthesia, spinal
94801|NCT02696122|Anesthesia, local|anesthesia, local
94802|NCT02696122|Anesthesia, general|anesthesia, general
94803|NCT02696122|Quality of life|quality of life
94804|NCT02696122|Anesthesia recovery period|anesthesia recovery period
94805|NCT02696122|Personal satisfaction|personal satisfaction
94806|NCT02696122|Postoperative complications|postoperative complications
94807|NCT02696122|Quality of recovery|quality of recovery
94808|NCT02696109|Transition age youth|transition age youth
94809|NCT02696109|Mental health|mental health
94810|NCT02696109|Mental health services|mental health services
94811|NCT02696109|Engagement|engagement
94812|NCT02696070|Pain|pain
94813|NCT02696070|Diabetic Neuropathy|diabetic neuropathy
94814|NCT02696070|Pulsed Electromagnetic Energy Field|pulsed electromagnetic energy field
94815|NCT02696070|PEMF|pemf
94816|NCT02696070|PPDN|ppdn
94817|NCT02696044|Gastrointestinal Disorders|gastrointestinal disorders
94818|NCT02696031|non-radiographic spondyloarthritis|non-radiographic spondyloarthritis
94819|NCT02696031|axial spondyloarthritis|axial spondyloarthritis
94820|NCT02696018|Diaphragm|diaphragm
94821|NCT02696018|Ultrasound|ultrasound
94822|NCT02696018|Critically ill patients|critically ill patients
94823|NCT02695992|Rate control in atrial fibrillation|rate control in atrial fibrillation
94824|NCT02695992|Beta blockers|beta blockers
94825|NCT02695992|Calcium channel blockers|calcium channel blockers
96613|NCT02685215|prognosis|prognosis
94826|NCT02695992|Permanent atrial fibrillation|permanent atrial fibrillation
94827|NCT02695992|Management of atrial fibrillation|management of atrial fibrillation
94828|NCT02695992|Atrial fibrillation and biomarkers|atrial fibrillation and biomarkers
94829|NCT02695992|Arrhythmias, cardiac|arrhythmias, cardiac
94830|NCT02695992|Heart Diseases|heart diseases
94831|NCT02695992|Pathological processes|pathological processes
94832|NCT02695992|Diltiazem|diltiazem
94836|NCT02695992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists
94837|NCT02695992|Adrenergic beta-Antagonists|adrenergic beta-antagonists
94838|NCT02695992|Anti-Arrhythmia Agents|anti-arrhythmia agents
94839|NCT02695992|Antihypertensive Agents|antihypertensive agents
94840|NCT02695992|Autonomic Agents|autonomic agents
94841|NCT02695992|Cardiovascular Agents|cardiovascular agents
94842|NCT02695992|Membrane Transport Modulators|membrane transport modulators
94843|NCT02695992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
94844|NCT02695992|Neurotransmitter Agents|neurotransmitter agents
94845|NCT02695992|Peripheral Nervous System Agents|peripheral nervous system agents
94846|NCT02695992|Physiological Effects of Drugs|physiological effects of drugs
94847|NCT02695992|Sympatholytics|sympatholytics
94848|NCT02695992|Therapeutic Uses|therapeutic uses
94849|NCT02695992|Vasodilator Agents|vasodilator agents
94850|NCT02695992|Troponins|troponins
94851|NCT02695992|NT-proBNP|nt-probnp
94852|NCT02695992|Biomarkers|biomarkers
94854|NCT02695953|biomarker|biomarker
94855|NCT02695953|Cognitive Processing Therapy|cognitive processing therapy
94856|NCT02695914|Inflammatory markers|inflammatory markers
94857|NCT02695901|Plaque index|plaque index
94858|NCT02695901|Melaleuca alternifolia oil.|melaleuca alternifolia oil.
94859|NCT02695901|Nanoparticles|nanoparticles
94860|NCT02695875|Fibromyalgia|fibromyalgia
94861|NCT02695875|Pain|pain
94862|NCT02695875|Postural balance|postural balance
94863|NCT02695875|Physical therapy|physical therapy
94864|NCT02695875|Aquatic therapy|aquatic therapy
94865|NCT02695849|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
94866|NCT02695836|Audit and Feedback|audit and feedback
94867|NCT02695836|Nursing Homes|nursing homes
94868|NCT02695836|Organizational Context|organizational context
94869|NCT02695836|Quality Improvement|quality improvement
94870|NCT02695836|Care Aides|care aides
94871|NCT02695836|Leadership|leadership
638047|NCT00733083|pre-emptive|pre-emptive
94872|NCT02695836|Resident Assessment Instrument (RAI)|resident assessment instrument (rai)
94972|NCT02694991|pain|pain
94873|NCT02695836|Alberta Context Tool (ACT)|alberta context tool (act)
94874|NCT02695823|intracranial hypertension|intracranial hypertension
94875|NCT02695823|liver transplantation|liver transplantation
94876|NCT02695823|transcranial Doppler|transcranial doppler
94877|NCT02695823|optic nerve sheath diameter|optic nerve sheath diameter
94878|NCT02695797|Intractable cryptogenic epilepsy with autoimmune antibody|intractable cryptogenic epilepsy with autoimmune antibody
94879|NCT02695797|Immunotherapy|immunotherapy
94880|NCT02695771|bladder tumors|bladder tumors
94881|NCT02695771|urinary tumors|urinary tumors
94882|NCT02695771|non-muscle invasive bladder tumors|non-muscle invasive bladder tumors
94883|NCT02695771|NMIBC|nmibc
94884|NCT02695732|Esophageal and Gastric Varices|esophageal and gastric varices
94885|NCT02695732|Primary Prophylaxis|primary prophylaxis
94886|NCT02695732|Carvedilol|carvedilol
94887|NCT02695732|Endoscopy|endoscopy
94888|NCT02695719|Drug therapy|drug therapy
94889|NCT02695706|Diabetes|diabetes
94890|NCT02695706|Skin acceptability|skin acceptability
94891|NCT02695706|Clinical Research|clinical research
94892|NCT02695680|Lung Cancer|lung cancer
94893|NCT02695680|SBRT|sbrt
94894|NCT02695680|Motion Management|motion management
94895|NCT02695641|Arteriovenous Fistula|arteriovenous fistula
94896|NCT02695641|Arteriovenous Graft|arteriovenous graft
94897|NCT02695641|Bevacizumab|bevacizumab
94898|NCT02695641|Hemodialysis|hemodialysis
94899|NCT02695641|VEGF|vegf
94900|NCT02695641|Avastin|avastin
94901|NCT02695615|cesarean operation|cesarean operation
94902|NCT02695615|Spielberger State Trait Anxiety Inventory|spielberger state trait anxiety inventory
94903|NCT02695615|pain|pain
94904|NCT02695563|Amniocentesis|amniocentesis
94905|NCT02695524|Rehabilitation|rehabilitation
94906|NCT02695524|Shoulder|shoulder
94907|NCT02695498|migraine with aura|migraine with aura
94908|NCT02695498|migraine without aura|migraine without aura
94909|NCT02695498|pain|pain
86228|NCT02748889|MPDL3280A|mpdl3280a
86229|NCT02748889|atezolizumab|atezolizumab
86230|NCT02748863|psoriasis|psoriasis
86231|NCT02748863|secukinumab|secukinumab
86232|NCT02748863|pre-filled syringes|pre-filled syringes
86233|NCT02748850|apheresis patients|apheresis patients
86235|NCT02748811|elderly|elderly
94910|NCT02695498|controls|controls
94911|NCT02695498|mind-body|mind-body
94912|NCT02695485|dorsal digital island flap|dorsal digital island flap
94913|NCT02695485|sensory reconstruction|sensory reconstruction
94914|NCT02695472|Depression|depression
94915|NCT02695472|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
97150|NCT02682134|Intubation|intubation
94916|NCT02695472|Major Depressive Disorder|major depressive disorder
94917|NCT02695472|Neurogenesis|neurogenesis
94918|NCT02695472|Synaptogenesis|synaptogenesis
94919|NCT02695472|NSI-189|nsi-189
94920|NCT02695472|Neuralstem|neuralstem
94921|NCT02695433|Pre-diabetes|pre-diabetes
94922|NCT02695433|Metabolic syndrome|metabolic syndrome
96195|NCT02688205|Resisted test|resisted test
94923|NCT02695433|Matsuda composite index of insulin sensitivity (MISI)|matsuda composite index of insulin sensitivity (misi)
94924|NCT02695433|Blood glucose|blood glucose
94925|NCT02695433|Insulin response|insulin response
94926|NCT02695433|HbA1c|hba1c
94927|NCT02695433|Lipid|lipid
94928|NCT02695433|Inflammation|inflammation
94929|NCT02695420|Heart Failure|heart failure
94930|NCT02695407|artery cannulation|artery cannulation
94931|NCT02695407|haemodynamic monitoring|haemodynamic monitoring
94932|NCT02695342|Balance|balance
94933|NCT02695342|Falls|falls
94934|NCT02695342|Exercise|exercise
94935|NCT02695342|COPD|copd
94936|NCT02695329|navigation system|navigation system
94937|NCT02695329|palm-sized|palm-sized
94938|NCT02695329|total knee arthroplasty|total knee arthroplasty
94939|NCT02695316|Migrants|migrants
94940|NCT02695316|Communication Barriers|communication barriers
94941|NCT02695316|Maternal Health Services|maternal health services
94942|NCT02695316|Health Services Needs and Demand|health services needs and demand
94943|NCT02695316|Access to Health Care|access to health care
94944|NCT02695316|Professional-Patient Relations|professional-patient relations
94945|NCT02695316|Eritrea|eritrea
94946|NCT02695316|Kosovo|kosovo
94947|NCT02695316|Switzerland|switzerland
94948|NCT02695277|Atrial Fibrillation|atrial fibrillation
94949|NCT02695277|Persistent and Longstanding Persistent AF|persistent and longstanding persistent af
94950|NCT02695277|Hybrid Procedure|hybrid procedure
94951|NCT02695277|Catheter Ablation|catheter ablation
94952|NCT02695264|intracranial pressure|intracranial pressure
94953|NCT02695264|intracranial hypertension|intracranial hypertension
94954|NCT02695264|severe traumatic brain injury|severe traumatic brain injury
94955|NCT02695199|Doppler Ultrasound|doppler ultrasound
94956|NCT02695199|Laparoscopic|laparoscopic
94957|NCT02695199|Microscopic Subinguinal Varicocelectomy|microscopic subinguinal varicocelectomy
94958|NCT02695186|Intestinal metaplasia|intestinal metaplasia
94959|NCT02695186|Metabolic syndrome|metabolic syndrome
94960|NCT02695186|Oxidative stress|oxidative stress
94961|NCT02695108|Scapula|scapula
94962|NCT02695108|Neck|neck
94963|NCT02695108|Pain|pain
94964|NCT02695108|Therapy|therapy
94965|NCT02695108|Kinematic|kinematic
94966|NCT02695069|Complete Placenta Previa|complete placenta previa
638048|NCT00733083|oxycodone|oxycodone
94967|NCT02695069|Random Placenta Margin Incision|random placenta margin incision
94968|NCT02695069|Cesarean Section|cesarean section
94969|NCT02695069|Hemorrhage|hemorrhage
94970|NCT02694991|surgery|surgery
94971|NCT02694991|outcome|outcome
94973|NCT02694991|osteopathic manipulative treatment|osteopathic manipulative treatment
94974|NCT02694978|iron deficiency anemia|iron deficiency anemia
94975|NCT02694978|IDA|ida
94976|NCT02694978|ferumoxytol|ferumoxytol
94977|NCT02694978|ferric carboxymaltose|ferric carboxymaltose
94978|NCT02694978|FCM|fcm
94979|NCT02694978|Injectafer|injectafer
94980|NCT02694926|adrenal crisis|adrenal crisis
94981|NCT02694926|education programme|education programme
94982|NCT02694887|Capillary blood|capillary blood
94983|NCT02694887|Venous blood|venous blood
94984|NCT02694887|Lactate|lactate
94985|NCT02694887|Emergency Department|emergency department
94986|NCT02694874|Adjunctive treatment|adjunctive treatment
94987|NCT02694874|Severe malaria|severe malaria
94988|NCT02694861|Angina Pectoris|angina pectoris
94989|NCT02694861|Angina, Stable|angina, stable
94990|NCT02694861|Chest Pain|chest pain
94991|NCT02693795|myocardial infarction|myocardial infarction
94992|NCT02693795|left ventricular remodeling|left ventricular remodeling
94993|NCT02693782|Fibre|fibre
94994|NCT02693782|Wheat Bran Extract|wheat bran extract
94995|NCT02693782|Microbiota|microbiota
94996|NCT02693782|Microbiota metabolites|microbiota metabolites
94997|NCT02693782|Gastrointestinal tolerance|gastrointestinal tolerance
94998|NCT02693743|suicidality|suicidality
94999|NCT02693743|rTMS|rtms
95000|NCT02693743|suicide ideation|suicide ideation
95001|NCT02694796|Web and smartphone-based physical activity program|web and smartphone-based physical activity program
95002|NCT02694796|Connected devices|connected devices
95003|NCT02694796|Balneotherapy|balneotherapy
95004|NCT02694783|JC VIRUS|jc virus
95005|NCT02694783|Progressive Multifocal Encephalopathy (PML)|progressive multifocal encephalopathy (pml)
95006|NCT02694770|aGvHD|agvhd
95007|NCT02694770|GvHD|gvhd
95008|NCT02694770|sr-aGvHD|sr-agvhd
95009|NCT02694770|biologics|biologics
95010|NCT02694770|monoclonal antibody|monoclonal antibody
95011|NCT02694757|Ostom-i|ostom-i
95012|NCT02694757|OIA device|oia device
95013|NCT02694744|Treatment of Hyperkalemia|treatment of hyperkalemia
95014|NCT02694744|Hyperkalemia|hyperkalemia
95015|NCT02694744|Potassium|potassium
95016|NCT02694744|Chronic Kidney Disease|chronic kidney disease
95017|NCT02694731|Craving|craving
95018|NCT02694731|Mobile Apps|mobile apps
95019|NCT02694705|Oxygen Inhalation Therapy|oxygen inhalation therapy
95020|NCT02694705|Intubation|intubation
95021|NCT02694705|Emergency Medicine|emergency medicine
95022|NCT02694679|social networks, maternal and child health, global health|social networks, maternal and child health, global health
95023|NCT02694653|C/section, Acetaminophen|c/section, acetaminophen
95024|NCT02694640|Breast cancer|breast cancer
95025|NCT02694640|Exercise|exercise
95026|NCT02694640|Physical activity|physical activity
95027|NCT02694640|Community volunteers|community volunteers
95029|NCT02694640|Peer coaches|peer coaches
95030|NCT02694640|Social support|social support
95031|NCT02694640|Exercise maintenance|exercise maintenance
95032|NCT02694627|gender, caregiving, MNCH, violence, sexual and reproductive health, parenting|gender, caregiving, mnch, violence, sexual and reproductive health, parenting
95033|NCT02694614|weight loss|weight loss
95034|NCT02694614|individualised dietary coaching|individualised dietary coaching
95035|NCT02694614|smartphone-assisted dietary coaching|smartphone-assisted dietary coaching
95036|NCT02694614|health behavior change|health behavior change
95037|NCT02694588|Vedolizumab|vedolizumab
95038|NCT02694588|Infliximab|infliximab
95039|NCT02694562|Metastatic Colorectal Carcinoma|metastatic colorectal carcinoma
95040|NCT02694549|Vascular Closure Devices|vascular closure devices
95041|NCT02694549|Catheterization Closure Devices|catheterization closure devices
95042|NCT02694549|Vascular Access Devices|vascular access devices
95043|NCT02694523|Psoriasis|psoriasis
95044|NCT02694523|Skin Diseases|skin diseases
95045|NCT02694523|Skin Diseases, Papulosquamous|skin diseases, papulosquamous
95046|NCT02694523|Adalimumab|adalimumab
95047|NCT02694523|Anti-Inflammatory Agents|anti-inflammatory agents
95048|NCT02694523|ABBV-066|abbv-066
95049|NCT02694523|BI 655066|bi 655066
95050|NCT02694523|Risankizumab|risankizumab
95051|NCT02694510|Preterm infants|preterm infants
95052|NCT02694510|Oxidative stress|oxidative stress
95053|NCT02694510|Parenteral nutrition|parenteral nutrition
95054|NCT02694497|transmission|transmission
95055|NCT02694497|women|women
95056|NCT02694497|genital|genital
95057|NCT02694497|anorectal|anorectal
95058|NCT02694484|Cytomegalovirus|cytomegalovirus
95059|NCT02694484|Stool sample|stool sample
95060|NCT02694484|Healthy Volunteers|healthy volunteers
95061|NCT02694484|Fecal microbiota transplant|fecal microbiota transplant
95062|NCT02694471|Ageing|ageing
95063|NCT02694471|Physical inactivity|physical inactivity
95064|NCT02694471|Functional decline|functional decline
95065|NCT02694471|Reconditioning|reconditioning
95066|NCT02694458|Vancomycin|vancomycin
95067|NCT02694458|Children|children
95068|NCT02694458|Infection|infection
95069|NCT02694458|Antibiotic|antibiotic
95070|NCT02694458|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
95170|NCT02693873|Exercise, Neuromuscular|exercise, neuromuscular
95071|NCT02694458|Population-based pharmacokinetic modeling|population-based pharmacokinetic modeling
95072|NCT02694458|Pharmacokinetics|pharmacokinetics
95073|NCT02694458|Pharmacodynamics|pharmacodynamics
95074|NCT02694458|Bayesian approach|bayesian approach
95075|NCT02694458|Therapeutic drug monitoring|therapeutic drug monitoring
95076|NCT02694432|high blood pressure, systolic, diastolic|high blood pressure, systolic, diastolic
95077|NCT02694432|complementary therapies, meditation|complementary therapies, meditation
95078|NCT02694419|endometrium|endometrium
95079|NCT02694406|Diagnosis|diagnosis
95080|NCT02694367|genetic basis|genetic basis
95081|NCT02694341|Management|management
95082|NCT02694328|Alkermes|alkermes
95083|NCT02694328|ALKS 3831|alks 3831
95084|NCT02694328|Samidorphan|samidorphan
95085|NCT02694328|Schizophrenia|schizophrenia
95086|NCT02694328|Olanzapine|olanzapine
95087|NCT02694328|Weight|weight
95088|NCT02694302|Stroke|stroke
95089|NCT02694250|cervical|cervical
95090|NCT02694250|fusion|fusion
95091|NCT02694250|radiculopathy|radiculopathy
95092|NCT02694250|DTRAX|dtrax
95093|NCT02694224|breast cancer|breast cancer
95094|NCT02694224|triple negative|triple negative
95095|NCT02694224|neoadjuvant|neoadjuvant
95096|NCT02694211|work related stress|work related stress
95097|NCT02694185|Medication Adherence|medication adherence
95098|NCT02694185|Randomized Controlled Trial|randomized controlled trial
95099|NCT02694185|Veterans|veterans
95100|NCT02694172|diabetes mellitus type 2|diabetes mellitus type 2
95101|NCT02694172|healthy subjects|healthy subjects
95102|NCT02694172|human microbiome|human microbiome
95103|NCT02694172|cereal bar|cereal bar
95104|NCT02694146|platelet-rich plasma (PRP)|platelet-rich plasma (prp)
95105|NCT02694146|hyaluronic acid (Hylan G-F 20).|hyaluronic acid (hylan g-f 20).
95106|NCT02694146|NSAIDs|nsaids
95107|NCT02694146|WOMAC|womac
95108|NCT02694133|telerehabilitation|telerehabilitation
95109|NCT02694133|aphasia|aphasia
95110|NCT02694133|speech therapy|speech therapy
95111|NCT02694133|rehabilitation device|rehabilitation device
95112|NCT02694133|visual action therapy|visual action therapy
95113|NCT02694133|naming drills|naming drills
95114|NCT02694094|cholesterol|cholesterol
95115|NCT02694094|seizure|seizure
95116|NCT02694094|epilepsy|epilepsy
95117|NCT02694094|ketogenic|ketogenic
95118|NCT02694094|diet|diet
95119|NCT02694081|reflux|reflux
95120|NCT02694081|residue|residue
95121|NCT02694081|Gastric stasis|gastric stasis
95122|NCT02694081|Emptying time|emptying time
95124|NCT02694068|Genetic|genetic
95125|NCT02694068|Peritoneal Membrane|peritoneal membrane
95126|NCT02694068|Peritoneal Equilibrium Test|peritoneal equilibrium test
95127|NCT02694068|Ultrafiltration Capacity|ultrafiltration capacity
95128|NCT02694068|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
95129|NCT02694055|Community Health Workers|community health workers
95130|NCT02694055|Community Case Management|community case management
95131|NCT02694055|Proactive Case Detection|proactive case detection
95132|NCT02694055|Under-five Child Mortality|under-five child mortality
95133|NCT02694055|Access to Health Care|access to health care
95134|NCT02694042|Pediatric inflammatory bowel disease|pediatric inflammatory bowel disease
95135|NCT02694042|Crohn's disease|crohn's disease
95136|NCT02694042|Ulcerative colitis|ulcerative colitis
95137|NCT02694042|Web-based teaching and support|web-based teaching and support
95138|NCT02694042|disease self-management|disease self-management
95139|NCT02694042|peer support|peer support
95140|NCT02694016|Remote ischemic preconditioning|remote ischemic preconditioning
95141|NCT02694016|Neuroprotection|neuroprotection
95142|NCT02694003|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
95143|NCT02694003|Fetal Alcohol Spectrum Disorder (FASD)|fetal alcohol spectrum disorder (fasd)
95144|NCT02694003|Cerebral Palsy (CP)|cerebral palsy (cp)
95145|NCT02694003|Attention-Deficit/Hyperactivity Disorder (ADHD)|attention-deficit/hyperactivity disorder (adhd)
95146|NCT02694003|Behavioural Insomnia|behavioural insomnia
95147|NCT02694003|Neurodevelopmental Disorders|neurodevelopmental disorders
95148|NCT02693990|Tumor lining the brain|tumor lining the brain
95149|NCT02693990|Meningioma|meningioma
95150|NCT02693990|Brain Tumor|brain tumor
95151|NCT02693977|OSA|osa
95152|NCT02693977|sleep apnea|sleep apnea
95153|NCT02693977|AT|at
95154|NCT02693977|adenotonsillectomy|adenotonsillectomy
95155|NCT02693977|pediatric|pediatric
95156|NCT02693964|Type 1 Diabetes|type 1 diabetes
95157|NCT02693964|Menopause|menopause
95158|NCT02693964|Cardiovascular Risk|cardiovascular risk
95159|NCT02693964|Bone Density|bone density
95160|NCT02693951|gastric varices|gastric varices
95161|NCT02693951|endoscopic injection of tissue adhesive|endoscopic injection of tissue adhesive
95162|NCT02693938|diabetes|diabetes
95163|NCT02693938|menstrual cycle|menstrual cycle
95164|NCT02693938|insulin|insulin
95165|NCT02693912|efferocytosis|efferocytosis
95166|NCT02693912|macrophage|macrophage
95167|NCT02693873|Osteoarthritis, Hip|osteoarthritis, hip
95168|NCT02693873|Osteoarthritis, Knee|osteoarthritis, knee
95169|NCT02693873|Patient Education|patient education
95190|NCT02693808|Lateral orbital wall decompression|lateral orbital wall decompression
95191|NCT02693808|Thyroid eye disease|thyroid eye disease
95192|NCT02693730|Irritable Bowel Syndrome|irritable bowel syndrome
95193|NCT02693730|IBS|ibs
95194|NCT02693730|Ulcerative Colitis|ulcerative colitis
95195|NCT02693730|UC|uc
95196|NCT02693730|Inflammatory Bowel Disease|inflammatory bowel disease
95197|NCT02693730|IBD|ibd
95198|NCT02693730|Healthy Control|healthy control
95199|NCT02693730|HC|hc
95200|NCT02693730|Visceral Pain|visceral pain
95201|NCT02693730|Gut|gut
95202|NCT02693730|Neuroimaging|neuroimaging
95203|NCT02693730|fMRI|fmri
95204|NCT02693730|resting state|resting state
95205|NCT02693730|structural MRI|structural mri
95206|NCT02693730|functional MRI|functional mri
95207|NCT02693730|diffusion tensor imaging|diffusion tensor imaging
95208|NCT02693730|MR Spectroscopy|mr spectroscopy
95209|NCT02693717|Cancer of urethra|cancer of urethra
95210|NCT02693717|Cancer of ureters|cancer of ureters
86560|NCT02746523|NHL|nhl
95211|NCT02693717|MTAP-deficient bladder cancer|mtap-deficient bladder cancer
95212|NCT02693717|MTAP wild-type bladder cancer|mtap wild-type bladder cancer
95213|NCT02693717|Metastatic|metastatic
95214|NCT02693717|Pemetrexed|pemetrexed
95215|NCT02693717|LY231514|ly231514
95216|NCT02693717|Alimta|alimta
95217|NCT02693717|MTA|mta
95218|NCT02693717|Multitargeted Antifolate|multitargeted antifolate
95219|NCT02693717|NSC-698037|nsc-698037
95220|NCT02693717|Folic Acid|folic acid
95221|NCT02693717|Folinic Acid|folinic acid
95222|NCT02693717|Vitamin B12|vitamin b12
95223|NCT02693717|Dexamethasone|dexamethasone
95224|NCT02693717|Decadron|decadron
95225|NCT02693678|Proprioception|proprioception
95226|NCT02693678|Doms|doms
95227|NCT02693678|Pain|pain
95228|NCT02693678|Massage|massage
95229|NCT02693678|Diathermy|diathermy
95248|NCT02693639|PANX1|panx1
95249|NCT02693639|Infection|infection
95250|NCT02693639|Liver transplantation|liver transplantation
95251|NCT02693626|mobile phone-based text message interventions|mobile phone-based text message interventions
95252|NCT02693626|'Happy Quit'|'happy quit'
95253|NCT02693626|smoking cessation|smoking cessation
95254|NCT02693613|Drug-drug interaction|drug-drug interaction
95255|NCT02693613|Kremezin|kremezin
95256|NCT02693613|Pharmacokinetics|pharmacokinetics
95257|NCT02693613|ASP1517|asp1517
95258|NCT02693600|Total Trapeziectomy|total trapeziectomy
95259|NCT02693600|Partial Trapeziectomy|partial trapeziectomy
95260|NCT02693600|Ligamentoplasty|ligamentoplasty
95261|NCT02693574|Helicobacter pylori|helicobacter pylori
95262|NCT02693574|Helicobacter Infections|helicobacter infections
95263|NCT02693574|Proton Pump Inhibitors|proton pump inhibitors
95264|NCT02693561|Self-help book|self-help book
95265|NCT02693561|Deep breathing|deep breathing
95266|NCT02693548|Familial Hypercholesterolaemia|familial hypercholesterolaemia
95267|NCT02693548|Prognosis|prognosis
95268|NCT02693548|Cardiovascular disease|cardiovascular disease
95269|NCT02693535|cancer|cancer
95270|NCT02693535|off-label|off-label
95271|NCT02693535|precision medicine|precision medicine
95272|NCT02693535|targeted therapy|targeted therapy
95273|NCT02693496|ResearchKit|researchkit
95274|NCT02693496|CT screening|ct screening
95379|NCT02692781|Obesity|obesity
95275|NCT02693496|Early Diagnosis|early diagnosis
95276|NCT02693496|Lung Cancer|lung cancer
95277|NCT02693392|Fenugreek seed extract|fenugreek seed extract
95278|NCT02693392|HbA1c|hba1c
95279|NCT02693392|Blood glucose|blood glucose
95280|NCT02693379|cervical cancer|cervical cancer
95283|NCT02693379|screening|screening
95284|NCT02693379|smartphone|smartphone
95285|NCT02693379|telemedicine|telemedicine
95286|NCT02693366|bone marrow cells, stem cells, cell therapy|bone marrow cells, stem cells, cell therapy
95287|NCT02693366|Glomerulosclerosis, Focal Segmental|glomerulosclerosis, focal segmental
95288|NCT02693366|Renal Insufficiency, Chronic|renal insufficiency, chronic
95289|NCT02693327|Gut Microbiome|gut microbiome
95290|NCT02693327|Mental Disorder|mental disorder
95291|NCT02693327|Dysbiosis|dysbiosis
95292|NCT02693314|Jarro-Dophilus|jarro-dophilus
95293|NCT02693314|probiotic|probiotic
95294|NCT02693314|microbiota|microbiota
95295|NCT02693314|gastrointestinal|gastrointestinal
95296|NCT02693301|Asthma|asthma
95297|NCT02693301|Respiratory symptoms|respiratory symptoms
95298|NCT02693301|Exercise program|exercise program
95299|NCT02693301|Functional capacity|functional capacity
95300|NCT02693301|Body composition|body composition
95301|NCT02693288|Wrist fracture|wrist fracture
95302|NCT02693288|postoperative pain|postoperative pain
95303|NCT02693288|local anesthesia|local anesthesia
95304|NCT02693275|Community Sampling|community sampling
95305|NCT02693262|defibrillator|defibrillator
95306|NCT02693262|heart failure|heart failure
95307|NCT02693262|ICD|icd
95308|NCT02693262|CRT-D|crt-d
95309|NCT02693262|cardiac resynchronization therapy|cardiac resynchronization therapy
95310|NCT02693262|rate response|rate response
95311|NCT02693262|CLS|cls
95312|NCT02693262|closed-loop stimulation|closed-loop stimulation
95313|NCT02693262|accelerometer|accelerometer
95314|NCT02693262|chronotropic incompetence|chronotropic incompetence
95315|NCT02693249|accidents|accidents
95316|NCT02693249|adolescents|adolescents
95317|NCT02693249|children|children
95318|NCT02693249|posttraumatic cognitions|posttraumatic cognitions
95319|NCT02693223|stroke|stroke
95320|NCT02693197|Hepatic Impairment|hepatic impairment
95321|NCT02693145|HIV/AIDS|hiv/aids
95322|NCT02693145|re-engagement in care|re-engagement in care
95323|NCT02693145|data to care|data to care
95324|NCT02693132|Obesity|obesity
95325|NCT02693132|Exercise|exercise
95326|NCT02693119|LHON|lhon
95327|NCT02693119|Ocuvia™|ocuvia™
95328|NCT02693119|elamipretide|elamipretide
95329|NCT02693119|MTP-131|mtp-131
95330|NCT02693041|Probiotics|probiotics
95331|NCT02693041|inflammation|inflammation
95332|NCT02693041|immunological response|immunological response
95333|NCT02693041|preterm birth|preterm birth
95334|NCT02693041|preeclampsia|preeclampsia
95335|NCT02693028|Microbiome|microbiome
95336|NCT02693028|probiotic|probiotic
95337|NCT02692976|Castration-resistant prostate cancer|castration-resistant prostate cancer
95338|NCT02692976|Dendritic Cells|dendritic cells
95339|NCT02692976|Immunotherapy|immunotherapy
95340|NCT02692976|Vaccines|vaccines
95341|NCT02692937|Neurosurgical Procedures|neurosurgical procedures
95342|NCT02692937|Nerve Block|nerve block
95343|NCT02692937|Exercise therapy|exercise therapy
95344|NCT02692937|Physical Therapy Specialty|physical therapy specialty
95345|NCT02692924|Pregnancy Complications|pregnancy complications
95346|NCT02692924|Ultrasound|ultrasound
95347|NCT02692911|Gallbaldder|gallbaldder
95348|NCT02692911|Cancer|cancer
95349|NCT02692911|Gallstones|gallstones
95350|NCT02692911|Cholecystectomy|cholecystectomy
95351|NCT02692911|Inflammation|inflammation
95352|NCT02692898|Brain Tumor|brain tumor
95353|NCT02692898|Molecular Pathology|molecular pathology
95354|NCT02692898|Clinical Data|clinical data
95355|NCT02692898|Imaging Data|imaging data
95356|NCT02692885|Phenotype|phenotype
95357|NCT02692885|Adipose Tissue|adipose tissue
95358|NCT02692885|Brown Adipose Tissue|brown adipose tissue
95359|NCT02692872|Alpha Thalassemia|alpha thalassemia
95360|NCT02692872|Double Deletion|double deletion
95361|NCT02692846|CONNECTIVE TISSUE DISEASES|connective tissue diseases
95362|NCT02692846|Cardiovascular Disease|cardiovascular disease
96643|NCT02685098|BKA|bka
95363|NCT02692846|Elastin Gene Mutation|elastin gene mutation
95364|NCT02692846|Multisystem Developmental Disorder|multisystem developmental disorder
95365|NCT02692833|Telomere|telomere
95366|NCT02692833|Telomerase|telomerase
95367|NCT02692833|DNA methylation|dna methylation
95368|NCT02692833|Cell aging|cell aging
95369|NCT02692833|Thoracic Surgery|thoracic surgery
95370|NCT02692820|Preterm|preterm
95371|NCT02692820|Probiotic|probiotic
95372|NCT02692807|hip arthroscopy|hip arthroscopy
95373|NCT02692807|femoroacetabular impingement|femoroacetabular impingement
95374|NCT02692807|exercise therapy after hip arthroscopy|exercise therapy after hip arthroscopy
95375|NCT02692807|rehabilitation after hip arthroscopy|rehabilitation after hip arthroscopy
95376|NCT02692794|sinusitis|sinusitis
95377|NCT02692794|oximetry|oximetry
95378|NCT02692794|paranasal sinus diseases|paranasal sinus diseases
95380|NCT02692768|total shoulder arthroplasty|total shoulder arthroplasty
95381|NCT02692768|total shoulder replacement|total shoulder replacement
95382|NCT02692768|adult|adult
95383|NCT02692768|reverse shoulder arthroplasty|reverse shoulder arthroplasty
95384|NCT02692755|African American|african american
95385|NCT02692742|Chemotherapy|chemotherapy
95386|NCT02692742|Chemotherapy-induced Neutropenia|chemotherapy-induced neutropenia
95387|NCT02692742|Supportive Care|supportive care
95388|NCT02692742|Myelosuppression|myelosuppression
95389|NCT02692742|CIN|cin
95390|NCT02692703|HCV Treatment Experienced|hcv treatment experienced
95391|NCT02692703|Hepatitis C|hepatitis c
95392|NCT02692703|HCV Genotype 3|hcv genotype 3
95393|NCT02692703|Without cirrhosis|without cirrhosis
95394|NCT02692703|Non-cirrhotic|non-cirrhotic
95395|NCT02692703|HCV Genotype 2|hcv genotype 2
95396|NCT02692703|Renal Transplant|renal transplant
95397|NCT02692703|HCV Treatment Naive|hcv treatment naive
95398|NCT02692703|Post transplant|post transplant
95399|NCT02692703|HCV Genotype 6|hcv genotype 6
95400|NCT02692703|Liver Transplant|liver transplant
95401|NCT02692703|HCV Genotype 5|hcv genotype 5
95402|NCT02692703|HCV Genotype 4|hcv genotype 4
95403|NCT02692703|Kidney Transplant|kidney transplant
95404|NCT02692703|HCV Genotype 1|hcv genotype 1
95405|NCT02692677|Healthy|healthy
95406|NCT02692677|JNJ-42756493|jnj-42756493
95407|NCT02692664|iliac side branch|iliac side branch
95408|NCT02692651|vancomycin|vancomycin
95409|NCT02692651|fidaxomicin|fidaxomicin
95411|NCT02692651|diarrhea|diarrhea
95412|NCT02692599|live attenuated mumps vaccine|live attenuated mumps vaccine
95413|NCT02692599|safety|safety
95414|NCT02692599|immunogenicity|immunogenicity
95415|NCT02692599|infant|infant
95416|NCT02692586|Thromboembolism|thromboembolism
95417|NCT02692586|Thrombectomy|thrombectomy
95418|NCT02692586|Right Heart Strain|right heart strain
95419|NCT02692586|Submassive PE|submassive pe
95420|NCT02692586|Right Ventricle Dysfunction|right ventricle dysfunction
95421|NCT02692586|Massive PE|massive pe
95422|NCT02692560|Sedentary time|sedentary time
95423|NCT02692560|Sit-to-stand transitions|sit-to-stand transitions
95424|NCT02692534|Anesthesia|anesthesia
95425|NCT02692534|Cocaine Use|cocaine use
95426|NCT02692508|cardiovascular MRI|cardiovascular mri
95427|NCT02692508|apical hypertrophic cardiomyopathy|apical hypertrophic cardiomyopathy
95428|NCT02692508|giant negative T-wave|giant negative t-wave
95429|NCT02692508|wall thickness|wall thickness
95430|NCT02692508|Nuclear Magnetic Resonance|nuclear magnetic resonance
95431|NCT02692508|Early Diagnosis|early diagnosis
95432|NCT02692508|Prognosis|prognosis
95433|NCT02692495|body odor|body odor
95434|NCT02692495|halitosis|halitosis
95435|NCT02692495|dysbiosis|dysbiosis
95436|NCT02692495|leaky gut|leaky gut
95437|NCT02692495|microbiome|microbiome
95438|NCT02692469|Bariatric Surgery, Obesity, Laparoscopy|bariatric surgery, obesity, laparoscopy
95439|NCT02692443|Congenital Heart Disease|congenital heart disease
95440|NCT02692443|Magnetic Brain Resonance|magnetic brain resonance
95441|NCT02692443|CHD|chd
95442|NCT02692443|MRI|mri
95443|NCT02692443|Neurodevelopmental|neurodevelopmental
95444|NCT02692430|Portosystemic Shunt|portosystemic shunt
95445|NCT02692430|Hepatic encephalopathy|hepatic encephalopathy
95446|NCT02692430|Portal hypertension|portal hypertension
95447|NCT02692430|Liver cirrhosis|liver cirrhosis
95448|NCT02692417|hypoactive desire disorder|hypoactive desire disorder
95449|NCT02692417|female sexual dysfunction|female sexual dysfunction
95450|NCT02692417|genital arousal disorder|genital arousal disorder
95451|NCT02692417|sexual|sexual
95452|NCT02692417|dysfunction|dysfunction
95453|NCT02692417|female|female
95454|NCT02692417|arousal|arousal
95455|NCT02692417|electrical stimulation|electrical stimulation
95456|NCT02692417|transcutaneous electrical stimulation|transcutaneous electrical stimulation
95457|NCT02692417|women|women
95458|NCT02692404|Postpartum Depression|postpartum depression
95459|NCT02692404|Perinatal Depression|perinatal depression
95460|NCT02692404|Pregnancy|pregnancy
95461|NCT02692404|Anesthesia|anesthesia
95462|NCT02692404|Obstetric|obstetric
95463|NCT02692404|Pain|pain
95464|NCT02692404|Analgesia|analgesia
95465|NCT02692404|Epidural|epidural
95467|NCT02692404|Infant Development|infant development
95468|NCT02692404|Pain Management|pain management
95469|NCT02692391|Acute pancreatitis|acute pancreatitis
95470|NCT02692391|Indomethacin|indomethacin
95471|NCT02692391|Organ failure|organ failure
95472|NCT02692391|Prevention|prevention
95473|NCT02692378|Haemodialysis|haemodialysis
95474|NCT02692378|sodium bicarbonate|sodium bicarbonate
95475|NCT02692378|potassium|potassium
95476|NCT02692378|arrhythmia|arrhythmia
95477|NCT02692378|muscle|muscle
95478|NCT02692378|symptoms|symptoms
95479|NCT02692339|Relapsed Multiple Myeloma|relapsed multiple myeloma
95480|NCT02692339|Refractory Multiple Myeloma|refractory multiple myeloma
95481|NCT02692339|Lenalidomide|lenalidomide
95482|NCT02692339|Dexamethasone|dexamethasone
95483|NCT02692339|Observational Study|observational study
95484|NCT02692339|Safety of Len/Dex|safety of len/dex
95485|NCT02692326|intrahepatic cholestasis|intrahepatic cholestasis
95486|NCT02692326|infant newborn|infant newborn
95487|NCT02692326|cyclic parenteral nutrition|cyclic parenteral nutrition
95488|NCT02692313|epinephrine|epinephrine
95489|NCT02692313|counterregulation|counterregulation
95490|NCT02692313|dose responses|dose responses
95491|NCT02692300|anesthesia|anesthesia
95492|NCT02692300|delirium|delirium
95493|NCT02692300|surgery|surgery
95494|NCT02692300|electroencephalography|electroencephalography
95495|NCT02692300|burst suppression|burst suppression
95496|NCT02692300|PTSD|ptsd
95497|NCT02692300|anxiety|anxiety
95498|NCT02692300|depression|depression
95499|NCT02692300|falls|falls
95500|NCT02692274|Point-of-care diagnostics|point-of-care diagnostics
95501|NCT02692274|Rural primary health care|rural primary health care
95502|NCT02692274|Access|access
95503|NCT02692274|Need|need
95504|NCT02692274|Usage|usage
95505|NCT02692274|Maternal Health|maternal health
95506|NCT02692235|carnitine|carnitine
95507|NCT02692235|leucine|leucine
95508|NCT02692222|pulse pressure variation monitoring|pulse pressure variation monitoring
95509|NCT02692222|Captesia|captesia
95510|NCT02692222|cardiac output monitoring|cardiac output monitoring
95511|NCT02692209|Mammography|mammography
95512|NCT02692196|Neurofeedback|neurofeedback
95513|NCT02692196|Emotion processing|emotion processing
95514|NCT02692196|Real-time|real-time
95515|NCT02692196|fMRI|fmri
95516|NCT02692183|Parkinson's disease|parkinson's disease
95518|NCT02692183|EEG|eeg
95519|NCT02692183|FUS|fus
95520|NCT02692183|BNA|bna
95521|NCT02692183|Essential tremor|essential tremor
95522|NCT02692131|Left Ventricle strain, speckle strain|left ventricle strain, speckle strain
95523|NCT02692105|prostate adenocarcinoma|prostate adenocarcinoma
95524|NCT02692105|intermediate risk group|intermediate risk group
95525|NCT02692105|brachytherapy|brachytherapy
95526|NCT02692105|High Dose Rate vs Low Dose Rate|high dose rate vs low dose rate
95527|NCT02692105|Quality of Life|quality of life
95528|NCT02692092|Complications|complications
95529|NCT02692092|Arthroplasty, Hip Replacement|arthroplasty, hip replacement
95530|NCT02692092|Arthroplasty, Knee Replacement|arthroplasty, knee replacement
95531|NCT02692079|Angiogenesis|angiogenesis
95532|NCT02692079|Bilateral infrabony defect|bilateral infrabony defect
95533|NCT02692079|Flap surgery|flap surgery
95534|NCT02692079|Titanium-prepared, platelet-rich ﬁbrin|titanium-prepared, platelet-rich ﬁbrin
95535|NCT02692040|obesity|obesity
95536|NCT02692040|diabetes mellitus|diabetes mellitus
95537|NCT02692040|glucagon-like peptide-1|glucagon-like peptide-1
95538|NCT02692027|Community-based initiation of antiretroviral therapy|community-based initiation of antiretroviral therapy
95539|NCT02692027|Home-based HIV testing and counseling|home-based hiv testing and counseling
95540|NCT02692027|Lesotho|lesotho
95541|NCT02692027|Sub-sahara Africa|sub-sahara africa
95542|NCT02692027|antiretroviral therapy|antiretroviral therapy
95543|NCT02692027|AIDS|aids
95544|NCT02692027|Test and treat|test and treat
95545|NCT02691988|Inhaled corticosteroids|inhaled corticosteroids
95546|NCT02691988|General practice|general practice
95547|NCT02691988|Primary care|primary care
95548|NCT02691988|Pharmacotherapy|pharmacotherapy
95549|NCT02691936|Genitourinary symptoms of menopause|genitourinary symptoms of menopause
95550|NCT02691936|Menopause|menopause
95551|NCT02691936|Atrophic vaginitis|atrophic vaginitis
95552|NCT02691923|High Grade Glioma|high grade glioma
95553|NCT02691923|Low Grade Glioma|low grade glioma
95554|NCT02691923|Brain Tumor|brain tumor
95555|NCT02691910|malaria|malaria
95556|NCT02691910|Plasmodium vivax|plasmodium vivax
95557|NCT02691910|treatment|treatment
95558|NCT02691910|Chloroquine|chloroquine
95559|NCT02691910|Primaquine|primaquine
95560|NCT02691897|Diabetes mellitus|diabetes mellitus
95561|NCT02691897|Melatonin|melatonin
95562|NCT02691897|Blood Glucose|blood glucose
95563|NCT02691897|Therapeutics|therapeutics
95564|NCT02691897|Pineal gland|pineal gland
95565|NCT02691884|Heart Rate, Fetal|heart rate, fetal
95566|NCT02691884|Electronic Fetal Monitoring|electronic fetal monitoring
95567|NCT02691884|Transducers, Pressure|transducers, pressure
95568|NCT02691858|Intussusception|intussusception
95569|NCT02691819|jailed-balloon technique|jailed-balloon technique
95570|NCT02691754|Paracetamol|paracetamol
95571|NCT02691754|PPI|ppi
95572|NCT02691754|Opioids|opioids
95573|NCT02691754|NSAID|nsaid
95574|NCT02691754|Drug Prescription|drug prescription
95575|NCT02691702|Multiple Ascending Dose Study|multiple ascending dose study
95576|NCT02691702|Safety and Tolerability|safety and tolerability
95577|NCT02691702|Pharmacokinetics|pharmacokinetics
95578|NCT02691702|Pharmacodynamics|pharmacodynamics
95579|NCT02691702|Melatonin|melatonin
95580|NCT02691702|Plasma|plasma
95581|NCT02691702|Dim Light Melatonin Onset|dim light melatonin onset
95582|NCT02691676|crystalloids, fluid therapy, Plasmalyte, Ringerfundin|crystalloids, fluid therapy, plasmalyte, ringerfundin
95583|NCT02691663|Geriatric|geriatric
95584|NCT02691663|bicarbonate|bicarbonate
95585|NCT02691650|serum cholinesterase|serum cholinesterase
95586|NCT02691650|plasma cholinesterase|plasma cholinesterase
95587|NCT02691650|pseudocholinesterase|pseudocholinesterase
95588|NCT02691650|systemic inflammation|systemic inflammation
95589|NCT02691650|SIRS|sirs
95590|NCT02691650|polytrauma|polytrauma
95591|NCT02691637|Helicobacter pylori infection|helicobacter pylori infection
95592|NCT02691637|Eradication treatment|eradication treatment
95593|NCT02691637|Reversibility|reversibility
95594|NCT02691637|atrophic gastritis|atrophic gastritis
95595|NCT02691637|intestinal metaplasia|intestinal metaplasia
95596|NCT02691624|Lymphedema of Upper Arm|lymphedema of upper arm
95597|NCT02691624|Breast cancer|breast cancer
95598|NCT02691624|Breast cancer-related Lymphedema|breast cancer-related lymphedema
95599|NCT02691624|Lymphoscintigraphy|lymphoscintigraphy
95600|NCT02691546|Chronic Kidney Diseases|chronic kidney diseases
95601|NCT02691546|Older|older
95602|NCT02691546|Geriatric assessment|geriatric assessment
95603|NCT02691546|Biomarkers|biomarkers
95604|NCT02691533|Acute|acute
95607|NCT02691494|Elagolix|elagolix
95608|NCT02691494|Menorrhagia|menorrhagia
95609|NCT02691494|Elagolix + Norethindrone acetate|elagolix + norethindrone acetate
95610|NCT02691494|Elagolix Sodium|elagolix sodium
95611|NCT02691494|HMB|hmb
95612|NCT02691494|Heavy menstrual bleeding|heavy menstrual bleeding
95613|NCT02691494|Leiomyomata|leiomyomata
95614|NCT02691494|Heavy uterine bleeding|heavy uterine bleeding
95615|NCT02691494|ABT-620|abt-620
95616|NCT02691494|Elagolix + E2/NETA|elagolix + e2/neta
95617|NCT02691468|one lung ventilation|one lung ventilation
95618|NCT02691468|double lumen endobronchial tube|double lumen endobronchial tube
95619|NCT02691468|displacement|displacement
95620|NCT02691468|Fiberoptic bronchoscope|fiberoptic bronchoscope
95621|NCT02691442|Peripheral nerve block|peripheral nerve block
95622|NCT02691429|Vitreoretinal surgery|vitreoretinal surgery
95623|NCT02691429|euterpe oleracea|euterpe oleracea
95624|NCT02691429|chromovitrectomy|chromovitrectomy
95625|NCT02691325|ELLIPTA|ellipta
95626|NCT02691325|GSK2269557|gsk2269557
95627|NCT02691325|Tolerability|tolerability
95628|NCT02691325|Safety|safety
95629|NCT02691325|Dry powder Inhaler (DPI)|dry powder inhaler (dpi)
95630|NCT02691325|Pharmacokinetics|pharmacokinetics
95631|NCT02691312|type 1 diabetes|type 1 diabetes
95632|NCT02691312|retinopathy|retinopathy
95633|NCT02691299|NSCLC|nsclc
95637|NCT02691247|T1DM|t1dm
95638|NCT02691247|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
95639|NCT02691247|T regulatory cell|t regulatory cell
95640|NCT02691247|Immunotherapy|immunotherapy
95641|NCT02691247|Cell therapy|cell therapy
95642|NCT02691247|T-Reg|t-reg
95643|NCT02691221|Suicidal behavior, Mobile Application, Mobile Health Tool|suicidal behavior, mobile application, mobile health tool
95644|NCT02691208|acupuncture|acupuncture
95645|NCT02691208|breast cancer|breast cancer
95646|NCT02691208|rehabilitation|rehabilitation
95647|NCT02691208|pain|pain
95648|NCT02691195|Ultrasound|ultrasound
95649|NCT02691195|Serratus Plane Block|serratus plane block
95650|NCT02691195|Quality of recovery|quality of recovery
95651|NCT02691156|Hematofluorometer|hematofluorometer
95652|NCT02691130|influenza|influenza
95653|NCT02691130|vaccine|vaccine
95654|NCT02691130|universal|universal
95655|NCT02691130|peptide|peptide
95656|NCT02691130|prime|prime
95657|NCT02691130|boost|boost
95658|NCT02691130|HAI|hai
95659|NCT02691130|CMI|cmi
95660|NCT02691130|UNISEC|unisec
95661|NCT02691117|Alopecia Areata|alopecia areata
95662|NCT02691117|Garlic concentrate|garlic concentrate
95663|NCT02691052|pancreatic cancer|pancreatic cancer
95664|NCT02691052|metastatic|metastatic
95665|NCT02691026|MPNST|mpnst
95666|NCT02691026|Pembrolizumab|pembrolizumab
95667|NCT02691000|depression|depression
95668|NCT02691000|depressive symptoms|depressive symptoms
95669|NCT02691000|stage b heart failure|stage b heart failure
95670|NCT02691000|bright white light|bright white light
95671|NCT02691000|light therapy|light therapy
95672|NCT02690987|tobacco|tobacco
95673|NCT02690987|GLP1|glp1
95674|NCT02690987|ghrelin|ghrelin
95675|NCT02690987|alcohol|alcohol
95676|NCT02690987|appetite|appetite
95684|NCT02690974|ACE inhibitor,|ace inhibitor,
95685|NCT02690974|ARBs,|arbs,
95686|NCT02690974|systolic heart failure,|systolic heart failure,
95687|NCT02690974|chronic heart failure,|chronic heart failure,
95688|NCT02690974|CHF,|chf,
95689|NCT02690974|reduced EF,|reduced ef,
95690|NCT02690974|Ejection Fraction|ejection fraction
95691|NCT02690961|Healthy|healthy
95692|NCT02690935|grass pollen|grass pollen
95693|NCT02690935|homeopathy|homeopathy
95694|NCT02690935|placebo|placebo
95695|NCT02690935|quality of life|quality of life
95696|NCT02690909|Uncontrolled Hypertension|uncontrolled hypertension
95697|NCT02690909|Resistant Hypertension|resistant hypertension
95698|NCT02690909|Renal Denervation|renal denervation
95699|NCT02690896|caregiver burden|caregiver burden
95700|NCT02690896|caregiver support groups|caregiver support groups
95701|NCT02690870|tamoxifen|tamoxifen
95702|NCT02690870|clomiphene|clomiphene
95703|NCT02690870|mild stimulation|mild stimulation
95704|NCT02690870|poor ovarian response|poor ovarian response
95705|NCT02690870|clinical pregnancy rate|clinical pregnancy rate
95706|NCT02690831|Asthma|asthma
95707|NCT02690831|Inspiratory Muscle Training|inspiratory muscle training
95708|NCT02690831|Manual Therapies|manual therapies
95709|NCT02690818|Tuberculosis|tuberculosis
95710|NCT02690818|Latent Tuberculosis|latent tuberculosis
95711|NCT02690818|Texting|texting
95712|NCT02690818|Adherence|adherence
95713|NCT02690818|Medication|medication
95714|NCT02690792|Healthy|healthy
95715|NCT02690792|NAFLD|nafld
95716|NCT02690792|NASH|nash
95717|NCT02690792|Liver Metabolism|liver metabolism
95718|NCT02690792|Vitamin E|vitamin e
95719|NCT02690766|Cancer|cancer
95720|NCT02690766|Breast Cancer|breast cancer
95721|NCT02690766|Endometrial cancer,|endometrial cancer,
95722|NCT02690766|Type 2 Diabetes|type 2 diabetes
95723|NCT02690753|Repositioning|repositioning
95724|NCT02690753|Incontinence care|incontinence care
95725|NCT02690753|Prevention|prevention
95726|NCT02690740|titrated quantitative conjunctival provocation test|titrated quantitative conjunctival provocation test
95727|NCT02690727|Fasting|fasting
95728|NCT02690727|Fed condition|fed condition
95729|NCT02690727|Pharmacokinetics|pharmacokinetics
95730|NCT02690701|psoriasis|psoriasis
95731|NCT02690701|plaque psoriasis|plaque psoriasis
95732|NCT02690701|secukinumab|secukinumab
95733|NCT02690701|AIN457|ain457
95734|NCT02690701|biologic|biologic
95735|NCT02690701|monoclonal antibody|monoclonal antibody
95736|NCT02690688|Pulse Pressure Variation|pulse pressure variation
95737|NCT02690688|NIRS|nirs
95738|NCT02690688|Pneumoperitoneum|pneumoperitoneum
95739|NCT02690688|Abdominal surgery|abdominal surgery
95740|NCT02690675|Neurodevelopment|neurodevelopment
95741|NCT02690675|Bayley Scale|bayley scale
95742|NCT02690675|Growth|growth
95743|NCT02690675|Iron fortification|iron fortification
95744|NCT02690662|Obesity|obesity
95745|NCT02690662|Kidney stones|kidney stones
95746|NCT02690662|Diet|diet
95747|NCT02690649|anticoagulants|anticoagulants
95748|NCT02690649|Personal Health Records|personal health records
95749|NCT02690623|hospitalist|hospitalist
95750|NCT02690623|pediatric inpatient care|pediatric inpatient care
95751|NCT02690610|EBUS, Mediastinal lesions, Mediastinal lymph node|ebus, mediastinal lesions, mediastinal lymph node
87007|NCT02744196|rheumatism|rheumatism
87008|NCT02744196|Acellbia|acellbia
87009|NCT02744196|methotrexate|methotrexate
87012|NCT02744196|rituximab|rituximab
95752|NCT02690597|Anxiety analogic visual scale|anxiety analogic visual scale
95753|NCT02690597|Pain|pain
95754|NCT02690597|State Trait Inventory anxiety scale|state trait inventory anxiety scale
95755|NCT02690597|Anxiety|anxiety
95756|NCT02690584|Psychotherapy|psychotherapy
95757|NCT02690571|Air Pollution|air pollution
95758|NCT02690571|Biodiesel exhaust|biodiesel exhaust
95759|NCT02690571|Bronchoscopy|bronchoscopy
95760|NCT02690571|Metabolomics|metabolomics
95761|NCT02690558|muscle-invasive|muscle-invasive
95762|NCT02690545|CAR T cells|car t cells
95763|NCT02690545|CD30|cd30
95764|NCT02690545|Lymphoma|lymphoma
95765|NCT02690545|T Lymphocytes|t lymphocytes
95766|NCT02690532|Celiac|celiac
95767|NCT02690532|Gluten|gluten
95768|NCT02690532|Sensitivity|sensitivity
95769|NCT02690532|Permeability|permeability
95770|NCT02690532|Non-celiac gluten intolerance|non-celiac gluten intolerance
95771|NCT02690532|Gastrointestinal Diseases|gastrointestinal diseases
95772|NCT02690532|Digestive System Diseases|digestive system diseases
95773|NCT02690519|Cystic fibrosis S1251N mutation|cystic fibrosis s1251n mutation
95774|NCT02690519|GLPG1837|glpg1837
95775|NCT02690506|pregabalin|pregabalin
96992|NCT02682966|troponin|troponin
95779|NCT02690480|metastases|metastases
95780|NCT02690480|postmenopausal|postmenopausal
95781|NCT02690480|breast cancer|breast cancer
95782|NCT02690480|hormone receptor positive|hormone receptor positive
95783|NCT02690467|Insulin therapy|insulin therapy
95784|NCT02690467|Needle|needle
95785|NCT02690454|ticagrelor|ticagrelor
95786|NCT02690454|ticagrelor active metabolite (AR-C124910XX)|ticagrelor active metabolite (ar-c124910xx)
95787|NCT02690454|platelet function tests|platelet function tests
95788|NCT02690454|the flow cytometric VASP assay|the flow cytometric vasp assay
95789|NCT02690454|the VerifyNow® device|the verifynow® device
95790|NCT02690454|the Multiplate® analyzer|the multiplate® analyzer
96193|NCT02688205|Ultrasound|ultrasound
95791|NCT02690454|pharmacokinetics|pharmacokinetics
95792|NCT02690454|pharmacodynamics|pharmacodynamics
95793|NCT02690454|Multiplate® ADPtest|multiplate® adptest
95794|NCT02690454|VerifyNow® PRUTest™|verifynow® prutest™
95795|NCT02690454|Platelet VASP/P2Y12 assay|platelet vasp/p2y12 assay
95797|NCT02690441|CBT|cbt
95798|NCT02690441|Physical exercise|physical exercise
95799|NCT02690441|Older adults|older adults
95800|NCT02690428|Hyperthermia, Induced|hyperthermia, induced
95801|NCT02690428|Laser Coagulation|laser coagulation
95802|NCT02690428|Laser Therapy|laser therapy
95803|NCT02690389|Acupuncture|acupuncture
95804|NCT02690389|Flumazenil|flumazenil
95805|NCT02690389|Narcotrend|narcotrend
95806|NCT02690389|General Anaesthesia|general anaesthesia
95807|NCT02690389|Sedation|sedation
95808|NCT02690337|Advanced solid malignant tumors|advanced solid malignant tumors
95809|NCT02690337|phase 1|phase 1
95810|NCT02690337|oncology|oncology
95811|NCT02690337|refractory|refractory
95817|NCT02690233|surgery|surgery
95818|NCT02690233|cardiovascular complications|cardiovascular complications
95819|NCT02690233|EndoPat|endopat
95820|NCT02690233|myocardial injury|myocardial injury
95821|NCT02690233|myocardial infarction|myocardial infarction
95822|NCT02690220|polypropylene mesh|polypropylene mesh
95823|NCT02690220|prolapse|prolapse
95824|NCT02690220|cystocele|cystocele
95825|NCT02690220|surgical mesh|surgical mesh
95826|NCT02690207|Herpes Zoster|herpes zoster
95827|NCT02690207|Safety|safety
95828|NCT02690207|Adults|adults
95829|NCT02690207|Cross-vaccination|cross-vaccination
95830|NCT02690194|Buddhify|buddhify
95831|NCT02690194|Stress|stress
95832|NCT02690194|Anxiety|anxiety
95833|NCT02690194|Relaxation Technique|relaxation technique
95834|NCT02690168|Fasting|fasting
95835|NCT02690168|Carbon-13 Magnetic Resonance Spectroscopy|carbon-13 magnetic resonance spectroscopy
95836|NCT02690168|Neuroimaging|neuroimaging
95837|NCT02690155|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
95838|NCT02690155|Prevention|prevention
95839|NCT02690155|Stroke|stroke
95840|NCT02690129|progesterone|progesterone
95841|NCT02690129|threatened abortion|threatened abortion
95842|NCT02690116|Meditative movement|meditative movement
95843|NCT02690116|Breast cancer survivors|breast cancer survivors
95844|NCT02690116|Qigong|qigong
95845|NCT02690116|Tai Chi Easy|tai chi easy
95846|NCT02690116|Fatigue|fatigue
95847|NCT02690103|Arabinoxylan|arabinoxylan
95849|NCT02690103|Viremia|viremia
95850|NCT02690103|Biobran|biobran
95851|NCT02690103|PEG interferon|peg interferon
95852|NCT02690090|Deep Vein Thrombosis|deep vein thrombosis
95853|NCT02690090|Prophylaxis|prophylaxis
95854|NCT02690090|Critically ill adults|critically ill adults
87110|NCT02743481|Cancer|cancer
95855|NCT02690077|Patient Satisfaction|patient satisfaction
95856|NCT02690077|Earlier Family Bond Initiation|earlier family bond initiation
95857|NCT02690077|Maternal and Neonatal Outcomes|maternal and neonatal outcomes
95858|NCT02690064|Endothelial Function|endothelial function
95859|NCT02690064|Maximal Exercise Capacity|maximal exercise capacity
95860|NCT02690064|Flow Mediated Dilation|flow mediated dilation
95861|NCT02690064|Antioxidant|antioxidant
95862|NCT02690064|FEV1|fev1
95863|NCT02690038|AECOPD|aecopd
95864|NCT02690038|COPD|copd
95865|NCT02689999|Gastroesophageal Reflux Disease (GERD), GERD, impedence|gastroesophageal reflux disease (gerd), gerd, impedence
95866|NCT02689986|Cold agglutinin|cold agglutinin
95867|NCT02689986|Cold agglutinin disease|cold agglutinin disease
95868|NCT02689986|Anemia|anemia
95869|NCT02689986|Hemolytic|hemolytic
95870|NCT02689986|Autoimmune|autoimmune
95871|NCT02689986|Bendamustine|bendamustine
95872|NCT02689986|Rituximab|rituximab
95873|NCT02689973|adolescence|adolescence
95874|NCT02689973|body fat|body fat
95875|NCT02689973|physical activity|physical activity
95876|NCT02689973|psychosocial intervention|psychosocial intervention
95877|NCT02689973|self-efficacy|self-efficacy
95878|NCT02689973|planning|planning
95879|NCT02689960|addison disease|addison disease
95880|NCT02689960|adrenal crisis|adrenal crisis
95881|NCT02689960|prednisone|prednisone
95892|NCT02689895|second line treatment failure|second line treatment failure
95894|NCT02689895|drug resistance|drug resistance
95895|NCT02689882|nicotinamide riboside|nicotinamide riboside
95896|NCT02689882|nicotinamide ribonucleoside|nicotinamide ribonucleoside
95897|NCT02689882|Nicotinamide-Adenine Dinucleotide|nicotinamide-adenine dinucleotide
95898|NCT02689869|indolent lymphoma|indolent lymphoma
95899|NCT02689869|novel agents|novel agents
95900|NCT02689869|chemotherapy free treatment|chemotherapy free treatment
95901|NCT02689869|ibrutinib|ibrutinib
95902|NCT02689869|obinutuzumab|obinutuzumab
95903|NCT02689869|GA101|ga101
95904|NCT02689843|Inflammation|inflammation
95905|NCT02689843|Complement system proteins|complement system proteins
95906|NCT02689843|Homocysteine|homocysteine
95907|NCT02689843|C-Reactive Protein|c-reactive protein
95908|NCT02689843|Cyproterone|cyproterone
95909|NCT02689843|Ethinyl Estradiol|ethinyl estradiol
95910|NCT02689843|Androgen Antagonists|androgen antagonists
95911|NCT02689843|Metformin|metformin
95912|NCT02689843|Thiazolidinediones|thiazolidinediones
95913|NCT02689843|Pioglitazone|pioglitazone
95914|NCT02689817|Pressure ulcer|pressure ulcer
95915|NCT02689817|Monitoring|monitoring
95916|NCT02689817|Pressure|pressure
95917|NCT02689817|Physiologic feedback|physiologic feedback
95918|NCT02689804|Emergency contraception|emergency contraception
95919|NCT02689791|Appetite|appetite
95920|NCT02689791|Food Intake|food intake
95921|NCT02689791|Satiety Hormones|satiety hormones
95922|NCT02689778|Pirfenidone|pirfenidone
95923|NCT02689778|Diabetic nephropathy|diabetic nephropathy
95924|NCT02689752|mass balance|mass balance
95926|NCT02689713|Burn Pain|burn pain
95927|NCT02689713|Hyperalgesia|hyperalgesia
95928|NCT02689713|TRPV1|trpv1
95929|NCT02689713|OLAMs|olams
95930|NCT02689700|Human Cytomegalovirus|human cytomegalovirus
95931|NCT02689700|Varicella Zoster Virus|varicella zoster virus
95932|NCT02689700|Materno-fetal antibody transfer|materno-fetal antibody transfer
95933|NCT02689700|Pregnancy|pregnancy
95934|NCT02689700|Gestational age|gestational age
95935|NCT02689622|Hematology|hematology
95936|NCT02689622|Elderly|elderly
95937|NCT02689622|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
95938|NCT02689609|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
95939|NCT02689609|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
95940|NCT02689609|Hypothyroidism|hypothyroidism
95941|NCT02689609|Predictors|predictors
95942|NCT02689583|Helicobacter pylori|helicobacter pylori
95943|NCT02689583|Antibiotic resistance|antibiotic resistance
95944|NCT02689583|Sequencing|sequencing
95945|NCT02689583|Mechanism|mechanism
95946|NCT02689583|Cause|cause
95947|NCT02689570|type 1 diabetes|type 1 diabetes
95948|NCT02689570|coronary artery calcifications|coronary artery calcifications
95949|NCT02689570|diastolic dysfunction|diastolic dysfunction
95950|NCT02689570|adipokines|adipokines
95951|NCT02689570|visceral adipose tissue|visceral adipose tissue
95952|NCT02689544|exercise muscle stretching|exercise muscle stretching
95953|NCT02689544|range of motion|range of motion
95954|NCT02689544|dynamometer of muscle strength|dynamometer of muscle strength
95955|NCT02689544|electromyography|electromyography
95956|NCT02689518|AMD|amd
95957|NCT02689518|Wet AMD|wet amd
95958|NCT02689518|Macular degeneration|macular degeneration
95959|NCT02689518|Wet macular degeneration|wet macular degeneration
95960|NCT02689518|Neovascularization|neovascularization
95961|NCT02689518|Retina|retina
95962|NCT02689518|Retinal degeneration|retinal degeneration
95963|NCT02689479|Clinical Islet Transplantation|clinical islet transplantation
87210|NCT02743078|Optune|optune
95964|NCT02689479|Positron Emission Tomography (PET) Computed Tomography (CT) imaging|positron emission tomography (pet) computed tomography (ct) imaging
95965|NCT02689466|Adult|adult
95966|NCT02689466|Acetylcholine|acetylcholine
95967|NCT02689466|Movement Disorder|movement disorder
95968|NCT02689466|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
95969|NCT02689466|PET Imaging|pet imaging
95970|NCT02689453|T-cell Lymphoproliferative Disorder|t-cell lymphoproliferative disorder
95971|NCT02689453|CD4/CD25 Expressing T-cells in Blood and Lymphoid Tissues|cd4/cd25 expressing t-cells in blood and lymphoid tissues
95972|NCT02689453|Anti-CD52 Monoclonal Antibody|anti-cd52 monoclonal antibody
95973|NCT02689453|Antibody Dependent Cellular Cytotoxicity|antibody dependent cellular cytotoxicity
95974|NCT02689440|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
95975|NCT02689440|CML|cml
95976|NCT02689440|Ph-positive chronic myelogenous leukemia|ph-positive chronic myelogenous leukemia
97191|NCT02681874|dietary pattern|dietary pattern
95977|NCT02689440|BCR-ABL positive chronic myelogenous leukemia|bcr-abl positive chronic myelogenous leukemia
95979|NCT02689440|BMS-354825|bms-354825
95980|NCT02689440|Sprycel|sprycel
95981|NCT02689427|Breast cancer|breast cancer
95982|NCT02689427|Invasive carcinoma of the breast|invasive carcinoma of the breast
95983|NCT02689427|Triple-negative breast cancer|triple-negative breast cancer
95984|NCT02689427|TNBC|tnbc
95985|NCT02689427|Enzalutamide|enzalutamide
95986|NCT02689427|MDV3100|mdv3100
95987|NCT02689427|XTANDI|xtandi
95988|NCT02689427|Paclitaxel|paclitaxel
95989|NCT02689427|Taxol|taxol
95990|NCT02689414|Atherosclerosis|atherosclerosis
95991|NCT02689401|Esophageal Cancer|esophageal cancer
95992|NCT02689401|lymph nodes tumor|lymph nodes tumor
95993|NCT02689388|analgesia|analgesia
95994|NCT02689388|regional analgesia|regional analgesia
95995|NCT02689388|femoral nerve block|femoral nerve block
95996|NCT02689388|older persons|older persons
95997|NCT02689388|frail|frail
95998|NCT02689362|Diabetes Mellitus Type 2|diabetes mellitus type 2
95999|NCT02689349|hearing|hearing
96000|NCT02689349|implant|implant
96001|NCT02689349|moderate degree|moderate degree
96002|NCT02689349|severe degree|severe degree
96003|NCT02689310|Wound Care|wound care
96004|NCT02689310|Medical Grade Honey|medical grade honey
96005|NCT02689310|Pressure Ulcers|pressure ulcers
96006|NCT02689284|Stomach Cancer|stomach cancer
96007|NCT02689284|Gastroesophageal Junction|gastroesophageal junction
96008|NCT02689284|Gastric Cancer|gastric cancer
96009|NCT02689284|Cancer of the Stomach|cancer of the stomach
96010|NCT02689284|Cancer of Stomach|cancer of stomach
96011|NCT02689284|Stomach|stomach
96012|NCT02689284|Pembrolizumab|pembrolizumab
96013|NCT02689284|Keytruda|keytruda
96014|NCT02689284|HER2+|her2+
96015|NCT02689284|GEJ|gej
96016|NCT02689284|HER2 positive|her2 positive
96017|NCT02689284|Metastatic|metastatic
96018|NCT02689284|Margetuximab|margetuximab
96019|NCT02689284|Immunotherapy|immunotherapy
96020|NCT02689284|Trastuzumab|trastuzumab
96021|NCT02689284|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
96022|NCT02689284|Human epidermal growth factor receptor 2-positive|human epidermal growth factor receptor 2-positive
96023|NCT02689284|gastroesophageal junction cancer|gastroesophageal junction cancer
96024|NCT02689284|Pembro|pembro
96025|NCT02689284|PD-L1|pd-l1
96026|NCT02689284|PD-1|pd-1
96027|NCT02689284|PD|pd
96028|NCT02689284|Tumor|tumor
96029|NCT02689284|Cancer|cancer
96030|NCT02689271|MRI|mri
96031|NCT02689271|Magnetic resonance imaging|magnetic resonance imaging
96032|NCT02689271|Biomarkers|biomarkers
96033|NCT02689271|Fluidics|fluidics
96034|NCT02689271|Diffusion MRI|diffusion mri
96035|NCT02689219|Antigens, CD30, Embryonal Germ Cell Tumors|antigens, cd30, embryonal germ cell tumors
96036|NCT02689206|Chronic kidney disease|chronic kidney disease
96037|NCT02689206|Efficacy|efficacy
96038|NCT02689206|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
96039|NCT02689206|GSK1278863|gsk1278863
96040|NCT02689206|Safety|safety
96041|NCT02689206|Hemodialysis-dependent anemia|hemodialysis-dependent anemia
96042|NCT02689206|Pharmacokinetics|pharmacokinetics
96043|NCT02689193|Proteomics|proteomics
96044|NCT02689193|Rapid Diagnostic Test|rapid diagnostic test
96045|NCT02689193|Salmonellosis|salmonellosis
96046|NCT02689180|heart failure|heart failure
96047|NCT02689180|diuretics|diuretics
96048|NCT02689180|furosemide|furosemide
96049|NCT02689167|renal cell carcinoma|renal cell carcinoma
96050|NCT02689167|sunitinib|sunitinib
96051|NCT02689167|metastatic|metastatic
96052|NCT02689167|schedule|schedule
96053|NCT02689167|toxicity|toxicity
96054|NCT02689167|safety|safety
96055|NCT02689154|Pediatric Obesity|pediatric obesity
96056|NCT02689154|Food Addiction|food addiction
96057|NCT02689154|Mobile Health (mHealth)|mobile health (mhealth)
96058|NCT02689154|Weight Management|weight management
96059|NCT02689141|chronic lymphocytic leukemia CLL|chronic lymphocytic leukemia cll
113896|NCT02581007|CML|cml
96060|NCT02689141|untreated chronic lymphocytic leukemia|untreated chronic lymphocytic leukemia
96061|NCT02689141|relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
96062|NCT02689141|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
96063|NCT02689128|Anesthesia|anesthesia
96064|NCT02689128|postoperative|postoperative
96065|NCT02689128|nausea|nausea
96066|NCT02689128|vomiting|vomiting
96067|NCT02689115|Nuclear factor Kappa B|nuclear factor kappa b
96068|NCT02689115|IKK epsilon|ikk epsilon
96069|NCT02689102|Optical coherence tomography|optical coherence tomography
96070|NCT02689102|Confocal laser endomicroscopy|confocal laser endomicroscopy
96071|NCT02689076|Patient transfer|patient transfer
96072|NCT02689076|Patient care management|patient care management
96073|NCT02689076|Health information exchange|health information exchange
96074|NCT02689063|Analgesic|analgesic
96075|NCT02689024|Nerve block|nerve block
96076|NCT02689024|Analgesia|analgesia
96077|NCT02689011|Total Knee Arthroplasty|total knee arthroplasty
96078|NCT02689011|Femoral Nerve Block|femoral nerve block
96079|NCT02689011|Epidural Analgesia|epidural analgesia
96080|NCT02689011|Urinary Retention|urinary retention
96081|NCT02689011|Lumbar Epidural|lumbar epidural
96082|NCT02688998|HER2 negative|her2 negative
96083|NCT02688959|motor attention training|motor attention training
96084|NCT02688959|exercise|exercise
96085|NCT02688959|tai chi|tai chi
96086|NCT02688959|ADHD|adhd
96087|NCT02688855|Bone Growth Stimulator|bone growth stimulator
96088|NCT02688855|Ankle Fracture|ankle fracture
96089|NCT02688829|stents,percutaneous coronary intervention|stents,percutaneous coronary intervention
96194|NCT02688205|Correlation|correlation
96090|NCT02688816|visual inspection with acetic acid|visual inspection with acetic acid
96091|NCT02688816|Xpert HPV|xpert hpv
96092|NCT02688816|OncoE6|oncoe6
96093|NCT02688816|screening|screening
96094|NCT02688803|HER2 Negative|her2 negative
96095|NCT02688790|Dalbavancin|dalbavancin
96096|NCT02688790|DALVANCE®|dalvance®
96097|NCT02688790|Suspected or Confirmed Bacterial Infection|suspected or confirmed bacterial infection
96098|NCT02688777|Rehabilitation|rehabilitation
96099|NCT02688777|Gait|gait
96100|NCT02688777|Postural Balance|postural balance
96101|NCT02688777|Exercise|exercise
96102|NCT02688777|Accidental Falls|accidental falls
96103|NCT02688777|Kinesiology, Applied|kinesiology, applied
96104|NCT02688764|PA21|pa21
96105|NCT02688764|phosphate binder|phosphate binder
96106|NCT02688712|IIA|iia
96107|NCT02688712|Xeloda|xeloda
96108|NCT02688712|radiation therapy|radiation therapy
96109|NCT02688712|LY2157299|ly2157299
96110|NCT02688712|tumor resection|tumor resection
96111|NCT02688712|capecitabine|capecitabine
96112|NCT02688712|5FU|5fu
96113|NCT02688712|Fluorouracil|fluorouracil
96114|NCT02688712|IIB|iib
96115|NCT02688712|IIC|iic
96116|NCT02688712|IV|iv
96117|NCT02688712|neoadjuvant|neoadjuvant
96118|NCT02688712|Rectal cancer|rectal cancer
96119|NCT02688712|Immunotherapy|immunotherapy
96120|NCT02688660|Pediatrics|pediatrics
96121|NCT02688660|Neuroimaging|neuroimaging
96122|NCT02688647|Pulmonary Fibrosis|pulmonary fibrosis
96123|NCT02688647|Fibrosis|fibrosis
96124|NCT02688647|Idiopathic Interstitial Pneumonias|idiopathic interstitial pneumonias
96125|NCT02688647|Lung Diseases|lung diseases
96126|NCT02688634|Cleft Palate Surgery|cleft palate surgery
96127|NCT02688634|Antibiotic treatment|antibiotic treatment
96128|NCT02688621|weight loss|weight loss
96129|NCT02688621|financial incentives|financial incentives
96130|NCT02688621|internet weight loss|internet weight loss
96131|NCT02688595|Infant, Newborn|infant, newborn
96132|NCT02688595|Ultrasonography|ultrasonography
96133|NCT02688582|Target Controlled Infusion|target controlled infusion
96134|NCT02688582|Pharmacokinetics|pharmacokinetics
96135|NCT02688582|Cefepime|cefepime
96136|NCT02688582|critically ill patients|critically ill patients
96137|NCT02688556|KCS|kcs
96138|NCT02688556|dry eye|dry eye
96139|NCT02688556|cyclosporine|cyclosporine
96140|NCT02688543|radio frequency treatment|radio frequency treatment
96141|NCT02688543|genicular nerves|genicular nerves
96142|NCT02688543|osteoarthritis of the knee|osteoarthritis of the knee
96143|NCT02688504|labelled medicines|labelled medicines
96144|NCT02688504|drivers involved in serious and non-serious road accidents|drivers involved in serious and non-serious road accidents
96145|NCT02688504|relevance and effectiveness of pictograms on medicines packaging|relevance and effectiveness of pictograms on medicines packaging
96146|NCT02688478|Phthalate|phthalate
96147|NCT02688478|Dibutylphthalate (DBP)|dibutylphthalate (dbp)
96148|NCT02688478|Airway responsiveness|airway responsiveness
96149|NCT02688478|Allergies|allergies
96150|NCT02688452|strenuous exercise|strenuous exercise
96151|NCT02688452|muscle soreness|muscle soreness
96152|NCT02688413|Virtual reality|virtual reality
96153|NCT02688413|Stroke|stroke
96154|NCT02688413|Neurorehabilitation|neurorehabilitation
96155|NCT02688413|Upper-limb rehabilitation|upper-limb rehabilitation
96156|NCT02688413|Training games|training games
96157|NCT02688400|Osteoarthritis|osteoarthritis
96158|NCT02688400|Knee|knee
96159|NCT02688400|Osteoarthritis, Knee|osteoarthritis, knee
96160|NCT02688400|Diacerein|diacerein
96161|NCT02688400|Celecoxib|celecoxib
96162|NCT02688400|Phase III|phase iii
96163|NCT02688400|Phase IV|phase iv
96164|NCT02688400|Phase III-IV|phase iii-iv
96165|NCT02688400|Canada|canada
96166|NCT02688400|Spain|spain
96167|NCT02688400|Austria|austria
96168|NCT02688400|Czech Republic|czech republic
96169|NCT02688400|WOMAC|womac
96170|NCT02688387|Ambrisentan|ambrisentan
96171|NCT02688387|Bioavailability|bioavailability
96172|NCT02688387|Tadalafil|tadalafil
96173|NCT02688387|Fixed Dose combination|fixed dose combination
96174|NCT02688322|sulbactam|sulbactam
96175|NCT02688322|pharmacokinetics|pharmacokinetics
96176|NCT02688322|pharmacodynamics|pharmacodynamics
96177|NCT02688322|Acinetobacter infections|acinetobacter infections
96178|NCT02688257|Magnetic Resonance Imaging|magnetic resonance imaging
96179|NCT02688257|Ultrasound|ultrasound
96180|NCT02688257|Breast Cancer|breast cancer
96181|NCT02688244|complicated appendicitis|complicated appendicitis
96182|NCT02688244|laparoscopic appendectomy|laparoscopic appendectomy
96183|NCT02688244|irrigation|irrigation
96184|NCT02688244|suction|suction
96185|NCT02688244|abdominal abscess|abdominal abscess
96186|NCT02688231|Multiple Sclerosis|multiple sclerosis
96187|NCT02688231|Upper limb rehabilitation|upper limb rehabilitation
96188|NCT02688218|exercise|exercise
96189|NCT02688218|artificial pancreas|artificial pancreas
96190|NCT02688218|hypoglycemia|hypoglycemia
96191|NCT02688218|type 1 diabetes|type 1 diabetes
96192|NCT02688205|Cyriax's functional examination|cyriax's functional examination
96198|NCT02688153|EDWARDS INTUITY|edwards intuity
96199|NCT02688140|APL|apl
96200|NCT02688140|acute promyelocytic leukemia (M3)|acute promyelocytic leukemia (m3)
97151|NCT02682134|Xylocaine|xylocaine
96201|NCT02688140|high-risk acute promyelocytic leukemia (APL/AML M3)|high-risk acute promyelocytic leukemia (apl/aml m3)
96202|NCT02688140|acute myeloid leukemia with t(15;17)(q22;q12)|acute myeloid leukemia with t(15;17)(q22;q12)
96203|NCT02688140|newly diagnosed|newly diagnosed
96204|NCT02688140|high-risk|high-risk
96205|NCT02688127|obstetric bleeding placenta previa|obstetric bleeding placenta previa
96206|NCT02688075|Diabetes Mellitus Type 2|diabetes mellitus type 2
96207|NCT02688075|Canagliflozin|canagliflozin
96208|NCT02688075|Observational Study|observational study
638049|NCT00733083|morphine|morphine
96210|NCT02688036|concurrent chemoradiotherapy|concurrent chemoradiotherapy
96211|NCT02688036|dose fractionation|dose fractionation
96212|NCT02688023|5-fluorouracil|5-fluorouracil
96214|NCT02688023|Oxaliplatin|oxaliplatin
96215|NCT02688023|Colorectal cancer|colorectal cancer
96216|NCT02688023|neoadjuvant|neoadjuvant
96217|NCT02688023|chemotherapy|chemotherapy
96218|NCT02688010|noise|noise
96219|NCT02688010|sound|sound
96220|NCT02688010|cycled light|cycled light
96221|NCT02688010|preterm infants|preterm infants
96222|NCT02688010|neonatal care|neonatal care
96223|NCT02688010|growth|growth
96224|NCT02688010|visual development|visual development
96225|NCT02687984|Schizophrenia|schizophrenia
96226|NCT02687984|Long-acting Risperidone|long-acting risperidone
96227|NCT02687984|Atrigel|atrigel
96228|NCT02687958|GEP/ NEC|gep/ nec
96229|NCT02687932|Functional Mitral Regurgitation|functional mitral regurgitation
96230|NCT02687932|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
96231|NCT02687919|diet (gluten-free)|diet (gluten-free)
96232|NCT02687919|diet therapy|diet therapy
96233|NCT02687919|quality of life|quality of life
96234|NCT02687893|Sleep|sleep
96235|NCT02687893|Exercise|exercise
96236|NCT02687867|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
96237|NCT02687867|Prevention|prevention
96238|NCT02687867|Stroke|stroke
96239|NCT02687854|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
96240|NCT02687854|Prevention|prevention
96241|NCT02687854|Stroke|stroke
96242|NCT02687841|acute kidney injury|acute kidney injury
96243|NCT02687841|indoxylsulfate|indoxylsulfate
96244|NCT02687841|p-cresol|p-cresol
96245|NCT02687841|AST-120|ast-120
96246|NCT02687828|Safety|safety
96247|NCT02687828|Adalimumab|adalimumab
96248|NCT02687828|Effectiveness|effectiveness
96249|NCT02687828|AMORE study|amore study
96250|NCT02687828|Intestinal Behcet's disease (BD)|intestinal behcet's disease (bd)
96251|NCT02687815|Vitamin D, severe asthma exacerbations, children|vitamin d, severe asthma exacerbations, children
96252|NCT02687802|respiratory mechanics|respiratory mechanics
96253|NCT02687802|Respiratory Insufficiency|respiratory insufficiency
96254|NCT02687802|artificial, ventilation|artificial, ventilation
96255|NCT02687789|Bacterial Vaginosis|bacterial vaginosis
96256|NCT02687789|BV|bv
96257|NCT02687776|Copeptin, human|copeptin, human
96258|NCT02687763|vaccines|vaccines
96259|NCT02687763|ProQuad|proquad
96260|NCT02687763|immunosuppressed|immunosuppressed
87530|NCT02740543|WTC|wtc
96261|NCT02687763|solid organ transplant|solid organ transplant
96262|NCT02687763|MMRV|mmrv
96263|NCT02687737|Tongue|tongue
96264|NCT02687737|Genioglossus|genioglossus
96265|NCT02687737|genioglossus recruitment|genioglossus recruitment
96266|NCT02687711|Non-interventional (NIS)|non-interventional (nis)
96267|NCT02687711|Epilepsy|epilepsy
96268|NCT02687711|Partial Onset Seizures (POS)|partial onset seizures (pos)
96269|NCT02687711|add-on therapy|add-on therapy
96270|NCT02687685|Skin to Skin Contact|skin to skin contact
96271|NCT02687685|Infant, Newborn|infant, newborn
96277|NCT02687529|Tuberculosis|tuberculosis
96278|NCT02687529|TB|tb
96279|NCT02687516|Treatment|treatment
96280|NCT02687516|Child|child
96281|NCT02687516|Obesity|obesity
96282|NCT02687516|Behavioral treatment|behavioral treatment
96283|NCT02687503|Immune system|immune system
96284|NCT02687503|Probiotics|probiotics
96285|NCT02687464|Pediatric Surgery|pediatric surgery
96286|NCT02687464|Pediatrics|pediatrics
96287|NCT02687464|Randomized controlled trial,|randomized controlled trial,
96288|NCT02687464|Antibiotics|antibiotics
96289|NCT02687464|Cost effectiveness|cost effectiveness
96290|NCT02687451|Surgical Pain|surgical pain
96291|NCT02687451|Acute Post-Surgical Pain|acute post-surgical pain
96292|NCT02687438|Steroid-eluting implant Mometasone Furoate|steroid-eluting implant mometasone furoate
96293|NCT02687425|Pioglitazone|pioglitazone
96294|NCT02687425|Chronic Myeloid Leukemia|chronic myeloid leukemia
96295|NCT02687412|Fast-track surgery|fast-track surgery
96296|NCT02687412|Gynecological oncology|gynecological oncology
96297|NCT02687412|Hospitalization post-operation|hospitalization post-operation
96298|NCT02687412|Complication|complication
96299|NCT02687399|knee arthroplasty|knee arthroplasty
96300|NCT02687386|Recurrent|recurrent
96301|NCT02687386|Refractory|refractory
96302|NCT02687373|Plasmodium falciparum|plasmodium falciparum
96303|NCT02687373|PfSPZ Vaccine|pfspz vaccine
96304|NCT02687308|Prostatic cancer|prostatic cancer
97501|NCT02679859|Surgery|surgery
96305|NCT02687308|Radical prostatectomy|radical prostatectomy
96306|NCT02687308|Minimally invasive prostate cancer surgery|minimally invasive prostate cancer surgery
96307|NCT02687282|Modified Mallampati score|modified mallampati score
96308|NCT02687282|Cesarean delivery|cesarean delivery
96309|NCT02687269|myocardial protection|myocardial protection
96310|NCT02687269|coronary artery bypass grafting|coronary artery bypass grafting
96311|NCT02687243|pediatrics|pediatrics
96312|NCT02687243|anxiety|anxiety
96313|NCT02687243|anesthesia|anesthesia
96314|NCT02687243|preoperative|preoperative
96315|NCT02687217|PerioperativeHyperoxygenation|perioperativehyperoxygenation
96316|NCT02687217|Wound Site Infection|wound site infection
96317|NCT02687217|Appendicitis|appendicitis
96318|NCT02687191|safety, maximum tolerated dose, modified continual reassessment method, intracerebral, hemorrhage, hematoma|safety, maximum tolerated dose, modified continual reassessment method, intracerebral, hemorrhage, hematoma
96319|NCT02687113|ablation|ablation
96320|NCT02687113|fusion|fusion
96321|NCT02687100|intubation|intubation
96322|NCT02687100|intensive care|intensive care
96323|NCT02687100|cardiac surgery|cardiac surgery
96324|NCT02687100|sore throat|sore throat
96325|NCT02687087|Radiotherapy Induced Xerostomia (RIX)|radiotherapy induced xerostomia (rix)
96326|NCT02687074|HFNC|hfnc
96327|NCT02687074|Respiratory Failure|respiratory failure
96328|NCT02687074|Intubation|intubation
96329|NCT02687074|Mortality|mortality
96330|NCT02687061|Recall study|recall study
96331|NCT02687061|Lost to follow-up|lost to follow-up
96332|NCT02687048|mindful meditation|mindful meditation
96333|NCT02687035|S3iCAP|s3icap
96334|NCT02687035|SAPIEN 3|sapien 3
96335|NCT02687035|Transfemoral|transfemoral
96336|NCT02687035|Commander|commander
96337|NCT02687035|Certitude|certitude
96338|NCT02687035|TAVR|tavr
96339|NCT02687035|TAVI|tavi
96340|NCT02687035|Aortic stenosis|aortic stenosis
96341|NCT02687035|THV|thv
96342|NCT02687035|Transcatheter Heart Valve|transcatheter heart valve
96343|NCT02687035|TVT|tvt
96344|NCT02687035|TVTR|tvtr
96345|NCT02687009|colon cancer|colon cancer
96346|NCT02687009|Wnt pathway|wnt pathway
96347|NCT02687009|Frizzled|frizzled
96348|NCT02686996|carnosine|carnosine
96349|NCT02686996|Insulin sensitivity|insulin sensitivity
96350|NCT02686996|low grade inflammation|low grade inflammation
96351|NCT02686996|Oxidative stress|oxidative stress
96352|NCT02686996|Advanced glycation|advanced glycation
96353|NCT02686996|Type 2 diabetes|type 2 diabetes
96354|NCT02686996|Cardiovascular disease|cardiovascular disease
96355|NCT02686970|Family|family
96356|NCT02686970|Quality|quality
96357|NCT02686970|Validate|validate
96358|NCT02686970|ICU|icu
96359|NCT02686944|GIST|gist
96360|NCT02686931|Developmental delayed|developmental delayed
96361|NCT02686931|Orthopedic disease|orthopedic disease
96362|NCT02686931|Longitudinal study|longitudinal study
96363|NCT02686892|Inflamatory bowel disease|inflamatory bowel disease
96364|NCT02686892|Crohns disease|crohns disease
96365|NCT02686892|ulcerative colitis|ulcerative colitis
96366|NCT02686892|incidence|incidence
96367|NCT02686892|epidemiology|epidemiology
96368|NCT02686879|hyperopes|hyperopes
96369|NCT02686879|axial length|axial length
96370|NCT02686879|peripheral defocus|peripheral defocus
96371|NCT02686853|Intrathecal administration|intrathecal administration
96372|NCT02686853|Liposomal amphotericin B|liposomal amphotericin b
96373|NCT02686853|Without Acquired Immune Deficiency Syndrome|without acquired immune deficiency syndrome
96374|NCT02686814|Valvular heart disease|valvular heart disease
96375|NCT02686814|Severe aortic stenosis|severe aortic stenosis
96376|NCT02686814|Aortic valve replacement|aortic valve replacement
96377|NCT02686801|nutrition|nutrition
96378|NCT02686801|prematurity|prematurity
96379|NCT02686801|body composition|body composition
96380|NCT02686788|multiple sclerosis|multiple sclerosis
96381|NCT02686788|relapsing remitting|relapsing remitting
96382|NCT02686788|nonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drug
96383|NCT02686788|contrast enhancing lesions|contrast enhancing lesions
96384|NCT02686762|NASH|nash
96385|NCT02686736|internet-based educational intervention|internet-based educational intervention
96386|NCT02686736|risky sexual behaviors|risky sexual behaviors
96387|NCT02686736|prevention|prevention
96388|NCT02686723|ACL injury|acl injury
96391|NCT02686723|Isokinetic evaluation|isokinetic evaluation
96392|NCT02686723|Risk factor|risk factor
96393|NCT02686697|L-Carnosine|l-carnosine
96394|NCT02686697|Schizophrenia|schizophrenia
96395|NCT02686697|Psychosis|psychosis
96396|NCT02686697|Cognition|cognition
96397|NCT02686671|Bursitis|bursitis
96398|NCT02686671|Injections|injections
96399|NCT02686671|Shoulder Pain|shoulder pain
96400|NCT02686658|Geographic Atrophy|geographic atrophy
96401|NCT02686658|Dry age-related macular degeneration|dry age-related macular degeneration
96402|NCT02686658|AMD|amd
96403|NCT02686658|Zimura®|zimura®
96404|NCT02686658|Anti-inflammatory|anti-inflammatory
96405|NCT02686658|Complement C5 inhibition|complement c5 inhibition
96501|NCT02686034|Vagus nerve stimulation|vagus nerve stimulation
96406|NCT02686645|Fecal Microbiota Transplantation|fecal microbiota transplantation
96407|NCT02686632|Denture Stomatitis|denture stomatitis
638557|NCT00726544|ADAMTS13|adamts13
96408|NCT02686632|Denture Erythematous Stomatitis|denture erythematous stomatitis
96409|NCT02686632|Prosthesis Stomatitis|prosthesis stomatitis
96410|NCT02686632|Oral Candidiasis|oral candidiasis
96411|NCT02686632|Palatal inflammation|palatal inflammation
96412|NCT02686593|Clofarabine|clofarabine
96413|NCT02686593|Acute Myeloid Leukemia|acute myeloid leukemia
96414|NCT02686567|transanal drainage tube|transanal drainage tube
96415|NCT02686567|anastomotic leakage|anastomotic leakage
96416|NCT02686567|laparoscopic anterior resection|laparoscopic anterior resection
96417|NCT02686567|rectal cancer|rectal cancer
96418|NCT02686554|Biomarker|biomarker
96419|NCT02686528|total hip arthroplasty|total hip arthroplasty
96420|NCT02686528|hip precautions|hip precautions
96421|NCT02686528|posterior approach|posterior approach
96422|NCT02686515|balance|balance
96545|NCT02685709|OOC-ACM-302|ooc-acm-302
96423|NCT02686476|Empagliflozin, Fatty Liver Disease|empagliflozin, fatty liver disease
96424|NCT02686463|malignant ovarian cancer|malignant ovarian cancer
96425|NCT02686463|laparoscopy|laparoscopy
96426|NCT02686463|laparotomy|laparotomy
96427|NCT02686437|shoulder dysfunction|shoulder dysfunction
96428|NCT02686437|kinesiology tape|kinesiology tape
96429|NCT02686437|rehabilitation|rehabilitation
96430|NCT02686424|MAGE-A3 protein|mage-a3 protein
96431|NCT02686424|NY-ESO-1 protein|ny-eso-1 protein
96432|NCT02686424|WT1 Proteins|wt1 proteins
96433|NCT02686424|PRAME protein|prame protein
96434|NCT02686411|Benign neoplasms|benign neoplasms
96435|NCT02686411|In situ neoplasms|in situ neoplasms
96436|NCT02686411|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
96437|NCT02686411|Consult with palliative care doctor|consult with palliative care doctor
96438|NCT02686411|Palliative care unit|palliative care unit
96439|NCT02686411|PCU|pcu
96440|NCT02686411|Questionnaires|questionnaires
96441|NCT02686411|Surveys|surveys
96442|NCT02686398|Influenza Vaccines|influenza vaccines
96443|NCT02686398|MF59 oil emulsion|mf59 oil emulsion
96444|NCT02686398|End Stage Renal Failure on Dialysis|end stage renal failure on dialysis
96445|NCT02686372|hepatocellular carcinoma|hepatocellular carcinoma
96446|NCT02686359|physiology|physiology
96447|NCT02686359|pain|pain
96448|NCT02686359|analgesia|analgesia
96449|NCT02686359|saliva|saliva
96450|NCT02686359|opiorphin|opiorphin
96451|NCT02686346|Relapsed|relapsed
96452|NCT02686346|Refractory|refractory
96453|NCT02686333|Meditation|meditation
96454|NCT02686333|Dialysis|dialysis
96455|NCT02686320|Rheumatoid arthritis|rheumatoid arthritis
96456|NCT02686320|Elderly|elderly
96457|NCT02686320|infections|infections
96458|NCT02686320|cardio-vascular disease|cardio-vascular disease
96459|NCT02686320|osteoporosis|osteoporosis
96460|NCT02686320|cancer|cancer
96461|NCT02686268|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
96462|NCT02686268|ALS|als
96463|NCT02686268|C9ORF72 gene mutation|c9orf72 gene mutation
96464|NCT02686268|Chromosome 9 open reading frame 72 protein|chromosome 9 open reading frame 72 protein
96465|NCT02686268|Natural history|natural history
96466|NCT02686268|Biomarkers|biomarkers
96467|NCT02686268|Amyotrophic Lateral Sclerosis, Familial|amyotrophic lateral sclerosis, familial
96468|NCT02686268|Amyotrophic Lateral Sclerosis, Sporadic|amyotrophic lateral sclerosis, sporadic
96469|NCT02686268|Frontotemporal Dementia-Amyotrophic Lateral Sclerosis|frontotemporal dementia-amyotrophic lateral sclerosis
96470|NCT02686242|cesarean section|cesarean section
96471|NCT02686242|spinal anesthesia|spinal anesthesia
96472|NCT02686242|general anesthesia|general anesthesia
96473|NCT02686229|Low grade glioma, registry, neurosurgery, brain tumor|low grade glioma, registry, neurosurgery, brain tumor
96474|NCT02686216|F-18 THK-5351 PET|f-18 thk-5351 pet
96475|NCT02686190|Alzheimer; luxtherapy, sleep disturbance, behaviour disturbance|alzheimer; luxtherapy, sleep disturbance, behaviour disturbance
96476|NCT02686177|Type 2 diabetes|type 2 diabetes
96477|NCT02686177|Angiogenesis|angiogenesis
96478|NCT02686177|Liraglutide|liraglutide
96479|NCT02686177|Glucagon like peptide 1 receptor agonist|glucagon like peptide 1 receptor agonist
96480|NCT02686164|Lenvatinib|lenvatinib
96481|NCT02686164|Lenvima|lenvima
96482|NCT02686164|E7080|e7080
96483|NCT02686164|Phase 1|phase 1
96484|NCT02686164|Solid tumors|solid tumors
96485|NCT02686164|Midazolam|midazolam
96486|NCT02686164|CYP3A4|cyp3a4
96487|NCT02686151|Letrozole|letrozole
96488|NCT02686151|OHSS|ohss
96489|NCT02686099|Rigid Fixation|rigid fixation
96490|NCT02686099|Sternal Plating|sternal plating
96491|NCT02686099|Sternal Closure|sternal closure
96492|NCT02686099|Sternalock|sternalock
96494|NCT02686073|progress of labor|progress of labor
96495|NCT02686073|nulliparous women|nulliparous women
96496|NCT02686047|Knee osteoarthritis|knee osteoarthritis
96497|NCT02686047|Hyaluronic acid|hyaluronic acid
96498|NCT02686047|Viscosupplementation|viscosupplementation
96499|NCT02686034|Migraine|migraine
96500|NCT02686034|Non-invasive vagus nerve stimulation|non-invasive vagus nerve stimulation
96507|NCT02685982|Depressive Disorder|depressive disorder
96508|NCT02685982|Behavioural Symptoms|behavioural symptoms
96509|NCT02685982|Mood Disorder|mood disorder
96510|NCT02685982|Adjunctive Therapy|adjunctive therapy
96511|NCT02685982|Music Therapy|music therapy
96512|NCT02685982|Brain Stimulation|brain stimulation
96513|NCT02685969|Prevention|prevention
96514|NCT02685969|Positron Emission Tomography|positron emission tomography
96515|NCT02685930|invasive mechanical ventilation|invasive mechanical ventilation
96516|NCT02685878|urinary continence|urinary continence
96517|NCT02685878|prevalence of depression|prevalence of depression
96518|NCT02685878|reproductive outcomes|reproductive outcomes
96519|NCT02685878|quality of life|quality of life
96520|NCT02685878|HIV status|hiv status
96521|NCT02685878|obstetric fistula|obstetric fistula
96522|NCT02685865|pancreatic fluid collection; pancreatic necrosis; stent;|pancreatic fluid collection; pancreatic necrosis; stent;
96523|NCT02685839|frailty syndrome, Intelligent POWER Rehabilitation Cluster Machine, Internet of Things, wearable|frailty syndrome, intelligent power rehabilitation cluster machine, internet of things, wearable
96524|NCT02685826|Open-label|open-label
96525|NCT02685826|Phase 1/2|phase 1/2
96526|NCT02685826|Durvalumab|durvalumab
96527|NCT02685826|MEDI4736|medi4736
96528|NCT02685826|Lenalidomide (Len)|lenalidomide (len)
96529|NCT02685826|Dexamethasone (dex)|dexamethasone (dex)
96530|NCT02685826|Multiple Myeloma|multiple myeloma
96531|NCT02685826|Newly-Diagnosed (NDMM)|newly-diagnosed (ndmm)
96532|NCT02685826|Transplant Non-eligible (TNE)|transplant non-eligible (tne)
96533|NCT02685826|PD-L1|pd-l1
96534|NCT02685813|Ultra sound|ultra sound
96535|NCT02685813|birth defects|birth defects
96536|NCT02685787|Care-giver burden|care-giver burden
96537|NCT02685787|Dementia|dementia
96538|NCT02685787|Alzheimer's disease|alzheimer's disease
96539|NCT02685787|Care-giver depression|care-giver depression
96540|NCT02685787|Care-giver anxiety|care-giver anxiety
96541|NCT02685709|Octreotide Capsules|octreotide capsules
96542|NCT02685709|Acromegaly|acromegaly
96543|NCT02685709|Somatostatin|somatostatin
96544|NCT02685709|Mpowered|mpowered
96551|NCT02685644|endometrioma|endometrioma
96552|NCT02685644|laparoscopy|laparoscopy
96553|NCT02685644|anti-mullerian hormone|anti-mullerian hormone
96554|NCT02685644|ovarian reserve|ovarian reserve
96555|NCT02685631|Hepatocellular carcinoma|hepatocellular carcinoma
96556|NCT02685631|Colorectal cancer|colorectal cancer
96557|NCT02685631|Neuroendocrine tumor|neuroendocrine tumor
96558|NCT02685631|Cholangiocarcinoma|cholangiocarcinoma
96559|NCT02685631|Breast cancer|breast cancer
96560|NCT02685631|Tumor of unknown primary|tumor of unknown primary
96561|NCT02685631|Pancreatic cancer|pancreatic cancer
96562|NCT02685605|Glioblastoma|glioblastoma
96563|NCT02685605|Intraoperative Radiotherapy|intraoperative radiotherapy
96564|NCT02685605|Radiotherapy Dose Escalation|radiotherapy dose escalation
96565|NCT02685592|Lentigo Maligna|lentigo maligna
96566|NCT02685592|Photodynamic Therapy|photodynamic therapy
96567|NCT02685592|Hyperspectral Imaging|hyperspectral imaging
96568|NCT02685566|Mammography|mammography
96569|NCT02685540|Anesthesia|anesthesia
96570|NCT02685540|mortality|mortality
96571|NCT02685514|HIFU|hifu
96572|NCT02685514|Graves' disease|graves' disease
96573|NCT02685514|treatment|treatment
96574|NCT02685475|Diabetes mellitus|diabetes mellitus
96575|NCT02685475|Axillary brachial plexus block|axillary brachial plexus block
96576|NCT02685475|Block duration|block duration
96577|NCT02685475|Time-to-first pain|time-to-first pain
96578|NCT02685475|Postoperative analgesia|postoperative analgesia
96579|NCT02685449|diabetes type 1|diabetes type 1
96580|NCT02685449|insulin pump|insulin pump
96581|NCT02685449|prandial insulin requirement|prandial insulin requirement
96582|NCT02685449|pure protein meal|pure protein meal
96583|NCT02685449|high protein meal|high protein meal
96584|NCT02685449|square bolus|square bolus
96585|NCT02685449|square-wave bolus|square-wave bolus
96586|NCT02685449|insulin bolus|insulin bolus
96587|NCT02685449|dietary protein|dietary protein
96592|NCT02685384|healthcare utilization|healthcare utilization
96593|NCT02685384|health expenditures|health expenditures
96594|NCT02685384|preventive services|preventive services
96595|NCT02685384|biomarkers|biomarkers
96596|NCT02685358|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
96597|NCT02685358|Primary Health Care|primary health care
96598|NCT02685358|Mobile Applications|mobile applications
96599|NCT02685358|Veterans|veterans
96600|NCT02685345|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
96601|NCT02685345|sitagliptin|sitagliptin
96602|NCT02685345|adult|adult
96603|NCT02685345|Phase 2|phase 2
96604|NCT02685280|rechargeable neurostimulators|rechargeable neurostimulators
96605|NCT02685254|Group Therapy|group therapy
96606|NCT02685254|Structured Skills Training|structured skills training
96607|NCT02685254|Dialectic Behavioural Therapy|dialectic behavioural therapy
96608|NCT02685241|Exhaled breath|exhaled breath
96609|NCT02685241|Biomarker|biomarker
96610|NCT02685215|intensive care unit|intensive care unit
96611|NCT02685215|muscular dystrophy|muscular dystrophy
96612|NCT02685215|mortality|mortality
96614|NCT02685215|tracheostomy|tracheostomy
96615|NCT02685202|orofacial pain|orofacial pain
96616|NCT02685202|sleep-disordered breathing|sleep-disordered breathing
96617|NCT02685202|temporomandibular disorder|temporomandibular disorder
96618|NCT02685202|oral appliance|oral appliance
96619|NCT02685202|upper airway collapse|upper airway collapse
96620|NCT02685176|hypothermia|hypothermia
96621|NCT02685176|rewarming|rewarming
96622|NCT02685176|non-shivering|non-shivering
96623|NCT02685150|Endoscopic Tri-Modal Imaging|endoscopic tri-modal imaging
96624|NCT02685150|Gastric juice|gastric juice
96625|NCT02685150|Functional dyspepsia|functional dyspepsia
96626|NCT02685150|Acid reflux disease|acid reflux disease
96627|NCT02685150|Bile reflux|bile reflux
96628|NCT02685137|Kernicterus|kernicterus
96629|NCT02685137|Neonatal Jaundice|neonatal jaundice
96630|NCT02685137|Newborn Jaundice|newborn jaundice
96631|NCT02685111|Breast cancer|breast cancer
96632|NCT02685111|Adjuvant|adjuvant
96633|NCT02685111|Docetaxel|docetaxel
96634|NCT02685111|Adriamycin|adriamycin
96635|NCT02685111|Cyclophosphamide|cyclophosphamide
96636|NCT02685111|Neutropenia|neutropenia
96637|NCT02685111|Filgrastim|filgrastim
96638|NCT02685111|Pegfilgrastim|pegfilgrastim
96639|NCT02685098|Stem cells|stem cells
96640|NCT02685098|MSCs|mscs
96641|NCT02685098|Mesenchymal|mesenchymal
96642|NCT02685098|Amputation|amputation
96644|NCT02685098|below knee amputation|below knee amputation
96645|NCT02685098|CHAMP|champ
96646|NCT02685072|Smoking Cessation|smoking cessation
96647|NCT02685072|Nicotine Cessation|nicotine cessation
96648|NCT02685059|breast cancer|breast cancer
96649|NCT02685059|Medi4736|medi4736
96650|NCT02685059|Anti PD-L1|anti pd-l1
96651|NCT02685059|Nab-Paclitaxel|nab-paclitaxel
96652|NCT02685059|Placebo|placebo
96653|NCT02685059|triple negative|triple negative
96654|NCT02685033|Osteomyelitis|osteomyelitis
96655|NCT02685033|dalbavancin|dalbavancin
96656|NCT02685033|antibiotic|antibiotic
96657|NCT02685020|Healthy|healthy
96658|NCT02685020|Human Immunodeficiency Virus|human immunodeficiency virus
96659|NCT02685020|adenovirus serotype 26|adenovirus serotype 26
96660|NCT02685020|Ad26.Mos.HIV|ad26.mos.hiv
96661|NCT02685020|Vaccine|vaccine
96662|NCT02685020|Placebo|placebo
96663|NCT02685020|Glycoprotein|glycoprotein
96664|NCT02685020|IPCAVD010|ipcavd010
96665|NCT02685007|minimal invasive surgery|minimal invasive surgery
96666|NCT02684994|Trauma|trauma
96667|NCT02684994|Sexual assault|sexual assault
96668|NCT02684994|Sexual abuse|sexual abuse
96669|NCT02684994|Physical assault|physical assault
87925|NCT02737943|Burn|burn
96670|NCT02684994|Physical abuse|physical abuse
96671|NCT02684994|PTSD|ptsd
96672|NCT02684994|Interpersonal Violence|interpersonal violence
96673|NCT02684994|Women|women
96674|NCT02684955|cardiac arrest|cardiac arrest
96675|NCT02684955|near-infrared spectroscopy|near-infrared spectroscopy
96676|NCT02684955|automated infrared pupillometry|automated infrared pupillometry
96677|NCT02684955|prognostication|prognostication
96678|NCT02684942|Meperidine|meperidine
96679|NCT02684942|Fentanyl|fentanyl
96680|NCT02684942|Pain management|pain management
96681|NCT02684942|brachytherapy|brachytherapy
96682|NCT02684929|insulin resistance|insulin resistance
96683|NCT02684929|bcaa|bcaa
96684|NCT02684929|mitochondrial biogenesis|mitochondrial biogenesis
96685|NCT02684916|Chiropractic spinal manipulation|chiropractic spinal manipulation
96686|NCT02684916|Children|children
96687|NCT02684916|Pediatric|pediatric
96688|NCT02684916|Headache|headache
96689|NCT02684903|Child Abuse|child abuse
96690|NCT02684903|Parent Child Interaction Therapy (PCIT)|parent child interaction therapy (pcit)
96691|NCT02684903|Evidenced Based Intervention|evidenced based intervention
96692|NCT02684903|Self-control|self-control
96693|NCT02684877|Fatigue|fatigue
96694|NCT02684877|Quality of life|quality of life
96695|NCT02684877|Critically ill patients|critically ill patients
96696|NCT02684864|biomarker|biomarker
96697|NCT02684864|inflammation|inflammation
96698|NCT02684864|knee|knee
96699|NCT02684864|prognosis|prognosis
96700|NCT02684838|Gliadel, Carmustine wafer implant|gliadel, carmustine wafer implant
96701|NCT02684825|Stroke|stroke
96702|NCT02684825|ischemic stroke|ischemic stroke
96703|NCT02684825|atrial fibrillation|atrial fibrillation
96704|NCT02684825|continuous cardiac monitoring|continuous cardiac monitoring
96705|NCT02684825|insertable cardiac monitoring|insertable cardiac monitoring
96706|NCT02684825|implantable loop recorder|implantable loop recorder
96707|NCT02684825|antithrombotics|antithrombotics
96708|NCT02684825|anticoagulants|anticoagulants
96709|NCT02684825|stroke subtype|stroke subtype
96710|NCT02684825|atherothrombotic stroke|atherothrombotic stroke
96711|NCT02684825|lacunar stroke|lacunar stroke
96712|NCT02684812|antifibrinolytic therapy|antifibrinolytic therapy
96713|NCT02684812|recurrent bleeding|recurrent bleeding
96714|NCT02684812|tranexamic acid|tranexamic acid
96715|NCT02684773|Hemodialysis|hemodialysis
96716|NCT02684773|Left Ventricular Mass|left ventricular mass
97598|NCT02679157|Anxiety|anxiety
96717|NCT02684773|Cardiac Magnetic resonance Imaging|cardiac magnetic resonance imaging
96718|NCT02684760|Inflammatory Bowel Disease|inflammatory bowel disease
96719|NCT02684747|Healthy Volunteers|healthy volunteers
96720|NCT02684747|Sports Medicine|sports medicine
96721|NCT02684747|Athletes|athletes
96722|NCT02684747|Anti-doping|anti-doping
96723|NCT02684734|Ulcerative Colitis|ulcerative colitis
96725|NCT02684734|Cytomegalovirus|cytomegalovirus
96726|NCT02684734|CMV|cmv
96727|NCT02684721|rehabilitation|rehabilitation
96728|NCT02684721|physical capacity|physical capacity
96729|NCT02684721|quality of life|quality of life
96730|NCT02684695|Magnetic resonance imaging|magnetic resonance imaging
96731|NCT02684695|Imaging biomarker|imaging biomarker
96732|NCT02684695|Diffusion-weighted imaging|diffusion-weighted imaging
96733|NCT02684682|Toothbrushing|toothbrushing
96734|NCT02684682|Gingivitis|gingivitis
96735|NCT02684682|Dental Plaque|dental plaque
96736|NCT02684682|Periodontal Diseases|periodontal diseases
96737|NCT02684682|Clinical Trial|clinical trial
96738|NCT02684669|burn injury|burn injury
96739|NCT02684669|controlled trial|controlled trial
96740|NCT02684669|latent sensitization|latent sensitization
96741|NCT02684669|naloxone|naloxone
96742|NCT02684669|secondary hyperalgesia|secondary hyperalgesia
96743|NCT02684669|volunteers|volunteers
96744|NCT02684656|Oxalate|oxalate
96745|NCT02684656|Inflammation|inflammation
96746|NCT02684656|Hemodiafiltration|hemodiafiltration
96747|NCT02684656|Hemodialysis|hemodialysis
96748|NCT02684656|Oxalate Blood Sample|oxalate blood sample
96749|NCT02684643|individualised therapy|individualised therapy
96750|NCT02684643|hyperphosphatemia|hyperphosphatemia
96751|NCT02684643|hemodialysis|hemodialysis
96752|NCT02684643|clinical trials|clinical trials
96753|NCT02684643|restricted phosphate diet|restricted phosphate diet
96754|NCT02684643|phosphate binders|phosphate binders
96755|NCT02684565|pre-diabetes|pre-diabetes
96756|NCT02684565|blood glucose regulation|blood glucose regulation
96757|NCT02684565|branching chain amino acids|branching chain amino acids
96758|NCT02684565|diabetes|diabetes
96759|NCT02684565|lower blood sugar|lower blood sugar
96760|NCT02684513|Well-being|well-being
96761|NCT02684513|Quality of Recovery|quality of recovery
96762|NCT02684513|Maternal complications|maternal complications
96763|NCT02684500|aSAH|asah
96764|NCT02684487|vitamin D|vitamin d
96765|NCT02684487|vitamin D3|vitamin d3
96766|NCT02684487|sepsis|sepsis
96767|NCT02684487|severe sepsis|severe sepsis
96768|NCT02684487|critical illness|critical illness
96769|NCT02684487|ICU|icu
96770|NCT02684396|Drug therapy|drug therapy
96771|NCT02684383|Dengue Vaccine|dengue vaccine
96772|NCT02684370|Psoriasis|psoriasis
96773|NCT02684370|Skin Diseases|skin diseases
96774|NCT02684370|Skin Diseases, Papulosquamous|skin diseases, papulosquamous
96775|NCT02684370|ustekinumab|ustekinumab
96776|NCT02684370|Dermatologic Agents|dermatologic agents
96777|NCT02684370|ABBV-066|abbv-066
96778|NCT02684370|BI 655066|bi 655066
96779|NCT02684370|risankizumab|risankizumab
96780|NCT02684357|ABBV-066|abbv-066
96781|NCT02684357|BI 655066|bi 655066
96782|NCT02684357|risankizumab|risankizumab
96783|NCT02684344|Post-Operative Urinary Retention|post-operative urinary retention
96784|NCT02684292|PD1|pd1
96785|NCT02684292|PD-1|pd-1
96786|NCT02684292|PDL1|pdl1
96787|NCT02684292|PD-L1|pd-l1
96788|NCT02684266|neoplasm, Cycline-Dependent Kinase|neoplasm, cycline-dependent kinase
96789|NCT02684253|Nivolumab|nivolumab
96790|NCT02684253|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
96792|NCT02684227|Endometrial cancer|endometrial cancer
96793|NCT02684227|Advanced Stage Endometrioid Endometrial Cancer|advanced stage endometrioid endometrial cancer
96794|NCT02684227|Recurrent Endometrioid Endometrial Cancer|recurrent endometrioid endometrial cancer
96795|NCT02684227|Enzalutamide|enzalutamide
96796|NCT02684227|MDV3100|mdv3100
96797|NCT02684227|XTANDI|xtandi
96798|NCT02684227|Carboplatin|carboplatin
96799|NCT02684227|Paclitaxel|paclitaxel
96800|NCT02684227|Taxol|taxol
96801|NCT02684214|food security|food security
96802|NCT02684201|Phantom Limb|phantom limb
96803|NCT02684201|Upper Amputee|upper amputee
96804|NCT02684201|Electrodes|electrodes
96805|NCT02684201|Implant|implant
96806|NCT02684201|Pain|pain
96807|NCT02684175|Audiometry|audiometry
96808|NCT02684175|Cochlear Implants|cochlear implants
96809|NCT02684175|Adult|adult
96810|NCT02684175|Telemedicine|telemedicine
96811|NCT02684175|Health Services Accessibility|health services accessibility
96812|NCT02684175|Rural Population|rural population
96813|NCT02684175|Technology Assessment, Biomedical|technology assessment, biomedical
96814|NCT02684162|Leukemia|leukemia
96815|NCT02684162|Myeloproliferative Diseases|myeloproliferative diseases
96816|NCT02684162|Acute myelogenous leukemia|acute myelogenous leukemia
96817|NCT02684162|AML|aml
96818|NCT02684162|Myelodysplastic syndrome|myelodysplastic syndrome
96819|NCT02684162|MDS|mds
96820|NCT02684162|Donor lymphocyte infusion|donor lymphocyte infusion
96821|NCT02684162|DLI|dli
96822|NCT02684162|Allogeneic stem cell transplant|allogeneic stem cell transplant
96823|NCT02684162|Stem cell transplantation|stem cell transplantation
96824|NCT02684162|AlloSCT|allosct
96825|NCT02684149|Intensive care|intensive care
96826|NCT02684149|Arterial puncture|arterial puncture
96827|NCT02684149|Cross-over|cross-over
96828|NCT02684149|Relational touch|relational touch
96829|NCT02684149|Pain|pain
96830|NCT02684136|insomnia|insomnia
96831|NCT02684136|fibromyalgia|fibromyalgia
96832|NCT02684136|polysomnography|polysomnography
96833|NCT02684136|pain management|pain management
96834|NCT02684123|Alopecia areata|alopecia areata
96835|NCT02684097|Alopecia, Alopecia Totalis, Alopecia Universalis|alopecia, alopecia totalis, alopecia universalis
96836|NCT02684084|Diabetic Macular Edema|diabetic macular edema
96837|NCT02684084|Ozurdex|ozurdex
96838|NCT02684084|Lucentis|lucentis
96839|NCT02684071|medulloblastoma, ependymoma, AT/RT, embryonal|medulloblastoma, ependymoma, at/rt, embryonal
96840|NCT02684058|Glioma|glioma
96841|NCT02684058|Anaplastic astrocytoma|anaplastic astrocytoma
96842|NCT02684058|Glioblastoma|glioblastoma
96843|NCT02684058|Giant cell glioblastoma|giant cell glioblastoma
96844|NCT02684058|Gliosarcoma|gliosarcoma
96845|NCT02684058|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
96846|NCT02684058|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
96847|NCT02684058|Anaplastic ependymoma|anaplastic ependymoma
96848|NCT02684058|Choroid plexus carcinoma|choroid plexus carcinoma
96849|NCT02684058|Anaplastic ganglioglioma|anaplastic ganglioglioma
96850|NCT02684058|Pineal parenchymal tumor|pineal parenchymal tumor
96851|NCT02684058|Pineoblastoma|pineoblastoma
96852|NCT02684058|Medulloblastoma|medulloblastoma
96853|NCT02684058|PNET|pnet
96854|NCT02684058|Rhabdoid tumor|rhabdoid tumor
96855|NCT02684058|Perineurioma|perineurioma
96856|NCT02684058|MPNST|mpnst
96857|NCT02684058|Malignant meningloma|malignant meningloma
96858|NCT02684058|Anaplastic hemangiopericytoma|anaplastic hemangiopericytoma
96859|NCT02684058|Dabrafenib|dabrafenib
96860|NCT02684058|Pediatrics|pediatrics
96861|NCT02684058|Brain neoplasma|brain neoplasma
96862|NCT02684032|PI3K (phosphoinositide 3-kinase)|pi3k (phosphoinositide 3-kinase)
96863|NCT02684032|mTOR (mechanistic target of rapamycin)|mtor (mechanistic target of rapamycin)
96864|NCT02684032|PI3K/mTOR|pi3k/mtor
96865|NCT02684032|metastatic breast cancer (MBC)|metastatic breast cancer (mbc)
96866|NCT02684032|ER+ (estrogen receptor positive)|er+ (estrogen receptor positive)
96867|NCT02684032|HER2- (human epidermal growth factor receptor 2 negative)|her2- (human epidermal growth factor receptor 2 negative)
96868|NCT02684019|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
96869|NCT02684019|sedation|sedation
96870|NCT02684019|dexmedetomidine|dexmedetomidine
96871|NCT02684019|propofol|propofol
96872|NCT02684019|Magnesium sulphate|magnesium sulphate
96873|NCT02684019|Bispectral index monitoring|bispectral index monitoring
96874|NCT02684006|Cancer|cancer
96875|NCT02684006|renal cell cancer|renal cell cancer
96876|NCT02684006|kidney disease|kidney disease
96877|NCT02684006|kidney neoplasms|kidney neoplasms
96878|NCT02684006|axitinib, sunitinib|axitinib, sunitinib
96879|NCT02683915|Acute kidney injury|acute kidney injury
96880|NCT02683915|Perinatal asphyxia|perinatal asphyxia
96881|NCT02683915|Therapeutic hypothermia|therapeutic hypothermia
96882|NCT02683915|Serum NGAL|serum ngal
96883|NCT02683915|Serum cystatin-C|serum cystatin-c
96884|NCT02683902|prediabetes|prediabetes
96885|NCT02683902|tDCS|tdcs
96886|NCT02683902|transcranial direct current stimulation|transcranial direct current stimulation
96887|NCT02683902|obesity|obesity
96888|NCT02683902|diabetes|diabetes
96889|NCT02683876|body odor, malodor, halitosis|body odor, malodor, halitosis
96890|NCT02683837|Intraoperative Neurophysiological Monitoring|intraoperative neurophysiological monitoring
96891|NCT02683837|Reflex, Pupillary|reflex, pupillary
96892|NCT02683837|remifentanil|remifentanil
96893|NCT02683811|adolescence|adolescence
96894|NCT02683811|prevention|prevention
96895|NCT02683811|wellbeing|wellbeing
96896|NCT02683811|evaluation|evaluation
96908|NCT02683746|Albiglutide|albiglutide
96909|NCT02683746|Tolerability|tolerability
96910|NCT02683746|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
96911|NCT02683746|Efficacy|efficacy
96912|NCT02683707|Percutaneous Coronary Intervention|percutaneous coronary intervention
96913|NCT02683707|Blood Platelets|blood platelets
96914|NCT02683707|Fentanyl|fentanyl
96915|NCT02683694|Epiretinal membrane|epiretinal membrane
96916|NCT02683694|lamellar holes of the macula|lamellar holes of the macula
96917|NCT02683694|macular holes|macular holes
96918|NCT02683694|vitreomacular traction syndrome|vitreomacular traction syndrome
96919|NCT02683668|Inhalers|inhalers
96920|NCT02683668|Tiotropium|tiotropium
96921|NCT02683629|Parkinson's Disease|parkinson's disease
96922|NCT02683629|Xenotransplantation|xenotransplantation
96923|NCT02683629|choroid plexus|choroid plexus
96924|NCT02683603|colistin|colistin
96925|NCT02683603|aerosol|aerosol
96926|NCT02683603|ventilator associated pneumonia|ventilator associated pneumonia
96927|NCT02683603|nephrotoxicity|nephrotoxicity
96928|NCT02683603|intravenous|intravenous
96929|NCT02683590|Sternectomie|sternectomie
96930|NCT02683590|Ceramic Implant|ceramic implant
96931|NCT02683590|Bones Tumors|bones tumors
96933|NCT02683525|Allogeneic|allogeneic
96934|NCT02683525|Sitagliptin|sitagliptin
96935|NCT02683499|Tooth preparation|tooth preparation
96936|NCT02683499|Prosthodontics|prosthodontics
96937|NCT02683447|Continuing Medical Education|continuing medical education
96938|NCT02683447|Simulation|simulation
96939|NCT02683447|Non-technical Skills|non-technical skills
96940|NCT02683447|Crisis Resource Management|crisis resource management
96941|NCT02683434|soccer|soccer
96942|NCT02683421|Rheumatoid arthritis|rheumatoid arthritis
96943|NCT02683421|tilmanocept|tilmanocept
96944|NCT02683421|imaging|imaging
96945|NCT02683395|PLX51107|plx51107
96946|NCT02683395|Acute Myeloid Leukemia|acute myeloid leukemia
96947|NCT02683395|Myelodysplastic Syndrome|myelodysplastic syndrome
96948|NCT02683395|Neoplasms|neoplasms
96949|NCT02683369|Non-anemic Iron Deficiency, Iron Supplementation|non-anemic iron deficiency, iron supplementation
96950|NCT02683356|Percutaneous Coronary Intervention|percutaneous coronary intervention
96951|NCT02683356|Stents|stents
96952|NCT02683330|PD|pd
96953|NCT02683330|Parkinson's|parkinson's
96954|NCT02683317|DHA|dha
96955|NCT02683317|Retinopathy of Prematurity|retinopathy of prematurity
96956|NCT02683291|Kidney transplantation|kidney transplantation
96957|NCT02683291|sirolimus|sirolimus
96958|NCT02683291|cytomegalovirus|cytomegalovirus
96959|NCT02683291|aged|aged
96960|NCT02683252|Magnetic resonance imaging|magnetic resonance imaging
96961|NCT02683252|perfusion|perfusion
96962|NCT02683252|quantitative|quantitative
96963|NCT02683213|fluoxetine|fluoxetine
96964|NCT02683213|outcome|outcome
96965|NCT02683213|depression|depression
96966|NCT02683213|plasticity|plasticity
96967|NCT02683187|insulin secretion|insulin secretion
96968|NCT02683187|GLP-1|glp-1
96969|NCT02683187|alpha cell|alpha cell
96970|NCT02683187|paracrine effect|paracrine effect
96971|NCT02683187|Glucagon-Like Peptide 1|glucagon-like peptide 1
96972|NCT02683174|syncope|syncope
96973|NCT02683122|Organ dysfunction scores|organ dysfunction scores
96974|NCT02683122|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
96975|NCT02683122|Intensive care units|intensive care units
96976|NCT02683070|Catheter-related bladder discomfort|catheter-related bladder discomfort
88232|NCT02736006|diving|diving
96977|NCT02683070|Pudendal nerve block|pudendal nerve block
96978|NCT02683070|Tramadol|tramadol
96979|NCT02683070|Randomized controlled trial|randomized controlled trial
96980|NCT02683070|catheter-related bladder discomfort prevention|catheter-related bladder discomfort prevention
96981|NCT02683044|Erectile dysfunction|erectile dysfunction
96982|NCT02683044|Low-Density Shock Waves|low-density shock waves
96983|NCT02683044|Randomized Clinical Trial|randomized clinical trial
96984|NCT02683031|fertilization arrest|fertilization arrest
96985|NCT02683031|Cleavage failure|cleavage failure
96986|NCT02683031|Embryonic development|embryonic development
96987|NCT02683031|Calcium ionophore|calcium ionophore
96988|NCT02683005|treatment|treatment
96989|NCT02683005|pharmacokinetics|pharmacokinetics
97789|NCT02677636|Dermatitis|dermatitis
96994|NCT02682966|pulmonary embolism|pulmonary embolism
96995|NCT02682966|Computed Tomography Angiography|computed tomography angiography
96996|NCT02682966|postoperative myocardial injury|postoperative myocardial injury
97003|NCT02682914|Psychological distress|psychological distress
97005|NCT02682914|Young patients|young patients
97006|NCT02682888|brain functional connectivity changes|brain functional connectivity changes
97010|NCT02682862|cigarette|cigarette
97011|NCT02682862|bronchodilator|bronchodilator
97012|NCT02682836|physical activity|physical activity
97013|NCT02682836|chemotherapy|chemotherapy
97014|NCT02682836|fatigue|fatigue
97015|NCT02682810|HIV|hiv
97016|NCT02682810|point-of-care HIV diagnosis|point-of-care hiv diagnosis
97017|NCT02682810|Alere Q|alere q
97018|NCT02682810|diagnostic|diagnostic
97019|NCT02682810|children|children
97020|NCT02682771|gastroplasty, breathing exercices, positive pressure|gastroplasty, breathing exercices, positive pressure
97021|NCT02682758|xenon|xenon
97022|NCT02682758|transpulmonary pressure|transpulmonary pressure
97023|NCT02682758|electrical impedance tomography|electrical impedance tomography
97024|NCT02682758|tidal volume|tidal volume
97025|NCT02682758|esophageal pressure measurement|esophageal pressure measurement
97026|NCT02682732|Acute Myeloid Leukemia|acute myeloid leukemia
97027|NCT02682732|PET/CT Scan|pet/ct scan
97028|NCT02682719|Natriuretic peptide, brain|natriuretic peptide, brain
97029|NCT02682719|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
97030|NCT02682719|Hypertension|hypertension
97031|NCT02682719|Cardiovascular prevention|cardiovascular prevention
97032|NCT02682719|Left atrial volume index|left atrial volume index
97033|NCT02682719|Angiotensin receptor neprilysin inhibitor|angiotensin receptor neprilysin inhibitor
97034|NCT02682719|LCZ696|lcz696
97035|NCT02682719|Valsartan|valsartan
97036|NCT02682719|Sacubitril|sacubitril
97037|NCT02682706|brown adipose tissue|brown adipose tissue
97038|NCT02682706|magnetic resonance imaging|magnetic resonance imaging
97039|NCT02682706|energy expenditure|energy expenditure
97040|NCT02682706|non-shivering thermogenesis|non-shivering thermogenesis
97041|NCT02682680|diabetes|diabetes
97042|NCT02682680|hyperlipidaemia|hyperlipidaemia
97043|NCT02682680|colesevelam|colesevelam
97044|NCT02682680|ezetimibe|ezetimibe
97045|NCT02682680|LDL cholesterol|ldl cholesterol
97046|NCT02682680|glycated hemoglobin|glycated hemoglobin
97047|NCT02682667|Apheresis Products|apheresis products
97048|NCT02682667|Immunological|immunological
97049|NCT02682667|Diverse Malignan|diverse malignan
97050|NCT02682667|Premalignant|premalignant
97051|NCT02682667|Protein|protein
97052|NCT02682654|Pain|pain
97053|NCT02682654|Ankle|ankle
97054|NCT02682654|Knee|knee
97055|NCT02682654|Brace|brace
97056|NCT02682615|Cardiac Index|cardiac index
97057|NCT02682615|Noninvasive|noninvasive
97058|NCT02682615|esCCO|escco
97059|NCT02682615|PiCCO|picco
97060|NCT02682615|Thermodilution|thermodilution
97061|NCT02682602|total hip arthroplasty|total hip arthroplasty
97062|NCT02682589|Complete Mesocolic Excision|complete mesocolic excision
97063|NCT02682589|locally advanced Colon Cancer|locally advanced colon cancer
97064|NCT02682589|Laparoscopic|laparoscopic
97065|NCT02682576|brachial artery ultrasound imaging|brachial artery ultrasound imaging
97066|NCT02682576|flow-mediated dilation|flow-mediated dilation
97067|NCT02682576|endothelium|endothelium
97068|NCT02682563|SGLT-2 inhibition, Renal, Cardiovascular, Type 2 diabetes, forxiga, dapagliflozin|sglt-2 inhibition, renal, cardiovascular, type 2 diabetes, forxiga, dapagliflozin
97069|NCT02682550|polytrauma|polytrauma
97070|NCT02682550|hemorrhagic shock|hemorrhagic shock
97071|NCT02682550|sepsis|sepsis
97072|NCT02682550|MODS|mods
97073|NCT02682537|Resting energy expenditure|resting energy expenditure
97074|NCT02682537|Calorie requirements|calorie requirements
97075|NCT02682537|Indirect Calorimetry|indirect calorimetry
97076|NCT02682511|Ifetroban|ifetroban
97077|NCT02682511|Scleroderma|scleroderma
97078|NCT02682511|Systemic Sclerosis|systemic sclerosis
97079|NCT02682498|Knee Arthroplasty, Total|knee arthroplasty, total
97080|NCT02682498|Liposomal Bupivicaine|liposomal bupivicaine
97081|NCT02682485|Rectal Cancer|rectal cancer
97082|NCT02682485|low anterior resection|low anterior resection
88338|NCT02735226|stroke|stroke
97083|NCT02682485|SES|ses
97084|NCT02682485|SES-DTA|ses-dta
97085|NCT02682485|anastomotic leak|anastomotic leak
97086|NCT02682485|anastomotic healing|anastomotic healing
97087|NCT02682485|intestinal healing|intestinal healing
97088|NCT02682485|anastomosis|anastomosis
97090|NCT02682459|crescentic glomerulonephritis|crescentic glomerulonephritis
97091|NCT02682459|rapidly progressive renal failure|rapidly progressive renal failure
97092|NCT02682459|chronic kidney disease|chronic kidney disease
97093|NCT02682459|ACE-inhibitors|ace-inhibitors
97095|NCT02682446|Early gastric cancer|early gastric cancer
97096|NCT02682446|endoscopic submucosal dissection|endoscopic submucosal dissection
97097|NCT02682446|serum pepsinogen|serum pepsinogen
97098|NCT02682446|Helicobacter pylori|helicobacter pylori
97099|NCT02682407|IgAN|igan
97100|NCT02682407|MN|mn
97101|NCT02682407|C3 Glomerulopathy|c3 glomerulopathy
97102|NCT02682407|Lupus Nephritis|lupus nephritis
97103|NCT02682394|Cancer of pancreas|cancer of pancreas
97104|NCT02682394|steatosis|steatosis
97105|NCT02682394|MRI|mri
97112|NCT02682381|short gut|short gut
97113|NCT02682381|SBS|sbs
97114|NCT02682381|parenteral nutrition|parenteral nutrition
97115|NCT02682368|surgeon performed ultrasound|surgeon performed ultrasound
97116|NCT02682329|Peroxide|peroxide
97119|NCT02682303|Adhesive elastic bandaging|adhesive elastic bandaging
97120|NCT02682303|balance|balance
97121|NCT02682303|posturography|posturography
97122|NCT02682290|SPUTUM|sputum
97123|NCT02682290|RHEOLOGY|rheology
97124|NCT02682277|obesity|obesity
97125|NCT02682277|body weight|body weight
97126|NCT02682277|overweight|overweight
97127|NCT02682277|weight loss|weight loss
97128|NCT02682277|polyglucosamine|polyglucosamine
97129|NCT02682277|L112|l112
97130|NCT02682277|caloric restriction|caloric restriction
97131|NCT02682277|physical activity|physical activity
97132|NCT02682264|acne|acne
97133|NCT02682251|Cardiac Resynchronization Therapy Devices|cardiac resynchronization therapy devices
97134|NCT02682251|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
97135|NCT02682225|Esketamine|esketamine
97136|NCT02682225|Placebo|placebo
97137|NCT02682225|Racemic ketamine|racemic ketamine
97138|NCT02682225|Pharmacokinetics|pharmacokinetics
97139|NCT02682212|Pelvic floor|pelvic floor
97140|NCT02682212|obstetrics|obstetrics
97141|NCT02682212|perineal tear|perineal tear
97142|NCT02682212|physiotherapy|physiotherapy
97143|NCT02682186|Prosthetic breast surgery|prosthetic breast surgery
97144|NCT02682186|Locoregional anesthesia|locoregional anesthesia
97145|NCT02682186|Pectoral nerve block|pectoral nerve block
97146|NCT02682186|Pain|pain
97147|NCT02682186|Postoperative analgesia|postoperative analgesia
97148|NCT02682160|bariatric surgery|bariatric surgery
97149|NCT02682134|Sore Throat|sore throat
97152|NCT02682134|Dexamethasone|dexamethasone
97153|NCT02682108|Hepatitis B|hepatitis b
97154|NCT02682108|Hepatitis C|hepatitis c
97155|NCT02682108|Fibrosis, Liver|fibrosis, liver
97156|NCT02682108|Magnetic Resonance Imaging|magnetic resonance imaging
97157|NCT02682095|Hypertension|hypertension
97158|NCT02682095|Blood Pressure Control|blood pressure control
97159|NCT02682095|Adherence|adherence
97160|NCT02682095|Mixed Methods|mixed methods
97161|NCT02682082|Pancreatic cancer|pancreatic cancer
97162|NCT02682082|Pain Management|pain management
97163|NCT02682082|Celiac plexus neurolysis|celiac plexus neurolysis
97164|NCT02682082|Bupivacaine|bupivacaine
97165|NCT02682082|Palliative treatment|palliative treatment
97166|NCT02682069|Diabetic foot ulcer|diabetic foot ulcer
97167|NCT02682069|venous leg ulcer|venous leg ulcer
97168|NCT02682069|fluorescence imaging|fluorescence imaging
97169|NCT02682069|wound imaging|wound imaging
97170|NCT02682056|Pediatrics|pediatrics
97171|NCT02682056|Endocrinology|endocrinology
97172|NCT02682056|Adolescent|adolescent
97173|NCT02682056|Microneedle|microneedle
97174|NCT02682030|Airway Clearance Devices|airway clearance devices
97175|NCT02682030|High Frequency Chest Compression Devices|high frequency chest compression devices
97176|NCT02682030|Cough Assist|cough assist
97177|NCT02682017|Seaweed|seaweed
97178|NCT02682017|Pork|pork
97179|NCT02682017|Fucoidan|fucoidan
97180|NCT02682017|Laminarin|laminarin
97181|NCT02682017|Functional Food|functional food
97182|NCT02682017|Antioxidant activity|antioxidant activity
97183|NCT02681913|Cardioplegia|cardioplegia
97184|NCT02681913|Cardiac Surgery|cardiac surgery
97185|NCT02681913|Adenosine|adenosine
97186|NCT02681913|Therapeutic Uses|therapeutic uses
97187|NCT02681913|Intermittent warm blood cardioplegia|intermittent warm blood cardioplegia
97188|NCT02681913|Minimally Invasive Surgery|minimally invasive surgery
97189|NCT02681913|minimally invasive mitral valve plasty (mini-MPL)|minimally invasive mitral valve plasty (mini-mpl)
97195|NCT02681874|obesity|obesity
97196|NCT02681874|children|children
97197|NCT02681874|minority|minority
97198|NCT02681874|pre-schoolers|pre-schoolers
97199|NCT02681861|Pharmacodynamics|pharmacodynamics
97200|NCT02681861|Pharmacokinetics|pharmacokinetics
97201|NCT02681861|ASP6294|asp6294
97202|NCT02681861|Maximum tolerated dose|maximum tolerated dose
97203|NCT02681861|Healthy subjects|healthy subjects
97204|NCT02681848|Primary care attendance|primary care attendance
97205|NCT02681848|All-cause|all-cause
97206|NCT02681848|Cause specific|cause specific
97207|NCT02681848|Hospital attendance|hospital attendance
97208|NCT02681822|Genome-wide association studies|genome-wide association studies
97209|NCT02681822|Environmental factors|environmental factors
97210|NCT02681822|Behavioral Assessment|behavioral assessment
97211|NCT02681822|Pathway analysis|pathway analysis
97212|NCT02681783|aflibercept|aflibercept
97213|NCT02681770|kidney transplantation|kidney transplantation
97214|NCT02681770|adherence|adherence
97215|NCT02681770|quality of life|quality of life
97216|NCT02681770|couples|couples
97217|NCT02681770|fundamental frequency|fundamental frequency
97218|NCT02681770|communication|communication
97219|NCT02681770|social support|social support
97220|NCT02681757|pediatric hand burn|pediatric hand burn
97221|NCT02681757|pediatric foot burn|pediatric foot burn
97222|NCT02681757|mepitel Ag|mepitel ag
97223|NCT02681757|soft cast technique for burn wound heaing|soft cast technique for burn wound heaing
97224|NCT02681718|A1C≥9%|a1c≥9%
97225|NCT02681718|minorities|minorities
97226|NCT02681718|economically disadvantaged|economically disadvantaged
97227|NCT02681692|colonoscopy|colonoscopy
97228|NCT02681692|colonoscopy education|colonoscopy education
97229|NCT02681692|magnetic endoscope imaging|magnetic endoscope imaging
97230|NCT02681692|Colonic Diseases|colonic diseases
97237|NCT02681653|Statins|statins
97238|NCT02681653|Septic Shock|septic shock
97239|NCT02681614|Imaging|imaging
97240|NCT02681614|Prostate|prostate
97241|NCT02681614|Multiparametric MRI|multiparametric mri
97242|NCT02681614|brachytherapy|brachytherapy
97243|NCT02681601|Diet, Food, and Nutrition|diet, food, and nutrition
97244|NCT02681588|diabetes, obesity, skinfold, newborn|diabetes, obesity, skinfold, newborn
97245|NCT02681562|olaparib|olaparib
97246|NCT02681510|medication tolerability|medication tolerability
97247|NCT02681497|canagliflozin|canagliflozin
97248|NCT02681497|diabetes|diabetes
97249|NCT02681497|SGLT2|sglt2
97250|NCT02681497|real-world data|real-world data
97251|NCT02681471|Monopolar|monopolar
97252|NCT02681471|Bipolar|bipolar
97253|NCT02681471|TURP syndrome|turp syndrome
97254|NCT02681471|hyponatremia|hyponatremia
97255|NCT02681432|HIPEC|hipec
97256|NCT02681432|ovarian cancer|ovarian cancer
97257|NCT02681432|peritoneal carcinomatosis|peritoneal carcinomatosis
97258|NCT02681393|Physical activity, brochures, telephone support, stroke|physical activity, brochures, telephone support, stroke
97259|NCT02681380|simulated patient|simulated patient
97260|NCT02681380|Balint|balint
97261|NCT02681380|empathy|empathy
97262|NCT02681380|medical student|medical student
97263|NCT02681367|Recurrent implantation failure|recurrent implantation failure
97264|NCT02681367|Freeze all policy|freeze all policy
97265|NCT02681367|endometrial receptivity|endometrial receptivity
97266|NCT02681367|implantation|implantation
97267|NCT02681367|clinical outcome|clinical outcome
97268|NCT02681354|elderly|elderly
97269|NCT02681289|infant|infant
97270|NCT02681289|risk|risk
97271|NCT02681289|rehabilitation|rehabilitation
97272|NCT02681276|Irrigation during root canal treatment|irrigation during root canal treatment
97273|NCT02681276|Sodium Hypochlorite|sodium hypochlorite
97274|NCT02681250|Zirconium|zirconium
97275|NCT02681250|Randomized Controlled Trial|randomized controlled trial
97276|NCT02681250|Dental Implants|dental implants
97277|NCT02681250|Dental Material|dental material
97278|NCT02681250|Titanium|titanium
97279|NCT02681211|migraine headache|migraine headache
97280|NCT02681211|acupuncture|acupuncture
97281|NCT02681198|Healthy|healthy
97282|NCT02681198|Lofexidine|lofexidine
97283|NCT02681198|Paroxetine|paroxetine
97284|NCT02681198|Volunteer|volunteer
97285|NCT02681172|CSF|csf
97286|NCT02681172|Alzheimer's Disease (AD) and related dementia|alzheimer's disease (ad) and related dementia
97287|NCT02681172|HAS recommendations|has recommendations
97288|NCT02681159|Anesthesia|anesthesia
97289|NCT02681146|education|education
97290|NCT02681146|physiotherapy|physiotherapy
97291|NCT02681133|Physical activity level|physical activity level
97292|NCT02681133|Knee osteoarthritis|knee osteoarthritis
97293|NCT02681133|Non pharmacological treatment|non pharmacological treatment
97294|NCT02681133|Survey|survey
97295|NCT02681133|Socio-demographic, clinical variables|socio-demographic, clinical variables
97296|NCT02681133|Barriers, facilitators Fears and beliefs|barriers, facilitators fears and beliefs
97297|NCT02681133|Function|function
97298|NCT02681120|Biomarkers|biomarkers
97299|NCT02681120|Breast imaging|breast imaging
97300|NCT02681107|Radiation therapy|radiation therapy
402911|NCT01229163|Motivational Incentive|motivational incentive
97301|NCT02681107|Accelerated partial breast irradiation (APBI)|accelerated partial breast irradiation (apbi)
97302|NCT02681107|Breast conserving surgery|breast conserving surgery
97303|NCT02681107|Stage 1|stage 1
97304|NCT02681094|Diabetes Mellitus Type 2,|diabetes mellitus type 2,
97305|NCT02681094|saxagliptin,|saxagliptin,
97306|NCT02681094|dapagliflozin,|dapagliflozin,
97307|NCT02681094|metformin|metformin
97308|NCT02681081|Neuroplasticity|neuroplasticity
97309|NCT02681068|Fecal microbiota transplantation (FMT)|fecal microbiota transplantation (fmt)
97310|NCT02681068|Clostridium difficile associated diarrhea (CDAD)|clostridium difficile associated diarrhea (cdad)
97311|NCT02681055|NASH|nash
97312|NCT02681055|NAFLD|nafld
97313|NCT02681029|Cleavage stage blastocyst transfer cryopreservation|cleavage stage blastocyst transfer cryopreservation
97314|NCT02681016|Calypso|calypso
97315|NCT02681016|Xience|xience
639436|NCT00736411|IVF|ivf
97334|NCT02680847|Pediatric|pediatric
97335|NCT02680847|pain indication|pain indication
97336|NCT02680847|controlled release oxycodone|controlled release oxycodone
97337|NCT02680834|venous stasis ulcer|venous stasis ulcer
97338|NCT02680834|wound|wound
97339|NCT02680834|chronic venous insufficiency|chronic venous insufficiency
97340|NCT02680821|Laxity|laxity
97341|NCT02680821|Knee|knee
97342|NCT02680821|Rupture|rupture
97343|NCT02680821|ALL|all
97344|NCT02680795|UGT1A1*28|ugt1a1*28
97345|NCT02680795|Belinostat|belinostat
97346|NCT02680795|beleodaq|beleodaq
97347|NCT02680795|wild type genotypes|wild type genotypes
97348|NCT02680795|heterozygous genotypes|heterozygous genotypes
97349|NCT02680795|homozygous genotypes|homozygous genotypes
97350|NCT02680782|Healthy Volunteers|healthy volunteers
97351|NCT02680782|Comparison|comparison
97352|NCT02680782|Once-Daily|once-daily
97353|NCT02680782|Twice-Daily|twice-daily
97354|NCT02680782|X4P-001|x4p-001
97355|NCT02680756|Iron Deficiency|iron deficiency
97356|NCT02680756|Anaemia|anaemia
97357|NCT02680756|Crohn's Disease|crohn's disease
97358|NCT02680756|Deficiency Diseases|deficiency diseases
97359|NCT02680756|Inflammatory Bowel Diseases|inflammatory bowel diseases
97360|NCT02680756|Intestinal Diseases|intestinal diseases
97361|NCT02680730|Autonomic nervous system|autonomic nervous system
97362|NCT02680730|Auditory processing disorder|auditory processing disorder
97363|NCT02680730|Social behavior|social behavior
97364|NCT02680691|infratentorial stroke|infratentorial stroke
97365|NCT02680691|robot|robot
97366|NCT02680691|postural balance|postural balance
97367|NCT02680691|Rehabilitation|rehabilitation
97368|NCT02680652|CVID|cvid
97369|NCT02680652|Common Variable Immune Deficiency|common variable immune deficiency
97370|NCT02680639|High-Frequency Ventilation|high-frequency ventilation
97371|NCT02680639|Biphasic Continuous Positive Airway Pressure|biphasic continuous positive airway pressure
97372|NCT02680587|Prostate Cancer|prostate cancer
97373|NCT02680587|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
97374|NCT02680587|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
97375|NCT02680587|Oligometastasis|oligometastasis
97397|NCT02680548|ankle pain|ankle pain
97398|NCT02680548|foot pain|foot pain
97399|NCT02680548|methylprednisolone|methylprednisolone
97400|NCT02680548|neuropathic pain|neuropathic pain
97401|NCT02680522|Parkinson's disease|parkinson's disease
97402|NCT02680522|Heart Rate Variability|heart rate variability
97403|NCT02680522|Physiotherapy|physiotherapy
97404|NCT02680496|Robot-Assistance|robot-assistance
97405|NCT02680496|Gait [MeSH]|gait [mesh]
97406|NCT02680496|Energy Consumption|energy consumption
97407|NCT02680496|Cardiorespiratory Load|cardiorespiratory load
97408|NCT02680496|Stroke [MeSH]|stroke [mesh]
97409|NCT02680483|Atrial fibrillation|atrial fibrillation
97410|NCT02680483|Registry|registry
97411|NCT02680483|Middle East|middle east
97412|NCT02680483|Jordan|jordan
97413|NCT02680483|risk factors|risk factors
97414|NCT02680483|in hospital management|in hospital management
97415|NCT02680483|long term management|long term management
97416|NCT02680470|Tuberculosis|tuberculosis
97417|NCT02680470|Management|management
97418|NCT02680470|Observed therapy|observed therapy
97419|NCT02680444|Mindfulness|mindfulness
97420|NCT02680444|Primary Promotion|primary promotion
97421|NCT02680444|Mental Health|mental health
97422|NCT02680444|Well-being|well-being
97423|NCT02680444|Positive Reappraisal|positive reappraisal
97424|NCT02680392|Pulsed and Continuous Radiofrequency Treatment|pulsed and continuous radiofrequency treatment
97425|NCT02680392|Continuous adductor canal block|continuous adductor canal block
97426|NCT02680392|Postoperative pain|postoperative pain
97427|NCT02680392|Functional recovery|functional recovery
97554|NCT02679443|Chemotherapy|chemotherapy
97428|NCT02680392|Total Knee Joint Replacement|total knee joint replacement
97429|NCT02680379|Fragile X Syndrome|fragile x syndrome
97431|NCT02680379|FMR1|fmr1
97432|NCT02680379|FRAXA|fraxa
97433|NCT02680340|Total Hip Arthroplasty THA|total hip arthroplasty tha
97434|NCT02680314|unripe cervix|unripe cervix
97435|NCT02680301|Wet Wraps|wet wraps
97436|NCT02680301|Topical Steroid|topical steroid
97437|NCT02680288|Psychostimulant, Craving, Cocaine.|psychostimulant, craving, cocaine.
97438|NCT02680275|Chronic endometritis|chronic endometritis
97439|NCT02680275|Miscarriage|miscarriage
97440|NCT02680275|Infertility|infertility
97441|NCT02680262|HPV self-sampling, cervical cancer screening|hpv self-sampling, cervical cancer screening
97442|NCT02680249|Safety, Bioavailability and Pharmacokinetics|safety, bioavailability and pharmacokinetics
97443|NCT02680236|Pain|pain
97444|NCT02680236|Cancer|cancer
97445|NCT02680236|Chemotherapy|chemotherapy
97446|NCT02680236|Anxiety|anxiety
97447|NCT02680236|Depression|depression
97448|NCT02680236|Isolation|isolation
97449|NCT02680197|COPD|copd
97450|NCT02680184|Malignant melanoma|malignant melanoma
97451|NCT02680171|Cognitive Rehabilitation|cognitive rehabilitation
97452|NCT02680171|Prism Adaptation|prism adaptation
97453|NCT02680171|Stroke|stroke
97454|NCT02680171|Spatial Neglect|spatial neglect
97455|NCT02680145|Pessary|pessary
97456|NCT02680145|Prolapse|prolapse
97457|NCT02680145|Cystocele|cystocele
97458|NCT02680106|Nanofibers|nanofibers
97459|NCT02680106|Dressing|dressing
97460|NCT02680106|Donor site|donor site
97461|NCT02680106|Polycaprolactone|polycaprolactone
97462|NCT02680067|Healthy Individual|healthy individual
97463|NCT02680067|Lymphatic Transport|lymphatic transport
97464|NCT02680067|Near InfraRed|near infrared
97465|NCT02680067|Imaging|imaging
97466|NCT02680067|Indocyanine Green|indocyanine green
97468|NCT02680067|NIR|nir
97469|NCT02680067|NIR-ICG|nir-icg
97470|NCT02680067|MSImager|msimager
97471|NCT02680067|rheumatoid arthritis|rheumatoid arthritis
97472|NCT02680015|PEERS|peers
97473|NCT02680015|friendships|friendships
97474|NCT02680015|brain|brain
97475|NCT02679989|Insulin sensitivity|insulin sensitivity
97476|NCT02679989|Weight loss|weight loss
97477|NCT02679989|Intermittent fasting|intermittent fasting
97478|NCT02679989|Sympathetic nervous system|sympathetic nervous system
97479|NCT02679950|Next generation genome sequencing|next generation genome sequencing
97480|NCT02679950|Late relapse|late relapse
97481|NCT02679950|Genetic profiles|genetic profiles
97482|NCT02679937|U.S. Military|u.s. military
97483|NCT02679937|Overweight|overweight
97484|NCT02679937|Obesity|obesity
97485|NCT02679937|Service Members|service members
97486|NCT02679937|Prevention|prevention
97487|NCT02679911|Onychomycosis|onychomycosis
97488|NCT02679898|Arterial function|arterial function
97489|NCT02679898|Whole-body vibration training|whole-body vibration training
97490|NCT02679898|Aortic blood pressures|aortic blood pressures
97491|NCT02679898|Wave reflection|wave reflection
97492|NCT02679898|Muscle strength|muscle strength
97493|NCT02679898|Endothelial function|endothelial function
97494|NCT02679898|Blood flow|blood flow
97495|NCT02679872|Non-technical skills|non-technical skills
97496|NCT02679872|Patient safety|patient safety
97497|NCT02679872|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
97498|NCT02679872|Operating theatre team|operating theatre team
97499|NCT02679872|Operating room|operating room
97500|NCT02679859|Natriuretic Peptide, Brain|natriuretic peptide, brain
97502|NCT02679846|withdrawal of antiepileptic drugs|withdrawal of antiepileptic drugs
97503|NCT02679846|monitoring VEEG|monitoring veeg
97504|NCT02679846|safety|safety
97505|NCT02679846|adverse event|adverse event
97506|NCT02679846|standardized protocol|standardized protocol
97507|NCT02679833|Cobalamin biomarkers|cobalamin biomarkers
97508|NCT02679833|Anemia|anemia
97509|NCT02679833|Vegan diet|vegan diet
97510|NCT02679833|Subclinical|subclinical
97511|NCT02679833|Metabolic functional markers|metabolic functional markers
97512|NCT02679833|Holotranscobalamin|holotranscobalamin
97513|NCT02679833|Methylmalonic acid|methylmalonic acid
97514|NCT02679755|Hormone receptor positive advanced breast cancer|hormone receptor positive advanced breast cancer
97515|NCT02679742|beta hydroxy beta methylbutyrate|beta hydroxy beta methylbutyrate
97516|NCT02679742|older people|older people
97517|NCT02679742|muscle mass|muscle mass
97518|NCT02679742|muscle strength|muscle strength
97519|NCT02679742|post-acute|post-acute
97520|NCT02679729|inhaled dose|inhaled dose
97521|NCT02679729|intravenous dose|intravenous dose
97522|NCT02679729|healthy subjects|healthy subjects
97523|NCT02679729|safety|safety
97524|NCT02679729|tolerability|tolerability
97525|NCT02679729|pharmacokinetics|pharmacokinetics
97526|NCT02679729|AZD5634|azd5634
97527|NCT02679729|jet nebulizer|jet nebulizer
97528|NCT02679677|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
97529|NCT02679677|Randomized controlled trial|randomized controlled trial
97530|NCT02679677|Physical activity|physical activity
97531|NCT02679638|breast cancer|breast cancer
97532|NCT02679638|treatment choice|treatment choice
97533|NCT02679638|factor|factor
97534|NCT02679638|perception|perception
97535|NCT02679573|Pneumonia|pneumonia
402912|NCT01229163|Automation|automation
88837|NCT02732184|AML|aml
97536|NCT02679560|femur fracture, hip fracture, exparel, liposomal bupivacaine|femur fracture, hip fracture, exparel, liposomal bupivacaine
97537|NCT02679547|Appendix|appendix
97538|NCT02679547|Breastfeeding|breastfeeding
97539|NCT02679547|Adult|adult
97540|NCT02679534|pain|pain
97541|NCT02679534|thoracic surgery|thoracic surgery
97542|NCT02679534|massage|massage
97543|NCT02679521|Extracorporeal Shock Wave Therapy|extracorporeal shock wave therapy
97544|NCT02679521|Painful Heel|painful heel
97545|NCT02679521|Plantar fasciitis|plantar fasciitis
97546|NCT02679508|Esophagitis|esophagitis
97547|NCT02679495|early gastric cancer|early gastric cancer
97548|NCT02679495|lifestyle|lifestyle
97549|NCT02679482|Primary Open Angle Glaucoma|primary open angle glaucoma
97550|NCT02679482|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
97551|NCT02679482|Pattern Scan Laser Trabeculoplasty|pattern scan laser trabeculoplasty
97552|NCT02679443|Lung Adenocarcinoma|lung adenocarcinoma
97553|NCT02679443|Non-squamous NSCLC|non-squamous nsclc
97555|NCT02679443|Pemetrexed|pemetrexed
97556|NCT02679443|Vitamin B12|vitamin b12
97557|NCT02679443|Folate|folate
97558|NCT02679443|Supplementation|supplementation
97559|NCT02679443|Cytopenia|cytopenia
97560|NCT02679417|Aminotransferase|aminotransferase
97561|NCT02679417|Fibrosis, liver|fibrosis, liver
97562|NCT02679417|Anthropometry|anthropometry
97563|NCT02679417|Exercise|exercise
97564|NCT02679404|Biological aortic valves|biological aortic valves
97565|NCT02679404|Mechanical aortic valves|mechanical aortic valves
97566|NCT02679404|Aortic conduits|aortic conduits
97567|NCT02679404|Sutureless Aortic Valve|sutureless aortic valve
97568|NCT02679391|Abdominoplasty|abdominoplasty
97569|NCT02679391|Early complications|early complications
97570|NCT02679391|Guidelines|guidelines
97571|NCT02679391|Sequelae|sequelae
97572|NCT02679391|bariatric patients|bariatric patients
97573|NCT02679326|Therapeutic ultrasound, Treatment, Plantar fasciitis|therapeutic ultrasound, treatment, plantar fasciitis
97574|NCT02679300|Chronic Low Back Pain|chronic low back pain
97575|NCT02679300|Virtual Reality|virtual reality
97576|NCT02679300|Serious Gaming|serious gaming
97577|NCT02679300|Exercise Therapy|exercise therapy
97578|NCT02679300|Distraction|distraction
97579|NCT02679287|Closed-Loop Control (CLC)|closed-loop control (clc)
97580|NCT02679287|Sensor-Augmented Therapy (SAP)|sensor-augmented therapy (sap)
97581|NCT02679287|USS Virginia|uss virginia
97582|NCT02679287|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
97583|NCT02679287|Insulin Pump|insulin pump
97584|NCT02679287|Artificial Pancreas (AP)|artificial pancreas (ap)
97585|NCT02679274|Aging, Frailty, Hypogonadism|aging, frailty, hypogonadism
97586|NCT02679261|Aortic dilation|aortic dilation
97587|NCT02679261|Statins|statins
97588|NCT02679261|Aortic degeneration|aortic degeneration
97589|NCT02679248|Pre-hypertension|pre-hypertension
97790|NCT02677636|Pruritus|pruritus
97590|NCT02679248|Mild hypertension|mild hypertension
97591|NCT02679248|Dietary supplement|dietary supplement
97592|NCT02679248|Efficacy|efficacy
97593|NCT02679248|Nitric oxide|nitric oxide
97594|NCT02679248|Neo40 Daily|neo40 daily
97595|NCT02679170|ALK+|alk+
97596|NCT02679157|Posttraumatic stress disorder|posttraumatic stress disorder
97597|NCT02679157|Depression|depression
97599|NCT02679157|ADL|adl
97600|NCT02679157|Health-related quality of life|health-related quality of life
97601|NCT02679157|ICU survivorship|icu survivorship
97602|NCT02679131|relapsed/refractory solid tumors|relapsed/refractory solid tumors
97603|NCT02679131|beleodaq|beleodaq
97604|NCT02679131|renal impairment|renal impairment
97605|NCT02679131|belinostat|belinostat
97606|NCT02679131|hematological malignancies|hematological malignancies
97607|NCT02679118|intestinal perforation|intestinal perforation
97608|NCT02679118|bariatric surgery|bariatric surgery
97609|NCT02679118|gastric bypass|gastric bypass
97610|NCT02679118|gastric perforation|gastric perforation
97611|NCT02679118|colonic perforation|colonic perforation
97612|NCT02679092|Induced Abortion|induced abortion
97613|NCT02679092|Mifepristone|mifepristone
97614|NCT02679092|Dilation and Evacuation|dilation and evacuation
97615|NCT02679092|Cervical Preparation|cervical preparation
97616|NCT02679092|Osmotic Dilators|osmotic dilators
97617|NCT02679092|Misoprostol|misoprostol
97618|NCT02678962|Multifocal Intraocular Lenses|multifocal intraocular lenses
97619|NCT02678962|bilateral implantation|bilateral implantation
97620|NCT02678897|Abortion, Drug-Induced|abortion, drug-induced
97621|NCT02678897|Pain Management|pain management
97622|NCT02678884|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
97623|NCT02678884|Radiation therapy|radiation therapy
97624|NCT02678884|Head and Neck Cancers|head and neck cancers
97625|NCT02678871|Aortic Valve Stenosis|aortic valve stenosis
97626|NCT02678871|Left atrial appendage|left atrial appendage
97627|NCT02678858|social cognition|social cognition
97628|NCT02678858|social skills|social skills
97629|NCT02678858|cognitive remediation|cognitive remediation
97630|NCT02678858|functional outcome|functional outcome
97631|NCT02678858|treatment adherence|treatment adherence
97632|NCT02678767|HIV|hiv
97633|NCT02678767|Dementia|dementia
97634|NCT02678767|Neuroimaging|neuroimaging
97635|NCT02678702|Sleep|sleep
97636|NCT02678702|Depression|depression
97637|NCT02678702|Comorbid Insomnia|comorbid insomnia
97638|NCT02678702|Cognitive Behavioral Therapy|cognitive behavioral therapy
97639|NCT02678702|Sleep Restriction|sleep restriction
97640|NCT02678702|Stimulus Control therapy|stimulus control therapy
97641|NCT02678702|Relaxation|relaxation
97642|NCT02678676|Drug Therapy|drug therapy
97643|NCT02678663|Colon polyp|colon polyp
97644|NCT02678663|Polypectomy|polypectomy
97645|NCT02678663|Cold snare|cold snare
97646|NCT02678663|Endoscopic mucosal resection|endoscopic mucosal resection
97647|NCT02678650|Volatile Anesthetics|volatile anesthetics
97648|NCT02678650|MicroRNA|microrna
97649|NCT02678650|Off-pump Coronary Artery Bypass Surgery|off-pump coronary artery bypass surgery
97650|NCT02678650|Internal Mammary Artery|internal mammary artery
97651|NCT02678650|Ascending Aorta|ascending aorta
97653|NCT02678637|CCSA|ccsa
97654|NCT02678637|Contractile Cross Sectional Area|contractile cross sectional area
97655|NCT02678637|Strength|strength
97656|NCT02678637|Calf muscle|calf muscle
97657|NCT02678611|Healthy participants|healthy participants
97658|NCT02678611|Dietary supplement|dietary supplement
97659|NCT02678611|Safety|safety
97660|NCT02678611|Tolerability|tolerability
97661|NCT02678611|Older Adults|older adults
97662|NCT02678611|Basis|basis
97663|NCT02678611|Nicotinamide riboside|nicotinamide riboside
97664|NCT02678611|Pterostilbene|pterostilbene
97665|NCT02678598|Micafungin|micafungin
97666|NCT02678598|Candida|candida
97667|NCT02678598|Aspergillosis|aspergillosis
97668|NCT02678598|Antifungal|antifungal
97669|NCT02678572|uveal liver PHP hepatic perfusion chemosaturation Delcath|uveal liver php hepatic perfusion chemosaturation delcath
97670|NCT02678559|Alveolar recruitment manoeuvre|alveolar recruitment manoeuvre
97671|NCT02678559|Lung recruitment|lung recruitment
97672|NCT02678559|Preload dependency|preload dependency
97673|NCT02678559|Cardiac surgery|cardiac surgery
97674|NCT02678559|Transoesophageal echocardiography|transoesophageal echocardiography
97675|NCT02678546|Traditional Chinese Medicine|traditional chinese medicine
97676|NCT02678533|Fanconi Anemia|fanconi anemia
97677|NCT02678533|CD34+ cells mobilization|cd34+ cells mobilization
97678|NCT02678533|G-CSF|g-csf
97679|NCT02678533|Plerixafor|plerixafor
97680|NCT02678533|gene therapy|gene therapy
97681|NCT02678520|Prostate Cancer|prostate cancer
97682|NCT02678520|Post Operative|post operative
97683|NCT02678520|Radiation|radiation
97684|NCT02678520|Prostatectomy|prostatectomy
97685|NCT02678520|3-D CRT|3-d crt
97686|NCT02678520|IMRT|imrt
97687|NCT02678520|RT|rt
97688|NCT02678520|CRT|crt
97689|NCT02678520|Conformal Radiation Therapy|conformal radiation therapy
97692|NCT02678520|Surgery|surgery
97693|NCT02678520|Hormonal Therapy|hormonal therapy
97694|NCT02678494|Spinal Cord Injury|spinal cord injury
97695|NCT02678481|multiparametric magnetic resonance imaging|multiparametric magnetic resonance imaging
97696|NCT02678481|MR-targeted prostate biopsy|mr-targeted prostate biopsy
97697|NCT02678481|saturation TRUS-guided prostate biopsy|saturation trus-guided prostate biopsy
97698|NCT02678455|Dengue Virus|dengue virus
97699|NCT02678416|comparison|comparison
97700|NCT02678403|peripheral artery disease|peripheral artery disease
97701|NCT02678403|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
97702|NCT02678403|walking ability|walking ability
97703|NCT02678403|endothelial function|endothelial function
97704|NCT02678364|Vitamin D-biofortified eggs|vitamin d-biofortified eggs
97705|NCT02678364|Vitamin D status|vitamin d status
97706|NCT02678364|RCT|rct
97707|NCT02678312|Pediatric Heart failure,|pediatric heart failure,
97708|NCT02678312|systemic left ventricle,|systemic left ventricle,
97709|NCT02678312|reduced ejection fraction|reduced ejection fraction
97710|NCT02678286|Abdominoplasty|abdominoplasty
97711|NCT02678286|Pain|pain
97712|NCT02678286|Analgesia|analgesia
97713|NCT02678286|N1539|n1539
97714|NCT02678286|Phase 3|phase 3
97715|NCT02678273|population|population
97716|NCT02678273|Singapore|singapore
97717|NCT02678260|Advanced malignancies|advanced malignancies
97718|NCT02678260|PDR001|pdr001
97719|NCT02678260|Japanese patients|japanese patients
97720|NCT02678260|adults|adults
97721|NCT02678247|prosthesis|prosthesis
97722|NCT02678247|prosthetic socket|prosthetic socket
97723|NCT02678247|transfemoral amputation|transfemoral amputation
97724|NCT02678247|socket comfort|socket comfort
97725|NCT02678247|gait biomechanics|gait biomechanics
97726|NCT02678156|Dura mater substitute|dura mater substitute
97727|NCT02678156|Graft|graft
97728|NCT02678156|Lyoplant|lyoplant
97729|NCT02678156|Lyostypt|lyostypt
97730|NCT02678156|Lyoplant onlay|lyoplant onlay
97731|NCT02678156|Xenograft|xenograft
97732|NCT02678130|Intervertebral disc degeneration|intervertebral disc degeneration
97733|NCT02678130|Bone Disease|bone disease
97734|NCT02678130|Musculoskeletal disease|musculoskeletal disease
97735|NCT02678130|Spinal disease|spinal disease
97736|NCT02678104|Dry Socket|dry socket
97737|NCT02678104|Honey|honey
97738|NCT02678104|Tooth Extraction|tooth extraction
97739|NCT02678078|cancer|cancer
97740|NCT02678078|diagnosis|diagnosis
97741|NCT02678078|biopsy|biopsy
97742|NCT02678078|chemotherapy drugs|chemotherapy drugs
97743|NCT02678078|tumor|tumor
97744|NCT02678052|Drug therapy|drug therapy
97745|NCT02677961|sarcoma|sarcoma
97746|NCT02677961|registry|registry
97747|NCT02677922|Acute Myeloid Leukemia|acute myeloid leukemia
97748|NCT02677922|Leukemia|leukemia
97749|NCT02677922|Azacitidine|azacitidine
97750|NCT02677922|AG-120|ag-120
97751|NCT02677922|AG-221|ag-221
97752|NCT02677909|Parenteral Nutrition|parenteral nutrition
97753|NCT02677909|Critical Care|critical care
98890|NCT02670356|EPA|epa
97754|NCT02677896|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
97755|NCT02677896|Metastatic hormone sensitive prostate cancer|metastatic hormone sensitive prostate cancer
97756|NCT02677896|Xtandi|xtandi
97757|NCT02677896|Enzalutamide|enzalutamide
97758|NCT02677870|Saproterin dihydrochloride|saproterin dihydrochloride
97759|NCT02677870|Kuvan|kuvan
97760|NCT02677870|Amish|amish
97761|NCT02677831|Physical functioning|physical functioning
97762|NCT02677831|Neuropsychiatric Disorders|neuropsychiatric disorders
97763|NCT02677831|Frailty|frailty
97764|NCT02677818|Plasma Factor VIII Levels|plasma factor viii levels
97765|NCT02677818|Ischemic stroke|ischemic stroke
97766|NCT02677818|Antithrombotic therapy|antithrombotic therapy
97767|NCT02677818|Bleeding|bleeding
97768|NCT02677766|Occupational Therapy|occupational therapy
97769|NCT02677766|Complex patients|complex patients
97770|NCT02677766|Randomized controlled trial|randomized controlled trial
97771|NCT02677766|Occupational performance problem|occupational performance problem
97772|NCT02677766|Rehabilitation Complexity Scale|rehabilitation complexity scale
97776|NCT02677727|Cisplatin-based chemotherapy|cisplatin-based chemotherapy
97777|NCT02677727|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
97778|NCT02677688|systemic lupus erythematosus|systemic lupus erythematosus
97779|NCT02677688|autologous anti-EBV CTL|autologous anti-ebv ctl
97780|NCT02677688|adoptive therapy|adoptive therapy
97781|NCT02677688|phase 1 -2|phase 1 -2
97782|NCT02677662|Diesel exhaust|diesel exhaust
97783|NCT02677662|Oxidative stress|oxidative stress
97784|NCT02677662|Systemic inflammation|systemic inflammation
97785|NCT02677662|Air pollution|air pollution
97786|NCT02677649|cranberry, microbiome, polyphenols, healthy|cranberry, microbiome, polyphenols, healthy
97787|NCT02677636|Dermatitis, Atopic|dermatitis, atopic
97788|NCT02677636|Eczema|eczema
97791|NCT02677636|Genetic Diseases, Inborn|genetic diseases, inborn
97792|NCT02677636|Hypersensitivity|hypersensitivity
97793|NCT02677636|Hypersensitivity, Immediate|hypersensitivity, immediate
97794|NCT02677636|Immune System Diseases|immune system diseases
97795|NCT02677636|Skin Diseases, Eczematous|skin diseases, eczematous
97796|NCT02677636|Skin Diseases, Genetic|skin diseases, genetic
97797|NCT02677636|Skin Diseases|skin diseases
97798|NCT02677636|Itching|itching
97799|NCT02677636|Rash|rash
97800|NCT02677636|Steroid|steroid
97801|NCT02677610|Dermatitis, Atopic|dermatitis, atopic
97802|NCT02677610|Eczema|eczema
97803|NCT02677610|Dermatitis|dermatitis
97804|NCT02677610|Pruritus|pruritus
97805|NCT02677610|Genetic Diseases, Inborn|genetic diseases, inborn
97806|NCT02677610|Hypersensitivity|hypersensitivity
97807|NCT02677610|Hypersensitivity, Immediate|hypersensitivity, immediate
97808|NCT02677610|Immune System Diseases|immune system diseases
97809|NCT02677610|Skin Diseases, Eczematous|skin diseases, eczematous
97810|NCT02677610|Skin Diseases, Genetic|skin diseases, genetic
97811|NCT02677610|Skin Diseases|skin diseases
97812|NCT02677610|Itching|itching
97813|NCT02677610|Rash|rash
97814|NCT02677610|Steroid|steroid
97815|NCT02677584|caffeine|caffeine
97816|NCT02677584|apnea|apnea
97817|NCT02677584|preterm infant|preterm infant
97818|NCT02677558|Pregnancy|pregnancy
97819|NCT02677558|Obesity|obesity
97820|NCT02677558|Echocardiography|echocardiography
97821|NCT02677519|ADHD|adhd
97822|NCT02677519|children|children
97823|NCT02677519|methylphenidate|methylphenidate
97824|NCT02677506|elbow|elbow
97825|NCT02677480|Microflora|microflora
97826|NCT02677480|Probiotics|probiotics
97827|NCT02677480|Hyposalivation|hyposalivation
97828|NCT02677480|Lactobacilli|lactobacilli
97829|NCT02677480|Mutans streptococci|mutans streptococci
97830|NCT02677480|pH-rising components|ph-rising components
97831|NCT02677454|Blood Glucose|blood glucose
97832|NCT02677454|Blood Glucose Self-Monitoring|blood glucose self-monitoring
97833|NCT02677428|Veterans|veterans
97834|NCT02677428|world wide web|world wide web
97835|NCT02677428|Counseling|counseling
97836|NCT02677428|Workman's Compensation|workman's compensation
97837|NCT02677415|Ischemic Stroke|ischemic stroke
97838|NCT02677415|Anesthesia|anesthesia
97839|NCT02677415|Endovascular Procedures|endovascular procedures
97840|NCT02677402|femoral vein|femoral vein
97841|NCT02677402|saphenous vein|saphenous vein
97842|NCT02677402|hydrostatic pressure|hydrostatic pressure
97843|NCT02677402|temperature|temperature
97844|NCT02677402|recovery|recovery
97845|NCT02677363|Elderly|elderly
97846|NCT02677363|Older|older
97847|NCT02677363|Adults|adults
97848|NCT02677363|Resistant Exercise|resistant exercise
97849|NCT02677363|Strength Training|strength training
97850|NCT02677363|Cognitive function|cognitive function
97851|NCT02677324|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
97852|NCT02677324|WM|wm
97853|NCT02677272|Nursing home|nursing home
97854|NCT02677272|emergency department|emergency department
97855|NCT02677272|inappropriate transfer|inappropriate transfer
97856|NCT02677272|elderly|elderly
97857|NCT02677259|luteal phase|luteal phase
97858|NCT02677259|estradiol|estradiol
97859|NCT02677259|pregnancy rate|pregnancy rate
97860|NCT02677246|Bone marrow transplantation|bone marrow transplantation
97861|NCT02677246|Children|children
97862|NCT02677246|Bone complications|bone complications
97863|NCT02677246|Denosumab.|denosumab.
97865|NCT02677181|Matched sibling donor|matched sibling donor
97866|NCT02677181|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
97867|NCT02677168|obstructive sleep apnea|obstructive sleep apnea
97868|NCT02677168|sleep apnea|sleep apnea
97869|NCT02677168|OSA|osa
97870|NCT02677168|cNEP|cnep
97871|NCT02677168|continuous negative external pressure|continuous negative external pressure
97872|NCT02677155|Follicular lymphoma|follicular lymphoma
97873|NCT02677155|Intranodal therapy|intranodal therapy
97874|NCT02677155|Autologous dendritic cells|autologous dendritic cells
97875|NCT02677155|Rituximab|rituximab
97876|NCT02677155|Immunotherapy|immunotherapy
97877|NCT02677155|Cancer vaccine|cancer vaccine
97878|NCT02677155|Anti-PD1|anti-pd1
97879|NCT02677155|Pembrolizumab|pembrolizumab
97880|NCT02677155|Radiotherapy|radiotherapy
97881|NCT02677142|pediatric|pediatric
97882|NCT02677142|Childhood Brain Tumour Survivors|childhood brain tumour survivors
97883|NCT02677142|Social Skills Rating System|social skills rating system
97884|NCT02677142|social skills intervention program (SSIP)|social skills intervention program (ssip)
97885|NCT02677103|Radial shock wave therapy,calcific tendinitis, ultrasound guidance|radial shock wave therapy,calcific tendinitis, ultrasound guidance
97886|NCT02677090|Fiber tolerability|fiber tolerability
97887|NCT02677090|Children|children
97888|NCT02677077|RRMS|rrms
97889|NCT02677077|MRI|mri
97890|NCT02677064|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
97891|NCT02677064|Identify Barriers|identify barriers
97892|NCT02677064|16-024|16-024
97895|NCT02677038|PDAC|pdac
97896|NCT02677038|Metastatic adenocarcinoma of the pancreas|metastatic adenocarcinoma of the pancreas
97897|NCT02677038|Family history of breast cancer|family history of breast cancer
97898|NCT02677038|Family history of ovarian cancer|family history of ovarian cancer
97899|NCT02677038|Family history of pancreatic cancer|family history of pancreatic cancer
97900|NCT02677038|Family history of gastric cancer|family history of gastric cancer
97901|NCT02677038|Family history of prostate cancer|family history of prostate cancer
97902|NCT02677038|Olaparib|olaparib
97903|NCT02677038|Lynparza|lynparza
97904|NCT02677025|HIV|hiv
97905|NCT02677025|Sexual Risk|sexual risk
98009|NCT02676349|Borderline|borderline
97906|NCT02677025|Sexually Transmitted Diseases|sexually transmitted diseases
97907|NCT02677025|Substance Abuse|substance abuse
97908|NCT02677025|Violence and Victimization|violence and victimization
97909|NCT02677012|Autologous fat grafting|autologous fat grafting
97910|NCT02677012|AFG|afg
97911|NCT02677012|Reconstructive surgery|reconstructive surgery
97912|NCT02677012|Fatty tissue processing|fatty tissue processing
97917|NCT02676973|pelvic organ prolapse|pelvic organ prolapse
97918|NCT02676973|POP|pop
97919|NCT02676973|vault prolapse|vault prolapse
97920|NCT02676973|cystocele|cystocele
97921|NCT02676973|vaginal prolapse|vaginal prolapse
97922|NCT02676973|post-hysterectomy vaginal prolapse|post-hysterectomy vaginal prolapse
97923|NCT02676921|sinus membrane|sinus membrane
97924|NCT02676921|osteogenic|osteogenic
97925|NCT02676908|endovenous ablation|endovenous ablation
97927|NCT02676908|radiofrequency|radiofrequency
97928|NCT02676908|stockings|stockings
97929|NCT02676882|Depressive Disorder|depressive disorder
97930|NCT02676882|Depression|depression
97931|NCT02676882|Antidepressants|antidepressants
97932|NCT02676882|Pregnancy|pregnancy
97933|NCT02676882|Folate|folate
97934|NCT02676882|Dietary Supplements|dietary supplements
97935|NCT02676882|Omega-3 Fatty Acids|omega-3 fatty acids
97936|NCT02676882|Women's Health|women's health
97937|NCT02676882|Vitamins|vitamins
97938|NCT02676856|acute myeloid leukemia|acute myeloid leukemia
97939|NCT02676856|hematopoietic stem cell microtransplantation|hematopoietic stem cell microtransplantation
97940|NCT02676817|colitis|colitis
97941|NCT02676817|endoscopy|endoscopy
97942|NCT02676804|Exercise|exercise
97943|NCT02676778|Peripheral T-cell lymphoma|peripheral t-cell lymphoma
97944|NCT02676778|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
97945|NCT02676778|E7777|e7777
97946|NCT02676778|Phase 2|phase 2
97947|NCT02676765|Allergic rhinitis|allergic rhinitis
97948|NCT02676765|Immunotherapy, Allergen|immunotherapy, allergen
97949|NCT02676765|Sublingual Immunotherapy|sublingual immunotherapy
97950|NCT02676752|head and neck cancer|head and neck cancer
97951|NCT02676752|lymphedema and fibrosis|lymphedema and fibrosis
97952|NCT02676726|extraperitoneal|extraperitoneal
97953|NCT02676726|transperitoneal|transperitoneal
97954|NCT02676726|laparoscopic aortic lymphadenectomy|laparoscopic aortic lymphadenectomy
97955|NCT02676726|endometrial cancer|endometrial cancer
97956|NCT02676726|ovarian cancer|ovarian cancer
97957|NCT02676726|surgical staging|surgical staging
97958|NCT02676713|Traditional Chinese Medicine|traditional chinese medicine
97959|NCT02676713|Chinese Herbal|chinese herbal
97960|NCT02676700|Urinary stress incontinence|urinary stress incontinence
97961|NCT02676700|pelvic floor muscle|pelvic floor muscle
97962|NCT02676700|Kaatsu training|kaatsu training
97963|NCT02676687|surgery, noneloquent area|surgery, noneloquent area
97964|NCT02676661|peri-implant disease|peri-implant disease
97965|NCT02676661|risk factors|risk factors
97966|NCT02676661|prevalence|prevalence
97967|NCT02676622|Crohn's Disease|crohn's disease
97968|NCT02676622|Autologous Hematopoietic Stem cell Transplant|autologous hematopoietic stem cell transplant
97969|NCT02676622|Cyclophosphamide|cyclophosphamide
97970|NCT02676622|IL-2|il-2
97971|NCT02676622|Aldesleukin|aldesleukin
97972|NCT02676622|Proleukin|proleukin
97973|NCT02676622|PCDAI|pcdai
97974|NCT02676609|Type 1 diabetes|type 1 diabetes
97975|NCT02676609|Smart phone application|smart phone application
97976|NCT02676609|carbohydrate counting|carbohydrate counting
97977|NCT02676609|meal insulin dose|meal insulin dose
97978|NCT02676583|pain|pain
97979|NCT02676583|tonsillectomy|tonsillectomy
97980|NCT02676583|tonsillar fossa|tonsillar fossa
97981|NCT02676583|suture|suture
97982|NCT02676583|tonsil fossa closure|tonsil fossa closure
97983|NCT02676544|Prostate Artery Embolization (PAE)|prostate artery embolization (pae)
97984|NCT02676544|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
97985|NCT02676544|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
97987|NCT02676544|BPH|bph
97988|NCT02676544|LUTS|luts
97989|NCT02676544|Prostate Artery Embolization|prostate artery embolization
97990|NCT02676544|Embospheres|embospheres
97991|NCT02676531|Walking Meditation|walking meditation
97992|NCT02676531|Vascular Function|vascular function
97993|NCT02676531|Flow-mediated dilatation|flow-mediated dilatation
97994|NCT02676531|Breast Cancer Patients|breast cancer patients
97995|NCT02676531|Anthracyclines Chemotherapy|anthracyclines chemotherapy
97996|NCT02676518|polycystic ovary syndrome|polycystic ovary syndrome
97997|NCT02676518|Serum anti-Mullerian hormone|serum anti-mullerian hormone
97998|NCT02676518|glucose intolerance|glucose intolerance
97999|NCT02676518|metabolic syndrome|metabolic syndrome
98000|NCT02676466|Mobility|mobility
98001|NCT02676440|Oral Health|oral health
98002|NCT02676401|Diabetic Nephropathy|diabetic nephropathy
98003|NCT02676388|Slow Transit Constipation|slow transit constipation
98004|NCT02676388|Freeze-dried, Capsulized FMT|freeze-dried, capsulized fmt
98005|NCT02676388|Fresh FMT|fresh fmt
98006|NCT02676349|mFolfirinox|mfolfirinox
98007|NCT02676349|Chemoradiotherapy|chemoradiotherapy
98008|NCT02676349|Neoadjuvant treatment|neoadjuvant treatment
98010|NCT02676336|FBC|fbc
98011|NCT02676336|cyclic mastalgia|cyclic mastalgia
98012|NCT02676336|breast discomfort|breast discomfort
98013|NCT02676323|Maximum tolerated dose|maximum tolerated dose
98014|NCT02676323|Childhood leukemia|childhood leukemia
98015|NCT02676323|Hematological malignancies|hematological malignancies
98016|NCT02676297|inhalation|inhalation
98017|NCT02676297|anticholinergic|anticholinergic
98018|NCT02676258|silicone hydrogel daily disposable soft contact lens|silicone hydrogel daily disposable soft contact lens
98019|NCT02676245|Prenatal Education|prenatal education
98020|NCT02676245|Residual Specimens|residual specimens
98021|NCT02676232|Online Intervention|online intervention
98022|NCT02676232|Recurrent Abdominal Pain|recurrent abdominal pain
98023|NCT02676232|Children|children
98024|NCT02676193|Tobacco Smoking|tobacco smoking
98025|NCT02676193|Cigarettes|cigarettes
98026|NCT02676193|Packaging|packaging
98027|NCT02676193|Text messaging|text messaging
98028|NCT02676193|Graphic Images|graphic images
98029|NCT02676193|Sensor-Based Assessments|sensor-based assessments
98030|NCT02676167|HIV prevention|hiv prevention
98031|NCT02676167|men who have sex with men|men who have sex with men
98032|NCT02676167|pre-exposure prophylaxis|pre-exposure prophylaxis
98033|NCT02676167|PrEP|prep
98034|NCT02676167|Greece|greece
98035|NCT02676167|people who inject drugs|people who inject drugs
89268|NCT02729597|brain|brain
98036|NCT02676154|Episodic Hypertension|episodic hypertension
98037|NCT02676154|Spinal Cord Injury|spinal cord injury
98038|NCT02676154|Traumatic Spinal Cord Injury|traumatic spinal cord injury
98039|NCT02676154|Blood Pressure|blood pressure
98040|NCT02676154|Fesoterodine|fesoterodine
98041|NCT02676154|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
98042|NCT02676154|Autonomic Dysreflexia|autonomic dysreflexia
98043|NCT02676154|Urodynamic Studies|urodynamic studies
98044|NCT02676154|24 Hour Ambulatory Blood Pressure Monitoring|24 hour ambulatory blood pressure monitoring
98045|NCT02676128|HIV|hiv
98046|NCT02676128|Medication Adherence|medication adherence
98047|NCT02676128|Mobile Health|mobile health
98048|NCT02676115|Cosmetic Wound Healing|cosmetic wound healing
98049|NCT02676115|anterior cruciate ligament (ACL)|anterior cruciate ligament (acl)
98050|NCT02676102|barber shops|barber shops
98051|NCT02676102|organ transplant|organ transplant
98052|NCT02676102|transplants|transplants
98053|NCT02676102|organ donor registration|organ donor registration
98054|NCT02676089|Asthma, Anticholinergics, Triple combination|asthma, anticholinergics, triple combination
98055|NCT02676076|asthma, anticholinergics, triple combination|asthma, anticholinergics, triple combination
98056|NCT02676063|predictive factors|predictive factors
98057|NCT02676063|neurodevelopmental disabilities|neurodevelopmental disabilities
98058|NCT02676011|Atropine|atropine
98059|NCT02676011|Succinycholine|succinycholine
98060|NCT02676011|Laparoscopy|laparoscopy
98061|NCT02676011|Gynecology|gynecology
98062|NCT02675985|Physical Therapy, early intervention|physical therapy, early intervention
98063|NCT02675972|stroke, blood pressure, prognosis|stroke, blood pressure, prognosis
98064|NCT02675959|stem cell transplantation|stem cell transplantation
98065|NCT02675959|sickle cell disease|sickle cell disease
98066|NCT02675959|haploidentical|haploidentical
98067|NCT02675959|defibrotide|defibrotide
98068|NCT02675946|WNT inhibitor|wnt inhibitor
98069|NCT02675920|surveillance|surveillance
98070|NCT02675920|ultrasonography|ultrasonography
98071|NCT02675920|computed tomography|computed tomography
98072|NCT02675907|Bunion|bunion
98073|NCT02675907|Bunionectomy|bunionectomy
98074|NCT02675907|Pain|pain
98075|NCT02675907|Analgesia|analgesia
98076|NCT02675907|N1539|n1539
98077|NCT02675907|Phase 3|phase 3
98078|NCT02675894|RFA|rfa
98079|NCT02675881|RFA|rfa
98080|NCT02675868|noradrenaline|noradrenaline
98081|NCT02675868|vasopressin|vasopressin
98082|NCT02675868|phenylephrine|phenylephrine
98083|NCT02675868|endotoxemia|endotoxemia
98084|NCT02675868|Lipopolysaccharide|lipopolysaccharide
98085|NCT02675868|vasopressor|vasopressor
98086|NCT02675855|Grafix|grafix
98087|NCT02675829|HER2 mutant|her2 mutant
98088|NCT02675829|HER2 amplified|her2 amplified
98089|NCT02675829|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine
98090|NCT02675829|15-335|15-335
98091|NCT02675816|Obstructive Sleep Apnea|obstructive sleep apnea
98093|NCT02675816|neurostimulation|neurostimulation
98094|NCT02675816|hypoglossal nerve|hypoglossal nerve
98095|NCT02675816|tongue|tongue
98096|NCT02675816|upper airway stimulation|upper airway stimulation
98097|NCT02675816|surgery|surgery
98098|NCT02675803|Rheumatoid arthritis|rheumatoid arthritis
98099|NCT02675790|hydroxyurea|hydroxyurea
98100|NCT02675790|sub-Saharan Africa|sub-saharan africa
98101|NCT02675790|secondary stroke prevention|secondary stroke prevention
98102|NCT02675777|Alcohol misuse|alcohol misuse
98103|NCT02675777|Unhealthy alcohol use|unhealthy alcohol use
98104|NCT02675777|Alcoholism|alcoholism
98105|NCT02675777|Alcohol dependence|alcohol dependence
98106|NCT02675777|Alcohol abuse|alcohol abuse
98107|NCT02675777|Risky drinking|risky drinking
98108|NCT02675764|hand function|hand function
98109|NCT02675751|myopia|myopia
98110|NCT02675673|Enteral Feeding|enteral feeding
98111|NCT02675673|G-Tube|g-tube
98112|NCT02675673|GJ Tube|gj tube
98113|NCT02675660|kinetic data|kinetic data
98114|NCT02675660|volunteers|volunteers
98115|NCT02675608|vaccine efficacy|vaccine efficacy
98116|NCT02675608|inflammation|inflammation
98117|NCT02675608|aging|aging
98118|NCT02675608|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
98119|NCT02675608|flu vaccine|flu vaccine
98120|NCT02675569|Vascular access|vascular access
98121|NCT02675569|Hemodialysis|hemodialysis
98122|NCT02675569|Kidney failure|kidney failure
98123|NCT02675569|Catheter|catheter
98124|NCT02675569|Fistula|fistula
98125|NCT02675556|Depression|depression
98126|NCT02675530|NMDA|nmda
98127|NCT02675530|glutamate|glutamate
98128|NCT02675530|schizophrenia|schizophrenia
98129|NCT02675504|scary scale|scary scale
98130|NCT02675491|Advanced solid tumor|advanced solid tumor
98131|NCT02675491|DS-6051b|ds-6051b
98132|NCT02675491|ROS1|ros1
98133|NCT02675491|NTRK|ntrk
98134|NCT02675491|refractory to standard therapy|refractory to standard therapy
98135|NCT02675491|no standard therapy|no standard therapy
98136|NCT02675478|AML|aml
98137|NCT02675478|phase 1|phase 1
98138|NCT02675478|oncology|oncology
98139|NCT02675465|Pompe, rhGAA|pompe, rhgaa
98140|NCT02675426|Anti-inflammatory agents|anti-inflammatory agents
98141|NCT02675426|Joint Disease|joint disease
98142|NCT02675426|Musculoskeletal Disease|musculoskeletal disease
98143|NCT02675426|Antirheumatic agents|antirheumatic agents
98144|NCT02675426|Arthritis|arthritis
98145|NCT02675413|Cerebral Spinal Fluid|cerebral spinal fluid
98146|NCT02675413|Dimethyl Fumarate|dimethyl fumarate
98147|NCT02675413|Tecfidera|tecfidera
98148|NCT02675413|Multiple Sclerosis|multiple sclerosis
98149|NCT02675413|Relapsing MS|relapsing ms
98150|NCT02675413|RRMS|rrms
98151|NCT02675413|Mechanism of Action|mechanism of action
98152|NCT02675400|ADHD|adhd
98153|NCT02675400|ADD|add
98154|NCT02675400|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
98155|NCT02675400|Attention|attention
98156|NCT02675400|Hyperactivity|hyperactivity
98157|NCT02675374|Cardiac surgery|cardiac surgery
98158|NCT02675374|cardiopulmonary bypass|cardiopulmonary bypass
98159|NCT02675374|dexchlorpheniramine|dexchlorpheniramine
98160|NCT02675374|H1 blockers|h1 blockers
98161|NCT02675374|norepinephrine|norepinephrine
98162|NCT02675374|histamine release|histamine release
98163|NCT02675361|Transfer to adult care|transfer to adult care
98164|NCT02675361|Continuity of patient care|continuity of patient care
98165|NCT02675361|Transition program|transition program
98166|NCT02675335|Diabetic foot ulcer, Sitagliptin|diabetic foot ulcer, sitagliptin
98167|NCT02675296|outcome|outcome
98168|NCT02675283|Point of care test|point of care test
98169|NCT02675283|Diagnosis|diagnosis
98170|NCT02675283|Case finding|case finding
98171|NCT02675257|Diabetes mellitus|diabetes mellitus
98172|NCT02675257|Affective disorders|affective disorders
98173|NCT02675257|Depressive symptoms|depressive symptoms
98174|NCT02675257|Diabetes distress|diabetes distress
98175|NCT02675257|Hyperglycaemia|hyperglycaemia
98176|NCT02675257|Dysglycaemia|dysglycaemia
98177|NCT02675257|Glycaemic control|glycaemic control
98178|NCT02675257|Self-care behaviour|self-care behaviour
98179|NCT02675257|Quality of Life|quality of life
98180|NCT02675257|Diabetes acceptance|diabetes acceptance
98181|NCT02675257|Diabetes complications|diabetes complications
98182|NCT02675257|Low-grade inflammation|low-grade inflammation
98183|NCT02675257|Inflammatory markers|inflammatory markers
98184|NCT02675257|Stress reactivity|stress reactivity
98185|NCT02675257|Health-care costs|health-care costs
98186|NCT02675244|Tricuspid Valve Regurgitation|tricuspid valve regurgitation
98187|NCT02675192|sarcopenia|sarcopenia
98188|NCT02675192|elderly|elderly
98189|NCT02675192|muscle biopsy|muscle biopsy
98190|NCT02675166|Childhood cancer|childhood cancer
98191|NCT02675166|Sequels|sequels
98192|NCT02675166|Complications|complications
98193|NCT02675166|Surgery|surgery
98194|NCT02675166|Radiotherapy|radiotherapy
98195|NCT02675166|Chemotherapy|chemotherapy
98196|NCT02675166|Cancer|cancer
98197|NCT02675153|Inflammatory Bowel Disease|inflammatory bowel disease
98198|NCT02675153|stenosis|stenosis
98199|NCT02675153|sirolimus|sirolimus
98200|NCT02675153|rapamycin|rapamycin
98201|NCT02675153|stricture|stricture
98202|NCT02675114|Sapien 3|sapien 3
98203|NCT02675114|cardiovascular disease|cardiovascular disease
98204|NCT02675114|heart disease|heart disease
98205|NCT02675114|aortic stenosis|aortic stenosis
98206|NCT02675114|SAVR|savr
98207|NCT02675114|TAVR|tavr
98208|NCT02675088|Extensive Stage Small Cell Lung Cancer|extensive stage small cell lung cancer
98209|NCT02675088|thoracic radiotherapy|thoracic radiotherapy
98210|NCT02675088|radiotherapy regimen|radiotherapy regimen
98211|NCT02675075|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
98212|NCT02675075|Voice|voice
98213|NCT02675075|Voice Quality|voice quality
98214|NCT02675075|Total Lung Capacity|total lung capacity
98215|NCT02675062|Accelerometry|accelerometry
98216|NCT02675062|Osteoarthritis|osteoarthritis
98217|NCT02675062|Habitual physical activity|habitual physical activity
98218|NCT02675062|Sedentary behaviour|sedentary behaviour
98219|NCT02675062|Knee arthroplasty|knee arthroplasty
98220|NCT02675049|Intranasal|intranasal
98221|NCT02675049|Dexmedetomidine|dexmedetomidine
98222|NCT02675049|Anaesthesia|anaesthesia
98223|NCT02675049|Breast Lumpectomy|breast lumpectomy
98224|NCT02675036|ectopiccanine teeth, impacted teeth, tooth eruption, orthodontics|ectopiccanine teeth, impacted teeth, tooth eruption, orthodontics
98225|NCT02674997|Goal setting|goal setting
98226|NCT02674997|Feasibility|feasibility
98227|NCT02674997|Standardized Goal Attainment Scaling menu for Hemophilia (GAS-Hem)|standardized goal attainment scaling menu for hemophilia (gas-hem)
98228|NCT02674997|Patient reported outcome (PRO)|patient reported outcome (pro)
98229|NCT02674997|Goal attainment scaling (GAS)|goal attainment scaling (gas)
98230|NCT02674958|endothelial progenitor cells|endothelial progenitor cells
98231|NCT02674958|aspirin|aspirin
98232|NCT02674958|acetylsalicylic acid|acetylsalicylic acid
98233|NCT02674958|alcohol septal ablation|alcohol septal ablation
98234|NCT02674945|fitbit|fitbit
98235|NCT02674945|activity tracker|activity tracker
98236|NCT02674945|sleep|sleep
98237|NCT02674945|quality of life|quality of life
98238|NCT02674919|Repeated-sprint ability|repeated-sprint ability
98239|NCT02674919|Nordic Hamstring exercise|nordic hamstring exercise
98240|NCT02674919|Eccentric hamstring muscle strength|eccentric hamstring muscle strength
98241|NCT02674893|BMI>27|bmi>27
98242|NCT02674893|Treatment with Liraglutide|treatment with liraglutide
98243|NCT02674841|Adolescent|adolescent
98244|NCT02674841|Physical therapy modalities|physical therapy modalities
98245|NCT02674841|Exercise intervention|exercise intervention
98246|NCT02674841|Auditive feedback|auditive feedback
98247|NCT02674841|Visual feedback|visual feedback
98248|NCT02674815|Exercise|exercise
98249|NCT02674815|Preoperative|preoperative
98250|NCT02674815|High Intensity Interval Training|high intensity interval training
98251|NCT02674815|Colorectal|colorectal
98252|NCT02674815|Thoracic|thoracic
98253|NCT02674815|Postoperative|postoperative
98254|NCT02674802|Reinfection|reinfection
98255|NCT02674802|Eradication therapy|eradication therapy
98256|NCT02674802|C-urea breath test|c-urea breath test
98257|NCT02674802|Helicobacter Pylori|helicobacter pylori
98258|NCT02674789|Exercise|exercise
98259|NCT02674789|Athletes|athletes
98260|NCT02674789|Ionized Magnesium|ionized magnesium
98261|NCT02674789|Variation|variation
98263|NCT02674763|Acute Myeloid Leukemia|acute myeloid leukemia
98264|NCT02674763|AML|aml
98265|NCT02674763|IMGN779|imgn779
98266|NCT02674763|ImmunoGen|immunogen
98267|NCT02674763|Phase 1|phase 1
98268|NCT02674763|Relapsed|relapsed
98269|NCT02674763|Refractory|refractory
98270|NCT02674763|CD33|cd33
98271|NCT02674763|Dose Escalation|dose escalation
98272|NCT02674763|Dose Expansion|dose expansion
98273|NCT02674750|DLBCL|dlbcl
98274|NCT02674750|MYC|myc
98275|NCT02674724|Resistance Training|resistance training
98276|NCT02674724|Postural Balance|postural balance
98277|NCT02674724|Exercise|exercise
98278|NCT02674711|patient education|patient education
98279|NCT02674711|low back pain|low back pain
98280|NCT02674711|post-surgical pain|post-surgical pain
98281|NCT02674711|chronic opioid use|chronic opioid use
98282|NCT02674711|Neck Pain|neck pain
98283|NCT02674672|VenaTech® Retrievable Vena Cava Filter|venatech® retrievable vena cava filter
98284|NCT02674672|safety|safety
98285|NCT02674672|efficacy|efficacy
98286|NCT02674659|resistance training, PCSK9, coronary artery bypass|resistance training, pcsk9, coronary artery bypass
98287|NCT02674633|ADHD|adhd
98288|NCT02674594|Anticoagulation|anticoagulation
98289|NCT02674568|SCLC|sclc
98290|NCT02674568|Small Cell Lung Cancer|small cell lung cancer
98291|NCT02674568|DLL3|dll3
98292|NCT02674568|Relapsed|relapsed
98295|NCT02674555|Metabolism|metabolism
98296|NCT02674555|Excretion|excretion
98297|NCT02674555|Absorption|absorption
98298|NCT02674555|[14C]-radioactivity|[14c]-radioactivity
98299|NCT02674555|Pharmacokinetics|pharmacokinetics
98300|NCT02674555|naquotinib|naquotinib
98301|NCT02674555|Oncology|oncology
98302|NCT02674542|Family planning|family planning
98303|NCT02674542|Birth spacing|birth spacing
98304|NCT02674529|Depression|depression
98305|NCT02674529|Neuroimaging biomarkers|neuroimaging biomarkers
98307|NCT02674529|Neurofeedback|neurofeedback
98308|NCT02674516|antisocial behavior|antisocial behavior
98309|NCT02674516|aggression|aggression
98560|NCT02672852|risankizumab|risankizumab
98310|NCT02674516|transcranial direct current stimulation|transcranial direct current stimulation
98311|NCT02674516|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
98312|NCT02674516|associated risk factors|associated risk factors
98313|NCT02674503|Walking|walking
98314|NCT02674503|Hospitalization|hospitalization
98315|NCT02674503|Randomized controlled trial|randomized controlled trial
98316|NCT02674490|aphasia, language|aphasia, language
98317|NCT02674373|gastric cancer|gastric cancer
98318|NCT02674373|biomarker|biomarker
98319|NCT02674373|Circulating tumor DNA|circulating tumor dna
98320|NCT02674373|Chemotherapy|chemotherapy
98321|NCT02674373|Prognosis|prognosis
98322|NCT02674373|Predictive|predictive
98323|NCT02674334|orthopedic procedures|orthopedic procedures
98324|NCT02674321|Tourette Syndrome|tourette syndrome
98325|NCT02674321|adolescents|adolescents
98326|NCT02674308|Drug therapy|drug therapy
98327|NCT02674295|Healthy|healthy
98328|NCT02674295|JNJ-54135419|jnj-54135419
98329|NCT02674295|Esketamine|esketamine
98330|NCT02674282|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
98331|NCT02674282|anterior cruciate ligament|anterior cruciate ligament
98332|NCT02674282|sports medicine|sports medicine
98333|NCT02674282|soccer|soccer
98334|NCT02674282|maximum oxygen uptake|maximum oxygen uptake
98335|NCT02674282|return to play|return to play
98336|NCT02674269|Overactive bladder|overactive bladder
98337|NCT02674269|Botox|botox
98338|NCT02674269|TC-3 Gel|tc-3 gel
98339|NCT02674269|Intravesical|intravesical
98340|NCT02674269|UroGen Pharma|urogen pharma
98341|NCT02674269|Botulinum Toxin|botulinum toxin
98342|NCT02674269|Urgency|urgency
98343|NCT02674269|OAB|oab
98344|NCT02674269|Incontinence|incontinence
98345|NCT02674269|I-QOL|i-qol
98346|NCT02674269|KHQ|khq
98347|NCT02674269|TBS|tbs
98348|NCT02674269|RTG|rtg
98349|NCT02674256|health|health
98350|NCT02674256|age between 18 to 60 years old|age between 18 to 60 years old
98351|NCT02674256|no history of gastrointestinal symptoms or complaints|no history of gastrointestinal symptoms or complaints
98352|NCT02674243|Malignant pleural effusion|malignant pleural effusion
98353|NCT02674243|Pleurodesis|pleurodesis
98354|NCT02674243|Talc|talc
98355|NCT02674243|Iodopovidone solution|iodopovidone solution
98356|NCT02674243|Povidone-iodine|povidone-iodine
98359|NCT02674191|miniplates ,molar intrusion, hyperdivergent|miniplates ,molar intrusion, hyperdivergent
98360|NCT02674139|post placental-caesarean-IUD|post placental-caesarean-iud
98361|NCT02674126|Cardiac Surgery|cardiac surgery
98362|NCT02674126|Maternal sound|maternal sound
98363|NCT02674126|Cortisol|cortisol
98364|NCT02674126|Blood sugar|blood sugar
98365|NCT02674126|Stress|stress
98366|NCT02674061|PD1|pd1
98367|NCT02674061|PD-1|pd-1
98368|NCT02674061|PDL1|pdl1
98369|NCT02674061|PD-L1|pd-l1
98370|NCT02674035|Abdominoplasty|abdominoplasty
98371|NCT02674035|Sutures|sutures
98372|NCT02674035|Abdominal deformities|abdominal deformities
98373|NCT02674035|Plication|plication
98374|NCT02674035|Monofilament nylon suture|monofilament nylon suture
98375|NCT02674035|Barbed suture|barbed suture
98376|NCT02674022|Maternal Health|maternal health
98377|NCT02674022|Autistic Disorder|autistic disorder
98378|NCT02674022|Metabolism|metabolism
98379|NCT02674022|Folic Acid|folic acid
98380|NCT02673996|antibody|antibody
98381|NCT02673996|autoimmune|autoimmune
98382|NCT02673996|adrenergic|adrenergic
98383|NCT02673996|autonomic|autonomic
98384|NCT02673983|Intestinal|intestinal
98385|NCT02673983|Biopsy|biopsy
98386|NCT02673983|full thickness|full thickness
98387|NCT02673983|endoscopic|endoscopic
98388|NCT02673970|Melanoma|melanoma
98389|NCT02673931|Open Heart Surgery|open heart surgery
98390|NCT02673931|Organ protection|organ protection
98391|NCT02673918|Rehabilitation|rehabilitation
98392|NCT02673918|Home-Based Intervention|home-based intervention
98393|NCT02673905|nasal chondrocytes|nasal chondrocytes
98394|NCT02673905|articular chondral lesions|articular chondral lesions
98395|NCT02673905|tissue engineering|tissue engineering
98396|NCT02673905|femoral condyle|femoral condyle
98397|NCT02673905|trochlea|trochlea
98404|NCT02673866|Spontaneous Pain|spontaneous pain
98405|NCT02673866|Hyperalgesia|hyperalgesia
98406|NCT02673866|Allodynia|allodynia
98407|NCT02673866|Average Daily Pain Score (ADPS)|average daily pain score (adps)
98408|NCT02673866|Pain Associated Sleep Interference|pain associated sleep interference
98409|NCT02673853|Supraglottic airway|supraglottic airway
98410|NCT02673853|Mini-dose atracurium|mini-dose atracurium
98411|NCT02673853|Postoperative residual paralysis|postoperative residual paralysis
98412|NCT02673840|dengue fever|dengue fever
98413|NCT02673840|dengue hemorrhagic fever|dengue hemorrhagic fever
98414|NCT02673840|ketotifen|ketotifen
98415|NCT02673840|vascular leakage|vascular leakage
98416|NCT02673840|pleural effusion|pleural effusion
98417|NCT02673840|plasma leakage|plasma leakage
98418|NCT02673801|Referral and Consultation|referral and consultation
98419|NCT02673801|Orthopedics|orthopedics
98420|NCT02673775|Macrophage|macrophage
98421|NCT02673749|Lactose maldigestion|lactose maldigestion
98422|NCT02673749|Dairy intolerance|dairy intolerance
98423|NCT02673749|Intolerance to milk|intolerance to milk
98424|NCT02673749|Intolerance to dairy|intolerance to dairy
98425|NCT02673749|Milk intolerance|milk intolerance
98426|NCT02673749|GI disorder|gi disorder
639437|NCT00736411|acupuncture|acupuncture
98427|NCT02673749|Lactose metabolism|lactose metabolism
98428|NCT02673749|GI symptoms after dairy ingestion|gi symptoms after dairy ingestion
98429|NCT02673736|PLX73086|plx73086
98430|NCT02673736|Synovitis, Pigmented Villonodular|synovitis, pigmented villonodular
98431|NCT02673736|Tenosynovial Giant Cell Tumor|tenosynovial giant cell tumor
98432|NCT02673736|Joint Diseases|joint diseases
98433|NCT02673736|Neoplasms|neoplasms
98434|NCT02673736|Synovitis|synovitis
98435|NCT02673723|docozine|docozine
98436|NCT02673697|Sutureless valve|sutureless valve
98437|NCT02673658|infant development, early intervention|infant development, early intervention
98438|NCT02673645|Educational Achievement|educational achievement
98439|NCT02673632|Anti-Müllerian hormone|anti-müllerian hormone
98440|NCT02673632|Ovarian stimulation|ovarian stimulation
98441|NCT02673632|Polycystic ovary syndrome|polycystic ovary syndrome
98442|NCT02673632|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
98443|NCT02673619|Topical|topical
98444|NCT02673619|Palmar Hyperhidrosis|palmar hyperhidrosis
98445|NCT02673619|Umeclidinium|umeclidinium
98446|NCT02673593|Safety|safety
89672|NCT02727062|radiation|radiation
89673|NCT02727062|head and neck cancer|head and neck cancer
89674|NCT02727062|smartphone pain app|smartphone pain app
89675|NCT02727062|OM Pain App|om pain app
98447|NCT02673593|Pharmacokinetics|pharmacokinetics
98448|NCT02673593|Food Effect|food effect
98449|NCT02673554|Glucose-dependent Insulinotropic Polypeptide (GIP)|glucose-dependent insulinotropic polypeptide (gip)
98450|NCT02673554|Glucagon-Like Peptide 1 (GLP-1)|glucagon-like peptide 1 (glp-1)
98451|NCT02673554|Incretin|incretin
98452|NCT02673554|Insulin secretion|insulin secretion
98453|NCT02673554|Tachyphylaxis|tachyphylaxis
98454|NCT02673528|appendectomy|appendectomy
98455|NCT02673528|laparoscopy|laparoscopy
98456|NCT02673528|laparoscopic assisted appendectomy|laparoscopic assisted appendectomy
98457|NCT02673528|cost utility|cost utility
98458|NCT02673515|Alternate Day Fasting|alternate day fasting
98463|NCT02673437|Acute coronary syndrome|acute coronary syndrome
98464|NCT02673411|elastography|elastography
98465|NCT02673411|ultrasonography|ultrasonography
98466|NCT02673372|Geriatric, Pain, Ketamine, Emergency Medicine|geriatric, pain, ketamine, emergency medicine
98467|NCT02673359|Preterm labor|preterm labor
98468|NCT02673359|Short cervix|short cervix
98469|NCT02673359|Progesterone|progesterone
98470|NCT02673359|Cervical cerclage|cervical cerclage
98473|NCT02673320|Acute Traumatic Cervical Central Cord Syndrom Injury|acute traumatic cervical central cord syndrom injury
98474|NCT02673320|Delay of Surgery|delay of surgery
98475|NCT02673320|Decompressive Surgery|decompressive surgery
98476|NCT02673320|Canal Stenosis|canal stenosis
98477|NCT02673320|Schneider Syndrom|schneider syndrom
98478|NCT02673320|Quality of life|quality of life
98479|NCT02673320|Functional Outcome|functional outcome
98480|NCT02673281|walnuts|walnuts
98481|NCT02673281|brain|brain
98482|NCT02673281|appetite|appetite
98483|NCT02673281|energy intake|energy intake
98484|NCT02673281|obesity|obesity
98485|NCT02673255|Plasma|plasma
98486|NCT02673255|Plasma Donor|plasma donor
98487|NCT02673255|Plasma Donation|plasma donation
98488|NCT02673255|Tetanus|tetanus
98490|NCT02673255|Immunoglobulin|immunoglobulin
98491|NCT02673255|Hyper-immunization|hyper-immunization
98492|NCT02673229|Santyl|santyl
98493|NCT02673229|Burn|burn
98494|NCT02673229|Partial Thickness Burn|partial thickness burn
98590|NCT02672592|Obesity|obesity
98495|NCT02673229|Second Degree Burn|second degree burn
98496|NCT02673229|Minor Burn Bacitracin|minor burn bacitracin
98497|NCT02673229|Scar Appearance|scar appearance
98498|NCT02673203|glucose monitoring|glucose monitoring
98499|NCT02673203|hunger levels|hunger levels
98500|NCT02673203|food intake|food intake
98501|NCT02673177|robot-assisted total mesorectal excision(RTME)|robot-assisted total mesorectal excision(rtme)
98502|NCT02673177|laparoscopic total mesorectal excision(LTME)|laparoscopic total mesorectal excision(ltme)
98503|NCT02673177|urinary function|urinary function
98504|NCT02673177|sexual function|sexual function
98505|NCT02673177|sphincter- preservation|sphincter- preservation
98506|NCT02673177|low rectal cancer|low rectal cancer
98507|NCT02673164|Heart failure|heart failure
98508|NCT02673164|stem cell|stem cell
98509|NCT02673164|adipose derived stem cell|adipose derived stem cell
98510|NCT02673164|Stem cell therapy|stem cell therapy
98511|NCT02673164|ischemic heart disease|ischemic heart disease
98512|NCT02673125|Preimplantation Genetic Screening|preimplantation genetic screening
98513|NCT02673112|Concussion|concussion
98514|NCT02673112|mild traumatic brain injury|mild traumatic brain injury
98515|NCT02673112|post concussion syndrome|post concussion syndrome
98516|NCT02673112|child|child
98517|NCT02673099|HDF online|hdf online
98518|NCT02673099|ESRD|esrd
98519|NCT02673099|Hemodialysis|hemodialysis
98520|NCT02673099|oxidative stress|oxidative stress
98521|NCT02673099|quality of life|quality of life
98522|NCT02673099|Hemodialysis treatment|hemodialysis treatment
98523|NCT02673086|retroclavicular approach|retroclavicular approach
98524|NCT02673086|coracoid approach|coracoid approach
98525|NCT02673086|ultrasound|ultrasound
98626|NCT02672345|Cytokines|cytokines
98526|NCT02673086|upper limb surgery|upper limb surgery
98527|NCT02673086|needle visibility|needle visibility
98528|NCT02673086|infraclavicular brachial plexus block|infraclavicular brachial plexus block
98529|NCT02673073|Heart failure|heart failure
98530|NCT02673073|patient's diary|patient's diary
98531|NCT02673073|self awareness|self awareness
98532|NCT02672995|stereotactic radiosurgery,Bevacizumab|stereotactic radiosurgery,bevacizumab
98533|NCT02672969|smoke evacuation system|smoke evacuation system
98534|NCT02672969|surgical smoke|surgical smoke
98535|NCT02672943|Parkinson disease|parkinson disease
98536|NCT02672943|Autonomic nervous system|autonomic nervous system
98537|NCT02672943|MicroRNA|microrna
98538|NCT02672943|Inflammation|inflammation
98539|NCT02672943|Oxidative stress|oxidative stress
98540|NCT02672943|noradrenergic network|noradrenergic network
98541|NCT02672943|Rehabilitation treatment|rehabilitation treatment
98542|NCT02672930|calcium gluconate|calcium gluconate
98543|NCT02672930|hyperpotassemia treatment|hyperpotassemia treatment
98544|NCT02672917|CA19-9 Positive Malignancies|ca19-9 positive malignancies
98545|NCT02672904|vocal cord|vocal cord
98546|NCT02672904|carcinoma|carcinoma
98547|NCT02672904|ktp laser|ktp laser
98548|NCT02672904|co2 laser|co2 laser
98549|NCT02672904|endoscopic surgery|endoscopic surgery
98550|NCT02672891|Postpartum Hemorrhage|postpartum hemorrhage
98551|NCT02672891|Uterine Tamponade|uterine tamponade
98552|NCT02672891|Condom Catheter|condom catheter
98553|NCT02672878|In-stent restenosis|in-stent restenosis
98554|NCT02672878|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
98555|NCT02672878|Stent|stent
98556|NCT02672878|Drug-eluting stent|drug-eluting stent
98557|NCT02672878|Coronary angiography|coronary angiography
98558|NCT02672852|ABBV-066|abbv-066
98559|NCT02672852|BI 655066|bi 655066
98561|NCT02672813|Pectoral nerve I and II blocks|pectoral nerve i and ii blocks
98562|NCT02672813|Breast surgery|breast surgery
98563|NCT02672813|Ropivacaine|ropivacaine
98564|NCT02672813|Postoperative opioid consumption|postoperative opioid consumption
98565|NCT02672787|Antihypertensive adherence|antihypertensive adherence
98566|NCT02672787|Emergency medicine|emergency medicine
98567|NCT02672787|Antihypertensives|antihypertensives
98568|NCT02672748|garden|garden
98569|NCT02672748|Native American|native american
98571|NCT02672748|Emotional health|emotional health
98572|NCT02672748|Physical health|physical health
98573|NCT02672735|corrective exercise program|corrective exercise program
98574|NCT02672735|movement efficiency|movement efficiency
98575|NCT02672722|This term was found doing the MeSH search and is the only thing that fits since we will be working with healthy subjects with no conditions.|this term was found doing the mesh search and is the only thing that fits since we will be working with healthy subjects with no conditions.
98576|NCT02672709|Factor Xa Inhibitors|factor xa inhibitors
98577|NCT02672709|Renal Dialysis|renal dialysis
98579|NCT02672696|Gamma Nail|gamma nail
98580|NCT02672657|Health-Related Quality of life|health-related quality of life
98581|NCT02672657|Cancer|cancer
98582|NCT02672657|Elderly|elderly
98583|NCT02672657|Caregivers|caregivers
98584|NCT02672618|heart failure|heart failure
98585|NCT02672618|infrared thermal imaging|infrared thermal imaging
98586|NCT02672592|Metabolic syndrome X|metabolic syndrome x
98587|NCT02672592|Hypogonadism|hypogonadism
98588|NCT02672592|Testosterone|testosterone
98589|NCT02672592|Inflammation|inflammation
98591|NCT02672553|Aortic Valve Replacement|aortic valve replacement
98592|NCT02672553|Minimal Invasive Sternotomy|minimal invasive sternotomy
98593|NCT02672540|Sickle Cell|sickle cell
98594|NCT02672540|Anemia|anemia
98595|NCT02672540|VOC|voc
98596|NCT02672540|Vaso occlusive crisis|vaso occlusive crisis
98597|NCT02672501|immunotherapy|immunotherapy
98598|NCT02672501|CAR-T|car-t
98599|NCT02672501|leukemia|leukemia
98600|NCT02672449|Prostate cancer|prostate cancer
98601|NCT02672449|Carbon ions|carbon ions
98602|NCT02672449|Radiobiology|radiobiology
98603|NCT02672449|Radiotherapy|radiotherapy
98604|NCT02672436|Diabetic Foot Ulcer|diabetic foot ulcer
98605|NCT02672436|Diabetes Mellitus|diabetes mellitus
98606|NCT02672436|Wound Healing|wound healing
98607|NCT02672397|Epidural|epidural
98608|NCT02672397|Ethnicity|ethnicity
98609|NCT02672397|Education|education
98610|NCT02672397|Labor|labor
98611|NCT02672397|obstetrical analgesia|obstetrical analgesia
98612|NCT02672384|Intensive care unit|intensive care unit
98613|NCT02672384|Invasive mechanical ventilation|invasive mechanical ventilation
98614|NCT02672384|Chronic periodontitis|chronic periodontitis
98615|NCT02672384|Point of Care P. gingivalis test|point of care p. gingivalis test
98616|NCT02672358|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
98617|NCT02672358|NSCLC|nsclc
98618|NCT02672358|dabrafenib|dabrafenib
98619|NCT02672358|trametinib|trametinib
98620|NCT02672358|Japanese patients|japanese patients
98621|NCT02672358|BRAF V600E mutation positive metastatic|braf v600e mutation positive metastatic
98622|NCT02672358|stage IV|stage iv
98623|NCT02672345|Sevoflurane|sevoflurane
98624|NCT02672345|MicroRNAs|micrornas
98625|NCT02672345|Inflammatory Response|inflammatory response
98627|NCT02672345|Anesthetics, Inhalation|anesthetics, inhalation
98628|NCT02672345|Macrophage Inflammatory Proteins|macrophage inflammatory proteins
98629|NCT02672267|AMI, hBMMSCs, stem cells,|ami, hbmmscs, stem cells,
98630|NCT02672241|Radiation Therapy|radiation therapy
98631|NCT02672241|Brainstem Tumor in Children|brainstem tumor in children
98632|NCT02672202|Chronic Pain|chronic pain
98633|NCT02672202|Pain Modulation Profile|pain modulation profile
98634|NCT02672202|CPM|cpm
98635|NCT02672202|acute post operative pain|acute post operative pain
98636|NCT02672189|Climacteric symptoms|climacteric symptoms
98637|NCT02672189|Menopause|menopause
98638|NCT02672189|Breast Cancer Survivors|breast cancer survivors
98639|NCT02672189|Internet-based|internet-based
98640|NCT02672189|Cognitive behavioral therapy|cognitive behavioral therapy
98641|NCT02672189|Psychosocial intervention|psychosocial intervention
98642|NCT02672176|Diabetes mellitus|diabetes mellitus
98643|NCT02672176|Motivational Interviewing|motivational interviewing
98644|NCT02672176|Mobile Health Technology|mobile health technology
98645|NCT02672176|Patient-generated Health Data (PGHD)|patient-generated health data (pghd)
98646|NCT02672163|autologous micrografts|autologous micrografts
98647|NCT02672163|heart failure|heart failure
98648|NCT02672163|coronary artery bypass surgery|coronary artery bypass surgery
98649|NCT02672163|cell therapy|cell therapy
98650|NCT02672163|atrial appendage|atrial appendage
98651|NCT02672163|epicardial cell delivery|epicardial cell delivery
98652|NCT02672150|evidence-based practice implementation|evidence-based practice implementation
98653|NCT02672150|system change|system change
98654|NCT02672150|interagency collaboration|interagency collaboration
98655|NCT02672150|substance use|substance use
98656|NCT02672150|treatment services|treatment services
98657|NCT02672150|data-driven decision making|data-driven decision making
98658|NCT02672150|juvenile justice|juvenile justice
98659|NCT02672150|adolescents|adolescents
98660|NCT02672150|justice-involved youth|justice-involved youth
98661|NCT02672150|cluster randomized trial|cluster randomized trial
98662|NCT02672137|myocardial infarction|myocardial infarction
98663|NCT02672137|knowledge transfer|knowledge transfer
98664|NCT02672137|acute coronary syndromes|acute coronary syndromes
98665|NCT02672020|pheochromocytoma|pheochromocytoma
98666|NCT02672020|paraganglioma|paraganglioma
98667|NCT02672020|adrenocortical carcinoma|adrenocortical carcinoma
98668|NCT02672007|Respiratory rate measurement methods.|respiratory rate measurement methods.
98669|NCT02671994|Geriatric Assessment|geriatric assessment
98670|NCT02671994|G8 screening|g8 screening
98671|NCT02671994|Oncologic treatment|oncologic treatment
98672|NCT02671968|CGM|cgm
98673|NCT02671968|hypoglycemic events|hypoglycemic events
98674|NCT02671955|Advanced Cancer|advanced cancer
98675|NCT02671955|JNJ-61610588|jnj-61610588
98676|NCT02671942|roflumilast|roflumilast
98677|NCT02671916|QoL and Survival one year after ICU stay|qol and survival one year after icu stay
98678|NCT02671864|Incretin-based therapy|incretin-based therapy
98680|NCT02671864|Angiogenesis Inflammation|angiogenesis inflammation
98681|NCT02671864|Hypoglycaemic treatment|hypoglycaemic treatment
98682|NCT02671851|Thoracic Paravertebral Blocks|thoracic paravertebral blocks
98683|NCT02671851|Ultrasound Guidance|ultrasound guidance
98684|NCT02671851|Reduction Mammoplasty|reduction mammoplasty
98685|NCT02671851|Time to First Pain|time to first pain
98686|NCT02671851|Postoperative Analgesia|postoperative analgesia
98687|NCT02671825|Pharmacokinetics|pharmacokinetics
98688|NCT02671812|dental implant|dental implant
98689|NCT02671812|patient satisfaction|patient satisfaction
98690|NCT02671812|treatment outcome|treatment outcome
98691|NCT02671812|cytokine profile|cytokine profile
98692|NCT02671812|risk factor|risk factor
98693|NCT02671812|risk predictor|risk predictor
98694|NCT02671786|Severe Acute Malnutrition|severe acute malnutrition
98695|NCT02671786|Severe Underweight|severe underweight
98696|NCT02671786|IAP Grade III-IV|iap grade iii-iv
98697|NCT02671786|Severe Stunting|severe stunting
98698|NCT02671786|Village Health Workers|village health workers
98699|NCT02671786|MAHAN RUTF & MAHAN Vit-Mim mix|mahan rutf & mahan vit-mim mix
98700|NCT02671773|Microbiota|microbiota
98701|NCT02671760|Short-term insomnia|short-term insomnia
98702|NCT02671760|difficulty sleeping|difficulty sleeping
98703|NCT02671760|sedative|sedative
98704|NCT02671760|hypnotic|hypnotic
98705|NCT02671734|endoscopy|endoscopy
98706|NCT02671682|Immunoadsorption|immunoadsorption
98707|NCT02671682|Plasmapheresis|plasmapheresis
98708|NCT02671656|Uricemia|uricemia
98709|NCT02671630|Cognitive function|cognitive function
98710|NCT02671630|Depression|depression
98711|NCT02671630|Quality of life|quality of life
98712|NCT02671630|Community-based computerized cognitive training program|community-based computerized cognitive training program
98713|NCT02671630|Randomized controlled trial|randomized controlled trial
98714|NCT02671617|Abdominal Cavity|abdominal cavity
98716|NCT02671604|acute renal failure|acute renal failure
98717|NCT02671604|prostatectomy|prostatectomy
98718|NCT02671604|minimal invasive surgery|minimal invasive surgery
98719|NCT02671578|nitrous oxide|nitrous oxide
98720|NCT02671578|conscious sedation|conscious sedation
98721|NCT02671578|pain|pain
98722|NCT02671578|anxiety|anxiety
98723|NCT02671565|Intraarticular hyaluronic acid injections|intraarticular hyaluronic acid injections
98724|NCT02671565|Total knee replacement|total knee replacement
98725|NCT02671565|Observational study|observational study
98726|NCT02671565|Intraarticular corticosteroid injections|intraarticular corticosteroid injections
98727|NCT02671565|Comparative effectiveness|comparative effectiveness
98728|NCT02671539|gene therapy|gene therapy
98729|NCT02671539|hereditary retinal degeneration|hereditary retinal degeneration
98730|NCT02671539|rAAV2.REP1|raav2.rep1
98731|NCT02671513|Melanoma|melanoma
98732|NCT02671513|Cycline-Dependent Kinase|cycline-dependent kinase
98733|NCT02671487|Problem Behavior|problem behavior
98734|NCT02671487|Aggression|aggression
98735|NCT02671487|Posttraumatic Stress Disorder|posttraumatic stress disorder
98736|NCT02671487|Adolescents|adolescents
98737|NCT02671448|Homebound|homebound
98738|NCT02671448|Homecare|homecare
98739|NCT02671448|15-022|15-022
98740|NCT02671396|Virtual Reality|virtual reality
98741|NCT02671396|Postural Stability|postural stability
98742|NCT02671396|Balance Training|balance training
98743|NCT02671396|Parkinson's Disease|parkinson's disease
98744|NCT02671383|Antiretroviral Agents|antiretroviral agents
98745|NCT02671383|Treatment|treatment
98746|NCT02671383|Viral Load|viral load
98747|NCT02671357|pancreatic surgery; neoplasms|pancreatic surgery; neoplasms
98748|NCT02671318|cytomegalovirus|cytomegalovirus
98749|NCT02671318|sirolimus|sirolimus
98750|NCT02671318|cytomegalovirus recurrence|cytomegalovirus recurrence
98751|NCT02671318|kidney transplant|kidney transplant
98752|NCT02671318|conversion|conversion
98753|NCT02671305|delayed cord clamping|delayed cord clamping
98754|NCT02671305|cord milking|cord milking
98755|NCT02671305|bedside neonatal resuscitation|bedside neonatal resuscitation
98756|NCT02671292|Loss of Control Eating|loss of control eating
98757|NCT02671292|Binge Eating|binge eating
98758|NCT02671292|Obesity|obesity
98759|NCT02671292|Prevention|prevention
98760|NCT02671292|Interpersonal Psychotherapy|interpersonal psychotherapy
98761|NCT02671292|Adolescent|adolescent
98762|NCT02671266|Oxytocin|oxytocin
98763|NCT02671266|Body dysmorphic disorder|body dysmorphic disorder
98764|NCT02671266|Obsessive-compulsive disorder|obsessive-compulsive disorder
98765|NCT02671240|Parkinson disease|parkinson disease
98766|NCT02671240|behavioral addiction|behavioral addiction
98767|NCT02671240|akinéto-rigid syndrome|akinéto-rigid syndrome
98768|NCT02671240|dopamine agonist|dopamine agonist
98769|NCT02671214|guar gum|guar gum
98771|NCT02671214|blood glucose|blood glucose
98772|NCT02671214|legume flour|legume flour
98773|NCT02671188|C-C chemokine receptor|c-c chemokine receptor
98774|NCT02671188|Psoriatic arthritis|psoriatic arthritis
98775|NCT02671188|Chemokine (C-C motif) ligand 20|chemokine (c-c motif) ligand 20
98776|NCT02671188|Monoclonal antibody|monoclonal antibody
98777|NCT02671188|psoriasis|psoriasis
98778|NCT02671188|Humanized Immunoglobulin G|humanized immunoglobulin g
98779|NCT02671162|Pruritus|pruritus
98780|NCT02671162|End-Stage Renal Disease|end-stage renal disease
98781|NCT02671110|weight loss treatment|weight loss treatment
98782|NCT02671110|Obesity|obesity
98783|NCT02671084|Sevoflurane|sevoflurane
98784|NCT02671084|Ck-MB|ck-mb
98785|NCT02671071|Cervix Cancer|cervix cancer
98786|NCT02671058|bioavailability|bioavailability
98787|NCT02671045|lung cancer|lung cancer
98788|NCT02671045|genomic profile|genomic profile
98789|NCT02671045|targeted therapy|targeted therapy
98790|NCT02671045|FoundationOne|foundationone
98791|NCT02671032|Cochlear Prosthesis Implantation|cochlear prosthesis implantation
98792|NCT02670980|Retina Implant|retina implant
98793|NCT02670980|Visual Prosthesis|visual prosthesis
98794|NCT02670941|aromatherapy|aromatherapy
98795|NCT02670941|chemotherapy|chemotherapy
98796|NCT02670941|ginger|ginger
98797|NCT02670941|lavender|lavender
98798|NCT02670941|orange|orange
98799|NCT02670941|jojoba|jojoba
98800|NCT02670941|essential oils|essential oils
98801|NCT02670941|cancer|cancer
98802|NCT02670928|Diabetes|diabetes
98803|NCT02670928|lifestyle change|lifestyle change
98804|NCT02670928|weight management|weight management
98805|NCT02670928|control of glycemic in HbA1C and FPG|control of glycemic in hba1c and fpg
98806|NCT02670889|Urea Cycle Disorder|urea cycle disorder
98807|NCT02670850|Mild Cognitive Impairment|mild cognitive impairment
98808|NCT02670850|Family caregiver|family caregiver
98809|NCT02670850|Intervention program|intervention program
98810|NCT02670850|Elders|elders
98811|NCT02670811|Hypertension|hypertension
98812|NCT02670811|Fermented Milk|fermented milk
98813|NCT02670811|Clinical Study|clinical study
98814|NCT02670811|Randomized|randomized
639438|NCT00736424|Epilepsy|epilepsy
98815|NCT02670811|Double-blind|double-blind
98816|NCT02670798|neuromuscular|neuromuscular
98817|NCT02670798|scoliosis|scoliosis
98818|NCT02670772|Antiretroviral Agents|antiretroviral agents
98819|NCT02670746|Pancreatic Cancer|pancreatic cancer
98820|NCT02670746|Observational|observational
98821|NCT02670746|Nab-Paclitaxel|nab-paclitaxel
98822|NCT02670746|Abraxane|abraxane
98823|NCT02670746|ABI-007|abi-007
98824|NCT02670746|Gemcitabine|gemcitabine
98825|NCT02670746|Non-interventional|non-interventional
98826|NCT02670746|Netherlands|netherlands
98827|NCT02670746|Quality of Life|quality of life
98828|NCT02670733|mechanical ventilation|mechanical ventilation
98829|NCT02670733|positive end-expiratory pressure|positive end-expiratory pressure
98830|NCT02670720|BCX4161|bcx4161
98831|NCT02670720|avoralstat|avoralstat
98832|NCT02670720|HAE|hae
98833|NCT02670720|hereditary angioedema|hereditary angioedema
98834|NCT02670720|prophylaxis|prophylaxis
98835|NCT02670707|vinblastine|vinblastine
98836|NCT02670707|prednisone|prednisone
98837|NCT02670707|cytarabine|cytarabine
98838|NCT02670707|Langerhans Cell Histiocytosis (LCH)|langerhans cell histiocytosis (lch)
98839|NCT02670694|Rett Syndrome|rett syndrome
98840|NCT02670694|Prader-Willi Syndrome|prader-willi syndrome
98841|NCT02670694|Angelman Syndrome|angelman syndrome
98842|NCT02670694|Sleep Problems|sleep problems
98843|NCT02670681|Exercise|exercise
98844|NCT02670681|Aerobic Exercise|aerobic exercise
98845|NCT02670668|BRCA1/2;Mutations;Neoadjuvant chemotherapy;TNBC|brca1/2;mutations;neoadjuvant chemotherapy;tnbc
98846|NCT02670655|Ablative fractional laser|ablative fractional laser
98847|NCT02670655|Iontophoresis|iontophoresis
98848|NCT02670655|Actinic keratosis|actinic keratosis
98849|NCT02670655|Photodynamic therapy|photodynamic therapy
98850|NCT02670629|Pediatric orthopedics|pediatric orthopedics
98851|NCT02670577|stage I|stage i
98852|NCT02670577|stage II|stage ii
98853|NCT02670577|HER2 positive|her2 positive
98854|NCT02670577|Triple Negative|triple negative
98855|NCT02670564|pharmacogenetics|pharmacogenetics
98856|NCT02670564|busulfan|busulfan
98857|NCT02670564|treosulfan|treosulfan
98858|NCT02670564|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
98859|NCT02670564|fludarabine|fludarabine
98860|NCT02670564|pediatric patients|pediatric patients
98861|NCT02670564|TBI|tbi
98862|NCT02670564|leukemia|leukemia
98863|NCT02670564|leukemia, lymphoid|leukemia, lymphoid
98864|NCT02670564|precursor cell lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
98865|NCT02670564|Immune System disease|immune system disease
98866|NCT02670564|Immunoproliferative Disorders|immunoproliferative disorders
98867|NCT02670564|stem cell transplantation|stem cell transplantation
98868|NCT02670564|children and adolescent|children and adolescent
100032|NCT02663219|MSM|msm
98874|NCT02670512|End-Stage Renal Disease|end-stage renal disease
98875|NCT02670512|Peritoneal Dialysis|peritoneal dialysis
98876|NCT02670512|Telehomecare|telehomecare
98877|NCT02670512|Telehome Monitoring|telehome monitoring
98878|NCT02670486|Overactive bladder|overactive bladder
98879|NCT02670486|Urge urinary incontinence|urge urinary incontinence
98880|NCT02670486|Urodynamics|urodynamics
98881|NCT02670408|Heart transplant|heart transplant
98882|NCT02670408|global gene expression|global gene expression
98883|NCT02670408|molecular diagnostics|molecular diagnostics
98884|NCT02670395|Healthy|healthy
98885|NCT02670395|JNJ-54416076|jnj-54416076
98886|NCT02670395|Ascending Dose|ascending dose
98887|NCT02670369|Sedentary time|sedentary time
98888|NCT02670369|Sit-to-stand transitions|sit-to-stand transitions
98889|NCT02670356|fish oil|fish oil
98891|NCT02670356|DHA|dha
98892|NCT02670356|krill oil|krill oil
98893|NCT02670356|Metabolic Syndrome|metabolic syndrome
98894|NCT02670330|Epidermolysis Bullosa|epidermolysis bullosa
98895|NCT02670330|Simplex|simplex
98896|NCT02670330|Recessive Dystrophic|recessive dystrophic
98897|NCT02670330|Junctional non-Herlitz|junctional non-herlitz
98898|NCT02670317|DLBCL|dlbcl
98899|NCT02670317|large B cell lymphoma|large b cell lymphoma
98900|NCT02670317|NHL|nhl
98901|NCT02670304|letrozole|letrozole
98902|NCT02670304|ovarian hyperstimulating syndrome|ovarian hyperstimulating syndrome
98903|NCT02670291|auditory hallucinations|auditory hallucinations
98904|NCT02670291|schizophrenia|schizophrenia
98905|NCT02670291|cTBS|ctbs
98906|NCT02670291|noninvasive brain stimulation|noninvasive brain stimulation
98907|NCT02670265|malnutrition|malnutrition
98908|NCT02670265|parenteral nutrition|parenteral nutrition
98909|NCT02670265|weight loss|weight loss
98910|NCT02670265|pancreatic cancer|pancreatic cancer
98911|NCT02670265|biliary tract cancer|biliary tract cancer
98912|NCT02670265|quality of life|quality of life
98913|NCT02670226|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
98914|NCT02670226|Muscle metabolism|muscle metabolism
98915|NCT02670226|Metabolomics|metabolomics
98916|NCT02670226|Transcriptomics|transcriptomics
98917|NCT02670200|psychooncology|psychooncology
98918|NCT02670200|mental health support|mental health support
98919|NCT02670200|ICBT|icbt
98920|NCT02670200|supportive treatment for cancer patients|supportive treatment for cancer patients
98921|NCT02670200|depression|depression
98922|NCT02670200|online-therapy|online-therapy
98923|NCT02670200|Psycho-oncological support via internet|psycho-oncological support via internet
98924|NCT02670200|internet-delivered cognitive behavior medicine|internet-delivered cognitive behavior medicine
99154|NCT02668536|melanoma|melanoma
98925|NCT02670187|MERS CoV, Vaccine, DNA|mers cov, vaccine, dna
98926|NCT02670174|Shoulder impingement syndrome|shoulder impingement syndrome
98927|NCT02670174|Overhead athletes|overhead athletes
98928|NCT02670174|Kinetic chain|kinetic chain
98929|NCT02670174|Exercise treatment|exercise treatment
98930|NCT02670148|Chiropractic Manipulative Therapy|chiropractic manipulative therapy
98931|NCT02670148|Low back pain|low back pain
98932|NCT02670148|Trunk muscle strength|trunk muscle strength
98933|NCT02670148|Balance|balance
98934|NCT02670148|Active military personnel|active military personnel
98935|NCT02670122|Hepatocellular Carcinoma|hepatocellular carcinoma
98936|NCT02670122|TACE|tace
98937|NCT02670096|acetazolamide|acetazolamide
98938|NCT02670096|Treatment Emergent Sleep Disordered Breathing|treatment emergent sleep disordered breathing
98939|NCT02670096|Sleep Apnea|sleep apnea
98940|NCT02670031|Hypertensive Heart Disease|hypertensive heart disease
98941|NCT02670031|Hypertension|hypertension
98942|NCT02670031|Left Ventricular Hypertrophy|left ventricular hypertrophy
98943|NCT02670031|Myocardial Fibrosis|myocardial fibrosis
98944|NCT02670031|Cardiovascular Magnetic Resonance Imaging|cardiovascular magnetic resonance imaging
98945|NCT02669992|Ileostomy|ileostomy
98946|NCT02669979|elderly|elderly
98947|NCT02669979|oral care|oral care
98948|NCT02669966|Kidney Transplantation|kidney transplantation
98949|NCT02669940|Ombitasvir|ombitasvir
98950|NCT02669940|Dasabuvir|dasabuvir
98951|NCT02669940|Paritaprevir|paritaprevir
98952|NCT02669927|hip surgery|hip surgery
98953|NCT02669927|frail older people|frail older people
98954|NCT02669901|Opioid-Related Disorders|opioid-related disorders
98955|NCT02669901|Naloxone|naloxone
98956|NCT02669901|Harm Reduction|harm reduction
98957|NCT02669901|Drug Overdose Deaths|drug overdose deaths
98960|NCT02669901|Universal Precautions|universal precautions
98961|NCT02669901|Opioid Substance Use Disorder|opioid substance use disorder
98962|NCT02669888|Indigo Naturalis|indigo naturalis
98963|NCT02669888|Atopic Dermatitis|atopic dermatitis
98966|NCT02669797|Obesity|obesity
98967|NCT02669797|Ecological Momentary Intervention|ecological momentary intervention
98968|NCT02669797|Video Feedback|video feedback
98969|NCT02669771|Xtandi|xtandi
98970|NCT02669771|MDV3100|mdv3100
98971|NCT02669771|long term use|long term use
98972|NCT02669771|enzalutamide|enzalutamide
98973|NCT02669758|Alkermes|alkermes
98974|NCT02669758|ALKS 3831|alks 3831
98975|NCT02669758|Samidorphan|samidorphan
98976|NCT02669758|Schizophrenia|schizophrenia
98977|NCT02669758|Safety|safety
98978|NCT02669745|Chinese women|chinese women
98979|NCT02669745|Breast cancer|breast cancer
98980|NCT02669732|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
98981|NCT02669732|Adult|adult
98982|NCT02669732|Developmental Phase II|developmental phase ii
98983|NCT02669719|Lung Cancer|lung cancer
98984|NCT02669719|Chemotherapy|chemotherapy
98985|NCT02669719|Immunotherapy|immunotherapy
98986|NCT02669693|Olives, oleuropein|olives, oleuropein
98987|NCT02669667|MEDI9314|medi9314
98988|NCT02669667|Safety|safety
98989|NCT02669667|Tolerability|tolerability
98990|NCT02669667|Pharmacokinetics|pharmacokinetics
98991|NCT02669667|Immunogenicity|immunogenicity
98992|NCT02669641|Steatosis, Fatty liver, Steatohepatitis|steatosis, fatty liver, steatohepatitis
98993|NCT02669615|multiple myeloma|multiple myeloma
98994|NCT02669615|Melphalan HCl|melphalan hcl
98995|NCT02669615|Autologous Transplantation|autologous transplantation
98996|NCT02669602|Nutritional epidemiology|nutritional epidemiology
98997|NCT02669602|Prospective|prospective
98998|NCT02669589|CRRT|crrt
98999|NCT02669589|AKI|aki
99000|NCT02669589|anticoagulation|anticoagulation
99001|NCT02669589|KDIGO|kdigo
99002|NCT02669576|Breast cancer|breast cancer
99003|NCT02669576|meopausal syptoms|meopausal syptoms
99004|NCT02669576|mind body medecine|mind body medecine
99005|NCT02669576|yoga|yoga
99006|NCT02669576|acupuncture|acupuncture
99007|NCT02669550|Fiberoptic bronchoscope|fiberoptic bronchoscope
99008|NCT02669550|Disposcope endoscope|disposcope endoscope
99009|NCT02669550|Awake orotracheal intubation|awake orotracheal intubation
99010|NCT02669511|DLBCL|dlbcl
99011|NCT02669485|ICG|icg
99012|NCT02669485|colectomy|colectomy
99013|NCT02669485|anastomotic leak|anastomotic leak
99014|NCT02669485|anastomotic leakage rate|anastomotic leakage rate
99015|NCT02669485|surgical decision|surgical decision
99016|NCT02669459|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
99017|NCT02669459|Imiquimod|imiquimod
99018|NCT02669459|Human papillomavirus|human papillomavirus
99019|NCT02669459|quality of life|quality of life
99020|NCT02669459|biological markers|biological markers
99021|NCT02669446|Non interventional study|non interventional study
99022|NCT02669446|Ectoin|ectoin
99023|NCT02669446|Lozenges|lozenges
99024|NCT02669446|pharyngitis|pharyngitis
99025|NCT02669433|Dementia with Lewy bodies|dementia with lewy bodies
99026|NCT02669433|Lewy bodies|lewy bodies
99027|NCT02669433|intepirdine|intepirdine
99028|NCT02669433|RVT-101|rvt-101
99029|NCT02669433|dementia|dementia
99030|NCT02669381|Phenylalanine|phenylalanine
99031|NCT02669381|Direct Amino Acid Oxidation|direct amino acid oxidation
99032|NCT02669381|Stable isotopes|stable isotopes
99033|NCT02669355|White coat physician attire|white coat physician attire
99034|NCT02669342|Infection|infection
99035|NCT02669342|Urinary Catheter|urinary catheter
99036|NCT02669342|Sharklet|sharklet
99037|NCT02669316|diet|diet
90279|NCT02723812|GCFLU|gcflu
99038|NCT02669303|Subacromial injection|subacromial injection
99039|NCT02669303|methylprednisolone|methylprednisolone
99040|NCT02669303|treatment|treatment
99041|NCT02669303|Platelet-rich plasma|platelet-rich plasma
99042|NCT02669251|Optimal Biologic Dose|optimal biologic dose
99043|NCT02669251|Safety|safety
99044|NCT02669251|Chronic Graft-Versus-Host Disease (cGVHD)|chronic graft-versus-host disease (cgvhd)
99045|NCT02669251|Inflammatory Lung Disease|inflammatory lung disease
99046|NCT02669251|FEV1|fev1
99047|NCT02669225|18 F florbetaben|18 f florbetaben
99048|NCT02669225|Sleep Deprivation|sleep deprivation
99049|NCT02669225|rested wakefulness|rested wakefulness
99050|NCT02669225|glymphatic system|glymphatic system
99051|NCT02669212|Chronic Fatigue Syndrome|chronic fatigue syndrome
99052|NCT02669212|Lyme Disease|lyme disease
99053|NCT02669212|Healthy Volunteers|healthy volunteers
99054|NCT02669212|Movement Disorder|movement disorder
99055|NCT02669186|analgesia|analgesia
99056|NCT02669186|cancer|cancer
99057|NCT02669186|natural killer cell|natural killer cell
99058|NCT02669186|opioid|opioid
99059|NCT02669173|Myeloid derived suppressor cells|myeloid derived suppressor cells
99060|NCT02669173|brain tumor|brain tumor
99062|NCT02669173|GBM|gbm
99063|NCT02669173|recurrent|recurrent
99064|NCT02669160|Motorized Orthotic Devices|motorized orthotic devices
99065|NCT02669160|Minors|minors
99066|NCT02669160|CP (Cerebral Palsy)|cp (cerebral palsy)
99067|NCT02669160|Exoskeleton Device|exoskeleton device
99068|NCT02669134|cardiac resynchronization therapy|cardiac resynchronization therapy
99069|NCT02669134|optimization|optimization
99070|NCT02669134|heart failure|heart failure
99071|NCT02669134|reverse left ventricular remodeling|reverse left ventricular remodeling
99072|NCT02669121|Drug therapy|drug therapy
99073|NCT02669108|testis|testis
99074|NCT02669108|spermatogenesis|spermatogenesis
99075|NCT02669082|Drug Therapy|drug therapy
99076|NCT02669069|Bi-modal neuromodulation|bi-modal neuromodulation
99077|NCT02669004|Analgesia, Epidural,Pain, Postoperative|analgesia, epidural,pain, postoperative
99078|NCT02668991|Autism Spectrum Disorder|autism spectrum disorder
99079|NCT02668991|Janssen Autism Knowledge Engine|janssen autism knowledge engine
99080|NCT02668991|Autism Behavior Inventory|autism behavior inventory
99081|NCT02668978|lung surgery|lung surgery
99082|NCT02668978|air leak|air leak
99083|NCT02668978|prevention|prevention
99084|NCT02668965|Clinical pregnancy rate|clinical pregnancy rate
99085|NCT02668913|gynaecology|gynaecology
99086|NCT02668913|Oncology|oncology
99087|NCT02668900|Feasibility trial|feasibility trial
99088|NCT02668900|Cardiovascular disease|cardiovascular disease
99089|NCT02668900|Decision Support|decision support
99090|NCT02668900|Patient Decision Aid|patient decision aid
99091|NCT02668900|implantable cardioverter defibrillator|implantable cardioverter defibrillator
99092|NCT02668900|implantable cardioverter defibrillator replacement|implantable cardioverter defibrillator replacement
99093|NCT02668874|Pit and Fissure sealants|pit and fissure sealants
99094|NCT02668874|Isolation|isolation
99095|NCT02668874|permanent teeth|permanent teeth
99096|NCT02668874|children|children
99097|NCT02668874|Isolite®|isolite®
99098|NCT02668874|Dental caries|dental caries
99099|NCT02668848|Stroke|stroke
99100|NCT02668848|Dehydration|dehydration
99101|NCT02668848|Fluid therapy|fluid therapy
99102|NCT02668770|Advanced Cancers|advanced cancers
99103|NCT02668770|Melanoma|melanoma
99104|NCT02668770|Advanced solid malignancies|advanced solid malignancies
99105|NCT02668770|Metastatic|metastatic
99106|NCT02668770|MGN1703|mgn1703
99107|NCT02668770|Ipilimumab|ipilimumab
99108|NCT02668770|Yervoy|yervoy
99123|NCT02668666|CDK4/6 Inhibitor|cdk4/6 inhibitor
99136|NCT02668640|Work productivity|work productivity
99137|NCT02668640|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
99138|NCT02668640|Adalimumab|adalimumab
99139|NCT02668640|Quality of life (QOL)|quality of life (qol)
99140|NCT02668627|Stroke|stroke
99141|NCT02668627|Collateral status|collateral status
99142|NCT02668627|Endovascular treatment|endovascular treatment
99143|NCT02668614|Detection|detection
99144|NCT02668601|Gestational Diabetes Mellitus|gestational diabetes mellitus
99145|NCT02668601|Childhood Obesity|childhood obesity
99146|NCT02668601|Offspring|offspring
99147|NCT02668575|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
99148|NCT02668562|acute coronary syndrome|acute coronary syndrome
99149|NCT02668562|coronary artery bypass surgery|coronary artery bypass surgery
99150|NCT02668562|ticagrelor|ticagrelor
99151|NCT02668562|antiplatelet therapy|antiplatelet therapy
99152|NCT02668562|platelet function testing|platelet function testing
99153|NCT02668536|sunscreen|sunscreen
99155|NCT02668536|improved protection from uv rays|improved protection from uv rays
99156|NCT02668523|Presbyopia|presbyopia
99157|NCT02668523|Corneal Inlay|corneal inlay
99158|NCT02668523|Pseudophakic|pseudophakic
99159|NCT02668523|Pseudophakia|pseudophakia
90377|NCT02723305|XXY|xxy
99160|NCT02668510|Heel Pain|heel pain
99161|NCT02668510|extracorporeal shock wave therapy|extracorporeal shock wave therapy
99162|NCT02668510|ESWT|eswt
99163|NCT02668510|shock wave|shock wave
99164|NCT02668510|Soldiers|soldiers
99165|NCT02668510|Platelet rich plasma|platelet rich plasma
99167|NCT02668510|Autologous conditioned plasma|autologous conditioned plasma
99168|NCT02668510|Military|military
99169|NCT02668497|Movement disorders|movement disorders
99170|NCT02668497|Botulinum toxin type A|botulinum toxin type a
99171|NCT02668497|Tremor|tremor
99172|NCT02668497|Kinematics|kinematics
99173|NCT02668484|TAVI|tavi
99174|NCT02668484|trans-femoral|trans-femoral
99175|NCT02668484|Sapien|sapien
99176|NCT02668484|Lotus|lotus
99177|NCT02668445|Concurrent|concurrent
99178|NCT02668445|muscle|muscle
99179|NCT02668445|glycogen|glycogen
99180|NCT02668445|molecular|molecular
99181|NCT02668406|Blood infection, melioidosis, rapid diagnostic test|blood infection, melioidosis, rapid diagnostic test
99182|NCT02668380|Apatinib|apatinib
99183|NCT02668380|metastatic gastric cancer|metastatic gastric cancer
99184|NCT02668380|Non-interventionalStudy|non-interventionalstudy
99185|NCT02668367|Viral Diseases|viral diseases
99186|NCT02668367|Antiviral|antiviral
99187|NCT02668367|Paramyxoviridae Infections|paramyxoviridae infections
99188|NCT02668367|RSV|rsv
99189|NCT02668367|Respiratory Syncytial Virus|respiratory syncytial virus
99190|NCT02668367|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
99191|NCT02668367|Aviragen Therapeutics|aviragen therapeutics
99192|NCT02668367|Aviragen|aviragen
99193|NCT02668354|Childhood Cancer|childhood cancer
99194|NCT02668354|Pediatric Oncology|pediatric oncology
99195|NCT02668354|Infant tumors|infant tumors
99196|NCT02668302|Steroid-eluting implant|steroid-eluting implant
99197|NCT02668302|Mometasone furoate|mometasone furoate
99198|NCT02668276|Prostatic neoplasms|prostatic neoplasms
99199|NCT02668276|Oncotype DX|oncotype dx
99200|NCT02668276|Treatment Decisions|treatment decisions
99201|NCT02668263|Breast cancer|breast cancer
99202|NCT02668263|mastectomy|mastectomy
99203|NCT02668263|seromas|seromas
99204|NCT02668211|osteoarthritis|osteoarthritis
99205|NCT02668211|radiostereometric analysis|radiostereometric analysis
99206|NCT02668211|correction of functional deformity|correction of functional deformity
99207|NCT02668211|procedures|procedures
99208|NCT02668211|total hip arthroplasty|total hip arthroplasty
99209|NCT02668211|musculoskeletal diseases|musculoskeletal diseases
99210|NCT02668198|Endoscopic mucosal resection, residual polyp, near focus imaging|endoscopic mucosal resection, residual polyp, near focus imaging
99211|NCT02668172|pegvisomant|pegvisomant
99212|NCT02668172|pasireotide LAR|pasireotide lar
99213|NCT02668172|long acting somatostatin analogues|long acting somatostatin analogues
99214|NCT02668146|essential tremor|essential tremor
99215|NCT02668146|Perampanel|perampanel
99216|NCT02668146|clinical trial|clinical trial
99217|NCT02668133|zinc deficiency|zinc deficiency
99218|NCT02668133|zinc absorption|zinc absorption
99219|NCT02668120|chronic histiocytic intervillositis|chronic histiocytic intervillositis
99220|NCT02668120|serum alkaline phosphatase|serum alkaline phosphatase
99221|NCT02668120|placenta|placenta
99222|NCT02668120|case-control study|case-control study
99223|NCT02668094|propofol|propofol
99224|NCT02668094|lidocaine|lidocaine
99225|NCT02668094|pregabalin|pregabalin
99226|NCT02668081|Endoscopic sphincterotomy|endoscopic sphincterotomy
99227|NCT02668081|Endoscopic papillary balloon dilation|endoscopic papillary balloon dilation
99228|NCT02668081|Metagenomics|metagenomics
99229|NCT02668068|Pneumoconiosis|pneumoconiosis
99230|NCT02668068|Mesenchymal Stem Cells|mesenchymal stem cells
99231|NCT02668068|whole-lung lavage (WLL)|whole-lung lavage (wll)
99232|NCT02668055|TB4|tb4
99233|NCT02668055|Difficult to heal|difficult to heal
99234|NCT02668029|Oxygen therapy|oxygen therapy
99235|NCT02668003|Prevention trial|prevention trial
99236|NCT02668003|Cognitive Behaviour Therapy|cognitive behaviour therapy
99237|NCT02668003|CWP|cwp
99238|NCT02668003|Chronic widespread pain|chronic widespread pain
99239|NCT02668003|RCT|rct
99240|NCT02668003|Fibromyalgia|fibromyalgia
99241|NCT02668003|Prevention|prevention
99242|NCT02667990|metatarsalgia|metatarsalgia
99243|NCT02667990|pedobar|pedobar
99244|NCT02667990|foot|foot
99245|NCT02667990|stiletto|stiletto
99246|NCT02667990|insoles|insoles
99247|NCT02667977|fluids, pediatric, gastroenteritis|fluids, pediatric, gastroenteritis
99248|NCT02667951|Elderly|elderly
99249|NCT02667951|Dementia|dementia
99250|NCT02667951|Intervention program|intervention program
99251|NCT02667925|ovarian cancer|ovarian cancer
99252|NCT02667925|intraperitoneal chemotherapy|intraperitoneal chemotherapy
99253|NCT02667912|Hypertension, Endovascular Procedures, Catheter Ablation, Renal Artery|hypertension, endovascular procedures, catheter ablation, renal artery
99254|NCT02667899|disorders of consciousness|disorders of consciousness
99255|NCT02667899|deep brain stimulation|deep brain stimulation
117762|NCT02559115|14-146|14-146
99256|NCT02667899|transcranial magnetic stimulation|transcranial magnetic stimulation
99257|NCT02667860|intracorporeal anastomosis|intracorporeal anastomosis
99258|NCT02667860|laparoscopic colectomy|laparoscopic colectomy
99259|NCT02667860|outcomes|outcomes
99260|NCT02667860|length of stay|length of stay
99261|NCT02667860|analgesia|analgesia
99262|NCT02667860|aesthetic|aesthetic
99263|NCT02667860|extracorporeal anastomosis|extracorporeal anastomosis
99264|NCT02667860|laparoscopic|laparoscopic
99265|NCT02667847|preoperative anxiety assessment|preoperative anxiety assessment
99266|NCT02667847|levels of preoperative anxiety using two different scales|levels of preoperative anxiety using two different scales
99267|NCT02667834|social cognition|social cognition
99268|NCT02667834|cognitive remediation|cognitive remediation
99269|NCT02667782|Mindfulness-based interventions|mindfulness-based interventions
99270|NCT02667782|Dementia|dementia
99271|NCT02667782|Caregiving|caregiving
99272|NCT02667782|Burden|burden
99273|NCT02667782|Stress|stress
99274|NCT02667782|Anxiety|anxiety
99275|NCT02667782|Depression|depression
99276|NCT02667782|Community care|community care
99277|NCT02667756|biomarker|biomarker
99278|NCT02667756|inflammation|inflammation
99279|NCT02667756|prognosis|prognosis
99280|NCT02667756|knee|knee
99281|NCT02667743|NSCLC|nsclc
99282|NCT02667743|Paclitaxel Micelles for Injection|paclitaxel micelles for injection
99283|NCT02667691|superoxyde dismutase|superoxyde dismutase
99284|NCT02667691|melon concentrate|melon concentrate
99285|NCT02667691|oxydative stress|oxydative stress
99286|NCT02667691|overweight women|overweight women
99287|NCT02667665|Alzheimer's Disease Dementia|alzheimer's disease dementia
99288|NCT02667652|T2DM|t2dm
99289|NCT02667652|RYGB|rygb
99290|NCT02667652|RCT|rct
99291|NCT02667639|safety|safety
99292|NCT02667639|tolerability|tolerability
99293|NCT02667639|RPH-104|rph-104
99294|NCT02667639|RPH104|rph104
99295|NCT02667626|Breast cancer survivor|breast cancer survivor
99296|NCT02667626|Cancer survivorship|cancer survivorship
99297|NCT02667626|Survivorship care plan|survivorship care plan
99298|NCT02667626|Vaginal dryness|vaginal dryness
99299|NCT02667626|Vulvovaginal atrophy|vulvovaginal atrophy
99300|NCT02667626|Vasomotor symptom|vasomotor symptom
99301|NCT02667626|Infertility|infertility
99302|NCT02667626|Family planning|family planning
99303|NCT02667613|motor skill learning|motor skill learning
639439|NCT00736424|SUDEP|sudep
99304|NCT02667613|functional changes|functional changes
99305|NCT02667613|neuroplastic changes|neuroplastic changes
99306|NCT02667600|Cesarean|cesarean
99307|NCT02667600|Blood Loss|blood loss
99308|NCT02667600|Triton|triton
99309|NCT02667574|basal cell carcinoma|basal cell carcinoma
99310|NCT02667574|surgery|surgery
99311|NCT02667574|stage|stage
99312|NCT02667574|vismodegib|vismodegib
99313|NCT02667548|percutaneous coronary intervention|percutaneous coronary intervention
99314|NCT02667509|Evolutionary Model|evolutionary model
99315|NCT02667483|Duchenne muscular dystrophy|duchenne muscular dystrophy
99316|NCT02667483|DMD|dmd
99317|NCT02667483|Oligonucleotides, Antisense|oligonucleotides, antisense
99318|NCT02667483|Exon skipping|exon skipping
99319|NCT02667470|Solifenacin|solifenacin
99320|NCT02667470|Overactive bladder|overactive bladder
99321|NCT02667431|SUI|sui
99322|NCT02667418|Clostridium|clostridium
99323|NCT02667418|Difficile|difficile
99324|NCT02667418|Fidaxomicin|fidaxomicin
99325|NCT02667418|Vancomycin|vancomycin
99326|NCT02667418|Recurrent|recurrent
99327|NCT02667418|Pulse|pulse
99328|NCT02667418|Taper|taper
99329|NCT02667392|Stroke|stroke
99330|NCT02667392|Gait|gait
99331|NCT02667392|Walking|walking
99332|NCT02667392|Rehabilitation|rehabilitation
99333|NCT02667392|Exercise|exercise
99334|NCT02667392|Exercise Therapy|exercise therapy
99335|NCT02667392|Physical Therapy Modalities|physical therapy modalities
99336|NCT02667392|Exercise Movement Techniques|exercise movement techniques
99337|NCT02667379|Cat|cat
99338|NCT02667379|allergy|allergy
99339|NCT02667379|dander|dander
99340|NCT02667379|Fel d 1|fel d 1
99341|NCT02667379|Felis domesticus|felis domesticus
99342|NCT02667366|mild and moderate depression|mild and moderate depression
99343|NCT02667353|electroconvulsive|electroconvulsive
99344|NCT02667353|hippocampus|hippocampus
99345|NCT02667353|elderly|elderly
99346|NCT02667353|working mechanism|working mechanism
99347|NCT02667340|exercise|exercise
99348|NCT02667340|carbohydrate|carbohydrate
99349|NCT02667340|Superstarch|superstarch
99350|NCT02667327|diabetic foot ulcer|diabetic foot ulcer
99351|NCT02667327|diabetic complications|diabetic complications
99352|NCT02667327|diabetes|diabetes
99353|NCT02667327|wound healing|wound healing
99354|NCT02667327|Granexin gel|granexin gel
99355|NCT02667327|FirstString Research|firststring research
99356|NCT02667314|Cognition|cognition
99357|NCT02667314|Cognitive Aging|cognitive aging
99358|NCT02667314|Dementia|dementia
99359|NCT02667314|Neurocognitive Disorders|neurocognitive disorders
99360|NCT02667314|Cognitive Therapy|cognitive therapy
99361|NCT02667314|Cognitive Reserve|cognitive reserve
99362|NCT02667314|Cognitive Enrichment|cognitive enrichment
99363|NCT02667314|Jigsaw Puzzles|jigsaw puzzles
99364|NCT02667275|seborrheic keratosis|seborrheic keratosis
99365|NCT02667249|cholecystectomy, check list|cholecystectomy, check list
99366|NCT02667236|seborrheic keratosis|seborrheic keratosis
99367|NCT02667223|pharmacokinetics|pharmacokinetics
99368|NCT02667223|pharmacodynamics|pharmacodynamics
99369|NCT02667223|RN316|rn316
99370|NCT02667223|recombinant human hyaluronidase|recombinant human hyaluronidase
99371|NCT02667145|hand osteoarthritis|hand osteoarthritis
99372|NCT02667145|self care program|self care program
99373|NCT02667145|assistive tecnology|assistive tecnology
99374|NCT02667132|Granulomatous, Mastitis|granulomatous, mastitis
99375|NCT02667132|C17.800.090.968.400|c17.800.090.968.400
99376|NCT02667132|C13.703.844.603.400|c13.703.844.603.400
99377|NCT02667093|Acute Leukemia|acute leukemia
99378|NCT02667093|Acute Myeloid Leukemia|acute myeloid leukemia
99379|NCT02667093|AML|aml
99380|NCT02667080|Semen quality|semen quality
99381|NCT02667080|Sexual Abstinence|sexual abstinence
99382|NCT02667080|sperm motility|sperm motility
99383|NCT02667080|DNA fragmentation|dna fragmentation
99384|NCT02667015|Substance Use Disorders|substance use disorders
99385|NCT02667015|Anxiety|anxiety
99386|NCT02667015|Anxiety Sensitivity|anxiety sensitivity
99387|NCT02667015|Brief Intervention|brief intervention
99389|NCT02666989|Depression|depression
99390|NCT02666989|Placebo|placebo
99391|NCT02666989|Open-label|open-label
99392|NCT02666989|Clinical practice|clinical practice
99393|NCT02666976|Gastroesophageal reflux, proton pump inhibitors, ilaprazole|gastroesophageal reflux, proton pump inhibitors, ilaprazole
99394|NCT02666963|RTA 901|rta 901
99395|NCT02666963|RTA 901 capsules|rta 901 capsules
99396|NCT02666898|Residual disease|residual disease
99397|NCT02666885|Personalized Medicine|personalized medicine
99398|NCT02666885|Radiation Oncology|radiation oncology
99399|NCT02666885|Functional Imaging|functional imaging
99400|NCT02666885|Biomarker|biomarker
99401|NCT02666885|Decision Support System|decision support system
99402|NCT02666885|Radiomics|radiomics
99403|NCT02666872|Vaccination|vaccination
99404|NCT02666872|Infant|infant
99405|NCT02666872|Parents|parents
99406|NCT02666872|Intention|intention
99407|NCT02666846|UVB Pain Model|uvb pain model
99409|NCT02666846|Topical|topical
99410|NCT02666846|NSAIDs|nsaids
99411|NCT02666833|Skin Cancer|skin cancer
99412|NCT02666833|Basal Cell Carcinoma|basal cell carcinoma
99413|NCT02666833|Squamous Cell Carcinoma|squamous cell carcinoma
99414|NCT02666833|Mohs Surgery|mohs surgery
99415|NCT02666833|Imaging|imaging
99416|NCT02666807|NF-κB|nf-κb
99417|NCT02666807|Ginger|ginger
99418|NCT02666794|analgesia|analgesia
99419|NCT02666794|fetal bradycardia|fetal bradycardia
99420|NCT02666794|hypertonic uterine|hypertonic uterine
99421|NCT02666781|OSA, Surgery, Postoperative, Rostral Fluid Shift|osa, surgery, postoperative, rostral fluid shift
99422|NCT02666755|Lung Neoplasms digital polymerase chain reaction|lung neoplasms digital polymerase chain reaction
99423|NCT02666716|pharmacokinetics|pharmacokinetics
99424|NCT02666716|fluconazole|fluconazole
99425|NCT02666716|invasive fungal infection|invasive fungal infection
99426|NCT02666716|candidiasis|candidiasis
99427|NCT02666716|intensive care unit|intensive care unit
99428|NCT02666703|cardiac surgery|cardiac surgery
99429|NCT02666703|systemic inflammatory response|systemic inflammatory response
99430|NCT02666703|immunoadsorption|immunoadsorption
99431|NCT02666677|polytrauma, emergency medicine|polytrauma, emergency medicine
99432|NCT02666664|hyperlipidemia|hyperlipidemia
99433|NCT02666664|cholesterol|cholesterol
99434|NCT02666664|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
99435|NCT02666664|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
99436|NCT02666664|ASCVD|ascvd
99437|NCT02666664|HeFH|hefh
99438|NCT02666664|LDL|ldl
99439|NCT02666638|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
99440|NCT02666612|Patients|patients
99441|NCT02666599|F-18-FDG|f-18-fdg
99442|NCT02666599|neoplasm|neoplasm
99443|NCT02666599|probe|probe
99444|NCT02666599|positron|positron
99445|NCT02666599|diagnosis|diagnosis
99446|NCT02666599|surgery|surgery
99447|NCT02666599|radioguided surgery|radioguided surgery
99448|NCT02666573|drug therapy|drug therapy
99449|NCT02666573|Photosensitizing Agents|photosensitizing agents
99450|NCT02666573|therapeutic use|therapeutic use
99451|NCT02666560|Auditory Cueing|auditory cueing
99452|NCT02666560|Gait|gait
99453|NCT02666547|68Ga-NODAGA-RGD|68ga-nodaga-rgd
99454|NCT02666547|18F-FDG|18f-fdg
99455|NCT02666547|18F-FET|18f-fet
99456|NCT02666547|PET/CT|pet/ct
99457|NCT02666547|neoangiogenesis|neoangiogenesis
99458|NCT02666534|Ablative fractional laser|ablative fractional laser
90683|NCT02721355|IgY|igy
99558|NCT02666014|sugammadex|sugammadex
99459|NCT02666534|microinvasive squamous cell carcinoma|microinvasive squamous cell carcinoma
99460|NCT02666534|photodynamic therapy|photodynamic therapy
99461|NCT02666521|Primary Health Care|primary health care
99462|NCT02666508|plaque identifying toothpaste|plaque identifying toothpaste
99463|NCT02666508|plaque score|plaque score
99464|NCT02666508|C-reactive protein|c-reactive protein
99465|NCT02666495|Schema Therapy|schema therapy
99466|NCT02666482|smoking|smoking
99467|NCT02666482|stop smoking|stop smoking
99468|NCT02666482|tobacco use cessation|tobacco use cessation
99469|NCT02666469|Hyperbaric oxygen treatment, rehabilitation|hyperbaric oxygen treatment, rehabilitation
99470|NCT02666443|brachial plexus|brachial plexus
99471|NCT02666443|supraclavicular|supraclavicular
99472|NCT02666443|duration|duration
99473|NCT02666443|dexamethasone|dexamethasone
99474|NCT02666443|block|block
99475|NCT02666417|Iron fortification|iron fortification
99476|NCT02666417|Anemia|anemia
99477|NCT02666417|Iron Deficiency|iron deficiency
99478|NCT02666417|Iron Absorption|iron absorption
99479|NCT02666417|Prebiotics|prebiotics
99480|NCT02666417|Stable isotopes|stable isotopes
99481|NCT02666404|Volume Resuscitation|volume resuscitation
99482|NCT02666404|Shock|shock
99483|NCT02666404|Body Impedance Measurement|body impedance measurement
99484|NCT02666404|Renal Resistive Index|renal resistive index
99485|NCT02666404|Acute Kidney Injury|acute kidney injury
99486|NCT02666404|Renal Replacement Therapy|renal replacement therapy
99585|NCT02665754|Dogs|dogs
99487|NCT02666378|HER-2 Positive Breast Cancer|her-2 positive breast cancer
99489|NCT02666365|surgical antimicrobial prophylaxis|surgical antimicrobial prophylaxis
99490|NCT02666365|surgical site infections|surgical site infections
99491|NCT02666339|Hortitherapy|hortitherapy
99492|NCT02666339|Care-garden|care-garden
99493|NCT02666339|Anxiety|anxiety
99494|NCT02666339|Therapeutic alliance|therapeutic alliance
99495|NCT02666326|Acute Coronary Syndrome|acute coronary syndrome
99496|NCT02666326|Prehospital emergency care|prehospital emergency care
99497|NCT02666326|Biological markers|biological markers
99498|NCT02666326|Copeptin|copeptin
99499|NCT02666326|Troponin|troponin
99500|NCT02666326|Rule-out|rule-out
99501|NCT02666326|Point-of-Care systems|point-of-care systems
99502|NCT02666326|Infarction|infarction
99503|NCT02666326|Cardiovascular Diseases|cardiovascular diseases
99504|NCT02666326|Heart Diseases|heart diseases
99505|NCT02666326|Ischemia|ischemia
99506|NCT02666326|Myocardial Ischemia|myocardial ischemia
99507|NCT02666326|copeptins|copeptins
99508|NCT02666326|Troponin T|troponin t
99509|NCT02666326|Diagnostic Techniques (Cardiovascular)|diagnostic techniques (cardiovascular)
99510|NCT02666300|Postoperative sore throat,Anesthesia|postoperative sore throat,anesthesia
99511|NCT02666287|Fluticasone furoate|fluticasone furoate
99512|NCT02666287|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
99513|NCT02666287|Batefenterol|batefenterol
99514|NCT02666287|Dry Powder Inhaler|dry powder inhaler
99515|NCT02666287|Respiratory|respiratory
99516|NCT02666287|Pharmacokinetics|pharmacokinetics
99517|NCT02666287|Ellipta|ellipta
99518|NCT02666287|Healthy Subjects|healthy subjects
99519|NCT02666274|carbapenem resistance|carbapenem resistance
99520|NCT02666274|bacterial carriage|bacterial carriage
99521|NCT02666274|multi-drug resistant gram negative bacteria|multi-drug resistant gram negative bacteria
99522|NCT02666222|hearing loss|hearing loss
99523|NCT02666222|sensorineural|sensorineural
99524|NCT02666222|hearing implant|hearing implant
99525|NCT02666209|Multiple Myeloma|multiple myeloma
99526|NCT02666209|Relapsed Multiple Myeloma|relapsed multiple myeloma
99527|NCT02666209|Refractory Multiple Myeloma|refractory multiple myeloma
99528|NCT02666183|cancer|cancer
99529|NCT02666183|caregiver|caregiver
99530|NCT02666183|videoconferencing|videoconferencing
99531|NCT02666157|atrial fibrillation|atrial fibrillation
99532|NCT02666157|stroke|stroke
99533|NCT02666157|systemic embolism|systemic embolism
99534|NCT02666157|bleeding|bleeding
99535|NCT02666157|oral anticoagulant|oral anticoagulant
99536|NCT02666131|diabetic foot ulcer|diabetic foot ulcer
99537|NCT02666131|diabetic complications|diabetic complications
99538|NCT02666131|diabetes|diabetes
99539|NCT02666131|wound healing|wound healing
99540|NCT02666131|Granexin gel|granexin gel
99541|NCT02666131|FirstString Research|firststring research
99542|NCT02666118|pain|pain
99543|NCT02666118|pain management|pain management
99544|NCT02666118|shoulder repair|shoulder repair
99545|NCT02666118|nerve blockade|nerve blockade
99546|NCT02666118|regional anesthesia|regional anesthesia
99547|NCT02666118|pediatrics|pediatrics
99548|NCT02666105|NSCLC|nsclc
99549|NCT02666092|IgE|ige
99550|NCT02666092|Immunoelectrophoresis|immunoelectrophoresis
99551|NCT02666092|Western Blot|western blot
99552|NCT02666092|ImmunoCAP|immunocap
99553|NCT02666079|Wide local excision (WLE) for breast cancer|wide local excision (wle) for breast cancer
99554|NCT02666027|Fluid monitoring|fluid monitoring
90842|NCT02720237|ART|art
99555|NCT02666014|PONV|ponv
99556|NCT02666014|nausea|nausea
99557|NCT02666014|vomiting|vomiting
99559|NCT02666014|neostigmine|neostigmine
99683|NCT02665117|Insulin resistance|insulin resistance
99560|NCT02665988|Transcranial Direct Current Stimulation|transcranial direct current stimulation
99561|NCT02665975|Tinnitus treatment|tinnitus treatment
99562|NCT02665975|Internet-intervention|internet-intervention
99564|NCT02665962|newly diagnosed patients|newly diagnosed patients
99565|NCT02665936|epidural analgesia|epidural analgesia
99566|NCT02665871|vaccine|vaccine
99567|NCT02665871|safety|safety
99568|NCT02665871|intranasal administration|intranasal administration
99569|NCT02665806|Ciclesonide|ciclesonide
99570|NCT02665806|Fluticasone propionate|fluticasone propionate
99571|NCT02665806|Nasal Polyposis|nasal polyposis
99572|NCT02665806|Chronic Sinuitis|chronic sinuitis
99573|NCT02665806|Chronic rhinosinusitis|chronic rhinosinusitis
99574|NCT02665793|Peanut allergy|peanut allergy
99575|NCT02665793|Food allergy|food allergy
99576|NCT02665793|Thresholds|thresholds
99577|NCT02665793|Anaphylaxis|anaphylaxis
99578|NCT02665780|halitosis, periodontal debridement, chemotherapeutics|halitosis, periodontal debridement, chemotherapeutics
99579|NCT02665767|Telesonography, Appendix|telesonography, appendix
99580|NCT02665754|Allergic rhinitis|allergic rhinitis
99581|NCT02665754|Injection, intralymphatic|injection, intralymphatic
99582|NCT02665754|Immunotherapy|immunotherapy
99583|NCT02665754|Dermatophagoides farinae|dermatophagoides farinae
100697|NCT02659709|Tablet|tablet
99584|NCT02665754|Dermatophagoides pteronyssinus|dermatophagoides pteronyssinus
99587|NCT02665741|distal colonoscope attachments, colon cancer screening, screening colonoscopy, adenoma detection|distal colonoscope attachments, colon cancer screening, screening colonoscopy, adenoma detection
99588|NCT02665715|Reactive hypoglycemia|reactive hypoglycemia
99589|NCT02665715|Hyperinsulinaemia|hyperinsulinaemia
99590|NCT02665715|Diet|diet
99591|NCT02665715|Glucagon-like Peptide-1|glucagon-like peptide-1
99592|NCT02665715|Glucagon|glucagon
99593|NCT02665715|Peptide YY|peptide yy
99594|NCT02665715|Ghrelin|ghrelin
99595|NCT02665689|Diabetic Macular Edema, Ranibizumab, Visual Acuity, Diabetic Control,|diabetic macular edema, ranibizumab, visual acuity, diabetic control,
99596|NCT02665676|Childhood Cancer|childhood cancer
99597|NCT02665676|Pediatric Oncology|pediatric oncology
99598|NCT02665676|Embryonal Neoplasms|embryonal neoplasms
99599|NCT02665676|Embryonic Neoplasms|embryonic neoplasms
99600|NCT02665676|Embryonic Tumors|embryonic tumors
99601|NCT02665676|Embryonal Tumors|embryonal tumors
99602|NCT02665624|Bowel cleansing|bowel cleansing
99603|NCT02665624|Colonoscopy|colonoscopy
99604|NCT02665624|Stewed apricot juice|stewed apricot juice
99605|NCT02665624|Senna|senna
99606|NCT02665598|Posterior Reversible Encephalopathy Syndrome,Prognosis|posterior reversible encephalopathy syndrome,prognosis
99607|NCT02665585|carotid disease|carotid disease
99608|NCT02665585|stroke|stroke
99609|NCT02665585|stent|stent
99610|NCT02665585|carotid stenting|carotid stenting
99611|NCT02665572|renal transplantation|renal transplantation
99612|NCT02665572|defunctionalized bladder|defunctionalized bladder
99613|NCT02665572|bladder recycling|bladder recycling
99614|NCT02665559|HIV|hiv
99615|NCT02665559|Hypogonadism|hypogonadism
99616|NCT02665559|Metabolic Syndrom|metabolic syndrom
99617|NCT02665559|Reservoirs|reservoirs
99618|NCT02665559|Osteodensitometry|osteodensitometry
99619|NCT02665559|Erectil dysfonction|erectil dysfonction
99620|NCT02665559|Depression|depression
99621|NCT02665546|Dyspnea|dyspnea
99622|NCT02665546|pulmonary hypertension|pulmonary hypertension
99623|NCT02665546|Histiocytosis Langerhans cells|histiocytosis langerhans cells
99624|NCT02665546|exercise test|exercise test
99625|NCT02665533|pain measurement|pain measurement
99626|NCT02665533|edema|edema
99627|NCT02665533|trismus|trismus
99628|NCT02665520|stem cells injections|stem cells injections
99629|NCT02665520|erectile dysfunction|erectile dysfunction
99630|NCT02665507|Photobiomodulation|photobiomodulation
99631|NCT02665507|Aviation|aviation
99632|NCT02665481|Exercise|exercise
99633|NCT02665481|Mindfulness|mindfulness
99634|NCT02665481|Education|education
99635|NCT02665481|Elderly|elderly
99636|NCT02665468|Supported adoption|supported adoption
99637|NCT02665468|Secure messaging|secure messaging
99638|NCT02665468|Patient aligned care team (PACT)|patient aligned care team (pact)
99639|NCT02665468|My HealtheVet Coordinator|my healthevet coordinator
99640|NCT02665455|Diabetes Mellitus|diabetes mellitus
99641|NCT02665455|Sensing Technology|sensing technology
99642|NCT02665442|Esophageal Stylet|esophageal stylet
99643|NCT02665442|EsoSure|esosure
99644|NCT02665442|Atrial Fibrillation|atrial fibrillation
99645|NCT02665442|Catheter Ablation|catheter ablation
99646|NCT02665442|Mechanical esophageal displacement|mechanical esophageal displacement
99647|NCT02665429|Emergency Medicine|emergency medicine
99648|NCT02665390|lung cancer|lung cancer
118257|NCT02556177|TBI|tbi
99649|NCT02665390|Percutaneous cryoablation|percutaneous cryoablation
99650|NCT02665390|treatment of medically inoperable|treatment of medically inoperable
99651|NCT02665338|transcranial magnetic stimulation|transcranial magnetic stimulation
99652|NCT02665338|fMRI|fmri
99653|NCT02665338|cue craving|cue craving
99654|NCT02665325|TSH-suppressive therapy|tsh-suppressive therapy
99655|NCT02665325|cognitive function|cognitive function
99656|NCT02665312|cardiotoxicity|cardiotoxicity
99657|NCT02665312|fluoropyrimidine|fluoropyrimidine
99658|NCT02665312|colorectal cancer|colorectal cancer
99659|NCT02665299|colon cancer|colon cancer
99660|NCT02665299|colon polyps|colon polyps
99661|NCT02665299|colon adenomas|colon adenomas
99662|NCT02665299|colonoscopy|colonoscopy
99663|NCT02665299|circulating tumor DNA|circulating tumor dna
99664|NCT02665234|Dry Eye|dry eye
99665|NCT02665221|Multiple Sclerosis|multiple sclerosis
99666|NCT02665221|erythema|erythema
99667|NCT02665208|cigarettes|cigarettes
99668|NCT02665208|smoking|smoking
99669|NCT02665208|opiate-dependence|opiate-dependence
99670|NCT02665208|alcohol|alcohol
99671|NCT02665208|detoxification|detoxification
99672|NCT02665182|orchitis|orchitis
99673|NCT02665182|testicular diseases|testicular diseases
99674|NCT02665169|Postural Balance|postural balance
99675|NCT02665169|Cost-Benefit Analysis|cost-benefit analysis
99676|NCT02665169|Morbidity|morbidity
99677|NCT02665169|Exercise|exercise
99678|NCT02665143|acute myeloid leukemia|acute myeloid leukemia
99679|NCT02665130|COPD|copd
99680|NCT02665130|Pulmonary rehabilitation|pulmonary rehabilitation
99681|NCT02665117|Hypokalemia|hypokalemia
100792|NCT02659241|DNA|dna
99684|NCT02665117|Aldosterone|aldosterone
99685|NCT02665117|Hepatic fat|hepatic fat
99686|NCT02665117|Muscle Magnesium|muscle magnesium
99687|NCT02665117|Liver fat|liver fat
99688|NCT02665104|Cerebral oxygen saturation|cerebral oxygen saturation
99690|NCT02665104|NIRS|nirs
99691|NCT02665104|Carotid endarterectomy|carotid endarterectomy
99692|NCT02665078|Lung Cancer|lung cancer
99693|NCT02665065|Acute Myeloid Leukemia|acute myeloid leukemia
99694|NCT02665065|Leukemia, Acute Myeloid|leukemia, acute myeloid
99695|NCT02665065|Myeloid Leukemia, Acute|myeloid leukemia, acute
99696|NCT02665065|Bone Marrow Cell Transplantation|bone marrow cell transplantation
99697|NCT02665065|Transplantation, Bone Marrow|transplantation, bone marrow
99698|NCT02665065|HCT|hct
99699|NCT02665065|HSCT|hsct
99700|NCT02665065|Refractory AML|refractory aml
99701|NCT02665065|Relapsed AML|relapsed aml
99702|NCT02665065|BC8|bc8
99703|NCT02665065|I-131|i-131
99704|NCT02665065|Iomab|iomab
99705|NCT02665065|Iomab-B|iomab-b
99706|NCT02665065|CD45|cd45
99707|NCT02665065|Iodine|iodine
99708|NCT02665065|Iodine-131|iodine-131
99709|NCT02665065|131-I|131-i
99710|NCT02665065|AML|aml
99711|NCT02665065|BMT|bmt
99712|NCT02665065|radioimmunotherapy|radioimmunotherapy
99713|NCT02665052|Rehabilitation|rehabilitation
99714|NCT02665052|Motor Recovery|motor recovery
99715|NCT02665052|upper extremity|upper extremity
99716|NCT02664987|pain management, pain control, cancer|pain management, pain control, cancer
99717|NCT02664961|TRC105|trc105
99718|NCT02664961|CD105|cd105
99719|NCT02664961|Endoglin|endoglin
99720|NCT02664961|Angiogenesis inhibitor|angiogenesis inhibitor
99721|NCT02664961|GTN|gtn
99722|NCT02664961|Bevacizumab|bevacizumab
99723|NCT02664961|Avastin|avastin
99724|NCT02664948|early follow-up|early follow-up
99725|NCT02664948|geriatrics|geriatrics
99726|NCT02664935|NSCLC|nsclc
99727|NCT02664935|Lung Cancer|lung cancer
99728|NCT02664935|Adenocarcinoma|adenocarcinoma
99729|NCT02664935|Matrix|matrix
99730|NCT02664935|SMP2|smp2
99731|NCT02664935|Umbrella Trial Design|umbrella trial design
99732|NCT02664935|Multi-arm|multi-arm
99733|NCT02664922|Electrophysiology|electrophysiology
99734|NCT02664922|Anesthetics|anesthetics
99735|NCT02664909|Hip Hemiarthroplasty|hip hemiarthroplasty
99736|NCT02664909|Tranexamic Acid|tranexamic acid
99737|NCT02664909|Topical|topical
99738|NCT02664909|Blood Transfusion|blood transfusion
99739|NCT02664896|Knee pain|knee pain
99740|NCT02664896|Knee Osteoarthritis|knee osteoarthritis
99741|NCT02664870|synovial fluid|synovial fluid
99742|NCT02664870|biomarkers|biomarkers
99743|NCT02664857|Vitamin D|vitamin d
99744|NCT02664857|Postoperative Pain|postoperative pain
99745|NCT02664857|Mental Motor Retardation|mental motor retardation
99746|NCT02664844|Obesity|obesity
99747|NCT02664844|Appetite regulation|appetite regulation
99748|NCT02664844|Insulin sensitivity|insulin sensitivity
99749|NCT02664844|Adolescents|adolescents
99750|NCT02664844|Exercise|exercise
99751|NCT02664831|cardiac arrest|cardiac arrest
99752|NCT02664831|inflammation|inflammation
99753|NCT02664831|obesity|obesity
99754|NCT02664831|neuregulin|neuregulin
99755|NCT02664831|lipids|lipids
99756|NCT02664818|Heart failure|heart failure
99757|NCT02664818|China|china
99758|NCT02664818|Registry|registry
99759|NCT02664818|Characteristic|characteristic
99760|NCT02664818|Outcome|outcome
99761|NCT02664792|Non-small cell lung carcinoma|non-small cell lung carcinoma
99762|NCT02664792|PET/CT|pet/ct
99763|NCT02664792|18F-FDG|18f-fdg
99764|NCT02664766|Heavy drinking|heavy drinking
99765|NCT02664766|Heavy drinking cessation|heavy drinking cessation
99766|NCT02664766|Alcohol abuse|alcohol abuse
99767|NCT02664766|alcohol use disorder|alcohol use disorder
99768|NCT02664740|Phage Therapy|phage therapy
99769|NCT02664727|alcohol|alcohol
99770|NCT02664727|alcohol abuse|alcohol abuse
99771|NCT02664727|alcohol dependence|alcohol dependence
99772|NCT02664727|alcohol use disorder|alcohol use disorder
99773|NCT02664727|heavy drinking|heavy drinking
99774|NCT02664727|alcohol abuse cessation|alcohol abuse cessation
99775|NCT02664714|physiotherapy, perineometer, adherence|physiotherapy, perineometer, adherence
99776|NCT02664688|spondylolisthesis|spondylolisthesis
99777|NCT02664688|low back pain|low back pain
99778|NCT02664688|stabilization exercise|stabilization exercise
99779|NCT02664662|randomized controlled trial, breast cancer, health literacy, tailored education|randomized controlled trial, breast cancer, health literacy, tailored education
99780|NCT02664649|TAVR|tavr
99781|NCT02664649|Apixaban|apixaban
99782|NCT02664649|Anticoagulant|anticoagulant
99783|NCT02664649|VKA|vka
99784|NCT02664649|Antiplatelet therapy|antiplatelet therapy
99785|NCT02664649|Aortic stenosis|aortic stenosis
99786|NCT02664610|hypertension treatment|hypertension treatment
99787|NCT02664610|stroke prevention|stroke prevention
99788|NCT02664597|ADNEXMR SCORING system|adnexmr scoring system
99789|NCT02664597|MRI|mri
99790|NCT02664597|adnexal masses|adnexal masses
99791|NCT02664519|Chronic Kidney Disease|chronic kidney disease
99792|NCT02664519|Functional sympatholysis|functional sympatholysis
99793|NCT02664519|Exercise training|exercise training
99794|NCT02664519|Exercise intolerance|exercise intolerance
99795|NCT02664519|Handgrip exercise|handgrip exercise
99796|NCT02664519|Near infrared spectroscopy|near infrared spectroscopy
99797|NCT02664519|Lower body negative pressure|lower body negative pressure
99798|NCT02664493|kidney transplantation|kidney transplantation
99799|NCT02664493|subclinical borderline rejection|subclinical borderline rejection
99800|NCT02664493|steroid pulse therapy|steroid pulse therapy
99801|NCT02664480|Salivary Alpha-amylase|salivary alpha-amylase
99802|NCT02664480|ovulation|ovulation
99803|NCT02664454|Elderly|elderly
99804|NCT02664454|Health care organization|health care organization
99805|NCT02664454|Primary care|primary care
99806|NCT02664441|Obesity|obesity
99807|NCT02664441|Drug intervention|drug intervention
99808|NCT02664441|Children|children
99809|NCT02664441|Adolescents|adolescents
99810|NCT02664441|Young adults|young adults
99811|NCT02664441|Hypothalamic lesion|hypothalamic lesion
99812|NCT02664441|Change of weight status|change of weight status
99813|NCT02664441|Food intake|food intake
99814|NCT02664441|Energy expenditure|energy expenditure
99815|NCT02664441|Hormonal changes|hormonal changes
99816|NCT02664441|Glucagon-like peptide-1 agonist|glucagon-like peptide-1 agonist
99817|NCT02664441|Bydureon|bydureon
99818|NCT02664441|Weight Loss|weight loss
99819|NCT02664441|Energy balance|energy balance
99820|NCT02664415|Human Monoclonal Antibody|human monoclonal antibody
99821|NCT02664402|Palliative Care|palliative care
99822|NCT02664402|Pain|pain
99823|NCT02664402|Community Health|community health
99824|NCT02664376|sarcopenia|sarcopenia
99825|NCT02664376|geriatry|geriatry
99826|NCT02664311|Pulmonary Vein Isolation|pulmonary vein isolation
99827|NCT02664311|Jet Ventilation|jet ventilation
99828|NCT02664311|Atrial Fibrillation|atrial fibrillation
99829|NCT02664298|severely atrophic jaw|severely atrophic jaw
99830|NCT02664298|cranial bone-graft|cranial bone-graft
99831|NCT02664298|dental implants|dental implants
99832|NCT02664298|immediate loading|immediate loading
99833|NCT02664298|augmentation maxilla/mandible|augmentation maxilla/mandible
99834|NCT02664298|sinus-floor elevation/sinuslift|sinus-floor elevation/sinuslift
99835|NCT02664298|dental prosthesis|dental prosthesis
99836|NCT02664298|implant supported|implant supported
99837|NCT02664298|provisional implants|provisional implants
99838|NCT02664298|temporary implants|temporary implants
99839|NCT02664298|one-stage surgery|one-stage surgery
99840|NCT02664298|alveolar ridge augmentation|alveolar ridge augmentation
99841|NCT02664298|maxilla|maxilla
99842|NCT02664259|Endobronchial ultrasonography|endobronchial ultrasonography
99843|NCT02664259|Peripheral pulmonary lesions|peripheral pulmonary lesions
99844|NCT02664259|Ultrathin bronchoscopy|ultrathin bronchoscopy
99845|NCT02664246|contrast-induced nephropathy|contrast-induced nephropathy
99846|NCT02664246|Percutaneous coronary intervention|percutaneous coronary intervention
99847|NCT02664246|risk factors|risk factors
99848|NCT02664246|incidence|incidence
99849|NCT02664233|Diabetes|diabetes
99850|NCT02664233|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
99851|NCT02664233|obesity|obesity
91062|NCT02718833|Relapse|relapse
99852|NCT02664233|self-monitoring|self-monitoring
99853|NCT02664233|goal setting|goal setting
99854|NCT02664233|mobile health|mobile health
99855|NCT02664233|connected health|connected health
99856|NCT02664220|Povidone-iodine irrigation|povidone-iodine irrigation
99857|NCT02664207|Myelomeningocele repair|myelomeningocele repair
99858|NCT02664207|Open Neural Tube Defect|open neural tube defect
99859|NCT02664207|BMI of 35-40 kg/m2,|bmi of 35-40 kg/m2,
99860|NCT02664207|Open Fetal Surgery|open fetal surgery
99861|NCT02664207|Elevated body mass index|elevated body mass index
99862|NCT02664194|Hypothermia|hypothermia
99863|NCT02664194|Rewarming|rewarming
99864|NCT02664194|Myocardial Infarction|myocardial infarction
99865|NCT02664194|Percutaneous Cornonary Intervention|percutaneous cornonary intervention
99866|NCT02664181|Cancer|cancer
99867|NCT02664181|Nivolumab|nivolumab
99868|NCT02664181|Decitabine|decitabine
99869|NCT02664181|Tetrahydrouridine|tetrahydrouridine
99870|NCT02664155|Renal insufficiency|renal insufficiency
99871|NCT02664155|Direct oral anticoagulants (DOA)|direct oral anticoagulants (doa)
99872|NCT02664155|Deep Vein Thrombosis (DVT)|deep vein thrombosis (dvt)
99873|NCT02664155|Pulmonary Embolism (PE)|pulmonary embolism (pe)
99874|NCT02664155|Venous Thromboembolism (VTE)|venous thromboembolism (vte)
99875|NCT02664155|Heparins|heparins
99876|NCT02664142|General Surgery|general surgery
99877|NCT02664142|Child|child
99878|NCT02664142|Anaesthesia|anaesthesia
99879|NCT02664142|Depth of anaesthesia|depth of anaesthesia
99880|NCT02664142|BIS monitoring|bis monitoring
99881|NCT02664116|Severe Migraine Headache|severe migraine headache
99882|NCT02664090|acute respiratory distress syndrome|acute respiratory distress syndrome
99883|NCT02664090|prone ventilation|prone ventilation
99884|NCT02664090|trans-esophageal doppler|trans-esophageal doppler
99886|NCT02664077|Colon cancer|colon cancer
99887|NCT02664077|Regorafenib|regorafenib
99888|NCT02664077|Stage III|stage iii
99889|NCT02664077|Adjuvant therapy|adjuvant therapy
99890|NCT02664064|prediabetes, weight loss, behavior modification|prediabetes, weight loss, behavior modification
99891|NCT02664038|AUD|aud
99892|NCT02664038|Neuropsychology|neuropsychology
99893|NCT02664038|Cognitive Remediation|cognitive remediation
99894|NCT02664025|teaching vaginal examination|teaching vaginal examination
99895|NCT02664012|adoption|adoption
99896|NCT02664012|electronic cigarettes|electronic cigarettes
99897|NCT02664012|e-cigarettes|e-cigarettes
99898|NCT02664012|menthol|menthol
99899|NCT02664012|combustible cigarettes|combustible cigarettes
99900|NCT02664012|nicotine polacrilex|nicotine polacrilex
99901|NCT02664012|own brand cigarette|own brand cigarette
99902|NCT02664012|subjective measures|subjective measures
99908|NCT02663986|Organization, Time Management, and Planning (OTMP)|organization, time management, and planning (otmp)
99910|NCT02663960|Regional citrate anticoagulation|regional citrate anticoagulation
99911|NCT02663960|Protocol|protocol
99912|NCT02663960|Filter lifespan|filter lifespan
99913|NCT02663947|ventriculoperitoneal shunt|ventriculoperitoneal shunt
99914|NCT02663947|optic nerve sheath diameter|optic nerve sheath diameter
99915|NCT02663947|intracranial pressure|intracranial pressure
99916|NCT02663934|HIV, AIDS, Cognition, Memory, Exercise, Stretching|hiv, aids, cognition, memory, exercise, stretching
99917|NCT02663921|Fitzpatrick Skin-Type|fitzpatrick skin-type
99919|NCT02663921|Ultraviolet Light (UV)|ultraviolet light (uv)
99920|NCT02663882|smoking|smoking
99921|NCT02663882|self control|self control
99922|NCT02663791|Alcohol|alcohol
99923|NCT02663791|Aortic stiffness|aortic stiffness
99924|NCT02663791|Arterial stiffness|arterial stiffness
99925|NCT02663791|Pulse wave velocity|pulse wave velocity
99926|NCT02663791|Longitudinal|longitudinal
99927|NCT02663752|deferasirox|deferasirox
99928|NCT02663752|MDS|mds
99929|NCT02663752|RNA expression|rna expression
99930|NCT02663752|predictive biomarker|predictive biomarker
99931|NCT02663739|Stanford type B aortic dissection|stanford type b aortic dissection
99932|NCT02663739|Malperfusion|malperfusion
99933|NCT02663739|Rupture|rupture
99934|NCT02663739|Acute disease|acute disease
99935|NCT02663739|Endovascular procedures|endovascular procedures
99936|NCT02663726|Physically inactive|physically inactive
99937|NCT02663726|Older adults|older adults
99938|NCT02663713|Pharmacodynamics|pharmacodynamics
99939|NCT02663713|Ticagrelor|ticagrelor
99940|NCT02663713|Clopidogrel|clopidogrel
99950|NCT02663674|Coccidioidomycosis|coccidioidomycosis
99951|NCT02663674|FLEET|fleet
99952|NCT02663674|Fluconazole|fluconazole
99953|NCT02663674|Parent Study of 16-0008|parent study of 16-0008
99954|NCT02663674|Pneumonia|pneumonia
99955|NCT02663661|Diabetes Mellitus, Type 1 (T1DM)|diabetes mellitus, type 1 (t1dm)
99956|NCT02663661|TrialNet|trialnet
99957|NCT02663661|Pathway to Prevention (PTP)|pathway to prevention (ptp)
99958|NCT02663661|First and second degree relatives of persons with T1DM|first and second degree relatives of persons with t1dm
99959|NCT02663661|Insulin-glucagon-glucose (IGG)|insulin-glucagon-glucose (igg)
99960|NCT02663648|myeloproliferative disorders|myeloproliferative disorders
99961|NCT02663648|cell cycle regulatory protein|cell cycle regulatory protein
99962|NCT02663609|Cushing's Syndrome|cushing's syndrome
99963|NCT02663609|Mifepristone|mifepristone
99964|NCT02663609|Adrenal|adrenal
99965|NCT02663609|Retrospective|retrospective
99966|NCT02663609|Chart Review|chart review
99967|NCT02663596|Pediatric|pediatric
99968|NCT02663596|Continuous Renal Replacement Therapy|continuous renal replacement therapy
99969|NCT02663596|Dialysis|dialysis
99970|NCT02663596|Therapeutic drug monitoring|therapeutic drug monitoring
99971|NCT02663596|Pharmacokinetics|pharmacokinetics
99972|NCT02663596|Pharmacodynamics|pharmacodynamics
99973|NCT02663583|Oropharynx squamous cell carcinoma|oropharynx squamous cell carcinoma
99974|NCT02663583|OPSCC|opscc
99975|NCT02663583|Actigraph accelerometer|actigraph accelerometer
99976|NCT02663583|MD Anderson Symptom Inventory - Head and Neck module|md anderson symptom inventory - head and neck module
99977|NCT02663583|MDASI-HN|mdasi-hn
99978|NCT02663583|Intensity-Modulated Proton Therapy|intensity-modulated proton therapy
99979|NCT02663583|IMPT|impt
99980|NCT02663583|TransOral Robotic Surgery|transoral robotic surgery
99981|NCT02663583|TORS|tors
99982|NCT02663583|Surveys|surveys
99983|NCT02663583|Questionnaires|questionnaires
99984|NCT02663557|stroke, blood pressure, prognosis|stroke, blood pressure, prognosis
99985|NCT02663544|Diabetes|diabetes
99986|NCT02663544|Metabolic syndrome|metabolic syndrome
99987|NCT02663544|Obesity|obesity
99988|NCT02663544|NAFLD|nafld
99989|NCT02663492|Acupuncture|acupuncture
99990|NCT02663492|electrical stimulation of acupoints|electrical stimulation of acupoints
99991|NCT02663492|chemotherapy|chemotherapy
99992|NCT02663492|Diyu Shengbai Pian|diyu shengbai pian
99993|NCT02663492|nursing care|nursing care
99994|NCT02663466|pilonidal sinus|pilonidal sinus
99995|NCT02663466|Limberg flap|limberg flap
99996|NCT02663466|off-midline closure concept|off-midline closure concept
99998|NCT02663453|preterm|preterm
99999|NCT02663453|parenteral nutrition|parenteral nutrition
100003|NCT02663427|pepsinogen Ⅱ|pepsinogen ⅱ
100004|NCT02663427|gastric cancer screening|gastric cancer screening
100005|NCT02663427|helicobacter pylori|helicobacter pylori
100006|NCT02663427|gastrin|gastrin
100007|NCT02663375|TAVI|tavi
100008|NCT02663375|Aortic Stenosis|aortic stenosis
100009|NCT02663375|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
100010|NCT02663375|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
100011|NCT02663375|Transapical Access|transapical access
100012|NCT02663362|magnetic resonance imaging|magnetic resonance imaging
100013|NCT02663362|magnetic resonance spectroscopy|magnetic resonance spectroscopy
100014|NCT02663336|masked hypertension, chronic kidney disease|masked hypertension, chronic kidney disease
100015|NCT02663323|Coronary Artery Disease|coronary artery disease
100016|NCT02663323|MeRes-1 Extend|meres-1 extend
100017|NCT02663323|MeRes100|meres100
100018|NCT02663323|Sirolimus Eluting Bioresorbable Vascular Scaffold System|sirolimus eluting bioresorbable vascular scaffold system
100019|NCT02663310|spinal cord injury|spinal cord injury
100020|NCT02663310|Kunming Locomotor Scale|kunming locomotor scale
100021|NCT02663310|surgical decompression|surgical decompression
100022|NCT02663310|untethering|untethering
100023|NCT02663310|weight bearing rehabilitation|weight bearing rehabilitation
100024|NCT02663297|CAR T cells|car t cells
100025|NCT02663297|CD30|cd30
100026|NCT02663297|Lymphoma|lymphoma
100027|NCT02663297|T Lymphocytes|t lymphocytes
100030|NCT02663232|V600 BRAF mutation|v600 braf mutation
100031|NCT02663232|Metastatic melanoma|metastatic melanoma
100033|NCT02663219|ART|art
100034|NCT02663219|CCM|ccm
100035|NCT02663219|DAIDS|daids
100036|NCT02663219|HPTN|hptn
100037|NCT02663219|ACA|aca
100038|NCT02663219|PAF|paf
100039|NCT02663219|PEP|pep
100040|NCT02663219|RDS|rds
100041|NCT02663206|spastic esophageal disorders|spastic esophageal disorders
100042|NCT02663206|achalasia|achalasia
100043|NCT02663206|diffuse esophageal spasm|diffuse esophageal spasm
100044|NCT02663206|hypercontractile (jackhammer) esophagus|hypercontractile (jackhammer) esophagus
100045|NCT02663206|Botulinum toxin injection|botulinum toxin injection
100046|NCT02663206|peroral endoscopic myotomy|peroral endoscopic myotomy
100047|NCT02663193|Prostate Cancer|prostate cancer
100048|NCT02663193|Observational study|observational study
100049|NCT02663193|Enzalutamide|enzalutamide
100050|NCT02663193|Abiraterone Acetate|abiraterone acetate
100051|NCT02663193|Prednisone|prednisone
100052|NCT02663193|Tolerability|tolerability
100053|NCT02663154|Aromatherapy|aromatherapy
100054|NCT02663102|Safety|safety
100055|NCT02663102|Post-marketing|post-marketing
100056|NCT02663102|Korea|korea
100057|NCT02663102|Drug utilization study|drug utilization study
100058|NCT02663102|Fluarix Tetra|fluarix tetra
100059|NCT02663089|total radioactivity|total radioactivity
100060|NCT02663089|[14C]-GSK961081|[14c]-gsk961081
100061|NCT02663089|Pharmacokinetics|pharmacokinetics
100062|NCT02663089|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
100063|NCT02663089|Microtracer|microtracer
100064|NCT02663063|Complementary and alternative medicine|complementary and alternative medicine
100065|NCT02663063|Hospice Palliative Care|hospice palliative care
100066|NCT02663050|Dysmenorrhea|dysmenorrhea
100067|NCT02663050|kinesio tape|kinesio tape
100068|NCT02663037|Segmentation|segmentation
100069|NCT02663037|Health needs|health needs
100070|NCT02662985|Power Doppler Ultrasonography, Psoriatic Arthritis, Enthesitis, Synovitis, Outcome Measures in Rheumatology, Spondyloarthritis Research Consortium of Canada|power doppler ultrasonography, psoriatic arthritis, enthesitis, synovitis, outcome measures in rheumatology, spondyloarthritis research consortium of canada
100071|NCT02662972|Nerve block|nerve block
100072|NCT02662972|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
100073|NCT02662972|Botulinum Toxins, Type A|botulinum toxins, type a
100074|NCT02662959|Chemotherapy, metastatic gastric cancer, irinotecan|chemotherapy, metastatic gastric cancer, irinotecan
100075|NCT02662907|Head and Neck Cancer|head and neck cancer
100076|NCT02662907|Post-radiotherapy H&N cancer survivors|post-radiotherapy h&n cancer survivors
100077|NCT02662907|Aspiration|aspiration
100078|NCT02662907|Expiratory muscle strength training|expiratory muscle strength training
100079|NCT02662907|EMST|emst
100086|NCT02662868|Breast cancer|breast cancer
100087|NCT02662868|Metastasis|metastasis
100088|NCT02662842|infusion set|infusion set
100089|NCT02662842|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
100090|NCT02662829|Lesotho|lesotho
100091|NCT02662829|tuberculosis|tuberculosis
100093|NCT02662829|HIV|hiv
100094|NCT02662829|adherence|adherence
100095|NCT02662829|community-based intervention|community-based intervention
100096|NCT02662829|retention|retention
100097|NCT02662816|Glutathione|glutathione
100098|NCT02662816|Liver|liver
100099|NCT02662816|Muscle|muscle
639440|NCT00736424|DBS|dbs
100100|NCT02662816|Proton magnetic resonance spectroscopy|proton magnetic resonance spectroscopy
100102|NCT02662803|Generalized Anxiety Disorder|generalized anxiety disorder
100104|NCT02662803|physical exercise|physical exercise
100105|NCT02662803|aerobe exercise|aerobe exercise
100106|NCT02662803|mental disorder|mental disorder
100107|NCT02662803|high-intensive aerobe exercise|high-intensive aerobe exercise
100108|NCT02662777|esophageal anastomosis leakage|esophageal anastomosis leakage
100109|NCT02662777|endoscopic vacuum therapy|endoscopic vacuum therapy
100110|NCT02662777|esophageal perforation|esophageal perforation
100111|NCT02662777|upper gastrointestinal tract|upper gastrointestinal tract
100112|NCT02662777|esophageal leak|esophageal leak
100113|NCT02662777|endoscopy|endoscopy
100114|NCT02662738|Blood glucose|blood glucose
100115|NCT02662725|melanoma|melanoma
100116|NCT02662725|brain metastasis|brain metastasis
100117|NCT02662725|stereotactic radiosurgery|stereotactic radiosurgery
100118|NCT02662725|Ipilimumab|ipilimumab
100119|NCT02662725|survival|survival
100120|NCT02662725|safety|safety
100121|NCT02662725|efficacy|efficacy
100122|NCT02662712|Healthy|healthy
100123|NCT02662712|Hepatitis, Chronic|hepatitis, chronic
100124|NCT02662712|JNJ-56136379|jnj-56136379
100125|NCT02662712|Placebo|placebo
100126|NCT02662699|Anemia|anemia
100127|NCT02662699|Hematologic Diseases|hematologic diseases
100128|NCT02662699|Erythrocytes|erythrocytes
100129|NCT02662699|Hemoglobin|hemoglobin
100130|NCT02662699|Hemolytic|hemolytic
100131|NCT02662686|Embryo Implantation|embryo implantation
100132|NCT02662686|Mitochondrial genes|mitochondrial genes
100133|NCT02662686|Mitochondrial DNA|mitochondrial dna
100134|NCT02662686|MitoScore|mitoscore
100135|NCT02662686|Embryo selection|embryo selection
100136|NCT02662686|Embryo viability|embryo viability
100137|NCT02662686|Embryo biomarker|embryo biomarker
100138|NCT02662686|Diagnosis of embryo viability in euploids embryos|diagnosis of embryo viability in euploids embryos
100139|NCT02662673|HIFU|hifu
100140|NCT02662673|Prostate Cancer|prostate cancer
100141|NCT02662673|Focal|focal
100142|NCT02662673|Quality of life|quality of life
100143|NCT02662673|Index study|index study
100144|NCT02662647|demethylating agent|demethylating agent
100145|NCT02662647|lymphocyte infusion|lymphocyte infusion
100146|NCT02662634|NSCLC|nsclc
100147|NCT02662634|resectable|resectable
100148|NCT02662634|non-small cell lung cancer|non-small cell lung cancer
100149|NCT02662634|immunotherapy|immunotherapy
100150|NCT02662634|autologous|autologous
100151|NCT02662634|dendritic cell|dendritic cell
100159|NCT02662608|Brontictuzumab|brontictuzumab
100160|NCT02662595|mHealth|mhealth
100161|NCT02662595|mobile phones|mobile phones
100162|NCT02662595|measles vaccination|measles vaccination
100163|NCT02662582|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
100164|NCT02662582|CK-2127107|ck-2127107
100165|NCT02662582|COPD|copd
100166|NCT02662543|rotavirus,|rotavirus,
100167|NCT02662543|acute gastroenteritis|acute gastroenteritis
100168|NCT02662543|vaccination|vaccination
100169|NCT02662543|Estonia|estonia
100170|NCT02662543|impact|impact
100171|NCT02662543|severity scales|severity scales
100172|NCT02662517|Neurotrophins|neurotrophins
100173|NCT02662517|Stem Cells|stem cells
100174|NCT02662517|Prematurity|prematurity
100175|NCT02662504|mesothelioma|mesothelioma
100176|NCT02662504|multimodal treatment|multimodal treatment
100177|NCT02662504|PDT|pdt
100178|NCT02662504|pleura|pleura
100179|NCT02662478|Laparoscopic gastric resection|laparoscopic gastric resection
100180|NCT02662478|gastrointestinal stromal tumor|gastrointestinal stromal tumor
100181|NCT02662478|laparoscopic surgery|laparoscopic surgery
100182|NCT02662465|Interventional|interventional
100183|NCT02662465|Treatment|treatment
100186|NCT02662439|Bioimpedance analysis|bioimpedance analysis
100187|NCT02662439|Fluid overload|fluid overload
100188|NCT02662426|Seasonal Influenza|seasonal influenza
100190|NCT02662426|RCT|rct
100191|NCT02662361|peri-implant disease; risk factors; prevalence|peri-implant disease; risk factors; prevalence
100192|NCT02662322|Communication|communication
100193|NCT02662322|Confusion|confusion
100194|NCT02662322|Intravenous Catheterization|intravenous catheterization
100195|NCT02662322|Comfort|comfort
100198|NCT02662283|IGA Nephropathy|iga nephropathy
100199|NCT02662283|proteinurien|proteinurien
100200|NCT02662283|Reh-acteoside|reh-acteoside
100201|NCT02662283|Prednisolone|prednisolone
100202|NCT02662270|Fibromyalgia|fibromyalgia
100203|NCT02662270|QEEG|qeeg
100204|NCT02662270|Brain activity|brain activity
100205|NCT02662270|fMRI|fmri
100206|NCT02662270|Diagnosis|diagnosis
100207|NCT02662257|Sevoflurane|sevoflurane
100208|NCT02662257|Propofol|propofol
100209|NCT02662257|Aged|aged
100210|NCT02662257|Neoplasm|neoplasm
100211|NCT02662257|Surgical Procedure, Operative|surgical procedure, operative
100212|NCT02662257|Delirium|delirium
100213|NCT02662257|Postoperative Complications|postoperative complications
100214|NCT02662231|Surgical Site Infection|surgical site infection
100215|NCT02662231|General Surgery|general surgery
100216|NCT02662231|Laparotomy|laparotomy
100217|NCT02662231|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
100218|NCT02662231|Developing Countries|developing countries
100219|NCT02662231|International Cooperation|international cooperation
100220|NCT02662231|Specialties, Surgical|specialties, surgical
100221|NCT02662231|Developed Countries|developed countries
100222|NCT02662231|Quality of Health Care|quality of health care
100223|NCT02662179|Elderly patients|elderly patients
100224|NCT02662179|Onco-geriatrics|onco-geriatrics
100225|NCT02662179|Fried criteria|fried criteria
100226|NCT02662166|bladder cancer|bladder cancer
100228|NCT02662166|TUR-BT|tur-bt
100229|NCT02662166|cystectomy|cystectomy
100230|NCT02662166|chemotherapy|chemotherapy
100231|NCT02662075|alternative tobacco products (ATPs)|alternative tobacco products (atps)
100232|NCT02662075|electronic cigarettes|electronic cigarettes
100233|NCT02662062|Non-metastatic muscle invasive bladder cancer|non-metastatic muscle invasive bladder cancer
100234|NCT02662023|Healthy Human Volunteers|healthy human volunteers
100235|NCT02662010|AGEs|ages
100236|NCT02662010|glycemic control|glycemic control
100237|NCT02662010|T2DM|t2dm
100238|NCT02661997|Tai Chi|tai chi
100239|NCT02661997|Wellness|wellness
100240|NCT02661997|Mind-body|mind-body
100241|NCT02661997|Gulf War Illness|gulf war illness
100242|NCT02661997|Gulf War Veteran's Illness|gulf war veteran's illness
100243|NCT02661997|GWVI|gwvi
100244|NCT02661984|FeNO, exhaled nitric oxide|feno, exhaled nitric oxide
100245|NCT02661958|acne vulgaris|acne vulgaris
100246|NCT02661958|acne|acne
100247|NCT02661945|near focus with narrow band imaging|near focus with narrow band imaging
100248|NCT02661945|tumor margin|tumor margin
100249|NCT02661945|indigocarmine chromoendoscopy|indigocarmine chromoendoscopy
100250|NCT02661932|Fertility preservation|fertility preservation
100251|NCT02661932|letrozole|letrozole
100252|NCT02661932|Ovarian stimulation|ovarian stimulation
100253|NCT02661919|Epilepsy|epilepsy
100254|NCT02661919|Seizure|seizure
100255|NCT02661919|Seizures|seizures
100256|NCT02661919|Mattress monitor|mattress monitor
100257|NCT02661919|Bed monitor|bed monitor
100258|NCT02661919|Bed alarm|bed alarm
100259|NCT02661919|Generalized tonic-clonic seizure|generalized tonic-clonic seizure
100260|NCT02661919|GTC|gtc
100261|NCT02661893|Healthy|healthy
100262|NCT02661893|JNJ-42847922|jnj-42847922
100263|NCT02661893|Rifampin|rifampin
100264|NCT02661893|Pharmacokinetics|pharmacokinetics
100265|NCT02661867|Childbirth|childbirth
100266|NCT02661867|Pelvic organ prolapse|pelvic organ prolapse
100267|NCT02661867|Urinary incontinence|urinary incontinence
100268|NCT02661867|Fecal incontinence|fecal incontinence
100269|NCT02661854|Rhinitis / Rhinoconjunctivitis|rhinitis / rhinoconjunctivitis
100270|NCT02661854|Vaccine|vaccine
100271|NCT02661854|Immunotherapy|immunotherapy
100272|NCT02661854|Mite|mite
100273|NCT02661854|Allergy|allergy
100274|NCT02661828|Tapering Antidepressant Regimen|tapering antidepressant regimen
100275|NCT02661828|Antidepressant Discontinuation Syndrome|antidepressant discontinuation syndrome
100276|NCT02661789|Mental health|mental health
100277|NCT02661789|Brain Imaging|brain imaging
100278|NCT02661789|Steroid hormones|steroid hormones
100279|NCT02661789|Serotonin|serotonin
100280|NCT02661789|PET|pet
91467|NCT02716467|spirituality|spirituality
91468|NCT02716467|clinical trials|clinical trials
100281|NCT02661789|MRI|mri
100282|NCT02661789|fMRI|fmri
100283|NCT02661789|human|human
100284|NCT02661789|gender|gender
100285|NCT02661789|risk model|risk model
100286|NCT02661776|natural killer cell|natural killer cell
100287|NCT02661776|head and neck cancer|head and neck cancer
100288|NCT02661776|opioid|opioid
100289|NCT02661763|Rheumatic heart disease|rheumatic heart disease
100290|NCT02661750|Cleansing the colon|cleansing the colon
100291|NCT02661711|Macular Oedema Retinitis Pigmentosa|macular oedema retinitis pigmentosa
100292|NCT02661685|Cancer immunotherapy|cancer immunotherapy
100293|NCT02661685|IFN-γ-producing killer dendritic cell-like cells|ifn-γ-producing killer dendritic cell-like cells
100294|NCT02661685|Natural killer cells|natural killer cells
100295|NCT02661672|Intracranial hemorrhage|intracranial hemorrhage
100296|NCT02661672|Neurosurgery|neurosurgery
100297|NCT02661659|mesothelioma|mesothelioma
100298|NCT02661659|multipeptide vaccine|multipeptide vaccine
100299|NCT02661659|S-588210|s-588210
100300|NCT02661646|Chronic Swelling|chronic swelling
100301|NCT02661646|Leg Lymphedema|leg lymphedema
100302|NCT02661646|Primary Lymphedema|primary lymphedema
100303|NCT02661646|Secondary Lymphedema|secondary lymphedema
100304|NCT02661620|REDAPT Femoral System modular stem implant|redapt femoral system modular stem implant
100305|NCT02661620|Total Hip arthroplasty revision|total hip arthroplasty revision
100306|NCT02661594|TQT|tqt
100307|NCT02661594|amisulpride|amisulpride
100308|NCT02661594|volunteer|volunteer
100309|NCT02661594|ECG|ecg
100310|NCT02661581|Diabetes|diabetes
100311|NCT02661581|Peer Leader Support|peer leader support
100312|NCT02661529|Shunt|shunt
100313|NCT02661529|Echocardiogram|echocardiogram
100314|NCT02661490|Norovirus|norovirus
100315|NCT02661464|Healthy|healthy
100316|NCT02661464|Ebola viruses|ebola viruses
100317|NCT02661464|Ebola virus disease (EVD)|ebola virus disease (evd)
100318|NCT02661464|Filoviruses|filoviruses
100320|NCT02661464|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
100321|NCT02661464|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector (MVA‐BN Filo)|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector (mva‐bn filo)
100322|NCT02661464|Hemorrhagic fever|hemorrhagic fever
100323|NCT02661451|Valve|valve
100324|NCT02661438|Usability Test|usability test
100325|NCT02661425|IBS-D|ibs-d
100326|NCT02661425|IBS|ibs
100327|NCT02661412|immediate loading|immediate loading
100328|NCT02661412|biological stability|biological stability
100329|NCT02661412|mechanical stability|mechanical stability
100330|NCT02661412|long-term|long-term
100331|NCT02661412|marginal bone level|marginal bone level
100332|NCT02661412|maxilla|maxilla
100333|NCT02661412|immediate placement|immediate placement
100334|NCT02661412|dental implant|dental implant
100335|NCT02661412|fibre-reinforced provisional fixed prosthesis|fibre-reinforced provisional fixed prosthesis
100336|NCT02661399|CIPN|cipn
100337|NCT02661373|Antimalarial|antimalarial
100338|NCT02661373|First-in-Human|first-in-human
100339|NCT02661373|Pharmacokinetic|pharmacokinetic
100340|NCT02661360|swaddling|swaddling
100341|NCT02661347|First Episode|first episode
100342|NCT02661347|Schizophreniform|schizophreniform
100343|NCT02661347|Schizoaffective Disorder|schizoaffective disorder
100344|NCT02661347|Psychosis|psychosis
100345|NCT02661347|Schizophrenia|schizophrenia
100346|NCT02661347|tDCS|tdcs
100347|NCT02661347|Risperidone|risperidone
100348|NCT02661347|Anti-psychotic medication|anti-psychotic medication
100349|NCT02661334|creatine|creatine
100350|NCT02661334|creatine monohydrate|creatine monohydrate
100351|NCT02661334|supplement|supplement
100352|NCT02661334|exercise|exercise
100353|NCT02661334|fitness|fitness
100354|NCT02661282|Glioblastoma|glioblastoma
100355|NCT02661282|Gliosarcoma|gliosarcoma
100356|NCT02661282|Brain tumor|brain tumor
100357|NCT02661282|Cytomegalovirus stimulated adoptive T cells|cytomegalovirus stimulated adoptive t cells
100358|NCT02661282|CMV|cmv
100359|NCT02661282|Temozolomide|temozolomide
100360|NCT02661282|Temodar|temodar
100361|NCT02661282|TMZ|tmz
100362|NCT02661282|Phone call|phone call
100363|NCT02661282|T cell infusion|t cell infusion
100364|NCT02661282|Surgery|surgery
100365|NCT02661256|pharyngeal swallow|pharyngeal swallow
100366|NCT02661256|airway compromise|airway compromise
100367|NCT02661256|NICU|nicu
100368|NCT02661243|Sjogren's Syndrome|sjogren's syndrome
100369|NCT02661243|Dental Implants|dental implants
100370|NCT02661230|exergaming|exergaming
100371|NCT02661230|intensive care unit|intensive care unit
100372|NCT02661230|feasibility acceptability|feasibility acceptability
100373|NCT02661230|heart|heart
100374|NCT02661230|brain function|brain function
100375|NCT02661217|Acute decompensated heart failure|acute decompensated heart failure
100376|NCT02661217|Reduced ejection fraction|reduced ejection fraction
100377|NCT02661217|Pre-discharge treatment|pre-discharge treatment
100378|NCT02661217|Post-discharge treatment|post-discharge treatment
100379|NCT02661217|Angiotensin receptor neprilysine inhibitor|angiotensin receptor neprilysine inhibitor
100380|NCT02661217|HFrEF|hfref
100381|NCT02661191|asthma|asthma
100382|NCT02661191|vitamin D|vitamin d
100383|NCT02661191|exacerbations|exacerbations
100384|NCT02661191|airway obstruction|airway obstruction
100495|NCT02660710|R-CHOP|r-chop
100385|NCT02661178|Parasitic Diseases|parasitic diseases
100386|NCT02661178|Helminthiasis|helminthiasis
100387|NCT02661178|Nematode Infections|nematode infections
100388|NCT02661178|Secernentea Infections|secernentea infections
100389|NCT02661178|Spirurida Infections|spirurida infections
100390|NCT02661178|Filariasis|filariasis
100391|NCT02661178|Skin Diseases, Parasitic|skin diseases, parasitic
100392|NCT02661178|Skin and Connective Tissue Diseases|skin and connective tissue diseases
100393|NCT02661178|Skin Diseases|skin diseases
100394|NCT02661178|Skin Diseases, Infectious|skin diseases, infectious
100395|NCT02661178|Depsipeptides|depsipeptides
100396|NCT02661178|Emodepside|emodepside
100397|NCT02661178|Neglected disease|neglected disease
100398|NCT02661178|Africa|africa
100399|NCT02661178|New drug|new drug
100400|NCT02661178|Oral drug|oral drug
100401|NCT02661178|Parasite|parasite
100402|NCT02661178|Anthelmintic drug|anthelmintic drug
100403|NCT02661178|Cyclooctadepsipeptide|cyclooctadepsipeptide
100404|NCT02661178|Single ascending dose|single ascending dose
100405|NCT02661178|Volunteers|volunteers
100406|NCT02661178|Phase 1|phase 1
100407|NCT02661178|Safety|safety
100408|NCT02661178|Tolerability|tolerability
639441|NCT00736437|UV-induced|uv-induced
100409|NCT02661178|Pharmacokinetics|pharmacokinetics
100410|NCT02661178|Relative bioavailability|relative bioavailability
100411|NCT02661178|Onchocerciasis|onchocerciasis
100412|NCT02661139|bisphosphonates and/or targeted therapy by monoclonal antibodies|bisphosphonates and/or targeted therapy by monoclonal antibodies
100415|NCT02661139|quality of life|quality of life
100417|NCT02661113|CNS Disease|cns disease
100419|NCT02661113|Intracranial Supratentorial GBM|intracranial supratentorial gbm
100420|NCT02661113|Gliosarcoma|gliosarcoma
100421|NCT02661113|GS|gs
100422|NCT02661113|Glioblastoma|glioblastoma
100423|NCT02661113|GBM|gbm
100424|NCT02661113|Dasatinib|dasatinib
100425|NCT02661113|Sprycel|sprycel
100426|NCT02661113|Temozolomide|temozolomide
100427|NCT02661113|TMZ|tmz
100428|NCT02661113|Temodar|temodar
100429|NCT02661113|Radiation Therapy|radiation therapy
100430|NCT02661113|Radiotherapy|radiotherapy
100431|NCT02661113|RT|rt
100432|NCT02661100|Vaccine|vaccine
100433|NCT02661100|NY-ESO-1|ny-eso-1
100434|NCT02661100|DEC-205|dec-205
100435|NCT02661100|Poly-ICLC|poly-iclc
100436|NCT02661100|Pembrolizumab|pembrolizumab
100437|NCT02661100|Cancer|cancer
100438|NCT02661087|submucosal myoma|submucosal myoma
100439|NCT02661087|hysteroscopic resection|hysteroscopic resection
100440|NCT02661087|bipolar energy|bipolar energy
100441|NCT02661087|monopolar energy|monopolar energy
100442|NCT02661074|Fisherman|fisherman
100443|NCT02661074|Fish industry|fish industry
100444|NCT02661061|ketamine|ketamine
100445|NCT02661061|glutamate|glutamate
100446|NCT02661061|relapse prevention|relapse prevention
100447|NCT02661035|AML|aml
100448|NCT02661035|ALL|all
100449|NCT02661035|CML|cml
100450|NCT02661035|MDS|mds
100451|NCT02661035|CLL|cll
100452|NCT02661035|SLL|sll
100453|NCT02661035|NHL|nhl
100454|NCT02661009|NSCLC|nsclc
100455|NCT02661009|EGFR|egfr
100456|NCT02661009|EGFR-TKI|egfr-tki
100457|NCT02661009|PCR|pcr
100458|NCT02660970|Iberogast|iberogast
100459|NCT02660970|Acupressure|acupressure
100460|NCT02660970|gut-brain-axis|gut-brain-axis
100461|NCT02660957|Smoking cessation|smoking cessation
100462|NCT02660931|Pediatrics|pediatrics
100463|NCT02660905|HIV-HCV co-infected|hiv-hcv co-infected
100464|NCT02660905|HCV|hcv
100465|NCT02660905|HIV|hiv
100466|NCT02660905|Hep C|hep c
100467|NCT02660905|Hepatitis C|hepatitis c
100468|NCT02660905|HCV positive|hcv positive
100469|NCT02660892|IAAO|iaao
100470|NCT02660892|Threonine|threonine
100471|NCT02660892|Children|children
100472|NCT02660879|Education|education
100473|NCT02660879|Inhaler|inhaler
100474|NCT02660866|intermittent claudication|intermittent claudication
100475|NCT02660866|randomized controlled trial|randomized controlled trial
100476|NCT02660853|Exacerbations|exacerbations
100477|NCT02660814|Chemerin|chemerin
100478|NCT02660814|Interleukin-6|interleukin-6
100479|NCT02660814|Gingival crevicular fluid|gingival crevicular fluid
100480|NCT02660801|spinal manipulation|spinal manipulation
100481|NCT02660801|spinal mobilization|spinal mobilization
100482|NCT02660801|spinal stiffness|spinal stiffness
100483|NCT02660788|6-24 months overdue|6-24 months overdue
100484|NCT02660788|screening mammography|screening mammography
100485|NCT02660775|schizophrenia|schizophrenia
100486|NCT02660736|Albiglutide|albiglutide
100487|NCT02660736|Randomized|randomized
100488|NCT02660736|Pharmacokinetics|pharmacokinetics
100489|NCT02660736|GSK716155|gsk716155
100490|NCT02660736|Bioequivalence study|bioequivalence study
100491|NCT02660723|M01.774.500|m01.774.500
100492|NCT02660723|Volunteers|volunteers
100493|NCT02660710|single arm phase 2|single arm phase 2
100494|NCT02660710|safety and efficacy|safety and efficacy
100496|NCT02660697|socket preservation, implant site development|socket preservation, implant site development
100497|NCT02660684|Prograf|prograf
100498|NCT02660684|Graft versus host disease|graft versus host disease
100499|NCT02660684|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
100500|NCT02660684|Prophylaxis|prophylaxis
100501|NCT02660684|Peripheral hematopoietic stem cell transplantation|peripheral hematopoietic stem cell transplantation
100502|NCT02660645|Cysview|cysview
100503|NCT02660645|Hexaminolevulinate|hexaminolevulinate
100504|NCT02660645|Hexvix|hexvix
100505|NCT02660645|NMIBC|nmibc
100506|NCT02660645|BLCC|blcc
100507|NCT02660645|Blue Light Cystoscopy with Cysview|blue light cystoscopy with cysview
100508|NCT02660645|Cystoscopy|cystoscopy
100509|NCT02660645|TURBT|turbt
100510|NCT02660645|TUR|tur
100511|NCT02660645|Fluorescent cystoscopy|fluorescent cystoscopy
100512|NCT02660645|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
100513|NCT02660645|Transurethral resection (TUR)|transurethral resection (tur)
100514|NCT02660593|Diabetes Mellitus|diabetes mellitus
100515|NCT02660593|Chinese medicine|chinese medicine
100516|NCT02660593|exercise|exercise
100517|NCT02660593|diet|diet
100518|NCT02660580|Adalimumab|adalimumab
100519|NCT02660580|MSB11022|msb11022
100520|NCT02660580|Psoriasis|psoriasis
100521|NCT02660580|Phase III|phase iii
100522|NCT02660567|postpartum hemorrhage|postpartum hemorrhage
100524|NCT02660567|atonic|atonic
100525|NCT02660567|new maneuver|new maneuver
100526|NCT02660554|Pneumonia|pneumonia
100527|NCT02660554|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
100528|NCT02660554|Polymerase Chain Reaction|polymerase chain reaction
100529|NCT02660554|Intensive care units|intensive care units
100530|NCT02660554|Drug Resistance|drug resistance
100531|NCT02660541|Dressing for burn wounds|dressing for burn wounds
100532|NCT02660515|complete articular distal radius fracture|complete articular distal radius fracture
100533|NCT02660515|wrist arthroscopy|wrist arthroscopy
100534|NCT02660489|CRTH2 antagonist|crth2 antagonist
100535|NCT02660489|Prostaglandin D2 receptor|prostaglandin d2 receptor
100536|NCT02660489|Anti-Asthmatic Agents|anti-asthmatic agents
100537|NCT02660489|OC459|oc459
100538|NCT02660489|Allergic asthma|allergic asthma
100539|NCT02660489|Eosinophilia|eosinophilia
100540|NCT02660476|Diet|diet
100541|NCT02660476|Middle East and North Africa country|middle east and north africa country
100542|NCT02660476|Health|health
100543|NCT02660476|Complication|complication
100544|NCT02660476|Cardiovascular disease|cardiovascular disease
100545|NCT02660476|Obesity|obesity
100546|NCT02660476|Stress|stress
100547|NCT02660476|Obstructive Sleep Apnoea (OSA)|obstructive sleep apnoea (osa)
100548|NCT02660463|incidence|incidence
100549|NCT02660463|risk factors|risk factors
100550|NCT02660437|COPD|copd
100551|NCT02660437|Carbon dioxide partial pressure (pCO2)|carbon dioxide partial pressure (pco2)
100552|NCT02660437|Cerebral blood flow (CBF)|cerebral blood flow (cbf)
100553|NCT02660437|Cognitive dysfunction|cognitive dysfunction
100554|NCT02660437|Mild/Moderate Cognitive Impairment (MCI)|mild/moderate cognitive impairment (mci)
100555|NCT02660437|Pulmonary Rehabilitation (PR)|pulmonary rehabilitation (pr)
100556|NCT02660437|Standardized Mini Mental State Examination (SMMSE)|standardized mini mental state examination (smmse)
100557|NCT02660437|Addenbrooke's Cognitive Examination (ACE-R)|addenbrooke's cognitive examination (ace-r)
100558|NCT02660437|Montreal Cognitive Assessment (MoCA)|montreal cognitive assessment (moca)
100559|NCT02660437|Telephone Interview for Cognitive Status (TICS)|telephone interview for cognitive status (tics)
100560|NCT02660437|Stroop test (Reaction Time)|stroop test (reaction time)
100561|NCT02660411|Sevoflurane|sevoflurane
100562|NCT02660411|Propofol|propofol
100563|NCT02660411|Aged|aged
100564|NCT02660411|Neoplasm|neoplasm
100565|NCT02660411|Surgical Procedure, Operative|surgical procedure, operative
100566|NCT02660411|Long-term survival|long-term survival
100567|NCT02660385|pain|pain
100568|NCT02660385|insomnia|insomnia
100569|NCT02660385|cardiac failure|cardiac failure
100570|NCT02660385|sleep|sleep
100571|NCT02660385|fatigue|fatigue
100572|NCT02660385|heart disease|heart disease
100573|NCT02660385|anxiety|anxiety
100574|NCT02660385|actigraphy|actigraphy
100575|NCT02660385|psychomotor vigilance|psychomotor vigilance
100576|NCT02660385|six minute walk|six minute walk
100577|NCT02660385|depression|depression
100578|NCT02660385|cognitive behavioral therapy|cognitive behavioral therapy
100579|NCT02660385|self-management|self-management
100580|NCT02660385|self-care|self-care
100581|NCT02660346|IL-10|il-10
100582|NCT02660346|MRSA|mrsa
100583|NCT02660346|Bacteremia|bacteremia
100584|NCT02660333|Obesity|obesity
100585|NCT02660333|Inflammation|inflammation
100586|NCT02660333|Nutritional status|nutritional status
100587|NCT02660333|Prebiotic|prebiotic
100588|NCT02660333|Synbiotic|synbiotic
100589|NCT02660307|stress|stress
100590|NCT02660307|work|work
100591|NCT02660307|employees|employees
100592|NCT02660307|mindfulness|mindfulness
100593|NCT02660307|depression|depression
100594|NCT02660307|anxiety|anxiety
100595|NCT02660268|Clinical pathway|clinical pathway
100596|NCT02660268|Infection|infection
100598|NCT02660268|Prosthesis|prosthesis
100599|NCT02660255|CBD|cbd
100600|NCT02660255|Epidiolex|epidiolex
100601|NCT02660255|Myoclonic|myoclonic
100602|NCT02660255|Brain Disease|brain disease
100603|NCT02660255|Central Nervous System Disease|central nervous system disease
100604|NCT02660255|GWP42003|gwp42003
100605|NCT02660242|T1D|t1d
100606|NCT02660242|Type 1 Diabetes|type 1 diabetes
100607|NCT02660242|Mini-dose Glucagon|mini-dose glucagon
100608|NCT02660242|Adults|adults
100609|NCT02660242|Exercise|exercise
100610|NCT02660242|Hypoglycemia|hypoglycemia
100611|NCT02660229|Intravenous injection in cancer pain|intravenous injection in cancer pain
100612|NCT02660216|minimally invasive|minimally invasive
100613|NCT02660216|le fort I osteotomy|le fort i osteotomy
100614|NCT02660216|3D virtual treatment planning|3d virtual treatment planning
100615|NCT02660216|accuracy|accuracy
100616|NCT02660203|chest physiotherapy|chest physiotherapy
100617|NCT02660203|post operative period|post operative period
100618|NCT02660203|forced expiration|forced expiration
100619|NCT02660203|pleural drainage duration|pleural drainage duration
100620|NCT02660164|Concussion|concussion
100621|NCT02660125|ICSI|icsi
101700|NCT02654054|HMB|hmb
100622|NCT02660125|endometrial injury|endometrial injury
100623|NCT02660125|implantation rate|implantation rate
100624|NCT02660086|Weight|weight
100625|NCT02660086|Prevention|prevention
100626|NCT02660086|Food choice|food choice
100627|NCT02660086|Nutrition|nutrition
100628|NCT02660086|Behavior change|behavior change
100629|NCT02660086|Behavioral economics|behavioral economics
100630|NCT02660086|Feedback|feedback
100631|NCT02660086|Incentives|incentives
100632|NCT02660060|Pramipexole|pramipexole
100633|NCT02660060|Bioequivalence|bioequivalence
100634|NCT02660060|Pharmacokinetics|pharmacokinetics
100635|NCT02660047|South Asian descent|south asian descent
100636|NCT02660034|Dose Escalation|dose escalation
100637|NCT02660034|Dose Expansion|dose expansion
100638|NCT02660034|BGB-A317|bgb-a317
100639|NCT02660034|BGB-290|bgb-290
100640|NCT02660021|three-dimensional virtual treatment planning|three-dimensional virtual treatment planning
100641|NCT02660021|orthognathic surgery|orthognathic surgery
100642|NCT02659995|glycemic variability|glycemic variability
100643|NCT02659995|infection|infection
100644|NCT02659956|Multiple Sclerosis|multiple sclerosis
100645|NCT02659956|Longitudinal Prospective Follow-Up|longitudinal prospective follow-up
100646|NCT02659943|Gene Therapy|gene therapy
100647|NCT02659943|Adoptive T Cell Therapy|adoptive t cell therapy
100648|NCT02659943|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
100649|NCT02659943|T-cell infusion|t-cell infusion
100650|NCT02659943|Residual Malignancy|residual malignancy
100651|NCT02659930|HIV|hiv
100652|NCT02659930|AIDS|aids
100653|NCT02659930|Multicentric Castleman Disease|multicentric castleman disease
100654|NCT02659917|glass-ionomer cement|glass-ionomer cement
100655|NCT02659917|atraumatic restorative treatment|atraumatic restorative treatment
100656|NCT02659917|pit and fissure sealants|pit and fissure sealants
100657|NCT02659904|Free gingival graft|free gingival graft
100658|NCT02659904|Palatal donor site healing|palatal donor site healing
100659|NCT02659878|Takotsubo cardiomyopathy;NT-proBNP;urine metanephrine|takotsubo cardiomyopathy;nt-probnp;urine metanephrine
100660|NCT02659852|Hilar malignant biliary obstruction|hilar malignant biliary obstruction
100661|NCT02659852|bilateral metal stent|bilateral metal stent
100662|NCT02659852|stent in stent|stent in stent
100663|NCT02659852|side by side|side by side
100664|NCT02659839|Cancer|cancer
100665|NCT02659839|Intensive care unit|intensive care unit
100666|NCT02659839|Mortality|mortality
100667|NCT02659826|Transcutaneous spinal direct current stimulation|transcutaneous spinal direct current stimulation
100668|NCT02659826|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
100669|NCT02659826|Gait Training|gait training
100670|NCT02659826|Central Nervous System Excitability|central nervous system excitability
100671|NCT02659826|Healthy|healthy
100672|NCT02659813|Orthodontic wires|orthodontic wires
100673|NCT02659774|Smoking cessation interventions|smoking cessation interventions
100674|NCT02659761|Human Immunodeficiency Virus|human immunodeficiency virus
100675|NCT02659761|Injection drug use|injection drug use
100676|NCT02659761|Single-tablet antiretroviral treatment|single-tablet antiretroviral treatment
100677|NCT02659761|Dolutegravir|dolutegravir
100678|NCT02659761|Tolerability|tolerability
100679|NCT02659761|Adherence|adherence
100680|NCT02659761|Efficacy|efficacy
100681|NCT02659748|Bioactive fatty acids|bioactive fatty acids
100682|NCT02659748|Insulin sensitivity|insulin sensitivity
119531|NCT02548299|Cooking|cooking
91881|NCT02714114|Serum|serum
100683|NCT02659748|Diet|diet
100684|NCT02659748|Milk fat|milk fat
100685|NCT02659748|Lipid metabolism|lipid metabolism
100686|NCT02659748|Inflammation markers|inflammation markers
100687|NCT02659748|Fecal microbiota composition|fecal microbiota composition
100688|NCT02659735|Influenza A virus|influenza a virus
100689|NCT02659735|JNJ-63623872|jnj-63623872
100690|NCT02659735|Healthy|healthy
100691|NCT02659722|INTERVERTEBRAL DISC DEGENERATION|intervertebral disc degeneration
100692|NCT02659722|Bone Disease|bone disease
100693|NCT02659722|Musculoskeletal disease|musculoskeletal disease
100694|NCT02659722|Spinal disease|spinal disease
100695|NCT02659709|Glaucoma|glaucoma
100696|NCT02659709|Smartphone|smartphone
100698|NCT02659709|Application|application
100699|NCT02659631|P-cadherin|p-cadherin
100700|NCT02659631|PF-06671008|pf-06671008
100701|NCT02659631|solid tumors|solid tumors
100702|NCT02659631|lung cancer|lung cancer
100703|NCT02659631|breast cancer|breast cancer
100704|NCT02659631|colorectal cancer|colorectal cancer
100705|NCT02659631|NSCLC|nsclc
100706|NCT02659631|TNBC|tnbc
100708|NCT02659631|neoplasms|neoplasms
100709|NCT02659631|Triple negative breast cancer|triple negative breast cancer
100710|NCT02659631|Non-small cell lung cancer|non-small cell lung cancer
100711|NCT02659618|Asthma|asthma
100712|NCT02659605|pre-term birth|pre-term birth
100716|NCT02659592|ovarian tissue transplantation|ovarian tissue transplantation
100717|NCT02659592|ovarian endocrine function|ovarian endocrine function
100718|NCT02659592|assisted reproductive technology|assisted reproductive technology
100719|NCT02659592|pregnancy and live birth|pregnancy and live birth
100721|NCT02659579|Vocabulary|vocabulary
100722|NCT02659579|Language Development|language development
100723|NCT02659579|Young Children|young children
100724|NCT02659579|Randomised Control Trial|randomised control trial
100725|NCT02659566|Markers|markers
100726|NCT02659566|Parasitemia|parasitemia
100727|NCT02659566|Coartem|coartem
100728|NCT02659566|Plasmodium|plasmodium
100729|NCT02659566|Infection|infection
100730|NCT02659553|Liver Transplantation - Steatosis - Fatty Liver|liver transplantation - steatosis - fatty liver
100731|NCT02659540|Ipilimumab|ipilimumab
100732|NCT02659540|Nivolumab|nivolumab
100733|NCT02659540|Radiotherapy|radiotherapy
100734|NCT02659514|Poziotinib|poziotinib
100735|NCT02659514|Metastatic Breast Cancer|metastatic breast cancer
100736|NCT02659514|HER2-positive|her2-positive
100737|NCT02659514|Pan-HER inhibitor|pan-her inhibitor
100738|NCT02659501|Breast reconstruction|breast reconstruction
100739|NCT02659501|Bupivacaine|bupivacaine
100740|NCT02659501|Liposomal bupivacaine|liposomal bupivacaine
100741|NCT02659501|Postoperative analgesia|postoperative analgesia
100742|NCT02659462|Repaired Congenital Heart Disease|repaired congenital heart disease
100743|NCT02659462|Cardio Pulmonary Exercise Testing|cardio pulmonary exercise testing
100744|NCT02659462|Fontan|fontan
100745|NCT02659462|Fontan Palliation|fontan palliation
100746|NCT02659462|functional capacity|functional capacity
100747|NCT02659449|hands|hands
100748|NCT02659436|Cognitive Behavioural Therapy|cognitive behavioural therapy
100749|NCT02659423|Bystanding behaviors|bystanding behaviors
100750|NCT02659423|Campus|campus
100751|NCT02659423|Prevention|prevention
100752|NCT02659423|Sexual Assault|sexual assault
100753|NCT02659423|CampusSave|campussave
100754|NCT02659410|Physiologically based pharmacokinetic modeling|physiologically based pharmacokinetic modeling
100755|NCT02659410|Organic solvents|organic solvents
100756|NCT02659397|LDL-cholesterol|ldl-cholesterol
100757|NCT02659397|Hypercholesterolemia|hypercholesterolemia
100758|NCT02659397|ETC-1002|etc-1002
100759|NCT02659397|Adenosine triphosphate citrate lyase|adenosine triphosphate citrate lyase
100760|NCT02659397|Atorvastatin|atorvastatin
100761|NCT02659358|Advanced solid malignancy|advanced solid malignancy
100762|NCT02659358|Activity monitor|activity monitor
100763|NCT02659358|Biosensor|biosensor
100764|NCT02659358|Fitbit|fitbit
100765|NCT02659358|Patient Reported Outcomes (PRO)|patient reported outcomes (pro)
100766|NCT02659358|Stage 3/4 cancer|stage 3/4 cancer
100767|NCT02659358|Performance Status|performance status
100768|NCT02659358|Eastern Cooperative Oncology Group Performance Status (ECOG-PS)|eastern cooperative oncology group performance status (ecog-ps)
100769|NCT02659345|Art Therapy|art therapy
100770|NCT02659345|Chemotherapy|chemotherapy
100771|NCT02659319|Child overweight|child overweight
100772|NCT02659319|Child obesity|child obesity
100773|NCT02659319|Family dynamics|family dynamics
100774|NCT02659319|Peer relationships|peer relationships
100775|NCT02659319|Family intervention|family intervention
100776|NCT02659319|School intervention|school intervention
100777|NCT02659319|Parenting|parenting
100778|NCT02659293|Multiple myeloma|multiple myeloma
100779|NCT02659293|stem-cell transplant|stem-cell transplant
100780|NCT02659293|Symptomatic myeloma|symptomatic myeloma
100781|NCT02659293|lenalidomide|lenalidomide
100782|NCT02659293|carfilzomib|carfilzomib
91947|NCT02713815|prefrontal-striatal circuits|prefrontal-striatal circuits
91948|NCT02713815|Glutamate/GABA|glutamate/gaba
91949|NCT02713815|motivational and cognitive intervention|motivational and cognitive intervention
91950|NCT02713815|rTMS|rtms
100783|NCT02659293|dexamethasone|dexamethasone
100784|NCT02659280|telerehabilitation|telerehabilitation
100785|NCT02659267|Health Promotion|health promotion
100786|NCT02659267|Physical Activity|physical activity
100787|NCT02659267|Eating habits|eating habits
100788|NCT02659267|Health System|health system
100789|NCT02659267|Users from Health Academy Program|users from health academy program
100790|NCT02659254|Drug-Eluting Stents,Absorbable Implants,Stents|drug-eluting stents,absorbable implants,stents
100791|NCT02659241|Molecular results|molecular results
100793|NCT02659241|RNA|rna
100794|NCT02659241|Protein expression|protein expression
100795|NCT02659241|AZD1775|azd1775
100796|NCT02659215|Hyaluronic Acid|hyaluronic acid
100797|NCT02659215|Cartilage Repair|cartilage repair
100798|NCT02659215|Knee|knee
100799|NCT02659202|Exercise|exercise
100800|NCT02659202|Heart Failure|heart failure
100801|NCT02659202|Blood Pressure|blood pressure
100806|NCT02659150|tocilizumab|tocilizumab
100807|NCT02659150|subcutaneous injection|subcutaneous injection
100808|NCT02659150|rheumatoid arthritis|rheumatoid arthritis
100809|NCT02659150|plaque inflammation|plaque inflammation
100810|NCT02659150|atherosclerotic plaque|atherosclerotic plaque
100811|NCT02659150|joint inflammation|joint inflammation
100812|NCT02659150|FDG-PET|fdg-pet
100813|NCT02659150|PET-MR|pet-mr
100814|NCT02659150|ACTEMRA|actemra
100815|NCT02659137|LBBB|lbbb
100816|NCT02659137|TAVI|tavi
100817|NCT02659124|facial laser|facial laser
100818|NCT02659124|fraction ablative resurfacing|fraction ablative resurfacing
100819|NCT02659124|total ablative resurfacing|total ablative resurfacing
100820|NCT02659124|EpiFix|epifix
100821|NCT02659124|rhytides|rhytides
100822|NCT02659124|wrinkles|wrinkles
100823|NCT02659124|AmnioFix|amniofix
100824|NCT02659111|Exercise Therapy|exercise therapy
100825|NCT02659098|Best Corrected Visual Acuity|best corrected visual acuity
100826|NCT02659098|Geographic Atrophy|geographic atrophy
100827|NCT02659098|Macular Degeneration|macular degeneration
100828|NCT02659098|CNTO 2476|cnto 2476
100829|NCT02659085|Depressive Disorder, Major|depressive disorder, major
100830|NCT02659085|Antidepressive Agents/adverse effects|antidepressive agents/adverse effects
100831|NCT02659085|Depressive Disorder, Major/drug therapy|depressive disorder, major/drug therapy
100832|NCT02659085|Infusions, Intravenous|infusions, intravenous
100833|NCT02659085|Ketamine/administration & dosage*|ketamine/administration & dosage*
100834|NCT02659085|Ketamine/adverse effects|ketamine/adverse effects
100835|NCT02659085|Treatment Outcome|treatment outcome
100836|NCT02659085|Electroconvulsive therapy|electroconvulsive therapy
100837|NCT02659046|Traumatic Brain Injury|traumatic brain injury
100838|NCT02659033|microbiota|microbiota
100839|NCT02659033|resistant bacteria|resistant bacteria
100840|NCT02659007|yoga|yoga
100841|NCT02659007|balance|balance
100842|NCT02658968|Radioimmunotherapy|radioimmunotherapy
100843|NCT02658968|Lu-177|lu-177
100844|NCT02658968|Phase I study|phase i study
100845|NCT02658968|Betalutin|betalutin
100846|NCT02658968|ARC|arc
100847|NCT02658968|Antibody Radionuclide Conjugate|antibody radionuclide conjugate
100848|NCT02658968|HH1|hh1
100849|NCT02658968|Rituximab|rituximab
100850|NCT02658968|177Lu-DOTA-HH1|177lu-dota-hh1
100851|NCT02658968|Lilotomab|lilotomab
100852|NCT02658968|Lutetium (177Lu)-lilotomab satetraxetan|lutetium (177lu)-lilotomab satetraxetan
100853|NCT02658968|Additional relevant MeSH terms:|additional relevant mesh terms:
100854|NCT02658968|Lymphoma|lymphoma
100855|NCT02658968|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
100856|NCT02658968|Immune System Diseases|immune system diseases
100857|NCT02658968|Immunoproliferative Disorders|immunoproliferative disorders
100858|NCT02658968|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
100859|NCT02658968|Lymphatic Diseases|lymphatic diseases
100860|NCT02658968|Lymphoproliferative Disorders|lymphoproliferative disorders
100861|NCT02658968|Neoplasms|neoplasms
100862|NCT02658968|Neoplasms by Histologic Type|neoplasms by histologic type
100863|NCT02658968|DLBCL|dlbcl
100864|NCT02658968|Refractory DLBCL|refractory dlbcl
100865|NCT02658968|Relapsed DLBCL|relapsed dlbcl
100866|NCT02658955|Abdominal wall closure|abdominal wall closure
100867|NCT02658942|renal stones|renal stones
100868|NCT02658942|lower calyx|lower calyx
100869|NCT02658942|Ureteroscopy|ureteroscopy
100870|NCT02658942|Shockwave lithotripsy|shockwave lithotripsy
100871|NCT02658942|Holmium laser|holmium laser
100872|NCT02658942|Adult|adult
100873|NCT02658942|Kidney|kidney
100874|NCT02658903|Foley|foley
100875|NCT02658903|Infection|infection
100876|NCT02658903|Hospital acquired|hospital acquired
100877|NCT02658903|catheter associated|catheter associated
100878|NCT02658903|urinary|urinary
100879|NCT02658877|Xolair|xolair
100880|NCT02658877|corticosteroids|corticosteroids
100881|NCT02658877|asthma|asthma
100882|NCT02658877|long-acting beta-agonists|long-acting beta-agonists
100883|NCT02658864|lafutidine tablet|lafutidine tablet
100884|NCT02658864|pharmacokinetics|pharmacokinetics
100885|NCT02658864|food|food
100886|NCT02658864|safety|safety
100887|NCT02658864|healthy subjects|healthy subjects
100888|NCT02658851|lymphocele|lymphocele
100889|NCT02658851|pelvic lymph node dissection|pelvic lymph node dissection
100890|NCT02658851|robotic assisted radical prostatectomy|robotic assisted radical prostatectomy
100891|NCT02658851|PLND|plnd
100892|NCT02658851|RARP|rarp
100893|NCT02658851|prostatectomy|prostatectomy
100894|NCT02658851|Patel|patel
100895|NCT02658825|Healthy|healthy
100896|NCT02658825|JNJ-63623872|jnj-63623872
100897|NCT02658825|Moxifloxacin|moxifloxacin
100898|NCT02658812|Breast Cancer|breast cancer
100899|NCT02658812|Inflammatory breast cancer|inflammatory breast cancer
100901|NCT02658812|Non-inflammatory breast cancer|non-inflammatory breast cancer
100902|NCT02658812|Inoperable local recurrence|inoperable local recurrence
100903|NCT02658812|Talimogene laherparepvec|talimogene laherparepvec
100904|NCT02658812|T-VEC|t-vec
100905|NCT02658812|OncoVEX GM-CSF|oncovex gm-csf
100906|NCT02658799|periodontitis|periodontitis
100907|NCT02658799|anti-inflammatory agents|anti-inflammatory agents
100908|NCT02658760|Femoral Fractures|femoral fractures
100909|NCT02658721|Systemic Tramadol|systemic tramadol
100910|NCT02658721|Adjunct Tramadol|adjunct tramadol
100911|NCT02658721|Lidocain|lidocain
100912|NCT02658695|ICSI|icsi
100913|NCT02658695|embryo transfer|embryo transfer
100914|NCT02658695|air bubbles depth|air bubbles depth
100915|NCT02658669|Insomnia|insomnia
100916|NCT02658669|Injury, Brain, Traumatic Mild|injury, brain, traumatic mild
100917|NCT02658656|Exoskeleton|exoskeleton
100918|NCT02658643|biliodigestive anastomosis techniques|biliodigestive anastomosis techniques
100919|NCT02658630|arm rehabilitation|arm rehabilitation
100920|NCT02658630|recovery of function|recovery of function
100921|NCT02658617|Empathy|empathy
100922|NCT02658617|Interoceptive Awareness|interoceptive awareness
100923|NCT02658617|fMRI|fmri
100924|NCT02658617|MRS|mrs
100925|NCT02658591|Food intake|food intake
100926|NCT02658591|Satiety|satiety
100927|NCT02658591|Appetite|appetite
100928|NCT02658591|Glycemia|glycemia
100929|NCT02658591|Faba bean|faba bean
100930|NCT02658591|Protein|protein
100931|NCT02658591|Snack|snack
100932|NCT02658565|Intraoperative Consultation|intraoperative consultation
100933|NCT02658552|HIFU|hifu
100934|NCT02658552|Benign thyroid nodule|benign thyroid nodule
100935|NCT02658552|Low risk|low risk
100936|NCT02658552|New treatment|new treatment
100937|NCT02658539|Body fat distribution|body fat distribution
100938|NCT02658539|Bone mineral density|bone mineral density
100939|NCT02658539|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
100940|NCT02658526|cognition|cognition
100941|NCT02658526|anesthesia|anesthesia
100942|NCT02658526|surgery|surgery
100943|NCT02658526|stress|stress
100944|NCT02658526|child|child
100945|NCT02658500|early infant feeding|early infant feeding
100946|NCT02658500|infant intestinal flora|infant intestinal flora
100947|NCT02658500|infant health|infant health
100948|NCT02658474|Chronic pain|chronic pain
100949|NCT02658474|Acceptance and Commitment Therapy|acceptance and commitment therapy
100950|NCT02658474|Multidisciplinary treatment|multidisciplinary treatment
100951|NCT02658474|Group treatment|group treatment
100952|NCT02658435|Malaria|malaria
100953|NCT02658435|Retinal|retinal
100954|NCT02658435|Ophthalmic|ophthalmic
100955|NCT02658435|Plasmodium. vivax|plasmodium. vivax
100956|NCT02658435|Tafenoquine|tafenoquine
100957|NCT02658435|Pharmacodynamic|pharmacodynamic
100958|NCT02658409|CCIV|cciv
100959|NCT02658409|quadrivalent cell-culture based influenza vaccine|quadrivalent cell-culture based influenza vaccine
100960|NCT02658409|Influenza vaccine|influenza vaccine
100961|NCT02658409|Vaccination|vaccination
100962|NCT02658396|Multiple Myeloma|multiple myeloma
100963|NCT02658396|Relapsed Multiple Myeloma|relapsed multiple myeloma
100964|NCT02658396|Refractory Multiple Myeloma|refractory multiple myeloma
100965|NCT02658370|physical exercises|physical exercises
100966|NCT02658370|physical therapy|physical therapy
100967|NCT02658370|Wii game console|wii game console
100968|NCT02658370|patients perspective|patients perspective
100969|NCT02658344|Stem cell|stem cell
100970|NCT02658344|adipose tissue derived mesenchymal stem cell|adipose tissue derived mesenchymal stem cell
100971|NCT02658344|osteoarthritis|osteoarthritis
100972|NCT02658344|degenerative arthritis|degenerative arthritis
100973|NCT02658344|biostar|biostar
100974|NCT02658344|Rbio|rbio
100975|NCT02658331|Ebola Virus Disease|ebola virus disease
100976|NCT02658331|Rapid Diagnosis|rapid diagnosis
100977|NCT02658331|Point of care|point of care
100978|NCT02658331|Molecular platform|molecular platform
119925|NCT02545855|HOT|hot
100979|NCT02658318|peri- and postoperative complications|peri- and postoperative complications
100980|NCT02658318|airway obstruction|airway obstruction
100981|NCT02658318|adapted Furlow palatoplasty|adapted furlow palatoplasty
100982|NCT02658305|transoral approach|transoral approach
100983|NCT02658305|transbuccal approach|transbuccal approach
100984|NCT02658305|postoperative complications|postoperative complications
100985|NCT02658292|fungus|fungus
100986|NCT02658292|antifungal|antifungal
100987|NCT02658292|skin infection|skin infection
100988|NCT02658292|hair infection|hair infection
100989|NCT02658292|dermatophyte|dermatophyte
100990|NCT02658292|scalp|scalp
100991|NCT02658292|skin|skin
100992|NCT02658292|eyebrows|eyebrows
100993|NCT02658292|eyelashes|eyelashes
100994|NCT02658292|hair|hair
100995|NCT02658292|Trichophyton|trichophyton
100996|NCT02658292|Microsporum|microsporum
100997|NCT02658292|Endothrix|endothrix
100998|NCT02658292|spores|spores
100999|NCT02658279|Pembrolizumab (MK-3475)|pembrolizumab (mk-3475)
101000|NCT02658279|15-227|15-227
101001|NCT02658279|Hypermutator Phenotype|hypermutator phenotype
101002|NCT02658266|resistance training|resistance training
101003|NCT02658266|adult|adult
101004|NCT02658266|muscle strength|muscle strength
101005|NCT02658266|muscle endurance|muscle endurance
101006|NCT02658266|muscle metabolism|muscle metabolism
101007|NCT02658253|Placental malaria vaccine|placental malaria vaccine
101008|NCT02658253|Plasmodium|plasmodium
101009|NCT02658253|PRIMALVAC|primalvac
101010|NCT02658240|Nerve block|nerve block
101210|NCT02657122|Phase 1|phase 1
101011|NCT02658240|Periarticular infiltration|periarticular infiltration
101012|NCT02658240|Ropivacaine|ropivacaine
101013|NCT02658240|Pain|pain
101014|NCT02658214|durvalumab, MEDI4736, tremelimumab, small-cell lung, head and neck, triple negative breast, gastric/GEJ or ovarian cancer, immuno oncology, first-line chemo|durvalumab, medi4736, tremelimumab, small-cell lung, head and neck, triple negative breast, gastric/gej or ovarian cancer, immuno oncology, first-line chemo
101015|NCT02658188|Restless legs syndrome patients|restless legs syndrome patients
101016|NCT02658188|ASP8825|asp8825
101017|NCT02658188|XP13512|xp13512
101018|NCT02658110|Postprandial glycemia|postprandial glycemia
101019|NCT02658110|Metabolic health measures|metabolic health measures
101020|NCT02658097|Lung Cancer|lung cancer
101021|NCT02658097|pembrolizumab|pembrolizumab
101022|NCT02658097|focal radiation|focal radiation
101023|NCT02658097|RT|rt
101024|NCT02658084|HER2-Positive|her2-positive
101025|NCT02658084|Metastatic Breast Cancer|metastatic breast cancer
101026|NCT02658071|exfoliative glaucoma|exfoliative glaucoma
101027|NCT02658071|cataract|cataract
101028|NCT02658071|ocular pressure|ocular pressure
101029|NCT02658058|Ultrasound|ultrasound
101030|NCT02658058|Spinal anesthesia|spinal anesthesia
101032|NCT02658058|Landmark|landmark
101033|NCT02658045|oxygen saturation|oxygen saturation
101034|NCT02658045|monitoring|monitoring
101035|NCT02658045|oximeter|oximeter
101036|NCT02658019|Hepatocellular Carcinoma|hepatocellular carcinoma
101037|NCT02658019|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
101038|NCT02658019|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
101039|NCT02658006|Near Infrared Spectroscopy|near infrared spectroscopy
101040|NCT02658006|Ultrasonography|ultrasonography
101041|NCT02658006|Hepatic vein Doppler|hepatic vein doppler
101042|NCT02658006|Portal vein Doppler|portal vein doppler
101043|NCT02658006|Lung ultrasound|lung ultrasound
101044|NCT02658006|Positive fluid balance|positive fluid balance
101045|NCT02658006|Mixed venous saturation|mixed venous saturation
101046|NCT02657993|Breast Neoplasms|breast neoplasms
101047|NCT02657993|Aromatase Inhibitors|aromatase inhibitors
101048|NCT02657993|Musculoskeletal Pain|musculoskeletal pain
101049|NCT02657993|Hypnosis|hypnosis
101050|NCT02657993|Medication Adherence|medication adherence
101051|NCT02657993|Cost-Benefit Analysis|cost-benefit analysis
101052|NCT02657993|Treatment Outcomes|treatment outcomes
101053|NCT02657980|Major Depressive Disorder|major depressive disorder
101054|NCT02657980|tDCS|tdcs
101055|NCT02657980|MDD|mdd
101056|NCT02657980|transcranial Direct Current Stimulation|transcranial direct current stimulation
101057|NCT02657954|Homeless persons|homeless persons
101058|NCT02657954|Veterans|veterans
101059|NCT02657954|Mental disorders|mental disorders
101060|NCT02657954|Cognition|cognition
101061|NCT02657954|Rehabilitation|rehabilitation
101062|NCT02657941|Schizophrenia|schizophrenia
101063|NCT02657941|Obesity|obesity
101064|NCT02657941|Metabolic Syndrome|metabolic syndrome
101065|NCT02657915|FF-VEP|ff-vep
101066|NCT02657915|mfVEP|mfvep
101067|NCT02657915|Human anti-LINGO-1|human anti-lingo-1
101068|NCT02657915|BIIB033|biib033
101069|NCT02657915|AON|aon
101070|NCT02657889|PARP inhibitor|parp inhibitor
101071|NCT02657889|PD-1|pd-1
101072|NCT02657889|Niraparib|niraparib
101073|NCT02657889|Pembrolizumab|pembrolizumab
101074|NCT02657889|Keynote|keynote
101075|NCT02657889|TOPACIO|topacio
101076|NCT02657837|CF|cf
101077|NCT02657837|Multiple Breath Washout|multiple breath washout
101078|NCT02657837|Lung Clearance Index|lung clearance index
101079|NCT02657837|Pediatrics|pediatrics
101080|NCT02657824|Ejection fraction|ejection fraction
101081|NCT02657824|mitral valve|mitral valve
101082|NCT02657824|e-point septal separation|e-point septal separation
101083|NCT02657811|Time-Lapse Imaging|time-lapse imaging
101084|NCT02657811|Embryo Culture Techniques|embryo culture techniques
101085|NCT02657811|Fertilization in Vitro|fertilization in vitro
101086|NCT02657811|Embryology|embryology
101087|NCT02657811|Assisted Reproductive Techniques|assisted reproductive techniques
101088|NCT02657811|Infertility|infertility
101089|NCT02657811|Preimplantation diagnosis|preimplantation diagnosis
101090|NCT02657772|Target Ultra coils|target ultra coils
101091|NCT02657772|small aneurysms|small aneurysms
101092|NCT02657746|blood pressure monitoring|blood pressure monitoring
101093|NCT02657746|high blood pressure|high blood pressure
101094|NCT02657746|cardiovascular disease|cardiovascular disease
101095|NCT02657746|Antihypertensive agents|antihypertensive agents
101096|NCT02657746|Non-pharmacological treatment|non-pharmacological treatment
101097|NCT02657746|community health care workers|community health care workers
101098|NCT02657746|cost-effectiveness|cost-effectiveness
101099|NCT02657733|Respiratory Conditions for Adults|respiratory conditions for adults
101100|NCT02657720|Respiratory Conditions for Adults|respiratory conditions for adults
101101|NCT02657707|stent|stent
101102|NCT02657707|stenosis|stenosis
101103|NCT02657707|artery|artery
101104|NCT02657707|carotid|carotid
101105|NCT02657668|Irritable Bowel Syndrome|irritable bowel syndrome
101106|NCT02657668|Emotion Focused Therapy|emotion focused therapy
101107|NCT02657668|Stress|stress
101108|NCT02657668|Resilience|resilience
101109|NCT02657668|Coping Strategies|coping strategies
101110|NCT02657655|Parkinson's Disease|parkinson's disease
101111|NCT02657655|Dyskinesia|dyskinesia
101112|NCT02657655|Tremor|tremor
101113|NCT02657655|Symptom Management|symptom management
101114|NCT02657655|Technology|technology
101115|NCT02657655|Wearable Sensors|wearable sensors
101116|NCT02657655|Continuous Monitoring|continuous monitoring
101117|NCT02657655|Mobility|mobility
101118|NCT02657642|drug related problems, elderly|drug related problems, elderly
101119|NCT02657603|Peripheral Nerve Blocks|peripheral nerve blocks
101120|NCT02657577|Women|women
101121|NCT02657577|Infants and Children|infants and children
101122|NCT02657551|Thyroid Cancer|thyroid cancer
101123|NCT02657538|Interproximal caries|interproximal caries
101124|NCT02657538|Enamel caries|enamel caries
101125|NCT02657538|Caries detection|caries detection
101126|NCT02657538|Caries diagnostics|caries diagnostics
101127|NCT02657538|Near-infrared light transillumination|near-infrared light transillumination
101128|NCT02657538|DIAGNOcam|diagnocam
101129|NCT02657512|Rivaroxaban, pharmacokinetics, activated charcoal, poisoning|rivaroxaban, pharmacokinetics, activated charcoal, poisoning
101130|NCT02657499|healthcare access|healthcare access
101131|NCT02657499|utilization|utilization
101132|NCT02657499|expenditures|expenditures
101133|NCT02657499|preventive services|preventive services
101134|NCT02657486|BGJ398|bgj398
101135|NCT02657486|15-090|15-090
101136|NCT02657460|chemotherapy|chemotherapy
101137|NCT02657460|microparticle|microparticle
101138|NCT02657460|malignant pleural effusion|malignant pleural effusion
101139|NCT02657447|Radioimmunotherapy|radioimmunotherapy
101140|NCT02657447|Lu-177|lu-177
101141|NCT02657447|Phase I study|phase i study
101142|NCT02657447|Betalutin|betalutin
101143|NCT02657447|ARC|arc
101144|NCT02657447|Antibody Radionuclide Conjugate|antibody radionuclide conjugate
101145|NCT02657447|HH1|hh1
101146|NCT02657447|Rituximab|rituximab
101147|NCT02657447|177Lu-DOTA-HH1|177lu-dota-hh1
101148|NCT02657447|Lymphoma|lymphoma
101149|NCT02657447|Lymphoma Non-Hodgkin|lymphoma non-hodgkin
101150|NCT02657447|Immune System Diseases|immune system diseases
101151|NCT02657447|Follicular Lymphoma|follicular lymphoma
101152|NCT02657447|Marginal Zone Lymphoma|marginal zone lymphoma
101153|NCT02657447|Lymphoplasmacytoid|lymphoplasmacytoid
101154|NCT02657447|Lymphatic Diseases|lymphatic diseases
101155|NCT02657447|Lymphoproliferative Disorders|lymphoproliferative disorders
101156|NCT02657447|Neoplasms|neoplasms
101157|NCT02657447|Neoplasms by Histological Type|neoplasms by histological type
101158|NCT02657447|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
101159|NCT02657447|Classical Mantle Cell Lymphoma|classical mantle cell lymphoma
101160|NCT02657447|Lilotomab|lilotomab
101161|NCT02657447|Lutetium (177Lu) lilotomab satetraxetan|lutetium (177lu) lilotomab satetraxetan
101162|NCT02657382|Biofeedback|biofeedback
101163|NCT02657382|Myocardial Imaging|myocardial imaging
101164|NCT02657369|Lenvatinib|lenvatinib
101165|NCT02657369|Thyroid Cancer, Anaplastic|thyroid cancer, anaplastic
101166|NCT02657369|Lenvima|lenvima
101167|NCT02657369|E7080|e7080
101168|NCT02657356|Pulmonary Hypertension|pulmonary hypertension
101169|NCT02657356|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
101170|NCT02657356|Connective Tissue Disease-Associated Pulmonary Arterial Hypertension|connective tissue disease-associated pulmonary arterial hypertension
101171|NCT02657356|Bardoxolone methyl|bardoxolone methyl
101172|NCT02657356|PAH|pah
101173|NCT02657356|RTA 402|rta 402
101174|NCT02657356|6-minute walk distance|6-minute walk distance
101175|NCT02657343|Breast Cancer With Positive HER2|breast cancer with positive her2
101176|NCT02657330|Locally Advanced|locally advanced
101177|NCT02657330|Metastatic|metastatic
101178|NCT02657317|chronic pain|chronic pain
101179|NCT02657317|pain management|pain management
101180|NCT02657317|trauma|trauma
101181|NCT02657317|ptsd|ptsd
101182|NCT02657317|tbi|tbi
101183|NCT02657317|opioid medication|opioid medication
101184|NCT02657304|Sleep Apnea|sleep apnea
101185|NCT02657304|CPAP|cpap
101186|NCT02657278|Peripheral arterial disease,|peripheral arterial disease,
101187|NCT02657278|Cardipulmonary Exercise Test|cardipulmonary exercise test
101188|NCT02657252|telangiectasis|telangiectasis
101189|NCT02657252|varicose veins|varicose veins
101190|NCT02657252|veins|veins
101191|NCT02657252|glucose|glucose
101192|NCT02657252|sclerotherapy|sclerotherapy
101193|NCT02657239|Physical Function|physical function
101194|NCT02657213|Diabetes, Type 1|diabetes, type 1
101195|NCT02657213|Hypoglycemia|hypoglycemia
101196|NCT02657213|Insulin Infusion Systems|insulin infusion systems
101197|NCT02657200|miscarriage|miscarriage
101198|NCT02657200|Flanders|flanders
101199|NCT02657200|spontaneous abortion|spontaneous abortion
101201|NCT02657200|midwives|midwives
101202|NCT02657174|third molar|third molar
101203|NCT02657174|auriculotherapy|auriculotherapy
101204|NCT02657174|inflammation|inflammation
101205|NCT02657174|pain|pain
101206|NCT02657122|Single ascending dose|single ascending dose
101207|NCT02657122|SAD|sad
101208|NCT02657122|multiple ascending dose|multiple ascending dose
101209|NCT02657122|MAD|mad
101211|NCT02657122|first-in-human|first-in-human
101212|NCT02657122|volunteers|volunteers
101213|NCT02657122|TD-1473|td-1473
101214|NCT02657109|valve replacement|valve replacement
101215|NCT02657109|physical therapy|physical therapy
101216|NCT02657109|early mobilization|early mobilization
101217|NCT02657096|Chronic Periodontitis|chronic periodontitis
101218|NCT02657096|Hybenx|hybenx
101219|NCT02657096|Desiccant agent|desiccant agent
101220|NCT02657096|Healing|healing
101221|NCT02657096|Microbiology|microbiology
101222|NCT02657096|Periodontal Diseases|periodontal diseases
101223|NCT02657096|Periodontitis|periodontitis
101224|NCT02657096|Split-mouth clinical Study|split-mouth clinical study
101225|NCT02657070|Stroke|stroke
101226|NCT02657070|learned non-use|learned non-use
101227|NCT02657070|Virtual Reality|virtual reality
101228|NCT02657070|Hemiparesis|hemiparesis
101229|NCT02657057|neuromodulation|neuromodulation
101230|NCT02657057|electrical estimulation|electrical estimulation
101231|NCT02657057|percutaneous|percutaneous
101232|NCT02657057|transcutaneous|transcutaneous
101233|NCT02657057|OAB|oab
101234|NCT02657044|EMR|emr
101235|NCT02657044|ESD|esd
101236|NCT02657044|endoscopic mucosal resection|endoscopic mucosal resection
101237|NCT02657044|endoscopic submucosal resection|endoscopic submucosal resection
101238|NCT02657044|colorectal adenomas|colorectal adenomas
101239|NCT02657031|Headache, Migraine|headache, migraine
101240|NCT02656992|Bronchiectasis|bronchiectasis
101241|NCT02656992|High-intensity inspiratory muscle training|high-intensity inspiratory muscle training
101242|NCT02656979|Glaucoma|glaucoma
101243|NCT02656979|Blood flow|blood flow
101244|NCT02656979|Pseudoexfoliation|pseudoexfoliation
101245|NCT02656979|Intraocular pressure|intraocular pressure
101246|NCT02656979|Brain perfusion|brain perfusion
101247|NCT02656979|Magnetic Resonance Imaging|magnetic resonance imaging
101248|NCT02656953|VDU workers|vdu workers
101249|NCT02656953|VDU lenses|vdu lenses
101250|NCT02656953|Neck complaints|neck complaints
101251|NCT02656953|Visual complaints|visual complaints
101252|NCT02656940|obesity|obesity
101253|NCT02656940|lipids|lipids
101254|NCT02656940|energy expenditure|energy expenditure
101255|NCT02656940|gene expression|gene expression
101256|NCT02656927|Spinal Cord Injury|spinal cord injury
101257|NCT02656927|Yoga|yoga
101258|NCT02656927|Psychological Flexibility|psychological flexibility
101259|NCT02656927|Mindfulness|mindfulness
101260|NCT02656927|Pain|pain
101261|NCT02656849|Solid Tumor|solid tumor
101262|NCT02656823|ANKYLOS|ankylos
101263|NCT02656823|Simplant|simplant
101264|NCT02656823|maxilla|maxilla
101265|NCT02656823|edentulous|edentulous
101266|NCT02656823|short implants|short implants
101267|NCT02656797|Leishmania major|leishmania major
101268|NCT02656797|Leishmania tropica|leishmania tropica
101269|NCT02656797|Amphotericin B|amphotericin b
101270|NCT02656771|THA|tha
101271|NCT02656771|Hip|hip
101272|NCT02656771|arthroplasties|arthroplasties
101273|NCT02656745|Smoking|smoking
101274|NCT02656745|Cigarette Smoking|cigarette smoking
101275|NCT02656745|Tobacco Smoking|tobacco smoking
101276|NCT02656745|Nicotine|nicotine
101277|NCT02656745|Drug|drug
101278|NCT02656745|Addiction|addiction
101279|NCT02656745|Tobacco|tobacco
101280|NCT02656719|tracheostomy|tracheostomy
92442|NCT02710656|SFA|sfa
101281|NCT02656719|complications|complications
101282|NCT02656719|ultrasound|ultrasound
101283|NCT02656719|bronchoscopy|bronchoscopy
101284|NCT02656706|Adjuvant melanoma|adjuvant melanoma
101285|NCT02656706|Advanced melanoma|advanced melanoma
101286|NCT02656693|Weight Reduction Programs|weight reduction programs
101287|NCT02656693|Weight Loss Programs|weight loss programs
101288|NCT02656693|Obesity|obesity
101289|NCT02656667|COPD pulmonary rehabilitation|copd pulmonary rehabilitation
101290|NCT02656667|neuromuscular electrical stimulation|neuromuscular electrical stimulation
101291|NCT02656667|sit to stand test COPD|sit to stand test copd
101292|NCT02656667|quadriceps strengthening|quadriceps strengthening
101293|NCT02656602|Computer Assisted Instruction|computer assisted instruction
101294|NCT02656602|Patient Counselling|patient counselling
101295|NCT02656602|Endoscopy|endoscopy
101296|NCT02656589|breast cancer|breast cancer
101297|NCT02656589|herceptin|herceptin
101298|NCT02656589|microRNA|microrna
101299|NCT02656576|Human Papillomavirus|human papillomavirus
101300|NCT02656576|oropharynx biopsy|oropharynx biopsy
101301|NCT02656576|tonsillar lesion|tonsillar lesion
101302|NCT02656550|Uterine Transplant|uterine transplant
101303|NCT02656550|AUI|aui
101304|NCT02656550|Rokitansky Syndrome|rokitansky syndrome
101305|NCT02656524|Metastatic colorectal cancer|metastatic colorectal cancer
101306|NCT02656511|immediate antiretroviral therapy|immediate antiretroviral therapy
101307|NCT02656511|hyperacute infection|hyperacute infection
101308|NCT02656498|Tau, neurodegeneration, positron emission computed tomography|tau, neurodegeneration, positron emission computed tomography
101309|NCT02656472|Pediatric Cardiac surgery|pediatric cardiac surgery
101310|NCT02656472|Inflammatory response|inflammatory response
101311|NCT02656472|Tranexamic acid|tranexamic acid
101718|NCT02653924|bacteria|bacteria
101312|NCT02656472|Epsilon Aminocaproic Acid|epsilon aminocaproic acid
101313|NCT02656459|gene expression|gene expression
101314|NCT02656446|Neuraxial|neuraxial
101315|NCT02656446|Ultrasound|ultrasound
101316|NCT02656433|QEEG|qeeg
101317|NCT02656433|ERP|erp
101318|NCT02656433|tRNS|trns
101319|NCT02656433|Brain injury|brain injury
101320|NCT02656433|Motor Impairment|motor impairment
101321|NCT02656433|Transcranial Brain non-invasive stimulation|transcranial brain non-invasive stimulation
101322|NCT02656433|electroencephalogram|electroencephalogram
101323|NCT02656407|Functional Ultrasound|functional ultrasound
101324|NCT02656407|Intraoperative|intraoperative
101325|NCT02656407|Brain|brain
101326|NCT02656407|Doppler|doppler
101327|NCT02656407|Ultrasound|ultrasound
101328|NCT02656394|ocular surface disease|ocular surface disease
101329|NCT02656394|glaucoma medications|glaucoma medications
101330|NCT02656381|Sarcoidosis|sarcoidosis
101331|NCT02656381|Behcet's Disease|behcet's disease
101332|NCT02656381|Natural History Study|natural history study
101333|NCT02656381|Biological Specimens|biological specimens
101334|NCT02656381|Immune System|immune system
101335|NCT02656355|Gait Initiation|gait initiation
101336|NCT02656355|Freezing of gait|freezing of gait
101337|NCT02656355|Balance training|balance training
101338|NCT02656355|Anticipatory postural adjustments|anticipatory postural adjustments
101340|NCT02656329|Heart Failure (HF)|heart failure (hf)
101341|NCT02656329|Single photon emission computer tomography scan (SPECT)|single photon emission computer tomography scan (spect)
101342|NCT02656329|Implantable cardioverter defibrillator (ICD)|implantable cardioverter defibrillator (icd)
101343|NCT02656329|Left Ventricular ejection fraction (LVEF)|left ventricular ejection fraction (lvef)
101344|NCT02656329|New York Health Association (NYHA)|new york health association (nyha)
101345|NCT02656329|Metaiodobenzylguanidine (mIBG)|metaiodobenzylguanidine (mibg)
101346|NCT02656329|123I-iobenguane|123i-iobenguane
101347|NCT02656329|Heart-to-mediastinal ratio (H/M)|heart-to-mediastinal ratio (h/m)
101348|NCT02656329|ADMIRE-ICD (AdreView Myocardial Imaging for Risk Evaluation - Implantable Cardioverter Defibrillator|admire-icd (adreview myocardial imaging for risk evaluation - implantable cardioverter defibrillator
101349|NCT02656329|All-cause mortality|all-cause mortality
101350|NCT02656329|Cardiac mortality|cardiac mortality
101351|NCT02656251|biofilms|biofilms
101352|NCT02656251|cross over trial|cross over trial
101353|NCT02656251|chlorhexidine|chlorhexidine
101354|NCT02656238|CTEPH|cteph
101355|NCT02656238|Balloon pulmonary angioplasty|balloon pulmonary angioplasty
101356|NCT02656238|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
101357|NCT02656238|Pulmonary endarterectomy|pulmonary endarterectomy
101358|NCT02656238|BPA|bpa
101359|NCT02656238|PEA|pea
101360|NCT02656225|postpartum anemia|postpartum anemia
101361|NCT02656225|hemoglobin|hemoglobin
101362|NCT02656225|iron metabolism|iron metabolism
101363|NCT02656225|Traditional Chinese Medicine|traditional chinese medicine
101364|NCT02656225|Ejiao|ejiao
101365|NCT02656212|epicatechin|epicatechin
101366|NCT02656212|pre-diabetes|pre-diabetes
101367|NCT02656199|Diaphragm|diaphragm
101368|NCT02656199|Ventilators, Mechanical|ventilators, mechanical
101369|NCT02656173|Tamsulosin|tamsulosin
101370|NCT02656173|Overactive bladder|overactive bladder
101371|NCT02656173|Benign prostatic hypertrophy|benign prostatic hypertrophy
101372|NCT02656173|Mirabegron|mirabegron
101373|NCT02656147|Leukemia|leukemia
101374|NCT02656147|Lymphoma|lymphoma
101375|NCT02656147|CAR γδT|car γδt
101376|NCT02656134|Familial Adenomatous Polyposis|familial adenomatous polyposis
101377|NCT02656121|PCOS, vitamin D|pcos, vitamin d
101378|NCT02656082|Discoid lupus erythematosus|discoid lupus erythematosus
101379|NCT02656082|Intradermal injection of etanercept|intradermal injection of etanercept
101380|NCT02656017|kidney disease|kidney disease
101381|NCT02656017|polycystic kidney disease|polycystic kidney disease
101382|NCT02656017|autosomal dominant kidney disease|autosomal dominant kidney disease
101383|NCT02656017|kidney cysts|kidney cysts
101384|NCT02656017|PKD|pkd
101385|NCT02656004|Eucalyptus|eucalyptus
101386|NCT02656004|Autonomic nervous system|autonomic nervous system
101387|NCT02656004|Isometric resistance exercise|isometric resistance exercise
101388|NCT02655991|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
101389|NCT02655991|Ambulatory Care|ambulatory care
101390|NCT02655991|Telemedicine|telemedicine
101391|NCT02655991|Remote Consultation|remote consultation
101392|NCT02655991|Health Services Accessibility|health services accessibility
101393|NCT02655965|Breast cancer|breast cancer
101394|NCT02655965|lumpectomy|lumpectomy
101395|NCT02655965|mastectomy|mastectomy
101396|NCT02655965|PECS bloc|pecs bloc
101397|NCT02655939|Gonarthrosis|gonarthrosis
101399|NCT02655926|DBS|dbs
639928|NCT00730938|Lens|lens
101400|NCT02655926|Deep Brain Stimulation|deep brain stimulation
101401|NCT02655913|Sodium ascorbate|sodium ascorbate
101402|NCT02655913|Non-Small-Cell Lung cancer|non-small-cell lung cancer
101403|NCT02655913|Oncothermia|oncothermia
101404|NCT02655913|Immune function|immune function
101405|NCT02655913|Life quality|life quality
101406|NCT02655913|Tumor marker|tumor marker
101719|NCT02653911|Acupuncture|acupuncture
101407|NCT02655913|Survival time|survival time
101408|NCT02655900|Obstetric anal sphincter injury,|obstetric anal sphincter injury,
101409|NCT02655900|Ultrasound diagnosis|ultrasound diagnosis
101410|NCT02655874|Seasonal Influenza|seasonal influenza
101411|NCT02655874|Antibody response|antibody response
101412|NCT02655874|Influenza Vaccines|influenza vaccines
101413|NCT02655874|Hemagglutination Inhibition|hemagglutination inhibition
101414|NCT02655874|Elderly|elderly
101415|NCT02655874|immunosenescence|immunosenescence
101416|NCT02655874|Tropics|tropics
101417|NCT02655848|Popeye|popeye
101418|NCT02655848|Long Head Biceps Tendon|long head biceps tendon
101419|NCT02655848|Arthroscopy|arthroscopy
101420|NCT02655848|Functional result|functional result
101421|NCT02655835|mindfulness|mindfulness
101422|NCT02655835|meditation|meditation
101423|NCT02655835|internet|internet
101424|NCT02655822|NSCLC|nsclc
101425|NCT02655822|MEL|mel
101426|NCT02655822|RCC|rcc
101427|NCT02655822|TNBC|tnbc
101429|NCT02655822|Neoplasms|neoplasms
101431|NCT02655822|Lung Cancer|lung cancer
101432|NCT02655822|Kidney Cancer|kidney cancer
101433|NCT02655822|Colon Cancer|colon cancer
101434|NCT02655822|Rectal Cancer|rectal cancer
101435|NCT02655822|Skin Cancer|skin cancer
101436|NCT02655822|Breast Cancer|breast cancer
101437|NCT02655822|mCRPC|mcrpc
101438|NCT02655822|Prostate Cancer|prostate cancer
101439|NCT02655796|Accidental Falls|accidental falls
101440|NCT02655796|Risk Assessment|risk assessment
101441|NCT02655796|Frail Elderly|frail elderly
101442|NCT02655783|induction of labor|induction of labor
101443|NCT02655744|Neurobehavioral Assessment|neurobehavioral assessment
101444|NCT02655744|Radiotherapy (RT)|radiotherapy (rt)
101445|NCT02655744|Chemotherapy|chemotherapy
101446|NCT02655744|Neurotoxicity|neurotoxicity
101447|NCT02655718|ACS|acs
101448|NCT02655718|Non obstructive coronary atherosclerosis|non obstructive coronary atherosclerosis
101449|NCT02655705|Cyclosporine|cyclosporine
101450|NCT02655705|Methotrexate|methotrexate
101451|NCT02655692|PTSD|ptsd
101452|NCT02655692|Ketamine|ketamine
101453|NCT02655692|Veteran|veteran
101454|NCT02655692|Military|military
101455|NCT02655692|Clinical Trial|clinical trial
101456|NCT02655679|eczema|eczema
101457|NCT02655640|illness perceptions|illness perceptions
101458|NCT02655627|Type 2 DM|type 2 dm
101459|NCT02655627|internet based exercise training|internet based exercise training
101460|NCT02655627|group exercise training|group exercise training
101461|NCT02655627|glycemic control|glycemic control
101462|NCT02655575|dizziness|dizziness
101463|NCT02655575|cognitive therapy|cognitive therapy
101464|NCT02655575|primary care|primary care
101465|NCT02655575|vestibular rehabilitation|vestibular rehabilitation
101466|NCT02655575|chronic|chronic
101467|NCT02655484|COPD|copd
101468|NCT02655484|noninvasive ventilation|noninvasive ventilation
101469|NCT02655484|exercise|exercise
101470|NCT02655484|CO2 rebreathing|co2 rebreathing
101471|NCT02655458|Multiple Myeloma|multiple myeloma
101472|NCT02655458|Induction Therapy|induction therapy
101473|NCT02655458|Autologous Stem Cell Transplant|autologous stem cell transplant
101474|NCT02655458|ASCT|asct
101475|NCT02655458|Auto-SCT|auto-sct
101476|NCT02655419|cIAIs in hospitalized adults|ciais in hospitalized adults
101477|NCT02655406|Foam sclerotherapy|foam sclerotherapy
101478|NCT02655406|Compression|compression
101479|NCT02655367|MRI|mri
101480|NCT02655367|oats|oats
101481|NCT02655367|porridge|porridge
101482|NCT02655367|satiety|satiety
101483|NCT02655367|GI hormones|gi hormones
101484|NCT02655367|processing|processing
101485|NCT02655341|Dehydration|dehydration
101486|NCT02655341|Primary PCI|primary pci
101487|NCT02655341|Acute Myocardial Infarction|acute myocardial infarction
101488|NCT02655341|Bioimpedance|bioimpedance
101489|NCT02655341|Renal Angiography|renal angiography
101490|NCT02655328|asthma|asthma
101491|NCT02655328|athlete|athlete
101492|NCT02655315|Parkinson|parkinson
101493|NCT02655315|Deferiprone|deferiprone
101494|NCT02655315|Chelation|chelation
101495|NCT02655302|Interleukin-17|interleukin-17
101496|NCT02655302|Interleukin-22|interleukin-22
101497|NCT02655302|Microbiota|microbiota
101498|NCT02655302|Exacerbations|exacerbations
101499|NCT02655302|Immunity|immunity
101500|NCT02655302|Mucosal|mucosal
101501|NCT02655276|microencapsulated glycine|microencapsulated glycine
101502|NCT02655276|attentional performance|attentional performance
101503|NCT02655276|motoric activity|motoric activity
101504|NCT02655276|hyperactivity|hyperactivity
640436|NCT00741663|cirrhosis|cirrhosis
101505|NCT02655198|refractory childhood epilepsy|refractory childhood epilepsy
101506|NCT02655198|Lennox Gastaut syndrome|lennox gastaut syndrome
101507|NCT02655198|fenfluramine|fenfluramine
101508|NCT02655198|anti-epileptic treatment|anti-epileptic treatment
101509|NCT02655185|Lipids|lipids
101510|NCT02655185|Atrial Fibrillation|atrial fibrillation
101511|NCT02655185|Heart Failure|heart failure
101512|NCT02655172|Schizophrenia, affordance,|schizophrenia, affordance,
101513|NCT02655172|perception-action binding,|perception-action binding,
101514|NCT02655172|stimulus-response-compatibility|stimulus-response-compatibility
101515|NCT02655159|Breast Cancer|breast cancer
101516|NCT02655159|Metastatic breast cancer|metastatic breast cancer
101517|NCT02655159|nab-paclitaxel|nab-paclitaxel
101518|NCT02655159|Abraxane|abraxane
101519|NCT02655159|Observational|observational
101520|NCT02655159|Retrospective|retrospective
101521|NCT02655159|AMBER|amber
101522|NCT02655146|Frozen embryo transfer,luteal support, GnRHa|frozen embryo transfer,luteal support, gnrha
101523|NCT02655120|Femoral head necrosis|femoral head necrosis
101524|NCT02655120|Autologous Bone Marrow|autologous bone marrow
101525|NCT02655120|BMP7|bmp7
101526|NCT02655107|blood gas monitoring|blood gas monitoring
101527|NCT02655107|non-invasive|non-invasive
101528|NCT02655107|hemoglobin|hemoglobin
101529|NCT02655094|minimal-invasive surgery, mitral valve|minimal-invasive surgery, mitral valve
101530|NCT02655081|Urinary diversion|urinary diversion
101531|NCT02655081|Bladder Neoplasm|bladder neoplasm
101532|NCT02655081|Nutritional Supplement|nutritional supplement
101533|NCT02655081|Cystectomy|cystectomy
101534|NCT02655068|Head and Neck Cancer|head and neck cancer
101535|NCT02655068|Definitive Therapy|definitive therapy
101536|NCT02655068|Positron Emission Tomography - Computed Tomography (PET/CT)|positron emission tomography - computed tomography (pet/ct)
101537|NCT02655068|Computed Tomography (CT)|computed tomography (ct)
101538|NCT02655055|apheresis|apheresis
101539|NCT02655055|citrate anticoagulation|citrate anticoagulation
101540|NCT02655055|blood donor|blood donor
101541|NCT02655055|bone|bone
101542|NCT02655016|Ovarian Cancer|ovarian cancer
101543|NCT02655016|PARP Inhibitor|parp inhibitor
101544|NCT02655016|HRD|hrd
101545|NCT02655016|HRD positive|hrd positive
101546|NCT02655016|PRIMA|prima
101547|NCT02655016|PRIMA Clinical Trial|prima clinical trial
101548|NCT02655016|PRIMA Study|prima study
101549|NCT02655003|behavioral symptoms|behavioral symptoms
101550|NCT02655003|psychological symptoms|psychological symptoms
101551|NCT02655003|dementia|dementia
101552|NCT02655003|neuropsychiatric symptoms|neuropsychiatric symptoms
101553|NCT02654990|multiple myeloma|multiple myeloma
101554|NCT02654990|relapsed or relapsed/refractory|relapsed or relapsed/refractory
101555|NCT02654990|LBH589|lbh589
101556|NCT02654990|panobinostat|panobinostat
101557|NCT02654990|bortezomib|bortezomib
101558|NCT02654990|dexamethasone|dexamethasone
101559|NCT02654951|Stroke|stroke
101560|NCT02654951|Rehabilitation Robotics|rehabilitation robotics
101561|NCT02654951|Bimanual|bimanual
101562|NCT02654951|Compensatory movements|compensatory movements
101563|NCT02654951|Hemiplegia|hemiplegia
101564|NCT02654951|Kinematics|kinematics
101565|NCT02654951|Reaching|reaching
101566|NCT02654951|Trunk|trunk
101567|NCT02654938|prostate cancer|prostate cancer
101568|NCT02654938|adenovirus|adenovirus
101569|NCT02654938|TLR5|tlr5
101570|NCT02654938|immunotherapy|immunotherapy
101571|NCT02654912|malaria|malaria
101572|NCT02654912|elimination|elimination
101573|NCT02654912|surveillance and response|surveillance and response
101574|NCT02654912|dihydroartemisinin+piperaquine|dihydroartemisinin+piperaquine
101575|NCT02654899|Healthy subjects|healthy subjects
120632|NCT02541396|Bunion|bunion
101576|NCT02654899|Single Ascending Dose|single ascending dose
101577|NCT02654899|Hyperlipidemia|hyperlipidemia
101578|NCT02654899|Dyslipidemia|dyslipidemia
101579|NCT02654886|exercise|exercise
101580|NCT02654886|Pompe disease|pompe disease
101581|NCT02654886|Pompe|pompe
101582|NCT02654873|histopathology|histopathology
101583|NCT02654873|gallbladder|gallbladder
101584|NCT02654873|specimen|specimen
101585|NCT02654847|vasopressor|vasopressor
101586|NCT02654847|blood pressure|blood pressure
101587|NCT02654847|Cesarean section|cesarean section
101588|NCT02654847|spinal anesthesia|spinal anesthesia
101589|NCT02654821|Melanoma|melanoma
101590|NCT02654821|TCR|tcr
101591|NCT02654808|gynecology|gynecology
101592|NCT02654808|laparoscopy|laparoscopy
101593|NCT02654808|pneumoperitoneum|pneumoperitoneum
101594|NCT02654808|CO2 absorption|co2 absorption
101595|NCT02654756|Risk Assessment|risk assessment
101596|NCT02654704|Personalized Medicine|personalized medicine
101597|NCT02654704|Precision Medicine|precision medicine
101598|NCT02654691|Chemotherapy|chemotherapy
101603|NCT02654587|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
101605|NCT02654587|Immunotherapy|immunotherapy
101606|NCT02654587|Cancer vaccine|cancer vaccine
101607|NCT02654587|Metastasis|metastasis
640437|NCT00741663|ascites|ascites
101608|NCT02654574|Alzheimer's disease or related disorders|alzheimer's disease or related disorders
101609|NCT02654574|Functional autonomy level|functional autonomy level
101610|NCT02654574|Lawton Instrumental Activities of Daily Living|lawton instrumental activities of daily living
101611|NCT02654574|The Functional autonomy level|the functional autonomy level
101612|NCT02654561|Severe sepsis|severe sepsis
101613|NCT02654561|Disseminated intravascular coagulation|disseminated intravascular coagulation
101614|NCT02654561|Unfractionated heparin|unfractionated heparin
101615|NCT02654535|Systematic review and meta-analysis|systematic review and meta-analysis
101720|NCT02653898|Malaria|malaria
101616|NCT02654535|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
101617|NCT02654535|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
101618|NCT02654535|Clinical practice guidelines|clinical practice guidelines
101619|NCT02654535|Clinical trials|clinical trials
101620|NCT02654535|Tree Nuts|tree nuts
101622|NCT02654535|Body weight|body weight
101623|NCT02654535|Prospective cohort studies|prospective cohort studies
101624|NCT02654496|Gut Microbiota|gut microbiota
101625|NCT02654496|Weight Regain|weight regain
101626|NCT02654496|Gastric Bypass|gastric bypass
101627|NCT02654457|Immunohistochemical|immunohistochemical
101628|NCT02654457|Ki-67|ki-67
101629|NCT02654457|Breast cancer|breast cancer
101630|NCT02654457|IHC|ihc
101631|NCT02654444|Immunohistochemical (IHC)|immunohistochemical (ihc)
101632|NCT02654444|Her2/Neu|her2/neu
101633|NCT02654444|Breast cancer|breast cancer
101634|NCT02654431|Immunohistochemical (IHC)|immunohistochemical (ihc)
101635|NCT02654431|ER/PR|er/pr
101636|NCT02654431|Breast cancer|breast cancer
101637|NCT02654418|colonic polyps ≥20 mm,|colonic polyps ≥20 mm,
101638|NCT02654418|adenomas|adenomas
101639|NCT02654418|polyps|polyps
101640|NCT02654405|HDAC inhibitors|hdac inhibitors
101641|NCT02654405|Inflammation|inflammation
101642|NCT02654392|Omega-3|omega-3
101643|NCT02654392|Omega-6|omega-6
101644|NCT02654392|Exercise Performance|exercise performance
101645|NCT02654366|Syringe exchange|syringe exchange
101646|NCT02654366|HIV risk reduction|hiv risk reduction
101647|NCT02654366|Drug-free community support|drug-free community support
101648|NCT02654353|Persistent atrial fibrillation, catheter ablation, outcome|persistent atrial fibrillation, catheter ablation, outcome
101649|NCT02654327|Extracorporeal|extracorporeal
101650|NCT02654327|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
101651|NCT02654327|Protective Lung Ventilation|protective lung ventilation
101652|NCT02654327|Ventilator Induced Lung Injury|ventilator induced lung injury
101653|NCT02654327|Carbon Dioxide Removal|carbon dioxide removal
101654|NCT02654327|Lung|lung
101655|NCT02654327|Lung Injury|lung injury
101656|NCT02654314|prevention; delirium; in-patients; melatonin,|prevention; delirium; in-patients; melatonin,
101657|NCT02654301|Xylose|xylose
101658|NCT02654301|prediabetes|prediabetes
101659|NCT02654301|postprandial hyperglycemia|postprandial hyperglycemia
101660|NCT02654301|glucose|glucose
101661|NCT02654288|pancreatic cancer|pancreatic cancer
101662|NCT02654288|gemcitabine|gemcitabine
101663|NCT02654288|chemotherapy|chemotherapy
101664|NCT02654288|immunoglobulin G 4|immunoglobulin g 4
101665|NCT02654249|Hemorrhoids grade III and IV|hemorrhoids grade iii and iv
101666|NCT02654249|transanal hemorrhoidal dearterialization|transanal hemorrhoidal dearterialization
101667|NCT02654249|hemorroidectomy|hemorroidectomy
101668|NCT02654249|THD|thd
101669|NCT02654249|LigaSure|ligasure
101670|NCT02654223|Rhinitis / Rhinoconjunctivitis|rhinitis / rhinoconjunctivitis
101671|NCT02654223|Vaccine|vaccine
101672|NCT02654223|Immunotherapy|immunotherapy
101673|NCT02654223|Grass pollen|grass pollen
101674|NCT02654223|Allergy|allergy
101675|NCT02654210|birth cohort|birth cohort
101676|NCT02654210|infectious diseases|infectious diseases
101677|NCT02654210|microbiome|microbiome
101678|NCT02654210|immune system|immune system
101679|NCT02654210|immune response|immune response
101680|NCT02654184|Right lateral|right lateral
101681|NCT02654184|Induction|induction
101682|NCT02654184|Children|children
101683|NCT02654184|Anesthesia|anesthesia
101684|NCT02654171|RSV|rsv
101685|NCT02654171|AK0529|ak0529
101686|NCT02654158|acute upper respiratory infection|acute upper respiratory infection
101687|NCT02654145|mepolizumab|mepolizumab
101688|NCT02654145|Omalizumab|omalizumab
101689|NCT02654145|SGRQ|sgrq
101690|NCT02654145|severe eosinophilic asthma|severe eosinophilic asthma
101691|NCT02654145|ACQ|acq
101692|NCT02654145|exacerbations|exacerbations
101693|NCT02654106|multiple brain metastases|multiple brain metastases
101694|NCT02654106|large brain metastases|large brain metastases
101695|NCT02654106|meningeal metastases|meningeal metastases
101696|NCT02654106|fractionated stereotactic radiotherapy|fractionated stereotactic radiotherapy
101697|NCT02654106|temozolomide|temozolomide
101698|NCT02654054|Elagolix + E2/NETA|elagolix + e2/neta
101699|NCT02654054|Menorrhagia|menorrhagia
101701|NCT02654054|Elagolix + Norethindrone Acetate|elagolix + norethindrone acetate
101702|NCT02654054|ABT-620|abt-620
101703|NCT02654054|Heavy Menstrual Bleeding|heavy menstrual bleeding
101704|NCT02654054|Heavy Uterine Bleeding|heavy uterine bleeding
101705|NCT02654054|Elagolix Sodium|elagolix sodium
101706|NCT02654054|Leiomyomata|leiomyomata
101707|NCT02654054|Elagolix|elagolix
101708|NCT02654015|intracranial hemorrhage|intracranial hemorrhage
101709|NCT02654015|neurosurgery|neurosurgery
101710|NCT02653963|Steroid, Triamcinolone, Ahmed Glaucoma valve|steroid, triamcinolone, ahmed glaucoma valve
101711|NCT02653937|IBS|ibs
101712|NCT02653937|MUPS|mups
101713|NCT02653937|FSS|fss
101714|NCT02653937|shigyakusan|shigyakusan
101715|NCT02653937|Katsumi's points|katsumi's points
101716|NCT02653937|Nakatani's N line|nakatani's n line
101717|NCT02653924|Suture|suture
101721|NCT02653898|Antimalarials|antimalarials
101722|NCT02653898|Malaria Elimination|malaria elimination
101723|NCT02653898|Mass Drug Administration|mass drug administration
101724|NCT02653898|Malaria Prophylaxis|malaria prophylaxis
101725|NCT02653898|Mobile population|mobile population
101726|NCT02653898|Drug resistance|drug resistance
101727|NCT02653898|Focused screening and treatment|focused screening and treatment
101728|NCT02653898|Monthly Malaria Prophylaxis|monthly malaria prophylaxis
101729|NCT02653898|Mass screening and treatment|mass screening and treatment
101730|NCT02653898|Primaquine|primaquine
101731|NCT02653898|Malaria transmission|malaria transmission
101732|NCT02653898|Permethrin insecticide|permethrin insecticide
101733|NCT02653898|Thai-Cambodian border|thai-cambodian border
101734|NCT02653898|Cambodia|cambodia
101735|NCT02653898|AFRIMS|afrims
101736|NCT02653885|cardiac surgery|cardiac surgery
101737|NCT02653885|open heart surgery|open heart surgery
101738|NCT02653885|hemogram|hemogram
101739|NCT02653872|Non-randomized|non-randomized
101740|NCT02653872|Verapamil|verapamil
101741|NCT02653872|Itraconazole|itraconazole
101742|NCT02653872|Diltiazem|diltiazem
101743|NCT02653872|Safety|safety
101744|NCT02653872|Tolerability|tolerability
101745|NCT02653872|Pharmacokinetics|pharmacokinetics
101746|NCT02653859|CTC|ctc
101747|NCT02653859|PCR|pcr
101748|NCT02653833|Becker|becker
101749|NCT02653833|Muscular Dystrophy|muscular dystrophy
101750|NCT02653833|Skeletal Muscle|skeletal muscle
101751|NCT02653833|blood flow|blood flow
101752|NCT02653833|Ultrasound|ultrasound
101753|NCT02653807|manual therapy|manual therapy
101754|NCT02653807|osteopathy|osteopathy
101755|NCT02653807|mobilization with movement|mobilization with movement
101756|NCT02653807|ankle|ankle
101757|NCT02653807|stiffness|stiffness
101758|NCT02653794|Juvenile Subjects'characteristics|juvenile subjects'characteristics
101759|NCT02653768|Osteoarthritis, Knee|osteoarthritis, knee
101760|NCT02653768|Exercise|exercise
101761|NCT02653755|Breast Cancer Radiation|breast cancer radiation
101762|NCT02653755|Radiotherapy for Favorable-Risk Breast cancer|radiotherapy for favorable-risk breast cancer
101763|NCT02653755|Radiotherapy Omission|radiotherapy omission
101764|NCT02653729|cognitive behaviour therapy|cognitive behaviour therapy
101765|NCT02653729|first episode|first episode
101766|NCT02653716|New Orleans Intervention Model|new orleans intervention model
101767|NCT02653716|Case Management|case management
101768|NCT02653716|Maltreatment|maltreatment
101769|NCT02653716|Child|child
101770|NCT02653664|Chronic Pain|chronic pain
101771|NCT02653664|Sleep|sleep
101772|NCT02653651|Ketamine|ketamine
101773|NCT02653651|Lidocaine|lidocaine
101774|NCT02653651|Nephrectomy|nephrectomy
101775|NCT02653651|Chronic pain|chronic pain
101776|NCT02653638|Cerebral Vasodilator Function|cerebral vasodilator function
101777|NCT02653638|White Matter Hyperintensity Volume|white matter hyperintensity volume
101778|NCT02653638|Default Mode Network Connectivity|default mode network connectivity
101779|NCT02653638|Cognitive Function|cognitive function
101780|NCT02653638|Cardiorespiratory Fitness|cardiorespiratory fitness
101781|NCT02653638|Aging|aging
101782|NCT02653625|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
101783|NCT02653612|surgery|surgery
101784|NCT02653612|folate receptor|folate receptor
101785|NCT02653586|resilience|resilience
101786|NCT02653586|prevention program|prevention program
101787|NCT02653586|body image|body image
101788|NCT02653586|self esteem|self esteem
101789|NCT02653573|young adult|young adult
101790|NCT02653560|Potassium|potassium
101791|NCT02653560|Magnesium|magnesium
101792|NCT02653560|Citrate|citrate
101793|NCT02653560|DASH|dash
101794|NCT02653547|tinnitus|tinnitus
101795|NCT02653547|transcranial random noise stimulation|transcranial random noise stimulation
101796|NCT02653547|rTMS|rtms
101797|NCT02653547|multisite stimulation|multisite stimulation
101798|NCT02653547|non-invasive brain stimulation|non-invasive brain stimulation
101799|NCT02653534|Kangaroo Mother Care in community|kangaroo mother care in community
101800|NCT02653534|mortality|mortality
101801|NCT02653521|Esophageal Cancer|esophageal cancer
101802|NCT02653521|Adaptive Radiation Therapy|adaptive radiation therapy
101803|NCT02653508|BMI: Body Mass Index|bmi: body mass index
101804|NCT02653508|obesity|obesity
101805|NCT02653508|adolescents|adolescents
101806|NCT02653508|overweight|overweight
101807|NCT02653508|CI:confidence interval|ci:confidence interval
101808|NCT02653508|CDC: Center Disease Control|cdc: center disease control
101809|NCT02653482|diabetes|diabetes
101810|NCT02653482|heart failure|heart failure
101811|NCT02653482|dapagliflozin|dapagliflozin
101812|NCT02653482|SGLT-2 inhibitors|sglt-2 inhibitors
101813|NCT02653456|excimer laser|excimer laser
101814|NCT02653456|percutaneous catheter|percutaneous catheter
101815|NCT02653456|photoablation|photoablation
101816|NCT02653456|chronic total occlusion|chronic total occlusion
101817|NCT02653456|symptomatic infrainguinal lower extremity vascular disease|symptomatic infrainguinal lower extremity vascular disease
101818|NCT02653443|INTERCEPT|intercept
101819|NCT02653443|Platelet|platelet
101820|NCT02653443|Pathogen Inactivation|pathogen inactivation
101821|NCT02653443|Platelets Components Stored|platelets components stored
101822|NCT02653443|Therapeutic Efficacy|therapeutic efficacy
101823|NCT02653430|obesity|obesity
101824|NCT02653430|BMI|bmi
101825|NCT02653430|efficacy|efficacy
101826|NCT02653430|bariatric surgery|bariatric surgery
101827|NCT02653430|gut flora|gut flora
101828|NCT02653430|fMRI|fmri
101829|NCT02653391|Fuchs' Corneal Endothelial Dystrophy|fuchs' corneal endothelial dystrophy
101830|NCT02653391|FCED|fced
101831|NCT02653391|Ocuvia™|ocuvia™
101832|NCT02653391|MTP-131|mtp-131
101833|NCT02653352|randomized controlled trials|randomized controlled trials
101834|NCT02653352|soft drinks|soft drinks
101835|NCT02653352|hypercholesterolemia|hypercholesterolemia
101836|NCT02653352|serum cholesterol|serum cholesterol
101837|NCT02653352|blood glucose|blood glucose
101838|NCT02653352|overweight|overweight
101839|NCT02653352|carbonated beverages|carbonated beverages
101840|NCT02653339|traditional Chinese medicine|traditional chinese medicine
101841|NCT02653339|Loratadine|loratadine
101842|NCT02653339|questionnaire survey|questionnaire survey
101843|NCT02653326|Tertiary Prevention|tertiary prevention
101844|NCT02653326|Telerehabilitation|telerehabilitation
101845|NCT02653287|Fatigue, Physical Activity, Lupus|fatigue, physical activity, lupus
101846|NCT02653274|MRI|mri
101847|NCT02653274|blood glucose|blood glucose
101848|NCT02653274|satiety|satiety
101849|NCT02653274|breakfast|breakfast
101850|NCT02653274|porridge|porridge
101851|NCT02653274|grains|grains
101852|NCT02653261|tranexamic acid|tranexamic acid
101853|NCT02653261|Transurethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
101854|NCT02653261|Transurethral Resection of a Bladder Tumor (TURBT)|transurethral resection of a bladder tumor (turbt)
101855|NCT02653261|Hemorrhage|hemorrhage
101856|NCT02653261|Blood Transfusion|blood transfusion
101857|NCT02653222|Ethanol Sympathicolysis|ethanol sympathicolysis
101858|NCT02653222|Computer Tomography guidance|computer tomography guidance
101859|NCT02653222|Denervation|denervation
101860|NCT02653222|Kidney Transplantation|kidney transplantation
101861|NCT02653222|Dialysis|dialysis
101862|NCT02653209|Type 2 diabetes|type 2 diabetes
101863|NCT02653209|Stratification|stratification
101864|NCT02653209|Biomarkers|biomarkers
101865|NCT02653209|Pharmacogenetics|pharmacogenetics
101866|NCT02653209|SGLT2 inhibitors|sglt2 inhibitors
101867|NCT02653209|Thiazolidinediones|thiazolidinediones
101868|NCT02653209|DPP4 inhibitors|dpp4 inhibitors
101869|NCT02653170|acute stroke|acute stroke
101870|NCT02653170|care transitions|care transitions
101871|NCT02653170|patient engagement|patient engagement
101872|NCT02653170|patient education|patient education
101873|NCT02653170|caregivers|caregivers
101874|NCT02653170|social workers|social workers
101875|NCT02653157|multidrug resistance|multidrug resistance
101876|NCT02653157|burns|burns
101877|NCT02653157|infections, gram-negative bacilli|infections, gram-negative bacilli
101878|NCT02653157|ventilator-associated pneumonia|ventilator-associated pneumonia
101879|NCT02653157|ventilator-associated tracheobronchitis|ventilator-associated tracheobronchitis
101880|NCT02653157|gram-negative bacilli colonization|gram-negative bacilli colonization
101881|NCT02653144|post operative pain, Dexmedetomidine, Regional anesthesia|post operative pain, dexmedetomidine, regional anesthesia
101882|NCT02653131|Short bowel syndrome|short bowel syndrome
101883|NCT02653105|High risk of cancer, BRCA1 or 2 mutation, Olfactomedine 4|high risk of cancer, brca1 or 2 mutation, olfactomedine 4
101884|NCT02653066|recruitment|recruitment
101885|NCT02653040|Lighting|lighting
101886|NCT02653040|Inpatients|inpatients
101887|NCT02653040|Recovery|recovery
101888|NCT02653040|Sleep|sleep
101889|NCT02653027|Genetics|genetics
101890|NCT02652988|tDCS|tdcs
101891|NCT02652988|chronic pain|chronic pain
101892|NCT02652988|fibromyalgia|fibromyalgia
101893|NCT02652923|ultrasound contrast agent|ultrasound contrast agent
101894|NCT02652923|lymphosonography|lymphosonography
101895|NCT02652923|breast cancer|breast cancer
101896|NCT02652897|bleeding|bleeding
101897|NCT02652897|clotting tests|clotting tests
101898|NCT02652897|neurosurgery|neurosurgery
101899|NCT02652897|clotting time|clotting time
101900|NCT02652897|maximum clot firmness|maximum clot firmness
101901|NCT02652897|kinetics|kinetics
101903|NCT02652897|primary hemostasis|primary hemostasis
101904|NCT02652897|platelet dysfunction|platelet dysfunction
101905|NCT02652897|coagulation|coagulation
101906|NCT02652884|transient hypoparathyroidism|transient hypoparathyroidism
101907|NCT02652884|steroids|steroids
101908|NCT02652884|total thyroidectomy|total thyroidectomy
101909|NCT02652871|Leukemia|leukemia
101910|NCT02652871|Acute Myeloid Leukemia|acute myeloid leukemia
101911|NCT02652871|AML|aml
101912|NCT02652871|Relapsed or Refractory|relapsed or refractory
101913|NCT02652871|Acute myelogenous leukemia|acute myelogenous leukemia
101914|NCT02652871|LY2510924|ly2510924
101915|NCT02652871|Idarubicin|idarubicin
101916|NCT02652871|Idamycin|idamycin
101917|NCT02652871|Cytarabine|cytarabine
101918|NCT02652871|Ara-C|ara-c
101919|NCT02652871|Cytosar|cytosar
101920|NCT02652871|DepoCyt|depocyt
101921|NCT02652871|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
101922|NCT02652819|Chronic Kidney Disease|chronic kidney disease
101923|NCT02652806|Chronic Kidney Disease|chronic kidney disease
101924|NCT02652780|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
101925|NCT02652780|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
101926|NCT02652780|Heredity Optic Atrophy|heredity optic atrophy
101927|NCT02652780|Eye Diseases|eye diseases
101928|NCT02652780|Hereditary Eye Diseases|hereditary eye diseases
101929|NCT02652780|Inborn Genetic Disease|inborn genetic disease
101930|NCT02652780|Genetic Therapy|genetic therapy
101931|NCT02652780|Intravitreal Injections|intravitreal injections
101932|NCT02652780|Mitochondrial Disease|mitochondrial disease
101933|NCT02652780|AAV2 Vectors|aav2 vectors
101934|NCT02652780|Nervous System Diseases|nervous system diseases
101935|NCT02652780|Neurodegenerative Disease|neurodegenerative disease
101936|NCT02652780|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
101937|NCT02652767|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
101938|NCT02652767|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
101939|NCT02652767|Heredity Optic Atrophy|heredity optic atrophy
101940|NCT02652767|Eye Diseases|eye diseases
101941|NCT02652767|Hereditary Eye Diseases|hereditary eye diseases
101942|NCT02652767|Inborn Genetic Disease|inborn genetic disease
101943|NCT02652767|Genetic Therapy|genetic therapy
101944|NCT02652767|Intravitreal Injections|intravitreal injections
101945|NCT02652767|Mitochondrial Disease|mitochondrial disease
101946|NCT02652767|AAV2 Vectors|aav2 vectors
101947|NCT02652767|Nervous System Diseases|nervous system diseases
101948|NCT02652767|Neurodegenerative Disease|neurodegenerative disease
101949|NCT02652767|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
101950|NCT02652754|Granexin|granexin
101951|NCT02652754|diabetic foot ulcers|diabetic foot ulcers
101952|NCT02652754|pharmacokinetic study|pharmacokinetic study
101953|NCT02652754|FirstString Research|firststring research
101954|NCT02652702|circular stapler-assisted colostomy|circular stapler-assisted colostomy
101955|NCT02652689|pulmonary embolism|pulmonary embolism
101956|NCT02652689|pulmonary disease|pulmonary disease
101957|NCT02652689|Lung Doppler signals|lung doppler signals
101958|NCT02652676|Infant Cardiac Transplantation|infant cardiac transplantation
101959|NCT02652676|End-stage Idiopathic Dilated Cardiomyopathy|end-stage idiopathic dilated cardiomyopathy
101960|NCT02652676|Mechanical Circulatory Device|mechanical circulatory device
101961|NCT02652676|End Stage Dilated Left Ventriculopathy|end stage dilated left ventriculopathy
101962|NCT02652676|Acute-on-Chronic Left Ventricular Failure|acute-on-chronic left ventricular failure
101963|NCT02652663|colorectal cancer|colorectal cancer
101964|NCT02652663|liver|liver
101965|NCT02652663|MRI|mri
101966|NCT02652663|contrast|contrast
101967|NCT02652663|gadoxetic acid|gadoxetic acid
101968|NCT02652650|Healthy|healthy
101969|NCT02652650|JNJ-63623872|jnj-63623872
101970|NCT02652650|Ethinylestradiol|ethinylestradiol
101971|NCT02652650|Norethindrone|norethindrone
101972|NCT02652611|Screw Removal vs. Non-screw removal|screw removal vs. non-screw removal
101973|NCT02652611|Complications|complications
101974|NCT02652611|SI Screw Stabilization|si screw stabilization
101975|NCT02652585|Alcoholism|alcoholism
101976|NCT02652585|alcohol self-administration|alcohol self-administration
101977|NCT02652572|Granexin|granexin
101978|NCT02652572|venous leg ulcer|venous leg ulcer
101979|NCT02652572|pharmacokinetic study|pharmacokinetic study
101980|NCT02652572|FirstString Research|firststring research
101981|NCT02652559|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
101982|NCT02652559|Non-invasive ventilation|non-invasive ventilation
101983|NCT02652559|Home initiation|home initiation
101984|NCT02652546|HIV/AIDS|hiv/aids
101985|NCT02652546|Immune Activation|immune activation
101986|NCT02652546|Anti-Inflammatory|anti-inflammatory
101987|NCT02652546|TNF|tnf
101988|NCT02652546|Phosphodieterase Inhibitor|phosphodieterase inhibitor
101989|NCT02652520|Kidney transplantation|kidney transplantation
101990|NCT02652520|Organ preservation|organ preservation
101991|NCT02652507|Sedation|sedation
101992|NCT02652507|MRI|mri
101993|NCT02652507|Dexmedetomidine|dexmedetomidine
101994|NCT02652507|Ketamine|ketamine
101995|NCT02652507|General anesthesia|general anesthesia
101996|NCT02652507|MRI of Brain|mri of brain
101997|NCT02652507|MRI of Brain/Spine|mri of brain/spine
101998|NCT02652494|Psoriasis|psoriasis
101999|NCT02652494|Observational|observational
102000|NCT02652494|Apremilast|apremilast
102001|NCT02652494|APRIL|april
102002|NCT02652494|Non-Interventional|non-interventional
102003|NCT02652494|The Netherlands|the netherlands
102004|NCT02652455|cutaneous|cutaneous
102005|NCT02652455|unresectable|unresectable
102006|NCT02652455|mucosal metastatic stage III/IV melanoma|mucosal metastatic stage iii/iv melanoma
102007|NCT02652455|ocular metastatic stage III/IV melanoma|ocular metastatic stage iii/iv melanoma
102008|NCT02652442|dizziness|dizziness
102009|NCT02652442|postural balance|postural balance
102010|NCT02652442|rehabilitation|rehabilitation
102011|NCT02652429|PAH|pah
102012|NCT02652429|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
102013|NCT02652429|Inhaled Nitric Oxide|inhaled nitric oxide
102014|NCT02652429|iNO|ino
102015|NCT02652403|Denture, Complete|denture, complete
102016|NCT02652403|Mouth, Edentulous|mouth, edentulous
102017|NCT02652351|Stem cell|stem cell
102018|NCT02652351|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
102019|NCT02652351|Mesenchymal Stem Cell|mesenchymal stem cell
102020|NCT02652351|Hepatic Cirrhosis|hepatic cirrhosis
102021|NCT02652338|heart rhythm disturbances and symptoms|heart rhythm disturbances and symptoms
102022|NCT02652338|dietary supplement|dietary supplement
102023|NCT02652312|Dexmedetomidine|dexmedetomidine
102024|NCT02652312|Desflurane|desflurane
102025|NCT02652312|Bispectral Index BIS|bispectral index bis
102026|NCT02652299|Fibrocytes|fibrocytes
102027|NCT02652299|Synovial biopsy|synovial biopsy
102028|NCT02652286|VATS|vats
102029|NCT02652286|Energy sealing|energy sealing
102030|NCT02652247|trauma|trauma
102031|NCT02652247|ventilator|ventilator
102032|NCT02652247|surgical ICU|surgical icu
102033|NCT02652208|decision making|decision making
102034|NCT02652208|decision aids|decision aids
102035|NCT02652208|shared decision making|shared decision making
102036|NCT02652208|stable angina|stable angina
102037|NCT02652208|cardiology|cardiology
102038|NCT02652195|Neural correlates|neural correlates
102039|NCT02652195|oxytocin administration|oxytocin administration
102040|NCT02652156|transversus abdominis plane|transversus abdominis plane
102041|NCT02652156|postoperative|postoperative
102042|NCT02652156|pain|pain
102043|NCT02652143|in vivo culture|in vivo culture
102044|NCT02652130|GVHD, Graft versus Host Disease|gvhd, graft versus host disease
102045|NCT02652104|Advanced|advanced
102046|NCT02652104|Deep brain stimulation|deep brain stimulation
102047|NCT02652091|Adherence|adherence
102048|NCT02652091|Persistence|persistence
102049|NCT02652091|Patient satisfaction|patient satisfaction
102050|NCT02652065|Psoriasis|psoriasis
102051|NCT02652065|Microcirculation|microcirculation
102052|NCT02652065|TRPV1|trpv1
102053|NCT02652026|dental root planing and scaling|dental root planing and scaling
102054|NCT02652026|periodontal disease|periodontal disease
102055|NCT02652026|type 2 diabetes mellitus|type 2 diabetes mellitus
102056|NCT02652026|glycosylated hemoglobin A|glycosylated hemoglobin a
102057|NCT02651974|neoplasm|neoplasm
102058|NCT02651974|colorectal|colorectal
102059|NCT02651974|cancer|cancer
102060|NCT02651974|uninsured|uninsured
102061|NCT02651974|FIT|fit
102062|NCT02651974|fecal immunochemical test|fecal immunochemical test
102063|NCT02651961|Total hip prosthesis|total hip prosthesis
102064|NCT02651961|Total knee prosthesis|total knee prosthesis
102065|NCT02651961|Chronic infection|chronic infection
93219|NCT02705508|nasal type|nasal type
93220|NCT02705508|chemotherapy|chemotherapy
93221|NCT02705508|radiotherapy|radiotherapy
102066|NCT02651961|One stage exchange|one stage exchange
102067|NCT02651961|Two stage exchange|two stage exchange
102068|NCT02651961|Cost-effectiveness|cost-effectiveness
102069|NCT02651935|Respiration, Artificial|respiration, artificial
102070|NCT02651935|weaning|weaning
102071|NCT02651935|critical care|critical care
102072|NCT02651922|Nervous restlessness|nervous restlessness
102073|NCT02651922|Pascoflair|pascoflair
102074|NCT02651922|Passiflora incarnata|passiflora incarnata
102075|NCT02651922|Benzodiazepine|benzodiazepine
102076|NCT02651883|Cervical cancer screening|cervical cancer screening
102077|NCT02651883|HPV testing|hpv testing
102078|NCT02651883|Self-collection|self-collection
102079|NCT02651870|Hypertension|hypertension
102080|NCT02651844|Progesterone receptor isoforms|progesterone receptor isoforms
102081|NCT02651844|Antiprogestins|antiprogestins
102082|NCT02651844|Mifepristone|mifepristone
102083|NCT02651844|Neoadjuvant|neoadjuvant
102084|NCT02651844|Breast cancer|breast cancer
102086|NCT02651831|Immune checkpoint modulators|immune checkpoint modulators
102087|NCT02651818|Goiter|goiter
102088|NCT02651818|Thyroid disease|thyroid disease
102089|NCT02651818|Struma|struma
102090|NCT02651805|Palliative Care|palliative care
102091|NCT02651805|Respiratory Secretion|respiratory secretion
102092|NCT02651792|ketamine|ketamine
102093|NCT02651792|propofol|propofol
102094|NCT02651792|pethidine|pethidine
102095|NCT02651792|ERCP|ercp
102096|NCT02651792|endoscopist|endoscopist
102097|NCT02651740|Rifaximin|rifaximin
102098|NCT02651740|Fecal microbiota transplantation|fecal microbiota transplantation
102099|NCT02651740|Gut microbiota|gut microbiota
102100|NCT02651610|PPHM 1401|pphm 1401
102101|NCT02651610|bavituximab|bavituximab
102102|NCT02651610|Peregrine|peregrine
102103|NCT02651610|Breast Cancer|breast cancer
102104|NCT02651610|HER-2 Negative|her-2 negative
102105|NCT02651610|HER2 Negative|her2 negative
102106|NCT02651597|Oatmeal|oatmeal
102107|NCT02651597|Beta glucan|beta glucan
102108|NCT02651597|Postprandial Glycemic Response|postprandial glycemic response
102109|NCT02651597|Blood Glucose|blood glucose
102110|NCT02651571|Knee|knee
102111|NCT02651571|Replacement|replacement
102112|NCT02651571|Prosthesis|prosthesis
102113|NCT02651571|Mobile-bearing|mobile-bearing
102114|NCT02651532|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
102115|NCT02651532|inflammation|inflammation
102116|NCT02651532|Irritable Bowel Syndrome|irritable bowel syndrome
102117|NCT02651519|bispectral index|bispectral index
102118|NCT02651519|regional cerebral oxygen saturation|regional cerebral oxygen saturation
102119|NCT02651519|Stellate-ganglion block|stellate-ganglion block
102120|NCT02651506|Lung cancer biopsy|lung cancer biopsy
102121|NCT02651506|Electromagnetic Navigation Bronchoscopy|electromagnetic navigation bronchoscopy
102122|NCT02651506|Transthoracic Needle Biopsy|transthoracic needle biopsy
102123|NCT02651480|Diet, Vegetarian|diet, vegetarian
102124|NCT02651480|Diet, Fat-Restricted|diet, fat-restricted
102125|NCT02651480|Quality of Life|quality of life
102126|NCT02651480|Glycemic Index|glycemic index
102127|NCT02651454|metabolic syndrome|metabolic syndrome
102128|NCT02651454|Daesiho-tang|daesiho-tang
102129|NCT02651454|Taeeumjowi-tang|taeeumjowi-tang
102130|NCT02651454|Korean medicine|korean medicine
102131|NCT02651441|D-CIK|d-cik
102132|NCT02651441|lung cancer|lung cancer
102133|NCT02651428|Kidney Failure, Chronic|kidney failure, chronic
102134|NCT02651428|Catheter-Related Infections|catheter-related infections
102135|NCT02651428|Central Venous Catheter|central venous catheter
102136|NCT02651415|Metastatic colorectal cancer|metastatic colorectal cancer
102137|NCT02651415|Metastatic colorectal carcinoma|metastatic colorectal carcinoma
102138|NCT02651415|mCRC|mcrc
102139|NCT02651415|Regorafenib|regorafenib
102140|NCT02651415|Stivarga|stivarga
102141|NCT02651415|Perindopril|perindopril
102142|NCT02651415|Perindopril erbumine|perindopril erbumine
102143|NCT02651415|Coversyl|coversyl
102144|NCT02651402|Anxiety Disorders|anxiety disorders
102145|NCT02651402|Internalizing|internalizing
102146|NCT02651402|Anxiety|anxiety
102147|NCT02651389|Digital Orthoptic Platform|digital orthoptic platform
102148|NCT02651389|Vision test|vision test
102149|NCT02651376|Immunodeficiency|immunodeficiency
102150|NCT02651376|Allogenic Mononuclear Cell Transplantation|allogenic mononuclear cell transplantation
102151|NCT02651350|Drug-induced Liver Injury|drug-induced liver injury
102152|NCT02651350|Recurrence|recurrence
102153|NCT02651350|Methylprednisolone|methylprednisolone
102154|NCT02651285|G-CSF|g-csf
102155|NCT02651285|BLASTOCYST|blastocyst
102156|NCT02651285|IVF|ivf
102157|NCT02651272|Pulmonary Hypertension|pulmonary hypertension
102158|NCT02651272|Sickle Cell Disease|sickle cell disease
102159|NCT02651272|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
102160|NCT02651272|Macitentan|macitentan
121374|NCT02536599|Fever|fever
102161|NCT02651194|Treatment-naïve|treatment-naïve
102162|NCT02651194|HCV Gentoype 6|hcv gentoype 6
102163|NCT02651194|HCV Gentoype 1|hcv gentoype 1
102164|NCT02651194|Compensated cirrhotic|compensated cirrhotic
102165|NCT02651194|HCV Gentoype 2|hcv gentoype 2
102166|NCT02651194|Treatment-experienced|treatment-experienced
102167|NCT02651194|Non-cirrhotic|non-cirrhotic
102168|NCT02651194|Chronic Hepatitis C|chronic hepatitis c
102169|NCT02651194|HCV Gentoype 5|hcv gentoype 5
102170|NCT02651194|HCV Gentoype 3|hcv gentoype 3
102171|NCT02651194|HCV Gentoype 4|hcv gentoype 4
102172|NCT02651168|Diabetic Macular Edema|diabetic macular edema
102173|NCT02651168|Ocular Cytokines|ocular cytokines
102174|NCT02651168|aflibercept|aflibercept
102175|NCT02651168|ranibizumab|ranibizumab
102176|NCT02651155|Drug therapy|drug therapy
102177|NCT02651129|noise|noise
102178|NCT02651129|obstetric|obstetric
102179|NCT02651129|operating rooms|operating rooms
102180|NCT02651116|cough, acute cough, pediatric, Dextromethorphan Hydrobromide, antitussive, ambulatory cough recording device|cough, acute cough, pediatric, dextromethorphan hydrobromide, antitussive, ambulatory cough recording device
102181|NCT02651090|contraindication for CECT|contraindication for cect
102182|NCT02651090|contraindication for CEMRI|contraindication for cemri
102183|NCT02651090|liver pathology|liver pathology
102184|NCT02651090|renal failure|renal failure
102185|NCT02651090|contrast enhanced ultrasound|contrast enhanced ultrasound
102186|NCT02651090|sonazoid|sonazoid
102187|NCT02651077|Endometriosis, chemical contaminants, BFRs|endometriosis, chemical contaminants, bfrs
102188|NCT02651064|Supplemental Nutrition Assistance Program (SNAP)|supplemental nutrition assistance program (snap)
102189|NCT02651064|fruits and vegetables|fruits and vegetables
102190|NCT02651064|price incentive|price incentive
102191|NCT02651051|Postprandial glycemia|postprandial glycemia
102192|NCT02651051|Metabolic health measures|metabolic health measures
102193|NCT02651012|acne|acne
102194|NCT02651012|acne vulgaris|acne vulgaris
102195|NCT02651012|papule|papule
102196|NCT02651012|pustule|pustule
102197|NCT02651012|adolescent acne|adolescent acne
102198|NCT02650973|Bioequivalence|bioequivalence
102199|NCT02650947|Sucralose|sucralose
102200|NCT02650947|Insulin Secretion|insulin secretion
102201|NCT02650947|Insulin Sensitivity|insulin sensitivity
102202|NCT02650947|Incretin|incretin
102203|NCT02650947|Gut Microbiota|gut microbiota
102204|NCT02650947|Food and Eating Behaviour|food and eating behaviour
102205|NCT02650947|Healthy Volunteers|healthy volunteers
102206|NCT02650934|STEMI, Heart Failure, Inflammation, Haptoglobin Polymorphisms, Adverse Remodeling, Genetics, GWAS, MRI|stemi, heart failure, inflammation, haptoglobin polymorphisms, adverse remodeling, genetics, gwas, mri
102207|NCT02650908|Lesion|lesion
102208|NCT02650908|Meniscus|meniscus
102209|NCT02650908|Avivement|avivement
102210|NCT02650908|Suturing area|suturing area
102211|NCT02650882|Respiratory muscles|respiratory muscles
102212|NCT02650882|athletic performance|athletic performance
102213|NCT02650882|handball|handball
102214|NCT02650869|Necrotizing Enterocolitis|necrotizing enterocolitis
102215|NCT02650869|probiotics|probiotics
102216|NCT02650869|very low birth weight|very low birth weight
102217|NCT02650856|Blood loss|blood loss
102218|NCT02650856|Tranexamic acid|tranexamic acid
102219|NCT02650856|Platelet rich plasma|platelet rich plasma
102220|NCT02650856|Total knee arthroplasty|total knee arthroplasty
102221|NCT02650843|Parkinsonism|parkinsonism
102222|NCT02650843|DAT Dopamine transporter|dat dopamine transporter
102223|NCT02650843|SPECT|spect
102224|NCT02650830|type 2 diabetes|type 2 diabetes
102225|NCT02650830|prediabetes|prediabetes
102226|NCT02650830|bile acids profile|bile acids profile
102228|NCT02650830|FGF-19|fgf-19
102229|NCT02650804|Cancer|cancer
102230|NCT02650804|Advanced Pancreatic Cancer|advanced pancreatic cancer
102231|NCT02650778|Breast Cancer|breast cancer
102232|NCT02650778|Automated whole breast ultrasound|automated whole breast ultrasound
102233|NCT02650778|BI-RADS category 3 lesions|bi-rads category 3 lesions
102234|NCT02650765|Brain injury|brain injury
102235|NCT02650765|Head injury|head injury
102236|NCT02650765|Computed tomography|computed tomography
102237|NCT02650765|Emergency department|emergency department
102238|NCT02650752|Lapatinib|lapatinib
102239|NCT02650752|Capecitabine|capecitabine
102240|NCT02650752|HER2|her2
102241|NCT02650752|15-278|15-278
102242|NCT02650687|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
102243|NCT02650687|Elderly, geriatric|elderly, geriatric
102244|NCT02650687|Anesthesia|anesthesia
102245|NCT02650687|Anesthetic depth|anesthetic depth
102246|NCT02650687|Bispectral index monitor|bispectral index monitor
102247|NCT02650687|Function|function
102248|NCT02650687|Recovery after surgery|recovery after surgery
102249|NCT02650687|Surgery|surgery
102250|NCT02650674|glycemic & insulin response|glycemic & insulin response
102251|NCT02650674|SDS|sds
102252|NCT02650674|cereal product|cereal product
102253|NCT02650674|Nutrition|nutrition
102254|NCT02650674|Carbohydrate|carbohydrate
102255|NCT02650674|Absorption|absorption
102256|NCT02650674|Intestine|intestine
102257|NCT02650661|Cancer survivors|cancer survivors
102258|NCT02650648|Humanized Anti-GD2 Antibody Hu3F8|humanized anti-gd2 antibody hu3f8
102259|NCT02650648|Allogeneic Natural Killer Cells|allogeneic natural killer cells
102260|NCT02650648|rIL-2|ril-2
102261|NCT02650648|15-272|15-272
102262|NCT02650622|Metabolism|metabolism
102263|NCT02650622|Genetics|genetics
102264|NCT02650622|Metabolomics|metabolomics
102265|NCT02650622|Genomics|genomics
102266|NCT02650609|chronic subdural hematomas|chronic subdural hematomas
102267|NCT02650609|surgical treatment|surgical treatment
102268|NCT02650609|corticosteroids|corticosteroids
102269|NCT02650570|Cancer|cancer
102270|NCT02650570|Cachexia|cachexia
102271|NCT02650557|coronary slow flow|coronary slow flow
102272|NCT02650557|P-wave dispersion|p-wave dispersion
102273|NCT02650544|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
102274|NCT02650544|Depression|depression
102275|NCT02650544|mirtazapine|mirtazapine
102276|NCT02650544|patients health questionnaire (PHQ-9)|patients health questionnaire (phq-9)
102277|NCT02650531|Follow up studies|follow up studies
102278|NCT02650531|Risk factors|risk factors
102279|NCT02650518|Catheter-Associated Urinary Tract Infections|catheter-associated urinary tract infections
102280|NCT02650518|Antimicrobial Stewardship|antimicrobial stewardship
102281|NCT02650518|Short-Course Antimicrobials|short-course antimicrobials
102282|NCT02650492|Hyperthermia, Induced|hyperthermia, induced
641939|NCT00739063|OSI-774|osi-774
102283|NCT02650492|Laser Coagulation|laser coagulation
102284|NCT02650492|Laser Therapy|laser therapy
102285|NCT02650453|Stent|stent
102286|NCT02650453|Angioplasty|angioplasty
102287|NCT02650453|Endophlebectomy|endophlebectomy
102288|NCT02650440|robotics|robotics
102289|NCT02650440|locomotion|locomotion
102290|NCT02650440|gait|gait
102291|NCT02650440|walking|walking
102292|NCT02650440|rehabilitation|rehabilitation
102293|NCT02650414|Biological: CART 22|biological: cart 22
102294|NCT02650401|TRK|trk
102295|NCT02650401|Tyrosine kinase|tyrosine kinase
102296|NCT02650401|NTRK|ntrk
102297|NCT02650401|NTRK1|ntrk1
102298|NCT02650401|NTRK2|ntrk2
102299|NCT02650401|NTRK3|ntrk3
102300|NCT02650401|ROS1|ros1
102301|NCT02650401|ALK|alk
102302|NCT02650401|Pediatric|pediatric
102303|NCT02650401|Relapsed|relapsed
102304|NCT02650401|Refractory|refractory
102305|NCT02650401|Solid Tumor|solid tumor
102306|NCT02650401|Metastatic Cancer|metastatic cancer
102307|NCT02650401|Gene rearrangement|gene rearrangement
102308|NCT02650401|Neuroblastoma|neuroblastoma
102309|NCT02650401|Infantile fibrosarcoma|infantile fibrosarcoma
102310|NCT02650401|Secretory breast cancer|secretory breast cancer
102411|NCT02649764|LY2606368|ly2606368
102311|NCT02650401|Congenital mesoblastic nephroma|congenital mesoblastic nephroma
102312|NCT02650401|Pontine glioma|pontine glioma
102313|NCT02650401|Brain tumors|brain tumors
102314|NCT02650401|CNS tumors|cns tumors
102315|NCT02650401|Sarcoma|sarcoma
102316|NCT02650401|Ewing sarcoma|ewing sarcoma
102317|NCT02650401|Glial tumors|glial tumors
102318|NCT02650401|Salivary Gland Cancer (MASC)|salivary gland cancer (masc)
102319|NCT02650401|Papillary thyroid cancer|papillary thyroid cancer
102320|NCT02650401|Medulloblastoma|medulloblastoma
102321|NCT02650401|Wilms tumor (anaplastic)|wilms tumor (anaplastic)
102322|NCT02650362|spinal cord stimulation|spinal cord stimulation
102323|NCT02650362|resting state functional magnetic resonance|resting state functional magnetic resonance
102324|NCT02650362|voxel-based magnetic resonance morphometry|voxel-based magnetic resonance morphometry
102325|NCT02650349|spinal cord stimulation|spinal cord stimulation
102326|NCT02650349|resting state functional magnetic resonance|resting state functional magnetic resonance
102328|NCT02650297|Lymphedema secondary to breast cancer|lymphedema secondary to breast cancer
102330|NCT02650297|Body image|body image
102331|NCT02650271|adjuvant|adjuvant
102332|NCT02650271|entecavir|entecavir
102333|NCT02650271|hepatocellular carcinoma|hepatocellular carcinoma
102334|NCT02650271|hepatic resection|hepatic resection
102335|NCT02650245|breath|breath
102336|NCT02650245|gastroenterology|gastroenterology
102337|NCT02650245|ammonia|ammonia
102338|NCT02650245|blood|blood
102339|NCT02650245|protein|protein
102340|NCT02650245|cirrhosis|cirrhosis
102341|NCT02650245|encephalopathy|encephalopathy
102342|NCT02650232|Volunteers|volunteers
102343|NCT02650206|diabetes|diabetes
102344|NCT02650206|macrophage|macrophage
102345|NCT02650206|inflammation|inflammation
102346|NCT02650206|adipose tissue|adipose tissue
102347|NCT02650206|weight loss|weight loss
102348|NCT02650206|liraglutide|liraglutide
102349|NCT02650193|HSP-130 Phase 1-2 Study in patients with Breast cancer|hsp-130 phase 1-2 study in patients with breast cancer
102350|NCT02650180|Rehabilitation|rehabilitation
102351|NCT02650154|sedation|sedation
102352|NCT02650154|children|children
102353|NCT02650154|infants|infants
102354|NCT02650154|ketamine|ketamine
102355|NCT02650154|neurotoxicity|neurotoxicity
102356|NCT02650128|Coronary Artery Disease|coronary artery disease
102357|NCT02650128|Calcified Coronary Lesions|calcified coronary lesions
121659|NCT02534246|EUS|eus
102358|NCT02650128|Coronary Arterial Stenosis|coronary arterial stenosis
102359|NCT02650089|Resistance Exercise|resistance exercise
102360|NCT02650089|Postexercise Hypotension|postexercise hypotension
102361|NCT02650089|Sympathovagal balance|sympathovagal balance
102362|NCT02650089|Professor|professor
102363|NCT02650011|Chronic liver disease|chronic liver disease
102364|NCT02650011|Liver cirrhosis|liver cirrhosis
102365|NCT02649998|Fursemide|fursemide
102366|NCT02649998|Isosorbide Dinitrate|isosorbide dinitrate
102367|NCT02649998|Heart Decompensation|heart decompensation
102368|NCT02649998|Clinical Trials, Randomized|clinical trials, randomized
102369|NCT02649998|Clinical Efficacy|clinical efficacy
102370|NCT02649972|Cobimetinib|cobimetinib
102371|NCT02649972|15-216|15-216
102372|NCT02649959|Autism|autism
102373|NCT02649933|pregnancy|pregnancy
102374|NCT02649933|obstructive sleep apnea|obstructive sleep apnea
102375|NCT02649920|unfavorable cervix|unfavorable cervix
102376|NCT02649920|obese pregnant women|obese pregnant women
102377|NCT02649894|malignant pleural effusion|malignant pleural effusion
102378|NCT02649881|macrophage|macrophage
102379|NCT02649881|vulnerable coronary plaque|vulnerable coronary plaque
102380|NCT02649868|Radio-Opaque Bland Beads|radio-opaque bland beads
102381|NCT02649868|Thermal Ablation|thermal ablation
102382|NCT02649868|Transarterial Embolization|transarterial embolization
102384|NCT02649855|Vaccine|vaccine
102385|NCT02649855|Immunotherapy|immunotherapy
102386|NCT02649855|Immune Response|immune response
102387|NCT02649855|Androgen Deprivation Therapy|androgen deprivation therapy
102388|NCT02649829|dendritic cell vaccination|dendritic cell vaccination
102389|NCT02649829|chemo-immunotherapy|chemo-immunotherapy
102390|NCT02649829|Wilms' tumor 1 (WT1)|wilms' tumor 1 (wt1)
102391|NCT02649816|Pit and fissure sealants|pit and fissure sealants
102392|NCT02649816|Dental Caries|dental caries
102393|NCT02649816|Prevention|prevention
102394|NCT02649816|Dental undergraduate students|dental undergraduate students
102395|NCT02649816|patient's caries risk|patient's caries risk
102396|NCT02649803|pediatric|pediatric
102397|NCT02649803|asthma control|asthma control
102398|NCT02649803|community|community
102399|NCT02649790|Multiple Myeloma|multiple myeloma
102400|NCT02649790|Karyopharm|karyopharm
102401|NCT02649790|KPT-8602|kpt-8602
102402|NCT02649790|MM|mm
102403|NCT02649790|Phase 1|phase 1
102404|NCT02649790|Relapsed/refractory Multiple Myeloma|relapsed/refractory multiple myeloma
102405|NCT02649777|oxidative stress|oxidative stress
102406|NCT02649764|Acute Myelogenous Leukemia|acute myelogenous leukemia
102407|NCT02649764|AML|aml
102408|NCT02649764|Relapsed/Refractory|relapsed/refractory
102409|NCT02649764|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
102410|NCT02649764|HRMDS|hrmds
102412|NCT02649764|Fludarabine|fludarabine
102413|NCT02649764|Fludarabine Phosphate|fludarabine phosphate
102414|NCT02649764|Fludara|fludara
102415|NCT02649764|Cytarabine|cytarabine
102416|NCT02649764|Ara-C|ara-c
102417|NCT02649764|Cytosar|cytosar
102418|NCT02649764|DepoCyt|depocyt
102419|NCT02649764|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
102420|NCT02649751|Cystic Fibrosis|cystic fibrosis
102421|NCT02649751|Roscovitine|roscovitine
102422|NCT02649751|Seliciclib|seliciclib
102423|NCT02649751|CYC202|cyc202
102424|NCT02649738|keratoconus|keratoconus
102425|NCT02649738|corneal tissue inlay|corneal tissue inlay
102426|NCT02649699|Primary Brain Cancer|primary brain cancer
102428|NCT02649673|topotecan|topotecan
102429|NCT02649673|Hycamtin|hycamtin
102430|NCT02649673|ovarian neoplasms|ovarian neoplasms
102431|NCT02649673|LCL161|lcl161
102432|NCT02649673|IAP inhibitors|iap inhibitors
102433|NCT02649660|Fabry Disease|fabry disease
102434|NCT02649660|Platelets|platelets
102435|NCT02649660|Lipidomics|lipidomics
102436|NCT02649660|Sphingolipids|sphingolipids
102437|NCT02649660|α-Galactosidase A|α-galactosidase a
102438|NCT02649660|Globotriaosylceramide|globotriaosylceramide
102439|NCT02649660|Gb3|gb3
102440|NCT02649660|GL-3|gl-3
102441|NCT02649660|CD77|cd77
102442|NCT02649660|Alpha-galactosidase|alpha-galactosidase
102443|NCT02649660|Platelet activation|platelet activation
102444|NCT02649660|Lysosomal storage disease|lysosomal storage disease
102445|NCT02649660|LysoGb3|lysogb3
102446|NCT02649660|Spingosine-1-Phosphate|spingosine-1-phosphate
102447|NCT02649660|Platelet function|platelet function
102448|NCT02649660|CD62P|cd62p
102449|NCT02649660|P-selectin|p-selectin
102450|NCT02649647|Rectal cancer|rectal cancer
102451|NCT02649647|Neoadjuvant therapy|neoadjuvant therapy
102452|NCT02649647|Chemoradiotherapy|chemoradiotherapy
102453|NCT02649647|Resection margin|resection margin
102454|NCT02649647|Bowel function|bowel function
102455|NCT02649647|Anastomosis|anastomosis
102456|NCT02649634|Motivational Interviewing|motivational interviewing
102457|NCT02649634|Obesity|obesity
102458|NCT02649634|Weight Loss|weight loss
102459|NCT02649634|Behavioral Medicine|behavioral medicine
102460|NCT02649621|Limbal Stem Cell Deficiency Amniotic Membrane Extract Eye Drop in vivo cultivation|limbal stem cell deficiency amniotic membrane extract eye drop in vivo cultivation
102461|NCT02649595|Homeless|homeless
102462|NCT02649595|Homelessness|homelessness
102463|NCT02649595|Respite care|respite care
102464|NCT02649595|EQ-5D|eq-5d
102465|NCT02649595|Quality of life questionnaire|quality of life questionnaire
102466|NCT02649595|Economic evaluation|economic evaluation
102467|NCT02649595|Cost-utility analysis|cost-utility analysis
102468|NCT02649582|Dendritic cells|dendritic cells
102469|NCT02649582|Chemoimmunotherapy|chemoimmunotherapy
102470|NCT02649582|Adjuvant therapy|adjuvant therapy
102471|NCT02649556|Candidate modified risk tobacco product|candidate modified risk tobacco product
102472|NCT02649556|Conventional cigarette|conventional cigarette
102473|NCT02649556|Exposure response|exposure response
102474|NCT02649556|Smoking|smoking
102475|NCT02649556|Tobacco Heating System|tobacco heating system
102476|NCT02649543|Surgical Wound Infection|surgical wound infection
102477|NCT02649543|Negative-Pressure Wound Therapy|negative-pressure wound therapy
102478|NCT02649543|Wound Closure Techniques|wound closure techniques
102479|NCT02649543|Laparotomy.|laparotomy.
102480|NCT02649543|Abdominal Wound Closure Techniques|abdominal wound closure techniques
102481|NCT02649517|decompensated heart failure|decompensated heart failure
102482|NCT02649517|ischemic heart disease|ischemic heart disease
102483|NCT02649517|inflammatory cardiomyopathy|inflammatory cardiomyopathy
102484|NCT02649491|Radiotherapy|radiotherapy
102485|NCT02649491|Chemotherapy|chemotherapy
102486|NCT02649491|Metabonomics|metabonomics
102487|NCT02649491|Electronic Sensing|electronic sensing
102488|NCT02649491|GI Toxicity|gi toxicity
102689|NCT02648321|Exercise|exercise
102489|NCT02649452|Whole body Vibration|whole body vibration
102490|NCT02649439|Vaccine|vaccine
102492|NCT02649439|Surveillance|surveillance
102493|NCT02649439|Immunotherapy|immunotherapy
102494|NCT02649426|denervation|denervation
102495|NCT02649426|resistant hypertension|resistant hypertension
102496|NCT02649426|essential hypertension|essential hypertension
102497|NCT02649361|Anlotinib|anlotinib
102498|NCT02649335|Non selective beta blockers|non selective beta blockers
102499|NCT02649335|Ascites|ascites
102500|NCT02649309|Ischemic Preconditioning|ischemic preconditioning
102501|NCT02649309|Postconditioning|postconditioning
102502|NCT02649309|Angioplasty|angioplasty
102503|NCT02649270|Tolerability|tolerability
102504|NCT02649270|Safety|safety
102505|NCT02649270|Pharmacokinetic Study|pharmacokinetic study
102506|NCT02649270|preliminary pharmacodynamic study|preliminary pharmacodynamic study
102507|NCT02649270|Humanized Anti-CD6 Monoclonal Antibody(T1h)|humanized anti-cd6 monoclonal antibody(t1h)
102508|NCT02649257|IOL rotation|iol rotation
102509|NCT02649257|capsular tension ring|capsular tension ring
102510|NCT02649257|IOL rotational stability|iol rotational stability
102511|NCT02649218|QGE031|qge031
102512|NCT02649218|chronic|chronic
102513|NCT02649218|spontaneous|spontaneous
102514|NCT02649218|Urticaria|urticaria
102515|NCT02649218|CSU|csu
102516|NCT02649218|adults|adults
102517|NCT02649218|Safety|safety
102518|NCT02649192|Children|children
102519|NCT02649192|Vitamin Supplements|vitamin supplements
102520|NCT02649192|Influenza virus vaccine|influenza virus vaccine
102521|NCT02649166|Essential tremor|essential tremor
102522|NCT02649166|Kinetic tremor|kinetic tremor
102523|NCT02649166|Intention tremor|intention tremor
102524|NCT02649140|24-hour urine|24-hour urine
102525|NCT02649140|Calcium oxalate|calcium oxalate
102526|NCT02649140|Vinegar|vinegar
102527|NCT02649127|exercise|exercise
102528|NCT02649127|biomarker|biomarker
102529|NCT02649088|microcirculation|microcirculation
102530|NCT02649088|tissue oxygenation|tissue oxygenation
102531|NCT02649088|outcome|outcome
102532|NCT02649075|IBD|ibd
102533|NCT02649075|Inflammatory Bowel Disease|inflammatory bowel disease
102534|NCT02649075|Crohn's|crohn's
102535|NCT02649075|Crohns|crohns
102536|NCT02649075|SBI|sbi
102537|NCT02649075|Serum-derived bovine immunoglobulin / protein isolate|serum-derived bovine immunoglobulin / protein isolate
102538|NCT02649075|EnteraGam|enteragam
102539|NCT02649010|Type 1 Diabetes|type 1 diabetes
102540|NCT02649010|Type 2 Diabetes|type 2 diabetes
102541|NCT02649010|Enlite 3 Sensor|enlite 3 sensor
102542|NCT02649010|Continuous Glucose Monitoring|continuous glucose monitoring
102543|NCT02648997|Atypical Meningioma|atypical meningioma
102544|NCT02648997|Anaplastic Meningioma|anaplastic meningioma
102545|NCT02648984|Pulmonary vascular disease|pulmonary vascular disease
102546|NCT02648971|knee|knee
102547|NCT02648971|arthroscopy|arthroscopy
102548|NCT02648971|portal|portal
102549|NCT02648971|meniscus|meniscus
102550|NCT02648971|cartilage injury|cartilage injury
102551|NCT02648932|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
102552|NCT02648932|High-Risk Myelodysplastic Syndrome (MDS)|high-risk myelodysplastic syndrome (mds)
102553|NCT02648932|hematopoietic cell transplantation|hematopoietic cell transplantation
102554|NCT02648932|haplo-cord search|haplo-cord search
102555|NCT02648932|matched unrelated donor search|matched unrelated donor search
102556|NCT02648893|iron|iron
102557|NCT02648893|zinc|zinc
102558|NCT02648893|vitamin A|vitamin a
102559|NCT02648893|biofortified|biofortified
102560|NCT02648893|efficacy|efficacy
102561|NCT02648893|India|india
102562|NCT02648893|infant|infant
102563|NCT02648893|trial|trial
102564|NCT02648880|Exercise|exercise
102565|NCT02648880|Physical Activity|physical activity
102566|NCT02648841|gastric cancer|gastric cancer
102567|NCT02648841|adjuvant chemo-radiotherapy|adjuvant chemo-radiotherapy
102568|NCT02648828|Judgment|judgment
102569|NCT02648828|risk assessment|risk assessment
102570|NCT02648828|clinical deterioration|clinical deterioration
102571|NCT02648828|cardiac arrest|cardiac arrest
102572|NCT02648828|Rothman Index|rothman index
102573|NCT02648815|Necrotizing pancreatitis|necrotizing pancreatitis
102574|NCT02648815|Sepsis|sepsis
102575|NCT02648815|Infection|infection
102576|NCT02648815|Drainage|drainage
102577|NCT02648802|breast-conserving surgery(BCS)|breast-conserving surgery(bcs)
102578|NCT02648802|Cavity shave margin|cavity shave margin
102579|NCT02648802|Proportion of positive margins|proportion of positive margins
102580|NCT02648789|Primary oral cancer|primary oral cancer
102581|NCT02648789|DNA methylation|dna methylation
102582|NCT02648789|Recurrence oral cancer|recurrence oral cancer
102583|NCT02648776|hypnotic agents|hypnotic agents
102603|NCT02648633|Radiosurgery|radiosurgery
102605|NCT02648620|Paclitaxel|paclitaxel
102606|NCT02648620|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
102607|NCT02648620|PAD|pad
102608|NCT02648620|Peripheral Artery Disease|peripheral artery disease
102609|NCT02648620|Pharmacokinetics|pharmacokinetics
102610|NCT02648607|Pelvic Girdle Pain|pelvic girdle pain
102611|NCT02648607|Chronic Pelvic Girdle Pain|chronic pelvic girdle pain
102612|NCT02648607|Symphysis Pubis Dysfunction|symphysis pubis dysfunction
102613|NCT02648607|Sacroiliac Joint Dysfunction|sacroiliac joint dysfunction
102614|NCT02648607|Physiotherapy|physiotherapy
102615|NCT02648607|Physical Therapy|physical therapy
102616|NCT02648607|Orthoses|orthoses
102617|NCT02648607|Orthosis|orthosis
102618|NCT02648607|Orthotic Devices|orthotic devices
102619|NCT02648594|lung|lung
102620|NCT02648594|thoracoscopy|thoracoscopy
102621|NCT02648594|hook wire localization|hook wire localization
102622|NCT02648581|Behçet|behçet
102623|NCT02648581|ulcers|ulcers
102624|NCT02648581|uveitis|uveitis
102625|NCT02648581|ustekinumab|ustekinumab
102626|NCT02648581|biologics|biologics
102627|NCT02648568|Sleepwalking|sleepwalking
102628|NCT02648568|sleep terrors|sleep terrors
102629|NCT02648568|arousal disorders|arousal disorders
102630|NCT02648568|F513 (CIM-10)|f513 (cim-10)
102631|NCT02648568|F514 (CIM-10)|f514 (cim-10)
102632|NCT02648529|Benign childhood epilepsy with centro-temporal spikes|benign childhood epilepsy with centro-temporal spikes
102633|NCT02648529|rolandic epilepsy|rolandic epilepsy
102634|NCT02648529|brain development|brain development
102635|NCT02648529|DTI|dti
102636|NCT02648529|functional MRI|functional mri
102637|NCT02648529|structural MRI|structural mri
102638|NCT02648529|idiopathic focal epilepsy|idiopathic focal epilepsy
102639|NCT02648529|cryptogenic epilepsy of childhood|cryptogenic epilepsy of childhood
102640|NCT02648516|Immune Reconstitution|immune reconstitution
102641|NCT02648516|Allogenic HLA-Mismatched Mononuclear Cells Transplantation|allogenic hla-mismatched mononuclear cells transplantation
102642|NCT02648503|Sugammadex|sugammadex
102643|NCT02648503|Post-operative Quality Recovery Scale (PQRS)|post-operative quality recovery scale (pqrs)
754069|NCT01178801|liver cancer|liver cancer
102647|NCT02648464|Myocardial infarction|myocardial infarction
102648|NCT02648464|cardiovascular diseases|cardiovascular diseases
102649|NCT02648438|AZD7594|azd7594
102650|NCT02648438|Bioavailability|bioavailability
102651|NCT02648438|Healthy male subjects|healthy male subjects
102652|NCT02648438|Safety|safety
102653|NCT02648438|Tolerability|tolerability
102654|NCT02648438|Pharmacokinetics|pharmacokinetics
102655|NCT02648438|Monodose inhaler|monodose inhaler
102656|NCT02648438|Multiple-dose dry powder inhaler|multiple-dose dry powder inhaler
102657|NCT02648425|ASLAN001|aslan001
102658|NCT02648399|thyroid carcinoma|thyroid carcinoma
102659|NCT02648399|center lymph node dissection|center lymph node dissection
102660|NCT02648360|exercise|exercise
102661|NCT02648360|diet|diet
102662|NCT02648360|patients, underserved|patients, underserved
102663|NCT02648360|text messaging|text messaging
102687|NCT02648334|popliteal peripheral Artery|popliteal peripheral artery
102688|NCT02648321|Motivational Interviewing|motivational interviewing
102690|NCT02648308|Education, Medical|education, medical
102691|NCT02648282|vaccine|vaccine
102692|NCT02648282|immunotherapy|immunotherapy
102693|NCT02648282|antibody|antibody
102694|NCT02648282|PD-1|pd-1
102695|NCT02648282|radiation|radiation
102696|NCT02648256|Pneumocystis jirovecii|pneumocystis jirovecii
102697|NCT02648256|Polymerase Chain Reaction|polymerase chain reaction
102698|NCT02648256|Oropharyngeal Rinse|oropharyngeal rinse
102699|NCT02648243|Qatar|qatar
102700|NCT02648243|Acute Coronary Syndrome|acute coronary syndrome
102701|NCT02648243|Pharmacist|pharmacist
102702|NCT02648243|Medication burden|medication burden
102703|NCT02648243|Mortality|mortality
102704|NCT02648243|Readmission|readmission
102705|NCT02648243|Adherence|adherence
102706|NCT02648243|Impact|impact
102707|NCT02648230|Ischemia|ischemia
102708|NCT02648230|Fractional Flow Reserve|fractional flow reserve
102709|NCT02648230|Stent|stent
102710|NCT02648191|Obesity|obesity
102711|NCT02648191|Bariatric Surgery|bariatric surgery
102712|NCT02648191|No invasive intra-auricular vagus nerve stimulation|no invasive intra-auricular vagus nerve stimulation
102713|NCT02648191|Weight loss|weight loss
102714|NCT02648191|Autonomic nervous system|autonomic nervous system
102715|NCT02648113|Myocardial Infarction|myocardial infarction
102716|NCT02648113|Anemia|anemia
102717|NCT02648113|Blood Transfusion|blood transfusion
102718|NCT02648100|Muscle invasive bladder cancer|muscle invasive bladder cancer
102719|NCT02648100|Basal subtype|basal subtype
102720|NCT02648100|Anti-EGFR treatment|anti-egfr treatment
102721|NCT02648100|Nanostring|nanostring
102722|NCT02648074|asthma|asthma
102723|NCT02648074|eosinophils|eosinophils
102724|NCT02648074|airway smooth muscle|airway smooth muscle
102725|NCT02648074|airway remodelling|airway remodelling
102726|NCT02648074|integrins|integrins
102727|NCT02648074|cytokines|cytokines
102728|NCT02648061|Blood circulation|blood circulation
102729|NCT02648061|Follow-up studies|follow-up studies
102730|NCT02648061|Biological markers|biological markers
102731|NCT02648061|Hemodynamics|hemodynamics
102732|NCT02648048|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
102733|NCT02648048|Vismodegib|vismodegib
102734|NCT02648048|Pirfenidone|pirfenidone
102735|NCT02648022|Care Integration|care integration
102736|NCT02648022|Hepatitis C|hepatitis c
102737|NCT02648022|Substance Use Disorder|substance use disorder
102738|NCT02648022|PTSD|ptsd
102739|NCT02647970|Energy metabolism|energy metabolism
102740|NCT02647957|acute ischemic stroke|acute ischemic stroke
102741|NCT02647957|quality|quality
102742|NCT02647866|4083-002|4083-002
102743|NCT02647866|Intestinal Diseases|intestinal diseases
102744|NCT02647866|Ulcerative Colitis|ulcerative colitis
102745|NCT02647866|UC|uc
102746|NCT02647866|Mayo Clinic Scoring|mayo clinic scoring
102747|NCT02647866|Gastrointestinal Tract|gastrointestinal tract
102748|NCT02647840|dysphonia|dysphonia
102749|NCT02647840|voice therapy|voice therapy
102750|NCT02647827|Acupuncture|acupuncture
102751|NCT02647827|Metformin|metformin
102752|NCT02647827|Glucose metabolism|glucose metabolism
102753|NCT02647827|Hba1c|hba1c
102754|NCT02647814|Parent activation|parent activation
102755|NCT02647814|Text-messages|text-messages
102756|NCT02647814|LEP|lep
102757|NCT02647814|Latino populations|latino populations
102758|NCT02647814|pediatrics|pediatrics
102759|NCT02647801|Network approach|network approach
102760|NCT02647801|mindfulness|mindfulness
102761|NCT02647801|self-control|self-control
102762|NCT02647801|ambulatory assessment|ambulatory assessment
102763|NCT02647788|Pain, Postoperative|pain, postoperative
102764|NCT02647775|Thoracoscopic surgery|thoracoscopic surgery
102765|NCT02647723|Omega-3|omega-3
102766|NCT02647723|Fatty acid|fatty acid
102768|NCT02647723|Pregnant|pregnant
102769|NCT02647723|neurodevelopment|neurodevelopment
102770|NCT02647723|stress|stress
102771|NCT02647723|urban|urban
102772|NCT02647723|african-american|african-american
102773|NCT02647723|supplement|supplement
102774|NCT02647723|nutrition|nutrition
102775|NCT02647723|mental health|mental health
102776|NCT02647710|HIV Prevention|hiv prevention
102777|NCT02647710|Juvenile Justice|juvenile justice
102778|NCT02647710|Sexual Health|sexual health
102779|NCT02647710|Evidence Based Intervention|evidence based intervention
102780|NCT02647697|UCB3491|ucb3491
102781|NCT02647697|Phase 1|phase 1
102782|NCT02647697|Pharmacokinetics|pharmacokinetics
102783|NCT02647697|Radiprodil|radiprodil
102784|NCT02647697|Healthy volunteers|healthy volunteers
102785|NCT02647684|Cancer|cancer
102786|NCT02647684|Parenting|parenting
642412|NCT00747825|melanoma|melanoma
102787|NCT02647684|Self-directed Triple P|self-directed triple p
102788|NCT02647671|Colon polyp|colon polyp
102789|NCT02647671|Colorectal cancer|colorectal cancer
102790|NCT02647671|Chemoprevention|chemoprevention
102791|NCT02647671|Natural product|natural product
102792|NCT02647658|acute low back pain|acute low back pain
102793|NCT02647658|primary care|primary care
102794|NCT02647658|psychologically informed physical therapy|psychologically informed physical therapy
103184|NCT02644954|Metformin|metformin
102795|NCT02647658|cluster randomized pragmatic trial|cluster randomized pragmatic trial
102796|NCT02647658|comparative effectiveness|comparative effectiveness
102797|NCT02647658|secondary prevention|secondary prevention
102798|NCT02647632|HCV genotype 1 or 4|hcv genotype 1 or 4
102799|NCT02647632|failure to DAA|failure to daa
102800|NCT02647619|Primary Dd disase|primary dd disase
102801|NCT02647619|MCP joint|mcp joint
102802|NCT02647580|Growth|growth
102803|NCT02647580|Children|children
102804|NCT02647580|Appetite-regulating hormones|appetite-regulating hormones
102805|NCT02647580|Gut Microbiota|gut microbiota
102806|NCT02647567|Cognitive|cognitive
102807|NCT02647567|Aerobic Exercise|aerobic exercise
102808|NCT02647567|Performance|performance
102809|NCT02647554|sepsis|sepsis
102810|NCT02647554|septic shock|septic shock
102811|NCT02647554|Ulinastatin|ulinastatin
102812|NCT02647554|adult|adult
102813|NCT02647554|China|china
102814|NCT02647541|Children|children
102815|NCT02647541|Congenital heart disease|congenital heart disease
102816|NCT02647541|Nutritional status|nutritional status
102817|NCT02647541|Bioelectrical impedance|bioelectrical impedance
102818|NCT02647476|immunonutrition|immunonutrition
102819|NCT02647476|gastric cancer|gastric cancer
102820|NCT02647476|enteral nutrition|enteral nutrition
102821|NCT02647463|Attachment|attachment
102822|NCT02647463|Cortisol|cortisol
102823|NCT02647463|Parent sensitivity|parent sensitivity
102824|NCT02647411|Prevalence|prevalence
102825|NCT02647411|Myopia|myopia
102826|NCT02647398|Cancer survivors|cancer survivors
102827|NCT02647398|training|training
102828|NCT02647398|exercise|exercise
102829|NCT02647398|cancer-related fatigue|cancer-related fatigue
102830|NCT02647385|serratus anterior plane block|serratus anterior plane block
102831|NCT02647385|pectoral nerve block|pectoral nerve block
102832|NCT02647385|breast surgery|breast surgery
102833|NCT02647385|cancer|cancer
102834|NCT02647385|analgesia|analgesia
102835|NCT02647385|inflammatory cytokines|inflammatory cytokines
102836|NCT02647372|parkinson|parkinson
102837|NCT02647372|deep brain stimulation|deep brain stimulation
102838|NCT02647372|globus pallidus|globus pallidus
102839|NCT02647372|subthalamic nucleus|subthalamic nucleus
102840|NCT02647320|type 2 diabetes mellitus|type 2 diabetes mellitus
102841|NCT02647320|interventional|interventional
102842|NCT02647320|double blind|double blind
102843|NCT02647320|phase 2|phase 2
102844|NCT02647281|Single dose|single dose
102845|NCT02647281|Multiple ascending doses (MAD)|multiple ascending doses (mad)
102846|NCT02647281|Pharmacokinetics|pharmacokinetics
102847|NCT02647281|Safety|safety
102848|NCT02647281|GSK3389404|gsk3389404
102849|NCT02647281|Tolerability|tolerability
102850|NCT02647268|Uterine contraction|uterine contraction
102851|NCT02647268|Oxytocin|oxytocin
102852|NCT02647268|Magnesium sulphate|magnesium sulphate
102853|NCT02647255|crescentic IgA nephropathy|crescentic iga nephropathy
102854|NCT02647255|plasma exchange treatment or plasmapheresis|plasma exchange treatment or plasmapheresis
102855|NCT02647255|randomized controlled trial|randomized controlled trial
102856|NCT02647255|intensive immunosuppressive treatment|intensive immunosuppressive treatment
102857|NCT02647255|methylprednisolone pulse|methylprednisolone pulse
102858|NCT02647216|Mindfulness Based Cognitive Therapy (MBCT)|mindfulness based cognitive therapy (mbct)
102859|NCT02647216|anxiety|anxiety
102860|NCT02647216|depression|depression
102861|NCT02647203|Fluoride toothpaste|fluoride toothpaste
102862|NCT02647203|Root caries|root caries
102863|NCT02647203|Randomized clinical trial|randomized clinical trial
102864|NCT02647190|Erwinia Chrysanthemi Asparaginase|erwinia chrysanthemi asparaginase
102865|NCT02647190|15-107|15-107
102868|NCT02647151|Acid Methyl Aminolevulinate (MAL)|acid methyl aminolevulinate (mal)
102869|NCT02647151|Aminolevulinic Gel (ALA) and Actinic Keratosis|aminolevulinic gel (ala) and actinic keratosis
102870|NCT02647112|Bladder cancer|bladder cancer
102871|NCT02647112|Urine|urine
102872|NCT02647112|Methylation|methylation
102873|NCT02647099|Aspirin|aspirin
102874|NCT02647099|PI3K signaling pathway|pi3k signaling pathway
102875|NCT02647086|Eczema|eczema
102876|NCT02647073|Mobile Monitoring|mobile monitoring
102877|NCT02647073|Post-Opioid Consumption|post-opioid consumption
102878|NCT02647073|Vital Signs|vital signs
102879|NCT02647060|cardiopulmonary exercise testing|cardiopulmonary exercise testing
102880|NCT02647060|right ventricle function|right ventricle function
102881|NCT02647060|cardio output|cardio output
102882|NCT02647060|pulmonary hypertension|pulmonary hypertension
102883|NCT02647060|quality of life|quality of life
102884|NCT02647047|spinal analgesia|spinal analgesia
102885|NCT02647047|epidural analgesia|epidural analgesia
102886|NCT02647047|laparotomic liver resection|laparotomic liver resection
102887|NCT02647047|ERAS|eras
102888|NCT02647047|length of stay|length of stay
102889|NCT02647021|physical therapy|physical therapy
102890|NCT02647021|cancer rehabilitation|cancer rehabilitation
102891|NCT02647021|exercise|exercise
102892|NCT02647008|outpatient hysteroscopy, TENS|outpatient hysteroscopy, tens
102893|NCT02646982|Alzheimer's disease|alzheimer's disease
102894|NCT02646982|Vascular function|vascular function
102895|NCT02646982|Neuroinflammation|neuroinflammation
102896|NCT02646956|Sweet Taste|sweet taste
102897|NCT02646956|Psychophysics|psychophysics
102898|NCT02646956|Genetics|genetics
102899|NCT02646956|Diet|diet
102900|NCT02646956|Age|age
102901|NCT02646956|Nonnutritive Sweetener|nonnutritive sweetener
102902|NCT02646943|Cohort|cohort
102903|NCT02646943|Biomarkers|biomarkers
102904|NCT02646943|Cardiomyopathy|cardiomyopathy
102905|NCT02646930|chronic endometritis|chronic endometritis
102906|NCT02646930|invitro fertilization|invitro fertilization
102907|NCT02646930|spontaneous abortion|spontaneous abortion
102908|NCT02646891|Rotavirus Vaccine|rotavirus vaccine
102909|NCT02646878|Type 1 Diabetes|type 1 diabetes
102910|NCT02646878|Type 2 Diabetes|type 2 diabetes
102911|NCT02646878|Harmony Sensor|harmony sensor
102912|NCT02646878|Continuous Glucose Monitoring|continuous glucose monitoring
102913|NCT02646878|CGM|cgm
102914|NCT02646865|social phobia|social phobia
102915|NCT02646865|compassion|compassion
102916|NCT02646865|shame|shame
102917|NCT02646839|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
102918|NCT02646839|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
102919|NCT02646839|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
102920|NCT02646839|KIR-Favorable|kir-favorable
102921|NCT02646839|Haploidentical Transplantation|haploidentical transplantation
102922|NCT02646839|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
102923|NCT02646800|Micafungin|micafungin
102924|NCT02646800|Candidiasis|candidiasis
102925|NCT02646800|Aspergillosis|aspergillosis
102926|NCT02646800|Antifungal|antifungal
102927|NCT02646774|Aspergillosis|aspergillosis
102928|NCT02646774|Antifungal|antifungal
102929|NCT02646774|Micafungin|micafungin
102930|NCT02646748|Advanced|advanced
102931|NCT02646670|diabetic macular edema|diabetic macular edema
102932|NCT02646670|aflibercept|aflibercept
102933|NCT02646670|ranibizumab|ranibizumab
102934|NCT02646605|Depression|depression
102935|NCT02646605|AIDS|aids
102936|NCT02646605|HIV|hiv
102937|NCT02646579|Orthopedics|orthopedics
102938|NCT02646527|dignity, end of life, existential, treatment|dignity, end of life, existential, treatment
102939|NCT02646514|Cholangiocarcinoma, radiofrequency ablation, metal stent|cholangiocarcinoma, radiofrequency ablation, metal stent
102940|NCT02646488|cholesterol|cholesterol
102941|NCT02646488|smoking|smoking
102942|NCT02646488|aspirin|aspirin
102943|NCT02646488|chronic care model|chronic care model
102944|NCT02646475|renin-angiotensin system|renin-angiotensin system
102945|NCT02646475|angiotensin|angiotensin
102946|NCT02646475|insulin resistance|insulin resistance
102947|NCT02646475|blood pressure|blood pressure
102948|NCT02646462|pancreas adenocarcinoma, lymph node metastases|pancreas adenocarcinoma, lymph node metastases
102949|NCT02646449|Major Depressive Disorder|major depressive disorder
102950|NCT02646449|Alcohol Use Disorder|alcohol use disorder
102951|NCT02646436|unplanned peritoneal dialysis|unplanned peritoneal dialysis
102952|NCT02646436|unplanned heamodialysis|unplanned heamodialysis
102953|NCT02646423|Trial of labor after cesarean|trial of labor after cesarean
102954|NCT02646423|Elective repeat cesarean delivery|elective repeat cesarean delivery
102955|NCT02646423|Decision tool|decision tool
102956|NCT02646423|Shared decision making|shared decision making
102957|NCT02646410|malaria|malaria
102958|NCT02646410|seasonal malaria chemoprevention|seasonal malaria chemoprevention
102959|NCT02646410|immunity|immunity
102960|NCT02646410|resistance|resistance
102961|NCT02646410|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
102962|NCT02646410|amodiaquine|amodiaquine
102963|NCT02646410|delivery method|delivery method
102964|NCT02646397|glomerular filtration rate|glomerular filtration rate
102965|NCT02646397|hypertension|hypertension
102966|NCT02646345|Checklist|checklist
102967|NCT02646345|Mortality|mortality
102968|NCT02646345|Latin America|latin america
102969|NCT02646345|Surgery|surgery
102970|NCT02646345|Morbidity|morbidity
102971|NCT02646332|Helicobacter pylori|helicobacter pylori
102972|NCT02646332|Eradication rate|eradication rate
102973|NCT02646306|shoulder|shoulder
102974|NCT02646306|proprioception|proprioception
102975|NCT02646306|movement|movement
102976|NCT02646306|reaching|reaching
102977|NCT02646280|Low back pain|low back pain
102978|NCT02646280|interoceptive awareness|interoceptive awareness
642413|NCT00747825|tumor|tumor
102979|NCT02646280|motor imagery|motor imagery
102980|NCT02646280|massage|massage
102981|NCT02646267|Atrial fibrillation|atrial fibrillation
102982|NCT02646267|Dabigatran|dabigatran
102983|NCT02646267|Warfarin|warfarin
102984|NCT02646267|Anticoagulation|anticoagulation
102985|NCT02646267|Elderly|elderly
102986|NCT02646254|tetralogy of fallot, cardioplegia|tetralogy of fallot, cardioplegia
102987|NCT02646241|stomach neoplasm|stomach neoplasm
102988|NCT02646241|biopsy|biopsy
102989|NCT02646150|Magnetic Resonance perfusion imaging|magnetic resonance perfusion imaging
102990|NCT02646150|distal perfusion|distal perfusion
102991|NCT02646150|Critical Limb Ischemia|critical limb ischemia
103678|NCT02641717|vaginitis|vaginitis
102992|NCT02646150|endovascular revascularization|endovascular revascularization
102993|NCT02646111|"Hepatitis C Virus"|"hepatitis c virus"
102994|NCT02646111|"Triple Therapy"|"triple therapy"
102995|NCT02646111|"PI Failure"|"pi failure"
102996|NCT02646111|"Genotype 1"|"genotype 1"
102998|NCT02646098|mantle cell lymphoma|mantle cell lymphoma
122387|NCT02530437|XRT|xrt
102999|NCT02646098|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
103000|NCT02646072|diabetes mellitus|diabetes mellitus
103001|NCT02646072|aqueous humor|aqueous humor
103002|NCT02646072|inflammatory cytokines|inflammatory cytokines
103003|NCT02646072|cystoid macular edema, postoperative|cystoid macular edema, postoperative
103004|NCT02646072|nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
103005|NCT02646046|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
103006|NCT02646046|Emergency Medical Services|emergency medical services
103007|NCT02646046|Cell phones|cell phones
103008|NCT02646046|Simulation Training|simulation training
103009|NCT02646033|Intraocular Pressure, Trendelenburg position|intraocular pressure, trendelenburg position
103010|NCT02646020|pruritus|pruritus
103011|NCT02646020|Non-small Cell Lung Cancer|non-small cell lung cancer
103012|NCT02646020|Receptor, Epidermal Growth Factor|receptor, epidermal growth factor
103013|NCT02646020|tyrosine kinase inhibitor|tyrosine kinase inhibitor
103014|NCT02646007|Autologous Cell therapy Kienböck's disease|autologous cell therapy kienböck's disease
103015|NCT02646007|bone marrow derived mesenchymal stromal/stem cell|bone marrow derived mesenchymal stromal/stem cell
103016|NCT02645994|Closed Loop Anesthesia Delivery System|closed loop anesthesia delivery system
103017|NCT02645994|Target Controlled Infusion|target controlled infusion
103018|NCT02645981|Donafeinb|donafeinb
103019|NCT02645981|Sorafenib|sorafenib
103020|NCT02645981|Phase 3|phase 3
103021|NCT02645981|Overall Survival|overall survival
103022|NCT02645968|Pneumology|pneumology
103023|NCT02645968|Registry|registry
103024|NCT02645968|EXCITING|exciting
103025|NCT02645968|Interstitial lung disease|interstitial lung disease
103026|NCT02645968|ILD|ild
103027|NCT02645942|Carnitine|carnitine
103028|NCT02645942|placebo|placebo
103029|NCT02645942|risk factors|risk factors
103030|NCT02645916|Cold Hypersensitivity in the Hands|cold hypersensitivity in the hands
103031|NCT02645916|Korean medicine|korean medicine
103032|NCT02645916|DSGOST|dsgost
103033|NCT02645903|transversus abdominis plane block|transversus abdominis plane block
103034|NCT02645903|living liver transplantation|living liver transplantation
103035|NCT02645903|postoperative analgesia|postoperative analgesia
103036|NCT02645890|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
103037|NCT02645890|Healthy Male Volunteer|healthy male volunteer
103038|NCT02645890|Tamsulosin|tamsulosin
103039|NCT02645890|Tadalafil|tadalafil
103040|NCT02645877|Pre-hospital Care|pre-hospital care
103041|NCT02645877|Diseases Spectrum|diseases spectrum
103042|NCT02645877|Call Demands|call demands
103043|NCT02645877|Emergency Response Time|emergency response time
103044|NCT02645864|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
103045|NCT02645864|Apatinib|apatinib
103046|NCT02645864|Irinotecan|irinotecan
103047|NCT02645851|Fluid Therapy|fluid therapy
103048|NCT02645851|Plasma Substitutes|plasma substitutes
103049|NCT02645851|Fluid Balance|fluid balance
103050|NCT02645838|Motivational Interviewing|motivational interviewing
103051|NCT02645838|Smoking Cessation|smoking cessation
103052|NCT02645825|superficial adenopathy - echography|superficial adenopathy - echography
103053|NCT02645812|Fatigue|fatigue
754070|NCT01178801|data mining|data mining
103054|NCT02645812|Brief Fatigue Inventory (BFI)|brief fatigue inventory (bfi)
103055|NCT02645812|Primary care|primary care
103056|NCT02645812|General Practitioners|general practitioners
103057|NCT02645786|thyroid neoplasms|thyroid neoplasms
103059|NCT02645786|thyroxine|thyroxine
103060|NCT02645786|thyrotoxicosis|thyrotoxicosis
103061|NCT02645708|RIRS|rirs
103062|NCT02645708|EPVL|epvl
103063|NCT02645708|PDI(Percussion,Diuresis,Inversion)|pdi(percussion,diuresis,inversion)
103064|NCT02645708|Randomized Controlled Trial|randomized controlled trial
103065|NCT02645695|Pulmonary Rehabilitation|pulmonary rehabilitation
103066|NCT02645695|Chest Physiotherapy|chest physiotherapy
103067|NCT02645695|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
103068|NCT02645682|central venous catheter (CVC)|central venous catheter (cvc)
103069|NCT02645682|catheter-related bloodstream infection (CRBSI)|catheter-related bloodstream infection (crbsi)
103070|NCT02645682|catheter-related thrombosis (CRT)|catheter-related thrombosis (crt)
103071|NCT02645656|Oral Submucous Fibrosis|oral submucous fibrosis
103072|NCT02645656|Curcumin|curcumin
103073|NCT02645643|medical students|medical students
103074|NCT02645643|professionalism|professionalism
103075|NCT02645643|medical education|medical education
103076|NCT02645643|study emotion|study emotion
103077|NCT02645630|Cervical spine|cervical spine
103078|NCT02645630|Spinal manipulation|spinal manipulation
103079|NCT02645604|Artemisinin Combination Therapy (ACT)|artemisinin combination therapy (act)
103080|NCT02645591|Prostate cancer|prostate cancer
103081|NCT02645591|Dehydrated human amnion/chorion membrane|dehydrated human amnion/chorion membrane
103082|NCT02645591|dHACM|dhacm
103185|NCT02644928|Chronic kidney disease|chronic kidney disease
103083|NCT02645591|Robotic assisted laparoscopic radical prostatectomy|robotic assisted laparoscopic radical prostatectomy
103084|NCT02645591|RARP|rarp
103085|NCT02645591|AmnioFix®|amniofix®
103086|NCT02645591|Sexual function score|sexual function score
103087|NCT02645591|Neurovascular bundle inflammation|neurovascular bundle inflammation
103088|NCT02645591|Questionnaire|questionnaire
103089|NCT02645591|Survey|survey
103090|NCT02645578|Coma|coma
103091|NCT02645578|traumatic brain injury|traumatic brain injury
103092|NCT02645578|median nerve stimulation|median nerve stimulation
103093|NCT02645552|Traumatic brain injury|traumatic brain injury
103094|NCT02645513|mHealth|mhealth
103095|NCT02645513|text message|text message
103096|NCT02645513|case management|case management
103097|NCT02645500|Physical Activity|physical activity
103098|NCT02645500|Family well-being|family well-being
103099|NCT02645448|Resistance Exercise|resistance exercise
103100|NCT02645448|Diabetes Mellitus|diabetes mellitus
103101|NCT02645448|Heart Rate Variability|heart rate variability
103102|NCT02645409|Fluorescence|fluorescence
103103|NCT02645409|Imaging|imaging
103104|NCT02645409|Partial nephrectomy|partial nephrectomy
103105|NCT02645409|Radical nephrectomy|radical nephrectomy
103106|NCT02645396|Cytomegalovirus|cytomegalovirus
103107|NCT02645383|Pattern scan laser|pattern scan laser
103108|NCT02645383|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
103109|NCT02645383|Pain|pain
103110|NCT02645370|Migraine|migraine
103111|NCT02645370|Danzhen|danzhen
103112|NCT02645370|Topiramate|topiramate
103113|NCT02645370|Headache diary APP|headache diary app
103114|NCT02645370|preventive treatment|preventive treatment
103115|NCT02645357|Oncology Patients|oncology patients
103116|NCT02645357|evidence-based|evidence-based
103117|NCT02645357|computerized|computerized
103118|NCT02645357|decision|decision
103119|NCT02645357|support system|support system
103120|NCT02645357|linked|linked
103121|NCT02645357|electronic health records|electronic health records
103122|NCT02645344|Unilateral neglect|unilateral neglect
103123|NCT02645344|Right hemiplegia|right hemiplegia
103124|NCT02645318|Circulating Tumor DNA|circulating tumor dna
103125|NCT02645318|Lung cancer|lung cancer
103126|NCT02645318|Targeted sequencing|targeted sequencing
103127|NCT02645305|Safety and Efficacy|safety and efficacy
103128|NCT02645305|Adipose stem cells|adipose stem cells
103129|NCT02645305|Stem Cell therapy|stem cell therapy
103130|NCT02645279|newborn|newborn
103132|NCT02645279|oral 30% glucose|oral 30% glucose
103133|NCT02645253|Safety|safety
103134|NCT02645253|Pharmacokinetics|pharmacokinetics
103135|NCT02645253|Pharmacodynamics|pharmacodynamics
103136|NCT02645253|Glucocorticoid receptor modulator|glucocorticoid receptor modulator
103137|NCT02645253|Healthy male subjects|healthy male subjects
103138|NCT02645201|probiotic|probiotic
103139|NCT02645188|Electromyography|electromyography
103140|NCT02645188|Exercise|exercise
103141|NCT02645175|Paclitaxel|paclitaxel
103142|NCT02645175|docetaxel|docetaxel
103143|NCT02645175|vinorelbine|vinorelbine
103144|NCT02645175|eribulin|eribulin
103145|NCT02645162|Pakistan|pakistan
103146|NCT02645162|Early Child Development, Care and Education|early child development, care and education
103147|NCT02645162|Youth Leaders|youth leaders
103148|NCT02645149|Metastatic Melanoma|metastatic melanoma
103149|NCT02645149|Molecular Testing|molecular testing
104183|NCT02638831|Pain|pain
103150|NCT02645149|Targeted Therapy|targeted therapy
103151|NCT02645123|spinal mobilization|spinal mobilization
103153|NCT02645123|gait analysis|gait analysis
103154|NCT02645123|low back pain|low back pain
103155|NCT02645123|chronic|chronic
103156|NCT02645097|Adult|adult
103157|NCT02645097|nerve blocks in foot and ankle surgery|nerve blocks in foot and ankle surgery
103158|NCT02645097|saphenous|saphenous
103159|NCT02645071|physical activity|physical activity
103160|NCT02645071|family well being,|family well being,
103161|NCT02645071|health|health
103162|NCT02645058|Ureterorenoscopy|ureterorenoscopy
103163|NCT02645058|extracorporeal shock waves lithotripsy|extracorporeal shock waves lithotripsy
103164|NCT02645045|Dry eye|dry eye
103165|NCT02645045|Lipiview|lipiview
103166|NCT02645045|Tear Lipid Layer|tear lipid layer
103167|NCT02645045|meibomian gland dysfunction|meibomian gland dysfunction
103168|NCT02645032|Typhoid conjugate vaccine|typhoid conjugate vaccine
103169|NCT02645032|Vi-DT|vi-dt
103170|NCT02645032|Safety|safety
103171|NCT02645032|Immunogenicuty|immunogenicuty
103172|NCT02645006|falls|falls
103173|NCT02645006|elderly|elderly
103174|NCT02645006|Exercise,Physical|exercise,physical
103175|NCT02645006|vitamin d|vitamin d
103176|NCT02645006|home hazards|home hazards
103177|NCT02645006|mediterranean diet|mediterranean diet
103178|NCT02645006|body mass index|body mass index
103179|NCT02645006|lower extremity exercise movement technics|lower extremity exercise movement technics
103180|NCT02645006|vitamin D intake|vitamin d intake
103181|NCT02645006|Short Physical Performance Battery (SPPB o Test de Guralnik)|short physical performance battery (sppb o test de guralnik)
103182|NCT02644980|Target Controlled Infusion|target controlled infusion
103183|NCT02644954|psoriasis|psoriasis
103186|NCT02644928|Bariatric Surgery Candidate|bariatric surgery candidate
103187|NCT02644928|Caloric restriction|caloric restriction
103188|NCT02644915|ischemia-reperfusion(I/R) injury|ischemia-reperfusion(i/r) injury
103189|NCT02644915|Edaravone|edaravone
103190|NCT02644902|Avatar assisted cascade training and supervision|avatar assisted cascade training and supervision
103191|NCT02644902|maternal depression|maternal depression
103192|NCT02644902|postconflict|postconflict
103193|NCT02644902|THP|thp
103194|NCT02644889|Epidermal growth factor receptor(EGFR)|epidermal growth factor receptor(egfr)
103195|NCT02644889|NSCLC|nsclc
103196|NCT02644876|Postoperative pulmonary complications|postoperative pulmonary complications
103197|NCT02644876|Selective anticholinergic bronchodilator|selective anticholinergic bronchodilator
103198|NCT02644876|High risk patients|high risk patients
103199|NCT02644876|Postoperative period|postoperative period
103200|NCT02644876|Postoperative complications|postoperative complications
103201|NCT02644824|Congenital Heart Disease (CHD)|congenital heart disease (chd)
103202|NCT02644824|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
103203|NCT02644824|Cardiac Index|cardiac index
103204|NCT02644824|Hemodynamics|hemodynamics
103205|NCT02644824|Pediatrics|pediatrics
103206|NCT02644811|Miniscrew|miniscrew
103207|NCT02644811|Temporary anchorage device (TAD)|temporary anchorage device (tad)
103208|NCT02644811|mini-implants|mini-implants
103209|NCT02644811|Miniscrew implant (MSI)|miniscrew implant (msi)
103210|NCT02644798|ARDS|ards
103211|NCT02644798|Gene polymorphism|gene polymorphism
103212|NCT02644785|cardiac by-pass|cardiac by-pass
103213|NCT02644785|protamine|protamine
103214|NCT02644785|tryptase|tryptase
103215|NCT02644785|hypotension|hypotension
103216|NCT02644785|anaphylaxis|anaphylaxis
103217|NCT02644772|Acute Exacerbation of COPD|acute exacerbation of copd
103218|NCT02644772|Clinical problems in COPD|clinical problems in copd
103219|NCT02644759|Stem Cells|stem cells
103220|NCT02644759|Transplantation|transplantation
103221|NCT02644759|Immunomodulation|immunomodulation
103222|NCT02644759|CD34|cd34
103223|NCT02644759|CD133|cd133
103224|NCT02644759|ClinicMACS|clinicmacs
103225|NCT02644746|degenerative lumbar spinal stenosis|degenerative lumbar spinal stenosis
103226|NCT02644746|acupuncture|acupuncture
103227|NCT02644746|randomized controlled trial|randomized controlled trial
103228|NCT02644655|Recurrent B-Cell Tumor|recurrent b-cell tumor
103229|NCT02644655|Refractory B-Cell Tumor|refractory b-cell tumor
103230|NCT02644655|New Cluster of Differentiation Antigen 19-chimeric Antigen Receptor T Cells|new cluster of differentiation antigen 19-chimeric antigen receptor t cells
103231|NCT02644655|safety|safety
103232|NCT02644655|prognosis|prognosis
103233|NCT02644616|tolvaptan|tolvaptan
103234|NCT02644616|safety and efficacy|safety and efficacy
103235|NCT02644616|left heart valves replacement|left heart valves replacement
103236|NCT02644603|Enhanced Recovery After Surgery|enhanced recovery after surgery
103237|NCT02644603|hepatocellular carcinoma|hepatocellular carcinoma
103238|NCT02644590|Melatonin|melatonin
103239|NCT02644590|Nocturnal Hypertension|nocturnal hypertension
103240|NCT02644590|Type 1 Diabetes Melitus|type 1 diabetes melitus
103241|NCT02644577|Metformin|metformin
103242|NCT02644577|antipsychotic-induced metabolic syndrome|antipsychotic-induced metabolic syndrome
103243|NCT02644577|bipolar disorder|bipolar disorder
103244|NCT02644564|Soft tissue shoulder injury|soft tissue shoulder injury
103246|NCT02644564|Ultrasonography|ultrasonography
103247|NCT02644538|HBsAg clearance|hbsag clearance
103248|NCT02644525|Cameroon|cameroon
103249|NCT02644525|Filaricidal|filaricidal
103250|NCT02644525|Randomized|randomized
103251|NCT02644525|Ivermectin|ivermectin
103252|NCT02644525|Worm|worm
103253|NCT02644434|Percutaneous Coronary Intervention|percutaneous coronary intervention
103254|NCT02644434|Coronary Bifurcation Intervention|coronary bifurcation intervention
103255|NCT02644434|Randomized Clinical Trial|randomized clinical trial
103256|NCT02644421|Neuropathic Pain|neuropathic pain
103257|NCT02644421|Sciatica|sciatica
103258|NCT02644408|Chemoradiotherapy|chemoradiotherapy
103259|NCT02644408|Esophageal Squamous Cancer|esophageal squamous cancer
103260|NCT02644408|Megestrol|megestrol
103261|NCT02644382|breast cancer|breast cancer
103262|NCT02644382|decision making|decision making
103263|NCT02644382|surgery|surgery
103264|NCT02644382|qualitative|qualitative
103265|NCT02644317|Motor development delay|motor development delay
103266|NCT02644317|balance|balance
103267|NCT02644317|flatfoot|flatfoot
103268|NCT02644317|shoe insert|shoe insert
103269|NCT02644291|medulloblastoma|medulloblastoma
103270|NCT02644291|Diffuse Intrinsic Pontine Glioma (DIPG)|diffuse intrinsic pontine glioma (dipg)
103271|NCT02644291|high grade glioma|high grade glioma
103272|NCT02644291|glioblastoma|glioblastoma
103273|NCT02644291|brain stem malignant glioma|brain stem malignant glioma
103274|NCT02644265|Acute acquired brain injury|acute acquired brain injury
103275|NCT02644265|Disorders of consciousness|disorders of consciousness
103276|NCT02644265|Traumatic brain injury|traumatic brain injury
103277|NCT02644265|Non-traumatic brain injury|non-traumatic brain injury
103278|NCT02644265|Anoxic-ischemic encephalopathy|anoxic-ischemic encephalopathy
103279|NCT02644265|Stroke|stroke
103280|NCT02644265|Vegetative state|vegetative state
94383|NCT02698228|anesthesia|anesthesia
94384|NCT02698202|Tomosynthesis,sensitivity,specificity,screening,mammography|tomosynthesis,sensitivity,specificity,screening,mammography
94385|NCT02698176|OTX015|otx015
94386|NCT02698176|MK-8628|mk-8628
94452|NCT02697734|UFC|ufc
103281|NCT02644265|Minimal conscious state|minimal conscious state
103282|NCT02644265|Locked-in syndrome|locked-in syndrome
103283|NCT02644265|Functional magnetic resonance imaging|functional magnetic resonance imaging
103284|NCT02644265|Electroencephalography|electroencephalography
103285|NCT02644174|Obesity|obesity
103286|NCT02644174|Lung function test|lung function test
103287|NCT02644174|Bariatric surgery|bariatric surgery
103288|NCT02644161|stroke|stroke
103289|NCT02644161|depression|depression
103290|NCT02644161|stroke sequelae|stroke sequelae
103291|NCT02644161|acupuncture|acupuncture
103292|NCT02644161|DCEAS|dceas
103293|NCT02644161|CAI|cai
103294|NCT02644161|LAS|las
103295|NCT02644135|Healthy volunteer|healthy volunteer
103296|NCT02644122|advanced cancer|advanced cancer
103297|NCT02644122|metastatic cancer|metastatic cancer
103298|NCT02644122|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
103299|NCT02644122|SCCHN|scchn
103300|NCT02644122|gene mutation|gene mutation
103301|NCT02644122|PIK3R1, PIK3R5 and PIK3AP1|pik3r1, pik3r5 and pik3ap1
103302|NCT02644122|PIK3CG|pik3cg
103303|NCT02644122|AKT and mTOR|akt and mtor
103304|NCT02644122|PIK3CA gene|pik3ca gene
103305|NCT02644122|PI-3 kinase inhibitor|pi-3 kinase inhibitor
103306|NCT02644122|PI-3 kinase pathway genes|pi-3 kinase pathway genes
103307|NCT02644096|Rehabilitation|rehabilitation
103308|NCT02644096|RCT|rct
103309|NCT02644096|User Involvement|user involvement
103310|NCT02644096|Self-Rated Health|self-rated health
103311|NCT02644070|Alveolar bone loss|alveolar bone loss
103312|NCT02644070|Alveoloplasty|alveoloplasty
103313|NCT02644070|Bone remodeling|bone remodeling
103314|NCT02644070|Xenograft|xenograft
103315|NCT02644070|Tooth socket|tooth socket
103316|NCT02644070|Dental implant|dental implant
103317|NCT02644044|Progressive multiple sclerosis|progressive multiple sclerosis
103318|NCT02644044|methotrexate|methotrexate
103319|NCT02644031|Instrumentation|instrumentation
103320|NCT02644031|Post-operative pain|post-operative pain
103321|NCT02644031|Root canal preparation|root canal preparation
103322|NCT02644018|Ingavirin|ingavirin
103323|NCT02644018|Common Cold|common cold
103324|NCT02644018|Influenza|influenza
103325|NCT02644018|Acute Respiratory Viral Infections|acute respiratory viral infections
103326|NCT02644018|pediatric clinical trial|pediatric clinical trial
103327|NCT02644018|Imidazolyl ethanamide pentandioic acid|imidazolyl ethanamide pentandioic acid
103328|NCT02643979|Ketamine|ketamine
103329|NCT02643979|Propofol|propofol
103330|NCT02643979|Ketofol|ketofol
103331|NCT02643979|Obese|obese
103332|NCT02643979|Upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
103333|NCT02643979|Sedation|sedation
103334|NCT02643979|Bariatric|bariatric
103335|NCT02643966|whole breast ultrasound|whole breast ultrasound
103336|NCT02643966|digital breast tomosynthesis|digital breast tomosynthesis
103337|NCT02643966|breast density|breast density
103338|NCT02643966|breast cancer screening|breast cancer screening
103339|NCT02643953|Maternal Health|maternal health
103340|NCT02643953|Maternal Mortality|maternal mortality
103341|NCT02643953|Global Health|global health
103342|NCT02643953|RCT|rct
103343|NCT02643940|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
103344|NCT02643940|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
103346|NCT02643940|Instantaneous wave-free ratio (iFR)|instantaneous wave-free ratio (ifr)
103347|NCT02643875|myopia control|myopia control
103348|NCT02643875|orthokeratology|orthokeratology
103349|NCT02643823|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
103350|NCT02643823|Mesenchymal Stem Cell|mesenchymal stem cell
103351|NCT02643823|Rheumatoid Arthritis|rheumatoid arthritis
103352|NCT02643810|exercise training|exercise training
103353|NCT02643797|diabetes|diabetes
103354|NCT02643797|medical assistant|medical assistant
103355|NCT02643797|health coach|health coach
103356|NCT02643797|glycemic control|glycemic control
103357|NCT02643797|pragmatic trial|pragmatic trial
103358|NCT02643784|acute ischemic stroke|acute ischemic stroke
103359|NCT02643771|Dental Scaling|dental scaling
103360|NCT02643771|Blood Glucose|blood glucose
103361|NCT02643771|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
103362|NCT02643758|Myopia control, bifocal soft contact lenses, children|myopia control, bifocal soft contact lenses, children
103363|NCT02643745|acute kidney injury|acute kidney injury
103364|NCT02643745|cardiac surgery|cardiac surgery
103365|NCT02643732|Activity|activity
103366|NCT02643719|migraine|migraine
103367|NCT02643719|topiramate|topiramate
103368|NCT02643706|Aldehyde dehydrogenase 2|aldehyde dehydrogenase 2
94545|NCT02697305|GIP|gip
103369|NCT02643706|contrast induced nephropathy|contrast induced nephropathy
103370|NCT02643706|Gene polymorphism|gene polymorphism
103371|NCT02643693|Conventional cigarette|conventional cigarette
103372|NCT02643693|Nicotine lactate delivery system|nicotine lactate delivery system
103373|NCT02643693|e-cigarette|e-cigarette
103374|NCT02643693|VUSE|vuse
103375|NCT02643693|Combustible cigarette|combustible cigarette
103376|NCT02643680|Biocellulose|biocellulose
103377|NCT02643680|Silk sericin|silk sericin
103378|NCT02643680|Polyhexamethylene biguanide|polyhexamethylene biguanide
103379|NCT02643680|Split thickness skin graft donor site|split thickness skin graft donor site
103380|NCT02643667|Radical prostatectomy (RP)|radical prostatectomy (rp)
103381|NCT02643654|interleukin-1alpha|interleukin-1alpha
103382|NCT02643641|Grass pollen allergy|grass pollen allergy
103383|NCT02643641|subcutaneous immunotherapy|subcutaneous immunotherapy
103384|NCT02643641|allergy vaccine|allergy vaccine
103385|NCT02643641|dose regimen|dose regimen
103386|NCT02643615|Visual Evoked Potentials|visual evoked potentials
103387|NCT02643589|haploidentical hematopoietic Stem Cell Transplantation Antithymocyte globulin|haploidentical hematopoietic stem cell transplantation antithymocyte globulin
103388|NCT02643589|acute graft-versus-host disease|acute graft-versus-host disease
103389|NCT02643589|antithymocyte globulin|antithymocyte globulin
103390|NCT02643563|Brachial Plexus Block|brachial plexus block
103391|NCT02643563|Anesthetics, Local|anesthetics, local
103392|NCT02643524|Adult|adult
103393|NCT02643524|CAM boot|cam boot
103394|NCT02643524|controlled ankle movement|controlled ankle movement
103395|NCT02643498|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
103396|NCT02643498|15-109|15-109
103397|NCT02643472|neonate|neonate
103398|NCT02643472|newborn|newborn
103399|NCT02643472|neonatal intensive care unit|neonatal intensive care unit
103400|NCT02643472|NICU|nicu
103401|NCT02643472|NICU discharge|nicu discharge
103402|NCT02643472|parent navigator|parent navigator
103403|NCT02643472|peer to peer|peer to peer
103404|NCT02643472|peer coaching|peer coaching
103405|NCT02643459|Triage|triage
103406|NCT02643459|Risk stratification|risk stratification
103407|NCT02643459|Acute care|acute care
103408|NCT02643459|suPAR|supar
103409|NCT02643446|Poliovirus Vaccine, Inactivated|poliovirus vaccine, inactivated
103410|NCT02643446|Poliovirus Vaccine, Oral|poliovirus vaccine, oral
103411|NCT02643446|Immunity|immunity
103412|NCT02643446|Seroconversion|seroconversion
103413|NCT02643433|Immunogenicity|immunogenicity
103414|NCT02643433|Coadministration|coadministration
103415|NCT02643433|Measles|measles
103416|NCT02643433|Rubella|rubella
103417|NCT02643433|Japanese encephalitis|japanese encephalitis
103418|NCT02643433|Vaccine|vaccine
103419|NCT02643420|Neutropenia|neutropenia
103420|NCT02643420|Breast Cancer|breast cancer
103421|NCT02643420|Long-acting Myeloid Growth Factor|long-acting myeloid growth factor
103422|NCT02643420|Early Stage Breast Cancer|early stage breast cancer
103423|NCT02643420|Docetaxel + Cyclophosphamide (TC) chemotherapy|docetaxel + cyclophosphamide (tc) chemotherapy
103424|NCT02643407|squamous cell carcinoma|squamous cell carcinoma
103425|NCT02643407|nedaplatin|nedaplatin
103426|NCT02643407|cisplatin|cisplatin
103427|NCT02643407|docetaxel|docetaxel
103428|NCT02643394|Acetaminophen|acetaminophen
103429|NCT02643394|Postoperative pain|postoperative pain
103430|NCT02643394|Sinus Surgery|sinus surgery
103431|NCT02643381|etomidate|etomidate
103432|NCT02643381|ketamine|ketamine
103433|NCT02643381|endotracheal intubation|endotracheal intubation
103434|NCT02643381|anesthesia induction medications|anesthesia induction medications
103435|NCT02643368|Polio|polio
103436|NCT02643368|Inactivated polio vaccine|inactivated polio vaccine
104570|NCT02636751|Hip|hip
103437|NCT02643368|oral polio vaccine|oral polio vaccine
103438|NCT02643368|monovalent type 2 oral polio vaccine|monovalent type 2 oral polio vaccine
103439|NCT02643355|Narcotic Withdrawal|narcotic withdrawal
103440|NCT02643355|Opiate Withdrawal|opiate withdrawal
103441|NCT02643355|Emergency Department|emergency department
103442|NCT02643342|myopia control|myopia control
103443|NCT02643342|orthokeratology|orthokeratology
103445|NCT02643303|MEDI4736|medi4736
103446|NCT02643303|Tremelimumab|tremelimumab
103447|NCT02643303|PolyICLC|polyiclc
103448|NCT02643303|Hiltonol|hiltonol
103449|NCT02643303|Locally Recurrent Breast Cancer|locally recurrent breast cancer
103450|NCT02643303|Metastatic Melanoma|metastatic melanoma
103452|NCT02643303|CTLA-4 Antibody|ctla-4 antibody
103453|NCT02643303|PD-L1 Antibody|pd-l1 antibody
103454|NCT02643303|TLR3 Agonist|tlr3 agonist
103455|NCT02643290|Adult Scoliosis|adult scoliosis
103456|NCT02643290|Pain Management|pain management
103457|NCT02643290|Orthosis|orthosis
103458|NCT02643264|insula|insula
103459|NCT02643264|alcohol addiction|alcohol addiction
103460|NCT02643264|transcranial magnetic stimulation|transcranial magnetic stimulation
103461|NCT02643251|Diabetes Mellitus|diabetes mellitus
103462|NCT02643251|Pain|pain
103463|NCT02643251|Foot Pain|foot pain
103464|NCT02643251|Neuropathy|neuropathy
103465|NCT02643160|Trunk Training|trunk training
103466|NCT02643160|Motor Function|motor function
103467|NCT02643147|Heart Failure|heart failure
103468|NCT02643147|Renal Failure|renal failure
103469|NCT02643147|Biomarker guided-therapy|biomarker guided-therapy
103470|NCT02643147|Loop diuretics|loop diuretics
103471|NCT02643147|Carbohydrate antigen 125|carbohydrate antigen 125
103472|NCT02643134|ESWL|eswl
103473|NCT02643134|EPVL|epvl
103474|NCT02643134|PDI(Percussion,Diuresis,Inversion)|pdi(percussion,diuresis,inversion)
103475|NCT02643134|Randomized Controlled Trial(RCT)|randomized controlled trial(rct)
103478|NCT02643108|Vacuum extraction|vacuum extraction
103479|NCT02643108|Anal incontinence|anal incontinence
103480|NCT02643069|Frailty|frailty
103481|NCT02643069|Frailty tools|frailty tools
103482|NCT02643069|Clinical settings|clinical settings
103483|NCT02643069|Disability|disability
103484|NCT02643069|Quality of life|quality of life
103485|NCT02643069|Functional Autonomy|functional autonomy
103488|NCT02643017|cognitive function|cognitive function
103489|NCT02643017|desflurane|desflurane
103490|NCT02643017|dexmedetomidine|dexmedetomidine
103491|NCT02642978|minimally invasive surgery|minimally invasive surgery
103492|NCT02642978|colorectal liver metastasis|colorectal liver metastasis
103493|NCT02642978|robotic surgery|robotic surgery
103494|NCT02642978|Patients with resectable colorectal liver metastasis|patients with resectable colorectal liver metastasis
103495|NCT02642952|arterial stiffness, central hemodynamics|arterial stiffness, central hemodynamics
103496|NCT02642926|menorrhagia|menorrhagia
103497|NCT02642926|higham PBAC score|higham pbac score
103498|NCT02642926|endometrial ablation|endometrial ablation
103499|NCT02642926|bipolar energy|bipolar energy
103500|NCT02642926|monopolar energy|monopolar energy
103501|NCT02642913|Enzalutamide|enzalutamide
103502|NCT02642913|Sorafenib|sorafenib
103503|NCT02642913|15-279|15-279
103504|NCT02642900|Complete denture|complete denture
103505|NCT02642900|Candida spp|candida spp
103506|NCT02642900|Photodynamic therapy|photodynamic therapy
103507|NCT02642887|gingival recession|gingival recession
103508|NCT02642887|tunnel technique|tunnel technique
103509|NCT02642887|Miller Class I and II|miller class i and ii
103510|NCT02642835|mesh|mesh
103511|NCT02642835|pelvic organ prolapse|pelvic organ prolapse
103512|NCT02642822|Cytomegalovirus|cytomegalovirus
103513|NCT02642796|Percutaneous Electric Nerve Stimulation|percutaneous electric nerve stimulation
103514|NCT02642796|Lumbosacral plexus|lumbosacral plexus
103515|NCT02642796|surgical wound|surgical wound
103516|NCT02642796|postoperative analgesia|postoperative analgesia
103517|NCT02642796|transcutaneous electrical stimulation|transcutaneous electrical stimulation
103518|NCT02642783|laxatives|laxatives
103519|NCT02642783|sensory evaluation|sensory evaluation
103520|NCT02642783|acceptability|acceptability
103521|NCT02642783|colonoscopy|colonoscopy
103522|NCT02642770|Transesophageal echocardiography, Speckle tracking strain|transesophageal echocardiography, speckle tracking strain
103523|NCT02642757|alcohol drinking|alcohol drinking
103524|NCT02642757|hazardous alcohol use|hazardous alcohol use
103525|NCT02642757|risky alcohol consumption|risky alcohol consumption
103526|NCT02642757|heavy alcohol consumption|heavy alcohol consumption
103527|NCT02642731|total knee arthroplasty|total knee arthroplasty
103528|NCT02642731|Kidney function|kidney function
103529|NCT02642731|Renal markers|renal markers
103530|NCT02642718|preemptive analgesia|preemptive analgesia
103531|NCT02642718|postoperative pain|postoperative pain
103532|NCT02642718|NSAIDs|nsaids
103533|NCT02642718|ketorolac|ketorolac
103534|NCT02642718|abdominal hysterectomy|abdominal hysterectomy
103535|NCT02642692|ACL reconstruction|acl reconstruction
103536|NCT02642692|Single bundle|single bundle
103537|NCT02642692|Clinical results|clinical results
103538|NCT02642692|Soccer players|soccer players
103539|NCT02642679|Split-thickness skin graft, donor site, chitosan, dressing|split-thickness skin graft, donor site, chitosan, dressing
103540|NCT02642666|Attention|attention
103541|NCT02642666|Hyperactivity|hyperactivity
103542|NCT02642666|Impulsivity|impulsivity
103543|NCT02642666|Yoga|yoga
103544|NCT02642666|Preschool|preschool
103545|NCT02642653|Fra(X) Syndrome|fra(x) syndrome
103546|NCT02642653|Trinucleotide Repeat Expansion|trinucleotide repeat expansion
103547|NCT02642653|Fragile X Syndrome|fragile x syndrome
103548|NCT02642653|Fragile X Mental Retardation Syndrome|fragile x mental retardation syndrome
103549|NCT02642653|Intellectual Disability|intellectual disability
103550|NCT02642653|Parent Implemented Language Intervention (PILI)|parent implemented language intervention (pili)
103551|NCT02642653|FXS|fxs
103552|NCT02642653|Mental Retardation, X-linked|mental retardation, x-linked
103553|NCT02642653|Genetic Diseases, X-linked|genetic diseases, x-linked
103554|NCT02642653|Neurobehavioral Manifestations|neurobehavioral manifestations
103555|NCT02642653|Chromosome Disorders|chromosome disorders
103556|NCT02642601|indomethacin, ICSI, difficult embryo transfer|indomethacin, icsi, difficult embryo transfer
103557|NCT02642562|Intravenous iron|intravenous iron
103558|NCT02642562|PROBE design|probe design
103559|NCT02642536|Veteran|veteran
103560|NCT02642523|natriuretic peptide|natriuretic peptide
103561|NCT02642523|insulin|insulin
103562|NCT02642523|lipolysis|lipolysis
103563|NCT02642523|hormones|hormones
103564|NCT02642523|metabolism|metabolism
103565|NCT02642497|postoperative analgesia|postoperative analgesia
103566|NCT02642497|ketamine|ketamine
103567|NCT02642497|total thyroidectomy|total thyroidectomy
103568|NCT02642471|sentinel lymph node|sentinel lymph node
103569|NCT02642471|pelvic lymphadenectomy|pelvic lymphadenectomy
103570|NCT02642471|cervical carcinoma|cervical carcinoma
103572|NCT02642471|radiotherapy|radiotherapy
103573|NCT02642445|Renal sympathetic denervation;hypertension|renal sympathetic denervation;hypertension
103574|NCT02642432|HCV Genotype 1|hcv genotype 1
103575|NCT02642432|HCV Genotype 4|hcv genotype 4
103576|NCT02642432|HCV Genotype 2|hcv genotype 2
103577|NCT02642432|Cirrhotic|cirrhotic
103578|NCT02642432|Interferon-Free|interferon-free
103579|NCT02642432|Compensated Cirrhosis|compensated cirrhosis
103580|NCT02642432|HCV Genotype 5|hcv genotype 5
103581|NCT02642432|Hepatitis C|hepatitis c
103582|NCT02642432|HCV Genotype 6|hcv genotype 6
103583|NCT02642393|SURE-PD3|sure-pd3
103584|NCT02642393|Parkinson's disease|parkinson's disease
103586|NCT02642393|Inosine|inosine
103587|NCT02642393|Urate|urate
103588|NCT02642393|Parkinson Study Group (PSG)|parkinson study group (psg)
103589|NCT02642380|ITP|itp
103590|NCT02642380|high-dose dexamethasone|high-dose dexamethasone
103591|NCT02642328|VO2Max|vo2max
103592|NCT02642328|Aerobic Exercise|aerobic exercise
103593|NCT02642328|Physical Conditioning|physical conditioning
103594|NCT02642302|VO2Max|vo2max
103595|NCT02642302|Aerobic Exercise|aerobic exercise
103596|NCT02642302|Physical Conditioning|physical conditioning
103597|NCT02642289|Probiotics|probiotics
103598|NCT02642276|exercise training|exercise training
103599|NCT02642250|safety|safety
103600|NCT02642250|efficacy|efficacy
103601|NCT02642237|Fluenz|fluenz
103602|NCT02642237|innate immune response|innate immune response
103603|NCT02642237|endotoxin tolerance|endotoxin tolerance
103604|NCT02642237|priming|priming
103605|NCT02642224|Violence|violence
103606|NCT02642224|firearm|firearm
103607|NCT02642224|guns|guns
103608|NCT02642224|homicide|homicide
103609|NCT02642224|trauma|trauma
103610|NCT02642224|injury|injury
103611|NCT02642198|NiBP|nibp
103612|NCT02642185|microwave|microwave
103613|NCT02642185|ablation|ablation
103614|NCT02642185|resection|resection
103615|NCT02642185|liver|liver
103616|NCT02642185|colorectal|colorectal
103617|NCT02642185|survival|survival
103618|NCT02642185|metastasis|metastasis
103619|NCT02642172|Inulin, OFS (oligofructose)|inulin, ofs (oligofructose)
103620|NCT02642107|nasopharyngeal carcinoma|nasopharyngeal carcinoma
103621|NCT02642107|elective neck irradiation|elective neck irradiation
103622|NCT02642081|NSAIDs|nsaids
103623|NCT02642081|Heart failure|heart failure
103624|NCT02642081|Acute kidney injury|acute kidney injury
103625|NCT02642068|Drug-naïve Adult ADHD|drug-naïve adult adhd
103626|NCT02642068|Neuropsychology|neuropsychology
103627|NCT02642068|Neurophysiology|neurophysiology
103628|NCT02642068|Neuroimaging|neuroimaging
103629|NCT02642068|Follow-up|follow-up
103630|NCT02642055|ADHD|adhd
103631|NCT02642055|Neurofeedback|neurofeedback
103632|NCT02642055|Biofeedback|biofeedback
103633|NCT02642055|Neuro+|neuro+
103634|NCT02642055|Go/no-go|go/no-go
103635|NCT02642055|Attention training|attention training
103636|NCT02642029|time perception|time perception
103637|NCT02642029|executive function|executive function
103638|NCT02642029|psychosis|psychosis
103639|NCT02642029|mood symptoms|mood symptoms
103640|NCT02642016|KTN0158|ktn0158
103641|NCT02642016|Advanced Cancer|advanced cancer
103642|NCT02642016|Phase 1|phase 1
103643|NCT02642016|Monoclonal Antibody|monoclonal antibody
103644|NCT02642016|Safety and Pharmacokinetics|safety and pharmacokinetics
103645|NCT02641925|Metabolic syndrome|metabolic syndrome
103646|NCT02641925|gastric cancer|gastric cancer
103647|NCT02641925|omentectomy|omentectomy
103648|NCT02641899|Adult|adult
103649|NCT02641899|Male|male
103650|NCT02641899|Female|female
103651|NCT02641899|Volunteers|volunteers
103652|NCT02641886|traditional Chinese medicine granules|traditional chinese medicine granules
103653|NCT02641886|Cognitive Impairment|cognitive impairment
642414|NCT00747838|Afib|afib
103654|NCT02641886|Acute cerebral infraction|acute cerebral infraction
103655|NCT02641886|prevention|prevention
103656|NCT02641873|metastatic Colorectal Cancer|metastatic colorectal cancer
103657|NCT02641873|mCRC|mcrc
103658|NCT02641847|triple negative breast cancer|triple negative breast cancer
103659|NCT02641847|mRNA-lncRNA signature|mrna-lncrna signature
103660|NCT02641847|chemotherapy|chemotherapy
103661|NCT02641847|high risk|high risk
103662|NCT02641834|diet|diet
103663|NCT02641834|vegetarian|vegetarian
103664|NCT02641834|cardiovascular risk|cardiovascular risk
103665|NCT02641795|cochlear implantation|cochlear implantation
103666|NCT02641795|robotics|robotics
103667|NCT02641795|image guidance|image guidance
103668|NCT02641782|High Risk Neuroblastoma|high risk neuroblastoma
103669|NCT02641756|HIV reservoir|hiv reservoir
103670|NCT02641756|phylogenetic analysis|phylogenetic analysis
103671|NCT02641756|sequencing|sequencing
103672|NCT02641730|Guselkumab|guselkumab
103673|NCT02641730|CNTO 1959|cnto 1959
103674|NCT02641730|Placebo|placebo
103675|NCT02641730|Palmoplantar Pustulosis|palmoplantar pustulosis
103676|NCT02641717|patient-collected|patient-collected
103677|NCT02641717|self-collected|self-collected
103679|NCT02641717|vaginosis, bacterial|vaginosis, bacterial
103680|NCT02641717|candidiasis|candidiasis
103681|NCT02641717|trichomonas|trichomonas
103682|NCT02641717|vaginal discharge|vaginal discharge
103683|NCT02641678|Atrial Fibrillation|atrial fibrillation
103684|NCT02641678|stroke|stroke
103685|NCT02641678|implantable cardiac monitor|implantable cardiac monitor
103686|NCT02641678|automated ECG analysis|automated ecg analysis
103687|NCT02641652|paroxysmal hypertension|paroxysmal hypertension
103688|NCT02641652|pseudopheochromocytoma|pseudopheochromocytoma
103689|NCT02641626|cardiac arrest|cardiac arrest
103690|NCT02641626|survival|survival
103691|NCT02641626|neurologic prognosis|neurologic prognosis
103692|NCT02641626|coronariography|coronariography
103693|NCT02641626|hypothermia|hypothermia
103694|NCT02641587|Smoking|smoking
103695|NCT02641587|Combustible cigarette|combustible cigarette
103696|NCT02641587|Reduced exposure|reduced exposure
103697|NCT02641587|Confinement|confinement
103698|NCT02641587|Ambulatory|ambulatory
103699|NCT02641587|Carbon Heated Tobacco Product|carbon heated tobacco product
103700|NCT02640599|Vestibular|vestibular
103701|NCT02640599|Rehabilitation|rehabilitation
103702|NCT02640560|Children|children
103703|NCT02640560|Allergy|allergy
103704|NCT02640560|Peanuts|peanuts
103705|NCT02640560|Hazelnuts|hazelnuts
103706|NCT02640560|Walnuts|walnuts
103707|NCT02640560|Mollusks|mollusks
103708|NCT02640560|Shellfish|shellfish
103709|NCT02640560|Food|food
103710|NCT02640547|Fibrosis|fibrosis
103711|NCT02640547|Chronic Hepatitis C|chronic hepatitis c
103712|NCT02640547|Cirrhosis|cirrhosis
103713|NCT02640547|Work Ability|work ability
103714|NCT02640547|Dasabuvir|dasabuvir
103715|NCT02640547|Quality of Life|quality of life
103716|NCT02640547|Observational Study|observational study
103717|NCT02640547|Paritaprevir/r/Ombitasvir|paritaprevir/r/ombitasvir
103718|NCT02640534|Prostate cancer|prostate cancer
103719|NCT02640534|Cancer of the prostate|cancer of the prostate
103720|NCT02640534|Metformin|metformin
103721|NCT02640534|Enzalutamide|enzalutamide
103722|NCT02640534|Xtandi|xtandi
103723|NCT02640534|castration resistant prostate cancer|castration resistant prostate cancer
103724|NCT02640534|phase II|phase ii
103725|NCT02640534|Androgen deprivation therapy|androgen deprivation therapy
103726|NCT02640495|Treatment Efficacy|treatment efficacy
103727|NCT02640495|drug resistance|drug resistance
103728|NCT02640495|Artemisinin|artemisinin
103729|NCT02640482|Treatment-Naive|treatment-naive
103730|NCT02640482|Hepatitis C Virus Genotype 2|hepatitis c virus genotype 2
103731|NCT02640482|Sofosbuvir (SOF)-Experienced|sofosbuvir (sof)-experienced
103732|NCT02640482|Treatment-Experienced|treatment-experienced
103733|NCT02640482|Non-cirrhotic|non-cirrhotic
103734|NCT02640469|chlorhexidine|chlorhexidine
103735|NCT02640469|sterility|sterility
103736|NCT02640469|sterile hands|sterile hands
103737|NCT02640456|retropharyngeal abscess|retropharyngeal abscess
103738|NCT02640456|parapharyngeal abscess|parapharyngeal abscess
103739|NCT02640456|peritonsillar abscess|peritonsillar abscess
103740|NCT02640456|bacteriology|bacteriology
103741|NCT02640456|Fusobacterium necrophorum|fusobacterium necrophorum
103742|NCT02640417|Nucleotides (uridine, cytidine)|nucleotides (uridine, cytidine)
103743|NCT02640417|Vitamin B1|vitamin b1
103744|NCT02640417|Vitamin B6|vitamin b6
103745|NCT02640417|Vitamin B12|vitamin b12
103746|NCT02640404|Meningitis|meningitis
103747|NCT02640404|Meningococcal Meningitis|meningococcal meningitis
103748|NCT02640404|Meningococcal Infections|meningococcal infections
103749|NCT02640404|Menactra®|menactra®
103750|NCT02640404|Meningococcal Vaccine|meningococcal vaccine
103751|NCT02640391|Ulcerative colitis|ulcerative colitis
103752|NCT02640391|fecal calprotectin|fecal calprotectin
103753|NCT02640391|mucosal healing|mucosal healing
103754|NCT02639624|hemodialysis|hemodialysis
103755|NCT02639624|kidney|kidney
103766|NCT02641561|Indomethacin|indomethacin
103767|NCT02641561|Lactated ringer's|lactated ringer's
103769|NCT02641522|Type 1 diabetes|type 1 diabetes
103770|NCT02641496|Obstructive Sleep Apnea|obstructive sleep apnea
103771|NCT02641496|PTSD|ptsd
103772|NCT02641496|Posttraumatic Stress Disorder|posttraumatic stress disorder
103773|NCT02641496|Cognitive Behavioral Therapy|cognitive behavioral therapy
103774|NCT02641496|Continuous Positive Airway Pressure|continuous positive airway pressure
103775|NCT02641496|CPAP|cpap
103776|NCT02641496|Cognition|cognition
103777|NCT02641496|Memory|memory
103778|NCT02641496|Quality of Life|quality of life
103779|NCT02641496|Self Efficacy|self efficacy
103780|NCT02641496|CBT|cbt
103781|NCT02641457|rubeosis iridis|rubeosis iridis
103782|NCT02641457|glaucoma|glaucoma
103783|NCT02641457|ranibizumab|ranibizumab
103788|NCT02641431|syncope|syncope
103789|NCT02641418|Exercise|exercise
103790|NCT02641405|Gait analysis|gait analysis
103791|NCT02641405|Proprioceptive focal stimulation|proprioceptive focal stimulation
103792|NCT02641405|Parkinson|parkinson
103798|NCT02641353|Apremilast|apremilast
103799|NCT02641353|Healthy volunteers|healthy volunteers
103800|NCT02641353|Bioavailability|bioavailability
103801|NCT02641353|Food effect|food effect
103802|NCT02641353|Pharmacokinetic|pharmacokinetic
103803|NCT02641327|Inhospital patients|inhospital patients
103804|NCT02641314|high risk neuroblastoma|high risk neuroblastoma
103805|NCT02641301|obesity|obesity
103806|NCT02641301|Roux-en-Y-gastric bypass|roux-en-y-gastric bypass
103807|NCT02641301|pharmacokinetics|pharmacokinetics
103808|NCT02641301|Pain|pain
103809|NCT02641301|morphine|morphine
103810|NCT02641275|Parental stress|parental stress
103811|NCT02641275|Muscular Dystrophies|muscular dystrophies
103812|NCT02641275|Coping|coping
103813|NCT02641275|Parental support|parental support
103814|NCT02641262|Myocardial Infarction|myocardial infarction
103815|NCT02641262|Angioplasty, Balloon, Coronary|angioplasty, balloon, coronary
103816|NCT02641262|Drug Therapy|drug therapy
103817|NCT02641236|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
103818|NCT02641236|Acute GVH Disease|acute gvh disease
103819|NCT02641210|Chronic periodontitis|chronic periodontitis
103820|NCT02641210|Hepcidin|hepcidin
103821|NCT02641210|Hemoglobin|hemoglobin
103822|NCT02641210|Inflammation|inflammation
103823|NCT02641197|flow-mediated dilation|flow-mediated dilation
103824|NCT02641197|AngioDefender|angiodefender
103825|NCT02641197|device precision|device precision
103826|NCT02641197|repeatability|repeatability
103827|NCT02641197|reproducibility|reproducibility
103828|NCT02641197|cardiovascular diseases|cardiovascular diseases
103829|NCT02641184|Myocardial Infarction|myocardial infarction
103830|NCT02641184|Cardiovascular Diseases|cardiovascular diseases
103831|NCT02641184|Heart Diseases|heart diseases
103832|NCT02641184|Infarction|infarction
103833|NCT02641184|Diabetes|diabetes
103835|NCT02641158|Hepatitis C|hepatitis c
103836|NCT02641158|Substance users|substance users
103837|NCT02641158|Drug users|drug users
103838|NCT02641145|amyloidosis|amyloidosis
103839|NCT02641145|F-18 florbetapir|f-18 florbetapir
103840|NCT02641145|Positron emission tomography|positron emission tomography
103841|NCT02641145|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
103842|NCT02641119|Albumin|albumin
103843|NCT02641119|Resuscitation|resuscitation
103844|NCT02641106|Telemedicine|telemedicine
103845|NCT02641106|Mobile Phone|mobile phone
103846|NCT02641106|Adherence|adherence
103847|NCT02641106|Latent Tuberculosis Infection|latent tuberculosis infection
103848|NCT02641106|Directly Observed Therapy|directly observed therapy
103849|NCT02641106|Video DOT|video dot
103850|NCT02641041|Japanese|japanese
103851|NCT02641041|Single Ascending Dose (SAD)|single ascending dose (sad)
103852|NCT02641041|Multiple Ascending Dose (MAD)|multiple ascending dose (mad)
103853|NCT02641015|UTI|uti
103864|NCT02640989|Influenza Vaccine|influenza vaccine
103865|NCT02640989|Safety|safety
103866|NCT02640989|Immunogenicity|immunogenicity
103867|NCT02640976|in vitro fertilization|in vitro fertilization
103868|NCT02640976|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
103869|NCT02640976|poor ovarian response|poor ovarian response
103870|NCT02640976|estrogen receptor 2 gene polymorphism|estrogen receptor 2 gene polymorphism
103871|NCT02640976|follicle stimulating hormone receptor gene polymorphism|follicle stimulating hormone receptor gene polymorphism
103872|NCT02640976|anti-mullerian hormone|anti-mullerian hormone
103873|NCT02640963|exercise|exercise
103874|NCT02640963|older adults|older adults
103875|NCT02640963|physical performance|physical performance
103876|NCT02640937|Staphylococcus epidermidis|staphylococcus epidermidis
103877|NCT02640937|biofilm formation|biofilm formation
103878|NCT02640937|antibiotic resistance|antibiotic resistance
103879|NCT02640937|Orthopaedic device related infections|orthopaedic device related infections
103880|NCT02640937|risk factor|risk factor
104400|NCT02637661|risk factor|risk factor
103881|NCT02640924|Hepatocellular carcinoma|hepatocellular carcinoma
103882|NCT02640924|Proton therapy|proton therapy
103883|NCT02640924|Radiation therapy|radiation therapy
103983|NCT02640144|Knee arthroscopy|knee arthroscopy
103884|NCT02640924|Switching control radiofrequency ablation|switching control radiofrequency ablation
103885|NCT02640872|sarcopenia|sarcopenia
103886|NCT02640872|sarcopenic obesity|sarcopenic obesity
103887|NCT02640872|osteoporosis|osteoporosis
103888|NCT02640872|fracture|fracture
103889|NCT02640872|cardiovascular disease|cardiovascular disease
103890|NCT02640872|mortality|mortality
103891|NCT02640846|Levosimendan|levosimendan
103892|NCT02640846|Milrinone|milrinone
103893|NCT02640846|Myocardial strain|myocardial strain
103894|NCT02640846|Septic cardiomyopathy|septic cardiomyopathy
103895|NCT02640833|Refractory Lymphoma|refractory lymphoma
103896|NCT02640833|Relapsed Leukemia|relapsed leukemia
103898|NCT02640820|Verruca Vulgaris|verruca vulgaris
103899|NCT02640807|sepsis lymphocytopenia IL-7|sepsis lymphocytopenia il-7
103900|NCT02640807|immune reconstitution|immune reconstitution
103901|NCT02640794|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
103902|NCT02640794|Antithrombotic treatment|antithrombotic treatment
103903|NCT02640794|Clopidogrel|clopidogrel
103904|NCT02640794|Aspirin/acetylsalicylic acid|aspirin/acetylsalicylic acid
103905|NCT02640794|Myocardial Infarction|myocardial infarction
103906|NCT02640794|Ischemic stroke|ischemic stroke
103907|NCT02640794|Major bleeding|major bleeding
103908|NCT02640768|in-hospital diabetes|in-hospital diabetes
103909|NCT02640768|clinical and management model|clinical and management model
103910|NCT02640755|Radiolabelled|radiolabelled
103911|NCT02640729|Lewy body dementia|lewy body dementia
103912|NCT02640729|Dementia with Lewy bodies|dementia with lewy bodies
103913|NCT02640729|Parkinson's disease dementia|parkinson's disease dementia
103914|NCT02640729|Lewy bodies|lewy bodies
103915|NCT02640729|Visual hallucinations|visual hallucinations
103916|NCT02640690|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
103917|NCT02640690|Yoga|yoga
103918|NCT02640690|Cognitive Therapy|cognitive therapy
103919|NCT02640690|Chronic Pain|chronic pain
103920|NCT02640690|Veterans|veterans
103921|NCT02640690|cytokines|cytokines
103922|NCT02640690|acoustic startle reflex|acoustic startle reflex
103923|NCT02640664|open-label, long-term, extension study|open-label, long-term, extension study
103924|NCT02640664|intravitreal ranibizumab|intravitreal ranibizumab
103925|NCT02640664|laser ablation therapy|laser ablation therapy
103926|NCT02640664|retinopathy of prematurity|retinopathy of prematurity
103927|NCT02640664|preterm infants|preterm infants
103928|NCT02640664|RAINBOW|rainbow
103929|NCT02640638|Racial disparities|racial disparities
103931|NCT02640625|Probiotics|probiotics
103932|NCT02640625|Microbiota|microbiota
103933|NCT02640625|Mucosal immunology|mucosal immunology
103934|NCT02640625|Gut biopsy|gut biopsy
103935|NCT02640365|cancer|cancer
103936|NCT02640365|GERCOR|gercor
103937|NCT02640365|unresectable|unresectable
103938|NCT02640365|MM-398|mm-398
103939|NCT02640365|CPT-11|cpt-11
103940|NCT02640365|colorectal|colorectal
103941|NCT02640365|non colorectal|non colorectal
103942|NCT02640326|Urinary Catheterization|urinary catheterization
103943|NCT02640326|Randomized Controlled Trial|randomized controlled trial
103944|NCT02640326|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
103945|NCT02640326|Quality Improvement|quality improvement
103946|NCT02640326|Evidence-Based Practice|evidence-based practice
103947|NCT02640326|Post-operative complications|post-operative complications
103948|NCT02640313|18F-fluormethylcholine|18f-fluormethylcholine
103949|NCT02640313|[F18] choline|[f18] choline
103950|NCT02640313|[F18] fluormethylcholine|[f18] fluormethylcholine
103951|NCT02640300|antipsychotics, clozapine, schizophrenia, switching strategy|antipsychotics, clozapine, schizophrenia, switching strategy
103952|NCT02640274|Practise Patterns, Nurses'|practise patterns, nurses'
103953|NCT02640274|Directive Counseling|directive counseling
103954|NCT02640274|Self Care|self care
103955|NCT02640261|r-hLH|r-hlh
103956|NCT02640261|Cytokines|cytokines
103957|NCT02640261|Follicular Fluid|follicular fluid
103958|NCT02640235|Hemostasis|hemostasis
103959|NCT02640235|Oxidized Cellulose Strip|oxidized cellulose strip
103960|NCT02640235|Traumacel|traumacel
103961|NCT02640235|Traumastem|traumastem
103962|NCT02640235|Cardiothoracic Surgery|cardiothoracic surgery
103963|NCT02640235|General Surgery|general surgery
103964|NCT02640235|Vascular Surgery|vascular surgery
103965|NCT02640196|Laryngoscope|laryngoscope
103966|NCT02640196|Macintosh|macintosh
103967|NCT02640196|Glidescope|glidescope
103968|NCT02640196|King Vision|king vision
103969|NCT02640196|Airtraq|airtraq
103970|NCT02640196|Double Lumen Tube|double lumen tube
103971|NCT02640157|interferon free|interferon free
103972|NCT02640157|Hepatitis C|hepatitis c
103973|NCT02640157|daclatasvir|daclatasvir
103974|NCT02640157|Sovaldi|sovaldi
103977|NCT02640157|Hepatitis C Genotype 3|hepatitis c genotype 3
103979|NCT02640157|sofosbuvir|sofosbuvir
103980|NCT02640157|Chronic Hepatitis C|chronic hepatitis c
103981|NCT02640157|Daklinza|daklinza
103982|NCT02640144|Hyaluronic acid|hyaluronic acid
103987|NCT02640144|cartilage lesion|cartilage lesion
103988|NCT02640144|rehabilitation following knee arthroscopy|rehabilitation following knee arthroscopy
103989|NCT02640144|Hyaluronic acid injection|hyaluronic acid injection
103990|NCT02640131|prostate cancer|prostate cancer
103991|NCT02640131|radical prostatectomy|radical prostatectomy
103992|NCT02640131|survivorship|survivorship
103993|NCT02640131|quality of life|quality of life
103994|NCT02640131|erectile dysfunction|erectile dysfunction
103995|NCT02640131|sexual dysfunction|sexual dysfunction
103996|NCT02640131|feasibility study|feasibility study
103997|NCT02640079|Cognitive behavioral therapy|cognitive behavioral therapy
103998|NCT02640079|Laboratory pain responsivity|laboratory pain responsivity
103999|NCT02640014|Food allergy|food allergy
123644|NCT02522585|p16|p16
104000|NCT02640014|Health-related quality of life (HRQL)|health-related quality of life (hrql)
104001|NCT02640014|Quality-adjusted life-years (QALYs)|quality-adjusted life-years (qalys)
104002|NCT02640014|Oral immunotherapy (OIT)|oral immunotherapy (oit)
104003|NCT02640014|Cow´s milk allergy (CMA)|cow´s milk allergy (cma)
104004|NCT02640014|Milk oral immunotherapy (MOIT)|milk oral immunotherapy (moit)
104005|NCT02639988|type 2 diabetes mellitus|type 2 diabetes mellitus
104006|NCT02639988|Rheumatoid arthritis|rheumatoid arthritis
104007|NCT02639975|Adenosine A3 receptor antagonist|adenosine a3 receptor antagonist
104008|NCT02639962|culprit lesion|culprit lesion
104009|NCT02639962|arteriosclerosis|arteriosclerosis
104010|NCT02639962|cardiac CT|cardiac ct
104011|NCT02639923|TBI|tbi
104012|NCT02639923|microRNA|microrna
104013|NCT02639923|S-100B|s-100b
104014|NCT02639910|CD19|cd19
104015|NCT02639910|MOR208|mor208
104016|NCT02639910|MOR00208|mor00208
104017|NCT02639910|CLL|cll
104018|NCT02639910|SLL|sll
104019|NCT02639910|COSMOS|cosmos
104020|NCT02639871|Huntington disease|huntington disease
104021|NCT02639871|Neuroimaging metabolic biomarker|neuroimaging metabolic biomarker
104022|NCT02639832|Triple Negative Breast Cancer|triple negative breast cancer
104023|NCT02639832|Breast Cancer|breast cancer
104024|NCT02639832|Natural Killer Cells|natural killer cells
104025|NCT02639832|BRCA Mutation|brca mutation
104026|NCT02639819|Intracerebral Hemorrhage|intracerebral hemorrhage
104027|NCT02639819|Stroke|stroke
104028|NCT02639819|Cerebrovascular|cerebrovascular
104029|NCT02639806|stroke|stroke
104030|NCT02639806|endovascular|endovascular
104031|NCT02639806|thrombectomy|thrombectomy
104032|NCT02639806|ischemic stroke|ischemic stroke
104033|NCT02639806|general anesthetic|general anesthetic
104034|NCT02639806|local anesthetic|local anesthetic
104035|NCT02639806|recanalization|recanalization
104036|NCT02639793|arrhythmias, quality of life|arrhythmias, quality of life
104037|NCT02639767|Pemetrexed|pemetrexed
104038|NCT02639767|Cisplatin|cisplatin
104039|NCT02639767|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
104040|NCT02639767|15-304|15-304
104041|NCT02639741|Melatonin|melatonin
104042|NCT02639741|Vitamin C|vitamin c
104043|NCT02639741|Morphine consumption|morphine consumption
104044|NCT02639728|Bowel surgery|bowel surgery
104045|NCT02639728|Postoperative bowel recovery|postoperative bowel recovery
104046|NCT02639702|Clozapine|clozapine
104047|NCT02639702|Dosing|dosing
104048|NCT02639702|Once daily|once daily
104049|NCT02639702|Regimen|regimen
104050|NCT02639702|Schizophrenia|schizophrenia
104051|NCT02639689|Deficits of foot relievers of central origin|deficits of foot relievers of central origin
104052|NCT02639689|Walkaide|walkaide
104056|NCT02639650|gestational trophoblastic tumor|gestational trophoblastic tumor
104057|NCT02639650|paclitaxel|paclitaxel
104058|NCT02639650|cisplatin|cisplatin
104059|NCT02639650|carboplatin|carboplatin
104060|NCT02639650|chemotherapy|chemotherapy
104061|NCT02639637|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
104062|NCT02639637|Sitagliptin|sitagliptin
104063|NCT02639637|Dipeptidyl Peptidase IV Inhibitors|dipeptidyl peptidase iv inhibitors
104064|NCT02639637|Angiotensin Converting Enzyme Inhibitors|angiotensin converting enzyme inhibitors
104065|NCT02639637|Enalaprilat|enalaprilat
104066|NCT02639637|Neuropeptide Y|neuropeptide y
104071|NCT02639520|Uncomplicated urinary tract infection|uncomplicated urinary tract infection
104072|NCT02639481|traumatic brain injury|traumatic brain injury
104074|NCT02639481|disorders of consciousness|disorders of consciousness
104075|NCT02639481|rehabilitation|rehabilitation
104076|NCT02639481|robotic rehabilitation device|robotic rehabilitation device
104077|NCT02639416|severe acute malnutrition|severe acute malnutrition
104078|NCT02639416|polymeric therapeutic formula|polymeric therapeutic formula
104079|NCT02639416|elemental therapeutic formula|elemental therapeutic formula
104080|NCT02639403|Rectal cancer|rectal cancer
104081|NCT02639403|Radiotherapy|radiotherapy
104082|NCT02639403|Occlusion|occlusion
104083|NCT02639390|Robotics|robotics
104084|NCT02639390|upper extremity|upper extremity
104085|NCT02639390|neurorehabilitation|neurorehabilitation
104086|NCT02639390|movement therapy|movement therapy
104087|NCT02639377|Dental Implantation|dental implantation
104088|NCT02639377|Chlorhexidine gluconate|chlorhexidine gluconate
104089|NCT02639338|Chronic|chronic
104090|NCT02639325|Brain Tumor|brain tumor
104091|NCT02639325|Brain Cancer|brain cancer
104092|NCT02639325|Seizure Disorder|seizure disorder
104093|NCT02639325|Seizures|seizures
104094|NCT02639312|Cranofacial|cranofacial
104095|NCT02639312|Microsomia|microsomia
104096|NCT02639312|Mandibular|mandibular
104097|NCT02639312|Facial Defects|facial defects
104098|NCT02639312|Hasburg Jaw|hasburg jaw
104099|NCT02639299|Subjects|subjects
104100|NCT02639299|Venipuncture|venipuncture
104101|NCT02639299|Research|research
104102|NCT02639299|Evaluate|evaluate
104103|NCT02639299|Recruit|recruit
104104|NCT02639286|Lipodystrophy|lipodystrophy
104105|NCT02639286|Hypertriglyceridemia|hypertriglyceridemia
104106|NCT02639273|Nalmefene|nalmefene
104107|NCT02639273|fMRI|fmri
104108|NCT02639273|Incentive Salience|incentive salience
104109|NCT02639273|Reward Processing|reward processing
104110|NCT02639273|Aversive Event Processing|aversive event processing
104111|NCT02639260|Nephrotic Syndrome|nephrotic syndrome
104112|NCT02639260|Glomerular Filtration Rate|glomerular filtration rate
104113|NCT02639260|Sialic Acid|sialic acid
104114|NCT02639260|Proteinuria|proteinuria
104115|NCT02639247|Chronic|chronic
104116|NCT02639208|Breast Cancer I|breast cancer i
104117|NCT02639208|Breast Cancer Stage II|breast cancer stage ii
104118|NCT02639208|Breast Cancer Stage III|breast cancer stage iii
104119|NCT02639182|Axitinib|axitinib
104120|NCT02639182|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
104121|NCT02639182|AGS-16C3F|ags-16c3f
104122|NCT02639169|music therapy|music therapy
104123|NCT02639169|Distress|distress
104124|NCT02639169|Mood|mood
104125|NCT02639169|HSCT|hsct
104126|NCT02639130|Gastric Inhibitory Polypeptide (GIP)|gastric inhibitory polypeptide (gip)
104127|NCT02639130|Glucagon-Like Peptide 1 (GLP-1)|glucagon-like peptide 1 (glp-1)
104128|NCT02639130|DPP-4 inhibition; Exendin [9-39]|dpp-4 inhibition; exendin [9-39]
104129|NCT02639130|Gastric emptying|gastric emptying
104130|NCT02639130|Glucagon|glucagon
104131|NCT02639130|Incretin|incretin
104132|NCT02639130|Insulin Secretion|insulin secretion
104133|NCT02639130|Normal glucose-tolerant|normal glucose-tolerant
104134|NCT02639117|basal cell carcinoma, photodynamic therapy, vismodegib|basal cell carcinoma, photodynamic therapy, vismodegib
104135|NCT02639104|neck pain|neck pain
104136|NCT02639104|cervical lordosis|cervical lordosis
104137|NCT02639104|long thoracic nerve|long thoracic nerve
104144|NCT02639078|Single ascending dose|single ascending dose
104145|NCT02639078|volunteers|volunteers
104146|NCT02639078|Phase 1|phase 1
104147|NCT02639078|first-in-human|first-in-human
104148|NCT02639078|TD-0714|td-0714
104149|NCT02639065|Durvalumab|durvalumab
104150|NCT02639065|MEDI4736|medi4736
104151|NCT02639065|PD-L1 inhibitor|pd-l1 inhibitor
104152|NCT02639052|Itch|itch
104153|NCT02639052|Botox|botox
104154|NCT02639052|Healthy Volunteers|healthy volunteers
104155|NCT02638987|Dry needling|dry needling
104156|NCT02638987|office workers|office workers
104157|NCT02638987|myofascial pain|myofascial pain
104158|NCT02638987|electromyography|electromyography
104159|NCT02638961|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
104160|NCT02638961|physical therapy|physical therapy
104161|NCT02638961|exercise capacity|exercise capacity
104162|NCT02638961|quality of life|quality of life
104163|NCT02638935|Virtual Touch Tissue Imaging|virtual touch tissue imaging
104164|NCT02638935|VTIQ|vtiq
104165|NCT02638935|Elastography|elastography
104166|NCT02638935|Breast Cancer|breast cancer
104169|NCT02638935|Breast Lesion|breast lesion
104170|NCT02638909|Gastrointestinal malignancies|gastrointestinal malignancies
104171|NCT02638896|Ankylosing Spondylitis|ankylosing spondylitis
104172|NCT02638896|Etanercept|etanercept
104173|NCT02638896|Sulfasalazine|sulfasalazine
104174|NCT02638896|Efficacy|efficacy
104175|NCT02638896|Safety|safety
104176|NCT02638896|dose|dose
104177|NCT02638896|reduction|reduction
104178|NCT02638857|Recurrence Hepatocellular Carcinoma|recurrence hepatocellular carcinoma
104179|NCT02638857|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
104180|NCT02638857|Dendritic Cell -Precision Multiple Antigen T Cells|dendritic cell -precision multiple antigen t cells
104181|NCT02638857|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
104182|NCT02638844|echocardiography|echocardiography
104184|NCT02638831|Gonarthrosis|gonarthrosis
104185|NCT02638831|Low Back Pain|low back pain
104186|NCT02638831|Ketorolac Tromethamine|ketorolac tromethamine
104187|NCT02638831|Ketoprofen|ketoprofen
104188|NCT02638818|pancreaticoduodenectomy|pancreaticoduodenectomy
104189|NCT02638818|Whipple|whipple
104190|NCT02638779|Septic shock|septic shock
104191|NCT02638779|severe trauma|severe trauma
104192|NCT02638779|severe burn|severe burn
104193|NCT02638779|major surgery|major surgery
104194|NCT02638779|immunosuppression|immunosuppression
104195|NCT02638779|Healthcare-Associated Infections|healthcare-associated infections
104196|NCT02638766|metastatic|metastatic
104197|NCT02638766|unresectable|unresectable
104198|NCT02638766|KIT/PDGFR wild type GIST|kit/pdgfr wild type gist
104199|NCT02638753|non specific chronic low back pain|non specific chronic low back pain
104200|NCT02638753|education on pain neurophysiology|education on pain neurophysiology
104201|NCT02638753|education on pain biology|education on pain biology
104202|NCT02638753|education on pain neuroscience|education on pain neuroscience
104203|NCT02638753|hypnosis|hypnosis
104204|NCT02638727|vascular disease|vascular disease
104205|NCT02638727|endothelial function|endothelial function
104206|NCT02638727|L-Citrulline|l-citrulline
104207|NCT02638714|Optic Neuropathies|optic neuropathies
104208|NCT02638714|Stem Cell Therapy|stem cell therapy
104209|NCT02638675|financial health incentives|financial health incentives
104210|NCT02638675|physical activity|physical activity
104211|NCT02638675|behavioral economics|behavioral economics
104212|NCT02638675|randomized control trial|randomized control trial
104213|NCT02638675|workplace health|workplace health
104214|NCT02638649|lung ultrasound|lung ultrasound
104215|NCT02638636|Cognitive behavior therapy|cognitive behavior therapy
104216|NCT02638636|Randomized controlled trial|randomized controlled trial
104217|NCT02638636|Exposure therapy|exposure therapy
104218|NCT02638636|Fibromyalgia|fibromyalgia
104219|NCT02638623|Knee Arthroplasty|knee arthroplasty
104220|NCT02638623|Hip Arthroplasty|hip arthroplasty
104221|NCT02638584|Ilaprazole|ilaprazole
104222|NCT02638584|Gastric Adenoma|gastric adenoma
104223|NCT02638584|Early Gastric Cancer|early gastric cancer
104224|NCT02638584|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
104225|NCT02638532|Fat Pad|fat pad
104226|NCT02638532|Fat Pad Atrophy|fat pad atrophy
104227|NCT02638532|Foot|foot
104228|NCT02638532|Feet|feet
104229|NCT02638532|Heel|heel
104230|NCT02638532|Forefoot|forefoot
104231|NCT02638506|Headaches, Migraines, Fentanyl|headaches, migraines, fentanyl
104233|NCT02638493|tenofovir-emtricitabine|tenofovir-emtricitabine
104234|NCT02638493|antiretroviral therapy|antiretroviral therapy
104235|NCT02638493|Prevention|prevention
104236|NCT02638493|tenofovir alafenamide|tenofovir alafenamide
104237|NCT02638454|Exercise|exercise
104238|NCT02638454|Anabolic Resistance|anabolic resistance
104239|NCT02638454|Skeletal Muscle|skeletal muscle
104240|NCT02638454|microRNA|microrna
104241|NCT02638441|psychological health|psychological health
104242|NCT02638441|women|women
104243|NCT02638441|anxiety|anxiety
104244|NCT02638441|depression|depression
104245|NCT02638415|HVPG|hvpg
104246|NCT02638402|glycosylation|glycosylation
104247|NCT02638402|mucin|mucin
104248|NCT02638402|receptor tyrosin kinases|receptor tyrosin kinases
104249|NCT02638402|ovarian cancer|ovarian cancer
104250|NCT02638402|endometrial cancer|endometrial cancer
104251|NCT02638376|Keraroconus|keraroconus
104252|NCT02638376|keratectasia|keratectasia
104253|NCT02638376|treatment|treatment
104254|NCT02638350|lung ultrasound|lung ultrasound
104255|NCT02638350|Pulmonary Edema|pulmonary edema
104256|NCT02638350|Respiratory Distress Syndrome|respiratory distress syndrome
104259|NCT02638259|Biosimilars|biosimilars
104260|NCT02638259|Rheumatoid Arthritis|rheumatoid arthritis
104261|NCT02638259|Etanercept|etanercept
104262|NCT02638233|CHC|chc
104263|NCT02638233|IVDA (intravenous drug abuse)|ivda (intravenous drug abuse)
104264|NCT02638233|Hepatitis C|hepatitis c
104265|NCT02638233|Sofosbuvir|sofosbuvir
104266|NCT02638233|Ledipasvir|ledipasvir
104267|NCT02638233|Opiate Substitution Therapy|opiate substitution therapy
104268|NCT02638220|Cerebrotendinous Xanthomatosis|cerebrotendinous xanthomatosis
104269|NCT02638220|CTX Prevalence Study|ctx prevalence study
104270|NCT02638220|CTX|ctx
104271|NCT02638220|Idiopathic Bilateral Cataracts|idiopathic bilateral cataracts
104272|NCT02638220|Cataracts|cataracts
104273|NCT02638220|Bilateral Cataracts|bilateral cataracts
104274|NCT02638220|Early-Onset Idiopathic Bilateral Cataracts|early-onset idiopathic bilateral cataracts
104275|NCT02638220|Observational Study|observational study
104276|NCT02638220|Ophthalmology|ophthalmology
104277|NCT02638207|Chronic Inflammatory Demyelinating Poly Neuropathy (CIDP)|chronic inflammatory demyelinating poly neuropathy (cidp)
104278|NCT02638194|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
104279|NCT02638194|smoking|smoking
104280|NCT02638194|secondhand smoke|secondhand smoke
104281|NCT02638181|matrix metalloproteinase 13|matrix metalloproteinase 13
104282|NCT02638181|tissue inhibitor of metalloproteinases 3|tissue inhibitor of metalloproteinases 3
104283|NCT02638181|calcium-sensing receptor|calcium-sensing receptor
104284|NCT02638181|trabecular meshwork|trabecular meshwork
104285|NCT02638181|open-angle glaucoma|open-angle glaucoma
104286|NCT02638142|loop diuretic|loop diuretic
104287|NCT02638142|heart failure|heart failure
104288|NCT02638142|renal dysfunction|renal dysfunction
104289|NCT02638142|congestion signs|congestion signs
104290|NCT02638142|BNP|bnp
104291|NCT02638129|Drug therapy|drug therapy
104292|NCT02638116|Ibrutinib|ibrutinib
104293|NCT02638116|Proton pump inhibitors|proton pump inhibitors
104294|NCT02638116|Pharmacokinetics|pharmacokinetics
104295|NCT02638116|Drug Interaction|drug interaction
104296|NCT02638090|advanced lung cancer|advanced lung cancer
104297|NCT02638090|immune therapy naive|immune therapy naive
104298|NCT02638090|immune therapy pre-treated|immune therapy pre-treated
104299|NCT02638090|NSCLC|nsclc
104300|NCT02638090|Stage IV lung cancer|stage iv lung cancer
104301|NCT02638090|pembrolizumab|pembrolizumab
104302|NCT02638090|vorinostat|vorinostat
104303|NCT02638090|immunogenicity|immunogenicity
104304|NCT02638077|Differentiated Thyroid Cancer|differentiated thyroid cancer
104305|NCT02638077|the initial management|the initial management
104306|NCT02638051|Peritoneal Carcinomatosis|peritoneal carcinomatosis
104307|NCT02638051|Malignant Ascites|malignant ascites
95410|NCT02692651|CDI|cdi
104308|NCT02638051|Modulated Electro-Hyperthermia|modulated electro-hyperthermia
104309|NCT02638051|Traditional Chinese Medicine|traditional chinese medicine
104310|NCT02637960|VA106483, fedovapagon, BPH, nocturia, EQUINOC|va106483, fedovapagon, bph, nocturia, equinoc
104311|NCT02637921|bed rest|bed rest
104312|NCT02637921|bone metabolism|bone metabolism
104313|NCT02637908|Mindfulness|mindfulness
104314|NCT02637908|Parents|parents
104315|NCT02637908|Families|families
104316|NCT02637895|PTSD,|ptsd,
104317|NCT02637895|trauma|trauma
104318|NCT02637895|stress disorder|stress disorder
104319|NCT02637895|post-traumatic stress disorder|post-traumatic stress disorder
104320|NCT02637895|anxiety disorder|anxiety disorder
104321|NCT02637869|Health Expenditures|health expenditures
104322|NCT02637869|Prospective Payment System|prospective payment system
104323|NCT02637869|Health Care Utilization|health care utilization
104324|NCT02637869|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
104325|NCT02637843|radial|radial
104326|NCT02637843|angiography|angiography
104327|NCT02637843|angioplasty|angioplasty
104328|NCT02637843|randomized|randomized
104329|NCT02637843|sheath|sheath
104330|NCT02637843|slender|slender
104331|NCT02637791|Stroke|stroke
104332|NCT02637791|Rehabilitation|rehabilitation
104333|NCT02637791|Virtual Reality|virtual reality
104334|NCT02637778|nutrient profiles|nutrient profiles
104335|NCT02637778|menu plans|menu plans
104336|NCT02637778|n-3 LC-PUFA|n-3 lc-pufa
104337|NCT02637778|SFA|sfa
104338|NCT02637778|MUFA|mufa
104339|NCT02637778|PUFA|pufa
104340|NCT02637778|cardiovascular risk|cardiovascular risk
104341|NCT02637765|Breast Cancer|breast cancer
104342|NCT02637765|Physical Activity|physical activity
104343|NCT02637765|Quality of life|quality of life
104344|NCT02637752|Pediatric Obesity|pediatric obesity
104345|NCT02637752|Body Mass Index|body mass index
104346|NCT02637752|Dentistry|dentistry
104347|NCT02637739|hysteroscope|hysteroscope
104348|NCT02637726|Total intravenous anesthesia|total intravenous anesthesia
104349|NCT02637726|Target Controlled Infusion|target controlled infusion
104350|NCT02637726|Propofol|propofol
104351|NCT02637726|Bispectral index|bispectral index
104352|NCT02637726|Children|children
104353|NCT02637713|GERD|gerd
104354|NCT02637713|sleeve gastrectomy|sleeve gastrectomy
104355|NCT02637713|reflux|reflux
104356|NCT02637713|morbidly obese|morbidly obese
104357|NCT02637700|Small Fiber Neuropathy|small fiber neuropathy
104358|NCT02637700|Painful Neuropathy|painful neuropathy
104359|NCT02637700|Intravenous Immunoglobulin Therapy|intravenous immunoglobulin therapy
104360|NCT02637687|Pediatric|pediatric
104361|NCT02637687|NTRK1|ntrk1
104362|NCT02637687|NTRK2|ntrk2
104363|NCT02637687|NTRK3|ntrk3
104364|NCT02637687|Fusion|fusion
104365|NCT02637687|Tumors|tumors
104366|NCT02637687|Solid Tumors|solid tumors
104367|NCT02637687|CNS Tumors|cns tumors
104368|NCT02637687|Central Nervous System Tumors|central nervous system tumors
104369|NCT02637687|NTRK Fusion Positive|ntrk fusion positive
104370|NCT02637687|TRKA|trka
104371|NCT02637687|TRKB|trkb
104372|NCT02637687|TRKC|trkc
104373|NCT02637687|Infantile Fibrosarcoma|infantile fibrosarcoma
104374|NCT02637687|NTRK Gene Rearrangements|ntrk gene rearrangements
104375|NCT02637687|TRK Fusion|trk fusion
104376|NCT02637687|NTRK1 fusion|ntrk1 fusion
104377|NCT02637687|NTRK2 fusion|ntrk2 fusion
104378|NCT02637687|NTRK3 fusion|ntrk3 fusion
104379|NCT02637687|NTRK1 gene rearrangement|ntrk1 gene rearrangement
104380|NCT02637687|NTRK2 gene rearrangement|ntrk2 gene rearrangement
104579|NCT02636686|Drisapersen|drisapersen
104381|NCT02637687|NTRK3 gene rearrangement|ntrk3 gene rearrangement
104382|NCT02637687|ETV6-NTRK3|etv6-ntrk3
104383|NCT02637687|ETV6|etv6
104384|NCT02637687|ETV6 fusion|etv6 fusion
104385|NCT02637687|ETV6 gene rearrangement|etv6 gene rearrangement
104386|NCT02637687|Solid CNS tumor|solid cns tumor
104387|NCT02637687|Primary CNS tumor|primary cns tumor
104388|NCT02637687|Advanced CNS tumor|advanced cns tumor
104389|NCT02637687|Metastatic CNS tumor|metastatic cns tumor
754071|NCT01178801|knowledge discovering|knowledge discovering
104390|NCT02637687|Metastatic infantile fibrosarcoma|metastatic infantile fibrosarcoma
104391|NCT02637687|Advanced infantile fibrosarcoma|advanced infantile fibrosarcoma
104393|NCT02637687|Congenital mesoblastic nephroma|congenital mesoblastic nephroma
104394|NCT02637687|Congenital nephroma|congenital nephroma
104395|NCT02637687|Thyroid|thyroid
104396|NCT02637687|Larotrectinib|larotrectinib
104397|NCT02637674|allotransplantation|allotransplantation
104398|NCT02637661|earlobe crease|earlobe crease
104399|NCT02637661|acute myocardial infarction|acute myocardial infarction
104401|NCT02637635|Mammaplasty|mammaplasty
104402|NCT02637635|Transplantation, Autologous|transplantation, autologous
104403|NCT02637635|Mastectomy|mastectomy
104404|NCT02637635|Breast Implants|breast implants
104405|NCT02637635|Radiotherapy, Adjuvant|radiotherapy, adjuvant
104406|NCT02637622|conjoint analysis|conjoint analysis
104407|NCT02637622|stated-preference methods|stated-preference methods
104408|NCT02637622|patient centered outcome research (PCOR)|patient centered outcome research (pcor)
104409|NCT02637622|community-based participatory research (CBPR)|community-based participatory research (cbpr)
104410|NCT02637622|patient preference|patient preference
104411|NCT02637622|diabetes|diabetes
104412|NCT02637609|conjoint analysis|conjoint analysis
104413|NCT02637609|stated-preference methods|stated-preference methods
104414|NCT02637609|patient centered outcome research (PCOR)|patient centered outcome research (pcor)
104415|NCT02637609|community-based participatory research (CBPR)|community-based participatory research (cbpr)
104416|NCT02637609|patient priority|patient priority
104417|NCT02637609|diabetes|diabetes
104418|NCT02637583|conjugate vaccine|conjugate vaccine
104419|NCT02637583|polysaccharide vaccine|polysaccharide vaccine
104420|NCT02637570|healthy male athletes|healthy male athletes
104421|NCT02637570|18-35 years old|18-35 years old
104422|NCT02637531|IPI-549|ipi-549
104423|NCT02637531|Phase 1|phase 1
104424|NCT02637531|Advanced Solid Tumor|advanced solid tumor
104425|NCT02637531|Non-small cell lung cancer|non-small cell lung cancer
104426|NCT02637531|Melanoma|melanoma
104427|NCT02637531|PI3K|pi3k
104428|NCT02637531|Squamous Cell Cancer of the Head and Neck|squamous cell cancer of the head and neck
104429|NCT02637518|Frailty|frailty
104430|NCT02637518|Frailty screening tools|frailty screening tools
104431|NCT02637518|Clinical settings|clinical settings
104432|NCT02637518|Social settings|social settings
104433|NCT02637518|Geriatrics|geriatrics
104434|NCT02637518|Functional autonomy|functional autonomy
104435|NCT02637518|Disability|disability
104436|NCT02637505|Articular cartilage|articular cartilage
104437|NCT02637505|Focal cartilage injury|focal cartilage injury
104438|NCT02637505|Focal cartilage injury in the knee|focal cartilage injury in the knee
104439|NCT02637505|Knee cartilage|knee cartilage
104440|NCT02637505|Microfracture|microfracture
104441|NCT02637505|Debridement|debridement
104442|NCT02637492|Critical limb ischaemia|critical limb ischaemia
104443|NCT02637492|Peripheral occlusive arterial disease|peripheral occlusive arterial disease
104444|NCT02637492|Clinical prediction|clinical prediction
104445|NCT02637492|Ankle pressure|ankle pressure
104446|NCT02637492|Transcutaneous oxygen pressure|transcutaneous oxygen pressure
104447|NCT02637492|Toe pressure|toe pressure
104448|NCT02637492|Microcirculation|microcirculation
104449|NCT02637453|Paroxysmal Atrial Fibrillation;Additional Linear Ablation|paroxysmal atrial fibrillation;additional linear ablation
104450|NCT02637427|Fresh frozen plasma|fresh frozen plasma
104451|NCT02637427|Bleeding|bleeding
104452|NCT02637414|Stress|stress
104453|NCT02637414|Well-being|well-being
104454|NCT02637414|Positive psychology|positive psychology
104455|NCT02637388|Appetite|appetite
104456|NCT02637388|Beta-glucans|beta-glucans
104457|NCT02637388|Energy Intake|energy intake
104458|NCT02637388|Glucagon-Like Peptide 1|glucagon-like peptide 1
104459|NCT02637388|Glucose|glucose
104460|NCT02637388|Insulin|insulin
104461|NCT02637388|Incretins|incretins
104462|NCT02637375|triple-negative breast cancer|triple-negative breast cancer
104463|NCT02637336|Therapies. Autonomic nervous system. Cardiovascular stress|therapies. autonomic nervous system. cardiovascular stress
104464|NCT02637323|Osteoarthritis|osteoarthritis
104465|NCT02637323|Knee|knee
104466|NCT02637323|Pain|pain
104467|NCT02637323|Steroid|steroid
104468|NCT02637323|Intra-articular|intra-articular
104469|NCT02637323|Injection|injection
104470|NCT02637284|Healthy volunteers|healthy volunteers
104471|NCT02637271|Calorie restriction|calorie restriction
104472|NCT02637271|Meal replacement|meal replacement
104473|NCT02637271|fMRI|fmri
104474|NCT02637271|Food-cue reactivity|food-cue reactivity
104475|NCT02637271|Obesity|obesity
104476|NCT02637258|optic nerve sheath diameter|optic nerve sheath diameter
104477|NCT02637258|neurological outcome|neurological outcome
104478|NCT02637258|OHCA|ohca
104479|NCT02637245|diabetic macular edema|diabetic macular edema
104480|NCT02637245|diabetic retinopathy|diabetic retinopathy
104481|NCT02637206|Healthy Japanese|healthy japanese
104482|NCT02637206|GSK2894512|gsk2894512
104483|NCT02637206|skin safety|skin safety
104484|NCT02637180|osteoporosis|osteoporosis
104486|NCT02637180|liaison service|liaison service
104487|NCT02637167|Heart failure|heart failure
104488|NCT02637167|inflammation|inflammation
104489|NCT02637167|rifaximin|rifaximin
104490|NCT02637167|Saccharomyces boulardii|saccharomyces boulardii
104491|NCT02637167|gut microbiota|gut microbiota
104492|NCT02637154|Adolescent|adolescent
104493|NCT02637154|Type 1 diabetes|type 1 diabetes
104494|NCT02637154|Metabolic control|metabolic control
104495|NCT02637154|Motivational interviewing|motivational interviewing
104496|NCT02637141|celiac|celiac
104497|NCT02637141|gluten|gluten
104498|NCT02637141|IL-15|il-15
104499|NCT02637141|AMG 714|amg 714
104500|NCT02637128|MALARIA, FALCIPARUM|malaria, falciparum
104501|NCT02637128|MALAWI|malawi
104502|NCT02637128|ARTEMETHER-LUMEFANTRINE|artemether-lumefantrine
104503|NCT02637128|ARTESUNATE-AMODIAQUINE|artesunate-amodiaquine
95605|NCT02691520|Treatment Resistant Depression|treatment resistant depression
95606|NCT02691507|Eczema, Itchy Skin|eczema, itchy skin
104504|NCT02637115|Gut microbiota|gut microbiota
104505|NCT02637115|Akkermansia muciniphila|akkermansia muciniphila
104506|NCT02637076|Xyrem|xyrem
104507|NCT02637076|narcolepsy with cataplexy|narcolepsy with cataplexy
104508|NCT02637076|positron emission tomography|positron emission tomography
104509|NCT02637076|dopamine|dopamine
104510|NCT02637063|Lifestyle behavior change|lifestyle behavior change
104511|NCT02637050|Type IV Pulmonary Hypertension|type iv pulmonary hypertension
104512|NCT02637050|Chronic Thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
104513|NCT02637050|CTEPH|cteph
104514|NCT02637037|dapagliflozin/metformin XR 5/500 mg|dapagliflozin/metformin xr 5/500 mg
104515|NCT02637037|dapagliflozin/metformin XR10/1000 mg|dapagliflozin/metformin xr10/1000 mg
104516|NCT02637037|bioequivalence|bioequivalence
104517|NCT02637037|fixed dose combination tablets|fixed dose combination tablets
104518|NCT02637037|pharmacokinetic|pharmacokinetic
104519|NCT02637037|type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
104520|NCT02637037|safety|safety
104521|NCT02637024|Breast Cancer|breast cancer
104522|NCT02637024|DCIS|dcis
104523|NCT02637024|Radiotherapy|radiotherapy
104524|NCT02637024|Partial breast irradiation|partial breast irradiation
104525|NCT02637024|Radiation fractions|radiation fractions
104526|NCT02637011|acute respiratory distress syndrome|acute respiratory distress syndrome
104527|NCT02637011|intensive care medicine|intensive care medicine
104528|NCT02637011|critical illness|critical illness
104529|NCT02637011|long-term outcomes|long-term outcomes
104530|NCT02637011|quality of life|quality of life
104531|NCT02637011|return to work|return to work
104532|NCT02637011|quality of care|quality of care
104533|NCT02636972|TLR2|tlr2
104534|NCT02636972|TLR4|tlr4
104535|NCT02636972|Biomarker|biomarker
104536|NCT02636972|TLR responsiveness|tlr responsiveness
104537|NCT02636972|Peripheral blood responsiveness|peripheral blood responsiveness
104538|NCT02636972|Inflammatory pain|inflammatory pain
104539|NCT02636933|Asthma|asthma
104540|NCT02636933|Allergic Rhinitis|allergic rhinitis
104541|NCT02636933|Children|children
104542|NCT02636933|Atopy|atopy
104543|NCT02636920|Asthma|asthma
104544|NCT02636920|Children|children
104545|NCT02636855|Solid and Hematological Malignancies|solid and hematological malignancies
104546|NCT02636855|Screening|screening
104547|NCT02636855|Metastatic|metastatic
104548|NCT02636855|Previously Treated|previously treated
104549|NCT02636855|NY-ESO-1|ny-eso-1
104550|NCT02636855|MAGE A10|mage a10
104551|NCT02636855|MAGE-A4|mage-a4
104552|NCT02636842|Schizophrenia|schizophrenia
104553|NCT02636842|Schizoaffective Disorder|schizoaffective disorder
104554|NCT02636842|Aripiprazole Lauroxil|aripiprazole lauroxil
104555|NCT02636842|Aripiprazole|aripiprazole
104556|NCT02636842|ALKS 9072|alks 9072
104557|NCT02636842|Alkermes|alkermes
104558|NCT02636803|trichuris|trichuris
104559|NCT02636803|hookworms|hookworms
104560|NCT02636803|Ascaris|ascaris
104561|NCT02636777|low back pain|low back pain
104562|NCT02636777|chronic pain|chronic pain
104563|NCT02636777|self-management|self-management
104564|NCT02636777|longitudinal study|longitudinal study
104565|NCT02636777|predictive modelling|predictive modelling
104566|NCT02636751|Prehabilitation|prehabilitation
104567|NCT02636751|Telemedicine|telemedicine
104568|NCT02636751|Osteoarthritis|osteoarthritis
104569|NCT02636751|Arthroplasty|arthroplasty
104571|NCT02636751|Knee|knee
104572|NCT02636725|Advanced Alveolar Soft Part Sarcoma|advanced alveolar soft part sarcoma
104573|NCT02636725|ASPS|asps
104574|NCT02636725|Soft Tissue Sarcomas|soft tissue sarcomas
104575|NCT02636725|STS|sts
104576|NCT02636725|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
104577|NCT02636686|DMD|dmd
104578|NCT02636686|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
104580|NCT02636686|Kyndrisa|kyndrisa
104581|NCT02636686|exon-skipping|exon-skipping
104582|NCT02636686|exon-51|exon-51
104583|NCT02636686|BMN-051-302|bmn-051-302
104584|NCT02636686|051-302|051-302
104585|NCT02636660|Critical care|critical care
104586|NCT02636660|Mechanical Ventilation|mechanical ventilation
104587|NCT02636660|Quality of Life|quality of life
104588|NCT02636660|Stressors|stressors
104589|NCT02636660|Nursing Sensitive Outcomes|nursing sensitive outcomes
104590|NCT02636660|Nursing|nursing
104591|NCT02636647|hepatic encephalopathy|hepatic encephalopathy
104592|NCT02636647|fecal transplant|fecal transplant
104593|NCT02636647|cirrhosis|cirrhosis
104594|NCT02636634|diagnostic strategy|diagnostic strategy
104595|NCT02636634|brain metastases|brain metastases
104596|NCT02636634|radiation necrosis|radiation necrosis
104597|NCT02636634|relapse|relapse
104598|NCT02636634|PET-FET and MSR|pet-fet and msr
104599|NCT02636634|radiosurgery|radiosurgery
104600|NCT02636621|Fatigue|fatigue
104794|NCT02635451|vitamin c|vitamin c
402913|NCT01229163|Contingency Management|contingency management
95796|NCT02690441|GAD|gad
104601|NCT02636621|excessive daytime sleepiness|excessive daytime sleepiness
104602|NCT02636621|flow limitation|flow limitation
104603|NCT02636608|Observational Study|observational study
104604|NCT02636608|Chronic Hepatitis C|chronic hepatitis c
104605|NCT02636608|Cirrhosis|cirrhosis
104606|NCT02636608|Paritaprevir/r/Ombitasvir|paritaprevir/r/ombitasvir
104607|NCT02636608|Dasabuvir|dasabuvir
104608|NCT02636608|Work Ability|work ability
104609|NCT02636608|Quality of Life|quality of life
104610|NCT02636608|Fibrosis|fibrosis
104611|NCT02636595|Hepatitis C Genotype 4|hepatitis c genotype 4
104612|NCT02636595|Hepatitis C|hepatitis c
104613|NCT02636595|Chronic Hepatitis C|chronic hepatitis c
104614|NCT02636595|Hepatitis C Genotype 6|hepatitis c genotype 6
104615|NCT02636595|Hepatitis C Genotype 5|hepatitis c genotype 5
104616|NCT02636556|thymoma|thymoma
104617|NCT02636556|thymic carcinoma|thymic carcinoma
104618|NCT02636556|chemoradiotherapy|chemoradiotherapy
104619|NCT02636556|inoperable|inoperable
104620|NCT02636543|genetic diagnosis|genetic diagnosis
104621|NCT02636543|information|information
104622|NCT02636543|letter model|letter model
104623|NCT02636517|Fecal Microbiota transplant|fecal microbiota transplant
104624|NCT02636504|Pulp vitality|pulp vitality
104625|NCT02636504|Pulp testing|pulp testing
104626|NCT02636439|Diastolic heart failure|diastolic heart failure
104627|NCT02636439|Heart Failure|heart failure
104628|NCT02636439|Elderly|elderly
104629|NCT02636439|Obesity|obesity
104630|NCT02636426|phase I study|phase i study
104631|NCT02636426|sorafenib|sorafenib
104632|NCT02636426|high-dose schedule|high-dose schedule
104633|NCT02636426|pharmacokinetics|pharmacokinetics
104634|NCT02636426|drug monitoring|drug monitoring
104635|NCT02636400|Infertility|infertility
104636|NCT02636400|endometriosis|endometriosis
104637|NCT02636348|Calcium|calcium
104638|NCT02636348|Vitamin D|vitamin d
104639|NCT02636322|Lymphoma|lymphoma
104640|NCT02636322|High Risk Diffuse Large B-Cell Lymphoma|high risk diffuse large b-cell lymphoma
104641|NCT02636322|DLBCL|dlbcl
104642|NCT02636322|Rituximab|rituximab
104643|NCT02636322|Rituxan|rituxan
104644|NCT02636322|Ibrutinib|ibrutinib
104645|NCT02636322|PCI-32765|pci-32765
104646|NCT02636322|Imbruvica|imbruvica
104647|NCT02636322|Lenalidomide|lenalidomide
104648|NCT02636322|CC-5013|cc-5013
104649|NCT02636322|Revlimid|revlimid
104650|NCT02636322|Etoposide|etoposide
104651|NCT02636322|VePesid|vepesid
104652|NCT02636322|Prednisone|prednisone
104653|NCT02636322|Vincristine|vincristine
104654|NCT02636322|Oncovin|oncovin
104655|NCT02636322|Cyclophosphamide|cyclophosphamide
104656|NCT02636322|Cytoxan|cytoxan
104657|NCT02636322|Neosar|neosar
104658|NCT02636322|Doxorubicin|doxorubicin
104659|NCT02636322|Hydroxydaunorubicin|hydroxydaunorubicin
104660|NCT02636322|Adriamycin PFS|adriamycin pfs
104661|NCT02636322|Adriamycin RDF|adriamycin rdf
104662|NCT02636322|Adriamycin|adriamycin
104663|NCT02636322|Rubex|rubex
104664|NCT02636309|ergonomics|ergonomics
642518|NCT00748943|halitosis|halitosis
104665|NCT02636309|multifaceted intervention|multifaceted intervention
104666|NCT02636309|industry|industry
104667|NCT02636309|physiotherapy|physiotherapy
104668|NCT02636309|physical exercises|physical exercises
104669|NCT02636309|workplace|workplace
104670|NCT02636309|acupuncture|acupuncture
104671|NCT02636309|work|work
104672|NCT02636309|quality of life|quality of life
104673|NCT02636309|absenteeism|absenteeism
104674|NCT02636309|efficiency|efficiency
104675|NCT02636309|musculoskeletal pain|musculoskeletal pain
104676|NCT02636309|WMSD|wmsd
104677|NCT02636296|Pilates method|pilates method
104678|NCT02636296|elderly|elderly
104679|NCT02636296|postural balance|postural balance
104680|NCT02636257|Silicone Nasolacrimal Intubation|silicone nasolacrimal intubation
104681|NCT02636257|Dacryocystorhinostomy|dacryocystorhinostomy
104682|NCT02636231|Endostar|endostar
104683|NCT02636231|IMRT|imrt
104684|NCT02636231|recurrent|recurrent
104686|NCT02636218|Ketamine|ketamine
104687|NCT02636192|Sodium-glucose co-transporter 2 inhibitors|sodium-glucose co-transporter 2 inhibitors
104688|NCT02636192|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
104689|NCT02636179|In Vitro Fertilization, follow-up of children|in vitro fertilization, follow-up of children
104690|NCT02636166|Pregnancy|pregnancy
104691|NCT02636153|phosphorus,dietary|phosphorus,dietary
104692|NCT02636153|circadian rhythm|circadian rhythm
104693|NCT02636153|phosphorus|phosphorus
104694|NCT02636088|Phase II study, clinical trial|phase ii study, clinical trial
104695|NCT02636062|Coronary disease|coronary disease
104696|NCT02636062|Coronary artery disease (CAD)|coronary artery disease (cad)
104697|NCT02636062|Endothelial dysfunction|endothelial dysfunction
104698|NCT02636062|Coronary artery calcium (CAC)|coronary artery calcium (cac)
104699|NCT02636049|pharmacokinetics|pharmacokinetics
104700|NCT02636049|healthy adult volunteer|healthy adult volunteer
104701|NCT02635997|osteoporosis|osteoporosis
104702|NCT02635997|ibandronate|ibandronate
95812|NCT02690337|no standard treatment|no standard treatment
95813|NCT02690272|kidney transplant|kidney transplant
95814|NCT02690272|psychic process|psychic process
95815|NCT02690259|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
95816|NCT02690233|endothelial dysfunction|endothelial dysfunction
95848|NCT02690103|HCV|hcv
104703|NCT02635997|vitamine D|vitamine d
104704|NCT02635997|calcium|calcium
104705|NCT02635997|bone mineral density|bone mineral density
104706|NCT02635997|health-related quality of life|health-related quality of life
104707|NCT02635971|transcatheter arterial infusion|transcatheter arterial infusion
104708|NCT02635971|randomized controlled trial|randomized controlled trial
104709|NCT02635971|chemotherapy|chemotherapy
104710|NCT02635958|Body Mass Index|body mass index
104711|NCT02635958|BMI|bmi
104712|NCT02635958|InBody|inbody
104713|NCT02635958|iDXA|idxa
104714|NCT02635958|validation|validation
104715|NCT02635945|adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
104716|NCT02635945|adenosine receptor modulator|adenosine receptor modulator
104717|NCT02635945|COPD|copd
104718|NCT02635945|asthma|asthma
104719|NCT02635919|Nicotine addiction|nicotine addiction
104720|NCT02635919|Cigarette smoking|cigarette smoking
104721|NCT02635919|Smoking cessation|smoking cessation
104722|NCT02635919|Quit smoking|quit smoking
104723|NCT02635906|BED REST|bed rest
104724|NCT02635906|CORONARY ANGIOPLASTY|coronary angioplasty
104725|NCT02635893|SCI|sci
104726|NCT02635867|vital pulp|vital pulp
104727|NCT02635867|reversible pulpitis|reversible pulpitis
104728|NCT02635867|pulp capping|pulp capping
104729|NCT02635867|deep cavity|deep cavity
104730|NCT02635867|Management of Deep Dental Caries|management of deep dental caries
104731|NCT02635854|leukocyte and platelet aggregates|leukocyte and platelet aggregates
104732|NCT02635854|platelet activation|platelet activation
104733|NCT02635841|Pantothenate Kinase-Associated Neurodegeneration|pantothenate kinase-associated neurodegeneration
104734|NCT02635841|PKAN|pkan
104735|NCT02635841|Neurodegeneration with Brain Iron Accumulation|neurodegeneration with brain iron accumulation
104736|NCT02635841|NBIA|nbia
104737|NCT02635841|Deferiprone|deferiprone
104738|NCT02635841|Ferriprox|ferriprox
104739|NCT02635828|Palonosetron|palonosetron
104740|NCT02635828|Craniotomy|craniotomy
104741|NCT02635828|Nausea|nausea
104742|NCT02635828|Vomiting|vomiting
104743|NCT02635802|remifentanil|remifentanil
104744|NCT02635802|analgesia|analgesia
104745|NCT02635802|intensive care units|intensive care units
104746|NCT02635789|Sirolimus|sirolimus
104747|NCT02635789|Skin lesions|skin lesions
104748|NCT02635789|TSC|tsc
104749|NCT02635789|Tuberous Sclerosis Complex|tuberous sclerosis complex
104750|NCT02635789|NPC-12G|npc-12g
104751|NCT02635789|Angiofibroma|angiofibroma
104752|NCT02635789|Hypomelanotic macule|hypomelanotic macule
104753|NCT02635789|Plaque|plaque
104754|NCT02635776|AR101 (Characterized Peanut Allergen)|ar101 (characterized peanut allergen)
104755|NCT02635776|Characterized Peanut Allergen|characterized peanut allergen
104756|NCT02635776|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
104757|NCT02635776|OIT (oral immunotherapy)|oit (oral immunotherapy)
104758|NCT02635776|Oral Immunotherapy|oral immunotherapy
104759|NCT02635776|Peanut Allergy|peanut allergy
104760|NCT02635776|Allergy|allergy
104761|NCT02635776|Peanut-Allergic Children|peanut-allergic children
104762|NCT02635776|Peanut-Allergic Adults|peanut-allergic adults
104765|NCT02635763|general anesthesia|general anesthesia
104766|NCT02635763|hip fracture|hip fracture
104767|NCT02635763|recovery|recovery
104768|NCT02635724|Acute uncomplicated|acute uncomplicated
104769|NCT02635724|Elderly|elderly
104770|NCT02635685|Atrial fibrillation|atrial fibrillation
104771|NCT02635685|Stroke|stroke
104772|NCT02635685|Clinical Decision Support|clinical decision support
104773|NCT02635685|Anticoagulants|anticoagulants
104774|NCT02635672|Solid tumors|solid tumors
104775|NCT02635672|Aggressive non-hodgkin's lymphoma (NHL)|aggressive non-hodgkin's lymphoma (nhl)
104776|NCT02635659|food intake, satiety, satiation, nutrients, ileal brake|food intake, satiety, satiation, nutrients, ileal brake
104777|NCT02635633|partial epilepsy|partial epilepsy
104778|NCT02635633|unifocal neocortical|unifocal neocortical
104779|NCT02635633|treatment resistant|treatment resistant
104780|NCT02635633|transcranial magnetic stimulation|transcranial magnetic stimulation
104781|NCT02635633|thetaburst stimulation|thetaburst stimulation
104782|NCT02635620|e-cigarette, electronic cigarette, lung function|e-cigarette, electronic cigarette, lung function
105171|NCT02633904|osteotomy|osteotomy
104783|NCT02635607|GnRH antagonist|gnrh antagonist
104784|NCT02635607|fixed protocol|fixed protocol
104785|NCT02635607|flexible protocol|flexible protocol
104786|NCT02635542|Postoperative Pulmonary Complications|postoperative pulmonary complications
104787|NCT02635542|Residual Neuromuscular Blockade|residual neuromuscular blockade
104788|NCT02635542|Cardiac Surgical Procedures|cardiac surgical procedures
104789|NCT02635503|colorectal cancer|colorectal cancer
104790|NCT02635503|laparoscopic surgery|laparoscopic surgery
104791|NCT02635503|natural orifice specimen extraction|natural orifice specimen extraction
104792|NCT02635503|Inflammatory response|inflammatory response
104793|NCT02635490|prophylactic antibiotics, urinary tract infection.|prophylactic antibiotics, urinary tract infection.
104795|NCT02635451|Preterm Premature Rupture of Membranes|preterm premature rupture of membranes
104796|NCT02635438|Oropharyngeal Candidiasis|oropharyngeal candidiasis
104797|NCT02635412|Placenta|placenta
104798|NCT02635412|Accreta|accreta
104799|NCT02635412|Morbidly|morbidly
104800|NCT02635412|Adherent Placenta|adherent placenta
104801|NCT02635399|pancreaticoduodenectomy, delayed gastric emptying, duodenojejunopexy|pancreaticoduodenectomy, delayed gastric emptying, duodenojejunopexy
104802|NCT02635386|PCOS|pcos
104803|NCT02635386|GLP1 agonists|glp1 agonists
104804|NCT02635386|SGLT2 inhibitors|sglt2 inhibitors
104805|NCT02635373|Calciphylaxis|calciphylaxis
104806|NCT02635373|Rare disease (ORPHA280062)|rare disease (orpha280062)
104807|NCT02635373|Renal insufficiency|renal insufficiency
104808|NCT02635373|ESRD|esrd
104809|NCT02635373|Calcification|calcification
104810|NCT02635373|Chronic kidney disease|chronic kidney disease
104811|NCT02635373|Dialysis|dialysis
104812|NCT02635373|Vascular disease|vascular disease
104813|NCT02635360|advanced|advanced
104814|NCT02635360|cervical cancer|cervical cancer
104815|NCT02635360|pembrolizumab|pembrolizumab
104816|NCT02635360|chemoradiation|chemoradiation
104817|NCT02635360|immunotherapy|immunotherapy
104818|NCT02635347|Remote ischemic preconditioning|remote ischemic preconditioning
104819|NCT02635347|Remote ischemic perconditioning|remote ischemic perconditioning
104820|NCT02635347|Remote ischemic postconditioning|remote ischemic postconditioning
104821|NCT02635347|Remote ischemic conditioning|remote ischemic conditioning
104822|NCT02635347|Orthotopic liver transplant|orthotopic liver transplant
104823|NCT02635347|Brain Death Organ Donor|brain death organ donor
104825|NCT02635321|LGMD|lgmd
104826|NCT02635321|GMPPB|gmppb
104827|NCT02635308|hip fracture|hip fracture
104828|NCT02635308|physical function|physical function
104829|NCT02635308|muscle function|muscle function
104830|NCT02635308|symmetry|symmetry
104831|NCT02635295|Clinical practicum|clinical practicum
104832|NCT02635295|Nursing student|nursing student
104833|NCT02635295|Nurse teacher|nurse teacher
104834|NCT02635295|Mobile technology|mobile technology
104835|NCT02635295|Cooperation|cooperation
104836|NCT02635295|Nurse competence|nurse competence
104839|NCT02635256|hypofractionation|hypofractionation
104840|NCT02635256|prostate cancer|prostate cancer
104841|NCT02635256|radiotherapy|radiotherapy
104842|NCT02635230|Atrial Fibrillations|atrial fibrillations
104843|NCT02635230|Heart Valve Prostheses|heart valve prostheses
104844|NCT02635230|Acute Coronary Syndromes|acute coronary syndromes
104845|NCT02635230|Percutaneous Coronary Revascularization|percutaneous coronary revascularization
104846|NCT02635230|Coronary Artery Bypass Grafting|coronary artery bypass grafting
104847|NCT02635230|Coronary Artery Diseases|coronary artery diseases
104848|NCT02635230|Myocardial Infarction|myocardial infarction
104849|NCT02635230|Ischemic stroke|ischemic stroke
104850|NCT02635230|Bleeding|bleeding
104851|NCT02635230|Thrombosis|thrombosis
104852|NCT02635230|Myocardial Ischemia|myocardial ischemia
104853|NCT02635230|Heart Diseases|heart diseases
104854|NCT02635230|Cardiovascular Diseases|cardiovascular diseases
104855|NCT02635230|Embolism and Thrombosis|embolism and thrombosis
104856|NCT02635230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
104858|NCT02635230|Clopidogrel|clopidogrel
104859|NCT02635230|Ticagrelor|ticagrelor
104860|NCT02635230|Prasugrel|prasugrel
104861|NCT02635230|Antithrombotic treatment|antithrombotic treatment
104862|NCT02635230|Oral anticoagulation|oral anticoagulation
104863|NCT02635230|Warfarin|warfarin
104864|NCT02635230|Dabigatran etexilate mesylate|dabigatran etexilate mesylate
104865|NCT02635230|Apixaban|apixaban
104866|NCT02635230|Rivaroxaban|rivaroxaban
104867|NCT02635230|Direct Factor Xa Inhibitors|direct factor xa inhibitors
104868|NCT02635230|Direct Thrombin Inhibitors|direct thrombin inhibitors
104869|NCT02635217|Colonoscopy|colonoscopy
104870|NCT02635217|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
104871|NCT02635217|Patient satisfaction|patient satisfaction
104872|NCT02635217|Bidirectional endoscopies|bidirectional endoscopies
104873|NCT02635191|Helicobacter pylori|helicobacter pylori
104874|NCT02635191|Therapy|therapy
104875|NCT02635191|Children|children
104876|NCT02635139|meal skipping|meal skipping
104877|NCT02635139|isocaloric diet|isocaloric diet
104878|NCT02635139|macronutrient oxidation|macronutrient oxidation
104879|NCT02635139|glucose homeostasis|glucose homeostasis
104880|NCT02635139|arterial stiffness|arterial stiffness
104881|NCT02635113|balance|balance
104882|NCT02635113|gait|gait
104883|NCT02635113|falls|falls
104884|NCT02635113|sensory deficits|sensory deficits
124776|NCT02515266|protein|protein
104885|NCT02635113|vibration|vibration
104886|NCT02635113|visual acuity|visual acuity
104887|NCT02635113|dizziness|dizziness
104888|NCT02635113|postural control|postural control
104889|NCT02635113|proprioceptive function|proprioceptive function
104890|NCT02635113|stereoacuity|stereoacuity
104891|NCT02635113|depth perception|depth perception
104892|NCT02635113|vestibular dysfunction|vestibular dysfunction
104893|NCT02635100|Sleep Disordered Breathing|sleep disordered breathing
104894|NCT02635100|Sleep Apnea|sleep apnea
104990|NCT02634593|nutrition|nutrition
104895|NCT02635048|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
104896|NCT02635048|Kidney stones|kidney stones
104897|NCT02635048|Efficacy|efficacy
104898|NCT02635022|Fracture|fracture
104899|NCT02635022|Sarcopenia|sarcopenia
104900|NCT02635022|Osteoporosis|osteoporosis
104901|NCT02635022|Care management|care management
104902|NCT02635022|Medication adherence|medication adherence
104903|NCT02634983|COPD|copd
104904|NCT02634983|Smokers|smokers
104905|NCT02634983|Ex-smokers|ex-smokers
104906|NCT02634970|wet AMD, ranibizumab, aflibercept, neovascularization|wet amd, ranibizumab, aflibercept, neovascularization
104907|NCT02634957|phonomicrosurgery|phonomicrosurgery
104908|NCT02634957|benign vocal fold lesions|benign vocal fold lesions
104909|NCT02634957|voice rest|voice rest
104910|NCT02634957|vhi-10|vhi-10
104911|NCT02634957|CPP|cpp
104912|NCT02634944|Concussion|concussion
104913|NCT02634944|Vestibular|vestibular
104914|NCT02634944|Ocular-Motor|ocular-motor
104915|NCT02634931|Sirolimus|sirolimus
104916|NCT02634931|Skin lesions|skin lesions
104917|NCT02634931|TSC|tsc
104918|NCT02634931|Tuberous Sclerosis Complex|tuberous sclerosis complex
104919|NCT02634931|NPC-12G|npc-12g
104920|NCT02634931|Angiofibroma|angiofibroma
104921|NCT02634931|Hypomelanotic Macule|hypomelanotic macule
104922|NCT02634931|Plaque|plaque
104923|NCT02634918|ultrasound,|ultrasound,
104924|NCT02634918|ultrasonography|ultrasonography
104925|NCT02634918|hemophilic joint|hemophilic joint
104926|NCT02634918|Doppler|doppler
104927|NCT02634905|atopic dermatitis|atopic dermatitis
104928|NCT02634905|Therapeutic patient education|therapeutic patient education
104929|NCT02634905|pediatric dermatology|pediatric dermatology
104930|NCT02634892|Sacral|sacral
104931|NCT02634892|Overlay Mattress|overlay mattress
104932|NCT02634892|Cooling|cooling
104933|NCT02634866|hypertension|hypertension
104934|NCT02634866|exercise|exercise
104935|NCT02634866|diastolic heart failure|diastolic heart failure
104936|NCT02634853|Dry Eye|dry eye
104937|NCT02634840|inferior alveolar nerve|inferior alveolar nerve
104938|NCT02634840|neurosensory disturbance|neurosensory disturbance
104939|NCT02634840|bilateral sagittal spilt osteotomy|bilateral sagittal spilt osteotomy
104940|NCT02634840|mandibular surgery|mandibular surgery
104941|NCT02634840|neurosensory function|neurosensory function
104942|NCT02634801|Fumaderm|fumaderm
104943|NCT02634788|Post-Surgical Pain|post-surgical pain
104944|NCT02634788|Bunionectomy|bunionectomy
104945|NCT02634775|Pediatrics|pediatrics
104946|NCT02634775|Nephrology|nephrology
104947|NCT02634775|Dialysis|dialysis
104948|NCT02634749|Nordic countries|nordic countries
104949|NCT02634749|Eating behavior|eating behavior
104950|NCT02634749|Human microbiome|human microbiome
104951|NCT02634749|Child nutrition|child nutrition
104952|NCT02634749|Metabolic profile|metabolic profile
104953|NCT02634749|Body composition|body composition
104954|NCT02634710|soft tissue sarcoma|soft tissue sarcoma
104955|NCT02634697|Atrial Fibrillation|atrial fibrillation
104956|NCT02634697|Relaxation Response Resiliency Program Intervention|relaxation response resiliency program intervention
104957|NCT02634697|AF Symptom Severity and Burden|af symptom severity and burden
104958|NCT02634697|Stress, Anxiety, Depression and Hostility|stress, anxiety, depression and hostility
104959|NCT02634697|Quality of Life|quality of life
104960|NCT02634697|AF|af
104961|NCT02634697|QOL|qol
104962|NCT02634697|3RP|3rp
104963|NCT02634684|Schizophrenia|schizophrenia
104964|NCT02634684|Schizoaffective Disorder|schizoaffective disorder
104965|NCT02634684|Mental Disorders|mental disorders
104966|NCT02634684|Anti-Dyskinesia Agents|anti-dyskinesia agents
104967|NCT02634684|Antiparkinson Agents|antiparkinson agents
104968|NCT02634684|Central Nervous System Agents|central nervous system agents
104969|NCT02634684|Dopamine Agents|dopamine agents
104970|NCT02634684|Excitatory Amino Acid Agents|excitatory amino acid agents
104971|NCT02634684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists
104972|NCT02634684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
104973|NCT02634684|Neurotransmitter Agents|neurotransmitter agents
104974|NCT02634684|Pharmacologic Actions|pharmacologic actions
104975|NCT02634684|Physiological Effects of Drugs|physiological effects of drugs
104976|NCT02634684|Therapeutic Uses|therapeutic uses
105271|NCT02633241|MRI|mri
104977|NCT02634684|Prepulse inhibition|prepulse inhibition
104978|NCT02634684|Neurocognition|neurocognition
104979|NCT02634684|Working memory|working memory
104980|NCT02634684|Dextroamphetamine|dextroamphetamine
104981|NCT02634684|MATRICS Consensus Cognitive Battery|matrics consensus cognitive battery
104982|NCT02634684|Pharmacologic Augmentation of Cognitive Therapies|pharmacologic augmentation of cognitive therapies
104983|NCT02634684|Sensory discrimination learning|sensory discrimination learning
104984|NCT02634684|Targeted Cognitive Training|targeted cognitive training
754171|NCT01176617|Atrial Fibrillation|atrial fibrillation
104985|NCT02634684|rs4680 polymorphism of catechol-O-methyltransferase (COMT)|rs4680 polymorphism of catechol-o-methyltransferase (comt)
104986|NCT02634671|schizophrenia|schizophrenia
104987|NCT02634671|Facial emotions|facial emotions
104988|NCT02634619|urethral stricture|urethral stricture
104989|NCT02634606|Cholesterol|cholesterol
104991|NCT02634580|Japanese|japanese
104992|NCT02634580|High cholesterol|high cholesterol
104993|NCT02634580|Treatment of high cholesterol|treatment of high cholesterol
104994|NCT02634580|Lowering cholesterol|lowering cholesterol
104995|NCT02634580|Lowering high cholesterol|lowering high cholesterol
104996|NCT02634580|Hypercholesterolemia|hypercholesterolemia
104997|NCT02634580|Statin intolerant|statin intolerant
104998|NCT02634528|intermediate-acting human isophane insulin, biosimilar|intermediate-acting human isophane insulin, biosimilar
104999|NCT02634515|soluble human insulin, biosimilar|soluble human insulin, biosimilar
105000|NCT02634502|radiofrequency|radiofrequency
105001|NCT02634502|chemotherapy|chemotherapy
105002|NCT02634502|microRNA|microrna
105003|NCT02634489|Bladder outlet obstruction|bladder outlet obstruction
105004|NCT02634489|Overactive bladder|overactive bladder
105005|NCT02634489|Urinary incontinence|urinary incontinence
105006|NCT02634489|Omnic OCAS®|omnic ocas®
105007|NCT02634489|Vesicare®|vesicare®
105008|NCT02634489|Tamsulosin hydrochloride|tamsulosin hydrochloride
105009|NCT02634489|Solifenacin succinate|solifenacin succinate
105010|NCT02634476|Alcohol|alcohol
105011|NCT02634476|Substance use disorder|substance use disorder
105012|NCT02634476|cognitive bias|cognitive bias
105013|NCT02634476|behavioral intervention|behavioral intervention
105014|NCT02634476|computerised training|computerised training
105015|NCT02634463|Immunoassay|immunoassay
105016|NCT02634463|Antipsychotic|antipsychotic
105017|NCT02634463|Aripiprazole|aripiprazole
105018|NCT02634463|Olanzapine|olanzapine
105019|NCT02634463|Paliperidone|paliperidone
105020|NCT02634463|Risperidone|risperidone
105021|NCT02634450|HIV|hiv
105022|NCT02634450|Diagnostic|diagnostic
105023|NCT02634450|children|children
105024|NCT02634424|Hemophilia A|hemophilia a
105025|NCT02634424|Prophylaxy|prophylaxy
105026|NCT02634424|Pharmacokinetic|pharmacokinetic
105027|NCT02634424|Bayesian|bayesian
105028|NCT02634411|Ventilator Associated|ventilator associated
105029|NCT02634411|Pneumonia|pneumonia
105030|NCT02634411|Antibiotic treatment|antibiotic treatment
105031|NCT02634411|Pseudomonas aeruginosa|pseudomonas aeruginosa
105032|NCT02634372|Bipolar Disorder|bipolar disorder
105033|NCT02634372|Traumatic event|traumatic event
105034|NCT02634372|Eye Movement Desensitization Reprocessing|eye movement desensitization reprocessing
105035|NCT02634372|Supportive therapy|supportive therapy
105036|NCT02634372|Relapse prevention|relapse prevention
105037|NCT02634346|Alkermes|alkermes
105038|NCT02634346|ALKS 3831|alks 3831
105039|NCT02634346|Samidorphan|samidorphan
105040|NCT02634346|Schizophrenia|schizophrenia
105041|NCT02634346|Acute Exacerbation of Schizophrenia|acute exacerbation of schizophrenia
105042|NCT02634333|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
105043|NCT02634333|nonproliferative diabetic retinopathy|nonproliferative diabetic retinopathy
105044|NCT02634320|Alkermes|alkermes
105045|NCT02634320|ARISTADA|aristada
105046|NCT02634320|Aripiprazole Lauroxil|aripiprazole lauroxil
105047|NCT02634320|Schizophrenia|schizophrenia
105048|NCT02634307|Multiple Sclerosis|multiple sclerosis
105050|NCT02634307|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
105051|NCT02634307|RRMS|rrms
105052|NCT02634307|dimethyl fumarate|dimethyl fumarate
105053|NCT02634307|DMF|dmf
105054|NCT02634294|Hematological Neoplasms|hematological neoplasms
105055|NCT02634294|recurrence|recurrence
105056|NCT02634294|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
105057|NCT02634294|peginterferon alfa-2b|peginterferon alfa-2b
105058|NCT02634294|Graft vs Host Disease|graft vs host disease
105059|NCT02634268|randomized controlled trial|randomized controlled trial
105060|NCT02634268|diet|diet
105061|NCT02634268|exercise|exercise
105062|NCT02634268|obesity|obesity
105063|NCT02634268|overweight|overweight
105064|NCT02634268|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
105065|NCT02634268|lifestyle|lifestyle
105066|NCT02634255|rocuronium|rocuronium
105067|NCT02634255|onset time|onset time
105068|NCT02634255|anxiety|anxiety
105069|NCT02634242|Si Wu Tang|si wu tang
105070|NCT02634242|antioxidation|antioxidation
105071|NCT02634242|anthropometric measurements|anthropometric measurements
105072|NCT02634242|liver|liver
105073|NCT02634242|skin|skin
125101|NCT02513303|AVF|avf
96209|NCT02688036|Limited Disease Small Cell Lung Cancer|limited disease small cell lung cancer
96213|NCT02688023|Irinotecan|irinotecan
105077|NCT02634229|insulin secretion|insulin secretion
105078|NCT02634216|Hyperglycemia|hyperglycemia
105079|NCT02634216|Capros|capros
105080|NCT02634216|Type 1 Diabetes|type 1 diabetes
105081|NCT02634203|Chronic Thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
105082|NCT02634203|Balloon Pulmonary Angioplasty|balloon pulmonary angioplasty
105083|NCT02634203|Riociguat|riociguat
105084|NCT02634190|Cervical cancer screening|cervical cancer screening
105085|NCT02634190|High risk Human Papillomavirus|high risk human papillomavirus
105120|NCT02631928|biosimilar|biosimilar
105121|NCT02631902|Community-based intervention|community-based intervention
105122|NCT02631902|Exercise program|exercise program
105123|NCT02631902|Dietary intervention program|dietary intervention program
105124|NCT02631902|Health promotion|health promotion
105125|NCT02631902|Subjective well-being|subjective well-being
105126|NCT02631902|Cardiovascular risk|cardiovascular risk
105127|NCT02631876|Epithelial ovarian cancer|epithelial ovarian cancer
105128|NCT02631876|Fallopian tube cancer|fallopian tube cancer
105129|NCT02631876|Primary peritoneal cancer|primary peritoneal cancer
105130|NCT02631876|IMGN853|imgn853
105131|NCT02631876|ADC|adc
105132|NCT02631876|Antibody drug conjugate|antibody drug conjugate
105133|NCT02631876|ImmunoGen|immunogen
105134|NCT02631876|Antibody|antibody
105135|NCT02631876|Folate receptor alpha|folate receptor alpha
105136|NCT02631876|mirvetuximab soravtansine|mirvetuximab soravtansine
105137|NCT02631876|Phase 3|phase 3
105138|NCT02631876|platinum-resistant|platinum-resistant
105139|NCT02634112|anastomotic leakage|anastomotic leakage
105140|NCT02634112|rectal cancer surgery|rectal cancer surgery
105141|NCT02634112|anastomotic leakage predictive score|anastomotic leakage predictive score
105142|NCT02634099|major pediatric surgery|major pediatric surgery
105143|NCT02634099|hemoglobin measurement|hemoglobin measurement
105144|NCT02634086|Coronary artery disease|coronary artery disease
105145|NCT02634086|Percutaneous coronary intervention|percutaneous coronary intervention
105146|NCT02634086|Coronary artery bypass graft|coronary artery bypass graft
105147|NCT02634086|Medication therapy|medication therapy
105148|NCT02634073|Lamivudine|lamivudine
105149|NCT02634073|Safety|safety
105150|NCT02634073|Sorbitol|sorbitol
105151|NCT02634073|Pharmacokinetics|pharmacokinetics
105152|NCT02634060|adalimumab|adalimumab
105153|NCT02634060|fecal calprotectin|fecal calprotectin
105154|NCT02634060|home based|home based
106195|NCT02628223|SLT|slt
105155|NCT02634047|transesophageal echocardiography|transesophageal echocardiography
105156|NCT02634047|videolaryngoscope|videolaryngoscope
105157|NCT02634047|oropharyngeal injury|oropharyngeal injury
105158|NCT02634008|Genotype 1|genotype 1
105159|NCT02633956|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
105160|NCT02633956|NAFLD|nafld
105161|NCT02633956|Fatty Liver Disease|fatty liver disease
105162|NCT02633956|NASH|nash
105163|NCT02633930|helicobacter pylori|helicobacter pylori
105164|NCT02633930|berberine-containing quadruple therapy|berberine-containing quadruple therapy
105165|NCT02633930|clarithromycin-containing quadruple therapy|clarithromycin-containing quadruple therapy
105166|NCT02633917|Low back pain|low back pain
105167|NCT02633917|Motor control|motor control
105168|NCT02633917|Joint mobilization|joint mobilization
105169|NCT02633904|Hip Dislocation|hip dislocation
105170|NCT02633904|Congenital|congenital
105172|NCT02633904|Femur Head Necrosis|femur head necrosis
105173|NCT02633891|neuropathies|neuropathies
105174|NCT02633891|metabolic diseases|metabolic diseases
105175|NCT02633891|nervous system diseases|nervous system diseases
105176|NCT02633891|peripheral nervous system diseases|peripheral nervous system diseases
105177|NCT02633865|patient characteristics|patient characteristics
105178|NCT02633852|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
105179|NCT02633852|Aflibercept (EYLEA)|aflibercept (eylea)
105180|NCT02633839|Adults|adults
105181|NCT02633826|alloreactive T cell|alloreactive t cell
105182|NCT02633826|donor-specific antibody|donor-specific antibody
105183|NCT02633813|Bioequivalence|bioequivalence
105184|NCT02633813|Tinea pedis|tinea pedis
105185|NCT02633813|Naftin|naftin
105186|NCT02633800|Squamous cell cancer of the head and neck|squamous cell cancer of the head and neck
105187|NCT02633800|Squamous cell carcinoma|squamous cell carcinoma
105188|NCT02633800|Head and neck cancer|head and neck cancer
105189|NCT02633800|Neoplasms by site|neoplasms by site
105190|NCT02633787|Meningitis|meningitis
105191|NCT02633787|Meningococcal Meningitis|meningococcal meningitis
105192|NCT02633787|Meningococcal Infections|meningococcal infections
105193|NCT02633787|Menactra®|menactra®
105194|NCT02633761|Fetal death|fetal death
105195|NCT02633761|mifepristone|mifepristone
105196|NCT02633761|misoprostol|misoprostol
105197|NCT02633735|Clinical Decision Support|clinical decision support
105198|NCT02633696|Clinical trial|clinical trial
105199|NCT02633696|Phase I|phase i
105200|NCT02633696|Healthy volunteers|healthy volunteers
105201|NCT02633696|Clinical Pharmacology|clinical pharmacology
105202|NCT02633696|Bioavailability|bioavailability
105203|NCT02633696|Silybin|silybin
105204|NCT02633696|Liver Trasplantation|liver trasplantation
105205|NCT02633683|Restless Legs Syndrome|restless legs syndrome
105207|NCT02633657|Restless Legs Syndrome|restless legs syndrome
105209|NCT02633644|Heart Failure|heart failure
105210|NCT02633644|Cardiovascular Diseases|cardiovascular diseases
105211|NCT02633644|Heart Diseases|heart diseases
105212|NCT02633592|High Resolution Anorectal Manometry|high resolution anorectal manometry
105213|NCT02633592|Magnetic Resonance Imaging|magnetic resonance imaging
105214|NCT02633592|Balloon Expulsion|balloon expulsion
105215|NCT02633592|Position|position
105216|NCT02633579|Healthy volunteers|healthy volunteers
105217|NCT02633566|Flatfoot|flatfoot
105218|NCT02633566|orthoses|orthoses
105219|NCT02633566|children|children
105220|NCT02633553|thymoma|thymoma
105913|NCT02629640|dementia|dementia
105221|NCT02633553|adjuvant radiotherapy|adjuvant radiotherapy
105222|NCT02633553|complete resection|complete resection
105223|NCT02633540|T1a Larynx Cancer|t1a larynx cancer
105224|NCT02633540|T2a Larynx Cancer|t2a larynx cancer
105225|NCT02633514|thymoma|thymoma
105226|NCT02633514|thymic carcinoma|thymic carcinoma
105227|NCT02633514|adjuvant radiotherapy|adjuvant radiotherapy
105228|NCT02633514|adjuvant radiochemotherapy|adjuvant radiochemotherapy
105229|NCT02633514|incomplete resection|incomplete resection
105230|NCT02633475|interleukin-10|interleukin-10
105231|NCT02633475|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
105232|NCT02633449|tDCS|tdcs
105233|NCT02633449|cognitive behavioral therapy|cognitive behavioral therapy
105234|NCT02633436|esophageal cancer|esophageal cancer
105235|NCT02633436|SLC1A5|slc1a5
105236|NCT02633423|Cardiopulmonary bypass|cardiopulmonary bypass
105237|NCT02633423|Mechanical ventilation|mechanical ventilation
105238|NCT02633423|Expiratory Flow Limitation|expiratory flow limitation
105239|NCT02633423|Best PEEP|best peep
105240|NCT02633397|SCD|scd
105241|NCT02633397|Sickle Cell Disease|sickle cell disease
105242|NCT02633397|Riociguat|riociguat
105243|NCT02633397|Adempas|adempas
105244|NCT02633384|Parenteral nutrition associated cholestasis|parenteral nutrition associated cholestasis
642519|NCT00748943|bacteria|bacteria
105245|NCT02633384|Intravenous lipid emulsions|intravenous lipid emulsions
105246|NCT02633384|Surgical neonates|surgical neonates
105247|NCT02633384|Congenital gastrointestinal abnormalities|congenital gastrointestinal abnormalities
105248|NCT02633358|Acute myocardial infarction, cardiogenic shock|acute myocardial infarction, cardiogenic shock
105249|NCT02633319|Parenting|parenting
105250|NCT02633319|Child maltreatment|child maltreatment
106314|NCT02627677|CML|cml
105251|NCT02633319|Economic strengthening|economic strengthening
105252|NCT02633319|Early childhood development|early childhood development
105253|NCT02633319|Cluster randomized controlled trial|cluster randomized controlled trial
105254|NCT02633319|Pilot evaluation|pilot evaluation
105255|NCT02633306|trigeminal region pain|trigeminal region pain
105256|NCT02633293|Treprostinil|treprostinil
105257|NCT02633293|PH|ph
105258|NCT02633293|ILD|ild
105259|NCT02633293|CPFE|cpfe
105260|NCT02633293|6 Minute Walk Test|6 minute walk test
105261|NCT02633267|social anxiety|social anxiety
105262|NCT02633267|unemployment|unemployment
105263|NCT02633267|cognitive behavioral therapy|cognitive behavioral therapy
105264|NCT02633267|group therapy|group therapy
105265|NCT02633267|work|work
105266|NCT02633267|vocation|vocation
105267|NCT02633241|pediatrics|pediatrics
105268|NCT02633241|sedation|sedation
105269|NCT02633241|dexmedetomidine|dexmedetomidine
105270|NCT02633241|propofol|propofol
105272|NCT02633228|Multifocal Intraocular Lens|multifocal intraocular lens
105273|NCT02633228|Binocular Trifocality|binocular trifocality
105274|NCT02633228|Cataract Surgery|cataract surgery
105275|NCT02633228|Spectacle Independence|spectacle independence
105276|NCT02633228|Intermediate Vision|intermediate vision
105277|NCT02633228|Photopic Vision|photopic vision
105278|NCT02633228|Mesopic Vision|mesopic vision
105279|NCT02633228|Scotopic Vision|scotopic vision
105280|NCT02633228|Binocular Vision|binocular vision
105281|NCT02633215|motor recovery|motor recovery
105282|NCT02633215|neuroplasticity|neuroplasticity
105283|NCT02633215|chronic|chronic
105284|NCT02633215|human|human
105285|NCT02633215|sensory|sensory
105286|NCT02633202|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
105287|NCT02633202|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
105288|NCT02633202|intermediate risk|intermediate risk
105289|NCT02633202|intensity-modulated radiotherapy|intensity-modulated radiotherapy
105290|NCT02633189|stage IV|stage iv
105291|NCT02633189|stage IIIB|stage iiib
105292|NCT02633189|EGFR mutation|egfr mutation
105293|NCT02633189|non-squamous|non-squamous
105294|NCT02633189|liquid biopsy|liquid biopsy
105295|NCT02633189|erlotinib|erlotinib
105296|NCT02633189|bevacizumab|bevacizumab
105297|NCT02633163|Systemic Lupus Erythematosus|systemic lupus erythematosus
105298|NCT02633163|Stem Cell|stem cell
105299|NCT02633163|Lupus|lupus
105300|NCT02633150|Obesity|obesity
105301|NCT02633150|insulinoresistant|insulinoresistant
105302|NCT02633150|menopausal women|menopausal women
105303|NCT02633150|polyphenol|polyphenol
105304|NCT02633137|Lenalidomide|lenalidomide
105305|NCT02633137|15-196|15-196
105306|NCT02633124|Premature infants|premature infants
105307|NCT02633124|Catheter-related bacteremia|catheter-related bacteremia
105308|NCT02633124|Infusion device|infusion device
105309|NCT02633124|Neonatal intensive care|neonatal intensive care
105310|NCT02633124|Central Venous Catheter|central venous catheter
105311|NCT02633124|Drug Infusion Systems|drug infusion systems
105312|NCT02633111|DNA Sequencing|dna sequencing
105313|NCT02633111|15-180|15-180
105314|NCT02633098|Artesunate|artesunate
105315|NCT02633098|Artemisinins|artemisinins
105316|NCT02633098|Antimalarial|antimalarial
105317|NCT02633098|Neoadjuvant|neoadjuvant
105318|NCT02633098|Pre-operative|pre-operative
105319|NCT02633085|Unicompartment Knee Replacement|unicompartment knee replacement
105320|NCT02632981|Interleukin-32|interleukin-32
105321|NCT02632981|periodontitis|periodontitis
105322|NCT02632955|arteriovenous fistula|arteriovenous fistula
105323|NCT02632955|hemodialysis|hemodialysis
105324|NCT02632955|drug coated balloon|drug coated balloon
105325|NCT02632942|arteriovenous fistula|arteriovenous fistula
105326|NCT02632942|hemodialysis|hemodialysis
105327|NCT02632942|maturation|maturation
105328|NCT02632929|foot ulcer, diabetic|foot ulcer, diabetic
105329|NCT02632929|wound healing|wound healing
105330|NCT02632929|diabetic foot ulcer|diabetic foot ulcer
105331|NCT02632877|pirfenidone|pirfenidone
105332|NCT02632877|Modified oxide diallyl disulfide (MODD)|modified oxide diallyl disulfide (modd)
105333|NCT02632877|ketanserin|ketanserin
105334|NCT02632877|diabetic foot ulcer|diabetic foot ulcer
105335|NCT02632851|inhalation|inhalation
105336|NCT02632851|isotonic saline|isotonic saline
105337|NCT02632851|NaCl solution 0.9 %|nacl solution 0.9 %
105338|NCT02632851|Ectoin|ectoin
105339|NCT02632851|bronchitis|bronchitis
105340|NCT02632851|respiratory tract infection|respiratory tract infection
105341|NCT02632838|Hypertension|hypertension
105342|NCT02632838|mHealth|mhealth
105343|NCT02632838|underserved community|underserved community
105344|NCT02632825|Nasal High Flow|nasal high flow
642520|NCT00748943|saliva|saliva
105345|NCT02632825|gas exchange|gas exchange
105346|NCT02632825|newborn|newborn
105347|NCT02632799|Nasal High Flow|nasal high flow
105348|NCT02632799|CPAP|cpap
105349|NCT02632799|airway pressure|airway pressure
105350|NCT02632799|newborn|newborn
105351|NCT02632786|amyloidosis|amyloidosis
105352|NCT02632786|ntprobnp|ntprobnp
105353|NCT02632786|NEOD001|neod001
105354|NCT02632786|Prothena|prothena
105355|NCT02632786|PRONTO|pronto
105356|NCT02632786|amyloid|amyloid
105357|NCT02632786|plasma cell dyscrasia|plasma cell dyscrasia
105358|NCT02632786|immunotherapy|immunotherapy
105359|NCT02632773|Language Intervention|language intervention
105360|NCT02632773|Parent-Mediated Intervention|parent-mediated intervention
105361|NCT02632734|alveolar bone preservation|alveolar bone preservation
105362|NCT02632734|coral grafting device|coral grafting device
105363|NCT02632708|Acute Myeloid Leukemia|acute myeloid leukemia
105364|NCT02632708|AML|aml
105365|NCT02632708|Untreated AML|untreated aml
105366|NCT02632708|De novo AML|de novo aml
105367|NCT02632708|Secondary AML|secondary aml
105368|NCT02632708|Newly diagnosed AML|newly diagnosed aml
105369|NCT02632708|IDH1|idh1
105370|NCT02632708|IDH2|idh2
105371|NCT02632708|Induction therapy|induction therapy
105372|NCT02632708|Consolidation therapy|consolidation therapy
105373|NCT02632708|IDH|idh
105374|NCT02632682|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
105668|NCT02630992|pediatrics|pediatrics
105375|NCT02632669|Focal brachytherapy|focal brachytherapy
105376|NCT02632669|Seed implant|seed implant
105377|NCT02632669|Quality of life|quality of life
105378|NCT02632669|Toxicity|toxicity
105379|NCT02632643|TMD|tmd
105380|NCT02632643|HYPERTONIA|hypertonia
105381|NCT02632643|PARAFUNCTIONS|parafunctions
105382|NCT02632643|SENSORIMOTOR APPROACH|sensorimotor approach
105383|NCT02632630|Peripheral Parenteral Nutrition|peripheral parenteral nutrition
105384|NCT02632630|Oral nutritional supplementation|oral nutritional supplementation
105385|NCT02632630|Acute Care hospitals|acute care hospitals
105386|NCT02632617|Heart Valve Diseases|heart valve diseases
105387|NCT02632617|Coronary Artery Disease|coronary artery disease
105388|NCT02632617|Computed Tomographic Angiography|computed tomographic angiography
105389|NCT02632617|Preoperative Procedure|preoperative procedure
105390|NCT02632565|osteoarthritis|osteoarthritis
105391|NCT02632565|lidocaine|lidocaine
105392|NCT02632565|pain|pain
105393|NCT02632565|ultrasound|ultrasound
105394|NCT02632552|care transition|care transition
105395|NCT02632552|technology|technology
105396|NCT02632552|chronic heart failure|chronic heart failure
96502|NCT02686034|Vagal nerve stimulation|vagal nerve stimulation
96503|NCT02686034|gammaCore|gammacore
96504|NCT02686034|episodic migraine|episodic migraine
96505|NCT02685982|Unipolar|unipolar
105397|NCT02632552|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
105398|NCT02632552|virtual nurse|virtual nurse
105399|NCT02632552|texting|texting
105400|NCT02632552|informatics|informatics
105401|NCT02632552|Veterans|veterans
105402|NCT02632539|ventilator associated pneumonia|ventilator associated pneumonia
105403|NCT02632539|Subglottic Secretion Drainage|subglottic secretion drainage
105404|NCT02632539|manual air-impingement operation|manual air-impingement operation
105405|NCT02632526|AZD5718 oral suspension crystalline|azd5718 oral suspension crystalline
105406|NCT02632526|AZD5718 oral suspension amorphous|azd5718 oral suspension amorphous
105407|NCT02632526|Single ascending dose/multiple ascending dose (SAD/MAD)|single ascending dose/multiple ascending dose (sad/mad)
105408|NCT02632526|Placebo-controlled|placebo-controlled
105409|NCT02632526|Safety|safety
105410|NCT02632526|Tolerability|tolerability
105411|NCT02632526|Pharmacokinetics|pharmacokinetics
105412|NCT02632526|Pharmacodynamics|pharmacodynamics
105512|NCT02632045|Breast Cancer|breast cancer
105413|NCT02632513|continuous ultrasonic irrigation, syringe irrigation|continuous ultrasonic irrigation, syringe irrigation
105414|NCT02632500|Cardio-Pulmonary Resuscitation|cardio-pulmonary resuscitation
105415|NCT02632500|Cardiac Arrest|cardiac arrest
105416|NCT02632500|Training|training
105417|NCT02632474|HIV Infections|hiv infections
105418|NCT02632474|Tenofovir|tenofovir
105419|NCT02632474|Efavirenz|efavirenz
105420|NCT02632461|Diet|diet
105421|NCT02632461|Weight Loss|weight loss
105422|NCT02632461|Tracking|tracking
105423|NCT02632461|Calories|calories
105424|NCT02632448|Metastatic cancer|metastatic cancer
105425|NCT02632448|Advanced cancer|advanced cancer
105426|NCT02632448|Recurrent cancer|recurrent cancer
105427|NCT02632448|Colorectal neoplasms|colorectal neoplasms
105428|NCT02632448|Triple negative breast cancer|triple negative breast cancer
105429|NCT02632448|Ovarian neoplasms|ovarian neoplasms
105430|NCT02632448|Colon neoplasms|colon neoplasms
105431|NCT02632448|Rectal neoplasms|rectal neoplasms
105432|NCT02632448|Triple negative breast neoplasms|triple negative breast neoplasms
105433|NCT02632435|HER2 positive|her2 positive
105434|NCT02632383|Diabetes type 1|diabetes type 1
105435|NCT02632383|Transition|transition
105436|NCT02632383|Telemedicine|telemedicine
105437|NCT02632383|mHealth app|mhealth app
105438|NCT02632383|Youth|youth
105439|NCT02632383|Self-management|self-management
105440|NCT02632370|Malignant Gliomas|malignant gliomas
105441|NCT02632370|5-ALA|5-ala
642623|NCT00749346|Pemetrexed|pemetrexed
105442|NCT02632370|tumor resection|tumor resection
105443|NCT02632370|malignant tumor|malignant tumor
105444|NCT02632357|Neurodynamics|neurodynamics
105445|NCT02632344|Laryngeal papilloma, recurrent|laryngeal papilloma, recurrent
105446|NCT02632344|Respiratory papillomatosis|respiratory papillomatosis
105447|NCT02632344|Juvenile-onset recurrent respiratory papillomatosis|juvenile-onset recurrent respiratory papillomatosis
105448|NCT02632344|Human papillomavirus|human papillomavirus
105449|NCT02632344|Virally-related diseases|virally-related diseases
105450|NCT02632331|Food effect|food effect
105451|NCT02632331|Pharmacokinetics|pharmacokinetics
105452|NCT02632331|ASP8825|asp8825
105453|NCT02632331|XP13512|xp13512
105454|NCT02632305|unresectable biliary tract cancer|unresectable biliary tract cancer
105455|NCT02632305|nab-paclitaxel|nab-paclitaxel
105456|NCT02632305|cisplatin|cisplatin
105457|NCT02632305|gemcitabine|gemcitabine
105458|NCT02632279|Parkinson's disease|parkinson's disease
105459|NCT02632279|Deep Brain Stimulation|deep brain stimulation
105460|NCT02632279|Subthalamic nucleus|subthalamic nucleus
105461|NCT02632279|Tryptophan depletion|tryptophan depletion
105462|NCT02632279|Serotonin|serotonin
105463|NCT02632266|prematurity|prematurity
105465|NCT02632266|nutrition|nutrition
105466|NCT02632266|human milk fortifier|human milk fortifier
105467|NCT02632253|exercise therapy|exercise therapy
105468|NCT02632253|GUCH|guch
105469|NCT02632253|ventricular ejection fraction|ventricular ejection fraction
105470|NCT02632253|HIIT|hiit
105471|NCT02632253|MICE|mice
105472|NCT02632240|gingival recession|gingival recession
105473|NCT02632240|mucogingival surgery|mucogingival surgery
105474|NCT02632240|collagen matrix|collagen matrix
105475|NCT02632240|connective tissue graft|connective tissue graft
105476|NCT02632240|tunnel technique|tunnel technique
105477|NCT02632214|Face processing|face processing
105478|NCT02632214|asymmetry|asymmetry
105479|NCT02632214|deaf|deaf
105480|NCT02632214|fMRI|fmri
105481|NCT02632201|gastric cancer|gastric cancer
105482|NCT02632201|liver metastasis|liver metastasis
105483|NCT02632201|PIK-HER2 cells|pik-her2 cells
105484|NCT02632201|dendritic cell-precision multiple antigen T cells|dendritic cell-precision multiple antigen t cells
105485|NCT02632188|Recurrence|recurrence
105486|NCT02632188|Metastasis|metastasis
105487|NCT02632188|liver cancer|liver cancer
105488|NCT02632175|Ulcerative Colitis|ulcerative colitis
105489|NCT02632149|PINS Vagus Nerve Stimulator|pins vagus nerve stimulator
105490|NCT02632136|Laparoscopic|laparoscopic
105491|NCT02632136|TAP Block|tap block
105492|NCT02632136|Total extra peritoneal Inguinal hernia repair|total extra peritoneal inguinal hernia repair
105493|NCT02632123|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
105494|NCT02632123|outcome|outcome
105495|NCT02632123|prognosis|prognosis
105496|NCT02632123|survival|survival
105497|NCT02632110|Actinic Keratosis|actinic keratosis
105498|NCT02632097|inguinal hernia|inguinal hernia
105499|NCT02632097|mesh fixation|mesh fixation
105500|NCT02632097|glue|glue
105501|NCT02632097|cyanoacrylate|cyanoacrylate
105502|NCT02632097|Lichtenstein|lichtenstein
105503|NCT02632097|ambulatory surgery|ambulatory surgery
105504|NCT02632071|Breast Cancer|breast cancer
105505|NCT02632071|Breast Carcinoma|breast carcinoma
105506|NCT02632071|Breast tumors|breast tumors
105507|NCT02632071|Cancer of the Breast|cancer of the breast
105508|NCT02632071|Malignant tumor of the breast|malignant tumor of the breast
105509|NCT02632071|Metastatic Breast Cancer|metastatic breast cancer
105510|NCT02632071|Unresectable breast cancer|unresectable breast cancer
105511|NCT02632045|Breast Neoplasms|breast neoplasms
105513|NCT02632045|Breast Carcinoma|breast carcinoma
105514|NCT02632045|Breast tumors|breast tumors
105515|NCT02632045|Cancer of the Breast|cancer of the breast
105516|NCT02632032|Type 1 diabetes|type 1 diabetes
105517|NCT02632032|children|children
105518|NCT02632032|diabetes camps|diabetes camps
105519|NCT02632032|glycemic control|glycemic control
105520|NCT02632019|advanced biliary tract malignant tumor|advanced biliary tract malignant tumor
105521|NCT02632019|dendritic cell|dendritic cell
105522|NCT02632019|precision T cell for neo-antigen|precision t cell for neo-antigen
105523|NCT02631850|Constraint-induced movement therapy|constraint-induced movement therapy
105524|NCT02631850|gaming|gaming
105525|NCT02631850|virtual reality|virtual reality
105526|NCT02631850|upper extremity|upper extremity
105527|NCT02631850|CI therapy|ci therapy
105528|NCT02631850|rehabilitation|rehabilitation
105529|NCT02631850|stroke|stroke
105530|NCT02631850|hemiparesis|hemiparesis
105531|NCT02631850|therapy|therapy
105532|NCT02631837|NOTES|notes
105533|NCT02631837|Laparoscopic surgery|laparoscopic surgery
105534|NCT02631824|fragility fractures|fragility fractures
105535|NCT02631824|hip fractures|hip fractures
105536|NCT02631824|augmentation|augmentation
105537|NCT02631824|tip-apex distance|tip-apex distance
105538|NCT02631811|acute leukaemia|acute leukaemia
105539|NCT02631811|supportive / palliative care|supportive / palliative care
105540|NCT02631785|ANXIETY|anxiety
105542|NCT02631785|fMRI|fmri
105543|NCT02631785|Fear conditioning|fear conditioning
105544|NCT02631785|Fear extinction|fear extinction
105545|NCT02631759|Acute intraCerebral Haemorrhage, Epileptic seizures, Lévétiracetam|acute intracerebral haemorrhage, epileptic seizures, lévétiracetam
105546|NCT02631668|iron deficiency anemia, vitamin C, ferrous succinate|iron deficiency anemia, vitamin c, ferrous succinate
105547|NCT02631629|Vitamin D|vitamin d
105548|NCT02631629|Fortification|fortification
105549|NCT02631616|Prostatic Neoplasma, Castration-Resistant|prostatic neoplasma, castration-resistant
754172|NCT01176617|A-Fib|a-fib
105550|NCT02631616|neuroendocrine differentiation|neuroendocrine differentiation
105551|NCT02631616|68Ga-DOTATET|68ga-dotatet
105553|NCT02631590|intra-hepatic biliary system|intra-hepatic biliary system
105554|NCT02631590|extra-hepatic biliary system|extra-hepatic biliary system
105555|NCT02631590|gall bladder|gall bladder
105556|NCT02631590|advanced biliary cancer|advanced biliary cancer
105557|NCT02631590|unresectable|unresectable
105558|NCT02631590|locally advanced|locally advanced
105559|NCT02631590|metastatic disease|metastatic disease
105560|NCT02631564|mCRC;TACE;hepatic infusion;raltitrexed|mcrc;tace;hepatic infusion;raltitrexed
105561|NCT02631551|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
105562|NCT02631538|Subcutaneous|subcutaneous
105563|NCT02631538|Rituximab|rituximab
105564|NCT02631538|Intravenous|intravenous
105565|NCT02631538|Safety|safety
105566|NCT02631538|Efficacy|efficacy
105567|NCT02631538|Sjogren's syndrome|sjogren's syndrome
105568|NCT02631538|Belimumab|belimumab
105569|NCT02631525|Airway extubation|airway extubation
105570|NCT02631525|Anesthesia Recovery Period|anesthesia recovery period
105571|NCT02631525|Desflurane|desflurane
105572|NCT02631525|Propofol|propofol
105573|NCT02631525|Intravenous anesthesia|intravenous anesthesia
105574|NCT02631525|Balanced Anesthesia|balanced anesthesia
105575|NCT02631499|Circulating Tumor Cells|circulating tumor cells
105576|NCT02631499|Hepatoectomy|hepatoectomy
105577|NCT02631499|TACE|tace
105578|NCT02631499|prognosis|prognosis
105579|NCT02631499|relapse|relapse
105580|NCT02631499|Chemoembolization, Therapeutic|chemoembolization, therapeutic
105581|NCT02631486|Rotator Cuff Tears|rotator cuff tears
125659|NCT02509884|surgery|surgery
105582|NCT02631447|Metastatic Melanoma|metastatic melanoma
105583|NCT02631447|BRAF mutation|braf mutation
105584|NCT02631408|spinal fusion|spinal fusion
105585|NCT02631408|topical antibiotics|topical antibiotics
105586|NCT02631408|vancomycin|vancomycin
105587|NCT02631408|surgical site infection|surgical site infection
105588|NCT02631395|Exercise movement techniques|exercise movement techniques
105589|NCT02631382|wet cupping Saudi Arabia|wet cupping saudi arabia
105590|NCT02631343|Kangaroo mother care in the community|kangaroo mother care in the community
105591|NCT02631330|Geriatric Assessment|geriatric assessment
105592|NCT02631330|Physical Education and Training|physical education and training
105593|NCT02631317|acute ischemic stroke|acute ischemic stroke
105594|NCT02631317|intravenous rt-PA thrombolysis|intravenous rt-pa thrombolysis
105595|NCT02631317|process reengineering|process reengineering
105596|NCT02631317|door-to-needle time|door-to-needle time
105597|NCT02631304|Postoperative delirium|postoperative delirium
105598|NCT02631304|Cholinesterase activity|cholinesterase activity
105599|NCT02631304|Buturylcholinesterase activity|buturylcholinesterase activity
105600|NCT02631304|Acetylcholinesterase activity|acetylcholinesterase activity
105601|NCT02631304|Elderly patients|elderly patients
105602|NCT02631304|Cardiac surgery|cardiac surgery
105603|NCT02631265|Type 1 diabetes|type 1 diabetes
105604|NCT02631265|Exercise|exercise
105605|NCT02631265|Hypoglycemia|hypoglycemia
105606|NCT02631265|Insulin pump|insulin pump
105607|NCT02631252|Leukemia|leukemia
105710|NCT02630836|fracture|fracture
105608|NCT02631252|Acute Myelogenous|acute myelogenous
105609|NCT02631252|Phase I|phase i
105610|NCT02631252|Mitoxantrone|mitoxantrone
105611|NCT02631252|Etoposide|etoposide
105612|NCT02631252|Hydroxychloroquine|hydroxychloroquine
105613|NCT02631252|Relapsed|relapsed
105614|NCT02631252|Autophagy inhibitor|autophagy inhibitor
105615|NCT02631252|AML|aml
105616|NCT02631252|Relapsed AML|relapsed aml
105617|NCT02631200|Advance Care Planning|advance care planning
105618|NCT02631200|Palliative care|palliative care
105619|NCT02631200|Frail Elderly|frail elderly
105620|NCT02631200|Renal Dialysis|renal dialysis
105621|NCT02631187|Grade 2 retraction of the pars tensa of the tympanic membrane|grade 2 retraction of the pars tensa of the tympanic membrane
105622|NCT02631187|Grade 3 retraction of the pars tensa of the tympanic membrane|grade 3 retraction of the pars tensa of the tympanic membrane
105623|NCT02631135|Dexmedetomidine|dexmedetomidine
105624|NCT02631135|cognitive functions|cognitive functions
105625|NCT02631135|MMSE|mmse
105626|NCT02631122|Retroclavicular|retroclavicular
105627|NCT02631122|Supraclavicular|supraclavicular
105628|NCT02631122|Diagphram|diagphram
105629|NCT02631122|hemiparesis|hemiparesis
105630|NCT02631122|nerve block|nerve block
105631|NCT02631122|regional anesthesia|regional anesthesia
105632|NCT02631122|anesthesiology|anesthesiology
105633|NCT02631109|Pegaspargase|pegaspargase
105634|NCT02631109|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
105635|NCT02631109|Epstein Barr virus|epstein barr virus
105636|NCT02631070|Luspatercept|luspatercept
105637|NCT02631070|Transfusion dependent|transfusion dependent
105638|NCT02631070|Lower risk|lower risk
105639|NCT02631070|Low risk|low risk
105640|NCT02631070|Myelodysplastic Syndromes|myelodysplastic syndromes
105641|NCT02631070|ESA refractory|esa refractory
105642|NCT02631070|ESA intolerant|esa intolerant
105643|NCT02631070|ESA ineligible|esa ineligible
105644|NCT02631070|ACE-536|ace-536
105645|NCT02631070|Anemia|anemia
105646|NCT02631070|Ring Sideroblasts|ring sideroblasts
105647|NCT02631070|Require Red Blood Cell Transfusions|require red blood cell transfusions
105648|NCT02631070|MEDALIST|medalist
105649|NCT02631070|MDS|mds
105650|NCT02631070|IPSS-R very low/IPSS-R low/IPSS-R intermediate|ipss-r very low/ipss-r low/ipss-r intermediate
105651|NCT02631044|JCAR017|jcar017
105652|NCT02631044|chimeric antigen receptor|chimeric antigen receptor
105653|NCT02631044|non-Hodgkin lymphoma|non-hodgkin lymphoma
105654|NCT02631044|CAR|car
105655|NCT02631044|CAR T cells|car t cells
105656|NCT02631044|autologous T cell therapy|autologous t cell therapy
105657|NCT02631044|cell therapy|cell therapy
105658|NCT02631044|NHL|nhl
105659|NCT02631031|Chronokinetics|chronokinetics
105660|NCT02631031|chronodynamics|chronodynamics
105661|NCT02631031|chronopharmacology|chronopharmacology
105662|NCT02631031|valsartan|valsartan
105663|NCT02631005|systemic lupus erythematosus|systemic lupus erythematosus
105664|NCT02631005|exercise|exercise
105665|NCT02630992|ear infections|ear infections
105666|NCT02630992|antibiotics|antibiotics
105667|NCT02630992|antibiotic resistance|antibiotic resistance
105669|NCT02630992|infants|infants
105670|NCT02630992|children|children
105671|NCT02630992|amoxicillin-clavulanate|amoxicillin-clavulanate
105672|NCT02630966|Drug therapy|drug therapy
105673|NCT02630953|Physical Activity|physical activity
105674|NCT02630953|Latinas|latinas
105675|NCT02630953|Spanish-language|spanish-language
105676|NCT02630953|Text-Message|text-message
105677|NCT02630927|Safety and Tolerability|safety and tolerability
105678|NCT02630927|Pharmacokinetic Study|pharmacokinetic study
105679|NCT02630927|Healthy Volunteer|healthy volunteer
105680|NCT02630927|Pyruvate Kinase|pyruvate kinase
105681|NCT02630927|Rare Genetic|rare genetic
105682|NCT02630914|Epicardial surgical removal|epicardial surgical removal
105683|NCT02630914|Closure of the left atrial|closure of the left atrial
105684|NCT02630914|Left atrial appendage (LAA)|left atrial appendage (laa)
105685|NCT02630888|Bipolar Disorder|bipolar disorder
105686|NCT02630888|Memantine|memantine
105687|NCT02630888|Lithium|lithium
105688|NCT02630888|Aripiprazole|aripiprazole
105689|NCT02630888|Quetiapine|quetiapine
105690|NCT02630888|Central Nervous System Agents|central nervous system agents
105691|NCT02630888|Therapeutic Uses|therapeutic uses
105692|NCT02630888|Pharmacologic Actions|pharmacologic actions
105693|NCT02630888|Psychotropic Drugs|psychotropic drugs
105694|NCT02630888|Cognitive effect of drugs|cognitive effect of drugs
105695|NCT02630862|oxidative stress|oxidative stress
105696|NCT02630862|atherosclerosis|atherosclerosis
105697|NCT02630862|carotid stenosis|carotid stenosis
105698|NCT02630862|oxysterols|oxysterols
105699|NCT02630862|vitamin E|vitamin e
105700|NCT02630862|lipid peroxidation|lipid peroxidation
105701|NCT02630862|antioxidants|antioxidants
105702|NCT02630862|aspirin|aspirin
105703|NCT02630862|dipyridamole|dipyridamole
105704|NCT02630836|mesenchymal stromal cells|mesenchymal stromal cells
105705|NCT02630836|stem cells|stem cells
105706|NCT02630836|elderly|elderly
105707|NCT02630836|allogeneic|allogeneic
105708|NCT02630836|bone marrow|bone marrow
105709|NCT02630836|bone regeneration|bone regeneration
105711|NCT02630784|Non-invasive ventilation|non-invasive ventilation
105712|NCT02630784|NIV ventilator|niv ventilator
105713|NCT02630784|Exhalation by a calibrated leak|exhalation by a calibrated leak
105714|NCT02630784|ICU ventilator|icu ventilator
105715|NCT02630784|Respiratory acidosis|respiratory acidosis
105716|NCT02630784|ICU|icu
105717|NCT02630758|depression|depression
105718|NCT02630758|yoga|yoga
105719|NCT02630758|mindfulness|mindfulness
105720|NCT02630745|endodontic treatment|endodontic treatment
105721|NCT02630745|open flap debridement|open flap debridement
105722|NCT02630732|Back School|back school
105723|NCT02630732|Brain School|brain school
105724|NCT02630732|Lumbar surgery|lumbar surgery
105725|NCT02630732|Education|education
105726|NCT02630719|headache|headache
105727|NCT02630628|Lupus Nephritis|lupus nephritis
105728|NCT02630628|mycophenolate mofetil|mycophenolate mofetil
105729|NCT02630628|tacrolimus|tacrolimus
105730|NCT02630615|Circulating tumor cells|circulating tumor cells
105731|NCT02630589|tinnitus|tinnitus
105732|NCT02630589|auditory brainstem implant|auditory brainstem implant
105733|NCT02630589|electrical stimulation|electrical stimulation
105734|NCT02630576|electromyography|electromyography
643097|NCT00750438|Obesity|obesity
105735|NCT02630576|neuromuscular blockade|neuromuscular blockade
105736|NCT02630550|Cardiac output|cardiac output
105737|NCT02630550|Intraoperative Monitoring|intraoperative monitoring
105738|NCT02630550|Echocardiography, Transesophageal|echocardiography, transesophageal
105739|NCT02630550|Vascular cross-clamping|vascular cross-clamping
105740|NCT02630550|Endarterectomy|endarterectomy
105741|NCT02630550|Monitoring, Physiologic/instrumentation|monitoring, physiologic/instrumentation
105742|NCT02630550|Cardiography, Impedance|cardiography, impedance
105743|NCT02630537|Cytomegalovirus|cytomegalovirus
105744|NCT02630537|Epstein- Barr virus|epstein- barr virus
105745|NCT02630537|Cell-mediated immunity|cell-mediated immunity
105746|NCT02630537|T-Track® CMV|t-track® cmv
754173|NCT01176617|AF|af
105747|NCT02630537|T-Track® EBV|t-track® ebv
105748|NCT02630537|hemodialysis|hemodialysis
105750|NCT02630498|pain|pain
105751|NCT02630498|surgical|surgical
105752|NCT02630498|brachial plexus|brachial plexus
105753|NCT02630485|Randomized Controlled Trial|randomized controlled trial
105754|NCT02630459|Migraine Prevention|migraine prevention
105755|NCT02630459|Headache|headache
105756|NCT02630459|Prophylaxis|prophylaxis
105757|NCT02630446|respite care|respite care
105758|NCT02630446|effectiveness|effectiveness
105759|NCT02630446|cost-effectiveness|cost-effectiveness
105760|NCT02630446|support|support
105761|NCT02630446|caregiver|caregiver
105762|NCT02630446|dementia|dementia
105763|NCT02630446|community-based|community-based
105764|NCT02630433|Biliary pancreatitis|biliary pancreatitis
105765|NCT02630433|Cholecystectomy|cholecystectomy
105766|NCT02630394|sickle cell disease|sickle cell disease
105767|NCT02630394|acute chest syndrome|acute chest syndrome
105768|NCT02630381|high-energy shock waves|high-energy shock waves
105769|NCT02630368|Advanced Soft-tissue Sarcoma|advanced soft-tissue sarcoma
105770|NCT02630368|Advanced Breast Cancer|advanced breast cancer
105771|NCT02630368|Maximum Tolerated Dose|maximum tolerated dose
105772|NCT02630368|Efficacy and safety|efficacy and safety
105773|NCT02630342|Mock Scanner|mock scanner
105774|NCT02630342|Child Life Specialist|child life specialist
105775|NCT02630342|Patient Preparation|patient preparation
96897|NCT02683811|effectiveness|effectiveness
96898|NCT02683811|school-based program|school-based program
96899|NCT02683798|Weight loss maintenance|weight loss maintenance
96906|NCT02683746|Pharmacodynamics|pharmacodynamics
96907|NCT02683746|Safety|safety
105776|NCT02630342|Child, Preschool|child, preschool
105777|NCT02630342|Child|child
105778|NCT02630342|Anxiety|anxiety
105779|NCT02630342|Human|human
105780|NCT02630342|Anesthesia, General|anesthesia, general
105781|NCT02630329|NOTES|notes
105782|NCT02630329|Benign adnexal disease|benign adnexal disease
105783|NCT02630329|Laparoscopy|laparoscopy
105784|NCT02630316|Treprostinil|treprostinil
105785|NCT02630316|PH|ph
105786|NCT02630316|ILD|ild
105787|NCT02630316|CPFE|cpfe
105788|NCT02630316|6 Minute Walk Test|6 minute walk test
105789|NCT02630303|light emitting diode-red light|light emitting diode-red light
105790|NCT02630303|LED-RL|led-rl
105791|NCT02630303|high fluence|high fluence
105792|NCT02630303|skin fibrosis|skin fibrosis
105793|NCT02630303|wound healing|wound healing
105794|NCT02630303|scar|scar
105795|NCT02630303|keloid|keloid
105796|NCT02630303|RCT|rct
105797|NCT02630290|Brachial plexus block|brachial plexus block
105798|NCT02630290|Dexmedetomidine|dexmedetomidine
105799|NCT02630290|Ropivacaine|ropivacaine
105800|NCT02630290|ultrasound-guided nerve block|ultrasound-guided nerve block
105801|NCT02630290|supraclavicular brachial plexus block|supraclavicular brachial plexus block
105802|NCT02630277|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
105803|NCT02630277|High Risk PDR|high risk pdr
105804|NCT02630277|aflibercept|aflibercept
105805|NCT02630277|regression of retinal neovascularization|regression of retinal neovascularization
105806|NCT02630264|clinical trial|clinical trial
105807|NCT02630264|Recombinant Human Endostatin Adenovirus|recombinant human endostatin adenovirus
105808|NCT02630264|randomized|randomized
105809|NCT02630251|Cancer|cancer
105810|NCT02630251|Safety|safety
105811|NCT02630251|GSK2820151|gsk2820151
105812|NCT02630251|Dose escalation|dose escalation
105813|NCT02630251|Tolerability|tolerability
105814|NCT02630251|Pharmacodynamics|pharmacodynamics
105815|NCT02630251|Pharmacokinetics|pharmacokinetics
105816|NCT02630238|Exercise|exercise
105817|NCT02630238|Amino Acids, Branched-Chain|amino acids, branched-chain
105818|NCT02630225|case management|case management
105819|NCT02630225|motivational interviewing|motivational interviewing
105820|NCT02630212|Aortic dissection|aortic dissection
105821|NCT02630212|Aldehyde dehydrogenase 2 polymorphism|aldehyde dehydrogenase 2 polymorphism
105822|NCT02630212|Risk factor|risk factor
105823|NCT02630212|aldehyde dehydrogenase 2|aldehyde dehydrogenase 2
105824|NCT02630173|endodontic treatment|endodontic treatment
105825|NCT02630173|scaling|scaling
105826|NCT02630173|root planning|root planning
105827|NCT02630147|Late preterm|late preterm
105828|NCT02630147|Vanilla|vanilla
105829|NCT02630147|Hypoxic intermittent events|hypoxic intermittent events
105830|NCT02630108|HCC|hcc
105831|NCT02630108|TACE|tace
105832|NCT02630108|Thermal Ablation|thermal ablation
105833|NCT02630108|Safety/Efficacy|safety/efficacy
105834|NCT02630095|anticoagulation|anticoagulation
105835|NCT02630082|HIV Preventive Vaccine|hiv preventive vaccine
105836|NCT02630082|HIV Seronegativity|hiv seronegativity
105837|NCT02630082|Immune Response, Mucosal|immune response, mucosal
105838|NCT02630069|amphetamine type stimulant|amphetamine type stimulant
105839|NCT02630069|adolescents|adolescents
105840|NCT02630056|radiotherapy hematologic toxicity pelvic bone marrow|radiotherapy hematologic toxicity pelvic bone marrow
105841|NCT02630004|Mucositis|mucositis
105842|NCT02630004|Head and Neck cancer|head and neck cancer
105843|NCT02630004|Chemoradiation|chemoradiation
105844|NCT02629991|Prader-Willi Syndrome (PWS)|prader-willi syndrome (pws)
105845|NCT02629991|Hyperphagia|hyperphagia
105846|NCT02629978|pulmonary|pulmonary
105847|NCT02629978|lung|lung
105848|NCT02629978|cancer|cancer
105849|NCT02629978|carcinoma|carcinoma
105850|NCT02629978|nodule|nodule
105851|NCT02629978|malignant|malignant
105852|NCT02629978|radiofrequency ablation|radiofrequency ablation
105853|NCT02629978|RFA|rfa
105854|NCT02629952|glucose tolerance|glucose tolerance
105855|NCT02629952|type 2 diabetes|type 2 diabetes
105856|NCT02629952|blueberry tea|blueberry tea
105857|NCT02629900|Weight Loss|weight loss
105858|NCT02629900|Intermittent fasting|intermittent fasting
105859|NCT02629887|supraglottic airway|supraglottic airway
105860|NCT02629887|neonatal resuscitation|neonatal resuscitation
105861|NCT02629887|ventilation|ventilation
105862|NCT02629887|term infant|term infant
105863|NCT02629874|EA-230|ea-230
105864|NCT02629874|Inflammatory response|inflammatory response
105865|NCT02629874|Kidney Injury|kidney injury
105866|NCT02629874|Endotoxemia|endotoxemia
105867|NCT02629848|Drug therapy|drug therapy
105868|NCT02629809|Leukemia|leukemia
105869|NCT02629809|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
105870|NCT02629809|CLL|cll
105871|NCT02629809|Mutated immunoglobulin heavy chair variable region|mutated immunoglobulin heavy chair variable region
105872|NCT02629809|IGHV|ighv
105873|NCT02629809|non-del(17p) fluorescence in-situ hybridization|non-del(17p) fluorescence in-situ hybridization
105874|NCT02629809|FISH|fish
105875|NCT02629809|Obinutuzumab|obinutuzumab
105876|NCT02629809|GA101|ga101
105877|NCT02629809|Gazyva|gazyva
105878|NCT02629809|Fludarabine|fludarabine
105879|NCT02629809|Fludarabine Phosphate|fludarabine phosphate
105880|NCT02629809|Fludara|fludara
105881|NCT02629809|Cyclophosphamide|cyclophosphamide
105882|NCT02629809|Cytoxan|cytoxan
105883|NCT02629809|Neosar|neosar
105884|NCT02629809|Ibrutinib|ibrutinib
105885|NCT02629809|PCI-32765|pci-32765
105886|NCT02629809|Imbruvica|imbruvica
105887|NCT02629809|Allopurinol|allopurinol
105888|NCT02629809|Lopurin|lopurin
105889|NCT02629809|Zurinol|zurinol
105890|NCT02629809|Zyloprim|zyloprim
105891|NCT02629809|Valacyclovir|valacyclovir
105892|NCT02629809|Valtrex|valtrex
105893|NCT02629796|Biomarker|biomarker
105894|NCT02629796|CIDP|cidp
105895|NCT02629796|IVIG|ivig
105896|NCT02629796|treatment response|treatment response
105897|NCT02629757|High-grade glioma|high-grade glioma
105898|NCT02629757|chemotherapy|chemotherapy
105899|NCT02629757|β-elemene|β-elemene
105900|NCT02629731|foot|foot
105901|NCT02629731|ankle|ankle
105902|NCT02629731|osteoarthritis|osteoarthritis
105903|NCT02629731|flat foot|flat foot
105904|NCT02629718|neoadjuvant chemotherapy|neoadjuvant chemotherapy
105905|NCT02629718|radical surgery|radical surgery
105906|NCT02629718|cervical carcinoma|cervical carcinoma
105907|NCT02629653|carotid endarterectomy|carotid endarterectomy
105908|NCT02629653|stroke|stroke
105909|NCT02629653|hypothermia|hypothermia
105910|NCT02629653|endovascular cooling|endovascular cooling
105911|NCT02629640|vCJD|vcjd
105912|NCT02629640|prion disease|prion disease
105914|NCT02629640|old-age|old-age
105915|NCT02629640|surveillance|surveillance
105916|NCT02629640|brain banking|brain banking
105917|NCT02629640|public health|public health
105918|NCT02629627|Conjugated Linoleic Acid|conjugated linoleic acid
105919|NCT02629627|Leucine|leucine
105920|NCT02629627|visceral fat area|visceral fat area
105921|NCT02629627|Epicardial Fat|epicardial fat
105922|NCT02629627|Hemodinamic Parameters|hemodinamic parameters
105923|NCT02628574|Metastatic|metastatic
105924|NCT02628574|Stage III or IV|stage iii or iv
105925|NCT02628574|recurrent|recurrent
105926|NCT02628574|refractory|refractory
105927|NCT02628574|solid tumors|solid tumors
105928|NCT02628535|B7-H3-expressing neoplasms|b7-h3-expressing neoplasms
105929|NCT02629601|physical activity|physical activity
105930|NCT02629601|financial incentives|financial incentives
105931|NCT02629601|behavioral economics|behavioral economics
105932|NCT02629588|Coma|coma
105933|NCT02629588|Persistent Vegetative State|persistent vegetative state
105934|NCT02629588|Sensory Stimulation|sensory stimulation
105935|NCT02629497|platelets|platelets
105936|NCT02629497|12-lipoxygenase|12-lipoxygenase
105937|NCT02629497|fatty acids|fatty acids
105938|NCT02629497|DGLA|dgla
105940|NCT02629497|EPA|epa
105941|NCT02629497|12-LOX|12-lox
105942|NCT02629484|echocardiography|echocardiography
105943|NCT02629484|hip fracture|hip fracture
105944|NCT02629484|surgery|surgery
105945|NCT02629484|outcomes|outcomes
105946|NCT02629432|MRI|mri
105947|NCT02629432|COPD|copd
105948|NCT02629419|STAT3 deficient Hyper IgE syndrome|stat3 deficient hyper ige syndrome
105949|NCT02629419|Gain of function STAT1 defects|gain of function stat1 defects
105950|NCT02629419|Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)|autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (apeced)
105951|NCT02629419|IL-17/IL-22 autoantibodies from thymoma|il-17/il-22 autoantibodies from thymoma
105952|NCT02629419|Job's Syndrome (Hyperimmunoglobulin E Syndrome, Buckley Syndrome)|job's syndrome (hyperimmunoglobulin e syndrome, buckley syndrome)
105953|NCT02629406|HIF|hif
105954|NCT02629406|hypoxia|hypoxia
105955|NCT02629406|chemoreflex|chemoreflex
105956|NCT02629406|baroreflex|baroreflex
105957|NCT02629406|MIR210|mir210
105958|NCT02629393|Molybdenum Cofactor Deficiency (MoCD)|molybdenum cofactor deficiency (mocd)
105959|NCT02629393|Molybdenum Cofactor (MoCo) biosynthesis|molybdenum cofactor (moco) biosynthesis
105960|NCT02629393|sulfite oxidase (SO)|sulfite oxidase (so)
105961|NCT02629393|S sulfocysteine (SSC)|s sulfocysteine (ssc)
105962|NCT02629393|xanthine oxidoreductase|xanthine oxidoreductase
105963|NCT02629393|aldehyde oxidase|aldehyde oxidase
105964|NCT02629380|meniscectomy|meniscectomy
105965|NCT02629380|hyaluronic acid|hyaluronic acid
105966|NCT02629380|intra-op injection|intra-op injection
105967|NCT02629380|randomized controlled trial|randomized controlled trial
105968|NCT02629380|placebo|placebo
105969|NCT02629341|woman osteopenia osteoporosis enriched calcium vit D yogurt|woman osteopenia osteoporosis enriched calcium vit d yogurt
105970|NCT02629328|CardioCel|cardiocel
105971|NCT02629328|FDA cleared|fda cleared
105972|NCT02629328|Tri-leaflet repair|tri-leaflet repair
105973|NCT02629328|Aortic valves|aortic valves
105974|NCT02629289|HSP-130|hsp-130
105975|NCT02629289|Pharmacodynamic and Pharmacokinetic equivalence|pharmacodynamic and pharmacokinetic equivalence
105976|NCT02629289|Pegfilgrastim|pegfilgrastim
105977|NCT02629276|neck pain|neck pain
105978|NCT02629276|arm pain|arm pain
105979|NCT02629276|neurodynamic tests|neurodynamic tests
105980|NCT02629276|quantitative sensory testing|quantitative sensory testing
105981|NCT02629276|somatosensory profile|somatosensory profile
105982|NCT02629250|proximal femoral fracture|proximal femoral fracture
105983|NCT02629250|goal-directed therapy|goal-directed therapy
105984|NCT02629250|myocardial injury|myocardial injury
105985|NCT02629250|supernormal oxygen delivery|supernormal oxygen delivery
105986|NCT02629250|elders|elders
105987|NCT02629250|stroke volume maximization|stroke volume maximization
105988|NCT02629237|glaucoma surgery|glaucoma surgery
105989|NCT02629237|educational intervention|educational intervention
105990|NCT02629237|satisfaction|satisfaction
105991|NCT02629237|rural|rural
105992|NCT02629224|Impaired renal function|impaired renal function
105993|NCT02629224|Haemodialysis|haemodialysis
105994|NCT02629224|ASP8825|asp8825
105995|NCT02629224|XP13512|xp13512
105996|NCT02629211|Inflammatory Bowel Diseases|inflammatory bowel diseases
105997|NCT02629211|Colitis, Ulcerative|colitis, ulcerative
105998|NCT02629211|Crohn Disease|crohn disease
105999|NCT02629211|Single-Balloon Enteroscopy|single-balloon enteroscopy
106000|NCT02629211|NaviAid AB™ Device|naviaid ab™ device
106001|NCT02629211|NaviAid AB™ Procedure|naviaid ab™ procedure
106002|NCT02629211|AB Device|ab device
106003|NCT02629211|Pediatric IBD|pediatric ibd
106004|NCT02629211|Pediatric Enteroscopy|pediatric enteroscopy
106005|NCT02629198|Vitamin D|vitamin d
106006|NCT02629185|Bone|bone
106007|NCT02629185|Vitamin D|vitamin d
106008|NCT02629185|Cardiovascular|cardiovascular
106009|NCT02629172|Genotype 1|genotype 1
106010|NCT02629172|Ritonavir|ritonavir
106011|NCT02629172|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
106012|NCT02629172|Ombitasvir|ombitasvir
106013|NCT02629172|Paritaprevir|paritaprevir
106014|NCT02629159|Antirheumatic agents|antirheumatic agents
106015|NCT02629159|Anti-inflammatory agents|anti-inflammatory agents
106016|NCT02629159|Musculoskeletal disease|musculoskeletal disease
106017|NCT02629159|Arthritis|arthritis
106018|NCT02629159|Joint disease|joint disease
106019|NCT02629146|Midazolam|midazolam
106020|NCT02629146|Fentanyl|fentanyl
106021|NCT02629133|Intimate Partner Violence|intimate partner violence
106022|NCT02629133|Sheltered Battered Women|sheltered battered women
106023|NCT02629133|Substance Use|substance use
106024|NCT02629120|Chronic Granulomatous Disease|chronic granulomatous disease
106025|NCT02629120|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
106026|NCT02629120|Graft Versus Host Disease|graft versus host disease
106027|NCT02629120|Matched Unrelated Donor BMT|matched unrelated donor bmt
106028|NCT02629120|Nonmyeloablative Conditioning Regimen|nonmyeloablative conditioning regimen
106029|NCT02629107|Sleep|sleep
106030|NCT02629107|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
106031|NCT02629107|Electroencephalogram (EEG)|electroencephalogram (eeg)
106032|NCT02629094|Hepatic Steatosis|hepatic steatosis
106033|NCT02629094|Cardiac Steatosis|cardiac steatosis
106034|NCT02629094|Aldosterone|aldosterone
106035|NCT02629094|Eplerenone|eplerenone
106036|NCT02629094|Mineralcorticoid Receptor|mineralcorticoid receptor
106037|NCT02629081|heartburn|heartburn
106038|NCT02629081|GERD|gerd
106039|NCT02629081|NERD|nerd
106040|NCT02629081|non-erosive reflux disease|non-erosive reflux disease
106041|NCT02629068|Adolescent|adolescent
106042|NCT02629068|Social Support|social support
106043|NCT02629068|Social Media|social media
106044|NCT02629068|Parents|parents
106045|NCT02629068|Shame|shame
106046|NCT02629068|Stigma|stigma
106047|NCT02629055|Non-invasive ventilation|non-invasive ventilation
106048|NCT02629055|Respiratory electromyography|respiratory electromyography
106049|NCT02629042|Anesthesia|anesthesia
106050|NCT02629042|Corticosteroids|corticosteroids
106055|NCT02629042|Partial Endodontic Treatment|partial endodontic treatment
106056|NCT02629003|Positron Emission Tomography|positron emission tomography
106058|NCT02629003|5-HT2A|5-ht2a
106059|NCT02629003|Radioligand|radioligand
106060|NCT02629003|Radiation dosimetry|radiation dosimetry
106061|NCT02629003|Radiation dosage|radiation dosage
106062|NCT02628964|smoking|smoking
106063|NCT02628964|cigarettes|cigarettes
106064|NCT02628938|Halitosis|halitosis
106065|NCT02628938|Oral Malodor|oral malodor
106066|NCT02628938|Miswak|miswak
106067|NCT02628938|Salvadora Persica|salvadora persica
106068|NCT02628925|mass screening|mass screening
106069|NCT02628925|Nursing diagnosis|nursing diagnosis
106070|NCT02628925|Psychiatric Status Rating Scale|psychiatric status rating scale
106071|NCT02628912|Cardiopulmonary Fitness|cardiopulmonary fitness
106072|NCT02628912|Long-Term Survivors|long-term survivors
106073|NCT02628912|15-277|15-277
106075|NCT02628912|Survivors|survivors
106076|NCT02628886|maternal and neonatal pneumococcal conjugate vaccination|maternal and neonatal pneumococcal conjugate vaccination
106077|NCT02628886|pneumococcal carriage|pneumococcal carriage
106078|NCT02628873|HSG|hsg
106079|NCT02628873|HyCoSy|hycosy
106080|NCT02628873|Contraception|contraception
106081|NCT02628873|Essure|essure
106082|NCT02628873|Saline Infused sonography|saline infused sonography
106083|NCT02628873|SIS|sis
106084|NCT02628873|Air bubbles|air bubbles
106085|NCT02628860|ferric carboxymaltose|ferric carboxymaltose
106086|NCT02628860|Ferinject®|ferinject®
106087|NCT02628860|pancreatoduodenectomy|pancreatoduodenectomy
106088|NCT02628847|stroke|stroke
106089|NCT02628847|rehabilitation|rehabilitation
106090|NCT02628847|motor skills|motor skills
106091|NCT02628847|sildenafil citrate|sildenafil citrate
106092|NCT02628847|White matter|white matter
106093|NCT02628834|Loading|loading
106094|NCT02628834|Gait|gait
106095|NCT02628834|Multiple Sclerosis|multiple sclerosis
106096|NCT02628834|Manual Therapy|manual therapy
106097|NCT02628808|autism|autism
106098|NCT02628808|asperger|asperger
106099|NCT02628808|Pervasive Developmental Disorder No Otherwise Specify|pervasive developmental disorder no otherwise specify
106100|NCT02628808|gene|gene
106101|NCT02628808|polymorphism|polymorphism
106102|NCT02628808|mutation|mutation
106103|NCT02628795|total hip arthroplasty|total hip arthroplasty
106104|NCT02628795|total knee arthroplasty|total knee arthroplasty
106105|NCT02628782|large bore endovascular catheterization procedures|large bore endovascular catheterization procedures
106106|NCT02628782|Vascular Closure Device|vascular closure device
106107|NCT02628769|Solithromycin|solithromycin
106108|NCT02628769|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
106109|NCT02628769|Inflammation|inflammation
106110|NCT02628769|Macrolide|macrolide
106111|NCT02628730|Atrial Fibrillation|atrial fibrillation
106112|NCT02628730|Ablation|ablation
106113|NCT02628730|Pulmonary vein isolation|pulmonary vein isolation
106114|NCT02628730|Ablation Index|ablation index
106115|NCT02628717|Hepatitis C|hepatitis c
106116|NCT02628717|sofosbuvir|sofosbuvir
106117|NCT02628717|ledipasvir|ledipasvir
106118|NCT02628717|daclatasvir|daclatasvir
106119|NCT02628717|simeprevir|simeprevir
106120|NCT02628704|Karyopharm|karyopharm
106121|NCT02628704|selinexor|selinexor
106122|NCT02628704|KPT-330|kpt-330
106123|NCT02628704|multiple myeloma|multiple myeloma
106124|NCT02628704|SCORE|score
106125|NCT02628678|Prebiotic|prebiotic
106126|NCT02628678|FOS|fos
106127|NCT02628678|fructooligosaccharide|fructooligosaccharide
106128|NCT02628678|polyglycan|polyglycan
106129|NCT02628678|microbiome|microbiome
106130|NCT02628678|microbiota|microbiota
106131|NCT02628678|Healthy Volunteers|healthy volunteers
106132|NCT02628652|Microbiome|microbiome
106133|NCT02628652|FOS|fos
106134|NCT02628652|polyglycan|polyglycan
106135|NCT02628652|prebiotic|prebiotic
106136|NCT02628652|Healthy Volunteers|healthy volunteers
106137|NCT02628626|Incontinence|incontinence
106138|NCT02628626|Diarrhea|diarrhea
106139|NCT02628626|Bile acid|bile acid
106140|NCT02628626|Microbiome|microbiome
106141|NCT02628613|Breast cancer|breast cancer
106142|NCT02628613|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
106144|NCT02628587|Acute Coronary Syndrome|acute coronary syndrome
106145|NCT02628587|Clopidogrel|clopidogrel
106146|NCT02628587|Platelet reactivity|platelet reactivity
106147|NCT02628522|ADRC|adrc
106148|NCT02628522|Celution|celution
106149|NCT02628509|Acquired Von Willebrand|acquired von willebrand
106150|NCT02628509|Trans aortic valve replacement|trans aortic valve replacement
107175|NCT02622867|Lactobacillus plantarum|lactobacillus plantarum
106151|NCT02628509|mechanical circulatory support|mechanical circulatory support
106152|NCT02628470|Cervical pain, cervicalgia|cervical pain, cervicalgia
106153|NCT02628457|occupation ratio|occupation ratio
106154|NCT02628457|pseudoatrophy|pseudoatrophy
106155|NCT02628444|Dengue Fever|dengue fever
106156|NCT02628444|Dengue virus|dengue virus
106157|NCT02628444|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
106158|NCT02628444|CYD Dengue Vaccine|cyd dengue vaccine
106159|NCT02628418|Rehabilitation|rehabilitation
106160|NCT02628418|Robotics|robotics
106161|NCT02628392|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
106162|NCT02628392|Adult|adult
106163|NCT02628392|Developmental Phase II|developmental phase ii
106164|NCT02628379|Genomic Testing|genomic testing
106165|NCT02628379|Cancer of Unknown Primary|cancer of unknown primary
106166|NCT02628379|CUP|cup
106167|NCT02628366|Cluster Randomized Controlled Trial|cluster randomized controlled trial
106168|NCT02628366|Personalized Dialysate Temperature|personalized dialysate temperature
106169|NCT02628366|Cardiovascular Events|cardiovascular events
106170|NCT02628366|Mortality|mortality
106171|NCT02628353|Cardiovascular diseases|cardiovascular diseases
106172|NCT02628353|endothelial function|endothelial function
106173|NCT02628353|systolic blood pressure|systolic blood pressure
97316|NCT02681016|Coronary stenosis|coronary stenosis
97317|NCT02681016|Drug-eluting stent|drug-eluting stent
97318|NCT02681016|Coronary angioplasty with stenting|coronary angioplasty with stenting
97319|NCT02681016|Ischemic Heart Disease|ischemic heart disease
97320|NCT02680977|Mucuna pruriens|mucuna pruriens
97321|NCT02680977|Levodopa|levodopa
97322|NCT02680951|Pediatric|pediatric
97323|NCT02680951|Adolescent|adolescent
97324|NCT02680912|Bi syndrome|bi syndrome
97325|NCT02680899|science education|science education
97326|NCT02680899|health promotion|health promotion
97327|NCT02680899|mental health promotion|mental health promotion
97328|NCT02680899|stigmatization|stigmatization
97329|NCT02680899|behavioral intervention|behavioral intervention
97330|NCT02680886|Rapid Absorbable Suture Material|rapid absorbable suture material
97331|NCT02680886|Children / Adults|children / adults
97332|NCT02680886|Novosyn Quick|novosyn quick
97333|NCT02680873|type 2 diabetes , obesity , SASI|type 2 diabetes , obesity , sasi
106174|NCT02628353|metabolomics|metabolomics
106175|NCT02628353|cardiovascular risk factor|cardiovascular risk factor
106176|NCT02628353|bioavailability|bioavailability
106207|NCT02628132|triple negative|triple negative
106208|NCT02628132|breast cancer|breast cancer
106209|NCT02628132|durvalumab|durvalumab
106210|NCT02628132|paclitaxel|paclitaxel
106211|NCT02628132|safety|safety
106212|NCT02628132|efficacy|efficacy
106213|NCT02628132|PD-L1|pd-l1
106214|NCT02628132|PD-1|pd-1
106215|NCT02628132|Metastatic|metastatic
106216|NCT02628132|AstraZeneca|astrazeneca
106217|NCT02628132|MEDI4736|medi4736
106218|NCT02628119|Hemodialysis|hemodialysis
106219|NCT02628119|vascular access|vascular access
106220|NCT02628119|access flow|access flow
106221|NCT02628080|Hypoxia|hypoxia
106255|NCT02628054|PSG|psg
106256|NCT02628054|Typhoid Vaccine|typhoid vaccine
106257|NCT02628054|Depression|depression
106258|NCT02628054|Inflammation|inflammation
106259|NCT02628041|High-Dose-Rate Brachytherapy|high-dose-rate brachytherapy
106260|NCT02628041|HDR Monotherapy|hdr monotherapy
106261|NCT02628041|LDR monotherapy|ldr monotherapy
106262|NCT02628015|Theory of Mind|theory of mind
106263|NCT02628015|Very Low Birthweight Infants|very low birthweight infants
106264|NCT02628002|antigravity treadmill|antigravity treadmill
106265|NCT02628002|bruce protocol|bruce protocol
106266|NCT02628002|stress myocardial perfusion imaging|stress myocardial perfusion imaging
106267|NCT02628002|single photon emission computed tomography|single photon emission computed tomography
106268|NCT02628002|cardiac catheterization|cardiac catheterization
106269|NCT02628002|[E01.370.370.380.500]|[e01.370.370.380.500]
106270|NCT02628002|[E01.370.370.380.250]|[e01.370.370.380.250]
106271|NCT02628002|[E01.370.370.380.140]|[e01.370.370.380.140]
106272|NCT02627937|Pediatric obstructive sleep apnea/hypopnea syndrome|pediatric obstructive sleep apnea/hypopnea syndrome
106273|NCT02627937|Polysomnography|polysomnography
106274|NCT02627924|patient-reported QoL(Quality of Life)|patient-reported qol(quality of life)
106275|NCT02627924|Work productivity|work productivity
106276|NCT02627924|Rheumatoid Arthritis|rheumatoid arthritis
106277|NCT02627898|Green tea extract|green tea extract
106278|NCT02627898|Arterial stiffness|arterial stiffness
106279|NCT02627898|PWVao|pwvao
106280|NCT02627885|internet treatment|internet treatment
106281|NCT02627885|cognitive behavioral therapy|cognitive behavioral therapy
106282|NCT02627885|level of functioning|level of functioning
106283|NCT02627885|quality of life|quality of life
106284|NCT02627833|induced Sputum|induced sputum
106285|NCT02627833|lung clearance index|lung clearance index
106286|NCT02627833|miRNA|mirna
106287|NCT02627833|inflammation|inflammation
106288|NCT02627833|chronic lung disease|chronic lung disease
106289|NCT02627820|Senile|senile
106290|NCT02627820|ATTRwt|attrwt
106291|NCT02627820|wild-type transthyretin amyloidosis|wild-type transthyretin amyloidosis
106292|NCT02627807|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
106293|NCT02627807|Intensity modulated radiotherapy|intensity modulated radiotherapy
106294|NCT02627807|Clinical target volume|clinical target volume
106298|NCT02627794|Endoscopic Sinus Surgery|endoscopic sinus surgery
97430|NCT02680379|Autism|autism
106299|NCT02627794|Silastic spacer|silastic spacer
106300|NCT02627794|Restora™ steroid eluting MM spacer|restora™ steroid eluting mm spacer
106301|NCT02627781|acute appendicitis|acute appendicitis
106302|NCT02627781|Alvarado Score|alvarado score
106303|NCT02627781|negative appendectomy|negative appendectomy
106304|NCT02627781|right abdominal pain|right abdominal pain
106305|NCT02627768|STELARA|stelara
106306|NCT02627768|Psoriatic Arthritis|psoriatic arthritis
106307|NCT02627768|Ustekinumab|ustekinumab
106308|NCT02627755|videolaryngoscopy|videolaryngoscopy
106309|NCT02627755|difficult airway management|difficult airway management
106310|NCT02627716|Psychiatric advanced directives|psychiatric advanced directives
106311|NCT02627716|Joint crisis plan|joint crisis plan
106312|NCT02627716|Schizophrenia|schizophrenia
106313|NCT02627716|Primary care|primary care
106315|NCT02627677|CP-CML|cp-cml
106316|NCT02627677|Leukemia|leukemia
106317|NCT02627677|Leukemia, Myeloid|leukemia, myeloid
106318|NCT02627677|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
106319|NCT02627677|Neoplasms by Histologic Type|neoplasms by histologic type
106320|NCT02627677|Neoplasms|neoplasms
106321|NCT02627677|Myeloproliferative Disorders|myeloproliferative disorders
106322|NCT02627677|Bone Marrow Diseases|bone marrow diseases
106323|NCT02627677|Hematologic Diseases|hematologic diseases
106324|NCT02627664|Idiopathic early|idiopathic early
106325|NCT02627664|Parkinson's Disease|parkinson's disease
106326|NCT02627638|osteopathy|osteopathy
106327|NCT02627638|complementary therapy|complementary therapy
106328|NCT02627638|symptoms in cancer patients|symptoms in cancer patients
106329|NCT02627625|inhalation|inhalation
106330|NCT02627625|anticholinergic|anticholinergic
106331|NCT02627612|veteran|veteran
106332|NCT02627612|mentorship|mentorship
106333|NCT02627612|Iraq/Afghanistan|iraq/afghanistan
106334|NCT02627612|treatment|treatment
106335|NCT02627612|PTSD|ptsd
106336|NCT02627612|Suicide|suicide
106337|NCT02627612|Criminal Activity|criminal activity
106338|NCT02627599|COPD|copd
106339|NCT02627599|LTOT|ltot
106465|NCT02626949|HIV|hiv
106340|NCT02627599|Long-Term Oxygen Therapy|long-term oxygen therapy
106341|NCT02627599|Oxygen Conserving Device|oxygen conserving device
106342|NCT02627599|Quality of Life|quality of life
106343|NCT02627599|Six Minute Walk Distance|six minute walk distance
106344|NCT02627599|Portable Oxygen Source|portable oxygen source
106345|NCT02627599|Oxygen Saturation|oxygen saturation
106346|NCT02627599|Breath Responsive Variable Bolus Oxygen Conserving Device|breath responsive variable bolus oxygen conserving device
106347|NCT02627599|BRVB-OCD|brvb-ocd
106348|NCT02627599|Pulse Oximetry|pulse oximetry
106349|NCT02627586|exercise therapy|exercise therapy
106350|NCT02627586|left ventricular remodeling|left ventricular remodeling
106351|NCT02627586|ventricular ejection fraction|ventricular ejection fraction
106352|NCT02627586|high-intensity interval training|high-intensity interval training
106353|NCT02627573|Cyclophosphamide|cyclophosphamide
106354|NCT02627573|Thymoglobulin|thymoglobulin
106355|NCT02627573|Myelodysplastic Syndromes|myelodysplastic syndromes
106356|NCT02627573|Immunosuppressive Agents|immunosuppressive agents
106357|NCT02627573|Immune System Diseases|immune system diseases
106358|NCT02627573|Busulfan|busulfan
106359|NCT02627573|Fludarabine|fludarabine
106360|NCT02627573|Tacrolimus|tacrolimus
106567|NCT02626377|Elderly|elderly
106361|NCT02627573|Mycophenolate mofetil|mycophenolate mofetil
106362|NCT02627573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
106363|NCT02627573|Myeloablative Agonists|myeloablative agonists
106364|NCT02627573|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
106365|NCT02627573|Allogeneic Transplantation|allogeneic transplantation
106366|NCT02627573|Leukemia, Chronic Myeloid|leukemia, chronic myeloid
106367|NCT02627573|Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative|leukemia, myeloid, chronic, atypical, bcr-abl negative
106368|NCT02627560|Administration, topical|administration, topical
106369|NCT02627560|Tranexamic acid|tranexamic acid
106370|NCT02627560|Postoperative care|postoperative care
106371|NCT02627560|Mastectomy|mastectomy
106372|NCT02627547|Flavanones|flavanones
106373|NCT02627547|Endurance-trained athletes|endurance-trained athletes
106374|NCT02627547|Biological availability|biological availability
106375|NCT02627534|Photodynamic therapy|photodynamic therapy
106376|NCT02627534|Ultrasonic debridement|ultrasonic debridement
106377|NCT02627534|Chronic periodontitis|chronic periodontitis
106378|NCT02627534|Type 2 diabetes|type 2 diabetes
106382|NCT02627495|maladaptive plasticity|maladaptive plasticity
106383|NCT02627495|Limb amputation|limb amputation
106384|NCT02627495|phantom limb pain|phantom limb pain
106385|NCT02627495|tDCS|tdcs
106386|NCT02627495|non-invasive brain stimulation|non-invasive brain stimulation
106387|NCT02627469|Microbiota|microbiota
106388|NCT02627469|aged|aged
106389|NCT02627469|oral health|oral health
106390|NCT02627456|Malaria|malaria
106391|NCT02627456|Cryopreserved|cryopreserved
106392|NCT02627456|Infection|infection
106393|NCT02627456|Human|human
106394|NCT02627456|Immunization|immunization
106395|NCT02627417|ITP|itp
106396|NCT02627417|Dapsone|dapsone
106397|NCT02627404|Bipolar disorders|bipolar disorders
106398|NCT02627404|Genetic|genetic
106399|NCT02627404|Biomarkers|biomarkers
106400|NCT02627404|Circadian rhythm|circadian rhythm
106401|NCT02627391|Aortic valve|aortic valve
106402|NCT02627391|Stenosis|stenosis
106403|NCT02627391|Surgery|surgery
106404|NCT02627365|ART|art
106405|NCT02627365|mobile messaging|mobile messaging
106406|NCT02627365|behaviour|behaviour
106407|NCT02627365|motivation|motivation
106408|NCT02627352|Glaucoma|glaucoma
106409|NCT02627352|Micropulse Transscleral Cyclophotocoagulation|micropulse transscleral cyclophotocoagulation
106410|NCT02627352|IOP|iop
106411|NCT02627339|Contrast Sensitivity|contrast sensitivity
106412|NCT02627326|chlorhexidine|chlorhexidine
106413|NCT02627326|endodontic treatment|endodontic treatment
106414|NCT02627313|Feasibility Studies|feasibility studies
106416|NCT02627261|residual disease|residual disease
106417|NCT02627235|Physical Activity|physical activity
106418|NCT02627235|Cancer Prevention|cancer prevention
106419|NCT02627222|Pro-vitamin A|pro-vitamin a
106420|NCT02627222|Cassava|cassava
106421|NCT02627222|Vitamin A deficiency|vitamin a deficiency
106422|NCT02627222|Retinol Isotope Dilution|retinol isotope dilution
106423|NCT02627222|Preschool children|preschool children
106424|NCT02627222|Nigeria|nigeria
106425|NCT02627209|Angiotensin converting enzyme|angiotensin converting enzyme
106426|NCT02627209|Lysozyme|lysozyme
106427|NCT02627209|Ankylosing spondylitis|ankylosing spondylitis
106428|NCT02627209|Behcet's disease|behcet's disease
106429|NCT02627209|Sarcoidosis|sarcoidosis
106430|NCT02627209|Syphilis|syphilis
106431|NCT02627209|Tuberculosis|tuberculosis
106432|NCT02627209|Ocular inflammation|ocular inflammation
106433|NCT02627196|Heart Failure|heart failure
106434|NCT02627196|BAROSTIM NEO®|barostim neo®
106435|NCT02627196|Baroreceptor|baroreceptor
106436|NCT02627196|Baroreflex|baroreflex
106437|NCT02627196|Baroreflex Activation Therapy™|baroreflex activation therapy™
106438|NCT02627196|New York Heart Associate Class III Heart Failure|new york heart associate class iii heart failure
106439|NCT02627183|Atrial Fibrillation|atrial fibrillation
106440|NCT02627170|Adults|adults
106441|NCT02627144|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
106442|NCT02627144|Avastin|avastin
106443|NCT02627144|Bevacizumab|bevacizumab
106444|NCT02627131|Autism|autism
106445|NCT02627131|Stem Cells|stem cells
106446|NCT02627105|weight loss|weight loss
106447|NCT02627066|Exercise|exercise
106448|NCT02627066|Nutrition|nutrition
106449|NCT02627066|Hemodialysis|hemodialysis
106450|NCT02627014|Chronic Migraine|chronic migraine
106451|NCT02627014|Temporomandibular Disorders|temporomandibular disorders
106452|NCT02627014|Physical Therapy|physical therapy
106453|NCT02627014|Manual Therapy|manual therapy
106454|NCT02627014|Home physical Therapy|home physical therapy
106455|NCT02626988|Diet Diversity|diet diversity
106456|NCT02626988|Biodiversity|biodiversity
106457|NCT02626988|Agrobiodiversity|agrobiodiversity
106458|NCT02626988|Nutrition|nutrition
106459|NCT02626988|Vietnam|vietnam
106460|NCT02626975|knee|knee
106461|NCT02626975|short hamstring autograft|short hamstring autograft
106462|NCT02626975|ligament|ligament
106463|NCT02626975|MRI|mri
106464|NCT02626962|melanoma|melanoma
106466|NCT02626949|AIDS|aids
106467|NCT02626949|Mindfulness|mindfulness
106468|NCT02626949|Mindfulness-based stress reduction|mindfulness-based stress reduction
106469|NCT02626949|Stress|stress
106470|NCT02626949|Intervention|intervention
106471|NCT02626949|Inflammation|inflammation
106472|NCT02626936|Type 1 diabetes|type 1 diabetes
106473|NCT02626936|Artificial pancreas|artificial pancreas
106474|NCT02626936|Closed-loop system|closed-loop system
106576|NCT02626312|Hepatocellular carcinoma|hepatocellular carcinoma
106475|NCT02626936|Postprandial glucose control|postprandial glucose control
106476|NCT02626936|Hypoglycemia|hypoglycemia
106477|NCT02626936|Insulin|insulin
106478|NCT02626936|Glucagon|glucagon
106479|NCT02626910|Disability|disability
106480|NCT02626910|Activity of Daily Living|activity of daily living
106481|NCT02626910|Patient Satisfaction|patient satisfaction
106482|NCT02626897|Sarcoidosis|sarcoidosis
106483|NCT02626897|Daily activity|daily activity
106484|NCT02626897|Exercise|exercise
106485|NCT02626897|Accelerometer|accelerometer
106486|NCT02626845|Granulomatosis with Polyangiitis|granulomatosis with polyangiitis
106487|NCT02626845|Wegener's Granulomatosis|wegener's granulomatosis
106488|NCT02626845|GPA|gpa
106489|NCT02626845|Rituximab|rituximab
106490|NCT02626845|Rituxan|rituxan
106491|NCT02626845|ENT GPA|ent gpa
106492|NCT02626832|vasopressin|vasopressin
106493|NCT02626832|AVP|avp
106494|NCT02626832|NMDA|nmda
106495|NCT02626832|osmolality|osmolality
106496|NCT02626819|Obesity|obesity
106497|NCT02626819|Weight Management|weight management
106498|NCT02626819|Primary Care|primary care
106499|NCT02626819|Health Coach|health coach
106500|NCT02626819|iPad|ipad
106501|NCT02626819|Goal Setting|goal setting
106502|NCT02626819|5As|5as
106503|NCT02626819|technology|technology
106504|NCT02626806|exercise test|exercise test
106505|NCT02626806|HS -troponin|hs -troponin
106506|NCT02626806|Coronary artery disease|coronary artery disease
106507|NCT02626793|Plaque psoriasis|plaque psoriasis
106508|NCT02626793|Apremilast|apremilast
106509|NCT02626793|Otezla®|otezla®
106510|NCT02626793|LAPIS-Pso|lapis-pso
106511|NCT02626793|Observational|observational
106512|NCT02626793|CC-10004|cc-10004
106513|NCT02626793|non-interventional|non-interventional
106514|NCT02626793|Germany|germany
106515|NCT02626767|high-intensity interval training|high-intensity interval training
106516|NCT02626767|adolescents|adolescents
106517|NCT02626767|school-based exercise|school-based exercise
106518|NCT02626767|cardiometabolic health|cardiometabolic health
106519|NCT02626754|Sunitinib, 2/1 schedule, Renal cell carcinoma|sunitinib, 2/1 schedule, renal cell carcinoma
106520|NCT02626702|immune modulators|immune modulators
106521|NCT02626702|IVF outcomes|ivf outcomes
106522|NCT02626702|relationship|relationship
106523|NCT02626689|Beta-Thalassemia|beta-thalassemia
106524|NCT02626689|Quality of Life|quality of life
106525|NCT02626689|Healthcare Utilization|healthcare utilization
106526|NCT02626689|Transfusion dependent (TD) β-thalassemia|transfusion dependent (td) β-thalassemia
106527|NCT02626689|Non-transfusion dependent β-thalassemia|non-transfusion dependent β-thalassemia
106528|NCT02626689|Standard of care|standard of care
106529|NCT02626689|TransQoL|transqol
106530|NCT02626689|SF36v2|sf36v2
106531|NCT02626689|Fact-An|fact-an
106532|NCT02626689|NTD beta-thalassemia PRO|ntd beta-thalassemia pro
106533|NCT02626676|renal dialysis, hyperphosphatemia, educational programme|renal dialysis, hyperphosphatemia, educational programme
106534|NCT02626637|children with cancer|children with cancer
106535|NCT02626637|fatigue|fatigue
106536|NCT02626637|physical activity|physical activity
106537|NCT02626598|facial wrinkles|facial wrinkles
106538|NCT02626598|photoaging|photoaging
106539|NCT02626585|rhinoplasty|rhinoplasty
106540|NCT02626585|postrhinoplasty taping|postrhinoplasty taping
106541|NCT02626585|edema|edema
106542|NCT02626585|draping|draping
106543|NCT02626585|postoperative edema|postoperative edema
106544|NCT02626585|nasal skin thickness|nasal skin thickness
106545|NCT02626585|supratip fullness|supratip fullness
106546|NCT02626585|postoperative swelling|postoperative swelling
106547|NCT02626533|Cytokines|cytokines
106548|NCT02626507|ER+/HER2|er+/her2
106549|NCT02626481|Multiple Myeloma|multiple myeloma
106550|NCT02626481|Cancer|cancer
106551|NCT02626481|refractory|refractory
106552|NCT02626481|daratumumab|daratumumab
106553|NCT02626455|Clinical trial, Phase III|clinical trial, phase iii
106554|NCT02626455|Phosphatidylinositol-3-kinase|phosphatidylinositol-3-kinase
106555|NCT02626455|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
106556|NCT02626455|Indolent B-cell non-Hodgkin's lymphoma|indolent b-cell non-hodgkin's lymphoma
106557|NCT02626442|Cognition|cognition
106558|NCT02626442|Exercise|exercise
106559|NCT02626416|Telemedicine|telemedicine
106560|NCT02626403|vegetative state|vegetative state
106561|NCT02626403|minimally conscious state|minimally conscious state
106562|NCT02626403|disorder of consciousness|disorder of consciousness
106563|NCT02626403|transcranial current direct stimulation|transcranial current direct stimulation
106564|NCT02626403|non invasive brain stimulation|non invasive brain stimulation
106565|NCT02626403|neuromodulation|neuromodulation
106566|NCT02626377|Informal caregivers|informal caregivers
106568|NCT02626377|Quality of life|quality of life
106569|NCT02626377|Cost effectiveness|cost effectiveness
106570|NCT02626377|Cohort study|cohort study
106571|NCT02626377|Randomized study|randomized study
106572|NCT02626351|postnatal|postnatal
106573|NCT02626312|Liver Cancer|liver cancer
106574|NCT02626312|Impaired Liver Function|impaired liver function
106575|NCT02626312|Liver tumors|liver tumors
106577|NCT02626312|HCC|hcc
106578|NCT02626312|Cholangiocarcinoma|cholangiocarcinoma
106579|NCT02626312|Liver metastases|liver metastases
106580|NCT02626312|Low functional liver volume|low functional liver volume
106581|NCT02626312|Radiation therapy|radiation therapy
106582|NCT02626312|XRT|xrt
106583|NCT02626312|Chemotherapy|chemotherapy
106584|NCT02626312|Questionnaire|questionnaire
106585|NCT02626312|Survey|survey
106586|NCT02626312|High dose radiotherapy|high dose radiotherapy
106587|NCT02626299|Preterm birth, very low birth weight|preterm birth, very low birth weight
106588|NCT02626286|HIV|hiv
106589|NCT02626286|Men who have sex with men|men who have sex with men
106590|NCT02626273|obesity|obesity
106591|NCT02626273|adolescents|adolescents
106592|NCT02626273|physical activity|physical activity
106593|NCT02626273|adipocytes|adipocytes
106594|NCT02626273|osteocytes|osteocytes
106595|NCT02626273|weight loss|weight loss
106596|NCT02626273|bone|bone
106597|NCT02626273|fat|fat
106598|NCT02626247|elderly|elderly
106599|NCT02626234|cMET, INC280, rosuvastatin, digoxin|cmet, inc280, rosuvastatin, digoxin
106600|NCT02626208|Contraceptive vaginal ring|contraceptive vaginal ring
106601|NCT02626195|malnutrition|malnutrition
106602|NCT02626195|nutrition|nutrition
106603|NCT02626195|nutritional support|nutritional support
106604|NCT02626195|hepatobiliary pancreatic cancer|hepatobiliary pancreatic cancer
106605|NCT02626195|hepatobiliary pancreatic surgery|hepatobiliary pancreatic surgery
106606|NCT02626169|15-epi-lipoxin A4|15-epi-lipoxin a4
106607|NCT02626169|inflammation|inflammation
106608|NCT02626169|atherosclerosis|atherosclerosis
106609|NCT02626156|post healed venous leg ulcer|post healed venous leg ulcer
106610|NCT02626156|posted healed diabetic foot ulcer|posted healed diabetic foot ulcer
106611|NCT02626130|Kidney Cancer|kidney cancer
106612|NCT02626130|Tremelimumab|tremelimumab
106613|NCT02626130|Cryoablation|cryoablation
106614|NCT02626130|Cryoprobe|cryoprobe
106615|NCT02626104|lactoferrin|lactoferrin
106616|NCT02626104|clostridium difficile|clostridium difficile
754174|NCT01176617|Persistent|persistent
106621|NCT02626091|Anastomotic perfusion|anastomotic perfusion
106622|NCT02626091|ICG Fluorescence|icg fluorescence
106623|NCT02626091|Enhanced reality|enhanced reality
106624|NCT02626091|Left-sided colonic resection|left-sided colonic resection
106625|NCT02626078|Malnutrition|malnutrition
106626|NCT02626078|Food practices|food practices
106627|NCT02626078|Elderly|elderly
106628|NCT02626078|Nursing Home|nursing home
106629|NCT02626078|Aging|aging
106630|NCT02626078|Nutritional status|nutritional status
106631|NCT02626078|Quality of life|quality of life
106632|NCT02626065|Melanoma|melanoma
106633|NCT02626065|Anti-PD1 monoclonal antibodies|anti-pd1 monoclonal antibodies
106634|NCT02626065|Immune modulation|immune modulation
106635|NCT02626065|BRAF|braf
106636|NCT02626052|Skull vibration induced nystagmus test|skull vibration induced nystagmus test
106637|NCT02626052|mastoid vibration test|mastoid vibration test
106638|NCT02626039|Metastatic Breast Cancer|metastatic breast cancer
106639|NCT02626039|CTCs|ctcs
106640|NCT02626039|cfDNA|cfdna
106641|NCT02626039|genomics|genomics
106642|NCT02626039|somatic mutations|somatic mutations
106643|NCT02626000|Recurrent Metastatic Squamous Cell Carcinoma Head and Neck|recurrent metastatic squamous cell carcinoma head and neck
106644|NCT02625987|Appendicectomy, wound complications, skin closure|appendicectomy, wound complications, skin closure
106645|NCT02625961|PD1|pd1
106646|NCT02625961|PDL1|pdl1
106647|NCT02625961|PD-L1|pd-l1
106648|NCT02625961|PD-1|pd-1
106649|NCT02625948|Intracerebral Hemorrhage|intracerebral hemorrhage
106650|NCT02625948|tranexamic acid|tranexamic acid
106651|NCT02625948|spot sign|spot sign
106652|NCT02625935|Prosigna|prosigna
106653|NCT02625935|estrogen receptor positive|estrogen receptor positive
106654|NCT02625935|node negative|node negative
106655|NCT02625935|HER2 negative|her2 negative
106656|NCT02625922|Serelaxin,|serelaxin,
106657|NCT02625922|Chronic heart failure,|chronic heart failure,
106658|NCT02625922|Spiroergometry,|spiroergometry,
106659|NCT02625922|Troponin,|troponin,
106660|NCT02625922|New York Heart Association (NYHA) functional Class II/III,|new york heart association (nyha) functional class ii/iii,
106661|NCT02625922|Left ventricular ejection fraction,|left ventricular ejection fraction,
106662|NCT02625896|Aviation|aviation
106663|NCT02625896|Parachuting|parachuting
106664|NCT02625883|Resuscitation, quality of life|resuscitation, quality of life
106665|NCT02625857|Prostatic Neoplasms, Castration-Resistant|prostatic neoplasms, castration-resistant
106666|NCT02625857|JNJ-64041809|jnj-64041809
106667|NCT02625857|Listeria monocytogenes|listeria monocytogenes
106668|NCT02625831|ficolin-3|ficolin-3
106669|NCT02625831|anti-ficolin-3 antibodies|anti-ficolin-3 antibodies
106864|NCT02624726|mCRC|mcrc
106670|NCT02625831|lupus nephritis|lupus nephritis
106671|NCT02625831|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
106672|NCT02625831|biomarker|biomarker
106673|NCT02625818|Emergency Services, Psychiatric|emergency services, psychiatric
106674|NCT02625818|Prognosis|prognosis
106675|NCT02625818|Biological markers|biological markers
106676|NCT02625818|Anxiety|anxiety
106677|NCT02625818|Panic|panic
106678|NCT02625818|Psychomotor Agitation|psychomotor agitation
106679|NCT02625818|Self-injurious Behavior|self-injurious behavior
106680|NCT02625792|Post ESD ulcer|post esd ulcer
106681|NCT02625792|Bleeding|bleeding
106682|NCT02625792|Prophylaxis|prophylaxis
106683|NCT02625779|Bipolar depression|bipolar depression
106684|NCT02625779|Cytidine|cytidine
106685|NCT02625779|Creatine|creatine
106686|NCT02625779|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
106687|NCT02625766|Operative vs. Non-operative|operative vs. non-operative
106688|NCT02625766|LC pelvic fracture|lc pelvic fracture
106689|NCT02625766|Complications|complications
106690|NCT02625753|photorefractive keratectomy|photorefractive keratectomy
106691|NCT02625753|pain|pain
106692|NCT02625753|analgesia|analgesia
106693|NCT02625753|opioid|opioid
106694|NCT02625727|knee osteoarthritis|knee osteoarthritis
106695|NCT02625727|hyaluronic acid|hyaluronic acid
106696|NCT02625727|corticosteroid|corticosteroid
106697|NCT02625727|intra-articular injection|intra-articular injection
106698|NCT02625727|therapeutic effect|therapeutic effect
106699|NCT02625701|operative mortality|operative mortality
106700|NCT02625701|myocardial infarct, arrhythmia, heart failure, stroke|myocardial infarct, arrhythmia, heart failure, stroke
106701|NCT02625701|pneumonia, atelectasis, acute lung injury|pneumonia, atelectasis, acute lung injury
106702|NCT02625701|surgical site infection|surgical site infection
106703|NCT02625701|acute kidney injury|acute kidney injury
106704|NCT02625701|body weight|body weight
106705|NCT02625662|muscular dystrophy|muscular dystrophy
106706|NCT02625662|natural history|natural history
106707|NCT02625662|genetic profilling|genetic profilling
106708|NCT02625649|Roux-en-Y gastric bypass|roux-en-y gastric bypass
106710|NCT02625649|type 2 diabetes mellitus|type 2 diabetes mellitus
106711|NCT02625649|diabetic nephropathy|diabetic nephropathy
106712|NCT02625649|diabetic retinopathy|diabetic retinopathy
106713|NCT02625623|Avelumab|avelumab
106714|NCT02625623|Gastric cancer|gastric cancer
106715|NCT02625623|Gastroesophageal junction adenocarcinoma|gastroesophageal junction adenocarcinoma
106716|NCT02625610|Avelumab|avelumab
106717|NCT02625610|Cancer|cancer
106718|NCT02625610|Unresectable|unresectable
106719|NCT02625610|Locally advanced|locally advanced
106720|NCT02625610|Metastatic|metastatic
106721|NCT02625610|Adenocarcinoma of the stomach|adenocarcinoma of the stomach
106722|NCT02625610|Gastro-esophageal junction|gastro-esophageal junction
106723|NCT02625584|Shared Book Reading|shared book reading
106724|NCT02625584|Dialogic Reading|dialogic reading
106725|NCT02625584|Language Development|language development
106726|NCT02625584|Syntax|syntax
106727|NCT02625584|Vocabulary|vocabulary
106728|NCT02625584|Young Children|young children
106729|NCT02625584|Randomised Control Trial|randomised control trial
106730|NCT02625584|Language Intervention|language intervention
106731|NCT02625558|riociguat|riociguat
106732|NCT02625558|saph|saph
106733|NCT02625558|sarcoidosis|sarcoidosis
106734|NCT02625558|sarcoidosis associated pulmonary hypertension|sarcoidosis associated pulmonary hypertension
106735|NCT02625532|Controlled Ovarian stimulation|controlled ovarian stimulation
106736|NCT02625532|Follicular phase|follicular phase
106737|NCT02625532|Luteal phase|luteal phase
106738|NCT02625532|Reproductive Techniques, Assisted|reproductive techniques, assisted
106739|NCT02625519|Controlled ovarian stimulation|controlled ovarian stimulation
106740|NCT02625519|Follicle-stimulating hormone|follicle-stimulating hormone
106741|NCT02625519|Receptor N680S follicle-stimulating hormone receptor (FSHR) gene polymorphism|receptor n680s follicle-stimulating hormone receptor (fshr) gene polymorphism
106742|NCT02625519|Oocyte donors|oocyte donors
106743|NCT02625493|Percutaneous coronary intervention|percutaneous coronary intervention
106744|NCT02625493|Patient Preference|patient preference
106745|NCT02625493|Radial access|radial access
106746|NCT02625493|Femoral access|femoral access
106747|NCT02625493|Coronary angiography|coronary angiography
106748|NCT02625493|Shared decision making|shared decision making
106749|NCT02625467|Keratoconus|keratoconus
106750|NCT02625454|Acetaminophen|acetaminophen
106751|NCT02625454|Labor|labor
106752|NCT02625454|Intrapartum Fever|intrapartum fever
106753|NCT02625454|Maternal Fever|maternal fever
106754|NCT02625454|Fetal Tachycardia|fetal tachycardia
106755|NCT02625454|Intravenous Acetaminophen|intravenous acetaminophen
106756|NCT02625441|Breast cancer|breast cancer
106757|NCT02625441|docetaxel|docetaxel
106758|NCT02625441|pertuzumab|pertuzumab
106759|NCT02625441|trastuzumab|trastuzumab
106760|NCT02625441|HER2|her2
106761|NCT02625402|decision making|decision making
106762|NCT02625402|decision aids|decision aids
106763|NCT02625402|decision quality instruments|decision quality instruments
106764|NCT02625402|osteoarthritis|osteoarthritis
106765|NCT02625402|shared decision making|shared decision making
106766|NCT02625389|scheduled for selective transarterial catheterization|scheduled for selective transarterial catheterization
106767|NCT02625363|Glycemic Index|glycemic index
106768|NCT02625363|Water Intake|water intake
106769|NCT02625363|Glycemic Response|glycemic response
106770|NCT02625350|instant noodle|instant noodle
106771|NCT02625350|water content|water content
106772|NCT02625350|glycemic index|glycemic index
106773|NCT02625350|serving method|serving method
106774|NCT02625298|periapical diseases|periapical diseases
106775|NCT02625298|dental injuries|dental injuries
106776|NCT02625298|MTA|mta
106777|NCT02625272|hand-assisted laparoscopic surgery|hand-assisted laparoscopic surgery
106778|NCT02625272|right colon cancer|right colon cancer
106779|NCT02625272|complete mesocolic excision|complete mesocolic excision
643302|NCT00737659|Recipients|recipients
106783|NCT02625246|bronchiectasis|bronchiectasis
106784|NCT02625246|mesenchymal stem cell|mesenchymal stem cell
106785|NCT02625246|lung|lung
106786|NCT02625246|pulmonary|pulmonary
106787|NCT02625246|interstitial lung disease|interstitial lung disease
106788|NCT02625207|Maraviroc, CYP3A5, pharmacokinetics, pharmacogenomics|maraviroc, cyp3a5, pharmacokinetics, pharmacogenomics
106789|NCT02625181|Decision support|decision support
106790|NCT02625181|Prediction models|prediction models
97926|NCT02676908|laser|laser
106791|NCT02625181|PONV|ponv
106792|NCT02625181|prophylaxis|prophylaxis
106793|NCT02625181|Decision Support Systems, Clinical|decision support systems, clinical
106794|NCT02625181|Decision Support Techniques|decision support techniques
106795|NCT02625168|Afatinib|afatinib
106796|NCT02625168|Erlotinib|erlotinib
106797|NCT02625168|Metastatic non-small cell lung cancer|metastatic non-small cell lung cancer
106798|NCT02625168|Efficacy|efficacy
106799|NCT02625168|Safety|safety
106800|NCT02625155|Pharmacogenomics|pharmacogenomics
106801|NCT02625155|Urine Drug Testing|urine drug testing
106802|NCT02625155|antidepressants|antidepressants
106803|NCT02625155|benzodiazepines|benzodiazepines
106804|NCT02625155|opioids|opioids
107785|NCT02619253|Safety|safety
106805|NCT02625155|muscle relaxants|muscle relaxants
106806|NCT02625155|non-steroidal anti-inflammatory agents|non-steroidal anti-inflammatory agents
106807|NCT02625155|TDRAE|tdrae
106808|NCT02625142|Morning Rounds|morning rounds
106809|NCT02625142|Patient-centered Care|patient-centered care
106810|NCT02625142|Hospital Medicine|hospital medicine
106811|NCT02625142|Pediatrics|pediatrics
106812|NCT02625142|Hospitals, Pediatric|hospitals, pediatric
106813|NCT02625116|Cohort|cohort
106814|NCT02625103|Schizophrenia, Clozapine, TDM, Serum Concentration|schizophrenia, clozapine, tdm, serum concentration
106818|NCT02625077|Valvuloplasty|valvuloplasty
106819|NCT02625077|Fundoplication|fundoplication
106820|NCT02625077|Acid reflux|acid reflux
106821|NCT02625077|GERD|gerd
106822|NCT02625077|Reflux disease|reflux disease
106823|NCT02625077|Hiatal hernia|hiatal hernia
106824|NCT02625064|ARDS|ards
106825|NCT02625064|biomarkers|biomarkers
106826|NCT02625064|proteomic|proteomic
106827|NCT02625012|Ultraviolet Therapy|ultraviolet therapy
106828|NCT02625012|Vitiligo|vitiligo
106829|NCT02625012|Melanocytes|melanocytes
106830|NCT02625012|Pigmentation|pigmentation
106831|NCT02624999|Head and Neck Cancer|head and neck cancer
106832|NCT02624999|SCCHN|scchn
106833|NCT02624999|R/M SCCHN|r/m scchn
106834|NCT02624999|Carcinoma|carcinoma
106835|NCT02624973|neoadjuvant treatment|neoadjuvant treatment
106836|NCT02624973|personalized medicine|personalized medicine
106837|NCT02624947|RSV|rsv
106838|NCT02624895|"metastatic colorectal cancer gene RAS not mutated WILD TYPE"|"metastatic colorectal cancer gene ras not mutated wild type"
106839|NCT02624882|blistering distal dactylitis|blistering distal dactylitis
106840|NCT02624882|Streptococcus pyogenes|streptococcus pyogenes
106841|NCT02624882|antibiotics|antibiotics
106842|NCT02624869|Hypercholesterolemia|hypercholesterolemia
106843|NCT02624869|Elevated Cholesterol|elevated cholesterol
106844|NCT02624869|High Cholesterol|high cholesterol
106845|NCT02624869|PCSK9 mutations|pcsk9 mutations
106846|NCT02624869|Severe Familial Hypercholesterolemia|severe familial hypercholesterolemia
106847|NCT02624869|evolocumab|evolocumab
106848|NCT02624869|Repatha|repatha
106849|NCT02624869|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
106850|NCT02624869|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
106851|NCT02624869|Pediatric|pediatric
106852|NCT02624869|Paediatric|paediatric
106853|NCT02624856|primary total knee arthroplasty|primary total knee arthroplasty
106854|NCT02624856|liposomal bupivacaine|liposomal bupivacaine
106855|NCT02624804|Diabetes|diabetes
106856|NCT02624791|astigmatism, contact lens, driving|astigmatism, contact lens, driving
106857|NCT02624765|RCT A: Fetal Atrial Flutter without Hydrops|rct a: fetal atrial flutter without hydrops
106858|NCT02624765|RCT B: Fetal Supraventricular Tachycardia without Hydrops|rct b: fetal supraventricular tachycardia without hydrops
106859|NCT02624765|RCT C: Fetal Supraventricular Tachycardia with Hydrops|rct c: fetal supraventricular tachycardia with hydrops
106860|NCT02624752|Oral Nutrition Supplementation|oral nutrition supplementation
106861|NCT02624726|1st line|1st line
106862|NCT02624726|FOLFIRI|folfiri
106863|NCT02624726|Aflibercept|aflibercept
107272|NCT02622282|Diabetes|diabetes
106865|NCT02624713|eating disorder|eating disorder
106866|NCT02624713|childhood obesity|childhood obesity
106867|NCT02624713|family based treatment|family based treatment
106868|NCT02624700|ER-negative|er-negative
106869|NCT02624700|PgR-negative|pgr-negative
106870|NCT02624700|Human epidermal growth factor receptor 2 (HER2-negative)|human epidermal growth factor receptor 2 (her2-negative)
106871|NCT02624700|Triple Negative Breast Cancer|triple negative breast cancer
106872|NCT02624700|HER2-negative|her2-negative
106873|NCT02624661|Trigeminal ganglion|trigeminal ganglion
106874|NCT02624661|Glycerol|glycerol
106875|NCT02624661|Nerve block|nerve block
106876|NCT02624648|Sexual Dysfunction|sexual dysfunction
106877|NCT02624648|Postmenopausal women|postmenopausal women
106878|NCT02624648|Sexual desire|sexual desire
106879|NCT02624635|Manual Therapy|manual therapy
106881|NCT02624635|Hip|hip
106882|NCT02624635|Muscle Strength|muscle strength
106883|NCT02624622|omphalitis|omphalitis
106884|NCT02624622|neonate|neonate
106885|NCT02624622|developing countries|developing countries
106886|NCT02624596|OCD|ocd
106887|NCT02624583|Fasting|fasting
106888|NCT02624583|Clopidogrel|clopidogrel
106889|NCT02624570|AML|aml
106890|NCT02624570|FLT3|flt3
106891|NCT02624570|ITD|itd
106892|NCT02624570|TKD|tkd
106893|NCT02624570|acute myeloid leukemia|acute myeloid leukemia
106894|NCT02624570|induction|induction
106895|NCT02624570|consolidation|consolidation
106896|NCT02624570|continuation|continuation
106897|NCT02624570|EAP|eap
106898|NCT02624570|ETP|etp
106899|NCT02624570|midostaurin|midostaurin
106900|NCT02624570|PKC412|pkc412
106901|NCT02624557|Hepatic impairment|hepatic impairment
106902|NCT02624557|Healthy volunteers|healthy volunteers
106903|NCT02624557|Clinical pharmacology study|clinical pharmacology study
106904|NCT02624557|BYL719|byl719
106905|NCT02624557|alpelisib|alpelisib
106906|NCT02624531|NACT|nact
106907|NCT02624531|Cervical cancer|cervical cancer
106908|NCT02624531|Fertility sparing|fertility sparing
106909|NCT02624531|Pregnancy|pregnancy
106910|NCT02624531|Treatment Strategy|treatment strategy
106911|NCT02624479|Pharmacokinetics|pharmacokinetics
106912|NCT02624466|Pediatrics|pediatrics
106913|NCT02624466|Nephrology|nephrology
106914|NCT02624466|Dialysis|dialysis
106915|NCT02624453|cryptococcus|cryptococcus
106916|NCT02624453|IMMY LFA|immy lfa
106917|NCT02624453|meningitis|meningitis
106918|NCT02624453|antigen|antigen
106919|NCT02624440|Multiple Myeloma|multiple myeloma
106920|NCT02624440|Infection|infection
106921|NCT02624440|Clarithromycin|clarithromycin
106922|NCT02624440|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
106923|NCT02624427|Glaucoma|glaucoma
106924|NCT02624427|Intraocular Pressure|intraocular pressure
106925|NCT02624388|Genistein|genistein
106926|NCT02624388|Soy|soy
106927|NCT02624388|Chemotherapy side-effects|chemotherapy side-effects
106928|NCT02624388|Pediatric Cancer|pediatric cancer
106929|NCT02624388|Isoflavone|isoflavone
106930|NCT02624362|Odor|odor
106931|NCT02624362|trigger|trigger
106932|NCT02624362|inflammation|inflammation
106933|NCT02624362|nocebo|nocebo
106934|NCT02624336|periodontal disease|periodontal disease
106935|NCT02624336|caries|caries
106936|NCT02624323|ultrasonography|ultrasonography
106937|NCT02624323|catheterization|catheterization
106938|NCT02624323|central line|central line
106939|NCT02624323|mechanical ventilation|mechanical ventilation
106940|NCT02624323|intensive care|intensive care
106941|NCT02624323|axillary vein|axillary vein
106942|NCT02624323|jugular vein|jugular vein
106943|NCT02624323|randomization|randomization
106944|NCT02624297|Coronary artery disease|coronary artery disease
106945|NCT02624297|Chemoreceptors|chemoreceptors
106946|NCT02624297|Sympathetic nerve activity|sympathetic nerve activity
106947|NCT02624297|Exercise|exercise
106948|NCT02624271|gastric cancer|gastric cancer
106949|NCT02624271|gastric precancerous lesions|gastric precancerous lesions
106950|NCT02624271|blood test|blood test
106951|NCT02624232|Anorectal malformation|anorectal malformation
106952|NCT02624232|Anorectal atresia|anorectal atresia
106953|NCT02624232|anorectal stenosis|anorectal stenosis
106954|NCT02624232|Follow-Up Studies|follow-up studies
106955|NCT02624219|A/H5N8|a/h5n8
106956|NCT02624219|AS03|as03
106957|NCT02624219|Controlled|controlled
106958|NCT02624219|Double-Blind|double-blind
106959|NCT02624219|Immunogenicity|immunogenicity
106960|NCT02624219|Inactivated|inactivated
106961|NCT02624219|Influenza|influenza
106962|NCT02624219|MF59|mf59
106963|NCT02624219|Monovalent|monovalent
106964|NCT02624219|Randomized|randomized
106965|NCT02624219|Reactogenicity|reactogenicity
106966|NCT02624219|Safety|safety
106967|NCT02624219|Trial|trial
106968|NCT02624219|Vaccine|vaccine
106969|NCT02624193|Treatment Adherence|treatment adherence
106970|NCT02624193|Mental Health|mental health
106971|NCT02624193|Well-being|well-being
106972|NCT02624193|Emerging Adults|emerging adults
106973|NCT02624193|Youth|youth
106974|NCT02624128|head and neck cancer|head and neck cancer
106975|NCT02624128|valproic acid|valproic acid
106976|NCT02624128|recurrent|recurrent
106977|NCT02624128|metastatic|metastatic
106978|NCT02624102|Major depressive disorder|major depressive disorder
106979|NCT02624102|Cognitive behavioral therapy|cognitive behavioral therapy
106980|NCT02624102|Trial based cognitive therapy|trial based cognitive therapy
106981|NCT02624102|Behavioral activation|behavioral activation
106982|NCT02624076|unexplained infertility|unexplained infertility
106983|NCT02624076|Acupuncture|acupuncture
106984|NCT02624050|ACEI|acei
106985|NCT02624050|ARB|arb
106986|NCT02624050|Hypotension|hypotension
106987|NCT02624050|General Anesthesia|general anesthesia
106988|NCT02624050|Methohexital|methohexital
106989|NCT02624050|Propofol|propofol
106990|NCT02624037|Inflammatory Bowel Disease, Ulcerative Colitis|inflammatory bowel disease, ulcerative colitis
106991|NCT02624037|Crohn's Disease|crohn's disease
106992|NCT02624037|Pharmacokinetics, Individualized Dosage, Dashboard System|pharmacokinetics, individualized dosage, dashboard system
127422|NCT02500147|MRI|mri
106993|NCT02624037|Remicade, Infliximab|remicade, infliximab
106994|NCT02623998|Diabetes|diabetes
106995|NCT02623998|Insulin|insulin
106996|NCT02623998|Glargine|glargine
106997|NCT02623998|Metformin|metformin
106998|NCT02623998|Sitagliptin|sitagliptin
106999|NCT02623998|Diet|diet
107000|NCT02623998|Excercise|excercise
107001|NCT02623998|Lifestyle|lifestyle
107002|NCT02623972|inflammatory breast cancer|inflammatory breast cancer
107003|NCT02623972|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|human epidermal growth factor 2 negative carcinoma of breast
107004|NCT02623959|Advanced Cancers|advanced cancers
107005|NCT02623959|Malignant pleural effusions|malignant pleural effusions
107006|NCT02623959|MPE|mpe
107007|NCT02623959|Indwelling pleural catheter|indwelling pleural catheter
107008|NCT02623959|IPC|ipc
107009|NCT02623959|Questionnaires|questionnaires
107010|NCT02623959|Surveys|surveys
107011|NCT02623959|Fentanyl patch|fentanyl patch
754175|NCT01176617|Permanent|permanent
107020|NCT02623933|HDR monotherapy|hdr monotherapy
107021|NCT02623933|MRI guidance|mri guidance
107022|NCT02623933|Intraprostatic lesion|intraprostatic lesion
107023|NCT02623933|dose paining|dose paining
107024|NCT02623894|Vascular aging.|vascular aging.
107025|NCT02623894|Arterial stiffness.|arterial stiffness.
107026|NCT02623894|Lifestyles.|lifestyles.
107027|NCT02623894|Vascular structure.|vascular structure.
107028|NCT02623894|Telomere length,|telomere length,
107029|NCT02623894|Psychological factors.|psychological factors.
107030|NCT02623894|Inflammatory factors.|inflammatory factors.
107031|NCT02623894|Oxidative stress|oxidative stress
107032|NCT02623881|Cervical pessary|cervical pessary
107033|NCT02623881|Vaginal progesterone|vaginal progesterone
107034|NCT02623881|Twins|twins
107035|NCT02623881|Premature birth|premature birth
107036|NCT02623855|Parks|parks
107037|NCT02623855|Well-being|well-being
107038|NCT02623855|Stress|stress
107039|NCT02623855|Physical Activity|physical activity
107040|NCT02623855|Nature|nature
107041|NCT02623855|Greenspace|greenspace
107042|NCT02623842|urinary incontinence|urinary incontinence
107043|NCT02623842|woman|woman
107044|NCT02623842|radiofrequency|radiofrequency
107045|NCT02623829|scar prophylaxis|scar prophylaxis
107046|NCT02623829|Botulinum Toxin|botulinum toxin
107047|NCT02623764|Alzheimer´s disease|alzheimer´s disease
107048|NCT02623764|Lewy body dementia|lewy body dementia
107049|NCT02623764|Parkinson dementia|parkinson dementia
107050|NCT02623764|EEG|eeg
107051|NCT02623764|Cholinergic index|cholinergic index
107052|NCT02623725|Dengue Fever|dengue fever
107053|NCT02623725|Dengue virus|dengue virus
107054|NCT02623725|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
107055|NCT02623725|CYD Dengue Vaccine|cyd dengue vaccine
107056|NCT02623699|Isis-SOD1Rx|isis-sod1rx
107057|NCT02623699|SOD1|sod1
107058|NCT02623699|ALS|als
107059|NCT02623686|Sleep|sleep
107060|NCT02623686|ICU|icu
107061|NCT02623686|Massage Therapy|massage therapy
107062|NCT02623686|Inhalation Patch|inhalation patch
107063|NCT02623660|Inflammation|inflammation
107064|NCT02623660|Edema|edema
107065|NCT02623660|Arthroplasty|arthroplasty
107066|NCT02623660|Rehabilitation|rehabilitation
107067|NCT02623660|Replacement|replacement
107068|NCT02623660|Knee|knee
107069|NCT02623660|Total Knee Replacement|total knee replacement
107070|NCT02623660|Pain, Postoperative|pain, postoperative
107071|NCT02623660|Exercise Therapy|exercise therapy
107072|NCT02623660|Therapeutics|therapeutics
107073|NCT02623660|Early Ambulation|early ambulation
107074|NCT02623660|Myofunctional Therapy|myofunctional therapy
107075|NCT02623660|Electric Stimulation Therapy|electric stimulation therapy
107076|NCT02623660|Orthopedic Procedures|orthopedic procedures
107077|NCT02623660|Wound Healing|wound healing
107078|NCT02623660|Total Knee Arthroplasty|total knee arthroplasty
107079|NCT02623634|Cuff leak test, relative factors|cuff leak test, relative factors
107080|NCT02623608|type 2 diabetes risk|type 2 diabetes risk
107081|NCT02623608|cardiovascular disease risk|cardiovascular disease risk
107082|NCT02623595|non-small cell lung cancer|non-small cell lung cancer
643401|NCT00737997|Pediatrics|pediatrics
107083|NCT02623595|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
107084|NCT02623595|Stereotactic body radiotherapy|stereotactic body radiotherapy
107085|NCT02623595|abscopal effect|abscopal effect
107087|NCT02623595|immunotherapy|immunotherapy
107088|NCT02623556|diagnosis of tuberculosis|diagnosis of tuberculosis
107089|NCT02623556|ESAT6-CFP10|esat6-cfp10
107090|NCT02623556|skin test|skin test
107091|NCT02623556|diagnostic test|diagnostic test
107092|NCT02623530|Nursing|nursing
107093|NCT02623530|Nursing education research|nursing education research
107094|NCT02623530|Critical thinking|critical thinking
107095|NCT02623530|Decision Making|decision making
107096|NCT02623517|CIED|cied
107098|NCT02623517|arrhythmia|arrhythmia
107099|NCT02623517|atrial fibrillation|atrial fibrillation
107100|NCT02623517|cardiac device|cardiac device
107101|NCT02623517|pacemaker|pacemaker
107102|NCT02623517|defibrillator|defibrillator
107103|NCT02623504|Carbamazepine|carbamazepine
107104|NCT02623504|Equetro|equetro
107105|NCT02623504|Bipolar I Disorder|bipolar i disorder
107106|NCT02623504|Bipolar I Disorder in Children|bipolar i disorder in children
107107|NCT02623491|JNJ-55375515|jnj-55375515
107108|NCT02623491|Healthy|healthy
107109|NCT02623491|Placebo|placebo
107110|NCT02623439|hematologic malignancies|hematologic malignancies
107111|NCT02623426|uveitic macular edema|uveitic macular edema
107112|NCT02623426|uveitis|uveitis
107113|NCT02623400|preterm birth|preterm birth
107114|NCT02623400|perinatal stress|perinatal stress
107115|NCT02623400|growth and development|growth and development
107116|NCT02623387|paravertebral block|paravertebral block
107117|NCT02623348|dialysis|dialysis
107118|NCT02623348|end-stage renal disease|end-stage renal disease
107119|NCT02623335|patient decision making|patient decision making
107120|NCT02623335|surgical decision making|surgical decision making
107121|NCT02623335|question prompt list|question prompt list
107122|NCT02623335|shared decision making|shared decision making
107123|NCT02623335|decision support techniques|decision support techniques
107124|NCT02623257|Non-small Cell Lung Cancer|non-small cell lung cancer
107125|NCT02623257|circulating tumor DNA|circulating tumor dna
107126|NCT02623257|amplification refractory mutation system|amplification refractory mutation system
107127|NCT02623244|ovarian endometrioma|ovarian endometrioma
107128|NCT02623244|lower urinary tract symptoms|lower urinary tract symptoms
107129|NCT02623244|sexual dysfunction|sexual dysfunction
107130|NCT02623244|gastrointestinal symptoms|gastrointestinal symptoms
107131|NCT02623218|traumatic brain injury|traumatic brain injury
107132|NCT02623218|acupuncture|acupuncture
107133|NCT02623218|transcranial doppler ultrasound|transcranial doppler ultrasound
107134|NCT02623166|Pneumonia|pneumonia
107135|NCT02623166|Fever|fever
107136|NCT02623166|Diarrhoea|diarrhoea
107137|NCT02623140|Coronary drug eluting stents|coronary drug eluting stents
107138|NCT02623140|Outcomes|outcomes
107139|NCT02623127|Thymic carcinoma|thymic carcinoma
107140|NCT02623127|Sunitinib|sunitinib
107141|NCT02623127|Metastatic|metastatic
107142|NCT02623127|Recurrent|recurrent
107143|NCT02623101|Reflectance confocal microscopy|reflectance confocal microscopy
107144|NCT02623101|Basal cell carcinoma|basal cell carcinoma
107145|NCT02623101|Biopsy|biopsy
107146|NCT02623101|Diagnostics|diagnostics
107147|NCT02623088|Obstructive Sleep Apnea|obstructive sleep apnea
107148|NCT02623088|Endothelial dysfunction|endothelial dysfunction
107149|NCT02623088|Arterial stiffness|arterial stiffness
107150|NCT02623088|PAP therapies|pap therapies
107151|NCT02623049|New oral anticoagulants|new oral anticoagulants
107152|NCT02623049|Blood levels|blood levels
107153|NCT02623049|Octogenarians|octogenarians
107154|NCT02623036|chronotherapy|chronotherapy
107155|NCT02623036|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
107156|NCT02623036|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
107157|NCT02623010|Primary CNS lymphoma|primary cns lymphoma
107158|NCT02623010|Ibrutinib|ibrutinib
107159|NCT02623010|Elderly|elderly
107160|NCT02623010|Maintenance|maintenance
107161|NCT02622997|HPV self-sampling|hpv self-sampling
107162|NCT02622971|phototherapy|phototherapy
107163|NCT02622971|cryotherapy|cryotherapy
107164|NCT02622971|exercise|exercise
107165|NCT02622971|fatigue|fatigue
107166|NCT02622971|recovery|recovery
107167|NCT02622958|Social Anxiety Disorder|social anxiety disorder
107168|NCT02622958|Social Phobia|social phobia
107169|NCT02622958|Performance Anxiety|performance anxiety
107170|NCT02622958|Social Anxiety|social anxiety
107171|NCT02622958|Anxiety|anxiety
107172|NCT02622906|Gastrointestinal angiodysplasia|gastrointestinal angiodysplasia
107173|NCT02622906|Pasireotide|pasireotide
107174|NCT02622906|Gastrointestinal bleeding|gastrointestinal bleeding
107179|NCT02622854|plasma exchange|plasma exchange
107180|NCT02622854|hypertriglyceridemia|hypertriglyceridemia
107181|NCT02622841|First in man|first in man
107182|NCT02622841|Spinal metastases|spinal metastases
107183|NCT02622841|Stereotactic bodyradiotherapy|stereotactic bodyradiotherapy
107184|NCT02622841|Palliative care|palliative care
107186|NCT02622841|Surgical stabilisation|surgical stabilisation
107187|NCT02622828|wheelchairs|wheelchairs
107188|NCT02622828|social participation|social participation
107189|NCT02622815|Hypercoagulation|hypercoagulation
107190|NCT02622815|Thrombosis|thrombosis
107191|NCT02622815|Cancer Risk Assessment|cancer risk assessment
107192|NCT02622815|Cancer Prognosis|cancer prognosis
107193|NCT02622802|ex-vivo placenta perfusion|ex-vivo placenta perfusion
107194|NCT02622802|transplacental transfer|transplacental transfer
107195|NCT02622802|paracetamol|paracetamol
107196|NCT02622802|erythromycin|erythromycin
107197|NCT02622802|azithromycin|azithromycin
107198|NCT02622789|Spinal alignment|spinal alignment
107199|NCT02622789|Kinematics|kinematics
107200|NCT02622789|Pilates|pilates
107201|NCT02622789|Physical Therapy|physical therapy
107202|NCT02622763|Tolerogenic Dendritic Cells|tolerogenic dendritic cells
107203|NCT02622750|triple-branched stent graft|triple-branched stent graft
107204|NCT02622750|total arch replace|total arch replace
107205|NCT02622750|the occluded rate of false lumen|the occluded rate of false lumen
107206|NCT02622737|Parkinson disease|parkinson disease
107207|NCT02622737|Accidental Falls|accidental falls
107208|NCT02622737|Exercise therapy|exercise therapy
107209|NCT02622737|Virtual Reality Exposure Therapy|virtual reality exposure therapy
107210|NCT02622724|ARDS, human|ards, human
107211|NCT02622724|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
107212|NCT02622724|Respiratory Insufficiency|respiratory insufficiency
107213|NCT02622711|breast cancer|breast cancer
107214|NCT02622711|obesity|obesity
107215|NCT02622711|weight control|weight control
107216|NCT02622711|exercise and physical fitness|exercise and physical fitness
107217|NCT02622672|Antioxidation|antioxidation
107218|NCT02622672|Anti-inflammation|anti-inflammation
107219|NCT02622672|Blood glucose|blood glucose
107220|NCT02622672|Blood lipids|blood lipids
107221|NCT02622659|acute upper respiratory infection|acute upper respiratory infection
107222|NCT02622620|dynamic contrast-enhanced MR imaging|dynamic contrast-enhanced mr imaging
107223|NCT02622620|three-dimensional arterial spin labeling|three-dimensional arterial spin labeling
107224|NCT02622620|diffusion-weighted imaging|diffusion-weighted imaging
107226|NCT02622607|Prevention|prevention
107227|NCT02622607|lung cancer|lung cancer
107228|NCT02622529|Awake craniotomy|awake craniotomy
107229|NCT02622529|Psychological consequences|psychological consequences
107230|NCT02622529|Fear and Anxiety|fear and anxiety
107236|NCT02622438|FSHD|fshd
107237|NCT02622438|Usual care performed at Montpellier hospital|usual care performed at montpellier hospital
107238|NCT02622438|Muscle function|muscle function
107239|NCT02622438|Antioxidants|antioxidants
107240|NCT02622438|Oxidative stress|oxidative stress
107241|NCT02622438|Quality of life|quality of life
107242|NCT02622438|Physical activities, development of food-based dietary guidelines|physical activities, development of food-based dietary guidelines
107243|NCT02622438|Co-morbidity|co-morbidity
107244|NCT02622425|Carotenoid|carotenoid
107245|NCT02622425|Bacillus|bacillus
107246|NCT02622425|Microbiota|microbiota
107247|NCT02622425|Cardiovascular health|cardiovascular health
107248|NCT02622412|Quality of Life|quality of life
107249|NCT02622412|Palliative Therapy|palliative therapy
107250|NCT02622412|Outpatient Services|outpatient services
107251|NCT02622386|Psoriasis|psoriasis
107252|NCT02622373|Pea Pod|pea pod
107253|NCT02622373|Body composition|body composition
107254|NCT02622308|Arterial leg ulcers|arterial leg ulcers
107255|NCT02622308|Intermittent Negative Pressure|intermittent negative pressure
107256|NCT02622308|Peripheral Circulation|peripheral circulation
107257|NCT02622308|Wound healing|wound healing
107258|NCT02622308|Peripheral blood flow|peripheral blood flow
107259|NCT02622295|metabolism|metabolism
107260|NCT02622295|glucose|glucose
107261|NCT02622295|osteoporosis|osteoporosis
107262|NCT02622295|secondary health conditions|secondary health conditions
107263|NCT02622295|quality of life|quality of life
107264|NCT02622295|standing|standing
107265|NCT02622295|electrical stimulation|electrical stimulation
107266|NCT02622295|diabetes|diabetes
107267|NCT02622295|insulin|insulin
107268|NCT02622295|skeletal muscle|skeletal muscle
107269|NCT02622282|physical activity|physical activity
107270|NCT02622282|physical inactivity|physical inactivity
107271|NCT02622282|PAD|pad
107273|NCT02622282|High blood pressure|high blood pressure
107274|NCT02622282|High cholesterol|high cholesterol
107275|NCT02622282|Smoking|smoking
107276|NCT02622269|Urography|urography
107277|NCT02622269|Radiation dosage|radiation dosage
107278|NCT02622269|image enhancement|image enhancement
107279|NCT02622256|Social Media|social media
107280|NCT02622256|Twitter|twitter
107281|NCT02622256|Hypertension|hypertension
107282|NCT02622256|Cardiovascular|cardiovascular
107283|NCT02622256|CVD|cvd
107284|NCT02622256|HTN|htn
107285|NCT02622230|Uygur Medicine|uygur medicine
107286|NCT02622217|anesthesiology|anesthesiology
107287|NCT02622217|non technical kills|non technical kills
107288|NCT02622191|Glaucoma|glaucoma
107289|NCT02622191|Optical Coherence Tomography|optical coherence tomography
107290|NCT02622191|Primary Open Angle Glaucoma|primary open angle glaucoma
107291|NCT02622191|Visual Field|visual field
107292|NCT02622165|health promotion|health promotion
107293|NCT02622165|nutrition|nutrition
107294|NCT02622165|intervention|intervention
107295|NCT02622165|adolescents|adolescents
107296|NCT02622165|serious game|serious game
107297|NCT02622152|Right lateral|right lateral
107298|NCT02622152|Oxygenation|oxygenation
107299|NCT02622152|Cardiac|cardiac
107300|NCT02622152|Congenital|congenital
107301|NCT02622152|Pediatric|pediatric
107302|NCT02622152|Postoperative|postoperative
107303|NCT02622139|Photoacoustics|photoacoustics
107304|NCT02622139|Optoacoustics|optoacoustics
107305|NCT02622139|Ultrasound|ultrasound
107306|NCT02622126|Preloading|preloading
107307|NCT02622126|Colloid|colloid
107308|NCT02622126|Cesarean section|cesarean section
107309|NCT02622126|D-dimer|d-dimer
107310|NCT02622126|Hypotension|hypotension
107311|NCT02622113|insulin resistance|insulin resistance
107312|NCT02622100|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
107313|NCT02622100|Routine Clinical Practice|routine clinical practice
107314|NCT02622100|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
107315|NCT02622100|Coronary Artery Disease|coronary artery disease
107316|NCT02622100|drug eluting stent|drug eluting stent
107317|NCT02622074|PD1|pd1
107318|NCT02622074|PD-1|pd-1
107319|NCT02622074|PDL1|pdl1
107320|NCT02622074|PD-L1|pd-l1
107321|NCT02622074|Triple Negative Breast Cancer|triple negative breast cancer
107322|NCT02622048|Mental Health|mental health
107323|NCT02622048|Psychosis|psychosis
107324|NCT02622048|Parent|parent
107325|NCT02622035|Virtual Reality Technology|virtual reality technology
107326|NCT02622035|Methodology|methodology
107327|NCT02622022|randomised|randomised
107328|NCT02622022|placebo controlled|placebo controlled
107329|NCT02622022|clinical trial|clinical trial
107330|NCT02622009|stable COPD; bronchoalveolar lavage; biopsy; HRV; RSV|stable copd; bronchoalveolar lavage; biopsy; hrv; rsv
107331|NCT02621996|Surface Electromyography|surface electromyography
107332|NCT02621996|Hypotonia|hypotonia
107333|NCT02621996|Patient Positioning|patient positioning
107334|NCT02621983|Schizophrenia|schizophrenia
107335|NCT02621983|Exercise|exercise
107336|NCT02621983|Cognition|cognition
107337|NCT02621905|Prophylaxis|prophylaxis
107338|NCT02621905|Steady-State|steady-state
107339|NCT02621905|Bioavailability|bioavailability
107340|NCT02621866|hypertension|hypertension
107341|NCT02621866|ultraviolet|ultraviolet
107342|NCT02621853|Steatosis|steatosis
107343|NCT02621827|vitamin D|vitamin d
107344|NCT02621827|Africa|africa
107345|NCT02621814|Infant|infant
107346|NCT02621814|Growth|growth
107347|NCT02621814|Body Weight Changes|body weight changes
107348|NCT02621814|Infant Formula|infant formula
107349|NCT02621814|Randomized Controlled Trial|randomized controlled trial
107350|NCT02621788|mind/body medicine|mind/body medicine
107352|NCT02621788|stress management|stress management
107353|NCT02621788|resident burnout|resident burnout
107354|NCT02621775|Stress management|stress management
107355|NCT02621775|Cognitive behavioural therapy (CBT)|cognitive behavioural therapy (cbt)
107356|NCT02621775|Self-help|self-help
107357|NCT02621775|e-health|e-health
107358|NCT02621775|Adjustment disorder with anxiety|adjustment disorder with anxiety
107359|NCT02621736|children|children
107360|NCT02621736|desmopressin|desmopressin
107361|NCT02621736|copeptin|copeptin
107362|NCT02621723|Preventability|preventability
107363|NCT02621697|dual task|dual task
107364|NCT02621697|aging|aging
107365|NCT02621671|Healthy Volunteers|healthy volunteers
107366|NCT02621658|Colorectal Cancer|colorectal cancer
107367|NCT02621658|Colonoscopy|colonoscopy
107368|NCT02621658|Adenoma Detection Rate|adenoma detection rate
107369|NCT02621658|Bowel Preparation|bowel preparation
107370|NCT02621658|Time to Cecal Intubation|time to cecal intubation
107371|NCT02621645|monochorionic|monochorionic
107372|NCT02621645|TRAP|trap
107373|NCT02621645|acardiac twin|acardiac twin
107374|NCT02621632|Compression therapy|compression therapy
107375|NCT02621619|Older adults|older adults
107376|NCT02621619|Elderly|elderly
107377|NCT02621619|Acute pain|acute pain
107378|NCT02621619|IV acetaminophen|iv acetaminophen
107379|NCT02621619|IV hydromorphone|iv hydromorphone
107380|NCT02621619|Analgesia|analgesia
107381|NCT02621619|Adjunctive analgesia|adjunctive analgesia
107382|NCT02621593|Meibomian Gland Dysfunction|meibomian gland dysfunction
107383|NCT02621593|Dry eye symptoms|dry eye symptoms
107384|NCT02621593|Intense Pulsed Light|intense pulsed light
107385|NCT02621580|Panretinal Photocoagulation|panretinal photocoagulation
107386|NCT02621554|Memory|memory
107387|NCT02621554|Resveratrol|resveratrol
107388|NCT02621554|elderly|elderly
107389|NCT02621554|cognition|cognition
643402|NCT00737997|Scoliosis|scoliosis
107390|NCT02621541|neuroendocrine tumor|neuroendocrine tumor
107391|NCT02621541|pancreas|pancreas
107392|NCT02621541|diagnosis|diagnosis
107393|NCT02621541|positron emission tomography|positron emission tomography
107394|NCT02621528|CeraFlex occluder|ceraflex occluder
107395|NCT02621515|Nivolumab|nivolumab
107396|NCT02621515|Brain metastasis|brain metastasis
107397|NCT02621515|Melanoma|melanoma
107398|NCT02621502|Quinoa|quinoa
107399|NCT02621502|Satiety|satiety
107400|NCT02621502|Visual analogue scale|visual analogue scale
107401|NCT02621502|Cross-over studies|cross-over studies
107402|NCT02621489|Glucagon-like peptide-1|glucagon-like peptide-1
107403|NCT02621489|Endothelialization|endothelialization
107404|NCT02621489|Cardiac Function|cardiac function
107405|NCT02621489|Exenatide|exenatide
107406|NCT02621489|Optical Coherence Tomography|optical coherence tomography
107407|NCT02621450|chronic renal failure|chronic renal failure
98570|NCT02672748|BMI|bmi
107408|NCT02621450|hypertension|hypertension
107409|NCT02621450|ampulatory blood pressure|ampulatory blood pressure
107410|NCT02621437|pain|pain
107411|NCT02621437|quality of life|quality of life
107412|NCT02621437|osteopathy|osteopathy
107413|NCT02621437|oncology|oncology
107414|NCT02621437|surgery|surgery
107415|NCT02621437|breast|breast
107416|NCT02621424|dementia|dementia
107417|NCT02621424|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
107418|NCT02621424|RTMS|rtms
107419|NCT02621424|CVLT|cvlt
107420|NCT02621411|Substance abuse|substance abuse
107421|NCT02621411|Emergency operation|emergency operation
107422|NCT02621411|Preoperative screen|preoperative screen
107423|NCT02621320|Vitamin D|vitamin d
107424|NCT02621320|Exercise Performance|exercise performance
107425|NCT02621320|Wheelchair Athletes|wheelchair athletes
107426|NCT02621320|Indoor sports|indoor sports
107427|NCT02621320|Wingate|wingate
107428|NCT02621320|Isokinetic Dynamometer|isokinetic dynamometer
107429|NCT02621307|postprandial glycemia|postprandial glycemia
107430|NCT02621307|subjective appetite|subjective appetite
107431|NCT02621307|Salba|salba
107432|NCT02621307|Flax|flax
107433|NCT02621294|Protein|protein
107434|NCT02621294|indicator amino acid oxidation method|indicator amino acid oxidation method
107435|NCT02621294|athletes|athletes
107436|NCT02621281|hypothermic machine perfusion|hypothermic machine perfusion
107437|NCT02621281|Kidney Transplantation|kidney transplantation
107438|NCT02621281|Delayed graft function|delayed graft function
107439|NCT02621281|perfusion pressure|perfusion pressure
107440|NCT02621229|Optimal rate of refeeding|optimal rate of refeeding
107441|NCT02621229|inpatients|inpatients
107442|NCT02621229|hospitalized|hospitalized
107443|NCT02621216|percutaneous coronary intervention|percutaneous coronary intervention
107444|NCT02621190|circulating tumor cells|circulating tumor cells
107445|NCT02621190|predictive factor|predictive factor
107446|NCT02621151|combination therapy|combination therapy
107447|NCT02621151|immunotherapy|immunotherapy
107448|NCT02621151|immune checkpoint inhibition|immune checkpoint inhibition
107449|NCT02621099|handheld gamma camera|handheld gamma camera
107450|NCT02621086|Oligosaccharide, Tolerability,|oligosaccharide, tolerability,
107451|NCT02621073|lower extremity|lower extremity
107452|NCT02621073|status-post ORIF|status-post orif
107453|NCT02621060|Chlorogenic acid|chlorogenic acid
107454|NCT02621060|Control glucose|control glucose
107455|NCT02621060|Insulin Secretion|insulin secretion
107456|NCT02621060|Insulin Sensitivity|insulin sensitivity
107457|NCT02621047|Healthy volunteer|healthy volunteer
107458|NCT02621047|Alectinib|alectinib
107459|NCT02621047|Hepatic impairment|hepatic impairment
107460|NCT02621034|Root canal treatment|root canal treatment
107461|NCT02621034|pain|pain
107462|NCT02621034|endodontic instruments|endodontic instruments
107463|NCT02621021|Melanoma|melanoma
107464|NCT02621021|Skin Cancer|skin cancer
107465|NCT02621021|Immunotherapy|immunotherapy
107466|NCT02621021|Cell Therapy|cell therapy
107467|NCT02621008|diabetes|diabetes
107468|NCT02621008|hypertension|hypertension
107469|NCT02621008|obesity|obesity
107470|NCT02621008|mobile phone|mobile phone
107471|NCT02621008|stress|stress
107472|NCT02621008|healthy living|healthy living
107473|NCT02621008|pre-diabetes|pre-diabetes
107474|NCT02620995|hypertension|hypertension
107475|NCT02620995|endothelial dysfunction|endothelial dysfunction
107476|NCT02620995|erectile dysfunction|erectile dysfunction
107477|NCT02620995|sildenafil|sildenafil
107478|NCT02620982|Shockwave|shockwave
107479|NCT02620982|vascular ED|vascular ed
107480|NCT02620982|Organic ED|organic ed
107481|NCT02620969|Paediatrics|paediatrics
107482|NCT02620969|Haemodialysis|haemodialysis
107483|NCT02620969|Kinetics|kinetics
107484|NCT02620943|Anemia|anemia
107485|NCT02620943|Pregnancy Outcome|pregnancy outcome
107486|NCT02620943|Pregnancy|pregnancy
107487|NCT02620943|Dietary Diversity|dietary diversity
107488|NCT02620943|Birth Weight|birth weight
107489|NCT02620930|Sleep Disorders|sleep disorders
107490|NCT02620930|Sleep Apnea|sleep apnea
643403|NCT00737997|Morphine|morphine
107491|NCT02620930|Apnea-Hypopnea Index (AHI)|apnea-hypopnea index (ahi)
107492|NCT02620930|Respiratory Disturbance Index (RDI)|respiratory disturbance index (rdi)
107493|NCT02620917|type 1 diabetes|type 1 diabetes
107494|NCT02620917|CSII|csii
107495|NCT02620904|mifepristone|mifepristone
107496|NCT02620904|randomized controlled trial|randomized controlled trial
107497|NCT02620904|vaginal delivery|vaginal delivery
107498|NCT02620904|progesterone receptor modulator|progesterone receptor modulator
107499|NCT02620904|induction of labor|induction of labor
107500|NCT02620891|helium oxygen mixture|helium oxygen mixture
107501|NCT02620891|Meconium aspiration syndrome|meconium aspiration syndrome
107502|NCT02620878|Artificial pancreas|artificial pancreas
107503|NCT02620878|SAP therapy|sap therapy
107504|NCT02620878|children|children
107505|NCT02620878|adolescents|adolescents
107506|NCT02620878|type 1 diabetes|type 1 diabetes
107507|NCT02620852|Breast cancer|breast cancer
107508|NCT02620852|Ductal carcinoma in situ|ductal carcinoma in situ
107509|NCT02620852|DCIS|dcis
107510|NCT02620839|HPV+|hpv+
107511|NCT02620813|acne|acne
107512|NCT02620813|sebaceous gland|sebaceous gland
107513|NCT02620813|lipid|lipid
107514|NCT02620813|sebum|sebum
107515|NCT02620800|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
107516|NCT02620800|Adenocarcinoma|adenocarcinoma
107517|NCT02620800|Open-label|open-label
107518|NCT02620800|Phase 1/2|phase 1/2
107519|NCT02620800|Metronomic|metronomic
107520|NCT02620800|Chemotherapy|chemotherapy
107521|NCT02620800|ABI-007|abi-007
107522|NCT02620800|nab-paclitaxel|nab-paclitaxel
107523|NCT02620800|Abraxane|abraxane
107524|NCT02620800|gemcitabine|gemcitabine
107526|NCT02620800|bevacizumab|bevacizumab
107527|NCT02620800|Avastin|avastin
107528|NCT02620800|5-Fluorouracil (5-FU)|5-fluorouracil (5-fu)
107529|NCT02620800|leucovorin|leucovorin
107530|NCT02620800|oxaliplatin|oxaliplatin
107531|NCT02620800|Eloxatin|eloxatin
107532|NCT02620735|Exercise, health coaching, RCT, telehealth,|exercise, health coaching, rct, telehealth,
107533|NCT02620722|tourniquet|tourniquet
107534|NCT02620722|safety|safety
107535|NCT02620722|personalized|personalized
107536|NCT02620722|surgery|surgery
107537|NCT02620709|Native Hawaiians|native hawaiians
107538|NCT02620709|Community-based participatory research|community-based participatory research
107539|NCT02620709|Health disparities|health disparities
107540|NCT02620709|Minority populations|minority populations
107541|NCT02620709|Chronic disease|chronic disease
107542|NCT02620683|lidocaine, jaw|lidocaine, jaw
107543|NCT02620670|Physical Activity|physical activity
107544|NCT02620670|Glycemic Variability|glycemic variability
107545|NCT02620644|no retinopathy|no retinopathy
107546|NCT02620631|Morphine|morphine
107548|NCT02620631|Pain|pain
107549|NCT02620631|TKR|tkr
107550|NCT02620631|Arthroplasty|arthroplasty
107551|NCT02620618|Safety|safety
107552|NCT02620618|Efficacy|efficacy
107553|NCT02620618|intravitreal infliximab|intravitreal infliximab
107554|NCT02620618|ocular behcets|ocular behcets
107555|NCT02620618|refractory posterior uveitis|refractory posterior uveitis
107556|NCT02620605|Cabergoline|cabergoline
107557|NCT02620605|Ovarian Hyper Stimulation Syndrome (OHSS)|ovarian hyper stimulation syndrome (ohss)
107558|NCT02620592|Healthy Subject|healthy subject
107559|NCT02620592|ZYDPLA1|zydpla1
107560|NCT02620592|DPPIV inhibitor|dppiv inhibitor
107561|NCT02620592|Pharmacokinetics|pharmacokinetics
107562|NCT02620592|Safety|safety
107563|NCT02620579|Personalized Pharmaceutical|personalized pharmaceutical
107564|NCT02620579|Personalized Education|personalized education
107565|NCT02620566|caudal block|caudal block
107566|NCT02620566|local wound infiltration|local wound infiltration
107567|NCT02620566|hernia repair|hernia repair
107568|NCT02620553|Type 1 Diabetes|type 1 diabetes
107569|NCT02620553|Diabetes|diabetes
107570|NCT02620553|Autoimmune Diabetes|autoimmune diabetes
107571|NCT02620540|Broselow Tape|broselow tape
107572|NCT02620540|Weight estimation|weight estimation
107573|NCT02620540|Patient safety|patient safety
107574|NCT02620527|Circulating Tumor DNA|circulating tumor dna
107575|NCT02620527|Cancer|cancer
107576|NCT02620527|Neoplasms|neoplasms
107577|NCT02620527|Genomic Testing|genomic testing
107578|NCT02620527|FoundationOne|foundationone
107579|NCT02620527|Cell Free DNA|cell free dna
107580|NCT02620527|ctDNA|ctdna
107581|NCT02620527|cfDNA|cfdna
107582|NCT02620514|Digestive Disease and Disorders|digestive disease and disorders
107583|NCT02620514|Inflammation|inflammation
107584|NCT02620501|EGD|egd
107585|NCT02620501|topical lidocaine|topical lidocaine
107586|NCT02620501|recovery time|recovery time
107587|NCT02620501|intravenous sedation|intravenous sedation
107588|NCT02620488|Pain Perception|pain perception
107589|NCT02620488|Autonomic Nervous System|autonomic nervous system
107590|NCT02620488|Sickle Cell Disease|sickle cell disease
107591|NCT02620488|Hypnosis|hypnosis
107592|NCT02620488|Guided Imagery|guided imagery
107593|NCT02620462|Postural Balance|postural balance
107594|NCT02620462|Pain|pain
107595|NCT02620462|Gait|gait
107596|NCT02620462|Physical Activity Level|physical activity level
107597|NCT02620449|phosphorus|phosphorus
107598|NCT02620449|fibroblast growth factor 23|fibroblast growth factor 23
107599|NCT02620449|diet|diet
107600|NCT02620436|Maternal & Child Health|maternal & child health
107601|NCT02620436|Mother Shelters|mother shelters
107602|NCT02620436|Maternity Waiting Homes|maternity waiting homes
107603|NCT02620423|Pancreatic|pancreatic
107604|NCT02620423|Cancer|cancer
107605|NCT02620423|REOLYSIN®|reolysin®
107606|NCT02620423|Chemotherapy|chemotherapy
107607|NCT02620423|Pembrolizumab|pembrolizumab
107608|NCT02620423|KEYTRUDA®|keytruda®
107609|NCT02620423|Pelareorep|pelareorep
107610|NCT02620423|Reovirus|reovirus
107611|NCT02620423|Oncolytic virus|oncolytic virus
107612|NCT02620410|OAB|oab
107613|NCT02620384|Metolazone|metolazone
107614|NCT02620384|Heart Failure|heart failure
107615|NCT02620358|Mechanical Ventilation|mechanical ventilation
107616|NCT02620358|Weaning|weaning
107617|NCT02620345|Fibroids|fibroids
107618|NCT02620319|bronchoscopy|bronchoscopy
107619|NCT02620319|polydioxanone|polydioxanone
107620|NCT02620319|absorbable implants|absorbable implants
107621|NCT02620319|stents|stents
107622|NCT02620280|Triple Negative Breast Cancer|triple negative breast cancer
107623|NCT02620267|Mismatch Negativity|mismatch negativity
107624|NCT02620267|Transcranial Direct Current Stimulation|transcranial direct current stimulation
107625|NCT02620267|MMN|mmn
107626|NCT02620267|tDCS|tdcs
107627|NCT02620254|mastocytosis|mastocytosis
107628|NCT02620254|cutaneous mastocytosis|cutaneous mastocytosis
107629|NCT02620254|urticaria pigmentosa|urticaria pigmentosa
107630|NCT02620254|telangiectasia macularis eruptiva perstans (TMEP)|telangiectasia macularis eruptiva perstans (tmep)
107631|NCT02620254|diffuse cutaneous mastocytosis|diffuse cutaneous mastocytosis
107632|NCT02620254|solitary cutaneous mastocytosis|solitary cutaneous mastocytosis
107633|NCT02620254|systemic mastocytosis|systemic mastocytosis
107634|NCT02620254|indolent systemic mastocytosis|indolent systemic mastocytosis
107635|NCT02620254|smoldering systemic mastocytosis|smoldering systemic mastocytosis
107636|NCT02620254|aggressive systemic mastocytosis|aggressive systemic mastocytosis
107637|NCT02620254|systemic mastocytosis with associated clonal hematologic non-mast cell lineage disease|systemic mastocytosis with associated clonal hematologic non-mast cell lineage disease
107638|NCT02620254|mast cell leukemia|mast cell leukemia
107639|NCT02620241|gastro-oesophageal reflux|gastro-oesophageal reflux
107640|NCT02620241|intrapulmonary percussive ventilation|intrapulmonary percussive ventilation
107641|NCT02620241|positioning|positioning
107642|NCT02620228|Bioimpedance|bioimpedance
107643|NCT02620228|Biopsy|biopsy
107644|NCT02620228|Liver tumour|liver tumour
107645|NCT02620228|Biopsy needle guidance|biopsy needle guidance
107646|NCT02620202|Troponin|troponin
107647|NCT02620202|Myocardial infarction|myocardial infarction
107648|NCT02620150|HIV|hiv
107649|NCT02620150|AIDS|aids
107650|NCT02620150|Depression|depression
107651|NCT02620150|SSRI|ssri
107652|NCT02620150|Escitalopram|escitalopram
107653|NCT02620150|Immunity|immunity
107654|NCT02620085|Graves' disease|graves' disease
107655|NCT02620085|Hyperthyroidism|hyperthyroidism
107656|NCT02620085|Personality traits|personality traits
107657|NCT02620072|Type 1 diabetes|type 1 diabetes
107658|NCT02620072|T1D|t1d
107659|NCT02620072|diabetes mellitus|diabetes mellitus
107660|NCT02620072|oral insulin|oral insulin
107661|NCT02620072|oral tolerance|oral tolerance
107662|NCT02620072|autoantigen|autoantigen
107663|NCT02620072|self tolerance|self tolerance
107664|NCT02620072|prevention|prevention
107665|NCT02620072|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
107666|NCT02620072|juvenile diabetes|juvenile diabetes
107667|NCT02620072|dysglycemia|dysglycemia
107668|NCT02620059|Postpartum Period|postpartum period
107669|NCT02620046|Drug therapy|drug therapy
107670|NCT02620033|Prostatectomy|prostatectomy
107671|NCT02620033|Yoga therapy|yoga therapy
107672|NCT02620033|Health related quality of life|health related quality of life
107673|NCT02620007|Adult|adult
107674|NCT02620007|AIEC|aiec
107675|NCT02619994|MDR tuberculosis|mdr tuberculosis
107676|NCT02619994|linezolid|linezolid
107677|NCT02619994|delamanid|delamanid
107678|NCT02619994|Korea|korea
107679|NCT02619968|Chronic renal failure|chronic renal failure
107680|NCT02619968|Arteriovenous fistula|arteriovenous fistula
107681|NCT02619968|Isometric exercises|isometric exercises
107682|NCT02619968|Vascular endothelium|vascular endothelium
107683|NCT02619955|hepcidin deficiency|hepcidin deficiency
107684|NCT02619955|genetic|genetic
107685|NCT02619955|except C282Y Homozygosity|except c282y homozygosity
107782|NCT02619266|Anorexia|anorexia
107688|NCT02619929|Advanced Non-Small-Cell Lung Cancer|advanced non-small-cell lung cancer
107690|NCT02619916|Cancer|cancer
107691|NCT02619916|Depression|depression
107692|NCT02619916|MBCT|mbct
107693|NCT02619916|CBT|cbt
107694|NCT02619890|Adult Glioma|adult glioma
107695|NCT02619890|MRI|mri
107696|NCT02619838|Double Arthrodesis|double arthrodesis
107697|NCT02619838|Triple Arthrodesis|triple arthrodesis
107698|NCT02619838|Subtalar Arthrodesis|subtalar arthrodesis
107699|NCT02619825|Child|child
107700|NCT02619799|magnesium sulphate|magnesium sulphate
107701|NCT02619799|intrathecal route|intrathecal route
107702|NCT02619799|midazolam|midazolam
107703|NCT02619773|Colorectal Surgery|colorectal surgery
107911|NCT02618551|Dynamic hyperinflation|dynamic hyperinflation
107704|NCT02619760|Percutaneous Coronary Intervention|percutaneous coronary intervention
107705|NCT02619760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
107706|NCT02619747|pH monitoring|ph monitoring
107707|NCT02619734|Cell Therapy|cell therapy
107708|NCT02619734|Sickle cell disease|sickle cell disease
107709|NCT02619734|Autologous implantation|autologous implantation
107710|NCT02619734|Mesenchymal stromal cell|mesenchymal stromal cell
107711|NCT02619734|Edothelial Progenitor cell|edothelial progenitor cell
107712|NCT02619721|PINS SNS OAB|pins sns oab
107713|NCT02619708|immersive preoperative experience|immersive preoperative experience
107714|NCT02619695|ketoprofen|ketoprofen
107715|NCT02619695|gel|gel
107716|NCT02619695|low back pain|low back pain
107717|NCT02619695|emergency department|emergency department
107718|NCT02619669|Neoadjuvant|neoadjuvant
107719|NCT02619669|TAK-228 (MLN0128)|tak-228 (mln0128)
107720|NCT02619669|Letrozole|letrozole
107721|NCT02619669|ER+|er+
107722|NCT02619669|HER2-|her2-
107723|NCT02619656|PEG|peg
107724|NCT02619656|CO2 insufflation|co2 insufflation
107725|NCT02619656|Room Air insufflation|room air insufflation
107726|NCT02619656|pneumoperitoneum|pneumoperitoneum
107727|NCT02619617|Cluster Headache|cluster headache
107728|NCT02619617|Patient Diary collection of headache pain|patient diary collection of headache pain
107729|NCT02619617|Biomarker - saliva samples|biomarker - saliva samples
107730|NCT02619578|Transcutaneous electric acupoint stimulation (TEAS)|transcutaneous electric acupoint stimulation (teas)
107731|NCT02619578|gynecological laparoscopic surgery|gynecological laparoscopic surgery
107732|NCT02619578|QoQ-40|qoq-40
107733|NCT02619578|MMSE|mmse
107734|NCT02619578|VAS|vas
107735|NCT02619565|Myelodysplastic syndromes|myelodysplastic syndromes
107736|NCT02619565|mutations|mutations
107737|NCT02619565|overall survival|overall survival
107738|NCT02619565|prognosis|prognosis
107739|NCT02619513|Paravertebral Blocks|paravertebral blocks
107740|NCT02619513|Dexmedetomidine|dexmedetomidine
107741|NCT02619513|Analgesia|analgesia
107742|NCT02619513|Inflammatory response|inflammatory response
107743|NCT02619513|Thoracotomy|thoracotomy
107744|NCT02619474|Parent Satisfaction|parent satisfaction
107745|NCT02619474|Patient Satisfaction|patient satisfaction
107746|NCT02619474|Whiteboard|whiteboard
107747|NCT02619474|Communication|communication
107748|NCT02619448|inoperable|inoperable
107749|NCT02619448|Solitary [T1bN0, T2aN0, T2bN0] lesion measuring 2-7 cm|solitary [t1bn0, t2an0, t2bn0] lesion measuring 2-7 cm
107750|NCT02619435|RAS-mutant|ras-mutant
107751|NCT02619422|Cardiac rehabilitation programs|cardiac rehabilitation programs
107752|NCT02619422|Adherence to secondary preventive measures|adherence to secondary preventive measures
107753|NCT02619422|Acute coronary syndrome|acute coronary syndrome
107754|NCT02619422|More intensive cardiac rehabilitation program in less time|more intensive cardiac rehabilitation program in less time
107755|NCT02619396|radiofrequency power|radiofrequency power
107756|NCT02619396|lesion size index|lesion size index
107757|NCT02619396|esophageal temperature alerts|esophageal temperature alerts
107758|NCT02619383|HBOT|hbot
107759|NCT02619383|hyperbaric oxygen|hyperbaric oxygen
107760|NCT02619383|DCE|dce
107761|NCT02619383|ED|ed
107762|NCT02619383|erectile dysfunction|erectile dysfunction
107763|NCT02619370|advance care planning|advance care planning
107764|NCT02619370|advance directive|advance directive
107765|NCT02619370|caregiving|caregiving
107766|NCT02619357|Asthma|asthma
107767|NCT02619357|wearable physical activity monitor|wearable physical activity monitor
107768|NCT02619357|step counts|step counts
107769|NCT02619357|Exercise|exercise
107770|NCT02619357|energy expenditure|energy expenditure
107771|NCT02619357|COPD|copd
107772|NCT02619357|indirect calorimetry|indirect calorimetry
107776|NCT02619292|cancer survivor|cancer survivor
107777|NCT02619292|immune function|immune function
107778|NCT02619266|Cancer Anorexia Cachexia Syndrome|cancer anorexia cachexia syndrome
107779|NCT02619266|Acupuncture|acupuncture
107780|NCT02619266|Megestrol acetate|megestrol acetate
107781|NCT02619266|Poor Appetite|poor appetite
107783|NCT02619266|Randomized Controlled Trial|randomized controlled trial
107784|NCT02619253|Immunotherapy|immunotherapy
107786|NCT02619253|Pharmacodynamics|pharmacodynamics
107787|NCT02619253|Efficacy|efficacy
107788|NCT02619214|Oxidative Stress|oxidative stress
107789|NCT02619214|Oxygen|oxygen
107790|NCT02619214|General Anesthesia|general anesthesia
107791|NCT02619201|vomiting in children|vomiting in children
107792|NCT02619201|ondansetron|ondansetron
107793|NCT02619201|metoclopramide|metoclopramide
107794|NCT02619201|antiemetics|antiemetics
107795|NCT02619188|Nutrition|nutrition
107796|NCT02619188|Hyperemesis gravidarum|hyperemesis gravidarum
107797|NCT02619188|Prealbumin|prealbumin
107798|NCT02619188|Questionnaire|questionnaire
107799|NCT02619162|breast cancer non metastatic|breast cancer non metastatic
107800|NCT02619162|adjuvant letrozole|adjuvant letrozole
107801|NCT02619162|Nintedanib BIFF1120|nintedanib biff1120
107802|NCT02619136|Blood Transfusion|blood transfusion
107803|NCT02619123|breast density|breast density
107804|NCT02619123|breast cancer|breast cancer
107805|NCT02619123|risk-based screening|risk-based screening
107806|NCT02619123|Tailored breast cancer screening|tailored breast cancer screening
107807|NCT02619123|premenopausal women|premenopausal women
107808|NCT02619110|Chronic Stroke|chronic stroke
107809|NCT02619110|cardiopulmonary|cardiopulmonary
107810|NCT02619110|Berg Balance Scale (BBS)|berg balance scale (bbs)
107811|NCT02619084|Tourette Syndrome|tourette syndrome
107812|NCT02619084|Subthalamic Nucleus|subthalamic nucleus
98964|NCT02669888|TCM|tcm
107814|NCT02619084|Deep Brain Stimulation|deep brain stimulation
107815|NCT02619084|DBS|dbs
107816|NCT02619084|Tic|tic
107817|NCT02619084|Obsessive-compulsive disorders|obsessive-compulsive disorders
107818|NCT02619071|acute myeloid leukemia- refractory AML- relapsed AML- precision medecine-|acute myeloid leukemia- refractory aml- relapsed aml- precision medecine-
107819|NCT02619058|NKT|nkt
107820|NCT02619058|metastatic melanoma|metastatic melanoma
107821|NCT02619032|remifentanil|remifentanil
107822|NCT02619032|fentanyl|fentanyl
107823|NCT02619032|dental surgery|dental surgery
107824|NCT02619006|Anemia, Iron-Deficiency|anemia, iron-deficiency
107825|NCT02619006|Myelination|myelination
107826|NCT02619006|Ferritin|ferritin
107827|NCT02619006|Umbilical cord clamping|umbilical cord clamping
107828|NCT02619006|Umbilical Cord Milking|umbilical cord milking
107829|NCT02619006|Placental Transfusion|placental transfusion
107830|NCT02619006|Brain Development|brain development
107834|NCT02618980|gastrointestinal bleeding|gastrointestinal bleeding
107835|NCT02618980|endoscopy|endoscopy
107837|NCT02618967|Healthy Volunteer|healthy volunteer
107838|NCT02618967|Safety Study|safety study
107839|NCT02618967|Placebo Control|placebo control
107840|NCT02618967|Phase 1|phase 1
107841|NCT02618954|Rheumatoid arthritis|rheumatoid arthritis
107842|NCT02618954|Articular ultrasound|articular ultrasound
107843|NCT02618954|Synovitis|synovitis
107844|NCT02618954|Relapse risk|relapse risk
107845|NCT02618928|Chronic Hepatitis C|chronic hepatitis c
107846|NCT02618928|HCV|hcv
107847|NCT02618915|gene therapy|gene therapy
107848|NCT02618915|Hemophilia B|hemophilia b
107849|NCT02618902|patient safety|patient safety
107850|NCT02618902|tolerogenic dendritic cells|tolerogenic dendritic cells
107851|NCT02618902|tolDC|toldc
107852|NCT02618850|metabolic response|metabolic response
107853|NCT02618850|chemotherapy|chemotherapy
107854|NCT02618850|PET|pet
107855|NCT02618837|NSTEMI|nstemi
107856|NCT02618837|NSTEACS|nsteacs
107857|NCT02618837|prasugrel|prasugrel
107858|NCT02618837|ticagrelor|ticagrelor
107859|NCT02618837|Downstream versus Upstream strategy|downstream versus upstream strategy
107860|NCT02618811|sarcopenia|sarcopenia
107861|NCT02618811|myosteatosis|myosteatosis
107862|NCT02618811|enhanced recovery after surgery|enhanced recovery after surgery
107863|NCT02618811|colorectal cancer|colorectal cancer
107864|NCT02618811|minimally invasive surgery|minimally invasive surgery
107865|NCT02618811|complications|complications
107866|NCT02618798|chronic liver disease|chronic liver disease
107867|NCT02618798|CLD|cld
107868|NCT02618798|platelet function|platelet function
107869|NCT02618785|Hysterosalpingography|hysterosalpingography
107870|NCT02618785|antispasmodic drug|antispasmodic drug
107871|NCT02618785|infertile women|infertile women
107872|NCT02618772|Pediatrics|pediatrics
107873|NCT02618772|Laceration|laceration
107874|NCT02618772|Anxiety|anxiety
107875|NCT02618772|Anti-Anxiety Agents|anti-anxiety agents
107876|NCT02618746|Telemonitoring|telemonitoring
107877|NCT02618746|Home Rehabilitation|home rehabilitation
107878|NCT02618746|Exacerbations|exacerbations
107879|NCT02618746|Physical Activity|physical activity
107880|NCT02618746|COPD|copd
107881|NCT02618720|Antimicrobial prophylaxis|antimicrobial prophylaxis
107882|NCT02618720|Colorectal surgery|colorectal surgery
107883|NCT02618720|Surgical Site Infection|surgical site infection
107884|NCT02618720|Postoperative morbidity|postoperative morbidity
107885|NCT02618707|Lactate|lactate
107886|NCT02618707|Congenital cardiac defect|congenital cardiac defect
107887|NCT02618707|CPB|cpb
107888|NCT02618707|Pediatric|pediatric
107889|NCT02618694|adrenal|adrenal
107890|NCT02618694|supra-renal|supra-renal
107891|NCT02618694|adrenalectomy|adrenalectomy
107892|NCT02618694|retroperitoneoscopy|retroperitoneoscopy
107893|NCT02618694|posterior retroperitoneoscopy|posterior retroperitoneoscopy
107894|NCT02618694|Laparoscopic adrenalectomy|laparoscopic adrenalectomy
107895|NCT02618681|earlobe crease|earlobe crease
107896|NCT02618681|acute myocardial infarction|acute myocardial infarction
107897|NCT02618655|TBDs；diagnosis|tbds；diagnosis
107898|NCT02618603|Stroke|stroke
107899|NCT02618603|Should pain|should pain
107900|NCT02618603|Botulinum Toxin|botulinum toxin
107901|NCT02618590|non-small cell lung cancer|non-small cell lung cancer
107902|NCT02618590|EGFR mutant type|egfr mutant type
107903|NCT02618590|first/second line EGFR-TKI|first/second line egfr-tki
107904|NCT02618577|Anticoagulation|anticoagulation
107905|NCT02618577|atrial high rate episodes|atrial high rate episodes
107906|NCT02618577|Atrial Fibrillation|atrial fibrillation
107907|NCT02618577|VKA|vka
107908|NCT02618577|NOAC|noac
107909|NCT02618551|Thermoplasty|thermoplasty
107910|NCT02618551|Severe asthma|severe asthma
107912|NCT02618499|birth|birth
107913|NCT02618499|oxytocin|oxytocin
107914|NCT02618499|placental transfusion|placental transfusion
107915|NCT02618499|umbilical cord clamping|umbilical cord clamping
107916|NCT02618473|Coronary computed tomography angiography|coronary computed tomography angiography
107917|NCT02618473|motion artifacts|motion artifacts
107918|NCT02618473|motion correction algorithm|motion correction algorithm
107919|NCT02618473|diagnostic utility|diagnostic utility
107920|NCT02618460|Non-contrast enhanced MRI|non-contrast enhanced mri
107921|NCT02618460|healthy volunteers|healthy volunteers
107922|NCT02618460|renal diffusion|renal diffusion
107923|NCT02618460|renal perfusion|renal perfusion
107924|NCT02618369|High Intensity Focused Ultrasound|high intensity focused ultrasound
107925|NCT02618317|renal dialysis|renal dialysis
107926|NCT02618304|Meibomian gland dysfunction|meibomian gland dysfunction
108883|NCT02611973|Aspirin|aspirin
107927|NCT02618304|Lipiview|lipiview
107928|NCT02618304|Tear Lipid Layer|tear lipid layer
107929|NCT02618291|primary health care|primary health care
107930|NCT02618265|stroke|stroke
107931|NCT02618265|secondary prevention|secondary prevention
107932|NCT02618265|platelet response polymorphism|platelet response polymorphism
107933|NCT02618265|mobile terminal|mobile terminal
107934|NCT02618252|difficult IV access|difficult iv access
107935|NCT02618252|ultrasound|ultrasound
107936|NCT02618252|veinviewer|veinviewer
107937|NCT02618252|near infrared device|near infrared device
107938|NCT02618239|intestinal gas|intestinal gas
107939|NCT02618239|Healthy subjects|healthy subjects
107940|NCT02618239|microbiota|microbiota
107941|NCT02618239|prebiotics|prebiotics
107942|NCT02618226|Traumatic Brain Injury|traumatic brain injury
107943|NCT02618226|TBI|tbi
107944|NCT02618226|Optic nerve ultrasound|optic nerve ultrasound
107945|NCT02618226|ONUS|onus
107946|NCT02618226|Intracranial pressure|intracranial pressure
107947|NCT02618226|ICP|icp
107948|NCT02618226|Intracranial hypertension|intracranial hypertension
107949|NCT02618213|Continuous Positive Airway Pressure|continuous positive airway pressure
107950|NCT02618213|High Flow Oxygenation therapy|high flow oxygenation therapy
107951|NCT02618213|Bronchiolitis|bronchiolitis
107952|NCT02618213|Children|children
107953|NCT02618200|Prostate cancer|prostate cancer
107954|NCT02618200|Computer-Aided Diagnosis|computer-aided diagnosis
107955|NCT02618161|EBRT and HDR Brachytherapy|ebrt and hdr brachytherapy
107956|NCT02618109|B acute lymphoblastic leukemia|b acute lymphoblastic leukemia
107957|NCT02618109|leukemia relapse|leukemia relapse
107958|NCT02618109|pediatric onco-hematology|pediatric onco-hematology
107959|NCT02618096|membrane sweeping|membrane sweeping
107960|NCT02618096|dinoprostone|dinoprostone
107961|NCT02618096|multiparas|multiparas
107962|NCT02618096|labor induction|labor induction
107963|NCT02618096|cesarean delivery|cesarean delivery
107964|NCT02618044|Gastroesophageal reflux|gastroesophageal reflux
107965|NCT02618044|Obesity|obesity
107966|NCT02618044|Esophageal manometry|esophageal manometry
107967|NCT02618044|24 H impedance pH-monitoring|24 h impedance ph-monitoring
107968|NCT02618044|Laparoscopic Roux-en-Y Gastric Bypass|laparoscopic roux-en-y gastric bypass
107969|NCT02618031|capillary index score|capillary index score
107970|NCT02618031|acute ischemic stroke|acute ischemic stroke
107971|NCT02618031|collateral circulation|collateral circulation
107972|NCT02618031|cerebral ischemia|cerebral ischemia
107973|NCT02618031|diagnostic imaging|diagnostic imaging
107974|NCT02618018|astigmatism|astigmatism
107975|NCT02618018|toric intraocular lens|toric intraocular lens
107976|NCT02618005|Astronauts|astronauts
107977|NCT02618005|Probiotics|probiotics
107978|NCT02618005|Immune function|immune function
107979|NCT02618005|Intestinal microbiota|intestinal microbiota
107980|NCT02617966|Retina|retina
107981|NCT02617966|Retinal Degeneration|retinal degeneration
107982|NCT02617966|Retinitis Pigmentosa|retinitis pigmentosa
107983|NCT02617966|Stargardt's Disease|stargardt's disease
107984|NCT02617966|Dark Adaptation|dark adaptation
107985|NCT02617953|Tinnitus|tinnitus
107986|NCT02617953|EEG|eeg
107987|NCT02617953|ERP|erp
107988|NCT02617940|dental caries|dental caries
107989|NCT02617940|primary tooth|primary tooth
107990|NCT02617940|resin-based sealants|resin-based sealants
107991|NCT02617914|ARDS|ards
107992|NCT02617914|PEEP|peep
107993|NCT02617914|ECMO|ecmo
107994|NCT02617901|Bone age|bone age
107998|NCT02617901|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
107999|NCT02617888|radiation|radiation
108000|NCT02617888|cardiac computed tomography|cardiac computed tomography
108001|NCT02617888|CCTA|ccta
108002|NCT02617888|breast shielding|breast shielding
108003|NCT02617888|Myocardial perfusion scintigraphy|myocardial perfusion scintigraphy
108004|NCT02617888|MPS|mps
108005|NCT02617888|Invasive coronary angiography|invasive coronary angiography
108006|NCT02617888|ICA|ica
108007|NCT02617875|Pre-hospital|pre-hospital
108008|NCT02617875|Emergency medical system|emergency medical system
108009|NCT02617875|Telemedicine|telemedicine
108010|NCT02617875|Tele consultation|tele consultation
108011|NCT02617875|Remote treatment|remote treatment
108012|NCT02617862|Diagnostic imaging|diagnostic imaging
108013|NCT02617862|Retina|retina
108014|NCT02617862|Pediatrics|pediatrics
108015|NCT02617810|Healthy|healthy
108016|NCT02617810|JNJ-42847922|jnj-42847922
108017|NCT02617810|Midazolam|midazolam
99109|NCT02668770|BMS-734016|bms-734016
99110|NCT02668770|MDX010|mdx010
99111|NCT02668770|Refractory|refractory
99112|NCT02668770|Relapsed|relapsed
99113|NCT02668718|radiotherapy, adjuvant|radiotherapy, adjuvant
99114|NCT02668718|prostatectomy|prostatectomy
99115|NCT02668692|LEO 80185 gel, calcipotriol, betamethasone|leo 80185 gel, calcipotriol, betamethasone
99116|NCT02668679|Dream Doctors|dream doctors
99117|NCT02668679|Medical Clown|medical clown
99118|NCT02668679|Pediatrics|pediatrics
99119|NCT02668679|Sedation|sedation
99120|NCT02668679|Endoscopy|endoscopy
99121|NCT02668666|Palbociclib|palbociclib
99122|NCT02668666|Tamoxifen|tamoxifen
99166|NCT02668510|PRP|prp
108018|NCT02617810|Warfarin|warfarin
108019|NCT02617810|Pharmacokinetics|pharmacokinetics
108020|NCT02617797|Urinary Stress Incontinence|urinary stress incontinence
108021|NCT02617797|Radiofrequency|radiofrequency
108022|NCT02617797|Women|women
108023|NCT02617758|Healthy|healthy
108024|NCT02617758|Bioequivalence Study|bioequivalence study
108025|NCT02617758|JNJ-35685-AAA-G021|jnj-35685-aaa-g021
108026|NCT02617758|DURAGESIC|duragesic
108027|NCT02617745|Stupp protocol, glioblastoma, thrombocytopenia|stupp protocol, glioblastoma, thrombocytopenia
108028|NCT02617732|glucose variability|glucose variability
108029|NCT02617732|continuous glucose mornitoring system|continuous glucose mornitoring system
108031|NCT02617706|Anorectal surgeries|anorectal surgeries
108032|NCT02617706|infection|infection
108033|NCT02617706|topical oxygen|topical oxygen
108034|NCT02617680|Desflurane|desflurane
108035|NCT02617680|end tidal concentration|end tidal concentration
108037|NCT02617680|anesthesia|anesthesia
108038|NCT02617641|Secondary Prevention|secondary prevention
108039|NCT02617641|Walking|walking
108040|NCT02617641|Health Behavior|health behavior
108041|NCT02617641|Internet|internet
108042|NCT02617641|eHealth|ehealth
108043|NCT02617641|Computer-Assisted Instruction|computer-assisted instruction
108044|NCT02617641|Multicenter Study|multicenter study
108045|NCT02617641|Randomized Controlled Trial|randomized controlled trial
108046|NCT02617641|Intervention Studies|intervention studies
108047|NCT02617641|Motivation|motivation
108048|NCT02617641|Self Efficacy|self efficacy
108049|NCT02617641|Theory, Nursing|theory, nursing
108050|NCT02617641|Theory, Psychological|theory, psychological
108051|NCT02617641|Nursing Research|nursing research
108052|NCT02617628|opioid addiction|opioid addiction
108053|NCT02617615|MB-110|mb-110
108054|NCT02617602|Congenital heart defect|congenital heart defect
108055|NCT02617602|Cardiopulmonary bypass|cardiopulmonary bypass
108056|NCT02617602|Goal directed therapy|goal directed therapy
108057|NCT02617602|Acute heart failure|acute heart failure
108058|NCT02617563|spondylolisthesis|spondylolisthesis
108059|NCT02617563|CD Horizon® Spinal Systems|cd horizon® spinal systems
108060|NCT02617563|minimal invasive|minimal invasive
108061|NCT02617563|Spinal Fusion|spinal fusion
108062|NCT02617563|MAST procedure|mast procedure
108063|NCT02617563|Lumbar fusion|lumbar fusion
108064|NCT02617524|dedicated sheath|dedicated sheath
108065|NCT02617498|living donor liver transplantation|living donor liver transplantation
108066|NCT02617459|Safety|safety
108067|NCT02617459|efficacy|efficacy
108068|NCT02617459|Levobetaxolol eye drops|levobetaxolol eye drops
108069|NCT02617459|Chinese patients|chinese patients
108073|NCT02617407|Dental Plaque|dental plaque
108074|NCT02617407|Gingivitis|gingivitis
108075|NCT02617407|Bacterial Infection|bacterial infection
108076|NCT02617407|Oral Hygiene|oral hygiene
108077|NCT02617407|HSCT|hsct
108078|NCT02617407|Oral Microbiome|oral microbiome
108079|NCT02617368|Keratoconus, Corneal crosslinking, Fourier Analysis of Topographic Data|keratoconus, corneal crosslinking, fourier analysis of topographic data
108080|NCT02617342|Intervention|intervention
108081|NCT02617342|Autism Spectrum Disorder|autism spectrum disorder
108082|NCT02617342|Social Skills|social skills
108584|NCT02614092|Veterans|veterans
108089|NCT02617303|Primary Care|primary care
108090|NCT02617303|Randomized clinical trial|randomized clinical trial
108091|NCT02617303|Otago exercise programme|otago exercise programme
108092|NCT02617290|Coronary Artery Disease (CAD)|coronary artery disease (cad)
108093|NCT02617290|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
108094|NCT02617277|AZD1775|azd1775
108095|NCT02617277|MEDI4736|medi4736
108096|NCT02617277|AZD1775 + MEDI4736|azd1775 + medi4736
643404|NCT00737997|Surgery|surgery
108097|NCT02617277|Advanced Solid Tumours|advanced solid tumours
108098|NCT02617277|Durvalumab|durvalumab
108099|NCT02617238|arterial stiffness|arterial stiffness
108100|NCT02617238|cardiovascular risk|cardiovascular risk
108101|NCT02617238|cardiovascular events|cardiovascular events
108102|NCT02617238|renal events|renal events
108103|NCT02617212|dental implant|dental implant
108104|NCT02617212|bone preservation|bone preservation
108105|NCT02617212|definitive abutment|definitive abutment
108106|NCT02617212|one abutment one time|one abutment one time
108107|NCT02617199|epidural anesthesia|epidural anesthesia
108108|NCT02617199|pain management|pain management
108109|NCT02617199|microcirculation|microcirculation
108110|NCT02617160|Insulin Pump Treatment|insulin pump treatment
108111|NCT02617160|Type 1 Diabetes|type 1 diabetes
108112|NCT02617160|Insulin Pump Setting|insulin pump setting
108113|NCT02617160|Pump Advisor|pump advisor
108114|NCT02617108|uterine septum|uterine septum
108115|NCT02617108|intrauterine adhesions|intrauterine adhesions
108116|NCT02617108|Foley balloon|foley balloon
108117|NCT02617082|breast cancer|breast cancer
108118|NCT02617082|partial breast irradiation|partial breast irradiation
108120|NCT02617069|Atrial fibrillation|atrial fibrillation
108121|NCT02617069|botulinum toxin|botulinum toxin
108122|NCT02617056|electrodermal response|electrodermal response
108123|NCT02617043|breast cancer|breast cancer
108124|NCT02617043|hypofractionated whole breast irradiation|hypofractionated whole breast irradiation
108125|NCT02617017|Parkinson disease|parkinson disease
108126|NCT02617017|Levodopa induce dyskinesia|levodopa induce dyskinesia
108127|NCT02616952|Stress urinary incontinence|stress urinary incontinence
108128|NCT02616952|Chinese Herb|chinese herb
108129|NCT02616952|Traditional Chinese medicine|traditional chinese medicine
108130|NCT02616952|Pelvic floor muscle training|pelvic floor muscle training
108131|NCT02616939|Multidetector computed tomography|multidetector computed tomography
108135|NCT02616926|radiofrequency ablation|radiofrequency ablation
108137|NCT02616874|Early treatment|early treatment
108138|NCT02616874|Romidepsin|romidepsin
108139|NCT02616874|HDACi|hdaci
108140|NCT02616874|Therapeutic Vaccines|therapeutic vaccines
108141|NCT02616874|HIVconsv|hivconsv
108142|NCT02616874|HIV reservoir|hiv reservoir
108143|NCT02616874|Population PK/PD analysis|population pk/pd analysis
108144|NCT02616848|Everolimus|everolimus
108145|NCT02616848|eribulin|eribulin
108146|NCT02616822|hypertension|hypertension
108147|NCT02616822|endothelium|endothelium
108148|NCT02616822|resveratrol|resveratrol
108149|NCT02616822|clinical trials|clinical trials
108150|NCT02616783|HIV 1 Infection|hiv 1 infection
108151|NCT02616783|HIV|hiv
108152|NCT02616783|Virologically-Suppressed|virologically-suppressed
108153|NCT02616744|aromatase inhibitors|aromatase inhibitors
108154|NCT02616744|breast cancer|breast cancer
108155|NCT02616744|bone mineral density|bone mineral density
108156|NCT02616692|HCC|hcc
108157|NCT02616692|Patient preferences|patient preferences
108158|NCT02616666|Type 2 diabetes mellitus|type 2 diabetes mellitus
108159|NCT02616666|Randomised|randomised
108160|NCT02616666|Pragmatic|pragmatic
108161|NCT02616666|Standard of Care|standard of care
108162|NCT02616666|Dapagliflozin|dapagliflozin
108163|NCT02616666|FORXIGA|forxiga
108172|NCT02616627|bone mineral density|bone mineral density
108173|NCT02616627|chronic dialysis|chronic dialysis
108174|NCT02616627|end-stage renal disease|end-stage renal disease
108175|NCT02616627|body composition analysis|body composition analysis
108176|NCT02616627|sarcopenia|sarcopenia
108177|NCT02616588|advanced stage cancer,|advanced stage cancer,
108178|NCT02616588|patient navigator,|patient navigator,
108179|NCT02616588|social work|social work
108180|NCT02616575|home care|home care
108181|NCT02616575|monitoring system|monitoring system
108182|NCT02616575|risk assessment|risk assessment
108183|NCT02616575|telehealth|telehealth
108184|NCT02616536|Flipped classroom|flipped classroom
108185|NCT02616536|Teaching methods|teaching methods
108186|NCT02616536|Knowledge gain|knowledge gain
108187|NCT02616523|dexmedetomidine|dexmedetomidine
108188|NCT02616523|lidocaine|lidocaine
108189|NCT02616523|neuropathic pain|neuropathic pain
108190|NCT02616523|laparoscopic intestine resection|laparoscopic intestine resection
108191|NCT02616523|cognitive function|cognitive function
108192|NCT02616497|aspirin|aspirin
108193|NCT02616497|triflusal|triflusal
108194|NCT02616497|antiplatelet drugs|antiplatelet drugs
108195|NCT02616497|atherothrombosis|atherothrombosis
108196|NCT02616497|secondary prevention|secondary prevention
108197|NCT02616484|Sodium Dichloroacetate|sodium dichloroacetate
108198|NCT02616484|Treatment of PDCD with Dichloroacetate|treatment of pdcd with dichloroacetate
108199|NCT02616471|Cheese|cheese
108200|NCT02616471|Dairy|dairy
108201|NCT02616471|Saturated fat|saturated fat
108202|NCT02616471|Blood lipid concentrations|blood lipid concentrations
108203|NCT02616471|Lipoprotein particle size|lipoprotein particle size
108204|NCT02616471|Metabolic Syndrome|metabolic syndrome
108205|NCT02616471|Insulin sensitivity|insulin sensitivity
108206|NCT02616471|Blood glucose concentrations|blood glucose concentrations
108207|NCT02616445|Xanamem|xanamem
108208|NCT02616432|Tomosynthesis|tomosynthesis
108209|NCT02616432|Digital Breast Tomosynthesis (DBT)|digital breast tomosynthesis (dbt)
108210|NCT02616432|Breast Imaging|breast imaging
108211|NCT02616432|Full-field digital mammography|full-field digital mammography
108212|NCT02616432|Breast screening|breast screening
108213|NCT02616419|Emergency Department|emergency department
108214|NCT02616419|Procedural pain|procedural pain
108215|NCT02616419|Procedural anxiety|procedural anxiety
108216|NCT02616419|Needle-related procedures|needle-related procedures
108217|NCT02616419|Clinical Nursing Research|clinical nursing research
108315|NCT02615561|Safety|safety
108218|NCT02616419|Nursing practice|nursing practice
108219|NCT02616419|Non-pharmacological method|non-pharmacological method
108220|NCT02616406|recovery of function|recovery of function
108221|NCT02616380|Work productivity|work productivity
108222|NCT02616380|Quality of life (QOL)|quality of life (qol)
108223|NCT02616380|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
108224|NCT02616354|Pharmacokinetics; pharmacodynamic; imipenem; sepsis|pharmacokinetics; pharmacodynamic; imipenem; sepsis
108225|NCT02616315|Drug therapy|drug therapy
108226|NCT02616302|Drug therapy|drug therapy
108227|NCT02616276|Glycemic Index|glycemic index
108228|NCT02616276|Postprandial Period|postprandial period
108229|NCT02616276|Vascular Stiffness|vascular stiffness
108230|NCT02616276|Blood glucose|blood glucose
108231|NCT02616276|Cognition|cognition
108232|NCT02616237|Chinese population|chinese population
108233|NCT02616237|acupressure|acupressure
108234|NCT02616237|physical activity|physical activity
108236|NCT02616237|Facebook|facebook
108237|NCT02616198|glass ionomers|glass ionomers
108238|NCT02616198|surface coating|surface coating
108239|NCT02616198|clinical trial|clinical trial
108240|NCT02616120|Herbal therapy|herbal therapy
108241|NCT02616120|Parkinson's Disease|parkinson's disease
108242|NCT02616120|Non-motor Symptoms|non-motor symptoms
108243|NCT02616120|Randomized controlled trial|randomized controlled trial
108244|NCT02616107|Caregiver|caregiver
108245|NCT02616107|Self-management|self-management
108246|NCT02616107|Care options|care options
108247|NCT02616107|Goals of care|goals of care
108248|NCT02616107|Breast cancer|breast cancer
108249|NCT02616107|Palliative care|palliative care
108250|NCT02616081|Urinary Bladder|urinary bladder
108251|NCT02616081|Neurogenic|neurogenic
108252|NCT02616081|Quality of Life|quality of life
108253|NCT02616081|Spinal cord injury|spinal cord injury
108254|NCT02616081|incontinence|incontinence
108255|NCT02616081|Bladder|bladder
108256|NCT02616042|Centella asiatica|centella asiatica
108257|NCT02616042|bamboo salt|bamboo salt
108258|NCT02616042|dentifrice|dentifrice
108259|NCT02616003|Morbid Obesity|morbid obesity
108260|NCT02616003|Giant Obese|giant obese
108261|NCT02616003|Preoperative Procedure|preoperative procedure
108262|NCT02616003|Liraglutide|liraglutide
108263|NCT02616003|Leucine|leucine
108264|NCT02615977|Pavlovian conditioning, Operant conditioning|pavlovian conditioning, operant conditioning
108265|NCT02615977|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
108266|NCT02615977|Functional imaging|functional imaging
108267|NCT02615977|Relapse risk|relapse risk
108268|NCT02615977|Behavioural Intervention|behavioural intervention
108269|NCT02615951|Regulatory B cells (Breg)|regulatory b cells (breg)
108270|NCT02615951|Genes|genes
108271|NCT02615951|Cell surface proteins|cell surface proteins
108272|NCT02615951|Nutrient transporters|nutrient transporters
108273|NCT02615951|Chemokine receptors|chemokine receptors
108274|NCT02615899|Older Adults, Falls|older adults, falls
108275|NCT02615886|rice bran|rice bran
108276|NCT02615886|infants|infants
108277|NCT02615886|stool metabolome|stool metabolome
108278|NCT02615886|stool microbiome|stool microbiome
108279|NCT02615886|dietary intervention|dietary intervention
108280|NCT02615873|Parkinson's Disease|parkinson's disease
108281|NCT02615873|Fluctuating Parkinson's Disease|fluctuating parkinson's disease
108282|NCT02615873|Carbidopa|carbidopa
108283|NCT02615873|Levodopa|levodopa
108284|NCT02615873|Accordion|accordion
108285|NCT02615860|HIV-infection|hiv-infection
108286|NCT02615860|anal cancer (AC)|anal cancer (ac)
108287|NCT02615860|anal cancer prevention|anal cancer prevention
108288|NCT02615860|anal dysplasia|anal dysplasia
108289|NCT02615860|anal intraepithelial neoplasia (AIN)|anal intraepithelial neoplasia (ain)
108290|NCT02615860|human papillomavirus (HPV)|human papillomavirus (hpv)
108291|NCT02615860|HPV-induced anal cancer precursor lesions|hpv-induced anal cancer precursor lesions
108292|NCT02615860|electrocautery (ECA)|electrocautery (eca)
108293|NCT02615860|topical trichloroacetic acid (TCA) treatment.|topical trichloroacetic acid (tca) treatment.
108294|NCT02615704|Brilique treatment adherence via electronic device application (APP)|brilique treatment adherence via electronic device application (app)
108295|NCT02615678|neuropathy|neuropathy
108296|NCT02615678|peripheral|peripheral
108297|NCT02615678|chemotherapy|chemotherapy
108298|NCT02615678|breast cancer|breast cancer
108299|NCT02615665|NK-cells|nk-cells
108300|NCT02615665|T-cells|t-cells
99408|NCT02666846|PK|pk
108301|NCT02615639|HPDC-T cells|hpdc-t cells
108302|NCT02615639|CHB|chb
108303|NCT02615639|immuno therapy|immuno therapy
108304|NCT02615626|Visfatin|visfatin
108305|NCT02615626|GCF|gcf
108306|NCT02615626|serum|serum
108307|NCT02615626|Non-surgical Periodontal Treatment.|non-surgical periodontal treatment.
108308|NCT02615613|Hedonics, Ghrelin, Hunger|hedonics, ghrelin, hunger
108309|NCT02615600|tinnitus|tinnitus
108310|NCT02615600|transcranial random noise stimulation|transcranial random noise stimulation
108311|NCT02615600|tRNS|trns
108312|NCT02615600|auditory cortex|auditory cortex
108313|NCT02615600|non-invasive brain stimulation|non-invasive brain stimulation
108314|NCT02615587|non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
108316|NCT02615561|Efficacy|efficacy
108317|NCT02615561|Atopic dermatitis|atopic dermatitis
108318|NCT02615561|Cosmetic products|cosmetic products
108319|NCT02615548|exercises|exercises
108320|NCT02615535|traumatic brain injury|traumatic brain injury
108321|NCT02615522|primary TKR|primary tkr
108322|NCT02614443|Depression|depression
108323|NCT02614443|Anxiety|anxiety
108324|NCT02614443|Stress|stress
108325|NCT02614443|Online interventions|online interventions
108326|NCT02614443|University students|university students
108327|NCT02614443|CBT|cbt
108328|NCT02614430|Rehabilitation|rehabilitation
108329|NCT02614430|Prediction|prediction
108330|NCT02614430|Inflammation|inflammation
108331|NCT02614404|Plasmodium falciparum|plasmodium falciparum
108332|NCT02614404|Uncomplicated malarial|uncomplicated malarial
108333|NCT02614404|imatinib mesylate|imatinib mesylate
108334|NCT02614404|antimalarials|antimalarials
108335|NCT02614391|Procedural pain|procedural pain
108336|NCT02614391|Phlebotomy|phlebotomy
108337|NCT02614391|Distraction|distraction
108338|NCT02614391|Videogame|videogame
108339|NCT02614391|Computer tablet|computer tablet
108341|NCT02614378|abortive effect|abortive effect
108342|NCT02614326|Depression|depression
108343|NCT02614326|Cognitive risk factors|cognitive risk factors
108344|NCT02614326|Autobiographical memory|autobiographical memory
108345|NCT02614326|Cognitive bias|cognitive bias
108346|NCT02614326|Relapse prevention|relapse prevention
108347|NCT02614313|Fructose|fructose
108348|NCT02614313|Irritable Bowel Syndrome|irritable bowel syndrome
108349|NCT02614313|Breath test|breath test
108350|NCT02614313|Placebo|placebo
108351|NCT02614300|pulmonary rehabilitation|pulmonary rehabilitation
108352|NCT02614300|chest physiotherapy|chest physiotherapy
108353|NCT02614300|non-cystic fibrosis bronchiectasis|non-cystic fibrosis bronchiectasis
108354|NCT02614300|exercise tolerance|exercise tolerance
108355|NCT02614300|bronchiectasis|bronchiectasis
108356|NCT02614300|respiratory therapy|respiratory therapy
108357|NCT02614287|prevention|prevention
108358|NCT02614287|prophylaxis|prophylaxis
108359|NCT02614287|headache|headache
108360|NCT02614274|knee|knee
108361|NCT02614274|pain|pain
108362|NCT02614274|osteoarthritis|osteoarthritis
108363|NCT02614274|nutraceutical|nutraceutical
108364|NCT02614274|nutrition|nutrition
108365|NCT02614274|supplement|supplement
108366|NCT02614274|non-surgical|non-surgical
108367|NCT02614274|biomarker|biomarker
108368|NCT02614274|joint health|joint health
108369|NCT02614261|prevention|prevention
108370|NCT02614261|prophylaxis|prophylaxis
108371|NCT02614261|headache|headache
108372|NCT02615496|Health Care Surveys|health care surveys
108373|NCT02615496|Vascular Endothelial Growth Factor|vascular endothelial growth factor
108374|NCT02615470|Pneumococcal Vaccines|pneumococcal vaccines
108375|NCT02615470|Shingles|shingles
108376|NCT02615470|Pharmacy|pharmacy
108377|NCT02615470|Vaccine|vaccine
108378|NCT02615470|Immunization|immunization
108379|NCT02615444|Metabolic Syndrome X|metabolic syndrome x
108380|NCT02615444|Overweight|overweight
108381|NCT02615444|Waist Circumference|waist circumference
108382|NCT02615444|Blood Pressure|blood pressure
108383|NCT02615444|Cholesterol|cholesterol
108384|NCT02615444|Oat beta glucan|oat beta glucan
108385|NCT02615392|RCT|rct
108386|NCT02615392|Park Prescription|park prescription
108387|NCT02615392|Park Use|park use
108388|NCT02615392|Physical Activity|physical activity
108389|NCT02615392|Health Promotion|health promotion
108390|NCT02615392|Health Behavior|health behavior
108391|NCT02615392|Mental Well-Being|mental well-being
108392|NCT02615392|Body composition|body composition
108393|NCT02615392|Blood levels|blood levels
108394|NCT02615392|Accelerometry|accelerometry
108395|NCT02615392|Improving general physical and mental health|improving general physical and mental health
108396|NCT02615379|instrumented spinal fusion|instrumented spinal fusion
108397|NCT02615379|infection|infection
108398|NCT02615379|topical oxygen|topical oxygen
108399|NCT02615340|delirium|delirium
108400|NCT02615340|melatonin|melatonin
108401|NCT02615340|pharmacokinetics|pharmacokinetics
108402|NCT02615340|feasibility|feasibility
108403|NCT02615340|prevention|prevention
108405|NCT02615327|Polydextrose|polydextrose
108406|NCT02615327|Glycemic Index|glycemic index
108407|NCT02615314|migraine|migraine
108408|NCT02615314|benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
108409|NCT02615288|Vitamin D|vitamin d
108410|NCT02615275|Head and Neck Cancer|head and neck cancer
108411|NCT02615275|Bioelectrical impedance analysis|bioelectrical impedance analysis
108412|NCT02615275|BIA|bia
108413|NCT02615275|Eight-electrode BIA device|eight-electrode bia device
108414|NCT02615275|SECA mBCA|seca mbca
108415|NCT02615275|Computed tomography|computed tomography
108416|NCT02615275|CT|ct
108417|NCT02615275|Positron emission tomography|positron emission tomography
108418|NCT02615275|PET|pet
108419|NCT02615275|Symptom questionnaire|symptom questionnaire
108420|NCT02615275|Survey|survey
108421|NCT02615275|Radiation therapy|radiation therapy
108422|NCT02615275|RT|rt
108423|NCT02615275|XRT|xrt
108424|NCT02615262|Pediatric cardiac surgery|pediatric cardiac surgery
108425|NCT02615262|Dexamethasone|dexamethasone
108426|NCT02615262|Steroids|steroids
108427|NCT02615262|Cardiopulmonary bypass|cardiopulmonary bypass
108428|NCT02615262|Congenital heart defects|congenital heart defects
108429|NCT02615262|Infants|infants
108430|NCT02615197|PTSD|ptsd
108431|NCT02615197|Multi-diagnostic|multi-diagnostic
108432|NCT02615197|Dialectical Behavior Therapy|dialectical behavior therapy
108433|NCT02615197|Prolonged Exposure Therapy|prolonged exposure therapy
108434|NCT02615184|Drug therapy|drug therapy
108435|NCT02615158|Feeding practices|feeding practices
108436|NCT02615158|Diet|diet
108437|NCT02615158|Physical activity|physical activity
108438|NCT02615158|Prevention|prevention
108439|NCT02615145|Quality of life|quality of life
108440|NCT02615145|Chronic Hepatitis C|chronic hepatitis c
108441|NCT02615145|Dasabuvir|dasabuvir
108442|NCT02615145|Observational Study|observational study
108443|NCT02615145|Work-ability|work-ability
108444|NCT02615145|Cirrhosis|cirrhosis
108445|NCT02615145|Ombitasvir+Paritaprevir+Ritonavir|ombitasvir+paritaprevir+ritonavir
108446|NCT02615145|Fibrosis|fibrosis
108447|NCT02615119|heartbeat|heartbeat
108448|NCT02615119|respiration|respiration
108449|NCT02615119|interoception|interoception
108450|NCT02615119|anxiety|anxiety
108451|NCT02615119|eating|eating
108452|NCT02615106|Radiation Therapy|radiation therapy
108453|NCT02615106|Neuroblastoma|neuroblastoma
108454|NCT02615067|Diagnostic|diagnostic
108455|NCT02615067|Active surveillance|active surveillance
108456|NCT02615067|Very low risk|very low risk
108457|NCT02615067|Imaging|imaging
108458|NCT02615067|PSMA|psma
108459|NCT02615067|SPECT/CT|spect/ct
108460|NCT02615067|99mTc|99mtc
108461|NCT02615067|Newly Diagnosed|newly diagnosed
108462|NCT02615067|Prostatectomy|prostatectomy
108463|NCT02615067|Biopsy|biopsy
108464|NCT02615054|Cardiovascular Impairment|cardiovascular impairment
108465|NCT02615054|15-258|15-258
108466|NCT02615041|Meropenem|meropenem
108467|NCT02615041|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
108468|NCT02615041|population pharmacokinetics|population pharmacokinetics
108469|NCT02615041|pharmacokinetics|pharmacokinetics
108470|NCT02615041|pharmacodynamics|pharmacodynamics
108471|NCT02615028|Force plate, Balance ability|force plate, balance ability
108472|NCT02615015|Deoxyribonuclease|deoxyribonuclease
108473|NCT02615002|Cognition|cognition
108474|NCT02615002|mild Alzheimer's disease|mild alzheimer's disease
108475|NCT02615002|Sleep|sleep
108476|NCT02614989|Tremor|tremor
108477|NCT02614989|Thalamotomy|thalamotomy
108478|NCT02614963|Irritable Bowel Syndrome|irritable bowel syndrome
108479|NCT02614963|Clostridium Butyricum|clostridium butyricum
108480|NCT02614911|Early Onset Entheropathy|early onset entheropathy
108481|NCT02614833|Hormone receptor positive|hormone receptor positive
108482|NCT02614820|Ischemic preconditioning|ischemic preconditioning
108483|NCT02614820|sefety|sefety
108484|NCT02614820|efficacy|efficacy
108486|NCT02614807|Dietary Supplement|dietary supplement
108487|NCT02614794|Tucatinib|tucatinib
108488|NCT02614794|Capecitabine|capecitabine
108489|NCT02614794|Trastuzumab|trastuzumab
108490|NCT02614794|Xeloda|xeloda
108491|NCT02614794|Herceptin|herceptin
108492|NCT02614794|Breast Cancer|breast cancer
108493|NCT02614794|ARRY-380|arry-380
108494|NCT02614794|ONT-380|ont-380
108495|NCT02614794|HER2 Positive Breast Carcinoma|her2 positive breast carcinoma
108496|NCT02614794|HER2 Positive Locally Advanced Breast Cancer|her2 positive locally advanced breast cancer
108497|NCT02614794|HER-2 Positive Breast Cancer|her-2 positive breast cancer
108498|NCT02614794|HER-2 Positive Breast Carcinoma|her-2 positive breast carcinoma
108499|NCT02614794|HER-2 Positive Locally Advanced Breast Cancer|her-2 positive locally advanced breast cancer
108500|NCT02614794|Recurrent Breast Carcinoma|recurrent breast carcinoma
108501|NCT02614794|Stage IV Breast Cancer|stage iv breast cancer
108502|NCT02614794|Metastatic Breast Cancer|metastatic breast cancer
108503|NCT02614794|Breast Carcinoma|breast carcinoma
108504|NCT02614794|Metastatic Malignant Neoplasm in the Brain|metastatic malignant neoplasm in the brain
108505|NCT02614794|Brain Metastases in Breast Cancer|brain metastases in breast cancer
108506|NCT02614794|Asymptomatic Brain Metastases in Breast Cancer|asymptomatic brain metastases in breast cancer
108507|NCT02614794|Low Symptomatic Brain Metastases in Breast Cancer|low symptomatic brain metastases in breast cancer
108508|NCT02614768|Glucose Monitoring System|glucose monitoring system
108509|NCT02614755|Older Adults Volunteers|older adults volunteers
108510|NCT02614755|Seniors|seniors
108511|NCT02614755|Brain Performance Test|brain performance test
108512|NCT02614729|High Protein|high protein
108513|NCT02614729|Satiety|satiety
108514|NCT02614729|Appetite Control|appetite control
108515|NCT02614729|Protein Distribution|protein distribution
108516|NCT02614729|Cognitive Function|cognitive function
108517|NCT02614729|Ad libitum Food Intake|ad libitum food intake
108518|NCT02614729|Obesity prevention|obesity prevention
108519|NCT02614729|Obesity treatment|obesity treatment
108520|NCT02614703|Barrett's Esophagus|barrett's esophagus
108927|NCT02611713|Long-term|long-term
108521|NCT02614703|Acetic Acid Chromoendoscopy|acetic acid chromoendoscopy
108522|NCT02614690|Fracture of the upper limb|fracture of the upper limb
108523|NCT02614677|Disability Evaluation System|disability evaluation system
108524|NCT02614677|SF-12|sf-12
108525|NCT02614677|ICF model|icf model
108526|NCT02614612|Acute Graft Versus Host Disease|acute graft versus host disease
108527|NCT02614599|ADD|add
108528|NCT02614599|ADHD|adhd
108529|NCT02614599|Proteins|proteins
108530|NCT02614599|Dietary|dietary
108531|NCT02614599|Nutrition|nutrition
108532|NCT02614599|QEEG|qeeg
108533|NCT02614599|ERP|erp
108534|NCT02614599|ICA|ica
108535|NCT02614586|Drug Therapy|drug therapy
108536|NCT02614573|Dependent|dependent
108542|NCT02614521|Pulmonary veins ablation|pulmonary veins ablation
108543|NCT02614521|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
108545|NCT02614482|Antimuscarinics|antimuscarinics
108546|NCT02614482|Antocholinergics|antocholinergics
108547|NCT02614482|Overactive bladder|overactive bladder
108548|NCT02614235|Cardiac Arrhythmia|cardiac arrhythmia
108549|NCT02614235|Syncope|syncope
108550|NCT02614235|Ambulatory Electrocardiography Monitoring|ambulatory electrocardiography monitoring
108551|NCT02614222|Computer Assisted Instrument Guidance (CAIG)|computer assisted instrument guidance (caig)
108552|NCT02614222|Peripheral Nerve Block|peripheral nerve block
108553|NCT02614222|Clear Guide ONE|clear guide one
108554|NCT02614222|Needle path|needle path
108555|NCT02614222|Needle Guidance|needle guidance
108556|NCT02614222|Ultrasound|ultrasound
108557|NCT02614209|ED|ed
108558|NCT02614209|BNP|bnp
108559|NCT02614196|prevention|prevention
108560|NCT02614196|prophylaxis|prophylaxis
108561|NCT02614196|headache|headache
108562|NCT02614183|prevention|prevention
108563|NCT02614183|prophylaxis|prophylaxis
108564|NCT02614183|headache|headache
108565|NCT02614157|rectal cancer|rectal cancer
108566|NCT02614157|lateral lymph node dissection|lateral lymph node dissection
108567|NCT02614157|neoadjuvant chemoradiation|neoadjuvant chemoradiation
108568|NCT02614157|total mesorectal excision|total mesorectal excision
108569|NCT02614157|surgery|surgery
108570|NCT02614157|recurrence|recurrence
108571|NCT02614157|metastasis|metastasis
108572|NCT02614157|overall survival|overall survival
108573|NCT02614144|Hospital Acquired Pneumonia|hospital acquired pneumonia
108574|NCT02614144|Mortality|mortality
108575|NCT02614118|Endodontic treatment|endodontic treatment
108576|NCT02614118|non steroid|non steroid
108577|NCT02614118|pain|pain
108578|NCT02614118|pre medication|pre medication
108579|NCT02614092|Mild Cognitive Impairment|mild cognitive impairment
108580|NCT02614092|memory impairment|memory impairment
108581|NCT02614092|Physical Activity|physical activity
108582|NCT02614092|Exercise|exercise
108583|NCT02614092|Cognitive Training|cognitive training
108585|NCT02614092|Older Adults|older adults
108586|NCT02614079|lumbago|lumbago
108587|NCT02614079|low back pain|low back pain
108588|NCT02614079|leg pain|leg pain
108589|NCT02614040|crystalloid|crystalloid
108590|NCT02614040|acute kidney injury|acute kidney injury
108591|NCT02614001|breathing training, congestive heart failure, stroke|breathing training, congestive heart failure, stroke
108592|NCT02613988|Glioblastoma|glioblastoma
108593|NCT02613988|MRI|mri
108594|NCT02613988|standard treatment|standard treatment
108595|NCT02613949|fibromyalgia|fibromyalgia
108596|NCT02613949|pain|pain
108597|NCT02613949|stimulation|stimulation
108598|NCT02613936|traumatic brain injury|traumatic brain injury
108599|NCT02613936|post concussive symptoms|post concussive symptoms
108600|NCT02613936|depression|depression
108601|NCT02613936|executive dysfunction|executive dysfunction
108602|NCT02613936|brain stimulation|brain stimulation
108603|NCT02613923|Breast Cancer|breast cancer
108604|NCT02613923|GO! to sleep|go! to sleep
108606|NCT02613910|Ofatumumab|ofatumumab
108607|NCT02613910|Pemphigus Vulgaris|pemphigus vulgaris
108608|NCT02613910|Long-Term Extension Study|long-term extension study
108609|NCT02613845|Postoperative delirium|postoperative delirium
108610|NCT02613845|Cardiac surgery|cardiac surgery
108611|NCT02613845|Cardiopulmonary bypass|cardiopulmonary bypass
108612|NCT02613845|Risk factor|risk factor
108613|NCT02613832|Noncooperative patients|noncooperative patients
108614|NCT02613806|Dexmedetomidine|dexmedetomidine
108615|NCT02613806|Coughing Response|coughing response
108616|NCT02613806|Postoperative Recovery Quality|postoperative recovery quality
108617|NCT02613806|Thyroid Surgery|thyroid surgery
108618|NCT02613793|Preterm pre-eclampsia|preterm pre-eclampsia
108619|NCT02613793|Neurological dysfunction|neurological dysfunction
108620|NCT02613793|Saccadic reaction time|saccadic reaction time
108621|NCT02613728|Colorectal cancer|colorectal cancer
108622|NCT02613728|Colorectal cancer surgery|colorectal cancer surgery
108623|NCT02613728|Polyp(s)|polyp(s)
108624|NCT02613728|Accelerated Enhanced Recovery|accelerated enhanced recovery
108625|NCT02613728|RecoverMI|recovermi
108626|NCT02613728|Fluid diary|fluid diary
108627|NCT02613728|Questionnaires|questionnaires
108628|NCT02613728|Surveys|surveys
108629|NCT02613728|RecoverMI device|recovermi device
108630|NCT02613715|Flavonoids|flavonoids
108631|NCT02613715|Anthocyanins|anthocyanins
108632|NCT02613715|Blackberry Juice|blackberry juice
108633|NCT02613715|Bioavailability|bioavailability
108635|NCT02613702|Free gingival graft|free gingival graft
108636|NCT02613702|keratinized gingival tissue|keratinized gingival tissue
108637|NCT02613689|smokeless tobacco, text message, tobacco cessation, tobacco|smokeless tobacco, text message, tobacco cessation, tobacco
108638|NCT02613637|lung cancer|lung cancer
108639|NCT02613637|registry study|registry study
108640|NCT02613637|Biological Disease Profile|biological disease profile
108641|NCT02613624|KMC in community|kmc in community
108642|NCT02613559|Neovascular Age-Related Macular Degeneration, Subfoveal CNV, TK001|neovascular age-related macular degeneration, subfoveal cnv, tk001
108643|NCT02613546|cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
108644|NCT02613546|Sexual Dysfunctions|sexual dysfunctions
108645|NCT02613546|Women|women
108646|NCT02613520|PfSPZ Vaccine|pfspz vaccine
108647|NCT02613520|Plasmodium falciparum|plasmodium falciparum
108648|NCT02613494|clozapine|clozapine
108649|NCT02613494|hypersalivation|hypersalivation
108650|NCT02613494|refractory schizophrenia|refractory schizophrenia
108651|NCT02613468|Pregnancy|pregnancy
108652|NCT02613468|Low birth weight|low birth weight
108653|NCT02613468|Gingivitis|gingivitis
108654|NCT02613468|Inflammation|inflammation
108655|NCT02613468|Periodontitis|periodontitis
108656|NCT02613390|Epidural metastasis|epidural metastasis
108657|NCT02613390|Magnetic resonance imaging|magnetic resonance imaging
108658|NCT02613390|MRI|mri
108659|NCT02613390|Guidance system|guidance system
108660|NCT02613390|Spinal surgery|spinal surgery
108661|NCT02613390|Questionnaires|questionnaires
108662|NCT02613390|Surveys|surveys
108663|NCT02613377|Transfusion-related acute lung injury, Red Blood Cell|transfusion-related acute lung injury, red blood cell
108664|NCT02613351|Exercise Tolerance|exercise tolerance
108665|NCT02613351|Lung Diseases, Obstructive|lung diseases, obstructive
108666|NCT02613325|Melanoma|melanoma
108667|NCT02613325|Imaging|imaging
108668|NCT02613325|Pigmented Lesions|pigmented lesions
108669|NCT02613325|Melanoma Management|melanoma management
108670|NCT02613247|Viscosupplementation|viscosupplementation
108671|NCT02613247|Hyaluronic acid|hyaluronic acid
108672|NCT02613247|Synvisc|synvisc
108673|NCT02613247|Synvisc-One|synvisc-one
108674|NCT02613247|Patellofemoral pain syndrome|patellofemoral pain syndrome
108675|NCT02613247|PFPS|pfps
108676|NCT02613247|Anterior knee pain|anterior knee pain
108677|NCT02613247|Runner's knee|runner's knee
108678|NCT02613234|Epilepsy|epilepsy
108679|NCT02613234|128-Channel EEG|128-channel eeg
108680|NCT02613234|Dipole Localization|dipole localization
108681|NCT02613234|Transcranial Direct Current Stimulation|transcranial direct current stimulation
108781|NCT02612649|Irritable bowel syndrome|irritable bowel syndrome
108682|NCT02613221|Metastatic colorectal cancer, Panitumumab, TAS-102|metastatic colorectal cancer, panitumumab, tas-102
108683|NCT02613195|Ischemia-Reperfusion Injury|ischemia-reperfusion injury
108684|NCT02613195|oxidative stress|oxidative stress
108685|NCT02613195|organ preservation|organ preservation
108686|NCT02613195|Hydrogen|hydrogen
108687|NCT02613195|Kidney Transplantation|kidney transplantation
108688|NCT02613169|M. tuberculosis infection|m. tuberculosis infection
108689|NCT02613169|isoniazid|isoniazid
108690|NCT02613169|HIV-exposed infants|hiv-exposed infants
108691|NCT02613156|laparoscopic|laparoscopic
108692|NCT02613156|hepatocellular carcinoma|hepatocellular carcinoma
108693|NCT02613156|recurrence|recurrence
108694|NCT02613143|malignant glaucoma|malignant glaucoma
108695|NCT02613143|zonulo-hyaloido-vitrectomy|zonulo-hyaloido-vitrectomy
108696|NCT02613091|volunteers|volunteers
108697|NCT02613078|Children|children
108698|NCT02613078|Functional Abdominal Pain Syndrome|functional abdominal pain syndrome
108699|NCT02613078|Irritable Bowel Syndrome|irritable bowel syndrome
108700|NCT02613078|Gut-Directed Hypnotherapy|gut-directed hypnotherapy
108701|NCT02613078|Probiotic|probiotic
108702|NCT02613065|Ad libitum|ad libitum
108703|NCT02613065|Energy balance|energy balance
108704|NCT02613065|Protein|protein
108705|NCT02613039|oral contraceptives|oral contraceptives
108706|NCT02613039|female sexuality|female sexuality
108707|NCT02613026|Breast tumor|breast tumor
108708|NCT02613026|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
108709|NCT02613026|Pathological complete remission|pathological complete remission
108710|NCT02612987|CBT|cbt
108711|NCT02612987|Internet based|internet based
108712|NCT02612974|Qurse mafasil|qurse mafasil
108713|NCT02612974|leech therapy|leech therapy
108714|NCT02612974|Hirudinaria granulosa|hirudinaria granulosa
108715|NCT02612961|Mechanically ventilated patients|mechanically ventilated patients
108716|NCT02612961|Normal Saline|normal saline
108717|NCT02612961|Tracheostomy Tube Suctioning|tracheostomy tube suctioning
108718|NCT02612922|Influenza|influenza
108719|NCT02612909|Avian Influenza|avian influenza
108720|NCT02612909|A/H5N1 vaccine|a/h5n1 vaccine
108721|NCT02612909|IVAC|ivac
108722|NCT02612896|Taenia solium|taenia solium
108723|NCT02612896|control|control
108724|NCT02612896|elimination|elimination
108725|NCT02612896|One Health|one health
108726|NCT02612883|Flux measurement|flux measurement
108727|NCT02612870|Breast Cancer|breast cancer
108728|NCT02612870|Sentinel Node|sentinel node
108729|NCT02612870|Sentinel Node Biopsy|sentinel node biopsy
108730|NCT02612870|Breast Surgery|breast surgery
108731|NCT02612857|dermatomyositis|dermatomyositis
108732|NCT02612857|IMO-8400|imo-8400
108733|NCT02612857|Pioneer|pioneer
108734|NCT02612818|coelioscopy|coelioscopy
108735|NCT02612766|celiac disease|celiac disease
108736|NCT02612766|oat|oat
108737|NCT02612766|gluten free diet|gluten free diet
108738|NCT02612753|Aphasia|aphasia
108739|NCT02612753|Speaking therapy|speaking therapy
108740|NCT02612753|Language therapy|language therapy
108741|NCT02612753|transcranial Direct current stimulation|transcranial direct current stimulation
108742|NCT02612740|Bio Oss|bio oss
108743|NCT02612740|critical-size defect|critical-size defect
108744|NCT02612740|bone grafting|bone grafting
108745|NCT02612740|cyst|cyst
108746|NCT02612740|CT bone analysis|ct bone analysis
108747|NCT02612740|alveolar bone|alveolar bone
108748|NCT02612727|Hyperbilirubinemia, Neonatal|hyperbilirubinemia, neonatal
108749|NCT02612714|diabetes|diabetes
108750|NCT02612714|hypercholesterolemia|hypercholesterolemia
108751|NCT02612714|sexual dysfunction|sexual dysfunction
108752|NCT02612714|statin|statin
108753|NCT02612714|testosterone|testosterone
108754|NCT02612701|Myocardial perfusion|myocardial perfusion
108755|NCT02612701|Electronic cigarettes|electronic cigarettes
108756|NCT02612701|Cigarettes|cigarettes
108757|NCT02612701|Cigarette smoking|cigarette smoking
108758|NCT02612688|Advance Care Planning|advance care planning
108759|NCT02612688|Advance Directives|advance directives
108760|NCT02612688|Alzheimer Disease|alzheimer disease
108761|NCT02612688|Dementia|dementia
108762|NCT02612688|Do-Not-Resuscitate Orders|do-not-resuscitate orders
108763|NCT02612688|Enteral Nutrition|enteral nutrition
108764|NCT02612688|Heart Failure|heart failure
108765|NCT02612688|Hospices|hospices
108766|NCT02612688|Hospitalization|hospitalization
108767|NCT02612688|Instructional Films and Videos|instructional films and videos
108768|NCT02612688|Intubation|intubation
108769|NCT02612688|Nursing Homes|nursing homes
108770|NCT02612688|Parenteral Nutrition|parenteral nutrition
108771|NCT02612688|Pragmatic Clinical Trials|pragmatic clinical trials
108772|NCT02612688|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
108773|NCT02612688|Randomized Controlled Trials|randomized controlled trials
108774|NCT02612688|Resuscitation Orders|resuscitation orders
108775|NCT02612688|Skilled Nursing Facilities|skilled nursing facilities
108776|NCT02612662|AZD4076|azd4076
108777|NCT02612662|Healthy male subjects|healthy male subjects
108778|NCT02612662|Safety|safety
108779|NCT02612662|Subcutaneous|subcutaneous
108780|NCT02612662|Tolerability|tolerability
108782|NCT02612649|YM060|ym060
108783|NCT02612649|Ramosetron|ramosetron
108784|NCT02612649|Survey|survey
108785|NCT02612636|Delirium|delirium
108786|NCT02612636|Ear Plug|ear plug
108787|NCT02612636|Eye Mask|eye mask
108788|NCT02612636|Mechanical ventilation|mechanical ventilation
108789|NCT02612636|Sleep|sleep
108790|NCT02612597|before and after bedrest|before and after bedrest
108791|NCT02612597|healthy untrained|healthy untrained
583427|NCT00511745|Gastric Ulcer|gastric ulcer
108792|NCT02612597|before and after exercise training|before and after exercise training
108793|NCT02612558|Warm antibody autoimmune hemolytic anemia (AIHA)|warm antibody autoimmune hemolytic anemia (aiha)
108794|NCT02612545|Plasmodium Falciparum|plasmodium falciparum
108795|NCT02612545|Artemisinin Combination Therapy|artemisinin combination therapy
108796|NCT02612545|Triple Artemisinin Combination Therapy|triple artemisinin combination therapy
108797|NCT02612545|Piperaquine|piperaquine
108798|NCT02612545|Mefloquine|mefloquine
108799|NCT02612493|obesity surgery|obesity surgery
108800|NCT02612493|type I diabetes|type i diabetes
108801|NCT02612493|weight loss|weight loss
108802|NCT02612493|insulin dosage|insulin dosage
108803|NCT02612493|postsurgery metabolic changes|postsurgery metabolic changes
99903|NCT02664012|pharmacokinetics|pharmacokinetics
99904|NCT02664012|pharmacodynamics|pharmacodynamics
99905|NCT02664012|cigarette|cigarette
99906|NCT02663999|dose proportionality|dose proportionality
99907|NCT02663999|diazepam nasal spray|diazepam nasal spray
99909|NCT02663973|Breast cancer|breast cancer
99918|NCT02663921|Melanin|melanin
108804|NCT02612480|endotoxin|endotoxin
108805|NCT02612480|LPS|lps
108806|NCT02612480|ticagrelor|ticagrelor
108807|NCT02612480|clopidogrel|clopidogrel
108808|NCT02612480|acetylsalicyclic acid|acetylsalicyclic acid
108809|NCT02612480|placebo|placebo
108810|NCT02612467|start back tool|start back tool
108811|NCT02612467|stratified care|stratified care
108812|NCT02612467|targeted treatment|targeted treatment
108813|NCT02612454|Eczema|eczema
108814|NCT02612441|stroke|stroke
108815|NCT02612389|COPD|copd
108816|NCT02612389|Qigong|qigong
108817|NCT02612389|ANS|ans
108818|NCT02612389|Meditative Movement|meditative movement
108819|NCT02612389|Flight Attendants|flight attendants
108820|NCT02612389|Secondhand Smoke|secondhand smoke
108821|NCT02612389|Nicotine|nicotine
108822|NCT02612389|Blood Pressure|blood pressure
108823|NCT02612389|6 minute walk test|6 minute walk test
108824|NCT02612363|septic shock|septic shock
108825|NCT02612363|sedation|sedation
108826|NCT02612363|microcirculation|microcirculation
108827|NCT02612350|ctDNA|ctdna
108828|NCT02612350|high risk for developing cancer|high risk for developing cancer
108829|NCT02612350|Plasma|plasma
108830|NCT02612350|Relative Risk|relative risk
108831|NCT02612350|Early Detection of Cancer|early detection of cancer
108832|NCT02612350|Cancer Screening Tests|cancer screening tests
108833|NCT02612350|Cancer Screening|cancer screening
108834|NCT02612337|Meniere's Disease|meniere's disease
108835|NCT02612337|Vertigo|vertigo
108836|NCT02612324|adolescents|adolescents
108837|NCT02612324|teen pregnancy prevention|teen pregnancy prevention
108838|NCT02612324|sexually transmitted infections prevention|sexually transmitted infections prevention
108839|NCT02612324|place-based programs|place-based programs
108840|NCT02612324|health education|health education
108841|NCT02612298|Essential Hypertension|essential hypertension
108842|NCT02612298|Arotinolol|arotinolol
108843|NCT02612298|Morning Blood Pressure|morning blood pressure
108844|NCT02612233|Pain|pain
108845|NCT02612220|liver resection|liver resection
108846|NCT02612181|dexmedetomidine|dexmedetomidine
108847|NCT02612181|microcirculation|microcirculation
108848|NCT02612181|septic shock|septic shock
108849|NCT02612168|Diagnosis|diagnosis
108850|NCT02612168|skin imaging|skin imaging
108851|NCT02612155|Hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
108852|NCT02612155|autologous cord blood cells|autologous cord blood cells
108853|NCT02612155|newborn infants|newborn infants
108854|NCT02612129|NPC1|npc1
108855|NCT02612129|Niemann-Pick Type C|niemann-pick type c
108856|NCT02612129|Niemann-Pick|niemann-pick
108857|NCT02612129|arimoclomol|arimoclomol
108858|NCT02612129|lysosomal storage disorder|lysosomal storage disorder
108859|NCT02612129|lysosomal storage disease|lysosomal storage disease
108860|NCT02612129|NPC2|npc2
108861|NCT02612129|NP-C|np-c
108862|NCT02612103|Biochemical markers|biochemical markers
108863|NCT02612090|Nutrition|nutrition
108864|NCT02612090|Polyphenols|polyphenols
108865|NCT02612090|Berries|berries
108866|NCT02612090|Lipid Panels|lipid panels
108867|NCT02612051|patients|patients
108868|NCT02612051|FTIH|ftih
108869|NCT02612051|healthy volunteers|healthy volunteers
108870|NCT02612051|GSK3008348|gsk3008348
108871|NCT02612051|[18F]-FBA-A20FMDV2|[18f]-fba-a20fmdv2
108872|NCT02612051|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
108873|NCT02612051|PET|pet
108874|NCT02612038|Obstructive sleep apnea|obstructive sleep apnea
108875|NCT02612038|Expiratory flow limitation|expiratory flow limitation
108876|NCT02612012|breast cancer|breast cancer
108877|NCT02612012|positive sentinel lymph nodes|positive sentinel lymph nodes
108878|NCT02612012|axillary radiotherapy|axillary radiotherapy
108879|NCT02611999|Physicians' ordering behavior with price information|physicians' ordering behavior with price information
108880|NCT02611986|Airway management|airway management
108881|NCT02611986|video laryngoscope|video laryngoscope
108882|NCT02611973|Essential Thrombocythemia|essential thrombocythemia
108888|NCT02611947|emphysema|emphysema
108889|NCT02611947|airway remodelling|airway remodelling
108890|NCT02611947|multidetector computed tomography|multidetector computed tomography
108896|NCT02611908|cancer|cancer
108897|NCT02611908|obinutuzumab|obinutuzumab
108898|NCT02611908|ibrutinib|ibrutinib
108899|NCT02611908|SLL|sll
108900|NCT02611895|Aviremic HIV-1 infected patients|aviremic hiv-1 infected patients
100000|NCT02663453|cholestasis|cholestasis
100001|NCT02663453|fish oil|fish oil
100002|NCT02663427|pepsinogen Ⅰ|pepsinogen ⅰ
108901|NCT02611895|HAART|haart
108902|NCT02611895|Integrase inhibitor Raltegravir|integrase inhibitor raltegravir
108903|NCT02611895|Ongoing HIV infection|ongoing hiv infection
108904|NCT02611856|twin to twin,|twin to twin,
108905|NCT02611856|transfusion syndrome|transfusion syndrome
108906|NCT02611843|peer support|peer support
108907|NCT02611843|web-based treatment|web-based treatment
108908|NCT02611843|veterans|veterans
108909|NCT02611843|PTSD|ptsd
108910|NCT02611843|Substance Use Disorders|substance use disorders
108911|NCT02611830|Drug therapy|drug therapy
108912|NCT02611817|Drug therapy|drug therapy
108913|NCT02611791|Treatment by Pulsed Radio Frequency, Collagen, Female|treatment by pulsed radio frequency, collagen, female
108914|NCT02611713|effectiveness|effectiveness
108915|NCT02611713|Caregiver Burden|caregiver burden
108916|NCT02611713|motor and non-motor symptoms|motor and non-motor symptoms
108917|NCT02611713|Duodopa/Duopa|duodopa/duopa
108918|NCT02611713|fluctuations|fluctuations
108919|NCT02611713|OFF time|off time
108920|NCT02611713|carbidopa levodopa enteral suspension (CLES)|carbidopa levodopa enteral suspension (cles)
108921|NCT02611713|dyskinesia|dyskinesia
108922|NCT02611713|Observational|observational
108923|NCT02611713|tremor|tremor
108924|NCT02611713|levodopa-carbidopa intestinal gel (LCIG)|levodopa-carbidopa intestinal gel (lcig)
108925|NCT02611713|Quality of Life|quality of life
108926|NCT02611713|Advanced Parkinson's Disease|advanced parkinson's disease
108928|NCT02611635|non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
108929|NCT02611635|Patient treatment preference|patient treatment preference
108930|NCT02611635|NOAC|noac
108931|NCT02611635|VKA|vka
108932|NCT02611583|TENS|tens
108933|NCT02611570|Lung cancer|lung cancer
108934|NCT02611570|Low dose computed tomography|low dose computed tomography
108935|NCT02611570|Screening|screening
108936|NCT02611570|Non-smoker|non-smoker
108937|NCT02611570|Gender issue|gender issue
108938|NCT02611557|MRI|mri
108939|NCT02611557|lymphedema|lymphedema
108940|NCT02611557|manual lymphatic drainage|manual lymphatic drainage
108941|NCT02611544|Fear of Cancer Recurrence|fear of cancer recurrence
108942|NCT02611544|Fear of Cancer Return|fear of cancer return
108943|NCT02611544|Breast Cancer Survivor|breast cancer survivor
108944|NCT02611544|Breast Cancer Remission|breast cancer remission
108945|NCT02611518|Healthy|healthy
108946|NCT02611518|JNJ-54861911|jnj-54861911
108947|NCT02611518|Rosuvastatin|rosuvastatin
108948|NCT02611518|Metformin|metformin
108949|NCT02611505|Healthy|healthy
108950|NCT02611505|Esketamine|esketamine
108951|NCT02611505|Hepatic Impairment|hepatic impairment
108952|NCT02611505|Pharmacokinetics|pharmacokinetics
108953|NCT02611479|patient reported outcomes|patient reported outcomes
108954|NCT02611466|Osteoarthritis|osteoarthritis
108955|NCT02611466|ASP7962|asp7962
108956|NCT02611453|choledocholithiasis|choledocholithiasis
108957|NCT02611453|ERCP|ercp
108958|NCT02611453|cholangiography|cholangiography
108959|NCT02611453|biliary stricture|biliary stricture
108960|NCT02611453|bile ducts|bile ducts
108961|NCT02611453|carbon dioxide|carbon dioxide
108962|NCT02611440|ischemic stroke|ischemic stroke
108963|NCT02611440|medication adherence|medication adherence
108964|NCT02611440|cardiovascular disease prevention|cardiovascular disease prevention
108965|NCT02611427|spine|spine
108966|NCT02611427|lumbar|lumbar
108967|NCT02611427|postoperative|postoperative
108968|NCT02611427|physical activity|physical activity
108969|NCT02611414|functional dyspepsia|functional dyspepsia
108970|NCT02611414|tDCS|tdcs
108971|NCT02611401|multiple sclerosis|multiple sclerosis
108972|NCT02611401|depression|depression
108973|NCT02611401|mindfulness|mindfulness
108974|NCT02611336|Left Ventricular Hypertrophy|left ventricular hypertrophy
108975|NCT02611336|Diastolic Dysfunction|diastolic dysfunction
108976|NCT02611336|Myocardial Fibrosis|myocardial fibrosis
108977|NCT02611336|Acromegaly|acromegaly
108978|NCT02611297|Cryoprobes|cryoprobes
108979|NCT02611297|Cryobiopsy|cryobiopsy
108980|NCT02611297|Transbronchial lung biopsy|transbronchial lung biopsy
108981|NCT02611284|Beractant|beractant
108982|NCT02611284|Feasibility Studies|feasibility studies
108983|NCT02611284|Infant, Premature|infant, premature
108984|NCT02611284|Noninvasive Ventilation|noninvasive ventilation
108985|NCT02611258|Left Ventricular Hypertrophy|left ventricular hypertrophy
108986|NCT02611258|Diastolic Dysfunction|diastolic dysfunction
108987|NCT02611258|Myocardial Fibrosis|myocardial fibrosis
108988|NCT02611258|Cushing's Syndrome|cushing's syndrome
108989|NCT02611245|Thoracic Duct|thoracic duct
108990|NCT02611245|Sentinel lymph node biopsy|sentinel lymph node biopsy
108991|NCT02611232|Diabetes Type 1|diabetes type 1
108992|NCT02611232|Diabetes, Insulin-Dependent|diabetes, insulin-dependent
108993|NCT02611232|Liraglutide|liraglutide
100103|NCT02662803|GAD|gad
108994|NCT02611232|Preclinical Type 1 Diabetes|preclinical type 1 diabetes
108995|NCT02611232|GLP-1 Analogue|glp-1 analogue
108996|NCT02611206|rTMS|rtms
643405|NCT00737997|Analgesia|analgesia
108997|NCT02611167|mesenchymal stem cells|mesenchymal stem cells
108998|NCT02611154|Healthy Volunteers|healthy volunteers
108999|NCT02611154|Sports Medicine|sports medicine
109000|NCT02611154|Men's Health|men's health
109001|NCT02611154|Athletes|athletes
109002|NCT02611154|Anti-Doping|anti-doping
109003|NCT02611141|Retromolar Intubation|retromolar intubation
109004|NCT02611115|Pulmonary Embolism|pulmonary embolism
109005|NCT02611115|Multidetector Computed Tomography|multidetector computed tomography
109006|NCT02611115|Radiation Dosage|radiation dosage
109007|NCT02611115|Contrast Media|contrast media
109008|NCT02611115|Individualized Medicine|individualized medicine
109009|NCT02611089|Muscle connective tissue|muscle connective tissue
109010|NCT02611089|Small leucine-rich proteoglycans|small leucine-rich proteoglycans
109011|NCT02611089|Limb development|limb development
109012|NCT02611076|smoking cessation|smoking cessation
109013|NCT02611076|self-help|self-help
109014|NCT02611076|Spanish language|spanish language
109015|NCT02611063|allogeneic stem cell transplant|allogeneic stem cell transplant
109016|NCT02611050|patient decision aid|patient decision aid
109017|NCT02611050|multi-vessel coronary artery disease|multi-vessel coronary artery disease
109019|NCT02611037|Unresectable|unresectable
109020|NCT02611037|Respiratory|respiratory
109021|NCT02611037|Intrathoracic|intrathoracic
109022|NCT02611037|Transarterial|transarterial
109023|NCT02611037|Chemoperfusion|chemoperfusion
109024|NCT02611024|lurbinectedin|lurbinectedin
109025|NCT02611024|PM01183|pm01183
109026|NCT02611024|tumors|tumors
109027|NCT02611024|cancer|cancer
109028|NCT02611024|Pharma Mar|pharma mar
109029|NCT02611011|Congo Red Dot Test|congo red dot test
109030|NCT02610985|Imaging, Three-Dimensional|imaging, three-dimensional
109031|NCT02610985|Hysterectomy|hysterectomy
109032|NCT02610985|laparoscopic hysterectomy|laparoscopic hysterectomy
109033|NCT02610972|Congo Red test GV-005|congo red test gv-005
109034|NCT02610946|pediatric|pediatric
109035|NCT02610946|adolescent|adolescent
109036|NCT02610946|compliance|compliance
109037|NCT02610933|vascular calcification|vascular calcification
109038|NCT02610933|hemodialysis|hemodialysis
109039|NCT02610933|rivaroxaban|rivaroxaban
109040|NCT02610933|vitamin K2|vitamin k2
109041|NCT02610894|postoperative symptom management|postoperative symptom management
109042|NCT02610894|symptom management|symptom management
109043|NCT02610894|mHealth application|mhealth application
109044|NCT02610868|Cerebral Palsy|cerebral palsy
109045|NCT02610868|ALS|als
109046|NCT02610868|Stroke|stroke
109047|NCT02610868|Neuroleptics|neuroleptics
109048|NCT02610803|stroke|stroke
109049|NCT02610803|ischemic stroke|ischemic stroke
109050|NCT02610803|recurrent stroke|recurrent stroke
109051|NCT02610803|atrial fibrillation|atrial fibrillation
109052|NCT02610803|premature atrial complexes|premature atrial complexes
109053|NCT02610803|heart rhythm monitoring|heart rhythm monitoring
109054|NCT02610803|cardiac telemetry|cardiac telemetry
109055|NCT02610790|connected bracelets, footsteps|connected bracelets, footsteps
109056|NCT02610777|Drug Therapy|drug therapy
109057|NCT02610764|Circulating Tumor Cells|circulating tumor cells
109058|NCT02610764|Response evaluation|response evaluation
109059|NCT02610751|Maternal Smoking|maternal smoking
109060|NCT02610751|Female Fetal Testosterone|female fetal testosterone
109061|NCT02610751|Anogenital Distance|anogenital distance
109062|NCT02610751|Maternal Testosterone|maternal testosterone
109063|NCT02610751|Maternal Cotinine|maternal cotinine
109064|NCT02610712|ketamine|ketamine
109065|NCT02610712|treatment-resistant|treatment-resistant
109066|NCT02610712|depression|depression
109067|NCT02610712|spectroscopy|spectroscopy
109068|NCT02610712|neuroinflammation|neuroinflammation
109069|NCT02610686|Plasmodium vivax|plasmodium vivax
109070|NCT02610686|recurrence|recurrence
109071|NCT02610686|drug resistance|drug resistance
109072|NCT02610634|Parkinson's disease|parkinson's disease
109073|NCT02610634|Older adults|older adults
109074|NCT02610634|Vision|vision
109075|NCT02610634|Cognition|cognition
109076|NCT02610634|Visual cues|visual cues
109077|NCT02610634|Eye-tracking|eye-tracking
109078|NCT02610634|Gait|gait
109079|NCT02610634|Saccades|saccades
109080|NCT02610634|Dual task|dual task
109081|NCT02610634|Visual sampling|visual sampling
109082|NCT02610621|Clinically node negative|clinically node negative
109083|NCT02610621|T1 and T2 invasive breast cancer|t1 and t2 invasive breast cancer
109288|NCT02609373|intervention|intervention
109085|NCT02610595|Jianpiyiqi Recipe|jianpiyiqi recipe
109086|NCT02610595|Huoxuejiedu Recipe|huoxuejiedu recipe
109087|NCT02610595|Effectiveness|effectiveness
109088|NCT02610595|Safety|safety
109089|NCT02610582|CNGA3-linked|cnga3-linked
109090|NCT02610569|Colonic capsule|colonic capsule
109091|NCT02610569|ulcerative colitis|ulcerative colitis
109092|NCT02610569|mucosal healing|mucosal healing
109093|NCT02610569|endoscopic score|endoscopic score
109094|NCT02610556|NPC|npc
109095|NCT02610556|concurrent chemotherapy|concurrent chemotherapy
109096|NCT02610556|docetaxel|docetaxel
109097|NCT02610556|cisplatin|cisplatin
109098|NCT02610543|Primary Sjögren's Syndrome|primary sjögren's syndrome
109099|NCT02610530|type 2 diabetes|type 2 diabetes
109100|NCT02610530|metabolic surgery|metabolic surgery
109101|NCT02610530|medical treatment|medical treatment
109102|NCT02610517|Hazardous alcohol use|hazardous alcohol use
109103|NCT02610517|Computer based intervention (CBI)|computer based intervention (cbi)
109104|NCT02610517|Pharmacotherapy|pharmacotherapy
109105|NCT02610504|degenerative arthritis|degenerative arthritis
109106|NCT02610478|HAI Testing|hai testing
109107|NCT02610478|Multi-Center Trial|multi-center trial
109108|NCT02610478|Oropharyngeal Swab|oropharyngeal swab
109109|NCT02610478|Standard of Care|standard of care
109110|NCT02610478|Viral Shedding|viral shedding
109111|NCT02610465|Computed Tomography|computed tomography
109112|NCT02610465|Image Reconstruction|image reconstruction
109113|NCT02610465|Iterative Reconstruction|iterative reconstruction
109114|NCT02610452|clown therapy|clown therapy
109116|NCT02610387|stroke|stroke
109117|NCT02610387|Spasticity|spasticity
109119|NCT02610348|Hepatitis B|hepatitis b
109120|NCT02610348|Hexaxim®|hexaxim®
109121|NCT02610348|Hexyon®|hexyon®
109122|NCT02610348|Hexacima®|hexacima®
109123|NCT02610348|Prevnar®|prevnar®
109124|NCT02610348|DTaP-IPV-HB-Hib hexavalent vaccine|dtap-ipv-hb-hib hexavalent vaccine
109125|NCT02610335|lumbar spinal stenosis|lumbar spinal stenosis
109126|NCT02610309|family-based crisis intervention|family-based crisis intervention
109127|NCT02610309|adolescent suicide|adolescent suicide
109128|NCT02610283|AKI|aki
109129|NCT02610270|Sport|sport
109130|NCT02610270|fatty acid|fatty acid
109131|NCT02610270|omega 3|omega 3
109132|NCT02610257|Parkinson's disease|parkinson's disease
109133|NCT02610257|Freezing of gait|freezing of gait
109134|NCT02610257|Motor blocks|motor blocks
109135|NCT02610257|Somatosensory|somatosensory
109136|NCT02610257|Proprioception|proprioception
109137|NCT02610257|Muscle vibration|muscle vibration
109138|NCT02610257|Handwriting|handwriting
109139|NCT02610231|Parkinson's disease|parkinson's disease
109140|NCT02610231|Moderate to Severe Parkinson's Disease|moderate to severe parkinson's disease
109141|NCT02610218|Cell free DNA|cell free dna
109142|NCT02610218|Circulating tumor cell|circulating tumor cell
109143|NCT02610218|Therapeutic efficacy|therapeutic efficacy
109144|NCT02610205|Caring touch|caring touch
109145|NCT02610205|Tactile massage|tactile massage
109146|NCT02610205|Healing touch|healing touch
109147|NCT02610192|Autologous Protein Solution|autologous protein solution
109148|NCT02610192|Patellofemoral Osteoarthritis|patellofemoral osteoarthritis
109149|NCT02610192|Female|female
109150|NCT02610114|Assisted reproductive technology (ART)|assisted reproductive technology (art)
109151|NCT02610114|zygotes|zygotes
109152|NCT02610114|Z-score (Zygote Score)|z-score (zygote score)
109153|NCT02610114|Infertility|infertility
109154|NCT02610088|Diabetes|diabetes
109155|NCT02610088|Atherosclerosis|atherosclerosis
109156|NCT02610088|Cardiovascular disease|cardiovascular disease
109157|NCT02610088|Endothelial dysfunction|endothelial dysfunction
109158|NCT02610088|Vascular function|vascular function
109159|NCT02610088|Dapagliflozin|dapagliflozin
109160|NCT02610088|Gliclazide|gliclazide
109161|NCT02610075|AZD1775|azd1775
109162|NCT02610075|Metastatic solid tumors|metastatic solid tumors
109163|NCT02610075|Ovarian cancer|ovarian cancer
109165|NCT02610062|Acute Myeloid Leukemia|acute myeloid leukemia
109166|NCT02610049|PTSD|ptsd
109167|NCT02610036|diabetes|diabetes
109168|NCT02610036|foot ulcer|foot ulcer
109169|NCT02610010|NPC|npc
109170|NCT02610010|concurrent chemotherapy|concurrent chemotherapy
109171|NCT02610010|IMRT|imrt
109172|NCT02610010|stage II|stage ii
109173|NCT02609997|Intraocular lens|intraocular lens
109174|NCT02609984|immunotherapy|immunotherapy
109175|NCT02609984|CMB305|cmb305
109176|NCT02609984|LV305|lv305
109177|NCT02609984|GLA-SE|gla-se
109178|NCT02609984|Atezolizumab|atezolizumab
109179|NCT02609984|NY-ESO-1|ny-eso-1
109180|NCT02609971|Anterior cruciate ligament|anterior cruciate ligament
109181|NCT02609971|Neuromuscular Performance and balance|neuromuscular performance and balance
109182|NCT02609945|Migraine attacks|migraine attacks
109183|NCT02609932|Interferon-gamma|interferon-gamma
109184|NCT02609932|innate immunity|innate immunity
109289|NCT02609373|occupational|occupational
109188|NCT02609906|AO 11-A3 fracture|ao 11-a3 fracture
109189|NCT02609906|MultiLoc|multiloc
109190|NCT02609906|Philos augmented|philos augmented
109191|NCT02609893|HCV|hcv
109192|NCT02609880|Psycho-Oncology|psycho-oncology
109193|NCT02609880|Psychoneuroimmunology|psychoneuroimmunology
109194|NCT02609880|Cognitive Behavioral Therapy|cognitive behavioral therapy
109195|NCT02609880|Gynecologic Cancer|gynecologic cancer
109196|NCT02609880|Insomnia|insomnia
109197|NCT02609880|Pain|pain
130194|NCT02483962|Chronic|chronic
109198|NCT02609880|Distress|distress
109199|NCT02609880|Cortisol|cortisol
109200|NCT02609880|Cytokines|cytokines
109201|NCT02609854|herniated disc|herniated disc
109202|NCT02609854|sustained acoustic medicine|sustained acoustic medicine
109203|NCT02609854|ultrasound|ultrasound
109204|NCT02609854|CLBP|clbp
109205|NCT02609828|Metastatic cancer bone pain|metastatic cancer bone pain
109206|NCT02609828|Multiple myeloma|multiple myeloma
109207|NCT02609789|Systemic Lupus Erythematosus|systemic lupus erythematosus
109208|NCT02609789|JNJ-55920839|jnj-55920839
109209|NCT02609789|Healthy Volunteers|healthy volunteers
109210|NCT02609789|CNTO 6358|cnto 6358
109211|NCT02609776|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
109212|NCT02609776|JNJ-61186372|jnj-61186372
109213|NCT02609776|First-in-Human|first-in-human
109214|NCT02609776|Human Bispecific Epidermal Growth Factor Receptor (EGFR)|human bispecific epidermal growth factor receptor (egfr)
109215|NCT02609776|cMet Antibody|cmet antibody
109216|NCT02609737|Radiolabeled Somatostatin Antagonists|radiolabeled somatostatin antagonists
109217|NCT02609737|68Ga-DOTA-JR11|68ga-dota-jr11
109218|NCT02609737|177Lu-DOTA-JR11|177lu-dota-jr11
109219|NCT02609737|Pet scan|pet scan
109220|NCT02609737|CT scan|ct scan
109221|NCT02609737|15-161|15-161
109222|NCT02609724|breast cancer|breast cancer
109223|NCT02609724|lymphedema|lymphedema
109224|NCT02609724|manual lymph drainage|manual lymph drainage
109225|NCT02609724|near infrared fluorescence imaging|near infrared fluorescence imaging
109226|NCT02609698|Stent|stent
109227|NCT02609698|Polymer-free|polymer-free
109228|NCT02609698|Antiplatelet therapy|antiplatelet therapy
109229|NCT02609698|Clopidogrel|clopidogrel
109230|NCT02609698|DES|des
109231|NCT02609698|DAPT|dapt
109232|NCT02609685|Thyroid cancer|thyroid cancer
109233|NCT02609685|Active surveillance|active surveillance
109234|NCT02609685|PTMC|ptmc
109235|NCT02609672|Exercise|exercise
109236|NCT02609672|Resilience|resilience
109237|NCT02609659|Chronic Hepatitis C Infection|chronic hepatitis c infection
109238|NCT02609646|Anti-Infective Agents|anti-infective agents
109239|NCT02609646|Pharmacokinetics|pharmacokinetics
109240|NCT02609646|Critically ill patients|critically ill patients
109241|NCT02609594|human amniotic membrane|human amniotic membrane
109242|NCT02609594|compression therapy|compression therapy
109243|NCT02609594|venous leg ulcer|venous leg ulcer
109244|NCT02609581|Non Interventional Study|non interventional study
109245|NCT02609581|NIS|nis
109246|NCT02609581|sublingual immunotherapy|sublingual immunotherapy
109247|NCT02609581|allergen|allergen
109248|NCT02609581|Mites|mites
109249|NCT02609568|Children|children
109250|NCT02609568|Head injury|head injury
109251|NCT02609568|Salivary biomarker|salivary biomarker
109252|NCT02609568|Trauma Brain Injury|trauma brain injury
109253|NCT02609555|TEM|tem
109254|NCT02609555|Rectopexy|rectopexy
109255|NCT02609555|rectal prolapse|rectal prolapse
109256|NCT02609542|oral language|oral language
109257|NCT02609542|STOL|stol
109258|NCT02609542|memory|memory
109259|NCT02609542|eye tracking|eye tracking
109260|NCT02609529|Irritable Bowel Syndrome|irritable bowel syndrome
109261|NCT02609529|Pediatrics|pediatrics
109262|NCT02609529|Nutrition|nutrition
109263|NCT02609516|Multimorbidity|multimorbidity
109264|NCT02609516|Health inequalities|health inequalities
109265|NCT02609516|Ageing|ageing
109266|NCT02609516|Mortality|mortality
109267|NCT02609477|Recreational stimulant users|recreational stimulant users
109268|NCT02609477|Recreational Drug Users|recreational drug users
109273|NCT02609438|worksite|worksite
109274|NCT02609438|intervention|intervention
109275|NCT02609438|sitting|sitting
109276|NCT02609399|Influenza|influenza
109277|NCT02609399|Antiviral treatment|antiviral treatment
109278|NCT02609399|Emergency department|emergency department
109279|NCT02609399|Influenza therapeutics|influenza therapeutics
109280|NCT02609399|Rapid influenza testing|rapid influenza testing
109281|NCT02609386|Head and Neck Neoplasms|head and neck neoplasms
109282|NCT02609386|Immunotherapy|immunotherapy
109283|NCT02609386|Cancer|cancer
109284|NCT02609386|Oral Cavity|oral cavity
109285|NCT02609373|shiftwork|shiftwork
109286|NCT02609373|sleep hygiene|sleep hygiene
109287|NCT02609373|prevention|prevention
109290|NCT02609373|biological|biological
109291|NCT02609373|breast cancer|breast cancer
109292|NCT02609373|lifestyle|lifestyle
109293|NCT02609360|Acute Respiratory Failure|acute respiratory failure
109294|NCT02609360|ARDS|ards
109295|NCT02609360|ECMO|ecmo
109296|NCT02609360|Lung transplantation|lung transplantation
109297|NCT02609360|Acid-Base Equilibrium|acid-base equilibrium
109298|NCT02609347|Manual Therapy|manual therapy
109299|NCT02609347|Ankle Fracture|ankle fracture
109300|NCT02609347|Hindfoot Fracture|hindfoot fracture
109301|NCT02609321|Paravertebral|paravertebral
109302|NCT02609321|Single injection|single injection
109303|NCT02609321|Breast surgery|breast surgery
109304|NCT02609321|Analgesia|analgesia
100416|NCT02661113|Brain|brain
109305|NCT02609308|ankle sprain|ankle sprain
109306|NCT02609308|platelet-rich plasma|platelet-rich plasma
109307|NCT02609308|ankle injuries|ankle injuries
109308|NCT02609295|α-linolenic acid|α-linolenic acid
109309|NCT02609295|perilla oil|perilla oil
109310|NCT02609295|aPTT|aptt
109311|NCT02609295|Collagen-epinephrine closure time|collagen-epinephrine closure time
109312|NCT02609295|Lp-PLA2|lp-pla2
109313|NCT02609282|Sedentary behaviour|sedentary behaviour
109314|NCT02609282|sitting|sitting
109315|NCT02609282|workplace|workplace
109316|NCT02609282|prompts|prompts
109317|NCT02609256|Intracranial hypertension|intracranial hypertension
109318|NCT02609256|cerebral herniation|cerebral herniation
109319|NCT02609256|Stereotactic infarct tissue aspiration|stereotactic infarct tissue aspiration
109320|NCT02609256|fatality|fatality
109321|NCT02609256|disability|disability
109322|NCT02609243|prediabetes|prediabetes
109323|NCT02609243|diabetes mellitus type 2|diabetes mellitus type 2
109324|NCT02609243|obesity|obesity
109325|NCT02609243|NAFLD|nafld
109326|NCT02609243|dyslipoproteinemia|dyslipoproteinemia
109327|NCT02609217|elective|elective
109328|NCT02609217|cesarean|cesarean
109329|NCT02609178|artificial crown|artificial crown
109330|NCT02609178|biomorphic|biomorphic
109331|NCT02609178|functional generated path|functional generated path
109332|NCT02609178|muscle-action theory|muscle-action theory
109333|NCT02609178|anatomic theory|anatomic theory
109334|NCT02609126|osteoarthritis|osteoarthritis
109335|NCT02609126|knee|knee
109336|NCT02609113|Carpal Tunnel Syndrome|carpal tunnel syndrome
109337|NCT02609074|bone substitute|bone substitute
109338|NCT02609074|CPC|cpc
109339|NCT02609074|rhBMP-2|rhbmp-2
109340|NCT02609048|PBC|pbc
109341|NCT02609022|Myasthenia Gravis|myasthenia gravis
109342|NCT02609022|CV-MG01 therapeutic vaccine|cv-mg01 therapeutic vaccine
109343|NCT02609022|Acetylcholine receptor mimetic peptides|acetylcholine receptor mimetic peptides
109344|NCT02609022|Safety|safety
109345|NCT02609022|Immunogenic response|immunogenic response
109346|NCT02609022|First-in-Human|first-in-human
109347|NCT02609022|Proof-of-Concept|proof-of-concept
109348|NCT02609022|Myasterix|myasterix
109349|NCT02609009|Back Pain|back pain
109350|NCT02609009|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
109351|NCT02609009|Spinal Manipulation|spinal manipulation
109352|NCT02608983|Seaweed|seaweed
109353|NCT02608983|Hydrocolloid|hydrocolloid
109354|NCT02608983|Functional Food|functional food
109355|NCT02608983|Dietary Fibre|dietary fibre
109356|NCT02608983|Prebiotic|prebiotic
754176|NCT01176617|Pulmonary Vein isolation|pulmonary vein isolation
109357|NCT02608983|Low molecular weight polysaccharides|low molecular weight polysaccharides
109358|NCT02608983|Alginate|alginate
109359|NCT02608983|Agar|agar
109360|NCT02608983|HYFFI|hyffi
109361|NCT02608983|Low molecular weight seaweed derived hydrocolloids as functional food ingredients|low molecular weight seaweed derived hydrocolloids as functional food ingredients
109362|NCT02608983|subjects|subjects
109363|NCT02608931|delta-9-tetrahydrocannabinol (THC)|delta-9-tetrahydrocannabinol (thc)
109364|NCT02608892|Breastfeeding|breastfeeding
109365|NCT02608892|Skin to skin care|skin to skin care
109366|NCT02608892|Sucrose|sucrose
109367|NCT02608892|Newborn screening|newborn screening
109368|NCT02608892|Blood test|blood test
109369|NCT02608892|Neonate|neonate
109370|NCT02608892|Infant|infant
109371|NCT02608892|Knowledge translation|knowledge translation
109372|NCT02608879|proinflammatory cytokines|proinflammatory cytokines
109373|NCT02608879|microbiome|microbiome
109374|NCT02608879|radiation therapy|radiation therapy
109375|NCT02608866|stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
109376|NCT02608866|spine metastasis|spine metastasis
109377|NCT02608840|slow-wave sleep|slow-wave sleep
109378|NCT02608840|cognition|cognition
109379|NCT02608840|auditory stimulation|auditory stimulation
109380|NCT02608827|Hypertension; slow breathing; sympathetic nerve activity|hypertension; slow breathing; sympathetic nerve activity
109381|NCT02608788|postoperative sore throat|postoperative sore throat
109382|NCT02608788|American Society of Anesthesiologists status|american society of anesthesiologists status
109383|NCT02608788|general anesthesia|general anesthesia
109384|NCT02608788|post-anesthesia care unit(PACU)|post-anesthesia care unit(pacu)
109385|NCT02608775|ANI|ani
109386|NCT02608775|SPI|spi
109387|NCT02608775|Autonomic balance|autonomic balance
109388|NCT02608775|Nociception measurement|nociception measurement
109389|NCT02608762|Pediatric brain tumors|pediatric brain tumors
109390|NCT02608762|Radiation therapy|radiation therapy
109391|NCT02608762|Neurobehavioral functions|neurobehavioral functions
109392|NCT02608762|Proton radiotherapy|proton radiotherapy
109393|NCT02608749|Osteoporosis|osteoporosis
109394|NCT02608749|Fall|fall
109395|NCT02608749|Fracture|fracture
109396|NCT02608749|Sacopenia|sacopenia
109397|NCT02608749|Body Composition|body composition
109398|NCT02608736|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
109399|NCT02608736|histone deacetylases|histone deacetylases
109400|NCT02608736|valproic acid|valproic acid
109401|NCT02608736|acetylation|acetylation
109402|NCT02608736|chemoprevention|chemoprevention
109403|NCT02608736|DNA methyltransferase|dna methyltransferase
109404|NCT02608736|methylation|methylation
109405|NCT02608723|shock wave|shock wave
109406|NCT02608723|plantar fasciitis|plantar fasciitis
109407|NCT02608723|placebo effect|placebo effect
109408|NCT02608723|nocebo effect|nocebo effect
109409|NCT02608684|immunotherapy, platinum-resistant ovarian cancer, immune checkpoint inhibitors|immunotherapy, platinum-resistant ovarian cancer, immune checkpoint inhibitors
109410|NCT02608671|Episiotomy|episiotomy
109411|NCT02608671|continuous suture|continuous suture
109412|NCT02608671|Skin adhesive tape|skin adhesive tape
109413|NCT02608658|Cirrhosis|cirrhosis
109414|NCT02608658|Ascites|ascites
109415|NCT02608658|SBP|sbp
109416|NCT02608632|Renal denervation|renal denervation
109417|NCT02608632|Ablation|ablation
109418|NCT02608619|18F-fluorocholine|18f-fluorocholine
109419|NCT02608619|Pet imaging|pet imaging
109420|NCT02608619|Biopsy|biopsy
109421|NCT02608619|15-268|15-268
109422|NCT02608580|pediatric hospital care|pediatric hospital care
109423|NCT02608580|adult hospital care|adult hospital care
109424|NCT02608580|sickle cell disease|sickle cell disease
109425|NCT02608554|Polycystic ovary sybdrome|polycystic ovary sybdrome
109426|NCT02608554|Taichi|taichi
109427|NCT02608541|Multiple Rib Fractures, Frail Chest|multiple rib fractures, frail chest
109428|NCT02608476|acne|acne
109429|NCT02608463|neuropathic pain|neuropathic pain
109430|NCT02608463|pregnancy|pregnancy
109431|NCT02608450|acne|acne
109432|NCT02608437|melanoma|melanoma
109433|NCT02608437|ipilimumab|ipilimumab
109434|NCT02608437|SGI-110|sgi-110
109435|NCT02608424|Foot mechanical stimulation|foot mechanical stimulation
109436|NCT02608424|Autonomic nervous system|autonomic nervous system
109437|NCT02608424|Inflammation|inflammation
109438|NCT02608424|Parkinson's disease|parkinson's disease
109439|NCT02608424|Spectral analysis|spectral analysis
109440|NCT02608424|Heart rate variability|heart rate variability
109441|NCT02608424|Blood pressure variability|blood pressure variability
109442|NCT02608398|obesity|obesity
109443|NCT02608398|weight-loss|weight-loss
109444|NCT02608398|metabonomics|metabonomics
109445|NCT02608398|gut microbiome|gut microbiome
109446|NCT02608372|Seaweed|seaweed
109447|NCT02608372|Insulin|insulin
109448|NCT02608372|Glucose tolerance|glucose tolerance
109449|NCT02608372|C-peptide|c-peptide
109450|NCT02608372|Appetide|appetide
109451|NCT02608372|Metabolomics|metabolomics
109452|NCT02608359|Post-Marketing Surveillance|post-marketing surveillance
109453|NCT02608359|Abiraterone Acetate|abiraterone acetate
109454|NCT02608359|Zytiga|zytiga
109455|NCT02608346|Circulating tumor DNA|circulating tumor dna
109456|NCT02608346|BRCA1 mutation|brca1 mutation
109457|NCT02608346|Circulating tumor cells|circulating tumor cells
109458|NCT02608333|Early intervention|early intervention
109459|NCT02608333|ESDM|esdm
109460|NCT02608333|behavioral and developmental intervention|behavioral and developmental intervention
109461|NCT02608320|Healthy|healthy
109462|NCT02608320|JNJ-35685-AAA-G016|jnj-35685-aaa-g016
109463|NCT02608320|JNJ-35685-AAA-G021|jnj-35685-aaa-g021
109464|NCT02608320|DURAGESIC|duragesic
109465|NCT02608320|Fentanyl|fentanyl
109466|NCT02608307|Treatment Decision-Making|treatment decision-making
109467|NCT02608307|Adolescents and Young Adult Oncology|adolescents and young adult oncology
109468|NCT02608294|stroke|stroke
109469|NCT02608294|gait|gait
109470|NCT02608294|balance|balance
109471|NCT02608281|Spectral Mammography|spectral mammography
109472|NCT02608281|Dual energy|dual energy
109473|NCT02608281|Contrast enhanced|contrast enhanced
109474|NCT02608268|Solid tumors|solid tumors
109475|NCT02608268|Melanoma|melanoma
109476|NCT02608268|Non small cell lung cancer|non small cell lung cancer
109477|NCT02608268|NSCLC|nsclc
109478|NCT02608268|Renal cell carcinoma|renal cell carcinoma
109479|NCT02608268|RCC|rcc
109480|NCT02608268|Phase I-Ib/II|phase i-ib/ii
109481|NCT02608268|MBG453|mbg453
109482|NCT02608268|PDR001|pdr001
109483|NCT02608268|Checkpoint inhibitor|checkpoint inhibitor
109484|NCT02608268|PD-1|pd-1
109485|NCT02608268|TIM-3|tim-3
109486|NCT02608164|Healthy adults|healthy adults
109487|NCT02608151|neurodevelopement|neurodevelopement
109488|NCT02608151|Very preterm infant|very preterm infant
109489|NCT02608138|iodine|iodine
109490|NCT02608138|urine|urine
109491|NCT02608138|children|children
109492|NCT02608138|schools|schools
109493|NCT02608138|cognitive performance|cognitive performance
109494|NCT02608138|salt fortification|salt fortification
109495|NCT02608125|FGFR|fgfr
109496|NCT02608099|Atrial fibrillation|atrial fibrillation
109497|NCT02608099|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
109498|NCT02608099|Catheter ablation|catheter ablation
109499|NCT02608099|Apixaban|apixaban
109500|NCT02608099|Warfarin|warfarin
402914|NCT01229163|Counseling Adherance|counseling adherance
130604|NCT02481427|Total|total
109501|NCT02608099|Harvard Clinical Research Institute|harvard clinical research institute
109502|NCT02608086|PTSD|ptsd
109503|NCT02608086|Trauma|trauma
109504|NCT02608086|Emergency|emergency
109505|NCT02608086|RCT|rct
109506|NCT02608086|Psychological First Aid|psychological first aid
109507|NCT02608021|Alzheimer's Disease|alzheimer's disease
109508|NCT02608021|MRI|mri
109509|NCT02608008|3D-Ultrasound|3d-ultrasound
109510|NCT02608008|Live X-rays|live x-rays
109511|NCT02608008|EchoNavigator System|echonavigator system
109512|NCT02607982|Esophageal cancer|esophageal cancer
109513|NCT02607982|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
109514|NCT02607982|Oxaliplatin|oxaliplatin
109515|NCT02607982|Paclitaxel|paclitaxel
109516|NCT02607982|Survival|survival
109517|NCT02607982|Toxicity|toxicity
109518|NCT02607969|Deformational Plagiocephaly,Treatment,Compliance|deformational plagiocephaly,treatment,compliance
109520|NCT02607943|acute stroke|acute stroke
109521|NCT02607943|hyperglycemia|hyperglycemia
109522|NCT02607943|regular insulin|regular insulin
109523|NCT02607943|long-acting insulin|long-acting insulin
109524|NCT02607930|HIV|hiv
109525|NCT02607917|Cardiovascular Disease|cardiovascular disease
109526|NCT02607904|Cannabidiol|cannabidiol
109527|NCT02607904|GWP42003-P|gwp42003-p
109528|NCT02607904|Epidiolex|epidiolex
109529|NCT02607904|Stiripentol|stiripentol
109530|NCT02607904|Valproate|valproate
109531|NCT02607891|Cannabidiol|cannabidiol
109532|NCT02607891|GWP42003-P|gwp42003-p
109533|NCT02607891|Epidiolex|epidiolex
109534|NCT02607891|Stiripentol|stiripentol
109535|NCT02607891|Valproate|valproate
109536|NCT02607878|Cardiac arrest|cardiac arrest
109537|NCT02607878|Coma|coma
109538|NCT02607878|Prognosis|prognosis
109539|NCT02607878|Automated pupillometry|automated pupillometry
109540|NCT02607878|EEG|eeg
109541|NCT02607878|Evoked potentials|evoked potentials
109542|NCT02607878|Targeted Temperature Management (TTM)|targeted temperature management (ttm)
109543|NCT02607852|Patient Reported Outcomes Measure|patient reported outcomes measure
109544|NCT02607852|Burns|burns
109545|NCT02607839|lipid handling by the gut and liver|lipid handling by the gut and liver
109546|NCT02607813|LXH254, CRAF, MAPK, solid tumor, PDR001|lxh254, craf, mapk, solid tumor, pdr001
109547|NCT02607800|Chronic Hepatitis C Infection|chronic hepatitis c infection
109548|NCT02607787|Exercise Rehabilitation|exercise rehabilitation
109549|NCT02607774|Plaque psoriasis|plaque psoriasis
109550|NCT02607774|disease-drug-drug-interaction|disease-drug-drug-interaction
109551|NCT02607774|midazolam|midazolam
109552|NCT02607774|secukinumab|secukinumab
109553|NCT02607761|infertility|infertility
109554|NCT02607761|fertility awareness|fertility awareness
109555|NCT02607761|health interventions|health interventions
109556|NCT02607761|young adults|young adults
109557|NCT02607748|18F-NaF PET|18f-naf pet
109558|NCT02607748|18F-sodium fluoride PET|18f-sodium fluoride pet
754177|NCT01176617|Ablation|ablation
109565|NCT02607644|Laryngeal Masks|laryngeal masks
109566|NCT02607644|Laryngeal Tube|laryngeal tube
109567|NCT02607644|airway management|airway management
109568|NCT02607631|Thymic epithelial tumors|thymic epithelial tumors
109569|NCT02607631|Pembrolizumab|pembrolizumab
109570|NCT02607605|lung cancer|lung cancer
109571|NCT02607605|leptomeningeal metastases|leptomeningeal metastases
109572|NCT02607605|cell-free DNA|cell-free dna
109573|NCT02607592|Non-Small-Cell Lung cancer|non-small-cell lung cancer
109574|NCT02607592|overall toxicity value|overall toxicity value
109575|NCT02607566|Diabetes|diabetes
109576|NCT02607566|Yoga|yoga
109577|NCT02607566|Walking|walking
109578|NCT02607566|Stress|stress
109579|NCT02607540|Chemoradiotherapy|chemoradiotherapy
109580|NCT02607540|Esophageal Squamous Cancer|esophageal squamous cancer
109581|NCT02607540|Cisplatin-5-fluorouracil|cisplatin-5-fluorouracil
109582|NCT02607501|coil embolization|coil embolization
109583|NCT02607501|bifurcation|bifurcation
109584|NCT02607488|Obese patients|obese patients
109585|NCT02607488|Undergoing bariatric surgery|undergoing bariatric surgery
109586|NCT02607475|telesonography|telesonography
109587|NCT02607475|ultrasound|ultrasound
109588|NCT02607475|robotic telesonography|robotic telesonography
109589|NCT02607449|MDR TB|mdr tb
109590|NCT02607449|Tuberculosis|tuberculosis
109591|NCT02607410|Type 2 diabetes|type 2 diabetes
109592|NCT02607410|sitagliptin|sitagliptin
109593|NCT02607410|NPH insulin|nph insulin
109594|NCT02607410|GLP-1|glp-1
109595|NCT02607371|Patient treatment preference|patient treatment preference
109987|NCT02604888|Baldness|baldness
109601|NCT02607358|antiplatelet therapy|antiplatelet therapy
109603|NCT02607358|VerifyNow|verifynow
109604|NCT02607332|single-center|single-center
109605|NCT02607332|prospective|prospective
109606|NCT02607332|single-arm|single-arm
109607|NCT02607332|open-label|open-label
109608|NCT02607332|phase II|phase ii
109609|NCT02607319|Recurrent Implantation Failure|recurrent implantation failure
109610|NCT02607319|Implantation|implantation
100713|NCT02659605|delayed cord clamping|delayed cord clamping
100714|NCT02659605|skin to skin|skin to skin
100715|NCT02659592|fertility preservation|fertility preservation
100720|NCT02659579|Shared Book Reading|shared book reading
109611|NCT02607319|low molecular weight heparin|low molecular weight heparin
109612|NCT02607319|In vitro Fertilization|in vitro fertilization
109613|NCT02607319|Assisted Reproductive Technology|assisted reproductive technology
109614|NCT02607319|Pregnancy|pregnancy
109615|NCT02607293|Polycystic Ovary Syndrome|polycystic ovary syndrome
109616|NCT02607293|Gonadotropin releasing hormone agonist (GnRH-a)|gonadotropin releasing hormone agonist (gnrh-a)
109617|NCT02607293|Gonal-f|gonal-f
109618|NCT02607293|Assisted Reproductive Technology|assisted reproductive technology
109619|NCT02607280|Diabetic peripheral neuropathic pain|diabetic peripheral neuropathic pain
109620|NCT02607280|post-herpetic neuralgia|post-herpetic neuralgia
109621|NCT02607280|renal impairment|renal impairment
109622|NCT02607267|EOSS|eoss
109623|NCT02607267|Metabolic Surgery|metabolic surgery
109624|NCT02607267|postoperative outcome|postoperative outcome
109625|NCT02607267|30 - day mortality|30 - day mortality
109626|NCT02607241|drug-coated balloon|drug-coated balloon
109627|NCT02607241|bioresorbable scaffold|bioresorbable scaffold
109628|NCT02607241|fractional flow reserve|fractional flow reserve
109629|NCT02607241|optical coherence tomography|optical coherence tomography
109630|NCT02607150|Spinal Fusion|spinal fusion
109631|NCT02607150|Cerebral Oxygenation|cerebral oxygenation
109632|NCT02607150|Blood Transfusion|blood transfusion
109633|NCT02607124|DIPG|dipg
109634|NCT02607111|Dalteparin|dalteparin
109635|NCT02607111|Dosage|dosage
109636|NCT02607111|Home Hemodialysis|home hemodialysis
109637|NCT02607072|APREMEC, aspirin, colorectal cancer, adjuvant therapy, recurrence, metastasis, survival|apremec, aspirin, colorectal cancer, adjuvant therapy, recurrence, metastasis, survival
109638|NCT02607046|rehabilitation|rehabilitation
109639|NCT02607046|exercise training|exercise training
109643|NCT02607007|Dairy|dairy
109644|NCT02607007|Post-prandial Glycemia|post-prandial glycemia
109645|NCT02607007|Satiety|satiety
109646|NCT02607007|Food Intake|food intake
109647|NCT02607007|Insulin|insulin
109648|NCT02607007|Milk|milk
109649|NCT02607007|Greek yogurt|greek yogurt
109650|NCT02607007|Cheese|cheese
109651|NCT02607007|Soy beverage|soy beverage
109655|NCT02606981|Water treatment|water treatment
109656|NCT02606981|Child growth|child growth
109657|NCT02606981|Enteric infection|enteric infection
109658|NCT02606955|Bioimpedance|bioimpedance
109659|NCT02606955|Dry weight|dry weight
109660|NCT02606955|Hemodialysis|hemodialysis
109661|NCT02606955|Resistance|resistance
109662|NCT02606942|chondromalacia patellae (CMP)|chondromalacia patellae (cmp)
109663|NCT02606942|patella|patella
109664|NCT02606916|Once-daily Simultaneous Modulated Accelerated Radiotherapy|once-daily simultaneous modulated accelerated radiotherapy
109665|NCT02606916|S-1|s-1
109666|NCT02606916|DDP|ddp
109667|NCT02606916|elderly patients|elderly patients
109668|NCT02606890|Magnetic Resonance Imaging|magnetic resonance imaging
109669|NCT02606890|Stroke Lesion Pattern|stroke lesion pattern
109670|NCT02606890|Atrial Fibrillation|atrial fibrillation
109671|NCT02606890|Stroke|stroke
109672|NCT02606851|Proton Pump Inhibitor, GERD, GERD Q|proton pump inhibitor, gerd, gerd q
109673|NCT02606799|Esophagectomy Inflammation Hemoperfusion Cytokines|esophagectomy inflammation hemoperfusion cytokines
109674|NCT02606786|stabilization exercises|stabilization exercises
109675|NCT02606773|vitamin C supplementation|vitamin c supplementation
109676|NCT02606760|Nail psoriasis|nail psoriasis
109677|NCT02606747|DPN|dpn
109678|NCT02606747|fall|fall
109679|NCT02606747|fMRI|fmri
109680|NCT02606747|balance|balance
109681|NCT02606721|Food Hypersensitivity|food hypersensitivity
109682|NCT02606721|Oral Food Challenge|oral food challenge
109683|NCT02606721|Skin Prick Test|skin prick test
109684|NCT02606721|Food Biomarkers|food biomarkers
109685|NCT02606695|Spine Surgery Patients|spine surgery patients
109686|NCT02606682|Phase 1|phase 1
109687|NCT02606682|Safety|safety
109688|NCT02606682|Tolerability|tolerability
109689|NCT02606682|Pharmacokinetics|pharmacokinetics
109690|NCT02606682|Parkinson's Disease|parkinson's disease
109691|NCT02606630|Relapsing multiple sclerosis|relapsing multiple sclerosis
109692|NCT02606617|Mosapride|mosapride
109693|NCT02606617|blood glucose|blood glucose
109694|NCT02606617|serum lipid|serum lipid
109695|NCT02606604|Functional Electrical Stimulation|functional electrical stimulation
109696|NCT02606604|Cycling|cycling
109697|NCT02606591|Electroencephalograph|electroencephalograph
109698|NCT02606591|EEG|eeg
109699|NCT02606591|Hair sample|hair sample
109700|NCT02606591|Cognitive tests|cognitive tests
109701|NCT02606591|Cortisol analysis|cortisol analysis
109702|NCT02606591|Brain activity|brain activity
109703|NCT02606591|Stress hormones|stress hormones
109704|NCT02606552|drug eluting stent|drug eluting stent
109705|NCT02606552|atrial appendage closure|atrial appendage closure
109706|NCT02606539|gestaional trophoblastic neoplasm|gestaional trophoblastic neoplasm
109707|NCT02606539|hystrectomy|hystrectomy
109708|NCT02606539|chemotherapy|chemotherapy
109709|NCT02606539|methotrxate|methotrxate
109710|NCT02606513|Computed Tomography Urography|computed tomography urography
109711|NCT02606513|Magnetic Resonance Urography|magnetic resonance urography
109712|NCT02606487|CF|cf
109713|NCT02606487|Exacerbation|exacerbation
109714|NCT02606487|Hyerpolarized xenon MRI|hyerpolarized xenon mri
109715|NCT02606487|Pediatrics|pediatrics
643406|NCT00738010|NMES|nmes
109716|NCT02606487|Lung Clearance Index|lung clearance index
109717|NCT02606461|Advanced unresectable dedifferentiated liposarcoma|advanced unresectable dedifferentiated liposarcoma
109718|NCT02606461|selinexor|selinexor
109719|NCT02606461|KCP-330|kcp-330
109720|NCT02606461|Karyopharm|karyopharm
109721|NCT02606461|Phase 2 / 3|phase 2 / 3
109722|NCT02606461|dedifferentiated liposarcoma|dedifferentiated liposarcoma
109723|NCT02606461|liposarcoma|liposarcoma
109724|NCT02606448|pain control|pain control
109725|NCT02606448|patient satisfaction|patient satisfaction
109726|NCT02606448|liposomal bupivacaine|liposomal bupivacaine
109727|NCT02606448|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
109728|NCT02606422|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
109729|NCT02606422|neurodegeneration|neurodegeneration
109730|NCT02606422|language therapy|language therapy
109731|NCT02606422|Primary Progressive Aphasia (PPA)|primary progressive aphasia (ppa)
109732|NCT02606370|Unstable Shoes;Trunk muscles;Lumbar lordosis;Low Back Pain|unstable shoes;trunk muscles;lumbar lordosis;low back pain
109733|NCT02606318|Occupational Therapy|occupational therapy
109734|NCT02606318|Quality of Life|quality of life
109735|NCT02606305|Epithelial ovarian cancer|epithelial ovarian cancer
109736|NCT02606305|Fallopian tube cancer|fallopian tube cancer
109737|NCT02606305|Primary peritoneal cancer|primary peritoneal cancer
109738|NCT02606305|Endometrial cancer|endometrial cancer
109739|NCT02606305|IMGN853|imgn853
109740|NCT02606305|ADC|adc
109741|NCT02606305|Antibody drug conjugate|antibody drug conjugate
109742|NCT02606305|ImmunoGen|immunogen
109743|NCT02606305|Antibody|antibody
109744|NCT02606305|Phase 1|phase 1
109745|NCT02606305|Folate receptor alpha|folate receptor alpha
109746|NCT02606253|loop diuretics|loop diuretics
109747|NCT02606253|thiazide diuretics|thiazide diuretics
109748|NCT02606253|vasopressin antagonists|vasopressin antagonists
109749|NCT02606253|diuretic resistance|diuretic resistance
109750|NCT02606253|heart failure|heart failure
109751|NCT02606227|Pregnant smokers|pregnant smokers
109752|NCT02606227|smoking cessation|smoking cessation
109753|NCT02606227|financial incentives|financial incentives
109754|NCT02606227|control group|control group
109755|NCT02606227|randomized study|randomized study
109756|NCT02606214|Tuberculosis|tuberculosis
109757|NCT02606214|TBA-354|tba-354
109758|NCT02606214|Pulmonary Tuberculosis|pulmonary tuberculosis
109759|NCT02606214|TB|tb
109760|NCT02606201|stress urinary incontinence|stress urinary incontinence
109761|NCT02606201|intrinsic sphincter deficiency|intrinsic sphincter deficiency
109762|NCT02606201|myofiber|myofiber
109763|NCT02606201|autologous|autologous
109764|NCT02606201|skeletal muscle precursor cells|skeletal muscle precursor cells
109765|NCT02606201|autologous serum|autologous serum
109766|NCT02606188|Modified High-flow nasal cannula|modified high-flow nasal cannula
109767|NCT02606188|Bronchoscopy|bronchoscopy
109768|NCT02606188|Oxygen therapy|oxygen therapy
109769|NCT02606175|health literacy|health literacy
109770|NCT02606175|patient medication knowledge|patient medication knowledge
109771|NCT02606175|kidney transplantation|kidney transplantation
109772|NCT02606175|medication adherence|medication adherence
109773|NCT02606175|kidney transplant|kidney transplant
109774|NCT02606175|renal transplantation|renal transplantation
109775|NCT02606149|Lung cancer|lung cancer
109776|NCT02606149|chemotherapy outcome|chemotherapy outcome
109777|NCT02606149|ethics|ethics
109778|NCT02606149|information|information
109779|NCT02606136|Duchenne|duchenne
109780|NCT02606136|muscular|muscular
109781|NCT02606136|dystrophy|dystrophy
109782|NCT02606136|DMD|dmd
109783|NCT02606136|non-ambulatory|non-ambulatory
109784|NCT02606123|Prostate Cancer|prostate cancer
109785|NCT02606123|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
109786|NCT02606110|ReBuilder|rebuilder
109787|NCT02606110|breast cancer|breast cancer
109788|NCT02606110|chemotherapy induced|chemotherapy induced
109789|NCT02606084|Renal Impairment|renal impairment
109790|NCT02606084|Healthy|healthy
109791|NCT02606084|Esketamine|esketamine
109792|NCT02606071|cardiac resynchronization therapy|cardiac resynchronization therapy
109793|NCT02606071|multipoint left ventricular pacing|multipoint left ventricular pacing
109794|NCT02606045|menorrhagia|menorrhagia
109795|NCT02606045|VWD|vwd
109796|NCT02606032|Fecal Microbiota Transplant|fecal microbiota transplant
109797|NCT02606032|Antibiotics|antibiotics
109798|NCT02606019|Pentraxin 3|pentraxin 3
109799|NCT02606019|Vascular Endothelial Growth Factor|vascular endothelial growth factor
109800|NCT02606019|dengue|dengue
109801|NCT02606006|Physical Therapy Modalities|physical therapy modalities
109802|NCT02606006|Motivation|motivation
109803|NCT02606006|Patient Participation|patient participation
109804|NCT02606006|Animal Assisted Therapy|animal assisted therapy
109805|NCT02605993|complement inhibitor|complement inhibitor
109806|NCT02605967|PDR001,|pdr001,
109807|NCT02605967|nasopharyngeal cancer,|nasopharyngeal cancer,
109808|NCT02605967|moderately differentiated/undifferentiated,|moderately differentiated/undifferentiated,
109809|NCT02605967|locally advanced,|locally advanced,
109810|NCT02605967|recurrent or metastatic NPC,|recurrent or metastatic npc,
109811|NCT02605967|after first- line platinum-based therapy|after first- line platinum-based therapy
109812|NCT02605954|HIV 1 Infection|hiv 1 infection
109814|NCT02605954|Virologically-Suppressed|virologically-suppressed
109815|NCT02605954|Antiretroviral agents|antiretroviral agents
109816|NCT02605941|DNA methylation|dna methylation
109817|NCT02605941|Cervical cancer|cervical cancer
109818|NCT02605928|Arthritis|arthritis
109819|NCT02605928|Bioimpedance|bioimpedance
109820|NCT02605928|Glucocorticoid|glucocorticoid
109821|NCT02605928|Intra-articular injection|intra-articular injection
109822|NCT02605928|Needle Guidance|needle guidance
109823|NCT02605902|Chronic tic disorders|chronic tic disorders
109824|NCT02605902|Tourette syndrome|tourette syndrome
109825|NCT02605876|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
109826|NCT02605863|Enzalutamide|enzalutamide
109827|NCT02605863|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
109828|NCT02605863|Androgen Deprivation Therapy|androgen deprivation therapy
109829|NCT02605850|heart health|heart health
109830|NCT02605811|limited small cell lung cancer|limited small cell lung cancer
109831|NCT02605811|brain metastases|brain metastases
109832|NCT02605811|prophylactic cranial radiotherapy|prophylactic cranial radiotherapy
109833|NCT02605811|temozolomide|temozolomide
109834|NCT02605785|PSP|psp
109835|NCT02605733|Premature infant|premature infant
109836|NCT02605733|Amplitude integrated EEG|amplitude integrated eeg
109837|NCT02605733|Near-infrared spectroscopy|near-infrared spectroscopy
109838|NCT02605707|Endothelial Progenitor Cells|endothelial progenitor cells
109839|NCT02605707|Transplantation|transplantation
109840|NCT02605707|Stroke|stroke
109841|NCT02605681|midkine|midkine
109842|NCT02605681|endothelial injury|endothelial injury
109843|NCT02605681|sepsis|sepsis
109844|NCT02605668|Anxiety Disorders|anxiety disorders
109845|NCT02605668|Extinction Learning|extinction learning
109846|NCT02605668|Optimized Extinction|optimized extinction
109847|NCT02605668|Behavioral Therapy|behavioral therapy
109848|NCT02605668|Massed Confrontation|massed confrontation
109849|NCT02605668|Social Anxiety Disorder|social anxiety disorder
109850|NCT02605668|Specific Phobia|specific phobia
109851|NCT02605668|Panic Disorder|panic disorder
109852|NCT02605668|Agoraphobia|agoraphobia
109853|NCT02605655|obesity|obesity
109854|NCT02605655|hyperlipidemia|hyperlipidemia
109855|NCT02605655|hyperglycemia|hyperglycemia
109856|NCT02605642|Inflectra|inflectra
109857|NCT02605642|Infliximab|infliximab
109858|NCT02605642|Observational|observational
109859|NCT02605642|Remicade|remicade
109860|NCT02605603|Gaucher Type 1, Gaucher Type 2, Gaucher Type 3|gaucher type 1, gaucher type 2, gaucher type 3
109861|NCT02605577|late preterm infants|late preterm infants
109862|NCT02605577|nutrition|nutrition
109863|NCT02605577|systemic management|systemic management
109864|NCT02605525|IgAN|igan
109865|NCT02605512|Radiotherapy|radiotherapy
109866|NCT02605512|Echocardiography|echocardiography
109867|NCT02605512|Strain strain rate|strain strain rate
109868|NCT02605512|Coronary computed tomography angiography|coronary computed tomography angiography
109869|NCT02605512|Segments of coronary arteries|segments of coronary arteries
109870|NCT02605512|Subclinical functional and anatomical cardiac lesions|subclinical functional and anatomical cardiac lesions
109871|NCT02605512|Biomarkers|biomarkers
109872|NCT02605512|Heart dosimetry|heart dosimetry
109873|NCT02605486|palbociclib|palbociclib
109874|NCT02605486|bicalutamide|bicalutamide
109875|NCT02605486|AR(+)|ar(+)
109876|NCT02605486|15-207|15-207
109877|NCT02605473|Melanoma|melanoma
109878|NCT02605473|Malignant melanoma|malignant melanoma
109879|NCT02605473|Unresectable|unresectable
109880|NCT02605473|Decitabine|decitabine
109881|NCT02605473|PEG Interferon Alpha-2b|peg interferon alpha-2b
109882|NCT02605473|PEG Intron|peg intron
109883|NCT02605473|5-Aza-Deoxycytidine|5-aza-deoxycytidine
109884|NCT02605473|Dacogen|dacogen
109885|NCT02605460|Bone Marrow Transplantation|bone marrow transplantation
109886|NCT02605460|Conditioning Regimen|conditioning regimen
109887|NCT02605434|Parkinson's Disease|parkinson's disease
109888|NCT02605434|Fluctuating Parkinson's Disease|fluctuating parkinson's disease
109889|NCT02605434|Advanced Parkinson's Disease|advanced parkinson's disease
109890|NCT02605434|Carbidopa|carbidopa
109891|NCT02605434|Levodopa|levodopa
109892|NCT02605434|Accordion|accordion
109893|NCT02605434|Accordance|accordance
109894|NCT02605421|High-risk neuroblastoma|high-risk neuroblastoma
109895|NCT02605421|Neuroblastoma|neuroblastoma
109896|NCT02605421|Myeloablative chemotherapy|myeloablative chemotherapy
109897|NCT02605421|Myeloablative consolidation chemotherapy|myeloablative consolidation chemotherapy
109898|NCT02605421|Autologous peripheral blood stem cell rescue|autologous peripheral blood stem cell rescue
109899|NCT02605421|PBSC|pbsc
109900|NCT02605421|Autologous stem cell rescue|autologous stem cell rescue
109901|NCT02605395|Bioequivalence|bioequivalence
109902|NCT02605395|Fed condition|fed condition
109903|NCT02605395|PARIET 20 mg|pariet 20 mg
109906|NCT02605382|Dental Implantation|dental implantation
109907|NCT02605382|Chlorhexidine gluconate|chlorhexidine gluconate
109908|NCT02605356|Radium-223 dichloride|radium-223 dichloride
109910|NCT02605356|dexamethasone|dexamethasone
109911|NCT02605356|early relapsed multiple myeloma|early relapsed multiple myeloma
109912|NCT02605356|combination therapy multiple myeloma|combination therapy multiple myeloma
109913|NCT02605343|PGx|pgx
109914|NCT02605343|pharmacogenetic testing|pharmacogenetic testing
109915|NCT02605343|Pain Management|pain management
109916|NCT02605343|AltheaDx|altheadx
109917|NCT02605343|Post-Operative Pain Management|post-operative pain management
109918|NCT02605317|Emergency Physicians|emergency physicians
109919|NCT02605317|Consulting Physicians|consulting physicians
109920|NCT02605317|WhatsApp|whatsapp
109921|NCT02605278|Primary Health Care, Patient Education, Care Managament|primary health care, patient education, care managament
109922|NCT02605265|Neoadjuvant Chemoradiation|neoadjuvant chemoradiation
109923|NCT02605265|Irinotecan|irinotecan
109924|NCT02605265|UGT1A1|ugt1a1
109925|NCT02605252|Chronic hepatitis B|chronic hepatitis b
109926|NCT02605252|Peginterferon alfa-2b|peginterferon alfa-2b
109927|NCT02605252|Nucleotide analogue|nucleotide analogue
109928|NCT02605200|Diabetes|diabetes
109929|NCT02605200|Endocrinology|endocrinology
109930|NCT02605200|Pediatrics|pediatrics
109931|NCT02605187|cesarean|cesarean
109932|NCT02605187|postoperative pain|postoperative pain
109933|NCT02605187|patient choice|patient choice
109934|NCT02605161|Blood brain barrier|blood brain barrier
109935|NCT02605161|movement disorder|movement disorder
109936|NCT02605161|deep brain stimulation|deep brain stimulation
109937|NCT02605161|essential tremor|essential tremor
109938|NCT02605161|cervical dystonia|cervical dystonia
109939|NCT02605161|magnetic resonance imaging|magnetic resonance imaging
109940|NCT02605161|neostriatum|neostriatum
109941|NCT02605148|Islet autoimmunity|islet autoimmunity
109942|NCT02605148|gluten free diet|gluten free diet
109943|NCT02605148|prediabetes|prediabetes
109944|NCT02605148|prevention|prevention
109945|NCT02605148|type 1 diabetes|type 1 diabetes
109946|NCT02605148|glucose tolerance test|glucose tolerance test
109950|NCT02605109|MERS-CoV|mers-cov
109951|NCT02605109|Infection control|infection control
109952|NCT02605109|Case-control studies|case-control studies
109953|NCT02605096|suspected scaphoid fracture|suspected scaphoid fracture
109954|NCT02605083|Cancer|cancer
109955|NCT02605083|Neoplasm|neoplasm
109956|NCT02605083|Solid Tumor|solid tumor
109957|NCT02605083|Breast|breast
109958|NCT02605083|Head and Neck|head and neck
109962|NCT02605083|Melanoma|melanoma
109963|NCT02605083|Colon|colon
109964|NCT02605083|Renal|renal
109965|NCT02605083|Thyroid|thyroid
109966|NCT02605083|Prostate|prostate
109967|NCT02605083|Ovarian|ovarian
109968|NCT02605083|MNK1|mnk1
109969|NCT02605083|MNK2|mnk2
109970|NCT02605083|eIF4E|eif4e
109971|NCT02605005|interscalene block, general anesthesia, shoulder arthroscopy, cerebral oxygen saturation, beach chair position|interscalene block, general anesthesia, shoulder arthroscopy, cerebral oxygen saturation, beach chair position
109972|NCT02604992|Comparative Bioavailability|comparative bioavailability
109973|NCT02604966|P. falciparum|p. falciparum
109974|NCT02604966|resistance to artemisinin|resistance to artemisinin
109975|NCT02604966|Central Vietnam|central vietnam
109976|NCT02604953|glaucoma|glaucoma
109978|NCT02604953|PERG|perg
109979|NCT02604953|SD-tVEP|sd-tvep
109980|NCT02604953|ss-PERG|ss-perg
109981|NCT02604940|Postoperative narcotic requirements|postoperative narcotic requirements
109982|NCT02604940|Dexmedetomidine|dexmedetomidine
109983|NCT02604940|Bariatric Surgery|bariatric surgery
109984|NCT02604901|medication adherence|medication adherence
109985|NCT02604901|community pharmacies|community pharmacies
109986|NCT02604901|screening and brief intervention|screening and brief intervention
109988|NCT02604888|Alopecia Areata|alopecia areata
109989|NCT02604888|Alopecia|alopecia
109990|NCT02604888|Hair loss|hair loss
109991|NCT02604784|Pressurized Intra Peritoneal Air-flow Chemotherapy (PIPAC)|pressurized intra peritoneal air-flow chemotherapy (pipac)
109992|NCT02604784|Chemotherapy|chemotherapy
109993|NCT02604784|Peritoneal Carcinomatosis|peritoneal carcinomatosis
109994|NCT02604758|Alcoholics [M01.066]|alcoholics [m01.066]
109995|NCT02604745|degenerative mitral regurgitation|degenerative mitral regurgitation
109996|NCT02604667|Biomarkers|biomarkers
109997|NCT02604667|Mechanisms|mechanisms
109998|NCT02604667|Transcranial Doppler|transcranial doppler
131294|NCT02477332|CSU|csu
109999|NCT02604641|skin rejuvenation|skin rejuvenation
110000|NCT02604641|anti-ageing effects|anti-ageing effects
110001|NCT02604641|minimal erythema dose|minimal erythema dose
110002|NCT02604641|dermis structure|dermis structure
110003|NCT02604641|physiological skin condition|physiological skin condition
110004|NCT02604641|wrinkling|wrinkling
110005|NCT02604641|dry skin|dry skin
110006|NCT02604628|Pneumonia|pneumonia
110007|NCT02604628|Antibiotic Stewardship|antibiotic stewardship
110008|NCT02604628|Stepped wedge|stepped wedge
110009|NCT02604628|Antibiotic|antibiotic
110010|NCT02604615|Chemoradiotherapy|chemoradiotherapy
110011|NCT02604615|Esophageal Squamous Cancer|esophageal squamous cancer
110012|NCT02604615|Capecitabine and oxaliplatin|capecitabine and oxaliplatin
110013|NCT02604615|Chinese|chinese
110014|NCT02604615|Randomized Controlled Trials|randomized controlled trials
110016|NCT02604589|Catheters, Indwelling|catheters, indwelling
110017|NCT02604589|Infusion Pumps|infusion pumps
110018|NCT02604589|Anesthesia, Local|anesthesia, local
110019|NCT02604589|Analgesia, Patient-Controlled|analgesia, patient-controlled
110020|NCT02604589|Bupivacaine|bupivacaine
110021|NCT02604576|functional dyspepsia|functional dyspepsia
110022|NCT02604524|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
110023|NCT02604524|Artificial Pancreas (AP)|artificial pancreas (ap)
110024|NCT02604524|Sensor-Augmented Pump (SAP) Therapy|sensor-augmented pump (sap) therapy
110025|NCT02604524|Closed Loop Control|closed loop control
110026|NCT02604524|Insulin Pump|insulin pump
110027|NCT02604524|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
110028|NCT02604511|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
110029|NCT02604485|Hypoglycemia|hypoglycemia
110030|NCT02604485|Congenital Hyperinsulinism|congenital hyperinsulinism
110031|NCT02604472|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
110032|NCT02604472|induction chemotherapy|induction chemotherapy
110033|NCT02604472|concurrent chemoradiotherapy|concurrent chemoradiotherapy
110034|NCT02604446|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
110035|NCT02604446|Analgesics|analgesics
110036|NCT02604446|Administration and dosage|administration and dosage
110037|NCT02604446|Knee|knee
110038|NCT02604446|Postoperational care|postoperational care
110039|NCT02604446|Pain management|pain management
110040|NCT02604433|ACE-536|ace-536
110041|NCT02604433|Safety|safety
110042|NCT02604433|Efficacy|efficacy
110043|NCT02604433|Placebo|placebo
110044|NCT02604433|Red Blood Cell Transfusions|red blood cell transfusions
110045|NCT02604433|Beta -Thalassemia|beta -thalassemia
110046|NCT02604394|Rheolytic Thrombectomy|rheolytic thrombectomy
110047|NCT02604394|Percutaneous Coronary Intervention|percutaneous coronary intervention
110048|NCT02604394|Angioplasty|angioplasty
110049|NCT02604394|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
110050|NCT02604394|Myocardial Salvage Index|myocardial salvage index
110051|NCT02604394|STEMI, ST elevation Myocardial Infarction|stemi, st elevation myocardial infarction
111000|NCT02599064|NVAMD|nvamd
110052|NCT02604394|Corrected TIMI Frame Count, cTFC|corrected timi frame count, ctfc
110053|NCT02604394|Index of microcirculatory resistance, thermodilution, IMR|index of microcirculatory resistance, thermodilution, imr
110054|NCT02604381|Osteoarthritis|osteoarthritis
110056|NCT02604381|Glucosamine Sulfate|glucosamine sulfate
110057|NCT02604381|Ginkgo Biloba|ginkgo biloba
110058|NCT02604381|WOMAC|womac
110059|NCT02604381|Joint Health Wellness|joint health wellness
110060|NCT02604381|Interleukin-1-beta|interleukin-1-beta
110061|NCT02604368|hemoglobin SS|hemoglobin ss
110062|NCT02604368|hemoglobin SC|hemoglobin sc
110063|NCT02604368|hemoglobin S/β°-thalassemia|hemoglobin s/β°-thalassemia
110064|NCT02604329|low level laser therapy|low level laser therapy
110065|NCT02604329|oral mucositis|oral mucositis
110066|NCT02604329|child|child
110067|NCT02604316|Overweight and Obesity|overweight and obesity
110068|NCT02604316|Appetite|appetite
110069|NCT02604316|Gut hormones and obesity|gut hormones and obesity
110070|NCT02604316|Arabinoxylan, Beta-Glucan|arabinoxylan, beta-glucan
110071|NCT02604316|SmartPill|smartpill
110072|NCT02604303|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
110073|NCT02604303|RhoA|rhoa
110074|NCT02604303|Biomarker|biomarker
110075|NCT02604290|Kinesio taping|kinesio taping
110076|NCT02604290|Neuromuscular taping|neuromuscular taping
110077|NCT02604290|Targeted treatment|targeted treatment
110078|NCT02604290|Chronic low back pain|chronic low back pain
110079|NCT02604290|Randomised controlled trial|randomised controlled trial
110080|NCT02604277|Psychology|psychology
110694|NCT02600871|Antiseptic|antiseptic
110081|NCT02604238|Pulmonary Embolism at intermediate risk|pulmonary embolism at intermediate risk
110082|NCT02604225|Anaethesiology|anaethesiology
110083|NCT02604186|Spasticity|spasticity
110084|NCT02604186|Botulinum Toxin|botulinum toxin
110085|NCT02604186|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
110086|NCT02604134|silver nitrate|silver nitrate
110087|NCT02604134|children|children
110088|NCT02604134|dental caries|dental caries
110089|NCT02604134|medical management|medical management
110090|NCT02604134|quality of life|quality of life
110091|NCT02604121|oral cavity|oral cavity
110092|NCT02604121|cancerous and precancerous lesions|cancerous and precancerous lesions
110093|NCT02604108|physical activity|physical activity
110094|NCT02604108|healthy diet|healthy diet
110095|NCT02604095|Acanthosis nigricans|acanthosis nigricans
110096|NCT02604095|Obesity|obesity
110097|NCT02604069|Breast reconstruction|breast reconstruction
110098|NCT02604069|Breast cancer|breast cancer
110099|NCT02604069|Microsurgery|microsurgery
110100|NCT02604069|Continuous flap monitor|continuous flap monitor
110101|NCT02604043|supraglottic pH|supraglottic ph
110102|NCT02604017|HCV GT1|hcv gt1
110103|NCT02604017|Non-cirrhotic|non-cirrhotic
110104|NCT02604017|RBV Free|rbv free
110105|NCT02604017|Without cirrhosis|without cirrhosis
110106|NCT02604017|Chronic Hepatitis C|chronic hepatitis c
110107|NCT02604017|Hepatitis C Genotype 1 (GT1)|hepatitis c genotype 1 (gt1)
110108|NCT02604017|IFN free|ifn free
110109|NCT02604017|Hepatitis C|hepatitis c
110110|NCT02604017|Ribavirin Free|ribavirin free
110111|NCT02604017|Interferon (IFN) Free|interferon (ifn) free
110112|NCT02604017|HCV|hcv
110113|NCT02604017|Hepatitis C virus|hepatitis c virus
110114|NCT02604017|DAA|daa
110115|NCT02604004|lamivudine|lamivudine
110116|NCT02604004|bioequivalence test|bioequivalence test
110117|NCT02604004|pharmacokinetics|pharmacokinetics
110118|NCT02604004|high-performance liquid chromatography|high-performance liquid chromatography
110119|NCT02604004|3TC|3tc
110120|NCT02604004|LC-MS/MS|lc-ms/ms
110121|NCT02604004|mass spectrometry|mass spectrometry
110122|NCT02603991|children and adolescents|children and adolescents
110123|NCT02603991|Prospective cohort study|prospective cohort study
110124|NCT02603991|vagus nerve stimulation|vagus nerve stimulation
110125|NCT02603991|PINS|pins
110126|NCT02603952|Influenza|influenza
110127|NCT02603952|Influenza A|influenza a
110128|NCT02603952|Flu|flu
110129|NCT02603952|Flu A|flu a
110130|NCT02603939|Pain|pain
110131|NCT02603939|Magnetic resonance imaging|magnetic resonance imaging
110132|NCT02603913|Pre-eclampsia|pre-eclampsia
110133|NCT02603913|Pregnancy induced hypertension|pregnancy induced hypertension
110134|NCT02603913|Preterm birth|preterm birth
110135|NCT02603913|Intra-uterine growth restriction|intra-uterine growth restriction
110136|NCT02603913|Oxidative stress|oxidative stress
110137|NCT02603900|Adductor Canal Catheter|adductor canal catheter
110138|NCT02603900|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
110139|NCT02603900|Local infiltration of analgesia|local infiltration of analgesia
110140|NCT02603887|Smoldering Multiple Myeloma|smoldering multiple myeloma
110141|NCT02603887|SMM|smm
110142|NCT02603887|Intermediate or high-risk|intermediate or high-risk
110143|NCT02603887|Pembrolizumab|pembrolizumab
110144|NCT02603887|Keytruda|keytruda
110145|NCT02603887|MK-3475|mk-3475
110146|NCT02603887|SCH-900475|sch-900475
110147|NCT02603874|Fluoroscopy|fluoroscopy
110148|NCT02603874|Spinal Fusion|spinal fusion
110149|NCT02603874|Wrong Level Surgery|wrong level surgery
110150|NCT02603848|Inguinal surgery|inguinal surgery
110151|NCT02603848|Hernia Repair|hernia repair
110152|NCT02603848|Orchidopexy|orchidopexy
110153|NCT02603848|Hydrocele|hydrocele
110154|NCT02603848|Pediatric|pediatric
110155|NCT02603848|Post-operative pain|post-operative pain
110156|NCT02603848|Morphine sulfate|morphine sulfate
110157|NCT02603848|Ibuprofen|ibuprofen
110158|NCT02603835|SSO2 Therapy|sso2 therapy
110159|NCT02603835|Acute myocardial infarction|acute myocardial infarction
110160|NCT02603835|Anterior myocardial infarction|anterior myocardial infarction
110161|NCT02603835|SuperSaturated oxygen delivery|supersaturated oxygen delivery
110162|NCT02603835|Left main coronary artery|left main coronary artery
110163|NCT02603835|Myocardial infarction|myocardial infarction
110164|NCT02603835|Heart attack|heart attack
110165|NCT02603835|Percutaneous coronary intervention|percutaneous coronary intervention
110166|NCT02603835|Cardiac catheterization laboratory|cardiac catheterization laboratory
110167|NCT02603835|PCI|pci
110168|NCT02603835|Stent|stent
110169|NCT02603835|Stenting|stenting
110170|NCT02603835|Stents|stents
110171|NCT02603835|Angioplasty|angioplasty
110172|NCT02603835|LMCA|lmca
110173|NCT02603835|Delivery of supersaturated oxygen (SSO2) therapy for the treatment of anterior acute myocardial infarction|delivery of supersaturated oxygen (sso2) therapy for the treatment of anterior acute myocardial infarction
110174|NCT02603796|3-Dimensional|3-dimensional
110175|NCT02603796|continuous positive airway pressure|continuous positive airway pressure
110176|NCT02603796|nasal changes|nasal changes
110177|NCT02603757|Vitamin D|vitamin d
110281|NCT02603172|systemic amyloidosis|systemic amyloidosis
110282|NCT02603172|CPHPC|cphpc
110178|NCT02603744|Premature ovarian failure adipose derived stromal cells intraovarian injection|premature ovarian failure adipose derived stromal cells intraovarian injection
110179|NCT02603718|Stroke|stroke
110180|NCT02603718|On-line EEG|on-line eeg
110181|NCT02603718|BEI index|bei index
110182|NCT02603718|Attention|attention
110183|NCT02603718|Rehabilitation|rehabilitation
110184|NCT02603705|chronic pain|chronic pain
110185|NCT02603705|opioid|opioid
110186|NCT02603705|oxycodone|oxycodone
110187|NCT02603705|non cancer pain|non cancer pain
110188|NCT02603705|moderate to severe|moderate to severe
643407|NCT00738010|ACL|acl
110189|NCT02603692|Newly diagnosed brain tumor|newly diagnosed brain tumor
110190|NCT02603692|Progressive brain tumor|progressive brain tumor
110191|NCT02603692|PROMIS|promis
110192|NCT02603692|Quality of life|quality of life
110193|NCT02603679|Cyclin-Dependent Kinase Inhibitor p16|cyclin-dependent kinase inhibitor p16
110194|NCT02603666|cystic fibrosis|cystic fibrosis
110195|NCT02603666|elastography|elastography
110196|NCT02603666|liver biopsy|liver biopsy
110197|NCT02603614|Chronic Heart Failure|chronic heart failure
110198|NCT02603614|Renal Insufficiency|renal insufficiency
110199|NCT02603614|Natriuretic Peptides|natriuretic peptides
110200|NCT02603614|Cenderitide|cenderitide
110201|NCT02603601|Randomized controlled trial|randomized controlled trial
110202|NCT02603601|Mindfulness|mindfulness
110203|NCT02603601|Obesity|obesity
110204|NCT02603588|Acupuncture|acupuncture
110205|NCT02603588|Sphenopalatine ganglion|sphenopalatine ganglion
110206|NCT02603588|Nasal ventilation|nasal ventilation
110207|NCT02603588|Neuropeptides|neuropeptides
110208|NCT02603575|Caspofungin|caspofungin
110209|NCT02603575|corticosteroids|corticosteroids
110210|NCT02603575|Pneumocystis Pneumonia|pneumocystis pneumonia
110211|NCT02603575|Immunocompromised|immunocompromised
110212|NCT02603575|Non-HIV|non-hiv
110213|NCT02603575|respiratory failure|respiratory failure
110214|NCT02603562|FSHD|fshd
110215|NCT02603536|Text Messaging|text messaging
110216|NCT02603536|Harm Reduction|harm reduction
110217|NCT02603523|accidental falls|accidental falls
110218|NCT02603523|older people|older people
110219|NCT02603523|dance|dance
110220|NCT02603523|randomized controlled trial|randomized controlled trial
110221|NCT02603497|ASP015K|asp015k
110222|NCT02603497|impaired renal function|impaired renal function
110223|NCT02603497|Pharmacokinetics|pharmacokinetics
110224|NCT02603471|HIV+|hiv+
110225|NCT02603471|Alcohol dependence|alcohol dependence
110226|NCT02603471|Mobile Technology|mobile technology
110227|NCT02603458|Schizophrenia|schizophrenia
110228|NCT02603458|Naurex|naurex
110229|NCT02603458|Intravenous Treatment|intravenous treatment
110230|NCT02603458|NRX-1074|nrx-1074
110231|NCT02603445|BCL201|bcl201
110232|NCT02603445|idelalisib|idelalisib
110233|NCT02603445|Follicular lymphoma|follicular lymphoma
110235|NCT02603445|mantle cell lymphoma|mantle cell lymphoma
110236|NCT02603445|MCL|mcl
110237|NCT02603432|Bladder cancer|bladder cancer
110238|NCT02603432|Urologic neoplasms|urologic neoplasms
110239|NCT02603432|urothelial carcinoma|urothelial carcinoma
110240|NCT02603432|PD-L1|pd-l1
110241|NCT02603432|programmed cell death protein|programmed cell death protein
110242|NCT02603432|maintenance treatment|maintenance treatment
110243|NCT02603419|classical Hodgkins Lymphoma (relapsed/refractory)|classical hodgkins lymphoma (relapsed/refractory)
110244|NCT02603419|anti PD-L1|anti pd-l1
110245|NCT02603419|Phase 1|phase 1
110246|NCT02603419|PK|pk
110247|NCT02603419|Receptor occupancy|receptor occupancy
110253|NCT02603380|qualitative|qualitative
110254|NCT02603328|Cerebral cavernous malformation|cerebral cavernous malformation
110255|NCT02603328|Statins|statins
110256|NCT02603328|MRI|mri
110257|NCT02603328|Permeability|permeability
110258|NCT02603328|Quantitative susceptibility mapping|quantitative susceptibility mapping
110259|NCT02603302|rectal cancer|rectal cancer
110260|NCT02603302|radiotherapy|radiotherapy
110261|NCT02603302|escalated dose|escalated dose
110262|NCT02603302|interval|interval
110263|NCT02603276|hypercholesterolemia|hypercholesterolemia
110264|NCT02603276|dietary supplements|dietary supplements
110265|NCT02603276|red yeast rice|red yeast rice
110266|NCT02603276|plant sterols|plant sterols
110267|NCT02603263|social norms|social norms
110268|NCT02603263|healthy eating|healthy eating
110269|NCT02603263|vegetables|vegetables
110270|NCT02603263|field study|field study
110271|NCT02603250|Anemia|anemia
110272|NCT02603250|Iron deficiency|iron deficiency
110273|NCT02603250|noninvasive anemia screening|noninvasive anemia screening
110274|NCT02603211|breast cancer|breast cancer
110275|NCT02603198|third molar|third molar
110276|NCT02603198|tooth extraction|tooth extraction
110277|NCT02603198|impacted tooth|impacted tooth
110278|NCT02603185|Phase 1, Healthy subjects|phase 1, healthy subjects
110279|NCT02603172|GSK3039294|gsk3039294
110280|NCT02603172|GSK2315698|gsk2315698
110283|NCT02603172|dose-escalation|dose-escalation
110284|NCT02603159|Chemoradiotherapy|chemoradiotherapy
110285|NCT02603159|Esophageal Squamous Cancer|esophageal squamous cancer
110286|NCT02603159|Capecitabine|capecitabine
110287|NCT02603146|RA prevention|ra prevention
110288|NCT02603146|hydroxychloroquine (HCQ)|hydroxychloroquine (hcq)
110289|NCT02603146|anti-CCP|anti-ccp
110290|NCT02603133|healthcare|healthcare
110291|NCT02603133|burnout|burnout
110292|NCT02603133|resilience|resilience
110293|NCT02603133|fatigue|fatigue
110294|NCT02603133|NICU|nicu
110295|NCT02603133|safety culture|safety culture
110296|NCT02603133|quality of care|quality of care
110297|NCT02603081|Meniere's|meniere's
110298|NCT02603081|hearing loss|hearing loss
110299|NCT02603081|vertigo|vertigo
110300|NCT02603081|tinnitus|tinnitus
110301|NCT02603081|ebselen|ebselen
110302|NCT02603055|Safety|safety
110303|NCT02603055|immunogenicity|immunogenicity
110304|NCT02603055|Hepatitis E|hepatitis e
110305|NCT02603029|skin rejuvenation|skin rejuvenation
110306|NCT02603029|anti-ageing effects|anti-ageing effects
110307|NCT02603029|minimal erythema dose|minimal erythema dose
110308|NCT02603029|dermis structure|dermis structure
110309|NCT02603029|physiological skin condition|physiological skin condition
110310|NCT02603029|wrinkling|wrinkling
110311|NCT02603016|Clinical Nutrition|clinical nutrition
110312|NCT02603003|Circulating tumor cells(CTCs)|circulating tumor cells(ctcs)
110313|NCT02603003|Traditional Chinese Medicine(TCM)|traditional chinese medicine(tcm)
110314|NCT02603003|Myeloid-derived suppressor cells(MDSCs)|myeloid-derived suppressor cells(mdscs)
110315|NCT02602990|Cerebral|cerebral
110316|NCT02602990|Arteriovenous|arteriovenous
110317|NCT02602990|Malformation|malformation
110318|NCT02602990|Embolization|embolization
110319|NCT02602990|Endovascular|endovascular
110320|NCT02602977|inflammation|inflammation
110321|NCT02602977|remote ischemic preconditioning|remote ischemic preconditioning
110322|NCT02602938|aspirin|aspirin
110323|NCT02602938|circulating tumor cells|circulating tumor cells
110324|NCT02602938|metastatic breast cancer|metastatic breast cancer
110325|NCT02602938|metastatic colorectal cancer|metastatic colorectal cancer
110326|NCT02602899|PINS|pins
110327|NCT02602899|Deep Brain Stimulator|deep brain stimulator
110328|NCT02602899|Refractory Epilepsy|refractory epilepsy
110329|NCT02602899|Anterior Thalamic Nucleus|anterior thalamic nucleus
110330|NCT02602860|SV2A|sv2a
110331|NCT02602860|Levetiracetam|levetiracetam
110332|NCT02602860|Brivaracetam|brivaracetam
110333|NCT02602860|PET|pet
110334|NCT02602847|Liver transplantation|liver transplantation
110335|NCT02602847|HBV|hbv
110336|NCT02602847|cccDNA|cccdna
110337|NCT02602834|exercise test|exercise test
110338|NCT02602834|biological markers|biological markers
110339|NCT02602808|acute pancreatitis|acute pancreatitis
110340|NCT02602808|non-coding RNA|non-coding rna
110341|NCT02602808|biological markers|biological markers
110342|NCT02602808|receiver operating characteristic curve|receiver operating characteristic curve
110343|NCT02602795|Opiate Dependence|opiate dependence
110344|NCT02602795|Sexually Transmitted Diseases|sexually transmitted diseases
110345|NCT02602795|HIV|hiv
110346|NCT02602795|Extended release naltrexone|extended release naltrexone
110348|NCT02602743|sedation|sedation
110349|NCT02602743|remifentanyl|remifentanyl
110350|NCT02602743|pediatric patient|pediatric patient
110351|NCT02602743|colonoscopy|colonoscopy
110352|NCT02602730|Cigarette smoking|cigarette smoking
110353|NCT02602730|Smoking, Tobacco|smoking, tobacco
110354|NCT02602730|postpartum|postpartum
110355|NCT02602730|internet|internet
110356|NCT02602730|interactive|interactive
110357|NCT02602730|coach|coach
110358|NCT02602717|follicular origin|follicular origin
110359|NCT02602691|Heart transplantation|heart transplantation
110360|NCT02602691|AlloMap® gene expression profiling test|allomap® gene expression profiling test
110361|NCT02602691|Medico-economic study|medico-economic study
110362|NCT02602678|Children.|children.
110363|NCT02602678|prone position|prone position
110364|NCT02602678|acute viral bronchiolitis|acute viral bronchiolitis
110365|NCT02602678|syncytial virus|syncytial virus
110366|NCT02602678|work of breathing|work of breathing
110367|NCT02602678|intrinsic PEEP|intrinsic peep
110368|NCT02602665|catheter placement|catheter placement
110369|NCT02602652|geometric mean titer|geometric mean titer
110370|NCT02602652|seroprotection|seroprotection
110371|NCT02602652|live attenuated chimeric JE vaccine|live attenuated chimeric je vaccine
110372|NCT02602652|JE-CV|je-cv
110373|NCT02602652|SA14-14-2 vaccine|sa14-14-2 vaccine
110374|NCT02602626|Human Papillomavirus|human papillomavirus
110375|NCT02602626|HPV|hpv
110376|NCT02602626|Postpartum|postpartum
110377|NCT02602587|acute myeloid leukemia|acute myeloid leukemia
110378|NCT02602587|Dendrogenin A|dendrogenin a
110379|NCT02602587|5,6-cholesterol epoxide|5,6-cholesterol epoxide
110380|NCT02602587|6-oxo-cholestane-3beta|6-oxo-cholestane-3beta
110381|NCT02602587|5alpha-diol|5alpha-diol
110382|NCT02602587|cholesterol epoxide hydrolase|cholesterol epoxide hydrolase
110383|NCT02602587|oxysterols|oxysterols
110384|NCT02602574|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
110385|NCT02602574|Pancreatitis|pancreatitis
110386|NCT02602574|Heat-Shock Proteins|heat-shock proteins
110387|NCT02602574|Pentraxin 3 protein|pentraxin 3 protein
110388|NCT02602574|C-Reactive Protein|c-reactive protein
110389|NCT02602574|procalcitonin|procalcitonin
110390|NCT02602574|Interleukin-1 beta|interleukin-1 beta
644333|NCT00752544|HCV|hcv
110391|NCT02602574|Leukocytes, Mononuclear|leukocytes, mononuclear
110392|NCT02602574|Killer Cells, Natural|killer cells, natural
131752|NCT02474680|MDD|mdd
110393|NCT02602574|natural-killer group 2, member D receptor|natural-killer group 2, member d receptor
110395|NCT02602561|beta-hydroxy-beta-methylbutyrate|beta-hydroxy-beta-methylbutyrate
110396|NCT02602561|ACL|acl
110397|NCT02602561|surgery|surgery
110398|NCT02602561|muscle mass|muscle mass
110399|NCT02602548|Propionibacterium acnes|propionibacterium acnes
110400|NCT02602548|shoulder surgery|shoulder surgery
110401|NCT02602548|infection|infection
110402|NCT02602496|Diet|diet
110403|NCT02602496|Whole grain|whole grain
110404|NCT02602496|Fruits|fruits
110405|NCT02602496|Vegetables|vegetables
110406|NCT02602496|Gut health|gut health
110407|NCT02602496|Anti-inflammatory|anti-inflammatory
110408|NCT02602483|temporomandibular|temporomandibular
110409|NCT02602483|joint|joint
110410|NCT02602483|pain|pain
110411|NCT02602483|ibuprofen|ibuprofen
110412|NCT02602483|magnesium|magnesium
110413|NCT02602483|vitamin C|vitamin c
110414|NCT02602457|Atrial Fibrillation|atrial fibrillation
110415|NCT02602444|ticagrelor|ticagrelor
110416|NCT02602444|STEMI|stemi
110417|NCT02602444|NSTEMI|nstemi
110418|NCT02602444|pharmacokinetics|pharmacokinetics
110419|NCT02602444|pharmacodynamics|pharmacodynamics
110420|NCT02602431|laser|laser
110421|NCT02602431|third molar|third molar
110422|NCT02602431|low laser|low laser
110423|NCT02602431|inflammatory response|inflammatory response
110424|NCT02602418|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
110425|NCT02602418|working memory training|working memory training
110426|NCT02602418|brain function|brain function
110427|NCT02602418|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
110428|NCT02602405|Outcome Assessment (Health Care)|outcome assessment (health care)
110429|NCT02602405|Return to work|return to work
110430|NCT02602405|Registries|registries
110431|NCT02602405|Norway|norway
110432|NCT02602392|Self management|self management
110433|NCT02602392|Education|education
110434|NCT02602392|Children|children
110435|NCT02602392|Caregivers|caregivers
110436|NCT02602392|Health Care Providers|health care providers
110437|NCT02602379|Pain|pain
110438|NCT02602379|Monitoring|monitoring
110439|NCT02602379|Analgesia Nociception Index|analgesia nociception index
110440|NCT02602379|NoL|nol
110441|NCT02602379|Nociception Level|nociception level
110442|NCT02602379|Remifentanil|remifentanil
110443|NCT02602366|HIV|hiv
110444|NCT02602366|DCE|dce
110445|NCT02602366|MPT|mpt
110446|NCT02602366|Microbicide|microbicide
110447|NCT02602327|radioembolization|radioembolization
110448|NCT02602327|Yttrium-90|yttrium-90
110449|NCT02602327|90Y|90y
110450|NCT02602327|Resin microspheres|resin microspheres
110451|NCT02602327|Tas-102|tas-102
110452|NCT02602327|Lonsurf|lonsurf
110453|NCT02602327|SIR-Sphere|sir-sphere
110454|NCT02602314|Chronic myeloid leukemia|chronic myeloid leukemia
110455|NCT02602314|Nilotinib|nilotinib
110456|NCT02602314|Imatinib|imatinib
110457|NCT02602301|oxytocin|oxytocin
110458|NCT02602223|Alveolar Ridge Augmentation|alveolar ridge augmentation
110459|NCT02602223|Tooth Socket|tooth socket
110460|NCT02602223|Guided Tissue Regeneration|guided tissue regeneration
110461|NCT02602223|Membranes|membranes
110462|NCT02602210|cirrhosis|cirrhosis
110463|NCT02602210|liver|liver
110464|NCT02602210|corticosteroids|corticosteroids
110465|NCT02602210|hypotension|hypotension
110466|NCT02602210|sepsis|sepsis
110467|NCT02602210|cortisol|cortisol
110468|NCT02602197|Paracetamol|paracetamol
110469|NCT02602197|Dexketoprofen|dexketoprofen
110470|NCT02602197|postoperative pain|postoperative pain
110471|NCT02602197|septoplasty|septoplasty
110472|NCT02602184|skin regeneration|skin regeneration
110473|NCT02602184|re-epithelialization|re-epithelialization
110474|NCT02602184|split thickness wounds|split thickness wounds
110475|NCT02602184|Abdominoplasty|abdominoplasty
110476|NCT02602158|breath test|breath test
110477|NCT02602158|lipid emulsions|lipid emulsions
110478|NCT02602158|MRI|mri
110479|NCT02602158|gastric emptying|gastric emptying
110480|NCT02602145|femoral|femoral
110481|NCT02602145|popliteal|popliteal
110482|NCT02602145|stent|stent
110483|NCT02602145|modeling|modeling
110484|NCT02602145|flexion|flexion
110485|NCT02602132|INDWELLING URINARY CATHETER|indwelling urinary catheter
110486|NCT02602132|CLAMPING|clamping
110487|NCT02602132|REMOVAL|removal
110488|NCT02602106|Aquatic activities|aquatic activities
110489|NCT02602106|Aerobic exercise|aerobic exercise
110490|NCT02602106|Resistance exercise|resistance exercise
110491|NCT02602106|Pregnancy|pregnancy
110492|NCT02602106|Maternal weight gain|maternal weight gain
110493|NCT02602106|birthweight|birthweight
110494|NCT02602093|Lumbar Disk Herniation|lumbar disk herniation
110495|NCT02602093|Percutaneous Transforaminal Endoscopic Discectomy|percutaneous transforaminal endoscopic discectomy
110496|NCT02602093|Micro Discectomy|micro discectomy
110497|NCT02602093|Minimal Invasive Spine Surgery|minimal invasive spine surgery
101621|NCT02654535|Peanuts|peanuts
110498|NCT02602054|persistent ductus arteriosus|persistent ductus arteriosus
110499|NCT02602054|preterm infants|preterm infants
110500|NCT02602054|surgical treatment|surgical treatment
110501|NCT02602054|pharmacological treatment|pharmacological treatment
110502|NCT02602028|Familial Mediterranean Fever|familial mediterranean fever
110503|NCT02602028|Colchicine|colchicine
110504|NCT02602002|Remifentanil, Pharmacodynamic Pain assessments, Intravenous, South Korea|remifentanil, pharmacodynamic pain assessments, intravenous, south korea
110505|NCT02601976|PegInterferon alpha-2a|peginterferon alpha-2a
110506|NCT02601976|Ribavirin|ribavirin
110507|NCT02601976|Hepatitis C Virus|hepatitis c virus
110508|NCT02601976|Sustained Virological Response|sustained virological response
110509|NCT02601976|End of Treatment Response|end of treatment response
110510|NCT02601976|Unipeg|unipeg
110511|NCT02601976|Ribazole|ribazole
110512|NCT02601924|Anesthesia|anesthesia
110513|NCT02601924|injection|injection
110514|NCT02601924|pain|pain
110515|NCT02601924|pressure massage|pressure massage
110516|NCT02601924|topical gel|topical gel
110517|NCT02601911|Failure|failure
110518|NCT02601911|Injection|injection
110519|NCT02601911|Ketorolac|ketorolac
110520|NCT02601911|Premedication|premedication
110521|NCT02601885|Secondary progressive|secondary progressive
110522|NCT02601885|Relapsing-remitting|relapsing-remitting
110523|NCT02601885|Relapsing forms|relapsing forms
110524|NCT02601833|Caries|caries
110525|NCT02601833|Cavity|cavity
110526|NCT02601820|patient-reported outcomes|patient-reported outcomes
110527|NCT02601820|observational|observational
110528|NCT02601820|HCV|hcv
110529|NCT02601820|Hepatitis|hepatitis
110530|NCT02601820|Hepatitis C|hepatitis c
110531|NCT02601820|Chronic Liver Disease|chronic liver disease
110532|NCT02601820|Liver Disease|liver disease
110533|NCT02601820|Liver|liver
110534|NCT02601820|Infectious Disease|infectious disease
110535|NCT02601820|Hep C|hep c
110536|NCT02601820|HepC|hepc
110537|NCT02601820|PROs|pros
110538|NCT02601807|Back|back
110539|NCT02601807|Pain|pain
110540|NCT02601807|PSWT|pswt
110541|NCT02601807|ActiPatch|actipatch
110542|NCT02601807|Pulsed shortwave therapy|pulsed shortwave therapy
110543|NCT02601794|Breast Cancer|breast cancer
110544|NCT02601794|mHealth|mhealth
110545|NCT02601794|Mindfulness|mindfulness
110546|NCT02601794|Complementary Therapies|complementary therapies
110547|NCT02601781|Bioresorbable Vascular Scaffold (BVS)|bioresorbable vascular scaffold (bvs)
110548|NCT02601781|STEMI|stemi
110549|NCT02601781|Primary PCI|primary pci
110550|NCT02601768|ASD II|asd ii
110551|NCT02601768|transcatheter closure|transcatheter closure
110552|NCT02601768|percutaneous closure|percutaneous closure
110553|NCT02601768|3D TEE|3d tee
110554|NCT02601768|balloon-sizing|balloon-sizing
110555|NCT02601742|zinc|zinc
110556|NCT02601742|Duration|duration
110557|NCT02601729|Type 1 diabetes|type 1 diabetes
110558|NCT02601729|real-time continuous glucose monitoring|real-time continuous glucose monitoring
110559|NCT02601729|observational study|observational study
110560|NCT02601729|insulin pump|insulin pump
110561|NCT02601729|Belgium|belgium
110562|NCT02601716|Plasmodium falciparum|plasmodium falciparum
110563|NCT02601716|PfSPZ Vaccine|pfspz vaccine
110564|NCT02601716|Sporozoites|sporozoites
110565|NCT02601716|Controlled Human Malaria Infection|controlled human malaria infection
110566|NCT02601690|Rye Grass|rye grass
110567|NCT02601690|Ragweed|ragweed
110568|NCT02601690|Cat|cat
110569|NCT02601690|House Dust Mite|house dust mite
110570|NCT02601677|Obsessive Compulsive Disorder|obsessive compulsive disorder
110571|NCT02601677|Deep Brain Stimulation|deep brain stimulation
110572|NCT02601677|Nucleus accumbens|nucleus accumbens
110573|NCT02601651|Totally Extraperitoneal Inguinal Hernioplasty|totally extraperitoneal inguinal hernioplasty
110574|NCT02601651|Lidocaine infusion|lidocaine infusion
110575|NCT02601651|Postoperative opioid consumption|postoperative opioid consumption
110576|NCT02601625|Tolerability|tolerability
110577|NCT02601625|Anifrolumab|anifrolumab
110578|NCT02601625|Subcutaneous injection|subcutaneous injection
110579|NCT02601625|Intravenous infusion|intravenous infusion
110580|NCT02601599|Smoking Cessation|smoking cessation
110581|NCT02601599|Tobacco Use Cessation|tobacco use cessation
110582|NCT02601599|Motivational Interviewing|motivational interviewing
110583|NCT02601599|Students, Medical|students, medical
110584|NCT02601599|Randomized Controlled Trial|randomized controlled trial
110585|NCT02601560|Coronary Artery Disease|coronary artery disease
110586|NCT02601560|CAD|cad
110587|NCT02601547|Positron-Emission Tomography|positron-emission tomography
110588|NCT02601547|chemotherapy-induced brain damage|chemotherapy-induced brain damage
110589|NCT02601547|neuro-cognitive function alteration|neuro-cognitive function alteration
110693|NCT02600871|Abscess|abscess
110596|NCT02601482|exercise|exercise
110597|NCT02601482|Interval Training|interval training
110598|NCT02601456|Amputation, Traumatic|amputation, traumatic
110599|NCT02601456|Biomechanics|biomechanics
110600|NCT02601456|Asymmetry|asymmetry
131958|NCT02473497|ALK|alk
110601|NCT02601456|Amputee Running|amputee running
110602|NCT02601456|Prolonged Effort|prolonged effort
110603|NCT02601417|Cholangitis|cholangitis
110604|NCT02601417|Bile culture|bile culture
110605|NCT02601391|STEPPS-HI|stepps-hi
110606|NCT02601391|personality disorder|personality disorder
110607|NCT02601391|evaluation|evaluation
110608|NCT02601391|forensic|forensic
110609|NCT02601378|Uveal melanoma|uveal melanoma
110610|NCT02601378|Metastatic uveal melanoma|metastatic uveal melanoma
110611|NCT02601378|Phase I|phase i
110612|NCT02601378|LXS196|lxs196
110613|NCT02601378|PKC inhibitor|pkc inhibitor
110614|NCT02601378|dose escalation|dose escalation
110615|NCT02601339|spectroscopy, Near-Infrared|spectroscopy, near-infrared
110616|NCT02601300|Ulcerative Colitis|ulcerative colitis
110617|NCT02601300|GED-0301|ged-0301
110618|NCT02601300|Mongersen|mongersen
110619|NCT02601300|Efficacy|efficacy
110620|NCT02601300|Safety|safety
110621|NCT02601261|pregnant|pregnant
110622|NCT02601261|gestational ages|gestational ages
110623|NCT02601261|hospitalized|hospitalized
110624|NCT02601261|problem of pregnancy|problem of pregnancy
110625|NCT02601248|safety, PK|safety, pk
110626|NCT02601235|rhinitis|rhinitis
110627|NCT02601222|chronic eczema|chronic eczema
110628|NCT02601222|efficacy and safety|efficacy and safety
110629|NCT02601222|Runzao zhiyang capsule|runzao zhiyang capsule
110630|NCT02601196|Leiomyoma|leiomyoma
110631|NCT02601196|Infertility|infertility
110633|NCT02601196|Ulipristal acetate|ulipristal acetate
110634|NCT02601183|brain temperture，thrombolysis，early diagnosis|brain temperture，thrombolysis，early diagnosis
110635|NCT02601170|Platelet Rich Plasma|platelet rich plasma
110636|NCT02601170|Hemophilia|hemophilia
110637|NCT02601170|Hemophilic arthropathy|hemophilic arthropathy
110638|NCT02601157|stent|stent
110639|NCT02601157|polymer|polymer
110640|NCT02601157|antiplatelet therapy|antiplatelet therapy
110641|NCT02601157|clopidogrel|clopidogrel
110642|NCT02601144|DBS|dbs
110643|NCT02601144|VFS|vfs
110644|NCT02601144|FOG|fog
110645|NCT02601131|platelet count|platelet count
110646|NCT02601131|platelet transfusion|platelet transfusion
110647|NCT02601131|complement factors|complement factors
110648|NCT02601131|endothelial markers|endothelial markers
110649|NCT02601131|stem cell transplantation|stem cell transplantation
110650|NCT02601105|gotu kola|gotu kola
110651|NCT02601105|centella asiatica|centella asiatica
110652|NCT02601092|Mini Gastric Bypass|mini gastric bypass
110653|NCT02601092|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
110654|NCT02601092|RCT|rct
110655|NCT02601079|Biopsy|biopsy
110656|NCT02601079|Diagnostics|diagnostics
110657|NCT02601079|Genetic analysis|genetic analysis
110658|NCT02601066|LMNA|lmna
110659|NCT02601066|Sudden Death|sudden death
110660|NCT02601066|Neuromuscular|neuromuscular
110661|NCT02601040|Safety|safety
110662|NCT02601040|Immunogenicity|immunogenicity
110663|NCT02601040|Vaccine|vaccine
110664|NCT02601040|Hepatitis A|hepatitis a
110665|NCT02601014|Hormone-Resistant Prostate Cancer|hormone-resistant prostate cancer
110666|NCT02601014|Prostate Carcinoma Metastatic in the Bone|prostate carcinoma metastatic in the bone
110667|NCT02600988|Graft-Versus-Host-Disease|graft-versus-host-disease
110668|NCT02600988|post-allogeneic transplant|post-allogeneic transplant
110669|NCT02600988|haematopoietic progenitors|haematopoietic progenitors
110670|NCT02600949|Pancreatic cancer|pancreatic cancer
110671|NCT02600949|Colorectal Cancer|colorectal cancer
110672|NCT02600949|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
110673|NCT02600949|PDA|pda
110674|NCT02600949|CRC|crc
110675|NCT02600949|Personalized peptide vaccine|personalized peptide vaccine
110676|NCT02600949|Phone call|phone call
110677|NCT02600949|Advanced/metastatic|advanced/metastatic
110684|NCT02600923|palbociclib, ibrance, breast cancer|palbociclib, ibrance, breast cancer
110685|NCT02600910|Manual Wheelchair|manual wheelchair
110686|NCT02600910|Shoulder injury|shoulder injury
110687|NCT02600910|Shoulder function|shoulder function
110688|NCT02600910|rotator cuff|rotator cuff
110689|NCT02600910|Tendinopathy|tendinopathy
110690|NCT02600910|Spinal cord injury|spinal cord injury
110691|NCT02600910|Shoulder pain|shoulder pain
110692|NCT02600910|Shoulder impingement|shoulder impingement
110695|NCT02600871|Provodine|provodine
110696|NCT02600871|Povidone-Iodine|povidone-iodine
110697|NCT02600819|end stage renal disease (ESRD)|end stage renal disease (esrd)
110698|NCT02600819|hemodialysis (HD)|hemodialysis (hd)
110699|NCT02600819|open-label|open-label
110700|NCT02600819|HIV-1 Infection|hiv-1 infection
110701|NCT02600806|Community-acquired pneumonia|community-acquired pneumonia
110702|NCT02600806|Procalcitonin|procalcitonin
110703|NCT02600806|Outpatients|outpatients
110704|NCT02600806|Outcomes|outcomes
110705|NCT02600806|Azithromycin|azithromycin
110706|NCT02600806|Fluoroquinolones|fluoroquinolones
110707|NCT02600780|Febuxostat|febuxostat
110708|NCT02600780|Efficacy|efficacy
110709|NCT02600780|Safety|safety
132096|NCT02472886|HCV|hcv
110710|NCT02600780|Allopurinol|allopurinol
110711|NCT02600780|Hyperuricemia|hyperuricemia
110712|NCT02600780|Zurig|zurig
110713|NCT02600780|Getz Pharma|getz pharma
110714|NCT02600754|older adults, depressive symptoms, psychosocial treatment|older adults, depressive symptoms, psychosocial treatment
110715|NCT02600741|Schizophrenia|schizophrenia
110716|NCT02600741|Caregiver|caregiver
110717|NCT02600741|Psycho-education and skills training|psycho-education and skills training
110718|NCT02600741|Paliperidone Palmitate|paliperidone palmitate
110719|NCT02600741|Oral Antipsychotic|oral antipsychotic
110720|NCT02600728|Parkinson Disease|parkinson disease
110721|NCT02600728|Gait|gait
110722|NCT02600728|cues|cues
110723|NCT02600728|memory|memory
110724|NCT02600728|training|training
110725|NCT02600702|Home base exercise|home base exercise
110726|NCT02600689|Pulmonary rehab|pulmonary rehab
110727|NCT02600689|Exergame|exergame
110728|NCT02600689|Home-based|home-based
110729|NCT02600637|stroke|stroke
110730|NCT02600637|depression|depression
110731|NCT02600637|anxiety|anxiety
110732|NCT02600637|mindfulness|mindfulness
110733|NCT02600637|meditation|meditation
110734|NCT02600572|balance, postural|balance, postural
110735|NCT02600572|postural equilibrium|postural equilibrium
110736|NCT02600572|mental speed|mental speed
110737|NCT02600572|isometric exercise|isometric exercise
110738|NCT02600572|eccentric exercise|eccentric exercise
110739|NCT02600559|Otitis media|otitis media
110740|NCT02600559|Ear infection|ear infection
110741|NCT02600559|Tympanostomy tubes|tympanostomy tubes
110742|NCT02599844|acute kidney injury|acute kidney injury
110743|NCT02599831|Electrical pudendal nerve stimulation|electrical pudendal nerve stimulation
110744|NCT02599831|Pelvic floor muscle training|pelvic floor muscle training
110745|NCT02599831|Transanal electrical stimulation|transanal electrical stimulation
110746|NCT02599831|Post radical prostatectomy incontinence|post radical prostatectomy incontinence
110747|NCT02599831|Comparative study|comparative study
110748|NCT02600533|minority group recruitment|minority group recruitment
110749|NCT02600533|stages of implementation|stages of implementation
110750|NCT02600533|clinical trials education|clinical trials education
110751|NCT02600481|standard-pressure pneumoperitoneum|standard-pressure pneumoperitoneum
110752|NCT02600481|prolonged pneumoperitoneum|prolonged pneumoperitoneum
110753|NCT02600481|myocardial injuries|myocardial injuries
110754|NCT02600481|troponin T(TnT)|troponin t(tnt)
110755|NCT02600481|Trendelenburg position|trendelenburg position
110756|NCT02600481|chest CT scan|chest ct scan
110757|NCT02600481|low-pressure pneumoperitoneum|low-pressure pneumoperitoneum
110758|NCT02600481|robot-assisted surgery|robot-assisted surgery
110759|NCT02600442|Neoadjuvant Therapy|neoadjuvant therapy
110760|NCT02600442|Chemotherapy|chemotherapy
110761|NCT02600442|Positron-Emission Tomography|positron-emission tomography
110762|NCT02600442|PET-CT|pet-ct
110763|NCT02600442|FDG|fdg
110764|NCT02600442|Fluorodeoxyglucose|fluorodeoxyglucose
110765|NCT02600442|Diagnosis|diagnosis
110766|NCT02600442|Prognosis|prognosis
110767|NCT02600442|Pathological complete response|pathological complete response
110768|NCT02600442|molecular biology|molecular biology
110769|NCT02600442|proliferation genes|proliferation genes
110770|NCT02600429|Neurotrophic Keratopathy|neurotrophic keratopathy
110772|NCT02600403|Visual Evoked Potentials|visual evoked potentials
110773|NCT02600403|Optical Coherence Tomography|optical coherence tomography
110774|NCT02600403|Visual Fields|visual fields
110775|NCT02600390|Leg Ulcer|leg ulcer
110776|NCT02600390|LU|lu
110777|NCT02600390|SANGUINATE|sanguinate
110778|NCT02600390|QOL|qol
110779|NCT02600390|SCD|scd
110780|NCT02600390|Sickle Cell Disease|sickle cell disease
110781|NCT02600390|Sickle Cell|sickle cell
110782|NCT02600390|Anemia|anemia
110783|NCT02600390|Leg Wound|leg wound
110784|NCT02600390|Leg|leg
110785|NCT02600390|Skin Lesion|skin lesion
110786|NCT02600364|Aneurysm|aneurysm
110787|NCT02600364|intracerebral|intracerebral
110788|NCT02600364|stroke|stroke
110789|NCT02600364|p64|p64
110790|NCT02600351|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
110791|NCT02600351|Ledipasvir/Sofosbuvir|ledipasvir/sofosbuvir
110792|NCT02600351|Ribavirin|ribavirin
110793|NCT02600338|Systematic review and meta-analysis|systematic review and meta-analysis
110794|NCT02600338|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
110895|NCT02599649|Myelodysplastic syndrome|myelodysplastic syndrome
110795|NCT02600338|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
110796|NCT02600338|Clinical practice guidelines|clinical practice guidelines
110797|NCT02600338|Clinical trials|clinical trials
110798|NCT02600338|Legumes|legumes
110799|NCT02600338|Beans, peas, chickpeas, lentils, soy, peanuts, lupins|beans, peas, chickpeas, lentils, soy, peanuts, lupins
110800|NCT02600338|Cardiometabolic risk factors|cardiometabolic risk factors
110801|NCT02600338|Blood pressure|blood pressure
110802|NCT02600325|Acute Hepatitis C|acute hepatitis c
110803|NCT02600325|Human Immunodeficiency virus|human immunodeficiency virus
110804|NCT02600325|Grazoprevir|grazoprevir
101902|NCT02652897|lysis|lysis
110805|NCT02600325|Elbasvir|elbasvir
110806|NCT02600286|Physical medicine and rehabilitation|physical medicine and rehabilitation
110807|NCT02600286|Neurology|neurology
110808|NCT02600260|thrombophilia|thrombophilia
110809|NCT02600260|thrombosis|thrombosis
110810|NCT02600260|Pregnancy, High-Risk|pregnancy, high-risk
110811|NCT02600260|venous thrombosis|venous thrombosis
110812|NCT02600260|enoxaparin|enoxaparin
110813|NCT02600260|risk assessment|risk assessment
110814|NCT02600260|deep vein thrombosis|deep vein thrombosis
110815|NCT02600260|pulmonary embolism|pulmonary embolism
110816|NCT02600260|hospitalization|hospitalization
110817|NCT02600247|Total knee arthroplasty|total knee arthroplasty
110818|NCT02600247|Duloxetine|duloxetine
110819|NCT02600221|ACOS|acos
110820|NCT02600195|Intensive Care, Neonatal|intensive care, neonatal
110821|NCT02600195|Nosocomial Infections|nosocomial infections
110822|NCT02600195|Quality Improvement|quality improvement
110823|NCT02600182|Thoracic surgery|thoracic surgery
110824|NCT02600182|Non-invasive ventilation|non-invasive ventilation
110825|NCT02600182|Physiotherapy|physiotherapy
110826|NCT02600143|Melanoma|melanoma
110827|NCT02600143|Colitis|colitis
110828|NCT02600143|Ipilimumab|ipilimumab
110829|NCT02600143|Nivolumab|nivolumab
110830|NCT02600143|Pembrolizumab|pembrolizumab
110831|NCT02600091|Anxiety|anxiety
110832|NCT02600091|Depression|depression
110833|NCT02600091|Type 1 Diabetes|type 1 diabetes
110834|NCT02600091|Mindfulness-based Cognitive Therapy|mindfulness-based cognitive therapy
110835|NCT02600091|Glycaemic control|glycaemic control
110836|NCT02600078|hypoxia|hypoxia
110837|NCT02600078|ataxia|ataxia
110838|NCT02600013|incomplete motor SCI|incomplete motor sci
110839|NCT02600013|robotic gait training|robotic gait training
110840|NCT02600013|exoskeleton|exoskeleton
110841|NCT02600013|rehabilitation tool|rehabilitation tool
110842|NCT02600013|EKSO-GT|ekso-gt
110843|NCT02599961|Glut 1 DS|glut 1 ds
110844|NCT02599935|Nutritional status|nutritional status
110845|NCT02599935|MNA|mna
110846|NCT02599935|GSA|gsa
110847|NCT02599909|Liver Cancer|liver cancer
110848|NCT02599909|Hepatocellular Carcinoma|hepatocellular carcinoma
110849|NCT02599909|Liver Tumors|liver tumors
110850|NCT02599909|Liver Resection|liver resection
110851|NCT02599896|Dose Escalation|dose escalation
110852|NCT02599896|HIV Prevention|hiv prevention
110853|NCT02599896|Broadly HIV-1 Neutralizing Activity|broadly hiv-1 neutralizing activity
110854|NCT02599896|Open-Label|open-label
110855|NCT02599896|Half-Life|half-life
110856|NCT02599883|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
110857|NCT02599883|Diagnostic Imaging|diagnostic imaging
110858|NCT02599883|Disease Management|disease management
110859|NCT02599883|Clinical Decision Support Systems|clinical decision support systems
110860|NCT02599883|Cost-Utility Analysis|cost-utility analysis
110861|NCT02599870|PGx|pgx
110862|NCT02599870|pharmacogenetic testing|pharmacogenetic testing
110863|NCT02599870|IDgenetix|idgenetix
110864|NCT02599870|Pain Management|pain management
110865|NCT02599870|AltheaDx|altheadx
110866|NCT02599870|Post-Operative Pain Management|post-operative pain management
111795|NCT02594124|SMA|sma
110867|NCT02599792|Safety and Pharmacokinetics|safety and pharmacokinetics
110868|NCT02599779|Renal cell cancer|renal cell cancer
110869|NCT02599779|SBRT|sbrt
110870|NCT02599779|Pembrolizumab|pembrolizumab
110871|NCT02599766|animal assisted intervention, brain injury, rehabilitation|animal assisted intervention, brain injury, rehabilitation
110872|NCT02599740|Blood glucose|blood glucose
110873|NCT02599727|balance, postural|balance, postural
110874|NCT02599727|postural equilibrium|postural equilibrium
110875|NCT02599727|heart rate|heart rate
110876|NCT02599727|blood pressure|blood pressure
110877|NCT02599727|pulse oxygenation|pulse oxygenation
110878|NCT02599727|mental speed|mental speed
110879|NCT02599714|AZD2014|azd2014
110880|NCT02599714|Palbociclib|palbociclib
110881|NCT02599714|Fulvestrant|fulvestrant
110882|NCT02599714|Hormonal Therapy|hormonal therapy
110883|NCT02599714|Estrogen Receptor Positive|estrogen receptor positive
110884|NCT02599714|Breast Cancer|breast cancer
110885|NCT02599701|Delta Sleep|delta sleep
110886|NCT02599701|Growth Hormone|growth hormone
110887|NCT02599701|IGF-1|igf-1
110888|NCT02599675|Muscle|muscle
110889|NCT02599675|Vitamin D|vitamin d
110890|NCT02599675|Strength|strength
110891|NCT02599675|Endurance|endurance
110892|NCT02599675|Muscle fiber|muscle fiber
110893|NCT02599662|Cancer|cancer
110894|NCT02599662|Intraoperative Radiation Therapy - IORT|intraoperative radiation therapy - iort
110897|NCT02599649|Low or intermediate-1 MDS|low or intermediate-1 mds
110898|NCT02599649|High Risk MDS|high risk mds
110899|NCT02599649|Lirilumab|lirilumab
110900|NCT02599649|Nivolumab|nivolumab
110901|NCT02599649|BMS-936558|bms-936558
110902|NCT02599649|Opdivo|opdivo
110903|NCT02599649|Azacitidine|azacitidine
110904|NCT02599649|5-azacytidine|5-azacytidine
110905|NCT02599649|5-aza|5-aza
110906|NCT02599649|Vidaza|vidaza
110907|NCT02599649|5-AZC|5-azc
110908|NCT02599649|AZA-CR|aza-cr
110909|NCT02599649|Ladakamycin|ladakamycin
110910|NCT02599649|NSC-102816|nsc-102816
110911|NCT02599649|Azacytidine|azacytidine
110912|NCT02599623|Incarcerated|incarcerated
110913|NCT02599623|Anesthesia|anesthesia
110915|NCT02599610|labor, vaginal examination, transperineal ultrasound, pain, anxiety|labor, vaginal examination, transperineal ultrasound, pain, anxiety
110916|NCT02599584|behaviour|behaviour
110917|NCT02599558|EOE|eoe
110918|NCT02599532|Apixaban|apixaban
110919|NCT02599532|Pharmacokinetics|pharmacokinetics
110920|NCT02599532|Pharmacodynamics|pharmacodynamics
110921|NCT02599506|breast cancer|breast cancer
110922|NCT02599506|fear of recurrence|fear of recurrence
110923|NCT02599506|longitudinal study|longitudinal study
110924|NCT02599506|radiation therapy|radiation therapy
110925|NCT02599506|emotional concerns|emotional concerns
110926|NCT02599506|trajectory|trajectory
110927|NCT02599506|psychological constructs|psychological constructs
110928|NCT02599506|diary keeping|diary keeping
110929|NCT02599480|HFpEF|hfpef
110930|NCT02599480|left ventricular hypertrophy|left ventricular hypertrophy
110931|NCT02599480|cardiac remodeling,|cardiac remodeling,
110932|NCT02599467|Nerve Pain|nerve pain
110933|NCT02599467|Electromyography|electromyography
110934|NCT02599467|Median Nerve|median nerve
110935|NCT02599467|Breast Neoplasms|breast neoplasms
110936|NCT02599415|psoriasis patients referred to receive TL01 NB-UVB therapy|psoriasis patients referred to receive tl01 nb-uvb therapy
110937|NCT02599389|in-stent restenosis; drug-coated balloons; Excimer Laser, cost effectiveness study, quality of life|in-stent restenosis; drug-coated balloons; excimer laser, cost effectiveness study, quality of life
110938|NCT02599350|Ventilation|ventilation
110939|NCT02599350|Gas exchange|gas exchange
110940|NCT02599350|V/Q ratio|v/q ratio
110941|NCT02599350|Requirement for mechanical ventilation|requirement for mechanical ventilation
110942|NCT02599337|bioequivalence|bioequivalence
110943|NCT02599311|pelvic organ prolapse|pelvic organ prolapse
110944|NCT02599298|sleep|sleep
110945|NCT02599298|treatment|treatment
110946|NCT02599259|Stroke|stroke
110947|NCT02599259|Oral anticoagulants|oral anticoagulants
110948|NCT02599259|NOAC|noac
110949|NCT02599259|wireless monitoring|wireless monitoring
110950|NCT02599259|Warfarin|warfarin
110951|NCT02599259|Xarelto|xarelto
110952|NCT02599259|compliance|compliance
110953|NCT02599259|adherence|adherence
110954|NCT02599259|monitoring|monitoring
110955|NCT02599259|directly observed therapy|directly observed therapy
110956|NCT02599259|DOT|dot
110957|NCT02599259|mobile device|mobile device
110958|NCT02599259|electronic monitoring|electronic monitoring
110959|NCT02599259|artificial intelligence|artificial intelligence
110960|NCT02599259|oral anticoagulation therapy|oral anticoagulation therapy
110961|NCT02599259|adherence monitoring methods|adherence monitoring methods
110962|NCT02599259|nonadherence|nonadherence
110963|NCT02599259|non-adherence|non-adherence
110964|NCT02599246|Home ventilator|home ventilator
110965|NCT02599246|FiO2|fio2
110966|NCT02599246|O2|o2
110967|NCT02599246|NIV|niv
110968|NCT02599246|COPD|copd
110969|NCT02599233|pain trajectory|pain trajectory
110970|NCT02599181|Perineural cathether|perineural cathether
110979|NCT02599155|infant|infant
110980|NCT02599155|cardiac surgery|cardiac surgery
110981|NCT02599142|radiotherapy immobilisation|radiotherapy immobilisation
110982|NCT02599142|open-face shells|open-face shells
110983|NCT02599129|Alopecia areata|alopecia areata
110984|NCT02599116|cytoreductive surgery|cytoreductive surgery
110985|NCT02599116|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
110986|NCT02599116|microbiome|microbiome
110987|NCT02599090|Glioblastoma|glioblastoma
110988|NCT02599090|Gliosarcoma|gliosarcoma
110989|NCT02599090|Brain Cancer|brain cancer
110990|NCT02599090|Sorafenib|sorafenib
110991|NCT02599090|Temozolomide|temozolomide
110992|NCT02599090|Radiation|radiation
110993|NCT02599090|Radiotherapy|radiotherapy
110994|NCT02599090|XRT|xrt
110995|NCT02599077|oral contraceptives|oral contraceptives
110996|NCT02599077|endometrioma|endometrioma
110997|NCT02599077|dienogest|dienogest
110998|NCT02599064|Age-related macular degeneration|age-related macular degeneration
110999|NCT02599064|RXI-109|rxi-109
111003|NCT02599064|Retinal fibrosis|retinal fibrosis
111004|NCT02599064|Subretinal fibrosis|subretinal fibrosis
111005|NCT02599064|Eye diseases|eye diseases
111006|NCT02599038|NAFLD|nafld
111007|NCT02599038|NASH|nash
111008|NCT02599038|Serine|serine
111009|NCT02599038|Glutathione|glutathione
111010|NCT02599025|Cerebral palsy|cerebral palsy
111011|NCT02599025|passive cycling|passive cycling
111012|NCT02599025|autonomic control system|autonomic control system
111013|NCT02598986|glycemic index, pita bread, phosphorus, potassium, magnesium|glycemic index, pita bread, phosphorus, potassium, magnesium
111014|NCT02598973|Parkinson Disease|parkinson disease
111015|NCT02598973|exercise|exercise
111016|NCT02598947|posterior shoulder tightness|posterior shoulder tightness
111017|NCT02598947|shoulder impingement syndrome|shoulder impingement syndrome
111018|NCT02598947|Glenohumeral joint|glenohumeral joint
111019|NCT02598947|exercise|exercise
111020|NCT02598921|Assisted reproductive technology|assisted reproductive technology
111021|NCT02598882|Elderly|elderly
111022|NCT02598882|Videogame|videogame
111023|NCT02598882|energy expenditure|energy expenditure
111024|NCT02598882|electromyography|electromyography
111025|NCT02598882|rehabilitation|rehabilitation
111026|NCT02598869|Triamcinolone acetonide|triamcinolone acetonide
111027|NCT02598856|Emergency Treatment|emergency treatment
111028|NCT02598856|Morphine Derivates|morphine derivates
111029|NCT02598856|Heroin|heroin
111030|NCT02598856|Antidotes|antidotes
111031|NCT02598856|Administration, Intravenous|administration, intravenous
111032|NCT02598856|Pharmacology|pharmacology
111033|NCT02598856|Naloxone|naloxone
111034|NCT02598856|Healthy volunteers|healthy volunteers
111035|NCT02598856|Administration, intramuscular|administration, intramuscular
111036|NCT02598856|Administration, intranasal|administration, intranasal
111037|NCT02598830|Cachexia|cachexia
111038|NCT02598830|Vitamin D|vitamin d
111039|NCT02598830|Muscle|muscle
111040|NCT02598830|Strength training|strength training
111041|NCT02598804|Physical activity level|physical activity level
111042|NCT02598804|Knee osteoarthritis|knee osteoarthritis
111043|NCT02598804|Randomized controlled trials|randomized controlled trials
111044|NCT02598804|Alternate month design study|alternate month design study
111045|NCT02598804|Self-management|self-management
111046|NCT02598804|Self-care|self-care
111047|NCT02598804|Education and exercise in knee osteoarthritis|education and exercise in knee osteoarthritis
111048|NCT02598804|Education|education
111049|NCT02598804|Non pharmacological treatment|non pharmacological treatment
111050|NCT02598791|incretin hormones|incretin hormones
111051|NCT02598791|GIP|gip
111052|NCT02598791|GLP-1|glp-1
111053|NCT02598765|Glaucoma|glaucoma
111054|NCT02598765|Trabeculectomy|trabeculectomy
111055|NCT02598765|Eye Disease|eye disease
111056|NCT02598765|Intraocular Pressure|intraocular pressure
111057|NCT02598765|Visual Acuity|visual acuity
111061|NCT02598739|Physical exercise|physical exercise
111062|NCT02598739|Psoriatic arthritis|psoriatic arthritis
111063|NCT02598739|Quality of life|quality of life
111064|NCT02598700|total hip arthroplasty|total hip arthroplasty
111065|NCT02598700|imaging|imaging
111066|NCT02598700|arthritis|arthritis
111067|NCT02598700|surgical technique|surgical technique
111068|NCT02598674|acute kidney injury|acute kidney injury
111069|NCT02598661|Myelodysplastic Syndromes|myelodysplastic syndromes
111070|NCT02598661|Imetelstat|imetelstat
111071|NCT02598648|FXR|fxr
111072|NCT02598648|RIPK3|ripk3
111073|NCT02598648|Neonates|neonates
111074|NCT02598648|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
111075|NCT02598648|Acute Lung Injury|acute lung injury
111076|NCT02598635|Cholecalciferol|cholecalciferol
111077|NCT02598635|peritoneal dialysis|peritoneal dialysis
111078|NCT02598635|FGF23|fgf23
111079|NCT02598635|Calcium|calcium
111080|NCT02598635|Phosphorus|phosphorus
111081|NCT02598609|Adverse event|adverse event
111082|NCT02598609|Neonatal Intensive Care Unit|neonatal intensive care unit
111083|NCT02598609|Catheter-related Bloodstream Infection (CRBSI) nos|catheter-related bloodstream infection (crbsi) nos
111084|NCT02598609|Extravasation injury|extravasation injury
111085|NCT02598609|Medication error|medication error
111086|NCT02598609|Central venous catheter complication|central venous catheter complication
111087|NCT02598609|Unprogrammed extubation|unprogrammed extubation
111088|NCT02598596|Refractory gout|refractory gout
111089|NCT02598596|Chronic gout|chronic gout
111090|NCT02598583|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
111091|NCT02598583|PNH|pnh
111092|NCT02598583|complement inhibitor|complement inhibitor
111093|NCT02598570|Relapsed Lymphoma|relapsed lymphoma
111094|NCT02598570|Phosphoinositide 3-kinase (PI3K) Inhibitor|phosphoinositide 3-kinase (pi3k) inhibitor
111095|NCT02598570|Duvelisib|duvelisib
111096|NCT02598570|Japanese|japanese
111097|NCT02598570|Refractory Lymphoma|refractory lymphoma
111098|NCT02598518|Integrating Combined Therapies|integrating combined therapies
111099|NCT02598518|Alcohol Use Disorder|alcohol use disorder
111100|NCT02598518|Mental Health Disorder|mental health disorder
111101|NCT02598492|Mechanical Ventilator|mechanical ventilator
111103|NCT02598479|Insulin Potentiation Low Dose Chemotherapy|insulin potentiation low dose chemotherapy
111104|NCT02598479|IPT|ipt
111105|NCT02598479|IPTLD|iptld
111106|NCT02598479|Nutrition therapy|nutrition therapy
111107|NCT02598427|Breast Cancer|breast cancer
111108|NCT02598427|HER2 Positive|her2 positive
111109|NCT02598427|HER2+|her2+
111110|NCT02598427|Brain Metastases|brain metastases
111111|NCT02598427|Metastatic Breast Cancer|metastatic breast cancer
111112|NCT02598427|Intrathecal Treatment|intrathecal treatment
111113|NCT02598427|Lumbar Puncture|lumbar puncture
111114|NCT02598427|Pertuzumab|pertuzumab
111115|NCT02598427|Trastuzumab|trastuzumab
111116|NCT02598427|Advanced Breast Cancer|advanced breast cancer
111117|NCT02598427|Duke University|duke university
111118|NCT02598414|Colorectal Disease|colorectal disease
111119|NCT02598414|Robotic Surgery|robotic surgery
111120|NCT02598414|Indocyanine Green Fluorescence Imaging|indocyanine green fluorescence imaging
111121|NCT02598414|Anastomotic Leak|anastomotic leak
111122|NCT02598414|Short-term Outcomes|short-term outcomes
111123|NCT02598388|Healthy|healthy
111124|NCT02598388|Vaccine|vaccine
111125|NCT02598388|Ebola viruses|ebola viruses
111126|NCT02598388|Ebola virus disease (EVD)|ebola virus disease (evd)
111127|NCT02598388|Filoviruses|filoviruses
111128|NCT02598388|Hemorrhagic fever|hemorrhagic fever
111129|NCT02598388|Monovalent vaccine|monovalent vaccine
111130|NCT02598388|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
111131|NCT02598388|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
111132|NCT02598388|Safety|safety
111133|NCT02598388|Immunogenicity|immunogenicity
111134|NCT02598375|Early reached target enteral nutrition in PICU feeding intolerance IFABP|early reached target enteral nutrition in picu feeding intolerance ifabp
111135|NCT02598362|ciprofloxacin|ciprofloxacin
111136|NCT02598362|pharmacokinetics|pharmacokinetics
111137|NCT02598362|excretion|excretion
111138|NCT02598362|clearance|clearance
111139|NCT02598362|infant|infant
111140|NCT02598362|children|children
111141|NCT02598362|adolescent|adolescent
111142|NCT02598349|Unresectable|unresectable
111143|NCT02598349|Borderline resectable|borderline resectable
111144|NCT02598336|Structured Light Plethysmography|structured light plethysmography
111145|NCT02598336|Spirometry|spirometry
111146|NCT02598336|Pneumotachograph|pneumotachograph
111147|NCT02598297|Ruxolitinib|ruxolitinib
111148|NCT02598297|INC424|inc424
111149|NCT02598297|early myelofibrosis|early myelofibrosis
111150|NCT02598297|High molecular risk mutations|high molecular risk mutations
111151|NCT02598297|HMR|hmr
111152|NCT02598284|Preventive measures|preventive measures
111153|NCT02598284|Quality Improvement|quality improvement
111154|NCT02598271|Acute Kidney Injury|acute kidney injury
111155|NCT02598271|Cardiac Surgery|cardiac surgery
111156|NCT02598258|Sauna|sauna
111157|NCT02598258|Cold water bath|cold water bath
111158|NCT02598245|urinary incontinence, CESA, VASA, TOT, TVT|urinary incontinence, cesa, vasa, tot, tvt
111159|NCT02598219|Sentinel node|sentinel node
111160|NCT02598206|food effect|food effect
111161|NCT02598206|healthy volunteers|healthy volunteers
111162|NCT02598206|pharmacokinetics|pharmacokinetics
111163|NCT02598206|CCR2i|ccr2i
111164|NCT02598141|Protheses, nails, screws or plates|protheses, nails, screws or plates
111165|NCT02598115|collaborative pharmaceutical care|collaborative pharmaceutical care
111166|NCT02598089|Seasonal Influenza|seasonal influenza
111167|NCT02598089|Trivalent Vaccine|trivalent vaccine
111168|NCT02598089|Inactivated Vaccine|inactivated vaccine
111169|NCT02598050|postoperative health outcomes|postoperative health outcomes
111170|NCT02598050|older surgical patients|older surgical patients
111171|NCT02598037|Obesity|obesity
111172|NCT02598037|Polymorphism|polymorphism
111173|NCT02598037|Hormones|hormones
111174|NCT02597985|Frailty|frailty
111175|NCT02597959|ergonomic risk factors|ergonomic risk factors
111176|NCT02597959|allied health professionals|allied health professionals
111177|NCT02597959|surgical care|surgical care
111178|NCT02597881|natural history|natural history
111179|NCT02597868|therapy|therapy
111180|NCT02597868|Capecitabine|capecitabine
111181|NCT02597868|breast cancer|breast cancer
111182|NCT02597842|Postoperative nausea and vomiting|postoperative nausea and vomiting
111183|NCT02597842|TEAS|teas
111184|NCT02597829|Inflammatory Bowel Disease|inflammatory bowel disease
111185|NCT02597829|Mucosal Healing|mucosal healing
111186|NCT02597829|Certolizumab pegol|certolizumab pegol
111187|NCT02597803|Dry Eye Syndrome|dry eye syndrome
111188|NCT02597803|Dry Eye|dry eye
111189|NCT02597803|DES|des
111190|NCT02597790|endothelial function|endothelial function
111191|NCT02597790|cardiovascular risk|cardiovascular risk
111192|NCT02597790|HIV|hiv
111193|NCT02597790|Hepatitis C|hepatitis c
111194|NCT02597790|metabolic disease|metabolic disease
111195|NCT02597790|inflammation|inflammation
111196|NCT02597764|Diaphragmatic breathing (DB)|diaphragmatic breathing (db)
111197|NCT02597764|Bladder and bowel disorders (BBD)|bladder and bowel disorders (bbd)
111198|NCT02597764|Autonomic nervous system (ANS)|autonomic nervous system (ans)
111199|NCT02597764|Heart rate variability (HRV)|heart rate variability (hrv)
111200|NCT02597764|Deep breathing|deep breathing
111201|NCT02597764|Randomized controlled trial (RCT)|randomized controlled trial (rct)
111202|NCT02597751|DCD|dcd
111203|NCT02597751|Neuroimaging|neuroimaging
111204|NCT02597751|Rehabilitation|rehabilitation
111205|NCT02597725|Urodynamics|urodynamics
111206|NCT02597725|Late effects|late effects
111207|NCT02597725|Urinary Incontinence|urinary incontinence
111208|NCT02597712|acid reflux|acid reflux
111209|NCT02597712|intragastric pH|intragastric ph
111210|NCT02597712|gastrin|gastrin
111211|NCT02597712|hypergastrinemia|hypergastrinemia
111212|NCT02597699|Termination of pregnancy|termination of pregnancy
111213|NCT02597699|Feticide|feticide
111214|NCT02597699|Fetal pain|fetal pain
111215|NCT02597699|Remifentanil Ultiva®|remifentanil ultiva®
111216|NCT02597699|Fetal asystole|fetal asystole
111217|NCT02597699|Fetopathologic analysis|fetopathologic analysis
111218|NCT02597660|patellar tendinopathy|patellar tendinopathy
111219|NCT02597660|somatropin|somatropin
111220|NCT02597660|jumper's knee|jumper's knee
111221|NCT02597647|immunology|immunology
111222|NCT02597647|Microbiota|microbiota
111223|NCT02597582|LigaSure|ligasure
111224|NCT02597582|Neck dissection|neck dissection
111225|NCT02597582|Operative duration|operative duration
111226|NCT02597582|Postoperative drainage|postoperative drainage
111227|NCT02597582|Postoperative pain|postoperative pain
111228|NCT02597569|stroke|stroke
111229|NCT02597569|Cognitive Orientation to daily Occupational Performance|cognitive orientation to daily occupational performance
111230|NCT02597569|health services accessibility|health services accessibility
111231|NCT02597569|cognitive impairment|cognitive impairment
111232|NCT02597569|rehabilitation|rehabilitation
111233|NCT02597569|integrated knowledge translation|integrated knowledge translation
111234|NCT02597569|interrupted time series|interrupted time series
111235|NCT02597569|The CO-OP Approach|the co-op approach
111236|NCT02597556|Albendazole|albendazole
111237|NCT02597556|Ancylostoma duodenale|ancylostoma duodenale
111238|NCT02597556|Ascariasis lumbricoides|ascariasis lumbricoides
111239|NCT02597556|Coinfection|coinfection
111240|NCT02597556|Diarrhea|diarrhea
111241|NCT02597556|Helminths|helminths
111242|NCT02597556|Necator americanus|necator americanus
111243|NCT02597556|Microbiota|microbiota
111244|NCT02597556|Trichuris trichiura|trichuris trichiura
111245|NCT02597543|heart transplantation|heart transplantation
111246|NCT02597543|cardiac MRI|cardiac mri
111247|NCT02597543|graft rejection|graft rejection
111248|NCT02597543|nonspecific allograft dysfunction|nonspecific allograft dysfunction
111249|NCT02597543|allograft vasculopathy|allograft vasculopathy
111250|NCT02597530|TEAS|teas
111251|NCT02597530|anesthesia|anesthesia
111252|NCT02597517|gastritis|gastritis
111253|NCT02597517|chromoendoscopy|chromoendoscopy
111254|NCT02597517|magnification|magnification
111255|NCT02597517|Helicobacter pylori|helicobacter pylori
111256|NCT02597517|Atrophic gastritis|atrophic gastritis
111257|NCT02597491|Smoking,|smoking,
111258|NCT02597491|Smoking cessation|smoking cessation
111259|NCT02597491|Sequential, multiple assignment, randomized trials (SMART)|sequential, multiple assignment, randomized trials (smart)
111260|NCT02597491|Lung cancer screening|lung cancer screening
111261|NCT02597478|Advanced Cancers|advanced cancers
111262|NCT02597478|Fentanyl Sublingual Spray|fentanyl sublingual spray
111263|NCT02597478|Fentanyl SL Spray|fentanyl sl spray
111264|NCT02597478|FSS|fss
111266|NCT02597478|Surveys|surveys
111267|NCT02597478|Mental Abilities Test|mental abilities test
111268|NCT02597478|Phone Call|phone call
111269|NCT02597478|Shuttle Walk Test|shuttle walk test
111270|NCT02597452|breast lump|breast lump
111271|NCT02597452|breast exam|breast exam
111272|NCT02597452|breast cancer screening|breast cancer screening
111273|NCT02597452|breast lump detection|breast lump detection
111274|NCT02597439|Ultra-high risk|ultra-high risk
111275|NCT02597439|UHR|uhr
111276|NCT02597439|psychosis|psychosis
111277|NCT02597426|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
111278|NCT02597426|Intensity-Modulated Radiotherapy|intensity-modulated radiotherapy
111279|NCT02597426|Post treatment|post treatment
111280|NCT02597374|Electroencephalography|electroencephalography
111281|NCT02597374|mu rhythm|mu rhythm
111282|NCT02597374|Sensorimotor Cortex|sensorimotor cortex
111283|NCT02597374|Unilateral Cerebral Palsy|unilateral cerebral palsy
111284|NCT02597374|Child|child
111285|NCT02597361|Ehlers-Danlos syndrome, vascular type|ehlers-danlos syndrome, vascular type
111286|NCT02597361|Type 2 Angiotensin Receptor Blockers|type 2 angiotensin receptor blockers
111287|NCT02597348|Liver|liver
111288|NCT02597348|Metastasis|metastasis
111289|NCT02597348|Colorectal cancer|colorectal cancer
111290|NCT02597348|Liver transplantation|liver transplantation
111291|NCT02597335|Glioma|glioma
111297|NCT02597322|T2a Renal tumor|t2a renal tumor
111298|NCT02597322|organ confined tumors|organ confined tumors
111299|NCT02597322|nephron sparing surgery|nephron sparing surgery
111300|NCT02597322|nephron sparing procedure|nephron sparing procedure
111301|NCT02597322|radical nephrectomy|radical nephrectomy
111302|NCT02597283|Bifurcation lesions|bifurcation lesions
111303|NCT02597283|Percutaneous coronary intervention|percutaneous coronary intervention
644334|NCT00752544|Hepatitis C|hepatitis c
111305|NCT02597270|Hepatitis C virus|hepatitis c virus
111306|NCT02597257|Lidocaine infusion therapy|lidocaine infusion therapy
111307|NCT02597244|Lumbar foraminal stenosis|lumbar foraminal stenosis
111308|NCT02597231|Delirium|delirium
111309|NCT02597231|Melatonin|melatonin
111310|NCT02597218|Hepatectomy|hepatectomy
111311|NCT02597218|Prophylaxis|prophylaxis
111312|NCT02597205|Medical adherence|medical adherence
111313|NCT02597205|Lifestyle modification|lifestyle modification
111314|NCT02597205|Mobile Health|mobile health
111315|NCT02597205|Secondary Prevention|secondary prevention
111316|NCT02597192|gingivitis|gingivitis
111317|NCT02597192|gingival inflammation|gingival inflammation
111318|NCT02597192|probiotics|probiotics
111319|NCT02597192|Bacillus|bacillus
111320|NCT02597075|Colorectal Cancer|colorectal cancer
111321|NCT02597075|Metastatic Colorectal Cancer|metastatic colorectal cancer
111322|NCT02597075|Physical Activity|physical activity
111323|NCT02597075|Quality of life|quality of life
111325|NCT02596997|Adenovirus Brincidofovir|adenovirus brincidofovir
111326|NCT02596984|Intensive Care Unit|intensive care unit
111327|NCT02596984|Shock|shock
111328|NCT02596984|Antifungal agent|antifungal agent
111329|NCT02596984|Pharmacokinetics|pharmacokinetics
111330|NCT02596984|Sepsis|sepsis
111331|NCT02596932|Intrapartum|intrapartum
111338|NCT02596880|Hepatitis C|hepatitis c
111339|NCT02596880|Cirrhosis|cirrhosis
111340|NCT02596880|Sofosbuvir|sofosbuvir
111341|NCT02596880|Daclatasvir|daclatasvir
111342|NCT02596880|Ribavirin|ribavirin
111343|NCT02596867|B adrenergic pathway|b adrenergic pathway
111344|NCT02596867|B Blocker|b blocker
111345|NCT02596841|Lung diffusing capacity|lung diffusing capacity
111346|NCT02596841|Idiopathic Interstitial Pneumonias|idiopathic interstitial pneumonias
111347|NCT02596828|molecular targeted therapy|molecular targeted therapy
111348|NCT02596828|protein kinase inhibitor|protein kinase inhibitor
111349|NCT02596828|mTOR Inhibitor|mtor inhibitor
111350|NCT02596828|cytostatic topoisomerase-I-inhibitor|cytostatic topoisomerase-i-inhibitor
111351|NCT02596828|temozolomide|temozolomide
111352|NCT02596828|irinotecan|irinotecan
111353|NCT02596828|dasatinib|dasatinib
111354|NCT02596828|rapamycin|rapamycin
111355|NCT02596802|Fetoscopic Endoluminal Tracheal Occlusion|fetoscopic endoluminal tracheal occlusion
111356|NCT02596802|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
111357|NCT02596763|Off-label prescription|off-label prescription
111358|NCT02596763|Alcoholism|alcoholism
111359|NCT02596763|Pharmacovigilance|pharmacovigilance
111360|NCT02596763|Pharmacoepidemiology|pharmacoepidemiology
111361|NCT02596763|Baclofen|baclofen
111362|NCT02596737|health|health
111363|NCT02596737|work|work
111364|NCT02596737|lifestyle|lifestyle
111365|NCT02596737|behavior|behavior
111366|NCT02596737|management|management
111367|NCT02596737|stress|stress
111368|NCT02596737|physical activity|physical activity
111369|NCT02596737|nutrition|nutrition
111370|NCT02596737|mortality|mortality
111371|NCT02596737|morbidity|morbidity
111372|NCT02596737|public health|public health
111373|NCT02596724|Breast Cancer|breast cancer
111374|NCT02596724|Neoadjuvant therapy for breast cancer|neoadjuvant therapy for breast cancer
111375|NCT02596711|Cancer Prevention|cancer prevention
111376|NCT02596711|Tobacco Use Cessation|tobacco use cessation
111377|NCT02596711|Nicotine Patch|nicotine patch
111379|NCT02596711|Questionnaires|questionnaires
111380|NCT02596711|Surveys|surveys
111381|NCT02596711|Carbon Monoxide Test|carbon monoxide test
111382|NCT02596711|CO|co
111383|NCT02596711|Health Education|health education
111384|NCT02596711|Handouts|handouts
111385|NCT02596711|Pamphlets|pamphlets
111386|NCT02596711|Counseling sessions|counseling sessions
111387|NCT02596698|Mood Disorder|mood disorder
111388|NCT02596672|physical activity|physical activity
111389|NCT02596672|older adults|older adults
111390|NCT02596672|retirement homes|retirement homes
111391|NCT02596672|walking|walking
111392|NCT02596672|feasibility study|feasibility study
111393|NCT02596659|lateral epicondylosis|lateral epicondylosis
111394|NCT02596659|lateral epicondylitis|lateral epicondylitis
111395|NCT02596659|shockwave|shockwave
111396|NCT02596659|sonoelastography|sonoelastography
111397|NCT02596659|tennis elbow|tennis elbow
111398|NCT02596659|pain intensity|pain intensity
111399|NCT02596659|grip strength|grip strength
111400|NCT02596659|upper limb function|upper limb function
111401|NCT02596659|stiffness of common extensor tendon|stiffness of common extensor tendon
111402|NCT02596620|Helicobacter pylori|helicobacter pylori
111403|NCT02596620|Proton pump inhibitor|proton pump inhibitor
111404|NCT02596620|Eradication|eradication
111503|NCT02595970|AIN457A|ain457a
111504|NCT02595957|Exome Sequencing|exome sequencing
111405|NCT02596607|ischemic stroke, acute phase, thrombolysis, management times|ischemic stroke, acute phase, thrombolysis, management times
111407|NCT02596594|severe IUGR|severe iugr
111408|NCT02596594|brain sparing|brain sparing
644431|NCT00752986|ZD6474|zd6474
111409|NCT02596594|fetal nutrition|fetal nutrition
111410|NCT02596594|Prolongation|prolongation
111411|NCT02596594|pregnancy|pregnancy
111412|NCT02596594|neonatal outcome|neonatal outcome
111413|NCT02596581|periodontitis|periodontitis
111414|NCT02596581|diabetes mellitus|diabetes mellitus
111415|NCT02596581|chemerin|chemerin
111416|NCT02596581|interleukin-6|interleukin-6
111417|NCT02596503|young adults|young adults
111418|NCT02596503|adolescents|adolescents
111419|NCT02596490|Non-Small Cell Lung Cancer|non-small cell lung cancer
111420|NCT02596490|NSCLC|nsclc
111421|NCT02596490|Couples-based meditation program|couples-based meditation program
111422|NCT02596490|Couples-based cancer-related discussion program|couples-based cancer-related discussion program
111423|NCT02596490|Questionnaires|questionnaires
111424|NCT02596490|Surveys|surveys
111425|NCT02596490|Metastatic lung cancer|metastatic lung cancer
111426|NCT02596490|Quality of life|quality of life
111427|NCT02596490|QOL|qol
111428|NCT02596477|Heart failure|heart failure
111429|NCT02596412|children|children
111430|NCT02596412|botulinum toxin|botulinum toxin
111431|NCT02596412|augmented reality|augmented reality
111432|NCT02596412|Pain|pain
111433|NCT02596399|Healthy volunteers|healthy volunteers
111434|NCT02596399|DSTA4637S|dsta4637s
111435|NCT02596360|Antinociception|antinociception
111436|NCT02596360|Freeze-induced hyperalgesia model|freeze-induced hyperalgesia model
111437|NCT02596360|Dextromethorphan|dextromethorphan
111438|NCT02596360|NMDA-receptors|nmda-receptors
111439|NCT02596360|Pharmacogenetic|pharmacogenetic
111440|NCT02596360|CYP3A4 gene|cyp3a4 gene
111441|NCT02596360|MDR1 gene|mdr1 gene
111442|NCT02596334|HIV-1 infected patient|hiv-1 infected patient
111443|NCT02596334|monotherapy|monotherapy
111444|NCT02596334|dolutegravir|dolutegravir
111445|NCT02596321|House Dust Mite|house dust mite
111446|NCT02596308|Plague vaccine|plague vaccine
111447|NCT02596308|Immunogenicity|immunogenicity
111448|NCT02596308|Safety|safety
111449|NCT02596282|neonatal male circumcision|neonatal male circumcision
111450|NCT02596282|Clinical officers vs Nurse midwives|clinical officers vs nurse midwives
111451|NCT02596282|Rakai, Uganda|rakai, uganda
111452|NCT02596282|acceptability and safety of neonatal male circumcision|acceptability and safety of neonatal male circumcision
111453|NCT02596243|CIN2, CIN2/3, CIN3|cin2, cin2/3, cin3
111454|NCT02596243|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
111455|NCT02596243|High-Risk HPV|high-risk hpv
111456|NCT02596243|HPV infection|hpv infection
111457|NCT02596243|precancer Diseases|precancer diseases
111458|NCT02596243|Double Blind|double blind
111459|NCT02596243|Safety/Efficacy|safety/efficacy
111460|NCT02596217|ABBV-066|abbv-066
111461|NCT02596217|BI 655066|bi 655066
111462|NCT02596217|risankizumab|risankizumab
111463|NCT02596165|validation|validation
111464|NCT02596165|pulse wave analysis|pulse wave analysis
111465|NCT02596165|blood pressure monitoring|blood pressure monitoring
111466|NCT02596152|balance|balance
111467|NCT02596152|strength|strength
111468|NCT02596152|barriers towards exercise|barriers towards exercise
111469|NCT02596152|quality of life|quality of life
111470|NCT02596152|body dissatisfaction|body dissatisfaction
111471|NCT02596152|executive functions|executive functions
111472|NCT02596152|eating behavior|eating behavior
111473|NCT02596152|fitness|fitness
111474|NCT02596126|Polypill|polypill
111475|NCT02596126|Prevention of Secondary Cardiovascular Disease|prevention of secondary cardiovascular disease
111476|NCT02596126|Cardiovascular Disease|cardiovascular disease
111477|NCT02596126|Myocardial Infarction|myocardial infarction
111478|NCT02596126|Cardiovascular Combination Polypill AAR|cardiovascular combination polypill aar
111479|NCT02596126|Cardiovascular Disease in the Elderly|cardiovascular disease in the elderly
111481|NCT02596126|SECURE|secure
111482|NCT02596126|Elderly|elderly
111483|NCT02596126|Secondary Cardiovascular Disease|secondary cardiovascular disease
111484|NCT02596126|Secondary Cardiovascular Prevention|secondary cardiovascular prevention
111485|NCT02596126|Randomized Cardiovascular Trial|randomized cardiovascular trial
111486|NCT02596126|Randomized Trial|randomized trial
111487|NCT02596126|Cardiovascular Polypill|cardiovascular polypill
111488|NCT02596113|colorectal cancer|colorectal cancer
111489|NCT02596113|genes involved in carcinogenesis of the colon|genes involved in carcinogenesis of the colon
111490|NCT02596113|screening colorectal cancer|screening colorectal cancer
111491|NCT02596100|Bioequivalence|bioequivalence
111492|NCT02596009|COPD|copd
111493|NCT02595983|FAP|fap
111494|NCT02595983|Familial Amyloidotic Polyneuropathy|familial amyloidotic polyneuropathy
111495|NCT02595983|ATTR Amyloidosis|attr amyloidosis
111496|NCT02595983|Orthotopic Liver Transplant|orthotopic liver transplant
111497|NCT02595983|RNAi therapeutic|rnai therapeutic
111498|NCT02595970|Psoriasis|psoriasis
111499|NCT02595970|Secukinumab|secukinumab
111500|NCT02595970|Simplified Psoriasis Index|simplified psoriasis index
111501|NCT02595970|CAIN457A|cain457a
111502|NCT02595970|AIN457AFR01|ain457afr01
111505|NCT02595957|Incidental or Secondary Findings|incidental or secondary findings
111506|NCT02595853|Upper GastroIntestinal bleeding, endoscopy, Hemospray|upper gastrointestinal bleeding, endoscopy, hemospray
111507|NCT02595827|Pediatrics|pediatrics
111508|NCT02595827|Epidemiology|epidemiology
111509|NCT02595827|Fever|fever
111510|NCT02595827|Democratic Republic of the Congo|democratic republic of the congo
111511|NCT02595827|Randomized Controlled Trial|randomized controlled trial
111512|NCT02595814|Registry|registry
111513|NCT02595814|Heart failure|heart failure
111514|NCT02595814|Hospitalized|hospitalized
111515|NCT02595814|Global|global
133112|NCT02467374|OCD|ocd
102584|NCT02648776|sleep disorders|sleep disorders
102585|NCT02648776|elderly|elderly
102586|NCT02648750|self-management|self-management
102587|NCT02648750|rehabilitation|rehabilitation
102588|NCT02648737|Parkinson's disease|parkinson's disease
102589|NCT02648737|Cognitive Behavioural therapy|cognitive behavioural therapy
102590|NCT02648737|generalized anxiety disorder|generalized anxiety disorder
102592|NCT02648737|cerebral connectivity|cerebral connectivity
102594|NCT02648711|solid tumors|solid tumors
102595|NCT02648698|chronic endometritis|chronic endometritis
102597|NCT02648685|post prandial glucose (PPG)|post prandial glucose (ppg)
102598|NCT02648685|basal blood glucose (BBG)|basal blood glucose (bbg)
102599|NCT02648685|overall glycaemia|overall glycaemia
102600|NCT02648633|Brain Cancer|brain cancer
102601|NCT02648633|Immunotherapy|immunotherapy
102602|NCT02648633|Nivolumab|nivolumab
102604|NCT02648633|Gamma Knife|gamma knife
111516|NCT02595814|Morbidity|morbidity
111517|NCT02595814|Mortality|mortality
111518|NCT02595814|Quality of life|quality of life
111519|NCT02595814|AHF|ahf
111520|NCT02595775|endoscopy measures|endoscopy measures
111521|NCT02595775|audit and feedback|audit and feedback
111522|NCT02595775|quality improvement|quality improvement
111523|NCT02595775|randomized controlled trial|randomized controlled trial
111524|NCT02595775|Colonoscopy|colonoscopy
111525|NCT02595710|Cryptogenic Chronic Hepatitis|cryptogenic chronic hepatitis
111526|NCT02595710|Bartonellosis|bartonellosis
111527|NCT02595684|Obesity|obesity
111528|NCT02595684|Tadalfil|tadalfil
111529|NCT02595684|Insulin secretion|insulin secretion
111530|NCT02595684|Insulin sensitivity|insulin sensitivity
111531|NCT02595671|Digital coaching|digital coaching
111532|NCT02595671|Sustainable weight loss|sustainable weight loss
111533|NCT02595671|Self-determination theory|self-determination theory
111534|NCT02595671|Obesity|obesity
111535|NCT02595671|Overweight|overweight
111536|NCT02595671|Diet|diet
111537|NCT02595671|Physical activity|physical activity
111538|NCT02595645|colorectal adenoma|colorectal adenoma
111539|NCT02595645|colorectal cancer|colorectal cancer
111540|NCT02595645|next generation sequencing|next generation sequencing
111541|NCT02595645|liquid biopsy|liquid biopsy
111542|NCT02595645|screening colonoscopy|screening colonoscopy
111543|NCT02595645|surveillance strategies|surveillance strategies
111544|NCT02595619|AKI|aki
111545|NCT02595619|Extracorporeal Carbon Dioxide Removal|extracorporeal carbon dioxide removal
111546|NCT02595619|Renal Replacement Therapy|renal replacement therapy
111547|NCT02595619|Mechanical Ventilation|mechanical ventilation
111548|NCT02595606|dry eye syndromes|dry eye syndromes
111549|NCT02595606|diabetes mellitus|diabetes mellitus
111550|NCT02595593|Trauma|trauma
111551|NCT02595593|Rib Plate|rib plate
111552|NCT02595593|Rib Fixation|rib fixation
111553|NCT02595580|Blood Glucose Self-Monitoring|blood glucose self-monitoring
111554|NCT02595567|Liver disease|liver disease
111555|NCT02595567|Pleural effusion|pleural effusion
111556|NCT02595554|Cervical cancer, Stage IIB, Neoadjuvant chemotherapy|cervical cancer, stage iib, neoadjuvant chemotherapy
111557|NCT02595541|pediatric|pediatric
111558|NCT02595541|cardiac|cardiac
111559|NCT02595541|sildenfil|sildenfil
111560|NCT02595541|milrinone|milrinone
111561|NCT02595541|pulmonary hypertension|pulmonary hypertension
111562|NCT02595489|Leukodystrophy|leukodystrophy
111563|NCT02595489|ABCD1|abcd1
111564|NCT02595489|Demyelination|demyelination
111565|NCT02595489|Inflammation|inflammation
111566|NCT02595489|ALD|ald
111567|NCT02595489|Vitamin D|vitamin d
111568|NCT02595489|Oxidative Stress|oxidative stress
111569|NCT02595489|X- linked|x- linked
111570|NCT02595489|Adrenoleukodystrophy|adrenoleukodystrophy
111571|NCT02595476|analgesia|analgesia
111572|NCT02595476|pupillometry|pupillometry
111573|NCT02595476|general anesthesia|general anesthesia
111574|NCT02595450|Non-small cell lung cancer|non-small cell lung cancer
111575|NCT02595437|dialysis|dialysis
111576|NCT02595437|pediatric|pediatric
111577|NCT02595437|chronic kidney disease|chronic kidney disease
111578|NCT02595411|Children|children
111579|NCT02595411|Rehabilitation|rehabilitation
102685|NCT02648334|Drug-Coated Balloon|drug-coated balloon
102686|NCT02648334|Superficial Femoral artery|superficial femoral artery
111580|NCT02595411|Upper Limb|upper limb
111581|NCT02595411|Assessments|assessments
111582|NCT02595411|Outcome Measures|outcome measures
111583|NCT02595398|Uveitis|uveitis
111584|NCT02595398|UME|ume
111585|NCT02595398|Posterior Uveitis|posterior uveitis
111586|NCT02595398|Anterior Uveitis|anterior uveitis
111587|NCT02595398|Intermediate Uveitis|intermediate uveitis
111588|NCT02595398|Panuveitis|panuveitis
111589|NCT02595398|Non-infectious Uveitis|non-infectious uveitis
111590|NCT02595398|Triamcinolone|triamcinolone
111591|NCT02595398|Choroid|choroid
111592|NCT02595398|Choroidal Injection|choroidal injection
111593|NCT02595398|Suprachoroidal|suprachoroidal
111594|NCT02595398|Microneedle|microneedle
111595|NCT02595398|Microinjection|microinjection
111596|NCT02595359|endophthalmitis|endophthalmitis
111597|NCT02595359|antibiotic therapy|antibiotic therapy
111598|NCT02595359|cataract surgery|cataract surgery
111599|NCT02595359|prevention|prevention
111600|NCT02595333|repeat cesarean section|repeat cesarean section
111601|NCT02595333|pain|pain
111602|NCT02595320|breast, gastrointestinal,capecitabine, cancer, metastatic|breast, gastrointestinal,capecitabine, cancer, metastatic
111603|NCT02595307|Risk Recall|risk recall
111604|NCT02595307|Pamphlet|pamphlet
111605|NCT02595307|Brochure|brochure
111606|NCT02595307|Patient satisfaction|patient satisfaction
111607|NCT02595307|Informed Consent|informed consent
111608|NCT02595281|Ovarian Carcinoma|ovarian carcinoma
111609|NCT02595281|neoadjuvant|neoadjuvant
111610|NCT02595281|ROMA|roma
111611|NCT02595281|Ca125|ca125
111612|NCT02595281|HE4|he4
111613|NCT02595281|biomarker|biomarker
111614|NCT02595268|Healthy|healthy
111615|NCT02595268|Pitavastatin|pitavastatin
111616|NCT02595268|JNJ-63623872|jnj-63623872
111617|NCT02595255|chemotherapy/GnRH analogues/lymphoma/children/fertility|chemotherapy/gnrh analogues/lymphoma/children/fertility
111618|NCT02595203|Bioavailability|bioavailability
111619|NCT02595190|Sacral perineurial cysts(Tarlov Cysts)|sacral perineurial cysts(tarlov cysts)
111620|NCT02595190|Resting state functional magnetic resonance imaging (rfMRI)|resting state functional magnetic resonance imaging (rfmri)
111621|NCT02595190|VAS|vas
111622|NCT02595190|Medicine conservative treatment|medicine conservative treatment
111623|NCT02595190|Surgical treatment|surgical treatment
111624|NCT02595177|multifocal IOL|multifocal iol
111625|NCT02595177|monovision|monovision
111626|NCT02595177|hybrid monovision|hybrid monovision
111627|NCT02595177|spectacles independence|spectacles independence
111628|NCT02595151|Probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
111629|NCT02595151|chronic atrophic antral gastritis|chronic atrophic antral gastritis
111630|NCT02595151|microcirculatory dynamics|microcirculatory dynamics
111631|NCT02595138|zoledronic acid|zoledronic acid
111632|NCT02595138|triple-negative breast cancer|triple-negative breast cancer
111633|NCT02595138|adjuvant treatment|adjuvant treatment
111634|NCT02595125|intrauterine device|intrauterine device
111635|NCT02595125|contraceptive method|contraceptive method
111636|NCT02595125|direct technique|direct technique
111637|NCT02595125|torpedo technique|torpedo technique
111638|NCT02595125|verbal numeric scale|verbal numeric scale
111639|NCT02595112|staphylococcal infections|staphylococcal infections
111640|NCT02595112|nasal carriage|nasal carriage
111641|NCT02595112|nasal cavity|nasal cavity
111642|NCT02595112|Staphylococcus aureus|staphylococcus aureus
111643|NCT02595060|acute lung injury, molgramostim, GM-CSF, pneumonia, barrier restoration|acute lung injury, molgramostim, gm-csf, pneumonia, barrier restoration
111644|NCT02595047|Self-regeneration, in vivo tissue prefabrication,|self-regeneration, in vivo tissue prefabrication,
111645|NCT02595021|Total or subtotal colectomy|total or subtotal colectomy
111646|NCT02595021|Ovarian cancer|ovarian cancer
111647|NCT02595021|Complications|complications
111648|NCT02595021|One-year disease-free survival|one-year disease-free survival
111649|NCT02595021|Stage IIIc|stage iiic
111650|NCT02595021|Stage IV|stage iv
111651|NCT02594982|Delirium|delirium
111652|NCT02594982|intensive care nursing|intensive care nursing
111653|NCT02594982|Acute acquired brain injury|acute acquired brain injury
111654|NCT02594982|neurointensive care|neurointensive care
111655|NCT02594982|Intensive care delirium screening checklist|intensive care delirium screening checklist
111656|NCT02594982|Confusion Assessment Method for the ICU|confusion assessment method for the icu
111657|NCT02594969|atopic dermatitis|atopic dermatitis
111658|NCT02594956|nasogastric decompression|nasogastric decompression
111659|NCT02594943|Diagnostics|diagnostics
111660|NCT02594943|Biopsy|biopsy
111661|NCT02594943|Diffuse gastric cancer|diffuse gastric cancer
111662|NCT02594930|synovial biopsy|synovial biopsy
111663|NCT02594930|knee arthroplasty|knee arthroplasty
111664|NCT02594930|infection|infection
111665|NCT02594904|G6PD Deficiency|g6pd deficiency
111666|NCT02594904|Neonatal Hyperbilirubinemia|neonatal hyperbilirubinemia
111667|NCT02594904|Yinzhihuang Oral Liquid|yinzhihuang oral liquid
111668|NCT02594904|Indirect Bilirubin|indirect bilirubin
111669|NCT02594891|cholangitis|cholangitis
111670|NCT02594891|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
111671|NCT02594891|complication|complication
111672|NCT02594878|Chronic non-bacterial osteomyelitis|chronic non-bacterial osteomyelitis
111673|NCT02594878|Chronic recurrent multifocal osteomyelitis|chronic recurrent multifocal osteomyelitis
111674|NCT02594878|Non- bacterial osteomyelitis|non- bacterial osteomyelitis
111675|NCT02594878|SAPHO syndrome|sapho syndrome
111676|NCT02594878|Whole body MRI|whole body mri
111677|NCT02594878|Pamidronate|pamidronate
111678|NCT02594878|Inflammatory bone disease|inflammatory bone disease
111679|NCT02594878|Autoinflammatory disease|autoinflammatory disease
111680|NCT02594865|Enteral Nutrition|enteral nutrition
111681|NCT02594865|Continuous Glucose Monitoring|continuous glucose monitoring
111682|NCT02594839|interstitial lung disease|interstitial lung disease
111683|NCT02594839|idiopathic interstitial pneumonia|idiopathic interstitial pneumonia
111684|NCT02594839|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
111685|NCT02594839|stem cells|stem cells
111686|NCT02594800|Atherosclerotic Intracranial Arterial Stenosis|atherosclerotic intracranial arterial stenosis
111687|NCT02594800|Intensive Rosuvastatin Therapy|intensive rosuvastatin therapy
111688|NCT02594800|Computed Tomography Perfusion (CTP)|computed tomography perfusion (ctp)
111689|NCT02594735|Juvenile dermatomyositis|juvenile dermatomyositis
111690|NCT02594735|inflammatory myopathies|inflammatory myopathies
111691|NCT02594735|Orencia|orencia
111692|NCT02594735|Abatacept|abatacept
111693|NCT02594722|COPD|copd
111694|NCT02594722|Functional Electrical Stimulation Cycling|functional electrical stimulation cycling
111695|NCT02594722|Pulmonary Rehabilitation|pulmonary rehabilitation
111696|NCT02594696|Major depression and Cancer|major depression and cancer
111697|NCT02594696|Schizophrenia and Cancer|schizophrenia and cancer
111698|NCT02594696|Bipolar disorder and Cancer|bipolar disorder and cancer
111699|NCT02594696|Lung Cancer|lung cancer
111700|NCT02594696|Breast Cancer|breast cancer
111701|NCT02594696|Head and Neck cancer|head and neck cancer
111702|NCT02594696|GI cancer|gi cancer
111703|NCT02594696|Schizophrenia|schizophrenia
111704|NCT02594696|Bipolar disorder|bipolar disorder
111705|NCT02594670|acupoints|acupoints
111706|NCT02594670|insomnia|insomnia
111707|NCT02594670|acupuncture|acupuncture
111708|NCT02594670|randomized controlled trial|randomized controlled trial
111709|NCT02594657|Eccentric|eccentric
111710|NCT02594657|Ergometer|ergometer
111711|NCT02594657|Pedal rate|pedal rate
111712|NCT02594657|Oxygen consumption|oxygen consumption
111713|NCT02594657|Only health volunteers|only health volunteers
111714|NCT02594631|Urethral stones|urethral stones
111715|NCT02594631|Acute Cacular urinary retention|acute cacular urinary retention
111716|NCT02594631|Extracorporeal Shock Wave Lithotripsy (ESWL)|extracorporeal shock wave lithotripsy (eswl)
111717|NCT02594631|Visual lithotripsy|visual lithotripsy
111718|NCT02594631|bladder stone|bladder stone
111719|NCT02594592|Osteoporosis|osteoporosis
111720|NCT02594592|Osteoporosis Self-Assessment Tool|osteoporosis self-assessment tool
111721|NCT02594592|One-Minute Osteoporosis Risk Test|one-minute osteoporosis risk test
111722|NCT02594592|Asians|asians
111723|NCT02594566|Cytomegalovirus|cytomegalovirus
111724|NCT02594566|Vaccine|vaccine
111725|NCT02594566|Congenital Infection|congenital infection
111726|NCT02594553|Antibiotics|antibiotics
111727|NCT02594553|Children|children
111728|NCT02594553|General Practitioner|general practitioner
111729|NCT02594553|GP|gp
111730|NCT02594553|After-hours care|after-hours care
111731|NCT02594553|Out-of-hours care|out-of-hours care
111732|NCT02594553|Booklet|booklet
111733|NCT02594553|Primary Health Care|primary health care
111734|NCT02594553|Child|child
111735|NCT02594527|Older people|older people
111736|NCT02594527|Physical activity|physical activity
111737|NCT02594527|Hospital|hospital
111738|NCT02594514|cardiovascular risk|cardiovascular risk
111739|NCT02594514|metabolic profile|metabolic profile
111740|NCT02594488|Myocardial infarction|myocardial infarction
111741|NCT02594488|Autonomic nervous system|autonomic nervous system
111742|NCT02594488|Risk stratification|risk stratification
111743|NCT02594488|Implantable cardiac monitor|implantable cardiac monitor
111744|NCT02594488|Sudden cardiac death|sudden cardiac death
111745|NCT02594488|ECG|ecg
111746|NCT02594475|endoscopic retrograde cholangiopancreatography, position|endoscopic retrograde cholangiopancreatography, position
111747|NCT02594462|contraception|contraception
111748|NCT02594462|Anemia, Sickle Cell|anemia, sickle cell
111749|NCT02594449|Pharmacodynamic Study of BCS|pharmacodynamic study of bcs
111750|NCT02594436|Actinic Keratosis|actinic keratosis
111751|NCT02594436|topical|topical
111752|NCT02594436|ingenol mebutate|ingenol mebutate
111753|NCT02594436|Picato®|picato®
111754|NCT02594384|Phase 1|phase 1
111755|NCT02594384|Safety|safety
111756|NCT02594384|Apilimod dimesylate|apilimod dimesylate
111757|NCT02594384|Pharmacokinetics|pharmacokinetics
111758|NCT02594384|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
111759|NCT02594358|Caffeine|caffeine
133489|NCT02465216|TB|tb
111760|NCT02594332|eosinophilic asthma|eosinophilic asthma
111761|NCT02594332|mepolizumab|mepolizumab
111768|NCT02594267|PTCL|ptcl
111769|NCT02594267|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
111770|NCT02594267|Folotyn|folotyn
111771|NCT02594267|Pralatrexate|pralatrexate
111772|NCT02594267|CHOP|chop
111773|NCT02594241|Ventral hernia|ventral hernia
111774|NCT02594241|Abdominal wall reconstruction|abdominal wall reconstruction
111775|NCT02594241|Enhanced recovery after surgery|enhanced recovery after surgery
111776|NCT02594241|Steroid|steroid
111777|NCT02594215|Overgrowth|overgrowth
111778|NCT02594202|Specimen Collection|specimen collection
111897|NCT02593474|Youth|youth
111779|NCT02594202|Carcinogenesis|carcinogenesis
111780|NCT02594202|Prognostic Biomarkers|prognostic biomarkers
111781|NCT02594202|Molecular Mechanims|molecular mechanims
111782|NCT02594202|Cell Lines|cell lines
111783|NCT02594189|Influenza A|influenza a
111784|NCT02594189|H3N2|h3n2
111785|NCT02594189|Challenge Model|challenge model
111786|NCT02594189|Influenza|influenza
111787|NCT02594189|Human Challenge|human challenge
111788|NCT02594176|Osteoarthritis|osteoarthritis
111789|NCT02594176|Pain|pain
111790|NCT02594176|NSAID|nsaid
111791|NCT02594176|Sequessome|sequessome
111799|NCT02594124|ISIS-SMN Rx|isis-smn rx
111800|NCT02594124|ISIS 396443|isis 396443
111802|NCT02594124|IONIS-SMNRx|ionis-smnrx
111803|NCT02594124|IONIS-SMN Rx|ionis-smn rx
111804|NCT02594124|Spinraza|spinraza
111805|NCT02594124|nusinersen|nusinersen
111806|NCT02594111|inflammation|inflammation
111807|NCT02594111|percutaneous coronary intervention|percutaneous coronary intervention
111808|NCT02594111|coronary artery disease|coronary artery disease
111809|NCT02594111|colchicine|colchicine
111810|NCT02594098|Atopic dermatitis|atopic dermatitis
111811|NCT02594098|extrinsic atopic dermatitis|extrinsic atopic dermatitis
111812|NCT02594098|intrinsic atopic dermatitis|intrinsic atopic dermatitis
111813|NCT02594059|endothelial function, idiopathic pulmonary fibrosis|endothelial function, idiopathic pulmonary fibrosis
111814|NCT02594020|suspected caries|suspected caries
111815|NCT02594020|initial enamel lesions|initial enamel lesions
111816|NCT02594007|telehealth|telehealth
111817|NCT02594007|heart failure|heart failure
111823|NCT02593981|sleep|sleep
111824|NCT02593981|fruit|fruit
111825|NCT02593981|honey|honey
111826|NCT02593981|geriatric|geriatric
111827|NCT02593929|squamous cell carcinoma|squamous cell carcinoma
111828|NCT02593929|head and neck cancer|head and neck cancer
111829|NCT02593929|operable|operable
111830|NCT02593903|Antibiotic Prophylaxis|antibiotic prophylaxis
111831|NCT02593890|Breast Cancer|breast cancer
111832|NCT02593890|Breast Surgery|breast surgery
111833|NCT02593890|Mastectomy|mastectomy
111834|NCT02593890|Lumpectomy|lumpectomy
111835|NCT02593890|Post-operative|post-operative
111836|NCT02593890|Bra|bra
111837|NCT02593890|Lingerie|lingerie
111838|NCT02593890|Body Image|body image
111839|NCT02593890|Psycho-social|psycho-social
111840|NCT02593890|Impact|impact
111841|NCT02593877|Trauma|trauma
111842|NCT02593877|Hemostasis|hemostasis
111843|NCT02593877|Resuscitation|resuscitation
111844|NCT02593877|Coagulopathy|coagulopathy
111845|NCT02593877|Transfusion|transfusion
111846|NCT02593851|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
111847|NCT02593851|JNJ-53718678|jnj-53718678
111848|NCT02593851|Placebo|placebo
111849|NCT02593851|Infants|infants
111850|NCT02593812|Learning|learning
111851|NCT02593812|Practice|practice
111852|NCT02593799|Liver cirrhosis|liver cirrhosis
111853|NCT02593799|Esophageal and Gastric Varices|esophageal and gastric varices
111854|NCT02593799|Endoscopy|endoscopy
111855|NCT02593773|Interferon gamma|interferon gamma
111856|NCT02593747|Allergy|allergy
111857|NCT02593708|HER2+|her2+
111858|NCT02593695|Anorexia Nervosa|anorexia nervosa
111859|NCT02593695|Deep Brain Stimulation|deep brain stimulation
111860|NCT02593695|Nucleus accumbens|nucleus accumbens
111861|NCT02593656|protein ingestion|protein ingestion
111862|NCT02593656|resistance exercise|resistance exercise
111863|NCT02593656|interval exercise|interval exercise
111864|NCT02593656|stretching exercise|stretching exercise
111865|NCT02593656|endurance exercise|endurance exercise
111866|NCT02593643|Major Depressive Disorder|major depressive disorder
111867|NCT02593643|Bipolar Disorder|bipolar disorder
111868|NCT02593643|Depression|depression
111869|NCT02593643|Suicide|suicide
111870|NCT02593643|Suicidal Ideation|suicidal ideation
111871|NCT02593643|Ketamine|ketamine
111872|NCT02593643|Midazolam|midazolam
111873|NCT02593643|Inpatients|inpatients
111874|NCT02593617|Energy Drinks|energy drinks
111875|NCT02593617|Alcohol Drinking|alcohol drinking
111876|NCT02593617|Substance Use|substance use
111877|NCT02593604|Hidradenitis suppurativa|hidradenitis suppurativa
111878|NCT02593604|Wide excision|wide excision
111879|NCT02593604|Quality of Life|quality of life
111880|NCT02593604|Sexual Function|sexual function
111881|NCT02593539|APDS|apds
111882|NCT02593539|Safety|safety
111883|NCT02593539|Pharmacokinetics|pharmacokinetics
111884|NCT02593539|GSK2269557|gsk2269557
111885|NCT02593539|PASLI|pasli
111886|NCT02593513|Embryo Transfer|embryo transfer
111887|NCT02593513|Embryo Selection Criteria for Implantation|embryo selection criteria for implantation
111888|NCT02593513|Assisted Reproductive Technology|assisted reproductive technology
111889|NCT02593500|Bioequivalence, budesonide,|bioequivalence, budesonide,
111890|NCT02593487|Coronary Artery Disease|coronary artery disease
111891|NCT02593487|Hyperlipidemia|hyperlipidemia
111892|NCT02593487|Rosuvastatin|rosuvastatin
111893|NCT02593487|Lipoproteins|lipoproteins
111894|NCT02593487|high-density lipoprotein|high-density lipoprotein
111895|NCT02593487|HDL2|hdl2
111896|NCT02593474|Adolescent|adolescent
111898|NCT02593461|Embryo Transfer|embryo transfer
111899|NCT02593461|Embryo Selection Criteria for Implantation|embryo selection criteria for implantation
111900|NCT02593461|Assisted Reproductive Technology|assisted reproductive technology
111901|NCT02593448|Cardiopulmonary Bypass|cardiopulmonary bypass
111902|NCT02593448|Anoxia|anoxia
111903|NCT02593435|BRCA1/2 gene mutation|brca1/2 gene mutation
111904|NCT02593435|Breast Cancer|breast cancer
111905|NCT02593435|Chinese high risk group|chinese high risk group
111906|NCT02593422|ovarian cancer|ovarian cancer
111907|NCT02593422|expressive writing|expressive writing
111908|NCT02593422|writing interventions|writing interventions
111909|NCT02593422|psychosocial support|psychosocial support
111910|NCT02593409|HIV-1|hiv-1
111911|NCT02593409|pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
111912|NCT02593409|immune response|immune response
111913|NCT02593396|sexual dysfunctions|sexual dysfunctions
111914|NCT02593396|erectile dysfunctions|erectile dysfunctions
111915|NCT02593396|hypoactive sexual desire dysfunctions|hypoactive sexual desire dysfunctions
111916|NCT02593383|safety|safety
111917|NCT02593383|efficacy|efficacy
111918|NCT02593370|Hip surgery anesthesia|hip surgery anesthesia
111919|NCT02593370|Perioperative analgesia|perioperative analgesia
111920|NCT02593357|endothelial function|endothelial function
111921|NCT02593357|COPD|copd
111922|NCT02593357|pulmonary function|pulmonary function
111923|NCT02593344|asthma, endothelial function|asthma, endothelial function
111924|NCT02593318|energy metabolism|energy metabolism
111925|NCT02593318|oxaloacetate|oxaloacetate
111926|NCT02593305|nitrate|nitrate
111927|NCT02593305|blood flow|blood flow
111928|NCT02593305|blood pressure|blood pressure
111929|NCT02593305|vascular function|vascular function
111930|NCT02593305|hypoxia|hypoxia
111931|NCT02593292|Clinical pathway|clinical pathway
111932|NCT02593292|Electronic Health Records|electronic health records
111933|NCT02593292|Maternal Health Services & administration|maternal health services & administration
111934|NCT02593292|Patient Access to Records|patient access to records
111935|NCT02593292|Patient Satisfaction|patient satisfaction
111936|NCT02593292|Prenatal Care/methods|prenatal care/methods
111937|NCT02593279|Asthma|asthma
111938|NCT02593279|phenotype|phenotype
111939|NCT02593279|small|small
111940|NCT02593279|airway|airway
111941|NCT02593279|proximal|proximal
111942|NCT02593279|dysfunction|dysfunction
111943|NCT02593266|Prevention|prevention
111944|NCT02593266|Family|family
111945|NCT02593266|Intervention|intervention
111946|NCT02593266|Depression|depression
111947|NCT02593266|Children|children
111948|NCT02593253|Quality Improvement|quality improvement
111949|NCT02593253|Quality Indicators, Health Care|quality indicators, health care
111950|NCT02593253|Hospital Medicine|hospital medicine
111951|NCT02593240|Energy|energy
111952|NCT02593240|Presenteeism|presenteeism
111953|NCT02593240|Absenteeism|absenteeism
111954|NCT02593240|Cardiometabolic health|cardiometabolic health
111955|NCT02593240|Obesity|obesity
111956|NCT02593240|Overweight|overweight
111957|NCT02593240|Weight Loss|weight loss
111958|NCT02593240|Quality of Life|quality of life
111959|NCT02593240|Weight Control|weight control
111960|NCT02593240|Eating Behavior|eating behavior
111961|NCT02593240|Food Cravings|food cravings
111962|NCT02593240|Hunger|hunger
111963|NCT02593240|Worksite Wellness|worksite wellness
111964|NCT02593227|TNBC|tnbc
111965|NCT02593214|Condoms, Female|condoms, female
111966|NCT02593214|Contraception, Barrier|contraception, barrier
111967|NCT02593175|Triple-Negative Breast Cancer|triple-negative breast cancer
111968|NCT02593175|TNBC|tnbc
111969|NCT02593175|Panitumumab|panitumumab
111970|NCT02593175|Vectibix|vectibix
111971|NCT02593175|Paclitaxel|paclitaxel
111972|NCT02593175|Taxol|taxol
111973|NCT02593175|Carboplatin|carboplatin
111974|NCT02593175|Paraplatin|paraplatin
111975|NCT02593175|Biopsy|biopsy
111976|NCT02593175|Fine-needle aspiration|fine-needle aspiration
111978|NCT02593136|Vitamins|vitamins
111979|NCT02593136|Public Health|public health
111980|NCT02593136|Nutrition|nutrition
111981|NCT02593084|Resistance Training|resistance training
111982|NCT02593084|Exercise|exercise
111984|NCT02593084|Safety|safety
111985|NCT02593084|Feasibility Studies|feasibility studies
111986|NCT02593058|Anhedonia|anhedonia
111987|NCT02593058|Apathy|apathy
111988|NCT02593058|Negative symptoms|negative symptoms
111989|NCT02593058|Anticipatory pleasure|anticipatory pleasure
111996|NCT02593006|comparative effectiveness|comparative effectiveness
111997|NCT02592967|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
111998|NCT02592967|JNJ-64041757|jnj-64041757
111999|NCT02592967|Listeria monocytogenes|listeria monocytogenes
112000|NCT02592928|eHealth|ehealth
112001|NCT02592928|Spirometry|spirometry
112002|NCT02592928|Lung Function|lung function
112003|NCT02592928|Primary Care|primary care
112008|NCT02592902|laryngeal cyst|laryngeal cyst
112009|NCT02592902|phonosurgery|phonosurgery
112010|NCT02592902|oesophageal impedance|oesophageal impedance
112011|NCT02592889|MITRAL REGURGITATION|mitral regurgitation
112608|NCT02589275|sublingual|sublingual
112012|NCT02592876|Antibodies, Monoclonal|antibodies, monoclonal
112013|NCT02592876|Antibody-Drug Conjugate|antibody-drug conjugate
112014|NCT02592876|Antigens, CD19|antigens, cd19
112015|NCT02592876|Autologous Stem Cell Transplant|autologous stem cell transplant
112016|NCT02592876|Drug Therapy|drug therapy
112017|NCT02592876|Follicular Lymphoma Grade 3b|follicular lymphoma grade 3b
112018|NCT02592876|Hematologic Diseases|hematologic diseases
112019|NCT02592876|Immune System Diseases|immune system diseases
112020|NCT02592876|Immunoproliferative Disorders|immunoproliferative disorders
112021|NCT02592876|Immunotherapy|immunotherapy
112022|NCT02592876|Lymphatic Diseases|lymphatic diseases
112023|NCT02592876|Lymphoma|lymphoma
112024|NCT02592876|Lymphoma, B-Cell|lymphoma, b-cell
112025|NCT02592876|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
112026|NCT02592876|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
112027|NCT02592876|Monomethylauristatin F|monomethylauristatin f
112028|NCT02592876|Neoplasms|neoplasms
112029|NCT02592876|Neoplasms by Histologic Type|neoplasms by histologic type
112030|NCT02592876|Transformed Lymphoma / DLBCL|transformed lymphoma / dlbcl
112031|NCT02592876|Rituximab|rituximab
112032|NCT02592876|Ifosfamide|ifosfamide
112033|NCT02592876|Carboplatin|carboplatin
112034|NCT02592876|Etoposide|etoposide
112035|NCT02592850|Osteopathic manipulative treatment|osteopathic manipulative treatment
112036|NCT02592850|Frequent Episodic Tension-Type Headache|frequent episodic tension-type headache
112037|NCT02592850|Randomized Controlled Trial|randomized controlled trial
112038|NCT02592837|Endobronchial ultrasound|endobronchial ultrasound
112040|NCT02592837|TBNA|tbna
112041|NCT02592837|Mediastinal ymphadenopathy|mediastinal ymphadenopathy
112042|NCT02592837|Hilar lymphadenopathy|hilar lymphadenopathy
112043|NCT02592837|Lung cancer|lung cancer
112044|NCT02592824|glutamate, heart failure, coronary artery bypass surgery|glutamate, heart failure, coronary artery bypass surgery
112045|NCT02592811|Cholangiopancreatography|cholangiopancreatography
112046|NCT02592811|therapeutic strategy|therapeutic strategy
112047|NCT02592811|Endoscopic Retrograde|endoscopic retrograde
112048|NCT02592772|menthol|menthol
112049|NCT02592772|nicotine|nicotine
112050|NCT02592772|reduced nicotine|reduced nicotine
112051|NCT02592772|smoking|smoking
112052|NCT02592772|cigarette|cigarette
112053|NCT02592772|cigarettes|cigarettes
112054|NCT02592772|men smoking|men smoking
112055|NCT02592772|smoking research|smoking research
112056|NCT02592772|nicotine dependence|nicotine dependence
112057|NCT02592720|Acute Coronary Syndromes|acute coronary syndromes
112058|NCT02592720|Fractional Flow Reserve|fractional flow reserve
112059|NCT02592720|Percutaneous Coronary Intervention|percutaneous coronary intervention
112060|NCT02592681|menstrual migraine|menstrual migraine
112061|NCT02592681|acupuncture|acupuncture
112062|NCT02592681|acupressure|acupressure
112063|NCT02592655|tourniquet|tourniquet
112064|NCT02592655|arterial|arterial
112065|NCT02592655|pre-hospital|pre-hospital
112066|NCT02592655|SOFTT-W|softt-w
112067|NCT02592655|Battle Wrap|battle wrap
112068|NCT02592655|windlass|windlass
112069|NCT02592655|exsanguination|exsanguination
112070|NCT02592655|hemorrhage|hemorrhage
112071|NCT02592655|amputation|amputation
112078|NCT02592629|subacromial injection|subacromial injection
112079|NCT02592629|rotator cuff disease|rotator cuff disease
112080|NCT02592629|steroid injection|steroid injection
112081|NCT02592616|Exercise|exercise
112082|NCT02592616|Appetite|appetite
112083|NCT02592616|Energy intake|energy intake
112084|NCT02592603|Serrated lesions|serrated lesions
112085|NCT02592603|Surveillance|surveillance
112086|NCT02592603|Colorectal cancer|colorectal cancer
112087|NCT02592603|Endocuff|endocuff
112088|NCT02592603|Sessile serrated adenoma|sessile serrated adenoma
112089|NCT02592603|Colonoscopy|colonoscopy
112090|NCT02592590|Exercise|exercise
112091|NCT02592590|Physical Activity|physical activity
112092|NCT02592590|Smartphone|smartphone
112093|NCT02592590|Technology|technology
112094|NCT02592577|Previously Treated|previously treated
112095|NCT02592577|Cell Therapy|cell therapy
112096|NCT02592577|T Cell Therapy|t cell therapy
112097|NCT02592577|MAGE-A10|mage-a10
112098|NCT02592577|Immuno-oncology|immuno-oncology
112099|NCT02592577|T Cell Receptor|t cell receptor
112100|NCT02592577|Metastatic|metastatic
112105|NCT02592538|Biliary duct carcinoma;|biliary duct carcinoma;
112106|NCT02592538|radiofrequency ablation|radiofrequency ablation
112107|NCT02592538|S-1|s-1
112108|NCT02592512|Hypoxia|hypoxia
112109|NCT02592512|hypercapnia|hypercapnia
112110|NCT02592499|HM III|hm iii
112111|NCT02592499|survival|survival
112112|NCT02592499|LVAD|lvad
112113|NCT02592486|quadrivalent influenza vaccine|quadrivalent influenza vaccine
112114|NCT02592486|23-valent pneumococcal vaccine|23-valent pneumococcal vaccine
112115|NCT02592486|immunogenicity|immunogenicity
112116|NCT02592473|Prostate Artery Embolization (PAE)|prostate artery embolization (pae)
112117|NCT02592473|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
112118|NCT02592473|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
112119|NCT02592473|BPH|bph
112120|NCT02592473|PAE|pae
112121|NCT02592473|LUTS|luts
112122|NCT02592473|Prostatic Artery Embolization|prostatic artery embolization
112123|NCT02592447|CML|cml
112124|NCT02592447|chronic phase CML|chronic phase cml
112125|NCT02592447|leukemia|leukemia
112126|NCT02592434|Arthritis|arthritis
112127|NCT02592434|Pediatric|pediatric
112128|NCT02592434|Tofacitinib|tofacitinib
112129|NCT02592434|Long-term|long-term
112130|NCT02592434|JIA|jia
112131|NCT02592434|polyarticular|polyarticular
112132|NCT02592434|CP-690,550|cp-690,550
112133|NCT02592434|Xeljanz|xeljanz
112134|NCT02592395|pancreatic adenocarcinoma|pancreatic adenocarcinoma
112135|NCT02592395|electrochemotherapy|electrochemotherapy
112136|NCT02592395|electroporation|electroporation
112137|NCT02592395|radiogenomics|radiogenomics
112138|NCT02592395|imaging|imaging
112139|NCT02592395|magnetic resonance spectroscopy|magnetic resonance spectroscopy
112140|NCT02592356|Full-body dual-energy x-ray absorptiometry|full-body dual-energy x-ray absorptiometry
112141|NCT02592356|DXA|dxa
112142|NCT02592356|Body measurement|body measurement
112143|NCT02592356|Weight of participant|weight of participant
112144|NCT02592356|Questionnaires|questionnaires
112145|NCT02592356|Surveys|surveys
112146|NCT02592356|Chemotherapy|chemotherapy
112147|NCT02592356|Advanced Cancers|advanced cancers
112148|NCT02592356|Endocrine Tumor|endocrine tumor
112149|NCT02592343|fecal microbiota transplantation|fecal microbiota transplantation
112150|NCT02592343|lyophilized|lyophilized
112151|NCT02592330|CALEC|calec
112152|NCT02592330|Limbal Stem Cell Deficiency|limbal stem cell deficiency
112153|NCT02592330|LSCD|lscd
112154|NCT02592317|JNJ-56021927|jnj-56021927
112155|NCT02592317|Prostatic Neoplasms, Castration-Resistant|prostatic neoplasms, castration-resistant
112156|NCT02592291|Mobile health|mobile health
112157|NCT02592291|Apps|apps
112158|NCT02592291|Applications|applications
112159|NCT02592291|Smart phone|smart phone
112160|NCT02592291|mHealth|mhealth
112161|NCT02592291|Chronic and Complex Conditions|chronic and complex conditions
112162|NCT02592291|Self-Management|self-management
112163|NCT02592291|Self-Care|self-care
112164|NCT02592278|Dental Caries|dental caries
112165|NCT02592278|Fluoride Varnish|fluoride varnish
112166|NCT02592278|Preschool child|preschool child
112167|NCT02592278|Prevention|prevention
112168|NCT02592239|Functional brain MRI|functional brain mri
112169|NCT02592239|functional dyspepsia|functional dyspepsia
112170|NCT02592239|hedonic response|hedonic response
112171|NCT02592200|Female|female
112172|NCT02592200|Constipation|constipation
112173|NCT02592200|Lactobacillus gasseri DSM 27123|lactobacillus gasseri dsm 27123
112174|NCT02592200|Probiotics|probiotics
112175|NCT02592187|Life-logging|life-logging
112176|NCT02592187|Cognitive Training|cognitive training
112177|NCT02592187|Mild Cognitive Impairment|mild cognitive impairment
112178|NCT02592187|Memory|memory
112179|NCT02592187|Information and communications technology (ICT) in healthcare|information and communications technology (ict) in healthcare
112180|NCT02592187|Portable camera|portable camera
112181|NCT02592135|Acute Cardiac Insufficiency|acute cardiac insufficiency
112182|NCT02592135|Acute Heart Failure|acute heart failure
112183|NCT02592122|Mechanical ventilation|mechanical ventilation
112184|NCT02592122|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
112185|NCT02592122|Airway resistance|airway resistance
112186|NCT02592122|Bronchial dilation test|bronchial dilation test
112385|NCT02590796|Inattention|inattention
112187|NCT02592109|Complementary Feeding Recommendation|complementary feeding recommendation
112188|NCT02592109|Linear Programming|linear programming
112189|NCT02592109|Nutritional Status|nutritional status
112190|NCT02592109|Omega-3 Fatty Acids|omega-3 fatty acids
112191|NCT02592109|Malondialdehyde|malondialdehyde
112192|NCT02592109|alpha-Tocopherol|alpha-tocopherol
112193|NCT02592096|safety and bioavailability|safety and bioavailability
112194|NCT02592083|Neoadjuvant Therapy|neoadjuvant therapy
112195|NCT02592083|Cyclin-Dependent Kinase Inhibitor p16|cyclin-dependent kinase inhibitor p16
112196|NCT02592044|pain|pain
112197|NCT02592044|anxiety|anxiety
112198|NCT02592044|Catheterization, Peripheral|catheterization, peripheral
112199|NCT02592005|pollution|pollution
112200|NCT02591979|Sleep Apnea Syndrome|sleep apnea syndrome
112201|NCT02591979|Primary Health Care|primary health care
112202|NCT02591940|cardiovascular modeling|cardiovascular modeling
112203|NCT02591940|aortic coarctation|aortic coarctation
112204|NCT02591940|aortic valve disease|aortic valve disease
112205|NCT02591927|myocardial infarction|myocardial infarction
112206|NCT02591927|glucose-insulin-potassium|glucose-insulin-potassium
112207|NCT02591901|Spinal Cord Injuries|spinal cord injuries
112208|NCT02591901|Multiple Sclerosis|multiple sclerosis
112209|NCT02591901|Transverse Myelitis|transverse myelitis
112210|NCT02591901|Neurogenic Bladder Dysfunction|neurogenic bladder dysfunction
112211|NCT02591901|Feasibility Study|feasibility study
112212|NCT02591901|Urinary Tract Infection|urinary tract infection
112213|NCT02591875|Cardiac Catheter Ablation|cardiac catheter ablation
112214|NCT02591875|Cardiac Arrhythmias|cardiac arrhythmias
112215|NCT02591875|Atrial Flutter|atrial flutter
112216|NCT02591836|LDL‐C|ldl‐c
112217|NCT02591836|Lipid Regulator|lipid regulator
112218|NCT02591797|pain|pain
112219|NCT02591797|Infant Behavior|infant behavior
112220|NCT02591797|Heart rate|heart rate
112221|NCT02591797|Dental Anxiety|dental anxiety
112222|NCT02591784|nimotuzumab esophageal radiotherapy|nimotuzumab esophageal radiotherapy
112223|NCT02591771|Adrenaline|adrenaline
112224|NCT02591771|Extra Corporeal Life Support|extra corporeal life support
112225|NCT02591771|Inotropes|inotropes
112226|NCT02591758|Hexo-Skin|hexo-skin
112227|NCT02591758|Hexoskin|hexoskin
112228|NCT02591758|NOVA-SKIN|nova-skin
112229|NCT02591758|angina|angina
112230|NCT02591758|biometric vest|biometric vest
112231|NCT02591706|Single missing tooth|single missing tooth
112232|NCT02591706|Implants|implants
112233|NCT02591706|Peri-implant bone remodeling|peri-implant bone remodeling
112234|NCT02591706|Bone thickness|bone thickness
112235|NCT02591706|Thickness of soft tissue|thickness of soft tissue
112236|NCT02591693|Family Caregivers|family caregivers
112237|NCT02591693|Occupational Therapy|occupational therapy
112238|NCT02591693|Activities of Daily Living|activities of daily living
112239|NCT02591667|Colorectal cancer|colorectal cancer
112240|NCT02591667|Peritoneal metastasis|peritoneal metastasis
112241|NCT02591667|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
112242|NCT02591667|5-Fluorouracil|5-fluorouracil
112243|NCT02591667|Oxaliplatin|oxaliplatin
112244|NCT02591667|Irinotecan|irinotecan
112245|NCT02591667|Bevacizumab|bevacizumab
112246|NCT02591667|Histopathological response|histopathological response
112248|NCT02591654|Pembrolizumab|pembrolizumab
112249|NCT02591654|Metastatic Melanoma|metastatic melanoma
112250|NCT02591654|MK-3475|mk-3475
112251|NCT02591641|pre-hospital transport|pre-hospital transport
112252|NCT02591641|shear force|shear force
112253|NCT02591641|tissue interface pressure|tissue interface pressure
112254|NCT02591628|Hypertension|hypertension
112255|NCT02591628|Thiazide diuretics|thiazide diuretics
112256|NCT02591589|Hyperoxia|hyperoxia
112257|NCT02591589|Delirium|delirium
112258|NCT02591589|Normoxic|normoxic
112259|NCT02591589|t-MoCA|t-moca
112260|NCT02591576|Diabetes|diabetes
112261|NCT02591576|ST-elevation myocardial infarction (STEMI)|st-elevation myocardial infarction (stemi)
112262|NCT02591576|non-STEMI|non-stemi
112263|NCT02591576|Excess mortality|excess mortality
112264|NCT02591576|Relative survival|relative survival
112265|NCT02591550|chronic cough|chronic cough
112266|NCT02591550|cough reflex sensitivity|cough reflex sensitivity
112267|NCT02591550|transient receptor potential vanilloid 1|transient receptor potential vanilloid 1
112268|NCT02591550|transient receptor potential ankyrin 1|transient receptor potential ankyrin 1
112269|NCT02591498|cognitive training|cognitive training
112270|NCT02591485|PTSD prevention|ptsd prevention
112271|NCT02591485|Acute stress disorder|acute stress disorder
112272|NCT02591485|Attention training|attention training
112273|NCT02591485|Cognitive bias modification|cognitive bias modification
112274|NCT02591459|Autism|autism
112275|NCT02591446|TMS|tms
112276|NCT02591446|Autism Spectrum Disorders|autism spectrum disorders
112277|NCT02591446|Plasticity|plasticity
112278|NCT02591407|Continuous Epidural Analgesia|continuous epidural analgesia
112279|NCT02591407|Transversus Abdominis Plane block|transversus abdominis plane block
112280|NCT02591381|urinary stress incontinence|urinary stress incontinence
112281|NCT02591355|Platelet Rich Plasma|platelet rich plasma
112282|NCT02591355|Hair Loss|hair loss
112966|NCT02587260|Endopath|endopath
112283|NCT02591342|femoral neck fracture|femoral neck fracture
112284|NCT02591342|hip arthroplasty|hip arthroplasty
112285|NCT02591342|complication|complication
112286|NCT02591342|periprosthetic femoral fracture|periprosthetic femoral fracture
112287|NCT02591316|nutrition|nutrition
112288|NCT02591316|physical activity|physical activity
112289|NCT02591316|breast cancer survivor|breast cancer survivor
112290|NCT02591316|cognition|cognition
112291|NCT02591303|Insomnia|insomnia
112293|NCT02591303|Real-life stressful events|real-life stressful events
112294|NCT02591290|Meningitis|meningitis
112295|NCT02591290|Meningococcal Meningitis|meningococcal meningitis
134110|NCT02461693|Mood|mood
112296|NCT02591290|Meningococcal Infections|meningococcal infections
112297|NCT02591290|Menactra®|menactra®
112298|NCT02591290|Meningococcal Vaccine|meningococcal vaccine
112299|NCT02591277|Hepatitis C virus|hepatitis c virus
112300|NCT02591277|observational|observational
112301|NCT02591277|post-marketing|post-marketing
112302|NCT02591277|ledipasvir/sofosbuvir|ledipasvir/sofosbuvir
112303|NCT02591277|Japan|japan
112304|NCT02591238|smoking|smoking
112305|NCT02591238|melatonin|melatonin
112306|NCT02591238|vascular injury|vascular injury
112307|NCT02591225|left atrial thrombus size|left atrial thrombus size
112308|NCT02591225|transesophageale echocardiography|transesophageale echocardiography
112309|NCT02591225|silent cerebral embolism|silent cerebral embolism
112310|NCT02591212|Bystanding behaviors|bystanding behaviors
112311|NCT02591212|Campus|campus
112312|NCT02591212|Prevention|prevention
112313|NCT02591212|Sexual Assault|sexual assault
112314|NCT02591212|CampusSave|campussave
112315|NCT02591173|Autonomic|autonomic
112316|NCT02591173|Hypertension|hypertension
112609|NCT02589275|3-month|3-month
112317|NCT02591173|Renin-Angiotensin System|renin-angiotensin system
112318|NCT02591134|weight loss|weight loss
112319|NCT02591134|NNS|nns
112320|NCT02591134|beverages|beverages
112321|NCT02591134|diet|diet
112322|NCT02591134|appetite|appetite
112323|NCT02591134|satiety|satiety
112324|NCT02591134|weight control|weight control
112325|NCT02591108|train of four|train of four
112326|NCT02591108|neuromuscular blockade|neuromuscular blockade
112327|NCT02591108|surgery|surgery
112328|NCT02591069|Vagus nerve stimulation|vagus nerve stimulation
112329|NCT02591069|vegetative state|vegetative state
112330|NCT02591069|minimally conscious state|minimally conscious state
112331|NCT02591069|akinetic mutism|akinetic mutism
112332|NCT02591069|consciousness|consciousness
112333|NCT02591069|connectivity|connectivity
112334|NCT02591043|Pelvic|pelvic
112335|NCT02591043|Treatment Outcome|treatment outcome
112336|NCT02591030|Bile Duct Cancer|bile duct cancer
112337|NCT02591030|phase II/III|phase ii/iii
112338|NCT02591030|Modified folfirinox|modified folfirinox
112339|NCT02591030|Gemcis|gemcis
112340|NCT02591004|Neuroprotection|neuroprotection
112341|NCT02591004|calcium channel blockers|calcium channel blockers
112342|NCT02591004|magnesium sulhate|magnesium sulhate
112343|NCT02591004|Middle cerebral artery doppler|middle cerebral artery doppler
112344|NCT02590978|gallstone pancreatitis|gallstone pancreatitis
112345|NCT02590978|mild acute pancreatitis|mild acute pancreatitis
112346|NCT02590978|adult|adult
112347|NCT02590952|safety, PK|safety, pk
112348|NCT02590926|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
112349|NCT02590913|fructose|fructose
112350|NCT02590913|metabolism|metabolism
112351|NCT02590913|acute|acute
112352|NCT02590900|pharmacokinetics|pharmacokinetics
112353|NCT02590900|pregnancy|pregnancy
112354|NCT02590900|oral contraceptives|oral contraceptives
112355|NCT02590900|oestradiol|oestradiol
112356|NCT02590874|Mild Cognitive Impairment|mild cognitive impairment
112357|NCT02590874|Cognition|cognition
112358|NCT02590874|Memory|memory
112359|NCT02590874|Depression|depression
112360|NCT02590874|Depressive disorder|depressive disorder
112361|NCT02590874|Antidepressive agents|antidepressive agents
112362|NCT02590874|Duloxetine|duloxetine
112363|NCT02590874|Cymbalta|cymbalta
112364|NCT02590874|Selective serotonin and norepinephrine uptake inhibitors|selective serotonin and norepinephrine uptake inhibitors
112365|NCT02590861|Partial Dentures|partial dentures
112366|NCT02590861|Dental Implants|dental implants
112367|NCT02590861|Quality of Life|quality of life
112368|NCT02590861|Partial Edentulism|partial edentulism
112369|NCT02590848|Walnut intake|walnut intake
112370|NCT02590848|Brain development|brain development
112371|NCT02590848|Nutritional intervention|nutritional intervention
112372|NCT02590848|Healthy adolescents|healthy adolescents
112373|NCT02590835|Adult patients|adult patients
112374|NCT02590835|Patient demand for orthodontic treatment|patient demand for orthodontic treatment
112375|NCT02590822|Diabetes|diabetes
112376|NCT02590822|T2DM|t2dm
112377|NCT02590822|young adults|young adults
112378|NCT02590822|heart|heart
112379|NCT02590822|weight loss|weight loss
112380|NCT02590822|MRI|mri
112381|NCT02590822|exercise|exercise
112382|NCT02590822|diastolic function|diastolic function
112383|NCT02590809|Left ventricular obstruction|left ventricular obstruction
112384|NCT02590796|Delirium|delirium
112386|NCT02590796|Medical device|medical device
112387|NCT02590796|Software application|software application
112388|NCT02590796|Validation study|validation study
112389|NCT02590796|Diagnosis|diagnosis
112390|NCT02590796|Dementia|dementia
112391|NCT02590783|treatment|treatment
112392|NCT02590757|non-invasive ventilation|non-invasive ventilation
112393|NCT02590757|non-invasive neurally adjusted ventilatory assist|non-invasive neurally adjusted ventilatory assist
112394|NCT02590757|nasal continuous positive airway pressure|nasal continuous positive airway pressure
134237|NCT02461017|airway|airway
112395|NCT02590744|Emergence Agitation|emergence agitation
112396|NCT02590744|eye patch|eye patch
112397|NCT02590744|preschool children|preschool children
112398|NCT02590653|STEMI|stemi
112399|NCT02590653|myocardial strain|myocardial strain
112400|NCT02590653|atorvastatin|atorvastatin
112401|NCT02590627|Parasite clearance, Treatment failure|parasite clearance, treatment failure
112402|NCT02590601|PPCM|ppcm
112403|NCT02590601|Bromocriptine|bromocriptine
112404|NCT02590601|Peripartum cardiomyopathy|peripartum cardiomyopathy
112405|NCT02590588|IgM-associated AL amyloidosis|igm-associated al amyloidosis
112406|NCT02590575|extracorporeal CO2 removal|extracorporeal co2 removal
112407|NCT02590575|renal replacement therapy|renal replacement therapy
112408|NCT02590575|Prismalung|prismalung
112409|NCT02590575|ARDS|ards
112410|NCT02590575|hypercapnia|hypercapnia
112411|NCT02590575|Changes in the arterial pCO2 value|changes in the arterial pco2 value
112412|NCT02590575|ventilated|ventilated
112413|NCT02590575|Hypercapnic|hypercapnic
112414|NCT02590549|Keratoconus|keratoconus
112415|NCT02590549|riboflavin|riboflavin
112416|NCT02590549|corneal collagen crosslinking|corneal collagen crosslinking
112897|NCT02587598|PIM kinases|pim kinases
112417|NCT02590549|intrasromal ring|intrasromal ring
112418|NCT02590536|Sildenafil|sildenafil
112419|NCT02590536|Fetal growth Restriction|fetal growth restriction
112420|NCT02590536|Umbilical Artery Doppler|umbilical artery doppler
112421|NCT02590510|Intrathecal chemotherapy|intrathecal chemotherapy
112422|NCT02590471|Angioplasty with stenting of the superficial femoral artery|angioplasty with stenting of the superficial femoral artery
112423|NCT02590471|Fasciotomy in Hunter's channel|fasciotomy in hunter's channel
112424|NCT02590471|Breakage of stent|breakage of stent
112425|NCT02590458|Breast Cancer|breast cancer
112426|NCT02590458|Short Breast MRI Scan|short breast mri scan
112427|NCT02590458|SBMRI|sbmri
112428|NCT02590458|Routine MRI|routine mri
112429|NCT02590458|High risk for breast cancer|high risk for breast cancer
112430|NCT02590458|Screening|screening
112431|NCT02590432|Immunogenicity|immunogenicity
112432|NCT02590432|Irritable Bowel Syndrome with Constipation|irritable bowel syndrome with constipation
112433|NCT02590432|Chronic Idiopathic Constipation|chronic idiopathic constipation
112434|NCT02590432|Linaclotide|linaclotide
112435|NCT02590432|Linzess|linzess
112436|NCT02590406|Morbid Obesity|morbid obesity
112437|NCT02590406|Bariatric Surgery|bariatric surgery
112438|NCT02590406|Pre-Oxygenation|pre-oxygenation
112439|NCT02590406|Anesthesia Induction|anesthesia induction
112440|NCT02590406|Positive pressure ventilation|positive pressure ventilation
112441|NCT02590406|Non hypoxic apnea time|non hypoxic apnea time
112442|NCT02590406|Positive-Pressure Respiration|positive-pressure respiration
112443|NCT02590406|Anesthesia, General|anesthesia, general
112444|NCT02590393|Nicotine addiction|nicotine addiction
112445|NCT02590393|Cigarette smoking|cigarette smoking
112446|NCT02590393|E-cigarettes|e-cigarettes
112447|NCT02590380|Adolescent|adolescent
112448|NCT02590380|paediatric|paediatric
112449|NCT02590380|pediatric|pediatric
112450|NCT02590380|scoliosis|scoliosis
112451|NCT02590380|spine deformity|spine deformity
112452|NCT02590367|oxaliplatin-induced peripheral neuropathy|oxaliplatin-induced peripheral neuropathy
112453|NCT02590367|HD6610 granule|hd6610 granule
112454|NCT02590367|colorectal cancer|colorectal cancer
112455|NCT02590354|Treatment interruption|treatment interruption
112456|NCT02590354|functional cure|functional cure
112457|NCT02590341|myocarditis|myocarditis
112458|NCT02590341|children|children
112459|NCT02590341|adolescents|adolescents
112460|NCT02590341|registry|registry
112461|NCT02590341|multi-center|multi-center
112462|NCT02590341|pediatric|pediatric
112463|NCT02590341|heart failure|heart failure
112464|NCT02590341|inflammatory heart disease|inflammatory heart disease
112465|NCT02590341|inflammatory cardiomyopathy|inflammatory cardiomyopathy
112466|NCT02590328|Neonatal Screening|neonatal screening
112467|NCT02590328|Severe Combined Immunodeficiency|severe combined immunodeficiency
112468|NCT02590328|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
112469|NCT02590328|DNA Repair-Deficiency Disorders|dna repair-deficiency disorders
112470|NCT02590328|T-cell Receptor Excision Circle|t-cell receptor excision circle
112471|NCT02590315|BC|bc
112472|NCT02590302|Clinical pathway|clinical pathway
112473|NCT02590302|Mental Health|mental health
112474|NCT02590302|Emergency Department|emergency department
112475|NCT02590302|Paediatric|paediatric
112476|NCT02590302|Risk assessment|risk assessment
112477|NCT02590302|Service integration|service integration
112478|NCT02590302|Transitions in care|transitions in care
112479|NCT02590302|Implementation|implementation
112480|NCT02590302|Scoring tools|scoring tools
112481|NCT02590302|Clinical Pathway Evaluation|clinical pathway evaluation
112482|NCT02590276|frontotemporal Dementia|frontotemporal dementia
112483|NCT02590276|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
112484|NCT02590276|Biomarkers|biomarkers
112485|NCT02590276|brain Imaging PET|brain imaging pet
112486|NCT02590263|WHO grade III|who grade iii
112487|NCT02590263|WHO grade IV|who grade iv
134366|NCT02460367|IDO|ido
112488|NCT02590237|Laryngoscopy|laryngoscopy
112490|NCT02590211|experimental study|experimental study
644432|NCT00752986|Vandetanib|vandetanib
112491|NCT02590211|cognitive mechanisms|cognitive mechanisms
112492|NCT02590211|poker|poker
112493|NCT02590211|cognitive remediation therapy|cognitive remediation therapy
112494|NCT02590133|Refractory Nasopharyngeal Carcinoma, Endostar, 5-Fu|refractory nasopharyngeal carcinoma, endostar, 5-fu
112495|NCT02590081|Normal saline|normal saline
112496|NCT02590081|Destrose 5%|destrose 5%
112497|NCT02590081|Blood pressure|blood pressure
112498|NCT02590081|Interdialytic weight gain|interdialytic weight gain
112499|NCT02590081|thirst level|thirst level
112500|NCT02590081|End Stage Renal Failure|end stage renal failure
112501|NCT02589990|health|health
112502|NCT02589990|muscle strength|muscle strength
112503|NCT02589990|exercise genomics|exercise genomics
112504|NCT02589977|magnetic resonance imaging|magnetic resonance imaging
112505|NCT02589977|positron-emission tomography|positron-emission tomography
112506|NCT02589977|echocardiography|echocardiography
112507|NCT02589977|myocardial blood flow|myocardial blood flow
112508|NCT02589977|energy metabolism|energy metabolism
112509|NCT02589964|probiotics|probiotics
112510|NCT02589964|antibiotic associated diarrhea|antibiotic associated diarrhea
112511|NCT02589964|clostridium difficile|clostridium difficile
112512|NCT02589925|deep brain stimulation|deep brain stimulation
112513|NCT02589925|subthalamic nucleus|subthalamic nucleus
112514|NCT02589925|Nucleus basalis Meynert|nucleus basalis meynert
112515|NCT02589886|Self-help|self-help
112516|NCT02589886|Education|education
112517|NCT02589886|e-Health|e-health
112518|NCT02589873|Lifestyle Intervention|lifestyle intervention
112519|NCT02589873|Workplace|workplace
112520|NCT02589873|Diabetes Prevention|diabetes prevention
112521|NCT02589860|Stem Cell Transplantation|stem cell transplantation
112522|NCT02589847|Clostridium difficile|clostridium difficile
112523|NCT02589847|C diff|c diff
112524|NCT02589847|CDI|cdi
112525|NCT02589847|CDAD|cdad
112526|NCT02589847|Fecal transplant|fecal transplant
112527|NCT02589847|Fecal Microbiota transplant|fecal microbiota transplant
112528|NCT02589847|diarrhea|diarrhea
112529|NCT02589847|FMT|fmt
112530|NCT02589847|microbiota restoration therapy|microbiota restoration therapy
112531|NCT02589847|microbiota suspension|microbiota suspension
112532|NCT02589847|fecal bacteriotherapy|fecal bacteriotherapy
112533|NCT02589847|C diff diarrhea|c diff diarrhea
112534|NCT02589808|pre-operative|pre-operative
112535|NCT02589808|transthoracic echocardiography|transthoracic echocardiography
112536|NCT02589808|handheld|handheld
112537|NCT02589795|safety|safety
112538|NCT02589795|immunogenicity|immunogenicity
112539|NCT02589795|HIV vaccine|hiv vaccine
112540|NCT02589782|bedaquiline|bedaquiline
112541|NCT02589782|Nitroimidazoles|nitroimidazoles
112542|NCT02589782|diarylquinolines|diarylquinolines
112543|NCT02589782|linezolid|linezolid
112544|NCT02589782|clofazimine|clofazimine
112545|NCT02589782|pretomanid|pretomanid
112546|NCT02589782|moxifloxacin|moxifloxacin
112547|NCT02589756|obesity|obesity
112548|NCT02589756|persistent organic pollutants|persistent organic pollutants
112549|NCT02589756|metabolic syndrome|metabolic syndrome
112550|NCT02589743|clinical trial|clinical trial
112551|NCT02589743|pit and fissure sealants|pit and fissure sealants
112552|NCT02589743|tooth eruption|tooth eruption
112553|NCT02589743|retention|retention
112554|NCT02589743|adhesive system|adhesive system
112555|NCT02589743|intermediary layer|intermediary layer
112556|NCT02589730|Smartphone app|smartphone app
112557|NCT02589730|diabetic management|diabetic management
112558|NCT02589730|lifestyle behaviors|lifestyle behaviors
112559|NCT02589730|medication management|medication management
112560|NCT02589678|AIDS|aids
112561|NCT02589678|Immunology|immunology
112562|NCT02589678|Public Health|public health
112563|NCT02589678|Female sex workers|female sex workers
112564|NCT02589678|Single mothers|single mothers
112565|NCT02589665|IL-23 antibody|il-23 antibody
112566|NCT02589652|Pegylated interferon|pegylated interferon
112567|NCT02589652|Entecavir|entecavir
112568|NCT02589600|Bone loss|bone loss
112569|NCT02589600|Frail Geriatric Women|frail geriatric women
112570|NCT02589600|Nursing Home Patients|nursing home patients
112571|NCT02589600|Long-term Care Patients|long-term care patients
112572|NCT02589600|Osteoporosis|osteoporosis
112573|NCT02589600|Osteoporotic Fractures|osteoporotic fractures
112574|NCT02589561|hearing loss|hearing loss
112575|NCT02589561|hearing aids|hearing aids
112576|NCT02589548|Hodgkin Lymphoma|hodgkin lymphoma
112577|NCT02589548|Hodgkin Disease|hodgkin disease
112578|NCT02589509|Event-related potentials|event-related potentials
112579|NCT02589509|Attention|attention
115681|NCT02571452|Veteran|veteran
112580|NCT02589509|Cognitive rehabilitation|cognitive rehabilitation
112581|NCT02589509|Independent activities of daily living|independent activities of daily living
112582|NCT02589470|cognitive rehabilitation|cognitive rehabilitation
112583|NCT02589470|memory|memory
112584|NCT02589470|epilepsy|epilepsy
113471|NCT02583763|Heart Function Tests|heart function tests
112585|NCT02589457|Chronic Hepatitis B virus, HIV-1 infection|chronic hepatitis b virus, hiv-1 infection
112586|NCT02589457|Healthy Male Volunteer|healthy male volunteer
644433|NCT00752986|Zactima|zactima
112587|NCT02589457|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
112588|NCT02589444|Clinical Endocrinology|clinical endocrinology
112589|NCT02589444|Immunology|immunology
112590|NCT02589444|Inflammation|inflammation
112591|NCT02589444|Microbiology|microbiology
112592|NCT02589444|Respiratory Disorders|respiratory disorders
112593|NCT02589444|Vitamins|vitamins
112594|NCT02589431|hypothalamo pituitary adrenal axis|hypothalamo pituitary adrenal axis
112595|NCT02589418|Manual acupuncture|manual acupuncture
112596|NCT02589418|Experimental dental pain|experimental dental pain
112597|NCT02589418|Psychophysics|psychophysics
112598|NCT02589418|Autonomic nervous system|autonomic nervous system
112599|NCT02589418|Subjective pain ratings|subjective pain ratings
112600|NCT02589379|postoperative pancreatic fistula|postoperative pancreatic fistula
112601|NCT02589379|soft and hard pancreas|soft and hard pancreas
112602|NCT02589366|Lymphoseek|lymphoseek
112603|NCT02589366|endometrial cancer|endometrial cancer
112604|NCT02589366|sentinel lymph node|sentinel lymph node
112605|NCT02589366|lymph node dissection|lymph node dissection
112606|NCT02589275|TNX-102 SL|tnx-102 sl
112607|NCT02589275|bedtime|bedtime
112610|NCT02589275|long term safety|long term safety
112611|NCT02589275|long term efficacy|long term efficacy
112612|NCT02589275|Fibromyalgia|fibromyalgia
112613|NCT02589236|Cystic Fibrosis|cystic fibrosis
112614|NCT02589236|N91115|n91115
112615|NCT02589236|Cavosonstat|cavosonstat
112616|NCT02589223|multisensory stimulation|multisensory stimulation
112617|NCT02589210|Diabetes Mellitus|diabetes mellitus
112618|NCT02589210|Foot Disease|foot disease
112619|NCT02589210|Foot Ulcer|foot ulcer
112620|NCT02589197|osteoarthritis|osteoarthritis
112621|NCT02589197|correction of functional deformity|correction of functional deformity
112622|NCT02589197|procedures|procedures
112623|NCT02589197|traumatic osteoarthritis|traumatic osteoarthritis
112624|NCT02589197|degenerative osteoarthritis|degenerative osteoarthritis
112625|NCT02589197|total knee arthroplasty|total knee arthroplasty
112626|NCT02589197|Healthy Volunteers|healthy volunteers
112627|NCT02589197|electromyography|electromyography
112628|NCT02589197|Musculoskeletal Diseases|musculoskeletal diseases
112629|NCT02589184|balance, postural|balance, postural
112630|NCT02589184|postural equilibrium|postural equilibrium
112631|NCT02589184|pain scale|pain scale
112632|NCT02589184|range of motion|range of motion
112633|NCT02589145|Blood And Marrow Transplantation|blood and marrow transplantation
112634|NCT02589145|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
112635|NCT02589145|DLBCL|dlbcl
112636|NCT02589145|Busulfan|busulfan
112637|NCT02589145|Busulfex|busulfex
112638|NCT02589145|Myleran|myleran
112639|NCT02589145|Lenalidomide|lenalidomide
112640|NCT02589145|CC-5013|cc-5013
112641|NCT02589145|Revlimid|revlimid
112642|NCT02589145|Vorinostat|vorinostat
112643|NCT02589145|SAHA|saha
112644|NCT02589145|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
112645|NCT02589145|MSK-390|msk-390
112646|NCT02589145|Zolinza|zolinza
112647|NCT02589145|Gemcitabine|gemcitabine
112648|NCT02589145|Gemcitabine Hydrochloride|gemcitabine hydrochloride
112649|NCT02589145|Gemzar|gemzar
112650|NCT02589145|Melphalan|melphalan
112651|NCT02589145|Alkeran|alkeran
112652|NCT02589145|Rituximab|rituximab
112653|NCT02589145|Rituxan|rituxan
112654|NCT02589145|Dexamethasone|dexamethasone
112655|NCT02589145|Decadron|decadron
112656|NCT02589145|Glutamine|glutamine
112657|NCT02589145|Enterex|enterex
112658|NCT02589145|Glutapack-10|glutapack-10
112659|NCT02589145|NutreStore|nutrestore
112660|NCT02589145|Resource|resource
112661|NCT02589145|GlutaSolve|glutasolve
112662|NCT02589145|Sympt-X G.I.|sympt-x g.i.
112663|NCT02589145|Symptx-X|symptx-x
112664|NCT02589145|Pyridoxine|pyridoxine
112665|NCT02589145|Enoxaparin|enoxaparin
112666|NCT02589145|Lovenox Injection|lovenox injection
112667|NCT02589145|Palifermin|palifermin
112668|NCT02589145|Kepivance|kepivance
112669|NCT02589119|cryptoglandular|cryptoglandular
112670|NCT02589119|perianal fistula|perianal fistula
112671|NCT02589119|cryptoglandular perianal fistulas|cryptoglandular perianal fistulas
112672|NCT02589106|Anisotropic Textile Braces|anisotropic textile braces
112673|NCT02589093|Analgesia|analgesia
112674|NCT02589093|Monitoring|monitoring
112675|NCT02589093|Analgesia Nociception Index|analgesia nociception index
112677|NCT02589093|PhysioDoloris|physiodoloris
112678|NCT02589093|Pain|pain
112679|NCT02589041|intraneural sciatic block|intraneural sciatic block
112680|NCT02589028|diabetes mellitus|diabetes mellitus
115682|NCT02571452|Insomnia|insomnia
112681|NCT02589028|incretin hormone|incretin hormone
112682|NCT02589028|glucose level|glucose level
103756|NCT02639624|dialysis|dialysis
103757|NCT02639611|Breast Expanders|breast expanders
103758|NCT02639598|chronic migraine|chronic migraine
103759|NCT02639598|prophylaxis|prophylaxis
103760|NCT02639598|flunarizine|flunarizine
103761|NCT02639598|topiramate|topiramate
103762|NCT02639585|daclatasvir|daclatasvir
103763|NCT02639585|asunaprevir|asunaprevir
103764|NCT02641561|Pancreatitis|pancreatitis
103765|NCT02641561|ERCP|ercp
112683|NCT02589028|GLP-1|glp-1
112684|NCT02589028|GIP|gip
112685|NCT02589028|premeal protein|premeal protein
112686|NCT02589015|morbid obesity|morbid obesity
112687|NCT02589015|neck circumference|neck circumference
644434|NCT00752986|Fulvestrant|fulvestrant
112688|NCT02589015|difficult mask ventilation|difficult mask ventilation
112689|NCT02589015|difficult laryngoscopy|difficult laryngoscopy
112690|NCT02589002|sucralose|sucralose
112691|NCT02589002|insulin sensitivity|insulin sensitivity
112692|NCT02589002|beta-cell response|beta-cell response
112693|NCT02589002|appetite regulating hormone|appetite regulating hormone
112694|NCT02588976|Activated clotting time|activated clotting time
112695|NCT02588976|Sonoclot|sonoclot
112696|NCT02588963|upper respiratory tract infections|upper respiratory tract infections
112697|NCT02588963|lower respiratory tract infections|lower respiratory tract infections
112698|NCT02588963|health promotion|health promotion
112699|NCT02588963|respiratory physiotherapy|respiratory physiotherapy
112700|NCT02588963|infant|infant
112701|NCT02588937|Entecavir, EntecaBell ODT., Hepatitis B|entecavir, entecabell odt., hepatitis b
112702|NCT02588924|Parkinson Disease|parkinson disease
112703|NCT02588924|ENVIRONMENTAL AND OCCUPATIONAL EXPOSURE TO METALS|environmental and occupational exposure to metals
112704|NCT02588911|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
112705|NCT02588911|Operative Surgical Procedure|operative surgical procedure
112706|NCT02588911|Saphenous Vein|saphenous vein
112707|NCT02588885|physical therapy|physical therapy
112708|NCT02588885|psychotherapy|psychotherapy
112709|NCT02588885|dysfunctional sexual behavior|dysfunctional sexual behavior
112710|NCT02588885|pelvic pain|pelvic pain
112711|NCT02588885|posttraumatic stress|posttraumatic stress
112712|NCT02588885|PTSD|ptsd
112713|NCT02588885|chronic pain|chronic pain
112714|NCT02588872|platelet-rich plasma|platelet-rich plasma
112715|NCT02588872|hyaluronic acid|hyaluronic acid
112716|NCT02588859|T2DM, Diabetes|t2dm, diabetes
112717|NCT02588846|Prostate|prostate
112718|NCT02588846|Radiotherapy|radiotherapy
112719|NCT02588846|IGRT|igrt
112720|NCT02588846|VMAT|vmat
112721|NCT02588846|Image-guided radiation therapy|image-guided radiation therapy
112722|NCT02588846|Volumetric modulated arc therapy|volumetric modulated arc therapy
112723|NCT02588846|Adaptive radiotherapy|adaptive radiotherapy
112725|NCT02588794|sepsis, acute kidney injury , CytoSorb|sepsis, acute kidney injury , cytosorb
112726|NCT02588768|Low-level laser therapy|low-level laser therapy
112727|NCT02588768|Light emitting diodes|light emitting diodes
112728|NCT02588768|Rugby|rugby
112729|NCT02588768|Field test|field test
112730|NCT02588768|Photobiomodulation|photobiomodulation
112731|NCT02588755|Chemoembolization|chemoembolization
112732|NCT02588755|Therapeutic|therapeutic
112733|NCT02588755|Tegafur|tegafur
112734|NCT02588742|elderly ICU patients|elderly icu patients
112735|NCT02588729|Gestational diabetes|gestational diabetes
112736|NCT02588729|app|app
112737|NCT02588729|RCT|rct
112738|NCT02588729|diet|diet
112739|NCT02588729|physical activity|physical activity
112740|NCT02588716|Hepatectomy, Surgical Blood Loss, terlipressin|hepatectomy, surgical blood loss, terlipressin
112741|NCT02588677|Amyotrophic Lateral Sclerosis (ALS) - masitinib|amyotrophic lateral sclerosis (als) - masitinib
112742|NCT02588664|Early Supported Discharge|early supported discharge
112743|NCT02588651|Lymphoma|lymphoma
112744|NCT02588651|Leukemia|leukemia
112745|NCT02588651|Brentuximab Vedotin|brentuximab vedotin
112746|NCT02588638|NGS|ngs
112747|NCT02588638|Quality of life|quality of life
112748|NCT02588638|Diagnosis|diagnosis
112749|NCT02588638|Rare disease|rare disease
112750|NCT02588638|Next-generation sequencing|next-generation sequencing
112751|NCT02588612|Previously Treated|previously treated
112752|NCT02588612|Cell Therapy|cell therapy
112753|NCT02588612|T Cell Therapy|t cell therapy
112754|NCT02588612|NY-ESO-1|ny-eso-1
112755|NCT02588612|Immuno-oncology|immuno-oncology
112756|NCT02588612|T Cell Receptor|t cell receptor
112757|NCT02588586|HIV|hiv
112758|NCT02588586|3BNC117|3bnc117
112759|NCT02588586|Broadly neutralizing antibody|broadly neutralizing antibody
112760|NCT02588560|lymphoma, hepatitis C virus, chemotherapy|lymphoma, hepatitis c virus, chemotherapy
103930|NCT02640625|HIV|hiv
112761|NCT02588547|Shivering|shivering
112762|NCT02588547|Granisetron|granisetron
112763|NCT02588547|Pethidine|pethidine
112764|NCT02588547|Spinal|spinal
112765|NCT02588547|Cesarean section|cesarean section
112766|NCT02588534|etanercept, healthy subject,open-label, randomized, auto-injection, bioequivalence, pharmacokinetic|etanercept, healthy subject,open-label, randomized, auto-injection, bioequivalence, pharmacokinetic
112767|NCT02588508|perineal tear|perineal tear
112768|NCT02588508|pain|pain
112769|NCT02588508|pelvic floor|pelvic floor
112770|NCT02588508|Labour|labour
112771|NCT02588495|Ultrasound|ultrasound
112772|NCT02588495|Gastric area|gastric area
112773|NCT02588495|Accuracy|accuracy
112774|NCT02588495|Aspirate|aspirate
112775|NCT02588482|electroencephalography (EEG)|electroencephalography (eeg)
112776|NCT02588482|mismatch negativity (MMN)|mismatch negativity (mmn)
112777|NCT02588469|pediatric obesity|pediatric obesity
112782|NCT02588391|premature birth; executive function; preschool|premature birth; executive function; preschool
200988|NCT02112682|Sentinel lymph node metastasis|sentinel lymph node metastasis
112783|NCT02588365|Attention Deficit Hyperactivity Disorder; executive function; preschool|attention deficit hyperactivity disorder; executive function; preschool
644435|NCT00752986|Faslodex|faslodex
112785|NCT02588339|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
112791|NCT02588274|Chronic prostatitis|chronic prostatitis
112792|NCT02588274|chronic pelvic pain syndrome|chronic pelvic pain syndrome
112793|NCT02588274|acupuncture|acupuncture
112794|NCT02588274|placebo needle|placebo needle
112795|NCT02588274|randomized controlled trial|randomized controlled trial
112796|NCT02588261|erlotinib|erlotinib
112797|NCT02588261|EGFR mutation|egfr mutation
112798|NCT02588261|naquotinib|naquotinib
112799|NCT02588261|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
112800|NCT02588261|ASP8273|asp8273
112801|NCT02588261|gefitinib|gefitinib
112802|NCT02588183|atrial fibrillation|atrial fibrillation
112803|NCT02588183|catheter ablation|catheter ablation
112804|NCT02588183|pulmonary vein|pulmonary vein
112805|NCT02588183|cryoenergy|cryoenergy
112806|NCT02588183|cryoablation|cryoablation
112807|NCT02588183|ArcticFront|arcticfront
112808|NCT02588157|Rapid sequence induction intubation|rapid sequence induction intubation
112809|NCT02588157|McGrath X-Blade|mcgrath x-blade
112810|NCT02588157|Glidescope|glidescope
112811|NCT02588157|Macintosh|macintosh
112812|NCT02588144|Parkinson's disease|parkinson's disease
112813|NCT02588144|freezing of gait|freezing of gait
112814|NCT02588144|deep brain stimulation|deep brain stimulation
112815|NCT02588144|substantia nigra pars reticulata|substantia nigra pars reticulata
112816|NCT02588144|subthalamic nucleus|subthalamic nucleus
112817|NCT02588131|tremelimumab|tremelimumab
112818|NCT02588131|anti-PD-L1 MEDI4736 (Durvalumab)|anti-pd-l1 medi4736 (durvalumab)
112819|NCT02588131|malignant mesothelioma|malignant mesothelioma
112820|NCT02588105|Phase I, open label study; safety and efficacy of AZD0156; ATM inhibitor|phase i, open label study; safety and efficacy of azd0156; atm inhibitor
112821|NCT02588079|Dental Fear|dental fear
112822|NCT02588079|Dental Phobia|dental phobia
112823|NCT02588079|Internet based cognitive behavioral therapy|internet based cognitive behavioral therapy
112824|NCT02588079|specific phobia|specific phobia
112825|NCT02588079|children and adolescents anxiety|children and adolescents anxiety
112826|NCT02588079|Self Efficacy|self efficacy
112827|NCT02588040|Chronic Lateral Epicondylitis|chronic lateral epicondylitis
112828|NCT02588040|Leukocyte- and Platelet-Rich Plasma|leukocyte- and platelet-rich plasma
112829|NCT02588040|Recover-L-PRP|recover-l-prp
112830|NCT02587988|Erectile dysfunction & Hypertension|erectile dysfunction & hypertension
112831|NCT02587949|acute cerebrovascular stroke|acute cerebrovascular stroke
112832|NCT02587936|Chronic|chronic
112833|NCT02587936|Risk prediction model|risk prediction model
112834|NCT02587936|Quality Improvement (QI)|quality improvement (qi)
112835|NCT02587936|Pragmatic trial|pragmatic trial
112836|NCT02587936|Cluster randomization|cluster randomization
112837|NCT02587936|Collaborative care|collaborative care
112838|NCT02587936|clinical informatics|clinical informatics
112839|NCT02587936|Chronic kidney disease|chronic kidney disease
112840|NCT02587936|hypertension|hypertension
112841|NCT02587936|high BP|high bp
112842|NCT02587936|diabetes|diabetes
112843|NCT02587897|Ultrasonography|ultrasonography
112844|NCT02587897|Nerve Conduction Velocity|nerve conduction velocity
112845|NCT02587897|Ergonomics|ergonomics
112846|NCT02587897|Work Related Injury|work related injury
112847|NCT02587897|Cumulative Trauma Disorders|cumulative trauma disorders
112848|NCT02587884|Recurrence|recurrence
112849|NCT02587884|Microvascular Invasion|microvascular invasion
112850|NCT02587884|Aspartate beta-hydroxylase|aspartate beta-hydroxylase
112851|NCT02587858|NBIA|nbia
112852|NCT02587858|PKAN|pkan
112853|NCT02587858|brain iron|brain iron
112854|NCT02587858|Neurodegeneration with Brain Iron Accumulation|neurodegeneration with brain iron accumulation
112855|NCT02587858|Hallervorden Spatz Syndrome|hallervorden spatz syndrome
402915|NCT01229150|Kinase Signal Transduction Pathway|kinase signal transduction pathway
112856|NCT02587858|Pantothenate Kinase Associated Neurodegeneration|pantothenate kinase associated neurodegeneration
112857|NCT02587845|total hip arthroplasty|total hip arthroplasty
112858|NCT02587845|transexamic acid|transexamic acid
112859|NCT02587832|cpap|cpap
112860|NCT02587832|HHHFNC|hhhfnc
112861|NCT02587832|RDS|rds
112862|NCT02587832|ELBW|elbw
112863|NCT02587806|RRMS|rrms
112864|NCT02587793|Hepatocellular Carcinoma|hepatocellular carcinoma
112865|NCT02587793|primary culture|primary culture
112866|NCT02587793|fine-needle aspiration|fine-needle aspiration
112867|NCT02587793|cancer-associated fibroblast|cancer-associated fibroblast
112868|NCT02587741|type 2 diabetes mellitus|type 2 diabetes mellitus
112869|NCT02587741|Diabetic Retinopathy|diabetic retinopathy
112870|NCT02587741|glucose fluctuation|glucose fluctuation
112871|NCT02587741|oxidative stress|oxidative stress
112872|NCT02587741|Insulin|insulin
112873|NCT02587741|Oral drugs|oral drugs
112874|NCT02587728|Carpal Tunnel Syndrome|carpal tunnel syndrome
112875|NCT02587728|Amyloidosis|amyloidosis
112876|NCT02587715|RRMS|rrms
112877|NCT02587702|Term Infants|term infants
112878|NCT02587650|Metastatic|metastatic
112879|NCT02587650|BRAF Wild-Type (WT)|braf wild-type (wt)
112880|NCT02587650|NRAS Wild-Type (WT)|nras wild-type (wt)
112881|NCT02587650|KRAS Wild-Type (WT)|kras wild-type (wt)
112882|NCT02587650|HRAS Wild-Type (WT)|hras wild-type (wt)
112883|NCT02587650|GNAQ Wild-Type (WT)|gnaq wild-type (wt)
112884|NCT02587650|GNA11 Wild-Type (WT)|gna11 wild-type (wt)
112885|NCT02587650|KIT Wild-Type (WT)|kit wild-type (wt)
112886|NCT02587624|atrial fibrillation|atrial fibrillation
112887|NCT02587624|catheter ablation|catheter ablation
112888|NCT02587624|remote magnetic navigation|remote magnetic navigation
112889|NCT02587598|leukemia|leukemia
112890|NCT02587598|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
112891|NCT02587598|myelodysplastic/myeloproliferative neoplasms (MDS/MPN)|myelodysplastic/myeloproliferative neoplasms (mds/mpn)
112892|NCT02587598|myelofibrosis (MF)|myelofibrosis (mf)
112893|NCT02587598|lymphoproliferative disorders|lymphoproliferative disorders
112894|NCT02587598|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
112895|NCT02587598|lymphomas|lymphomas
112896|NCT02587598|multiple myeloma (MM)|multiple myeloma (mm)
112898|NCT02587559|physical therapy|physical therapy
112899|NCT02587546|laryngeal carcinoma|laryngeal carcinoma
112900|NCT02587546|bilateral vocal cord paralysis|bilateral vocal cord paralysis
112901|NCT02587546|laryngotracheal stenosis|laryngotracheal stenosis
112902|NCT02587546|laser treatment|laser treatment
112903|NCT02587546|decannulation|decannulation
112904|NCT02587546|voice|voice
112905|NCT02587546|swallowing|swallowing
112906|NCT02587533|Baroreflex|baroreflex
112907|NCT02587533|Chemoreflex|chemoreflex
112908|NCT02587533|Autonomic nervous system|autonomic nervous system
112909|NCT02587533|Sympathetic activity|sympathetic activity
112910|NCT02587533|Muscle sympathetic nerve activity (MSNA)|muscle sympathetic nerve activity (msna)
112911|NCT02587533|Microneurography|microneurography
112912|NCT02587533|Electrical baroreflex stimulation|electrical baroreflex stimulation
112913|NCT02587533|Resistant hypertension|resistant hypertension
112914|NCT02587533|Device-based therapy|device-based therapy
112915|NCT02587520|Tetanus|tetanus
112916|NCT02587520|Diphtheria|diphtheria
112917|NCT02587520|Pertussis|pertussis
112918|NCT02587520|SP0173|sp0173
112919|NCT02587520|Tdap vaccine|tdap vaccine
112920|NCT02587481|Acute coronary syndrom|acute coronary syndrom
112921|NCT02587481|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
112922|NCT02587481|Myocardial infarction|myocardial infarction
112923|NCT02587481|Blood based biomarkers|blood based biomarkers
112924|NCT02587468|phenolics|phenolics
112925|NCT02587468|absorption|absorption
112926|NCT02587468|fruit & vegetable concentrate|fruit & vegetable concentrate
112927|NCT02587468|Bioavailability of phenolic compounds|bioavailability of phenolic compounds
112928|NCT02587455|Non-small cell carcinoma|non-small cell carcinoma
112929|NCT02587442|Acute Radiation Syndrome|acute radiation syndrome
112931|NCT02587442|Amifostine|amifostine
112932|NCT02587442|Radio-protectants|radio-protectants
112933|NCT02587416|Pharmacokinetics|pharmacokinetics
112934|NCT02587416|Lipid Regulator|lipid regulator
112935|NCT02587390|Pharmacokinetics|pharmacokinetics
112936|NCT02587390|Lipid Regulator|lipid regulator
112937|NCT02587364|Pharmacokinetics|pharmacokinetics
112938|NCT02587364|Lipid Regulator|lipid regulator
112939|NCT02587351|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
112940|NCT02587351|COPD|copd
112941|NCT02587351|Exacerbation|exacerbation
112942|NCT02587351|Lung function|lung function
112943|NCT02587351|Cardiac|cardiac
112944|NCT02587351|Cardiovascular|cardiovascular
112945|NCT02587351|Beta blockers|beta blockers
112946|NCT02587351|Metoprolol succinate|metoprolol succinate
112947|NCT02587351|Smoking|smoking
112948|NCT02587338|Subjective Memory Impairment|subjective memory impairment
112949|NCT02587338|tDCS|tdcs
112950|NCT02587338|NIRS|nirs
112951|NCT02587338|Cognitive Training|cognitive training
104067|NCT02639533|fibromyalgia|fibromyalgia
104068|NCT02639533|pregabalin|pregabalin
104069|NCT02639533|cortical excitability|cortical excitability
104070|NCT02639533|functional near infrared spectroscopy|functional near infrared spectroscopy
104073|NCT02639481|stroke|stroke
112952|NCT02587338|Working Memory|working memory
112953|NCT02587286|mHealth|mhealth
112954|NCT02587286|Telemedicine|telemedicine
112955|NCT02587286|Randomized Controlled Trial|randomized controlled trial
112956|NCT02587286|Glucose control|glucose control
112957|NCT02587273|Critical care|critical care
112958|NCT02587273|Intensive Care|intensive care
112959|NCT02587273|Fentanyl|fentanyl
112960|NCT02587273|Pharmacokinetics|pharmacokinetics
112961|NCT02587273|Multiple Organ Failure|multiple organ failure
112962|NCT02587260|P2Y12 inhibitors|p2y12 inhibitors
112963|NCT02587260|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
112964|NCT02587260|Endothelial function|endothelial function
112965|NCT02587260|Adenosine measurement in human subject|adenosine measurement in human subject
112967|NCT02587234|motor recovery|motor recovery
112969|NCT02587234|human|human
112970|NCT02587234|sensory|sensory
112971|NCT02587234|afferent input|afferent input
112972|NCT02587234|motor training|motor training
112973|NCT02587208|circumcision|circumcision
112974|NCT02587208|plastibell|plastibell
112975|NCT02587208|infants|infants
112976|NCT02587208|open sleeve|open sleeve
112977|NCT02587195|Multiple Sclerosis|multiple sclerosis
112978|NCT02587169|liposarcoma|liposarcoma
112979|NCT02587169|leiomyosarcoma|leiomyosarcoma
112988|NCT02587117|Antioxidant|antioxidant
112990|NCT02587117|Prednisolone|prednisolone
112991|NCT02587104|Diabetes Mellitus|diabetes mellitus
112992|NCT02587104|Foot Diseases|foot diseases
112993|NCT02587104|Foot Ulcer|foot ulcer
112994|NCT02587078|Haemodynamic stabilization|haemodynamic stabilization
112995|NCT02587052|biopsy-proven acute rejection|biopsy-proven acute rejection
112996|NCT02587052|graft loss|graft loss
112997|NCT02587052|graft survival|graft survival
112998|NCT02587039|delirium|delirium
113000|NCT02587039|valve|valve
113001|NCT02587039|graft|graft
113002|NCT02587039|surgery|surgery
113003|NCT02587039|coronary|coronary
113004|NCT02587026|Biorepository|biorepository
113005|NCT02587026|Precision Genomics|precision genomics
113006|NCT02587000|adenomyosis|adenomyosis
113007|NCT02587000|ulipristal acetate|ulipristal acetate
113008|NCT02587000|sonography|sonography
113009|NCT02587000|Magnetic resonance imaging [MRI]|magnetic resonance imaging [mri]
113010|NCT02587000|Pictorial Blood-loss Assessment Chart [PBAC]|pictorial blood-loss assessment chart [pbac]
113019|NCT02586974|CO2 insufflation|co2 insufflation
113020|NCT02586974|robot assisted radical prostatectomy|robot assisted radical prostatectomy
113021|NCT02586974|laparoscopy|laparoscopy
113022|NCT02586974|hypothermia|hypothermia
113023|NCT02586974|cytokine response|cytokine response
113024|NCT02586961|randomized prospective study|randomized prospective study
113025|NCT02586961|complication rate|complication rate
113026|NCT02586961|bronchiolitis|bronchiolitis
113027|NCT02586961|children|children
113028|NCT02586948|extracorporeal CO2 removal|extracorporeal co2 removal
113029|NCT02586935|ASD|asd
113030|NCT02586935|Autism|autism
113031|NCT02586909|Alzheimer's disease|alzheimer's disease
113032|NCT02586909|RVT-101|rvt-101
113033|NCT02586909|donepezil|donepezil
113034|NCT02586883|Dilation of the Bronchi|dilation of the bronchi
113035|NCT02586883|Bronchial potential difference|bronchial potential difference
113036|NCT02586883|Dilation of the Bronchi (DDB)|dilation of the bronchi (ddb)
113037|NCT02586857|Glioblastoma Multiforme|glioblastoma multiforme
113038|NCT02586857|GBM|gbm
113039|NCT02586844|NET|net
113040|NCT02586844|PanNET|pannet
113041|NCT02586844|Molecular profiling|molecular profiling
113042|NCT02586844|Transcriptome sequencing|transcriptome sequencing
113043|NCT02586831|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
113044|NCT02586831|Hypoglycemia|hypoglycemia
113045|NCT02586831|Autoimmune Diseases|autoimmune diseases
113046|NCT02586831|Diabetes Mellitus|diabetes mellitus
113047|NCT02586805|DX-2930|dx-2930
113048|NCT02586805|Hereditary Angioedema|hereditary angioedema
113049|NCT02586805|Dyax|dyax
113050|NCT02586792|H7N7|h7n7
113051|NCT02586792|H7N9|h7n9
113052|NCT02586792|Influenza|influenza
113053|NCT02586792|Intramusclar|intramusclar
113054|NCT02586792|Non-adjuvanted|non-adjuvanted
113055|NCT02586792|Open-Label|open-label
113056|NCT02586792|sub-study|sub-study
113057|NCT02586792|Vaccine|vaccine
113058|NCT02586779|Referral and consultation|referral and consultation
113059|NCT02586779|emergency department|emergency department
113060|NCT02586779|WhatsApp|whatsapp
113061|NCT02586766|Youth Violence|youth violence
113062|NCT02586727|Radiation Retinopathy|radiation retinopathy
104167|NCT02638935|BI-RADS|bi-rads
104168|NCT02638935|Differentiation of breast lesions|differentiation of breast lesions
113063|NCT02586727|aflibercept|aflibercept
113064|NCT02586688|child depression|child depression
113065|NCT02586688|depression|depression
113066|NCT02586688|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
113067|NCT02586688|Adolescent Major Depressive Disorder|adolescent major depressive disorder
113068|NCT02586688|TMS|tms
113069|NCT02586688|adolescent depression|adolescent depression
113070|NCT02586675|ER+ breast cancer|er+ breast cancer
113071|NCT02586675|PR+ breast cancer|pr+ breast cancer
113072|NCT02586675|hormone receptor positive|hormone receptor positive
113073|NCT02586675|HER2- breast cancer|her2- breast cancer
113074|NCT02586675|HER2 negative|her2 negative
113075|NCT02586675|locally advanced|locally advanced
113076|NCT02586675|metastatic|metastatic
113077|NCT02586662|scapular dyskinesis|scapular dyskinesis
113078|NCT02586662|kinematics|kinematics
113079|NCT02586649|tiotropium bromide|tiotropium bromide
113080|NCT02586636|Metformin|metformin
113081|NCT02586636|OCT1|oct1
113082|NCT02586610|Pembrolizumab|pembrolizumab
113083|NCT02586610|Chemoradiation|chemoradiation
113084|NCT02586610|Anti-PD-1 Antibody|anti-pd-1 antibody
113085|NCT02586610|MK-3475|mk-3475
113086|NCT02586597|Stroke|stroke
113087|NCT02586597|PAS|pas
113088|NCT02586597|TMS|tms
113089|NCT02586597|cortical excitability|cortical excitability
113090|NCT02586597|plasticity|plasticity
113091|NCT02586584|Patient-Reported Outcome, Antiretroviral Therapy|patient-reported outcome, antiretroviral therapy
113092|NCT02586571|Body Composition|body composition
113093|NCT02586571|Breast Feeding|breast feeding
113094|NCT02586571|Growth|growth
113095|NCT02586571|Infant|infant
113096|NCT02586571|Milk, Human|milk, human
113097|NCT02586571|Nutritional Sciences|nutritional sciences
113098|NCT02586571|Weaning|weaning
113099|NCT02586532|Detection|detection
113100|NCT02586532|Cancer|cancer
113101|NCT02586532|Antibody|antibody
113102|NCT02586532|Biopsy|biopsy
113103|NCT02586532|Registry|registry
113104|NCT02586519|wearable technology|wearable technology
113105|NCT02586519|Orpyx|orpyx
113106|NCT02586519|SurroSense Rx|surrosense rx
113107|NCT02586519|smart insole|smart insole
113108|NCT02586519|TCC|tcc
113109|NCT02586519|total contact cast|total contact cast
113110|NCT02586519|insole|insole
113111|NCT02586519|removable cast walker|removable cast walker
113112|NCT02586519|RCW|rcw
113113|NCT02586506|correct use of inhaler|correct use of inhaler
113114|NCT02586506|dose left|dose left
113115|NCT02586506|ease of use|ease of use
113116|NCT02586506|ELLIPTA|ellipta
113117|NCT02586506|Asthma|asthma
113118|NCT02586493|Placebo|placebo
113119|NCT02586493|ELLIPTA inhaler|ellipta inhaler
113120|NCT02586493|Correct use|correct use
113121|NCT02586493|COPD|copd
113122|NCT02586493|Ease of use|ease of use
113123|NCT02586480|bradycardia|bradycardia
113124|NCT02586454|Transmuscular quadratus lumborum block, total abdominal hysterectomy|transmuscular quadratus lumborum block, total abdominal hysterectomy
113125|NCT02586441|Bispectral index (BIS)|bispectral index (bis)
113126|NCT02586441|EEG|eeg
113127|NCT02586441|Depth of anesthesia|depth of anesthesia
113128|NCT02586415|endovascular|endovascular
113129|NCT02586415|endovascular procedure|endovascular procedure
113130|NCT02586415|Mechanical Thrombectomy|mechanical thrombectomy
113131|NCT02586402|ESAs CKD|esas ckd
113132|NCT02586363|Entecavir|entecavir
113133|NCT02586363|Food effect|food effect
113134|NCT02586363|Cavir Tab 0.5mg|cavir tab 0.5mg
113135|NCT02586363|Baraclude Tab. 0.5mg|baraclude tab. 0.5mg
113136|NCT02586285|S-Adenosyl Methionine|s-adenosyl methionine
113137|NCT02586285|Recurrence|recurrence
113138|NCT02586272|Embryo Transfer|embryo transfer
113139|NCT02586272|assisted reproductive technology|assisted reproductive technology
113140|NCT02586246|CDP870|cdp870
113141|NCT02586246|Rheumatoid arthritis|rheumatoid arthritis
113142|NCT02586246|Long-term|long-term
113143|NCT02586233|Acute Ischemic Stroke in the anterior circulation|acute ischemic stroke in the anterior circulation
113144|NCT02586207|Larynx|larynx
113145|NCT02586207|Squamous Cell|squamous cell
113146|NCT02586207|Oral cavity|oral cavity
113147|NCT02586207|Oropharynx|oropharynx
113148|NCT02586207|Hypopharynx|hypopharynx
113149|NCT02586194|Impaired hepatic function|impaired hepatic function
113150|NCT02586194|Pharmacokinetics|pharmacokinetics
113151|NCT02586194|ASP015K|asp015k
113152|NCT02586168|Insulin Resistance|insulin resistance
113153|NCT02586168|Lipid Regulator|lipid regulator
113154|NCT02586142|spasticity|spasticity
113155|NCT02586142|claw toe|claw toe
113156|NCT02586142|ultrasounds guidance|ultrasounds guidance
113157|NCT02586142|botulinum toxin|botulinum toxin
113158|NCT02586142|stretching exercise|stretching exercise
113159|NCT02586090|Pediatric Obesity|pediatric obesity
113160|NCT02586090|Lifestyle Intervention|lifestyle intervention
113161|NCT02586090|Family-based Intervention|family-based intervention
113162|NCT02586090|Motivational Interviewing|motivational interviewing
113163|NCT02586064|posttraumatic stress disorder|posttraumatic stress disorder
113164|NCT02586064|Veterans|veterans
113165|NCT02586064|Psychotherapy|psychotherapy
113166|NCT02586064|Randomized Controlled Trial|randomized controlled trial
113167|NCT02585999|Hormonal contraception, hormone pharmacokinetics|hormonal contraception, hormone pharmacokinetics
113168|NCT02585973|AZD1775|azd1775
113169|NCT02585973|Cisplatin|cisplatin
113170|NCT02585973|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
113171|NCT02585973|HNSCC|hnscc
113172|NCT02585973|Chemoradiotherapy|chemoradiotherapy
113173|NCT02585973|Radiotherapy|radiotherapy
113174|NCT02585973|CRT|crt
113175|NCT02585947|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
113176|NCT02585947|Tenofovir|tenofovir
113177|NCT02585934|Alzheimer's disease|alzheimer's disease
113178|NCT02585934|RVT-101|rvt-101
113179|NCT02585934|donepezil|donepezil
113180|NCT02585934|intepirdine|intepirdine
113181|NCT02585934|dementia|dementia
113182|NCT02585921|Urban Health|urban health
113183|NCT02585895|LDL-C Apheresis|ldl-c apheresis
113186|NCT02585895|High Cholesterol|high cholesterol
113187|NCT02585895|PCSK9 mutations|pcsk9 mutations
113188|NCT02585895|Severe Familial Hypercholesterolemia|severe familial hypercholesterolemia
113189|NCT02585895|evolocumab|evolocumab
113190|NCT02585895|Repatha|repatha
113191|NCT02585869|Lipid Regulator|lipid regulator
113192|NCT02585869|TG|tg
113193|NCT02585856|Biliary duct carcinoma|biliary duct carcinoma
113194|NCT02585856|Photodynamic therapy|photodynamic therapy
113195|NCT02585843|Heart Failure|heart failure
113196|NCT02585843|Mineralocorticoid receptor antagonists|mineralocorticoid receptor antagonists
113197|NCT02585843|Loop diuretic resistance|loop diuretic resistance
113198|NCT02585817|Cardiac Implantable Electronic Devices|cardiac implantable electronic devices
113199|NCT02585804|FSGS, SGLT2, chronic kidney disease, GFR, proteinuria|fsgs, sglt2, chronic kidney disease, gfr, proteinuria
113200|NCT02585791|electronic cigarette|electronic cigarette
113201|NCT02585791|airway inflammation|airway inflammation
113202|NCT02585791|nasal potential difference|nasal potential difference
113203|NCT02585726|Varicose Veins|varicose veins
113204|NCT02585726|Great Saphenous Vein|great saphenous vein
113205|NCT02585726|Venous Insufficiency|venous insufficiency
113207|NCT02585622|Diabetic Kidney Disease|diabetic kidney disease
113208|NCT02585622|Mesenchymal Stromal Cells (MSC)|mesenchymal stromal cells (msc)
113209|NCT02585622|immune response|immune response
113210|NCT02585622|allogeneic|allogeneic
113211|NCT02585622|disease progression|disease progression
113212|NCT02585609|Sleep|sleep
113213|NCT02585583|Deep Brain|deep brain
113214|NCT02585583|Essential tremor|essential tremor
113215|NCT02585583|Parkinson Disease|parkinson disease
113216|NCT02585583|Tremor|tremor
113217|NCT02585583|Radiosurgery|radiosurgery
113218|NCT02585583|Thalamotomy|thalamotomy
113219|NCT02585583|deep brain stimulation|deep brain stimulation
113220|NCT02585583|DBS|dbs
113221|NCT02585583|intractable, drug resistant, invalidating tremor|intractable, drug resistant, invalidating tremor
113222|NCT02585570|shoulder|shoulder
113223|NCT02585570|phenylephrine|phenylephrine
113224|NCT02585570|hypotension|hypotension
113225|NCT02585544|genital prolapse|genital prolapse
113226|NCT02585544|day-care management|day-care management
113227|NCT02585544|vaginal route|vaginal route
113228|NCT02585544|prosthetic reinforcement|prosthetic reinforcement
113229|NCT02585531|Bronchiolitis|bronchiolitis
113230|NCT02585531|Dexamethasone|dexamethasone
113231|NCT02585531|Epinephrine|epinephrine
113232|NCT02585531|Hypertonic saline|hypertonic saline
113233|NCT02585427|Diabetes|diabetes
113234|NCT02585427|Obesity|obesity
113235|NCT02585427|metabolic disorders|metabolic disorders
113236|NCT02585388|pretreated metastatic breast cancer|pretreated metastatic breast cancer
113237|NCT02585362|palliative|palliative
113238|NCT02585336|Sugar-Sweetened beverages|sugar-sweetened beverages
113239|NCT02585336|Metabolic health|metabolic health
113240|NCT02585336|Soft drinks|soft drinks
113241|NCT02585323|Physical activity|physical activity
113242|NCT02585323|Osteoarthritis|osteoarthritis
113243|NCT02585323|Knee|knee
113244|NCT02585323|Exercise|exercise
113245|NCT02585323|Arthritis|arthritis
113246|NCT02585310|PRBC transfusion|prbc transfusion
113247|NCT02585310|CABGs|cabgs
113248|NCT02585245|Hospital Nutrition screens|hospital nutrition screens
113249|NCT02585232|Behavioral sciences|behavioral sciences
113250|NCT02585232|Counseling|counseling
113251|NCT02585232|Intervention Studies|intervention studies
113252|NCT02585232|Cognitive Behavioral Therapy|cognitive behavioral therapy
113253|NCT02585232|Telemedicine|telemedicine
113254|NCT02585232|Mindfulness|mindfulness
113255|NCT02585206|Mobile Phone|mobile phone
113256|NCT02585206|Text Messaging|text messaging
113257|NCT02585206|Internet|internet
113258|NCT02585206|Tobacco Use|tobacco use
113259|NCT02585180|Ventilator-associated pneumonia|ventilator-associated pneumonia
113260|NCT02585180|Surveillance|surveillance
113261|NCT02585180|Subglottic-secretions|subglottic-secretions
113262|NCT02585180|Critically ill patients|critically ill patients
113263|NCT02585180|Prevention|prevention
113264|NCT02585167|VAAFT|vaaft
113265|NCT02585167|anal fistula|anal fistula
113266|NCT02585167|sphincter reconstruction|sphincter reconstruction
113267|NCT02585154|Deep Brain Stimulation|deep brain stimulation
113268|NCT02585128|Delirium|delirium
113269|NCT02585128|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
113270|NCT02585128|Elderly|elderly
113271|NCT02585102|Vegetables|vegetables
113272|NCT02585089|Hypertension|hypertension
116178|NCT02568683|Refractory|refractory
113273|NCT02585089|active biopeptide|active biopeptide
113274|NCT02585089|cardiovascular pathophysiology|cardiovascular pathophysiology
113275|NCT02585089|angiotensin converting enzyme inhibition|angiotensin converting enzyme inhibition
113276|NCT02585089|cured-pork ham|cured-pork ham
113277|NCT02585076|Stroke prevention|stroke prevention
113278|NCT02585076|Risk assessment|risk assessment
113279|NCT02585063|independent prescribing,|independent prescribing,
113280|NCT02585063|optometrist|optometrist
113281|NCT02585063|acute care|acute care
113282|NCT02585050|do not attempt resuscitation|do not attempt resuscitation
113283|NCT02585050|neurological outcome|neurological outcome
113284|NCT02585050|live discharged ratio|live discharged ratio
113285|NCT02585024|smoking|smoking
113286|NCT02585024|cytisine|cytisine
113287|NCT02585024|Pharmacokinetics|pharmacokinetics
113288|NCT02585011|Hemiarthroplasty|hemiarthroplasty
113289|NCT02585011|Anesthesia, Local|anesthesia, local
113290|NCT02585011|Pain, Postoperative|pain, postoperative
113291|NCT02584972|Postural control|postural control
113292|NCT02584972|Gait|gait
113293|NCT02584972|Children|children
113294|NCT02584972|Autism Spectrum Disorder|autism spectrum disorder
113295|NCT02584933|ALK|alk
113296|NCT02584933|Malignancies|malignancies
113297|NCT02584907|Critically ill|critically ill
113298|NCT02584907|Diet|diet
113299|NCT02584907|Blood glucose|blood glucose
113300|NCT02584894|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
113301|NCT02584894|trauma exposure|trauma exposure
113302|NCT02584894|Repeated transcranial magnetic stimulation|repeated transcranial magnetic stimulation
113306|NCT02584816|Rotavirus vaccine|rotavirus vaccine
113307|NCT02584816|lot-to-lot consistency|lot-to-lot consistency
113308|NCT02584816|interference with routine immunization|interference with routine immunization
113309|NCT02584790|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
113310|NCT02584790|Narrow band imaging|narrow band imaging
113311|NCT02584777|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
113312|NCT02584777|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
113313|NCT02584738|Asthma|asthma
113314|NCT02584738|Exacerbation|exacerbation
113315|NCT02584738|Nebulization|nebulization
113316|NCT02584738|Magnesium|magnesium
113317|NCT02584738|Pediatric|pediatric
113318|NCT02584725|Tranexamic Acid|tranexamic acid
113319|NCT02584725|Total Joint Arthroplasty|total joint arthroplasty
113320|NCT02584725|Intraoperative Blood Loss|intraoperative blood loss
113321|NCT02584660|Rivaroxaban|rivaroxaban
113322|NCT02584660|JNJ39039039|jnj39039039
113323|NCT02584660|Pulmonary embolism|pulmonary embolism
113324|NCT02584647|Unresectable|unresectable
113325|NCT02584634|Non-Small Cell Lung Cancer|non-small cell lung cancer
113326|NCT02584634|NSCLC|nsclc
113327|NCT02584634|ALK|alk
113328|NCT02584634|avelumab|avelumab
113329|NCT02584634|crizotinib|crizotinib
113330|NCT02584634|PF-06463922|pf-06463922
113331|NCT02584595|Tachycardia|tachycardia
113332|NCT02584595|Ventricular Tachycardia|ventricular tachycardia
113333|NCT02584595|Cardiac Arrhythmias|cardiac arrhythmias
113334|NCT02584595|Cardiovascular Diseases|cardiovascular diseases
113335|NCT02584595|Heart Diseases|heart diseases
113336|NCT02584582|Glucagon|glucagon
113337|NCT02584582|Glukagon-like peptide-1 (GLP-1)|glukagon-like peptide-1 (glp-1)
113338|NCT02584582|GLP-1 receptor agonist (GLP-1RA)|glp-1 receptor agonist (glp-1ra)
113339|NCT02584582|Incretins|incretins
113340|NCT02584569|Drug therapy|drug therapy
113341|NCT02584530|ultrasound|ultrasound
113342|NCT02584530|PICC line|picc line
113343|NCT02584530|neonate|neonate
113344|NCT02584517|Vasculitis|vasculitis
113345|NCT02584517|Autoimmune disease|autoimmune disease
113346|NCT02584517|Connective tissue disease|connective tissue disease
113347|NCT02584517|Polymyalgia rheumatica|polymyalgia rheumatica
113348|NCT02584517|Musculoskeletal Diseases|musculoskeletal diseases
113349|NCT02584517|Immune disorder|immune disorder
113350|NCT02584517|Rheumatic disease|rheumatic disease
113351|NCT02584478|Dual receptor Tyrosine Kinase Inhibitor|dual receptor tyrosine kinase inhibitor
113352|NCT02584478|Anti-angiogenic therapy|anti-angiogenic therapy
113353|NCT02584478|Combination Therapy|combination therapy
113354|NCT02584439|ivabradine|ivabradine
113355|NCT02584439|heart rate|heart rate
113356|NCT02584439|aging|aging
113357|NCT02584439|visco-elasticity|visco-elasticity
113358|NCT02584426|Cefazolin|cefazolin
113359|NCT02584400|prostatic tumors|prostatic tumors
113360|NCT02584400|[18F]HX4 Pet imaging|[18f]hx4 pet imaging
113361|NCT02584400|hypoxia|hypoxia
113362|NCT02584400|phase II trial|phase ii trial
113363|NCT02584400|esophageal tumors|esophageal tumors
113364|NCT02584400|rectal tumors|rectal tumors
113365|NCT02584400|brain metastases|brain metastases
113366|NCT02584400|primary brain tumors|primary brain tumors
113367|NCT02584374|iliac vein compression|iliac vein compression
113368|NCT02584361|Hearing loss|hearing loss
113369|NCT02584361|Cochlear implant|cochlear implant
113470|NCT02583763|Velocity Vector Imaging|velocity vector imaging
113370|NCT02584348|ultrasound, antrum, pulmonary aspiration, emergency surgery|ultrasound, antrum, pulmonary aspiration, emergency surgery
113371|NCT02584335|wound treatment|wound treatment
113372|NCT02584335|lidocaine|lidocaine
113373|NCT02584335|pain reduction|pain reduction
113374|NCT02584335|local anesthetic|local anesthetic
113375|NCT02584283|Liver Transplantation|liver transplantation
113376|NCT02584283|Donation after Circulatory Death|donation after circulatory death
113377|NCT02584283|Machine Perfusion|machine perfusion
113378|NCT02584270|palatal drop prosthesis|palatal drop prosthesis
113379|NCT02584231|Desmopressin|desmopressin
113380|NCT02584231|Paediatrics|paediatrics
113381|NCT02584231|urinary concentration test|urinary concentration test
113382|NCT02584205|inspiratory muscle training|inspiratory muscle training
113383|NCT02584205|obstructive sleep apnea|obstructive sleep apnea
113384|NCT02584205|functional capacity|functional capacity
113385|NCT02584179|mpMRI, significant cancer|mpmri, significant cancer
113386|NCT02584166|Morbidity|morbidity
113387|NCT02584166|Mortality|mortality
113388|NCT02584166|conferences|conferences
113389|NCT02584166|human science|human science
113390|NCT02584153|Hernia|hernia
113391|NCT02584153|Ventral|ventral
113392|NCT02584153|Incisional|incisional
113393|NCT02584153|Abdominal|abdominal
113394|NCT02584153|Herniorrhaphy|herniorrhaphy
113395|NCT02584153|Recurrence|recurrence
113396|NCT02584153|laparotomy|laparotomy
113397|NCT02584153|prevention|prevention
113399|NCT02584140|Pre-exposure Prophylaxis|pre-exposure prophylaxis
113400|NCT02584140|HIV Prevention|hiv prevention
113401|NCT02584127|Smoking|smoking
113402|NCT02584127|cessation|cessation
113403|NCT02584127|Internet program|internet program
113404|NCT02584101|Acceptance and Commitment Therapy|acceptance and commitment therapy
113405|NCT02584088|NovaSure|novasure
113406|NCT02584088|Ablation|ablation
113407|NCT02584088|Menorrhagia|menorrhagia
113408|NCT02584088|Endometrium|endometrium
113409|NCT02584049|Osteopathic treatment|osteopathic treatment
113410|NCT02584049|Care-induced Pain|care-induced pain
113411|NCT02584049|Pain|pain
113412|NCT02584049|Elderly|elderly
113413|NCT02584036|influenza|influenza
113414|NCT02584036|vaccine|vaccine
113415|NCT02584036|public health|public health
113416|NCT02584036|preventable disease|preventable disease
113417|NCT02584036|vaccine history|vaccine history
113418|NCT02584036|point-of-care|point-of-care
113419|NCT02584023|ultrasonography|ultrasonography
113420|NCT02584023|infant|infant
113421|NCT02584023|perioperative period|perioperative period
113422|NCT02584023|general anesthesia|general anesthesia
113423|NCT02584010|Postoperative scars|postoperative scars
113424|NCT02584010|Cicatrix|cicatrix
113425|NCT02584010|Cicatrization|cicatrization
113426|NCT02583997|To suture or not to suture....|to suture or not to suture....
113427|NCT02583997|Tooth extraction|tooth extraction
113428|NCT02583997|Third molar|third molar
113429|NCT02583971|Direct current cardioversion|direct current cardioversion
113430|NCT02583971|Medical management|medical management
113431|NCT02583971|Atrial fibrillation ablation|atrial fibrillation ablation
113432|NCT02583945|acute kidney injury|acute kidney injury
113433|NCT02583945|hemodynamic stabilisation|hemodynamic stabilisation
113434|NCT02583945|nephrotoxic medication|nephrotoxic medication
113435|NCT02583932|Randomized controlled trial|randomized controlled trial
113436|NCT02583932|Psychological|psychological
113437|NCT02583932|Meaning|meaning
113438|NCT02583932|Existential|existential
113439|NCT02583932|Quality of life|quality of life
113440|NCT02583932|Intervention|intervention
113441|NCT02583932|Cancer|cancer
113442|NCT02583932|Advanced disease|advanced disease
113443|NCT02583932|New diagnosis|new diagnosis
113444|NCT02583880|nutritional status|nutritional status
113445|NCT02583880|malnutrition|malnutrition
113446|NCT02583880|energy intake|energy intake
113447|NCT02583880|caloric deficit|caloric deficit
113448|NCT02583880|ICU|icu
113449|NCT02583880|hospital|hospital
113450|NCT02583880|enteral nutrition|enteral nutrition
113451|NCT02583880|parenteral nutrition|parenteral nutrition
113452|NCT02583880|nutrition|nutrition
113453|NCT02583854|Coronary angiography|coronary angiography
113454|NCT02583854|Transradial|transradial
113455|NCT02583854|Patient experience|patient experience
113456|NCT02583854|VAS|vas
113457|NCT02583854|Compression device|compression device
113458|NCT02583802|MHD|mhd
113459|NCT02583802|ear pills|ear pills
113460|NCT02583802|Shengmai capsule|shengmai capsule
113461|NCT02583802|Chinese medicine treatment|chinese medicine treatment
113462|NCT02583776|continuous glucose monitoring (cgm)|continuous glucose monitoring (cgm)
113463|NCT02583776|neonatal hypoglycemia|neonatal hypoglycemia
113464|NCT02583776|very low birth weight infants (VLBWI)|very low birth weight infants (vlbwi)
113465|NCT02583776|preterm infants|preterm infants
113466|NCT02583763|pro-brain natriuretic peptide (1-76)|pro-brain natriuretic peptide (1-76)
113467|NCT02583763|Insulin-Like Growth Factor Binding Proteins|insulin-like growth factor binding proteins
113468|NCT02583763|Insulin-Like Growth Factor I|insulin-like growth factor i
113469|NCT02583763|Echocardiography|echocardiography
113472|NCT02583750|glucose metabolism|glucose metabolism
113473|NCT02583750|sleep deprivation|sleep deprivation
113474|NCT02583737|bone|bone
113475|NCT02583737|maxillary sinus|maxillary sinus
113477|NCT02583659|Gastric cancer|gastric cancer
113478|NCT02583659|First-line chemotherapy|first-line chemotherapy
113479|NCT02583659|Biomarker|biomarker
113480|NCT02583646|Obesity|obesity
113481|NCT02583646|Puberty|puberty
113482|NCT02583646|Ultrasound|ultrasound
113483|NCT02583646|Pediatric|pediatric
113484|NCT02583620|high myopia|high myopia
113485|NCT02583568|breast cancer|breast cancer
113486|NCT02583568|image-guided surgery|image-guided surgery
113487|NCT02583555|Quality of Life|quality of life
113488|NCT02583555|Health Care Utilization|health care utilization
113489|NCT02583542|breast|breast
113490|NCT02583542|lung|lung
113491|NCT02583542|squamous|squamous
113492|NCT02583542|KRAS|kras
113493|NCT02583542|AZD|azd
113494|NCT02583542|selumetinib|selumetinib
113495|NCT02583529|Parkinson Disease|parkinson disease
113496|NCT02583529|Neurogenic Overactive Bladder|neurogenic overactive bladder
113497|NCT02583529|Posterior Tibial Nerve Electrostimulation|posterior tibial nerve electrostimulation
113498|NCT02583503|Total knee arthroplasty|total knee arthroplasty
113499|NCT02583503|Total knee replacement|total knee replacement
113500|NCT02583503|TKA|tka
113501|NCT02583503|TKR|tkr
114392|NCT02578355|MI|mi
113503|NCT02583490|Low Pulse Amplitude Focal Electroconvulsive Therapy|low pulse amplitude focal electroconvulsive therapy
113504|NCT02583490|ECT|ect
113505|NCT02583490|Depression|depression
113506|NCT02583490|Suicidal Ideation|suicidal ideation
113507|NCT02583477|Pancreatic Ductal Adenocarcinoma, PDAC, immunotherapy, PDL1, AZD5069, MEDI4736|pancreatic ductal adenocarcinoma, pdac, immunotherapy, pdl1, azd5069, medi4736
113508|NCT02583438|Gut Microbiota|gut microbiota
113509|NCT02583438|inflammatory marker|inflammatory marker
113510|NCT02583438|Glucose and lipid metabolism|glucose and lipid metabolism
113511|NCT02583399|Pediatric (Birth to less than 6 months of age)|pediatric (birth to less than 6 months of age)
113512|NCT02583399|Pain|pain
113513|NCT02583399|Fever|fever
113514|NCT02583386|mobility|mobility
113515|NCT02583386|falls|falls
113516|NCT02583386|fall prevention|fall prevention
113517|NCT02583386|gait and balance|gait and balance
113518|NCT02583386|automatic fall detector|automatic fall detector
113519|NCT02583373|Pneumonia|pneumonia
113520|NCT02583373|Streptococcus pneumoniae|streptococcus pneumoniae
113521|NCT02583373|Pneumolysin|pneumolysin
113522|NCT02583360|Infant|infant
113523|NCT02583360|Feeding difficulties|feeding difficulties
113524|NCT02583360|Dysphagia|dysphagia
113525|NCT02583334|acupuncture|acupuncture
113526|NCT02583334|fibromyalgia|fibromyalgia
113527|NCT02583334|rheumatism|rheumatism
113528|NCT02583334|clinical trial|clinical trial
113529|NCT02583321|chlorhexidine gluconate|chlorhexidine gluconate
113530|NCT02583321|oral care|oral care
113531|NCT02583321|mechanical ventilation|mechanical ventilation
113532|NCT02583321|critically ill patients|critically ill patients
113533|NCT02583321|tracheal secretions|tracheal secretions
113534|NCT02583321|subglottic secretions|subglottic secretions
113535|NCT02583308|Ventilator-associated pneumonia|ventilator-associated pneumonia
113536|NCT02583308|Surveillance|surveillance
113537|NCT02583308|Subglottic-secretions|subglottic-secretions
113538|NCT02583308|Critically ill patients|critically ill patients
113539|NCT02583308|Prevention|prevention
113540|NCT02583295|Awareness|awareness
113541|NCT02583295|Cardiac Surgery|cardiac surgery
113542|NCT02583295|Maternal|maternal
113543|NCT02583295|Pediatric|pediatric
113544|NCT02583295|Sound|sound
113545|NCT02583295|Music|music
113546|NCT02583243|Opioid dependence|opioid dependence
113547|NCT02583243|HIV/AIDS|hiv/aids
113548|NCT02583243|Hepatitis C|hepatitis c
113549|NCT02583243|Severe mental illness|severe mental illness
113550|NCT02583243|Injection Drug Use|injection drug use
113551|NCT02583230|Antidepressant Medication|antidepressant medication
113552|NCT02583230|Adherence|adherence
113553|NCT02583230|Mobile Smartphone Intervention|mobile smartphone intervention
113554|NCT02583230|Telemedicine|telemedicine
113555|NCT02583230|Primary Care|primary care
113556|NCT02583217|Laryngeal mask|laryngeal mask
113557|NCT02583217|Ketamine|ketamine
113558|NCT02583217|Remifentanyl|remifentanyl
113559|NCT02583165|advanced solid tumors|advanced solid tumors
113560|NCT02583165|immunotherapy|immunotherapy
113561|NCT02583165|immuno-oncology|immuno-oncology
402916|NCT01229150|Tumor Mutational Analysis|tumor mutational analysis
113562|NCT02583139|Children, Moderate and/or highly emetogenic chemotherapy|children, moderate and/or highly emetogenic chemotherapy
113563|NCT02583126|Teenager|teenager
113564|NCT02583126|moderate and/or highly emetogenic chemotherapy|moderate and/or highly emetogenic chemotherapy
113565|NCT02583113|Total Knee Replacement|total knee replacement
113566|NCT02583113|Unicompartment Knee Replacement|unicompartment knee replacement
113567|NCT02583087|Barrett esophagus|barrett esophagus
113568|NCT02583087|Esophageal adenocarcinoma|esophageal adenocarcinoma
113670|NCT02582567|Oxidative stress|oxidative stress
113569|NCT02583087|Endoscopic submucosal dissection|endoscopic submucosal dissection
113570|NCT02583074|deep brain stimulation|deep brain stimulation
113571|NCT02583074|Subthalamic Nucleus|subthalamic nucleus
113572|NCT02583074|dystonia|dystonia
113573|NCT02583035|cancer|cancer
113574|NCT02583035|geriatric|geriatric
113575|NCT02582996|Headache|headache
113576|NCT02582996|Aura|aura
113577|NCT02582996|Migraine|migraine
113578|NCT02582996|Moderate to Severe|moderate to severe
113579|NCT02582957|ARDS|ards
113580|NCT02582957|Shock Lung|shock lung
113581|NCT02582957|Acute Chest Syndrome|acute chest syndrome
113582|NCT02582957|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
113583|NCT02582957|Respiratory insufficiency|respiratory insufficiency
113584|NCT02582957|Trauma|trauma
113585|NCT02582918|Randomized Controlled Trial|randomized controlled trial
113586|NCT02582918|Mass Screening|mass screening
113587|NCT02582905|Alcohol Use Disorder|alcohol use disorder
113588|NCT02582905|Bipolar Disorder|bipolar disorder
113589|NCT02582905|Mood|mood
113590|NCT02582905|Alcohol craving|alcohol craving
113591|NCT02582905|Pregnenolone|pregnenolone
113592|NCT02582905|Citicoline|citicoline
113593|NCT02582879|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
113595|NCT02582879|Small Lymphocytic Leukemia|small lymphocytic leukemia
113596|NCT02582879|SLL|sll
114477|NCT02577705|trauma|trauma
113597|NCT02582866|Lacosamide|lacosamide
113599|NCT02582866|Epilepsy|epilepsy
113600|NCT02582866|Partial onset seizures|partial onset seizures
113601|NCT02582866|Tonic-clonic seizures|tonic-clonic seizures
113602|NCT02582866|Monotherapy|monotherapy
113603|NCT02582866|AED|aed
113604|NCT02582853|GBS|gbs
113605|NCT02582853|AIDP|aidp
113606|NCT02582853|Spinal fluid|spinal fluid
113607|NCT02582853|sCD163|scd163
113608|NCT02582840|Japanese patients with type 1 diabetes with inadequate glycemic control on insulin|japanese patients with type 1 diabetes with inadequate glycemic control on insulin
113609|NCT02582827|Advanced Solid Tumors|advanced solid tumors
113610|NCT02582827|solid tumor|solid tumor
113611|NCT02582827|lymphoma|lymphoma
113612|NCT02582814|Japanese patients with type 1 diabetes with inadequate glycemic control on insulin|japanese patients with type 1 diabetes with inadequate glycemic control on insulin
113613|NCT02582801|PET/CT|pet/ct
113614|NCT02582801|Alfatide Ⅱ|alfatide ⅱ
113615|NCT02582801|breast cancer|breast cancer
113616|NCT02582762|Nail gel|nail gel
113617|NCT02582762|Nail surface abnormality|nail surface abnormality
113618|NCT02582762|Efficacy|efficacy
113619|NCT02582749|Androgen Deprivation Therapy|androgen deprivation therapy
113620|NCT02582749|Androgen Receptor Antagonist|androgen receptor antagonist
113621|NCT02582749|Radium-223 Dichloride|radium-223 dichloride
113622|NCT02582749|Placebo|placebo
113623|NCT02582736|Antipsychotics|antipsychotics
113624|NCT02582736|Drug side effects|drug side effects
113625|NCT02582736|Psychosis|psychosis
113626|NCT02582736|Hyperglycemic emergencies|hyperglycemic emergencies
113627|NCT02582736|Diabetes|diabetes
113628|NCT02582736|Epidemiology|epidemiology
113629|NCT02582736|Database research|database research
113630|NCT02582736|CNODES|cnodes
113631|NCT02582697|Germ Cell|germ cell
113632|NCT02582697|Intermediate and poor-risk metastatic germ cell tumours|intermediate and poor-risk metastatic germ cell tumours
113633|NCT02582671|Real World Effectiveness|real world effectiveness
113634|NCT02582658|Paritaprevir|paritaprevir
113635|NCT02582658|Dasabuvir|dasabuvir
113636|NCT02582658|Ombitasvir|ombitasvir
113637|NCT02582658|Chronic Hepatitis C|chronic hepatitis c
113638|NCT02582658|HCV|hcv
113639|NCT02582645|impaction|impaction
113640|NCT02582645|impacted canine|impacted canine
113641|NCT02582645|palatally|palatally
113642|NCT02582645|open window|open window
113643|NCT02582645|closed window|closed window
113644|NCT02582645|management|management
113645|NCT02582632|Hepatitis C Virus|hepatitis c virus
113646|NCT02582632|Interferon-Free|interferon-free
113647|NCT02582632|Ribavirin-Free|ribavirin-free
113648|NCT02582632|Hepatitis C|hepatitis c
113649|NCT02582632|Hepatitis C Genotype 1b|hepatitis c genotype 1b
113650|NCT02582619|Spinal Cord Injury and Employment|spinal cord injury and employment
113651|NCT02582606|Insulin Resistance|insulin resistance
113652|NCT02582606|Meal pattern|meal pattern
113653|NCT02582606|Obese|obese
113654|NCT02582593|Cognitive Aging|cognitive aging
113655|NCT02582593|Neuromodulation|neuromodulation
113656|NCT02582593|Low Level Light Therapy|low level light therapy
113657|NCT02582593|Near Infrared Light|near infrared light
104763|NCT02635776|Desensitization|desensitization
104764|NCT02635763|nerve block|nerve block
113658|NCT02582593|Neurostimulation|neurostimulation
113659|NCT02582580|pelvic floor|pelvic floor
113660|NCT02582580|perineal trauma|perineal trauma
113661|NCT02582580|physiotherapy|physiotherapy
113662|NCT02582580|perineal integrity|perineal integrity
113663|NCT02582567|Pregnant Women|pregnant women
113664|NCT02582567|Quality of Life|quality of life
113665|NCT02582567|Exercise|exercise
113666|NCT02582567|Sleep|sleep
113667|NCT02582567|Fetal Research|fetal research
113668|NCT02582567|Diet, Mediterranean|diet, mediterranean
113669|NCT02582567|Physical Fitness|physical fitness
113671|NCT02582567|Inflammation|inflammation
113672|NCT02582528|cognitive remediation|cognitive remediation
113673|NCT02582528|cognition|cognition
113679|NCT02582515|habit reversal training|habit reversal training
113680|NCT02582502|Hyperbaric Oxygen|hyperbaric oxygen
113681|NCT02582502|HBOT|hbot
113682|NCT02582502|Hyperbaric Chamber|hyperbaric chamber
113683|NCT02582502|Pressurized Oxygen|pressurized oxygen
113684|NCT02582489|Mesenchymal stem cells|mesenchymal stem cells
113685|NCT02582489|Bone marrow aspirate concentrate|bone marrow aspirate concentrate
113686|NCT02582476|Hypokalemic Periodic Paralysis|hypokalemic periodic paralysis
113687|NCT02582476|Bumetanide|bumetanide
113688|NCT02582476|Periodic Paralysis|periodic paralysis
113689|NCT02582463|Risk Assessment|risk assessment
113690|NCT02582463|Hospitals|hospitals
113691|NCT02582463|Pharmacists|pharmacists
113692|NCT02582463|Medication Systems|medication systems
113693|NCT02582463|Patient Selection|patient selection
113694|NCT02582463|Prognosis research|prognosis research
113695|NCT02582450|Haemophilia|haemophilia
113696|NCT02582450|Adherence of Treatment|adherence of treatment
113697|NCT02582450|Knowledge of Illness|knowledge of illness
113698|NCT02582450|Medical-patient Relationship|medical-patient relationship
113699|NCT02582450|Illness Behavior|illness behavior
113700|NCT02582450|Treatment Difficulties|treatment difficulties
113701|NCT02582450|Veritas|veritas
113702|NCT02582437|Minimum Alveolar Concentration|minimum alveolar concentration
113703|NCT02582411|Healthy Subjects|healthy subjects
113704|NCT02582385|Amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
113706|NCT02582385|Neuropathology|neuropathology
113707|NCT02582359|Acute Myeloid Leukemia|acute myeloid leukemia
113708|NCT02582346|MRI|mri
113709|NCT02582346|Neurography|neurography
113710|NCT02582346|Tractography|tractography
113711|NCT02582346|Pelvic nerves|pelvic nerves
113712|NCT02582203|Ceftaroline fosamil|ceftaroline fosamil
113713|NCT02582203|Vancomycin|vancomycin
113714|NCT02582203|Acute bacterial skin and skin structure infections|acute bacterial skin and skin structure infections
113715|NCT02582203|Methicillin-resistant S. aureus|methicillin-resistant s. aureus
113716|NCT02582190|electrical cardioversion|electrical cardioversion
113717|NCT02582190|persistent atrial fibrillation|persistent atrial fibrillation
113718|NCT02582177|Fungal infection|fungal infection
113719|NCT02582177|Skin infection|skin infection
113720|NCT02582177|Dermatophytoses|dermatophytoses
113721|NCT02582164|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
113722|NCT02582164|Swept Source OCT|swept source oct
113723|NCT02582138|physical frailty|physical frailty
113724|NCT02582138|sarcopenia|sarcopenia
113725|NCT02582138|exercise|exercise
113726|NCT02582138|nutrition|nutrition
113727|NCT02582138|information and communications technology|information and communications technology
113728|NCT02582125|ONO-4538|ono-4538
113729|NCT02582125|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
113730|NCT02582047|influenza vaccine|influenza vaccine
113731|NCT02582047|pneumococcal vaccine|pneumococcal vaccine
113732|NCT02582047|simultaneous vaccination|simultaneous vaccination
113733|NCT02582034|Optimized Dosimetry versus standard Dosimetry|optimized dosimetry versus standard dosimetry
113734|NCT02582034|Internal Radiation Therapy|internal radiation therapy
113735|NCT02582021|Microvascular Coronary Dysfunction (MCD)|microvascular coronary dysfunction (mcd)
113736|NCT02582021|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
113737|NCT02582021|Coronary angiography|coronary angiography
113738|NCT02582021|Coronary Vascular Dysfunction (CVD)|coronary vascular dysfunction (cvd)
113739|NCT02581995|Diabetic macular edema|diabetic macular edema
113740|NCT02581995|Intravitreal injection|intravitreal injection
113741|NCT02581969|Hemophilia A, Congenital|hemophilia a, congenital
113742|NCT02581956|Immunology|immunology
113743|NCT02581891|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
113744|NCT02581891|nAMD)|namd)
113751|NCT02581839|eribulin|eribulin
113752|NCT02581839|central nervous system|central nervous system
113753|NCT02581839|CNS|cns
113754|NCT02581839|Eribulin Mesylate|eribulin mesylate
113755|NCT02581839|Halaven|halaven
113756|NCT02581813|Bone health|bone health
113757|NCT02581813|Body composition|body composition
113758|NCT02581813|Dairy foods|dairy foods
113759|NCT02581813|Exercise|exercise
113760|NCT02581813|inflammation|inflammation
104857|NCT02635230|Aspirin|aspirin
113761|NCT02581813|nutrition intervention|nutrition intervention
113762|NCT02581813|weight management|weight management
113763|NCT02581774|induction|induction
113764|NCT02581774|cesarean delivery|cesarean delivery
114380|NCT02578381|validation|validation
585629|NCT00513448|Chronic Disabling Condition|chronic disabling condition
113765|NCT02581761|Hemodynamically stable women >18 years old|hemodynamically stable women >18 years old
113766|NCT02581761|with abnormal plateauing serum βHCG|with abnormal plateauing serum βhcg
113767|NCT02581735|Haemophilia|haemophilia
113768|NCT02581735|Adherence|adherence
113769|NCT02581735|Prophylaxis treatment|prophylaxis treatment
113770|NCT02581735|Quality of Life|quality of life
113771|NCT02581735|Illness Behavior|illness behavior
113772|NCT02581735|Veritas-Pro questionnaire|veritas-pro questionnaire
113773|NCT02581735|uPatient|upatient
113774|NCT02581722|PrePex, Male Circumcision, HIV Prevention, Adolescents|prepex, male circumcision, hiv prevention, adolescents
113775|NCT02581709|Feasibility study|feasibility study
113776|NCT02581709|Cognition|cognition
113777|NCT02581709|Chemotherapy|chemotherapy
113778|NCT02581709|Neoplasms|neoplasms
113779|NCT02581670|oligometastatic breast cancer|oligometastatic breast cancer
113780|NCT02581618|ischemic preconditioning|ischemic preconditioning
113781|NCT02581618|myocardial injury|myocardial injury
113782|NCT02581618|percutaneous coronary intervention|percutaneous coronary intervention
113783|NCT02581592|Hepatic Impairment|hepatic impairment
113784|NCT02581592|Hepatitis|hepatitis
113785|NCT02581592|Liver Cirrhosis|liver cirrhosis
113786|NCT02581579|Tuberculosis|tuberculosis
113787|NCT02581579|Tregs|tregs
113788|NCT02581579|Tolerance|tolerance
113789|NCT02581579|Probiotic|probiotic
113790|NCT02581579|Mycobacteria|mycobacteria
113791|NCT02581540|Troponin|troponin
113792|NCT02581540|High Sensitivity Troponin T|high sensitivity troponin t
113793|NCT02581540|MACE|mace
113794|NCT02581540|risk stratification|risk stratification
113795|NCT02581540|suspected cardiac chest pain|suspected cardiac chest pain
113796|NCT02581540|Acute Coronary Syndrome|acute coronary syndrome
113797|NCT02581540|GRACE|grace
113798|NCT02581540|TIMI|timi
113799|NCT02581540|HEART|heart
113800|NCT02581514|decision algorithm|decision algorithm
113801|NCT02581501|Xeloda|xeloda
113802|NCT02581501|Gemcitabine|gemcitabine
113803|NCT02581501|Abraxane|abraxane
113804|NCT02581501|Pancreatic Cancer|pancreatic cancer
113805|NCT02581501|Metastatic Cancer|metastatic cancer
113806|NCT02581501|Phase I|phase i
113807|NCT02581501|5-FU|5-fu
113808|NCT02581501|Capecitabine|capecitabine
113809|NCT02581501|Gemzar|gemzar
113810|NCT02581501|NAB-Paclitaxel|nab-paclitaxel
113811|NCT02581501|Chemotherapy|chemotherapy
113812|NCT02581488|Diabetes|diabetes
113813|NCT02581488|diabetic foot ulcer|diabetic foot ulcer
113814|NCT02581488|foot sore|foot sore
113815|NCT02581488|type 2 diabetes|type 2 diabetes
113816|NCT02581488|type 1 diabetes|type 1 diabetes
113817|NCT02581488|neuropathy|neuropathy
113818|NCT02581488|DFU|dfu
113819|NCT02581475|Adenoma detection rate|adenoma detection rate
113820|NCT02581475|Colonoscopy|colonoscopy
113821|NCT02581475|Withdrawal time|withdrawal time
113822|NCT02581449|omega-3 fatty acids|omega-3 fatty acids
113937|NCT02580812|Sepsis|sepsis
113823|NCT02581449|hemodialysis|hemodialysis
113824|NCT02581449|oxidative stress|oxidative stress
113825|NCT02581449|dyslipidemia|dyslipidemia
113826|NCT02581436|Prediction test|prediction test
113827|NCT02581436|genetic transcription profile|genetic transcription profile
113828|NCT02581436|Transplant follow-up|transplant follow-up
113829|NCT02581436|Chronic index|chronic index
113830|NCT02581436|Graft Function|graft function
113831|NCT02581410|Zostavax®|zostavax®
113832|NCT02581410|≥ 65 years of age|≥ 65 years of age
113833|NCT02581410|Herpes Zoster|herpes zoster
113834|NCT02581410|Shingles|shingles
113835|NCT02581410|Immunogenicity|immunogenicity
113836|NCT02581410|Safety|safety
113837|NCT02581397|cough|cough
113838|NCT02581397|expectorant|expectorant
113839|NCT02581397|upper respiratory tract infections|upper respiratory tract infections
113840|NCT02581397|respiratory tract infections|respiratory tract infections
113841|NCT02581397|antitussive agents|antitussive agents
113842|NCT02581384|Ewing Sarcoma|ewing sarcoma
113843|NCT02581384|Rhabdomyosarcoma|rhabdomyosarcoma
113844|NCT02581384|Wilms Tumor|wilms tumor
113845|NCT02581371|Cerebrolysin|cerebrolysin
113846|NCT02581371|neuroplasticity|neuroplasticity
113847|NCT02581371|upper limb|upper limb
113848|NCT02581371|middle cerebral artery|middle cerebral artery
113849|NCT02581371|NBS|nbs
113850|NCT02581371|navigation brain stimulation|navigation brain stimulation
113851|NCT02581371|paretic limb|paretic limb
113852|NCT02581371|stroke|stroke
113853|NCT02581371|ischemic stroke|ischemic stroke
113854|NCT02581371|rehabilitation|rehabilitation
113855|NCT02581371|Frenchay Arm Test|frenchay arm test
113856|NCT02581371|NBS eXimia Nexstim|nbs eximia nexstim
113857|NCT02581371|Barthel index|barthel index
113858|NCT02581358|scoliosis|scoliosis
113859|NCT02581358|spinal deformity|spinal deformity
113860|NCT02581358|Cobb angle|cobb angle
113861|NCT02581358|assessment|assessment
113862|NCT02581358|ultrasound|ultrasound
113863|NCT02581345|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
113864|NCT02581345|Psoriasis|psoriasis
113865|NCT02581332|behavioral intervention|behavioral intervention
113866|NCT02581254|Snare|snare
113867|NCT02581254|Polypectomy|polypectomy
113868|NCT02581241|QT interval prolongation|qt interval prolongation
113869|NCT02581215|mFOLFIRINOX|mfolfirinox
113870|NCT02581215|Ramucirumab|ramucirumab
113871|NCT02581202|antiretroviral therapy|antiretroviral therapy
113872|NCT02581189|Chronic Hepatitis C|chronic hepatitis c
113873|NCT02581189|Patient reported outcomes|patient reported outcomes
113874|NCT02581189|Effectiveness|effectiveness
113875|NCT02581189|Influence of adherence|influence of adherence
113876|NCT02581189|Genotype 1 or 4|genotype 1 or 4
113877|NCT02581163|Effectiveness|effectiveness
113878|NCT02581163|Influence of adherence|influence of adherence
113879|NCT02581150|Outpatient hospitalization|outpatient hospitalization
113880|NCT02581150|Randomized trial|randomized trial
113881|NCT02581150|Peripheral arterial disease|peripheral arterial disease
113882|NCT02581150|Endovascular treatment|endovascular treatment
113883|NCT02581150|Health Economics|health economics
113884|NCT02581124|JTZ-951|jtz-951
113885|NCT02581124|Lapatinib|lapatinib
113886|NCT02581124|Pharmacokinetics|pharmacokinetics
113887|NCT02581085|Tocotrienol|tocotrienol
113888|NCT02581085|Vitamin E|vitamin e
113889|NCT02581059|Regorafenib|regorafenib
113890|NCT02581059|American Ginseng|american ginseng
113891|NCT02581059|Fatigue|fatigue
113892|NCT02581020|Observation|observation
113893|NCT02581020|Japanese|japanese
113894|NCT02581020|Hepatitis C|hepatitis c
113895|NCT02581020|Follow-up|follow-up
113897|NCT02581007|AML|aml
113898|NCT02581007|MDS|mds
113899|NCT02581007|ALL|all
113900|NCT02581007|CLL/CPL|cll/cpl
113901|NCT02581007|HD|hd
113902|NCT02581007|NHL|nhl
113903|NCT02581007|MPS|mps
113904|NCT02581007|CMML|cmml
113905|NCT02581007|MM|mm
113906|NCT02580994|Small Cell Lung Cancer|small cell lung cancer
113913|NCT02580981|ALL|all
113914|NCT02580981|Genomics|genomics
113915|NCT02580981|Genetics|genetics
113916|NCT02580981|Sequencing|sequencing
113917|NCT02580981|DNA|dna
113918|NCT02580981|RNA|rna
113919|NCT02580981|Ph-like|ph-like
113920|NCT02580968|Electroacupuncture therapy|electroacupuncture therapy
113921|NCT02580968|Migraine|migraine
113922|NCT02580968|Acupuncture Therapy|acupuncture therapy
113923|NCT02580929|Radiotherapy|radiotherapy
113924|NCT02580929|General Surgery|general surgery
113925|NCT02580916|non-melanoma skin cancer|non-melanoma skin cancer
113926|NCT02580916|outcome assessment|outcome assessment
113927|NCT02580916|quality of life|quality of life
113928|NCT02580877|oral insulin|oral insulin
113929|NCT02580838|Stroke|stroke
113930|NCT02580838|Spasticity|spasticity
113931|NCT02580838|OnabotulinumtoxinA|onabotulinumtoxina
113932|NCT02580825|Childhood obesity|childhood obesity
113933|NCT02580825|Ground reaction force|ground reaction force
113934|NCT02580825|Knee pain|knee pain
113935|NCT02580812|Perinatal listeriosis|perinatal listeriosis
113936|NCT02580812|Neurological impairment|neurological impairment
113938|NCT02580812|Prematurity|prematurity
113939|NCT02580812|Neurotropism|neurotropism
113940|NCT02580812|Listeria monocytogenes|listeria monocytogenes
113941|NCT02580812|Intellectual Quotient|intellectual quotient
113942|NCT02580773|Sickle cell disease|sickle cell disease
113943|NCT02580773|Anemia|anemia
113944|NCT02580773|Rare disease|rare disease
113945|NCT02580773|Reanimation|reanimation
113946|NCT02580773|Prophylactic anticoagulation|prophylactic anticoagulation
113947|NCT02580760|Silicone|silicone
113948|NCT02580760|Transgender|transgender
113949|NCT02580760|Dermatology|dermatology
113950|NCT02580760|Blood contamination|blood contamination
113951|NCT02580760|Adverse event after injection|adverse event after injection
113952|NCT02580734|burning mouth syndrome|burning mouth syndrome
113953|NCT02580734|treatment|treatment
113954|NCT02580734|oral chronic pain|oral chronic pain
113955|NCT02580721|mucosal tissue thickness|mucosal tissue thickness
113956|NCT02580721|dental implant|dental implant
113957|NCT02580721|marginal bone loss|marginal bone loss
113958|NCT02580721|soft tissue|soft tissue
113959|NCT02580643|Autologous Protein Solution|autologous protein solution
113960|NCT02580643|Osteoarthritis|osteoarthritis
113961|NCT02580643|Intra-articular Injection|intra-articular injection
113962|NCT02580630|Strength training, injection, glucocorticoid|strength training, injection, glucocorticoid
113963|NCT02580565|sickle cell disease|sickle cell disease
113964|NCT02580552|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
113965|NCT02580552|CTCL|ctcl
113966|NCT02580552|Mycosis Fungoides|mycosis fungoides
113967|NCT02580539|Allogeneic Transplantation|allogeneic transplantation
113968|NCT02580539|T cell|t cell
113969|NCT02580539|Epstein-Barr Virus|epstein-barr virus
105049|NCT02634307|MS|ms
113970|NCT02580513|Circadian Rhythm|circadian rhythm
113971|NCT02580513|Circadian Misalignment|circadian misalignment
113972|NCT02580513|Insulin Sensitivity|insulin sensitivity
113973|NCT02580500|Epidural anesthesia|epidural anesthesia
113974|NCT02580500|Spinal anesthesia|spinal anesthesia
113975|NCT02580500|pilonidal dermoid sinus|pilonidal dermoid sinus
113976|NCT02580487|acute appendicitis|acute appendicitis
113977|NCT02580487|pain management|pain management
113978|NCT02580487|analgesics|analgesics
113979|NCT02580487|pediatric patients|pediatric patients
113980|NCT02580487|laparoscopy|laparoscopy
113981|NCT02580487|open surgery|open surgery
113982|NCT02580461|family caregivers|family caregivers
113983|NCT02580461|cancer|cancer
113984|NCT02580461|exercise intervention|exercise intervention
113985|NCT02580461|center based|center based
113986|NCT02580448|Breast Cancer|breast cancer
113987|NCT02580448|Breast|breast
113988|NCT02580448|Advanced Breast Cancer|advanced breast cancer
113989|NCT02580448|Metastatic Breast Cancer|metastatic breast cancer
113990|NCT02580448|CYP17|cyp17
113991|NCT02580448|Male Breast Cancer|male breast cancer
113992|NCT02580448|Triple Negative Cancer|triple negative cancer
113993|NCT02580448|ER+ Breast Cancer|er+ breast cancer
113994|NCT02580435|multiple sclerosis|multiple sclerosis
113995|NCT02580435|microbiome|microbiome
113996|NCT02580435|prediction|prediction
113997|NCT02580435|outcome|outcome
113998|NCT02580422|Echocardiography|echocardiography
113999|NCT02580409|health care utilization|health care utilization
114000|NCT02580409|health care costs|health care costs
114001|NCT02580383|Radiofrequency ablation|radiofrequency ablation
114002|NCT02580383|RF-MB|rf-mb
114003|NCT02580383|Lumbar RF|lumbar rf
114004|NCT02580383|Facet joint syndrome|facet joint syndrome
114005|NCT02580383|Multifidus twitching|multifidus twitching
114006|NCT02580383|Sensory stimulation|sensory stimulation
114008|NCT02580357|Connective tissue graft|connective tissue graft
114009|NCT02580357|Gingival recession|gingival recession
114010|NCT02580357|Low level laser therapy|low level laser therapy
114011|NCT02580305|SUVN-502|suvn-502
114012|NCT02580305|5-HT6|5-ht6
114013|NCT02580305|Phase 2|phase 2
114014|NCT02580305|Cognition|cognition
114015|NCT02580305|Donepezil|donepezil
114016|NCT02580305|Memantine|memantine
114017|NCT02580305|Alzheimer's Disease|alzheimer's disease
114018|NCT02580279|Breast Neoplasms|breast neoplasms
114019|NCT02580279|prevention & control|prevention & control
114020|NCT02580279|Epigallocatechin gallate|epigallocatechin gallate
114021|NCT02580279|Dermatitis|dermatitis
114022|NCT02580266|Kidney|kidney
114023|NCT02580266|Diabetes|diabetes
114024|NCT02580240|septic shock|septic shock
114025|NCT02580240|hydrocortisone|hydrocortisone
114026|NCT02580240|mortality|mortality
114027|NCT02580227|Tranexamic Acid|tranexamic acid
114028|NCT02580227|Blood Transfusions|blood transfusions
114029|NCT02580188|Neuromuscular blockade|neuromuscular blockade
114030|NCT02580188|Sugammadex|sugammadex
114031|NCT02580188|Laparoscopic surgery|laparoscopic surgery
114032|NCT02580188|Intra abdominal pressure alarm|intra abdominal pressure alarm
114033|NCT02580136|Esthesioneuroblastoma|esthesioneuroblastoma
114034|NCT02580136|Tumor|tumor
114035|NCT02580136|Skull Base Surgery|skull base surgery
114036|NCT02580136|Sinonasal Cancer|sinonasal cancer
114037|NCT02580110|no specific condition|no specific condition
114038|NCT02580097|Arterial Spin Labeling|arterial spin labeling
114039|NCT02580097|Ischemic stroke|ischemic stroke
114040|NCT02580097|Collateral Circulation|collateral circulation
114041|NCT02580097|Perfusion imaging|perfusion imaging
114042|NCT02580084|atherosclerosis of the peripheral arteries|atherosclerosis of the peripheral arteries
114043|NCT02580084|Aorta-femoral Bypass|aorta-femoral bypass
114044|NCT02580084|Hybrid Intervention|hybrid intervention
114045|NCT02580084|Iliac Arteries With Stenting and Plasty of the Common Femoral Artery|iliac arteries with stenting and plasty of the common femoral artery
114046|NCT02580084|plastic arteries with lesions of the common femoral artery and deep femoral artery|plastic arteries with lesions of the common femoral artery and deep femoral artery
114047|NCT02580071|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
114048|NCT02580071|Chinese Herbal Medicine|chinese herbal medicine
114049|NCT02580071|immune reconstitution|immune reconstitution
114050|NCT02580071|clinical trial|clinical trial
114052|NCT02580071|AML|aml
114053|NCT02580058|platinum resistant|platinum resistant
114054|NCT02580058|platinum refractory|platinum refractory
114055|NCT02580045|metastatic cancer|metastatic cancer
114056|NCT02580045|lumbar puncture|lumbar puncture
114057|NCT02580045|advanced cancer|advanced cancer
114058|NCT02580045|brain metastases|brain metastases
114059|NCT02580045|chemotherapy|chemotherapy
114060|NCT02580045|endocrine therapy|endocrine therapy
114061|NCT02580045|HER2 targeted therapy|her2 targeted therapy
114062|NCT02580045|immune therapy|immune therapy
114063|NCT02580045|anti-cancer therapy|anti-cancer therapy
114064|NCT02580045|blood brain barrier|blood brain barrier
114065|NCT02580045|pharmacokinetics|pharmacokinetics
114066|NCT02580045|Duke University|duke university
114067|NCT02580045|brain metastasis|brain metastasis
114068|NCT02580019|Cellular therapy|cellular therapy
114069|NCT02580019|Stroke|stroke
114070|NCT02580019|Neuronal Plasticity|neuronal plasticity
114071|NCT02580019|Recovery|recovery
114072|NCT02580019|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
114073|NCT02580019|Transplantation|transplantation
114074|NCT02580019|Cardiovascular Diseases|cardiovascular diseases
114075|NCT02580019|Ischemia|ischemia
114076|NCT02580019|Brain Infarction|brain infarction
114077|NCT02580019|Brain Ischemia|brain ischemia
114078|NCT02580019|Cerebrovascular Disorders|cerebrovascular disorders
114079|NCT02579993|Cornea|cornea
114080|NCT02579993|Limbal stem cell|limbal stem cell
114081|NCT02579967|Haploidentical|haploidentical
114082|NCT02579967|Autoimmunity|autoimmunity
114083|NCT02579967|Immune Dysregulation|immune dysregulation
114084|NCT02579967|Congenital|congenital
114085|NCT02579967|Opportunistic Infection|opportunistic infection
114086|NCT02579941|Hyperfibrinolysis|hyperfibrinolysis
114087|NCT02579941|Pregnant women at term|pregnant women at term
114088|NCT02579941|Tranexamic acid|tranexamic acid
114089|NCT02579928|Ketamine|ketamine
114090|NCT02579928|Depression|depression
114091|NCT02579928|Major Depressive Disorder|major depressive disorder
114092|NCT02579928|Anxiety|anxiety
114093|NCT02579928|School refusal|school refusal
114094|NCT02579928|Suicide|suicide
114095|NCT02579928|Generalized Anxiety|generalized anxiety
114096|NCT02579928|Suicidal Ideation|suicidal ideation
114097|NCT02579902|Irritable Bowel Syndrome|irritable bowel syndrome
114098|NCT02579902|inflammation|inflammation
114099|NCT02579902|oxidative stress|oxidative stress
114100|NCT02579902|clinical signs|clinical signs
114102|NCT02579889|Closed Loop Stimulation|closed loop stimulation
114103|NCT02579889|Atrial Fibrillation|atrial fibrillation
114104|NCT02579889|Stroke|stroke
114105|NCT02579889|Heart Failure|heart failure
114106|NCT02579889|Pacemaker|pacemaker
114107|NCT02579889|ICD|icd
114108|NCT02579876|Milk Allergy|milk allergy
114109|NCT02579876|Viaskin Milk|viaskin milk
114110|NCT02579876|Epicutaneous ImmunoTherapy (EPIT)|epicutaneous immunotherapy (epit)
114111|NCT02579876|Eosinophilic Esophagitis|eosinophilic esophagitis
114112|NCT02579876|Milk-Induced Eosinophilic Esophagitis|milk-induced eosinophilic esophagitis
114113|NCT02579863|PD1|pd1
114114|NCT02579863|PD-1|pd-1
114115|NCT02579863|PD-L1|pd-l1
114116|NCT02579863|PDL1|pdl1
114117|NCT02579850|COPD|copd
114118|NCT02579850|COPD Exacerbation|copd exacerbation
114119|NCT02579850|EXACT-PRO|exact-pro
114120|NCT02579837|screening|screening
114121|NCT02579824|Myeloma|myeloma
114122|NCT02579824|Relapsed and/or Refractory|relapsed and/or refractory
114123|NCT02579824|Multiple Myeloma|multiple myeloma
114124|NCT02579824|MM|mm
114125|NCT02579824|DS-3032b|ds-3032b
114126|NCT02579811|Kidney|kidney
114127|NCT02579811|Cancer|cancer
114128|NCT02579811|Axitinib|axitinib
114129|NCT02579811|Pd-1 inhibitor|pd-1 inhibitor
114130|NCT02579811|Pd-L1 inhibitor|pd-l1 inhibitor
114131|NCT02579798|Bariatric surgery|bariatric surgery
114132|NCT02579798|Post-surgery hypoxemia|post-surgery hypoxemia
114133|NCT02579798|Obesity|obesity
114134|NCT02579785|Family Planning|family planning
114135|NCT02579785|Abortion|abortion
114136|NCT02579785|mHealth|mhealth
114137|NCT02579785|Behaviour Change Communication|behaviour change communication
114138|NCT02579785|Menstrual Regulation|menstrual regulation
114139|NCT02579785|Postabortion|postabortion
114140|NCT02579785|Bangladesh|bangladesh
114141|NCT02579759|PXT3003|pxt3003
114142|NCT02579746|hypertension|hypertension
114143|NCT02579746|immigrant|immigrant
114144|NCT02579746|dietary intervention|dietary intervention
114145|NCT02579746|lifestyle modification|lifestyle modification
114146|NCT02579720|Recurrent Grass Pollen Allergy|recurrent grass pollen allergy
114147|NCT02579720|Pollinex® Quattro|pollinex® quattro
114148|NCT02579707|Healthy Volunteers|healthy volunteers
114149|NCT02579681|Cognition|cognition
114150|NCT02579681|Tecfidera|tecfidera
114151|NCT02579681|RRMS|rrms
114152|NCT02579681|BG00012|bg00012
114153|NCT02579642|Moderate to severe depression|moderate to severe depression
114154|NCT02579642|Monopolar|monopolar
114155|NCT02579642|Bipolar|bipolar
114156|NCT02579642|Ketamine|ketamine
114157|NCT02579642|ECT|ect
114158|NCT02579642|Electroconvulsive therapy|electroconvulsive therapy
114159|NCT02579642|NMDA|nmda
114160|NCT02579629|Analgesia|analgesia
114161|NCT02579629|Cesarean section|cesarean section
114162|NCT02579629|Opiates|opiates
114163|NCT02579616|Lenvatinib|lenvatinib
114164|NCT02579616|E7080|e7080
114165|NCT02579616|Unresectable biliary tract cancer|unresectable biliary tract cancer
114166|NCT02579616|BTC|btc
114167|NCT02579616|Gemcitabine-based combination chemotherapy|gemcitabine-based combination chemotherapy
114168|NCT02579616|Lenvima|lenvima
114169|NCT02579538|Total Knee Arthroplasty|total knee arthroplasty
114170|NCT02579538|Thoracotomy|thoracotomy
114171|NCT02579538|Mastectomy|mastectomy
114172|NCT02579538|Video-Assisted Thoracoscopic Surgery (VATS)|video-assisted thoracoscopic surgery (vats)
114573|NCT02577250|depression|depression
114176|NCT02579525|tissue perfusion|tissue perfusion
114177|NCT02579525|macrocirculatory|macrocirculatory
114178|NCT02579525|mean arterial pressure|mean arterial pressure
114179|NCT02579525|vasopressor use|vasopressor use
114180|NCT02579525|days alive free of organ support|days alive free of organ support
114181|NCT02579499|Coronary artery disease|coronary artery disease
114182|NCT02579499|LDL choelsterol|ldl choelsterol
114184|NCT02579473|Continuous dopaminergic stimulation|continuous dopaminergic stimulation
114185|NCT02579460|Barrett's esophagus|barrett's esophagus
114186|NCT02579460|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
114187|NCT02579434|CYP3A|cyp3a
114188|NCT02579408|NAFLD|nafld
114189|NCT02579408|LDLT|ldlt
114190|NCT02579408|steatosis|steatosis
114191|NCT02579408|CAP|cap
114192|NCT02579408|transient elastography|transient elastography
114193|NCT02579382|HBV|hbv
114194|NCT02579382|Hepatitis|hepatitis
114195|NCT02579382|Liver Disease|liver disease
114196|NCT02579369|Epidermolysis Bullosa|epidermolysis bullosa
114197|NCT02579369|stem cell|stem cell
114198|NCT02579317|Baroreflex mechanism|baroreflex mechanism
114199|NCT02579317|Alcohol Use Disorder|alcohol use disorder
114200|NCT02579317|Substance Use Disorder|substance use disorder
114201|NCT02579317|Heart Rate Variability|heart rate variability
114202|NCT02579317|Breathing|breathing
114203|NCT02579291|Stroke|stroke
114204|NCT02579291|Dry needling|dry needling
114205|NCT02579291|Spasticity|spasticity
114206|NCT02579291|Motor function|motor function
114207|NCT02579291|Stabilometry|stabilometry
114208|NCT02579278|EMVI|emvi
114209|NCT02579278|Extramural Venous Invasion|extramural venous invasion
114210|NCT02579278|mrEMVI|mremvi
114211|NCT02579278|Rectal Cancer|rectal cancer
114212|NCT02579278|ctDNA|ctdna
114213|NCT02579278|Neoplasm DNA|neoplasm dna
114214|NCT02579278|MRI|mri
114215|NCT02579265|Parenteral nutrition|parenteral nutrition
114216|NCT02579265|Neonates|neonates
114217|NCT02579265|Infants|infants
114218|NCT02579265|Lipid emulsions|lipid emulsions
114219|NCT02579265|Intravenous|intravenous
114220|NCT02579252|vaccine|vaccine
114221|NCT02579252|tau protein|tau protein
114222|NCT02579252|active|active
114223|NCT02579252|immunization|immunization
114224|NCT02579252|KLH|klh
114225|NCT02579252|immunotherapy|immunotherapy
114226|NCT02579252|tau|tau
114227|NCT02579239|LGMD2B|lgmd2b
114228|NCT02579239|FSHD|fshd
114229|NCT02579226|AZD2811|azd2811
114230|NCT02579226|Irinotecan|irinotecan
114231|NCT02579226|Advanced solid tumours|advanced solid tumours
114232|NCT02579226|Small-cell lung cancer|small-cell lung cancer
114233|NCT02579213|electronic nose|electronic nose
114234|NCT02579213|abnormal fetal karyotype|abnormal fetal karyotype
114235|NCT02579161|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
114236|NCT02579161|Kidney Stones|kidney stones
114237|NCT02579161|Antibiotics|antibiotics
114238|NCT02579148|erectile dysfunction|erectile dysfunction
114239|NCT02579148|stem cell|stem cell
114240|NCT02579148|collagen scaffold|collagen scaffold
114241|NCT02579135|Condoms|condoms
114242|NCT02579135|Sexual Abstinence|sexual abstinence
114243|NCT02579135|Sexual Communication|sexual communication
114244|NCT02579122|Reviparin|reviparin
114245|NCT02579122|Bridging|bridging
114246|NCT02579122|Phenprocoumon|phenprocoumon
114247|NCT02579096|Gout|gout
114248|NCT02579096|Allopurinol|allopurinol
114249|NCT02579096|Febuxostat|febuxostat
114250|NCT02579096|CKD|ckd
114251|NCT02579070|Diabetic Foot|diabetic foot
114252|NCT02579070|foot temperature|foot temperature
114253|NCT02579070|diabetic foot ulcer|diabetic foot ulcer
114254|NCT02579057|Congestive heart failure|congestive heart failure
114255|NCT02579057|Furosemide|furosemide
114256|NCT02579031|Percutaneous Coronary Intervention|percutaneous coronary intervention
114257|NCT02579031|Stents|stents
114258|NCT02579031|Drug-Eluting Stents|drug-eluting stents
114259|NCT02579031|Coronary Artery Disease|coronary artery disease
114260|NCT02579031|Acute Coronary Syndrome|acute coronary syndrome
114261|NCT02579018|Anorexia Nervosa|anorexia nervosa
114262|NCT02579018|Exercise|exercise
114263|NCT02579018|Healthy Adults|healthy adults
114264|NCT02579018|Physical Activity|physical activity
114269|NCT02578992|intubating stylet|intubating stylet
114270|NCT02578992|head and neck position|head and neck position
114271|NCT02578979|atrial fibrillation|atrial fibrillation
114272|NCT02578979|ischemic stroke|ischemic stroke
114273|NCT02578979|electrocardiogram|electrocardiogram
114274|NCT02578979|holter|holter
114275|NCT02578966|Early Childhood Caries|early childhood caries
114276|NCT02578966|Randomized clinical trial|randomized clinical trial
114280|NCT02578953|Japanese male healthy subjects|japanese male healthy subjects
114285|NCT02578914|grass allergy|grass allergy
114286|NCT02578914|tree allergy|tree allergy
114287|NCT02578914|NS2|ns2
114288|NCT02578914|Aldeyra|aldeyra
114289|NCT02578901|Thrombocytopenia|thrombocytopenia
114290|NCT02578901|Tranexamic Acid|tranexamic acid
114291|NCT02578901|TXA|txa
114292|NCT02578901|Chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
114300|NCT02578823|Targeted Temperature Management(TTM)|targeted temperature management(ttm)
114301|NCT02578823|in-hospital cardiac arrest(IHCA)|in-hospital cardiac arrest(ihca)
114302|NCT02578823|restoration of spontaneous circulation(ROSC)|restoration of spontaneous circulation(rosc)
114303|NCT02578823|unconsciousness|unconsciousness
114304|NCT02578823|brain injury|brain injury
114305|NCT02578797|Castration-Resistant Prostate Cancer (CRPC)|castration-resistant prostate cancer (crpc)
114306|NCT02578797|Prostatic Neoplasms|prostatic neoplasms
114307|NCT02578797|Genital Diseases, Male|genital diseases, male
114308|NCT02578797|Genital Neoplasms, Male|genital neoplasms, male
114309|NCT02578797|Neoplasms|neoplasms
114310|NCT02578797|Neoplasms by Site|neoplasms by site
114311|NCT02578797|Prostatic Diseases|prostatic diseases
114312|NCT02578797|Urogenital Neoplasms|urogenital neoplasms
114313|NCT02578784|Dialysis|dialysis
114314|NCT02578758|Transdiagnostic Internet-based Protocol|transdiagnostic internet-based protocol
114315|NCT02578758|Positive affect regulation|positive affect regulation
114316|NCT02578706|HIV|hiv
114317|NCT02578706|Aspirin|aspirin
114318|NCT02578706|Clopidogrel|clopidogrel
114319|NCT02578706|Platelet|platelet
114320|NCT02578706|Inflammation|inflammation
114321|NCT02578706|Cardiovascular disease|cardiovascular disease
114322|NCT02578706|Arachidonic acid|arachidonic acid
114323|NCT02578706|Cyclooxygenase inhibitor|cyclooxygenase inhibitor
114324|NCT02578706|ADP inhibitor|adp inhibitor
114325|NCT02578706|Immune activation|immune activation
114326|NCT02578706|Monocyte|monocyte
114327|NCT02578706|Coagulation|coagulation
114328|NCT02578706|Thrombogenicity|thrombogenicity
114329|NCT02578680|PD1|pd1
114331|NCT02578680|PDL1|pdl1
114332|NCT02578680|PD-L1|pd-l1
114333|NCT02578680|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
114334|NCT02578641|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
114335|NCT02578641|Epstein-Barr Virus|epstein-barr virus
114336|NCT02578641|Cell therapy|cell therapy
114337|NCT02578641|Cytotoxic T Lymphocytes|cytotoxic t lymphocytes
114338|NCT02578576|Diagnostic Techniques|diagnostic techniques
114339|NCT02578576|Digestive System|digestive system
114340|NCT02578550|Immunodeficiency Virus Type 1, Human|immunodeficiency virus type 1, human
114341|NCT02578550|Darunavir|darunavir
114342|NCT02578550|Cobicistat|cobicistat
114343|NCT02578550|Emtricitabine|emtricitabine
114344|NCT02578550|Tenofovir alafenamide|tenofovir alafenamide
114345|NCT02578550|Healthy participants|healthy participants
114346|NCT02578537|Ticagrelor|ticagrelor
114347|NCT02578537|Pharmacokinetics|pharmacokinetics
114348|NCT02578537|NSTE-ACS|nste-acs
114349|NCT02578537|CKD|ckd
114350|NCT02578524|cataract satisfaction|cataract satisfaction
114351|NCT02578511|Acute Lymphoblastic Leukemia in Complete Remission|acute lymphoblastic leukemia in complete remission
114352|NCT02578511|Lymphoblastic Lymphoma in Complete Remission|lymphoblastic lymphoma in complete remission
114353|NCT02578511|Mixed Phenotype Acute Leukemia in Complete Remission|mixed phenotype acute leukemia in complete remission
114354|NCT02578511|IXAZOMIB|ixazomib
114355|NCT02578511|POMP/D|pomp/d
114356|NCT02578511|Phase I|phase i
114357|NCT02578511|Early Phase|early phase
114358|NCT02578511|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
114359|NCT02578511|Lymphoblastic Lymphoma|lymphoblastic lymphoma
114360|NCT02578511|Mixed Phenotype Acute Leukemia|mixed phenotype acute leukemia
114361|NCT02578511|ALL|all
114362|NCT02578498|glucagon|glucagon
114363|NCT02578498|Carbohydrate diet|carbohydrate diet
114364|NCT02578472|Healthy|healthy
114365|NCT02578472|JNJ-42847922|jnj-42847922
114366|NCT02578472|zolpidem|zolpidem
114367|NCT02578472|Placebo|placebo
114368|NCT02578459|Cancer pain|cancer pain
114369|NCT02578459|Intrathecal therapy|intrathecal therapy
114370|NCT02578459|Pain|pain
114371|NCT02578459|Pancreatic cancer|pancreatic cancer
114372|NCT02578433|Mindful Self Compassion short form|mindful self compassion short form
114373|NCT02578433|Progressive Muscle Relaxation|progressive muscle relaxation
114374|NCT02578394|Gout|gout
114375|NCT02578394|Kidney|kidney
114376|NCT02578394|Depo-Medrone|depo-medrone
114377|NCT02578394|Anakinra|anakinra
114378|NCT02578381|pressure wire|pressure wire
114379|NCT02578381|coronary angiogram|coronary angiogram
114381|NCT02578368|gastric cancer|gastric cancer
114382|NCT02578368|perioperative|perioperative
114383|NCT02578368|FLOT|flot
114384|NCT02578368|limited metastatic|limited metastatic
114385|NCT02578368|GEJ cancer|gej cancer
114386|NCT02578355|Atherosclerosis|atherosclerosis
114387|NCT02578355|Coronary Artery Disease|coronary artery disease
114388|NCT02578355|Cardiovascular Disease|cardiovascular disease
114389|NCT02578355|Coronary Computed Tomographic Angiography|coronary computed tomographic angiography
114390|NCT02578355|CCTA|ccta
114391|NCT02578355|Myocardial Infarction|myocardial infarction
114393|NCT02578355|OPeRA|opera
114394|NCT02578329|Mediterranean diet|mediterranean diet
114395|NCT02578329|blood fatty acid|blood fatty acid
114396|NCT02578329|Coronary Artery Disease|coronary artery disease
114397|NCT02578316|Advanced Solid Tumors|advanced solid tumors
114398|NCT02578316|Lymphomas|lymphomas
114399|NCT02578303|sleep apnea|sleep apnea
114400|NCT02578303|phase-contrast MRI|phase-contrast mri
114401|NCT02578303|cerebral blood flow|cerebral blood flow
114402|NCT02578303|vascular risk factor|vascular risk factor
114403|NCT02578303|dementia|dementia
114404|NCT02578290|decision support systems|decision support systems
114405|NCT02578290|clinical|clinical
114406|NCT02578238|Korea|korea
114407|NCT02578238|Humira|humira
114408|NCT02578238|Pediatric Crohn's Disease|pediatric crohn's disease
114409|NCT02578225|Heart|heart
114410|NCT02578225|Chronic|chronic
114411|NCT02578225|Failure|failure
114412|NCT02578225|MI|mi
114413|NCT02578225|real life|real life
114414|NCT02578225|Turkey|turkey
114415|NCT02578160|pain|pain
114416|NCT02578160|infant behaviour|infant behaviour
114417|NCT02578160|heart rate|heart rate
114418|NCT02578160|dental anxiety|dental anxiety
114419|NCT02578147|risky sexual behavior|risky sexual behavior
114420|NCT02578147|early intervention|early intervention
114421|NCT02578121|Relapsed|relapsed
114422|NCT02578121|Response Rate|response rate
114423|NCT02578121|Progression free|progression free
114424|NCT02578082|Renal Impairment|renal impairment
114425|NCT02578082|Renal Insufficiency|renal insufficiency
114426|NCT02578069|Ischemic Stroke|ischemic stroke
114427|NCT02578069|Intracranial Stenting|intracranial stenting
114428|NCT02578056|pelvic organ prolapse|pelvic organ prolapse
114429|NCT02578056|urinary incontinence|urinary incontinence
114430|NCT02578017|Sickle Cell Disease|sickle cell disease
114431|NCT02578017|Hydroxyurea|hydroxyurea
114432|NCT02578017|Adherence|adherence
114436|NCT02577965|ST segment Elevation Myocardial Infarction|st segment elevation myocardial infarction
114437|NCT02577965|Optical Coherence Tomography|optical coherence tomography
114438|NCT02577965|Percutaneous Coronary Intervention|percutaneous coronary intervention
114439|NCT02577965|Thrombus histopathology|thrombus histopathology
114440|NCT02577965|Gender differences|gender differences
114441|NCT02577952|lipodystrophy|lipodystrophy
114442|NCT02577952|lipodystrophy, congenital generalized|lipodystrophy, congenital generalized
114443|NCT02577952|Berardinelli-Seip Congenital Lipodystrophy|berardinelli-seip congenital lipodystrophy
114444|NCT02577952|Congenital generalized lipodystrophy|congenital generalized lipodystrophy
114445|NCT02577952|generalized lipodystrophy|generalized lipodystrophy
114446|NCT02577952|lipodystrophy, familial partial|lipodystrophy, familial partial
114447|NCT02577952|partial lipodystrophy|partial lipodystrophy
114448|NCT02577952|lipodystrophy, partial, acquired|lipodystrophy, partial, acquired
114449|NCT02577952|acquired lipodystrophy|acquired lipodystrophy
114450|NCT02577913|contraception|contraception
114451|NCT02577913|contraceptive patch|contraceptive patch
114452|NCT02577913|Levonorgestrel|levonorgestrel
114453|NCT02577913|gestodene|gestodene
114454|NCT02577913|safety|safety
114455|NCT02577900|foot ulcer and honey and silver|foot ulcer and honey and silver
114456|NCT02577861|limbal stem cells deficinecy, LSCD, ocular burn|limbal stem cells deficinecy, lscd, ocular burn
114457|NCT02577848|Glucagon-like peptide-1|glucagon-like peptide-1
114458|NCT02577848|Non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
114459|NCT02577848|Left ventricular ejection fraction|left ventricular ejection fraction
114460|NCT02577835|Hypertension|hypertension
114461|NCT02577835|Arterial Stiffness|arterial stiffness
114462|NCT02577835|Ambulatory blood pressure|ambulatory blood pressure
114463|NCT02577796|radial artery spasm|radial artery spasm
114464|NCT02577796|radial artery occlusion|radial artery occlusion
114465|NCT02577796|radial access|radial access
114466|NCT02577783|Doxorubicin Hydrochloride|doxorubicin hydrochloride
114467|NCT02577770|Acupuncture|acupuncture
114468|NCT02577770|caffeine|caffeine
114469|NCT02577770|pain|pain
114470|NCT02577757|Languages network|languages network
114471|NCT02577757|Functional MRI|functional mri
114472|NCT02577744|Electrical Impedance Tomography|electrical impedance tomography
114473|NCT02577731|Trauma|trauma
114474|NCT02577705|food insecurity|food insecurity
648346|NCT00771199|Durogesic|durogesic
114475|NCT02577705|adverse childhood experiences|adverse childhood experiences
114478|NCT02577705|poverty|poverty
114479|NCT02577705|TANF|tanf
114480|NCT02577705|assets|assets
114481|NCT02577705|depression|depression
114482|NCT02577705|randomized control trial|randomized control trial
114483|NCT02577679|Dentistry|dentistry
114484|NCT02577653|balance, postural|balance, postural
114485|NCT02577653|postural equilibrium|postural equilibrium
114486|NCT02577614|Cardiopulmonary Bypass|cardiopulmonary bypass
114487|NCT02577614|Aortic Valve Repair|aortic valve repair
114488|NCT02577614|Coronary Re-Implantation|coronary re-implantation
114489|NCT02577614|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
114490|NCT02577614|Factor VIII Inhibitor Bypass Activity|factor viii inhibitor bypass activity
114491|NCT02577614|Transfusion|transfusion
114494|NCT02577588|p53 Antigen|p53 antigen
136877|NCT02444741|XRT|xrt
114495|NCT02577588|T cell therapy|t cell therapy
114496|NCT02577588|autologous|autologous
114497|NCT02577588|Adoptive Cellular Immunotherapy|adoptive cellular immunotherapy
114498|NCT02577575|Oxytocin|oxytocin
114499|NCT02577575|Syntocinon|syntocinon
114500|NCT02577575|Social Cognition|social cognition
114501|NCT02577575|Schizophrenia|schizophrenia
114502|NCT02577549|Knee Pain|knee pain
114503|NCT02577549|Exercise|exercise
114504|NCT02577549|Diet|diet
114505|NCT02577549|Weight Loss|weight loss
114506|NCT02577536|Pregnancy outcome|pregnancy outcome
114507|NCT02577536|Neonatal outcome|neonatal outcome
114508|NCT02577536|Birth weight|birth weight
114509|NCT02577536|Weight gain|weight gain
114510|NCT02577536|Physical disability|physical disability
114511|NCT02577510|Lateral Femoral Cutaneous Nerve Block|lateral femoral cutaneous nerve block
114512|NCT02577510|Meralgia Parasthetica|meralgia parasthetica
114513|NCT02577510|nerve stimulator|nerve stimulator
114514|NCT02577510|ultrasound|ultrasound
114515|NCT02577484|Fractional Flow Reserve|fractional flow reserve
114516|NCT02577484|Rapid Exchange|rapid exchange
114517|NCT02577484|Catheter|catheter
114518|NCT02577471|Constipation|constipation
114519|NCT02577471|pregnancy|pregnancy
114520|NCT02577471|delivery|delivery
114521|NCT02577432|spinal anesthesia|spinal anesthesia
114522|NCT02577419|breast milk|breast milk
114523|NCT02577419|chylothorax|chylothorax
114524|NCT02577419|infants|infants
114525|NCT02577419|cardiac surgery|cardiac surgery
114526|NCT02577419|modified fat breast milk|modified fat breast milk
114527|NCT02577406|AG-221|ag-221
114528|NCT02577406|CC-90007|cc-90007
114529|NCT02577406|Efficacy|efficacy
114530|NCT02577406|Safety|safety
114531|NCT02577406|Leukemia|leukemia
114532|NCT02577406|Acute myloid meukemia|acute myloid meukemia
114533|NCT02577406|Isocitrate dehydrogenase 2 mutation|isocitrate dehydrogenase 2 mutation
114534|NCT02577406|Enasidenib|enasidenib
114535|NCT02577393|Lung Neoplasms|lung neoplasms
114536|NCT02577393|esophagitis|esophagitis
114537|NCT02577393|Prevention & Control|prevention & control
114538|NCT02577393|Epigallocatechin Gallate|epigallocatechin gallate
114539|NCT02577367|Hypothyroidism|hypothyroidism
114540|NCT02577367|Tube Feeding|tube feeding
114541|NCT02577341|Nimotuzumab, Chemoradiotherapy,Squamous Cell Lung Cancer|nimotuzumab, chemoradiotherapy,squamous cell lung cancer
114542|NCT02577289|simultaneous implantation|simultaneous implantation
114543|NCT02577289|Dental implant|dental implant
114544|NCT02577289|Open sinus Lifting|open sinus lifting
114545|NCT02577289|PRF|prf
114546|NCT02577289|platelet rich fibrin (PRF)|platelet rich fibrin (prf)
114547|NCT02577276|stroke|stroke
114548|NCT02577276|remote monitoring|remote monitoring
114549|NCT02577276|hemiparesis|hemiparesis
114550|NCT02577250|ketamine|ketamine
114551|NCT02577250|stress disorders, post-traumatic|stress disorders, post-traumatic
114552|NCT02577250|stress disorders, traumatic|stress disorders, traumatic
114553|NCT02577250|anxiety disorders|anxiety disorders
114554|NCT02577250|mental disorders|mental disorders
114555|NCT02577250|adjuvants, anesthesia|adjuvants, anesthesia
114556|NCT02577250|analgesics|analgesics
114557|NCT02577250|anesthetics|anesthetics
114558|NCT02577250|anesthetics, dissociative|anesthetics, dissociative
114559|NCT02577250|anesthetics, general|anesthetics, general
114560|NCT02577250|anesthetics, intravenous|anesthetics, intravenous
114561|NCT02577250|excitatory amino acid agents|excitatory amino acid agents
114562|NCT02577250|excitatory amino acid antagonists|excitatory amino acid antagonists
114563|NCT02577250|hypnotics and sedatives|hypnotics and sedatives
114564|NCT02577250|molecular mechanisms of pharmacological action|molecular mechanisms of pharmacological action
114565|NCT02577250|neurotransmitter agents|neurotransmitter agents
114566|NCT02577250|peripheral nervous system agents|peripheral nervous system agents
114567|NCT02577250|pharmacologic actions|pharmacologic actions
114568|NCT02577250|physiological effects of drugs|physiological effects of drugs
114569|NCT02577250|psychotropic drugs|psychotropic drugs
114570|NCT02577250|sensory system agents|sensory system agents
114571|NCT02577250|central nervous system agents|central nervous system agents
114572|NCT02577250|central nervous system depressants|central nervous system depressants
648347|NCT00771199|Cancer|cancer
114574|NCT02577250|depressive disorder|depressive disorder
114575|NCT02577250|depressive disorder, treatment-resistant|depressive disorder, treatment-resistant
114576|NCT02577250|behavioral symptoms|behavioral symptoms
114577|NCT02577250|mood disorders|mood disorders
114578|NCT02577250|therapeutic uses|therapeutic uses
114579|NCT02577237|caregiver|caregiver
114580|NCT02577237|simulation|simulation
114581|NCT02577224|Patient-led care|patient-led care
114582|NCT02577224|Botulinum toxin|botulinum toxin
114583|NCT02577224|Dystonia|dystonia
114584|NCT02577224|Randomised controlled trial|randomised controlled trial
114585|NCT02577224|Acceptability|acceptability
114586|NCT02577211|Critically ill|critically ill
114587|NCT02577211|Enteral nutrition|enteral nutrition
114588|NCT02577172|Testicular cancer|testicular cancer
114589|NCT02577172|Physical Exercise|physical exercise
114590|NCT02577172|Chemotherapy|chemotherapy
114591|NCT02577159|sodium-glucose cotransporter 2 inhibitor|sodium-glucose cotransporter 2 inhibitor
114592|NCT02577159|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
114593|NCT02577159|dyslipidemia|dyslipidemia
114594|NCT02577159|remnants|remnants
114595|NCT02577159|apolipoprotein B-48|apolipoprotein b-48
114596|NCT02577146|stone|stone
114597|NCT02577146|ureter|ureter
114598|NCT02577146|ultrasound|ultrasound
114599|NCT02577133|colic|colic
114600|NCT02577133|probiotic|probiotic
114601|NCT02577133|Lactobacillus reuteri|lactobacillus reuteri
114602|NCT02577133|prevention|prevention
114603|NCT02577120|Epiceram|epiceram
114604|NCT02577120|Ceramiseal|ceramiseal
114605|NCT02577107|Age-related macular degeneration,|age-related macular degeneration,
114606|NCT02577107|ranibizumab,|ranibizumab,
114607|NCT02577107|conbercept,|conbercept,
114608|NCT02577107|plasma VEGF|plasma vegf
114609|NCT02577107|PK|pk
114610|NCT02577094|CD22 positive- lymphoblastic leukemia-RIT-Yttrium|cd22 positive- lymphoblastic leukemia-rit-yttrium
114611|NCT02577055|Multiple leiomyoma|multiple leiomyoma
114612|NCT02577055|Uterine Artery Embolization|uterine artery embolization
114613|NCT02577055|Surgery|surgery
114614|NCT02577055|childbearing age|childbearing age
114615|NCT02577055|Fertility|fertility
114616|NCT02577055|Noninferiority trial|noninferiority trial
114617|NCT02577042|Raltegravir|raltegravir
114618|NCT02577042|protease inhibitors|protease inhibitors
114619|NCT02577042|darunavir|darunavir
114620|NCT02577042|inflammation|inflammation
114621|NCT02577042|statins|statins
114623|NCT02576990|PD1|pd1
114624|NCT02576990|PD-1|pd-1
114625|NCT02576990|PDL1|pdl1
114626|NCT02576990|PD-L1|pd-l1
114627|NCT02576977|PDL1|pdl1
114628|NCT02576977|PD1|pd1
114629|NCT02576977|Multiple Myeloma|multiple myeloma
114630|NCT02576938|Atopic Eczema|atopic eczema
114631|NCT02576912|Cannabis|cannabis
114632|NCT02576912|Marijuana|marijuana
114633|NCT02576912|THC|thc
114634|NCT02576912|Pregnenolone|pregnenolone
114635|NCT02576912|Psychotic Disorders|psychotic disorders
114636|NCT02576912|PREG|preg
114637|NCT02576899|smoking cessation|smoking cessation
114638|NCT02576899|posttraumatic stress disorder|posttraumatic stress disorder
114639|NCT02576899|tobacco|tobacco
114640|NCT02576899|treatment|treatment
114641|NCT02576899|smoking|smoking
114642|NCT02576899|mindfulness|mindfulness
114643|NCT02576899|acceptance|acceptance
114644|NCT02576899|functioning|functioning
114645|NCT02576886|supine|supine
114646|NCT02576886|prone|prone
114647|NCT02576886|myocardial perfusion imaging|myocardial perfusion imaging
114648|NCT02576886|radiation exposure|radiation exposure
114649|NCT02576886|pre-screening tool|pre-screening tool
114650|NCT02576873|Survival|survival
114651|NCT02576873|Hemodiafiltration|hemodiafiltration
114652|NCT02576873|End-stage renal disease|end-stage renal disease
114653|NCT02576873|Hemodialysis|hemodialysis
114654|NCT02576821|Amnesia, Alzheimer, hippocampal sclerosis, fronto-temporal lobar degeneration|amnesia, alzheimer, hippocampal sclerosis, fronto-temporal lobar degeneration
114655|NCT02576795|Haemophilia A|haemophilia a
114656|NCT02576795|Gene Therapy|gene therapy
114657|NCT02576795|Clotting Disorders|clotting disorders
114658|NCT02576795|Blood Disorder|blood disorder
114659|NCT02576782|regional anesthesia|regional anesthesia
114660|NCT02576782|dexamethasone|dexamethasone
114661|NCT02576782|bupivacaine|bupivacaine
114662|NCT02576782|femoral|femoral
114663|NCT02576782|sciatic|sciatic
114664|NCT02576769|Basal cell carcinoma|basal cell carcinoma
114665|NCT02576769|Pigmentation|pigmentation
114666|NCT02576769|Melanocyte|melanocyte
114667|NCT02576769|Melanin|melanin
114668|NCT02576769|Skin cancer|skin cancer
114669|NCT02576756|Risk on aspiration|risk on aspiration
114670|NCT02576756|Postoperative|postoperative
114671|NCT02576756|Difficult Intubation|difficult intubation
114672|NCT02576743|Stroke|stroke
114673|NCT02576743|AVM|avm
114674|NCT02576743|Aneurysm|aneurysm
114675|NCT02576717|MS|ms
114676|NCT02576717|RMS|rms
114677|NCT02576717|Multiple Sclerosis|multiple sclerosis
114678|NCT02576717|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
114679|NCT02576691|cardiac arrest|cardiac arrest
114680|NCT02576691|percutaneous coronary intervention|percutaneous coronary intervention
114681|NCT02576691|cardiogenic shock|cardiogenic shock
114683|NCT02576678|Psoriasis|psoriasis
114684|NCT02576678|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
114685|NCT02576678|Plaque Psoriasis|plaque psoriasis
114686|NCT02576678|CC-10004|cc-10004
114687|NCT02576678|Apremilast|apremilast
114688|NCT02576678|Pharmacokinetics|pharmacokinetics
114689|NCT02576678|Open-label|open-label
114690|NCT02576678|Safety|safety
114691|NCT02576678|Pediatric|pediatric
114692|NCT02576652|bone biopsy|bone biopsy
114693|NCT02576652|tetracycline|tetracycline
114694|NCT02576652|demeclocycline|demeclocycline
114695|NCT02576652|total hip replacement|total hip replacement
114696|NCT02576639|Alzheimer's Disease,|alzheimer's disease,
114697|NCT02576639|Amyloid Beta,|amyloid beta,
114698|NCT02576639|cerebrospinal fluid,|cerebrospinal fluid,
114699|NCT02576639|beta secretase|beta secretase
114700|NCT02576626|Nebulizer|nebulizer
114701|NCT02576626|DPI|dpi
114702|NCT02576626|COPD|copd
114703|NCT02576626|indacaterol|indacaterol
114704|NCT02576626|ipratropium|ipratropium
114705|NCT02576626|glycopyrronium|glycopyrronium
114706|NCT02576626|salbutamol|salbutamol
114707|NCT02576626|Breezhaler|breezhaler
114708|NCT02576626|Nebuliser|nebuliser
114709|NCT02576626|Hyperinflation|hyperinflation
114710|NCT02576626|Dyspnea|dyspnea
114711|NCT02576626|SABA|saba
114712|NCT02576626|short-acting muscarinic antagonists (SAMA)|short-acting muscarinic antagonists (sama)
114713|NCT02576626|long-acting beta2-agonist (LABA)|long-acting beta2-agonist (laba)
114714|NCT02576626|LAMA|lama
114715|NCT02576626|FEV1|fev1
114716|NCT02576574|Avelumab|avelumab
114717|NCT02576574|MSB0010718C|msb0010718c
114718|NCT02576574|Non-Small Cell Lung Cancer|non-small cell lung cancer
114719|NCT02576561|human papillomavirus|human papillomavirus
114720|NCT02576561|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
114721|NCT02576561|Cold Knife Conization|cold knife conization
114722|NCT02576561|hysterectomy|hysterectomy
114723|NCT02576561|Loop Electrosurgical Excision Procedure|loop electrosurgical excision procedure
114724|NCT02576561|LEEP|leep
114725|NCT02576561|HSIL|hsil
114726|NCT02576561|High-Grade Squamous Intraepithelial Lesion|high-grade squamous intraepithelial lesion
114727|NCT02576496|phase 1 clinical trial|phase 1 clinical trial
114728|NCT02576496|multiple myeloma|multiple myeloma
114729|NCT02576496|Hodgkin's lymphoma|hodgkin's lymphoma
114730|NCT02576496|peripheral T-cell lymphoma|peripheral t-cell lymphoma
114731|NCT02576496|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
114732|NCT02576470|swallowing|swallowing
114733|NCT02576470|stroke|stroke
114734|NCT02576470|dysphagia|dysphagia
114735|NCT02576470|deglutition|deglutition
114736|NCT02576431|NTRK Fusion Positive|ntrk fusion positive
114737|NCT02576431|LOXO-101|loxo-101
114738|NCT02576431|Loxo|loxo
114739|NCT02576431|TRK|trk
114740|NCT02576431|TRK Fusion|trk fusion
114741|NCT02576431|NTRK1|ntrk1
114742|NCT02576431|NTRK2|ntrk2
114743|NCT02576431|NTRK3|ntrk3
114744|NCT02576431|TRKA|trka
114745|NCT02576431|TRKB|trkb
114746|NCT02576431|TRKC|trkc
114747|NCT02576431|ETV6|etv6
114748|NCT02576431|NTRK|ntrk
114749|NCT02576431|larotrectinib|larotrectinib
114750|NCT02576431|fusion|fusion
114751|NCT02576431|tumors|tumors
114752|NCT02576431|CNS tumors|cns tumors
114753|NCT02576431|solid tumors|solid tumors
114754|NCT02576431|central nervous system tumors|central nervous system tumors
114755|NCT02576431|solid CNS tumors|solid cns tumors
114756|NCT02576431|primary CNS tumor|primary cns tumor
114757|NCT02576431|Advanced CNS tumor|advanced cns tumor
114758|NCT02576431|Metastatic CNS tumor|metastatic cns tumor
114759|NCT02576431|NTRK1 fusion|ntrk1 fusion
114760|NCT02576431|NTRK2 fusion|ntrk2 fusion
114761|NCT02576431|NTRK3 fusion|ntrk3 fusion
114762|NCT02576431|ETV6-NTRK3|etv6-ntrk3
114763|NCT02576431|ETV6 fusion|etv6 fusion
114764|NCT02576418|Partosure TTD test|partosure ttd test
114765|NCT02576418|CL|cl
114766|NCT02576418|ART|art
114767|NCT02576418|SN|sn
114768|NCT02576418|SP|sp
114769|NCT02576418|PPV|ppv
114770|NCT02576418|NPV|npv
114771|NCT02576379|Helicopter Emergency Medical System|helicopter emergency medical system
114772|NCT02576379|Mortality|mortality
114773|NCT02576379|Labour market affiliation|labour market affiliation
114774|NCT02576379|Modified Rankin Scale|modified rankin scale
114775|NCT02576327|Lymphoma|lymphoma
114776|NCT02576327|Aprepitant|aprepitant
114777|NCT02576327|Chemotherapy-induced nausea and vomiting (CINV)|chemotherapy-induced nausea and vomiting (cinv)
114778|NCT02576327|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
114779|NCT02576327|Hematological Malignancies|hematological malignancies
114780|NCT02576301|AML|aml
114781|NCT02576301|MDS|mds
114782|NCT02576288|Sitagliptin|sitagliptin
114783|NCT02576288|Brachial artery flow mediated dilation|brachial artery flow mediated dilation
114784|NCT02576288|Carotid stiffness|carotid stiffness
114785|NCT02576288|Pro-inflammatory|pro-inflammatory
114786|NCT02576288|Pro-atherogenic|pro-atherogenic
114787|NCT02576288|M1 macrophages|m1 macrophages
114788|NCT02576275|Phase 3|phase 3
114789|NCT02576275|iNHL|inhl
114790|NCT02576275|Follicular Lymphoma|follicular lymphoma
114791|NCT02576275|FL|fl
114792|NCT02576275|PI3K|pi3k
114793|NCT02576275|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
114794|NCT02576275|SLL|sll
114795|NCT02576275|Marginal Zone Lymphoma|marginal zone lymphoma
114796|NCT02576275|MZL|mzl
114797|NCT02576249|osteoarthritis|osteoarthritis
114798|NCT02576249|injection|injection
114799|NCT02576249|steroid|steroid
114800|NCT02576249|anesthetic|anesthetic
114801|NCT02576236|Naïve patient|naïve patient
137249|NCT02442414|Cancer|cancer
114802|NCT02576236|Suspicion of H pylori infection|suspicion of h pylori infection
114803|NCT02576236|Endoscopy|endoscopy
114804|NCT02576236|Antibiotics therapeutic strategies|antibiotics therapeutic strategies
114805|NCT02576236|Urea breath test|urea breath test
114806|NCT02576223|Peripheral Nerve Blocks|peripheral nerve blocks
114807|NCT02576197|mild to moderate|mild to moderate
114808|NCT02576197|probiotic|probiotic
114809|NCT02576184|Incisional hernia|incisional hernia
114810|NCT02576184|Stoma|stoma
114811|NCT02576184|rectal cancer|rectal cancer
114812|NCT02576184|synthetic mesh|synthetic mesh
114813|NCT02576184|biologic mesh|biologic mesh
114814|NCT02576171|cognitive behavioral therapy;|cognitive behavioral therapy;
114815|NCT02576171|guided self-help|guided self-help
114816|NCT02576171|adolescent|adolescent
114817|NCT02576067|Atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
114818|NCT02576067|Inflammation reduction|inflammation reduction
114819|NCT02576041|driving simulator|driving simulator
114820|NCT02576028|Total Hip Replacement|total hip replacement
114821|NCT02576028|Manipulation Therapy|manipulation therapy
114822|NCT02576002|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
114823|NCT02575989|Trauma|trauma
114824|NCT02575989|Prehospital|prehospital
114825|NCT02575989|Hypothermia|hypothermia
114826|NCT02575976|Rehabilitation|rehabilitation
114827|NCT02575976|Coronary artery disease|coronary artery disease
114828|NCT02575976|Patient Education|patient education
114829|NCT02575976|Randomized Controlled Trial|randomized controlled trial
114830|NCT02575976|Protocol|protocol
114831|NCT02575937|low glycemic diet|low glycemic diet
114832|NCT02575937|diabetes|diabetes
114833|NCT02575924|media|media
114834|NCT02575924|blastocyst|blastocyst
114835|NCT02575924|male infertility|male infertility
114836|NCT02575924|poor responders|poor responders
114837|NCT02575924|pgs|pgs
114838|NCT02575859|HIPEC|hipec
114839|NCT02575859|peritoneal lavage|peritoneal lavage
114840|NCT02575833|Angina|angina
114841|NCT02575833|Stable Angina|stable angina
114842|NCT02575833|Cardiovascular Disease|cardiovascular disease
114843|NCT02575833|Exercise-induced Angina|exercise-induced angina
114844|NCT02575807|Ovarian cancer|ovarian cancer
114845|NCT02575807|Fallopian cancer|fallopian cancer
114846|NCT02575807|Primary peritoneal cancer|primary peritoneal cancer
114847|NCT02575755|Azithromycin|azithromycin
114848|NCT02575755|Piperaquine|piperaquine
114849|NCT02575755|IPTp|iptp
114850|NCT02575755|Pharmacokinetics|pharmacokinetics
114851|NCT02575755|Efficacy|efficacy
114852|NCT02575729|carpal tunnel syndrome|carpal tunnel syndrome
114853|NCT02575729|local steroid injection|local steroid injection
114854|NCT02575729|sonography|sonography
114855|NCT02575729|sonography-guided|sonography-guided
114856|NCT02575716|McGrath®|mcgrath®
114857|NCT02575716|Videolaryngoscope|videolaryngoscope
114858|NCT02575716|intubating condition|intubating condition
114859|NCT02575716|muscle relaxant|muscle relaxant
114860|NCT02575716|intubation|intubation
114861|NCT02575690|spirulina, placebo, obesity,antihypertensive treatment|spirulina, placebo, obesity,antihypertensive treatment
114862|NCT02575677|labor pain|labor pain
114863|NCT02575677|oxycodone|oxycodone
114864|NCT02575664|Pain|pain
114865|NCT02575664|Arthroplasty|arthroplasty
114866|NCT02575664|Buprenorphine|buprenorphine
114867|NCT02575651|PARP|parp
114868|NCT02575651|Advanced Solid Malignancies|advanced solid malignancies
114869|NCT02575651|Fluzoparib|fluzoparib
114870|NCT02575651|Ovarian Cancer|ovarian cancer
114871|NCT02575651|BRCA|brca
114872|NCT02575625|Liver steatosis|liver steatosis
114873|NCT02575625|Steatohepatitis|steatohepatitis
114874|NCT02575625|Fibroscan|fibroscan
114875|NCT02575599|Self-management|self-management
114876|NCT02575599|web-based|web-based
114877|NCT02575599|quantitative approach|quantitative approach
114878|NCT02575586|Trigger Points|trigger points
114879|NCT02575586|Dry needling|dry needling
114880|NCT02575586|Torque|torque
114881|NCT02575586|H-Reflex|h-reflex
114882|NCT02575573|resuscitation decision|resuscitation decision
115594|NCT02571933|Cameroon|cameroon
114883|NCT02575560|Progression-Free Survival|progression-free survival
114884|NCT02575547|Nutritional Status|nutritional status
114885|NCT02575547|Locoregionally Advanced Nasopharyngeal Carcinoma|locoregionally advanced nasopharyngeal carcinoma
114886|NCT02575534|anti-arrhythmic therapy|anti-arrhythmic therapy
114887|NCT02575482|SUVN-D4010|suvn-d4010
114893|NCT02575482|single dose|single dose
114894|NCT02575482|repeat dose|repeat dose
114895|NCT02575417|advance care planning|advance care planning
114896|NCT02575417|end-of-life care|end-of-life care
114897|NCT02575417|health games|health games
114898|NCT02575417|Family caregivers|family caregivers
114899|NCT02575417|Advance directives|advance directives
114900|NCT02575404|Metastatic|metastatic
114901|NCT02575404|Keytruda|keytruda
114902|NCT02575404|pembrolizumab|pembrolizumab
114903|NCT02575404|GR-MD-02|gr-md-02
114904|NCT02575404|Galactoarabino-rhamnogalacturonate|galactoarabino-rhamnogalacturonate
105939|NCT02629497|DHA|dha
114905|NCT02575404|Immunotherapy|immunotherapy
114906|NCT02575391|L-Glutamine|l-glutamine
114907|NCT02575391|chemotherapy|chemotherapy
114908|NCT02575391|radiotherapy|radiotherapy
114909|NCT02575391|therapeutic toxicity|therapeutic toxicity
114910|NCT02575378|Metastatic Colorectal Cancer|metastatic colorectal cancer
114911|NCT02575378|Maintenance Treatment|maintenance treatment
114912|NCT02575378|Chinese Traditional Medicine|chinese traditional medicine
114913|NCT02575378|Clinical Trial|clinical trial
114914|NCT02575378|efficacy|efficacy
114915|NCT02575378|safety|safety
114916|NCT02575365|RRMS,|rrms,
114917|NCT02575365|Cognition,|cognition,
114918|NCT02575365|brain,|brain,
114919|NCT02575365|Fingolimod,|fingolimod,
114920|NCT02575365|Multiple Sclerosis,|multiple sclerosis,
114921|NCT02575365|neurodegeneration,|neurodegeneration,
114922|NCT02575365|Brain atrophy,|brain atrophy,
114923|NCT02575365|gray matter atrophy,|gray matter atrophy,
114924|NCT02575365|thalamic atrophy,|thalamic atrophy,
114925|NCT02575365|biomarkers,|biomarkers,
114926|NCT02575365|BICAMS Battery,|bicams battery,
114927|NCT02575352|Bone Substitute|bone substitute
114928|NCT02575352|Calcium Phosphate Cement|calcium phosphate cement
114929|NCT02575352|GRAFTYS|graftys
114930|NCT02575352|GRAFTYS®HBS|graftys®hbs
114931|NCT02575352|GRAFTYS®QUICKSET|graftys®quickset
114932|NCT02575352|Bone void filler|bone void filler
114933|NCT02575352|Bone growth|bone growth
114934|NCT02575352|Registry|registry
114935|NCT02575352|Bone defect|bone defect
114936|NCT02575352|Revision arthroplasty|revision arthroplasty
114937|NCT02575352|Arthrodesis|arthrodesis
114944|NCT02575326|Asthma, Body Mass Idex, BMI, Overweight, Obesity|asthma, body mass idex, bmi, overweight, obesity
114945|NCT02575313|L-Glutamine|l-glutamine
114946|NCT02575313|chemotherapy|chemotherapy
114947|NCT02575313|radiotherapy|radiotherapy
114948|NCT02575313|therapeutic toxicity|therapeutic toxicity
114949|NCT02575300|neuroendocrine tumors (NETs)|neuroendocrine tumors (nets)
114950|NCT02575300|gastroenteropancreatic NETs|gastroenteropancreatic nets
114951|NCT02575300|pancreatic NETs|pancreatic nets
114952|NCT02575300|gastrointestinal (GI) tract NET|gastrointestinal (gi) tract net
114953|NCT02575300|advanced carcinoid tumors|advanced carcinoid tumors
114954|NCT02575274|Peri-implantitis|peri-implantitis
114955|NCT02575274|Peri-implant disease|peri-implant disease
114956|NCT02575274|Dental implants|dental implants
114957|NCT02575274|Guided bone regeneration|guided bone regeneration
114958|NCT02575261|CAR-T cell immunotherapy|car-t cell immunotherapy
114959|NCT02575261|EphA2|epha2
114960|NCT02575261|malignant glioma|malignant glioma
114961|NCT02575248|dienogest|dienogest
114962|NCT02575248|infertility|infertility
114963|NCT02575248|endometriosis|endometriosis
114964|NCT02575235|Sarcopenia|sarcopenia
114965|NCT02575235|Cetylpyridinium chloride|cetylpyridinium chloride
114966|NCT02575222|Immunotherapy|immunotherapy
114967|NCT02575222|PD-1|pd-1
114968|NCT02575222|anti-PD-1|anti-pd-1
114969|NCT02575222|antibody|antibody
114970|NCT02575222|Kidney Cancer|kidney cancer
114972|NCT02575222|non-metastatic|non-metastatic
114973|NCT02575196|Cardiac arrest|cardiac arrest
114974|NCT02575196|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
114975|NCT02575196|CPR|cpr
114976|NCT02575196|cerebral blood flow|cerebral blood flow
114977|NCT02575196|cerebral perfusion|cerebral perfusion
114978|NCT02575183|Waterpipe smoking|waterpipe smoking
114979|NCT02575183|Nicotine dependence|nicotine dependence
114980|NCT02575183|Smoking cessation|smoking cessation
114981|NCT02575183|Varinecline, Chantix therapy|varinecline, chantix therapy
114982|NCT02575183|Behavioral therapy|behavioral therapy
114983|NCT02575170|amino acid|amino acid
114984|NCT02575170|cesarean delivery|cesarean delivery
114985|NCT02575170|hypothermia|hypothermia
114986|NCT02575131|satiety|satiety
114987|NCT02575131|overweight|overweight
114988|NCT02575131|breakfast|breakfast
114989|NCT02575131|ecological validity|ecological validity
115486|NCT02572531|Third Molar|third molar
114990|NCT02575105|Bispectral Index Hydrocephalus|bispectral index hydrocephalus
114991|NCT02575092|Hyperhomocysteinemia|hyperhomocysteinemia
114992|NCT02575092|Coronary angiography|coronary angiography
114993|NCT02575092|Percutaneous coronary intervention|percutaneous coronary intervention
114994|NCT02575092|Hypertension|hypertension
114995|NCT02575092|Contrast-induced nephropathy|contrast-induced nephropathy
114996|NCT02575066|pazopanib|pazopanib
114997|NCT02575066|radiotherapy|radiotherapy
114998|NCT02575053|latex allergy|latex allergy
114999|NCT02575053|latex hypersensitivity|latex hypersensitivity
115000|NCT02575053|powder free latex surgical gloves|powder free latex surgical gloves
115001|NCT02575053|latex safe protocol|latex safe protocol
115002|NCT02575001|Type 1 diabetes|type 1 diabetes
115003|NCT02575001|Children and adolescents|children and adolescents
115005|NCT02575001|Genetic factors|genetic factors
115006|NCT02575001|Psychological background|psychological background
115007|NCT02574988|drug allergy|drug allergy
115008|NCT02574988|drug hypersensitivity|drug hypersensitivity
115009|NCT02574988|adverse drug reactions|adverse drug reactions
115010|NCT02574988|severe cutaneous adverse reactions|severe cutaneous adverse reactions
115011|NCT02574949|radiation|radiation
115012|NCT02574949|fluoroscopy|fluoroscopy
115013|NCT02574949|diagnostic|diagnostic
115014|NCT02574936|karydakis modification|karydakis modification
115015|NCT02574936|pilonidal sinus|pilonidal sinus
115016|NCT02574936|complication|complication
115017|NCT02574923|Cerebral Palsy|cerebral palsy
115018|NCT02574923|Stem Cells|stem cells
115019|NCT02574871|Stress|stress
115020|NCT02574871|Chronic stress|chronic stress
115021|NCT02574871|Perceived stress|perceived stress
115022|NCT02574871|Psychological distress|psychological distress
115023|NCT02574832|Pain|pain
115024|NCT02574832|Surgery|surgery
115025|NCT02574832|Pregnancy|pregnancy
115026|NCT02574832|Anesthesia|anesthesia
115027|NCT02574819|opioid-induced constipation|opioid-induced constipation
115028|NCT02574806|BNP|bnp
115029|NCT02574806|Reference values|reference values
115030|NCT02574806|Newborn|newborn
115031|NCT02574806|Ventricular function|ventricular function
115032|NCT02574806|Stress|stress
115033|NCT02574806|Pediatrics|pediatrics
115034|NCT02574806|Biomarkers|biomarkers
115035|NCT02574793|Glucose Fluctuation|glucose fluctuation
115036|NCT02574793|GH-Secreting Adenoma|gh-secreting adenoma
115037|NCT02574793|Cushing Syndrome|cushing syndrome
115038|NCT02574780|lymphedema|lymphedema
115039|NCT02574780|complex physical therapy|complex physical therapy
115040|NCT02574780|muscle strength|muscle strength
115041|NCT02574767|Weight gain, Fatty Acids, Omega-3|weight gain, fatty acids, omega-3
115042|NCT02574754|warfarin|warfarin
115043|NCT02574754|pharmacokinetics|pharmacokinetics
115044|NCT02574754|bioequivalence|bioequivalence
115045|NCT02574754|healthy volunteer|healthy volunteer
115046|NCT02574728|Pediatrics|pediatrics
115047|NCT02574728|Brain Tumors|brain tumors
115048|NCT02574728|Neuroblastoma|neuroblastoma
115049|NCT02574728|Osteosarcoma|osteosarcoma
115050|NCT02574728|Ewing's Sarcoma|ewing's sarcoma
115051|NCT02574728|Rhabdomyosarcoma|rhabdomyosarcoma
115052|NCT02574728|Wilms Tumors|wilms tumors
115053|NCT02574728|Soft Tissue Sarcomas|soft tissue sarcomas
115054|NCT02574702|superficial surgical site infection|superficial surgical site infection
115055|NCT02574702|loop ileostomy|loop ileostomy
115056|NCT02574702|Ileostomy closure|ileostomy closure
115057|NCT02574689|Physical Activity|physical activity
115058|NCT02574689|Cancer Prevention|cancer prevention
115059|NCT02574637|MEDI2070|medi2070
115060|NCT02574637|inflammatory bowel disease|inflammatory bowel disease
115061|NCT02574637|moderate to severe Crohn's Disease|moderate to severe crohn's disease
115062|NCT02574637|IL-23|il-23
115063|NCT02574598|PDL1|pdl1
115064|NCT02574598|monoclonal antibody|monoclonal antibody
115065|NCT02574585|Spinal cord injury|spinal cord injury
115066|NCT02574585|Paraplegia|paraplegia
115067|NCT02574585|Stem cells|stem cells
115068|NCT02574585|Mesenchymal cells|mesenchymal cells
115069|NCT02574572|Spinal cord injury|spinal cord injury
115070|NCT02574572|Mesenchymal cells|mesenchymal cells
115071|NCT02574572|Stem cells|stem cells
115072|NCT02574559|Caregiver|caregiver
115073|NCT02574559|Stress|stress
115074|NCT02574559|Depression|depression
115075|NCT02574559|Autism Spectrum Disorder|autism spectrum disorder
115076|NCT02574559|Compassion Meditation|compassion meditation
115077|NCT02574546|Mastectomy|mastectomy
115078|NCT02574533|Immunotherapy|immunotherapy
115079|NCT02574533|PD-1 inhibitor|pd-1 inhibitor
115080|NCT02574533|Keytruda|keytruda
115081|NCT02574533|checkpoint inhibitor|checkpoint inhibitor
115082|NCT02574533|vaccine|vaccine
115083|NCT02574533|FANG|fang
115084|NCT02574533|Vigil|vigil
115085|NCT02574520|Post-operative pain|post-operative pain
115086|NCT02574520|opioid|opioid
115087|NCT02574520|opioid reduction|opioid reduction
115088|NCT02574520|laparoscopic cholecystectomy|laparoscopic cholecystectomy
115089|NCT02574520|laparoscopic surgery|laparoscopic surgery
115090|NCT02574520|bupivacaine|bupivacaine
115091|NCT02574520|extended release|extended release
115092|NCT02574520|locally acting analgesic|locally acting analgesic
115093|NCT02574507|breast cancer|breast cancer
115094|NCT02574507|weight management|weight management
115095|NCT02574507|couples|couples
115096|NCT02574507|symptom management|symptom management
115097|NCT02574481|atherosclerosis|atherosclerosis
115098|NCT02574481|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
115099|NCT02574481|Proximal Popliteal Artery (PPA)|proximal popliteal artery (ppa)
115100|NCT02574481|lower extremities|lower extremities
115101|NCT02574481|stenting|stenting
115102|NCT02574481|paclitaxel|paclitaxel
115103|NCT02574468|Dexamethasone|dexamethasone
115104|NCT02574468|Direct pulp capping|direct pulp capping
115106|NCT02574468|pulpotomy|pulpotomy
115107|NCT02574442|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
115108|NCT02574442|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
106143|NCT02628613|TEKT4|tekt4
115109|NCT02574442|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
115110|NCT02574442|adenocarcinoma in situ|adenocarcinoma in situ
115111|NCT02574429|Borderline Personality Disorder|borderline personality disorder
115112|NCT02574429|Posttraumatic Stress Disorder|posttraumatic stress disorder
115113|NCT02574429|Cognitive Processing Therapy|cognitive processing therapy
115114|NCT02574429|Group Therapy|group therapy
115115|NCT02574429|Comorbidity|comorbidity
115116|NCT02574429|Dialectical Behavior Therapy|dialectical behavior therapy
115117|NCT02574416|Health behaviour|health behaviour
115118|NCT02574416|Health outcomes|health outcomes
115119|NCT02574416|Diet quality|diet quality
115120|NCT02574416|Physical function|physical function
115121|NCT02574416|Lifestyle|lifestyle
115122|NCT02574416|Older adults|older adults
115123|NCT02574403|atypical hemolytic uremic syndrome (aHUS)|atypical hemolytic uremic syndrome (ahus)
115124|NCT02574403|eculizumab discontinuation|eculizumab discontinuation
115126|NCT02574390|stem cell|stem cell
115127|NCT02574390|biomarker|biomarker
115128|NCT02574390|disease progression|disease progression
115129|NCT02574364|abdomen CT|abdomen ct
115130|NCT02574364|open appendicectomy|open appendicectomy
115131|NCT02574312|Mechanical Axis Alignment|mechanical axis alignment
115132|NCT02574312|Knee Arthroplasty, Total|knee arthroplasty, total
115133|NCT02574299|dyslexia|dyslexia
115134|NCT02574299|training|training
115135|NCT02574299|auditory rehabilitation|auditory rehabilitation
115136|NCT02574299|hearing loss|hearing loss
115137|NCT02574299|evoked potentials|evoked potentials
115138|NCT02574299|dichotic|dichotic
115139|NCT02574299|plasticity|plasticity
115140|NCT02574299|noise|noise
115141|NCT02574247|Audiology|audiology
115142|NCT02574247|Auditory Pathways|auditory pathways
115143|NCT02574247|Auditory Perception|auditory perception
115144|NCT02574247|Brain Stem|brain stem
115145|NCT02574247|Cochlea|cochlea
115146|NCT02574247|Ear, Inner|ear, inner
115147|NCT02574247|Efferent Pathways|efferent pathways
115148|NCT02574247|Hair Cells, Auditory, Outer|hair cells, auditory, outer
115150|NCT02574247|Neurons, Efferent|neurons, efferent
115151|NCT02574247|Speech Perception|speech perception
115152|NCT02574234|Postoperative cognitive disorders POCD|postoperative cognitive disorders pocd
115153|NCT02574234|inflammation|inflammation
115154|NCT02574234|Surgery|surgery
115155|NCT02574208|Adult outpatients|adult outpatients
115156|NCT02574208|Paris, France|paris, france
115157|NCT02574195|Diabetes Mellitus|diabetes mellitus
115158|NCT02574195|microvascular complications|microvascular complications
115159|NCT02574195|macrovascular complications|macrovascular complications
115160|NCT02574195|epidemiology|epidemiology
115161|NCT02574195|Russia|russia
115162|NCT02574182|Mild Cognitive Impairment|mild cognitive impairment
115163|NCT02574182|Magnetic Resonance Imaging|magnetic resonance imaging
115164|NCT02574169|Alveolar Recruitment Maneuvers (ARM)|alveolar recruitment maneuvers (arm)
115165|NCT02574169|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
115166|NCT02574169|Extended Sigh (eSigh)|extended sigh (esigh)
115167|NCT02574143|Prognosis|prognosis
115168|NCT02574143|Prospective Study|prospective study
115169|NCT02574143|Quality of Life|quality of life
115170|NCT02574143|Radiology|radiology
115171|NCT02574143|Rehabilitation|rehabilitation
115172|NCT02574143|Registry;|registry;
115173|NCT02574143|Signs and Symptoms|signs and symptoms
115174|NCT02574143|Therapy|therapy
115175|NCT02574143|Bronchiectiasis|bronchiectiasis
115176|NCT02574143|Diagnosis|diagnosis
115177|NCT02574143|Epidemiology|epidemiology
115178|NCT02574143|Etiology|etiology
115179|NCT02574143|Longitudinal Study|longitudinal study
115180|NCT02574143|Microbiology|microbiology
115181|NCT02574104|Intensive Care Units, Neonatal|intensive care units, neonatal
115182|NCT02574104|Patient simulation|patient simulation
115183|NCT02574104|Interdisciplinary Communication|interdisciplinary communication
115184|NCT02574104|Human factors|human factors
115185|NCT02574104|Hazard Analysis and Critical Control Points|hazard analysis and critical control points
115186|NCT02574091|EGFR inhibitor|egfr inhibitor
115187|NCT02574091|topical agent|topical agent
115188|NCT02574091|psoriasis|psoriasis
115189|NCT02574091|phase 1|phase 1
115190|NCT02574065|crying|crying
115191|NCT02574065|colicky|colicky
115192|NCT02574065|infants|infants
115193|NCT02574065|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
115194|NCT02574052|Menu Labelling;|menu labelling;
115195|NCT02574052|Nutrition Education;|nutrition education;
115196|NCT02574052|dietary assessment tools;|dietary assessment tools;
115197|NCT02574039|volunteers|volunteers
115198|NCT02574039|oat|oat
115199|NCT02574039|phenolic acid|phenolic acid
115200|NCT02574039|bioavailability|bioavailability
115201|NCT02574026|MEG|meg
115202|NCT02574026|EEG|eeg
115203|NCT02574026|MRI|mri
115204|NCT02574026|Brain mapping|brain mapping
115205|NCT02574026|functional imaging|functional imaging
115206|NCT02574026|brain computer interface|brain computer interface
106295|NCT02627807|Clinical trial|clinical trial
106296|NCT02627794|Middle Meatus|middle meatus
106297|NCT02627794|Synechiae|synechiae
115207|NCT02573974|undernutrition|undernutrition
115208|NCT02573974|gastrointestinal cancer|gastrointestinal cancer
115209|NCT02573974|skeletal muscle|skeletal muscle
115210|NCT02573974|energy metabolism|energy metabolism
115211|NCT02573948|People who inject drugs|people who inject drugs
115212|NCT02573948|Vietnam|vietnam
115213|NCT02573948|Community support groups|community support groups
115214|NCT02573935|Multiple Myeloma|multiple myeloma
115215|NCT02573935|Clarithromycin|clarithromycin
115216|NCT02573935|Induction Chemotherapy|induction chemotherapy
115217|NCT02573935|Transplantation, Autologous|transplantation, autologous
115218|NCT02573922|constipation|constipation
115219|NCT02573922|opioid|opioid
115220|NCT02573922|Oxycodone|oxycodone
115221|NCT02573922|Oxycodone-naloxone|oxycodone-naloxone
115222|NCT02573922|spine surgery|spine surgery
115223|NCT02573896|relapsed refractory neuroblastoma|relapsed refractory neuroblastoma
115224|NCT02573883|Vulva|vulva
115225|NCT02573883|Lichen Sclerosus|lichen sclerosus
115226|NCT02573883|Fractionated Carbon Dioxide Laser|fractionated carbon dioxide laser
115227|NCT02573883|Mona Lisa Laser|mona lisa laser
115228|NCT02573883|Clobetasol Proprionate|clobetasol proprionate
115229|NCT02573883|Vulvodynia|vulvodynia
115230|NCT02573870|COPD|copd
115231|NCT02573870|DPI|dpi
115232|NCT02573870|Batefenterol|batefenterol
115233|NCT02573870|Fluticasone Furoate|fluticasone furoate
115234|NCT02573857|Induced blood stage malaria|induced blood stage malaria
115235|NCT02573857|Transmission|transmission
115236|NCT02573857|Gametocytemia|gametocytemia
115237|NCT02573844|irritable bowel syndrome|irritable bowel syndrome
115238|NCT02573844|abdominal pain|abdominal pain
115239|NCT02573844|rome III criteria|rome iii criteria
115240|NCT02573844|abdominal distension|abdominal distension
115241|NCT02573844|consistency of stools|consistency of stools
115242|NCT02573844|stool frequency|stool frequency
115243|NCT02573844|meteorism|meteorism
115244|NCT02573844|flatulence|flatulence
115245|NCT02573844|abdominal discomfort|abdominal discomfort
115246|NCT02573844|proklama|proklama
115247|NCT02573844|probiotics|probiotics
115248|NCT02573844|alga klamath|alga klamath
115249|NCT02573844|aphanizomenon flos-aquae|aphanizomenon flos-aquae
115250|NCT02573844|prebiotics|prebiotics
115251|NCT02573844|colitis ulcerosa|colitis ulcerosa
115252|NCT02573831|labor|labor
115253|NCT02573831|pain|pain
115254|NCT02573831|oxycodone|oxycodone
115255|NCT02573831|placenta|placenta
115256|NCT02573818|sedation for EGD and colonoscopy procedures|sedation for egd and colonoscopy procedures
115257|NCT02573805|nocturnal penile tumescence and rigidity|nocturnal penile tumescence and rigidity
115258|NCT02573805|erectile dysfunction|erectile dysfunction
115259|NCT02573805|Chinese males|chinese males
115260|NCT02573792|First onset of optical neuritis|first onset of optical neuritis
115261|NCT02573779|human milk|human milk
115262|NCT02573779|enteral nutrition|enteral nutrition
115263|NCT02573779|microbiome|microbiome
115264|NCT02573779|Microbiota|microbiota
115265|NCT02573766|Neurofeedback training|neurofeedback training
115266|NCT02573766|EEG|eeg
115267|NCT02573766|electroencephalograph|electroencephalograph
115268|NCT02573766|Questionnaires|questionnaires
115269|NCT02573766|Surveys|surveys
115270|NCT02573766|Chemotherapy-Induced Peripheral Neuropathy|chemotherapy-induced peripheral neuropathy
115271|NCT02573766|CIPN|cipn
115272|NCT02573740|Mild Cognitive Impairment|mild cognitive impairment
115273|NCT02573740|Alzheimer's Disease|alzheimer's disease
115274|NCT02573714|Ketamine|ketamine
115275|NCT02573714|Intranasal|intranasal
115276|NCT02573714|Pain crisis|pain crisis
115277|NCT02573714|Vasoocclusive Pain|vasoocclusive pain
115278|NCT02573714|Sickle cell disease|sickle cell disease
115279|NCT02573701|Schizophrenia|schizophrenia
115280|NCT02573701|Adolescents|adolescents
115281|NCT02573701|Treatment|treatment
115282|NCT02573701|Guidelines|guidelines
115283|NCT02573688|Obesity|obesity
115284|NCT02573688|Metabolic Syndrome X|metabolic syndrome x
115285|NCT02573688|Interdisciplinary Studies|interdisciplinary studies
115286|NCT02573675|hemodialysis|hemodialysis
115287|NCT02573675|peritoneal dialysis|peritoneal dialysis
648348|NCT00771199|Transdermal|transdermal
115288|NCT02573662|Metabolic complications|metabolic complications
115289|NCT02573662|Type 2 diabetes|type 2 diabetes
115290|NCT02573662|Sedentary lifestyle|sedentary lifestyle
115291|NCT02573662|Low grade inflammation|low grade inflammation
115292|NCT02573662|Lipid metabolism|lipid metabolism
115293|NCT02573662|Glucose metabolism|glucose metabolism
115294|NCT02573662|Bone metabolism|bone metabolism
115295|NCT02573662|Physical inactivity|physical inactivity
115296|NCT02573623|Immunology diagnosis test|immunology diagnosis test
115297|NCT02573623|Children|children
115299|NCT02573571|single nucleotide polymorphisms|single nucleotide polymorphisms
115300|NCT02573571|cytokines|cytokines
115301|NCT02573571|microbiome|microbiome
115302|NCT02573545|liver|liver
115303|NCT02573532|myocardial ischemia/diagnosis|myocardial ischemia/diagnosis
115304|NCT02573532|myocardial ischemia/epidemiology|myocardial ischemia/epidemiology
115305|NCT02573532|perioperative|perioperative
115306|NCT02573532|perioperative complications/diagnosis|perioperative complications/diagnosis
115307|NCT02573532|prognosis|prognosis
115308|NCT02573519|11C Donepezil PET/CT scan|11c donepezil pet/ct scan
115309|NCT02573519|3D-Transit|3d-transit
115310|NCT02573519|Diabetes Mellitus|diabetes mellitus
115311|NCT02573519|Gastrointestinal motility disorder|gastrointestinal motility disorder
115312|NCT02573519|Diabetic autonomic neuropathy|diabetic autonomic neuropathy
115313|NCT02573506|Non-small cell lung cancer|non-small cell lung cancer
115314|NCT02573506|Split-course Chemoradiotherapy|split-course chemoradiotherapy
115315|NCT02573506|Consolidation chemotherapy|consolidation chemotherapy
115316|NCT02573480|youth violence, intervention, emergency medicine|youth violence, intervention, emergency medicine
115317|NCT02573467|sporadic inclusion body myositis,|sporadic inclusion body myositis,
115318|NCT02573467|muscle wasting,|muscle wasting,
115319|NCT02573467|extension study,|extension study,
115320|NCT02573467|BYM338,|bym338,
115321|NCT02573467|bimagrumab,|bimagrumab,
115322|NCT02573428|Autism Spectrum Disorder|autism spectrum disorder
115323|NCT02573428|Eye Gaze|eye gaze
115324|NCT02573428|Remote Eye Gaze Tracking|remote eye gaze tracking
115325|NCT02573428|Autism|autism
115326|NCT02573402|electric stimulation|electric stimulation
115327|NCT02573402|urodynamic study|urodynamic study
115328|NCT02573389|pancreatic fistula, pancreatectomy, endoscopic stenting, pancreatic stenting, distal pancreatectomy|pancreatic fistula, pancreatectomy, endoscopic stenting, pancreatic stenting, distal pancreatectomy
115329|NCT02573376|HIV|hiv
115330|NCT02573376|Hepatitis C|hepatitis c
115331|NCT02573376|Drug Abuse|drug abuse
115332|NCT02573376|Hepatitis C Virus|hepatitis c virus
115333|NCT02573376|sofosbuvir|sofosbuvir
115334|NCT02573376|ledipasvir|ledipasvir
115335|NCT02573376|pharmacology|pharmacology
115336|NCT02573376|pharmacokinetics|pharmacokinetics
115337|NCT02573324|Newly Diagnosed Glioblastoma|newly diagnosed glioblastoma
115338|NCT02573324|Brain Cancer|brain cancer
115339|NCT02573324|Temozolomide|temozolomide
115340|NCT02573324|EGFR Amplified|egfr amplified
115341|NCT02573324|Radiology Therapy Oncology Group|radiology therapy oncology group
115342|NCT02573324|ABT-414|abt-414
115343|NCT02573324|EGFRvIII|egfrviii
115344|NCT02573324|Antibody Drug Conjugate|antibody drug conjugate
115345|NCT02573324|Epithelial Growth Factor Receptor|epithelial growth factor receptor
115346|NCT02573324|Brain Tumor Group|brain tumor group
115347|NCT02573324|First Line Therapy|first line therapy
115348|NCT02573324|Brain Tumor|brain tumor
115349|NCT02573298|cryotherapy|cryotherapy
115350|NCT02573298|power Doppler score|power doppler score
115351|NCT02573298|synovial fluid cytokines|synovial fluid cytokines
115352|NCT02573298|pain VAS|pain vas
115353|NCT02573259|efficacy|efficacy
115354|NCT02573259|safety|safety
115355|NCT02573259|pharmacokinetics|pharmacokinetics
115356|NCT02573259|pharmacodynamics|pharmacodynamics
115357|NCT02573259|open label|open label
115358|NCT02573259|dose response|dose response
115359|NCT02573259|multiple ascending dose|multiple ascending dose
115360|NCT02573259|immunogenicity|immunogenicity
115361|NCT02573246|neurostimulation|neurostimulation
115362|NCT02573246|cognitive restructuring|cognitive restructuring
115363|NCT02573246|TMS|tms
115364|NCT02573194|Appetite|appetite
115365|NCT02573194|Amino acids|amino acids
115366|NCT02573194|Protein Source|protein source
115367|NCT02573168|Pharmacogenomic|pharmacogenomic
115368|NCT02573168|Pharmacogenomic Testing|pharmacogenomic testing
115369|NCT02573168|Pharmacogenomics|pharmacogenomics
115370|NCT02573168|Genetic Testing|genetic testing
115371|NCT02573168|Genetics|genetics
115372|NCT02573168|GeneSight|genesight
115373|NCT02573168|Enhanced GeneSight|enhanced genesight
115374|NCT02573168|Psychotropic|psychotropic
115375|NCT02573155|Pharmacokinetics|pharmacokinetics
115376|NCT02573155|Pharmacodynamics|pharmacodynamics
115377|NCT02573155|AZD8871|azd8871
115378|NCT02573155|Safety|safety
115379|NCT02573155|Tolerability|tolerability
115380|NCT02573155|mild persistent asthma|mild persistent asthma
115381|NCT02573155|moderate to severe COPD|moderate to severe copd
115382|NCT02573142|obesity|obesity
115383|NCT02573142|treatment|treatment
115384|NCT02573142|community|community
115385|NCT02573142|integrated|integrated
115386|NCT02573129|cardiovascular disease risk|cardiovascular disease risk
115391|NCT02573116|periodontitis|periodontitis
115392|NCT02573090|Occlusal caries|occlusal caries
115393|NCT02573090|Resin based fissure sealant|resin based fissure sealant
115394|NCT02573090|Composite resin restoration|composite resin restoration
115395|NCT02573090|Effectiveness|effectiveness
115396|NCT02573090|Longevity|longevity
115397|NCT02573077|Hyponatremia due to SIADH|hyponatremia due to siadh
115398|NCT02573077|Cancer|cancer
115399|NCT02573038|Aflibercept|aflibercept
115400|NCT02573038|choroidal neovascularization|choroidal neovascularization
138014|NCT02438449|HUI|hui
115401|NCT02573038|angioid streaks|angioid streaks
115402|NCT02573038|young patient|young patient
115403|NCT02572999|Aged|aged
115404|NCT02572999|Frail|frail
115405|NCT02572999|Functional decline|functional decline
115406|NCT02572999|Impairment|impairment
115407|NCT02572999|valvular heart disease|valvular heart disease
115408|NCT02572999|Cohort|cohort
115409|NCT02572999|risk factors|risk factors
115410|NCT02572947|Dolutegravir|dolutegravir
115411|NCT02572947|HIV infection|hiv infection
115412|NCT02572947|Anti-Retroviral Agents|anti-retroviral agents
115413|NCT02572947|HIV Integrase Inhibitors|hiv integrase inhibitors
115414|NCT02572947|Integrase Inhibitors|integrase inhibitors
115415|NCT02572947|Pharmacologic Actions|pharmacologic actions
115416|NCT02572947|Therapeutic Uses|therapeutic uses
115417|NCT02572934|Testicular cancer|testicular cancer
115418|NCT02572934|Survivorship|survivorship
115419|NCT02572934|late adverse treatment effects|late adverse treatment effects
115420|NCT02572921|Positive Psychotherapy|positive psychotherapy
115421|NCT02572921|Depression|depression
115422|NCT02572921|Happiness|happiness
115423|NCT02572908|wheat, IBS, gluten, ATI|wheat, ibs, gluten, ati
115424|NCT02572895|Cranberry|cranberry
115425|NCT02572895|Proanthocyanidins|proanthocyanidins
115426|NCT02572895|Urinary catabolites|urinary catabolites
115427|NCT02572882|hemodialysis|hemodialysis
115428|NCT02572882|p-inulin|p-inulin
115429|NCT02572882|gut microbiome|gut microbiome
115434|NCT02572856|Feasibility|feasibility
115435|NCT02572856|continuous glucose monitor|continuous glucose monitor
115436|NCT02572856|surgery|surgery
115437|NCT02572843|NSCLC|nsclc
115438|NCT02572843|lung cancer|lung cancer
115439|NCT02572843|MEDI4736|medi4736
115440|NCT02572843|non-small cell lung cancer|non-small cell lung cancer
115441|NCT02572843|immunotherapy|immunotherapy
115442|NCT02572843|anti-PD-L1|anti-pd-l1
115443|NCT02572830|Reconsolidation|reconsolidation
115444|NCT02572830|EMDR|emdr
115445|NCT02572830|PTSD|ptsd
115446|NCT02572817|Anti-Influenza Immune Plasma|anti-influenza immune plasma
115447|NCT02572804|bladder cancer-cystectomy|bladder cancer-cystectomy
115448|NCT02572804|rectus sheath catheter|rectus sheath catheter
115449|NCT02572804|epidural|epidural
115450|NCT02572713|Parkinson's Disease|parkinson's disease
115451|NCT02572713|alpha-synuclein|alpha-synuclein
115452|NCT02572713|biomarker|biomarker
115453|NCT02572687|metastatic|metastatic
115454|NCT02572687|advanced|advanced
115455|NCT02572687|immuno-oncology|immuno-oncology
115456|NCT02572687|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
115457|NCT02572687|angiogenesis|angiogenesis
115458|NCT02572687|PD-1|pd-1
115459|NCT02572687|PD-L1|pd-l1
115460|NCT02572674|Bipolar disorder|bipolar disorder
115461|NCT02572674|relapse risk factors|relapse risk factors
115462|NCT02572674|prospective follow up|prospective follow up
115463|NCT02572661|Radiotherapy, Sentinel Node Mapping, Spect|radiotherapy, sentinel node mapping, spect
115464|NCT02572648|Cardiomyopathy|cardiomyopathy
115465|NCT02572648|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
115466|NCT02572635|Pneumococcal Infection|pneumococcal infection
115467|NCT02572635|Phase I|phase i
115468|NCT02572635|Immunogenicity|immunogenicity
115469|NCT02572635|Safety|safety
115470|NCT02572635|Vaccination|vaccination
115471|NCT02572622|exercise|exercise
115472|NCT02572622|deep friction massage|deep friction massage
115473|NCT02572622|spinal decompression|spinal decompression
115474|NCT02572622|non-surgical spinal decompression|non-surgical spinal decompression
115475|NCT02572596|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
115476|NCT02572596|Thrombopoietin|thrombopoietin
115477|NCT02572583|Reconciling Exterior and Interior Therapy|reconciling exterior and interior therapy
115478|NCT02572583|Influenza|influenza
115479|NCT02572570|Adult dental care|adult dental care
115480|NCT02572557|Spray Cryotherapy|spray cryotherapy
115481|NCT02572544|young healthy adults|young healthy adults
115482|NCT02572544|single pinhole glasses|single pinhole glasses
115483|NCT02572544|multiple pinhole glasses|multiple pinhole glasses
115484|NCT02572531|Lactobacillus reuteri|lactobacillus reuteri
115485|NCT02572531|Wound Healing|wound healing
115487|NCT02572531|Postoperative Complications|postoperative complications
115488|NCT02572518|immunity yellow fever vaccine|immunity yellow fever vaccine
115489|NCT02572505|HIV-Discordant|hiv-discordant
115490|NCT02572505|Preexposure Prophylaxis|preexposure prophylaxis
115491|NCT02572492|Multiple Myeloma|multiple myeloma
115492|NCT02572492|Recurrence|recurrence
115493|NCT02572492|Carfilzomib|carfilzomib
115494|NCT02572492|Salvage Therapy|salvage therapy
115495|NCT02572492|Transplantation, Autologous|transplantation, autologous
115496|NCT02572479|fatty acids, amyotrophic lateral sclerosis, nutrient status|fatty acids, amyotrophic lateral sclerosis, nutrient status
115497|NCT02572466|high-sensitive troponin-I|high-sensitive troponin-i
115498|NCT02572466|End-stage renal disease|end-stage renal disease
115499|NCT02572466|hemodialysis|hemodialysis
115500|NCT02572440|Aortic arch surgery; Blood conservation; aPRP|aortic arch surgery; blood conservation; aprp
115501|NCT02572401|Human immunodeficiency virus|human immunodeficiency virus
115502|NCT02572401|Sexually transmitted disease|sexually transmitted disease
115503|NCT02572401|Behavioral intervention|behavioral intervention
115504|NCT02572401|Randomized controlled trial|randomized controlled trial
115505|NCT02572401|Text messages|text messages
115506|NCT02572401|Social cognitive theory|social cognitive theory
115507|NCT02572401|Theory of planned behavior|theory of planned behavior
115508|NCT02572401|Sexual behavior|sexual behavior
115509|NCT02572401|African Americans|african americans
115510|NCT02572401|Men|men
115511|NCT02572349|Healthy Subjects|healthy subjects
115512|NCT02572310|total knee arthroplasty|total knee arthroplasty
115513|NCT02572297|epilepsy|epilepsy
115514|NCT02572297|SUDEP|sudep
115515|NCT02572297|SpO2|spo2
115644|NCT02571673|15-245|15-245
115516|NCT02572284|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
115517|NCT02572284|High Risk Prostate Cancer|high risk prostate cancer
115518|NCT02572284|Preoperative SBRT|preoperative sbrt
115519|NCT02572284|Prostate Adenocarcinoma|prostate adenocarcinoma
115520|NCT02572284|Prostatectomy|prostatectomy
115521|NCT02572284|Quality of Life|quality of life
115522|NCT02572271|Autologous augmentation|autologous augmentation
115523|NCT02572271|Mastopexy|mastopexy
115524|NCT02572271|Massive weight loss|massive weight loss
115525|NCT02572245|Healthy Subjects|healthy subjects
115526|NCT02572245|Device|device
115527|NCT02572245|PK|pk
115528|NCT02572245|Phase 1|phase 1
115529|NCT02572245|Bioequivalence|bioequivalence
115530|NCT02572245|Adalimumab|adalimumab
115531|NCT02572245|Single Dose|single dose
115532|NCT02572193|achalasia|achalasia
115533|NCT02572193|surgery|surgery
115534|NCT02572167|Monomethyl auristatin E|monomethyl auristatin e
115535|NCT02572167|Antigens, CD30|antigens, cd30
115536|NCT02572167|Antibody-Drug Conjugate|antibody-drug conjugate
115537|NCT02572167|Antibodies, Monoclonal|antibodies, monoclonal
115538|NCT02572167|Immunotherapy|immunotherapy
115539|NCT02572167|Autologous stem cell transplant|autologous stem cell transplant
115540|NCT02572115|After-Hours Care|after-hours care
115541|NCT02572115|Primary Care|primary care
115542|NCT02572115|Emergency Medical Services/utilization|emergency medical services/utilization
115543|NCT02572115|Denmark|denmark
115544|NCT02572115|Questionnaires|questionnaires
115545|NCT02572115|Patient Satisfaction|patient satisfaction
115546|NCT02572115|Patient feeling of safety|patient feeling of safety
115547|NCT02572115|Triage/standards|triage/standards
115548|NCT02572115|Referral and Consultation/statistics & numerical data|referral and consultation/statistics & numerical data
115549|NCT02572115|Humans|humans
115550|NCT02572115|Male|male
115551|NCT02572115|Female|female
115552|NCT02572115|Hotlines|hotlines
115553|NCT02572115|telenursing|telenursing
115554|NCT02572115|Night Care/utilization|night care/utilization
115555|NCT02572115|postal service|postal service
115556|NCT02572102|ECG|ecg
115557|NCT02572102|Blood Pressure|blood pressure
115558|NCT02572102|Energy Drinks|energy drinks
115559|NCT02572102|Panax Ginseng|panax ginseng
115560|NCT02572037|Premature ejaculation|premature ejaculation
115561|NCT02572037|Dapoxetine|dapoxetine
115562|NCT02572037|local anaesthetics|local anaesthetics
115563|NCT02572037|nerve electrophysiology|nerve electrophysiology
115564|NCT02572011|Lower limb amputation|lower limb amputation
115565|NCT02572011|Transtibial|transtibial
115566|NCT02572011|Balance|balance
115567|NCT02572011|Postural Control|postural control
115568|NCT02572011|Limits of Stability|limits of stability
115569|NCT02572011|Rehabilitation|rehabilitation
115570|NCT02572011|Home-based intervention|home-based intervention
115571|NCT02572011|Nintendo Wii|nintendo wii
115572|NCT02572011|Balance Board|balance board
115573|NCT02571985|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
115574|NCT02571985|iliac aneurysm|iliac aneurysm
115575|NCT02571985|branch|branch
115576|NCT02571985|connections|connections
115577|NCT02571985|endovascular graft|endovascular graft
115578|NCT02571985|graft-iliac bifurcation|graft-iliac bifurcation
115579|NCT02571985|Aneurysm|aneurysm
115580|NCT02571985|Vascular Diseases|vascular diseases
115581|NCT02571985|Cardiovascular Diseases|cardiovascular diseases
115582|NCT02571972|dorzolamide-timolol|dorzolamide-timolol
115583|NCT02571972|topical aqueous suppression|topical aqueous suppression
115584|NCT02571972|neovascular age-related macular degeneration|neovascular age-related macular degeneration
115585|NCT02571972|macular edema|macular edema
115586|NCT02571972|intravitreal injection|intravitreal injection
115587|NCT02571972|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
115588|NCT02571959|Obesity|obesity
115589|NCT02571959|Pharmacology|pharmacology
115590|NCT02571959|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination
115591|NCT02571933|Pediatrics|pediatrics
115592|NCT02571933|Pain Scale|pain scale
115593|NCT02571933|Faces Pain Scale - Revised|faces pain scale - revised
115595|NCT02571920|cardiac surgery|cardiac surgery
115596|NCT02571920|cardiac output|cardiac output
115597|NCT02571907|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
115598|NCT02571907|Iliac aneurysm|iliac aneurysm
115599|NCT02571907|Branch|branch
115600|NCT02571907|Connections|connections
115601|NCT02571907|Endovascular graft|endovascular graft
115602|NCT02571907|Graft-iliac bifurcation|graft-iliac bifurcation
115603|NCT02571907|Aneurysm|aneurysm
115604|NCT02571907|Vascular Diseases|vascular diseases
115605|NCT02571907|Cardiovascular Diseases|cardiovascular diseases
115606|NCT02571881|constipation|constipation
115607|NCT02571881|oxycodone|oxycodone
115608|NCT02571881|caesarean section|caesarean section
115609|NCT02571855|insomnia|insomnia
115610|NCT02571855|Pharmacokinetics|pharmacokinetics
115611|NCT02571855|Safety|safety
115612|NCT02571855|Pharmacodynamics|pharmacodynamics
115613|NCT02571855|Healthy|healthy
115614|NCT02571842|Recurrent IgA nephropathy|recurrent iga nephropathy
115615|NCT02571842|Rituximab|rituximab
115616|NCT02571829|Liposarcoma|liposarcoma
115617|NCT02571829|Soft tissue sarcoma|soft tissue sarcoma
115618|NCT02571829|CDK4|cdk4
115619|NCT02571829|CDK6|cdk6
115620|NCT02571829|LEE011|lee011
115621|NCT02571829|ribociclib|ribociclib
115622|NCT02571816|ASP2215|asp2215
115623|NCT02571816|Healthy|healthy
115624|NCT02571816|Hepatic Impairment|hepatic impairment
115625|NCT02571816|Mild Hepatic Impairment|mild hepatic impairment
115626|NCT02571816|Moderate Hepatic Impairment|moderate hepatic impairment
115627|NCT02571803|coronary artery disease|coronary artery disease
115628|NCT02571803|atherosclerosis|atherosclerosis
115629|NCT02571803|DASH diet|dash diet
115630|NCT02571790|Patient with Generalized Anxiety Disorders|patient with generalized anxiety disorders
115631|NCT02571777|Asthma|asthma
115632|NCT02571725|Ovarian cancer|ovarian cancer
115633|NCT02571725|Fallopian tube cancer|fallopian tube cancer
115634|NCT02571725|Peritoneal cancer|peritoneal cancer
115635|NCT02571725|PARP|parp
115636|NCT02571725|BRCA|brca
115637|NCT02571725|Immunotherapy|immunotherapy
115638|NCT02571725|Olaparib|olaparib
115639|NCT02571725|Tremelimumab|tremelimumab
115640|NCT02571725|CTLA4|ctla4
115641|NCT02571673|Survivorship|survivorship
115642|NCT02571673|Quality of Life|quality of life
115643|NCT02571673|HN-STAR web-based|hn-star web-based
115645|NCT02571660|vitamin d levels|vitamin d levels
115646|NCT02571660|exacerbation of asthma|exacerbation of asthma
115647|NCT02571660|asthma control|asthma control
115648|NCT02571634|intranasal fentanyl|intranasal fentanyl
115649|NCT02571634|conscious sedation|conscious sedation
115650|NCT02571608|Type 2 diabetes mellitus, Metformin, peri-operative|type 2 diabetes mellitus, metformin, peri-operative
115651|NCT02571595|HIV - Human Immunodeficiency Virus|hiv - human immunodeficiency virus
115652|NCT02571595|digital cognitive behavioural therapy for insomnia (dCBT-I)|digital cognitive behavioural therapy for insomnia (dcbt-i)
115653|NCT02571595|insomnia|insomnia
115654|NCT02571595|cognitive Impairment|cognitive impairment
115655|NCT02571595|concentration|concentration
115656|NCT02571595|productivity|productivity
115657|NCT02571582|Predictors of mortality|predictors of mortality
115658|NCT02571543|Ibuprofen|ibuprofen
115659|NCT02571543|IVF|ivf
115660|NCT02571543|minimal stimulation|minimal stimulation
115661|NCT02571543|modified natural-cycle|modified natural-cycle
115662|NCT02571543|nonsteroidal anti-inflammatory drug (NSAID)|nonsteroidal anti-inflammatory drug (nsaid)
115663|NCT02571543|Anti-Inflammatory Agents, Non-Steroidal/therapeutic use|anti-inflammatory agents, non-steroidal/therapeutic use
115664|NCT02571543|Oocyte Retrieval|oocyte retrieval
115665|NCT02571543|Ovarian Follicle/drug effects|ovarian follicle/drug effects
115666|NCT02571517|Respiratory viral infection.|respiratory viral infection.
115667|NCT02571517|Respiratory syncytial virus bronchiolitis|respiratory syncytial virus bronchiolitis
115668|NCT02571517|METHYLPREDNISOLONE SODIUM SUCCINATE|methylprednisolone sodium succinate
115669|NCT02571504|HIV - Human Immunodeficiency Virus|hiv - human immunodeficiency virus
115670|NCT02571504|Memory|memory
115671|NCT02571504|Concentration|concentration
115672|NCT02571478|Military Couples|military couples
115673|NCT02571478|Marriage|marriage
115674|NCT02571478|Primary Care|primary care
115675|NCT02571478|Marriage Intervention|marriage intervention
115676|NCT02571478|Air Force|air force
115677|NCT02571465|functional hemodynamic parameter|functional hemodynamic parameter
115678|NCT02571465|passive leg raising|passive leg raising
115679|NCT02571465|stroke volume variation|stroke volume variation
648349|NCT00771212|Pain|pain
115680|NCT02571465|pulse pressure variation|pulse pressure variation
115683|NCT02571452|Primary Healthcare|primary healthcare
115684|NCT02571439|TAP block, post-cesarean analgesia|tap block, post-cesarean analgesia
115685|NCT02571413|animated cartoon-aided teaching|animated cartoon-aided teaching
115686|NCT02571413|oral presentation|oral presentation
115687|NCT02571413|allergic rhinitis|allergic rhinitis
115688|NCT02571413|intranasal corticosteroid|intranasal corticosteroid
115689|NCT02571413|how to use intranasal corticosteroid|how to use intranasal corticosteroid
115690|NCT02571400|Risk|risk
106780|NCT02625272|no touch isolation|no touch isolation
106781|NCT02625272|recurrence|recurrence
106782|NCT02625272|overall survival|overall survival
115691|NCT02571400|Opioid analgesics|opioid analgesics
115692|NCT02571400|Opioid-related disorders|opioid-related disorders
115693|NCT02571400|Surgery|surgery
115694|NCT02571400|Post-operative care|post-operative care
115695|NCT02571400|Post-operative period|post-operative period
115696|NCT02571400|Post-operative complications|post-operative complications
115697|NCT02571400|Opioid Use disorders|opioid use disorders
115698|NCT02571400|Pain, post-operative|pain, post-operative
115699|NCT02571400|Opiate Addiction|opiate addiction
115700|NCT02571387|Motivation|motivation
115701|NCT02571387|Impulsive eating|impulsive eating
115702|NCT02571387|Mindfulness|mindfulness
115703|NCT02571387|Self-help|self-help
115704|NCT02571387|Physical activity|physical activity
115705|NCT02571387|Weight-loss|weight-loss
115706|NCT02571374|symbiotic|symbiotic
115707|NCT02571374|colorectal cancer|colorectal cancer
115708|NCT02571361|Acetaminophen|acetaminophen
115709|NCT02571361|Ibuprofen|ibuprofen
115710|NCT02571361|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
115711|NCT02571309|Self-management|self-management
115712|NCT02571309|Asthma|asthma
115713|NCT02571309|Patient education|patient education
115714|NCT02571309|Health literacy|health literacy
115715|NCT02571309|Health-related quality of life|health-related quality of life
115716|NCT02571309|Asthma control|asthma control
115717|NCT02571309|Adherence|adherence
115718|NCT02571296|Preterm Birth|preterm birth
115719|NCT02571296|Oral Micronized Progesterone|oral micronized progesterone
115720|NCT02571283|Total Knee Arthroplasty|total knee arthroplasty
115721|NCT02571283|Total Knee Replacement|total knee replacement
115722|NCT02571283|Exparel|exparel
115723|NCT02571283|Cocktail Injection|cocktail injection
115724|NCT02571283|Pain Management|pain management
115725|NCT02571270|Exercise|exercise
115726|NCT02571270|quality of life|quality of life
115727|NCT02571270|healthy|healthy
115728|NCT02571270|cardiac remodeling|cardiac remodeling
115729|NCT02571257|LDL-C|ldl-c
115730|NCT02571257|Lipid Regulator|lipid regulator
115731|NCT02571244|Tobacco Use Disorder|tobacco use disorder
115732|NCT02571244|Hospitalized patients|hospitalized patients
115733|NCT02571244|Text message|text message
115734|NCT02571244|Motivational Interview|motivational interview
115735|NCT02571244|Substance-Related Disorders|substance-related disorders
115736|NCT02571244|Behaviors and Mental Disorders|behaviors and mental disorders
115737|NCT02571218|atrial fibrillation|atrial fibrillation
115738|NCT02571218|mapping|mapping
115739|NCT02571218|substrate|substrate
115740|NCT02571218|ablation|ablation
115741|NCT02571205|testosterone|testosterone
115742|NCT02571205|pubertal delay|pubertal delay
115743|NCT02571192|ADME|adme
115744|NCT02571179|Labor pain|labor pain
115745|NCT02571179|Fentanyl|fentanyl
115746|NCT02571179|Transmucosal|transmucosal
115747|NCT02571153|Intravenous anesthesia|intravenous anesthesia
115748|NCT02571153|Postoperative nausea vomiting|postoperative nausea vomiting
115749|NCT02571153|Postoperative pain|postoperative pain
115750|NCT02571153|Patient satisfaction|patient satisfaction
115751|NCT02571153|Quality of health care|quality of health care
115752|NCT02571153|Ketamine|ketamine
115753|NCT02571114|Glycemic Responses|glycemic responses
115754|NCT02571114|Metabolic Responses|metabolic responses
115755|NCT02571114|Males|males
115756|NCT02571114|Females|females
115757|NCT02571101|Clomipramine|clomipramine
115758|NCT02571101|Premature ejaculation|premature ejaculation
115759|NCT02571101|CDFR0812|cdfr0812
115760|NCT02571101|Sildenafil|sildenafil
115761|NCT02571088|Sickle Cell Hemoglobin C Disease|sickle cell hemoglobin c disease
115762|NCT02571088|Sports Training|sports training
115763|NCT02571088|Hemoglobin S Disease|hemoglobin s disease
115764|NCT02571088|Lactate|lactate
115765|NCT02571075|auricular|auricular
115766|NCT02571075|acupuncture|acupuncture
115767|NCT02571075|pain|pain
115768|NCT02571062|bioequivalence|bioequivalence
115769|NCT02571036|Gastrointestinal stromal tumors (GIST)|gastrointestinal stromal tumors (gist)
115770|NCT02571036|systemic mastocytosis (SM)|systemic mastocytosis (sm)
115771|NCT02571036|PDGFR-alpha|pdgfr-alpha
115772|NCT02571036|KIT|kit
115773|NCT02571036|mast cell leukemia (MCL)|mast cell leukemia (mcl)
115774|NCT02571036|mast cell disease (MCD)|mast cell disease (mcd)
115775|NCT02571036|DCC-2618|dcc-2618
115776|NCT02571036|melanoma|melanoma
115777|NCT02571036|aggressive systemic mastocytosis (ASM)|aggressive systemic mastocytosis (asm)
115778|NCT02571023|Skull Base Trauma|skull base trauma
115779|NCT02571023|microscope surgery|microscope surgery
115780|NCT02571023|neuroendoscope surgery|neuroendoscope surgery
115781|NCT02571010|static mechanical allodynia|static mechanical allodynia
115782|NCT02571010|somatosensory rehabilitation|somatosensory rehabilitation
115783|NCT02571010|vibrotactile stimulation|vibrotactile stimulation
115784|NCT02570997|Alzheimer's Disease|alzheimer's disease
115785|NCT02570997|Mild Cognitive Impairment|mild cognitive impairment
115786|NCT02570971|mannitol|mannitol
115787|NCT02570971|treatment|treatment
115788|NCT02570958|robotic surgery|robotic surgery
115789|NCT02570958|indocyanine green|indocyanine green
115790|NCT02570958|electromagnetic navigational bronchoscopy|electromagnetic navigational bronchoscopy
115791|NCT02570932|Adult Autologous Bone Marrow Mesenchymal Cells Expanded|adult autologous bone marrow mesenchymal cells expanded
115792|NCT02570932|chronic spinal cord injury (SCI)|chronic spinal cord injury (sci)
115793|NCT02570919|Prostate cancer|prostate cancer
115794|NCT02570919|IGRT|igrt
115795|NCT02570919|Hypofractionation|hypofractionation
115796|NCT02570919|Extreme|extreme
115797|NCT02570919|Single Fraction|single fraction
115798|NCT02570919|Urethral Sparing|urethral sparing
115799|NCT02570919|MRI|mri
115800|NCT02570893|Esophageal cancer;adjuvant therapy;chemotherapy;radiotherapy|esophageal cancer;adjuvant therapy;chemotherapy;radiotherapy
115801|NCT02570867|glaucoma|glaucoma
115802|NCT02570867|brain function|brain function
115803|NCT02570867|fMRI|fmri
115804|NCT02570854|Anemia|anemia
115805|NCT02570841|Heat pain threshold|heat pain threshold
115806|NCT02570841|Cold pain threshold|cold pain threshold
115807|NCT02570841|Mechanical pain threshold|mechanical pain threshold
115808|NCT02570841|High dose Capsaicin|high dose capsaicin
115809|NCT02570828|healthy neonate, tachypnea, thermal imaging, pneumonia|healthy neonate, tachypnea, thermal imaging, pneumonia
115810|NCT02570815|lung cancer|lung cancer
115811|NCT02570815|segmentectomy|segmentectomy
115812|NCT02570815|robotic surgery|robotic surgery
115813|NCT02570815|near-infrared fluorescent|near-infrared fluorescent
115814|NCT02570815|IC-GREEN|ic-green
115815|NCT02570815|indocyanine green|indocyanine green
115816|NCT02570815|early-stage lung cancer|early-stage lung cancer
115817|NCT02570776|Helicobacter pylori|helicobacter pylori
115818|NCT02570776|UBT|ubt
115819|NCT02570776|Sensitivity|sensitivity
115820|NCT02570776|specificity|specificity
115821|NCT02570776|prevalence|prevalence
115822|NCT02570763|neurostimulation|neurostimulation
115823|NCT02570763|comorbidity|comorbidity
115824|NCT02570763|tDCS|tdcs
115825|NCT02570763|CBT|cbt
115826|NCT02570763|anxiety|anxiety
115827|NCT02570763|alcohol|alcohol
115828|NCT02570685|Gratitude Intervention|gratitude intervention
115829|NCT02570685|positive emotion|positive emotion
115830|NCT02570685|friendships|friendships
115831|NCT02570685|positive psychology|positive psychology
115832|NCT02570685|life satisfaction|life satisfaction
115833|NCT02570659|WAD|wad
115834|NCT02570659|Whiplash|whiplash
115835|NCT02570659|Information Video|information video
115836|NCT02570633|Migraine|migraine
115837|NCT02570633|Ginger|ginger
115838|NCT02570633|Prophylactic treatment|prophylactic treatment
115839|NCT02570594|Cognition|cognition
115840|NCT02570594|Autobiographical|autobiographical
115841|NCT02570594|memoryCognitive|memorycognitive
115842|NCT02570594|remediation|remediation
115843|NCT02570581|volonteeres|volonteeres
115844|NCT02570568|Venepuncture|venepuncture
115845|NCT02570568|Transillumination|transillumination
115846|NCT02570555|driving|driving
115847|NCT02570542|CD34+ Cell Dose|cd34+ cell dose
115848|NCT02570542|Autologous Stem Cell Transplantation|autologous stem cell transplantation
115849|NCT02570542|15-193|15-193
115850|NCT02570529|Pancreatic cancer|pancreatic cancer
115851|NCT02570529|Chemoradiotherapy|chemoradiotherapy
115852|NCT02570529|Gastrointestinal toxicity|gastrointestinal toxicity
115853|NCT02570529|Albis|albis
115854|NCT02570516|Indigo carmine chromoendoscopy|indigo carmine chromoendoscopy
115855|NCT02570516|Narrow band imaging|narrow band imaging
115856|NCT02570516|Colonoscopy|colonoscopy
115857|NCT02570490|fusidic acid|fusidic acid
115858|NCT02570490|skin infection|skin infection
115859|NCT02570451|cognitive impairment|cognitive impairment
115860|NCT02570451|post surgical outcomes|post surgical outcomes
115861|NCT02570451|elective joint replacement surgery|elective joint replacement surgery
115862|NCT02570438|postoperative outcomes|postoperative outcomes
115863|NCT02570438|older surgical patients|older surgical patients
115864|NCT02570386|In-vitro fertilization|in-vitro fertilization
115865|NCT02570386|frozen thawed embryo transfer|frozen thawed embryo transfer
115866|NCT02570386|fresh embryo transfer|fresh embryo transfer
115867|NCT02570373|Healthy|healthy
115868|NCT02570373|Guselkumab|guselkumab
115869|NCT02570347|Snake Envenomation|snake envenomation
115870|NCT02570347|Antibiotic Prophylaxis|antibiotic prophylaxis
115871|NCT02570347|Viperidae|viperidae
115872|NCT02570334|early ART|early art
115873|NCT02570334|neurocognitive evaluation|neurocognitive evaluation
115874|NCT02570321|Cornea|cornea
115875|NCT02570321|Ulcer|ulcer
115876|NCT02570321|Infectious keratitis|infectious keratitis
115877|NCT02570321|Bacterial|bacterial
115878|NCT02570321|Fungal|fungal
115879|NCT02570295|Army|army
115880|NCT02570295|Sport|sport
115881|NCT02570295|Physical Fitness|physical fitness
115882|NCT02570295|Injuries|injuries
115883|NCT02570295|Psychological Tests|psychological tests
115884|NCT02570295|Attrition|attrition
115885|NCT02570282|Female|female
115886|NCT02570256|stroke|stroke
115887|NCT02570256|upper extremity|upper extremity
115888|NCT02570256|motor exploration|motor exploration
115889|NCT02570256|error augmentation|error augmentation
115890|NCT02570256|robotic rehabilitation|robotic rehabilitation
115891|NCT02570243|heparin|heparin
115892|NCT02570243|radial artery|radial artery
115893|NCT02570230|Thoracotomy|thoracotomy
115894|NCT02570230|Postoperative pain|postoperative pain
115895|NCT02570230|Ketamine|ketamine
115896|NCT02570217|NCPAP, High Flow Nasal Cannula, pretem infants, NICU|ncpap, high flow nasal cannula, pretem infants, nicu
115897|NCT02570178|clinical trial|clinical trial
115898|NCT02570178|accidental falls|accidental falls
115899|NCT02570178|postural balance|postural balance
115900|NCT02570178|elderly|elderly
115901|NCT02570178|primary Health Care|primary health care
115902|NCT02570165|efficacy|efficacy
115903|NCT02570165|dry powder inhaler|dry powder inhaler
115904|NCT02570165|vilanterol|vilanterol
115905|NCT02570165|batefenterol|batefenterol
115906|NCT02570152|Dengue|dengue
115907|NCT02570152|Non-laboratory confirmed dengue (non-LCD)|non-laboratory confirmed dengue (non-lcd)
115908|NCT02570152|Acute febrile illness (AFI)|acute febrile illness (afi)
115909|NCT02570152|Laboratory confirmed dengue (LCD)|laboratory confirmed dengue (lcd)
115910|NCT02570126|Immunogenicity|immunogenicity
115911|NCT02570126|Varicella|varicella
115912|NCT02570126|Safety|safety
115913|NCT02570126|Human serum albumin|human serum albumin
115914|NCT02570126|Healthy children|healthy children
115915|NCT02570126|12 to 23 months|12 to 23 months
115916|NCT02570100|Cancer Stem Cells|cancer stem cells
115917|NCT02570087|Coronary ChronicTotal Occlusion|coronary chronictotal occlusion
115918|NCT02570087|Coronary Angioplasty|coronary angioplasty
115919|NCT02570087|Reduced Ejection Fraction|reduced ejection fraction
115920|NCT02570061|recruitment|recruitment
115921|NCT02570061|comprehension|comprehension
115922|NCT02570061|satisfaction|satisfaction
115923|NCT02570061|informed consent|informed consent
115924|NCT02570061|telephone|telephone
115925|NCT02570035|Mirabegron|mirabegron
115926|NCT02570035|Overactive Bladder|overactive bladder
115927|NCT02570035|Cardiovascular Disease|cardiovascular disease
115928|NCT02570022|Pain control|pain control
115929|NCT02570022|liposomal bupivacaine|liposomal bupivacaine
115930|NCT02570022|exparel|exparel
115931|NCT02570022|shoulder arthroplasty|shoulder arthroplasty
115932|NCT02570009|couples|couples
115933|NCT02570009|weight loss treatment|weight loss treatment
115934|NCT02570009|home environment|home environment
115935|NCT02569970|Epilepsy|epilepsy
115936|NCT02569970|SUDEP|sudep
115937|NCT02569970|fluoxetine|fluoxetine
115938|NCT02569970|placebo|placebo
115939|NCT02569970|SpO2|spo2
115940|NCT02569918|Neuroplasticity|neuroplasticity
115941|NCT02569918|Sensory Feedback|sensory feedback
115942|NCT02569918|Transcutaneous electrical stimulation|transcutaneous electrical stimulation
115943|NCT02569918|Robotic hand|robotic hand
115944|NCT02569905|flurbiprofen|flurbiprofen
115945|NCT02569905|Parecoxib sodium|parecoxib sodium
115946|NCT02569905|Postoperative Shivering|postoperative shivering
115947|NCT02569879|Boostrix™|boostrix™
115948|NCT02569879|Bagota|bagota
115953|NCT02569866|plastic surgery|plastic surgery
115954|NCT02569866|mammaplasty|mammaplasty
115955|NCT02569866|wound infection|wound infection
115956|NCT02569866|prophylaxis|prophylaxis
115957|NCT02569827|Uncomplicated Dengue Fever|uncomplicated dengue fever
115958|NCT02569827|Treatment|treatment
115959|NCT02569827|Phase Ib/IIa|phase ib/iia
115960|NCT02569827|single centre|single centre
115961|NCT02569827|double-blind|double-blind
115962|NCT02569827|placebo-controlled|placebo-controlled
115963|NCT02569827|parallel-group dose ranging trial|parallel-group dose ranging trial
115964|NCT02569827|Modipafant|modipafant
115965|NCT02569827|Celgosivir|celgosivir
115966|NCT02569788|re-irradiation|re-irradiation
115967|NCT02569788|carbon ion radiotherapy|carbon ion radiotherapy
115968|NCT02569775|Cerebral Palsy|cerebral palsy
115969|NCT02569775|Stem Cells|stem cells
115970|NCT02569762|Non-Nutritive Sweeteners|non-nutritive sweeteners
115971|NCT02569762|Artificial Sweeteners|artificial sweeteners
115972|NCT02569762|Glucose Metabolism|glucose metabolism
115973|NCT02569762|Microbiota|microbiota
115974|NCT02569762|Dysbiosis|dysbiosis
115975|NCT02569671|Dental Implants, Single-Tooth|dental implants, single-tooth
115976|NCT02569645|Rectal cancer|rectal cancer
115977|NCT02569645|Rosuvastatin|rosuvastatin
115978|NCT02569632|Meningococcal Vaccines|meningococcal vaccines
648552|NCT00772070|Meningitis|meningitis
115979|NCT02569632|Neisseria Meningitidis|neisseria meningitidis
115980|NCT02569632|Factor H-binding Protein|factor h-binding protein
115981|NCT02569619|Physical Activity|physical activity
115982|NCT02569619|Mental Health|mental health
115983|NCT02569619|Physical Exercise|physical exercise
116179|NCT02568644|Migraine|migraine
115984|NCT02569619|Mental disorder|mental disorder
115985|NCT02569619|Promotion|promotion
107086|NCT02623595|safety|safety
115986|NCT02569606|consumption of blood|consumption of blood
115987|NCT02569606|consumption of coagulation products|consumption of coagulation products
115988|NCT02569606|coagulation algorithm|coagulation algorithm
115989|NCT02569606|trauma related transfusion|trauma related transfusion
115990|NCT02569580|anti-lice treatment|anti-lice treatment
115991|NCT02569567|Smart-Shear Wave(SSW)|smart-shear wave(ssw)
115992|NCT02569567|Transient Elastography(TE)|transient elastography(te)
115993|NCT02569567|Liver cirrhosis|liver cirrhosis
115994|NCT02569554|PF-06463922|pf-06463922
115995|NCT02569554|rabeprazole|rabeprazole
115996|NCT02569554|proton pump inhibitor (PPI)|proton pump inhibitor (ppi)
115997|NCT02569554|pharmacokinetics(PK)|pharmacokinetics(pk)
115998|NCT02569554|food effect|food effect
115999|NCT02569541|fusidic acid|fusidic acid
116000|NCT02569541|prosthetic joint infections|prosthetic joint infections
116001|NCT02569541|bone infections|bone infections
116002|NCT02569541|osteomyelitis|osteomyelitis
116003|NCT02569528|atrial fibrillation|atrial fibrillation
116004|NCT02569528|anticoagulation|anticoagulation
116005|NCT02569476|BGB-3111|bgb-3111
116006|NCT02569476|Obinutuzumab|obinutuzumab
116007|NCT02569476|B-cell|b-cell
116008|NCT02569476|Lymphoma|lymphoma
116009|NCT02569476|Leukemia|leukemia
116010|NCT02569476|Therapeutic uses|therapeutic uses
116011|NCT02569450|Surgery|surgery
116012|NCT02569450|Performance|performance
116013|NCT02569450|Outcome|outcome
116014|NCT02569450|Control chart|control chart
116015|NCT02569437|doxycycline|doxycycline
116016|NCT02569437|oral methylprednisone|oral methylprednisone
116017|NCT02569437|sinusitis with nasal polyps|sinusitis with nasal polyps
116018|NCT02569424|PEEP level|peep level
116019|NCT02569424|Trendelenburg position|trendelenburg position
116020|NCT02569424|cross-sectional area of the jugular and subclavian veins|cross-sectional area of the jugular and subclavian veins
116021|NCT02569424|central venous catheter|central venous catheter
116022|NCT02569398|Alzheimer disease|alzheimer disease
116023|NCT02569398|JNJ-54861911|jnj-54861911
116024|NCT02569398|Dementia|dementia
116025|NCT02569385|Weaning TTE|weaning tte
116026|NCT02569385|patients in prolonged weaning|patients in prolonged weaning
116027|NCT02569346|Triumeq|triumeq
116028|NCT02569346|Pharmacokinetics|pharmacokinetics
116029|NCT02569346|Crushing|crushing
116030|NCT02569346|Drip feed|drip feed
116031|NCT02569333|ulcerative colitis|ulcerative colitis
116032|NCT02569333|inflammatory bowel disease|inflammatory bowel disease
116033|NCT02569333|education|education
116034|NCT02569333|patient-reported outcomes|patient-reported outcomes
116035|NCT02569307|At Risk of Mental State|at risk of mental state
116036|NCT02569307|Prodromal Phase|prodromal phase
116037|NCT02569307|Psychosis|psychosis
116038|NCT02569294|group interventions|group interventions
116039|NCT02569294|emotional distress|emotional distress
116040|NCT02569294|breast cancer|breast cancer
116041|NCT02569294|yoga|yoga
116042|NCT02569294|hypnosis|hypnosis
116874|NCT02564484|Cancer Therapy|cancer therapy
116043|NCT02569294|cognitive-behavioral therapy|cognitive-behavioral therapy
116044|NCT02569281|Subacromial pain syndrome|subacromial pain syndrome
116045|NCT02569281|Eccentric exercise|eccentric exercise
116046|NCT02569281|Pressure pain|pressure pain
116047|NCT02569281|US-guided percutaneous electrolysis|us-guided percutaneous electrolysis
116048|NCT02569268|Arteriosclerosis|arteriosclerosis
116049|NCT02569268|Vascular function|vascular function
116050|NCT02569268|Vascular disease early detection system|vascular disease early detection system
116051|NCT02569229|children|children
116052|NCT02569229|cystic fibrosis|cystic fibrosis
116053|NCT02569229|glucose intolerance|glucose intolerance
116054|NCT02569229|continuous glucose measurement|continuous glucose measurement
116055|NCT02569216|Electrical Inhibition|electrical inhibition
116056|NCT02569216|Preterm Birth|preterm birth
116057|NCT02569216|Premature Birth|premature birth
116058|NCT02569216|Preterm Labor|preterm labor
116059|NCT02569216|Premature Labor|premature labor
116060|NCT02569216|tocolytic|tocolytic
116062|NCT02569177|myocardial infarction|myocardial infarction
116063|NCT02569177|cardiac surgery|cardiac surgery
116064|NCT02569177|troponin|troponin
116065|NCT02569177|heart-type fatty acid binding protein|heart-type fatty acid binding protein
116066|NCT02569138|Balance|balance
116067|NCT02569138|Footwear|footwear
116068|NCT02569138|Shoes|shoes
116069|NCT02569138|Falls|falls
116070|NCT02569125|segmental overgrowth syndrome|segmental overgrowth syndrome
116071|NCT02569099|stroke survivors|stroke survivors
116072|NCT02569099|caregivers|caregivers
116073|NCT02569099|burden of care|burden of care
116074|NCT02569099|quality of life|quality of life
116075|NCT02569099|function|function
116076|NCT02569099|community reintegration|community reintegration
116077|NCT02569099|caregiver training|caregiver training
116078|NCT02569073|Functional Chest Pain|functional chest pain
116079|NCT02569073|Non-Cardiac Chest Pain|non-cardiac chest pain
116080|NCT02569073|Esophageal Hypersensitivity|esophageal hypersensitivity
138882|NCT02433158|SCD|scd
116081|NCT02569060|diabetes mellitus|diabetes mellitus
116082|NCT02569060|community intervention|community intervention
116083|NCT02569060|intervention|intervention
116084|NCT02569060|randomized|randomized
116085|NCT02569060|dietary intervention|dietary intervention
116086|NCT02569060|self-management support|self-management support
116087|NCT02569060|food bank|food bank
116088|NCT02569047|Atraumatic Restorative Treatment|atraumatic restorative treatment
116089|NCT02569047|Occlusoproximal|occlusoproximal
116090|NCT02569047|Primary Teeth|primary teeth
116091|NCT02569047|Glass Ionomer Cements|glass ionomer cements
116092|NCT02569047|Hall Technique|hall technique
116093|NCT02569021|Parkinsons Disease|parkinsons disease
116094|NCT02569021|Essential Tremor|essential tremor
116095|NCT02569021|DBS|dbs
116096|NCT02569021|Depp Brain Stimulation|depp brain stimulation
116097|NCT02569008|Fluid Challenge|fluid challenge
116098|NCT02569008|Mean systemic filling pressure|mean systemic filling pressure
116099|NCT02569008|Fluid therapy|fluid therapy
116100|NCT02568995|postoperative pain|postoperative pain
116101|NCT02568995|morphine|morphine
116102|NCT02568995|total hip arthroplasty|total hip arthroplasty
116103|NCT02568995|femoral nerve block|femoral nerve block
116104|NCT02568982|Cushing's disease|cushing's disease
116105|NCT02568982|Quality of life|quality of life
116106|NCT02568982|Metabolic|metabolic
116107|NCT02568982|patients with Cushing's disease|patients with cushing's disease
116108|NCT02568982|cardiovascular|cardiovascular
116109|NCT02568982|thromboembolic|thromboembolic
116110|NCT02568982|bone complications|bone complications
116111|NCT02568969|Cardiosurgery, lactate|cardiosurgery, lactate
116112|NCT02568943|multiple myelome, MM, expanded treatment, panobinostat, bortezomib, dexamethasone, relapsed, refractory, LBH589|multiple myelome, mm, expanded treatment, panobinostat, bortezomib, dexamethasone, relapsed, refractory, lbh589
116113|NCT02568930|quality of life heart failure mechanical support transplant|quality of life heart failure mechanical support transplant
116114|NCT02568917|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
116115|NCT02568917|Composite Resins|composite resins
116116|NCT02568917|Primary Teeth|primary teeth
116117|NCT02568917|Permanent Teeth|permanent teeth
116118|NCT02568917|Clinical Effectiveness|clinical effectiveness
116119|NCT02568917|Cost Analysis|cost analysis
116120|NCT02568878|Depression|depression
116121|NCT02568878|Anxiety|anxiety
116122|NCT02568878|Methamphetamine dependence|methamphetamine dependence
116123|NCT02568852|D-dimer|d-dimer
116124|NCT02568852|Fibrinogen|fibrinogen
116125|NCT02568852|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
116126|NCT02568839|Neoadjuvant therapy|neoadjuvant therapy
116127|NCT02568826|Low Back Pain|low back pain
116128|NCT02568826|Muscle relaxant|muscle relaxant
116129|NCT02568813|epilepsy|epilepsy
116130|NCT02568813|depression|depression
116131|NCT02568813|mood disorder|mood disorder
116132|NCT02568813|anxiety|anxiety
116133|NCT02568813|cyclothymia|cyclothymia
116134|NCT02568813|Behavioral neuropsychiatric features|behavioral neuropsychiatric features
116135|NCT02568787|NAFLD|nafld
116136|NCT02568787|cytokines|cytokines
116137|NCT02568787|interleukin (IL)|interleukin (il)
116138|NCT02568787|interferon (IFN)|interferon (ifn)
116139|NCT02568787|liver function test (LFTS)|liver function test (lfts)
116140|NCT02568787|nutrition|nutrition
116141|NCT02568787|bran arabinoxylan compound (RBAC)|bran arabinoxylan compound (rbac)
116271|NCT02568228|Fish|fish
116142|NCT02568787|tumor necrosis factor -- type I receptor (TNF-RI)|tumor necrosis factor -- type i receptor (tnf-ri)
116143|NCT02568787|TNF-RII (tumor necrosis factor -- type II receptor (TNF-RII)|tnf-rii (tumor necrosis factor -- type ii receptor (tnf-rii)
116144|NCT02568774|Post-stroke|post-stroke
116145|NCT02568761|Snoring|snoring
116146|NCT02568761|Sleep apnea|sleep apnea
116147|NCT02568761|Obstructive sleep apnea|obstructive sleep apnea
116148|NCT02568761|Speech therapy|speech therapy
116149|NCT02568761|Injection snoreplasty|injection snoreplasty
116150|NCT02568761|Ethanol|ethanol
116151|NCT02568761|Oropharyngeal exercises|oropharyngeal exercises
116152|NCT02568735|Dexketoprofen|dexketoprofen
116153|NCT02568735|Etoricoxib|etoricoxib
116154|NCT02568735|hip arthroplasty|hip arthroplasty
116155|NCT02568735|pain|pain
116156|NCT02568722|Renal replacement therapy|renal replacement therapy
116157|NCT02568722|Acute kidney injury|acute kidney injury
116158|NCT02568722|Dialysis|dialysis
116159|NCT02568722|Hemodialysis|hemodialysis
116160|NCT02568722|Critical illness|critical illness
116161|NCT02568709|Oxytocin|oxytocin
116162|NCT02568709|Syntocinon|syntocinon
116163|NCT02568709|Social Cognition|social cognition
116164|NCT02568709|Schizophrenia|schizophrenia
116165|NCT02568709|Magnetoencephalography (MEG)|magnetoencephalography (meg)
116166|NCT02568696|kidney transplantation|kidney transplantation
116167|NCT02568696|renal transplantation|renal transplantation
116203|NCT02568514|text messaging|text messaging
116204|NCT02568514|secure text messaging|secure text messaging
116205|NCT02568514|communication|communication
116206|NCT02568501|diabetes|diabetes
116207|NCT02568501|adolescent|adolescent
116208|NCT02568501|young adult|young adult
116209|NCT02568501|behavioral economics|behavioral economics
116210|NCT02568501|financial incentives|financial incentives
116211|NCT02568501|social incentives|social incentives
116212|NCT02568475|nursing home residents, decision aid, acute care transfers|nursing home residents, decision aid, acute care transfers
116213|NCT02568462|Stents|stents
116214|NCT02568462|Angioplasty|angioplasty
116215|NCT02568462|Coronary Vessels|coronary vessels
116216|NCT02568462|Coronary Artery Disease|coronary artery disease
116217|NCT02568462|Angina Pectoris|angina pectoris
116218|NCT02568462|Myocardial Ischemia|myocardial ischemia
116219|NCT02568462|Myocardial Infarction|myocardial infarction
116220|NCT02568462|Myocardial Revascularization|myocardial revascularization
116221|NCT02568410|Mast Cells|mast cells
116222|NCT02568410|Blood Platelets|blood platelets
116223|NCT02568410|cardiac surgical procedures|cardiac surgical procedures
116224|NCT02568371|biobank|biobank
116226|NCT02568371|genetic|genetic
116227|NCT02568371|young adults|young adults
116228|NCT02568371|cohort study|cohort study
116229|NCT02568345|Dose-Response Relationship|dose-response relationship
116230|NCT02568345|Drug|drug
116231|NCT02568345|Obesity|obesity
116232|NCT02568345|Cyclodextrins|cyclodextrins
116265|NCT02568241|Interferon Alfa-2b|interferon alfa-2b
116266|NCT02568241|Relapse|relapse
116267|NCT02568241|Donor lymphocyte infusion|donor lymphocyte infusion
116268|NCT02568228|Triacylglycerols|triacylglycerols
116269|NCT02568228|Omega-3 fatty acids|omega-3 fatty acids
116270|NCT02568228|Krill oil|krill oil
116272|NCT02568228|Healthy Volunteers|healthy volunteers
116273|NCT02568215|HIV-1 Infections|hiv-1 infections
116274|NCT02568189|Sepsis|sepsis
116275|NCT02568189|Gastroenteritis|gastroenteritis
116276|NCT02568189|Dehydration|dehydration
116277|NCT02568189|Ultrasound|ultrasound
116278|NCT02568189|Ultrasonography|ultrasonography
116279|NCT02568189|Inferior Vena Cava|inferior vena cava
116280|NCT02568176|Healthy|healthy
116281|NCT02568176|Pharmacokinetics|pharmacokinetics
116282|NCT02568176|Esketamine|esketamine
116283|NCT02568176|JNJ-54135419|jnj-54135419
116284|NCT02568176|Midazolam|midazolam
116285|NCT02568176|Bupropion|bupropion
116286|NCT02568137|mobile health|mobile health
116287|NCT02568137|Behavior change|behavior change
116288|NCT02568137|Africa|africa
116289|NCT02568124|Tranexamic acid|tranexamic acid
116290|NCT02568124|Cyklokapron|cyklokapron
116291|NCT02568124|Conservative management|conservative management
116292|NCT02568124|Medical management|medical management
116293|NCT02568111|erythema|erythema
116294|NCT02568111|PLEGRIDY|plegridy
116295|NCT02568111|injection site reaction (ISR)|injection site reaction (isr)
116296|NCT02568111|MS|ms
116297|NCT02568111|RRMS|rrms
116298|NCT02568098|Drug combination|drug combination
116299|NCT02568098|Ivermectin|ivermectin
116300|NCT02568098|Primaquine|primaquine
116301|NCT02568098|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
116302|NCT02568098|Albendazole|albendazole
116303|NCT02568098|Pharmacokinetics|pharmacokinetics
116304|NCT02568098|Mosquito-Lethal Effect|mosquito-lethal effect
116305|NCT02568098|Healthy adult subject|healthy adult subject
116306|NCT02568072|exercise|exercise
116309|NCT02568046|Metastatic Colorectal Cancer|metastatic colorectal cancer
116310|NCT02567981|chronic undernutrition|chronic undernutrition
116311|NCT02567981|anemia|anemia
116312|NCT02567981|micronutrient supplement|micronutrient supplement
116313|NCT02567955|HPV vaccines, interchangeable use|hpv vaccines, interchangeable use
116314|NCT02567877|hypothyroidism|hypothyroidism
116315|NCT02567877|deiodinase polymorphism|deiodinase polymorphism
116316|NCT02567877|cognitive function|cognitive function
116317|NCT02567877|thyroidectomy|thyroidectomy
116318|NCT02567877|levothyroxine|levothyroxine
116319|NCT02567851|Brentuximab Vedotin|brentuximab vedotin
116320|NCT02567851|PET scans|pet scans
116321|NCT02567851|Lymphoma|lymphoma
116322|NCT02567825|ear infection|ear infection
116323|NCT02567825|antibiotics|antibiotics
116324|NCT02567825|infants|infants
116325|NCT02567825|children|children
116326|NCT02567825|pediatrics|pediatrics
116327|NCT02567825|tympanostomy tubes|tympanostomy tubes
116328|NCT02567799|Lung Neoplasms|lung neoplasms
116329|NCT02567773|Itraconazole|itraconazole
116330|NCT02567773|GSK2881078|gsk2881078
116331|NCT02567773|CYP3A4|cyp3a4
116332|NCT02567773|Selective Androgen Receptor Modulator|selective androgen receptor modulator
116333|NCT02567773|Safety|safety
116334|NCT02567773|Pharmacokinetics|pharmacokinetics
116335|NCT02567773|Tolerability|tolerability
116336|NCT02567760|MP1|mp1
116337|NCT02567760|cognitive enhancing effect|cognitive enhancing effect
116338|NCT02567760|menopausal women|menopausal women
116339|NCT02567747|Colombia|colombia
116340|NCT02567747|otitis|otitis
116341|NCT02567747|Database|database
116342|NCT02567747|pneumonia|pneumonia
116343|NCT02567734|irreversible electroporation|irreversible electroporation
116344|NCT02567734|ablation|ablation
116345|NCT02567734|neoplasms|neoplasms
116346|NCT02567734|cancer|cancer
116347|NCT02567734|carcinoma|carcinoma
116348|NCT02567734|NanoKnife|nanoknife
116349|NCT02567734|Ablation Techniques|ablation techniques
116350|NCT02567721|Post-authorisation safety study (PASS)|post-authorisation safety study (pass)
116351|NCT02567721|Adverse Drug Reaction Reporting Systems|adverse drug reaction reporting systems
116352|NCT02567721|Post marketing product surveillance|post marketing product surveillance
116353|NCT02567721|European Medicines Agency (EMA)|european medicines agency (ema)
116354|NCT02567721|Influenza Vaccine|influenza vaccine
116355|NCT02567721|Computerized Medical Record System|computerized medical record system
116356|NCT02567721|United Kingdom|united kingdom
116357|NCT02567721|Primary Health Care|primary health care
116358|NCT02567708|GSK2269557|gsk2269557
116359|NCT02567708|Asthma|asthma
116360|NCT02567708|Pharmacokinetics|pharmacokinetics
116361|NCT02567708|Safety|safety
116362|NCT02567708|Adults|adults
116363|NCT02567708|DISKUS Dry Powder Inhaler|diskus dry powder inhaler
116364|NCT02567708|Efficacy|efficacy
116365|NCT02567682|anemia, sickle cell|anemia, sickle cell
116366|NCT02567669|radiotherapy|radiotherapy
116367|NCT02567656|CTCL|ctcl
116368|NCT02567656|PTCL|ptcl
116369|NCT02567656|RP6530|rp6530
116370|NCT02567643|Brain|brain
116371|NCT02567643|CNS|cns
116372|NCT02567643|Metastases|metastases
116373|NCT02567630|Cerebral Palsy|cerebral palsy
116374|NCT02567630|physical|physical
116375|NCT02567630|sensory|sensory
116376|NCT02567630|motor impairments|motor impairments
116377|NCT02567630|upper extremity|upper extremity
116378|NCT02567630|Constraint-Induced Movement Therapy|constraint-induced movement therapy
116379|NCT02567617|Polyphenols, Prostaglandin E2, hormonal contraceptives|polyphenols, prostaglandin e2, hormonal contraceptives
116380|NCT02567591|pre liver transplantation patients|pre liver transplantation patients
116381|NCT02567552|endometrial receptivity|endometrial receptivity
116382|NCT02567552|endometrial predecidualization|endometrial predecidualization
116383|NCT02567552|endometrial genomics|endometrial genomics
116384|NCT02567552|endometrial receptivity array|endometrial receptivity array
116385|NCT02567526|food and fluid intake|food and fluid intake
116386|NCT02567526|nursing home residents|nursing home residents
116387|NCT02567526|staffing|staffing
116388|NCT02567513|food and fluid intake|food and fluid intake
116389|NCT02567513|nursing homes|nursing homes
116390|NCT02567500|emotional|emotional
116391|NCT02567500|auditory hallucinations|auditory hallucinations
116392|NCT02567500|non-psychotic children|non-psychotic children
116393|NCT02567474|chronic lung disease|chronic lung disease
116394|NCT02567461|dual antiplatelet therapy|dual antiplatelet therapy
116395|NCT02567461|clopidogrel|clopidogrel
116396|NCT02567461|aspirin|aspirin
116397|NCT02567461|edoxaban|edoxaban
116398|NCT02567448|Obstructive Sleep Apnea|obstructive sleep apnea
116399|NCT02567448|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
116400|NCT02567448|Overlap syndrome|overlap syndrome
116401|NCT02567448|Pcrit|pcrit
116402|NCT02567448|Critical closing pressure|critical closing pressure
116403|NCT02567383|head and neck cancer|head and neck cancer
116404|NCT02567383|hyperthermia, Thermotron RF-8|hyperthermia, thermotron rf-8
116406|NCT02567370|Schizophrenia or Schizoaffective Disorder|schizophrenia or schizoaffective disorder
116407|NCT02567357|change triggered temper outbursts|change triggered temper outbursts
116408|NCT02567357|parent training|parent training
116409|NCT02567357|autism|autism
116410|NCT02567357|intellectual disability|intellectual disability
116411|NCT02567357|Prader-Willi syndrome|prader-willi syndrome
116412|NCT02567357|Fragile X syndrome|fragile x syndrome
116413|NCT02567357|web-based training|web-based training
116414|NCT02567357|Down syndrome|down syndrome
116415|NCT02567344|Cannabis|cannabis
116416|NCT02567344|rTMS|rtms
116417|NCT02567344|Craving|craving
116418|NCT02567344|Decision making|decision making
116419|NCT02567318|Pain|pain
116420|NCT02567318|Secondary hyperalgesia|secondary hyperalgesia
116421|NCT02567318|Healthy volunteers|healthy volunteers
116422|NCT02567318|Magnetic Resonance Imaging|magnetic resonance imaging
116423|NCT02567292|Digestive Disease and Disorders|digestive disease and disorders
116424|NCT02567292|Neonatal|neonatal
116425|NCT02567292|Pediatric Disorders|pediatric disorders
116426|NCT02567253|Cytoreductive surgery|cytoreductive surgery
116427|NCT02567253|(H)ipec|(h)ipec
116428|NCT02567253|Ovarian cancer|ovarian cancer
116429|NCT02567253|Cisplatin|cisplatin
116430|NCT02567253|Peritoneal carcinomatosis|peritoneal carcinomatosis
116431|NCT02567253|Pharmacokinetics|pharmacokinetics
116432|NCT02567253|Pharmacodynamics|pharmacodynamics
116433|NCT02567214|dyspnea|dyspnea
116434|NCT02567214|exercise|exercise
116435|NCT02567214|shuttle test|shuttle test
116436|NCT02567214|long-acting β2-agonists|long-acting β2-agonists
116437|NCT02567214|longacting muscarinic antagonist|longacting muscarinic antagonist
116438|NCT02567214|indacaterol|indacaterol
116439|NCT02567214|glycopyrronium|glycopyrronium
116440|NCT02567214|tiotropium|tiotropium
116441|NCT02567201|Voluntary attention|voluntary attention
116442|NCT02567201|Electroencephalogram|electroencephalogram
116443|NCT02567201|Brain-computer interface|brain-computer interface
116444|NCT02567201|Disorders of consciousness|disorders of consciousness
116445|NCT02567162|Intracerebral hemorrhage|intracerebral hemorrhage
116446|NCT02567162|Hemorrhagic stroke|hemorrhagic stroke
116447|NCT02567162|Intraparenchymal hemorrhage|intraparenchymal hemorrhage
116448|NCT02567162|Cerebrovascular disease|cerebrovascular disease
116449|NCT02567162|Stroke|stroke
116450|NCT02567149|Wart|wart
116451|NCT02567110|Mid-life Depression|mid-life depression
116452|NCT02567110|Bipolar Disorder|bipolar disorder
116453|NCT02567110|DSM-5 MDE|dsm-5 mde
116454|NCT02567110|Inflammation|inflammation
116455|NCT02567110|CNS Glutamate|cns glutamate
116456|NCT02567084|Bone substitute|bone substitute
116457|NCT02567084|benign bone cyst|benign bone cyst
116458|NCT02567084|ceramic|ceramic
116459|NCT02567084|remodelling|remodelling
116460|NCT02567071|C-section|c-section
116461|NCT02567071|Microbiota|microbiota
116462|NCT02567058|Achilles tendon|achilles tendon
116463|NCT02567045|Immunochemical fecal occult blood test|immunochemical fecal occult blood test
116464|NCT02567045|Colonoscopy|colonoscopy
116465|NCT02567045|Screening uptake|screening uptake
116466|NCT02567045|Screening participation|screening participation
116467|NCT02567045|Familiar risk|familiar risk
116468|NCT02567045|Colorectal Cancer|colorectal cancer
116469|NCT02567032|Oxytocin|oxytocin
116470|NCT02567032|Syntocinon|syntocinon
116471|NCT02567032|Social Cognition|social cognition
116472|NCT02567032|Schizophrenia|schizophrenia
116473|NCT02567006|vaccines|vaccines
116474|NCT02567006|reminders|reminders
116475|NCT02567006|immunization timeliness|immunization timeliness
116476|NCT02567006|vaccine coverage|vaccine coverage
116477|NCT02566980|depression|depression
116478|NCT02566980|mood disorder|mood disorder
116479|NCT02566980|post-partum depression|post-partum depression
116480|NCT02566980|suicidality|suicidality
116481|NCT02566980|post-partum suicidality|post-partum suicidality
116482|NCT02566980|perinatal depression|perinatal depression
116483|NCT02566980|perinatal mood disorder|perinatal mood disorder
116484|NCT02566980|inflammation|inflammation
116485|NCT02566980|kynurenine pathway|kynurenine pathway
116486|NCT02566980|glutamate|glutamate
116487|NCT02566954|radiology|radiology
116488|NCT02566954|3D measurement|3d measurement
116489|NCT02566954|lower limb|lower limb
116490|NCT02566941|critical illness polyneuropathy|critical illness polyneuropathy
116491|NCT02566941|critical illness myopathy|critical illness myopathy
116492|NCT02566941|neuromuscular electrical stimulation|neuromuscular electrical stimulation
116493|NCT02566941|intensive care unit acquired weakness|intensive care unit acquired weakness
116494|NCT02566941|prevention of critical illness polyneuropathy|prevention of critical illness polyneuropathy
116495|NCT02566928|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
116496|NCT02566928|Recurrence|recurrence
116497|NCT02566928|Practice Based Research Network|practice based research network
116498|NCT02566928|Community Health Workers/Promotoras|community health workers/promotoras
116499|NCT02566928|Decolonization and Decontamination|decolonization and decontamination
116500|NCT02566928|Staphylococcal Skin Infections|staphylococcal skin infections
116501|NCT02566928|Household Transmission|household transmission
116502|NCT02566889|Pediatric Inflammatory Bowel Disease|pediatric inflammatory bowel disease
116503|NCT02566889|Infliximab|infliximab
116504|NCT02566889|Pediatric Participants|pediatric participants
116505|NCT02566889|Pediatric Ulcerative Colitis|pediatric ulcerative colitis
116506|NCT02566889|Pediatric Crohn's Disease|pediatric crohn's disease
116507|NCT02566889|Dose Escalation|dose escalation
116508|NCT02566876|Children|children
116509|NCT02566876|Abdominal Pain|abdominal pain
116510|NCT02566876|Functional Dyspepsia|functional dyspepsia
116511|NCT02566876|Irritable Bowel Syndrome|irritable bowel syndrome
116512|NCT02566876|Quality of Life|quality of life
116513|NCT02566863|dexmedetomidine|dexmedetomidine
116514|NCT02566863|heart rate|heart rate
116515|NCT02566863|heart rate variability|heart rate variability
116516|NCT02566837|ultrasound|ultrasound
116517|NCT02566837|Electrical stimulation guidance|electrical stimulation guidance
116518|NCT02566837|botulinum toxin|botulinum toxin
116519|NCT02566772|Prostate Cancer|prostate cancer
116520|NCT02566759|Drug therapy|drug therapy
116521|NCT02566733|remifentanil|remifentanil
116522|NCT02566720|amantadine|amantadine
116523|NCT02566720|tractography|tractography
116524|NCT02566720|mri|mri
116525|NCT02566720|coma|coma
116526|NCT02566720|abi|abi
116527|NCT02566720|tbi|tbi
116528|NCT02566720|traumatic brain injury|traumatic brain injury
116529|NCT02566720|acquired brain injury|acquired brain injury
116530|NCT02566668|Asthma|asthma
116531|NCT02566668|Severe Asthma|severe asthma
116532|NCT02566668|IL-10|il-10
116533|NCT02566668|IL-27|il-27
116534|NCT02566668|IL-13|il-13
116535|NCT02566668|Epithelial Cells|epithelial cells
116536|NCT02566668|T lymphocytes|t lymphocytes
116537|NCT02566668|Interferon-g|interferon-g
116538|NCT02566629|microbiota community|microbiota community
116539|NCT02566629|IBS|ibs
116540|NCT02566603|ITP|itp
116541|NCT02566603|Thrombocytopenia|thrombocytopenia
116542|NCT02566577|Chronic anemia|chronic anemia
116543|NCT02566577|Cardiopulmonary testing|cardiopulmonary testing
116544|NCT02566577|Transfusion-dependent anemia|transfusion-dependent anemia
116545|NCT02566551|Prostatic artery embolization|prostatic artery embolization
116546|NCT02566551|Transurethral resection of the prostate|transurethral resection of the prostate
116547|NCT02566538|Cohort study|cohort study
116548|NCT02566538|psychometric tests|psychometric tests
116549|NCT02566538|cognitive function|cognitive function
116550|NCT02566538|cardiovascular risk|cardiovascular risk
116551|NCT02566538|prediction algorithm|prediction algorithm
116552|NCT02566525|CytoSorb device|cytosorb device
116553|NCT02566525|Plasma free hemoglobin|plasma free hemoglobin
116554|NCT02566525|inflammation|inflammation
116555|NCT02566525|extracorporeal bypass|extracorporeal bypass
116556|NCT02566512|Tracheostomy|tracheostomy
116557|NCT02566512|weaning|weaning
116558|NCT02566512|respiratory failure|respiratory failure
116559|NCT02566512|cough strength|cough strength
116560|NCT02566499|Medical imaging|medical imaging
116561|NCT02566499|Microwaves|microwaves
116562|NCT02566473|Patient reported outcomes|patient reported outcomes
116563|NCT02566473|Osteoarthritis|osteoarthritis
116564|NCT02566473|Total joint replacement|total joint replacement
116565|NCT02566460|Lactate clearance|lactate clearance
116566|NCT02566460|systemic central venous oxygen saturation|systemic central venous oxygen saturation
116567|NCT02566460|septic shock|septic shock
116568|NCT02566460|haemodynamic therapy|haemodynamic therapy
116571|NCT02566395|Haploidentical Donors|haploidentical donors
116575|NCT02566356|Oxytocin|oxytocin
116576|NCT02566356|Syntocinon|syntocinon
116577|NCT02566356|Social Cognition|social cognition
116578|NCT02566356|Schizophrenia|schizophrenia
116579|NCT02566356|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
116580|NCT02566343|Spirometry|spirometry
116581|NCT02566343|Exercise Test|exercise test
116582|NCT02566343|Blood Gas Analysis|blood gas analysis
116583|NCT02566343|Respiratory Function Tests|respiratory function tests
116584|NCT02566343|Diagnostic Techniques, Respiratory System|diagnostic techniques, respiratory system
116585|NCT02566343|Surgical Procedures, Operative|surgical procedures, operative
116586|NCT02566330|EndoBarrier|endobarrier
116587|NCT02566330|Duodenojejunal Bypass Liner|duodenojejunal bypass liner
116588|NCT02566291|laryngeal mask|laryngeal mask
116589|NCT02566291|airway leakage|airway leakage
116590|NCT02566291|airway morbidity|airway morbidity
116591|NCT02566278|Obstructive Sleep Apnea|obstructive sleep apnea
116592|NCT02566278|Pcrit|pcrit
116593|NCT02566278|Upper airway collapsibility|upper airway collapsibility
116594|NCT02566265|influenza|influenza
116595|NCT02566265|multiple myeloma|multiple myeloma
116596|NCT02566265|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
116597|NCT02566252|Safety|safety
116598|NCT02566252|tolerability|tolerability
116599|NCT02566239|aging|aging
116600|NCT02566239|ORCATECH|orcatech
116601|NCT02566239|Oregon Center for Aging & Technology|oregon center for aging & technology
116602|NCT02566239|Life Lab|life lab
116603|NCT02566239|Living Lab|living lab
116604|NCT02566239|in-home assessment|in-home assessment
116605|NCT02566239|technology and aging|technology and aging
116606|NCT02566213|volunteers|volunteers
116607|NCT02566200|Acute coronary syndrome|acute coronary syndrome
116608|NCT02566200|Cardiology|cardiology
116609|NCT02566174|Cancer Caregivers|cancer caregivers
116610|NCT02566174|Cancer Patients|cancer patients
116611|NCT02566174|Role Adjustment|role adjustment
116612|NCT02566174|Mutuality|mutuality
116613|NCT02566174|Well-Being|well-being
116614|NCT02566161|Genetics|genetics
116615|NCT02566161|Genomics|genomics
116616|NCT02566148|Life-event survey|life-event survey
116617|NCT02566148|observational survey among migrants in France|observational survey among migrants in france
116619|NCT02566135|I-gel|i-gel
116620|NCT02566135|ventilating bougie|ventilating bougie
116621|NCT02566135|intubation|intubation
116622|NCT02566096|major abdominal cancer|major abdominal cancer
116623|NCT02566070|Enteral feeding|enteral feeding
116624|NCT02566070|Continuous gastric feeding|continuous gastric feeding
116625|NCT02566070|Bolus gastric feeding|bolus gastric feeding
116626|NCT02566044|Cystic Fibrosis|cystic fibrosis
116627|NCT02566031|COPD|copd
116628|NCT02566031|open-label|open-label
116629|NCT02566031|QVA149|qva149
116630|NCT02566031|symptomatic|symptomatic
116631|NCT02566031|tiotropium|tiotropium
116632|NCT02566018|elderly|elderly
116633|NCT02566005|Misoprostol|misoprostol
116634|NCT02566005|Induction|induction
116635|NCT02566005|Foley|foley
116636|NCT02565992|Pembrolizumab|pembrolizumab
116637|NCT02565992|Coxsackievirus A21|coxsackievirus a21
116638|NCT02565992|melanoma|melanoma
116639|NCT02565992|CAVATAK|cavatak
116640|NCT02565992|CVA21|cva21
116641|NCT02565992|checkpoint inhibitor|checkpoint inhibitor
116642|NCT02565979|Resveratrol|resveratrol
116643|NCT02565979|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
116644|NCT02565979|Insulin Resistance|insulin resistance
116645|NCT02565979|Metabolic Diseases|metabolic diseases
116646|NCT02565979|Glucose Metabolism Disorders|glucose metabolism disorders
116647|NCT02565953|Vascular access devices obstruction|vascular access devices obstruction
116648|NCT02565927|Trachea|trachea
116649|NCT02565927|Stent|stent
116650|NCT02565927|Intraluminal brachytherapy|intraluminal brachytherapy
116651|NCT02565888|Hepatitis C|hepatitis c
116652|NCT02565888|HIV|hiv
116653|NCT02565888|atazanavir|atazanavir
116654|NCT02565888|ritonavir|ritonavir
116655|NCT02565888|daclatasvir|daclatasvir
116656|NCT02565888|cobicistat|cobicistat
116657|NCT02565875|Efficiency, Organizational|efficiency, organizational
116658|NCT02565875|Simulation|simulation
116659|NCT02565875|Communication|communication
116660|NCT02565875|Laparoscopy|laparoscopy
116661|NCT02565875|Medical Education|medical education
116662|NCT02565862|HCV|hcv
116663|NCT02565862|Diabetes Mellitus|diabetes mellitus
116664|NCT02565862|Daclatasvir|daclatasvir
116665|NCT02565862|Metformin|metformin
116666|NCT02565862|drug-drug interaction|drug-drug interaction
116667|NCT02565862|pharmacokinetics|pharmacokinetics
116668|NCT02565836|Vitamin K 1|vitamin k 1
116669|NCT02565836|prothrombin complex concentrates|prothrombin complex concentrates
116670|NCT02565836|warfarin|warfarin
116671|NCT02565823|Exercise|exercise
116672|NCT02565797|Decubitus Ulcer, Peri-operative, support surface, alternating pressure, neurosurgery|decubitus ulcer, peri-operative, support surface, alternating pressure, neurosurgery
116673|NCT02565771|Childhood cancer|childhood cancer
116675|NCT02565771|Sequels|sequels
116676|NCT02565771|Surgery|surgery
116677|NCT02565771|Complications|complications
116678|NCT02565771|Chemotherapy|chemotherapy
116679|NCT02565771|Radiotherapy|radiotherapy
116680|NCT02565758|Advanced Solid Tumor|advanced solid tumor
116681|NCT02565758|Cancer|cancer
116682|NCT02565758|Neoplasm|neoplasm
116683|NCT02565745|Prevention|prevention
116684|NCT02565745|Pressure ulcers|pressure ulcers
116685|NCT02565745|Clinical trial|clinical trial
116686|NCT02565745|Nursing|nursing
116687|NCT02565706|Fruit, vegetables, income, WIC program, farmers' market|fruit, vegetables, income, wic program, farmers' market
116688|NCT02565680|acute urticaria|acute urticaria
116689|NCT02565680|glucocorticoids|glucocorticoids
116690|NCT02565680|antihistamines|antihistamines
116691|NCT02565680|prurit|prurit
116692|NCT02565680|itch score|itch score
116693|NCT02565680|rash|rash
116694|NCT02565667|low rectal carcinoma|low rectal carcinoma
116695|NCT02565667|anastomosis|anastomosis
116696|NCT02565667|anterior rectal resection|anterior rectal resection
116697|NCT02565654|Irritable bowel syndrome(IBS)|irritable bowel syndrome(ibs)
116698|NCT02565654|Small intestinal bacterial overgrowth (SIBO)|small intestinal bacterial overgrowth (sibo)
116699|NCT02565654|Rifaximin|rifaximin
116700|NCT02565602|Calcium metabolism|calcium metabolism
116701|NCT02565602|Osteoporosis|osteoporosis
116702|NCT02565602|Postmenopausal women|postmenopausal women
116703|NCT02565576|CFZ533, Myasthenia Gravis|cfz533, myasthenia gravis
116704|NCT02565563|EMDR|emdr
117468|NCT02560012|RCC|rcc
116705|NCT02565563|Mechanisms|mechanisms
116706|NCT02565563|Eye Movement Desensitisation Reprocessing|eye movement desensitisation reprocessing
116707|NCT02565550|Microbiota Community|microbiota community
116708|NCT02565550|FODMAPs|fodmaps
116710|NCT02565524|schizophrenia|schizophrenia
116711|NCT02565524|early dissociative disorder|early dissociative disorder
116712|NCT02565524|genetic|genetic
116713|NCT02565511|Randomization, Placebo controlled, Parallel-group, APOE4 Homozygotes, Preclinical Alzheimer's Disease (AD), Aβ lowering|randomization, placebo controlled, parallel-group, apoe4 homozygotes, preclinical alzheimer's disease (ad), aβ lowering
116714|NCT02565498|Soft tissue sarcoma|soft tissue sarcoma
116715|NCT02565498|Extremity|extremity
116716|NCT02565498|Preoperative radiotherapy|preoperative radiotherapy
116717|NCT02565498|Postoperative radiotherapy|postoperative radiotherapy
116718|NCT02565485|pulse pressure|pulse pressure
116719|NCT02565485|fetal heart rate|fetal heart rate
116720|NCT02565485|epidural analgesia|epidural analgesia
116721|NCT02565485|hypotension|hypotension
116722|NCT02565485|preload|preload
116723|NCT02565485|fluid bolus|fluid bolus
116724|NCT02565485|central hypovolemia|central hypovolemia
116725|NCT02565459|Mesenchymal stromal cells|mesenchymal stromal cells
116726|NCT02565459|kidney transplantation|kidney transplantation
116727|NCT02565459|tolerance|tolerance
116728|NCT02565433|brain metastases|brain metastases
116729|NCT02565433|Gamma Knife|gamma knife
116730|NCT02565433|Radiosurgery|radiosurgery
116731|NCT02565433|Quality of Life|quality of life
116732|NCT02565355|Pediatric Gastroenterology|pediatric gastroenterology
116733|NCT02565342|Clavicle|clavicle
116734|NCT02565303|cesarean section|cesarean section
116735|NCT02565303|ropivacaine|ropivacaine
116736|NCT02565303|minimum effective dose|minimum effective dose
116737|NCT02565303|dose-response|dose-response
116738|NCT02565303|subarachnoid|subarachnoid
116739|NCT02565290|polyunsaturated fatty acid|polyunsaturated fatty acid
116740|NCT02565290|fetal ductus arteriosus|fetal ductus arteriosus
107813|NCT02619084|STN|stn
116741|NCT02565290|inflammation|inflammation
116742|NCT02565251|sepsis|sepsis
116743|NCT02565251|hemodynamic monitoring|hemodynamic monitoring
116744|NCT02565251|septic shock|septic shock
116745|NCT02565251|volemic resuscitation|volemic resuscitation
116746|NCT02565251|fluid resuscitation|fluid resuscitation
116747|NCT02565212|Montelukast|montelukast
116748|NCT02565212|Sniffin' Sticks test|sniffin' sticks test
116749|NCT02565212|allergic rhinitis|allergic rhinitis
116750|NCT02565212|mometasone furoate|mometasone furoate
116751|NCT02565199|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
116752|NCT02565173|glaucoma|glaucoma
116753|NCT02565173|primary open-angle glaucoma|primary open-angle glaucoma
116754|NCT02565173|ocular hypertension|ocular hypertension
116755|NCT02565173|adenosine agonist|adenosine agonist
116756|NCT02565173|eye drop|eye drop
116757|NCT02565173|trabodenoson|trabodenoson
116758|NCT02565173|trabecular meshwork|trabecular meshwork
116759|NCT02565147|STEMI, infarct size, CMR, bivalirudin|stemi, infarct size, cmr, bivalirudin
116760|NCT02565121|Olfactory perception|olfactory perception
116855|NCT02564575|Ebolavirus|ebolavirus
116761|NCT02565121|Adrenal cortex hormones|adrenal cortex hormones
116762|NCT02565121|Steroids|steroids
116763|NCT02565121|Education|education
116764|NCT02565108|Cannabidiol|cannabidiol
116765|NCT02565108|GWP42003-P|gwp42003-p
116766|NCT02565108|Clobazam|clobazam
116767|NCT02565108|Epidiolex|epidiolex
116768|NCT02565082|Hemostatic potential|hemostatic potential
116769|NCT02565082|Sickle cell disease|sickle cell disease
116770|NCT02565082|Thrombin generation test|thrombin generation test
116771|NCT02565056|Acceptance and Commitment Therapy|acceptance and commitment therapy
116894|NCT02564341|Chronic Opioid Therapy|chronic opioid therapy
116772|NCT02565030|Chronic thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
116773|NCT02565030|Distal Chronic thromboembolic Pulmonary Hypertension|distal chronic thromboembolic pulmonary hypertension
116774|NCT02565030|Proximal Chronic thromboembolic Pulmonary Hypertension|proximal chronic thromboembolic pulmonary hypertension
116775|NCT02565030|Operable disease|operable disease
116776|NCT02565030|In-operable disease|in-operable disease
116777|NCT02565030|Pulmonary Endarterectomy|pulmonary endarterectomy
116778|NCT02565030|PH specific targeted therapy|ph specific targeted therapy
116779|NCT02565030|Phosphodiesterase type 5 Inhibitors|phosphodiesterase type 5 inhibitors
116780|NCT02565030|Endothelin Receptor Antagonist|endothelin receptor antagonist
116781|NCT02565030|Prostacyclin analogues|prostacyclin analogues
116782|NCT02565030|Soluble Guanylate cyclase stimulator|soluble guanylate cyclase stimulator
116783|NCT02565030|Sildenafil|sildenafil
116784|NCT02565030|Tadalafil|tadalafil
116785|NCT02565030|Bosentan|bosentan
116786|NCT02565030|Ambrisentan|ambrisentan
116787|NCT02565030|Macitentan|macitentan
116788|NCT02565030|Iloprost|iloprost
116789|NCT02565030|Riociguat|riociguat
116790|NCT02565030|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
116791|NCT02565017|IBM Watson|ibm watson
116792|NCT02565017|Clinical Decision Support System|clinical decision support system
116793|NCT02565017|Patient Preferences|patient preferences
116794|NCT02565017|15-226|15-226
116795|NCT02565004|Genetic|genetic
116796|NCT02565004|Sample Collection|sample collection
116797|NCT02564991|Alcoholism|alcoholism
116798|NCT02564991|MRI|mri
116799|NCT02564991|Structural MRI|structural mri
116800|NCT02564991|Cerebellum|cerebellum
116801|NCT02564978|Age-Related Macular Degeneration|age-related macular degeneration
116802|NCT02564978|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
116803|NCT02564978|Geographic Atrophy|geographic atrophy
116804|NCT02564978|Minocycline|minocycline
116805|NCT02564978|Atrophic Macular Degeneration|atrophic macular degeneration
116806|NCT02564965|Acute Necrotizing Pancreatitis|acute necrotizing pancreatitis
116807|NCT02564965|Walled-Off Pancreatic Necrosis|walled-off pancreatic necrosis
116808|NCT02564952|Cannabidiol|cannabidiol
116809|NCT02564952|GWP42003-P|gwp42003-p
116810|NCT02564952|Clobazam|clobazam
116811|NCT02564952|Epidiolex|epidiolex
116812|NCT02564939|prevention|prevention
116813|NCT02564926|DM|dm
116814|NCT02564913|tongue diagnosis|tongue diagnosis
116815|NCT02564913|heart rate variability|heart rate variability
116816|NCT02564913|nailfold videocapillaroscopy|nailfold videocapillaroscopy
116817|NCT02564900|Advanced solid tumors|advanced solid tumors
116818|NCT02564900|phase 1|phase 1
116819|NCT02564900|oncology|oncology
116820|NCT02564900|HER2|her2
116821|NCT02564900|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
116822|NCT02564887|dysphagia|dysphagia
116823|NCT02564887|oral pharyngeal cancer|oral pharyngeal cancer
116824|NCT02564887|Iowa Oral Performance Instrument (IOPI)|iowa oral performance instrument (iopi)
116825|NCT02564887|IOPI|iopi
116826|NCT02564861|pharmacokinetics|pharmacokinetics
116827|NCT02564848|Clinical T1-2N0 ER+|clinical t1-2n0 er+
116828|NCT02564848|Invasive breast cancer|invasive breast cancer
116829|NCT02564848|estrogen-positive|estrogen-positive
116830|NCT02564822|migraine disorders|migraine disorders
116831|NCT02564822|cortical excitability|cortical excitability
116832|NCT02564822|transcranial magnetic stimulation|transcranial magnetic stimulation
116833|NCT02564822|electroencephalography|electroencephalography
116834|NCT02564796|Erythropoetin|erythropoetin
116835|NCT02564796|Cyanotic Heart Disease|cyanotic heart disease
116836|NCT02564796|Transfusion|transfusion
116837|NCT02564796|Congenital Heart Disease|congenital heart disease
116838|NCT02564731|children|children
116839|NCT02564731|prognosis|prognosis
116840|NCT02564718|Pediatric|pediatric
116841|NCT02564679|bariatric surgery|bariatric surgery
116842|NCT02564679|sleeve gastrectomy|sleeve gastrectomy
116843|NCT02564666|hepatocellular carcinoma|hepatocellular carcinoma
116844|NCT02564666|sorafenib|sorafenib
116845|NCT02564666|telephone counseling|telephone counseling
116846|NCT02564640|videolaryngoscope|videolaryngoscope
116847|NCT02564640|direct laryngoscope|direct laryngoscope
116848|NCT02564640|hemodynamic changes|hemodynamic changes
116849|NCT02564640|elderly patients|elderly patients
116850|NCT02564601|intervention|intervention
116851|NCT02564601|cognition|cognition
116852|NCT02564601|aging|aging
116853|NCT02564601|piano training|piano training
116854|NCT02564601|computer brain training|computer brain training
116856|NCT02564562|PF-06463922|pf-06463922
651630|NCT00784368|Candidiasis|candidiasis
116857|NCT02564562|[14C]PF-06463922|[14c]pf-06463922
116858|NCT02564562|Human ADME|human adme
116859|NCT02564562|Radiolabel|radiolabel
116860|NCT02564562|Mass Balance|mass balance
116861|NCT02564562|Pharmacokinetics|pharmacokinetics
116862|NCT02564549|low risk prostate cancer|low risk prostate cancer
116863|NCT02564523|Healthy|healthy
116864|NCT02564523|Vaccine|vaccine
116865|NCT02564523|Ebola viruses|ebola viruses
116866|NCT02564523|Ebola virus disease (EVD)|ebola virus disease (evd)
116867|NCT02564523|Filoviruses|filoviruses
116868|NCT02564523|Hemorrhagic fever|hemorrhagic fever
116869|NCT02564523|Monovalent vaccine|monovalent vaccine
116870|NCT02564523|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
116871|NCT02564523|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
116872|NCT02564523|Safety|safety
116873|NCT02564523|Immunogenicity|immunogenicity
116878|NCT02564484|Vincristine-Induced Neuropathy|vincristine-induced neuropathy
116879|NCT02564484|Cancer Survivor|cancer survivor
116880|NCT02564432|amputee|amputee
116881|NCT02564354|Cystic Fibrosis|cystic fibrosis
116882|NCT02564354|CF|cf
116883|NCT02564354|ΔF508|δf508
116884|NCT02564354|CFTR|cftr
116885|NCT02564354|QR-010|qr-010
116886|NCT02564354|antisense oligonucleotide|antisense oligonucleotide
116887|NCT02564354|RNA therapy|rna therapy
116888|NCT02564354|F508del|f508del
116889|NCT02564354|NPD|npd
116890|NCT02564354|nasal potential difference|nasal potential difference
116891|NCT02564341|HIV Infection|hiv infection
116892|NCT02564341|Pain|pain
116893|NCT02564341|Collaborative Care|collaborative care
116895|NCT02564341|Addiction|addiction
116896|NCT02564341|Analgesics, Opioid|analgesics, opioid
116897|NCT02564328|Stroke|stroke
116898|NCT02564328|Bone Marrow Mesenchymal Stem Cell|bone marrow mesenchymal stem cell
116899|NCT02564328|Transplantation|transplantation
116900|NCT02564315|Smoking|smoking
116901|NCT02564315|Cessation|cessation
116902|NCT02564315|Tobacco|tobacco
116903|NCT02564315|Relapse|relapse
116905|NCT02564302|Atrial Fibrillation|atrial fibrillation
116906|NCT02564302|MUSE Headband|muse headband
116907|NCT02564302|Mindfulness|mindfulness
116908|NCT02564289|microvesicles, microparticles|microvesicles, microparticles
116909|NCT02564289|Plethysmography|plethysmography
116910|NCT02564289|Snus|snus
116911|NCT02564289|Arterial Stiffness|arterial stiffness
116912|NCT02564289|EPC|epc
116913|NCT02564276|Indocyanine Green|indocyanine green
116914|NCT02564276|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
116919|NCT02564237|Group A streptococcal|group a streptococcal
116920|NCT02564198|relapsed pediatric solid tumors|relapsed pediatric solid tumors
116921|NCT02564198|unspecified childhood solid tumor|unspecified childhood solid tumor
116922|NCT02564198|brain and central nervous system tumors|brain and central nervous system tumors
116923|NCT02564159|malnutrition|malnutrition
116924|NCT02564159|muscle ultrasound|muscle ultrasound
116925|NCT02564159|intensive care unit|intensive care unit
116926|NCT02564159|mechanical ventilation|mechanical ventilation
116927|NCT02564159|albumin|albumin
116928|NCT02564159|prealbumin|prealbumin
116929|NCT02564159|nutrition|nutrition
116930|NCT02564055|Vehicle-Controlled|vehicle-controlled
116931|NCT02564055|GSK2894512|gsk2894512
116932|NCT02564055|Double blind|double blind
116933|NCT02564055|Dose-finding|dose-finding
116934|NCT02564055|Atopic Dermatitis|atopic dermatitis
116935|NCT02564042|Double blind|double blind
116936|NCT02564042|Dose-finding|dose-finding
116937|NCT02564042|Vehicle-Controlled|vehicle-controlled
116938|NCT02564042|GSK2894512|gsk2894512
107995|NCT02617901|Greulich & Pyle|greulich & pyle
107996|NCT02617901|TW3|tw3
107997|NCT02617901|Radiography|radiography
116939|NCT02564042|Plaque Psoriasis|plaque psoriasis
116940|NCT02563977|Breast reconstruction|breast reconstruction
116941|NCT02563977|Deep inferior epigastric perforator flap|deep inferior epigastric perforator flap
116942|NCT02563977|Abdominal wall morbidity|abdominal wall morbidity
116943|NCT02563977|Plastic and reconstructive surgery|plastic and reconstructive surgery
116944|NCT02563964|Myocardial infarction|myocardial infarction
116945|NCT02563964|vulnerable plaque|vulnerable plaque
116946|NCT02563964|Positron emission tomography (PET)|positron emission tomography (pet)
116947|NCT02563964|Cardiac magnetic resonance imaging (CMR)|cardiac magnetic resonance imaging (cmr)
116948|NCT02563964|Biomarkers|biomarkers
116949|NCT02563951|Nausea|nausea
116950|NCT02563951|Vomiting|vomiting
116951|NCT02563951|Chemotherapy|chemotherapy
116952|NCT02563951|Radiation therapy|radiation therapy
116953|NCT02563925|Brain Irradiation|brain irradiation
116954|NCT02563925|Tremelimumab|tremelimumab
116955|NCT02563925|15-038|15-038
116956|NCT02563912|Children|children
116957|NCT02563912|resuscitation|resuscitation
116958|NCT02563912|simulation|simulation
116959|NCT02563912|medication error|medication error
116960|NCT02563899|Primary Axillary Hyperhidrosis|primary axillary hyperhidrosis
116961|NCT02563899|GSK573719|gsk573719
116962|NCT02563899|Hyperhidrosis Disease Severity Scale (HDSS)|hyperhidrosis disease severity scale (hdss)
116963|NCT02563899|Topical|topical
116964|NCT02563899|PRO|pro
116965|NCT02563899|Hyperhidrosis Symptom Severity Measure (HSSM)|hyperhidrosis symptom severity measure (hssm)
116966|NCT02563899|Umeclidinium|umeclidinium
116967|NCT02563821|Termination of pregancy|termination of pregancy
116968|NCT02563821|Third trimester|third trimester
116969|NCT02563821|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
116970|NCT02563821|Continuous epidural infusion|continuous epidural infusion
116971|NCT02563821|Epidural analgesia|epidural analgesia
116972|NCT02563821|Legally induced abortion|legally induced abortion
116973|NCT02563795|Spinal anesthesia|spinal anesthesia
116974|NCT02563795|Cesarean|cesarean
116975|NCT02563795|Maternal hypotension|maternal hypotension
116976|NCT02563769|Cocaine|cocaine
116977|NCT02563769|Clavulanic Acid|clavulanic acid
116978|NCT02563756|Medial gonarthritis, knee osteoarthritis,|medial gonarthritis, knee osteoarthritis,
116979|NCT02563756|Muscle function, muscle mass, muscle atrophy|muscle function, muscle mass, muscle atrophy
116980|NCT02563756|Total knee arthroplasty (TKA)|total knee arthroplasty (tka)
116981|NCT02563756|Unicondylar knee arthroplasty (UKA)|unicondylar knee arthroplasty (uka)
116982|NCT02563756|Total knee replacement (TKR)|total knee replacement (tkr)
116983|NCT02563756|Unicondylar knee replacement (UKR)|unicondylar knee replacement (ukr)
116984|NCT02563756|Health-related quality of life (HRQoL)|health-related quality of life (hrqol)
116985|NCT02563756|Patient related outcome measurements (PROMs)|patient related outcome measurements (proms)
116986|NCT02563743|Sick-leave|sick-leave
116987|NCT02563743|Return to work|return to work
116988|NCT02563743|Occupational health|occupational health
116989|NCT02563743|Common mental disorder|common mental disorder
116990|NCT02563743|Depression|depression
116991|NCT02563743|Anxiety disorders|anxiety disorders
116992|NCT02563743|Adjustment disorders|adjustment disorders
116993|NCT02563743|Problem solving therapy|problem solving therapy
116994|NCT02563743|Occupational Health Services|occupational health services
116995|NCT02563743|Randomized controlled trial|randomized controlled trial
116996|NCT02563743|Intervention studies|intervention studies
116998|NCT02563730|Cryobiopsy|cryobiopsy
116999|NCT02563730|lung biopsy|lung biopsy
117000|NCT02563730|interstitial lung disease|interstitial lung disease
117001|NCT02563717|Resuscitation|resuscitation
117002|NCT02563717|Positive-Pressure Respiration|positive-pressure respiration
117003|NCT02563717|Infant, Extremely Premature|infant, extremely premature
117004|NCT02563717|Continuous Positive Airway Pressure|continuous positive airway pressure
117005|NCT02563717|Intubation|intubation
117006|NCT02563704|Artesunate|artesunate
117007|NCT02563704|Quinine|quinine
117008|NCT02563704|Efficacy|efficacy
117009|NCT02563704|Malaria|malaria
117010|NCT02563704|Children|children
117011|NCT02563704|Cameroon|cameroon
117012|NCT02563652|Abdomen/surgery|abdomen/surgery
117013|NCT02563652|Biological markers|biological markers
117014|NCT02563652|Length of stay|length of stay
117015|NCT02563652|Postoperative care|postoperative care
117016|NCT02563652|Anesthesia recovery period|anesthesia recovery period
117017|NCT02563652|Prognosis|prognosis
117018|NCT02563639|newly diagnosed|newly diagnosed
117019|NCT02563639|paroxysmal|paroxysmal
117020|NCT02563639|persistent|persistent
117021|NCT02563626|coronary artery aneurysm|coronary artery aneurysm
117022|NCT02563626|prognosis|prognosis
117023|NCT02563626|outcomes|outcomes
117024|NCT02563626|management|management
117025|NCT02563626|incidence|incidence
117026|NCT02563626|heart failure|heart failure
140015|NCT02427464|ViroMed|viromed
117027|NCT02563626|acute coronary syndrome|acute coronary syndrome
117028|NCT02563626|death|death
117029|NCT02563613|community-based intervention|community-based intervention
117030|NCT02563613|family holistic health|family holistic health
117031|NCT02563613|positive psychology|positive psychology
117032|NCT02563613|physical exercise|physical exercise
117033|NCT02563613|healthy diet|healthy diet
117034|NCT02563587|Laughter|laughter
117035|NCT02563587|children|children
117036|NCT02563587|postoperative|postoperative
117037|NCT02563587|pain|pain
117038|NCT02563587|anxiety|anxiety
117039|NCT02563587|cortisol|cortisol
117040|NCT02563574|Alcohol and brain function|alcohol and brain function
117041|NCT02563574|HIV and brain function|hiv and brain function
117042|NCT02563574|Motivational Interviewing|motivational interviewing
117043|NCT02563561|Bladder Cancer|bladder cancer
117044|NCT02563561|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
117045|NCT02563561|Apaziquone|apaziquone
117046|NCT02563561|TURBT|turbt
117047|NCT02563561|Stage Ta, G1-G2|stage ta, g1-g2
117048|NCT02563522|non healing ulcers|non healing ulcers
117049|NCT02563522|VM202|vm202
117050|NCT02563522|Diabetic ulcers|diabetic ulcers
117051|NCT02563522|foot ulcers|foot ulcers
117052|NCT02563509|HIV|hiv
117053|NCT02563509|cellular immunity therapy|cellular immunity therapy
117054|NCT02563509|functional cure|functional cure
117055|NCT02563496|pharmacokinetic|pharmacokinetic
117056|NCT02563496|pediatric|pediatric
117057|NCT02563496|Tafenoquine|tafenoquine
651812|NCT00785005|Exercise|exercise
117058|NCT02563496|Plasmodium vivax Malaria|plasmodium vivax malaria
117059|NCT02563496|G6PD deficiency|g6pd deficiency
117060|NCT02563483|caregivers|caregivers
117061|NCT02563483|anxiety|anxiety
117062|NCT02563483|depression|depression
117063|NCT02563483|yoga|yoga
117064|NCT02563483|meditation|meditation
117065|NCT02563483|stress|stress
117066|NCT02563457|diabetic patients|diabetic patients
117067|NCT02563457|periodontal treatment|periodontal treatment
117068|NCT02563457|glycaemic control|glycaemic control
117069|NCT02563444|Diagnostic (Biopsy) or Therapeutic Procedure (Infiltration, Ablation)|diagnostic (biopsy) or therapeutic procedure (infiltration, ablation)
117070|NCT02563431|shoulder pain|shoulder pain
117071|NCT02563431|prevention program|prevention program
117072|NCT02563418|video oculography|video oculography
117073|NCT02563405|alpha receptor blocker|alpha receptor blocker
117074|NCT02563405|uric acid|uric acid
117075|NCT02563405|CCB|ccb
117076|NCT02563405|blood pressure variability|blood pressure variability
117077|NCT02563366|kidney transplantation|kidney transplantation
117078|NCT02563366|mesenchymal stem cell therapy|mesenchymal stem cell therapy
117079|NCT02563366|poor early graft function|poor early graft function
117080|NCT02563366|delayed graft function|delayed graft function
117081|NCT02563366|ischemia reperfusion injury|ischemia reperfusion injury
117082|NCT02563366|donation after cardiac death|donation after cardiac death
117083|NCT02563353|whole body vibration|whole body vibration
117084|NCT02563353|PTH|pth
117085|NCT02563340|kidney transplantation|kidney transplantation
117086|NCT02563340|antibody-mediated rejection|antibody-mediated rejection
117087|NCT02563340|mesenchymal stem cell therapy|mesenchymal stem cell therapy
117088|NCT02563340|donor specific antibody|donor specific antibody
117089|NCT02563340|acute rejection|acute rejection
117090|NCT02563314|Noninvasive Ventilation|noninvasive ventilation
117091|NCT02563314|Pulmonary Disease|pulmonary disease
117092|NCT02563314|Chronic Obstructive|chronic obstructive
117093|NCT02563314|Renal Doppler|renal doppler
117094|NCT02563314|Oxygen|oxygen
117095|NCT02563314|Hypercapnia|hypercapnia
117097|NCT02563288|dexmedetomidine|dexmedetomidine
117098|NCT02563288|opioids|opioids
117099|NCT02563197|Device study|device study
117100|NCT02563197|Peak inspiratory flow rate|peak inspiratory flow rate
117101|NCT02563197|Non-cystic fibrosis bronchiectasis|non-cystic fibrosis bronchiectasis
117102|NCT02563197|T-326 Inhaler|t-326 inhaler
117103|NCT02563171|visceral adipose-specific serpin|visceral adipose-specific serpin
117104|NCT02563171|intelectin 1 (omentin)|intelectin 1 (omentin)
117105|NCT02563171|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
117106|NCT02563158|liver resection|liver resection
117107|NCT02563158|blood inflow control|blood inflow control
117108|NCT02563158|ischemia-reperfusion injury|ischemia-reperfusion injury
117109|NCT02563158|inflammatory response|inflammatory response
117110|NCT02563158|randomized controlled trial|randomized controlled trial
117111|NCT02563145|Real-time fMRI feedback|real-time fmri feedback
117112|NCT02563132|colonoscopy|colonoscopy
117113|NCT02563132|carbon dioxide|carbon dioxide
117114|NCT02563132|inflammatory bowel disease|inflammatory bowel disease
117115|NCT02563093|Influenza|influenza
117116|NCT02563093|Fluzone® Quadrivalent, Influenza Vaccine|fluzone® quadrivalent, influenza vaccine
117117|NCT02563093|Fluzone® Intradermal Quadrivalent, Influenza Vaccine|fluzone® intradermal quadrivalent, influenza vaccine
117118|NCT02563093|Fluzone® High Dose, Influenza Vaccine|fluzone® high dose, influenza vaccine
117119|NCT02563080|exocrine insufficiency|exocrine insufficiency
117120|NCT02563080|acute pancreatitis|acute pancreatitis
117121|NCT02563080|severe|severe
117122|NCT02563080|moderately severe|moderately severe
117123|NCT02563067|Asthma|asthma
117124|NCT02563067|QAW039|qaw039
117125|NCT02563028|Visual Evoked Potentials|visual evoked potentials
117126|NCT02563028|Microdiscectomy|microdiscectomy
117127|NCT02563028|SightSaver|sightsaver
117128|NCT02563015|Infant|infant
117129|NCT02563015|Vitamin D|vitamin d
117130|NCT02563015|Deficiency|deficiency
117131|NCT02563015|Lean Mass|lean mass
117132|NCT02563002|PD1|pd1
117133|NCT02563002|PDL1|pdl1
117134|NCT02563002|PD-L1|pd-l1
117135|NCT02562924|MEDIHONEY|medihoney
117136|NCT02562924|Chronic Rhinosinusitis With Nasal Polyposis|chronic rhinosinusitis with nasal polyposis
117137|NCT02562924|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
117138|NCT02562911|cystic fibrosis|cystic fibrosis
117139|NCT02562911|menstrual cycle|menstrual cycle
117140|NCT02562911|puberty|puberty
117141|NCT02562885|Benign epilepsy with centro-temporal spikes|benign epilepsy with centro-temporal spikes
117142|NCT02562885|Continuous spike waves in slow wave sleep|continuous spike waves in slow wave sleep
117143|NCT02562885|Electroencephalography|electroencephalography
117144|NCT02562885|Sleep, slow wave|sleep, slow wave
117145|NCT02562872|Controlled|controlled
117146|NCT02562872|Human|human
117147|NCT02562872|Malaria|malaria
117148|NCT02562872|Infection|infection
117149|NCT02562872|Healthy|healthy
117150|NCT02562872|Volunteer|volunteer
117151|NCT02562846|electroconvulsive therapy|electroconvulsive therapy
117152|NCT02562846|response prediction|response prediction
117153|NCT02562846|cognitive side effects|cognitive side effects
117154|NCT02562833|Osteoarthritis|osteoarthritis
117155|NCT02562833|Self-management|self-management
117156|NCT02562833|Multi-Component Exercise|multi-component exercise
117157|NCT02562807|Urinary Incontinence|urinary incontinence
117158|NCT02562807|Urinary Incontinence, Stress|urinary incontinence, stress
117159|NCT02562807|Lower Urinary Tract Symptoms|lower urinary tract symptoms
117160|NCT02562794|refugee|refugee
117161|NCT02562781|postoperative complications|postoperative complications
117162|NCT02562781|postoperative cognitive dysfunction|postoperative cognitive dysfunction
117163|NCT02562781|oxygen|oxygen
117164|NCT02562755|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
117165|NCT02562755|Pexastimogene Devacirepvec (Pexa-Vec)|pexastimogene devacirepvec (pexa-vec)
117166|NCT02562755|Sorafenib|sorafenib
117167|NCT02562755|GM-CSF therapy|gm-csf therapy
117170|NCT02562755|Recombinant Vaccinia Virus|recombinant vaccinia virus
117171|NCT02562755|Oncolytic Virus Therapy|oncolytic virus therapy
117172|NCT02562755|Oncolytic virotherapy|oncolytic virotherapy
117173|NCT02562742|Hepatitis C virus|hepatitis c virus
117174|NCT02562742|observational|observational
117175|NCT02562742|post-marketing|post-marketing
117176|NCT02562742|sofosbuvir|sofosbuvir
117177|NCT02562742|Infection|infection
117178|NCT02562729|Cervical cancer; Nerve-sparing hysterectomy; simplified|cervical cancer; nerve-sparing hysterectomy; simplified
117179|NCT02562690|Coronary Artery Disease|coronary artery disease
117180|NCT02562690|Myocardial Ischemia|myocardial ischemia
117181|NCT02562690|Arterial Occlusive Diseases|arterial occlusive diseases
117182|NCT02562690|Coronary Thrombosis|coronary thrombosis
117183|NCT02562651|STEMI, adverse LVR (left ventricular remodeling), MMPs, Doxycycline|stemi, adverse lvr (left ventricular remodeling), mmps, doxycycline
117184|NCT02562638|NPO|npo
117185|NCT02562638|NBM|nbm
117186|NCT02562638|pre-procedure|pre-procedure
117187|NCT02562638|cardiac|cardiac
117188|NCT02562599|Induction Chemotherapy|induction chemotherapy
117189|NCT02562599|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
117190|NCT02562586|Suction|suction
117191|NCT02562586|Arthroplasty|arthroplasty
117192|NCT02562586|Replacement|replacement
117193|NCT02562586|Hip|hip
117194|NCT02562534|ECG|ecg
117195|NCT02562534|MRI|mri
117196|NCT02562534|rythm troubles|rythm troubles
117197|NCT02562534|conductive troubles|conductive troubles
117198|NCT02562534|ECG artifacts|ecg artifacts
117199|NCT02562534|Database|database
117200|NCT02562508|Human Papilloma Virus 16|human papilloma virus 16
117201|NCT02562508|Human Papilloma Virus 18|human papilloma virus 18
117202|NCT02562508|vaccine|vaccine
117203|NCT02562508|adolescent girl|adolescent girl
117204|NCT02562508|bridging trial|bridging trial
117205|NCT02562508|non-inferiority|non-inferiority
117206|NCT02562495|severe cerebral pathology|severe cerebral pathology
117207|NCT02562495|Ultrasound|ultrasound
117208|NCT02562495|thickness of the quadriceps|thickness of the quadriceps
117209|NCT02562482|Antibody Response|antibody response
117210|NCT02562482|Immune Response|immune response
117211|NCT02562482|Healthy Volunteer|healthy volunteer
117212|NCT02562482|Vaccine-Mediated Protection|vaccine-mediated protection
117213|NCT02562482|Chikungunya Virus|chikungunya virus
117214|NCT02562482|Vaccines, Virus-like Particles|vaccines, virus-like particles
117215|NCT02562456|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
117216|NCT02562456|Composite Resins|composite resins
117217|NCT02562456|Primary Teeth|primary teeth
117218|NCT02562456|Clinical Efficacy|clinical efficacy
117219|NCT02562456|Cost Analysis|cost analysis
117222|NCT02562430|Placebo response|placebo response
117223|NCT02562391|atrial fibrillation|atrial fibrillation
117224|NCT02562391|ablation|ablation
117225|NCT02562391|thoracoscopy|thoracoscopy
117226|NCT02562391|left atrial appendage|left atrial appendage
117227|NCT02562365|adjuvent chemotherapy|adjuvent chemotherapy
117228|NCT02562365|ovarian cancer|ovarian cancer
117229|NCT02562352|polypharmacy|polypharmacy
117230|NCT02562352|multimorbidity|multimorbidity
117231|NCT02562352|randomized controlled trial|randomized controlled trial
117232|NCT02562352|drug discontinuation|drug discontinuation
117233|NCT02562352|patient preference|patient preference
117234|NCT02562352|eHealth|ehealth
117235|NCT02562274|Menopause|menopause
117236|NCT02562274|Cognitive impairment|cognitive impairment
117237|NCT02562274|Working memory|working memory
117238|NCT02562274|Bone formation markers|bone formation markers
117239|NCT02562274|Osteoporosis|osteoporosis
117240|NCT02562261|sepsis|sepsis
117241|NCT02562261|platelet|platelet
117242|NCT02562261|platelet reactivity|platelet reactivity
117243|NCT02562261|P2Y12|p2y12
117244|NCT02562235|Pulmonary arterial hypertension|pulmonary arterial hypertension
117245|NCT02562222|migraine disorders|migraine disorders
117246|NCT02562222|transcranial direct current stimulation|transcranial direct current stimulation
117247|NCT02562222|electric stimulation therapy|electric stimulation therapy
117248|NCT02562222|pain|pain
117249|NCT02562222|rehabilitation|rehabilitation
117250|NCT02562209|Obesity|obesity
117251|NCT02562209|Abdominal adiposity|abdominal adiposity
117252|NCT02562209|High protein diet|high protein diet
117253|NCT02562196|migraine disorders|migraine disorders
117645|NCT02560077|middle aged|middle aged
117254|NCT02562196|transcranial direct current stimulation|transcranial direct current stimulation
117255|NCT02562196|electric stimulation therapy|electric stimulation therapy
117256|NCT02562196|pain|pain
117257|NCT02562170|breast|breast
117258|NCT02562170|reconstruction|reconstruction
117259|NCT02562170|mesh|mesh
117260|NCT02562170|acellular dermal matrix|acellular dermal matrix
117261|NCT02562131|PET-MR|pet-mr
117262|NCT02562131|recidive|recidive
117263|NCT02562131|PET/MR imaging|pet/mr imaging
117264|NCT02562131|18F-Fluciclovine|18f-fluciclovine
117265|NCT02562131|radical treatment|radical treatment
117266|NCT02562131|recurrence|recurrence
117267|NCT02562105|Intensive care unit|intensive care unit
117268|NCT02562105|Hematological malignancy|hematological malignancy
117269|NCT02562105|Acute respiratory failure|acute respiratory failure
117270|NCT02562105|Prognosis|prognosis
117271|NCT02562105|Mechanical ventilation|mechanical ventilation
117272|NCT02562092|AIDS|aids
117273|NCT02562092|Health Promotion|health promotion
117274|NCT02562079|T lymphocyte|t lymphocyte
117275|NCT02562079|OX40/OX40L|ox40/ox40l
117276|NCT02562040|Pediatrics|pediatrics
117277|NCT02562040|Primary Snoring|primary snoring
117278|NCT02562040|Adenotonsillectomy|adenotonsillectomy
117279|NCT02562001|Spinal Cord Injuries|spinal cord injuries
117280|NCT02562001|gait training|gait training
117281|NCT02562001|robotic|robotic
117282|NCT02562001|Lokomat|lokomat
117283|NCT02562001|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
117284|NCT02562001|transcranial direct-current stimulation|transcranial direct-current stimulation
117285|NCT02562001|Electroencephalography|electroencephalography
117286|NCT02561975|Double pulmonary diffusing capacity to carbon monoxyd (CO) associated to nitric oxide (NO)|double pulmonary diffusing capacity to carbon monoxyd (co) associated to nitric oxide (no)
117287|NCT02561975|Evolution of membrane and capillar damages|evolution of membrane and capillar damages
117288|NCT02561975|Early pronostic value of congenital heart disease|early pronostic value of congenital heart disease
117289|NCT02561962|Multiple Myeloma|multiple myeloma
117290|NCT02561962|Relapsed Multiple Myeloma|relapsed multiple myeloma
117291|NCT02561962|Refractory Multiple Myeloma|refractory multiple myeloma
117292|NCT02561949|Depression/therapy|depression/therapy
117293|NCT02561949|Developing Countries|developing countries
117294|NCT02561949|Interpersonal Relations|interpersonal relations
117295|NCT02561949|Life Change Events|life change events
117296|NCT02561949|Psychotherapy, group|psychotherapy, group
117297|NCT02561949|Resilience, Psychological|resilience, psychological
117298|NCT02561949|Sierra Leone|sierra leone
117299|NCT02561949|Survivors/psychology|survivors/psychology
117300|NCT02561949|Social Adjustment|social adjustment
117301|NCT02561949|Social Behavior|social behavior
117302|NCT02561949|War|war
117303|NCT02561936|Healthy|healthy
117304|NCT02561936|EUDRANT|eudrant
117305|NCT02561936|Rilpivirine|rilpivirine
117306|NCT02561923|Healthy|healthy
117307|NCT02561923|Rivaroxaban|rivaroxaban
117308|NCT02561923|XARELTO|xarelto
117309|NCT02561910|Inguinal hernia repair|inguinal hernia repair
117310|NCT02561910|laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
117311|NCT02561910|TAPP|tapp
117312|NCT02561871|Ad26.RSV.FA2 (JNJ-61187165-AAA)|ad26.rsv.fa2 (jnj-61187165-aaa)
117313|NCT02561871|Ad35.RSV.FA2 (JNJ-61187191-AAA)|ad35.rsv.fa2 (jnj-61187191-aaa)
117314|NCT02561871|Healthy participants|healthy participants
108404|NCT02615327|Fiber|fiber
117315|NCT02561858|Renal Ammonium ;uric acid|renal ammonium ;uric acid
117316|NCT02561845|Effectiveness of statins, on lipid goal attainment and lipid parameters in Percutaneous Coronary Intervention patients|effectiveness of statins, on lipid goal attainment and lipid parameters in percutaneous coronary intervention patients
117317|NCT02561832|breast cancer|breast cancer
117318|NCT02561819|Short Bowel Syndrome|short bowel syndrome
117319|NCT02561819|Congenital Short Bowel Syndrome|congenital short bowel syndrome
117320|NCT02561819|Body Composition|body composition
117321|NCT02561819|Parenteral Nutrition|parenteral nutrition
117322|NCT02561819|Intestinal Failure|intestinal failure
117323|NCT02561780|Mental Health Knowledge|mental health knowledge
117324|NCT02561780|Stigma|stigma
117325|NCT02561780|Mental Health Literacy|mental health literacy
117326|NCT02561767|kidney transplantation|kidney transplantation
117327|NCT02561767|mesenchymal stem cell|mesenchymal stem cell
117328|NCT02561767|donation after citizen's death|donation after citizen's death
117329|NCT02561767|ischemia reperfusion injury|ischemia reperfusion injury
117330|NCT02561767|renal function recovery|renal function recovery
117331|NCT02561754|Diet|diet
117332|NCT02561754|Obesity|obesity
117333|NCT02561754|Adolescents|adolescents
117334|NCT02561754|Intellectual and Developmental Disability|intellectual and developmental disability
117335|NCT02561728|Helmet|helmet
117336|NCT02561728|Hangar|hangar
117337|NCT02561728|P-Pod|p-pod
117338|NCT02561728|Plagiocephaly|plagiocephaly
117339|NCT02561728|Surgery|surgery
117340|NCT02561715|Parkinson's|parkinson's
117341|NCT02561715|Anosognosia|anosognosia
117342|NCT02561715|DBS|dbs
117343|NCT02561715|Deep Brain Surgery|deep brain surgery
117344|NCT02561689|Occlusal caries|occlusal caries
117345|NCT02561689|Resin fissure sealant|resin fissure sealant
117346|NCT02561689|Longevity|longevity
117347|NCT02561689|Effectiveness|effectiveness
117348|NCT02561676|Mindfulness|mindfulness
117349|NCT02561676|Spinal Cord Injury|spinal cord injury
117350|NCT02561663|microcirculation|microcirculation
117351|NCT02561663|blood pressure|blood pressure
117352|NCT02561663|pulse wave analysis|pulse wave analysis
117353|NCT02561663|pulse wave velocity|pulse wave velocity
117354|NCT02561637|Case management|case management
117355|NCT02561624|mHealth|mhealth
117356|NCT02561624|Text message|text message
117357|NCT02561611|Pedal Desk|pedal desk
117358|NCT02561611|Workplace Intervention|workplace intervention
117359|NCT02561611|Physical Activity|physical activity
117360|NCT02561611|Energy Expenditure|energy expenditure
117361|NCT02561546|concurrent|concurrent
117362|NCT02561520|platelet rich plasma|platelet rich plasma
117363|NCT02561520|platelet poor plasma|platelet poor plasma
117364|NCT02561520|ocular GVHD|ocular gvhd
117365|NCT02561455|Advanced solid tumors|advanced solid tumors
117366|NCT02561455|Acute myeloid leukemia|acute myeloid leukemia
117367|NCT02561455|ASP2215|asp2215
117368|NCT02561416|Fibromyalgia syndrome|fibromyalgia syndrome
117369|NCT02561416|Mindfulness (MBSR)|mindfulness (mbsr)
117370|NCT02561416|Neuroimaging|neuroimaging
117371|NCT02561416|Cytokines|cytokines
117372|NCT02561416|Randomized Controlled Trial|randomized controlled trial
117373|NCT02561416|Cost-effectiveness|cost-effectiveness
117374|NCT02561416|Psychoeducation (FibroQol)|psychoeducation (fibroqol)
117375|NCT02561403|traumatic brain injury (TBI)|traumatic brain injury (tbi)
117376|NCT02561403|aging|aging
117377|NCT02561403|cognitive training|cognitive training
117378|NCT02561403|Cognitive Aging|cognitive aging
117379|NCT02561377|resistance training|resistance training
117380|NCT02561377|Prediabetic state|prediabetic state
117381|NCT02561377|Metabolomics|metabolomics
117382|NCT02561364|Fetal Biophysical Profile|fetal biophysical profile
117383|NCT02561351|bronchial asthma|bronchial asthma
117384|NCT02561351|fractional exhaled nitric oxide (FeNO)|fractional exhaled nitric oxide (feno)
117385|NCT02561351|asthma exacerbation|asthma exacerbation
117386|NCT02561338|GKA,T2DM,HMS5552|gka,t2dm,hms5552
117387|NCT02561325|Blood pressure|blood pressure
117388|NCT02561325|Sodium Chloride|sodium chloride
117389|NCT02561325|Sodium Bicarbonate|sodium bicarbonate
117390|NCT02561299|Drug-coated Balloons|drug-coated balloons
117391|NCT02561299|Calcified Lesions|calcified lesions
117392|NCT02561299|Orbital Atherectomy|orbital atherectomy
117393|NCT02561299|Below the Knee|below the knee
117394|NCT02561299|Paclitaxel|paclitaxel
117395|NCT02561299|Lutonix 014 Drug-coated Balloon|lutonix 014 drug-coated balloon
117396|NCT02561286|Human immunodeficiency virus|human immunodeficiency virus
117397|NCT02561286|Sexually transmitted disease|sexually transmitted disease
117398|NCT02561286|Men who have sex with men|men who have sex with men
117399|NCT02561286|African Americans|african americans
117400|NCT02561286|Behavioral intervention|behavioral intervention
117401|NCT02561286|Randomized controlled trial|randomized controlled trial
117402|NCT02561286|Sexual behavior|sexual behavior
117403|NCT02561286|Mediation analysis|mediation analysis
117404|NCT02561286|Social cognitive theory|social cognitive theory
117405|NCT02561286|Theory of planned behavior|theory of planned behavior
117406|NCT02561247|Acute Kidney Injury|acute kidney injury
117407|NCT02561247|Continuous Renal Replacement Therapy|continuous renal replacement therapy
117408|NCT02561247|Blood Urea Nitrogen (BUN)|blood urea nitrogen (bun)
117409|NCT02561247|Prismaflex|prismaflex
117410|NCT02561247|Pediatric|pediatric
117411|NCT02561221|primary care|primary care
117412|NCT02561221|pragmatic trial|pragmatic trial
117413|NCT02561221|weight loss|weight loss
117414|NCT02561221|overweight|overweight
117415|NCT02561221|diet|diet
117416|NCT02561221|physical activity|physical activity
117417|NCT02561221|PCORI|pcori
117418|NCT02561208|Patient adherence|patient adherence
117419|NCT02561208|Mobile Health|mobile health
117420|NCT02561208|HPV DNA Tests|hpv dna tests
117421|NCT02561208|Self-collected|self-collected
117422|NCT02561195|Clostridium difficile, Vaccine.|clostridium difficile, vaccine.
117423|NCT02561169|antiviral|antiviral
117424|NCT02561169|oseltamivir|oseltamivir
117425|NCT02561156|Drug therapy|drug therapy
117426|NCT02561143|cachexia|cachexia
117427|NCT02561143|nutrition supplementation|nutrition supplementation
117428|NCT02561143|IAtta|iatta
117429|NCT02561143|palliative care|palliative care
117430|NCT02561143|quality of life|quality of life
117431|NCT02561130|Diabetes|diabetes
117432|NCT02561130|Insulin|insulin
117433|NCT02561130|Glargine|glargine
117434|NCT02561130|Metformin|metformin
117435|NCT02561130|Forxiga|forxiga
117436|NCT02561130|Diet|diet
117437|NCT02561130|Exercise|exercise
117438|NCT02561130|Lifestyle|lifestyle
117439|NCT02561104|cataract|cataract
117440|NCT02561104|phacoemulsification|phacoemulsification
117441|NCT02561104|laser-assisted surgery|laser-assisted surgery
117442|NCT02561104|femtosecond laser|femtosecond laser
117443|NCT02561091|Deafness|deafness
117444|NCT02561091|Hearing Loss, Sensorineural|hearing loss, sensorineural
117445|NCT02561091|Ear Diseases|ear diseases
117446|NCT02561091|Hearing Disorders|hearing disorders
117447|NCT02561091|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
117448|NCT02561091|Sensation Disorders|sensation disorders
117449|NCT02561091|Signs and Symptoms|signs and symptoms
117450|NCT02561091|Hearing and Speech impairment|hearing and speech impairment
117451|NCT02561091|Hearing Loss, Unilateral|hearing loss, unilateral
117452|NCT02561078|insulin pumps|insulin pumps
117453|NCT02561078|concentrated insulin|concentrated insulin
117455|NCT02561065|Health Lifestyle|health lifestyle
117456|NCT02561065|Lifestyle Risk Reduction|lifestyle risk reduction
117457|NCT02561065|Health Behavior|health behavior
117658|NCT02559869|Biomarkers|biomarkers
117458|NCT02561065|Sedentary Lifestyle|sedentary lifestyle
117459|NCT02561065|Intervention Studies|intervention studies
117460|NCT02561065|Cardiovascular risk in office workers|cardiovascular risk in office workers
117461|NCT02561065|Motivational Interview|motivational interview
117462|NCT02561065|Preventive health services|preventive health services
117463|NCT02561065|Health education|health education
117464|NCT02561065|Physical activity|physical activity
117465|NCT02561065|Dietary behaviour intervention|dietary behaviour intervention
117466|NCT02561065|Workplace|workplace
117467|NCT02560012|Renal Cell Carcinoma|renal cell carcinoma
117469|NCT02560012|Personalized therapy|personalized therapy
117470|NCT02560012|targeted inhibitors|targeted inhibitors
117471|NCT02559999|Healthy Volunteers|healthy volunteers
117472|NCT02559999|Pain|pain
117473|NCT02559999|EEG|eeg
117474|NCT02559973|Buprenorphine|buprenorphine
117475|NCT02559973|opioid use disorder|opioid use disorder
117476|NCT02559921|Recombinant Human Rabies Immunoglobin (rhRIG)|recombinant human rabies immunoglobin (rhrig)
117477|NCT02561026|Frozen plasma|frozen plasma
117478|NCT02561026|INR|inr
117479|NCT02561026|procedures|procedures
117480|NCT02561000|Platelets|platelets
117481|NCT02561000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
117482|NCT02561000|Protease-Activated Receptor 1|protease-activated receptor 1
117483|NCT02561000|Hemorrhage|hemorrhage
117484|NCT02560961|Kinesio Taping|kinesio taping
117485|NCT02560961|Soccer|soccer
117486|NCT02560961|Hop Test|hop test
117487|NCT02560961|Vertical Jump|vertical jump
117488|NCT02560935|primary stroke prevention|primary stroke prevention
117489|NCT02560935|hydroxyurea|hydroxyurea
117490|NCT02560935|low income country|low income country
117491|NCT02560935|sub-Saharan Africa|sub-saharan africa
117492|NCT02560922|Osteoarthritis|osteoarthritis
117493|NCT02560922|Knee Osteoarthritis|knee osteoarthritis
117494|NCT02560922|Hip Osteoarthritis|hip osteoarthritis
117495|NCT02560896|Family|family
117496|NCT02560896|History|history
117497|NCT02560896|Pancreas|pancreas
117498|NCT02560896|Cancer|cancer
117499|NCT02560896|Genetic|genetic
117500|NCT02560883|Hairy Cell|hairy cell
117501|NCT02560857|Quantiferon-Monitor|quantiferon-monitor
117502|NCT02560857|organ rejection|organ rejection
117503|NCT02560857|global immunity|global immunity
117504|NCT02560831|Osteoarthritis|osteoarthritis
117505|NCT02560831|Therapeutic exercises|therapeutic exercises
117506|NCT02560831|Pain|pain
117507|NCT02560831|Muscle strength|muscle strength
117508|NCT02560831|Postural balance|postural balance
108605|NCT02613923|sleep|sleep
117509|NCT02560818|splice profiles of messenger RNA|splice profiles of messenger rna
117510|NCT02560779|TRC105|trc105
117511|NCT02560779|CD105|cd105
117512|NCT02560779|Endoglin|endoglin
117513|NCT02560779|Angiogenesis inhibitor|angiogenesis inhibitor
117515|NCT02560779|TKI|tki
117516|NCT02560779|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
117517|NCT02560779|Sorafenib|sorafenib
117518|NCT02560779|Nexavar|nexavar
117519|NCT02560766|Restless Leg Syndrome|restless leg syndrome
117520|NCT02560766|RLS|rls
117521|NCT02560727|Inflammatory Bowel Diseases|inflammatory bowel diseases
117522|NCT02560727|Fecal Microbiota Transplantation|fecal microbiota transplantation
117523|NCT02560727|transendoscopic enteral tubing|transendoscopic enteral tubing
117524|NCT02560714|sacroiliac joint fusion|sacroiliac joint fusion
117525|NCT02560714|SIJ Fusion|sij fusion
117526|NCT02560714|SI Joint|si joint
117527|NCT02560714|SIJ|sij
117528|NCT02560701|high-deductible health plans|high-deductible health plans
117529|NCT02560701|medication adherence|medication adherence
117530|NCT02560688|drug interaction|drug interaction
117531|NCT02560688|clopidogrel|clopidogrel
117532|NCT02560688|healthy subjects|healthy subjects
117533|NCT02560675|Whiplash Injury Pain|whiplash injury pain
117534|NCT02560675|Chronic Pain|chronic pain
117535|NCT02560675|TBI|tbi
117536|NCT02560662|Breast cancer, physical exercise, recovery|breast cancer, physical exercise, recovery
117537|NCT02560636|Muscle Invasive|muscle invasive
117538|NCT02560636|Metastatic|metastatic
117539|NCT02560636|Advanced|advanced
117540|NCT02560623|Barrett's|barrett's
117541|NCT02560623|esophagus|esophagus
117543|NCT02560623|esophageal adenocarcinoma|esophageal adenocarcinoma
117544|NCT02560597|epilepsy|epilepsy
117545|NCT02560597|epilepsia partialis continua|epilepsia partialis continua
117546|NCT02560597|status epilepticus|status epilepticus
117547|NCT02560597|treatment resistant|treatment resistant
117646|NCT02560051|Prostate Cancer|prostate cancer
117548|NCT02560597|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
117549|NCT02560584|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
117550|NCT02560584|NMIBC|nmibc
117551|NCT02560584|Cysview|cysview
117552|NCT02560558|Immunosuppression|immunosuppression
117553|NCT02560558|Transplantation Immunology|transplantation immunology
117554|NCT02560532|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
117555|NCT02560532|cerebral vasospasm|cerebral vasospasm
117556|NCT02560532|clazosentan|clazosentan
117557|NCT02560519|human serum albumin solution|human serum albumin solution
117558|NCT02560519|Cardiopulmonary Bypass|cardiopulmonary bypass
117559|NCT02560493|BMIz|bmiz
117560|NCT02560493|Exergaming|exergaming
117561|NCT02560493|Cardiovascular Disease|cardiovascular disease
117562|NCT02560480|groin pain, groin injury, magnetic resonance imaging|groin pain, groin injury, magnetic resonance imaging
117563|NCT02560454|Cognitive Remediation|cognitive remediation
117564|NCT02560454|Working Memory Training|working memory training
117565|NCT02560454|Cognitive training|cognitive training
117566|NCT02560428|Mixed Methods|mixed methods
117567|NCT02560428|Cardiovascular Health|cardiovascular health
117568|NCT02560428|Implementation Evaluation|implementation evaluation
117569|NCT02560428|Cardiovascular Prevention Screening|cardiovascular prevention screening
117570|NCT02560415|Autism Spectrum Disorder|autism spectrum disorder
117571|NCT02560415|Serious Game|serious game
117572|NCT02560415|Controlled trial|controlled trial
117573|NCT02560415|Denver model|denver model
117574|NCT02560402|Glomerular hyperfiltration|glomerular hyperfiltration
117575|NCT02560402|Renal Resistive Index (RRI)|renal resistive index (rri)
117576|NCT02560389|Posttraumatic Stress Disorder|posttraumatic stress disorder
117577|NCT02560389|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
117578|NCT02560389|Levodopa (L-DOPA)|levodopa (l-dopa)
117579|NCT02560389|Exposure Therapy|exposure therapy
117580|NCT02560389|Fear Extinction|fear extinction
117581|NCT02560376|PET/CT|pet/ct
117582|NCT02560376|glucagon-like peptide-1 receptor (GLP-1R) imaging|glucagon-like peptide-1 receptor (glp-1r) imaging
117583|NCT02560363|AZD9977|azd9977
117584|NCT02560363|Safety|safety
117585|NCT02560363|Tolerability|tolerability
117586|NCT02560363|Pharmacokinetics|pharmacokinetics
117587|NCT02560363|Food effect|food effect
117588|NCT02560363|AZD9977 capsules|azd9977 capsules
117589|NCT02560363|AZD9977 suspension|azd9977 suspension
117590|NCT02560350|adipose-derived stem cells|adipose-derived stem cells
117591|NCT02560350|small intestinal submucosa|small intestinal submucosa
117592|NCT02560350|adipocyte-containing hypodermis|adipocyte-containing hypodermis
117593|NCT02560337|Ovarian cancer|ovarian cancer
117594|NCT02560337|Relapse|relapse
117595|NCT02560337|Recurrence|recurrence
117596|NCT02560337|Chemotherapy resistance|chemotherapy resistance
117597|NCT02560324|Ramelteon|ramelteon
117598|NCT02560324|Nicotine|nicotine
117599|NCT02560324|Nicotine dependence|nicotine dependence
117600|NCT02560324|Insomnia|insomnia
117601|NCT02560324|Tobacco Dependence|tobacco dependence
117602|NCT02560285|Risk assessment|risk assessment
117603|NCT02560285|Mortality|mortality
117604|NCT02560285|Morbidity|morbidity
117605|NCT02560285|Risk factor|risk factor
117606|NCT02560272|vaccine|vaccine
117607|NCT02560272|haemophilus influenzae type b|haemophilus influenzae type b
117608|NCT02560259|knee pain|knee pain
117609|NCT02560246|Microbiome|microbiome
117610|NCT02560233|Neurofeedback|neurofeedback
117611|NCT02560233|Stress|stress
117612|NCT02560233|fMRI|fmri
117613|NCT02560233|Real-time fMRI Neurofeedback|real-time fmri neurofeedback
117614|NCT02560233|Anterior cingulate cortex|anterior cingulate cortex
117615|NCT02560233|Hypothalamic-pituitary-adrenal axis|hypothalamic-pituitary-adrenal axis
117616|NCT02560233|Cortisol|cortisol
117617|NCT02560233|EEG|eeg
117618|NCT02560233|Heart rate variability|heart rate variability
117619|NCT02560233|Blood pressure|blood pressure
117620|NCT02560233|Simultaneous EEG/fMRI|simultaneous eeg/fmri
117621|NCT02560181|recurrent prostate cancer,HDR whole gland salvage|recurrent prostate cancer,hdr whole gland salvage
117622|NCT02560168|Coronary artery disease|coronary artery disease
117623|NCT02560168|iECG|iecg
117624|NCT02560168|MyoVista|myovista
117625|NCT02560168|Heart Test Labs|heart test labs
117626|NCT02560168|Wavelet analysis|wavelet analysis
117627|NCT02560168|Surface electrocardiogram|surface electrocardiogram
117628|NCT02560155|Orthopedic surgery|orthopedic surgery
117629|NCT02560155|Surgical site infection|surgical site infection
117630|NCT02560155|Decolonization|decolonization
117631|NCT02560155|Staphylococcus aureus|staphylococcus aureus
117632|NCT02560129|recovery|recovery
117633|NCT02560129|ICU|icu
117634|NCT02560129|clinic|clinic
117635|NCT02560129|survivor|survivor
117636|NCT02560129|physical function|physical function
117637|NCT02560116|Pulmonary artery systolic pressure|pulmonary artery systolic pressure
117639|NCT02560090|Diabetes|diabetes
117640|NCT02560077|cognitive|cognitive
117641|NCT02560077|memory|memory
117642|NCT02560077|physical fitness|physical fitness
117643|NCT02560077|psychological fitness|psychological fitness
117644|NCT02560077|elderly|elderly
117647|NCT02560051|Advanced|advanced
117648|NCT02560051|Local Failures|local failures
117649|NCT02560038|Urothelial Cancer|urothelial cancer
117650|NCT02560038|Bladder Cancer|bladder cancer
117651|NCT02560038|Metastatic|metastatic
117652|NCT02560025|Acute Myeloid Leukemia|acute myeloid leukemia
117653|NCT02559869|Biofluid|biofluid
117654|NCT02559869|ALS|als
117655|NCT02559869|MRI|mri
117656|NCT02559869|PET|pet
117657|NCT02559869|Imaging|imaging
117659|NCT02559869|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
117660|NCT02559869|TRACK ALS|track als
117661|NCT02559869|pathology|pathology
117662|NCT02559843|pomegranate|pomegranate
117663|NCT02559843|diabetes|diabetes
117664|NCT02559843|oxidative stress|oxidative stress
117665|NCT02559817|Irritable Bowel Syndrome with Constipation in children|irritable bowel syndrome with constipation in children
117666|NCT02559817|Linzess|linzess
117667|NCT02559791|Reslizumab|reslizumab
117668|NCT02559791|Eosinophils|eosinophils
117669|NCT02559791|Asthma|asthma
117670|NCT02559791|Airway inflammation|airway inflammation
117671|NCT02559791|Prednisone|prednisone
117672|NCT02559765|physiotherapy|physiotherapy
117673|NCT02559765|progressive multiple sclerosis|progressive multiple sclerosis
117674|NCT02559765|rehabilitation|rehabilitation
117675|NCT02559765|rehabilitation services|rehabilitation services
117676|NCT02559739|Stroke|stroke
117677|NCT02559739|Ischemic Attack, Transient|ischemic attack, transient
117678|NCT02559739|Cardiovascular Diseases|cardiovascular diseases
117679|NCT02559739|Sleep Apnea Syndromes|sleep apnea syndromes
117680|NCT02559739|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
117681|NCT02559739|Insomnia|insomnia
117682|NCT02559739|Restless Legs Syndrome|restless legs syndrome
117683|NCT02559739|Sleep Deprivation|sleep deprivation
117684|NCT02559726|Hypertrophic cardiomyopathy, hyper-synchronicity, outflow-tract obstruction, dual chamber pacing|hypertrophic cardiomyopathy, hyper-synchronicity, outflow-tract obstruction, dual chamber pacing
117685|NCT02559713|Lactation|lactation
117686|NCT02559713|Lactating Women|lactating women
117687|NCT02559713|Vedolizumab|vedolizumab
117688|NCT02559713|Colitis Ulcerative|colitis ulcerative
117689|NCT02559713|Crohn Disease|crohn disease
117691|NCT02559700|Healthy Ageing|healthy ageing
117692|NCT02559687|PD1|pd1
117693|NCT02559687|PD-L1|pd-l1
117694|NCT02559687|PDL1|pdl1
117695|NCT02559674|Pancreas|pancreas
117696|NCT02559674|Pancreatic|pancreatic
117697|NCT02559674|Cancer|cancer
117698|NCT02559674|Advanced Pancreatic Cancer|advanced pancreatic cancer
117699|NCT02559674|Immunotherapy|immunotherapy
117700|NCT02559674|Immunotherapeutic|immunotherapeutic
117701|NCT02559674|Interleukin-15|interleukin-15
117702|NCT02559674|Gemcitabine|gemcitabine
117703|NCT02559674|Nab-paclitaxel|nab-paclitaxel
117704|NCT02559674|Solid Tumor|solid tumor
117705|NCT02559674|Metastatic Disease|metastatic disease
117706|NCT02559674|Combination Immunotherapy|combination immunotherapy
117707|NCT02559583|Multiple Myeloma|multiple myeloma
117708|NCT02559583|chronic lymphocytic leukemia|chronic lymphocytic leukemia
117709|NCT02559583|Non-Hodgkin lymphoma|non-hodgkin lymphoma
117710|NCT02559570|Functional constipation in children|functional constipation in children
117711|NCT02559570|Linzess|linzess
117712|NCT02559544|failed prior endocrine therapy|failed prior endocrine therapy
117713|NCT02559518|Cerebellum|cerebellum
117714|NCT02559518|Transcranial Direct Current Stimulation|transcranial direct current stimulation
117715|NCT02559518|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
117716|NCT02559518|Motor Learning|motor learning
117717|NCT02559518|Serial Reaction Time Task|serial reaction time task
117718|NCT02559518|HandwritingTask|handwritingtask
117719|NCT02559505|natural influenza infection|natural influenza infection
117720|NCT02559505|live attenuated influenza vaccination (LAIV)|live attenuated influenza vaccination (laiv)
117721|NCT02559505|inactivated influenza vaccination (IIV)|inactivated influenza vaccination (iiv)
117722|NCT02559505|infants|infants
117723|NCT02559505|children|children
117724|NCT02559466|pharmaco-resistant depressed patients|pharmaco-resistant depressed patients
117725|NCT02559427|sleep apnea|sleep apnea
117726|NCT02559427|Venous Insufficiency|venous insufficiency
117727|NCT02559427|SPA treatment|spa treatment
117728|NCT02559401|Eloquent cortex|eloquent cortex
117729|NCT02559349|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
117730|NCT02559349|SBRT|sbrt
117731|NCT02559336|Palliative Care|palliative care
117732|NCT02559336|Cancer|cancer
117738|NCT02559297|Regulatory T cells|regulatory t cells
117740|NCT02559297|Desflurane|desflurane
117741|NCT02559297|Cytokines|cytokines
117742|NCT02559297|Flow cytometry|flow cytometry
117743|NCT02559297|Living Donor Kidney Transplant|living donor kidney transplant
117748|NCT02559180|Diabetes|diabetes
117749|NCT02559180|Macular Edema|macular edema
117750|NCT02559180|Diabetic Retinopathy|diabetic retinopathy
117751|NCT02559141|haemodynamic optimization|haemodynamic optimization
117752|NCT02559141|cardiac index|cardiac index
117753|NCT02559141|non-invasive|non-invasive
117754|NCT02559141|pulse pressure variation|pulse pressure variation
117755|NCT02559128|Insulin Resistance|insulin resistance
118156|NCT02556684|BSGI|bsgi
117756|NCT02559128|Chronic Heart Failure|chronic heart failure
117757|NCT02559128|Type 2 Diabetes|type 2 diabetes
117758|NCT02559128|Endothelial Dysfunction|endothelial dysfunction
117759|NCT02559115|68Ga-RM2|68ga-rm2
117760|NCT02559115|PET/CT scan|pet/ct scan
117761|NCT02559115|Gastrin Releasing Peptide Receptor (GRPr)|gastrin releasing peptide receptor (grpr)
117763|NCT02559102|Dexmedetomidine sedation|dexmedetomidine sedation
117764|NCT02559102|General anaesthesia|general anaesthesia
117765|NCT02559102|Neurodevelopment|neurodevelopment
117766|NCT02559102|Infants|infants
117767|NCT02559102|Neonates|neonates
117768|NCT02559076|Overweight|overweight
117769|NCT02559076|Obesity|obesity
117770|NCT02559076|Preschool children|preschool children
117771|NCT02559076|United Arab Emirates|united arab emirates
117772|NCT02559076|Dietary patterns|dietary patterns
117773|NCT02559076|BMI z-scores|bmi z-scores
117774|NCT02559063|cognitive training|cognitive training
117775|NCT02559063|speed of processing|speed of processing
117776|NCT02559063|neuroplasticity|neuroplasticity
117777|NCT02559063|cognitive aging|cognitive aging
117778|NCT02559037|acupuncture|acupuncture
117779|NCT02559037|moxibustion|moxibustion
117780|NCT02559037|intestinal microbiota|intestinal microbiota
117781|NCT02559037|Mucosal immunity|mucosal immunity
117782|NCT02559024|Metastatic colorectal cancer|metastatic colorectal cancer
117783|NCT02559024|liver lesion|liver lesion
117784|NCT02559024|anti-OX40 antibody|anti-ox40 antibody
117785|NCT02559024|MEDI6469|medi6469
117786|NCT02559024|Immunotherapy|immunotherapy
117787|NCT02559011|Arrhythmias, Cardiac|arrhythmias, cardiac
117788|NCT02559011|Transcatheter Aortic Valve implantation|transcatheter aortic valve implantation
117789|NCT02559011|Aortic Valve Stenosis|aortic valve stenosis
117790|NCT02558985|Pulmonary Compliance|pulmonary compliance
117791|NCT02558985|Casting|casting
117792|NCT02558972|Postural Tachycardia Syndrome (POTS)|postural tachycardia syndrome (pots)
117793|NCT02558972|Vasovagal Syncope (VVS)|vasovagal syncope (vvs)
117797|NCT02558972|Northera|northera
117798|NCT02558933|Fetal Alcohol Syndrome|fetal alcohol syndrome
117799|NCT02558933|Prenatal exposure|prenatal exposure
117800|NCT02558933|Biomarkers|biomarkers
117801|NCT02558933|Oxidative stress|oxidative stress
117802|NCT02558933|Epigallocatechin gallate|epigallocatechin gallate
117803|NCT02558920|Systematic review and meta-analysis|systematic review and meta-analysis
117804|NCT02558920|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
117805|NCT02558920|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
117806|NCT02558920|Clinical practice guidelines|clinical practice guidelines
117807|NCT02558920|Clinical trials|clinical trials
117808|NCT02558920|Dietary sugars|dietary sugars
117809|NCT02558920|Fructose|fructose
117810|NCT02558920|Sucrose|sucrose
117811|NCT02558920|High fructose corn syrup|high fructose corn syrup
117812|NCT02558920|Isocaloric|isocaloric
117813|NCT02558920|Hypercaloric|hypercaloric
117814|NCT02558920|Body weight|body weight
141029|NCT02421861|anxiety|anxiety
117815|NCT02558920|Prospective cohort studies|prospective cohort studies
117816|NCT02558907|geriatrics|geriatrics
117817|NCT02558907|cancer|cancer
117818|NCT02558907|MMS test|mms test
117819|NCT02558907|MoCA test|moca test
117820|NCT02558907|cognitive evaluation|cognitive evaluation
117821|NCT02558894|Pancreatic Ductal Adenocarcinoma, PDAC|pancreatic ductal adenocarcinoma, pdac
117822|NCT02558881|screening|screening
117823|NCT02558881|colorectal cancer|colorectal cancer
117824|NCT02558881|colon capsule|colon capsule
117825|NCT02558881|virtual colonoscopy|virtual colonoscopy
117826|NCT02558855|Thrust Joint Manipulation|thrust joint manipulation
117827|NCT02558855|Non-thrust Joint Manipulation|non-thrust joint manipulation
651813|NCT00785005|Women|women
117828|NCT02558855|Transversus Abdominis|transversus abdominis
117829|NCT02558829|Adult Growth Hormone Deficiency|adult growth hormone deficiency
117830|NCT02558803|HPV Vaccinations|hpv vaccinations
117831|NCT02558803|Quadrivalent Vaccine|quadrivalent vaccine
117832|NCT02558790|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
117833|NCT02558790|ADHD|adhd
117834|NCT02558790|Attention Deficit Disorder|attention deficit disorder
117835|NCT02558790|ADD|add
117836|NCT02558790|Magnesium|magnesium
117837|NCT02558777|Delirium|delirium
117838|NCT02558777|Pilot Study|pilot study
117839|NCT02558777|Nurse intervention|nurse intervention
117840|NCT02558777|Hospitalization|hospitalization
117841|NCT02558751|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
117842|NCT02558751|aging HIV|aging hiv
117843|NCT02558738|dermatitis and irritations at the outer ear canal|dermatitis and irritations at the outer ear canal
117844|NCT02558738|prevention of subacute otitis externa|prevention of subacute otitis externa
117845|NCT02558712|screening|screening
117846|NCT02558712|tele-ophthalmology|tele-ophthalmology
117847|NCT02558686|trigger points|trigger points
117848|NCT02558686|disability|disability
117849|NCT02558686|post-dry needling soreness|post-dry needling soreness
117850|NCT02558686|eccentric exercise|eccentric exercise
117851|NCT02558673|Trimethylamine-N-oxide|trimethylamine-n-oxide
117852|NCT02558673|Biomarkers|biomarkers
117853|NCT02558673|Production|production
117854|NCT02558673|Metabolism|metabolism
117855|NCT02558673|Gut microbiome|gut microbiome
117857|NCT02558660|Supplemental Nutrition Incentive Program (SNAP)|supplemental nutrition incentive program (snap)
117858|NCT02558660|economic incentive|economic incentive
117859|NCT02558621|Robotic Spinal Fusion Surgery|robotic spinal fusion surgery
117860|NCT02558608|Prime Spontaneous Pneumothorax|prime spontaneous pneumothorax
117861|NCT02558608|recurrence|recurrence
117862|NCT02558595|PKD|pkd
117863|NCT02558595|Kidney disease|kidney disease
117864|NCT02558595|Vitamin B3|vitamin b3
117865|NCT02558582|Pulmonary arterial hypertension|pulmonary arterial hypertension
117866|NCT02558582|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
117867|NCT02558582|Rehabilitation|rehabilitation
117868|NCT02558582|Oxygen|oxygen
117869|NCT02558569|fentanyl, scalp block|fentanyl, scalp block
117870|NCT02558556|Laparoscopic cholecystectomy (LC)|laparoscopic cholecystectomy (lc)
117871|NCT02558556|Indocyanine green (ICG)|indocyanine green (icg)
117872|NCT02558556|Near-Infrared Fluorescence Imaging (NIRF)|near-infrared fluorescence imaging (nirf)
117873|NCT02558556|Critical View of Safety (CVS)|critical view of safety (cvs)
117874|NCT02558517|Systemic Lupus Erythematosus|systemic lupus erythematosus
117875|NCT02558517|Corticosteroids|corticosteroids
117876|NCT02558517|Chronic disease|chronic disease
117877|NCT02558491|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
117878|NCT02558491|Artificial Pancreas Project (APP)|artificial pancreas project (app)
117879|NCT02558491|Diabetes Assistant (DiAs)|diabetes assistant (dias)
117880|NCT02558491|Insulin Pump|insulin pump
117881|NCT02558491|Continuous Glucose Monitor|continuous glucose monitor
117882|NCT02558491|Exercise|exercise
117883|NCT02558491|Glucose Variability|glucose variability
117884|NCT02558491|Decision Support System|decision support system
117885|NCT02558491|Multiple Daily Injections (MDI)|multiple daily injections (mdi)
117886|NCT02558478|Whole exome sequencing|whole exome sequencing
117887|NCT02558465|Xarelto, rivaroxaban, VTE, PE, DVT, Japan, PMS, SDUI|xarelto, rivaroxaban, vte, pe, dvt, japan, pms, sdui
117888|NCT02558452|elderly kidney transplant recipient|elderly kidney transplant recipient
117889|NCT02558452|registry|registry
117890|NCT02558452|tacrolimus once daily|tacrolimus once daily
117891|NCT02558426|Chronic Venous Disease|chronic venous disease
117892|NCT02558426|Estrogen receptors|estrogen receptors
117893|NCT02558426|GPER|gper
117894|NCT02558413|Viral Diseases|viral diseases
117895|NCT02558413|Antiviral|antiviral
117896|NCT02558413|Paramyxoviridae Infections|paramyxoviridae infections
117897|NCT02558413|RSV|rsv
117898|NCT02558413|Respiratory Syncytial Virus|respiratory syncytial virus
117899|NCT02558413|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
117900|NCT02558413|Aviragen Therapeutics|aviragen therapeutics
117901|NCT02558413|Aviragen|aviragen
117902|NCT02558348|Dual receptor Tyrosine Kinase Inhibitor|dual receptor tyrosine kinase inhibitor
117903|NCT02558348|Anti-angiogenic therapy|anti-angiogenic therapy
117904|NCT02558257|Advanced Cancers|advanced cancers
117905|NCT02558257|Survey|survey
117906|NCT02558257|Questionnaire|questionnaire
117907|NCT02558244|Childhood Cancer|childhood cancer
117908|NCT02558244|Image-defined Risk Factors|image-defined risk factors
117909|NCT02558244|Pediatric Oncology|pediatric oncology
117910|NCT02558192|LGG|lgg
117911|NCT02558192|Probiotics|probiotics
117912|NCT02558192|nosocomial infection prevention|nosocomial infection prevention
117913|NCT02558192|pediatrics|pediatrics
117914|NCT02558166|Acute Kidney Injury (AKI)|acute kidney injury (aki)
117915|NCT02558166|Renal Resistive Index (RRI)|renal resistive index (rri)
117916|NCT02558153|drug eluting balloon|drug eluting balloon
117917|NCT02558153|percutaneous balloon angioplasty|percutaneous balloon angioplasty
117918|NCT02558127|asthma|asthma
117919|NCT02558127|cystic fibrosis|cystic fibrosis
117920|NCT02558101|Screening|screening
117921|NCT02558101|Early detection|early detection
117922|NCT02558101|Health inequality|health inequality
117923|NCT02558101|Uptake|uptake
117924|NCT02558088|salmeterol|salmeterol
117925|NCT02558088|pharmacokinetics|pharmacokinetics
117926|NCT02558088|doping|doping
117927|NCT02558088|beta2-agonists|beta2-agonists
117928|NCT02558088|long-acting beta2-agonists|long-acting beta2-agonists
117929|NCT02558062|Ventilator Associated Pneumonia|ventilator associated pneumonia
117930|NCT02558062|Distal lung|distal lung
117931|NCT02558049|Patient decision aid|patient decision aid
117932|NCT02558036|Head Neck Position Videolaryngoscopy|head neck position videolaryngoscopy
117933|NCT02558023|PRE-ECLAMPSIA|pre-eclampsia
117934|NCT02558023|URAPIDIL|urapidil
117935|NCT02558023|NICARDIPINE|nicardipine
117936|NCT02558010|Methadone|methadone
117937|NCT02558010|Gabapentin|gabapentin
117938|NCT02558010|Postoperative Pain|postoperative pain
117939|NCT02558010|Posterior Spinal Fusion|posterior spinal fusion
117940|NCT02558010|Pediatric|pediatric
117941|NCT02557997|HIV reservoir|hiv reservoir
117942|NCT02557997|HIV-1 DNA|hiv-1 dna
117943|NCT02557997|Immune activation|immune activation
117944|NCT02557997|Monocyte function|monocyte function
117945|NCT02557997|Activation biomarkers|activation biomarkers
117946|NCT02557984|Dopamine|dopamine
117947|NCT02557984|Opioid|opioid
117948|NCT02557984|Reward|reward
117949|NCT02557958|COPD, pulmonary disease|copd, pulmonary disease
117950|NCT02557932|PPI standard triple therapy|ppi standard triple therapy
117951|NCT02557932|Bismuth quadruple therapy|bismuth quadruple therapy
117952|NCT02557932|Helicobacter|helicobacter
117953|NCT02557906|Acellular dermal matrix|acellular dermal matrix
117954|NCT02557906|ADM|adm
117955|NCT02557906|SurgiMend|surgimend
117956|NCT02557906|Breast reconstruction|breast reconstruction
117957|NCT02557906|Immediate breast reconstruction|immediate breast reconstruction
117958|NCT02557906|Autologous reconstruction|autologous reconstruction
117959|NCT02557906|Biological mesh|biological mesh
117960|NCT02557867|dexmedetomidine|dexmedetomidine
117961|NCT02557867|pharmacokinetic|pharmacokinetic
117962|NCT02557867|obesity|obesity
117963|NCT02557841|Cerebellum|cerebellum
117964|NCT02557841|Transcranial Direct Current Stimulation|transcranial direct current stimulation
117965|NCT02557841|Motor Learning|motor learning
117966|NCT02557841|Serial Reaction Time Task|serial reaction time task
117967|NCT02557841|Handwriting|handwriting
117968|NCT02557815|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
117969|NCT02557815|Emotion Regulation|emotion regulation
117970|NCT02557815|Craving|craving
117971|NCT02557789|Absolute bioavailability|absolute bioavailability
117972|NCT02557789|Pharmacokinetics|pharmacokinetics
117973|NCT02557776|BRCA1|brca1
117974|NCT02557776|BRCA2|brca2
117975|NCT02557776|hereditary breast cancer|hereditary breast cancer
117976|NCT02557776|genetic counseling|genetic counseling
117977|NCT02557763|Oxford UKA|oxford uka
117978|NCT02557763|anterior knee pain|anterior knee pain
117979|NCT02557763|lateral facet of patella|lateral facet of patella
117980|NCT02557750|Childhood Cancer|childhood cancer
117991|NCT02557711|acoustic radiation force impulse|acoustic radiation force impulse
117993|NCT02557659|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
117994|NCT02557659|Endovascular|endovascular
117995|NCT02557594|Hepatitis B|hepatitis b
117996|NCT02557568|nasal carriage|nasal carriage
117997|NCT02557568|Staphylococcus aureus|staphylococcus aureus
117998|NCT02557568|hemodialysis patients|hemodialysis patients
117999|NCT02557542|Varicose Veins; One Stop Clinic|varicose veins; one stop clinic
118000|NCT02557529|Head and Neck Cancer|head and neck cancer
118001|NCT02557529|Concomitant chemoradiotherapy|concomitant chemoradiotherapy
118002|NCT02557529|Exercise Training|exercise training
118003|NCT02557529|Progressive Resistance Training|progressive resistance training
118004|NCT02557529|Weight loss|weight loss
118005|NCT02557529|Lean Body Mass|lean body mass
118006|NCT02557529|Body Composition|body composition
118007|NCT02557503|TACE; oxaliplatin; fluorouracil; liver cancer|tace; oxaliplatin; fluorouracil; liver cancer
118008|NCT02557490|TACE; hepatic artery infusion; oxaliplatin; raltitrexed|tace; hepatic artery infusion; oxaliplatin; raltitrexed
109115|NCT02610387|tDCS|tdcs
118009|NCT02557464|semantic memory|semantic memory
118010|NCT02557464|eye movements|eye movements
118011|NCT02557464|reading|reading
118012|NCT02557438|Bone|bone
118013|NCT02557438|Child Health|child health
118014|NCT02557438|Nutrition|nutrition
118015|NCT02557425|malaria|malaria
118016|NCT02557425|infant|infant
118017|NCT02557425|pregnancy|pregnancy
118018|NCT02557425|prophylaxis|prophylaxis
118019|NCT02557425|dihyroartemisinin-piperaquine|dihyroartemisinin-piperaquine
118020|NCT02557425|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
118021|NCT02557425|behavior|behavior
118022|NCT02557425|neurodevelopment|neurodevelopment
118023|NCT02557425|cognitive|cognitive
118024|NCT02557399|Clindamycin|clindamycin
118026|NCT02557399|Benzoyl Peroxide|benzoyl peroxide
118027|NCT02557399|Acne Vulgaris|acne vulgaris
118028|NCT02557386|Cruciate ligament surgery|cruciate ligament surgery
118029|NCT02557386|Adductor canal|adductor canal
118030|NCT02557386|Nerve block|nerve block
118031|NCT02557373|rice bran|rice bran
118032|NCT02557373|infants|infants
118033|NCT02557373|stool metabolome and microbiome|stool metabolome and microbiome
118034|NCT02557373|dietary intervention|dietary intervention
118035|NCT02557360|liver injury|liver injury
118036|NCT02557360|detoxification|detoxification
118037|NCT02557360|S-adenosyl-L-methionine|s-adenosyl-l-methionine
118038|NCT02557360|quality of life|quality of life
118039|NCT02557334|Strawberry Powder|strawberry powder
118040|NCT02557334|Cardiovascular Disease Risk Factors|cardiovascular disease risk factors
118041|NCT02557269|Pollenosis|pollenosis
118042|NCT02557269|Congestion|congestion
118043|NCT02557269|Mucoadhesive Treatment|mucoadhesive treatment
118044|NCT02557269|Nasal Decongestant|nasal decongestant
118045|NCT02557269|Nasal Antihistamine|nasal antihistamine
118046|NCT02557269|Nasal Corticosteroid|nasal corticosteroid
118047|NCT02557256|Childhood Cancer|childhood cancer
118048|NCT02557256|Abdominal Tumors|abdominal tumors
118049|NCT02557256|Pelvic Tumors|pelvic tumors
118050|NCT02557256|Pediatric Oncology|pediatric oncology
118051|NCT02557243|Childhood Cancer|childhood cancer
118052|NCT02557243|Soft Tissue Tumors|soft tissue tumors
118053|NCT02557243|Bone Tumors|bone tumors
118054|NCT02557243|Extremity Tumor|extremity tumor
118055|NCT02557243|Pediatric Oncology|pediatric oncology
118056|NCT02557230|Childhood Cancer|childhood cancer
118057|NCT02557230|Genitourinary tumors|genitourinary tumors
118058|NCT02557230|urogenital tumors|urogenital tumors
118059|NCT02557230|Pediatric Oncology|pediatric oncology
118060|NCT02557204|nasogastric tube insertion|nasogastric tube insertion
118061|NCT02557204|Video laryngoscope|video laryngoscope
118062|NCT02557204|success rate|success rate
118063|NCT02557165|Muscle regeneration|muscle regeneration
118064|NCT02557113|cement leakage|cement leakage
118065|NCT02557113|cement augmentation|cement augmentation
118066|NCT02557113|vertebral body fracture|vertebral body fracture
118067|NCT02557113|vertebral cavity|vertebral cavity
118068|NCT02557113|vertebroplasty|vertebroplasty
118849|NCT02552407|STEMI|stemi
118069|NCT02557048|Childhood Cancer|childhood cancer
118070|NCT02557048|Head and Neck Tumors|head and neck tumors
118071|NCT02557048|Pediatric Oncology|pediatric oncology
118072|NCT02557022|Systematic review and meta-analysis|systematic review and meta-analysis
118073|NCT02557022|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
118074|NCT02557022|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
118075|NCT02557022|Clinical practice guidelines|clinical practice guidelines
118076|NCT02557022|Glycemic index|glycemic index
118077|NCT02557022|Glycemic load|glycemic load
118078|NCT02557022|Body weight|body weight
118079|NCT02557022|Cardiovascular risk factors|cardiovascular risk factors
118080|NCT02557022|Cardiovascular disease|cardiovascular disease
118081|NCT02557009|Hemodynamics|hemodynamics
118082|NCT02557009|Central Venous Pressure|central venous pressure
118083|NCT02557009|Pulmonary Artery Pressure|pulmonary artery pressure
118084|NCT02557009|Cardiac Output|cardiac output
118085|NCT02556983|Appendicitis|appendicitis
118086|NCT02556983|Tomography, X-Ray Computed|tomography, x-ray computed
118087|NCT02556983|Receiver operating characteristic (ROC) Curve|receiver operating characteristic (roc) curve
118088|NCT02556983|Computer Simulation|computer simulation
118089|NCT02556944|Depth of focus|depth of focus
118090|NCT02556931|immunosuppression|immunosuppression
118091|NCT02556931|nonmyeloablative|nonmyeloablative
118092|NCT02556931|non-myeloablative|non-myeloablative
118093|NCT02556931|allogeneic|allogeneic
118094|NCT02556931|tacrolimus|tacrolimus
118095|NCT02556931|peripheral blood|peripheral blood
118096|NCT02556931|cyclophosphamide|cyclophosphamide
118097|NCT02556931|mycophenolate mofetil|mycophenolate mofetil
118098|NCT02556918|Coronary artery bypass graft surgery (CABG)|coronary artery bypass graft surgery (cabg)
118099|NCT02556918|Type 2 Diabetes|type 2 diabetes
118100|NCT02556905|Multiple Myeloma|multiple myeloma
118101|NCT02556905|Revlimid|revlimid
118102|NCT02556905|Lenalidomide|lenalidomide
118103|NCT02556905|Observational|observational
118104|NCT02556905|Korea|korea
118105|NCT02556905|Post Marketing Surveillance[PMS]|post marketing surveillance[pms]
118106|NCT02556892|Lymphocytic Leukemia|lymphocytic leukemia
118107|NCT02556892|Ibrutinib|ibrutinib
118108|NCT02556892|PCI-32765|pci-32765
118109|NCT02556892|JNJ-54179060|jnj-54179060
118110|NCT02556879|Liver transplantation|liver transplantation
118111|NCT02556879|Graft failure|graft failure
118114|NCT02556853|Double lumen tube|double lumen tube
118115|NCT02556840|Monogenic diabetes|monogenic diabetes
118116|NCT02556840|maturity-onset diabetes of the young|maturity-onset diabetes of the young
118117|NCT02556840|MODY|mody
118118|NCT02556840|Pregnancy|pregnancy
118119|NCT02556840|Gestational diabetes|gestational diabetes
118120|NCT02556840|Glucokinase|glucokinase
118121|NCT02556840|Insulin therapy during pregnancy|insulin therapy during pregnancy
118122|NCT02556840|Evaluation of fetal growth by ultrasonography measurements|evaluation of fetal growth by ultrasonography measurements
118123|NCT02556827|demodex|demodex
118124|NCT02556827|oxidative stress|oxidative stress
118125|NCT02556827|reflectance confocal microscopy|reflectance confocal microscopy
118127|NCT02556814|Caffeic Acid|caffeic acid
118128|NCT02556814|dexamethasone|dexamethasone
118383|NCT02555306|Macular Degeneration|macular degeneration
118129|NCT02556801|Sublingual immunotherapy|sublingual immunotherapy
118130|NCT02556801|Dose range finding|dose range finding
118131|NCT02556801|Grass pollen|grass pollen
118132|NCT02556801|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
118133|NCT02556801|Immunogenicity|immunogenicity
118137|NCT02556762|Esophageal cancer|esophageal cancer
118138|NCT02556762|Simultaneous modulated accelerated boost|simultaneous modulated accelerated boost
118139|NCT02556762|Standard dose radiotherapy|standard dose radiotherapy
118140|NCT02556762|Chemotherapy|chemotherapy
118141|NCT02556762|Survival|survival
118142|NCT02556749|Cranberries|cranberries
118143|NCT02556749|blood pressure|blood pressure
118144|NCT02556749|cholesterol|cholesterol
118145|NCT02556749|SphygmoCor|sphygmocor
118146|NCT02556736|gene therapy|gene therapy
118147|NCT02556736|optogenetics|optogenetics
118148|NCT02556736|channelrhodopsin|channelrhodopsin
118149|NCT02556736|retina|retina
118150|NCT02556736|retinitis pigmentosa|retinitis pigmentosa
118151|NCT02556710|Osteoarthritis|osteoarthritis
118152|NCT02556710|Osteoarthritis of the Knee|osteoarthritis of the knee
118153|NCT02556684|Breast-Specific Gamma Imaging|breast-specific gamma imaging
118154|NCT02556684|Locally Advanced Breast Cancer|locally advanced breast cancer
118155|NCT02556684|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
118157|NCT02556658|Smartpilot View|smartpilot view
118158|NCT02556658|Hip fracture surgery|hip fracture surgery
118159|NCT02556658|Depth of anaesthesia|depth of anaesthesia
118160|NCT02556658|Intraoperative hypotension|intraoperative hypotension
118161|NCT02556658|Quality of anaesthesia|quality of anaesthesia
118162|NCT02556645|Combat|combat
118163|NCT02556645|Psychological Treatment|psychological treatment
118164|NCT02556645|Military|military
118165|NCT02556645|Psychotherapy|psychotherapy
118166|NCT02556645|Trauma|trauma
118167|NCT02556645|Posttraumatic Stress|posttraumatic stress
118168|NCT02556645|Posttraumatic Stress Disorder|posttraumatic stress disorder
118169|NCT02556619|Liver Cancer|liver cancer
118170|NCT02556619|Randomized Control Trial|randomized control trial
118171|NCT02556619|Palliative Care|palliative care
118172|NCT02556619|Liver Cell Carcinoma|liver cell carcinoma
118173|NCT02556619|Palliative Therapy|palliative therapy
118175|NCT02556606|depression|depression
118176|NCT02556606|treatment resistant|treatment resistant
118177|NCT02556606|treatment resistant depression|treatment resistant depression
118178|NCT02556606|late life depression|late life depression
118179|NCT02556606|depression in the elderly|depression in the elderly
118180|NCT02556606|geriatric depression|geriatric depression
118181|NCT02556593|Non-Small Cell Lung Cancer|non-small cell lung cancer
118182|NCT02556593|IMRT|imrt
118183|NCT02556593|erlotinib|erlotinib
118184|NCT02556593|whole-brain radiotherapy|whole-brain radiotherapy
118185|NCT02556580|albumin|albumin
118186|NCT02556580|surgery|surgery
118187|NCT02556580|inflammation|inflammation
118188|NCT02556580|volume kinetics|volume kinetics
118189|NCT02556567|Sleep patterns|sleep patterns
118190|NCT02556567|Physical activity|physical activity
118191|NCT02556567|Fitbit|fitbit
118192|NCT02556515|CMC1|cmc1
118193|NCT02556515|arthritis|arthritis
118194|NCT02556515|degenerative arthritis|degenerative arthritis
118195|NCT02556515|thumb|thumb
118196|NCT02556515|interpositional arthroplasty|interpositional arthroplasty
118197|NCT02556515|total joint replacement|total joint replacement
118198|NCT02556489|immunological memory|immunological memory
118199|NCT02556476|critical care|critical care
118200|NCT02556476|intensive care|intensive care
118201|NCT02556476|health related quality of life|health related quality of life
118202|NCT02556476|cost benefit analysis|cost benefit analysis
118203|NCT02556463|MEDI9197|medi9197
118204|NCT02556463|TLR 7/8 Agonist|tlr 7/8 agonist
118205|NCT02556463|Durvalumab|durvalumab
118206|NCT02556463|MEDI4736|medi4736
118207|NCT02556463|Imfinzi|imfinzi
118208|NCT02556437|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
118210|NCT02556424|Ophthalmology|ophthalmology
118211|NCT02556424|Uveitic macular edema|uveitic macular edema
118212|NCT02556424|Triamcinolone subconjunctival injection|triamcinolone subconjunctival injection
118213|NCT02556424|Dexamethasone intraocular implant|dexamethasone intraocular implant
118214|NCT02556372|AIH|aih
118215|NCT02556372|JKB-122|jkb-122
118216|NCT02556372|autoimmune|autoimmune
118217|NCT02556372|hepatitis|hepatitis
118218|NCT02556346|CD20|cd20
118219|NCT02556346|immunotoxin|immunotoxin
118220|NCT02556346|CLL|cll
118221|NCT02556346|SLL|sll
118222|NCT02556346|leukemia|leukemia
118223|NCT02556346|lymphocytic lymphoma|lymphocytic lymphoma
118224|NCT02556346|lymphocytic leukemia|lymphocytic leukemia
118225|NCT02556346|MT-3724|mt-3724
118226|NCT02556346|relapsed|relapsed
118227|NCT02556346|refractory|refractory
118228|NCT02556346|immunotherapy|immunotherapy
118229|NCT02556346|cancer|cancer
118230|NCT02556346|antibodies|antibodies
118231|NCT02556346|safety|safety
118232|NCT02556346|pharmacokinetics|pharmacokinetics
118233|NCT02556333|TAF|taf
118234|NCT02556333|F/TAF|f/taf
118235|NCT02556333|ART|art
118236|NCT02556333|TDF|tdf
118237|NCT02556333|DOT|dot
118238|NCT02556294|HIV risk behavior|hiv risk behavior
118239|NCT02556268|Single-Dose, Open-Label, Non-Blinded, Non-Placebo-|single-dose, open-label, non-blinded, non-placebo-
118344|NCT02555631|type 2 diabetes|type 2 diabetes
118240|NCT02556268|Controlled, Stratified Design|controlled, stratified design
118241|NCT02556255|Peripheral Arterial Disease|peripheral arterial disease
118242|NCT02556255|Peripheral Artery Disease|peripheral artery disease
118243|NCT02556255|PAD|pad
118244|NCT02556255|Atherosclerosis|atherosclerosis
118245|NCT02556255|Arterial Occlusive Diseases|arterial occlusive diseases
118246|NCT02556255|Peripheral Vascular Diseases|peripheral vascular diseases
118247|NCT02556255|PVD|pvd
118248|NCT02556242|vector control|vector control
118249|NCT02556242|insecticide|insecticide
118250|NCT02556229|Aflibercept|aflibercept
118251|NCT02556229|inflammatory choroidal neovascularization|inflammatory choroidal neovascularization
118252|NCT02556229|young patient|young patient
118253|NCT02556216|bone biopsy; bone density|bone biopsy; bone density
118254|NCT02556203|TAVR|tavr
118255|NCT02556203|TAVI|tavi
118384|NCT02555293|Liver resection|liver resection
118256|NCT02556203|Transfemoral aortic valve implantation|transfemoral aortic valve implantation
118258|NCT02556177|MR|mr
118259|NCT02556177|mTBI|mtbi
118260|NCT02556177|NFL|nfl
118261|NCT02556177|MRI|mri
118262|NCT02556164|Electroacupuncture|electroacupuncture
118263|NCT02556164|Body Worn Sensor|body worn sensor
118264|NCT02556164|Gait|gait
118265|NCT02556164|Balance|balance
118266|NCT02556138|Intragastric Balloon|intragastric balloon
118267|NCT02556138|ORBERA Intragastric Balloon|orbera intragastric balloon
118268|NCT02556138|Weight Loss|weight loss
118269|NCT02556138|BMI >35|bmi >35
118270|NCT02556125|SCI|sci
118272|NCT02556125|Diaphragm pacing|diaphragm pacing
118273|NCT02556125|Diaphragm stimulation|diaphragm stimulation
118274|NCT02556073|asthma control|asthma control
118275|NCT02556073|adherence|adherence
118276|NCT02556073|asthma self management plan|asthma self management plan
118277|NCT02556073|airway inflammation|airway inflammation
118278|NCT02556060|ketamine use disorder|ketamine use disorder
118279|NCT02556060|lamotrigine|lamotrigine
118280|NCT02556060|craving|craving
118281|NCT02556008|Children|children
118282|NCT02556008|Epilepsy|epilepsy
118283|NCT02556008|Cannabidiol|cannabidiol
118284|NCT02555995|AMD|amd
118285|NCT02555995|OCT|oct
118286|NCT02555982|Essential Head tremor|essential head tremor
118287|NCT02555982|Botulinum toxin injections|botulinum toxin injections
118288|NCT02555982|Quality of life|quality of life
118289|NCT02555982|Embarrassment assessment|embarrassment assessment
118290|NCT02555956|Macular grid|macular grid
118291|NCT02555956|Subthreshold|subthreshold
118292|NCT02555956|diabetic macular edema|diabetic macular edema
118293|NCT02555956|decrease in visual acuity|decrease in visual acuity
118294|NCT02555891|Prescriptions|prescriptions
118295|NCT02555891|Epidemiology|epidemiology
118296|NCT02555891|Health Administration Databases|health administration databases
118297|NCT02555891|Elderly|elderly
118298|NCT02555891|STOPP/START criteria|stopp/start criteria
118299|NCT02555878|Cancer|cancer
118300|NCT02555878|Rivaroxaban|rivaroxaban
118301|NCT02555878|Venous thromboembolism|venous thromboembolism
118302|NCT02555865|etiology|etiology
118303|NCT02555865|children|children
118304|NCT02555852|Proton Pump Inhibitors|proton pump inhibitors
118305|NCT02555852|Pneumonia|pneumonia
118306|NCT02555852|NSAIDs|nsaids
118307|NCT02555852|Histamine H2 Antagonists|histamine h2 antagonists
118308|NCT02555852|Drug safety|drug safety
118309|NCT02555839|Relapsed Multiple Myeloma|relapsed multiple myeloma
118310|NCT02555839|Refractory Multiple Myeloma|refractory multiple myeloma
118314|NCT02555813|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
118315|NCT02555813|nab-Paclitaxel|nab-paclitaxel
118316|NCT02555813|Gemcitabine|gemcitabine
118317|NCT02555813|Non-interventional|non-interventional
118318|NCT02555800|Laryngeal papillomatosis|laryngeal papillomatosis
118319|NCT02555800|Cidofovir|cidofovir
118320|NCT02555800|Bevacizumab|bevacizumab
118321|NCT02555800|Recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
118322|NCT02555787|FK506E|fk506e
118323|NCT02555787|Tacrolimus|tacrolimus
118324|NCT02555787|Observational|observational
118325|NCT02555787|Kidney transplantation|kidney transplantation
118326|NCT02555787|Advagraf|advagraf
118327|NCT02555774|subjective memory impairment|subjective memory impairment
118328|NCT02555774|cognitive training|cognitive training
118329|NCT02555735|pancreatic cancer|pancreatic cancer
118330|NCT02555696|Metastatic Breast Cancer|metastatic breast cancer
118331|NCT02555696|nab-paclitaxel|nab-paclitaxel
118332|NCT02555696|Abraxane|abraxane
118333|NCT02555683|Asthma|asthma
118334|NCT02555683|QAW039|qaw039
118335|NCT02555670|Muscles|muscles
118336|NCT02555670|Intensive Care|intensive care
118337|NCT02555670|Tomography, X-Ray Computed|tomography, x-ray computed
118338|NCT02555670|Electric Impedance|electric impedance
118339|NCT02555657|PD1|pd1
118340|NCT02555657|PD-1|pd-1
118341|NCT02555657|PDL1|pdl1
118342|NCT02555657|PD-LI|pd-li
118343|NCT02555644|cancer|cancer
118345|NCT02555631|prevention|prevention
118346|NCT02555631|men|men
118347|NCT02555618|Vaccine|vaccine
118348|NCT02555605|children|children
118349|NCT02555605|dexmedetomidine|dexmedetomidine
118350|NCT02555605|magnetic resonance imaging scans|magnetic resonance imaging scans
118351|NCT02555605|deep sedation|deep sedation
118352|NCT02555605|adverse respiratory events|adverse respiratory events
118353|NCT02555553|Cognitive behavioral therapy guided self-help|cognitive behavioral therapy guided self-help
118354|NCT02555553|Mobile Mental Health|mobile mental health
118355|NCT02555553|Binge Eating|binge eating
118356|NCT02555553|Cognitive Behavioral Therapy|cognitive behavioral therapy
118357|NCT02555553|Eating Disorder Treatment|eating disorder treatment
118358|NCT02555553|Self-monitoring|self-monitoring
118359|NCT02555553|Eating Disorders|eating disorders
118360|NCT02555553|Ecological Momentary Intervention|ecological momentary intervention
118361|NCT02555501|children|children
118362|NCT02555501|cancer|cancer
118363|NCT02555501|stomatitis|stomatitis
118364|NCT02555501|clinical trial|clinical trial
118365|NCT02555501|laser therapy, low-level|laser therapy, low-level
118366|NCT02555501|methylene blue|methylene blue
118367|NCT02555501|photochemotherapy|photochemotherapy
118368|NCT02555475|Hepatitis C|hepatitis c
118369|NCT02555475|primary care|primary care
118370|NCT02555397|Prostate Cancer|prostate cancer
118371|NCT02555397|Locally Recurrent|locally recurrent
118372|NCT02555397|Gene Therapy|gene therapy
118373|NCT02555397|IL-12|il-12
118374|NCT02555397|Adenovirus|adenovirus
118378|NCT02555358|Resectable advanced gastric cancer|resectable advanced gastric cancer
118379|NCT02555345|classic asthma, cough variant asthma,eosinophilic bronchitis|classic asthma, cough variant asthma,eosinophilic bronchitis
118380|NCT02555319|Pulmonary Valve|pulmonary valve
118381|NCT02555319|Transcatheter Pulmonary Valve|transcatheter pulmonary valve
118382|NCT02555319|Congenital Heart Disease|congenital heart disease
118385|NCT02555293|fibrosis|fibrosis
118386|NCT02555293|inflammation|inflammation
118387|NCT02555293|Rifaximin|rifaximin
118388|NCT02555267|geriatric assessment|geriatric assessment
118389|NCT02555267|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
118390|NCT02555267|activity of daily living|activity of daily living
118391|NCT02555267|instrumental activity of daily living|instrumental activity of daily living
118392|NCT02555267|Charlson's comorbidity index|charlson's comorbidity index
118393|NCT02555254|cardiac arrest|cardiac arrest
118394|NCT02555254|targeted temperature management|targeted temperature management
118395|NCT02555254|hypothermia induced|hypothermia induced
118396|NCT02555254|shockable rhythm|shockable rhythm
118397|NCT02555241|ASD, Children|asd, children
118398|NCT02555228|simethicone|simethicone
118399|NCT02555228|gastroscopy|gastroscopy
118400|NCT02555228|McNalley score|mcnalley score
118401|NCT02555215|Pediatrics|pediatrics
118402|NCT02555202|dyspnea|dyspnea
118403|NCT02555163|bladder cancer, laser|bladder cancer, laser
118404|NCT02555137|chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
118405|NCT02555137|pulmonary embolism|pulmonary embolism
118406|NCT02555137|pulmonary hypertension|pulmonary hypertension
118407|NCT02555137|screening|screening
118408|NCT02555137|echocardiography|echocardiography
118409|NCT02555124|Healthy|healthy
118410|NCT02555124|JNJ-42847922|jnj-42847922
118411|NCT02555111|thrombosis|thrombosis
118412|NCT02554058|Spinal cord injury|spinal cord injury
118413|NCT02554058|rehabilitation|rehabilitation
118414|NCT02554058|cycling|cycling
118415|NCT02555072|Yellow Fever Vaccine, immunity evolution|yellow fever vaccine, immunity evolution
118416|NCT02555059|Ciprofloxacin|ciprofloxacin
141795|NCT02418702|suicide|suicide
109519|NCT02607956|HIV|hiv
118417|NCT02555059|Japan|japan
118418|NCT02555059|Post-marketing surveillance|post-marketing surveillance
118419|NCT02555046|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
118420|NCT02555046|Endovascular Procedures|endovascular procedures
118421|NCT02555046|Local Anesthesia|local anesthesia
118422|NCT02555046|General Anesthesia|general anesthesia
118423|NCT02555033|Instability resistance training|instability resistance training
118424|NCT02555033|unstable surface|unstable surface
118425|NCT02555033|elderly people|elderly people
118426|NCT02554994|ASPRA cohort|aspra cohort
118427|NCT02554994|multifactorial intervention|multifactorial intervention
118428|NCT02554994|Medicaid services|medicaid services
118429|NCT02554994|Geriatric disorder|geriatric disorder
118430|NCT02554994|Short Physical Performance Battery|short physical performance battery
118431|NCT02554929|Social Anxiety Disorder|social anxiety disorder
118432|NCT02554929|Selective Mutism|selective mutism
118433|NCT02554929|CBT|cbt
118434|NCT02554929|preschool anxiety disorders|preschool anxiety disorders
118435|NCT02554916|Mobility decline|mobility decline
118436|NCT02554903|LVAD|lvad
118437|NCT02554890|Acute|acute
118438|NCT02554890|Heart Failure|heart failure
118439|NCT02554890|reduced ejection fraction|reduced ejection fraction
118440|NCT02554890|NTproBNP|ntprobnp
118441|NCT02554890|Heart failure with reduced ejection fraction (HFREF)|heart failure with reduced ejection fraction (hfref)
118442|NCT02554838|Specific phobia|specific phobia
118443|NCT02554838|Fear of Falling|fear of falling
118444|NCT02554838|Life-space area|life-space area
118445|NCT02554812|anti PD-L1|anti pd-l1
118446|NCT02554812|anti 4-1BB|anti 4-1bb
118447|NCT02554812|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
118448|NCT02554812|melanoma|melanoma
118449|NCT02554812|squamous cell carcinoma of head and neck (SCCHN)|squamous cell carcinoma of head and neck (scchn)
118450|NCT02554812|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
118451|NCT02554812|colorectal cancer (CRC)|colorectal cancer (crc)
118452|NCT02554786|QMF149, Mometasone furoate (MF), asthma|qmf149, mometasone furoate (mf), asthma
118453|NCT02554773|Hemophilia|hemophilia
118454|NCT02554773|RNAi therapeutic|rnai therapeutic
118455|NCT02554721|Healthy Volunteers|healthy volunteers
118456|NCT02554708|Aneurysm|aneurysm
118457|NCT02554708|bifurcation|bifurcation
118458|NCT02554708|wide neck|wide neck
118459|NCT02554708|pCONus|pconus
118460|NCT02554708|intracerebral|intracerebral
118461|NCT02554708|stroke|stroke
118462|NCT02554695|adrenergic|adrenergic
118463|NCT02554682|Adolescent Health|adolescent health
118464|NCT02554682|Sexual Health|sexual health
118465|NCT02554682|Parent-Teen Communication|parent-teen communication
118466|NCT02554682|Teen Driving|teen driving
118467|NCT02554682|Alcohol Prevention|alcohol prevention
118468|NCT02554669|Blood glucose (indicated by interstitial glucose)|blood glucose (indicated by interstitial glucose)
118469|NCT02554669|Markers of systemic inflammation|markers of systemic inflammation
118470|NCT02554643|intermittent exercise|intermittent exercise
118471|NCT02554643|continuous exercise|continuous exercise
118472|NCT02554643|blood glucose|blood glucose
118473|NCT02554643|intramyocellular lipids|intramyocellular lipids
118474|NCT02554643|diabetes|diabetes
118475|NCT02554643|gene expression|gene expression
118476|NCT02554617|healthy people|healthy people
118477|NCT02554617|fractional exhaled nitric oxide (FeNo)|fractional exhaled nitric oxide (feno)
118478|NCT02554617|factors|factors
118480|NCT02554604|Preeclampsia|preeclampsia
118481|NCT02554604|saliva|saliva
118482|NCT02554578|mHealth|mhealth
118483|NCT02554578|multidisciplinary team|multidisciplinary team
118484|NCT02554578|immunosuppressive medication|immunosuppressive medication
118485|NCT02554578|pharmaceutical care|pharmaceutical care
118486|NCT02554578|adherence|adherence
118487|NCT02554578|heart transplant|heart transplant
118488|NCT02554578|recipients|recipients
118489|NCT02554565|Patients with cervical cancer|patients with cervical cancer
118490|NCT02554552|Osteoarthritis|osteoarthritis
118491|NCT02554526|hemophilia A|hemophilia a
118492|NCT02554526|inhibitor|inhibitor
118493|NCT02554526|bypassing therapy|bypassing therapy
118494|NCT02554526|factor VIII|factor viii
118495|NCT02554513|Apraxia of Speech|apraxia of speech
118496|NCT02554513|Treatment|treatment
118497|NCT02554487|stroke|stroke
118498|NCT02554487|sleep disordered breathing|sleep disordered breathing
118499|NCT02554487|sleep apnea|sleep apnea
118500|NCT02554487|infarct volume|infarct volume
118501|NCT02554487|penumbra|penumbra
118502|NCT02554474|Physical activity|physical activity
118503|NCT02554474|Exercise|exercise
118504|NCT02554474|Rheumatoid|rheumatoid
118505|NCT02554474|Arthritis|arthritis
118506|NCT02554474|Lupus|lupus
118507|NCT02554474|SLE|sle
118508|NCT02554448|Circulating Tumor Cells|circulating tumor cells
118509|NCT02554448|rectal Neoplasms|rectal neoplasms
118510|NCT02554448|neoadjuvant otherapy|neoadjuvant otherapy
118511|NCT02554435|physical activity|physical activity
118512|NCT02554435|activity monitor|activity monitor
118513|NCT02554435|older adults|older adults
118514|NCT02554435|5 A's counseling|5 a's counseling
118515|NCT02554409|Fluzone Quadrivalent Intradermal Influenza Vaccine|fluzone quadrivalent intradermal influenza vaccine
118516|NCT02554409|Pregnancy Registry|pregnancy registry
118517|NCT02554409|Influenza|influenza
118518|NCT02554396|ophthalmology|ophthalmology
118519|NCT02554396|vision|vision
118520|NCT02554396|ocular|ocular
118521|NCT02554383|pediatrics|pediatrics
118522|NCT02554383|antibiotics|antibiotics
118523|NCT02554383|placebo|placebo
118524|NCT02554344|CIN3|cin3
118525|NCT02554344|Squamous CIN3|squamous cin3
118526|NCT02554331|Gait|gait
118527|NCT02554331|REM sleep behavior disorder|rem sleep behavior disorder
118528|NCT02554331|Parkinson's disease|parkinson's disease
118529|NCT02554331|Follow-up|follow-up
118530|NCT02554318|Tempeh|tempeh
118531|NCT02554318|Body weight|body weight
118532|NCT02554318|Handgrip strength|handgrip strength
118533|NCT02554318|6MWT|6mwt
118534|NCT02554318|Supplementation|supplementation
118535|NCT02554318|Wasting|wasting
118536|NCT02554305|efficacy and safety of fusion Oxygenation System|efficacy and safety of fusion oxygenation system
118537|NCT02554305|isolated Coronary Artery Bypass Grafting|isolated coronary artery bypass grafting
118538|NCT02554305|Bypass Grafting|bypass grafting
118539|NCT02554227|Spondylodiscitis|spondylodiscitis
118540|NCT02554227|erosive osteochondrosis|erosive osteochondrosis
118541|NCT02554227|infection|infection
118542|NCT02554227|cytokine profiles|cytokine profiles
118543|NCT02554227|lumbar spine|lumbar spine
118544|NCT02554201|pudendal nerve modulation|pudendal nerve modulation
118545|NCT02554201|transanal/transvaginal electrical stimulation|transanal/transvaginal electrical stimulation
118546|NCT02554188|Dietary Intervention|dietary intervention
118547|NCT02554188|Fasting-mimicking|fasting-mimicking
118548|NCT02554188|Influenza Vaccines|influenza vaccines
118549|NCT02554175|Propofol|propofol
118550|NCT02554175|Schnider model|schnider model
118551|NCT02554162|Satiety, appetite, wholegrain rye|satiety, appetite, wholegrain rye
118552|NCT02554149|total hip|total hip
118553|NCT02554149|stem version|stem version
118554|NCT02554149|replacement|replacement
118555|NCT02554149|hip|hip
118556|NCT02554097|laparoscopic transcystic common bile duct exploration|laparoscopic transcystic common bile duct exploration
118557|NCT02554097|laparoscopic common bile duct exploration|laparoscopic common bile duct exploration
118558|NCT02554097|endoscopic sphincterotomy,|endoscopic sphincterotomy,
118559|NCT02554097|cost-effective analysis|cost-effective analysis
118560|NCT02554032|antegrade cerebral perfusion|antegrade cerebral perfusion
118561|NCT02554032|innominate artery cannulation|innominate artery cannulation
118562|NCT02554032|axillary artery cannulation|axillary artery cannulation
118563|NCT02554032|aortic surgery|aortic surgery
118564|NCT02554032|deep hypothermic circulatory arrest|deep hypothermic circulatory arrest
118565|NCT02554019|SLE, Lupus|sle, lupus
118782|NCT02552901|albumin|albumin
118566|NCT02554019|IL10, IL-10, BT063, BT-063|il10, il-10, bt063, bt-063
118567|NCT02553993|Stroke|stroke
118568|NCT02553993|Cognition|cognition
118569|NCT02553993|Exergames|exergames
118570|NCT02553993|Weight shifting|weight shifting
118571|NCT02553993|Balance|balance
118572|NCT02553993|Rehabilitation|rehabilitation
119381|NCT02549235|IVF|ivf
118573|NCT02553980|Physical activity|physical activity
118574|NCT02553980|Information technology|information technology
118575|NCT02553980|Middle-aged|middle-aged
118576|NCT02553980|Health promotion|health promotion
118577|NCT02553967|functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
118578|NCT02553967|Breast reconstructive surgery|breast reconstructive surgery
118579|NCT02553967|Breast Q questionnaire|breast q questionnaire
118580|NCT02553954|Mechanisms of Senescence|mechanisms of senescence
118581|NCT02553954|Senescence markers|senescence markers
118582|NCT02553915|Omega-3|omega-3
118583|NCT02553915|EPA|epa
118584|NCT02553915|Depression|depression
118585|NCT02553915|Overweight|overweight
118586|NCT02553915|Inflammation|inflammation
118587|NCT02553915|Eicosapentaenoic acid|eicosapentaenoic acid
118588|NCT02553902|Positional therapy|positional therapy
118589|NCT02553902|MAD|mad
118590|NCT02553902|Oral appliance|oral appliance
118591|NCT02553902|Sleep position trainer|sleep position trainer
118592|NCT02553902|POSA|posa
118593|NCT02553876|neurostimulation|neurostimulation
118594|NCT02553876|dorsal root ganglion|dorsal root ganglion
118595|NCT02553876|hand pain|hand pain
118596|NCT02553876|upper limb pain|upper limb pain
118597|NCT02553863|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
118598|NCT02553863|acupuncture|acupuncture
118599|NCT02553863|pain|pain
118600|NCT02553863|cost-effectiveness|cost-effectiveness
118601|NCT02553837|Healthy Volunteers|healthy volunteers
118602|NCT02553824|binge eating|binge eating
118603|NCT02553824|bulimia nervosa|bulimia nervosa
118604|NCT02553824|binge eating disorder|binge eating disorder
118605|NCT02553824|eating disorder treatment|eating disorder treatment
118606|NCT02553811|carpal tunnel syndrome|carpal tunnel syndrome
118607|NCT02553811|clinical examination|clinical examination
118608|NCT02553811|diagnosis|diagnosis
118609|NCT02553811|clinical trial|clinical trial
118610|NCT02553811|median nerve compression|median nerve compression
118611|NCT02553811|accuracy|accuracy
118612|NCT02553811|ultrasonography|ultrasonography
118613|NCT02553811|electromyography|electromyography
118614|NCT02553811|electrodiagnostic testing|electrodiagnostic testing
118615|NCT02553785|BioVentrix|bioventrix
118616|NCT02553785|Revivent|revivent
118617|NCT02553785|Revivent TC|revivent tc
118618|NCT02553759|observed action|observed action
118619|NCT02553759|range of motion|range of motion
118620|NCT02553759|mirror neuron|mirror neuron
118621|NCT02553746|Ultrasound|ultrasound
118622|NCT02553746|Spinal anesthesia|spinal anesthesia
118623|NCT02553746|Epidural anesthesia|epidural anesthesia
118624|NCT02553733|Dietary nitrate supplementation|dietary nitrate supplementation
118625|NCT02553733|Beetroot juice|beetroot juice
118626|NCT02553720|Post thrombotic syndrome|post thrombotic syndrome
118627|NCT02553720|Chronic venous insufficiency|chronic venous insufficiency
118628|NCT02553694|OSA, Apnea|osa, apnea
118629|NCT02553668|Proteomics|proteomics
118631|NCT02553668|Pathways|pathways
118632|NCT02553642|Tumor Mutation|tumor mutation
118633|NCT02553642|Nivolumab|nivolumab
118634|NCT02553642|Nivolumab plus Ipilimumab|nivolumab plus ipilimumab
118635|NCT02553642|Predicted Neo-antigen Burden|predicted neo-antigen burden
118636|NCT02553642|15-126|15-126
118637|NCT02553590|Non Interventional Study|non interventional study
118638|NCT02553590|NIS|nis
118639|NCT02553590|sublingual immunotherapy|sublingual immunotherapy
118644|NCT02553577|prenatal|prenatal
118645|NCT02553577|cytokines|cytokines
118646|NCT02553538|cancer screening|cancer screening
118647|NCT02553538|patient navigation|patient navigation
118648|NCT02553525|Deep Brain Stimulation|deep brain stimulation
118649|NCT02553525|Movement Disorders|movement disorders
118650|NCT02553525|Parkinson Disease|parkinson disease
118651|NCT02553525|Essential Tremor|essential tremor
118652|NCT02553525|Subthalamic Nucleus|subthalamic nucleus
118653|NCT02553525|Globus Pallidus|globus pallidus
118654|NCT02553525|Thalamus|thalamus
118655|NCT02553525|Tremor|tremor
118656|NCT02553525|Bradykinesia|bradykinesia
118657|NCT02553525|Temporal Pattern|temporal pattern
118658|NCT02553525|Electrical Stimulation|electrical stimulation
118659|NCT02553525|Neuromodulation|neuromodulation
118660|NCT02553525|PD|pd
118661|NCT02553525|ET|et
118662|NCT02553525|MS|ms
118663|NCT02553525|STN|stn
118664|NCT02553525|GPi|gpi
118665|NCT02553525|DBS|dbs
118666|NCT02553525|Nervous System Diseases|nervous system diseases
118667|NCT02553525|Neurodegenerative Diseases|neurodegenerative diseases
118668|NCT02553499|Solid tumor|solid tumor
118669|NCT02553499|PD1|pd1
118670|NCT02553499|PD-L1|pd-l1
118671|NCT02553499|PDL1|pdl1
118672|NCT02553486|adoption|adoption
118673|NCT02553486|children|children
118674|NCT02553486|quality of life|quality of life
118675|NCT02553460|Infants|infants
118676|NCT02553434|pigtail catheter|pigtail catheter
118677|NCT02553434|small-bore catheter|small-bore catheter
118678|NCT02553434|trauma|trauma
118679|NCT02553434|hemothorax|hemothorax
118680|NCT02553421|infiltration|infiltration
118681|NCT02553421|extravasation|extravasation
118682|NCT02553421|peripheral intravenous therapy|peripheral intravenous therapy
118683|NCT02553356|Female Subjects|female subjects
118684|NCT02553343|Influenza|influenza
118685|NCT02553343|High-Dose Quadrivalent Influenza Vaccine|high-dose quadrivalent influenza vaccine
118686|NCT02553343|High-Dose Trivalent Influenza Vaccine|high-dose trivalent influenza vaccine
118687|NCT02553330|Hair loss|hair loss
118688|NCT02553330|alopecia areata|alopecia areata
118689|NCT02553330|alopecia totalis|alopecia totalis
118690|NCT02553330|alopecia universalis|alopecia universalis
118691|NCT02553330|JAK inhibitors|jak inhibitors
118692|NCT02553330|topical hair growth|topical hair growth
118693|NCT02553278|abdominoplasty|abdominoplasty
118694|NCT02553265|Familial dysautonomia (HSAN III)|familial dysautonomia (hsan iii)
118695|NCT02553265|Norepinephrine|norepinephrine
118696|NCT02553265|Sympathetic nervous system|sympathetic nervous system
118697|NCT02553265|Autonomic nervous system|autonomic nervous system
118698|NCT02553265|Blood pressure variability|blood pressure variability
118699|NCT02553265|Hypertension|hypertension
118700|NCT02553265|Carbidopa/Lodosyn|carbidopa/lodosyn
118701|NCT02553265|Afferent baroreflex failure|afferent baroreflex failure
118702|NCT02553265|Clinical trial|clinical trial
118703|NCT02553252|post traumatic stress disorder (PTSD)|post traumatic stress disorder (ptsd)
118704|NCT02553252|Sudarshan Kriya Yoga (SKY)|sudarshan kriya yoga (sky)
118705|NCT02553239|Atrial Fibrillation|atrial fibrillation
118706|NCT02553239|Paroxysmal|paroxysmal
118707|NCT02553239|Cryoablation|cryoablation
118708|NCT02553226|Active phase of labour|active phase of labour
118709|NCT02553226|Discontinuation|discontinuation
118710|NCT02553226|Caesarean section|caesarean section
118711|NCT02553200|intubated patients|intubated patients
109813|NCT02605954|HIV|hiv
118712|NCT02553200|secretion clearance|secretion clearance
118713|NCT02553200|lung function|lung function
118714|NCT02553200|breathing exercise|breathing exercise
118715|NCT02553161|Depression|depression
118716|NCT02553148|prevalence|prevalence
118717|NCT02553148|epidemiology|epidemiology
118718|NCT02553148|palliative care|palliative care
118719|NCT02553148|pediatric|pediatric
118720|NCT02553135|choroideremia, gene therapy|choroideremia, gene therapy
118721|NCT02553122|Blood Loss|blood loss
118722|NCT02553122|Tranexamic Acid|tranexamic acid
118723|NCT02553122|Evicel|evicel
118724|NCT02553109|small paraclinoid|small paraclinoid
118728|NCT02553031|Application of MR-PET|application of mr-pet
118729|NCT02553005|Acupuncture|acupuncture
118730|NCT02553005|Rheumatoid Arthritis|rheumatoid arthritis
118731|NCT02553005|Quality of life|quality of life
118732|NCT02553005|Hand Strength|hand strength
118733|NCT02552979|atopic dermatitis|atopic dermatitis
118734|NCT02552979|atopic patch test|atopic patch test
118735|NCT02552927|PDA|pda
118736|NCT02552927|Jaundice|jaundice
118737|NCT02552927|Phototherapy|phototherapy
118738|NCT02552914|Colli-Pee|colli-pee
118739|NCT02552914|STI|sti
118740|NCT02552914|first-void urine|first-void urine
118741|NCT02552901|hepatic|hepatic
118742|NCT02552901|liver|liver
118743|NCT02552901|LFT|lft
118744|NCT02552901|hepatic assessment|hepatic assessment
118745|NCT02552901|ICG dye|icg dye
118746|NCT02552901|indocyanine green dye|indocyanine green dye
118747|NCT02552901|Diagnostic Green|diagnostic green
118748|NCT02552901|Pulsion|pulsion
118749|NCT02552901|Akorn|akorn
118750|NCT02552901|Cardiox|cardiox
118751|NCT02552901|anazen|anazen
118752|NCT02552901|essence|essence
118753|NCT02552901|dye detection monitor|dye detection monitor
118754|NCT02552901|Earpads|earpads
118755|NCT02552901|flow sensor|flow sensor
118756|NCT02552901|scaphoid fossa|scaphoid fossa
118757|NCT02552901|liver disease|liver disease
118758|NCT02552901|acute hepatic failure|acute hepatic failure
118759|NCT02552901|AHF|ahf
118760|NCT02552901|NASH|nash
118761|NCT02552901|hepatitis C|hepatitis c
118762|NCT02552901|cirrhosis|cirrhosis
118763|NCT02552901|MELD|meld
118764|NCT02552901|pulse dye densitometry|pulse dye densitometry
118765|NCT02552901|liver transplant|liver transplant
118766|NCT02552901|fluorescence|fluorescence
118767|NCT02552901|near infra-red|near infra-red
118768|NCT02552901|serial blood draws|serial blood draws
118769|NCT02552901|PDR|pdr
118770|NCT02552901|plasma disappearance rate|plasma disappearance rate
118771|NCT02552901|R15|r15
118772|NCT02552901|k coefficient|k coefficient
118773|NCT02552901|transcutaneously|transcutaneously
118774|NCT02552901|liver donor|liver donor
118775|NCT02552901|liver dysfunction|liver dysfunction
118776|NCT02552901|Child-Pugh|child-pugh
118777|NCT02552901|AST|ast
118778|NCT02552901|ALT|alt
118779|NCT02552901|GGT|ggt
118780|NCT02552901|alk phos|alk phos
118781|NCT02552901|prothrombin time|prothrombin time
118783|NCT02552901|serum ICG|serum icg
118784|NCT02552901|liver function tests|liver function tests
118785|NCT02552888|Endothelial Dysfunction|endothelial dysfunction
118786|NCT02552888|Inflammation|inflammation
118787|NCT02552875|Acceleromyography|acceleromyography
118788|NCT02552875|staircase phenomenon|staircase phenomenon
118789|NCT02552875|tetanic stimulation|tetanic stimulation
118790|NCT02552797|Shared Decision Making|shared decision making
118792|NCT02552758|violence|violence
118793|NCT02552758|PET|pet
118794|NCT02552758|omega-3 fatty acid|omega-3 fatty acid
118795|NCT02552758|schizophrenia|schizophrenia
118796|NCT02552758|patient|patient
118797|NCT02552719|Injustice Experience|injustice experience
118798|NCT02552719|Questionnaire|questionnaire
118799|NCT02552719|Validation|validation
118800|NCT02552719|German translation|german translation
118801|NCT02552706|probiotics|probiotics
118802|NCT02552706|preterm very low birth weight infants|preterm very low birth weight infants
118803|NCT02552706|necrotizing enterocolitis|necrotizing enterocolitis
118804|NCT02552706|gut microflora|gut microflora
118805|NCT02552706|TLR|tlr
118806|NCT02552706|NF-KB|nf-kb
118807|NCT02552706|inflammatory factors|inflammatory factors
118808|NCT02552693|Enhancing retention|enhancing retention
118809|NCT02552680|Work-Related Musculoskeletal Disorders|work-related musculoskeletal disorders
118810|NCT02552680|Quality of life|quality of life
118811|NCT02552680|Health Education|health education
118812|NCT02552667|Asthma|asthma
118813|NCT02552667|Allergic rhinitis|allergic rhinitis
118814|NCT02552628|Wilson's Disease|wilson's disease
118815|NCT02552628|Deep Brain Stimulation|deep brain stimulation
118816|NCT02552628|dystonia|dystonia
118817|NCT02552615|scoliosis, verticality perception, body symmetry|scoliosis, verticality perception, body symmetry
118819|NCT02552602|Multivitamins|multivitamins
118820|NCT02552589|clinical trial, phase III|clinical trial, phase iii
118821|NCT02552589|plaque index|plaque index
109904|NCT02605395|IDIAZOLE 20mg|idiazole 20mg
109905|NCT02605395|Rabeprazole|rabeprazole
109909|NCT02605356|bortezomib|bortezomib
118822|NCT02552589|gingivitis index|gingivitis index
118823|NCT02552589|fluoride|fluoride
118824|NCT02552589|toothpaste|toothpaste
118825|NCT02552550|squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
118826|NCT02552550|swallowing, speech|swallowing, speech
118827|NCT02552550|quality of life|quality of life
118828|NCT02552524|pathological gambling|pathological gambling
118829|NCT02552524|rTMS|rtms
118830|NCT02552524|cognitive tests|cognitive tests
118831|NCT02552524|autonomic nervous system|autonomic nervous system
118832|NCT02552524|craving|craving
118833|NCT02552472|Asthma|asthma
118834|NCT02552472|Inhaler Use|inhaler use
118835|NCT02552472|Adherence|adherence
118836|NCT02552472|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
118837|NCT02552459|dexmedetomidine|dexmedetomidine
118838|NCT02552459|patient controlled analgesia|patient controlled analgesia
118839|NCT02552433|nutritional deficiencies|nutritional deficiencies
118840|NCT02552433|plastic surgery|plastic surgery
118841|NCT02552433|post-bariatric|post-bariatric
118842|NCT02552433|protein|protein
118843|NCT02552433|skin surplus|skin surplus
118844|NCT02552420|infrared thermal imaging|infrared thermal imaging
118845|NCT02552420|deep venous thrombosis|deep venous thrombosis
118846|NCT02552407|thrombectomy|thrombectomy
118847|NCT02552407|acute coronary syndromes|acute coronary syndromes
118848|NCT02552407|percutaneous coronary intervention|percutaneous coronary intervention
118860|NCT02552329|mild cognitive impairment|mild cognitive impairment
118862|NCT02552329|cognitive functions|cognitive functions
118863|NCT02552316|microbiome|microbiome
118864|NCT02552316|bacteria|bacteria
118865|NCT02552316|NB-UVB Phototherapy|nb-uvb phototherapy
118866|NCT02552316|light therapy|light therapy
118867|NCT02552277|Diabetic|diabetic
118868|NCT02552277|PDA-002|pda-002
118869|NCT02552277|Placenta-Derived Cells|placenta-derived cells
118870|NCT02552277|Peripheral neuropathy|peripheral neuropathy
118871|NCT02552277|Neuropathy|neuropathy
118872|NCT02552277|Double-Blind|double-blind
118873|NCT02552277|Safety|safety
118874|NCT02552277|Efficacy|efficacy
118875|NCT02552277|Human Placenta-derived Cells|human placenta-derived cells
118876|NCT02552238|Lumason|lumason
118877|NCT02552238|Dobutamine stress echo|dobutamine stress echo
118878|NCT02552238|stress echo|stress echo
118879|NCT02552238|coronary artery disease|coronary artery disease
118880|NCT02552225|laryngeal sensory neuropathy, chronic laryngeal neuropathy|laryngeal sensory neuropathy, chronic laryngeal neuropathy
118892|NCT02552160|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
118893|NCT02552160|Fixed-dose Combination|fixed-dose combination
118894|NCT02552160|LAMA/LABA (Long Acting Beta2-Agonists / Long Acting Muscarinic Antagonists)|lama/laba (long acting beta2-agonists / long acting muscarinic antagonists)
118895|NCT02552160|Inhaler|inhaler
118896|NCT02552160|Aclidinium/Formoterol|aclidinium/formoterol
118897|NCT02552160|Glycopyrronium/Indacaterol|glycopyrronium/indacaterol
118898|NCT02552160|Umeclidinium/Vilanterol|umeclidinium/vilanterol
118899|NCT02552147|Autism spectrum disorder|autism spectrum disorder
118900|NCT02552147|Aggression|aggression
118901|NCT02552147|Irritability|irritability
118902|NCT02552147|Nicotine|nicotine
118903|NCT02552147|Nicotinic acetylcholine receptor|nicotinic acetylcholine receptor
118904|NCT02552147|Nicotinic agonist|nicotinic agonist
118905|NCT02552147|Adult autism|adult autism
118906|NCT02552134|Access to physical activity resources, community based exercise programme, sports-clubs, health resort,|access to physical activity resources, community based exercise programme, sports-clubs, health resort,
118909|NCT02552121|endometrium cancer|endometrium cancer
118910|NCT02552121|bladder cancer|bladder cancer
118911|NCT02552121|prostate cancer (CRPC)|prostate cancer (crpc)
118912|NCT02552121|esophagus cancer|esophagus cancer
118913|NCT02552121|lung cancer (NSCLC)|lung cancer (nsclc)
118914|NCT02552108|Cognitive-behavioural therapy|cognitive-behavioural therapy
118915|NCT02552056|Child Adolescent Mental Integration PHC Traditional Healers|child adolescent mental integration phc traditional healers
118916|NCT02552043|Cystic fibrosis|cystic fibrosis
118917|NCT02552043|Exercise capacity|exercise capacity
118918|NCT02552043|Interactive gaming console|interactive gaming console
118919|NCT02552043|Pulmonary rehabilitation|pulmonary rehabilitation
118920|NCT02552017|adenoma detection rate|adenoma detection rate
118922|NCT02552017|Endocuff Vision|endocuff vision
118923|NCT02552017|colonoscopy|colonoscopy
118924|NCT02552017|bowel cancer screening|bowel cancer screening
118925|NCT02552017|bowel cancer|bowel cancer
118926|NCT02552004|pCLE|pcle
118927|NCT02552004|Digestive surgery|digestive surgery
118928|NCT02552004|Endocrine surgery|endocrine surgery
118929|NCT02551991|Pancreatic cancer|pancreatic cancer
118930|NCT02551991|MM-398|mm-398
118931|NCT02551991|Metastatic pancreatic cancer|metastatic pancreatic cancer
118932|NCT02551991|First line pancreatic cancer treatment|first line pancreatic cancer treatment
142428|NCT02415673|Nitinol|nitinol
118933|NCT02551978|obesity|obesity
118934|NCT02551978|child|child
118935|NCT02551978|primary prevention|primary prevention
118936|NCT02551978|serious game|serious game
118937|NCT02551978|nutrition|nutrition
118938|NCT02551978|physical activity|physical activity
118939|NCT02551978|psychosocial|psychosocial
118940|NCT02551978|stress|stress
118941|NCT02551978|knowledge|knowledge
118942|NCT02551978|diet|diet
118943|NCT02551965|Cancer|cancer
118944|NCT02551965|Patient|patient
118945|NCT02551965|Oncology|oncology
118946|NCT02551965|Caregiver|caregiver
118947|NCT02551952|Games|games
118948|NCT02551952|Cognitive Tests|cognitive tests
118949|NCT02551952|General Anesthesia|general anesthesia
118950|NCT02551952|Surgery|surgery
118951|NCT02551913|Psychological Theory|psychological theory
118952|NCT02551913|adolescents|adolescents
118953|NCT02551900|Type 2 Diabetes|type 2 diabetes
118954|NCT02551900|Vascular Function|vascular function
118955|NCT02551900|Water Exercise|water exercise
118956|NCT02551900|Warm Water|warm water
118957|NCT02551900|Cold Water|cold water
118958|NCT02551887|HPV Vaccinations|hpv vaccinations
118959|NCT02551887|Quadrivalent Vaccine|quadrivalent vaccine
118960|NCT02551848|Movement disorders|movement disorders
118961|NCT02551848|Botulinum toxin type A|botulinum toxin type a
118962|NCT02551848|Kinematics|kinematics
118963|NCT02551835|ODIN|odin
118964|NCT02551835|Meta-analysis|meta-analysis
118965|NCT02551835|Cholecalciferol|cholecalciferol
118966|NCT02551835|25(OH)D|25(oh)d
118967|NCT02551835|Subgroup effects|subgroup effects
118968|NCT02551822|Urge Urinary Incontinence, sacral neuromodulation|urge urinary incontinence, sacral neuromodulation
118969|NCT02551796|lenticule extraction|lenticule extraction
118970|NCT02551796|laser in situ keratomileusis|laser in situ keratomileusis
118971|NCT02551796|femtosecond laser-assisted laser in situ keratomileusis|femtosecond laser-assisted laser in situ keratomileusis
118972|NCT02551796|tear|tear
118973|NCT02551796|inflammatory mediators|inflammatory mediators
118974|NCT02551783|urethral stricture|urethral stricture
118975|NCT02551783|urethroplasty|urethroplasty
118976|NCT02551783|buccal mucosa|buccal mucosa
118977|NCT02551783|graft|graft
118978|NCT02551757|Rehabilitation|rehabilitation
118979|NCT02551757|Continuous Positive Airway Pressure|continuous positive airway pressure
118980|NCT02551744|histamine-2 receptor antagonist|histamine-2 receptor antagonist
118981|NCT02551744|proton pump inhibitor|proton pump inhibitor
118982|NCT02551744|thienopyridine|thienopyridine
118983|NCT02551744|clopidogrel|clopidogrel
118984|NCT02551744|prevention|prevention
118985|NCT02551679|Stem cells|stem cells
118986|NCT02551679|Endothelial progenitor cells|endothelial progenitor cells
118987|NCT02551679|Autologous cells|autologous cells
118988|NCT02551679|Vascular disease|vascular disease
118989|NCT02551679|Peripheral arterial disease|peripheral arterial disease
118990|NCT02551679|Regenerative medicine|regenerative medicine
118991|NCT02551653|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
118992|NCT02551653|Biodistribution|biodistribution
118993|NCT02551653|Positron Emission Tomography|positron emission tomography
118994|NCT02551653|[11C]-GSK2256098|[11c]-gsk2256098
118995|NCT02551653|Healthy subjects|healthy subjects
118996|NCT02551614|lipopolysaccharide|lipopolysaccharide
118997|NCT02551614|COPD|copd
118998|NCT02551614|neutrophil|neutrophil
118999|NCT02551601|subfoveal choroidal thickness|subfoveal choroidal thickness
119000|NCT02551601|optical coherence tomography|optical coherence tomography
119001|NCT02551601|enhanced depth imaging|enhanced depth imaging
119002|NCT02551588|fibrosis|fibrosis
119003|NCT02551588|Magnetic resonance imaging|magnetic resonance imaging
119004|NCT02551549|Subjects|subjects
119005|NCT02551536|Allergic rhinitis|allergic rhinitis
119006|NCT02551536|montelukast|montelukast
119007|NCT02551536|fexofenadine|fexofenadine
119008|NCT02551536|levocetrizine|levocetrizine
119009|NCT02551510|Skin Adhesive|skin adhesive
119010|NCT02551510|Suture|suture
119011|NCT02551510|Port Incisions|port incisions
119012|NCT02551497|volunteer drug interaction study|volunteer drug interaction study
119013|NCT02551471|Locally advanced rectal cancer|locally advanced rectal cancer
119014|NCT02551471|Fixed primary rectal cancer|fixed primary rectal cancer
119015|NCT02551471|Pelvic recurrence|pelvic recurrence
119016|NCT02551471|Benchmarking France Australia|benchmarking france australia
119017|NCT02551432|pembrolizumab|pembrolizumab
119018|NCT02551432|paclitaxel|paclitaxel
119019|NCT02551419|mild cognitive impairment|mild cognitive impairment
119020|NCT02551419|ketones|ketones
119021|NCT02551419|medium chain triglycerides|medium chain triglycerides
119022|NCT02551419|Positron emission tomography|positron emission tomography
119023|NCT02551419|magnetic resonance imaging|magnetic resonance imaging
119024|NCT02551419|cognition|cognition
119025|NCT02551419|brain|brain
119026|NCT02551419|neuroimaging|neuroimaging
119027|NCT02551406|nocturnal hypoventilation|nocturnal hypoventilation
119028|NCT02551406|capno-oxymetry|capno-oxymetry
119029|NCT02551393|Older adults|older adults
119030|NCT02551393|Home Blood Pressure Monitoring|home blood pressure monitoring
119031|NCT02551367|letrozole|letrozole
119032|NCT02551354|Labor, Obstetric|labor, obstetric
119033|NCT02551354|pain|pain
119034|NCT02551354|pupil diameter|pupil diameter
119035|NCT02551354|Visual Analogic Scale (VAS)|visual analogic scale (vas)
119036|NCT02551341|prostatectomy|prostatectomy
119037|NCT02551341|robotic|robotic
119038|NCT02551315|Intra-cortical pore volume|intra-cortical pore volume
119039|NCT02551315|HR-pQCT|hr-pqct
119041|NCT02551315|bone mineral density|bone mineral density
119042|NCT02551315|bone turnover markers|bone turnover markers
119043|NCT02551315|urinary pentosidine|urinary pentosidine
119044|NCT02551289|MRI|mri
119045|NCT02551289|Gluten|gluten
119046|NCT02551289|Imaging|imaging
119047|NCT02551289|Enteropathy-Associated T-Cell Lymphoma|enteropathy-associated t-cell lymphoma
119048|NCT02551263|Breast Cancer|breast cancer
119049|NCT02551263|Eribulin|eribulin
119050|NCT02551263|HER2-negative|her2-negative
119051|NCT02551263|hormone-resistant|hormone-resistant
119052|NCT02551263|inoperable|inoperable
119053|NCT02551263|recurrent metastatic|recurrent metastatic
119054|NCT02551250|hepatocellular carcinoma|hepatocellular carcinoma
119055|NCT02551250|surveillance|surveillance
119056|NCT02551250|liver cirrhosis|liver cirrhosis
119057|NCT02551250|ultrasonography|ultrasonography
119058|NCT02551250|magnetic resonance imaging|magnetic resonance imaging
119059|NCT02551237|Elderly patient|elderly patient
119060|NCT02551237|Radiotherapy|radiotherapy
119061|NCT02551237|Radio chemotherapy|radio chemotherapy
119062|NCT02551237|Neoadjuvant treatment|neoadjuvant treatment
119063|NCT02551224|COPD|copd
119064|NCT02551198|polyethylene glycol with ascorbic acid|polyethylene glycol with ascorbic acid
119065|NCT02551198|oral sulfate solution|oral sulfate solution
119066|NCT02551198|bowel preparation|bowel preparation
119067|NCT02551159|programmed cell death ligand 1 (PD-L1), MEDI4736, Cytotoxic T-lymphocyte-associated antigen 4 {CTLA-4}, PFS, SCCHN|programmed cell death ligand 1 (pd-l1), medi4736, cytotoxic t-lymphocyte-associated antigen 4 {ctla-4}, pfs, scchn
119068|NCT02551133|Dexamethasone|dexamethasone
119069|NCT02551133|mastectomy|mastectomy
119070|NCT02551133|persistent surgical pain|persistent surgical pain
119071|NCT02551120|Idiopathic hypoparathyroidism|idiopathic hypoparathyroidism
119072|NCT02551120|Autosomal dominant hypocalcaemia|autosomal dominant hypocalcaemia
119073|NCT02551120|Pseudohypoparathyroidism|pseudohypoparathyroidism
119074|NCT02551120|Quality of Life|quality of life
119075|NCT02551120|Bone Mineral Density|bone mineral density
119076|NCT02551120|Muscle strength|muscle strength
119077|NCT02551120|Cardiovascular indices|cardiovascular indices
119078|NCT02551055|Drug Therapy|drug therapy
119079|NCT02551042|Digital Ulcers|digital ulcers
119080|NCT02551042|Raynauds Phenomenon|raynauds phenomenon
119081|NCT02551042|Factor XIII|factor xiii
119082|NCT02551029|Magnetic Resonance Imaging|magnetic resonance imaging
119083|NCT02551029|Brainstem|brainstem
119084|NCT02551029|Solitary Nucleus|solitary nucleus
119085|NCT02551029|Visceral Nervous System|visceral nervous system
119086|NCT02551029|Transient Receptor Potential Channels|transient receptor potential channels
119087|NCT02550977|Contraception|contraception
119088|NCT02550977|Transdermal contraceptive patch|transdermal contraceptive patch
119089|NCT02550977|Safety|safety
119090|NCT02550977|Efficacy|efficacy
119091|NCT02550977|Pharmacokinetic|pharmacokinetic
119092|NCT02550964|Autoimmune Disease|autoimmune disease
119093|NCT02550964|Rheumatoid Arthritis|rheumatoid arthritis
119191|NCT02550236|Lifestyle|lifestyle
119094|NCT02550964|Systemic Lupus Erythematosus|systemic lupus erythematosus
119095|NCT02550964|Hydroxychloroquine(HCQ)|hydroxychloroquine(hcq)
119096|NCT02550964|Chloroquine(CQ)|chloroquine(cq)
119097|NCT02550964|Toxic Maculopathy|toxic maculopathy
119098|NCT02550925|Cancer survivors|cancer survivors
119099|NCT02550886|Work Burden|work burden
119100|NCT02550886|Ambulatory Orthopedic Surgery|ambulatory orthopedic surgery
119101|NCT02550886|Anesthesiology|anesthesiology
119102|NCT02550886|Perioperative Care|perioperative care
119103|NCT02550860|intravenous fat emulsions|intravenous fat emulsions
119104|NCT02550860|parenteral nutrition|parenteral nutrition
119105|NCT02550860|skin barrier function|skin barrier function
119106|NCT02550860|essential fatty acids|essential fatty acids
119107|NCT02550860|transepidermal water loss|transepidermal water loss
119108|NCT02550847|MR/PET|mr/pet
119109|NCT02550847|pancreatic cancer|pancreatic cancer
119110|NCT02550834|Core stability|core stability
119111|NCT02550834|Indoors curling exercises|indoors curling exercises
119112|NCT02550834|Motivation|motivation
119113|NCT02550821|Physical activity levels|physical activity levels
119114|NCT02550821|Bronchiectasis|bronchiectasis
119115|NCT02550782|perineural dexmedetomidine|perineural dexmedetomidine
119116|NCT02550782|infraclavicular perineural catheter|infraclavicular perineural catheter
119117|NCT02550782|postoperative analgesia|postoperative analgesia
119118|NCT02550769|Transanal NOTES|transanal notes
119119|NCT02550769|Transanal TME|transanal tme
119120|NCT02550769|Laparoscopic Low Anterior Resection|laparoscopic low anterior resection
119121|NCT02550769|Surgery|surgery
110234|NCT02603445|FL|fl
119122|NCT02550717|Low-dose Acetylsalicylic Acid,|low-dose acetylsalicylic acid,
119123|NCT02550717|Bleeding,|bleeding,
119124|NCT02550717|The Health Improvement Network (THIN),|the health improvement network (thin),
119125|NCT02550717|Cardiovascular|cardiovascular
119126|NCT02550717|Secondary prevention of cardiovascular events|secondary prevention of cardiovascular events
119127|NCT02550704|Irritable Bowel syndrome|irritable bowel syndrome
119128|NCT02550704|Intestinal permeability|intestinal permeability
119129|NCT02550704|Visceral hypersensitivity|visceral hypersensitivity
119130|NCT02550704|Low grade inflammation|low grade inflammation
119131|NCT02550678|Untreated nBCC|untreated nbcc
119132|NCT02550678|Low-Risk|low-risk
119133|NCT02550665|Alzheimer's disease|alzheimer's disease
119134|NCT02550665|donepezil|donepezil
119135|NCT02550626|delirium|delirium
119136|NCT02550626|alpha synucleinopathy|alpha synucleinopathy
119137|NCT02550626|spine surgery|spine surgery
119138|NCT02550613|MR/PET, hepatocellular carcinoma, HCC|mr/pet, hepatocellular carcinoma, hcc
119139|NCT02550600|ARDS|ards
119140|NCT02550600|Acute lung impairment|acute lung impairment
119141|NCT02550600|Extracorporeal lung assist|extracorporeal lung assist
119142|NCT02550600|ECMO|ecmo
119143|NCT02550600|ECLA|ecla
119144|NCT02550600|Murray-score|murray-score
119145|NCT02550600|SOFA-score|sofa-score
119146|NCT02550587|Patient Satisfaction|patient satisfaction
119147|NCT02550587|anesthesia Care|anesthesia care
119148|NCT02550561|Posterior tibial nerve stimulation|posterior tibial nerve stimulation
119149|NCT02550561|PTNS|ptns
119150|NCT02550561|IC|ic
119151|NCT02550548|Incretins|incretins
119152|NCT02550548|GLP-1|glp-1
119153|NCT02550548|GIP|gip
119154|NCT02550548|hyperglycemic clamp|hyperglycemic clamp
119155|NCT02550535|Gene Therapy|gene therapy
119156|NCT02550535|WT1 TCR|wt1 tcr
119157|NCT02550535|Gene modified T cels|gene modified t cels
119158|NCT02550522|without associated head injury|without associated head injury
119159|NCT02550509|stroke|stroke
119160|NCT02550509|Botulinum toxin|botulinum toxin
119161|NCT02550509|Muscle alterations|muscle alterations
119162|NCT02550483|Healthy volunteers|healthy volunteers
119163|NCT02550444|Clonidine|clonidine
119164|NCT02550444|Anesthesia, Obstetrical|anesthesia, obstetrical
119165|NCT02550379|Social Anxiety|social anxiety
119166|NCT02550379|Social Phobia|social phobia
119167|NCT02550379|Depression|depression
119168|NCT02550379|Emotion Recognition Training|emotion recognition training
119169|NCT02550366|Cardiac MRI|cardiac mri
119170|NCT02550366|Accelerate imaging|accelerate imaging
119171|NCT02550366|coronary artery disease|coronary artery disease
119172|NCT02550353|lenticule extraction|lenticule extraction
119173|NCT02550353|femtosecond laser-assisted laser in situ keratomileusis|femtosecond laser-assisted laser in situ keratomileusis
119174|NCT02550353|tear|tear
119175|NCT02550353|inflammatory mediators|inflammatory mediators
119176|NCT02550340|Arrhythmia|arrhythmia
119177|NCT02550340|Alcohol|alcohol
119178|NCT02550340|ECG|ecg
119179|NCT02550327|resectable|resectable
119180|NCT02550327|potentially resectable|potentially resectable
119181|NCT02550327|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
119182|NCT02550327|PDAC|pdac
119183|NCT02550301|mean platelet volume|mean platelet volume
119184|NCT02550262|Epidural|epidural
119185|NCT02550262|Labor analgesia|labor analgesia
119186|NCT02550262|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
119187|NCT02550236|Children|children
119188|NCT02550236|Obesity|obesity
119189|NCT02550236|Pregnancy|pregnancy
119190|NCT02550236|Growth|growth
119192|NCT02550236|Metabolic and cardiovascular health|metabolic and cardiovascular health
119193|NCT02550236|Birth|birth
119194|NCT02550236|Development|development
119195|NCT02550210|Breast Conserving Surgery|breast conserving surgery
119197|NCT02550210|Breast Diagnostics|breast diagnostics
119198|NCT02550197|Influenza|influenza
119199|NCT02550197|Quadrivalent influenza vaccine|quadrivalent influenza vaccine
119200|NCT02550197|Trivalent influenza vaccine|trivalent influenza vaccine
119201|NCT02550184|Patients with symptoms of acute respiratory problems|patients with symptoms of acute respiratory problems
119202|NCT02550171|Biobank|biobank
119203|NCT02550171|Genetics|genetics
119204|NCT02550171|DNA|dna
119205|NCT02550171|Cohort|cohort
119206|NCT02550171|normal control|normal control
119207|NCT02550158|Crohn's Disease|crohn's disease
119208|NCT02550158|Ulcerative Colitis|ulcerative colitis
119209|NCT02550158|Educational program|educational program
119210|NCT02550158|Inflammatory Bowel Disease|inflammatory bowel disease
119211|NCT02550158|Psycho-pedagogic score|psycho-pedagogic score
119212|NCT02550158|IBD|ibd
119213|NCT02550145|Hyperinsulinemic|hyperinsulinemic
119214|NCT02550145|post-bariatric surgery|post-bariatric surgery
119215|NCT02550132|electromyography|electromyography
119216|NCT02550132|biomechanical phenomena|biomechanical phenomena
651814|NCT00785005|Research|research
119217|NCT02550132|dose-response relationship|dose-response relationship
119218|NCT02550132|musculoskeletal manipulations|musculoskeletal manipulations
119219|NCT02550132|spinal manipulation|spinal manipulation
119220|NCT02550106|CHRONIC SPONTANEOUS URTICARIA, OMALIZUMAB, URTICARIA CONTROL TEST|chronic spontaneous urticaria, omalizumab, urticaria control test
119221|NCT02550093|Volunteers|volunteers
119222|NCT02550067|HIV infection|hiv infection
119223|NCT02550067|DepoLevonorgestrel|depolevonorgestrel
119224|NCT02550067|Contraception|contraception
119225|NCT02550067|DMPA|dmpa
119226|NCT02550067|Copper IUD|copper iud
119227|NCT02550067|Levonorgestrel implant|levonorgestrel implant
119228|NCT02550067|IUD|iud
119229|NCT02550041|Bronchitis aspergillus|bronchitis aspergillus
119230|NCT02550041|cystic fibrosis|cystic fibrosis
119231|NCT02550028|Neonates|neonates
119232|NCT02550028|Seizure|seizure
119233|NCT02550015|Exercise training|exercise training
119234|NCT02550015|Oxygen consumption|oxygen consumption
119235|NCT02549989|LY3023414|ly3023414
119236|NCT02549989|15-079|15-079
119237|NCT02549989|Persistent Endometrial Cancer|persistent endometrial cancer
119238|NCT02549976|Crohn's Disease|crohn's disease
119239|NCT02549976|Digestive Damage|digestive damage
119240|NCT02549976|Lemann Index|lemann index
119241|NCT02549950|Accelerated orthodontic tooth movement (AOTM)|accelerated orthodontic tooth movement (aotm)
119242|NCT02549950|Peizo-corticission|peizo-corticission
119243|NCT02549924|Resveratrol|resveratrol
119244|NCT02549924|Glycemic Variability|glycemic variability
119245|NCT02549924|MAGE|mage
119246|NCT02549911|chemotherapy|chemotherapy
119247|NCT02549911|surgery|surgery
119248|NCT02549911|Surgically-Created Resection Cavity|surgically-created resection cavity
119249|NCT02549911|Adverse Reaction to Drug|adverse reaction to drug
119250|NCT02549885|Migraine disorders|migraine disorders
119251|NCT02549885|Muscle stretching exercises|muscle stretching exercises
119252|NCT02549872|Dementia|dementia
119253|NCT02549872|Validity|validity
119254|NCT02549872|Mortality|mortality
119255|NCT02549872|Electronic health records|electronic health records
119256|NCT02549859|DBS|dbs
119257|NCT02549859|Low frequency stimulation|low frequency stimulation
119258|NCT02549859|Dysphagia|dysphagia
119259|NCT02549859|Freezing of gait|freezing of gait
119260|NCT02549833|low-grade glioma|low-grade glioma
119261|NCT02549833|WHO grade II|who grade ii
119262|NCT02549833|vaccine|vaccine
119263|NCT02549833|immunotherapy|immunotherapy
119264|NCT02549833|glioma|glioma
119265|NCT02549820|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
119266|NCT02549820|Tracheal Occlusion|tracheal occlusion
119267|NCT02549807|Vascular hemiplegia|vascular hemiplegia
119268|NCT02549807|2D ultrasound|2d ultrasound
119269|NCT02549807|Muscle elasticity|muscle elasticity
119270|NCT02549807|Pennation angle|pennation angle
119271|NCT02549794|low concentration contrast agent|low concentration contrast agent
119272|NCT02549794|Low dose contrast agent|low dose contrast agent
119273|NCT02549794|computed tomography|computed tomography
119274|NCT02549781|pathological gambler|pathological gambler
119275|NCT02549781|Go-Nogo test|go-nogo test
119276|NCT02549768|Dexmedetomidine|dexmedetomidine
119277|NCT02549768|Pituitary|pituitary
119278|NCT02549768|Transsphenoidal|transsphenoidal
119279|NCT02549768|Cortisol|cortisol
119280|NCT02549742|Electrochemotherapy|electrochemotherapy
119281|NCT02549742|head neck cancer|head neck cancer
119282|NCT02549742|bleomycin|bleomycin
119283|NCT02549716|Acetaminophen|acetaminophen
119284|NCT02549716|interleukin-6|interleukin-6
119285|NCT02549716|interleukin-1|interleukin-1
119286|NCT02549716|thromboxane A2|thromboxane a2
119287|NCT02549703|multiple sclerosis|multiple sclerosis
119288|NCT02549703|progressive multiple sclerosis|progressive multiple sclerosis
119289|NCT02549703|mitochondria|mitochondria
119290|NCT02549703|neurodegeneration|neurodegeneration
119291|NCT02549690|IVF, Testosterone gel, DHEA, poor responder.|ivf, testosterone gel, dhea, poor responder.
119292|NCT02549664|Hypertrophic Cardiomyopathy (HCM)|hypertrophic cardiomyopathy (hcm)
119293|NCT02549664|Long QT Syndrome (LQTS)|long qt syndrome (lqts)
119295|NCT02549651|MEDI4736|medi4736
119296|NCT02549651|tremelimumab|tremelimumab
119297|NCT02549651|AZD9150|azd9150
119298|NCT02549651|anti-PD-L1|anti-pd-l1
119299|NCT02549651|anti-CTLA-4|anti-ctla-4
119300|NCT02549651|immunotherapy|immunotherapy
119301|NCT02549651|IMTC|imtc
119302|NCT02549651|STAT3|stat3
119303|NCT02549625|Single right ventricular failure|single right ventricular failure
119304|NCT02549612|Conductive hearing loss|conductive hearing loss
119305|NCT02549612|middle ear pressure equalization|middle ear pressure equalization
119306|NCT02549612|middle ear effusion|middle ear effusion
119307|NCT02549599|Digital and mobile health|digital and mobile health
119308|NCT02549599|Sexual and reproductive health|sexual and reproductive health
119309|NCT02549599|Adolescents and young adults|adolescents and young adults
119310|NCT02549586|solid organ transplant|solid organ transplant
119311|NCT02549586|immune tolerance|immune tolerance
119312|NCT02549586|autologous stem cell transplant|autologous stem cell transplant
119313|NCT02549586|blood and marrow transplant|blood and marrow transplant
110394|NCT02602561|HMB|hmb
119314|NCT02549586|autoimmune disease|autoimmune disease
119315|NCT02549573|Motor Symptoms|motor symptoms
119316|NCT02549573|Parkinson's disease|parkinson's disease
119317|NCT02549573|Apokyn|apokyn
119318|NCT02549573|Apomorphine|apomorphine
119319|NCT02549573|PD|pd
119320|NCT02549560|tDCS|tdcs
119321|NCT02549560|Cardiac Surgery|cardiac surgery
119322|NCT02549547|anxiety|anxiety
119323|NCT02549547|depression|depression
119324|NCT02549547|exercise|exercise
119325|NCT02549547|group|group
119326|NCT02549547|group medical visit|group medical visit
119327|NCT02549547|mood disorder|mood disorder
119328|NCT02549547|physical activity|physical activity
119329|NCT02549547|primary care|primary care
119330|NCT02549534|Taxane|taxane
119331|NCT02549534|Neuropathy|neuropathy
119332|NCT02549534|Chemotherapy-Induced Peripheral Neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
119333|NCT02549534|Breast Cancer|breast cancer
119334|NCT02549534|Local skin heating|local skin heating
119335|NCT02549534|Axon reflex|axon reflex
119336|NCT02549534|Axon flare|axon flare
119337|NCT02549534|Total Neuropathy Score (TNS)|total neuropathy score (tns)
119338|NCT02549534|Laser Doppler Flowmetry (LDF)|laser doppler flowmetry (ldf)
119339|NCT02549534|Laser Speckle Contrast Imaging (LSCI)|laser speckle contrast imaging (lsci)
119340|NCT02549534|Full-field laser perfusion imaging (FLPI)|full-field laser perfusion imaging (flpi)
119341|NCT02549534|Paclitaxel|paclitaxel
119342|NCT02549534|Taxol|taxol
119343|NCT02549521|calcium|calcium
119344|NCT02549521|magnesium|magnesium
119345|NCT02549521|vitamin D|vitamin d
119346|NCT02549521|bone turnover markers|bone turnover markers
119347|NCT02549482|Central volume deficit|central volume deficit
119348|NCT02549482|Head-up tilt|head-up tilt
119349|NCT02549482|Systolic pressure variation|systolic pressure variation
119350|NCT02549456|natural orifice surgery|natural orifice surgery
119351|NCT02549456|natural orifice specimen extraction|natural orifice specimen extraction
119352|NCT02549456|taTME|tatme
119353|NCT02549443|Catabolic response|catabolic response
119354|NCT02549443|Amino Acids|amino acids
119355|NCT02549443|Insulin|insulin
119356|NCT02549430|Advanced breast cancer|advanced breast cancer
119357|NCT02549430|Postmenopausal|postmenopausal
119358|NCT02549430|ER positive|er positive
119359|NCT02549430|Her2 negative|her2 negative
119360|NCT02549378|microcirculation|microcirculation
119361|NCT02549378|confocal microscopy|confocal microscopy
119362|NCT02549378|hypocapnia|hypocapnia
119363|NCT02549326|Vitamin D|vitamin d
119364|NCT02549313|brain lesion|brain lesion
119365|NCT02549313|intracranial pressure|intracranial pressure
119366|NCT02549313|cerebral perfusion pressure|cerebral perfusion pressure
119367|NCT02549300|connective tissue massage|connective tissue massage
119368|NCT02549300|adolescent tension-type headache|adolescent tension-type headache
119369|NCT02549274|Cervicalgia|cervicalgia
119370|NCT02549274|self-rehabilitation|self-rehabilitation
119371|NCT02549274|physiotherapy|physiotherapy
119372|NCT02549261|nimotuzumab|nimotuzumab
119373|NCT02549261|non-small cell lung cancer|non-small cell lung cancer
119374|NCT02549261|radiochemotherapy|radiochemotherapy
119375|NCT02549261|stage IIIA/IIIB non-small cell lung cancer|stage iiia/iiib non-small cell lung cancer
119376|NCT02549248|Interstitial Lung Diseases|interstitial lung diseases
119377|NCT02549248|nanoparticles|nanoparticles
119378|NCT02549248|lung|lung
119379|NCT02549248|broncho-alveolar lavage|broncho-alveolar lavage
119380|NCT02549248|bronchial washings|bronchial washings
119382|NCT02549235|Miscarriage|miscarriage
119383|NCT02549235|Uterine septum|uterine septum
119384|NCT02549222|pathogen reduction|pathogen reduction
119385|NCT02549222|INTERCEPT|intercept
119386|NCT02549222|platelet|platelet
119387|NCT02549222|pulmonary|pulmonary
119388|NCT02549222|ARDS|ards
119389|NCT02549222|hematology|hematology
119390|NCT02549222|oncology|oncology
119391|NCT02549222|assisted ventilation|assisted ventilation
119392|NCT02549222|transfusion of platelet components|transfusion of platelet components
119393|NCT02549222|hematology-oncology patients|hematology-oncology patients
119394|NCT02549209|Pembrolizumab|pembrolizumab
119395|NCT02549209|Keytruda|keytruda
119396|NCT02549209|Anti-Programmed [Cell] Death Protein 1 (PD-1) Antibody|anti-programmed [cell] death protein 1 (pd-1) antibody
119397|NCT02549209|Carboplatin|carboplatin
119398|NCT02549209|Paclitaxel|paclitaxel
119399|NCT02549183|Spinal Cord Stimulation|spinal cord stimulation
119400|NCT02549170|Autoimmune Diseases|autoimmune diseases
119401|NCT02549170|Polyneuropathies|polyneuropathies
119402|NCT02549170|Nervous System Diseases|nervous system diseases
119403|NCT02549170|Peripheral Nervous System Diseases|peripheral nervous system diseases
119404|NCT02549170|Polyradiculoneuropathy|polyradiculoneuropathy
119405|NCT02549170|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
119406|NCT02549170|Immunoglobulins|immunoglobulins
119407|NCT02549170|Immune System Diseases|immune system diseases
119408|NCT02549170|Demyelinating Diseases|demyelinating diseases
401966|NCT01232556|relapsed/refractory lymphoma|relapsed/refractory lymphoma
143084|NCT02411760|MRI|mri
119409|NCT02549170|Polyradiculoneuropathy, Chronic Inflammatory Demyelinating|polyradiculoneuropathy, chronic inflammatory demyelinating
119410|NCT02549170|Neuromuscular Diseases|neuromuscular diseases
119411|NCT02549144|HDL biochemical composition and function|hdl biochemical composition and function
119412|NCT02549105|EMLA CREAM|emla cream
119413|NCT02549105|LIDOCAINE INFILTERATION|lidocaine infilteration
119414|NCT02549105|PAIN RELIEF|pain relief
119415|NCT02549092|carbidopa|carbidopa
119416|NCT02549092|efficacy|efficacy
119417|NCT02549092|Advanced Parkinson's Disease|advanced parkinson's disease
119418|NCT02549092|Parkinson's Disease Sleep Scale PDSS-2|parkinson's disease sleep scale pdss-2
119419|NCT02549092|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
119420|NCT02549092|Non-Motor Symptom Scale NMSS|non-motor symptom scale nmss
119421|NCT02549092|levodopa|levodopa
119422|NCT02549066|cardiopulmonary bypass|cardiopulmonary bypass
119423|NCT02549066|renal blood flow|renal blood flow
119424|NCT02549066|renal function|renal function
119425|NCT02549066|renal oxygenation|renal oxygenation
119426|NCT02549001|Onychomycosis|onychomycosis
119427|NCT02549001|Nail fungus|nail fungus
119428|NCT02548975|Cardiac surgery|cardiac surgery
119429|NCT02548975|Risk factors|risk factors
119430|NCT02548975|Postoperative delirium|postoperative delirium
119431|NCT02548962|Multiple Myeloma|multiple myeloma
119432|NCT02548962|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
119433|NCT02548962|PCI-32765|pci-32765
119434|NCT02548962|Pomalidomide|pomalidomide
119435|NCT02548962|Dexamethasone|dexamethasone
119436|NCT02548962|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
119437|NCT02548962|Ibrutinib|ibrutinib
119438|NCT02548936|Cholesterol, LDL|cholesterol, ldl
119439|NCT02548936|Carotid Intima-Media Thickness|carotid intima-media thickness
119440|NCT02548936|Atherosclerosis|atherosclerosis
119441|NCT02548936|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination
119442|NCT02548936|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
119443|NCT02548897|Parkinson's Disease with Freezing of Gait Symptoms|parkinson's disease with freezing of gait symptoms
119444|NCT02548858|Perineorrhaphy|perineorrhaphy
119445|NCT02548858|Pelvic organ prolapse|pelvic organ prolapse
119446|NCT02548858|Vaginal or abdominal reconstruction|vaginal or abdominal reconstruction
119447|NCT02548858|Body image|body image
119448|NCT02548845|hyponatremia|hyponatremia
119449|NCT02548845|SIADH|siadh
119450|NCT02548845|Oncologic patients|oncologic patients
119451|NCT02548832|Berberine|berberine
119452|NCT02548832|Bezafibrate|bezafibrate
119453|NCT02548806|Clonidine|clonidine
119454|NCT02548793|Cardiac Arrest|cardiac arrest
119455|NCT02548793|CPR|cpr
119456|NCT02548793|Family-centered Care|family-centered care
119457|NCT02548793|Health Literacy|health literacy
119458|NCT02548793|Health Education|health education
119459|NCT02548793|Education Dissemination|education dissemination
119460|NCT02548780|unresectable|unresectable
119461|NCT02548767|High fructose corn syrup|high fructose corn syrup
119462|NCT02548767|Sugar|sugar
119463|NCT02548754|atrial fibrillation|atrial fibrillation
119464|NCT02548754|neuromodulation|neuromodulation
119465|NCT02548754|inflammation|inflammation
119466|NCT02548741|Metformin|metformin
119467|NCT02548741|diabetes|diabetes
119468|NCT02548741|type 2 diabetes|type 2 diabetes
119469|NCT02548741|diabetes complications|diabetes complications
119470|NCT02548741|methylglyoxal|methylglyoxal
119471|NCT02548741|Prediabetes|prediabetes
119472|NCT02548728|Opioid Dependence|opioid dependence
119473|NCT02548728|Opioid Withdrawal|opioid withdrawal
119474|NCT02548728|Opioid|opioid
119475|NCT02548728|Oxytocin|oxytocin
119476|NCT02548728|OT (oxytocin)|ot (oxytocin)
119477|NCT02548728|Intranasal administration|intranasal administration
119478|NCT02548715|thyroxine|thyroxine
119479|NCT02548715|Otolaryngology|otolaryngology
119480|NCT02548702|Sport|sport
119481|NCT02548702|type 2 diabetes|type 2 diabetes
119482|NCT02548702|community intervention programme|community intervention programme
119483|NCT02548702|Fit4life|fit4life
119484|NCT02548702|Exercise|exercise
119485|NCT02548689|alopecia|alopecia
119486|NCT02548689|hair loss|hair loss
119487|NCT02548663|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
119488|NCT02548663|sport therapy|sport therapy
119489|NCT02548663|osteopathic manual treatment|osteopathic manual treatment
119490|NCT02548663|muscle oxidative metabolism|muscle oxidative metabolism
119491|NCT02548650|myocardial infarction|myocardial infarction
119492|NCT02548650|diabetes mellitus|diabetes mellitus
119493|NCT02548650|vorapaxar|vorapaxar
119494|NCT02548650|peripheral arterial disease|peripheral arterial disease
119495|NCT02548585|MEDI0382, diabetes|medi0382, diabetes
119496|NCT02548572|Transcorneal Electrical Stimulation|transcorneal electrical stimulation
119497|NCT02548572|TES|tes
119498|NCT02548572|Retinitis Pigmentosa|retinitis pigmentosa
119499|NCT02548572|RP|rp
119500|NCT02548416|Atelectasis|atelectasis
119501|NCT02548416|Positive End-Expiratory Pressure|positive end-expiratory pressure
119502|NCT02548416|Oxygenation|oxygenation
110632|NCT02601196|IVF|ivf
119503|NCT02548416|Anaesthesia|anaesthesia
119504|NCT02548416|Computed tomography|computed tomography
119505|NCT02548403|Bowel preparation|bowel preparation
119506|NCT02548403|Simethicone|simethicone
119507|NCT02548403|Polyethylene glycol with ascorbic acid|polyethylene glycol with ascorbic acid
119508|NCT02548390|Phase 1/1b|phase 1/1b
119509|NCT02548390|open-label|open-label
119510|NCT02548390|dose-escalation|dose-escalation
119511|NCT02548390|pharmacokinetics|pharmacokinetics
119512|NCT02548390|solid tumor|solid tumor
119513|NCT02548390|metastatic cancer|metastatic cancer
119514|NCT02548390|chemotherapy|chemotherapy
119515|NCT02548390|nano formulation|nano formulation
119516|NCT02548390|alkylator|alkylator
119517|NCT02548377|Head and Neck Neoplasms|head and neck neoplasms
119518|NCT02548377|Surgical Flaps|surgical flaps
119519|NCT02548377|Ischemic Preconditioning|ischemic preconditioning
119520|NCT02548377|Hemostasis|hemostasis
119521|NCT02548377|Thrombosis|thrombosis
119522|NCT02548377|Immune System|immune system
119523|NCT02548377|Reperfusion Injury|reperfusion injury
119524|NCT02548364|Vitamin D|vitamin d
119525|NCT02548364|Myocardial Infarction|myocardial infarction
119526|NCT02548364|Ventricular remodeling|ventricular remodeling
119527|NCT02548364|Biomarkers|biomarkers
120122|NCT02544607|Depression|depression
119528|NCT02548351|Non Alcoholic Steatohepatitis, fatty liver disease, NASH|non alcoholic steatohepatitis, fatty liver disease, nash
119529|NCT02548312|Readers' perceptions|readers' perceptions
119530|NCT02548299|Diabetes|diabetes
119532|NCT02548299|Nutrition|nutrition
119533|NCT02548299|Lifestyle Medicine|lifestyle medicine
119534|NCT02548286|Hypertension|hypertension
119535|NCT02548286|Healthy male volunteer|healthy male volunteer
119536|NCT02548286|Candesartan, Amlodipine|candesartan, amlodipine
119537|NCT02548273|Corneal endothelium|corneal endothelium
119538|NCT02548273|phacoemulsification|phacoemulsification
119539|NCT02548247|Stool frequency|stool frequency
119540|NCT02548247|Bowel motor function|bowel motor function
119541|NCT02548247|Orafti® Inulin|orafti® inulin
119542|NCT02548247|Dietary Fiber|dietary fiber
119543|NCT02548234|Stroke|stroke
119544|NCT02548234|Randomized control trial|randomized control trial
119545|NCT02548234|Mirror therapy|mirror therapy
119546|NCT02548234|Bilateral arm training|bilateral arm training
119547|NCT02548234|Comparative efficacy research|comparative efficacy research
119548|NCT02548234|Neurorehabilitation|neurorehabilitation
119549|NCT02548221|Thoracentesis|thoracentesis
119550|NCT02548221|Pleural Effusions|pleural effusions
119551|NCT02548221|Transthoracic echocardiogram|transthoracic echocardiogram
119552|NCT02548221|Lung volume measurements|lung volume measurements
119553|NCT02548195|GEMOX|gemox
119554|NCT02548195|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
119555|NCT02548195|adjuvant therapy|adjuvant therapy
119556|NCT02548195|oxaliplatin|oxaliplatin
119557|NCT02548195|gemcitabine|gemcitabine
119558|NCT02548195|capecitabine|capecitabine
119559|NCT02548195|curative surgery|curative surgery
119560|NCT02548169|Dendritic Cell Vaccine|dendritic cell vaccine
119561|NCT02548169|FOLFIRINOX|folfirinox
119562|NCT02548169|nab-paclitaxel|nab-paclitaxel
119563|NCT02548169|gemcitabine|gemcitabine
119564|NCT02548117|Testosterone therapy|testosterone therapy
119565|NCT02548117|erythrocytosis|erythrocytosis
119566|NCT02548117|finasteride|finasteride
119567|NCT02548091|non invasive ventilation|non invasive ventilation
119568|NCT02548091|reperfusion pulmonary edema|reperfusion pulmonary edema
119569|NCT02548091|chronic thrombolic pulmonary hypertension|chronic thrombolic pulmonary hypertension
119570|NCT02548091|pulmonary artery angioplasty|pulmonary artery angioplasty
119571|NCT02548078|Protection against Ebola Zaire virus|protection against ebola zaire virus
119572|NCT02548065|Fibromyalgia Syndrome|fibromyalgia syndrome
119573|NCT02548065|Balneotherapy|balneotherapy
119574|NCT02548065|Vetriolo Water|vetriolo water
119575|NCT02548052|retinoic acid receptor-related orphan receptor (ROR) gamma inverse agonist|retinoic acid receptor-related orphan receptor (ror) gamma inverse agonist
119576|NCT02548052|Plaque type psoriasis|plaque type psoriasis
119577|NCT02548052|psoriasis plaque test|psoriasis plaque test
119578|NCT02548052|Topical|topical
119579|NCT02548052|GSK2981278|gsk2981278
119580|NCT02548039|Anovulatory|anovulatory
119581|NCT02548039|Clomiphene|clomiphene
119582|NCT02548026|meal frequency|meal frequency
119583|NCT02548026|eating frequency|eating frequency
119584|NCT02548026|ingestive frequency|ingestive frequency
119585|NCT02548026|positive energy balance|positive energy balance
119587|NCT02548026|appetite|appetite
119588|NCT02548026|hunger|hunger
119589|NCT02547987|breast cancer|breast cancer
119590|NCT02547987|triple negative|triple negative
119591|NCT02547987|TNBC|tnbc
119592|NCT02547987|triple negative breast cancer|triple negative breast cancer
119593|NCT02547974|Safety|safety
119594|NCT02547974|Immunogenicity|immunogenicity
119595|NCT02547974|Reactogenicity|reactogenicity
119596|NCT02547961|breast cancer|breast cancer
119597|NCT02547961|HER2|her2
119598|NCT02547961|CAR-T cell|car-t cell
119599|NCT02547948|CD19|cd19
119600|NCT02547948|CAR T Cells|car t cells
119601|NCT02547948|Lymphoma|lymphoma
119602|NCT02547922|lupus, nephritis, randomized, placebo, anifrolumab, safety, efficacy, adult|lupus, nephritis, randomized, placebo, anifrolumab, safety, efficacy, adult
119603|NCT02547896|codeine|codeine
119604|NCT02547896|diclofenac|diclofenac
119605|NCT02547896|impacted third molar tooth|impacted third molar tooth
119606|NCT02547883|Statins|statins
119607|NCT02547883|Elderly|elderly
119608|NCT02547883|Mortality|mortality
119609|NCT02547883|Quality of life|quality of life
119610|NCT02547883|Randomized trial|randomized trial
119611|NCT02547883|Cost effectiveness study|cost effectiveness study
119612|NCT02547883|Primary care|primary care
119613|NCT02547870|Rilpivirine|rilpivirine
119614|NCT02547870|Healthy participants|healthy participants
119615|NCT02547857|Pelvic ultrasound|pelvic ultrasound
119616|NCT02547857|Transvaginal ultrasound|transvaginal ultrasound
119617|NCT02547818|Early stage AD|early stage ad
119618|NCT02547818|MCI|mci
119619|NCT02547818|aMCI|amci
119620|NCT02547818|prodromal|prodromal
119621|NCT02547818|Memory loss|memory loss
119622|NCT02547818|Memory problems|memory problems
119623|NCT02547818|Aging|aging
119624|NCT02547818|Early Alzheimer's Disease|early alzheimer's disease
119625|NCT02547818|Early AD|early ad
119626|NCT02547805|Urine Oxalate|urine oxalate
120520|NCT02542085|seroma|seroma
119627|NCT02547805|Nephrolithiasis|nephrolithiasis
119628|NCT02547805|Kidney Stones|kidney stones
119629|NCT02547805|Hyperoxaluria|hyperoxaluria
119630|NCT02547805|Enteric Hyperoxaluria|enteric hyperoxaluria
119631|NCT02547805|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
119632|NCT02547805|Urological Diseases|urological diseases
119633|NCT02547805|Kidney Diseases|kidney diseases
119634|NCT02547805|Supersaturation|supersaturation
119635|NCT02547805|Dietary Oxalate|dietary oxalate
119636|NCT02547792|Influenza B|influenza b
119637|NCT02547779|crystalloid|crystalloid
119638|NCT02547779|acute kidney injury|acute kidney injury
119639|NCT02547766|Ventricular Assist Device|ventricular assist device
119640|NCT02547766|Recovery of Function|recovery of function
119641|NCT02547753|Tooth extraction|tooth extraction
119642|NCT02547753|Antibiotic prophylaxis|antibiotic prophylaxis
119643|NCT02547753|Postoperative complications|postoperative complications
119645|NCT02547740|visual fields|visual fields
119646|NCT02547740|optical coherence tomography|optical coherence tomography
119647|NCT02547740|glaucoma progression|glaucoma progression
119648|NCT02547740|retinal ganglion cells|retinal ganglion cells
119649|NCT02547727|rabies vaccination|rabies vaccination
119650|NCT02547714|cyclosporine A|cyclosporine a
119651|NCT02547610|MR/PET in the evaluation|mr/pet in the evaluation
119652|NCT02547610|patients|patients
119653|NCT02547597|Beta-blockers|beta-blockers
119654|NCT02547597|Anti-anginal effect|anti-anginal effect
119655|NCT02547597|Lipid metabolism|lipid metabolism
119656|NCT02547597|Glucose metabolism|glucose metabolism
119657|NCT02547571|Outpatient|outpatient
119658|NCT02547558|Indacaterol|indacaterol
119659|NCT02547558|Pulmonary gas exchange|pulmonary gas exchange
119660|NCT02547558|Long-acting bronchodilators|long-acting bronchodilators
119661|NCT02547532|COPD|copd
119662|NCT02547532|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
119663|NCT02547532|microbioma|microbioma
119664|NCT02547519|Type 1 diabetes|type 1 diabetes
119665|NCT02547519|T1D|t1d
119666|NCT02547519|diabetes mellitus|diabetes mellitus
119667|NCT02547519|oral insulin|oral insulin
119668|NCT02547519|oral tolerance|oral tolerance
119669|NCT02547519|autoantigen|autoantigen
119670|NCT02547519|self tolerance|self tolerance
119671|NCT02547519|prevention|prevention
119672|NCT02547519|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
119673|NCT02547519|juvenile diabetes|juvenile diabetes
119674|NCT02547506|cardiorespiratory fitness|cardiorespiratory fitness
119675|NCT02547506|group exercise|group exercise
119676|NCT02547493|Vaccination against Pneumococcal|vaccination against pneumococcal
119677|NCT02547493|Naïve Abatacept patients|naïve abatacept patients
119678|NCT02547480|liver|liver
119679|NCT02547480|metastatic|metastatic
119680|NCT02547467|mortality|mortality
119681|NCT02547415|Pain, Chronic|pain, chronic
119682|NCT02547415|children|children
119683|NCT02547376|Telomeres|telomeres
119684|NCT02547376|Telomerase|telomerase
119685|NCT02547376|Alternative lengthening of Telomeres Mechanism|alternative lengthening of telomeres mechanism
119686|NCT02547285|biomechanics of walking|biomechanics of walking
119687|NCT02547285|footwear|footwear
119688|NCT02547272|Intensive care|intensive care
119689|NCT02547272|S Aureus|s aureus
119690|NCT02547259|schizophrenia|schizophrenia
119691|NCT02547259|memory|memory
119692|NCT02547259|pain|pain
119693|NCT02547246|bulimia|bulimia
119694|NCT02547246|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
119695|NCT02547194|coronary artery bypass grafting|coronary artery bypass grafting
119696|NCT02547194|saphenous vein|saphenous vein
119697|NCT02547194|no-touch technique|no-touch technique
119698|NCT02547181|Fracture|fracture
119699|NCT02547181|Follow-up|follow-up
119700|NCT02547181|metacarpal|metacarpal
119701|NCT02547168|Atrial Fibrillation|atrial fibrillation
119702|NCT02547168|Symptomatic Atrial Fibrillation|symptomatic atrial fibrillation
119703|NCT02547168|Asymptomatic Atrial Fibrillation|asymptomatic atrial fibrillation
119704|NCT02547168|Lung Resection|lung resection
119705|NCT02547168|Ambulatory Cardiac Monitor|ambulatory cardiac monitor
119706|NCT02547142|Randomized Controlled Trial|randomized controlled trial
119707|NCT02547142|Early Palliative care|early palliative care
119708|NCT02547142|FACT-E questionnaire|fact-e questionnaire
119709|NCT02547142|HADS questionnaire|hads questionnaire
119710|NCT02547142|Patient Health Questionnaire-9 (PHQ-9)|patient health questionnaire-9 (phq-9)
119711|NCT02547103|Chlorhexidine gluconate|chlorhexidine gluconate
119712|NCT02547103|Mupirocin ointment|mupirocin ointment
119713|NCT02547103|Normal saline|normal saline
119714|NCT02547103|Peritonitis|peritonitis
119715|NCT02547103|Peritoneal dialysis|peritoneal dialysis
119716|NCT02547064|intubation|intubation
119717|NCT02547064|stylet|stylet
119718|NCT02547064|videolaryngoscope|videolaryngoscope
119719|NCT02547051|Stuttering|stuttering
119720|NCT02547051|Stammering|stammering
119721|NCT02547051|Speech Disorders|speech disorders
119722|NCT02547051|Fluency Disorders|fluency disorders
119723|NCT02547038|Helicobacter pylori|helicobacter pylori
119724|NCT02547038|Eradication rate|eradication rate
119727|NCT02547025|antibiotic susceptibility|antibiotic susceptibility
119728|NCT02547025|Eradication|eradication
119729|NCT02547012|Helicobacter pylori|helicobacter pylori
119730|NCT02547012|Eradication rate|eradication rate
119731|NCT02547012|Rescue treatment|rescue treatment
119734|NCT02546986|CC-486|cc-486
119735|NCT02546986|Azacitidine|azacitidine
119736|NCT02546986|Oral azacitidine|oral azacitidine
119737|NCT02546986|Methyltransferase inhibitor|methyltransferase inhibitor
119738|NCT02546986|Hypomethylation|hypomethylation
119739|NCT02546986|Hypomethylating agent|hypomethylating agent
119740|NCT02546986|Epigenetic|epigenetic
119741|NCT02546986|MK-3475|mk-3475
119742|NCT02546986|Pembrolizumab|pembrolizumab
119743|NCT02546986|Keytruda|keytruda
119744|NCT02546986|PD-1|pd-1
119745|NCT02546986|PD-L1|pd-l1
119746|NCT02546986|ImmunotherapyAdvanced non-small cell lung cancer|immunotherapyadvanced non-small cell lung cancer
119747|NCT02546986|Metastatic non-small cell lung cancer|metastatic non-small cell lung cancer
119748|NCT02546986|Non-small cell lung cancer|non-small cell lung cancer
119749|NCT02546986|NSCLC|nsclc
119750|NCT02546986|Merck Pembrolizumab (Keynote-117)|merck pembrolizumab (keynote-117)
119751|NCT02546960|Healthy|healthy
119752|NCT02546960|JNJ-63871860|jnj-63871860
119753|NCT02546960|ExPEC4V|expec4v
119754|NCT02546947|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
119755|NCT02546947|Neuromuscular Blocking Agents|neuromuscular blocking agents
119756|NCT02546947|Atracurium|atracurium
119757|NCT02546947|Mechanical ventilation|mechanical ventilation
119758|NCT02546947|ARDS|ards
119759|NCT02546947|partial pressure of oxygen(PaO2) /inspired oxygen (FiO2) < 200|partial pressure of oxygen(pao2) /inspired oxygen (fio2) < 200
119760|NCT02546947|Positive End Expiratory Pressure (PEEP) > 5 since less than 48 hrs|positive end expiratory pressure (peep) > 5 since less than 48 hrs
119761|NCT02546934|triple negative breast cancer|triple negative breast cancer
119762|NCT02546934|fine line chemotherapy|fine line chemotherapy
119763|NCT02546921|IgE antibody|ige antibody
119764|NCT02546921|Folate receptor|folate receptor
119765|NCT02546921|Cancer Immunotherapy|cancer immunotherapy
119766|NCT02546921|First in class|first in class
119767|NCT02546908|Prostatic Neoplasms|prostatic neoplasms
119768|NCT02546908|Non-interventional|non-interventional
119769|NCT02546908|Observational|observational
119770|NCT02546895|head and neck cancer patients|head and neck cancer patients
119771|NCT02546895|clinical data|clinical data
119772|NCT02546895|tissue collection|tissue collection
119773|NCT02546895|prospective registration|prospective registration
119774|NCT02546895|patients|patients
119775|NCT02546882|stromal vascular fraction|stromal vascular fraction
119776|NCT02546882|skin graft|skin graft
119777|NCT02546843|rocuronium|rocuronium
119778|NCT02546843|sugammadex|sugammadex
119779|NCT02546843|pediatric anesthesia|pediatric anesthesia
119780|NCT02546843|cisatracurium|cisatracurium
119879|NCT02546154|Anaemia|anaemia
119781|NCT02546843|surgical conditions|surgical conditions
119782|NCT02546817|Treatment|treatment
119783|NCT02546817|Tx|tx
119784|NCT02546817|Prevent|prevent
119785|NCT02546778|Radio frequency|radio frequency
119786|NCT02546778|Female|female
119787|NCT02546778|Humans|humans
119788|NCT02546778|Esthetics|esthetics
119789|NCT02546765|analgesics|analgesics
119790|NCT02546765|cardiac surgery|cardiac surgery
119791|NCT02546765|sedation|sedation
119792|NCT02546739|Leukemia|leukemia
119793|NCT02546739|Lymphoma|lymphoma
119794|NCT02546739|CAR T|car t
119795|NCT02546726|heat therapy|heat therapy
119796|NCT02546726|steam-room|steam-room
119797|NCT02546726|aerobic exercise|aerobic exercise
119798|NCT02546726|hypertension|hypertension
143571|NCT02409056|CVD|cvd
110914|NCT02599623|Hernia|hernia
651815|NCT00785005|Bike|bike
119799|NCT02546726|multiple behavior change|multiple behavior change
119800|NCT02546726|lifestyle modification|lifestyle modification
119801|NCT02546713|dental implants|dental implants
119802|NCT02546687|Anastomotic Leak|anastomotic leak
119803|NCT02546687|Esophagectomy Gastric Pull-up|esophagectomy gastric pull-up
119804|NCT02546674|Chronic Myeloid Leukemia|chronic myeloid leukemia
119805|NCT02546674|Nilotinib|nilotinib
119806|NCT02546674|Molecular Response|molecular response
119808|NCT02546661|AZD4547|azd4547
119809|NCT02546661|MEDI4736|medi4736
119810|NCT02546661|Durvalumab|durvalumab
119811|NCT02546661|Olaparib|olaparib
119812|NCT02546661|AZD2281|azd2281
119813|NCT02546661|AZD1775|azd1775
119814|NCT02546661|Muscle invasive bladder cancer|muscle invasive bladder cancer
119815|NCT02546661|MIBC|mibc
119816|NCT02546661|BISCAY|biscay
119817|NCT02546661|AZD2014|azd2014
119818|NCT02546661|Vistusertib|vistusertib
119819|NCT02546622|Factor|factor
119820|NCT02546622|Coagulation|coagulation
119821|NCT02546622|Inhibitor|inhibitor
119822|NCT02546622|HTC|htc
119823|NCT02546622|Bleeding|bleeding
119824|NCT02546557|CABG|cabg
119825|NCT02546557|Coronary Artery Bypass Grafting|coronary artery bypass grafting
119826|NCT02546544|Linsitinib|linsitinib
119827|NCT02546544|anti-IGF-1R/IR|anti-igf-1r/ir
119828|NCT02546544|Ewing Sarcoma|ewing sarcoma
119829|NCT02546544|dual IGF-1R/IR inhibition|dual igf-1r/ir inhibition
119830|NCT02546544|Relapsed Ewing Sarcoma|relapsed ewing sarcoma
119831|NCT02546544|Refractory Ewing Sarcoma|refractory ewing sarcoma
119832|NCT02546544|Metastatic Ewing Sarcoma|metastatic ewing sarcoma
119833|NCT02546518|Conductive hearing loss|conductive hearing loss
119834|NCT02546518|Middle ear effusion|middle ear effusion
119835|NCT02546518|Middle ear pressure equalization|middle ear pressure equalization
119836|NCT02546505|Consumer behavior|consumer behavior
119837|NCT02546505|Nutrition Labeling|nutrition labeling
119838|NCT02546479|Mortality|mortality
119839|NCT02546479|Radiation|radiation
119840|NCT02546479|Spine deformities|spine deformities
119841|NCT02546466|low back pain|low back pain
119842|NCT02546466|functional taping|functional taping
119843|NCT02546466|balance|balance
119844|NCT02546466|posture|posture
119845|NCT02546466|rehabilitation|rehabilitation
119846|NCT02546466|psychosocial factors|psychosocial factors
119847|NCT02546466|minimal intervention strategy|minimal intervention strategy
119848|NCT02546453|high risk solid tumor pediatric, genetic alteration, Metastatic solid tumor pediatric|high risk solid tumor pediatric, genetic alteration, metastatic solid tumor pediatric
119849|NCT02546414|Platelet count/spleen diameter ratio|platelet count/spleen diameter ratio
119850|NCT02546414|China|china
119851|NCT02546375|Bosutinib|bosutinib
119852|NCT02546375|chronic myeloid leukaemia|chronic myeloid leukaemia
119853|NCT02546375|retrospective|retrospective
119854|NCT02546375|observational|observational
119855|NCT02546349|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
119856|NCT02546349|airway inflammation|airway inflammation
119857|NCT02546349|eosinophilic airway inflammation|eosinophilic airway inflammation
119858|NCT02546349|exhaled nitric oxide|exhaled nitric oxide
119859|NCT02546336|Ultrasound Guidance|ultrasound guidance
119860|NCT02546336|Cooled Radiofrequency|cooled radiofrequency
119861|NCT02546336|Hip Denervation|hip denervation
119862|NCT02546323|Rosuvastatin 20 mg treatment, Carotid Intima-Media Thickness, Chinese subjects, Subclinical atherosclerosis|rosuvastatin 20 mg treatment, carotid intima-media thickness, chinese subjects, subclinical atherosclerosis
119863|NCT02546297|LAMA,ICS+LABA|lama,ics+laba
119864|NCT02546284|CMML|cmml
119865|NCT02546258|Fungal Nail|fungal nail
119866|NCT02546232|locally advanced breast cancer|locally advanced breast cancer
119867|NCT02546232|metastatic breast cancer|metastatic breast cancer
119868|NCT02546219|eosinophilic esophagitis|eosinophilic esophagitis
119869|NCT02546219|EoE|eoe
119870|NCT02546219|integrins|integrins
119871|NCT02546206|Bifidobacterium|bifidobacterium
119872|NCT02546206|Gingivitis|gingivitis
119873|NCT02546206|Gingival crevicular fluid|gingival crevicular fluid
119874|NCT02546206|Interleukin-1beta|interleukin-1beta
119875|NCT02546206|Probiotics|probiotics
119876|NCT02546180|Patient education|patient education
119877|NCT02546180|Preoperative anxiety|preoperative anxiety
119878|NCT02546154|Iron|iron
119880|NCT02546154|Anaemia, Iron-Deficiency|anaemia, iron-deficiency
119881|NCT02546154|Kidney Diseases|kidney diseases
119882|NCT02546154|Inflammatory Bowel Diseases|inflammatory bowel diseases
119884|NCT02546076|Keloid|keloid
119885|NCT02546076|Hypertrophic scars|hypertrophic scars
119886|NCT02546076|Er-YAG Lasers|er-yag lasers
119887|NCT02546050|Gut microbiota|gut microbiota
119888|NCT02546050|metformin|metformin
119889|NCT02546050|Metabolism|metabolism
119890|NCT02546050|Metagenomics|metagenomics
119891|NCT02546050|Metabolomics|metabolomics
119892|NCT02546037|coagulation|coagulation
119893|NCT02546037|haemodialysis|haemodialysis
119894|NCT02546024|Major depressive disorder|major depressive disorder
119895|NCT02546024|late-onset|late-onset
119896|NCT02546024|treatment response|treatment response
119897|NCT02546024|predictors|predictors
119898|NCT02546024|moderators|moderators
119899|NCT02545998|Telehealthcare|telehealthcare
119900|NCT02545985|sirolimus|sirolimus
119901|NCT02545985|coronary stent|coronary stent
119902|NCT02545985|Prolim|prolim
119903|NCT02545972|immunosuppression|immunosuppression
119904|NCT02545959|Intrathecal Rituximab|intrathecal rituximab
119905|NCT02545959|intrathecal chemotherapy|intrathecal chemotherapy
119906|NCT02545959|cerebrospinal fluid|cerebrospinal fluid
119907|NCT02545959|lumbar puncture|lumbar puncture
119908|NCT02545959|Physiological Effects of Drugs|physiological effects of drugs
119909|NCT02545959|Rituximab|rituximab
119910|NCT02545946|traditional incision and drainage|traditional incision and drainage
119911|NCT02545946|minimally invasive incision and drainage|minimally invasive incision and drainage
119912|NCT02545946|vessel loop|vessel loop
119913|NCT02545946|emergency department|emergency department
119914|NCT02545946|pediatrics|pediatrics
119915|NCT02545933|prasugrel|prasugrel
119916|NCT02545933|ticagrelor|ticagrelor
119917|NCT02545933|vorapaxar|vorapaxar
119918|NCT02545920|haemodialysis|haemodialysis
119919|NCT02545920|hypotension|hypotension
119920|NCT02545907|Amyloidosis|amyloidosis
119921|NCT02545907|AL Amyloidosis|al amyloidosis
119922|NCT02545855|myAIRVO2|myairvo2
119923|NCT02545855|high-flow nasal cannula therapy|high-flow nasal cannula therapy
119924|NCT02545855|home oxygen therapy|home oxygen therapy
119926|NCT02545790|coarctation of aorta|coarctation of aorta
119927|NCT02545790|aortic stenosis|aortic stenosis
119928|NCT02545790|biomarkers|biomarkers
119929|NCT02545790|cardiac hypertrophy|cardiac hypertrophy
119930|NCT02545777|Acute gouty arthritis|acute gouty arthritis
119931|NCT02545777|tonifying spleen and descending the turbid|tonifying spleen and descending the turbid
119932|NCT02545777|soaking|soaking
119933|NCT02545777|wet wrapping|wet wrapping
119934|NCT02545764|Gait Analysis|gait analysis
119935|NCT02545764|Knee Adduction Moment|knee adduction moment
119936|NCT02545764|Physiotherapy|physiotherapy
119937|NCT02545764|Obesity|obesity
119938|NCT02545751|Esophageal cancer|esophageal cancer
119939|NCT02545751|Metastatic esophageal cancer|metastatic esophageal cancer
119940|NCT02545751|Radiotherapy|radiotherapy
119941|NCT02545751|Thymalfasin|thymalfasin
119942|NCT02545751|ZADAXIN's®|zadaxin's®
119943|NCT02545751|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
119944|NCT02545725|Colorectal Cancer|colorectal cancer
119945|NCT02545725|Quality of life|quality of life
119946|NCT02545725|Questionnaires|questionnaires
119947|NCT02545712|Ethanol|ethanol
119948|NCT02545712|Propylene glycol|propylene glycol
119949|NCT02545712|Benzyl alcohol|benzyl alcohol
119950|NCT02545712|Acesulfam potassium|acesulfam potassium
119951|NCT02545712|Aspartame|aspartame
119952|NCT02545712|Glycerin|glycerin
119953|NCT02545712|Sorbitol|sorbitol
119954|NCT02545712|Methyl-p-hydroxybenzoate|methyl-p-hydroxybenzoate
119955|NCT02545712|Propanyl-p-hydroxybenzoate|propanyl-p-hydroxybenzoate
119956|NCT02545712|Patients|patients
119957|NCT02545699|Adenoma|adenoma
119958|NCT02545699|Polyp|polyp
119960|NCT02545699|Colonoscopy|colonoscopy
119961|NCT02545699|Detection Yield|detection yield
119962|NCT02545673|Intervention Studies|intervention studies
119963|NCT02545673|Access to Health Care|access to health care
119964|NCT02545673|Social Stigma|social stigma
119965|NCT02545673|Social Support|social support
119966|NCT02545634|probiotic|probiotic
119967|NCT02545634|ADHD|adhd
119968|NCT02545634|anxiety|anxiety
119969|NCT02545634|digestive health|digestive health
119970|NCT02545634|children|children
119971|NCT02545634|attention deficit|attention deficit
119972|NCT02545634|gut brain axis|gut brain axis
119973|NCT02545634|nutritional supplement|nutritional supplement
119974|NCT02545634|microbiome|microbiome
119975|NCT02545621|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
119976|NCT02545621|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
119977|NCT02545621|Monocyte/Macrophage activation|monocyte/macrophage activation
119978|NCT02545621|Fluorescence-Activated Cell Sorting (FACS) analysis|fluorescence-activated cell sorting (facs) analysis
119979|NCT02545621|Thioredoxin interacting protein (TXNIP)|thioredoxin interacting protein (txnip)
119980|NCT02545621|NOD-like receptor family, pyrin domain containing 3 (NLRP3)|nod-like receptor family, pyrin domain containing 3 (nlrp3)
119981|NCT02545621|Inflammasome|inflammasome
119982|NCT02545595|General anaesthesia|general anaesthesia
119983|NCT02545595|Curarization with rocuronium|curarization with rocuronium
119984|NCT02545556|Liver Cancer|liver cancer
119985|NCT02545556|HepaSphere|hepasphere
119986|NCT02545556|cryosurgery|cryosurgery
119987|NCT02545530|renal dialysis|renal dialysis
119988|NCT02545530|hypertension|hypertension
119989|NCT02545530|clonidine|clonidine
119990|NCT02545504|Gastroesophageal junction (GEJ)|gastroesophageal junction (gej)
119991|NCT02545504|Stomach cancer|stomach cancer
119992|NCT02545491|CCD|ccd
143799|NCT02407743|surgery|surgery
119995|NCT02545491|caregiver|caregiver
119996|NCT02545478|septic shock|septic shock
119997|NCT02545478|infection|infection
119998|NCT02545478|inflammation|inflammation
119999|NCT02545478|pathologic process|pathologic process
120000|NCT02545478|biomarkers|biomarkers
120001|NCT02545465|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
120002|NCT02545465|Inoperable Chronic Thromboembolic Pulmonary Hypertension|inoperable chronic thromboembolic pulmonary hypertension
120003|NCT02545465|Persistent Chronic Thromboembolic Pulmonary Hypertension|persistent chronic thromboembolic pulmonary hypertension
120004|NCT02545465|Recurrent Chronic Thromboembolic Pulmonary Hypertension|recurrent chronic thromboembolic pulmonary hypertension
120005|NCT02545465|Switch of therapy|switch of therapy
120006|NCT02545465|Titration phase|titration phase
120007|NCT02545465|Retrospective chart review|retrospective chart review
120008|NCT02545439|Alkermes|alkermes
120009|NCT02545439|Samidorphan|samidorphan
120010|NCT02545439|ALKS 5461|alks 5461
120011|NCT02545439|Healthy Volunteer|healthy volunteer
120012|NCT02545439|Pharmacokinetics|pharmacokinetics
120013|NCT02545426|myocardial stunning|myocardial stunning
120014|NCT02545426|dialysate calcium concentration|dialysate calcium concentration
120015|NCT02545426|nutritional status|nutritional status
120016|NCT02545426|hemodinamic|hemodinamic
120017|NCT02545426|hemodialysis|hemodialysis
120018|NCT02545374|chronic wound|chronic wound
120019|NCT02545374|tablet|tablet
120020|NCT02545374|telemedicine|telemedicine
120021|NCT02545374|wounds consultation|wounds consultation
120022|NCT02545374|Smartphone|smartphone
120025|NCT02545270|Surgery, Laparoscopic|surgery, laparoscopic
120026|NCT02545270|surgical rating scale|surgical rating scale
120027|NCT02545257|Aged people|aged people
120028|NCT02545257|Home care|home care
120029|NCT02545257|Drug related problems, DRPs|drug related problems, drps
120030|NCT02545257|Coordinated medication management model|coordinated medication management model
120031|NCT02545244|Gingivitis, Black Tea, Green Tea,Chlorhexidine, Biofilm,|gingivitis, black tea, green tea,chlorhexidine, biofilm,
120032|NCT02545218|Perineum. Perineorraphy. Pelvic floor exercise.|perineum. perineorraphy. pelvic floor exercise.
120033|NCT02545205|Rehabilitation|rehabilitation
120034|NCT02545205|Robotics|robotics
120036|NCT02545166|Stroke|stroke
120037|NCT02545166|Purines|purines
120038|NCT02545166|SMARTChip|smartchip
120039|NCT02545166|Ischaemia|ischaemia
120040|NCT02545166|Carotid endarterectomy|carotid endarterectomy
120041|NCT02545166|Biosensor|biosensor
120042|NCT02545140|risk factors|risk factors
120043|NCT02545140|screening|screening
120044|NCT02545140|adolescents|adolescents
120045|NCT02545127|inadequate milk production|inadequate milk production
120046|NCT02545114|Hyponatremia|hyponatremia
120047|NCT02545114|SIADH, stroke|siadh, stroke
120048|NCT02545114|SAH; ICH|sah; ich
120049|NCT02545114|AIS|ais
120050|NCT02545101|Hyponatremia due to SIADH|hyponatremia due to siadh
120051|NCT02545101|tolvaptan|tolvaptan
120052|NCT02545088|Rehabilitation|rehabilitation
120053|NCT02545088|Robotics|robotics
120054|NCT02545049|Type 2 Diabetes|type 2 diabetes
120055|NCT02545049|Kidney diseases|kidney diseases
120056|NCT02545036|chronic kidney disease|chronic kidney disease
120057|NCT02545036|Daycare|daycare
120058|NCT02545036|Traditional Chinese Medicine(TCM)|traditional chinese medicine(tcm)
120059|NCT02544984|prophylactic macrolides|prophylactic macrolides
120060|NCT02544984|RSV|rsv
120061|NCT02544984|chronic lung disease|chronic lung disease
120062|NCT02544984|respiratory infections|respiratory infections
120063|NCT02544958|Enlarged pores|enlarged pores
120064|NCT02544958|Er:YAG laser|er:yag laser
120065|NCT02544945|Radiotherapy|radiotherapy
120066|NCT02544932|anticoagulant|anticoagulant
120067|NCT02544932|atherosclerosis|atherosclerosis
120068|NCT02544932|endothelium|endothelium
120069|NCT02544919|SMOF|smof
120070|NCT02544919|neurological complications|neurological complications
120071|NCT02544919|neurotoxicity|neurotoxicity
120072|NCT02544919|liver transplantation|liver transplantation
120073|NCT02544919|Lipid emulsions|lipid emulsions
120074|NCT02544906|recipients|recipients
120075|NCT02544880|HNSCC|hnscc
120076|NCT02544880|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
120077|NCT02544880|Tadalafil|tadalafil
120078|NCT02544880|PDE5 Inhibition|pde5 inhibition
120079|NCT02544880|Anti-MUC1 Vaccine|anti-muc1 vaccine
120080|NCT02544880|Recurrent Head and Neck Squamous Cell Carcinoma|recurrent head and neck squamous cell carcinoma
120081|NCT02544880|Recurrent HNSCC|recurrent hnscc
120082|NCT02544880|Second primary site disease stage III|second primary site disease stage iii
120083|NCT02544880|Second primary site disease stage IV|second primary site disease stage iv
120084|NCT02544880|Anti-Influenza Vaccine|anti-influenza vaccine
120085|NCT02544854|Pharmacokinetics, pharmacodynamics, propofol, pediatrics|pharmacokinetics, pharmacodynamics, propofol, pediatrics
120086|NCT02544828|Osteoarthritis|osteoarthritis
120087|NCT02544828|knee arthroplasty|knee arthroplasty
120088|NCT02544828|iron|iron
120089|NCT02544815|digoxin, eficacy, safety|digoxin, eficacy, safety
120090|NCT02544776|pco|pco
120091|NCT02544776|Amlodipine|amlodipine
120092|NCT02544737|Esophageal cancer|esophageal cancer
120093|NCT02544737|Metastatic esophageal cancer|metastatic esophageal cancer
120094|NCT02544737|Apatinib|apatinib
120095|NCT02544724|Relapsed|relapsed
120096|NCT02544724|Refractory|refractory
120097|NCT02544724|DLBCL|dlbcl
120098|NCT02544724|Chemotherapy|chemotherapy
120099|NCT02544711|Pelvis|pelvis
120100|NCT02544711|Surgical resection|surgical resection
120101|NCT02544711|Patient specific instrument|patient specific instrument
120102|NCT02544698|vaccine|vaccine
120103|NCT02544698|safety|safety
120104|NCT02544685|Febrile neutropenia|febrile neutropenia
120105|NCT02544685|Synbiotic|synbiotic
120106|NCT02544685|Probiotic|probiotic
120107|NCT02544685|Prebiotic|prebiotic
120108|NCT02544685|Safety|safety
120109|NCT02544685|Cancer|cancer
120110|NCT02544685|Oncology|oncology
120111|NCT02544685|Chemotherapy|chemotherapy
120112|NCT02544685|Symbiotic|symbiotic
120113|NCT02544659|Treatment|treatment
120114|NCT02544659|Bisphosphonates|bisphosphonates
120115|NCT02544659|Response rate|response rate
120116|NCT02544646|trabeculectomy|trabeculectomy
120117|NCT02544633|Mirati|mirati
120118|NCT02544633|MGCD265|mgcd265
120119|NCT02544633|MET|met
120120|NCT02544633|NSCLC|nsclc
120121|NCT02544607|Ketamine|ketamine
120123|NCT02544607|Anxious Depression|anxious depression
120124|NCT02544607|MRI|mri
120125|NCT02544568|high fat|high fat
120126|NCT02544568|high protein|high protein
120127|NCT02544568|high carbohydrate|high carbohydrate
120128|NCT02544568|insulin|insulin
120129|NCT02544568|glucose|glucose
120130|NCT02544555|Peripheral arterial disease|peripheral arterial disease
120131|NCT02544555|Atherosclerosis|atherosclerosis
120132|NCT02544555|Intraluminal approach|intraluminal approach
120133|NCT02544555|Subintimal approach|subintimal approach
120134|NCT02544542|Mild Hypothermia|mild hypothermia
120135|NCT02544542|Hypoxic-Ischemic Encephalopathy|hypoxic-ischemic encephalopathy
120136|NCT02544516|Schizophrenia|schizophrenia
120137|NCT02544516|motor and sensory perceptions|motor and sensory perceptions
120138|NCT02544490|Sepsis|sepsis
120139|NCT02544490|MicroRNAs|micrornas
120140|NCT02544490|Diagnosis|diagnosis
120141|NCT02544490|Prognosis|prognosis
120142|NCT02544464|osteoarthritis|osteoarthritis
120143|NCT02544464|knee arthroplasty|knee arthroplasty
120144|NCT02544464|iron|iron
120145|NCT02544412|Mindfulness|mindfulness
120146|NCT02544412|School Teachers|school teachers
120147|NCT02544412|preservice teachers|preservice teachers
120148|NCT02544412|teacher education|teacher education
120149|NCT02544399|Bone microarchitecture|bone microarchitecture
120150|NCT02544399|Playing golf|playing golf
120151|NCT02544399|Walkers|walkers
120152|NCT02544386|bone microarchitecture|bone microarchitecture
120153|NCT02544386|hemiplegia|hemiplegia
120154|NCT02544373|OSA|osa
120155|NCT02544373|Obstructive Sleep Apnea|obstructive sleep apnea
120156|NCT02544373|Cognition|cognition
120157|NCT02544373|Cognitive Dysfunction|cognitive dysfunction
120158|NCT02544373|Memory|memory
120159|NCT02544373|Positive Aiway Pressure|positive aiway pressure
120160|NCT02544373|CPAP|cpap
120161|NCT02544373|MS|ms
120162|NCT02544360|photoaging mobile apps|photoaging mobile apps
120163|NCT02544360|adolescent smoking|adolescent smoking
120164|NCT02544360|tobacco prevention|tobacco prevention
120165|NCT02544360|school-based prevention|school-based prevention
120166|NCT02544360|adolescent health|adolescent health
120167|NCT02544360|school health|school health
120168|NCT02544360|smoking|smoking
120169|NCT02544360|tobacco|tobacco
120170|NCT02544347|vaspin|vaspin
120171|NCT02544347|omentin|omentin
120172|NCT02544347|diabetes mellitus|diabetes mellitus
120173|NCT02544347|chronic periodontitis|chronic periodontitis
120174|NCT02544347|tumor-necrosis factor alfa|tumor-necrosis factor alfa
120175|NCT02544347|gingival crevicular fluid|gingival crevicular fluid
120176|NCT02544334|Rheumatoid arthritis|rheumatoid arthritis
120177|NCT02544334|Metagenome|metagenome
120178|NCT02544334|microbiome|microbiome
120179|NCT02544308|Solitary, Bone|solitary, bone
120180|NCT02544282|Analgesics|analgesics
120181|NCT02544282|Opioid|opioid
120182|NCT02544282|Mastectomy|mastectomy
120183|NCT02544282|Segmental Mastectomy|segmental mastectomy
120184|NCT02544282|Pecs II|pecs ii
120185|NCT02544269|Lumbosacral plexus blockade|lumbosacral plexus blockade
120186|NCT02544269|Continuous spinal anesthesia|continuous spinal anesthesia
120187|NCT02544269|Hemodynamics|hemodynamics
120188|NCT02544256|Microcirculation|microcirculation
120189|NCT02544256|Mild Hypothermia, Induced|mild hypothermia, induced
120190|NCT02544256|Subarachnoid Hemorrhage, Aneurysmal|subarachnoid hemorrhage, aneurysmal
120191|NCT02544256|Aneurysmal Clipping|aneurysmal clipping
120192|NCT02544256|Vasospasms|vasospasms
120193|NCT02544230|granulocyte transfusions|granulocyte transfusions
120194|NCT02544191|azoospermia nonobstructive|azoospermia nonobstructive
120195|NCT02544191|male infertility|male infertility
120196|NCT02544178|radiotherapy|radiotherapy
144077|NCT02405845|FFT|fft
111304|NCT02597283|Randomized controlled trial|randomized controlled trial
120197|NCT02544178|neurocognitive defect|neurocognitive defect
120198|NCT02544178|leukoencephalopathy|leukoencephalopathy
120199|NCT02544165|smoking|smoking
120200|NCT02544165|caffeine intake|caffeine intake
120201|NCT02544165|haemodynamic parameters|haemodynamic parameters
120202|NCT02544165|Advanced Glycation End Products (AGEs)|advanced glycation end products (ages)
120203|NCT02544165|Non-invasive measurements devices|non-invasive measurements devices
120204|NCT02544087|fire-heat syndrome|fire-heat syndrome
120205|NCT02544087|blood stasis syndrome|blood stasis syndrome
120206|NCT02544087|method of clearing heat|method of clearing heat
120207|NCT02544087|method of promoting blood circulation|method of promoting blood circulation
120208|NCT02544048|Immune|immune
120209|NCT02544048|Parasitemia|parasitemia
120210|NCT02544048|Menactra|menactra
120211|NCT02544048|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
120212|NCT02544048|Coartem|coartem
120213|NCT02544035|Childhood Growth and Development|childhood growth and development
120214|NCT02544035|Development|development
120215|NCT02544022|Pain Scale|pain scale
120216|NCT02544022|QOL|qol
120217|NCT02544022|Tool Validation|tool validation
120218|NCT02544022|Cognitive Interviews|cognitive interviews
120219|NCT02544009|Energy Expenditure|energy expenditure
120220|NCT02544009|Obesity|obesity
120221|NCT02544009|Behavioral Weight Loss Treatment|behavioral weight loss treatment
120222|NCT02543996|Sample Collection|sample collection
120223|NCT02543996|Laboratory Research Specimens|laboratory research specimens
120224|NCT02543996|Biospecimen Procurement|biospecimen procurement
120225|NCT02543996|Rare Diseases|rare diseases
120226|NCT02543983|Neurobiology|neurobiology
120227|NCT02543983|Suicide|suicide
120228|NCT02543983|Ketamine|ketamine
120229|NCT02543983|Major Depression Disorder|major depression disorder
120230|NCT02543983|Biomarkers|biomarkers
120231|NCT02543957|ERCP|ercp
120232|NCT02543957|Cholangitis|cholangitis
120233|NCT02543957|Bacteremia|bacteremia
120234|NCT02543957|Antibiotics|antibiotics
120235|NCT02543931|turmeric|turmeric
120236|NCT02543931|curcumin|curcumin
120237|NCT02543931|curcuminoids|curcuminoids
120238|NCT02543931|arthritis|arthritis
120239|NCT02543931|methotrexate|methotrexate
120240|NCT02543892|Vaccine|vaccine
120241|NCT02543879|AML|aml
120242|NCT02543879|BET Inhibitor|bet inhibitor
120243|NCT02543879|FT-1101|ft-1101
120244|NCT02543879|Acute Leukemia|acute leukemia
120245|NCT02543879|Myelodysplastic Syndrome|myelodysplastic syndrome
120246|NCT02543840|Quality Improvement|quality improvement
120247|NCT02543840|Organization of Services|organization of services
120248|NCT02543840|Implementation|implementation
120249|NCT02543827|Vaccine|vaccine
120250|NCT02543827|Recurrent Urinary Tract Infections (RUTI)|recurrent urinary tract infections (ruti)
120251|NCT02543827|Female Urogenital Diseases and Pregnancy Complications|female urogenital diseases and pregnancy complications
120252|NCT02543788|optic neuritis|optic neuritis
120253|NCT02543788|vision|vision
120254|NCT02543788|quality of life|quality of life
120255|NCT02543788|pathophysiology|pathophysiology
120256|NCT02543775|Cervical Cancer|cervical cancer
120257|NCT02543775|Sentinel Lymph Node|sentinel lymph node
120258|NCT02543775|Lymphadenectomy|lymphadenectomy
120259|NCT02543762|Chromoendoscopy|chromoendoscopy
120260|NCT02543762|Ulcerative Colitis|ulcerative colitis
120261|NCT02543762|Crohn disease|crohn disease
120262|NCT02543762|Colorectal Neoplasia|colorectal neoplasia
120263|NCT02543749|CML|cml
120264|NCT02543749|DC vaccine|dc vaccine
120265|NCT02543723|medication adherence, telehealth strategies, nurse coaching|medication adherence, telehealth strategies, nurse coaching
120266|NCT02543684|glycemic response|glycemic response
120267|NCT02543684|diabetes|diabetes
120268|NCT02543684|insulinemic response|insulinemic response
120269|NCT02543684|mixed meals|mixed meals
120270|NCT02543684|glycemic index|glycemic index
120271|NCT02543671|vitamin D status|vitamin d status
120272|NCT02543671|25-hydroxyvitamin D|25-hydroxyvitamin d
120273|NCT02543671|cheese|cheese
120274|NCT02543671|Randomized controlled trial|randomized controlled trial
120275|NCT02543671|postmenopausal women|postmenopausal women
120276|NCT02543671|enriched|enriched
120277|NCT02543671|vitamin D3|vitamin d3
120278|NCT02543658|Acute Pancreatitis|acute pancreatitis
120279|NCT02543658|Intra-abdominal hypertension|intra-abdominal hypertension
120280|NCT02543658|Abdominal compartment syndrome|abdominal compartment syndrome
120281|NCT02543658|Curative Effect|curative effect
120282|NCT02543658|Security|security
120283|NCT02543658|Neostigmine|neostigmine
120284|NCT02543632|heart failure|heart failure
120285|NCT02543632|parachute|parachute
120286|NCT02543632|partitioning device|partitioning device
120287|NCT02543593|tDCS|tdcs
120288|NCT02543567|Ebola viruses|ebola viruses
120289|NCT02543567|Ebola virus disease (EVD)|ebola virus disease (evd)
120290|NCT02543567|Filoviruses|filoviruses
120291|NCT02543567|Monovalent vaccine|monovalent vaccine
120292|NCT02543567|Safety|safety
120293|NCT02543567|Immunogenicity|immunogenicity
120294|NCT02543567|Ebola vaccine|ebola vaccine
120295|NCT02543567|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
120296|NCT02543567|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector (MVA‐BN Filo)|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector (mva‐bn filo)
120297|NCT02543567|Healthy participants|healthy participants
120298|NCT02543541|Palliative Care|palliative care
120299|NCT02543541|Supportive Care|supportive care
120300|NCT02543541|Caregiver|caregiver
120301|NCT02543541|Phase I|phase i
120302|NCT02543515|following hysteroscopy|following hysteroscopy
120303|NCT02543502|Periodontitis|periodontitis
120304|NCT02543502|atherosclerosis|atherosclerosis
120305|NCT02543502|Heart Disease|heart disease
120306|NCT02543476|PD-L1 status, biomarkers, prevalence, SCCHN, overall survival|pd-l1 status, biomarkers, prevalence, scchn, overall survival
120307|NCT02543450|Chronic stroke|chronic stroke
120308|NCT02543450|Participation|participation
120309|NCT02543450|Walking ability|walking ability
120310|NCT02543385|S Ketamine|s ketamine
120311|NCT02543385|Morphine|morphine
120312|NCT02543385|Consumption|consumption
120313|NCT02543372|concerned significant other|concerned significant other
120314|NCT02543372|problem gambling|problem gambling
120315|NCT02543372|internet-delivered cognitive-behavioral therapy|internet-delivered cognitive-behavioral therapy
120316|NCT02543372|behavioral couples therapy|behavioral couples therapy
120317|NCT02543359|Training|training
120318|NCT02543359|Implementation|implementation
120319|NCT02543359|Community-Based Mental Health Services|community-based mental health services
120613|NCT02541474|Prospective|prospective
120320|NCT02543359|Parent-Child Interaction Therapy|parent-child interaction therapy
120321|NCT02543359|Children|children
120322|NCT02543333|Acute Asthma,|acute asthma,
120323|NCT02543320|Head and Neck Cancer|head and neck cancer
120324|NCT02543320|LORETA|loreta
120325|NCT02543320|Low Resolution Electromagnetic Tomography|low resolution electromagnetic tomography
120326|NCT02543320|Pain|pain
120327|NCT02543320|Radiotherapy|radiotherapy
120328|NCT02543320|Electroencephalograph|electroencephalograph
120329|NCT02543320|EEG|eeg
120330|NCT02543320|Questionnaires|questionnaires
120331|NCT02543320|Surveys|surveys
120332|NCT02543320|Neurofeedback training|neurofeedback training
120333|NCT02543307|Hip Replacement|hip replacement
120334|NCT02543307|Spinal Diseases|spinal diseases
120335|NCT02543307|Rotator Cuff Reconstruction|rotator cuff reconstruction
120336|NCT02543307|Nursing|nursing
120337|NCT02543307|Nurse-led|nurse-led
120338|NCT02543307|Pathways|pathways
120339|NCT02543307|Patient Satisfaction|patient satisfaction
120340|NCT02543307|Quality of Nursing Care|quality of nursing care
120341|NCT02543294|Heart Failure|heart failure
120342|NCT02543294|Echocardiogram|echocardiogram
120343|NCT02543294|ECHO|echo
120344|NCT02543294|Electrocardiogram|electrocardiogram
120345|NCT02543294|ECG|ecg
120346|NCT02543294|Questionnaire|questionnaire
120347|NCT02543294|Survey|survey
120348|NCT02543294|Telephone Follow-Up|telephone follow-up
120349|NCT02543294|HF|hf
120350|NCT02543294|Cancer treatment induced left ventricular dysfunction|cancer treatment induced left ventricular dysfunction
120351|NCT02543294|CILVD|cilvd
120352|NCT02543294|Left ventricular ejection fraction|left ventricular ejection fraction
120353|NCT02543294|LVEF|lvef
120354|NCT02543268|Ebola viruses|ebola viruses
120355|NCT02543268|Ebola virus disease (EVD)|ebola virus disease (evd)
120356|NCT02543268|Filoviruses|filoviruses
120357|NCT02543268|Monovalent vaccine|monovalent vaccine
120358|NCT02543268|Safety|safety
120359|NCT02543268|Immunogenicity|immunogenicity
120360|NCT02543268|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
120361|NCT02543268|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector (MVA‐BN Filo)|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector (mva‐bn filo)
120362|NCT02543268|Healthy participants|healthy participants
120363|NCT02543255|High risk|high risk
120364|NCT02543242|Urinary Incontinence|urinary incontinence
120365|NCT02543242|Stress Urinary Incontinence|stress urinary incontinence
120366|NCT02543242|Urge Incontinence|urge incontinence
120367|NCT02543242|Mixed Urinary Incontience|mixed urinary incontience
120368|NCT02543242|Female Pelvic Health|female pelvic health
120369|NCT02543216|fatty acids, FADS gene, genotype, diet|fatty acids, fads gene, genotype, diet
120370|NCT02543203|Relaxation|relaxation
120371|NCT02543190|Care Transition|care transition
120372|NCT02543190|Readmission|readmission
120373|NCT02543190|Rehospitalization|rehospitalization
120374|NCT02543177|NSTEMI, CKD|nstemi, ckd
120375|NCT02543164|Glycemic Index|glycemic index
120376|NCT02543164|glycemic response|glycemic response
120377|NCT02543151|Biliary stricture|biliary stricture
120378|NCT02543151|Cholangioscopy|cholangioscopy
120379|NCT02543151|Spyglass|spyglass
120380|NCT02543151|Liver transplant|liver transplant
120381|NCT02543125|very low birth weight|very low birth weight
120382|NCT02543125|respiratory distress|respiratory distress
120383|NCT02543125|NHFOV|nhfov
120384|NCT02543125|NIPPV|nippv
120385|NCT02543099|endothelial function|endothelial function
120386|NCT02543099|policosanol|policosanol
120387|NCT02543099|efficacy|efficacy
120388|NCT02543099|safety|safety
120389|NCT02543086|Phase 1, malaria, inoculum, P. falciparum, KAE609, Piperaquine|phase 1, malaria, inoculum, p. falciparum, kae609, piperaquine
120390|NCT02543021|Colitis|colitis
120391|NCT02543021|Dysplasia|dysplasia
120392|NCT02543021|Chromoendoscopy|chromoendoscopy
120393|NCT02543008|Asymptomatic individuals|asymptomatic individuals
120394|NCT02542982|tDCS|tdcs
120395|NCT02542982|motor recovery|motor recovery
120396|NCT02542956|Tummy tuck (abdominoplasty)|tummy tuck (abdominoplasty)
120397|NCT02542956|Breast Surgery|breast surgery
120398|NCT02542930|Non-small cell lung cancer|non-small cell lung cancer
120399|NCT02542930|Metastatic Non-small cell lung cancer|metastatic non-small cell lung cancer
120400|NCT02542930|Radiotherapy|radiotherapy
120401|NCT02542930|Thymalfasin|thymalfasin
120402|NCT02542930|ZADAXIN's®|zadaxin's®
120403|NCT02542891|e-health|e-health
120404|NCT02542891|depressive disorder|depressive disorder
120405|NCT02542891|cost-effectiveness|cost-effectiveness
120406|NCT02542891|Cognitive behavioral treatment|cognitive behavioral treatment
120407|NCT02542878|myofascial release|myofascial release
120408|NCT02542878|back extensors endurance|back extensors endurance
120409|NCT02542878|foam roller|foam roller
120410|NCT02542878|sport|sport
120411|NCT02542852|HIV-1|hiv-1
120412|NCT02542839|Botulinum Toxin|botulinum toxin
120413|NCT02542839|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
120414|NCT02542826|Pulmonary Rehabilitation|pulmonary rehabilitation
120519|NCT02542085|hybrid repair|hybrid repair
120415|NCT02542826|3-minute constant rate shuttle walk test|3-minute constant rate shuttle walk test
120416|NCT02542826|3-minute constant rate step test|3-minute constant rate step test
120417|NCT02542826|Dyspnea|dyspnea
120418|NCT02542813|Pharmacokinetics|pharmacokinetics
120419|NCT02542813|safety|safety
120420|NCT02542813|tolerability|tolerability
120421|NCT02542813|oxytocin|oxytocin
120422|NCT02542787|MS|ms
120423|NCT02542787|Spasticity|spasticity
120424|NCT02542787|VSN16R|vsn16r
120425|NCT02542774|Diabetes mellitus|diabetes mellitus
120426|NCT02542774|Stroke|stroke
120427|NCT02542774|Myocardial infarction|myocardial infarction
120428|NCT02542774|Stable angina pectoris|stable angina pectoris
120429|NCT02542774|Heart failure|heart failure
120430|NCT02542774|Quality of care|quality of care
120431|NCT02542748|norepinephrine|norepinephrine
120432|NCT02542748|ephedrine|ephedrine
120433|NCT02542722|lifestyle modification|lifestyle modification
120434|NCT02542722|olive oil|olive oil
120435|NCT02542722|Mediterranean diet|mediterranean diet
120436|NCT02542683|congenital heart diseases|congenital heart diseases
120437|NCT02542683|cognition|cognition
120438|NCT02542683|adaptive behavior|adaptive behavior
120439|NCT02542683|physical activity|physical activity
120440|NCT02542683|neurodevelopment|neurodevelopment
120441|NCT02542644|Fuchs' Endothelial Dystrophy, DMEK|fuchs' endothelial dystrophy, dmek
120442|NCT02542618|Depression|depression
120443|NCT02542618|Treatment|treatment
120444|NCT02542618|IBSR|ibsr
120445|NCT02542618|CBT|cbt
120446|NCT02542605|Migraine|migraine
120447|NCT02542605|Headache|headache
120448|NCT02542605|Migraine Headache|migraine headache
120449|NCT02542605|Headache, Migraine|headache, migraine
120450|NCT02542605|Amgen|amgen
120451|NCT02542592|Glucocorticoids|glucocorticoids
120452|NCT02542592|Immune Signaling|immune signaling
120453|NCT02542592|Recovery|recovery
120454|NCT02542592|Hip arthroplasty, total|hip arthroplasty, total
120455|NCT02542540|Osteogenesis Imperfecta|osteogenesis imperfecta
120456|NCT02542540|physical exercise training|physical exercise training
120457|NCT02542540|Wii|wii
120458|NCT02542540|muscular strength|muscular strength
120459|NCT02542514|PCNSL|pcnsl
120460|NCT02542514|IOL|iol
120461|NCT02542462|mechanisms for intussusception|mechanisms for intussusception
120462|NCT02542462|rotavirus vaccine|rotavirus vaccine
120463|NCT02542449|Green tea|green tea
120464|NCT02542449|weight maintenance|weight maintenance
120465|NCT02542449|obesity|obesity
120466|NCT02542449|fat mass|fat mass
120467|NCT02542384|abdominal surgery|abdominal surgery
120468|NCT02542384|laparoscopy|laparoscopy
120469|NCT02542384|Hysterectomy|hysterectomy
120470|NCT02542384|Prostatectomy|prostatectomy
120471|NCT02542384|Hemi-colectomy|hemi-colectomy
120472|NCT02542384|Ventral Hernia repair|ventral hernia repair
120473|NCT02542384|CR845|cr845
120474|NCT02542384|analgesic|analgesic
120475|NCT02542384|kappa opioid|kappa opioid
120476|NCT02542384|partial bowel resection|partial bowel resection
120477|NCT02542371|HIV|hiv
120478|NCT02542371|Atherosclerosis|atherosclerosis
120479|NCT02542371|Tilmanocept|tilmanocept
120480|NCT02542345|Cardiac Multislice CT|cardiac multislice ct
120481|NCT02542345|MRI coronarography|mri coronarography
120482|NCT02542332|lung cancer screening|lung cancer screening
120483|NCT02542332|statistical background|statistical background
120484|NCT02542306|Blood loss|blood loss
120485|NCT02542306|coagulopathy|coagulopathy
120486|NCT02542306|fibrinogen concentrate|fibrinogen concentrate
120487|NCT02542306|transfusion|transfusion
120488|NCT02542293|NSCLC|nsclc
120489|NCT02542293|PDL1|pdl1
120490|NCT02542293|MEDI4736|medi4736
120491|NCT02542293|Durvalumab|durvalumab
120492|NCT02542293|Tremelimumab|tremelimumab
120493|NCT02542293|OS|os
120494|NCT02542267|Bare Metal Stent|bare metal stent
120495|NCT02542267|In-Stent Restenosis|in-stent restenosis
120496|NCT02542241|Open abdomen|open abdomen
120497|NCT02542241|hypertonic saline solution|hypertonic saline solution
120498|NCT02542241|intensive care|intensive care
120499|NCT02542228|Immune Deficiency, antibody|immune deficiency, antibody
120500|NCT02542228|Quality of Life survey|quality of life survey
120501|NCT02542176|Metabolic Syndrome|metabolic syndrome
120502|NCT02542176|Grape|grape
120503|NCT02542176|HDL|hdl
120504|NCT02542176|Lipoproteins|lipoproteins
120505|NCT02542137|Small cell lung cancer|small cell lung cancer
120506|NCT02542137|Metastatic small cell lung cancer|metastatic small cell lung cancer
120507|NCT02542137|ZADAXIN|zadaxin
120508|NCT02542137|radiotherapy|radiotherapy
120509|NCT02542137|Thymalfasin|thymalfasin
120510|NCT02542124|CTCL|ctcl
120511|NCT02542124|Total Skin Electron Beam Therapy (TSEBT)|total skin electron beam therapy (tsebt)
120512|NCT02542124|Mycosis fungoides|mycosis fungoides
120513|NCT02542124|Sézary syndrome|sézary syndrome
120514|NCT02542124|recombinant human Interleukin-12 (rHuIL-12)|recombinant human interleukin-12 (rhuil-12)
120515|NCT02542124|T Cell|t cell
120516|NCT02542111|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
120517|NCT02542085|incisional hernia|incisional hernia
120518|NCT02542085|laparoscopic repair|laparoscopic repair
120521|NCT02542085|recurrent hernia|recurrent hernia
120522|NCT02542033|postprandial glycemia; apple juice; sugar reduction; glucose oxidase|postprandial glycemia; apple juice; sugar reduction; glucose oxidase
120523|NCT02542007|intracoronary stent|intracoronary stent
120524|NCT02542007|drug eluting stent|drug eluting stent
120525|NCT02542007|sirolimus|sirolimus
120526|NCT02542007|endothelial progenitor cells|endothelial progenitor cells
120527|NCT02541981|Heart transplant|heart transplant
120528|NCT02541981|renal insufficiency|renal insufficiency
120529|NCT02541955|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
120530|NCT02541955|Musculoskeletal ultrasound (MSUS)|musculoskeletal ultrasound (msus)
120531|NCT02541929|Alzheimer's disease|alzheimer's disease
120532|NCT02541929|Docosahexaenoic acid|docosahexaenoic acid
120533|NCT02541929|brain health|brain health
120534|NCT02541929|memory|memory
120535|NCT02541929|fish oil|fish oil
120536|NCT02541929|cognition|cognition
120537|NCT02541929|DHA|dha
120538|NCT02541929|omega 3 fatty acid|omega 3 fatty acid
120539|NCT02541929|brain|brain
120540|NCT02541916|Transplantation Tolerance|transplantation tolerance
120541|NCT02541916|Immune Tolerance|immune tolerance
120542|NCT02541916|Transplantation|transplantation
120543|NCT02541916|Liver Transplantation|liver transplantation
120544|NCT02541916|Biological Markers|biological markers
120545|NCT02541916|Gene Expression|gene expression
120546|NCT02541916|Immunosuppression|immunosuppression
120547|NCT02541916|Immunology|immunology
120548|NCT02541916|Multiplex Polymerase Chain Reaction|multiplex polymerase chain reaction
120549|NCT02541916|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
120550|NCT02541903|Epidermal growth factor receptor (EGFR),|epidermal growth factor receptor (egfr),
120551|NCT02541903|Human Papillomavirus (HPV)|human papillomavirus (hpv)
120552|NCT02541903|Penile squamous cell carcinoma (PSCC)|penile squamous cell carcinoma (pscc)
120553|NCT02541903|Gilotrif|gilotrif
120554|NCT02541890|Rehabilitation|rehabilitation
120555|NCT02541890|Return to Work|return to work
120556|NCT02541864|Helicobacter pylori|helicobacter pylori
120557|NCT02541864|Hybrid therapy|hybrid therapy
120558|NCT02541864|Bismuth containing quadruple therapy|bismuth containing quadruple therapy
120559|NCT02541864|Eradication|eradication
120560|NCT02541838|Autonomic Neuropathy|autonomic neuropathy
120561|NCT02541838|diabetes|diabetes
120562|NCT02541838|balance control|balance control
120563|NCT02541825|transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
120564|NCT02541812|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
120565|NCT02541812|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
120566|NCT02541812|Error processing|error processing
120567|NCT02541799|informed consent|informed consent
120568|NCT02541799|telemedicine|telemedicine
120569|NCT02541799|research methods|research methods
120570|NCT02541786|dexlansoprazole MR|dexlansoprazole mr
120571|NCT02541786|rabeprazole|rabeprazole
120572|NCT02541786|Helicobacter pylori|helicobacter pylori
120573|NCT02541786|triple therapy|triple therapy
120574|NCT02541773|Chronic Heart Failure|chronic heart failure
120575|NCT02541773|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
120964|NCT02539290|Saline|saline
120576|NCT02541773|Vascular Biomarker|vascular biomarker
120577|NCT02541773|miRNA|mirna
120578|NCT02541773|Extracellular Matrix|extracellular matrix
651816|NCT00785005|Type|type
120579|NCT02541773|Brain Natruetic Peptide|brain natruetic peptide
120583|NCT02541734|radiopeptides|radiopeptides
120584|NCT02541734|gelofusine|gelofusine
120585|NCT02541734|Beta cell|beta cell
120586|NCT02541695|Experimental challenge trial|experimental challenge trial
120587|NCT02541669|Drug therapy|drug therapy
120588|NCT02541656|Preload dependence indices|preload dependence indices
120589|NCT02541656|pulse pressure variation|pulse pressure variation
120590|NCT02541656|plethysmographic waveform of pulse oximetry variation|plethysmographic waveform of pulse oximetry variation
120591|NCT02541656|stroke volume variation|stroke volume variation
120592|NCT02541656|laparoscopy|laparoscopy
120593|NCT02541656|pneumoperitoneum|pneumoperitoneum
120594|NCT02541643|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
120595|NCT02541630|Mindfulness|mindfulness
120596|NCT02541591|post cardiac arrest|post cardiac arrest
120597|NCT02541591|hemodynamics|hemodynamics
120598|NCT02541578|stroke, acute; gait, complexity|stroke, acute; gait, complexity
120599|NCT02541552|Knee arthroscopy|knee arthroscopy
120600|NCT02541552|Quadriceps weakness|quadriceps weakness
120601|NCT02541552|ropivacaine|ropivacaine
120602|NCT02541552|saphenous nerve block|saphenous nerve block
120603|NCT02541552|Adductor canal|adductor canal
120604|NCT02541526|amphetamine type stimulant dependence|amphetamine type stimulant dependence
120605|NCT02541526|mirtazepine|mirtazepine
120606|NCT02541513|paliparidone|paliparidone
120607|NCT02541513|amphetamine type stimulant dependence|amphetamine type stimulant dependence
120608|NCT02541500|minocycline|minocycline
120609|NCT02541500|amphetamine type stimulant dependence|amphetamine type stimulant dependence
120610|NCT02541474|Controlled trial|controlled trial
120612|NCT02541474|Before-After design|before-after design
120614|NCT02541474|complex interventions|complex interventions
120615|NCT02541461|Procedure: Laparoscopic gastrectomy with Billroth I|procedure: laparoscopic gastrectomy with billroth i
120616|NCT02541461|Procedure: Laparoscopic gastrectomy with Roux-en-Y|procedure: laparoscopic gastrectomy with roux-en-y
120617|NCT02541461|Other: Body composition measurement|other: body composition measurement
120618|NCT02541461|Other: Lipid profile|other: lipid profile
120619|NCT02541435|Radiotherapy|radiotherapy
120620|NCT02541435|Biological markers|biological markers
120621|NCT02541435|Magnetic resonance imaging|magnetic resonance imaging
120622|NCT02541435|Echocardiography|echocardiography
120623|NCT02541435|Tomography, X-Ray Computed|tomography, x-ray computed
120624|NCT02541435|Risk factors|risk factors
120625|NCT02541435|Heart|heart
120626|NCT02541435|Quality of Life|quality of life
120627|NCT02541409|directly observed therapy|directly observed therapy
120628|NCT02541409|sofosbuvir|sofosbuvir
120629|NCT02541409|ribavirin|ribavirin
120630|NCT02541409|pegylated interferon|pegylated interferon
120631|NCT02541409|resource-limited setting|resource-limited setting
120633|NCT02541396|Bunionectomy|bunionectomy
120634|NCT02541383|Untreated Multiple Myeloma|untreated multiple myeloma
120635|NCT02541383|daratumumab|daratumumab
120636|NCT02541357|Colorectal Surgery|colorectal surgery
120637|NCT02541331|IgE-dependent asthma|ige-dependent asthma
120638|NCT02541318|peri-menopausal women|peri-menopausal women
120639|NCT02541318|sleep disturbances|sleep disturbances
120640|NCT02541318|Dao-in exercise|dao-in exercise
120641|NCT02541318|body constitution|body constitution
120642|NCT02541305|falls prevention|falls prevention
120643|NCT02541305|proprioception|proprioception
120644|NCT02541305|physical condition|physical condition
120645|NCT02541266|Imaging|imaging
120646|NCT02541266|Questionnaire|questionnaire
120647|NCT02541240|resilience|resilience
120648|NCT02541240|optimism|optimism
120649|NCT02541240|stress|stress
120650|NCT02541240|coping|coping
120651|NCT02541240|curriculum|curriculum
120652|NCT02541201|Plant sterols|plant sterols
120653|NCT02541201|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
120654|NCT02541201|Phytosterols|phytosterols
120655|NCT02541188|Breast cancer|breast cancer
120656|NCT02541175|Electrocardiography|electrocardiography
120657|NCT02541175|Automation|automation
120658|NCT02541175|Arrhythmias, Cardiac|arrhythmias, cardiac
120659|NCT02541175|Atrial Fibrillation|atrial fibrillation
120660|NCT02541175|Atrial Flutter|atrial flutter
120661|NCT02541175|Atrial Premature Complexes|atrial premature complexes
120662|NCT02541175|Esophagus|esophagus
120663|NCT02541136|exercise|exercise
120664|NCT02541136|resilience|resilience
120665|NCT02541136|physiotherapy|physiotherapy
120666|NCT02541136|fMRI|fmri
120667|NCT02541123|Traumatic Brain Injury|traumatic brain injury
120668|NCT02541123|Head Injury|head injury
120669|NCT02541084|Age-related macular degeneration|age-related macular degeneration
120670|NCT02541084|Caregiver burden|caregiver burden
120671|NCT02541084|Anti-vascular endothelial growth factor (VEGF) therapy|anti-vascular endothelial growth factor (vegf) therapy
651817|NCT00785005|Control|control
120672|NCT02541058|Velocardiofacial Syndrome|velocardiofacial syndrome
120673|NCT02541058|Shprintzen Syndrome|shprintzen syndrome
121058|NCT02538796|Conscious|conscious
111792|NCT02594137|Decompressive craniectomy|decompressive craniectomy
111793|NCT02594137|Brain Edema|brain edema
111794|NCT02594124|Spinal Muscular Atrophy|spinal muscular atrophy
111796|NCT02594124|SMN|smn
111797|NCT02594124|SMNRx|smnrx
111798|NCT02594124|ISIS-SMNRx|isis-smnrx
111801|NCT02594124|SHINE|shine
120674|NCT02541058|Conotruncal Defects|conotruncal defects
120675|NCT02541058|Chromosomal Abnormalities|chromosomal abnormalities
120676|NCT02541058|22q, 22q.11.2|22q, 22q.11.2
120677|NCT02541058|deletion|deletion
120678|NCT02541058|duplication|duplication
120679|NCT02541045|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
120680|NCT02541045|metadoxine|metadoxine
120681|NCT02541045|efficacy|efficacy
120683|NCT02541019|C23.888.821.712.700|c23.888.821.712.700
120684|NCT02541006|FEV1|fev1
120686|NCT02541006|AUC 0-24|auc 0-24
120687|NCT02541006|bronchodilator efficacy|bronchodilator efficacy
120688|NCT02541006|tiotropium|tiotropium
120689|NCT02540993|Type 2 Diabetes|type 2 diabetes
120690|NCT02540993|Kidney diseases|kidney diseases
120691|NCT02540967|Contrast enhancement in the following MR imaging|contrast enhancement in the following mr imaging
120692|NCT02540967|Brain and spine|brain and spine
120693|NCT02540967|Body and extremities|body and extremities
120694|NCT02540967|Gadobutrol|gadobutrol
120695|NCT02540954|Age-related macular degeneration (AMD)|age-related macular degeneration (amd)
120696|NCT02540954|Eylea treatment|eylea treatment
120697|NCT02540954|Treat and Extend|treat and extend
120698|NCT02540954|Intravitreal|intravitreal
120699|NCT02540902|Knee replacement|knee replacement
120700|NCT02540902|Knee arthroplasty|knee arthroplasty
120701|NCT02540902|All-polyethylene tibia|all-polyethylene tibia
120702|NCT02540902|Bone density|bone density
120703|NCT02540863|myofascial pain syndrome|myofascial pain syndrome
120704|NCT02540863|exercise therapy|exercise therapy
120705|NCT02540863|randomized controlled trial|randomized controlled trial
120706|NCT02540850|septin 9|septin 9
120707|NCT02540850|SEPT9|sept9
120708|NCT02540850|colorectal cancer|colorectal cancer
120709|NCT02540850|CRC|crc
120710|NCT02540850|screening|screening
120711|NCT02540850|methylation|methylation
120712|NCT02540850|adenoma|adenoma
120713|NCT02540850|polyps|polyps
120714|NCT02540850|FIT|fit
120715|NCT02540850|FOBT|fobt
120716|NCT02540850|colonoscopy|colonoscopy
120717|NCT02540824|Apatinib|apatinib
120718|NCT02540824|RET|ret
120719|NCT02540824|gene fusion|gene fusion
120720|NCT02540824|Non-small Cell Lung Cancer|non-small cell lung cancer
120721|NCT02540798|Anxiety|anxiety
120722|NCT02540798|Urodynamics|urodynamics
120723|NCT02540798|Symptom reproducibility|symptom reproducibility
120724|NCT02540798|Lower urinary tract symptoms|lower urinary tract symptoms
120725|NCT02540798|Women|women
120726|NCT02540785|Refractive Surgical Procedures|refractive surgical procedures
120727|NCT02540785|small-incision lenticule extraction|small-incision lenticule extraction
120728|NCT02540785|lenticule extraction|lenticule extraction
120729|NCT02540785|inflammatory mediators|inflammatory mediators
120730|NCT02540772|Confabulations|confabulations
120731|NCT02540772|Neuropsychological rehabilitation|neuropsychological rehabilitation
120732|NCT02540772|Memory|memory
120733|NCT02540759|Buglossoides arvensis|buglossoides arvensis
120734|NCT02540759|vegetable oil|vegetable oil
120735|NCT02540759|omega-3 fatty acids|omega-3 fatty acids
120736|NCT02540759|participants|participants
120737|NCT02540746|Emotional Dysregulation|emotional dysregulation
120738|NCT02540746|Early Intervention|early intervention
120739|NCT02540746|Youth Mental Health|youth mental health
120740|NCT02540746|Staging|staging
120741|NCT02540746|Motivational Enhancement|motivational enhancement
120742|NCT02540746|Family Connections|family connections
120743|NCT02540746|Family Skills Training|family skills training
120744|NCT02540733|cerebral infarction|cerebral infarction
120745|NCT02540733|diabetes|diabetes
120746|NCT02540733|rehabilitation|rehabilitation
120747|NCT02540733|MRI|mri
120748|NCT02540681|Transtibial amputation|transtibial amputation
120749|NCT02540681|Prosthetic fit|prosthetic fit
120750|NCT02540681|Prosthetic alignment|prosthetic alignment
120751|NCT02540655|Stem Cells|stem cells
120752|NCT02540655|Adult Stem Cells|adult stem cells
120753|NCT02540655|Spinocerebellar Ataxia|spinocerebellar ataxia
120754|NCT02540655|Steminent|steminent
120755|NCT02540629|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
120756|NCT02540629|Emergency Medicine|emergency medicine
120757|NCT02540616|MdDS|mdds
120758|NCT02540616|TES|tes
120759|NCT02540616|TMS|tms
120760|NCT02540590|microcirculation|microcirculation
120761|NCT02540590|wound healing|wound healing
120762|NCT02540590|tunnel technique|tunnel technique
120763|NCT02540590|gingival recession|gingival recession
120764|NCT02540590|Mucograft|mucograft
120765|NCT02540590|laser speckle contrast analyzer|laser speckle contrast analyzer
120766|NCT02540538|Adjuvants, immunologic|adjuvants, immunologic
120767|NCT02540538|Interleukin-2|interleukin-2
120768|NCT02540538|Hepatitis B vaccines|hepatitis b vaccines
120769|NCT02540538|Non-responders|non-responders
120770|NCT02540525|stress incontinence|stress incontinence
120771|NCT02540525|transobturator sling|transobturator sling
120772|NCT02540525|single-incision mini-sling|single-incision mini-sling
120773|NCT02540499|lung cancer|lung cancer
120774|NCT02540499|breath hold|breath hold
120775|NCT02540499|radiotherapy|radiotherapy
120776|NCT02540486|Type 2 diabetes|type 2 diabetes
120777|NCT02540486|T2DM|t2dm
120778|NCT02540473|Resilience|resilience
120779|NCT02540447|Liver transplantation|liver transplantation
120780|NCT02540447|Graft rinse|graft rinse
120781|NCT02540447|Ischemia reperfusion injury|ischemia reperfusion injury
120782|NCT02540434|Hypofibrinogenemia|hypofibrinogenemia
120783|NCT02540434|ROTEM|rotem
120784|NCT02540434|Cardiac Surgery|cardiac surgery
120785|NCT02540434|Concentrated Fibrinogen|concentrated fibrinogen
120786|NCT02540421|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
120787|NCT02540421|human papillomavirus|human papillomavirus
120788|NCT02540421|conization|conization
120789|NCT02540408|Occupational COPD|occupational copd
120790|NCT02540408|Pathophysiology|pathophysiology
120791|NCT02540408|Exercise limitation|exercise limitation
120792|NCT02540408|Pulmonary hyperinflation|pulmonary hyperinflation
120793|NCT02540408|Arterial stiffness|arterial stiffness
120794|NCT02540395|Kidney transplantation|kidney transplantation
120795|NCT02540395|Immunosuppression|immunosuppression
120796|NCT02540395|IFN-γ|ifn-γ
120797|NCT02540382|TIPS|tips
120798|NCT02540382|Hepatocellular Carcinoma|hepatocellular carcinoma
120799|NCT02540382|Portasystemic Shunt|portasystemic shunt
120800|NCT02540369|Diabetic macular edema|diabetic macular edema
120801|NCT02540369|Wet Age-related macular degeneration|wet age-related macular degeneration
120802|NCT02540343|Translation|translation
120803|NCT02540343|Validation|validation
120804|NCT02540343|Orebro-G|orebro-g
120805|NCT02540291|E7046|e7046
120806|NCT02540291|Advanced malignancies|advanced malignancies
120807|NCT02540291|malignancies|malignancies
120808|NCT02540265|Bunion|bunion
120809|NCT02540265|Bunionectomy|bunionectomy
120810|NCT02540265|Pain|pain
120811|NCT02540265|Analgesia|analgesia
120812|NCT02540265|N1539|n1539
120813|NCT02540252|Lower Limb Amputation|lower limb amputation
120814|NCT02540252|Nutrition|nutrition
120815|NCT02540252|Eating|eating
120816|NCT02540252|Inflammation|inflammation
120817|NCT02540252|Nursing|nursing
120818|NCT02540226|Tranexamic Acid|tranexamic acid
120819|NCT02540226|Total Knee Arthroplasty|total knee arthroplasty
120820|NCT02540226|Total Knee Replacement|total knee replacement
120821|NCT02540187|haemophilia|haemophilia
120822|NCT02540187|TFPI|tfpi
120823|NCT02540187|thrombin generation|thrombin generation
120824|NCT02540187|hemorrhagic score|hemorrhagic score
120825|NCT02540174|alcohol and tobacco consumption|alcohol and tobacco consumption
120826|NCT02540174|addiction treatment|addiction treatment
120827|NCT02540161|Sym004|sym004
120828|NCT02540161|Glioblastoma|glioblastoma
120829|NCT02540161|Desjardins|desjardins
120830|NCT02540161|Pro00063483|pro00063483
120831|NCT02540161|Symphogen|symphogen
120832|NCT02540161|Duke Cancer Institute|duke cancer institute
120833|NCT02540135|high grade glioma|high grade glioma
120834|NCT02540135|glioblastoma multiforme|glioblastoma multiforme
120835|NCT02540135|anaplastic astrocytoma|anaplastic astrocytoma
120836|NCT02540135|flourescein|flourescein
120837|NCT02540135|flourescence-guided surgery|flourescence-guided surgery
120838|NCT02540135|intraoperative MRI|intraoperative mri
120839|NCT02540135|iMRI|imri
120840|NCT02540109|Stroke|stroke
120841|NCT02540109|Anomia|anomia
120842|NCT02540096|mental practice|mental practice
120843|NCT02540096|motor imagery|motor imagery
120844|NCT02540096|hemiparesis|hemiparesis
120845|NCT02540096|stroke|stroke
120846|NCT02540096|gait|gait
120847|NCT02540096|mobility|mobility
120848|NCT02540070|Adductor canal Block|adductor canal block
120849|NCT02540070|ultrasound|ultrasound
120850|NCT02540070|periarticular injections|periarticular injections
120851|NCT02540070|Dexmedetomidine|dexmedetomidine
120852|NCT02540018|DEB, drug-eluting balloon, Paclitaxel, peripheral artery disease|deb, drug-eluting balloon, paclitaxel, peripheral artery disease
120853|NCT02539979|IV Paracetamol|iv paracetamol
120854|NCT02539979|Radiofrequency Lesion/Ablation of medial branch nerve|radiofrequency lesion/ablation of medial branch nerve
120855|NCT02539979|Preventative Pain Management|preventative pain management
120856|NCT02539940|Below-the-knee|below-the-knee
120857|NCT02539914|Virtual reality|virtual reality
120858|NCT02539914|Motor and cognitive rehabilitation|motor and cognitive rehabilitation
120859|NCT02539914|Positive emotion stimuli|positive emotion stimuli
120860|NCT02539901|cochlear implant|cochlear implant
120861|NCT02539901|Developmental Psychology|developmental psychology
112004|NCT02592928|Telehealth|telehealth
112005|NCT02592928|Integrated Care|integrated care
112006|NCT02592902|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
112007|NCT02592902|extra oesophageal reflux|extra oesophageal reflux
112039|NCT02592837|EBUS|ebus
120862|NCT02539901|cognitive development|cognitive development
120863|NCT02539901|communicative development|communicative development
120864|NCT02539901|perceptual development|perceptual development
120865|NCT02539901|deaf child|deaf child
120866|NCT02539875|Effectiveness of quit immediately (QI) and cut down to quit (CDTQ) interventions in achieving smoking abstinence|effectiveness of quit immediately (qi) and cut down to quit (cdtq) interventions in achieving smoking abstinence
120867|NCT02539862|Insomnia|insomnia
120868|NCT02539862|behavioral and cognitive therapies|behavioral and cognitive therapies
120869|NCT02539836|children's obesity|children's obesity
120870|NCT02539836|gut microbiome|gut microbiome
120871|NCT02539836|body mass index|body mass index
120872|NCT02539836|fruit and vegetable fermentation extraction|fruit and vegetable fermentation extraction
120873|NCT02539836|dietary nutrition intervention|dietary nutrition intervention
120874|NCT02539784|stimulation|stimulation
120875|NCT02539771|vaso-occlusive crisis|vaso-occlusive crisis
120876|NCT02539771|obstructive sleep apnea|obstructive sleep apnea
120877|NCT02539771|priapism|priapism
120878|NCT02539758|acute angle closure|acute angle closure
120879|NCT02539758|ocular massage|ocular massage
120880|NCT02539745|vitamin D|vitamin d
120881|NCT02539745|primary open- angle glaucoma|primary open- angle glaucoma
120883|NCT02539732|Spontaneous breathing trial|spontaneous breathing trial
120884|NCT02539732|Neurally-adjusted ventilator assist|neurally-adjusted ventilator assist
120885|NCT02539732|Electrical activity of the diaphragm|electrical activity of the diaphragm
120886|NCT02539719|Platinum-Resistant|platinum-resistant
120887|NCT02539719|Refractory|refractory
120888|NCT02539680|Phosphate transporter|phosphate transporter
120889|NCT02539680|CKD|ckd
120890|NCT02539680|duodenal biopsies|duodenal biopsies
120891|NCT02539602|High school|high school
120892|NCT02539602|Longitudnal|longitudnal
120893|NCT02539602|Sexual initiation|sexual initiation
120894|NCT02539602|Contraception|contraception
120895|NCT02539602|Adolescents|adolescents
120896|NCT02539602|Pregnancy prevention|pregnancy prevention
120897|NCT02539602|Sexual health|sexual health
120898|NCT02539576|pharmacokinetics|pharmacokinetics
120899|NCT02539576|Healthy subjects|healthy subjects
120900|NCT02539576|Abacavir/dolutegravir/lamivudine|abacavir/dolutegravir/lamivudine
120901|NCT02539576|Japanese|japanese
120902|NCT02539576|Fixed-dose combination|fixed-dose combination
120903|NCT02539576|safety|safety
120904|NCT02539563|labor duration|labor duration
120905|NCT02539550|PF-06266047|pf-06266047
120906|NCT02539550|safety|safety
120907|NCT02539550|tolerability|tolerability
120908|NCT02539550|pharmacokinetics|pharmacokinetics
120909|NCT02539550|first-in-human|first-in-human
121593|NCT02534727|TDM|tdm
120910|NCT02539550|healthy volunteers|healthy volunteers
120911|NCT02539550|PDE4|pde4
120912|NCT02539550|phosphodiesterase-4|phosphodiesterase-4
120913|NCT02539537|locally advanced pancreatic carcinoma|locally advanced pancreatic carcinoma
120914|NCT02539537|FOLFIRINOX|folfirinox
120915|NCT02539524|clinical impact|clinical impact
120916|NCT02539524|anxiety|anxiety
120917|NCT02539524|quality of life|quality of life
120918|NCT02539524|Yoga|yoga
120919|NCT02539498|Primary Hyperparathyroidism|primary hyperparathyroidism
120920|NCT02539498|Parathyroid Hormone|parathyroid hormone
120921|NCT02539498|High-Resolution peripheral Quantitative Computed Tomography|high-resolution peripheral quantitative computed tomography
120922|NCT02539498|Bone densitometry|bone densitometry
120923|NCT02539498|Bone microarchitecture|bone microarchitecture
120924|NCT02539446|Aging|aging
120925|NCT02539446|External focus|external focus
120926|NCT02539446|Internal focus|internal focus
120927|NCT02539446|Attention|attention
120928|NCT02539446|Posture balance|posture balance
120929|NCT02539446|Parkinson's disease|parkinson's disease
120930|NCT02539407|β-lactam antibiotics|β-lactam antibiotics
120931|NCT02539407|Children|children
120932|NCT02539407|Anti-infectives|anti-infectives
120933|NCT02539407|Aminoglycosides, glycopeptides|aminoglycosides, glycopeptides
120934|NCT02539407|Fluoroquinolone|fluoroquinolone
120935|NCT02539407|Fungal|fungal
120936|NCT02539407|Antiviral|antiviral
120937|NCT02539394|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
120938|NCT02539394|Dysphagia|dysphagia
120939|NCT02539394|ACDF|acdf
120940|NCT02539368|Infliximab|infliximab
120941|NCT02539368|Observational|observational
120942|NCT02539368|Follow-up|follow-up
120943|NCT02539368|Safety|safety
120944|NCT02539368|Effectiveness|effectiveness
120945|NCT02539355|Insulin resistance|insulin resistance
120946|NCT02539355|Diabetes|diabetes
120947|NCT02539355|Cancer|cancer
120948|NCT02539355|Obesity|obesity
120949|NCT02539355|Inflammation|inflammation
120950|NCT02539342|Oral Mucositis|oral mucositis
120951|NCT02539342|Cancer|cancer
120952|NCT02539342|Chemotherapy|chemotherapy
120953|NCT02539329|neuropathy|neuropathy
120954|NCT02539329|antibodies antiFGFR3|antibodies antifgfr3
120955|NCT02539329|Biological diagnostic criteria|biological diagnostic criteria
120956|NCT02539316|Parenteral Nutrition|parenteral nutrition
120957|NCT02539290|Unexplained infertility|unexplained infertility
120958|NCT02539290|Infertility|infertility
120959|NCT02539290|Tubal flushing|tubal flushing
120960|NCT02539290|Uterine flushing|uterine flushing
120961|NCT02539290|Live birth|live birth
120962|NCT02539290|Pregnancy|pregnancy
120963|NCT02539290|Randomized controlled trial|randomized controlled trial
120965|NCT02539290|Physiological saline|physiological saline
120966|NCT02539264|All patients registered for A PSG|all patients registered for a psg
120967|NCT02539264|polysomnography|polysomnography
120968|NCT02539251|Early Child Development|early child development
120969|NCT02539251|Ages and Stages Questionnaire _3|ages and stages questionnaire _3
120970|NCT02539251|Validation|validation
120971|NCT02539238|Medical Education|medical education
120972|NCT02539238|cardiopulmonary resuscitation|cardiopulmonary resuscitation
120974|NCT02539238|cost-effectiveness analysis|cost-effectiveness analysis
120975|NCT02539212|microwave|microwave
120976|NCT02539212|radiofrequency|radiofrequency
120977|NCT02539212|ablation|ablation
120978|NCT02539160|coronary artery disease|coronary artery disease
120979|NCT02539160|diabetes mellitus|diabetes mellitus
120980|NCT02539160|chronic kidney disease|chronic kidney disease
120981|NCT02539160|ticagrelor|ticagrelor
120982|NCT02539147|lipopolysaccharide|lipopolysaccharide
120983|NCT02539147|sepsis|sepsis
120984|NCT02539147|caspase-4 and -5|caspase-4 and -5
120985|NCT02539147|monocytes|monocytes
120986|NCT02539147|IL-1β and IL-1α|il-1β and il-1α
120987|NCT02539134|Drug therapy|drug therapy
120988|NCT02539121|Labor|labor
120989|NCT02539121|Acupuncture|acupuncture
120990|NCT02539121|Postpartum hemorrhage|postpartum hemorrhage
120991|NCT02539121|Placental expulsion time|placental expulsion time
120992|NCT02539121|Postpartum blood loss|postpartum blood loss
120993|NCT02539108|Influenza|influenza
120994|NCT02539108|Influenza virus vaccine|influenza virus vaccine
120995|NCT02539108|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
120996|NCT02539095|intra-articular injection|intra-articular injection
120997|NCT02539095|intra-articular collagen injection|intra-articular collagen injection
120998|NCT02539095|collagen|collagen
120999|NCT02539095|knee joint pain|knee joint pain
121000|NCT02539082|collagen|collagen
121001|NCT02539082|collagen injection|collagen injection
121002|NCT02539082|plantar fasciitis|plantar fasciitis
121003|NCT02539069|cartilage defects|cartilage defects
121004|NCT02539069|Chondron|chondron
121005|NCT02539069|Autologous cultured Chondrocyte|autologous cultured chondrocyte
121006|NCT02539069|arthroscopy|arthroscopy
121007|NCT02539056|cartilage defects|cartilage defects
121008|NCT02539056|Chondron|chondron
121594|NCT02534701|stroke|stroke
121009|NCT02539056|Autologous cultured Chondrocyte|autologous cultured chondrocyte
121010|NCT02539043|Lipolysis|lipolysis
121011|NCT02539043|Subcutaneous Fat, Abdominal/metabolism|subcutaneous fat, abdominal/metabolism
121012|NCT02539043|Subcutaneous Fat, Abdominal/ultrasonography|subcutaneous fat, abdominal/ultrasonography
121013|NCT02539043|High-Intensity Focused Ultrasound Ablation/methods|high-intensity focused ultrasound ablation/methods
121014|NCT02539043|Waist Circumference|waist circumference
121015|NCT02539043|Pilot Projects|pilot projects
121016|NCT02539043|Subcutaneous Fat|subcutaneous fat
121017|NCT02539043|High-Intensity Focused Ultrasound Ablation|high-intensity focused ultrasound ablation
121018|NCT02539043|Adiposity|adiposity
121019|NCT02539030|Cartilage defect of knee|cartilage defect of knee
121020|NCT02539030|microfracture|microfracture
121021|NCT02539030|modified microfracture|modified microfracture
121022|NCT02539030|collagen|collagen
121023|NCT02539017|cellular immune therapy|cellular immune therapy
121024|NCT02539017|triple negative breast cancer|triple negative breast cancer
121025|NCT02539017|adjuvant therapy|adjuvant therapy
121026|NCT02539004|kidney stones|kidney stones
121027|NCT02539004|ureteral stones|ureteral stones
121028|NCT02538991|Bulkamid|bulkamid
121029|NCT02538991|Tension-Free Vaginal Tape|tension-free vaginal tape
121030|NCT02538991|Women|women
121031|NCT02538978|CLI|cli
121032|NCT02538965|Lenalidomide|lenalidomide
121033|NCT02538965|Revlimid|revlimid
121034|NCT02538965|Pediatric|pediatric
121035|NCT02538965|Relapsed or Refractory|relapsed or refractory
121036|NCT02538965|Acute Myeloid Leukemia|acute myeloid leukemia
121037|NCT02538965|Leukemia|leukemia
121038|NCT02538952|GeneXpert|genexpert
121039|NCT02538952|Tuberculosis|tuberculosis
121040|NCT02538952|Human immunodeficiency virus|human immunodeficiency virus
121041|NCT02538952|Diagnostic accuracy|diagnostic accuracy
121042|NCT02538952|Impact|impact
112247|NCT02591654|FLT|flt
121043|NCT02538939|Calcific tendinitis, Shoulder, Needle lavage, Sodium thiosulfate|calcific tendinitis, shoulder, needle lavage, sodium thiosulfate
121044|NCT02538913|Exercise|exercise
121045|NCT02538913|Pelvic floor|pelvic floor
121046|NCT02538913|Prehabilitation|prehabilitation
121047|NCT02538913|Fecal incontinence|fecal incontinence
121048|NCT02538913|Urinary incontinence|urinary incontinence
121049|NCT02538913|Sexual dysfunction, physiological|sexual dysfunction, physiological
121050|NCT02538900|peripheral arterial disease, peripheral artery disease, PAD, exercise|peripheral arterial disease, peripheral artery disease, pad, exercise
121051|NCT02538822|aortic aneurysm|aortic aneurysm
121052|NCT02538822|thoracic ascending aorta|thoracic ascending aorta
121053|NCT02538822|ATA|ata
121054|NCT02538822|dynamic imaging|dynamic imaging
121055|NCT02538822|mechanical testing|mechanical testing
121056|NCT02538796|Anorexia Nervosa|anorexia nervosa
121057|NCT02538796|Cognition|cognition
121059|NCT02538796|Non-Conscious|non-conscious
121060|NCT02538705|Diabetic foot syndrome|diabetic foot syndrome
121062|NCT02538679|transversus abdominis plane block|transversus abdominis plane block
121063|NCT02538679|tap block|tap block
121064|NCT02538679|regional anesthesia|regional anesthesia
121065|NCT02538679|colorectal surgery|colorectal surgery
121066|NCT02538653|glycemic & insulin response, SDS, cereal product, Nutrition|glycemic & insulin response, sds, cereal product, nutrition
121067|NCT02538640|Nutrition, glycemic response, cereal products|nutrition, glycemic response, cereal products
121068|NCT02538627|Heregulin-positive|heregulin-positive
121069|NCT02538627|EGFR|egfr
121070|NCT02538627|ErbB3|erbb3
121071|NCT02538627|Phase I|phase i
121072|NCT02538627|Oncology|oncology
121073|NCT02538627|Cancer|cancer
121074|NCT02538601|Post Traumatic Stress Disorder|post traumatic stress disorder
121075|NCT02538601|PTSD|ptsd
121076|NCT02538601|Cigarette Smoking|cigarette smoking
121077|NCT02538601|Lower Respiratory Symptoms|lower respiratory symptoms
121078|NCT02538601|Cognitive Behavioral Therapy|cognitive behavioral therapy
121079|NCT02538601|CBT|cbt
121080|NCT02538601|Transdiagnostic Treatments|transdiagnostic treatments
121081|NCT02538601|World Trade Center|world trade center
121082|NCT02538588|Healthy Volunteers|healthy volunteers
121083|NCT02538575|Cystic Fibrosis|cystic fibrosis
121084|NCT02538575|Adults|adults
121085|NCT02538575|6-minute walk test|6-minute walk test
121086|NCT02538497|NBO|nbo
121087|NCT02538497|The Newborn Behavioral Observation|the newborn behavioral observation
121088|NCT02538497|postpartum depression|postpartum depression
121089|NCT02538497|postnatal depression|postnatal depression
121090|NCT02538497|attachment|attachment
121091|NCT02538458|Saline Solution, Hypertonic (3 %)|saline solution, hypertonic (3 %)
121092|NCT02538458|Infant|infant
121093|NCT02538445|Schizophrenia|schizophrenia
121094|NCT02538445|Memory|memory
121095|NCT02538445|Cognition|cognition
121096|NCT02538432|Disease Progression|disease progression
121097|NCT02538432|Non-Responsive Disease|non-responsive disease
121098|NCT02538432|Advanced Disease|advanced disease
121099|NCT02538406|Adenoma|adenoma
121100|NCT02538406|withdrawal time|withdrawal time
121101|NCT02538406|Colonoscopy|colonoscopy
121102|NCT02538380|Lung cancer|lung cancer
121103|NCT02538380|Adrenal gland metastasis|adrenal gland metastasis
121104|NCT02538354|Riboflavin (vitamin B2)|riboflavin (vitamin b2)
121105|NCT02538354|Faecalibacterium prausnitzii|faecalibacterium prausnitzii
121106|NCT02538328|laparoscopy|laparoscopy
121107|NCT02538328|obesity|obesity
121108|NCT02538328|harmonic scalpel|harmonic scalpel
121109|NCT02538328|ligasure|ligasure
121110|NCT02538315|[18F]FODPA, Parkinson's, PET/CT, Stem Cell transplantation|[18f]fodpa, parkinson's, pet/ct, stem cell transplantation
121111|NCT02538302|Minirin|minirin
121112|NCT02538302|Oxybutynin|oxybutynin
121113|NCT02538302|Nocturnal enuresis|nocturnal enuresis
121114|NCT02538289|Dyspnea|dyspnea
121115|NCT02538289|Palliative Care|palliative care
121116|NCT02538289|Heart Failure|heart failure
121117|NCT02538289|Chronic Pulmonary Disease|chronic pulmonary disease
121118|NCT02538289|Opioids|opioids
121119|NCT02538276|carotid endarterectomy, carotid stenosis, carotid stenting|carotid endarterectomy, carotid stenosis, carotid stenting
121120|NCT02538250|Oral nutritional supplement|oral nutritional supplement
121121|NCT02538250|supplementation|supplementation
121122|NCT02538250|adult patients|adult patients
121123|NCT02538224|Periodontitis|periodontitis
121124|NCT02538224|doxycycline/ketoprofen topical gel therapeutic|doxycycline/ketoprofen topical gel therapeutic
121125|NCT02538198|lenalidomide (CC-5013)|lenalidomide (cc-5013)
121126|NCT02538198|maintenance|maintenance
121127|NCT02538198|15-129|15-129
121128|NCT02538172|Cell-mediated immunity|cell-mediated immunity
121129|NCT02538172|Antiviral prophylaxis|antiviral prophylaxis
121130|NCT02538172|Transplantation|transplantation
121131|NCT02538159|Non-tunneled Central venous catheter|non-tunneled central venous catheter
121132|NCT02538159|Bacteraemia|bacteraemia
121133|NCT02538159|Peripherally inserted central venous catheter|peripherally inserted central venous catheter
121134|NCT02538146|pain|pain
121135|NCT02538146|depression|depression
121136|NCT02538146|cytokines|cytokines
121137|NCT02538146|well-being|well-being
121138|NCT02538133|99mTc-Exametazime (HMPAO)-Labeled Leukocytes|99mtc-exametazime (hmpao)-labeled leukocytes
121139|NCT02538133|suspected subdiaphragmatic vascular prosthesis infection|suspected subdiaphragmatic vascular prosthesis infection
121140|NCT02538133|diagnosis|diagnosis
121141|NCT02538094|Cognitive Enhancement|cognitive enhancement
121142|NCT02538094|tDCS|tdcs
121143|NCT02538094|stimulation|stimulation
121144|NCT02538094|MS|ms
121145|NCT02538094|Multiple Sclerosis|multiple sclerosis
121146|NCT02538094|Encephalitis|encephalitis
121147|NCT02538081|schizophrenia|schizophrenia
121148|NCT02538081|olanzapine|olanzapine
121149|NCT02538081|risperidone|risperidone
121150|NCT02538081|alpha 7 nicotinic receptors|alpha 7 nicotinic receptors
121151|NCT02538081|cognition|cognition
121152|NCT02538068|Purpose in Life|purpose in life
121153|NCT02538068|Self-determination|self-determination
121154|NCT02538068|Physical activity|physical activity
121155|NCT02538068|Self-monitoring|self-monitoring
121156|NCT02538068|Behavior change|behavior change
121157|NCT02538055|Community Health Workers|community health workers
121158|NCT02538055|Diabetes Mellitus|diabetes mellitus
121159|NCT02538055|Chronic Pain|chronic pain
121160|NCT02538029|Dual tasking|dual tasking
121161|NCT02538016|Cystinuria|cystinuria
121162|NCT02538016|Kidney Stones|kidney stones
121163|NCT02537964|chlorhexidine|chlorhexidine
121164|NCT02537951|autofluorescent flavoprotein imaging, capsaicin|autofluorescent flavoprotein imaging, capsaicin
121165|NCT02537925|COX-2 inhibitors|cox-2 inhibitors
121166|NCT02537925|radiosensitivity|radiosensitivity
121167|NCT02537925|nasopharyngeal carcinoma|nasopharyngeal carcinoma
121168|NCT02537912|peanut skin|peanut skin
121169|NCT02537912|body fat|body fat
121170|NCT02537912|blood glucose|blood glucose
121171|NCT02537912|waistline|waistline
121172|NCT02537912|body weight|body weight
121173|NCT02537886|PCOR|pcor
121174|NCT02537873|Cocaine Use Disorder|cocaine use disorder
121175|NCT02537847|Sitafloxacin|sitafloxacin
121176|NCT02537847|Extended-Spectrum ß-lactamase-producing Escherichia coli|extended-spectrum ß-lactamase-producing escherichia coli
121177|NCT02537847|Treatment for Acute Pyelonephritis|treatment for acute pyelonephritis
121178|NCT02537847|Ertapenem|ertapenem
121179|NCT02537795|Deep Brain Stimulation|deep brain stimulation
121180|NCT02537795|Anterior Capsulotomy|anterior capsulotomy
121181|NCT02537782|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
121182|NCT02537782|Heart Failure|heart failure
121183|NCT02537782|Left ventricular dyssynchrony|left ventricular dyssynchrony
121184|NCT02537782|Echocardiography|echocardiography
121185|NCT02537782|Apical rocking|apical rocking
121186|NCT02537782|Septal flash|septal flash
121187|NCT02537769|LVAD|lvad
121188|NCT02537769|Tricuspid regurgitation|tricuspid regurgitation
121189|NCT02537769|Heart failure|heart failure
121190|NCT02537769|Transplant|transplant
121191|NCT02537769|3D transesophageal echocardiography (TEE)|3d transesophageal echocardiography (tee)
121192|NCT02537769|2D transesophageal echocardiography (TEE)|2d transesophageal echocardiography (tee)
121193|NCT02537769|Mild|mild
121194|NCT02537769|Moderate|moderate
121195|NCT02537743|Patient Reported Outcomes|patient reported outcomes
121196|NCT02537704|Obesity|obesity
121197|NCT02537704|Translational|translational
121198|NCT02537704|Diabetes Prevention Program|diabetes prevention program
121199|NCT02537704|Group Lifestyle Balance Program|group lifestyle balance program
121200|NCT02537652|Central blood pressure|central blood pressure
121201|NCT02537652|Transient ischaemic attack|transient ischaemic attack
121202|NCT02537639|Simulator in transesophageal echocardiography|simulator in transesophageal echocardiography
121203|NCT02537613|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
121204|NCT02537600|BRAF mutation|braf mutation
121205|NCT02537600|Brain metastasis|brain metastasis
121206|NCT02537600|Cobimetinib + Vemurafenib combination treatment|cobimetinib + vemurafenib combination treatment
121207|NCT02537587|Blood glucose|blood glucose
121208|NCT02537587|Blood insulin|blood insulin
121209|NCT02537587|Humans|humans
121210|NCT02537587|Postprandial|postprandial
121211|NCT02537587|Carbohydrate|carbohydrate
121212|NCT02537587|Protein|protein
121213|NCT02537587|Resistant starch|resistant starch
121214|NCT02537587|Sugar|sugar
121215|NCT02537574|Alkermes|alkermes
121216|NCT02537574|Buprenorphine|buprenorphine
121217|NCT02537574|Naltrexone|naltrexone
121218|NCT02537574|Vivitrol|vivitrol
121219|NCT02537574|Opioid Use|opioid use
121220|NCT02537574|Opiates|opiates
121221|NCT02537574|Dependence|dependence
121222|NCT02537574|Abuse|abuse
121223|NCT02537574|Heroin|heroin
121224|NCT02537574|Painkillers|painkillers
121225|NCT02537574|Substance Abuse|substance abuse
121226|NCT02537496|Alzheimer's Disease|alzheimer's disease
121227|NCT02537496|Brain stimulation|brain stimulation
121228|NCT02537496|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
121229|NCT02537496|Neuroplasticity|neuroplasticity
121230|NCT02537496|cognitive enhancement|cognitive enhancement
145443|NCT02398019|CPB|cpb
121231|NCT02537496|TMS-EEG|tms-eeg
121232|NCT02537496|rTMS|rtms
121233|NCT02537496|PAS|pas
121234|NCT02537431|KRN23|krn23
121235|NCT02537431|Fibroblast growth factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
121236|NCT02537431|XLH|xlh
121237|NCT02537431|X-linked Hypophosphatemia|x-linked hypophosphatemia
121238|NCT02537379|Hepatitis C virus|hepatitis c virus
121239|NCT02537379|observational|observational
121240|NCT02537379|post-marketing|post-marketing
121241|NCT02537379|sofosbuvir|sofosbuvir
121242|NCT02537353|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
121243|NCT02537353|Hemospray|hemospray
121244|NCT02537353|Endoscopic hemostasis|endoscopic hemostasis
121245|NCT02537340|PET/CT|pet/ct
121246|NCT02537340|MRI|mri
121247|NCT02537340|EMVI|emvi
121248|NCT02537340|Liver metastasis|liver metastasis
121249|NCT02537340|FDG|fdg
121250|NCT02537327|Recurrent caries|recurrent caries
121251|NCT02537327|Secondary caries|secondary caries
121252|NCT02537327|Dental composite|dental composite
121253|NCT02537327|Dental amalgam|dental amalgam
121254|NCT02537314|Normal Body Weight|normal body weight
122369|NCT02530463|5-AZC|5-azc
121255|NCT02537301|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
121256|NCT02537301|social networking|social networking
121257|NCT02537301|group chat|group chat
121258|NCT02537288|VA106483|va106483
121259|NCT02537288|fedovapagon|fedovapagon
121260|NCT02537288|males|males
121261|NCT02537288|females|females
121262|NCT02537288|moxifloxacin|moxifloxacin
121264|NCT02537288|QT/QTC|qt/qtc
121265|NCT02537288|ECG|ecg
121266|NCT02537288|Nocturia|nocturia
121267|NCT02537262|carbohydrate|carbohydrate
121268|NCT02537262|quality of recovery(QOR) 40|quality of recovery(qor) 40
121269|NCT02537262|enhanced recovery after surgery(ERAS)|enhanced recovery after surgery(eras)
121270|NCT02537249|dexmedetomidine|dexmedetomidine
121271|NCT02537249|quality of recovery|quality of recovery
121272|NCT02537236|Omega-3 Fatty Acids|omega-3 fatty acids
121273|NCT02537236|Therapeutic Lifestyle Changes|therapeutic lifestyle changes
121274|NCT02537236|Human Immunodeficiency Virus|human immunodeficiency virus
121275|NCT02537236|Cardiac Risk|cardiac risk
121276|NCT02537236|Dyslipidemia|dyslipidemia
121277|NCT02537171|Apatinib|apatinib
121278|NCT02537171|Locally Advanced Gastric Cancer|locally advanced gastric cancer
121279|NCT02537171|Metastatic Gastric Cancer|metastatic gastric cancer
121280|NCT02537158|sorafenib|sorafenib
121281|NCT02537158|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
121282|NCT02537158|hepatocellular carcinoma|hepatocellular carcinoma
121283|NCT02537158|microvascular invasion|microvascular invasion
121284|NCT02537145|compliance|compliance
121285|NCT02537145|do-it-yourself methodology|do-it-yourself methodology
121286|NCT02537145|pilot|pilot
121287|NCT02537145|human microbiome|human microbiome
121288|NCT02537132|Non Invasive Ventilation (NIV)|non invasive ventilation (niv)
121289|NCT02537132|Amyotrophic Lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
121290|NCT02537132|adaptation|adaptation
121291|NCT02537132|home care|home care
121292|NCT02537106|Brain Tumors|brain tumors
121293|NCT02537106|Microcirculation|microcirculation
121294|NCT02537106|Osmotherapy|osmotherapy
121295|NCT02537106|Hypertonic NaCl|hypertonic nacl
121296|NCT02537106|Natremia|natremia
121297|NCT02537080|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
121298|NCT02537080|Nimodipin|nimodipin
121299|NCT02537080|Anesthesia|anesthesia
121300|NCT02537067|a partial cartilage defect of ankle|a partial cartilage defect of ankle
121301|NCT02537067|Chondron|chondron
121302|NCT02537067|Autologus Chondrocyte|autologus chondrocyte
121303|NCT02537054|Choroidal neovascularization|choroidal neovascularization
121304|NCT02537054|Angioid streaks|angioid streaks
121305|NCT02537054|Pseudoxanthoma Elasticum|pseudoxanthoma elasticum
121306|NCT02537054|vascular endothelial growth factor|vascular endothelial growth factor
121307|NCT02537054|aflibercept|aflibercept
121308|NCT02537028|MSC2364447C|msc2364447c
121309|NCT02537028|Phase 1|phase 1
121310|NCT02537028|BTK inhibitor|btk inhibitor
121311|NCT02537028|Systemic Lupus Erythematosus|systemic lupus erythematosus
121312|NCT02537028|M2951|m2951
121313|NCT02537028|Lupus|lupus
121314|NCT02537002|PF-05230907|pf-05230907
121315|NCT02537002|Pharmacokinetics|pharmacokinetics
121316|NCT02537002|Pharmacodynamic|pharmacodynamic
121317|NCT02537002|Immunogenicity|immunogenicity
121318|NCT02536989|peptic ulcer bleeding|peptic ulcer bleeding
121319|NCT02536989|blood clot|blood clot
121320|NCT02536989|dose|dose
121321|NCT02536976|mirabegron|mirabegron
121322|NCT02536950|bionic pancreas|bionic pancreas
121323|NCT02536950|closed-loop control|closed-loop control
121324|NCT02536950|artificial pancreas|artificial pancreas
121325|NCT02536885|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
121326|NCT02536885|Blood pressure|blood pressure
121327|NCT02536885|Anesthesia|anesthesia
121328|NCT02536872|infection overactive bladder|infection overactive bladder
121329|NCT02536846|Healthy volunteers|healthy volunteers
121330|NCT02536846|antipsychotic drugs|antipsychotic drugs
121331|NCT02536846|brain metabolism|brain metabolism
121332|NCT02536833|OA|oa
121333|NCT02536833|Samumed|samumed
121334|NCT02536781|Anthocyanin|anthocyanin
121335|NCT02536781|Inflammation|inflammation
121336|NCT02536781|Orthodontic treatment|orthodontic treatment
121337|NCT02536768|Medication adherence|medication adherence
121338|NCT02536768|ART|art
121339|NCT02536768|Counseling|counseling
121340|NCT02536768|Adherence Guidelines for Chronic Diseases (HIV, TB and NCDs)|adherence guidelines for chronic diseases (hiv, tb and ncds)
121341|NCT02536742|Breast Cancer|breast cancer
121342|NCT02536742|Metastatic|metastatic
121343|NCT02536742|HER2 negative|her2 negative
121344|NCT02536742|Palbociclib|palbociclib
121345|NCT02536716|Dental Implant|dental implant
121346|NCT02536690|propofol|propofol
121347|NCT02536690|midazolam|midazolam
121348|NCT02536690|remifentanil|remifentanil
121349|NCT02536690|combination|combination
121350|NCT02536690|synergic|synergic
121351|NCT02536690|pharmacodynamics|pharmacodynamics
121352|NCT02536690|Loss of consciousness|loss of consciousness
121353|NCT02536677|Acute Chest Pain|acute chest pain
121354|NCT02536677|Acute Coronary Syndrome|acute coronary syndrome
121355|NCT02536677|Evaluation and Management|evaluation and management
121356|NCT02536677|Decision Aid|decision aid
121357|NCT02536677|Healthcare Utilization|healthcare utilization
121358|NCT02536651|validation studies, patient-reported outcome measures|validation studies, patient-reported outcome measures
121360|NCT02536638|pregnancy|pregnancy
121361|NCT02536638|pyelonephritis|pyelonephritis
121362|NCT02536638|kidney infection|kidney infection
121363|NCT02536625|everolimus|everolimus
121365|NCT02536625|metastatic|metastatic
121366|NCT02536612|Motivation|motivation
121367|NCT02536612|Behavioral Economics|behavioral economics
121368|NCT02536612|Conditional Economic Incentives|conditional economic incentives
121369|NCT02536612|Conditional cash transfers|conditional cash transfers
121370|NCT02536612|Contingency management|contingency management
121371|NCT02536599|Febrile Neutropenia|febrile neutropenia
121372|NCT02536599|Childhood Cancer|childhood cancer
121373|NCT02536599|Pediatric Oncology|pediatric oncology
121375|NCT02536599|Neutropenia|neutropenia
121376|NCT02536573|Total hip replacement|total hip replacement
121377|NCT02536560|intestinal microbiota|intestinal microbiota
121378|NCT02536560|antibiotics|antibiotics
121380|NCT02536560|allergy|allergy
121381|NCT02536547|Clinical pulmonary infection score|clinical pulmonary infection score
121382|NCT02536547|sepsis|sepsis
121383|NCT02536547|lung ultrasound|lung ultrasound
121384|NCT02536547|ventilator-associated pneumonia|ventilator-associated pneumonia
121385|NCT02536534|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
121386|NCT02536534|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
121387|NCT02536456|screening|screening
121388|NCT02536456|counseling|counseling
121389|NCT02536456|follow-up|follow-up
121390|NCT02536456|cardiovascular disease|cardiovascular disease
121391|NCT02536456|population-based project|population-based project
121392|NCT02536456|China|china
121393|NCT02536443|heart failure|heart failure
121394|NCT02536443|prognosis|prognosis
121395|NCT02536443|clinical characteristics|clinical characteristics
121396|NCT02536430|Infra alveolar nerve block|infra alveolar nerve block
121397|NCT02536430|Ketorolac|ketorolac
121398|NCT02536430|Success rate|success rate
121399|NCT02536417|Melatonin|melatonin
121403|NCT02536352|Prenatal Vitamin|prenatal vitamin
121404|NCT02536352|Pregnancy Nutrition|pregnancy nutrition
121405|NCT02536352|Prenatal Nutrition|prenatal nutrition
121406|NCT02536287|secondary hyperparathyroidism|secondary hyperparathyroidism
121407|NCT02536287|total parathyroidectomy|total parathyroidectomy
121408|NCT02536287|autotransplantation|autotransplantation
121409|NCT02536287|morbidity|morbidity
121410|NCT02536287|recurrence|recurrence
121411|NCT02536287|postoperative hypocalcemia|postoperative hypocalcemia
121412|NCT02536261|Prolactinoma|prolactinoma
121413|NCT02536261|dopamine agonist|dopamine agonist
121414|NCT02536261|withdrawal|withdrawal
121415|NCT02536261|cavernous sinus|cavernous sinus
121416|NCT02536248|sitagliptin|sitagliptin
121417|NCT02536248|diabetes|diabetes
121418|NCT02536248|inflammation|inflammation
121419|NCT02536196|Cerebral protection, aortic stenosis, transcatheter aortic valve implantation, TAVI, TriGuard, Keystone Heart|cerebral protection, aortic stenosis, transcatheter aortic valve implantation, tavi, triguard, keystone heart
121420|NCT02536183|Solid tumors|solid tumors
121421|NCT02536183|relapsed pediatric solid tumors|relapsed pediatric solid tumors
121422|NCT02536183|high intensity focused ultrasound|high intensity focused ultrasound
121423|NCT02536183|Lyso-thermosensitive liposomal doxorubicin|lyso-thermosensitive liposomal doxorubicin
121424|NCT02536183|ThermoDox|thermodox
121425|NCT02536183|relapsed sarcoma|relapsed sarcoma
121426|NCT02536183|Ewing Sarcoma family of tumors|ewing sarcoma family of tumors
121427|NCT02536183|Osteosarcoma|osteosarcoma
121428|NCT02536183|Neuroblastoma|neuroblastoma
121429|NCT02536183|Wilms Tumor|wilms tumor
121430|NCT02536183|Hepatic Tumor|hepatic tumor
121431|NCT02536183|Germ Cell Tumors|germ cell tumors
121432|NCT02536170|Arginine Therapy|arginine therapy
121433|NCT02536157|Volar plate|volar plate
121434|NCT02536144|colon capsule|colon capsule
121435|NCT02536144|magnetic|magnetic
121436|NCT02536144|maneuverability|maneuverability
121437|NCT02536144|colonoscopy|colonoscopy
121438|NCT02536131|Psychosomatics|psychosomatics
121439|NCT02536131|Gastroenterology|gastroenterology
121440|NCT02536131|Psychoneuroimmunology|psychoneuroimmunology
121441|NCT02536105|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
121442|NCT02536105|ADHD|adhd
121443|NCT02536053|[E04.100.814.603]|[e04.100.814.603]
121444|NCT02536040|silver diamine fluoride|silver diamine fluoride
121445|NCT02536040|diammine silver fluoride|diammine silver fluoride
121446|NCT02536040|children|children
121447|NCT02536027|continuous venovenous hemofiltration|continuous venovenous hemofiltration
121448|NCT02536027|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
121449|NCT02536027|sepsis|sepsis
121450|NCT02536027|acute kidney injury|acute kidney injury
121451|NCT02536014|Dexmedetomidine|dexmedetomidine
121452|NCT02536014|pneumoperitoneum|pneumoperitoneum
121453|NCT02536014|trendelenburg position|trendelenburg position
121454|NCT02536014|QTc interval|qtc interval
121455|NCT02536014|Tp-e interval|tp-e interval
121456|NCT02536014|robotic prostatectomy|robotic prostatectomy
121457|NCT02536001|Vaginal mesh|vaginal mesh
121458|NCT02536001|Total vaginal length|total vaginal length
121459|NCT02536001|Quality of life|quality of life
121460|NCT02535988|Colorectal Cancer|colorectal cancer
121461|NCT02535988|Metastatic Colorectal Cancer|metastatic colorectal cancer
121463|NCT02535988|Abscopal Effect|abscopal effect
121464|NCT02535988|Radiotherapy|radiotherapy
121465|NCT02535962|PFAPA|pfapa
121466|NCT02535936|Cerebral Palsy|cerebral palsy
121467|NCT02535923|Schizophrenia and Disorders with Psychotic Feature|schizophrenia and disorders with psychotic feature
121468|NCT02535923|Mental Disorders|mental disorders
121469|NCT02535923|Insomnia Disorder|insomnia disorder
121470|NCT02535910|vitamin D3|vitamin d3
121471|NCT02535910|25(OH)D3|25(oh)d3
121472|NCT02535910|vitamin D status|vitamin d status
121473|NCT02535910|risk factors of cardiovascular diease|risk factors of cardiovascular diease
121474|NCT02535884|Huntington Disease|huntington disease
121476|NCT02535884|Chorea|chorea
121477|NCT02535858|Anxiety|anxiety
121478|NCT02535832|Rheumatoid Arthritis|rheumatoid arthritis
121479|NCT02535819|Cataract surgery|cataract surgery
121480|NCT02535806|Relapsed, Refractory|relapsed, refractory
121481|NCT02535767|Primaquine|primaquine
121482|NCT02535741|Knee Replacement|knee replacement
121483|NCT02535741|Arthroplasty|arthroplasty
121484|NCT02535728|Frail Elderly|frail elderly
121485|NCT02535728|Cardiac Surgical Procedure|cardiac surgical procedure
121486|NCT02535728|Risk Assessment|risk assessment
121487|NCT02535728|Quality of Life|quality of life
121488|NCT02535715|Oral Insulin|oral insulin
121489|NCT02535702|fMRI|fmri
121490|NCT02535702|EEG|eeg
121495|NCT02535676|schizophrenia|schizophrenia
121496|NCT02535676|transcranial stimulation|transcranial stimulation
121497|NCT02535663|rhamnogalacturonan|rhamnogalacturonan
121498|NCT02535663|Natural killer cell activity|natural killer cell activity
121499|NCT02535663|interleukin-12|interleukin-12
121500|NCT02535663|interferon-gamma|interferon-gamma
121501|NCT02535663|immune function|immune function
121502|NCT02535663|inflammatory|inflammatory
121503|NCT02535572|Electroconvulsive Therapy|electroconvulsive therapy
121504|NCT02535546|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
121505|NCT02535546|Streptococcus pneumoniae|streptococcus pneumoniae
121506|NCT02535546|Pneumonia|pneumonia
121507|NCT02535546|Pneumococcal conjugate vaccine-13 (PCV-13)|pneumococcal conjugate vaccine-13 (pcv-13)
121508|NCT02535546|Pneumococcal polysaccharide vaccine-23 (PPV-23)|pneumococcal polysaccharide vaccine-23 (ppv-23)
121509|NCT02535546|Pneumococcal vaccine|pneumococcal vaccine
121510|NCT02535533|Kidney cancer|kidney cancer
121511|NCT02535533|Selenium (Se)|selenium (se)
121512|NCT02535507|pyrotinib|pyrotinib
121513|NCT02535507|HER2|her2
121514|NCT02535507|Non-small Cell Lung Cancer|non-small cell lung cancer
121515|NCT02535507|Phase II|phase ii
121516|NCT02535481|epidermal graft|epidermal graft
121517|NCT02535481|suction blister|suction blister
121518|NCT02535481|blister graft|blister graft
121519|NCT02535481|suction graft|suction graft
121520|NCT02535481|Epidermis/su, tr [Surgery, Transplantation]|epidermis/su, tr [surgery, transplantation]
121521|NCT02535390|cognitive remediation|cognitive remediation
121522|NCT02535390|vocational outcomes|vocational outcomes
121523|NCT02535377|Cryodamage|cryodamage
121524|NCT02535377|microarrays|microarrays
121525|NCT02535377|Insemination|insemination
121526|NCT02535377|sperm|sperm
121527|NCT02535364|acute lymphoblastic leukemia|acute lymphoblastic leukemia
121528|NCT02535364|ALL|all
121529|NCT02535364|chimeric antigen receptor|chimeric antigen receptor
121530|NCT02535364|CAR|car
121531|NCT02535364|CAR T cells|car t cells
121532|NCT02535364|JCAR015|jcar015
121533|NCT02535364|autologous T cell therapy|autologous t cell therapy
121534|NCT02535364|cell therapy|cell therapy
121535|NCT02535351|Clear cell Metastatic renal cell carcinoma|clear cell metastatic renal cell carcinoma
121536|NCT02535351|Cytoreductive nephrectomy|cytoreductive nephrectomy
121537|NCT02535351|First line treatment|first line treatment
121538|NCT02535299|telomere-telomerase|telomere-telomerase
121539|NCT02535299|Par-4|par-4
121540|NCT02535299|GLP-1|glp-1
121541|NCT02535299|metformin|metformin
121542|NCT02535273|dexmedetomidine|dexmedetomidine
121543|NCT02535273|prone position|prone position
121544|NCT02535273|spine surgery|spine surgery
121545|NCT02535273|Minimally invasive|minimally invasive
121546|NCT02535273|local anesthesia|local anesthesia
121547|NCT02535260|Pregnancy|pregnancy
121548|NCT02535221|Premenopausal Patients|premenopausal patients
121549|NCT02535221|Estrogen Receptor-Positive HER2 negative|estrogen receptor-positive her2 negative
121550|NCT02535169|at risk for type 2 diabetes|at risk for type 2 diabetes
121551|NCT02535169|currently has type 2 diabetes|currently has type 2 diabetes
121552|NCT02535065|Low Profile|low profile
121553|NCT02535065|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
121554|NCT02535065|Endovascular|endovascular
121555|NCT02535039|Elderly|elderly
121556|NCT02535039|cognitive retention disorder|cognitive retention disorder
121557|NCT02535039|methylprednisolone|methylprednisolone
121559|NCT02534974|Trauma patients|trauma patients
121560|NCT02534961|Hepatocellular carcinoma|hepatocellular carcinoma
121561|NCT02534961|Radiofrequency ablation|radiofrequency ablation
121562|NCT02534961|Antibiotics|antibiotics
121563|NCT02534948|mindfulness|mindfulness
121564|NCT02534948|MABT|mabt
121565|NCT02534948|social anxiety|social anxiety
121566|NCT02534948|mindfulness and acceptance|mindfulness and acceptance
121567|NCT02534948|group therapy|group therapy
121568|NCT02534935|Phase 2 Immunogenicity|phase 2 immunogenicity
121569|NCT02534935|Safety|safety
121570|NCT02534935|Tolerability Study|tolerability study
121571|NCT02534935|rLP2086 Vaccine|rlp2086 vaccine
121572|NCT02534935|Healthy Toddlers|healthy toddlers
121573|NCT02534935|Neisseria meningitidis|neisseria meningitidis
121574|NCT02534935|Duration of Immunogenicity|duration of immunogenicity
121575|NCT02534909|PNH|pnh
121576|NCT02534870|Volunteer|volunteer
121577|NCT02534857|randomized double blinded study|randomized double blinded study
121578|NCT02534857|live birth rate|live birth rate
121579|NCT02534857|IVF treatment|ivf treatment
121580|NCT02534857|brief incubation of oocytes and sperm|brief incubation of oocytes and sperm
121581|NCT02534844|Niemann-Pick Type C1 (NPC1) Disease|niemann-pick type c1 (npc1) disease
121582|NCT02534844|neurologic disease|neurologic disease
121583|NCT02534844|gross motor dysfunction|gross motor dysfunction
121584|NCT02534844|fine motor dysfunction|fine motor dysfunction
121585|NCT02534844|dysphagia|dysphagia
121586|NCT02534844|swallowing problems|swallowing problems
121587|NCT02534844|cognitive dysfunction|cognitive dysfunction
121588|NCT02534844|gait abnormalities|gait abnormalities
121589|NCT02534844|pediatrics|pediatrics
121590|NCT02534727|Tuberculosis|tuberculosis
121591|NCT02534727|Non-Tuberculous Mycobacterim|non-tuberculous mycobacterim
121592|NCT02534727|Xpert/MDR-RIF|xpert/mdr-rif
121595|NCT02534701|clot retrieval system|clot retrieval system
121596|NCT02534701|recanalization|recanalization
121597|NCT02534649|Molecular profiling|molecular profiling
121598|NCT02534649|Genomic alteration|genomic alteration
121599|NCT02534649|Advanced cancer|advanced cancer
121600|NCT02534610|preemptive|preemptive
121601|NCT02534610|postoperative pain|postoperative pain
121602|NCT02534610|etoricoxib|etoricoxib
121603|NCT02534584|acute kidney injury|acute kidney injury
121604|NCT02534584|outcome|outcome
121605|NCT02534584|mortality|mortality
121606|NCT02534584|care-bundle|care-bundle
121607|NCT02534558|MicroRNA-29|microrna-29
121608|NCT02534558|shoulder stiffness|shoulder stiffness
121609|NCT02534558|mir-29a|mir-29a
121610|NCT02534545|Intracranial atherosclerotic stenosis|intracranial atherosclerotic stenosis
121611|NCT02534545|ischemia|ischemia
121612|NCT02534545|remote ischemic conditioning|remote ischemic conditioning
121613|NCT02534545|stroke|stroke
121614|NCT02534532|Atrial fibrillation screening|atrial fibrillation screening
121615|NCT02534506|Advanced malignant tumors|advanced malignant tumors
121616|NCT02534506|Metastatic malignant tumors|metastatic malignant tumors
121617|NCT02534480|Amyloid|amyloid
121618|NCT02534415|Antiinflammatory|antiinflammatory
121619|NCT02534415|Gingiva|gingiva
121620|NCT02534415|Hyaluronic acid|hyaluronic acid
121621|NCT02534415|Palate|palate
121622|NCT02534415|Transplants|transplants
121623|NCT02534415|Wound healing|wound healing
121624|NCT02534402|Biomarkers|biomarkers
121625|NCT02534402|Genomics|genomics
121626|NCT02534402|Prednisone|prednisone
121627|NCT02534389|rectal cancer|rectal cancer
121628|NCT02534389|inflammation|inflammation
121629|NCT02534389|omega-3|omega-3
121630|NCT02534389|fish oil|fish oil
121631|NCT02534389|nutritional status|nutritional status
145940|NCT02395029|PD|pd
121632|NCT02534376|prostatectomy, cholesterol, statin|prostatectomy, cholesterol, statin
121633|NCT02534363|Cognition|cognition
121634|NCT02534363|Psychosis|psychosis
121635|NCT02534363|Antipsychotic Agents|antipsychotic agents
121636|NCT02534363|Treatment|treatment
121637|NCT02534363|Effectiveness|effectiveness
121638|NCT02534363|Aripiprazole|aripiprazole
121639|NCT02534363|Quetiapine|quetiapine
121640|NCT02534363|Ziprasidone|ziprasidone
121641|NCT02534363|Neurocognition|neurocognition
121642|NCT02534350|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
121643|NCT02534350|Antiviral|antiviral
121644|NCT02534350|Lung Transplant|lung transplant
121645|NCT02534324|Hypertension|hypertension
121646|NCT02534324|Emergency|emergency
121647|NCT02534298|single sided deafness.|single sided deafness.
121648|NCT02534298|Auditory plasticity|auditory plasticity
121649|NCT02534298|Asymmetrical hearing loss|asymmetrical hearing loss
121650|NCT02534298|Cochlear implants|cochlear implants
121651|NCT02534298|Inter hemispheric asymmetry|inter hemispheric asymmetry
121652|NCT02534298|Lateralization index|lateralization index
121653|NCT02534298|Dichotic hearing|dichotic hearing
121654|NCT02534285|Anesthesia, Inhalation|anesthesia, inhalation
121656|NCT02534285|Noise, Occupational|noise, occupational
121657|NCT02534246|Core tissue biopsy|core tissue biopsy
121658|NCT02534246|Core needle biopsy|core needle biopsy
121660|NCT02534246|Fine needle biopsy|fine needle biopsy
122450|NCT02530034|MDS|mds
121661|NCT02534246|Fine needle aspiration|fine needle aspiration
121662|NCT02534233|barrett's esophagus with dysplasia|barrett's esophagus with dysplasia
121663|NCT02534233|early esophageal cancer|early esophageal cancer
121664|NCT02534220|Toothbrushing|toothbrushing
121665|NCT02534220|Oral hygiene|oral hygiene
121666|NCT02534220|Dental hygiene|dental hygiene
121667|NCT02534194|Gestation|gestation
121668|NCT02534194|Premature|premature
121669|NCT02534194|Infants|infants
121670|NCT02534181|Refeeding Syndrome|refeeding syndrome
121671|NCT02534181|Cancer|cancer
121672|NCT02534168|genetic polymorphisms|genetic polymorphisms
121673|NCT02534155|MitraClip®|mitraclip®
121675|NCT02534155|DMR|dmr
121676|NCT02534155|high-risk patients|high-risk patients
121677|NCT02534155|mitral regurgitation|mitral regurgitation
121678|NCT02534155|surgery|surgery
121679|NCT02534155|intermediate risk patients|intermediate risk patients
121680|NCT02534129|breast cancer|breast cancer
121681|NCT02534129|radiation|radiation
121682|NCT02534129|dermatitis|dermatitis
121683|NCT02534116|abdominal reconstruction|abdominal reconstruction
121684|NCT02534090|Premature|premature
121685|NCT02534090|Preterm|preterm
121686|NCT02534090|Necrotizing|necrotizing
121687|NCT02534090|Enterocolitis|enterocolitis
121688|NCT02534090|NIRS|nirs
121689|NCT02534077|omegaven|omegaven
121690|NCT02534077|cholestasis|cholestasis
121691|NCT02534077|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
121692|NCT02534064|Menopause|menopause
121693|NCT02534064|Osteoporosis|osteoporosis
121694|NCT02534064|Hip fractures|hip fractures
121695|NCT02534064|vitamin D deficiency|vitamin d deficiency
121696|NCT02534051|clinical care path|clinical care path
121697|NCT02534051|care pathway|care pathway
121698|NCT02534051|obesity|obesity
121699|NCT02534051|pregnancy|pregnancy
121700|NCT02534038|Disinhibition|disinhibition
121701|NCT02533986|Berry|berry
121702|NCT02533986|Inflammation|inflammation
121703|NCT02533986|Cognition|cognition
121704|NCT02533986|Polyphenols|polyphenols
121705|NCT02533986|Appetite|appetite
121706|NCT02533986|Glucose metabolism|glucose metabolism
121707|NCT02533960|Registry of Acute Stroke Under Novel Oral Anticoagulants|registry of acute stroke under novel oral anticoagulants
121708|NCT02533947|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
121709|NCT02533947|Hematological Malignancies|hematological malignancies
121710|NCT02533947|Exercise Intervention|exercise intervention
121711|NCT02533947|Cognitive Function|cognitive function
121712|NCT02533947|Fatigue|fatigue
121713|NCT02533947|Randomized Controlled Trial|randomized controlled trial
121714|NCT02533934|HIV|hiv
121715|NCT02533934|Hepatitis C|hepatitis c
121716|NCT02533934|Liver Disease|liver disease
121717|NCT02533934|HCV Treatment|hcv treatment
121718|NCT02533934|transplant|transplant
121719|NCT02533921|Palliative Care|palliative care
121720|NCT02533921|Parkinson's Disease|parkinson's disease
121721|NCT02533869|low-dose computed tomography|low-dose computed tomography
121722|NCT02533817|Fructose|fructose
121723|NCT02533817|Insulin|insulin
121724|NCT02533817|Postprandial lipemia|postprandial lipemia
121725|NCT02533817|Ambulatory blood pressure|ambulatory blood pressure
121726|NCT02533817|Ethnicity|ethnicity
121727|NCT02533804|health|health
121728|NCT02533804|wellness|wellness
121729|NCT02533804|life expectancy|life expectancy
121730|NCT02533804|quality of life|quality of life
121731|NCT02533804|performance|performance
121732|NCT02533804|religion|religion
121733|NCT02533804|skin|skin
112930|NCT02587442|ARS|ars
121734|NCT02533804|cardiovascular|cardiovascular
121735|NCT02533804|joints|joints
121736|NCT02533804|bone|bone
121737|NCT02533804|respiration|respiration
121738|NCT02533804|pain|pain
121739|NCT02533804|nervous system diseases|nervous system diseases
121740|NCT02533804|oral health|oral health
121741|NCT02533804|behavior|behavior
121742|NCT02533804|child|child
121743|NCT02533804|depression|depression
121744|NCT02533804|mood|mood
121745|NCT02533804|panic|panic
121746|NCT02533804|sleep|sleep
121747|NCT02533804|stress|stress
121748|NCT02533804|nutrition|nutrition
121749|NCT02533804|exercise|exercise
121750|NCT02533804|life change events|life change events
121751|NCT02533804|personality|personality
121752|NCT02533804|employment|employment
121753|NCT02533804|social networking|social networking
121754|NCT02533804|time management|time management
121755|NCT02533804|residence characteristics|residence characteristics
121756|NCT02533791|Safety|safety
121757|NCT02533791|immunogenicity|immunogenicity
121758|NCT02533791|Ebola vaccine|ebola vaccine
121759|NCT02533791|boosting|boosting
121760|NCT02533765|Cisplatin-resistant|cisplatin-resistant
121761|NCT02533765|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
121762|NCT02533765|Salvage treatment|salvage treatment
121763|NCT02533765|olaparib|olaparib
121764|NCT02533752|Left Atrial Appendage Closure|left atrial appendage closure
121765|NCT02533752|Watchman device|watchman device
121766|NCT02533752|LAA Closure|laa closure
121768|NCT02533726|Bedsores|bedsores
121769|NCT02533726|Decubitus Ulcer|decubitus ulcer
121770|NCT02533726|Pressure Sore|pressure sore
121771|NCT02533713|rehabilitation|rehabilitation
121772|NCT02533713|bone strength|bone strength
121773|NCT02533713|quality of life|quality of life
121774|NCT02533687|prostate|prostate
121775|NCT02533687|transurethral resection|transurethral resection
121776|NCT02533687|bipolar|bipolar
121777|NCT02533687|monopolar|monopolar
121778|NCT02533661|Effectiveness|effectiveness
121779|NCT02533661|Genes|genes
121780|NCT02533661|Intervention|intervention
121781|NCT02533661|Neurodevelopment|neurodevelopment
121782|NCT02533661|Prematurity|prematurity
121783|NCT02533661|Preschool Age|preschool age
121784|NCT02533648|Type 2 diabetes mellitus, oxidative stress|type 2 diabetes mellitus, oxidative stress
121785|NCT02533648|insulin sensitivity|insulin sensitivity
121786|NCT02533648|insulin resistance|insulin resistance
121787|NCT02533648|mitochondrial dysfunction|mitochondrial dysfunction
121788|NCT02533648|skeletal muscle|skeletal muscle
121789|NCT02533648|xanthine oxidase|xanthine oxidase
121790|NCT02533648|allopurinol|allopurinol
121791|NCT02533622|progressive mobility|progressive mobility
121792|NCT02533583|pulse oximetry|pulse oximetry
121793|NCT02533583|clinical assessment|clinical assessment
121794|NCT02533583|neonate|neonate
121795|NCT02533583|lung disease|lung disease
121796|NCT02533570|Lupus|lupus
121797|NCT02533557|brachial plexus block|brachial plexus block
121798|NCT02533557|nerve stimulator|nerve stimulator
121799|NCT02533557|ultrasound|ultrasound
121800|NCT02533544|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
121801|NCT02533505|Respiratory|respiratory
121802|NCT02533505|COPD|copd
121803|NCT02533505|O2 Consumption|o2 consumption
121804|NCT02533492|total knee replacement|total knee replacement
121805|NCT02533492|vicryl plus|vicryl plus
121806|NCT02533492|surgical site infection|surgical site infection
121807|NCT02533453|Type 2 Diabetes Mellitus, T2DM, GLP-1, GLP-1 Once weekly, Exenatide|type 2 diabetes mellitus, t2dm, glp-1, glp-1 once weekly, exenatide
121808|NCT02533414|kidney stone|kidney stone
121809|NCT02533414|retrograde intrarenal surgery|retrograde intrarenal surgery
121810|NCT02533414|ureteral access sheath|ureteral access sheath
121811|NCT02533414|kidney function|kidney function
121812|NCT02533388|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
121813|NCT02533388|stress response|stress response
121814|NCT02533375|efficacy|efficacy
121815|NCT02533375|safety|safety
121816|NCT02533349|laryngopharyngeal reflux disease|laryngopharyngeal reflux disease
121817|NCT02533349|prokinetics|prokinetics
121818|NCT02533349|proton pump inhibitor|proton pump inhibitor
121819|NCT02533336|Malaria control|malaria control
121820|NCT02533336|Insecticide treated durable Wall Liners|insecticide treated durable wall liners
121821|NCT02533336|Malaria incidence|malaria incidence
121822|NCT02533336|Randomized Trial|randomized trial
121823|NCT02533323|NK/T-cell lymphoma|nk/t-cell lymphoma
121824|NCT02533323|induction chemotherapy|induction chemotherapy
121825|NCT02533323|survival|survival
121826|NCT02533310|Specific phobia|specific phobia
121827|NCT02533310|Exposure therapy|exposure therapy
121828|NCT02533310|Virtual reality|virtual reality
121829|NCT02533310|Randomized controlled trial|randomized controlled trial
121830|NCT02533297|standardization,|standardization,
121831|NCT02533297|performance clinical skills|performance clinical skills
121832|NCT02533297|nursing|nursing
121833|NCT02533297|learning curve|learning curve
121834|NCT02533271|rectal cancer|rectal cancer
112980|NCT02587169|retroperitoneum|retroperitoneum
112981|NCT02587169|chondrosarcoma|chondrosarcoma
112982|NCT02587130|intractable pain|intractable pain
112983|NCT02587130|pressure ulcer|pressure ulcer
112984|NCT02587130|bed sore|bed sore
112985|NCT02587130|palliative medicine|palliative medicine
112986|NCT02587130|ketamine|ketamine
112987|NCT02587130|pain management|pain management
112999|NCT02587039|heart|heart
121835|NCT02533271|short-term radiotherapy|short-term radiotherapy
121836|NCT02533271|neoadjuvant chemotherapy|neoadjuvant chemotherapy
121837|NCT02533271|total mesorectal excision|total mesorectal excision
121838|NCT02533258|advanced renal cell carcinoma, disease progression, sunitinib, interferon alpha|advanced renal cell carcinoma, disease progression, sunitinib, interferon alpha
121839|NCT02533245|Exercise Training|exercise training
121840|NCT02533245|Quality of Life|quality of life
121841|NCT02533245|Patient Reported Outcomes|patient reported outcomes
121842|NCT02533245|Organ Transplantation|organ transplantation
121843|NCT02533232|Schizophrenia|schizophrenia
121844|NCT02533232|Anti-inflammatory|anti-inflammatory
121845|NCT02533232|Clozapine|clozapine
121846|NCT02533232|Minocycline|minocycline
121847|NCT02533232|Psychosis NOS|psychosis nos
121848|NCT02533219|Hyperinsulinemic hypoglycemia|hyperinsulinemic hypoglycemia
121849|NCT02533219|PET/CT|pet/ct
121850|NCT02533219|PET/MRI|pet/mri
121851|NCT02533219|[18F]-DOPA|[18f]-dopa
121852|NCT02533219|PET/MR|pet/mr
121853|NCT02533219|Congenital Hyperinsulinism|congenital hyperinsulinism
121854|NCT02533193|enhanced recovery after surgery protocal|enhanced recovery after surgery protocal
121855|NCT02533193|laparoscopic hepatectomy|laparoscopic hepatectomy
121856|NCT02533180|Liver allograft recipient|liver allograft recipient
122370|NCT02530463|AZA-CR|aza-cr
121857|NCT02533180|Immunosuppression withdrawal|immunosuppression withdrawal
121858|NCT02533180|Calcineurin inhibitor (CNI) based immunosuppression|calcineurin inhibitor (cni) based immunosuppression
121859|NCT02533180|Living Donor (of the Respective Liver Transplant Recipient)|living donor (of the respective liver transplant recipient)
121860|NCT02533141|Investigation of the changes of flicker induced vasodilatation before, during and after withdrawal of therapy with simvastatin|investigation of the changes of flicker induced vasodilatation before, during and after withdrawal of therapy with simvastatin
121861|NCT02533128|Intraoperative blood pressure|intraoperative blood pressure
121863|NCT02533128|Anesthetic overdose|anesthetic overdose
121864|NCT02533128|Major adverse cardiac events (MACE)|major adverse cardiac events (mace)
121865|NCT02533128|Myocardial injury after noncardiac surgery (MINS)|myocardial injury after noncardiac surgery (mins)
121866|NCT02533128|Perioperative risk stratification|perioperative risk stratification
121867|NCT02533128|Brain-type natriuretic peptide (BNP)|brain-type natriuretic peptide (bnp)
121868|NCT02533128|High-sensitivity cardiac Troponin I (hs-cTnI)|high-sensitivity cardiac troponin i (hs-ctni)
121869|NCT02533115|VYXEOS|vyxeos
121870|NCT02533102|Pharmacokinetics|pharmacokinetics
121871|NCT02533102|E7050|e7050
121872|NCT02533102|Healthy Subjects|healthy subjects
121873|NCT02533050|obstructive sleep apnea|obstructive sleep apnea
121874|NCT02533050|acute coronary event|acute coronary event
121875|NCT02533050|cognitive functions|cognitive functions
121876|NCT02533050|Continuous positive airway pressure night|continuous positive airway pressure night
121877|NCT02533011|Sepsis|sepsis
121878|NCT02533011|Heparin Binding Protein|heparin binding protein
121879|NCT02532998|Pharmacodynamics|pharmacodynamics
121880|NCT02532998|AZD9977|azd9977
121881|NCT02532998|Safety|safety
121882|NCT02532998|Tolerability|tolerability
121883|NCT02532998|Pharmacokinetics|pharmacokinetics
121884|NCT02532998|Eplerenone|eplerenone
121885|NCT02532998|Fludrocortisone|fludrocortisone
121886|NCT02532985|Gastrointestinal tolerability|gastrointestinal tolerability
121887|NCT02532985|dietary fiber|dietary fiber
121888|NCT02532985|clinical trial|clinical trial
121889|NCT02532985|healthy subjects|healthy subjects
121890|NCT02532933|Replacement, Knee|replacement, knee
121891|NCT02532920|Natural history|natural history
121892|NCT02532920|Atopic dermatitis|atopic dermatitis
121893|NCT02532920|Atopic march|atopic march
121895|NCT02532894|endothelial dysfunction|endothelial dysfunction
121896|NCT02532894|microvesicles|microvesicles
121897|NCT02532894|endothelial progenitor cells|endothelial progenitor cells
121898|NCT02532894|electronic cigarettes|electronic cigarettes
121899|NCT02532842|Schizophrenia|schizophrenia
121900|NCT02532842|Paliperidone palmitate|paliperidone palmitate
121901|NCT02532816|stunting|stunting
121902|NCT02532816|indonesia|indonesia
121903|NCT02532803|Cancer|cancer
121904|NCT02532803|Rectum|rectum
121905|NCT02532803|Rectal Cancer|rectal cancer
121906|NCT02532803|Polyps|polyps
121907|NCT02532790|Mild proteinuria|mild proteinuria
121908|NCT02532764|cystic fibrosis|cystic fibrosis
146324|NCT02392637|ABI-007|abi-007
121909|NCT02532764|ΔF508|δf508
121910|NCT02532764|RNA therapies|rna therapies
121911|NCT02532764|antisense oligonucleotide|antisense oligonucleotide
121912|NCT02532764|CFTR|cftr
121913|NCT02532764|F508del|f508del
121914|NCT02532764|CF|cf
121915|NCT02532764|RNA therapy|rna therapy
121916|NCT02532738|efficacy of MSC|efficacy of msc
121917|NCT02532738|refractory|refractory
121918|NCT02532725|heat stress response|heat stress response
121919|NCT02532725|cardiopulmonary exercise test|cardiopulmonary exercise test
121920|NCT02532725|men|men
121921|NCT02532725|middle aged|middle aged
121922|NCT02532725|heat-shock response|heat-shock response
121923|NCT02532712|EC-18|ec-18
121924|NCT02532712|Hematology|hematology
121925|NCT02532712|Cancer|cancer
121926|NCT02532712|Neutropenia|neutropenia
121927|NCT02532699|Antrodia cinnamomea mycelia|antrodia cinnamomea mycelia
121928|NCT02532699|blood pressure|blood pressure
121929|NCT02532699|adenosine|adenosine
121930|NCT02532699|antrosterol|antrosterol
121931|NCT02532699|clinical trial|clinical trial
121932|NCT02532699|gamma-aminobutyric acid|gamma-aminobutyric acid
121933|NCT02532686|Treatment resistant|treatment resistant
121934|NCT02532686|DAAOI|daaoi
121935|NCT02532686|NMDA|nmda
121936|NCT02532634|ramosetron|ramosetron
121937|NCT02532634|palonosetron|palonosetron
121938|NCT02532634|chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
121939|NCT02532582|nerve compression|nerve compression
121940|NCT02532530|Aortic valve replacement with or without CABG|aortic valve replacement with or without cabg
121941|NCT02532504|postnatal depression|postnatal depression
121942|NCT02532504|Cognitive behaviour Therapy|cognitive behaviour therapy
121943|NCT02532504|Traditional Birth Attendants|traditional birth attendants
121944|NCT02532504|low income country|low income country
121945|NCT02532491|Psychosis|psychosis
121946|NCT02532491|Antipsychotic Agents|antipsychotic agents
121947|NCT02532491|Treatment|treatment
121948|NCT02532491|Effectiveness|effectiveness
121949|NCT02532491|Aripiprazole|aripiprazole
121950|NCT02532491|Risperidone|risperidone
121951|NCT02532452|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
121952|NCT02532452|Adenovirus (ADV)|adenovirus (adv)
121953|NCT02532452|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
121954|NCT02532452|T-Cells|t-cells
121955|NCT02532452|Donor|donor
121956|NCT02532439|fracture osteoporosis|fracture osteoporosis
121957|NCT02532439|bone microarchitecture|bone microarchitecture
121958|NCT02532439|Inflammatory joint diseases|inflammatory joint diseases
121959|NCT02532439|Bone fragility|bone fragility
121960|NCT02532439|Rheumatoid Arthritis|rheumatoid arthritis
121961|NCT02532439|Spondyloarthritis|spondyloarthritis
121962|NCT02532439|Primary Hyperparathyroidism|primary hyperparathyroidism
121963|NCT02532439|constitutional thinness|constitutional thinness
121964|NCT02532439|anorexia nervosa|anorexia nervosa
121965|NCT02532426|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
121966|NCT02532426|Muscle biopsy|muscle biopsy
121967|NCT02532426|Chronic hypoxia|chronic hypoxia
121968|NCT02532426|OXYPHEN|oxyphen
121969|NCT02532426|Oxydative phenotype|oxydative phenotype
121970|NCT02532426|Exercise|exercise
121971|NCT02532400|Breast Neoplasms|breast neoplasms
121972|NCT02532400|Neoadjuvant Endocrine Therapy|neoadjuvant endocrine therapy
121973|NCT02532400|Ovarian Function Suppression|ovarian function suppression
121974|NCT02532400|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
121975|NCT02532374|nicotine absorption|nicotine absorption
121976|NCT02532374|nicotine containing product|nicotine containing product
121977|NCT02532374|adult smoker|adult smoker
121978|NCT02532374|Nicorette|nicorette
121979|NCT02532374|nicotine delivery system|nicotine delivery system
121980|NCT02532361|Sterilization|sterilization
121981|NCT02532361|Hysteroscopic Device Placement|hysteroscopic device placement
121982|NCT02532361|Tubal Ligation|tubal ligation
121983|NCT02532348|Human Immunodeficiency Virus|human immunodeficiency virus
121984|NCT02532348|HIV|hiv
121985|NCT02532348|antiretroviral therapy|antiretroviral therapy
121986|NCT02532348|platelets|platelets
121987|NCT02532348|Immune activation|immune activation
121988|NCT02532348|Inflammatory state|inflammatory state
121989|NCT02532335|FXR|fxr
121990|NCT02532335|bile acids|bile acids
121991|NCT02532335|FGF19|fgf19
121992|NCT02532335|C4|c4
121993|NCT02532335|gut microbiota|gut microbiota
122101|NCT02531945|cobb angle|cobb angle
121994|NCT02532335|Pharmacodynamics of FXR activation in the small bowel|pharmacodynamics of fxr activation in the small bowel
121995|NCT02532309|Rosuvastatin|rosuvastatin
122128|NCT02531815|pharmacokinetics|pharmacokinetics
121996|NCT02532309|Carotid Atherosclerosis plaque|carotid atherosclerosis plaque
121997|NCT02532309|Crestor|crestor
121998|NCT02532309|Rosuvastatin calcium|rosuvastatin calcium
121999|NCT02532283|Influenza A virus|influenza a virus
122000|NCT02532283|JNJ-63623872|jnj-63623872
122001|NCT02532283|Oseltamivir|oseltamivir
122002|NCT02532270|obstetric|obstetric
122003|NCT02532270|anesthesia|anesthesia
113184|NCT02585895|Hypercholesterolemia|hypercholesterolemia
113185|NCT02585895|Elevated Cholesterol|elevated cholesterol
122004|NCT02532270|hypotension|hypotension
122005|NCT02532270|arterial pressure|arterial pressure
122006|NCT02532270|measurement techniques|measurement techniques
122007|NCT02532257|Lymphoma|lymphoma
122008|NCT02532257|Follicular Lymphoma|follicular lymphoma
122009|NCT02532257|FL|fl
122010|NCT02532257|Previously untreated|previously untreated
122011|NCT02532257|Lenalidomide|lenalidomide
122012|NCT02532257|CC-5013|cc-5013
122013|NCT02532257|Revlimid|revlimid
122014|NCT02532257|Rituximab|rituximab
122015|NCT02532257|Rituxan|rituxan
122016|NCT02532257|Ibrutinib|ibrutinib
122017|NCT02532257|PCI-32765|pci-32765
122018|NCT02532257|Imbruvica|imbruvica
122019|NCT02532244|distal hereditary motor neuronopathy|distal hereditary motor neuronopathy
122020|NCT02532231|Leukemia|leukemia
122021|NCT02532231|Acute myeloid leukemia|acute myeloid leukemia
122022|NCT02532231|AML|aml
122023|NCT02532231|High risk for relapse|high risk for relapse
122024|NCT02532231|Nivolumab|nivolumab
122025|NCT02532231|BMS-936558|bms-936558
122026|NCT02532231|Opdivo|opdivo
122027|NCT02532192|Lymphoma|lymphoma
122028|NCT02532192|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
122029|NCT02532192|DLBCL|dlbcl
122030|NCT02532192|Relapsed|relapsed
122031|NCT02532192|Refractory|refractory
122032|NCT02532192|Belinostat|belinostat
122033|NCT02532192|Rituximab|rituximab
122034|NCT02532192|Rituxan|rituxan
122035|NCT02532192|Cisplatin|cisplatin
122036|NCT02532192|Platinol-AQ|platinol-aq
122037|NCT02532192|Platinol|platinol
122038|NCT02532192|CDDP|cddp
122039|NCT02532192|Cytarabine|cytarabine
122040|NCT02532192|Ara-C|ara-c
122041|NCT02532192|Cytosar|cytosar
122042|NCT02532192|DepoCyt|depocyt
122043|NCT02532192|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
122044|NCT02532192|Dexamethasone|dexamethasone
122045|NCT02532192|Decadron|decadron
122046|NCT02532192|Ciprofloxacin|ciprofloxacin
122047|NCT02532192|Ciprofloxacin hydrochloride|ciprofloxacin hydrochloride
122048|NCT02532192|Cipro|cipro
122049|NCT02532192|Fluconazole|fluconazole
122050|NCT02532192|Diflucan|diflucan
122371|NCT02530463|Ladakamycin|ladakamycin
122051|NCT02532179|subcutaneous immunotherapy (SCIT)|subcutaneous immunotherapy (scit)
122052|NCT02532179|glycerinated mouse allergenic extract|glycerinated mouse allergenic extract
122053|NCT02532179|mouse specific IgE|mouse specific ige
122054|NCT02532179|mouse specific IgG and IgG4|mouse specific igg and igg4
122055|NCT02532179|mouse prick skin test wheal|mouse prick skin test wheal
122056|NCT02532166|narrow band imaging|narrow band imaging
122058|NCT02532166|Lugol|lugol
122059|NCT02532153|Suicidal Ideation|suicidal ideation
122060|NCT02532153|Suicide|suicide
122061|NCT02532153|Suicidal Thoughts|suicidal thoughts
122062|NCT02532153|Depression|depression
122063|NCT02532153|Ketamine|ketamine
122064|NCT02532127|Low-dose risk|low-dose risk
122065|NCT02532075|COPD|copd
122066|NCT02532075|Respiratory Muscle Warm Up|respiratory muscle warm up
122067|NCT02532062|lung cancer risk|lung cancer risk
122068|NCT02532062|cigarette smokers|cigarette smokers
122069|NCT02532049|Malaria|malaria
122070|NCT02532049|Vaccine|vaccine
122071|NCT02532049|Immune Response|immune response
122072|NCT02532036|MVA85A|mva85a
122073|NCT02532036|Tuberculosis|tuberculosis
122074|NCT02532036|Vaccine|vaccine
122075|NCT02532036|Aerosol|aerosol
122076|NCT02532023|omega 3 fatty acid|omega 3 fatty acid
122077|NCT02532023|curcumin|curcumin
122078|NCT02532023|COX-2|cox-2
122079|NCT02532023|iNOs|inos
122080|NCT02532023|VCAM-1|vcam-1
122081|NCT02532023|ICAM-1|icam-1
122082|NCT02532023|IL-1β|il-1β
122083|NCT02532023|IL-6|il-6
122084|NCT02532023|TNF-α|tnf-α
122085|NCT02532023|hsCRP|hscrp
122086|NCT02532023|migraine|migraine
122087|NCT02531997|self-image|self-image
122088|NCT02531997|sexual health|sexual health
122089|NCT02531997|breast cancer|breast cancer
122090|NCT02531997|gynecologic cancer|gynecologic cancer
122091|NCT02531997|ovarian cancer|ovarian cancer
122092|NCT02531997|cervical cancer|cervical cancer
122093|NCT02531997|uterine cancer|uterine cancer
122094|NCT02531997|mind body|mind body
122095|NCT02531997|hypnotic relaxation therapy|hypnotic relaxation therapy
122096|NCT02531997|hypnosis|hypnosis
122097|NCT02531997|progressive muscle relaxation|progressive muscle relaxation
122098|NCT02531971|Bioequivalence|bioequivalence
122099|NCT02531971|Therapeutic Equivalency|therapeutic equivalency
122100|NCT02531945|topography|topography
122102|NCT02531932|advanced triple negative breast cancer|advanced triple negative breast cancer
122103|NCT02531919|tumor acidity|tumor acidity
122104|NCT02531893|Irritability|irritability
122105|NCT02531893|Disruptive Mood|disruptive mood
122106|NCT02531893|Tantrums|tantrums
122107|NCT02531893|Frustration|frustration
122108|NCT02531893|Interpretation Bias|interpretation bias
122109|NCT02531893|Emotional Judgment|emotional judgment
122110|NCT02531893|Cognitive-Behavioral|cognitive-behavioral
122111|NCT02531893|Exposure|exposure
122112|NCT02531893|Research Psychotherapy|research psychotherapy
122114|NCT02531880|Manganese Enhanced MRI|manganese enhanced mri
122115|NCT02531880|Seizure Disorder|seizure disorder
122116|NCT02531880|Seizures|seizures
122117|NCT02531880|Epileptic Focus|epileptic focus
122118|NCT02531867|HPP|hpp
122119|NCT02531867|Bone Disease|bone disease
122120|NCT02531867|Soft Bones|soft bones
122121|NCT02531867|Low Alkaline Phosphatase|low alkaline phosphatase
122122|NCT02531867|Genetic Metabolic Disorder|genetic metabolic disorder
122123|NCT02531867|Alkaline Phosphatase|alkaline phosphatase
122124|NCT02531867|Rickets|rickets
122125|NCT02531867|Osteomalacia|osteomalacia
122126|NCT02531815|safety|safety
122127|NCT02531815|tolerability|tolerability
122129|NCT02531815|pharmacodynamics|pharmacodynamics
122130|NCT02531815|Phase 1|phase 1
122131|NCT02531815|first in human|first in human
122132|NCT02531815|monoclonal antibody|monoclonal antibody
122133|NCT02531815|tissue factor pathway inhibitor|tissue factor pathway inhibitor
122134|NCT02531815|japanese|japanese
122135|NCT02531802|ETEC diarrhea|etec diarrhea
122136|NCT02531802|Escherichia Coli (ETEC)|escherichia coli (etec)
122137|NCT02531776|Diabetes|diabetes
122138|NCT02531776|Needle|needle
122139|NCT02531776|Pen needle|pen needle
122140|NCT02531763|mHealth|mhealth
122141|NCT02531763|behavioral economics|behavioral economics
122142|NCT02531763|social incentives|social incentives
122143|NCT02531750|Metabolism|metabolism
122144|NCT02531750|Bone metabolism|bone metabolism
122145|NCT02531750|Glucose Metabolism|glucose metabolism
122146|NCT02531750|Lipid metabolism|lipid metabolism
122147|NCT02531750|Low grade inflamation|low grade inflamation
122148|NCT02531724|acute kidney injury|acute kidney injury
122149|NCT02531724|cardiac surgery|cardiac surgery
122150|NCT02531724|renal blood flow|renal blood flow
122151|NCT02531724|levosimendan|levosimendan
122152|NCT02531711|Lumbosacral|lumbosacral
122153|NCT02531711|radicular|radicular
122154|NCT02531685|dmLT|dmlt
122155|NCT02531685|Enteric|enteric
122156|NCT02531685|Escherichia coli Infections|escherichia coli infections
122157|NCT02531685|Shigella|shigella
122158|NCT02531685|Toxin LTR192G/L211A|toxin ltr192g/l211a
122159|NCT02531672|11C-choline|11c-choline
122261|NCT02530788|Heart Failure|heart failure
122160|NCT02531672|Positron Emission Tomography|positron emission tomography
122161|NCT02531672|15-117|15-117
122162|NCT02531646|pulmonary nodule|pulmonary nodule
122163|NCT02531633|Giant Cell Arteritis, Sirukumab, Prednisone|giant cell arteritis, sirukumab, prednisone
122164|NCT02531620|prehabilitation|prehabilitation
122165|NCT02531620|colorectal surgery|colorectal surgery
122166|NCT02531555|chronic periodontitis|chronic periodontitis
122167|NCT02531555|dental scaling|dental scaling
122168|NCT02531555|gingival crevicular fluid|gingival crevicular fluid
122169|NCT02531555|lasers|lasers
122170|NCT02531555|periodontal pocket|periodontal pocket
122171|NCT02531555|root planing|root planing
122172|NCT02531516|Prostatic neoplasms|prostatic neoplasms
122173|NCT02531516|Prostate Cancer|prostate cancer
122174|NCT02531516|High-Risk prostate cancer|high-risk prostate cancer
122175|NCT02531516|JNJ-56021927|jnj-56021927
122176|NCT02531516|Apalutamide|apalutamide
122177|NCT02531516|ATLAS|atlas
122178|NCT02531516|Radiation|radiation
122179|NCT02531516|Long-term hormone therapy|long-term hormone therapy
122180|NCT02531516|Localized or locally advanced prostate cancer|localized or locally advanced prostate cancer
122181|NCT02531516|Janssen|janssen
122182|NCT02531503|Asthma remission|asthma remission
122183|NCT02531503|Predicting factors|predicting factors
122184|NCT02531503|Children|children
122185|NCT02531464|family caregiver|family caregiver
122186|NCT02531464|quality of life|quality of life
122187|NCT02531464|supportive care|supportive care
122188|NCT02531464|distress screening|distress screening
122189|NCT02531464|needs assessment|needs assessment
122190|NCT02531451|Muscle mass|muscle mass
122191|NCT02531451|strength|strength
122192|NCT02531451|NSAID|nsaid
122193|NCT02531451|Ibuprofen|ibuprofen
122194|NCT02531451|resistance exercise|resistance exercise
122195|NCT02531425|TNBC|tnbc
122196|NCT02531425|Triple Negative Breast Cancer|triple negative breast cancer
122197|NCT02531412|Acute kidney injury|acute kidney injury
122198|NCT02531412|Critically ill cancer patients|critically ill cancer patients
122199|NCT02531412|Spironolactone|spironolactone
122200|NCT02531399|flicker induced changes|flicker induced changes
122201|NCT02531399|total volumetric retinal blood flow|total volumetric retinal blood flow
122202|NCT02531308|diffuse large b-cell lymphoma (DLBCL),|diffuse large b-cell lymphoma (dlbcl),
122203|NCT02531308|lymphoma|lymphoma
122205|NCT02531282|Health promotion|health promotion
122206|NCT02531282|Patient participation|patient participation
122207|NCT02531282|Self efficacy|self efficacy
122208|NCT02531256|Laryngeal Mask Airway|laryngeal mask airway
122209|NCT02531243|prodrome|prodrome
122210|NCT02531243|family therapy|family therapy
122211|NCT02531243|clinical high risk|clinical high risk
122212|NCT02531204|ASP1585|asp1585
122213|NCT02531204|Bioequivalence|bioequivalence
122214|NCT02531204|Pharmacodynamic|pharmacodynamic
122215|NCT02531204|Phosphate binder|phosphate binder
122216|NCT02531204|Bixalomer|bixalomer
122217|NCT02531204|urinary phosphorus excretion|urinary phosphorus excretion
122218|NCT02531191|ASP015K|asp015k
122219|NCT02531191|JAK inhibitor|jak inhibitor
122220|NCT02531191|bioequivalence study|bioequivalence study
122221|NCT02531178|Rheumatoid Arthritis|rheumatoid arthritis
122222|NCT02531139|Cerebrovascular Circulation|cerebrovascular circulation
122223|NCT02531139|Anesthesia|anesthesia
122224|NCT02531139|Blood pressure|blood pressure
122225|NCT02531139|Peripheral Arterial Diseases|peripheral arterial diseases
122226|NCT02531074|Mobile Applications|mobile applications
122227|NCT02531061|Rheumatoid Arthritis|rheumatoid arthritis
122228|NCT02531061|bDMARDs|bdmards
122229|NCT02531061|biotherapy|biotherapy
122230|NCT02531061|remission|remission
122231|NCT02531061|erosion|erosion
122232|NCT02531048|healthy volunteers|healthy volunteers
122233|NCT02530957|Intubation|intubation
122234|NCT02530957|Preoxygenation|preoxygenation
122235|NCT02530957|Complications|complications
122236|NCT02530957|Non invasive ventilation|non invasive ventilation
122237|NCT02530957|High flow nasal cannula|high flow nasal cannula
122238|NCT02530944|Lupus|lupus
122239|NCT02530944|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
122240|NCT02530944|genetic|genetic
122241|NCT02530944|online|online
122242|NCT02530944|genome wide association|genome wide association
122243|NCT02530944|systemic lupus erythematosus|systemic lupus erythematosus
122244|NCT02530944|genome wide association study (GWAS)|genome wide association study (gwas)
122246|NCT02530905|Duchenne muscular dystrophy|duchenne muscular dystrophy
122247|NCT02530905|Exon Skipping|exon skipping
122248|NCT02530892|embryo|embryo
122249|NCT02530892|in vitro fertilization|in vitro fertilization
122250|NCT02530892|IVF|ivf
122251|NCT02530840|imbalanced diabetic patients|imbalanced diabetic patients
122252|NCT02530840|HbA1c|hba1c
122253|NCT02530840|peers|peers
122254|NCT02530827|energy expenditure|energy expenditure
122255|NCT02530827|doubly labeled water|doubly labeled water
122256|NCT02530827|accelerometer|accelerometer
122257|NCT02530827|HIV|hiv
122258|NCT02530827|lipodystrophy syndrome.|lipodystrophy syndrome.
122259|NCT02530814|organochlorine compounds|organochlorine compounds
122260|NCT02530814|pesticides|pesticides
122262|NCT02530788|Cardiac Surgery|cardiac surgery
122263|NCT02530788|Ventricular Assist Device|ventricular assist device
122264|NCT02530788|Selenium|selenium
122265|NCT02530762|Gastrointestinal tolerability|gastrointestinal tolerability
122266|NCT02530762|dietary fiber|dietary fiber
122267|NCT02530762|clinical trial|clinical trial
122268|NCT02530762|healthy subjects|healthy subjects
122269|NCT02530749|Surgery|surgery
122270|NCT02530749|Frailty|frailty
122271|NCT02530736|Gait speed|gait speed
122272|NCT02530736|Pulmonary Rehabilitation|pulmonary rehabilitation
122273|NCT02530723|power training|power training
122274|NCT02530723|high-speed training|high-speed training
122275|NCT02530723|high-velocity training|high-velocity training
122276|NCT02530723|function|function
122277|NCT02530723|older adults|older adults
122278|NCT02530723|older women|older women
122279|NCT02530697|Leishmaniasis|leishmaniasis
122280|NCT02530697|Mucocutaneous|mucocutaneous
122281|NCT02530697|Miltefosine|miltefosine
122282|NCT02530697|Pentoxifylline|pentoxifylline
122283|NCT02530671|multi-directional power toothbrush|multi-directional power toothbrush
122284|NCT02530671|manual toothbrush|manual toothbrush
122285|NCT02530658|Genetic Predisposition|genetic predisposition
122286|NCT02530658|Pediatric|pediatric
122287|NCT02530658|Genomic Analysis|genomic analysis
122288|NCT02530658|Heritable Disease|heritable disease
122289|NCT02530658|Cancer Risk|cancer risk
122290|NCT02530658|Genetic Counseling|genetic counseling
122291|NCT02530658|DNA|dna
122292|NCT02530658|Clinical Genomics|clinical genomics
122293|NCT02530658|Clinical Decision-Making|clinical decision-making
122294|NCT02530658|Treatment Planning|treatment planning
122295|NCT02530632|microperfusion|microperfusion
122296|NCT02530632|temperature|temperature
122297|NCT02530632|near-infrared spectroscopy|near-infrared spectroscopy
122298|NCT02530632|anesthesia|anesthesia
122299|NCT02530632|total intravenous anaesthesia|total intravenous anaesthesia
122300|NCT02530580|GABA modulator|gaba modulator
122301|NCT02530580|AZD7325|azd7325
122302|NCT02530580|Object manipulation|object manipulation
122303|NCT02530580|Cutaneous sensation|cutaneous sensation
122304|NCT02530580|Manual dexterity|manual dexterity
122305|NCT02530567|portal pressure|portal pressure
122306|NCT02530567|portosystemic pressure gradient|portosystemic pressure gradient
122307|NCT02530567|azygos blood flow|azygos blood flow
122308|NCT02530554|Pilot Projects|pilot projects
122309|NCT02530515|Leukemia|leukemia
122310|NCT02530515|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
122311|NCT02530515|CLL|cll
122312|NCT02530515|T-cells|t-cells
122313|NCT02530515|Immune cells|immune cells
122314|NCT02530515|Rituximab|rituximab
122315|NCT02530515|Rituxan|rituxan
122316|NCT02530515|Cyclophosphamide|cyclophosphamide
122317|NCT02530515|Cytoxan|cytoxan
122318|NCT02530515|Neosar|neosar
122319|NCT02530515|Fludarabine Phosphate|fludarabine phosphate
122320|NCT02530515|Fludarabine|fludarabine
122321|NCT02530515|Fludara|fludara
122322|NCT02530515|Bendamustine|bendamustine
122323|NCT02530515|Bendamustine Hydrochloride|bendamustine hydrochloride
122324|NCT02530515|Bendamustine HCL|bendamustine hcl
122325|NCT02530515|CEP-18083|cep-18083
122326|NCT02530515|SDX-105|sdx-105
122327|NCT02530515|Treanda|treanda
122328|NCT02530515|Lenalidomide|lenalidomide
122329|NCT02530515|CC-5013|cc-5013
122330|NCT02530515|Revlimid|revlimid
122331|NCT02530489|Breast Cancer|breast cancer
122332|NCT02530489|Triple negative breast cancer|triple negative breast cancer
122333|NCT02530489|TNBC|tnbc
122334|NCT02530489|Invasive adenocarcinoma of the breast|invasive adenocarcinoma of the breast
122335|NCT02530489|MPDL3280A|mpdl3280a
122336|NCT02530489|Nab-paclitaxel|nab-paclitaxel
122337|NCT02530489|Paclitaxel|paclitaxel
122338|NCT02530489|Abraxane|abraxane
122339|NCT02530489|ABI-007|abi-007
122340|NCT02530476|Leukemia|leukemia
122341|NCT02530476|Acute myeloid leukemia|acute myeloid leukemia
122342|NCT02530476|AML|aml
122343|NCT02530476|Relapsed/Refractory|relapsed/refractory
122344|NCT02530476|FLT3-ITD mutation|flt3-itd mutation
122345|NCT02530476|FLT3-mutated high-risk myelodysplastic syndrome|flt3-mutated high-risk myelodysplastic syndrome
122346|NCT02530476|MDS|mds
122347|NCT02530476|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
122348|NCT02530476|CMML|cmml
122349|NCT02530476|Selinexor|selinexor
122350|NCT02530476|KPT-330|kpt-330
122351|NCT02530476|Sorafenib|sorafenib
122352|NCT02530476|Nexavar|nexavar
122353|NCT02530476|BAY 43-9006|bay 43-9006
122354|NCT02530476|FLT3-inhibitor therapy|flt3-inhibitor therapy
122355|NCT02530463|Leukemia|leukemia
122356|NCT02530463|Myelodysplastic syndrome|myelodysplastic syndrome
122357|NCT02530463|MDS|mds
122358|NCT02530463|Nivolumab|nivolumab
122359|NCT02530463|BMS-936558|bms-936558
122360|NCT02530463|Opdivo|opdivo
122361|NCT02530463|Ipilimumab|ipilimumab
122362|NCT02530463|Yervoy|yervoy
122363|NCT02530463|BMS-734016|bms-734016
122364|NCT02530463|MDX010|mdx010
122365|NCT02530463|5-azacitidine|5-azacitidine
122366|NCT02530463|Azacitidine|azacitidine
122367|NCT02530463|5-AZA|5-aza
122368|NCT02530463|Vidaza|vidaza
122372|NCT02530463|NSC-102816|nsc-102816
122373|NCT02530463|Azacytidine|azacytidine
122374|NCT02530450|children|children
122375|NCT02530450|poor adherence|poor adherence
122376|NCT02530450|continuous glucose monitoring|continuous glucose monitoring
122377|NCT02530437|Esophageal Cancer|esophageal cancer
122378|NCT02530437|Adenocarcinoma of the Esophagus|adenocarcinoma of the esophagus
122379|NCT02530437|Adenocarcinoma of the Gastroesophageal Junction|adenocarcinoma of the gastroesophageal junction
122380|NCT02530437|Chemoradiation|chemoradiation
122381|NCT02530437|LY2940680|ly2940680
122382|NCT02530437|Paclitaxel (Protein-Bound)|paclitaxel (protein-bound)
122384|NCT02530437|Carboplatin|carboplatin
122385|NCT02530437|Paraplatin|paraplatin
122386|NCT02530437|Radiation therapy|radiation therapy
122388|NCT02530437|External beam|external beam
122389|NCT02530437|Endoscopy|endoscopy
122390|NCT02530424|HER2-positive|her2-positive
122391|NCT02530424|ER-positive|er-positive
122392|NCT02530424|invasive|invasive
122393|NCT02530424|CDK4,6|cdk4,6
122394|NCT02530424|Palbociclib|palbociclib
122395|NCT02530424|neoadjuvant treatment|neoadjuvant treatment
122396|NCT02530411|Hormone resistance|hormone resistance
122397|NCT02530411|vandetanib|vandetanib
122398|NCT02530411|fulvestrant|fulvestrant
122399|NCT02530359|septic acute kidney injury|septic acute kidney injury
122400|NCT02530359|pirfenidone|pirfenidone
122401|NCT02530320|Palbociclib|palbociclib
122402|NCT02530320|oligodendroglioma|oligodendroglioma
122403|NCT02530320|oligoastrocytoma anaplastic|oligoastrocytoma anaplastic
122404|NCT02530307|Stroke,|stroke,
122405|NCT02530307|Rehabilitation|rehabilitation
122406|NCT02530307|Ischemic|ischemic
122407|NCT02530307|fMRI|fmri
122408|NCT02530268|psoriatic arthritis|psoriatic arthritis
122409|NCT02530268|spondyloarthritis|spondyloarthritis
122410|NCT02530268|disease registry|disease registry
122411|NCT02530255|retinal amyloid|retinal amyloid
122412|NCT02530255|Retinal amyloid index|retinal amyloid index
122413|NCT02530255|Alzheimer disease|alzheimer disease
122414|NCT02530255|telomere attrition|telomere attrition
122415|NCT02530255|telomere activation|telomere activation
122416|NCT02530242|Sickle Cell Anemia|sickle cell anemia
122417|NCT02530229|periprosthetic joint infection|periprosthetic joint infection
122418|NCT02530229|septic arthritis|septic arthritis
122419|NCT02530203|post-operative atrial fibrillation|post-operative atrial fibrillation
113594|NCT02582879|CLL|cll
122420|NCT02530203|spinal cord stimulation|spinal cord stimulation
122421|NCT02530203|CABG|cabg
122422|NCT02530177|Alopecia|alopecia
122423|NCT02530177|Skin Aging|skin aging
122424|NCT02530177|Nail Changes|nail changes
122425|NCT02530177|Hair Changes|hair changes
122426|NCT02530177|15-198|15-198
122427|NCT02530164|tDCS|tdcs
122428|NCT02530164|SSRI|ssri
122429|NCT02530151|Hip arthroscopy|hip arthroscopy
122430|NCT02530151|Intra-articular injection|intra-articular injection
122431|NCT02530151|Morphine|morphine
122432|NCT02530151|Clonidine|clonidine
122433|NCT02530073|congenital diaphragmatic hernia|congenital diaphragmatic hernia
122434|NCT02530073|FETO|feto
122435|NCT02530073|tracheal occlusion|tracheal occlusion
122436|NCT02530060|Healthy|healthy
122437|NCT02530060|Rilpivirine|rilpivirine
122438|NCT02530060|Tenofovir|tenofovir
122439|NCT02530060|Emtricitabine|emtricitabine
122440|NCT02530060|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
122441|NCT02530047|Ovarian cancer|ovarian cancer
122442|NCT02530047|Epithelial ovarian cancer|epithelial ovarian cancer
122443|NCT02530047|Mesenchymal Stem Cells Secreting Interferon Beta|mesenchymal stem cells secreting interferon beta
122444|NCT02530047|MSC-INFb|msc-infb
122445|NCT02530047|Questionnaires|questionnaires
122446|NCT02530047|Surveys|surveys
122447|NCT02530034|Leukemia|leukemia
122448|NCT02530034|Advanced Hematologic Malignancies|advanced hematologic malignancies
122449|NCT02530034|Myelodysplastic syndrome|myelodysplastic syndrome
122451|NCT02530034|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
122452|NCT02530034|CMML|cmml
122453|NCT02530034|Acute myeloid leukemia|acute myeloid leukemia
122454|NCT02530034|AML|aml
122455|NCT02530034|Myelofibrosis|myelofibrosis
122456|NCT02530034|Hu8F4|hu8f4
122457|NCT02530021|Ischemic heart disease|ischemic heart disease
122458|NCT02530021|Heart rate variability|heart rate variability
122459|NCT02530021|Exercise Strss Test|exercise strss test
122460|NCT02529956|Psoriasis|psoriasis
122461|NCT02529956|UCB4940|ucb4940
122462|NCT02529943|Spinal Stenosis|spinal stenosis
122463|NCT02529943|Motor Evoked Potential|motor evoked potential
122464|NCT02529930|HSIL|hsil
122465|NCT02529930|CIN 2/3|cin 2/3
122466|NCT02529930|Therapeutic DNA vaccine|therapeutic dna vaccine
122467|NCT02529930|Human Papillomavirus|human papillomavirus
122468|NCT02529930|Immunotherapy|immunotherapy
122469|NCT02529891|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
122470|NCT02529891|COPD|copd
122471|NCT02529891|Volatile Organic Compounds|volatile organic compounds
122472|NCT02529891|Exacerbation|exacerbation
122473|NCT02529878|gastric caner|gastric caner
122474|NCT02529878|Apatinib|apatinib
122475|NCT02529878|S1|s1
122476|NCT02529878|conversion therapy|conversion therapy
122477|NCT02529878|metastatic gastric cancer|metastatic gastric cancer
122478|NCT02529865|Cell Transplantation|cell transplantation
122479|NCT02529852|Lymphoma|lymphoma
122480|NCT02529852|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
122481|NCT02529852|DLBCL|dlbcl
122482|NCT02529852|Lenalidomide|lenalidomide
122483|NCT02529852|CC-5013|cc-5013
122484|NCT02529852|Revlimid|revlimid
122485|NCT02529852|Obinutuzumab|obinutuzumab
122486|NCT02529852|GA101|ga101
122487|NCT02529852|Gazyva|gazyva
122488|NCT02529852|Cyclophosphamide|cyclophosphamide
122489|NCT02529852|Cytoxan|cytoxan
122490|NCT02529852|Neosar|neosar
122491|NCT02529852|Doxorubicin|doxorubicin
122492|NCT02529852|Doxorubicin Hydrochloride|doxorubicin hydrochloride
122493|NCT02529852|Adriamycin PFS|adriamycin pfs
122494|NCT02529852|Adriamycin RDF|adriamycin rdf
122495|NCT02529852|Adriamycin|adriamycin
122496|NCT02529852|Rubex|rubex
122497|NCT02529852|Vincristine|vincristine
122498|NCT02529852|Prednisone|prednisone
122499|NCT02529839|MS|ms
122500|NCT02529839|BMT|bmt
122501|NCT02529826|Cancer-affected prepubertal boys|cancer-affected prepubertal boys
122502|NCT02529813|Leukemia|leukemia
122503|NCT02529813|Lymphoma|lymphoma
122504|NCT02529813|Advanced Lymphoid Malignancies|advanced lymphoid malignancies
122505|NCT02529813|CD19+ lymphoid malignancy|cd19+ lymphoid malignancy
122506|NCT02529813|Multiple myeloma|multiple myeloma
122507|NCT02529813|MM|mm
122508|NCT02529813|CD19-specific T cells|cd19-specific t cells
122509|NCT02529813|Chimeric Antigen Receptor T cells|chimeric antigen receptor t cells
122510|NCT02529813|CAR T cells|car t cells
122511|NCT02529813|Autologous|autologous
122512|NCT02529813|Allogeneic|allogeneic
122513|NCT02529813|Fludarabine|fludarabine
122514|NCT02529813|Fludarabine phosphate|fludarabine phosphate
122515|NCT02529813|Cyclophosphamide|cyclophosphamide
122516|NCT02529813|Cytoxan|cytoxan
122517|NCT02529813|Neosar|neosar
122518|NCT02529813|nonviral|nonviral
122519|NCT02529813|non-viral|non-viral
122520|NCT02529813|DNA plasmids|dna plasmids
122522|NCT02529761|sorafenib|sorafenib
122523|NCT02529761|TACE|tace
122524|NCT02529761|overall survival|overall survival
113674|NCT02582528|youth|youth
113675|NCT02582528|mental health|mental health
113676|NCT02582528|functional outcome|functional outcome
113677|NCT02582515|d-cycloserine|d-cycloserine
113678|NCT02582515|comprehensive behavioral intervention for tics|comprehensive behavioral intervention for tics
122525|NCT02529696|accelerometer|accelerometer
122526|NCT02529696|RASS|rass
122527|NCT02529683|Nuvaring|nuvaring
122528|NCT02529683|contraceptive vaginal ring|contraceptive vaginal ring
122529|NCT02529683|Kenya|kenya
122530|NCT02529683|adherence|adherence
122531|NCT02529683|acceptability|acceptability
122532|NCT02529683|immunological effects|immunological effects
122533|NCT02529670|Low Level Laser Therapy|low level laser therapy
122534|NCT02529670|Low Back Pain|low back pain
122535|NCT02529670|Diagnosis|diagnosis
122536|NCT02529670|Genetic|genetic
122537|NCT02529670|Clinical trial|clinical trial
122538|NCT02529657|Lower Level Laser Therapy (LLLT)|lower level laser therapy (lllt)
122539|NCT02529657|inflammation|inflammation
122540|NCT02529657|cytokines|cytokines
122541|NCT02529657|wound healing|wound healing
122542|NCT02529657|laminectomy|laminectomy
122543|NCT02529657|clinical study|clinical study
122544|NCT02529644|HIV Screening|hiv screening
122545|NCT02529644|African American|african american
122546|NCT02529644|Church|church
122547|NCT02529631|Polyglucosamine|polyglucosamine
122548|NCT02529631|L 112|l 112
122549|NCT02529631|overweight,|overweight,
122550|NCT02529631|obesity|obesity
122551|NCT02529631|orlistat|orlistat
122552|NCT02529631|weight reduction|weight reduction
122553|NCT02529605|dietary supplement|dietary supplement
122554|NCT02529605|pharmacokinetics|pharmacokinetics
122555|NCT02529605|Healthy Volunteers|healthy volunteers
122556|NCT02529592|Sickness behavior|sickness behavior
122557|NCT02529592|Cytokines|cytokines
122558|NCT02529592|Psychoneuroimmunology|psychoneuroimmunology
122559|NCT02529579|adoptive Cellular Immunotherapy|adoptive cellular immunotherapy
122560|NCT02529579|patient safety|patient safety
122561|NCT02529579|therapeutic effect|therapeutic effect
651818|NCT00785005|Healthy|healthy
122562|NCT02529566|Lumbar Degenerative Disc Disease|lumbar degenerative disc disease
122563|NCT02529566|Degenerative Spinal Conditions|degenerative spinal conditions
122564|NCT02529566|Adjacent Segment Disease|adjacent segment disease
122565|NCT02529566|Autologous Bone Marrow|autologous bone marrow
122566|NCT02529566|Lower Back Pain|lower back pain
122567|NCT02529566|Chronic Lower Back Pain|chronic lower back pain
122568|NCT02529566|Stem Cells|stem cells
122569|NCT02529566|Lumbar disk|lumbar disk
122570|NCT02529566|Mesenchymal Stem Cells|mesenchymal stem cells
122571|NCT02529566|Stabilization|stabilization
122572|NCT02529566|CLBP|clbp
122573|NCT02529566|Autograft|autograft
122574|NCT02529566|Allograft|allograft
122575|NCT02529566|Autograft versus Allograft|autograft versus allograft
122576|NCT02529566|Facet Joint|facet joint
122577|NCT02529566|Radicular Pain|radicular pain
122578|NCT02529566|Adipose|adipose
122579|NCT02529566|Disc Replacement|disc replacement
122580|NCT02529566|Facet Joint Replacement|facet joint replacement
122581|NCT02529553|bladder cancer|bladder cancer
122582|NCT02529540|Myopia|myopia
122583|NCT02529540|self-refraction|self-refraction
122584|NCT02529540|glasses|glasses
122585|NCT02529540|spectacles|spectacles
122586|NCT02529514|Baclofen|baclofen
122587|NCT02529514|Cardiac Surgery|cardiac surgery
122588|NCT02529514|Polysomnography|polysomnography
122589|NCT02529514|Intensive Care Units|intensive care units
122590|NCT02529514|Sleep|sleep
122591|NCT02529449|ASP1941|asp1941
122592|NCT02529449|type 1 diabetes mellitus|type 1 diabetes mellitus
122593|NCT02529449|SGLT2 inhibitor|sglt2 inhibitor
122594|NCT02529436|overuse antidepressant|overuse antidepressant
122595|NCT02529436|dementia|dementia
122596|NCT02529423|food intake|food intake
122597|NCT02529423|food-related behaviour|food-related behaviour
122598|NCT02529423|obesity|obesity
122599|NCT02529423|socioeconomic environment|socioeconomic environment
122600|NCT02529423|depression|depression
122601|NCT02529423|nutritional strategies|nutritional strategies
122602|NCT02529397|Working Memory Training, Weight Loss,|working memory training, weight loss,
122603|NCT02529384|Breast magnetic resonance imaging|breast magnetic resonance imaging
122604|NCT02529384|Diffusion-weighted imaging|diffusion-weighted imaging
122605|NCT02529384|Multiple b-value diffusion weighted imaging|multiple b-value diffusion weighted imaging
122606|NCT02529358|Maintenance intervention|maintenance intervention
122607|NCT02529358|Text messages|text messages
122608|NCT02529358|Emotion Regulation|emotion regulation
122609|NCT02529332|Endoscopic Sellar/Parasellar Tumor Resection|endoscopic sellar/parasellar tumor resection
122610|NCT02529319|atrial fibrillation|atrial fibrillation
122611|NCT02529319|ablation|ablation
122612|NCT02529306|men|men
122613|NCT02529280|Latinas|latinas
122614|NCT02529280|Breast Cancer|breast cancer
122615|NCT02529280|Clinical Trials|clinical trials
122616|NCT02529280|Participation|participation
122617|NCT02529267|Cohort Studies|cohort studies
122618|NCT02529267|intimate partner violence|intimate partner violence
122619|NCT02529267|orthopaedic surgery|orthopaedic surgery
122620|NCT02529267|epidemiology|epidemiology
122621|NCT02529267|outcomes in fracture care|outcomes in fracture care
122622|NCT02529254|post graduate surgical education|post graduate surgical education
122623|NCT02529254|video coaching|video coaching
122624|NCT02529254|Surgical education|surgical education
122625|NCT02529254|coaching|coaching
122626|NCT02529202|Dexmedetomidine|dexmedetomidine
122627|NCT02529202|Neonate|neonate
122628|NCT02529202|Pharmacokinetics|pharmacokinetics
122629|NCT02529202|Therapeutic Hypothermia|therapeutic hypothermia
122630|NCT02529202|Hypoxic-ischemic Encephalopathy|hypoxic-ischemic encephalopathy
122631|NCT02529202|Adrenergic Agents|adrenergic agents
122632|NCT02529202|Adrenergic Agonists|adrenergic agonists
122633|NCT02529202|Analgesics|analgesics
122634|NCT02529202|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists
122635|NCT02529202|Central Nervous System Agents|central nervous system agents
122636|NCT02529202|Central Nervous System Depressants|central nervous system depressants
122637|NCT02529189|Stable Angina|stable angina
122638|NCT02529189|Angioplasty|angioplasty
122639|NCT02529189|Optical Coherence Tomography|optical coherence tomography
122640|NCT02529189|Nitrate|nitrate
122641|NCT02529176|telemetry|telemetry
122642|NCT02529176|cardiac monitoring|cardiac monitoring
122643|NCT02529163|Integrated Care Pathway|integrated care pathway
122644|NCT02529163|Acute Psychotic Episode|acute psychotic episode
122645|NCT02529163|Randomised Control Trial|randomised control trial
122646|NCT02529124|Ageing|ageing
122647|NCT02529124|Body Composition|body composition
122648|NCT02529124|Nutrition|nutrition
122649|NCT02529124|Physical Activity|physical activity
122650|NCT02529111|Atrial Septal Defects (ASD)|atrial septal defects (asd)
122651|NCT02529111|Percutaneous closure|percutaneous closure
122652|NCT02529098|functional magnetic resonance imaging|functional magnetic resonance imaging
122653|NCT02529098|Lens implantation|lens implantation
122654|NCT02529098|pseudophakia|pseudophakia
122655|NCT02529020|mouthguard|mouthguard
122656|NCT02529020|ventilation|ventilation
122657|NCT02529020|anaerobic power|anaerobic power
122658|NCT02529020|ergogenic effects|ergogenic effects
122659|NCT02529007|Colonoscopy|colonoscopy
122660|NCT02529007|early cancer detection|early cancer detection
122661|NCT02529007|cancer screening|cancer screening
122662|NCT02528994|Dietary supplements|dietary supplements
122663|NCT02528994|Metabolism|metabolism
122664|NCT02528981|GBS|gbs
122665|NCT02528981|Probiotics|probiotics
122666|NCT02528981|Group B Streptococcal|group b streptococcal
122667|NCT02528981|Pregnancy|pregnancy
122668|NCT02528968|Pharmacokinetic dosing|pharmacokinetic dosing
122669|NCT02528968|Haemophilia|haemophilia
122670|NCT02528955|Head and neck cancer|head and neck cancer
122671|NCT02528955|postoperative|postoperative
122672|NCT02528955|radiotherapy|radiotherapy
122673|NCT02528955|de-intensification|de-intensification
122674|NCT02528942|Lung cancer|lung cancer
122675|NCT02528942|Radiation therapy|radiation therapy
122676|NCT02528942|4DCT-ventilation imaging|4dct-ventilation imaging
122677|NCT02528890|group B streptococcus|group b streptococcus
122678|NCT02528890|GBS|gbs
122679|NCT02528864|biomarker|biomarker
122680|NCT02528864|cancer metabolism|cancer metabolism
122681|NCT02528864|chemical exchange saturation transfer|chemical exchange saturation transfer
122682|NCT02528864|endometrial cancer|endometrial cancer
122683|NCT02528864|diffusion-weighted imaging|diffusion-weighted imaging
122684|NCT02528864|magnetic resonance spectroscopy|magnetic resonance spectroscopy
122685|NCT02528864|uterine malignancy|uterine malignancy
122686|NCT02528851|CPAP|cpap
122687|NCT02528851|preterm|preterm
122688|NCT02528851|cardiac output|cardiac output
122689|NCT02528838|Myeloma|myeloma
122690|NCT02528838|Non-interventional|non-interventional
122691|NCT02528838|Observational|observational
122692|NCT02528838|Lenalidomide|lenalidomide
122693|NCT02528838|REVIEW|review
122694|NCT02528838|Post-authorization|post-authorization
122695|NCT02528838|Netherlands|netherlands
122696|NCT02528786|Drug therapy|drug therapy
122697|NCT02528734|pneumothorax|pneumothorax
122698|NCT02528708|fibrinogen concentrate|fibrinogen concentrate
122699|NCT02528708|coagulation|coagulation
122700|NCT02528695|18F-FDG PET/CT|18f-fdg pet/ct
122701|NCT02528695|Adipose tissue|adipose tissue
122702|NCT02528695|type 2 diabetes|type 2 diabetes
122703|NCT02528682|dendritic cells|dendritic cells
122704|NCT02528682|PD-L1/L2 silencing|pd-l1/l2 silencing
122705|NCT02528682|vaccination|vaccination
122706|NCT02528682|stem cell transplantation|stem cell transplantation
122707|NCT02528682|minor histocompatibility antigens|minor histocompatibility antigens
122708|NCT02528669|accelerometer|accelerometer
122709|NCT02528669|patient ambulation|patient ambulation
122710|NCT02528656|Pectus Excavatum|pectus excavatum
122711|NCT02528656|Pectus Carinatum|pectus carinatum
122712|NCT02528656|Vacuum Bell|vacuum bell
122713|NCT02528656|Dynamic compression system|dynamic compression system
122714|NCT02528656|Hearth variability|hearth variability
122715|NCT02528656|Autonomic Nervous System|autonomic nervous system
122716|NCT02528643|MDV3100|mdv3100
122717|NCT02528643|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
123113|NCT02525965|Recurrence|recurrence
122718|NCT02528643|enzalutamide|enzalutamide
122719|NCT02528643|Xtandi|xtandi
122720|NCT02528643|ASP9785|asp9785
122721|NCT02528604|Catheter Ablation|catheter ablation
122722|NCT02528604|Permanent pacemaker|permanent pacemaker
122723|NCT02528604|AV node ablation|av node ablation
122724|NCT02528604|Electrical Cardioversion|electrical cardioversion
122725|NCT02528604|Implantable loop recorder|implantable loop recorder
122726|NCT02528591|patient|patient
122727|NCT02528591|renal transplant|renal transplant
122728|NCT02528578|healthy volunteers|healthy volunteers
122729|NCT02528539|Prevention|prevention
122730|NCT02528539|lymphedema|lymphedema
122731|NCT02528539|acupuncture|acupuncture
122732|NCT02528539|self-management|self-management
122733|NCT02528526|Hypoxia|hypoxia
122734|NCT02528526|Pancreatic Neoplasms|pancreatic neoplasms
122735|NCT02528526|Hepatocellular Cancer|hepatocellular cancer
122736|NCT02528526|Cholangiocarcinoma|cholangiocarcinoma
122737|NCT02528526|Colorectal Neoplasms|colorectal neoplasms
122738|NCT02528526|Treatment|treatment
122739|NCT02528513|sedation|sedation
122740|NCT02528513|Midazolam|midazolam
122741|NCT02528513|Propofol|propofol
122742|NCT02528513|Dexmedetomidine|dexmedetomidine
122743|NCT02528487|Pulmonary Rehabilitation|pulmonary rehabilitation
122744|NCT02528487|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
122745|NCT02528487|Psychiatric Disorders|psychiatric disorders
122746|NCT02528461|Sofosbuvir|sofosbuvir
122747|NCT02528461|Direct acting anti-viral treatment|direct acting anti-viral treatment
122748|NCT02528461|liver cirrhosis|liver cirrhosis
122749|NCT02528448|Vasoactive hormones|vasoactive hormones
122750|NCT02528448|bio markers|bio markers
122751|NCT02528448|salt regulation|salt regulation
122752|NCT02528448|Renal variables|renal variables
122753|NCT02528435|Methotrexate|methotrexate
122754|NCT02528383|Postmenopausal Women on Aromatase Inhibitors|postmenopausal women on aromatase inhibitors
122755|NCT02528383|Vagifem|vagifem
651819|NCT00785018|Endotoxin|endotoxin
122756|NCT02528370|COPD exacerbation|copd exacerbation
122757|NCT02528370|Telemedicine|telemedicine
122758|NCT02528370|Intervention Studies|intervention studies
122759|NCT02528370|Patient Readmission|patient readmission
122760|NCT02528357|mAb|mab
122761|NCT02528357|GSK3174998|gsk3174998
122762|NCT02528357|anticancer agent|anticancer agent
122763|NCT02528357|checkpoint|checkpoint
122764|NCT02528357|OX40|ox40
122765|NCT02528357|Pembrolizumab|pembrolizumab
122766|NCT02528357|MK-3475-167|mk-3475-167
122767|NCT02528357|solid tumor|solid tumor
122768|NCT02528357|immunotherapy|immunotherapy
122769|NCT02528357|KEYNOTE-167|keynote-167
122770|NCT02528357|monoclonal antibody|monoclonal antibody
122771|NCT02528357|antitumor|antitumor
122772|NCT02528344|High Intensity Interval Training|high intensity interval training
122773|NCT02528331|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
122774|NCT02528331|Cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
122775|NCT02528305|High-intensity Interval Training|high-intensity interval training
122776|NCT02528292|Rheumatoid Arthritis|rheumatoid arthritis
122777|NCT02528292|Anti-TNF|anti-tnf
122778|NCT02528292|Ultrasound|ultrasound
122779|NCT02528292|Synovial histomorphology|synovial histomorphology
122780|NCT02528292|Ectopic Lymphoneogenesis|ectopic lymphoneogenesis
122781|NCT02528279|Plasmodium ovale|plasmodium ovale
122782|NCT02528279|relapse|relapse
122783|NCT02528279|artemether-lumefantrine|artemether-lumefantrine
122784|NCT02528279|mixed species malaria|mixed species malaria
122785|NCT02528279|non-falciparum malaria|non-falciparum malaria
122786|NCT02528253|Chronic low back pain|chronic low back pain
122787|NCT02528253|Chronic pain|chronic pain
122788|NCT02528240|platelets|platelets
122789|NCT02528201|Ankylosing Spondylitis|ankylosing spondylitis
122790|NCT02528201|Celecoxib|celecoxib
122791|NCT02528201|Diclofenac|diclofenac
122792|NCT02528162|gestational diabetes|gestational diabetes
122793|NCT02528162|education|education
122794|NCT02528149|Fibromuscular Dysplasia|fibromuscular dysplasia
122795|NCT02528149|dysplastic renal artery aneurysm|dysplastic renal artery aneurysm
122796|NCT02528149|renal artery aneurysms|renal artery aneurysms
122797|NCT02528149|non atheromatous|non atheromatous
122798|NCT02528149|dysplastic|dysplastic
122799|NCT02528149|anatomopathologic|anatomopathologic
122800|NCT02528149|genetic|genetic
122801|NCT02528123|Small incision lenticule extraction (SMILE)|small incision lenticule extraction (smile)
122802|NCT02528123|Femtosecond laser|femtosecond laser
122803|NCT02528084|rotator cuff, shoulder, rehabilitation, yoga|rotator cuff, shoulder, rehabilitation, yoga
122804|NCT02528071|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
122805|NCT02528071|ALS|als
122806|NCT02528071|Diaphragmatic Endurance Test|diaphragmatic endurance test
122807|NCT02528058|Myopic traction maculopathy|myopic traction maculopathy
122808|NCT02528045|Myopic traction maculopathy|myopic traction maculopathy
122809|NCT02528032|Left ventricular dysfunction|left ventricular dysfunction
122810|NCT02528032|Other cardiac dysrhythmias|other cardiac dysrhythmias
122811|NCT02528006|Spasmodic Dysphonia|spasmodic dysphonia
122812|NCT02528006|Type 2 Thyroplasty|type 2 thyroplasty
122813|NCT02528006|Titanium Bridges|titanium bridges
122814|NCT02528006|Operation|operation
122815|NCT02527980|electronic cigarettes|electronic cigarettes
122816|NCT02527980|nicotine dependence|nicotine dependence
122817|NCT02527980|smoking|smoking
122818|NCT02527980|tobacco use|tobacco use
122819|NCT02527967|colorectal cancer|colorectal cancer
122820|NCT02527967|enhanced recovery after surgery|enhanced recovery after surgery
122821|NCT02527967|perioperative care|perioperative care
122822|NCT02527967|fast-track surgery|fast-track surgery
122823|NCT02527967|laparoscopy|laparoscopy
122824|NCT02527967|minimally invasive surgery|minimally invasive surgery
122825|NCT02527967|complications|complications
122826|NCT02527954|Y-chromosome microdeletions|y-chromosome microdeletions
122827|NCT02527954|aneuploidy|aneuploidy
122828|NCT02527954|embryos|embryos
122829|NCT02527954|spermatozoa|spermatozoa
122830|NCT02527941|Genital immunology|genital immunology
122831|NCT02527941|HIV susceptibility|hiv susceptibility
122832|NCT02527941|Microbiome|microbiome
122833|NCT02527941|Bacterial vaginosis|bacterial vaginosis
122834|NCT02527941|Virus entry assay|virus entry assay
122835|NCT02527928|pharmacoeconomics|pharmacoeconomics
122836|NCT02527902|IGA Glomerulonephritis|iga glomerulonephritis
122837|NCT02527902|Autonomic nervous system|autonomic nervous system
122838|NCT02527902|ANS|ans
122839|NCT02527889|Exercise|exercise
122840|NCT02527889|blood flow velocity|blood flow velocity
122841|NCT02527889|tissue oxygenation|tissue oxygenation
122842|NCT02527889|BCRL|bcrl
122843|NCT02527876|Exercise|exercise
122844|NCT02527876|Smoking|smoking
122845|NCT02527863|Tolvaptan|tolvaptan
122846|NCT02527863|L-NMMA|l-nmma
122847|NCT02527863|ADPKD|adpkd
122848|NCT02527824|biliary tract neoplasm|biliary tract neoplasm
122849|NCT02527824|oxaliplatin|oxaliplatin
122850|NCT02527824|irinotecan|irinotecan
122851|NCT02527824|S-1|s-1
122852|NCT02527811|ulinastatin|ulinastatin
122853|NCT02527811|CPB|cpb
122854|NCT02527811|pediatric|pediatric
122855|NCT02527785|stomach neoplasm|stomach neoplasm
122856|NCT02527785|oxaliplatin|oxaliplatin
122857|NCT02527785|irinotecan|irinotecan
122859|NCT02527720|Mindfulness|mindfulness
122860|NCT02527720|Therapy|therapy
122861|NCT02527720|Problem Drinking|problem drinking
122862|NCT02527720|Breathing-based mindfulness training|breathing-based mindfulness training
122863|NCT02527694|Emergency medical services|emergency medical services
122864|NCT02527694|Resuscitation|resuscitation
122865|NCT02527512|Scoliosis|scoliosis
122866|NCT02527512|Spine fusion|spine fusion
122867|NCT02527512|0.35% povidone-iodine|0.35% povidone-iodine
122868|NCT02527486|COPD|copd
122869|NCT02527486|Asthma|asthma
122870|NCT02527486|ACOS|acos
122871|NCT02527486|Bronchiectasis|bronchiectasis
122872|NCT02527460|Inflammation|inflammation
122873|NCT02527460|Cognitive Function|cognitive function
122874|NCT02527460|HIV|hiv
122875|NCT02527447|Measurable Residual Disease|measurable residual disease
122876|NCT02527447|Relapsed/Refractory AML|relapsed/refractory aml
122877|NCT02527447|Salvage Chemotherapy|salvage chemotherapy
122878|NCT02527434|Urothelial bladder cancer, Triple-negative breast cancer, Pancreatic ductal adenocarcinoma, Advanced Solid Tumors, Tremelimumab, MEDI4736, ORR|urothelial bladder cancer, triple-negative breast cancer, pancreatic ductal adenocarcinoma, advanced solid tumors, tremelimumab, medi4736, orr
122879|NCT02527395|Experimental pain|experimental pain
122880|NCT02527395|Men|men
122881|NCT02527369|Fat Reduction|fat reduction
122882|NCT02527369|Lipolysis|lipolysis
122883|NCT02527330|Myocardial iron deposition|myocardial iron deposition
122884|NCT02527330|T2* imaging|t2* imaging
122885|NCT02527330|heart failure|heart failure
122886|NCT02527317|Early|early
122887|NCT02527291|Cytomegalovirus|cytomegalovirus
122888|NCT02527291|Interleukin|interleukin
122889|NCT02527291|Polymerase Chain Reaction|polymerase chain reaction
122890|NCT02527291|CMV antibodies|cmv antibodies
122891|NCT02527252|Massage|massage
122892|NCT02527252|Craniosacral|craniosacral
122893|NCT02527252|Disability Evaluation|disability evaluation
122894|NCT02527252|Randomized Controlled Trial|randomized controlled trial
122895|NCT02527187|Immune System Diseases|immune system diseases
122896|NCT02527187|Prick Test|prick test
122897|NCT02527187|Betula verrucosa|betula verrucosa
122898|NCT02527135|SMS|sms
122899|NCT02527135|Text messages|text messages
122900|NCT02527135|Young women|young women
122901|NCT02527135|HIV|hiv
122902|NCT02527122|Immune System Diseases|immune system diseases
122903|NCT02527122|Prick Test|prick test
122904|NCT02527122|Dermatophagoides pteronyssinus|dermatophagoides pteronyssinus
122905|NCT02527122|Dermatophagoides farinae|dermatophagoides farinae
122906|NCT02527096|dolutegravir(Tivicay®)|dolutegravir(tivicay®)
122907|NCT02527096|lamivudine(Epivir®)|lamivudine(epivir®)
122908|NCT02527096|HIV-1|hiv-1
122909|NCT02527096|efficacy|efficacy
122910|NCT02527096|safety|safety
122911|NCT02527057|Diffusion-weighted magnetic resonance imaging|diffusion-weighted magnetic resonance imaging
122912|NCT02527057|Preoperative concurrent chemoradiation|preoperative concurrent chemoradiation
122913|NCT02527057|Response|response
122914|NCT02527044|Coronary Artery Bypass|coronary artery bypass
122915|NCT02527044|Flow Reserve|flow reserve
125012|NCT02513693|Neostigmine|neostigmine
122916|NCT02527031|Emergency Medical Services|emergency medical services
122917|NCT02527031|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
122918|NCT02527018|OBGYN|obgyn
122919|NCT02527018|Nexfin|nexfin
122920|NCT02527018|Hypertensive|hypertensive
122921|NCT02527018|Hemodynamic|hemodynamic
122923|NCT02527005|malaria|malaria
122924|NCT02527005|pregnant|pregnant
122925|NCT02527005|HIV positive|hiv positive
122926|NCT02526979|OAB|oab
122927|NCT02526979|overactive bladder|overactive bladder
122928|NCT02526979|Myrbetric|myrbetric
122929|NCT02526979|neurogenic detrusor overactivity|neurogenic detrusor overactivity
122930|NCT02526979|Betanis|betanis
122931|NCT02526979|Myrbetriq|myrbetriq
122932|NCT02526979|NDO|ndo
122933|NCT02526979|YM178|ym178
122934|NCT02526979|mirabegron|mirabegron
122935|NCT02526979|Betmiga|betmiga
122936|NCT02526953|anal cancer|anal cancer
122937|NCT02526953|chemoradiation|chemoradiation
122938|NCT02526953|intensity-modulated radiotherapy|intensity-modulated radiotherapy
122939|NCT02526953|paclitaxel|paclitaxel
122940|NCT02526940|Human Immunodeficiency Virus|human immunodeficiency virus
122941|NCT02526940|HIV|hiv
122942|NCT02526940|HAART|haart
122943|NCT02526940|Highly Active antiretroviral therapy|highly active antiretroviral therapy
122944|NCT02526940|GALT|galt
122945|NCT02526940|Gut Associated Lymphoid Tissue|gut associated lymphoid tissue
122946|NCT02526940|reservoir|reservoir
122947|NCT02526940|rectum|rectum
122948|NCT02526927|Anorexia Nervosa|anorexia nervosa
122949|NCT02526927|microarchitecture|microarchitecture
122950|NCT02526927|prepubertal|prepubertal
122951|NCT02526914|social cognition|social cognition
122952|NCT02526914|oxytocin|oxytocin
122953|NCT02526914|vasopressin|vasopressin
122954|NCT02526914|decision making|decision making
122955|NCT02526914|social decision making|social decision making
122956|NCT02526914|economic games|economic games
122957|NCT02526888|pharmacokinetic|pharmacokinetic
122958|NCT02526888|interaction|interaction
122959|NCT02526875|hypertension, Telmisartan/S-Amlodipine|hypertension, telmisartan/s-amlodipine
122960|NCT02526862|noninvasive mechanical ventilation (NIVM)|noninvasive mechanical ventilation (nivm)
122961|NCT02526862|continuous positive airway pressure (CPAP) ventilation|continuous positive airway pressure (cpap) ventilation
122962|NCT02526862|bilevel positive airway pressure (BIPAP) ventilation|bilevel positive airway pressure (bipap) ventilation
122963|NCT02526862|pressure ulcer (PU)|pressure ulcer (pu)
122964|NCT02526862|nursing assessment|nursing assessment
122965|NCT02526849|Fecal Microbiota Transplantation|fecal microbiota transplantation
122966|NCT02526849|Slow Transit Constipation|slow transit constipation
122967|NCT02526849|Randomized Controlled Trial|randomized controlled trial
122968|NCT02526836|colon cancer mesocolic excision central ligation|colon cancer mesocolic excision central ligation
122969|NCT02526810|glargine|glargine
122970|NCT02526810|continuous subcutaneous insulin injection|continuous subcutaneous insulin injection
122971|NCT02526810|blood glucose control|blood glucose control
122972|NCT02526810|blood glucose fluctuation|blood glucose fluctuation
122973|NCT02526810|Oxidative Stress|oxidative stress
122974|NCT02526797|prostate biopsy|prostate biopsy
122975|NCT02526797|prostate cancer|prostate cancer
122976|NCT02526797|Magnetic resonance imaging|magnetic resonance imaging
122977|NCT02526797|Neoplasm staging|neoplasm staging
122978|NCT02526771|lymph node dissection|lymph node dissection
122979|NCT02526758|Pulmonary disease|pulmonary disease
122980|NCT02526758|chronic obstructive|chronic obstructive
122981|NCT02526758|small airway|small airway
122983|NCT02526745|safety|safety
122984|NCT02526745|immunogenicity|immunogenicity
122985|NCT02526732|NASH|nash
122986|NCT02526732|fatty Liver|fatty liver
122987|NCT02526732|VO2 max|vo2 max
122988|NCT02526732|M30 antigen|m30 antigen
122989|NCT02526719|bilateral prophylactic mastectomies|bilateral prophylactic mastectomies
122990|NCT02526719|immediate breast reconstruction|immediate breast reconstruction
122991|NCT02526719|nipple sparing|nipple sparing
122992|NCT02526719|BRCA1 Protein|brca1 protein
122993|NCT02526706|Bleb filtration|bleb filtration
122994|NCT02526706|VisionBlue|visionblue
122995|NCT02526680|OrCam|orcam
122996|NCT02526680|Low-vision device|low-vision device
122997|NCT02526680|End-stage glaucoma|end-stage glaucoma
122998|NCT02526641|Direct acting antiviral treatment|direct acting antiviral treatment
122999|NCT02526641|sCD163|scd163
123000|NCT02526641|Portal hypertension|portal hypertension
123001|NCT02526641|Metabolic liver function|metabolic liver function
123002|NCT02526641|Cirrhosis|cirrhosis
114173|NCT02579538|Persistent Pain|persistent pain
114174|NCT02579538|Cognitive Flexibility|cognitive flexibility
114175|NCT02579525|septic shock|septic shock
114183|NCT02579499|Statin|statin
123003|NCT02526628|Testosterone|testosterone
123004|NCT02526628|Neurocognition|neurocognition
123005|NCT02526615|rosiglitazone|rosiglitazone
123006|NCT02526615|metformin|metformin
123007|NCT02526615|muscle|muscle
123008|NCT02526576|Facial Atrophy|facial atrophy
123009|NCT02526576|Autologous|autologous
123010|NCT02526576|Adult|adult
123011|NCT02526576|Adipose Derived Stem Cells|adipose derived stem cells
123012|NCT02526576|Stromal Vascular Fraction|stromal vascular fraction
123013|NCT02526576|Collagenase|collagenase
123311|NCT02524860|Focal-Fusion Bx|focal-fusion bx
123014|NCT02526550|Live attenuated Japanese Encephalitis vaccine|live attenuated japanese encephalitis vaccine
123015|NCT02526550|IMOJEV|imojev
123016|NCT02526550|CD.JEVAX|cd.jevax
123017|NCT02526550|Booster|booster
123018|NCT02526550|Thai children|thai children
123019|NCT02526550|Immunogenicity|immunogenicity
123020|NCT02526550|Safety|safety
123021|NCT02526550|Interchangeability|interchangeability
123022|NCT02526550|Hepatitis A vaccine|hepatitis a vaccine
123023|NCT02526550|Vaccination or Other Immunization Procedure|vaccination or other immunization procedure
123024|NCT02526537|Gefitinib|gefitinib
123025|NCT02526537|NSCLC|nsclc
123026|NCT02526537|postoperative|postoperative
123027|NCT02526537|stage Ib|stage ib
123028|NCT02526537|Relapse Free Survival in 2 years|relapse free survival in 2 years
123029|NCT02526485|heparin|heparin
123030|NCT02526485|thrombocytopenia|thrombocytopenia
123031|NCT02526485|genomics|genomics
123032|NCT02526472|embryo transfer, in vitro fertilization|embryo transfer, in vitro fertilization
123033|NCT02526446|Chinese|chinese
123034|NCT02526446|caregiver stress|caregiver stress
123035|NCT02526446|self-administered acupressure|self-administered acupressure
123036|NCT02526433|depression|depression
123037|NCT02526433|mental wellbeing|mental wellbeing
123038|NCT02526433|motherhood|motherhood
123039|NCT02526433|music|music
123040|NCT02526433|alternative therapies|alternative therapies
123041|NCT02526420|VRS-317|vrs-317
123042|NCT02526420|Long Acting Growth Hormone|long acting growth hormone
123043|NCT02526420|Versartis|versartis
123044|NCT02526420|somavaratan|somavaratan
123045|NCT02526420|Growth Hormone Deficiency|growth hormone deficiency
123046|NCT02526420|Adult Growth Hormone Deficiency|adult growth hormone deficiency
123047|NCT02526420|AGHD|aghd
123048|NCT02526420|Growth Hormone Replacement|growth hormone replacement
123049|NCT02526420|Growth Hormone Replacement Therapy|growth hormone replacement therapy
123050|NCT02526420|XTEN|xten
123051|NCT02526407|postnatal depression|postnatal depression
123052|NCT02526407|mental wellbeing|mental wellbeing
123053|NCT02526407|baby blues|baby blues
123054|NCT02526407|mothers|mothers
123055|NCT02526407|music|music
123056|NCT02526407|alternative therapies|alternative therapies
123057|NCT02526355|Postnatal depression|postnatal depression
123058|NCT02526355|Mobile phone based intervention|mobile phone based intervention
123059|NCT02526355|Learning Through Play|learning through play
123061|NCT02526355|Intelligent Real Time Therapy|intelligent real time therapy
123062|NCT02526316|cervical cancer|cervical cancer
123063|NCT02526316|vulvar cancer|vulvar cancer
123064|NCT02526316|vaginal cancer|vaginal cancer
123065|NCT02526316|penile cancer|penile cancer
123066|NCT02526316|anal cancer|anal cancer
123067|NCT02526316|head and neck cancer|head and neck cancer
123068|NCT02526277|RLS|rls
123069|NCT02526264|stoma|stoma
123070|NCT02526264|quality of life|quality of life
123071|NCT02526251|IBD|ibd
123072|NCT02526251|Fecal calprotectin|fecal calprotectin
123073|NCT02526251|Microbiome|microbiome
123074|NCT02526251|Dysbiosis|dysbiosis
123075|NCT02526251|Disease activity|disease activity
123076|NCT02526251|telemedicine|telemedicine
123077|NCT02526238|transcranial magnetic stimulation|transcranial magnetic stimulation
123078|NCT02526238|trunk rotation|trunk rotation
123079|NCT02526225|acute ischemic stroke|acute ischemic stroke
123080|NCT02526225|safety and effectiveness|safety and effectiveness
123081|NCT02526225|Ginkgo diterpene lactone meglumine injection|ginkgo diterpene lactone meglumine injection
123082|NCT02526212|opioid use disorder|opioid use disorder
123083|NCT02526212|group counseling|group counseling
123084|NCT02526212|office-based buprenorphine treatment|office-based buprenorphine treatment
123085|NCT02526199|Local anesthetics|local anesthetics
123086|NCT02526199|Perineural nerve blocks|perineural nerve blocks
123087|NCT02526199|Perineurial Dexamethasone|perineurial dexamethasone
123088|NCT02526160|KRN23|krn23
123089|NCT02526160|Fibroblast growth factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
123090|NCT02526160|XLH|xlh
123091|NCT02526160|X-linked hypophosphatemia|x-linked hypophosphatemia
123092|NCT02526134|Laying of medical devices (radio opaque markers)|laying of medical devices (radio opaque markers)
114277|NCT02578966|Motivational Interviewing|motivational interviewing
114278|NCT02578953|Bioequivalence|bioequivalence
114279|NCT02578953|Fasted state|fasted state
114281|NCT02578953|Dutasteride|dutasteride
123093|NCT02526095|Esophagus|esophagus
123094|NCT02526095|Surgery|surgery
123095|NCT02526082|cardiovascular disease|cardiovascular disease
123096|NCT02526082|frailty|frailty
123097|NCT02526082|quality of life|quality of life
123098|NCT02526082|mortality|mortality
123099|NCT02526082|prevention|prevention
123100|NCT02526030|psychosis|psychosis
123101|NCT02526030|antipsychotic agents|antipsychotic agents
123102|NCT02526030|treatment|treatment
123103|NCT02526030|effectiveness|effectiveness
123104|NCT02526004|Cystic Fibrosis|cystic fibrosis
123105|NCT02526004|Microbiome|microbiome
123106|NCT02526004|Stratified Antibacterial therapy|stratified antibacterial therapy
123107|NCT02526004|Resistance|resistance
123108|NCT02526004|Pathogen Host Interaction|pathogen host interaction
123109|NCT02525991|schizophrenia|schizophrenia
123110|NCT02525991|bipolar disorder|bipolar disorder
123111|NCT02525978|Heart Rate|heart rate
123112|NCT02525965|Wide resection margin|wide resection margin
123114|NCT02525965|Early-stage hepatocellular carcinoma|early-stage hepatocellular carcinoma
123115|NCT02525952|Carcinoma, Hepatocellular|carcinoma, hepatocellular
123116|NCT02525952|Hepatectomy|hepatectomy
123117|NCT02525952|Transarterial Chemoembolization|transarterial chemoembolization
123118|NCT02525952|Scoring System|scoring system
123119|NCT02525913|Breast|breast
123120|NCT02525913|Mastectomy|mastectomy
123121|NCT02525874|Tecfidera|tecfidera
123122|NCT02525874|DMF|dmf
123123|NCT02525874|dimethyl fumarate|dimethyl fumarate
123124|NCT02525757|Lung Cancer|lung cancer
123125|NCT02525757|Non-small cell lung cancer|non-small cell lung cancer
123126|NCT02525757|NSCLC|nsclc
123127|NCT02525757|Unresectable|unresectable
123128|NCT02525757|MPDL3280A|mpdl3280a
123129|NCT02525757|Carboplatin|carboplatin
123130|NCT02525757|Paraplatin|paraplatin
123131|NCT02525757|Paclitaxel|paclitaxel
123132|NCT02525757|Taxol|taxol
123133|NCT02525757|Radiation therapy|radiation therapy
123134|NCT02525757|XRT|xrt
123135|NCT02525731|HIV Infection|hiv infection
123136|NCT02525731|Pain|pain
123137|NCT02525731|Chronic Opioid Therapy|chronic opioid therapy
123138|NCT02525731|Addiction|addiction
123139|NCT02525731|Analgesics, Opioid|analgesics, opioid
123140|NCT02525718|Breast Reconstruction|breast reconstruction
123141|NCT02525718|Mastectomy|mastectomy
123142|NCT02525705|infants|infants
123143|NCT02525705|oesophageal atresia|oesophageal atresia
123144|NCT02525705|dumping syndrome|dumping syndrome
123145|NCT02525705|prevalence|prevalence
123146|NCT02525705|Type III and IV|type iii and iv
123147|NCT02525705|Oral glucose tolerance test|oral glucose tolerance test
123148|NCT02525705|early hyperglycemia|early hyperglycemia
123149|NCT02525705|late hypoglycemia|late hypoglycemia
123150|NCT02525653|Albumin-Bound|albumin-bound
123151|NCT02525653|Paclitaxel|paclitaxel
123152|NCT02525653|Gemcitabine|gemcitabine
123153|NCT02525653|15-054|15-054
123154|NCT02525640|Single sided hearing loss|single sided hearing loss
123155|NCT02525640|Single sided deafness|single sided deafness
123156|NCT02525640|Hearing loss music appreciation|hearing loss music appreciation
123157|NCT02525536|Drug Therapy|drug therapy
123158|NCT02525510|Mild Hypothermia|mild hypothermia
123159|NCT02525510|Machine Perfusion|machine perfusion
123160|NCT02525510|Kidney Transplantation|kidney transplantation
123161|NCT02525497|Automated PD|automated pd
123162|NCT02525497|Effectiveness|effectiveness
123163|NCT02525497|Safety|safety
123164|NCT02525497|Manipulability|manipulability
123363|NCT02524340|PCATS|pcats
123165|NCT02525458|antimicrobial|antimicrobial
123166|NCT02525458|biofilms|biofilms
123167|NCT02525458|acrylic resin|acrylic resin
123168|NCT02525458|polymethyl methacrylate|polymethyl methacrylate
123169|NCT02525458|confocal laser scanning microscopy|confocal laser scanning microscopy
123170|NCT02525458|split-mouth design|split-mouth design
123171|NCT02525458|quaternary ammonium methacryloxy silicate|quaternary ammonium methacryloxy silicate
123172|NCT02525445|placebo effects|placebo effects
123173|NCT02525445|communication|communication
123174|NCT02525445|acupuncture therapy|acupuncture therapy
123175|NCT02525445|relaxation|relaxation
123176|NCT02525432|Mesenchymal Stromal Cells, Multipotent|mesenchymal stromal cells, multipotent
123177|NCT02525432|Multipotent Mesenchymal Stromal Cells|multipotent mesenchymal stromal cells
123178|NCT02525432|Stem Cells, Mesenchymal|stem cells, mesenchymal
123179|NCT02525393|Rehabilitation|rehabilitation
123180|NCT02525393|Non Invasive Brain Stimulation|non invasive brain stimulation
123181|NCT02525380|Transarterial chemoembolization|transarterial chemoembolization
123182|NCT02525380|Doxorubicin-Eluting-Bead Embolization|doxorubicin-eluting-bead embolization
123183|NCT02525380|DC Bead TACE|dc bead tace
123184|NCT02525380|Hepatocellular carcinoma|hepatocellular carcinoma
123185|NCT02525367|Parkinson's disease|parkinson's disease
123186|NCT02525367|Multiple Sclerosis|multiple sclerosis
123187|NCT02525367|Depressed Elderly|depressed elderly
123188|NCT02525367|Cognitive Dysfunction|cognitive dysfunction
123189|NCT02525367|Online Cognitive Training|online cognitive training
123190|NCT02525354|arachidonic aci|arachidonic aci
123191|NCT02525354|adiposity|adiposity
123192|NCT02525354|atopy|atopy
123193|NCT02525341|Yoga|yoga
123194|NCT02525341|exercises|exercises
123195|NCT02525341|knee osteoarthritis|knee osteoarthritis
123196|NCT02525341|older adults|older adults
123197|NCT02525328|Constitutional Thinness|constitutional thinness
123198|NCT02525328|linkage study|linkage study
123199|NCT02525328|genome wide scan (GWAS)|genome wide scan (gwas)
123200|NCT02525315|Schizophrenia|schizophrenia
123201|NCT02525315|auditory hallucinations|auditory hallucinations
123202|NCT02525315|TMS|tms
123203|NCT02525302|DMD|dmd
123204|NCT02525302|neuromuscular|neuromuscular
123205|NCT02525302|Duchenne|duchenne
123206|NCT02525289|mobility|mobility
123207|NCT02525289|coronary artery bypass|coronary artery bypass
123208|NCT02525289|positioning|positioning
123209|NCT02525289|body|body
123210|NCT02525263|Neo-Kidney Augment|neo-kidney augment
123211|NCT02525263|Type 2 Diabetes|type 2 diabetes
123212|NCT02525263|Chronic Kidney Disease|chronic kidney disease
123213|NCT02525263|Cell Therapy|cell therapy
123312|NCT02524834|Thoracoabdominal lesions|thoracoabdominal lesions
123214|NCT02525250|Acute myeloid leukemia or myelodysplasic syndrome|acute myeloid leukemia or myelodysplasic syndrome
123215|NCT02525198|Mild cognitive impairment|mild cognitive impairment
123216|NCT02525198|Subjective memory impairment|subjective memory impairment
123217|NCT02525198|Dementia|dementia
123218|NCT02525198|Flavonoids|flavonoids
123219|NCT02525198|Fatty acids|fatty acids
123220|NCT02525198|Cognition|cognition
123221|NCT02525198|Gut microflora|gut microflora
123222|NCT02525172|immune modulation therapy|immune modulation therapy
123223|NCT02525172|acid α-glucosidase|acid α-glucosidase
123224|NCT02525172|antibody|antibody
123225|NCT02525159|3,3'-diindolylmethane|3,3'-diindolylmethane
123226|NCT02525159|premenopause|premenopause
123227|NCT02525159|2-hydroxyestrone|2-hydroxyestrone
123228|NCT02525146|HIV|hiv
123229|NCT02525146|Reengagement in HIV Care|reengagement in hiv care
123230|NCT02525146|ARTAS|artas
123231|NCT02525133|post operative pain|post operative pain
123232|NCT02525133|hernioplasty|hernioplasty
123233|NCT02525133|bupivacaine|bupivacaine
123234|NCT02525120|Disc herniation|disc herniation
123235|NCT02525120|Herniated disc|herniated disc
123236|NCT02525120|Triojection|triojection
123237|NCT02525120|Ozone|ozone
123238|NCT02525120|Lumbar spine|lumbar spine
123239|NCT02525120|Leg pain|leg pain
123240|NCT02525107|Prevention of Vaso Occlusive Painful Crisis|prevention of vaso occlusive painful crisis
123241|NCT02525094|Eczema|eczema
123242|NCT02525081|Microvascular Angina|microvascular angina
123244|NCT02525068|enzalutamide|enzalutamide
123245|NCT02525068|AZD5363|azd5363
123246|NCT02525068|Prostate|prostate
123247|NCT02525055|Flu|flu
123248|NCT02525055|Influenza|influenza
123249|NCT02525055|Human Viral Challenge Model|human viral challenge model
123250|NCT02525055|Wild-Type|wild-type
123251|NCT02525055|H3N2|h3n2
123252|NCT02525055|H1N1|h1n1
123253|NCT02525055|Universal Influenza Vaccine|universal influenza vaccine
123254|NCT02525055|intra-seasonal vaccines|intra-seasonal vaccines
123255|NCT02525055|antiviral|antiviral
123256|NCT02525042|Ankylosing Spondylitis|ankylosing spondylitis
123257|NCT02525042|Dendritic cells (DC)|dendritic cells (dc)
123258|NCT02525042|RNA|rna
123259|NCT02525042|Axial spondyloarthritis|axial spondyloarthritis
123260|NCT02525042|Lod score|lod score
123261|NCT02525042|Human leucocyte antigen (HLA-B27)|human leucocyte antigen (hla-b27)
123262|NCT02525029|GVHD|gvhd
123364|NCT02524301|anorexia nervosa|anorexia nervosa
124281|NCT02518659|PPI|ppi
123263|NCT02525016|Bariatric surgery, lidocaine, plasmatic concentration, MonoEthylGlycineXylidide (MEGx), safety|bariatric surgery, lidocaine, plasmatic concentration, monoethylglycinexylidide (megx), safety
123264|NCT02525003|vitamin D|vitamin d
123265|NCT02525003|Serum 25-hydroxyvitamin D|serum 25-hydroxyvitamin d
123266|NCT02525003|vitamin D2|vitamin d2
123267|NCT02525003|UV-irradiated yeast|uv-irradiated yeast
123268|NCT02525003|serum 25-hydroxyvitamin D3|serum 25-hydroxyvitamin d3
123269|NCT02525003|serum 25-hydroxyvitamin D2|serum 25-hydroxyvitamin d2
123270|NCT02525003|randomized controlled trial|randomized controlled trial
123271|NCT02525003|vitamin D3|vitamin d3
123272|NCT02525003|bioavailability|bioavailability
123273|NCT02524990|Medical abortion|medical abortion
123274|NCT02524990|pregnancy tests|pregnancy tests
123275|NCT02524964|left ventricular remodeling|left ventricular remodeling
123276|NCT02524964|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
123277|NCT02524964|acute myocardial infarction|acute myocardial infarction
123283|NCT02524925|pancreatectomy|pancreatectomy
123285|NCT02524925|ACTH/Cortsiosol|acth/cortsiosol
123286|NCT02524925|postoperative stress|postoperative stress
123287|NCT02524899|Schizotypal Personality Disorder|schizotypal personality disorder
123288|NCT02524899|SPD|spd
123289|NCT02524899|cognitive remediation therapy|cognitive remediation therapy
123290|NCT02524899|CRT|crt
123291|NCT02524899|guanfacine|guanfacine
123292|NCT02524899|cognitive impairment|cognitive impairment
123293|NCT02524899|working memory|working memory
123294|NCT02524899|pharmacological cognitive enhancing agent|pharmacological cognitive enhancing agent
123295|NCT02524899|neuropsychological testing|neuropsychological testing
123296|NCT02524899|schizophrenia spectrum disorders|schizophrenia spectrum disorders
123297|NCT02524899|Personality Disorders|personality disorders
123298|NCT02524886|Deep Brain Simulation|deep brain simulation
123299|NCT02524886|Psychiatric|psychiatric
123300|NCT02524886|Side-effects|side-effects
123301|NCT02524860|Prostate Cancer|prostate cancer
123302|NCT02524860|Biopsy|biopsy
123303|NCT02524860|Focal Healthcare|focal healthcare
123304|NCT02524860|Fusion Targeted Biopsy|fusion targeted biopsy
123305|NCT02524860|High Risk Cancer|high risk cancer
123306|NCT02524860|Imaging|imaging
123307|NCT02524860|Diagnostic|diagnostic
123308|NCT02524860|Ultrasound|ultrasound
123309|NCT02524860|Multiparametric Magnetic Resonance Imaging (MP-MRI)|multiparametric magnetic resonance imaging (mp-mri)
123310|NCT02524860|MRI-Ultrasound Fusion|mri-ultrasound fusion
123608|NCT02522793|skin lesion|skin lesion
123313|NCT02524795|Omega 3, Cytokines, Adipokines, Systemic lupus erythematosus|omega 3, cytokines, adipokines, systemic lupus erythematosus
123314|NCT02524782|MEDI-4166, diabetes|medi-4166, diabetes
123315|NCT02524769|Urge Urinary Incontinence|urge urinary incontinence
123316|NCT02524769|Urinary Incontinence|urinary incontinence
123317|NCT02524756|nerve sparing radical hysterectomy|nerve sparing radical hysterectomy
123318|NCT02524743|Rocuronium|rocuronium
123319|NCT02524743|lidocaine|lidocaine
123320|NCT02524743|acetaminophen,|acetaminophen,
123321|NCT02524743|pain|pain
123322|NCT02524743|injection|injection
123323|NCT02524717|Hepatic Impairment|hepatic impairment
123324|NCT02524717|JNJ-56021927|jnj-56021927
123325|NCT02524704|Cystic fibrosis|cystic fibrosis
123326|NCT02524704|Electrical Impedance Tomography|electrical impedance tomography
123327|NCT02524626|Vagus nerve stimulation|vagus nerve stimulation
123328|NCT02524626|Postoperative ileus|postoperative ileus
123329|NCT02524561|mammographic density|mammographic density
123330|NCT02524561|abnormal mammogram|abnormal mammogram
123331|NCT02524561|biopsy|biopsy
123332|NCT02524548|Aromatase inhibitors|aromatase inhibitors
123333|NCT02524548|Reminder Systems|reminder systems
123334|NCT02524522|Integrated Pulmonary Index|integrated pulmonary index
123335|NCT02524522|automated protocol-driven weaning|automated protocol-driven weaning
123336|NCT02524522|pulmonary recruitment maneuver|pulmonary recruitment maneuver
123337|NCT02524509|Chonodron|chonodron
123338|NCT02524509|Microfracture|microfracture
123339|NCT02524509|autologous cultured chondrocyte|autologous cultured chondrocyte
123340|NCT02524509|cartilage defect of knee|cartilage defect of knee
123341|NCT02524444|Intermittent preventive therapy|intermittent preventive therapy
123342|NCT02524444|malaria|malaria
123343|NCT02524444|pregnant|pregnant
123344|NCT02524444|HIV positive|hiv positive
123345|NCT02524444|Prevention|prevention
123346|NCT02524431|Mitochondria|mitochondria
123347|NCT02524431|trabeculectomy|trabeculectomy
123348|NCT02524431|trabecular meshwork|trabecular meshwork
123349|NCT02524431|Glaucoma surgery|glaucoma surgery
123350|NCT02524418|Main Pancreatic Duct|main pancreatic duct
123351|NCT02524392|independent medical evaluation|independent medical evaluation
123352|NCT02524392|sick leave|sick leave
123353|NCT02524392|sickness absence|sickness absence
123354|NCT02524392|physician primary care|physician primary care
123355|NCT02524392|general practitioner|general practitioner
123356|NCT02524392|family physician|family physician
123357|NCT02524366|Stress Urinary Incontinence|stress urinary incontinence
123358|NCT02524366|Artificial Urinary Sphincter|artificial urinary sphincter
123359|NCT02524353|cardiac surgery|cardiac surgery
123360|NCT02524340|JIA|jia
123361|NCT02524340|Arthritis|arthritis
123362|NCT02524340|pJIA|pjia
123365|NCT02524301|opioid receptors|opioid receptors
123366|NCT02524301|Positron emission tomography (PET)|positron emission tomography (pet)
123367|NCT02524301|diprenorphine|diprenorphine
123368|NCT02524262|atrohpic gastritis|atrohpic gastritis
123370|NCT02524262|ethanol|ethanol
123371|NCT02524262|L-cysteine|l-cysteine
123372|NCT02524236|BPH, OAB, Botox, dose response|bph, oab, botox, dose response
123373|NCT02524223|medically assisted procreation|medically assisted procreation
123374|NCT02524210|volunteers|volunteers
123375|NCT02524197|Hip|hip
123376|NCT02524197|Knee|knee
123377|NCT02524197|Arthritis|arthritis
123378|NCT02524197|pain|pain
123379|NCT02524197|CR845|cr845
123380|NCT02524197|kappa opioid|kappa opioid
123381|NCT02524171|crime|crime
123382|NCT02524171|mental health|mental health
123383|NCT02524171|substance abuse|substance abuse
123384|NCT02524171|homelessness|homelessness
123385|NCT02524171|Veterans|veterans
123386|NCT02524158|Yoga|yoga
148213|NCT02381964|NIRS|nirs
123387|NCT02524158|Mind-Body Therapies|mind-body therapies
123388|NCT02524158|Chronic Low Back Pain|chronic low back pain
123389|NCT02524158|Military Veterans|military veterans
123390|NCT02524158|VA patients|va patients
123391|NCT02524080|Ambulance|ambulance
123392|NCT02524080|Trust|trust
123393|NCT02524080|Patients|patients
123394|NCT02524080|Healthcare chain|healthcare chain
123395|NCT02524054|Dyspnea|dyspnea
123396|NCT02524054|Hospitalized patients|hospitalized patients
123397|NCT02524054|Ambulatory outpatients|ambulatory outpatients
123398|NCT02524054|Shortness of breath|shortness of breath
123399|NCT02524054|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
123400|NCT02524054|Pulmonary disease|pulmonary disease
123401|NCT02524041|Hyperparathyroidism|hyperparathyroidism
123402|NCT02524041|microarchitecture|microarchitecture
123403|NCT02524041|periostin|periostin
123404|NCT02524028|Atrial Fibrillation|atrial fibrillation
123405|NCT02524028|fMRI|fmri
123406|NCT02524015|stroke|stroke
123407|NCT02524015|pusher syndrome|pusher syndrome
123408|NCT02524015|contraversive pushing|contraversive pushing
123409|NCT02524015|lateropulsion|lateropulsion
123410|NCT02524015|rehabilitation|rehabilitation
123411|NCT02524015|physical therapy|physical therapy
123412|NCT02524002|Abnormal Labor|abnormal labor
123413|NCT02524002|Prolonged Induction|prolonged induction
123414|NCT02524002|Ketosis|ketosis
123415|NCT02524002|Diet|diet
123416|NCT02523989|arsenic|arsenic
123417|NCT02523989|heavy metal|heavy metal
123418|NCT02523976|Acute|acute
123419|NCT02523976|Leukemia|leukemia
123420|NCT02523976|Lymphoid|lymphoid
123421|NCT02523976|Philadelphia chromosome|philadelphia chromosome
123422|NCT02523976|dasatinib|dasatinib
123423|NCT02523963|family work shop|family work shop
123424|NCT02523937|Pulmonary Embolism|pulmonary embolism
123425|NCT02523937|Deep Venous Thrombosis|deep venous thrombosis
123426|NCT02523937|Soluble Fibrin|soluble fibrin
123427|NCT02523937|D-Dimers|d-dimers
123428|NCT02523937|Low and intermediate clinical probability|low and intermediate clinical probability
123429|NCT02523911|Suprep|suprep
123430|NCT02523911|Simethicone|simethicone
123431|NCT02523911|Colorectal cancer screening|colorectal cancer screening
123432|NCT02523911|Routine colonoscopy|routine colonoscopy
123433|NCT02523911|sodium sulfate/potassium sulfate/magnesium sulfate|sodium sulfate/potassium sulfate/magnesium sulfate
123434|NCT02523911|Bowel cleansing|bowel cleansing
123435|NCT02523911|Mass screening|mass screening
123436|NCT02523898|Clomiphene|clomiphene
123437|NCT02523898|infertility|infertility
123438|NCT02523898|insuline resistant|insuline resistant
123439|NCT02523898|metformine|metformine
123440|NCT02523898|PCOS|pcos
123441|NCT02523885|Pneumonia, Bacterial [C01.252.620]|pneumonia, bacterial [c01.252.620]
123442|NCT02523885|Bronchopneumonia [C08.381.677.127]|bronchopneumonia [c08.381.677.127]
123443|NCT02523885|Pleuropneumonia [C08.730.610.473]|pleuropneumonia [c08.730.610.473]
123444|NCT02523885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
123445|NCT02523872|Fluid overload|fluid overload
123446|NCT02523872|Acute respiratory failure|acute respiratory failure
123447|NCT02523872|Acute respiratory distress syndrome|acute respiratory distress syndrome
123448|NCT02523872|Medication administration|medication administration
123449|NCT02523846|IV-Patient Controlled Analgesia (IV-PCA)|iv-patient controlled analgesia (iv-pca)
123450|NCT02523846|background morphine infusion|background morphine infusion
123451|NCT02523846|patient re-education|patient re-education
123452|NCT02523781|preeclampsia|preeclampsia
123453|NCT02523781|information pamphlet|information pamphlet
123454|NCT02523781|patient education|patient education
123455|NCT02523755|epidural analgesia for labor|epidural analgesia for labor
123456|NCT02523755|respiratory function|respiratory function
123457|NCT02523755|electrical impedance tomography|electrical impedance tomography
123458|NCT02523729|lactation|lactation
123459|NCT02523729|human milk|human milk
123460|NCT02523729|maltz|maltz
123461|NCT02523729|antioxidant|antioxidant
123462|NCT02523716|Hypoxic conditioning|hypoxic conditioning
123463|NCT02523716|Cardio pulmonary exercise testing|cardio pulmonary exercise testing
123563|NCT02523092|CXCL9|cxcl9
123464|NCT02523651|Periodontal Diseases|periodontal diseases
123465|NCT02523651|Bone Regeneration|bone regeneration
123466|NCT02523651|Dental Pulp Stem Cell|dental pulp stem cell
124211|NCT02519036|HTTRx|httrx
123467|NCT02523638|Pegylated-Proline-interferon alpha-2b (AOP2014)|pegylated-proline-interferon alpha-2b (aop2014)
123468|NCT02523638|Polycythemia Vera|polycythemia vera
123469|NCT02523638|PEN-PV|pen-pv
123470|NCT02523638|PROUD-PV|proud-pv
123471|NCT02523638|CONTINUATION-PV|continuation-pv
123472|NCT02523638|AOP Orphan|aop orphan
123473|NCT02523638|Polycythemia|polycythemia
123474|NCT02523638|Hematologic Diseases|hematologic diseases
123475|NCT02523638|Myeloproliferative Disorders|myeloproliferative disorders
123476|NCT02523638|Bone Marrow Diseases|bone marrow diseases
123477|NCT02523638|Interferon-alpha|interferon-alpha
123478|NCT02523638|Peginterferon alfa-2b|peginterferon alfa-2b
123479|NCT02523625|Ultrasound|ultrasound
123480|NCT02523599|post operative pain|post operative pain
123481|NCT02523599|hernioplasty|hernioplasty
123482|NCT02523599|bupivacaine|bupivacaine
123483|NCT02523586|oxygen concentration|oxygen concentration
123484|NCT02523586|oxygen therapy|oxygen therapy
123485|NCT02523586|oxygen delivery|oxygen delivery
123486|NCT02523586|oxygen masks|oxygen masks
123487|NCT02523560|Telerehabilitation|telerehabilitation
123488|NCT02523560|Home Monitoring|home monitoring
123489|NCT02523560|Heart Failure|heart failure
123490|NCT02523547|entecavir|entecavir
123491|NCT02523495|Molecular Targeted Therapy|molecular targeted therapy
123492|NCT02523495|metastasis colorectal cancer|metastasis colorectal cancer
123493|NCT02523495|biomarker|biomarker
123494|NCT02523482|Prescriptions|prescriptions
123495|NCT02523482|Epidemiology|epidemiology
123496|NCT02523482|STOPP/START Criteria|stopp/start criteria
123497|NCT02523482|Beers Criteria|beers criteria
123498|NCT02523456|Early warning score|early warning score
123499|NCT02523456|Cardiac arrest|cardiac arrest
123500|NCT02523443|Epidural Analgesia|epidural analgesia
123501|NCT02523443|Intravenous Patient Controlled|intravenous patient controlled
123502|NCT02523443|15-148|15-148
123503|NCT02523430|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
123504|NCT02523430|HepaSphere|hepasphere
123505|NCT02523417|Breast Cancer|breast cancer
123506|NCT02523417|HepaSphere|hepasphere
123507|NCT02523404|Lung Cancer|lung cancer
123508|NCT02523404|HepaSphere|hepasphere
123609|NCT02522728|Knee|knee
123509|NCT02523378|Advanced Cancers|advanced cancers
123510|NCT02523378|Recurrent|recurrent
123511|NCT02523378|Locally advanced|locally advanced
123512|NCT02523378|Metastatic|metastatic
123513|NCT02523378|Edmonton Symptom Assessment Scale|edmonton symptom assessment scale
123514|NCT02523378|ESAS|esas
123515|NCT02523378|Survey|survey
123516|NCT02523378|Interview|interview
123517|NCT02523378|Symptom questionnaire|symptom questionnaire
123518|NCT02523365|Cervical Carcinoma|cervical carcinoma
123519|NCT02523365|HepaSphere|hepasphere
123520|NCT02523326|Genomic DNA|genomic dna
123521|NCT02523326|chronic periodontitis|chronic periodontitis
123522|NCT02523326|saliva|saliva
123523|NCT02523326|mouthwash|mouthwash
123524|NCT02523326|PCR|pcr
123525|NCT02523326|genotyping|genotyping
123526|NCT02523326|sequencing|sequencing
123527|NCT02523235|moderate pain|moderate pain
123528|NCT02523235|severe pain|severe pain
123529|NCT02523235|surgery|surgery
123530|NCT02523235|postop analgesia|postop analgesia
123531|NCT02523235|TKA|tka
123532|NCT02523235|adductor catheter|adductor catheter
123533|NCT02523235|poplital catheter|poplital catheter
123534|NCT02523235|foot/ankle surgery|foot/ankle surgery
123535|NCT02523222|dextrose gel|dextrose gel
123536|NCT02523222|newborn hypoglycemia|newborn hypoglycemia
123537|NCT02523222|late preterm infant|late preterm infant
123538|NCT02523222|large for gestational age|large for gestational age
123539|NCT02523222|small for gestational age|small for gestational age
123540|NCT02523222|prophylactic|prophylactic
123541|NCT02523222|neonatal hypoglycemia|neonatal hypoglycemia
123542|NCT02523209|Osteoporosis|osteoporosis
123543|NCT02523209|chronic kidney disease|chronic kidney disease
123544|NCT02523209|kidney transplantation|kidney transplantation
123545|NCT02523209|fracture risk|fracture risk
123546|NCT02523196|Hepatic Venous Pressure Gradient (HVPG) testing|hepatic venous pressure gradient (hvpg) testing
123547|NCT02523196|HepQuant-SHUNT|hepquant-shunt
123548|NCT02523196|Liver Function|liver function
123549|NCT02523183|Epilepsy|epilepsy
123550|NCT02523183|Marijuana|marijuana
123551|NCT02523144|Transthoracic echocardiography|transthoracic echocardiography
123552|NCT02523144|echo|echo
123553|NCT02523144|TTE|tte
123554|NCT02523131|Type 1 diabetes|type 1 diabetes
123555|NCT02523131|Closed-loop glucose control|closed-loop glucose control
123556|NCT02523131|Artificial Pancreas|artificial pancreas
123557|NCT02523131|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
123558|NCT02523131|Continuous glucose monitoring|continuous glucose monitoring
123559|NCT02523131|threshold suspend|threshold suspend
123560|NCT02523131|predictive low glucose suspend|predictive low glucose suspend
123561|NCT02523092|sarcoidosis|sarcoidosis
123562|NCT02523092|Acthar|acthar
123564|NCT02523092|chemokine ligand 9|chemokine ligand 9
123565|NCT02523053|Hepatocellular Carcinoma|hepatocellular carcinoma
123566|NCT02523053|Recurrence|recurrence
123567|NCT02523053|Microvascular Invasion|microvascular invasion
123568|NCT02523053|5-Fluorouracil|5-fluorouracil
123569|NCT02523040|Langerhans cell histiocytosis (LCH)|langerhans cell histiocytosis (lch)
123570|NCT02523040|Erdheim-Chester disease (ECD)|erdheim-chester disease (ecd)
123571|NCT02523040|Histiocytic Sarcoma (HS)|histiocytic sarcoma (hs)
123572|NCT02522988|cancer-related fatigue|cancer-related fatigue
123573|NCT02522975|biosimilar epoetin|biosimilar epoetin
123574|NCT02522975|efficacy|efficacy
123575|NCT02522975|safety|safety
123576|NCT02522975|immunogenicity|immunogenicity
123577|NCT02522975|renal anaemia|renal anaemia
148484|NCT02380625|EVD|evd
123578|NCT02522962|physical therapy|physical therapy
123579|NCT02522962|group-based|group-based
123580|NCT02522962|core stability|core stability
123581|NCT02522962|balance|balance
123582|NCT02522962|movement quality|movement quality
123583|NCT02522962|somatosensory stimulation|somatosensory stimulation
123584|NCT02522962|coordination|coordination
123585|NCT02522923|Physical Therapy Modalities|physical therapy modalities
123586|NCT02522923|Primary Care|primary care
123587|NCT02522923|Health Services Research|health services research
123588|NCT02522884|Angioplasty|angioplasty
123589|NCT02522884|Peripheral Artery Disease|peripheral artery disease
123590|NCT02522884|PAD|pad
123591|NCT02522884|Lesion|lesion
123592|NCT02522884|Claudication|claudication
123593|NCT02522858|premedication|premedication
123594|NCT02522858|dexmedetomidine|dexmedetomidine
123595|NCT02522858|anesthesia, spinal|anesthesia, spinal
123596|NCT02522845|Varicose Veins|varicose veins
123597|NCT02522845|Compression Stockings|compression stockings
123598|NCT02522845|Laser Ablation|laser ablation
123599|NCT02522845|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
123600|NCT02522819|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
123601|NCT02522819|acute stroke|acute stroke
123602|NCT02522819|apnea-hypopnea index (AHI)|apnea-hypopnea index (ahi)
123603|NCT02522806|Endometrial biopsy|endometrial biopsy
123604|NCT02522806|previous ovarian hyperstimulation cycle|previous ovarian hyperstimulation cycle
123605|NCT02522806|first IVF|first ivf
123606|NCT02522806|antagonist protocol|antagonist protocol
123607|NCT02522806|clinical pregnancy rate|clinical pregnancy rate
123610|NCT02522728|Arthroplasty|arthroplasty
123611|NCT02522728|Implant|implant
123612|NCT02522689|kidney stone|kidney stone
123613|NCT02522689|percutaneous nephrolithotripsy|percutaneous nephrolithotripsy
123614|NCT02522689|ultra-mini PCNL|ultra-mini pcnl
123615|NCT02522689|micro PCNL|micro pcnl
123616|NCT02522676|kidney stone|kidney stone
123617|NCT02522676|percutaneous nephrolithotripsy|percutaneous nephrolithotripsy
123618|NCT02522676|retrograde intrarenal surgery|retrograde intrarenal surgery
123619|NCT02522676|extracorporeal shock wave lithotripsy|extracorporeal shock wave lithotripsy
123620|NCT02522676|mini PCNL|mini pcnl
123621|NCT02522676|ultra-mini PCNL|ultra-mini pcnl
123622|NCT02522676|micro PCNL|micro pcnl
123623|NCT02522663|telephone support|telephone support
123624|NCT02522663|discharge management|discharge management
123625|NCT02522663|readmission|readmission
123626|NCT02522663|aortic valve replacement|aortic valve replacement
123627|NCT02522650|amiloride|amiloride
123628|NCT02522650|proteinuric kidney disease|proteinuric kidney disease
123629|NCT02522650|urokinase plasminogen activator receptor|urokinase plasminogen activator receptor
123630|NCT02522650|proteinuria|proteinuria
123631|NCT02522637|exercise|exercise
123632|NCT02522637|training|training
123633|NCT02522637|endurance|endurance
123634|NCT02522624|Health insurance|health insurance
123635|NCT02522624|Health services accessibility|health services accessibility
123636|NCT02522624|Decision making|decision making
123637|NCT02522624|Health literacy|health literacy
123638|NCT02522611|Palliative Care|palliative care
123639|NCT02522611|Adults|adults
123640|NCT02522611|Cancer Pain|cancer pain
123641|NCT02522611|Nerve Block|nerve block
123642|NCT02522611|Quality of Life|quality of life
123643|NCT02522585|expectant management|expectant management
123645|NCT02522585|immunohistochemistry|immunohistochemistry
123646|NCT02522585|regression|regression
123647|NCT02522585|progression|progression
123648|NCT02522585|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
123649|NCT02522572|Renal Transplantation|renal transplantation
123650|NCT02522572|Desensitization|desensitization
123651|NCT02522572|plerixafor|plerixafor
123652|NCT02522572|bortezomib|bortezomib
123653|NCT02522520|Undergoing chemotherapy|undergoing chemotherapy
123654|NCT02522520|Exercise intervention|exercise intervention
123655|NCT02522520|Health counselling|health counselling
123656|NCT02522520|Symptom management|symptom management
123657|NCT02522481|Lumason|lumason
123658|NCT02522481|Dobutamine stress echo|dobutamine stress echo
123659|NCT02522481|stress echo|stress echo
123660|NCT02522481|coronary artery disease|coronary artery disease
123661|NCT02522455|Flow-cycled pressure-support ventilation|flow-cycled pressure-support ventilation
123662|NCT02522403|distal radius fracture|distal radius fracture
124172|NCT02519283|ER|er
123663|NCT02522403|laser acupuncture|laser acupuncture
123664|NCT02522403|rehabilitation|rehabilitation
123665|NCT02522390|data collection|data collection
123666|NCT02522390|personal health services|personal health services
123667|NCT02522390|personal health records|personal health records
123668|NCT02522390|do-it-yourself|do-it-yourself
123669|NCT02522390|nutrition researchers|nutrition researchers
123670|NCT02522390|cohort studies|cohort studies
123671|NCT02522390|databases, factual|databases, factual
123672|NCT02522390|self-quantification methods|self-quantification methods
123673|NCT02522377|Ketamine|ketamine
123674|NCT02522377|Electroconvulsive Therapy|electroconvulsive therapy
148601|NCT02380027|MRI|mri
123675|NCT02522377|Major Depressive Disorder|major depressive disorder
123676|NCT02522377|Treatment Resistant Depression|treatment resistant depression
123677|NCT02522377|electroconvulsive treatment|electroconvulsive treatment
123678|NCT02522377|Severe depression|severe depression
123679|NCT02522364|Postoperative atrial fibrillation|postoperative atrial fibrillation
123680|NCT02522364|Dysfunction Following Cardiac Surgery|dysfunction following cardiac surgery
123681|NCT02522312|Dry Eye|dry eye
123682|NCT02522299|double-blind|double-blind
123683|NCT02522299|PI3Kdelta|pi3kdelta
123684|NCT02522299|GSK2269557|gsk2269557
123685|NCT02522299|exacerbation|exacerbation
123686|NCT02522299|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
123687|NCT02522299|randomised|randomised
123688|NCT02522299|placebo-controlled|placebo-controlled
123689|NCT02522286|patient engagement|patient engagement
123690|NCT02522286|physician's role|physician's role
123691|NCT02522286|patient- centered care|patient- centered care
123692|NCT02522286|communication|communication
123693|NCT02522273|Obstetric|obstetric
123694|NCT02522273|Midwifery|midwifery
123695|NCT02522273|Fetal blood sample|fetal blood sample
123696|NCT02522273|Lactate|lactate
123697|NCT02522273|Handheld meter|handheld meter
123698|NCT02522260|Breast cancer, chemotherapy, symptoms, optimal training|breast cancer, chemotherapy, symptoms, optimal training
123699|NCT02522234|Neutropenia|neutropenia
123700|NCT02522234|Chemotherapy|chemotherapy
123701|NCT02522221|chronic anticoagulation|chronic anticoagulation
123702|NCT02522221|vitamin K antagonist|vitamin k antagonist
123703|NCT02522221|mechanical heart valve|mechanical heart valve
123704|NCT02522221|CYP2C9|cyp2c9
123705|NCT02522221|warfarin|warfarin
123706|NCT02522221|tecarfarin|tecarfarin
123707|NCT02522195|shift work|shift work
123708|NCT02522195|nutritional status|nutritional status
123709|NCT02522195|nursing professionals|nursing professionals
123710|NCT02522195|meal distribution|meal distribution
123711|NCT02522195|food intake|food intake
123712|NCT02522182|Cardiovascular Secondary Prevention|cardiovascular secondary prevention
123713|NCT02522182|Nurse's Role|nurse's role
123714|NCT02522143|self-harm|self-harm
123715|NCT02522143|self-mutilation|self-mutilation
123716|NCT02522143|cutting|cutting
123717|NCT02522117|Kidney Transplantation|kidney transplantation
123718|NCT02522117|Atorvastatin|atorvastatin
123719|NCT02522117|Human Leukocyte Antigens|human leukocyte antigens
123720|NCT02522117|Interleukin|interleukin
123721|NCT02522104|Pharmacokinetics of Hydroxyurea|pharmacokinetics of hydroxyurea
123722|NCT02522078|misoprostol|misoprostol
123723|NCT02522078|abortion|abortion
123724|NCT02522065|Hypokinesia|hypokinesia
123725|NCT02522065|Patient Outcome Assessment|patient outcome assessment
123726|NCT02522013|post-dural puncture headache|post-dural puncture headache
123727|NCT02522013|Aminophylline|aminophylline
123728|NCT02521948|MANTA|manta
123729|NCT02521948|Arterial Closure Device|arterial closure device
123730|NCT02521948|Large Bore Closure Device|large bore closure device
123731|NCT02521909|Root Canal length|root canal length
123732|NCT02521909|Electronic apex locator|electronic apex locator
123733|NCT02521909|Endodontics|endodontics
123734|NCT02521870|Skin Cancer|skin cancer
123735|NCT02521870|Skin Tumors|skin tumors
123736|NCT02521870|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
123737|NCT02521870|Cancer Immunotherapy|cancer immunotherapy
123738|NCT02521857|Alkermes|alkermes
123739|NCT02521857|Samidorphan|samidorphan
123740|NCT02521857|ALKS 5461|alks 5461
123741|NCT02521857|Healthy Volunteer|healthy volunteer
123742|NCT02521857|Pharmacokinetics|pharmacokinetics
123743|NCT02521844|solid tumors|solid tumors
123744|NCT02521844|responsive to Wnt signalling regulation|responsive to wnt signalling regulation
123745|NCT02521831|Circumcision|circumcision
123746|NCT02521818|cognition|cognition
123747|NCT02521818|dementia|dementia
123748|NCT02521818|neuropsychological|neuropsychological
123749|NCT02521818|elderly|elderly
123750|NCT02521818|nutrition|nutrition
123751|NCT02521818|diet|diet
123752|NCT02521805|Appetite|appetite
123753|NCT02521805|Protein|protein
123754|NCT02521805|Protein quality|protein quality
123755|NCT02521805|Dietary fibre|dietary fibre
123756|NCT02521805|Satiety|satiety
123757|NCT02521792|Open-label study|open-label study
123758|NCT02521792|Clinical trial Phase 2|clinical trial phase 2
123759|NCT02521792|Efficacy and safety|efficacy and safety
123760|NCT02521792|Heterotopic ossification|heterotopic ossification
123761|NCT02521792|Fibrodysplasia Ossificans Progressiva|fibrodysplasia ossificans progressiva
123762|NCT02521792|Flare-up|flare-up
123763|NCT02521792|Palovarotene|palovarotene
123764|NCT02521792|Retinoic acid receptor agonist|retinoic acid receptor agonist
123767|NCT02521792|Myositis Ossificans Progressiva|myositis ossificans progressiva
123768|NCT02521792|Munchmeyer's Disease|munchmeyer's disease
123769|NCT02521792|FOP|fop
123770|NCT02521779|Inflammation|inflammation
123771|NCT02521779|Endotoxemia|endotoxemia
123772|NCT02521779|Lipopolysaccharide|lipopolysaccharide
123773|NCT02521779|Diet|diet
123774|NCT02521779|Fat|fat
123775|NCT02521779|Postprandial|postprandial
123776|NCT02521753|Polycystic ovary syndrome|polycystic ovary syndrome
123777|NCT02521753|Obesity|obesity
123778|NCT02521753|Metformin|metformin
123779|NCT02521753|Magnesium|magnesium
123780|NCT02521753|Polyunsaturated fatty acids|polyunsaturated fatty acids
123781|NCT02521740|biological marker|biological marker
123782|NCT02521740|frailty|frailty
123783|NCT02521740|burden|burden
123784|NCT02521740|nutrition|nutrition
123785|NCT02521740|elderly|elderly
123786|NCT02521714|Revlimid|revlimid
123787|NCT02521714|lenalidomide|lenalidomide
123788|NCT02521714|bioavailability|bioavailability
123789|NCT02521714|healthy volunteers|healthy volunteers
123790|NCT02521714|food effect|food effect
123791|NCT02521714|pharmacokinetics|pharmacokinetics
123792|NCT02521662|Electronic Cigarettes|electronic cigarettes
123793|NCT02521662|Nicotine Patch|nicotine patch
123794|NCT02521662|Smoking Cessation|smoking cessation
123795|NCT02521649|Gastric Cancer|gastric cancer
123796|NCT02521649|G17DT|g17dt
123797|NCT02521649|PAS|pas
123798|NCT02521649|Insegia|insegia
123799|NCT02521649|Gastrimmune|gastrimmune
123800|NCT02521623|Acelullar Dermal Matrix|acelullar dermal matrix
123801|NCT02521623|Immediate Breast Reconstruction|immediate breast reconstruction
123802|NCT02521623|Breast Implant|breast implant
123803|NCT02521584|Liver transplant recipient|liver transplant recipient
123804|NCT02521545|Oral Remyelination|oral remyelination
123805|NCT02521519|Facet induced pain|facet induced pain
123806|NCT02521519|Myofascial pain|myofascial pain
123807|NCT02521519|Trigger points|trigger points
123808|NCT02521519|Low back pain|low back pain
123809|NCT02521454|policing|policing
123810|NCT02521454|resilience|resilience
123811|NCT02521454|implicit bias|implicit bias
123812|NCT02521454|violence|violence
123813|NCT02521441|Neutropenia|neutropenia
123814|NCT02521441|Myelotoxic Chemotherapy|myelotoxic chemotherapy
123815|NCT02521441|G-CSF|g-csf
123816|NCT02521363|Implantable Microdevice|implantable microdevice
123817|NCT02521363|In Vivo Drug Sensitivity Testing|in vivo drug sensitivity testing
123818|NCT02521363|HER2-Positive|her2-positive
123819|NCT02521363|Triple Negative|triple negative
123820|NCT02521363|15-127|15-127
123821|NCT02521350|Acute Kidney Injury|acute kidney injury
123822|NCT02521350|Surgery|surgery
123823|NCT02521350|Perioperative care|perioperative care
123824|NCT02521311|multiple sclerosis|multiple sclerosis
123825|NCT02521311|eye pain|eye pain
123826|NCT02521311|vision loss|vision loss
123827|NCT02521259|anesthetic depth|anesthetic depth
123828|NCT02521259|emergence agitation|emergence agitation
123829|NCT02521220|L-citrulline|l-citrulline
123830|NCT02521220|Endothelial dysfunction|endothelial dysfunction
123831|NCT02521194|Advanced Cancers|advanced cancers
123832|NCT02521194|Inpatient occupational therapy|inpatient occupational therapy
123833|NCT02521194|Questionnaire|questionnaire
123834|NCT02521194|Survey|survey
123835|NCT02521168|euthyroid sick syndrome|euthyroid sick syndrome
123836|NCT02521168|cardiopulmonary bypass|cardiopulmonary bypass
123837|NCT02521168|congenital heart disease|congenital heart disease
123838|NCT02521168|time to extubation|time to extubation
123839|NCT02521155|Oral health literacy intervention|oral health literacy intervention
123840|NCT02521155|oral hygiene behavior|oral hygiene behavior
123841|NCT02521142|OCT Angiography|oct angiography
123842|NCT02521116|retinal oxygenation|retinal oxygenation
123843|NCT02521116|retinal vessel diameters|retinal vessel diameters
123844|NCT02521116|Dynamic vessel analyzer (DVA)|dynamic vessel analyzer (dva)
123845|NCT02521116|Oxymap T1|oxymap t1
123846|NCT02521077|Ascorbic Acid|ascorbic acid
123847|NCT02521077|Breast Neoplasms|breast neoplasms
123848|NCT02521077|Fatigue|fatigue
123849|NCT02521064|IBD|ibd
123850|NCT02521064|enteral nutrition|enteral nutrition
123851|NCT02521064|corticosteroids|corticosteroids
123852|NCT02521051|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
123853|NCT02521051|Anaplatic lymphoma kinase|anaplatic lymphoma kinase
123854|NCT02521051|ALK|alk
123855|NCT02521051|Brain metastases|brain metastases
123856|NCT02521012|Depression|depression
123857|NCT02521012|Depressive symptoms|depressive symptoms
123858|NCT02521012|Vitamin D|vitamin d
123859|NCT02521012|Intervention|intervention
123860|NCT02520986|Sexually transmitted disease|sexually transmitted disease
123861|NCT02520986|Genital Warts|genital warts
123862|NCT02520986|Venereal Warts|venereal warts
123863|NCT02520960|Catheter Ablation|catheter ablation
124610|NCT02516280|mobility|mobility
123864|NCT02520960|Pulmonary Vein Isolation|pulmonary vein isolation
123865|NCT02520960|Radiofrequency|radiofrequency
123866|NCT02520947|desflurane|desflurane
123867|NCT02520947|BIS|bis
123868|NCT02520947|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
123869|NCT02520934|Enzyme Replacement Therapy|enzyme replacement therapy
123870|NCT02520934|Miglustat|miglustat
123871|NCT02520934|Gaucher Disease|gaucher disease
123872|NCT02520921|Diabetes mellitus|diabetes mellitus
115125|NCT02574390|ALS|als
123873|NCT02520921|Acute coronary syndrome|acute coronary syndrome
123874|NCT02520921|Coronary artery disease|coronary artery disease
123875|NCT02520921|Aspirin|aspirin
123876|NCT02520921|Secondary prevention|secondary prevention
123877|NCT02520895|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
123878|NCT02520895|Non-Hodgkin lymphoma|non-hodgkin lymphoma
123879|NCT02520895|Follicular Lymphoma|follicular lymphoma
123880|NCT02520895|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
123881|NCT02520895|MALT Lymphoma|malt lymphoma
123882|NCT02520895|T Cell Lymphoma|t cell lymphoma
123883|NCT02520895|Immune Repertoire|immune repertoire
123884|NCT02520895|Infection|infection
123885|NCT02520895|relapse|relapse
123886|NCT02520895|survival|survival
123887|NCT02520895|treatment response|treatment response
123888|NCT02520895|VJ rearrangement|vj rearrangement
123889|NCT02520882|PET/CT|pet/ct
123890|NCT02520882|Bombesin|bombesin
123891|NCT02520882|gastrin-releasing peptide receptor|gastrin-releasing peptide receptor
123892|NCT02520882|68Gallium labeling|68gallium labeling
123893|NCT02520830|blueberry polyphenols|blueberry polyphenols
123894|NCT02520830|Polyphenol metabolites|polyphenol metabolites
123895|NCT02520830|endothelial function|endothelial function
123896|NCT02520830|Molecular mechanisms of action|molecular mechanisms of action
123897|NCT02520830|Vascular function|vascular function
123898|NCT02520830|Healthy men|healthy men
123899|NCT02520817|Antioxidants|antioxidants
123900|NCT02520817|Zinc|zinc
123901|NCT02520817|Truck drivers|truck drivers
123902|NCT02520804|balanced salt solution|balanced salt solution
123903|NCT02520765|Obesity Index, ICSI|obesity index, icsi
123904|NCT02520752|cMET, INC280, caffeine, midazolam|cmet, inc280, caffeine, midazolam
123905|NCT02520739|olive oil|olive oil
123906|NCT02520739|phenolic compounds|phenolic compounds
123907|NCT02520739|triterpenes|triterpenes
123908|NCT02520739|oxidation and inflammation|oxidation and inflammation
125013|NCT02513693|TOF|tof
123909|NCT02520726|Posttraumatic stress disorder|posttraumatic stress disorder
123910|NCT02520726|PTSD|ptsd
123911|NCT02520726|Sertraline|sertraline
123912|NCT02520726|Burns|burns
123913|NCT02520713|Pediatric Solid Tumor|pediatric solid tumor
123914|NCT02520648|Back pain|back pain
123915|NCT02520648|Manual therapy|manual therapy
123916|NCT02520635|prognosis|prognosis
123917|NCT02520635|supra-early chemotherapy|supra-early chemotherapy
123918|NCT02520609|Metabolomics|metabolomics
123919|NCT02520609|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
123920|NCT02520609|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
123921|NCT02520609|Energy Expenditure|energy expenditure
123922|NCT02520596|Raspberries|raspberries
123923|NCT02520596|Anthocyanins|anthocyanins
123924|NCT02520596|Ellagitannins|ellagitannins
123925|NCT02520596|Metabolites|metabolites
123926|NCT02520557|Epilepsy|epilepsy
123927|NCT02520557|Genetic associations with severe Cutaneous Adverse Reactions|genetic associations with severe cutaneous adverse reactions
123928|NCT02520492|intracranial pressure|intracranial pressure
123929|NCT02520479|extranodal natural killer/T-cell lymphoma|extranodal natural killer/t-cell lymphoma
123930|NCT02520479|nasal type|nasal type
123931|NCT02520479|radiotherapy|radiotherapy
123932|NCT02520479|chemotherapy|chemotherapy
123933|NCT02520440|Citrulline|citrulline
123935|NCT02520440|MOF|mof
123936|NCT02520440|Calprotectina|calprotectina
123937|NCT02520440|intraabdominal pressure|intraabdominal pressure
123938|NCT02520427|Amgen|amgen
123939|NCT02520427|Phase 1|phase 1
123940|NCT02520427|Clinical Trial|clinical trial
123941|NCT02520427|Oncology/Hematology|oncology/hematology
123942|NCT02520427|Relapsed/Refractory AML|relapsed/refractory aml
123943|NCT02520427|Immunotherapy|immunotherapy
123944|NCT02520310|Mitral Regurgitation|mitral regurgitation
123945|NCT02520310|mitral valve surgery|mitral valve surgery
123946|NCT02520310|AVJ-514 Delivery System|avj-514 delivery system
123947|NCT02520310|Symptomatic Heart Failure|symptomatic heart failure
123948|NCT02520310|Heart Valve Disease|heart valve disease
123949|NCT02520297|Pain|pain
123950|NCT02520297|Long bone|long bone
123951|NCT02520297|Fracture|fracture
123952|NCT02520271|Mood Disorders|mood disorders
123953|NCT02520271|Motivational Interview|motivational interview
123954|NCT02520271|Behavioral Activation|behavioral activation
123955|NCT02520258|artificial sweeteners|artificial sweeteners
123956|NCT02520258|obesity|obesity
123957|NCT02520258|diabetes|diabetes
123958|NCT02520258|metabolic syndrome|metabolic syndrome
123959|NCT02520258|aspartame|aspartame
123960|NCT02520232|chronic exercise|chronic exercise
123961|NCT02520232|genetic polymorphisms|genetic polymorphisms
123962|NCT02520232|brain imagery|brain imagery
123963|NCT02520232|executive functions|executive functions
123964|NCT02520232|alzheimer's disease|alzheimer's disease
123965|NCT02520219|Peripheral T-cell lymphomas,Endostar|peripheral t-cell lymphomas,endostar
123966|NCT02520193|Early mobilisation|early mobilisation
123967|NCT02520193|Invasive ventilation|invasive ventilation
123968|NCT02520193|Ventilator free days|ventilator free days
123969|NCT02520193|Intensive Care Unit|intensive care unit
123970|NCT02520167|Gestational weight gain|gestational weight gain
123971|NCT02520154|Ovarian Cancer|ovarian cancer
123972|NCT02520154|Metastatic Ovarian Cancer|metastatic ovarian cancer
123973|NCT02520154|High-grade epithelial non-mucinous ovarian cancer|high-grade epithelial non-mucinous ovarian cancer
123974|NCT02520154|Advanced stage ovarian cancer|advanced stage ovarian cancer
123975|NCT02520154|Carboplatin|carboplatin
123976|NCT02520154|Paraplatin|paraplatin
123977|NCT02520154|Paclitaxel|paclitaxel
123978|NCT02520154|Taxol|taxol
123979|NCT02520154|Pembrolizumab|pembrolizumab
123980|NCT02520154|Keytruda|keytruda
123981|NCT02520154|MK-3475|mk-3475
123982|NCT02520154|SCH-900475|sch-900475
123983|NCT02520141|Biliary cancer|biliary cancer
123984|NCT02520141|Advanced biliary cancers|advanced biliary cancers
123985|NCT02520141|Intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
123986|NCT02520141|Extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
123987|NCT02520141|Gallbladder cancer|gallbladder cancer
123988|NCT02520141|Received prior chemotherapy|received prior chemotherapy
123989|NCT02520141|Ramucirumab|ramucirumab
123990|NCT02520141|IMC-1121B|imc-1121b
123991|NCT02520128|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
123992|NCT02520128|Radiotherapy|radiotherapy
123993|NCT02520089|platelet-rich plasma|platelet-rich plasma
123994|NCT02520089|bone grafting|bone grafting
123995|NCT02520089|pseudoarthrosis|pseudoarthrosis
123996|NCT02520076|Islet Transplantation|islet transplantation
123997|NCT02520063|hormone-receptor positive breast cancer|hormone-receptor positive breast cancer
123998|NCT02520063|Her2 negative breast cancer|her2 negative breast cancer
123999|NCT02520063|neoadjuvant|neoadjuvant
124000|NCT02520063|everolimus|everolimus
124001|NCT02520063|TRC105|trc105
124002|NCT02520063|letrozole|letrozole
124003|NCT02520050|Type 2 diabetes|type 2 diabetes
124004|NCT02520050|Obesity|obesity
124005|NCT02520050|Nutrition|nutrition
124006|NCT02520050|Medical Nutrition Therapy|medical nutrition therapy
124007|NCT02520037|Fluid responsiveness|fluid responsiveness
124008|NCT02520037|Volume responsiveness|volume responsiveness
124009|NCT02520037|Hemodynamics|hemodynamics
124010|NCT02520024|self-directed care|self-directed care
124011|NCT02520024|serious mental illness|serious mental illness
124012|NCT02520011|Refractory AML|refractory aml
124013|NCT02520011|Relapsed AML|relapsed aml
124014|NCT02520011|AML|aml
124015|NCT02520011|Newly diagnosed high-risk AML|newly diagnosed high-risk aml
124016|NCT02519998|Biomarkers|biomarkers
124017|NCT02519998|Electrocardiography|electrocardiography
124018|NCT02519998|Balance|balance
124019|NCT02519998|Neuropsychiatric assessment|neuropsychiatric assessment
124020|NCT02519998|Cortisol|cortisol
124021|NCT02519998|Calcitonin-gene-related peptide|calcitonin-gene-related peptide
124022|NCT02519998|Electroencephalography|electroencephalography
124023|NCT02519998|Optical coherence tomography|optical coherence tomography
124024|NCT02519998|Von Frey Testing|von frey testing
124025|NCT02519985|VHF digital ultrasound|vhf digital ultrasound
124026|NCT02519985|Corneal thickness|corneal thickness
124027|NCT02519985|Epithelial thickness|epithelial thickness
124028|NCT02519985|Angle diameter|angle diameter
124029|NCT02519985|Sulcus diameter|sulcus diameter
124030|NCT02519985|Anterior chamber depth|anterior chamber depth
124031|NCT02519985|Repeatability|repeatability
124032|NCT02519985|Reproducibility|reproducibility
124033|NCT02519972|Low dose CT screening|low dose ct screening
124034|NCT02519972|Family history of lung cancer|family history of lung cancer
124035|NCT02519946|Heart Transplantation|heart transplantation
124036|NCT02519946|Tonometry|tonometry
124037|NCT02519946|Exercise Test|exercise test
124038|NCT02519946|Diet|diet
124039|NCT02519946|Cardiovascular Physiology|cardiovascular physiology
124040|NCT02519946|Telemedicine|telemedicine
124041|NCT02519946|Pediatrics|pediatrics
124042|NCT02519946|Health Behavior|health behavior
124043|NCT02519946|Physical Fitness|physical fitness
124044|NCT02519946|Exercise Movement Techniques|exercise movement techniques
124045|NCT02519946|Adolescent Behavior|adolescent behavior
124046|NCT02519946|Child Behavior|child behavior
124047|NCT02519933|hemodialysis|hemodialysis
124048|NCT02519933|vascular access|vascular access
124049|NCT02519907|Nerve Stimulation|nerve stimulation
124050|NCT02519907|Neuroplasticity|neuroplasticity
124051|NCT02519907|Sensory Feedback|sensory feedback
124052|NCT02519881|cartilage defect in ankle|cartilage defect in ankle
124053|NCT02519881|microfracture|microfracture
124054|NCT02519881|modified microfracture using collagen|modified microfracture using collagen
124055|NCT02519881|collagen|collagen
124056|NCT02519868|Neuromodulation|neuromodulation
124057|NCT02519868|Local anaesthetics|local anaesthetics
124058|NCT02519829|Suture|suture
124059|NCT02519829|Skin staples|skin staples
124060|NCT02519829|Vicryl|vicryl
124061|NCT02519829|Monocryl|monocryl
124062|NCT02519816|post stem cell transplantation|post stem cell transplantation
124063|NCT02519816|Steroid refractory|steroid refractory
124064|NCT02519816|dependent chronic|dependent chronic
124065|NCT02519777|HIV-Associated Neurocognitive Disorder|hiv-associated neurocognitive disorder
124066|NCT02519764|volunteer runners who are participating in the 2015 Mont Blanc Ultra Trail|volunteer runners who are participating in the 2015 mont blanc ultra trail
124067|NCT02519764|hydration protocol|hydration protocol
124068|NCT02519764|natremia|natremia
124069|NCT02519764|Volunteers|volunteers
124070|NCT02519725|Family|family
124071|NCT02519725|PTSD|ptsd
124072|NCT02519725|Anxiety disorders|anxiety disorders
124073|NCT02519725|Depression disorders|depression disorders
124074|NCT02519725|Qualitative research|qualitative research
124075|NCT02519712|Induction Chemotherapy|induction chemotherapy
124076|NCT02519712|G-CSF-Mobilized Stem Cells|g-csf-mobilized stem cells
124077|NCT02519712|Haploidentical Related Donors|haploidentical related donors
124078|NCT02519712|15-141|15-141
124079|NCT02519660|Ralydan|ralydan
124080|NCT02519660|EMLA cream|emla cream
124081|NCT02519660|Procedural pain|procedural pain
124082|NCT02519660|Phlebotomy|phlebotomy
124083|NCT02519660|Child|child
124084|NCT02519634|Super-Mini Percutaneous Nephrolithotomy|super-mini percutaneous nephrolithotomy
124085|NCT02519634|SMP|smp
124086|NCT02519634|Retrograde Intrarenal Surgery|retrograde intrarenal surgery
124087|NCT02519634|RIRS|rirs
124088|NCT02519634|Randomized Controlled Trial|randomized controlled trial
124089|NCT02519634|RCT|rct
124090|NCT02519621|diabetic ulcer|diabetic ulcer
124091|NCT02519621|pressure ulcer|pressure ulcer
124092|NCT02519621|chronic or traumatic wound|chronic or traumatic wound
124093|NCT02519621|sub-acute or dehisced wound|sub-acute or dehisced wound
124094|NCT02519608|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
124095|NCT02519608|stable coronary artery disease|stable coronary artery disease
124096|NCT02519608|ticagrelor|ticagrelor
124097|NCT02519608|clopidogrel|clopidogrel
124098|NCT02519608|endothelial function|endothelial function
124099|NCT02519608|inflammation|inflammation
124100|NCT02519608|platelet reactivity|platelet reactivity
124101|NCT02519595|Procedural sedation|procedural sedation
124102|NCT02519595|ketamine|ketamine
124103|NCT02519595|children|children
124110|NCT02519543|insulin resistance|insulin resistance
124111|NCT02519530|Positive Youth Development|positive youth development
124112|NCT02519530|Teen Outreach|teen outreach
124113|NCT02519530|Teen Pregnancy Prevention|teen pregnancy prevention
124114|NCT02519504|Galactose-1-phosphate uridylyltransferase deficiency|galactose-1-phosphate uridylyltransferase deficiency
124115|NCT02519504|Cognitive disorders|cognitive disorders
124116|NCT02519478|football|football
124117|NCT02519478|Training Techniques|training techniques
124118|NCT02519478|education|education
124119|NCT02519478|Athletic Injuries|athletic injuries
124120|NCT02519478|Brain Concussion|brain concussion
124121|NCT02519465|nasal cannula|nasal cannula
124122|NCT02519465|Inhalation Devices|inhalation devices
124123|NCT02519452|Multiple Myeloma|multiple myeloma
124124|NCT02519452|Daratumumab (JNJ-54767414)|daratumumab (jnj-54767414)
124125|NCT02519452|Recombinant Human Hyaluronidase|recombinant human hyaluronidase
124126|NCT02519439|Partial Onset Seizures|partial onset seizures
124127|NCT02519439|complex partial seizures|complex partial seizures
124128|NCT02519439|simple partial seizures|simple partial seizures
124129|NCT02519439|anticonvulsant|anticonvulsant
124130|NCT02519439|ganaxolone|ganaxolone
124131|NCT02519439|neurosteroid|neurosteroid
124132|NCT02519439|Marinus|marinus
124133|NCT02519439|epilepsy|epilepsy
124134|NCT02519426|Third molar|third molar
124135|NCT02519426|Classification|classification
124136|NCT02519426|Inferior alveolar nerve|inferior alveolar nerve
124137|NCT02519426|Lingual nerve injuries|lingual nerve injuries
124138|NCT02519426|Mandibular canal|mandibular canal
124139|NCT02519413|lymphocyte|lymphocyte
124140|NCT02519413|serious infections|serious infections
124141|NCT02519413|opportunistic infections|opportunistic infections
124142|NCT02519413|Relapsing Forms|relapsing forms
124143|NCT02519400|amitriptyline|amitriptyline
124144|NCT02519400|cyp2d6|cyp2d6
124145|NCT02519400|cyp2c19|cyp2c19
124146|NCT02519374|Fiber tolerability|fiber tolerability
124147|NCT02519374|Children|children
124148|NCT02519361|elderly|elderly
124149|NCT02519361|immune response|immune response
124150|NCT02519361|acute infection|acute infection
124157|NCT02519335|cardiopulmonary bypass|cardiopulmonary bypass
124158|NCT02519335|ischemia reperfusion injury|ischemia reperfusion injury
124159|NCT02519322|Melanoma|melanoma
124160|NCT02519322|Oligometastatic melanoma|oligometastatic melanoma
124161|NCT02519322|Resectable|resectable
124162|NCT02519322|Nivolumab|nivolumab
124163|NCT02519322|BMS-936558|bms-936558
124164|NCT02519322|Opdivo|opdivo
124165|NCT02519322|Ipilimumab|ipilimumab
124166|NCT02519322|Yervoy|yervoy
124167|NCT02519322|BMS-734016|bms-734016
124168|NCT02519322|MDX010|mdx010
124170|NCT02519283|HF|hf
124171|NCT02519283|ED|ed
124173|NCT02519283|Emergency Department|emergency department
124174|NCT02519283|Emergency Room|emergency room
124176|NCT02519257|VHD|vhd
124177|NCT02519257|Thy-1|thy-1
124178|NCT02519244|Multiple Sclerosis|multiple sclerosis
124179|NCT02519244|Ambulation|ambulation
124180|NCT02519244|Rehabilitation|rehabilitation
124181|NCT02519244|Wearable Robotic Devices|wearable robotic devices
124182|NCT02519231|IUD|iud
124183|NCT02519231|naproxen|naproxen
124184|NCT02519231|bleeding|bleeding
124185|NCT02519153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors
124186|NCT02519153|PDE5i|pde5i
124187|NCT02519153|Sildinafil|sildinafil
124188|NCT02519140|Gastric cancer|gastric cancer
124189|NCT02519140|colon cancer|colon cancer
124190|NCT02519140|EMR|emr
124191|NCT02519140|biopsy|biopsy
124192|NCT02519140|bariatric surgery|bariatric surgery
124193|NCT02519114|M Myeloma|m myeloma
124194|NCT02519114|KIR ligand mismatch|kir ligand mismatch
124195|NCT02519114|Haploidentical|haploidentical
124196|NCT02519088|Homologous Blood Transfusion|homologous blood transfusion
124197|NCT02519088|Total Hip Replacement|total hip replacement
124198|NCT02519088|Patient Blood Management|patient blood management
124199|NCT02519075|Hepatocarcinoma|hepatocarcinoma
124200|NCT02519075|TARE|tare
124201|NCT02519075|response assessment|response assessment
124202|NCT02519062|Carcinoma|carcinoma
124203|NCT02519062|Non-Small-Cell Lung|non-small-cell lung
124204|NCT02519062|FDG PET|fdg pet
124205|NCT02519062|hypoxia markers|hypoxia markers
124206|NCT02519062|immune markers|immune markers
124207|NCT02519049|Mesothelioma|mesothelioma
124208|NCT02519049|11C-methionine PET|11c-methionine pet
124209|NCT02519049|talc pleurodesis|talc pleurodesis
124210|NCT02519036|Huntington's Disease|huntington's disease
124212|NCT02519036|Early Manifest Huntington's Disease|early manifest huntington's disease
124213|NCT02518997|Preterm Infants|preterm infants
124214|NCT02518997|Bedside Reading aloud|bedside reading aloud
124215|NCT02518997|Parental wellbeing|parental wellbeing
124216|NCT02518997|Parental Bonding|parental bonding
124217|NCT02518997|cardio-respiratory stability|cardio-respiratory stability
124218|NCT02518945|Type 1 Diabetes|type 1 diabetes
124219|NCT02518945|Liraglutide|liraglutide
124220|NCT02518945|Dapagliflozin|dapagliflozin
124221|NCT02518945|Triple Therapy|triple therapy
124222|NCT02518919|Children|children
124223|NCT02518919|Emergency Department|emergency department
124224|NCT02518919|Sedation|sedation
124225|NCT02518906|Psychotherapy|psychotherapy
124226|NCT02518906|psychotherapy process|psychotherapy process
124227|NCT02518906|therapeutic alliance|therapeutic alliance
124228|NCT02518906|psychotherapeutic change|psychotherapeutic change
124229|NCT02518906|psychophysiology|psychophysiology
124230|NCT02518893|Military Personnel|military personnel
124231|NCT02518893|Air Force Personnel|air force personnel
124232|NCT02518893|Army Personnel|army personnel
124233|NCT02518893|Navy Personnel|navy personnel
124234|NCT02518893|Armed Forces Personnel|armed forces personnel
124235|NCT02518893|Marines|marines
124236|NCT02518893|Soldiers|soldiers
124237|NCT02518893|Sailors|sailors
124238|NCT02518893|Airmen|airmen
124239|NCT02518893|Decision Making|decision making
124240|NCT02518893|Research Subjects|research subjects
124241|NCT02518893|Life Experiences|life experiences
124242|NCT02518893|Patient Participation|patient participation
124243|NCT02518893|Refusal to Participate|refusal to participate
124244|NCT02518893|Healthcare Research|healthcare research
124245|NCT02518893|Qualitative Research|qualitative research
124246|NCT02518893|Interview|interview
124247|NCT02518893|Interviews, Telephone|interviews, telephone
124248|NCT02518893|Ethics, Research|ethics, research
124249|NCT02518867|Cerebral palsy|cerebral palsy
124250|NCT02518867|Transcranial magnetic stimulation|transcranial magnetic stimulation
124251|NCT02518841|ThermaWedge TM|thermawedge tm
124252|NCT02518841|stretches|stretches
124253|NCT02518828|Acute Heart Failure|acute heart failure
124254|NCT02518802|Gefitinib|gefitinib
124255|NCT02518802|Pemetrexed|pemetrexed
124256|NCT02518802|Synchronous therapy|synchronous therapy
124257|NCT02518802|Adjuvent therapy|adjuvent therapy
124258|NCT02518789|myoclonus|myoclonus
124259|NCT02518789|Etomidate|etomidate
124260|NCT02518789|Dexmedetomidine|dexmedetomidine
124261|NCT02518750|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
124262|NCT02518750|Salvage Regimen|salvage regimen
124263|NCT02518750|Re-Induction Therapy|re-induction therapy
124264|NCT02518750|Multi-agent chemotherapy|multi-agent chemotherapy
124265|NCT02518737|Glucose-dependent Insulinotropic Polypeptide|glucose-dependent insulinotropic polypeptide
124266|NCT02518737|Receptor Deficiency|receptor deficiency
124267|NCT02518711|symptoms of ADHD|symptoms of adhd
124268|NCT02518698|Castrated resistant prostate cancer|castrated resistant prostate cancer
124269|NCT02518698|Patients with bone metastases|patients with bone metastases
124270|NCT02518685|Obesity|obesity
124271|NCT02518685|Weight loss|weight loss
124272|NCT02518685|Device|device
124273|NCT02518685|Non-surgical|non-surgical
124274|NCT02518685|Endoscopic|endoscopic
124279|NCT02518659|inulin|inulin
124280|NCT02518659|FOS|fos
124282|NCT02518659|proton-pump inhibitors|proton-pump inhibitors
124283|NCT02518646|Delirium|delirium
124284|NCT02518646|Intensive care unit|intensive care unit
124285|NCT02518646|Adult|adult
124286|NCT02518646|Clinical prediction|clinical prediction
124287|NCT02518633|obesity|obesity
124288|NCT02518633|hypoxia|hypoxia
124289|NCT02518633|adipose tissue|adipose tissue
124290|NCT02518607|Safety and Tolerability|safety and tolerability
124291|NCT02518607|Male Volunteers|male volunteers
124292|NCT02518594|women|women
124293|NCT02518594|cervical length of less than 30 millimeters|cervical length of less than 30 millimeters
124294|NCT02518594|carrying twins|carrying twins
124295|NCT02518594|short cervix|short cervix
124296|NCT02518516|Statins, HMG-CoA|statins, hmg-coa
124297|NCT02518516|Acute kidney injury|acute kidney injury
124298|NCT02518516|Kidney diseases|kidney diseases
124299|NCT02518516|Renal failure|renal failure
124300|NCT02518503|Diabetes Mellitus|diabetes mellitus
124301|NCT02518503|Statins|statins
124302|NCT02518503|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
124303|NCT02518477|breast cancer surgery|breast cancer surgery
124304|NCT02518477|axillary lymph node dissection|axillary lymph node dissection
124305|NCT02518477|resistance training|resistance training
124306|NCT02518477|breast cancer related lymphedema|breast cancer related lymphedema
124307|NCT02518464|headache|headache
124308|NCT02518464|chronic|chronic
124309|NCT02518464|migraine|migraine
124310|NCT02518464|right to left shunt|right to left shunt
124311|NCT02518451|antihypertensive|antihypertensive
124312|NCT02518451|bioequivalence|bioequivalence
124313|NCT02518451|formulation|formulation
124314|NCT02518451|pharmakokinetic|pharmakokinetic
124315|NCT02518451|valsartan|valsartan
124316|NCT02518451|subjects|subjects
124317|NCT02518451|Fasting conditions|fasting conditions
124318|NCT02518438|Tramadol|tramadol
124319|NCT02518438|Postoperative analgesia|postoperative analgesia
124320|NCT02518438|Infiltration|infiltration
124321|NCT02518438|Cesarean section|cesarean section
124322|NCT02518412|Alzheimers disease|alzheimers disease
124323|NCT02518412|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
124324|NCT02518412|Neuromodulation|neuromodulation
124325|NCT02518412|Neuropsychology|neuropsychology
124326|NCT02518399|Blood vessels|blood vessels
124327|NCT02518399|Heat|heat
124328|NCT02518399|Cardiovascular diseases|cardiovascular diseases
124329|NCT02518386|emergency department|emergency department
124330|NCT02518386|epidemiology|epidemiology
124331|NCT02518386|prehospital care|prehospital care
124332|NCT02518386|dispatch|dispatch
124333|NCT02518386|acute self poisoning|acute self poisoning
124334|NCT02518360|NON SPECIFIC LOW BACK PAIN|non specific low back pain
124335|NCT02518360|OSTEOPATHY|osteopathy
124336|NCT02518360|FOOT PRESSURE PLATFORM|foot pressure platform
124337|NCT02518360|POSTURAL BALANCE|postural balance
124338|NCT02518334|type two diabetes|type two diabetes
124339|NCT02518334|glycemic control|glycemic control
124340|NCT02518321|Toileting|toileting
124341|NCT02518321|Technology-Assisted Toilets|technology-assisted toilets
124342|NCT02518321|Rehabilitation|rehabilitation
124343|NCT02518321|Assistive Devices|assistive devices
124344|NCT02518321|Activities of Daily Living|activities of daily living
124345|NCT02518282|high-sensitivity troponin T|high-sensitivity troponin t
124346|NCT02518282|Acute myocardial infarction|acute myocardial infarction
124347|NCT02518282|Heart valvular surgery|heart valvular surgery
124348|NCT02518282|Cardiac surgery|cardiac surgery
124349|NCT02518269|hip|hip
124350|NCT02518269|arthroplasty|arthroplasty
124351|NCT02518269|G7|g7
124352|NCT02518269|EchoBimetric|echobimetric
124353|NCT02518269|E1|e1
124354|NCT02518269|ceramic|ceramic
124355|NCT02518269|Arcom XL|arcom xl
124356|NCT02518256|Neoplasms|neoplasms
124357|NCT02518256|Glandular and Epithelial|glandular and epithelial
124358|NCT02518256|Ovarian Neoplasms|ovarian neoplasms
124359|NCT02518256|Ovarian cancer|ovarian cancer
124360|NCT02518204|cognitive assessment|cognitive assessment
124361|NCT02518204|neuropsychological assessment|neuropsychological assessment
124362|NCT02518204|Brain Performance Test|brain performance test
124363|NCT02518204|computerized assessment|computerized assessment
124364|NCT02518191|GnRHa|gnrha
124365|NCT02518191|ovarian function|ovarian function
124366|NCT02518191|anti-mullerian hormone|anti-mullerian hormone
124367|NCT02518178|NFC|nfc
124368|NCT02518178|randomization|randomization
124369|NCT02518178|RCT|rct
124370|NCT02518178|mHealth|mhealth
124371|NCT02518178|maternal and child health|maternal and child health
124372|NCT02518165|Cognitive Domain: Speed|cognitive domain: speed
125118|NCT02513264|Asthma|asthma
124374|NCT02518165|Cognitive Domain: Attention|cognitive domain: attention
124375|NCT02518165|Cognitive Domain: Executive Function|cognitive domain: executive function
124376|NCT02518165|Cognitive Domain Memory|cognitive domain memory
124377|NCT02518165|Sleep Quality|sleep quality
124378|NCT02518165|Sleep Efficiency|sleep efficiency
124379|NCT02518139|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
149570|NCT02374476|VT|vt
124380|NCT02518126|LIF IUGR|lif iugr
124381|NCT02518087|CPB|cpb
124382|NCT02518087|OXIRIS®|oxiris®
124383|NCT02518087|AKI|aki
124384|NCT02518087|SIRS|sirs
124385|NCT02518087|Cytokines|cytokines
124386|NCT02518087|LPS|lps
124387|NCT02518074|volunteers|volunteers
124388|NCT02518061|Glioma; 11C-Methionine PET|glioma; 11c-methionine pet
124389|NCT02518048|Psoriasis|psoriasis
124390|NCT02518022|Type 1 Diabetes mellitus|type 1 diabetes mellitus
124391|NCT02518022|Hypoglycemia|hypoglycemia
124392|NCT02518022|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
124393|NCT02518022|Alcohol|alcohol
124394|NCT02518022|continuous glucose monitoring system|continuous glucose monitoring system
124395|NCT02518022|Nutrition|nutrition
124396|NCT02517983|chronic respiratory diseases phenotyping|chronic respiratory diseases phenotyping
124397|NCT02517970|infant feeding|infant feeding
124398|NCT02517970|breast-feeding|breast-feeding
124399|NCT02517970|bottle-feeding|bottle-feeding
124400|NCT02517970|feeding interactions|feeding interactions
124401|NCT02517970|maternal feeding practices|maternal feeding practices
124402|NCT02517957|Xiashi surgical|xiashi surgical
124403|NCT02517944|Familial hypercholesterolemia|familial hypercholesterolemia
124404|NCT02517918|Advanced solid tumor|advanced solid tumor
124405|NCT02517918|Bone metastasis and advanced pretreated osteosarcoma|bone metastasis and advanced pretreated osteosarcoma
124406|NCT02517918|Phase I trial|phase i trial
124505|NCT02517073|mechanical ventilation|mechanical ventilation
124407|NCT02517918|Dose escalation and expansion cohort|dose escalation and expansion cohort
124408|NCT02517918|Biomarkers study|biomarkers study
124409|NCT02517879|ITNs|itns
124410|NCT02517879|malaria prevention|malaria prevention
124411|NCT02517866|Drug therapy|drug therapy
124412|NCT02517827|common femoral artery|common femoral artery
124413|NCT02517827|drug-coated balloon|drug-coated balloon
124414|NCT02517827|surgical endarterectomy|surgical endarterectomy
124415|NCT02517801|anthocyanins|anthocyanins
124416|NCT02517801|Post-menopausal women|post-menopausal women
124417|NCT02517801|endothelial function|endothelial function
124418|NCT02517801|vascular function|vascular function
124419|NCT02517775|polyphenols|polyphenols
124420|NCT02517775|vascular function|vascular function
124421|NCT02517775|endothelial function|endothelial function
124422|NCT02517775|cranberry|cranberry
124423|NCT02517775|healthy|healthy
124424|NCT02517723|Borderline Personality Disorder|borderline personality disorder
124425|NCT02517723|comorbid Posttraumatic Stress Disorder|comorbid posttraumatic stress disorder
124426|NCT02517723|Narrative Exposure Therapy|narrative exposure therapy
652124|NCT00779363|Diabetes|diabetes
124427|NCT02517723|Dialectical-Behavioral Therapy|dialectical-behavioral therapy
124428|NCT02517684|Crohn's disease|crohn's disease
124429|NCT02517684|pediatric|pediatric
124430|NCT02517684|infliximab|infliximab
124431|NCT02517684|top-down|top-down
124432|NCT02517684|TISKids|tiskids
124433|NCT02517671|Fitness|fitness
124434|NCT02517671|Run time|run time
124435|NCT02517671|VO2max|vo2max
124436|NCT02517671|VEGF|vegf
124437|NCT02517671|Central blood pressure|central blood pressure
124438|NCT02517671|Augmentation Index|augmentation index
124439|NCT02517671|Pulse wave analysis|pulse wave analysis
124440|NCT02517632|Physical activity|physical activity
124441|NCT02517632|Cardiac rehabilitation|cardiac rehabilitation
124442|NCT02517619|Iontophoresis|iontophoresis
124443|NCT02517619|Ophthalmology|ophthalmology
124444|NCT02517619|Non-Infectious Anterior Segment Uveitis|non-infectious anterior segment uveitis
124445|NCT02517593|BCRAT|bcrat
124446|NCT02517593|IBIS|ibis
124447|NCT02517593|PRS|prs
124448|NCT02517593|breast cancer|breast cancer
124449|NCT02517593|Tyrer-Cuzick|tyrer-cuzick
124450|NCT02517554|meet National Comprehensive Cancer Network® criteria for cancer genetic testing for breast, ovarian and colorectal cancers|meet national comprehensive cancer network® criteria for cancer genetic testing for breast, ovarian and colorectal cancers
124451|NCT02517528|(HCV) Infection|(hcv) infection
124452|NCT02517528|Compensated Cirrhosis|compensated cirrhosis
124453|NCT02517515|HCV Infection|hcv infection
124454|NCT02517502|DHA|dha
124455|NCT02517502|Omega-3|omega-3
124456|NCT02517502|neoadjuvant chemotherapy|neoadjuvant chemotherapy
124457|NCT02517502|chemotherapy|chemotherapy
124458|NCT02517502|breast cancer|breast cancer
124459|NCT02517489|Community-Acquired Pneumonia (CAP)|community-acquired pneumonia (cap)
124460|NCT02517489|Hydrocortisone|hydrocortisone
124461|NCT02517489|Corticosteroids|corticosteroids
124462|NCT02517463|Emergency contraception|emergency contraception
124463|NCT02517463|ulipristal acetate|ulipristal acetate
124464|NCT02517463|efficacy|efficacy
124465|NCT02517450|Subjects|subjects
124466|NCT02517411|COPD|copd
124467|NCT02517411|physiotherapy|physiotherapy
124468|NCT02517411|Stable disease|stable disease
124469|NCT02517398|Solid tumor|solid tumor
124470|NCT02517398|MSB0011359C (M7824)|msb0011359c (m7824)
124471|NCT02517398|Metastatic or Locally Advanced Solid Tumors|metastatic or locally advanced solid tumors
124472|NCT02517346|CPAP compliance|cpap compliance
124473|NCT02517346|Telemonitoring|telemonitoring
124474|NCT02517346|Standard management|standard management
124475|NCT02517346|Cost effectiveness|cost effectiveness
124476|NCT02517333|Motor skill proficiency|motor skill proficiency
124477|NCT02517333|movement difficulties|movement difficulties
124478|NCT02517333|Developmental Coordination Disorder (DCD)|developmental coordination disorder (dcd)
124479|NCT02517333|Low physical fitness|low physical fitness
124480|NCT02517320|Diabetic Nephropathy|diabetic nephropathy
124481|NCT02517294|Nasotracheal intubation|nasotracheal intubation
124482|NCT02517294|adenoid size|adenoid size
124483|NCT02517294|epistaxis|epistaxis
124484|NCT02517294|nasopharyngeal mucosal injury|nasopharyngeal mucosal injury
124485|NCT02517255|ST segment elevation myocardial infarction|st segment elevation myocardial infarction
124486|NCT02517255|Failed Thrombolysis|failed thrombolysis
124487|NCT02517255|Rescue Percutaneous Coronary Intervention|rescue percutaneous coronary intervention
124488|NCT02517255|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
124489|NCT02517229|volunteers|volunteers
124490|NCT02517216|volunteers|volunteers
124491|NCT02517190|volunteers|volunteers
124492|NCT02517177|volunteers|volunteers
124493|NCT02517151|iron|iron
124494|NCT02517151|fatigue|fatigue
124495|NCT02517151|crohn's disease|crohn's disease
124496|NCT02517151|ulcerative colitis|ulcerative colitis
124497|NCT02517151|IBD|ibd
124498|NCT02517138|volunteers|volunteers
124499|NCT02517112|volunteers|volunteers
124500|NCT02517099|Preschool|preschool
124501|NCT02517099|Wheeze|wheeze
124502|NCT02517099|Moderate|moderate
124503|NCT02517099|Severe|severe
124504|NCT02517086|blood circulation|blood circulation
124506|NCT02517073|epidemiology|epidemiology
124507|NCT02517073|intensive care unit|intensive care unit
124508|NCT02517073|national survey|national survey
124509|NCT02517060|Social perceptions|social perceptions
124510|NCT02517008|non-monetary incentive|non-monetary incentive
124511|NCT02517008|institutional delivery|institutional delivery
124512|NCT02516982|mHealth|mhealth
124513|NCT02516982|Telemedicine|telemedicine
124514|NCT02516982|Perinatal depression|perinatal depression
124515|NCT02516982|Screening|screening
124516|NCT02516982|Edinburgh Postnatal Depression Scale|edinburgh postnatal depression scale
124517|NCT02516982|Whooley Questions|whooley questions
124518|NCT02516982|Data collection|data collection
124519|NCT02516982|Mood disorders|mood disorders
124520|NCT02516982|Mental health|mental health
124521|NCT02516982|Antenatal care|antenatal care
124522|NCT02516982|Prenatal Care|prenatal care
124523|NCT02516956|Breakfast|breakfast
652222|NCT00779792|efficacy|efficacy
124524|NCT02516956|Food choices|food choices
124525|NCT02516956|Lunch|lunch
124526|NCT02516956|Eating habits|eating habits
124527|NCT02516956|Appetite|appetite
124528|NCT02516956|Neural activation|neural activation
124529|NCT02516956|Attention|attention
124530|NCT02516956|Glucose|glucose
124531|NCT02516956|Insulin|insulin
124532|NCT02516956|fMRI|fmri
124533|NCT02516943|Arterial blood gas analysis|arterial blood gas analysis
124534|NCT02516930|health promotion|health promotion
124535|NCT02516930|crowdsourcing|crowdsourcing
124536|NCT02516904|Subjects|subjects
124537|NCT02516891|treatment|treatment
124538|NCT02516891|stent|stent
124539|NCT02516891|coronary bifurcations lesions|coronary bifurcations lesions
124540|NCT02516878|acupuncture|acupuncture
124541|NCT02516878|Chinese Medicine|chinese medicine
124542|NCT02516878|obesity|obesity
124543|NCT02516865|postpartum|postpartum
124544|NCT02516865|physical activity|physical activity
124545|NCT02516852|community development; poultry; animal-source food; stunting|community development; poultry; animal-source food; stunting
124546|NCT02516839|Overweight|overweight
124547|NCT02516839|Obesity|obesity
124548|NCT02516839|Overeating|overeating
124549|NCT02516839|Body Mass Index|body mass index
124550|NCT02516839|Weight|weight
124551|NCT02516839|Treatment|treatment
124552|NCT02516839|Cravings|cravings
124553|NCT02516839|Intervention|intervention
124554|NCT02516839|Behavioral Treatment|behavioral treatment
124555|NCT02516813|M3814|m3814
124556|NCT02516813|Advanced solid tumors|advanced solid tumors
124557|NCT02516813|DNA-PK Inhibitor|dna-pk inhibitor
124558|NCT02516813|Radiotherapy|radiotherapy
124559|NCT02516813|Chemotherapy|chemotherapy
124560|NCT02516787|volunteers|volunteers
124561|NCT02516761|Fibromyalgia|fibromyalgia
124562|NCT02516644|Parkinson Disease|parkinson disease
124563|NCT02516644|Mobility|mobility
124564|NCT02516644|Balance|balance
124565|NCT02516644|Virtual Reality|virtual reality
124566|NCT02516644|treadmill training|treadmill training
124567|NCT02516631|Labour, induced|labour, induced
124572|NCT02516605|Primary Biliary Cirrhosis, PBC|primary biliary cirrhosis, pbc
124574|NCT02516566|Positive end-expiratory pressure ventilation|positive end-expiratory pressure ventilation
124575|NCT02516566|Optic nerve sheath diameter|optic nerve sheath diameter
124576|NCT02516540|hereditary breast and ovarian cancer (HBOC)|hereditary breast and ovarian cancer (hboc)
124577|NCT02516540|BRCA1/2 mutation carriers|brca1/2 mutation carriers
124578|NCT02516540|Mediterranean diet|mediterranean diet
124579|NCT02516540|Structured exercise training|structured exercise training
124580|NCT02516540|prevention|prevention
124581|NCT02516514|Blood culture|blood culture
124582|NCT02516514|Bacteremia|bacteremia
124583|NCT02516514|Single sampling|single sampling
124584|NCT02516501|Ketogenic Diet|ketogenic diet
124585|NCT02516501|Body composition|body composition
124586|NCT02516501|Radiation therapy|radiation therapy
124587|NCT02516436|Bunavail|bunavail
124588|NCT02516436|Suboxone|suboxone
124589|NCT02516436|Heroin|heroin
124590|NCT02516436|Zubsolv|zubsolv
124591|NCT02516436|Buprenorphine|buprenorphine
124592|NCT02516436|Naloxone|naloxone
124593|NCT02516436|Opioids|opioids
124594|NCT02516436|Addiction|addiction
124595|NCT02516436|Induction|induction
124596|NCT02516397|body fat mass reduction|body fat mass reduction
124597|NCT02516384|Fecal Microbiota Transplantation|fecal microbiota transplantation
124598|NCT02516384|Ulcerative Colitis|ulcerative colitis
124599|NCT02516345|Physical activity|physical activity
124600|NCT02516345|Financial incentives|financial incentives
124601|NCT02516345|Children|children
124602|NCT02516345|Parents|parents
124603|NCT02516345|RCT|rct
124604|NCT02516345|Wireless pedometer|wireless pedometer
124605|NCT02516306|Presbyopia, Vision|presbyopia, vision
124606|NCT02516280|Total knee replacement|total knee replacement
124607|NCT02516280|Cold|cold
124608|NCT02516280|Neurocryostimulation|neurocryostimulation
124612|NCT02516267|acute coronary syndrome|acute coronary syndrome
124613|NCT02516267|coronary artery bypass graft|coronary artery bypass graft
124614|NCT02516254|vitamin D|vitamin d
124615|NCT02516254|fortified bread|fortified bread
124616|NCT02516254|efficacy|efficacy
124617|NCT02516254|Vitamin D Deficiency|vitamin d deficiency
124618|NCT02516241|Urothelial Cancer|urothelial cancer
124619|NCT02516241|Phase III|phase iii
124620|NCT02516189|Microcirculation|microcirculation
124621|NCT02516189|Electromyography|electromyography
124622|NCT02516189|Motor Activity|motor activity
124623|NCT02516176|stroke|stroke
124624|NCT02516176|cerebral vascular accident|cerebral vascular accident
124625|NCT02516176|balance|balance
124626|NCT02516176|treadmill|treadmill
124627|NCT02516176|falls|falls
124628|NCT02516176|hemiparesis|hemiparesis
124629|NCT02516150|Type 1 Diabetes|type 1 diabetes
124630|NCT02516150|Bionic Pancreas|bionic pancreas
124631|NCT02516150|Artificial Pancreas|artificial pancreas
124632|NCT02516150|Insulin|insulin
124633|NCT02516150|Glucagon|glucagon
124634|NCT02516150|Alcohol|alcohol
124635|NCT02516150|Alcohol Clamp|alcohol clamp
124636|NCT02516137|Dry needling|dry needling
124637|NCT02516124|Autoimmune diseases|autoimmune diseases
124638|NCT02516124|Systemic sclerosis|systemic sclerosis
124639|NCT02516124|Autologous Hematopoietic stem cell transplant|autologous hematopoietic stem cell transplant
124640|NCT02516072|remote ischemic preconditioning|remote ischemic preconditioning
124641|NCT02516059|thoracic epidural analgesia|thoracic epidural analgesia
124642|NCT02516059|oxycodone|oxycodone
124643|NCT02516059|oral naloxone|oral naloxone
124644|NCT02516059|radical cystectomy|radical cystectomy
124645|NCT02516059|bowel function|bowel function
124646|NCT02516059|pain|pain
124647|NCT02516033|Atrial Fibrillation|atrial fibrillation
124648|NCT02516033|Hybrid Ablation|hybrid ablation
124649|NCT02516033|Efficacy|efficacy
124650|NCT02516033|Risk Profile|risk profile
124651|NCT02516033|Biomarkers|biomarkers
124653|NCT02516020|ICSI|icsi
124654|NCT02516020|culture media|culture media
124655|NCT02516020|sequential|sequential
124656|NCT02515981|tobacco dependence|tobacco dependence
124657|NCT02515981|smoking cessation|smoking cessation
124658|NCT02515981|mental health|mental health
124659|NCT02515981|cardiovascular disease|cardiovascular disease
124660|NCT02515981|obesity|obesity
124661|NCT02515955|Healthy|healthy
124662|NCT02515955|JNJ-54175446|jnj-54175446
124663|NCT02515929|Oligomeric Proanthocyanidins|oligomeric proanthocyanidins
124664|NCT02515929|Periodontal Disease|periodontal disease
124665|NCT02515903|Endoscopy|endoscopy
124666|NCT02515903|Intracerebral hemorrhage|intracerebral hemorrhage
124667|NCT02515903|surgery|surgery
124668|NCT02515903|stereotactic aspiration|stereotactic aspiration
124670|NCT02515903|Intracerebral hemorrhage surgical treatment|intracerebral hemorrhage surgical treatment
124671|NCT02515903|Transparent endoscopic sheath|transparent endoscopic sheath
124672|NCT02515903|Agitation-aspiration device|agitation-aspiration device
124673|NCT02515890|midazolam|midazolam
124674|NCT02515890|dexmedetomidine|dexmedetomidine
124675|NCT02515890|memory|memory
124676|NCT02515890|ketamine|ketamine
124677|NCT02515864|Male and Female Volunteers|male and female volunteers
124678|NCT02515786|Chronic respiratory failure|chronic respiratory failure
124679|NCT02515786|Oxygen therapy|oxygen therapy
124680|NCT02515786|Nasal catheter|nasal catheter
124681|NCT02515786|Mucociliary clearance|mucociliary clearance
124682|NCT02515747|Lipoprotein(a)|lipoprotein(a)
124683|NCT02515747|coronary artery bypass grafting (CABG)|coronary artery bypass grafting (cabg)
124684|NCT02515747|apo(a)|apo(a)
124685|NCT02515747|prognosis|prognosis
124686|NCT02515747|myocardial infarction|myocardial infarction
124687|NCT02515747|cardiovascular death|cardiovascular death
124688|NCT02515747|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
124689|NCT02515734|FOLFOXIRI|folfoxiri
124690|NCT02515734|Bmab|bmab
124691|NCT02515734|Cmab|cmab
124692|NCT02515617|Ventilator-associated pneumonia|ventilator-associated pneumonia
124693|NCT02515617|Subglottic-secretions drainage|subglottic-secretions drainage
124694|NCT02515617|Critically ill patients|critically ill patients
124695|NCT02515617|Cost-utility analysis|cost-utility analysis
124696|NCT02515617|Prevention|prevention
124697|NCT02515591|Healthy volunteer|healthy volunteer
124698|NCT02515591|Respiratory|respiratory
124699|NCT02515591|Bronchoalveolar lavage|bronchoalveolar lavage
124703|NCT02515565|pneumonia|pneumonia
124704|NCT02515565|Exacerbation|exacerbation
124705|NCT02515565|physiotherapy|physiotherapy
124706|NCT02515565|hospitalization|hospitalization
124707|NCT02515539|Transcatheter Mitral Valve Replacement|transcatheter mitral valve replacement
124708|NCT02515539|Mitral Regurgitation|mitral regurgitation
124709|NCT02515539|Mitral Insufficiency|mitral insufficiency
124710|NCT02515539|Transapical|transapical
124711|NCT02515539|Transfemoral|transfemoral
124712|NCT02515513|Pancreas|pancreas
124713|NCT02515513|Pancreas Cancer|pancreas cancer
124714|NCT02515513|Muscle Biopsy|muscle biopsy
124715|NCT02515513|Cachexia|cachexia
124716|NCT02515513|Muscle Cachexia|muscle cachexia
124717|NCT02515500|cigarette reduction|cigarette reduction
124718|NCT02515500|digital health|digital health
124719|NCT02515500|mobile health|mobile health
124720|NCT02515500|technology|technology
124721|NCT02515500|Quitbit|quitbit
124722|NCT02515500|mHealth|mhealth
124723|NCT02515500|smoking cessation|smoking cessation
124724|NCT02515500|quit smoking|quit smoking
124725|NCT02515500|self-regulation|self-regulation
124726|NCT02515487|Post-chemotherapy|post-chemotherapy
124727|NCT02515487|cognitive impairment|cognitive impairment
124728|NCT02515474|Cholangiopancreatography|cholangiopancreatography
124729|NCT02515474|Endoscopic|endoscopic
124730|NCT02515474|Common bile duct|common bile duct
124731|NCT02515474|Complication|complication
124732|NCT02515474|Recurrence|recurrence
124733|NCT02515474|Laparoscopic|laparoscopic
124734|NCT02515461|Diabetes mellitus|diabetes mellitus
124735|NCT02515461|Low energy shockwave therapy|low energy shockwave therapy
124736|NCT02515461|Chronic Renal Insufficiency|chronic renal insufficiency
124737|NCT02515448|VAP|vap
124738|NCT02515448|Critical care|critical care
124739|NCT02515448|Pharmacokinetics|pharmacokinetics
124740|NCT02515448|Gentamicin|gentamicin
124741|NCT02515435|apatinib|apatinib
124742|NCT02515435|NSCLC|nsclc
124743|NCT02515435|safety|safety
124744|NCT02515435|efficacy|efficacy
124745|NCT02515422|Caesarean Section|caesarean section
124746|NCT02515409|Obstructive Sleep Apnea Syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
124747|NCT02515409|Heated Humidified High Flow Nasal Cannula (HHHNC)|heated humidified high flow nasal cannula (hhhnc)
124748|NCT02515409|Continues positive airway pressure (CPAP)|continues positive airway pressure (cpap)
124749|NCT02515409|Children|children
124750|NCT02515409|Non invasive ventilation|non invasive ventilation
124751|NCT02515409|Treatment|treatment
124752|NCT02515383|Adolescent Cancer|adolescent cancer
124753|NCT02515383|MD Anderson Symptom Inventory (modified for adolescent use)|md anderson symptom inventory (modified for adolescent use)
124754|NCT02515383|MDASI|mdasi
124755|NCT02515383|Surveys|surveys
124756|NCT02515383|Questionnaires|questionnaires
124757|NCT02515383|Interviews|interviews
124758|NCT02515383|Symptoms|symptoms
124759|NCT02515370|Option B plus|option b plus
124760|NCT02515370|HIV infected women|hiv infected women
124761|NCT02515357|Sleep Disorders|sleep disorders
124762|NCT02515357|Metabolic Syndrome|metabolic syndrome
124763|NCT02515357|Mediterranean Diet|mediterranean diet
124764|NCT02515357|Mediterranean Lifestyle|mediterranean lifestyle
124765|NCT02515344|Patients|patients
124766|NCT02515344|early detection of cancer|early detection of cancer
124767|NCT02515344|patient compliance|patient compliance
125517|NCT02511002|Influenza|influenza
124768|NCT02515331|resistant hypertension|resistant hypertension
124769|NCT02515318|COPD|copd
124770|NCT02515318|Exacerbation|exacerbation
124771|NCT02515318|Hospitalisation|hospitalisation
124772|NCT02515318|Physiotherapy|physiotherapy
125027|NCT02513654|repeat dosing|repeat dosing
124773|NCT02515292|IUGR (intrauterine growth restriction)|iugr (intrauterine growth restriction)
124774|NCT02515292|IGF2 (insulin-like growth factor 2)|igf2 (insulin-like growth factor 2)
124775|NCT02515292|morbidity|morbidity
124777|NCT02515266|growth|growth
124778|NCT02515266|head circumference|head circumference
124779|NCT02515253|Breast Pain|breast pain
124780|NCT02515253|Mastalgia|mastalgia
124781|NCT02515253|Bras|bras
124782|NCT02515253|Breast Support|breast support
124783|NCT02515227|peptide|peptide
124784|NCT02515227|vaccine|vaccine
124785|NCT02515227|Montanide ISA-51|montanide isa-51
124786|NCT02515227|pembrolizumab|pembrolizumab
124787|NCT02515227|PD-1|pd-1
124788|NCT02515227|KEYTRUDA|keytruda
124789|NCT02515214|bariatric surgery|bariatric surgery
124790|NCT02515214|reproduction|reproduction
124791|NCT02515175|HSV|hsv
124792|NCT02515175|Herpes|herpes
124793|NCT02515175|Genital Herpes|genital herpes
124794|NCT02515175|Vaccine|vaccine
124795|NCT02515162|conization|conization
124796|NCT02515162|LLETZ|lletz
124797|NCT02515162|cervical dysplasia|cervical dysplasia
124798|NCT02515162|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
124799|NCT02515162|Fischer cone biopsy excisor|fischer cone biopsy excisor
124800|NCT02515162|loop electrosurgical excision procedure|loop electrosurgical excision procedure
124801|NCT02515149|linkage to care|linkage to care
124802|NCT02515149|point of care diagnostics|point of care diagnostics
124803|NCT02515149|point of care CD4|point of care cd4
124804|NCT02515149|HIV care cascade|hiv care cascade
124805|NCT02515149|Kenya|kenya
124806|NCT02515123|intensive care unit|intensive care unit
124807|NCT02515123|malnutrition|malnutrition
124808|NCT02515123|GI motility|gi motility
124809|NCT02515123|nutritional intake|nutritional intake
124810|NCT02515110|lumpectomy|lumpectomy
124811|NCT02515110|mastectomy without reconstruction|mastectomy without reconstruction
124812|NCT02515110|mastectomy with reconstruction|mastectomy with reconstruction
124813|NCT02515110|Estrogen Receptor Negative|estrogen receptor negative
124814|NCT02515110|Estrogen Receptor Positive|estrogen receptor positive
124815|NCT02515110|HER2/Neu Negative|her2/neu negative
124816|NCT02515110|HER2/Neu Positive|her2/neu positive
124817|NCT02515110|Progesterone Receptor Negative|progesterone receptor negative
124818|NCT02515110|Progesterone Receptor Positive|progesterone receptor positive
124819|NCT02515110|Stage IA Breast Cancer|stage ia breast cancer
124820|NCT02515110|Stage IB Breast Cancer|stage ib breast cancer
124821|NCT02515110|Stage IIA Breast Cancer|stage iia breast cancer
124822|NCT02515110|Stage IIB Breast Cancer|stage iib breast cancer
124823|NCT02515110|Stage IIIA Breast Cancer|stage iiia breast cancer
124824|NCT02515084|recurrence Thyroid cancer|recurrence thyroid cancer
124825|NCT02515084|18F-FDG PET-CT|18f-fdg pet-ct
124826|NCT02515084|diffusion-weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
124827|NCT02515045|Cataract|cataract
124828|NCT02515045|Surgery|surgery
124829|NCT02515045|Prophylaxis|prophylaxis
124830|NCT02515019|Anaesthetics inhalation|anaesthetics inhalation
124831|NCT02515019|Bispectral index|bispectral index
124832|NCT02515019|Cardiopulmonary bypass|cardiopulmonary bypass
124833|NCT02514993|Sternal fracture|sternal fracture
124834|NCT02514993|Thoracic spine fracture|thoracic spine fracture
124835|NCT02514993|Thoracic cage injury|thoracic cage injury
124836|NCT02514967|SLE|sle
124837|NCT02514967|Lupus|lupus
124838|NCT02514967|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
124839|NCT02514967|Autoimmune Diseases|autoimmune diseases
124840|NCT02514967|A-623|a-623
124841|NCT02514967|Blisibimod|blisibimod
124842|NCT02514967|Nephritis|nephritis
124843|NCT02514902|Lateral Flow Device (LFD)|lateral flow device (lfd)
124844|NCT02514902|Acute Stroke|acute stroke
124845|NCT02514902|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
124846|NCT02514902|Point of Care (POC)|point of care (poc)
124847|NCT02514902|Biomarker|biomarker
124848|NCT02514824|recurrent merkel cell carcinoma|recurrent merkel cell carcinoma
124849|NCT02514824|metastatic merkel cell carcinoma|metastatic merkel cell carcinoma
124850|NCT02514798|COPD|copd
124851|NCT02514798|HFNC|hfnc
124852|NCT02514798|work of breathing|work of breathing
124853|NCT02514746|Japanese Encephalitis Vaccines|japanese encephalitis vaccines
124854|NCT02514746|Flavivirus Infections|flavivirus infections
124855|NCT02514733|kidney|kidney
124856|NCT02514733|transplant|transplant
124857|NCT02514655|Tracheal intubation|tracheal intubation
124858|NCT02514655|Cuff pressure|cuff pressure
124859|NCT02514655|Ventilator-acquired pneumonia|ventilator-acquired pneumonia
124860|NCT02514655|Intensive care unit|intensive care unit
124861|NCT02514655|Tracheal injuries|tracheal injuries
124862|NCT02514629|Hypogonadism|hypogonadism
124863|NCT02514629|Obesity|obesity
124864|NCT02514629|Erectile Dysfunction|erectile dysfunction
124865|NCT02514629|Testosterone|testosterone
124866|NCT02514629|Metformin|metformin
124867|NCT02514629|Weight Loss|weight loss
124868|NCT02514629|Insulin Resistance|insulin resistance
124869|NCT02514616|Reflux|reflux
124870|NCT02514616|Reflux disease|reflux disease
124871|NCT02514616|Gastroesophageal reflux disease|gastroesophageal reflux disease
124872|NCT02514616|Lower esophageal sphincter stimulation|lower esophageal sphincter stimulation
124873|NCT02514603|Neoplasm metastasis|neoplasm metastasis
124874|NCT02514603|Checkpoint Kinase 1|checkpoint kinase 1
124875|NCT02514603|CHK1|chk1
124876|NCT02514603|CHK1 inhibitor|chk1 inhibitor
124877|NCT02514551|stomach cancer|stomach cancer
124878|NCT02514512|Lung Cancer|lung cancer
402917|NCT01229150|Tissue Immunohistochemistry|tissue immunohistochemistry
124879|NCT02514512|Stereotactic Ablative Radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
124880|NCT02514512|MLC Tracking|mlc tracking
124881|NCT02514512|Radiotherapy|radiotherapy
124882|NCT02514499|patients|patients
124883|NCT02514460|stents|stents
124884|NCT02514460|atherectomy|atherectomy
124885|NCT02514460|femoral artery|femoral artery
124886|NCT02514460|popliteal artery|popliteal artery
124887|NCT02514447|SCLC|sclc
124888|NCT02514421|pancreatic adenocarcinoma|pancreatic adenocarcinoma
124889|NCT02514421|electrochemotherapy|electrochemotherapy
124890|NCT02514421|electroporation|electroporation
124891|NCT02514421|radiogenomics|radiogenomics
124892|NCT02514421|imaging|imaging
124893|NCT02514421|magnetic resonance spectroscopy|magnetic resonance spectroscopy
124894|NCT02514395|linguistic validation|linguistic validation
124895|NCT02514395|KOOS|koos
124896|NCT02514395|Marathi translation|marathi translation
124897|NCT02514356|behavioral economics|behavioral economics
124898|NCT02514356|antiretroviral adherence|antiretroviral adherence
124900|NCT02514356|mobile health (mHealth)|mobile health (mhealth)
124901|NCT02514356|Adolescents|adolescents
124902|NCT02514356|Uganda|uganda
124903|NCT02514356|HIV|hiv
124904|NCT02514343|radius fracture|radius fracture
124905|NCT02514343|magnesium sulfate|magnesium sulfate
124906|NCT02514343|rehabilitation|rehabilitation
124907|NCT02514343|bupivacaine|bupivacaine
124908|NCT02514330|Drop Jump|drop jump
124909|NCT02514330|High Intensity Interval Training|high intensity interval training
124910|NCT02514330|Muscle Fatigue|muscle fatigue
124911|NCT02514330|Aerobic Performance|aerobic performance
124912|NCT02514278|Organ preservation|organ preservation
124913|NCT02514278|Local excision|local excision
124914|NCT02514278|Radiochemotherapy|radiochemotherapy
124915|NCT02514278|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
124916|NCT02514278|Folfirinox|folfirinox
124917|NCT02514278|Tumour response|tumour response
124918|NCT02514265|pelvic pain, bladder pain|pelvic pain, bladder pain
124919|NCT02514252|Advanced Cancers|advanced cancers
124920|NCT02514252|Metastatic|metastatic
124921|NCT02514252|Recurrent cancer|recurrent cancer
124922|NCT02514252|Incurable cancer|incurable cancer
124923|NCT02514252|Fentanyl sublingual spray|fentanyl sublingual spray
124924|NCT02514252|FSS|fss
124925|NCT02514252|Questionnaires|questionnaires
124926|NCT02514252|Surveys|surveys
124927|NCT02514252|Mental ability tests|mental ability tests
124928|NCT02514252|Phone calls|phone calls
124929|NCT02514252|Study diary|study diary
124930|NCT02514252|Pain control|pain control
124931|NCT02514226|microbiology|microbiology
124932|NCT02514226|halitosis|halitosis
124933|NCT02514213|PSA|psa
124934|NCT02514187|Osteogenesis|osteogenesis
124935|NCT02514161|Smokers|smokers
124936|NCT02514161|Maximum Inspiratory Pressure|maximum inspiratory pressure
124937|NCT02514148|patient education|patient education
124938|NCT02514148|therapeutic exercise|therapeutic exercise
124939|NCT02514148|manual therapy|manual therapy
124940|NCT02514109|neuronopathy|neuronopathy
124941|NCT02514109|antibodies|antibodies
124942|NCT02514109|Clinical and biological diagnostic criteria|clinical and biological diagnostic criteria
124943|NCT02514083|Ibrutinib|ibrutinib
124944|NCT02514083|Fludarabine|fludarabine
124945|NCT02514083|BTK Inhibitor|btk inhibitor
124946|NCT02514083|T-Cell Modulation|t-cell modulation
124947|NCT02514070|LDL-C|ldl-c
124948|NCT02514070|Omega-3 Fatty Acid|omega-3 fatty acid
124949|NCT02514070|PCSK9|pcsk9
124950|NCT02514070|HDL-C|hdl-c
124951|NCT02514018|Varicella-Zoster Virus|varicella-zoster virus
124952|NCT02514018|Immune Activation|immune activation
124953|NCT02514018|HIV Vaccine|hiv vaccine
124954|NCT02514018|Mucosal Immunity|mucosal immunity
124955|NCT02514005|Trigger points|trigger points
124956|NCT02514005|Manual therapy|manual therapy
124957|NCT02514005|Patellofemoral syndrome|patellofemoral syndrome
124958|NCT02514005|Dry needling|dry needling
124959|NCT02513992|ictal SPECT|ictal spect
124960|NCT02513979|Angiotensin type II receptor (AT2R) antagonists|angiotensin type ii receptor (at2r) antagonists
124961|NCT02513979|Acute postoperative pain|acute postoperative pain
124962|NCT02513979|Chronic postoperative pain|chronic postoperative pain
124963|NCT02513979|Abdominal surgery|abdominal surgery
124964|NCT02513953|Endometriosis|endometriosis
124965|NCT02513953|Mesosalpinx|mesosalpinx
124966|NCT02513953|Broad Ligament|broad ligament
124967|NCT02513953|Laparoscopy|laparoscopy
124968|NCT02513940|Torsades de pointes|torsades de pointes
124969|NCT02513940|Testosterone|testosterone
124970|NCT02513940|Progesterone|progesterone
124971|NCT02513940|Clinical trial|clinical trial
124972|NCT02513940|Risk reduction|risk reduction
124973|NCT02513940|Electrocardiography|electrocardiography
124974|NCT02513927|Blood pressure variability|blood pressure variability
124976|NCT02513927|beta-receptor blockers|beta-receptor blockers
124977|NCT02513927|heart rate|heart rate
124978|NCT02513914|endovascular neurosurgery|endovascular neurosurgery
124979|NCT02513901|Chidamide|chidamide
124980|NCT02513901|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
116168|NCT02568696|fibrinolysis|fibrinolysis
116169|NCT02568696|cell mediated rejection|cell mediated rejection
116170|NCT02568696|coagulation|coagulation
116171|NCT02568696|delayed graft function|delayed graft function
116172|NCT02568696|Halloran criteria|halloran criteria
116173|NCT02568696|graft rejection|graft rejection
116174|NCT02568696|thrombin generation|thrombin generation
116175|NCT02568696|fibrin generation|fibrin generation
116176|NCT02568683|DLBCL|dlbcl
116177|NCT02568683|Relapsed|relapsed
116180|NCT02568644|Ginger|ginger
116181|NCT02568644|Acute treatment|acute treatment
116182|NCT02568631|Autistic Disorder|autistic disorder
116183|NCT02568618|Military|military
116184|NCT02568618|Genomics|genomics
116185|NCT02568618|Pain|pain
116186|NCT02568605|Dietary intervention|dietary intervention
116187|NCT02568605|Prebiotic fibre|prebiotic fibre
116188|NCT02568605|Weight loss|weight loss
116189|NCT02568605|Gut microbiota|gut microbiota
116190|NCT02568605|Obesity|obesity
116191|NCT02568605|Liver fat|liver fat
116192|NCT02568605|Hepatic fibrosis|hepatic fibrosis
116193|NCT02568540|Hepatitis C|hepatitis c
116194|NCT02568540|Smartphone|smartphone
116195|NCT02568540|app|app
116196|NCT02568540|Tracker|tracker
116197|NCT02568540|C Tracker|c tracker
116198|NCT02568527|LSCD|lscd
116199|NCT02568527|SLET|slet
116200|NCT02568527|Donor Human Amniotic Membrane (hAM)|donor human amniotic membrane (ham)
116201|NCT02568527|PLGA|plga
116202|NCT02568514|mhealth|mhealth
116225|NCT02568371|DNA|dna
124981|NCT02513901|HIV-1 Reservoir|hiv-1 reservoir
124982|NCT02513901|Chronic HIV infections|chronic hiv infections
124983|NCT02513901|Antiretroviral Therapy|antiretroviral therapy
124984|NCT02513901|HIV Eradication|hiv eradication
124985|NCT02513862|autologous platelet rich plasma|autologous platelet rich plasma
124986|NCT02513862|deep hypothermic circulatory arrest|deep hypothermic circulatory arrest
124987|NCT02513862|transfusion|transfusion
124988|NCT02513849|esophagus|esophagus
124989|NCT02513849|gastroscopy|gastroscopy
124990|NCT02513849|tamoxifen|tamoxifen
124991|NCT02513823|blood pressure|blood pressure
124992|NCT02513823|vitamin D|vitamin d
124993|NCT02513784|Microbiome|microbiome
124994|NCT02513784|Esophagus|esophagus
124995|NCT02513784|Endoscopy|endoscopy
124996|NCT02513784|Mouthwash|mouthwash
124997|NCT02513758|HIV patients|hiv patients
124998|NCT02513758|Genital HIV penetration|genital hiv penetration
124999|NCT02513745|cataract|cataract
125000|NCT02513745|toric|toric
125001|NCT02513745|phacoemulsification|phacoemulsification
125002|NCT02513732|Drug Eluting Stent|drug eluting stent
125003|NCT02513732|Coronary Stent|coronary stent
125004|NCT02513732|Everolimus|everolimus
125005|NCT02513732|Stent Thrombosis|stent thrombosis
125006|NCT02513719|drug eluting stent|drug eluting stent
125007|NCT02513719|stent|stent
125008|NCT02513719|real world|real world
125009|NCT02513693|Anesthesia|anesthesia
125010|NCT02513693|Rocuronium|rocuronium
125011|NCT02513693|Sugammadex|sugammadex
125014|NCT02513693|Radical Prostatectomy|radical prostatectomy
125015|NCT02513693|Robotic Surgery|robotic surgery
125016|NCT02513693|Accelerometry|accelerometry
125017|NCT02513680|Skin Aging|skin aging
125018|NCT02513680|laser phototherapy|laser phototherapy
125019|NCT02513680|Rejuvenation|rejuvenation
125020|NCT02513680|Infrared Rays/therapeutic use|infrared rays/therapeutic use
125021|NCT02513680|Female|female
125022|NCT02513680|Humans|humans
125023|NCT02513680|Esthetics|esthetics
125024|NCT02513680|Phototherapy|phototherapy
125025|NCT02513680|facial rejuvenation|facial rejuvenation
125026|NCT02513654|tolerability|tolerability
125028|NCT02513654|safety|safety
125029|NCT02513654|healthy Chinese subjects|healthy chinese subjects
125030|NCT02513654|Pharmacokinetics|pharmacokinetics
125031|NCT02513654|lamotrigine|lamotrigine
125032|NCT02513628|Cardiac arrest|cardiac arrest
125033|NCT02513628|neuroprognostication|neuroprognostication
125034|NCT02513628|optic nerve sheath diameter|optic nerve sheath diameter
125035|NCT02513628|outcome|outcome
125036|NCT02513628|ultrasonography|ultrasonography
125037|NCT02513615|Fibrosis|fibrosis
125038|NCT02513615|Peritoneal Dialysis|peritoneal dialysis
125039|NCT02513615|Epigenetics|epigenetics
125040|NCT02513615|Peritoneal membrane injury|peritoneal membrane injury
125041|NCT02513615|Glucose exposure|glucose exposure
125042|NCT02513602|implantology|implantology
125043|NCT02513602|kidney|kidney
125044|NCT02513602|renal disease|renal disease
125045|NCT02513602|edentulism|edentulism
125046|NCT02513602|tooth loss|tooth loss
125047|NCT02513589|Positron emission tomography|positron emission tomography
125048|NCT02513589|Carotid plaque|carotid plaque
125049|NCT02513589|Inflammation|inflammation
125050|NCT02513589|Stroke|stroke
125051|NCT02513576|Sternal instability|sternal instability
125052|NCT02513576|physical therapy|physical therapy
125053|NCT02513576|Respiratory muscle strength|respiratory muscle strength
125054|NCT02513563|Squamous cell lung cancer|squamous cell lung cancer
125055|NCT02513524|hypertension|hypertension
125056|NCT02513524|adherence|adherence
125057|NCT02513524|resistant hypertension|resistant hypertension
125058|NCT02513524|blood pressure|blood pressure
125059|NCT02513524|non-adherence|non-adherence
125060|NCT02513511|difficult airway|difficult airway
125061|NCT02513511|awake intubation|awake intubation
125062|NCT02513485|Inflammation|inflammation
125063|NCT02513485|Anhedonia|anhedonia
125064|NCT02513485|Psychomotor retardation|psychomotor retardation
125065|NCT02513472|Eribulin Mesylate|eribulin mesylate
125066|NCT02513472|Pembrolizumab|pembrolizumab
125067|NCT02513472|Metastatic Triple-Negative Breast Cancer|metastatic triple-negative breast cancer
125068|NCT02513472|mTNBC|mtnbc
125069|NCT02513459|ABBV-066|abbv-066
125070|NCT02513459|BI 655066|bi 655066
125071|NCT02513459|risankizumab|risankizumab
125072|NCT02513433|Lumbar epidural anaesthesia|lumbar epidural anaesthesia
125073|NCT02513420|levator ani avulsion|levator ani avulsion
125892|NCT02508701|HPV|hpv
125074|NCT02513420|perineal muscle training|perineal muscle training
125075|NCT02513420|pelvic floor ultrasound|pelvic floor ultrasound
125076|NCT02513394|HR+/HER2- breast cancer|hr+/her2- breast cancer
125077|NCT02513394|Palbociclib|palbociclib
125078|NCT02513368|aesthetic|aesthetic
125079|NCT02513368|connective tissue graft|connective tissue graft
125080|NCT02513368|mucosa thickness|mucosa thickness
125081|NCT02513355|Non-small cell lung cancer,Endostar|non-small cell lung cancer,endostar
125082|NCT02513342|Endostar,Advanced lung squamous carcinoma|endostar,advanced lung squamous carcinoma
125083|NCT02513329|Breast Cancer|breast cancer
125084|NCT02513329|Anti-estrogens|anti-estrogens
125085|NCT02513329|Hot Flushes|hot flushes
125086|NCT02513329|Tamoxifen|tamoxifen
125087|NCT02513329|Aromatase inhibitors|aromatase inhibitors
125088|NCT02513329|Hot Flashes|hot flashes
125089|NCT02513316|Microbleeds|microbleeds
125090|NCT02513303|Dialysis|dialysis
125091|NCT02513303|End Stage Renal Disease|end stage renal disease
125092|NCT02513303|End Stage Kidney Disease|end stage kidney disease
125094|NCT02513303|Chronic Kidney Failure|chronic kidney failure
125095|NCT02513303|Chronic Renal Failure|chronic renal failure
125096|NCT02513303|Chronic Kidney Disease|chronic kidney disease
125097|NCT02513303|Hemodialysis|hemodialysis
125098|NCT02513303|Vascular Access|vascular access
125099|NCT02513303|Arteriovenous Fistula|arteriovenous fistula
125100|NCT02513303|AV Fistula|av fistula
125102|NCT02513303|Nephrology|nephrology
125103|NCT02513303|Vascular Surgery|vascular surgery
125104|NCT02513303|Dialysis Access|dialysis access
125105|NCT02513290|quality of life|quality of life
125106|NCT02513290|allergic rhinitis|allergic rhinitis
125107|NCT02513290|bilastine|bilastine
125108|NCT02513290|loratadine|loratadine
125109|NCT02513290|clinical trial|clinical trial
125110|NCT02513277|type 2 diabetes|type 2 diabetes
125111|NCT02513277|impaired glucose regulation|impaired glucose regulation
125112|NCT02513277|intellectual disability|intellectual disability
125113|NCT02513277|learning disability|learning disability
125114|NCT02513277|screening|screening
125115|NCT02513277|prevention|prevention
125116|NCT02513277|lifestyle education|lifestyle education
125121|NCT02513199|Trans-Arterial Chemoembolization|trans-arterial chemoembolization
125122|NCT02513199|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
125123|NCT02513199|HCC|hcc
125124|NCT02513199|TACE|tace
125125|NCT02513199|SBRT|sbrt
125126|NCT02513173|low back pain|low back pain
125127|NCT02513173|verbal instruction|verbal instruction
125128|NCT02513173|lumbar multifidus|lumbar multifidus
125129|NCT02513173|ultrasound imaging|ultrasound imaging
125130|NCT02513173|Muscle thickness|muscle thickness
125131|NCT02513134|IOL power calculations|iol power calculations
125132|NCT02513134|Intraoperative|intraoperative
125133|NCT02513134|OCT|oct
125134|NCT02513134|Refractive outcome|refractive outcome
125135|NCT02513134|Biometry|biometry
125136|NCT02513121|NAFLD|nafld
125137|NCT02513121|Steatohepatitis|steatohepatitis
125138|NCT02513121|NASH|nash
125139|NCT02513121|Liver|liver
125140|NCT02513121|Diet|diet
125141|NCT02513121|Pediatric|pediatric
125142|NCT02513121|Adolescent|adolescent
125143|NCT02513056|non-conditional pacemakers|non-conditional pacemakers
125144|NCT02513056|implantable cardioverter defibrillator|implantable cardioverter defibrillator
125145|NCT02513017|partially randomized clinical trial|partially randomized clinical trial
125146|NCT02513017|cardiovascular disease|cardiovascular disease
125147|NCT02513017|insomnia|insomnia
125148|NCT02513017|preference|preference
125149|NCT02513017|acceptability|acceptability
125150|NCT02512978|myocardial infarction|myocardial infarction
125151|NCT02512978|hypothyroidism|hypothyroidism
125152|NCT02512978|levothyroxine|levothyroxine
125153|NCT02512978|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
125154|NCT02512978|myocardial perfusion/metabolism radionuclide imaging|myocardial perfusion/metabolism radionuclide imaging
125155|NCT02512978|myocardial fibrosis|myocardial fibrosis
125156|NCT02512978|myocardial perfusion/metabolism|myocardial perfusion/metabolism
125157|NCT02512978|cardiac function|cardiac function
125158|NCT02512952|Periodontal regeneration|periodontal regeneration
125159|NCT02512952|Growth factors|growth factors
125160|NCT02512939|tuberculosis|tuberculosis
125161|NCT02512939|diagnostic test|diagnostic test
125162|NCT02512926|Solid Tumors|solid tumors
125163|NCT02512926|Leukemia|leukemia
125164|NCT02512926|Relapsed|relapsed
125165|NCT02512926|Refractory|refractory
125170|NCT02512900|Asthma|asthma
125171|NCT02512887|Hypospadias|hypospadias
125172|NCT02512887|Caudal Block|caudal block
125173|NCT02512887|Dorsal Penile Block|dorsal penile block
125174|NCT02512887|Anesthesia|anesthesia
125175|NCT02512887|Complications|complications
125176|NCT02512887|Post-operative|post-operative
125375|NCT02511873|Pain|pain
125177|NCT02512887|Urethrocutaneous Fistula|urethrocutaneous fistula
125178|NCT02512887|Glans dehiscence|glans dehiscence
125179|NCT02512861|Bupivacaine|bupivacaine
125180|NCT02512861|Cardiac Surgery|cardiac surgery
125181|NCT02512861|Pediatrics|pediatrics
125182|NCT02512861|Nerve Block|nerve block
125184|NCT02512848|endometrial sampling|endometrial sampling
125185|NCT02512848|vaginal bleeding|vaginal bleeding
125186|NCT02512835|Primary health care|primary health care
125187|NCT02512835|Public health|public health
125188|NCT02512835|Medical Informatics|medical informatics
125189|NCT02512835|Social Determinants of Health|social determinants of health
125190|NCT02512822|radiofrequency|radiofrequency
125191|NCT02512822|submental fat|submental fat
125192|NCT02512822|fat reduction|fat reduction
125193|NCT02512822|body contouring|body contouring
125194|NCT02512796|Liver transplantation|liver transplantation
125195|NCT02512796|Renal transplantation|renal transplantation
125196|NCT02512796|Pancreas transplantation|pancreas transplantation
125197|NCT02512783|Propofol|propofol
125198|NCT02512783|Lidocaine|lidocaine
125199|NCT02512783|Intravenous propofol|intravenous propofol
125200|NCT02512757|Neoplasms, Lung|neoplasms, lung
125201|NCT02512757|Pulmonary Neoplasms|pulmonary neoplasms
125202|NCT02512757|Pulmonary Cancer|pulmonary cancer
125203|NCT02512744|Tracheostomy|tracheostomy
125204|NCT02512744|Decannulation|decannulation
125205|NCT02512744|Adult airway management|adult airway management
125206|NCT02512718|intravenous fat emulsions|intravenous fat emulsions
125207|NCT02512718|fish oil lipid emulsion|fish oil lipid emulsion
125208|NCT02512692|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
125209|NCT02512692|cholangiocarcinoma|cholangiocarcinoma
125210|NCT02512692|90Y TARE|90y tare
125211|NCT02512692|radioembolization|radioembolization
125212|NCT02512692|gemcitabine and cisplatin|gemcitabine and cisplatin
125213|NCT02512679|Hematopoietic Stem Cell Transplantation Pediatrics,|hematopoietic stem cell transplantation pediatrics,
125214|NCT02512679|stem cell transplantation|stem cell transplantation
125215|NCT02512679|bone marrow transplantation|bone marrow transplantation
125216|NCT02512679|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
125217|NCT02512679|Allogeneic Transplantation|allogeneic transplantation
125218|NCT02512679|pediatrics|pediatrics
125219|NCT02512679|Combined Immune Deficiency|combined immune deficiency
125220|NCT02512679|Chronic Granulomatous disease|chronic granulomatous disease
125221|NCT02512666|Hematologic malignancy|hematologic malignancy
125222|NCT02512653|Allergy to Cupressus pollen|allergy to cupressus pollen
125223|NCT02512640|Pressure-controlled ventilation|pressure-controlled ventilation
125224|NCT02512640|Volume-controlled ventilation|volume-controlled ventilation
125225|NCT02512640|Laparoscopy|laparoscopy
125226|NCT02512640|Oxidative stress|oxidative stress
125227|NCT02512627|mild cognitive impairment|mild cognitive impairment
125228|NCT02512627|exercise|exercise
125229|NCT02512627|cognitive training|cognitive training
125231|NCT02512575|Healthy subjects|healthy subjects
125232|NCT02512575|Phase 1|phase 1
125233|NCT02512575|placebo controlled|placebo controlled
125234|NCT02512575|single ascending dose|single ascending dose
125235|NCT02512575|Pharmacokinetics|pharmacokinetics
125236|NCT02512575|Pharmacodynamics|pharmacodynamics
125237|NCT02512575|Rheumatoid Arthritis|rheumatoid arthritis
125238|NCT02512549|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
125239|NCT02512549|rehabiltation|rehabiltation
125240|NCT02512523|Type 2 diabetes mellitus|type 2 diabetes mellitus
125241|NCT02512523|CGMS|cgms
125242|NCT02512523|Teneligliptin|teneligliptin
125243|NCT02512523|Sitagliptin|sitagliptin
125244|NCT02512510|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
125245|NCT02512497|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
125246|NCT02512497|CTCL|ctcl
125247|NCT02512497|T-Prolymphocytic Leukemia|t-prolymphocytic leukemia
125248|NCT02512497|T-PLL|t-pll
125249|NCT02512497|T-Large Granulocytic Leukemia|t-large granulocytic leukemia
125250|NCT02512497|T-LGL|t-lgl
125251|NCT02512497|T-Lymphoblastic Leukemia/Lymphoma|t-lymphoblastic leukemia/lymphoma
125252|NCT02512497|T-ALL|t-all
125253|NCT02512497|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
125254|NCT02512497|PTCL|ptcl
125255|NCT02512497|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
125256|NCT02512497|Romidepsin|romidepsin
125257|NCT02512497|Istodax|istodax
125258|NCT02512497|Depsipeptide|depsipeptide
125259|NCT02512497|FK228|fk228
125260|NCT02512497|Busulfan|busulfan
125261|NCT02512497|Busulfex|busulfex
125262|NCT02512497|Myleran|myleran
125263|NCT02512497|Fludarabine|fludarabine
125264|NCT02512497|Fludarabine phosphate|fludarabine phosphate
125265|NCT02512497|Fludara|fludara
125266|NCT02512484|tuberculosis|tuberculosis
125267|NCT02512484|accident and emergency|accident and emergency
125268|NCT02512471|minimum effective volume|minimum effective volume
125269|NCT02512471|ropivacaine|ropivacaine
125270|NCT02512471|ultrasound-guided supraclavicular block|ultrasound-guided supraclavicular block
125271|NCT02512419|Physical Activity|physical activity
125272|NCT02512419|Latinos|latinos
125273|NCT02512419|Mexican American Men|mexican american men
125274|NCT02512419|Spanish-Language|spanish-language
125275|NCT02512419|Text-Message|text-message
125276|NCT02512406|Tourette Syndrome|tourette syndrome
125277|NCT02512406|Tics|tics
125278|NCT02512341|Computer Aided Auscultation (CAA)|computer aided auscultation (caa)
125279|NCT02512341|Electronic Stethoscope|electronic stethoscope
125280|NCT02512341|Phonocardiography|phonocardiography
125281|NCT02512341|Heart Auscultation|heart auscultation
125282|NCT02512328|Colonoscopy|colonoscopy
125283|NCT02512328|new media|new media
125284|NCT02512328|APP|app
125285|NCT02512328|colonoscopy preparation|colonoscopy preparation
125286|NCT02512328|SPA|spa
125287|NCT02512328|smartphone application|smartphone application
125288|NCT02512315|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
125289|NCT02512315|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
125290|NCT02512315|Concurrent chemoradiation|concurrent chemoradiation
125291|NCT02512315|Distant metastasis|distant metastasis
125292|NCT02512315|Survival|survival
125293|NCT02512302|COPD|copd
125294|NCT02512276|Medication Non-adherence|medication non-adherence
125295|NCT02512276|Hyperlipidemia|hyperlipidemia
125296|NCT02512276|Diabetes|diabetes
125297|NCT02512276|Hypertension|hypertension
125298|NCT02512237|HER2|her2
125299|NCT02512237|breast cancer|breast cancer
125300|NCT02512237|ADC|adc
125301|NCT02512237|antibody drug conjugate|antibody drug conjugate
125302|NCT02512237|elevated HER2 expression|elevated her2 expression
125303|NCT02512224|parenteral nutrition|parenteral nutrition
125304|NCT02512224|enteral nutrition|enteral nutrition
125305|NCT02512211|Hemophilia|hemophilia
125306|NCT02512211|Validation|validation
125307|NCT02512211|Questionnaires|questionnaires
125308|NCT02512211|Activities|activities
125309|NCT02512211|Sport|sport
125310|NCT02512211|Patients|patients
125311|NCT02512198|Professional Practice|professional practice
125312|NCT02512198|General Practitioners|general practitioners
125313|NCT02512198|Inappropriate Prescribing|inappropriate prescribing
125314|NCT02512198|Persuasive Communication|persuasive communication
125315|NCT02512198|Information Theory|information theory
125316|NCT02512198|Feedback|feedback
125317|NCT02512185|Prostate cancer|prostate cancer
125318|NCT02512185|Chemotherapy|chemotherapy
125319|NCT02512185|mCRPC|mcrpc
125320|NCT02512159|Diabetic foot ulcer|diabetic foot ulcer
125321|NCT02512159|Foot care|foot care
125322|NCT02512159|Wound management|wound management
125323|NCT02512146|IBS|ibs
125324|NCT02512146|Ionotropic glutamate receptors|ionotropic glutamate receptors
125325|NCT02512133|MIGS|migs
125326|NCT02512133|SLT|slt
125327|NCT02512094|Barthel index|barthel index
125328|NCT02512094|Hip fracture|hip fracture
116569|NCT02566434|Dietary Supplements|dietary supplements
116570|NCT02566395|Stem Cell Transplantation|stem cell transplantation
125329|NCT02512094|Validity|validity
125330|NCT02512094|Reliability|reliability
125331|NCT02512081|Sciatica|sciatica
125332|NCT02512081|Patient Experience|patient experience
125333|NCT02512081|Investigations|investigations
125334|NCT02512081|Qualitative Research|qualitative research
125335|NCT02512016|Pelvic floor|pelvic floor
125336|NCT02511990|HIV|hiv
125337|NCT02511990|10-1074|10-1074
125338|NCT02511990|Monoclonal Antibody|monoclonal antibody
125339|NCT02511977|Dental Prosthesis|dental prosthesis
125340|NCT02511977|Implant-Supported|implant-supported
125341|NCT02511964|Aerobic Exercise|aerobic exercise
125342|NCT02511964|HIT,|hit,
125343|NCT02511964|VO2Max|vo2max
125344|NCT02511964|Performance|performance
125345|NCT02511951|postoperative pancreatic fistula|postoperative pancreatic fistula
125346|NCT02511951|postoperative hospital stay time|postoperative hospital stay time
125347|NCT02511951|anastomosis time|anastomosis time
125348|NCT02511951|reoperation rate|reoperation rate
125349|NCT02511951|morbidity|morbidity
125350|NCT02511951|pancreaticojejunostomy|pancreaticojejunostomy
125351|NCT02511951|pancreaticoduodenectomy|pancreaticoduodenectomy
125352|NCT02511938|childhood obesity|childhood obesity
125353|NCT02511938|restaurant|restaurant
125354|NCT02511938|away from home foods|away from home foods
125355|NCT02511925|Critical care|critical care
125356|NCT02511925|Feedback|feedback
125357|NCT02511899|Microcirculation|microcirculation
125358|NCT02511899|Endothelial function|endothelial function
125359|NCT02511899|Metabolism|metabolism
125360|NCT02511899|Cardiovascular Disease|cardiovascular disease
125361|NCT02511899|human study|human study
125362|NCT02511899|healthy subjects|healthy subjects
125363|NCT02511899|Mangifera indica|mangifera indica
125364|NCT02511899|Careless|careless
125365|NCT02511886|Alcoholism|alcoholism
125366|NCT02511886|Alcohol Abuse|alcohol abuse
125367|NCT02511886|Alcohol Addiction|alcohol addiction
125368|NCT02511886|Alcohol Dependence|alcohol dependence
125369|NCT02511886|Alcohol Induced Disorders|alcohol induced disorders
125370|NCT02511886|Alcoholic Intoxication|alcoholic intoxication
125371|NCT02511873|Fycompa|fycompa
125372|NCT02511873|Small Fiber Neuropathy|small fiber neuropathy
125373|NCT02511873|SFN|sfn
125374|NCT02511873|Neuropathy|neuropathy
125376|NCT02511847|Breast Cancer|breast cancer
125377|NCT02511847|EGFR|egfr
125378|NCT02511847|Afatinib|afatinib
125379|NCT02511847|Paclitaxel|paclitaxel
125380|NCT02511847|Pathologic complete remission|pathologic complete remission
125381|NCT02511808|Drinking|drinking
125382|NCT02511808|Alcohol Problems|alcohol problems
125384|NCT02511808|Reduced Drinking|reduced drinking
125385|NCT02511808|Problematic Drinking|problematic drinking
125386|NCT02511808|Non-Abstinence-based Drinking|non-abstinence-based drinking
125387|NCT02511808|Controlled Drinking|controlled drinking
125388|NCT02511808|Heavy Drinking|heavy drinking
125389|NCT02511795|AZD1775|azd1775
125390|NCT02511795|Olaparib|olaparib
125391|NCT02511795|AZD1775 plus Olaparib|azd1775 plus olaparib
125392|NCT02511795|Refractory solid tumours|refractory solid tumours
125393|NCT02511782|children|children
125394|NCT02511782|bone marrow transplant|bone marrow transplant
125395|NCT02511782|GVHD|gvhd
125396|NCT02511756|Perfusion-computed tomography|perfusion-computed tomography
125397|NCT02511730|Mammography|mammography
125398|NCT02511704|Nicotine|nicotine
125399|NCT02511704|Electronic cigarette|electronic cigarette
125400|NCT02511704|Cigarette|cigarette
125401|NCT02511639|Hormone receptor positive|hormone receptor positive
125402|NCT02511639|HER2 negative|her2 negative
125403|NCT02511626|endometriosis|endometriosis
125404|NCT02511626|quality of life|quality of life
125405|NCT02511626|professional activity|professional activity
125406|NCT02511626|pain|pain
125407|NCT02511626|infertility|infertility
125408|NCT02511626|sexuality|sexuality
125409|NCT02511626|partnership|partnership
125410|NCT02511626|anxiety|anxiety
125411|NCT02511626|depression|depression
125412|NCT02511626|stress|stress
125413|NCT02511626|childhood trauma|childhood trauma
125414|NCT02511626|medical support|medical support
125415|NCT02511626|dyspareunia|dyspareunia
125416|NCT02511600|Lung Diseases|lung diseases
125417|NCT02511600|Mesothelioma|mesothelioma
125418|NCT02511600|Pleurectomy decortication|pleurectomy decortication
125424|NCT02511600|IAL|ial
125425|NCT02511574|progesterone|progesterone
125426|NCT02511574|uterine cervix|uterine cervix
125427|NCT02511574|cervical pessary|cervical pessary
125428|NCT02511561|Otitis externa|otitis externa
125429|NCT02511561|Swimmer's ear|swimmer's ear
125430|NCT02511561|Ear infection|ear infection
125431|NCT02511509|Schizophrenia|schizophrenia
125432|NCT02511509|Electroconvulsive Therapy|electroconvulsive therapy
116674|NCT02565771|Cancer|cancer
125433|NCT02511509|Bifrontal ECT|bifrontal ect
125434|NCT02511509|Bitemporal ECT|bitemporal ect
125435|NCT02511509|Cognitive functions|cognitive functions
125436|NCT02511509|Postictal delirium|postictal delirium
125437|NCT02511483|COMT|comt
125438|NCT02511483|Beta-blocker|beta-blocker
125439|NCT02511483|Hemicolectomy|hemicolectomy
125440|NCT02511470|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
125441|NCT02511470|Pediatric simulation study|pediatric simulation study
125442|NCT02511470|Metronome|metronome
125443|NCT02511444|GBS|gbs
125444|NCT02511444|GBS culture|gbs culture
125445|NCT02511444|GBS PCR|gbs pcr
125446|NCT02511444|GBS colonization|gbs colonization
125447|NCT02511431|Delta Hepatitis|delta hepatitis
125448|NCT02511431|Hepatitis D|hepatitis d
125449|NCT02511431|Liver Disease|liver disease
125450|NCT02511431|Hepatitis D Virus|hepatitis d virus
125451|NCT02511431|Chronic Hepatitis|chronic hepatitis
125452|NCT02511405|rGBM|rgbm
125453|NCT02511405|Recurrent Glioblastoma|recurrent glioblastoma
125454|NCT02511405|Recurrent GBM|recurrent gbm
125455|NCT02511366|ileal brake|ileal brake
125456|NCT02511353|malaria|malaria
125457|NCT02511353|plasmodium|plasmodium
125458|NCT02511353|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
125459|NCT02511353|ivermectin|ivermectin
125460|NCT02511327|Pertussis|pertussis
125461|NCT02511327|Pregnancy|pregnancy
125462|NCT02511327|Vaccination|vaccination
125463|NCT02511327|Preterm|preterm
125464|NCT02511327|Breast milk|breast milk
125465|NCT02511327|Humoral immune response|humoral immune response
125466|NCT02511327|Cellular immune response|cellular immune response
125467|NCT02511327|Maternal antibodies|maternal antibodies
125468|NCT02511314|Nursing homes|nursing homes
125469|NCT02511314|quasi-experimental|quasi-experimental
125470|NCT02511314|mixed methods|mixed methods
125471|NCT02511314|parallel study|parallel study
125472|NCT02511314|urinary incontinence|urinary incontinence
125473|NCT02511288|hematologic test|hematologic test
125474|NCT02511275|parenchymal clamping|parenchymal clamping
125475|NCT02511275|microdialysis technique|microdialysis technique
125476|NCT02511275|partial nephrectomy|partial nephrectomy
125477|NCT02511249|neonatal arterial ischemic stroke|neonatal arterial ischemic stroke
125478|NCT02511249|language development|language development
125479|NCT02511249|global intellectual functioning|global intellectual functioning
125480|NCT02511249|motor abilities|motor abilities
125481|NCT02511197|PET|pet
125482|NCT02511197|lung injury|lung injury
125483|NCT02511197|integrin receptor|integrin receptor
125484|NCT02511184|crizotinib|crizotinib
125485|NCT02511184|pembrolizumab|pembrolizumab
125486|NCT02511184|ALK-positive NSCLC|alk-positive nsclc
125487|NCT02511184|Lung Cancer|lung cancer
125488|NCT02511184|ALK-translocated NSCLC|alk-translocated nsclc
125489|NCT02511184|Non Small Cell Lung Cancer|non small cell lung cancer
125490|NCT02511158|Anterior Cruciate Ligament, Posterior Cruciate Ligament, Medial Collateral Ligament, Lateral Collateral Ligament|anterior cruciate ligament, posterior cruciate ligament, medial collateral ligament, lateral collateral ligament
125491|NCT02511145|volunteers|volunteers
125492|NCT02511132|Ewing's Sarcoma Family of Tumors, ESFT, Sarcoma|ewing's sarcoma family of tumors, esft, sarcoma
125493|NCT02511132|Soft Tissue Sarcoma|soft tissue sarcoma
125494|NCT02511106|Stage IB-IIA-IIIA Non-Small Cell Lung Cancer; EGFRm+; Ex19Del; L858R; AZD9291; Phase III, adjuvant chemotherapy; complete tumour resection; EGFR-TKI|stage ib-iia-iiia non-small cell lung cancer; egfrm+; ex19del; l858r; azd9291; phase iii, adjuvant chemotherapy; complete tumour resection; egfr-tki
125495|NCT02511093|Hypertension|hypertension
125496|NCT02511093|Team-based care|team-based care
125497|NCT02511093|Collaboration|collaboration
125498|NCT02511093|Healthcare professionals|healthcare professionals
125499|NCT02511093|Healthcare services|healthcare services
125500|NCT02511080|Spot-on; perioperative hypothermia.|spot-on; perioperative hypothermia.
125501|NCT02511054|Immunogenicity|immunogenicity
125502|NCT02511054|Liver Stage|liver stage
125503|NCT02511054|Parasites|parasites
125504|NCT02511054|Blood|blood
125505|NCT02511054|Infection|infection
125506|NCT02511041|CDG|cdg
125507|NCT02511041|PGM3|pgm3
125508|NCT02511041|Immune|immune
125509|NCT02511028|MRI|mri
125510|NCT02511028|Multiple Sclerosis|multiple sclerosis
125511|NCT02511028|Healthy Volunteer|healthy volunteer
125518|NCT02511002|Hemagglutinin (HA)|hemagglutinin (ha)
125519|NCT02511002|Post Influenza Challenge|post influenza challenge
125520|NCT02511002|Neuranimidase (NA)|neuranimidase (na)
125521|NCT02511002|Influenza Illness|influenza illness
125522|NCT02510989|Syndromic obesity|syndromic obesity
125523|NCT02510989|Genes|genes
125524|NCT02510989|Exome|exome
125525|NCT02510963|Vertical infection transmission|vertical infection transmission
125526|NCT02510963|Tenofovir|tenofovir
125527|NCT02510937|pulmonary fibrosis|pulmonary fibrosis
125528|NCT02510937|pharmacokinetic|pharmacokinetic
125529|NCT02510937|pharmacodynamics|pharmacodynamics
125530|NCT02510937|CC-90001|cc-90001
125531|NCT02510937|Safety|safety
125532|NCT02510924|Intubation|intubation
125533|NCT02510924|Airtraq|airtraq
125534|NCT02510924|General anesthesia|general anesthesia
125535|NCT02510924|Difficult airway|difficult airway
125536|NCT02510911|colectomy|colectomy
125537|NCT02510911|laparoscopy|laparoscopy
125538|NCT02510911|caffeine|caffeine
125539|NCT02510885|neovascular age-related macular degeneration|neovascular age-related macular degeneration
125540|NCT02510885|age-related macular degeneration|age-related macular degeneration
125541|NCT02510885|diabetic retinopathy|diabetic retinopathy
125542|NCT02510885|SD-OCT|sd-oct
125543|NCT02510885|Angiography|angiography
125544|NCT02510885|diabetic macular edema|diabetic macular edema
125545|NCT02510846|Polyhandicap|polyhandicap
125546|NCT02510846|Behavior disorders|behavior disorders
125547|NCT02510846|Educative program|educative program
125548|NCT02510846|Caregivers|caregivers
125549|NCT02510846|Quality of life.|quality of life.
125550|NCT02510833|Parkinson Disease|parkinson disease
125551|NCT02510833|Physical Therapy Modalities|physical therapy modalities
125552|NCT02510833|Quality of Life|quality of life
125553|NCT02510833|Self Care|self care
125554|NCT02510768|alba|alba
125555|NCT02510664|Adolescence|adolescence
125556|NCT02510664|Adherence|adherence
125557|NCT02510651|: non-segmental vitiligo|: non-segmental vitiligo
125558|NCT02510651|melanocyte-keratinocyte suspension|melanocyte-keratinocyte suspension
125559|NCT02510651|cryoblebbing|cryoblebbing
125560|NCT02510651|CO2 laser|co2 laser
125561|NCT02510612|Dexmedetomidine|dexmedetomidine
125562|NCT02510612|Diabetic|diabetic
125563|NCT02510612|glycometabolism|glycometabolism
125564|NCT02510612|sedation|sedation
125565|NCT02510599|NASH|nash
125566|NCT02510599|Liver disease|liver disease
125567|NCT02510508|addiction|addiction
125568|NCT02510508|substance abuse|substance abuse
125569|NCT02510508|alcohol|alcohol
125570|NCT02510508|drugs|drugs
125571|NCT02510508|community reinforcement|community reinforcement
125572|NCT02510508|family treatment|family treatment
125573|NCT02510508|randomized control trial|randomized control trial
125574|NCT02510495|Sphincterotomy|sphincterotomy
125575|NCT02510495|Dilatation|dilatation
125576|NCT02510495|Common bile duct|common bile duct
125577|NCT02510495|Pancreatitis|pancreatitis
125578|NCT02510482|cardiac biomarkers|cardiac biomarkers
125579|NCT02510443|Permanent contraception method|permanent contraception method
125580|NCT02510443|Contraceptive device|contraceptive device
125581|NCT02510391|modular|modular
125582|NCT02510391|anxiety|anxiety
125583|NCT02510391|preschool|preschool
125584|NCT02510391|exposure and response prevention|exposure and response prevention
125585|NCT02510391|Cognitive behavioral therapy|cognitive behavioral therapy
125586|NCT02510352|Rotator cuff tear|rotator cuff tear
125587|NCT02510352|MRI|mri
125588|NCT02510287|analgesia, epidural|analgesia, epidural
125589|NCT02510287|labor pain|labor pain
125590|NCT02510287|patient satisfaction|patient satisfaction
125591|NCT02510274|ASP3325|asp3325
125592|NCT02510274|pharmacokinetics|pharmacokinetics
125593|NCT02510274|pharmacodynamics|pharmacodynamics
125594|NCT02510274|Chronic Kidney Disease|chronic kidney disease
125595|NCT02510274|Hyperphosphatemia|hyperphosphatemia
125596|NCT02510261|RNAi therapeutic|rnai therapeutic
125598|NCT02510261|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
125599|NCT02510261|TTR|ttr
125600|NCT02510261|Transthyretin|transthyretin
125601|NCT02510261|Amyloidosis|amyloidosis
125602|NCT02510235|Dry Eye|dry eye
125603|NCT02510222|child|child
125604|NCT02510209|Teen pregnancy|teen pregnancy
125605|NCT02510183|Acupressure|acupressure
125606|NCT02510183|Perioperative Care|perioperative care
125607|NCT02510183|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
125608|NCT02510183|Nursing Care Management|nursing care management
125609|NCT02510170|Fetus|fetus
125610|NCT02510170|Skull|skull
125611|NCT02510170|ultrasonography|ultrasonography
125612|NCT02510157|sugammadex|sugammadex
125613|NCT02510157|dexamethasone|dexamethasone
125614|NCT02510157|neuromuscular blockade|neuromuscular blockade
125615|NCT02510118|ChangTai Keli|changtai keli
125616|NCT02510118|Colon cancer|colon cancer
125617|NCT02510105|Critical Care|critical care
125618|NCT02510105|ARDS|ards
125718|NCT02509520|Nutritional supplementation|nutritional supplementation
125619|NCT02510105|Intrapulmonary Percussive Ventilation|intrapulmonary percussive ventilation
125620|NCT02510105|VDR4|vdr4
125621|NCT02510105|Lung aeration|lung aeration
125622|NCT02510105|CT scan|ct scan
125623|NCT02510066|Pancreatic Cancer|pancreatic cancer
125624|NCT02510066|Pain|pain
125625|NCT02510066|Acupuncture|acupuncture
125626|NCT02510040|Convergence Insufficiency|convergence insufficiency
125627|NCT02510040|Divergence Insufficiency|divergence insufficiency
125628|NCT02510040|Small-angle Hypertropia|small-angle hypertropia
125629|NCT02510040|Strabismus|strabismus
125630|NCT02510027|HPV testing|hpv testing
125631|NCT02510027|Triage|triage
125632|NCT02510027|Mexico|mexico
125633|NCT02510027|Cervical cancer screening|cervical cancer screening
125634|NCT02510001|RASMT CRC|rasmt crc
125635|NCT02510001|RASWT/c-MET CRC|raswt/c-met crc
125636|NCT02510001|Dose Escalation|dose escalation
125637|NCT02510001|Histologically or cytologically confirmed|histologically or cytologically confirmed
125638|NCT02510001|Dose Expansion|dose expansion
125639|NCT02509988|Nutrition|nutrition
125640|NCT02509988|Glucose metabolism|glucose metabolism
125641|NCT02509988|Body composition|body composition
125642|NCT02509975|embolization|embolization
125643|NCT02509975|prostate|prostate
125644|NCT02509962|Energy metabolism|energy metabolism
125645|NCT02509962|Glucose tolerance|glucose tolerance
125646|NCT02509962|Blood pressure|blood pressure
125647|NCT02509962|Immunoregulation|immunoregulation
125648|NCT02509923|Male Subjects|male subjects
125649|NCT02509910|Major abdominal surgery|major abdominal surgery
125650|NCT02509910|Goal directed therapy|goal directed therapy
125651|NCT02509897|Hypoxia training|hypoxia training
125652|NCT02509897|Activity energy expenditure|activity energy expenditure
125653|NCT02509897|Immunoregulation|immunoregulation
125654|NCT02509897|Energy Metabolism|energy metabolism
125655|NCT02509897|Exercise|exercise
125656|NCT02509884|Alveolar Echinococcosis (AE)|alveolar echinococcosis (ae)
125657|NCT02509884|Echinococcus multilocularis|echinococcus multilocularis
125658|NCT02509884|antiparasitic treatment|antiparasitic treatment
125660|NCT02509884|classification|classification
125661|NCT02509884|staging|staging
125662|NCT02509884|prospective cohort study|prospective cohort study
125663|NCT02509871|Body composition|body composition
125664|NCT02509858|Diabetes mellitus, thyroxine|diabetes mellitus, thyroxine
125665|NCT02509832|Therapeutic Hypothermia (TH)|therapeutic hypothermia (th)
125666|NCT02509832|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
125667|NCT02509832|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
125668|NCT02509819|rehabilitation|rehabilitation
125669|NCT02509819|IDEO|ideo
125670|NCT02509780|Vichy|vichy
125671|NCT02509780|urine alkalization|urine alkalization
125672|NCT02509767|Contraceptive Methods|contraceptive methods
125673|NCT02509767|Female Contraception|female contraception
125674|NCT02509767|Contraceptive satisfaction|contraceptive satisfaction
125675|NCT02509767|Injectable contraception|injectable contraception
125676|NCT02509767|Birth control|birth control
125677|NCT02509754|atrial fibrillation|atrial fibrillation
125678|NCT02509754|congestive heart failure|congestive heart failure
125679|NCT02509754|catheter ablation|catheter ablation
125680|NCT02509754|rate control|rate control
125681|NCT02509754|left ventricular function|left ventricular function
125682|NCT02509741|obesity|obesity
125683|NCT02509741|nutrition|nutrition
125684|NCT02509741|intervention|intervention
125685|NCT02509741|food replacement|food replacement
125687|NCT02509728|choline|choline
125688|NCT02509728|docosahexaenoic acid|docosahexaenoic acid
125689|NCT02509715|thyroidectomy|thyroidectomy
125690|NCT02509715|nerve monitoring|nerve monitoring
125691|NCT02509702|Mobile health|mobile health
125692|NCT02509702|Screening|screening
125693|NCT02509702|Early detection of cancer|early detection of cancer
125694|NCT02509702|Telemedicine|telemedicine
125695|NCT02509689|mTBI|mtbi
125696|NCT02509689|cognition disorders|cognition disorders
125697|NCT02509689|post-concussive syndrome|post-concussive syndrome
125698|NCT02509689|neuroplasticity|neuroplasticity
125699|NCT02509689|EEG|eeg
125700|NCT02509689|biofeedback|biofeedback
125701|NCT02509689|stress disorder/post-traumatic|stress disorder/post-traumatic
125702|NCT02509689|depression|depression
125703|NCT02509676|dynamic stretching training|dynamic stretching training
125704|NCT02509676|muscle tendon unit|muscle tendon unit
125705|NCT02509676|ultrasound|ultrasound
125706|NCT02509650|Exome sequencing|exome sequencing
125707|NCT02509650|Skin disease|skin disease
125708|NCT02509650|Familial lipomatosis|familial lipomatosis
125709|NCT02509637|Respiratory System|respiratory system
125710|NCT02509637|Physical Therapy Modalities|physical therapy modalities
125711|NCT02509611|Yoga|yoga
125712|NCT02509611|Parkinson's disease|parkinson's disease
125713|NCT02509611|redox status|redox status
125714|NCT02509611|motor function|motor function
125715|NCT02509559|Receptors, Adrenergic|receptors, adrenergic
125716|NCT02509559|Propranolol|propranolol
125717|NCT02509533|Vacuum Assisted Closure|vacuum assisted closure
125816|NCT02509156|AIC|aic
125719|NCT02509520|Neuromuscular Electric Stimulation|neuromuscular electric stimulation
125720|NCT02509520|ICU acquired weakness|icu acquired weakness
125721|NCT02509520|Post ICU Syndrome|post icu syndrome
125722|NCT02509520|sarcopenia|sarcopenia
125723|NCT02509507|Liver tumours|liver tumours
125724|NCT02509494|Vaccine|vaccine
125725|NCT02509494|Ebola|ebola
125726|NCT02509494|Ebola virus disease|ebola virus disease
125727|NCT02509494|EVD|evd
125728|NCT02509494|Hemorrhagic fever|hemorrhagic fever
125729|NCT02509494|Sierra Leone|sierra leone
125730|NCT02509494|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
125731|NCT02509494|Safety|safety
125732|NCT02509494|Immunogenicity|immunogenicity
125733|NCT02509494|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector
125734|NCT02509494|(MVA‐BN Filo)|(mva‐bn filo)
125735|NCT02509481|malaria|malaria
125736|NCT02509481|lymphatic filariasis|lymphatic filariasis
125737|NCT02509481|mosquito|mosquito
125738|NCT02509481|ivermectin|ivermectin
125739|NCT02509481|mass drug administration|mass drug administration
125740|NCT02509455|Balance control|balance control
125741|NCT02509455|Body-mounted sensors|body-mounted sensors
125742|NCT02509455|Balance Measures|balance measures
125743|NCT02509442|mapping brain functions|mapping brain functions
125744|NCT02509442|Direct electric stimulation (DES)|direct electric stimulation (des)
125745|NCT02509442|potential evoked|potential evoked
125746|NCT02509429|T1DM|t1dm
125747|NCT02509429|Type 1 Diabetes|type 1 diabetes
125748|NCT02509429|Artificial Pancreas|artificial pancreas
125749|NCT02509429|DiAs platform|dias platform
125750|NCT02509416|endoscopic ultrasound|endoscopic ultrasound
125751|NCT02509416|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
125752|NCT02509416|competency|competency
125753|NCT02509403|Perineal hygiene|perineal hygiene
125754|NCT02509403|Hygiene wipes|hygiene wipes
125755|NCT02509403|Hygiene Towels|hygiene towels
125756|NCT02509403|Safety|safety
125757|NCT02509403|Essential oils|essential oils
125758|NCT02509403|Natural Health Product|natural health product
125759|NCT02509390|Fibrinogen level|fibrinogen level
125760|NCT02509390|Hyperfibrinogenemia|hyperfibrinogenemia
125761|NCT02509390|Trauma|trauma
125762|NCT02509390|Thrombosis risk|thrombosis risk
125763|NCT02509377|Fetal Surgery|fetal surgery
125764|NCT02509377|Open Fetal Surgery|open fetal surgery
125765|NCT02509377|Elevated BMI|elevated bmi
125766|NCT02509377|Body Mass Index|body mass index
125767|NCT02509377|Spina Bifida|spina bifida
125768|NCT02509364|AE-IPF|ae-ipf
125769|NCT02509312|Analgesia, Obstetrical|analgesia, obstetrical
125770|NCT02509312|Blood Loss, Surgical|blood loss, surgical
125771|NCT02509312|Analgesics, Opioid/administration & dosage|analgesics, opioid/administration & dosage
125772|NCT02509312|Cyclooxygenase Inhibitors/administration & dosage|cyclooxygenase inhibitors/administration & dosage
125773|NCT02509312|Cesarean Section|cesarean section
125774|NCT02509312|Female|female
125775|NCT02509312|Humans|humans
125776|NCT02509312|Ketorolac/administration & dosage|ketorolac/administration & dosage
125777|NCT02509312|Hydromorphone/administration & dosage|hydromorphone/administration & dosage
125778|NCT02509312|Pain, Postoperative/drug therapy|pain, postoperative/drug therapy
125779|NCT02509312|Pregnancy|pregnancy
125780|NCT02509312|Morphine/administration & dosage|morphine/administration & dosage
125781|NCT02509299|COPD|copd
125782|NCT02509299|Quality of life|quality of life
125783|NCT02509299|Perceived health status|perceived health status
125784|NCT02509286|Esophageal neoplasms|esophageal neoplasms
125785|NCT02509286|gastro-esophageal junction neoplasms|gastro-esophageal junction neoplasms
125786|NCT02509286|adenocarcinoma|adenocarcinoma
125787|NCT02509286|esophagectomy|esophagectomy
125791|NCT02509260|colorectal surgery|colorectal surgery
125792|NCT02509247|sleep apnea|sleep apnea
125793|NCT02509247|CPAP|cpap
125794|NCT02509247|telemonitoring|telemonitoring
125795|NCT02509247|telecare|telecare
125796|NCT02509234|pediatric sarcomas|pediatric sarcomas
125797|NCT02509234|Ewing sarcoma|ewing sarcoma
125798|NCT02509234|rhabdomyosarcoma|rhabdomyosarcoma
125799|NCT02509234|soft tissue sarcoma|soft tissue sarcoma
125800|NCT02509208|iliac crest bone graft|iliac crest bone graft
125801|NCT02509208|ICBG|icbg
125802|NCT02509208|pelvic osteotomy|pelvic osteotomy
125803|NCT02509208|spinal fusion|spinal fusion
125804|NCT02509208|hemostasis|hemostasis
125805|NCT02509208|haemostasis|haemostasis
125806|NCT02509208|hemostatic|hemostatic
125807|NCT02509208|haemostatic|haemostatic
125808|NCT02509208|dextran|dextran
125809|NCT02509208|SurgiClot|surgiclot
125810|NCT02509208|cancellous bone bleeding|cancellous bone bleeding
125811|NCT02509182|Hyperoxia|hyperoxia
125812|NCT02509182|One-Lung Ventilation|one-lung ventilation
125813|NCT02509182|Thoracic Surgery|thoracic surgery
125814|NCT02509182|Anesthesiology|anesthesiology
125815|NCT02509156|Cardiomyopathy|cardiomyopathy
125817|NCT02509156|Anthracyclines|anthracyclines
125818|NCT02509156|Chemotherapy|chemotherapy
125819|NCT02509156|Allogeneic|allogeneic
125820|NCT02509156|Mesenchymal stem cells|mesenchymal stem cells
125821|NCT02509156|MSCs|mscs
125822|NCT02509156|Cancer survivors|cancer survivors
125823|NCT02509156|Breast Cancer|breast cancer
125824|NCT02509156|Leukemia|leukemia
125825|NCT02509156|Lymphoma|lymphoma
125826|NCT02509156|Sarcoma|sarcoma
125827|NCT02509143|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
125828|NCT02509143|Colorectal Neoplasms|colorectal neoplasms
125829|NCT02509130|Severe Asthma|severe asthma
125830|NCT02509130|Asthma|asthma
125831|NCT02509130|Specialised Asthma Care|specialised asthma care
125832|NCT02509130|Asthma Care|asthma care
125833|NCT02509117|Alzheimer's disease|alzheimer's disease
125834|NCT02509104|Bioavailability|bioavailability
125835|NCT02509104|Dutasteride|dutasteride
125836|NCT02509104|Healthy Male Subjects|healthy male subjects
125837|NCT02509104|Fixed Dose Combination|fixed dose combination
125838|NCT02509078|ARDS|ards
125839|NCT02509078|neuromuscular blocker|neuromuscular blocker
125840|NCT02509078|cisatracurium|cisatracurium
125841|NCT02509065|bionic pancreas|bionic pancreas
125842|NCT02509065|artificial pancreas|artificial pancreas
125843|NCT02509065|insulin|insulin
125844|NCT02509065|glucagon|glucagon
125845|NCT02509065|continuous glucose monitor (CGM)|continuous glucose monitor (cgm)
125846|NCT02509065|insulin pump|insulin pump
125847|NCT02509065|outpatient|outpatient
125848|NCT02509039|CC-122|cc-122
125849|NCT02509039|Phase1|phase1
125850|NCT02509039|solid tumor|solid tumor
125851|NCT02509039|non-Hodgkin's lymphom|non-hodgkin's lymphom
125852|NCT02509026|non-radiographic axial spondyloarthritis|non-radiographic axial spondyloarthritis
125853|NCT02509013|chronic kidney disease|chronic kidney disease
125854|NCT02509013|stable coronary heart disease|stable coronary heart disease
125855|NCT02509013|prevalence|prevalence
125856|NCT02508987|Obesity|obesity
125857|NCT02508987|oxidative stress|oxidative stress
125858|NCT02508987|antioxidants|antioxidants
125859|NCT02508987|periodontal disease|periodontal disease
125860|NCT02508961|Physical Activity|physical activity
125861|NCT02508961|Exercise|exercise
125862|NCT02508961|Physiotherapy|physiotherapy
125863|NCT02508948|airway management|airway management
125864|NCT02508948|critically ill|critically ill
125865|NCT02508948|hemodynamic management|hemodynamic management
125866|NCT02508948|intubation|intubation
125867|NCT02508948|prospective study|prospective study
125868|NCT02508948|risk factors|risk factors
125869|NCT02508909|Videoassisted surgery|videoassisted surgery
125870|NCT02508883|Cancer|cancer
125871|NCT02508883|hemorrhage|hemorrhage
125872|NCT02508883|endoscopy|endoscopy
125873|NCT02508883|gastrointestinal hemorrhage|gastrointestinal hemorrhage
125874|NCT02508857|pain, postoperative|pain, postoperative
125875|NCT02508857|anesthesia adjuvants|anesthesia adjuvants
125876|NCT02508857|magnesium sulfate|magnesium sulfate
125877|NCT02508844|Probiotics|probiotics
125878|NCT02508844|Vivomixx®|vivomixx®
125879|NCT02508844|Microbiota|microbiota
125880|NCT02508831|Bilateral amputation|bilateral amputation
125881|NCT02508831|upper limb|upper limb
125882|NCT02508831|allograft|allograft
125883|NCT02508779|Diabetes|diabetes
125884|NCT02508779|Blood Glucose Management|blood glucose management
125885|NCT02508779|Preconception|preconception
125886|NCT02508779|Hypoglycemia|hypoglycemia
125887|NCT02508779|Women with diabetes|women with diabetes
125888|NCT02508766|Postural Control|postural control
125889|NCT02508766|Plantar Stimulation|plantar stimulation
125890|NCT02508766|Volunteers|volunteers
125896|NCT02508688|thoracoscopic surgery|thoracoscopic surgery
126000|NCT02508103|PMS|pms
125897|NCT02508688|diaphragmatic defect|diaphragmatic defect
125898|NCT02508675|injury|injury
125899|NCT02508675|risk factors|risk factors
125900|NCT02508675|outcome|outcome
125901|NCT02508675|costs|costs
125902|NCT02508662|Advanced Cancers|advanced cancers
125903|NCT02508662|Solid Tumors|solid tumors
125904|NCT02508662|Genomic Mutations|genomic mutations
125905|NCT02508662|FDA Approved Off-Label Chemotherapy|fda approved off-label chemotherapy
125906|NCT02508662|Refractory|refractory
125907|NCT02508623|Portal hypertension|portal hypertension
125908|NCT02508623|liver cirrhosis|liver cirrhosis
125909|NCT02508623|Rifaximin|rifaximin
125910|NCT02508597|Smoking cessation intervention|smoking cessation intervention
125911|NCT02508571|Infant, Premature|infant, premature
125912|NCT02508571|Intervention Studies|intervention studies
125913|NCT02508571|Bottle feeding|bottle feeding
125914|NCT02508506|ALKS 5461|alks 5461
125915|NCT02508506|Alkermes|alkermes
125916|NCT02508506|Samidorphan|samidorphan
125917|NCT02508506|Renal Impairment|renal impairment
125918|NCT02508506|Pharmacokinetics|pharmacokinetics
125919|NCT02508506|Buprenorphine|buprenorphine
125920|NCT02508480|Stigma|stigma
125921|NCT02508480|Community Integration|community integration
125922|NCT02508467|Liver cancer|liver cancer
125923|NCT02508467|FGF19 gene amplification|fgf19 gene amplification
125924|NCT02508467|FGF19 overexpression|fgf19 overexpression
125925|NCT02508467|FGF19 upregulation|fgf19 upregulation
125926|NCT02508467|Cyclin D1 (CCND1) gene amplification|cyclin d1 (ccnd1) gene amplification
125927|NCT02508467|Cyclin D1 (CCND1) copy number gain|cyclin d1 (ccnd1) copy number gain
125928|NCT02508467|BLU-554|blu-554
125929|NCT02508467|FGFR4|fgfr4
125930|NCT02508467|Hepatocellular carcinoma|hepatocellular carcinoma
125931|NCT02508467|Liver Disease|liver disease
125932|NCT02508467|Liver Neoplasms|liver neoplasms
125933|NCT02508454|Prevention|prevention
125934|NCT02508454|Screening|screening
125935|NCT02508454|Biobanking|biobanking
125936|NCT02508441|Neoplasms|neoplasms
125937|NCT02508441|Solid Tumors|solid tumors
125938|NCT02508441|Advanced Malignancy|advanced malignancy
125939|NCT02508441|Cancer|cancer
151494|NCT02363075|glioma|glioma
125940|NCT02508428|Osteolysis|osteolysis
125941|NCT02508428|Polyethylene|polyethylene
125942|NCT02508428|Crosslinked Polyethylene|crosslinked polyethylene
125943|NCT02508428|Total Hip Replacement|total hip replacement
125944|NCT02508428|Marathon|marathon
125945|NCT02508415|obesity|obesity
125946|NCT02508415|periodontal disease|periodontal disease
125947|NCT02508415|intervention|intervention
125948|NCT02508389|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
125949|NCT02508389|oral cavity|oral cavity
125950|NCT02508389|oropharynx|oropharynx
125951|NCT02508389|intensity-modulated radiation therapy|intensity-modulated radiation therapy
125952|NCT02508389|chemotherapy|chemotherapy
125953|NCT02508389|oral mucositis|oral mucositis
125954|NCT02508389|superoxide dismutase|superoxide dismutase
125955|NCT02508389|radioprotection|radioprotection
125956|NCT02508376|adjuvants|adjuvants
125957|NCT02508376|AP10-602|ap10-602
125958|NCT02508376|GLA-SE|gla-se
125959|NCT02508376|ID93|id93
125960|NCT02508376|Tuberculosis|tuberculosis
125961|NCT02508376|vaccine|vaccine
125962|NCT02508363|Taxi drivers|taxi drivers
125963|NCT02508363|Health care access|health care access
125964|NCT02508363|15-163|15-163
125965|NCT02508311|Tetraplegia|tetraplegia
125966|NCT02508311|High Paraplegia|high paraplegia
125968|NCT02508298|ARFI|arfi
125969|NCT02508298|portal hypertension|portal hypertension
125970|NCT02508298|cirrhosis|cirrhosis
125971|NCT02508298|diagnostic study|diagnostic study
125972|NCT02508272|Transcriptome profiling|transcriptome profiling
125973|NCT02508259|mitochondria|mitochondria
125974|NCT02508259|purinergic signaling|purinergic signaling
125975|NCT02508259|cell danger response|cell danger response
125976|NCT02508194|RSV|rsv
125977|NCT02508194|Older adults|older adults
125978|NCT02508194|MEDI7510|medi7510
125979|NCT02508194|Vaccine|vaccine
125980|NCT02508194|Efficacy|efficacy
125981|NCT02508181|intra ocular pressure|intra ocular pressure
125982|NCT02508181|I-gel|i-gel
125983|NCT02508181|LMA Supreme|lma supreme
125984|NCT02508181|strabismus surgery|strabismus surgery
125985|NCT02508168|Drug therapy|drug therapy
125986|NCT02508129|Insomnia|insomnia
125987|NCT02508129|hypertension|hypertension
125988|NCT02508129|blood pressure|blood pressure
125989|NCT02508129|sleep|sleep
125990|NCT02508129|behavioral treatment|behavioral treatment
125991|NCT02508129|Cognitive Behavioral Treatment of Insomnia (CBTI)|cognitive behavioral treatment of insomnia (cbti)
125992|NCT02508129|Brief Behavioral Treatment of Insomnia (BBTI)|brief behavioral treatment of insomnia (bbti)
125993|NCT02508129|pragmatic trial|pragmatic trial
125994|NCT02508129|internet|internet
125995|NCT02508116|pharmacogenetics|pharmacogenetics
125996|NCT02508116|clopidogrel|clopidogrel
125997|NCT02508116|genotype|genotype
125998|NCT02508103|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
125999|NCT02508103|Premenstrual Syndrome|premenstrual syndrome
126001|NCT02508103|PMDD|pmdd
126002|NCT02508038|alpha beta depleted|alpha beta depleted
126003|NCT02508038|alphabeta|alphabeta
126004|NCT02508038|TCR alpha beta depleted|tcr alpha beta depleted
126005|NCT02508038|alpha beta|alpha beta
126006|NCT02508038|haploidentical|haploidentical
126007|NCT02508038|Zoledronate|zoledronate
126008|NCT02508038|Zoledronic acid|zoledronic acid
126009|NCT02508038|Pediatric cancers|pediatric cancers
126010|NCT02508038|alfa beta|alfa beta
126011|NCT02508038|αβ T cell depleted HSCT|αβ t cell depleted hsct
126012|NCT02508038|alpha beta T cell and B cell depleted HSCT|alpha beta t cell and b cell depleted hsct
126013|NCT02508038|haploidentical HSCT|haploidentical hsct
126014|NCT02508025|disability evaluation|disability evaluation
126015|NCT02508025|psychosocial factors|psychosocial factors
126016|NCT02508012|anti-TNF|anti-tnf
126017|NCT02508012|Immuno-monitoring|immuno-monitoring
126018|NCT02508012|Anti-drug antibody (ADAb)|anti-drug antibody (adab)
126019|NCT02508012|Inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
126020|NCT02508012|Crohn's disease|crohn's disease
126021|NCT02508012|Ulcerative colitis|ulcerative colitis
126022|NCT02507973|Mechanical Ventilation|mechanical ventilation
126023|NCT02507973|Intracranial Pressure|intracranial pressure
126024|NCT02507973|Airway Pressure Release Ventilation|airway pressure release ventilation
126025|NCT02507934|Dry Eye|dry eye
126026|NCT02507908|neuroendocrine tumors|neuroendocrine tumors
126027|NCT02507908|5-hydroxyindolacetic acid|5-hydroxyindolacetic acid
126028|NCT02507908|serotonin|serotonin
126029|NCT02507908|isotope-dilution massa-spectrometer|isotope-dilution massa-spectrometer
126030|NCT02507895|Stroke|stroke
126031|NCT02507895|lower extremeties|lower extremeties
126032|NCT02507895|Brain-computer interface|brain-computer interface
126033|NCT02507895|Motor imagery|motor imagery
126034|NCT02507895|Rehabilitation|rehabilitation
126035|NCT02507895|TMS|tms
126036|NCT02507843|Vitamin D|vitamin d
126037|NCT02507817|LIF,Magnesium Sulphate|lif,magnesium sulphate
126038|NCT02507791|Fitbit|fitbit
126039|NCT02507791|Obesity|obesity
126040|NCT02507791|Pediatrics|pediatrics
126041|NCT02507778|Lung|lung
126042|NCT02507778|Cancer|cancer
126043|NCT02507778|Biomarkers|biomarkers
126044|NCT02507778|Early detection|early detection
126045|NCT02507778|Circulating tumor cell|circulating tumor cell
126047|NCT02507713|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
126048|NCT02507713|Ultrasonography|ultrasonography
126049|NCT02507713|Motor neurons|motor neurons
126050|NCT02507713|Neuromuscular diseases|neuromuscular diseases
126051|NCT02507713|Fasciculation|fasciculation
126052|NCT02507700|nerve block|nerve block
126053|NCT02507674|appendicitis|appendicitis
126054|NCT02507674|pediatric|pediatric
126055|NCT02507674|ultrasound|ultrasound
126056|NCT02507635|cytokines|cytokines
126057|NCT02507635|persistent allergic rhinitis|persistent allergic rhinitis
126058|NCT02507635|H1 antihistamines|h1 antihistamines
126059|NCT02507583|Brain Tumor|brain tumor
126060|NCT02507583|Glioma|glioma
126061|NCT02507583|Newly Diagnosed|newly diagnosed
126062|NCT02507557|Therapy, Fluid|therapy, fluid
126063|NCT02507557|Digestive System Surgical Procedures|digestive system surgical procedures
126064|NCT02507557|Postoperative Complications|postoperative complications
126065|NCT02507544|Advanced Solid Malignancy|advanced solid malignancy
126066|NCT02507544|Safety and Tolerability|safety and tolerability
126067|NCT02507544|Tumor Response|tumor response
126068|NCT02507544|Hematology|hematology
126069|NCT02507544|Oncology|oncology
126070|NCT02507518|lung cancer, PET, progression free survival|lung cancer, pet, progression free survival
126071|NCT02507492|POMC, LEPR, PCSK1|pomc, lepr, pcsk1
126072|NCT02507466|locomotion|locomotion
126073|NCT02507453|volunteers|volunteers
126074|NCT02507427|Prostate cancer, robot, nerve mapping and monitoring|prostate cancer, robot, nerve mapping and monitoring
126075|NCT02507414|Mesenteric Traction Syndrome|mesenteric traction syndrome
126076|NCT02507414|Upper gastrointestinal cancer surgery|upper gastrointestinal cancer surgery
126077|NCT02507375|Non-Squamous|non-squamous
126078|NCT02507362|keratoconus , corneal collagen cross-linking|keratoconus , corneal collagen cross-linking
126079|NCT02507349|serious mental illness|serious mental illness
126080|NCT02507349|mental health services research|mental health services research
126081|NCT02507349|measurement-based care|measurement-based care
126082|NCT02507349|shared decision making|shared decision making
126083|NCT02507349|psychiatric medication management|psychiatric medication management
126084|NCT02507349|community psychiatry|community psychiatry
126085|NCT02507349|comparative effectiveness research|comparative effectiveness research
126086|NCT02507349|mixed methods research|mixed methods research
126087|NCT02507336|Mantle Cell Lymphoma (MCL)|mantle cell lymphoma (mcl)
126088|NCT02507336|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
126089|NCT02507258|osteoarthritis|osteoarthritis
126090|NCT02507258|avascular necrosis|avascular necrosis
126091|NCT02507258|correction of functional deformity|correction of functional deformity
126092|NCT02507258|painful hip dysplasia|painful hip dysplasia
126093|NCT02507258|protrusio acetabuli|protrusio acetabuli
126094|NCT02507258|rheumatoid arthritis|rheumatoid arthritis
126095|NCT02507258|ankylosis|ankylosis
126096|NCT02507245|GHD|ghd
126097|NCT02507232|glioma|glioma
126098|NCT02507232|temozolomide|temozolomide
126099|NCT02507232|brain|brain
126100|NCT02507232|NovoTTF-200A|novottf-200a
126101|NCT02507232|cancer|cancer
126102|NCT02507232|low-grade glioma|low-grade glioma
126103|NCT02507206|schizotypal personality disorder|schizotypal personality disorder
126104|NCT02507206|cognitive impairment|cognitive impairment
126105|NCT02507206|working memory|working memory
126106|NCT02507206|Dopamine Agonists|dopamine agonists
126107|NCT02507206|Cognition Disorders|cognition disorders
126108|NCT02507206|Personality Disorders|personality disorders
126109|NCT02507206|Delirium|delirium
126110|NCT02507206|Dementia|dementia
126111|NCT02507206|Amnestic|amnestic
126112|NCT02507206|Cognitive Disorders|cognitive disorders
126113|NCT02507206|Mental Disorders|mental disorders
126114|NCT02507206|Dihydrexidine|dihydrexidine
126115|NCT02507206|Dopamine A|dopamine a
126116|NCT02507180|clinical decision rule|clinical decision rule
126117|NCT02507180|Ultrasound|ultrasound
126223|NCT02506439|Pregnancy|pregnancy
126118|NCT02507180|Suspected Deep Vein Thrombosis|suspected deep vein thrombosis
126119|NCT02507180|D-Dimer|d-dimer
126120|NCT02507154|cetuximab|cetuximab
126121|NCT02507154|NK cells|nk cells
126122|NCT02507154|nasopharyngeal cancer|nasopharyngeal cancer
126123|NCT02507154|head and neck squamous cell cancer|head and neck squamous cell cancer
126124|NCT02507141|Reflectance Confocal Microscopy|reflectance confocal microscopy
126125|NCT02507141|15-128|15-128
126126|NCT02507050|Ivabradine|ivabradine
126127|NCT02507050|Microvascular dysfunction|microvascular dysfunction
126128|NCT02507050|PCI|pci
126129|NCT02507050|Procedural related myocardial injury|procedural related myocardial injury
126130|NCT02507050|IMR|imr
126131|NCT02507050|Index of Microvascular Resistance|index of microvascular resistance
126132|NCT02506998|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
126133|NCT02506998|Dialyzable Leukocyte Extracts|dialyzable leukocyte extracts
126134|NCT02506985|Rivaroxaban|rivaroxaban
126135|NCT02506985|CDT (Catheter directed thrombolysis)|cdt (catheter directed thrombolysis)
126136|NCT02506985|PE (pulmonary embolism)|pe (pulmonary embolism)
126137|NCT02506985|NETs|nets
126138|NCT02506985|factor Xa|factor xa
126139|NCT02506972|Blood glucose|blood glucose
126140|NCT02506972|Humans|humans
126141|NCT02506972|Postprandial|postprandial
126142|NCT02506972|Sugar|sugar
126143|NCT02506972|Carbohydrate|carbohydrate
126144|NCT02506972|Oat beta-glucan|oat beta-glucan
126145|NCT02506959|Multiple myeloma (MM)|multiple myeloma (mm)
126146|NCT02506959|MM|mm
126147|NCT02506959|Refractory|refractory
126148|NCT02506959|Relapsed|relapsed
126149|NCT02506959|Stem Cell Transplant|stem cell transplant
126150|NCT02506959|Busulfan|busulfan
126151|NCT02506959|Busulfex|busulfex
126152|NCT02506959|Myleran|myleran
126153|NCT02506959|Palifermin|palifermin
126154|NCT02506959|Kepivance|kepivance
126155|NCT02506959|Panobinostat|panobinostat
126156|NCT02506959|LBH589B|lbh589b
126157|NCT02506959|Gemcitabine|gemcitabine
126158|NCT02506959|Gemcitabine Hydrochloride|gemcitabine hydrochloride
126159|NCT02506959|Gemzar|gemzar
126160|NCT02506959|Melphalan|melphalan
126161|NCT02506959|Alkeran|alkeran
126162|NCT02506959|Dexamethasone|dexamethasone
126163|NCT02506959|Decadron|decadron
126164|NCT02506959|Pyridoxine|pyridoxine
126165|NCT02506959|Caphosol|caphosol
126166|NCT02506959|Glutamine|glutamine
126167|NCT02506959|Enterex|enterex
126168|NCT02506959|Glutapak|glutapak
126169|NCT02506959|NutreStore|nutrestore
126170|NCT02506959|Resource|resource
126171|NCT02506959|GlutaSolve|glutasolve
126172|NCT02506959|Sympt-X|sympt-x
126173|NCT02506946|Polycystic Ovary Syndrome|polycystic ovary syndrome
126174|NCT02506946|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
126175|NCT02506946|Adolescents|adolescents
126176|NCT02506946|Young Women|young women
126177|NCT02506946|MRI|mri
126178|NCT02506946|MRS|mrs
126179|NCT02506946|DXA|dxa
126180|NCT02506946|Hirsutism|hirsutism
126181|NCT02506946|Amenorrhea|amenorrhea
126182|NCT02506946|Metabolic syndrome|metabolic syndrome
126183|NCT02506946|Dyslipidemia|dyslipidemia
126184|NCT02506946|Percentage liver fat|percentage liver fat
126185|NCT02506920|Postprandial lipemia|postprandial lipemia
126186|NCT02506920|glycemic response|glycemic response
126187|NCT02506881|darbepoetin alfa|darbepoetin alfa
126188|NCT02506881|pharmacokinetics|pharmacokinetics
126189|NCT02506881|pharmacodynamics|pharmacodynamics
126190|NCT02506881|healthy volunteers|healthy volunteers
126191|NCT02506868|darbepoetin alfa|darbepoetin alfa
126192|NCT02506842|Pancreatic Cancer|pancreatic cancer
126193|NCT02506842|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
126194|NCT02506842|AG|ag
126195|NCT02506842|OFF|off
126196|NCT02506842|Second-Line Adjuvant Therapy|second-line adjuvant therapy
126197|NCT02506829|Inpatients|inpatients
126198|NCT02506790|Melatonin, metformin, toremifene|melatonin, metformin, toremifene
126199|NCT02506777|Melatonin, metformin, chemotherapy|melatonin, metformin, chemotherapy
126200|NCT02506738|telemonitoring|telemonitoring
126201|NCT02506738|mHealth|mhealth
126202|NCT02506738|functional status|functional status
126203|NCT02506738|older people|older people
126204|NCT02506725|prenatal care|prenatal care
126205|NCT02506725|pregnancy|pregnancy
126206|NCT02506725|prematurity|prematurity
126207|NCT02506673|Audiovisual Aids|audiovisual aids
126208|NCT02506673|Perioperative Period|perioperative period
126209|NCT02506673|Anxiety|anxiety
126210|NCT02506634|symptom|symptom
126211|NCT02506608|Neuroplasticty, Sensory Feedback|neuroplasticty, sensory feedback
126212|NCT02506556|Pi3K pathway|pi3k pathway
126213|NCT02506543|Adolescent Health|adolescent health
126214|NCT02506543|Ethiopia|ethiopia
126215|NCT02506543|Sexual Violence|sexual violence
126216|NCT02506530|lymphedema|lymphedema
126217|NCT02506530|breast cancer|breast cancer
126218|NCT02506517|HER pathway aberrations|her pathway aberrations
126219|NCT02506439|Vitamin D|vitamin d
126220|NCT02506439|Cholecalciferol|cholecalciferol
126221|NCT02506439|Dose-response|dose-response
126222|NCT02506439|Randomized Controlled Trial|randomized controlled trial
126224|NCT02506439|Cord blood|cord blood
126225|NCT02506439|Serum 25-hydroxyvitamin D|serum 25-hydroxyvitamin d
126226|NCT02506439|Vitamin D Deficiency|vitamin d deficiency
126227|NCT02506439|Nutrition|nutrition
126228|NCT02506439|Dietary intervention study|dietary intervention study
126229|NCT02506426|Chronic Sinusitis|chronic sinusitis
126230|NCT02506426|Chronic Rhinosinusitis|chronic rhinosinusitis
126231|NCT02506426|Endoscopic sinus surgery|endoscopic sinus surgery
126232|NCT02506426|Septoplasty|septoplasty
126233|NCT02506413|Maternal and Newborn Health|maternal and newborn health
126234|NCT02506361|TOP2α|top2α
126235|NCT02506361|anthracyclines|anthracyclines
126236|NCT02506361|taxanes|taxanes
126237|NCT02506361|non dose-dense chemotherapy|non dose-dense chemotherapy
117454|NCT02561078|OmniPod|omnipod
126238|NCT02506335|Liver disease|liver disease
126239|NCT02506335|cardiomyopathy|cardiomyopathy
126240|NCT02506335|congenital heart disease|congenital heart disease
126241|NCT02506322|Bipolar I Disorder|bipolar i disorder
126242|NCT02506322|Bipolar II Disorder|bipolar ii disorder
126243|NCT02506322|Relapse Prevention|relapse prevention
126244|NCT02506296|type 2 diabetes|type 2 diabetes
126245|NCT02506296|endogenous insulin secretion|endogenous insulin secretion
126246|NCT02506283|cryotherapy|cryotherapy
126247|NCT02506283|recovery|recovery
126248|NCT02506283|athletic performance|athletic performance
126249|NCT02506283|maximum voluntary contraction|maximum voluntary contraction
126250|NCT02506283|rated perceived exertion|rated perceived exertion
126251|NCT02506283|delayed onset muscle soreness|delayed onset muscle soreness
126252|NCT02506283|jump performance|jump performance
126253|NCT02506244|Atrial Fibrillation|atrial fibrillation
126254|NCT02506244|Wearable device|wearable device
126255|NCT02506244|Wristband|wristband
126256|NCT02506244|ECG Patch|ecg patch
126257|NCT02506244|Strokes|strokes
126258|NCT02506244|Asymptomatic|asymptomatic
126259|NCT02506244|Heart Rhythm|heart rhythm
126260|NCT02506244|Home Monitoring|home monitoring
126261|NCT02506231|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
126262|NCT02506231|GVHD prophylaxis|gvhd prophylaxis
126263|NCT02506231|Methotrexate|methotrexate
126264|NCT02506231|Folinic acid|folinic acid
126265|NCT02506231|Leucovorin|leucovorin
126266|NCT02506231|Mucositis|mucositis
126267|NCT02506192|Gulf War Illness|gulf war illness
126268|NCT02506192|Chronic Inflammation|chronic inflammation
126269|NCT02506192|Delayed-Release Prednisone|delayed-release prednisone
126270|NCT02506192|Health-Related Quality of Life|health-related quality of life
126271|NCT02506179|Moderate to severe ulcerative colitis (UC)|moderate to severe ulcerative colitis (uc)
126272|NCT02506179|Real-life effect|real-life effect
126273|NCT02506179|Adalimumab|adalimumab
126274|NCT02506179|Ulcerative colitis (UC)|ulcerative colitis (uc)
126275|NCT02506179|Patient reported outcomes (PRO)|patient reported outcomes (pro)
126276|NCT02506166|sleep apnea|sleep apnea
126277|NCT02506166|sleep disordered breathing|sleep disordered breathing
126278|NCT02506166|sudden cardiac death|sudden cardiac death
126279|NCT02506166|heart failure|heart failure
126280|NCT02506166|ischemic cardiomyopathy|ischemic cardiomyopathy
126281|NCT02506166|implantable cardioverter-defibrillator (ICD) therapy|implantable cardioverter-defibrillator (icd) therapy
126282|NCT02506166|cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
126283|NCT02506166|risk stratification|risk stratification
126284|NCT02506166|positive airway pressure therapy|positive airway pressure therapy
126285|NCT02506166|SERVE-HF|serve-hf
126286|NCT02506140|minor stroke|minor stroke
126287|NCT02506140|transient ischemic attack|transient ischemic attack
126288|NCT02506140|ticagrelor|ticagrelor
126290|NCT02506140|dual anti-platelet therapy|dual anti-platelet therapy
126291|NCT02506140|platelet reactivity|platelet reactivity
126292|NCT02506127|TBS, MDD, Sham-controlled, neuromodulation, TMS|tbs, mdd, sham-controlled, neuromodulation, tms
126293|NCT02506114|prostate|prostate
126294|NCT02506062|ischemic preconditioning|ischemic preconditioning
126295|NCT02506062|Raynaud's Phenomenon|raynaud's phenomenon
126297|NCT02506036|Treatment|treatment
126807|NCT02503462|HIV|hiv
126298|NCT02506036|Social-Cognitive Training|social-cognitive training
126299|NCT02506036|Web-based|web-based
126300|NCT02506036|Right Hemisphere Stroke|right hemisphere stroke
126301|NCT02506036|Frontotemporal Dementia|frontotemporal dementia
126302|NCT02506036|Right Sided Cerebral Hemisphere Cerebrovascular Accident|right sided cerebral hemisphere cerebrovascular accident
126303|NCT02506023|Factor VIII antigen|factor viii antigen
126304|NCT02506023|von Willebrand factor (vWF) antigen|von willebrand factor (vwf) antigen
126305|NCT02506023|Mutation type|mutation type
126306|NCT02506010|Hypoxia|hypoxia
126307|NCT02505984|oxytocin, bonding|oxytocin, bonding
126308|NCT02505971|hemangioma, propranolol, nadolol|hemangioma, propranolol, nadolol
126309|NCT02505958|insulin resistance, obesity, caloric intake|insulin resistance, obesity, caloric intake
126310|NCT02505945|Esophageal Reflux|esophageal reflux
126311|NCT02505945|Gastric Acid Reflux Disease|gastric acid reflux disease
126312|NCT02505945|Heartburn|heartburn
126313|NCT02505932|Shoulder instability|shoulder instability
126314|NCT02505919|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
126315|NCT02505906|Late toxicity|late toxicity
126316|NCT02505906|Simultaneous integrated boost (SIB)|simultaneous integrated boost (sib)
126317|NCT02505906|Radiotherapy|radiotherapy
126318|NCT02505880|Hypnosis|hypnosis
126319|NCT02505880|Pediatric surgery|pediatric surgery
126320|NCT02505880|Anesthesia|anesthesia
126321|NCT02505854|Obesity|obesity
126322|NCT02505854|Probiotic|probiotic
126323|NCT02505854|Symbiotic|symbiotic
126324|NCT02505854|Weight loss|weight loss
126325|NCT02505854|Gut microbiota|gut microbiota
126326|NCT02505854|Bifidobacterium lactis|bifidobacterium lactis
126327|NCT02505854|Fructooligosaccharide|fructooligosaccharide
126328|NCT02505854|Blood sugar|blood sugar
117542|NCT02560623|reflux|reflux
126329|NCT02505854|Lipemia|lipemia
126330|NCT02505841|Appendectomy|appendectomy
126331|NCT02505841|Laparoscopy|laparoscopy
126332|NCT02505841|pediatric surgery|pediatric surgery
126333|NCT02505828|Arthritis|arthritis
126334|NCT02505828|septic|septic
126335|NCT02505828|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
126336|NCT02505828|diagnosis|diagnosis
126337|NCT02505828|proteomic|proteomic
126338|NCT02505828|cytokine|cytokine
126339|NCT02505828|monocytes|monocytes
126340|NCT02505802|Stroke|stroke
126341|NCT02505802|Botulinum Toxins|botulinum toxins
126342|NCT02505802|Muscle Spasticity|muscle spasticity
126343|NCT02505802|Gait|gait
126344|NCT02505789|Epstein-Barr Virus|epstein-barr virus
126345|NCT02505789|Post-transplant lymphoproliferative disease (PTLD)|post-transplant lymphoproliferative disease (ptld)
126346|NCT02505789|Infection|infection
126347|NCT02505789|Cell Transplants|cell transplants
126348|NCT02505789|Herpesvirus 4, Human|herpesvirus 4, human
126349|NCT02505711|Agriculture|agriculture
126350|NCT02505711|Food|food
126351|NCT02505711|Micronutrients|micronutrients
126352|NCT02505711|Pregnancy|pregnancy
126353|NCT02505711|Infants|infants
126354|NCT02505711|Women's groups|women's groups
126355|NCT02505711|Bangladesh|bangladesh
126356|NCT02505698|Breast Imaging|breast imaging
126357|NCT02505698|Mammography|mammography
126358|NCT02505698|Anatomical Imaging|anatomical imaging
126359|NCT02505685|Lung|lung
126360|NCT02505685|Cancer|cancer
126361|NCT02505685|Biomarkers|biomarkers
126362|NCT02505685|PET-CT|pet-ct
126363|NCT02505685|Early detection|early detection
126364|NCT02505672|Vestibular function|vestibular function
126365|NCT02505672|chemoradiotherapy|chemoradiotherapy
126366|NCT02505659|Anterior cruciate ligament rupture|anterior cruciate ligament rupture
126367|NCT02505659|Preoperative re-education|preoperative re-education
126368|NCT02505659|Knee functional performance|knee functional performance
126369|NCT02505659|Anterior cruciate ligament surgery|anterior cruciate ligament surgery
126370|NCT02505659|Single-leg hop for distance test performance|single-leg hop for distance test performance
126371|NCT02505646|circulatory failure|circulatory failure
126372|NCT02505646|fluid responsiveness|fluid responsiveness
126373|NCT02505646|abdominal compression|abdominal compression
126374|NCT02505633|brachial plexus block|brachial plexus block
126375|NCT02505633|nerve stimulator|nerve stimulator
126376|NCT02505633|ultrasound|ultrasound
126377|NCT02505620|Neurocognitive function|neurocognitive function
126378|NCT02505620|OSAS|osas
126379|NCT02505594|Obstructive Sleep Apnea|obstructive sleep apnea
126380|NCT02505594|Vasoreactivity|vasoreactivity
126381|NCT02505594|Endothelial function|endothelial function
126382|NCT02505594|Exercise|exercise
126383|NCT02505581|Postoperative Wound Infection|postoperative wound infection
126384|NCT02505581|Surgical Wound Infection|surgical wound infection
126385|NCT02505581|Colorectal Surgery Infection Prophylaxis|colorectal surgery infection prophylaxis
126386|NCT02505568|Behcet Disease|behcet disease
126388|NCT02505568|Adult participants|adult participants
126389|NCT02505555|feasibility|feasibility
126390|NCT02505555|accuracy|accuracy
126391|NCT02505555|tolerability|tolerability
126392|NCT02505555|four dimensional hysterosalpingo-contrast sonography|four dimensional hysterosalpingo-contrast sonography
126393|NCT02505542|Axial Spondyloarthritis|axial spondyloarthritis
126394|NCT02505542|axSpA|axspa
126395|NCT02505542|Ankylosing Spondylitis|ankylosing spondylitis
126396|NCT02505542|Anti TNF-alpha|anti tnf-alpha
126397|NCT02505542|Certolizumab Pegol|certolizumab pegol
126398|NCT02505542|Remission|remission
126399|NCT02505542|Spondylarthropathies|spondylarthropathies
126400|NCT02505542|Arthritis|arthritis
126401|NCT02505542|Spinal Diseases|spinal diseases
126402|NCT02505542|Immunosuppressive Agents|immunosuppressive agents
126403|NCT02505529|Aging|aging
126404|NCT02505529|Muscle|muscle
126405|NCT02505529|Weakness|weakness
126406|NCT02505529|Sarcopenia|sarcopenia
126407|NCT02505529|Dynapenia|dynapenia
126408|NCT02505516|pathology|pathology
126409|NCT02505503|Claudication|claudication
126410|NCT02505503|Footwear|footwear
126411|NCT02505503|Shoes|shoes
126412|NCT02505503|Walking capacity|walking capacity
126413|NCT02505503|Walking distance|walking distance
126414|NCT02505490|Lunch|lunch
126415|NCT02505490|Television|television
126416|NCT02505490|Macaroni and Cheese|macaroni and cheese
126417|NCT02505490|Salad tossed in dressing|salad tossed in dressing
126418|NCT02505477|schiozphrenia|schiozphrenia
126419|NCT02505477|cognition|cognition
126420|NCT02505477|negative symptoms|negative symptoms
126421|NCT02505477|glutamate|glutamate
126422|NCT02505477|glutathione|glutathione
126423|NCT02505477|N-acetylcysteine|n-acetylcysteine
126424|NCT02505451|Metabolic syndrome|metabolic syndrome
126425|NCT02505451|diabetes|diabetes
126426|NCT02505451|myocardial function|myocardial function
126427|NCT02505451|dobutamine|dobutamine
126428|NCT02505399|Rotational Atherectomy|rotational atherectomy
117638|NCT02560116|Optison|optison
126429|NCT02505399|clopidogrel|clopidogrel
126430|NCT02505399|thrombosis|thrombosis
126431|NCT02505399|ticagrelor|ticagrelor
126432|NCT02505386|Ertapenem|ertapenem
126433|NCT02505386|Subcutaneously|subcutaneously
126434|NCT02505386|Aged|aged
126435|NCT02505386|Elderly|elderly
126436|NCT02505386|Pharmacokinetics|pharmacokinetics
126437|NCT02505373|Brief Therapy|brief therapy
126438|NCT02505373|Attempted Suicide|attempted suicide
126439|NCT02505373|Therapeutic Alliance|therapeutic alliance
126440|NCT02505373|Suicidal Ideation|suicidal ideation
126441|NCT02505373|Suicide|suicide
126442|NCT02505373|ASSIP|assip
126443|NCT02505321|insulin resistance|insulin resistance
126444|NCT02505321|physiology|physiology
126445|NCT02505321|genetics|genetics
126446|NCT02505321|gene variants|gene variants
126447|NCT02505321|pathogenesis|pathogenesis
126448|NCT02505321|type 2 diabetes|type 2 diabetes
126449|NCT02505321|fat|fat
126450|NCT02505321|polygenic lipodystrophy|polygenic lipodystrophy
126451|NCT02505308|insulin|insulin
126452|NCT02505308|proinsulin|proinsulin
126453|NCT02505308|genotype|genotype
126454|NCT02505308|beta cells|beta cells
126455|NCT02505308|physiology|physiology
126456|NCT02505308|genetics|genetics
126457|NCT02505308|pathogenesis|pathogenesis
126458|NCT02505308|rare variants|rare variants
126459|NCT02505308|type 2 diabetes|type 2 diabetes
126460|NCT02505282|Orthostatic hypotension|orthostatic hypotension
126461|NCT02505282|Vitamin K|vitamin k
126462|NCT02505269|limited stage|limited stage
126463|NCT02505269|Hodgkin's disease|hodgkin's disease
126464|NCT02505269|non-bulky|non-bulky
126465|NCT02505243|ribavirin|ribavirin
126466|NCT02505243|direct-acting antivirals|direct-acting antivirals
126467|NCT02505243|pharmacokinetics|pharmacokinetics
126468|NCT02505243|therapeutic drug monitoring|therapeutic drug monitoring
126469|NCT02505217|platelet reactivity, thrombin generation|platelet reactivity, thrombin generation
126470|NCT02505204|clonidine|clonidine
126471|NCT02505204|paravertebral block|paravertebral block
126472|NCT02505204|hemodynamic stability|hemodynamic stability
126473|NCT02505191|Pharmacokinetics|pharmacokinetics
126474|NCT02505178|Depression|depression
126475|NCT02505178|Depressive Disorder|depressive disorder
126476|NCT02505178|Depressive Disorder, Major|depressive disorder, major
126477|NCT02505178|Mental Disorders|mental disorders
126478|NCT02505178|Mood Disorders|mood disorders
126479|NCT02505178|Behavioural Symptoms|behavioural symptoms
126480|NCT02505178|Problem Solving Therapy|problem solving therapy
126481|NCT02505165|Intervention|intervention
126482|NCT02505165|Illness Uncertainty|illness uncertainty
126483|NCT02505165|Childhood Cancer|childhood cancer
126484|NCT02505165|Solid Tumor|solid tumor
126485|NCT02505165|Leukemia|leukemia
126486|NCT02505165|Lymphoma|lymphoma
126487|NCT02505165|Brain Tumor|brain tumor
126488|NCT02505165|Randomized clinical trial|randomized clinical trial
126490|NCT02505165|Parent|parent
126491|NCT02505165|Oncology|oncology
126492|NCT02505165|Pediatric|pediatric
126493|NCT02505152|Hypertension, Portal|hypertension, portal
126494|NCT02505152|Portal Vein, Cavernous Transformation Of|portal vein, cavernous transformation of
126495|NCT02505152|Portosystemic shunt|portosystemic shunt
126496|NCT02505152|Radiology, Interventional|radiology, interventional
126497|NCT02505139|nasopharyngeal carcinoma|nasopharyngeal carcinoma
126498|NCT02505139|distant metastasis|distant metastasis
126499|NCT02505139|circulating tumor cells|circulating tumor cells
126500|NCT02505139|outcome prediction|outcome prediction
126501|NCT02505113|Portal Vein, Cavernous Transformation Of|portal vein, cavernous transformation of
126502|NCT02505113|Hypertension, Portal|hypertension, portal
126503|NCT02505100|threat of premature birth|threat of premature birth
126504|NCT02505087|Selenoprotein N-related myopathy|selenoprotein n-related myopathy
126505|NCT02505087|biomarkers|biomarkers
126506|NCT02505087|washout|washout
126507|NCT02505087|N-ACETYLCYSTEINE|n-acetylcysteine
126508|NCT02505074|mitral valve|mitral valve
126509|NCT02505074|tricuspid valve|tricuspid valve
126510|NCT02505074|Melody valve|melody valve
126511|NCT02505035|Palliative care|palliative care
126512|NCT02505035|Pragmatic trial|pragmatic trial
126513|NCT02505022|Cognition|cognition
126514|NCT02505022|Early mental illness|early mental illness
126515|NCT02505022|Role functioning|role functioning
126516|NCT02505009|Therapeutic Uses|therapeutic uses
126517|NCT02505009|Entecavir|entecavir
126518|NCT02505009|Tenofovir|tenofovir
126519|NCT02505009|Engerix-B|engerix-b
126520|NCT02505009|DNA Virus Infections|dna virus infections
126521|NCT02505009|Antiviral Agents|antiviral agents
126522|NCT02505009|Vaccination|vaccination
126523|NCT02504996|sciatalgia|sciatalgia
126524|NCT02504996|emergency department|emergency department
126525|NCT02504996|paracetamol|paracetamol
126526|NCT02504996|morphine|morphine
126527|NCT02504983|SNPs|snps
126528|NCT02504970|Anesthesia|anesthesia
126529|NCT02504970|Quality Improvement|quality improvement
117733|NCT02559336|Health Services Research|health services research
117734|NCT02559310|Pneumonia|pneumonia
117735|NCT02559310|CABP|cabp
117736|NCT02559310|CAP|cap
117737|NCT02559310|Community acquired bacterial pneumonia|community acquired bacterial pneumonia
117739|NCT02559297|Sevoflurane|sevoflurane
126530|NCT02504957|Photodynamic therapy|photodynamic therapy
126531|NCT02504944|Retinopathy of prematurity|retinopathy of prematurity
126532|NCT02504944|Propranolol|propranolol
126533|NCT02504944|Newborn|newborn
126534|NCT02504944|Eye Drops|eye drops
126535|NCT02504944|Retinal angiogenesis|retinal angiogenesis
126785|NCT02503566|heart rate|heart rate
126536|NCT02504944|Retinal neovascularization|retinal neovascularization
126537|NCT02504931|PTSD|ptsd
126538|NCT02504931|Alcohol|alcohol
126539|NCT02504931|Dual Diagnosis|dual diagnosis
126540|NCT02504931|Sertraline|sertraline
126541|NCT02504931|SSRI|ssri
126542|NCT02504918|Plasmodium Falciparum|plasmodium falciparum
126543|NCT02504918|Regulatory|regulatory
126544|NCT02504918|Chemoprevention|chemoprevention
126545|NCT02504918|Coartem|coartem
126546|NCT02504918|Parasitemia|parasitemia
126547|NCT02504905|Parietal Lobe|parietal lobe
126548|NCT02504905|Plasticity|plasticity
126549|NCT02504905|Cerebellum|cerebellum
126550|NCT02504905|Dystonia|dystonia
126551|NCT02504905|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
126552|NCT02504892|Overall Response Rate|overall response rate
126553|NCT02504892|Hereditary Cancer Syndrome|hereditary cancer syndrome
126554|NCT02504892|mTOR Therapy Naive|mtor therapy naive
126555|NCT02504879|Osteosclerosis|osteosclerosis
126556|NCT02504879|Hyperostosis|hyperostosis
126557|NCT02504866|Aerobic Exercise Training|aerobic exercise training
126558|NCT02504866|Balance|balance
126559|NCT02504866|TBI|tbi
126560|NCT02504853|Eosinophilic Esophagitis|eosinophilic esophagitis
126561|NCT02504853|Loeys-Dietz Syndrome|loeys-dietz syndrome
126562|NCT02504853|TGFbeta|tgfbeta
126563|NCT02504840|Multiple Sclerosis|multiple sclerosis
126564|NCT02504840|Clinically Isolated Syndrome|clinically isolated syndrome
126565|NCT02504840|CNS Inflammatory Demyellnation|cns inflammatory demyellnation
126566|NCT02504840|Radiologically Isolated Syndrome|radiologically isolated syndrome
126567|NCT02504827|pharmacokinetics|pharmacokinetics
126568|NCT02504827|ceftazidime/avibactam|ceftazidime/avibactam
126569|NCT02504814|nasal high flow|nasal high flow
126570|NCT02504801|primary lung cancer patients|primary lung cancer patients
126571|NCT02504788|Whole Brain Radiotherapy (WBRT)|whole brain radiotherapy (wbrt)
126572|NCT02504788|Neurocognitive Functions (NCFs)|neurocognitive functions (ncfs)
126573|NCT02504788|Hippocampus|hippocampus
126574|NCT02504788|Hippocampus Sparing during Whole Brain Radiotherapy (HS-WBRT)|hippocampus sparing during whole brain radiotherapy (hs-wbrt)
126575|NCT02504749|GIT motility|git motility
126576|NCT02504749|General anaesthesia|general anaesthesia
126577|NCT02504749|spinal anaesthesia|spinal anaesthesia
126578|NCT02504736|LDL cholesterol|ldl cholesterol
126579|NCT02504736|A1c|a1c
126580|NCT02504736|High risk South Asians|high risk south asians
126581|NCT02504736|Colesevelam|colesevelam
126582|NCT02504723|Gastric varices|gastric varices
126583|NCT02504723|cyanoacrylate|cyanoacrylate
126584|NCT02504723|carvedilol|carvedilol
126585|NCT02504710|Musculoskeletal Manipulations|musculoskeletal manipulations
126586|NCT02504710|Learning|learning
126587|NCT02504710|Feedback|feedback
126588|NCT02504710|Kinematics|kinematics
126589|NCT02504710|Inertial Sensor|inertial sensor
126590|NCT02504684|varicose veins|varicose veins
126591|NCT02504684|endovenous laser treatment|endovenous laser treatment
126592|NCT02504684|endovenous thermal ablation|endovenous thermal ablation
126593|NCT02504684|saphenous vein|saphenous vein
126594|NCT02504671|DMARD-IR|dmard-ir
126595|NCT02504671|GSK3196165|gsk3196165
126596|NCT02504671|Rheumatoid Arthritis|rheumatoid arthritis
126597|NCT02504658|adolescents text messages eating exercise self-efficacy diabetes|adolescents text messages eating exercise self-efficacy diabetes
126598|NCT02504632|platelet activation|platelet activation
126599|NCT02504632|transcatheter aortic valve implantation|transcatheter aortic valve implantation
126600|NCT02504593|Quality Assurance|quality assurance
126601|NCT02504593|Monitoring & Evaluation|monitoring & evaluation
126602|NCT02504593|Malaria rapid diagnostic test (RDT)|malaria rapid diagnostic test (rdt)
126603|NCT02504593|Community-based malaria diagnosis|community-based malaria diagnosis
126604|NCT02504593|Community health workers|community health workers
126605|NCT02504567|Catheter Ablation|catheter ablation
126606|NCT02504567|Radiofrequency|radiofrequency
126607|NCT02504567|Laser|laser
126608|NCT02504567|Atrial Fibrillation|atrial fibrillation
126609|NCT02504554|children|children
126610|NCT02504541|Hypogonadism|hypogonadism
126611|NCT02504541|Testosterone enanthate|testosterone enanthate
126612|NCT02504528|asthma|asthma
126613|NCT02504528|allergy|allergy
126614|NCT02504528|bronchial hyperresponsiveness|bronchial hyperresponsiveness
126615|NCT02504528|provocation|provocation
126616|NCT02504502|Whole Genome Sequencing|whole genome sequencing
126619|NCT02504502|Communication of Results|communication of results
126620|NCT02504502|Patient Provider Communication|patient provider communication
126621|NCT02504476|Schizophrenia or Schizoaffective Disorder|schizophrenia or schizoaffective disorder
126622|NCT02504463|Alkermes|alkermes
126623|NCT02504463|Samidorphan|samidorphan
126624|NCT02504463|ALKS 33|alks 33
126625|NCT02504463|Healthy Volunteer|healthy volunteer
126626|NCT02504463|Pharmacokinetics|pharmacokinetics
126627|NCT02504450|Bipolar 1 disorder|bipolar 1 disorder
126628|NCT02504450|schizophrenia|schizophrenia
126629|NCT02504424|Tissue Expansion|tissue expansion
126630|NCT02504424|Tissue Expander|tissue expander
126631|NCT02504424|Breast Tissue Expansion|breast tissue expansion
126632|NCT02504424|Breast Tissue Expander|breast tissue expander
126633|NCT02504424|Breast Reconstruction|breast reconstruction
126634|NCT02504424|2 Stage Breast Reconstruction|2 stage breast reconstruction
126639|NCT02504359|BEAM|beam
126640|NCT02504359|allogeneic|allogeneic
126641|NCT02504359|myeloma|myeloma
126642|NCT02504359|ixazomib|ixazomib
126643|NCT02504359|transplant|transplant
126644|NCT02504359|plasma cell leukemia|plasma cell leukemia
126645|NCT02504333|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
126646|NCT02504333|Nab-paclitaxel|nab-paclitaxel
126647|NCT02504333|Gemcitabine|gemcitabine
126648|NCT02504333|modified FOLFOX|modified folfox
126649|NCT02504320|Drug therapy|drug therapy
126650|NCT02504255|Crohn disease|crohn disease
126651|NCT02504255|inflammatory biomarkers|inflammatory biomarkers
126652|NCT02504255|immunologic markers|immunologic markers
126653|NCT02504255|calprotectin|calprotectin
126654|NCT02504216|Rivaroxaban|rivaroxaban
126655|NCT02504216|Xarelto|xarelto
126656|NCT02504216|Aspirin|aspirin
126657|NCT02504216|Acetylic salicylic acid|acetylic salicylic acid
126658|NCT02504216|Anticoagulant|anticoagulant
126659|NCT02504216|Peripheral artery disease|peripheral artery disease
126786|NCT02503566|antibodies|antibodies
126660|NCT02504216|Peripheral arterial disease|peripheral arterial disease
126661|NCT02504216|Revascularization|revascularization
126662|NCT02504216|Acute limb ischemia|acute limb ischemia
126663|NCT02504216|Amputation|amputation
126664|NCT02504216|Cardiovascular events|cardiovascular events
126665|NCT02504190|Lymphoma|lymphoma
126666|NCT02504190|TEAM conditioning|team conditioning
126667|NCT02504190|autologous stem cells transplantation|autologous stem cells transplantation
126668|NCT02504164|midazolam|midazolam
126669|NCT02504164|satisfaction|satisfaction
126670|NCT02504164|endoscopic submucosal dissection|endoscopic submucosal dissection
126671|NCT02504099|Chronic Hepatitis C Infection|chronic hepatitis c infection
126672|NCT02504099|Early Stage Hepatocellular Carcinoma|early stage hepatocellular carcinoma
126673|NCT02504073|Clinical Reasoning|clinical reasoning
126674|NCT02504073|Physiotherapists|physiotherapists
126675|NCT02504060|diarrhea|diarrhea
126676|NCT02504060|abdominal pain|abdominal pain
126677|NCT02504047|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
126678|NCT02504034|Portal Vein, Cavernous Transformation Of|portal vein, cavernous transformation of
126679|NCT02504034|Hypertension, Portal|hypertension, portal
126680|NCT02504034|Radiology, Interventional|radiology, interventional
126681|NCT02504034|Portalsystemic shunt|portalsystemic shunt
126682|NCT02504008|bisphosphonate|bisphosphonate
126683|NCT02504008|CRPS|crps
126686|NCT02504008|CRPS-1|crps-1
126687|NCT02504008|acute on chronic pain|acute on chronic pain
126688|NCT02504008|chronic pain|chronic pain
126689|NCT02504008|zoledronic acid|zoledronic acid
126690|NCT02503969|Colorectal Cancer|colorectal cancer
126691|NCT02503969|Mass Screening|mass screening
126692|NCT02503969|Uptake|uptake
126693|NCT02503969|Morbidity|morbidity
126694|NCT02503969|Mental Health|mental health
126695|NCT02503943|GLP-1|glp-1
126696|NCT02503943|Masked hypertension|masked hypertension
126697|NCT02503943|Lipid metabolism|lipid metabolism
126698|NCT02503917|Imaging, Ultrasound|imaging, ultrasound
126699|NCT02503917|Image-guided radiotherapy|image-guided radiotherapy
126700|NCT02503917|Cancer|cancer
126701|NCT02503904|Pharmacology|pharmacology
126702|NCT02503904|Lidocaine|lidocaine
126703|NCT02503904|Epinephrine|epinephrine
126704|NCT02503904|Cefazolin|cefazolin
126705|NCT02503904|Metronidazole|metronidazole
126706|NCT02503904|Infection|infection
126707|NCT02503904|prevention|prevention
126708|NCT02503904|prophylaxis|prophylaxis
126709|NCT02503904|SSI|ssi
126710|NCT02503904|Surgery|surgery
126711|NCT02503904|Complications|complications
126712|NCT02503865|Metabolic syndrome|metabolic syndrome
126713|NCT02503865|Diabetes mellitus,|diabetes mellitus,
126714|NCT02503865|Hypertension|hypertension
126715|NCT02503865|Overweight|overweight
126716|NCT02503865|analimentary detoxication|analimentary detoxication
127012|NCT02502396|Cancer|cancer
126720|NCT02503852|Androgenic Alopecia|androgenic alopecia
126721|NCT02503852|Hair Loss|hair loss
126722|NCT02503839|Host-modulating therapy|host-modulating therapy
126723|NCT02503839|Vaccine|vaccine
126724|NCT02503839|Cyclooxygenase inhibitors|cyclooxygenase inhibitors
126725|NCT02503813|brain death|brain death
126726|NCT02503813|apnea challenge test|apnea challenge test
126727|NCT02503787|chronic pain|chronic pain
126728|NCT02503787|intractable pain|intractable pain
126729|NCT02503787|failed back surgery syndrome|failed back surgery syndrome
126730|NCT02503774|Solid Tumours, MEDI9447, MEDI4736, durvalumab, CD73, PD-L1|solid tumours, medi9447, medi4736, durvalumab, cd73, pd-l1
126731|NCT02503761|meropenem|meropenem
126732|NCT02503761|infusion|infusion
126733|NCT02503761|late-onset sepsis|late-onset sepsis
126734|NCT02503761|newborn|newborn
126735|NCT02503761|management|management
126736|NCT02503735|CKD|ckd
126737|NCT02503735|HCV|hcv
126738|NCT02503696|Inflammatory Bowel Disease|inflammatory bowel disease
126739|NCT02503696|Cancer|cancer
126740|NCT02503696|Colorectal Cancer|colorectal cancer
126741|NCT02503696|Neoplasm|neoplasm
126742|NCT02503696|Colorectal Neoplasm|colorectal neoplasm
126743|NCT02503696|Intestinal Neoplasms|intestinal neoplasms
126744|NCT02503696|Gastrointestinal Neoplasms|gastrointestinal neoplasms
126745|NCT02503696|Digestive System Neoplasms|digestive system neoplasms
126746|NCT02503696|Neoplasms by Site|neoplasms by site
126747|NCT02503696|Neoplasms|neoplasms
126748|NCT02503696|Digestive System Diseases|digestive system diseases
126749|NCT02503696|Gastrointestinal Diseases|gastrointestinal diseases
126750|NCT02503696|Colonic Diseases|colonic diseases
126751|NCT02503696|Intestinal Diseases|intestinal diseases
126752|NCT02503696|Rectal Diseases|rectal diseases
126753|NCT02503683|RNAi therapeutic|rnai therapeutic
126754|NCT02503683|AAT|aat
126755|NCT02503683|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
126756|NCT02503657|tipelukast|tipelukast
126757|NCT02503657|IPF|ipf
126758|NCT02503657|fibrosis|fibrosis
126759|NCT02503657|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
126760|NCT02503644|diffuse cutaneous systemic sclerosis|diffuse cutaneous systemic sclerosis
126761|NCT02503644|scleroderma|scleroderma
126762|NCT02503644|IVA337|iva337
126763|NCT02503644|dcSSc|dcssc
126764|NCT02503631|Cancer|cancer
126765|NCT02503631|Colorectal Cancer|colorectal cancer
126766|NCT02503631|Neoplasm|neoplasm
126767|NCT02503631|Colorectal Neoplasm|colorectal neoplasm
126768|NCT02503631|Intestinal Neoplasms|intestinal neoplasms
126769|NCT02503631|Gastrointestinal Neoplasms|gastrointestinal neoplasms
126770|NCT02503631|Digestive System Neoplasms|digestive system neoplasms
126771|NCT02503631|Neoplasms by Site|neoplasms by site
126772|NCT02503631|Neoplasms|neoplasms
126773|NCT02503631|Digestive System Diseases|digestive system diseases
126774|NCT02503631|Gastrointestinal Diseases|gastrointestinal diseases
126775|NCT02503631|Colonic Diseases|colonic diseases
126776|NCT02503631|Intestinal Diseases|intestinal diseases
126777|NCT02503631|Rectal Diseases|rectal diseases
126778|NCT02503605|Biosimilar|biosimilar
126779|NCT02503605|ovarian stimulation|ovarian stimulation
126780|NCT02503605|oocyte donor|oocyte donor
126781|NCT02503579|Brain-derived neurotropic factor|brain-derived neurotropic factor
126782|NCT02503579|Executive function|executive function
126783|NCT02503566|CAV|cav
126784|NCT02503566|OCT|oct
126787|NCT02503553|option grid|option grid
126788|NCT02503553|neurosurgery|neurosurgery
126789|NCT02503553|cerebral aneurysm|cerebral aneurysm
126790|NCT02503540|macular edema|macular edema
126791|NCT02503540|rvo|rvo
126797|NCT02503527|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
126798|NCT02503527|Blood glucose|blood glucose
126799|NCT02503527|Insulin|insulin
126800|NCT02503501|Memory|memory
126801|NCT02503501|Insulin glulisine|insulin glulisine
126802|NCT02503501|Alzheimer's disease|alzheimer's disease
126803|NCT02503501|Mild Cognitive Impairment|mild cognitive impairment
126804|NCT02503501|Intranasal insulin|intranasal insulin
126805|NCT02503501|Cognition Disorders|cognition disorders
126806|NCT02503488|Appetitive Aggression|appetitive aggression
126808|NCT02503462|darunavir|darunavir
126809|NCT02503462|ritonavir|ritonavir
126810|NCT02503462|cobicistat|cobicistat
126811|NCT02503462|CSF|csf
126812|NCT02503462|pharmacokinetics|pharmacokinetics
126813|NCT02503449|Pulmonary Cryptococcosis|pulmonary cryptococcosis
126815|NCT02503410|back|back
126816|NCT02503410|pain|pain
126817|NCT02503345|Kidney Stones|kidney stones
126818|NCT02503345|Nephrolithiasis|nephrolithiasis
126819|NCT02503345|Urine Oxalate|urine oxalate
126820|NCT02503345|Hyperoxaluria|hyperoxaluria
126821|NCT02503345|Enteric Hyperoxaluria|enteric hyperoxaluria
126822|NCT02503345|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
126823|NCT02503345|Urological Diseases|urological diseases
126824|NCT02503345|Kidney Diseases|kidney diseases
126825|NCT02503345|Dietary Oxalate|dietary oxalate
126826|NCT02503280|Cardiovascular|cardiovascular
126827|NCT02503280|Secondary|secondary
126828|NCT02503267|antithrombin III deficiency|antithrombin iii deficiency
118025|NCT02557399|Gel|gel
126829|NCT02503267|congenital heart diseases|congenital heart diseases
126830|NCT02503254|Smoking|smoking
126831|NCT02503254|Modified risk tobacco product|modified risk tobacco product
126832|NCT02503254|Conventional cigarette|conventional cigarette
126833|NCT02503254|Reduced exposure|reduced exposure
126834|NCT02503254|Confinement|confinement
126835|NCT02503254|Carbon Heated Tobacco Product|carbon heated tobacco product
126836|NCT02503215|Hemodialysis|hemodialysis
126837|NCT02503215|Obstructive sleep apnea|obstructive sleep apnea
126841|NCT02503189|Conjunctival diseases|conjunctival diseases
126842|NCT02503176|Dry eye syndromes|dry eye syndromes
126843|NCT02503176|Corneal diseases|corneal diseases
126844|NCT02503176|Conjunctival diseases|conjunctival diseases
126845|NCT02502201|six-minute walk|six-minute walk
126846|NCT02502188|Healthy Subjects|healthy subjects
126847|NCT02502188|Severe Plaque Psoriasis|severe plaque psoriasis
126848|NCT02502188|Moderate|moderate
126849|NCT02502188|Phase 1|phase 1
126850|NCT02502188|Safety|safety
126851|NCT02502188|Tolerability|tolerability
126852|NCT02502188|CC-90005|cc-90005
126853|NCT02502175|Opium tincture|opium tincture
126854|NCT02502175|opium|opium
126855|NCT02502175|methadone|methadone
126856|NCT02502175|opioid dependence|opioid dependence
126857|NCT02502175|opiate dependence|opiate dependence
126858|NCT02502175|clinical trial|clinical trial
126859|NCT02502175|Iran|iran
126860|NCT02502149|rFVIIIFc|rfviiifc
126861|NCT02502149|Eloctate|eloctate
126862|NCT02502149|Hemophilia|hemophilia
126863|NCT02502136|CO2 insufflation|co2 insufflation
126864|NCT02503163|Dry eye syndromes|dry eye syndromes
126865|NCT02503163|Corneal diseases|corneal diseases
126866|NCT02503163|Conjunctival diseases|conjunctival diseases
126867|NCT02503150|Colorectal Cancer|colorectal cancer
126868|NCT02503150|Tumor Therapeutic Vaccine|tumor therapeutic vaccine
126869|NCT02503150|Dendritic Cell|dendritic cell
126870|NCT02503137|male pattern baldness|male pattern baldness
126871|NCT02503137|SM04554|sm04554
126872|NCT02503137|AGA|aga
126873|NCT02503111|Men who have sex with men|men who have sex with men
126874|NCT02503111|Human immunodeficiency virus|human immunodeficiency virus
126875|NCT02503111|Human papillomavirus|human papillomavirus
126876|NCT02503111|Anal intraepithelial neoplasia|anal intraepithelial neoplasia
126877|NCT02503111|Squamous cell carcinoma|squamous cell carcinoma
126878|NCT02503111|High-resolution anoscopy|high-resolution anoscopy
126879|NCT02503111|Anal cancer|anal cancer
126880|NCT02503111|High-risk oncogenic|high-risk oncogenic
126881|NCT02503111|Intraepithelial lesion|intraepithelial lesion
126882|NCT02503111|Low-risk non-oncogenic|low-risk non-oncogenic
126883|NCT02503111|Dysplasia|dysplasia
126884|NCT02503111|High-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
126885|NCT02503111|Low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
126886|NCT02503111|Ablative therapy|ablative therapy
126887|NCT02503111|Electrocautery|electrocautery
126888|NCT02503111|Infrared coagulation|infrared coagulation
127620|NCT02498912|15-014|15-014
126889|NCT02503111|Active surveillance|active surveillance
126890|NCT02503098|Eating Disorders|eating disorders
126891|NCT02503098|Cognitive Behavioral Therapy|cognitive behavioral therapy
126893|NCT02503098|Smartphone|smartphone
126894|NCT02503098|App|app
126895|NCT02503098|Binge Eating Disorder|binge eating disorder
126896|NCT02503098|Bulimia Nervosa|bulimia nervosa
126897|NCT02503098|Signal Detection Analysis|signal detection analysis
126898|NCT02503072|ARV adherence|arv adherence
126899|NCT02503020|Arachidonic acid|arachidonic acid
126900|NCT02503020|Omega-6/omega-3 ratio|omega-6/omega-3 ratio
126901|NCT02503020|Preterm infants nutrition|preterm infants nutrition
126902|NCT02502981|CKD|ckd
126903|NCT02502981|left ventricle|left ventricle
126904|NCT02502981|aldosterone|aldosterone
126905|NCT02502981|spironolactone|spironolactone
126906|NCT02502955|Quality Control|quality control
126907|NCT02502955|Cardiosurgery|cardiosurgery
126908|NCT02502955|Cardiology|cardiology
126909|NCT02502955|Vascular Surgery|vascular surgery
126910|NCT02502955|ICU|icu
126911|NCT02502942|Obstructive Sleep Apnea|obstructive sleep apnea
126912|NCT02502942|Exercise|exercise
126913|NCT02502942|Upper airway muscle|upper airway muscle
126914|NCT02502929|Diabetes|diabetes
126915|NCT02502929|Depression|depression
126916|NCT02502929|Medication therapy management|medication therapy management
126917|NCT02502929|Community health workers|community health workers
126918|NCT02502929|Cambodian|cambodian
126919|NCT02502929|Refugee|refugee
126920|NCT02502929|Prevention|prevention
126921|NCT02502890|asthma|asthma
126922|NCT02502890|nested case-control study|nested case-control study
126923|NCT02502890|difficult-to-control asthma|difficult-to-control asthma
126924|NCT02502890|asthma exacerbations|asthma exacerbations
126925|NCT02502890|cold symptoms|cold symptoms
126926|NCT02502890|gene expression|gene expression
126930|NCT02502812|bioequivalence|bioequivalence
126931|NCT02502812|SB224326|sb224326
118112|NCT02556879|Donor specific antibodies|donor specific antibodies
118113|NCT02556853|Ultrasound|ultrasound
126932|NCT02502812|clopidogrel|clopidogrel
126933|NCT02502812|Relative bioavailability|relative bioavailability
126934|NCT02502786|Humanized Monoclonal Antibody 3F8 (Hu3F8)|humanized monoclonal antibody 3f8 (hu3f8)
401967|NCT01232543|Atopic Dermatitis|atopic dermatitis
126935|NCT02502786|Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)|granulocyte-macrophage colony stimulating factor (gm-csf)
126936|NCT02502786|15-096|15-096
126937|NCT02502773|Goal-directed therapy|goal-directed therapy
126938|NCT02502773|Fluid loading|fluid loading
126939|NCT02502773|Abdominal surgery|abdominal surgery
126940|NCT02502773|Postoperative morbidity|postoperative morbidity
126941|NCT02502773|Postoperative mortality|postoperative mortality
126942|NCT02502773|Individualized goal-directed fluid therapy|individualized goal-directed fluid therapy
126943|NCT02502773|Elective or emergency abdominal surgery|elective or emergency abdominal surgery
126944|NCT02502773|General Anesthesia|general anesthesia
126945|NCT02502773|Moderate-to-high risk surgical patients|moderate-to-high risk surgical patients
126946|NCT02502760|Postoperative Complications|postoperative complications
126947|NCT02502760|Perioperative Care|perioperative care
126948|NCT02502760|Colorectal Surgery|colorectal surgery
126949|NCT02502760|Frail Elderly|frail elderly
126950|NCT02502734|inhaled corticosteroids|inhaled corticosteroids
126951|NCT02502734|pediatric subjects|pediatric subjects
126952|NCT02502734|asthma|asthma
126953|NCT02502734|fluticasone furoate|fluticasone furoate
126954|NCT02502721|Male|male
126955|NCT02502708|glioblastoma multiforme|glioblastoma multiforme
126956|NCT02502708|glioma|glioma
126957|NCT02502708|gliosarcoma|gliosarcoma
126958|NCT02502708|malignant brain tumor|malignant brain tumor
126959|NCT02502708|ependymoma|ependymoma
126960|NCT02502708|medulloblastoma|medulloblastoma
126961|NCT02502695|VATS Lobectomy and Segmentectomy for Lung Cancer|vats lobectomy and segmentectomy for lung cancer
126962|NCT02502695|Lung Cancer|lung cancer
126963|NCT02502682|Chlorhexidine bathing|chlorhexidine bathing
126964|NCT02502669|acne|acne
126965|NCT02502669|nodulocystic|nodulocystic
126966|NCT02502669|finasteride|finasteride
126967|NCT02502669|5 alpha reductase inhibitor|5 alpha reductase inhibitor
126968|NCT02502656|RAS mutation|ras mutation
126969|NCT02502656|DNA|dna
126970|NCT02502656|Colorectal Cancer|colorectal cancer
126971|NCT02502643|Safety and Efficacy|safety and efficacy
126972|NCT02502643|Thoracic Surgery|thoracic surgery
126973|NCT02502617|Psychopathology|psychopathology
126974|NCT02502617|Cognition|cognition
126975|NCT02502617|Depression|depression
126976|NCT02502617|Nutrition|nutrition
126977|NCT02502617|Cortisol|cortisol
126978|NCT02502617|Anorexia nervosa|anorexia nervosa
126979|NCT02502604|Cognitive Remediation|cognitive remediation
126980|NCT02502604|Goal Management Training|goal management training
126981|NCT02502604|Major Depressive Disorder|major depressive disorder
126982|NCT02502604|Post-traumatic Stress Disorder|post-traumatic stress disorder
126983|NCT02502604|Neuropsychological Functioning|neuropsychological functioning
126984|NCT02502578|Triglyceride Deposit Cardiomyovasculopathy|triglyceride deposit cardiomyovasculopathy
126985|NCT02502552|Crohn's Disease|crohn's disease
126986|NCT02502552|Ulcerative Colitis|ulcerative colitis
126987|NCT02502552|Inflammatory Bowel Disease|inflammatory bowel disease
126988|NCT02502552|anti-glycan antibodies|anti-glycan antibodies
126989|NCT02502552|antibodies stability|antibodies stability
126990|NCT02502552|mucosal healing|mucosal healing
126991|NCT02502552|predictive markers|predictive markers
126992|NCT02502539|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
126993|NCT02502539|Physical exercise|physical exercise
126994|NCT02502539|Pro-anti-inflammatory balance|pro-anti-inflammatory balance
126995|NCT02502539|Interleukins|interleukins
126996|NCT02502539|miRNA|mirna
126997|NCT02502539|Calgranulins|calgranulins
126998|NCT02502487|Analgesia|analgesia
126999|NCT02502487|Cystoscopy|cystoscopy
127000|NCT02502487|Dorsal nerve of penis|dorsal nerve of penis
127001|NCT02502487|Nerve block|nerve block
127002|NCT02502487|Ropivacaine|ropivacaine
127003|NCT02502474|staphylococcus aureus|staphylococcus aureus
127004|NCT02502474|digestive carriage|digestive carriage
127005|NCT02502474|mucosal colonization|mucosal colonization
127006|NCT02502448|rotational thromboelastometry|rotational thromboelastometry
127007|NCT02502448|cardiac surgery|cardiac surgery
127008|NCT02502448|acute normovolemic hemodilution|acute normovolemic hemodilution
127009|NCT02502422|Laryngeal mask airway|laryngeal mask airway
127010|NCT02502409|Hemophilia B|hemophilia b
127011|NCT02502409|Hemophilia B with Inhibitors|hemophilia b with inhibitors
127013|NCT02502396|Deep-vein thrombosis of the lower and upper extremities|deep-vein thrombosis of the lower and upper extremities
127014|NCT02502396|Pulmonary embolism|pulmonary embolism
127015|NCT02502396|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
127016|NCT02502396|Chart review|chart review
127017|NCT02502396|VTE|vte
127018|NCT02502396|NVAF|nvaf
127019|NCT02502396|Rivaroxaban|rivaroxaban
118209|NCT02556437|MMN|mmn
127020|NCT02502383|Adolescent|adolescent
127021|NCT02502383|Overweight|overweight
127022|NCT02502383|Obesity|obesity
127023|NCT02502383|Weight loss|weight loss
127024|NCT02502383|Nutrition|nutrition
127025|NCT02502383|Physical Activity|physical activity
127026|NCT02502383|School-based|school-based
127027|NCT02502383|Primary care|primary care
127028|NCT02502383|Motivational Interviewing|motivational interviewing
127029|NCT02502357|pain control|pain control
127030|NCT02502357|healing statements|healing statements
127031|NCT02502357|pelvic prolapse|pelvic prolapse
127032|NCT02502344|insulin resistance|insulin resistance
127033|NCT02502344|abnormal glucose tolerance|abnormal glucose tolerance
127034|NCT02502344|DM prevention|dm prevention
127035|NCT02502331|Oral Cholera Vaccine|oral cholera vaccine
127036|NCT02502331|immunogenicity|immunogenicity
127037|NCT02502331|safety|safety
127038|NCT02502318|Proven or suspected lung cancer treated by lobectomy|proven or suspected lung cancer treated by lobectomy
127039|NCT02502305|health literacy|health literacy
127040|NCT02502305|attitude|attitude
127041|NCT02502305|motivation|motivation
127042|NCT02502292|Health Literacy|health literacy
127043|NCT02502292|Health Ageing|health ageing
127044|NCT02502292|Health Literacy Interventions|health literacy interventions
127045|NCT02502292|IROHLA|irohla
127046|NCT02502292|Photo Novel Study|photo novel study
127047|NCT02502240|ALK|alk
127048|NCT02502240|Latin American|latin american
127049|NCT02502227|mindfulness|mindfulness
127050|NCT02502227|psychological stress|psychological stress
127051|NCT02502227|wellness programs|wellness programs
127052|NCT02502227|cortisol|cortisol
127053|NCT02502214|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
127054|NCT02502214|PGD|pgd
127055|NCT02502214|Next-Generation Sequencing|next-generation sequencing
127056|NCT02502214|NGS|ngs
127057|NCT02502214|Single-Gene disorders|single-gene disorders
127058|NCT02502214|Cystic Fibrosis|cystic fibrosis
127059|NCT02502214|CFTR|cftr
127060|NCT02502214|Single-cell analysis|single-cell analysis
127061|NCT02502214|PCR|pcr
127062|NCT02502214|SNP|snp
127063|NCT02502214|Whole Genome Amplification|whole genome amplification
127064|NCT02502110|Atrial Fibrillation|atrial fibrillation
127065|NCT02502110|statin|statin
127066|NCT02502110|radiofrequency ablation|radiofrequency ablation
127067|NCT02502006|Non-steroidal Anti-inflammatory Drugs|non-steroidal anti-inflammatory drugs
127068|NCT02502006|Healthy volunteers|healthy volunteers
127069|NCT02502006|Celecoxib|celecoxib
127070|NCT02502006|Naproxen|naproxen
127071|NCT02502006|Prostaglandin|prostaglandin
127072|NCT02502006|Cyclooxygenase|cyclooxygenase
127073|NCT02501980|Screening|screening
127074|NCT02501980|Hepatocellular Cancer|hepatocellular cancer
127075|NCT02501980|Biomarker|biomarker
127076|NCT02501980|Mortality rate|mortality rate
127077|NCT02501967|multiple chronic conditions|multiple chronic conditions
127078|NCT02501941|Ketamine|ketamine
127079|NCT02501941|Cortical Spreading Depolarization|cortical spreading depolarization
127080|NCT02501941|Cortical Spreading Depression|cortical spreading depression
127081|NCT02501928|neurogenic detrusor overactivity|neurogenic detrusor overactivity
127082|NCT02501928|fesoterodine|fesoterodine
127083|NCT02501928|Japan|japan
127084|NCT02501915|Muscle|muscle
127085|NCT02501902|Ibrance, palbociclib, Abraxane, nab-paclitaxel, pancreas,|ibrance, palbociclib, abraxane, nab-paclitaxel, pancreas,
127086|NCT02501889|obesity|obesity
127087|NCT02501889|overweight|overweight
127088|NCT02501889|weight loss|weight loss
127089|NCT02501889|satiety|satiety
127090|NCT02501889|walnuts|walnuts
127091|NCT02501889|gastrointestinal peptides|gastrointestinal peptides
127092|NCT02501876|The risk of progession|the risk of progession
127093|NCT02501876|patients|patients
127094|NCT02501850|Lipoprotein (a)|lipoprotein (a)
127095|NCT02501837|Healthy women|healthy women
127096|NCT02501811|Heart Failure|heart failure
127097|NCT02501811|Ischemia|ischemia
127098|NCT02501811|Autologous Stem Cells|autologous stem cells
127099|NCT02501811|LV dysfunction|lv dysfunction
127100|NCT02501811|Mesenchymal Stem Cells|mesenchymal stem cells
127101|NCT02501811|ckit Cardiac Stem Cells|ckit cardiac stem cells
127102|NCT02501811|Combination Cell Therapy|combination cell therapy
127103|NCT02501811|LV function|lv function
127104|NCT02501811|Functional status|functional status
127105|NCT02501798|ADHD|adhd
127106|NCT02501798|Methylphenidate|methylphenidate
127107|NCT02501798|Academic|academic
127108|NCT02501798|Motivation|motivation
127109|NCT02501785|Quality of Life|quality of life
127110|NCT02501785|Patient care givers|patient care givers
127111|NCT02501785|15-145|15-145
127112|NCT02501785|Ambulatory Extended Recovery|ambulatory extended recovery
127113|NCT02501746|Group medical care|group medical care
127114|NCT02501746|Microfinance|microfinance
127115|NCT02501746|Hypertension|hypertension
127116|NCT02501746|Community-based intervention|community-based intervention
127117|NCT02501746|Global health|global health
127118|NCT02501733|Total Knee Replacement|total knee replacement
153021|NCT02354261|BCC|bcc
118311|NCT02555839|Pomalidomide|pomalidomide
118312|NCT02555839|Imnovid|imnovid
118313|NCT02555839|Non-interventional|non-interventional
127119|NCT02501733|Total Knee Arthroplasty|total knee arthroplasty
127120|NCT02501720|burn|burn
127121|NCT02501720|hand|hand
127122|NCT02501720|flexion contracture|flexion contracture
127123|NCT02501720|tourniquet|tourniquet
127124|NCT02501720|tumescent technique|tumescent technique
127125|NCT02501720|children|children
127126|NCT02501707|echocardiography|echocardiography
127127|NCT02501707|radiation-induced lung injury|radiation-induced lung injury
127128|NCT02501707|prognostic|prognostic
127129|NCT02501707|chemo radiotherapy|chemo radiotherapy
127130|NCT02501707|non-small cell lung cancer|non-small cell lung cancer
127131|NCT02501707|NSCLC|nsclc
127132|NCT02501681|sublingual microcirculation|sublingual microcirculation
127133|NCT02501681|cardiovascular surgery|cardiovascular surgery
127134|NCT02501616|SGLT2 inhibitor|sglt2 inhibitor
127135|NCT02501564|Osteoarthritis|osteoarthritis
127136|NCT02501564|NAPROXEN SODIUM|naproxen sodium
127137|NCT02501551|Malignant melanoma|malignant melanoma
127138|NCT02501551|C-KIT mutation|c-kit mutation
127139|NCT02501525|renal stone|renal stone
127140|NCT02501525|retrograde intrarenal surgery|retrograde intrarenal surgery
127141|NCT02501525|ureteral access sheath|ureteral access sheath
127142|NCT02501525|pain|pain
127143|NCT02501512|transesophageal signal|transesophageal signal
127144|NCT02501512|swallowing|swallowing
127145|NCT02501512|newborn|newborn
127146|NCT02501486|adrenal insufficiency|adrenal insufficiency
127147|NCT02501486|adverse drug reaction|adverse drug reaction
127148|NCT02501486|corticosteroid|corticosteroid
127149|NCT02501473|follicular lymphoma|follicular lymphoma
127150|NCT02501473|fNHL|fnhl
127151|NCT02501473|low-grade lymphoma|low-grade lymphoma
127152|NCT02501473|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
127153|NCT02501473|follicular NHL|follicular nhl
127154|NCT02501473|Marginal Zone|marginal zone
127155|NCT02501460|Adult cancer survivors|adult cancer survivors
127156|NCT02501460|Exercise|exercise
127157|NCT02501460|Dietary supplementation|dietary supplementation
127158|NCT02501434|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
127159|NCT02501434|unfractionated heparin|unfractionated heparin
127160|NCT02501434|neurobehavioral manifestations|neurobehavioral manifestations
127286|NCT02500849|Busulfan|busulfan
127161|NCT02501434|delayed ischemic neurological deficits|delayed ischemic neurological deficits
127162|NCT02501434|cerebral aneurysm|cerebral aneurysm
127163|NCT02501434|coil embolization|coil embolization
127164|NCT02501434|Montreal Cognitive Assessment|montreal cognitive assessment
127165|NCT02501421|vaccine|vaccine
127166|NCT02501421|influenza vector|influenza vector
127167|NCT02501421|tuberculosis|tuberculosis
127168|NCT02501382|Fasciitis|fasciitis
127169|NCT02501382|Fasciitis, Necrotizing|fasciitis, necrotizing
127170|NCT02501382|Soft tissue infections|soft tissue infections
127171|NCT02501382|Fournier's gangrene|fournier's gangrene
127172|NCT02501382|Immunopathogenesis|immunopathogenesis
127173|NCT02501356|prebiotic|prebiotic
127174|NCT02501356|dietary supplement|dietary supplement
127175|NCT02501343|Glucose metabolism|glucose metabolism
127176|NCT02501343|Potential renal acid load|potential renal acid load
127177|NCT02501343|Postprandial glycemia|postprandial glycemia
127178|NCT02501343|Body acid-base homeostasis|body acid-base homeostasis
127179|NCT02501343|Sodium bicarbonate|sodium bicarbonate
127180|NCT02501330|Drug use investigation in Japan|drug use investigation in japan
127181|NCT02501317|urinary incontinence|urinary incontinence
127182|NCT02501317|physical therapy|physical therapy
127183|NCT02501317|rehabilitation|rehabilitation
127184|NCT02501317|pelvic floor|pelvic floor
127186|NCT02501317|conservative treatment|conservative treatment
127187|NCT02501265|Nicotine addiction|nicotine addiction
127188|NCT02501265|Cigarette smoking|cigarette smoking
127189|NCT02501252|Community|community
127190|NCT02501252|Skilled birth attendance|skilled birth attendance
127191|NCT02501252|Rural|rural
127192|NCT02501252|Ethiopia|ethiopia
127193|NCT02501226|Psychiatry|psychiatry
127194|NCT02501226|Depression|depression
127195|NCT02501226|Psychoeducation|psychoeducation
127196|NCT02501226|Randomized controlled trial|randomized controlled trial
127197|NCT02501226|Treatment adherence|treatment adherence
127198|NCT02501226|Remission|remission
127199|NCT02501213|Diuretic|diuretic
127200|NCT02501213|Malignant ascites|malignant ascites
127201|NCT02501200|Dyslipidemia|dyslipidemia
127202|NCT02501200|CKD-391|ckd-391
127203|NCT02501200|Atorvastatin|atorvastatin
127204|NCT02501200|Ezetimibe|ezetimibe
127205|NCT02501174|Geriatric oncology|geriatric oncology
127206|NCT02501148|Embolic protection|embolic protection
127207|NCT02501148|Carotid artery stenting|carotid artery stenting
127208|NCT02501135|Femoral nerve blocks|femoral nerve blocks
127209|NCT02501135|children|children
127210|NCT02501135|knee and thigh surgery|knee and thigh surgery
127211|NCT02501122|Quality|quality
127212|NCT02501122|hospital care|hospital care
127213|NCT02501122|adenotonsillectomy|adenotonsillectomy
127214|NCT02501109|Aripiprazole|aripiprazole
127215|NCT02501109|Oral Soluble Film|oral soluble film
127216|NCT02501109|Schizophrenia|schizophrenia
127217|NCT02501096|Lenvatinib|lenvatinib
127218|NCT02501096|Lenvima|lenvima
127219|NCT02501096|E7080|e7080
127220|NCT02501096|Phase 1b/2|phase 1b/2
127221|NCT02501096|Pembrolizumab|pembrolizumab
127222|NCT02501096|Solid tumors|solid tumors
127223|NCT02501083|cardiomyopathy|cardiomyopathy
127224|NCT02501083|echocardiography|echocardiography
127225|NCT02501083|prognosis|prognosis
127226|NCT02501083|respiratory|respiratory
127227|NCT02501083|home mechanical ventilation|home mechanical ventilation
127228|NCT02501083|vital capacity|vital capacity
127229|NCT02501083|maximal inspiratory pressure|maximal inspiratory pressure
127230|NCT02501083|maximal expiratory pressure|maximal expiratory pressure
127231|NCT02501070|Percutaneous Coronary Intervention|percutaneous coronary intervention
127232|NCT02501070|Angioplasty|angioplasty
127233|NCT02501070|Stent|stent
127234|NCT02501070|Community Networks|community networks
127235|NCT02501057|Human Immunodeficiency Virus|human immunodeficiency virus
127236|NCT02501057|Unsafe Drinking|unsafe drinking
127237|NCT02501057|Antiretroviral Therapy (ART)|antiretroviral therapy (art)
127238|NCT02501031|Flaxseed|flaxseed
127239|NCT02501031|Postmenopause|postmenopause
127240|NCT02501031|Hormones|hormones
127241|NCT02501031|Lignans|lignans
127242|NCT02501031|No Evidence of Disease|no evidence of disease
127243|NCT02501018|CLI|cli
127244|NCT02500979|Type 1 Diabetes Mellitus; Pramlintide|type 1 diabetes mellitus; pramlintide
127245|NCT02500966|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
127246|NCT02500966|stenosis|stenosis
127247|NCT02500966|cervix|cervix
127248|NCT02500966|medical device|medical device
127249|NCT02500966|inventories|inventories
127250|NCT02500966|Uterine Cervix|uterine cervix
127251|NCT02500966|Intrauterine Devices|intrauterine devices
127252|NCT02500966|intrauterine|intrauterine
127253|NCT02500966|conization|conization
127254|NCT02500966|loop electrosurgical excision|loop electrosurgical excision
127255|NCT02500953|ASP3325|asp3325
127256|NCT02500953|pharmacokinetics|pharmacokinetics
127257|NCT02500953|pharmacodynamics|pharmacodynamics
127258|NCT02500927|ASP8273|asp8273
127259|NCT02500927|Non-Small Cell Lung Cancer|non-small cell lung cancer
127260|NCT02500927|EGFR Tyrosine Kinase Inhibitor|egfr tyrosine kinase inhibitor
127261|NCT02500927|EGFR Mutation|egfr mutation
127262|NCT02500914|small cell lung cancer|small cell lung cancer
127263|NCT02500901|Enzalutamide|enzalutamide
127264|NCT02500901|Niraparib|niraparib
127265|NCT02500901|PARP-1 inhibitor|parp-1 inhibitor
127266|NCT02500901|PARP-2 inhibitor|parp-2 inhibitor
127267|NCT02500901|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
127268|NCT02500888|OCD|ocd
127269|NCT02500888|Neurosurgery|neurosurgery
127270|NCT02500888|Radiosurgery|radiosurgery
127271|NCT02500875|Negative-Pressure Wound Therapy|negative-pressure wound therapy
127272|NCT02500875|Topical Negative Pressure Therapy|topical negative pressure therapy
127273|NCT02500875|Sodium Hypochlorite|sodium hypochlorite
127274|NCT02500862|Eye|eye
127275|NCT02500862|Imaging|imaging
127276|NCT02500849|Gene therapy|gene therapy
127277|NCT02500849|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
127278|NCT02500849|HIV Infections|hiv infections
127279|NCT02500849|Retroviridae Infections|retroviridae infections
127280|NCT02500849|RNA Virus Infections|rna virus infections
127281|NCT02500849|Virus Diseases|virus diseases
127282|NCT02500849|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
127283|NCT02500849|Sexually Transmitted Diseases|sexually transmitted diseases
127284|NCT02500849|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
127285|NCT02500849|Immune System Diseases|immune system diseases
127287|NCT02500849|Pharmacologic Actions|pharmacologic actions
127288|NCT02500836|Ear|ear
127289|NCT02500836|Nose|nose
127290|NCT02500836|Throat|throat
127291|NCT02500823|Mitochondrial DNA copy number|mitochondrial dna copy number
127292|NCT02500823|Peripheral blood cells|peripheral blood cells
127293|NCT02500810|neurotoxicity|neurotoxicity
127294|NCT02500810|chemotherapy|chemotherapy
127295|NCT02500810|monosialoganglioside|monosialoganglioside
127296|NCT02500810|prevention|prevention
127297|NCT02500758|Surgical scrubbing|surgical scrubbing
127298|NCT02500758|Chlorhexidine digluconate|chlorhexidine digluconate
127299|NCT02500758|Parachlorometaxylenol|parachlorometaxylenol
127300|NCT02500719|Posttraumatic Stress Disorder|posttraumatic stress disorder
127301|NCT02500719|Neurofeedback|neurofeedback
127302|NCT02500719|fMRI|fmri
127413|NCT02500225|Etomidate|etomidate
127303|NCT02500719|Skin Conductance Response|skin conductance response
127304|NCT02500693|Lung Cancer, Screening, COPD|lung cancer, screening, copd
127305|NCT02500680|Influenza|influenza
127306|NCT02500680|Adjuvant|adjuvant
127307|NCT02500667|N91115|n91115
153274|NCT02352766|FNA|fna
127308|NCT02500667|Rifampin|rifampin
127309|NCT02500667|drug interaction|drug interaction
127310|NCT02500667|Cavosonstat|cavosonstat
127311|NCT02500654|Peri-implantitis|peri-implantitis
127313|NCT02500654|Surgical therapy|surgical therapy
127314|NCT02500654|Enamel matrix derivative|enamel matrix derivative
127315|NCT02500654|Peri-implant microflora|peri-implant microflora
127316|NCT02500654|Peri-implant fluid|peri-implant fluid
127317|NCT02500641|Biological Markers|biological markers
127318|NCT02500641|Cardiovascular disease|cardiovascular disease
127319|NCT02500641|Humans|humans
127320|NCT02500641|Pulse Wave Velocity|pulse wave velocity
127321|NCT02500641|Cardiovascular risk factors|cardiovascular risk factors
127322|NCT02500641|Allopurinol|allopurinol
127323|NCT02500641|Pulse Wave Analysis|pulse wave analysis
127324|NCT02500641|Thiazoles|thiazoles
127325|NCT02500641|Inflammation|inflammation
127326|NCT02500641|Uric acid|uric acid
127327|NCT02500641|Febuxostat|febuxostat
127328|NCT02500641|Oxidative stress|oxidative stress
127329|NCT02500641|Tumor Necrosis Factor|tumor necrosis factor
127330|NCT02500641|Arthritis|arthritis
127331|NCT02500641|Hyperuricemia|hyperuricemia
127332|NCT02500628|metformin|metformin
127333|NCT02500628|mitochondria|mitochondria
127334|NCT02500628|complex 1|complex 1
127335|NCT02500628|fibromyalgia|fibromyalgia
127336|NCT02500628|neurogenic pain|neurogenic pain
127337|NCT02500628|diabetes|diabetes
127338|NCT02500628|tardive dyskinesia|tardive dyskinesia
127339|NCT02500628|heart rate variability|heart rate variability
127340|NCT02500602|PTSD|ptsd
127341|NCT02500602|alcohol use disorders|alcohol use disorders
127342|NCT02500602|posttraumatic stress disorder|posttraumatic stress disorder
127344|NCT02500602|Veteran|veteran
127347|NCT02500576|Melanoma|melanoma
127348|NCT02500576|Metastatic|metastatic
127349|NCT02500576|Cyclophosphamide|cyclophosphamide
127350|NCT02500576|Cytoxan|cytoxan
127351|NCT02500576|Neosar|neosar
127352|NCT02500576|Mesna|mesna
127353|NCT02500576|Mesnex|mesnex
127354|NCT02500576|Fludarabine|fludarabine
127355|NCT02500576|Fludarabine phosphate|fludarabine phosphate
127356|NCT02500576|MK-3475|mk-3475
127357|NCT02500576|Keytruda|keytruda
127358|NCT02500576|Pembrolizumab|pembrolizumab
127359|NCT02500576|SCH-900475|sch-900475
127360|NCT02500576|IL-2|il-2
127361|NCT02500576|Aldesleukin|aldesleukin
127362|NCT02500576|Interleukin-2|interleukin-2
127363|NCT02500576|Proleukin|proleukin
127364|NCT02500576|TIL|til
127365|NCT02500576|T-cells|t-cells
127366|NCT02500576|Questionnaires|questionnaires
127367|NCT02500576|Surveys|surveys
127368|NCT02500576|Phone calls|phone calls
127369|NCT02500550|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
127370|NCT02500550|Graft versus host disease|graft versus host disease
127371|NCT02500550|Immune reconstitution|immune reconstitution
127372|NCT02500550|Alloreactive T-cells|alloreactive t-cells
127373|NCT02500550|Photodynamic treatment|photodynamic treatment
127374|NCT02500550|Hematologic malignancy|hematologic malignancy
127375|NCT02500550|Transplant-related mortality|transplant-related mortality
127376|NCT02500485|SHR3824 SP2086 drug-drug interaction|shr3824 sp2086 drug-drug interaction
127377|NCT02500472|Tobacco|tobacco
127378|NCT02500472|Smoking|smoking
127379|NCT02500459|Topotecan|topotecan
127380|NCT02500459|Cleveland Multiport Catheter|cleveland multiport catheter
127381|NCT02500459|Cancer|cancer
127382|NCT02500433|Cerebral palsy|cerebral palsy
127383|NCT02500433|child|child
127384|NCT02500433|rehabilitation|rehabilitation
127385|NCT02500433|video games|video games
127386|NCT02500433|virtual reality.|virtual reality.
127387|NCT02500420|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
127388|NCT02500420|Stress MRI|stress mri
127389|NCT02500420|Cardiac MRI|cardiac mri
127390|NCT02500420|Stress echocardiography|stress echocardiography
127391|NCT02500420|T1 mapping|t1 mapping
127392|NCT02500420|2D strain|2d strain
127393|NCT02500394|renal replacement therapy|renal replacement therapy
127394|NCT02500342|Thyroid Dysfunction|thyroid dysfunction
127396|NCT02500342|Randomized Controlled Trial|randomized controlled trial
127397|NCT02500342|Thyroxine|thyroxine
127398|NCT02500342|Hypothyroidism|hypothyroidism
127399|NCT02500316|Growth hormone deficiency (GHD)|growth hormone deficiency (ghd)
127400|NCT02500316|r-hGH|r-hgh
127401|NCT02500316|Long-acting|long-acting
127402|NCT02500303|Amputation|amputation
127403|NCT02500290|ACS|acs
127404|NCT02500277|thoracoscopy|thoracoscopy
127405|NCT02500277|pleuroscopy|pleuroscopy
127406|NCT02500277|semirigid thoracoscopy|semirigid thoracoscopy
127407|NCT02500277|flexible cryoprobe|flexible cryoprobe
127408|NCT02500277|cryobiopsy|cryobiopsy
127409|NCT02500277|pleural biopsy|pleural biopsy
127410|NCT02500251|Transplantation|transplantation
127411|NCT02500251|belimumab|belimumab
127412|NCT02500251|Velcade|velcade
127414|NCT02500225|Sevoflurane|sevoflurane
127415|NCT02500199|HER2 positive|her2 positive
118630|NCT02553668|Oxygen|oxygen
127416|NCT02500173|radiotherapy|radiotherapy
127417|NCT02500173|side effects|side effects
128122|NCT02496169|PTCA|ptca
127418|NCT02500147|Polycystic Ovary Syndrome|polycystic ovary syndrome
127419|NCT02500147|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
127420|NCT02500147|Adolescents|adolescents
127421|NCT02500147|Young Women|young women
127423|NCT02500147|MRS|mrs
127424|NCT02500147|DXA|dxa
127425|NCT02500147|PNPLA3|pnpla3
127426|NCT02500147|Metformin|metformin
127427|NCT02500147|Randomized Clinical Trial|randomized clinical trial
127428|NCT02500147|Placebo|placebo
127429|NCT02500147|Hirsutism|hirsutism
127430|NCT02500147|Acne|acne
127431|NCT02500147|Amenorrhea|amenorrhea
127432|NCT02500147|Metabolic Syndrome|metabolic syndrome
127433|NCT02500147|Dyslipidemia|dyslipidemia
127434|NCT02500147|Percentage liver fat|percentage liver fat
127435|NCT02500121|Pembrolizumab|pembrolizumab
127436|NCT02500121|PD-1 Inhibitor|pd-1 inhibitor
127437|NCT02500108|Domperidone|domperidone
127438|NCT02500108|Ventricular Tachyarrhythmia|ventricular tachyarrhythmia
127439|NCT02500108|Sudden cardiac death|sudden cardiac death
127440|NCT02500108|Pharmacotherapy|pharmacotherapy
127441|NCT02500108|Adverse events|adverse events
127442|NCT02500082|citrate transporter deficiency|citrate transporter deficiency
127443|NCT02500082|SLC13A5 gene|slc13a5 gene
127444|NCT02500082|citric acid cycle|citric acid cycle
127445|NCT02500082|energy metabolism|energy metabolism
127446|NCT02500056|Inguinal hernia|inguinal hernia
127447|NCT02500056|Chronic pain|chronic pain
127448|NCT02500056|Mesh|mesh
127449|NCT02500056|Lichtenstein hernioplasty|lichtenstein hernioplasty
127450|NCT02500043|Gastric Cancer|gastric cancer
127451|NCT02500043|Metastatic Gastric Cancer|metastatic gastric cancer
127452|NCT02499965|Topical Anesthetic|topical anesthetic
127453|NCT02499965|Ethyl Chloride|ethyl chloride
127454|NCT02499965|Pain Reduction|pain reduction
127455|NCT02499965|IV cannulation|iv cannulation
127456|NCT02499952|Pembrolizumab|pembrolizumab
127457|NCT02499952|MK-3475|mk-3475
127458|NCT02499952|PMNSGCT|pmnsgct
127459|NCT02499952|PD-L1|pd-l1
127460|NCT02499952|Non Seminomatous Germ Cell Tumors|non seminomatous germ cell tumors
127461|NCT02499848|MRI Lesion|mri lesion
127462|NCT02499848|transperineal injection|transperineal injection
127463|NCT02499848|prostate biopsies|prostate biopsies
127464|NCT02499822|Hypertension|hypertension
127465|NCT02499822|Blood pressure variability|blood pressure variability
127466|NCT02499822|Home systolic blood pressure|home systolic blood pressure
127467|NCT02499822|Organ damage|organ damage
127468|NCT02499822|Nifedipine GITS|nifedipine gits
127469|NCT02499822|Ramipril|ramipril
127470|NCT02499809|Vibration therapy|vibration therapy
127471|NCT02499809|Recovery from exercise|recovery from exercise
127472|NCT02499796|Invasive mechanical ventilation|invasive mechanical ventilation
127473|NCT02499796|Humidifying devices|humidifying devices
127474|NCT02499796|Respiratory mechanics|respiratory mechanics
127475|NCT02499783|Biologic|biologic
127476|NCT02499783|China|china
127477|NCT02499783|Tumor necrosis factor (TNF)-alpha|tumor necrosis factor (tnf)-alpha
127478|NCT02499770|Small Cell Lung Cancer|small cell lung cancer
127479|NCT02499770|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
127480|NCT02499757|Perception|perception
127481|NCT02499757|brain response|brain response
127482|NCT02499757|nicotine|nicotine
127483|NCT02499757|taste|taste
127484|NCT02499744|NIPPV|nippv
127485|NCT02499744|HHFNC|hhfnc
127486|NCT02499744|RDS|rds
127487|NCT02499744|neonate|neonate
127488|NCT02499731|physical activity|physical activity
127489|NCT02499731|nutrition|nutrition
127490|NCT02499731|social network|social network
127491|NCT02499718|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
127492|NCT02499718|Non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
127493|NCT02499718|quality of life|quality of life
127494|NCT02499718|long-term oxygen therapy|long-term oxygen therapy
127495|NCT02499666|Exercise Capacity|exercise capacity
127496|NCT02499666|Chronic Total Occlusion|chronic total occlusion
127497|NCT02499653|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
127498|NCT02499653|Non Invasive Ventilation (NIV)|non invasive ventilation (niv)
127499|NCT02499653|Acceptance|acceptance
127500|NCT02499653|Adherence|adherence
127501|NCT02499653|Clinical Psychology|clinical psychology
127502|NCT02499640|Recovery of function|recovery of function
127503|NCT02499640|Autonomic nervous system|autonomic nervous system
127504|NCT02499640|Heart rate variability|heart rate variability
127505|NCT02499640|Cryotherapy|cryotherapy
127506|NCT02499640|Immersion|immersion
127507|NCT02499627|Lymphoma|lymphoma
127508|NCT02499627|Hodgkin|hodgkin
127509|NCT02499627|PTCL|ptcl
127510|NCT02499627|CD30+|cd30+
127511|NCT02499614|MET amplification|met amplification
127512|NCT02499614|ROS1 translocation|ros1 translocation
127513|NCT02499614|Crizotinib|crizotinib
402918|NCT01229150|MIB-1 (Ki-67) Rate|mib-1 (ki-67) rate
127514|NCT02499601|Heart Failure with Preserved Ejection Fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
127515|NCT02499601|Heart Failure (HF)|heart failure (hf)
127516|NCT02499601|New York Heart Association functional Class (NYHA f. Cl)|new york heart association functional class (nyha f. cl)
127517|NCT02499575|Exparel|exparel
127518|NCT02499575|bupivacaine|bupivacaine
127519|NCT02499575|Hallux valgus deformity|hallux valgus deformity
127520|NCT02499575|bunionectomy|bunionectomy
127521|NCT02499536|Atelectasis|atelectasis
127522|NCT02499536|Postoperative|postoperative
127523|NCT02499536|Lung ultrasound|lung ultrasound
127524|NCT02499510|femoropopliteal disease|femoropopliteal disease
127525|NCT02499510|restenosis|restenosis
127526|NCT02499497|Prostate Cancer|prostate cancer
127527|NCT02499432|Evidence Based Psychotherapy|evidence based psychotherapy
127528|NCT02499432|Implementation|implementation
127529|NCT02499432|PTSD|ptsd
127530|NCT02499393|newborn|newborn
652521|NCT00794131|cancer|cancer
127531|NCT02499393|therapeutic hypothermia|therapeutic hypothermia
127532|NCT02499393|magnesium sulphate|magnesium sulphate
127533|NCT02499380|RePneu|repneu
127534|NCT02499380|Coil|coil
127535|NCT02499380|LVRC|lvrc
127536|NCT02499380|PneumRx|pneumrx
127537|NCT02499367|triple negative|triple negative
127538|NCT02499367|metastatic|metastatic
127539|NCT02499341|Tramadol|tramadol
127540|NCT02499341|Ketamine|ketamine
127541|NCT02499341|Morphine|morphine
127542|NCT02499328|Carcinoma of the Head and Neck|carcinoma of the head and neck
127543|NCT02499276|mechanical ventilation|mechanical ventilation
127544|NCT02499276|pressure support ventilation|pressure support ventilation
127545|NCT02499276|NAVA|nava
127546|NCT02499276|PAV|pav
127547|NCT02499276|variable ventilation|variable ventilation
127548|NCT02499276|patient ventilator asynchrony|patient ventilator asynchrony
127549|NCT02499263|Adalimumab trough level|adalimumab trough level
127550|NCT02499263|Fecal Calprotectin|fecal calprotectin
127551|NCT02499263|Fecal microbiota|fecal microbiota
127552|NCT02499250|refractory angina pectoris|refractory angina pectoris
127553|NCT02499250|remote ischemic conditioning|remote ischemic conditioning
127554|NCT02499250|life quality|life quality
127555|NCT02499250|anxiety|anxiety
127556|NCT02499250|depression|depression
127557|NCT02499250|inflammation|inflammation
127558|NCT02499237|osteoporosis|osteoporosis
127559|NCT02499237|denosumab|denosumab
127560|NCT02499237|zoledronic acid|zoledronic acid
127561|NCT02499237|bone mineral density|bone mineral density
127562|NCT02499237|bone markers|bone markers
127563|NCT02499211|obesity|obesity
127564|NCT02499211|health disparities|health disparities
127565|NCT02499211|healthy food marketing|healthy food marketing
127566|NCT02499211|food environments|food environments
127567|NCT02499211|marketing environments|marketing environments
127568|NCT02499211|food access|food access
127569|NCT02499211|food purchase decision making|food purchase decision making
127570|NCT02499198|Nornicotine|nornicotine
127571|NCT02499198|Tobacco|tobacco
127572|NCT02499198|N'-nitrosonornicotine|n'-nitrosonornicotine
127573|NCT02499198|NNN|nnn
127574|NCT02499185|Biomarker|biomarker
127575|NCT02499185|Intra Abdominal Surgery|intra abdominal surgery
127576|NCT02499185|AKI|aki
127577|NCT02499172|Adverse pregnancy outcome|adverse pregnancy outcome
127578|NCT02499159|Exparel|exparel
127579|NCT02499159|Thoracoscopy|thoracoscopy
127580|NCT02499159|Bupivicaine|bupivicaine
127581|NCT02499159|Liposomal|liposomal
127582|NCT02499146|Palbociclib|palbociclib
127583|NCT02499146|PD-0332991|pd-0332991
127584|NCT02499146|pharmacokinetics|pharmacokinetics
127585|NCT02499146|breast cancer patients|breast cancer patients
127586|NCT02499146|Chinese|chinese
127587|NCT02499120|palbociclib, cetuximab, human papillomavirus, squamous cell carcinoma, head and neck cancer|palbociclib, cetuximab, human papillomavirus, squamous cell carcinoma, head and neck cancer
127588|NCT02499107|food intake|food intake
127589|NCT02499107|satiety|satiety
127590|NCT02499107|blood glucose|blood glucose
127591|NCT02499107|potato|potato
127592|NCT02499107|insulin|insulin
127593|NCT02499081|Relapsed|relapsed
127594|NCT02499081|Refractory|refractory
127595|NCT02499081|Proteasome Inhibitor|proteasome inhibitor
127596|NCT02499055|anxiety|anxiety
127605|NCT02499016|Single-incision|single-incision
127606|NCT02499003|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
127607|NCT02499003|Follicular lymphoma|follicular lymphoma
127608|NCT02499003|Transformed indolent lymphoma|transformed indolent lymphoma
127609|NCT02498977|Liver|liver
127610|NCT02498977|Transplant|transplant
127611|NCT02498977|Immunosuppression|immunosuppression
127612|NCT02498964|cardiac anesthesia simulation,NASA task load index|cardiac anesthesia simulation,nasa task load index
127613|NCT02498938|Pulmonary disease,chronic obstructive,|pulmonary disease,chronic obstructive,
127614|NCT02498938|generalized chronic periodontitis|generalized chronic periodontitis
127615|NCT02498938|SERPINA1 gene polymorphism|serpina1 gene polymorphism
127616|NCT02498912|T Cells|t cells
127617|NCT02498912|Cyclophosphamide|cyclophosphamide
127618|NCT02498912|MUC16ecto antigen|muc16ecto antigen
128123|NCT02496169|stenosis|stenosis
118818|NCT02552602|HIV|hiv
127625|NCT02498873|VO2Max|vo2max
127626|NCT02498873|Physical Conditioning|physical conditioning
127627|NCT02498873|Aerobic Exercise|aerobic exercise
127628|NCT02498873|Performance|performance
127629|NCT02498860|adenocarcinoma|adenocarcinoma
127630|NCT02498860|lung|lung
127631|NCT02498860|adjuvant chemotherapy|adjuvant chemotherapy
127632|NCT02498860|pemetrexed|pemetrexed
127633|NCT02498860|cisplatin|cisplatin
127634|NCT02498860|surgery|surgery
127635|NCT02498834|Communication|communication
127636|NCT02498834|provider|provider
127637|NCT02498834|caregiver|caregiver
127638|NCT02498834|adolescent|adolescent
127639|NCT02498821|PICC|picc
127640|NCT02498821|central catheter|central catheter
127641|NCT02498821|vascular access|vascular access
127642|NCT02498808|Interferon lambda|interferon lambda
127643|NCT02498808|Interleukin-29|interleukin-29
127644|NCT02498808|Neutrophil|neutrophil
127645|NCT02498795|Intratissue Percutaneous Electrolysis|intratissue percutaneous electrolysis
127646|NCT02498795|Dry needling|dry needling
127647|NCT02498795|Eccentric exercise|eccentric exercise
127648|NCT02498795|Patella|patella
127649|NCT02498782|Chagas Disease|chagas disease
127650|NCT02498782|Dosage forms|dosage forms
127651|NCT02498782|Regimens|regimens
127652|NCT02498769|Cardiac Surgery|cardiac surgery
127653|NCT02498769|Postoperative Complications|postoperative complications
127654|NCT02498769|Autonomic Nerve Block|autonomic nerve block
127655|NCT02498730|bipolar disorder|bipolar disorder
127656|NCT02498730|VO2max|vo2max
127657|NCT02498730|aerobic exercise|aerobic exercise
127658|NCT02498691|endometriosis|endometriosis
127659|NCT02498691|preterm delivery|preterm delivery
127660|NCT02498691|caesarean|caesarean
127661|NCT02498691|Pregnancy outcomes of women with or without endometriosis|pregnancy outcomes of women with or without endometriosis
127662|NCT02498665|Wilms' Tumor 1|wilms' tumor 1
127663|NCT02498665|Vaccine|vaccine
127664|NCT02498665|Neoplasms|neoplasms
127665|NCT02498639|balloon aortic valvuloplasty|balloon aortic valvuloplasty
127666|NCT02498639|rapid ventricular pacing|rapid ventricular pacing
127667|NCT02498639|outcome|outcome
127668|NCT02498626|mixed venous saturation|mixed venous saturation
127669|NCT02498626|open heart surgery|open heart surgery
127670|NCT02498626|children|children
127674|NCT02498587|Severe Acute Respiratory Infection|severe acute respiratory infection
127675|NCT02498496|COPD|copd
127676|NCT02498496|AECOPD|aecopd
127677|NCT02498496|Magnesium Sulfate|magnesium sulfate
127678|NCT02498496|Acute exacerbation of COPD|acute exacerbation of copd
127679|NCT02498496|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
127680|NCT02498496|ED|ed
127681|NCT02498496|ER|er
127682|NCT02498496|Emergency Department|emergency department
127683|NCT02498483|Infant|infant
127684|NCT02498457|maintenance hemodialysis patients|maintenance hemodialysis patients
127685|NCT02498457|coronary artery calcification|coronary artery calcification
127686|NCT02498457|low calcium dialysate|low calcium dialysate
127687|NCT02498457|effects|effects
127688|NCT02498457|safety|safety
127689|NCT02498444|Fontan|fontan
127690|NCT02498444|Treprostinil|treprostinil
127691|NCT02498444|Remodulin|remodulin
127692|NCT02498444|Single ventricle|single ventricle
127693|NCT02498431|irisin|irisin
127694|NCT02498431|myocardial infarction|myocardial infarction
127695|NCT02498431|coronary|coronary
127696|NCT02498392|Major Depressive Disorder|major depressive disorder
127697|NCT02498392|Depression|depression
127698|NCT02498392|Anxiety symptoms|anxiety symptoms
127699|NCT02498392|JNJ-42165279|jnj-42165279
127700|NCT02498379|novel radiotracer|novel radiotracer
127701|NCT02498379|biodistribution|biodistribution
127703|NCT02498340|G6PD|g6pd
127704|NCT02498340|genotype|genotype
127705|NCT02498340|phenotype|phenotype
127706|NCT02498340|diet restriction|diet restriction
127707|NCT02498327|Chronic|chronic
127708|NCT02498314|Manual therapy|manual therapy
127709|NCT02498314|Hip osteoarthritis|hip osteoarthritis
127710|NCT02498314|Mobilization|mobilization
127711|NCT02498301|travelers' diarrhea|travelers' diarrhea
127712|NCT02498301|military|military
127713|NCT02498301|enteric illness|enteric illness
127714|NCT02498301|gastrointestinal|gastrointestinal
127715|NCT02498288|capsule|capsule
127716|NCT02498288|Isotretinoin|isotretinoin
127717|NCT02498288|Bioequivalence|bioequivalence
127718|NCT02498262|Severe Mobility and Manipulation Impairments|severe mobility and manipulation impairments
127719|NCT02498249|Low-Level Laser Therapy|low-level laser therapy
127720|NCT02498249|trapezius muscle|trapezius muscle
127721|NCT02498249|neck pain|neck pain
127722|NCT02498236|Psychosis|psychosis
127723|NCT02498236|Schizophrenia|schizophrenia
127724|NCT02498236|Oxytocin|oxytocin
127725|NCT02498210|IVM|ivm
127726|NCT02498210|HIPPO signaling|hippo signaling
127727|NCT02498171|Labour analgesia|labour analgesia
127728|NCT02498171|Intrathecal morphine|intrathecal morphine
127729|NCT02498171|Bupivacaine|bupivacaine
127730|NCT02498171|Fentanyl|fentanyl
127731|NCT02498132|Mobile Technologies|mobile technologies
127732|NCT02498119|Type 2 DM|type 2 dm
127733|NCT02498119|lipid bodies|lipid bodies
127734|NCT02498106|nutrition|nutrition
127735|NCT02498106|aggression|aggression
127736|NCT02498106|n-3 fatty acids|n-3 fatty acids
127737|NCT02498106|psychiatry|psychiatry
127738|NCT02498106|inpatients admitted >2 years|inpatients admitted >2 years
127739|NCT02498093|Resistance training|resistance training
127740|NCT02498093|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
127741|NCT02498093|Professional-Patient Relations|professional-patient relations
127742|NCT02498093|Evidence-based practice|evidence-based practice
127743|NCT02498080|Drug eluting balloons|drug eluting balloons
127744|NCT02498080|Critical limb ischemia|critical limb ischemia
127745|NCT02498080|Infra-popliteal arteries|infra-popliteal arteries
127746|NCT02498080|Percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
127747|NCT02498041|Ultrathin Nasal Endoscopy|ultrathin nasal endoscopy
127748|NCT02498041|Barrett's Esophagus|barrett's esophagus
127749|NCT02498041|Transnasal Endoscopy|transnasal endoscopy
127750|NCT02498028|cervical fusion|cervical fusion
127751|NCT02498028|cervical arthroplasty|cervical arthroplasty
127752|NCT02498028|cervicobrachial pain|cervicobrachial pain
127753|NCT02498002|Diet|diet
127754|NCT02498002|Fasting|fasting
127755|NCT02498002|Intermittent Fasting|intermittent fasting
127756|NCT02498002|Alternate-day Fasting|alternate-day fasting
127757|NCT02498002|Physical Activity|physical activity
127758|NCT02498002|Glucose|glucose
127759|NCT02498002|Insulin|insulin
127760|NCT02498002|Appetite|appetite
127761|NCT02497989|Male circumcision|male circumcision
127762|NCT02497989|Demand creation|demand creation
127763|NCT02497976|Interstitial|interstitial
127764|NCT02497976|Cystitis|cystitis
127765|NCT02497976|Bladder|bladder
127766|NCT02497976|Pain|pain
127767|NCT02497950|HeartMate 3|heartmate 3
127768|NCT02497950|LVAS|lvas
127769|NCT02497950|LVAD|lvad
127770|NCT02497950|Heart-assist devices|heart-assist devices
127771|NCT02497950|Thoratec Corporation|thoratec corporation
127772|NCT02497937|GSK2798745|gsk2798745
127773|NCT02497937|TRPV4 Channel Blocker|trpv4 channel blocker
127774|NCT02497937|Pharmacodynamics|pharmacodynamics
127775|NCT02497937|Adults|adults
127776|NCT02497937|Congestive Heart Failure|congestive heart failure
127777|NCT02497911|Adductor Canal Catheter|adductor canal catheter
127778|NCT02497911|Intraarticular Catheter|intraarticular catheter
127779|NCT02497911|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
127780|NCT02497885|MERS|mers
127781|NCT02497885|healthcare personnel|healthcare personnel
127782|NCT02497859|Weight Reduction|weight reduction
127783|NCT02497859|Weight Loss Diet|weight loss diet
127784|NCT02497859|Satiety Response|satiety response
127785|NCT02497859|Insulin|insulin
127786|NCT02497859|Glucagon-Like Peptide 1|glucagon-like peptide 1
127787|NCT02497859|PYY (3-36) peptide|pyy (3-36) peptide
127788|NCT02497859|Ghrelin|ghrelin
127789|NCT02497859|Glucose|glucose
127790|NCT02497859|Eggs|eggs
127791|NCT02497859|Protein|protein
127792|NCT02497859|Energy Intake|energy intake
127793|NCT02497859|Breakfast|breakfast
127794|NCT02497846|Hyaluronic acid|hyaluronic acid
127795|NCT02497846|MiconJet needle|miconjet needle
127796|NCT02497807|Tourette syndrome|tourette syndrome
127797|NCT02497807|Iron deficiency|iron deficiency
127798|NCT02497794|chew gum|chew gum
127799|NCT02497794|bowel movements|bowel movements
127800|NCT02497794|cesarean section|cesarean section
127801|NCT02497781|Complicated urinary tract infections (cUTIs)|complicated urinary tract infections (cutis)
127802|NCT02497768|mastication|mastication
127803|NCT02497768|pistachios|pistachios
127804|NCT02497768|brazils|brazils
127805|NCT02497768|participants|participants
127806|NCT02497729|Endotracheal Intubation|endotracheal intubation
127807|NCT02497729|Checklist|checklist
127808|NCT02497729|Positioning|positioning
127809|NCT02497690|Cochlear Implant|cochlear implant
127810|NCT02497690|Hearing Aid|hearing aid
127811|NCT02497690|Telemedicine|telemedicine
127812|NCT02497677|parental sensitivity|parental sensitivity
127813|NCT02497677|child attachment|child attachment
127814|NCT02497664|Radiotherapy|radiotherapy
127815|NCT02497664|Active Breathing Control Technique|active breathing control technique
127816|NCT02497651|Smoking|smoking
127817|NCT02497651|Diabetes|diabetes
127818|NCT02497651|Incretin hormones|incretin hormones
127819|NCT02497651|Glucose tolerance|glucose tolerance
127820|NCT02497638|metformin|metformin
127821|NCT02497638|atorvastatin|atorvastatin
127822|NCT02497638|prostate-specific antigen|prostate-specific antigen
127823|NCT02497638|biochemical recurrence|biochemical recurrence
127824|NCT02497625|Low back pain|low back pain
127825|NCT02497625|Empathy|empathy
127826|NCT02497625|Subgroups|subgroups
127827|NCT02497625|Minimal intervention|minimal intervention
127828|NCT02497547|Atrophy|atrophy
127829|NCT02497547|Pathological Conditions, Anatomical|pathological conditions, anatomical
127830|NCT02497547|Oxytocin|oxytocin
127831|NCT02497547|Oxytocics|oxytocics
127832|NCT02497534|ataxia|ataxia
127833|NCT02497534|neuromuscular|neuromuscular
127834|NCT02497521|polycystic kidney disease|polycystic kidney disease
127835|NCT02497521|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
127836|NCT02497521|ADPKD|adpkd
127837|NCT02497521|Tolvaptan|tolvaptan
127838|NCT02497521|Jinarc|jinarc
127839|NCT02497508|progressive disease after at least 1 course of chemotherapy|progressive disease after at least 1 course of chemotherapy
127840|NCT02497495|Immersion|immersion
127841|NCT02497495|Recovery of Function|recovery of function
127842|NCT02497495|Lactate|lactate
127843|NCT02497495|Creatine Kinase|creatine kinase
127844|NCT02497495|Musculoskeletal Pain|musculoskeletal pain
127845|NCT02497469|Drug Therapy|drug therapy
127846|NCT02497456|HIV|hiv
127847|NCT02497456|Counselling|counselling
127848|NCT02497456|Care|care
127849|NCT02497456|antiretroviral therapy|antiretroviral therapy
127850|NCT02497456|linkage|linkage
127851|NCT02497456|Uganda|uganda
127852|NCT02497456|Africa|africa
127853|NCT02497443|drug-resistant symptomatic epilepsy|drug-resistant symptomatic epilepsy
127854|NCT02497443|seizure|seizure
127855|NCT02497443|autologous mesenchymal stem cells|autologous mesenchymal stem cells
127856|NCT02497443|safety|safety
127857|NCT02497443|remission|remission
127858|NCT02497443|electroencephalography|electroencephalography
127859|NCT02497443|refractory symptomatic epilepsy|refractory symptomatic epilepsy
127860|NCT02497443|autologous MSC|autologous msc
127861|NCT02497443|efficacy|efficacy
127862|NCT02497417|ARIES Clostridium difficile|aries clostridium difficile
127863|NCT02497378|Multiple Myeloma|multiple myeloma
127864|NCT02497378|Daratumumab|daratumumab
127865|NCT02497378|JNJ-54767414|jnj-54767414
127866|NCT02497378|Bortezomib|bortezomib
127867|NCT02497378|Dexamethasone|dexamethasone
127868|NCT02497365|keratits|keratits
127869|NCT02497365|besifloxacin|besifloxacin
127870|NCT02497339|Smoking cessation interventions|smoking cessation interventions
127871|NCT02497339|mindfulness training|mindfulness training
127872|NCT02497326|second degree burns|second degree burns
127873|NCT02497326|heparin|heparin
127874|NCT02497326|topical|topical
127875|NCT02497300|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists
127876|NCT02497300|Mineralocorticoid Effects|mineralocorticoid effects
127877|NCT02497287|Treatment-resistant Depression|treatment-resistant depression
127878|NCT02497287|Esketamine|esketamine
127879|NCT02497287|Oral Antidepressant|oral antidepressant
127880|NCT02497274|bariatric surgery|bariatric surgery
127881|NCT02497274|taste perception|taste perception
127882|NCT02497274|lipid receptors|lipid receptors
127883|NCT02497261|Food Allergy|food allergy
127884|NCT02497261|Peanut|peanut
127885|NCT02497261|Sensitization|sensitization
127886|NCT02497261|Child|child
127887|NCT02497261|Double-blind placebo-controlled challenge|double-blind placebo-controlled challenge
127888|NCT02497261|Prospective cohort|prospective cohort
127889|NCT02497248|Atrial Fibrillation|atrial fibrillation
127890|NCT02497248|Pulmonary Vein Ablation|pulmonary vein ablation
127891|NCT02497248|Mitral stenosis|mitral stenosis
127892|NCT02497248|Body surface mapping|body surface mapping
127893|NCT02497235|Drug therapy, Positron Emission Tomography, Brain enzyme occupancy, Cholesterol 24S-hydroxylase, CH24H|drug therapy, positron emission tomography, brain enzyme occupancy, cholesterol 24s-hydroxylase, ch24h
127894|NCT02497196|TPCS|tpcs
127895|NCT02497196|tDCS|tdcs
127896|NCT02497196|visceral pain|visceral pain
127897|NCT02497196|pancreatitis|pancreatitis
127902|NCT02497157|bevacizumab|bevacizumab
127903|NCT02497157|oxaliplatin|oxaliplatin
127904|NCT02497157|irinotecan|irinotecan
127905|NCT02497157|hydrochloride hydrate|hydrochloride hydrate
127906|NCT02497157|fluorouracil|fluorouracil
127907|NCT02497157|levofolinate calcium|levofolinate calcium
127908|NCT02497144|interstitial lung disease|interstitial lung disease
127909|NCT02497144|neuromuscular electrical stimulation|neuromuscular electrical stimulation
127910|NCT02497144|exercise capacity|exercise capacity
127911|NCT02497144|quality of life|quality of life
127912|NCT02497131|PTCL|ptcl
127913|NCT02497131|CD30+|cd30+
127914|NCT02497118|lung cancer Anti angiogenesis therapy survival|lung cancer anti angiogenesis therapy survival
127915|NCT02497105|Epilepsy|epilepsy
127916|NCT02497105|Intractable Seizures|intractable seizures
127917|NCT02497105|Ketogenic Diet|ketogenic diet
127918|NCT02497105|Biochemical Profiles|biochemical profiles
127919|NCT02497079|Bronchoscopy|bronchoscopy
127920|NCT02497079|Ultrasonography|ultrasonography
127921|NCT02497079|Tuberculous lymphadenitis|tuberculous lymphadenitis
127922|NCT02497079|Polymerase chain reaction|polymerase chain reaction
127923|NCT02497079|Sensitivity and specificity|sensitivity and specificity
127924|NCT02497066|topical|topical
127925|NCT02497066|compound|compound
127926|NCT02497066|pain|pain
127927|NCT02497053|MPM|mpm
127928|NCT02497040|craniotomy|craniotomy
127929|NCT02497040|local anesthetics|local anesthetics
127930|NCT02497040|scalp block|scalp block
127931|NCT02497040|head pinning|head pinning
127932|NCT02497027|pharmacogenetic, pharmacogenomic, depressive, mental health|pharmacogenetic, pharmacogenomic, depressive, mental health
127933|NCT02496988|Cytokine-Induced Killer Cells|cytokine-induced killer cells
652621|NCT00794456|anxiety|anxiety
127934|NCT02496988|Milignant Gliomas|milignant gliomas
127935|NCT02496988|Temozolomide|temozolomide
127936|NCT02496962|sleep deprivation|sleep deprivation
127937|NCT02496936|Energy Expenditure|energy expenditure
127938|NCT02496936|Appetite|appetite
127939|NCT02496936|Satiety|satiety
127940|NCT02496923|prophylactic NHFO|prophylactic nhfo
127941|NCT02496923|risk of developing postoperative pulmonary complications|risk of developing postoperative pulmonary complications
127942|NCT02496923|reduces hospital length of stay|reduces hospital length of stay
127943|NCT02496884|chronic kidney disease|chronic kidney disease
127944|NCT02496884|. α2δ ligands|. α2δ ligands
127945|NCT02496884|mirogabalin|mirogabalin
127946|NCT02496884|pain relief|pain relief
127947|NCT02496884|kidney metabolism|kidney metabolism
127948|NCT02496858|Young Patient|young patient
127949|NCT02496858|Genetic Characteristics|genetic characteristics
127950|NCT02496832|Hypoxia|hypoxia
127951|NCT02496832|18F-FAZA|18f-faza
127952|NCT02496832|18F-Fluoroazomycin arabinoside|18f-fluoroazomycin arabinoside
127953|NCT02496832|Positron emission tomography|positron emission tomography
127954|NCT02496832|PET|pet
127955|NCT02496832|Participating in study EMR200592-001|participating in study emr200592-001
127956|NCT02496819|Children|children
127957|NCT02496806|Polyphenols|polyphenols
127958|NCT02496806|Absorption|absorption
127959|NCT02496806|Metabolism|metabolism
127960|NCT02496806|Phlorotannins|phlorotannins
127961|NCT02496806|Seaweeds|seaweeds
127962|NCT02496767|fast skeletal troponin activator|fast skeletal troponin activator
127963|NCT02496767|tirasemtiv|tirasemtiv
127964|NCT02496767|CK-2017357|ck-2017357
127965|NCT02496767|double-blind|double-blind
127966|NCT02496767|randomized|randomized
127967|NCT02496767|placebo-controlled|placebo-controlled
127968|NCT02496741|isocitrate dehydrogenase 1/2 mutation|isocitrate dehydrogenase 1/2 mutation
127969|NCT02496741|metformin|metformin
127970|NCT02496741|chloroquine|chloroquine
127971|NCT02496728|Mobile Health|mobile health
127972|NCT02496728|Smartphone|smartphone
127973|NCT02496728|Cardiovascular health|cardiovascular health
127974|NCT02496728|College students|college students
127975|NCT02496728|Smoking|smoking
127976|NCT02496728|Physical activity|physical activity
127977|NCT02496728|Diet|diet
127978|NCT02496728|BMI|bmi
127979|NCT02496728|Blood pressure|blood pressure
127980|NCT02496728|Cholesterol|cholesterol
127981|NCT02496728|Glucose|glucose
127982|NCT02496728|Text|text
127983|NCT02496728|Facebook|facebook
127984|NCT02496728|Instagram|instagram
127985|NCT02496728|Push Notifications|push notifications
127986|NCT02496728|Ecological Momentary Assessment|ecological momentary assessment
127987|NCT02496702|exergaming|exergaming
127988|NCT02496702|Senior Fitness Test|senior fitness test
127989|NCT02496689|HPP|hpp
127990|NCT02496689|Bone Disease|bone disease
127991|NCT02496689|Soft Bones|soft bones
127992|NCT02496689|Low Alkaline Phosphatase|low alkaline phosphatase
128732|NCT02492737|MDS|mds
127993|NCT02496689|genetic metabolic disorder|genetic metabolic disorder
127994|NCT02496689|alkaline phosphatase|alkaline phosphatase
127995|NCT02496689|rickets|rickets
127996|NCT02496689|osteomalacia|osteomalacia
127997|NCT02496676|Lymphoma|lymphoma
127998|NCT02496676|Epstein-Barr Virus|epstein-barr virus
127999|NCT02496676|Immunodeficiency|immunodeficiency
128000|NCT02496676|MAGT1 Gene|magt1 gene
128001|NCT02496676|Intracellular Magnesium|intracellular magnesium
128002|NCT02496650|alcohol withdrawal state|alcohol withdrawal state
128003|NCT02496650|dexmedetomidine|dexmedetomidine
128004|NCT02496650|benzodiasepines|benzodiasepines
128005|NCT02496650|intensive care|intensive care
128006|NCT02496637|Obesity|obesity
128007|NCT02496637|Eating Disorders|eating disorders
128008|NCT02496637|Appetite regulation|appetite regulation
128009|NCT02496637|Eating Regulation|eating regulation
128010|NCT02496611|Obesity|obesity
128011|NCT02496611|Pharmacotherapy|pharmacotherapy
128012|NCT02496611|GLP-1|glp-1
128013|NCT02496611|Children|children
128014|NCT02496611|Exenatide|exenatide
128015|NCT02496611|BYDUREON|bydureon
128016|NCT02496611|Weight Loss|weight loss
128017|NCT02496611|Maintenance|maintenance
128018|NCT02496598|Reproductive Techniques, Assisted|reproductive techniques, assisted
128019|NCT02496598|Ovarian Follicle|ovarian follicle
128020|NCT02496585|Nintedanib (BIBF 1120)|nintedanib (bibf 1120)
128021|NCT02496585|Prednisone|prednisone
128022|NCT02496585|Radiation Pneumonitis|radiation pneumonitis
128023|NCT02496572|Tuberculosis, multidrug resistant|tuberculosis, multidrug resistant
128024|NCT02496572|Short-course regimen|short-course regimen
128025|NCT02496572|Medecins sans Frontieres, MSF|medecins sans frontieres, msf
128026|NCT02496572|Uzbekistan, Ministry of Health|uzbekistan, ministry of health
128027|NCT02496559|C-reactive Protein|c-reactive protein
128028|NCT02496559|Primary Health Care|primary health care
402919|NCT01229150|PERK Level|perk level
128029|NCT02496559|Child Welfare|child welfare
128030|NCT02496559|After-Hours Care|after-hours care
128031|NCT02496559|Anti-Bacterial Agents|anti-bacterial agents
128032|NCT02496559|Drug Prescriptions|drug prescriptions
128033|NCT02496520|dendritic cell vaccination|dendritic cell vaccination
128034|NCT02496520|sarcoma|sarcoma
128035|NCT02496520|central nervous system tumor|central nervous system tumor
128036|NCT02496520|childhood|childhood
128037|NCT02496520|adolescent|adolescent
128038|NCT02496520|immunotherapy|immunotherapy
128039|NCT02496507|sitting|sitting
128040|NCT02496507|intervention|intervention
128041|NCT02496507|desks|desks
128042|NCT02496507|workplace|workplace
128043|NCT02496507|cardiovascular|cardiovascular
128044|NCT02496507|metabolic|metabolic
128045|NCT02496507|qualitative|qualitative
128046|NCT02496507|randomised controlled trial|randomised controlled trial
128047|NCT02496468|childhood asthma|childhood asthma
128048|NCT02496468|preschool wheeze|preschool wheeze
128049|NCT02496468|adult asthma|adult asthma
128050|NCT02496468|transition|transition
128051|NCT02496468|phenotype|phenotype
128052|NCT02496468|endotype|endotype
128053|NCT02496468|trajectory|trajectory
128054|NCT02496455|NAV1.7 Voltage-Gated Sodium Channel|nav1.7 voltage-gated sodium channel
128055|NCT02496455|pain, postoperative|pain, postoperative
128056|NCT02496455|cesarean section|cesarean section
128057|NCT02496442|Transurethral Resection of Prostate|transurethral resection of prostate
128058|NCT02496442|Cystoscopy|cystoscopy
128059|NCT02496442|PCNL|pcnl
128060|NCT02496442|RERAS|reras
128061|NCT02496442|Urethroscopy|urethroscopy
128062|NCT02496403|buprenorphine-naloxone combination|buprenorphine-naloxone combination
128063|NCT02496403|Suboxone|suboxone
128064|NCT02496403|Buprenorphine|buprenorphine
128065|NCT02496403|Substance Use|substance use
128066|NCT02496403|Behavioral intervention|behavioral intervention
128067|NCT02496403|Opioid partial agonist|opioid partial agonist
128068|NCT02496403|medication assisted therapy|medication assisted therapy
128069|NCT02496403|opioid addiction|opioid addiction
128070|NCT02496390|Fecal Microbial Transplantation|fecal microbial transplantation
128071|NCT02496390|Gut microbiome|gut microbiome
128072|NCT02496390|Metabolic disorders|metabolic disorders
128073|NCT02496390|Obesity|obesity
128074|NCT02496377|Anaemia|anaemia
128075|NCT02496377|Iron deficiency|iron deficiency
128076|NCT02496377|Ferric carboxymaltose|ferric carboxymaltose
128077|NCT02496377|Patient blood management|patient blood management
128078|NCT02496377|Hip arthroplasty|hip arthroplasty
128079|NCT02496377|Knee arthroplasty|knee arthroplasty
128080|NCT02496364|Tranexamic Acid|tranexamic acid
128081|NCT02496364|Scoliosis|scoliosis
128082|NCT02496364|bleeding control|bleeding control
128083|NCT02496351|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
128084|NCT02496338|Menopause|menopause
128085|NCT02496338|Quality of Life|quality of life
128086|NCT02496338|Marital Satisfaction|marital satisfaction
128087|NCT02496338|training|training
128088|NCT02496325|Pudendal nerve block|pudendal nerve block
128089|NCT02496325|Ultrasound guided|ultrasound guided
128090|NCT02496325|Transperineal puncture|transperineal puncture
128091|NCT02496325|Perineal surgery|perineal surgery
128092|NCT02496325|children|children
128093|NCT02496312|Apathy|apathy
128094|NCT02496312|Goal-directed behavior|goal-directed behavior
128095|NCT02496312|Quantitative evaluation|quantitative evaluation
128096|NCT02496312|Sensor|sensor
128097|NCT02496312|Ethogram|ethogram
128098|NCT02496299|COMPARISSON|comparisson
128099|NCT02496299|CAUDAL BLOCK|caudal block
128100|NCT02496299|BUPIVACAINE|bupivacaine
128101|NCT02496299|DEXAMETHASONE|dexamethasone
128102|NCT02496286|Necessary paracentesis for symptom control|necessary paracentesis for symptom control
128103|NCT02496273|Dendritic Cells|dendritic cells
128104|NCT02496273|Cytotoxic T-Lymphocytes|cytotoxic t-lymphocytes
128105|NCT02496273|Adeno-Associated Virus|adeno-associated virus
128106|NCT02496260|Magnetic resonance imaging|magnetic resonance imaging
128107|NCT02496260|Cardiac function|cardiac function
128108|NCT02496260|Breast Cancer|breast cancer
128109|NCT02496247|malnutrition|malnutrition
128110|NCT02496247|undernutrition|undernutrition
128111|NCT02496247|Z-score|z-score
128112|NCT02496247|Guinea-Bissau|guinea-bissau
128113|NCT02496247|food aid|food aid
128114|NCT02496234|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
128115|NCT02496234|Acute kidney injury|acute kidney injury
128116|NCT02496234|Renal failure|renal failure
128117|NCT02496234|Biomarker|biomarker
128118|NCT02496221|Cholecystokinin|cholecystokinin
128119|NCT02496221|ultrasonography|ultrasonography
128120|NCT02496221|Albiglutide|albiglutide
128121|NCT02496221|Gallbladder ejection fraction|gallbladder ejection fraction
128124|NCT02496169|sirolimus|sirolimus
128125|NCT02496169|stent|stent
128126|NCT02496156|type 1 diabetes mellitus|type 1 diabetes mellitus
128127|NCT02496156|adolescence|adolescence
128128|NCT02496156|adherence|adherence
128129|NCT02496156|insulin pump|insulin pump
402920|NCT01229150|Lung Cancer|lung cancer
128130|NCT02496156|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
128131|NCT02496156|continuous glucose monitor|continuous glucose monitor
128132|NCT02496156|shared medical decision making|shared medical decision making
128133|NCT02496143|Healthy Volunteers|healthy volunteers
128134|NCT02496143|Phase I|phase i
128135|NCT02496143|Placebo controlled|placebo controlled
128136|NCT02496143|Single Ascending Dose|single ascending dose
128137|NCT02496143|PK|pk
128138|NCT02496143|Oral administration|oral administration
128139|NCT02496143|Softgel|softgel
128140|NCT02496130|minilaparotomy|minilaparotomy
128141|NCT02496130|morcellation|morcellation
128142|NCT02496130|laparoscopy|laparoscopy
128143|NCT02496104|Preterm|preterm
128144|NCT02496104|Infant|infant
128145|NCT02496104|Habituation|habituation
128146|NCT02496104|APIB|apib
128147|NCT02496065|breast cancer|breast cancer
128148|NCT02496065|BLZ-100|blz-100
128149|NCT02496065|Tumor Paint|tumor paint
128150|NCT02496065|breast tumors|breast tumors
128151|NCT02496052|amnion graft|amnion graft
128152|NCT02496052|New biological barrier system|new biological barrier system
128153|NCT02496039|PBA|pba
128154|NCT02496039|involuntary crying|involuntary crying
128155|NCT02496039|involuntary laughing|involuntary laughing
128156|NCT02496000|Diabetes Mellitus type 2|diabetes mellitus type 2
128157|NCT02496000|Metformin|metformin
128158|NCT02496000|oral insulin|oral insulin
128159|NCT02495974|Xtandi|xtandi
128160|NCT02495974|Enzalutamide|enzalutamide
128161|NCT02495974|Prostate cancer|prostate cancer
128162|NCT02495974|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
128163|NCT02495961|hyperlipidemias|hyperlipidemias
128164|NCT02495961|hyperglycemia|hyperglycemia
128165|NCT02495961|hypertension|hypertension
128166|NCT02495961|leptin|leptin
128167|NCT02495961|hyperhomocysteinemia|hyperhomocysteinemia
128168|NCT02494063|cervical cancer|cervical cancer
128169|NCT02494063|sentinel lymph node|sentinel lymph node
128170|NCT02494063|lymphadenectomy|lymphadenectomy
128171|NCT02494050|Depression|depression
128172|NCT02494050|Bipolar Disorder|bipolar disorder
128173|NCT02494050|Anhedonia|anhedonia
128174|NCT02494050|Women|women
128175|NCT02494024|PSP|psp
128176|NCT02494024|C2N-8E12|c2n-8e12
128177|NCT02494024|tauopathy|tauopathy
128178|NCT02494024|Progressive Supranuclear Palsy|progressive supranuclear palsy
128179|NCT02494024|Steele Richardson Olszewski Syndrome|steele richardson olszewski syndrome
128180|NCT02494024|Humanized anti-tau antibody|humanized anti-tau antibody
128181|NCT02494011|Colles' Fracture; CKCE; Russian current|colles' fracture; ckce; russian current
128182|NCT02493998|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
128183|NCT02493985|Brain physiology|brain physiology
128184|NCT02493985|Intracranial pressure|intracranial pressure
128185|NCT02493985|Cognition|cognition
128186|NCT02493985|Cerebrovascular|cerebrovascular
128187|NCT02493985|Head down tilt|head down tilt
128188|NCT02493985|Space flight|space flight
128189|NCT02493972|ovarian cancer|ovarian cancer
128190|NCT02493972|peritoneal carcinosis|peritoneal carcinosis
128191|NCT02493972|manual exploration|manual exploration
128192|NCT02493972|surgery|surgery
128193|NCT02493972|GelPort|gelport
128194|NCT02493959|PYY|pyy
128195|NCT02493959|Degradation|degradation
128196|NCT02493959|kinetics|kinetics
128197|NCT02493959|men|men
128198|NCT02495909|paediatric schistosomiasis|paediatric schistosomiasis
128199|NCT02495909|morbidity|morbidity
128200|NCT02495909|immunology|immunology
128201|NCT02495883|Essential Tremor|essential tremor
128202|NCT02495883|Magnetic Resonance Imaging|magnetic resonance imaging
128203|NCT02495883|Therapy|therapy
128204|NCT02495883|Alcohol|alcohol
128205|NCT02495883|Propranolol|propranolol
128206|NCT02495844|UCB0942|ucb0942
128207|NCT02495844|Treatment-resistant focal epilepsy|treatment-resistant focal epilepsy
128208|NCT02495844|Partial seizures|partial seizures
128209|NCT02495844|Seizure therapy|seizure therapy
128210|NCT02495831|PK study|pk study
128211|NCT02495818|Rotator cuff syndrome|rotator cuff syndrome
128212|NCT02495818|supraspinatus tendonitis|supraspinatus tendonitis
128213|NCT02495818|suprascapular nerve block|suprascapular nerve block
128214|NCT02495818|ultrasound guided|ultrasound guided
128215|NCT02495818|supraspinatus|supraspinatus
128216|NCT02495805|a continuous proximal adductor canal block (ACB)|a continuous proximal adductor canal block (acb)
128217|NCT02495805|continuous femoral nerve block (FNB)|continuous femoral nerve block (fnb)
128218|NCT02495779|PrEP|prep
128219|NCT02495779|HIV|hiv
128220|NCT02495779|MSM|msm
128221|NCT02495779|Men Having Sex With Men|men having sex with men
128222|NCT02495779|Episodic PrEP|episodic prep
128223|NCT02495779|Adherence|adherence
128224|NCT02495779|Episodic HIV Risk|episodic hiv risk
128225|NCT02495766|Multiple sclerosis|multiple sclerosis
128327|NCT02495194|Elderly|elderly
128226|NCT02495766|Bone marrow mesenchymal stromal cells|bone marrow mesenchymal stromal cells
128227|NCT02495766|Stem cells|stem cells
128228|NCT02495766|Nervous System Diseases|nervous system diseases
128229|NCT02495766|Demyelinating Diseases|demyelinating diseases
128230|NCT02495766|Autoimmune Diseases|autoimmune diseases
128231|NCT02495753|cesarean section|cesarean section
128232|NCT02495753|wound infection|wound infection
128233|NCT02495753|vaginal cleansing|vaginal cleansing
128234|NCT02495753|endometritis|endometritis
652721|NCT00794924|probiotics|probiotics
128235|NCT02495727|Step-reduction model|step-reduction model
128236|NCT02495727|Reduced activity|reduced activity
128238|NCT02495727|Skeletal Muscle|skeletal muscle
128239|NCT02495727|Sarcopenia|sarcopenia
128240|NCT02495727|Dynapenia|dynapenia
128241|NCT02495714|Exercise|exercise
128242|NCT02495714|Diet|diet
128243|NCT02495714|Learning|learning
128244|NCT02495688|General Anesthesia|general anesthesia
128245|NCT02495688|Regional Anesthesia|regional anesthesia
128246|NCT02495662|Vascular access|vascular access
128247|NCT02495662|Hemodialysis|hemodialysis
128248|NCT02495662|Arteriovenous shunt|arteriovenous shunt
128249|NCT02495662|Arteriovenous fistula|arteriovenous fistula
128250|NCT02495662|Maturation|maturation
128251|NCT02495662|Liposomal prednisolone|liposomal prednisolone
128252|NCT02495662|PEG-liposomal prednisolone sodium phosphate|peg-liposomal prednisolone sodium phosphate
128253|NCT02495662|Radio-cephalic|radio-cephalic
128254|NCT02495662|Shunt|shunt
128255|NCT02495610|NPH|nph
128256|NCT02495610|Gait analysis|gait analysis
128257|NCT02495610|neuropsychology|neuropsychology
128258|NCT02495610|micturition diary|micturition diary
128259|NCT02495610|MRI|mri
128260|NCT02495597|bronchial inflammation|bronchial inflammation
128261|NCT02495597|Bronchiolitis obliterans|bronchiolitis obliterans
128262|NCT02495597|Sputum|sputum
128263|NCT02495597|Blood|blood
128264|NCT02495597|Inflammation|inflammation
128265|NCT02495597|adaptive immune system|adaptive immune system
128266|NCT02495597|innate immune system|innate immune system
128267|NCT02495584|Vitamin D|vitamin d
128268|NCT02495584|Fortified milk|fortified milk
128269|NCT02495584|Supplementation|supplementation
128270|NCT02495584|UV exposure|uv exposure
128271|NCT02495584|Winter|winter
128272|NCT02495584|Healthy adults|healthy adults
128273|NCT02495584|Body Composition|body composition
128274|NCT02495584|Muscle function|muscle function
128275|NCT02495584|Blood pressure|blood pressure
128276|NCT02495571|ALS and Dysphagia|als and dysphagia
128277|NCT02495571|ALS and cough|als and cough
128278|NCT02495571|cough reflex test|cough reflex test
128279|NCT02495558|Cough Reflex test|cough reflex test
128280|NCT02495558|Decannulation|decannulation
128281|NCT02495545|spinal cord injury (SCI)|spinal cord injury (sci)
128282|NCT02495532|Neoplasm Metastasis|neoplasm metastasis
128283|NCT02495532|Colorectal Neoplasms|colorectal neoplasms
128284|NCT02495532|Lymph Nodes|lymph nodes
128285|NCT02495532|Lymph Node Revealing Solution|lymph node revealing solution
128286|NCT02495506|Cardiac surgery|cardiac surgery
128287|NCT02495506|bleeding|bleeding
128288|NCT02495506|platelet transfusion|platelet transfusion
128289|NCT02495480|disposable sheath|disposable sheath
128290|NCT02495480|intubation|intubation
128291|NCT02495480|colonoscopy|colonoscopy
128292|NCT02495428|Bandage|bandage
128293|NCT02495428|Treadmill|treadmill
128294|NCT02495428|Lactate Acid|lactate acid
128295|NCT02495389|urinary urgency incontinence|urinary urgency incontinence
128296|NCT02495376|YACS|yacs
128297|NCT02495376|cancer|cancer
128298|NCT02495376|MBSR|mbsr
128299|NCT02495311|adenomyosis|adenomyosis
128301|NCT02495311|lower urinary tract symptoms|lower urinary tract symptoms
128302|NCT02495311|sexual dysfunction|sexual dysfunction
128303|NCT02495311|gastrointestinal symptom|gastrointestinal symptom
128304|NCT02495298|Fascial manipulation|fascial manipulation
128305|NCT02495298|Carpal Tunnel Syndrome|carpal tunnel syndrome
128306|NCT02495285|pediatric patients gelatine|pediatric patients gelatine
128307|NCT02495272|Postpartum hemorrhage|postpartum hemorrhage
128308|NCT02495272|Third stage of labour|third stage of labour
128309|NCT02495272|Oxytocin|oxytocin
128310|NCT02495272|Uterotonics|uterotonics
128311|NCT02495272|Active management of third stage of labour|active management of third stage of labour
128312|NCT02495259|Double-lumen endobronchial tube|double-lumen endobronchial tube
128313|NCT02495259|Laryngoscopy|laryngoscopy
128314|NCT02495259|intubating stylet|intubating stylet
128315|NCT02495233|Erlotinib|erlotinib
128316|NCT02495233|ASP2215|asp2215
128317|NCT02495233|NSCLC|nsclc
128318|NCT02495233|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
128319|NCT02495220|dexmedetomidine|dexmedetomidine
128320|NCT02495220|subtenon anesthesia|subtenon anesthesia
128321|NCT02495220|postoperative pain|postoperative pain
128322|NCT02495220|pov|pov
128323|NCT02495194|Promotion of psychological well-being|promotion of psychological well-being
128324|NCT02495194|Horticultural therapy|horticultural therapy
128325|NCT02495194|Randomized Controlled Trial|randomized controlled trial
128326|NCT02495194|Gardening|gardening
128328|NCT02495129|Primary Sjögren's syndrome|primary sjögren's syndrome
128329|NCT02495129|Sicca syndrome|sicca syndrome
128330|NCT02495129|Salivary glands|salivary glands
128331|NCT02495129|Positron Emission Tomography|positron emission tomography
128332|NCT02495129|B cell depletion|b cell depletion
128333|NCT02493920|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
128334|NCT02493920|Delivery Room|delivery room
128335|NCT02493920|Resuscitation|resuscitation
128336|NCT02493920|Premature birth|premature birth
128337|NCT02493920|Infant, Newborn|infant, newborn
128338|NCT02493920|Respiration Artificial|respiration artificial
128339|NCT02493894|Bowel preparation|bowel preparation
128764|NCT02492620|kidney|kidney
128340|NCT02493894|perioperative bleeding|perioperative bleeding
128341|NCT02493894|lumbar fusion|lumbar fusion
128342|NCT02493881|Motor function of the extralaryngeal branches|motor function of the extralaryngeal branches
128343|NCT02493881|intraoperative neuromonitoring|intraoperative neuromonitoring
128344|NCT02493881|recurrent laryngeal nerve|recurrent laryngeal nerve
128345|NCT02493868|Treatment-resistant Depression|treatment-resistant depression
128346|NCT02493868|Esketamine|esketamine
128347|NCT02493868|Placebo|placebo
128348|NCT02493868|Oral Antidepressant|oral antidepressant
128349|NCT02493868|Relapse prevention|relapse prevention
128350|NCT02493855|Treatment naive|treatment naive
128351|NCT02493855|HCV|hcv
128352|NCT02493855|Interferon free|interferon free
128353|NCT02493855|Hepatitis C Genotype 1a|hepatitis c genotype 1a
128354|NCT02493855|Chronic Hepatitis C|chronic hepatitis c
128355|NCT02493855|Hepatitis C|hepatitis c
128356|NCT02493842|Nerve Stimulation|nerve stimulation
128357|NCT02493842|Neuroplasticity|neuroplasticity
128358|NCT02493842|Sensory Feedback|sensory feedback
128359|NCT02493790|cognitive dysfunction|cognitive dysfunction
128360|NCT02493790|Activity of Daily Living|activity of daily living
128361|NCT02493790|interference|interference
128362|NCT02493790|rehabilitation|rehabilitation
128363|NCT02493790|cognitive-motor dual task|cognitive-motor dual task
128364|NCT02493751|Cancer, renal cell cancer, kidney disease, kidney neoplasms, axitinib|cancer, renal cell cancer, kidney disease, kidney neoplasms, axitinib
128365|NCT02495103|Dose-Escalation|dose-escalation
128366|NCT02495103|Maximum Tolerated Dose|maximum tolerated dose
128367|NCT02495103|Safety|safety
128368|NCT02495103|Overall Response|overall response
128369|NCT02495090|Hypospadias|hypospadias
128370|NCT02495090|exome sequencing|exome sequencing
128371|NCT02495090|genital malformation|genital malformation
128372|NCT02495077|Kidney Transplantation|kidney transplantation
128373|NCT02495077|infliximab|infliximab
128374|NCT02495077|Tissue Donors|tissue donors
128375|NCT02495077|Remicade|remicade
128376|NCT02495077|Induction Therapy|induction therapy
128377|NCT02495077|Deceased Donor Kidney Transplant Recipients|deceased donor kidney transplant recipients
128378|NCT02495051|gastroesophageal reflux|gastroesophageal reflux
128379|NCT02495051|barrett esophagus|barrett esophagus
128380|NCT02495038|combination|combination
128381|NCT02495038|rocuronium|rocuronium
128382|NCT02495038|cisatracurium|cisatracurium
128383|NCT02495038|neuromuscular blockade monitoring|neuromuscular blockade monitoring
128384|NCT02495038|drug synergism|drug synergism
128385|NCT02495012|efficacy|efficacy
128386|NCT02495012|safety|safety
128387|NCT02495012|STEMI|stemi
128388|NCT02494999|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
128389|NCT02494999|immunogenicity|immunogenicity
128390|NCT02494999|safety|safety
128391|NCT02494986|Human immunodeficiency virus type 1|human immunodeficiency virus type 1
128392|NCT02494986|Rilpivirine|rilpivirine
128393|NCT02494986|Roll-over study|roll-over study
129131|NCT02489916|CM4307|cm4307
128394|NCT02494960|smoking cessation intervention|smoking cessation intervention
128395|NCT02494947|Coronary Angiography|coronary angiography
128396|NCT02494947|Exercise|exercise
128397|NCT02494921|Metastatic|metastatic
128398|NCT02494921|Castration-Resistant|castration-resistant
128399|NCT02494908|Parkinson Disease|parkinson disease
128400|NCT02494908|MRI|mri
128401|NCT02494882|Ruxolitinib|ruxolitinib
128402|NCT02494882|Dasatinib|dasatinib
128403|NCT02494882|Dexamethasone|dexamethasone
128404|NCT02494882|14-272|14-272
128405|NCT02494869|Aerobic Training|aerobic training
128406|NCT02494869|Exercise|exercise
128407|NCT02494869|Gene Expression|gene expression
128408|NCT02494869|15-093|15-093
128409|NCT02494856|Naproxen|naproxen
128410|NCT02494856|Lower third molar|lower third molar
128411|NCT02494856|Oral Surgery|oral surgery
128412|NCT02494856|Esomeprazole|esomeprazole
128413|NCT02494830|Anesthetic Drugs|anesthetic drugs
128414|NCT02494817|HIV prevention|hiv prevention
128415|NCT02494817|Toolkit|toolkit
128416|NCT02494817|Male couples|male couples
128417|NCT02494817|Sexual agreements|sexual agreements
128418|NCT02494804|Cytokine-Induced Killer Cells|cytokine-induced killer cells
128419|NCT02494804|Milignant Gliomas|milignant gliomas
128420|NCT02494804|Temozolomide|temozolomide
128421|NCT02494765|I-gelTM|i-geltm
128422|NCT02494765|Ambu® AuraOnceTM|ambu® auraoncetm
128423|NCT02494765|supraglottic devices|supraglottic devices
128424|NCT02494765|laryngeal mask effects on airway|laryngeal mask effects on airway
128527|NCT02494362|Therapeutic gaming|therapeutic gaming
128432|NCT02494739|polyphenols|polyphenols
128433|NCT02494739|yogurt|yogurt
128434|NCT02494726|Ischemic stroke|ischemic stroke
128435|NCT02494726|ICH stroke|ich stroke
128436|NCT02494726|TEG|teg
128437|NCT02494726|Thromboelastography|thromboelastography
128438|NCT02494726|Stroke|stroke
652722|NCT00794924|elderly|elderly
128439|NCT02494713|Advanced Prostate Cancer|advanced prostate cancer
128440|NCT02494713|Neoadjuvant|neoadjuvant
128441|NCT02494713|Hormone therapy|hormone therapy
128442|NCT02494713|ADT|adt
128443|NCT02494713|Androgen Deprivation Therapy|androgen deprivation therapy
128765|NCT02492607|Women|women
128444|NCT02494713|Chemotherapy|chemotherapy
128445|NCT02494713|Radical Prostatectomy|radical prostatectomy
128446|NCT02494700|Lymphoma|lymphoma
128447|NCT02494700|Low grade B lymphocyte (B cell) lymphoma|low grade b lymphocyte (b cell) lymphoma
128448|NCT02494700|Mantle cell lymphoma involving the ocular adnexa|mantle cell lymphoma involving the ocular adnexa
128449|NCT02494700|Limited and advanced stage|limited and advanced stage
128450|NCT02494700|Ocular adnexa|ocular adnexa
128451|NCT02494700|Radiation therapy|radiation therapy
128452|NCT02494700|XRT|xrt
128453|NCT02494661|Public Health|public health
128454|NCT02494661|Community|community
128455|NCT02494661|Obesity|obesity
128456|NCT02494661|Hispanic|hispanic
128457|NCT02494661|Women|women
128458|NCT02494661|Nutrition|nutrition
128459|NCT02494661|Mindfulness and stress|mindfulness and stress
128460|NCT02494661|Food shopping|food shopping
128461|NCT02494648|Obstructive sleep apnea|obstructive sleep apnea
128462|NCT02494648|Resistive inspiratory muscle training|resistive inspiratory muscle training
128463|NCT02494648|Coronary artery disease|coronary artery disease
128464|NCT02494648|Cardiac rehabilitation|cardiac rehabilitation
128473|NCT02494544|knee implant|knee implant
128474|NCT02494544|knee replacement|knee replacement
128475|NCT02494544|total knee replacement|total knee replacement
128476|NCT02494531|Alzheimer Disease|alzheimer disease
128477|NCT02494531|PET|pet
128478|NCT02494531|diagnosis|diagnosis
128479|NCT02494531|MCI|mci
128480|NCT02494531|illiterate|illiterate
128481|NCT02494518|stroke|stroke
128482|NCT02494518|aerobic exercise|aerobic exercise
128483|NCT02494518|forced exercise|forced exercise
128484|NCT02494518|repetitive task practice|repetitive task practice
128485|NCT02494518|arm function|arm function
128486|NCT02494518|upper extremity|upper extremity
128487|NCT02494505|chronic inflammatory demyelinating polyradiculopathy|chronic inflammatory demyelinating polyradiculopathy
128488|NCT02494505|intravenous immunoglobulin (IVIG)|intravenous immunoglobulin (ivig)
128489|NCT02494505|withdrawal|withdrawal
128490|NCT02494505|quality of life|quality of life
128491|NCT02494505|Clinical trial|clinical trial
128492|NCT02494505|cost|cost
128493|NCT02494492|Uveitis|uveitis
128494|NCT02494492|Lymphocyte cells|lymphocyte cells
128495|NCT02494492|lymphocyte T regulator|lymphocyte t regulator
128496|NCT02494492|vitreous haze|vitreous haze
128497|NCT02494492|intravitreal injection|intravitreal injection
128498|NCT02494479|Psoriasis|psoriasis
128499|NCT02494479|Topical Psoriasis|topical psoriasis
128500|NCT02494479|Mild Psoriasis|mild psoriasis
128501|NCT02494479|Moderate Psoriasis|moderate psoriasis
128502|NCT02494479|Active Psoriasis|active psoriasis
128503|NCT02494479|Plaque Psoriasis|plaque psoriasis
128504|NCT02494479|Skin Diseases|skin diseases
128505|NCT02494466|Airway Resistance|airway resistance
128506|NCT02494466|montelukast sodium|montelukast sodium
128507|NCT02494466|laryngeal mask airway|laryngeal mask airway
128508|NCT02494427|Crowns|crowns
128514|NCT02494401|systemic sclerosis|systemic sclerosis
128515|NCT02494401|ssc|ssc
128516|NCT02494375|Sleep|sleep
128517|NCT02494375|glycemic control|glycemic control
128518|NCT02494375|type 1 diabetes|type 1 diabetes
128519|NCT02494375|amylase|amylase
128520|NCT02494375|body composition|body composition
128521|NCT02494375|lean|lean
128522|NCT02494375|overweight|overweight
128523|NCT02494375|obese|obese
128524|NCT02494362|Hand exercises|hand exercises
128525|NCT02494362|Hand function|hand function
128526|NCT02494362|Computer based exercises|computer based exercises
128528|NCT02494349|α1-blockers|α1-blockers
128529|NCT02494349|antimuscarinic agent|antimuscarinic agent
128530|NCT02494323|Dual Channel Functional Electrical Stimulation|dual channel functional electrical stimulation
128531|NCT02494323|dropfoot, balanced dorsiflexion|dropfoot, balanced dorsiflexion
128532|NCT02494284|Coronary artery disease|coronary artery disease
128533|NCT02494284|Dual antiplatelet platelet therapy|dual antiplatelet platelet therapy
128534|NCT02494284|Drug eluting stent|drug eluting stent
128535|NCT02494258|CC-486|cc-486
128536|NCT02494258|Oral Azacitidine|oral azacitidine
128537|NCT02494258|Solid tumors|solid tumors
128538|NCT02494258|hematological disorders|hematological disorders
128539|NCT02494258|rollover study|rollover study
128540|NCT02494245|Rehabilitation|rehabilitation
128541|NCT02494245|Intervention|intervention
128542|NCT02494245|Walking|walking
128543|NCT02494232|minor blunt thoracic trauma|minor blunt thoracic trauma
128544|NCT02494232|physical examination|physical examination
154765|NCT02344290|HIV|hiv
128545|NCT02494219|Group A streptococcal pharyngitis|group a streptococcal pharyngitis
652723|NCT00794924|motility|motility
128546|NCT02494219|Rapid streptococcal test|rapid streptococcal test
128547|NCT02494219|Throat swab culture|throat swab culture
128548|NCT02494206|QBX258|qbx258
128549|NCT02494206|human monoclonal antibodies|human monoclonal antibodies
128550|NCT02494206|VAK694|vak694
128551|NCT02494206|QAX576|qax576
128552|NCT02494206|15-085|15-085
128553|NCT02494180|fentanyl|fentanyl
128554|NCT02494180|midazolam|midazolam
128555|NCT02494180|pethidine|pethidine
128556|NCT02494180|diazepam|diazepam
128557|NCT02494167|Acute Myeloid Leukemia|acute myeloid leukemia
128558|NCT02494167|Myelodysplastic Syndrome|myelodysplastic syndrome
128559|NCT02494167|MultiTAA Specific T cells|multitaa specific t cells
128560|NCT02494128|Child health service|child health service
128561|NCT02494128|Family health|family health
128562|NCT02494128|Nurse|nurse
128563|NCT02494128|Education|education
128564|NCT02494128|Parental group|parental group
128565|NCT02494128|Group leadership|group leadership
128566|NCT02494128|Health promotion|health promotion
128567|NCT02494102|Obstructive Sleep Apnea|obstructive sleep apnea
128568|NCT02494102|General Anesthesia|general anesthesia
128569|NCT02494102|Modafinil|modafinil
128570|NCT02494089|in situ simulation|in situ simulation
128571|NCT02494089|in hospital cardiac arrest|in hospital cardiac arrest
128572|NCT02494089|clinical audit|clinical audit
128573|NCT02494089|education|education
128574|NCT02494089|patient simulation|patient simulation
128575|NCT02493673|Continuous Positive Airway Pressure|continuous positive airway pressure
128576|NCT02493673|Stroke|stroke
128577|NCT02493673|Cerebrovascular reactivity|cerebrovascular reactivity
128578|NCT02493673|Brain oxygenation|brain oxygenation
128579|NCT02493660|Massive Rotator Cuff Tear|massive rotator cuff tear
128580|NCT02493660|Arthroscopy|arthroscopy
128581|NCT02493660|Shoulder Joint|shoulder joint
128582|NCT02493660|Rotator cuff partial repair|rotator cuff partial repair
128583|NCT02493634|Magnetic Resonance spectroscopy|magnetic resonance spectroscopy
128584|NCT02493634|Aortic Arch|aortic arch
128585|NCT02493621|Pain, Postoperative|pain, postoperative
128586|NCT02493621|Nerve Block|nerve block
128587|NCT02493621|Anesthesia, Epidural|anesthesia, epidural
128589|NCT02493582|Apatinib|apatinib
128590|NCT02493582|Lung Adenocarcinoma|lung adenocarcinoma
128591|NCT02493569|Breast cancer, hospital, epidemiology, diagnosis, treatment|breast cancer, hospital, epidemiology, diagnosis, treatment
128592|NCT02493556|Phototherapy|phototherapy
128593|NCT02493556|Plyometric exercise|plyometric exercise
128594|NCT02493556|Muscle recovery|muscle recovery
128595|NCT02493543|autoantibodies|autoantibodies
128596|NCT02493530|MDS/MPN|mds/mpn
128597|NCT02493504|Heparin|heparin
128598|NCT02493491|dysphonia|dysphonia
128599|NCT02493491|dysphagia|dysphagia
128600|NCT02493491|neurogenic|neurogenic
128601|NCT02493491|vocal fold augmentation|vocal fold augmentation
128602|NCT02493491|VFA|vfa
128603|NCT02493491|vocal fold insufficiency|vocal fold insufficiency
128604|NCT02493491|Prolaryn|prolaryn
128605|NCT02493491|Radiesse|radiesse
128606|NCT02493491|Coaptite|coaptite
128607|NCT02493491|voice|voice
128608|NCT02493491|Parkinson's Disease|parkinson's disease
128609|NCT02493491|Multiple Sclerosis|multiple sclerosis
128610|NCT02493491|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
128611|NCT02493491|ALS|als
128612|NCT02493491|MS|ms
128613|NCT02493491|calcium hydroxylapatite|calcium hydroxylapatite
128614|NCT02493491|hyaluronic acid|hyaluronic acid
128615|NCT02493478|Intubation|intubation
128616|NCT02493478|Advanced airway intervention|advanced airway intervention
128617|NCT02493478|Intensive care unit|intensive care unit
128618|NCT02493465|everolimus|everolimus
128619|NCT02493465|left ventricular hypertrophy|left ventricular hypertrophy
128620|NCT02493439|Best Possible Self|best possible self
128621|NCT02493439|Positive Psychology|positive psychology
128622|NCT02493439|Romanian Immigrants|romanian immigrants
128623|NCT02493439|Optimism|optimism
128624|NCT02493439|Future Thinking|future thinking
128625|NCT02493413|psychoneuroimmunology|psychoneuroimmunology
128626|NCT02493413|stress|stress
128627|NCT02493413|lymphocyte population|lymphocyte population
128628|NCT02493413|personality type|personality type
128629|NCT02493413|obesity|obesity
128630|NCT02493413|heart rate variability|heart rate variability
128631|NCT02493413|awareness|awareness
128632|NCT02493400|Follow up|follow up
128633|NCT02493400|Exercise|exercise
128634|NCT02493400|Rehabilitation|rehabilitation
128635|NCT02493387|Physiotherapist led group-based exercise|physiotherapist led group-based exercise
128636|NCT02493387|Physical activity|physical activity
128637|NCT02493387|Atrial fibrillation|atrial fibrillation
128638|NCT02493348|Fibromyalgia|fibromyalgia
128639|NCT02493348|Rhythmic Sensory Stimulation|rhythmic sensory stimulation
128640|NCT02493348|Gamma Stimulation|gamma stimulation
128641|NCT02493283|dapsone|dapsone
128642|NCT02493283|blood leucocytes|blood leucocytes
119807|NCT02546674|MR4.5|mr4.5
128643|NCT02493283|pharmacokinetics|pharmacokinetics
128644|NCT02493283|metabolism|metabolism
128645|NCT02493270|smoking cessation|smoking cessation
128646|NCT02493270|tobacco|tobacco
128647|NCT02493270|dental|dental
128648|NCT02493270|periodontal|periodontal
128649|NCT02493257|nonallergic irritant rhinitis|nonallergic irritant rhinitis
128650|NCT02493257|nasal congestion|nasal congestion
128651|NCT02493257|rhinorrhea|rhinorrhea
128652|NCT02493218|mindfulness|mindfulness
128653|NCT02493218|intervention|intervention
128654|NCT02493218|african american|african american
128655|NCT02493218|youth|youth
128656|NCT02493218|stress|stress
128657|NCT02493218|poverty|poverty
128766|NCT02492607|DCIS|dcis
128658|NCT02493205|Implantable Cardiac Monitor|implantable cardiac monitor
128659|NCT02493205|Stent|stent
128660|NCT02493192|Parturition|parturition
128661|NCT02493192|Humanizing Deliver|humanizing deliver
128662|NCT02493192|Labor Pain|labor pain
128663|NCT02493192|Natural Childbirth|natural childbirth
128664|NCT02493192|Labor Onset|labor onset
128665|NCT02493192|First Labor Stage|first labor stage
128666|NCT02493192|Birth ball|birth ball
128667|NCT02493192|meperidine|meperidine
128668|NCT02493192|pethidine|pethidine
128669|NCT02493140|Weight management|weight management
128670|NCT02493140|cashew apple extract|cashew apple extract
128671|NCT02493140|overweight|overweight
128672|NCT02493101|Periostin staining|periostin staining
128673|NCT02493101|Urine periostin level|urine periostin level
128674|NCT02493101|Lupus nephritis|lupus nephritis
128675|NCT02493101|IgA nephropathy|iga nephropathy
128676|NCT02493075|atrial fibrillation|atrial fibrillation
128677|NCT02493075|Catheter Ablation|catheter ablation
128678|NCT02493075|contact force|contact force
128679|NCT02493075|Chinese-specific|chinese-specific
128680|NCT02493062|Hysterotomy|hysterotomy
128681|NCT02493062|Myelomeningocele|myelomeningocele
128682|NCT02493062|Open fetal surgery|open fetal surgery
128683|NCT02493062|Sonohysterogram|sonohysterogram
128684|NCT02493049|Multiple Sclerosis|multiple sclerosis
128685|NCT02493049|Domperidone|domperidone
128686|NCT02493049|Relapsing-Remitting MS|relapsing-remitting ms
128687|NCT02493049|Demyelinating disease|demyelinating disease
128688|NCT02493049|Remyelination|remyelination
128689|NCT02493023|Bronchoscopy|bronchoscopy
128690|NCT02493023|Bronchoscopes|bronchoscopes
128691|NCT02493010|Virtual Reality Exposure Therapy|virtual reality exposure therapy
128692|NCT02493010|Computerized Cognitive Behavioral Therapy|computerized cognitive behavioral therapy
128693|NCT02493010|Public Speaking|public speaking
128694|NCT02493010|Social Phobia|social phobia
128695|NCT02493010|Biofeedback|biofeedback
128696|NCT02492997|body fat|body fat
128697|NCT02492984|FVIII inhibitor|fviii inhibitor
128698|NCT02492971|Assistive technology|assistive technology
128699|NCT02492971|functional needs|functional needs
128700|NCT02492971|system usability|system usability
128701|NCT02492945|Tennis elbow|tennis elbow
128702|NCT02492945|Polydeoxyribonucleotides|polydeoxyribonucleotides
128703|NCT02492945|Prolotherapy|prolotherapy
128704|NCT02492945|Randomized controlled trial|randomized controlled trial
128705|NCT02492945|Visual analogue scale|visual analogue scale
128706|NCT02492945|disability|disability
128707|NCT02492945|ultrasonography|ultrasonography
128708|NCT02492919|cardiac surgery|cardiac surgery
128709|NCT02492919|risk factors|risk factors
128710|NCT02492919|infection|infection
128711|NCT02492880|stimulation|stimulation
128712|NCT02492880|implantable|implantable
128713|NCT02492880|pulse generator|pulse generator
128714|NCT02492880|back pain|back pain
128715|NCT02492880|chronic pain|chronic pain
128716|NCT02492880|leg pain|leg pain
128717|NCT02492854|Lower Extremity Bypass|lower extremity bypass
128718|NCT02492854|Surgical Site Infection|surgical site infection
128719|NCT02492854|Wound Dressing|wound dressing
128720|NCT02492854|Negative Pressure Wound Dressing|negative pressure wound dressing
128721|NCT02492841|dentin substitute|dentin substitute
128722|NCT02492841|vital pulp therapy|vital pulp therapy
128723|NCT02492841|Biodentine|biodentine
128724|NCT02492841|caries|caries
128725|NCT02492789|immunotherapy|immunotherapy
128726|NCT02492789|solid tumor|solid tumor
128727|NCT02492789|PD-1 blockade|pd-1 blockade
128728|NCT02492776|Volunteers|volunteers
128729|NCT02492737|acute myeloid leukemia|acute myeloid leukemia
128730|NCT02492737|AML|aml
128735|NCT02492737|AITL|aitl
128736|NCT02492737|hematologic malignancies|hematologic malignancies
128737|NCT02492737|IDH1|idh1
128738|NCT02492737|IDH2|idh2
128739|NCT02492737|AG-881|ag-881
128740|NCT02492724|cervical spine|cervical spine
128741|NCT02492724|total disc replacement (cTDR)|total disc replacement (ctdr)
128742|NCT02492724|degenerative disc disease|degenerative disc disease
128743|NCT02492724|activ® C|activ® c
128744|NCT02492724|clinical outcome|clinical outcome
128745|NCT02492724|long-term results|long-term results
128747|NCT02492724|VAS|vas
128748|NCT02492724|heterotopic ossification (HO)|heterotopic ossification (ho)
119959|NCT02545699|CRC|crc
128749|NCT02492724|range of motion (ROM)|range of motion (rom)
128750|NCT02492724|adjacent segment degeneration|adjacent segment degeneration
128751|NCT02492698|Probiotic|probiotic
128752|NCT02492698|Weight loss|weight loss
128753|NCT02492698|Lp-PLA2|lp-pla2
128754|NCT02492685|Quantitative analysis|quantitative analysis
128755|NCT02492685|contrast enhanced endoscopic ultrasonography|contrast enhanced endoscopic ultrasonography
128756|NCT02492659|femtosecond laser|femtosecond laser
128757|NCT02492633|Smoking cessation|smoking cessation
128758|NCT02492633|Smoke-free housing|smoke-free housing
128759|NCT02492633|Affordable housing|affordable housing
128760|NCT02492633|Second-hand smoke|second-hand smoke
128761|NCT02492633|Tobacco control|tobacco control
128762|NCT02492620|ferric citrate|ferric citrate
128763|NCT02492620|phosphate|phosphate
128767|NCT02492607|Active surveillance|active surveillance
128768|NCT02492607|Standard treatment|standard treatment
128769|NCT02492581|Selincro|selincro
128770|NCT02492581|cohort|cohort
128771|NCT02492581|real-life|real-life
128772|NCT02492581|total alcohol consumption|total alcohol consumption
128773|NCT02492581|heavy drinking days|heavy drinking days
128774|NCT02492581|clinical global impression-severity|clinical global impression-severity
128775|NCT02492581|EQ5D|eq5d
128776|NCT02492581|AQoLS|aqols
128777|NCT02492581|Sheehan disability scale|sheehan disability scale
128778|NCT02492568|recurrent|recurrent
128779|NCT02492568|NSCLC|nsclc
128780|NCT02492568|pembrolizumab|pembrolizumab
128781|NCT02492568|SBRT|sbrt
128782|NCT02492555|IBD|ibd
128783|NCT02492555|Telemedicine|telemedicine
128784|NCT02492555|At-home monitoring|at-home monitoring
128785|NCT02492555|Disease activity|disease activity
128786|NCT02492555|fecal calprotectin|fecal calprotectin
128787|NCT02492542|electrical stimulation|electrical stimulation
128788|NCT02492542|urinary incontinence|urinary incontinence
128789|NCT02492529|Alzheimer, Recognition Memory, Mild Cognitive Impairment, fMRI|alzheimer, recognition memory, mild cognitive impairment, fmri
128790|NCT02492516|adipose tissue mesenchymal stem cell intravenous injection ALS|adipose tissue mesenchymal stem cell intravenous injection als
128791|NCT02492503|recurrent or metastatic carcinoma cervix chemotherapy|recurrent or metastatic carcinoma cervix chemotherapy
128792|NCT02492490|Kidney transplantation|kidney transplantation
128793|NCT02492490|DCD|dcd
128794|NCT02492490|Stromal Vascular Fraction|stromal vascular fraction
128795|NCT02492490|MSC|msc
128796|NCT02492451|intrauterine insemination|intrauterine insemination
128797|NCT02492451|pregnancy rate|pregnancy rate
128798|NCT02492451|endometrial injury|endometrial injury
128799|NCT02492438|pneumococcal vaccination|pneumococcal vaccination
128800|NCT02492438|dialysis|dialysis
128801|NCT02492438|immune response|immune response
128802|NCT02492425|Community Acquired Pneumonia|community acquired pneumonia
128803|NCT02492425|Healthcare Associated Pneumonia|healthcare associated pneumonia
128804|NCT02492399|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
128805|NCT02492399|mitral valve|mitral valve
128806|NCT02492399|SAM syndrome|sam syndrome
128807|NCT02492386|bioabsorbable vascular scaffold|bioabsorbable vascular scaffold
128808|NCT02492386|erectile dysfunction|erectile dysfunction
128809|NCT02492373|Post inflammatory hyperpigmentation|post inflammatory hyperpigmentation
128810|NCT02492373|topical high potency steroid|topical high potency steroid
128811|NCT02492373|Qs NdYAG laser|qs ndyag laser
128816|NCT02492308|kidney|kidney
128817|NCT02492308|transplantation|transplantation
128818|NCT02492308|MSC|msc
128819|NCT02492217|Ankylosing Spondylitis|ankylosing spondylitis
128820|NCT02492217|adalimumab|adalimumab
128821|NCT02492217|TNF-alpha agents|tnf-alpha agents
128822|NCT02492217|spondyloarthritis|spondyloarthritis
128823|NCT02492217|biologic therapies|biologic therapies
128824|NCT02492217|AS|as
128825|NCT02492217|biomarkers|biomarkers
128826|NCT02492217|efficacy prediction|efficacy prediction
128827|NCT02492191|Smart Phones|smart phones
128828|NCT02492191|Ambulatory Care|ambulatory care
128929|NCT02491632|Advanced Cancers|advanced cancers
128829|NCT02492191|Outcome and Process Assessment|outcome and process assessment
128830|NCT02492165|Japanese Encephalitis|japanese encephalitis
128831|NCT02492165|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
128832|NCT02492165|IMOJEV®|imojev®
128833|NCT02492165|Live attenuated vaccine|live attenuated vaccine
128834|NCT02492152|women|women
128835|NCT02492152|active labor|active labor
128836|NCT02492126|Chronic Cough|chronic cough
128837|NCT02492126|Gastroesophageal Reflux|gastroesophageal reflux
128838|NCT02492126|Esophageal Motility|esophageal motility
128839|NCT02492126|Cough Sensitivity|cough sensitivity
128840|NCT02492113|Mechanical ventilation|mechanical ventilation
128841|NCT02492113|Positive end-expiratory pressure|positive end-expiratory pressure
128842|NCT02492113|Work of breathing|work of breathing
128843|NCT02492113|Morbidly obese|morbidly obese
402921|NCT01229150|Non-Small Cell Lung Cancer|non-small cell lung cancer
119993|NCT02545491|Child development|child development
119994|NCT02545491|daycare|daycare
128844|NCT02492100|Sexual Dysfunction Post-Bone Marrow Transplant|sexual dysfunction post-bone marrow transplant
128845|NCT02492087|topical|topical
128846|NCT02492087|tranexamic acid|tranexamic acid
128847|NCT02492087|haemostasis|haemostasis
128848|NCT02492087|caesarean section|caesarean section
128849|NCT02492087|bleeding|bleeding
128850|NCT02492087|postpartum hemorrhage|postpartum hemorrhage
128851|NCT02492087|prophylactic|prophylactic
128852|NCT02492074|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
128853|NCT02492074|cannabidiol|cannabidiol
128854|NCT02492074|COMT|comt
128855|NCT02492061|couples' HCT married couples|couples' hct married couples
128856|NCT02492061|Rakai|rakai
128857|NCT02492061|Uganda|uganda
128858|NCT02492035|Hypertension|hypertension
128859|NCT02492035|lifestyle|lifestyle
128860|NCT02492035|clinical trials|clinical trials
128861|NCT02492035|primary care setting|primary care setting
128862|NCT02491996|desire model|desire model
128863|NCT02491983|metastatic breast cancer|metastatic breast cancer
128864|NCT02491983|Endocrine receptors positive|endocrine receptors positive
128865|NCT02491983|HER-2 negative|her-2 negative
128866|NCT02491957|Energy Expenditure|energy expenditure
128867|NCT02491957|Physical Endurance|physical endurance
128868|NCT02491957|Muscle Stength|muscle stength
128869|NCT02491957|Metabolism|metabolism
128870|NCT02491931|Cardiac Surgical Procedures|cardiac surgical procedures
128871|NCT02491931|Cardiovascular Surgical Procedures|cardiovascular surgical procedures
128872|NCT02491931|Dietary Supplements|dietary supplements
128873|NCT02491931|Glutamine|glutamine
128874|NCT02491931|TROPONIN I|troponin i
128875|NCT02491931|cardiopulmonary bypass|cardiopulmonary bypass
128876|NCT02491879|mechanical low back pain|mechanical low back pain
128877|NCT02491879|emergency department|emergency department
128878|NCT02491879|ketoprofen|ketoprofen
128880|NCT02491840|gastric cancer|gastric cancer
128881|NCT02491840|cardia cancer|cardia cancer
128882|NCT02491827|optical biopsy|optical biopsy
128883|NCT02491814|Dairy|dairy
128884|NCT02491814|Breakfast cereal|breakfast cereal
128885|NCT02491814|Postprandial Glycemia|postprandial glycemia
128886|NCT02491814|Satiety|satiety
128887|NCT02491814|Food Intake|food intake
128888|NCT02491814|Milk|milk
128889|NCT02491814|Yogurt|yogurt
128890|NCT02491814|Soy|soy
128891|NCT02491814|Almond|almond
128892|NCT02491801|Dairy|dairy
128893|NCT02491801|Milk|milk
128894|NCT02491801|Yogurt|yogurt
128895|NCT02491801|Cheese|cheese
128896|NCT02491801|Postprandial glycaemia|postprandial glycaemia
128897|NCT02491801|Satiety|satiety
128898|NCT02491801|Food Intake|food intake
128899|NCT02491801|Elderly|elderly
128900|NCT02491801|Prevention and Treatment|prevention and treatment
128901|NCT02491762|Serratus Anterior|serratus anterior
128902|NCT02491762|Accessory Respiratory|accessory respiratory
128903|NCT02491762|Tissue Expander|tissue expander
128904|NCT02491762|Respiratory Function Tests|respiratory function tests
128905|NCT02491749|Cardiac anesthesia|cardiac anesthesia
128906|NCT02491749|ultra fast track|ultra fast track
128907|NCT02491749|ICU stay|icu stay
128908|NCT02491710|Surgical education|surgical education
128909|NCT02491710|Laparoscopy|laparoscopy
128910|NCT02491710|Laparoscopic suturing|laparoscopic suturing
128911|NCT02491697|DC-CIK|dc-cik
128912|NCT02491697|Breast cancer|breast cancer
128913|NCT02491697|Capecitabine|capecitabine
128914|NCT02491684|asthma|asthma
128915|NCT02491684|Upper Respiratory Tract Infection|upper respiratory tract infection
128916|NCT02491684|exacerbation|exacerbation
128917|NCT02491684|Interferon|interferon
128918|NCT02491684|efficacy|efficacy
128922|NCT02491671|Lung Resection|lung resection
128923|NCT02491671|Thoracic Surgery|thoracic surgery
128924|NCT02491671|Post-operative Thoracic Air Leak|post-operative thoracic air leak
128925|NCT02491645|Autistic spectrum disorder|autistic spectrum disorder
128926|NCT02491645|Sensory processing abnormalities|sensory processing abnormalities
128927|NCT02491645|Sensory interventions|sensory interventions
128928|NCT02491645|occupational therapy|occupational therapy
130128|NCT02484209|diabetes|diabetes
128930|NCT02491632|Dexamethasone|dexamethasone
128931|NCT02491632|Decadron|decadron
128932|NCT02491632|Exercise|exercise
128933|NCT02491632|Physical activity|physical activity
128934|NCT02491632|Questionnaires|questionnaires
128935|NCT02491632|Surveys|surveys
128936|NCT02491632|Physical activity tests|physical activity tests
128937|NCT02491632|Phone calls|phone calls
128938|NCT02491619|Angle class III|angle class iii
128939|NCT02491619|tomography|tomography
128940|NCT02491619|tooth inclination|tooth inclination
128941|NCT02491619|bone thickness|bone thickness
128942|NCT02491593|fecal occult blood|fecal occult blood
128943|NCT02491554|Deep Brain Stimulation|deep brain stimulation
128944|NCT02491554|Essential tremor|essential tremor
128945|NCT02491554|DISTINCT|distinct
128946|NCT02491554|MR-tractography guided DBS implantation|mr-tractography guided dbs implantation
128947|NCT02491554|Conventional AC-PC based DBS implantation|conventional ac-pc based dbs implantation
128948|NCT02491515|Osteoporosis|osteoporosis
128949|NCT02491515|BMD|bmd
128950|NCT02491515|denosumab|denosumab
128951|NCT02491515|previous therapy|previous therapy
128952|NCT02491489|Manual therapy|manual therapy
128953|NCT02491476|Safety|safety
128954|NCT02491476|Electrodes|electrodes
128955|NCT02491476|Device|device
128956|NCT02491476|StereoElectroencephalograph|stereoelectroencephalograph
128957|NCT02491476|Epileptogenic zone|epileptogenic zone
128958|NCT02491476|Fast ripples|fast ripples
128959|NCT02491463|Reactogenicity|reactogenicity
128960|NCT02491463|Safety|safety
128961|NCT02491463|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
128962|NCT02491463|Vaccine|vaccine
128963|NCT02491463|Immunogenicity|immunogenicity
128964|NCT02491424|Osseointegration|osseointegration
128965|NCT02491424|Direct skeletal attachment|direct skeletal attachment
128966|NCT02491385|Thoracic epidural analgesia|thoracic epidural analgesia
128967|NCT02491385|bowel function recovery|bowel function recovery
128968|NCT02491333|polycystic ovary syndrome|polycystic ovary syndrome
128969|NCT02491333|acupuncture|acupuncture
128970|NCT02491333|insulin resistance|insulin resistance
128971|NCT02491333|HOMA-IR|homa-ir
128972|NCT02491333|metformin|metformin
128973|NCT02491320|polycystic ovary syndrome|polycystic ovary syndrome
128974|NCT02491320|acupuncture|acupuncture
128975|NCT02491320|pre-treatment|pre-treatment
128976|NCT02491320|Letrozole|letrozole
128977|NCT02491320|Live Birth|live birth
128978|NCT02491294|School|school
128979|NCT02491294|Family|family
128980|NCT02491294|Fruit and Vegetables|fruit and vegetables
128981|NCT02491294|Cooking|cooking
128982|NCT02491294|Physical Activity|physical activity
128983|NCT02491281|Primary Osteoarthritis, Total Knee Replacement, cartilage|primary osteoarthritis, total knee replacement, cartilage
128984|NCT02491242|HIV|hiv
128985|NCT02491242|dolutegravir|dolutegravir
128986|NCT02491242|intolerance|intolerance
128987|NCT02491242|dual therapies|dual therapies
128988|NCT02491229|non-alcoholic fatty liver disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
128989|NCT02491229|Obesity|obesity
128990|NCT02491229|Hepafast|hepafast
128991|NCT02491216|Frailty|frailty
128992|NCT02491216|Frail elderly|frail elderly
128993|NCT02491216|Acupressure|acupressure
128994|NCT02491216|Pragmatic Randomised Controlled Trial|pragmatic randomised controlled trial
128995|NCT02491203|Virtual reality|virtual reality
128996|NCT02491203|telerehabilitation|telerehabilitation
128997|NCT02491203|Stroke rehabilitation|stroke rehabilitation
128998|NCT02491177|HIV Transmission|hiv transmission
128999|NCT02491177|Prevention of Mother to Child Transmission|prevention of mother to child transmission
129000|NCT02491177|Linkage to care|linkage to care
129001|NCT02491177|Retention in care|retention in care
129002|NCT02491177|Community Mentor Mothers|community mentor mothers
129003|NCT02491177|Mobile phone text messaging|mobile phone text messaging
129004|NCT02491177|Antiretroviral therapy adherence|antiretroviral therapy adherence
129005|NCT02491177|Infant Health|infant health
129006|NCT02491177|Maternal CD4/viral loads|maternal cd4/viral loads
129007|NCT02491177|Early infant diagnosis|early infant diagnosis
129008|NCT02491177|Acceptability of interventions|acceptability of interventions
129009|NCT02491177|Vertical transmission|vertical transmission
129010|NCT02491138|participants|participants
129011|NCT02491086|intervention, nicotine replacement sampling, smoking cessation, smoking hotspots|intervention, nicotine replacement sampling, smoking cessation, smoking hotspots
129013|NCT02491034|Hispanics|hispanics
129014|NCT02491034|Stigma|stigma
129015|NCT02491034|Barriers to Treatment|barriers to treatment
129016|NCT02491008|Thyroid Dysfunction|thyroid dysfunction
129017|NCT02491008|Bone mineral density|bone mineral density
129018|NCT02491008|Osteoporosis|osteoporosis
129019|NCT02491008|Fractures, Bone|fractures, bone
129020|NCT02491008|Randomized Controlled Trial|randomized controlled trial
129021|NCT02490995|children|children
129022|NCT02490969|copeptin|copeptin
129023|NCT02490969|rule out marker, emergency department, cheast pain unit|rule out marker, emergency department, cheast pain unit
129024|NCT02490969|emergency department|emergency department
129025|NCT02490969|chest pain unit|chest pain unit
129227|NCT02489305|Observational|observational
129026|NCT02490956|Diagnostic immunization with rabies vaccine|diagnostic immunization with rabies vaccine
129027|NCT02490956|Primary immunodeficiency|primary immunodeficiency
129028|NCT02490943|peginterferon beta-1a|peginterferon beta-1a
129029|NCT02490943|MS (Multiple Sclerosis)|ms (multiple sclerosis)
129030|NCT02490943|Injection Site Reaction Erythema|injection site reaction erythema
129031|NCT02490930|lymphopenia|lymphopenia
129032|NCT02490917|Female urinary incontinence|female urinary incontinence
129033|NCT02490917|Sphincter deficiency|sphincter deficiency
129034|NCT02490904|Kidney transplantation|kidney transplantation
129035|NCT02490904|Eplerenon|eplerenon
129036|NCT02490891|Lymphoma, angiogenesis, PET scan|lymphoma, angiogenesis, pet scan
129037|NCT02490839|Helicobacter pylori|helicobacter pylori
129038|NCT02490839|high dose dual therapy|high dose dual therapy
129039|NCT02490839|bismuth-containing quadruple therapy|bismuth-containing quadruple therapy
129040|NCT02490839|antibiotic resistance|antibiotic resistance
652724|NCT00794924|diarrhea|diarrhea
129041|NCT02490826|Speech Sound Disorders|speech sound disorders
129042|NCT02490826|Tabletop|tabletop
129043|NCT02490826|Digital|digital
129044|NCT02490813|Fish allergy|fish allergy
129045|NCT02490813|shrimp allergy|shrimp allergy
129046|NCT02490813|crab allergy|crab allergy
129047|NCT02490813|traditional Chinese medicine|traditional chinese medicine
129048|NCT02490761|Geriatrics|geriatrics
129049|NCT02490761|Nutritional Status|nutritional status
129050|NCT02490761|Hospitalisation|hospitalisation
129051|NCT02490722|Patient education|patient education
129052|NCT02490722|Empowerment|empowerment
129053|NCT02490709|Rectal neoplasms|rectal neoplasms
129054|NCT02490709|Colorectal neoplasms|colorectal neoplasms
129055|NCT02490709|Local excision|local excision
129056|NCT02490696|PET scan|pet scan
129057|NCT02490696|FAZA|faza
129058|NCT02490696|F-Miso|f-miso
129059|NCT02490696|hypoxia|hypoxia
129060|NCT02490696|lung cancer|lung cancer
129061|NCT02490631|skin flora|skin flora
129062|NCT02490605|Postural balance|postural balance
129063|NCT02490605|Temporomandibular disorders|temporomandibular disorders
129064|NCT02490605|Splints|splints
129065|NCT02490579|video messaging|video messaging
129066|NCT02490579|exercise|exercise
129067|NCT02490579|diet|diet
129068|NCT02490579|weight gain|weight gain
129069|NCT02490579|pregnancy|pregnancy
129070|NCT02490566|chronic condition|chronic condition
129071|NCT02490566|telehealth|telehealth
129072|NCT02490566|nutrition|nutrition
129073|NCT02490566|exercise|exercise
129074|NCT02490553|air pollution|air pollution
129075|NCT02490553|epidemiological survey|epidemiological survey
129076|NCT02490553|representative sample|representative sample
129077|NCT02490540|opioids|opioids
129078|NCT02490540|analgesia|analgesia
129079|NCT02490540|pain|pain
129080|NCT02490540|anesthesia|anesthesia
129081|NCT02490527|myopathy|myopathy
129082|NCT02490527|muscular weakness|muscular weakness
129083|NCT02490527|cramping|cramping
129084|NCT02490527|fatigue|fatigue
129085|NCT02490488|ovarian cancer|ovarian cancer
129086|NCT02490462|Cerebral Palsy|cerebral palsy
129087|NCT02490462|Physical Therapy|physical therapy
129088|NCT02490462|Family-centered Care|family-centered care
129089|NCT02490384|Cervical cerclage|cervical cerclage
129090|NCT02490345|gabapentin|gabapentin
129091|NCT02490319|radiation pneumonitis|radiation pneumonitis
129092|NCT02490319|lung cancer|lung cancer
129093|NCT02490319|prediction models|prediction models
129094|NCT02490319|genetic variants|genetic variants
129095|NCT02490241|pregnant|pregnant
129096|NCT02490241|female|female
129097|NCT02490241|women|women
129098|NCT02490241|lithium|lithium
129099|NCT02490241|bipolar|bipolar
129100|NCT02490228|female|female
129101|NCT02490228|minimally invasive surgery|minimally invasive surgery
129102|NCT02490150|Corifollitropin alfa|corifollitropin alfa
129103|NCT02490150|Stimulation protocol|stimulation protocol
129104|NCT02490124|Diabetes Type 1|diabetes type 1
129105|NCT02490124|Vascular Function|vascular function
129106|NCT02490098|Type 1 diabetes|type 1 diabetes
129107|NCT02490098|Closed-loop system|closed-loop system
129108|NCT02490098|Artificial pancreas|artificial pancreas
129109|NCT02490098|Insulin|insulin
129110|NCT02490098|Glucagon|glucagon
129111|NCT02490098|Hypoglycemia|hypoglycemia
129112|NCT02490098|Postprandial glucose|postprandial glucose
129113|NCT02490085|Type 2 diabetes|type 2 diabetes
129114|NCT02490085|Closed-loop strategy|closed-loop strategy
129115|NCT02490085|Artificial pancreas|artificial pancreas
129117|NCT02490085|Elderly|elderly
129118|NCT02490085|Multiple daily injections|multiple daily injections
129119|NCT02490085|Hypoglycemia|hypoglycemia
129120|NCT02490046|D mannose|d mannose
129121|NCT02490046|multiple sclerosis|multiple sclerosis
129122|NCT02490046|recurrent urinary infections|recurrent urinary infections
129123|NCT02490020|Renal transplantation|renal transplantation
129124|NCT02490020|mesenchymal stem cell|mesenchymal stem cell
129125|NCT02490020|Transplantation Rejection|transplantation rejection
129126|NCT02490020|donation after cardiac death|donation after cardiac death
129127|NCT02490007|Acellular pertussis vaccine|acellular pertussis vaccine
129128|NCT02490007|whole cell pertussis vaccine|whole cell pertussis vaccine
129129|NCT02490007|IgE-mediated food allergy|ige-mediated food allergy
129130|NCT02489916|Metastatic Colorectal Cancer|metastatic colorectal cancer
129132|NCT02489916|Previously treated metastatic colorectal cancer|previously treated metastatic colorectal cancer
129133|NCT02489903|Epigenetics|epigenetics
129134|NCT02489903|resensitization|resensitization
129135|NCT02489903|Platinum doublets|platinum doublets
129136|NCT02489903|lung cancer|lung cancer
129137|NCT02489903|Ovarian epithelial cancer|ovarian epithelial cancer
129138|NCT02489877|multiple sclerosis|multiple sclerosis
129139|NCT02489877|HERV-W virus|herv-w virus
129140|NCT02489877|Herpesviridae family|herpesviridae family
129141|NCT02489864|Terlipressin|terlipressin
129142|NCT02489864|mean arterial pressure|mean arterial pressure
129143|NCT02489864|type 2 HRS|type 2 hrs
129144|NCT02489838|Liver Neoplasma|liver neoplasma
129145|NCT02489838|Lung Radiation dose|lung radiation dose
129146|NCT02489825|randomized controlled trial|randomized controlled trial
129147|NCT02489825|vertebral fracture|vertebral fracture
129148|NCT02489825|osteoporosis|osteoporosis
129149|NCT02489825|vertebroplasty|vertebroplasty
129150|NCT02489825|augmentation|augmentation
129151|NCT02489812|children|children
129152|NCT02489812|behavior|behavior
129153|NCT02489812|anxiety|anxiety
129154|NCT02489812|dentistry|dentistry
129155|NCT02489799|advance care planning|advance care planning
129156|NCT02489773|Lucica|lucica
129157|NCT02489773|glycated albumin|glycated albumin
129158|NCT02489773|GA|ga
129159|NCT02489773|fructosamine|fructosamine
129160|NCT02489760|Etanercept|etanercept
129161|NCT02489760|Adalimumab|adalimumab
129162|NCT02489760|Ankylosing Spondylitis|ankylosing spondylitis
129163|NCT02489760|Switch Study|switch study
129164|NCT02489747|cognitive function|cognitive function
129165|NCT02489747|CNT|cnt
129166|NCT02489747|memory function|memory function
129167|NCT02489747|Triticum aestivum L|triticum aestivum l
129168|NCT02489747|wheat bran|wheat bran
129169|NCT02489734|sevoflurane|sevoflurane
129170|NCT02489734|emergence delirium|emergence delirium
129171|NCT02489734|preschool|preschool
129172|NCT02489721|peripherally inserted central venous catheter|peripherally inserted central venous catheter
129173|NCT02489721|depp vein thrombosis|depp vein thrombosis
129174|NCT02489721|related blood stream infections|related blood stream infections
129175|NCT02489721|midline|midline
129176|NCT02489708|Bronchiolitis|bronchiolitis
129177|NCT02489708|Cough|cough
129178|NCT02489708|Ear Infection|ear infection
129179|NCT02489708|Respiratory Infection|respiratory infection
129180|NCT02489708|Wheezing|wheezing
129181|NCT02489708|Clinical Decision Support Systems|clinical decision support systems
129182|NCT02489695|locally advanced or metastatic|locally advanced or metastatic
129183|NCT02489656|Double loop ureteral stent|double loop ureteral stent
129184|NCT02489656|USSQ|ussq
129185|NCT02489656|Quality of life|quality of life
129186|NCT02489656|Pain|pain
129187|NCT02489604|neuroendocrine tumors|neuroendocrine tumors
129188|NCT02489578|Community Acquired Pneumonia|community acquired pneumonia
129189|NCT02489578|health care associated pneumonia|health care associated pneumonia
129190|NCT02489565|Coronary Artery Disease|coronary artery disease
129191|NCT02489565|stable|stable
129192|NCT02489565|Telemedicine|telemedicine
129193|NCT02489565|Patient Discharge|patient discharge
129194|NCT02489539|Aortic aneurysm|aortic aneurysm
129195|NCT02489539|Abdominal aorta|abdominal aorta
129196|NCT02489539|Stent graft|stent graft
129197|NCT02489539|Aneurysm|aneurysm
129198|NCT02489539|Vascular Diseases|vascular diseases
129199|NCT02489539|Cardiovascular Diseases|cardiovascular diseases
129200|NCT02489500|AL Amyloidosis|al amyloidosis
129201|NCT02489500|Stem Cell Transplantation|stem cell transplantation
129202|NCT02489448|Breast Cancer|breast cancer
129203|NCT02489383|Asthma|asthma
129204|NCT02489383|Continuous Exercise Training|continuous exercise training
129205|NCT02489383|interval Exercise Training|interval exercise training
129206|NCT02489383|Clinical Control|clinical control
129207|NCT02489383|Inflammation|inflammation
129208|NCT02489370|home care|home care
129209|NCT02489370|telecare|telecare
129210|NCT02489370|telehealth|telehealth
129212|NCT02489370|chronic heart failure|chronic heart failure
129213|NCT02489370|randomized controlled trial|randomized controlled trial
129214|NCT02489370|Congestive Heart Failure|congestive heart failure
129215|NCT02489370|telemedicine|telemedicine
129216|NCT02489331|Dyslipidemias|dyslipidemias
129217|NCT02489318|Prostate Cancer|prostate cancer
129218|NCT02489318|JNJ-56021927|jnj-56021927
129219|NCT02489318|Androgen Deprivation Therapy|androgen deprivation therapy
129220|NCT02489318|ARN-509|arn-509
129221|NCT02489318|Apalutamide|apalutamide
129222|NCT02489318|TITAN|titan
129223|NCT02489318|Metastatic Hormone-sensitive Prostate Cancer|metastatic hormone-sensitive prostate cancer
129224|NCT02489305|Depressive Disorder, Major|depressive disorder, major
129225|NCT02489305|Depression|depression
129226|NCT02489305|Anti-Depressant|anti-depressant
129228|NCT02489292|Urea Cycle Disorder|urea cycle disorder
129229|NCT02489292|UCD|ucd
129230|NCT02489292|cell therapy|cell therapy
129231|NCT02489292|stem cell|stem cell
129232|NCT02489279|Attention deficit hyperactivity disorder.|attention deficit hyperactivity disorder.
129233|NCT02489279|Attention training|attention training
129234|NCT02489279|Mobile devices|mobile devices
129235|NCT02489279|Brain training|brain training
129236|NCT02489266|Melanoma|melanoma
129237|NCT02489266|Immunotherapy|immunotherapy
129238|NCT02489227|PsO|pso
129239|NCT02489214|donafenib|donafenib
129240|NCT02489201|donafenib|donafenib
129241|NCT02489188|gait asymmetry|gait asymmetry
129242|NCT02489188|joint angles|joint angles
129243|NCT02489175|Parastomal hernia|parastomal hernia
129244|NCT02489175|prevention|prevention
129245|NCT02489175|stomaplasty|stomaplasty
129246|NCT02489175|ring|ring
129247|NCT02489149|food insecurity|food insecurity
129248|NCT02489136|spiritist passe|spiritist passe
129249|NCT02489136|laying of hands|laying of hands
129250|NCT02489136|newborn|newborn
129251|NCT02489136|adult|adult
129252|NCT02489136|conditions|conditions
129253|NCT02489110|Alzheimer's Disease|alzheimer's disease
129254|NCT02489110|Dementia|dementia
129255|NCT02489110|caregiving|caregiving
129256|NCT02489110|caregiver|caregiver
129257|NCT02489110|coping|coping
129258|NCT02489110|coping with caregiving|coping with caregiving
129259|NCT02489110|stress|stress
129260|NCT02489110|Hispanic caregiver|hispanic caregiver
129261|NCT02489110|Latino caregiver|latino caregiver
129262|NCT02489084|Head and Neck neoplasms|head and neck neoplasms
129263|NCT02489084|Genome-wide association study|genome-wide association study
129264|NCT02489084|Polymorphism, single nucleotide|polymorphism, single nucleotide
129265|NCT02489084|Toxicity|toxicity
129266|NCT02489019|Anesthesia|anesthesia
129267|NCT02489019|Fentanyl|fentanyl
129268|NCT02489019|Elderly|elderly
129269|NCT02488980|Falciparum Parasitaemia, Malaria|falciparum parasitaemia, malaria
129270|NCT02488954|Ulcerative colitis|ulcerative colitis
129271|NCT02488954|Probiotics|probiotics
129272|NCT02488954|treatments|treatments
129273|NCT02488954|Propionibacterium freudenreichii|propionibacterium freudenreichii
129274|NCT02488941|Liver Function Tests|liver function tests
129275|NCT02488941|Blood Coagulation|blood coagulation
129276|NCT02488928|NSCLC|nsclc
129277|NCT02488928|EBUS|ebus
129278|NCT02488928|elastography|elastography
129279|NCT02488928|predictive value|predictive value
129280|NCT02488928|strain|strain
129281|NCT02488915|Brain|brain
129282|NCT02488915|Brain Clot|brain clot
129283|NCT02488915|Brain Diseases|brain diseases
129284|NCT02488915|Brain Infarction|brain infarction
129285|NCT02488915|Cerebral Ischemia|cerebral ischemia
129286|NCT02488915|Cerebrovascular Disorders|cerebrovascular disorders
129287|NCT02488915|EmboTrap® Revascularization Device|embotrap® revascularization device
129288|NCT02488915|EmboTrap|embotrap
129289|NCT02488915|Ischemia|ischemia
129290|NCT02488915|Ischemic|ischemic
129291|NCT02488915|Ischemic Stroke|ischemic stroke
129292|NCT02488915|Mechanical Thrombectomy|mechanical thrombectomy
129293|NCT02488915|Neurovascular Intervention|neurovascular intervention
129294|NCT02488915|Revascularization|revascularization
129295|NCT02488915|Stent Retriever|stent retriever
129296|NCT02488915|Stroke|stroke
129297|NCT02488915|Vascular Diseases|vascular diseases
129298|NCT02488915|Neuravi|neuravi
129299|NCT02488889|Chantix|chantix
129300|NCT02488876|Cardiac surgery|cardiac surgery
129301|NCT02488876|Tissue sample database|tissue sample database
129302|NCT02488876|Inflammatory responds|inflammatory responds
129303|NCT02488850|immune monitoring|immune monitoring
129304|NCT02488850|T cell activation|t cell activation
129305|NCT02488850|early stage|early stage
129306|NCT02488837|Deep Brain Stimulation|deep brain stimulation
129307|NCT02488824|Quadriplegia|quadriplegia
129308|NCT02488824|Paraplegia|paraplegia
129309|NCT02488824|Spinal Cord Injury|spinal cord injury
129310|NCT02488824|Body Temperature Regulation|body temperature regulation
129311|NCT02488824|Mild Cognitive Impairment|mild cognitive impairment
129312|NCT02488785|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
129313|NCT02488785|Telehealth|telehealth
129314|NCT02488785|Hispanics|hispanics
129315|NCT02488785|Latinos|latinos
129316|NCT02488785|Self-Care|self-care
129317|NCT02488785|Mobile Health|mobile health
129318|NCT02488785|mHealth|mhealth
129319|NCT02488772|sleep quality|sleep quality
129320|NCT02488772|emergency department|emergency department
129321|NCT02488733|type 2 diabetes mellitus|type 2 diabetes mellitus
129322|NCT02488733|obesity|obesity
129323|NCT02488733|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
129324|NCT02488733|bariatric surgery|bariatric surgery
129325|NCT02488733|metabolic surgery|metabolic surgery
129326|NCT02488720|amyloid imaging|amyloid imaging
129327|NCT02488720|biomarkers|biomarkers
129328|NCT02488720|cognition|cognition
129329|NCT02488720|longitudinal|longitudinal
129330|NCT02488720|cognitive decline|cognitive decline
129331|NCT02488720|observational|observational
130029|NCT02484729|Safety|safety
129336|NCT02488707|intersphincteric resection|intersphincteric resection
129338|NCT02488707|subtotal intersphincteric resection|subtotal intersphincteric resection
129339|NCT02488707|total intersphincteric resection|total intersphincteric resection
129340|NCT02488707|trans-anal trans-abdominal resection|trans-anal trans-abdominal resection
129341|NCT02488707|laparoscopic intersphincteric resection|laparoscopic intersphincteric resection
129342|NCT02488707|anal sphincter preservation|anal sphincter preservation
129343|NCT02488707|total mesorectal excision|total mesorectal excision
129344|NCT02488707|TME|tme
129345|NCT02488707|TATA|tata
129346|NCT02488707|laparoscopic total mesorectal excision|laparoscopic total mesorectal excision
129347|NCT02488707|external sphincter preservation|external sphincter preservation
585630|NCT00513448|Comparative Evaluation|comparative evaluation
129348|NCT02488707|Neoadjuvant chemo-radiotherapy for rectal cancer|neoadjuvant chemo-radiotherapy for rectal cancer
129349|NCT02488707|fit patients for minimally invasive surgery|fit patients for minimally invasive surgery
129350|NCT02488668|Transcutaneous Electrical Stimulation|transcutaneous electrical stimulation
129351|NCT02488668|Neuroplasticity|neuroplasticity
129352|NCT02488668|Sensory Feedback|sensory feedback
129353|NCT02488642|Isosorbide dinitrate gel solution|isosorbide dinitrate gel solution
129354|NCT02488642|late intrauterine death|late intrauterine death
129355|NCT02488642|nitric oxide donors|nitric oxide donors
129356|NCT02488629|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
129362|NCT02488603|Breast Neoplasms|breast neoplasms
129363|NCT02488603|Tamoxifen|tamoxifen
129364|NCT02488603|Decision Aids|decision aids
129365|NCT02488564|HER-2 Positive Breast Cancer|her-2 positive breast cancer
129366|NCT02488564|operable breast cancer|operable breast cancer
129367|NCT02488564|locally advanced breast cancer|locally advanced breast cancer
129368|NCT02488564|no prior therapy|no prior therapy
129369|NCT02488564|pCR|pcr
129370|NCT02488525|Acquired Von Willebrand|acquired von willebrand
129371|NCT02488525|Gastro-intestinal bleeding|gastro-intestinal bleeding
129372|NCT02488525|LVAD|lvad
129373|NCT02488512|Relapsed/refractory diffuse large b cell|relapsed/refractory diffuse large b cell
129486|NCT02487888|Genetic Polymorphism|genetic polymorphism
129374|NCT02488512|Relapsed/refractory mantle cell lymphomas|relapsed/refractory mantle cell lymphomas
129375|NCT02488512|DLBCL|dlbcl
129376|NCT02488512|MCL|mcl
129377|NCT02488512|90Y-DOTATOC|90y-dotatoc
129378|NCT02488512|SSR-positive tumour|ssr-positive tumour
129379|NCT02488499|Disruptive Behaviour Disorder|disruptive behaviour disorder
129380|NCT02488499|Psychosocial|psychosocial
129381|NCT02488499|Group Treatment|group treatment
129382|NCT02488473|Volunteers|volunteers
129383|NCT02488460|Motor Activity|motor activity
129384|NCT02488460|Cognition|cognition
129385|NCT02488460|Academic Acheivement|academic acheivement
129386|NCT02488460|Preadolescent Children|preadolescent children
129387|NCT02488447|Allergy|allergy
129388|NCT02488447|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
129389|NCT02488447|Immunotherapy|immunotherapy
129390|NCT02488447|Life Quality|life quality
129391|NCT02488447|Adherence|adherence
129392|NCT02488434|ICSI|icsi
129393|NCT02488434|sperm selection|sperm selection
129394|NCT02488434|fertile chip|fertile chip
129395|NCT02488434|ıcsı outcomes|ıcsı outcomes
129396|NCT02488395|Parkinson's disease|parkinson's disease
129397|NCT02488395|Non-motor symptoms|non-motor symptoms
129398|NCT02488395|Visual deficits|visual deficits
129399|NCT02488395|Superior colliculus|superior colliculus
129400|NCT02488395|fMRI|fmri
129401|NCT02488382|lymphoma|lymphoma
129402|NCT02488382|multiple myeloma|multiple myeloma
129403|NCT02488382|stem cell mobilization|stem cell mobilization
129404|NCT02488382|autologous stem cell transplantation|autologous stem cell transplantation
129405|NCT02488369|Children and adolescents|children and adolescents
129406|NCT02488343|Multiple Sclerosis|multiple sclerosis
129407|NCT02488343|Adherence|adherence
129408|NCT02488343|Therapies|therapies
129409|NCT02488343|Psychological Intervention|psychological intervention
129410|NCT02488317|Chronic Kidney Disease|chronic kidney disease
129411|NCT02488317|Hemodialysis|hemodialysis
129412|NCT02488317|Peritoneal Dialysis|peritoneal dialysis
129413|NCT02488304|HRCT|hrct
129414|NCT02488304|High Resolution Computed Tomography scans|high resolution computed tomography scans
129415|NCT02488304|Functional Respiratory Imaging|functional respiratory imaging
129416|NCT02488304|FRI|fri
129417|NCT02488304|Computed Tomography|computed tomography
129418|NCT02488304|CT|ct
129419|NCT02488304|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
129420|NCT02488304|BOS|bos
129421|NCT02488304|Lung Transplant|lung transplant
129422|NCT02488291|Epidural|epidural
129423|NCT02488291|Analgesia labor|analgesia labor
129424|NCT02488291|Perinatal|perinatal
129425|NCT02488291|anesthesia|anesthesia
129426|NCT02488278|Glucose blood measurements, glucometers ,audio communication|glucose blood measurements, glucometers ,audio communication
129427|NCT02488265|Parkinson´s disease|parkinson´s disease
129428|NCT02488265|Physicaltherapy|physicaltherapy
129429|NCT02488265|Postural Balance|postural balance
129430|NCT02488265|Gait|gait
129431|NCT02488265|Rehabilitation|rehabilitation
129432|NCT02488252|Chinese Medicine|chinese medicine
129433|NCT02488252|ACEI|acei
129434|NCT02488252|ARB|arb
129435|NCT02488252|Pragmatic trial|pragmatic trial
129436|NCT02488213|Nutritional Counseling|nutritional counseling
129437|NCT02488213|Diet|diet
129438|NCT02488187|Breast Cancer|breast cancer
129439|NCT02488187|MRI|mri
129440|NCT02488187|Mammogram|mammogram
129441|NCT02488187|Whole Breast Sonogram|whole breast sonogram
129442|NCT02488187|ABUS|abus
129443|NCT02488161|Colorectal cancer|colorectal cancer
129444|NCT02488161|Risk factors|risk factors
155946|NCT02337322|HIV|hiv
129445|NCT02488161|Adverse events|adverse events
129446|NCT02488161|Predictive models|predictive models
129447|NCT02488122|Bone Mineral Density|bone mineral density
129448|NCT02488122|Isometric Exercise|isometric exercise
129454|NCT02488109|nutritional rehabilitation|nutritional rehabilitation
129455|NCT02488083|non-invasive|non-invasive
129456|NCT02488031|SCA, dysmetria|sca, dysmetria
129457|NCT02488018|Glycemic index|glycemic index
129458|NCT02488018|honey|honey
129459|NCT02488018|reference glucose|reference glucose
129460|NCT02488005|Inflammatory Bowel Disease|inflammatory bowel disease
129461|NCT02488005|Small Bowel|small bowel
129462|NCT02488005|Crohn's Disease|crohn's disease
129463|NCT02488005|Small Bowel Ultrasound|small bowel ultrasound
129464|NCT02487966|tDCS|tdcs
129465|NCT02487966|Mirror Therapy|mirror therapy
129466|NCT02487966|Phantom Limb Pain|phantom limb pain
129467|NCT02487966|Traumatic amputation|traumatic amputation
129473|NCT02487940|Recurrent implantation failure|recurrent implantation failure
129474|NCT02487940|IVF|ivf
129475|NCT02487940|ICSI|icsi
129476|NCT02487940|Intralipid|intralipid
129477|NCT02487914|Drug Delivery|drug delivery
129478|NCT02487914|Iontophoresis|iontophoresis
129479|NCT02487914|Lidocaine|lidocaine
129480|NCT02487914|Pressure|pressure
129481|NCT02487914|Tactile perception|tactile perception
129482|NCT02487901|arthrodesiss|arthrodesiss
129483|NCT02487901|cervical vertebra|cervical vertebra
129484|NCT02487901|laminoplasty|laminoplasty
129485|NCT02487888|Genetic Variation|genetic variation
129487|NCT02487888|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
129488|NCT02487888|Genetic Association Studies|genetic association studies
129489|NCT02487888|Healthcare Utilization|healthcare utilization
129490|NCT02487875|Sit-to-stand test|sit-to-stand test
129491|NCT02487875|Muscle strength|muscle strength
129492|NCT02487875|Pulmonary rehabilitation|pulmonary rehabilitation
129493|NCT02487836|Laying of the biliary stent|laying of the biliary stent
129494|NCT02487771|DHA|dha
129495|NCT02487771|childhood development|childhood development
129496|NCT02487745|Cocaine|cocaine
129497|NCT02487745|Methadone|methadone
129498|NCT02487745|Employment|employment
129499|NCT02487745|Opioids|opioids
129500|NCT02487732|Diabetic Patients With Non-ST Elevation|diabetic patients with non-st elevation
129501|NCT02487719|Iron deficiecy|iron deficiecy
129502|NCT02487719|pregnancy|pregnancy
129503|NCT02487719|prenatal care|prenatal care
129504|NCT02487706|Hemodialysis|hemodialysis
129505|NCT02487706|HIV-infection|hiv-infection
129506|NCT02487654|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
129507|NCT02487654|Pulmonary vein isolation|pulmonary vein isolation
129508|NCT02487654|Ganglionic plexi|ganglionic plexi
129509|NCT02487654|Radiofrequency|radiofrequency
129510|NCT02487654|late gadolinium enhancement cardiac MR imaging|late gadolinium enhancement cardiac mr imaging
129511|NCT02487654|High Frequency Stimulation|high frequency stimulation
129512|NCT02487641|Ultrasound|ultrasound
129513|NCT02487641|mid-trimester|mid-trimester
129514|NCT02487641|Obesity|obesity
129515|NCT02487641|pregnancy|pregnancy
129516|NCT02487615|Glycaemia|glycaemia
129517|NCT02487615|Subclinical Atherosclerosis|subclinical atherosclerosis
129518|NCT02487615|Carotid Doppler Ultrasound|carotid doppler ultrasound
129519|NCT02487615|Carotid Plaque|carotid plaque
129520|NCT02487615|Intima Media Thickness|intima media thickness
129521|NCT02487615|Ankle Brachial Index|ankle brachial index
129522|NCT02487615|Exercise Stress Test|exercise stress test
129523|NCT02487615|Coronary Calcium Score|coronary calcium score
129524|NCT02487615|Insulinemia|insulinemia
129525|NCT02487615|Leptin|leptin
130127|NCT02484222|fentanyl|fentanyl
129526|NCT02487615|Inflammation|inflammation
129527|NCT02487615|Resistin|resistin
129528|NCT02487615|Tumor Necrosis Factor alpha|tumor necrosis factor alpha
129529|NCT02487615|Phospholipase A2, Group VII|phospholipase a2, group vii
129530|NCT02487615|Body Mass Index|body mass index
129531|NCT02487615|Adipose Tissue Function|adipose tissue function
129532|NCT02487615|Single Gene Polymorphism|single gene polymorphism
129533|NCT02487589|Falls|falls
129534|NCT02487589|Elderly|elderly
129535|NCT02487589|e-Health|e-health
129536|NCT02487589|Telemedicine|telemedicine
129537|NCT02487563|Isolated thrombocytopenia|isolated thrombocytopenia
129538|NCT02487563|decitabine|decitabine
129539|NCT02487563|rhTPO|rhtpo
129540|NCT02487550|Renal neoplasma|renal neoplasma
129541|NCT02487550|CIK cells|cik cells
129542|NCT02487537|incretin release|incretin release
129543|NCT02487524|Neuropathic Pain|neuropathic pain
129544|NCT02487524|Breast Cancer|breast cancer
129545|NCT02487524|Post surgical|post surgical
129546|NCT02487498|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
129547|NCT02487472|France|france
129548|NCT02487472|Post-herpetic neuralgia|post-herpetic neuralgia
129549|NCT02487472|Herpes zoster|herpes zoster
129550|NCT02487472|Economic burden of disease|economic burden of disease
120682|NCT02541045|therapy|therapy
129551|NCT02487459|acute lymphoblastic leukemia|acute lymphoblastic leukemia
129552|NCT02487459|acute myeloid leukemia|acute myeloid leukemia
129553|NCT02487459|chronic myeloid leukemia|chronic myeloid leukemia
129554|NCT02487459|myelodysplastic syndrome|myelodysplastic syndrome
129555|NCT02487459|non-hodgkin lymphoma|non-hodgkin lymphoma
129556|NCT02487459|hodgkin lymphoma|hodgkin lymphoma
129557|NCT02487446|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
129558|NCT02487433|food effect|food effect
129559|NCT02487433|pharmacokinetics|pharmacokinetics
129560|NCT02487433|healthy volunteers|healthy volunteers
129561|NCT02487381|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
129562|NCT02487381|cannabidiol|cannabidiol
129563|NCT02487381|COMT|comt
129564|NCT02487381|Volunteers|volunteers
129565|NCT02487355|dexmedetomidine|dexmedetomidine
129566|NCT02487355|magnesium sulphate|magnesium sulphate
129567|NCT02487342|Dairy|dairy
129568|NCT02487342|appetite|appetite
129569|NCT02487342|feeding behaviour|feeding behaviour
129570|NCT02487329|Direct pulp capping|direct pulp capping
129571|NCT02487329|Er,Cr:YSGG laser|er,cr:ysgg laser
129572|NCT02487329|Tricalcium silicate|tricalcium silicate
129573|NCT02487316|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
129574|NCT02487316|anaplastic lymphoma kinase rearrangement|anaplastic lymphoma kinase rearrangement
129575|NCT02487316|crizotinib|crizotinib
129576|NCT02487316|CHOP chemotherapy|chop chemotherapy
129577|NCT02487303|Acetaminophen|acetaminophen
129578|NCT02487303|Pain, Postoperative|pain, postoperative
129579|NCT02487303|Analgesia, Obstetrical|analgesia, obstetrical
129580|NCT02487303|Cesarean Section|cesarean section
129581|NCT02487277|Pancreatic|pancreatic
129582|NCT02487251|Obesity|obesity
129583|NCT02487251|Family Mealtimes|family mealtimes
129584|NCT02487251|Prevention|prevention
129585|NCT02487238|Microbiome|microbiome
129586|NCT02487238|Microbiota|microbiota
129587|NCT02487238|Fecal Microbial Transplant|fecal microbial transplant
129588|NCT02487238|FMT|fmt
129589|NCT02487238|Pediatrics|pediatrics
129590|NCT02487238|Gastroenterology|gastroenterology
129591|NCT02487238|IBD|ibd
129592|NCT02487238|Inflammatory Bowel Disease|inflammatory bowel disease
129593|NCT02487238|Ulcerative Colitis|ulcerative colitis
129594|NCT02487238|UC|uc
129595|NCT02487238|Inflammatory Bowel Disease Unclassified|inflammatory bowel disease unclassified
129596|NCT02487238|IBD-U|ibd-u
129597|NCT02487238|Rebiotix|rebiotix
129598|NCT02487238|RBX2660|rbx2660
129599|NCT02487212|fractional laser|fractional laser
129600|NCT02487212|hypertrophic scar|hypertrophic scar
129601|NCT02487212|topical corticosteroid|topical corticosteroid
129602|NCT02487212|laser assisted delivery systems|laser assisted delivery systems
129603|NCT02487199|hepatitis C infection|hepatitis c infection
129604|NCT02487199|interferon|interferon
129605|NCT02487199|hepatitis C|hepatitis c
129606|NCT02487199|treatment experienced|treatment experienced
129607|NCT02487199|severe kidney disease|severe kidney disease
129608|NCT02487199|Chronic Kidney Disease|chronic kidney disease
129609|NCT02487186|Chronic periodontitis|chronic periodontitis
129610|NCT02487186|Local doxycycline|local doxycycline
129611|NCT02487186|Ultrasonic debridement|ultrasonic debridement
129612|NCT02487186|PLGA microspheres|plga microspheres
129613|NCT02487186|Microbiologic assessment|microbiologic assessment
129614|NCT02487147|Live Attenuated Influenza Vaccine (FluMist)|live attenuated influenza vaccine (flumist)
129615|NCT02487147|Free Air Portable Air Powered Respirator|free air portable air powered respirator
129616|NCT02487147|N95 Respirator|n95 respirator
129617|NCT02487147|Personal Protective Equipment|personal protective equipment
129618|NCT02487147|Viral Transmission|viral transmission
129619|NCT02487121|weight loss|weight loss
129620|NCT02487095|RB1 Inactivation|rb1 inactivation
129621|NCT02487095|Kinase Inhibitor|kinase inhibitor
129622|NCT02487095|DNA Damage Response Network|dna damage response network
129623|NCT02487095|MYC And CCNE1 Activation|myc and ccne1 activation
129624|NCT02487095|Defective ATM-p53 Signaling Pathway|defective atm-p53 signaling pathway
129625|NCT02487082|Autism Spectrum Disorder|autism spectrum disorder
129626|NCT02487082|Children|children
129627|NCT02487082|Melatonin|melatonin
129628|NCT02487082|Donepezil|donepezil
129629|NCT02487082|Sleep disorder|sleep disorder
129630|NCT02487056|Heart Failure|heart failure
129631|NCT02487056|Diagnosis|diagnosis
129632|NCT02487056|Management|management
129633|NCT02487043|Caries prevention|caries prevention
129634|NCT02487043|Early Childhood Caries|early childhood caries
129635|NCT02487030|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
129637|NCT02487030|Sustained Virologic Response|sustained virologic response
129638|NCT02487030|Direct Acting Antiviral|direct acting antiviral
129639|NCT02487030|Combination Therapy|combination therapy
129640|NCT02487030|GS-7977|gs-7977
129641|NCT02487030|GS-5885|gs-5885
129642|NCT02487030|Ribavirin|ribavirin
129643|NCT02487030|Sofosbuvir|sofosbuvir
129644|NCT02487030|ledipasvir|ledipasvir
129645|NCT02487030|Hepatitis C|hepatitis c
129646|NCT02487030|Hepatitis C, Chronic|hepatitis c, chronic
129647|NCT02487030|Liver Diseases|liver diseases
129648|NCT02487030|Virus Diseases|virus diseases
129649|NCT02487030|Antiviral Agents|antiviral agents
129650|NCT02486965|VAS|vas
129651|NCT02486965|thermode test|thermode test
129652|NCT02486965|training program|training program
129653|NCT02486965|6MWT|6mwt
129654|NCT02486913|Primary prevention|primary prevention
129655|NCT02486913|National Health Service Health Check|national health service health check
129656|NCT02486900|Craving|craving
129657|NCT02486900|Cue Reactivity|cue reactivity
129658|NCT02486900|Neurofeedback|neurofeedback
129659|NCT02486887|telemonitoring|telemonitoring
129660|NCT02486874|Human acellular dermal matrix, burns, wound healing|human acellular dermal matrix, burns, wound healing
129661|NCT02486861|Tomography, Optical Coherence|tomography, optical coherence
129662|NCT02486848|Hairloss|hairloss
129663|NCT02486848|Female Pattern Hair Loss|female pattern hair loss
129664|NCT02486848|Androgenetic Alopecia|androgenetic alopecia
129665|NCT02486848|Minoxidil|minoxidil
129666|NCT02486822|Labor scale|labor scale
129667|NCT02486822|Partograph|partograph
129668|NCT02486822|Spontaneous labor|spontaneous labor
129669|NCT02486822|Primigravida|primigravida
129670|NCT02486744|Acthar|acthar
129671|NCT02486744|Dialysis|dialysis
129672|NCT02486744|Kidney|kidney
129673|NCT02486744|Non-Diabetic|non-diabetic
129674|NCT02486731|Hormonal sensitivity|hormonal sensitivity
129675|NCT02486731|bone growth|bone growth
129676|NCT02486705|ptsd|ptsd
129677|NCT02486705|family|family
129678|NCT02486705|caregiver|caregiver
129679|NCT02486705|burden|burden
129680|NCT02486692|Mental Health|mental health
129681|NCT02486692|PTSD|ptsd
129682|NCT02486692|Stigma|stigma
129683|NCT02486692|Peer Education|peer education
129684|NCT02486692|Web Education|web education
129685|NCT02486692|Self Help|self help
129686|NCT02486653|tamsulosin|tamsulosin
129687|NCT02486653|randomized controlled trials as topic|randomized controlled trials as topic
129688|NCT02486653|double-blind method|double-blind method
129689|NCT02486653|random allocation|random allocation
129690|NCT02486653|placebos|placebos
129691|NCT02486653|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
129692|NCT02486653|urinary retention|urinary retention
129693|NCT02486653|urinary tract infections|urinary tract infections
129694|NCT02486653|urinary catheters|urinary catheters
129695|NCT02486653|catheter-related infections|catheter-related infections
129696|NCT02486653|postoperative complications|postoperative complications
129697|NCT02486640|RRMS, CIS|rrms, cis
129698|NCT02486627|cUTI|cuti
129699|NCT02486627|AP|ap
129700|NCT02486627|ACHN-490|achn-490
129701|NCT02486627|anti-infective|anti-infective
129702|NCT02486627|anti-bacterial|anti-bacterial
129703|NCT02486627|antibiotic|antibiotic
129704|NCT02486627|anti-microbial|anti-microbial
129705|NCT02486627|UTI|uti
129706|NCT02486627|bacterial infection|bacterial infection
129707|NCT02486627|Gram-negative|gram-negative
129708|NCT02486588|Financial incentives|financial incentives
129709|NCT02486588|Messaging|messaging
129710|NCT02486575|Residents|residents
129711|NCT02486575|Training|training
129712|NCT02486575|simulation|simulation
129713|NCT02486575|mentoring|mentoring
129714|NCT02486575|proctor|proctor
129715|NCT02486562|Multiple Sclerosis|multiple sclerosis
129716|NCT02486562|MS|ms
129717|NCT02486549|Pain|pain
129718|NCT02486549|Anesthesia Recovery Period|anesthesia recovery period
129719|NCT02486549|Brachial Plexus|brachial plexus
129720|NCT02486536|capsule endoscopy|capsule endoscopy
129721|NCT02486536|polyethylene glycol|polyethylene glycol
129722|NCT02486536|bowel preparation solutions|bowel preparation solutions
129723|NCT02486523|SAM, severe acute malnutrition|sam, severe acute malnutrition
129724|NCT02486510|HIV-1|hiv-1
129725|NCT02486510|CCR5 coreceptors|ccr5 coreceptors
129726|NCT02486510|Maraviroc|maraviroc
129727|NCT02486497|Pancreatic cancer|pancreatic cancer
129730|NCT02486497|Gemcitabine|gemcitabine
129731|NCT02486484|macular degeneration|macular degeneration
129732|NCT02486484|diabetic retinopathy|diabetic retinopathy
129733|NCT02486484|macular edema|macular edema
129734|NCT02486484|retinal vein occlusion|retinal vein occlusion
129735|NCT02486484|choroidal neovascularization|choroidal neovascularization
129736|NCT02486471|cervical dysplasia|cervical dysplasia
129737|NCT02486471|colposcopy|colposcopy
129738|NCT02486471|haemostatic procedure|haemostatic procedure
129739|NCT02486471|biopsy of the cervix uteri|biopsy of the cervix uteri
129740|NCT02486458|Fluoride|fluoride
129741|NCT02486458|Biofilm fluid|biofilm fluid
129742|NCT02486458|Calcium fluoride|calcium fluoride
129744|NCT02486445|Deep venous thrombosis|deep venous thrombosis
129745|NCT02486445|Rivaroxaban|rivaroxaban
129746|NCT02486406|Hepatitis C Genotype 4|hepatitis c genotype 4
129747|NCT02486406|Pediatric|pediatric
129748|NCT02486406|Hepatitis C Genotype 1|hepatitis c genotype 1
129749|NCT02486406|Hepatitis C Virus|hepatitis c virus
156272|NCT02335138|HIV|hiv
120882|NCT02539732|Weaning|weaning
129750|NCT02486341|continuous glucose monitoring system|continuous glucose monitoring system
129751|NCT02486341|basal insulin|basal insulin
129752|NCT02486341|diabetes mellitus|diabetes mellitus
129753|NCT02486341|elderly|elderly
129754|NCT02486328|Cognitive dysfunction|cognitive dysfunction
129755|NCT02486328|Colonoscopy|colonoscopy
129756|NCT02486328|Sedation|sedation
129757|NCT02486315|coronary bifurcation|coronary bifurcation
129758|NCT02486315|coronary stent|coronary stent
129759|NCT02486289|Mercury toxicity poisoning|mercury toxicity poisoning
129760|NCT02486263|infant|infant
129761|NCT02486263|esophagitis|esophagitis
129762|NCT02486263|neonate|neonate
129763|NCT02486263|GERD|gerd
129764|NCT02486237|diabetes mellitus|diabetes mellitus
129765|NCT02486237|complications|complications
129766|NCT02486237|prevalence|prevalence
129767|NCT02486224|deep sea mineral water|deep sea mineral water
129768|NCT02486224|exercise recovery|exercise recovery
129769|NCT02486224|hydration|hydration
129770|NCT02486224|salivary osmolar concentration|salivary osmolar concentration
129771|NCT02486224|urinary osmolar concentration|urinary osmolar concentration
129772|NCT02486211|heart arrest|heart arrest
129773|NCT02486211|resuscitation|resuscitation
129774|NCT02486211|seizures|seizures
129775|NCT02486211|hypothermia, induced|hypothermia, induced
129776|NCT02486211|Amantadine|amantadine
129777|NCT02486198|Gastrointestinal cancer|gastrointestinal cancer
129778|NCT02486198|oxaliplatin|oxaliplatin
129779|NCT02486198|neurotoxicity|neurotoxicity
129780|NCT02486120|Genetic Counseling|genetic counseling
129781|NCT02486120|Clinical Decision-Making|clinical decision-making
129782|NCT02486107|cervical vertebra|cervical vertebra
129783|NCT02486107|surgery|surgery
129784|NCT02486107|tubular retractor|tubular retractor
129785|NCT02486107|endoscope|endoscope
129786|NCT02486094|Imaging, Magnetic Resonance|imaging, magnetic resonance
129787|NCT02486094|Rectal Cancer|rectal cancer
129788|NCT02486094|Apoptosis|apoptosis
129789|NCT02486094|Proliferation|proliferation
129790|NCT02486094|Cancer|cancer
129791|NCT02486094|Tissue Study|tissue study
129792|NCT02486081|Assistive device|assistive device
129793|NCT02486081|the disabled|the disabled
129794|NCT02486081|special education|special education
129795|NCT02486081|movement analysis|movement analysis
129796|NCT02486081|system development|system development
129797|NCT02486055|Study safety of BPM31510 in healthy subjects|study safety of bpm31510 in healthy subjects
129799|NCT02486042|Premature infant|premature infant
129802|NCT02485990|Fallopian Tube|fallopian tube
129803|NCT02485990|Epithelial Ovarian|epithelial ovarian
129804|NCT02485990|EOC|eoc
129805|NCT02485977|Pulmonary hypertension|pulmonary hypertension
129806|NCT02485977|Magnetic Resonance Imaging|magnetic resonance imaging
129807|NCT02485964|Vaccine|vaccine
129808|NCT02485951|deep anterior lamellar keratoplasty|deep anterior lamellar keratoplasty
129809|NCT02485951|big-bubble technique|big-bubble technique
129810|NCT02485951|peripheral air injection|peripheral air injection
129811|NCT02485951|keratoconus|keratoconus
129812|NCT02485938|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
129813|NCT02485938|Cardiomyopathy|cardiomyopathy
129814|NCT02485925|Interventional|interventional
129815|NCT02485925|Radiofrequency ablation|radiofrequency ablation
129816|NCT02485925|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
129817|NCT02485925|Catheter ablation|catheter ablation
129818|NCT02485912|Ebola|ebola
129819|NCT02485912|vaccine|vaccine
129820|NCT02485912|safety|safety
129821|NCT02485912|immunogenicity|immunogenicity
129822|NCT02485899|Late infantile Neuronal Ceroid Lipofuscinosis Type 2|late infantile neuronal ceroid lipofuscinosis type 2
129823|NCT02485899|LINCL|lincl
129824|NCT02485899|NCL2|ncl2
129825|NCT02485899|CLN2|cln2
129826|NCT02485899|Jansky-Bielschowsky disease|jansky-bielschowsky disease
129827|NCT02485886|PET|pet
129828|NCT02485886|interstitial pulmonary fibrosis (IPF)|interstitial pulmonary fibrosis (ipf)
129829|NCT02485886|cysteine cathepsins|cysteine cathepsins
129830|NCT02485886|macrophage|macrophage
129831|NCT02485873|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
129832|NCT02485873|Pevention|pevention
129833|NCT02485873|Stroke|stroke
129834|NCT02485860|pilonidal cysts|pilonidal cysts
129835|NCT02485860|Cavity wound|cavity wound
129836|NCT02485860|long healing|long healing
129837|NCT02485860|honey|honey
129838|NCT02485847|Eye Diseases|eye diseases
129839|NCT02485821|Estradiol|estradiol
129840|NCT02485821|Misoprostol|misoprostol
129841|NCT02485821|Induction of labor|induction of labor
129842|NCT02485821|Cervical ripening|cervical ripening
129843|NCT02485821|Bishop score|bishop score
129844|NCT02485808|Lower Urinary Tract Symptoms|lower urinary tract symptoms
129845|NCT02485808|Bladder Symptoms|bladder symptoms
129846|NCT02485808|Overactive Bladder|overactive bladder
129847|NCT02485808|Urinary Urgency|urinary urgency
129848|NCT02485808|Lower Urinary Tract Dysfunction|lower urinary tract dysfunction
129849|NCT02485795|Pain Management|pain management
129850|NCT02485795|Genetic Variation|genetic variation
129851|NCT02485795|Genetic Polymorphism|genetic polymorphism
129852|NCT02485795|Polymorphism, Single Nucleotide Genetic Association Studies|polymorphism, single nucleotide genetic association studies
129853|NCT02485795|Healthcare Utilization|healthcare utilization
129854|NCT02485756|Drug interactions|drug interactions
129855|NCT02485743|satiation|satiation
129856|NCT02485743|satiety|satiety
129857|NCT02485743|weight loss|weight loss
129858|NCT02485743|maintained weight loss|maintained weight loss
129859|NCT02485730|Prevention|prevention
129860|NCT02485730|Cohort Analysis|cohort analysis
129861|NCT02485730|Healthy Participants|healthy participants
129862|NCT02485678|ambulatory toxicity management|ambulatory toxicity management
129863|NCT02485678|adjuvant or neoadjuvant chemotherapy|adjuvant or neoadjuvant chemotherapy
129864|NCT02485665|Prostate cancer|prostate cancer
129865|NCT02485665|Robot-assisted laparoscopic surgery|robot-assisted laparoscopic surgery
129866|NCT02485665|Radical prostatectomy|radical prostatectomy
129867|NCT02485665|Post-prostatectomy incontinence|post-prostatectomy incontinence
129868|NCT02485665|Pelvic floor muscle exercise|pelvic floor muscle exercise
129869|NCT02485665|Extracorporeal biofeedback device|extracorporeal biofeedback device
129870|NCT02485652|NSCLC|nsclc
129871|NCT02485652|EGFR-TKI|egfr-tki
129872|NCT02485652|non small cell lung cancer|non small cell lung cancer
129873|NCT02485652|HM61713|hm61713
129874|NCT02485652|T790M-positive|t790m-positive
129875|NCT02485652|lung cancer|lung cancer
129876|NCT02485652|Phase II|phase ii
129877|NCT02485652|Olmutinib|olmutinib
129878|NCT02485639|HA-specific plasmablasts|ha-specific plasmablasts
129879|NCT02485639|humoral immunity|humoral immunity
129880|NCT02485639|influenza|influenza
129881|NCT02485639|memory B cells|memory b cells
129882|NCT02485626|Anthracyclines|anthracyclines
129883|NCT02485600|LCIG|lcig
129884|NCT02485600|Duodopa|duodopa
129885|NCT02485600|Parkinson's disease|parkinson's disease
129886|NCT02485600|Observational|observational
129887|NCT02485600|Cadence|cadence
129888|NCT02485600|Levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
129889|NCT02485587|Arousal Biofeedback|arousal biofeedback
129890|NCT02485587|Electrodermal activity|electrodermal activity
129891|NCT02485574|Bone bridging|bone bridging
129892|NCT02485574|Arthrodesis|arthrodesis
129893|NCT02485574|Lumbar|lumbar
129894|NCT02485574|Cage|cage
129895|NCT02485561|Colon cancer screening|colon cancer screening
129896|NCT02485561|Colorectal cancer screening|colorectal cancer screening
129897|NCT02485561|Colonoscopy|colonoscopy
129898|NCT02485561|Sigmoidoscopy|sigmoidoscopy
129899|NCT02485561|Stool blood test|stool blood test
129900|NCT02485561|Narrative|narrative
129901|NCT02485522|fecal incontinence|fecal incontinence
129902|NCT02485522|diet|diet
129903|NCT02485522|nutrition|nutrition
129904|NCT02485522|metabolites|metabolites
129905|NCT02485522|stool|stool
129906|NCT02485522|FI|fi
129907|NCT02485379|Prostate cancer|prostate cancer
129908|NCT02485379|Multiparametric MRI|multiparametric mri
129909|NCT02485379|Prostate biopsy|prostate biopsy
129910|NCT02485379|Targeted biopsy|targeted biopsy
129911|NCT02485379|Comparative study|comparative study
129912|NCT02485366|Rejuvenated packed red blood cells|rejuvenated packed red blood cells
129913|NCT02485353|Vosaroxin|vosaroxin
129914|NCT02485353|Cytarabine|cytarabine
129915|NCT02485353|Remission Induction|remission induction
129916|NCT02485353|Safety|safety
129917|NCT02485353|Progression-Free Survival|progression-free survival
129918|NCT02485353|Mortality Rate|mortality rate
129919|NCT02485353|Length of Stay|length of stay
129920|NCT02485314|children|children
129921|NCT02485314|disability|disability
129922|NCT02485314|family|family
129923|NCT02485314|participation|participation
129924|NCT02485301|Protection against Ebola Zaire virus|protection against ebola zaire virus
129925|NCT02485275|High Resolution MRI|high resolution mri
129926|NCT02485275|Infarction|infarction
129927|NCT02485275|Intracranial artery stenosis|intracranial artery stenosis
129928|NCT02485275|Cerebral small-vessel disease|cerebral small-vessel disease
129929|NCT02485262|Protease inhibitor treatment|protease inhibitor treatment
129930|NCT02485249|Iontophoresis|iontophoresis
129931|NCT02485249|Macular Edema|macular edema
129932|NCT02485249|Ophthalmology|ophthalmology
129933|NCT02485223|Multiple Sclerosis|multiple sclerosis
129935|NCT02485223|Diagnostic test|diagnostic test
129936|NCT02485223|Central veins|central veins
129937|NCT02485223|MRI|mri
129938|NCT02485210|photodynamic therapy , Endodontic treatment|photodynamic therapy , endodontic treatment
129939|NCT02485197|Muscle Metabolic Function|muscle metabolic function
129940|NCT02485197|Vitamin D Status|vitamin d status
129941|NCT02485197|25(OH)D|25(oh)d
129942|NCT02485197|Older Adults|older adults
129943|NCT02485158|Subjective Effects|subjective effects
129944|NCT02485158|Alcohol|alcohol
129945|NCT02485158|Amphetamine|amphetamine
129946|NCT02485158|THC|thc
129947|NCT02485158|Personality|personality
129948|NCT02485145|Topical|topical
121061|NCT02538705|Ulcers|ulcers
129949|NCT02485145|Hand osteoarthritis|hand osteoarthritis
129950|NCT02485132|Type 2 diabetes|type 2 diabetes
129951|NCT02485132|Sulfonylurea|sulfonylurea
129952|NCT02485132|Hypoglycemia|hypoglycemia
129953|NCT02485132|Quality of life|quality of life
129954|NCT02485119|BAY 94-9343|bay 94-9343
129955|NCT02485119|Anetumab ravtansine|anetumab ravtansine
129956|NCT02485119|ADC (Antibody Drug Conjugate)|adc (antibody drug conjugate)
129957|NCT02485119|Phase I|phase i
129958|NCT02485119|Japan|japan
129959|NCT02485119|solid cancers|solid cancers
129960|NCT02485119|Advanced, refractory solid tumors|advanced, refractory solid tumors
129961|NCT02485119|mesothelin|mesothelin
129962|NCT02485119|endometrial|endometrial
129963|NCT02485119|adenocarcinoma of lung|adenocarcinoma of lung
129964|NCT02485119|gastrointestinal, ovarian, pancreatic, cholangio, mesothelioma and triple negative breast cancers|gastrointestinal, ovarian, pancreatic, cholangio, mesothelioma and triple negative breast cancers
129965|NCT02485080|hepatitis C|hepatitis c
129966|NCT02485080|liver transplantation|liver transplantation
129967|NCT02485080|genotype 1|genotype 1
129968|NCT02485067|Overactive Bladder|overactive bladder
129969|NCT02485067|Tolterodine (Detrusitol)|tolterodine (detrusitol)
129970|NCT02485067|Pilocarpine|pilocarpine
129971|NCT02485041|Dapoxetine|dapoxetine
129972|NCT02485041|Mirodenafil|mirodenafil
129973|NCT02485041|DDI study|ddi study
129974|NCT02485028|Dapoxetine|dapoxetine
129975|NCT02485028|Mirodenafil|mirodenafil
129976|NCT02485028|DDI study|ddi study
129977|NCT02485015|CIK|cik
129978|NCT02485015|gastric cancer|gastric cancer
129979|NCT02485015|Apatinib|apatinib
129980|NCT02485002|kidney|kidney
129981|NCT02485002|kidney stone|kidney stone
129982|NCT02485002|NGAL|ngal
129983|NCT02485002|ureterorenoscopy|ureterorenoscopy
129984|NCT02485002|intrarenal surgery|intrarenal surgery
129985|NCT02485002|kidney function|kidney function
129986|NCT02484976|Family Based Behavioral Treatment|family based behavioral treatment
129987|NCT02484976|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
129988|NCT02484976|Childhood Obesity|childhood obesity
129989|NCT02484976|Satiety|satiety
129990|NCT02484976|BMI z-score|bmi z-score
129991|NCT02484976|Impulsive|impulsive
129992|NCT02484976|Non-obese controls|non-obese controls
129993|NCT02484976|Visual food cues|visual food cues
129994|NCT02484976|Leptin|leptin
129995|NCT02484976|Hormones|hormones
129996|NCT02484950|Mesenchymal stem cells|mesenchymal stem cells
129997|NCT02484937|Pain management|pain management
129998|NCT02484911|chemotherapy nausea vomiting|chemotherapy nausea vomiting
129999|NCT02484885|Magnetic Resonance Imaging|magnetic resonance imaging
130000|NCT02484885|Pulmonary Function|pulmonary function
130001|NCT02484872|Inflammation|inflammation
130002|NCT02484872|Glasgow score|glasgow score
130003|NCT02484872|Intensive Care Unit|intensive care unit
130004|NCT02484872|Emergency|emergency
130005|NCT02484859|Drug: remifentanil|drug: remifentanil
130006|NCT02484859|Drug: tramadol|drug: tramadol
130007|NCT02484859|Drug: metoprolol|drug: metoprolol
130008|NCT02484859|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
130009|NCT02484859|Controlled hypotension|controlled hypotension
130010|NCT02484833|First line|first line
130011|NCT02484833|metastatic colorectal cancer|metastatic colorectal cancer
130012|NCT02484833|Cetuximab|cetuximab
130013|NCT02484833|strategy study|strategy study
130014|NCT02484820|Preterm Birth|preterm birth
130015|NCT02484820|pessary|pessary
130016|NCT02484820|threatened preterm labor|threatened preterm labor
130017|NCT02484794|Eating Disorders|eating disorders
130018|NCT02484794|Smartphone|smartphone
130019|NCT02484794|App|app
130020|NCT02484794|Mobile Health|mobile health
130021|NCT02484794|Recovery Record|recovery record
130022|NCT02484794|Cognitive Behavioural Therapy|cognitive behavioural therapy
130023|NCT02484794|Outpatient Program|outpatient program
130024|NCT02484794|Self Monitoring|self monitoring
130025|NCT02484781|Gait disorder|gait disorder
130026|NCT02484781|Resurfacing Hip Arthroplasty|resurfacing hip arthroplasty
130027|NCT02484781|Total Hip Arthroplasty|total hip arthroplasty
130028|NCT02484729|AZD9977|azd9977
130030|NCT02484729|Tolerability|tolerability
130031|NCT02484729|Pharmacokinetics|pharmacokinetics
130033|NCT02484729|Single Ascending Dose|single ascending dose
130034|NCT02484729|Regional absorption|regional absorption
130035|NCT02484729|Healthy male subjects|healthy male subjects
130036|NCT02484716|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
130037|NCT02484716|Antiangiogenic therapy|antiangiogenic therapy
130039|NCT02484651|deep neuromuscular block|deep neuromuscular block
130040|NCT02484651|sugammadex|sugammadex
130041|NCT02484651|stability of anesthesia|stability of anesthesia
130042|NCT02484651|suppression of EMG activity|suppression of emg activity
130043|NCT02484651|PQRS|pqrs
130044|NCT02484651|General Anesthesia|general anesthesia
130045|NCT02484651|Quality of Recovery|quality of recovery
130046|NCT02484625|snacking|snacking
130047|NCT02484625|food intake|food intake
130048|NCT02484625|satiety|satiety
130049|NCT02484625|obesity|obesity
130050|NCT02484625|type-2 diabetes|type-2 diabetes
130051|NCT02484599|Eating Disorders|eating disorders
130052|NCT02484599|Anorexia Nervosa|anorexia nervosa
130053|NCT02484599|Attention bias|attention bias
130054|NCT02484599|Attention bias modification|attention bias modification
130055|NCT02484586|Presbyopia|presbyopia
130056|NCT02484586|Refractive error|refractive error
130057|NCT02484586|Contact lens|contact lens
130058|NCT02484573|Cirrhosis|cirrhosis
130059|NCT02484573|Variceal Bleeding|variceal bleeding
130060|NCT02484573|Non-selective beta blocker|non-selective beta blocker
130061|NCT02484573|Intestinal Permeability|intestinal permeability
130062|NCT02484573|Gene expression|gene expression
130063|NCT02484573|Bacterial translocation|bacterial translocation
130064|NCT02484560|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
130065|NCT02484560|Neuromuscular Diseases|neuromuscular diseases
130066|NCT02484560|Muscular Dystrophy|muscular dystrophy
130067|NCT02484560|Genetic Diseases, X-linked|genetic diseases, x-linked
130068|NCT02484560|Musculoskeletal Diseases|musculoskeletal diseases
130069|NCT02484560|Nervous System Diseases|nervous system diseases
130070|NCT02484547|Aducanumab|aducanumab
130071|NCT02484547|BIIB037|biib037
130072|NCT02484534|Coagulation Factor|coagulation factor
130073|NCT02484534|cirrhosis|cirrhosis
130074|NCT02484508|Guli capsule|guli capsule
130075|NCT02484508|knee osteoarthritis|knee osteoarthritis
130076|NCT02484508|Changing of WOMAC and VAS score|changing of womac and vas score
130077|NCT02484495|Complementary feeding recommendation|complementary feeding recommendation
130078|NCT02484495|Program evaluation|program evaluation
130079|NCT02484495|Process and impact evaluation|process and impact evaluation
130080|NCT02484456|Major Depression|major depression
130081|NCT02484456|Glycine Receptor Antagonist|glycine receptor antagonist
130082|NCT02484456|4-Chlorokyneurenine|4-chlorokyneurenine
130083|NCT02484456|Treatment Resistant|treatment resistant
130084|NCT02484456|Glutamatergic System|glutamatergic system
130085|NCT02484417|Neutralizing Antibody|neutralizing antibody
130086|NCT02484417|Viral Shedding|viral shedding
130087|NCT02484417|Mucosal Immune Reponse|mucosal immune reponse
130088|NCT02484417|Upper Respiratory Infection|upper respiratory infection
130089|NCT02484404|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
130090|NCT02484404|PARP Inhibitor|parp inhibitor
130091|NCT02484404|VEGFR Inhibitor|vegfr inhibitor
130092|NCT02484378|ACS|acs
130093|NCT02484378|IVUS|ivus
130094|NCT02484378|HDL|hdl
130095|NCT02484365|Hemoglobins|hemoglobins
130096|NCT02484365|Monitoring, Outpatient|monitoring, outpatient
130097|NCT02484365|Preoperative Period|preoperative period
130098|NCT02484365|Pediatrics|pediatrics
130099|NCT02484352|dosage of oxycodone during intubation|dosage of oxycodone during intubation
130100|NCT02484326|ST-elevation myocardial infarction|st-elevation myocardial infarction
130101|NCT02484326|Cardiac rupture|cardiac rupture
130102|NCT02484326|Risk assessment|risk assessment
130103|NCT02484300|loop gain|loop gain
130104|NCT02484300|chemoreflex control|chemoreflex control
130105|NCT02484300|melatonin|melatonin
130106|NCT02484300|antioxidant|antioxidant
130107|NCT02484300|obstructive sleep apnea|obstructive sleep apnea
130108|NCT02484300|ventilatory control|ventilatory control
130109|NCT02484274|iron-deficiency|iron-deficiency
130110|NCT02484274|iron-deficiency anemia|iron-deficiency anemia
130111|NCT02484274|infants and toddlers|infants and toddlers
130112|NCT02484274|industrialised countries|industrialised countries
130113|NCT02484274|population-based study|population-based study
130114|NCT02484274|prevalence and risk factors|prevalence and risk factors
130115|NCT02484274|screening strategies|screening strategies
130116|NCT02484274|diagnosis markers|diagnosis markers
130117|NCT02484274|primary prevention|primary prevention
130118|NCT02484261|childhood leukemia|childhood leukemia
130119|NCT02484261|relapsed leukemia|relapsed leukemia
130120|NCT02484261|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
130121|NCT02484235|obesity|obesity
130122|NCT02484235|exercise|exercise
130123|NCT02484235|HIIT|hiit
130124|NCT02484235|Vo2|vo2
130125|NCT02484235|kinetics|kinetics
130126|NCT02484222|adenotonsillectomy|adenotonsillectomy
130129|NCT02484209|frailty|frailty
130130|NCT02484209|aged|aged
130131|NCT02484209|metformin|metformin
130133|NCT02484209|hypoglycaemia|hypoglycaemia
130134|NCT02484183|bubble continuous positive airway pressure (CPAP)|bubble continuous positive airway pressure (cpap)
130135|NCT02484183|pneumonia|pneumonia
130136|NCT02484183|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
130137|NCT02484183|malnutrition|malnutrition
130138|NCT02484183|Malawi|malawi
130139|NCT02484183|Africa|africa
130140|NCT02484183|Noninvasive Ventilation|noninvasive ventilation
130141|NCT02484183|child|child
130142|NCT02484183|pediatric|pediatric
130143|NCT02484183|hypoxemia|hypoxemia
130144|NCT02484170|Mannitol|mannitol
130145|NCT02484170|cream|cream
130146|NCT02484170|neuropathic pain|neuropathic pain
130147|NCT02484157|Whole Blood Coagulation Time|whole blood coagulation time
130148|NCT02484157|cardiac surgery|cardiac surgery
130149|NCT02484144|information|information
130150|NCT02484144|coronarography|coronarography
130151|NCT02484144|understanding|understanding
130152|NCT02484131|Osteoporosis|osteoporosis
130153|NCT02484131|DXA Screening|dxa screening
130154|NCT02484131|Women|women
130155|NCT02484131|Breast Cancer|breast cancer
130156|NCT02484131|Survivors|survivors
130157|NCT02484131|Educational materials|educational materials
130158|NCT02484131|Personal choices on delivery methods|personal choices on delivery methods
130159|NCT02484092|Hemophilia B|hemophilia b
130160|NCT02484092|Blood Coagulation Disorders|blood coagulation disorders
130161|NCT02484092|Gene Therapy|gene therapy
130162|NCT02484092|Gene Transfer|gene transfer
130163|NCT02484092|Factor IX Deficiency|factor ix deficiency
130164|NCT02484092|Factor IX Gene|factor ix gene
130165|NCT02484092|Factor IX Protein|factor ix protein
130166|NCT02484092|Vector|vector
130167|NCT02484092|AAV|aav
130168|NCT02484066|Virtual bronchoscopic navigation|virtual bronchoscopic navigation
130169|NCT02484066|Endobronchial ultrasound|endobronchial ultrasound
130170|NCT02484066|Guide Sheath|guide sheath
130171|NCT02484066|Transbronchial biopsy|transbronchial biopsy
130172|NCT02484066|Peripheral pulmonary lesions|peripheral pulmonary lesions
130173|NCT02484053|adult and pediatric cancers|adult and pediatric cancers
130174|NCT02484053|blood disorders|blood disorders
130175|NCT02484053|lymphoma|lymphoma
130176|NCT02484053|graft-versus-host-disease|graft-versus-host-disease
130177|NCT02484053|diseases of the immune system|diseases of the immune system
130178|NCT02484040|tumor response|tumor response
130179|NCT02484040|toxicity|toxicity
130180|NCT02484040|recurrence|recurrence
130181|NCT02484040|chemoradiotherpy|chemoradiotherpy
130182|NCT02484040|rectum|rectum
130183|NCT02484027|acute ischemic stroke|acute ischemic stroke
130184|NCT02484027|mRS|mrs
130185|NCT02484027|rosuvastatin|rosuvastatin
130186|NCT02484001|Eslicarbazepine acetate|eslicarbazepine acetate
130187|NCT02484001|BIA 2-093|bia 2-093
130188|NCT02484001|Epilepsy|epilepsy
130189|NCT02483975|Fluticasone Furoate|fluticasone furoate
130190|NCT02483975|Asthma|asthma
130191|NCT02483975|HPA axis|hpa axis
130192|NCT02483975|Children|children
130193|NCT02483975|Inhaled corticosteroid|inhaled corticosteroid
130195|NCT02483923|serratus anterior block|serratus anterior block
130196|NCT02483923|ultrasound|ultrasound
130197|NCT02483923|breast cancer|breast cancer
130198|NCT02483923|postoperative pain|postoperative pain
130199|NCT02483910|School-age children|school-age children
130200|NCT02483910|Pediatrics|pediatrics
130201|NCT02483910|Direct Instruction-Language for Learning|direct instruction-language for learning
130202|NCT02483884|Bombesin|bombesin
130203|NCT02483884|Gastrin-Releasing Peptide|gastrin-releasing peptide
130204|NCT02483884|Prostatic Neoplasms|prostatic neoplasms
130205|NCT02483884|Genital Diseases, Male|genital diseases, male
130206|NCT02483884|Genital Neoplasms, Male|genital neoplasms, male
130207|NCT02483884|Neoplasms|neoplasms
130208|NCT02483884|Neoplasms by Site|neoplasms by site
130209|NCT02483884|Urogenital Neoplasms|urogenital neoplasms
130210|NCT02483884|Gastrointestinal Agents|gastrointestinal agents
130211|NCT02483884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
130212|NCT02483884|Neurotransmitter Agents|neurotransmitter agents
130213|NCT02483884|Pharmacologic Actions|pharmacologic actions
130214|NCT02483884|Physiological Effects of Drugs|physiological effects of drugs
130215|NCT02483884|Therapeutic Uses|therapeutic uses
130216|NCT02483871|Estrogen Receptor Positive|estrogen receptor positive
130217|NCT02483858|oncology, solid tumors|oncology, solid tumors
130218|NCT02483819|Elderly patient|elderly patient
130219|NCT02483819|NICOM|nicom
130220|NCT02483819|TURP|turp
130221|NCT02483767|Premenopausal Breast Cancer|premenopausal breast cancer
130222|NCT02483767|Preservation of Ovarian Function|preservation of ovarian function
130223|NCT02483767|Gonadotropin-Releasing Hormone Agonist|gonadotropin-releasing hormone agonist
130224|NCT02483728|Metal Allergy|metal allergy
130225|NCT02483715|Helicobacter pylori|helicobacter pylori
130226|NCT02483715|high dose dual therapy|high dose dual therapy
130227|NCT02483715|bismuth-containing quadruple therapy|bismuth-containing quadruple therapy
130228|NCT02483715|antibiotic resistance|antibiotic resistance
130231|NCT02483702|graft versus host disease|graft versus host disease
130232|NCT02483702|TA-GVHD|ta-gvhd
130233|NCT02483702|potassium|potassium
130234|NCT02483702|Blood transfusion|blood transfusion
130235|NCT02483689|Post Operative Pain|post operative pain
130236|NCT02483689|Appendicitis|appendicitis
130237|NCT02483689|Appendectomy|appendectomy
130238|NCT02483689|Local Anesthetic|local anesthetic
130239|NCT02483689|Saline|saline
130240|NCT02483689|Pain Management|pain management
130241|NCT02483689|Surgery|surgery
130242|NCT02483689|Recovery|recovery
130243|NCT02483676|Rehabilitation|rehabilitation
130244|NCT02483676|Robotics|robotics
130245|NCT02483676|Gait|gait
130246|NCT02483663|Twins|twins
130247|NCT02483663|Obesity|obesity
130248|NCT02483663|Appetite|appetite
121364|NCT02536625|NK|nk
130249|NCT02483637|spray cryotherapy|spray cryotherapy
130250|NCT02483637|cryotherapy|cryotherapy
130251|NCT02483637|chronic bronchitis|chronic bronchitis
130252|NCT02483637|airflow restrictions|airflow restrictions
130253|NCT02483611|Onset|onset
130254|NCT02483611|Recovery|recovery
130255|NCT02483611|Lidocaine|lidocaine
130256|NCT02483611|Cisatracurium|cisatracurium
130257|NCT02483611|Magnesium sulfate|magnesium sulfate
130258|NCT02483611|Isotonic solution|isotonic solution
130259|NCT02483598|buspirone|buspirone
130260|NCT02483598|pharmacokinetics|pharmacokinetics
130261|NCT02483598|Cytochrome P450 3A4|cytochrome p450 3a4
130262|NCT02483585|Migraine|migraine
130263|NCT02483585|Headache|headache
130264|NCT02483585|Episodic|episodic
130265|NCT02483585|Prevention|prevention
130266|NCT02483585|Prophylaxis|prophylaxis
130267|NCT02483559|Sleep|sleep
130268|NCT02483559|Photoreceptor Cells, Vertebrate|photoreceptor cells, vertebrate
130269|NCT02483559|Melatonin|melatonin
130270|NCT02483546|Medical education|medical education
130271|NCT02483546|simulation|simulation
130272|NCT02483546|ACLS|acls
130273|NCT02483520|Family caregiver|family caregiver
130274|NCT02483507|Ultrasound guidance|ultrasound guidance
130275|NCT02483507|Vascular access|vascular access
130276|NCT02483507|Pediatric anesthesia|pediatric anesthesia
130277|NCT02483494|Telemedicine|telemedicine
130278|NCT02483494|Advanced Practice Nurse|advanced practice nurse
130279|NCT02483481|sinusoidal obstruction syndrome|sinusoidal obstruction syndrome
130280|NCT02483481|ultrasound elastography|ultrasound elastography
130281|NCT02483481|bone marrow transplant|bone marrow transplant
130282|NCT02483429|Vertigo|vertigo
130283|NCT02483429|Dizziness|dizziness
130284|NCT02483429|Unsteadiness|unsteadiness
130285|NCT02483429|Stroke|stroke
130286|NCT02483429|Vestibular neuritis|vestibular neuritis
130287|NCT02483429|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
130288|NCT02483429|Vestibulo-ocular reflex|vestibulo-ocular reflex
130289|NCT02483429|Video-oculography|video-oculography
130290|NCT02483429|Emergency department|emergency department
130291|NCT02483403|Magnetic Resonance Imaging|magnetic resonance imaging
130292|NCT02483403|Pulmonary Function|pulmonary function
130293|NCT02483403|Volunteers|volunteers
130294|NCT02483390|palliative care|palliative care
130295|NCT02483390|e-health|e-health
130296|NCT02483390|e-therapy|e-therapy
130297|NCT02483390|psychosocial services|psychosocial services
130298|NCT02483377|Sign or Symptom|sign or symptom
130299|NCT02483351|Blood Transfusion|blood transfusion
130300|NCT02483338|Psychometric validity|psychometric validity
130301|NCT02483338|Pain scale|pain scale
130302|NCT02483338|Postoperative|postoperative
130303|NCT02483338|Children|children
130304|NCT02483312|Recurrent|recurrent
130305|NCT02483299|response to therapy|response to therapy
130306|NCT02483286|Osteoporosis|osteoporosis
130307|NCT02483286|Fall|fall
130308|NCT02483286|Fracture|fracture
130309|NCT02483286|sarcopenia|sarcopenia
130310|NCT02483286|Exercise|exercise
130311|NCT02483273|Conjunctival microcirculation|conjunctival microcirculation
130312|NCT02483273|Sublingual microcirculation|sublingual microcirculation
130313|NCT02483273|Sidestream Dark Field (SDF) microscopy|sidestream dark field (sdf) microscopy
130314|NCT02483247|Neoplasms|neoplasms
130315|NCT02483195|Hair loss|hair loss
130316|NCT02483195|Post Menopausal|post menopausal
130317|NCT02483182|Herpes labialis, Cold sores, ZEP-3 ointment|herpes labialis, cold sores, zep-3 ointment
130318|NCT02483169|ischemic stroke|ischemic stroke
130319|NCT02483169|intracranial hemorrhage|intracranial hemorrhage
130320|NCT02483169|cilostazol|cilostazol
130321|NCT02483169|probucol|probucol
130322|NCT02483169|intima media thickness|intima media thickness
130324|NCT02483156|Sofosbuvir|sofosbuvir
130325|NCT02483156|Ribavirin|ribavirin
130326|NCT02483143|contrast media|contrast media
130327|NCT02483143|pulmonary embolism|pulmonary embolism
130328|NCT02483143|N-acetylcysteine|n-acetylcysteine
130329|NCT02483104|ABT-888|abt-888
130330|NCT02483104|BRCA|brca
130331|NCT02483104|Primary peritoneal cancer|primary peritoneal cancer
130332|NCT02483104|carboplatin|carboplatin
130333|NCT02483104|Fallopian tube|fallopian tube
130334|NCT02483104|Poly (ADP-ribose) polymerase (PARP)|poly (adp-ribose) polymerase (parp)
130335|NCT02483104|paclitaxel|paclitaxel
130336|NCT02483104|Ovarian cancer|ovarian cancer
130337|NCT02483104|veliparib|veliparib
130338|NCT02483091|Knowledge translation|knowledge translation
130339|NCT02483091|Clinical practice guidelines|clinical practice guidelines
130340|NCT02483091|Multimodal care|multimodal care
130341|NCT02483091|Brief Action Planning|brief action planning
130342|NCT02483091|Feasibility outcomes|feasibility outcomes
130343|NCT02483065|dementia|dementia
130344|NCT02483065|hospital admission|hospital admission
130345|NCT02483065|mortality|mortality
130346|NCT02483065|health-related quality of life|health-related quality of life
130347|NCT02483065|activities of daily living|activities of daily living
130348|NCT02483052|lobectomy|lobectomy
121475|NCT02535884|DBS|dbs
130349|NCT02483052|spray cryotherapy|spray cryotherapy
130350|NCT02483052|lung cancer|lung cancer
130351|NCT02483039|Acute kidney injury|acute kidney injury
130352|NCT02483039|Chronic kidney disease|chronic kidney disease
130353|NCT02483039|Quality improvement|quality improvement
130354|NCT02483013|whitening dentifrices|whitening dentifrices
130355|NCT02483013|color alteration|color alteration
130356|NCT02483013|tooth sensitivity|tooth sensitivity
130357|NCT02482987|dental|dental
130358|NCT02482987|extraction|extraction
130359|NCT02482987|socket preservation|socket preservation
130360|NCT02482987|ridge preservation|ridge preservation
130361|NCT02482987|implant site preparation|implant site preparation
130362|NCT02482974|Liver transplantation|liver transplantation
130363|NCT02482974|Everolimus|everolimus
130364|NCT02482974|Sirolimus|sirolimus
130365|NCT02482974|Treatment outcome|treatment outcome
130366|NCT02482974|Safety|safety
130367|NCT02482948|Debridement|debridement
130368|NCT02482948|collagenase|collagenase
130369|NCT02482948|leptospermum honey|leptospermum honey
130370|NCT02482922|feasibility studies|feasibility studies
130371|NCT02482922|intervention|intervention
130372|NCT02482922|Pre-Hypertensive|pre-hypertensive
130373|NCT02482922|Pre-Hyperlipidemia|pre-hyperlipidemia
130374|NCT02482844|TAVI|tavi
130375|NCT02482844|de novo and persistent LBBB|de novo and persistent lbbb
130376|NCT02482844|electrophysiology|electrophysiology
130377|NCT02482844|Holter|holter
130378|NCT02482844|pacemaker|pacemaker
130379|NCT02482831|Sciatic nerve block|sciatic nerve block
130380|NCT02482831|block duration|block duration
130381|NCT02482831|Semmes Weinstein monofilaments|semmes weinstein monofilaments
130382|NCT02482831|fasting blood glucose|fasting blood glucose
130383|NCT02482831|nerve block|nerve block
130384|NCT02482831|sensory block duration|sensory block duration
130385|NCT02482831|motor block duration|motor block duration
130386|NCT02482818|chronic cough|chronic cough
130387|NCT02482818|cough hypersensitivity|cough hypersensitivity
130388|NCT02482818|Lyrica|lyrica
130389|NCT02482818|Pregabalin|pregabalin
130390|NCT02482818|cough reflex sensitivity|cough reflex sensitivity
130391|NCT02482792|Musculoskeletal disorders|musculoskeletal disorders
130392|NCT02482792|Psychosomatic|psychosomatic
130393|NCT02482792|Pain|pain
130394|NCT02482753|Chidamide|chidamide
130395|NCT02482753|breast cancer|breast cancer
130396|NCT02482753|exemestane|exemestane
130397|NCT02482753|Estrogen Receptor|estrogen receptor
130499|NCT02482142|phosphorus|phosphorus
130398|NCT02482740|Uterine Cervical Neoplasms|uterine cervical neoplasms
130399|NCT02482740|antiestrogens|antiestrogens
130400|NCT02482727|Blood Flow Restriction|blood flow restriction
130401|NCT02482727|Occlusion training|occlusion training
130402|NCT02482727|Distal radius fracture|distal radius fracture
130403|NCT02482714|Quality of Life|quality of life
130404|NCT02482714|Physical Activity|physical activity
130405|NCT02482701|EMR|emr
130406|NCT02482701|EAC|eac
130407|NCT02482701|Barrett's Neoplasia|barrett's neoplasia
130408|NCT02482701|Multiband Mucosectomy|multiband mucosectomy
130409|NCT02482675|Dairy|dairy
130410|NCT02482675|Milk|milk
130411|NCT02482675|Glucose|glucose
130412|NCT02482675|Postprandial|postprandial
130413|NCT02482675|Hyperglycemia|hyperglycemia
130414|NCT02482675|Prediabetes|prediabetes
130415|NCT02482675|Blood glucose|blood glucose
130416|NCT02482675|Oxidative stress|oxidative stress
130417|NCT02482675|Vascular health|vascular health
130418|NCT02482675|Vascular function|vascular function
130419|NCT02482662|Diagnosis|diagnosis
130420|NCT02482636|infant immunisations|infant immunisations
130421|NCT02482636|vaccines|vaccines
130422|NCT02482636|paediatric|paediatric
130423|NCT02482636|pneumococcal|pneumococcal
130424|NCT02482636|meningococcal|meningococcal
130425|NCT02482623|Dementia|dementia
130426|NCT02482623|neuropsychiatric symptoms|neuropsychiatric symptoms
130427|NCT02482623|implementation science|implementation science
130428|NCT02482623|depression|depression
130429|NCT02482623|pain|pain
130430|NCT02482610|Dairy|dairy
130431|NCT02482610|Milk|milk
130432|NCT02482610|Glucose|glucose
130433|NCT02482610|Postprandial|postprandial
130434|NCT02482610|Hyperglycemia|hyperglycemia
130435|NCT02482610|Prediabetes|prediabetes
130436|NCT02482610|Blood glucose|blood glucose
130437|NCT02482610|Oxidative stress|oxidative stress
130438|NCT02482610|Vascular health|vascular health
130439|NCT02482610|Vascular function|vascular function
130440|NCT02482571|Functional MRS|functional mrs
130441|NCT02482571|Functional MRI|functional mri
130442|NCT02482558|Glycaemic Index|glycaemic index
130443|NCT02482558|NAFLD|nafld
130444|NCT02482558|Glycogen|glycogen
130445|NCT02482558|Liver|liver
130446|NCT02482558|Diet|diet
130447|NCT02482532|Melanoma|melanoma
130448|NCT02482532|metastatic|metastatic
130449|NCT02482532|relapsed|relapsed
130450|NCT02482532|refractory|refractory
130451|NCT02482506|African American|african american
130452|NCT02482506|Overweight|overweight
130453|NCT02482506|Adults|adults
130454|NCT02482480|SLEEP|sleep
130455|NCT02482480|APNEA|apnea
130456|NCT02482480|EXERCISE|exercise
130457|NCT02482467|ovarian cyst|ovarian cyst
130458|NCT02482467|prenatal diagnosis|prenatal diagnosis
130459|NCT02482467|puberty|puberty
130460|NCT02482454|radiofrequency ablation|radiofrequency ablation
130461|NCT02482454|cytokine-induced killer cells|cytokine-induced killer cells
130462|NCT02482454|cholangiocarcinoma|cholangiocarcinoma
130463|NCT02482441|Advanced Solid Tumors and in Combination|advanced solid tumors and in combination
130464|NCT02482441|FOLFIRI for Patients with Previously Treated Metastatic|folfiri for patients with previously treated metastatic
130465|NCT02482441|Colorectal Cancer|colorectal cancer
130466|NCT02482428|human papilloma virus (HPV), Genital Warts, Sexually transmitted disease (STD), viral disease|human papilloma virus (hpv), genital warts, sexually transmitted disease (std), viral disease
130467|NCT02482415|Palliative Care|palliative care
130468|NCT02482415|Randomized controlled trial|randomized controlled trial
130469|NCT02482415|Family caregivers|family caregivers
130470|NCT02482415|Intervention|intervention
130471|NCT02482415|Family|family
130472|NCT02482415|Intervention studies|intervention studies
130473|NCT02482415|Home Care|home care
130474|NCT02482311|AZD1775|azd1775
130475|NCT02482311|Ovarian cancer (BRCA1/2 mutation)|ovarian cancer (brca1/2 mutation)
130476|NCT02482311|Ovarian cancer (PARP-failure)|ovarian cancer (parp-failure)
130477|NCT02482311|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
130478|NCT02482311|Small-cell lung cancer (SCLC)|small-cell lung cancer (sclc)
130479|NCT02482311|Solid tumours|solid tumours
130480|NCT02482298|Sickle cell disease|sickle cell disease
130481|NCT02482298|Young adults|young adults
130482|NCT02482298|Hestia2|hestia2
130483|NCT02482298|Ticagrelor|ticagrelor
130484|NCT02482233|electronic cigarette|electronic cigarette
130485|NCT02482233|nicotine replacement therapy|nicotine replacement therapy
130486|NCT02482233|smoking cessation|smoking cessation
130487|NCT02482233|perioperative|perioperative
130488|NCT02482194|Spinal cord injury|spinal cord injury
130489|NCT02482194|mesenchymal stem cells|mesenchymal stem cells
130490|NCT02482194|transplantation|transplantation
130491|NCT02482181|diffusion weighted magnetic resonance imaging|diffusion weighted magnetic resonance imaging
130492|NCT02482168|immunotherapy|immunotherapy
130493|NCT02482168|CD40|cd40
130494|NCT02482155|pharmacokinetics|pharmacokinetics
130495|NCT02482155|MOMENTACT|momentact
130496|NCT02482155|ibuprofen 400 mg|ibuprofen 400 mg
130497|NCT02482155|oral|oral
130498|NCT02482155|granules|granules
130500|NCT02482142|lean|lean
130501|NCT02482142|obese|obese
130502|NCT02482142|energy expenditure|energy expenditure
130503|NCT02482129|Acute anterior uveitis|acute anterior uveitis
130504|NCT02482129|LME636|lme636
130505|NCT02482116|malaria|malaria
130506|NCT02482116|pneumonia|pneumonia
130507|NCT02482116|Nigeria|nigeria
130508|NCT02482116|IMCI|imci
130509|NCT02482116|diagnosis|diagnosis
130510|NCT02482103|Therapy resistant hypertension|therapy resistant hypertension
130511|NCT02482051|Carbapenem-resistant Enterobacteriaceae|carbapenem-resistant enterobacteriaceae
130512|NCT02482051|Accelerate ID/AST|accelerate id/ast
130513|NCT02482025|Medications|medications
130514|NCT02482025|Hospitalization|hospitalization
130515|NCT02482025|Electronic medical records|electronic medical records
130516|NCT02482012|research|research
130517|NCT02482012|vulnerable population|vulnerable population
130518|NCT02482012|45 CFR 46.406|45 cfr 46.406
130519|NCT02481999|Depth of anesthesia|depth of anesthesia
130520|NCT02481973|PMS|pms
130521|NCT02481973|Homoeopathy|homoeopathy
130522|NCT02481973|Grant Bentley Method|grant bentley method
130523|NCT02481934|Recurrent multiple myeloma|recurrent multiple myeloma
130524|NCT02481934|NK cells|nk cells
130525|NCT02481934|cell therapy|cell therapy
130526|NCT02481934|NKAE|nkae
130527|NCT02481934|Relapsed multiple myeloma|relapsed multiple myeloma
130528|NCT02481921|heart failure|heart failure
130529|NCT02481921|self-management|self-management
130530|NCT02481921|group intervention|group intervention
130531|NCT02481908|AECOPD|aecopd
130532|NCT02481908|left ventricular dysfunction|left ventricular dysfunction
130533|NCT02481908|valsalva maneuver|valsalva maneuver
130534|NCT02481908|systolic time intervals|systolic time intervals
130535|NCT02481895|cognition|cognition
130536|NCT02481895|psychosocial functioning|psychosocial functioning
130538|NCT02481869|unilateral|unilateral
130539|NCT02481869|pilon|pilon
130540|NCT02481843|Hyperoxia|hyperoxia
130541|NCT02481843|Microcirculation|microcirculation
130542|NCT02481843|Erythropoietin|erythropoietin
130543|NCT02481843|Normobaric Oxygen Paradox|normobaric oxygen paradox
130544|NCT02481804|diet|diet
130545|NCT02481804|vitamin|vitamin
130546|NCT02481778|Radiotherapy|radiotherapy
130547|NCT02481778|Cardiac|cardiac
130548|NCT02481778|Toxicity|toxicity
130549|NCT02481752|Tobacco Use|tobacco use
130550|NCT02481752|Nicotine Dependence|nicotine dependence
130551|NCT02481739|endometriosis|endometriosis
121655|NCT02534285|Hearing|hearing
130554|NCT02481726|68Ga|68ga
130555|NCT02481726|Alfatide II|alfatide ii
130556|NCT02481726|RGD|rgd
130557|NCT02481726|αvβ3|αvβ3
130558|NCT02481726|PET/CT|pet/ct
130559|NCT02481713|psychosis|psychosis
130560|NCT02481713|adherence|adherence
130561|NCT02481713|motivation|motivation
130562|NCT02481674|Prodromal Stage|prodromal stage
130563|NCT02481674|Early Manifest Stage|early manifest stage
130564|NCT02481635|Blood Vessels|blood vessels
130565|NCT02481635|Reconstructive Surgery|reconstructive surgery
130566|NCT02481622|HIV infection|hiv infection
130567|NCT02481622|vaginal tissues|vaginal tissues
130568|NCT02481622|uterine tissues|uterine tissues
130569|NCT02481609|Loss of Smell|loss of smell
130570|NCT02481609|Olfaction|olfaction
130571|NCT02481609|Hyposmia|hyposmia
130572|NCT02481596|family|family
130573|NCT02481596|support|support
130574|NCT02481596|diet|diet
130575|NCT02481596|exercise|exercise
130576|NCT02481596|social|social
130577|NCT02481583|levosulpiride|levosulpiride
130578|NCT02481583|pharmacokinetics|pharmacokinetics
130579|NCT02481583|adverse effects|adverse effects
130580|NCT02481583|bioavailability|bioavailability
130581|NCT02481570|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
130582|NCT02481570|Scoliosis surgery|scoliosis surgery
130583|NCT02481570|Pharmacokinetic simulation|pharmacokinetic simulation
130586|NCT02481492|Circumcision, Male|circumcision, male
130587|NCT02481492|Shang Ring|shang ring
130588|NCT02481492|Children|children
130589|NCT02481492|Foreskin|foreskin
130590|NCT02481466|Arterial plaque|arterial plaque
130591|NCT02481466|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
130592|NCT02481466|Portfolio diet|portfolio diet
130593|NCT02481466|Dietary modification|dietary modification
130594|NCT02481466|Dietary trials|dietary trials
130595|NCT02481466|hypercholesterolemia|hypercholesterolemia
130596|NCT02481466|diabetes|diabetes
130597|NCT02481466|exercise|exercise
130598|NCT02481466|cardiovascular disease risk|cardiovascular disease risk
130599|NCT02481466|glycemic index (GI)|glycemic index (gi)
130600|NCT02481466|Carotid Ultrasound|carotid ultrasound
130601|NCT02481466|Dietary Approaches to Stop Hypertension (DASH) diet|dietary approaches to stop hypertension (dash) diet
130602|NCT02481440|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
130603|NCT02481440|spinal cord injury|spinal cord injury
130605|NCT02481427|Unicondylar|unicondylar
130606|NCT02481427|Osteoarthritis|osteoarthritis
130607|NCT02481427|Arthroplasty|arthroplasty
130608|NCT02481427|Replacement|replacement
130609|NCT02481427|Knee|knee
131128|NCT02478385|oxytocin|oxytocin
130610|NCT02481414|HSIL, CIN II/III|hsil, cin ii/iii
130611|NCT02481401|cardiovascular health|cardiovascular health
130612|NCT02481401|behavior change|behavior change
130613|NCT02481401|community-based|community-based
130614|NCT02481401|family-based|family-based
130615|NCT02481401|prevention|prevention
130616|NCT02481375|iron|iron
130617|NCT02481375|ferritin|ferritin
130618|NCT02481375|soluble transferrin receptor|soluble transferrin receptor
130619|NCT02481375|hepcidin|hepcidin
130620|NCT02481375|reticulocyte count|reticulocyte count
130621|NCT02481375|hemoglobin|hemoglobin
130622|NCT02481375|supplementation|supplementation
130623|NCT02481349|Glioma|glioma
130624|NCT02481349|Hatha yoga|hatha yoga
130625|NCT02481349|Questionnaires|questionnaires
130626|NCT02481349|Surveys|surveys
130627|NCT02481336|Chemotherapy|chemotherapy
130628|NCT02481336|Peripheral Neuropathy|peripheral neuropathy
130629|NCT02481323|cerebral small vessel disease|cerebral small vessel disease
130630|NCT02481323|cerebrovascular reactivity|cerebrovascular reactivity
130631|NCT02481323|cilostazol|cilostazol
130632|NCT02481323|isosorbide mononitrate|isosorbide mononitrate
130633|NCT02481297|Leukemia|leukemia
130634|NCT02481297|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
130635|NCT02481297|CLL|cll
130636|NCT02481297|Refractory/Relapsed|refractory/relapsed
130637|NCT02481297|Untreated with high-risk molecular features|untreated with high-risk molecular features
130638|NCT02481297|Small lymphocytic leukemia|small lymphocytic leukemia
130639|NCT02481297|SLL|sll
130640|NCT02481297|Lirilumab|lirilumab
130641|NCT02481297|Rituximab|rituximab
130642|NCT02481297|Rituxan|rituxan
131342|NCT02477007|pain|pain
130644|NCT02481284|Deep inferior epigastric artery perforator flap|deep inferior epigastric artery perforator flap
130646|NCT02481284|Plastic and reconstructive surgery|plastic and reconstructive surgery
130647|NCT02481271|cholecystectomy|cholecystectomy
130648|NCT02481258|Stenosis|stenosis
130649|NCT02481258|Aortic Valve|aortic valve
130650|NCT02481258|Aorta|aorta
130651|NCT02481258|Calcified|calcified
130652|NCT02481258|Calcific|calcific
130653|NCT02481258|Calcification|calcification
130654|NCT02481245|Bipolar Disorder|bipolar disorder
130655|NCT02481245|Bezafibrate|bezafibrate
130656|NCT02481245|Depressive Episode|depressive episode
130657|NCT02481219|Polyps|polyps
130658|NCT02481219|Capsule endoscopy|capsule endoscopy
130659|NCT02481219|Bowel preparation regimen|bowel preparation regimen
130660|NCT02481219|Average risk patients for colorectal cancer screening|average risk patients for colorectal cancer screening
130661|NCT02481206|Ventricular Tachycardia|ventricular tachycardia
130662|NCT02481193|Cisatracurium|cisatracurium
130663|NCT02481193|Myalgia|myalgia
130664|NCT02481193|Fasciculation|fasciculation
130665|NCT02481193|Succinylcholine|succinylcholine
130666|NCT02481167|Aged|aged
130667|NCT02481167|Meibomian Glands|meibomian glands
130668|NCT02481167|dry eye|dry eye
130669|NCT02481167|Elderly|elderly
130670|NCT02481154|Glioma|glioma
130671|NCT02481154|IDH1|idh1
130672|NCT02481154|IDH2|idh2
130673|NCT02481154|Dual Mutation|dual mutation
130674|NCT02481154|AG-881|ag-881
130675|NCT02481128|lymphoscintigraphy|lymphoscintigraphy
130676|NCT02481128|sentinel lymph node biopsy|sentinel lymph node biopsy
130677|NCT02481076|malleolar fractures|malleolar fractures
130678|NCT02481076|ORIF|orif
130679|NCT02481076|compression|compression
130680|NCT02481076|infection|infection
130681|NCT02481076|wound dehisence|wound dehisence
130682|NCT02481063|Eccentric|eccentric
130683|NCT02481063|Running|running
130684|NCT02481063|Muscle|muscle
130685|NCT02481063|Tendon|tendon
130686|NCT02481063|Ultrasound|ultrasound
130687|NCT02481063|Thermography|thermography
130688|NCT02481050|Eribulin Mesylate|eribulin mesylate
130689|NCT02481050|Human Epidermal Growth Factor Receptor 2|human epidermal growth factor receptor 2
130690|NCT02481050|Metastatic Breast Cancer|metastatic breast cancer
130691|NCT02481050|HER2-Negative|her2-negative
130692|NCT02481024|Qualitative|qualitative
130693|NCT02481024|Care transition|care transition
130694|NCT02481024|Medication|medication
130695|NCT02481011|Fibrinolytic agents|fibrinolytic agents
130696|NCT02481011|Adverse effects|adverse effects
130697|NCT02481011|Registries|registries
130698|NCT02481011|Incidence|incidence
130699|NCT02481011|Risk assessment|risk assessment
130700|NCT02480985|Pituitary Disorders|pituitary disorders
130701|NCT02480985|Traumatic Brain Injury|traumatic brain injury
130702|NCT02480985|Critical Care|critical care
130703|NCT02480985|Outcome Research|outcome research
130704|NCT02480985|Risk Factors|risk factors
130705|NCT02480985|Patient Oriented Research|patient oriented research
130706|NCT02480972|fibrosis|fibrosis
130707|NCT02480972|cirrhosis|cirrhosis
130709|NCT02480946|Rheumatoid Arthritis|rheumatoid arthritis
130710|NCT02480946|Osteoclastogenesis inhibitor|osteoclastogenesis inhibitor
130711|NCT02480946|Anti-Inflammatory Agent|anti-inflammatory agent
130712|NCT02480946|Musculoskeletal Diseases|musculoskeletal diseases
130713|NCT02480946|Joint Diseases|joint diseases
130714|NCT02480920|Atrial fibrillation Drug Adherence|atrial fibrillation drug adherence
130715|NCT02480920|New Oral Anticoagulants|new oral anticoagulants
130716|NCT02480920|Drug Adherence|drug adherence
130717|NCT02480907|eating disorders|eating disorders
130718|NCT02480907|caregivers|caregivers
130719|NCT02480907|parents|parents
130720|NCT02480907|skills training|skills training
130721|NCT02480907|workshops|workshops
130722|NCT02480907|support|support
130723|NCT02480907|internet|internet
130724|NCT02480907|online|online
130725|NCT02480907|family|family
130726|NCT02480868|Primary or secondary osteoarthritis|primary or secondary osteoarthritis
130727|NCT02480868|fusion of the ankle|fusion of the ankle
130728|NCT02480855|work related stress|work related stress
130729|NCT02480855|questionnaire|questionnaire
130730|NCT02480855|early identification|early identification
130731|NCT02480842|Breast Neoplasms|breast neoplasms
130732|NCT02480842|Mammaplasty|mammaplasty
130733|NCT02480842|Breast Implantation|breast implantation
130734|NCT02480842|Range of Motion, Articular|range of motion, articular
130735|NCT02480842|Shoulder Joint|shoulder joint
130736|NCT02480842|Physical Therapy Modalities|physical therapy modalities
130737|NCT02480803|Parkinson|parkinson
130738|NCT02480803|Parkinson's Disease|parkinson's disease
130739|NCT02480803|Deep Brain Stimulation|deep brain stimulation
130740|NCT02480803|levodopa-carbidopa|levodopa-carbidopa
130741|NCT02480803|Duodopa|duodopa
130742|NCT02480803|continuous intrajejunal infusion|continuous intrajejunal infusion
130743|NCT02480764|Drug therapy|drug therapy
130942|NCT02479451|Olfaction|olfaction
130744|NCT02480751|Chronic Renal Failure|chronic renal failure
130745|NCT02480751|Prostaglandin|prostaglandin
130746|NCT02480751|Prostacyclin|prostacyclin
130747|NCT02480751|Glomerular Disease; Nephrosclerosis|glomerular disease; nephrosclerosis
130748|NCT02480738|subjective cognitive impairment|subjective cognitive impairment
130750|NCT02480725|CSF|csf
130751|NCT02480725|prion|prion
130752|NCT02480725|thrombin|thrombin
130753|NCT02480673|Metabolic Syndrome X|metabolic syndrome x
130754|NCT02480673|Chia|chia
130755|NCT02480673|Dyslipidemia|dyslipidemia
130756|NCT02480660|Hospitalized|hospitalized
130757|NCT02480660|adolescents|adolescents
130758|NCT02480660|knowledge|knowledge
130759|NCT02480660|transition|transition
130760|NCT02480660|educational intervention|educational intervention
130761|NCT02480634|zoledronic acid|zoledronic acid
157533|NCT02327546|HIF|hif
121894|NCT02532907|HCV|hcv
130762|NCT02480634|radiotherapy|radiotherapy
130763|NCT02480595|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
130764|NCT02480595|AAA|aaa
130765|NCT02480595|Endovascular|endovascular
130766|NCT02480595|EVAR|evar
130767|NCT02480595|Stent|stent
130768|NCT02480595|Stent Graft|stent graft
130769|NCT02480595|High Angle|high angle
130770|NCT02480595|Tortuous|tortuous
130771|NCT02480556|blood loss; caesarean section ; manual placental separation|blood loss; caesarean section ; manual placental separation
130772|NCT02480530|Medication Adherence|medication adherence
130773|NCT02480530|Reciprocal Peer|reciprocal peer
130774|NCT02480530|Telemonitoring|telemonitoring
130775|NCT02480517|Hypertension|hypertension
130776|NCT02480517|Renal Denervation|renal denervation
130777|NCT02480478|Intrahepatic Cholestasis of Pregnancy|intrahepatic cholestasis of pregnancy
130778|NCT02480439|Drug Therapy|drug therapy
130779|NCT02480413|Broselow Tape|broselow tape
130780|NCT02480413|Weight estimation|weight estimation
130781|NCT02480413|Patient safety|patient safety
130782|NCT02480400|MDD|mdd
130783|NCT02480400|Escitalopram|escitalopram
130784|NCT02480400|Placebo|placebo
130785|NCT02480361|Acupuncture|acupuncture
130786|NCT02480361|Gastric cancer|gastric cancer
130787|NCT02480322|metabolic alterations|metabolic alterations
130788|NCT02480257|intervention|intervention
130789|NCT02480257|emotion regulation|emotion regulation
130790|NCT02480257|fMRI|fmri
130791|NCT02480257|mindfulness|mindfulness
130792|NCT02480257|yoga-based movement|yoga-based movement
130793|NCT02480231|Tension-Free Vaginal Tape|tension-free vaginal tape
130794|NCT02480231|Suburethral Slings|suburethral slings
130795|NCT02480231|Midurethral Slings|midurethral slings
130796|NCT02480231|Mid-urethral sling|mid-urethral sling
130797|NCT02480231|urinary retention|urinary retention
130798|NCT02480218|cognition|cognition
130799|NCT02480218|tamoxifen|tamoxifen
130800|NCT02480218|aromatase inhibitors|aromatase inhibitors
130801|NCT02480205|CPAP|cpap
130802|NCT02480205|NIV|niv
130803|NCT02480205|NIPPV|nippv
130804|NCT02480205|Edi|edi
130805|NCT02480192|Vasomotor|vasomotor
130806|NCT02480192|Symptoms|symptoms
130807|NCT02480179|functional MRI|functional mri
130808|NCT02480179|appetite|appetite
130809|NCT02480179|neurofeedback|neurofeedback
130810|NCT02480166|hepatitis C, genotype 6|hepatitis c, genotype 6
130811|NCT02480153|Phase 3|phase 3
130812|NCT02480153|adalimumab|adalimumab
130813|NCT02480153|rheumatoid arthritis|rheumatoid arthritis
130814|NCT02480140|Self-regulation|self-regulation
130815|NCT02480140|Constraint-induced movement therapy|constraint-induced movement therapy
130816|NCT02480140|Stroke|stroke
130817|NCT02480140|Functional recovery|functional recovery
130818|NCT02480140|Randomized controlled trial|randomized controlled trial
130819|NCT02480101|influenza vaccine pandemic|influenza vaccine pandemic
130820|NCT02480075|Genetic Variation|genetic variation
130821|NCT02480075|Genetic Polymorphism|genetic polymorphism
130822|NCT02480075|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
130823|NCT02480075|Genetic Association Studies|genetic association studies
130824|NCT02480062|Decision Support System|decision support system
130825|NCT02480062|mHealth|mhealth
130826|NCT02480062|Primary Health Care|primary health care
130827|NCT02480062|Non-communicable diseases|non-communicable diseases
130828|NCT02480036|IORT|iort
130829|NCT02480036|Kyphoplasty|kyphoplasty
130830|NCT02480036|Spine|spine
130831|NCT02480036|Cancer|cancer
130832|NCT02479997|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
130833|NCT02479997|Indocyanine green (ICG)|indocyanine green (icg)
130834|NCT02479997|Radioisotope (RI)|radioisotope (ri)
130835|NCT02479997|Near infrared fluorescence camera|near infrared fluorescence camera
130836|NCT02479984|staging laparoscopy|staging laparoscopy
130837|NCT02479984|pancreatic cancer|pancreatic cancer
130838|NCT02479984|biliary cancer|biliary cancer
130839|NCT02479958|Photochemotherapy|photochemotherapy
130840|NCT02479958|Bacteria|bacteria
130841|NCT02479932|Extra-peritoneal cesarean|extra-peritoneal cesarean
130842|NCT02479932|Intra-peritoneal cesarean|intra-peritoneal cesarean
130843|NCT02479919|theta burst stimulation|theta burst stimulation
130844|NCT02479919|Social Cognition|social cognition
130845|NCT02479919|Schizophrenia|schizophrenia
130846|NCT02479919|transcranial magnetic stimulation|transcranial magnetic stimulation
130847|NCT02479906|Post-Traumatic Stress Disorder|post-traumatic stress disorder
130849|NCT02479906|dTMS|dtms
130850|NCT02479893|cold snare polypectomy|cold snare polypectomy
130851|NCT02479893|APC|apc
130852|NCT02479893|hot snare polypectomy|hot snare polypectomy
130853|NCT02479815|Complementary feeding recommendation|complementary feeding recommendation
130854|NCT02479815|Program evaluation|program evaluation
130855|NCT02479815|Process and impact evaluation|process and impact evaluation
130856|NCT02479815|Micronutrient powder (MNP) safety|micronutrient powder (mnp) safety
130857|NCT02479802|plasma exchange|plasma exchange
130858|NCT02479802|albumin|albumin
130859|NCT02479789|Intravenous Lidocaine|intravenous lidocaine
130860|NCT02479789|Recurrent laryngeal nerve|recurrent laryngeal nerve
130861|NCT02479789|Intra operative nerve monitoring|intra operative nerve monitoring
130862|NCT02479789|Thyroidectomy|thyroidectomy
130863|NCT02479763|Epidural waveform analysis|epidural waveform analysis
130864|NCT02479763|Loss of resistance|loss of resistance
130865|NCT02479737|Chest tube|chest tube
130866|NCT02479737|chest drainage|chest drainage
130867|NCT02479737|retained blood complications|retained blood complications
130868|NCT02479737|chest tube clogging|chest tube clogging
130869|NCT02479737|hemothorax|hemothorax
130870|NCT02479737|tamponade|tamponade
130871|NCT02479737|heart surgery|heart surgery
130872|NCT02479737|pleural effusion|pleural effusion
130873|NCT02479737|intensive care|intensive care
130874|NCT02479724|continuous, non-invasive|continuous, non-invasive
130875|NCT02479711|glass ionomer|glass ionomer
130876|NCT02479711|bulk fill composite|bulk fill composite
130877|NCT02479698|Stem cell transplant|stem cell transplant
130878|NCT02479698|Human Leukocyte Antigen|human leukocyte antigen
130879|NCT02479698|HLA|hla
130880|NCT02479698|BK specific CTL lines|bk specific ctl lines
130881|NCT02479698|BK-CTLs|bk-ctls
130882|NCT02479698|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
130883|NCT02479698|HSCT|hsct
130884|NCT02479698|BK Infection|bk infection
130885|NCT02479698|Cytotoxic T lymphocytes|cytotoxic t lymphocytes
130886|NCT02479698|CTLs|ctls
130887|NCT02479698|Myeloablative|myeloablative
130888|NCT02479698|Non-myeloablative|non-myeloablative
130889|NCT02479698|Graft Versus Host Disease|graft versus host disease
130890|NCT02479698|GVHD|gvhd
130891|NCT02479672|breathing tube placement|breathing tube placement
130892|NCT02479672|VideoTrac® laryngoscope|videotrac® laryngoscope
130893|NCT02479672|direct laryngoscopy|direct laryngoscopy
130894|NCT02479659|Immunizations|immunizations
130895|NCT02479646|Pegfilgrastim|pegfilgrastim
130896|NCT02479646|G-CSF|g-csf
130897|NCT02479646|Pharmacokinetics|pharmacokinetics
130898|NCT02479646|Pharmacodynamics|pharmacodynamics
130899|NCT02479633|prognostic factors|prognostic factors
130900|NCT02479607|Breast Cancer|breast cancer
130901|NCT02479607|Cytostatic Agents|cytostatic agents
130902|NCT02479607|Nursing|nursing
130903|NCT02479607|Health Literacy|health literacy
130904|NCT02479607|Quality of Life|quality of life
130905|NCT02479607|Oncology Nursing|oncology nursing
130906|NCT02479607|Self Care|self care
130907|NCT02479607|Symptom Management|symptom management
130908|NCT02479607|Participatory Care|participatory care
130909|NCT02479607|Person-centered Care|person-centered care
130910|NCT02479607|Information and Communication Technology|information and communication technology
130911|NCT02479607|Patient-reported symptoms|patient-reported symptoms
130912|NCT02479607|Mobile device|mobile device
130913|NCT02479594|competence-feedback|competence-feedback
131129|NCT02478385|epidural|epidural
130914|NCT02479581|Enhanced Recovery after Surgery|enhanced recovery after surgery
130915|NCT02479568|Cardiovascular disease|cardiovascular disease
130916|NCT02479568|biomarkers|biomarkers
130917|NCT02479568|transcriptomics|transcriptomics
130918|NCT02479568|orange juice|orange juice
130919|NCT02479568|hesperidin|hesperidin
130920|NCT02479568|systolic blood pressure|systolic blood pressure
130921|NCT02479568|metabolomics|metabolomics
130922|NCT02479568|cardiovascular risk factor|cardiovascular risk factor
130923|NCT02479542|Negative-Pressure Wound Therapy|negative-pressure wound therapy
130924|NCT02479542|Wound Healing|wound healing
130925|NCT02479542|Global Health|global health
130926|NCT02479542|Cameroon|cameroon
130927|NCT02479516|Diabetes screening|diabetes screening
130928|NCT02479516|Health Promotion|health promotion
130929|NCT02479516|Low and Middle Income Countries|low and middle income countries
130930|NCT02479516|CHAP|chap
130931|NCT02479503|antibiotic prophylaxis heart transplantation|antibiotic prophylaxis heart transplantation
130932|NCT02479490|metastatic renal cancer|metastatic renal cancer
130933|NCT02479490|failure of VEGFR_TKI|failure of vegfr_tki
130934|NCT02479490|prednisone|prednisone
130935|NCT02479490|everolimus|everolimus
130936|NCT02479477|Public Health|public health
130937|NCT02479477|Nursing Staff, Hospital|nursing staff, hospital
130938|NCT02479464|AssureRx|assurerx
130939|NCT02479464|Algorithm|algorithm
130940|NCT02479464|Major depressive disorder|major depressive disorder
130941|NCT02479451|End stage renal disease|end stage renal disease
130944|NCT02479451|Hemodialysis|hemodialysis
130948|NCT02479412|Mild to moderate asthma|mild to moderate asthma
130949|NCT02479412|FEV1|fev1
130950|NCT02479412|efficacy|efficacy
130951|NCT02479412|safety|safety
130952|NCT02479399|Suglat|suglat
130953|NCT02479399|SGLT-2 inhibitor|sglt-2 inhibitor
130954|NCT02479399|Ipragliflozin L-Proline|ipragliflozin l-proline
130955|NCT02479399|ASP1941 long-term use|asp1941 long-term use
130956|NCT02479347|General surgery|general surgery
130957|NCT02479347|Postoperative|postoperative
130958|NCT02479334|Spices|spices
130959|NCT02479334|Functional food|functional food
130960|NCT02479334|Cardiometabolic risk|cardiometabolic risk
130961|NCT02479334|Metabolic syndrome|metabolic syndrome
130962|NCT02479334|Inflammation|inflammation
130963|NCT02479334|Peripheral blood mononuclear cell|peripheral blood mononuclear cell
130964|NCT02479334|Acute|acute
130965|NCT02479321|Perioperative Goal-Directed Hemodynamic Therapy|perioperative goal-directed hemodynamic therapy
130966|NCT02479321|Fluid therapy|fluid therapy
130967|NCT02479321|Aged|aged
130968|NCT02479321|Perioperative complications|perioperative complications
130969|NCT02479321|Survival|survival
130970|NCT02479308|Alkermes|alkermes
130971|NCT02479308|Samidorphan|samidorphan
130972|NCT02479308|ALKS 5461|alks 5461
130973|NCT02479308|QT/QTc|qt/qtc
130974|NCT02479308|Buprenorphine|buprenorphine
130975|NCT02479308|Pharmacodynamics|pharmacodynamics
130976|NCT02479269|Brain Natriuretic Peptide|brain natriuretic peptide
130977|NCT02479269|aerobic execise|aerobic execise
130978|NCT02479269|C- Reactive Protein|c- reactive protein
130979|NCT02479256|PCOS|pcos
130980|NCT02479256|Induction of ovulation|induction of ovulation
130981|NCT02479256|Clomiphene citrate|clomiphene citrate
130982|NCT02479256|Tamoxifen|tamoxifen
130983|NCT02479243|Arterial Spin Labeling|arterial spin labeling
130984|NCT02479243|MRI|mri
130985|NCT02479243|Atherosclerotic Stenosis|atherosclerotic stenosis
130986|NCT02479243|Collateral Circulation|collateral circulation
130987|NCT02479243|Ischemic stroke|ischemic stroke
130988|NCT02479230|vaccine|vaccine
130989|NCT02479230|breast cancer|breast cancer
130990|NCT02479230|metastatic|metastatic
130991|NCT02479204|safety|safety
130992|NCT02479204|heart rate|heart rate
130993|NCT02479204|pharmacokinetics|pharmacokinetics
130994|NCT02479191|Abdominal|abdominal
130995|NCT02479191|Aortic|aortic
130996|NCT02479191|Aneurysm|aneurysm
130997|NCT02479152|Mechanical CPR|mechanical cpr
130998|NCT02479152|Hemodynamics|hemodynamics
130999|NCT02479126|Interstitial Lung Disease|interstitial lung disease
131000|NCT02479126|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
131001|NCT02479126|Electronic Health Records|electronic health records
131002|NCT02479126|Computed Tomography|computed tomography
131003|NCT02479126|Mortality|mortality
131004|NCT02479126|Hospitalization|hospitalization
131005|NCT02479126|Acute care visits|acute care visits
131006|NCT02479126|Anti-inflammatory drug therapies|anti-inflammatory drug therapies
131007|NCT02479113|GDM|gdm
131008|NCT02479113|Maternal Hypertriglyceridaemia|maternal hypertriglyceridaemia
131009|NCT02479100|Contrast Enhanced Spectral Mammography|contrast enhanced spectral mammography
131010|NCT02479100|Breast|breast
131011|NCT02479100|Cancer|cancer
131012|NCT02479100|Diagnosis|diagnosis
131013|NCT02479100|Patient management|patient management
131014|NCT02479087|von Willebrand Factor|von willebrand factor
131015|NCT02479087|Factor VIII|factor viii
131016|NCT02479087|Hemorrhage|hemorrhage
131017|NCT02479087|Immune Tolerance|immune tolerance
131018|NCT02479087|Hemophilia A|hemophilia a
131019|NCT02479074|Chronic|chronic
131020|NCT02479061|Observationnal study|observationnal study
131021|NCT02479061|Prevalence|prevalence
131022|NCT02479061|Palliative care|palliative care
131023|NCT02479061|Anti cancer center|anti cancer center
131024|NCT02479048|satiety/appetite|satiety/appetite
131025|NCT02479048|glycemic response|glycemic response
131026|NCT02479048|cardiometabolic risk|cardiometabolic risk
131027|NCT02479035|insulin sensitive|insulin sensitive
131028|NCT02479035|insulin resistant|insulin resistant
131029|NCT02479035|red raspberry|red raspberry
131030|NCT02479035|polyphenols|polyphenols
131031|NCT02479035|bioavailability|bioavailability
131032|NCT02478996|perioperative|perioperative
131033|NCT02478996|internet-based|internet-based
131034|NCT02478996|exercise program|exercise program
131035|NCT02478957|mastocytosis|mastocytosis
131036|NCT02478957|cromolyn sodium|cromolyn sodium
131037|NCT02478944|Inflammatory bowel disease|inflammatory bowel disease
131038|NCT02478944|Manometry|manometry
131039|NCT02478892|high risk|high risk
131040|NCT02478892|specifically those with BRCA1/2 mutations|specifically those with brca1/2 mutations
131041|NCT02478827|Cognitive Training|cognitive training
131042|NCT02478827|Working Memory|working memory
131043|NCT02478827|Processing Speed|processing speed
131044|NCT02478788|ADHD|adhd
131054|NCT02478736|cerebral blood flow velosity|cerebral blood flow velosity
131056|NCT02478723|Teeth|teeth
131057|NCT02478697|tobacco smoking behavior|tobacco smoking behavior
131058|NCT02478697|employment|employment
131059|NCT02478697|job-seeking|job-seeking
131060|NCT02478697|tobacco cessation|tobacco cessation
131061|NCT02478697|transtheoretical model|transtheoretical model
131062|NCT02478697|behavior change|behavior change
131063|NCT02478684|delayed cord clamping|delayed cord clamping
131064|NCT02478684|premature infants|premature infants
131065|NCT02478684|randomized study|randomized study
131066|NCT02478684|hematocrit|hematocrit
131067|NCT02478658|irisin|irisin
131068|NCT02478658|resistance training|resistance training
131069|NCT02478658|physical fitness|physical fitness
131070|NCT02478658|Volunteers|volunteers
131071|NCT02478632|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
131072|NCT02478632|dolutegravir plus rilpivirine|dolutegravir plus rilpivirine
131073|NCT02478632|two-drug regimen|two-drug regimen
131074|NCT02478632|bone mineral density|bone mineral density
131075|NCT02478632|dual energy X-ray absorptiometry (DEXA)|dual energy x-ray absorptiometry (dexa)
131076|NCT02478632|Human Immunodeficiency Virus-1|human immunodeficiency virus-1
131077|NCT02478632|nucleoside reverse transcriptase inhibitor -sparing regimen|nucleoside reverse transcriptase inhibitor -sparing regimen
131078|NCT02478632|integrase inhibitor|integrase inhibitor
131079|NCT02478619|Obesity|obesity
131080|NCT02478619|Respiratory Muscle Training|respiratory muscle training
131081|NCT02478619|Bariatric Surgery|bariatric surgery
131082|NCT02478619|Breathing exercises|breathing exercises
131083|NCT02478619|Gastroplasty|gastroplasty
131084|NCT02478606|Lower Extremity|lower extremity
131085|NCT02478606|Muscle Stretching Exercises|muscle stretching exercises
131086|NCT02478606|Muscle Strength|muscle strength
131087|NCT02478606|Static Stretching|static stretching
131088|NCT02478606|Proprioceptive Neuromuscular Facilitation (PNF) Stretching|proprioceptive neuromuscular facilitation (pnf) stretching
131089|NCT02478606|Muscle Strength Dynamometer|muscle strength dynamometer
131090|NCT02478593|Education|education
131091|NCT02478593|Geriatric|geriatric
131092|NCT02478593|Benzodiazepine|benzodiazepine
131093|NCT02478593|Prevalence|prevalence
131094|NCT02478580|Obstructive Sleep Apnea|obstructive sleep apnea
131095|NCT02478580|Obesity|obesity
131096|NCT02478580|Postoperative Recovery|postoperative recovery
131097|NCT02478554|Fetal growth restriction|fetal growth restriction
131098|NCT02478554|macrosomia|macrosomia
131099|NCT02478541|triglycerides|triglycerides
131100|NCT02478541|glucose|glucose
131101|NCT02478541|fructose|fructose
131102|NCT02478541|fatty acids|fatty acids
131103|NCT02478515|ranibizumab|ranibizumab
131104|NCT02478515|PRN regimen|prn regimen
131105|NCT02478515|macular edema|macular edema
131106|NCT02478515|branch retinal vein occlusion|branch retinal vein occlusion
131107|NCT02478502|testicular cancer|testicular cancer
131108|NCT02478502|cisplatin resistancy|cisplatin resistancy
131109|NCT02478489|alcohol|alcohol
131110|NCT02478489|heavy drinking|heavy drinking
131111|NCT02478489|naltrexone|naltrexone
131112|NCT02478489|hospital|hospital
131113|NCT02478489|alcohol use disorder|alcohol use disorder
131114|NCT02478489|alcohol dependence|alcohol dependence
131115|NCT02478489|comparative effectiveness|comparative effectiveness
131116|NCT02478463|Cabotegravir|cabotegravir
131117|NCT02478463|Pharmacokinetic|pharmacokinetic
131118|NCT02478463|Healthy Adult Volunteers|healthy adult volunteers
131119|NCT02478463|GSK1265744|gsk1265744
131120|NCT02478437|Lumbar Facet Syndrome|lumbar facet syndrome
131121|NCT02478411|muscle weakness|muscle weakness
131122|NCT02478411|rehabilitation|rehabilitation
131123|NCT02478411|intensive care|intensive care
131124|NCT02478411|mechanical ventilation|mechanical ventilation
131125|NCT02478411|cyclo ergometer|cyclo ergometer
131126|NCT02478411|physiotherapy|physiotherapy
131127|NCT02478385|Birth environment|birth environment
131130|NCT02478385|analgesia|analgesia
131131|NCT02478385|home-like|home-like
131132|NCT02478372|local infiltration analgesia|local infiltration analgesia
131133|NCT02478372|Epidural|epidural
131134|NCT02478372|Enhanced Recovery|enhanced recovery
131135|NCT02478372|Total Knee Arthroplasty|total knee arthroplasty
131136|NCT02478333|Healthy|healthy
131137|NCT02478333|ALS-008176|als-008176
131138|NCT02478333|Japanese adult participants|japanese adult participants
131139|NCT02478320|Advanced Cancers|advanced cancers
131140|NCT02478320|CDKN2A-Deficient Advanced Solid Cancers|cdkn2a-deficient advanced solid cancers
131141|NCT02478320|Advanced or metastatic cancer.|advanced or metastatic cancer.
131142|NCT02478320|Ilorasertib|ilorasertib
131143|NCT02478320|ABT-348|abt-348
131144|NCT02478307|chronic low back pain|chronic low back pain
131145|NCT02478307|mindfulness meditation|mindfulness meditation
131146|NCT02478307|cognitive therapy|cognitive therapy
131147|NCT02478307|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
131148|NCT02478307|efficacy|efficacy
131149|NCT02478307|mechanisms|mechanisms
131150|NCT02478307|coping|coping
131151|NCT02478294|Atrial Fibrillation|atrial fibrillation
131152|NCT02478294|Stroke|stroke
131153|NCT02478294|Systemic embolism|systemic embolism
131154|NCT02478294|Left atrial appendage excision|left atrial appendage excision
131155|NCT02478294|Warfarin|warfarin
131156|NCT02478268|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
131159|NCT02478255|Xenon gas|xenon gas
131160|NCT02478255|hyperpolarized|hyperpolarized
131161|NCT02478229|Liver transplant|liver transplant
131162|NCT02478229|Genotype 1 HCV infection|genotype 1 hcv infection
131163|NCT02478229|Sofosbuvir (SOF)/ Ledipasvir (LDV)|sofosbuvir (sof)/ ledipasvir (ldv)
131164|NCT02478229|Sustained virological response (SVR12 )|sustained virological response (svr12 )
131165|NCT02478203|Airtraq|airtraq
131166|NCT02478203|Glidescope|glidescope
131167|NCT02478203|pediatric|pediatric
131168|NCT02478203|face-to-face|face-to-face
131169|NCT02478177|Anticoagulant|anticoagulant
131170|NCT02478177|Stroke|stroke
131171|NCT02478177|Ischemic Stroke|ischemic stroke
131172|NCT02478177|Intracerebral hemorrhage|intracerebral hemorrhage
131173|NCT02478151|Deceased donor liver transplant|deceased donor liver transplant
131174|NCT02478151|Normothermic machine perfusion|normothermic machine perfusion
131175|NCT02478125|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
131176|NCT02478112|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
131177|NCT02478112|Balloon implant|balloon implant
131178|NCT02478099|MPDL3280A|mpdl3280a
131179|NCT02478099|bladder cancer|bladder cancer
131180|NCT02478099|non small cell lung cancer|non small cell lung cancer
131181|NCT02478099|triple negative breast cancer|triple negative breast cancer
131182|NCT02478086|amino acids|amino acids
131183|NCT02478086|renal function|renal function
131184|NCT02478086|extreme premature|extreme premature
131185|NCT02478060|Allergy|allergy
131186|NCT02478060|Birch|birch
131187|NCT02478060|Rhinitis|rhinitis
131188|NCT02478060|Rhinoconjuntivitis|rhinoconjuntivitis
131189|NCT02478060|SPIRE|spire
131190|NCT02478060|Toleromune|toleromune
131191|NCT02478047|to Evaluate the Effectiveness of Acupucnture in the Management of Chemotherapy-induced Nausea and Vomiting|to evaluate the effectiveness of acupucnture in the management of chemotherapy-induced nausea and vomiting
131192|NCT02478021|effects of cortisol on cognition|effects of cortisol on cognition
131193|NCT02478008|Transcatheter Mitral Valve Replacement|transcatheter mitral valve replacement
131194|NCT02478008|Mitral Regurgitation|mitral regurgitation
131195|NCT02478008|Mitral Insufficiency|mitral insufficiency
131196|NCT02478008|Transapical|transapical
131197|NCT02477995|Immunogenicity|immunogenicity
131198|NCT02477995|Safety|safety
131199|NCT02477995|DTaP Vaccine|dtap vaccine
131200|NCT02477982|Propofol|propofol
131201|NCT02477982|Cardiopulmonary Bypass|cardiopulmonary bypass
131202|NCT02477982|Pharmacokinetics|pharmacokinetics
131203|NCT02477982|Obesity|obesity
131204|NCT02477956|vitamin D|vitamin d
131205|NCT02477956|obesity|obesity
131206|NCT02477956|bariatric surgery|bariatric surgery
131207|NCT02477917|allergy|allergy
131208|NCT02477917|SCIT|scit
131209|NCT02477904|Autism|autism
131210|NCT02477904|Autism Spectrum Disorder|autism spectrum disorder
131211|NCT02477904|Ketogenic Diet|ketogenic diet
131212|NCT02477904|Biochemical Profiles|biochemical profiles
131213|NCT02477891|Multiple myeloma|multiple myeloma
131214|NCT02477891|Daratumumab|daratumumab
131215|NCT02477891|Early access|early access
131216|NCT02477878|Adult leukemias and myelodysplasia|adult leukemias and myelodysplasia
131217|NCT02477878|Adult lymphomas|adult lymphomas
131218|NCT02477878|Adult multiple myeloma|adult multiple myeloma
131219|NCT02477852|tuberculosis|tuberculosis
131220|NCT02477852|spinal|spinal
131221|NCT02477852|general|general
131222|NCT02477852|operation|operation
131223|NCT02477852|drug|drug
131224|NCT02477852|therapy|therapy
131226|NCT02477800|BIIB037|biib037
131227|NCT02477800|Aducanumab|aducanumab
131228|NCT02477787|HLA-haploidentical hematopoietic cell transplantation|hla-haploidentical hematopoietic cell transplantation
131229|NCT02477787|natural killer cells|natural killer cells
131230|NCT02477774|Anterolateral Thigh|anterolateral thigh
131231|NCT02477670|Negative Symptoms|negative symptoms
131232|NCT02477670|Schizophrenia|schizophrenia
131233|NCT02477670|AVP-786|avp-786
131234|NCT02477657|Adult patients with refractory malignant ascites secondary to GU or GI malignancy.|adult patients with refractory malignant ascites secondary to gu or gi malignancy.
131235|NCT02477644|Advanced FIGO IIIB|advanced figo iiib
131236|NCT02477644|IV high grade serious ovarian cancer|iv high grade serious ovarian cancer
131237|NCT02477644|endometrioid ovarian cancer|endometrioid ovarian cancer
131238|NCT02477644|standard first-line treatment|standard first-line treatment
131239|NCT02477644|platinum-taxane chemotherapy|platinum-taxane chemotherapy
131240|NCT02477644|bevacizumab|bevacizumab
131244|NCT02477631|oxidative stress|oxidative stress
131245|NCT02477631|labile plasma iron|labile plasma iron
131246|NCT02477592|long standing persistent atrial fibrillation|long standing persistent atrial fibrillation
131247|NCT02477592|novel approach|novel approach
131248|NCT02477592|ablation|ablation
131249|NCT02477566|pcos|pcos
131250|NCT02477566|Long acting Triptorelin|long acting triptorelin
131251|NCT02477566|Short acting Triptorelin|short acting triptorelin
131252|NCT02477566|In Vitro Fertilization|in vitro fertilization
131253|NCT02477553|decision aid|decision aid
131254|NCT02477553|cancer screening|cancer screening
131255|NCT02477553|colorectal neoplasm|colorectal neoplasm
131256|NCT02477553|decision making|decision making
131257|NCT02477553|risk communication|risk communication
131258|NCT02477553|numeracy|numeracy
131259|NCT02477553|health literacy|health literacy
131260|NCT02477527|atripla|atripla
131261|NCT02477527|stribild|stribild
131262|NCT02477527|dreams|dreams
131263|NCT02477501|Spinal anesthesia|spinal anesthesia
131264|NCT02477501|cesarean|cesarean
131265|NCT02477501|blood pressure|blood pressure
131266|NCT02477501|Norepinephrine|norepinephrine
131267|NCT02477501|Ephedrine|ephedrine
131268|NCT02477488|Allopurinol|allopurinol
131269|NCT02477488|Renal Dialysis|renal dialysis
131270|NCT02477475|reflux esophagitis|reflux esophagitis
131271|NCT02477475|Nexium|nexium
131272|NCT02477449|safety|safety
131273|NCT02477449|istaroxime|istaroxime
131274|NCT02477423|Microbiome|microbiome
131275|NCT02477423|Antibiotics|antibiotics
131276|NCT02477410|porcine protein|porcine protein
131277|NCT02477410|appetite|appetite
131278|NCT02477410|muscle protein synthesis|muscle protein synthesis
131279|NCT02477410|gastrointestinal hormones|gastrointestinal hormones
131280|NCT02477397|Spiromax|spiromax
131281|NCT02477397|Budesonide/formoterol|budesonide/formoterol
131282|NCT02477397|COPD|copd
131283|NCT02477397|exacerbations|exacerbations
131284|NCT02477397|SMART|smart
131285|NCT02477345|Cholestasis|cholestasis
131286|NCT02477345|Parenteral Nutrition|parenteral nutrition
131287|NCT02477345|Liver disease|liver disease
131288|NCT02477332|QGE031|qge031
131289|NCT02477332|omalizumab|omalizumab
131290|NCT02477332|chronic|chronic
131291|NCT02477332|spontaneous|spontaneous
131292|NCT02477332|urticaria|urticaria
131293|NCT02477332|adults|adults
131295|NCT02477293|Hyeonggaeyeongyo-tang|hyeonggaeyeongyo-tang
131296|NCT02477293|Chronic rhinitis|chronic rhinitis
131297|NCT02477293|Pattern identification|pattern identification
131298|NCT02477293|Korean medicine|korean medicine
131299|NCT02477254|lupus|lupus
131300|NCT02477241|overactive bladder syndrome|overactive bladder syndrome
131301|NCT02477241|urgency urinary incontinence|urgency urinary incontinence
131302|NCT02477241|fMRI|fmri
131303|NCT02477241|urodynamics|urodynamics
131304|NCT02477215|Multiple Myeloma|multiple myeloma
131305|NCT02477202|Mirena® IUD's|mirena® iud's
131306|NCT02477202|Women|women
131307|NCT02477202|risk-reducing salpingo-oophorectomy|risk-reducing salpingo-oophorectomy
131308|NCT02477202|risk-reducing salpingectomy|risk-reducing salpingectomy
131309|NCT02477163|Nephropathy induced by drugs medicaments and biological substances|nephropathy induced by drugs medicaments and biological substances
131310|NCT02477163|Other nephritis and nephropathy not specified as acute or chronic|other nephritis and nephropathy not specified as acute or chronic
131311|NCT02477150|lupus|lupus
131312|NCT02477137|Prostate Cancer|prostate cancer
131313|NCT02477137|Nursing|nursing
131314|NCT02477137|Health Literacy|health literacy
131315|NCT02477137|Quality of Life|quality of life
131316|NCT02477137|Radiotherapy|radiotherapy
131317|NCT02477137|Oncology Nursing|oncology nursing
131318|NCT02477137|Self Care|self care
131319|NCT02477137|Symptom Management|symptom management
131320|NCT02477137|Participatory Care|participatory care
131321|NCT02477137|Person-centered Care|person-centered care
131322|NCT02477137|Information and Communication Technology|information and communication technology
131323|NCT02477137|Patient-reported symptoms|patient-reported symptoms
131324|NCT02477137|Mobile device|mobile device
131325|NCT02477111|Endovascular repair|endovascular repair
131326|NCT02477098|rectus sheath block|rectus sheath block
131327|NCT02477098|cytokines|cytokines
131328|NCT02477098|sleep|sleep
131329|NCT02477085|Labor|labor
131330|NCT02477085|induction|induction
131331|NCT02477085|delivery|delivery
131332|NCT02477085|prostaglandins|prostaglandins
131333|NCT02477085|oxytocin|oxytocin
131334|NCT02477085|amniotomy|amniotomy
131335|NCT02477085|balloon catheter|balloon catheter
131336|NCT02477059|Hand OA|hand oa
131337|NCT02477059|Tocilizumab|tocilizumab
131338|NCT02477059|Osteoarthritis|osteoarthritis
131339|NCT02477059|Interleukin-6|interleukin-6
131340|NCT02477020|Drug Therapy|drug therapy
131341|NCT02477007|Paediatric emergency|paediatric emergency
131343|NCT02477007|long-bones fractures|long-bones fractures
131345|NCT02477007|ibuprofen|ibuprofen
131346|NCT02477007|paracetamol|paracetamol
131347|NCT02477007|children|children
131348|NCT02476994|Essential Fatty Acids (EFA)|essential fatty acids (efa)
131349|NCT02476994|Parenteral Nutrition|parenteral nutrition
131350|NCT02476994|Clinolipid/Clinoleic|clinolipid/clinoleic
131351|NCT02476994|Parenteral Nutrition Associated Cholestasis (PNAC)|parenteral nutrition associated cholestasis (pnac)
131352|NCT02476994|Parenteral Nutrition Associated Liver Disease (PNALD)|parenteral nutrition associated liver disease (pnald)
131353|NCT02476994|Intestinal Failure Associated Liver Disease (IFALD)|intestinal failure associated liver disease (ifald)
131354|NCT02476994|Phytosterols|phytosterols
131355|NCT02476994|Intralipid|intralipid
131356|NCT02476994|Infants/Preterm Infants|infants/preterm infants
131357|NCT02476994|FADS1 and FADS2|fads1 and fads2
131358|NCT02476994|Short Bowel Syndrome|short bowel syndrome
131359|NCT02476994|Cancer Nutrition|cancer nutrition
131360|NCT02476994|Olive Oil Emulsion|olive oil emulsion
131361|NCT02476994|Soybean Oil Emulsion|soybean oil emulsion
131362|NCT02476955|ARQ 092|arq 092
131363|NCT02476955|Carboplatin|carboplatin
131364|NCT02476955|Paclitaxel|paclitaxel
131365|NCT02476955|AKT inhibitor in combination therapy|akt inhibitor in combination therapy
131366|NCT02476955|Targeted therapy|targeted therapy
131367|NCT02476955|Molecular therapy|molecular therapy
131368|NCT02476955|Tyrosine kinase inhibitor (TKI)|tyrosine kinase inhibitor (tki)
131369|NCT02476955|Receptor tyrosine kinase (RTK)|receptor tyrosine kinase (rtk)
131370|NCT02476955|Biomarkers|biomarkers
131371|NCT02476955|Phase 1 - Phase I|phase 1 - phase i
131372|NCT02476955|Solid tumors|solid tumors
131373|NCT02476955|Metastatic solid tumors|metastatic solid tumors
131374|NCT02476955|Recurrent solid tumors|recurrent solid tumors
131375|NCT02476955|Ovarian cancer|ovarian cancer
131376|NCT02476955|Endometrial cancer|endometrial cancer
131377|NCT02476955|Cervical cancer|cervical cancer
131378|NCT02476955|Triple-negative breast cancer|triple-negative breast cancer
131379|NCT02476955|AKT kinases|akt kinases
131380|NCT02476955|AKT pathway|akt pathway
131381|NCT02476955|AKT signaling|akt signaling
131382|NCT02476955|AKT inhibitor|akt inhibitor
131383|NCT02476955|AKT pan inhibitor|akt pan inhibitor
131384|NCT02476955|Chemotherapy|chemotherapy
131385|NCT02476955|PI3K/AKT/mTOR signaling pathway|pi3k/akt/mtor signaling pathway
131386|NCT02476955|AKT1|akt1
131387|NCT02476955|AKT2|akt2
131388|NCT02476955|AKT3|akt3
131389|NCT02476955|Phase I Clinical Trial|phase i clinical trial
131390|NCT02476955|Clinical oncology|clinical oncology
131391|NCT02476955|Tumor|tumor
131392|NCT02476955|AKT1 inhibitor|akt1 inhibitor
131393|NCT02476955|AKT2 inhibitor|akt2 inhibitor
131394|NCT02476955|AKT3 inhibitor|akt3 inhibitor
131395|NCT02476955|AKT1 mutation|akt1 mutation
131396|NCT02476955|AKT2 mutation|akt2 mutation
131397|NCT02476955|AKT3 mutation|akt3 mutation
131398|NCT02476955|AKT1 amplification|akt1 amplification
131399|NCT02476955|AKT2 amplification|akt2 amplification
131400|NCT02476955|AKT3 amplification|akt3 amplification
131401|NCT02476955|Anastrozole|anastrozole
131402|NCT02476955|Estrogen receptor positive|estrogen receptor positive
131403|NCT02476929|Electronic nose|electronic nose
131404|NCT02476929|Nasal nitrous oxide|nasal nitrous oxide
131405|NCT02476929|Allergic Rhinitis|allergic rhinitis
131406|NCT02476929|Non-Allergic Rhinitis|non-allergic rhinitis
131407|NCT02476929|Nasal polyps|nasal polyps
131408|NCT02476916|Pyruvate Kinase Deficiency|pyruvate kinase deficiency
131409|NCT02476916|Hemolytic anemia|hemolytic anemia
131410|NCT02476916|Protein Kinase R (PKR)|protein kinase r (pkr)
131411|NCT02476916|Drive PK|drive pk
131412|NCT02476877|comorbidity|comorbidity
131413|NCT02476877|epidemiology|epidemiology
131414|NCT02476877|mental illness|mental illness
131415|NCT02476877|drug abuse|drug abuse
131416|NCT02476864|macitentan|macitentan
131417|NCT02476864|biocomparison|biocomparison
131418|NCT02476864|safety|safety
131419|NCT02476851|Blood Donation|blood donation
131420|NCT02476851|Whole Blood|whole blood
131421|NCT02476838|hand injury|hand injury
131422|NCT02476838|hand amputation|hand amputation
131423|NCT02476838|hand amputee|hand amputee
131424|NCT02476838|hand surgery|hand surgery
131425|NCT02476825|volunteers|volunteers
131426|NCT02476773|Hookworm Vaccine|hookworm vaccine
131427|NCT02476773|Na-APR-1 (M74)/Alhydrogel® Hookworm Vaccine|na-apr-1 (m74)/alhydrogel® hookworm vaccine
131428|NCT02476773|Na-GST-1/Alhydrogel® Hookworm Vaccine|na-gst-1/alhydrogel® hookworm vaccine
131429|NCT02476760|Incretins|incretins
131430|NCT02476760|Antidiabetic agents|antidiabetic agents
131431|NCT02476760|Pancreatitis|pancreatitis
131432|NCT02476747|Colonic polyp|colonic polyp
131634|NCT02475408|Ischemia|ischemia
131433|NCT02476734|REDIRECTED AUTOLOGOUS CART- 19 T-CELL IMMUNOTHERAPY|redirected autologous cart- 19 t-cell immunotherapy
131434|NCT02476721|pulmonary embolism|pulmonary embolism
131435|NCT02476721|emergency department|emergency department
131436|NCT02476708|schizophrenia|schizophrenia
131439|NCT02476708|curcumin|curcumin
131440|NCT02476695|CHB|chb
131441|NCT02476682|Sessile serrated polyps|sessile serrated polyps
131442|NCT02476682|Advanced mucosal neoplasia|advanced mucosal neoplasia
131444|NCT02476669|biomarker|biomarker
131445|NCT02476669|intensity-modulated radiation therapy|intensity-modulated radiation therapy
131446|NCT02476617|Treatment naive|treatment naive
131447|NCT02476617|Interferon free|interferon free
131448|NCT02476617|HCV|hcv
131449|NCT02476617|Chronic Hepatitis C|chronic hepatitis c
131450|NCT02476617|Hepatitis C Genotype 1a|hepatitis c genotype 1a
131451|NCT02476617|Hepatitis C|hepatitis c
131452|NCT02476617|pegIFN/RBV experienced|pegifn/rbv experienced
131453|NCT02476604|prevention|prevention
131454|NCT02476604|adult|adult
131455|NCT02476604|student|student
131456|NCT02476591|Resource utilization|resource utilization
131457|NCT02476591|intensive care unit|intensive care unit
131458|NCT02476578|Hypocholesterolemia|hypocholesterolemia
131459|NCT02476578|Frail Elderly|frail elderly
131460|NCT02476578|Aged|aged
131461|NCT02476578|Aged, 80 and over|aged, 80 and over
131462|NCT02476578|Cholesterol|cholesterol
131463|NCT02476578|Clinical Laboratory Information Systems|clinical laboratory information systems
131464|NCT02476578|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
131465|NCT02476578|diet therapy|diet therapy
131466|NCT02476578|Anticholesteremic Agents|anticholesteremic agents
131467|NCT02476578|Health Services for the Aged|health services for the aged
131468|NCT02476578|Hypoglycemic Agents|hypoglycemic agents
131469|NCT02476578|Hypoglycemia|hypoglycemia
131470|NCT02476565|Intubation|intubation
131471|NCT02476461|percutanepus needle fasciotomy|percutanepus needle fasciotomy
131472|NCT02476461|xiapex|xiapex
131473|NCT02476461|clostridium histolyticum|clostridium histolyticum
131474|NCT02476448|ureteral jet|ureteral jet
131475|NCT02476448|pelvic surgery|pelvic surgery
131476|NCT02476448|cystoscopy|cystoscopy
131477|NCT02476435|Depersonalization|depersonalization
131478|NCT02476435|Derealization|derealization
131479|NCT02476435|Embodiment|embodiment
131480|NCT02476435|Emotional numbing|emotional numbing
131481|NCT02476435|Transcranial magnetic stimulation|transcranial magnetic stimulation
131482|NCT02476435|Angular gyrus|angular gyrus
131483|NCT02476435|Temporo-parietal junction|temporo-parietal junction
131484|NCT02476422|Diclofenac potassium|diclofenac potassium
131485|NCT02476422|Post-operative dental pain|post-operative dental pain
131486|NCT02476422|Moderate to severe pain|moderate to severe pain
131487|NCT02476409|congestive heart failure|congestive heart failure
131488|NCT02476409|tolvaptan|tolvaptan
131489|NCT02476409|copeptin|copeptin
131490|NCT02476331|Cognitive training|cognitive training
131491|NCT02476331|Working memory|working memory
131492|NCT02476331|Emotion regulation|emotion regulation
131493|NCT02476266|resistance training|resistance training
131494|NCT02476266|strength training|strength training
131495|NCT02476266|balance|balance
131496|NCT02476266|muscle strength|muscle strength
131497|NCT02476253|acidosis|acidosis
131498|NCT02476253|shock|shock
131499|NCT02476253|sodium bicarbonate|sodium bicarbonate
131500|NCT02476253|renal replacement therapy|renal replacement therapy
131503|NCT02476227|atrial fibrillation|atrial fibrillation
131504|NCT02476227|pulmonary vein isolation|pulmonary vein isolation
131505|NCT02476227|RF ablation|rf ablation
131506|NCT02476214|group prenatal care, group guidance|group prenatal care, group guidance
131507|NCT02476201|Heart Failure|heart failure
131508|NCT02476201|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
131509|NCT02476201|Quadripolar Left Ventricular Lead|quadripolar left ventricular lead
131510|NCT02476201|Multipoint Pacing|multipoint pacing
131511|NCT02476201|Hemodynamic Response|hemodynamic response
131512|NCT02476188|Neutrophil extracellular traps, stroke|neutrophil extracellular traps, stroke
131513|NCT02476175|mirabegron|mirabegron
131514|NCT02476175|antimuscarinics|antimuscarinics
131515|NCT02476175|beta 3 agonist|beta 3 agonist
131516|NCT02476175|overactive bladder|overactive bladder
131517|NCT02476175|children|children
131518|NCT02476162|Childhood Cancer Survivor|childhood cancer survivor
131519|NCT02476162|Cancer Prevention and Control|cancer prevention and control
131520|NCT02476162|Blood Pressure Monitoring|blood pressure monitoring
131521|NCT02476162|Pre-Hypertension|pre-hypertension
131522|NCT02476136|individual patient data meta-analysis|individual patient data meta-analysis
131523|NCT02476136|anxiety disorder|anxiety disorder
131524|NCT02476136|antidepressants|antidepressants
131525|NCT02476136|selective serotonin reuptake inhibitors|selective serotonin reuptake inhibitors
131526|NCT02476136|serotonin-norepinephrine reuptake inhibitors|serotonin-norepinephrine reuptake inhibitors
131527|NCT02476110|Oral nutritive supplements|oral nutritive supplements
131528|NCT02476110|Nutritional risk screening|nutritional risk screening
131529|NCT02476110|Homecare|homecare
131530|NCT02476097|esomeprazole randomized study|esomeprazole randomized study
131531|NCT02476097|proton pump inhibitor|proton pump inhibitor
131532|NCT02476097|gastric acid rebound|gastric acid rebound
131533|NCT02476097|randomized study|randomized study
131534|NCT02476097|esomeprazole|esomeprazole
131535|NCT02476071|HIV prevention|hiv prevention
131536|NCT02476071|Demand for voluntary male circumcision|demand for voluntary male circumcision
131537|NCT02476058|Major Depressive Disorder|major depressive disorder
131538|NCT02476058|JNJ-42847922|jnj-42847922
131539|NCT02476058|Diphenhydramine|diphenhydramine
131540|NCT02476058|Placebo|placebo
131541|NCT02476045|metastatic colorectal cancer|metastatic colorectal cancer
131542|NCT02476045|RAS wild-type|ras wild-type
131543|NCT02476045|maintenance therapy|maintenance therapy
131544|NCT02476045|panitumumab|panitumumab
131545|NCT02476019|Obesity|obesity
131546|NCT02476019|Energy Expenditure|energy expenditure
131547|NCT02475993|Sickle Cell Disease|sickle cell disease
131548|NCT02475980|Adolescent|adolescent
131549|NCT02475980|Contraception|contraception
131550|NCT02475980|Counseling|counseling
131551|NCT02475967|E-Learning|e-learning
131552|NCT02475967|coronary artery disease|coronary artery disease
131553|NCT02475967|telerehabilitation|telerehabilitation
131554|NCT02475967|e-health|e-health
131555|NCT02475954|Depression|depression
131556|NCT02475954|Telehealth|telehealth
131557|NCT02475954|Parkinson's Disease|parkinson's disease
131558|NCT02475954|Veterans|veterans
131559|NCT02475954|Care-partners|care-partners
131560|NCT02475954|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
131561|NCT02475954|Caregiver|caregiver
131562|NCT02475941|geriatric fractures|geriatric fractures
131563|NCT02475915|Treatment interruption|treatment interruption
131564|NCT02475915|Controlling HIV|controlling hiv
131565|NCT02475902|prevention and control|prevention and control
131566|NCT02475824|ERCP|ercp
131567|NCT02475824|Sedation|sedation
131568|NCT02475824|safety|safety
131569|NCT02475811|3D ultrasonography|3d ultrasonography
131570|NCT02475811|fetal Lung Volume|fetal lung volume
131571|NCT02475811|neonatal respiratory function|neonatal respiratory function
131572|NCT02475798|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
131573|NCT02475798|Iliac aneurysm|iliac aneurysm
131574|NCT02475798|Branch|branch
131575|NCT02475798|Connections|connections
131576|NCT02475798|Endovascular graft|endovascular graft
131577|NCT02475798|Graft-iliac bifurcation|graft-iliac bifurcation
131578|NCT02475798|Aneurysm|aneurysm
131579|NCT02475798|Vascular Diseases|vascular diseases
131580|NCT02475798|Cardiovascular Diseases|cardiovascular diseases
131581|NCT02475785|Forsus Fatigue Resistant Device|forsus fatigue resistant device
131582|NCT02475785|Class II|class ii
131583|NCT02475785|anchorage|anchorage
131584|NCT02475785|FFRD|ffrd
131585|NCT02475785|mini plates|mini plates
131586|NCT02475785|fixed functional appliance|fixed functional appliance
131587|NCT02475772|ovarian cancer|ovarian cancer
131588|NCT02475772|recurrent|recurrent
131589|NCT02475772|chemotherapy|chemotherapy
131590|NCT02475772|intraperitoneal|intraperitoneal
131591|NCT02475772|cisplatin|cisplatin
131592|NCT02475772|doxorubicin|doxorubicin
131593|NCT02475746|drug interaction, PF-06372865, itraconazole|drug interaction, pf-06372865, itraconazole
131594|NCT02475707|leukemia|leukemia
131595|NCT02475707|lymphoblastic|lymphoblastic
131596|NCT02475707|ALL|all
131597|NCT02475707|multiTAA-specific T cells|multitaa-specific t cells
131598|NCT02475707|HSCT|hsct
131599|NCT02475590|Sleeve gastrectomy|sleeve gastrectomy
131600|NCT02475590|Roux-en-Y gastric bypass|roux-en-y gastric bypass
131601|NCT02475590|Excess weight loss|excess weight loss
131602|NCT02475590|Quality of life|quality of life
131603|NCT02475577|telemedicine|telemedicine
131604|NCT02475577|heart failure|heart failure
131605|NCT02475577|home blood pressure monitoring|home blood pressure monitoring
131606|NCT02475564|resveratrol|resveratrol
131607|NCT02475512|elderly|elderly
131608|NCT02475512|long-term care|long-term care
131609|NCT02475499|Incretins|incretins
131610|NCT02475499|Antidiabetic agents|antidiabetic agents
131611|NCT02475499|Pancreatic Cancer|pancreatic cancer
131612|NCT02475486|Rheumatoid Arthritis|rheumatoid arthritis
131613|NCT02475486|sympathetic nervous system|sympathetic nervous system
131614|NCT02475486|SNA|sna
131615|NCT02475486|fatigue|fatigue
131616|NCT02475473|Volunteers|volunteers
131617|NCT02475460|HeartMate 3|heartmate 3
131618|NCT02475460|LVAS|lvas
131619|NCT02475460|LVAD|lvad
131620|NCT02475460|Heart-assist Devices|heart-assist devices
131621|NCT02475460|Advanced|advanced
131622|NCT02475460|Ventricular Dysfunction|ventricular dysfunction
131623|NCT02475460|refractory left ventricular|refractory left ventricular
131624|NCT02475460|Thoratec Corporation|thoratec corporation
131625|NCT02475434|Human Milk|human milk
131626|NCT02475434|Prematurity|prematurity
131627|NCT02475434|Nutrition|nutrition
131628|NCT02475421|Diabetes|diabetes
131629|NCT02475421|Glucagon|glucagon
131630|NCT02475421|Metabolic clearance rate of glucagon|metabolic clearance rate of glucagon
131631|NCT02475408|Circulation, Collateral|circulation, collateral
131632|NCT02475408|Coronary Artery Disease|coronary artery disease
131633|NCT02475408|Internal Mammary-Coronary Artery Anastomosis|internal mammary-coronary artery anastomosis
131635|NCT02475395|Male Fertility|male fertility
131636|NCT02475395|Male Infertility|male infertility
131637|NCT02475395|Fertility|fertility
131638|NCT02475395|Sperm|sperm
131639|NCT02475395|Sperm Concentration|sperm concentration
131640|NCT02475369|pancreatic enzyme supplementation|pancreatic enzyme supplementation
131641|NCT02475356|Mirena|mirena
131642|NCT02475356|Heavy Menstrual Bleeding|heavy menstrual bleeding
131643|NCT02475356|Dysmenorrhea|dysmenorrhea
131644|NCT02475356|Japan|japan
131645|NCT02475356|Post-marketing surveillance|post-marketing surveillance
131646|NCT02475317|Volunteer|volunteer
653011|NCT00783302|Visipaque|visipaque
131647|NCT02475278|Drug therapy|drug therapy
131648|NCT02475265|Anorexia Nervosa|anorexia nervosa
131649|NCT02475265|Osteoporosis|osteoporosis
131650|NCT02475265|Eating Disorder|eating disorder
131651|NCT02475265|Disordered Eating|disordered eating
131652|NCT02475265|Estrogen|estrogen
131653|NCT02475265|Bone|bone
131654|NCT02475239|Benign Paroxysmal Positional Vertigo, Postural Restriction|benign paroxysmal positional vertigo, postural restriction
131655|NCT02475226|Traumatic Brain Injury|traumatic brain injury
131656|NCT02475226|Brain Damage|brain damage
131657|NCT02475226|Mortality|mortality
131658|NCT02475226|C10.228.140.199|c10.228.140.199
131659|NCT02475213|Malanoma, Non small cell lung cancer, SCCHN|malanoma, non small cell lung cancer, scchn
131660|NCT02475213|Other B7-H3 expressing cancers|other b7-h3 expressing cancers
131662|NCT02475187|MEA|mea
131663|NCT02475187|Thrombotic events|thrombotic events
131664|NCT02475187|VTE|vte
131665|NCT02475187|LMWH|lmwh
131666|NCT02475187|Hip fractures|hip fractures
131667|NCT02475161|Healthy|healthy
131668|NCT02475161|Rabeprazole|rabeprazole
131669|NCT02475161|JNJ-42847922|jnj-42847922
131670|NCT02475148|JNJ-54175446|jnj-54175446
131671|NCT02475148|Healthy|healthy
131672|NCT02475135|Immunodeficiency Virus Type 1, Human|immunodeficiency virus type 1, human
131673|NCT02475135|Immunodeficiency Virus Type 2, Human|immunodeficiency virus type 2, human
131674|NCT02475135|Darunavir|darunavir
131675|NCT02475135|Cobicistat|cobicistat
131676|NCT02475135|Tenofovir Alafenamide|tenofovir alafenamide
131677|NCT02475135|Emtricitabine|emtricitabine
131678|NCT02475135|Elvitegravir|elvitegravir
131679|NCT02475122|Measurement of azygos blood flow|measurement of azygos blood flow
131680|NCT02475109|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
131681|NCT02475083|Stroke|stroke
131682|NCT02475083|Virtual reality|virtual reality
131683|NCT02475083|Balance|balance
131684|NCT02475083|Falls|falls
131685|NCT02475057|Prostate Cancer|prostate cancer
131686|NCT02475057|Cardiovascular disease|cardiovascular disease
131687|NCT02475057|Degarelix|degarelix
131688|NCT02475044|post-concussion|post-concussion
131689|NCT02475044|Cognitive-Behavioral Theray|cognitive-behavioral theray
131690|NCT02475044|parenting|parenting
131691|NCT02475031|transversus abdominis plane block|transversus abdominis plane block
131692|NCT02475018|Shuhua Milk|shuhua milk
131693|NCT02475018|plant sterol esters|plant sterol esters
131694|NCT02475018|serum cholesterol|serum cholesterol
131695|NCT02475018|human|human
131696|NCT02475005|self management app|self management app
131697|NCT02475005|headache|headache
131698|NCT02475005|adolescent|adolescent
131699|NCT02474992|HIV|hiv
131700|NCT02474992|Social network|social network
131701|NCT02474992|Social support|social support
131702|NCT02474992|Disclosure|disclosure
131703|NCT02474992|Stigma|stigma
131704|NCT02474992|Kenya|kenya
131705|NCT02474979|Pressure ulcer|pressure ulcer
131706|NCT02474979|Prevention|prevention
131707|NCT02474979|Pressure mapping|pressure mapping
131708|NCT02474953|Curcumin|curcumin
131709|NCT02474953|Pharmacokinetic|pharmacokinetic
131710|NCT02474940|Multiple Sclerosis|multiple sclerosis
131711|NCT02474940|Chronic Pain|chronic pain
131712|NCT02474940|Chronic Fatigue|chronic fatigue
131713|NCT02474940|Autoimmune Diseases|autoimmune diseases
131714|NCT02474940|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
131715|NCT02474940|Central Nervous System Diseases|central nervous system diseases
131716|NCT02474940|Demyelinating Autoimmune Diseases, CNS|demyelinating autoimmune diseases, cns
131717|NCT02474940|Demyelinating Diseases|demyelinating diseases
131718|NCT02474927|antibody-mediated rejection|antibody-mediated rejection
131719|NCT02474927|lung transplant|lung transplant
131720|NCT02474927|Carfilzomib|carfilzomib
131721|NCT02474901|Shedding|shedding
131722|NCT02474901|Immunogenicity|immunogenicity
131723|NCT02474901|Safety|safety
131724|NCT02474901|HIV infected|hiv infected
131725|NCT02474901|Children|children
131726|NCT02474901|Young adults|young adults
131727|NCT02474875|Fibromyalgia|fibromyalgia
131728|NCT02474875|Patient education|patient education
131729|NCT02474875|Central sensitization|central sensitization
131730|NCT02474836|Allergy|allergy
131731|NCT02474810|central venous catheters|central venous catheters
131732|NCT02474810|hemodialysis|hemodialysis
131733|NCT02474810|thrombosis|thrombosis
131734|NCT02474810|tissue plasminogen activator|tissue plasminogen activator
131735|NCT02474797|Ultrasonography|ultrasonography
131844|NCT02474212|anti-FXa|anti-fxa
131739|NCT02474797|Critical care|critical care
131740|NCT02474797|Chest physiotherapy|chest physiotherapy
131741|NCT02474745|second stage of labor|second stage of labor
131742|NCT02474745|pushing techniques|pushing techniques
131743|NCT02474719|nephrology|nephrology
131744|NCT02474719|extra-renal purification|extra-renal purification
131745|NCT02474719|peritoneal dialysis|peritoneal dialysis
131746|NCT02474706|cefoxitin Patient safety|cefoxitin patient safety
131747|NCT02474706|Infectious diseases|infectious diseases
131748|NCT02474706|Extended-Spectrum β-lactamases E.coli|extended-spectrum β-lactamases e.coli
131749|NCT02474706|Antibiotics|antibiotics
131750|NCT02474680|depression|depression
131751|NCT02474680|Major Depressive Disorder|major depressive disorder
131753|NCT02474680|mental health|mental health
131754|NCT02474680|pharmacogenomics|pharmacogenomics
131755|NCT02474680|personalized medicine|personalized medicine
131756|NCT02474680|precision medicine|precision medicine
131757|NCT02474680|anti-depressants|anti-depressants
131758|NCT02474667|DGF|dgf
131759|NCT02474667|Delayed Graft Function|delayed graft function
131760|NCT02474667|Renal Transplantation|renal transplantation
131761|NCT02474667|Deseased Donor Kidney|deseased donor kidney
131762|NCT02474667|BB3|bb3
131763|NCT02474667|Kidney Transplantation|kidney transplantation
131764|NCT02474667|Acute Kidney Injury|acute kidney injury
131765|NCT02474641|Breast cancer|breast cancer
131766|NCT02474641|Hypofractionation with SIB|hypofractionation with sib
122858|NCT02527785|S-1|s-1
131767|NCT02474641|Non-inferiority|non-inferiority
131768|NCT02474641|adjuvant radiotherapy with simultaneous integrated boost|adjuvant radiotherapy with simultaneous integrated boost
131769|NCT02474628|Physiological Phenomena|physiological phenomena
131770|NCT02474615|Apicoectomy|apicoectomy
131771|NCT02474615|Oral surgery|oral surgery
131772|NCT02474615|Biocompatible materials|biocompatible materials
131773|NCT02474615|Dental Cements|dental cements
131774|NCT02474615|Translational Medical Research|translational medical research
131775|NCT02474602|phototherapy|phototherapy
131776|NCT02474602|strength training|strength training
131777|NCT02474602|photobiostimulation|photobiostimulation
131778|NCT02474602|muscle development|muscle development
131779|NCT02474589|Treatment|treatment
131780|NCT02474589|orthopoxvirus|orthopoxvirus
131781|NCT02474589|smallpox|smallpox
131782|NCT02474563|Multiple Myeloma|multiple myeloma
131783|NCT02474563|Bortezomib|bortezomib
131784|NCT02474563|Melphalan|melphalan
131785|NCT02474563|Prednisone|prednisone
131786|NCT02474550|diffuse large b cell lymphoma|diffuse large b cell lymphoma
131787|NCT02474550|peg-filgrastim|peg-filgrastim
131788|NCT02474550|febrile neutropenia|febrile neutropenia
131789|NCT02474537|hepatic impairment,|hepatic impairment,
131790|NCT02474537|INC280,|inc280,
131791|NCT02474537|Oral cMET Inhibitor,|oral cmet inhibitor,
131792|NCT02474537|Non-Cancer|non-cancer
131793|NCT02474524|Psychosis|psychosis
131794|NCT02474524|Schizophrenia|schizophrenia
131795|NCT02474524|Self-management|self-management
131796|NCT02474524|Recovery|recovery
131797|NCT02474524|Tablet computer|tablet computer
131798|NCT02474524|Digital health|digital health
131799|NCT02474524|Internet|internet
131800|NCT02474524|Online|online
131801|NCT02474524|Peer support|peer support
131802|NCT02474498|Regenerative therapy|regenerative therapy
131803|NCT02474498|Randomized clinical trial (RCT)|randomized clinical trial (rct)
131804|NCT02474498|Enamel matrix derivative|enamel matrix derivative
131805|NCT02474498|Hydroxyapatite-beta tricalcium phosphate|hydroxyapatite-beta tricalcium phosphate
131806|NCT02474498|Buccal furcation|buccal furcation
131807|NCT02474485|bioresorbable vascular scaffold|bioresorbable vascular scaffold
131808|NCT02474485|Absorb|absorb
131809|NCT02474485|drug eluting balloon|drug eluting balloon
131810|NCT02474485|percutaneous coronary intervention|percutaneous coronary intervention
131811|NCT02474472|Midline Laparotomy|midline laparotomy
131812|NCT02474472|Sternotomy|sternotomy
131813|NCT02474472|Thoracotomy|thoracotomy
131814|NCT02474472|Thoracoabdominal Incision|thoracoabdominal incision
131815|NCT02474459|Deep Brain Stimulation|deep brain stimulation
131816|NCT02474459|DBS|dbs
131817|NCT02474459|STN|stn
131818|NCT02474459|GPi|gpi
131819|NCT02474459|Globus pallidus|globus pallidus
131820|NCT02474459|Subthalamic nucleus|subthalamic nucleus
131821|NCT02474459|Neuromodulation|neuromodulation
131822|NCT02474407|Seizures|seizures
131823|NCT02474407|Epilepsy|epilepsy
131827|NCT02474329|Parkinson's disease|parkinson's disease
131828|NCT02474329|Ambulatory monitoring|ambulatory monitoring
131829|NCT02474329|Disease progression|disease progression
131830|NCT02474303|Truvada|truvada
131831|NCT02474303|EMTRICITABINE/TENOFOVIR DISPROXIL FUMARATE|emtricitabine/tenofovir disproxil fumarate
131832|NCT02474303|HIV PREEXPOSURE PROPHYLAXIS (PrEP)|hiv preexposure prophylaxis (prep)
131833|NCT02474303|Female Sex Workers|female sex workers
131834|NCT02474290|Acute Myeloid Leukemia|acute myeloid leukemia
131835|NCT02474290|FLT3-ITD|flt3-itd
131840|NCT02474212|Venous thromboembolism|venous thromboembolism
131841|NCT02474212|pulmonary embolism|pulmonary embolism
131842|NCT02474212|thromboprophylaxis|thromboprophylaxis
131843|NCT02474212|anticoagulant|anticoagulant
131845|NCT02474212|low-molecular weight heparin|low-molecular weight heparin
131846|NCT02474212|enoxaparin|enoxaparin
131847|NCT02474199|Regulatory T Cells ( Treg)|regulatory t cells ( treg)
131848|NCT02474199|Donor Alloantigen Reactive Tregs (darTregs)|donor alloantigen reactive tregs (dartregs)
131850|NCT02474199|Alloantigen Reactive Tregs|alloantigen reactive tregs
653012|NCT00783302|CCTA|ccta
131851|NCT02474199|Calcineurin Inhibitors (CNI)|calcineurin inhibitors (cni)
131852|NCT02474199|immunosuppressants (IS)|immunosuppressants (is)
131853|NCT02474186|breast|breast
131854|NCT02474186|cancer|cancer
131855|NCT02474186|metastatic|metastatic
131856|NCT02474186|breast cancer|breast cancer
131857|NCT02474186|metastatic breast cancer|metastatic breast cancer
131858|NCT02474186|radiation|radiation
131859|NCT02474186|radiotherapy|radiotherapy
131860|NCT02474186|radiation therapy|radiation therapy
131861|NCT02474186|abscopal|abscopal
131862|NCT02474186|abscopal effect|abscopal effect
131863|NCT02474186|T-cell|t-cell
131864|NCT02474186|GM-CSF|gm-csf
131865|NCT02474186|anti-tumor|anti-tumor
131866|NCT02474186|immune|immune
131867|NCT02474186|immune response|immune response
131868|NCT02474186|capecitabine|capecitabine
131869|NCT02474186|xeloda|xeloda
131870|NCT02474186|taxol|taxol
131871|NCT02474186|paclitaxel|paclitaxel
158909|NCT02320604|Obesity|obesity
122982|NCT02526745|vaccine|vaccine
131872|NCT02474186|other solid metastatic tumor|other solid metastatic tumor
131873|NCT02474108|atrial fibrillation|atrial fibrillation
131874|NCT02474108|radiofrequency ablation|radiofrequency ablation
131875|NCT02474108|prevention of AF|prevention of af
131876|NCT02474108|mitral valve|mitral valve
131877|NCT02474108|left atrium enlargement|left atrium enlargement
131878|NCT02474108|cryoablation|cryoablation
131879|NCT02474056|decreased blood volume vein volume flow ultrasound exam|decreased blood volume vein volume flow ultrasound exam
131880|NCT02474043|Injection drug use|injection drug use
131881|NCT02474017|Inhaler|inhaler
131882|NCT02474017|Adolescent|adolescent
131883|NCT02473978|During Labor|during labor
131884|NCT02473978|Complicating Anesthesia or Other Sedation|complicating anesthesia or other sedation
131885|NCT02473978|Cerebral|cerebral
131890|NCT02473887|ondansetron|ondansetron
131891|NCT02473887|palatability|palatability
131892|NCT02473887|vomiting|vomiting
131893|NCT02473861|exercise training|exercise training
131894|NCT02473861|breast cancer|breast cancer
131895|NCT02473861|taxane chemotherapy|taxane chemotherapy
131896|NCT02473861|peripheral neuropathy|peripheral neuropathy
131897|NCT02473861|fatigue|fatigue
131898|NCT02473861|autonomic function|autonomic function
131899|NCT02473835|T-lymphocyte|t-lymphocyte
131900|NCT02473835|Adipose tissue|adipose tissue
131901|NCT02473835|Inflammation|inflammation
131902|NCT02473835|Calorie restriction|calorie restriction
131903|NCT02473822|anterior cruciate ligament|anterior cruciate ligament
131904|NCT02473822|Tape Locking Screw|tape locking screw
131905|NCT02473822|LCA|lca
131906|NCT02473822|joint trauma|joint trauma
131907|NCT02473796|home based child care|home based child care
131908|NCT02473770|Registry|registry
131909|NCT02473770|Exposures|exposures
131910|NCT02473770|Biological Specimens|biological specimens
131911|NCT02473770|Occupational Health|occupational health
131912|NCT02473757|Recombinant DNA Product|recombinant dna product
131913|NCT02473757|Laboratory Evaluation|laboratory evaluation
131914|NCT02473757|NIH Office of Biotechnology Activities|nih office of biotechnology activities
131915|NCT02473757|Gamma-Retroviral Vectors|gamma-retroviral vectors
131916|NCT02473744|lower limb edema|lower limb edema
131917|NCT02473744|subcutaneous drainage|subcutaneous drainage
131918|NCT02473744|bioelectrical impedance|bioelectrical impedance
131919|NCT02473744|quality of life|quality of life
131920|NCT02473731|CDX3379|cdx3379
131921|NCT02473705|Geriatric|geriatric
131922|NCT02473705|bicarbonate|bicarbonate
131923|NCT02473705|omega polyunsaturated fatty acids|omega polyunsaturated fatty acids
131924|NCT02473705|exercise capacity|exercise capacity
131925|NCT02473679|First Responder|first responder
131926|NCT02473679|BLS|bls
131927|NCT02473679|AED|aed
131928|NCT02473679|Resuscitation|resuscitation
131929|NCT02473666|Patient Blood Management|patient blood management
131930|NCT02473666|Red Blood Cells|red blood cells
131931|NCT02473666|Platelet|platelet
131932|NCT02473627|Pharmacokinetics|pharmacokinetics
131933|NCT02473601|mivacurium chloramine|mivacurium chloramine
131934|NCT02473601|patients with liver cirrhosis|patients with liver cirrhosis
131935|NCT02473601|muscle relaxation effect|muscle relaxation effect
131936|NCT02473575|Caffeine, running, performance|caffeine, running, performance
131937|NCT02473562|Parkinson's disease|parkinson's disease
131938|NCT02473562|Varenicline|varenicline
131939|NCT02473562|Excessive daytime sleepiness|excessive daytime sleepiness
131940|NCT02473549|motor|motor
131941|NCT02473549|rehabilitation|rehabilitation
131942|NCT02473549|transcranial direct current stimulation|transcranial direct current stimulation
131943|NCT02473523|Fatigue|fatigue
131944|NCT02473523|Pain Alleviation|pain alleviation
131945|NCT02473523|Emotional Wellbeing|emotional wellbeing
131946|NCT02473523|Physical Wellbeing|physical wellbeing
131947|NCT02473523|Yoga|yoga
131948|NCT02473510|Trivalent|trivalent
131949|NCT02473510|Influenza|influenza
131950|NCT02473510|FluMist Quadrivalent|flumist quadrivalent
131951|NCT02473510|Vaccine|vaccine
131955|NCT02473497|activating mutation|activating mutation
131956|NCT02473497|activating genetic alteration|activating genetic alteration
131957|NCT02473497|genetic aberration|genetic aberration
131959|NCT02473497|ROS1|ros1
131960|NCT02473497|cMET|cmet
131961|NCT02473497|crizotinib|crizotinib
131962|NCT02473497|oral formulation|oral formulation
131963|NCT02473484|High Grade Glioma|high grade glioma
131964|NCT02473484|Proteomics|proteomics
131965|NCT02473484|MALDI-MSI|maldi-msi
131966|NCT02473471|Micro-Osteoperforation (MOPs)|micro-osteoperforation (mops)
131967|NCT02473471|regional acceleratory phenomenon (RAP)|regional acceleratory phenomenon (rap)
131968|NCT02473471|Malocculsion|malocculsion
131969|NCT02473458|Licorice|licorice
131970|NCT02473458|Glycyrrhizic acid|glycyrrhizic acid
131971|NCT02473458|Ischemic Stroke|ischemic stroke
131972|NCT02473458|Acute|acute
131973|NCT02473445|inherited mitochondrial disease|inherited mitochondrial disease
131974|NCT02473445|Leigh Syndrome|leigh syndrome
131975|NCT02473445|LHON|lhon
131976|NCT02473445|MERFF|merff
131977|NCT02473445|MELAS|melas
131978|NCT02473445|Kearn-Sayre syndrome|kearn-sayre syndrome
131979|NCT02473445|POLG-related disorders|polg-related disorders
131980|NCT02473445|MNGIE|mngie
131981|NCT02473432|respiratory muscle training|respiratory muscle training
131982|NCT02473432|neuromuscular electrical stimulation|neuromuscular electrical stimulation
131983|NCT02473432|oropharyngeal dysphagia|oropharyngeal dysphagia
131984|NCT02473432|stroke|stroke
131985|NCT02473432|rehabilitation|rehabilitation
131986|NCT02473419|Medical food|medical food
131987|NCT02473419|ADHD|adhd
131988|NCT02473419|Vayarin|vayarin
131989|NCT02473419|Fish Oil|fish oil
131990|NCT02473380|glioma|glioma
131991|NCT02473380|fluorescence spectroscopy|fluorescence spectroscopy
131992|NCT02473341|Bovine Colostrum|bovine colostrum
131993|NCT02473341|Corticosteriods|corticosteriods
131994|NCT02473341|Endotoxin|endotoxin
131995|NCT02473341|MELD|meld
131996|NCT02473341|mDF|mdf
131997|NCT02473328|dose reduction study|dose reduction study
131998|NCT02473289|Depressive disorder, major|depressive disorder, major
131999|NCT02473289|Sirukumab|sirukumab
132000|NCT02473263|Severe septic syndrome|severe septic syndrome
132001|NCT02473263|mobile intensive care unit|mobile intensive care unit
132002|NCT02473263|strategy|strategy
132003|NCT02473263|antibiotics|antibiotics
132004|NCT02473263|hemodynamic optimization|hemodynamic optimization
132005|NCT02473237|COPD|copd
132006|NCT02473237|biomass|biomass
132007|NCT02473224|challenge|challenge
132008|NCT02473224|GII.2|gii.2
132009|NCT02473224|HID50|hid50
132010|NCT02473224|Norovirus|norovirus
132011|NCT02473224|Snow Mountain filtrate|snow mountain filtrate
132012|NCT02473198|Total Knee Arthroplasty|total knee arthroplasty
132013|NCT02473198|Amide Local Anesthetic|amide local anesthetic
132014|NCT02473172|Weaning from mechanical ventilation|weaning from mechanical ventilation
132015|NCT02473159|Near-infrared fluorescence|near-infrared fluorescence
132016|NCT02473159|Indocyanine green, ICG|indocyanine green, icg
132017|NCT02473159|breast cancer|breast cancer
132018|NCT02473146|AML|aml
132019|NCT02473146|untreated|untreated
132020|NCT02473146|60-80 years old|60-80 years old
132021|NCT02473146|favorable and intermediate karyotype|favorable and intermediate karyotype
132022|NCT02473133|radiotherapy|radiotherapy
132023|NCT02473133|dose redistribution|dose redistribution
132024|NCT02473133|boost|boost
132025|NCT02473120|metastatic|metastatic
132026|NCT02473120|ESR1|esr1
132027|NCT02473120|aromatase inhibitor|aromatase inhibitor
132028|NCT02473120|breast cancer|breast cancer
132029|NCT02473107|Dental caries|dental caries
132030|NCT02473107|Primary tooth|primary tooth
132031|NCT02473107|Caries Detection|caries detection
132032|NCT02473094|Metformin|metformin
132033|NCT02473094|Rectal Cancer|rectal cancer
132034|NCT02473094|Rectum|rectum
132035|NCT02473094|Radiotherapy|radiotherapy
132036|NCT02473094|Capecitabine|capecitabine
132037|NCT02473094|Neoadjuvant|neoadjuvant
132038|NCT02473094|Adenocarcinoma|adenocarcinoma
132039|NCT02473094|Carcinoma|carcinoma
132042|NCT02473081|Glycemic control|glycemic control
132043|NCT02473081|Depressive symptoms|depressive symptoms
132044|NCT02473081|Problem Area in Diabetes|problem area in diabetes
132045|NCT02473081|Middle-aged and older adults|middle-aged and older adults
132046|NCT02473081|HbA1c protein, human|hba1c protein, human
132047|NCT02473068|CPAP|cpap
132048|NCT02473055|kangaroo care|kangaroo care
132049|NCT02473055|sleep|sleep
132050|NCT02473055|heart rate|heart rate
132051|NCT02473055|respiratory rate|respiratory rate
132052|NCT02473055|preterm infant|preterm infant
132053|NCT02473042|Post-operative nausea and vomiting|post-operative nausea and vomiting
132054|NCT02473042|PONV|ponv
132055|NCT02473042|Breast cancer|breast cancer
132056|NCT02473042|Neuromuscular blockade monitor|neuromuscular blockade monitor
132058|NCT02473042|Breast cancer surgery|breast cancer surgery
132059|NCT02473042|Prophylactic anti-emetics|prophylactic anti-emetics
132060|NCT02473042|Electrical stimulation|electrical stimulation
132062|NCT02473042|Ondansetron|ondansetron
132063|NCT02473042|Dexamethasone|dexamethasone
132064|NCT02473042|Decadron|decadron
132065|NCT02473042|Phenergan|phenergan
132066|NCT02473042|Promethazine|promethazine
132067|NCT02473042|Phenazine|phenazine
132068|NCT02473042|Phencen|phencen
132069|NCT02473042|Prometh|prometh
132070|NCT02473042|Prorex|prorex
132071|NCT02473042|V-Gan|v-gan
132072|NCT02473042|Pepcid|pepcid
132073|NCT02473042|Famotidine|famotidine
132074|NCT02473042|Questionnaire|questionnaire
132075|NCT02473042|Survey|survey
132076|NCT02473016|Classical Trigeminal Neuralgia|classical trigeminal neuralgia
132077|NCT02473003|Breast cancer|breast cancer
132078|NCT02473003|prostate cancer|prostate cancer
132079|NCT02473003|colorectal cancer|colorectal cancer
132080|NCT02473003|fatigue|fatigue
132081|NCT02473003|physical exercise|physical exercise
132082|NCT02473003|randomised trial|randomised trial
132083|NCT02473003|intervention|intervention
132084|NCT02472990|DMD|dmd
132085|NCT02472990|morphological predictive factors|morphological predictive factors
132086|NCT02472990|Mechanical|mechanical
132087|NCT02472938|Relapsing remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
132088|NCT02472912|Pharmacokinetics|pharmacokinetics
132089|NCT02472912|Adalimumab|adalimumab
132090|NCT02472912|Biosimilar Pharmaceuticals|biosimilar pharmaceuticals
132091|NCT02472899|Geriatrics|geriatrics
132092|NCT02472899|Neurocognitive Disorder|neurocognitive disorder
132093|NCT02472899|Biomarkers|biomarkers
132094|NCT02472899|Immunology|immunology
132095|NCT02472886|HCV genotype 1|hcv genotype 1
132097|NCT02472886|Sustained Virologic Response|sustained virologic response
132098|NCT02472886|Direct Acting Antiviral|direct acting antiviral
132099|NCT02472886|Combination Therapy|combination therapy
132100|NCT02472886|GS-7977|gs-7977
132101|NCT02472886|GS-5885|gs-5885
132102|NCT02472886|Ribavirin|ribavirin
132103|NCT02472886|Sofosbuvir|sofosbuvir
132104|NCT02472886|ledipasvir|ledipasvir
132105|NCT02472886|Hepatitis C|hepatitis c
132106|NCT02472886|Hepatitis C, Chronic|hepatitis c, chronic
132107|NCT02472886|Liver Diseases|liver diseases
132108|NCT02472886|Virus Diseases|virus diseases
132109|NCT02472886|Antiviral Agents|antiviral agents
132110|NCT02472886|HCV/HIV co-infection|hcv/hiv co-infection
132111|NCT02472873|endometrioma|endometrioma
132112|NCT02472873|endometriosis|endometriosis
132113|NCT02472873|sclerotherapy|sclerotherapy
132114|NCT02472873|ethanol|ethanol
132115|NCT02472873|aspiration|aspiration
132116|NCT02472873|laparoscopy|laparoscopy
132119|NCT02472847|Marinol|marinol
132120|NCT02472847|Dronabinol|dronabinol
132121|NCT02472847|Fear extinction|fear extinction
132122|NCT02472847|Healthy volunteers|healthy volunteers
132123|NCT02472834|Carbamylation|carbamylation
132124|NCT02472834|Albumin|albumin
132125|NCT02472834|Protein structure|protein structure
132126|NCT02472834|Kidney disease|kidney disease
132127|NCT02472795|Systemic lupus erythematosus|systemic lupus erythematosus
132128|NCT02472782|osteoporosis|osteoporosis
132129|NCT02472782|quality of life|quality of life
132130|NCT02472782|adherence|adherence
132131|NCT02472782|treatment|treatment
132132|NCT02472743|Phototherapy|phototherapy
132133|NCT02472730|Colonoscopy|colonoscopy
132134|NCT02472730|Training Techniques|training techniques
132135|NCT02472730|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
132136|NCT02472717|liraglutide, GLP-1 receptor agonists|liraglutide, glp-1 receptor agonists
132137|NCT02472704|celiac disease|celiac disease
132138|NCT02472704|lymphocytic enteritis|lymphocytic enteritis
132139|NCT02472704|non-celiac gluten sensitivity|non-celiac gluten sensitivity
132140|NCT02472704|double-blind gluten rechallenge|double-blind gluten rechallenge
132141|NCT02472691|relapse after allogeneic transplantation|relapse after allogeneic transplantation
132142|NCT02472691|MDS|mds
132143|NCT02472691|AML|aml
132144|NCT02472691|CMML|cmml
132145|NCT02472691|DLI|dli
132146|NCT02472691|Azacitidine|azacitidine
132147|NCT02472691|Lenalidomide|lenalidomide
132148|NCT02472691|C04.557.337.539.275|c04.557.337.539.275
132149|NCT02472691|C15.378.190.625|c15.378.190.625
132150|NCT02472691|C04.557.337.539.522|c04.557.337.539.522
132151|NCT02472665|pediatric|pediatric
132152|NCT02472665|plasma-derived FVIII concentrate|plasma-derived fviii concentrate
132153|NCT02472613|Post－Stroke Depression|post－stroke depression
132154|NCT02472613|Acupunture|acupunture
132155|NCT02472613|Fluoxetine|fluoxetine
132156|NCT02472613|RCT|rct
132157|NCT02472600|extended spectrum beta-lactamase producing enterobacteriaceae|extended spectrum beta-lactamase producing enterobacteriaceae
132158|NCT02472600|carbapenemase producing enterobacteriaceae|carbapenemase producing enterobacteriaceae
132159|NCT02472600|multidrug resistant bacteria|multidrug resistant bacteria
132160|NCT02472574|Intracerebral Hemorrhage|intracerebral hemorrhage
132161|NCT02472574|minimally invasive surgery|minimally invasive surgery
132162|NCT02472574|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
132163|NCT02472574|Dose-effect Relationship|dose-effect relationship
132165|NCT02472561|Vascular|vascular
132166|NCT02472561|Peripheral Artery Disease|peripheral artery disease
132168|NCT02472561|Mobile Health|mobile health
132169|NCT02472561|Exercise|exercise
132170|NCT02472561|PAD|pad
132171|NCT02472535|HoFH|hofh
132172|NCT02472509|Ursodeoxycholic acid (UDCA)|ursodeoxycholic acid (udca)
132173|NCT02472509|White blood cells (WBC)|white blood cells (wbc)
132174|NCT02472509|Alanine Transaminase (ALT)|alanine transaminase (alt)
132175|NCT02472509|Alkaline Phosphatase (ALP)|alkaline phosphatase (alp)
132176|NCT02472509|Aspartate Aminotransferase (AST)|aspartate aminotransferase (ast)
132177|NCT02472509|Gamma-Glutamyl Transpeptidase (GGT)|gamma-glutamyl transpeptidase (ggt)
132178|NCT02472509|Lactate dehydrogenase (LDH)|lactate dehydrogenase (ldh)
132179|NCT02472509|Low-Density Lipoprotein (LDL)|low-density lipoprotein (ldl)
132180|NCT02472509|High-Density Lipoprotein (HDL)|high-density lipoprotein (hdl)
132181|NCT02472509|Glucose-6-phosphate dehydrogenase (G6PD)|glucose-6-phosphate dehydrogenase (g6pd)
123243|NCT02525081|therapy|therapy
132182|NCT02472509|Ultrasound (US)|ultrasound (us)
132183|NCT02472470|rTMS|rtms
132184|NCT02472470|Depression|depression
132185|NCT02472470|Youth|youth
132186|NCT02472470|TBS|tbs
132187|NCT02472470|Brain Stimulation|brain stimulation
132188|NCT02472470|Electrophysiology|electrophysiology
132189|NCT02472470|Imaging|imaging
132190|NCT02472431|ADRC|adrc
132191|NCT02472431|Adipose-Derived Regenerative Cells|adipose-derived regenerative cells
132192|NCT02472431|Fat Tissue|fat tissue
132193|NCT02472431|Stem Cells|stem cells
132194|NCT02472431|Erectile Dysfunction|erectile dysfunction
132195|NCT02472431|Arteriogenic Impotence|arteriogenic impotence
132196|NCT02472431|Venogenic Impotence|venogenic impotence
132197|NCT02472431|Vasculogenic Impotence|vasculogenic impotence
132198|NCT02472431|Male Impotence|male impotence
132199|NCT02472431|Male Sexual Impotence|male sexual impotence
132200|NCT02472392|EWINGS, SARCOMA|ewings, sarcoma
132201|NCT02472379|Immune System|immune system
132202|NCT02472379|Behavioral Sciences|behavioral sciences
132203|NCT02472379|Women's Health|women's health
132204|NCT02472379|Health Psychology|health psychology
132205|NCT02472379|Writing|writing
132206|NCT02472353|breast|breast
132207|NCT02472353|cancer|cancer
132208|NCT02472353|doxorubicin|doxorubicin
132209|NCT02472353|metformin|metformin
132210|NCT02472353|cardiotoxicity|cardiotoxicity
132211|NCT02472353|ejection fraction|ejection fraction
132212|NCT02472353|LVEF|lvef
132213|NCT02472288|urinary retention|urinary retention
132214|NCT02472288|poststroke|poststroke
132215|NCT02472288|electroacupuncture|electroacupuncture
132216|NCT02472288|randomized controlled trial|randomized controlled trial
132217|NCT02472288|effectiveness|effectiveness
132218|NCT02472288|safety|safety
132219|NCT02472262|Environmental|environmental
132220|NCT02472262|Enteric|enteric
132221|NCT02472249|TACE|tace
132222|NCT02472249|CT perfusion|ct perfusion
132223|NCT02472249|Liver blood flow|liver blood flow
132224|NCT02472236|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
132225|NCT02472223|"Pink Eye"|"pink eye"
132226|NCT02472197|Endometrial polyp|endometrial polyp
132227|NCT02472197|Hysteroscopic resection|hysteroscopic resection
132228|NCT02472197|Morcellation|morcellation
132229|NCT02472184|Office hysteroscopy|office hysteroscopy
132230|NCT02472184|Endometrial biopsy|endometrial biopsy
132231|NCT02472184|Abnormal uterine bleeding|abnormal uterine bleeding
132232|NCT02472184|Uterine fibroids|uterine fibroids
132233|NCT02472171|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
132234|NCT02472171|blueberries|blueberries
132235|NCT02472158|Bandages|bandages
132236|NCT02472158|Central Venous Catheters|central venous catheters
132237|NCT02472158|Catheter-Related Infections|catheter-related infections
132238|NCT02472145|Leukemia, myeloid, acute|leukemia, myeloid, acute
132239|NCT02472145|DACOGEN|dacogen
132240|NCT02472145|Decitabine|decitabine
132241|NCT02472145|JNJ-56022473|jnj-56022473
132243|NCT02472132|Central Venous Catheter|central venous catheter
132244|NCT02472132|Point Of Care Ultra Sound|point of care ultra sound
132245|NCT02472132|Sub Clavian Vein|sub clavian vein
132246|NCT02472132|Internal Jugular Vein|internal jugular vein
132247|NCT02472132|Trans Thoracic Echocardiography|trans thoracic echocardiography
132248|NCT02472119|Celiac disease|celiac disease
132249|NCT02472119|Gluten-free diet|gluten-free diet
132250|NCT02472119|Wheat flour treatment|wheat flour treatment
132251|NCT02472119|Microbial transglutaminase|microbial transglutaminase
132252|NCT02472119|Lysine Ethyl Ester|lysine ethyl ester
132253|NCT02472119|Celiac Disease Treatment|celiac disease treatment
132254|NCT02472106|Aortic Valve|aortic valve
132255|NCT02472106|TAVI|tavi
132256|NCT02472106|Stenosis|stenosis
132257|NCT02472093|Postural exercise|postural exercise
132258|NCT02472093|Back pain|back pain
132259|NCT02472093|Tender points|tender points
132260|NCT02472093|Fibromyalgia|fibromyalgia
132261|NCT02472093|Perceptive rehabilitation|perceptive rehabilitation
132262|NCT02472067|Musculoskeletal Injury|musculoskeletal injury
132263|NCT02472067|physical therapy|physical therapy
132264|NCT02472067|psychological intervention|psychological intervention
132265|NCT02472067|risk factors|risk factors
132266|NCT02472054|hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
132267|NCT02472054|Alemtuzumab (CAMPATH®)|alemtuzumab (campath®)
132269|NCT02472028|Cerebrovascular Disorders|cerebrovascular disorders
132271|NCT02472028|Antihypertensive Agents|antihypertensive agents
132272|NCT02472028|Arterial Pressure|arterial pressure
132273|NCT02472028|Memory Disorders|memory disorders
132274|NCT02472015|neuropsychiatric symptoms|neuropsychiatric symptoms
132275|NCT02472015|dementia|dementia
132276|NCT02472015|telemedicine|telemedicine
132277|NCT02472015|long-term care facilities|long-term care facilities
132278|NCT02472002|Transplant coronary diseases|transplant coronary diseases
132279|NCT02472002|Mesenchymal cell therapy|mesenchymal cell therapy
132280|NCT02472002|Administration of CSM by NOGA system|administration of csm by noga system
132281|NCT02472002|Coronary disease in heart transplant patients|coronary disease in heart transplant patients
132282|NCT02471989|FODMAP|fodmap
132283|NCT02471989|Diet|diet
132284|NCT02471989|pH-impedance monitoring|ph-impedance monitoring
132285|NCT02471976|Leonetti law|leonetti law
132286|NCT02471976|palliative care|palliative care
132287|NCT02471963|Empagliflozin|empagliflozin
132288|NCT02471963|Diabetes mellitus|diabetes mellitus
132289|NCT02471963|Macro- and Microcirculation|macro- and microcirculation
132290|NCT02471963|Vascular Improvement|vascular improvement
132291|NCT02471963|Endothelium function|endothelium function
132292|NCT02471937|Streptococcus agalactiae|streptococcus agalactiae
132293|NCT02471937|Group B Streptococcus|group b streptococcus
132294|NCT02471937|Neonates|neonates
132295|NCT02471937|colonization|colonization
132296|NCT02471937|meningitis|meningitis
132297|NCT02471937|Clonal Complex CC17|clonal complex cc17
132298|NCT02471937|microbiota|microbiota
132299|NCT02471937|next generation sequencing (NGS)|next generation sequencing (ngs)
132300|NCT02471924|Pregnant women|pregnant women
132301|NCT02471911|DLBCL|dlbcl
132302|NCT02471911|Aggressive|aggressive
132303|NCT02471911|Diffuse|diffuse
132304|NCT02471911|Large|large
132305|NCT02471885|remote ischaemic conditioning|remote ischaemic conditioning
132306|NCT02471885|remote ischemic conditioning|remote ischemic conditioning
132307|NCT02471885|cardio-oncology|cardio-oncology
132308|NCT02471885|anthracycline|anthracycline
132309|NCT02471885|troponin|troponin
132310|NCT02471885|chemotherapy|chemotherapy
132311|NCT02471885|myocardial reperfusion injury|myocardial reperfusion injury
132312|NCT02471833|Hypertension|hypertension
132313|NCT02471833|Prevention|prevention
132314|NCT02471833|Family History|family history
132315|NCT02471833|inflammation|inflammation
132316|NCT02471833|blood brain barrier|blood brain barrier
132317|NCT02471833|amyloid|amyloid
132318|NCT02471820|Multiple Myeloma|multiple myeloma
132319|NCT02471794|Type II Diabetes|type ii diabetes
132320|NCT02471794|Personalized Health Planning|personalized health planning
132321|NCT02471794|Shared Medical Appointments|shared medical appointments
132322|NCT02471781|Aortic Aneurysm|aortic aneurysm
132323|NCT02471781|Aneurysm|aneurysm
132324|NCT02471781|Vascular Prosthesis|vascular prosthesis
132325|NCT02471781|Vascular Disease|vascular disease
132326|NCT02471781|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
132327|NCT02471768|central pressure|central pressure
132328|NCT02471768|Gensini score|gensini score
132329|NCT02471768|pulsatility|pulsatility
132330|NCT02471768|coronary artery disease|coronary artery disease
132331|NCT02471755|electro-acupuncture|electro-acupuncture
132332|NCT02471755|menopause|menopause
132333|NCT02471755|menopausal transition symptoms|menopausal transition symptoms
132334|NCT02471755|efficacy|efficacy
132335|NCT02471755|RCT|rct
132336|NCT02471755|placebo control|placebo control
132337|NCT02471729|Cardio-Renal Syndrome|cardio-renal syndrome
132338|NCT02471729|Chronic Heart Failure|chronic heart failure
132339|NCT02471729|Renal Denervation|renal denervation
132340|NCT02471729|Sympathetic activation|sympathetic activation
132341|NCT02471729|Heart Failure|heart failure
132342|NCT02471729|Cardiovascular Diseases|cardiovascular diseases
132343|NCT02471729|Heart Diseases|heart diseases
132344|NCT02471716|Diffuse Type Tenosynovial Giant Cell Tumor (dt-TGCT)|diffuse type tenosynovial giant cell tumor (dt-tgct)
132345|NCT02471703|Total Hip Arthroplasty|total hip arthroplasty
132346|NCT02471703|Total Hip Replacement|total hip replacement
132347|NCT02471703|Inflammatory Joint Disease|inflammatory joint disease
132348|NCT02471703|Non-Inflammatory Joint Disease|non-inflammatory joint disease
132349|NCT02471690|Volunteers|volunteers
132350|NCT02471677|Ovarian stimulation|ovarian stimulation
132351|NCT02471677|corifollitropin alfa|corifollitropin alfa
132352|NCT02471677|GnRH antagonist protocol|gnrh antagonist protocol
132353|NCT02471677|high responders|high responders
132354|NCT02471677|follitropin beta|follitropin beta
133043|NCT02467764|Hip|hip
132355|NCT02471664|Percutaneous mitral valve repair|percutaneous mitral valve repair
132356|NCT02471664|Coronary sinus annuloplasty|coronary sinus annuloplasty
132357|NCT02471664|Mitral loop cerclage|mitral loop cerclage
132358|NCT02471625|Controls|controls
132359|NCT02471599|IgA nephropathy|iga nephropathy
132360|NCT02471599|tonsillitis|tonsillitis
132361|NCT02471599|tonsil provocation test|tonsil provocation test
132362|NCT02471599|Tonsillectomy|tonsillectomy
132363|NCT02471573|IVF|ivf
132364|NCT02471573|Freeze-all|freeze-all
132365|NCT02471573|frozen embryo transfer|frozen embryo transfer
132366|NCT02471573|fresh transfer|fresh transfer
132367|NCT02471560|Microbiota|microbiota
132368|NCT02471560|DMF|dmf
132369|NCT02471560|Gastro intestinal|gastro intestinal
132370|NCT02471560|MS|ms
132371|NCT02471547|Recurrence|recurrence
132372|NCT02471495|NMIBC|nmibc
132373|NCT02471495|Non-Muscle-Invasive Bladder Cancer|non-muscle-invasive bladder cancer
132374|NCT02471495|Nonmuscle Invasive Bladder Cancer|nonmuscle invasive bladder cancer
132375|NCT02471495|BCG refractory|bcg refractory
132376|NCT02471495|BCG failure|bcg failure
132377|NCT02471495|Carcinoma in situ|carcinoma in situ
132378|NCT02471495|CIS|cis
132379|NCT02471482|Near Infra Red Spectrometry|near infra red spectrometry
132380|NCT02471482|Cerebral oxygenation|cerebral oxygenation
132381|NCT02471482|Mozart music|mozart music
132382|NCT02471404|Diabetes Mellitus Type 2,|diabetes mellitus type 2,
132383|NCT02471404|metformin,|metformin,
132384|NCT02471404|saxagliptin,|saxagliptin,
132385|NCT02471404|dapagliflozin,|dapagliflozin,
132386|NCT02471404|glimepiride,|glimepiride,
132387|NCT02471404|inadequate glycaemic control|inadequate glycaemic control
132388|NCT02471378|Assay|assay
132389|NCT02471378|Women|women
132390|NCT02471378|Infected|infected
132391|NCT02471378|Antibodies|antibodies
132392|NCT02471365|Exposure Assessment|exposure assessment
132393|NCT02471365|Questionnaire|questionnaire
132394|NCT02471365|Product Use|product use
132395|NCT02471365|Biomonitoring|biomonitoring
132396|NCT02471352|Dermatologic Condition|dermatologic condition
132397|NCT02471352|Skin Disease|skin disease
132398|NCT02471352|Biospecimen|biospecimen
132399|NCT02471352|Healthy Volunteers|healthy volunteers
132400|NCT02471352|Merkel Cell Carcinoma|merkel cell carcinoma
132401|NCT02471339|Psychological Intervention|psychological intervention
132402|NCT02471339|Coping|coping
132403|NCT02471339|Mindfulness|mindfulness
132404|NCT02471339|Randomized|randomized
132405|NCT02471326|HIV Neutralizing Antibodies|hiv neutralizing antibodies
132406|NCT02471326|HIV Therapy|hiv therapy
132407|NCT02471313|Cross-Sectional Imaging|cross-sectional imaging
132408|NCT02471313|Chemoembolization|chemoembolization
132409|NCT02471313|Radiation Therapy|radiation therapy
132410|NCT02471313|Tumor Hypoxia|tumor hypoxia
132411|NCT02471313|PET Imaging|pet imaging
132412|NCT02471300|Asthma|asthma
132413|NCT02471300|Inflammasome|inflammasome
132414|NCT02471300|Fasting|fasting
132415|NCT02471300|Airflow Obstruction|airflow obstruction
132416|NCT02471287|Ocular Genetic Diseases|ocular genetic diseases
132417|NCT02471287|GENETIC DISEASE|genetic disease
132418|NCT02471144|pediatric, chronic severe plaque psoriasis, secukinumab, etanercept|pediatric, chronic severe plaque psoriasis, secukinumab, etanercept
132419|NCT02471131|WATCHMAN|watchman
132420|NCT02471131|Atrial Fibrillation|atrial fibrillation
132421|NCT02471131|Hybrid Ablation|hybrid ablation
132422|NCT02471131|Safety|safety
132423|NCT02471131|Feasibility|feasibility
132424|NCT02471131|Stroke Prevention|stroke prevention
132425|NCT02471118|Inflammatory Type|inflammatory type
132426|NCT02471092|satiety|satiety
132427|NCT02471092|glycemia|glycemia
132428|NCT02471092|milk protein|milk protein
132429|NCT02471079|Radiation-induced health problems|radiation-induced health problems
132430|NCT02471079|Cardiovascular events|cardiovascular events
132431|NCT02471079|Lung toxicity|lung toxicity
132432|NCT02471053|Exercise|exercise
132433|NCT02471053|Quality of Life|quality of life
132434|NCT02471053|Complementary Therapies|complementary therapies
132435|NCT02471053|Neoadjuvant Therapy|neoadjuvant therapy
132436|NCT02471053|Feasibility Studies|feasibility studies
133040|NCT02467764|Knee|knee
132437|NCT02471040|brain metabolism|brain metabolism
132438|NCT02471040|cognitive function|cognitive function
132439|NCT02471027|Locally advanced cervical cancer|locally advanced cervical cancer
132440|NCT02471027|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
132441|NCT02471027|Disease-free survival|disease-free survival
132442|NCT02471027|Overall survival|overall survival
132443|NCT02471014|Pneumovax23|pneumovax23
132444|NCT02471014|Obesity|obesity
132445|NCT02471001|concentration|concentration
132446|NCT02471001|Isoflurane|isoflurane
132447|NCT02471001|cardioprotective|cardioprotective
132448|NCT02471001|cardioplegia|cardioplegia
132449|NCT02471001|heart surgery|heart surgery
132450|NCT02471001|Disorder|disorder
132451|NCT02471001|Heart|heart
132452|NCT02471001|Functional|functional
132453|NCT02471001|Postoperative|postoperative
132454|NCT02470949|body weight|body weight
132455|NCT02470949|Hispanics|hispanics
132456|NCT02470949|Energy Intake|energy intake
132458|NCT02470923|Smoking cessation|smoking cessation
132459|NCT02470923|Nicotine|nicotine
132460|NCT02470923|Spirometry|spirometry
132461|NCT02470923|Internal medicine|internal medicine
132462|NCT02470910|Prostate Cancer|prostate cancer
132463|NCT02470910|Stage I-III prostate adenocarcinoma|stage i-iii prostate adenocarcinoma
132464|NCT02470806|Venous leg ulcer|venous leg ulcer
132465|NCT02470806|ulcer|ulcer
132466|NCT02470806|venous stasis|venous stasis
132467|NCT02470806|compression|compression
132468|NCT02470806|diabetic foot ulcers|diabetic foot ulcers
132469|NCT02470806|dfu|dfu
132470|NCT02470806|vlu|vlu
132471|NCT02470793|Corneal Endothelial Cell Loss|corneal endothelial cell loss
132472|NCT02470793|Fuchs' Endothelial Dystrophy|fuchs' endothelial dystrophy
132473|NCT02470793|Lamellar Keratoplasty|lamellar keratoplasty
132474|NCT02470793|Descemet Stripping Endothelial Keratoplasty|descemet stripping endothelial keratoplasty
132475|NCT02470793|Descemet Membrane Endothelial Keratoplasty|descemet membrane endothelial keratoplasty
132476|NCT02470793|Minimal Surgical Procedure|minimal surgical procedure
132477|NCT02470728|patient readmission|patient readmission
132478|NCT02470728|pain relief units|pain relief units
132479|NCT02470728|pain centers|pain centers
132480|NCT02470728|multidisciplinary pain clinics|multidisciplinary pain clinics
132481|NCT02470728|multidisciplinary pain centers|multidisciplinary pain centers
132482|NCT02470728|pain clinics|pain clinics
132483|NCT02470728|hospital readmission|hospital readmission
132484|NCT02470728|emergencies|emergencies
132485|NCT02470728|emergency medicine|emergency medicine
132486|NCT02470728|critical care|critical care
132487|NCT02470728|emergency treatment|emergency treatment
132488|NCT02470728|opioid|opioid
132489|NCT02470728|acute pain service|acute pain service
132490|NCT02470715|genetic sequencing|genetic sequencing
132491|NCT02470715|genome|genome
132492|NCT02470715|cancer|cancer
132493|NCT02470715|DNA|dna
132494|NCT02470715|RNA|rna
132495|NCT02470715|protein|protein
132496|NCT02470715|metabolite|metabolite
132497|NCT02470702|Volunteers|volunteers
132498|NCT02470650|comparative effectiveness|comparative effectiveness
132499|NCT02470598|Automated Peritoneal Dialysis|automated peritoneal dialysis
132500|NCT02470598|Adapted APD (aAPD)|adapted apd (aapd)
132501|NCT02470598|Hydration status|hydration status
132502|NCT02470598|Residual Renal Function|residual renal function
132503|NCT02470598|Ultrafiltration|ultrafiltration
132504|NCT02470585|Overall Survival|overall survival
132505|NCT02470585|BRCA|brca
132506|NCT02470585|Veliparib|veliparib
132507|NCT02470585|Ovarian|ovarian
132508|NCT02470585|Poly Adenosine Diphosphate (ADP) - Ribose Polymerase (PARP)|poly adenosine diphosphate (adp) - ribose polymerase (parp)
132509|NCT02470585|ABT-888|abt-888
132510|NCT02470585|Paclitaxel|paclitaxel
132511|NCT02470585|Carboplatin|carboplatin
132512|NCT02470585|Randomized|randomized
132513|NCT02470546|Hepatic encephalopathy|hepatic encephalopathy
132514|NCT02470546|Metformin|metformin
132515|NCT02470546|Liver cirrhosis|liver cirrhosis
132516|NCT02470481|Psoriatic arthritis|psoriatic arthritis
132517|NCT02470468|Immunotherapy|immunotherapy
132518|NCT02470468|Metastatic|metastatic
132519|NCT02470468|NSCLC|nsclc
132520|NCT02470468|Biological|biological
132521|NCT02470468|Lung Cancer|lung cancer
132522|NCT02470468|Vaccine|vaccine
132523|NCT02470455|Atorvastatin|atorvastatin
132524|NCT02470455|Prediabetics|prediabetics
132525|NCT02470455|HbA1c|hba1c
132526|NCT02470416|duodenal|duodenal
132527|NCT02470416|ampulla|ampulla
132528|NCT02470403|dysglycemic, normoglycemic, prediabetes, type 2 diabetes mellitus|dysglycemic, normoglycemic, prediabetes, type 2 diabetes mellitus
132529|NCT02470390|Volunteer|volunteer
132530|NCT02470390|Pharmacokenetics (PK) (plasma and Cerebrospinal Fluid [CSF])|pharmacokenetics (pk) (plasma and cerebrospinal fluid [csf])
132531|NCT02470377|MdDS|mdds
132532|NCT02470377|TMS|tms
132533|NCT02470377|fMRI|fmri
132534|NCT02470377|EEG|eeg
132535|NCT02470364|Myasthenia gravis|myasthenia gravis
132536|NCT02470364|Quality of life|quality of life
132537|NCT02470325|Cerebral palsy|cerebral palsy
132538|NCT02470325|Genetic neurodegenerative diseases|genetic neurodegenerative diseases
132539|NCT02470312|utility of MediGuide system|utility of mediguide system
132540|NCT02470312|CRT|crt
132541|NCT02470312|EP|ep
132542|NCT02470299|ketorolac|ketorolac
132543|NCT02470299|GTPase|gtpase
132544|NCT02470299|cancer|cancer
132545|NCT02470299|peritoneal|peritoneal
132546|NCT02470299|fallopian|fallopian
132547|NCT02470299|ovarian|ovarian
132548|NCT02470273|Melanoma|melanoma
132549|NCT02470260|Diabetes|diabetes
132550|NCT02470260|Pre-diabetes|pre-diabetes
132551|NCT02470260|Cognition|cognition
132552|NCT02470260|Depressive symptoms|depressive symptoms
132553|NCT02470247|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
132554|NCT02470234|ADHD|adhd
132555|NCT02470234|Children|children
132556|NCT02470234|Pharmacokinetics|pharmacokinetics
653900|NCT00786916|lidocaine|lidocaine
132557|NCT02470221|goal-directed fluid therapy|goal-directed fluid therapy
132558|NCT02470221|intraoperative hemodynamics|intraoperative hemodynamics
132559|NCT02470221|postoperative complications|postoperative complications
132560|NCT02470208|Cytomegalovirus reactivation in stem cell transplant|cytomegalovirus reactivation in stem cell transplant
132561|NCT02470182|sleep apnea|sleep apnea
132562|NCT02470182|snoring|snoring
132886|NCT02468570|rAv-PAL PEG|rav-pal peg
132563|NCT02470156|community based participatory research|community based participatory research
132564|NCT02470156|healthy eating|healthy eating
132565|NCT02470156|physical activity|physical activity
132566|NCT02470156|obesity|obesity
132567|NCT02470143|Human-computer interaction|human-computer interaction
132568|NCT02470143|Fear|fear
132569|NCT02470143|Motivation|motivation
132570|NCT02470143|Usability|usability
132571|NCT02470130|simulation|simulation
132572|NCT02470130|anxiety|anxiety
132573|NCT02470130|debriefing|debriefing
132574|NCT02470130|memorization|memorization
132575|NCT02470104|children|children
132576|NCT02470104|bone marrow transplant|bone marrow transplant
132577|NCT02470104|autologous|autologous
132578|NCT02470104|allogeneic|allogeneic
132579|NCT02470104|breastmilk|breastmilk
132580|NCT02470104|hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
132581|NCT02470078|extubation|extubation
132582|NCT02470065|NSCLC|nsclc
132583|NCT02470065|Early stage|early stage
132584|NCT02470065|Phase II|phase ii
132585|NCT02470065|Randomized|randomized
132586|NCT02470065|EGFR mutated|egfr mutated
132587|NCT02470052|Endobronchial Valves|endobronchial valves
132588|NCT02470052|Intrabronchial Valves|intrabronchial valves
132589|NCT02470052|Bronchial Valve|bronchial valve
132590|NCT02470052|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
132591|NCT02470052|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
132592|NCT02470052|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
132593|NCT02470052|Emphysema|emphysema
132594|NCT02470052|Pulmonary Emphysema|pulmonary emphysema
132595|NCT02470052|Lung Diseases|lung diseases
132596|NCT02470052|Respiratory Tract Disease|respiratory tract disease
132597|NCT02470013|Malnutrition|malnutrition
132598|NCT02470013|Geriatrics|geriatrics
132599|NCT02470013|Enteral Nutrition|enteral nutrition
132600|NCT02470000|myofascial pain|myofascial pain
132601|NCT02470000|neck|neck
132602|NCT02470000|laser|laser
132603|NCT02470000|elastography|elastography
132604|NCT02470000|shear wave velocity|shear wave velocity
132605|NCT02470000|randomized control trial|randomized control trial
132606|NCT02470000|Intravascular Laser Irradiation of Blood|intravascular laser irradiation of blood
132607|NCT02469987|safety|safety
132608|NCT02469987|tolerability|tolerability
132609|NCT02469987|immunogenicity|immunogenicity
132610|NCT02469987|MYL-1402O|myl-1402o
132611|NCT02469987|PK|pk
132612|NCT02469987|Avastin®|avastin®
132613|NCT02469987|biosimilarity|biosimilarity
132614|NCT02469987|male|male
132615|NCT02469974|Myelofibrosis|myelofibrosis
132616|NCT02469974|RUXOLITINIB|ruxolitinib
132617|NCT02469974|Autologous stem cell transplant|autologous stem cell transplant
132618|NCT02469948|spasticity|spasticity
132619|NCT02469948|botulinum toxin|botulinum toxin
132620|NCT02469948|ultrasonography guidance|ultrasonography guidance
132621|NCT02469948|electric stimulation guidance|electric stimulation guidance
132622|NCT02469948|stroke|stroke
132623|NCT02469935|Validation|validation
132624|NCT02469935|Surgeon-performed ultrasound|surgeon-performed ultrasound
132625|NCT02469935|Gallstones|gallstones
132626|NCT02469909|Decannulation|decannulation
132627|NCT02469909|tracheostomy|tracheostomy
132628|NCT02469896|ALS|als
132629|NCT02469896|tocilizumab|tocilizumab
132630|NCT02469896|biomarker|biomarker
132631|NCT02469870|Parents of children who have autism|parents of children who have autism
132632|NCT02469870|video-conferencing|video-conferencing
132633|NCT02469870|Applied Behavior Analysis|applied behavior analysis
132634|NCT02469870|Acceptance Commitment Training|acceptance commitment training
132635|NCT02469870|optimism training|optimism training
132636|NCT02469870|Positive Behavior Support|positive behavior support
132637|NCT02469857|AB103|ab103
132638|NCT02469857|Necrotizing fasciitis|necrotizing fasciitis
132639|NCT02469818|pocus|pocus
132640|NCT02469818|ultrasonography|ultrasonography
132641|NCT02469818|glenohumeral dislocation|glenohumeral dislocation
132642|NCT02469792|Anterior cruciate ligament|anterior cruciate ligament
132643|NCT02469792|Ligament rupture|ligament rupture
132644|NCT02469792|Intraarticular injection|intraarticular injection
132645|NCT02469792|ADRC|adrc
132646|NCT02469792|Adipose-derived regenerative cells|adipose-derived regenerative cells
132647|NCT02469792|Adipose tissue|adipose tissue
132648|NCT02469792|Stem cells|stem cells
132649|NCT02469779|Tobacco Prevention|tobacco prevention
132650|NCT02469779|ASPIRE Website|aspire website
132651|NCT02469779|Surveys|surveys
132652|NCT02469779|Questionnaires|questionnaires
132653|NCT02469779|Focus Groups|focus groups
132654|NCT02469779|Health Interactive Website|health interactive website
132655|NCT02469766|ureteral stones|ureteral stones
132656|NCT02469766|ureter|ureter
132657|NCT02469766|ureteroscopy|ureteroscopy
132658|NCT02469766|flexible|flexible
132660|NCT02469753|NSAIDs|nsaids
132661|NCT02469753|Anti-TNF|anti-tnf
132662|NCT02469753|syndesmophytes|syndesmophytes
132663|NCT02469753|mSASSS|msasss
132664|NCT02469740|Ticagrelor|ticagrelor
132665|NCT02469740|Clopidogrel|clopidogrel
132666|NCT02469740|Coronary Artery Disease|coronary artery disease
132667|NCT02469740|Percutaneous Coronary Intervention|percutaneous coronary intervention
132668|NCT02469740|Acute Coronary Syndrome|acute coronary syndrome
132669|NCT02469714|Patient Navigator|patient navigator
132670|NCT02469714|Integrated Care|integrated care
132671|NCT02469714|Latino|latino
132672|NCT02469714|Mental health and wellness|mental health and wellness
132673|NCT02469714|Physical health and wellness|physical health and wellness
132674|NCT02469688|cedar pollinosis|cedar pollinosis
132675|NCT02469688|immunological response,|immunological response,
132676|NCT02469688|ASP4070|asp4070
132677|NCT02469688|vaccine|vaccine
132678|NCT02469675|Spinal Cord Injuries|spinal cord injuries
132679|NCT02469675|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
132680|NCT02469675|Transcranial magnetic stimulation, single pulse|transcranial magnetic stimulation, single pulse
132681|NCT02469675|non-invasive brain stimulation|non-invasive brain stimulation
132682|NCT02469662|Total Elbow Arthroplasty|total elbow arthroplasty
132683|NCT02469662|TEA|tea
132684|NCT02469662|Elbow Arthroplasty|elbow arthroplasty
132685|NCT02469662|Elbow Replacement|elbow replacement
132686|NCT02469662|Advanced Rheumatoid Arthritis|advanced rheumatoid arthritis
132687|NCT02469662|Post-Traumatic Arthritis|post-traumatic arthritis
132688|NCT02469662|Degenerative Arthritis|degenerative arthritis
132689|NCT02469662|Elbow Joint Destruction|elbow joint destruction
132690|NCT02469662|Post-Traumatic Lesions or Bone Loss|post-traumatic lesions or bone loss
132691|NCT02469662|Ankylosed Joints|ankylosed joints
132692|NCT02469662|Acute Comminuted Articular Fracture|acute comminuted articular fracture
132693|NCT02469662|significantly compromises daily living activities|significantly compromises daily living activities
132694|NCT02469662|degree of joint or soft tissue damage precludes reliable osteosynthesis|degree of joint or soft tissue damage precludes reliable osteosynthesis
132695|NCT02469662|precludes less radical procedures, including 13-C3 fractures of the distal humerus|precludes less radical procedures, including 13-c3 fractures of the distal humerus
132696|NCT02469610|Post surgical pain|post surgical pain
132697|NCT02469584|prolapse|prolapse
132698|NCT02469584|anterior colporrhaphy|anterior colporrhaphy
132699|NCT02469545|depression|depression
132700|NCT02469545|microbiota-gut-brain axis|microbiota-gut-brain axis
132701|NCT02469545|Lactobacillus Plantarum 299v|lactobacillus plantarum 299v
132702|NCT02469545|probiotic|probiotic
132703|NCT02469480|MCRC|mcrc
132704|NCT02469480|iron substitution|iron substitution
132705|NCT02469480|iron deficiency anemia|iron deficiency anemia
132706|NCT02469467|phosphate binder|phosphate binder
132707|NCT02469467|dialysis|dialysis
132708|NCT02469454|etonogestrel-implant|etonogestrel-implant
132709|NCT02469454|newborn|newborn
132710|NCT02469454|growth|growth
132711|NCT02469454|Child Development|child development
132712|NCT02469441|coffee|coffee
132713|NCT02469441|postoperative ileus|postoperative ileus
132714|NCT02469441|colorectal surgery|colorectal surgery
132715|NCT02469428|Controlled human exposure study|controlled human exposure study
132716|NCT02469428|Ozone|ozone
132717|NCT02469428|Inflammation|inflammation
132718|NCT02469415|Leukemia|leukemia
132719|NCT02469415|Myelodysplastic syndromes|myelodysplastic syndromes
132720|NCT02469415|MDS|mds
132721|NCT02469415|Lower-risk|lower-risk
132722|NCT02469415|Pacritinib|pacritinib
132723|NCT02469415|5-azacitidine|5-azacitidine
132724|NCT02469415|Azacitidine|azacitidine
132725|NCT02469415|5-azacytidine|5-azacytidine
132726|NCT02469415|Vidaza|vidaza
132727|NCT02469415|5-AZC|5-azc
132728|NCT02469415|AZA-CR|aza-cr
132729|NCT02469415|Ladakamycin|ladakamycin
132730|NCT02469415|NSC-102816|nsc-102816
132731|NCT02469415|Azacytidine|azacytidine
132732|NCT02469415|Decitabine|decitabine
132733|NCT02469415|Dacogen|dacogen
132734|NCT02469402|reduced|reduced
132735|NCT02469402|protein|protein
132736|NCT02469402|formula|formula
132737|NCT02469402|Alpha-lactalbumin|alpha-lactalbumin
132738|NCT02469402|infant|infant
132741|NCT02469363|Macintosh laryngoscope|macintosh laryngoscope
132742|NCT02469363|McCoy laryngoscope|mccoy laryngoscope
132743|NCT02469363|C-Mac videolaryngoscope|c-mac videolaryngoscope
132744|NCT02469363|McGrath videolaryngoscope|mcgrath videolaryngoscope
132745|NCT02469363|Hemodynamic parameters|hemodynamic parameters
132746|NCT02469350|Gait and balance disorders|gait and balance disorders
132747|NCT02469350|serious game|serious game
132748|NCT02469311|infection; arthroplasty; chlorhexidine; hip; knee|infection; arthroplasty; chlorhexidine; hip; knee
132749|NCT02469298|acute, uncomplicated influenza|acute, uncomplicated influenza
132750|NCT02469298|Danirixin|danirixin
132751|NCT02469298|oseltamivir|oseltamivir
132752|NCT02469285|Fatty acids|fatty acids
132753|NCT02469285|Lipids|lipids
132754|NCT02469285|Nitroso compounds|nitroso compounds
132755|NCT02469285|Lipid metabolism|lipid metabolism
132756|NCT02469285|Gut metabolism|gut metabolism
132757|NCT02469259|oxytocin|oxytocin
132764|NCT02469246|HIV-1 Positive|hiv-1 positive
132765|NCT02469246|Virologically-Suppressed|virologically-suppressed
132766|NCT02469220|Diet|diet
132767|NCT02469220|FODMAP|fodmap
132768|NCT02469220|Gut microbiota|gut microbiota
132769|NCT02469220|Inflammation|inflammation
132770|NCT02469207|regenerative medicine|regenerative medicine
132771|NCT02469207|stem cells|stem cells
132772|NCT02469207|immunomodulatory|immunomodulatory
132773|NCT02469207|induced pluripotent stem cells|induced pluripotent stem cells
132774|NCT02469207|gut physiology|gut physiology
132775|NCT02469129|positron emission tomography (PET) imaging|positron emission tomography (pet) imaging
132776|NCT02469129|poly(ADP-ribose) polymerase 1 (PARP1)|poly(adp-ribose) polymerase 1 (parp1)
132777|NCT02469129|[18F]FluorThanatrace ([18F]FTT)|[18f]fluorthanatrace ([18f]ftt)
132778|NCT02469129|PARP1 inhibitors|parp1 inhibitors
132779|NCT02469129|cancer treatments|cancer treatments
132780|NCT02469103|capsule colonoscopy|capsule colonoscopy
132781|NCT02469103|ulcerative colitis|ulcerative colitis
132782|NCT02469077|Chronic Low Back Pain|chronic low back pain
132783|NCT02469064|mechanical ventilation|mechanical ventilation
132784|NCT02469064|respiratory muscle|respiratory muscle
132785|NCT02469064|weaning|weaning
132786|NCT02469064|training|training
132787|NCT02469064|Intensive care|intensive care
132788|NCT02469012|chronic hepatitis C|chronic hepatitis c
132789|NCT02469012|antiviral treatment|antiviral treatment
132790|NCT02469012|interferon-free|interferon-free
132791|NCT02469012|neurocognitive performance|neurocognitive performance
132792|NCT02469012|emotional state|emotional state
132793|NCT02469012|quality of life|quality of life
132794|NCT02468999|Intranasal insulin|intranasal insulin
132795|NCT02468986|Rheumatoid Arthritis|rheumatoid arthritis
132796|NCT02468973|health behavior|health behavior
132797|NCT02468973|consultation|consultation
132798|NCT02468973|undergraduate|undergraduate
132799|NCT02468960|Coronary Artery Disease|coronary artery disease
132800|NCT02468960|OPN NC|opn nc
132801|NCT02468960|Angina|angina
132802|NCT02468960|Stable|stable
132803|NCT02468960|Unstable|unstable
132804|NCT02468947|Neonatal sepsis|neonatal sepsis
132805|NCT02468934|electrical stimulation|electrical stimulation
132806|NCT02468934|neurostimulation|neurostimulation
132807|NCT02468934|neuromodulation|neuromodulation
132808|NCT02468934|TKA pain|tka pain
132809|NCT02468934|pain following total knee replacement|pain following total knee replacement
132810|NCT02468934|total knee arthroplasty|total knee arthroplasty
132811|NCT02468921|Goitre|goitre
132812|NCT02468921|thyroid disease|thyroid disease
132813|NCT02468921|struma|struma
132814|NCT02468895|Myositis|myositis
132815|NCT02468895|Idiopathic inflammatory myopathy|idiopathic inflammatory myopathy
132816|NCT02468895|Antibodies|antibodies
132817|NCT02468895|Genetics|genetics
132818|NCT02468895|Biomarkers|biomarkers
132819|NCT02468882|Breast cancer|breast cancer
132820|NCT02468882|Radiotherapy|radiotherapy
132821|NCT02468882|Toxicity|toxicity
132822|NCT02468882|Outcomes|outcomes
132823|NCT02468882|Watercress|watercress
132824|NCT02468869|recall|recall
132825|NCT02468869|discharge communication|discharge communication
132826|NCT02468843|Deep brain stimulation|deep brain stimulation
132827|NCT02468843|DBS|dbs
132828|NCT02468843|Dystonia|dystonia
132829|NCT02468843|DYT1|dyt1
132830|NCT02468830|mirabegron|mirabegron
132831|NCT02468830|antimuscarinics|antimuscarinics
132832|NCT02468830|beta 3 agonist|beta 3 agonist
132833|NCT02468830|overactive bladder|overactive bladder
132834|NCT02468830|children|children
132837|NCT02468804|Parkinson's|parkinson's
132838|NCT02468804|Non-parkinsons|non-parkinsons
132839|NCT02468791|Rheumatoid Arthritis|rheumatoid arthritis
132840|NCT02468791|Autoimmune Diseases|autoimmune diseases
132841|NCT02468791|Rituximab|rituximab
132842|NCT02468791|Immune System Diseases|immune system diseases
132843|NCT02468791|Joint Diseases|joint diseases
132844|NCT02468791|Rheumatic Diseases|rheumatic diseases
132845|NCT02468778|HeartMate PHP|heartmate php
132846|NCT02468778|High Risk PCI|high risk pci
132847|NCT02468778|Left Ventricular Dysfunction|left ventricular dysfunction
132848|NCT02468778|Thoratec Corporation|thoratec corporation
132849|NCT02468713|Omega-3|omega-3
132850|NCT02468713|Blood lipid profiles|blood lipid profiles
132852|NCT02468713|EPA|epa
132853|NCT02468713|Triglyceride|triglyceride
132854|NCT02468713|Glucose|glucose
132855|NCT02468713|Insulin|insulin
132856|NCT02468713|LDL|ldl
132857|NCT02468713|TPN|tpn
132858|NCT02468687|Relapsed/Refractory|relapsed/refractory
133546|NCT02464774|Breast-Conserving Therapy|breast-conserving therapy
132868|NCT02468635|pulmonary function|pulmonary function
132869|NCT02468635|quality of daily life|quality of daily life
132870|NCT02468596|Axonal excitability|axonal excitability
132871|NCT02468596|Neuropathy|neuropathy
132872|NCT02468596|QTRAC|qtrac
132873|NCT02468596|anti-MAG|anti-mag
132874|NCT02468596|Electrophysiology|electrophysiology
132875|NCT02468583|Osteoarthritis|osteoarthritis
132876|NCT02468583|Post-traumatic|post-traumatic
132877|NCT02468583|Knee|knee
132878|NCT02468583|Pain|pain
132879|NCT02468583|Steroid|steroid
132880|NCT02468583|Intra-articular|intra-articular
132881|NCT02468583|Injection|injection
132882|NCT02468570|PKU|pku
132883|NCT02468570|PEG-PAL|peg-pal
132884|NCT02468570|Pegvaliase|pegvaliase
132885|NCT02468570|BMN 165|bmn 165
132887|NCT02468570|PRISM 302|prism 302
132888|NCT02468570|PRISM 303|prism 303
132889|NCT02468570|BioMarin|biomarin
132890|NCT02468570|165-302|165-302
132891|NCT02468557|Relapsed/refractory pancreatic ductal adenocarcinoma|relapsed/refractory pancreatic ductal adenocarcinoma
132892|NCT02468557|Previously untreated pancreatic ductal adenocarcinoma|previously untreated pancreatic ductal adenocarcinoma
132893|NCT02468544|Engagement in care|engagement in care
132894|NCT02468544|mHealth|mhealth
132895|NCT02468531|Xenon|xenon
123934|NCT02520440|GIF|gif
132896|NCT02468531|Standford A acute aortic dissection|standford a acute aortic dissection
132897|NCT02468505|Structured transition support program|structured transition support program
132898|NCT02468505|Transition 'as usual'|transition 'as usual'
132899|NCT02468492|Knee Osteoarthritis|knee osteoarthritis
132900|NCT02468492|Platelet Rich Plasma|platelet rich plasma
132901|NCT02468492|Mechanism of Action|mechanism of action
132902|NCT02468492|Stem Cells|stem cells
132903|NCT02468492|Synovial Fluid|synovial fluid
132904|NCT02468479|Liver cirrhosis|liver cirrhosis
132905|NCT02468466|suicide|suicide
132906|NCT02468466|prevention|prevention
132907|NCT02468453|velos|velos
132908|NCT02468453|Vascular|vascular
132909|NCT02468453|Rejuvenation|rejuvenation
132910|NCT02468440|renal insufficiency|renal insufficiency
132911|NCT02468440|kidney transplant|kidney transplant
132912|NCT02468440|educational therapy|educational therapy
132913|NCT02468414|Peritoneal Dialysis|peritoneal dialysis
132914|NCT02468414|End Stage Renal Disease|end stage renal disease
132915|NCT02468414|Anemia|anemia
132916|NCT02468388|maltitol|maltitol
132917|NCT02468388|xylitol|xylitol
132918|NCT02468388|quantitative light-induced fluorescence|quantitative light-induced fluorescence
132919|NCT02468388|saliva pH|saliva ph
132920|NCT02468388|re-mineralization|re-mineralization
132921|NCT02468388|dental caries|dental caries
132922|NCT02468362|Intersphincteric resection|intersphincteric resection
132923|NCT02468362|laparoscopic rectal rescetion|laparoscopic rectal rescetion
132924|NCT02468362|total mesorectal excsison|total mesorectal excsison
132925|NCT02468349|Acute Myocardial Infarction|acute myocardial infarction
132926|NCT02468349|Telemedicine|telemedicine
132927|NCT02468349|Readmissions|readmissions
132928|NCT02468336|Physiology|physiology
132929|NCT02468323|PONV|ponv
132930|NCT02468323|Palonosetron|palonosetron
132931|NCT02468323|Ondansetron|ondansetron
132932|NCT02468323|Cesarean section|cesarean section
132933|NCT02468310|Maternal mortality|maternal mortality
132934|NCT02468310|Neonatal mortality|neonatal mortality
132935|NCT02468310|Neonatal morbidity|neonatal morbidity
132936|NCT02468310|Text messaging|text messaging
132937|NCT02468310|Clinical decision making|clinical decision making
132938|NCT02468310|Maternal Morbidity|maternal morbidity
132939|NCT02468271|Clinimetrics|clinimetrics
132940|NCT02468271|Lung function|lung function
132941|NCT02468271|Lung clearance index|lung clearance index
132942|NCT02468258|Assisted Reproduction|assisted reproduction
132943|NCT02468245|Nursing intervention|nursing intervention
132944|NCT02468245|compliance|compliance
132945|NCT02468232|chronic heart failure|chronic heart failure
132946|NCT02468232|cardiovascular death|cardiovascular death
132947|NCT02468232|hospitalization|hospitalization
132948|NCT02468232|outcome study|outcome study
132949|NCT02468232|worsening heart failure|worsening heart failure
132950|NCT02468232|NT-proBNP|nt-probnp
132951|NCT02468232|NYHA|nyha
132952|NCT02468232|KCCQ|kccq
132953|NCT02468232|HF-rEF|hf-ref
132954|NCT02468219|aortic stenosis|aortic stenosis
132955|NCT02468219|aortic valve replacement|aortic valve replacement
132956|NCT02468219|transcatheter aortic valve implantation|transcatheter aortic valve implantation
132959|NCT02468193|Cushing's syndrome|cushing's syndrome
132962|NCT02468193|ectopic corticotropin syndrome|ectopic corticotropin syndrome
132963|NCT02468193|adrenal adenoma|adrenal adenoma
132964|NCT02468193|adrenal carcinoma|adrenal carcinoma
133091|NCT02467491|Aging|aging
132965|NCT02468193|ACTH-Independent Macronodular Adrenal Hyperplasia|acth-independent macronodular adrenal hyperplasia
132966|NCT02468193|AIMAH|aimah
132967|NCT02468193|Primary Pigmented Nodular Adrenal Dysplasia|primary pigmented nodular adrenal dysplasia
132968|NCT02468193|PPNAD|ppnad
132969|NCT02468128|Analgesic|analgesic
132970|NCT02468128|Opioids|opioids
132971|NCT02468128|Pain relief after surgery|pain relief after surgery
132972|NCT02468128|Dinalbuphine|dinalbuphine
132973|NCT02468128|Sebacoyl Dinalbuphine Ester|sebacoyl dinalbuphine ester
132974|NCT02468128|SDE|sde
132975|NCT02468128|SDN|sdn
132976|NCT02468128|LT1001|lt1001
132977|NCT02468102|Rivaroxaban|rivaroxaban
132978|NCT02468102|Venous Thrombosis/Pulmonary Embolism|venous thrombosis/pulmonary embolism
132979|NCT02468102|Stroke Prevention in Atrial Fibrillation|stroke prevention in atrial fibrillation
132980|NCT02468102|Anticoagulants|anticoagulants
132981|NCT02468102|Hematologic Agents|hematologic agents
132982|NCT02468102|Therapeutic Uses|therapeutic uses
132983|NCT02468102|Observational|observational
132984|NCT02468102|Pulmonary Embolism|pulmonary embolism
132985|NCT02468102|Venous Thrombosis|venous thrombosis
132986|NCT02468102|Venous Thromboembolism|venous thromboembolism
132987|NCT02468102|Intracranial Hemorrhages|intracranial hemorrhages
132988|NCT02468102|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
132989|NCT02468076|ERCP|ercp
132990|NCT02468076|radiofrequency ablation|radiofrequency ablation
132991|NCT02468076|obstructive jaundice|obstructive jaundice
132992|NCT02468050|Anxiety|anxiety
132993|NCT02468050|Depression|depression
132994|NCT02468050|Exercise|exercise
160327|NCT02312687|XLH|xlh
132995|NCT02468050|Breast Cancer|breast cancer
132996|NCT02468050|Biopsy|biopsy
132997|NCT02468050|Screening|screening
132998|NCT02468050|Diagnosis|diagnosis
132999|NCT02468037|iron|iron
133000|NCT02468037|diabetes|diabetes
133001|NCT02468037|phlebotomy|phlebotomy
133002|NCT02467998|meaningful use|meaningful use
133003|NCT02467998|electronic health records|electronic health records
133004|NCT02467998|structured language|structured language
133005|NCT02467998|NPWT|npwt
133006|NCT02467998|PQRS|pqrs
133007|NCT02467985|gynecological laparoscopic surgery|gynecological laparoscopic surgery
133008|NCT02467972|Hunger and satiety|hunger and satiety
133009|NCT02467972|Hormones gastrointestinal|hormones gastrointestinal
133010|NCT02467972|Bowel movements|bowel movements
133011|NCT02467959|emergency ultrasound|emergency ultrasound
133012|NCT02467959|acute appendicitis|acute appendicitis
133013|NCT02467959|bedside ultrasound|bedside ultrasound
133017|NCT02467894|Adherence|adherence
133018|NCT02467894|Exercise|exercise
133019|NCT02467881|Physical Activity|physical activity
133020|NCT02467881|Sedentary|sedentary
133021|NCT02467881|Lifestyle Intervention|lifestyle intervention
133022|NCT02467868|Pegfilgrastim|pegfilgrastim
133023|NCT02467868|Granulocyte Colony Stimulating Factor (G-CSF)|granulocyte colony stimulating factor (g-csf)
133024|NCT02467868|Breast Cancer|breast cancer
133025|NCT02467868|Neutropenia|neutropenia
133026|NCT02467855|Drug therapy|drug therapy
133027|NCT02467842|Influenza vaccine|influenza vaccine
133028|NCT02467842|Quadrivalent|quadrivalent
133029|NCT02467842|Inactivated cell culture-derived|inactivated cell culture-derived
133030|NCT02467829|Cerebral Palsy|cerebral palsy
133031|NCT02467829|Walking Aids|walking aids
133032|NCT02467816|Secondary schools|secondary schools
133033|NCT02467816|School lunch|school lunch
133034|NCT02467816|Plate waste|plate waste
133035|NCT02467803|humeral fracture|humeral fracture
133036|NCT02467803|exercise|exercise
133037|NCT02467803|musculoskeletal manipulations|musculoskeletal manipulations
133038|NCT02467777|orthopaedics|orthopaedics
133039|NCT02467777|post-operative warming|post-operative warming
133041|NCT02467764|Knee osteoarthritis|knee osteoarthritis
133042|NCT02467764|Knee replacement|knee replacement
133044|NCT02467764|Hip osteoarthritis|hip osteoarthritis
133045|NCT02467764|Hip replacement|hip replacement
133046|NCT02467725|Preimplantation Embryo Development|preimplantation embryo development
133047|NCT02467712|Fongal infection|fongal infection
133048|NCT02467712|joint prosthesis|joint prosthesis
133049|NCT02467712|prosthetic reconstruction|prosthetic reconstruction
133050|NCT02467699|Knee|knee
133051|NCT02467699|Knee osteoarthritis|knee osteoarthritis
133052|NCT02467699|Knee replacement|knee replacement
133053|NCT02467621|Stress ulcer prophylaxis|stress ulcer prophylaxis
133054|NCT02467621|Proton pump inhibitor|proton pump inhibitor
133055|NCT02467621|Pneumonia|pneumonia
653901|NCT00786916|sedation|sedation
133056|NCT02467621|Clostridium difficile infection|clostridium difficile infection
133057|NCT02467608|HUEXC030|huexc030
133058|NCT02467608|Pulmonary Tuberculosis|pulmonary tuberculosis
133059|NCT02467595|no muscle relaxant|no muscle relaxant
133060|NCT02467595|rocuronium|rocuronium
133061|NCT02467595|intubation condition|intubation condition
133064|NCT02467595|low-dose rocuronium|low-dose rocuronium
133066|NCT02467582|colon cancer|colon cancer
133067|NCT02467582|stage II|stage ii
133068|NCT02467582|stage III|stage iii
133069|NCT02467582|PIK3CA|pik3ca
133070|NCT02467582|double-blind|double-blind
133071|NCT02467582|placebo|placebo
133072|NCT02467582|Adjuvant Treatment|adjuvant treatment
133073|NCT02467556|CRPS|crps
133074|NCT02467556|intervention|intervention
133075|NCT02467556|multimodal|multimodal
133076|NCT02467543|Primary dysmenorrhea|primary dysmenorrhea
133077|NCT02467543|Viburnum opulus 3X|viburnum opulus 3x
133078|NCT02467543|Homoeopathic|homoeopathic
133079|NCT02467530|end stage renal disease|end stage renal disease
133080|NCT02467530|peritoneal dialysis (PD)|peritoneal dialysis (pd)
133081|NCT02467530|advanced glycation end products|advanced glycation end products
133082|NCT02467530|Gut Microbiota Inflammation|gut microbiota inflammation
133083|NCT02467517|Neuropathic pain|neuropathic pain
133084|NCT02467517|Ketamine|ketamine
133085|NCT02467517|Magnesium sulfate|magnesium sulfate
133086|NCT02467517|Quality of life|quality of life
133087|NCT02467517|Anxiety and depression|anxiety and depression
133088|NCT02467517|Mood and sleep|mood and sleep
133089|NCT02467491|Exercise|exercise
133090|NCT02467491|Technology|technology
133092|NCT02467478|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
133093|NCT02467478|Endothelial cells|endothelial cells
133193|NCT02467049|ECG|ecg
133094|NCT02467478|Cellular biomarker|cellular biomarker
133095|NCT02467478|endothelial dysfunction|endothelial dysfunction
133096|NCT02467478|CD34+|cd34+
133097|NCT02467478|Impaired renal function|impaired renal function
133098|NCT02467465|Fasciosis plantar|fasciosis plantar
133099|NCT02467465|physiotherapy|physiotherapy
124169|NCT02519283|AHF|ahf
133100|NCT02467465|fascitis plantar|fascitis plantar
133101|NCT02467465|dry needling|dry needling
133102|NCT02467439|unaware intervention;|unaware intervention;
133103|NCT02467439|contract sexual partner referral|contract sexual partner referral
133104|NCT02467439|peer referral|peer referral
133105|NCT02467426|Mesothelioma, malignant|mesothelioma, malignant
133106|NCT02467426|Chemotherapy|chemotherapy
133107|NCT02467413|Alzheimer's Disease|alzheimer's disease
133108|NCT02467413|Vascular Dementia|vascular dementia
133109|NCT02467400|bone formation|bone formation
133110|NCT02467387|Non-ischemic Heart Failure|non-ischemic heart failure
133111|NCT02467387|Stem Cells|stem cells
133113|NCT02467374|Neuroimaging|neuroimaging
133114|NCT02467374|Fear Extinction|fear extinction
133115|NCT02467374|Behavior Therapy|behavior therapy
133116|NCT02467361|Neoplasms|neoplasms
133117|NCT02467296|Sodium|sodium
133118|NCT02467296|outcomes|outcomes
133119|NCT02467283|chronic periodontitis|chronic periodontitis
133120|NCT02467283|genetics|genetics
133121|NCT02467283|microarray analysis|microarray analysis
133122|NCT02467283|gingiva|gingiva
133123|NCT02467283|genes|genes
133124|NCT02467283|inflammation|inflammation
133125|NCT02467270|Chronic Phase Chronic Myeloid Leukemia|chronic phase chronic myeloid leukemia
133127|NCT02467270|Leukemia|leukemia
133128|NCT02467270|Leukemia, Myeloid|leukemia, myeloid
133129|NCT02467270|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
133130|NCT02467270|Neoplasms by Histologic Type|neoplasms by histologic type
133131|NCT02467270|Neoplasms|neoplasms
133132|NCT02467270|Myeloproliferative Disorders|myeloproliferative disorders
133133|NCT02467270|Bone Marrow Diseases|bone marrow diseases
133134|NCT02467270|Hematologic Diseases|hematologic diseases
133135|NCT02467270|CP-CML|cp-cml
133136|NCT02467244|Hypothyroidism|hypothyroidism
133137|NCT02467244|Serum adiponectin|serum adiponectin
133138|NCT02467244|hsCRP|hscrp
133139|NCT02467244|Homeostatic Model Assessment (HOMA-IR)|homeostatic model assessment (homa-ir)
133140|NCT02467244|Quantitative Insulin Sensitivity Check Index (QUICKI)|quantitative insulin sensitivity check index (quicki)
133141|NCT02467244|Cardiovascular risk assessment scoring (Framingham scoring)|cardiovascular risk assessment scoring (framingham scoring)
133142|NCT02467244|Levothyroxin|levothyroxin
133143|NCT02467231|new diagnosis of cancer|new diagnosis of cancer
133144|NCT02467231|chemotherapy|chemotherapy
133145|NCT02467231|oncofertility|oncofertility
133146|NCT02467231|alkylating agent|alkylating agent
133147|NCT02467231|fertility preservation|fertility preservation
133148|NCT02467231|fertility after cancer|fertility after cancer
133149|NCT02467231|late effects|late effects
133150|NCT02467218|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
133151|NCT02467218|Fibromyalgia|fibromyalgia
133152|NCT02467218|Global Function|global function
133153|NCT02467218|Sleep|sleep
133154|NCT02467218|Chronic Pain|chronic pain
133155|NCT02467218|Depression|depression
133156|NCT02467218|Anxiety|anxiety
133157|NCT02467205|Physical Activity|physical activity
133158|NCT02467179|Arrhythmia|arrhythmia
133159|NCT02467179|cavo-tricuspid isthmus|cavo-tricuspid isthmus
133160|NCT02467179|atrial fibrillation|atrial fibrillation
133161|NCT02467179|atrial fibrillation ablation|atrial fibrillation ablation
133162|NCT02467166|esophagoscopy|esophagoscopy
133163|NCT02467166|atrial fibrillation ablation|atrial fibrillation ablation
133164|NCT02467166|radio frequency catheter ablation|radio frequency catheter ablation
133165|NCT02467166|esophageal lesion|esophageal lesion
133166|NCT02467166|arrhythmia|arrhythmia
133167|NCT02467166|atrial fibrillation|atrial fibrillation
133169|NCT02467166|esophageal damage|esophageal damage
133170|NCT02467153|Sarcopenia|sarcopenia
133171|NCT02467153|Older adult|older adult
133172|NCT02467153|Vitamin D|vitamin d
133173|NCT02467153|Physical activity|physical activity
133174|NCT02467153|Muscle atrophy|muscle atrophy
133175|NCT02467153|Muscle strength|muscle strength
133176|NCT02467153|Physical function|physical function
133177|NCT02467153|Frailty|frailty
133178|NCT02467153|Osteoporosis|osteoporosis
133179|NCT02467140|Inguinal hernia repair|inguinal hernia repair
133180|NCT02467140|Hernia|hernia
133181|NCT02467140|ProGrib self-fixating mesh|progrib self-fixating mesh
133182|NCT02467140|Biological mesh|biological mesh
133183|NCT02467140|Tack fixation|tack fixation
133184|NCT02467101|cicatricial alopecia|cicatricial alopecia
133185|NCT02467101|treatment|treatment
133186|NCT02467101|placebo|placebo
133187|NCT02467101|double-blind|double-blind
133188|NCT02467088|PMS|pms
133189|NCT02467088|Individualised homoeopathic treatment|individualised homoeopathic treatment
133190|NCT02467088|Indian females|indian females
133191|NCT02467075|CT, iodinated contrast, contrast-induced AKI, kidney injury|ct, iodinated contrast, contrast-induced aki, kidney injury
133192|NCT02467062|4D flow|4d flow
133194|NCT02467049|Ultrasound|ultrasound
133195|NCT02467049|Peripherally Inserted Central Catheters|peripherally inserted central catheters
133196|NCT02467049|PICC|picc
133197|NCT02467036|overweight children|overweight children
133198|NCT02467036|overweight parents|overweight parents
133199|NCT02467036|eating in the absence of hunger|eating in the absence of hunger
133200|NCT02467036|families with overweight child|families with overweight child
133201|NCT02467036|bmi|bmi
133202|NCT02467036|body mass index|body mass index
133203|NCT02467036|treatment|treatment
133204|NCT02467036|behavioral treatment|behavioral treatment
133205|NCT02467036|family based treatment|family based treatment
133206|NCT02467036|experiments|experiments
133207|NCT02467036|intervention|intervention
133208|NCT02467036|psychophysiological response to food cues|psychophysiological response to food cues
133209|NCT02467023|chronic critical illness|chronic critical illness
133210|NCT02467023|strength training|strength training
133211|NCT02467023|exercise|exercise
133212|NCT02467023|sepsis|sepsis
133213|NCT02467023|mechanical ventilation|mechanical ventilation
133214|NCT02467010|Bortezomib|bortezomib
133215|NCT02467010|cyclophosphamide|cyclophosphamide
133216|NCT02467010|dexamethason|dexamethason
133217|NCT02467010|multiple myeloma|multiple myeloma
133218|NCT02466997|Vitiligo|vitiligo
133219|NCT02466997|Tacrolimus|tacrolimus
133220|NCT02466997|Face|face
133221|NCT02466984|metoclopramide|metoclopramide
133222|NCT02466984|subcutaneous route|subcutaneous route
133223|NCT02466984|palliative care|palliative care
133224|NCT02466984|pharmacology|pharmacology
133225|NCT02466984|bioavailability|bioavailability
133226|NCT02466984|nausea|nausea
133227|NCT02466984|vomiting|vomiting
133228|NCT02466958|depressed|depressed
133229|NCT02466958|older adults|older adults
133230|NCT02466958|antidepressants|antidepressants
133231|NCT02466958|depression|depression
133232|NCT02466958|MDD|mdd
133233|NCT02466919|Helicobacter pylori|helicobacter pylori
133234|NCT02466906|Stage III colon cancer|stage iii colon cancer
133235|NCT02466906|rhGM-CSF|rhgm-csf
133236|NCT02466906|Immunotherapy|immunotherapy
133237|NCT02466906|Surgery|surgery
133238|NCT02466906|Adjuvant chemotherapy|adjuvant chemotherapy
133239|NCT02466880|Type 2|type 2
133240|NCT02466880|NIDDM|niddm
133241|NCT02466867|Ringworm|ringworm
133242|NCT02466854|Bleeding|bleeding
133243|NCT02466854|Acute Coronary Syndrome|acute coronary syndrome
133244|NCT02466854|percutaneous coronary intervention|percutaneous coronary intervention
133245|NCT02466854|1 year follow up|1 year follow up
133246|NCT02466815|Healthy|healthy
133247|NCT02466815|JNJ-42756493|jnj-42756493
133248|NCT02466802|Advanced|advanced
133249|NCT02466789|Bleeding Disorder, inherited|bleeding disorder, inherited
133250|NCT02466789|Von Willebrands Disease|von willebrands disease
133251|NCT02466789|Hematologic Test|hematologic test
133252|NCT02466789|VWF|vwf
133253|NCT02466789|VWD|vwd
133254|NCT02466763|round window|round window
133255|NCT02466763|cochlear implants|cochlear implants
133256|NCT02466763|cochleostomy|cochleostomy
133257|NCT02466737|axillary surgery|axillary surgery
133258|NCT02466737|sentinel lymph node biopsy|sentinel lymph node biopsy
133259|NCT02466711|gastric motility|gastric motility
133260|NCT02466698|Colectomy|colectomy
133261|NCT02466698|Surgical Procedures, Operative|surgical procedures, operative
133263|NCT02466685|Depression|depression
133264|NCT02466685|Cognition|cognition
133265|NCT02466685|Cognitive|cognitive
133266|NCT02466659|IXT|ixt
133267|NCT02466646|Periodontal Debridement|periodontal debridement
133268|NCT02466646|Gingival Crevicular Fluid|gingival crevicular fluid
133269|NCT02466646|Aggressive Periodontitis|aggressive periodontitis
133270|NCT02466646|Interleukin-1beta|interleukin-1beta
133271|NCT02466646|Interleukin-17|interleukin-17
133272|NCT02466620|Body Weight|body weight
133273|NCT02466620|Resuscitation|resuscitation
133274|NCT02466620|Pediatric weight estimation|pediatric weight estimation
133275|NCT02466607|Retinal function|retinal function
133276|NCT02466568|advanced|advanced
133277|NCT02466568|metastatic|metastatic
133278|NCT02466568|lung disease|lung disease
133279|NCT02466568|adenocarcinoma|adenocarcinoma
133280|NCT02466568|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
133281|NCT02466542|Esmolol|esmolol
133282|NCT02466542|Pain|pain
133283|NCT02466542|Anesthesia|anesthesia
133284|NCT02466542|Analgesia|analgesia
133285|NCT02466529|type 1 spinal muscular atrophy (SMA)|type 1 spinal muscular atrophy (sma)
133286|NCT02466516|GS-4997|gs-4997
133287|NCT02466516|Non-alcoholic fatty liver disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
133288|NCT02466516|Fibrosis|fibrosis
133289|NCT02466516|Simtuzumab|simtuzumab
133290|NCT02466477|Pharmacogenomic|pharmacogenomic
133291|NCT02466477|Pharmacogenomic Testing|pharmacogenomic testing
133292|NCT02466477|Pharmacogenomics|pharmacogenomics
133293|NCT02466477|Genetic Testing|genetic testing
133294|NCT02466477|Genetics|genetics
133295|NCT02466477|Major Depressive Disorder|major depressive disorder
133296|NCT02466477|GeneSight|genesight
133297|NCT02466477|Enhanced GeneSight|enhanced genesight
133298|NCT02466477|Psychotropic|psychotropic
133299|NCT02466438|Antibiotics|antibiotics
133300|NCT02466438|Piperacillin-tazobactam|piperacillin-tazobactam
133301|NCT02466438|Resistant bacteria|resistant bacteria
133302|NCT02466412|smoking|smoking
133303|NCT02466412|nicotine absorption|nicotine absorption
133304|NCT02466412|potential modified risk tobacco product|potential modified risk tobacco product
133305|NCT02466412|cigarette|cigarette
133306|NCT02466412|Carbon Heated Tobacco Product|carbon heated tobacco product
133307|NCT02466373|clonidine|clonidine
133308|NCT02466373|pharmacodynamics|pharmacodynamics
133309|NCT02466373|pharmacokinetics|pharmacokinetics
133310|NCT02466373|intensive care|intensive care
133311|NCT02466373|delirium|delirium
133312|NCT02466360|Non-specific chronic lower back pain|non-specific chronic lower back pain
133313|NCT02466360|Physical activity|physical activity
133314|NCT02466360|Self-exercises|self-exercises
133315|NCT02466360|Brakes|brakes
133316|NCT02466360|Levers|levers
133317|NCT02466360|Adhesion|adhesion
133318|NCT02466360|Self-care|self-care
133319|NCT02466321|Inverse Reverse Shoulder|inverse reverse shoulder
133320|NCT02466308|sustained acoustic medicine|sustained acoustic medicine
133321|NCT02466308|therapeutic ultrasound|therapeutic ultrasound
133322|NCT02466308|SAM|sam
133323|NCT02466308|LITUS|litus
133324|NCT02466269|Facial Nerve Injuries|facial nerve injuries
133325|NCT02466256|Intraocular lens implantation|intraocular lens implantation
133326|NCT02466230|Magnetic stimulation of the brain|magnetic stimulation of the brain
133327|NCT02466230|Antidepressant mechanisms|antidepressant mechanisms
133328|NCT02466217|Auto-immune disease|auto-immune disease
133329|NCT02466217|Auto-inflammatory disease|auto-inflammatory disease
133330|NCT02466217|Omics|omics
133331|NCT02466217|System biology|system biology
133332|NCT02466191|nystagmus|nystagmus
133333|NCT02466191|pharmacological trial|pharmacological trial
133334|NCT02466191|multiple sclerosis|multiple sclerosis
133335|NCT02466191|oscillopsia|oscillopsia
133336|NCT02466165|cardiometabolic risk|cardiometabolic risk
133337|NCT02466165|physical exercise|physical exercise
133338|NCT02466152|PK|pk
133339|NCT02466152|GSK2894512|gsk2894512
133340|NCT02466152|Atopic Dermatitis|atopic dermatitis
133341|NCT02466139|microbiology|microbiology
133342|NCT02466139|c reactive protein|c reactive protein
133441|NCT02465489|deferiprone|deferiprone
133343|NCT02466139|urgent cardiac surgery|urgent cardiac surgery
133344|NCT02466126|Depression|depression
133345|NCT02466126|brief Cognitive Behavioral Therapy (bCBT)|brief cognitive behavioral therapy (bcbt)
133346|NCT02466126|Randomized Controlled Trial|randomized controlled trial
133347|NCT02466074|Acetazolamide|acetazolamide
133348|NCT02466074|Lesions|lesions
133349|NCT02466074|T1 black hole|t1 black hole
133350|NCT02466061|BMI >= 30 kg/m2|bmi >= 30 kg/m2
133351|NCT02466048|spinal fusion|spinal fusion
133352|NCT02466048|bone graft|bone graft
133353|NCT02466048|collagen|collagen
133354|NCT02466009|Colorectal cancer|colorectal cancer
133355|NCT02466009|metastatic colorectal cancer|metastatic colorectal cancer
133356|NCT02466009|colorectal adenocarcinoma|colorectal adenocarcinoma
133357|NCT02465996|barrier dysfunction|barrier dysfunction
133358|NCT02465996|functional dyspepsia|functional dyspepsia
133359|NCT02465996|Confocal Laser Endomicroscopic|confocal laser endomicroscopic
133360|NCT02465996|therapeutic response|therapeutic response
133361|NCT02465983|Pancreatic Cancer|pancreatic cancer
133362|NCT02465983|CAR / CART|car / cart
133364|NCT02465983|Immunotherapy|immunotherapy
133365|NCT02465983|Gene therapy|gene therapy
133366|NCT02465983|Redirected T cells|redirected t cells
133367|NCT02465983|Autologous T cells|autologous t cells
133368|NCT02465970|Transcranial Direct Current Stimulation|transcranial direct current stimulation
133369|NCT02465957|Merkel Cell Carcinoma|merkel cell carcinoma
133370|NCT02465957|Neukoplast|neukoplast
133371|NCT02465957|NK-92|nk-92
133372|NCT02465957|Natural Killer Cell|natural killer cell
133374|NCT02465957|aNK|ank
133375|NCT02465944|inflammation|inflammation
133376|NCT02465931|Informed Consent|informed consent
133377|NCT02465931|Fragile X Syndrome|fragile x syndrome
133378|NCT02465931|Tablets|tablets
133379|NCT02465931|Decisional Capacity|decisional capacity
133380|NCT02465892|cancer|cancer
133381|NCT02465892|stress|stress
133382|NCT02465892|chronic pain|chronic pain
133383|NCT02465892|anxiety|anxiety
133384|NCT02465892|coping|coping
133385|NCT02465892|balance|balance
133386|NCT02465892|online course|online course
133387|NCT02465892|psychosocial|psychosocial
133388|NCT02465892|support|support
133389|NCT02465892|tools|tools
133390|NCT02465879|Psoriatic arthritis|psoriatic arthritis
133391|NCT02465879|Ankylosing spondylitis|ankylosing spondylitis
133392|NCT02465879|Rheumatoid arthritis|rheumatoid arthritis
133393|NCT02465879|Seronegative|seronegative
133394|NCT02465866|Plasma concentration|plasma concentration
133395|NCT02465866|Time to plasma concentration|time to plasma concentration
133396|NCT02465866|Elimination rate constant|elimination rate constant
133397|NCT02465866|Elimination half life|elimination half life
133398|NCT02465866|Area under the curve|area under the curve
160857|NCT02309567|FDG|fdg
133399|NCT02465853|hemiplegic shoulder pain|hemiplegic shoulder pain
133400|NCT02465853|quality of Life|quality of life
133401|NCT02465853|stroke|stroke
133402|NCT02465840|rehabilitation|rehabilitation
133403|NCT02465840|functional MRI|functional mri
133404|NCT02465814|Uterine fibroids|uterine fibroids
133405|NCT02465814|Heavy Menstrual Bleeding|heavy menstrual bleeding
133406|NCT02465788|Helos|helos
133407|NCT02465788|Hair Removal|hair removal
133408|NCT02465788|Hair Reduction|hair reduction
133409|NCT02465775|non-invasive|non-invasive
133410|NCT02465762|non-invasive|non-invasive
133411|NCT02465749|Retinitis Pigmentosa|retinitis pigmentosa
133412|NCT02465749|oxygen|oxygen
133413|NCT02465749|blue light|blue light
133414|NCT02465723|Intravoxel Incoherent Motion (IVIM)|intravoxel incoherent motion (ivim)
133415|NCT02465723|Diffusion-weighted Magnetic Resonance|diffusion-weighted magnetic resonance
133416|NCT02465723|Acid Sphingomyelinase/Ceramide Pathway Activation|acid sphingomyelinase/ceramide pathway activation
133417|NCT02465723|15-104|15-104
133418|NCT02465710|pelvic organ prolapse|pelvic organ prolapse
133419|NCT02465710|pelvic floor reconstruction surgery|pelvic floor reconstruction surgery
133420|NCT02465710|transvaginal mesh surgery|transvaginal mesh surgery
133421|NCT02465710|Women|women
133422|NCT02465710|Surgical treatment|surgical treatment
133423|NCT02465697|Borderline Personality Disorder|borderline personality disorder
133424|NCT02465697|Avoidant Personality Disorder|avoidant personality disorder
133425|NCT02465697|Brain Imaging|brain imaging
133426|NCT02465658|uterine prolapse|uterine prolapse
133427|NCT02465658|cervical elongation|cervical elongation
133428|NCT02465658|pelvic floor reconstruction surgery|pelvic floor reconstruction surgery
133429|NCT02465541|Cancer Survivors|cancer survivors
133430|NCT02465541|Yoga|yoga
133431|NCT02465541|Endometrial Cancer|endometrial cancer
133432|NCT02465528|ALK|alk
133433|NCT02465528|NSCLC|nsclc
133434|NCT02465528|hematological malignancy|hematological malignancy
133435|NCT02465515|cardiovascular events /outcomes|cardiovascular events /outcomes
133436|NCT02465515|Type 2 diabetes mellitus|type 2 diabetes mellitus
133437|NCT02465515|albiglutide|albiglutide
133438|NCT02465515|glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
133439|NCT02465502|Colorectal cancer|colorectal cancer
133440|NCT02465502|Regorafenib|regorafenib
133442|NCT02465489|deferiprone extended release formulation|deferiprone extended release formulation
133443|NCT02465489|pharmacokinetics|pharmacokinetics
133444|NCT02465476|skin disease|skin disease
133445|NCT02465476|telemedicine|telemedicine
133446|NCT02465463|fecal microbiota transplant|fecal microbiota transplant
133447|NCT02465463|probiotic|probiotic
133448|NCT02465424|quality of life questionnaires|quality of life questionnaires
133449|NCT02465398|Fracture shoulder arthroplasty|fracture shoulder arthroplasty
133450|NCT02465398|Three or four part fracture|three or four part fracture
133451|NCT02465398|Hemiarthroplasty|hemiarthroplasty
133452|NCT02465398|Multi-center|multi-center
133453|NCT02465398|Europe|europe
133454|NCT02465398|Non-controlled|non-controlled
133455|NCT02465398|Anatomical reconstruction|anatomical reconstruction
133456|NCT02465398|Proximal|proximal
133457|NCT02465372|Physical Activity|physical activity
133458|NCT02465372|Youth|youth
133459|NCT02465372|School Health|school health
133460|NCT02465346|acute stroke|acute stroke
133461|NCT02465346|prehospital|prehospital
133462|NCT02465346|treatment|treatment
133463|NCT02465333|heel|heel
133464|NCT02465333|atrophy|atrophy
133465|NCT02465333|fat|fat
133466|NCT02465333|adipose tissue|adipose tissue
133467|NCT02465333|fat pad|fat pad
133468|NCT02465307|Consciousness|consciousness
133469|NCT02465307|Alertness|alertness
133470|NCT02465307|Cognition|cognition
133471|NCT02465307|Activity level|activity level
133472|NCT02465307|Delirium|delirium
133473|NCT02465307|Hyperactive delirium|hyperactive delirium
133474|NCT02465307|Hypoactive delirium|hypoactive delirium
133475|NCT02465307|Facial expression|facial expression
133476|NCT02465307|Posture|posture
133477|NCT02465307|Intensive care unit|intensive care unit
133478|NCT02465294|Probiotics|probiotics
133479|NCT02465294|Weight loss|weight loss
133480|NCT02465294|Body composition|body composition
133481|NCT02465255|Acute Abdominal Pain|acute abdominal pain
133482|NCT02465255|Sublingual Analgesia|sublingual analgesia
133483|NCT02465255|Children|children
133484|NCT02465255|Ketorolac|ketorolac
133485|NCT02465255|Tramadol|tramadol
133486|NCT02465255|Paracetamol|paracetamol
133487|NCT02465255|Analgesia|analgesia
133488|NCT02465216|Tuberculosis|tuberculosis
133490|NCT02465216|Pulmonary|pulmonary
133491|NCT02465216|Vaccine|vaccine
133492|NCT02465216|Adjuvant|adjuvant
133493|NCT02465203|Hepatitis C, chronic|hepatitis c, chronic
133494|NCT02465190|Vaccine|vaccine
133495|NCT02465190|Effectiveness|effectiveness
133496|NCT02465190|Influenza|influenza
133497|NCT02465177|Unhealthy alcohol use|unhealthy alcohol use
133498|NCT02465177|ICU survivors|icu survivors
133499|NCT02465177|Alcohol use disorder|alcohol use disorder
133500|NCT02465177|SBIRT|sbirt
133501|NCT02465177|Screening, brief intervention, and referral to treatment|screening, brief intervention, and referral to treatment
133502|NCT02465034|Neural plasticity|neural plasticity
133503|NCT02465034|Noninvasive brain stimulation|noninvasive brain stimulation
133504|NCT02465034|Motor cortex|motor cortex
133505|NCT02465021|Satiety|satiety
133506|NCT02465021|Food intake|food intake
133507|NCT02465021|Breakfast cereals/snacks|breakfast cereals/snacks
133508|NCT02465021|Postprandial glycemia|postprandial glycemia
133509|NCT02465008|postoperative|postoperative
133510|NCT02465008|Patient-reported|patient-reported
133511|NCT02464995|Asthma,|asthma,
133512|NCT02464995|Asthma exacerbation|asthma exacerbation
133513|NCT02464995|Bronchial thermoplasty|bronchial thermoplasty
133514|NCT02464969|VTE, thromboembolism, thrombosis, embolism, apixaban, Eliquis|vte, thromboembolism, thrombosis, embolism, apixaban, eliquis
133515|NCT02464943|Aorta|aorta
133516|NCT02464943|Thoracic|thoracic
133517|NCT02464943|Aortic dissection|aortic dissection
133518|NCT02464943|Type B|type b
133519|NCT02464943|DeBakey type III|debakey type iii
133520|NCT02464943|Endovascular|endovascular
133521|NCT02464930|Blood|blood
133522|NCT02464930|Cytology|cytology
133523|NCT02464930|Esophagus|esophagus
133524|NCT02464930|microRNA|microrna
133525|NCT02464891|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
133526|NCT02464891|CCX168|ccx168
133527|NCT02464891|dialysis|dialysis
133528|NCT02464891|C5aR antagonist|c5ar antagonist
133529|NCT02464865|thiamine deficiency|thiamine deficiency
133530|NCT02464865|obese children|obese children
133531|NCT02464865|Thai|thai
133532|NCT02464839|Fungal nails and feet infection|fungal nails and feet infection
133533|NCT02464839|Onychomycosis|onychomycosis
133534|NCT02464839|Hallux valgus|hallux valgus
133535|NCT02464826|Onychomycosis|onychomycosis
133536|NCT02464826|Chronic paronychia|chronic paronychia
133537|NCT02464826|Treatment|treatment
133538|NCT02464813|pregabalin|pregabalin
133539|NCT02464813|idiopathic scoliosis|idiopathic scoliosis
133540|NCT02464800|diabetic retinopathy|diabetic retinopathy
133541|NCT02464787|antioxidants|antioxidants
133542|NCT02464787|carotenoids|carotenoids
133543|NCT02464787|diet|diet
133544|NCT02464774|Breast Cancer|breast cancer
133545|NCT02464774|Triple-Negative Breast Cancer|triple-negative breast cancer
133551|NCT02464735|Weaning|weaning
133552|NCT02464722|Remifentanil|remifentanil
133553|NCT02464722|Dexmedetomidine|dexmedetomidine
133554|NCT02464722|Endoscopic sinus surgery|endoscopic sinus surgery
133555|NCT02464709|Actinic Keratosis|actinic keratosis
653902|NCT00786916|pediatric|pediatric
133556|NCT02464709|Photodynamic Therapy|photodynamic therapy
133557|NCT02464709|Natural Daylight|natural daylight
133558|NCT02464696|Hematological Malignancies|hematological malignancies
133559|NCT02464696|Hypoxemic Respiratory Failure|hypoxemic respiratory failure
133560|NCT02464696|Blood cancer|blood cancer
133561|NCT02464696|Non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
133562|NCT02464696|NIPPV|nippv
133563|NCT02464696|High flow nasal cannula oxygen therapy|high flow nasal cannula oxygen therapy
133566|NCT02464657|Leukemia|leukemia
133567|NCT02464657|Acute myeloid leukemia|acute myeloid leukemia
133568|NCT02464657|AML|aml
133569|NCT02464657|Myelodysplastic Syndrome|myelodysplastic syndrome
133570|NCT02464657|MDS|mds
133571|NCT02464657|High-risk|high-risk
133572|NCT02464657|Nivolumab|nivolumab
133573|NCT02464657|BMS-936558|bms-936558
133574|NCT02464657|Opdivo|opdivo
133575|NCT02464657|Idarubicin|idarubicin
133576|NCT02464657|Idamycin|idamycin
133577|NCT02464657|Cytarabine|cytarabine
133578|NCT02464657|Ara-C|ara-c
133579|NCT02464657|Cytosar|cytosar
133580|NCT02464657|DepoCyt|depocyt
133581|NCT02464657|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
133582|NCT02464657|Solu-Medrol|solu-medrol
133583|NCT02464657|Methylprednisolone|methylprednisolone
133584|NCT02464657|Depo-Medrol|depo-medrol
133585|NCT02464657|Medrol|medrol
133586|NCT02464657|Dexamethasone|dexamethasone
133587|NCT02464657|Decadron|decadron
133588|NCT02464644|On-line Questionnaire|on-line questionnaire
133589|NCT02464644|No travel|no travel
133590|NCT02464644|Health|health
133591|NCT02464644|Medicines|medicines
133592|NCT02464644|Drugs|drugs
133593|NCT02464644|Lifestyle|lifestyle
133594|NCT02464644|Family|family
133595|NCT02464644|Help for others|help for others
133596|NCT02464644|Rare condition|rare condition
133597|NCT02464644|General population|general population
133598|NCT02464618|Colonoscopy|colonoscopy
133599|NCT02464618|Upper endoscopy|upper endoscopy
133600|NCT02464618|Adherence|adherence
133601|NCT02464618|Disparities|disparities
133602|NCT02464592|Cryoprobes|cryoprobes
133603|NCT02464592|Transbronchial lung biopsy|transbronchial lung biopsy
133604|NCT02464592|Cryobiopsy|cryobiopsy
133605|NCT02464579|breastfeeding rate|breastfeeding rate
133606|NCT02464579|preterm infant|preterm infant
124652|NCT02516020|IVF|ivf
133607|NCT02464579|neonatal intensive care unit|neonatal intensive care unit
133608|NCT02464553|Low Back Pain Pain|low back pain pain
133609|NCT02464553|Periradicular therapy|periradicular therapy
133610|NCT02464553|Spinal Stenosis with neurologic changes|spinal stenosis with neurologic changes
133611|NCT02464540|laminate veneers|laminate veneers
133612|NCT02464540|luting agent|luting agent
133613|NCT02464527|Stimulus-stimulus pairing|stimulus-stimulus pairing
133614|NCT02464514|Obesity|obesity
133615|NCT02464514|Orexigen|orexigen
133616|NCT02464514|Insulin|insulin
133617|NCT02464514|Leptin|leptin
133618|NCT02464514|Adiponectin|adiponectin
133619|NCT02464514|Growth hormone replacement|growth hormone replacement
133620|NCT02464501|PAD|pad
133621|NCT02464501|COPPER-A|copper-a
133622|NCT02464501|Peripheral Arterial Disease|peripheral arterial disease
133623|NCT02464501|OPC|opc
133624|NCT02464501|Occlusion Perfusion Catheter|occlusion perfusion catheter
133625|NCT02464501|Paclitaxel|paclitaxel
133626|NCT02464501|Pressana|pressana
133627|NCT02464501|Precision Delivery System|precision delivery system
133628|NCT02464488|Anticoagulants|anticoagulants
133629|NCT02464488|Factor Xa Inhibitors|factor xa inhibitors
133630|NCT02464488|Antithrombins|antithrombins
133631|NCT02464488|Pharmacokinetics|pharmacokinetics
133632|NCT02464488|Aged, 80 years and older|aged, 80 years and older
133633|NCT02464475|osteopathic manipulative treatment|osteopathic manipulative treatment
133634|NCT02464475|interoception|interoception
133635|NCT02464462|serum calcidiol|serum calcidiol
133636|NCT02464462|T2DM|t2dm
133637|NCT02464462|vitamin D3 supplementation|vitamin d3 supplementation
133638|NCT02464462|post-menopausal women|post-menopausal women
133639|NCT02464462|ethnic diverse|ethnic diverse
133640|NCT02464462|calcium supplementation|calcium supplementation
133641|NCT02464449|Cognitive Behavioral Therapy|cognitive behavioral therapy
133642|NCT02464449|Mobile Health Technology|mobile health technology
133643|NCT02464449|Patient Care Management|patient care management
133644|NCT02464436|RP|rp
133657|NCT02464371|microRNAs|micrornas
133658|NCT02464371|septic shock|septic shock
133659|NCT02464358|HPV|hpv
133660|NCT02464345|BED|bed
133661|NCT02464345|Binge Eating Disorer|binge eating disorer
133662|NCT02464345|BN|bn
133663|NCT02464345|Bulimia Nervosa|bulimia nervosa
133664|NCT02464345|Obesity|obesity
133665|NCT02464332|soft tissue sarcoma|soft tissue sarcoma
133666|NCT02464332|BLZ-100|blz-100
133667|NCT02464332|Tumor Paint|tumor paint
133668|NCT02464306|recipients|recipients
133669|NCT02464293|depression|depression
133670|NCT02464293|anxiety|anxiety
133671|NCT02464293|stress|stress
133672|NCT02464280|Tomosynthesis|tomosynthesis
133673|NCT02464280|osteosynthetic implant|osteosynthetic implant
133674|NCT02464280|CT|ct
133675|NCT02464280|monitoring|monitoring
133676|NCT02464267|patient reported outcome instrument|patient reported outcome instrument
133677|NCT02464254|Physical activity, positive affect, older adults, aging|physical activity, positive affect, older adults, aging
133678|NCT02464228|PTCL|ptcl
133679|NCT02464228|Lymphoma|lymphoma
133680|NCT02464228|AITL|aitl
133681|NCT02464215|gastric cancer|gastric cancer
133682|NCT02464215|D2|d2
133683|NCT02464215|laparoscopic|laparoscopic
133684|NCT02464215|open|open
133685|NCT02464215|surgery|surgery
133686|NCT02464202|Tooth autotransplantation|tooth autotransplantation
133687|NCT02464202|stereolithography tooth replica|stereolithography tooth replica
133688|NCT02464202|CBCT|cbct
133689|NCT02464202|Outcome|outcome
133690|NCT02464176|Arthroplasty, Hip, Replacement|arthroplasty, hip, replacement
133691|NCT02464176|Anesthesia, Local|anesthesia, local
133692|NCT02464176|Anesthesia Conduction|anesthesia conduction
133693|NCT02464176|Bupivacaine|bupivacaine
133694|NCT02464176|Dexamethasone|dexamethasone
133695|NCT02464176|Preanesthetic Medications|preanesthetic medications
133696|NCT02464176|Nerve Block|nerve block
133697|NCT02464176|Lumbar Plexus Block|lumbar plexus block
133698|NCT02464176|Analgesia|analgesia
133699|NCT02464176|Glucocorticoids|glucocorticoids
133700|NCT02464176|Local Anesthetics|local anesthetics
133701|NCT02464163|Influenza|influenza
133702|NCT02464150|gluten|gluten
133703|NCT02464150|antigen-specific T cells|antigen-specific t cells
133704|NCT02464150|transcriptome|transcriptome
133705|NCT02464098|Hematological Malignancies|hematological malignancies
133706|NCT02464098|Solid Tumors|solid tumors
133707|NCT02464098|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
133708|NCT02464098|Childhood Cancer|childhood cancer
133709|NCT02464098|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
133710|NCT02464085|Stroke|stroke
133711|NCT02464085|Upper limb|upper limb
133712|NCT02464085|Neuroplastic change|neuroplastic change
133713|NCT02464085|Longitudinal|longitudinal
133714|NCT02464085|Function|function
133715|NCT02464072|Parathyroidectomy|parathyroidectomy
133716|NCT02464072|Renal Insufficiency, Chronic|renal insufficiency, chronic
133717|NCT02464059|cathelicidin|cathelicidin
133718|NCT02464059|vitamin D|vitamin d
133719|NCT02464046|Insomnia|insomnia
133720|NCT02464046|JNJ-42847922|jnj-42847922
133721|NCT02464046|Placebo|placebo
133722|NCT02464033|Diamyd|diamyd
133723|NCT02464033|Diabetes|diabetes
133724|NCT02464033|Juvenile Diabetes|juvenile diabetes
133725|NCT02464033|Diabetes Type 1|diabetes type 1
133726|NCT02464033|Type 1 Diabetes|type 1 diabetes
133727|NCT02464033|Autoimmune Diabetes|autoimmune diabetes
133728|NCT02464033|Insulin Dependent Diabetes|insulin dependent diabetes
133729|NCT02464033|Type 1 Diabetes MellitusType 1 Diabetes Mellitus|type 1 diabetes mellitustype 1 diabetes mellitus
133730|NCT02464033|rhGAD65|rhgad65
133731|NCT02464033|GAD65|gad65
133732|NCT02464033|GAD-Alum|gad-alum
133733|NCT02464033|Diabetes Mellitus|diabetes mellitus
133734|NCT02464033|Diabetes mellitus Type 1|diabetes mellitus type 1
133735|NCT02464033|Glucose Metabolism Disorders|glucose metabolism disorders
133736|NCT02464033|Metabolic Diseases|metabolic diseases
133737|NCT02464033|Vitamin D|vitamin d
133738|NCT02464033|Etanercept|etanercept
133739|NCT02463955|flexible endoscopy|flexible endoscopy
133740|NCT02463929|Diphenhydramine|diphenhydramine
133741|NCT02463929|emergence agitation|emergence agitation
133742|NCT02463929|pediatric anesthesia|pediatric anesthesia
133743|NCT02463929|PAEDS|paeds
133744|NCT02463929|Withdrawal|withdrawal
133745|NCT02463903|Adaptation, Psychological|adaptation, psychological
133746|NCT02463903|Heart Failure|heart failure
133747|NCT02463903|Intervention Studies|intervention studies
133748|NCT02463903|Quality of Life|quality of life
133749|NCT02463903|Hospital Readmission|hospital readmission
133750|NCT02463903|Depression|depression
133752|NCT02463890|Sleep Apnea Syndromes|sleep apnea syndromes
133753|NCT02463890|Sleep Apnea, Obstructives|sleep apnea, obstructives
133754|NCT02463890|Training|training
133755|NCT02463864|frailty|frailty
133756|NCT02463864|older adult|older adult
133757|NCT02463864|hospital|hospital
133758|NCT02463864|exercise|exercise
133759|NCT02463864|randomised control trial|randomised control trial
133760|NCT02463864|functional decline|functional decline
133761|NCT02463851|Ablation|ablation
133762|NCT02463851|Multi-electrode catheter PVAC|multi-electrode catheter pvac
133763|NCT02463851|Single-tip catheter Contact Force|single-tip catheter contact force
133764|NCT02463851|Holter|holter
133765|NCT02463838|Medi-Cal|medi-cal
133766|NCT02463838|Health Plan|health plan
133767|NCT02463838|Frequent Users|frequent users
133768|NCT02463838|Heavy users|heavy users
133769|NCT02463838|Care Coordination|care coordination
133770|NCT02463838|Managed Care|managed care
133771|NCT02463838|Case Management|case management
133772|NCT02463838|Mental Health|mental health
133773|NCT02463838|Substance Use|substance use
133774|NCT02463838|Emergency Department|emergency department
133775|NCT02463799|prostatic neoplasms|prostatic neoplasms
133776|NCT02463799|castration-resistant|castration-resistant
133777|NCT02463799|bone metastasis|bone metastasis
133778|NCT02463799|radium-223|radium-223
133779|NCT02463799|sipuleucel-T|sipuleucel-t
133780|NCT02463773|ARDS, PEEP, Critical Care Ultrasound|ards, peep, critical care ultrasound
133781|NCT02463747|Neutropenic fever|neutropenic fever
133782|NCT02463747|extended infusion|extended infusion
133783|NCT02463747|beta-lactam|beta-lactam
133784|NCT02463747|empiric antibiotic treatment|empiric antibiotic treatment
133785|NCT02463721|sbp|sbp
133786|NCT02463721|culture|culture
133787|NCT02463708|Care Giver|care giver
133788|NCT02463708|Dementia|dementia
133789|NCT02463695|partial vestibular deficit|partial vestibular deficit
133790|NCT02463695|cortical vestibular evoked potential|cortical vestibular evoked potential
133791|NCT02463682|Artificial Pancreas|artificial pancreas
133792|NCT02463682|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
133793|NCT02463682|Autoimmune Diseases|autoimmune diseases
133794|NCT02463682|Diabetes Mellitus|diabetes mellitus
133795|NCT02463682|Endocrine System Diseases|endocrine system diseases
133796|NCT02463682|Glucose Metabolism Disorders|glucose metabolism disorders
133797|NCT02463682|Immune System Diseases|immune system diseases
133798|NCT02463682|Metabolic Diseases|metabolic diseases
133799|NCT02463669|Point-of-care ultrasound|point-of-care ultrasound
133800|NCT02463630|basilar invagination|basilar invagination
133801|NCT02463630|atlantoaxial dislocation|atlantoaxial dislocation
133802|NCT02463630|surgery|surgery
133803|NCT02463630|restoration technique|restoration technique
133804|NCT02463591|Direct Thrombin Inhibitor|direct thrombin inhibitor
133805|NCT02463591|Prothrombin Complex Concentrate|prothrombin complex concentrate
133806|NCT02463591|Dabigatran Etexilate|dabigatran etexilate
133807|NCT02463591|Beriplex|beriplex
133808|NCT02463591|Shed Blood|shed blood
133809|NCT02463591|Washed Blood|washed blood
133810|NCT02463591|Fibrinopeptide A|fibrinopeptide a
133811|NCT02463578|Pneumococcal infection|pneumococcal infection
133812|NCT02463578|Invasive pneumococcal disease (IPD)|invasive pneumococcal disease (ipd)
133813|NCT02463578|Pneumococcal vaccine|pneumococcal vaccine
133814|NCT02463578|Vaccinology|vaccinology
133815|NCT02463578|Immunocompromised|immunocompromised
133816|NCT02463578|Auto-immune diseases|auto-immune diseases
133817|NCT02463578|Systemic vasculitis|systemic vasculitis
133818|NCT02463578|ANCA-associated vasculitis|anca-associated vasculitis
133819|NCT02463565|nutritional assessment|nutritional assessment
133820|NCT02463565|food survey|food survey
133821|NCT02463565|hospitalized patients|hospitalized patients
133822|NCT02463565|hospital food|hospital food
133823|NCT02463539|Pneumococcal infection|pneumococcal infection
133824|NCT02463539|Invasive pneumococcal disease (IPD)|invasive pneumococcal disease (ipd)
133825|NCT02463539|Pneumococcal vaccine|pneumococcal vaccine
133826|NCT02463539|Systemic vasculitis|systemic vasculitis
133827|NCT02463539|ANCA-associated vasculitis|anca-associated vasculitis
133828|NCT02463539|Vaccinology|vaccinology
133829|NCT02463539|Immunocompromised|immunocompromised
133830|NCT02463539|Auto-immune disease|auto-immune disease
133831|NCT02463526|Shoulder Impingement Syndrome|shoulder impingement syndrome
133832|NCT02463526|Mulligan's Mobilization with Movement|mulligan's mobilization with movement
133833|NCT02463526|Physical Therapy|physical therapy
133834|NCT02463513|Riboflavin|riboflavin
133835|NCT02463513|Blood pressure|blood pressure
133836|NCT02463513|MTHFR|mthfr
133837|NCT02463513|Methylenetetrahydrofolate reductase|methylenetetrahydrofolate reductase
133838|NCT02463448|Underactive Bladder|underactive bladder
133839|NCT02463435|nutritional management|nutritional management
133840|NCT02463435|olive oil|olive oil
133841|NCT02463435|weight loss|weight loss
133842|NCT02463435|body composition|body composition
133843|NCT02463435|nutrigenomics|nutrigenomics
133844|NCT02463435|polymorphisms|polymorphisms
133845|NCT02463435|cardiovascular risk|cardiovascular risk
133849|NCT02463435|sedentary lifestyle|sedentary lifestyle
133850|NCT02463435|patient adherence|patient adherence
133851|NCT02463435|bone density|bone density
133852|NCT02463396|MBCT|mbct
133853|NCT02463396|Mindfulness|mindfulness
133854|NCT02463396|ADHD|adhd
133855|NCT02463383|PPAR-gamma|ppar-gamma
133856|NCT02463383|estrogens|estrogens
133857|NCT02463383|NSAIDS|nsaids
133858|NCT02463383|polymorphism|polymorphism
133859|NCT02463383|metabolomics|metabolomics
133860|NCT02463357|Exercise, Aerobic|exercise, aerobic
133861|NCT02463357|Cognitive Function|cognitive function
133862|NCT02463344|Dry AMD|dry amd
133863|NCT02463344|Geographic atrophy|geographic atrophy
133864|NCT02463331|autoimmune hepatitis|autoimmune hepatitis
133865|NCT02463331|chloroquine|chloroquine
133866|NCT02463331|treatment|treatment
133867|NCT02463318|Multiple sclerosis|multiple sclerosis
133868|NCT02463318|SIRT1|sirt1
133869|NCT02463318|MnSOD|mnsod
133870|NCT02463318|Catalase|catalase
133871|NCT02463318|Oxidative stress|oxidative stress
133872|NCT02463318|Antioxidant enzyme|antioxidant enzyme
133875|NCT02463292|quality of life|quality of life
654093|NCT00787644|Overweight|overweight
133876|NCT02463292|young adults|young adults
133877|NCT02463292|congenital heart disease|congenital heart disease
133878|NCT02463266|Primary Care|primary care
133879|NCT02463266|Elderly|elderly
133880|NCT02463266|Depression|depression
133881|NCT02463253|Renal Biopsy|renal biopsy
133882|NCT02463253|elevated serum creatinine|elevated serum creatinine
133883|NCT02463253|proteinuria|proteinuria
133884|NCT02463201|Sleep Apnea, Obstructive|sleep apnea, obstructive
133885|NCT02463201|Pediatric Obesity|pediatric obesity
133886|NCT02463188|Sleep|sleep
133887|NCT02463188|Substance Use|substance use
133888|NCT02463188|Adolescents|adolescents
133889|NCT02463175|Fluid Therapy;|fluid therapy;
133890|NCT02463175|Transesophageal Doppler|transesophageal doppler
133891|NCT02463149|School health|school health
133892|NCT02463136|Adolescence|adolescence
133893|NCT02463136|Brain Development|brain development
133895|NCT02463136|Neurofeedback|neurofeedback
133896|NCT02463136|Anxiety|anxiety
133897|NCT02463110|Acute Coronary Syndrome|acute coronary syndrome
133898|NCT02463110|Depression|depression
133899|NCT02463110|Coronary Artery Disease|coronary artery disease
133900|NCT02463110|Myocardial Infarction|myocardial infarction
133901|NCT02463110|Percutaneous Coronary Intervention|percutaneous coronary intervention
133902|NCT02463019|hepatitis B virus|hepatitis b virus
133903|NCT02463019|tenofovir|tenofovir
133904|NCT02462967|Liver Cirrhosis|liver cirrhosis
133905|NCT02462954|Contraception|contraception
133906|NCT02462954|Vaginal Gel|vaginal gel
133907|NCT02462954|Diaphragm|diaphragm
133908|NCT02462941|Heart transplant|heart transplant
133909|NCT02462941|Adenosine|adenosine
133910|NCT02462941|Pediatrics|pediatrics
133911|NCT02462863|Diabetes|diabetes
133912|NCT02462863|fish oil|fish oil
133913|NCT02462863|arginine|arginine
133914|NCT02462863|hyperglycemia|hyperglycemia
133915|NCT02462850|Pain|pain
133916|NCT02462850|Nausea|nausea
133917|NCT02462850|Vomiting|vomiting
133918|NCT02462837|Ureteral Stents|ureteral stents
133919|NCT02462837|Pain and Discomfort|pain and discomfort
133920|NCT02462837|Bladder Storage Symptoms|bladder storage symptoms
133921|NCT02462824|Peripheral Artery Disease|peripheral artery disease
133922|NCT02462824|Peripheral Arterial Disease|peripheral arterial disease
133923|NCT02462824|PAD|pad
133924|NCT02462811|Pain|pain
133925|NCT02462811|Nausea|nausea
133926|NCT02462811|Vomiting|vomiting
133927|NCT02462785|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
133928|NCT02462785|Adolescents|adolescents
133929|NCT02462785|Carbohydrate Counting|carbohydrate counting
133930|NCT02462785|Glycemic Control|glycemic control
133931|NCT02462785|Self-Management|self-management
133932|NCT02462785|T1DM|t1dm
133933|NCT02462772|Cabotegravir|cabotegravir
133934|NCT02462772|safety|safety
133935|NCT02462772|long-acting injectable|long-acting injectable
133936|NCT02462772|HIV prevention|hiv prevention
133937|NCT02462772|acceptability|acceptability
133938|NCT02462759|EMBRACE|embrace
133939|NCT02462759|Spinal Muscular Atrophy|spinal muscular atrophy
133940|NCT02462759|SMA|sma
133941|NCT02462746|Postpartum|postpartum
133942|NCT02462746|Dietary Supplements|dietary supplements
133943|NCT02462746|Breastfeeding Women|breastfeeding women
133944|NCT02462733|Self-control|self-control
133945|NCT02462733|Preschoolers|preschoolers
133946|NCT02462733|Tools of the Mind|tools of the mind
133947|NCT02462733|Playing to Learn|playing to learn
133948|NCT02462681|ketamine|ketamine
133949|NCT02462681|adjuvant|adjuvant
133950|NCT02462681|paravertebral block|paravertebral block
133951|NCT02462668|Bronchoscopy|bronchoscopy
133952|NCT02462668|Intubation|intubation
133953|NCT02462668|Noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
133954|NCT02462642|Brahmi, Cognition, Anxiety, Pharmacokinetics|brahmi, cognition, anxiety, pharmacokinetics
133955|NCT02462629|central nervous system tumor|central nervous system tumor
133956|NCT02462629|BLZ-100|blz-100
133957|NCT02462629|pediatrics|pediatrics
133958|NCT02462629|Tumor Paint|tumor paint
133959|NCT02462629|brain cancer|brain cancer
133960|NCT02462629|tozuleristide|tozuleristide
133961|NCT02462616|risk analysis|risk analysis
133962|NCT02462616|general Chinese population|general chinese population
133963|NCT02462616|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
133964|NCT02462603|Parkinson's Disease|parkinson's disease
133965|NCT02462603|PD|pd
133966|NCT02462603|EPI-589|epi-589
133967|NCT02462603|EPI589|epi589
133968|NCT02462590|Probiotics|probiotics
133969|NCT02462590|Ventilator Associated Pneumonia|ventilator associated pneumonia
133970|NCT02462590|Infections|infections
133971|NCT02462590|C-Difficile|c-difficile
133972|NCT02462590|Antibiotic-associated Diarrhea|antibiotic-associated diarrhea
133973|NCT02462590|Diarrhea|diarrhea
133974|NCT02462577|Local morphine|local morphine
133975|NCT02462577|Postmastectomy pain|postmastectomy pain
133976|NCT02462564|peritoneal surface malignancies|peritoneal surface malignancies
133977|NCT02462564|Post operative cognitive dysfunction|post operative cognitive dysfunction
133978|NCT02462551|Depression|depression
133979|NCT02462551|Treatment Resistant Depression|treatment resistant depression
133980|NCT02462525|relapsed multiple myeloma|relapsed multiple myeloma
133981|NCT02462525|antibody drug conjugate|antibody drug conjugate
133982|NCT02462525|refractory multiple myeloma|refractory multiple myeloma
133983|NCT02462512|Elastography|elastography
133984|NCT02462512|Thyroid nodule|thyroid nodule
133985|NCT02462473|Schizophrenia|schizophrenia
133986|NCT02462473|Schizoaffective Disorder|schizoaffective disorder
133987|NCT02462473|Aripiprazole|aripiprazole
133988|NCT02462473|Olanzapine|olanzapine
133989|NCT02462473|Paliperidone|paliperidone
133990|NCT02462473|Quetiapine|quetiapine
133991|NCT02462473|Risperidone|risperidone
133992|NCT02462473|Liquid Chromatography-Tandem Mass Spectrometry|liquid chromatography-tandem mass spectrometry
133993|NCT02462460|Breast MRI|breast mri
134669|NCT02458482|Acute|acute
133994|NCT02462460|T1 weighted and diffusion weighted MR|t1 weighted and diffusion weighted mr
133995|NCT02462460|screening pancreatic|screening pancreatic
133996|NCT02462460|screening ovarian|screening ovarian
133998|NCT02462447|prostate|prostate
133999|NCT02462447|cancer|cancer
134000|NCT02462447|biopsy|biopsy
134001|NCT02462447|PET|pet
134002|NCT02462434|Pediatric palliative care|pediatric palliative care
134003|NCT02462421|SGLT2|sglt2
134004|NCT02462421|SLC5A2|slc5a2
134005|NCT02462421|SLC5A4|slc5a4
134006|NCT02462421|SLC5A9|slc5a9
134007|NCT02462421|SLC2A9|slc2a9
134008|NCT02462421|GLUT9|glut9
134009|NCT02462421|SGLT3|sglt3
134010|NCT02462421|SGLT4|sglt4
134011|NCT02462421|pharmacogenomics|pharmacogenomics
134012|NCT02462356|CVATS|cvats
134013|NCT02462356|UVATS|uvats
134014|NCT02462356|perioperative effect|perioperative effect
134015|NCT02462356|ergonomic influence|ergonomic influence
134016|NCT02462330|Mesenchymal stem cells|mesenchymal stem cells
134017|NCT02462330|ischemic cardiomyopathy|ischemic cardiomyopathy
134018|NCT02462330|NogaStar XP system catheter|nogastar xp system catheter
134019|NCT02462317|Spasticity|spasticity
134020|NCT02462317|Post stroke motor recovery|post stroke motor recovery
134021|NCT02462317|Botulinum toxin|botulinum toxin
134022|NCT02462317|Baclofen|baclofen
134023|NCT02462317|Pharmacological modulation|pharmacological modulation
134024|NCT02462304|Diabetic Macula Edema|diabetic macula edema
134025|NCT02462304|End-Point-Management|end-point-management
134026|NCT02462304|ranibizumab|ranibizumab
134027|NCT02462304|bevacizumab|bevacizumab
134028|NCT02462291|Neurological Disorders|neurological disorders
134029|NCT02462291|Non Pharmacological Treatment|non pharmacological treatment
134030|NCT02462291|Ecological Therapy|ecological therapy
134031|NCT02462278|Fertility|fertility
134758|NCT02458053|couples|couples
134032|NCT02462278|Continuous temperature monitor|continuous temperature monitor
134033|NCT02462278|Basal Body Temperature|basal body temperature
134034|NCT02462278|Natural family planning|natural family planning
134035|NCT02462239|Muscle-invasive bladder cancer|muscle-invasive bladder cancer
134036|NCT02462239|Bladder cancer|bladder cancer
134037|NCT02462239|PET imaging|pet imaging
134038|NCT02462239|FDG|fdg
134039|NCT02462213|Cardiac amyloidosis|cardiac amyloidosis
134040|NCT02462213|Cardiac MRI|cardiac mri
134041|NCT02462213|Infiltrative cardiomyopathies|infiltrative cardiomyopathies
134042|NCT02462187|genital warts|genital warts
134043|NCT02462187|perianal warts|perianal warts
134044|NCT02462174|anesthesia|anesthesia
134045|NCT02462174|analgesia|analgesia
134046|NCT02462174|caudal|caudal
134047|NCT02462174|ketamine|ketamine
134048|NCT02462174|bupivacaine|bupivacaine
134049|NCT02462148|Anesthesia|anesthesia
134050|NCT02462148|Anesthesia, Conduction|anesthesia, conduction
134051|NCT02462148|Anesthesia, Local|anesthesia, local
134052|NCT02462148|Bupivacaine|bupivacaine
134457|NCT02459730|ART|art
134053|NCT02462148|Dexamethasone|dexamethasone
134054|NCT02462148|Saphenous|saphenous
134055|NCT02462148|Adductor Canal|adductor canal
134056|NCT02462148|Nerve Block|nerve block
134057|NCT02462148|Analgesia|analgesia
134058|NCT02462148|Preanesthetic Medication|preanesthetic medication
134059|NCT02462148|Perioperative Period|perioperative period
134060|NCT02462148|Peripheral Nerve Block|peripheral nerve block
134061|NCT02462135|Mild cognitive impairment|mild cognitive impairment
134062|NCT02462135|Memory training|memory training
134063|NCT02462135|Randomized controlled study|randomized controlled study
134064|NCT02462044|Computed tomography|computed tomography
134065|NCT02462044|Coronary CTA|coronary cta
134066|NCT02462044|Contrast media|contrast media
134067|NCT02462018|Cerebral Palsy|cerebral palsy
134068|NCT02462018|Muscle Spasticity|muscle spasticity
134069|NCT02462018|Orthoses|orthoses
134070|NCT02462018|Functional Electrical Stimulation|functional electrical stimulation
134071|NCT02462018|Prospective|prospective
134072|NCT02461992|FVIII activity|fviii activity
134073|NCT02461953|hemodialysis|hemodialysis
134074|NCT02461953|hemoperfusion|hemoperfusion
134075|NCT02461953|quality of life|quality of life
134076|NCT02461940|Sexual behavior|sexual behavior
134077|NCT02461940|condom use|condom use
134078|NCT02461940|secondary abstinence|secondary abstinence
134079|NCT02461914|Type 2 diabetes mellitus|type 2 diabetes mellitus
134080|NCT02461901|clostridium difficile|clostridium difficile
134081|NCT02461901|environment|environment
134082|NCT02461901|contamination|contamination
134083|NCT02461901|fidaxomicin|fidaxomicin
134084|NCT02461888|Relapsed|relapsed
134085|NCT02461888|Refractory|refractory
134086|NCT02461888|Cyclophosphamide|cyclophosphamide
134087|NCT02461888|Dexamethasone|dexamethasone
134088|NCT02461875|OHSS|ohss
134089|NCT02461875|Infertility|infertility
134090|NCT02461875|Cabergoline|cabergoline
134091|NCT02461875|GnRH antagonist|gnrh antagonist
134092|NCT02461875|IVF-ET|ivf-et
134093|NCT02461862|Contraception|contraception
134094|NCT02461862|Contraception Behavior|contraception behavior
134095|NCT02461862|Intra uterine device|intra uterine device
134763|NCT02458014|MRD|mrd
134096|NCT02461862|Intra uterine System|intra uterine system
134097|NCT02461862|IUD|iud
134098|NCT02461862|IUS|ius
134099|NCT02461862|Acute Pain|acute pain
134100|NCT02461771|AMD|amd
134101|NCT02461771|Wet AMD|wet amd
134102|NCT02461771|Neovascular AMD|neovascular amd
134103|NCT02461745|VIEKIRA PAK|viekira pak
134104|NCT02461732|posttraumatic stress disorder|posttraumatic stress disorder
134105|NCT02461732|PTSD|ptsd
134106|NCT02461732|substance dependence|substance dependence
134107|NCT02461732|substance use|substance use
134108|NCT02461706|Drug resistant epilepsy|drug resistant epilepsy
134109|NCT02461693|Vigilance|vigilance
134111|NCT02461693|Randomized Controlled Trial|randomized controlled trial
134112|NCT02461693|Probability|probability
134113|NCT02461680|partial section of the flexor tendons|partial section of the flexor tendons
134114|NCT02461667|alendronate, metformin|alendronate, metformin
134115|NCT02461641|amniotic tissue|amniotic tissue
134116|NCT02461641|diabetic foot ulcer|diabetic foot ulcer
134117|NCT02461641|Affinity|affinity
134118|NCT02461641|NuShield|nushield
134119|NCT02461628|Malaria|malaria
134120|NCT02461628|Antimalarial subsidy|antimalarial subsidy
134121|NCT02461628|Malaria rapid diagnostic test (RDT)|malaria rapid diagnostic test (rdt)
134122|NCT02461628|Public-private partnership|public-private partnership
134123|NCT02461628|Community health workers|community health workers
134124|NCT02461615|Pulmonary Surfactant|pulmonary surfactant
134125|NCT02461615|Rare Lung Disease|rare lung disease
134126|NCT02461615|Registry|registry
134127|NCT02461602|Warfarin|warfarin
134128|NCT02461576|HIV-1|hiv-1
134129|NCT02461550|Irreversible Electroporation Ablation|irreversible electroporation ablation
134130|NCT02461550|15-001|15-001
134131|NCT02461498|Warfarin|warfarin
134132|NCT02461485|adults|adults
134133|NCT02461485|moderate constipation|moderate constipation
134134|NCT02461472|risk factors|risk factors
134135|NCT02461472|risk analysis|risk analysis
134136|NCT02461472|diabetic cardiovascular autonomic neuropathy|diabetic cardiovascular autonomic neuropathy
134137|NCT02461472|general Chinese population|general chinese population
134138|NCT02461459|Tuberous Sclerosis Complex|tuberous sclerosis complex
134139|NCT02461459|TSC|tsc
134140|NCT02461459|Autism|autism
134141|NCT02461459|ASD|asd
134142|NCT02461459|Intellectual Disability|intellectual disability
134143|NCT02461459|ID|id
134144|NCT02461459|MRI|mri
134145|NCT02461446|germline heterozygous PTEN mutations|germline heterozygous pten mutations
134146|NCT02461446|MRI|mri
134147|NCT02461446|10q23.3|10q23.3
134148|NCT02461446|ASD|asd
134149|NCT02461446|Autism|autism
134150|NCT02461446|Macrocephaly|macrocephaly
134151|NCT02461446|PTEN Hamartoma Tumor Syndrome|pten hamartoma tumor syndrome
134152|NCT02461446|PTEN|pten
134153|NCT02461433|Obesity|obesity
134154|NCT02461433|Obese|obese
134155|NCT02461433|surgical site infection|surgical site infection
134156|NCT02461433|closed incisions|closed incisions
134657|NCT02458508|MC4R|mc4r
134157|NCT02461433|negative pressure therapy|negative pressure therapy
134158|NCT02461420|Phelan-McDermid Syndrome|phelan-mcdermid syndrome
134159|NCT02461420|PMS|pms
134160|NCT02461420|Genotype|genotype
134161|NCT02461420|Phenotype|phenotype
134162|NCT02461420|Natural History|natural history
134163|NCT02461420|Mapping|mapping
134164|NCT02461420|22q13 Deletion Syndrome|22q13 deletion syndrome
134165|NCT02461420|SHANK3|shank3
134166|NCT02461420|Autism Spectrum Disorder|autism spectrum disorder
134167|NCT02461420|ASD|asd
134168|NCT02461420|Intellectual Disability|intellectual disability
134169|NCT02461420|ID|id
134170|NCT02461381|Bayesian estimation, short-term heart rate variability, diabetic cardiovascular autonomic neuropathy, diagnostic performance|bayesian estimation, short-term heart rate variability, diabetic cardiovascular autonomic neuropathy, diagnostic performance
134171|NCT02461381|Diagnostic performance|diagnostic performance
134172|NCT02461381|short-term heart rate variability|short-term heart rate variability
134173|NCT02461381|diabetic cardiovascular autonomic neuropathy|diabetic cardiovascular autonomic neuropathy
134174|NCT02461381|DCAN|dcan
134175|NCT02461342|Genetic|genetic
134176|NCT02461342|environment|environment
134177|NCT02461342|interaction analysis|interaction analysis
134178|NCT02461342|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
134179|NCT02461342|CAN|can
134180|NCT02461329|Hip Replacement, Total|hip replacement, total
134181|NCT02461329|Gelatine solution|gelatine solution
134182|NCT02461329|Balanced Crystaloid Solution|balanced crystaloid solution
134183|NCT02461329|Volume therapy|volume therapy
134184|NCT02461329|Platelet aggregation|platelet aggregation
134185|NCT02461303|Klinefelter|klinefelter
134186|NCT02461303|Spermatogenesis|spermatogenesis
134187|NCT02461303|Puberty|puberty
134188|NCT02461303|Fertility|fertility
134189|NCT02461277|postoperative care|postoperative care
134190|NCT02461277|exercise test|exercise test
134191|NCT02461277|early ambulation|early ambulation
134192|NCT02461277|Fast-track|fast-track
134193|NCT02461251|Thromboelastometry|thromboelastometry
134194|NCT02461251|Obstetric Hemorrhage|obstetric hemorrhage
134195|NCT02461251|Blood Component Transfusion|blood component transfusion
134196|NCT02461212|HepaFat-Scan|hepafat-scan
134197|NCT02461212|Liver Disease|liver disease
134198|NCT02461212|Pediatrics|pediatrics
134199|NCT02461199|Fecal microbiota transplantation|fecal microbiota transplantation
134200|NCT02461199|Gut colonization|gut colonization
134201|NCT02461199|Multidrug-resistant bacteria|multidrug-resistant bacteria
134202|NCT02461199|Blood disorders|blood disorders
134203|NCT02461199|Drug Resistance, Multiple|drug resistance, multiple
134204|NCT02461199|Disease Eradication|disease eradication
134205|NCT02461186|Arterolane-piperaquine|arterolane-piperaquine
134206|NCT02461186|Dehydroartemisinin-piperaquine|dehydroartemisinin-piperaquine
134207|NCT02461186|therapeutic efficacy|therapeutic efficacy
134208|NCT02461186|Uncomplicated falciparum malaria|uncomplicated falciparum malaria
134209|NCT02461186|Artemisinin-resistant|artemisinin-resistant
134210|NCT02461160|Drug therapy|drug therapy
134211|NCT02461134|GVHD|gvhd
134212|NCT02461134|ponesimod|ponesimod
134213|NCT02461121|Acute Myeloid Leukemia|acute myeloid leukemia
134214|NCT02461121|microtransplantationHLA-mismatched microtransplantation|microtransplantationhla-mismatched microtransplantation
134215|NCT02461121|nonmyeloablative stem cell transplantation|nonmyeloablative stem cell transplantation
134216|NCT02461121|graft-versus-host disease|graft-versus-host disease
161794|NCT02304263|HIV|hiv
134217|NCT02461108|Public policy|public policy
134218|NCT02461108|Food choice|food choice
134219|NCT02461108|Nutrition labeling|nutrition labeling
134220|NCT02461108|Fat tax|fat tax
134221|NCT02461108|Vegetable subsidy|vegetable subsidy
134222|NCT02461108|Behavioral economics|behavioral economics
134223|NCT02461108|Health behavior|health behavior
134224|NCT02461069|dimethyl fumarate|dimethyl fumarate
134225|NCT02461056|ibuprofen|ibuprofen
134226|NCT02461056|hydromorphone|hydromorphone
134227|NCT02461056|drug interactions|drug interactions
134228|NCT02461043|esophageal cancer|esophageal cancer
134229|NCT02461043|adjuvant chemotherapy|adjuvant chemotherapy
134230|NCT02461043|esophageal surgery|esophageal surgery
134231|NCT02461043|paclitaxel|paclitaxel
134232|NCT02461030|Dentin hypersensitivity|dentin hypersensitivity
134233|NCT02461030|Periodontal disease|periodontal disease
134234|NCT02461030|Arginine|arginine
134235|NCT02461017|intubation|intubation
134236|NCT02461017|ventilation|ventilation
134238|NCT02461017|airleak|airleak
134239|NCT02461004|Dyslipidemia|dyslipidemia
134240|NCT02461004|CKD-391|ckd-391
134241|NCT02461004|Atorvastatin|atorvastatin
134242|NCT02461004|Ezetimibe|ezetimibe
134243|NCT02460978|Dapagliflozin|dapagliflozin
134244|NCT02460978|Efficacy|efficacy
134245|NCT02460978|Safety|safety
134246|NCT02460978|Add on to insulin|add on to insulin
134247|NCT02460978|Oral Antidiabetic|oral antidiabetic
134248|NCT02460978|Type 1 diabetes|type 1 diabetes
134249|NCT02460952|Pulmonary Embolism;|pulmonary embolism;
134250|NCT02460952|perioperative period;|perioperative period;
134251|NCT02460952|general anesthesia|general anesthesia
134252|NCT02460939|Pulmonary Vessel Disease|pulmonary vessel disease
134253|NCT02460939|metabolism of small molecules|metabolism of small molecules
134254|NCT02460926|Scaling and root planning|scaling and root planning
134255|NCT02460926|C-reactive protein|c-reactive protein
134256|NCT02460913|acupuncture|acupuncture
134257|NCT02460913|morphine|morphine
134258|NCT02460913|acute pain|acute pain
134259|NCT02460887|nasopharyngeal carcinoma|nasopharyngeal carcinoma
134260|NCT02460887|induction chemotherapy|induction chemotherapy
134261|NCT02460874|Brain Metastases|brain metastases
134262|NCT02460874|Stereotactic Radiosurgery|stereotactic radiosurgery
134263|NCT02460874|Glyburide|glyburide
134264|NCT02460861|Prostate Cancer|prostate cancer
134265|NCT02460861|Molecular staging|molecular staging
134266|NCT02460861|GSTP1|gstp1
134267|NCT02460861|Surgical margins|surgical margins
134268|NCT02460861|prostatovesiculectomy|prostatovesiculectomy
134269|NCT02460848|Malnutrition|malnutrition
134270|NCT02460848|Severe Acute Malnutrition|severe acute malnutrition
134271|NCT02460848|Cash Transfer|cash transfer
134272|NCT02460848|Democratic Republic of Congo|democratic republic of congo
134273|NCT02460848|Cluster randomize trial|cluster randomize trial
134274|NCT02460796|Parkinson's disease|parkinson's disease
134275|NCT02460796|Quality of life|quality of life
134276|NCT02460796|Gait velocity|gait velocity
134277|NCT02460796|Capacity|capacity
134278|NCT02460783|Biomarkers|biomarkers
134279|NCT02460783|Diabetes|diabetes
134280|NCT02460783|Obesity|obesity
134281|NCT02460783|Dementia of the Alzheimer Type|dementia of the alzheimer type
134282|NCT02460783|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
134283|NCT02460770|Left Ventricular Assist Device|left ventricular assist device
134284|NCT02460770|stem cell therapy|stem cell therapy
134285|NCT02460770|ischemic heart failure|ischemic heart failure
134286|NCT02460757|glottic movement|glottic movement
134287|NCT02460757|emphysema|emphysema
134288|NCT02460757|copd|copd
134289|NCT02460757|vocal cord|vocal cord
134290|NCT02460744|Breast cancer|breast cancer
134291|NCT02460744|hypofractionation|hypofractionation
134292|NCT02460744|radiotherapy|radiotherapy
134293|NCT02460731|PSP|psp
134294|NCT02460731|Young Plasma|young plasma
134298|NCT02460666|depressed|depressed
134299|NCT02460666|older adults|older adults
134300|NCT02460666|Major Depressive Disorder|major depressive disorder
134301|NCT02460666|Tai-Chi|tai-chi
134302|NCT02460666|geriatric|geriatric
134303|NCT02460653|High flow nasal cannula|high flow nasal cannula
134304|NCT02460653|Oxygen therapy|oxygen therapy
134305|NCT02460653|Ventilation|ventilation
134306|NCT02460640|Minimally invasive surgery|minimally invasive surgery
134307|NCT02460640|Partial nephrectomy|partial nephrectomy
134308|NCT02460627|Arthroscopy|arthroscopy
134309|NCT02460627|Meniscus|meniscus
134310|NCT02460627|Lidocaine|lidocaine
134311|NCT02460614|bronchiolitis|bronchiolitis
134312|NCT02460614|respiratory physiotherapy|respiratory physiotherapy
134313|NCT02460614|pediatrics|pediatrics
134314|NCT02460614|rhinopharyngeal clearance|rhinopharyngeal clearance
134315|NCT02460575|Safety|safety
134316|NCT02460562|resin denture base|resin denture base
134317|NCT02460549|therapeutic patient education|therapeutic patient education
134318|NCT02460549|insulinoresistance|insulinoresistance
134319|NCT02460549|empowerment|empowerment
134320|NCT02460549|prostate cancer|prostate cancer
134321|NCT02460549|oral endocrine therapy|oral endocrine therapy
134322|NCT02460549|side effects|side effects
134323|NCT02460536|attention bias modification treatment|attention bias modification treatment
134324|NCT02460536|attention training|attention training
134325|NCT02460536|anxiety disorders|anxiety disorders
134326|NCT02460536|clinical trials|clinical trials
134327|NCT02460471|Radiotherapy|radiotherapy
134328|NCT02460471|Palliative Care|palliative care
134329|NCT02460471|IMRT|imrt
134330|NCT02460458|Factor VIII|factor viii
134331|NCT02460458|Hemorrhage|hemorrhage
134332|NCT02460458|von Willebrand Diseases|von willebrand diseases
134333|NCT02460458|von Willebrand Factor|von willebrand factor
134334|NCT02460445|Functional hyperandrogenism|functional hyperandrogenism
134335|NCT02460445|Polycystic ovary syndrome|polycystic ovary syndrome
134336|NCT02460445|Idiopathic hyperandrogenism|idiopathic hyperandrogenism
134337|NCT02460445|Iron tissue depots|iron tissue depots
134338|NCT02460445|Phlebotomy|phlebotomy
134339|NCT02460445|Insulin resistance|insulin resistance
134340|NCT02460445|Carbohydrate metabolism|carbohydrate metabolism
134341|NCT02460445|Blood pressure|blood pressure
134342|NCT02460445|Autonomic dysfunction|autonomic dysfunction
134343|NCT02460445|Oxidative stress|oxidative stress
134344|NCT02460445|Blood clotting tests|blood clotting tests
134345|NCT02460445|Efficacy|efficacy
134346|NCT02460445|Side effects|side effects
134347|NCT02460445|Randomized clinical trial|randomized clinical trial
134348|NCT02460432|Drug-eluting Biliary stent|drug-eluting biliary stent
134349|NCT02460432|Covered metalic stent|covered metalic stent
134350|NCT02460419|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
134351|NCT02460419|metastasis|metastasis
134352|NCT02460419|capecitabine|capecitabine
134353|NCT02460406|strength training|strength training
134354|NCT02460406|virtual reality|virtual reality
134355|NCT02460406|plyometric exercises|plyometric exercises
134356|NCT02460406|cerebral palsy|cerebral palsy
134357|NCT02460406|hemiplegic|hemiplegic
134358|NCT02460393|tolerance|tolerance
134359|NCT02460393|safety and pharmacokinetic characteristics|safety and pharmacokinetic characteristics
134360|NCT02460367|Non-small Cell Lung Cancer|non-small cell lung cancer
134361|NCT02460367|Vaccine Therapy|vaccine therapy
134362|NCT02460367|Immunotherapy|immunotherapy
134363|NCT02460367|Second line therapy|second line therapy
134364|NCT02460367|Progressive|progressive
134365|NCT02460367|Relapsed|relapsed
134367|NCT02460367|IDO Inhibitor|ido inhibitor
134368|NCT02460354|Congenital nephrogenic diabetes insipidus|congenital nephrogenic diabetes insipidus
134369|NCT02460341|fMRI|fmri
134370|NCT02460341|Brain function|brain function
134371|NCT02460341|Sensory processing|sensory processing
654094|NCT00787644|Leptin|leptin
134372|NCT02460315|time of cholecystectomy after ERCP|time of cholecystectomy after ercp
134373|NCT02460276|Mantle cell lymphoma|mantle cell lymphoma
134374|NCT02460276|Relapsed mantle cell lymphoma|relapsed mantle cell lymphoma
134375|NCT02460276|Lenalidomide|lenalidomide
134376|NCT02460276|Rituximab|rituximab
134377|NCT02460276|Ibrutinib|ibrutinib
134378|NCT02460276|Response duration|response duration
134379|NCT02460276|Complete remission rate|complete remission rate
134380|NCT02460276|Quality of life|quality of life
134381|NCT02460276|Overall survival|overall survival
134382|NCT02460276|Safety|safety
134383|NCT02460250|Tissue and Organ Harvesting|tissue and organ harvesting
134384|NCT02460250|Liver graft|liver graft
134385|NCT02460250|Brain Death|brain death
134386|NCT02460250|FibroScan®|fibroscan®
134387|NCT02460237|HPV|hpv
134388|NCT02460224|Non-small cell lung cancer|non-small cell lung cancer
134389|NCT02460224|Melanoma|melanoma
134390|NCT02460224|Renal cancer|renal cancer
134391|NCT02460211|Cardiovascular Disease|cardiovascular disease
134392|NCT02460211|Vitamin D|vitamin d
134393|NCT02460211|Open Heart Surgery|open heart surgery
134394|NCT02460198|PD1|pd1
134395|NCT02460198|PD-1|pd-1
134396|NCT02460198|PDL1|pdl1
134397|NCT02460198|PD-L1|pd-l1
134398|NCT02460172|bi lateral|bi lateral
134399|NCT02460172|knee surgery|knee surgery
134400|NCT02460172|arthroplasty|arthroplasty
134401|NCT02460172|orthopedics|orthopedics
134402|NCT02460081|PDA-002|pda-002
134403|NCT02460081|Diabetic Foot Ulcer|diabetic foot ulcer
134404|NCT02460081|Peripheral arterial disease|peripheral arterial disease
134405|NCT02460081|Phase 2|phase 2
134406|NCT02460081|Randomized|randomized
134407|NCT02460068|melanoma brain metastases|melanoma brain metastases
134408|NCT02460068|nivolumab|nivolumab
134409|NCT02460068|ipilimumab|ipilimumab
134410|NCT02460055|EGD Dysphagia|egd dysphagia
134411|NCT02460055|ETT Intubation dysphagia|ett intubation dysphagia
134412|NCT02459990|Hypertension malformation fetal mortality|hypertension malformation fetal mortality
134413|NCT02459964|Advanced Cancers|advanced cancers
134414|NCT02459964|Pain|pain
134415|NCT02459964|Fentanyl nasal spray|fentanyl nasal spray
134416|NCT02459964|Hydromorphone hydrochloride|hydromorphone hydrochloride
134417|NCT02459964|Phone call|phone call
134418|NCT02459964|Numeric Rating Scale|numeric rating scale
134419|NCT02459964|NRS|nrs
134420|NCT02459951|Muscle Spasticity|muscle spasticity
134421|NCT02459951|Botox A|botox a
134422|NCT02459951|Upper limb hemiplegia|upper limb hemiplegia
134423|NCT02459912|Prostate|prostate
134424|NCT02459912|Minimally|minimally
134425|NCT02459912|Low-Risk|low-risk
134426|NCT02459912|Invasive|invasive
134427|NCT02459912|Cancer|cancer
134428|NCT02459886|alpha synuclein|alpha synuclein
134429|NCT02459886|PD|pd
134430|NCT02459860|depression|depression
134431|NCT02459860|randomized behavioral trial|randomized behavioral trial
134432|NCT02459860|aged|aged
134433|NCT02459860|Latinos|latinos
134434|NCT02459860|Spanish-speaking|spanish-speaking
134435|NCT02459860|chronic medical conditions|chronic medical conditions
134436|NCT02459834|Allulose|allulose
134437|NCT02459834|Fructose|fructose
134438|NCT02459834|Dose Response|dose response
134439|NCT02459834|Catalytic Dose|catalytic dose
134440|NCT02459834|Carbohydrate metabolism|carbohydrate metabolism
134441|NCT02459834|Randomized clinical trials|randomized clinical trials
134442|NCT02459821|Multiple sclerosis|multiple sclerosis
134443|NCT02459821|Gait rehabilitation|gait rehabilitation
134444|NCT02459821|Quality of life|quality of life
134445|NCT02459821|Stair climbing|stair climbing
134446|NCT02459821|Robotic|robotic
134447|NCT02459782|Ultrasound guided peribulbar anesthesia|ultrasound guided peribulbar anesthesia
134448|NCT02459756|anthocyanins|anthocyanins
134449|NCT02459756|bioavailability|bioavailability
134450|NCT02459743|Hematological malignancies|hematological malignancies
134451|NCT02459743|Next Generation Sequencing|next generation sequencing
134452|NCT02459743|Genotype-phenotype correlations|genotype-phenotype correlations
134453|NCT02459743|Prognosis|prognosis
134454|NCT02459743|Diagnosis|diagnosis
134455|NCT02459730|Dental caries|dental caries
134456|NCT02459730|glass ionomer cement|glass ionomer cement
134458|NCT02459704|Gingival Recession|gingival recession
134459|NCT02459704|Semilunar flap|semilunar flap
134460|NCT02459704|Enamel matrix derivative|enamel matrix derivative
134461|NCT02459704|Periodontal regeneration|periodontal regeneration
134462|NCT02459691|prediabetes|prediabetes
134463|NCT02459691|metabolic syndrome|metabolic syndrome
134464|NCT02459691|lifestyle|lifestyle
134465|NCT02459691|behavior change|behavior change
134466|NCT02459691|primary care|primary care
134467|NCT02459691|latinos|latinos
134468|NCT02459691|diet|diet
134469|NCT02459691|physical activity|physical activity
134470|NCT02459652|Borderline Resectable Pancreatic Cancer|borderline resectable pancreatic cancer
134471|NCT02459639|Chronic Widespread Pain|chronic widespread pain
134472|NCT02459639|Telomere length|telomere length
134473|NCT02459639|Multimodal rehabilitation|multimodal rehabilitation
654095|NCT00787644|Adiponectin|adiponectin
134474|NCT02459639|Integrative care|integrative care
134475|NCT02459639|Existential aspects|existential aspects
134476|NCT02459613|Radionuclide imaging|radionuclide imaging
134477|NCT02459613|Annexin|annexin
134478|NCT02459600|Eye surgery|eye surgery
134479|NCT02459600|Children|children
134480|NCT02459587|Self-Injurious Behavior|self-injurious behavior
134481|NCT02459587|suicide prevention|suicide prevention
134482|NCT02459574|Heart Failure|heart failure
134483|NCT02459561|Obesity|obesity
134484|NCT02459561|Diabetes|diabetes
134485|NCT02459561|Overweight|overweight
134486|NCT02459561|Medical device|medical device
134487|NCT02459561|Endobarrier|endobarrier
134488|NCT02459561|Clinical trial|clinical trial
134489|NCT02459561|Diet|diet
134490|NCT02459561|Exercise|exercise
134491|NCT02459561|Body weight|body weight
134492|NCT02459561|Medical therapy|medical therapy
134493|NCT02459561|Medicine|medicine
134494|NCT02459561|Device|device
134495|NCT02459561|Randomised|randomised
134497|NCT02459561|Intervention|intervention
134498|NCT02459561|EndoBarrier Medical device|endobarrier medical device
134499|NCT02459548|OSA|osa
134500|NCT02459548|CPAP treatment|cpap treatment
134501|NCT02459548|Primary care|primary care
134502|NCT02459548|Efficacy|efficacy
134503|NCT02459535|incretin release|incretin release
134504|NCT02459522|Bayesian estimation|bayesian estimation
134505|NCT02459522|short-term heart rate variability|short-term heart rate variability
134506|NCT02459522|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
134507|NCT02459522|diagnostic performance|diagnostic performance
134508|NCT02459509|Sedation|sedation
134509|NCT02459509|dexmedetomidine|dexmedetomidine
134510|NCT02459509|pediatric|pediatric
134511|NCT02459509|preoperative period|preoperative period
134512|NCT02459470|Fluid Responsiveness|fluid responsiveness
134513|NCT02459470|Pulse Pressure Variation|pulse pressure variation
134514|NCT02459470|Stroke Volume Variation|stroke volume variation
134515|NCT02459457|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
134516|NCT02459457|concurrent chemoradiotherapy|concurrent chemoradiotherapy
134517|NCT02459457|paclitaxel|paclitaxel
134518|NCT02459457|cisplatin|cisplatin
134519|NCT02459457|carboplatin|carboplatin
134520|NCT02459457|fluorouracil|fluorouracil
134521|NCT02459444|Respiratory Muscles|respiratory muscles
134522|NCT02459444|Muscle Weakness|muscle weakness
134523|NCT02459444|Hospitalization|hospitalization
134524|NCT02459444|Length of Stay|length of stay
134525|NCT02459444|Mortality|mortality
134526|NCT02459418|Afolia|afolia
134527|NCT02459418|Follitropin|follitropin
134528|NCT02459405|Colorectal surgery|colorectal surgery
134529|NCT02459405|Near infrared|near infrared
134530|NCT02459405|Indocyanine green|indocyanine green
134531|NCT02459405|anastomotic leak|anastomotic leak
134532|NCT02459405|Prevention of leak|prevention of leak
134533|NCT02459392|Epiduroscopy,|epiduroscopy,
134534|NCT02459392|Failed back surgery syndrome|failed back surgery syndrome
134535|NCT02459392|Spinal Stenosis with neurologic changes|spinal stenosis with neurologic changes
134536|NCT02459366|Thoracolumbar fascia|thoracolumbar fascia
134537|NCT02459366|Mechanical properties|mechanical properties
134538|NCT02459366|Low back pain|low back pain
134539|NCT02459353|dapagliflozin|dapagliflozin
134540|NCT02459353|glucose variability|glucose variability
134541|NCT02459327|Infant behavior|infant behavior
134542|NCT02459327|Child behavior|child behavior
134543|NCT02459327|Parenting|parenting
134544|NCT02459327|Child rearing|child rearing
134545|NCT02459327|Depression|depression
134546|NCT02459327|Personal satisfaction|personal satisfaction
134547|NCT02459327|Randomized controlled trials|randomized controlled trials
134548|NCT02459327|Intervention studies|intervention studies
134549|NCT02459327|Behavioral symptoms|behavioral symptoms
134550|NCT02459327|Social behavior|social behavior
134551|NCT02459288|Acute coronary syndrome|acute coronary syndrome
134552|NCT02459288|Chronic kidney disease|chronic kidney disease
134553|NCT02459288|End-Stage Renal Disease|end-stage renal disease
134554|NCT02459288|eGFR|egfr
134555|NCT02459288|Ticagrelor|ticagrelor
134556|NCT02459288|Clopidogrel|clopidogrel
134557|NCT02459275|feeding protocol|feeding protocol
134558|NCT02459275|enteral nutrition protocol|enteral nutrition protocol
134559|NCT02459275|critically ill|critically ill
134560|NCT02459275|surgical ICU|surgical icu
134561|NCT02459275|enteral nutrition|enteral nutrition
134562|NCT02459275|nutrition therapy|nutrition therapy
134563|NCT02459223|Nutritional intervention|nutritional intervention
134564|NCT02459223|iron deficiency anemia|iron deficiency anemia
134565|NCT02459210|clinical high risk for psychosis|clinical high risk for psychosis
134566|NCT02459210|psychosis prodrome|psychosis prodrome
134567|NCT02459210|cognitive remediation|cognitive remediation
134568|NCT02459210|psychosis prevention|psychosis prevention
134569|NCT02459197|Pain|pain
134570|NCT02459184|preventive medicine|preventive medicine
134571|NCT02459184|social determinants of health|social determinants of health
134572|NCT02459184|primary health care|primary health care
134580|NCT02459132|Carotid intima-media thickness|carotid intima-media thickness
134581|NCT02459132|Carotid distensibility|carotid distensibility
134582|NCT02459132|Respiratory sinus arrhythmia|respiratory sinus arrhythmia
134583|NCT02459119|urothelial cancer|urothelial cancer
134584|NCT02459119|Regorafenib|regorafenib
134585|NCT02459106|micro-RNA|micro-rna
134586|NCT02459106|insulin resistance|insulin resistance
134587|NCT02459093|wound complications|wound complications
134588|NCT02459080|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
134589|NCT02459054|Artificial Heart|artificial heart
134590|NCT02459054|Biventricular Heart Failure|biventricular heart failure
134591|NCT02459054|SynCardia|syncardia
134592|NCT02459002|Advanced lung cancer|advanced lung cancer
134593|NCT02459002|NSCLC|nsclc
134594|NCT02459002|palliative care|palliative care
134595|NCT02458989|Thyroidectomy|thyroidectomy
134596|NCT02458989|Thyroid surgery|thyroid surgery
134597|NCT02458989|Scalpel|scalpel
134598|NCT02458989|Electrocautery|electrocautery
134599|NCT02458976|Scar|scar
134601|NCT02458976|PDL|pdl
134602|NCT02458963|PCOS|pcos
134603|NCT02458963|Clomiphene citrate resistant|clomiphene citrate resistant
134604|NCT02458963|Gonadotropin|gonadotropin
134605|NCT02458963|IVF|ivf
134606|NCT02458950|Anorexia nervosa|anorexia nervosa
134607|NCT02458950|Siriraj Hospital|siriraj hospital
134608|NCT02458950|Thai|thai
134609|NCT02458937|Leukemia|leukemia
134610|NCT02458937|Hodgkin Disease|hodgkin disease
134611|NCT02458937|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
134612|NCT02458937|Sickle Cell Disease|sickle cell disease
134613|NCT02458937|Hip Core Decompression|hip core decompression
134614|NCT02458937|Function Outcomes|function outcomes
134615|NCT02458885|myocardial infarction|myocardial infarction
134616|NCT02458885|observational registry|observational registry
134617|NCT02458885|mortality|mortality
134618|NCT02458872|Clinical Alarms|clinical alarms
134619|NCT02458872|Patient Safety|patient safety
134620|NCT02458859|Chronic|chronic
134621|NCT02458859|Subacute|subacute
134630|NCT02458820|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
134631|NCT02458820|Return of Spontaneous Circulation|return of spontaneous circulation
134632|NCT02458820|ROSC|rosc
134633|NCT02458820|Electroencephalogram|electroencephalogram
134634|NCT02458742|spinal anesthesia|spinal anesthesia
125686|NCT02509741|IOT|iot
134635|NCT02458742|intrathecal morphine|intrathecal morphine
134636|NCT02458742|transurethral resection of prostate|transurethral resection of prostate
134637|NCT02458742|postoperative pain|postoperative pain
134638|NCT02458729|Tranexamic Acid|tranexamic acid
134639|NCT02458729|Total Knee Arthroplasty|total knee arthroplasty
134640|NCT02458729|Rivaroxaban|rivaroxaban
134641|NCT02458703|workload|workload
134642|NCT02458703|oxygen level|oxygen level
134643|NCT02458703|oxygen consumption|oxygen consumption
134644|NCT02458703|breathing reserve|breathing reserve
134645|NCT02458703|ventilatory efficiency|ventilatory efficiency
134646|NCT02458690|Primary Care|primary care
134647|NCT02458690|Older Adults|older adults
134648|NCT02458690|Antidepressant Medications|antidepressant medications
134649|NCT02458690|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
134650|NCT02458690|Computer-Based Psychotherapy|computer-based psychotherapy
134651|NCT02458612|cerebral palsy|cerebral palsy
134652|NCT02458612|mirror therapy|mirror therapy
134653|NCT02458612|strength training|strength training
134654|NCT02458560|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
134655|NCT02458560|Aortic Stenosis|aortic stenosis
134656|NCT02458534|Simulated manikin|simulated manikin
134658|NCT02458508|chemotherapy|chemotherapy
134659|NCT02458508|radiotherapy|radiotherapy
134660|NCT02458495|Internet|internet
134661|NCT02458495|Mobile Health|mobile health
134662|NCT02458495|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
134663|NCT02458495|Medication Adherence|medication adherence
134664|NCT02458495|Psychological Theory|psychological theory
134665|NCT02458482|Children|children
134666|NCT02458482|Positive Airway Pressure|positive airway pressure
134667|NCT02458482|Nebulizer|nebulizer
134668|NCT02458482|Moderate|moderate
134670|NCT02458482|AccuPAP|accupap
134671|NCT02458417|Ablative laser|ablative laser
134672|NCT02458417|Fractional laser|fractional laser
134673|NCT02458417|Vitiligo|vitiligo
134674|NCT02458417|Piebaldism|piebaldism
134675|NCT02458417|Cell suspension grafting|cell suspension grafting
134676|NCT02458391|Breast Cancer|breast cancer
134677|NCT02458391|Lymphedema|lymphedema
134678|NCT02457546|Fibrin sealant|fibrin sealant
134679|NCT02457546|CSF leak|csf leak
134680|NCT02457494|CALVIH|calvih
134681|NCT02457494|Renal stone|renal stone
134682|NCT02457494|HIV1|hiv1
134683|NCT02457494|Renal colic|renal colic
134684|NCT02457494|Atazanavir|atazanavir
134685|NCT02457494|Crystalluria|crystalluria
134686|NCT02457494|Chronic Kidney Disease|chronic kidney disease
134687|NCT02457494|Calcium Oxalate|calcium oxalate
134688|NCT02457481|Embryo Culture Techniques|embryo culture techniques
134689|NCT02457481|Embryonic Development|embryonic development
134690|NCT02457468|coflex|coflex
134691|NCT02457468|interlaminar stabilization|interlaminar stabilization
134692|NCT02457468|lumbar spinal stenosis|lumbar spinal stenosis
134693|NCT02457468|neurogenic claudication|neurogenic claudication
134694|NCT02457468|decompression|decompression
134695|NCT02457455|inflight emergencies|inflight emergencies
134696|NCT02457442|Anesthetics, Inhalation|anesthetics, inhalation
134697|NCT02457442|Anesthetics, Intravenous|anesthetics, intravenous
134698|NCT02457442|Analgesics, Opioid|analgesics, opioid
134699|NCT02457429|Gastro-oesophageal reflux|gastro-oesophageal reflux
134700|NCT02457429|Children|children
134701|NCT02457429|Dx-pH Pharyngeal probe|dx-ph pharyngeal probe
134702|NCT02457429|GORD|gord
134703|NCT02457429|Trans-nasal catheter|trans-nasal catheter
134704|NCT02457416|Peanut allergy|peanut allergy
134705|NCT02457416|Oral immunotherapy|oral immunotherapy
134706|NCT02457390|contrast enhanced laparoscopic ultrasound|contrast enhanced laparoscopic ultrasound
134707|NCT02457390|CE-LUS|ce-lus
134708|NCT02457390|LUS|lus
134712|NCT02457377|laparoscopy|laparoscopy
134713|NCT02457377|cervical imcompetence|cervical imcompetence
134714|NCT02457364|non-operative management|non-operative management
134715|NCT02458365|Violence|violence
134716|NCT02458365|Bullying|bullying
134717|NCT02458365|Social skills|social skills
134718|NCT02458365|Prevention & control|prevention & control
134719|NCT02458365|Adolescent|adolescent
134720|NCT02458339|Brain tumor|brain tumor
134721|NCT02458339|Malignant Fourth Ventricular Brain Tumors|malignant fourth ventricular brain tumors
134722|NCT02458326|Migraine|migraine
134723|NCT02458326|Fibromyalgia|fibromyalgia
134724|NCT02458326|Aerobic exercise|aerobic exercise
134725|NCT02458300|Bronchiolitis|bronchiolitis
134727|NCT02458300|Physical therapy|physical therapy
134728|NCT02458287|mixed dyslipidemia|mixed dyslipidemia
134729|NCT02458248|Chronic Kidney Disease|chronic kidney disease
134730|NCT02458248|Sodium Reduction|sodium reduction
134731|NCT02458248|eGFR 30-60ml/min/1.73m2|egfr 30-60ml/min/1.73m2
134732|NCT02458235|pediatric leukemia myelodysplastic syndrome azacitidine|pediatric leukemia myelodysplastic syndrome azacitidine
134733|NCT02458209|PK, bococizumab, comparability, LDL-C|pk, bococizumab, comparability, ldl-c
134734|NCT02458196|IgG4 related disease|igg4 related disease
134735|NCT02458196|IgG4-RD|igg4-rd
134736|NCT02458196|Response rate|response rate
134737|NCT02458196|Relapse|relapse
134738|NCT02458170|Rheumatoid arthritis|rheumatoid arthritis
134739|NCT02458170|Synovial tissue|synovial tissue
134740|NCT02458170|Joint destruction|joint destruction
134741|NCT02458170|Inflammation|inflammation
134742|NCT02458157|ICU|icu
134743|NCT02458157|Intensive|intensive
134744|NCT02458157|CRRT|crrt
134745|NCT02458157|Fluid Removal|fluid removal
134746|NCT02458157|AKI|aki
134747|NCT02458157|Critical Care|critical care
134748|NCT02458131|community-based participatory research|community-based participatory research
134749|NCT02458131|adolescents|adolescents
134750|NCT02458118|chronic|chronic
134751|NCT02458118|pancreatitis|pancreatitis
134752|NCT02458118|secretin|secretin
134753|NCT02458118|Blood flow|blood flow
134754|NCT02458105|Acceptance and commitment therapy|acceptance and commitment therapy
134755|NCT02458105|Cognitive behavior therapy|cognitive behavior therapy
134756|NCT02458053|African American|african american
134757|NCT02458053|male|male
134759|NCT02458053|randomized control trial|randomized control trial
134760|NCT02458014|Leukemia|leukemia
134761|NCT02458014|B-cell Lineage Acute Lymphocytic Leukemia|b-cell lineage acute lymphocytic leukemia
134762|NCT02458014|Positive minimal residual disease|positive minimal residual disease
134764|NCT02458014|Acute lymphocytic leukemia|acute lymphocytic leukemia
134765|NCT02458014|ALL|all
134766|NCT02458014|Blinatumomab|blinatumomab
134767|NCT02458014|Blinacyto|blinacyto
134768|NCT02458014|Phone calls|phone calls
134769|NCT02457949|Social Assistance|social assistance
134770|NCT02457949|Drug Use|drug use
654096|NCT00787644|Wheezing|wheezing
134771|NCT02457949|Drug-Related harm|drug-related harm
134772|NCT02457923|mobile phone counselling|mobile phone counselling
134773|NCT02457923|infant feeding|infant feeding
134774|NCT02457923|nutrition|nutrition
134775|NCT02457897|Brown Adipose Tissue|brown adipose tissue
134776|NCT02457897|Liothyronine|liothyronine
134777|NCT02457897|Insulin Receptors|insulin receptors
134778|NCT02457884|Diabetic macular oedema|diabetic macular oedema
134779|NCT02457884|Perceptual learning|perceptual learning
134780|NCT02457884|Chinese|chinese
134781|NCT02457884|Hong Kong|hong kong
134782|NCT02457858|Type 1 Diabetes|type 1 diabetes
134783|NCT02457858|Islet Transplant|islet transplant
134784|NCT02457845|Brain Tumor, Recurrent|brain tumor, recurrent
134785|NCT02457845|Glioma|glioma
134786|NCT02457845|Glioblastoma|glioblastoma
134787|NCT02457845|Gliosarcoma|gliosarcoma
134788|NCT02457845|Anaplastic Astrocytoma|anaplastic astrocytoma
134789|NCT02457845|Oligodendroglioma|oligodendroglioma
134790|NCT02457845|Rhabdoid Tumor|rhabdoid tumor
134791|NCT02457845|Cerebral Primitive Neuroectodermal Tumor|cerebral primitive neuroectodermal tumor
134792|NCT02457845|PNET|pnet
134793|NCT02457845|Ependymoma|ependymoma
134794|NCT02457845|Germ Cell Tumor|germ cell tumor
134795|NCT02457845|Choroid Plexus Carcinoma|choroid plexus carcinoma
134796|NCT02457845|Oncolytic Virus Therapy|oncolytic virus therapy
134797|NCT02457845|Virotherapy, Oncolytic|virotherapy, oncolytic
134798|NCT02457845|Immunotherapy|immunotherapy
134799|NCT02457845|Central Nervous System Agents|central nervous system agents
134800|NCT02457845|Antineoplastic Agents|antineoplastic agents
134801|NCT02457845|Neoplasms|neoplasms
134802|NCT02457845|Pediatric|pediatric
134803|NCT02457845|Pediatrics|pediatrics
135461|NCT02453724|Ultrasonography|ultrasonography
134804|NCT02457832|Magnetic Resonance Imaging|magnetic resonance imaging
134806|NCT02457832|Neurosciences|neurosciences
134807|NCT02457832|Physical Medicine|physical medicine
134808|NCT02457832|Parkinson Disease|parkinson disease
134809|NCT02457832|Rehabilitation|rehabilitation
134810|NCT02457806|Dental Anesthesia|dental anesthesia
134811|NCT02457780|PTSD|ptsd
134812|NCT02457780|Trauma|trauma
134813|NCT02457780|World Trade Center|world trade center
134814|NCT02457780|Respiratory|respiratory
134815|NCT02457780|Mind-Body|mind-body
134816|NCT02457741|Mechanical ventilation|mechanical ventilation
134817|NCT02457741|PEEP|peep
134818|NCT02457741|Respiratory mechanics|respiratory mechanics
134819|NCT02457741|End-expiratory lung volume|end-expiratory lung volume
134820|NCT02457689|Human Immunodeficiency Virus|human immunodeficiency virus
134821|NCT02457689|Immunodeficiency Virus, Human|immunodeficiency virus, human
134822|NCT02457676|Self-Regulation Training|self-regulation training
134823|NCT02457676|Neuroimaging|neuroimaging
134824|NCT02457676|Response Inhibition|response inhibition
134825|NCT02457676|Behavioral Regulation|behavioral regulation
134826|NCT02457676|Emotional Regulation|emotional regulation
134827|NCT02457663|Burns|burns
134828|NCT02457637|chronic liver disease|chronic liver disease
134829|NCT02457637|acute liver injury|acute liver injury
134830|NCT02457637|acute decompensation|acute decompensation
134831|NCT02457637|multiple organ failures|multiple organ failures
134832|NCT02457637|acute on chronic liver failure|acute on chronic liver failure
134833|NCT02457624|gastric cancer|gastric cancer
134834|NCT02457624|chronic atrophic gastritis|chronic atrophic gastritis
134835|NCT02457624|intestinal metaplasia|intestinal metaplasia
134836|NCT02457351|Phase 1|phase 1
134837|NCT02457351|Advanced solid tumor|advanced solid tumor
134838|NCT02457351|pan-CDK inhibitor|pan-cdk inhibitor
134839|NCT02457351|Drug-drug Interaction|drug-drug interaction
134840|NCT02457338|C-section|c-section
134841|NCT02457338|Infants|infants
134842|NCT02457338|Probiotic|probiotic
134843|NCT02457338|B. infantis|b. infantis
134844|NCT02457338|Microbiota|microbiota
134845|NCT02457338|Gut|gut
134846|NCT02457338|Breast milk|breast milk
134847|NCT02457338|Vaginal|vaginal
134848|NCT02457325|Articaine|articaine
134849|NCT02457325|Lower third molar|lower third molar
134850|NCT02457325|Oral Surgery|oral surgery
134851|NCT02457299|Esophagectomy|esophagectomy
134852|NCT02457299|Gastric Conduit|gastric conduit
134853|NCT02457299|Esophageal Cancer|esophageal cancer
134854|NCT02457273|PDNC(Poorly Differentiated Neuroendocrine Carcinomas)|pdnc(poorly differentiated neuroendocrine carcinomas)
134855|NCT02457273|TLC-388 (Lipotecan®)|tlc-388 (lipotecan®)
134856|NCT02457247|Drug therapy|drug therapy
134857|NCT02457234|fruits and vegetables|fruits and vegetables
134858|NCT02457234|cultural immersion|cultural immersion
134859|NCT02457221|Tacrolimus|tacrolimus
134860|NCT02457221|Cyclophosphamide|cyclophosphamide
134861|NCT02457221|Prograf|prograf
134862|NCT02457221|lupus nephritis|lupus nephritis
134863|NCT02457208|pharmacokinetics|pharmacokinetics
134864|NCT02457195|PONV|ponv
134865|NCT02457195|anesthesia|anesthesia
134866|NCT02457195|granisetron|granisetron
134867|NCT02457156|Pancreatico-jejunostomy|pancreatico-jejunostomy
134868|NCT02457156|Pancreato-duodenectomy|pancreato-duodenectomy
134869|NCT02457156|Cattell-Warren anastomosis|cattell-warren anastomosis
134870|NCT02457156|Blumgart anastomosis|blumgart anastomosis
134871|NCT02457143|recall|recall
134872|NCT02457143|income-related disparities|income-related disparities
134873|NCT02457143|cancer screening|cancer screening
134874|NCT02457117|CyberKnife|cyberknife
134875|NCT02457117|Partial breast irradiation|partial breast irradiation
134876|NCT02457117|accelerated partial breast irradiation|accelerated partial breast irradiation
134877|NCT02457117|breast sbrt|breast sbrt
134878|NCT02457091|multiple sclerosis|multiple sclerosis
134879|NCT02457091|exercise|exercise
134880|NCT02457091|home-based|home-based
134881|NCT02457091|training|training
134882|NCT02457091|fitness|fitness
134883|NCT02457078|nutritional supplements|nutritional supplements
134884|NCT02457078|lutein|lutein
134885|NCT02457078|DHA|dha
134886|NCT02457078|vitamin E|vitamin e
134887|NCT02457078|infant brain development|infant brain development
134888|NCT02457065|survivors|survivors
134889|NCT02457065|family|family
134890|NCT02457052|Medical device|medical device
134891|NCT02457039|Chemo-brain|chemo-brain
134892|NCT02457039|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
134893|NCT02457039|Mild Cognitive Impairment|mild cognitive impairment
134894|NCT02457039|Breast cancer|breast cancer
134895|NCT02457026|neovascular age-related macular degeneration|neovascular age-related macular degeneration
134896|NCT02457026|age-related macular degeneration|age-related macular degeneration
134897|NCT02457026|verteporfin|verteporfin
134898|NCT02457026|persistent disease activity|persistent disease activity
134899|NCT02457026|photodynamic therapy|photodynamic therapy
134900|NCT02457026|Aflibercept|aflibercept
134901|NCT02457000|Sleep|sleep
134902|NCT02457000|Skin|skin
134903|NCT02457000|Circadian Rhythm|circadian rhythm
134904|NCT02456961|Collagen crosslinking (CXL)|collagen crosslinking (cxl)
134905|NCT02456961|Standard corneal crosslinking (CXL)|standard corneal crosslinking (cxl)
134906|NCT02456961|Transepithelial CXL|transepithelial cxl
134907|NCT02456961|Iontophoresis|iontophoresis
134908|NCT02456961|Riboflavin|riboflavin
134909|NCT02456948|treatment resistant depression|treatment resistant depression
134910|NCT02456948|inflammation|inflammation
134911|NCT02456948|microglia|microglia
134912|NCT02456948|minocycline|minocycline
134913|NCT02456922|Type 1 Diabetes|type 1 diabetes
134914|NCT02456922|Type 2 Diabetes|type 2 diabetes
134915|NCT02456922|Harmony 1|harmony 1
134916|NCT02456896|Oxcarbazepine|oxcarbazepine
134917|NCT02456896|Brain Derived Neurotrophic Factor|brain derived neurotrophic factor
134918|NCT02456896|Bipolar disorder|bipolar disorder
134919|NCT02456896|Neuroprotection|neuroprotection
134920|NCT02456883|ASP2215|asp2215
134921|NCT02456883|14C-labeled gilteritinib|14c-labeled gilteritinib
134922|NCT02456883|Advanced Solid Tumors|advanced solid tumors
134923|NCT02456883|Pharmacokinetics|pharmacokinetics
134924|NCT02456883|gilteritinib|gilteritinib
134925|NCT02456870|Adipose tissue|adipose tissue
134926|NCT02456870|Overfeeding|overfeeding
134927|NCT02456857|Breast cancer|breast cancer
134928|NCT02456857|Triple-Negative Breast Cancer|triple-negative breast cancer
134929|NCT02456857|TNBC|tnbc
134930|NCT02456857|Tumors insensitive to standard neoadjuvant chemotherapy|tumors insensitive to standard neoadjuvant chemotherapy
134931|NCT02456857|Temsirolimus|temsirolimus
134932|NCT02456857|CCI-779|cci-779
134933|NCT02456857|Torisel|torisel
125967|NCT02508298|ICG|icg
134934|NCT02456857|Liposomal Doxorubicin|liposomal doxorubicin
134935|NCT02456857|Doxil|doxil
134936|NCT02456857|Doxorubicin Hydrochloride (Liposomal)|doxorubicin hydrochloride (liposomal)
134937|NCT02456857|Bevacizumab|bevacizumab
134938|NCT02456857|Avastin|avastin
134939|NCT02456857|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
134940|NCT02456857|rhuMAb-VEGF|rhumab-vegf
134941|NCT02456818|Colonization|colonization
134942|NCT02456818|Multi-resistant gram negative bacteria|multi-resistant gram negative bacteria
134943|NCT02456818|Infection control measures|infection control measures
134944|NCT02456818|Hand hygiene program|hand hygiene program
134945|NCT02456818|Contact precautions|contact precautions
134946|NCT02456818|Immunocompromised host|immunocompromised host
134947|NCT02456792|PCOS|pcos
134948|NCT02456792|Clomiphene citrate resistant|clomiphene citrate resistant
134949|NCT02456792|LOD|lod
134950|NCT02456792|IVF|ivf
134951|NCT02456779|pepsin|pepsin
134952|NCT02456779|peptest|peptest
134953|NCT02456779|GERD|gerd
134954|NCT02456779|NERD|nerd
134955|NCT02456779|diagnostic|diagnostic
134956|NCT02456766|FibroTouch|fibrotouch
135055|NCT02456168|Lupus|lupus
134957|NCT02456766|acoustic attenuation parameter|acoustic attenuation parameter
134958|NCT02456766|liver biopsy|liver biopsy
134959|NCT02456766|hepatic steatosis|hepatic steatosis
134960|NCT02456753|in labor|in labor
134961|NCT02456753|Ultrasonography|ultrasonography
134962|NCT02456753|clinical examination|clinical examination
134963|NCT02456753|Prenatal|prenatal
134964|NCT02456740|Migraine|migraine
134965|NCT02456740|Headache|headache
134966|NCT02456740|Prevention|prevention
134967|NCT02456740|Prophylaxis|prophylaxis
134968|NCT02456727|Acupuncture|acupuncture
654097|NCT00787644|Vermont|vermont
134969|NCT02456727|Group/Community Acupuncture|group/community acupuncture
134970|NCT02456727|Individual Acupuncture|individual acupuncture
134971|NCT02456727|Chronic Pain|chronic pain
134972|NCT02456727|Underserved|underserved
134973|NCT02456727|Urban Primary Care|urban primary care
134974|NCT02456727|Osteoarthritis|osteoarthritis
134975|NCT02456727|Back Pain|back pain
134976|NCT02456727|Neck Pain|neck pain
134977|NCT02456714|Cholangiocarcinoma|cholangiocarcinoma
134978|NCT02456714|FOLFIRINOX|folfirinox
134979|NCT02456714|Phase II study|phase ii study
134981|NCT02456675|Refractory Hodgkin lymphoma|refractory hodgkin lymphoma
134982|NCT02456675|Relapsed Hodgkin Lymphoma|relapsed hodgkin lymphoma
134983|NCT02456649|lumpectomy margins|lumpectomy margins
134984|NCT02456636|Weight loss|weight loss
134985|NCT02456636|Weight management|weight management
134986|NCT02456636|Diabetes|diabetes
134987|NCT02456636|Heart disease|heart disease
134988|NCT02456597|Peripheral Nerve Blocks|peripheral nerve blocks
134989|NCT02456584|depot medroxyprogesterone acetate (DMPA)|depot medroxyprogesterone acetate (dmpa)
134990|NCT02456584|confidence interval (CI)|confidence interval (ci)
134991|NCT02456584|Subcutaneous (sub-Q)|subcutaneous (sub-q)
134992|NCT02456584|Intrauterine device (IUD)|intrauterine device (iud)
134993|NCT02456584|Levonorgestrel (LNG)|levonorgestrel (lng)
134994|NCT02456584|intrauterine system (IUS)|intrauterine system (ius)
134995|NCT02456558|HIV infection|hiv infection
134996|NCT02456558|antiretroviral drugs|antiretroviral drugs
134997|NCT02456558|deferiprone|deferiprone
134998|NCT02456558|pharmacokinetics|pharmacokinetics
134999|NCT02456519|children|children
135000|NCT02456519|surgery|surgery
135001|NCT02456428|Incretins|incretins
135002|NCT02456428|Antidiabetic Agents|antidiabetic agents
135003|NCT02456428|Heart Failure|heart failure
135004|NCT02456389|Probable cancer|probable cancer
135005|NCT02456389|Proven cancer|proven cancer
135006|NCT02456389|Elective cancer surgery|elective cancer surgery
135007|NCT02456389|Postoperative death|postoperative death
135008|NCT02456389|Postoperative complications|postoperative complications
135009|NCT02456389|Healthcare utilization|healthcare utilization
135010|NCT02456389|Quality of life|quality of life
135011|NCT02456389|Adjuvant therapy|adjuvant therapy
135012|NCT02456389|Disease-free survival|disease-free survival
135013|NCT02456389|Overall survival|overall survival
135014|NCT02456376|Sensor Fusion|sensor fusion
135015|NCT02456376|Stochastic Resonance Stimulation|stochastic resonance stimulation
135016|NCT02456376|Sensory deficits|sensory deficits
135017|NCT02456376|Postural Control|postural control
135018|NCT02456363|Adalimumab|adalimumab
135019|NCT02456363|NSAIDs|nsaids
135020|NCT02456363|safety|safety
135021|NCT02456363|efficacy|efficacy
135022|NCT02456337|Gingival Recession|gingival recession
135023|NCT02456337|Coronally advanced flap|coronally advanced flap
135024|NCT02456337|Periodontal regeneration|periodontal regeneration
135025|NCT02456324|Fistula, Anorectal|fistula, anorectal
135026|NCT02456311|VATS|vats
135027|NCT02456311|Energy sealing|energy sealing
135028|NCT02456298|Telehealth|telehealth
135029|NCT02456298|Applied behavior analysis|applied behavior analysis
135030|NCT02456272|Otosclerosis|otosclerosis
135031|NCT02456272|Surgical treatment|surgical treatment
135032|NCT02456272|Hearing aids|hearing aids
162787|NCT02298608|Safety|safety
126046|NCT02507765|SBRT|sbrt
135033|NCT02456259|internal jugular vein patency|internal jugular vein patency
135034|NCT02456259|MICS|mics
135035|NCT02456259|neck cannula|neck cannula
135036|NCT02456259|Jugular veins|jugular veins
135037|NCT02456246|Stereotactive Body Radiation Therapy (SBRT)|stereotactive body radiation therapy (sbrt)
135038|NCT02456246|Lung Fibrosis|lung fibrosis
135039|NCT02456246|FLT-PET|flt-pet
135040|NCT02456246|NSCLC|nsclc
135041|NCT02456233|rotor|rotor
135042|NCT02456233|FIRM|firm
135043|NCT02456233|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
135044|NCT02456233|persistent atrial fibrillation|persistent atrial fibrillation
135045|NCT02456233|atrial tachyarrhythmia|atrial tachyarrhythmia
135046|NCT02456233|ablation|ablation
135047|NCT02456233|contact mapping|contact mapping
135048|NCT02456233|clinical trial|clinical trial
135049|NCT02456233|signal processing|signal processing
135050|NCT02456220|Herbst appliance|herbst appliance
135051|NCT02456220|Computed tomography|computed tomography
135052|NCT02456220|3D imaging|3d imaging
135053|NCT02456220|Growth and development|growth and development
135054|NCT02456220|Orthodontic Appliances, Functional|orthodontic appliances, functional
135056|NCT02456168|SLE|sle
135057|NCT02456155|bedside placement|bedside placement
135058|NCT02456155|nasal jejunal tube|nasal jejunal tube
135062|NCT02456155|efficacy|efficacy
135063|NCT02456155|safety|safety
135064|NCT02456129|Clinical Trial, Phase I|clinical trial, phase i
135067|NCT02456051|Pancreatic Carcinoma|pancreatic carcinoma
135068|NCT02456051|New-Onset Diabetes|new-onset diabetes
135069|NCT02456051|Adrenomedullin|adrenomedullin
135070|NCT02456051|Early Diagnosis|early diagnosis
135071|NCT02456051|Biological Markers|biological markers
135072|NCT02456012|peptic ulcer hemorrhage|peptic ulcer hemorrhage
135073|NCT02456012|comorbidity|comorbidity
135074|NCT02456012|clinical trial|clinical trial
135075|NCT02455973|obesity|obesity
135076|NCT02455973|overweight|overweight
135077|NCT02455947|Burnout|burnout
135078|NCT02455947|Teachers|teachers
135079|NCT02455947|Meditation|meditation
135080|NCT02455947|IBSR|ibsr
135081|NCT02455947|"The Work"|"the work"
135082|NCT02455947|Byron Katie|byron katie
135083|NCT02455895|Blepharitis|blepharitis
135084|NCT02455856|Healthy|healthy
135085|NCT02455856|Itraconazole|itraconazole
135086|NCT02455856|JNJ-42847922|jnj-42847922
135087|NCT02455843|microwave ablation|microwave ablation
135088|NCT02455843|chemotherapy|chemotherapy
135089|NCT02455830|Neonatal encephalopathy|neonatal encephalopathy
135090|NCT02455830|Hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
135091|NCT02455830|Newborn infants|newborn infants
135092|NCT02455830|Cytokines|cytokines
135093|NCT02455830|Trophic factors|trophic factors
135094|NCT02455791|Breast Cancer|breast cancer
135095|NCT02455791|Triple negative breast cancer|triple negative breast cancer
135096|NCT02455791|HER2 amplified breast cancer|her2 amplified breast cancer
135097|NCT02455791|Ultrasound-guided biopsy|ultrasound-guided biopsy
135098|NCT02455791|Fine needle aspirate|fine needle aspirate
135099|NCT02455791|FNA|fna
135100|NCT02455791|Core biopsy|core biopsy
135101|NCT02455752|LE-TME|le-tme
135102|NCT02455752|Laparoscopic rectal resection|laparoscopic rectal resection
135103|NCT02455752|Retroperitoneal resection|retroperitoneal resection
135104|NCT02455739|intestinal function|intestinal function
135105|NCT02455739|chewing gum|chewing gum
135106|NCT02455726|Peripheral Arterial Disease|peripheral arterial disease
135107|NCT02455726|Magnesium Oxide|magnesium oxide
135108|NCT02455726|Pain|pain
135109|NCT02455687|Bronchial asthma|bronchial asthma
135110|NCT02455687|Magnesium Sulfate|magnesium sulfate
135112|NCT02455674|weight estimation|weight estimation
135113|NCT02455674|emergency|emergency
135114|NCT02455674|child|child
135115|NCT02455635|Office Hysteroscopy|office hysteroscopy
135116|NCT02455635|tubal patency|tubal patency
135117|NCT02455635|infertility|infertility
135118|NCT02455635|Lower Abdominal Pain|lower abdominal pain
135119|NCT02455609|dexmedetomidine|dexmedetomidine
135120|NCT02455609|ketamine|ketamine
135121|NCT02455609|postoperative pain|postoperative pain
135122|NCT02455596|Novaferon|novaferon
135123|NCT02455596|Recombinant anti-tumor and anti-virus protein for injection|recombinant anti-tumor and anti-virus protein for injection
135124|NCT02455596|Carcinoid Tumor|carcinoid tumor
135125|NCT02455596|Pancreatic Neuroendocrine Tumor|pancreatic neuroendocrine tumor
135126|NCT02455583|HIV prevention|hiv prevention
135127|NCT02455583|Sexual activity biomarker|sexual activity biomarker
135128|NCT02455583|Youth|youth
135129|NCT02455583|Adolescents|adolescents
135130|NCT02455570|Endoscopic Ultrasound|endoscopic ultrasound
135131|NCT02455570|Quality Management|quality management
135132|NCT02455570|Education and training|education and training
135133|NCT02455570|Safety|safety
135134|NCT02455570|Learning curve|learning curve
135135|NCT02455544|Urine congophilia|urine congophilia
135136|NCT02455518|pain|pain
135137|NCT02455505|Cancer Care and Bereavement|cancer care and bereavement
135138|NCT02455505|Supportive Care|supportive care
135139|NCT02455505|15-095|15-095
135140|NCT02455492|Mortality|mortality
135141|NCT02455492|Perioperative period|perioperative period
135142|NCT02455492|Elective surgical procedures|elective surgical procedures
135143|NCT02455479|cocaine vaccine|cocaine vaccine
135144|NCT02455479|cocaine dependence|cocaine dependence
135145|NCT02455479|Cocaine|cocaine
135146|NCT02455440|esmolol|esmolol
135147|NCT02455440|anesthetics|anesthetics
135148|NCT02455427|transcranial direct current stimulation|transcranial direct current stimulation
135149|NCT02455427|conventional physical therapy|conventional physical therapy
135150|NCT02455401|Postoperative Vomiting|postoperative vomiting
135151|NCT02455388|Nutrition|nutrition
135152|NCT02455388|Obesity|obesity
135153|NCT02455388|Pediatric|pediatric
135154|NCT02455375|Puumala virus|puumala virus
135155|NCT02455375|diagnostic|diagnostic
135156|NCT02455375|France|france
135157|NCT02455336|tetraplegia|tetraplegia
135158|NCT02455336|paraplegia|paraplegia
135159|NCT02455336|hypertriglyceridemia|hypertriglyceridemia
135160|NCT02455336|hyperlipidemia|hyperlipidemia
135161|NCT02455336|peroxisome proliferator-activated receptor alpha|peroxisome proliferator-activated receptor alpha
135162|NCT02455323|Efficacy|efficacy
135163|NCT02455323|Tension-type headache|tension-type headache
135164|NCT02455323|Manual therapy|manual therapy
135165|NCT02455284|MRI|mri
135166|NCT02455284|Tractography|tractography
135167|NCT02455284|white|white
135168|NCT02455284|physiology|physiology
135169|NCT02455284|analysis|analysis
135170|NCT02455284|matter|matter
135171|NCT02455284|tracts|tracts
135172|NCT02455271|Insomnia|insomnia
135173|NCT02455258|Inactivity|inactivity
654098|NCT00787644|Pulmonary|pulmonary
135174|NCT02455180|Critical Care|critical care
135175|NCT02455167|HCV|hcv
135176|NCT02455167|Hepatitis C|hepatitis c
135177|NCT02455154|Chinese Traditional Medicine|chinese traditional medicine
135178|NCT02455154|Osteoporosis|osteoporosis
135179|NCT02455154|adjuvant endocrine therapy|adjuvant endocrine therapy
135180|NCT02455154|early breast cancer|early breast cancer
135181|NCT02455141|chemptherapy|chemptherapy
135182|NCT02455141|triple negative|triple negative
135183|NCT02455141|paclitaxel|paclitaxel
135184|NCT02455141|carboplatin|carboplatin
135185|NCT02455128|Anxiety|anxiety
135186|NCT02455128|Fear|fear
135187|NCT02455128|Colorectal Surgery|colorectal surgery
135188|NCT02455128|Colorectal Neoplasms|colorectal neoplasms
135189|NCT02455115|Acute kidney injury|acute kidney injury
135190|NCT02455115|Liver transplantation|liver transplantation
135191|NCT02455115|Postoperative care|postoperative care
135192|NCT02455115|Glomerular filtration rate|glomerular filtration rate
135193|NCT02455115|Renal blood flow|renal blood flow
135194|NCT02455115|Vasopressor|vasopressor
135195|NCT02455115|Norepinephrine|norepinephrine
135196|NCT02455102|Prevention|prevention
135197|NCT02455102|Anticoagulation|anticoagulation
135198|NCT02455102|Electronic warning system|electronic warning system
135199|NCT02455089|Flare|flare
135200|NCT02455089|Therapeutic adjustments|therapeutic adjustments
135201|NCT02455089|Biological Marker|biological marker
135202|NCT02455089|Immunologic Marker|immunologic marker
135203|NCT02455089|Prognosis|prognosis
135204|NCT02455076|Hypoglycemia|hypoglycemia
135205|NCT02455037|Concussion|concussion
135206|NCT02455037|Contact sport|contact sport
135207|NCT02455037|Collision sport|collision sport
135208|NCT02455037|Neck strengthening|neck strengthening
135209|NCT02455024|Leukemia|leukemia
135210|NCT02455024|Leukemia, Myeloid|leukemia, myeloid
135211|NCT02455024|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
135213|NCT02455024|Pharmacologic Actions|pharmacologic actions
135214|NCT02455024|Protein Kinase Inhibitors|protein kinase inhibitors
135215|NCT02455024|Risk factor|risk factor
135216|NCT02455024|Leukemia, Myelogenous, Chronic|leukemia, myelogenous, chronic
135217|NCT02455024|CML|cml
135218|NCT02455024|CP-CML|cp-cml
135219|NCT02455024|Iclusig|iclusig
135220|NCT02455024|AP24534|ap24534
135221|NCT02455024|AP-CML|ap-cml
135222|NCT02455024|BP-CML|bp-cml
135223|NCT02455024|Ph+ALL|ph+all
135224|NCT02454998|Unilateral complete cleft lip|unilateral complete cleft lip
135225|NCT02454998|Alveolar bone graft|alveolar bone graft
135226|NCT02454946|Blood Group Antigens|blood group antigens
135227|NCT02454946|erectile dysfunction|erectile dysfunction
135228|NCT02454933|Phase III Open Label Study; AZD9291 plus MEDI4736 versus AZD9291 Monotherapy; NSCLC After Previous EGFR TKI Therapy; T790M Mutation Positive Tumours.|phase iii open label study; azd9291 plus medi4736 versus azd9291 monotherapy; nsclc after previous egfr tki therapy; t790m mutation positive tumours.
135229|NCT02454920|Strabismus|strabismus
135230|NCT02454920|Optical Coherence Tomography|optical coherence tomography
135231|NCT02454920|Extraocular muscles|extraocular muscles
135232|NCT02454868|Remifentanil|remifentanil
135233|NCT02454868|Intubation|intubation
135234|NCT02454868|Children|children
135235|NCT02454855|quality of life|quality of life
135236|NCT02454855|melatonin|melatonin
135237|NCT02454855|Elderly patient|elderly patient
135238|NCT02454842|TH-4000|th-4000
135239|NCT02454842|low-oxygen conditions|low-oxygen conditions
135240|NCT02454842|hypoxia|hypoxia
135241|NCT02454842|non-small cell lung cancer|non-small cell lung cancer
135242|NCT02454842|NSCLC|nsclc
135243|NCT02454842|squamous cell carcinoma|squamous cell carcinoma
135244|NCT02454842|Tarloxotinib|tarloxotinib
135245|NCT02454829|Ovarian cortex cryopreservation|ovarian cortex cryopreservation
135246|NCT02454829|ovarian function|ovarian function
135247|NCT02454790|Acute toxicity|acute toxicity
135248|NCT02454790|Late toxicity|late toxicity
135249|NCT02454790|Prediction models|prediction models
135250|NCT02454738|pulmonary tuberculosis|pulmonary tuberculosis
135251|NCT02454738|chest|chest
135252|NCT02454738|ultralow dose computed tomography|ultralow dose computed tomography
135253|NCT02454725|HIV Testing|hiv testing
135254|NCT02454725|Latino|latino
135255|NCT02454712|Prodrug|prodrug
135256|NCT02454712|PF614|pf614
135257|NCT02454712|oxycodone extended-release|oxycodone extended-release
135258|NCT02454712|oral|oral
135259|NCT02454699|antiviral|antiviral
135260|NCT02454699|ascending dose|ascending dose
135261|NCT02454699|Cytomegalovirus|cytomegalovirus
135262|NCT02454699|food effect|food effect
135263|NCT02454699|Herpesviridae|herpesviridae
135264|NCT02454699|MBX-400|mbx-400
135265|NCT02454686|Complications after hepatectomy|complications after hepatectomy
135266|NCT02454673|Radiotherapy|radiotherapy
135267|NCT02454673|Neoadjuvant therapy|neoadjuvant therapy
135268|NCT02454673|Pharmacodynamics|pharmacodynamics
135269|NCT02454673|Pharmacokinetics|pharmacokinetics
135270|NCT02454673|Nonlinear Dynamics|nonlinear dynamics
135271|NCT02454660|adherence|adherence
654099|NCT00787644|Lung|lung
135272|NCT02454660|hypertension|hypertension
135273|NCT02454660|mobile technology|mobile technology
135274|NCT02454660|intervention|intervention
135275|NCT02454647|Radiotherapy|radiotherapy
135276|NCT02454647|Neoadjuvant therapy|neoadjuvant therapy
135277|NCT02454647|Induction chemotherapy|induction chemotherapy
135278|NCT02454647|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
135279|NCT02454647|Preoperative factors|preoperative factors
135280|NCT02454647|Dynamic factors|dynamic factors
135281|NCT02454647|Prognostic Factor|prognostic factor
135282|NCT02454634|IDH1R132H|idh1r132h
135283|NCT02454634|peptide vaccine|peptide vaccine
135284|NCT02454634|immunotherapy|immunotherapy
135285|NCT02454634|IDH1R132H-mutated glioma|idh1r132h-mutated glioma
135286|NCT02454556|Assisted reproduction technologies|assisted reproduction technologies
135287|NCT02454556|Follicle stimulating hormone (FSH).|follicle stimulating hormone (fsh).
135288|NCT02454543|metastatic|metastatic
135289|NCT02454543|prostatectomy|prostatectomy
135290|NCT02454543|androgen deprivation|androgen deprivation
135291|NCT02454543|best systemic therapy|best systemic therapy
135292|NCT02454504|Sugammadex|sugammadex
135293|NCT02454504|Delayed Emergence from Anesthesia|delayed emergence from anesthesia
135294|NCT02454504|Curare|curare
135295|NCT02454504|Robotic Surgical Procedures|robotic surgical procedures
135296|NCT02454491|percutaneous coronary interventions|percutaneous coronary interventions
135297|NCT02454491|radial artery access|radial artery access
135298|NCT02454491|access site complications|access site complications
135299|NCT02454491|verapamil|verapamil
135300|NCT02454491|heparin|heparin
135301|NCT02454478|lenvatinib|lenvatinib
135302|NCT02454478|Everolimus|everolimus
135303|NCT02454478|Carcinoma|carcinoma
135304|NCT02454478|Unresectable advanced renal cell carcinoma|unresectable advanced renal cell carcinoma
135305|NCT02454478|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
135306|NCT02454452|Varicose Veins|varicose veins
135956|NCT02450240|Anxiety|anxiety
135307|NCT02454439|Heart Failure with reduced ejection fraction (<35%)|heart failure with reduced ejection fraction (<35%)
135308|NCT02454439|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
135309|NCT02454439|Non specific intraventricular conduction|non specific intraventricular conduction
135310|NCT02454439|Efficacy|efficacy
135311|NCT02454439|Life expectancy expected to exceed one year with a good functional status|life expectancy expected to exceed one year with a good functional status
135312|NCT02454439|QRS morphology : NICD according to the AHA/ACCF/HRS Recommendations (non-LBBB and non-RBBB):|qrs morphology : nicd according to the aha/accf/hrs recommendations (non-lbbb and non-rbbb):
135313|NCT02454439|QRS duration > 130 ms|qrs duration > 130 ms
135314|NCT02454426|Depression|depression
135315|NCT02454426|Heart disease|heart disease
135316|NCT02454413|dentures hygiene|dentures hygiene
135317|NCT02454413|biofilm formation|biofilm formation
135318|NCT02454413|oral health|oral health
135319|NCT02454400|physical therapy|physical therapy
135320|NCT02454400|lumbar spine surgery|lumbar spine surgery
135321|NCT02454400|pre-surgical intervention|pre-surgical intervention
135322|NCT02454400|RCT|rct
135323|NCT02454374|Physiotherapy|physiotherapy
135324|NCT02454374|Knee Loading|knee loading
135325|NCT02454374|Randomised Controlled Trial|randomised controlled trial
135326|NCT02454374|Pain|pain
135327|NCT02454361|Safety|safety
135328|NCT02454361|tolerability|tolerability
135329|NCT02454361|pharmacokinetics|pharmacokinetics
135330|NCT02454361|KBP-7072|kbp-7072
135331|NCT02454348|septic shock|septic shock
135332|NCT02454348|vasopressin|vasopressin
135333|NCT02454348|norepinephrine|norepinephrine
135334|NCT02454296|Laminaria|laminaria
135335|NCT02454270|First-in-Human|first-in-human
135336|NCT02454270|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
135337|NCT02454270|Diffuse Large-Cell Lymphoma|diffuse large-cell lymphoma
135338|NCT02454270|Follicular Lymphoma|follicular lymphoma
135339|NCT02454270|Mantle-Cell Lymphoma|mantle-cell lymphoma
135340|NCT02454270|Acute Lymphoid Leukemia|acute lymphoid leukemia
135341|NCT02454270|Dose Escalation Study|dose escalation study
135342|NCT02454270|Duvortuxizumab|duvortuxizumab
135343|NCT02454231|EPC|epc
135344|NCT02454231|CD34+|cd34+
135345|NCT02454231|CD14+CD34low|cd14+cd34low
135346|NCT02454218|Fibromyalgia|fibromyalgia
135347|NCT02454218|Transcranial direct current stimulation|transcranial direct current stimulation
135348|NCT02454192|Evidence-based intervention|evidence-based intervention
135349|NCT02454192|Implementation|implementation
135350|NCT02454192|Underserved communities|underserved communities
135351|NCT02454127|nutrition|nutrition
135352|NCT02454127|popular diets|popular diets
135353|NCT02454127|weight loss|weight loss
135354|NCT02454127|lifestyle|lifestyle
135355|NCT02454127|counseling|counseling
135357|NCT02454114|Community|community
135358|NCT02454114|Hospital|hospital
135359|NCT02454114|Respiratory|respiratory
135360|NCT02454114|Infection|infection
135361|NCT02454088|Volume|volume
135362|NCT02454088|Hands|hands
135363|NCT02454088|Filler|filler
135364|NCT02454088|Radiesse|radiesse
135365|NCT02454088|Calcium hydroxylapatite|calcium hydroxylapatite
135366|NCT02454075|YF476|yf476
135367|NCT02454075|netazepide|netazepide
135368|NCT02454075|gastric carcinoids|gastric carcinoids
135369|NCT02454075|Zollinger-Ellison syndrome|zollinger-ellison syndrome
135370|NCT02454062|Phase I|phase i
135371|NCT02454062|Solid Tumors|solid tumors
135372|NCT02454062|Pharmacokinetics|pharmacokinetics
135373|NCT02454062|Pharmacodynamics|pharmacodynamics
135374|NCT02454062|MTD|mtd
135375|NCT02454023|Stroke|stroke
135376|NCT02454023|Transient ischemic attack|transient ischemic attack
135377|NCT02454023|Obstructive sleep apnea|obstructive sleep apnea
135378|NCT02454023|Portable sleep monitor|portable sleep monitor
135379|NCT02454023|Screening|screening
135380|NCT02453997|lupus nephritis|lupus nephritis
135381|NCT02453997|mycophenolic acid|mycophenolic acid
135382|NCT02453997|pharmacokinetics|pharmacokinetics
135383|NCT02453997|pharmacogenomics|pharmacogenomics
135384|NCT02453984|89Zr-MPLD3280A-PET|89zr-mpld3280a-pet
135385|NCT02453984|triple-negative breast cancer|triple-negative breast cancer
135386|NCT02453984|non small cell lung cancer|non small cell lung cancer
135387|NCT02453984|bladder cancer|bladder cancer
135388|NCT02453971|alcohol consumption|alcohol consumption
135389|NCT02453971|binge drinking|binge drinking
135390|NCT02453971|web-based personalized feedback program|web-based personalized feedback program
135391|NCT02453971|students|students
135392|NCT02453958|Injury|injury
135393|NCT02453958|Brain|brain
135394|NCT02453958|Traumatic Mild|traumatic mild
135395|NCT02453958|Mild Traumatic Brain Injury|mild traumatic brain injury
135396|NCT02453945|pain|pain
135397|NCT02453945|comfort|comfort
135398|NCT02453945|healing|healing
135399|NCT02453945|quality of life|quality of life
135400|NCT02453932|Vascular dementia|vascular dementia
135401|NCT02453932|Tianzhi granule|tianzhi granule
135402|NCT02453932|Herbal medicine|herbal medicine
135403|NCT02453932|Randomized controlled trial|randomized controlled trial
135404|NCT02453932|Three arms|three arms
135405|NCT02453919|functional cardiac abnormality|functional cardiac abnormality
135406|NCT02453919|morphologic cardiac abnormality|morphologic cardiac abnormality
135407|NCT02453919|blood pressure abnormality|blood pressure abnormality
135408|NCT02453893|Iloperidone|iloperidone
135409|NCT02453893|Risperidone|risperidone
135410|NCT02453893|PANSS|panss
135411|NCT02453880|anxiety|anxiety
135412|NCT02453880|depression|depression
135413|NCT02453880|chronic illness|chronic illness
135414|NCT02453880|teen|teen
135415|NCT02453880|young adult|young adult
135416|NCT02453867|kidney transplantation|kidney transplantation
135417|NCT02453867|senior kidney transplant recipients|senior kidney transplant recipients
135418|NCT02453867|tacrolimus once daily|tacrolimus once daily
135419|NCT02453867|reduced immunosuppression|reduced immunosuppression
135420|NCT02453867|recipients >65 years|recipients >65 years
135421|NCT02453867|Senior|senior
135422|NCT02453802|Tranexamic Acid|tranexamic acid
135423|NCT02453802|Total Knee Arthroplasty|total knee arthroplasty
135424|NCT02453802|Rivaroxaban|rivaroxaban
135425|NCT02453789|alginate oligosaccharide|alginate oligosaccharide
135426|NCT02453789|cystic fibrosis|cystic fibrosis
135427|NCT02453789|Burkholderia|burkholderia
135428|NCT02453789|aztreonam|aztreonam
135429|NCT02453776|Crohns Disease|crohns disease
135430|NCT02453776|Ulcerative Colitis|ulcerative colitis
163278|NCT02295592|PPH|pph
135431|NCT02453776|Infliximab|infliximab
135432|NCT02453776|Sustained|sustained
135433|NCT02453776|Remission|remission
135434|NCT02453776|Inflammatory bowel disease|inflammatory bowel disease
135435|NCT02453776|IBD|ibd
135436|NCT02453763|Transcranial direct current stimulation|transcranial direct current stimulation
135437|NCT02453763|Noninvasive brain stimulation|noninvasive brain stimulation
135438|NCT02453763|Brain|brain
135439|NCT02453763|Central Nervous System Diseases|central nervous system diseases
135440|NCT02453763|Nervous System Diseases|nervous system diseases
135441|NCT02453763|Parkinson disease|parkinson disease
135442|NCT02453763|Stroke|stroke
135443|NCT02453763|Epilepsy|epilepsy
135444|NCT02453763|Depression|depression
135445|NCT02453763|Schizophrenia|schizophrenia
135446|NCT02453763|Brain imaging|brain imaging
135447|NCT02453763|Electrical impedance tomography|electrical impedance tomography
135448|NCT02453763|Magnetic resonance electrical impedance tomography|magnetic resonance electrical impedance tomography
135449|NCT02453763|Diffusion tensor imaging|diffusion tensor imaging
135450|NCT02453763|Functional magnetic imaging|functional magnetic imaging
135451|NCT02453763|Rehabilitation|rehabilitation
135452|NCT02453750|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
135453|NCT02453750|Airway Inflammation|airway inflammation
135454|NCT02453750|Asthma|asthma
135455|NCT02453750|Hypersaline|hypersaline
135456|NCT02453750|Pediatrics|pediatrics
135465|NCT02453698|Stop task|stop task
135466|NCT02453698|modulatory effect of MPH|modulatory effect of mph
135467|NCT02453698|bottom-up and top-down|bottom-up and top-down
135468|NCT02453698|cognitive processes|cognitive processes
135469|NCT02453633|Appointment reminder|appointment reminder
135470|NCT02453633|Attendance|attendance
135471|NCT02453633|No-show|no-show
135472|NCT02453594|PD1|pd1
135473|NCT02453594|PD-1|pd-1
135474|NCT02453594|PDL1|pdl1
135475|NCT02453594|PD-L1|pd-l1
135476|NCT02453542|hemophilia|hemophilia
135477|NCT02453542|inhibitors|inhibitors
135478|NCT02453542|thrombin|thrombin
135479|NCT02453529|plasma concentration|plasma concentration
135480|NCT02453529|pulmonary concentration|pulmonary concentration
135481|NCT02453516|Serratus Block|serratus block
135482|NCT02453516|Breast Surgery|breast surgery
135483|NCT02453503|Lichen planus|lichen planus
135484|NCT02453503|Mucoadhesive film|mucoadhesive film
135485|NCT02453503|licorice|licorice
135486|NCT02453490|Colorectal Cancer|colorectal cancer
135487|NCT02453490|liver metastasis|liver metastasis
135488|NCT02453490|neoadjuvant chemotherapy|neoadjuvant chemotherapy
135489|NCT02453477|Beta thalassemia|beta thalassemia
135490|NCT02453477|Gene therapy|gene therapy
135491|NCT02453477|Lentiviral vector|lentiviral vector
135492|NCT02453451|MitraClip|mitraclip
135493|NCT02453451|atrial septal defect|atrial septal defect
135494|NCT02453451|iatrogenic|iatrogenic
135495|NCT02453425|renal blood flow|renal blood flow
135496|NCT02453425|renal oxygenation|renal oxygenation
135497|NCT02453425|glomerular filtration rate|glomerular filtration rate
135498|NCT02453425|filtration fraction|filtration fraction
135499|NCT02453425|blood pressure|blood pressure
135500|NCT02453412|Arteriovenous fistulae (AVFs)|arteriovenous fistulae (avfs)
135501|NCT02453412|Non-maturation|non-maturation
135502|NCT02453412|Computational simulation|computational simulation
135503|NCT02453386|Motor fluctuations|motor fluctuations
135504|NCT02453386|Off time|off time
135505|NCT02453386|On time|on time
135506|NCT02453386|Dyskinesia|dyskinesia
135507|NCT02453360|Anesthesia|anesthesia
135508|NCT02453360|Analgesia|analgesia
135509|NCT02453347|Stable chronic medical conditions|stable chronic medical conditions
135510|NCT02453347|No current alcohol or substance abuse|no current alcohol or substance abuse
135511|NCT02453347|Alpha Stim|alpha stim
135512|NCT02453321|Continuous Femoral Nerve Block|continuous femoral nerve block
135513|NCT02453321|Continuous Adductor Canal Block|continuous adductor canal block
135514|NCT02453308|Artemisinin combination Therapies|artemisinin combination therapies
135516|NCT02453295|Arm Disability|arm disability
135517|NCT02453295|Cancer Survivorship|cancer survivorship
135518|NCT02453295|Intervention|intervention
135519|NCT02453282|NSCLC, PD-L1, MEDI4736, Tremelimumab, PFS, OS|nsclc, pd-l1, medi4736, tremelimumab, pfs, os
135520|NCT02453269|Obesity|obesity
135521|NCT02453269|Children|children
135522|NCT02453269|Health Colective|health colective
135523|NCT02453243|Suicide screening in the ED|suicide screening in the ed
135524|NCT02453243|Safety Planning|safety planning
135525|NCT02453217|severe mental illness|severe mental illness
135526|NCT02453217|physical health screening|physical health screening
135527|NCT02453217|randomised controlled trial|randomised controlled trial
135528|NCT02453217|health behaviour change|health behaviour change
135529|NCT02453178|physical activity|physical activity
135530|NCT02453178|aging|aging
135531|NCT02453178|cognition|cognition
135532|NCT02453178|brain|brain
135533|NCT02453178|exercise|exercise
135534|NCT02453165|vaginal dehiscence|vaginal dehiscence
135535|NCT02453152|myotubular myopathy|myotubular myopathy
135536|NCT02453152|respiratory muscles|respiratory muscles
135537|NCT02453152|natural history|natural history
135538|NCT02453126|Eosinophilic Esophagitis|eosinophilic esophagitis
135539|NCT02453126|Esophageal Stricture|esophageal stricture
135540|NCT02453048|Pertussis|pertussis
135541|NCT02453048|Colonization|colonization
135542|NCT02453048|Vaccine|vaccine
135543|NCT02453048|Immune response|immune response
135544|NCT02453048|BPZE1|bpze1
135545|NCT02453048|Infection|infection
135546|NCT02453048|Bordetella pertussis|bordetella pertussis
135547|NCT02453048|B. pertussis|b. pertussis
135548|NCT02453048|respiratory Tract Infection|respiratory tract infection
135549|NCT02453035|bioresorbable scaffold|bioresorbable scaffold
135550|NCT02453035|CAD|cad
135551|NCT02453022|Bioavailability|bioavailability
135552|NCT02453022|Omeprazole|omeprazole
135553|NCT02453022|Danirixin|danirixin
135554|NCT02453022|Food Effect|food effect
135555|NCT02453022|Pharmacokinetics|pharmacokinetics
135556|NCT02452996|GNbAC1|gnbac1
135557|NCT02452996|Multiple Sclerosis|multiple sclerosis
135654|NCT02452203|floating|floating
135558|NCT02452996|Multiple Sclerosis Associated Retrovirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
135559|NCT02452996|MSRV-Envelope protein|msrv-envelope protein
135560|NCT02452996|Monoclonal antibody|monoclonal antibody
135562|NCT02452983|Leukemia|leukemia
135563|NCT02452983|Hematologic diseases|hematologic diseases
135564|NCT02452983|Cytopenias|cytopenias
135565|NCT02452983|Bone marrow diseases|bone marrow diseases
135566|NCT02452983|Preleukemia|preleukemia
135567|NCT02452944|nerve stimulator, obturator nerve, ultrasound|nerve stimulator, obturator nerve, ultrasound
135568|NCT02452918|skin infection|skin infection
135569|NCT02452892|Depression|depression
135570|NCT02452892|Major depression|major depression
135571|NCT02452892|Low-field magnetic stimulation|low-field magnetic stimulation
135572|NCT02452892|LFMS|lfms
135573|NCT02452840|neovascular age-related macular degeneration|neovascular age-related macular degeneration
135574|NCT02452840|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
135575|NCT02452840|verteporfin|verteporfin
135576|NCT02452840|photodynamic therapy|photodynamic therapy
135577|NCT02452840|persistent disease activity|persistent disease activity
135578|NCT02452710|Fatigue in Cancer Survivors|fatigue in cancer survivors
135579|NCT02452697|Nonmyeloablative|nonmyeloablative
135580|NCT02452697|Stem Cell|stem cell
135581|NCT02452697|Transplant|transplant
135582|NCT02452684|Insomnia|insomnia
135583|NCT02452658|Fast food literacy|fast food literacy
135584|NCT02452645|Food|food
135585|NCT02452645|Nutrition|nutrition
135586|NCT02452645|Physical Activity|physical activity
135587|NCT02452645|Family|family
135588|NCT02452645|Child Care|child care
135589|NCT02452645|Home|home
135590|NCT02452645|Environment|environment
135591|NCT02452632|ASP1941|asp1941
135592|NCT02452632|Type 2 diabetes mellitus|type 2 diabetes mellitus
135593|NCT02452619|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
135594|NCT02452619|brain trauma|brain trauma
135595|NCT02452619|cognitive impairment|cognitive impairment
135596|NCT02452606|Stalevo|stalevo
135597|NCT02452606|sleep disturbance|sleep disturbance
135598|NCT02452606|central circadian clock|central circadian clock
135599|NCT02452606|narcolepsy|narcolepsy
135600|NCT02452593|incontinence; pelvic floor exercises; neuromodulation|incontinence; pelvic floor exercises; neuromodulation
135601|NCT02452580|Kangaroo Mother Care|kangaroo mother care
135602|NCT02452580|Neonatal Intensive Care Units|neonatal intensive care units
135603|NCT02452580|Postnatal growth|postnatal growth
135604|NCT02452541|Traumatic Brain Injury|traumatic brain injury
135605|NCT02452541|Critically ill Patients|critically ill patients
135606|NCT02452541|Death|death
135607|NCT02452541|Head Injury|head injury
135608|NCT02452541|TBI-Prognosis|tbi-prognosis
135609|NCT02452541|Critical Care Medicine|critical care medicine
135610|NCT02452541|Withdrawal of Life Sustaining Therapy|withdrawal of life sustaining therapy
135611|NCT02452541|Prognosis|prognosis
135612|NCT02452541|Prognostic Evaluation|prognostic evaluation
135613|NCT02452541|Outcome Research|outcome research
135614|NCT02452541|Mortality|mortality
135615|NCT02452541|Decision-making|decision-making
135616|NCT02452528|Hepatitis B Virus|hepatitis b virus
135617|NCT02452528|Chronic Hepatitis B|chronic hepatitis b
135619|NCT02452502|stroke|stroke
135620|NCT02452502|thrombolytic therapy|thrombolytic therapy
135621|NCT02452502|atorvastatin|atorvastatin
135622|NCT02452489|Different acupoints compatibility|different acupoints compatibility
135623|NCT02452437|oxycodone|oxycodone
135624|NCT02452437|hemodialysis|hemodialysis
135625|NCT02452411|Internet|internet
135626|NCT02452411|Adjustment disorders|adjustment disorders
135627|NCT02452411|Homework assignments|homework assignments
135628|NCT02452411|Cognitive-Behavioral treatment|cognitive-behavioral treatment
135629|NCT02452411|Online therapy|online therapy
135630|NCT02452411|Emotional Regulation|emotional regulation
135631|NCT02452411|ICT's|ict's
135632|NCT02452398|Hair removal|hair removal
135633|NCT02452398|depilation|depilation
135634|NCT02452398|epilation|epilation
135635|NCT02452372|RNAi therapeutic|rnai therapeutic
135636|NCT02452372|Porphyria|porphyria
135637|NCT02452372|AIP|aip
135638|NCT02452359|stretch marks|stretch marks
135639|NCT02452346|MDS|mds
135640|NCT02452333|Excisional breast biopsy|excisional breast biopsy
135641|NCT02452333|Oncoplastic surgery|oncoplastic surgery
135642|NCT02452333|Oncoplastic reconstruction|oncoplastic reconstruction
135643|NCT02452333|Breast conserving surgery|breast conserving surgery
135644|NCT02452333|Tezel method of breast volume measurement|tezel method of breast volume measurement
135645|NCT02452320|bariatric|bariatric
135646|NCT02452320|Post-operative nausea and vomiting|post-operative nausea and vomiting
135647|NCT02452320|laparoscopic Sleeve gastrectomy|laparoscopic sleeve gastrectomy
135648|NCT02452320|intravenous acetaminophen|intravenous acetaminophen
135649|NCT02452294|Brain|brain
135650|NCT02452281|Therapeutically Unresectable|therapeutically unresectable
135651|NCT02452281|Stage III or Stage IV|stage iii or stage iv
135652|NCT02452281|Malignant Melanoma|malignant melanoma
135653|NCT02452281|Advanced Melanoma|advanced melanoma
135655|NCT02452203|interoception|interoception
135656|NCT02452177|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
135657|NCT02452177|vitamin D|vitamin d
135658|NCT02452177|short bowel syndrome|short bowel syndrome
135659|NCT02452177|farnesoid X receptor|farnesoid x receptor
135660|NCT02452177|cholestasis|cholestasis
135661|NCT02452164|otoscopy|otoscopy
135662|NCT02452164|otitis media|otitis media
135663|NCT02452164|cellphone|cellphone
135664|NCT02452164|family|family
135665|NCT02452151|Inflectra|inflectra
135666|NCT02452151|Infliximab|infliximab
135667|NCT02452151|Biosimilar|biosimilar
135668|NCT02452099|DMSO|dmso
135669|NCT02452099|cryopreservation|cryopreservation
135670|NCT02452099|autologous transplantation|autologous transplantation
135671|NCT02452099|hematopoietic stem cells|hematopoietic stem cells
135672|NCT02452099|hematological malignancies|hematological malignancies
135673|NCT02452073|low triiodothyronine syndrome|low triiodothyronine syndrome
135674|NCT02452073|chronic radiation enteritis|chronic radiation enteritis
135675|NCT02452073|triiodothyronine|triiodothyronine
135676|NCT02452073|thyroxine|thyroxine
135677|NCT02452073|thyroid stimulating hormone|thyroid stimulating hormone
135678|NCT02452060|perioperative period|perioperative period
135679|NCT02452060|pain|pain
135680|NCT02452060|gastric bypass|gastric bypass
135681|NCT02452008|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
135682|NCT02452008|enzalutamide|enzalutamide
135683|NCT02452008|LY2157299|ly2157299
135684|NCT02452008|TGF-β receptor inhibitor|tgf-β receptor inhibitor
135685|NCT02451943|leiomyosarcoma|leiomyosarcoma
135686|NCT02451943|soft tissue sarcoma (STS)|soft tissue sarcoma (sts)
135687|NCT02451943|advanced soft tissue sarcoma|advanced soft tissue sarcoma
135688|NCT02451943|metastatic soft tissue sarcoma|metastatic soft tissue sarcoma
135689|NCT02451943|liposarcoma|liposarcoma
135690|NCT02451943|undifferentiated pleomorphic sarcoma|undifferentiated pleomorphic sarcoma
135691|NCT02451943|doxorubicin|doxorubicin
135692|NCT02451917|Glargine insulin|glargine insulin
135693|NCT02451917|Chronic Kidney Disease|chronic kidney disease
135694|NCT02451917|CGMS|cgms
135695|NCT02451904|Pathogenesis|pathogenesis
135696|NCT02451904|Microvascular function|microvascular function
135697|NCT02451904|Metabolic dysregulation|metabolic dysregulation
135698|NCT02451904|Metabolomics|metabolomics
135699|NCT02451878|shyness|shyness
135700|NCT02451878|internet|internet
135701|NCT02451878|self-help|self-help
135702|NCT02451878|psychology|psychology
135703|NCT02451878|wellbeing|wellbeing
135704|NCT02451839|Adalimumab|adalimumab
135705|NCT02451839|Quality of Life|quality of life
135706|NCT02451839|Crohn Disease|crohn disease
135707|NCT02451839|Patient Outcome Assessment|patient outcome assessment
135708|NCT02451839|Psoriasis|psoriasis
135709|NCT02451839|Global Health|global health
135711|NCT02451826|ovulation inhibition|ovulation inhibition
135712|NCT02451826|endometrial changes|endometrial changes
135713|NCT02451826|bleeding patterns|bleeding patterns
135714|NCT02451813|opening injection pressure|opening injection pressure
135715|NCT02451813|femoral nerve block|femoral nerve block
135716|NCT02451813|fascia iliaca|fascia iliaca
135717|NCT02451813|ultrasound guided nerve block|ultrasound guided nerve block
135718|NCT02451774|pediatric|pediatric
135719|NCT02451774|apoptosis|apoptosis
135720|NCT02451761|chromosomal rearrangement|chromosomal rearrangement
135721|NCT02451761|next generation sequencing|next generation sequencing
135722|NCT02451761|intellectual disability|intellectual disability
135723|NCT02451761|multiple congenital anomalies|multiple congenital anomalies
135724|NCT02451761|gene disruption|gene disruption
135725|NCT02451735|female breast cancer|female breast cancer
135726|NCT02451735|bilateral breast cancer|bilateral breast cancer
135727|NCT02451735|triple negative breast cancer|triple negative breast cancer
135728|NCT02451735|breast cancer diagnosis|breast cancer diagnosis
135730|NCT02451735|BRCA 2|brca 2
135731|NCT02451735|psychoeducational intervention (PEI)|psychoeducational intervention (pei)
135732|NCT02451735|genetic counseling|genetic counseling
135733|NCT02451735|hereditary breast and ovarian cancer (HBOC)|hereditary breast and ovarian cancer (hboc)
135734|NCT02451735|cancer education materials|cancer education materials
135736|NCT02451631|Mobile Application|mobile application
135737|NCT02451631|Diabetes management|diabetes management
135738|NCT02451618|Perinatal Depression|perinatal depression
135739|NCT02451605|surgery|surgery
135740|NCT02451592|Fungemia|fungemia
135741|NCT02451592|Hematologic malignancies|hematologic malignancies
135742|NCT02451579|Actinic Keratoses|actinic keratoses
135743|NCT02451579|Photodynamic Therapy|photodynamic therapy
135744|NCT02451579|PDT|pdt
135745|NCT02451579|Blue Light|blue light
135746|NCT02451566|Abdominal|abdominal
135747|NCT02451566|Aortic|aortic
135748|NCT02451566|Aneurysm|aneurysm
135749|NCT02451540|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
135750|NCT02451540|dynamics hyperinflation|dynamics hyperinflation
136650|NCT02445950|Lifestyle|lifestyle
135751|NCT02451540|Computed Tomography scan|computed tomography scan
135752|NCT02451540|CT scan|ct scan
135753|NCT02451540|Functional Respiratory Imaging|functional respiratory imaging
135754|NCT02451540|FRI|fri
135755|NCT02451540|Roflumilast|roflumilast
135756|NCT02451540|PRO|pro
135757|NCT02451514|Antibody persistence|antibody persistence
135758|NCT02451514|Young Adults|young adults
135759|NCT02451514|Healthy Adolescents|healthy adolescents
135760|NCT02451514|MenABCWY vaccine|menabcwy vaccine
135761|NCT02451514|Booster response|booster response
135762|NCT02451514|MenABCWY+OMV|menabcwy+omv
135763|NCT02451475|Pregabalin|pregabalin
135764|NCT02451475|Fibromyalgia|fibromyalgia
135765|NCT02451462|hematopoietic stem cell transplant|hematopoietic stem cell transplant
135766|NCT02451462|bone marrow transplant|bone marrow transplant
135767|NCT02451449|Celiac disease|celiac disease
135768|NCT02451449|Infertility|infertility
135769|NCT02451449|Prevalence study|prevalence study
135770|NCT02451436|Adolescents, sleep, media use, obesity, type 2 diabetes|adolescents, sleep, media use, obesity, type 2 diabetes
135771|NCT02451423|Non-metastatic|non-metastatic
135772|NCT02451423|Bladder|bladder
135773|NCT02451410|Nutrition|nutrition
135774|NCT02451410|Physical activity|physical activity
135775|NCT02451410|Overweight|overweight
135776|NCT02451410|Obesity|obesity
135777|NCT02451410|Malnutrition|malnutrition
135778|NCT02451371|Schizophrenia|schizophrenia
135779|NCT02451371|Refractory auditory hallucination|refractory auditory hallucination
135780|NCT02451371|tDCS|tdcs
135781|NCT02451358|Influenza|influenza
135782|NCT02451358|Quadrivalent Inactivated Influenza Vaccine (QIV)|quadrivalent inactivated influenza vaccine (qiv)
135783|NCT02451345|Prostate cancer|prostate cancer
135784|NCT02451345|Tranformative Impact Award|tranformative impact award
135785|NCT02451345|Early stage|early stage
135786|NCT02451345|Active Surveillance|active surveillance
135787|NCT02451345|Decision aid|decision aid
135788|NCT02451345|Coaching session|coaching session
135789|NCT02451345|Personalized|personalized
135790|NCT02451345|UCSF|ucsf
135791|NCT02451345|validation|validation
135792|NCT02451319|RIRS, holmium, 1-2 cm,stones,kidney|rirs, holmium, 1-2 cm,stones,kidney
135793|NCT02451293|Depression|depression
135794|NCT02451293|Acute Coronary Syndrome|acute coronary syndrome
135795|NCT02451293|Anxiety|anxiety
135796|NCT02451293|Sleep|sleep
135797|NCT02451293|Circadian|circadian
135798|NCT02451280|stroke rehabilitation|stroke rehabilitation
135799|NCT02451280|robot-assisted therapy|robot-assisted therapy
135800|NCT02451280|hybrid therapy|hybrid therapy
135801|NCT02451267|neck pain|neck pain
135802|NCT02451267|aerobic exercise|aerobic exercise
135803|NCT02451267|cervical pain|cervical pain
135804|NCT02451241|Acupuncture|acupuncture
135805|NCT02451228|Pharmacokinetics|pharmacokinetics
135806|NCT02451228|Pharmacodynamics|pharmacodynamics
135807|NCT02451228|Preterm labor|preterm labor
135808|NCT02451228|Preterm birth|preterm birth
135809|NCT02451228|Estradiol|estradiol
135810|NCT02451228|Indomethacin|indomethacin
135811|NCT02451228|Pregnancy|pregnancy
135812|NCT02451228|Short Cervix|short cervix
135813|NCT02451228|CYP2C9 Genotype|cyp2c9 genotype
135814|NCT02451202|"surgical conditions"|"surgical conditions"
135815|NCT02451202|"deep neuromuscular blockade"|"deep neuromuscular blockade"
135816|NCT02451202|"deep neuromuscular paralysis"|"deep neuromuscular paralysis"
135818|NCT02451189|Weight maintenance|weight maintenance
135819|NCT02451189|Appetite|appetite
135820|NCT02451189|Energy intake|energy intake
135821|NCT02451189|Dietary fibre|dietary fibre
135822|NCT02451189|Short-chain fatty acids|short-chain fatty acids
135823|NCT02451189|Fermentation|fermentation
135824|NCT02451189|Overweight|overweight
135825|NCT02451150|Drug therapy|drug therapy
135826|NCT02451124|Barrett|barrett
135827|NCT02451124|Cancer|cancer
135828|NCT02451124|Screening|screening
135829|NCT02451111|Rituximab|rituximab
135830|NCT02451111|Ibrutinib|ibrutinib
126838|NCT02503215|Compression stockings|compression stockings
126839|NCT02503189|Dry eye syndromes|dry eye syndromes
126840|NCT02503189|Corneal diseases|corneal diseases
135831|NCT02451111|Follicular Lymphoma|follicular lymphoma
135832|NCT02451085|hip|hip
135833|NCT02451085|surgery|surgery
135834|NCT02451085|Replacement|replacement
135835|NCT02451059|community resource|community resource
135836|NCT02451059|well-child care visit|well-child care visit
135837|NCT02451059|low-income|low-income
135838|NCT02451046|Liver transplantation|liver transplantation
135839|NCT02451046|Primary dysfunction|primary dysfunction
135840|NCT02451033|Regenerative medicine|regenerative medicine
135841|NCT02451020|healthy volunteers|healthy volunteers
135842|NCT02451020|acclimatization|acclimatization
135843|NCT02451020|sleep|sleep
135844|NCT02451020|hypoxia|hypoxia
135845|NCT02450994|airway disease|airway disease
135846|NCT02450994|bronchitis|bronchitis
135847|NCT02450994|emphysema|emphysema
135848|NCT02450994|lung|lung
135849|NCT02450994|treatment|treatment
135850|NCT02450994|sleep|sleep
135851|NCT02450968|airway disease|airway disease
135852|NCT02450968|bronchitis|bronchitis
135853|NCT02450968|emphysema|emphysema
135854|NCT02450968|lung|lung
135855|NCT02450968|treatment|treatment
135856|NCT02450955|Tension-type headache|tension-type headache
135857|NCT02450955|manual therapy|manual therapy
135858|NCT02450955|disability|disability
135859|NCT02450955|spinal manipulation|spinal manipulation
135860|NCT02450929|post operative|post operative
135861|NCT02450929|pneumonia|pneumonia
135862|NCT02450929|vascular|vascular
135863|NCT02450929|orthopedic|orthopedic
135864|NCT02450929|urologic|urologic
135865|NCT02450929|neurologic|neurologic
135866|NCT02450916|work-related injury|work-related injury
135867|NCT02450916|occupational disease|occupational disease
135868|NCT02450916|workers' compensation|workers' compensation
135869|NCT02450916|psychological|psychological
135871|NCT02450903|Non-Small-Cell Lung Cancer, ALK, LDK378|non-small-cell lung cancer, alk, ldk378
135872|NCT02450890|ORADUR®-Methylphenidate|oradur®-methylphenidate
135873|NCT02450877|Children|children
135874|NCT02450877|Young Adults|young adults
135875|NCT02450877|Azacitidine|azacitidine
135876|NCT02450877|Acute Myeloid Leukemia|acute myeloid leukemia
135877|NCT02450877|Molecular Relapse|molecular relapse
135878|NCT02450877|Vidaza|vidaza
135879|NCT02450877|AZA-AML-004|aza-aml-004
135880|NCT02450864|Stiffness of Shoulder, Not Elsewhere Classified|stiffness of shoulder, not elsewhere classified
135881|NCT02450851|Rare Diseases|rare diseases
135882|NCT02450851|Undiagnosed Disease|undiagnosed disease
135883|NCT02450838|Dengue Vaccine|dengue vaccine
135884|NCT02450812|mCRPC|mcrpc
135885|NCT02450773|postpartum|postpartum
135886|NCT02450773|preeclampsia|preeclampsia
135887|NCT02450773|gestational hypertension|gestational hypertension
135888|NCT02450747|Visual Acuity|visual acuity
135889|NCT02450734|ultrasound-guided intermediate cervical plexus block|ultrasound-guided intermediate cervical plexus block
135890|NCT02450721|atherosclerosis|atherosclerosis
135891|NCT02450721|biomarkers|biomarkers
135892|NCT02450721|carotid artery stenosis|carotid artery stenosis
135893|NCT02450721|ischemic stroke.|ischemic stroke.
135894|NCT02450708|Allogeneic Hematopoietic Cell Donors|allogeneic hematopoietic cell donors
135895|NCT02450708|KIR and HLA Genotypes|kir and hla genotypes
135896|NCT02450708|15-059|15-059
135897|NCT02450695|rTMS|rtms
135898|NCT02450695|treatment refractory|treatment refractory
135899|NCT02450695|treatment resistant|treatment resistant
135900|NCT02450695|SSRI|ssri
135901|NCT02450695|clomipramine|clomipramine
135902|NCT02450669|Intubation|intubation
135903|NCT02450669|Extubation|extubation
135904|NCT02450669|Weaning|weaning
135905|NCT02450669|Mechanical ventilation|mechanical ventilation
135906|NCT02450617|Complex PTSD|complex ptsd
135907|NCT02450604|Prevalence Study|prevalence study
135908|NCT02450604|Fabry's disease|fabry's disease
135909|NCT02450604|Chronic pain|chronic pain
135910|NCT02450591|Sensitizing EGFR Mutations|sensitizing egfr mutations
135911|NCT02450591|Erlotinib|erlotinib
135912|NCT02450591|Surgery|surgery
135913|NCT02450591|Radiation Therapy|radiation therapy
135914|NCT02450591|15-067|15-067
135915|NCT02450552|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
135917|NCT02450552|Lou Gehrig|lou gehrig
135918|NCT02450539|patient reported outcomes (PRO)|patient reported outcomes (pro)
135919|NCT02450539|patient focused outcomes (PFO)|patient focused outcomes (pfo)
135920|NCT02450539|biomarkers|biomarkers
135921|NCT02450539|CDK 4 and 6|cdk 4 and 6
135922|NCT02450513|adalimumab|adalimumab
135923|NCT02450513|anti-TNF|anti-tnf
135924|NCT02450513|pharmacokinetics|pharmacokinetics
135925|NCT02450513|trough level|trough level
135926|NCT02450513|immunogenicity|immunogenicity
135927|NCT02450487|Piroxicam|piroxicam
135928|NCT02450487|Pharmacogenetic|pharmacogenetic
135929|NCT02450487|Lower Third molar|lower third molar
135930|NCT02450448|Renal Neoplasms|renal neoplasms
135931|NCT02450448|Circulating Tumor Cells|circulating tumor cells
135932|NCT02450435|Prostatic Neoplasms|prostatic neoplasms
135933|NCT02450435|Circulating TUmor Cells|circulating tumor cells
135934|NCT02450422|Colorectal Neoplasms|colorectal neoplasms
135935|NCT02450422|Circulating Tumor Cells|circulating tumor cells
135936|NCT02450409|Total knee arthroplasty|total knee arthroplasty
135937|NCT02450409|Midflexion instability|midflexion instability
135938|NCT02450409|Gap technique|gap technique
135939|NCT02450409|Anatomical alignment|anatomical alignment
135940|NCT02450396|Rare diseases|rare diseases
135941|NCT02450396|pregnancy|pregnancy
135942|NCT02450396|pregnancy,|pregnancy,
135943|NCT02450357|Breast Neoplasms|breast neoplasms
135944|NCT02450357|Circulating Tumor Cells|circulating tumor cells
135945|NCT02450279|Aerosol delivery|aerosol delivery
135946|NCT02450279|Invasive mechanical ventilation|invasive mechanical ventilation
135947|NCT02450279|Jet Nebulizer|jet nebulizer
135948|NCT02450279|Vibrating-Mesh nebulizer|vibrating-mesh nebulizer
135949|NCT02450266|Primary disease|primary disease
135950|NCT02450266|multiparametric MRI|multiparametric mri
135951|NCT02450266|targeted prostate biopsy|targeted prostate biopsy
135952|NCT02450266|MRI/ultrasound fusion-guided prostate biopsy|mri/ultrasound fusion-guided prostate biopsy
135953|NCT02450266|systematic transrectal ultrasound-guided prostate biopsy|systematic transrectal ultrasound-guided prostate biopsy
135954|NCT02450253|Vascular cognitive impairment|vascular cognitive impairment
135955|NCT02450240|Depression|depression
135957|NCT02450240|Eating Disorders|eating disorders
135958|NCT02450240|Substance Use|substance use
135959|NCT02450240|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
135960|NCT02450240|Genetics|genetics
135961|NCT02450240|Behavior|behavior
135962|NCT02450240|Mental Health|mental health
135963|NCT02450214|Ketamine|ketamine
135964|NCT02450214|Magnesium|magnesium
135965|NCT02450214|Analgesia|analgesia
135966|NCT02450214|Liposuction|liposuction
135967|NCT02450214|Lipoabdominoplasty|lipoabdominoplasty
135968|NCT02450214|Preemptive analgesia|preemptive analgesia
135969|NCT02450188|Erectile Dysfunction|erectile dysfunction
135970|NCT02450188|PDE5 inhibitors|pde5 inhibitors
135971|NCT02450188|Cognitive-behavioral Sex Therapy|cognitive-behavioral sex therapy
135972|NCT02450175|Platelet Activation|platelet activation
135973|NCT02450175|metastasis|metastasis
135974|NCT02450110|spinal cord stimulation|spinal cord stimulation
135975|NCT02450110|heart failure|heart failure
135976|NCT02450110|autonomic regulation|autonomic regulation
135978|NCT02450110|left ventricle systolic dysfunction|left ventricle systolic dysfunction
135979|NCT02450071|Pre-hospital|pre-hospital
135980|NCT02450071|Out-of-hospital|out-of-hospital
135981|NCT02450071|Prehospital emergency care (MeSH)|prehospital emergency care (mesh)
135982|NCT02450071|Emergency medical services (MeSH)|emergency medical services (mesh)
135983|NCT02450071|Helicopter emergency medical service|helicopter emergency medical service
135984|NCT02450071|Critical care (MeSH)|critical care (mesh)
135985|NCT02450071|Airway management (MeSH)|airway management (mesh)
135986|NCT02450071|Endotracheal intubation (MeSH)|endotracheal intubation (mesh)
135987|NCT02450071|Difficult endotracheal intubation|difficult endotracheal intubation
135988|NCT02450071|Complications (MeSH)|complications (mesh)
135989|NCT02450071|Patient safety|patient safety
135990|NCT02450058|early breast cancer|early breast cancer
135991|NCT02450058|adjuvant chemotherapy|adjuvant chemotherapy
135992|NCT02450058|FEC|fec
135993|NCT02450058|paclitaxel|paclitaxel
135994|NCT02449993|diagnostic study|diagnostic study
135995|NCT02449993|analysis of estrogen receptor|analysis of estrogen receptor
135996|NCT02449993|progesterone receptor|progesterone receptor
135997|NCT02449993|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
135998|NCT02449993|Ki-67|ki-67
135999|NCT02449980|Spontaneous Pneumothorax|spontaneous pneumothorax
136000|NCT02449980|Video Assisted Thoracoscopic Surgery|video assisted thoracoscopic surgery
136001|NCT02449980|Tube Thoracostomy|tube thoracostomy
136002|NCT02449980|Pediatric Surgery|pediatric surgery
136003|NCT02449967|Pancreatic Cancer|pancreatic cancer
136004|NCT02449967|HepaSphere|hepasphere
136005|NCT02449954|Stress and Immune Responses|stress and immune responses
136006|NCT02449954|morphine|morphine
136008|NCT02449954|ketorolac|ketorolac
136009|NCT02449941|Stomach Neoplasms|stomach neoplasms
136010|NCT02449941|proton pump inhibitor|proton pump inhibitor
136011|NCT02449941|endoscopic submucosal dissection|endoscopic submucosal dissection
136012|NCT02449941|Helicobacter pylori|helicobacter pylori
136013|NCT02449941|Gastritis, Atrophic|gastritis, atrophic
136014|NCT02449928|Severe Sepsis with Septic Shock, Lactate|severe sepsis with septic shock, lactate
136015|NCT02449915|sacrocolpopexy|sacrocolpopexy
136016|NCT02449915|rectocele repair|rectocele repair
136017|NCT02449902|VVA|vva
136018|NCT02449902|Postmenopausal|postmenopausal
136019|NCT02449902|Painful Sex|painful sex
136020|NCT02449863|Lung ultrasound|lung ultrasound
136021|NCT02449863|Mechanical ventilation|mechanical ventilation
136022|NCT02449863|Respiratory distress syndrome|respiratory distress syndrome
136023|NCT02449863|Transient tachypnea of the newborn|transient tachypnea of the newborn
136024|NCT02449850|In-utero environment|in-utero environment
136025|NCT02449850|Asthma|asthma
136026|NCT02449850|Allergic diseases|allergic diseases
136027|NCT02449850|Food allergy|food allergy
136028|NCT02449850|Birth cohort study|birth cohort study
136029|NCT02449850|Primary prevention|primary prevention
136030|NCT02449850|Intervention study|intervention study
136031|NCT02449850|Atopic dermatitis|atopic dermatitis
136032|NCT02449850|Rhinitis|rhinitis
136033|NCT02449850|Allergy|allergy
136034|NCT02449850|Lung function|lung function
136035|NCT02449850|Non-communicable diseases|non-communicable diseases
136036|NCT02449850|Foetal growth|foetal growth
136037|NCT02449824|neoadjuvant chemotherapy|neoadjuvant chemotherapy
136038|NCT02449824|magnetic resonance imaging|magnetic resonance imaging
136039|NCT02449798|Difficult IV access|difficult iv access
136040|NCT02449798|AccuCath|accucath
136041|NCT02449798|IV outcomes|iv outcomes
136042|NCT02449798|patient satisfaction|patient satisfaction
136043|NCT02449785|Cystic fibrosis|cystic fibrosis
136044|NCT02449785|MRI|mri
136045|NCT02449785|UTE|ute
136046|NCT02449785|CT|ct
136047|NCT02449785|Exacerbation|exacerbation
136048|NCT02449785|Quality of life|quality of life
136049|NCT02449785|Pulmonary function|pulmonary function
136050|NCT02449772|N04.452.442.422.336|n04.452.442.422.336
136051|NCT02449746|Schizophrenia|schizophrenia
136052|NCT02449746|Psychosis|psychosis
136053|NCT02449746|Mental Health|mental health
136054|NCT02449746|Autoimmunity|autoimmunity
136055|NCT02449746|Psychoneuroimmunology|psychoneuroimmunology
136057|NCT02449733|couples voluntary counseling and testing (CVCT)|couples voluntary counseling and testing (cvct)
136058|NCT02449733|pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
136060|NCT02449733|male|male
136061|NCT02449733|South Africa|south africa
136062|NCT02449720|intraperitoneal|intraperitoneal
136063|NCT02449720|ropivacaine|ropivacaine
136064|NCT02449720|bowel resection|bowel resection
136065|NCT02449720|local anaesthetic|local anaesthetic
136066|NCT02449720|recovery|recovery
136067|NCT02449681|squamous cell carcinoma|squamous cell carcinoma
136068|NCT02449681|the head and neck|the head and neck
136069|NCT02449681|skin|skin
136070|NCT02449681|TH-4000|th-4000
136071|NCT02449681|Hypoxia|hypoxia
136072|NCT02449681|Tarloxotinib|tarloxotinib
136073|NCT02449668|Acupuncture|acupuncture
136074|NCT02449668|Shoulder pain|shoulder pain
136075|NCT02449668|Impingement syndrome|impingement syndrome
136076|NCT02449668|Rotator cuff tendinitis|rotator cuff tendinitis
136077|NCT02449668|Traditional Chinese medicine (TCM)|traditional chinese medicine (tcm)
136078|NCT02449642|luteinizing hormone pulsatility|luteinizing hormone pulsatility
136079|NCT02449642|estradiol level|estradiol level
136080|NCT02449642|progesterone level|progesterone level
136081|NCT02449629|HIV|hiv
136082|NCT02449629|Transgender|transgender
136083|NCT02449629|HIV Continuum of Care|hiv continuum of care
136084|NCT02449616|Sickle cell|sickle cell
136085|NCT02449616|vaso-occlusive crisis|vaso-occlusive crisis
136086|NCT02449603|Chinese population|chinese population
136087|NCT02449590|Onion|onion
136088|NCT02449590|Cardiovascular disease|cardiovascular disease
136089|NCT02449590|metabolomics|metabolomics
136090|NCT02449590|Gene expression|gene expression
136091|NCT02449590|Biomarker|biomarker
136092|NCT02449577|Metabolomics|metabolomics
136093|NCT02449577|Beer|beer
136094|NCT02449577|Biomarker|biomarker
136095|NCT02449577|Glucose response|glucose response
136096|NCT02449577|Insulin response|insulin response
136097|NCT02449486|Requirement of postoperative pain medication|requirement of postoperative pain medication
136098|NCT02449473|Asthma|asthma
136099|NCT02449473|Reactive Airways|reactive airways
136100|NCT02449473|Respiratory Tract Disease|respiratory tract disease
136101|NCT02449473|Obstructive Tract Disease|obstructive tract disease
136102|NCT02449473|Lung Diseases|lung diseases
136103|NCT02449460|hypertension|hypertension
136104|NCT02449460|epidemiology|epidemiology
136105|NCT02449460|glucose|glucose
136106|NCT02449460|body mass index|body mass index
136107|NCT02449460|lipids|lipids
136108|NCT02449460|smoking|smoking
136768|NCT02445300|TKA|tka
136114|NCT02449447|Cognitive behavior Therapy (CBT)|cognitive behavior therapy (cbt)
136115|NCT02449447|Face-to-face|face-to-face
136116|NCT02449447|internet-based treatment|internet-based treatment
136118|NCT02449382|continuous venovenous hemofiltration|continuous venovenous hemofiltration
136119|NCT02449382|conventional treatment|conventional treatment
136120|NCT02449382|mortality|mortality
136121|NCT02449382|acute severe hypernatremia|acute severe hypernatremia
136122|NCT02449356|Prone position ventilation|prone position ventilation
136123|NCT02449356|Endotracheal intubation|endotracheal intubation
136124|NCT02449356|Displacement|displacement
136127|NCT02449304|endometrial ablation, heavy menstrual bleeding, novosure|endometrial ablation, heavy menstrual bleeding, novosure
136128|NCT02449278|advanced-stage DLBCL|advanced-stage dlbcl
164146|NCT02291107|Lokomat|lokomat
136129|NCT02449278|ISRT|isrt
136130|NCT02449278|chemotherapy|chemotherapy
136131|NCT02449265|limited-stage DLBCL|limited-stage dlbcl
136132|NCT02449265|consolidation involved-site radiotherapy|consolidation involved-site radiotherapy
136133|NCT02449265|Chemotherapy|chemotherapy
136134|NCT02449252|limited stage FL|limited stage fl
136135|NCT02449252|Involved-site Radiotherapy|involved-site radiotherapy
136136|NCT02449252|Chemotherapy|chemotherapy
136137|NCT02449239|Urinary Bladder Cancer|urinary bladder cancer
136138|NCT02449239|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
136139|NCT02449239|Bladder Neoplasm|bladder neoplasm
136140|NCT02449239|Bladder Tumor|bladder tumor
136141|NCT02449239|CIS|cis
136142|NCT02449239|Papillary bladder cancer|papillary bladder cancer
136143|NCT02449239|High grade bladder cancer|high grade bladder cancer
136144|NCT02449200|cervical radiculopathy|cervical radiculopathy
136145|NCT02449200|exercise|exercise
136146|NCT02449200|manual therapy|manual therapy
136147|NCT02449200|tape|tape
136148|NCT02449174|C. difficile|c. difficile
654600|NCT00789048|radiograph|radiograph
136149|NCT02449174|Fecal Microbiota transplantation|fecal microbiota transplantation
136150|NCT02449161|endometrial ablation|endometrial ablation
136151|NCT02449148|energy restriction|energy restriction
136152|NCT02449148|fasting|fasting
136153|NCT02449148|intermittent fast|intermittent fast
136154|NCT02449148|cancer prevention|cancer prevention
136155|NCT02449148|subcutaneous fat tissue gene expression|subcutaneous fat tissue gene expression
136156|NCT02449135|Pancreatic Cancer|pancreatic cancer
136157|NCT02449135|Nano drug|nano drug
136158|NCT02449122|Lung Cancer|lung cancer
136159|NCT02449122|Nano drug|nano drug
136160|NCT02449109|Liver Cancer|liver cancer
136161|NCT02449109|Nano drug|nano drug
136162|NCT02449083|MRI|mri
136163|NCT02449083|Shunt|shunt
136164|NCT02449083|COPD|copd
136165|NCT02449083|Dynamic T2 Preparation Puls|dynamic t2 preparation puls
136166|NCT02449083|new sequences|new sequences
136167|NCT02449083|magnet resonance imaging|magnet resonance imaging
136168|NCT02449083|ventricular septal defect|ventricular septal defect
136169|NCT02449083|Atrial septal defect|atrial septal defect
136170|NCT02449070|Nicorandil|nicorandil
136171|NCT02449070|Cardiac MRI|cardiac mri
136172|NCT02449044|Hyponatremia|hyponatremia
136173|NCT02449018|COPD,|copd,
136174|NCT02449018|chronic bronchitis,|chronic bronchitis,
136175|NCT02449018|inflammation,|inflammation,
136176|NCT02449018|airway,|airway,
136177|NCT02449018|LCI,|lci,
136178|NCT02449018|pulmonary function test,|pulmonary function test,
136179|NCT02449018|lung function,|lung function,
136180|NCT02449018|controlled clinical trial,|controlled clinical trial,
136181|NCT02449018|randomized,|randomized,
136182|NCT02449018|airflow,|airflow,
136183|NCT02449018|smoker|smoker
136184|NCT02449005|regeneration|regeneration
136185|NCT02449005|stem cells|stem cells
136186|NCT02449005|infrabony periodontal defect|infrabony periodontal defect
136187|NCT02449005|fibrin glue|fibrin glue
136188|NCT02449005|collagen fleece|collagen fleece
136189|NCT02448992|Neurobehavioral Assessments|neurobehavioral assessments
136190|NCT02448992|Neurocognitive Functions (NCF)|neurocognitive functions (ncf)
136191|NCT02448992|Prophylactic Cranial Irradiation (PCI)|prophylactic cranial irradiation (pci)
136192|NCT02448992|Hippocampus|hippocampus
136193|NCT02448992|Hippocampal-Sparing PCI|hippocampal-sparing pci
136194|NCT02448953|Without cervical lymph node involvement|without cervical lymph node involvement
136195|NCT02448940|probiotics|probiotics
136196|NCT02448940|Lactobacillus|lactobacillus
136197|NCT02448940|obesity|obesity
136198|NCT02448940|body composition|body composition
136199|NCT02448927|transcatheter aortic valve implantation|transcatheter aortic valve implantation
136200|NCT02448927|Balloon aortic valvuloplasty|balloon aortic valvuloplasty
136201|NCT02448927|Aortic stenosis|aortic stenosis
136203|NCT02448927|TAVR (transcatheter aortic valve replacement)|tavr (transcatheter aortic valve replacement)
136204|NCT02448927|CoreValve|corevalve
136205|NCT02448927|BAV|bav
136206|NCT02448927|Evolut R|evolut r
136207|NCT02448862|IV-PCA|iv-pca
136208|NCT02448862|Elderly patients|elderly patients
136209|NCT02448862|Yound adults|yound adults
136210|NCT02448862|Side effect|side effect
136211|NCT02448862|Postoperative pain|postoperative pain
136212|NCT02448862|Postoperative nausea and vomiting|postoperative nausea and vomiting
136213|NCT02448849|Autologous|autologous
136214|NCT02448849|nonunion fracture|nonunion fracture
136215|NCT02448849|bone marrow|bone marrow
136216|NCT02448849|mesenchymal|mesenchymal
136217|NCT02448849|stromal cell|stromal cell
136218|NCT02448849|platelet lysate product|platelet lysate product
136219|NCT02448823|HIV|hiv
136220|NCT02448823|combined prevention|combined prevention
136221|NCT02448823|demand generation|demand generation
136222|NCT02448784|Donepezil Hydrochloride|donepezil hydrochloride
136223|NCT02448784|ARICEPT|aricept
136224|NCT02448784|Dementia|dementia
136225|NCT02448784|Lewy bodies|lewy bodies
136226|NCT02448784|Dementia with Lewy bodies|dementia with lewy bodies
136227|NCT02448784|Post-marketing surveillance|post-marketing surveillance
136228|NCT02448771|Unresectable locally advanced invasive breast cancer|unresectable locally advanced invasive breast cancer
136229|NCT02448771|Metastatic invasive breast cancer|metastatic invasive breast cancer
136230|NCT02448758|mutation|mutation
136231|NCT02448732|ACM-1|acm-1
136232|NCT02448732|intravitreal injection|intravitreal injection
136233|NCT02448732|neovascularization|neovascularization
136234|NCT02448706|hearing aid|hearing aid
136235|NCT02448693|endoscopic mucosal resection|endoscopic mucosal resection
136236|NCT02448693|piecemeal polypectomy scar|piecemeal polypectomy scar
136237|NCT02448693|colorectal neoplasms|colorectal neoplasms
136238|NCT02448693|Narrow Band Imaging|narrow band imaging
136239|NCT02448693|chromoendoscopy|chromoendoscopy
136240|NCT02448641|ischemic stroke|ischemic stroke
136241|NCT02448641|chronic stroke|chronic stroke
136242|NCT02448641|fixed motor deficits|fixed motor deficits
136243|NCT02448628|Hypertension|hypertension
136244|NCT02448628|moderate renal impairment|moderate renal impairment
585631|NCT00513448|Physical Activity|physical activity
136245|NCT02448628|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
136246|NCT02448628|CS-3150|cs-3150
136247|NCT02448628|Japanese|japanese
136248|NCT02448615|Kenya|kenya
136249|NCT02448615|Cohort|cohort
136250|NCT02448602|Different acupoints compatibility|different acupoints compatibility
136251|NCT02448589|Advanced Solid Tumors|advanced solid tumors
136252|NCT02448589|Dose Escalation|dose escalation
136253|NCT02448589|Dose Expansion|dose expansion
136255|NCT02448589|TAS-119|tas-119
136256|NCT02448589|Aurora A Kinase Inhibitor|aurora a kinase inhibitor
136257|NCT02448576|phase 3 randomized controlled trial|phase 3 randomized controlled trial
136258|NCT02448576|prophylactic cranial irradiation|prophylactic cranial irradiation
136259|NCT02448576|triple negative breast cancer|triple negative breast cancer
136260|NCT02448576|brain metastasis|brain metastasis
136261|NCT02448576|advanced breast cancer|advanced breast cancer
136262|NCT02448563|Pregnancy|pregnancy
136263|NCT02448563|African American|african american
136264|NCT02448563|Weight Management Program|weight management program
136265|NCT02448563|Behavioral Modifications|behavioral modifications
136266|NCT02448537|Metastatic Sarcoma|metastatic sarcoma
136267|NCT02448537|Unresectable Sarcoma|unresectable sarcoma
136268|NCT02448537|PM01183|pm01183
136269|NCT02448524|Treatment|treatment
136270|NCT02448524|patients|patients
136271|NCT02448524|primary in situ CHD (de novo) lesions|primary in situ chd (de novo) lesions
136272|NCT02448511|ozone gas|ozone gas
136273|NCT02448511|ulcer|ulcer
136274|NCT02448511|infected ulcer|infected ulcer
136275|NCT02448433|Phototherapy|phototherapy
136276|NCT02448433|Light|light
136277|NCT02448433|Depression|depression
136278|NCT02448433|Sleep and circadian disturbances|sleep and circadian disturbances
136279|NCT02448433|Youth|youth
136280|NCT02448407|Knee osteoarthritis|knee osteoarthritis
136281|NCT02448407|Platelet-rich plasma|platelet-rich plasma
136282|NCT02448407|Pain's treatment|pain's treatment
136283|NCT02448394|community support workers|community support workers
136284|NCT02448394|retention in care|retention in care
136285|NCT02448381|CTCL|ctcl
136286|NCT02448381|Mycosis fungoides|mycosis fungoides
136287|NCT02448381|Hypericin|hypericin
136288|NCT02448381|SGX301|sgx301
136289|NCT02448381|MF|mf
136290|NCT02448355|OCT|oct
136291|NCT02448342|Heart Failure|heart failure
136292|NCT02448342|Remote Patient Monitoring|remote patient monitoring
136293|NCT02448342|Non Invasive Lung Fluid Status Monitor|non invasive lung fluid status monitor
136294|NCT02448290|gastric adenocarcinoma patients with low/high MEK signature,|gastric adenocarcinoma patients with low/high mek signature,
136295|NCT02448277|Macintosh laryngoscope, Pentax, Glidescope|macintosh laryngoscope, pentax, glidescope
136296|NCT02448264|kallikrein inhibitor|kallikrein inhibitor
136297|NCT02448264|oral prophylaxis|oral prophylaxis
136298|NCT02448264|BioCryst|biocryst
136299|NCT02448264|first-in-human|first-in-human
136300|NCT02448264|hereditary angioedema|hereditary angioedema
136301|NCT02448238|Human Immunodeficiency Virus|human immunodeficiency virus
136302|NCT02448238|probiotic|probiotic
136303|NCT02448238|microbial translocation|microbial translocation
136304|NCT02448238|immune activation|immune activation
136305|NCT02448238|inflammation|inflammation
136306|NCT02448238|VSL#3|vsl#3
136307|NCT02448238|Mali|mali
136308|NCT02448238|Africa|africa
136309|NCT02448212|PET|pet
136310|NCT02448212|Receptor Occupancy|receptor occupancy
136311|NCT02448199|pain|pain
136312|NCT02448199|Knee|knee
136313|NCT02448147|Heart failure|heart failure
136314|NCT02448147|Exercise|exercise
136315|NCT02448147|Biomarkers|biomarkers
136316|NCT02448147|Sympathetic Nervous System|sympathetic nervous system
136317|NCT02448147|MicroRNA|microrna
136318|NCT02448121|Cell therapy|cell therapy
136319|NCT02448121|Sickle cell disease|sickle cell disease
136320|NCT02448121|Hip Osteonecrosis|hip osteonecrosis
136321|NCT02448121|Autologous implantation|autologous implantation
127343|NCT02500602|AUD|aud
136322|NCT02448121|Mesenchymal stromal cell|mesenchymal stromal cell
136323|NCT02448121|Humeral Osteonecrosis|humeral osteonecrosis
136324|NCT02448121|Knee Osteonecrosis|knee osteonecrosis
136325|NCT02448121|Ankle Osteonecrosis|ankle osteonecrosis
136326|NCT02448095|Chronic myeloid leukemia|chronic myeloid leukemia
136327|NCT02448095|Philadelphia positive|philadelphia positive
136328|NCT02448095|Compassionate use|compassionate use
136329|NCT02448082|Dandruff|dandruff
136330|NCT02448082|Pityriasis capitis|pityriasis capitis
136331|NCT02448082|Ichthyol® Pale|ichthyol® pale
136332|NCT02448082|Sodium shale oil sulponate 1%|sodium shale oil sulponate 1%
136333|NCT02448043|brittleness|brittleness
136334|NCT02448030|Metaboreflex|metaboreflex
136335|NCT02448030|Variation of blood flow|variation of blood flow
136336|NCT02448030|Functional electrical stimulation|functional electrical stimulation
136337|NCT02448030|Isometric exercise.|isometric exercise.
136338|NCT02448004|Healthy|healthy
136339|NCT02448004|JNJ-63623872|jnj-63623872
136340|NCT02448004|14C-JNJ-63623872|14c-jnj-63623872
136341|NCT02447965|Rectus Sheath Blocks|rectus sheath blocks
654705|NCT00789490|folic acid|folic acid
136342|NCT02447965|Abdominal Surgery|abdominal surgery
136343|NCT02447952|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
136344|NCT02447952|Biotelemetry|biotelemetry
136345|NCT02447939|pharmacokinetics|pharmacokinetics
136346|NCT02447939|trametinib|trametinib
136347|NCT02447939|cutaneous melanoma|cutaneous melanoma
136348|NCT02447939|dabrafenib|dabrafenib
136349|NCT02447939|safety|safety
136350|NCT02447926|leukapheresis|leukapheresis
136351|NCT02447926|regulatory T cells|regulatory t cells
136352|NCT02447926|liver transplantation|liver transplantation
136353|NCT02447913|Family planning|family planning
136354|NCT02447913|Voucher|voucher
136355|NCT02447913|Immunisations|immunisations
136356|NCT02447835|Metabolic Disorders|metabolic disorders
136357|NCT02447809|microRNA|microrna
136358|NCT02447809|Platelet|platelet
136359|NCT02447809|Clopidogrel low response|clopidogrel low response
136360|NCT02447796|(AVF)|(avf)
136361|NCT02447796|surgery|surgery
136362|NCT02447783|Flavanols|flavanols
136363|NCT02447783|Cocoa flavanols|cocoa flavanols
136364|NCT02447783|Blood pressure|blood pressure
136365|NCT02447783|Platelet Function|platelet function
136366|NCT02447770|Flavanols|flavanols
136367|NCT02447770|Cocoa flavanols|cocoa flavanols
136368|NCT02447770|Blood pressure|blood pressure
136369|NCT02447770|Platelet Function|platelet function
136370|NCT02447757|Remifentanil, delivery, childbirth, analgesia, parturition, confinement|remifentanil, delivery, childbirth, analgesia, parturition, confinement
136371|NCT02447744|depression|depression
136372|NCT02447744|anxiety|anxiety
136373|NCT02447744|early life stress|early life stress
136374|NCT02447731|respiratory insufficiency|respiratory insufficiency
136375|NCT02447692|Proportional Assist Ventilation|proportional assist ventilation
136376|NCT02447692|Pressure Support Ventilation|pressure support ventilation
136377|NCT02447692|Weaning|weaning
136378|NCT02447666|Azacitidine|azacitidine
136379|NCT02447666|Myelodysplastic syndrome|myelodysplastic syndrome
136380|NCT02447666|Juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
136381|NCT02447666|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
136382|NCT02447666|Vidaza|vidaza
136383|NCT02447666|Hypomethylating agent|hypomethylating agent
136384|NCT02447640|Volunteers|volunteers
136385|NCT02447614|follow up|follow up
136386|NCT02447614|Primary Snoring|primary snoring
136387|NCT02447614|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
136388|NCT02447588|intrauterine insemination|intrauterine insemination
136389|NCT02447588|progesterone|progesterone
136390|NCT02447549|IMRT|imrt
136391|NCT02447549|IGRT|igrt
136392|NCT02447549|Muscle invasive|muscle invasive
136393|NCT02447549|Adaptive Radiotherapy|adaptive radiotherapy
136394|NCT02447536|Immunization|immunization
136395|NCT02447536|Morbidity|morbidity
136396|NCT02447536|Mortality|mortality
136397|NCT02447536|BCG|bcg
136398|NCT02447484|female sex workers|female sex workers
136399|NCT02447484|HIV sexual risk reduction|hiv sexual risk reduction
136400|NCT02447484|behavior maintenance|behavior maintenance
136401|NCT02447484|text messaging|text messaging
136402|NCT02447458|Drug therapy|drug therapy
136403|NCT02447432|Invasive disease by Streptococcus pneumoniae (S. pneumoniae) (including sepsis, meningitis, pneumonia, bacteraemia and acute otitis media)|invasive disease by streptococcus pneumoniae (s. pneumoniae) (including sepsis, meningitis, pneumonia, bacteraemia and acute otitis media)
136404|NCT02447432|Infants|infants
136405|NCT02447432|Multidose|multidose
136406|NCT02447432|Haemophilus influenzae|haemophilus influenzae
136407|NCT02447432|Streptococcus pneumoniae|streptococcus pneumoniae
136408|NCT02447432|Preservative|preservative
136409|NCT02447432|Safety|safety
136410|NCT02447432|Pneumonia|pneumonia
136411|NCT02447432|Immunogenicity|immunogenicity
136412|NCT02447432|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
752595|NCT01173276|Assisted Reproductive Technology|assisted reproductive technology
136413|NCT02447432|Acute otitis media caused by non-typeable Haemophilus influenzae (NTHi).|acute otitis media caused by non-typeable haemophilus influenzae (nthi).
136414|NCT02447432|Respiratory tract infections|respiratory tract infections
136415|NCT02447367|α1-blockers|α1-blockers
136416|NCT02447367|antimuscarinic agent|antimuscarinic agent
136417|NCT02447315|Pilocarpine|pilocarpine
136418|NCT02447289|Dental caries|dental caries
136419|NCT02447289|Moderate sedation|moderate sedation
136420|NCT02447263|Liver Cancer|liver cancer
136421|NCT02447263|HepaSphere|hepasphere
136422|NCT02447250|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
136423|NCT02447250|very low birth weight|very low birth weight
136424|NCT02447250|albuterol|albuterol
136425|NCT02447250|pulmonary function test|pulmonary function test
136426|NCT02447237|liquid diet|liquid diet
136427|NCT02447237|solid diet|solid diet
136428|NCT02447224|appendicitis|appendicitis
136429|NCT02447224|non operative management|non operative management
136430|NCT02447224|appendectomy|appendectomy
136431|NCT02447185|Lucentis|lucentis
136432|NCT02447185|Ranibizumab|ranibizumab
136433|NCT02447185|Triamcinolone Acetonide|triamcinolone acetonide
136434|NCT02447185|Vitrectomy|vitrectomy
136435|NCT02447185|PDR|pdr
136436|NCT02447185|25-Gauge Vitrectomy|25-gauge vitrectomy
136438|NCT02447159|Developing Countries|developing countries
136846|NCT02444897|epidural|epidural
136440|NCT02447159|Hospitals/Economics|hospitals/economics
136441|NCT02447159|HIV|hiv
136442|NCT02447133|no known ocular pathology|no known ocular pathology
136443|NCT02447120|Volunteers with Healthy Eyes|volunteers with healthy eyes
136444|NCT02447107|Chronic Pain|chronic pain
136445|NCT02447107|Technology|technology
136446|NCT02447107|Mobile Phone Applications|mobile phone applications
136447|NCT02447094|ischemic|ischemic
136448|NCT02447094|tPA|tpa
136449|NCT02447094|tele-medicine|tele-medicine
136450|NCT02447094|robot|robot
136451|NCT02447094|tele-stroke|tele-stroke
136452|NCT02447042|sepsis|sepsis
136453|NCT02447042|Fluids|fluids
136454|NCT02447042|Mean systemic filling pressure|mean systemic filling pressure
136455|NCT02447029|abortion|abortion
136456|NCT02447029|pain management|pain management
136457|NCT02447003|PD1|pd1
136458|NCT02447003|PD-1|pd-1
136459|NCT02447003|PDL1|pdl1
136460|NCT02447003|PD-L1|pd-l1
136461|NCT02446977|ischemic|ischemic
136462|NCT02446977|stroke|stroke
136463|NCT02446977|vitamin B2|vitamin b2
136464|NCT02446938|mechanical ventilation|mechanical ventilation
136465|NCT02446938|esophageal pressure|esophageal pressure
136466|NCT02446938|catheter position|catheter position
136467|NCT02446938|validation|validation
136468|NCT02446912|Active Systemic Lupus Erythematosus|active systemic lupus erythematosus
136469|NCT02446899|Active Systemic Lupus Erythematosus|active systemic lupus erythematosus
136470|NCT02446886|Multiple Sclerosis|multiple sclerosis
136471|NCT02446886|MS|ms
136472|NCT02446886|RRMS|rrms
136473|NCT02446886|SPMS|spms
136474|NCT02446886|ACTH|acth
136475|NCT02446873|children|children
136476|NCT02446873|Ecuador|ecuador
136477|NCT02446873|rural|rural
136478|NCT02446873|poor|poor
136479|NCT02446847|HIV|hiv
136480|NCT02446847|3BNC117|3bnc117
136481|NCT02446847|Broadly neutralizing antibody|broadly neutralizing antibody
136482|NCT02446834|PCOS|pcos
136483|NCT02446834|intensive lifestyle intervention|intensive lifestyle intervention
136484|NCT02446834|IGT|igt
136485|NCT02446834|drugs treatment|drugs treatment
136486|NCT02446795|Renal cell carcinoma|renal cell carcinoma
136487|NCT02446795|Isoquercetin|isoquercetin
136488|NCT02446795|kidney cancer|kidney cancer
136489|NCT02446795|sunitinib|sunitinib
136490|NCT02446795|fatigue|fatigue
136491|NCT02446782|thoracoscopy|thoracoscopy
136492|NCT02446782|pleuroscopy|pleuroscopy
136493|NCT02446782|antibiotic prophylaxis|antibiotic prophylaxis
136494|NCT02446782|pleural effusion|pleural effusion
136495|NCT02446756|Osteoarthritis|osteoarthritis
136496|NCT02446756|MRI|mri
136497|NCT02446756|Cartilage|cartilage
136498|NCT02446756|Acupuncture|acupuncture
136499|NCT02446743|Nervous System Diseases|nervous system diseases
136500|NCT02446743|Meningitis|meningitis
136501|NCT02446743|Central Nervous System Diseases|central nervous system diseases
136502|NCT02446717|HCV GT5|hcv gt5
136503|NCT02446717|Interferon (IFN) free|interferon (ifn) free
136504|NCT02446717|Hepatitis C|hepatitis c
136505|NCT02446717|HCV Genotype 4|hcv genotype 4
136506|NCT02446717|HCV Genotype 5|hcv genotype 5
136507|NCT02446717|HCV|hcv
136508|NCT02446717|HCV Genotype 6|hcv genotype 6
136509|NCT02446717|Chronic Hepatitis C|chronic hepatitis c
136510|NCT02446717|HCV Genotype 1|hcv genotype 1
136511|NCT02446717|Chronic HCV|chronic hcv
136512|NCT02446717|Hepatitis C Genotype 1|hepatitis c genotype 1
136513|NCT02446717|HCV GT4|hcv gt4
136514|NCT02446717|HCV GT1|hcv gt1
136515|NCT02446704|Small Cell Lung Cancer|small cell lung cancer
136516|NCT02446704|SCLC|sclc
136517|NCT02446678|Gastrointestinal bleeding|gastrointestinal bleeding
136518|NCT02446678|emergency department|emergency department
136519|NCT02446678|PillCam ESO2|pillcam eso2
136520|NCT02446652|Advanced cervical cancer|advanced cervical cancer
136521|NCT02446652|Epigenetic therapy|epigenetic therapy
136522|NCT02446652|Randomized phase III|randomized phase iii
136523|NCT02446626|Lyme Disease|lyme disease
136524|NCT02446626|Ixodes scapularis|ixodes scapularis
136525|NCT02446626|Borrelia Burgdorferi|borrelia burgdorferi
136526|NCT02446626|Post treatment|post treatment
136527|NCT02446626|Infection|infection
136528|NCT02446613|Allergic Rhinitis|allergic rhinitis
136529|NCT02446613|Nasal allergen challenge|nasal allergen challenge
136530|NCT02446613|Allergic Asthma|allergic asthma
136531|NCT02446613|Effect on Allergen Reactivity|effect on allergen reactivity
136532|NCT02446587|endovascular therapy|endovascular therapy
136533|NCT02446587|thrombectomy|thrombectomy
136534|NCT02446587|selection|selection
136535|NCT02446587|imaging|imaging
136536|NCT02446587|perfusion|perfusion
136537|NCT02446587|collaterals|collaterals
136538|NCT02446587|ASPECTS|aspects
136539|NCT02446574|chemoradiation|chemoradiation
136540|NCT02446574|dose escalation|dose escalation
136543|NCT02446548|direct renin inhibitor|direct renin inhibitor
136544|NCT02446548|kidney transplantation|kidney transplantation
136545|NCT02446548|albuminuria|albuminuria
136546|NCT02446496|Bioequivalence|bioequivalence
136547|NCT02446496|film coated tablets|film coated tablets
136548|NCT02446496|cefadroxil|cefadroxil
136549|NCT02446483|Idiazole 20mg|idiazole 20mg
136550|NCT02446483|PARIET 20 mg|pariet 20 mg
136551|NCT02446483|Rabeprazole|rabeprazole
136552|NCT02446483|bioequivalence|bioequivalence
136553|NCT02446470|calcaneus|calcaneus
136554|NCT02446470|fracture fixation, internal|fracture fixation, internal
136555|NCT02446457|Lymphoma|lymphoma
136556|NCT02446457|Follicular lymphoma|follicular lymphoma
136557|NCT02446457|FL|fl
136558|NCT02446457|Relapsed|relapsed
136559|NCT02446457|Rituximab|rituximab
136560|NCT02446457|Rituxan|rituxan
136561|NCT02446457|Pembrolizumab|pembrolizumab
136562|NCT02446457|Keytruda|keytruda
136563|NCT02446457|MK-3475|mk-3475
136564|NCT02446457|SCH-900475|sch-900475
136565|NCT02446457|Lenalidomide|lenalidomide
136566|NCT02446457|CC-5013|cc-5013
136567|NCT02446457|Revlimid|revlimid
136568|NCT02446457|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
136569|NCT02446457|DLBCL|dlbcl
136570|NCT02446444|High risk|high risk
136571|NCT02446444|clinically localised prostate cancer|clinically localised prostate cancer
136572|NCT02446431|Metronomic Drug Therapy|metronomic drug therapy
136573|NCT02446418|dry powder inahler|dry powder inahler
136574|NCT02446418|vilanerol|vilanerol
136575|NCT02446418|efficacy|efficacy
136576|NCT02446418|safety|safety
136577|NCT02446418|fluticasone furoate|fluticasone furoate
136578|NCT02446418|quality of life|quality of life
136579|NCT02446405|metastatic prostate cancer|metastatic prostate cancer
136580|NCT02446405|prostate cancer|prostate cancer
136581|NCT02446405|prostate cancer treatment|prostate cancer treatment
136582|NCT02446405|enzalutamide|enzalutamide
136583|NCT02446353|Male Volunteers|male volunteers
136584|NCT02446340|ShK-186|shk-186
136585|NCT02446340|dalazatide|dalazatide
136586|NCT02446340|Kv1.3|kv1.3
136587|NCT02446340|SHK|shk
136588|NCT02446301|Nalbuphine|nalbuphine
136589|NCT02446301|SDE|sde
136590|NCT02446301|dinalbuphine|dinalbuphine
136591|NCT02446301|SDN|sdn
136592|NCT02446301|pain|pain
136593|NCT02446301|LT1001|lt1001
136594|NCT02446275|efficacy, manual therapy, migraine, quality of life|efficacy, manual therapy, migraine, quality of life
136595|NCT02446262|Pain|pain
136596|NCT02446262|Visual Analogue Pain Scale|visual analogue pain scale
136597|NCT02446262|Placebo|placebo
136598|NCT02446262|Affective Neuroscience|affective neuroscience
136599|NCT02446262|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
136600|NCT02446249|Gene Therapy|gene therapy
136601|NCT02446249|Xerostomia|xerostomia
136602|NCT02446223|Actinic Keratosis AKs Chest Pre-Cancer|actinic keratosis aks chest pre-cancer
136603|NCT02446210|SCI|sci
136604|NCT02446210|Neural Control|neural control
136605|NCT02446210|Bilateral Movement|bilateral movement
136607|NCT02446184|urethral obstruction|urethral obstruction
136608|NCT02446184|posterior urethral valves|posterior urethral valves
136609|NCT02446184|lower urinary tract obstruction|lower urinary tract obstruction
136610|NCT02446171|naloxegol tablet crushed|naloxegol tablet crushed
136611|NCT02446171|naloxegol oral solution|naloxegol oral solution
136612|NCT02446171|naloxegol whole tablet|naloxegol whole tablet
136613|NCT02446171|relative bioavailability|relative bioavailability
136614|NCT02446171|Phase I|phase i
136615|NCT02446171|healthy subjects|healthy subjects
136616|NCT02446106|Monosodium L-Glutamate (MSG)|monosodium l-glutamate (msg)
136617|NCT02446106|Satiety|satiety
136618|NCT02446106|Soups|soups
136619|NCT02446106|Energy Intake|energy intake
136620|NCT02446106|Snack Intake|snack intake
136621|NCT02446093|pancreas|pancreas
136622|NCT02446093|pancreatic adenocarcinoma|pancreatic adenocarcinoma
136623|NCT02446093|GMCI|gmci
164761|NCT02287805|impacts|impacts
136624|NCT02446093|AdV-tk|adv-tk
136625|NCT02446093|aglatimagene besadenovec|aglatimagene besadenovec
136626|NCT02446080|Constipation|constipation
136627|NCT02446080|Probiotics|probiotics
136628|NCT02446080|Women|women
136629|NCT02446067|Transcranial Doppler (TCD) sonography|transcranial doppler (tcd) sonography
136630|NCT02446067|rTMS|rtms
136631|NCT02446067|Cerebral hemodynamics|cerebral hemodynamics
136632|NCT02446054|T2DM, type II diabetes Mellitus, HbA1c|t2dm, type ii diabetes mellitus, hba1c
136633|NCT02446041|COPD|copd
136634|NCT02446041|Chronic Bronchitis|chronic bronchitis
136635|NCT02446041|Pulmonary Emphysema|pulmonary emphysema
136636|NCT02446002|Volunteer|volunteer
136637|NCT02445989|HIV|hiv
136638|NCT02445989|Contraceptive Vaginal Ring|contraceptive vaginal ring
136639|NCT02445989|Bacterial Vaginosis|bacterial vaginosis
136640|NCT02445976|mCRPC|mcrpc
136641|NCT02445976|metastatic|metastatic
136642|NCT02445976|castration-resistant prostate cancer|castration-resistant prostate cancer
136643|NCT02445950|Coaching|coaching
136644|NCT02445950|Well-being|well-being
136645|NCT02445950|Digital Health|digital health
136646|NCT02445950|Profiling|profiling
136647|NCT02445950|Customer Satisfaction|customer satisfaction
136648|NCT02445950|User Experience|user experience
136649|NCT02445950|Occupational Health|occupational health
136651|NCT02445950|Psychological Stress|psychological stress
136652|NCT02445950|Cost-Effectiveness|cost-effectiveness
136653|NCT02445950|Guideline Adherence|guideline adherence
136654|NCT02445937|decision making for incapacitated patients|decision making for incapacitated patients
136655|NCT02445937|intensive care|intensive care
136656|NCT02445937|surrogate decision making|surrogate decision making
136657|NCT02445937|patient centered care|patient centered care
136658|NCT02445937|palliative care|palliative care
136659|NCT02445924|genetic signature|genetic signature
136660|NCT02445924|non-small cell lung cancer|non-small cell lung cancer
136661|NCT02445924|micro RNA|micro rna
136662|NCT02445898|Glucocorticoid|glucocorticoid
136663|NCT02445898|Orthostatic Intolerance|orthostatic intolerance
136664|NCT02445898|Heart Rate Variability|heart rate variability
136665|NCT02445898|Hip arthroplasty, total|hip arthroplasty, total
136666|NCT02445885|Myocardial infarction|myocardial infarction
136667|NCT02445885|Late presenters|late presenters
136668|NCT02445885|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
136669|NCT02445885|Reperfusion|reperfusion
136670|NCT02445885|Angioplasty|angioplasty
136671|NCT02445885|Duration of ischemia|duration of ischemia
136672|NCT02445885|Cardiovascular magnetic resonance imaging|cardiovascular magnetic resonance imaging
136674|NCT02445872|Vomiting|vomiting
136675|NCT02445872|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
136676|NCT02445872|CINV|cinv
136677|NCT02445872|Aprepitant|aprepitant
136678|NCT02445872|Lung cancer|lung cancer
136679|NCT02445859|Antibiotic|antibiotic
136680|NCT02445859|prophylaxis|prophylaxis
136681|NCT02445859|surgical site infection|surgical site infection
136682|NCT02445833|Obesity|obesity
136683|NCT02445833|Internet intervention|internet intervention
136684|NCT02445833|Cardiovascular disease|cardiovascular disease
136685|NCT02445833|Hypertension|hypertension
136686|NCT02445833|Lifestyle intervention|lifestyle intervention
136687|NCT02445833|Weight loss treatment|weight loss treatment
136688|NCT02445755|Neonates|neonates
136689|NCT02445755|Bilicare System|bilicare system
136690|NCT02445742|Chronic Myeloblastic Leukaemia|chronic myeloblastic leukaemia
136691|NCT02445729|Cesarean Section|cesarean section
136692|NCT02445729|Wound Healing|wound healing
136693|NCT02445677|TENS|tens
136694|NCT02445677|chronic pain|chronic pain
136695|NCT02445677|rehabilitation|rehabilitation
136696|NCT02445664|Patient education|patient education
136697|NCT02445664|Video intervention|video intervention
136698|NCT02445651|Integrative Medicine|integrative medicine
136699|NCT02445651|Alternative Medicine|alternative medicine
136700|NCT02445651|Complementary Medicine|complementary medicine
136701|NCT02445651|Parkinson's disease|parkinson's disease
136702|NCT02445651|Neurodegenerative Diseases|neurodegenerative diseases
136703|NCT02445651|Idiopathic Parkinson's disease|idiopathic parkinson's disease
136704|NCT02445651|Single Photon Emission Computed Tomography (SPECT)|single photon emission computed tomography (spect)
136705|NCT02445651|Central Nervous System Diseases|central nervous system diseases
136706|NCT02445651|Movement Disorders|movement disorders
136707|NCT02445651|Nervous System Diseases|nervous system diseases
136708|NCT02445651|Brain Diseases|brain diseases
136709|NCT02445651|Oral supplements|oral supplements
136710|NCT02445651|N-acetyl cysteine|n-acetyl cysteine
136711|NCT02445612|fundus flavimaculatus|fundus flavimaculatus
136713|NCT02445612|long term follow-up|long term follow-up
136714|NCT02445612|juvenile macular dystrophy|juvenile macular dystrophy
136715|NCT02445599|thoracotomy|thoracotomy
136716|NCT02445599|pain management|pain management
136717|NCT02445599|analgesia|analgesia
136718|NCT02445599|postoperative care|postoperative care
136719|NCT02445599|premedication|premedication
164885|NCT02286843|PET/CT|pet/ct
136720|NCT02445599|preventive|preventive
136721|NCT02445573|stress urinary incontinence|stress urinary incontinence
136722|NCT02445573|electroacupuncture|electroacupuncture
136723|NCT02445573|efficacy|efficacy
136724|NCT02445560|probiotics|probiotics
136725|NCT02445560|prebiotics|prebiotics
136726|NCT02445560|high protein diet|high protein diet
136727|NCT02445560|microbiota|microbiota
136728|NCT02445534|Cell Therapy|cell therapy
136729|NCT02445456|Rectal cancer|rectal cancer
136730|NCT02445456|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
136731|NCT02445417|Perinatal depression|perinatal depression
136732|NCT02445378|Aromatherapy|aromatherapy
136733|NCT02445378|essential oils|essential oils
136734|NCT02445378|Acute Leukemia|acute leukemia
136735|NCT02445365|Ulcerative colitis|ulcerative colitis
136736|NCT02445365|Remote ischemic conditioning|remote ischemic conditioning
136737|NCT02445339|Alcohol Dependence|alcohol dependence
136738|NCT02445339|Alcohol Use Disorder|alcohol use disorder
136739|NCT02445339|Care Management|care management
136740|NCT02445339|Case Management|case management
136741|NCT02445339|Emergency Care Services|emergency care services
136742|NCT02445339|Emergency Department|emergency department
136743|NCT02445339|Emergency Room|emergency room
136744|NCT02445339|Extended-release naltrexone|extended-release naltrexone
136745|NCT02445339|Frequent Users|frequent users
136746|NCT02445339|Health Care Utilization|health care utilization
136747|NCT02445339|Medical Management|medical management
136748|NCT02445339|Naltrexone|naltrexone
136749|NCT02445339|Population Health|population health
136750|NCT02445339|Public Health|public health
136751|NCT02445339|Vivitrol|vivitrol
136752|NCT02445339|XR-NTX|xr-ntx
136753|NCT02445339|XR-NTX+CM|xr-ntx+cm
136754|NCT02445339|Alcoholism|alcoholism
136755|NCT02445339|Alcohol-Related Disorders|alcohol-related disorders
136756|NCT02445339|Central Nervous System Agents|central nervous system agents
136757|NCT02445339|Chemically-Induced Disorders|chemically-induced disorders
136758|NCT02445339|Clinical Trial|clinical trial
136759|NCT02445339|Emergency Medicine|emergency medicine
136760|NCT02445339|Mental Disorders|mental disorders
136761|NCT02445339|Narcotic Antagonists|narcotic antagonists
136762|NCT02445339|Peripheral Nervous System Agents|peripheral nervous system agents
136763|NCT02445339|Pharmacologic Actions|pharmacologic actions
136764|NCT02445339|Physiological Effects of Drugs|physiological effects of drugs
136765|NCT02445339|Sensory System Agents|sensory system agents
136766|NCT02445339|Substance-Related Disorders|substance-related disorders
136767|NCT02445300|dressing|dressing
136769|NCT02445261|MOBILE PHONE ON AND IN AND|mobile phone on and in and
136770|NCT02445261|UMBILICAL ARTERY DOPPLER|umbilical artery doppler
136771|NCT02445261|FETAL CARDIOTOCOGRAPHY|fetal cardiotocography
136772|NCT02445261|GROWTH RESTRICTED FETUS|growth restricted fetus
138407|NCT02436044|FOLFOX4|folfox4
136773|NCT02445261|NORMAL GROWTH FETUS|normal growth fetus
136774|NCT02445248|Diffuse large B-cell lymphoma,|diffuse large b-cell lymphoma,
136775|NCT02445248|DLBCL,|dlbcl,
136776|NCT02445248|Relapsed/refractory,|relapsed/refractory,
136777|NCT02445248|CTL019|ctl019
136778|NCT02445248|CART19|cart19
136779|NCT02445248|CART|cart
136780|NCT02445248|CAR T cells|car t cells
136781|NCT02445248|Chimeric antigen receptor|chimeric antigen receptor
136782|NCT02445235|pain|pain
136783|NCT02445235|wound care|wound care
136784|NCT02445235|fungal infections|fungal infections
136785|NCT02445235|scars|scars
136786|NCT02445235|chronic pain|chronic pain
136787|NCT02445235|outcomes|outcomes
136788|NCT02445235|PRO|pro
136789|NCT02445209|HER2-negative gastric and GEJ adenocarcinoma|her2-negative gastric and gej adenocarcinoma
136790|NCT02445209|first-line palliative chemotherapy|first-line palliative chemotherapy
136791|NCT02445209|EOX|eox
136792|NCT02445209|mDCF|mdcf
136793|NCT02445209|efficacy|efficacy
136794|NCT02445209|safety|safety
136795|NCT02445170|Diabetes|diabetes
136796|NCT02445170|amputation|amputation
136797|NCT02445170|below-knee|below-knee
136798|NCT02445170|transmetatarsal|transmetatarsal
136799|NCT02445170|[M01.150.100]|[m01.150.100]
136800|NCT02445170|[C19.246.099]|[c19.246.099]
136801|NCT02445157|Gait speed|gait speed
136802|NCT02445157|Functional outcome measure|functional outcome measure
137499|NCT02441413|FRI|fri
136803|NCT02445144|Inflammation|inflammation
136804|NCT02445144|Blood Flow|blood flow
136805|NCT02445144|Cognition|cognition
136807|NCT02445118|adipose, allograft|adipose, allograft
136808|NCT02445092|Intrauterine insemination|intrauterine insemination
136809|NCT02445092|Insemination catheter prewashing|insemination catheter prewashing
136810|NCT02445092|Pregnancy outcome|pregnancy outcome
136811|NCT02445066|Vitamin D|vitamin d
136812|NCT02445053|Cystic Fibrosis|cystic fibrosis
136813|NCT02445040|High Frequency Oscillatory Ventilation|high frequency oscillatory ventilation
136814|NCT02445040|Infant, Very Low Birth Weight|infant, very low birth weight
136815|NCT02445040|Periventricular Leukomalacia|periventricular leukomalacia
136816|NCT02445040|Intraventricular Hemorrhage|intraventricular hemorrhage
136817|NCT02445040|multi-center study|multi-center study
136818|NCT02445027|Primary Care|primary care
136819|NCT02445027|Healthy|healthy
136820|NCT02445014|Barrett's|barrett's
136821|NCT02445014|GERD|gerd
136822|NCT02445014|Capsule|capsule
136823|NCT02445014|SECM|secm
136824|NCT02444988|crystalloid|crystalloid
136825|NCT02444988|acute kidney injury|acute kidney injury
136826|NCT02444975|Urinary Tract Infections|urinary tract infections
136827|NCT02444975|Water intake|water intake
136828|NCT02444936|solid tumor|solid tumor
136829|NCT02444936|chemotherapy|chemotherapy
136830|NCT02444936|vaccine|vaccine
136831|NCT02444923|Corneal rigid gas permeable contact lenses|corneal rigid gas permeable contact lenses
136832|NCT02444923|Scleral rigid gas permeable contact lenses|scleral rigid gas permeable contact lenses
136833|NCT02444923|Custom Scleral contact lenses|custom scleral contact lenses
136834|NCT02444923|Irregular cornea|irregular cornea
136835|NCT02444923|Keratoconus|keratoconus
136836|NCT02444923|Pellucid marginal degeneration|pellucid marginal degeneration
136837|NCT02444923|Post keratoplasty irregular cornea|post keratoplasty irregular cornea
136838|NCT02444923|Post refractive surgery irregular cornea|post refractive surgery irregular cornea
136839|NCT02444923|Traumatic irregular cornea|traumatic irregular cornea
136840|NCT02444910|KDT501|kdt501
136841|NCT02444910|Diabetes|diabetes
136842|NCT02444910|Diabetes Mellitus|diabetes mellitus
136843|NCT02444910|Type 2|type 2
136844|NCT02444910|KinDex|kindex
136845|NCT02444897|Gastric cancer|gastric cancer
136853|NCT02444858|paraquat poisoning|paraquat poisoning
136854|NCT02444858|lung injury|lung injury
136855|NCT02444858|stem cell therapy|stem cell therapy
136856|NCT02444858|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
136857|NCT02444858|phase 1/2 clinical study|phase 1/2 clinical study
136858|NCT02444858|allogeneic stem cell transplantation|allogeneic stem cell transplantation
136859|NCT02444819|HM61713|hm61713
136860|NCT02444819|Epidermal Growth Factor Receptor mutation positive NSCLC|epidermal growth factor receptor mutation positive nsclc
136861|NCT02444819|olmutinib|olmutinib
136862|NCT02444806|Sleep disordered breathing|sleep disordered breathing
136863|NCT02444806|Domiciliary NIV|domiciliary niv
136864|NCT02444741|Lung Cancer|lung cancer
136865|NCT02444741|Non-small cell lung cancer|non-small cell lung cancer
136866|NCT02444741|NSCLC|nsclc
136867|NCT02444741|Metastatic|metastatic
136868|NCT02444741|Pembrolizumab|pembrolizumab
136869|NCT02444741|Keytruda|keytruda
136870|NCT02444741|MK-3475|mk-3475
136871|NCT02444741|SCH-900475|sch-900475
136872|NCT02444741|Stereotactic body radiation therapy|stereotactic body radiation therapy
136873|NCT02444741|SBRT|sbrt
136874|NCT02444741|Wide-field radiation therapy|wide-field radiation therapy
136875|NCT02444741|WFRT|wfrt
136876|NCT02444741|Radiation therapy|radiation therapy
136878|NCT02444728|thrombocytopenia|thrombocytopenia
136879|NCT02444728|systemic lupus erythematosus|systemic lupus erythematosus
136880|NCT02444728|hydroxychloroquine|hydroxychloroquine
136881|NCT02444728|cyclophosphamide|cyclophosphamide
136882|NCT02444728|remission|remission
136883|NCT02444715|Lifestyle coaching|lifestyle coaching
136884|NCT02444715|Phone-based system|phone-based system
136885|NCT02444715|CVD prevention|cvd prevention
136886|NCT02444715|Patient-centered decision support|patient-centered decision support
136887|NCT02444702|spinal stenosis, clinical predictors rules, MRI, fusion, low back pain|spinal stenosis, clinical predictors rules, mri, fusion, low back pain
136888|NCT02444689|Blood pressure|blood pressure
136889|NCT02444689|Cardiovascular disease|cardiovascular disease
136890|NCT02444689|Children|children
136891|NCT02444689|Adolescent|adolescent
136892|NCT02444689|Pediatrics|pediatrics
136893|NCT02444689|End-organ damage|end-organ damage
136894|NCT02444650|Correlation|correlation
136895|NCT02444650|pulse wave velocity measurement|pulse wave velocity measurement
136896|NCT02444650|tonometry|tonometry
136897|NCT02444624|necrotizing enterocolitis|necrotizing enterocolitis
136898|NCT02444624|Clostridium|clostridium
136899|NCT02444624|premature birth|premature birth
136907|NCT02444598|wounds|wounds
136908|NCT02444598|negative-pressure wound therapy|negative-pressure wound therapy
136909|NCT02444598|conflict|conflict
136910|NCT02444598|gunshot wound|gunshot wound
136911|NCT02444598|blast injuries|blast injuries
136912|NCT02444598|civilian|civilian
136913|NCT02444598|war|war
136914|NCT02444559|Volunteers|volunteers
136915|NCT02444533|Liposomal Bupivacaine|liposomal bupivacaine
136916|NCT02444481|Mycotic Vaginitis|mycotic vaginitis
136917|NCT02444455|cellular therapy|cellular therapy
136918|NCT02444455|acute lung injury|acute lung injury
136919|NCT02444455|acute respiratory distress snydrome|acute respiratory distress snydrome
136920|NCT02444455|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
136921|NCT02444455|phase 1/2 clinical study|phase 1/2 clinical study
136922|NCT02444455|allogeneic stem cell transplantation|allogeneic stem cell transplantation
136923|NCT02444455|ALI|ali
136924|NCT02444455|ARDS|ards
136925|NCT02444442|Renal denervation|renal denervation
136926|NCT02444442|Blood pressure|blood pressure
136927|NCT02444442|Cardiovascular risk|cardiovascular risk
136928|NCT02444442|Target organ damage|target organ damage
136929|NCT02444442|Sympathetic activity|sympathetic activity
136930|NCT02444442|Non-compliance|non-compliance
136931|NCT02444429|Screening renal biopsy|screening renal biopsy
136932|NCT02444429|Immunosuppression|immunosuppression
136933|NCT02444403|HIV|hiv
136934|NCT02444403|Viral hepatitis|viral hepatitis
136935|NCT02444403|HCV|hcv
136936|NCT02444403|Needle-stick injury|needle-stick injury
136937|NCT02444403|Needle/syringes|needle/syringes
136938|NCT02444403|Structural intervention|structural intervention
136939|NCT02444403|Stepped wedge|stepped wedge
136940|NCT02444403|Police|police
136941|NCT02444403|Occupational safety|occupational safety
136942|NCT02444403|Police Training|police training
136943|NCT02444390|Failed non steroidal aromatases inhibitors|failed non steroidal aromatases inhibitors
136944|NCT02444390|Eligible for everolimus+exemestane|eligible for everolimus+exemestane
136945|NCT02444364|diabetes|diabetes
136946|NCT02444364|bone loss|bone loss
136947|NCT02444364|Bone Density|bone density
136948|NCT02444325|group prenatal care|group prenatal care
136949|NCT02444325|CenteringPregnancy|centeringpregnancy
136950|NCT02444325|diabetes|diabetes
136951|NCT02444312|Caregiving|caregiving
136952|NCT02444312|Benefit Finding|benefit finding
136953|NCT02444312|Writing Intervention|writing intervention
136954|NCT02444273|liver diseases|liver diseases
136955|NCT02444273|liver transplantation|liver transplantation
136956|NCT02444273|preoperative care|preoperative care
136957|NCT02444273|physical therapy|physical therapy
136958|NCT02444260|Inguinal Hernia,|inguinal hernia,
136959|NCT02444260|Local Anesthesia|local anesthesia
136960|NCT02444260|Randomized Clinical trial|randomized clinical trial
136961|NCT02444260|HERNIOPLASTY|hernioplasty
136962|NCT02444221|Atrial Fibrillation|atrial fibrillation
136963|NCT02444221|Rivaroxaban|rivaroxaban
136965|NCT02444195|gynecologic cancer|gynecologic cancer
136966|NCT02444195|guided imagery|guided imagery
136967|NCT02444195|postoperative distress|postoperative distress
136968|NCT02444195|perioperative distress|perioperative distress
136969|NCT02444143|Kidney|kidney
136970|NCT02444143|Immunosuppression|immunosuppression
136971|NCT02444143|Transplant|transplant
136972|NCT02444130|multifocality|multifocality
136973|NCT02444130|monovision|monovision
136974|NCT02444117|neurophysiology|neurophysiology
136975|NCT02444104|Left Ventricular Assist Device|left ventricular assist device
136976|NCT02444091|Chronic Fatigue Syndrome|chronic fatigue syndrome
136977|NCT02444091|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
136978|NCT02444091|Cyclophosphamide|cyclophosphamide
136979|NCT02444091|Immunomodulatory treatment|immunomodulatory treatment
136981|NCT02444078|Alzheimer Disease|alzheimer disease
136982|NCT02444078|Dementia|dementia
136983|NCT02444078|Physical activity|physical activity
136984|NCT02444078|Functional ability|functional ability
136985|NCT02444078|Disability|disability
136986|NCT02444078|Functional limitation|functional limitation
136987|NCT02444065|Cognitive behavior therapy|cognitive behavior therapy
136988|NCT02444065|Motivational interviewing|motivational interviewing
136989|NCT02444065|Bulimia nervosa|bulimia nervosa
136990|NCT02444065|Rapid response|rapid response
136991|NCT02444013|Contrast induced nephropathy|contrast induced nephropathy
136992|NCT02444000|chemotherapy|chemotherapy
136993|NCT02444000|PCV|pcv
136994|NCT02444000|radiotherapy|radiotherapy
136995|NCT02444000|post operative treatment|post operative treatment
136996|NCT02444000|anaplastic gliomas|anaplastic gliomas
136997|NCT02444000|1p/19q codeletion|1p/19q codeletion
136998|NCT02444000|cognition|cognition
136999|NCT02443987|Tension-Free Vaginal Tape|tension-free vaginal tape
137000|NCT02443961|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
137001|NCT02443961|pulmonary hypertension|pulmonary hypertension
137002|NCT02443961|stem cell therapy|stem cell therapy
137003|NCT02443961|mesenchymal stem cells|mesenchymal stem cells
137004|NCT02443961|very low weight preterm babies|very low weight preterm babies
137005|NCT02443922|type 2 diabetes|type 2 diabetes
137006|NCT02443922|beta cell function|beta cell function
137007|NCT02443922|meal tolerance test (MTT)|meal tolerance test (mtt)
137008|NCT02443922|maximal stimulation test (MaxStim)|maximal stimulation test (maxstim)
137009|NCT02443922|method standardization|method standardization
137010|NCT02443922|insulin secretion|insulin secretion
137011|NCT02443922|prediabetes|prediabetes
137012|NCT02443922|insulin sensitivity|insulin sensitivity
137013|NCT02443922|glimepiride|glimepiride
137014|NCT02443922|sitagliptin|sitagliptin
137015|NCT02443922|metformin|metformin
137016|NCT02443909|Holmium Laser|holmium laser
137017|NCT02443909|Kidney Stones|kidney stones
137018|NCT02443909|RIRS|rirs
137019|NCT02443883|stomach cancer|stomach cancer
137020|NCT02443844|BPH|bph
137021|NCT02443844|bladder cancer|bladder cancer
137022|NCT02443844|treatment|treatment
137023|NCT02443844|recurrence|recurrence
137024|NCT02443844|progression|progression
137025|NCT02443831|high risk relapsed CD19+ hematological malignancies|high risk relapsed cd19+ hematological malignancies
137026|NCT02443766|Integrative Medicine|integrative medicine
137027|NCT02443766|Alternative Medicine|alternative medicine
137028|NCT02443766|Complementary Medicine|complementary medicine
137029|NCT02443766|Meditation Retreat|meditation retreat
137030|NCT02443766|Ignatian Retreat|ignatian retreat
137031|NCT02443766|Single Photon Emission Computed Tomography (SPECT)|single photon emission computed tomography (spect)
137032|NCT02443766|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
137033|NCT02443766|Wellbeing|wellbeing
137034|NCT02443766|General Health|general health
137035|NCT02443740|First in human|first in human
137036|NCT02443740|Single Ascending Dose Study|single ascending dose study
137037|NCT02443740|Safety and Tolerability|safety and tolerability
137038|NCT02443740|Pharmacokinetics|pharmacokinetics
137039|NCT02443740|Plasma|plasma
137040|NCT02443740|Cerebrospinal Fluid|cerebrospinal fluid
137041|NCT02443714|Needle-Free Jet Injection|needle-free jet injection
137042|NCT02443714|Insulin Lispro|insulin lispro
137043|NCT02443714|pharmacokinetics|pharmacokinetics
137044|NCT02443714|pharmacodynamics|pharmacodynamics
137045|NCT02443636|Depression|depression
137046|NCT02443636|Mental Health|mental health
137047|NCT02443636|Registry|registry
137048|NCT02443636|Reliability|reliability
137049|NCT02443636|Post Traumatic Stress Disorder|post traumatic stress disorder
137050|NCT02443636|Bipolar Disorder|bipolar disorder
137051|NCT02443636|Mood disorder|mood disorder
137053|NCT02443610|Postpartum Hemorrhage|postpartum hemorrhage
137054|NCT02443610|Venous Thromboembolism|venous thromboembolism
137055|NCT02443610|Pregnancy|pregnancy
137056|NCT02443597|ultrasound|ultrasound
137057|NCT02443597|trisomy screening|trisomy screening
137058|NCT02443597|obesity|obesity
137059|NCT02443584|depression|depression
137060|NCT02443584|pharmacogenetics|pharmacogenetics
137061|NCT02443584|pharmacogenomics|pharmacogenomics
137062|NCT02443584|major depressive disorder|major depressive disorder
137063|NCT02443584|genetics|genetics
137064|NCT02443584|anti-depressants|anti-depressants
137065|NCT02443571|observational study|observational study
137066|NCT02443558|Robotics|robotics
137067|NCT02443558|Cerebral cortex|cerebral cortex
137068|NCT02443558|Brain waves|brain waves
137069|NCT02443558|Electroencephalography|electroencephalography
137070|NCT02443558|Rehabilitation|rehabilitation
137071|NCT02443558|Brain-Computer Interfaces|brain-computer interfaces
137072|NCT02443545|Iron overload|iron overload
137073|NCT02443545|Sickle cell disease|sickle cell disease
137074|NCT02443545|Deferiprone|deferiprone
137075|NCT02443545|Ferriprox|ferriprox
137076|NCT02443545|Iron chelation|iron chelation
137077|NCT02443519|Mindfulness|mindfulness
137078|NCT02443519|MBCT|mbct
137079|NCT02443519|Cognitive Therapy|cognitive therapy
137080|NCT02443519|Disability|disability
137081|NCT02443428|Breast Cancer|breast cancer
137082|NCT02443402|Non diabetic hyperglycemia|non diabetic hyperglycemia
137083|NCT02443389|nephrotoxic|nephrotoxic
137084|NCT02443389|Fluid overload|fluid overload
137085|NCT02443389|Acute renal failure|acute renal failure
137086|NCT02443389|Prematurity|prematurity
137087|NCT02443389|Risk factors|risk factors
137088|NCT02443389|Epidemiology|epidemiology
137089|NCT02443324|immuno-oncology|immuno-oncology
137090|NCT02443324|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
137091|NCT02443324|angiogenesis|angiogenesis
137092|NCT02443324|PD-1|pd-1
137093|NCT02443324|carcinoma of the bladder|carcinoma of the bladder
137094|NCT02443324|carcinoma of the urethra|carcinoma of the urethra
137095|NCT02443324|carcinoma of the ureter|carcinoma of the ureter
137096|NCT02443324|carcinoma of the renal pelvis|carcinoma of the renal pelvis
137097|NCT02443324|carcinoma of the biliary tract|carcinoma of the biliary tract
137098|NCT02443298|ABBV-066|abbv-066
137099|NCT02443298|BI 655066|bi 655066
137100|NCT02443298|risankizumab|risankizumab
137101|NCT02443259|NAPI|napi
137102|NCT02443259|late preterm|late preterm
137103|NCT02443207|Toothache|toothache
137104|NCT02443207|Quality of life|quality of life
137105|NCT02443207|Oral Health|oral health
137106|NCT02443207|Children|children
137107|NCT02443194|depression|depression
137108|NCT02443194|glioblastoma|glioblastoma
137109|NCT02443181|Essential tremor; closed-loop DBS|essential tremor; closed-loop dbs
137110|NCT02443168|Pharmacokinetic|pharmacokinetic
137111|NCT02443168|Healthy|healthy
137112|NCT02443168|Male|male
137113|NCT02443168|AG-221|ag-221
137114|NCT02443168|[14C]|[14c]
137115|NCT02443168|Single dose|single dose
137116|NCT02443168|Oral|oral
137117|NCT02443168|Intravenous|intravenous
137118|NCT02443142|mild TBI|mild tbi
137119|NCT02443142|concussion|concussion
137120|NCT02443142|post-concussion syndrome|post-concussion syndrome
137121|NCT02443103|pilot study|pilot study
137122|NCT02443103|guanabenz acetate|guanabenz acetate
137123|NCT02443090|secondary hypogonadism|secondary hypogonadism
137124|NCT02443090|sexual dysfunction|sexual dysfunction
137125|NCT02443090|erectile dysfunction|erectile dysfunction
752596|NCT01173276|Fertility|fertility
137126|NCT02443064|Pharmacokinetics/pharmacodynamics|pharmacokinetics/pharmacodynamics
137127|NCT02443064|vancomycin|vancomycin
137128|NCT02443064|blood stream infections|blood stream infections
137129|NCT02443064|Chinese patients|chinese patients
137130|NCT02443064|MRSA|mrsa
137131|NCT02443038|patient fall|patient fall
137132|NCT02443038|yoga|yoga
137133|NCT02443038|balance|balance
137134|NCT02443012|Diabetic Macular Edema|diabetic macular edema
137135|NCT02443012|Nepafenac|nepafenac
137136|NCT02443012|Laser therapy|laser therapy
137137|NCT02443012|Clinically significant macular edema|clinically significant macular edema
137138|NCT02443012|Adjunct Treatment|adjunct treatment
137139|NCT02443012|Topical Nepafenac|topical nepafenac
137140|NCT02442986|weaning failure|weaning failure
137141|NCT02442986|polyneuropathy|polyneuropathy
137142|NCT02442986|encephalopathy|encephalopathy
137143|NCT02442986|sepsis|sepsis
137144|NCT02442947|stress when dressed|stress when dressed
137145|NCT02442947|protective garment|protective garment
137146|NCT02442947|work clothes|work clothes
137147|NCT02442934|Critical Care|critical care
137148|NCT02442934|Critical Care Nursing|critical care nursing
137149|NCT02442934|Discomfort|discomfort
137150|NCT02442934|Sleep deprivation|sleep deprivation
137151|NCT02442934|Noise|noise
137152|NCT02442934|Thirst|thirst
137153|NCT02442934|Pain|pain
137154|NCT02442895|mature oocytes|mature oocytes
137155|NCT02442895|antral follicles count|antral follicles count
137156|NCT02442895|follicle stimulating hormone|follicle stimulating hormone
137157|NCT02442895|antimullerian hormone|antimullerian hormone
137158|NCT02442882|Brain Concussion|brain concussion
137159|NCT02442882|Balance|balance
137160|NCT02442882|Locomotion|locomotion
137161|NCT02442882|Mild Traumatic Brain Injury|mild traumatic brain injury
137162|NCT02442869|Suicide|suicide
137163|NCT02442817|DPP-4 Inhibitor|dpp-4 inhibitor
137164|NCT02442817|Linagliptin|linagliptin
137165|NCT02442817|SDF1-α|sdf1-α
137166|NCT02442804|Pomegranate|pomegranate
137167|NCT02442804|Stroke|stroke
137168|NCT02442804|Neuropsychology|neuropsychology
137169|NCT02442791|Cardiac arrest|cardiac arrest
137170|NCT02442791|GLP-1|glp-1
137171|NCT02442791|Neuroprotection|neuroprotection
137172|NCT02442752|Drug therapy|drug therapy
137173|NCT02442739|Ketamine|ketamine
137174|NCT02442739|Prevention of depression|prevention of depression
137175|NCT02442726|Heat Injury|heat injury
137176|NCT02442726|Humans|humans
137177|NCT02442726|Laser Stimulation|laser stimulation
137178|NCT02442726|Quantitative Sensory Testing|quantitative sensory testing
137179|NCT02442726|Reaction Time|reaction time
137180|NCT02442726|Secondary Hyperalgesia|secondary hyperalgesia
137181|NCT02442726|Thermal Thresholds|thermal thresholds
137182|NCT02442713|Polysomnograph|polysomnograph
137183|NCT02442713|fluvoxamine|fluvoxamine
137184|NCT02442700|HIV-infected patients with dyslipidemia and receiving atazanavir/ritonavir|hiv-infected patients with dyslipidemia and receiving atazanavir/ritonavir
137185|NCT02442674|Hyponatremia|hyponatremia
137186|NCT02442674|Euvolemic|euvolemic
137187|NCT02442674|Hypervolemic|hypervolemic
137188|NCT02442674|Serum sodium|serum sodium
137189|NCT02442674|Dilutional hyponatremia|dilutional hyponatremia
137190|NCT02442674|Electrolyte abnormality|electrolyte abnormality
137191|NCT02442674|Electrolyte imbalance|electrolyte imbalance
137192|NCT02442674|Metabolic disease|metabolic disease
137193|NCT02442674|Water-Electrolyte Imbalance|water-electrolyte imbalance
137194|NCT02442648|Renal Transplantation|renal transplantation
137195|NCT02442648|Carfilzomib|carfilzomib
137196|NCT02442648|Kyprolis|kyprolis
137197|NCT02442648|Desensitization|desensitization
137198|NCT02442622|de Quervain's disease|de quervain's disease
137199|NCT02442622|de Quervain's tenosynovitis.|de quervain's tenosynovitis.
137200|NCT02442622|ASTYM|astym
137201|NCT02442622|de Quervain's treatment|de quervain's treatment
137202|NCT02442609|internet|internet
137203|NCT02442609|anesthesia|anesthesia
137204|NCT02442609|information|information
137205|NCT02442609|surgery|surgery
137206|NCT02442609|question|question
137207|NCT02442596|Abdominal sepsis|abdominal sepsis
137208|NCT02442596|Sepsis|sepsis
137209|NCT02442596|Septic shock|septic shock
137210|NCT02442596|Epidemiology|epidemiology
137211|NCT02442596|Etiology|etiology
137212|NCT02442596|Microbiology|microbiology
137213|NCT02442596|Abdomen|abdomen
137214|NCT02442596|Intra-abdominal|intra-abdominal
137215|NCT02442596|Infection|infection
137216|NCT02442596|Gastrointestinal tract|gastrointestinal tract
137217|NCT02442596|Perforation|perforation
137218|NCT02442596|Peritonitis|peritonitis
137219|NCT02442596|Pancreas|pancreas
137220|NCT02442596|Biliary tract|biliary tract
137221|NCT02442596|Megacolon|megacolon
137222|NCT02442583|colorectal cancer|colorectal cancer
137223|NCT02442583|survivor|survivor
137224|NCT02442583|exercise|exercise
137225|NCT02442583|physical activity|physical activity
137226|NCT02442583|sedentary|sedentary
137227|NCT02442570|alpha B-crystallin|alpha b-crystallin
137228|NCT02442570|immune tolerance|immune tolerance
128237|NCT02495727|Atrophy|atrophy
137229|NCT02442557|alpha B-crystallin|alpha b-crystallin
137230|NCT02442557|immune tolerance|immune tolerance
137231|NCT02442518|placenta accreta|placenta accreta
137232|NCT02442518|placenta previa|placenta previa
137233|NCT02442518|ultrasound|ultrasound
137234|NCT02442505|Atrial Fibrillation; Pacemaker; Device-detected|atrial fibrillation; pacemaker; device-detected
137235|NCT02442492|sildenafil|sildenafil
137236|NCT02442492|IUGR|iugr
137237|NCT02442492|FGR|fgr
137238|NCT02442492|STRIDER|strider
137239|NCT02442479|exercise|exercise
137240|NCT02442479|resistance training|resistance training
137241|NCT02442479|muscle strength|muscle strength
137242|NCT02442479|muscle hypertrophy|muscle hypertrophy
137243|NCT02442440|anisodamine|anisodamine
137244|NCT02442440|septic shock|septic shock
137245|NCT02442427|Respiratory syncytial virus|respiratory syncytial virus
137246|NCT02442427|Palivizumab|palivizumab
137247|NCT02442427|Bronchiolitis|bronchiolitis
137248|NCT02442427|Treatment|treatment
137250|NCT02442414|Advanced Solid Tumors|advanced solid tumors
137251|NCT02442414|EGFR|egfr
137252|NCT02442414|HER2|her2
137253|NCT02442414|HER3|her3
137254|NCT02442414|HER4|her4
137255|NCT02442414|ALK mutations|alk mutations
137256|NCT02442414|irreversible tyrosine kinase inhibitor|irreversible tyrosine kinase inhibitor
137257|NCT02442414|Metastatic Non Small Cell Lung Cancer|metastatic non small cell lung cancer
137258|NCT02442414|Gastric Cancer|gastric cancer
137259|NCT02442414|Colorectal Cancer|colorectal cancer
137260|NCT02442388|pain|pain
137261|NCT02442388|root canal therapy|root canal therapy
137262|NCT02442388|endodontics|endodontics
137263|NCT02442388|file|file
137264|NCT02442375|head and neck cancer|head and neck cancer
137265|NCT02442375|accelerated radiotherapy|accelerated radiotherapy
137266|NCT02442375|dose reduction|dose reduction
137267|NCT02442375|dose de-escalation|dose de-escalation
137268|NCT02442375|elective lymph nodes|elective lymph nodes
137269|NCT02442375|FDG-PET|fdg-pet
137270|NCT02442349|Phase II, Open Label, Single-arm study, Safety and Efficacy of AZD9291, Asia Pacific, NSCLC with T790M mutation within the Epidermal Growth Factor Receptor Gene|phase ii, open label, single-arm study, safety and efficacy of azd9291, asia pacific, nsclc with t790m mutation within the epidermal growth factor receptor gene
137271|NCT02442310|deferiprone|deferiprone
137272|NCT02442310|deferiprone delayed release formulation|deferiprone delayed release formulation
137273|NCT02442310|pharmacokinetics|pharmacokinetics
137274|NCT02442297|Glioblastoma|glioblastoma
137275|NCT02442297|T cells Expressing HER2-specific Chimeric Antigen Receptors|t cells expressing her2-specific chimeric antigen receptors
137276|NCT02442297|HER2-specific T cells|her2-specific t cells
137277|NCT02442297|intracranial injection|intracranial injection
137278|NCT02442284|Chronic Hepatitis C|chronic hepatitis c
137279|NCT02442284|Interferon-Free|interferon-free
137280|NCT02442284|Hepatitis C Genotype 1|hepatitis c genotype 1
137281|NCT02442284|Hepatitis C Virus|hepatitis c virus
137282|NCT02442284|Hepatitis C|hepatitis c
137283|NCT02442284|Cirrhosis|cirrhosis
137284|NCT02442271|Chronic Hepatitis C|chronic hepatitis c
137285|NCT02442271|Hepatitis C Treatment Naive|hepatitis c treatment naive
137286|NCT02442271|Hepatitis C Genotype 1|hepatitis c genotype 1
138502|NCT02435537|intrathecal|intrathecal
137287|NCT02442271|Hepatitis C Treatment Experienced|hepatitis c treatment experienced
137288|NCT02442271|Hepatitis C Virus|hepatitis c virus
137289|NCT02442258|Renal Impairment|renal impairment
137290|NCT02442219|gluten|gluten
137291|NCT02442219|Tetramer|tetramer
137292|NCT02442206|QVA149, cardiac function, ventricular enddiastolic volume, hyperinflated COPD patients|qva149, cardiac function, ventricular enddiastolic volume, hyperinflated copd patients
137293|NCT02442154|early tracheostomy|early tracheostomy
137294|NCT02442154|severe head injury|severe head injury
137295|NCT02442154|endotracheal intubation|endotracheal intubation
137296|NCT02442141|Near-Infrared Spectroscopy|near-infrared spectroscopy
137297|NCT02442141|Cerebral|cerebral
137298|NCT02442141|Infants|infants
137299|NCT02442141|Anesthesia|anesthesia
137300|NCT02442141|Neurodevelopmental|neurodevelopmental
137301|NCT02442128|Fentany|fentany
137302|NCT02442128|intubation|intubation
137303|NCT02442128|sevoflurane|sevoflurane
137304|NCT02442128|children|children
137305|NCT02442128|Propofol|propofol
137306|NCT02442115|Autism|autism
137307|NCT02442115|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
137308|NCT02442115|Tummy Troubles|tummy troubles
137309|NCT02442115|Constipation|constipation
137310|NCT02442115|GI Disorders|gi disorders
137311|NCT02442115|Gastrointestinal Disorders|gastrointestinal disorders
137312|NCT02442115|Gastrointestinal|gastrointestinal
137313|NCT02442115|Oxidative Stress|oxidative stress
137314|NCT02442115|Stomach problems|stomach problems
137315|NCT02442115|Behaviors|behaviors
137317|NCT02442115|ASD|asd
137318|NCT02442115|MET gene|met gene
137319|NCT02442115|GID|gid
137320|NCT02442115|Pediatric|pediatric
137321|NCT02442115|Pediatric GI disorders|pediatric gi disorders
137322|NCT02442115|Children with Autism|children with autism
137323|NCT02442115|functional constipation|functional constipation
137324|NCT02442102|deglutition disorders|deglutition disorders
137325|NCT02442102|therapeutics|therapeutics
137326|NCT02442102|rehabilitation|rehabilitation
137327|NCT02442102|outcome assessment|outcome assessment
137328|NCT02442102|intubation|intubation
137329|NCT02442102|critical care|critical care
137330|NCT02442102|larynx|larynx
137331|NCT02442102|voice|voice
137332|NCT02442089|mHealth|mhealth
137333|NCT02442089|eHealth|ehealth
137334|NCT02442089|Health Systems|health systems
137335|NCT02442089|Health Technology|health technology
137336|NCT02442089|No Show|no show
137337|NCT02442089|Non-attendance|non-attendance
137338|NCT02442089|Chile|chile
137339|NCT02442089|Randomized controlled trial|randomized controlled trial
137340|NCT02442089|Efficiency, Organizational|efficiency, organizational
137341|NCT02442089|Pediatric Hospitals|pediatric hospitals
137342|NCT02442089|Global Health|global health
137343|NCT02442089|Referral and Consultation|referral and consultation
137344|NCT02442089|Health Care Systems|health care systems
137345|NCT02442089|Community Health Systems|community health systems
137346|NCT02442089|Health Information Systems|health information systems
137450|NCT02441764|Halaven|halaven
137347|NCT02442089|Integrated Health Care Systems|integrated health care systems
137348|NCT02442089|Community Medicine|community medicine
137349|NCT02442076|Skin vibration|skin vibration
137350|NCT02442076|Acupuncture needle vibration|acupuncture needle vibration
137351|NCT02442050|CABG|cabg
137352|NCT02442050|valve surgery|valve surgery
137353|NCT02442050|cardioplegia|cardioplegia
137354|NCT02442050|heart surgery|heart surgery
137355|NCT02442050|cardiac surgery|cardiac surgery
137356|NCT02442050|Cardio-Pulmonary Bypass|cardio-pulmonary bypass
137357|NCT02442050|myocardial arrest|myocardial arrest
137358|NCT02442050|coronary artery bypass graft|coronary artery bypass graft
137359|NCT02442050|CPB|cpb
137360|NCT02442037|cellular therapy|cellular therapy
137361|NCT02442037|active ulcerative colitis|active ulcerative colitis
137362|NCT02442037|phase 1/2 clinical study|phase 1/2 clinical study
137363|NCT02442037|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
137364|NCT02442037|allogeneic stem cell transplantation|allogeneic stem cell transplantation
137365|NCT02442037|UC|uc
137366|NCT02442024|diabetes mellitus|diabetes mellitus
137367|NCT02442024|diet|diet
137368|NCT02442024|nutrient sensing|nutrient sensing
137369|NCT02442011|Hematology Biobank|hematology biobank
137370|NCT02441998|Colorectal Cancer|colorectal cancer
137371|NCT02441998|Diminutive Polyps|diminutive polyps
137372|NCT02441998|Narrow Band Imaging|narrow band imaging
137373|NCT02441998|Colonic Polyps|colonic polyps
137374|NCT02441998|colonoscopy|colonoscopy
137375|NCT02441998|diagnostic imaging|diagnostic imaging
137376|NCT02441998|optical diagnosis|optical diagnosis
137377|NCT02441985|Primary orthostatic tremor|primary orthostatic tremor
137378|NCT02441946|cyclin-dependent kinase (CDK) 4/6 inhibitor|cyclin-dependent kinase (cdk) 4/6 inhibitor
137379|NCT02441946|CDK 4 and 6 inhibitor|cdk 4 and 6 inhibitor
137380|NCT02441907|Diabetic Macular Edema|diabetic macular edema
137381|NCT02441907|Ocular Cytokines|ocular cytokines
137382|NCT02441907|Triamcinolone Acetonide|triamcinolone acetonide
137383|NCT02441881|Radiofrequency ablation|radiofrequency ablation
137384|NCT02441881|varicose veins|varicose veins
137385|NCT02441881|endothermal ablation|endothermal ablation
137386|NCT02441881|RFITT|rfitt
137387|NCT02441881|Venefit|venefit
137388|NCT02441842|β-blocker|β-blocker
137389|NCT02441842|ACE inhibitor|ace inhibitor
137390|NCT02441842|Stress|stress
137391|NCT02441842|Craniotomy|craniotomy
137392|NCT02441842|Postop hypertension|postop hypertension
137393|NCT02441842|neurosurgical patients|neurosurgical patients
137394|NCT02441829|Renal Impairment|renal impairment
137395|NCT02441816|wet AMD|wet amd
137396|NCT02441816|neovascular AMD|neovascular amd
137397|NCT02441803|Leukemia|leukemia
137398|NCT02441803|Acute myeloid leukemia|acute myeloid leukemia
137399|NCT02441803|AML|aml
137400|NCT02441803|Refractory|refractory
137401|NCT02441803|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
137402|NCT02441803|AHSCT|ahsct
137403|NCT02441803|Busulfan|busulfan
137404|NCT02441803|Busulfex|busulfex
137405|NCT02441803|Myleran|myleran
137406|NCT02441803|Fludarabine|fludarabine
137407|NCT02441803|Fludarabine Phosphate|fludarabine phosphate
137408|NCT02441803|Fludara|fludara
137409|NCT02441803|Clofarabine|clofarabine
137410|NCT02441803|Clofarex|clofarex
137411|NCT02441803|Clolar|clolar
137412|NCT02441803|Total body irradiation|total body irradiation
137413|NCT02441803|TBI|tbi
137414|NCT02441803|XRT|xrt
137415|NCT02441803|Thymoglobulin|thymoglobulin
137416|NCT02441803|ATG (Rabbit)|atg (rabbit)
137417|NCT02441803|Rabbit antithymocyte Globulin|rabbit antithymocyte globulin
137418|NCT02441803|Rabbit Antilymphocyte Globulin|rabbit antilymphocyte globulin
137420|NCT02441803|rATG|ratg
137421|NCT02441803|Stem cell infusion|stem cell infusion
137422|NCT02441803|Cyclophosphamide|cyclophosphamide
137423|NCT02441803|Cytoxan|cytoxan
137424|NCT02441803|Neosar|neosar
137425|NCT02441803|Tacrolimus|tacrolimus
137426|NCT02441803|Prograf|prograf
137427|NCT02441803|Mycophenolate mofetil|mycophenolate mofetil
137428|NCT02441803|MMF|mmf
137429|NCT02441803|CellCept|cellcept
137430|NCT02441803|Decitabine|decitabine
137431|NCT02441803|Dacogen|dacogen
137432|NCT02441803|Cytarabine|cytarabine
137433|NCT02441803|Ara-C|ara-c
137434|NCT02441803|Cytosar|cytosar
137435|NCT02441803|DepoCyt|depocyt
137436|NCT02441803|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
137437|NCT02441803|Idarubicin|idarubicin
137438|NCT02441803|Idamycin|idamycin
137439|NCT02441790|5th metacarpal|5th metacarpal
137440|NCT02441790|EAROM|earom
137441|NCT02441790|standard immobilization|standard immobilization
137442|NCT02441790|Boxer's Fracture|boxer's fracture
137443|NCT02441790|hand function|hand function
137444|NCT02441790|DASH|dash
137445|NCT02441790|trauma|trauma
137446|NCT02441777|retinal imaging|retinal imaging
137447|NCT02441777|optical imaging|optical imaging
137448|NCT02441777|optical coherence tomography|optical coherence tomography
654803|NCT00789854|Depression|depression
137452|NCT02441764|locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
137454|NCT02441751|Hemorrhage|hemorrhage
137455|NCT02441751|Monitoring, Intraoperative|monitoring, intraoperative
137456|NCT02441738|Atrial Fibrillation|atrial fibrillation
137457|NCT02441738|Hybrid Ablation|hybrid ablation
137458|NCT02441738|Catheter Ablation|catheter ablation
137459|NCT02441686|Multiple Myeloma|multiple myeloma
137464|NCT02441621|fluid responsiveness|fluid responsiveness
137465|NCT02441621|diastolic dysfunction|diastolic dysfunction
137466|NCT02441621|left ventricular|left ventricular
137467|NCT02441556|thrombectomy|thrombectomy
137468|NCT02441556|rt-PA|rt-pa
137469|NCT02441556|stroke|stroke
137470|NCT02441556|endovascular treatment|endovascular treatment
137471|NCT02441556|randomized|randomized
137472|NCT02441530|vitamin D|vitamin d
137473|NCT02441517|Xtandi|xtandi
137474|NCT02441517|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
137475|NCT02441517|Metastatic|metastatic
137476|NCT02441517|Prostate Cancer|prostate cancer
137477|NCT02441517|Chemotherapy|chemotherapy
137478|NCT02441517|Castration-resistant|castration-resistant
137479|NCT02441517|Enzalutamide|enzalutamide
137480|NCT02441504|Exercise training|exercise training
137481|NCT02441504|microvascular rarefaction|microvascular rarefaction
137482|NCT02441478|cooperative behavior, therapy adherence, fMRI|cooperative behavior, therapy adherence, fmri
137483|NCT02441452|Nuss procedure|nuss procedure
137484|NCT02441452|postoperative care|postoperative care
137485|NCT02441452|early ambulation|early ambulation
137486|NCT02441426|Cognitive development|cognitive development
137487|NCT02441426|Diarrheal disease|diarrheal disease
137488|NCT02441426|Enteric infections|enteric infections
137489|NCT02441426|Malnutrition|malnutrition
137490|NCT02441426|Vaccine Response|vaccine response
137491|NCT02441426|Enteropathy|enteropathy
137492|NCT02441426|Antibiotic use|antibiotic use
137493|NCT02441426|Micronutrients|micronutrients
137494|NCT02441426|Breast feeding|breast feeding
137495|NCT02441426|Gut inflammation|gut inflammation
137496|NCT02441413|HRCT|hrct
137691|NCT02440464|Hematologic Disorders|hematologic disorders
137497|NCT02441413|High Resolution Computed Tomography scans|high resolution computed tomography scans
137498|NCT02441413|Functional Respiratory Imaging|functional respiratory imaging
137500|NCT02441413|Computed Tomography|computed tomography
137501|NCT02441413|CT|ct
137502|NCT02441413|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
137503|NCT02441413|BOS|bos
137504|NCT02441413|Lung Transplant|lung transplant
137505|NCT02441400|GERD|gerd
137506|NCT02441400|LES Pressure|les pressure
137507|NCT02441400|Electrical Stimulation|electrical stimulation
137508|NCT02441387|depression|depression
137509|NCT02441387|elderly|elderly
137510|NCT02441387|remission|remission
137511|NCT02441387|treatment response|treatment response
137512|NCT02441387|predictors of response|predictors of response
137513|NCT02441387|cognitive decline|cognitive decline
137514|NCT02441387|structural neuroimage|structural neuroimage
137515|NCT02441387|genetic polymorphism|genetic polymorphism
137516|NCT02441387|psychoeducation|psychoeducation
137517|NCT02441374|Stroke|stroke
137518|NCT02441374|Hemiparesis|hemiparesis
137519|NCT02441374|Upper limb|upper limb
137520|NCT02441348|Voice Therapy|voice therapy
137521|NCT02441348|Muscle Tension Dysphonia|muscle tension dysphonia
137522|NCT02441348|Lesions|lesions
137523|NCT02441309|Metastatic and/or Recurrent Osteosarcoma|metastatic and/or recurrent osteosarcoma
137524|NCT02441283|Hepatitis C|hepatitis c
137525|NCT02441283|Sustained virologic response|sustained virologic response
137526|NCT02441283|Direct Acting Antiviral|direct acting antiviral
137527|NCT02441283|Chronic hepatitis C|chronic hepatitis c
137528|NCT02441283|Hepatitis C virus|hepatitis c virus
137529|NCT02441257|Gastroesophageal Reflux|gastroesophageal reflux
137530|NCT02441257|Laryngeal Mask Airway|laryngeal mask airway
137531|NCT02441257|Control Ventilation|control ventilation
752597|NCT01173276|HIV|hiv
128588|NCT02493582|CIK|cik
137532|NCT02441257|Spontaneous Ventilation|spontaneous ventilation
137533|NCT02441205|High Intensity Interval Training|high intensity interval training
137534|NCT02441192|physical training|physical training
137535|NCT02441192|aerobic training|aerobic training
137536|NCT02441192|resistance training|resistance training
137537|NCT02441179|acute intermittent hypoxia|acute intermittent hypoxia
137538|NCT02441179|rehabilitation|rehabilitation
137539|NCT02441179|spinal cord injury|spinal cord injury
137540|NCT02441166|Bone marrow tryptase|bone marrow tryptase
137541|NCT02441166|cutaneous mastocytosis|cutaneous mastocytosis
137542|NCT02441140|Stage III Ovarian Cancer|stage iii ovarian cancer
137543|NCT02441140|Stage IV Ovarian Cancer|stage iv ovarian cancer
137544|NCT02441127|free gingival graft|free gingival graft
137545|NCT02441127|diode laser|diode laser
137546|NCT02441127|donor site|donor site
137547|NCT02441127|mucogingival surgery|mucogingival surgery
137548|NCT02441101|Cardiac Resynchronization therapy|cardiac resynchronization therapy
137549|NCT02441075|patients|patients
137551|NCT02441075|cyclosporine|cyclosporine
137552|NCT02441075|tacrolimus|tacrolimus
137553|NCT02441075|HSCT|hsct
137554|NCT02441049|Latino|latino
137555|NCT02441049|Hispanic|hispanic
137556|NCT02441049|Diet|diet
137557|NCT02441049|Family health|family health
137558|NCT02441049|Promotora|promotora
137559|NCT02441049|Intervention|intervention
137560|NCT02441036|Gene expression and protein production|gene expression and protein production
137561|NCT02441023|type 2 diabetes mellitus|type 2 diabetes mellitus
137562|NCT02441023|nutritional therapy|nutritional therapy
137563|NCT02441023|health education|health education
137564|NCT02441023|self-management|self-management
137565|NCT02441023|multimedia|multimedia
137566|NCT02440997|aromatherapy, peppermint|aromatherapy, peppermint
137567|NCT02440984|enteric nervous system|enteric nervous system
137568|NCT02440984|anorectal disorder|anorectal disorder
137569|NCT02440984|barostat anorectal|barostat anorectal
137570|NCT02440984|physiology|physiology
137571|NCT02440984|spina bifida|spina bifida
137572|NCT02440971|Adaptive Servo Ventilation|adaptive servo ventilation
137573|NCT02440971|Acute decompensated heart failure|acute decompensated heart failure
137574|NCT02440971|SleepMinder|sleepminder
137575|NCT02440971|ApneaLink Plus|apnealink plus
137576|NCT02440971|Sleep disordered breathing|sleep disordered breathing
137577|NCT02440971|Natriuretic peptide|natriuretic peptide
137578|NCT02440932|low Phenylalanine diet|low phenylalanine diet
137579|NCT02440932|PKU supplements|pku supplements
137580|NCT02440932|diet induced thermogenesis|diet induced thermogenesis
137581|NCT02440932|appetite|appetite
137582|NCT02440932|body weight|body weight
137583|NCT02440919|Respiratory mechanics|respiratory mechanics
137584|NCT02440919|Oxygenation|oxygenation
137585|NCT02440919|Suction|suction
137586|NCT02440919|Mechanical ventilation|mechanical ventilation
137587|NCT02440919|Respiratory therapy|respiratory therapy
137588|NCT02440919|Capnography|capnography
137589|NCT02440919|Pulmonary Ventilation|pulmonary ventilation
137590|NCT02440906|Asthma|asthma
137591|NCT02440906|Cerebrovascular Disease|cerebrovascular disease
137592|NCT02440906|Intracranial Injury|intracranial injury
137593|NCT02440906|Neoplasms|neoplasms
137594|NCT02440906|Heart Failure|heart failure
137595|NCT02440906|HIV/AIDs|hiv/aids
137596|NCT02440906|Hereditary and Degenerative Diseases of the Central Nervous System|hereditary and degenerative diseases of the central nervous system
137597|NCT02440906|Disorders of the Peripheral Nervous System|disorders of the peripheral nervous system
137598|NCT02440906|Rheumatoid Arthritis and Other Inflammatory Polyarthropathies|rheumatoid arthritis and other inflammatory polyarthropathies
137599|NCT02440906|History of hepatitis C|history of hepatitis c
137600|NCT02440906|Schizophrenia|schizophrenia
137601|NCT02440906|Episodic Mood Disorders|episodic mood disorders
137602|NCT02440906|Delusional Disorders|delusional disorders
137603|NCT02440906|Other Non-Organic Psychoses|other non-organic psychoses
137604|NCT02440906|Organic Psychotic Conditions|organic psychotic conditions
137605|NCT02440906|Neurotic Disorders|neurotic disorders
137606|NCT02440906|Other Non-Psychotic Mental Disorders|other non-psychotic mental disorders
137607|NCT02440867|theta burst stimulation|theta burst stimulation
137608|NCT02440867|Social Cognition|social cognition
137609|NCT02440867|MRSI|mrsi
137610|NCT02440867|Schizophrenia|schizophrenia
137611|NCT02440867|transcranial magnetic stimulation|transcranial magnetic stimulation
137612|NCT02440841|VA106483|va106483
137613|NCT02440841|fedovapagon|fedovapagon
137614|NCT02440841|drug-drug interaction|drug-drug interaction
137615|NCT02440841|DDI|ddi
137616|NCT02440841|males|males
137617|NCT02440841|rifampicin|rifampicin
137618|NCT02440841|rifampin|rifampin
137619|NCT02440841|itraconazole|itraconazole
137620|NCT02440841|CYP3A4|cyp3a4
137621|NCT02440841|pharmacokinetics|pharmacokinetics
137623|NCT02440815|Psychotherapy|psychotherapy
137624|NCT02440815|Problem Solving Therapy (PST)|problem solving therapy (pst)
137625|NCT02440815|Depression|depression
137626|NCT02440815|Major Depression|major depression
137627|NCT02440815|Major Depressive Disorder|major depressive disorder
137628|NCT02440815|Late Life Depression|late life depression
137629|NCT02440815|Multimodal imaging|multimodal imaging
137630|NCT02440815|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
137631|NCT02440815|Cerebral blood flow|cerebral blood flow
137632|NCT02440815|Cortical atrophy|cortical atrophy
137633|NCT02440815|White matter lesion|white matter lesion
137634|NCT02440763|Natural History|natural history
137635|NCT02440737|Newly diagnosed|newly diagnosed
137636|NCT02440737|Cancer patient|cancer patient
137637|NCT02440737|Caregiver|caregiver
137638|NCT02440737|Support person|support person
137639|NCT02440724|winged stents|winged stents
137640|NCT02440724|Self-expandable Metal Stents(SEMS)|self-expandable metal stents(sems)
137641|NCT02440724|partial covered|partial covered
137642|NCT02440724|uncovered|uncovered
137643|NCT02440724|endoscopic insertion|endoscopic insertion
137644|NCT02440685|DLBCL|dlbcl
137645|NCT02440685|FL|fl
137646|NCT02440685|MCL|mcl
137647|NCT02440685|PTCL|ptcl
137648|NCT02440685|MF|mf
137649|NCT02440685|CLL|cll
137650|NCT02440672|Osteoarthritis|osteoarthritis
137651|NCT02440672|TKA|tka
137652|NCT02440672|Degenerative Knee Disease|degenerative knee disease
137653|NCT02440659|Chronic Kidney Disease|chronic kidney disease
137654|NCT02440659|Hemodialysis|hemodialysis
137655|NCT02440659|Peritoneal Dialysis|peritoneal dialysis
137656|NCT02440646|Computed tomography angiography|computed tomography angiography
137657|NCT02440646|Quantitative coronary angiography|quantitative coronary angiography
137658|NCT02440646|Coronary artery disease|coronary artery disease
137659|NCT02440646|Natural history of atherosclerosis|natural history of atherosclerosis
137660|NCT02440646|Radiocontrast-induced thyroid dysfunction|radiocontrast-induced thyroid dysfunction
137661|NCT02440646|Contrast-induced nephropathy|contrast-induced nephropathy
137662|NCT02440646|Plaque burden|plaque burden
137663|NCT02440646|Glagovian artery remodeling|glagovian artery remodeling
137664|NCT02440646|Radiation dose|radiation dose
137665|NCT02440646|SYNTAX score|syntax score
137666|NCT02440646|Fractional flow reserve|fractional flow reserve
137667|NCT02440620|Heart failure related to medical treatment of breast cancer|heart failure related to medical treatment of breast cancer
137668|NCT02440607|Randomization|randomization
137669|NCT02440607|cognitive aids types|cognitive aids types
137670|NCT02440607|aids|aids
137671|NCT02440594|Primary Care|primary care
137672|NCT02440594|Depression|depression
137673|NCT02440594|Elderly|elderly
137674|NCT02440555|diabetes, capillary blood glucose, self-administered questionnaire|diabetes, capillary blood glucose, self-administered questionnaire
137675|NCT02440542|Nerve block|nerve block
137676|NCT02440542|Ankle|ankle
137677|NCT02440542|Talus|talus
137678|NCT02440542|Pain, Postoperative|pain, postoperative
137679|NCT02440516|Standardized|standardized
137680|NCT02440516|Physical therapy|physical therapy
137681|NCT02440516|occupational therapy|occupational therapy
137682|NCT02440516|quality of life|quality of life
137683|NCT02440516|disability|disability
137684|NCT02440516|activities of daily living|activities of daily living
137685|NCT02440516|ambulatory therapy|ambulatory therapy
137686|NCT02440516|multiple sclerosis|multiple sclerosis
137687|NCT02440464|Multiple Myeloma|multiple myeloma
137688|NCT02440464|Allogeneic Transplant|allogeneic transplant
137689|NCT02440464|Maintenance Therapy|maintenance therapy
137690|NCT02440464|Anti-Myeloma Agents|anti-myeloma agents
137692|NCT02440438|Clostridium difficile, recurrence, relapse, antibodies, immune response, prognosis|clostridium difficile, recurrence, relapse, antibodies, immune response, prognosis
137693|NCT02440425|platinum resistant|platinum resistant
137694|NCT02440425|recurrent|recurrent
137695|NCT02440425|persistent|persistent
137696|NCT02440425|epithelial|epithelial
137697|NCT02440425|ovarian|ovarian
137698|NCT02440425|fallopian tube|fallopian tube
137699|NCT02440425|primary peritoneal|primary peritoneal
137700|NCT02440425|carcinoma|carcinoma
137701|NCT02440412|Massage|massage
137702|NCT02440412|Stress|stress
137703|NCT02440412|salivary cortisol|salivary cortisol
137704|NCT02440360|chronic homelessness|chronic homelessness
137705|NCT02440347|local anesthesia|local anesthesia
137706|NCT02440347|articaine|articaine
137707|NCT02440347|AMSA|amsa
137708|NCT02440334|cryosurgery|cryosurgery
137709|NCT02440334|ultrasonography|ultrasonography
137710|NCT02440282|patients|patients
137711|NCT02440256|Cost-effectiveness|cost-effectiveness
137712|NCT02440256|Opioid substitution treatment|opioid substitution treatment
137713|NCT02440256|Integrated care|integrated care
137714|NCT02440256|HIV|hiv
137715|NCT02440256|HAART|haart
137716|NCT02440256|Testing|testing
137717|NCT02440256|Linkage to care|linkage to care
137718|NCT02440256|Treatment adherence|treatment adherence
137719|NCT02440230|adjuvant endocrine therapy|adjuvant endocrine therapy
137723|NCT02440230|anastrozole|anastrozole
137724|NCT02440204|sevoflurane|sevoflurane
137725|NCT02440204|remifentanil|remifentanil
137726|NCT02440204|intubation without using muscle relaxants|intubation without using muscle relaxants
137727|NCT02440178|leukemia|leukemia
137728|NCT02440178|induction|induction
137729|NCT02440178|prophylaxis|prophylaxis
137730|NCT02440178|antifungal|antifungal
137731|NCT02440178|micafungin|micafungin
137732|NCT02440178|phase II|phase ii
137733|NCT02440165|nutrition|nutrition
137734|NCT02440165|nurse|nurse
137735|NCT02440165|intervention|intervention
137736|NCT02440165|malnutrition|malnutrition
137737|NCT02440126|Multiple Sclerosis|multiple sclerosis
137738|NCT02440126|immunological|immunological
137739|NCT02440126|biomarkers|biomarkers
137740|NCT02440126|observational|observational
137741|NCT02440126|Relapsing|relapsing
137742|NCT02440126|Remitting Multiple Sclerosis|remitting multiple sclerosis
137743|NCT02440100|Phase 1|phase 1
137744|NCT02440100|Multiple doses of PF-06648671|multiple doses of pf-06648671
137745|NCT02440100|safety, tolerability, PK|safety, tolerability, pk
137746|NCT02440100|plasma and CSF abeta|plasma and csf abeta
137747|NCT02440100|drug interaction|drug interaction
137748|NCT02440074|Lumbar pain|lumbar pain
137749|NCT02440074|Mesenchymal Stem Cells|mesenchymal stem cells
137750|NCT02440061|Ghrelin|ghrelin
137751|NCT02440061|age, BMI, and gender matched controls|age, bmi, and gender matched controls
137752|NCT02440048|extraction|extraction
137753|NCT02440048|Bond Apatite|bond apatite
137754|NCT02440035|Healthy Participants|healthy participants
137755|NCT02440035|Ad35.RSV.FA2|ad35.rsv.fa2
137756|NCT02440035|JNJ-61187191|jnj-61187191
137757|NCT02439996|Kawasaki disease IVIG DNA variation|kawasaki disease ivig dna variation
137758|NCT02439970|kidney transplant allograft|kidney transplant allograft
137759|NCT02439970|recipients|recipients
137760|NCT02439944|Nicotine Patch|nicotine patch
137761|NCT02439944|Nicotine Mouth Spray|nicotine mouth spray
137762|NCT02439944|Smoking Cessation|smoking cessation
137763|NCT02439944|Quit Smoking|quit smoking
137764|NCT02439944|Abstinence|abstinence
137765|NCT02439944|Dependence|dependence
137766|NCT02439944|Nicotine|nicotine
137767|NCT02439944|Tobacco|tobacco
137768|NCT02439944|Transdermal Nicotine Replacement Therapy|transdermal nicotine replacement therapy
137769|NCT02439944|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
137770|NCT02439944|Neuroimaging|neuroimaging
137771|NCT02439944|Cue Reactivity|cue reactivity
137772|NCT02439944|Resting State|resting state
137773|NCT02439944|BOLD fMRI|bold fmri
137774|NCT02439905|inflammatory cytokine|inflammatory cytokine
137775|NCT02439905|protective effect|protective effect
137776|NCT02439905|Dexmedetomidine|dexmedetomidine
137777|NCT02439905|Precedex|precedex
137778|NCT02439905|one lung ventilation|one lung ventilation
137779|NCT02439905|ischemia-reperfusion|ischemia-reperfusion
137780|NCT02439892|Radiotherapy|radiotherapy
137781|NCT02439892|Exercise|exercise
137782|NCT02439892|Diet therapy|diet therapy
137783|NCT02439892|Rehabilitation|rehabilitation
137784|NCT02439892|Patient Compliance|patient compliance
137785|NCT02439892|Feasibility Studies|feasibility studies
137786|NCT02439892|Sample Size|sample size
137787|NCT02439892|Patient satisfaction|patient satisfaction
137788|NCT02439853|primary progressive aphasia|primary progressive aphasia
137789|NCT02439853|progressive nonfluent aphasia|progressive nonfluent aphasia
137790|NCT02439853|progressive aphasia|progressive aphasia
137791|NCT02439853|frontotemporal dementia|frontotemporal dementia
137792|NCT02439853|frontotemporal lobar degeneration|frontotemporal lobar degeneration
137793|NCT02439827|Lifestyle|lifestyle
137794|NCT02439827|Intervention|intervention
138100|NCT02437942|diagnosis|diagnosis
137795|NCT02439827|Motor Activity|motor activity
137796|NCT02439827|Mediating Variables|mediating variables
137797|NCT02439827|Mental Health|mental health
137798|NCT02439827|Obesity|obesity
137799|NCT02439827|Adolescent Health|adolescent health
137800|NCT02439827|School|school
137801|NCT02439827|Health Promotion|health promotion
137802|NCT02439827|Brazil|brazil
137803|NCT02439801|PEEP|peep
137804|NCT02439801|compliance|compliance
137805|NCT02439801|peak airway pressures|peak airway pressures
137806|NCT02439788|Neuroblastoma|neuroblastoma
137807|NCT02439788|Natural Killer T Cells|natural killer t cells
137808|NCT02439788|Gene Therapy|gene therapy
137809|NCT02439788|Chimeric Antigen Receptor|chimeric antigen receptor
137810|NCT02439775|Uncontrolled hypertension|uncontrolled hypertension
137811|NCT02439775|Renal denervation|renal denervation
137812|NCT02439762|Veterans|veterans
137813|NCT02439762|Cognitive Behavioral Therapy|cognitive behavioral therapy
137814|NCT02439749|Uncontrolled hypertension|uncontrolled hypertension
137815|NCT02439749|Renal denervation|renal denervation
137816|NCT02439736|Traumatic Brain Injury|traumatic brain injury
137817|NCT02439736|Head Injury|head injury
137818|NCT02439723|Regorafenib|regorafenib
137819|NCT02439723|Lean body mass|lean body mass
137820|NCT02439723|Proton pump inhibitors pharmacokinetics|proton pump inhibitors pharmacokinetics
137821|NCT02439684|HbA1c|hba1c
137822|NCT02439684|Diagnostic accuracy|diagnostic accuracy
137823|NCT02439684|Diabetes Mellitus|diabetes mellitus
137824|NCT02439684|Chinese|chinese
166282|NCT02278874|XXX|xxx
128879|NCT02491879|gel|gel
137825|NCT02439684|Impaired fasting glucose|impaired fasting glucose
137826|NCT02439671|Transition Support Program for young adults|transition support program for young adults
137827|NCT02439658|genetic research|genetic research
137828|NCT02439645|genetic research|genetic research
137829|NCT02439606|GlideRite|gliderite
137830|NCT02439606|Stylet|stylet
137831|NCT02439606|Parker|parker
137832|NCT02439606|orotracheal|orotracheal
137833|NCT02439606|intubation|intubation
137834|NCT02439606|GlideScope|glidescope
137835|NCT02439593|Pancreas|pancreas
137836|NCT02439593|chemoradiotherapy|chemoradiotherapy
654805|NCT00789854|TRD|trd
137837|NCT02439593|hyperthermia|hyperthermia
137838|NCT02439580|Patients|patients
137839|NCT02439580|After Surgery|after surgery
137840|NCT02439567|Cirrhosis|cirrhosis
137841|NCT02439567|Chronic hepatitis C|chronic hepatitis c
137842|NCT02439567|Clinically significant portal hypertension|clinically significant portal hypertension
137843|NCT02439567|Portal hypertension|portal hypertension
137844|NCT02439567|Elastography|elastography
137845|NCT02439567|Antiviral therapy|antiviral therapy
137846|NCT02439541|cellular therapy|cellular therapy
137847|NCT02439541|Chronic ischemic heart disease|chronic ischemic heart disease
137848|NCT02439541|phase 1/2 clinical study|phase 1/2 clinical study
137849|NCT02439541|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
137850|NCT02439541|ischemic heart disease|ischemic heart disease
137851|NCT02439541|allogeneic stem cell transplantation|allogeneic stem cell transplantation
137852|NCT02439528|pulmonary fibrosis|pulmonary fibrosis
137853|NCT02439528|syndrome|syndrome
137854|NCT02439528|genetic|genetic
137855|NCT02439528|emphysema|emphysema
137856|NCT02439515|post-acute stroke|post-acute stroke
137857|NCT02439515|functional electrical stimulation|functional electrical stimulation
137858|NCT02439515|biofeedback|biofeedback
137859|NCT02439515|balance|balance
137860|NCT02439515|cycling|cycling
137861|NCT02439515|rehabilitation|rehabilitation
137862|NCT02439515|gait|gait
137863|NCT02439476|Multiple myeloma|multiple myeloma
137864|NCT02439476|ASCT|asct
137865|NCT02439476|plerixafor|plerixafor
137866|NCT02439476|stem cell mobilization|stem cell mobilization
137867|NCT02439476|Salvage ASCT using plerixafor-based stem cell mobilization in relapsed multiple myeloma|salvage asct using plerixafor-based stem cell mobilization in relapsed multiple myeloma
137868|NCT02439450|lung|lung
137869|NCT02439450|cancer|cancer
137870|NCT02439450|gp96|gp96
137871|NCT02439450|vaccine|vaccine
137872|NCT02439450|immunotherapy|immunotherapy
137873|NCT02439450|Heat Biologics|heat biologics
137874|NCT02439450|Nivolumab|nivolumab
137875|NCT02439450|checkpoint inhibitor|checkpoint inhibitor
137876|NCT02439385|Curcumin|curcumin
137877|NCT02439385|Avastin|avastin
137878|NCT02439385|FOLFIRI|folfiri
137879|NCT02439385|Colorectal cancer|colorectal cancer
137880|NCT02439385|Unresectable metastasis|unresectable metastasis
137881|NCT02439346|Advanced solid tumors|advanced solid tumors
137882|NCT02439346|Docetaxel|docetaxel
137883|NCT02439346|mitogen-activated protein (MAP) kinase-interacting serine / threonine-protein kinase 1, also known as Mnk1 (MKNK1 inhibitor)|mitogen-activated protein (map) kinase-interacting serine / threonine-protein kinase 1, also known as mnk1 (mknk1 inhibitor)
137884|NCT02439346|Taxanes|taxanes
137885|NCT02439346|Non-small cell lung cancer|non-small cell lung cancer
137886|NCT02439333|Acute exacerbation of chronic obstructive pulmonary disease|acute exacerbation of chronic obstructive pulmonary disease
137887|NCT02439333|Nasal high flow therapy|nasal high flow therapy
137888|NCT02439333|Oxygen therapy|oxygen therapy
137889|NCT02439307|Rifaximin|rifaximin
137890|NCT02439307|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
137891|NCT02439294|Recent acute myocardial infarction|recent acute myocardial infarction
137892|NCT02439294|Obstructive sleep apnée (syndrome)|obstructive sleep apnée (syndrome)
137893|NCT02439294|Ventricular remodeling|ventricular remodeling
137894|NCT02439294|Continuous Positive Airway Pressure|continuous positive airway pressure
137895|NCT02439281|Ropivacaine|ropivacaine
137896|NCT02439281|Anesthesia adjuncts|anesthesia adjuncts
137897|NCT02439281|clonidine|clonidine
137898|NCT02439281|laparoscopic appendectomy|laparoscopic appendectomy
137899|NCT02439281|rectus sheath block|rectus sheath block
137900|NCT02439242|stroke volume, haemodynamic, fluid resucitation|stroke volume, haemodynamic, fluid resucitation
137901|NCT02439216|Muscular Dystrophies|muscular dystrophies
137902|NCT02439216|Musculoskeletal Diseases|musculoskeletal diseases
137903|NCT02439216|Nervous System Diseases|nervous system diseases
137904|NCT02439216|Neuromuscular Diseases|neuromuscular diseases
137905|NCT02439216|Duchenne muscular dystrophy|duchenne muscular dystrophy
137907|NCT02439216|dystrophin|dystrophin
137908|NCT02439216|dystrophy|dystrophy
137909|NCT02439216|Duchenne|duchenne
137910|NCT02439203|Parkinson Disease|parkinson disease
137911|NCT02439203|Levodopa Induced Dyskinesia (LID)|levodopa induced dyskinesia (lid)
137912|NCT02439203|Dyskinesia|dyskinesia
137913|NCT02439177|Blood glucose monitoring system|blood glucose monitoring system
137914|NCT02439177|System Accuracy|system accuracy
137915|NCT02439164|sedation|sedation
137916|NCT02439164|eloquent area glioma|eloquent area glioma
137917|NCT02439164|neurologic function|neurologic function
137918|NCT02439151|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
137919|NCT02439138|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
137920|NCT02439125|levodopa|levodopa
137921|NCT02439125|dyskinesia|dyskinesia
137922|NCT02439125|parkinsons disease|parkinsons disease
137923|NCT02439125|PD|pd
137924|NCT02439112|Exercise|exercise
137925|NCT02439112|Physical Function|physical function
137926|NCT02439112|Physical Activity|physical activity
137927|NCT02439112|Quality of Life|quality of life
137931|NCT02439086|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
137932|NCT02439086|long course radiotherapy|long course radiotherapy
137934|NCT02439047|reconstructive surgery|reconstructive surgery
137935|NCT02439047|abdominal surgery|abdominal surgery
137936|NCT02439034|pain management|pain management
137937|NCT02439034|brachytherapy|brachytherapy
137940|NCT02438969|Alcohol|alcohol
137941|NCT02438969|Alcohol Dependence|alcohol dependence
137942|NCT02438969|Stress|stress
137943|NCT02438969|Fear Conditioning|fear conditioning
137944|NCT02438917|Hepatitis C|hepatitis c
137945|NCT02438917|Cirrhosis|cirrhosis
137946|NCT02438917|Biomarkers|biomarkers
137947|NCT02438917|Fibrosis|fibrosis
137948|NCT02438904|Blood And Marrow Transplantation|blood and marrow transplantation
137949|NCT02438904|Stem cell transplantation|stem cell transplantation
137950|NCT02438904|SCT|sct
137951|NCT02438904|Poor graft function|poor graft function
137952|NCT02438904|CD34+ cell infusion|cd34+ cell infusion
137953|NCT02438865|Upper Tract Urothelial Carcinoma|upper tract urothelial carcinoma
137954|NCT02438865|Intravesical Chemotherapy|intravesical chemotherapy
137955|NCT02438865|Epirubicin|epirubicin
137956|NCT02438865|Urothelial Carcinoma|urothelial carcinoma
137957|NCT02438800|Postpartum Period|postpartum period
137958|NCT02438787|Ankylosing Spondylitis|ankylosing spondylitis
137959|NCT02438787|Ustekinumab|ustekinumab
137960|NCT02438787|Golimumab|golimumab
137961|NCT02438787|STELARA|stelara
137962|NCT02438774|Post-harvest practices , complementary foods|post-harvest practices , complementary foods
137963|NCT02438774|aflatoxins and fumonisins exposure,|aflatoxins and fumonisins exposure,
137964|NCT02438774|Maize, breast milk|maize, breast milk
137965|NCT02438774|child growth, Tanzania|child growth, tanzania
137966|NCT02438761|Acute Myeloid Leukemia|acute myeloid leukemia
137967|NCT02438761|Myelodysplastic Syndrome|myelodysplastic syndrome
137968|NCT02438761|PIK/Akt/mTor|pik/akt/mtor
137969|NCT02438748|Oxidized Phosphatidylcholines|oxidized phosphatidylcholines
137970|NCT02438735|ovarian endometriomas|ovarian endometriomas
137971|NCT02438735|AMH|amh
137972|NCT02438735|ovarian reserve|ovarian reserve
137973|NCT02438670|Artificial Pancreas|artificial pancreas
137974|NCT02438670|Type 1 Diabetes|type 1 diabetes
137975|NCT02438670|MPC|mpc
137976|NCT02438670|PID|pid
137977|NCT02438631|placenta|placenta
137978|NCT02438631|placental passage|placental passage
137979|NCT02438605|Nellix|nellix
137980|NCT02438605|EVAS|evas
137981|NCT02438605|EVAR|evar
137982|NCT02438605|Dynamic CT|dynamic ct
137983|NCT02438605|Dyna CT|dyna ct
137984|NCT02438592|Continuum of care|continuum of care
137985|NCT02438579|Hypertonic saline|hypertonic saline
137986|NCT02438579|nasal irrigation|nasal irrigation
137987|NCT02438579|gargling|gargling
137988|NCT02438579|URTI|urti
137989|NCT02438566|Tranexamic Acid|tranexamic acid
137990|NCT02438566|Blood Loss|blood loss
137991|NCT02438566|Total Hip Replacement|total hip replacement
137992|NCT02438566|Bilateral Knee Replacement|bilateral knee replacement
137993|NCT02438540|acupuncture|acupuncture
137994|NCT02438540|obesity|obesity
137995|NCT02438540|type 2 diabetic mellitus|type 2 diabetic mellitus
137996|NCT02438540|insulin sensitivity|insulin sensitivity
137997|NCT02438540|metformin|metformin
137998|NCT02438540|inflammatory factor|inflammatory factor
137999|NCT02438540|adipokines|adipokines
138000|NCT02438540|lipid profile|lipid profile
138001|NCT02438501|low-dose involved field radiotherapy|low-dose involved field radiotherapy
138002|NCT02438501|recurrent|recurrent
138003|NCT02438501|advanced|advanced
138004|NCT02438501|follicular lymphoma|follicular lymphoma
138005|NCT02438462|Pulmonary Embolism|pulmonary embolism
138006|NCT02438462|Soluble Fibrin|soluble fibrin
138007|NCT02438462|D-Dimers|d-dimers
138008|NCT02438462|Clinical Probability Score|clinical probability score
138009|NCT02438462|Imaging|imaging
138010|NCT02438449|breast reconstruction|breast reconstruction
138011|NCT02438449|mastectomy|mastectomy
138012|NCT02438449|health-related quality of life|health-related quality of life
138013|NCT02438449|Health Utilities Index|health utilities index
138015|NCT02438449|prospective|prospective
138016|NCT02438449|quality-adjusted life years|quality-adjusted life years
138017|NCT02438449|QALY|qaly
138018|NCT02438410|infliximab|infliximab
138019|NCT02438410|remicade|remicade
138020|NCT02438410|IBD|ibd
138021|NCT02438410|Colitis, Ulcerative|colitis, ulcerative
138022|NCT02438371|pregnancy|pregnancy
138023|NCT02438371|preterm labor|preterm labor
138024|NCT02438371|tocolysis|tocolysis
138025|NCT02438293|rhinovirus|rhinovirus
138026|NCT02438293|cardiac surgery|cardiac surgery
138027|NCT02438293|paediatric|paediatric
138028|NCT02438293|respiratory infection|respiratory infection
138029|NCT02438293|children|children
138030|NCT02438280|Orthodontic|orthodontic
138031|NCT02438280|Orthodontic treatment|orthodontic treatment
138032|NCT02438280|Accelerated orthodontics|accelerated orthodontics
138033|NCT02438280|Vibration|vibration
138034|NCT02438241|Pain Measurement|pain measurement
138035|NCT02438241|Electric Stimulation|electric stimulation
138036|NCT02438241|Spirometry|spirometry
138037|NCT02438241|Manometry|manometry
138038|NCT02438228|cardiac output|cardiac output
138039|NCT02438228|transpulmonary thermodilution|transpulmonary thermodilution
138040|NCT02438228|pulse contour analysis|pulse contour analysis
138041|NCT02438228|G09.330.380.124|g09.330.380.124
138042|NCT02438215|PD|pd
138043|NCT02438215|Parkinson's Disease|parkinson's disease
138044|NCT02438189|Type 1 Diabetes|type 1 diabetes
138045|NCT02438189|Hypoglycemia|hypoglycemia
138046|NCT02438189|Hyperglycemia|hyperglycemia
138047|NCT02438189|Artificial Pancreas|artificial pancreas
138048|NCT02438163|Theta Burst Stimulation|theta burst stimulation
138049|NCT02438150|Disaster|disaster
138050|NCT02438150|Training|training
138051|NCT02438137|Obstructive Sleep Apnea|obstructive sleep apnea
138052|NCT02438137|OSA|osa
138053|NCT02438137|sleep apnea|sleep apnea
138054|NCT02438137|snoring|snoring
138055|NCT02438137|dimethyl fumarate|dimethyl fumarate
138056|NCT02438137|CPAP|cpap
138057|NCT02438137|continuous positive airway pressure|continuous positive airway pressure
138058|NCT02438124|Parkinson's disease|parkinson's disease
138059|NCT02438124|Rhythmic auditory stimulation|rhythmic auditory stimulation
138060|NCT02438124|Gait|gait
138061|NCT02438098|Rivaroxaban|rivaroxaban
138062|NCT02438098|Obesity|obesity
138063|NCT02438098|Bariatric surgery|bariatric surgery
138064|NCT02438098|Pharmacokinetics|pharmacokinetics
138065|NCT02438098|Pharmacodynamics|pharmacodynamics
138066|NCT02438085|acute coronary syndromes|acute coronary syndromes
138067|NCT02438085|outcome|outcome
138068|NCT02438085|medical management|medical management
138069|NCT02438085|comorbidities|comorbidities
138070|NCT02438085|registry|registry
138071|NCT02438072|antidepressive agent|antidepressive agent
138072|NCT02438072|drug metabolism|drug metabolism
138073|NCT02438072|CYP450|cyp450
138074|NCT02438072|P-glycoprotein|p-glycoprotein
138075|NCT02438072|Phenotypic study|phenotypic study
138076|NCT02438059|Inequality in health|inequality in health
138077|NCT02438059|workplace health promotion|workplace health promotion
138078|NCT02438059|internet|internet
138079|NCT02438059|mobile app|mobile app
138080|NCT02438059|weight loss|weight loss
138081|NCT02438059|intervention|intervention
138082|NCT02438059|randomized controlled trial|randomized controlled trial
138083|NCT02438046|Connective Tissue Grafts|connective tissue grafts
138084|NCT02438046|Wound healing|wound healing
138085|NCT02438046|Biomaterials|biomaterials
138086|NCT02438046|Pain|pain
138087|NCT02438046|Clinical Trials|clinical trials
138088|NCT02438046|Mucogingival Surgery|mucogingival surgery
138089|NCT02438033|Deep Brain Stimulation|deep brain stimulation
138090|NCT02438033|Globus Pallidus|globus pallidus
138091|NCT02438033|GPi|gpi
138092|NCT02438033|PC+S|pc+s
138093|NCT02438020|Acanthosis nigricans|acanthosis nigricans
138094|NCT02438020|obesity|obesity
138095|NCT02438020|children|children
138096|NCT02438020|metformin|metformin
138097|NCT02437942|Athletic injuries|athletic injuries
138098|NCT02437942|chronic|chronic
138099|NCT02437942|rehabilitation|rehabilitation
138101|NCT02437942|biomechanics|biomechanics
138102|NCT02437916|Melanoma|melanoma
138103|NCT02437916|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
138104|NCT02437916|Squamous Cell Carcinoma|squamous cell carcinoma
138105|NCT02437916|Carcinoma|carcinoma
138106|NCT02437916|Head and Neck|head and neck
138107|NCT02437916|Transitional Cell Carinoma (TCC)|transitional cell carinoma (tcc)
138108|NCT02437916|Bladder|bladder
138109|NCT02437916|Colorectal|colorectal
138110|NCT02437916|Colorectal Cancer (CRC)|colorectal cancer (crc)
138111|NCT02437903|voluma temporal, facial, volume loss|voluma temporal, facial, volume loss
138112|NCT02437877|Respiration|respiration
138113|NCT02437877|Learning|learning
138114|NCT02437877|Speech|speech
138115|NCT02437877|Language and Hearing Sciences|language and hearing sciences
138116|NCT02437799|Pulse oximeter|pulse oximeter
138117|NCT02437799|Caesarean section|caesarean section
138118|NCT02437799|hypotension|hypotension
138119|NCT02437799|Spinal anaesthesia|spinal anaesthesia
138120|NCT02437773|OCD|ocd
138121|NCT02437747|clinical trial|clinical trial
138122|NCT02437708|regenerative endodontics|regenerative endodontics
138123|NCT02437708|platelet rich fibrin|platelet rich fibrin
138124|NCT02437695|Robotic Surgical Procedures|robotic surgical procedures
138125|NCT02437695|Trendelenburg Position|trendelenburg position
138126|NCT02437682|Gastro-esophageal Reflux Disease|gastro-esophageal reflux disease
138127|NCT02437682|Proton pump inhibitor|proton pump inhibitor
138129|NCT02437669|Hydromorphone|hydromorphone
138130|NCT02437669|Pediatric|pediatric
138131|NCT02437669|Emergency department|emergency department
138132|NCT02437656|Radiochemotherapy|radiochemotherapy
138133|NCT02437656|Metformin|metformin
138134|NCT02437656|Rectal cancer|rectal cancer
138135|NCT02437617|Advanced cancers|advanced cancers
138136|NCT02437617|Tumor tissue|tumor tissue
138137|NCT02437617|Genomic profile test|genomic profile test
138138|NCT02437617|Analysis of treatment outcomes|analysis of treatment outcomes
138139|NCT02437617|Molecular profiling|molecular profiling
138140|NCT02437617|Molecular alteration|molecular alteration
138141|NCT02437591|ASP2819|asp2819
138142|NCT02437591|PAR-101|par-101
138143|NCT02437591|OPT-80|opt-80
138144|NCT02437591|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
138145|NCT02437591|Clostridium difficile Infection (CDI)|clostridium difficile infection (cdi)
138146|NCT02437591|fidaxomicin|fidaxomicin
138147|NCT02437591|Dificlir|dificlir
138148|NCT02437578|vitamin d|vitamin d
138149|NCT02437578|fertility|fertility
138150|NCT02437578|markers|markers
138151|NCT02437578|endocrine disruption|endocrine disruption
138152|NCT02437578|reproduction|reproduction
138153|NCT02437552|Cardiac Surgery, Coronary Artery Bypass, Exercise Movement Techniques|cardiac surgery, coronary artery bypass, exercise movement techniques
138154|NCT02437526|Cure|cure
138155|NCT02437526|Analytic treatment interruption|analytic treatment interruption
138156|NCT02437513|Dysphagia|dysphagia
138157|NCT02437513|Aspiration|aspiration
138158|NCT02437513|Laryngeal cancer|laryngeal cancer
138159|NCT02437474|vegan diet|vegan diet
138160|NCT02437474|lacto-ovo-vegetarian diet|lacto-ovo-vegetarian diet
138161|NCT02437474|cancer|cancer
138162|NCT02437474|tumor remission|tumor remission
138163|NCT02437461|knee synovitis|knee synovitis
138164|NCT02437461|triamcinolone hexacetonide|triamcinolone hexacetonide
138165|NCT02437461|treatment response|treatment response
138166|NCT02437448|Mass spectrometry|mass spectrometry
138167|NCT02437448|Exhaled breath analysis|exhaled breath analysis
138168|NCT02437435|assisted reproduction|assisted reproduction
138169|NCT02437435|physical therapy|physical therapy
138170|NCT02437435|manual therapy|manual therapy
138171|NCT02437435|uterine artery|uterine artery
138172|NCT02437435|Vascularization Index (VI)|vascularization index (vi)
138173|NCT02437435|Doppler ultrasonography|doppler ultrasonography
138174|NCT02437435|vocal|vocal
138175|NCT02437409|Ischemic, Acute|ischemic, acute
138176|NCT02437357|Psychotherapy, Group|psychotherapy, group
138177|NCT02437357|Metacognition|metacognition
138178|NCT02437357|Cognitive Bias|cognitive bias
138179|NCT02437331|Advanced heart failure|advanced heart failure
138180|NCT02437331|diseased experience|diseased experience
138181|NCT02437318|HR+|hr+
138182|NCT02437318|HER2-negative|her2-negative
138183|NCT02437318|advanced breast cancer|advanced breast cancer
138184|NCT02437318|alpelisib|alpelisib
138185|NCT02437318|fulvestrant|fulvestrant
138186|NCT02437318|PI3K|pi3k
138187|NCT02437318|Phase III|phase iii
138188|NCT02437318|ER+|er+
138189|NCT02437318|PgR+|pgr+
138190|NCT02437318|men|men
138191|NCT02437318|postmenopausal|postmenopausal
138192|NCT02437318|aromatase inhibitor|aromatase inhibitor
138193|NCT02437318|neoplasms|neoplasms
138194|NCT02437305|Melanoma|melanoma
138195|NCT02437305|People of Color|people of color
138196|NCT02437279|Palpable|palpable
138197|NCT02437279|Stage III|stage iii
138198|NCT02437279|Skin melanoma|skin melanoma
138199|NCT02437279|Ipilimumab|ipilimumab
138200|NCT02437279|Nivolumab|nivolumab
138201|NCT02437279|Surgery|surgery
138202|NCT02437253|Mucopolysaccharidosis|mucopolysaccharidosis
138203|NCT02437253|Inflammation|inflammation
138204|NCT02437253|Tumor necrosis factor - alpha inhibitor|tumor necrosis factor - alpha inhibitor
138205|NCT02437240|Pilates-based exercise|pilates-based exercise
138206|NCT02437240|respiratory mechanics|respiratory mechanics
138207|NCT02437240|cardiopulmonary physical therapy|cardiopulmonary physical therapy
138208|NCT02437240|sternotomy|sternotomy
138209|NCT02437175|pelvic pain|pelvic pain
138210|NCT02437175|quality of life|quality of life
138211|NCT02437175|adenomyosis|adenomyosis
138212|NCT02437162|Axial Spondyloarthritis|axial spondyloarthritis
138213|NCT02437162|Ustekinumab|ustekinumab
138214|NCT02437162|Golimumab|golimumab
138215|NCT02437162|Stelara|stelara
138216|NCT02437149|Texting and driving|texting and driving
138217|NCT02437149|Teenager and driving|teenager and driving
138218|NCT02437149|Distracted Driving Campaign|distracted driving campaign
138219|NCT02437123|mHealth|mhealth
138220|NCT02437123|Indigenous|indigenous
138221|NCT02437123|HIV prevention|hiv prevention
138883|NCT02433158|VOC|voc
138222|NCT02437123|substance use|substance use
138223|NCT02437110|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
138224|NCT02437110|Virus|virus
138225|NCT02437110|Antiretroviral Therapy|antiretroviral therapy
138226|NCT02437071|Radiotherapy|radiotherapy
138227|NCT02437071|Ablation|ablation
138228|NCT02437071|Pembrolizumab|pembrolizumab
138229|NCT02437071|15-069|15-069
654806|NCT00789867|Single dose|single dose
138230|NCT02437071|Metastatic Colorectal Cancer Patients|metastatic colorectal cancer patients
138231|NCT02437032|GDF-9|gdf-9
138232|NCT02437032|BMP-15|bmp-15
138233|NCT02437032|Steroids|steroids
138234|NCT02437032|Apoptosis rate|apoptosis rate
138235|NCT02437032|Endocrinology|endocrinology
138236|NCT02437019|PCI-32765|pci-32765
138237|NCT02437019|Ibrutinib|ibrutinib
138238|NCT02437019|Early access program|early access program
138239|NCT02437019|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
138240|NCT02437019|Relapsed or refractory chronic lymphocytic leukemia|relapsed or refractory chronic lymphocytic leukemia
138241|NCT02437006|stroke|stroke
138242|NCT02437006|exercise capacity|exercise capacity
138243|NCT02436993|Neoadjuvant Treatment|neoadjuvant treatment
138244|NCT02436993|Carboplatin|carboplatin
138245|NCT02436993|Paclitaxel|paclitaxel
138246|NCT02436993|Pertuzumab|pertuzumab
138247|NCT02436993|Trastuzumab|trastuzumab
138248|NCT02436993|Bevacizumab|bevacizumab
138249|NCT02436980|premedication|premedication
138250|NCT02436980|ERCP|ercp
138251|NCT02436980|midazolam|midazolam
138252|NCT02436980|tramadol|tramadol
138253|NCT02436980|cognitive|cognitive
138254|NCT02436928|H7N9 Influenza|h7n9 influenza
138255|NCT02436928|Avian influenza A|avian influenza a
138256|NCT02436928|cell culture derived|cell culture derived
138257|NCT02436915|Slow gait|slow gait
138258|NCT02436915|Executive function|executive function
138259|NCT02436915|Transcranial direct current stimulation|transcranial direct current stimulation
138260|NCT02436876|Osteosynthesis|osteosynthesis
138261|NCT02436876|Complications|complications
138262|NCT02436876|Infection or Inflammation|infection or inflammation
138263|NCT02436876|Orthopedic|orthopedic
138264|NCT02436876|Device|device
138265|NCT02436876|Fracture|fracture
138266|NCT02436863|Laminectomy|laminectomy
138267|NCT02436863|Laminoplasty|laminoplasty
138268|NCT02436863|Internal fixation|internal fixation
138269|NCT02436863|deformity|deformity
138270|NCT02436850|Thoracentesis|thoracentesis
138271|NCT02436850|Pocket Ultrasound Device|pocket ultrasound device
138272|NCT02436850|Ultrasound|ultrasound
138273|NCT02436850|Soroka University Medical Center|soroka university medical center
138274|NCT02436850|Physical Examination|physical examination
138275|NCT02436850|Ethical Committee|ethical committee
138276|NCT02436824|topical patch|topical patch
138277|NCT02436824|chronic low back pain|chronic low back pain
138278|NCT02436811|Health literacy|health literacy
138279|NCT02436811|Pregnant women|pregnant women
138280|NCT02436811|Feeding behaviour|feeding behaviour
138281|NCT02436811|Oral health|oral health
138282|NCT02436811|Child|child
138283|NCT02436798|QT prolongation|qt prolongation
138284|NCT02436798|Genomic biomarkers|genomic biomarkers
138285|NCT02436785|music therapy|music therapy
138286|NCT02436785|pain management|pain management
138287|NCT02436785|self efficacy|self efficacy
138288|NCT02436785|patient education|patient education
138289|NCT02436785|relaxation|relaxation
138290|NCT02436746|Von Recklinghausen's disease|von recklinghausen's disease
138291|NCT02436746|Bourneville's disease|bourneville's disease
138292|NCT02436746|Cognitive variability|cognitive variability
138293|NCT02436746|Loss of heterozygosity|loss of heterozygosity
138294|NCT02436733|pleural mesothelioma|pleural mesothelioma
138295|NCT02436733|phase II|phase ii
138296|NCT02436733|randomized|randomized
138297|NCT02436733|surgery|surgery
138298|NCT02436733|chemotherapy|chemotherapy
138299|NCT02436733|feasibility|feasibility
138300|NCT02436694|Dexamethasone|dexamethasone
138301|NCT02436694|Perineural|perineural
138302|NCT02436655|aortic stenosis|aortic stenosis
138303|NCT02436655|normal ejection fraction|normal ejection fraction
138304|NCT02436655|asymptomatic|asymptomatic
138305|NCT02436629|Red beetroot juice|red beetroot juice
138306|NCT02436629|High intensity intermittent exercise|high intensity intermittent exercise
138307|NCT02436629|Nitrite|nitrite
138308|NCT02436629|Soccer|soccer
138309|NCT02436616|EEG|eeg
138310|NCT02436616|Preterm Infants|preterm infants
138311|NCT02436616|Neonate|neonate
138312|NCT02436616|wireless|wireless
138313|NCT02436603|Irritable Bowel Syndrome|irritable bowel syndrome
138314|NCT02436603|IBS|ibs
138315|NCT02436603|Mind-Body Training|mind-body training
138316|NCT02436603|Integrative Medicine|integrative medicine
138317|NCT02436603|FODMAP|fodmap
138318|NCT02436590|osteoarthritis|osteoarthritis
138319|NCT02436590|knee|knee
138320|NCT02436590|pulsed electromagnetic fields|pulsed electromagnetic fields
138321|NCT02436590|PEMF|pemf
138322|NCT02436577|ticagrelor orodispersible tablet|ticagrelor orodispersible tablet
138323|NCT02436577|ticagrelor immediate-release tablet|ticagrelor immediate-release tablet
138325|NCT02436577|Phase I|phase i
138326|NCT02436577|healthy Japanese subjects|healthy japanese subjects
138327|NCT02436564|pancreas|pancreas
138328|NCT02436564|stem cells|stem cells
138329|NCT02436564|tumours|tumours
138330|NCT02436564|in vitro models|in vitro models
138331|NCT02436564|organoids|organoids
138332|NCT02436564|cancer,|cancer,
138333|NCT02436564|bile duct|bile duct
138334|NCT02436564|liver|liver
138335|NCT02436538|anti-Müllerian hormone (AMH)|anti-müllerian hormone (amh)
138336|NCT02436538|Mullerian anomalies|mullerian anomalies
138337|NCT02436538|ICSI|icsi
138338|NCT02436447|Renal Impairment, Renal function, MTP-131, Bendavia™|renal impairment, renal function, mtp-131, bendavia™
138339|NCT02436434|Pulsed radiofrequency, osteoarthritis|pulsed radiofrequency, osteoarthritis
138340|NCT02436395|gastric cancer|gastric cancer
138341|NCT02436395|gastrectomy|gastrectomy
138342|NCT02436395|laparotomy|laparotomy
138343|NCT02436395|SSIs|ssis
138344|NCT02436395|povidone-iodine|povidone-iodine
138345|NCT02436395|normal saline|normal saline
138346|NCT02436369|diabetic patients|diabetic patients
138347|NCT02436369|flaxseed|flaxseed
138348|NCT02436369|lipid profile|lipid profile
139044|NCT02432183|individual|individual
138349|NCT02436369|cardiovascular risc factors|cardiovascular risc factors
138350|NCT02436343|left ventricular functions|left ventricular functions
138351|NCT02436343|pregnancy|pregnancy
138352|NCT02436343|obesity|obesity
138353|NCT02436330|Exergaming, Weight management|exergaming, weight management
138354|NCT02436317|Point Of Care Ultrasonography|point of care ultrasonography
138355|NCT02436317|Soroka University Medical Center|soroka university medical center
138356|NCT02436317|Heart Failure|heart failure
138357|NCT02436317|cardiovascular|cardiovascular
138358|NCT02436278|Gait speed|gait speed
138359|NCT02436278|Mortality|mortality
138360|NCT02436278|Morbidity|morbidity
138361|NCT02436265|Neuraxial|neuraxial
138362|NCT02436265|Caudal|caudal
138363|NCT02436265|Block|block
138364|NCT02436265|Anesthesia|anesthesia
138365|NCT02436265|Dexamethasone|dexamethasone
138366|NCT02436252|Myelodysplastic Syndrome|myelodysplastic syndrome
138368|NCT02436226|PCOS|pcos
138369|NCT02436226|Clomiphene citrate resistant|clomiphene citrate resistant
138371|NCT02436213|workload|workload
138372|NCT02436213|oxygen level|oxygen level
138373|NCT02436213|oxygen consumption|oxygen consumption
138374|NCT02436213|breathing reserve|breathing reserve
138375|NCT02436213|ventilatory efficiency|ventilatory efficiency
138376|NCT02436200|Intermittent Claudication|intermittent claudication
138377|NCT02436200|IC|ic
138378|NCT02436200|Peripheral Arterial Disease|peripheral arterial disease
138379|NCT02436200|Peripheral Vascular Disease|peripheral vascular disease
138380|NCT02436200|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
138381|NCT02436187|NSTEMI|nstemi
138382|NCT02436187|excess mortality|excess mortality
138383|NCT02436187|evidence-based care|evidence-based care
138384|NCT02436187|MINAP|minap
138385|NCT02436161|Heart Failure|heart failure
138386|NCT02436161|Comorbidity|comorbidity
138387|NCT02436161|Patient Care Management|patient care management
138388|NCT02436161|Primary Health Care|primary health care
138389|NCT02436161|Delivery of Health Care, Integrated|delivery of health care, integrated
138390|NCT02436148|PEQ validation study, Finland|peq validation study, finland
138391|NCT02436122|Prostate cancer|prostate cancer
138392|NCT02436122|Preoperative|preoperative
138393|NCT02436122|Glycemic control|glycemic control
138394|NCT02436122|Hemoglobin A1c|hemoglobin a1c
138395|NCT02436122|Pathologic outcomes|pathologic outcomes
138396|NCT02436122|Oncological outcomes|oncological outcomes
138397|NCT02436122|Treatment Outcome|treatment outcome
138398|NCT02436122|Hemoglobin A1c Protein, Human|hemoglobin a1c protein, human
138399|NCT02436096|Pain|pain
138400|NCT02436096|Sleep|sleep
138401|NCT02436070|Pediatrics|pediatrics
138402|NCT02436070|Emergency Medicine|emergency medicine
138403|NCT02436070|Text messaging|text messaging
138404|NCT02436044|Hepatocellular Carcinoma|hepatocellular carcinoma
138405|NCT02436044|Locally advanced stge|locally advanced stge
138406|NCT02436044|HAIC|haic
138408|NCT02436044|Locally advanced|locally advanced
138409|NCT02436018|Sedation|sedation
138410|NCT02436018|Low pulse oximetry|low pulse oximetry
138411|NCT02436018|Upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
138412|NCT02436018|WEI NASAL JET|wei nasal jet
138413|NCT02434965|Neonates|neonates
138414|NCT02434965|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
138415|NCT02434965|human placental-derived stem cells|human placental-derived stem cells
138416|NCT02434965|autologous|autologous
138417|NCT02434952|Malaria, Falciparum|malaria, falciparum
138418|NCT02434952|G6PD deficiency|g6pd deficiency
138419|NCT02434952|Primaquine|primaquine
138420|NCT02434952|Asia|asia
138421|NCT02434926|fetoscopy|fetoscopy
138422|NCT02434926|fetal surgery|fetal surgery
138423|NCT02434926|anesthetic complications|anesthetic complications
139099|NCT02431975|HIV|hiv
138424|NCT02434913|Proximal interphalangeal joint deformity|proximal interphalangeal joint deformity
129449|NCT02488122|Bone Growth|bone growth
129450|NCT02488109|anorexia nervosa|anorexia nervosa
129451|NCT02488109|eating disorders|eating disorders
129452|NCT02488109|refeeding|refeeding
129453|NCT02488109|adolescent medicine|adolescent medicine
138425|NCT02434913|Arthroplasty|arthroplasty
138427|NCT02435979|proximal strengthening|proximal strengthening
138428|NCT02435979|hand therapy|hand therapy
138429|NCT02435953|Hepatocellular Carcinoma,TACE,Chemoembolization, RFA,Intermediate-stage|hepatocellular carcinoma,tace,chemoembolization, rfa,intermediate-stage
138430|NCT02435940|inherited retinal degenerative disease|inherited retinal degenerative disease
138431|NCT02435940|retinitis pigmentosa|retinitis pigmentosa
138432|NCT02435940|Usher|usher
138433|NCT02435940|Leber|leber
138434|NCT02435940|Bardet-Biedl|bardet-biedl
138435|NCT02435940|Batten|batten
138436|NCT02435940|Best|best
138437|NCT02435940|cone dystrophy|cone dystrophy
138438|NCT02435940|cone-rod dystrophy|cone-rod dystrophy
138439|NCT02435940|choroideremia|choroideremia
138440|NCT02435940|congenital night blindness|congenital night blindness
138441|NCT02435940|enhanced s-cone|enhanced s-cone
138442|NCT02435940|cone monochromacy|cone monochromacy
138443|NCT02435940|Goldmann-Favre|goldmann-favre
138444|NCT02435940|Kearns-Sayre|kearns-sayre
138445|NCT02435940|Refsum|refsum
138446|NCT02435940|retinoschisis|retinoschisis
138447|NCT02435940|rod-cone dystrophy|rod-cone dystrophy
138451|NCT02435940|stargardt|stargardt
138452|NCT02435940|achromatopsia|achromatopsia
138453|NCT02435940|juvenile inherited macular degeneration|juvenile inherited macular degeneration
138454|NCT02435940|cone dichromacy|cone dichromacy
138455|NCT02435940|cone trichromacy|cone trichromacy
138456|NCT02435940|Charcot-Marie-Tooth|charcot-marie-tooth
138457|NCT02435940|albipunctate dystrophy|albipunctate dystrophy
138458|NCT02435901|Reduced Intensity Conditioning Regimen|reduced intensity conditioning regimen
138459|NCT02435888|Resting energy expenditure|resting energy expenditure
138460|NCT02435888|Predictive equations|predictive equations
138461|NCT02435888|Overweight|overweight
138462|NCT02435875|hypertension|hypertension
138463|NCT02435875|perioperative|perioperative
138464|NCT02435875|baroreflex sensitivity|baroreflex sensitivity
138465|NCT02435862|Vitreolysis of the Vitreous|vitreolysis of the vitreous
138466|NCT02435849|Pediatric, ALL, Cell therapy|pediatric, all, cell therapy
138467|NCT02435810|Neuroinflammation|neuroinflammation
138468|NCT02435810|Infections|infections
138469|NCT02435797|nicorandil|nicorandil
138470|NCT02435797|primary percutaneous coronary intervention|primary percutaneous coronary intervention
138471|NCT02435797|acute ST segment elevation myocardial infarction|acute st segment elevation myocardial infarction
138472|NCT02435797|thrombus aspiration|thrombus aspiration
138473|NCT02435784|2-COM|2-com
138474|NCT02435745|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
138475|NCT02435745|Obstructive Sleep Apnea|obstructive sleep apnea
138476|NCT02435745|Prevalence|prevalence
138477|NCT02435745|Aortic Aneurysm|aortic aneurysm
138478|NCT02435719|HCAIs|hcais
138479|NCT02435719|Handgel|handgel
138480|NCT02435719|Hospital|hospital
138481|NCT02435719|Effectiveness|effectiveness
138482|NCT02435706|Dental implants|dental implants
138483|NCT02435706|surgical flap|surgical flap
138484|NCT02435706|esthetics|esthetics
138485|NCT02435706|alveolar process|alveolar process
138486|NCT02435693|pharmaceutical care|pharmaceutical care
138487|NCT02435680|MCS110; carboplatin; gemcitabine; TNBC; TAMs|mcs110; carboplatin; gemcitabine; tnbc; tams
138488|NCT02435667|Resistance Training|resistance training
138489|NCT02435667|Exercise|exercise
138490|NCT02435667|Heart Failure preserved Ejection Fraction|heart failure preserved ejection fraction
138491|NCT02435654|Genes Polymorphisms|genes polymorphisms
138492|NCT02435654|Plasma Concentration|plasma concentration
138493|NCT02435602|endoscopy, gastrointestinal|endoscopy, gastrointestinal
138494|NCT02435602|cancer screening|cancer screening
138495|NCT02435576|Acute toxicity|acute toxicity
138496|NCT02435576|Late toxicity|late toxicity
138497|NCT02435576|NTCP models|ntcp models
138498|NCT02435563|Anti-HIV Agents|anti-hiv agents
138499|NCT02435563|cardiovascular agents|cardiovascular agents
138500|NCT02435563|drug interactions|drug interactions
138501|NCT02435537|analgesia|analgesia
138503|NCT02435537|opioids|opioids
138504|NCT02435537|morphine|morphine
138505|NCT02435537|dexmedetomidine|dexmedetomidine
138506|NCT02435524|Breast Feeding, Exclusive|breast feeding, exclusive
138507|NCT02435524|Infant Nutrition|infant nutrition
138508|NCT02435524|Burkina Faso|burkina faso
138509|NCT02435511|agent-based modeling|agent-based modeling
138510|NCT02435511|community resources|community resources
138511|NCT02435511|simulation modeling|simulation modeling
138512|NCT02435511|information intervention|information intervention
138513|NCT02435511|clinic-to-community linkages|clinic-to-community linkages
138514|NCT02435485|degerative lumbar spondylolisthesis|degerative lumbar spondylolisthesis
138515|NCT02435485|rehabilitation|rehabilitation
138516|NCT02435485|balance|balance
138517|NCT02435472|Active Surveillance|active surveillance
138518|NCT02435472|Exercise|exercise
138519|NCT02435472|Prostate cancer|prostate cancer
138520|NCT02435472|Life style|life style
138521|NCT02435472|Survey|survey
139187|NCT02431559|PLD|pld
138532|NCT02435342|ShK-186|shk-186
138533|NCT02435342|dalazatide|dalazatide
138534|NCT02435342|psoriasis|psoriasis
138535|NCT02435342|Kv1.3,|kv1.3,
138536|NCT02435342|autoimmune|autoimmune
138537|NCT02435316|Education|education
138538|NCT02435290|prediction|prediction
138539|NCT02435290|prescribing error|prescribing error
138540|NCT02435290|risk factors|risk factors
138541|NCT02435277|Diabetes|diabetes
138542|NCT02435212|New formulation, deferasirox, chelation, iron overload, compliance, satisfaction, palatability, PRO, PK, safety, PK/PD, ICL670|new formulation, deferasirox, chelation, iron overload, compliance, satisfaction, palatability, pro, pk, safety, pk/pd, icl670
138543|NCT02435186|p53 gene|p53 gene
138544|NCT02435186|chemotherapy|chemotherapy
138545|NCT02435186|recurrent|recurrent
138546|NCT02435186|epithelial|epithelial
138547|NCT02435186|ovarian cancer|ovarian cancer
138548|NCT02435186|fallopian tube cancer|fallopian tube cancer
138549|NCT02435186|primary peritoneal cancer|primary peritoneal cancer
138550|NCT02435173|APDS PASLI PI3Kdelta|apds pasli pi3kdelta
138551|NCT02435108|MET poisitivity is defined as at least half of tumor cells show weak, moderate or high staining|met poisitivity is defined as at least half of tumor cells show weak, moderate or high staining
138552|NCT02435095|Schizophrenia|schizophrenia
138553|NCT02435095|Maintenance treatment, Intermittent treatment|maintenance treatment, intermittent treatment
138554|NCT02435095|Brain volume|brain volume
138555|NCT02435095|Antipsychotics|antipsychotics
138556|NCT02435082|Concussion|concussion
138557|NCT02435082|Vascular Assessment|vascular assessment
138558|NCT02435082|Vascular Regulation|vascular regulation
138559|NCT02435082|mild Traumatic Brain Injury, mTBI|mild traumatic brain injury, mtbi
138560|NCT02435082|Traumatic Brain Injury, TBI|traumatic brain injury, tbi
138561|NCT02435082|Cerebrovascular Regulation|cerebrovascular regulation
138562|NCT02435082|Cerebral Blood Flow|cerebral blood flow
138563|NCT02435082|Cerebral Blood Flow Velocity, CBFV|cerebral blood flow velocity, cbfv
138564|NCT02435082|Cerebral Blood Flow Velocity Variability|cerebral blood flow velocity variability
138565|NCT02435082|Cerebrovascular Assessment|cerebrovascular assessment
138566|NCT02435069|cecostomy|cecostomy
138567|NCT02435069|appendicostomy|appendicostomy
138568|NCT02435056|medication overuse headache|medication overuse headache
138569|NCT02435056|health care system|health care system
138570|NCT02435030|NP-C|np-c
138571|NCT02435030|LSD|lsd
138572|NCT02435030|lysosomal storage disorder|lysosomal storage disorder
138573|NCT02435030|lysosomal storage disease|lysosomal storage disease
138574|NCT02435030|NPC2|npc2
138575|NCT02435030|NPC1|npc1
138576|NCT02435030|Niemann-Pick Type C|niemann-pick type c
138577|NCT02435030|Niemann-Pick,|niemann-pick,
138578|NCT02435030|Arimoclomol|arimoclomol
138579|NCT02435017|kidney disease|kidney disease
138580|NCT02435017|recommended dietary allowances|recommended dietary allowances
138581|NCT02435017|nutrition assessment|nutrition assessment
138582|NCT02435017|food|food
138583|NCT02435017|dietary proteins|dietary proteins
138584|NCT02435017|Vitamin D|vitamin d
138585|NCT02435017|dietary fats|dietary fats
138586|NCT02435017|ethnology|ethnology
138587|NCT02435017|Continental Population Groups|continental population groups
138588|NCT02435017|Phosphorus, dietary|phosphorus, dietary
138589|NCT02435017|Phosphorus/analysis|phosphorus/analysis
138590|NCT02434991|trouble swallowing|trouble swallowing
138591|NCT02434991|food sticking|food sticking
138592|NCT02434991|Achalasia|achalasia
138593|NCT02434822|Cholera|cholera
138594|NCT02434822|Shanchol™|shanchol™
138595|NCT02434822|Cholera Vaccine|cholera vaccine
138596|NCT02434809|Respiratory Motion-Corrected Cone-Beam CT|respiratory motion-corrected cone-beam ct
138597|NCT02434809|Radiation|radiation
138598|NCT02434809|14-225|14-225
138599|NCT02434796|Intimate Partner Violence|intimate partner violence
138600|NCT02434796|Gender-Based Violence|gender-based violence
138601|NCT02434796|Gender|gender
138602|NCT02434796|HIV|hiv
138603|NCT02434783|Blood circulation|blood circulation
138604|NCT02434783|Blood vessels|blood vessels
138605|NCT02434783|Mitochondria|mitochondria
138606|NCT02434783|Muscle, skeletal|muscle, skeletal
138607|NCT02434783|Legs|legs
138608|NCT02434783|Energy metabolism|energy metabolism
138609|NCT02434731|Procedural pain|procedural pain
138610|NCT02434731|Phlebotomy|phlebotomy
138611|NCT02434731|Intellectual Disability|intellectual disability
138612|NCT02434731|Child|child
138613|NCT02434731|Buzzy|buzzy
138614|NCT02434705|Eosinophilic|eosinophilic
139249|NCT02431312|immunotherapy|immunotherapy
138615|NCT02434692|Primary Open Angle Glaucoma|primary open angle glaucoma
138617|NCT02434692|Glaucoma|glaucoma
138618|NCT02434692|Cataract|cataract
138619|NCT02434692|Surgery|surgery
138620|NCT02434692|Ocular Pressure|ocular pressure
138621|NCT02434679|antibiotics resistance integrons|antibiotics resistance integrons
138622|NCT02434679|neonatology newborns|neonatology newborns
138623|NCT02434679|digestive acquisition|digestive acquisition
138624|NCT02434679|dynamic of the acquisition of integrons|dynamic of the acquisition of integrons
138625|NCT02434627|Becker|becker
138626|NCT02434627|Dystrophy|dystrophy
138627|NCT02434601|Non-carious cervical lesions|non-carious cervical lesions
138628|NCT02434601|Randomized clinical trial|randomized clinical trial
138629|NCT02434601|Permanent dental restoration|permanent dental restoration
138630|NCT02434601|Dentin|dentin
138631|NCT02434601|Adhesion|adhesion
138632|NCT02434601|Restoration|restoration
138633|NCT02434601|Sensitivity|sensitivity
138634|NCT02434601|Prophylaxis|prophylaxis
138635|NCT02434601|Randomized|randomized
138636|NCT02434575|Lower Urinary Tract Symptoms|lower urinary tract symptoms
138637|NCT02434575|Prostatic artery embolisation|prostatic artery embolisation
138638|NCT02434575|Transurethral resection of the prostate|transurethral resection of the prostate
138639|NCT02434575|Benign prostatic hyperplasia|benign prostatic hyperplasia
139045|NCT02432144|MPS 7|mps 7
138640|NCT02434575|Benign prostatic enlargement|benign prostatic enlargement
138641|NCT02434549|Randomized Controlled Trial|randomized controlled trial
138642|NCT02434549|Placebo Controlled|placebo controlled
138643|NCT02434549|Double Blinded|double blinded
138644|NCT02434549|Botulinum Toxin Type A|botulinum toxin type a
138645|NCT02434549|Adults|adults
138646|NCT02434549|Pain|pain
138647|NCT02434549|Spasticity|spasticity
138648|NCT02434549|Cerebral Palsy, Spastic|cerebral palsy, spastic
138649|NCT02434549|Dysport|dysport
138650|NCT02434536|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
138651|NCT02434536|Disease Exacerbation Clinical Prediction Rule|disease exacerbation clinical prediction rule
138652|NCT02434536|Decision Analysis|decision analysis
138653|NCT02434523|laryngeal sensory neuropathy|laryngeal sensory neuropathy
138654|NCT02434510|Infection|infection
138655|NCT02434510|Total Knee Arthroplasty|total knee arthroplasty
138656|NCT02434510|Total Hip Arthroplasty|total hip arthroplasty
138657|NCT02434510|Splash Basins|splash basins
138658|NCT02434497|LDL-C|ldl-c
138659|NCT02434497|HoFH|hofh
138660|NCT02434497|Hyperlipidemia|hyperlipidemia
138661|NCT02434484|Symbenda|symbenda
138662|NCT02434484|Non-Hodgkin's lymphomas|non-hodgkin's lymphomas
138663|NCT02434484|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
138664|NCT02434484|Multiple myeloma|multiple myeloma
138665|NCT02434484|Bendamustine Hydrochloride|bendamustine hydrochloride
138666|NCT02434458|fibromyalgia,|fibromyalgia,
138667|NCT02434458|polyneuropathy|polyneuropathy
138668|NCT02434458|small fiber neuropathy|small fiber neuropathy
138669|NCT02434458|rheumatoid arthritis|rheumatoid arthritis
138670|NCT02434458|sudomotor|sudomotor
138671|NCT02434406|Anxiety|anxiety
138672|NCT02434406|Anxiety disorders|anxiety disorders
138673|NCT02434406|Mental health|mental health
138674|NCT02434406|Postpartum period|postpartum period
138675|NCT02434406|maternal welfare|maternal welfare
138676|NCT02434406|internet|internet
138677|NCT02434406|intervention studies|intervention studies
138678|NCT02434406|feasibility studies|feasibility studies
138679|NCT02434406|randomized controlled trial|randomized controlled trial
138680|NCT02434406|patient acceptance of health care|patient acceptance of health care
138681|NCT02434393|Depression|depression
138682|NCT02434393|Late Life Depression|late life depression
138683|NCT02434393|LLD|lld
138684|NCT02434393|amyloid imaging|amyloid imaging
138685|NCT02434393|biomarkers|biomarkers
138686|NCT02434380|Vitamin D|vitamin d
138687|NCT02434380|Bone mineral content|bone mineral content
138688|NCT02434380|Knee-heel length|knee-heel length
138689|NCT02434380|Middle East|middle east
138690|NCT02434367|Cancer|cancer
138691|NCT02434354|Clinical stage III (nodal and/or intransit disease) or resectable stage IV melanoma (MEL), with or without prior treatment|clinical stage iii (nodal and/or intransit disease) or resectable stage iv melanoma (mel), with or without prior treatment
138692|NCT02434328|AMD|amd
138693|NCT02434328|CNV|cnv
138694|NCT02434328|IVT|ivt
138695|NCT02434315|Diabetes Mellitus|diabetes mellitus
138696|NCT02434315|Sensing Technology|sensing technology
138697|NCT02434289|Older adults|older adults
138698|NCT02434289|Dietary protein|dietary protein
138699|NCT02434289|Resistance exercise|resistance exercise
138700|NCT02434289|Feasibility study|feasibility study
138701|NCT02434289|Physical functioning|physical functioning
138702|NCT02434289|Real-life setting|real-life setting
138703|NCT02434250|Open angle glaucoma|open angle glaucoma
138704|NCT02434250|Ocular hypertension|ocular hypertension
138705|NCT02434250|Cataract|cataract
138706|NCT02434250|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
138707|NCT02434250|Eximer Laser Trabeculectomy|eximer laser trabeculectomy
138708|NCT02434250|Phacoemulsification Cataract Extraction|phacoemulsification cataract extraction
138709|NCT02434224|Music therapy|music therapy
138710|NCT02434224|premature infant|premature infant
138711|NCT02434224|brain development|brain development
138712|NCT02434198|pulmonary rehabilitation|pulmonary rehabilitation
138713|NCT02434198|balance assessment|balance assessment
138714|NCT02434198|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
138715|NCT02434185|Musculoskeletal Physiological Phenomena|musculoskeletal physiological phenomena
138716|NCT02434185|Postmenopause|postmenopause
138717|NCT02434185|Muscle Strength|muscle strength
138718|NCT02434185|Absorptiometry, Photon|absorptiometry, photon
138720|NCT02434172|Cryptococcus|cryptococcus
138721|NCT02434172|Lateral Flow Assay|lateral flow assay
138722|NCT02434172|sub-Saharan Africa|sub-saharan africa
138724|NCT02434172|treatment|treatment
138725|NCT02434172|cryptococcal meningitis|cryptococcal meningitis
138726|NCT02434120|MRI|mri
138727|NCT02434120|Orbital neoplasm|orbital neoplasm
138728|NCT02434107|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
138729|NCT02434107|Lymph Node Excision|lymph node excision
138730|NCT02434094|Diabetes Assistant (DiAs)|diabetes assistant (dias)
138731|NCT02434094|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
138732|NCT02434094|Insulin Pump|insulin pump
138733|NCT02434094|Human Factors|human factors
138734|NCT02434094|Focus Group|focus group
139143|NCT02431728|Melatonin|melatonin
138735|NCT02434094|Artificial Pancreas (AP)|artificial pancreas (ap)
138736|NCT02434094|eDAPT (electronic Diabetes Artificial Pancreas Training)|edapt (electronic diabetes artificial pancreas training)
138737|NCT02434081|NSCLC|nsclc
138738|NCT02434081|IIIA/B|iiia/b
138739|NCT02434068|kidney calculi|kidney calculi
138740|NCT02434068|followup studies|followup studies
138741|NCT02434042|probiotic|probiotic
138742|NCT02434042|children|children
138743|NCT02434042|gastrointestinal|gastrointestinal
138744|NCT02434042|upper respiratory|upper respiratory
138745|NCT02434016|Diaphragm|diaphragm
138746|NCT02434016|Mechanical ventilation|mechanical ventilation
138747|NCT02434003|3D reconstruction|3d reconstruction
138748|NCT02434003|AIS|ais
138749|NCT02434003|Computer models|computer models
138750|NCT02434003|Spinal Deformity|spinal deformity
138751|NCT02433990|Congenital Heart Disease|congenital heart disease
138752|NCT02433990|Acquired Cardiovascular Disease|acquired cardiovascular disease
138753|NCT02433977|Asthma|asthma
138754|NCT02433977|Obesity|obesity
138755|NCT02433977|conjugated linolenic acid|conjugated linolenic acid
138756|NCT02433977|nitrate|nitrate
138757|NCT02433977|nitrite|nitrite
138758|NCT02433977|nutritional supplements|nutritional supplements
138759|NCT02433964|laser|laser
138760|NCT02433964|LED|led
138761|NCT02433964|PRICE|price
138762|NCT02433964|pain|pain
138763|NCT02433964|edema|edema
138764|NCT02433951|exercise tolerance|exercise tolerance
138765|NCT02433925|resveratrol|resveratrol
138766|NCT02433925|oxidative stress|oxidative stress
138767|NCT02433925|inflammation|inflammation
138768|NCT02433873|Microbiota|microbiota
138769|NCT02433873|Body weight|body weight
138770|NCT02433873|Digestive system|digestive system
138771|NCT02433847|mosapride|mosapride
138772|NCT02433821|Mechanical Neck Pain|mechanical neck pain
138773|NCT02433821|Pain|pain
138774|NCT02433821|Function|function
138775|NCT02433821|Quality of life|quality of life
138776|NCT02433821|Pilates|pilates
138777|NCT02433795|Marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
138778|NCT02433795|bendamustine plus rituximab|bendamustine plus rituximab
138779|NCT02433782|Haemophilia|haemophilia
138780|NCT02433782|Arthropathy|arthropathy
138781|NCT02433782|Pain|pain
138782|NCT02433782|Range of motion|range of motion
138783|NCT02433782|Miofascial techniques|miofascial techniques
138784|NCT02433743|HIV/AIDS|hiv/aids
138785|NCT02433743|RUTF|rutf
138786|NCT02433743|fat free mass|fat free mass
138787|NCT02433743|anemia|anemia
138788|NCT02433743|zinc|zinc
138789|NCT02433743|Senegal|senegal
138790|NCT02433717|schizophrenia|schizophrenia
138791|NCT02433717|schizoaffective disorder|schizoaffective disorder
138792|NCT02433717|pharmacogenetics|pharmacogenetics
138793|NCT02433717|pharmacokinetics|pharmacokinetics
138794|NCT02433717|event-related potentials|event-related potentials
138795|NCT02433717|paliperidone|paliperidone
138796|NCT02433691|(An)aerobic exercise|(an)aerobic exercise
138797|NCT02433691|memory training|memory training
138798|NCT02433691|cognitive benefits|cognitive benefits
138799|NCT02433652|Dengue Vaccine|dengue vaccine
138800|NCT02433639|advanced biliary tract cancer, TH-302|advanced biliary tract cancer, th-302
138801|NCT02433613|Pulmonary Vein Isolation|pulmonary vein isolation
138802|NCT02433613|Phased Radiofrequency Ablation|phased radiofrequency ablation
138803|NCT02433574|radiosurgery|radiosurgery
138804|NCT02433574|Neoadjuvant Therapy|neoadjuvant therapy
138805|NCT02433548|Analgesia|analgesia
138806|NCT02433548|Emergency medicine|emergency medicine
138807|NCT02433548|Anesthesia, Regional|anesthesia, regional
138808|NCT02433535|severe asthma|severe asthma
138809|NCT02433535|simvastatin|simvastatin
138815|NCT02433522|Microscopic polyangiitis|microscopic polyangiitis
138816|NCT02433509|acute ischemic stroke|acute ischemic stroke
138817|NCT02433509|umbilical cord blood|umbilical cord blood
138818|NCT02433496|Opioid|opioid
138819|NCT02433483|Adolescent|adolescent
138820|NCT02433483|Children|children
138821|NCT02433483|Microtransplant|microtransplant
138822|NCT02433483|Leukemia|leukemia
138823|NCT02433457|Healthy Volunteers|healthy volunteers
138824|NCT02433457|CC-292|cc-292
138825|NCT02433457|Open-Label|open-label
138826|NCT02433457|Bioavailability Pharmacokinetics|bioavailability pharmacokinetics
138827|NCT02433457|Phase I|phase i
138828|NCT02433444|Biosensing Techniques|biosensing techniques
138829|NCT02433431|mindfulness|mindfulness
138830|NCT02433431|psychological stress|psychological stress
138831|NCT02433431|immune marker|immune marker
138832|NCT02433431|wellness programs|wellness programs
138833|NCT02433431|mobile applications|mobile applications
138834|NCT02433431|cortisol|cortisol
138835|NCT02433405|Serum Amyloid A|serum amyloid a
138836|NCT02433405|Fetuin-A|fetuin-a
139248|NCT02431312|Chronic HBV|chronic hbv
138837|NCT02433405|gingival crevicular fluid|gingival crevicular fluid
138838|NCT02433405|serum|serum
138839|NCT02433405|periodontal diseases|periodontal diseases
138840|NCT02433392|drug-eluting beads|drug-eluting beads
138841|NCT02433392|irinotecan hydrochloride|irinotecan hydrochloride
138842|NCT02433353|PTSD|ptsd
138843|NCT02433353|posttraumatic stress disorder|posttraumatic stress disorder
138844|NCT02433353|venlafaxine|venlafaxine
138845|NCT02433353|EMDR|emdr
138846|NCT02433353|eye movement desensitization reprocessing|eye movement desensitization reprocessing
138847|NCT02433353|antidepressant|antidepressant
138848|NCT02433353|psychotherapy|psychotherapy
138849|NCT02433340|Tolerability|tolerability
138850|NCT02433340|Methotrexate|methotrexate
138851|NCT02433340|Safety|safety
138852|NCT02433327|Paediatric Early Warning System|paediatric early warning system
138853|NCT02433327|trigger tool|trigger tool
138854|NCT02433327|screening tool|screening tool
138855|NCT02433327|risk assessment|risk assessment
138856|NCT02433327|early recognition|early recognition
138857|NCT02433301|chemotherapy|chemotherapy
138858|NCT02433301|GEJ cancer|gej cancer
138859|NCT02433301|PET/MR-imaging|pet/mr-imaging
138860|NCT02433288|smart phone-based|smart phone-based
138861|NCT02433288|rosuvastatin|rosuvastatin
138862|NCT02433288|duration of treatment|duration of treatment
138863|NCT02433288|Treatment adherence|treatment adherence
138864|NCT02433223|outreach nursing|outreach nursing
138865|NCT02433223|respiratory nursing guidelines|respiratory nursing guidelines
138866|NCT02433197|Testicular cancer|testicular cancer
138867|NCT02433197|Germ cell cancer|germ cell cancer
138868|NCT02433197|Physical exercise|physical exercise
138869|NCT02433197|Cancer-related fatigue|cancer-related fatigue
138870|NCT02433197|Chemotherapy|chemotherapy
138871|NCT02433197|Clinical rules|clinical rules
138872|NCT02433197|Metabolomics|metabolomics
138873|NCT02433184|Etanercept|etanercept
138874|NCT02433184|treat to target|treat to target
138875|NCT02433184|Disease Modifying Antirheumatic Drugs (DMARDs)|disease modifying antirheumatic drugs (dmards)
138876|NCT02433171|regrowth|regrowth
138877|NCT02433171|radiosurgery|radiosurgery
138878|NCT02433171|radiation necrosis|radiation necrosis
138879|NCT02433158|Rivipansel|rivipansel
138880|NCT02433158|GMI-1070|gmi-1070
138881|NCT02433158|Selectin Inhibitor|selectin inhibitor
138884|NCT02433145|ADHD in preschoolers|adhd in preschoolers
138885|NCT02433145|neuropsychological functions|neuropsychological functions
138886|NCT02433145|behavior inhibition|behavior inhibition
138887|NCT02433145|family function and parenting|family function and parenting
138888|NCT02433132|Cystic fibrosis|cystic fibrosis
138889|NCT02433132|Adults|adults
138890|NCT02433132|Atypical form|atypical form
138891|NCT02433132|Nasal brushing|nasal brushing
138892|NCT02433132|Epithelial cells|epithelial cells
138893|NCT02433132|Ion transport|ion transport
138894|NCT02433106|Balance|balance
138895|NCT02433106|Exercise|exercise
138896|NCT02433054|deep vein thrombosis|deep vein thrombosis
138897|NCT02433054|chronic venous disease|chronic venous disease
138898|NCT02433054|May-Thurner syndrome|may-thurner syndrome
138899|NCT02433054|venous stent|venous stent
138900|NCT02433041|Postoperative delirium|postoperative delirium
138901|NCT02433041|Cortisol|cortisol
138902|NCT02433041|NSE|nse
138903|NCT02433041|S-100beta|s-100beta
138904|NCT02433041|MMSE|mmse
138906|NCT02433041|ICDSC|icdsc
138907|NCT02433041|DOS|dos
138908|NCT02433041|Haloperidol|haloperidol
138909|NCT02433041|Ketamine|ketamine
138910|NCT02433041|Combination of Haloperidol and Ketamine|combination of haloperidol and ketamine
138911|NCT02433041|Placebo|placebo
138912|NCT02433041|Prevention of|prevention of
138913|NCT02433028|MS key phases of disease evolution|ms key phases of disease evolution
139027|NCT02432287|aging|aging
138914|NCT02433028|MS New Treatment Options|ms new treatment options
138915|NCT02433015|Electronic Cigarette|electronic cigarette
138916|NCT02433002|eGFR|egfr
138917|NCT02433002|CKD|ckd
138923|NCT02432989|Concussion Recovery|concussion recovery
138924|NCT02432976|Quality of Life|quality of life
138925|NCT02432976|Cardiac Surgery|cardiac surgery
138926|NCT02432976|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
138927|NCT02432976|Incretin mimetic|incretin mimetic
138928|NCT02432976|Exenatide|exenatide
138929|NCT02432937|Corever|corever
138930|NCT02432937|hypertension|hypertension
138931|NCT02432885|cardiac magnetic resonance|cardiac magnetic resonance
138932|NCT02432885|myocardial fibrosis|myocardial fibrosis
138933|NCT02432885|muscular dystrophies|muscular dystrophies
138934|NCT02432820|Prostate Cancer|prostate cancer
138939|NCT02432755|home-based rehabilitation|home-based rehabilitation
138940|NCT02432755|stroke|stroke
138941|NCT02432755|combination therapy|combination therapy
138942|NCT02432755|client-centered approach|client-centered approach
138943|NCT02432755|post-acute|post-acute
138944|NCT02432742|hyaluronic acid, comparative study, NLF|hyaluronic acid, comparative study, nlf
138945|NCT02432729|smoking cessation|smoking cessation
138946|NCT02432729|smoking abstinence|smoking abstinence
138947|NCT02432729|clinical, biological and functional changes|clinical, biological and functional changes
138948|NCT02432729|one year|one year
138949|NCT02432729|healthy smokers|healthy smokers
138950|NCT02432729|quit smoking|quit smoking
138951|NCT02432703|Social Anxiety Disorder|social anxiety disorder
138952|NCT02432703|JNJ-42165279|jnj-42165279
138953|NCT02432690|Neoplasms|neoplasms
138954|NCT02432677|tDCS|tdcs
138955|NCT02432677|Opioid|opioid
138956|NCT02432677|Pain|pain
138957|NCT02432677|Pain threshold|pain threshold
138958|NCT02432651|oxidative stress|oxidative stress
138959|NCT02432651|hops|hops
138960|NCT02432651|xanthohumol|xanthohumol
138961|NCT02432651|DNA damage|dna damage
138962|NCT02432651|cancer|cancer
138963|NCT02432625|Osteogenesis Imperfecta|osteogenesis imperfecta
138964|NCT02432625|Collagen|collagen
138965|NCT02432625|Brittle Bone Disorder|brittle bone disorder
138966|NCT02432625|Rare Disease Clinical Research Network|rare disease clinical research network
138967|NCT02432625|COL1A2|col1a2
138968|NCT02432599|F18-choline|f18-choline
138969|NCT02432586|T1DM|t1dm
138970|NCT02432586|Diabetes|diabetes
138971|NCT02432586|Child|child
138972|NCT02432586|Toddler|toddler
138973|NCT02432573|timing|timing
138974|NCT02432560|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
138975|NCT02432560|LAM|lam
138976|NCT02432560|rare lung|rare lung
138977|NCT02432560|Rare Lung Disease|rare lung disease
138978|NCT02432547|Diabetic|diabetic
138979|NCT02432547|Macular Oedema|macular oedema
138980|NCT02432547|Retinopathy|retinopathy
138981|NCT02432521|stroke|stroke
138982|NCT02432521|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
138983|NCT02432521|Electroencephalography (EEG)|electroencephalography (eeg)
138984|NCT02432521|Cerebrovascular Accident|cerebrovascular accident
138985|NCT02432521|Brain Vascular Accident|brain vascular accident
138986|NCT02432508|acupuncture|acupuncture
138987|NCT02432508|laser|laser
138988|NCT02432508|uremic pruritus|uremic pruritus
138989|NCT02432508|randomized clinical trial|randomized clinical trial
138990|NCT02432482|Tobacco|tobacco
138991|NCT02432482|Cigarette|cigarette
138992|NCT02432482|HIV|hiv
138993|NCT02432482|Treatment|treatment
138994|NCT02432482|Mobile|mobile
138995|NCT02432482|Smartphone|smartphone
138996|NCT02432469|coronary artery bypass|coronary artery bypass
138997|NCT02432469|medication adherence|medication adherence
138998|NCT02432469|secondary prevention|secondary prevention
138999|NCT02432469|mobile applications|mobile applications
139000|NCT02432443|Motor Skills|motor skills
139001|NCT02432443|Pre-literacy Skills|pre-literacy skills
139002|NCT02432443|Early Intervention|early intervention
139003|NCT02432430|N05.300.150.410|n05.300.150.410
139004|NCT02432430|practice guideline|practice guideline
139005|NCT02432430|D20.215.894.899.290.130|d20.215.894.899.290.130
139006|NCT02432430|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
139007|NCT02432417|Glioblastoma|glioblastoma
139008|NCT02432417|Autophagy|autophagy
139009|NCT02432417|EGFR|egfr
139010|NCT02432417|EGFRvIII|egfrviii
139011|NCT02432417|Chloroquine|chloroquine
139012|NCT02432417|Radiotherapy|radiotherapy
139013|NCT02432417|Temozolomide|temozolomide
139014|NCT02432404|HSV-2|hsv-2
139015|NCT02432404|Contraceptive Vaginal Ring|contraceptive vaginal ring
139016|NCT02432365|Paclitaxel|paclitaxel
139017|NCT02432365|Cisplatin|cisplatin
139018|NCT02432365|Cervical cancer|cervical cancer
139019|NCT02432365|Radical hysterectomy|radical hysterectomy
139020|NCT02432365|Neoadjuvant|neoadjuvant
139021|NCT02432339|immune system|immune system
139022|NCT02432339|RENIN-ANGIOTENSIN SYSTEM|renin-angiotensin system
139023|NCT02432326|Neoplasms|neoplasms
139024|NCT02432300|Traumatic Brain Injury|traumatic brain injury
139025|NCT02432300|Alexithymia|alexithymia
139026|NCT02432300|Emotions|emotions
139028|NCT02432287|metformin|metformin
139029|NCT02432287|prediabetes|prediabetes
139030|NCT02432274|E7080|e7080
139031|NCT02432274|Lenvatinib|lenvatinib
139032|NCT02432274|Solid malignancies|solid malignancies
139033|NCT02432274|Osteosarcoma|osteosarcoma
139034|NCT02432274|Differentiated Thyroid Cancer|differentiated thyroid cancer
139035|NCT02432261|spermatogenesis|spermatogenesis
139036|NCT02432261|androgen|androgen
139037|NCT02432261|male contraception|male contraception
139038|NCT02432248|DHEA|dhea
139039|NCT02432248|live birth rate|live birth rate
139040|NCT02432248|poor ovarian responder|poor ovarian responder
139041|NCT02432196|Mitral Valve Repair|mitral valve repair
139042|NCT02432196|Transapical|transapical
139043|NCT02432196|artificial chordae|artificial chordae
139046|NCT02432144|Sly Syndrome|sly syndrome
139047|NCT02432144|MPS VII|mps vii
139048|NCT02432144|Enzyme Replacement Therapy|enzyme replacement therapy
139049|NCT02432144|Rare Disease|rare disease
139050|NCT02432144|Mucopolysaccharidosis Type 7|mucopolysaccharidosis type 7
139051|NCT02432144|Lysosomal Storage Disease|lysosomal storage disease
139052|NCT02432144|Metabolic Disorder|metabolic disorder
139053|NCT02432092|Cardiomegaly|cardiomegaly
139054|NCT02432092|Cardiovascular Diseases|cardiovascular diseases
139055|NCT02432092|Heart Diseases|heart diseases
139056|NCT02432092|Systolic dysfunction|systolic dysfunction
139057|NCT02432092|Diastolic dysfunction|diastolic dysfunction
139058|NCT02432092|Ventricular hypertrophy|ventricular hypertrophy
139059|NCT02432092|Heart failure|heart failure
139060|NCT02432079|Abnormalities, Multiple|abnormalities, multiple
139061|NCT02432079|Asplenia|asplenia
139062|NCT02432079|Bilary Atresia|bilary atresia
139063|NCT02432079|Birth Defect|birth defect
139064|NCT02432079|Cardiovascular Abnormalities|cardiovascular abnormalities
139065|NCT02432079|Cardiovascular Diseases|cardiovascular diseases
139066|NCT02432079|Congenital Abnormalities|congenital abnormalities
139067|NCT02432079|Congenital Heart Disease|congenital heart disease
139068|NCT02432079|Dextrocardia Syndrome|dextrocardia syndrome
139069|NCT02432079|Disturbed Internal Organ Positioning|disturbed internal organ positioning
139070|NCT02432079|Genetics|genetics
139071|NCT02432079|Genetic Testing|genetic testing
139072|NCT02432079|Heart Defects, Congenital|heart defects, congenital
139073|NCT02432079|Heart Diseases|heart diseases
139074|NCT02432079|Heterotaxy syndrome|heterotaxy syndrome
139075|NCT02432079|Intestinal malrotation|intestinal malrotation
139076|NCT02432079|Laterality|laterality
139077|NCT02432079|Left Atrial Isomerism|left atrial isomerism
139078|NCT02432079|Pediatrics|pediatrics
139079|NCT02432079|Polysplenia|polysplenia
139080|NCT02432079|Right Atrial Isomerism|right atrial isomerism
139081|NCT02432079|Splenic Diseases|splenic diseases
139082|NCT02432079|Cilia|cilia
139083|NCT02432079|Situs inversus|situs inversus
139084|NCT02432079|Dextrocardia|dextrocardia
139085|NCT02432066|Smoking|smoking
139086|NCT02432066|Smoking Cessation|smoking cessation
139087|NCT02432053|FK506|fk506
139088|NCT02432053|Advagraf|advagraf
139089|NCT02432053|Tacrolimus|tacrolimus
139090|NCT02432053|Transplantation|transplantation
139091|NCT02432040|chronic plaque psoriasis|chronic plaque psoriasis
139092|NCT02432040|psoriasis|psoriasis
139093|NCT02432040|atorvastatin|atorvastatin
139094|NCT02432040|psoriasis area and severity index|psoriasis area and severity index
139095|NCT02432040|betamethasone valerate|betamethasone valerate
139096|NCT02431988|Relapsed|relapsed
139097|NCT02431988|refractory|refractory
139098|NCT02431988|DLBCL|dlbcl
139100|NCT02431975|infant|infant
139101|NCT02431975|antiretroviral therapy, highly active|antiretroviral therapy, highly active
139102|NCT02431975|antiretroviral agents|antiretroviral agents
139103|NCT02431962|Lung Cancer|lung cancer
139104|NCT02431962|Screening|screening
139105|NCT02431962|Computed Tomography|computed tomography
139106|NCT02431949|Music|music
139107|NCT02431949|Amusia|amusia
139108|NCT02431936|Stress|stress
139109|NCT02431936|Blood Pressure|blood pressure
139110|NCT02431936|Salt Sensitivity|salt sensitivity
139111|NCT02431936|Renin-Angiotensin-Aldosterone System|renin-angiotensin-aldosterone system
139112|NCT02431936|Sympathetic Nervous System|sympathetic nervous system
139113|NCT02431923|Sequelae|sequelae
139114|NCT02431923|Seroprevalence|seroprevalence
139115|NCT02431923|Household Contacts|household contacts
139116|NCT02431910|Electromyography|electromyography
139117|NCT02431910|Baropodometry|baropodometry
139118|NCT02431910|Torque|torque
139119|NCT02431897|Pelvic Organ Prolapse|pelvic organ prolapse
139120|NCT02431897|Pelvic Floor Disorders|pelvic floor disorders
139121|NCT02431897|Therapy, Estrogen Replacement|therapy, estrogen replacement
139122|NCT02431897|Estrogens, Conjugated|estrogens, conjugated
139123|NCT02431871|Developmental dysplasia of the hip|developmental dysplasia of the hip
139124|NCT02431871|Hip dysplasia|hip dysplasia
139125|NCT02431871|Occlusal defect|occlusal defect
139127|NCT02431858|Catheter|catheter
139128|NCT02431858|Catheter over needle|catheter over needle
139129|NCT02431858|Femoral Nerve|femoral nerve
139130|NCT02431858|Anaesthesia|anaesthesia
139131|NCT02431858|[E04.525.210.550]|[e04.525.210.550]
139132|NCT02431858|[E02.148]|[e02.148]
139133|NCT02431845|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
139134|NCT02431845|Pharmacogenetics|pharmacogenetics
139135|NCT02431832|Elderly|elderly
139136|NCT02431819|Peripheral Arterial Disease|peripheral arterial disease
139137|NCT02431819|Progressive compressive stockings|progressive compressive stockings
139138|NCT02431793|Opioids|opioids
139139|NCT02431780|Neonatal Seizures|neonatal seizures
139140|NCT02431780|Decision Support Algorithm|decision support algorithm
139141|NCT02431780|EEG|eeg
139142|NCT02431741|Presence of at least one exuding malignant (fungating) wound in need for antimicrobial treatment|presence of at least one exuding malignant (fungating) wound in need for antimicrobial treatment
139144|NCT02431728|Post-acute withdrawal symptoms|post-acute withdrawal symptoms
139145|NCT02431728|Anxiety|anxiety
139146|NCT02431728|Depression|depression
139147|NCT02431728|Insomnia|insomnia
139148|NCT02431728|Stress|stress
139149|NCT02431728|Substance withdrawal syndrome|substance withdrawal syndrome
139150|NCT02431702|Paliperidone Palmitate|paliperidone palmitate
139151|NCT02431702|Oral Antipsychotics|oral antipsychotics
139152|NCT02431702|Schizophrenia|schizophrenia
139153|NCT02431702|Psychotic Disorders|psychotic disorders
139154|NCT02431702|Cognition in Schizophrenia|cognition in schizophrenia
139155|NCT02431702|Brain intracortical myelin volume|brain intracortical myelin volume
139156|NCT02431702|Personal and Social Performance|personal and social performance
139157|NCT02431702|Disease Modification|disease modification
139158|NCT02431663|refractory convulsive status epilepticus|refractory convulsive status epilepticus
139159|NCT02431663|ketamine|ketamine
139160|NCT02431663|conventional anesthetics|conventional anesthetics
139161|NCT02431663|children|children
139162|NCT02431650|Induced blood stage malaria|induced blood stage malaria
139163|NCT02431650|Transmission|transmission
139164|NCT02431650|Mosquito feeding|mosquito feeding
139165|NCT02431650|OZ439|oz439
139166|NCT02431650|Primaquine|primaquine
139167|NCT02431650|Piperaquine|piperaquine
139168|NCT02431650|Artefonomel|artefonomel
139169|NCT02431637|Induced blood stage malaria|induced blood stage malaria
139170|NCT02431637|Transmission|transmission
139171|NCT02431637|Standard membrane feeding assay|standard membrane feeding assay
139172|NCT02431624|Healthy Volunteer|healthy volunteer
139173|NCT02431585|abdominal pain|abdominal pain
139174|NCT02431585|gluten free diet|gluten free diet
139175|NCT02431585|functional gastrointestinal disorders|functional gastrointestinal disorders
139176|NCT02431572|Intracranial Tumors|intracranial tumors
139177|NCT02431572|Glioblastoma|glioblastoma
139178|NCT02431572|Melanoma|melanoma
139179|NCT02431559|Ovarian Cancer|ovarian cancer
139180|NCT02431559|Motolimod|motolimod
139181|NCT02431559|Immunotherapy|immunotherapy
139182|NCT02431559|PD-L1|pd-l1
139183|NCT02431559|MEDI4736|medi4736
139184|NCT02431559|Pegylated|pegylated
139185|NCT02431559|Liposomal|liposomal
139186|NCT02431559|Doxorubicin|doxorubicin
139188|NCT02431559|TLR-8|tlr-8
139189|NCT02431559|Durvalumab|durvalumab
139190|NCT02431546|Cardiology|cardiology
139191|NCT02431546|Vascular|vascular
139192|NCT02431546|CAD|cad
139193|NCT02431546|Duke|duke
139194|NCT02431546|Cardiac Rehabilitation|cardiac rehabilitation
139195|NCT02431546|Prevention|prevention
139196|NCT02431546|CVD|cvd
139197|NCT02431546|Mobile Health|mobile health
139198|NCT02431546|Exercise|exercise
139199|NCT02431533|IBS-D|ibs-d
139200|NCT02431533|diarrhea predominant|diarrhea predominant
139201|NCT02431520|Patient Compliance|patient compliance
139202|NCT02431520|HPV-DNA probes|hpv-dna probes
139203|NCT02431520|Papanicolaou test|papanicolaou test
139204|NCT02431520|Cervical cancer|cervical cancer
139205|NCT02431507|apnea|apnea
139206|NCT02431507|sleep apnea|sleep apnea
139207|NCT02431507|magnetic sleep apnea device|magnetic sleep apnea device
139208|NCT02431507|hyoid bone|hyoid bone
139209|NCT02431455|Bariatric Surgery|bariatric surgery
139210|NCT02431455|obesity, morbid|obesity, morbid
139211|NCT02431455|incentive spirometry|incentive spirometry
139212|NCT02431442|Heterozygous|heterozygous
139213|NCT02431442|MC4R deficiency|mc4r deficiency
139214|NCT02431442|associated|associated
139215|NCT02431429|leishmaniasis|leishmaniasis
139216|NCT02431429|miltefosine|miltefosine
139217|NCT02431429|spermiogram|spermiogram
139218|NCT02431416|females|females
139219|NCT02431416|ghrelin|ghrelin
139220|NCT02431416|GnRH|gnrh
139221|NCT02431416|randomized, controlled study|randomized, controlled study
139222|NCT02431416|children|children
139228|NCT02431364|KPT-335|kpt-335
139229|NCT02431364|Verdinexor|verdinexor
139230|NCT02431364|Karyopharm|karyopharm
139231|NCT02431364|First-in-Human|first-in-human
139232|NCT02431364|Adult Subjects|adult subjects
139233|NCT02431351|KPT-330|kpt-330
139234|NCT02431351|Karyopharm|karyopharm
139235|NCT02431351|Selinexor|selinexor
139236|NCT02431351|SIER|sier
139237|NCT02431351|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
139238|NCT02431351|Erythropoietin (EPO)|erythropoietin (epo)
139239|NCT02431351|Refractory|refractory
139240|NCT02431338|Remote ischemic conditioning|remote ischemic conditioning
139241|NCT02431338|Cost-effectiveness analysis|cost-effectiveness analysis
139242|NCT02431325|HIV|hiv
139243|NCT02431325|Atherosclerosis|atherosclerosis
139244|NCT02431325|Microbial Translocation|microbial translocation
139245|NCT02431325|Teduglutide|teduglutide
139246|NCT02431325|Gastrointestinal Permeability|gastrointestinal permeability
139247|NCT02431325|Inflammation|inflammation
139256|NCT02431273|MVC|mvc
139257|NCT02431273|TDF-FTC|tdf-ftc
139258|NCT02431273|TDF-FTC-MVC|tdf-ftc-mvc
139259|NCT02431273|IVR|ivr
139260|NCT02431273|ARV|arv
139261|NCT02431260|solid tumor|solid tumor
139262|NCT02431260|lymphoma|lymphoma
139263|NCT02431260|BET bromodomain inhibitor|bet bromodomain inhibitor
139264|NCT02431260|BRD|brd
139265|NCT02431260|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
139266|NCT02431260|Burkitt's lymphoma|burkitt's lymphoma
139267|NCT02431260|c-MYC|c-myc
139268|NCT02431260|colorectal cancer|colorectal cancer
139269|NCT02431260|Non-small cell lung cancer|non-small cell lung cancer
139270|NCT02431260|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
139271|NCT02431260|castration-resistant prostate cancer|castration-resistant prostate cancer
139272|NCT02431260|breast cancer|breast cancer
139273|NCT02431260|NUT midline carcinoma|nut midline carcinoma
139274|NCT02431260|leukemia|leukemia
139275|NCT02431260|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
139276|NCT02431260|atypical chronic myeloid leukemia (aCML)|atypical chronic myeloid leukemia (acml)
139277|NCT02431260|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
139278|NCT02431260|myeloproliferative neoplasms|myeloproliferative neoplasms
139279|NCT02431260|myelofibrosis (MF)|myelofibrosis (mf)
139280|NCT02431260|multiple myeloma (MM)|multiple myeloma (mm)
139281|NCT02431260|CMML|cmml
139282|NCT02431260|MDS/MPN-U|mds/mpn-u
139283|NCT02431260|RARS-T|rars-t
139290|NCT02431234|Type 2 diabetes|type 2 diabetes
139291|NCT02431234|Arterial calcification|arterial calcification
139292|NCT02431234|Mediacalcosis|mediacalcosis
139293|NCT02431234|Calcium score|calcium score
139294|NCT02431221|perhexiline|perhexiline
139295|NCT02431221|HCM|hcm
139296|NCT02431221|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
139297|NCT02431221|CPEX|cpex
139298|NCT02431195|obesity|obesity
139299|NCT02431195|bariatric surgery|bariatric surgery
139300|NCT02431195|physical activity|physical activity
139301|NCT02431195|eating habits|eating habits
139302|NCT02431156|presbyopia|presbyopia
139303|NCT02431156|monovision|monovision
139304|NCT02431156|activities of daily living,|activities of daily living,
139305|NCT02431156|pseudophakic|pseudophakic
139306|NCT02431130|Training Program|training program
139307|NCT02431091|Optical Coherence Tomography|optical coherence tomography
139308|NCT02431078|CTCs|ctcs
139309|NCT02431078|ZEB1|zeb1
139310|NCT02431078|gastric cancer|gastric cancer
139311|NCT02431065|Rectus sheath block|rectus sheath block
139312|NCT02431065|Single port laparoscopy|single port laparoscopy
139313|NCT02431026|induced mild hypothermia|induced mild hypothermia
139314|NCT02431026|cervical cooling collar|cervical cooling collar
139315|NCT02431026|mri brain thermometry|mri brain thermometry
139316|NCT02431026|MRI thermometry|mri thermometry
139317|NCT02431026|rate-of-cooling|rate-of-cooling
139318|NCT02431026|Excel Cryo Cooling Collar|excel cryo cooling collar
139319|NCT02431013|Drug-drug interaction|drug-drug interaction
139320|NCT02431013|Pharmacokinetics|pharmacokinetics
139321|NCT02430961|Critical Care|critical care
139322|NCT02430961|Palliative Care|palliative care
139323|NCT02430948|Screening|screening
139324|NCT02430948|Shared Decision Making|shared decision making
139325|NCT02430935|Psychosis|psychosis
139326|NCT02430935|Psychosis NOS|psychosis nos
139327|NCT02430935|Schizophrenia|schizophrenia
139328|NCT02430935|Schizoaffective Disorder|schizoaffective disorder
139329|NCT02430935|Early Intervention|early intervention
139330|NCT02430896|Neuropsychological|neuropsychological
139331|NCT02430896|neuroimaging|neuroimaging
139332|NCT02430896|genetic markers|genetic markers
139333|NCT02430896|treatment response predictor|treatment response predictor
139334|NCT02430883|pain, RIRS, kidney|pain, rirs, kidney
139335|NCT02430870|Drug therapy|drug therapy
139336|NCT02430844|acute kidney injury|acute kidney injury
139337|NCT02430844|radiographic contrast|radiographic contrast
139338|NCT02430844|critically ill|critically ill
139339|NCT02430844|biomarker|biomarker
139340|NCT02430818|ketamine|ketamine
139341|NCT02430818|emergency medicine|emergency medicine
139342|NCT02430818|orthopedics|orthopedics
139343|NCT02430805|hypertension|hypertension
139344|NCT02430805|microinflammation and oxidative stress|microinflammation and oxidative stress
139345|NCT02430805|renal disease|renal disease
139346|NCT02430805|heart failure|heart failure
139347|NCT02430805|genetics markers|genetics markers
139348|NCT02430805|genomics markers|genomics markers
139349|NCT02430805|proteomics markers|proteomics markers
139350|NCT02430792|Prostatic Neoplasms|prostatic neoplasms
139351|NCT02430792|Exercise|exercise
139352|NCT02430792|Football|football
139353|NCT02430792|Quality of Life|quality of life
139354|NCT02430779|irreversible electroporation|irreversible electroporation
139355|NCT02430779|Unresectable Renal Pelvic and Ureteral Neoplasms|unresectable renal pelvic and ureteral neoplasms
139356|NCT02430766|irreversible electroporation|irreversible electroporation
139357|NCT02430766|Unresectable Lymph Node Metastases|unresectable lymph node metastases
139358|NCT02430753|irreversible electroporation|irreversible electroporation
139359|NCT02430753|Lung Neoplasms|lung neoplasms
139360|NCT02430753|Respiratory Function Insufficiency|respiratory function insufficiency
139361|NCT02430740|Fertilization in Vitro|fertilization in vitro
139362|NCT02430740|antagonist protocol|antagonist protocol
139363|NCT02430740|antral follicle count|antral follicle count
139364|NCT02430740|Anti-Mullerian Hormone|anti-mullerian hormone
139365|NCT02430740|Reproductive Techniques, Assisted|reproductive techniques, assisted
139366|NCT02430714|Thyroid Cancer|thyroid cancer
139367|NCT02430714|Lenvima|lenvima
139368|NCT02430714|Post-marketing surveillance|post-marketing surveillance
139369|NCT02430714|LEN01T|len01t
139370|NCT02430714|All-Patient Investigation|all-patient investigation
139371|NCT02430714|Lenvatinib Mesylate|lenvatinib mesylate
139372|NCT02430701|irreversible electroporation|irreversible electroporation
139373|NCT02430701|Unresectable Esophageal Neoplasms|unresectable esophageal neoplasms
139374|NCT02430688|irreversible electroporation|irreversible electroporation
139375|NCT02430688|Unresectable Extremities|unresectable extremities
139376|NCT02430675|irreversible electroporation|irreversible electroporation
139377|NCT02430675|Unresectable Laryngeal Neoplasms|unresectable laryngeal neoplasms
139378|NCT02430662|irreversible electroporation|irreversible electroporation
139379|NCT02430662|Unresectable Gallbladder Neoplasms|unresectable gallbladder neoplasms
139380|NCT02430649|irreversible electroporation|irreversible electroporation
139381|NCT02430649|Unresectable Prostatic Neoplasms|unresectable prostatic neoplasms
139382|NCT02430636|irreversible electroporation|irreversible electroporation
139383|NCT02430636|Unresectable Stomach Neoplasms|unresectable stomach neoplasms
139384|NCT02430623|irreversible electroporation|irreversible electroporation
139385|NCT02430623|Unresectable Urinary Neoplasms|unresectable urinary neoplasms
139386|NCT02430610|irreversible electroporation|irreversible electroporation
139387|NCT02430610|Unresectable Uterine Cervical Neoplasms|unresectable uterine cervical neoplasms
139388|NCT02430597|irreversible electroporation|irreversible electroporation
139389|NCT02430597|Hilus Pulmonary Neoplasms|hilus pulmonary neoplasms
139390|NCT02430545|Glasdegib|glasdegib
139391|NCT02430545|PF-04449913|pf-04449913
139392|NCT02430545|Drug-drug interaction|drug-drug interaction
139393|NCT02430545|CYP3A4 inducer|cyp3a4 inducer
139394|NCT02430545|Pharmacokinetics|pharmacokinetics
139395|NCT02430532|INSPIRE|inspire
139396|NCT02430532|SPMS|spms
139397|NCT02430532|Tecfidera|tecfidera
139398|NCT02430532|BG00012|bg00012
139399|NCT02430519|Chronic Periodontitis|chronic periodontitis
139400|NCT02430519|Clinical Parameters|clinical parameters
139401|NCT02430519|Furcation defects|furcation defects
139402|NCT02430519|Radiographic bone fill|radiographic bone fill
139403|NCT02430493|ACS|acs
139404|NCT02430480|Multiparametric MRI|multiparametric mri
139405|NCT02430480|Prostatectomy|prostatectomy
139406|NCT02430480|Focal Prostate Cancer|focal prostate cancer
139407|NCT02430480|Normal Testosterone|normal testosterone
139408|NCT02430480|Non Metastatic|non metastatic
139409|NCT02430454|ICU|icu
139410|NCT02430454|decision making|decision making
139411|NCT02430402|Climatotherapy|climatotherapy
139412|NCT02430389|hemodynamic stability|hemodynamic stability
139413|NCT02430389|remifentanil|remifentanil
139414|NCT02430376|Non-Muscle Myosin|non-muscle myosin
139415|NCT02430363|pembrolizumab|pembrolizumab
139416|NCT02430363|MK-3475|mk-3475
139417|NCT02430363|Glioblastoma|glioblastoma
139418|NCT02430363|Gliosarcoma|gliosarcoma
139419|NCT02430363|Suppressor of the PI3K/Akt pathways|suppressor of the pi3k/akt pathways
139420|NCT02430363|Pictilisib|pictilisib
139421|NCT02430363|GDC-0941|gdc-0941
139422|NCT02430363|BEZ235|bez235
139423|NCT02430363|NVP-BEZ235|nvp-bez235
139424|NCT02430363|Ipatasertib|ipatasertib
139425|NCT02430363|GDC-0068|gdc-0068
139426|NCT02430311|Chinese Patients|chinese patients
139427|NCT02430285|biliary stone|biliary stone
139428|NCT02430285|cholelithiasis|cholelithiasis
139429|NCT02430285|pancreatitis|pancreatitis
139431|NCT02430285|ERCP|ercp
139432|NCT02430285|early|early
139433|NCT02430285|choledocholithiasis|choledocholithiasis
139434|NCT02430272|Child|child
139435|NCT02430272|outpatient|outpatient
139436|NCT02430272|premedication|premedication
139437|NCT02430259|rifapentine|rifapentine
139438|NCT02430259|isoniazid|isoniazid
139439|NCT02430259|QuantiFERON Gold In-Tube|quantiferon gold in-tube
139440|NCT02430259|tuberculin skin test|tuberculin skin test
139441|NCT02430207|Pulmonary Embolism|pulmonary embolism
139442|NCT02430207|Temporary Pacing|temporary pacing
139443|NCT02430207|Femoral Vein|femoral vein
139444|NCT02430207|Subclavian Vein|subclavian vein
139446|NCT02430168|RIRs|rirs
139447|NCT02430168|PCNL|pcnl
139448|NCT02430168|Pain|pain
139449|NCT02430155|condom-loaded Foley's catheter|condom-loaded foley's catheter
139450|NCT02430155|Bakri balloon|bakri balloon
139451|NCT02430155|primary atonic postpartum hemorrhage|primary atonic postpartum hemorrhage
139452|NCT02430142|microcirculation|microcirculation
139453|NCT02430142|oxygen uptake|oxygen uptake
139454|NCT02430142|hypoxia|hypoxia
139455|NCT02430142|adenosine|adenosine
139456|NCT02430142|central venous saturation|central venous saturation
139457|NCT02430142|hypoxanthine|hypoxanthine
139458|NCT02430142|laserdoppler|laserdoppler
139459|NCT02430103|Breast Cancer|breast cancer
139460|NCT02430103|Preservation of Ovarian Reserve Function|preservation of ovarian reserve function
139461|NCT02430090|regionel anesthesia|regionel anesthesia
139462|NCT02430090|levobupivacaine|levobupivacaine
139463|NCT02430090|ceserean section|ceserean section
139464|NCT02430077|Hepatic Steatosis|hepatic steatosis
139465|NCT02430051|sensory processing|sensory processing
139466|NCT02430051|oral care|oral care
139467|NCT02430051|electrodermal activity|electrodermal activity
139468|NCT02430051|cooperation|cooperation
139469|NCT02430051|anxiety|anxiety
139470|NCT02430051|distress|distress
139471|NCT02430051|stress|stress
139472|NCT02430051|behavior|behavior
139473|NCT02430051|occupational therapy|occupational therapy
139474|NCT02430038|transperineal ultrasound|transperineal ultrasound
139475|NCT02430038|labour|labour
139476|NCT02430038|sonopartogram|sonopartogram
139477|NCT02430038|prediction model|prediction model
139478|NCT02430025|Cardiovascular Diseases|cardiovascular diseases
139479|NCT02430025|Vascular Diseases|vascular diseases
139480|NCT02430025|Acute Coronary Syndrome|acute coronary syndrome
139481|NCT02430025|Chest Pain|chest pain
139482|NCT02430025|Heart Diseases|heart diseases
139483|NCT02430025|Myocardial Ischemia|myocardial ischemia
139484|NCT02430025|Pathologic Processes|pathologic processes
139485|NCT02430012|coronary artery bypass grafting|coronary artery bypass grafting
139486|NCT02430012|quality improvement|quality improvement
139487|NCT02430012|secondary preventions|secondary preventions
139488|NCT02429986|Adaptive Servo-Ventilation|adaptive servo-ventilation
139489|NCT02429986|Chronic Heart Failure|chronic heart failure
139490|NCT02429986|Central Sleep Apnea Syndrome|central sleep apnea syndrome
139491|NCT02429986|Central and Obstructive Sleep Apnea Syndrome|central and obstructive sleep apnea syndrome
139492|NCT02429986|Complex Sleep Apnea Syndrome|complex sleep apnea syndrome
139493|NCT02429986|Hunter-Cheyne-Stokes Breathing|hunter-cheyne-stokes breathing
139494|NCT02429986|Periodic Breathing|periodic breathing
139495|NCT02429973|Osteosarcoma|osteosarcoma
139496|NCT02429960|Nociception|nociception
139497|NCT02429960|Analgesia|analgesia
139498|NCT02429960|Intraoperative|intraoperative
139499|NCT02429960|Monitoring|monitoring
139500|NCT02429947|Charcot Marie Tooth disease|charcot marie tooth disease
139501|NCT02429947|CMT|cmt
139502|NCT02429947|HMSN|hmsn
139503|NCT02429947|HMN|hmn
139504|NCT02429947|HSN|hsn
139505|NCT02429934|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
139506|NCT02429934|Abatacept (Orencia)|abatacept (orencia)
139507|NCT02429934|Arthritis|arthritis
139508|NCT02429921|dietary intervention|dietary intervention
139509|NCT02429921|arsenic poisoning|arsenic poisoning
139510|NCT02429921|high-Se lentils|high-se lentils
139511|NCT02429895|Methotrexate|methotrexate
139512|NCT02429895|Efficacy|efficacy
139513|NCT02429895|Safety|safety
139514|NCT02429882|Ankylosing Spondyloarthritis; non-radiographic axial spondyloarthritis|ankylosing spondyloarthritis; non-radiographic axial spondyloarthritis
139515|NCT02429843|Non-squamous cell lung cancer|non-squamous cell lung cancer
139516|NCT02429843|Non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
139517|NCT02429843|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
139518|NCT02429843|TRC105|trc105
139519|NCT02429830|gastroesophageal reflux disease|gastroesophageal reflux disease
139520|NCT02429830|GERD|gerd
139521|NCT02429830|obesity|obesity
139522|NCT02429830|LSG|lsg
139523|NCT02429830|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
139524|NCT02429817|Pulmonary aerosol distribution|pulmonary aerosol distribution
139526|NCT02429817|High flow nasal cannula|high flow nasal cannula
139527|NCT02429817|Vibrating-mesh nebulizer|vibrating-mesh nebulizer
139528|NCT02429817|Jet nebulizer|jet nebulizer
139529|NCT02429791|two-drug regimen|two-drug regimen
139530|NCT02429791|virologically-suppressed|virologically-suppressed
139531|NCT02429791|dolutegravir plus rilpivirine|dolutegravir plus rilpivirine
139532|NCT02429791|integrase inhibitor|integrase inhibitor
139533|NCT02429791|protease inhibitor|protease inhibitor
139534|NCT02429791|NNRTI-sparing|nnrti-sparing
139535|NCT02429791|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
139536|NCT02429791|HIV|hiv
139537|NCT02429791|nucleoside reverse transcriptase inhibitors|nucleoside reverse transcriptase inhibitors
139538|NCT02429752|inspiratory muscle training|inspiratory muscle training
139545|NCT02429739|Reading comprehension|reading comprehension
139546|NCT02429726|malignant pleural effusion, p53 gene therapy, cisplatin|malignant pleural effusion, p53 gene therapy, cisplatin
139547|NCT02429713|tourniquet|tourniquet
130552|NCT02481739|fertility|fertility
130553|NCT02481739|endometriosis surgery|endometriosis surgery
139548|NCT02429713|total knee arthroplasty|total knee arthroplasty
139549|NCT02429713|blood loss|blood loss
139550|NCT02429674|Depression|depression
139551|NCT02429674|Adolescence|adolescence
139552|NCT02429648|AF|af
139553|NCT02429635|Exercise|exercise
139554|NCT02429635|lifestyle diseases|lifestyle diseases
139555|NCT02429635|well-being|well-being
139556|NCT02429596|antiepileptic drugs|antiepileptic drugs
139557|NCT02429596|generic substitution|generic substitution
139558|NCT02429570|meclofenamate|meclofenamate
139559|NCT02429570|15-068|15-068
139560|NCT02429557|autonomic failure|autonomic failure
139561|NCT02429557|orthostatic hypotension|orthostatic hypotension
139562|NCT02429557|compression garments|compression garments
139563|NCT02429557|treatment|treatment
139564|NCT02429544|Breast cancer|breast cancer
139565|NCT02429544|Stage IV breast cancer|stage iv breast cancer
139566|NCT02429544|Metastatic|metastatic
139567|NCT02429544|Residential group programs|residential group programs
139568|NCT02429544|Questionnaires|questionnaires
139569|NCT02429544|Surveys|surveys
139570|NCT02429544|EEG|eeg
139571|NCT02429544|Computer testing|computer testing
139572|NCT02429544|Saliva test|saliva test
139573|NCT02429544|Study diary|study diary
139574|NCT02429544|Actigraph|actigraph
139575|NCT02429531|Pneumovax 23|pneumovax 23
139576|NCT02429531|Typhim Vi|typhim vi
139577|NCT02429531|allohemagglutinins|allohemagglutinins
139578|NCT02429518|leishmaniasis|leishmaniasis
139579|NCT02429518|miltefosine|miltefosine
139580|NCT02429518|EKG|ekg
139581|NCT02429492|Pathophysiology|pathophysiology
139582|NCT02429492|Spinal interneurons|spinal interneurons
139583|NCT02429492|Electrophysiology|electrophysiology
139584|NCT02429492|EMG|emg
139585|NCT02429492|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
139586|NCT02429479|Advance Care Planning|advance care planning
139587|NCT02429479|Living Will|living will
139588|NCT02429479|Family Caregiver|family caregiver
139589|NCT02429479|Advance Directive|advance directive
139590|NCT02429479|Surrogate Decision Maker|surrogate decision maker
139591|NCT02429479|Proxy|proxy
139592|NCT02429479|Self-Efficacy|self-efficacy
139599|NCT02429453|Warfarin|warfarin
139600|NCT02429453|Traumatic intracranial hemorrhage|traumatic intracranial hemorrhage
139601|NCT02429453|prothrombin complex concentrate|prothrombin complex concentrate
139602|NCT02429453|fresh frozen plasma|fresh frozen plasma
139603|NCT02429453|Spontaneous intracranial hemorrhage|spontaneous intracranial hemorrhage
139604|NCT02429427|Primary Breast Cancer|primary breast cancer
139605|NCT02429427|Celecoxib|celecoxib
139606|NCT02429414|Surgical Procedure|surgical procedure
139607|NCT02429414|Fiberoptic bronchoscopy|fiberoptic bronchoscopy
139608|NCT02429414|FOB|fob
139609|NCT02429414|Non-Video Double Lumen Tube|non-video double lumen tube
139610|NCT02429414|DLT|dlt
139611|NCT02429414|Video Double Lumen Tube|video double lumen tube
139612|NCT02429414|VDLT|vdlt
139613|NCT02429401|binge drinking|binge drinking
139614|NCT02429401|heavy drinking|heavy drinking
139615|NCT02429388|Heart failure|heart failure
139616|NCT02429388|Spironolactone|spironolactone
139617|NCT02429388|Diuretics|diuretics
139618|NCT02429375|Mocetinostat (MGCD0103)|mocetinostat (mgcd0103)
139619|NCT02429375|Brentuximab Vedotin (SGN-35)|brentuximab vedotin (sgn-35)
139620|NCT02429375|Relapsed|relapsed
139621|NCT02429375|Refractory|refractory
139622|NCT02429323|induction|induction
139623|NCT02429323|pediatrics|pediatrics
139624|NCT02429323|sevoflurane|sevoflurane
139625|NCT02429323|intubation time|intubation time
139626|NCT02429310|Intermittent Claudication|intermittent claudication
139627|NCT02429310|IC|ic
139628|NCT02429310|Peripheral Arterial Disease|peripheral arterial disease
139629|NCT02429310|Peripheral Vascular Disease|peripheral vascular disease
139630|NCT02429310|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
139631|NCT02429310|Lower Limb Arterial Disease|lower limb arterial disease
139759|NCT02428660|CYP3A4|cyp3a4
139632|NCT02429310|Supervised Exercise Therapy|supervised exercise therapy
139633|NCT02429310|Supervised Exercise Programme|supervised exercise programme
139634|NCT02429310|Exercise Therapy|exercise therapy
654808|NCT00789867|Safety|safety
139635|NCT02429297|Hypertension|hypertension
139636|NCT02429297|Diabetes|diabetes
139637|NCT02429297|mHealth|mhealth
139638|NCT02429297|Interactive Voice Response|interactive voice response
139639|NCT02429297|Bolivia|bolivia
139640|NCT02429297|Chronic disease|chronic disease
139641|NCT02429284|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
139642|NCT02429284|Pulmonary Endarterectomy (PEA)|pulmonary endarterectomy (pea)
139643|NCT02429284|Pulmonary Thromboendarterectomy (PTE)|pulmonary thromboendarterectomy (pte)
139644|NCT02429284|Pulmonary Hypertension|pulmonary hypertension
139645|NCT02429284|Balloon Pulmonary Angioplasty (BPA)|balloon pulmonary angioplasty (bpa)
139646|NCT02429271|undergoing thrombolysis|undergoing thrombolysis
130708|NCT02480972|MRI|mri
139647|NCT02429245|Knee|knee
139648|NCT02429245|Knee osteoarthritis|knee osteoarthritis
139649|NCT02429245|Knee replacement|knee replacement
139650|NCT02429232|Pioglitazone|pioglitazone
139651|NCT02429232|Linagliptin|linagliptin
139652|NCT02429232|Diabetes mellitus|diabetes mellitus
139653|NCT02429232|Diabetic macular edema|diabetic macular edema
139654|NCT02429232|Kidney|kidney
139655|NCT02429154|spectroscopy, near-infrared|spectroscopy, near-infrared
139656|NCT02429154|Infant|infant
139657|NCT02429154|Anesthesia, general|anesthesia, general
139658|NCT02429128|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
139659|NCT02429115|peer mentoring|peer mentoring
139660|NCT02429115|chronic kidney disease|chronic kidney disease
139661|NCT02429115|quality of life|quality of life
139662|NCT02429115|pcori|pcori
139663|NCT02429115|caregiver burden|caregiver burden
139664|NCT02429102|Phase 1|phase 1
139665|NCT02429102|Healthy subjects|healthy subjects
139666|NCT02429102|Pharmacokinetics of MT-8554|pharmacokinetics of mt-8554
139667|NCT02429089|recurrent|recurrent
139668|NCT02429089|metastatic|metastatic
139669|NCT02429063|Solid Tumors|solid tumors
139670|NCT02429050|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
139671|NCT02429050|Dyspnea|dyspnea
139672|NCT02429050|Breathlessness|breathlessness
139673|NCT02429050|Morphine|morphine
139674|NCT02429050|Opioid|opioid
139675|NCT02429050|Symptom Management|symptom management
139677|NCT02429037|gene therapy|gene therapy
139678|NCT02429037|head and neck cancer|head and neck cancer
139679|NCT02429024|Diabetes Mellitus|diabetes mellitus
139680|NCT02429024|A1c|a1c
139681|NCT02429011|depression|depression
139682|NCT02429011|MRI|mri
139683|NCT02429011|treatment-resistant|treatment-resistant
139684|NCT02429011|imaging|imaging
139685|NCT02429011|ketamine|ketamine
139686|NCT02428985|Riociguat|riociguat
139687|NCT02428985|Adempas|adempas
139688|NCT02428985|soluble guanylate cyclase (sGC) stimulator|soluble guanylate cyclase (sgc) stimulator
139689|NCT02428985|Pulmonary arterial hypertension|pulmonary arterial hypertension
139690|NCT02428985|Japan|japan
139691|NCT02428985|Post-marketing surveillance|post-marketing surveillance
139692|NCT02428972|brain tumor|brain tumor
139693|NCT02428972|quality of life|quality of life
139694|NCT02428972|cognition|cognition
139695|NCT02428972|anesthetic technique|anesthetic technique
139696|NCT02428959|Amyl Nitrite|amyl nitrite
139697|NCT02428959|High Resolution Manometry|high resolution manometry
139698|NCT02428946|Insulin Sensitivity|insulin sensitivity
139699|NCT02428946|obesity|obesity
139700|NCT02428946|dopamine|dopamine
139701|NCT02428933|Brown Adipose Tissue|brown adipose tissue
139702|NCT02428933|Obesity|obesity
139703|NCT02428933|Insulin Sensitivity|insulin sensitivity
139704|NCT02428933|Dopamine|dopamine
139705|NCT02428920|cardiovascular health|cardiovascular health
139706|NCT02428920|behavior change|behavior change
139707|NCT02428920|community-based|community-based
139708|NCT02428920|prevention|prevention
139709|NCT02428907|simulation training|simulation training
139710|NCT02428907|minimal sedation|minimal sedation
139711|NCT02428907|colonoscopy|colonoscopy
139712|NCT02428907|patient satisfaction|patient satisfaction
139713|NCT02428907|teamwork|teamwork
139714|NCT02428907|team training|team training
139715|NCT02428907|patient safety|patient safety
139716|NCT02428881|onabotulinumtoxin A|onabotulinumtoxin a
139717|NCT02428868|hip fracture|hip fracture
139718|NCT02428868|anemia|anemia
139719|NCT02428868|blood transfusion|blood transfusion
139720|NCT02428868|tranexamic acid|tranexamic acid
139721|NCT02428868|intravenous iron|intravenous iron
139722|NCT02428855|Cholangiocarcinoma|cholangiocarcinoma
139723|NCT02428842|Cervical cancer|cervical cancer
139724|NCT02428842|Tumor biopsies|tumor biopsies
139725|NCT02428842|Standard treatment|standard treatment
139726|NCT02428842|Molecular profile|molecular profile
139727|NCT02428842|Next Generation Sequencing|next generation sequencing
139728|NCT02428829|hip|hip
139729|NCT02428829|replacement|replacement
139730|NCT02428829|arthroplasty|arthroplasty
139731|NCT02428829|total|total
139732|NCT02428829|orthopaedic|orthopaedic
139733|NCT02428829|rehabiliation|rehabiliation
139734|NCT02428829|physiotherapy|physiotherapy
139735|NCT02428829|therapy|therapy
139736|NCT02428816|differential diagnosis|differential diagnosis
139737|NCT02428816|multimodal MRI|multimodal mri
139738|NCT02428816|Parkinson's Disease|parkinson's disease
139739|NCT02428816|Multiple System Atrophy|multiple system atrophy
139740|NCT02428803|Peritoneal Dialysis|peritoneal dialysis
139741|NCT02428777|Hysteroscopy|hysteroscopy
139742|NCT02428751|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
139743|NCT02428751|liposomal doxorubicin|liposomal doxorubicin
139744|NCT02428751|doxorubicin|doxorubicin
139745|NCT02428751|event-free survival|event-free survival
139746|NCT02428738|Influenza Vaccine|influenza vaccine
139747|NCT02428738|Text Message|text message
139748|NCT02428673|Osteopenia|osteopenia
139749|NCT02428673|spinal muscular atrophy|spinal muscular atrophy
139750|NCT02428673|cerebral palsy|cerebral palsy
139751|NCT02428673|muscular dystrophy|muscular dystrophy
139752|NCT02428673|spina bifida|spina bifida
139753|NCT02428673|Rett Syndrome|rett syndrome
139754|NCT02428660|Polypharmacy|polypharmacy
139755|NCT02428660|Chronic conditions|chronic conditions
139756|NCT02428660|Drug Therapy Problems|drug therapy problems
139757|NCT02428660|Medication Therapy Management|medication therapy management
139758|NCT02428660|Medication-Related Problems|medication-related problems
139760|NCT02428660|CYP3A5|cyp3a5
139761|NCT02428660|Drug-drug interactions|drug-drug interactions
139762|NCT02428660|Drug-gene interactions|drug-gene interactions
139763|NCT02428660|Drug-drug-gene interactions|drug-drug-gene interactions
139764|NCT02428660|Adverse Drug Reactions|adverse drug reactions
139765|NCT02428660|Activities of Daily Living|activities of daily living
139766|NCT02428647|growth|growth
139767|NCT02428647|plasma zinc concentration|plasma zinc concentration
139768|NCT02428634|Cardiovascular health promotion|cardiovascular health promotion
139769|NCT02428634|Children|children
139770|NCT02428634|School intervention|school intervention
139771|NCT02428621|early orthodontic treatment|early orthodontic treatment
139772|NCT02428621|activator|activator
139773|NCT02428621|removable appliance|removable appliance
139774|NCT02428621|Twicare®|twicare®
139775|NCT02428621|Herbst appliance|herbst appliance
139776|NCT02428608|Glabellar Lines|glabellar lines
139777|NCT02428608|Botulinum toxin, Type A|botulinum toxin, type a
139778|NCT02428582|endovascular treatment|endovascular treatment
139779|NCT02428582|arterial occlusive disease|arterial occlusive disease
139780|NCT02428582|bare metal stent|bare metal stent
139781|NCT02428582|polytetrafluoroethylene covered stent|polytetrafluoroethylene covered stent
139782|NCT02428569|shared decision making|shared decision making
139783|NCT02428569|patient education|patient education
139784|NCT02428569|decision aids|decision aids
139785|NCT02428556|Decision making|decision making
139786|NCT02428543|FLT3-ITD patients in first complete remission|flt3-itd patients in first complete remission
139787|NCT02428517|acute lymphoblastic leukemia|acute lymphoblastic leukemia
139788|NCT02428517|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
139789|NCT02428517|alternative hematopoietic stem cell donor|alternative hematopoietic stem cell donor
139790|NCT02428517|busulfan|busulfan
139791|NCT02428517|antithymocyte globulin|antithymocyte globulin
139792|NCT02428504|Questionnaire|questionnaire
139793|NCT02428491|Diphtheria|diphtheria
139794|NCT02428491|Tetanus|tetanus
139795|NCT02428491|Pertussis|pertussis
139796|NCT02428491|Poliomyelitis|poliomyelitis
139797|NCT02428491|Hepatitis B|hepatitis b
139798|NCT02428491|DTaP-IPV-Hep B-PRP-T Combined Vaccine (Hexaxim™)|dtap-ipv-hep b-prp-t combined vaccine (hexaxim™)
139799|NCT02428452|autism|autism
139800|NCT02428452|Autism SPectrum Disorder|autism spectrum disorder
139801|NCT02428452|early intervention|early intervention
139802|NCT02428452|infant|infant
139803|NCT02428452|toddler|toddler
139804|NCT02428452|early identification|early identification
139805|NCT02428452|pivotal response training (PRT)|pivotal response training (prt)
139806|NCT02428452|control group|control group
139807|NCT02428452|treatment group|treatment group
139808|NCT02428452|at risk|at risk
139809|NCT02428452|social communication|social communication
139810|NCT02428452|positive affect|positive affect
139811|NCT02428452|smiling|smiling
139812|NCT02428439|genetic markers|genetic markers
139813|NCT02428439|predictors|predictors
139814|NCT02428439|Antidepressive Agents|antidepressive agents
139815|NCT02428439|Suicidal Ideation|suicidal ideation
139816|NCT02428439|Adolescent|adolescent
139817|NCT02428426|Mucosal Microbiome|mucosal microbiome
139818|NCT02428426|gastric intestinal metaplasia|gastric intestinal metaplasia
139819|NCT02428426|duodenum|duodenum
139820|NCT02428413|Waste Anesthetic Gas (WAG)|waste anesthetic gas (wag)
139821|NCT02428387|caregivers|caregivers
139822|NCT02428387|intervention|intervention
139823|NCT02428387|health related quality of life|health related quality of life
139824|NCT02428387|dementia|dementia
139826|NCT02428374|Ventricular function, left|ventricular function, left
139827|NCT02428309|Tregs|tregs
139828|NCT02428296|Clinical Trial|clinical trial
139829|NCT02428296|Congenital Malformations|congenital malformations
139830|NCT02428296|Overgrowth|overgrowth
139831|NCT02428296|Pilot Drug Treatment Trial|pilot drug treatment trial
139833|NCT02428257|elderly|elderly
139834|NCT02428257|continous spinal anesthesia|continous spinal anesthesia
139835|NCT02428257|hypobaric bupivacaine|hypobaric bupivacaine
139836|NCT02428257|isobaric bupivacaine|isobaric bupivacaine
139837|NCT02428257|hypotension|hypotension
139838|NCT02428244|Smoking|smoking
139839|NCT02428244|Cessation|cessation
139840|NCT02428244|Trauma|trauma
139841|NCT02428244|Fracture|fracture
139842|NCT02428244|Complications|complications
139843|NCT02428218|Randomized|randomized
139844|NCT02428218|Ages 10-17|ages 10-17
139845|NCT02428218|Pediatrics|pediatrics
139846|NCT02428218|Placebo controlled|placebo controlled
139847|NCT02428218|Relapse-Remitting|relapse-remitting
139848|NCT02428218|Multiple Sclerosis|multiple sclerosis
139849|NCT02428218|Safety|safety
139850|NCT02428218|Efficacy|efficacy
139851|NCT02428218|BG00012|bg00012
139852|NCT02428179|Surgical site infection|surgical site infection
139853|NCT02428179|Intraoperative briefings|intraoperative briefings
139854|NCT02428179|Mortality|mortality
139855|NCT02428179|Wound closure|wound closure
139856|NCT02428179|Surgical procedure|surgical procedure
139857|NCT02428166|crosslinking|crosslinking
139858|NCT02428166|keratoconus|keratoconus
139859|NCT02428166|keratometry|keratometry
139860|NCT02428166|pachymetry|pachymetry
139861|NCT02428166|pentacam|pentacam
139862|NCT02428153|static stretching|static stretching
139863|NCT02428153|dynamic stretching|dynamic stretching
139864|NCT02428153|muscle-tendon unit|muscle-tendon unit
139865|NCT02428153|ultrasound|ultrasound
139866|NCT02428153|Subjects|subjects
139867|NCT02428140|ischemic stroke|ischemic stroke
139868|NCT02428140|atrial fibrillation|atrial fibrillation
139869|NCT02428140|etiologic investigations|etiologic investigations
139870|NCT02428140|secondary prevention|secondary prevention
139871|NCT02428140|anticoagulation|anticoagulation
139872|NCT02428140|arrhythmias|arrhythmias
139873|NCT02428140|embolic stroke, undetermined etiology|embolic stroke, undetermined etiology
139874|NCT02428140|implantable loop recorder|implantable loop recorder
139875|NCT02428140|external loop recorder|external loop recorder
139876|NCT02428062|Post-operative complications|post-operative complications
139877|NCT02428062|Mild cognitive impairment|mild cognitive impairment
139878|NCT02428062|Delirium|delirium
139879|NCT02428036|TBI-1401(HF10)|tbi-1401(hf10)
139880|NCT02428036|HF10|hf10
139881|NCT02428036|HSV-1|hsv-1
139882|NCT02428036|Oncolytic virus|oncolytic virus
139883|NCT02428036|Oncolytic virotherapy|oncolytic virotherapy
139884|NCT02428036|Phase I|phase i
139885|NCT02428036|Melanoma|melanoma
139886|NCT02428036|Intratumoral administration|intratumoral administration
139887|NCT02428023|Thalassemia|thalassemia
139888|NCT02428023|trait|trait
139889|NCT02428023|coronary|coronary
139890|NCT02428023|stroke|stroke
139891|NCT02427997|Virtual Reality|virtual reality
139892|NCT02427997|Treadmill|treadmill
139893|NCT02427997|Multiple Sclerosis|multiple sclerosis
139894|NCT02427984|Internal Left Hip Prosthesis|internal left hip prosthesis
139895|NCT02427984|Internal Right Hip Prosthesis|internal right hip prosthesis
139896|NCT02427958|Drug Therapy|drug therapy
139897|NCT02427945|Information provision|information provision
139898|NCT02427932|Pharmacokinetics (PK)|pharmacokinetics (pk)
139899|NCT02427932|Pharmacodynamics (PD)|pharmacodynamics (pd)
139900|NCT02427919|G-CSF|g-csf
139901|NCT02427919|G-CSF receptor|g-csf receptor
139903|NCT02427919|refractory AML|refractory aml
139904|NCT02427919|Neutropenic fever|neutropenic fever
139905|NCT02427919|salvage chemotherapy|salvage chemotherapy
139906|NCT02427906|cirrhosis|cirrhosis
139907|NCT02427906|gut microbiota|gut microbiota
139908|NCT02427906|transjugular portosystemic shunt|transjugular portosystemic shunt
139909|NCT02427906|hepatic encephalopathy|hepatic encephalopathy
139910|NCT02427893|immunotherapy|immunotherapy
139911|NCT02427893|Vemurafenib|vemurafenib
139912|NCT02427893|Cobimetinib|cobimetinib
139913|NCT02427880|Edema|edema
139914|NCT02427880|Nephrotic syndrome|nephrotic syndrome
139915|NCT02427880|Acetazolamide|acetazolamide
139916|NCT02427880|Furosemide|furosemide
139917|NCT02427867|remote ischemic preconditioning|remote ischemic preconditioning
139918|NCT02427867|non cardiac surgery|non cardiac surgery
139919|NCT02427867|myocardial ischemia|myocardial ischemia
139920|NCT02427854|Major delivery complications|major delivery complications
139921|NCT02427854|Perineal injuries|perineal injuries
139922|NCT02427854|episiotomy|episiotomy
139923|NCT02427789|Physical exercise|physical exercise
139924|NCT02427789|Biomarkers|biomarkers
139925|NCT02427789|Neuroprotection|neuroprotection
139926|NCT02427789|ergospirometry|ergospirometry
139927|NCT02427789|Major Depressive Disorder|major depressive disorder
139928|NCT02427763|Removable Orthodontic Appliance;|removable orthodontic appliance;
139929|NCT02427763|malocclusion|malocclusion
139930|NCT02427763|Streptococcus mutans|streptococcus mutans
139931|NCT02427763|Lactobacillus|lactobacillus
139932|NCT02427763|Epithelium|epithelium
139933|NCT02427737|Magnetic Resonance Imaging|magnetic resonance imaging
139951|NCT02427633|comatose|comatose
139952|NCT02427633|resource limited|resource limited
139953|NCT02427620|Lymphoma|lymphoma
139954|NCT02427620|Mantle cell lymphoma|mantle cell lymphoma
139955|NCT02427620|MCL|mcl
139956|NCT02427620|B-lymphocyte antigen|b-lymphocyte antigen
139957|NCT02427620|CD20|cd20
139958|NCT02427620|Ibrutinib|ibrutinib
139959|NCT02427620|PCI-32765|pci-32765
139960|NCT02427620|Imbruvica|imbruvica
139961|NCT02427620|Rituximab|rituximab
139962|NCT02427620|Rituxan|rituxan
139963|NCT02427620|Cyclophosphamide|cyclophosphamide
139964|NCT02427620|Cytoxan|cytoxan
139965|NCT02427620|Neosar|neosar
139966|NCT02427620|Vincristine|vincristine
139967|NCT02427620|Mesna|mesna
139968|NCT02427620|Mesnex|mesnex
139969|NCT02427620|Dexamethasone|dexamethasone
139970|NCT02427620|Decadron|decadron
139971|NCT02427620|Doxorubicin|doxorubicin
139972|NCT02427620|Doxorubicin hydrochloride|doxorubicin hydrochloride
139973|NCT02427620|Adriamycin PFS|adriamycin pfs
139974|NCT02427620|Adriamycin RDF|adriamycin rdf
139975|NCT02427620|Adriamycin|adriamycin
139976|NCT02427620|Rubex|rubex
139977|NCT02427620|G-CSF|g-csf
139978|NCT02427620|Filgrastim|filgrastim
139979|NCT02427620|Neupogen|neupogen
139980|NCT02427620|Methotrexate|methotrexate
139981|NCT02427620|Cytarabine|cytarabine
139982|NCT02427620|Ara-C|ara-c
139983|NCT02427620|Cytosar|cytosar
139984|NCT02427620|DepoCyt|depocyt
139985|NCT02427620|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
139986|NCT02427620|Citrovorum|citrovorum
139987|NCT02427620|Leucovorin|leucovorin
139988|NCT02427620|Wellcovorin|wellcovorin
139989|NCT02427607|Epilepsy|epilepsy
139990|NCT02427607|Perampanel|perampanel
139996|NCT02427568|Anxiety|anxiety
139997|NCT02427568|MDMA|mdma
139998|NCT02427568|Life-threatening illness|life-threatening illness
139999|NCT02427568|psychotherapy|psychotherapy
140000|NCT02427542|Randomized Controlled Trial|randomized controlled trial
140001|NCT02427529|hcg|hcg
140002|NCT02427503|asthma|asthma
140003|NCT02427503|sinonasal polyposis|sinonasal polyposis
140004|NCT02427503|eosinophilic bronchial inflammation|eosinophilic bronchial inflammation
140005|NCT02427503|endoscopic sinus surgery|endoscopic sinus surgery
140006|NCT02427490|Palliative Care|palliative care
140007|NCT02427490|Caregivers|caregivers
140008|NCT02427490|Medical Oncology|medical oncology
140009|NCT02427464|diabetic|diabetic
140010|NCT02427464|neuropathy|neuropathy
140011|NCT02427464|shooting pain|shooting pain
140012|NCT02427464|burning pain|burning pain
140013|NCT02427464|pins and needles pain|pins and needles pain
140014|NCT02427464|foot pain|foot pain
140016|NCT02427438|video|video
140017|NCT02427438|handout|handout
140018|NCT02427438|home program|home program
140019|NCT02427438|stabilization|stabilization
140020|NCT02427438|strengthening|strengthening
140021|NCT02427438|core|core
140022|NCT02427425|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
140023|NCT02427425|Pain|pain
140024|NCT02427412|Tranexamic Acid|tranexamic acid
140025|NCT02427412|Knee Arthroplasty|knee arthroplasty
140026|NCT02427412|Blood loss|blood loss
140027|NCT02427412|Blood transfusion|blood transfusion
140028|NCT02427412|Thrombolic complication|thrombolic complication
140029|NCT02427412|Total blood loss 24 h after ended surgery.|total blood loss 24 h after ended surgery.
140030|NCT02427412|Total blood loss 2 days after ended surgery.|total blood loss 2 days after ended surgery.
140031|NCT02427386|Endometriosis|endometriosis
140032|NCT02427386|Pelvic pain|pelvic pain
140033|NCT02427386|Homeopathy|homeopathy
140034|NCT02427386|RCT|rct
140035|NCT02427373|bioavailability|bioavailability
140036|NCT02427373|fish oil|fish oil
140037|NCT02427373|krill oil|krill oil
140038|NCT02427360|Retrospective Studies|retrospective studies
140039|NCT02427360|Clinical Efficacy|clinical efficacy
140040|NCT02427321|Cystoscopy|cystoscopy
140041|NCT02427321|Bladder cancer|bladder cancer
140042|NCT02427321|Bladder imaging|bladder imaging
140043|NCT02427308|leishmaniasis|leishmaniasis
140044|NCT02427308|miltefosine|miltefosine
140045|NCT02427308|pregnancy|pregnancy
140046|NCT02427269|Barrett's Esophagus|barrett's esophagus
140047|NCT02427269|Esophageal Cancer|esophageal cancer
140048|NCT02427269|Intramucosal Adenocarcinoma|intramucosal adenocarcinoma
140049|NCT02427230|Pelvic Floor Muscle Training|pelvic floor muscle training
140649|NCT02423733|e-therapy|e-therapy
140050|NCT02427230|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
140051|NCT02427230|Urinary Incontinence|urinary incontinence
140052|NCT02427230|Spinal Cord Injury|spinal cord injury
140053|NCT02427204|Hepatitis C infection|hepatitis c infection
140054|NCT02427204|Hepatitis C treatment|hepatitis c treatment
140055|NCT02427191|Chronic plantar fasciitis|chronic plantar fasciitis
140056|NCT02427191|Heel pain|heel pain
140057|NCT02427178|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
140058|NCT02427178|MNGIE|mngie
140059|NCT02427178|Stem Cell transplant|stem cell transplant
140060|NCT02427113|TMD|tmd
140061|NCT02427113|Music Medicine|music medicine
140062|NCT02427113|Vibroacousitc Therapy|vibroacousitc therapy
140063|NCT02427100|Homeless|homeless
140064|NCT02427100|Randomized Controlled Trial|randomized controlled trial
140065|NCT02427100|Diet|diet
140066|NCT02427100|Physical Activity|physical activity
140067|NCT02427087|Nonalcoholic fatty liver|nonalcoholic fatty liver
140068|NCT02427087|Physical activity|physical activity
140069|NCT02427087|NAFLD|nafld
140070|NCT02427087|Anthropometry|anthropometry
140071|NCT02427087|Body Composition|body composition
140072|NCT02427048|Clinical Practice Guidelines|clinical practice guidelines
140073|NCT02427022|evidence based practices, critical time intervention|evidence based practices, critical time intervention
169032|NCT02262416|IVF|ivf
140074|NCT02426944|atrial fibrillation|atrial fibrillation
140075|NCT02426944|cardioembolic event|cardioembolic event
140076|NCT02426944|stroke|stroke
140077|NCT02426944|left atrial appendage closure|left atrial appendage closure
140078|NCT02426944|novel anticoagulants|novel anticoagulants
140079|NCT02426931|retrograde intrarenal surgery|retrograde intrarenal surgery
140080|NCT02426931|flexible ureteroscopy|flexible ureteroscopy
140081|NCT02426931|renal calculi|renal calculi
140082|NCT02426892|Solid Tumors|solid tumors
140083|NCT02426892|HPV-16 Positive Incurable Solid Tumors|hpv-16 positive incurable solid tumors
140084|NCT02426892|ISA101|isa101
140809|NCT02422875|Myositis|myositis
140085|NCT02426892|HPV-16 vaccination|hpv-16 vaccination
140086|NCT02426892|Nivolumab|nivolumab
140087|NCT02426892|BMS-936558|bms-936558
140088|NCT02426892|Opdivo|opdivo
140089|NCT02426879|three-field lymphadenectomy|three-field lymphadenectomy
140090|NCT02426879|cervical metastases|cervical metastases
140091|NCT02426879|esophagectomy|esophagectomy
140092|NCT02426853|Cancer Prevention|cancer prevention
140093|NCT02426853|Sun protection|sun protection
140094|NCT02426853|Photograph|photograph
140095|NCT02426853|UV photograph|uv photograph
140096|NCT02426853|Ultraviolet|ultraviolet
140097|NCT02426853|Pamphlets|pamphlets
140098|NCT02426853|Handouts|handouts
140099|NCT02426853|Questionnaires|questionnaires
140100|NCT02426853|Surveys|surveys
140101|NCT02426853|Skin cancer risk behaviors|skin cancer risk behaviors
140102|NCT02426840|Adverse bone health|adverse bone health
140103|NCT02426840|Bone demineralization|bone demineralization
140104|NCT02426840|HIV-infection|hiv-infection
140105|NCT02426840|Children|children
140106|NCT02426840|Adolescents|adolescents
140107|NCT02426840|Calcium|calcium
140108|NCT02426840|Vitamin D|vitamin d
140109|NCT02426840|Supplementation|supplementation
140110|NCT02426814|Patient Compliance|patient compliance
140111|NCT02426814|Mobile Applications|mobile applications
140112|NCT02426801|Patient Compliance|patient compliance
140113|NCT02426801|Mobile Applications|mobile applications
140114|NCT02426801|Medication Adherence|medication adherence
140115|NCT02426788|medically unexplained|medically unexplained
140116|NCT02426788|fibromyalgia|fibromyalgia
140117|NCT02426788|PoTS|pots
140118|NCT02426788|non-cardiac chest pain|non-cardiac chest pain
140119|NCT02426788|CFS|cfs
140120|NCT02426788|IBS|ibs
140121|NCT02426788|functional neurological|functional neurological
140122|NCT02426788|chronic pain|chronic pain
140123|NCT02426788|hyperventilation|hyperventilation
140124|NCT02426762|skin sealant|skin sealant
140125|NCT02426762|laparoscopic surgery|laparoscopic surgery
140126|NCT02426762|surgical site infection|surgical site infection
140127|NCT02426762|wound healing|wound healing
140128|NCT02426736|Shoulder Joint|shoulder joint
140129|NCT02426736|Arthroscopy|arthroscopy
140130|NCT02426736|Ambulatory surgical procedures|ambulatory surgical procedures
140131|NCT02426736|Pain, Postoperative|pain, postoperative
140132|NCT02426736|Brachial Plexus Block|brachial plexus block
140133|NCT02426736|Corticosteroid|corticosteroid
140134|NCT02426736|Dexamethasone|dexamethasone
140135|NCT02426736|Bupivacaine|bupivacaine
140136|NCT02426736|Perineural|perineural
140137|NCT02426710|ablation, atrial flutter, intracardiac echocardiography|ablation, atrial flutter, intracardiac echocardiography
140138|NCT02426697|bone metastasis, radiotherapy, pain, prevention|bone metastasis, radiotherapy, pain, prevention
140139|NCT02426684|End Stage Renal Disease|end stage renal disease
140140|NCT02426684|Kidney Transplant|kidney transplant
140141|NCT02426684|Desensitization|desensitization
140142|NCT02426684|Highly Sensitized|highly sensitized
140143|NCT02426684|Antibodies|antibodies
140144|NCT02426671|neuromodulation|neuromodulation
140145|NCT02426671|Minimum Masking Level|minimum masking level
140146|NCT02426645|Biomarkers|biomarkers
140147|NCT02426645|Sepsis|sepsis
140148|NCT02426645|Multi organ dysfunction|multi organ dysfunction
140149|NCT02426645|Immunomonitoring|immunomonitoring
140151|NCT02426632|Healthy|healthy
140152|NCT02426632|JNJ-53718678|jnj-53718678
140153|NCT02426606|Lentils|lentils
140154|NCT02426606|Post-prandial|post-prandial
140155|NCT02426606|Glycemic response|glycemic response
140156|NCT02426606|Insulin response|insulin response
140157|NCT02426606|Diabetes|diabetes
140158|NCT02426606|Mixed meal|mixed meal
140159|NCT02426606|Glycemia|glycemia
140160|NCT02426606|Slowly digestible starch|slowly digestible starch
140161|NCT02426606|Post-prandial glycemia|post-prandial glycemia
140163|NCT02426593|Heart Failure|heart failure
140164|NCT02426567|Crohn's Disease|crohn's disease
140165|NCT02426567|Exclusive Enteral Nutrition|exclusive enteral nutrition
140166|NCT02426567|Dietary Treatment|dietary treatment
140167|NCT02426567|Gut microbiota|gut microbiota
140168|NCT02426541|Diabetes Mellitus|diabetes mellitus
140169|NCT02426541|Dapagliflozin|dapagliflozin
140170|NCT02426541|Placebo|placebo
140171|NCT02426541|Insulin resistance|insulin resistance
140172|NCT02426541|Insulin sensitivity|insulin sensitivity
140173|NCT02426476|heart rate variability|heart rate variability
131157|NCT02478268|xenon gas|xenon gas
131158|NCT02478255|Radiation induced lung injury|radiation induced lung injury
140174|NCT02426476|biofeedback|biofeedback
140175|NCT02426476|chronic pain|chronic pain
140176|NCT02426476|Veterans|veterans
140177|NCT02426463|Neonatal intensive care|neonatal intensive care
140178|NCT02426463|need for intratracheal intubation|need for intratracheal intubation
140179|NCT02426437|Acute Exacerbation of COPD (AECOPD)|acute exacerbation of copd (aecopd)
140180|NCT02426437|COPD|copd
140181|NCT02426437|Emphysema|emphysema
140182|NCT02426437|Chronic Bronchitis|chronic bronchitis
140183|NCT02426424|c-PAP|c-pap
140184|NCT02426398|EEG|eeg
140185|NCT02426372|Ulcerative Colitis|ulcerative colitis
140186|NCT02426372|Inflammatory Bowel Disease|inflammatory bowel disease
140187|NCT02426346|Adolescent; Adolescent obesity; Community-based; Overweight|adolescent; adolescent obesity; community-based; overweight
140188|NCT02426307|Thrombosis|thrombosis
140189|NCT02426307|Cardiovascular disease|cardiovascular disease
140190|NCT02426307|Oral anticoagulation|oral anticoagulation
140191|NCT02426307|bioprosthesis|bioprosthesis
140192|NCT02426307|Multidetector Computed Tomography|multidetector computed tomography
140193|NCT02426268|cardiac surgery|cardiac surgery
140194|NCT02426268|cerebral oximetry|cerebral oximetry
140195|NCT02426268|lower extremity oximetry|lower extremity oximetry
140196|NCT02426255|Severe trauma|severe trauma
140197|NCT02426255|traumatic Brain injury|traumatic brain injury
140198|NCT02426255|Hemorrhage|hemorrhage
140199|NCT02426242|brain-injury|brain-injury
140200|NCT02426242|extubation|extubation
140201|NCT02426229|SSc|ssc
140202|NCT02426229|systemic sclerosis|systemic sclerosis
140203|NCT02426229|cutaneous systemic sclerosis|cutaneous systemic sclerosis
140204|NCT02426216|prostate cancer|prostate cancer
140205|NCT02426216|chemoprevention|chemoprevention
140206|NCT02426216|biomarker|biomarker
140207|NCT02426203|Echocardiography|echocardiography
140208|NCT02426177|postpartum hypertension|postpartum hypertension
140209|NCT02426177|labetalol in postpartum hypertension|labetalol in postpartum hypertension
140210|NCT02426177|nifedipine in postpartum hypertension|nifedipine in postpartum hypertension
140211|NCT02426125|carcinoma of the bladder|carcinoma of the bladder
140212|NCT02426125|carcinoma of the urethra|carcinoma of the urethra
140213|NCT02426125|carcinoma the of ureter|carcinoma the of ureter
140214|NCT02426125|carcinoma of the renal pelvis|carcinoma of the renal pelvis
140215|NCT02426125|transitional cell carcinoma|transitional cell carcinoma
140216|NCT02426125|transitional cell tumor|transitional cell tumor
140217|NCT02426125|RANGE|range
140218|NCT02426125|bladder cancer|bladder cancer
140219|NCT02426099|Resistant hypertension|resistant hypertension
140220|NCT02426099|diabetes mellitus|diabetes mellitus
140221|NCT02426099|Spironolactone|spironolactone
140222|NCT02426099|African|african
140223|NCT02426086|Myelofibrosis|myelofibrosis
140224|NCT02426086|JNJ-63935937|jnj-63935937
140225|NCT02426086|Imetelstat|imetelstat
140226|NCT02426073|Inflammaging|inflammaging
140227|NCT02426047|seizures|seizures
140228|NCT02426047|epilepsy|epilepsy
140229|NCT02426047|catamenial|catamenial
140230|NCT02426047|ketogenic diet|ketogenic diet
140231|NCT02426047|modified Atkins diet|modified atkins diet
140232|NCT02426047|intractable epilepsy|intractable epilepsy
140233|NCT02426047|medically refractory epilepsy|medically refractory epilepsy
140234|NCT02426047|adult|adult
140235|NCT02426047|medium chain triglyceride|medium chain triglyceride
140236|NCT02426034|Advanced|advanced
140237|NCT02426034|Metastatic|metastatic
140238|NCT02425995|ACL|acl
140239|NCT02425995|Hidden lesions of the medial meniscus|hidden lesions of the medial meniscus
140240|NCT02425995|Chronic knee instability|chronic knee instability
140241|NCT02425995|Intercondylar and posteromedial arthroscopy|intercondylar and posteromedial arthroscopy
140242|NCT02425995|Arthroscopic Posteromedial and Intercondylar portal|arthroscopic posteromedial and intercondylar portal
140243|NCT02425995|Diagnosis capacity of hidden lesions of the medial meniscus|diagnosis capacity of hidden lesions of the medial meniscus
140245|NCT02425982|Lateral elbow pain|lateral elbow pain
140246|NCT02425982|Latera epicondylitis|latera epicondylitis
140247|NCT02425930|gastric cancer|gastric cancer
140248|NCT02425930|complement system|complement system
140249|NCT02425930|overal survival|overal survival
140250|NCT02425904|Langerhans Cell Histiocytosis|langerhans cell histiocytosis
140252|NCT02425839|shear wave elastography|shear wave elastography
140253|NCT02425839|surface electromyogram|surface electromyogram
140254|NCT02425839|masseter|masseter
140255|NCT02425826|Parapsoriasis|parapsoriasis
140256|NCT02425826|Plaque Psoriasis|plaque psoriasis
140257|NCT02425826|CC-10004|cc-10004
140258|NCT02425826|Apremilast|apremilast
140259|NCT02425826|Moderate Plaque Psoriasis|moderate plaque psoriasis
140260|NCT02425826|Safety|safety
140261|NCT02425787|Loss of a child|loss of a child
140262|NCT02425787|Grief|grief
140263|NCT02425774|Prucalopride|prucalopride
140264|NCT02425774|Vagus Nerve Stimulation|vagus nerve stimulation
140265|NCT02425774|Postoperative Ileus|postoperative ileus
140266|NCT02425761|Cerebrospinal Fluid Shunts|cerebrospinal fluid shunts
140267|NCT02425761|Randomized Controlled Trial|randomized controlled trial
140268|NCT02425748|γδ T Cell, non small lung cancer, Without EGFR Mutation|γδ t cell, non small lung cancer, without egfr mutation
140269|NCT02425735|Immunotherapy, γδ T Cell, heptocellular liver cancer|immunotherapy, γδ t cell, heptocellular liver cancer
140270|NCT02425722|ASP0456|asp0456
140271|NCT02425722|linaclotide|linaclotide
140272|NCT02425722|chronic constipation|chronic constipation
140273|NCT02425696|right-to-left shunt|right-to-left shunt
140274|NCT02425696|contrast-enhanced transcranial Doppler|contrast-enhanced transcranial doppler
140275|NCT02425696|migraine|migraine
140276|NCT02425696|silent cerebral infarction|silent cerebral infarction
140277|NCT02425683|Colon Cancer|colon cancer
140278|NCT02425683|Rectal Cancer|rectal cancer
140279|NCT02425683|Colorectal Cancer|colorectal cancer
140280|NCT02425683|Stage IIIC Colorectal Cancer|stage iiic colorectal cancer
140281|NCT02425670|Brain attack|brain attack
140282|NCT02425670|stroke|stroke
140283|NCT02425670|Ischemic stroke|ischemic stroke
140284|NCT02425670|stem cell therapy|stem cell therapy
140285|NCT02425657|Education|education
140286|NCT02425657|Training|training
140287|NCT02425657|Fast track|fast track
140288|NCT02425657|Colonoscopy|colonoscopy
140289|NCT02425644|relapsing multiple sclerosis|relapsing multiple sclerosis
140290|NCT02425631|SI joint fusion|si joint fusion
140291|NCT02425631|SI joint pain|si joint pain
140292|NCT02425631|SI joint|si joint
140293|NCT02425631|SI joint treatment|si joint treatment
140294|NCT02425631|SI joint disease|si joint disease
140295|NCT02425631|Sacroiliac joint|sacroiliac joint
140296|NCT02425631|Simmetry|simmetry
140297|NCT02425566|autonomic nervous system|autonomic nervous system
140298|NCT02425566|hypertension|hypertension
140299|NCT02425566|ganglionic blocker|ganglionic blocker
140300|NCT02425566|trimethaphan|trimethaphan
140301|NCT02425566|splanchnic circulation|splanchnic circulation
140302|NCT02425566|capacitance|capacitance
140303|NCT02425553|Diet|diet
140304|NCT02425553|Reflux|reflux
140305|NCT02425553|Dyspepsia|dyspepsia
140306|NCT02425553|Symptoms|symptoms
140307|NCT02425553|Alcohol|alcohol
140308|NCT02425540|Pelvic MRI|pelvic mri
140309|NCT02425527|Brain Injuries|brain injuries
140310|NCT02425527|Traumatic Brain Injury|traumatic brain injury
140311|NCT02425527|Video Games|video games
140312|NCT02425514|Anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
140313|NCT02425514|NovoMax|novomax
140314|NCT02425514|Bioactive Glass-ceramic Intervertebral Spacer|bioactive glass-ceramic intervertebral spacer
140315|NCT02425501|Aflibercept|aflibercept
140316|NCT02425501|anti-VEGF|anti-vegf
140317|NCT02425488|Nursing|nursing
140318|NCT02425488|Outcome and Process Assessment|outcome and process assessment
140319|NCT02425488|Cardiac Resynchronization Therapy Devices|cardiac resynchronization therapy devices
140320|NCT02425488|Heart Failure|heart failure
140321|NCT02425488|Education|education
140322|NCT02425475|Dermoscopy|dermoscopy
140323|NCT02425449|succinylcholine|succinylcholine
140324|NCT02425449|depolarizing muscle relaxants|depolarizing muscle relaxants
140325|NCT02425449|pharmacologic effects|pharmacologic effects
140326|NCT02425410|Diabetes Mellitus|diabetes mellitus
140327|NCT02425410|Insulin-Dependent|insulin-dependent
140328|NCT02425410|Virus Diseases|virus diseases
140329|NCT02425410|Questionnaires|questionnaires
140330|NCT02425410|Risk assessment|risk assessment
140331|NCT02425410|Genome-Wide Association Study|genome-wide association study
140332|NCT02425397|Ototoxicity|ototoxicity
140333|NCT02425397|platinum derivatives|platinum derivatives
140334|NCT02425397|paediatrics|paediatrics
140335|NCT02425397|oncology|oncology
140336|NCT02425397|clinical research|clinical research
140337|NCT02425384|adolescent|adolescent
140338|NCT02425384|physical activity|physical activity
140339|NCT02425384|accelerometer|accelerometer
140340|NCT02425358|cell therapy|cell therapy
140342|NCT02425358|timing|timing
140343|NCT02425345|Physical Activity|physical activity
140344|NCT02425345|National Institute of Aging Go4Life|national institute of aging go4life
140345|NCT02425345|Postmenopausal Women|postmenopausal women
140346|NCT02425345|Balance|balance
140347|NCT02425345|Strength|strength
140348|NCT02425345|Exercise|exercise
140349|NCT02425345|Cardiovascular Disease|cardiovascular disease
140350|NCT02425345|Stroke|stroke
140351|NCT02425345|Mortality|mortality
140352|NCT02425345|Myocardial Infarction|myocardial infarction
140353|NCT02425345|Falls|falls
140354|NCT02425345|Venous Thromboembolic Event|venous thromboembolic event
140355|NCT02425345|Peripheral Artery Disease|peripheral artery disease
140356|NCT02425345|Physical Function|physical function
140357|NCT02425345|Mobility|mobility
140358|NCT02425345|Coronary Artery Bypass Graft (CABG)|coronary artery bypass graft (cabg)
140359|NCT02425345|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
140360|NCT02425345|Hip Fractures|hip fractures
140361|NCT02425345|Cardiovascular Mortality|cardiovascular mortality
140362|NCT02425332|Spinal Cord Injury|spinal cord injury
140363|NCT02425332|adaptive control|adaptive control
140364|NCT02425332|assessment|assessment
140365|NCT02425332|assist-as-needed|assist-as-needed
140366|NCT02425332|walking ability|walking ability
140367|NCT02425332|Lokomat|lokomat
140368|NCT02425306|peptide|peptide
140369|NCT02425306|vaccine|vaccine
140370|NCT02425306|adjuvant|adjuvant
140371|NCT02425306|polyICLC|polyiclc
140372|NCT02425306|cyclophosphamide|cyclophosphamide
140373|NCT02425306|Montanide ISA-51|montanide isa-51
140374|NCT02425267|Telerehabilitation|telerehabilitation
140375|NCT02425241|Vaccine|vaccine
140376|NCT02425241|DNA|dna
140377|NCT02425241|HIV-1|hiv-1
140378|NCT02425241|Serum amyloid P component (SAP)|serum amyloid p component (sap)
140379|NCT02425241|Clinical trial|clinical trial
140380|NCT02425241|Vaccination|vaccination
140381|NCT02425241|Prophylaxis|prophylaxis
140382|NCT02425241|Adult male|adult male
140383|NCT02425228|targeted biopsy|targeted biopsy
140384|NCT02425228|conventional biopsy|conventional biopsy
140385|NCT02425228|cognitive biopsy|cognitive biopsy
140386|NCT02425215|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
140387|NCT02425215|Late radiation injury|late radiation injury
140388|NCT02425215|Adult|adult
140389|NCT02425215|Malignancy|malignancy
140390|NCT02425215|Quality of Life|quality of life
140391|NCT02425215|Chronic Pain|chronic pain
140392|NCT02425202|pediatric|pediatric
140393|NCT02425202|obstructive sleep apnea|obstructive sleep apnea
140394|NCT02425202|tonsillectomy|tonsillectomy
140395|NCT02425202|analgesia|analgesia
140396|NCT02425176|botulinum toxin|botulinum toxin
140397|NCT02425176|sialorrhoea|sialorrhoea
140398|NCT02425176|drooling|drooling
140399|NCT02425163|Prostate Cancer|prostate cancer
140400|NCT02425163|Shear Wave Elastography|shear wave elastography
140401|NCT02425163|Prostate|prostate
140402|NCT02425163|Prostate Biopsy|prostate biopsy
140403|NCT02425150|Keratoconus|keratoconus
140404|NCT02425150|Corneal crosslinking|corneal crosslinking
140405|NCT02425150|Corneal biomechanics|corneal biomechanics
140406|NCT02425150|Corneal densitometry|corneal densitometry
140407|NCT02425150|Scheimpflug photography|scheimpflug photography
140408|NCT02425111|Drug therapy|drug therapy
140409|NCT02425098|Drug therapy|drug therapy
140410|NCT02425085|retinectomy|retinectomy
140411|NCT02425085|endodiathermy|endodiathermy
140412|NCT02425085|inferior|inferior
140413|NCT02425085|retinal redetachment|retinal redetachment
140414|NCT02425072|Cancer|cancer
140415|NCT02425072|Brain|brain
140416|NCT02425072|Lung|lung
140417|NCT02425072|Small-cell|small-cell
140418|NCT02425059|irreversible electroporation|irreversible electroporation
140419|NCT02425059|Unresectable Rectal Neoplasms|unresectable rectal neoplasms
140420|NCT02425046|family|family
140421|NCT02425033|POEM|poem
140422|NCT02425033|Minimally invasive surgery|minimally invasive surgery
140423|NCT02425033|Achalasia|achalasia
140424|NCT02425033|Spastic esophageal disorders|spastic esophageal disorders
140425|NCT02425020|Supplement|supplement
140426|NCT02425020|performance|performance
140427|NCT02425020|whey|whey
140428|NCT02425020|meat|meat
140429|NCT02425020|protein|protein
140430|NCT02424994|Morbidity|morbidity
140431|NCT02424994|Mortality|mortality
140432|NCT02424994|Health care utilization|health care utilization
140433|NCT02424994|Cohort|cohort
140434|NCT02424994|Epidemiology|epidemiology
140435|NCT02424994|Cardiovascular diseases|cardiovascular diseases
140436|NCT02424968|Healthy Stem Cell Donor|healthy stem cell donor
140437|NCT02424955|Liver cancer|liver cancer
140438|NCT02424955|Hepatocellular Carcinoma|hepatocellular carcinoma
140439|NCT02424955|Liver imaging|liver imaging
140440|NCT02424955|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
140441|NCT02424955|SABR|sabr
140442|NCT02424929|Deep Brain Stimulation|deep brain stimulation
140443|NCT02424916|Onco-dermatology|onco-dermatology
140444|NCT02424916|Adoptive transfer|adoptive transfer
140445|NCT02424916|Immunotherapy|immunotherapy
140446|NCT02424903|infection|infection
140447|NCT02424903|prosthesis|prosthesis
140448|NCT02424903|hip|hip
140449|NCT02424903|knee|knee
140450|NCT02424903|shoulder|shoulder
140451|NCT02424877|rheumatoid arthritis|rheumatoid arthritis
140452|NCT02424877|drug treatment|drug treatment
140453|NCT02424877|compliance|compliance
140454|NCT02424877|outcome|outcome
140455|NCT02424864|4D PET-CT|4d pet-ct
140456|NCT02424851|myeloma|myeloma
140457|NCT02424851|multiple myeloma|multiple myeloma
140458|NCT02424851|chronic kidney disease|chronic kidney disease
140459|NCT02424851|renal failure|renal failure
140460|NCT02424851|bortezomib|bortezomib
140461|NCT02424851|Velcade|velcade
140462|NCT02424851|thalidomide|thalidomide
140463|NCT02424851|bendamustine|bendamustine
140464|NCT02424851|dexamethasone|dexamethasone
140465|NCT02424851|serum free light chains|serum free light chains
140466|NCT02424851|proteosomal inhibition|proteosomal inhibition
140467|NCT02424851|immunomodulatory|immunomodulatory
140468|NCT02424825|diet|diet
140469|NCT02424825|cooking|cooking
140470|NCT02424825|multiple sclerosis|multiple sclerosis
140471|NCT02424825|fatigue|fatigue
140472|NCT02424812|handwashing|handwashing
140473|NCT02424812|behavior|behavior
140474|NCT02424799|Urticaria|urticaria
140475|NCT02424799|SYK Inhibitor|syk inhibitor
140476|NCT02424786|Adherence|adherence
140477|NCT02424786|Polypharmacy|polypharmacy
140478|NCT02424786|Elderly|elderly
140479|NCT02424786|Chronic kidney disease|chronic kidney disease
140480|NCT02424734|Late-onset Sepsis|late-onset sepsis
140481|NCT02424708|Reduced Glutathione|reduced glutathione
140482|NCT02424708|Intranasal|intranasal
140483|NCT02424708|(in)GSH|(in)gsh
140484|NCT02424708|Parkinson's Disease|parkinson's disease
140485|NCT02424708|Glutathione|glutathione
140486|NCT02424708|Uptake|uptake
140487|NCT02424708|central nervous system|central nervous system
140488|NCT02424695|Cortical arousal intensity|cortical arousal intensity
140489|NCT02424695|RLS|rls
140490|NCT02424695|Heart rate|heart rate
140491|NCT02424695|Blood pressure|blood pressure
140492|NCT02424695|PLMs|plms
140493|NCT02424630|sono-guided interscalene brachial plexus block|sono-guided interscalene brachial plexus block
140494|NCT02424630|arthroscopy-guided suprascapular nerve block|arthroscopy-guided suprascapular nerve block
140495|NCT02424630|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
140496|NCT02424630|postoperative pain|postoperative pain
140497|NCT02424591|Anesthesia Recovery Period|anesthesia recovery period
140498|NCT02424591|Spinal Fusion|spinal fusion
140499|NCT02424552|severe asthma|severe asthma
140500|NCT02424552|vitamin D|vitamin d
140501|NCT02424552|treatment|treatment
140502|NCT02424539|Seasonal|seasonal
140503|NCT02424539|Fluticasone Furoate|fluticasone furoate
140504|NCT02424539|Perennial|perennial
140505|NCT02424539|Allergic Rhinitis|allergic rhinitis
140506|NCT02424539|Nasal Spray|nasal spray
140507|NCT02424526|cerebral palsy|cerebral palsy
140508|NCT02424526|treadmill training|treadmill training
140509|NCT02424526|walking|walking
140510|NCT02424487|Initial pressure|initial pressure
140511|NCT02424487|changes of intracuff pressure|changes of intracuff pressure
140512|NCT02424487|infants and children|infants and children
140513|NCT02424474|cell free fetal DNA|cell free fetal dna
140514|NCT02424474|general population|general population
140515|NCT02424474|screening|screening
140516|NCT02424474|trisomy 21|trisomy 21
140517|NCT02424474|IVF|ivf
140518|NCT02424435|Friedreich Ataxia|friedreich ataxia
140519|NCT02424435|FRDA|frda
140520|NCT02424422|Corrective Orthodontics|corrective orthodontics
140521|NCT02424422|CBCT|cbct
140522|NCT02424422|Rapid Maxillary Expansion|rapid maxillary expansion
140523|NCT02424422|Cone Beam Computed Tomography|cone beam computed tomography
140524|NCT02424422|Hyrax Expansion|hyrax expansion
140525|NCT02424422|Craniofacial Sutures|craniofacial sutures
140526|NCT02424409|Asthma|asthma
140527|NCT02424409|Relapse|relapse
140528|NCT02424409|Therapeutic counselling|therapeutic counselling
140529|NCT02424409|Protocol of care|protocol of care
140530|NCT02424396|Interleukin 2, IL2|interleukin 2, il2
140531|NCT02424396|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
140532|NCT02424396|Autoimmune diseases|autoimmune diseases
140533|NCT02424396|Regulatory T cells, Tregs|regulatory t cells, tregs
140534|NCT02424370|Aortic stenosis|aortic stenosis
140535|NCT02424370|TAVR|tavr
140536|NCT02424370|Frailty|frailty
140537|NCT02424370|Elderly|elderly
140538|NCT02424357|Adjustable strabismus surgery|adjustable strabismus surgery
140539|NCT02424357|suture contamination|suture contamination
654903|NCT00790270|whiplash|whiplash
140540|NCT02424357|5%povidone iodine|5%povidone iodine
140542|NCT02424331|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
140543|NCT02424331|Respiratory mechanics|respiratory mechanics
140544|NCT02424331|Plethysmography|plethysmography
140545|NCT02424331|Diaphragm|diaphragm
140546|NCT02424331|Respiratory muscles|respiratory muscles
140547|NCT02424331|Breathing exercises|breathing exercises
140548|NCT02424292|Breast cancer|breast cancer
140549|NCT02424292|Physcial activity/exercise|physcial activity/exercise
140550|NCT02424292|anti-hormonal treatment|anti-hormonal treatment
140551|NCT02424279|pancreatic cancer|pancreatic cancer
140553|NCT02424279|splanchnicectomy|splanchnicectomy
140554|NCT02424266|Tear film|tear film
140555|NCT02424266|Imaging|imaging
140556|NCT02424266|Tomogrophy|tomogrophy
140557|NCT02424266|dry eye|dry eye
140558|NCT02424201|uterine atony|uterine atony
140559|NCT02424175|Fecal Transplant|fecal transplant
140560|NCT02424175|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
140561|NCT02424175|Fecal Microbiota Transplantation|fecal microbiota transplantation
140562|NCT02424110|bipolar radiofrequency ablation|bipolar radiofrequency ablation
140563|NCT02424110|argon beam coagulator|argon beam coagulator
140564|NCT02424097|Prevention|prevention
140565|NCT02424071|melatonin's|melatonin's
140566|NCT02424071|quality of recovery|quality of recovery
140567|NCT02424032|Neck pain|neck pain
140568|NCT02424032|stabilization exercise|stabilization exercise
140569|NCT02424032|connective tissue massage|connective tissue massage
140570|NCT02424006|keratoplasty|keratoplasty
140571|NCT02424006|bioengineered cornea|bioengineered cornea
140572|NCT02424006|donor cornea|donor cornea
140573|NCT02423993|Type 1 diabetes mellitus|type 1 diabetes mellitus
140574|NCT02423993|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
140575|NCT02423993|Quality of life|quality of life
140576|NCT02423993|Therapeutic education|therapeutic education
140577|NCT02423993|Insulin pump|insulin pump
140578|NCT02423941|Liver Transplantation|liver transplantation
140579|NCT02423941|Retrograde Reperfusion|retrograde reperfusion
140580|NCT02423941|Graft dysfunction|graft dysfunction
140581|NCT02423941|Randomized study|randomized study
140582|NCT02423928|immunotherapy|immunotherapy
140583|NCT02423928|cryoablation|cryoablation
140584|NCT02423928|prostate cancer|prostate cancer
140585|NCT02423928|dendritic cell|dendritic cell
140586|NCT02423915|Leukemia|leukemia
140587|NCT02423915|Lymphoma|lymphoma
140588|NCT02423915|Advanced hematologic malignancies|advanced hematologic malignancies
140589|NCT02423915|Graft versus host disease|graft versus host disease
140590|NCT02423915|GVHD|gvhd
140591|NCT02423915|Fucosylated umbilical cord blood Regulatory T cells|fucosylated umbilical cord blood regulatory t cells
140593|NCT02423915|Tregs|tregs
140594|NCT02423915|T cells|t cells
140595|NCT02423915|Cord blood transplant|cord blood transplant
140596|NCT02423915|Total body radiation|total body radiation
140597|NCT02423915|TBI|tbi
140598|NCT02423915|Radiation therapy|radiation therapy
140599|NCT02423915|XRT|xrt
140600|NCT02423915|Rituximab|rituximab
140601|NCT02423915|Rituxan|rituxan
140602|NCT02423915|Fludarabine|fludarabine
140603|NCT02423915|Fludarabine phosphate|fludarabine phosphate
140604|NCT02423915|Fludara|fludara
140605|NCT02423915|Cyclophosphamide|cyclophosphamide
140606|NCT02423915|Cytoxan|cytoxan
140607|NCT02423915|Neosar|neosar
140608|NCT02423915|Mycophenolate|mycophenolate
140609|NCT02423915|Mycophenolate mofetil|mycophenolate mofetil
140610|NCT02423915|MMF|mmf
140611|NCT02423915|CellCept|cellcept
140612|NCT02423915|Sirolimus|sirolimus
140613|NCT02423915|Rapamune|rapamune
140614|NCT02423915|G-CSF|g-csf
140615|NCT02423915|Filgrastim|filgrastim
140616|NCT02423915|Neupogen|neupogen
140617|NCT02423889|Hypofractionated radiotherapy|hypofractionated radiotherapy
140618|NCT02423889|SBRT|sbrt
140619|NCT02423863|Cancer|cancer
140620|NCT02423863|Immunotherapy|immunotherapy
140621|NCT02423863|Intratumoral Injection|intratumoral injection
140622|NCT02423863|Multicenter Study|multicenter study
140623|NCT02423863|Autovaccination|autovaccination
140624|NCT02423863|Solid Tumors|solid tumors
140625|NCT02423850|Diabetic foot ulcers|diabetic foot ulcers
140626|NCT02423850|Leg ulcers|leg ulcers
140627|NCT02423850|Ulcer healing|ulcer healing
140628|NCT02423850|Ulcer measurement|ulcer measurement
140629|NCT02423850|Ulcer area|ulcer area
140630|NCT02423850|Ulcer volume|ulcer volume
140631|NCT02423850|3D measurement|3d measurement
140632|NCT02423837|follicular lymphoma|follicular lymphoma
140633|NCT02423837|bendamustine|bendamustine
140634|NCT02423837|rituximab|rituximab
140635|NCT02423798|Diabetes|diabetes
140636|NCT02423798|Glucose sensor|glucose sensor
140637|NCT02423798|Sensor accuracy and performance|sensor accuracy and performance
140638|NCT02423798|CGM|cgm
140639|NCT02423759|Chemoprevention|chemoprevention
140640|NCT02423733|depression|depression
140641|NCT02423733|dysthymia|dysthymia
140642|NCT02423733|cognitive behavioural therapy|cognitive behavioural therapy
140643|NCT02423733|CBT|cbt
140644|NCT02423733|problem-solving therapy|problem-solving therapy
140645|NCT02423733|PST|pst
140646|NCT02423733|waitlist|waitlist
140647|NCT02423733|secondary mental health care|secondary mental health care
140648|NCT02423733|mental health|mental health
140655|NCT02423642|Acute Kidney Injury Requiring Continuous Renal Replacement Therapy|acute kidney injury requiring continuous renal replacement therapy
140656|NCT02423616|MIP|mip
140657|NCT02423616|Hand Grip|hand grip
140658|NCT02423616|Correlation|correlation
140659|NCT02423616|Inspiratory Pressure|inspiratory pressure
140660|NCT02423616|Hand Grip Force|hand grip force
140668|NCT02423590|Squamous|squamous
140669|NCT02423590|Lung|lung
140670|NCT02423590|Apatorsen|apatorsen
140671|NCT02423577|antiviral|antiviral
140672|NCT02423577|influenza|influenza
140673|NCT02423577|challenge|challenge
140674|NCT02423564|Probiotic|probiotic
140675|NCT02423564|Digesta-Lac|digesta-lac
140676|NCT02423564|Occasional Constipation|occasional constipation
140677|NCT02423564|Constipation|constipation
140678|NCT02423551|Gut microbiota|gut microbiota
140679|NCT02423551|Intestinal permeability|intestinal permeability
140680|NCT02423551|Gut barrier integrity|gut barrier integrity
140681|NCT02423525|glioblastoma|glioblastoma
140682|NCT02423525|astrocytoma|astrocytoma
140683|NCT02423525|oligodendroglioma|oligodendroglioma
140684|NCT02423525|mixed oligoastrocytoma|mixed oligoastrocytoma
140685|NCT02423525|low grade gliomas|low grade gliomas
169752|NCT02258191|NIV|niv
131661|NCT02475187|TEG|teg
140686|NCT02423525|brain metastases|brain metastases
140687|NCT02423525|meningiomas|meningiomas
140688|NCT02423525|leptomeningeal metastases|leptomeningeal metastases
140689|NCT02423512|Inflammatory Bowel Diseases|inflammatory bowel diseases
140690|NCT02423512|Vedolizumab|vedolizumab
140691|NCT02423512|Ulcerative Colitis|ulcerative colitis
140692|NCT02423512|Crohn's Disease|crohn's disease
140693|NCT02423512|MADCAM1|madcam1
140694|NCT02423512|integrin alpha4beta7|integrin alpha4beta7
140695|NCT02423499|Autism Spectrum Disorder|autism spectrum disorder
140696|NCT02423499|Bipolar Disorder|bipolar disorder
140697|NCT02423499|Emotions|emotions
140698|NCT02423460|Ulcerative Colitis|ulcerative colitis
140699|NCT02423460|Healthy Controls|healthy controls
140700|NCT02423460|Crohn's Disease|crohn's disease
140701|NCT02423434|Corneal Confocal Microscopy|corneal confocal microscopy
140702|NCT02423434|Diabetes Mellitus|diabetes mellitus
140703|NCT02423434|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
140704|NCT02423434|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
140705|NCT02423434|Diabetic Neuropathy|diabetic neuropathy
140706|NCT02423434|Diabetes Complications|diabetes complications
140707|NCT02423382|silicone oil|silicone oil
140708|NCT02423382|retinal saturation|retinal saturation
140709|NCT02423382|retinal blood flow|retinal blood flow
140710|NCT02423382|retinal detachment|retinal detachment
140711|NCT02423369|S-100B protein|s-100b protein
140712|NCT02423369|Neuron-specific Enolase|neuron-specific enolase
140713|NCT02423356|breast cancer|breast cancer
140714|NCT02423356|sarcoma|sarcoma
140715|NCT02423356|lymphoma|lymphoma
140716|NCT02423356|echocardiography|echocardiography
140717|NCT02423356|cardiotoxicity|cardiotoxicity
140718|NCT02423356|pharmacogenetics|pharmacogenetics
140719|NCT02423356|doxorubicin|doxorubicin
140720|NCT02423356|chemotherapy|chemotherapy
140721|NCT02423291|PMLBCL|pmlbcl
140722|NCT02423291|Brentuximab Vedotin|brentuximab vedotin
140723|NCT02423291|CD30-positive|cd30-positive
140724|NCT02423291|Mediastinal Lymphoma|mediastinal lymphoma
140725|NCT02423278|gastrectomy|gastrectomy
140726|NCT02423278|lymphadenectomy|lymphadenectomy
140727|NCT02423278|gastric cancer|gastric cancer
140728|NCT02423278|adjuvant chemotherapy|adjuvant chemotherapy
140729|NCT02423278|overall survival|overall survival
140730|NCT02423265|Chronic total coronary occlusions|chronic total coronary occlusions
140731|NCT02423265|Ranolazine|ranolazine
140732|NCT02423252|Critical illness|critical illness
140733|NCT02423252|Intervention|intervention
140734|NCT02423252|RCT|rct
140735|NCT02423252|Relaxation|relaxation
140736|NCT02423252|Guided imagery|guided imagery
140737|NCT02423252|Touch/Massage|touch/massage
140738|NCT02423252|Music listening|music listening
140739|NCT02423252|Neuropeptides|neuropeptides
140740|NCT02423252|Inflammatory molecules|inflammatory molecules
140741|NCT02423252|Post-traumatic stress|post-traumatic stress
140742|NCT02423252|Critical care nurse|critical care nurse
140743|NCT02423252|Psychocognitive nursing intervention|psychocognitive nursing intervention
140744|NCT02423252|Interpersonal support|interpersonal support
140745|NCT02423213|OCT|oct
140746|NCT02423213|image-guided surgery|image-guided surgery
140747|NCT02423213|ophthalmic surgery|ophthalmic surgery
140748|NCT02423187|Stomach ulcer|stomach ulcer
140749|NCT02423187|Duodenal ulcer|duodenal ulcer
140750|NCT02423187|Rabeprazole|rabeprazole
140751|NCT02423187|Recurrence|recurrence
140752|NCT02423161|OCT|oct
140753|NCT02423161|image-guided surgery|image-guided surgery
654904|NCT00790270|ibuprofen|ibuprofen
140754|NCT02423161|vitreoretinal surgery|vitreoretinal surgery
140755|NCT02423161|corneal surgery|corneal surgery
140756|NCT02423148|Lung Cancer|lung cancer
140757|NCT02423096|biomarker|biomarker
140758|NCT02423096|neuroendocrine|neuroendocrine
140759|NCT02423096|metabolite|metabolite
140760|NCT02423096|cognitive functioning|cognitive functioning
140761|NCT02423096|clinical symptoms|clinical symptoms
140762|NCT02423096|schizophrenia|schizophrenia
140763|NCT02423083|Neuroprotection|neuroprotection
140764|NCT02423083|Multiple Sclerosis|multiple sclerosis
140765|NCT02423083|Clinical Trial|clinical trial
140766|NCT02423083|Safety and Tolerability|safety and tolerability
140767|NCT02423070|Cell-free DNA|cell-free dna
140768|NCT02423070|Acute Rejection|acute rejection
140769|NCT02423070|Thoracic Organ Transplantation|thoracic organ transplantation
140770|NCT02423070|Non-Invasive Testing|non-invasive testing
140771|NCT02423070|Chronic Rejection|chronic rejection
140772|NCT02423057|Pharmacodynamics|pharmacodynamics
140773|NCT02423057|DNA Methylation|dna methylation
140774|NCT02423057|Pharmacokinetics|pharmacokinetics
140775|NCT02423057|Nucleoside Analogue|nucleoside analogue
140776|NCT02423057|Epigenetics|epigenetics
140777|NCT02423044|Anxiety|anxiety
140778|NCT02423044|fMRI|fmri
140779|NCT02423044|Virtual Reality|virtual reality
140780|NCT02423044|Shock Threat|shock threat
140781|NCT02423044|Healthy Volunteer|healthy volunteer
140782|NCT02423031|Physiological Measures|physiological measures
140783|NCT02423031|Emotional Context|emotional context
140784|NCT02423031|Pediatric|pediatric
140785|NCT02423031|Distresss Screening|distresss screening
140786|NCT02423005|Stress urinary incontinence|stress urinary incontinence
140787|NCT02423005|Neurotech Vital Compact|neurotech vital compact
140788|NCT02423005|1h Provacative Pad Test|1h provacative pad test
140789|NCT02423005|Neuroelectrical Muscle Stimulation (NEMS)|neuroelectrical muscle stimulation (nems)
140790|NCT02422992|Iron metabolism|iron metabolism
140792|NCT02422992|risk factors|risk factors
140793|NCT02422992|haptoglobin phenotype|haptoglobin phenotype
140794|NCT02422953|Stunting|stunting
140795|NCT02422953|Wasting|wasting
140796|NCT02422953|Underweight|underweight
140797|NCT02422927|C-Reactive Protein|c-reactive protein
140798|NCT02422927|Endothelial Microparticles|endothelial microparticles
140799|NCT02422927|Endothelium|endothelium
140800|NCT02422927|Nutraceutical|nutraceutical
140801|NCT02422927|Cholesterol|cholesterol
140802|NCT02422888|ST elevation myocardial infarction|st elevation myocardial infarction
140803|NCT02422888|Percutaneous coronary intervention|percutaneous coronary intervention
140804|NCT02422888|Endothelial function|endothelial function
140805|NCT02422888|Ticagrelor|ticagrelor
140806|NCT02422888|Prasugrel|prasugrel
140807|NCT02422875|Sjögren's Syndrome|sjögren's syndrome
140808|NCT02422875|Scleroderma|scleroderma
140810|NCT02422875|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
140811|NCT02422875|Rheumatoid Arthritis|rheumatoid arthritis
140812|NCT02422875|Inflammatory Arthritis|inflammatory arthritis
140813|NCT02422875|Undifferentiated Connective Tissue Disease|undifferentiated connective tissue disease
140814|NCT02422875|Idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
140815|NCT02422875|Graft vs Host Disease|graft vs host disease
140816|NCT02422875|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
140817|NCT02422875|Immunoglobulin G4 (IgG4)-related disease|immunoglobulin g4 (igg4)-related disease
140818|NCT02422875|Hepatitis C|hepatitis c
140819|NCT02422875|Epstein Barr Virus (infectious mononucleosis - EBV)|epstein barr virus (infectious mononucleosis - ebv)
140820|NCT02422875|Sepsis|sepsis
140821|NCT02422875|Guillain-Barre syndrome|guillain-barre syndrome
140822|NCT02422875|Mycoplasma pneumoniae|mycoplasma pneumoniae
140823|NCT02422875|Human Immunodeficiency Virus|human immunodeficiency virus
140824|NCT02422862|Physiotherapy|physiotherapy
140825|NCT02422862|Manual Therapy|manual therapy
140826|NCT02422849|Patient admission|patient admission
140827|NCT02422836|photodamage|photodamage
140828|NCT02422836|fine lines|fine lines
140829|NCT02422836|wrinkles|wrinkles
140830|NCT02422836|dyschromia|dyschromia
140831|NCT02422823|anesthesia|anesthesia
140832|NCT02422823|volumes|volumes
140833|NCT02422823|articaine|articaine
140834|NCT02422823|Inferior alveolar nerve block|inferior alveolar nerve block
140835|NCT02422797|HIV|hiv
140836|NCT02422797|NNRTI-sparing|nnrti-sparing
140837|NCT02422797|two-drug regimen|two-drug regimen
140838|NCT02422797|nucleoside reverse transcriptase inhibitors|nucleoside reverse transcriptase inhibitors
140839|NCT02422797|protease inhibitor|protease inhibitor
140840|NCT02422797|integrase inhibitor|integrase inhibitor
140841|NCT02422797|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
140842|NCT02422797|dolutegravir plus rilpivirine|dolutegravir plus rilpivirine
140843|NCT02422797|virologically-suppressed|virologically-suppressed
140844|NCT02422784|Vitamin D insufficient|vitamin d insufficient
140845|NCT02422784|rooibos tea|rooibos tea
140846|NCT02422784|calcium|calcium
140847|NCT02422758|hypothermia|hypothermia
140848|NCT02422758|perioperative nursing|perioperative nursing
140849|NCT02422758|prewarming|prewarming
140850|NCT02422758|prevention and control|prevention and control
140851|NCT02422745|Cocoa extract multivitamins cardiovascular disease cancer|cocoa extract multivitamins cardiovascular disease cancer
140852|NCT02422732|NF1|nf1
140853|NCT02422732|Children|children
140854|NCT02422732|Reading disability|reading disability
140855|NCT02422732|Morphological and functional MRI|morphological and functional mri
140856|NCT02422732|Genetic analysis|genetic analysis
140857|NCT02422719|Chronic myeloid leukemia|chronic myeloid leukemia
140858|NCT02422719|Intolerance|intolerance
140859|NCT02422719|Resitance|resitance
140860|NCT02422719|Radotinib|radotinib
140861|NCT02422693|hydrotherapy|hydrotherapy
140862|NCT02422693|aquatic|aquatic
140863|NCT02422680|Quality assurance|quality assurance
140864|NCT02422680|Caecum intubation rate|caecum intubation rate
140865|NCT02422680|Patient satisfaction|patient satisfaction
140866|NCT02422667|Orthopedics|orthopedics
140867|NCT02422667|Outcome Assessment|outcome assessment
140868|NCT02422628|EGFR inhibitor|egfr inhibitor
140869|NCT02422628|EGFR mutation|egfr mutation
140871|NCT02422628|adenocarcinoma|adenocarcinoma
140872|NCT02422628|EGFR TKI|egfr tki
140873|NCT02422628|treatment|treatment
140874|NCT02422628|Non small cell|non small cell
140875|NCT02422615|HR-positive|hr-positive
140876|NCT02422615|HER2-negative|her2-negative
140877|NCT02422615|Advanced breast cancer|advanced breast cancer
140878|NCT02422615|LEE011|lee011
140879|NCT02422615|ribociclib|ribociclib
140880|NCT02422615|fulvestrant|fulvestrant
140881|NCT02422615|faslodex|faslodex
140882|NCT02422615|CDK|cdk
140883|NCT02422615|CDK4|cdk4
140884|NCT02422615|CDK6|cdk6
140885|NCT02422615|CDK4/6|cdk4/6
140886|NCT02422615|CDK4/6 inhibitor|cdk4/6 inhibitor
140887|NCT02422615|Phase III|phase iii
140888|NCT02422615|ER-positive|er-positive
140889|NCT02422615|PR-positive|pr-positive
140890|NCT02422615|Postmenopausal|postmenopausal
140891|NCT02422615|Men|men
140892|NCT02422602|Patients|patients
140893|NCT02422602|treated by Rivaroxaban|treated by rivaroxaban
140894|NCT02422589|ALK-positive advanced tumors,|alk-positive advanced tumors,
140895|NCT02422589|midazolam,|midazolam,
140896|NCT02422589|warfarin,|warfarin,
140897|NCT02422589|ceritinib,|ceritinib,
140898|NCT02422589|ALK,|alk,
140899|NCT02422589|CYP3A-4,|cyp3a-4,
140900|NCT02422589|Drug drug intereaction|drug drug intereaction
140901|NCT02422563|neoadjuvant chemotherapy|neoadjuvant chemotherapy
140902|NCT02422563|FIGO IB2, FIGO IIB|figo ib2, figo iib
140903|NCT02422563|chemo-radiation|chemo-radiation
140904|NCT02422563|dose dense chemotherapy|dose dense chemotherapy
140905|NCT02422563|cisplatin|cisplatin
140906|NCT02422563|paclitaxel|paclitaxel
140907|NCT02422563|carboplatin|carboplatin
140908|NCT02422563|ifosfamide|ifosfamide
140909|NCT02422550|MRI|mri
140910|NCT02422550|15-073|15-073
140911|NCT02422550|participants undergoing radiation therapy|participants undergoing radiation therapy
140912|NCT02422524|Hepatic, impairment, PA-824, Tuberculosis, Pharmacokinetics, Safety|hepatic, impairment, pa-824, tuberculosis, pharmacokinetics, safety
140913|NCT02422511|Genome Sequencing|genome sequencing
140914|NCT02422511|Exome Sequencing|exome sequencing
140915|NCT02422511|Newborn Screening|newborn screening
140916|NCT02422511|Childhood Onset Genetic Conditions|childhood onset genetic conditions
140917|NCT02422498|Treated with Concurrent Cisplatin|treated with concurrent cisplatin
140918|NCT02422498|Treated with Radiation Therapy|treated with radiation therapy
140919|NCT02422498|Homologous Recombination Repair Status|homologous recombination repair status
140920|NCT02422498|Biomarker of Response|biomarker of response
140921|NCT02422498|15-032|15-032
140922|NCT02422498|Patients|patients
140923|NCT02422485|Salsalate|salsalate
140924|NCT02422446|Endothelial function|endothelial function
140925|NCT02422446|Eicosapentaenoic acid|eicosapentaenoic acid
140926|NCT02422446|Triglycerides|triglycerides
140927|NCT02422433|EGD|egd
140928|NCT02422433|OFDI|ofdi
140929|NCT02422433|Barrett's Esophagus|barrett's esophagus
140930|NCT02422433|Imaging|imaging
140931|NCT02422420|Diabetes Prevention|diabetes prevention
140932|NCT02422420|Financial Incentives|financial incentives
140933|NCT02422420|Medicaid|medicaid
140934|NCT02422420|Motivation|motivation
140935|NCT02422381|NSCLC|nsclc
140936|NCT02422381|lung cancer|lung cancer
140937|NCT02422381|Gemzar|gemzar
140938|NCT02422381|Pembrolizumab|pembrolizumab
140939|NCT02422381|Anti-PD-1|anti-pd-1
140940|NCT02422381|Immunotherapy|immunotherapy
140941|NCT02422368|Graves' ophthalmopathy|graves' ophthalmopathy
140942|NCT02422368|Antioxidant|antioxidant
140943|NCT02422368|Activity|activity
140944|NCT02422368|Severity|severity
140945|NCT02422355|hip|hip
140946|NCT02422355|femoral neck|femoral neck
140947|NCT02422355|Garden classification|garden classification
140948|NCT02422355|healing|healing
140949|NCT02422355|cut-out|cut-out
140950|NCT02422355|iatrogenic fracture|iatrogenic fracture
140951|NCT02422355|implant|implant
140952|NCT02422355|rotational stability|rotational stability
140953|NCT02422355|minimal invasive|minimal invasive
140954|NCT02422329|Advanced Cancers|advanced cancers
140955|NCT02422329|Constipation|constipation
140956|NCT02422329|Recurrent cancer|recurrent cancer
140957|NCT02422329|Locally advanced cancer|locally advanced cancer
140958|NCT02422329|Metastatic cancer|metastatic cancer
140959|NCT02422329|Video|video
140960|NCT02422329|Fact sheet|fact sheet
140961|NCT02422329|Questionnaires|questionnaires
140962|NCT02422329|Surveys|surveys
140963|NCT02422303|Depression|depression
140964|NCT02422303|Gynecoligical surgery|gynecoligical surgery
140965|NCT02422303|Ketamine|ketamine
140966|NCT02422290|Obsessive Compulsive Disorder|obsessive compulsive disorder
140967|NCT02422290|Ketamine|ketamine
140969|NCT02422290|OCD treatment|ocd treatment
140970|NCT02422290|OCD medication|ocd medication
140971|NCT02422277|Cystoprostatectomy|cystoprostatectomy
140972|NCT02422277|Sexual function|sexual function
140973|NCT02422277|Phosphodiestrase 5 inhibitors|phosphodiestrase 5 inhibitors
140974|NCT02422277|Low intensity extracorporeal shock wave therapy|low intensity extracorporeal shock wave therapy
140975|NCT02422277|Erectile dysfunction|erectile dysfunction
140976|NCT02422277|Penile rehabilitation|penile rehabilitation
140977|NCT02422212|metabolism|metabolism
140978|NCT02422212|Diet Induced Thermogenesis|diet induced thermogenesis
140979|NCT02422212|weight regain|weight regain
140980|NCT02422212|energy expenditure|energy expenditure
140981|NCT02422212|bariatric|bariatric
140982|NCT02422186|Depressive Disorder, Treatment-Resistant|depressive disorder, treatment-resistant
140983|NCT02422186|Esketamine|esketamine
140984|NCT02422186|Oral Antidepressant|oral antidepressant
140985|NCT02422186|Elderly Participants|elderly participants
140986|NCT02422134|Pregnancy|pregnancy
140987|NCT02422134|implantation|implantation
140988|NCT02422134|Cytokine|cytokine
140989|NCT02422108|RANKL|rankl
140990|NCT02422082|Osteopenia|osteopenia
140991|NCT02422082|Lactobacillus reuteri|lactobacillus reuteri
140992|NCT02422082|Volumetric bone mineral density|volumetric bone mineral density
140993|NCT02422056|Cleft Palate|cleft palate
140994|NCT02422056|Hemorrhage|hemorrhage
140995|NCT02422056|Palatoplasty|palatoplasty
140996|NCT02422043|adolescence|adolescence
140997|NCT02422030|Male Volunteers|male volunteers
140998|NCT02422017|Leg ulcer|leg ulcer
140999|NCT02422017|wound|wound
141000|NCT02422017|topical timolol|topical timolol
141001|NCT02422004|Rehabilitation|rehabilitation
141002|NCT02422004|Weight-bearing|weight-bearing
141003|NCT02422004|Range of motion|range of motion
141004|NCT02421978|Cognitive dysfunction|cognitive dysfunction
141005|NCT02421978|Inflammation|inflammation
141006|NCT02421978|Fatigue|fatigue
141007|NCT02421978|Decreased motivation|decreased motivation
141008|NCT02421965|Schizophrenia|schizophrenia
141009|NCT02421965|Schizoaffective Disorder|schizoaffective disorder
141010|NCT02421965|Bipolar Disorder|bipolar disorder
141011|NCT02421965|Major Depressive Disorder|major depressive disorder
141012|NCT02421965|Mobile Application|mobile application
141013|NCT02421965|Smartphone|smartphone
141015|NCT02421965|Illness Self-Management|illness self-management
141016|NCT02421965|EHealth|ehealth
141017|NCT02421965|E-Health|e-health
141018|NCT02421965|Health Technology|health technology
141019|NCT02421965|mHealth|mhealth
141020|NCT02421965|m-Health|m-health
141021|NCT02421939|ASP2215|asp2215
141022|NCT02421939|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
141023|NCT02421939|FLT3 Mutation|flt3 mutation
141024|NCT02421939|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
141025|NCT02421939|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
141026|NCT02421874|Patient care team|patient care team
141027|NCT02421874|Care management|care management
141028|NCT02421874|Electronic health records|electronic health records
141030|NCT02421861|intensive care unit|intensive care unit
141031|NCT02421861|critical care|critical care
141032|NCT02421848|Body composition|body composition
141033|NCT02421848|Sarcopenia|sarcopenia
141034|NCT02421848|Cirrhotic with Ascites|cirrhotic with ascites
141035|NCT02421796|n Non-Celiac Wheat Sensitivity|n non-celiac wheat sensitivity
141036|NCT02421796|Malnutrition|malnutrition
141037|NCT02421796|Celiac disease|celiac disease
141038|NCT02421796|Irritable Bowel Syndrome|irritable bowel syndrome
141039|NCT02421783|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
141040|NCT02421783|Multiple food allergy|multiple food allergy
141041|NCT02421783|Body mass index|body mass index
141042|NCT02421783|Osteoporosis|osteoporosis
141043|NCT02421757|Transcutaneous Magnetic Stimulation|transcutaneous magnetic stimulation
141044|NCT02421757|placebo|placebo
141045|NCT02421744|rehabilitation|rehabilitation
141046|NCT02421744|Multiple Sclerosis|multiple sclerosis
141047|NCT02421744|mobility|mobility
141048|NCT02421744|gait|gait
141049|NCT02421744|task-oriented training|task-oriented training
141050|NCT02421731|Rehabilitation|rehabilitation
141051|NCT02421731|Gait|gait
141052|NCT02421718|Acute toxicity|acute toxicity
141053|NCT02421718|Late toxicity|late toxicity
141054|NCT02421718|Prediction models|prediction models
141055|NCT02421679|PTSD|ptsd
141056|NCT02421679|Military-related PTSD and other related conditions|military-related ptsd and other related conditions
141057|NCT02421679|open-label extension|open-label extension
141058|NCT02421653|Micronutrient powders|micronutrient powders
141059|NCT02421653|MNP|mnp
141060|NCT02421653|Weaning|weaning
141061|NCT02421653|Home fortification|home fortification
141062|NCT02421653|Iodine|iodine
141063|NCT02421653|Iodine deficiency|iodine deficiency
141064|NCT02421653|Iodine Deficiency Disorder|iodine deficiency disorder
141065|NCT02421653|IDD|idd
141066|NCT02421653|Infant|infant
141067|NCT02421653|Growth|growth
141068|NCT02421653|Iodised oil|iodised oil
141069|NCT02421627|moxibustion|moxibustion
141070|NCT02421627|irritable bowel syndrome|irritable bowel syndrome
141071|NCT02421627|Magnetic Resonance Imaging|magnetic resonance imaging
141072|NCT02421614|acute respiratory failure|acute respiratory failure
141073|NCT02421614|lung|lung
141074|NCT02421614|enteral feeding|enteral feeding
141075|NCT02421614|feeding composition|feeding composition
141076|NCT02421614|olive|olive
141077|NCT02421614|high fat|high fat
141078|NCT02421549|Remote Monitoring|remote monitoring
141079|NCT02421549|Remote Care|remote care
141080|NCT02421549|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
141081|NCT02421549|Pacemaker|pacemaker
132061|NCT02473042|Zofran|zofran
141082|NCT02421549|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
141083|NCT02421523|Exercise|exercise
141084|NCT02421523|Strength training|strength training
141085|NCT02421510|High level of sugar (glucose) in the blood|high level of sugar (glucose) in the blood
141086|NCT02421484|Phase I clinical trial|phase i clinical trial
141087|NCT02421484|stem cell|stem cell
141088|NCT02421484|mesenchymal stromal cell|mesenchymal stromal cell
141089|NCT02421484|mesenchymal stem cell|mesenchymal stem cell
141090|NCT02421471|Actinic Keratosis|actinic keratosis
141091|NCT02421471|topical treatment|topical treatment
141092|NCT02421471|ingenol mebutate|ingenol mebutate
141093|NCT02421432|trananal TME|trananal tme
141094|NCT02421432|safety|safety
141095|NCT02421432|efficacy|efficacy
141096|NCT02421432|difficult cases|difficult cases
141097|NCT02421419|flexor tendon entrapment|flexor tendon entrapment
141098|NCT02421419|snapping finger|snapping finger
141099|NCT02421419|trigger digits|trigger digits
141100|NCT02421419|trigger thumb|trigger thumb
141101|NCT02421393|Bone quality|bone quality
141102|NCT02421393|Bone strength|bone strength
141103|NCT02421393|Fractures|fractures
141104|NCT02421393|Muscle strength|muscle strength
141105|NCT02421393|Gait and balance|gait and balance
141106|NCT02421393|Musculo-skeletal symptoms|musculo-skeletal symptoms
141107|NCT02421393|Falls|falls
141108|NCT02421380|Hyperpolarized Pyruvate|hyperpolarized pyruvate
141109|NCT02421380|MRI|mri
141110|NCT02421380|14-205|14-205
141111|NCT02421354|Myeloproliferative Diseases|myeloproliferative diseases
141112|NCT02421354|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
141113|NCT02421354|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
141114|NCT02421354|MF|mf
141115|NCT02421354|Nivolumab|nivolumab
141116|NCT02421354|BMS-936558|bms-936558
141117|NCT02421354|Questionnaire|questionnaire
141118|NCT02421354|Survey|survey
141119|NCT02421354|Phone call|phone call
141120|NCT02421341|Heart, Cardiovascular|heart, cardiovascular
141121|NCT02421341|Pulmonary|pulmonary
141122|NCT02421341|Skeletal Muscle|skeletal muscle
141123|NCT02421341|Exercise|exercise
141124|NCT02421315|OCD|ocd
141125|NCT02421315|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
141126|NCT02421315|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
141127|NCT02421289|CYP2B6 polymorphism|cyp2b6 polymorphism
141128|NCT02421289|efavirenz|efavirenz
141129|NCT02421289|Thai|thai
141130|NCT02421289|HIV-infected patient|hiv-infected patient
141131|NCT02421289|pharmacogenomic|pharmacogenomic
141132|NCT02421263|Psilocybin|psilocybin
141133|NCT02421263|Pharmacologic Actions|pharmacologic actions
141134|NCT02421263|Psychotropic Drugs|psychotropic drugs
141135|NCT02421224|Smoking Cessation|smoking cessation
141136|NCT02421224|Incentives|incentives
141137|NCT02421224|Health Behavior|health behavior
141138|NCT02421224|Smoking|smoking
141139|NCT02421224|Work-site|work-site
141140|NCT02421211|Hepatitis C, Chronic|hepatitis c, chronic
141141|NCT02421211|Simeprevir|simeprevir
141142|NCT02421211|Ledipasvir|ledipasvir
141143|NCT02421211|Sofosbuvir|sofosbuvir
141144|NCT02421198|Intervention Studies|intervention studies
141145|NCT02421185|Carcinoma, Hepatocellular|carcinoma, hepatocellular
141146|NCT02421185|JNJ 42756493|jnj 42756493
141147|NCT02421185|a pan-Fibroblast Growth Factor Receptor Tyrosine Kinase Inhibitor|a pan-fibroblast growth factor receptor tyrosine kinase inhibitor
141148|NCT02421172|Hidradenitis Suppurativa|hidradenitis suppurativa
141149|NCT02421159|HIV/AIDS|hiv/aids
141150|NCT02421159|vulnerable populations|vulnerable populations
141151|NCT02421159|heterosexuals at high risk|heterosexuals at high risk
141256|NCT02420860|CC-5013|cc-5013
141152|NCT02421159|peer-driven intervention|peer-driven intervention
141153|NCT02421159|tailored intervention|tailored intervention
141154|NCT02421159|African-American|african-american
141155|NCT02421159|Latino/Hispanic|latino/hispanic
141156|NCT02421159|Seek, test, treat, and retain (STTR)|seek, test, treat, and retain (sttr)
141157|NCT02421159|Brooklyn|brooklyn
141158|NCT02421133|Care transition program|care transition program
141159|NCT02421133|Patient readmission|patient readmission
141160|NCT02421133|Transition Nurse|transition nurse
141161|NCT02421133|Stepped wedge|stepped wedge
141162|NCT02421133|elderly|elderly
141163|NCT02421081|CD34|cd34
141164|NCT02421081|CD133|cd133
141165|NCT02421081|CD309|cd309
141166|NCT02421081|Radial Artery|radial artery
141167|NCT02421081|Ulnar Artery|ulnar artery
141168|NCT02421081|Lymphoid Cell|lymphoid cell
141169|NCT02421081|blood levels|blood levels
141170|NCT02421081|endothelial progenitor cells|endothelial progenitor cells
141172|NCT02421068|Paracetamol|paracetamol
141173|NCT02421068|Fentanyl|fentanyl
141174|NCT02421068|Phenobarbital|phenobarbital
141175|NCT02421068|Doxapram|doxapram
141176|NCT02421068|Midazolam|midazolam
141177|NCT02421068|Sildenafil|sildenafil
141178|NCT02421068|Levetiracetam|levetiracetam
132167|NCT02472561|Artery|artery
141179|NCT02421068|Pharmacokinetics|pharmacokinetics
141180|NCT02421068|Pharmacology|pharmacology
141181|NCT02421068|Fluconazole|fluconazole
141182|NCT02421068|Ibuprofen|ibuprofen
141183|NCT02421055|Bariatric Surgery|bariatric surgery
141184|NCT02421055|Gastric Bypass|gastric bypass
141185|NCT02421055|Sleeve Gastrectomy|sleeve gastrectomy
141186|NCT02421055|Gastroplasty|gastroplasty
141187|NCT02421042|Hepatic Impairment|hepatic impairment
141188|NCT02421042|Hepatic Function|hepatic function
141189|NCT02421029|gadolinium|gadolinium
141190|NCT02421029|calcium disodium ethylenediaminetetraacetic acid (EDTA)|calcium disodium ethylenediaminetetraacetic acid (edta)
141191|NCT02421029|heavy metal toxicity|heavy metal toxicity
141192|NCT02421016|De novo stenosis|de novo stenosis
141193|NCT02421016|bioresorbable polymer coating|bioresorbable polymer coating
141194|NCT02421016|bioresorbable polymer backbone|bioresorbable polymer backbone
141195|NCT02421003|heart surgery blood|heart surgery blood
141196|NCT02420990|ADHD|adhd
141197|NCT02420990|Adolescents|adolescents
141198|NCT02420990|Substance Use Disorders|substance use disorders
141199|NCT02420977|radiotracer|radiotracer
141200|NCT02420964|injectable|injectable
141201|NCT02420964|teaching methods|teaching methods
141202|NCT02420951|Knee|knee
141203|NCT02420951|Arthroplasty|arthroplasty
141204|NCT02420951|Bupivacaine|bupivacaine
141205|NCT02420951|Anesthetics, Local|anesthetics, local
141206|NCT02420938|Leukemia|leukemia
141207|NCT02420938|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
141209|NCT02420938|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
141210|NCT02420938|SLL|sll
141211|NCT02420938|Refractory/relapsed|refractory/relapsed
141212|NCT02420938|High-risk molecular features|high-risk molecular features
141213|NCT02420938|Rituximab|rituximab
141214|NCT02420938|Rituxan|rituxan
141215|NCT02420938|Urelumab|urelumab
141216|NCT02420925|Gastroparesis|gastroparesis
141217|NCT02420925|Celiac Plexus Block|celiac plexus block
141218|NCT02420912|Leukemia|leukemia
141219|NCT02420912|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
141220|NCT02420912|CLL|cll
141221|NCT02420912|Relapsed|relapsed
141222|NCT02420912|Refractory|refractory
141223|NCT02420912|High-risk|high-risk
141224|NCT02420912|Untreated|untreated
141225|NCT02420912|Nivolumab|nivolumab
141226|NCT02420912|BMS-936558|bms-936558
141227|NCT02420912|Opdivo|opdivo
141228|NCT02420912|Ibrutinib|ibrutinib
141229|NCT02420912|PCI-32765|pci-32765
141230|NCT02420912|Imbruvica|imbruvica
141231|NCT02420899|IVUS|ivus
141232|NCT02420899|ACS|acs
141233|NCT02420886|In Vitro culture of human embryos|in vitro culture of human embryos
141234|NCT02420873|Leukemia|leukemia
141235|NCT02420873|Hematological malignancy|hematological malignancy
141236|NCT02420873|Myelofibrosis|myelofibrosis
141237|NCT02420873|MF|mf
141238|NCT02420873|Blastic plasmacytoid dendritic cell neoplasm|blastic plasmacytoid dendritic cell neoplasm
141239|NCT02420873|BPDCN|bpdcn
141240|NCT02420873|CD56 tumor marker|cd56 tumor marker
141241|NCT02420873|Acute myeloid leukemia|acute myeloid leukemia
141242|NCT02420873|AML|aml
141243|NCT02420873|Natural-killer leukemia|natural-killer leukemia
141244|NCT02420873|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
141245|NCT02420873|ALL|all
141246|NCT02420873|CD56 expressing hematological malignancy|cd56 expressing hematological malignancy
141247|NCT02420873|IMGN901|imgn901
141248|NCT02420873|Lorvotuzumab mertansine|lorvotuzumab mertansine
141249|NCT02420860|Myeloma|myeloma
141250|NCT02420860|Multiple myeloma|multiple myeloma
141251|NCT02420860|MM|mm
141252|NCT02420860|Post autologous stem cell transplantation|post autologous stem cell transplantation
141254|NCT02420860|Elotuzumab|elotuzumab
141255|NCT02420860|Lenalidomide|lenalidomide
141257|NCT02420860|Revlimid|revlimid
141258|NCT02420860|Dexamethasone|dexamethasone
141259|NCT02420860|Decadron|decadron
141260|NCT02420860|Diphenhydramine|diphenhydramine
141261|NCT02420860|Benadryl|benadryl
141262|NCT02420860|Ranitidine|ranitidine
141263|NCT02420860|Ranitidine hydrochloride|ranitidine hydrochloride
141264|NCT02420860|Zantac|zantac
141265|NCT02420860|Symptom questionnaire|symptom questionnaire
141266|NCT02420860|Survey|survey
141267|NCT02420847|Bladder cancer|bladder cancer
141268|NCT02420847|Urothelial cancer|urothelial cancer
141269|NCT02420847|Transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
141270|NCT02420847|Metastatic|metastatic
141271|NCT02420847|Locally unresectable|locally unresectable
141272|NCT02420847|Ixazomib|ixazomib
141273|NCT02420847|Gemcitabine|gemcitabine
141274|NCT02420847|Gemcitabine hydrochloride|gemcitabine hydrochloride
141275|NCT02420847|Gemzar|gemzar
141276|NCT02420847|Doxorubicin|doxorubicin
141277|NCT02420847|Doxorubicin hydrochloride|doxorubicin hydrochloride
141278|NCT02420847|Adriamycin PFS|adriamycin pfs
141279|NCT02420847|Adriamycin RDF|adriamycin rdf
141280|NCT02420847|Adriamycin|adriamycin
141281|NCT02420847|Rubex|rubex
141282|NCT02420808|CAD|cad
132270|NCT02472028|Stroke|stroke
141283|NCT02420808|STEMI|stemi
141284|NCT02420808|non STEMI|non stemi
141285|NCT02420808|Unstable angina|unstable angina
141286|NCT02420808|Greece|greece
141287|NCT02420795|Lymphoma|lymphoma
141288|NCT02420795|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
141289|NCT02420795|Relapsed/Refractory|relapsed/refractory
141290|NCT02420795|NHL|nhl
141291|NCT02420795|Mantle cell lymphoma|mantle cell lymphoma
141292|NCT02420795|MCL|mcl
141293|NCT02420795|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
141294|NCT02420795|DLBCL|dlbcl
141295|NCT02420795|Transformed large cell lymphoma|transformed large cell lymphoma
141296|NCT02420795|TLCL|tlcl
141297|NCT02420795|ONC201|onc201
141298|NCT02420795|Phone call|phone call
141299|NCT02420782|Pharmacokinetics|pharmacokinetics
141300|NCT02420782|ASP6282|asp6282
141301|NCT02420782|Pharmacodynamics|pharmacodynamics
141302|NCT02420782|Drug-drug interaction|drug-drug interaction
141303|NCT02420782|Midazolam|midazolam
141304|NCT02420782|Safety and tolerability|safety and tolerability
141305|NCT02420782|Healthy volunteers|healthy volunteers
141306|NCT02420782|Itraconazole|itraconazole
141307|NCT02420769|CA 125|ca 125
141308|NCT02420769|Progesterone|progesterone
141309|NCT02420769|Doppler|doppler
141310|NCT02420769|Corpus Luteum|corpus luteum
141311|NCT02420743|PTD|ptd
141312|NCT02420717|Leukemia|leukemia
141313|NCT02420717|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
141314|NCT02420717|ALL|all
141315|NCT02420717|Philadelphia Chromosome (Ph)-Like|philadelphia chromosome (ph)-like
141316|NCT02420717|Relapsed|relapsed
141317|NCT02420717|Refractory|refractory
141318|NCT02420717|6-mercaptopurine|6-mercaptopurine
141319|NCT02420717|Mercaptopurine|mercaptopurine
141320|NCT02420717|6-MP|6-mp
141321|NCT02420717|Purinethol|purinethol
141322|NCT02420717|Ruxolitinib|ruxolitinib
141323|NCT02420717|Jakafi|jakafi
141324|NCT02420717|INCB018424|incb018424
141325|NCT02420717|INC424|inc424
141326|NCT02420717|Dasatinib|dasatinib
141327|NCT02420717|BMS-354825|bms-354825
141328|NCT02420717|Sprycel|sprycel
141329|NCT02420717|Rituximab|rituximab
141330|NCT02420717|Rituxan|rituxan
141331|NCT02420717|G-CSF|g-csf
141332|NCT02420717|Filgrastim|filgrastim
141333|NCT02420717|Neupogen|neupogen
141334|NCT02420717|Pegfilgrastim|pegfilgrastim
141335|NCT02420717|Neulasta|neulasta
141336|NCT02420717|PEG-G-CSF|peg-g-csf
141337|NCT02420717|Methotrexate|methotrexate
141338|NCT02420717|Cytarabine|cytarabine
141339|NCT02420717|Ara-C|ara-c
141340|NCT02420717|Cytosar|cytosar
141341|NCT02420717|DepoCyt|depocyt
141342|NCT02420717|Cytosine|cytosine
141343|NCT02420717|Arabinosine Hydrochloride|arabinosine hydrochloride
141344|NCT02420717|Cyclophosphamide|cyclophosphamide
141345|NCT02420717|Cytoxan|cytoxan
141346|NCT02420717|Neosar|neosar
141347|NCT02420717|Mesna|mesna
141348|NCT02420717|Mesnex|mesnex
141349|NCT02420717|Doxorubicin|doxorubicin
141350|NCT02420717|Doxorubucin hydrochloride|doxorubucin hydrochloride
141351|NCT02420717|Adriamycin PFS|adriamycin pfs
141352|NCT02420717|Adriamycin RDF|adriamycin rdf
141353|NCT02420717|Adriamycin|adriamycin
141354|NCT02420717|Rubex|rubex
141355|NCT02420717|Vincristine|vincristine
141356|NCT02420717|Dexamethasone|dexamethasone
141357|NCT02420717|Decadron|decadron
141358|NCT02420717|Solumedrol|solumedrol
141359|NCT02420717|Methylprednisolone|methylprednisolone
141360|NCT02420717|Depo-medrol|depo-medrol
141361|NCT02420717|Medrol|medrol
141362|NCT02420717|Solu-medrol|solu-medrol
141363|NCT02420717|Prednisone|prednisone
141364|NCT02420717|Leucovorin|leucovorin
141365|NCT02420717|Citrovorum|citrovorum
141366|NCT02420717|Wellcovorin|wellcovorin
141367|NCT02420704|IVF|ivf
141368|NCT02420704|endometrial thickness|endometrial thickness
141369|NCT02420704|cleavage stage embryo|cleavage stage embryo
141370|NCT02420704|blastocyst stage embryo|blastocyst stage embryo
141371|NCT02420704|Ongoing pregnancy rate|ongoing pregnancy rate
141372|NCT02420691|Gastrointestinal cancer|gastrointestinal cancer
141373|NCT02420691|Foregut neuroendocrine tumors|foregut neuroendocrine tumors
141374|NCT02420691|NET|net
141375|NCT02420691|Thymic|thymic
141376|NCT02420691|Bronchopulmonary|bronchopulmonary
141377|NCT02420691|Gastric|gastric
141378|NCT02420691|Duodenal|duodenal
141379|NCT02420691|Pancreatic|pancreatic
141380|NCT02420691|LEE011|lee011
141381|NCT02420665|Cervical Cancer|cervical cancer
141382|NCT02420665|Cervical Dysplasia|cervical dysplasia
141383|NCT02420665|Abnormal Pap test|abnormal pap test
141384|NCT02420665|Positive human papillomavirus test|positive human papillomavirus test
141385|NCT02420665|HPV|hpv
141386|NCT02420665|Visual inspection with acetic acid|visual inspection with acetic acid
141387|NCT02420665|VIA|via
141388|NCT02420665|Colposcopy|colposcopy
141389|NCT02420665|Proflavine|proflavine
141390|NCT02420665|Acetic acid|acetic acid
141391|NCT02420665|High-Resolution Microendoscopy|high-resolution microendoscopy
141392|NCT02420665|HRME|hrme
141393|NCT02420665|Phone call|phone call
141394|NCT02420613|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
141395|NCT02420613|DIPG|dipg
141396|NCT02420613|Newly Diagnosed|newly diagnosed
141397|NCT02420613|Progressive|progressive
141398|NCT02420613|Pediatrics|pediatrics
141399|NCT02420613|Vorinostat|vorinostat
141400|NCT02420613|SAHA|saha
141401|NCT02420613|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
141402|NCT02420613|MSK-390|msk-390
141403|NCT02420613|Zolinza|zolinza
141404|NCT02420613|Temsirolimus|temsirolimus
141405|NCT02420613|CCI-779|cci-779
141406|NCT02420613|Torisel|torisel
141407|NCT02420613|Radiation therapy|radiation therapy
141408|NCT02420613|XRT|xrt
141409|NCT02420600|Circulating tumor cells|circulating tumor cells
141410|NCT02420600|Head and neck cancer|head and neck cancer
141411|NCT02420600|PD-1|pd-1
141412|NCT02420600|natural killer cells|natural killer cells
141413|NCT02420600|cytotoxic T lymphocytes|cytotoxic t lymphocytes
141414|NCT02420587|Prostate Cancer|prostate cancer
141415|NCT02420587|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
141416|NCT02420587|Castration resistant prostate cancer metastatic to bone|castration resistant prostate cancer metastatic to bone
141417|NCT02420587|mCRPC|mcrpc
141418|NCT02420587|AMG 208|amg 208
141419|NCT02420587|Questionnaire|questionnaire
141420|NCT02420587|Survey|survey
141421|NCT02420561|Depression|depression
141422|NCT02420561|Substance-Related Disorders|substance-related disorders
141423|NCT02420561|Mental Health|mental health
141424|NCT02420535|Dementia|dementia
141425|NCT02420535|Alzheimer's Disease|alzheimer's disease
141426|NCT02420535|Caregivers|caregivers
141427|NCT02420535|Behavioral|behavioral
141428|NCT02420535|Caregiver burden|caregiver burden
141429|NCT02420496|Parental nutrition|parental nutrition
141430|NCT02420496|associated|associated
141431|NCT02420470|diabetes|diabetes
141432|NCT02420470|neural and vessel alteration|neural and vessel alteration
141433|NCT02420470|prodromal stage|prodromal stage
141434|NCT02420457|Fitness devices|fitness devices
141435|NCT02420418|Tobacco use disorder and bipolar disorders|tobacco use disorder and bipolar disorders
141436|NCT02420418|N-acetylcysteine|n-acetylcysteine
141437|NCT02420418|Oxidative stress|oxidative stress
141438|NCT02420418|inflammation|inflammation
141439|NCT02420405|Gene testing|gene testing
141440|NCT02420405|Endobronchial ultrasound (EBUS)|endobronchial ultrasound (ebus)
141441|NCT02420405|Next-generation sequencing (NGS)|next-generation sequencing (ngs)
141442|NCT02420405|Small biopsies|small biopsies
141443|NCT02420379|DMD|dmd
141444|NCT02420379|Duchenne muscular dystrophy|duchenne muscular dystrophy
141445|NCT02420379|eteplirsen|eteplirsen
141446|NCT02420379|Dystrophin|dystrophin
141447|NCT02420379|exon 51|exon 51
141448|NCT02420353|muscle atrophy|muscle atrophy
141449|NCT02420353|growth hormone|growth hormone
141450|NCT02420353|ACL tear|acl tear
141451|NCT02420340|Serious Mental Illness|serious mental illness
141452|NCT02420340|Psychosocial Rehabilitation|psychosocial rehabilitation
141453|NCT02420327|nicotine|nicotine
141454|NCT02420327|galantamine|galantamine
141455|NCT02420327|attention|attention
141456|NCT02420327|cognition|cognition
141457|NCT02420327|non-smoker|non-smoker
141458|NCT02420314|Ascorbate|ascorbate
141459|NCT02420314|Ascorbic acid|ascorbic acid
141460|NCT02420314|Vitamin C|vitamin c
141461|NCT02420314|NSCLC|nsclc
141462|NCT02420314|Non Small Cell Lung Cancer|non small cell lung cancer
141463|NCT02420314|carboplatin|carboplatin
141464|NCT02420314|paclitaxel|paclitaxel
141465|NCT02420288|Pregnancy|pregnancy
141466|NCT02420288|Fetoplacental growth|fetoplacental growth
141467|NCT02420288|Physical exercise|physical exercise
141468|NCT02420288|Pregnant|pregnant
141469|NCT02420288|Placental development|placental development
141470|NCT02420288|Active pregnancy|active pregnancy
141471|NCT02420275|brain injury|brain injury
141571|NCT02419664|Acromegaly|acromegaly
141472|NCT02420275|blue enriched withe bright light therapy|blue enriched withe bright light therapy
141473|NCT02420275|sequel fatigue|sequel fatigue
141474|NCT02420236|Exercise therapy|exercise therapy
141475|NCT02420236|Resistance training|resistance training
141476|NCT02420236|Multidisciplinary treatment|multidisciplinary treatment
141477|NCT02420223|Recipients|recipients
141478|NCT02420197|Exercise therapy|exercise therapy
141479|NCT02420197|Resistance training|resistance training
141480|NCT02420197|Multidisciplinary treatment|multidisciplinary treatment
141481|NCT02420171|In Vitro|in vitro
141482|NCT02420171|embryo quality|embryo quality
141483|NCT02420171|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
141484|NCT02420158|Irritable Bowel Syndrome|irritable bowel syndrome
141485|NCT02420158|Vagal nerve stimulation|vagal nerve stimulation
141486|NCT02420158|Quality of life|quality of life
141488|NCT02420119|serum phosphates|serum phosphates
141489|NCT02420119|vitamin D|vitamin d
141490|NCT02420106|cervical dystonia|cervical dystonia
141491|NCT02420106|neck pain|neck pain
141492|NCT02420106|OMM|omm
141493|NCT02420106|spasmodic torticollis|spasmodic torticollis
141494|NCT02420067|von Hippel-Lindau disease|von hippel-lindau disease
141495|NCT02420067|Endolymphatic sac tumors|endolymphatic sac tumors
141496|NCT02420067|Audiological examination|audiological examination
141497|NCT02420067|MRI|mri
141498|NCT02420067|Surveillance|surveillance
141499|NCT02420054|intermittent fasting|intermittent fasting
141500|NCT02420054|alternate day fasting|alternate day fasting
141501|NCT02420054|diabetes mellitus|diabetes mellitus
141502|NCT02420054|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
141503|NCT02420054|insulin sensitivity|insulin sensitivity
141504|NCT02420041|Sacroiliac Joint Injection|sacroiliac joint injection
141505|NCT02420041|Fluoroscopy|fluoroscopy
141506|NCT02420041|Ultrasound|ultrasound
141507|NCT02419989|Nontuberculous Mycobacteria|nontuberculous mycobacteria
141508|NCT02419963|microbiome|microbiome
141509|NCT02419963|biomarkers|biomarkers
141510|NCT02419963|Vitamin D|vitamin d
141511|NCT02419963|Serotonin|serotonin
141512|NCT02419950|inguinal hernia|inguinal hernia
141513|NCT02419950|TEP|tep
141514|NCT02419950|chronic pain|chronic pain
141515|NCT02419950|male sex|male sex
141516|NCT02419950|mesh fixation|mesh fixation
141517|NCT02419950|quality of life|quality of life
141518|NCT02419950|national register|national register
141519|NCT02419911|gastrointestinal|gastrointestinal
141520|NCT02419911|gynecologic|gynecologic
141521|NCT02419911|urologic|urologic
141522|NCT02419911|bariatric|bariatric
141523|NCT02419911|laparoscopic surgery|laparoscopic surgery
141524|NCT02419898|Feasibility|feasibility
141525|NCT02419885|finger amputation|finger amputation
141526|NCT02419885|composite graft|composite graft
141527|NCT02419885|adipo-fascia flap|adipo-fascia flap
141528|NCT02419859|Diabetes Mellitus|diabetes mellitus
141529|NCT02419859|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
141530|NCT02419859|Glucose Metabolism Disorders|glucose metabolism disorders
141531|NCT02419859|Metabolic Diseases|metabolic diseases
141532|NCT02419859|Endocrine System Diseases|endocrine system diseases
141533|NCT02419859|Insulin|insulin
141534|NCT02419859|Continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
141535|NCT02419859|Insulin pumps|insulin pumps
141536|NCT02419846|Informed Decision Making|informed decision making
141537|NCT02419846|Prostate|prostate
141538|NCT02419846|Cancer|cancer
141539|NCT02419833|non-STEMI|non-stemi
141540|NCT02419833|immediate|immediate
141541|NCT02419833|delayed|delayed
141542|NCT02419833|PCI|pci
141543|NCT02419807|Near Infrared Fluorescence Imaging|near infrared fluorescence imaging
141544|NCT02419807|Indocyanine Green|indocyanine green
141545|NCT02419807|axillary lymph node mapping|axillary lymph node mapping
141546|NCT02419807|Mastectomy, Segmental|mastectomy, segmental
141547|NCT02419807|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
141548|NCT02419807|Lumpectomy|lumpectomy
141549|NCT02419768|Long-range autocorrelations|long-range autocorrelations
141550|NCT02419768|Variability|variability
141551|NCT02419768|Physical Exercise|physical exercise
141552|NCT02419768|Parkinson's Disease|parkinson's disease
141553|NCT02419768|ICF|icf
141554|NCT02419755|Infant leukemia|infant leukemia
141555|NCT02419755|ALL|all
141556|NCT02419755|AML|aml
141557|NCT02419755|Biphenotypic leukemia|biphenotypic leukemia
141558|NCT02419755|Pediatric|pediatric
141559|NCT02419729|Vulvovaginal atrophy|vulvovaginal atrophy
141560|NCT02419729|Menopause|menopause
141561|NCT02419729|Fractional CO2 laser|fractional co2 laser
141562|NCT02419729|Estrogen cream|estrogen cream
141563|NCT02419716|colorectal cancer|colorectal cancer
141564|NCT02419716|Colorectal cancer screening|colorectal cancer screening
141565|NCT02419677|radiofrequency ablation|radiofrequency ablation
141566|NCT02419677|cytokine-induced killer cells|cytokine-induced killer cells
141567|NCT02419677|colorectal cancer iver metastases|colorectal cancer iver metastases
141568|NCT02419664|pituitary|pituitary
141569|NCT02419664|pituitary adenomas|pituitary adenomas
141570|NCT02419664|Ga-PET|ga-pet
141572|NCT02419664|TSHomas|tshomas
141573|NCT02419664|Cushing|cushing
141574|NCT02419651|out patient hysteroscopy|out patient hysteroscopy
141575|NCT02419638|relapsing-remitting MS|relapsing-remitting ms
141576|NCT02419638|lesions|lesions
141577|NCT02419638|treatment|treatment
141578|NCT02419573|cardiac arrest|cardiac arrest
141579|NCT02419573|cardiopulmonary resuscitation|cardiopulmonary resuscitation
141580|NCT02419573|laryngeal tube|laryngeal tube
141581|NCT02419573|endotracheal intubation|endotracheal intubation
141582|NCT02419573|non-traumatic Out of Hospital Cardiac Arrest (OOHCA)|non-traumatic out of hospital cardiac arrest (oohca)
141583|NCT02419560|Relapsed|relapsed
141584|NCT02419560|Laboratory biomarker research|laboratory biomarker research
141585|NCT02419560|Pharmacologic study|pharmacologic study
142188|NCT02416778|COPD|copd
141589|NCT02419547|ventricular tachycardia ablation|ventricular tachycardia ablation
141590|NCT02419547|effects of anesthesia on VT induction|effects of anesthesia on vt induction
141592|NCT02419534|Pediatric, fissure in ano|pediatric, fissure in ano
141593|NCT02419495|Advanced cancers|advanced cancers
170869|NCT02252042|PD1|pd1
141594|NCT02419495|Malignant neoplasms|malignant neoplasms
141595|NCT02419495|Paclitaxel|paclitaxel
141596|NCT02419495|Taxol|taxol
141597|NCT02419495|Eribulin|eribulin
141598|NCT02419495|E7389|e7389
141599|NCT02419495|Doxorubicin|doxorubicin
141600|NCT02419495|Doxorubicin Hydrochloride|doxorubicin hydrochloride
141601|NCT02419495|Adriamycin PFS|adriamycin pfs
141602|NCT02419495|Adriamycin RDF|adriamycin rdf
141603|NCT02419495|Adriamycin|adriamycin
141604|NCT02419495|Rubex|rubex
141605|NCT02419495|Cyclophosphamide|cyclophosphamide
141606|NCT02419495|Cytoxan|cytoxan
141607|NCT02419495|Neosar|neosar
141608|NCT02419495|Pemetrexed|pemetrexed
141609|NCT02419495|LY231514|ly231514
141610|NCT02419495|Alimta|alimta
141611|NCT02419495|MTA|mta
141612|NCT02419495|Multitargeted Antifolate|multitargeted antifolate
141613|NCT02419495|NSC-698037|nsc-698037
141614|NCT02419495|Topotecan|topotecan
141615|NCT02419495|Hycamtin|hycamtin
141616|NCT02419495|Selinexor|selinexor
141617|NCT02419495|KPT-330|kpt-330
141618|NCT02419495|Carboplatin|carboplatin
141619|NCT02419495|Paraplatin|paraplatin
141620|NCT02419495|Irinotecan|irinotecan
141621|NCT02419495|CPT-11|cpt-11
141622|NCT02419495|Camptosar|camptosar
141623|NCT02419495|5-FU|5-fu
141624|NCT02419495|Fluorouracil|fluorouracil
141625|NCT02419495|5-Fluorouracil|5-fluorouracil
141626|NCT02419495|Adrucil|adrucil
141627|NCT02419495|Efudex|efudex
141628|NCT02419495|Capecitabine|capecitabine
141629|NCT02419495|Xeloda|xeloda
141630|NCT02419495|Oxaliplatin|oxaliplatin
141631|NCT02419495|Eloxatin|eloxatin
141632|NCT02419495|Olaparib|olaparib
141633|NCT02419495|Lynparza|lynparza
141634|NCT02419495|Pembrolizumab|pembrolizumab
141635|NCT02419495|Keytruda|keytruda
141636|NCT02419495|MK-3475|mk-3475
141637|NCT02419495|SCH-900475|sch-900475
141638|NCT02419495|Nivolumab|nivolumab
141639|NCT02419495|BMS-936558|bms-936558
141640|NCT02419495|Opdivo|opdivo
141641|NCT02419482|Exercise therapy|exercise therapy
141642|NCT02419482|Reproductive Physiological Processes|reproductive physiological processes
141643|NCT02419482|Fertility|fertility
141644|NCT02419469|Leukemia|leukemia
141645|NCT02419469|Precursor-B acute lymphoblastic leukemia|precursor-b acute lymphoblastic leukemia
141646|NCT02419469|ALL|all
141647|NCT02419469|Lymphoblastic lymphoma|lymphoblastic lymphoma
141648|NCT02419469|LL|ll
141649|NCT02419469|Lymphoma|lymphoma
141650|NCT02419469|Cytarabine|cytarabine
141651|NCT02419469|Ara-C|ara-c
141652|NCT02419469|Cytosar|cytosar
141653|NCT02419469|DepoCyt|depocyt
141654|NCT02419469|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
141655|NCT02419469|Daunorubicin|daunorubicin
141656|NCT02419469|Daunorubicin Hydrochloride|daunorubicin hydrochloride
141657|NCT02419469|Cerubidine|cerubidine
141658|NCT02419469|Daunomycin|daunomycin
141659|NCT02419469|DNR|dnr
141660|NCT02419469|Vincristine|vincristine
141661|NCT02419469|Prednisone|prednisone
141662|NCT02419469|PEG asparaginase|peg asparaginase
141663|NCT02419469|Pegaspargase|pegaspargase
141664|NCT02419469|Oncaspar|oncaspar
141665|NCT02419469|Polyethylene glycol conjugated lasparaginase-H|polyethylene glycol conjugated lasparaginase-h
141666|NCT02419469|Ofatumumab|ofatumumab
141667|NCT02419469|Arzerra|arzerra
141668|NCT02419469|Rituximab|rituximab
141669|NCT02419469|Rituxan|rituxan
141670|NCT02419469|Methotrexate|methotrexate
141671|NCT02419469|Cyclophosphamide|cyclophosphamide
141672|NCT02419469|Cytoxan|cytoxan
141673|NCT02419469|Neosar|neosar
141674|NCT02419469|Mercaptopurine|mercaptopurine
141675|NCT02419469|6-mercaptopurine|6-mercaptopurine
141676|NCT02419469|Purinethol|purinethol
141677|NCT02419469|6-MP|6-mp
141678|NCT02419469|Doxorubicin|doxorubicin
141778|NCT02418858|DBS|dbs
141679|NCT02419469|Doxorubicin hydrochloride|doxorubicin hydrochloride
141680|NCT02419469|Adriamycin PFS|adriamycin pfs
141681|NCT02419469|Adriamycin RDF|adriamycin rdf
141682|NCT02419469|Adriamycin|adriamycin
141683|NCT02419469|Rubex|rubex
141684|NCT02419469|Dexamethasone|dexamethasone
141685|NCT02419469|Decadron|decadron
141686|NCT02419469|Thioguanine|thioguanine
141687|NCT02419469|6-thioguanine|6-thioguanine
141688|NCT02419443|inguinal hernia repair, chronic pain|inguinal hernia repair, chronic pain
141689|NCT02419430|well-being|well-being
141691|NCT02419430|resilience|resilience
141692|NCT02419430|self-compassion|self-compassion
141693|NCT02419391|RSV Vaccines|rsv vaccines
141694|NCT02419391|Respiratory Syncytial Virus Vaccines|respiratory syncytial virus vaccines
141695|NCT02419365|Primary Ciliary Dyskinesia (PCD)|primary ciliary dyskinesia (pcd)
141696|NCT02419352|Cognitive function|cognitive function
141697|NCT02419326|couples|couples
141698|NCT02419326|relationships|relationships
141699|NCT02419326|binge eating|binge eating
141700|NCT02419326|eating disorder|eating disorder
141701|NCT02419326|couple therapy|couple therapy
141702|NCT02419313|Tremor|tremor
141703|NCT02419313|Parkinson|parkinson
141704|NCT02419313|botulinum|botulinum
141705|NCT02419313|Xeomin|xeomin
141706|NCT02419287|ALK|alk
141707|NCT02419287|crizotinib|crizotinib
141708|NCT02419274|asthma|asthma
141709|NCT02419274|phenotype|phenotype
141710|NCT02419274|childhood|childhood
141711|NCT02419274|adulthood|adulthood
141712|NCT02419261|knee surgery|knee surgery
141713|NCT02419261|anterior cruciate ligament surgery|anterior cruciate ligament surgery
141714|NCT02419261|nerve block|nerve block
141715|NCT02419235|Refractory hypertension|refractory hypertension
141716|NCT02419235|Homoeopathy|homoeopathy
141717|NCT02419235|Homoeopathic complex|homoeopathic complex
141718|NCT02419235|Amylenum nitrosum 6cH|amylenum nitrosum 6ch
141719|NCT02419235|Crataegus oxyacantha 6cH|crataegus oxyacantha 6ch
141720|NCT02419235|Natrum muriaticum 6cH|natrum muriaticum 6ch
141721|NCT02419235|Scutellaria lateriflora 6cH|scutellaria lateriflora 6ch
141722|NCT02419209|Low sexual desire|low sexual desire
141723|NCT02419209|Perimenopause|perimenopause
141724|NCT02419209|Homeopathy|homeopathy
141725|NCT02419209|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
141726|NCT02419183|Mild Cognitive Impairment|mild cognitive impairment
141727|NCT02419183|Self-Administered Memory Screening Test With Automated Reporting (SAMSTAR)|self-administered memory screening test with automated reporting (samstar)
141728|NCT02419183|Rey Auditory Verbal Learning Test (RAVLT)|rey auditory verbal learning test (ravlt)
141729|NCT02419183|Word List Recall (WLR)|word list recall (wlr)
141730|NCT02419157|Cervical lesions|cervical lesions
141731|NCT02419157|Clinical trial|clinical trial
141732|NCT02419157|Self-etch adhesive|self-etch adhesive
141733|NCT02419144|older adults;|older adults;
141734|NCT02419144|oral hygiene;|oral hygiene;
141735|NCT02419144|adapted motivational interviewing|adapted motivational interviewing
141736|NCT02419118|Myeloma|myeloma
141737|NCT02419118|monoclonal antibody|monoclonal antibody
141738|NCT02419118|Daratumumab|daratumumab
141739|NCT02419105|Falls|falls
141740|NCT02419105|hypogonadal men|hypogonadal men
141741|NCT02419105|Seniors|seniors
141742|NCT02419105|Testosterone|testosterone
141743|NCT02419105|Colecalciferol|colecalciferol
141744|NCT02419092|Inflammation|inflammation
141745|NCT02419092|Insulin resistance|insulin resistance
141746|NCT02419092|Bariatric surgery|bariatric surgery
141747|NCT02419053|Surgical safety checklist|surgical safety checklist
141748|NCT02419053|perioperative complications|perioperative complications
141749|NCT02419053|pediatric|pediatric
141750|NCT02419040|shoulder pain|shoulder pain
141751|NCT02419040|rotator cuff|rotator cuff
141752|NCT02419040|calcific tendonitis|calcific tendonitis
141753|NCT02419040|barbotage|barbotage
141754|NCT02419027|GI Flora|gi flora
141755|NCT02419014|cranial electrotherapy|cranial electrotherapy
141756|NCT02419014|cranial electrical stimulation|cranial electrical stimulation
141757|NCT02419014|restless legs syndrome|restless legs syndrome
141758|NCT02418962|PfSPZ Vaccine|pfspz vaccine
141759|NCT02418949|hand|hand
141760|NCT02418949|rehabilitation|rehabilitation
141761|NCT02418949|active movement training|active movement training
141762|NCT02418949|passive cyclical stretching|passive cyclical stretching
141763|NCT02418936|Waardenburg syndrome|waardenburg syndrome
141764|NCT02418936|Large vestibular aqueduct syndrome|large vestibular aqueduct syndrome
141765|NCT02418936|Diagnosis|diagnosis
141766|NCT02418936|copy number variation|copy number variation
141767|NCT02418936|Multiplex polymerase chain reaction|multiplex polymerase chain reaction
141768|NCT02418910|bipolar|bipolar
141769|NCT02418910|self assessment|self assessment
141770|NCT02418910|prospective randomized trial|prospective randomized trial
141771|NCT02418897|Fatigue|fatigue
141772|NCT02418897|multiple sclerosis|multiple sclerosis
141773|NCT02418897|neuromuscular junction|neuromuscular junction
141774|NCT02418897|SFEMG|sfemg
141775|NCT02418871|cataract|cataract
141776|NCT02418871|presbyopia|presbyopia
141777|NCT02418858|Essential tremor|essential tremor
141779|NCT02418832|Azoospermia|azoospermia
141780|NCT02418832|Rete Testis|rete testis
141781|NCT02418832|TEFNA|tefna
141782|NCT02418806|Family Caregivers|family caregivers
141783|NCT02418806|Psychotherapy Group|psychotherapy group
141784|NCT02418793|Hemophilia|hemophilia
141785|NCT02418793|Factor VII|factor vii
141786|NCT02418793|Factor VIIa|factor viia
141787|NCT02418793|Inhibitors|inhibitors
141788|NCT02418793|Long Acting|long acting
141789|NCT02418728|obesity|obesity
142470|NCT02415491|TGA|tga
141790|NCT02418728|adipose tissue lipolysis|adipose tissue lipolysis
141792|NCT02418728|microdialysis|microdialysis
141793|NCT02418728|atrial natriuretic peptide|atrial natriuretic peptide
141794|NCT02418702|depression|depression
141796|NCT02418702|ketamine|ketamine
141797|NCT02418702|rapid intravenous bolus|rapid intravenous bolus
141798|NCT02418702|sub-anesthetic dose|sub-anesthetic dose
141799|NCT02418702|double-blind placebo control|double-blind placebo control
141800|NCT02418676|Human insulin|human insulin
141801|NCT02418676|Hydroxypropyl-beta-cyclodextrin|hydroxypropyl-beta-cyclodextrin
141802|NCT02418676|Pressure Ulcer|pressure ulcer
141803|NCT02418676|Wound Healing|wound healing
141804|NCT02418676|Gel|gel
141805|NCT02418663|fluid responsiveness|fluid responsiveness
141806|NCT02418663|enhanced recovery program|enhanced recovery program
141807|NCT02418650|volunteers|volunteers
141808|NCT02418637|worksite|worksite
141809|NCT02418637|screen|screen
141810|NCT02418637|migrant|migrant
141811|NCT02418637|agricultural|agricultural
141812|NCT02418637|worker|worker
141813|NCT02418637|hypertension|hypertension
141814|NCT02418637|Hyperlipidemia|hyperlipidemia
141815|NCT02418637|diabetes|diabetes
141816|NCT02418637|feasibility|feasibility
141817|NCT02418624|breast cancer 1, early onset (BRCA1)|breast cancer 1, early onset (brca1)
141818|NCT02418624|breast cancer 2, early onset (BRCA2)|breast cancer 2, early onset (brca2)
141819|NCT02418624|homologous recombination deficiency|homologous recombination deficiency
141820|NCT02418624|carboplatin|carboplatin
141821|NCT02418624|olaparib|olaparib
141822|NCT02418598|Adeno-associated virus|adeno-associated virus
141823|NCT02418598|Aromatic L-amino acid decarboxylase|aromatic l-amino acid decarboxylase
141824|NCT02418598|AAV-hAADC-2|aav-haadc-2
141825|NCT02418598|AAV-2|aav-2
141826|NCT02418598|Gene Therapy|gene therapy
141827|NCT02418598|Gene Transfer|gene transfer
141828|NCT02418598|Parkinson Disease|parkinson disease
141829|NCT02418598|Basal Ganglia Disease|basal ganglia disease
141830|NCT02418598|Brain Disease|brain disease
141831|NCT02418585|Treatment-resistant Depression|treatment-resistant depression
141832|NCT02418585|Esketamine|esketamine
141833|NCT02418585|Placebo|placebo
141834|NCT02418585|Oral Antidepressant|oral antidepressant
141835|NCT02418559|Healthy|healthy
141836|NCT02418559|JNJ-63623872|jnj-63623872
141837|NCT02418559|Japanese Adult Participants|japanese adult participants
141838|NCT02418533|infertility|infertility
141839|NCT02418533|in vitro fertilization|in vitro fertilization
141840|NCT02418533|fertility|fertility
141841|NCT02418533|preimplantation genetic screening|preimplantation genetic screening
141842|NCT02418533|embryo|embryo
141843|NCT02418533|PGS|pgs
141844|NCT02418533|Eeva|eeva
141845|NCT02418533|IVF|ivf
141846|NCT02418481|γδ T Cell|γδ t cell
141847|NCT02418481|breast cancer|breast cancer
141848|NCT02418481|her2-|her2-
141849|NCT02418481|er-|er-
141850|NCT02418481|pr-|pr-
141851|NCT02418468|COPD, FEV1, indacaterol|copd, fev1, indacaterol
141852|NCT02418455|MPS 7|mps 7
141853|NCT02418455|Sly Syndrome|sly syndrome
141854|NCT02418455|MPS VII|mps vii
141855|NCT02418455|Enzyme Replacement Therapy|enzyme replacement therapy
141856|NCT02418455|Rare Disease|rare disease
141857|NCT02418455|Mucopolysaccharidosis type 7|mucopolysaccharidosis type 7
141858|NCT02418455|Lysosomal Storage Disease|lysosomal storage disease
141859|NCT02418455|Metabolic Disorder|metabolic disorder
141860|NCT02418442|Systemic Arthritis|systemic arthritis
141861|NCT02418442|Oligoarthritis|oligoarthritis
141862|NCT02418442|Polyarthritis (Rheumatoid Factor Negative)|polyarthritis (rheumatoid factor negative)
141863|NCT02418442|Polyarthritis (Rheumatoid Factor Positive)|polyarthritis (rheumatoid factor positive)
141864|NCT02418442|Psoriatic Arthritis|psoriatic arthritis
141865|NCT02418442|Enthesitis Related Arthritis (ERA)|enthesitis related arthritis (era)
141866|NCT02418442|Undifferianted Arthritis|undifferianted arthritis
141867|NCT02418442|CARRA Consensus Treatment Plans|carra consensus treatment plans
141868|NCT02418442|FROST|frost
141869|NCT02418429|fat oxidation|fat oxidation
141870|NCT02418429|hunger|hunger
141871|NCT02418429|resistant starch|resistant starch
141872|NCT02418429|whey protein|whey protein
141873|NCT02418377|Obesity|obesity
141874|NCT02418377|Genetics|genetics
141875|NCT02418377|Whole exome sequencing|whole exome sequencing
141876|NCT02418377|Children|children
141877|NCT02418351|RRMS|rrms
141878|NCT02418325|RRMS|rrms
141879|NCT02418312|histamine-2 receptor antagonist|histamine-2 receptor antagonist
141880|NCT02418312|peptic ulcer|peptic ulcer
141881|NCT02418312|thienopyridine|thienopyridine
141882|NCT02418312|prevention|prevention
141883|NCT02418299|urinary incontinence|urinary incontinence
141884|NCT02418299|Er:YAG laser|er:yag laser
141885|NCT02418286|Low Back Pain|low back pain
141886|NCT02418286|Korean Rehabilitation Clinic|korean rehabilitation clinic
141887|NCT02418286|Patient Registry|patient registry
141888|NCT02418273|denosumab|denosumab
141889|NCT02418273|pediatric|pediatric
141890|NCT02418273|rheumatology|rheumatology
141891|NCT02418273|osteoporosis|osteoporosis
141892|NCT02418273|glucocorticoid|glucocorticoid
141894|NCT02418260|shaft|shaft
141895|NCT02418260|diaphyseal|diaphyseal
141896|NCT02418260|fractures|fractures
141897|NCT02418247|radioactive iodine therapy|radioactive iodine therapy
141898|NCT02418247|ablation|ablation
141899|NCT02418247|thyroid cancer|thyroid cancer
141900|NCT02418234|Non-small Cell Lung Cancer|non-small cell lung cancer
141901|NCT02418234|circulating tumor DNA|circulating tumor dna
141902|NCT02418234|T790M|t790m
141903|NCT02418234|amplification refractory mutation system|amplification refractory mutation system
141904|NCT02418234|digital droplet PCR|digital droplet pcr
132859|NCT02468674|Sarcopenia, muscle wasting, elderly, strength, physical|sarcopenia, muscle wasting, elderly, strength, physical
132867|NCT02468635|physical ability|physical ability
141905|NCT02418221|histamine, biogenic amines, diamine oxidase|histamine, biogenic amines, diamine oxidase
141906|NCT02418195|Depression|depression
141907|NCT02418195|Ketamine|ketamine
141908|NCT02418195|Suicide Attempt|suicide attempt
141909|NCT02418195|Suicidal Ideation|suicidal ideation
141910|NCT02418195|Suicidality|suicidality
141911|NCT02418182|Analgesic|analgesic
141912|NCT02418182|Pain Control|pain control
141913|NCT02418182|IVF|ivf
141914|NCT02418182|Tylenol|tylenol
141915|NCT02418182|Acetaminophen|acetaminophen
141916|NCT02418182|Egg Retrieval|egg retrieval
141917|NCT02418182|iv vitro Fertilization|iv vitro fertilization
141918|NCT02418117|Stereolitographic guide|stereolitographic guide
141919|NCT02418117|flapless surgery|flapless surgery
141920|NCT02418117|dental implants|dental implants
141921|NCT02418091|patients with moderate DKD and uncontrolled HTN|patients with moderate dkd and uncontrolled htn
141922|NCT02418065|Physical exercises|physical exercises
141923|NCT02418065|Oral nutritional supplementation|oral nutritional supplementation
141924|NCT02418065|Multimodal|multimodal
141925|NCT02418065|Hemodialysis|hemodialysis
141926|NCT02418065|Protein-Energy Wasting|protein-energy wasting
141927|NCT02418052|esophageal cancer|esophageal cancer
141928|NCT02418052|minimally invasive esophagectomy|minimally invasive esophagectomy
141929|NCT02418052|anastomotic leak|anastomotic leak
141930|NCT02418052|neck flexion|neck flexion
141931|NCT02418039|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
141932|NCT02418039|Nutrition|nutrition
141933|NCT02418013|Frailty|frailty
141934|NCT02418013|Umbilical cord blood|umbilical cord blood
141935|NCT02418013|Plasma|plasma
141936|NCT02418013|Randomized trial|randomized trial
141937|NCT02418013|Double-blinded trial|double-blinded trial
141938|NCT02418013|Placebo-controlled trial|placebo-controlled trial
141939|NCT02417974|Prevention|prevention
141940|NCT02417974|Recurrence|recurrence
141941|NCT02417974|Fecal Microbiota Therapy|fecal microbiota therapy
141942|NCT02417961|Asthma,|asthma,
141943|NCT02417961|Bronchial Diseases,|bronchial diseases,
141944|NCT02417961|Respiratory Tract Diseases,|respiratory tract diseases,
141945|NCT02417961|Lung Diseases,|lung diseases,
142144|NCT02416921|Online|online
141946|NCT02417961|Obstructive Lung Diseases,|obstructive lung diseases,
141947|NCT02417961|Benralizumab|benralizumab
141948|NCT02417909|Obesity|obesity
141949|NCT02417909|quality of life|quality of life
141950|NCT02417909|teenagers|teenagers
141951|NCT02417909|psychological impact|psychological impact
141952|NCT02417896|Acute kidney injury|acute kidney injury
141953|NCT02417896|Spironolactone|spironolactone
141954|NCT02417883|Furosemide|furosemide
141955|NCT02417883|Interstitial Fibrosis|interstitial fibrosis
141956|NCT02417870|Transplantation|transplantation
141957|NCT02417870|interleukin-2|interleukin-2
141958|NCT02417870|IL-2|il-2
141959|NCT02417870|Kidney|kidney
141960|NCT02417870|Renal|renal
141961|NCT02417857|Single İncision Laparoscopic Surgery|single incision laparoscopic surgery
141962|NCT02417857|Conventional Laparoscopic Surgery|conventional laparoscopic surgery
141963|NCT02417792|psoriasis|psoriasis
141964|NCT02417792|microbiota|microbiota
141965|NCT02417766|Genetic Testing|genetic testing
141966|NCT02417766|Secondary Findings|secondary findings
141967|NCT02417766|Immune-Mediated Disorders|immune-mediated disorders
141968|NCT02417766|Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal in|pediatric autoimmune neuropsychiatric disorders associated with streptococcal in
141969|NCT02417766|Whole Exome Sequencing|whole exome sequencing
141970|NCT02417753|PARACENTESIS|paracentesis
141971|NCT02417753|STAT3 Antisense Oligonucleotide|stat3 antisense oligonucleotide
141972|NCT02417753|Ascites|ascites
141973|NCT02417753|AZD9150|azd9150
141974|NCT02417753|Surgical Resection|surgical resection
141975|NCT02417740|Portal Hypertension|portal hypertension
141976|NCT02417740|Portal Fibrosis|portal fibrosis
141977|NCT02417740|Liver Disease|liver disease
141978|NCT02417740|Varices|varices
141979|NCT02417740|Splenomegaly|splenomegaly
141980|NCT02417727|MEMORY TESTING|memory testing
141981|NCT02417727|Biomarkers|biomarkers
141982|NCT02417727|Learning|learning
141983|NCT02417714|Computed Tomography|computed tomography
141984|NCT02417714|Radiation Reduction|radiation reduction
141985|NCT02417714|Iterative Reconstruction|iterative reconstruction
141986|NCT02417688|carotid atherosclerosis, PET imaging agent|carotid atherosclerosis, pet imaging agent
141987|NCT02417675|Option B+|option b+
141988|NCT02417675|Adherence Club|adherence club
141989|NCT02417675|Postpartum|postpartum
141990|NCT02417675|Breastfeeding|breastfeeding
141991|NCT02417675|Mother-to-child transmission|mother-to-child transmission
141993|NCT02417662|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
141994|NCT02417662|Radiotherapy|radiotherapy
141995|NCT02417662|Randomised|randomised
141996|NCT02417662|Controlled|controlled
132957|NCT02468219|frailty|frailty
132958|NCT02468219|cardiac rehabilitation|cardiac rehabilitation
132961|NCT02468193|LCI699|lci699
141997|NCT02417662|Oligometastatic|oligometastatic
141998|NCT02417610|Polynucleotide|polynucleotide
141999|NCT02417610|Hyaluronic acid|hyaluronic acid
142000|NCT02417610|Intra articular injection|intra articular injection
142001|NCT02417597|hepatitis E|hepatitis e
142002|NCT02417571|Chronic kidney disease|chronic kidney disease
142003|NCT02417571|Blood pressure|blood pressure
142004|NCT02417571|ambulatory blood pressure|ambulatory blood pressure
142005|NCT02417571|glomerular filtration rate|glomerular filtration rate
142006|NCT02417519|Coffee|coffee
142007|NCT02417519|Chlorogenic acid|chlorogenic acid
142008|NCT02417519|Insulin|insulin
142009|NCT02417519|Appetite|appetite
142010|NCT02417519|Metabolomics|metabolomics
142011|NCT02417506|Acute pain|acute pain
142012|NCT02417506|Herbal|herbal
142013|NCT02417506|VAS|vas
142014|NCT02417506|Stop watch|stop watch
142015|NCT02417493|Food allergy|food allergy
142016|NCT02417493|self-management|self-management
142017|NCT02417493|epinephrine self-injection|epinephrine self-injection
142018|NCT02417493|ntervention|ntervention
142019|NCT02417493|adolescents|adolescents
142020|NCT02417467|Electronic cigarette|electronic cigarette
142021|NCT02417467|E-cigarette|e-cigarette
142022|NCT02417467|Smoking cessation|smoking cessation
142023|NCT02417454|probiotic|probiotic
142024|NCT02417454|stress|stress
142025|NCT02417454|emotion psychophysiology|emotion psychophysiology
142026|NCT02417454|brain-body-gut interactions|brain-body-gut interactions
142027|NCT02417441|TiLE|tile
142028|NCT02417441|Embryo Assessment|embryo assessment
142029|NCT02417441|Pregnancy|pregnancy
142030|NCT02417441|Implantation|implantation
142031|NCT02417441|Fertilization|fertilization
142032|NCT02417428|Muscle function|muscle function
142033|NCT02417428|Functional capacity|functional capacity
142034|NCT02417415|Supine hypertension|supine hypertension
142035|NCT02417415|Autonomic failure|autonomic failure
142036|NCT02417415|Heat intolerance|heat intolerance
142037|NCT02417415|Orthostatic hypotension|orthostatic hypotension
142038|NCT02417415|Heat stress|heat stress
142039|NCT02417402|back pain|back pain
142040|NCT02417402|low back pain|low back pain
142041|NCT02417402|chronic low back pain|chronic low back pain
142042|NCT02417389|primary hyperparathyroidism|primary hyperparathyroidism
142043|NCT02417389|hypercalcemia|hypercalcemia
142044|NCT02417389|osteoporosis|osteoporosis
142045|NCT02417389|bone turnover|bone turnover
142046|NCT02417389|bone mineral density|bone mineral density
142047|NCT02417389|fractures|fractures
142048|NCT02417376|Coronary heart disease|coronary heart disease
142049|NCT02417376|Periodontitis|periodontitis
142050|NCT02417376|C-reactive protein|c-reactive protein
142051|NCT02417376|Blood pressure|blood pressure
142052|NCT02417363|biomarkers|biomarkers
142053|NCT02417363|renal disease|renal disease
142054|NCT02417363|periodontitis|periodontitis
142055|NCT02417324|medulloblastoma|medulloblastoma
142056|NCT02417324|ependymoma|ependymoma
142057|NCT02417324|pineoblastoma|pineoblastoma
142058|NCT02417324|CNS-PNET|cns-pnet
142059|NCT02417311|Engineered Heart Tissue (EHT)|engineered heart tissue (eht)
142060|NCT02417311|human induced pluripotent stem cells (hiPSC)|human induced pluripotent stem cells (hipsc)
142061|NCT02417298|ketamine|ketamine
142062|NCT02417298|pain|pain
142063|NCT02417298|sickle cell disorder|sickle cell disorder
142064|NCT02417285|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
142065|NCT02417285|Diffused Large B-Cell Lymphoma|diffused large b-cell lymphoma
142066|NCT02417285|Phase 1B|phase 1b
142067|NCT02417285|Open-Label|open-label
142068|NCT02417285|Safety and Efficacy|safety and efficacy
142069|NCT02417285|CC-122|cc-122
142070|NCT02417285|Obinutuzumab|obinutuzumab
142071|NCT02417285|GA101|ga101
142072|NCT02417285|Relapsed|relapsed
142073|NCT02417285|Refractory|refractory
142074|NCT02417272|Total Disc Replacement|total disc replacement
142075|NCT02417272|Anterior Cervical Decompression and Fusion|anterior cervical decompression and fusion
142076|NCT02417259|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
142077|NCT02417246|pharmacokinetics|pharmacokinetics
142078|NCT02417246|pharmacodynamics|pharmacodynamics
142079|NCT02417246|pharmacogenetics|pharmacogenetics
142080|NCT02417233|HIV-positive|hiv-positive
142081|NCT02417233|adherence|adherence
142082|NCT02417233|engagement to care|engagement to care
142083|NCT02417233|mHealth|mhealth
142084|NCT02417233|SMS|sms
142085|NCT02417233|peer navigation|peer navigation
142086|NCT02417233|retention|retention
142087|NCT02417207|hepatitis B immune globulin (HBIG)|hepatitis b immune globulin (hbig)
142088|NCT02417207|liver transplantation|liver transplantation
142089|NCT02417207|hepatitis B|hepatitis b
142090|NCT02417207|entecavir|entecavir
142091|NCT02417194|Renal cell carcinoma|renal cell carcinoma
142092|NCT02417194|hemoglobin A1c protein|hemoglobin a1c protein
133126|NCT02467270|CML|cml
142093|NCT02417194|Pathologic outcomes|pathologic outcomes
142094|NCT02417194|Oncological outcomes|oncological outcomes
142095|NCT02417194|Nephrectomy|nephrectomy
142096|NCT02417181|Physician assistants|physician assistants
142097|NCT02417181|Out-of-hours medical care|out-of-hours medical care
142098|NCT02417181|Primary healthcare|primary healthcare
142099|NCT02417181|Emergency Medical Services|emergency medical services
142100|NCT02417155|Autonomic Nerve System|autonomic nerve system
142101|NCT02417155|Epinephrin|epinephrin
142102|NCT02417155|Hyperventilation|hyperventilation
142103|NCT02417155|Hypoventilation|hypoventilation
142104|NCT02417064|Treatment-resistant Depression|treatment-resistant depression
142105|NCT02417064|Esketamine|esketamine
142106|NCT02417064|Placebo|placebo
142107|NCT02417064|Oral Antidepressant|oral antidepressant
142108|NCT02417051|Psychological Resilience|psychological resilience
142109|NCT02417051|Perceived Stress|perceived stress
142110|NCT02417051|Psychological Stress|psychological stress
142111|NCT02417051|Disaster Worker|disaster worker
142112|NCT02417051|Superstorm Sandy|superstorm sandy
142113|NCT02417051|Mental Health|mental health
142114|NCT02417051|Prevention|prevention
142115|NCT02417038|Postoperative Respiratory Monitoring|postoperative respiratory monitoring
142116|NCT02417038|Neuraxial Opioid Administration for Cesarean Delivery|neuraxial opioid administration for cesarean delivery
142117|NCT02417025|Military|military
142118|NCT02417025|Health Service Delivery|health service delivery
142119|NCT02417025|Telepsychology|telepsychology
142120|NCT02417025|Prolonged Exposure|prolonged exposure
142121|NCT02417025|Off-duty Activity of Military Personnel|off-duty activity of military personnel
142122|NCT02417012|lifestyle|lifestyle
142123|NCT02417012|exercise|exercise
142124|NCT02417012|physical activity|physical activity
142125|NCT02417012|diet|diet
142126|NCT02417012|glycemic control|glycemic control
142127|NCT02417012|hba1c|hba1c
142128|NCT02417012|glucose lowering drugs|glucose lowering drugs
142129|NCT02416999|glioma|glioma
142130|NCT02416999|high-grade glioma|high-grade glioma
142131|NCT02416960|female infertility|female infertility
142132|NCT02416960|glycemic index|glycemic index
142133|NCT02416960|leptin|leptin
142134|NCT02416960|ghrelin|ghrelin
142135|NCT02416960|overweight|overweight
142136|NCT02416960|obesity|obesity
142137|NCT02416960|in vitro fertilization|in vitro fertilization
142138|NCT02416947|Soluble Corn Fiber|soluble corn fiber
142139|NCT02416947|Osteoporosis|osteoporosis
142140|NCT02416947|Bone Loss|bone loss
142141|NCT02416921|Facebook|facebook
142142|NCT02416921|Weight Gain Prevention|weight gain prevention
142143|NCT02416921|Women's Health|women's health
142145|NCT02416921|Weight Gain|weight gain
142146|NCT02416921|Weight Loss|weight loss
142147|NCT02416921|Female Contraception|female contraception
142148|NCT02416921|Obesity|obesity
142149|NCT02416921|Body Weight|body weight
142150|NCT02416921|Internet|internet
142151|NCT02416882|active|active
142152|NCT02416882|not active|not active
142153|NCT02416882|normal body weight|normal body weight
142154|NCT02416869|Dexamethasone|dexamethasone
142155|NCT02416869|Lower third molar surgery|lower third molar surgery
142156|NCT02416856|Aphasia|aphasia
142157|NCT02416856|Brain|brain
142158|NCT02416856|Stimulation|stimulation
142159|NCT02416856|Communication|communication
142160|NCT02416856|Stroke|stroke
142161|NCT02416856|Speech Disorders|speech disorders
142162|NCT02416856|Communications Disorders|communications disorders
142163|NCT02416856|Neurobehavioral Manifestations|neurobehavioral manifestations
142164|NCT02416856|Neurologic Manifestations|neurologic manifestations
142165|NCT02416856|Nervous System Diseases|nervous system diseases
142166|NCT02416856|Signs and Symptoms|signs and symptoms
142167|NCT02416843|Adipose tissue|adipose tissue
142168|NCT02416843|metabolism|metabolism
142169|NCT02416843|inflammation|inflammation
142170|NCT02416843|post-prandial|post-prandial
142177|NCT02416817|Major Trauma|major trauma
142178|NCT02416817|Blood products|blood products
142179|NCT02416817|Thromboelastometry|thromboelastometry
142180|NCT02416804|buprenorphine|buprenorphine
142181|NCT02416804|transdermal system|transdermal system
142182|NCT02416804|Pain, postoperative|pain, postoperative
142183|NCT02416804|Quality of life|quality of life
142184|NCT02416804|Spinal stenosis|spinal stenosis
142285|NCT02416453|Filoviruses|filoviruses
142185|NCT02416804|Posterior lumbar fusion|posterior lumbar fusion
142186|NCT02416791|robotic therapy|robotic therapy
142187|NCT02416791|transcranial direct current stimulation|transcranial direct current stimulation
142189|NCT02416778|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
142190|NCT02416778|Iron deficiency|iron deficiency
142191|NCT02416778|6 Minute-Walking-Test|6 minute-walking-test
142192|NCT02416765|Closed-loop strategy|closed-loop strategy
142193|NCT02416765|Artificial pancreas|artificial pancreas
142194|NCT02416765|Postprandial glucose|postprandial glucose
142196|NCT02416765|Glucagon|glucagon
142197|NCT02416765|Hypoglycemia|hypoglycemia
142198|NCT02416765|Type 1 diabetes|type 1 diabetes
142224|NCT02416661|Lipid Metabolism Disorders|lipid metabolism disorders
142225|NCT02416661|Lipidoses|lipidoses
142226|NCT02416648|Adult HIV patients|adult hiv patients
142227|NCT02416648|Knowledge|knowledge
142228|NCT02416648|Attitudes|attitudes
142229|NCT02416648|Sexual behaviors|sexual behaviors
142230|NCT02416635|Liver Neoplasms|liver neoplasms
142231|NCT02416635|Circulating Tumor Cells|circulating tumor cells
142239|NCT02416609|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
142240|NCT02416609|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
142241|NCT02416609|Chemopotentiator|chemopotentiator
142242|NCT02416609|Low dose radiotherapy|low dose radiotherapy
142243|NCT02416609|Hyper-Radiosensitivity|hyper-radiosensitivity
142244|NCT02416596|ICSI|icsi
142245|NCT02416596|IVF|ivf
142246|NCT02416596|hysteroscopy|hysteroscopy
142247|NCT02416596|Supervision|supervision
142248|NCT02416596|In-vitro Fertilization|in-vitro fertilization
142249|NCT02416583|membrane sweeping|membrane sweeping
142250|NCT02416583|dinoprostone|dinoprostone
142251|NCT02416583|nulliparas|nulliparas
142252|NCT02416583|labor induction|labor induction
142253|NCT02416570|Clarithromycin|clarithromycin
142254|NCT02416544|Overweight|overweight
142255|NCT02416544|Obesity|obesity
142256|NCT02416544|Caloric Restriction|caloric restriction
142257|NCT02416544|Diet, Reducing|diet, reducing
142258|NCT02416544|Diet, Sodium-Restricted|diet, sodium-restricted
142259|NCT02416544|Body Weight Changes|body weight changes
142260|NCT02416544|Energy intake|energy intake
142261|NCT02416544|Feeding Behavior|feeding behavior
142262|NCT02416531|Vulvar lichen sclerosus|vulvar lichen sclerosus
142263|NCT02416531|Photodynamic therapy|photodynamic therapy
142264|NCT02416531|Low-level laser therapy|low-level laser therapy
142265|NCT02416531|Clobetasol propionate|clobetasol propionate
142266|NCT02416518|Cancer|cancer
142267|NCT02416518|Malignancy|malignancy
142268|NCT02416518|Genomic|genomic
142269|NCT02416518|Molecular|molecular
142270|NCT02416479|medication adherence|medication adherence
142271|NCT02416479|outcomes|outcomes
142272|NCT02416479|intervention|intervention
142273|NCT02416479|randomized controlled trial|randomized controlled trial
142274|NCT02416466|Colorectal cancer|colorectal cancer
142275|NCT02416466|Liver metastases|liver metastases
142276|NCT02416466|Breast cancer|breast cancer
142277|NCT02416466|Gastric cancer|gastric cancer
142278|NCT02416466|Pancreas cancer|pancreas cancer
142279|NCT02416466|Carcinoembryonic antigen|carcinoembryonic antigen
142281|NCT02416466|Immunotherapy|immunotherapy
142282|NCT02416453|Healthy|healthy
142283|NCT02416453|Ebola viruses|ebola viruses
142284|NCT02416453|Ebola Viral Disease (EVD)|ebola viral disease (evd)
142394|NCT02415933|Child Separation|child separation
142288|NCT02416453|Modified Vaccinia Virus Ankara - Bavarian Nordic Filo-vector (MVA-BN Filo)|modified vaccinia virus ankara - bavarian nordic filo-vector (mva-bn filo)
142289|NCT02416453|Safety|safety
142290|NCT02416453|Immunogenicity|immunogenicity
142291|NCT02416440|South African|south african
142292|NCT02416440|urban African|urban african
142293|NCT02416440|diabetes|diabetes
142294|NCT02416440|prevalence|prevalence
142295|NCT02416440|risk factors|risk factors
142296|NCT02416440|genetics|genetics
142297|NCT02416427|Atorvastatin|atorvastatin
142298|NCT02416427|TAZ|taz
142299|NCT02416427|Hippo pathway|hippo pathway
142300|NCT02416427|ki67|ki67
142301|NCT02416401|healthy|healthy
142302|NCT02416401|aging|aging
142303|NCT02416401|cognition|cognition
142304|NCT02416401|age-related cognitive decline|age-related cognitive decline
142305|NCT02416362|Postural Balance|postural balance
142306|NCT02416362|Electromyography|electromyography
142307|NCT02416362|Torque|torque
142308|NCT02416349|Stroke|stroke
142309|NCT02416349|Stretching|stretching
142310|NCT02416349|Respiratory muscle|respiratory muscle
142311|NCT02416349|Ventilatory pattern|ventilatory pattern
142312|NCT02416349|Optoelectronic plethysmography|optoelectronic plethysmography
142313|NCT02416336|sentinel lymph node|sentinel lymph node
142314|NCT02416336|lymphoscintigraphy|lymphoscintigraphy
142315|NCT02416336|intraoperative gamma camera|intraoperative gamma camera
142316|NCT02416310|TEAS|teas
142317|NCT02416310|cesarean section|cesarean section
142318|NCT02416310|gastrointestinal function|gastrointestinal function
142323|NCT02416258|Psoriasis|psoriasis
142324|NCT02416232|melanoma|melanoma
142325|NCT02416232|dabrafenib|dabrafenib
142326|NCT02416232|trametinib|trametinib
142327|NCT02416232|BRAF V600E/K mutation|braf v600e/k mutation
142328|NCT02416219|Cricoid cartilage, cricoid pressure, obstetric|cricoid cartilage, cricoid pressure, obstetric
142329|NCT02416206|Multiple myeloma|multiple myeloma
142330|NCT02416206|hematopoietic stem cell transplant|hematopoietic stem cell transplant
142331|NCT02416193|Diabetes|diabetes
142332|NCT02416193|Cognition|cognition
142333|NCT02416193|Functioning|functioning
142334|NCT02416180|EVOHALER|evohaler
142335|NCT02416180|Asthma|asthma
142336|NCT02416180|SERETIDE|seretide
142337|NCT02416180|DISKUS Inhaler|diskus inhaler
142338|NCT02416180|MDI|mdi
171742|NCT02247635|Obesity|obesity
133262|NCT02466685|Bipolar|bipolar
142339|NCT02416154|interferon-epsilon|interferon-epsilon
142340|NCT02416154|female reproductive tract|female reproductive tract
142341|NCT02416154|neopterin|neopterin
142342|NCT02416154|menstrual cycle|menstrual cycle
142343|NCT02416115|PONV|ponv
142344|NCT02416115|ramosetron|ramosetron
142345|NCT02416115|naloxone|naloxone
142346|NCT02416089|Tampostat|tampostat
142347|NCT02416089|Tamponade|tamponade
142348|NCT02416089|Postpartum hemorrhage|postpartum hemorrhage
142349|NCT02416076|Ulthera® System|ulthera® system
142350|NCT02416076|Ultherapy®|ultherapy®
142351|NCT02416076|Ulthera, Inc.|ulthera, inc.
142352|NCT02416050|Cocaine|cocaine
142353|NCT02416050|Dependence|dependence
142354|NCT02416050|Abstinence|abstinence
142355|NCT02416050|Prediction|prediction
142356|NCT02416050|Model|model
142357|NCT02416050|Humans|humans
142358|NCT02416050|MRI|mri
142359|NCT02416050|Cognitive|cognitive
142360|NCT02416050|Impulsivity|impulsivity
142361|NCT02416050|Craving|craving
142362|NCT02416037|ARDS|ards
142363|NCT02416037|prone position|prone position
142364|NCT02416037|PEEP|peep
142365|NCT02416037|mechanical ventilation|mechanical ventilation
142366|NCT02416024|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
142367|NCT02416024|anesthesia|anesthesia
142368|NCT02416011|e-cigarette|e-cigarette
142369|NCT02416011|nicotine dependence|nicotine dependence
142370|NCT02415998|TEE|tee
142371|NCT02415985|pharmacokinetics of rifabutin|pharmacokinetics of rifabutin
142372|NCT02415985|HIV/TB co-infection|hiv/tb co-infection
142373|NCT02415985|resource limited setting|resource limited setting
142374|NCT02415985|AUC|auc
142375|NCT02415985|Cmax|cmax
142376|NCT02415985|Cmin|cmin
142377|NCT02415985|Ctrough|ctrough
142378|NCT02415972|ultrasound imaging|ultrasound imaging
142379|NCT02415972|acute ischemic stroke|acute ischemic stroke
142380|NCT02415972|cerebral perfusion measurement in acute ischemic stroke|cerebral perfusion measurement in acute ischemic stroke
142381|NCT02415959|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
142382|NCT02415946|regenerative medicine|regenerative medicine
142383|NCT02415946|bone substitutes|bone substitutes
142384|NCT02415946|sinus floor augmentation|sinus floor augmentation
142385|NCT02415933|Burkina Faso|burkina faso
142386|NCT02415933|West Africa|west africa
142387|NCT02415933|Children|children
142388|NCT02415933|Child Abuse|child abuse
142389|NCT02415933|Child Mental Health|child mental health
142390|NCT02415933|Economic Empowerment|economic empowerment
142391|NCT02415933|Women's Empowerment|women's empowerment
142392|NCT02415933|Domestic Violence|domestic violence
142393|NCT02415933|Child and Family Well-being|child and family well-being
142492|NCT02415413|Melphalan|melphalan
142396|NCT02415933|Child Maltreatment|child maltreatment
142397|NCT02415920|Investigating oxytocin's effects|investigating oxytocin's effects
142398|NCT02415920|human communication|human communication
142399|NCT02415881|Panitumumab|panitumumab
142400|NCT02415881|Optical Imaging|optical imaging
142401|NCT02415868|Vaginal Microbiota|vaginal microbiota
142402|NCT02415842|Supra-seasonal influenza vaccine|supra-seasonal influenza vaccine
142403|NCT02415842|Pandemic|pandemic
142404|NCT02415842|Exploratory|exploratory
142405|NCT02415842|Protein epitopes|protein epitopes
142406|NCT02415842|Laboratory evaluation|laboratory evaluation
142407|NCT02415842|Retrospective|retrospective
142408|NCT02415829|Neoajuvant chemotherapy|neoajuvant chemotherapy
142409|NCT02415816|Pediatric|pediatric
142410|NCT02415816|Whole body DWI MRI|whole body dwi mri
142411|NCT02415803|low-dose ticagrelor|low-dose ticagrelor
142412|NCT02415803|clopidogrel|clopidogrel
142413|NCT02415803|Chinese patients with NSTE-ACS|chinese patients with nste-acs
142414|NCT02415803|platelet reactivity|platelet reactivity
142415|NCT02415803|inhibition of platelet aggregation|inhibition of platelet aggregation
142416|NCT02415790|E2027|e2027
142417|NCT02415790|Healthy Adult and Elderly Subjects|healthy adult and elderly subjects
142418|NCT02415790|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
142419|NCT02415738|Near infrared spectroscopy|near infrared spectroscopy
142420|NCT02415738|Cerebral oxygenation|cerebral oxygenation
142421|NCT02415738|Acute respiratory distress syndrom|acute respiratory distress syndrom
142422|NCT02415738|Prone positioning|prone positioning
142423|NCT02415712|Pharmacotherapy|pharmacotherapy
142424|NCT02415686|Dravet syndrome|dravet syndrome
142425|NCT02415686|Sudden Unexpected Death in Epilepsy (SUDEP)|sudden unexpected death in epilepsy (sudep)
142426|NCT02415686|Arrhythmias|arrhythmias
142427|NCT02415673|Orthodontics|orthodontics
142429|NCT02415660|trigger point dry needling|trigger point dry needling
142430|NCT02415660|thoracic spine manipulation|thoracic spine manipulation
142431|NCT02415660|deep cervical extensor muscle|deep cervical extensor muscle
142432|NCT02415660|deep cervical flexor muscle|deep cervical flexor muscle
142433|NCT02415660|shear wave elastography|shear wave elastography
142434|NCT02415647|children|children
133363|NCT02465983|T cells|t cells
142435|NCT02415647|mental health|mental health
142436|NCT02415647|family genetic study|family genetic study
142437|NCT02415621|metastatic|metastatic
142438|NCT02415621|castration resistant|castration resistant
142439|NCT02415621|abiraterone therapy|abiraterone therapy
142440|NCT02415582|Hypertension|hypertension
142441|NCT02415582|Bloodpressure|bloodpressure
142442|NCT02415582|Post-exercise hypotension|post-exercise hypotension
142443|NCT02415582|Combined exercise|combined exercise
142444|NCT02415582|Aerobic exercise|aerobic exercise
142445|NCT02415582|Resistance exercise|resistance exercise
142446|NCT02415582|Aging|aging
142447|NCT02415582|Elderly|elderly
142448|NCT02415582|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
142449|NCT02415569|bowel cleansing|bowel cleansing
142450|NCT02415569|bisacodyl|bisacodyl
142451|NCT02415569|polyethyleneglycol|polyethyleneglycol
142452|NCT02415569|colonoscopy|colonoscopy
142453|NCT02415569|the bristol stool form scale|the bristol stool form scale
142454|NCT02415556|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
142455|NCT02415556|Intranasal Insulin|intranasal insulin
142456|NCT02415556|Placebo|placebo
142457|NCT02415556|Memory|memory
142458|NCT02415556|Gait|gait
142459|NCT02415556|Non diabetic older controls|non diabetic older controls
142460|NCT02415517|Cognitive training|cognitive training
142461|NCT02415517|Cognitive impairment|cognitive impairment
142462|NCT02415517|Heart failure|heart failure
142463|NCT02415517|Cognition|cognition
142464|NCT02415504|Care transition|care transition
142465|NCT02415504|Behavioural and psychological symptoms of dementia|behavioural and psychological symptoms of dementia
142466|NCT02415504|BPSD|bpsd
142467|NCT02415504|Dementia|dementia
142468|NCT02415504|Persons with dementia|persons with dementia
142469|NCT02415504|Discharge processes|discharge processes
142471|NCT02415491|ASO|aso
142472|NCT02415491|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
142473|NCT02415491|young adulthood|young adulthood
142474|NCT02415478|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
585632|NCT00513448|Physical Therapy|physical therapy
142475|NCT02415478|endoscopic lung volume reduction|endoscopic lung volume reduction
142476|NCT02415478|Endobronchial valve|endobronchial valve
142477|NCT02415478|physical capacity|physical capacity
142478|NCT02415478|quality of life|quality of life
142479|NCT02415465|Knee|knee
142480|NCT02415465|Replacement|replacement
142481|NCT02415452|relationship|relationship
142482|NCT02415452|retinal artery lesions|retinal artery lesions
142483|NCT02415452|long-term outcomes|long-term outcomes
142484|NCT02415439|Safety|safety
142485|NCT02415439|tolerability|tolerability
142486|NCT02415439|pharmacokinetics|pharmacokinetics
142487|NCT02415439|adult|adult
142488|NCT02415439|volunteers|volunteers
142489|NCT02415413|Smoldering multiple myeloma|smoldering multiple myeloma
142490|NCT02415413|Carfilzomib|carfilzomib
142491|NCT02415413|Lenalidomide|lenalidomide
142493|NCT02415413|Dexamethasone|dexamethasone
142494|NCT02415413|Autologous stem cell transplantation|autologous stem cell transplantation
142495|NCT02415361|Parents|parents
142496|NCT02415361|Follow-Up Studies|follow-up studies
142497|NCT02415309|Melatonin|melatonin
142498|NCT02415309|Lumbar medial branch block (LMBB)|lumbar medial branch block (lmbb)
142499|NCT02415309|Anxiety|anxiety
142500|NCT02415309|Interventional Pain|interventional pain
142501|NCT02415309|Pain Procedure|pain procedure
142502|NCT02415296|gambling disorder|gambling disorder
142503|NCT02415296|screening model|screening model
142504|NCT02415296|online gambling|online gambling
142505|NCT02415296|clinical validation|clinical validation
142506|NCT02415257|Vestibular schwannoma|vestibular schwannoma
142507|NCT02415257|acoustic neuroma|acoustic neuroma
142508|NCT02415257|cerebellopontine angle tumour|cerebellopontine angle tumour
142509|NCT02415257|gentamicin|gentamicin
142510|NCT02415257|rehabilitation|rehabilitation
142511|NCT02415257|postural balance|postural balance
142512|NCT02415244|ultrasound|ultrasound
142513|NCT02415231|humor laughter C reactive protein|humor laughter c reactive protein
142514|NCT02415205|Pain and stress assessment in premature infants|pain and stress assessment in premature infants
142515|NCT02415192|safety data|safety data
142516|NCT02415192|hypertension therapy|hypertension therapy
142517|NCT02415179|Newly diagnosed asthma|newly diagnosed asthma
142518|NCT02415179|peripheral airway function|peripheral airway function
142519|NCT02415127|Interferon gamma|interferon gamma
142520|NCT02415114|Coenzyme Q10|coenzyme q10
142521|NCT02415114|Resveratrol|resveratrol
142522|NCT02415114|Statin|statin
142523|NCT02415101|Adenocarcinoma|adenocarcinoma
142524|NCT02415101|Squamous cell carcinoma|squamous cell carcinoma
142525|NCT02415101|Gastroesophageal Junction|gastroesophageal junction
142526|NCT02415088|Nerve block|nerve block
142527|NCT02415075|Return to work, state of subjective health, medical rehabilitation, motivational interviewing|return to work, state of subjective health, medical rehabilitation, motivational interviewing
142528|NCT02415062|Parkinson's disease|parkinson's disease
172009|NCT02246660|PAD|pad
142529|NCT02415062|dementia|dementia
142530|NCT02415036|HCC|hcc
142531|NCT02415036|ICC|icc
142532|NCT02415036|Percutaneous hepatic perfusion|percutaneous hepatic perfusion
142533|NCT02414997|RIPC (remote ischemic preconditioning)|ripc (remote ischemic preconditioning)
142534|NCT02414997|primary hypertension stage I|primary hypertension stage i
142535|NCT02414997|vascular function|vascular function
142536|NCT02414997|microRNA-126|microrna-126
142537|NCT02414997|microRNA-34a|microrna-34a
142538|NCT02414984|Rheumatoid Arthritis|rheumatoid arthritis
142539|NCT02414984|Golimumab|golimumab
142540|NCT02414984|Observational|observational
142541|NCT02414984|Compliance|compliance
142542|NCT02414971|cancer related fatigue|cancer related fatigue
142543|NCT02414971|prostate cancer|prostate cancer
142544|NCT02414971|mitochondria|mitochondria
142545|NCT02414932|ketamine|ketamine
142546|NCT02414932|electroconvulsive therapy|electroconvulsive therapy
142547|NCT02414932|glutamate|glutamate
142548|NCT02414906|Goal Directed Therapy|goal directed therapy
142549|NCT02414906|Acute Kidney Injury|acute kidney injury
142550|NCT02414880|Sugammadex|sugammadex
142551|NCT02414880|Neostigmine|neostigmine
142552|NCT02414880|Rocuronium|rocuronium
142553|NCT02414880|Cirrhosis|cirrhosis
142554|NCT02414880|Liver resection|liver resection
142555|NCT02414880|Neuromuscular|neuromuscular
142556|NCT02414841|radiocephalic|radiocephalic
142557|NCT02414841|arteriovenous fistula|arteriovenous fistula
142558|NCT02414841|AVF|avf
142559|NCT02414841|hemodialysis|hemodialysis
142560|NCT02414841|PRT-201|prt-201
142561|NCT02414841|vonapanitase|vonapanitase
142562|NCT02414841|vascular access|vascular access
142563|NCT02414841|kidney|kidney
142564|NCT02414841|renal|renal
142565|NCT02414841|PATENCY-2|patency-2
142566|NCT02414841|secondary patency|secondary patency
142567|NCT02414841|fistula abandonment|fistula abandonment
142568|NCT02414841|use for hemodialysis|use for hemodialysis
142569|NCT02414789|erythema migrans|erythema migrans
142570|NCT02414789|Lyme|lyme
142571|NCT02414789|early diagnosis|early diagnosis
142572|NCT02414789|skin biomarkers|skin biomarkers
655287|NCT00792051|vaccination|vaccination
142573|NCT02414789|proteomics diagnostic|proteomics diagnostic
142574|NCT02414789|mass spectrometry|mass spectrometry
142575|NCT02414750|Vemurafenib/cobimetinib (GDC-0973)|vemurafenib/cobimetinib (gdc-0973)
142576|NCT02414750|Melanoma|melanoma
142577|NCT02414750|Positron Emission Tomography|positron emission tomography
142578|NCT02414750|Tumor Characteristics|tumor characteristics
142579|NCT02414750|Response monitoring|response monitoring
142580|NCT02414750|Resistance prediction|resistance prediction
142581|NCT02414750|molecular targeted therapy|molecular targeted therapy
142582|NCT02414711|Depression|depression
142583|NCT02414711|Primary care|primary care
142584|NCT02414711|General Practitioners|general practitioners
142585|NCT02414685|poor-prognosis germ cell cancer, paclitaxel, ifosfamid and cisplatin regimen, tumor marker decline|poor-prognosis germ cell cancer, paclitaxel, ifosfamid and cisplatin regimen, tumor marker decline
142586|NCT02414672|psychosocial intervention|psychosocial intervention
142587|NCT02414672|advanced lung cancer|advanced lung cancer
142588|NCT02414672|caregivers|caregivers
142589|NCT02414672|self-care|self-care
142590|NCT02414633|Psoriatic Arthritis|psoriatic arthritis
142591|NCT02414620|Efficacy|efficacy
142592|NCT02414620|Dental Vibe Unit|dental vibe unit
142593|NCT02414620|Reduction|reduction
142594|NCT02414620|Elimination|elimination
142595|NCT02414620|Dental Anesthetic Injection|dental anesthetic injection
142596|NCT02414607|Elderberry juice|elderberry juice
142597|NCT02414607|Alzheimer's|alzheimer's
142598|NCT02414607|Inflammation|inflammation
142599|NCT02414555|Fluid Management|fluid management
142600|NCT02414516|HDAC|hdac
142601|NCT02414516|Epigenetic|epigenetic
142602|NCT02414516|Histone|histone
142603|NCT02414516|Acetylation|acetylation
142604|NCT02414503|oxytocin|oxytocin
142605|NCT02414503|social cognition|social cognition
142606|NCT02414490|CIDP|cidp
142607|NCT02414477|tobacco toxicants|tobacco toxicants
142608|NCT02414477|smokeless tobacco|smokeless tobacco
142609|NCT02414477|nitrosamines|nitrosamines
142610|NCT02414477|tobacco specific nitrosamines (TSNAs)|tobacco specific nitrosamines (tsnas)
142611|NCT02414464|tooth bleaching|tooth bleaching
142612|NCT02414464|adolescent|adolescent
142613|NCT02414464|clinical trial|clinical trial
142614|NCT02414451|Propranolol|propranolol
142615|NCT02414425|Fecal Incontinence|fecal incontinence
142616|NCT02414425|Botulinum Toxin A|botulinum toxin a
142617|NCT02414425|Rectal injection|rectal injection
142618|NCT02414412|Ulmus macrocarpa water extract|ulmus macrocarpa water extract
142619|NCT02414412|immunity|immunity
142620|NCT02414399|post-discharge mortality|post-discharge mortality
142621|NCT02414399|morbidity and mortality prevention|morbidity and mortality prevention
142622|NCT02414399|azithromycin|azithromycin
142623|NCT02414399|linear growth|linear growth
142624|NCT02414386|Vitamin D|vitamin d
142625|NCT02414386|Continuous Renal Replacement Therapy|continuous renal replacement therapy
142626|NCT02414386|Multi Organ Failure|multi organ failure
142627|NCT02414386|Acute Kidney Injury|acute kidney injury
142628|NCT02414386|Critical Care|critical care
142629|NCT02414386|Citrate anticoagulation|citrate anticoagulation
142630|NCT02414373|urination|urination
142631|NCT02414373|analgesia, epidural|analgesia, epidural
142632|NCT02414373|local anesthetics|local anesthetics
142633|NCT02414360|Review Literature as Topic|review literature as topic
142634|NCT02414347|Dementia|dementia
142635|NCT02414347|Tauopathies|tauopathies
142636|NCT02414347|Brain Diseases|brain diseases
142637|NCT02414347|Central Nervous System Diseases|central nervous system diseases
142638|NCT02414347|Mild Cognitive Impairment|mild cognitive impairment
142639|NCT02414347|Nervous System Diseases|nervous system diseases
142640|NCT02414347|Neurodegenerative Disease|neurodegenerative disease
142641|NCT02414334|Oligometastases|oligometastases
142642|NCT02414334|Stereotactic ablative radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
142643|NCT02414334|Metastatic tumours|metastatic tumours
142644|NCT02414308|Erectile dysfunction, Peyronie's disease, stem cell|erectile dysfunction, peyronie's disease, stem cell
142645|NCT02414295|Stem cell|stem cell
142646|NCT02414295|Kleinfelter syndrome|kleinfelter syndrome
142647|NCT02414295|Azoospermia|azoospermia
142648|NCT02414295|Sterility|sterility
142649|NCT02414295|Infertility|infertility
142650|NCT02414282|Dementia|dementia
142651|NCT02414282|Brain Diseases|brain diseases
142652|NCT02414282|mild cognitive impairment|mild cognitive impairment
142653|NCT02414282|Central Nervous System Diseases|central nervous system diseases
142654|NCT02414282|Neurodegenerative Disease|neurodegenerative disease
142655|NCT02414269|modified T cells|modified t cells
142656|NCT02414269|cyclophosphamide|cyclophosphamide
142657|NCT02414269|CAR T cells|car t cells
142658|NCT02414269|15-007|15-007
142659|NCT02414269|CAR|car
142660|NCT02414269|immunotherapy|immunotherapy
142661|NCT02414256|breast surgery|breast surgery
142662|NCT02414230|fronto-temporal dementia|fronto-temporal dementia
142663|NCT02414230|Tauopathies|tauopathies
142664|NCT02414230|Nervous System Diseases|nervous system diseases
142665|NCT02414230|Neurodegenerative Diseases|neurodegenerative diseases
655288|NCT00792051|children|children
142668|NCT02414204|Flow-Mediated Dilation (FMD)|flow-mediated dilation (fmd)
142669|NCT02414204|Nitroglycerin-Mediated (NMD)|nitroglycerin-mediated (nmd)
142670|NCT02414204|Venous Plethysmography (VP)|venous plethysmography (vp)
142672|NCT02414191|Temperature management|temperature management
142673|NCT02414191|Anesthesia|anesthesia
142674|NCT02414178|Dementia|dementia
142675|NCT02414178|Brain Diseases|brain diseases
142676|NCT02414178|Central Nervous System Diseases|central nervous system diseases
142677|NCT02414178|Mild Cognitive Impairment|mild cognitive impairment
142678|NCT02414178|nervous system diseases|nervous system diseases
142679|NCT02414178|Neurodegenerative Disease|neurodegenerative disease
142680|NCT02414165|Recurrence|recurrence
142681|NCT02414139|Non Small Cell Lung|non small cell lung
142682|NCT02414139|Non Small Cell Lung Cancer|non small cell lung cancer
142683|NCT02414139|Non-small cell lung cancer|non-small cell lung cancer
142684|NCT02414139|NSCLC|nsclc
142685|NCT02414139|INC280|inc280
142686|NCT02414139|EGFR wild-type (wt)|egfr wild-type (wt)
142687|NCT02414139|advanced non-small cell lung cancer|advanced non-small cell lung cancer
142688|NCT02414139|advanced/metastatic disease|advanced/metastatic disease
142689|NCT02414139|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
142690|NCT02414139|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
142691|NCT02414139|lung cancer|lung cancer
142692|NCT02414139|lung adenocarcinoma|lung adenocarcinoma
142693|NCT02414139|Non small cell lung carcinoma|non small cell lung carcinoma
142694|NCT02414139|MET exon 14 deletion|met exon 14 deletion
142695|NCT02414139|MET exon 14 skipping|met exon 14 skipping
142696|NCT02414139|MET exon 14 mutation|met exon 14 mutation
142697|NCT02414139|MET mutation|met mutation
142698|NCT02414139|MET amplification|met amplification
142699|NCT02414139|MET inhibitor|met inhibitor
142700|NCT02414139|MET dysregulation|met dysregulation
142701|NCT02414139|MET activation|met activation
142702|NCT02414139|MET signaling|met signaling
142703|NCT02414139|MET pathway|met pathway
142704|NCT02414139|met|met
142705|NCT02414139|cMET|cmet
142706|NCT02414126|Heart failure|heart failure
142707|NCT02414126|child|child
142708|NCT02414126|work of breathing|work of breathing
142709|NCT02414126|cardiac function|cardiac function
142710|NCT02414126|sleep|sleep
142711|NCT02414126|polysomnography|polysomnography
142712|NCT02414126|CPAP|cpap
142713|NCT02414087|flat foot|flat foot
142714|NCT02414087|therapeutic effect|therapeutic effect
142715|NCT02414087|insoles|insoles
142716|NCT02414087|children|children
142717|NCT02414061|Postprandial glycemia|postprandial glycemia
142718|NCT02414061|metabolic health measures|metabolic health measures
142719|NCT02414048|Hypoxia|hypoxia
142720|NCT02414048|Head and neck cancer|head and neck cancer
142721|NCT02414035|atrial fibrillation|atrial fibrillation
142722|NCT02414035|anticoagulation|anticoagulation
142723|NCT02414035|Dabigatran|dabigatran
142724|NCT02413996|Virtual Reality Therapy|virtual reality therapy
142725|NCT02413996|Rehabilitation|rehabilitation
142726|NCT02413996|Total Knee Replacement|total knee replacement
142727|NCT02413996|Knee Arthroplasty|knee arthroplasty
142728|NCT02413996|Exercise|exercise
142729|NCT02413996|Arthritis|arthritis
142730|NCT02413996|Rheumatic Disease|rheumatic disease
142731|NCT02413970|OSA|osa
142732|NCT02413970|Neurostimulation|neurostimulation
142733|NCT02413970|Hypoglossal nerve|hypoglossal nerve
142734|NCT02413970|Tongue|tongue
142735|NCT02413970|Upper airway stimulation|upper airway stimulation
142736|NCT02413970|Surgery|surgery
142737|NCT02413957|Elderly Patients|elderly patients
142738|NCT02413957|Medication Safety|medication safety
142739|NCT02413957|Pharmaceutical Care|pharmaceutical care
142740|NCT02413957|Medication Reconciliation|medication reconciliation
142741|NCT02413931|tuberculosis|tuberculosis
142742|NCT02413931|MDR-TB|mdr-tb
142743|NCT02413866|body composition|body composition
142744|NCT02413866|anthropometry|anthropometry
142745|NCT02413840|COPD|copd
142746|NCT02413840|Baduanjin qigong|baduanjin qigong
142747|NCT02413840|depression|depression
142748|NCT02413840|anxiety|anxiety
142749|NCT02413827|Yervoy™, CDX-1401|yervoy™, cdx-1401
142750|NCT02413801|Psoriasis|psoriasis
142751|NCT02413801|PDUS|pdus
142755|NCT02413749|Psoriatic Arthritis|psoriatic arthritis
142756|NCT02413723|intubation|intubation
142757|NCT02413723|critical care|critical care
142758|NCT02413723|laryngoscope|laryngoscope
142759|NCT02413723|videolaryngoscope|videolaryngoscope
142760|NCT02413723|intratracheal|intratracheal
142761|NCT02413658|Phenytoin|phenytoin
142762|NCT02413658|Skin graft donor site|skin graft donor site
142763|NCT02413658|Clean surgical site|clean surgical site
142764|NCT02413658|Wound model|wound model
142765|NCT02413632|HIV-positive MSM (men who have sex with men)|hiv-positive msm (men who have sex with men)
142766|NCT02413632|asymptomatic sexually transmitted infections|asymptomatic sexually transmitted infections
142767|NCT02413632|screening|screening
142768|NCT02413606|follow up care|follow up care
142769|NCT02413606|satisfaction with care|satisfaction with care
142770|NCT02413593|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
142771|NCT02413593|HCV|hcv
142772|NCT02413593|Sustained Virologic Response|sustained virologic response
142773|NCT02413593|Direct Acting Antiviral|direct acting antiviral
142774|NCT02413593|GS-7977|gs-7977
142775|NCT02413593|GS-5885|gs-5885
142776|NCT02413593|Ribavirin|ribavirin
142777|NCT02413593|Sofosbuvir|sofosbuvir
142778|NCT02413593|Ledipasvir|ledipasvir
142779|NCT02413593|Hepatitis C|hepatitis c
142780|NCT02413593|Hepatitis C, Chronic|hepatitis c, chronic
142781|NCT02413554|acetylcholinesterase inhibitors|acetylcholinesterase inhibitors
142782|NCT02413554|rivastigmine patch|rivastigmine patch
142783|NCT02413554|post-operational delirium|post-operational delirium
142784|NCT02413528|Patient Compliance|patient compliance
142785|NCT02413528|Mobile Applications|mobile applications
142786|NCT02413489|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
142787|NCT02413489|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
142788|NCT02413489|Lymphoma, Follicular|lymphoma, follicular
142789|NCT02413489|Daratumumab|daratumumab
143144|NCT02411357|HIV risk|hiv risk
142790|NCT02413476|robotic-assisted gastrectomy|robotic-assisted gastrectomy
142791|NCT02413476|laparoscopic-assisted gastrectomy|laparoscopic-assisted gastrectomy
142792|NCT02413476|gastric cancer|gastric cancer
142793|NCT02413450|induced Pluripotent Stem Cells (iPSC)|induced pluripotent stem cells (ipsc)
142794|NCT02413450|Channelopathies|channelopathies
142795|NCT02413450|Catecholaminergic|catecholaminergic
142796|NCT02413450|Arrhythmogenic|arrhythmogenic
142797|NCT02413437|contrast-enhanced ultrasound|contrast-enhanced ultrasound
142798|NCT02413437|biopsy|biopsy
142799|NCT02413424|sucralose|sucralose
142800|NCT02413411|Arthroplasty|arthroplasty
142801|NCT02413411|Osteoarthritis|osteoarthritis
142802|NCT02413411|Replacement|replacement
142803|NCT02413411|Intervention|intervention
142804|NCT02413385|lifestyle intervention|lifestyle intervention
142805|NCT02413385|physical activity|physical activity
142806|NCT02413385|exercise|exercise
142807|NCT02413385|eHealth|ehealth
142808|NCT02413385|technology|technology
142809|NCT02413385|coaching|coaching
142810|NCT02413385|healthy eating|healthy eating
142811|NCT02413372|First Line Therapy|first line therapy
142812|NCT02413372|NASH|nash
142813|NCT02413333|Contact lens solution|contact lens solution
142814|NCT02413320|TNBC, breast cancer, neoadjuvant, carboplatin, docetaxel, paclitaxel, doxorubicin, cyclophosphamide|tnbc, breast cancer, neoadjuvant, carboplatin, docetaxel, paclitaxel, doxorubicin, cyclophosphamide
142815|NCT02413307|Compassion Focused Therapy|compassion focused therapy
142816|NCT02413281|Healthy Volunteer|healthy volunteer
142817|NCT02413281|Abuse Liability|abuse liability
142818|NCT02413281|ALKS 5461|alks 5461
142819|NCT02413281|Alkermes|alkermes
142820|NCT02413255|Drug therapy|drug therapy
142821|NCT02413242|S. aureus|s. aureus
142822|NCT02413242|P. aeruginosa|p. aeruginosa
142823|NCT02413242|Colonization|colonization
142824|NCT02413242|Pneumonia|pneumonia
142826|NCT02413216|Tic Disorder|tic disorder
142827|NCT02413216|Tourette|tourette
142828|NCT02413216|Motor tic|motor tic
142829|NCT02413216|Vocal tic|vocal tic
142830|NCT02413216|Habit reversal training|habit reversal training
142831|NCT02413216|CBIT|cbit
142832|NCT02413216|TicHelper|tichelper
142833|NCT02413216|Behavior Therapy|behavior therapy
142834|NCT02413203|lipidomics|lipidomics
142835|NCT02413203|ex vivo human whole blood assay|ex vivo human whole blood assay
142836|NCT02413203|celecoxib|celecoxib
142837|NCT02413203|selective COX-2 inhibitor|selective cox-2 inhibitor
142838|NCT02413164|Schizophrenia|schizophrenia
142839|NCT02413164|Mental Health|mental health
142840|NCT02413164|Physical Therapy|physical therapy
142841|NCT02413164|Quality of life|quality of life
142842|NCT02413164|Metabolic Syndrome|metabolic syndrome
142843|NCT02413164|Stigma|stigma
142844|NCT02413164|Positive and negative symptoms|positive and negative symptoms
142845|NCT02413151|Exercise training|exercise training
142846|NCT02413151|Cardiac resynchronization therapy|cardiac resynchronization therapy
142847|NCT02413151|Autonomic nervous system modulation|autonomic nervous system modulation
142848|NCT02413151|Chronic Heart failure|chronic heart failure
142849|NCT02413138|GHD|ghd
142850|NCT02413112|Aging|aging
142851|NCT02413112|Sarcopenia|sarcopenia
142852|NCT02413112|Resistance training|resistance training
142853|NCT02413112|Strength|strength
142854|NCT02413112|Muscle mass|muscle mass
142855|NCT02413086|diabetic foot ulcer|diabetic foot ulcer
142856|NCT02413086|early-stage amputation|early-stage amputation
142857|NCT02413086|external therapy of herbs chitosan|external therapy of herbs chitosan
142858|NCT02413086|wound surface healing|wound surface healing
142859|NCT02413073|whole body vibration|whole body vibration
142860|NCT02413073|kidney disease|kidney disease
142861|NCT02413034|antibiotic|antibiotic
142862|NCT02413021|Acute Myeloid Leukemia|acute myeloid leukemia
142863|NCT02413021|Acute Lymphoid Leukemia|acute lymphoid leukemia
142864|NCT02413021|deferasirox|deferasirox
142865|NCT02412995|sea buckthorn|sea buckthorn
142866|NCT02412995|strawberry|strawberry
142867|NCT02412995|glucose response|glucose response
142869|NCT02412995|metabolomics|metabolomics
142870|NCT02412995|intake biomarker|intake biomarker
142871|NCT02412956|mHealth|mhealth
142872|NCT02412904|follicular stimulating hormone|follicular stimulating hormone
142873|NCT02412904|human menopausal gonadotrophin|human menopausal gonadotrophin
142874|NCT02412904|Recombinant follicular stimulating hormone (rFSH)|recombinant follicular stimulating hormone (rfsh)
142972|NCT02412449|Oral anemia treatment|oral anemia treatment
142898|NCT02412774|weight loss|weight loss
142899|NCT02412774|insulin sensitivity|insulin sensitivity
142900|NCT02412761|Anti-hypertensive medications|anti-hypertensive medications
142901|NCT02412761|Pediatrics|pediatrics
142902|NCT02412761|N-of-1 trial|n-of-1 trial
142903|NCT02412748|Non-Resident|non-resident
142905|NCT02412748|African American|african american
142930|NCT02412722|Drug therapy|drug therapy
142931|NCT02412709|Long QT Syndrome|long qt syndrome
142932|NCT02412709|LQTS|lqts
142933|NCT02412709|genetic testing|genetic testing
142935|NCT02412709|saliva testing|saliva testing
142936|NCT02412696|placental morphology|placental morphology
142937|NCT02412696|CPAP|cpap
142938|NCT02412696|placental secretory function|placental secretory function
142939|NCT02412592|HBeAg positive|hbeag positive
142940|NCT02412592|interferon|interferon
142941|NCT02412592|peginterferon|peginterferon
142942|NCT02412592|HBeAg seroconversion|hbeag seroconversion
142943|NCT02412592|sustained viral response|sustained viral response
142944|NCT02412592|relapse|relapse
142945|NCT02412579|HCC|hcc
142946|NCT02412579|Liver Cancer|liver cancer
142947|NCT02412566|cholestasis|cholestasis
142948|NCT02412566|growth failure|growth failure
142949|NCT02412566|intravenous fat emulsion|intravenous fat emulsion
142950|NCT02412566|SMOF|smof
142951|NCT02412514|polio|polio
142952|NCT02412514|inactivated poliovirus vaccine|inactivated poliovirus vaccine
142953|NCT02412514|oral poliovirus vaccine|oral poliovirus vaccine
142954|NCT02412514|IPV|ipv
142955|NCT02412514|OPV|opv
142956|NCT02412462|Phase I|phase i
142957|NCT02412462|Clusterin|clusterin
142958|NCT02412462|Epithelial-to-Mesenchymal Transition (EMT)|epithelial-to-mesenchymal transition (emt)
142959|NCT02412462|Circulating Tumor Cells (CTC)|circulating tumor cells (ctc)
142960|NCT02412462|EMT and Stem Cell Biomarkers|emt and stem cell biomarkers
142961|NCT02412462|Pharmacokinetics|pharmacokinetics
142962|NCT02412449|Pharmacokinetics|pharmacokinetics
142963|NCT02412449|Anemia|anemia
142964|NCT02412449|Chronic kidney disease|chronic kidney disease
142965|NCT02412449|CKD|ckd
142966|NCT02412449|Renal impairment|renal impairment
142967|NCT02412449|Chronic renal insufficiency|chronic renal insufficiency
142968|NCT02412449|Ferrous sulfate|ferrous sulfate
142969|NCT02412449|Iron|iron
142970|NCT02412449|End stage renal disease|end stage renal disease
142971|NCT02412449|Dialysis|dialysis
172486|NCT02244424|Infant|infant
142973|NCT02412449|Bioavailability|bioavailability
142974|NCT02412449|Erythropoietin|erythropoietin
142975|NCT02412449|Hypoxia-inducible factor|hypoxia-inducible factor
142976|NCT02412449|Volunteers|volunteers
142977|NCT02412410|laborist|laborist
142978|NCT02412410|efficacy|efficacy
142979|NCT02412410|sleep|sleep
142980|NCT02412410|fatigue|fatigue
142981|NCT02412410|SAFTE|safte
142982|NCT02412410|cognition|cognition
142983|NCT02412397|Shoulder|shoulder
142984|NCT02412384|Lung Neoplasms|lung neoplasms
142985|NCT02412384|Circulating Tumor Cells|circulating tumor cells
142986|NCT02412371|previously untreated|previously untreated
142987|NCT02412371|PARP inhibitor|parp inhibitor
142988|NCT02412371|radiotherapy|radiotherapy
142989|NCT02412371|paclitaxel|paclitaxel
142990|NCT02412371|ABT-888|abt-888
142991|NCT02412371|stage III|stage iii
142992|NCT02412371|first line|first line
142993|NCT02412371|carboplatin|carboplatin
142994|NCT02412371|veliparib|veliparib
142995|NCT02412371|non-small cell lung cancer|non-small cell lung cancer
142996|NCT02412358|toothbrushing|toothbrushing
142997|NCT02412358|plaque control|plaque control
142998|NCT02412358|gingivitis|gingivitis
142999|NCT02412345|Erectile Dysfunction|erectile dysfunction
143000|NCT02412345|Shockwave therapy|shockwave therapy
143001|NCT02412345|Renal Transplant|renal transplant
143002|NCT02412345|Male|male
143003|NCT02412345|Renal Transplant Recipients|renal transplant recipients
143004|NCT02412332|advanced COPD (stage III)|advanced copd (stage iii)
143005|NCT02412332|Adult stem cells|adult stem cells
143006|NCT02412332|Cell therapy|cell therapy
143007|NCT02412319|HBeAg positive chronic hepatitis B|hbeag positive chronic hepatitis b
143008|NCT02412319|HBeAg serum conversion rate|hbeag serum conversion rate
143009|NCT02412319|HBeAg serum disappearance rate|hbeag serum disappearance rate
143010|NCT02412319|HBeAg and HBsAg titer|hbeag and hbsag titer
143011|NCT02412306|Amgen|amgen
143012|NCT02412293|Perinatal|perinatal
143013|NCT02412293|neonatal|neonatal
143014|NCT02412293|newborn|newborn
143015|NCT02412293|mortality|mortality
143016|NCT02412189|Anesthesia|anesthesia
143017|NCT02412189|Blood pressure|blood pressure
143018|NCT02412189|Plasma volume|plasma volume
143019|NCT02412189|Vasopressor agents|vasopressor agents
143020|NCT02412189|Continuous noninvasive hemoglobin measurement|continuous noninvasive hemoglobin measurement
143021|NCT02412189|Coronary artery bypass|coronary artery bypass
143022|NCT02412176|pacemaker|pacemaker
143023|NCT02412176|dyssynchrony|dyssynchrony
143024|NCT02412176|apical pacing|apical pacing
143025|NCT02412176|mid-septum|mid-septum
143026|NCT02412098|Hepatic Impairment|hepatic impairment
143027|NCT02412085|golimumab|golimumab
143028|NCT02412085|ulcerative colitis|ulcerative colitis
143029|NCT02412085|steroid-dependent|steroid-dependent
143030|NCT02412072|Endometrial hyperplasia|endometrial hyperplasia
143031|NCT02412072|Progesterone|progesterone
143032|NCT02412072|LNG-IUS|lng-ius
143033|NCT02412072|dilatation & curettage|dilatation & curettage
143034|NCT02412072|endometrial aspiration sampling|endometrial aspiration sampling
143035|NCT02412046|Pressure ulcer|pressure ulcer
143036|NCT02412046|Interface pressure|interface pressure
143037|NCT02412046|Pressure mapping device|pressure mapping device
143038|NCT02412046|Ischemia reperfusion|ischemia reperfusion
143039|NCT02412046|Monitoring|monitoring
143040|NCT02412046|Microvascularization|microvascularization
143041|NCT02412033|vaginal misoprostol|vaginal misoprostol
143042|NCT02412007|spastic diplegia;cerebral palsy;activity based therapy|spastic diplegia;cerebral palsy;activity based therapy
143043|NCT02411981|Lung Clearance Index|lung clearance index
143044|NCT02411981|Non cystic fibrosis Bronchiectasis|non cystic fibrosis bronchiectasis
143045|NCT02411981|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
143047|NCT02411968|Carcinoma, renal cell|carcinoma, renal cell
143048|NCT02411968|Diagnostic Imaging|diagnostic imaging
143049|NCT02411968|Diagnostic techniques, urological|diagnostic techniques, urological
143050|NCT02411968|Radionuclide imaging|radionuclide imaging
143051|NCT02411968|Follow up|follow up
143052|NCT02411903|Clopidogrel-drug interactions|clopidogrel-drug interactions
143053|NCT02411890|postoperative pain|postoperative pain
143054|NCT02411890|femoral nerve block|femoral nerve block
143055|NCT02411890|adductor canal block|adductor canal block
143056|NCT02411890|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
143057|NCT02411877|Acute ischemic stroke|acute ischemic stroke
143058|NCT02411877|Mild hypothermia|mild hypothermia
143059|NCT02411877|Stroke|stroke
143060|NCT02411877|Hypothermia|hypothermia
143061|NCT02411877|Cerebral infarction|cerebral infarction
143062|NCT02411877|Ischemia|ischemia
143063|NCT02411877|Cerebrovascular disorder|cerebrovascular disorder
143064|NCT02411877|Brain disease|brain disease
143065|NCT02411877|Central nervous system disease|central nervous system disease
143066|NCT02411877|Nervous system disease|nervous system disease
143067|NCT02411877|Vascular disease|vascular disease
143068|NCT02411877|Cardiovascular disease|cardiovascular disease
143069|NCT02411877|Brain infarction|brain infarction
143070|NCT02411877|Brain ischemia|brain ischemia
143071|NCT02411877|Pathologic process|pathologic process
143072|NCT02411877|Body temperature change|body temperature change
143073|NCT02411877|Signs and symptoms|signs and symptoms
143074|NCT02411864|IVIM|ivim
143075|NCT02411864|brain|brain
143076|NCT02411864|diffusion-weighted imaging|diffusion-weighted imaging
143077|NCT02411851|Actinic Keratoses|actinic keratoses
143078|NCT02411838|Multiple sclerosis|multiple sclerosis
143079|NCT02411838|calorie restriction|calorie restriction
143080|NCT02411838|adipokines|adipokines
143081|NCT02411812|Orthodontic Appliances, Functional|orthodontic appliances, functional
143082|NCT02411812|Herbst Appliance|herbst appliance
143083|NCT02411812|Malocclusion, Angle Class II|malocclusion, angle class ii
143085|NCT02411747|Medical|medical
143086|NCT02411747|Urology|urology
143087|NCT02411747|Randomized Controlled Trial|randomized controlled trial
143088|NCT02411747|Endoscopy|endoscopy
143089|NCT02411747|Cystoscopy|cystoscopy
143090|NCT02411721|Anxiety|anxiety
143091|NCT02411721|Dog Intervention|dog intervention
143093|NCT02411721|Children|children
143094|NCT02411695|Adolescent|adolescent
143095|NCT02411695|Otsuka,|otsuka,
143096|NCT02411695|Brexpiprazole|brexpiprazole
143097|NCT02411669|Patient centred care|patient centred care
143098|NCT02411656|Breast cancer|breast cancer
143099|NCT02411656|Metastatic inflammatory breast cancer|metastatic inflammatory breast cancer
143100|NCT02411656|MIBC|mibc
143101|NCT02411656|IBC|ibc
143102|NCT02411656|Breast carcinoma|breast carcinoma
143103|NCT02411656|Metastatic|metastatic
143104|NCT02411656|MK-3475|mk-3475
143105|NCT02411656|Keytruda|keytruda
143106|NCT02411656|Pembrolizumab|pembrolizumab
143107|NCT02411656|SCH-900475|sch-900475
143108|NCT02411630|PrEP|prep
143109|NCT02411630|HIV Prevention|hiv prevention
143110|NCT02411578|T1D|t1d
143111|NCT02411578|Type 1 diabetes|type 1 diabetes
143112|NCT02411578|Mini-dose glucagon|mini-dose glucagon
143113|NCT02411578|adults|adults
143114|NCT02411578|non-severe hypoglycemia|non-severe hypoglycemia
143115|NCT02411565|epithelial|epithelial
143116|NCT02411565|ovarian|ovarian
143117|NCT02411565|fallopian tube|fallopian tube
143118|NCT02411565|primary peritoneal carcinoma|primary peritoneal carcinoma
143119|NCT02411565|peritoneal|peritoneal
143120|NCT02411565|ovary|ovary
143121|NCT02411539|HIV|hiv
143122|NCT02411539|VRC01|vrc01
143123|NCT02411500|Healthy|healthy
143124|NCT02411500|Male|male
143125|NCT02411500|Pharmacokinetics|pharmacokinetics
143126|NCT02411474|stem cell transplantation (SCT)|stem cell transplantation (sct)
143127|NCT02411461|Pediatric obesity|pediatric obesity
143128|NCT02411461|pseudohypoparathyroidism|pseudohypoparathyroidism
143129|NCT02411461|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
143130|NCT02411435|rifampin|rifampin
143131|NCT02411435|drug interaction|drug interaction
143132|NCT02411435|pharmacokinetics|pharmacokinetics
143133|NCT02411435|cabotegravir|cabotegravir
143134|NCT02411422|intubation|intubation
143135|NCT02411422|cardiopulmonary resuscitation|cardiopulmonary resuscitation
143137|NCT02411409|Health Information Technology (HIT)|health information technology (hit)
143138|NCT02411409|self-care|self-care
143139|NCT02411383|Diaphragm pacing|diaphragm pacing
143140|NCT02411383|Respiratory assistance|respiratory assistance
143141|NCT02411383|Lung transplant|lung transplant
143142|NCT02411357|Contraception|contraception
143143|NCT02411357|Unintended pregnancy|unintended pregnancy
143145|NCT02411357|Sexually transmitted infections|sexually transmitted infections
143146|NCT02411357|Women|women
143147|NCT02411357|Pregnancy|pregnancy
143148|NCT02411357|Neonatal health|neonatal health
143149|NCT02411357|Drug use|drug use
143150|NCT02411357|Drug treatment|drug treatment
143151|NCT02411357|Opioids|opioids
143152|NCT02411344|HER2+/HR+|her2+/hr+
143153|NCT02411344|breast cancer|breast cancer
143154|NCT02411331|Lock Solution|lock solution
143155|NCT02411331|Catheter related blood stream infections|catheter related blood stream infections
143156|NCT02411331|Central venous catheter infection|central venous catheter infection
143157|NCT02411331|Intravenous Drug Delivery Systems|intravenous drug delivery systems
143158|NCT02411331|Coagulase-negative staphylococci infection|coagulase-negative staphylococci infection
143159|NCT02411331|Ethanol lock solution|ethanol lock solution
143160|NCT02411331|Vancomycin lock solution|vancomycin lock solution
143161|NCT02411279|Heart failure|heart failure
143162|NCT02411279|telemonitoring|telemonitoring
143163|NCT02411279|intrusive sensors|intrusive sensors
143164|NCT02411279|intrusive devices|intrusive devices
143165|NCT02411279|Heart failure stage II|heart failure stage ii
143166|NCT02411279|Heart failure stage III|heart failure stage iii
143167|NCT02411279|heart disease|heart disease
143168|NCT02411253|IL2|il2
143169|NCT02411253|Interleukin 2|interleukin 2
143170|NCT02411253|IL-2|il-2
143171|NCT02411253|Auto-immune disease|auto-immune disease
143172|NCT02411253|Insulin|insulin
143173|NCT02411253|Diabetes|diabetes
143174|NCT02411253|Regulatory T cells|regulatory t cells
143175|NCT02411253|Treg|treg
143176|NCT02411253|Immunoregulation|immunoregulation
143177|NCT02411253|Immune tolerance|immune tolerance
143178|NCT02411253|Immunotherapy|immunotherapy
143179|NCT02411240|Air filtration|air filtration
143180|NCT02411240|cardiovascular health|cardiovascular health
143181|NCT02411240|cognition|cognition
143182|NCT02411240|particulate matter|particulate matter
143183|NCT02411240|mitochondrial DNA|mitochondrial dna
143184|NCT02411227|Neuropsychologic Testing|neuropsychologic testing
143185|NCT02411227|Neurocognitive|neurocognitive
143186|NCT02411227|Virtual Reality|virtual reality
143187|NCT02411227|Rehabilitation|rehabilitation
143188|NCT02411227|Driving|driving
143189|NCT02411175|Constipation|constipation
143190|NCT02411175|Homeopathy|homeopathy
143191|NCT02411162|atopic dermatitis|atopic dermatitis
143192|NCT02411162|FLIM|flim
143193|NCT02411162|chronic plaque psoriasis|chronic plaque psoriasis
143194|NCT02411162|healthy volunteers|healthy volunteers
143195|NCT02411162|GSK2894512|gsk2894512
143196|NCT02411162|Skin residency|skin residency
143197|NCT02411149|Adductor Canal Block|adductor canal block
143198|NCT02411149|Total Knee Arthroplasty|total knee arthroplasty
143199|NCT02411123|PGx|pgx
143200|NCT02411123|pharmacogenetics|pharmacogenetics
143201|NCT02411123|depression|depression
143202|NCT02411123|anxiety|anxiety
143203|NCT02411123|Neuropsychiatric diseases|neuropsychiatric diseases
143204|NCT02411123|IDgenetix|idgenetix
143205|NCT02411123|AltheaDx|altheadx
143206|NCT02411097|Deep venous thromboembolism|deep venous thromboembolism
143207|NCT02411097|Femoral nerve block|femoral nerve block
655381|NCT00792480|Obesity|obesity
143208|NCT02411097|Total knee arthroplasty|total knee arthroplasty
143209|NCT02411084|Graft vs Host Disease|graft vs host disease
143210|NCT02411084|Immune System Diseases|immune system diseases
143211|NCT02411084|Dipeptidyl Peptidase 4|dipeptidyl peptidase 4
143212|NCT02411084|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
143213|NCT02411084|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
143215|NCT02411071|antiretroviral treatment|antiretroviral treatment
143216|NCT02411071|low viral load|low viral load
143217|NCT02411071|low-level viremia|low-level viremia
143218|NCT02411058|information|information
143219|NCT02411058|incentives|incentives
143220|NCT02411045|Indirect incentives|indirect incentives
143221|NCT02411045|Exercise more|exercise more
143222|NCT02411019|Phase 2 follow up|phase 2 follow up
143223|NCT02411019|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
143224|NCT02411019|Adult|adult
143225|NCT02411019|Safety|safety
143226|NCT02411019|Efficacy|efficacy
143227|NCT02410941|Randomized controlled trial|randomized controlled trial
143228|NCT02410941|Practice management|practice management
143229|NCT02410941|tomography, x-ray computed/adverse effects|tomography, x-ray computed/adverse effects
143230|NCT02410941|Clinical decision support|clinical decision support
143231|NCT02410941|Computerized clinical decision support|computerized clinical decision support
143232|NCT02410941|Decision support systems, clinical|decision support systems, clinical
143233|NCT02410941|Health Expenditures|health expenditures
143234|NCT02410941|Physician's practice patterns|physician's practice patterns
143235|NCT02410941|Unnecessary Procedures/economics|unnecessary procedures/economics
143236|NCT02410941|Physician's Practice Patterns/economics|physician's practice patterns/economics
143237|NCT02410941|Diffusion of innovation|diffusion of innovation
143238|NCT02410941|Decision Support Models|decision support models
143239|NCT02410941|Clinical Prediction Rules|clinical prediction rules
143240|NCT02410915|Rehabilitation|rehabilitation
143241|NCT02410915|Robotics|robotics
143242|NCT02410902|Autism|autism
143243|NCT02410876|Bladder|bladder
143244|NCT02410876|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
143245|NCT02410876|benign prostatic obstruction|benign prostatic obstruction
143246|NCT02410863|Stage III or IV with BRAF V600E/K mutation|stage iii or iv with braf v600e/k mutation
143247|NCT02410850|Oral Appliance|oral appliance
143248|NCT02410850|objective adherence|objective adherence
143249|NCT02410850|cardiovascular events|cardiovascular events
143250|NCT02410850|cardiovascular mortality|cardiovascular mortality
143251|NCT02410850|cerebrovascular mortality|cerebrovascular mortality
143252|NCT02410850|cost effectiveness|cost effectiveness
143253|NCT02410837|lung lesion|lung lesion
143254|NCT02410837|biopsy|biopsy
143255|NCT02410837|bronchoscopy|bronchoscopy
143256|NCT02410811|Sickle Cell Disease (SCD)|sickle cell disease (scd)
143257|NCT02410811|Cardiac Magnetic Resonance Imaging (CMR)|cardiac magnetic resonance imaging (cmr)
143258|NCT02410811|Cardiomyopathy|cardiomyopathy
143259|NCT02410811|Pulmonary Hypertension|pulmonary hypertension
143260|NCT02410785|obesity,|obesity,
143261|NCT02410785|body weight,|body weight,
143262|NCT02410785|overweight,|overweight,
143263|NCT02410785|weight loss,|weight loss,
143264|NCT02410785|polyglucosamine,|polyglucosamine,
143265|NCT02410785|L112|l112
143266|NCT02410785|caloric restriction|caloric restriction
143267|NCT02410785|physical activity|physical activity
143268|NCT02410746|pain|pain
143269|NCT02410746|surgery|surgery
143270|NCT02410733|melanoma|melanoma
143271|NCT02410733|Lipo-MERIT|lipo-merit
143272|NCT02410733|cancer vaccine|cancer vaccine
143273|NCT02410733|RB_0003-01|rb_0003-01
143274|NCT02410733|BioNTech|biontech
143275|NCT02410733|BioNTech RNA Pharmaceuticals|biontech rna pharmaceuticals
143276|NCT02410733|BioNTech RNA|biontech rna
143277|NCT02410733|RNA|rna
143278|NCT02410720|Colonoscopy Preparation|colonoscopy preparation
143279|NCT02410720|Polyethylene Glycols|polyethylene glycols
143280|NCT02410720|Mobile application|mobile application
143281|NCT02410720|Software|software
143282|NCT02410720|Compliance|compliance
143283|NCT02410720|Patient Compliance|patient compliance
143284|NCT02410720|Adherence|adherence
143285|NCT02410707|procedural sedation|procedural sedation
143286|NCT02410707|procedural pain|procedural pain
143287|NCT02410707|procedural anxiolysis|procedural anxiolysis
143288|NCT02410655|Uterine atony|uterine atony
143289|NCT02410655|Postpartum hemorrhage|postpartum hemorrhage
143290|NCT02410655|Vaginal delivery|vaginal delivery
143291|NCT02410655|Uterotonic|uterotonic
143292|NCT02410655|Oxytocin|oxytocin
143293|NCT02410655|Bolus|bolus
143294|NCT02410655|Evidence-based|evidence-based
143295|NCT02410655|Protocol|protocol
143296|NCT02410642|cardiopulmonary bypass|cardiopulmonary bypass
143297|NCT02410629|Stroke|stroke
143298|NCT02410616|Psychotherapy|psychotherapy
143299|NCT02410616|Comparative Effectiveness Research|comparative effectiveness research
143300|NCT02410616|Randomized Controlled Trial|randomized controlled trial
143301|NCT02410616|Secondary Care|secondary care
143302|NCT02410603|Chemotherapy|chemotherapy
143303|NCT02410577|89Zr-J591|89zr-j591
143304|NCT02410577|15-002|15-002
143305|NCT02410564|insomnia|insomnia
143306|NCT02410564|Sleep|sleep
143307|NCT02410564|CBT-I intervention|cbt-i intervention
143308|NCT02410564|SHUTi|shuti
143309|NCT02410551|Myeloproliferative Diseases|myeloproliferative diseases
143310|NCT02410551|Myeloproliferative Neoplasms|myeloproliferative neoplasms
143311|NCT02410551|MPN|mpn
143312|NCT02410551|Myelofibrosis|myelofibrosis
143313|NCT02410551|Polycythemia vera|polycythemia vera
143314|NCT02410551|PV|pv
143315|NCT02410551|Essential thrombocythemia|essential thrombocythemia
143316|NCT02410551|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
143317|NCT02410551|Allo TP|allo tp
143318|NCT02410551|Pacritinib|pacritinib
143319|NCT02410551|Busulfan|busulfan
143320|NCT02410551|Busulfex|busulfex
143321|NCT02410551|Myleran|myleran
143322|NCT02410551|Questionnaires|questionnaires
143323|NCT02410551|Surveys|surveys
143324|NCT02410551|Phone calls|phone calls
143325|NCT02410525|hyperlipidemia|hyperlipidemia
143326|NCT02410525|positron emission tomography|positron emission tomography
143327|NCT02410499|Drug therapy|drug therapy
143328|NCT02410473|Congenital Heart Disease|congenital heart disease
143329|NCT02410473|Point-of-care coagulation monitoring|point-of-care coagulation monitoring
143330|NCT02410447|Shock waves|shock waves
143331|NCT02410434|Stigma|stigma
143332|NCT02410434|lesbian|lesbian
143333|NCT02410434|gay|gay
143334|NCT02410434|bisexual|bisexual
143335|NCT02410434|transgender|transgender
143336|NCT02410421|Individualized Medicine|individualized medicine
143337|NCT02410421|Functional Neuroimaging|functional neuroimaging
143338|NCT02410421|Robotic Proceedure|robotic proceedure
143339|NCT02410421|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
143340|NCT02410421|Transcranial Direct Current Stimulation Monocentric|transcranial direct current stimulation monocentric
143438|NCT02409875|body weight|body weight
143341|NCT02410421|Compariative Cross-Over 3 Arms Study Randomized, Single-Blind Method|compariative cross-over 3 arms study randomized, single-blind method
143342|NCT02410408|Patient Safety|patient safety
143343|NCT02410408|App|app
143344|NCT02410408|Root Cause Analysis|root cause analysis
143345|NCT02410408|Patient Safety Certification|patient safety certification
143346|NCT02410382|cancer|cancer
143347|NCT02410382|radiation therapy|radiation therapy
143348|NCT02410382|chemotherapy|chemotherapy
143349|NCT02410382|dexamethasone|dexamethasone
143350|NCT02410382|corticosteroids|corticosteroids
143351|NCT02410330|Therapeutic ultrasound|therapeutic ultrasound
143352|NCT02410330|Angiographic recanalization rate|angiographic recanalization rate
143353|NCT02410330|Salvagability index|salvagability index
143354|NCT02410330|Sonothrombolysis|sonothrombolysis
143355|NCT02410317|Postoperative pain|postoperative pain
143356|NCT02410317|Postoperative morphine consumption|postoperative morphine consumption
143357|NCT02410317|Emergency cesarean delivery|emergency cesarean delivery
143358|NCT02410317|Ropivacaine|ropivacaine
143359|NCT02410317|Local anesthetic wound 48-hours infusion|local anesthetic wound 48-hours infusion
143360|NCT02410317|Emergency cesarean section|emergency cesarean section
143361|NCT02410304|Rheumatoid arthritis / ultrasonography / synovitis|rheumatoid arthritis / ultrasonography / synovitis
143362|NCT02410265|guided self-help|guided self-help
143363|NCT02410265|student mental health|student mental health
143364|NCT02410265|task shifting|task shifting
143365|NCT02410265|prevention|prevention
143366|NCT02410252|continuous temperature monitoring|continuous temperature monitoring
143367|NCT02410252|patient self-management|patient self-management
143368|NCT02410252|iThermonitor|ithermonitor
143369|NCT02410252|Home monitoring|home monitoring
143370|NCT02410239|Cerebral Adrenoleukodystrophy|cerebral adrenoleukodystrophy
143371|NCT02410239|cALD|cald
143372|NCT02410200|Pediatrics|pediatrics
143373|NCT02410187|stereotactic body radiotherapy|stereotactic body radiotherapy
143374|NCT02410174|Renal Cell Carcinoma|renal cell carcinoma
143375|NCT02410174|RCC|rcc
143376|NCT02410174|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
143377|NCT02410174|SBRT|sbrt
143378|NCT02410161|ketone|ketone
143379|NCT02410161|α-linolenic acid|α-linolenic acid
143380|NCT02410161|flaxseed|flaxseed
143381|NCT02410161|aging|aging
143382|NCT02410161|β-hydroxybutyrate|β-hydroxybutyrate
143383|NCT02410161|acetoacetate|acetoacetate
143384|NCT02410161|omega-3 fatty acids|omega-3 fatty acids
143385|NCT02410161|ketogenesis|ketogenesis
143386|NCT02410148|open-angle glaucoma|open-angle glaucoma
143387|NCT02410148|papilledema|papilledema
143388|NCT02410148|non-invasive ICP|non-invasive icp
143389|NCT02410148|Intracranial pressure|intracranial pressure
143390|NCT02410135|Lower Urinary Tract Symptoms|lower urinary tract symptoms
143391|NCT02410135|Sleep Disturbance|sleep disturbance
143392|NCT02410096|exercise-induced asthma|exercise-induced asthma
143393|NCT02410096|cold chamber|cold chamber
143394|NCT02410096|exercise challenge|exercise challenge
143395|NCT02410096|cold air challenge|cold air challenge
143396|NCT02410096|oil supplementation|oil supplementation
655382|NCT00792480|Pregnancy|pregnancy
143397|NCT02410096|middle-chain and Polyunsaturated Fatty Acids|middle-chain and polyunsaturated fatty acids
143398|NCT02410070|Distal radial fracture|distal radial fracture
143399|NCT02410070|pronator quadratus|pronator quadratus
143400|NCT02410070|mini-approach|mini-approach
143401|NCT02410070|volar plating|volar plating
143402|NCT02410070|open reduction and internal fixation|open reduction and internal fixation
143403|NCT02410057|growth|growth
143404|NCT02410057|formula|formula
143405|NCT02410057|protein|protein
143406|NCT02410057|alpha-lactalbumin|alpha-lactalbumin
143407|NCT02410057|amino acids|amino acids
143408|NCT02410044|Patient Reported Outcomes|patient reported outcomes
143409|NCT02409992|Children with ODD and low prosocial emotions|children with odd and low prosocial emotions
143410|NCT02409979|colonoscopy|colonoscopy
143411|NCT02409979|carbon dioxide|carbon dioxide
143412|NCT02409979|water exchange|water exchange
143413|NCT02409979|discomfort|discomfort
143414|NCT02409979|colonoscopy pain|colonoscopy pain
143415|NCT02409966|periodontitis|periodontitis
143416|NCT02409966|therapeutics|therapeutics
143417|NCT02409966|quality of life|quality of life
143418|NCT02409966|fear|fear
143419|NCT02409966|anxiety|anxiety
143420|NCT02409966|pain|pain
143421|NCT02409953|volunteers|volunteers
143422|NCT02409927|Medium-chain triglycerides|medium-chain triglycerides
143423|NCT02409927|Metabolism|metabolism
143424|NCT02409927|Ketones|ketones
143425|NCT02409927|Lipids|lipids
143426|NCT02409927|Emulsification|emulsification
143427|NCT02409914|Insulin Resistance|insulin resistance
143428|NCT02409914|Brain metabolism|brain metabolism
143429|NCT02409914|PET|pet
143430|NCT02409914|MRI|mri
143431|NCT02409901|Physical Activity|physical activity
143432|NCT02409901|Exercise Rehabilitation|exercise rehabilitation
143433|NCT02409901|Kidney Function|kidney function
143434|NCT02409901|Employment|employment
143435|NCT02409901|Kidney Transplant|kidney transplant
143436|NCT02409875|early intervention|early intervention
143437|NCT02409875|obesity|obesity
143439|NCT02409875|body mass index|body mass index
143440|NCT02409875|overnutrition|overnutrition
143441|NCT02409875|early promoters, genetic|early promoters, genetic
143442|NCT02409862|oxytocin|oxytocin
143443|NCT02409862|socioemotional functioning|socioemotional functioning
143444|NCT02409862|aging|aging
143445|NCT02409849|Octreotide LAR|octreotide lar
143446|NCT02409849|Neuroendocrine carcinomas|neuroendocrine carcinomas
143447|NCT02409849|unresectable or metastatic|unresectable or metastatic
143448|NCT02409849|Disease-free survival|disease-free survival
143449|NCT02409823|adverse drug reactions|adverse drug reactions
143450|NCT02409823|adherence to treatment|adherence to treatment
143451|NCT02409823|quality of life|quality of life
143452|NCT02409823|clinical status|clinical status
143453|NCT02409784|Brain metabolism|brain metabolism
143454|NCT02409784|Ketones|ketones
143455|NCT02409784|Ketogenic diet|ketogenic diet
143456|NCT02409784|TEP scan|tep scan
143457|NCT02409758|Voice disorders|voice disorders
143458|NCT02409758|Hoarseness|hoarseness
143459|NCT02409758|Therapy|therapy
143460|NCT02409745|endometrial scratch|endometrial scratch
143461|NCT02409745|IVF|ivf
143462|NCT02409745|randomized controlled study|randomized controlled study
143463|NCT02409745|Prospective controlled trial|prospective controlled trial
143464|NCT02409745|Different time to perform endometrial scratch|different time to perform endometrial scratch
143465|NCT02409745|In vitro fertilization|in vitro fertilization
143466|NCT02409745|embryo transfer|embryo transfer
143467|NCT02409732|Actinic cheilitis|actinic cheilitis
143468|NCT02409732|Photodynamic therapy|photodynamic therapy
143469|NCT02409732|Levulan|levulan
143470|NCT02409732|Blue light|blue light
143471|NCT02409719|Arthritis, Degenerative|arthritis, degenerative
143472|NCT02409719|Recovery of function|recovery of function
143473|NCT02409706|Paediatric|paediatric
143474|NCT02409706|Critical care|critical care
143475|NCT02409706|Micronutrients|micronutrients
143476|NCT02409680|Preterm birth|preterm birth
143477|NCT02409680|Low dose aspirin|low dose aspirin
143478|NCT02409667|plaque, psoriasis|plaque, psoriasis
143479|NCT02409641|IOL|iol
143480|NCT02409628|Non-melanoma Skin Cancer|non-melanoma skin cancer
143481|NCT02409628|Basal Cell Carcinoma|basal cell carcinoma
143482|NCT02409628|Squamous Cell Carcinoma|squamous cell carcinoma
143483|NCT02409628|Surgical excision|surgical excision
143484|NCT02409628|EktoTherix|ektotherix
143485|NCT02409628|Secondary intention healing|secondary intention healing
143486|NCT02409628|Acute wound repair|acute wound repair
143487|NCT02409628|Tissue repair scaffold|tissue repair scaffold
143488|NCT02409628|Regenerative medicine scaffold|regenerative medicine scaffold
143489|NCT02409628|Electrospun scaffold|electrospun scaffold
143490|NCT02409615|Complementary therapies|complementary therapies
143491|NCT02409615|Hypnosis|hypnosis
143492|NCT02409615|Healing Touch|healing touch
143493|NCT02409602|Ultrasonography, Doppler, Color|ultrasonography, doppler, color
143494|NCT02409602|Postpartum hemorrhage|postpartum hemorrhage
143495|NCT02409602|Bilateral iliac artery ligation|bilateral iliac artery ligation
143496|NCT02409602|Dorsal clitoral artery|dorsal clitoral artery
143497|NCT02409576|EWS|ews
143498|NCT02409576|OS|os
143499|NCT02409576|RMS|rms
143500|NCT02409550|Allergic Rhinitis|allergic rhinitis
143501|NCT02409550|Asthma|asthma
143502|NCT02409550|Children|children
143503|NCT02409550|Control|control
143504|NCT02409537|Asymptomatic hypercholesterolemia,|asymptomatic hypercholesterolemia,
143505|NCT02409537|cardiovascular risk,|cardiovascular risk,
143506|NCT02409537|total antioxidant capacity|total antioxidant capacity
143507|NCT02409537|red wine polyphenol content|red wine polyphenol content
143508|NCT02409537|vitamin E.|vitamin e.
143509|NCT02409537|resveratrol|resveratrol
143510|NCT02409511|Type 1 Diabetic|type 1 diabetic
143511|NCT02409511|Type 2 Diabetic|type 2 diabetic
143512|NCT02409511|Hypertension|hypertension
143513|NCT02409511|Renal Injury|renal injury
143514|NCT02409511|Diabetic retinopathy|diabetic retinopathy
143515|NCT02409498|pudendal nerve block|pudendal nerve block
143516|NCT02409498|vaginal reconstructive surgery|vaginal reconstructive surgery
143517|NCT02409485|self-management|self-management
143518|NCT02409485|head and neck cancer|head and neck cancer
143519|NCT02409485|psychosocial intervention|psychosocial intervention
143520|NCT02409485|couples|couples
143521|NCT02409472|randomized clinical trial|randomized clinical trial
143522|NCT02409433|lacosamide|lacosamide
143523|NCT02409433|phenytoin|phenytoin
143524|NCT02409394|Subjects|subjects
143525|NCT02409303|Autism Spectrum Disorder|autism spectrum disorder
143526|NCT02409303|Screening|screening
143527|NCT02409303|Preventive intervention|preventive intervention
143529|NCT02409277|Self-Management|self-management
143530|NCT02409277|Asthma|asthma
143531|NCT02409264|Insomnia|insomnia
143532|NCT02409264|Females|females
143533|NCT02409264|Homeopathy|homeopathy
143534|NCT02409251|Antinuclear antibody (ANA)|antinuclear antibody (ana)
143535|NCT02409251|Overuse|overuse
143536|NCT02409251|Rheumatologists|rheumatologists
143537|NCT02409251|Quality of care|quality of care
143538|NCT02409238|Mild Cognitive Impairment|mild cognitive impairment
143539|NCT02409238|Insulin Resistance|insulin resistance
143540|NCT02409238|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
143541|NCT02409225|remote monitoring|remote monitoring
143542|NCT02409225|ICD|icd
143543|NCT02409225|CRT-D|crt-d
143544|NCT02409199|Gastric Carcinoma|gastric carcinoma
143545|NCT02409199|apatinib|apatinib
143546|NCT02409173|Metabolic syndrome|metabolic syndrome
143547|NCT02409173|Sleep disorders|sleep disorders
143548|NCT02409173|Bariatric Surgery|bariatric surgery
143549|NCT02409173|Noninvasive ventilation|noninvasive ventilation
143550|NCT02409173|Inflammation|inflammation
143551|NCT02409173|Quality of life|quality of life
143552|NCT02409160|Severe Obesity|severe obesity
143553|NCT02409160|Sleep Disorders|sleep disorders
143554|NCT02409160|Bariatric Surgery|bariatric surgery
143555|NCT02409160|Inflammation|inflammation
143556|NCT02409160|Quality of Life|quality of life
143557|NCT02409134|Bone Marrow Transplantation|bone marrow transplantation
143558|NCT02409134|Hematologic Malignancies|hematologic malignancies
143559|NCT02409134|Adults|adults
143560|NCT02409134|Cognition|cognition
143561|NCT02409121|hematopoietic cell transplantation|hematopoietic cell transplantation
143562|NCT02409121|caregivers|caregivers
143563|NCT02409121|health information technology|health information technology
143564|NCT02409121|patient-centered care|patient-centered care
143565|NCT02409069|Transcutaneous vagus nerve stimulation|transcutaneous vagus nerve stimulation
143566|NCT02409069|P300|p300
143567|NCT02409069|Memory task|memory task
143568|NCT02409056|intervention|intervention
143569|NCT02409056|translation|translation
143570|NCT02409056|workplace|workplace
143572|NCT02409056|CDSMP|cdsmp
143573|NCT02409043|Stroke|stroke
143575|NCT02409043|Hemorrhagic stroke|hemorrhagic stroke
143576|NCT02409043|Biomarkers|biomarkers
143577|NCT02409043|Angiotensins|angiotensins
143578|NCT02409017|insulin drip|insulin drip
143579|NCT02409017|labor|labor
143580|NCT02409004|Drug-drug interaction|drug-drug interaction
143581|NCT02408991|Chronic lower limb ischemia|chronic lower limb ischemia
143582|NCT02408991|Art-Assist Device|art-assist device
143583|NCT02408991|Neupogen|neupogen
143584|NCT02408926|Pertussis|pertussis
143585|NCT02408926|Pregnancy|pregnancy
143586|NCT02408926|Humoral immune response|humoral immune response
143587|NCT02408926|Functionality|functionality
143588|NCT02408926|Vaccination|vaccination
143589|NCT02408913|Immunity|immunity
143590|NCT02408913|Ebola Virus|ebola virus
143591|NCT02408913|Ebola Hemorrhagic Fever|ebola hemorrhagic fever
143592|NCT02408913|Healthy|healthy
143593|NCT02408913|Filovirus|filovirus
143594|NCT02408900|Spasticity|spasticity
143595|NCT02408900|Primary Lateral Sclerosis|primary lateral sclerosis
143596|NCT02408900|Elastography|elastography
143597|NCT02408900|Ultrasound|ultrasound
143598|NCT02408887|Thyroidectomy|thyroidectomy
143599|NCT02408887|pCND|pcnd
143600|NCT02408887|QOL|qol
143601|NCT02408887|Outcomes|outcomes
143614|NCT02408796|Acute otitis media with tympanostomy tubes|acute otitis media with tympanostomy tubes
143616|NCT02408757|cerebral perfusion|cerebral perfusion
143617|NCT02408757|cerebrospinal fluid drainage|cerebrospinal fluid drainage
143618|NCT02408744|nephroprotection|nephroprotection
143619|NCT02408744|pirfenidone|pirfenidone
143620|NCT02408744|polymorphisms|polymorphisms
143621|NCT02408718|Mobility|mobility
143622|NCT02408718|walking aids|walking aids
143623|NCT02408718|falls|falls
143624|NCT02408718|gait and balance|gait and balance
143625|NCT02408705|Endogenous Glucose Production|endogenous glucose production
143626|NCT02408705|Hypoglycemic clamp|hypoglycemic clamp
143627|NCT02408705|Tracer to Tracee Technique|tracer to tracee technique
143628|NCT02408705|Type 1 diabetes mellitus|type 1 diabetes mellitus
143629|NCT02408692|Emergency contraception|emergency contraception
143630|NCT02408692|Obese BMI|obese bmi
143631|NCT02408692|Normal BMI|normal bmi
143632|NCT02408679|Vitamin D|vitamin d
143633|NCT02408679|Vitamin D Deficiency|vitamin d deficiency
143634|NCT02408679|Vitamin D Insufficiency|vitamin d insufficiency
143635|NCT02408679|Healthy adults|healthy adults
143636|NCT02408679|Predictive questionnaire|predictive questionnaire
143637|NCT02408640|Internet-Based|internet-based
143638|NCT02408640|Treatment|treatment
143646|NCT02408536|chemotherapy|chemotherapy
143647|NCT02408536|hormone therapy|hormone therapy
143648|NCT02408536|borderline|borderline
143649|NCT02408536|low-grade|low-grade
143650|NCT02408536|serous ovarian cancer|serous ovarian cancer
143659|NCT02408471|Arthritis|arthritis
143660|NCT02408471|Rheumatoid Arthritis|rheumatoid arthritis
143661|NCT02408471|Systemic Lupus Erythematosus|systemic lupus erythematosus
143662|NCT02408471|Osteoarthritis|osteoarthritis
143663|NCT02408471|Autoimmune Diseases|autoimmune diseases
143664|NCT02408471|Connective Tissue Diseases|connective tissue diseases
143665|NCT02408471|Immune System Diseases|immune system diseases
143666|NCT02408471|Joint Diseases|joint diseases
143667|NCT02408471|Musculoskeletal Diseases|musculoskeletal diseases
143668|NCT02408471|Rheumatic Diseases|rheumatic diseases
143669|NCT02408445|body composition|body composition
143670|NCT02408445|Klinefelter syndrome|klinefelter syndrome
144384|NCT02404181|EEG|eeg
143672|NCT02408445|sex chromosome variation|sex chromosome variation
143673|NCT02408445|sex chromsome aneuploidy|sex chromsome aneuploidy
143674|NCT02408432|Blood And Marrow Transplantation|blood and marrow transplantation
143675|NCT02408432|Left ventricular dysfunction|left ventricular dysfunction
143676|NCT02408432|LV|lv
143677|NCT02408432|Heart failure secondary to chemotherapy with anthracyclines|heart failure secondary to chemotherapy with anthracyclines
143678|NCT02408432|Allogeneic human mesenchymal stem cells|allogeneic human mesenchymal stem cells
143679|NCT02408432|hMSCs|hmscs
143680|NCT02408432|Standard of care drugs for heart failure|standard of care drugs for heart failure
143681|NCT02408406|TNM Finding v7|tnm finding v7
143682|NCT02408393|Surgery|surgery
143683|NCT02408393|Paravertebral block|paravertebral block
143684|NCT02408393|Chronic pain|chronic pain
143685|NCT02408380|biomarker|biomarker
143686|NCT02408380|disease progression|disease progression
143687|NCT02408367|Training|training
143688|NCT02408367|Cognition|cognition
143689|NCT02408367|Multiple Sclerosis|multiple sclerosis
143690|NCT02408341|Propofol, Induction anesthesia, Doppler tissue imaging|propofol, induction anesthesia, doppler tissue imaging
134573|NCT02459184|poverty|poverty
134574|NCT02459184|income|income
134575|NCT02459184|health promotion|health promotion
134576|NCT02459132|High-intensity interval training|high-intensity interval training
134577|NCT02459132|VO2peak|vo2peak
134578|NCT02459132|Brachial flow-mediated dilation|brachial flow-mediated dilation
134579|NCT02459132|Carotid-femoral pulse wave velocity|carotid-femoral pulse wave velocity
143691|NCT02408315|induction of labor|induction of labor
143692|NCT02408315|safety|safety
143693|NCT02408315|pharmacokinetic|pharmacokinetic
143694|NCT02408315|misoprostol|misoprostol
143695|NCT02408250|algorithm|algorithm
143696|NCT02408250|critical illness|critical illness
143697|NCT02408250|early exercise|early exercise
143698|NCT02408250|feasibility|feasibility
143699|NCT02408250|intensive care unit|intensive care unit
143700|NCT02408250|physical therapy|physical therapy
143701|NCT02408237|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
143702|NCT02408237|tDCS for domiciliary use|tdcs for domiciliary use
143703|NCT02408237|Healthy Participants|healthy participants
143704|NCT02408224|ACS|acs
143705|NCT02408185|infections|infections
143706|NCT02408185|multidrug resistant Gram negative bacteria (MDR-GNB)|multidrug resistant gram negative bacteria (mdr-gnb)
143707|NCT02408185|Skin infections|skin infections
143708|NCT02408185|Pneumonia|pneumonia
143709|NCT02408185|Bacteriemia|bacteriemia
143710|NCT02408185|Nosocomial infections|nosocomial infections
143711|NCT02408172|hypertension|hypertension
143712|NCT02408172|Sleep apnea syndrome|sleep apnea syndrome
143713|NCT02408172|Amlodipine|amlodipine
143714|NCT02408172|metoprolol|metoprolol
143715|NCT02408159|Live, attenuated virus varicella-zoster vaccine|live, attenuated virus varicella-zoster vaccine
143716|NCT02408159|Zostavax|zostavax
143717|NCT02408159|herpes zoster|herpes zoster
143718|NCT02408159|shingles|shingles
143719|NCT02408133|Breast Cancer|breast cancer
143720|NCT02408133|elderly|elderly
143721|NCT02408133|quality of life|quality of life
143722|NCT02408133|exercise|exercise
143723|NCT02408120|Hyperglycemia|hyperglycemia
143724|NCT02408120|Hypoglycemia|hypoglycemia
143725|NCT02408107|Physical activity|physical activity
143726|NCT02408107|Randomized controlled trial|randomized controlled trial
143727|NCT02408094|Rheumatoid Arthritis|rheumatoid arthritis
143728|NCT02408094|Heat-dampness and blood stasis syndrome|heat-dampness and blood stasis syndrome
143729|NCT02408094|Protein markers|protein markers
143730|NCT02408081|Depression|depression
143731|NCT02408081|Family functioning|family functioning
143732|NCT02408081|Family Focused Nursing|family focused nursing
143733|NCT02408081|Quality of life|quality of life
143734|NCT02408068|subjects|subjects
143735|NCT02408029|Focus|focus
143736|NCT02408029|Testing Performance|testing performance
143737|NCT02408029|CORA Hemostasis System|cora hemostasis system
143738|NCT02408003|Transesophageal|transesophageal
143739|NCT02408003|Echocardiography|echocardiography
143740|NCT02408003|Milrinone|milrinone
143741|NCT02408003|Levosimendan|levosimendan
143742|NCT02408003|Strain|strain
143743|NCT02408003|Deformation|deformation
143744|NCT02408003|Diastole|diastole
143745|NCT02408003|Afterload|afterload
143746|NCT02408003|Preload|preload
143747|NCT02408003|Systole|systole
143748|NCT02407964|Drug-Induced Liver Injury|drug-induced liver injury
143749|NCT02407964|DILI|dili
143750|NCT02407938|dysphagia|dysphagia
143751|NCT02407938|reflux symptoms|reflux symptoms
143752|NCT02407938|retrosternal pain|retrosternal pain
143753|NCT02407925|Optical diagnosis|optical diagnosis
143754|NCT02407899|LADA|lada
143755|NCT02407899|saxagliptin|saxagliptin
143756|NCT02407899|vitamin D3|vitamin d3
143757|NCT02407899|C-Peptide|c-peptide
143758|NCT02407873|aged of 75 years or more|aged of 75 years or more
143759|NCT02407860|breast feeding|breast feeding
143761|NCT02407860|dysfunction|dysfunction
143762|NCT02407860|Latch assessment tool|latch assessment tool
143763|NCT02407860|visual analogic scale|visual analogic scale
144591|NCT02403154|Orthopaedic|orthopaedic
143764|NCT02407860|infant physiology|infant physiology
143765|NCT02407847|Nurse practitioners|nurse practitioners
143766|NCT02407847|Primary healthcare|primary healthcare
143767|NCT02407847|Emergency Medical Services|emergency medical services
143768|NCT02407847|Substitution of care|substitution of care
143769|NCT02407834|Biofilms|biofilms
143770|NCT02407834|Dentures|dentures
143771|NCT02407834|Denture Cleansers|denture cleansers
143772|NCT02407834|Castor Oil|castor oil
143773|NCT02407834|Stomatitis|stomatitis
143774|NCT02407821|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
143775|NCT02407821|Kidney Failure|kidney failure
143776|NCT02407821|Renal Insufficiency, Chronic|renal insufficiency, chronic
173492|NCT02239393|MSC|msc
143777|NCT02407821|Dialysis, Renal|dialysis, renal
143778|NCT02407821|Peritoneal Dialysis|peritoneal dialysis
143779|NCT02407821|Hemodialysis|hemodialysis
143780|NCT02407821|Depressive Symptoms|depressive symptoms
143781|NCT02407821|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
143782|NCT02407821|Antidepressants|antidepressants
143783|NCT02407821|Escitalopram|escitalopram
143784|NCT02407795|stereotactic radiotherapy|stereotactic radiotherapy
143785|NCT02407795|pain reduction|pain reduction
143786|NCT02407795|quality of life|quality of life
143787|NCT02407782|Scabies|scabies
143788|NCT02407782|children|children
143789|NCT02407782|cluster|cluster
143790|NCT02407782|permethrin|permethrin
143791|NCT02407782|Ivermectin|ivermectin
143792|NCT02407769|Liver transplantation|liver transplantation
143793|NCT02407769|Liver cirrhosis|liver cirrhosis
143794|NCT02407769|Branched chain amino acids|branched chain amino acids
143795|NCT02407769|Late evening supplementation|late evening supplementation
143796|NCT02407769|Nutritional status|nutritional status
143797|NCT02407756|Eczema|eczema
143798|NCT02407743|postoperative pain|postoperative pain
143800|NCT02407743|pain resolution|pain resolution
143801|NCT02407743|pain intensity|pain intensity
143802|NCT02407743|persistent postsurgical pain|persistent postsurgical pain
143803|NCT02407743|pain-related genes|pain-related genes
143804|NCT02407743|analgesic|analgesic
143805|NCT02407704|Exercise|exercise
143806|NCT02407704|Physical activity|physical activity
143807|NCT02407704|GABA|gaba
143808|NCT02407704|Venlafaxine|venlafaxine
143809|NCT02407704|fMRI|fmri
143810|NCT02407704|Spectroscopy|spectroscopy
143811|NCT02407704|Reward system|reward system
143812|NCT02407704|BDNF|bdnf
143813|NCT02407704|Sleep|sleep
143814|NCT02407704|Cognitive function|cognitive function
143815|NCT02407704|Biomarkers|biomarkers
143816|NCT02407704|Aerobic exercise|aerobic exercise
143817|NCT02407665|Tai Chi|tai chi
143818|NCT02407665|fMRI|fmri
143819|NCT02407639|insufflation|insufflation
143820|NCT02407639|abdominal pain|abdominal pain
143821|NCT02407626|ischemia|ischemia
143822|NCT02407626|cardiac surgery|cardiac surgery
143823|NCT02407626|volatile anesthetic|volatile anesthetic
143824|NCT02407626|total intravenous anesthesia|total intravenous anesthesia
143825|NCT02407613|breast cancer|breast cancer
143826|NCT02407613|MR-HIFU|mr-hifu
143827|NCT02407613|ablation|ablation
143828|NCT02407613|non-invasive treatment|non-invasive treatment
143829|NCT02407600|EMEND for Injection|emend for injection
143830|NCT02407600|5HT-3|5ht-3
143831|NCT02407600|Fosaprepitant|fosaprepitant
143832|NCT02407561|rectal|rectal
143833|NCT02407561|adenocarcinoma|adenocarcinoma
143834|NCT02407561|DecisionDx|decisiondx
143835|NCT02407548|cholesterol efflux|cholesterol efflux
143836|NCT02407548|dyslipidemia|dyslipidemia
143837|NCT02407522|Metabolic Syndrome|metabolic syndrome
143838|NCT02407522|black rice|black rice
143839|NCT02407483|Laparoscopy|laparoscopy
143840|NCT02407483|Training Programs|training programs
143841|NCT02407470|Severe Aplastic Anemia (SAA), Hematopoietic Stem Cells, HSC Transplantation|severe aplastic anemia (saa), hematopoietic stem cells, hsc transplantation
143842|NCT02407470|ATG, Mesenchymal Stem Cells, Transdifferentiation,|atg, mesenchymal stem cells, transdifferentiation,
143843|NCT02407444|Proximal hip fracture|proximal hip fracture
143844|NCT02407444|Elderly patients|elderly patients
143845|NCT02407444|Physiotherapy|physiotherapy
143846|NCT02407444|Leg cycling ergometer|leg cycling ergometer
143847|NCT02407418|spinal manipulation|spinal manipulation
143848|NCT02407418|muscle strength dynamometer|muscle strength dynamometer
143849|NCT02407418|muscle strength|muscle strength
143850|NCT02407379|Laser|laser
143851|NCT02407379|periodontitis|periodontitis
143852|NCT02407379|scaling root planing|scaling root planing
143853|NCT02407379|bacteria|bacteria
143854|NCT02407379|PMN|pmn
143855|NCT02407366|Inoperable stage III non-small cell lung cancer|inoperable stage iii non-small cell lung cancer
143856|NCT02407366|EGFR mutation|egfr mutation
143857|NCT02407366|Icotinib|icotinib
143858|NCT02407366|Radiotherapy|radiotherapy
143859|NCT02407366|Chemoradiotherapy|chemoradiotherapy
143861|NCT02407353|Double blind|double blind
143862|NCT02407353|Placebo-Controlled|placebo-controlled
143863|NCT02407353|Parallel Design|parallel design
143864|NCT02407353|CSF Aβ Concentrations|csf aβ concentrations
143865|NCT02407353|PF-06648671|pf-06648671
143866|NCT02407340|Alcohol Withdrawal Delirium|alcohol withdrawal delirium
143867|NCT02407327|Circulating tumour cells in Advanced Non Small Cell Lung Cancer|circulating tumour cells in advanced non small cell lung cancer
143868|NCT02407314|Peripheral Arterial Disease|peripheral arterial disease
143869|NCT02407314|Optical Coherence Tomography|optical coherence tomography
143870|NCT02407314|Ticagrelor|ticagrelor
143871|NCT02407314|Aspirin|aspirin
143872|NCT02407314|Claudication|claudication
143873|NCT02407314|Clopidogrel|clopidogrel
143874|NCT02407288|OCD|ocd
143876|NCT02407262|black seed|black seed
143877|NCT02407262|Nigella sativa|nigella sativa
143878|NCT02407262|supplementation|supplementation
143879|NCT02407236|Ustekinumab|ustekinumab
143880|NCT02407236|Inflammatory Bowel Diseases (IBD)|inflammatory bowel diseases (ibd)
143881|NCT02407236|Colitis, Ulcerative|colitis, ulcerative
143882|NCT02407223|Nonradiographic Axial Spondylitis, Ankylosing|nonradiographic axial spondylitis, ankylosing
143883|NCT02407223|Ustekinumab|ustekinumab
143884|NCT02407210|Azilsartan，Olmesartan Medoxomil|azilsartan，olmesartan medoxomil
143885|NCT02407197|T1 mapping|t1 mapping
143886|NCT02407197|CMR|cmr
143887|NCT02407197|Outcome|outcome
143888|NCT02407197|multicenter|multicenter
143889|NCT02407184|Microbiota|microbiota
143890|NCT02407184|Microbiome|microbiome
143891|NCT02407145|retropubic|retropubic
143892|NCT02407145|midurethral sling|midurethral sling
143893|NCT02407145|polyvinylidene fluoride|polyvinylidene fluoride
143894|NCT02407119|H. pylori eradication|h. pylori eradication
143895|NCT02407119|Atrophy|atrophy
143896|NCT02407119|Intestinal metaplasia|intestinal metaplasia
143897|NCT02407119|Endoscopic resection|endoscopic resection
143898|NCT02407106|BLIS K12|blis k12
143899|NCT02407106|streptococcus|streptococcus
143900|NCT02407093|Body Composition|body composition
143901|NCT02407093|Military|military
143902|NCT02407093|High-Intensity Functional Training|high-intensity functional training
143903|NCT02407093|Army Physical Fitness|army physical fitness
143904|NCT02407093|CrossFit|crossfit
143905|NCT02407002|Nitroglycerin|nitroglycerin
143907|NCT02406976|Exercise|exercise
143908|NCT02406976|Morbidity Obesity|morbidity obesity
143909|NCT02406963|telemedicine|telemedicine
143910|NCT02406950|Sitagliptin|sitagliptin
143911|NCT02406950|Endothelium|endothelium
143912|NCT02406950|Ischemia-Reperfusion Injury|ischemia-reperfusion injury
143913|NCT02406950|human|human
143914|NCT02406924|pin|pin
143915|NCT02406924|particulated graft|particulated graft
143916|NCT02406924|bone augmentation|bone augmentation
143917|NCT02406924|vertical augmentation|vertical augmentation
143918|NCT02406924|horizontal augmentation|horizontal augmentation
143919|NCT02406911|platelet|platelet
143920|NCT02406911|ticagrelor|ticagrelor
143921|NCT02406911|clopidogrel|clopidogrel
143922|NCT02406911|end stage renal disease|end stage renal disease
143923|NCT02406911|hemodialysis|hemodialysis
143924|NCT02406859|Spinal Cord Injury|spinal cord injury
143925|NCT02406859|Constipation|constipation
143926|NCT02406859|Fecal Incontinence|fecal incontinence
143927|NCT02406859|Neurogenic Bowel|neurogenic bowel
143928|NCT02406859|Bowel Biofeedback|bowel biofeedback
143929|NCT02406859|Manometry|manometry
143930|NCT02406846|Pancreatic Neoplasms|pancreatic neoplasms
143931|NCT02406846|Circulating Tumor Cells|circulating tumor cells
143932|NCT02406833|glaucoma|glaucoma
143933|NCT02406833|trabeculectomy|trabeculectomy
143934|NCT02406807|chronic low back pain|chronic low back pain
143935|NCT02406807|HVLA manipulation|hvla manipulation
143936|NCT02406794|Breast cancer|breast cancer
143937|NCT02406794|Hormonal therapy|hormonal therapy
143938|NCT02406794|Aromatase inhibitors|aromatase inhibitors
143939|NCT02406794|Estrogen deprivation|estrogen deprivation
143940|NCT02406794|Myalgia|myalgia
143941|NCT02406794|Arthralgia|arthralgia
143942|NCT02406794|Carpal tunnel syndrome|carpal tunnel syndrome
143943|NCT02406794|Pressure pain threshold|pressure pain threshold
143944|NCT02406794|Neuromuscular taping|neuromuscular taping
143945|NCT02406794|Kinesio taping|kinesio taping
143946|NCT02406781|Efficacy of MK 3475 with Metronomic Cyclophosphamide|efficacy of mk 3475 with metronomic cyclophosphamide
143947|NCT02406781|Advanced Sarcomas|advanced sarcomas
143948|NCT02406781|Leiomyosarcoma|leiomyosarcoma
143949|NCT02406781|Undifferentiated Sarcoma|undifferentiated sarcoma
143950|NCT02406781|Other Sarcoma|other sarcoma
143951|NCT02406781|GIST|gist
143952|NCT02406781|Osteosarcoma|osteosarcoma
143953|NCT02406768|normal controls|normal controls
143954|NCT02406742|CC-122|cc-122
143955|NCT02406742|Pharmacokinetics|pharmacokinetics
143956|NCT02406742|Safety|safety
143957|NCT02406742|Ibrutinib|ibrutinib
143958|NCT02406742|Obinutuzumab|obinutuzumab
143959|NCT02406742|GA101|ga101
143960|NCT02406742|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
143961|NCT02406742|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
143962|NCT02406703|local anesthesia|local anesthesia
143963|NCT02406703|regional anesthetic|regional anesthetic
143964|NCT02406690|Endometrial Insufficiency|endometrial insufficiency
143965|NCT02406690|Endometrial Receptivity|endometrial receptivity
144067|NCT02405884|Low Tension Glaucoma|low tension glaucoma
143966|NCT02406677|Acute Coronary Syndromes, ACS, Myocardial Infarction, STEMI, NSTEMI, MI, Co-Payments, Copay, Cost Sharing|acute coronary syndromes, acs, myocardial infarction, stemi, nstemi, mi, co-payments, copay, cost sharing
143967|NCT02406638|3D Pelvic floor USG|3d pelvic floor usg
143968|NCT02406638|Mid-Urethral Sling|mid-urethral sling
143970|NCT02406638|TVT-O|tvt-o
143971|NCT02406638|TVT-S|tvt-s
143972|NCT02406612|Vascular Closure Device|vascular closure device
143973|NCT02406612|Femoral Artery Closure|femoral artery closure
143974|NCT02406573|Sensitivity|sensitivity
143975|NCT02406547|Serrated lesion|serrated lesion
143976|NCT02406547|sessile serrated adenoma|sessile serrated adenoma
143977|NCT02406547|Narrow Band Imaging|narrow band imaging
143978|NCT02406547|Colonoscopy|colonoscopy
143979|NCT02406547|colorectal neoplasms|colorectal neoplasms
143980|NCT02406521|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
143981|NCT02406521|mRCC|mrcc
143982|NCT02406482|sex work, Kazakhstan, microfinance, drug use|sex work, kazakhstan, microfinance, drug use
143983|NCT02406443|Type 2 Diabetes, DPP-4 inhibitors, renal sodium excretion|type 2 diabetes, dpp-4 inhibitors, renal sodium excretion
143984|NCT02406339|Physical Therapy|physical therapy
143985|NCT02406339|Rehabilitation|rehabilitation
143986|NCT02406339|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
143987|NCT02406339|Muscle Strength|muscle strength
143988|NCT02406300|Hip Fracture|hip fracture
143989|NCT02406300|Regional Anesthesia|regional anesthesia
143990|NCT02406300|Peripheral Nerve Blocks|peripheral nerve blocks
143991|NCT02406300|Post-operative Mortality|post-operative mortality
143992|NCT02406300|Cognitive Dysfunction|cognitive dysfunction
143993|NCT02406300|Quality of Life|quality of life
143994|NCT02406274|Mammography|mammography
143995|NCT02406274|Contrast Enhanced Spectral Mammography|contrast enhanced spectral mammography
143996|NCT02406274|Palpable Breast Abnormalities|palpable breast abnormalities
143998|NCT02406248|NSTEMI|nstemi
143999|NCT02406222|Relapsed|relapsed
144000|NCT02406222|Refractory|refractory
144001|NCT02406222|Pomalidomide|pomalidomide
144002|NCT02406222|Dexamethasone|dexamethasone
144003|NCT02406222|Cyclophosphamide|cyclophosphamide
144004|NCT02406209|uveitis|uveitis
144005|NCT02406209|acute uveitis|acute uveitis
144006|NCT02406209|anterior uveitis|anterior uveitis
144007|NCT02406209|NS2|ns2
144008|NCT02406209|Aldeyra|aldeyra
144009|NCT02406209|prednisolone acetate|prednisolone acetate
144010|NCT02406157|diabetic macular edema|diabetic macular edema
144011|NCT02406157|micropulse|micropulse
144012|NCT02406157|laser|laser
144013|NCT02406157|subthreshold|subthreshold
144014|NCT02406144|Multiple Myeloma|multiple myeloma
144015|NCT02406131|Peripheral Vascular Diseases|peripheral vascular diseases
144016|NCT02406131|Ischemic Preconditioning|ischemic preconditioning
144017|NCT02406131|Inflammation|inflammation
144018|NCT02406131|Angioplasty|angioplasty
144019|NCT02406131|Restenosis|restenosis
144020|NCT02406131|RCT|rct
144021|NCT02406118|transanal TME quality|transanal tme quality
144022|NCT02406118|CRM|crm
144023|NCT02406105|tremor|tremor
144024|NCT02406105|Parkinson disease|parkinson disease
144025|NCT02406105|functional radioablation|functional radioablation
144026|NCT02406105|Cyber Knife radiosurgery|cyber knife radiosurgery
144027|NCT02406079|tracheotomy|tracheotomy
144028|NCT02406079|procalcitonin|procalcitonin
144029|NCT02406079|sepsis|sepsis
144030|NCT02406053|lung cancer|lung cancer
144031|NCT02406053|antioxidants|antioxidants
144032|NCT02406053|oxidative damage|oxidative damage
144033|NCT02406040|Protein synthesis|protein synthesis
144034|NCT02406040|Protein breakdown|protein breakdown
144035|NCT02406040|Muscle|muscle
144036|NCT02406040|Energy restriction|energy restriction
144037|NCT02406027|Alzheimer's Disease|alzheimer's disease
144038|NCT02406027|JNJ-54861911|jnj-54861911
144039|NCT02406027|Placebo|placebo
144040|NCT02406001|peri-implantitis|peri-implantitis
144041|NCT02406001|osseous defects|osseous defects
144042|NCT02406001|implant surface decontamination|implant surface decontamination
144043|NCT02406001|bone grafting|bone grafting
144044|NCT02406001|surgical therapy|surgical therapy
144045|NCT02406001|porous titanium granules|porous titanium granules
144046|NCT02406001|reconstruction|reconstruction
144047|NCT02405988|Emergency Treatment|emergency treatment
144048|NCT02405988|Morphine Derivates|morphine derivates
144049|NCT02405988|Heroin|heroin
144050|NCT02405988|Antidotes|antidotes
144051|NCT02405988|Administration, Intravenous|administration, intravenous
144052|NCT02405988|Pharmacology|pharmacology
144053|NCT02405988|Naloxone|naloxone
144054|NCT02405988|Healthy volunteers|healthy volunteers
144055|NCT02405962|Acceptance and Commitment Therapy|acceptance and commitment therapy
144056|NCT02405962|Childhood asthma|childhood asthma
144057|NCT02405962|Randomized controlled trial|randomized controlled trial
144060|NCT02405910|non-squamous|non-squamous
144061|NCT02405910|first line therapy|first line therapy
144062|NCT02405897|flexible bronchoscopy|flexible bronchoscopy
144063|NCT02405897|transbronchial lung biopsy|transbronchial lung biopsy
144064|NCT02405897|forceps|forceps
144065|NCT02405884|Glaucoma|glaucoma
144066|NCT02405884|Renal Insufficiency, Chronic|renal insufficiency, chronic
144068|NCT02405884|Ocular Hypertension|ocular hypertension
144069|NCT02405858|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
144070|NCT02405858|Abiraterone Acetate|abiraterone acetate
144071|NCT02405858|ZYTIGA|zytiga
144072|NCT02405858|Prednisolone|prednisolone
144176|NCT02405247|TKI|tki
144073|NCT02405845|Atherosclerosis|atherosclerosis
144074|NCT02405845|Internal Carotid Artery|internal carotid artery
144075|NCT02405845|Free-floating thrombus|free-floating thrombus
134980|NCT02456701|CDX3379|cdx3379
144076|NCT02405845|Ulcerated plaque|ulcerated plaque
144078|NCT02405819|Cancer|cancer
144079|NCT02405819|Oncology|oncology
144080|NCT02405819|Survivorship|survivorship
144081|NCT02405819|Care|care
144082|NCT02405819|Plan|plan
144083|NCT02405780|Rheumatoid|rheumatoid
144084|NCT02405780|Arthritis|arthritis
144085|NCT02405767|Diabetic foot ulcer|diabetic foot ulcer
144086|NCT02405754|CAD|cad
144087|NCT02405754|Clinical Utility|clinical utility
144088|NCT02405754|Personalized Medicine|personalized medicine
144089|NCT02405728|PICC|picc
144090|NCT02405728|BLOODSTREAM INFECTIONS|bloodstream infections
144091|NCT02405728|VASCULAR ACCESS|vascular access
144092|NCT02405702|Infection|infection
144093|NCT02405702|Knee|knee
144094|NCT02405702|knee replacement|knee replacement
144095|NCT02405676|Lymphoma|lymphoma
144096|NCT02405676|non-Hodgkin|non-hodgkin
144097|NCT02405676|B-lymphocytes|b-lymphocytes
144098|NCT02405676|Child|child
144099|NCT02405676|Multicenter study|multicenter study
144100|NCT02405663|blood loss|blood loss
144101|NCT02405663|caesarean section|caesarean section
144102|NCT02405663|placental delivery|placental delivery
144103|NCT02405650|CKD, chronic kidney disease, CRIC|ckd, chronic kidney disease, cric
144104|NCT02405637|Feeding intolerance|feeding intolerance
144105|NCT02405637|Simulated amniotic fluid|simulated amniotic fluid
144106|NCT02405637|Necrotizing enterocolitis|necrotizing enterocolitis
144107|NCT02405585|Pancreatic Cancer|pancreatic cancer
144108|NCT02405585|Immunotherapy|immunotherapy
144109|NCT02405585|Vaccine Therapy|vaccine therapy
144110|NCT02405572|formula-fed|formula-fed
144111|NCT02405572|infants|infants
144112|NCT02405546|Nasal intubation|nasal intubation
144113|NCT02405546|Counterclockwise rotation|counterclockwise rotation
144114|NCT02405533|AHCC|ahcc
144115|NCT02405533|nutritional supplement|nutritional supplement
144116|NCT02405533|HPV|hpv
144117|NCT02405520|human papillomavirus vaccine|human papillomavirus vaccine
144118|NCT02405520|condylomata acuminata|condylomata acuminata
144119|NCT02405507|Gastrointestinal Discomfort|gastrointestinal discomfort
144120|NCT02405507|Wheat germ|wheat germ
144121|NCT02405507|Constipation|constipation
144122|NCT02405507|Glycaemic Index|glycaemic index
144123|NCT02405507|Blood Cholesterol Level|blood cholesterol level
144124|NCT02405507|Glycaemic Response|glycaemic response
144125|NCT02405507|Cholesterol|cholesterol
144126|NCT02405507|PAC-SYM|pac-sym
144127|NCT02405507|Gut Microbiota|gut microbiota
144128|NCT02405468|blood microbiota|blood microbiota
144129|NCT02405468|coronary disease|coronary disease
144130|NCT02405468|myocardial infarction|myocardial infarction
144131|NCT02405455|cervical incompetence|cervical incompetence
144132|NCT02405455|cerclage|cerclage
144133|NCT02405455|cervical pessary|cervical pessary
144134|NCT02405416|Hepatocellular Carcinoma|hepatocellular carcinoma
144135|NCT02405416|Blood Loss|blood loss
144136|NCT02405416|Haemorrhage|haemorrhage
144137|NCT02405416|Vascular Control|vascular control
144138|NCT02405403|amyotrophic lateral sclerosis disease|amyotrophic lateral sclerosis disease
144139|NCT02405403|PET|pet
144140|NCT02405403|microglial activation|microglial activation
144141|NCT02405390|Storz C-Mac®|storz c-mac®
144142|NCT02405390|Pediatric Airway|pediatric airway
144143|NCT02405390|Cervical Spine Injury|cervical spine injury
144144|NCT02405390|Trauma Airway Management|trauma airway management
144145|NCT02405377|contrast-induced nephropathy|contrast-induced nephropathy
144146|NCT02405377|hydration|hydration
144147|NCT02405377|Percutaneous coronary intervention|percutaneous coronary intervention
144148|NCT02405364|Multiple Myeloma|multiple myeloma
144149|NCT02405364|Carfilzomib|carfilzomib
144150|NCT02405364|Lenalidomide|lenalidomide
144151|NCT02405364|Dexamethasone|dexamethasone
144152|NCT02405364|Patient up to 65 years|patient up to 65 years
144153|NCT02405364|initial management|initial management
144154|NCT02405351|Telemedicine, Stroke, Working Memory, Cognitive Training|telemedicine, stroke, working memory, cognitive training
144155|NCT02405338|AML|aml
144159|NCT02405325|older adults|older adults
144160|NCT02405312|communication|communication
144161|NCT02405312|palliative care|palliative care
144163|NCT02405299|child|child
144164|NCT02405299|disorders inhibition|disorders inhibition
144165|NCT02405299|neuropsychology|neuropsychology
144166|NCT02405299|rehabilitation|rehabilitation
144167|NCT02405299|ADHD|adhd
144168|NCT02405299|assessment of neurocognitive rehabilitations in ADHD in children|assessment of neurocognitive rehabilitations in adhd in children
144169|NCT02405273|Lung Cancer|lung cancer
144170|NCT02405273|Surgery|surgery
144171|NCT02405273|COPD|copd
144172|NCT02405273|Rehabilitation|rehabilitation
144173|NCT02405247|NSCLC|nsclc
144174|NCT02405247|T790M|t790m
144175|NCT02405247|EGFR|egfr
144177|NCT02405247|Resistance|resistance
144178|NCT02405247|Non Small Cell Lung Cancer|non small cell lung cancer
144179|NCT02405247|AZD9291|azd9291
144180|NCT02405234|Radial Head Arthroplasty|radial head arthroplasty
144181|NCT02405182|Magnetic Resonance Imaging|magnetic resonance imaging
144182|NCT02405182|MRI|mri
144183|NCT02405182|Biomarker|biomarker
144184|NCT02405169|Implantology|implantology
144185|NCT02405169|oral surgery|oral surgery
144186|NCT02405169|bone level changes|bone level changes
144187|NCT02405169|marginal bone level|marginal bone level
144188|NCT02405156|Letrozole|letrozole
144189|NCT02405156|misoprostol|misoprostol
144190|NCT02405156|second trimester miscarriage|second trimester miscarriage
144191|NCT02405143|Controlled clinical trial|controlled clinical trial
144192|NCT02405143|Electric Stimulation Therapy|electric stimulation therapy
144193|NCT02405117|Bipolar Disorder|bipolar disorder
144194|NCT02405117|Behavior Therapy|behavior therapy
144195|NCT02405117|Technology Assisted|technology assisted
144196|NCT02405117|Mobile Phone|mobile phone
144197|NCT02405117|Smartphone|smartphone
144198|NCT02405104|osteoarthritis|osteoarthritis
144199|NCT02405104|hip|hip
144200|NCT02405104|knee|knee
144201|NCT02405104|total hip arthroplasty|total hip arthroplasty
144202|NCT02405104|total knee arthroplasty|total knee arthroplasty
144203|NCT02405104|post operative pain management|post operative pain management
144204|NCT02405078|Lymphoma|lymphoma
144205|NCT02405078|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
144206|NCT02405078|DLBCL|dlbcl
144207|NCT02405078|Relapsed/Refractory|relapsed/refractory
144208|NCT02405078|Fluorodeoxyglucose-positron emission tomography/computed tomography|fluorodeoxyglucose-positron emission tomography/computed tomography
144209|NCT02405078|FDG-PET/CT|fdg-pet/ct
144210|NCT02405078|18F-Fluorodeoxyglucose|18f-fluorodeoxyglucose
144211|NCT02405078|Blood draws|blood draws
144212|NCT02405078|Chemotherapy|chemotherapy
144213|NCT02405039|DED|ded
144214|NCT02405039|Disease|disease
144215|NCT02405013|Africa|africa
144216|NCT02405013|Hepatitis C|hepatitis c
144217|NCT02405013|HIV|hiv
144218|NCT02405013|Antiviral treatment|antiviral treatment
144219|NCT02405013|Adults|adults
144220|NCT02405013|HCV genotype 1|hcv genotype 1
144221|NCT02405013|HCV genotype 2|hcv genotype 2
144222|NCT02405013|HCV genotype 4|hcv genotype 4
144223|NCT02404974|physical activity|physical activity
144224|NCT02404948|coronary artery disease|coronary artery disease
144225|NCT02404948|diagnosis|diagnosis
144226|NCT02404948|non-invasive|non-invasive
144227|NCT02404935|Metastatic colorectal cancer|metastatic colorectal cancer
144228|NCT02404935|cetuximab|cetuximab
144229|NCT02404935|maintenance|maintenance
144230|NCT02404922|Safety/Efficacy Study|safety/efficacy study
144231|NCT02404922|Randomized|randomized
144232|NCT02404922|Double Blind|double blind
144233|NCT02404883|Cancer|cancer
144234|NCT02404883|decisional conflict|decisional conflict
144235|NCT02404883|online|online
144236|NCT02404883|decision-aid tool|decision-aid tool
144237|NCT02404870|Diabetes|diabetes
144238|NCT02404870|Phosphate|phosphate
144239|NCT02404870|Fibroblast Growth Factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
144240|NCT02404870|Vitamin D|vitamin d
144241|NCT02404870|PTH|pth
144242|NCT02404857|Post stroke|post stroke
144243|NCT02404857|BCI|bci
144244|NCT02404857|Reeducation|reeducation
144245|NCT02404857|Hand movement|hand movement
144246|NCT02404831|Physiotherapy|physiotherapy
144247|NCT02404831|Pulmonary Rehabilitation|pulmonary rehabilitation
144248|NCT02404831|Exercise|exercise
144249|NCT02404831|Telerehab|telerehab
144250|NCT02404818|Radiation|radiation
144251|NCT02404818|Cardiac|cardiac
144252|NCT02404818|Hodgkin's lymphoma|hodgkin's lymphoma
144253|NCT02404805|dolutegravir|dolutegravir
144254|NCT02404805|simeprevir|simeprevir
144255|NCT02404805|HIV|hiv
144256|NCT02404805|HCV|hcv
144257|NCT02404792|Frail Elderly|frail elderly
144258|NCT02404792|IGF-1|igf-1
144259|NCT02404779|ICU|icu
144269|NCT02404766|range of movement|range of movement
144270|NCT02404753|Locally advanced gastric cancer|locally advanced gastric cancer
144271|NCT02404753|Laparoscopic distal D2 gastrectomy|laparoscopic distal d2 gastrectomy
144272|NCT02404753|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
144273|NCT02404740|VP shunted|vp shunted
144274|NCT02404740|Normal intracranial pathology|normal intracranial pathology
144275|NCT02404740|patients|patients
144276|NCT02404727|Osteoarthritis, Hip|osteoarthritis, hip
144277|NCT02404727|acetabular fixation|acetabular fixation
144278|NCT02404727|dual mobility cup|dual mobility cup
144279|NCT02404727|Radiostereometric Analysis|radiostereometric analysis
144280|NCT02404727|Dual-Energy Radiographic Absorptiometry|dual-energy radiographic absorptiometry
144281|NCT02404727|Accelerometry|accelerometry
144282|NCT02404727|total hip arthroplasty|total hip arthroplasty
144283|NCT02404727|intra-prosthetic dislocation|intra-prosthetic dislocation
144284|NCT02404662|Alcohol use disorder|alcohol use disorder
144285|NCT02404662|Depression|depression
144286|NCT02404662|Mood disorders|mood disorders
144287|NCT02404662|Bipolar disorder|bipolar disorder
144288|NCT02404662|Supportive text messages|supportive text messages
144289|NCT02404623|Vitamin D|vitamin d
144290|NCT02404623|Respiratory Morbidity|respiratory morbidity
144291|NCT02404623|prematurity|prematurity
144292|NCT02404610|propofol|propofol
144293|NCT02404610|moderate procedural sedation|moderate procedural sedation
144294|NCT02404610|deep procedural sedation|deep procedural sedation
144295|NCT02404610|memory|memory
144296|NCT02404610|emergency department|emergency department
144297|NCT02404597|Cardiac output|cardiac output
144298|NCT02404597|Low blood pressure|low blood pressure
144299|NCT02404597|Total Body Surface Area (TBSA)|total body surface area (tbsa)
144300|NCT02404584|Metastatic kidney cancer|metastatic kidney cancer
144301|NCT02404545|Hernia|hernia
144302|NCT02404545|Mesh|mesh
144303|NCT02404545|Ileal conduit|ileal conduit
144304|NCT02404532|OPC-14597 Digital|opc-14597 digital
144305|NCT02404532|Aripiprazole|aripiprazole
144306|NCT02404532|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
144307|NCT02404532|Ingestible Event Marker|ingestible event marker
144308|NCT02404519|Vitamin K|vitamin k
144309|NCT02404519|Menaquinone-7|menaquinone-7
144310|NCT02404519|Matrix Gla Protein|matrix gla protein
144311|NCT02404519|Vascular stiffness|vascular stiffness
144312|NCT02404506|Eribulin|eribulin
144313|NCT02404506|Breast Cancer|breast cancer
144314|NCT02404506|Elderly Patient|elderly patient
144315|NCT02404506|Phase II Trial|phase ii trial
144316|NCT02404506|HER2-neg|her2-neg
144317|NCT02404506|adenocarcinoma|adenocarcinoma
144318|NCT02404493|Atopic Dermatitis|atopic dermatitis
144319|NCT02404441|Phase I/II, PDR001, Checkpoint inhibitor, PD-1, PD-L1|phase i/ii, pdr001, checkpoint inhibitor, pd-1, pd-l1
144320|NCT02404428|active surveillance|active surveillance
144321|NCT02404428|MRI|mri
144322|NCT02404428|diet|diet
144323|NCT02404415|catheter ablation|catheter ablation
144324|NCT02404415|genomics|genomics
144325|NCT02404402|Traumatic Brain Injury|traumatic brain injury
144326|NCT02404402|Light Emitting Diodes|light emitting diodes
144327|NCT02404402|Cognition|cognition
144328|NCT02404402|Neuromodulation|neuromodulation
144329|NCT02404402|PTSD|ptsd
144330|NCT02404402|Neurorehabilitation|neurorehabilitation
144331|NCT02404402|Veterans|veterans
144332|NCT02404402|Sleep|sleep
144333|NCT02404389|Actinic keratosis, patients, topical, lesion count, clearance rate|actinic keratosis, patients, topical, lesion count, clearance rate
144334|NCT02404376|STEMI|stemi
144335|NCT02404376|Reperfusion Injury|reperfusion injury
144336|NCT02404376|Myocardial Infarction|myocardial infarction
144337|NCT02404376|Myocardial Ischemia|myocardial ischemia
144338|NCT02404376|Remote Ischemic Conditioning|remote ischemic conditioning
144339|NCT02404376|Exenatide|exenatide
144340|NCT02404376|Glucagon-Like Peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
144341|NCT02404376|Acute Coronary Syndrome|acute coronary syndrome
144342|NCT02404376|Cardioprotection|cardioprotection
144343|NCT02404363|Clopidogrel|clopidogrel
144344|NCT02404363|Pancreatic Cancer|pancreatic cancer
144345|NCT02404363|Efficacy|efficacy
144346|NCT02404363|Chemotherapy|chemotherapy
144347|NCT02404363|Microparticles|microparticles
144348|NCT02404363|Disease free survival|disease free survival
144349|NCT02404363|First line chemotherapy|first line chemotherapy
144350|NCT02404350|Psoriatic Arthritis, Arthritis, Psoriatic, Psoriatic Arthropathy|psoriatic arthritis, arthritis, psoriatic, psoriatic arthropathy
144351|NCT02404311|HIV|hiv
144352|NCT02404311|AIDS|aids
144353|NCT02404311|Vaccine|vaccine
144354|NCT02404298|Transcriptome analysis|transcriptome analysis
144355|NCT02404298|peripheral blood|peripheral blood
144356|NCT02404298|chronic inflammatory demyelinating polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
144357|NCT02404298|auto immune diseases|auto immune diseases
144358|NCT02404298|IVIg|ivig
144359|NCT02404272|Neonate|neonate
144360|NCT02404272|oral feeding disorder|oral feeding disorder
144361|NCT02404272|full oral feeding|full oral feeding
144362|NCT02404272|training|training
144363|NCT02404272|quality of health care|quality of health care
144364|NCT02404259|pharmacokinetics|pharmacokinetics
144365|NCT02404259|TDF|tdf
144366|NCT02404259|HIV-infected children|hiv-infected children
144367|NCT02404259|Thai|thai
144368|NCT02404259|non-nucleoside reverse transcriptase inhibitor (NNRTI)|non-nucleoside reverse transcriptase inhibitor (nnrti)
144369|NCT02404259|ritonavir-boosted protease inhibitor (bPI)|ritonavir-boosted protease inhibitor (bpi)
144370|NCT02404259|less than eighteen years old|less than eighteen years old
144371|NCT02404246|Bipolar|bipolar
144372|NCT02404246|Peers|peers
144373|NCT02404246|DBSA|dbsa
144374|NCT02404220|Syk inhibitor|syk inhibitor
144375|NCT02404220|Blood malignancy|blood malignancy
144376|NCT02404220|Leukemia|leukemia
144377|NCT02404207|Prevention|prevention
144378|NCT02404194|schizophrenia|schizophrenia
144379|NCT02404194|psychosis|psychosis
144381|NCT02404194|prodrome|prodrome
144382|NCT02404194|attenuated psychosis syndrome|attenuated psychosis syndrome
144383|NCT02404181|Validation Studies|validation studies
144385|NCT02404142|Trachel intubation|trachel intubation
144386|NCT02404142|IDS score|ids score
144387|NCT02404142|Videoaryngoscopy|videoaryngoscopy
144388|NCT02404142|Glidescope® Titanium®|glidescope® titanium®
144389|NCT02404142|NMBA|nmba
144390|NCT02404142|Curare (Atracurium)|curare (atracurium)
144391|NCT02404129|Fall|fall
144392|NCT02404129|Turn 180 test|turn 180 test
144393|NCT02404129|elderly|elderly
144394|NCT02404129|balance|balance
144395|NCT02404090|Obesity|obesity
144396|NCT02404090|Weight Loss|weight loss
144397|NCT02404090|Knee Osteoarthritis|knee osteoarthritis
144398|NCT02404090|Subchondral Mineralization|subchondral mineralization
144399|NCT02404077|Patients|patients
144400|NCT02404077|undergoing|undergoing
144401|NCT02404077|ICU|icu
144402|NCT02404051|Breast cancer|breast cancer
144403|NCT02404051|HER2Negative|her2negative
144404|NCT02404051|hormone receptor positive (HR+)|hormone receptor positive (hr+)
144405|NCT02404051|Metastatic|metastatic
144406|NCT02404051|Locally Advanced|locally advanced
144407|NCT02404051|fulvestrant|fulvestrant
144408|NCT02404051|everolimus|everolimus
144409|NCT02404051|exemestane|exemestane
144410|NCT02404038|choice|choice
144411|NCT02404038|young women|young women
144412|NCT02404038|adolescent girls|adolescent girls
144413|NCT02404038|preference|preference
144414|NCT02404025|Eltrombopag|eltrombopag
144415|NCT02404025|rabbit anti-thymocyte globulin|rabbit anti-thymocyte globulin
144416|NCT02404025|additive effect|additive effect
144417|NCT02404025|cyclosporine A|cyclosporine a
144418|NCT02404012|iron deficiency|iron deficiency
144419|NCT02404012|sleeve gastrectomy|sleeve gastrectomy
144420|NCT02404012|gastric bypass|gastric bypass
144421|NCT02404012|bariatric surgery|bariatric surgery
144422|NCT02403973|Patient hotel|patient hotel
144423|NCT02403973|Patient Satisfaction|patient satisfaction
144424|NCT02403973|Perioperative care|perioperative care
144425|NCT02403973|IN2005E|in2005e
144426|NCT02403947|Multiple Sclerosis|multiple sclerosis
144427|NCT02403947|Bone-marrow|bone-marrow
144428|NCT02403947|Stem cells|stem cells
144429|NCT02403947|Cell therapy|cell therapy
144430|NCT02403934|Airway Management|airway management
144431|NCT02403934|deep sedation|deep sedation
144432|NCT02403934|Jaw elevation device|jaw elevation device
144433|NCT02403921|biomarker|biomarker
144434|NCT02403908|radiofrequency denervation, pulmonary hypertension|radiofrequency denervation, pulmonary hypertension
144435|NCT02403882|behavioral economics|behavioral economics
144436|NCT02403882|food pantry|food pantry
144437|NCT02403882|food choice|food choice
144438|NCT02403869|Metastatic breast cancer|metastatic breast cancer
144439|NCT02403869|Monotherapy|monotherapy
144440|NCT02403869|chemotherapy|chemotherapy
144441|NCT02403869|second line|second line
144442|NCT02403869|treatment|treatment
144443|NCT02403869|Her 2 negative|her 2 negative
144444|NCT02403856|calcifying tendinitis|calcifying tendinitis
144445|NCT02403856|Needle lavage|needle lavage
144446|NCT02403856|Shoulder|shoulder
144447|NCT02403856|Corticosteroid injection|corticosteroid injection
144448|NCT02403856|Ultrasound-guided|ultrasound-guided
144450|NCT02403804|Dietary supplements|dietary supplements
144451|NCT02403804|serum choline|serum choline
144452|NCT02403804|women|women
144453|NCT02403791|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
144454|NCT02403778|Melanoma|melanoma
144455|NCT02403778|Malignant Melanoma|malignant melanoma
144456|NCT02403752|dementia|dementia
144457|NCT02403752|Alzheimer's disease|alzheimer's disease
144458|NCT02403752|exercise|exercise
144459|NCT02403739|Growth|growth
144460|NCT02403700|bone remodeling|bone remodeling
144461|NCT02403700|bone resorption|bone resorption
144462|NCT02403700|three-dimensional imaging|three-dimensional imaging
144463|NCT02403700|clinical trial|clinical trial
144464|NCT02403700|dental implant|dental implant
144465|NCT02403700|maxilla|maxilla
144466|NCT02403700|bone healing|bone healing
144467|NCT02403635|HSV|hsv
144468|NCT02403635|Herpes|herpes
144469|NCT02403635|volunteers|volunteers
144470|NCT02403635|drug-drug interaction|drug-drug interaction
144471|NCT02403609|cognitive assessment|cognitive assessment
144472|NCT02403609|Brain Performance Test|brain performance test
144473|NCT02403609|Lumosity|lumosity
144474|NCT02403609|test-retest reliability|test-retest reliability
144475|NCT02403609|computerized assessment|computerized assessment
144476|NCT02403596|Hip replacement|hip replacement
144477|NCT02403596|rivaroxaban|rivaroxaban
144478|NCT02403596|exacyl|exacyl
144479|NCT02403596|blood loss|blood loss
144480|NCT02403583|HIV Transmission|hiv transmission
144580|NCT02403193|PBF-509|pbf-509
144481|NCT02403583|Prevention of Mother to Child Transmission|prevention of mother to child transmission
144482|NCT02403583|Serodiscordancy|serodiscordancy
144483|NCT02403583|Home-based testing|home-based testing
144484|NCT02403583|Home-based counseling|home-based counseling
144485|NCT02403583|Linkage to care|linkage to care
144486|NCT02403583|Couples HIV Testing and Counseling|couples hiv testing and counseling
144487|NCT02403583|Acceptance of repeat HIV testing during pregnancy|acceptance of repeat hiv testing during pregnancy
144488|NCT02403583|Retention in care|retention in care
752598|NCT01173276|HIV Discordant|hiv discordant
144489|NCT02403570|Multiple Sclerosis, MRI, rotating frame|multiple sclerosis, mri, rotating frame
144490|NCT02403544|Clinical Trial, Phase I|clinical trial, phase i
144491|NCT02403544|Concurrent Chemoradiation|concurrent chemoradiation
144492|NCT02403544|Oxaliplatin|oxaliplatin
144493|NCT02403544|Capecitabine|capecitabine
144494|NCT02403544|Carcinoma, Hepatocellular|carcinoma, hepatocellular
144495|NCT02403531|Esophageal cancer|esophageal cancer
144496|NCT02403531|Chemoradiotherapy|chemoradiotherapy
144497|NCT02403531|induction chemotherapy|induction chemotherapy
144498|NCT02403505|Prostate Cancer|prostate cancer
144500|NCT02403505|Single Nucleotide Polymorphism|single nucleotide polymorphism
144501|NCT02403505|Genetics|genetics
144502|NCT02403505|Pharmacogenomic|pharmacogenomic
144503|NCT02403505|Pharmacogenetic|pharmacogenetic
144504|NCT02403505|gene|gene
144505|NCT02403505|genome|genome
144506|NCT02403505|genotype|genotype
144507|NCT02403505|genotyping|genotyping
144508|NCT02403505|Oncology|oncology
144509|NCT02403505|Chemotherapy|chemotherapy
144510|NCT02403505|Personalize|personalize
144511|NCT02403505|Individualize|individualize
144512|NCT02403492|Children|children
144513|NCT02403492|Obesity|obesity
144514|NCT02403492|Cardiovascular|cardiovascular
144515|NCT02403492|Sleep|sleep
144516|NCT02403492|Apnea|apnea
144517|NCT02403492|Obstructive|obstructive
144518|NCT02403466|Medical errors|medical errors
144519|NCT02403466|Communication|communication
144520|NCT02403466|Resident sign-out|resident sign-out
144521|NCT02403453|Radiculopathy|radiculopathy
144522|NCT02403453|Myelopathy|myelopathy
144523|NCT02403453|Spondylosis|spondylosis
144524|NCT02403453|Herniated Nucleus Pulposus|herniated nucleus pulposus
144525|NCT02403453|C3-C7|c3-c7
144526|NCT02403453|Osteophytes|osteophytes
144527|NCT02403453|Neurological deficit|neurological deficit
144528|NCT02403427|Bolus calculator|bolus calculator
144529|NCT02403427|Insulin pump|insulin pump
144530|NCT02403427|basal-bolus insulin therapy|basal-bolus insulin therapy
144531|NCT02403401|Pregnancy prevention|pregnancy prevention
144532|NCT02403388|Patient safety|patient safety
144533|NCT02403388|Primary care|primary care
144534|NCT02403388|Incident reporting|incident reporting
144535|NCT02403388|Pluridisciplinary care offices|pluridisciplinary care offices
144536|NCT02403388|Risk management|risk management
144537|NCT02403388|Assessment|assessment
144538|NCT02403310|adverse-risk AML|adverse-risk aml
144539|NCT02403310|poor-risk karyotype|poor-risk karyotype
144540|NCT02403310|cytogenetic abnormality|cytogenetic abnormality
144541|NCT02403310|poor-risk mutations|poor-risk mutations
144542|NCT02403310|antecedent hematologic disorder|antecedent hematologic disorder
144543|NCT02403310|treatment related AML|treatment related aml
144544|NCT02403297|Bleeding gums|bleeding gums
144545|NCT02403297|Gum inflammation|gum inflammation
144546|NCT02403297|Saliva|saliva
144547|NCT02403284|insulin resistance|insulin resistance
144548|NCT02403284|lipid metabolism|lipid metabolism
144550|NCT02403284|high fat diets|high fat diets
144551|NCT02403271|Pharmacyclics|pharmacyclics
144552|NCT02403271|PCYC|pcyc
144553|NCT02403271|Ibrutinib|ibrutinib
144554|NCT02403271|Durvalumab (MEDI4736)|durvalumab (medi4736)
144555|NCT02403271|Relapsed Refractory Solid Tumor|relapsed refractory solid tumor
144556|NCT02403271|Non-Small Cell Lung Cancer|non-small cell lung cancer
144557|NCT02403271|NSCLC|nsclc
144558|NCT02403271|Squamous|squamous
144559|NCT02403271|Squamous NSCLC|squamous nsclc
144560|NCT02403271|Squamous Non-Small Cell Lung Cancer|squamous non-small cell lung cancer
144561|NCT02403271|Immunotherapy|immunotherapy
144562|NCT02403271|IMBRUVICA®|imbruvica®
144563|NCT02403271|Tumor Immunotherapy|tumor immunotherapy
144564|NCT02403271|Anti-PD-L1|anti-pd-l1
144565|NCT02403271|Lung Cancer|lung cancer
144566|NCT02403258|acupuncture|acupuncture
144567|NCT02403258|plum-blossom needle|plum-blossom needle
144568|NCT02403258|tourette syndrome|tourette syndrome
144569|NCT02403258|randomized controlled trial|randomized controlled trial
144570|NCT02403245|Social interactions|social interactions
144571|NCT02403245|Dementia|dementia
144572|NCT02403245|Social stimulation|social stimulation
144573|NCT02403245|Direct observation|direct observation
144574|NCT02403232|Autologous adipose-derived stem cells|autologous adipose-derived stem cells
144575|NCT02403219|Dry eye|dry eye
144576|NCT02403219|Botulinum toxin A|botulinum toxin a
144577|NCT02403219|Orbicularis muscle of the eye|orbicularis muscle of the eye
144578|NCT02403193|Adenosine A2a receptor antagonist|adenosine a2a receptor antagonist
144579|NCT02403193|NSCLC|nsclc
144582|NCT02403193|adenosine|adenosine
144583|NCT02403193|PDR001|pdr001
144584|NCT02403193|immune checkpoint inhibitors|immune checkpoint inhibitors
144585|NCT02403193|Programmed Death-1 (PD-1) receptor|programmed death-1 (pd-1) receptor
144586|NCT02403193|Adenosine A2a receptor (A2AR)|adenosine a2a receptor (a2ar)
144587|NCT02403180|Visual Performance|visual performance
144588|NCT02403154|Anterior pelvic ring|anterior pelvic ring
144589|NCT02403154|Internal fixation|internal fixation
144590|NCT02403154|External fixation|external fixation
174494|NCT02234765|OSA|osa
144592|NCT02403154|Orthopedic|orthopedic
144593|NCT02403154|pubic rami|pubic rami
144594|NCT02403128|362.17|362.17
655383|NCT00792480|Exercise|exercise
144595|NCT02403102|Magnetic Resonance Imaging|magnetic resonance imaging
144596|NCT02403102|Myeloma|myeloma
144597|NCT02403102|Autograft|autograft
144598|NCT02403089|MAIT (Mucosal-Associated Invariant T) cells|mait (mucosal-associated invariant t) cells
144599|NCT02403089|Gut microbiota|gut microbiota
144600|NCT02403089|Preterm birth|preterm birth
144601|NCT02403089|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
144602|NCT02403089|Microbial infections|microbial infections
144603|NCT02403050|Neoplasm Staging|neoplasm staging
144604|NCT02403050|Radiotherapy|radiotherapy
144605|NCT02403050|Fiducial Markers|fiducial markers
144606|NCT02403037|Breast Neoplasms|breast neoplasms
144607|NCT02403037|Auricular Therapy|auricular therapy
144608|NCT02403037|Acupressure|acupressure
144609|NCT02403037|Chemotherapy|chemotherapy
144610|NCT02403037|Nausea|nausea
144611|NCT02403037|Vomiting|vomiting
144612|NCT02403024|Colon cancer|colon cancer
144613|NCT02403024|rectal cancer|rectal cancer
144614|NCT02403024|exercise|exercise
144615|NCT02403024|physical activity|physical activity
144616|NCT02403024|metabolic health|metabolic health
144617|NCT02403011|Congenital Muscular Torticollis|congenital muscular torticollis
144618|NCT02403011|Manual Therapy|manual therapy
144619|NCT02403011|Infant|infant
144620|NCT02402998|Primacy immune thrombocytopenia|primacy immune thrombocytopenia
144621|NCT02402998|Adults|adults
144622|NCT02402998|Eltrombopag|eltrombopag
144623|NCT02402998|Long-term remission|long-term remission
144624|NCT02402985|nutritional support|nutritional support
144625|NCT02402985|diet therapy|diet therapy
144626|NCT02402985|protein diet|protein diet
144627|NCT02402985|isocaloric diet|isocaloric diet
144628|NCT02402972|adjuvant chemotherapy|adjuvant chemotherapy
144629|NCT02402972|intraportal chemotherapy|intraportal chemotherapy
144630|NCT02402972|prevention|prevention
144631|NCT02402959|Insomnia|insomnia
144632|NCT02402959|Traditional Chinese Medicine|traditional chinese medicine
144633|NCT02402959|herbal medicine|herbal medicine
144634|NCT02402959|cohort study|cohort study
144635|NCT02402959|individualized treatment|individualized treatment
144636|NCT02402959|TCM pattern differentiation|tcm pattern differentiation
144637|NCT02402920|Lung Cancer|lung cancer
144638|NCT02402920|Small Cell Lung Cancer|small cell lung cancer
144639|NCT02402920|SCLC|sclc
144640|NCT02402920|Limited-Stage Small-Cell Lung Cancer|limited-stage small-cell lung cancer
144641|NCT02402920|LS-SCLC|ls-sclc
144642|NCT02402920|Extensive-Stage Small-Cell Lung Cancer|extensive-stage small-cell lung cancer
144643|NCT02402920|ES-SCLC|es-sclc
144644|NCT02402920|MK-3475|mk-3475
144645|NCT02402920|Keytruda|keytruda
144646|NCT02402920|Pembrolizumab|pembrolizumab
144647|NCT02402920|SCH-900475|sch-900475
144648|NCT02402920|Etoposide|etoposide
144649|NCT02402920|VePesid|vepesid
144650|NCT02402920|Cisplatin|cisplatin
144651|NCT02402920|Platinol-AQ|platinol-aq
144652|NCT02402920|Platinol|platinol
144653|NCT02402920|CDDP|cddp
144654|NCT02402920|Carboplatin|carboplatin
144655|NCT02402920|Radiation therapy|radiation therapy
144656|NCT02402920|XRT|xrt
144657|NCT02402907|cesarean section|cesarean section
144658|NCT02402907|chlorhexidine gluconate|chlorhexidine gluconate
144659|NCT02402907|CHG|chg
144660|NCT02402907|surgical site infection|surgical site infection
144661|NCT02402907|obstetrics|obstetrics
144662|NCT02402907|infection prevention|infection prevention
144663|NCT02402907|pregnancy|pregnancy
144664|NCT02402881|venous thromboembolism|venous thromboembolism
144665|NCT02402881|deep venous thrombosis|deep venous thrombosis
144666|NCT02402881|pulmonary embolism|pulmonary embolism
144667|NCT02402881|blood clots|blood clots
144668|NCT02402855|Couverture Maladie Universelle|couverture maladie universelle
144669|NCT02402855|Couverture Maladie Universelle-Complémentaire|couverture maladie universelle-complémentaire
144670|NCT02402855|free health care|free health care
144671|NCT02402842|gastrointestinal oncology|gastrointestinal oncology
144672|NCT02402842|immunology|immunology
144673|NCT02402842|taxane|taxane
144674|NCT02402764|Triple Negative Breast Cancer (TNBC)|triple negative breast cancer (tnbc)
144675|NCT02402764|Breast - Female|breast - female
144676|NCT02402764|Breast - Male|breast - male
144677|NCT02402764|Metastatic Triple Negative Breast Cancer|metastatic triple negative breast cancer
144678|NCT02402764|Receptor Tyrosine-protein Kinase erbB-2 (HER2) Negative|receptor tyrosine-protein kinase erbb-2 (her2) negative
144680|NCT02402751|Volunteers|volunteers
144681|NCT02402725|Relapsed Multiple Myeloma|relapsed multiple myeloma
144683|NCT02402699|HBC|hbc
144684|NCT02402647|Hoarding|hoarding
144685|NCT02402647|Compulsive Hoarding|compulsive hoarding
144686|NCT02402595|Drug-drug interaction|drug-drug interaction
144687|NCT02402595|Healthy Volunteers|healthy volunteers
144688|NCT02402595|Pharmacokinetics|pharmacokinetics
144689|NCT02402595|deuterated dextromethorphan|deuterated dextromethorphan
174630|NCT02234232|Safety|safety
144690|NCT02402595|dextromethorphan|dextromethorphan
144691|NCT02402595|dextromethorphan with quinidine|dextromethorphan with quinidine
144692|NCT02402595|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
655384|NCT00792480|Nutrition|nutrition
144693|NCT02402595|itraconazole|itraconazole
144694|NCT02402582|Family-Centered Empowerment Model|family-centered empowerment model
144695|NCT02402582|Quality of life|quality of life
144696|NCT02402582|Perceived stress|perceived stress
144697|NCT02402582|Anxiety|anxiety
144698|NCT02402582|Myocardial infarction|myocardial infarction
144699|NCT02402582|Clinical trial|clinical trial
144700|NCT02402582|Iran|iran
144701|NCT02402543|preemptive analgesia|preemptive analgesia
144702|NCT02402543|anorectal surgery|anorectal surgery
144703|NCT02402543|gabapentin|gabapentin
144704|NCT02402543|neurontin|neurontin
144705|NCT02402543|ketamine|ketamine
144706|NCT02402543|acetaminophen|acetaminophen
144707|NCT02402543|tylenol|tylenol
144708|NCT02402543|postoperative pain|postoperative pain
144709|NCT02402543|postoperative narcotic usage|postoperative narcotic usage
144710|NCT02402543|dexamethasone|dexamethasone
144711|NCT02402543|decadron|decadron
144712|NCT02402530|Neridronic Acid|neridronic acid
144713|NCT02402530|Neridronate|neridronate
144714|NCT02402530|CRPS|crps
144715|NCT02402530|RSD|rsd
144716|NCT02402517|Diabetes Prevention|diabetes prevention
144717|NCT02402517|Obesity Prevention|obesity prevention
144718|NCT02402491|Dual Antiplatelet Treatment|dual antiplatelet treatment
144719|NCT02402491|In-Stent Restenosis|in-stent restenosis
144720|NCT02402478|Clinical Cohort|clinical cohort
144721|NCT02402478|Electronic Health Records|electronic health records
144722|NCT02402478|Prognosis|prognosis
144723|NCT02402478|Stable Coronary Artery Disease|stable coronary artery disease
144724|NCT02402439|Type 1 diabetes|type 1 diabetes
144725|NCT02402439|diabetes mellitus|diabetes mellitus
144726|NCT02402439|pancreatic islet transplant|pancreatic islet transplant
144727|NCT02402439|beta cell replacement|beta cell replacement
144728|NCT02402426|Brain Health|brain health
144729|NCT02402426|Brain Research|brain research
144730|NCT02402426|Alzheimer's Disease|alzheimer's disease
144731|NCT02402426|Neurodegenerative Disease|neurodegenerative disease
144732|NCT02402426|Parkinson's Disease|parkinson's disease
144733|NCT02402426|Dementia|dementia
144734|NCT02402426|Stroke|stroke
144735|NCT02402426|PTSD|ptsd
144736|NCT02402426|Multiple Sclerosis|multiple sclerosis
144737|NCT02402400|NSTEMI|nstemi
144738|NCT02402361|Neuropathic pain|neuropathic pain
144739|NCT02402361|Diabetic Neuropathy|diabetic neuropathy
144740|NCT02402348|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
144741|NCT02402309|Sjögren-Larsson Syndrome|sjögren-larsson syndrome
144742|NCT02402309|SLS|sls
144743|NCT02402309|Ichthyosis|ichthyosis
144744|NCT02402309|FALDH Deficiency|faldh deficiency
144745|NCT02402309|Neuro-ichthyosis|neuro-ichthyosis
144746|NCT02402309|Fatty Alcohol:NAD+ Oxidoreductase Deficiency|fatty alcohol:nad+ oxidoreductase deficiency
144747|NCT02402309|Fatty Aldehyde Dehydrogenase Deficiency Disease|fatty aldehyde dehydrogenase deficiency disease
144748|NCT02402309|Congenital Icthyosis Mental Retardation Spasticity Syndrome|congenital icthyosis mental retardation spasticity syndrome
144749|NCT02402309|Spastic Neurologic Disorder|spastic neurologic disorder
144750|NCT02402309|Oligophrenia|oligophrenia
144751|NCT02402283|Bioequivalency|bioequivalency
144752|NCT02402283|two metronidazole-containing products|two metronidazole-containing products
144753|NCT02402270|Colonoscopy|colonoscopy
144754|NCT02402270|Preparation|preparation
144755|NCT02402257|Central Venous Catheter|central venous catheter
144756|NCT02402257|Simulation-based Mastery Learning|simulation-based mastery learning
144757|NCT02402257|Medical Education|medical education
144758|NCT02402257|Patient Outcomes|patient outcomes
144759|NCT02402257|Bloodstream Infection Due to Central Venous Catheter|bloodstream infection due to central venous catheter
144760|NCT02402257|Pneumothorax|pneumothorax
144761|NCT02402257|Inadvertent Arterial Puncture|inadvertent arterial puncture
144762|NCT02402205|Implementation; TF-CBT; adjudicated youth; RTF; trauma|implementation; tf-cbt; adjudicated youth; rtf; trauma
144763|NCT02402192|corifollitropin alfa|corifollitropin alfa
144764|NCT02402192|recombinant FSH|recombinant fsh
144765|NCT02402192|HP-hMG|hp-hmg
144766|NCT02402192|time-lapse|time-lapse
144767|NCT02402192|kinetics of development|kinetics of development
144768|NCT02402179|protein quality|protein quality
144770|NCT02402140|tacrolimus blood concentration|tacrolimus blood concentration
144771|NCT02402140|pharmaceutical intervention|pharmaceutical intervention
144775|NCT02402101|tDCS|tdcs
144776|NCT02402101|Dopamine|dopamine
144777|NCT02402101|PET|pet
144778|NCT02402088|stress|stress
144779|NCT02402088|food cues|food cues
144780|NCT02402088|obesity|obesity
144781|NCT02402075|muscle motor evoked potentials|muscle motor evoked potentials
144782|NCT02402075|spinal motor evoked potentials|spinal motor evoked potentials
144783|NCT02402075|D-wave|d-wave
144784|NCT02402075|brain tumor surgery|brain tumor surgery
135735|NCT02451683|SCI|sci
144785|NCT02402075|intraoperative neuromonitoring|intraoperative neuromonitoring
144786|NCT02402062|pNET|pnet
144787|NCT02401997|sperm|sperm
144788|NCT02401997|oxidative stress|oxidative stress
144789|NCT02401997|sexual abstinence|sexual abstinence
144790|NCT02401971|Thalidomide|thalidomide
144791|NCT02401971|Irinotecan|irinotecan
144792|NCT02401971|Second Line|second line
144793|NCT02401945|Macular Degeneration|macular degeneration
144794|NCT02401919|Nursing|nursing
144795|NCT02401919|Hospital|hospital
144796|NCT02401919|Communication|communication
144797|NCT02401919|Patient Participation|patient participation
144798|NCT02401919|Individualised Care|individualised care
144799|NCT02401893|aging|aging
144800|NCT02401893|influenza vaccine|influenza vaccine
144801|NCT02401893|immune responses|immune responses
144802|NCT02401867|transgender|transgender
144803|NCT02401867|female-to-male|female-to-male
144804|NCT02401867|cervical cancer|cervical cancer
144805|NCT02401867|HPV|hpv
144806|NCT02401867|sexual health|sexual health
144807|NCT02401854|atrial fibrillation|atrial fibrillation
144808|NCT02401854|hypertension|hypertension
144809|NCT02401854|risk factors|risk factors
144810|NCT02401854|primary care|primary care
144811|NCT02401854|elderly|elderly
144812|NCT02401815|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
144813|NCT02401815|KIT|kit
144814|NCT02401815|Biomarkers|biomarkers
144815|NCT02401815|PLX9486|plx9486
144816|NCT02401815|PLX3397|plx3397
144817|NCT02401815|Sunitinib|sunitinib
144818|NCT02401802|Colonoscopy|colonoscopy
144819|NCT02401802|Diet|diet
144820|NCT02401802|Polyethylene glycols|polyethylene glycols
144821|NCT02401802|Efficacy|efficacy
144822|NCT02401802|Personal satisfaction|personal satisfaction
144823|NCT02401802|Colorectal cancer screening|colorectal cancer screening
144824|NCT02401789|oral surgery|oral surgery
144825|NCT02401789|Implantology|implantology
144826|NCT02401776|heart rate|heart rate
144827|NCT02401776|blood pressure|blood pressure
144828|NCT02401776|caffeine|caffeine
144829|NCT02401776|energy drink|energy drink
144830|NCT02401763|biomarker|biomarker
144831|NCT02401737|Hepatitis B|hepatitis b
144832|NCT02401724|Hemispatial neglect|hemispatial neglect
144833|NCT02401724|Transcranial direct current stimulation|transcranial direct current stimulation
144834|NCT02401724|Rehabilitation|rehabilitation
144835|NCT02401698|Stroke|stroke
144836|NCT02401698|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
144837|NCT02401698|Neuronal Plasticity|neuronal plasticity
144838|NCT02401698|Rehabilitation|rehabilitation
144839|NCT02401685|breast cancer|breast cancer
144840|NCT02401685|sentinel lymph node biopsy|sentinel lymph node biopsy
144841|NCT02401685|axillary lymph node clearance|axillary lymph node clearance
144842|NCT02401685|axillary lymph node dissection|axillary lymph node dissection
144843|NCT02401685|macrometastases|macrometastases
144844|NCT02401685|axillary radiotherapy|axillary radiotherapy
144845|NCT02401685|POSNOC|posnoc
144846|NCT02401672|TMS|tms
144847|NCT02401672|nicotine dependence|nicotine dependence
144848|NCT02401672|smoking cessation|smoking cessation
144849|NCT02401659|remote monitoring|remote monitoring
144850|NCT02401659|satisfaction|satisfaction
144851|NCT02401659|telemonitoring|telemonitoring
144852|NCT02401659|quality of life|quality of life
144853|NCT02401633|Cardio-Pulmonary-Resuscitation|cardio-pulmonary-resuscitation
144854|NCT02401633|Advanced Cardiac Life Support|advanced cardiac life support
144855|NCT02401633|Compression-Only CPR|compression-only cpr
144856|NCT02401633|Chest compression CPR|chest compression cpr
144857|NCT02401620|AR: arthritis rheumatoid|ar: arthritis rheumatoid
144858|NCT02401620|DMARDs: Disease-modifying antirheumatic drugs|dmards: disease-modifying antirheumatic drugs
144859|NCT02401620|ACR. American College of Rheumatology|acr. american college of rheumatology
144860|NCT02401620|EULAR: European League against rheumatology|eular: european league against rheumatology
144861|NCT02401607|stress|stress
144862|NCT02401607|emergency physicians|emergency physicians
144863|NCT02401607|health care workers|health care workers
144864|NCT02401607|biomarkers|biomarkers
144865|NCT02401607|questionnaires|questionnaires
144866|NCT02401607|anxiety|anxiety
144867|NCT02401607|depression|depression
144868|NCT02401607|burn-out|burn-out
144869|NCT02401594|Non-major orthopaedic surgery|non-major orthopaedic surgery
144870|NCT02401594|deep vein thrombosis|deep vein thrombosis
144894|NCT02401516|Postural Reprogramming Insole|postural reprogramming insole
144896|NCT02401516|Posture|posture
144897|NCT02401516|Quality Of Life|quality of life
144898|NCT02401516|General Functional Capacity|general functional capacity
144899|NCT02401516|Respiratory Muscles Strength|respiratory muscles strength
144900|NCT02401516|Flexibility|flexibility
144901|NCT02401516|Arterial Systemic Hypertension|arterial systemic hypertension
144902|NCT02401503|CLL|cll
144903|NCT02401477|helicobacter pylori|helicobacter pylori
144904|NCT02401477|ilaprazole|ilaprazole
144905|NCT02401477|eradication|eradication
144906|NCT02401477|dual therapy|dual therapy
174912|NCT02232906|CKD|ckd
144907|NCT02401477|high dose therapy|high dose therapy
144908|NCT02401425|Letrozole|letrozole
144909|NCT02401425|Misoprostol|misoprostol
144910|NCT02401425|First-Trimester|first-trimester
144911|NCT02401425|Pretreatment|pretreatment
144912|NCT02401386|Fibromyalgia, The Lu Eight Brocades|fibromyalgia, the lu eight brocades
144913|NCT02401373|Vaccines|vaccines
144914|NCT02401373|Ebola Virus Disease|ebola virus disease
144915|NCT02401347|PALB2 mutation|palb2 mutation
144916|NCT02401347|BRIP1 mutation|brip1 mutation
144917|NCT02401347|BARD1 mutation|bard1 mutation
144918|NCT02401347|Rad51c mutation|rad51c mutation
144919|NCT02401347|PTEN mutation|pten mutation
144920|NCT02401347|CHEK2 mutation|chek2 mutation
144921|NCT02401347|ATM mutation|atm mutation
144922|NCT02401347|NBN mutation|nbn mutation
144923|NCT02401347|Rad51d mutation|rad51d mutation
144924|NCT02401347|Rad50 mutation|rad50 mutation
144925|NCT02401347|MRE11 mutation|mre11 mutation
144926|NCT02401347|FANC mutation|fanc mutation
144927|NCT02401347|HRD assay score|hrd assay score
144928|NCT02401347|ATR mutation|atr mutation
144929|NCT02401295|Relapsed multiple myeloma|relapsed multiple myeloma
144930|NCT02401256|Efavirenz|efavirenz
144931|NCT02401256|metabolism|metabolism
144932|NCT02401256|pharmacokinetics changes|pharmacokinetics changes
144933|NCT02401230|Human Immunodeficiency Virus|human immunodeficiency virus
144934|NCT02401230|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
144935|NCT02401230|Pre-exposure Prophylaxis|pre-exposure prophylaxis
144936|NCT02401204|Bacterial transmission|bacterial transmission
144937|NCT02401204|Surveillance|surveillance
144938|NCT02401204|Neonatal|neonatal
144939|NCT02401204|Drug Resistance|drug resistance
144940|NCT02401178|FLG-FADS genes variations-LCPUFA-atopic dermatitis|flg-fads genes variations-lcpufa-atopic dermatitis
144941|NCT02401165|GADD34|gadd34
144942|NCT02401165|Unfolded Protein Response|unfolded protein response
144943|NCT02401165|Anti-citrullinated protein antibodies|anti-citrullinated protein antibodies
144944|NCT02401100|Rectal Neoplasms|rectal neoplasms
144945|NCT02401061|ITP|itp
144946|NCT02401061|Thrombocytopenia|thrombocytopenia
144947|NCT02401035|candidate for acid suppression therapy|candidate for acid suppression therapy
144948|NCT02401035|presumptive diagnosis of GERD|presumptive diagnosis of gerd
144949|NCT02401035|clinical diagnosis of suspected GERD|clinical diagnosis of suspected gerd
144950|NCT02401035|symptomatic GERD|symptomatic gerd
144951|NCT02401035|endoscopically proven GERD|endoscopically proven gerd
144952|NCT02401022|smoking|smoking
144953|NCT02401022|smoking cessation|smoking cessation
144954|NCT02401022|cigarette|cigarette
144955|NCT02400996|Endocrine Pancreas|endocrine pancreas
144956|NCT02400996|Pancreatic Endocrine Neoplasm|pancreatic endocrine neoplasm
144957|NCT02400983|ACAP, Automatic Algorithm|acap, automatic algorithm
144958|NCT02400970|Polymerase Chain Reaction|polymerase chain reaction
144959|NCT02400970|fertility preservation|fertility preservation
144960|NCT02400957|silver nanoparticles|silver nanoparticles
144961|NCT02400957|demineralization|demineralization
144962|NCT02400957|brackets|brackets
144963|NCT02400944|MSK Tobacco Cessation Program|msk tobacco cessation program
144964|NCT02400944|smoking exposure|smoking exposure
144965|NCT02400944|15-047|15-047
144966|NCT02400905|PAD|pad
144967|NCT02400905|PVD|pvd
144968|NCT02400905|SFA stent|sfa stent
144969|NCT02400879|bispectral index|bispectral index
144970|NCT02400879|cardiac surgery|cardiac surgery
144971|NCT02400879|recovery|recovery
144972|NCT02400879|remifentanil|remifentanil
144973|NCT02400866|cancer patients receiving moderately emetogenic chemotherapy|cancer patients receiving moderately emetogenic chemotherapy
144974|NCT02400827|Polymerase Chain Reaction|polymerase chain reaction
144975|NCT02400827|fertility preservation|fertility preservation
144976|NCT02400801|endometriosis|endometriosis
144977|NCT02400801|infertility|infertility
144978|NCT02400801|assisted reproductive technology|assisted reproductive technology
144979|NCT02400775|Pharmacotherapy|pharmacotherapy
144980|NCT02400749|moderate to severe non-pustular palmo-plantar psoriasis|moderate to severe non-pustular palmo-plantar psoriasis
144981|NCT02400736|Individual Placement and Support|individual placement and support
144982|NCT02400736|Supported Employment|supported employment
144983|NCT02400736|Employment|employment
144984|NCT02400736|Vocational Rehabilitation|vocational rehabilitation
144985|NCT02400736|Veterans|veterans
144986|NCT02400736|Patient Aligned Care Team|patient aligned care team
144987|NCT02400723|behavioral intervention|behavioral intervention
144988|NCT02400723|relaxation|relaxation
144989|NCT02400723|Veterans|veterans
144990|NCT02400723|geriatric|geriatric
144991|NCT02400684|AFSr classification|afsr classification
144992|NCT02400684|laparoscopy|laparoscopy
144993|NCT02400658|breast cancer|breast cancer
144994|NCT02400658|early-stage|early-stage
144995|NCT02400658|IORT|iort
144996|NCT02400658|brachytherapy|brachytherapy
144997|NCT02400645|laparoscopic hysterectomy|laparoscopic hysterectomy
144998|NCT02400645|robotic assisted hysterectomy|robotic assisted hysterectomy
135870|NCT02450916|policy|policy
144999|NCT02400632|drug-eluting balloon|drug-eluting balloon
145000|NCT02400632|in-stent restenosis|in-stent restenosis
145001|NCT02400619|shockwaves|shockwaves
145002|NCT02400619|Physiotherapy|physiotherapy
145003|NCT02400619|Botulinum toxin|botulinum toxin
145004|NCT02400606|constructing VPs|constructing vps
145005|NCT02400606|knowledge and skills transfer|knowledge and skills transfer
145006|NCT02400580|Laparoscopic Hysterectomy|laparoscopic hysterectomy
145007|NCT02400580|IV acetaminophen|iv acetaminophen
145008|NCT02400580|Postoperative pain control|postoperative pain control
145009|NCT02400580|Surgery|surgery
145010|NCT02400567|Luminal|luminal
145011|NCT02400567|Post menopausal|post menopausal
145012|NCT02400567|Breast conservation|breast conservation
145013|NCT02400567|Neoadjuvant|neoadjuvant
145014|NCT02400554|Indian, North American|indian, north american
145015|NCT02400554|Oklahoma|oklahoma
145016|NCT02400554|Female|female
145017|NCT02400554|health promotion|health promotion
145018|NCT02400541|Anorexia nervosa|anorexia nervosa
145019|NCT02400541|Cognitive remediation therapy|cognitive remediation therapy
145020|NCT02400515|Exercise|exercise
145021|NCT02400515|Exercise Therapy|exercise therapy
145022|NCT02400515|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
145023|NCT02400502|Schizophrenia|schizophrenia
145024|NCT02400502|Treatment|treatment
145025|NCT02400502|Meditation|meditation
145026|NCT02400502|Mindfulness|mindfulness
145027|NCT02400502|Stress reactivity|stress reactivity
145028|NCT02400502|First Episode Psychosis|first episode psychosis
145029|NCT02400502|Coping|coping
145030|NCT02400489|Heart Valve Replacement Surgery|heart valve replacement surgery
145031|NCT02400489|Perimount|perimount
145032|NCT02400489|Edwards|edwards
145033|NCT02400476|HER2 +|her2 +
145034|NCT02400476|Breast Cancer|breast cancer
145035|NCT02400476|Neratinib|neratinib
145036|NCT02400450|Pre-diabetes|pre-diabetes
145037|NCT02400450|prediabetes|prediabetes
145038|NCT02400450|glycated hemoglobin|glycated hemoglobin
145039|NCT02400450|hemoglobin A1c|hemoglobin a1c
145040|NCT02400450|LDL cholesterol|ldl cholesterol
145041|NCT02400450|Cholesterol|cholesterol
145042|NCT02400450|metabolic function|metabolic function
145043|NCT02400450|vascular function|vascular function
145044|NCT02400450|functional food|functional food
145045|NCT02400437|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
145046|NCT02400424|Stereotactic lung radiation therapy|stereotactic lung radiation therapy
145047|NCT02400424|Radiochemotherapy|radiochemotherapy
145048|NCT02400424|Unresectable stage III Non-Small Cell lung Carcinoma|unresectable stage iii non-small cell lung carcinoma
145049|NCT02400424|Peripheral primary tumor|peripheral primary tumor
145050|NCT02400411|Carbohydrate|carbohydrate
145051|NCT02400411|Glycemic response|glycemic response
145052|NCT02400411|insulin|insulin
145053|NCT02400411|whole grain|whole grain
145054|NCT02400411|meal|meal
145055|NCT02400359|fMRI|fmri
145056|NCT02400359|Magnetic Resonance Imaging|magnetic resonance imaging
145057|NCT02400359|endocrinology|endocrinology
145058|NCT02400359|MRI|mri
145059|NCT02400359|obesity|obesity
145060|NCT02400359|weight loss|weight loss
145061|NCT02400359|lorcaserin|lorcaserin
145062|NCT02400333|ticagrelor orodispersible tablet|ticagrelor orodispersible tablet
145063|NCT02400333|ticagrelor immediate-release tablet|ticagrelor immediate-release tablet
145064|NCT02400333|relative bioavailability|relative bioavailability
145065|NCT02400333|Phase I|phase i
145066|NCT02400333|healthy subjects|healthy subjects
145067|NCT02400307|Phase 1|phase 1
145068|NCT02400307|Renally Impaired|renally impaired
145069|NCT02400294|Critical care|critical care
145070|NCT02400294|Mechanical ventilation|mechanical ventilation
145071|NCT02400294|Ventilator associated pneumonia|ventilator associated pneumonia
145072|NCT02400294|Oral care|oral care
145073|NCT02400268|Enterobacteriaceae|enterobacteriaceae
145074|NCT02400268|Bloodstream|bloodstream
145075|NCT02400268|Bacteremia|bacteremia
145076|NCT02400268|Recurrence|recurrence
145077|NCT02400268|Reinfection|reinfection
145078|NCT02400229|coronary artery disease|coronary artery disease
145079|NCT02400229|stable chest pain|stable chest pain
145080|NCT02400229|intermediate pretest probability|intermediate pretest probability
145081|NCT02400229|pragmatic randomised controlled trial|pragmatic randomised controlled trial
145082|NCT02400229|coronary computed tomography|coronary computed tomography
145083|NCT02400229|angiography|angiography
145084|NCT02400229|invasive coronary angiography|invasive coronary angiography
145085|NCT02400216|Chronic Hepatitis C|chronic hepatitis c
145086|NCT02400216|Cirrhosis|cirrhosis
145087|NCT02400216|Liver Biopsy|liver biopsy
145088|NCT02400216|Microbiome|microbiome
145089|NCT02400203|hemp oil,|hemp oil,
145090|NCT02400203|hemp|hemp
145091|NCT02400203|fatty acids|fatty acids
145092|NCT02400203|omega-6|omega-6
145093|NCT02400203|omega-3|omega-3
145094|NCT02400203|blood pressure|blood pressure
145095|NCT02400203|blood lipids|blood lipids
145096|NCT02400190|radiation|radiation
145097|NCT02400190|lumpectomy|lumpectomy
135977|NCT02450110|BNP|bnp
145098|NCT02400190|favorable biology|favorable biology
145099|NCT02400190|omission|omission
145100|NCT02400125|Patient Registry|patient registry
145101|NCT02400125|Coronary Artery Bypass|coronary artery bypass
145102|NCT02400125|Cardiac Valve Annuloplasty|cardiac valve annuloplasty
145103|NCT02400112|Vancomycin|vancomycin
145104|NCT02400086|neuroligical or neuromuscular diseases|neuroligical or neuromuscular diseases
145105|NCT02400086|bacterial respiratory tract flora|bacterial respiratory tract flora
145106|NCT02400086|long term tracheostomy|long term tracheostomy
655785|NCT00800501|Implantable|implantable
145107|NCT02400047|Paediatric surgery|paediatric surgery
145108|NCT02400034|midurethral sling|midurethral sling
145109|NCT02400034|Voiding trial|voiding trial
145110|NCT02400034|stress urinary incontinence|stress urinary incontinence
145111|NCT02399995|Quality of Life|quality of life
145112|NCT02399995|Hepatectomy|hepatectomy
145113|NCT02399995|15-057|15-057
145114|NCT02399982|Smartphone Application|smartphone application
145115|NCT02399982|mobile mental health|mobile mental health
145116|NCT02399982|Binge Eating|binge eating
145117|NCT02399982|Cognitive behavioral therapy|cognitive behavioral therapy
145118|NCT02399982|Eating Disorder treatment|eating disorder treatment
145119|NCT02399982|Cognitive behavioral therapy guided self-help|cognitive behavioral therapy guided self-help
145120|NCT02399982|self-monitoring|self-monitoring
145121|NCT02399982|eating disorders|eating disorders
145122|NCT02399982|ecological momentary intervention|ecological momentary intervention
145123|NCT02399969|Low back pain|low back pain
145124|NCT02399969|Acupuncture therapy|acupuncture therapy
145125|NCT02399969|Acupuncture, ear|acupuncture, ear
145126|NCT02399956|Lactation|lactation
145127|NCT02399956|Pediatric malignancies|pediatric malignancies
145128|NCT02399956|Cancer survivor|cancer survivor
145129|NCT02399917|Leukemia|leukemia
145130|NCT02399917|Acute Myeloid Leukemia|acute myeloid leukemia
145131|NCT02399917|Refractory|refractory
145132|NCT02399917|Relapsed|relapsed
145133|NCT02399917|AML|aml
145134|NCT02399917|Myelodysplastic Syndrome (MDS).|myelodysplastic syndrome (mds).
145135|NCT02399917|MDS|mds
145136|NCT02399917|High-risk|high-risk
145137|NCT02399917|5-azacytidine|5-azacytidine
145138|NCT02399917|Azacitidine|azacitidine
145139|NCT02399917|5-aza|5-aza
145140|NCT02399917|Vidaza|vidaza
145141|NCT02399917|5-AZC|5-azc
145142|NCT02399917|AZA-CR|aza-cr
145143|NCT02399917|Ladakamycin|ladakamycin
145144|NCT02399917|NSC-102816|nsc-102816
145145|NCT02399917|Azacytidine|azacytidine
145146|NCT02399917|Lirilumab|lirilumab
145147|NCT02399917|Phone call|phone call
145148|NCT02399891|Remodeling|remodeling
145149|NCT02399891|Prognosis|prognosis
145150|NCT02399891|Incidence|incidence
145151|NCT02399891|Quality Assurance|quality assurance
145152|NCT02399891|Ejection Fraction|ejection fraction
145153|NCT02399891|Sudden Death|sudden death
145154|NCT02399800|pancreatitis, chronic|pancreatitis, chronic
145155|NCT02399800|endosonography|endosonography
145156|NCT02399761|AADC deficiency, newborn screening|aadc deficiency, newborn screening
145157|NCT02399735|NK cells|nk cells
145158|NCT02399735|Liver Transplantation|liver transplantation
145159|NCT02399735|Hepatocellular Carcinoma Recurrence|hepatocellular carcinoma recurrence
145160|NCT02399722|Negative Pressure Wound Therapy, polymeric membrane dressing, wounds|negative pressure wound therapy, polymeric membrane dressing, wounds
145161|NCT02399670|Total hip arthroplasty|total hip arthroplasty
145162|NCT02399670|degenerative joint disease|degenerative joint disease
145163|NCT02399670|Femoral offset|femoral offset
145164|NCT02399670|Patient reported outcome|patient reported outcome
145165|NCT02399657|diabetes mellitus|diabetes mellitus
145166|NCT02399657|macular edema|macular edema
145167|NCT02399657|hard exudate|hard exudate
145168|NCT02399657|intravitreal injections|intravitreal injections
145169|NCT02399657|dexamethasone|dexamethasone
145172|NCT02399644|rehabilitation|rehabilitation
145173|NCT02399644|exercise|exercise
145174|NCT02399644|psychological|psychological
145175|NCT02399644|intervention|intervention
145176|NCT02399631|Perioperative treatment|perioperative treatment
145177|NCT02399631|Laparoscopic surgery|laparoscopic surgery
145178|NCT02399618|Clostridium difficile Infection|clostridium difficile infection
145179|NCT02399618|Fecal Microbiota Transplantation|fecal microbiota transplantation
145180|NCT02399618|Freeze-dried|freeze-dried
145181|NCT02399618|Acid-resistant Capsules|acid-resistant capsules
145182|NCT02399592|Platinum resistant|platinum resistant
145183|NCT02399579|cat allergy|cat allergy
145184|NCT02399579|symptom score|symptom score
145185|NCT02399566|erlotinib|erlotinib
145186|NCT02399566|pemetrexed|pemetrexed
145187|NCT02399566|maintenance therapy|maintenance therapy
145188|NCT02399527|Vascular Anomalies|vascular anomalies
145189|NCT02399527|Lymphatic Anomalies|lymphatic anomalies
145190|NCT02399527|Lymphatic Malformation|lymphatic malformation
145191|NCT02399514|Sleep|sleep
145192|NCT02399514|emphysema|emphysema
145193|NCT02399514|coils|coils
145194|NCT02399514|lung volume reduction|lung volume reduction
175258|NCT02231242|brain|brain
136056|NCT02449733|voluntary counseling and testing (VCT)|voluntary counseling and testing (vct)
136059|NCT02449733|homosexuality|homosexuality
145195|NCT02399501|2D ultrasound|2d ultrasound
145196|NCT02399501|3D ultrasound|3d ultrasound
145197|NCT02399501|sonohysterography|sonohysterography
145198|NCT02399501|hysteroscopy|hysteroscopy
145199|NCT02399501|Uterine factor of infertility|uterine factor of infertility
145200|NCT02399475|Levothyroxine|levothyroxine
145201|NCT02399475|Liothyronine|liothyronine
145202|NCT02399475|Thyrotropin Releasing Hormone|thyrotropin releasing hormone
145203|NCT02399475|Aging|aging
145204|NCT02399475|Hypothyroidism|hypothyroidism
145205|NCT02399475|Thyroid diseases|thyroid diseases
585633|NCT00513448|Rehabilitation|rehabilitation
145208|NCT02399436|Community-Based Participatory Research|community-based participatory research
145209|NCT02399436|Community-Institutional Relations|community-institutional relations
145210|NCT02399423|diabetes|diabetes
145211|NCT02399423|metabolism|metabolism
145212|NCT02399423|cardiovascular disease|cardiovascular disease
145213|NCT02399423|weight gain|weight gain
145214|NCT02399423|weight loss|weight loss
145215|NCT02399423|european|european
145216|NCT02399423|south asian|south asian
145217|NCT02399423|obesity|obesity
145218|NCT02399410|cytoreductive surgery|cytoreductive surgery
145219|NCT02399410|hipec|hipec
145220|NCT02399410|perioperative chemotherapy|perioperative chemotherapy
145221|NCT02399410|peritoneal carcinomatosis|peritoneal carcinomatosis
145222|NCT02399410|bevacizumab|bevacizumab
145223|NCT02399410|colorectal surgery|colorectal surgery
145224|NCT02399384|Cardiac Magnetic Resonance (CMR)|cardiac magnetic resonance (cmr)
145225|NCT02399358|Drug induced Hyponatremia|drug induced hyponatremia
145226|NCT02399358|Cyclophosphamide|cyclophosphamide
145227|NCT02399358|Hyponatremia|hyponatremia
145228|NCT02399358|Cyclophosphamide induced Hyponatremia|cyclophosphamide induced hyponatremia
145229|NCT02399345|Treatment naive|treatment naive
145230|NCT02399345|Hepatitis C Genotype 1|hepatitis c genotype 1
145231|NCT02399319|anterior pelvic ring|anterior pelvic ring
145232|NCT02399319|symphysis disruption|symphysis disruption
145233|NCT02399293|Cognitive training|cognitive training
145234|NCT02399293|Cognitive rehabilitation|cognitive rehabilitation
145235|NCT02399293|Acquired brain injury|acquired brain injury
145236|NCT02399293|N-back|n-back
145237|NCT02399293|Visual Search|visual search
145238|NCT02399293|Cognitive transfer|cognitive transfer
145239|NCT02399280|Meal pattern|meal pattern
145240|NCT02399280|weight loss|weight loss
145241|NCT02399280|high caloric intake|high caloric intake
145242|NCT02399280|Dinner|dinner
145243|NCT02399280|Lunch|lunch
145244|NCT02399267|mechanical ventilation|mechanical ventilation
145245|NCT02399267|weaning|weaning
145246|NCT02399267|critically ill|critically ill
145247|NCT02399267|spontaneous breathing trial|spontaneous breathing trial
145248|NCT02399267|screening|screening
145249|NCT02399267|invasive ventilation|invasive ventilation
145250|NCT02399267|SBT technique|sbt technique
145251|NCT02399254|Pulmonary Rehabilitation|pulmonary rehabilitation
145252|NCT02399228|radiation therapy|radiation therapy
145253|NCT02399228|chemotherapy|chemotherapy
145254|NCT02399228|head and neck cancer|head and neck cancer
145255|NCT02399202|Renal impairment, osilodrostat, LCI699|renal impairment, osilodrostat, lci699
145256|NCT02399189|Primary central nervous system lymphoma|primary central nervous system lymphoma
145257|NCT02399189|rituximab|rituximab
145258|NCT02399189|Methotrexate and Temozolomide|methotrexate and temozolomide
145259|NCT02399189|autologous stem cell transplantation|autologous stem cell transplantation
145260|NCT02399189|Carmustine and thiotepa|carmustine and thiotepa
145261|NCT02399176|Osteoporosis|osteoporosis
145262|NCT02399176|Yoga|yoga
145263|NCT02399150|acute abdomen|acute abdomen
145264|NCT02399150|Pain|pain
145265|NCT02399150|stress biomarker|stress biomarker
145266|NCT02399137|Pancreatic Cancer|pancreatic cancer
145267|NCT02399137|Front-line Pancreatic Cancer|front-line pancreatic cancer
145268|NCT02399137|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
145269|NCT02399137|Gemcitabine|gemcitabine
145270|NCT02399137|Nab-paclitaxel|nab-paclitaxel
145271|NCT02399137|Abraxane|abraxane
145272|NCT02399137|Free IGF-1|free igf-1
145273|NCT02399137|Heregulin|heregulin
145275|NCT02399124|Renal Cell Carcinoma|renal cell carcinoma
145276|NCT02399124|Kidney tumors|kidney tumors
145277|NCT02399111|Prevena Incision Management System (PIMS)|prevena incision management system (pims)
145278|NCT02399111|Surgical Site Infection (SSI)|surgical site infection (ssi)
145279|NCT02399085|DLBCL|dlbcl
145280|NCT02399085|CD19|cd19
145281|NCT02399085|monoclonal antibody|monoclonal antibody
145282|NCT02399085|MOR00208|mor00208
145283|NCT02399085|MOR208|mor208
145284|NCT02399059|recurrence|recurrence
145285|NCT02399033|Xihuang Capsules|xihuang capsules
145286|NCT02399033|hepatocellular carcinoma|hepatocellular carcinoma
145287|NCT02399033|Recurrence|recurrence
145288|NCT02399033|hepatectomy|hepatectomy
145289|NCT02398994|Clinical Trials Unit|clinical trials unit
145290|NCT02398994|Pediatric|pediatric
145291|NCT02398968|Iron|iron
145292|NCT02398968|RURTIs|rurtis
145293|NCT02398968|CARIFS|carifs
145294|NCT02398968|children|children
145295|NCT02398955|Drug-Eluting Stents|drug-eluting stents
145296|NCT02398955|Coronary Artery Disease|coronary artery disease
145297|NCT02398955|Sirolimus|sirolimus
145298|NCT02398955|Absorbable Implants|absorbable implants
145299|NCT02398903|Morbid obesity|morbid obesity
145300|NCT02398903|bariatric surgery|bariatric surgery
145301|NCT02398903|sleeve gastrectomy|sleeve gastrectomy
145302|NCT02398903|Roux-en-Y gastric bypass|roux-en-y gastric bypass
145303|NCT02398903|hormonal contraception|hormonal contraception
145613|NCT02397018|stroke|stroke
145304|NCT02398903|combined oral contraceptive|combined oral contraceptive
145433|NCT02398058|sarcoma|sarcoma
145305|NCT02398903|progestin contraceptive desogestrel|progestin contraceptive desogestrel
145306|NCT02398903|pharmacokinetics|pharmacokinetics
145307|NCT02398825|Chronic myeloid leukemia|chronic myeloid leukemia
145308|NCT02398825|Chronic phase|chronic phase
145309|NCT02398825|Adults|adults
145310|NCT02398825|Ponatinib|ponatinib
145311|NCT02398825|Imatinib resistant|imatinib resistant
145312|NCT02398760|Low Back Pain|low back pain
145313|NCT02398760|Clinical Instability|clinical instability
145314|NCT02398760|Motor Control Exercises|motor control exercises
145315|NCT02398760|Clinical Tests|clinical tests
145316|NCT02398734|sonolysis|sonolysis
145317|NCT02398734|carotid endarterectomy|carotid endarterectomy
145318|NCT02398734|stroke prevention|stroke prevention
145319|NCT02398734|brain infarction|brain infarction
145320|NCT02398721|FNAC|fnac
145321|NCT02398721|Small Incidental Thyroid Nodules|small incidental thyroid nodules
145322|NCT02398708|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
145323|NCT02398708|Graft versus Host Disease|graft versus host disease
145324|NCT02398695|Plaque|plaque
145325|NCT02398695|Saliva|saliva
145326|NCT02398695|Caries|caries
145327|NCT02398682|electronic alerts|electronic alerts
145328|NCT02398682|acute kidney injury|acute kidney injury
145329|NCT02398682|NHS|nhs
145330|NCT02398682|mortality|mortality
145331|NCT02398669|Obesity|obesity
145332|NCT02398669|Lorcaserin hydrochloride|lorcaserin hydrochloride
145333|NCT02398669|APD356|apd356
145334|NCT02398669|Pediatric|pediatric
145335|NCT02398669|Pharmacokinetics|pharmacokinetics
145336|NCT02398656|Minor Ischemic Stroke|minor ischemic stroke
145337|NCT02398643|Acute Exacerbation of COPD|acute exacerbation of copd
145338|NCT02398643|COPD|copd
145339|NCT02398643|Emphysema|emphysema
145340|NCT02398643|Chronic Bronchitis|chronic bronchitis
145341|NCT02398630|Histerosalpingography|histerosalpingography
145342|NCT02398630|MRI|mri
145343|NCT02398630|Magnetic Resonance Imaging|magnetic resonance imaging
145344|NCT02398630|HSG|hsg
145345|NCT02398630|Diagnostico Maipu|diagnostico maipu
145346|NCT02398630|Imaging|imaging
145347|NCT02398630|Carrascosa Patricia|carrascosa patricia
145348|NCT02398617|Heart Failure|heart failure
145349|NCT02398617|End of Life Care|end of life care
145350|NCT02398617|Decision Making|decision making
145351|NCT02398604|Pediatrics|pediatrics
145352|NCT02398604|HLHS|hlhs
145353|NCT02398591|Healthy|healthy
145354|NCT02398591|JNJ 53718678|jnj 53718678
145355|NCT02398552|metastatic renal cell carcinoma|metastatic renal cell carcinoma
145356|NCT02398552|sunitinib|sunitinib
145357|NCT02398552|schedule 2weeks on/1 week off|schedule 2weeks on/1 week off
145358|NCT02398526|Observational study|observational study
145359|NCT02398526|Bone metastases|bone metastases
145360|NCT02398526|Hormone Refractory Prostatic Cancer|hormone refractory prostatic cancer
145361|NCT02398526|Xofigo|xofigo
145362|NCT02398526|Radium-223|radium-223
145363|NCT02398500|First-in-human|first-in-human
145364|NCT02398500|anti-VEGF|anti-vegf
145365|NCT02398500|neovascular AMD (nvAMD)|neovascular amd (nvamd)
145366|NCT02398435|Auto-inflammatory disease|auto-inflammatory disease
145367|NCT02398435|Still's disease|still's disease
145368|NCT02398435|Arthritis Rheumatoid|arthritis rheumatoid
145369|NCT02398435|IL-18|il-18
145370|NCT02398435|interleukin-18|interleukin-18
145371|NCT02398435|IL-18 binding protein|il-18 binding protein
145372|NCT02398422|Autonomic nervous system|autonomic nervous system
145373|NCT02398422|Auditory processing disorder|auditory processing disorder
145374|NCT02398422|Social behavior|social behavior
145375|NCT02398409|stroke|stroke
145376|NCT02398409|Injury, Brain, Traumatic|injury, brain, traumatic
145377|NCT02398409|Family Caregivers|family caregivers
145378|NCT02398409|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
145379|NCT02398409|Informal Caregivers|informal caregivers
145380|NCT02398370|ED|ed
145381|NCT02398357|anticoagulation|anticoagulation
145382|NCT02398357|Zelen-designed randomized controlled trial|zelen-designed randomized controlled trial
145383|NCT02398331|Spinal cord injuries|spinal cord injuries
145384|NCT02398331|Sexual function|sexual function
145385|NCT02398331|Sexual response|sexual response
145386|NCT02398331|Sexuality|sexuality
145387|NCT02398331|Women|women
145388|NCT02398318|neurosurgery|neurosurgery
145389|NCT02398318|deep brain stimulation|deep brain stimulation
145390|NCT02398318|exposure response prevention|exposure response prevention
145391|NCT02398305|Cardiac catheterisation|cardiac catheterisation
145392|NCT02398305|Radial access|radial access
145393|NCT02398305|Compression|compression
145394|NCT02398305|Terumo TR Band|terumo tr band
145395|NCT02398305|radial artery|radial artery
145396|NCT02398305|diagnostic|diagnostic
145397|NCT02398279|schizophrenia|schizophrenia
145398|NCT02398279|L-Arginine|l-arginine
145399|NCT02398279|nitric oxide|nitric oxide
145400|NCT02398279|drug augmentation|drug augmentation
145401|NCT02398253|weight maintenance|weight maintenance
657496|NCT00807612|Apoptosis|apoptosis
145402|NCT02398253|cognitive behavior therapy|cognitive behavior therapy
145403|NCT02398253|successful weight loss|successful weight loss
145404|NCT02398227|Battered Women|battered women
145405|NCT02398227|Trauma|trauma
145406|NCT02398227|Domestic Violence|domestic violence
145407|NCT02398214|Sleep|sleep
145408|NCT02398214|Infants|infants
145409|NCT02398214|Toddlers|toddlers
145410|NCT02398214|Behavioral intervention|behavioral intervention
145411|NCT02398175|Pediatric polytrauma|pediatric polytrauma
145412|NCT02398175|thoracic injuries|thoracic injuries
145413|NCT02398162|Scrub Typhus in Pediatric|scrub typhus in pediatric
145414|NCT02398162|Immunology|immunology
145415|NCT02398136|intervention|intervention
145416|NCT02398136|ketamine|ketamine
145417|NCT02398136|PTSD|ptsd
145418|NCT02398136|treatment|treatment
145419|NCT02398136|posttraumatic stress disorder|posttraumatic stress disorder
145420|NCT02398123|Transversus Abdominis Plane|transversus abdominis plane
145421|NCT02398123|caudal block|caudal block
145422|NCT02398123|postoperative pain|postoperative pain
145423|NCT02398123|children|children
145424|NCT02398084|mastication|mastication
145425|NCT02398084|cashews|cashews
145426|NCT02398084|walnuts|walnuts
145427|NCT02398084|participants|participants
145428|NCT02398071|Positive Expiratory Pressure|positive expiratory pressure
145429|NCT02398071|Exercise Recovery|exercise recovery
145430|NCT02398071|COPD|copd
145431|NCT02398058|trabectedin|trabectedin
145432|NCT02398058|olaparib|olaparib
145434|NCT02398058|bone tumor|bone tumor
145435|NCT02398045|Obsessive-compulsive disorder|obsessive-compulsive disorder
145436|NCT02398045|cognitive behavioural therapy|cognitive behavioural therapy
145437|NCT02398045|computerised|computerised
145438|NCT02398032|sleep apnea|sleep apnea
145439|NCT02398032|hypertension|hypertension
145440|NCT02398032|mechanosensitivity|mechanosensitivity
145441|NCT02398032|chemosensitivity|chemosensitivity
145442|NCT02398032|adhesion factors|adhesion factors
145444|NCT02398019|OXIRIS®|oxiris®
145445|NCT02398019|SIRS|sirs
145446|NCT02398019|AKI|aki
145447|NCT02398019|Cytokines|cytokines
145448|NCT02398019|LPS|lps
145449|NCT02398006|Clavicle [mh]|clavicle [mh]
145450|NCT02398006|Fracture Healing [mh]|fracture healing [mh]
145451|NCT02398006|Fractures, Bone [mh]|fractures, bone [mh]
145452|NCT02398006|Treatment outcome [mh]|treatment outcome [mh]
145453|NCT02398006|Conservative treatment [tw]|conservative treatment [tw]
145454|NCT02397980|Caregivers|caregivers
145455|NCT02397967|NF1|nf1
145456|NCT02397967|children|children
145457|NCT02397967|reading disabilities|reading disabilities
145458|NCT02397954|idiopathic polypoidal choroidal vasculopathy|idiopathic polypoidal choroidal vasculopathy
145459|NCT02397954|IPCV|ipcv
145460|NCT02397954|Zimura®|zimura®
145461|NCT02397954|Avastin®|avastin®
145462|NCT02397954|Eylea®|eylea®
145463|NCT02397954|Lucentis®|lucentis®
145464|NCT02397928|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
145465|NCT02397928|Treatment|treatment
145466|NCT02397928|Minimal toxicity|minimal toxicity
145467|NCT02397928|TTFields|ttfields
145468|NCT02397928|Tumor Treating Fields|tumor treating fields
145469|NCT02397928|Novocure|novocure
145470|NCT02397928|Pemetrexed|pemetrexed
145471|NCT02397928|Carboplatin|carboplatin
145472|NCT02397928|Cisplatin|cisplatin
145473|NCT02397915|Nasal Spray|nasal spray
145474|NCT02397915|Fluticasone Furoate|fluticasone furoate
145475|NCT02397915|Attributes|attributes
145476|NCT02397915|Single Dose|single dose
145477|NCT02397915|Allergic Rhinitis|allergic rhinitis
145478|NCT02397915|Mometasone Furoate|mometasone furoate
145479|NCT02397915|Questionnaire|questionnaire
145480|NCT02397915|Preference|preference
145481|NCT02397889|posttraumatic stress disorder|posttraumatic stress disorder
145482|NCT02397889|PTSD|ptsd
145483|NCT02397889|ketamine|ketamine
145484|NCT02397889|trauma|trauma
145485|NCT02397889|treatment|treatment
145486|NCT02397889|New York|new york
145487|NCT02397889|NYC|nyc
145488|NCT02397876|Food Allergy|food allergy
145489|NCT02397876|Cows Milk Allergy|cows milk allergy
145490|NCT02397850|depression, chronic, psychotherapy, telephone, feasibility|depression, chronic, psychotherapy, telephone, feasibility
145491|NCT02397837|Bipolar Disorder|bipolar disorder
145492|NCT02397837|Cognition|cognition
145493|NCT02397785|chronic pelvic pain|chronic pelvic pain
145494|NCT02397785|electrical stimulation|electrical stimulation
145495|NCT02397785|pelvic floor rehabilitation|pelvic floor rehabilitation
145496|NCT02397785|neuromodulation|neuromodulation
145497|NCT02397772|Soil-transmitted helminths|soil-transmitted helminths
145498|NCT02397772|Intestinal Nematodes|intestinal nematodes
145499|NCT02397772|Hookworm|hookworm
145500|NCT02397772|Ascaris|ascaris
145501|NCT02397772|Mass Treatment|mass treatment
145502|NCT02397772|Kenya|kenya
145503|NCT02397746|osteoarthritis|osteoarthritis
145504|NCT02397746|avascular necrosis|avascular necrosis
145505|NCT02397746|ankylosis|ankylosis
145506|NCT02397746|protrusio acetabuli|protrusio acetabuli
657585|NCT00807898|mother|mother
145507|NCT02397746|rheumatoid arthritis|rheumatoid arthritis
145614|NCT02397018|cord blood|cord blood
145508|NCT02397746|correction of functional deformity|correction of functional deformity
145509|NCT02397746|revision procedures|revision procedures
145510|NCT02397720|Leukemia|leukemia
145511|NCT02397720|Acute myeloid leukemia|acute myeloid leukemia
145512|NCT02397720|AML|aml
145513|NCT02397720|Refractory/ relapsed|refractory/ relapsed
145514|NCT02397720|5-azacytidine|5-azacytidine
145515|NCT02397720|Azacitidine|azacitidine
145516|NCT02397720|5-aza|5-aza
145517|NCT02397720|Vidaza|vidaza
145518|NCT02397720|5-AZC|5-azc
145519|NCT02397720|AZA-CR|aza-cr
145520|NCT02397720|Ladakamycin|ladakamycin
145521|NCT02397720|NSC-102816|nsc-102816
145522|NCT02397720|Azacytidine|azacytidine
145523|NCT02397720|Nivolumab|nivolumab
145524|NCT02397720|BMS-936558|bms-936558
145525|NCT02397720|Phone calls|phone calls
145526|NCT02397694|Adult|adult
145527|NCT02397694|HIV|hiv
145528|NCT02397694|naive|naive
145529|NCT02397655|stroke|stroke
145530|NCT02397655|ischemia|ischemia
145531|NCT02397655|atherosclerosis|atherosclerosis
145532|NCT02397655|ultrasonography|ultrasonography
145533|NCT02397590|Fimasartan|fimasartan
145534|NCT02397564|scar|scar
145535|NCT02397564|ICD-10 CM:L90.5|icd-10 cm:l90.5
145536|NCT02397538|Fimasartan|fimasartan
145537|NCT02397447|Momordica Charantia|momordica charantia
145538|NCT02397447|Insulin secretion|insulin secretion
145539|NCT02397447|Insulin sensitivity|insulin sensitivity
145540|NCT02397434|assessment of QOL (EORTC QLQ-C30)|assessment of qol (eortc qlq-c30)
145541|NCT02397421|Heart failure|heart failure
145542|NCT02397421|Diabetes|diabetes
145543|NCT02397421|Left ventricular remodelling|left ventricular remodelling
145544|NCT02397421|SGLT-2 inhibitors|sglt-2 inhibitors
145545|NCT02397395|Renal Impairment|renal impairment
145546|NCT02397395|End-stage Renal Disease|end-stage renal disease
145547|NCT02397395|Simeprevir|simeprevir
145548|NCT02397395|Daclatasvir|daclatasvir
145549|NCT02397382|Psoriasis|psoriasis
145550|NCT02397382|Guselkumab|guselkumab
145551|NCT02397382|Cytochromes P450|cytochromes p450
145552|NCT02397369|Education and evaluate post intervention KAP|education and evaluate post intervention kap
145553|NCT02397356|ketamine|ketamine
145554|NCT02397343|Reduction of secondary hyperalgesia and/-or local inflammation|reduction of secondary hyperalgesia and/-or local inflammation
145555|NCT02397304|Intra-muscular triglyceride use|intra-muscular triglyceride use
145556|NCT02397291|Pregnancy|pregnancy
145557|NCT02397291|IUGR|iugr
145558|NCT02397265|Type 1 diabetes|type 1 diabetes
145559|NCT02397265|Hypoglycaemia|hypoglycaemia
145560|NCT02397265|Closed loop insulin pump|closed loop insulin pump
145561|NCT02397265|Artificial pancreas|artificial pancreas
145562|NCT02397265|Exercise|exercise
145563|NCT02397265|Mixed meals|mixed meals
145564|NCT02397265|Bihormonal pump|bihormonal pump
145565|NCT02397252|Human Papillomavirus|human papillomavirus
145566|NCT02397252|Screening|screening
145567|NCT02397252|Self-collection test|self-collection test
145568|NCT02397252|Pap test|pap test
145569|NCT02397226|Radiofrequency ablation|radiofrequency ablation
145570|NCT02397226|Plethysmography|plethysmography
145571|NCT02397226|Duplex ultrasound|duplex ultrasound
145572|NCT02397226|High ligation/stripping|high ligation/stripping
145573|NCT02397213|Ciclosporin|ciclosporin
145574|NCT02397213|Acute Kidney injury|acute kidney injury
145575|NCT02397213|Cardiac surgery|cardiac surgery
145576|NCT02397213|Ischemia|ischemia
145577|NCT02397213|Safety|safety
145578|NCT02397213|Cystatin C|cystatin c
145579|NCT02397200|Growth|growth
145580|NCT02397200|low weight|low weight
145581|NCT02397200|low height|low height
145582|NCT02397200|Nutritional Supplementation|nutritional supplementation
145583|NCT02397174|Polycystic Ovary syndrome|polycystic ovary syndrome
145584|NCT02397174|hypocaloric diet|hypocaloric diet
145585|NCT02397174|Ovarian Cysts|ovarian cysts
145586|NCT02397174|Ovarian Diseases|ovarian diseases
145587|NCT02397174|Obesity|obesity
145588|NCT02397174|Mediterranean Diet|mediterranean diet
145589|NCT02397135|genomic markers|genomic markers
145590|NCT02397083|Endometrial Cancer|endometrial cancer
145591|NCT02397083|Endometrial hyperplasia|endometrial hyperplasia
145592|NCT02397083|Intrauterine device|intrauterine device
136437|NCT02447159|Nigeria|nigeria
145593|NCT02397083|IUD|iud
145594|NCT02397083|Levonorgestrel intrauterine device|levonorgestrel intrauterine device
145595|NCT02397083|LIUD|liud
145596|NCT02397083|Mirena|mirena
145597|NCT02397083|Everolimus|everolimus
145598|NCT02397083|Afinitor|afinitor
145599|NCT02397083|Zortress|zortress
145600|NCT02397083|RAD001|rad001
145601|NCT02397083|Questionnaires|questionnaires
145602|NCT02397083|Survey|survey
145603|NCT02397083|Quality of life|quality of life
145604|NCT02397083|QOL|qol
145605|NCT02397070|Jaw exercise|jaw exercise
145606|NCT02397070|Occlusal splint|occlusal splint
145607|NCT02397070|Treatment|treatment
145608|NCT02397070|Muscular pain|muscular pain
145609|NCT02397070|Mandibular movement|mandibular movement
145610|NCT02397044|Implants, stability, loading|implants, stability, loading
145611|NCT02397031|borderline personality disorder|borderline personality disorder
145612|NCT02397031|mindfulness|mindfulness
145615|NCT02397018|umbilical cord blood|umbilical cord blood
145616|NCT02397018|hematopoietic stem cells|hematopoietic stem cells
145617|NCT02397018|acute ischemic stroke|acute ischemic stroke
145618|NCT02396992|Oropharyngeal Dysphagia|oropharyngeal dysphagia
145619|NCT02396992|Aspiration pneumonia|aspiration pneumonia
145620|NCT02396992|Malnutrition|malnutrition
145621|NCT02396992|Oral Health|oral health
145622|NCT02396992|Bacterial colonization|bacterial colonization
145623|NCT02396992|Aging|aging
145625|NCT02396940|Three-dimensional|three-dimensional
145626|NCT02396940|Laparoscopy|laparoscopy
145627|NCT02396940|Inguinal hernia repair|inguinal hernia repair
145628|NCT02396927|3D|3d
145629|NCT02396927|Three-dimensional|three-dimensional
145630|NCT02396927|laparoscopy|laparoscopy
145631|NCT02396927|cholecystectomy|cholecystectomy
145632|NCT02395887|Spinal stenosis|spinal stenosis
145633|NCT02395887|Spinal decompression|spinal decompression
145634|NCT02395887|Postural balance|postural balance
145635|NCT02395887|Neurogenic claudication|neurogenic claudication
145636|NCT02395848|recurrent|recurrent
145637|NCT02395848|infection|infection
145638|NCT02395835|body mass index|body mass index
145639|NCT02395835|methylation|methylation
145640|NCT02395835|PPAR gamma|ppar gamma
145641|NCT02395835|pregnancy|pregnancy
145642|NCT02395822|AML|aml
145643|NCT02395822|Relapsed|relapsed
145644|NCT02395822|Refractory|refractory
145645|NCT02396901|early goal direct therapy|early goal direct therapy
145646|NCT02396901|preventive strategies|preventive strategies
145647|NCT02396901|cardiac surgery|cardiac surgery
145648|NCT02396888|Blood vessel|blood vessel
145649|NCT02396888|Fibroplasia|fibroplasia
145650|NCT02396888|Wound healing|wound healing
145651|NCT02396888|Insulin|insulin
145652|NCT02396836|Hand hygiene|hand hygiene
145653|NCT02396836|Hand decontamination|hand decontamination
145654|NCT02396836|Microbial load|microbial load
145655|NCT02396836|Hand coverage|hand coverage
145656|NCT02396836|Glove juice technique|glove juice technique
145657|NCT02396836|Ayliffe technique|ayliffe technique
145658|NCT02396836|6 step technique|6 step technique
145659|NCT02396823|Blood pressure regulation|blood pressure regulation
145660|NCT02396823|Respiratory Muscle Training|respiratory muscle training
145661|NCT02396797|Sick leave|sick leave
145662|NCT02396797|Mental Health|mental health
145663|NCT02396797|Coping|coping
145664|NCT02396797|Social Support|social support
145665|NCT02396797|Subjective Health Complaints|subjective health complaints
145666|NCT02396784|child overweight|child overweight
145667|NCT02396784|child obesity|child obesity
145668|NCT02396784|prevention|prevention
145669|NCT02396784|targeted intervention|targeted intervention
145670|NCT02396784|development of overweight|development of overweight
145671|NCT02396771|Uterine|uterine
145672|NCT02396771|Massage|massage
145673|NCT02396771|Compression|compression
145674|NCT02396732|Aspirin|aspirin
145675|NCT02396732|Enoxaparin|enoxaparin
145676|NCT02396732|Thromboprophylaxis|thromboprophylaxis
145677|NCT02396732|Trauma|trauma
145678|NCT02396732|Venous thromboembolism|venous thromboembolism
145679|NCT02396693|Newborn|newborn
145680|NCT02396693|non invasive ventilation|non invasive ventilation
145681|NCT02396680|Ragweed Allergy|ragweed allergy
145682|NCT02396680|Rhinoconjunctivitis|rhinoconjunctivitis
145683|NCT02396680|Immunotherapy|immunotherapy
146371|NCT02392338|Hybrid|hybrid
145684|NCT02396680|Ragweed-SPIRE|ragweed-spire
145685|NCT02396641|Best Supportive Care|best supportive care
145686|NCT02396628|Graft-versus-Host Disease (GvHD)|graft-versus-host disease (gvhd)
145687|NCT02396628|resistance to therapy|resistance to therapy
145688|NCT02396628|allogeneic stem cell transplantation|allogeneic stem cell transplantation
145689|NCT02396628|Ruxolitinib|ruxolitinib
145690|NCT02396615|Ad libitum energy intake|ad libitum energy intake
145691|NCT02396615|Appetite|appetite
145692|NCT02396589|stroke rehabilitation|stroke rehabilitation
145693|NCT02396589|barriers to independence|barriers to independence
145694|NCT02396589|environmental support|environmental support
145695|NCT02396550|Expectations|expectations
145696|NCT02396537|Children|children
145697|NCT02396537|Midazolam|midazolam
145698|NCT02396537|Lidocaine|lidocaine
145699|NCT02396537|Intranasal|intranasal
145700|NCT02396524|Chronic Disease|chronic disease
145701|NCT02396524|Lifestyle Intervention|lifestyle intervention
145702|NCT02396524|Health Promotion|health promotion
145703|NCT02396524|Sport Mentorship|sport mentorship
145704|NCT02396524|Men|men
145705|NCT02396524|Health Technology|health technology
145706|NCT02396524|Prevention|prevention
145707|NCT02396524|Exercise|exercise
145708|NCT02396524|Diet|diet
145709|NCT02396472|social support|social support
145710|NCT02396459|Triac|triac
145711|NCT02396459|MCT8|mct8
145712|NCT02396459|Allan-Herndon-Dudley Syndrome|allan-herndon-dudley syndrome
145713|NCT02396433|Halaven|halaven
145714|NCT02396433|BRCA|brca
145715|NCT02396433|E7449|e7449
145716|NCT02396420|BPH|bph
145717|NCT02396420|prostatic hyperplasia|prostatic hyperplasia
145718|NCT02396420|enlarged prostate|enlarged prostate
145719|NCT02396420|benign prostatic hypertrophy|benign prostatic hypertrophy
145720|NCT02396407|Chlorine water treatment|chlorine water treatment
145721|NCT02396407|Point-of-use water treatment|point-of-use water treatment
145722|NCT02396407|Household water treatment with safe storage|household water treatment with safe storage
145723|NCT02396407|Handwashing with soap|handwashing with soap
145724|NCT02396407|Hand hygiene|hand hygiene
145725|NCT02396407|Latrines|latrines
145726|NCT02396407|Child potties|child potties
145727|NCT02396407|Intestinal parasitic infection|intestinal parasitic infection
145728|NCT02396407|Soil-transmitted helminths|soil-transmitted helminths
145729|NCT02396407|Water|water
145730|NCT02396407|Sanitation|sanitation
145731|NCT02396407|Handwashing|handwashing
145732|NCT02396407|Diarrhea|diarrhea
145733|NCT02396407|Herd immunity|herd immunity
145734|NCT02396407|Helminths|helminths
145735|NCT02396394|HIV|hiv
145736|NCT02396394|ART Adherence|art adherence
145737|NCT02396394|Retention in Care|retention in care
145738|NCT02396394|Pregnant Women|pregnant women
145739|NCT02396394|Postpartum Women|postpartum women
145740|NCT02396381|Candidate modified risk tobacco product|candidate modified risk tobacco product
145741|NCT02396381|Conventional cigarette|conventional cigarette
145742|NCT02396381|Exposure response|exposure response
145743|NCT02396381|Smoking|smoking
145744|NCT02396381|Tobacco Heating System|tobacco heating system
145745|NCT02396368|Prostate cancer|prostate cancer
145746|NCT02396368|Bone metastatic Castration-Resistant Prostate Cancer|bone metastatic castration-resistant prostate cancer
145747|NCT02396368|Radium 223|radium 223
145748|NCT02396368|Tasquinimod|tasquinimod
145749|NCT02396355|flow cytometry|flow cytometry
145750|NCT02396342|Hemophilia B, gene therapy|hemophilia b, gene therapy
145751|NCT02396303|General: To compare Carbetocin and Oxytocin for the control of PPH.|general: to compare carbetocin and oxytocin for the control of pph.
145752|NCT02396290|acne scar|acne scar
145753|NCT02396290|fractional carbon dioxide laser|fractional carbon dioxide laser
145754|NCT02396290|platelet rich plasma|platelet rich plasma
145755|NCT02396264|Mediterranean Diet|mediterranean diet
145756|NCT02396264|Ovarian Cysts|ovarian cysts
145757|NCT02396264|Treatment|treatment
145758|NCT02396264|Ovarian Diseases|ovarian diseases
145759|NCT02396264|normocaloric diet|normocaloric diet
145760|NCT02396225|voriconazole|voriconazole
145761|NCT02396225|inhalation|inhalation
145762|NCT02396225|aerosol|aerosol
145763|NCT02396225|epithelial lining fluid|epithelial lining fluid
145764|NCT02396225|concentration|concentration
145765|NCT02396225|pharmacokinetic|pharmacokinetic
145766|NCT02396199|Abdominal aortic aneurysm|abdominal aortic aneurysm
145767|NCT02396199|Endovascular|endovascular
145768|NCT02396199|Juxtarenal|juxtarenal
145769|NCT02396199|Pararenal|pararenal
145770|NCT02396199|Fenestrated|fenestrated
145771|NCT02396173|disability|disability
145772|NCT02396173|vocational|vocational
145773|NCT02396173|rehabilitation|rehabilitation
145774|NCT02396173|prediction|prediction
145775|NCT02396160|overactive bladder|overactive bladder
145776|NCT02396160|urinary incontinence|urinary incontinence
145777|NCT02396160|nocturia|nocturia
145778|NCT02396160|urinary frequency|urinary frequency
145779|NCT02396147|Drug therapy|drug therapy
145780|NCT02396095|female|female
145781|NCT02396095|cancer|cancer
145782|NCT02396082|care coordination|care coordination
145783|NCT02396082|quality of life|quality of life
145784|NCT02396082|community-based|community-based
145785|NCT02396082|care quality|care quality
145786|NCT02396082|Long term care placement|long term care placement
145787|NCT02396082|memory care|memory care
145788|NCT02396082|Neuropsychiatric behaviors|neuropsychiatric behaviors
145789|NCT02396056|Guided Bone Regeneration|guided bone regeneration
145790|NCT02396056|Gingival Mesenchymal Stem Cells|gingival mesenchymal stem cells
145791|NCT02395991|gadoxetic acid|gadoxetic acid
145792|NCT02395991|transient dyspnea|transient dyspnea
752599|NCT01173276|Infertility|infertility
136673|NCT02445872|Nausea|nausea
145793|NCT02395965|Osteopathic manipulative medicine|osteopathic manipulative medicine
145794|NCT02395965|Osteopathic manipulative treatment|osteopathic manipulative treatment
145795|NCT02395952|cornea|cornea
145796|NCT02395952|epithelial defect|epithelial defect
145797|NCT02395952|amniotic membrane|amniotic membrane
145798|NCT02395939|Cryobiopsy|cryobiopsy
145799|NCT02395939|Radial EBUS|radial ebus
145800|NCT02395939|Guide Sheath|guide sheath
145801|NCT02395939|Peripheral pulmonary lesions|peripheral pulmonary lesions
145802|NCT02395796|epidural|epidural
145803|NCT02395796|labor analgesia|labor analgesia
145804|NCT02395796|pressure monitoring|pressure monitoring
145805|NCT02395783|Preterm infants|preterm infants
145806|NCT02395783|diagnosis of cerebral white matter injury|diagnosis of cerebral white matter injury
145807|NCT02395770|Shoulder|shoulder
145808|NCT02395770|Rotator cuff|rotator cuff
145809|NCT02395770|Rehabilitation|rehabilitation
145810|NCT02395770|Motor control|motor control
145811|NCT02395757|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
145812|NCT02395757|Microperimetry|microperimetry
145813|NCT02395757|Diagnostic|diagnostic
145814|NCT02395731|dual eligible|dual eligible
145815|NCT02395731|care coordination|care coordination
145816|NCT02395731|community-based|community-based
145817|NCT02395731|care quality|care quality
145818|NCT02395731|care needs|care needs
145819|NCT02395731|health services|health services
145820|NCT02395731|care management|care management
145821|NCT02395731|low income|low income
145822|NCT02395731|Neuropsychiatric behaviors|neuropsychiatric behaviors
145823|NCT02395718|elderly|elderly
145824|NCT02395718|quick diagnostic unit|quick diagnostic unit
145825|NCT02395718|short stay unit|short stay unit
145826|NCT02395718|randomised controlled trial|randomised controlled trial
145827|NCT02395679|Dendritic cell-based immunotherapy|dendritic cell-based immunotherapy
145828|NCT02395666|Neuroblastoma in remission|neuroblastoma in remission
145829|NCT02395666|Relapsed Neuroblastoma|relapsed neuroblastoma
145830|NCT02395666|Refractory Neuroblastoma|refractory neuroblastoma
145831|NCT02395653|Pediatric|pediatric
145832|NCT02395653|Postoperative|postoperative
145833|NCT02395653|Pain Management|pain management
145834|NCT02395627|Hormone Therapy Resistant|hormone therapy resistant
145835|NCT02395627|Estrogen Receptor-Positive|estrogen receptor-positive
145836|NCT02395627|Estrogen Receptor-Negative|estrogen receptor-negative
145837|NCT02395614|tissue expander|tissue expander
145838|NCT02395614|breast reconstruction|breast reconstruction
145839|NCT02395601|B-Cell Lymphoma|b-cell lymphoma
145840|NCT02395601|EZH2 Inhibitor|ezh2 inhibitor
145841|NCT02395601|Phase 1|phase 1
145842|NCT02395497|Penile Transplant|penile transplant
145843|NCT02395497|VCA|vca
145844|NCT02395497|CTA|cta
145845|NCT02395497|Penis|penis
145846|NCT02395497|Amputation|amputation
145847|NCT02395497|Immunosuppression|immunosuppression
145848|NCT02395497|Composite Tissue|composite tissue
145849|NCT02395497|Male|male
145850|NCT02395497|Humans|humans
145851|NCT02395497|Allotransplantation|allotransplantation
145852|NCT02395458|Sequential therapy|sequential therapy
145853|NCT02395458|Triple therapy|triple therapy
145854|NCT02395458|Eradication|eradication
145855|NCT02395393|Acute rejection|acute rejection
145856|NCT02395393|Chronic rejection|chronic rejection
145857|NCT02395393|Confocal microscopy|confocal microscopy
145858|NCT02395380|CRP|crp
145859|NCT02395380|Postoperative complication|postoperative complication
145860|NCT02395380|Length of stay|length of stay
145861|NCT02395367|Prognosis|prognosis
145862|NCT02395367|Risk Factors|risk factors
145863|NCT02395354|Endoscopic treatment|endoscopic treatment
145864|NCT02395354|Stenosis|stenosis
145865|NCT02395354|Crohn's Disease|crohn's disease
145866|NCT02395354|balloon dilatation|balloon dilatation
145867|NCT02395354|self-expanding metallic stent|self-expanding metallic stent
145868|NCT02395354|chronic transmural inflammation|chronic transmural inflammation
145869|NCT02395354|steady narrowing of the intestinal lumen|steady narrowing of the intestinal lumen
145870|NCT02395341|reproductive hormones|reproductive hormones
145871|NCT02395341|cancer survivors|cancer survivors
145872|NCT02395341|endocrine function|endocrine function
145873|NCT02395341|antral follicle counts|antral follicle counts
145874|NCT02395341|female infertility due to diminished ovarian reserve|female infertility due to diminished ovarian reserve
145875|NCT02395341|perimenopause|perimenopause
145876|NCT02395341|premature menopause|premature menopause
145877|NCT02395328|Orphans and vulnerable children (OVC)|orphans and vulnerable children (ovc)
145881|NCT02395315|Diabetes Mellitus|diabetes mellitus
145882|NCT02395315|Osseointegration|osseointegration
145883|NCT02395315|Bone vascularity|bone vascularity
145884|NCT02395315|Primary implant stability|primary implant stability
145885|NCT02395289|Cognitive-Based Compassion Training (CBCT)|cognitive-based compassion training (cbct)
145886|NCT02395289|HIV-related clinical outcomes|hiv-related clinical outcomes
145887|NCT02395289|Stress and stress-related psychological adjustment|stress and stress-related psychological adjustment
145888|NCT02395289|Stress-related inflammatory biomarkers|stress-related inflammatory biomarkers
145889|NCT02395276|Congenital Heart Defects|congenital heart defects
145890|NCT02395276|Hypoxic Ischemic Brain Injury|hypoxic ischemic brain injury
145891|NCT02395276|Hypothermia Therapy|hypothermia therapy
145892|NCT02395276|Pediatrics|pediatrics
145893|NCT02395237|Fed Conditions|fed conditions
145894|NCT02395224|Follow-up studies|follow-up studies
145895|NCT02395224|Prognosis|prognosis
145896|NCT02395224|Palliative care|palliative care
145897|NCT02395224|Chemotherapy, adjuvant|chemotherapy, adjuvant
145898|NCT02395224|Cost-benefit analysis|cost-benefit analysis
145899|NCT02395224|Population|population
145900|NCT02395224|Antineoplastic agents/Adverse effects|antineoplastic agents/adverse effects
657586|NCT00807898|daughter|daughter
145901|NCT02395224|Terminal care|terminal care
145902|NCT02395224|Medical futility|medical futility
145903|NCT02395224|Survival rate|survival rate
145904|NCT02395224|Norway|norway
145905|NCT02395198|hepatitis c virus|hepatitis c virus
145906|NCT02395198|opioid substitution treatment|opioid substitution treatment
145907|NCT02395172|avelumab|avelumab
145908|NCT02395172|MSB0010718C|msb0010718c
145909|NCT02395172|Non-Small Cell Lung Cancer|non-small cell lung cancer
145910|NCT02395172|Anti-PD-L1|anti-pd-l1
145911|NCT02395159|vascular surgery patients|vascular surgery patients
145912|NCT02395159|wound management|wound management
145913|NCT02395133|Eczema|eczema
145914|NCT02395120|Dental Care|dental care
145915|NCT02395120|Caregiver Illness Perception|caregiver illness perception
145916|NCT02395120|Common Sense Model of Self-Regulation|common sense model of self-regulation
145917|NCT02395120|Dental Access|dental access
145918|NCT02395120|Referral letter|referral letter
145919|NCT02395120|Dental Caries|dental caries
145920|NCT02395107|Aortic Valve Stenosis|aortic valve stenosis
145921|NCT02395107|Functional Capacity|functional capacity
145922|NCT02395107|Cardiomyopathies|cardiomyopathies
145923|NCT02395107|Endomyocardial Fibrosis|endomyocardial fibrosis
145924|NCT02395107|Cardiovascular Diseases|cardiovascular diseases
145925|NCT02395107|Heart Diseases|heart diseases
145926|NCT02395107|Heart Valve Diseases|heart valve diseases
145927|NCT02395107|Atrial Fibrillation|atrial fibrillation
145928|NCT02395107|Hypertrophy|hypertrophy
145929|NCT02395107|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
145930|NCT02395107|Diastology|diastology
145931|NCT02395081|pregnancy|pregnancy
145932|NCT02395081|Mongolia|mongolia
145933|NCT02395081|Vitamin D|vitamin d
145934|NCT02395081|preeclampsia|preeclampsia
145935|NCT02395068|Pharmacokinetics|pharmacokinetics
145936|NCT02395068|Nimotuzumab|nimotuzumab
145937|NCT02395068|Safety|safety
145938|NCT02395068|Effcacy|effcacy
145939|NCT02395068|Irinotecan|irinotecan
145941|NCT02395003|Obesity|obesity
145942|NCT02395003|Pediatric|pediatric
145943|NCT02394977|CPR|cpr
145944|NCT02394977|Cardio first angle|cardio first angle
145945|NCT02394977|Clinical trial|clinical trial
145946|NCT02394951|chemotherapy|chemotherapy
145947|NCT02394938|Music therapy|music therapy
145948|NCT02394912|vena cava filter|vena cava filter
145949|NCT02394899|SCD|scd
145950|NCT02394899|early childhood intervention|early childhood intervention
145951|NCT02394899|parental stress|parental stress
145952|NCT02394899|neurocognition|neurocognition
145953|NCT02394873|Deep Second-Degree Burn Wound|deep second-degree burn wound
145954|NCT02394847|propofol|propofol
145955|NCT02394847|electroconvulsive therapy|electroconvulsive therapy
145956|NCT02394847|anesthesia|anesthesia
145957|NCT02394834|Metastatic colorectal cancer, Panitumumab, mFOLFOX6, Bevacizumab|metastatic colorectal cancer, panitumumab, mfolfox6, bevacizumab
145958|NCT02394795|Metastatic colorectal cancer, Panitumumab, mFOLFOX6, Bevacizumab|metastatic colorectal cancer, panitumumab, mfolfox6, bevacizumab
145959|NCT02394782|Multiple sclerosis, relapsing-remitting|multiple sclerosis, relapsing-remitting
145960|NCT02394782|Rebif|rebif
145961|NCT02394782|Interferon beta-1a|interferon beta-1a
145962|NCT02394782|RebiSmart®2.0|rebismart®2.0
145963|NCT02394782|MSdialog™|msdialog™
145964|NCT02394769|Colorectal Cancer|colorectal cancer
145965|NCT02394743|Glomerular Filtration Rate|glomerular filtration rate
145966|NCT02394730|HIV, d-dimer, hs-CRP, activated T-lymphocytes|hiv, d-dimer, hs-crp, activated t-lymphocytes
145967|NCT02394704|Rumination|rumination
146477|NCT02391662|Gemcitabine|gemcitabine
145968|NCT02394704|Sensory processing|sensory processing
145969|NCT02394704|Non-pharmacological intervention|non-pharmacological intervention
145970|NCT02394704|Depression|depression
145971|NCT02394704|Anxiety|anxiety
145972|NCT02394704|PTSD|ptsd
145973|NCT02394665|Glioblastoma|glioblastoma
145974|NCT02394665|Gliosarcoma|gliosarcoma
145975|NCT02394665|GBM|gbm
145976|NCT02394626|Recurrent glioblastoma|recurrent glioblastoma
145977|NCT02394626|Surgery|surgery
145978|NCT02394626|Complete resection of enhancing tumor|complete resection of enhancing tumor
145979|NCT02394626|Survival|survival
145980|NCT02394626|Quality of life|quality of life
145981|NCT02394613|Glaucoma|glaucoma
145982|NCT02394613|DARC|darc
145983|NCT02394613|Diagnosis|diagnosis
176266|NCT02227004|MRI|mri
145984|NCT02394600|rhinitis|rhinitis
145985|NCT02394600|allergy|allergy
145986|NCT02394587|mindfulness|mindfulness
145987|NCT02394587|MBSR|mbsr
145988|NCT02394587|SCD|scd
145989|NCT02394587|experimental|experimental
145990|NCT02394548|Locally advanced, inoperable non-small cell lung carcinoma|locally advanced, inoperable non-small cell lung carcinoma
145991|NCT02394548|Limited stage small cell lung carcinoma|limited stage small cell lung carcinoma
145992|NCT02394548|Acute esophagitis|acute esophagitis
145993|NCT02394548|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
145994|NCT02394535|Pancreatic Cancer|pancreatic cancer
145995|NCT02394535|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
145996|NCT02394535|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
145997|NCT02394535|Abraxane|abraxane
145998|NCT02394535|Nab-Paclitaxel|nab-paclitaxel
145999|NCT02394535|Paclitaxel (Protein-Bound)|paclitaxel (protein-bound)
146000|NCT02394535|ABI-007|abi-007
146001|NCT02394535|Radiation therapy|radiation therapy
146002|NCT02394535|XRT|xrt
146003|NCT02394535|Capecitabine|capecitabine
146004|NCT02394535|Xeloda|xeloda
146005|NCT02394535|Questionnaires|questionnaires
146006|NCT02394535|Surveys|surveys
146007|NCT02394522|Malaria|malaria
146008|NCT02394522|Spatial Repellents|spatial repellents
146009|NCT02394522|Plasmodium|plasmodium
146010|NCT02394509|Epilepsy Memory Problems|epilepsy memory problems
146011|NCT02394509|Self-Management|self-management
146012|NCT02394496|Fulvestrant|fulvestrant
146013|NCT02394496|Lapatinib|lapatinib
146014|NCT02394496|Aromatase Inhibitor|aromatase inhibitor
146015|NCT02394496|metastatic breast cancer|metastatic breast cancer
146016|NCT02394483|Single ascending dose|single ascending dose
146017|NCT02394483|double blind|double blind
146018|NCT02394470|congestion|congestion
146019|NCT02394470|total body water|total body water
146020|NCT02394470|bioimpedentiometry|bioimpedentiometry
146021|NCT02394470|lung ultrasound|lung ultrasound
146022|NCT02394470|diuretics|diuretics
146023|NCT02394470|dyspnea|dyspnea
146024|NCT02394470|pulmonary B lines|pulmonary b lines
146025|NCT02394470|deuterium|deuterium
146026|NCT02394457|Postdural puncture headache|postdural puncture headache
146027|NCT02394457|Epidural Blood Patch|epidural blood patch
146028|NCT02394457|Cosyntropin|cosyntropin
146029|NCT02394457|PDPH|pdph
146030|NCT02394457|Regional anesthesia|regional anesthesia
146031|NCT02394457|Lumbar puncture|lumbar puncture
146032|NCT02394457|ACTH|acth
146033|NCT02394457|Tetracosactin|tetracosactin
146034|NCT02394444|Intervention program|intervention program
146035|NCT02394444|Parenting stress|parenting stress
146036|NCT02394444|Parental mental health|parental mental health
146037|NCT02394444|Preterm infant's development|preterm infant's development
146038|NCT02394431|Sickle Cell Disease|sickle cell disease
146039|NCT02394431|Echocardiography|echocardiography
146040|NCT02394431|Speckle tracking|speckle tracking
146041|NCT02394392|Medication satisfaction|medication satisfaction
146042|NCT02394392|Quality of life|quality of life
146043|NCT02394392|Drug compliance|drug compliance
146044|NCT02394366|Skin oxygenation|skin oxygenation
146045|NCT02394366|peripheral perfusion|peripheral perfusion
146046|NCT02394353|bariatrics|bariatrics
146047|NCT02394353|transient elastography|transient elastography
146048|NCT02394314|MEDI0382, diabetes|medi0382, diabetes
146049|NCT02394301|Efficacy of Novel Drug Combinations for Relief of Psoriasis|efficacy of novel drug combinations for relief of psoriasis
146050|NCT02394288|Cardiac Troponin|cardiac troponin
146051|NCT02394288|Perioperative Period|perioperative period
146052|NCT02394288|surgery|surgery
146053|NCT02394262|Biological Markers|biological markers
146054|NCT02394262|Multidetector Computed Tomography|multidetector computed tomography
146055|NCT02394249|Insulin Resistance|insulin resistance
146056|NCT02394249|Cognition|cognition
146057|NCT02394249|Affect|affect
146058|NCT02394249|Insulin|insulin
146059|NCT02394249|Lipids|lipids
146060|NCT02394236|exercise training|exercise training
146061|NCT02394223|Cancer|cancer
146062|NCT02394223|Prostate|prostate
146063|NCT02394223|PSA|psa
146064|NCT02394223|Biopsies|biopsies
146065|NCT02394223|FFOCT procedure|ffoct procedure
146066|NCT02394210|Multiple myeloma asymptomatic relapse symptomatic relapse|multiple myeloma asymptomatic relapse symptomatic relapse
146067|NCT02394210|IMW Consensus Panel|imw consensus panel
146068|NCT02394210|anti-MM therapy|anti-mm therapy
146069|NCT02394197|Plasmodium vivax|plasmodium vivax
146070|NCT02394197|Mexico|mexico
146071|NCT02394197|treatment|treatment
146072|NCT02394197|chloroquine|chloroquine
146073|NCT02394197|primaquine|primaquine
146074|NCT02394197|14-day treatment (T14)|14-day treatment (t14)
146075|NCT02394197|intermittent single doses (ISD)|intermittent single doses (isd)
146076|NCT02394184|transcatheter aortic valve replacement|transcatheter aortic valve replacement
146077|NCT02394171|Physical Activity|physical activity
146078|NCT02394171|Social Cohesion|social cohesion
146079|NCT02394171|Intervention Development|intervention development
136980|NCT02444091|CFS|cfs
146080|NCT02394171|Ethnic Minorities|ethnic minorities
146081|NCT02394171|Nutrition|nutrition
146082|NCT02394158|Recurrent Gestational Diabetes Mellitus|recurrent gestational diabetes mellitus
146083|NCT02394158|Prevention|prevention
146084|NCT02394158|Metformin|metformin
146085|NCT02394145|platelet|platelet
146086|NCT02394145|ticagrelor|ticagrelor
146087|NCT02394145|clopidogrel|clopidogrel
146088|NCT02394145|end stage renal disease|end stage renal disease
146089|NCT02394145|hemodialysis|hemodialysis
146090|NCT02394145|genetics|genetics
146091|NCT02394132|Lentigo maligna|lentigo maligna
146092|NCT02394132|Imiquimod|imiquimod
146093|NCT02394132|Radiotherapy|radiotherapy
146094|NCT02394054|vasopressin|vasopressin
146095|NCT02394054|intranasal administration|intranasal administration
146096|NCT02394054|healthy sample|healthy sample
146097|NCT02394041|acupuncture|acupuncture
146098|NCT02394041|cervical dystocia|cervical dystocia
146099|NCT02394041|caesarean section|caesarean section
146100|NCT02394041|obstetric labor|obstetric labor
146101|NCT02394041|randomized controlled trial|randomized controlled trial
146102|NCT02394015|Platinum-sensitive Recurrent Ovarian Cancer|platinum-sensitive recurrent ovarian cancer
146103|NCT02394002|EEG, burst-suppression, N20, SEP, median nerve, facilitation|eeg, burst-suppression, n20, sep, median nerve, facilitation
146104|NCT02393911|vestibulitis|vestibulitis
146105|NCT02393911|microbiome|microbiome
146106|NCT02393872|Prevention|prevention
146107|NCT02393859|ALL|all
146108|NCT02393859|High-risk first relapse B-precursor ALL|high-risk first relapse b-precursor all
146109|NCT02393859|Precursor Cell Lymphoblastic Leukemia|precursor cell lymphoblastic leukemia
146110|NCT02393859|Neoplasms|neoplasms
146111|NCT02393859|Lymphoproliferative Disorders|lymphoproliferative disorders
146112|NCT02393859|Immunoproliferative Disorders|immunoproliferative disorders
146113|NCT02393859|Antibodies, Bispecific|antibodies, bispecific
146114|NCT02393846|ankle sprain|ankle sprain
146115|NCT02393846|topical ketoprofen|topical ketoprofen
146116|NCT02393846|non-steroidal anti-inflammatory drug|non-steroidal anti-inflammatory drug
146117|NCT02393846|emergency department|emergency department
146118|NCT02393833|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
146119|NCT02393833|Vascular cell adhesion molecule-1 (VCAM-1)|vascular cell adhesion molecule-1 (vcam-1)
146120|NCT02393833|HER2-ECD|her2-ecd
146121|NCT02393807|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
146122|NCT02393794|BRCA1|brca1
146123|NCT02393794|BRCA2|brca2
146124|NCT02393794|TNBC|tnbc
146125|NCT02393781|severe sepsis|severe sepsis
146126|NCT02393781|septic shock|septic shock
146127|NCT02393781|adrenomedullin|adrenomedullin
146128|NCT02393781|organ dysfunction|organ dysfunction
146129|NCT02393703|exosomes|exosomes
146130|NCT02393703|15-015|15-015
146131|NCT02393664|Thoracoscopy|thoracoscopy
146132|NCT02393664|Recovery|recovery
146133|NCT02393664|Tracheal intubation|tracheal intubation
146134|NCT02393638|Endoscopic Sphincterotomy|endoscopic sphincterotomy
146135|NCT02393625|NSCLC, ALK-positive|nsclc, alk-positive
146136|NCT02393586|Tuberculosis|tuberculosis
146137|NCT02393586|Whole blood Bactericidal Activity|whole blood bactericidal activity
146138|NCT02393586|WBA|wba
146139|NCT02393586|Faropenem|faropenem
146140|NCT02393573|Insulin Resistance|insulin resistance
146141|NCT02393573|Protein balance|protein balance
146142|NCT02393573|Surgery|surgery
146143|NCT02393573|Post operative complications|post operative complications
146144|NCT02393573|metformin|metformin
146145|NCT02393573|Pre-diabetes|pre-diabetes
146146|NCT02393573|Fasting blood glucose|fasting blood glucose
146147|NCT02393547|obesity|obesity
146148|NCT02393534|Primary Care|primary care
146149|NCT02393534|Health Services Research|health services research
146150|NCT02393534|Telemedicine|telemedicine
146151|NCT02393521|Vibration|vibration
146152|NCT02393521|Pressure Pain Threshold|pressure pain threshold
146153|NCT02393521|Trigger Points|trigger points
146154|NCT02393521|Neck Pain|neck pain
146155|NCT02393508|transfusion, red blood cell|transfusion, red blood cell
146156|NCT02393508|transfusion reaction|transfusion reaction
146157|NCT02393508|quality of life|quality of life
146158|NCT02393443|oxytocin|oxytocin
146159|NCT02393443|healthy sample|healthy sample
146160|NCT02393443|intranasal administration|intranasal administration
146161|NCT02393443|learning|learning
146162|NCT02393417|Verruca vulgaris|verruca vulgaris
146163|NCT02393417|Common Warts|common warts
146164|NCT02393378|Drug Therapy|drug therapy
146165|NCT02393365|Hepatitis C|hepatitis c
146166|NCT02393365|HCV|hcv
146168|NCT02393352|Body Composition|body composition
146169|NCT02393352|Autonomic Nervous System|autonomic nervous system
146170|NCT02393352|Oxygen|oxygen
146171|NCT02393352|Randomized Controlled Trial|randomized controlled trial
146172|NCT02393300|tranexamic acid|tranexamic acid
146173|NCT02393300|blood loss|blood loss
146174|NCT02393300|topical administration|topical administration
146175|NCT02393300|intravenous administration|intravenous administration
137052|NCT02443636|Suicide|suicide
146176|NCT02393248|alterations in FGF or FGFR|alterations in fgf or fgfr
146177|NCT02393248|squamous non-small cell lung cancer|squamous non-small cell lung cancer
146178|NCT02393248|gastric cancer|gastric cancer
146179|NCT02393248|urothelial cancer|urothelial cancer
146180|NCT02393248|endometrial cancer|endometrial cancer
146181|NCT02393248|multiple myeloma|multiple myeloma
146182|NCT02393248|MPN|mpn
146183|NCT02393235|unexplained infertility|unexplained infertility
146184|NCT02393235|tubal infertility|tubal infertility
146185|NCT02393235|pulsatility index|pulsatility index
146186|NCT02393235|resistance index|resistance index
146187|NCT02393235|fertile women|fertile women
146188|NCT02393222|Dialysis|dialysis
146189|NCT02393222|Cerebrovascular disease|cerebrovascular disease
146190|NCT02393222|ESRD|esrd
146191|NCT02393209|Drug therapy|drug therapy
146192|NCT02393196|colloid preloading|colloid preloading
146193|NCT02393196|colloid coloading|colloid coloading
146194|NCT02393183|Antioxidant|antioxidant
146195|NCT02393183|Graves' ophthalmopathy|graves' ophthalmopathy
146196|NCT02393183|Thyroid eye disease|thyroid eye disease
146197|NCT02393183|Severity score|severity score
146198|NCT02393183|Activity score|activity score
146199|NCT02393183|Quality of life|quality of life
146200|NCT02393144|Labor analysis|labor analysis
146201|NCT02393144|Transperineal ultrasound imaging|transperineal ultrasound imaging
146202|NCT02393144|Labor curve|labor curve
146203|NCT02393131|Brain Metastases|brain metastases
146204|NCT02393131|Whole Brain Radiotherapy|whole brain radiotherapy
146205|NCT02393131|Neurocognitive function|neurocognitive function
146206|NCT02393118|Assistive technology|assistive technology
146207|NCT02393118|Non-surgical visual prosthetic|non-surgical visual prosthetic
146208|NCT02393118|sensory substitution|sensory substitution
146209|NCT02393118|BrainPort|brainport
146210|NCT02393118|Blindness|blindness
146211|NCT02393118|Assistive device|assistive device
146212|NCT02393105|Breast Cancer|breast cancer
146213|NCT02393079|Traumatic Brain Injury|traumatic brain injury
146214|NCT02393079|Cognitive|cognitive
146215|NCT02393053|Gingival Recession|gingival recession
146216|NCT02393053|Case-Control Studies|case-control studies
146217|NCT02393053|Adipose Tissue|adipose tissue
146218|NCT02393040|Alopecia|alopecia
146219|NCT02393040|Androgenetic Alopecia|androgenetic alopecia
146220|NCT02393040|Alopecia, Male Pattern|alopecia, male pattern
146221|NCT02393040|Hair loss|hair loss
146222|NCT02393040|Platelet-Rich Plasma|platelet-rich plasma
146223|NCT02393040|Alopecia, Female Pattern|alopecia, female pattern
146224|NCT02393040|placebo|placebo
146225|NCT02393040|double-blind|double-blind
146226|NCT02393014|65 years old or older|65 years old or older
146227|NCT02393014|hospitalized in|hospitalized in
146228|NCT02393014|geriatrics|geriatrics
146229|NCT02393001|skin cancer|skin cancer
146230|NCT02393001|suspicious lesion|suspicious lesion
146231|NCT02393001|skin biopsy|skin biopsy
146232|NCT02393001|noninvasive|noninvasive
146233|NCT02393001|screening|screening
146234|NCT02392962|proprioception|proprioception
146235|NCT02392962|countermovement jump|countermovement jump
146236|NCT02392962|postural balance|postural balance
146237|NCT02392949|Spine|spine
146238|NCT02392949|mobilization|mobilization
146239|NCT02392936|according to the definition of the Comité Technique des Infections Nosocomiales et Liées aux Soins (2007)|according to the definition of the comité technique des infections nosocomiales et liées aux soins (2007)
146240|NCT02392923|health related quality of life|health related quality of life
146241|NCT02392910|Iron Sucrose|iron sucrose
146242|NCT02392910|Mortality|mortality
146243|NCT02392910|Hospitalization|hospitalization
146244|NCT02392897|meal frequency|meal frequency
146245|NCT02392897|eating frequency|eating frequency
146246|NCT02392897|ingestive frequency|ingestive frequency
146247|NCT02392897|Positive energy balance|positive energy balance
146248|NCT02392897|Satiation|satiation
146249|NCT02392884|Human Immunodeficiency Virus|human immunodeficiency virus
146250|NCT02392884|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
146251|NCT02392884|Cognitive Rehabilitation|cognitive rehabilitation
146252|NCT02392884|Minority Health|minority health
146253|NCT02392884|Vulnerable Populations|vulnerable populations
146254|NCT02392884|Underserved, Patients|underserved, patients
146255|NCT02392884|Medication Adherence|medication adherence
146256|NCT02392884|Medication Compliance|medication compliance
146257|NCT02392884|Medication Non-compliance|medication non-compliance
146258|NCT02392884|Medication Persistence|medication persistence
146259|NCT02392884|Medication Non-Adherence|medication non-adherence
146260|NCT02392871|Metastatic melanoma|metastatic melanoma
146261|NCT02392871|Palliative radiotherapy|palliative radiotherapy
146262|NCT02392845|Drug combination|drug combination
146263|NCT02392845|Accelerated chemotherapy|accelerated chemotherapy
146264|NCT02392845|Mathematical model|mathematical model
146265|NCT02392845|Hematotoxicity|hematotoxicity
146266|NCT02392845|Individualized dosage|individualized dosage
146267|NCT02392832|long-lasting microbial larvicide|long-lasting microbial larvicide
146268|NCT02392832|intervention|intervention
146269|NCT02392832|cluster randomised controlled trial|cluster randomised controlled trial
146270|NCT02392832|Anopheles mosquito|anopheles mosquito
146271|NCT02392806|Continuous positive airway pressure|continuous positive airway pressure
146272|NCT02392806|CPAP|cpap
146273|NCT02392806|Bubble CPAP|bubble cpap
146274|NCT02392806|Extubation failure|extubation failure
146275|NCT02392806|Preterm infant|preterm infant
146276|NCT02392767|L-Arginine|l-arginine
146277|NCT02392767|Pycnogenol|pycnogenol
146278|NCT02392767|vitamin K2|vitamin k2
146279|NCT02392767|vitamin B|vitamin b
146280|NCT02392767|endothelial function|endothelial function
146281|NCT02392767|hypertension|hypertension
146282|NCT02392767|Homocystein >10|homocystein >10
146283|NCT02392754|Screening|screening
146284|NCT02392754|Atrial Fibrillation|atrial fibrillation
146285|NCT02392754|ECG|ecg
146286|NCT02392754|Primary care|primary care
146287|NCT02392741|Physical Activity|physical activity
146296|NCT02392702|Subjects|subjects
146297|NCT02392702|Safety/Efficacy Study|safety/efficacy study
146298|NCT02392702|Randomized|randomized
146299|NCT02392702|Open Label|open label
146300|NCT02392689|procalcitonin|procalcitonin
146301|NCT02392689|biomarker|biomarker
146302|NCT02392689|antibiotic therapy|antibiotic therapy
146303|NCT02392689|emergency department|emergency department
146304|NCT02392689|cardiology|cardiology
146305|NCT02392689|in vitro diagnostics|in vitro diagnostics
146306|NCT02392676|Ovarian cancer|ovarian cancer
146307|NCT02392676|Platinum|platinum
146308|NCT02392676|Somatic BRCA mutation|somatic brca mutation
146309|NCT02392676|Homologous recombination repair|homologous recombination repair
146310|NCT02392663|Sputum clearance|sputum clearance
146311|NCT02392663|Cough severity|cough severity
146312|NCT02392663|Hypertonic saline|hypertonic saline
146313|NCT02392663|Acid hyaluronic|acid hyaluronic
146314|NCT02392663|Tolerability|tolerability
146315|NCT02392637|Biliary Tract Cancer|biliary tract cancer
146316|NCT02392637|Intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
146317|NCT02392637|Extrahepatic cholangiocarcinoma,|extrahepatic cholangiocarcinoma,
146318|NCT02392637|Gallbladder cancer|gallbladder cancer
146319|NCT02392637|Metastatic|metastatic
146320|NCT02392637|Unresectable|unresectable
146321|NCT02392637|Abraxane|abraxane
146322|NCT02392637|Nab-Paclitaxel|nab-paclitaxel
146323|NCT02392637|Paclitaxel (Protein-Bound)|paclitaxel (protein-bound)
146325|NCT02392637|Cisplatin|cisplatin
146326|NCT02392637|Platinol-AQ|platinol-aq
146327|NCT02392637|Platinol|platinol
146328|NCT02392637|CDDP|cddp
146329|NCT02392637|Gemcitabine|gemcitabine
146330|NCT02392637|Gemcitabine Hydrochloride|gemcitabine hydrochloride
146331|NCT02392637|Gemzar|gemzar
146332|NCT02392637|Phone calls|phone calls
146333|NCT02392611|Estrogen Receptor Positive Breast Cancer|estrogen receptor positive breast cancer
146334|NCT02392585|Leiomyoma of uterus|leiomyoma of uterus
146335|NCT02392585|Hemostasis, Surgical|hemostasis, surgical
146336|NCT02392585|Prevention of Surgical Blood Loss|prevention of surgical blood loss
146337|NCT02392585|mechanical uterine tourniquet|mechanical uterine tourniquet
146338|NCT02392572|Leukemia|leukemia
146339|NCT02392572|Acute myelogenous leukemia|acute myelogenous leukemia
146340|NCT02392572|AML|aml
146341|NCT02392572|Myelodysplastic syndrome|myelodysplastic syndrome
146342|NCT02392572|MDS|mds
146343|NCT02392572|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
146344|NCT02392572|ALL|all
146345|NCT02392572|Relapsed|relapsed
146346|NCT02392572|Refractory|refractory
146347|NCT02392572|ONC201|onc201
146356|NCT02392533|ultrasound|ultrasound
146357|NCT02392520|severe OHSS|severe ohss
146358|NCT02392520|antagonist administration|antagonist administration
146359|NCT02392520|conventional treatment|conventional treatment
146360|NCT02392442|Bronchoalveolar Lavage|bronchoalveolar lavage
146361|NCT02392442|Bronchoscopy|bronchoscopy
146362|NCT02392442|Endotoxin Instillation|endotoxin instillation
146363|NCT02392442|Immunophenotype|immunophenotype
146364|NCT02392442|miRNA|mirna
146365|NCT02392390|Topical Dynamic Phototherapy|topical dynamic phototherapy
146366|NCT02392390|Microbiota|microbiota
146367|NCT02392351|Hypertension|hypertension
146368|NCT02392351|Renal Denervation|renal denervation
146369|NCT02392338|Atrial fibrillation|atrial fibrillation
146370|NCT02392338|Ablation|ablation
146372|NCT02392312|kidney transplant|kidney transplant
146373|NCT02392312|ATG-F|atg-f
146374|NCT02392286|Corticosteroid|corticosteroid
146375|NCT02392273|migraine|migraine
146376|NCT02392273|cluster headache|cluster headache
146377|NCT02392273|primary headache|primary headache
146378|NCT02392273|Ausanil|ausanil
146379|NCT02392273|capsicum annuum|capsicum annuum
146380|NCT02392221|Crohn's disease (CD)|crohn's disease (cd)
146382|NCT02392221|Inflammatory Bowel Disease|inflammatory bowel disease
146383|NCT02392208|telavancin|telavancin
146384|NCT02392208|end-stage renal disease|end-stage renal disease
146385|NCT02392208|ESRD|esrd
146386|NCT02392208|pharmacokinetics|pharmacokinetics
146387|NCT02392208|hemodialysis|hemodialysis
146388|NCT02392208|chronic kidney disease|chronic kidney disease
146389|NCT02392208|CKD|ckd
146390|NCT02392208|dialysis|dialysis
146391|NCT02392208|Vibativ|vibativ
146392|NCT02392195|Plagiocephaly|plagiocephaly
146393|NCT02392182|lung|lung
146394|NCT02392169|neuroendocrine|neuroendocrine
146395|NCT02392169|ADHD|adhd
146396|NCT02392169|heredity|heredity
146397|NCT02392169|cognitive function|cognitive function
146398|NCT02392143|colorectal cancer screening|colorectal cancer screening
146399|NCT02392104|International Normalized Ratio|international normalized ratio
146400|NCT02392104|Warfarin|warfarin
146401|NCT02392078|Procedural Success|procedural success
146402|NCT02392078|Progression|progression
146403|NCT02392078|Quality of Life|quality of life
146404|NCT02392052|caregivers|caregivers
146405|NCT02392039|Lymphoma|lymphoma
146406|NCT02392039|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
146407|NCT02392039|Mantle Cell Lymphoma|mantle cell lymphoma
146408|NCT02392039|Grade 3B Follicular Lymphoma|grade 3b follicular lymphoma
146409|NCT02392039|Burkitt Lymphoma|burkitt lymphoma
146410|NCT02392039|Peripheral T cell Lymphoma NOS|peripheral t cell lymphoma nos
146411|NCT02392039|NK/T cell Lymphoma|nk/t cell lymphoma
146412|NCT02392039|Transformed Lymphoma|transformed lymphoma
146413|NCT02392039|Aggressive lymphoma|aggressive lymphoma
146414|NCT02392039|Bone pain|bone pain
146415|NCT02392039|Pegfilgrastim|pegfilgrastim
146416|NCT02392039|Neulasta|neulasta
146417|NCT02392039|PEG-G-CSF|peg-g-csf
146418|NCT02392039|Loratadine|loratadine
146419|NCT02392039|Placebo|placebo
146420|NCT02392039|Sugar pill|sugar pill
146421|NCT02392039|Questionnaires|questionnaires
146422|NCT02392039|Surveys|surveys
146423|NCT02392013|older adult falls|older adult falls
146424|NCT02392013|home hazards|home hazards
146425|NCT02392013|home barriers|home barriers
146426|NCT02392000|chronic insomnia|chronic insomnia
146427|NCT02392000|Veterans Health|veterans health
146428|NCT02391974|Hyaluronic acid|hyaluronic acid
146429|NCT02391974|Periodontal pockets|periodontal pockets
146430|NCT02391974|Periodontitis|periodontitis
146431|NCT02391948|Cerebral palsy|cerebral palsy
146432|NCT02391948|Gross motor delay|gross motor delay
146433|NCT02391935|Chronic Effect of Ultraviolet Radiation on Normal Skin (Photo-aging)|chronic effect of ultraviolet radiation on normal skin (photo-aging)
146434|NCT02391922|out of hospital cardiac arrest|out of hospital cardiac arrest
146435|NCT02391922|first aid|first aid
146436|NCT02391909|Vaccine|vaccine
146437|NCT02391883|clopidogrel therapy|clopidogrel therapy
146438|NCT02391883|platelet aggregation inhibitor|platelet aggregation inhibitor
146439|NCT02391883|adverse event|adverse event
146440|NCT02391870|depression|depression
146441|NCT02391870|mindfulness|mindfulness
146442|NCT02391870|pregnancy|pregnancy
146443|NCT02391870|prevention|prevention
146444|NCT02391870|cognitive behavioral therapy|cognitive behavioral therapy
146445|NCT02391857|cardiopulmonary resuscitation|cardiopulmonary resuscitation
146446|NCT02391857|Gastric emptying|gastric emptying
146447|NCT02391844|Knee|knee
146448|NCT02391844|Post-Operative Pain|post-operative pain
146449|NCT02391844|Xartemis|xartemis
146450|NCT02391831|SMA|sma
146451|NCT02391831|Spinal Muscular Atrophy|spinal muscular atrophy
146452|NCT02391831|Neuromuscular disease|neuromuscular disease
146453|NCT02391818|balance|balance
146454|NCT02391818|quality of life|quality of life
146455|NCT02391818|chemotherapy|chemotherapy
146456|NCT02391818|neuropathy|neuropathy
146457|NCT02391818|cancer|cancer
146458|NCT02391779|High normal blood pressure|high normal blood pressure
146459|NCT02391779|Stage I|stage i
146460|NCT02391766|Self-management|self-management
146461|NCT02391766|Caregiving|caregiving
146462|NCT02391766|Quality of life|quality of life
146463|NCT02391766|Empowerment|empowerment
146464|NCT02391753|levator avulsion|levator avulsion
146465|NCT02391753|transperineal ultrasound|transperineal ultrasound
146466|NCT02391753|levator hiatus|levator hiatus
146467|NCT02391727|SYN004|syn004
146468|NCT02391727|cetuximab|cetuximab
146469|NCT02391714|pain assessment|pain assessment
146470|NCT02391714|patient satisfaction|patient satisfaction
146471|NCT02391714|Visual Analog Scale|visual analog scale
146472|NCT02391714|contraceptive devices|contraceptive devices
146473|NCT02391714|nulliparity|nulliparity
146474|NCT02391662|Metastatic Pancreatic Adenocarcinoma|metastatic pancreatic adenocarcinoma
146479|NCT02391649|bibliotherapy program|bibliotherapy program
146481|NCT02391649|family caregivers|family caregivers
146482|NCT02391649|randomized controlled trial|randomized controlled trial
146483|NCT02391636|Postpartum Hemorrhage|postpartum hemorrhage
146484|NCT02391636|carbetocin|carbetocin
146485|NCT02391636|oxytocin|oxytocin
146486|NCT02391623|Multiple Ascending Dose|multiple ascending dose
146487|NCT02391623|Healthy Subjects|healthy subjects
146488|NCT02391623|Hyperlipidemia|hyperlipidemia
146489|NCT02391623|Lipid Metabolism Disorders|lipid metabolism disorders
146490|NCT02391623|Metabolic Diseases|metabolic diseases
146491|NCT02391610|birth cohort study|birth cohort study
146492|NCT02391610|environmental exposures|environmental exposures
146493|NCT02391610|birth defects|birth defects
146494|NCT02391610|pregnant outcomes|pregnant outcomes
146495|NCT02391610|children development|children development
146496|NCT02391545|Follicular Lymphoma|follicular lymphoma
146497|NCT02391545|Previously Untreated|previously untreated
146502|NCT02391506|First CMC joint|first cmc joint
146503|NCT02391506|Osteoarthritis|osteoarthritis
146504|NCT02391506|Cartilage Replacement|cartilage replacement
146505|NCT02391506|First CMC Joint Osteoarthritis|first cmc joint osteoarthritis
146506|NCT02391506|Damaged Articular Surface|damaged articular surface
146507|NCT02391493|bilinguals|bilinguals
146508|NCT02391493|language control|language control
146509|NCT02391493|executive functions|executive functions
146510|NCT02391493|functional MRI|functional mri
146511|NCT02391493|stimulation mapping|stimulation mapping
146512|NCT02391493|brain tumors|brain tumors
146513|NCT02391480|Bromodomain Inhibitor|bromodomain inhibitor
146514|NCT02391480|Cancer|cancer
146515|NCT02391454|Neoplasms|neoplasms
146516|NCT02391454|Cell Phones|cell phones
146517|NCT02391454|Motor Activity|motor activity
146518|NCT02391454|Feasibility|feasibility
146519|NCT02391441|Pulmonary|pulmonary
146520|NCT02391441|Arterial|arterial
146521|NCT02391441|Hypertension|hypertension
146522|NCT02391441|Lung|lung
146523|NCT02391441|Transplantation|transplantation
146524|NCT02391441|MRI|mri
146525|NCT02391428|ADHD|adhd
146526|NCT02391428|omega3|omega3
146527|NCT02391402|Brain injury|brain injury
146528|NCT02391402|TBI|tbi
146529|NCT02391402|PTSD|ptsd
146530|NCT02391402|Polytrauma|polytrauma
146531|NCT02391389|preterm infant|preterm infant
146532|NCT02391376|superficial heat|superficial heat
146533|NCT02391376|hot pack|hot pack
146534|NCT02391376|thermotherapy|thermotherapy
146535|NCT02391376|physiotherapy|physiotherapy
146536|NCT02391376|Schober Test|schober test
146537|NCT02391363|anxiety|anxiety
146538|NCT02391363|worry|worry
146539|NCT02391337|Atrial fibrillation|atrial fibrillation
146540|NCT02391337|Quality of life|quality of life
146541|NCT02391337|Left ventricular ejection fraction|left ventricular ejection fraction
146542|NCT02391337|Diastolic function|diastolic function
146543|NCT02391337|Echocardiography|echocardiography
146544|NCT02391337|Beta-blockers|beta-blockers
146545|NCT02391337|Digoxin|digoxin
146546|NCT02391311|tDCS|tdcs
146547|NCT02391311|Cognitive remediation therapy|cognitive remediation therapy
146548|NCT02391298|Multiple Sclerosis|multiple sclerosis
146549|NCT02391298|stress|stress
146550|NCT02391298|meditation|meditation
146551|NCT02391298|attention|attention
146552|NCT02391272|recombinant human thrombopoietin|recombinant human thrombopoietin
146553|NCT02391272|immune thrombocytopenia|immune thrombocytopenia
146554|NCT02391272|pregnancy|pregnancy
146555|NCT02391246|central nervous system tumours|central nervous system tumours
146556|NCT02391246|[18F]-fluorodeoxyglucose|[18f]-fluorodeoxyglucose
146557|NCT02391233|Effectiveness intervention|effectiveness intervention
146558|NCT02391233|Cost-effectiveness intervention|cost-effectiveness intervention
146559|NCT02391233|HIV prevention|hiv prevention
146560|NCT02391233|Sexually transmitted infections prevention|sexually transmitted infections prevention
146561|NCT02391233|Multimedia evidence-based intervention|multimedia evidence-based intervention
146562|NCT02391233|Drug-users|drug-users
146563|NCT02391233|Black/African-American women|black/african-american women
146564|NCT02391233|Probation|probation
146565|NCT02391233|HIV testing|hiv testing
146566|NCT02391194|AVB-620|avb-620
146567|NCT02391194|stage I|stage i
146568|NCT02391194|newly diagnosed|newly diagnosed
146569|NCT02391194|breast cancer|breast cancer
146570|NCT02391194|stage II|stage ii
146571|NCT02391194|stage III|stage iii
146572|NCT02391194|ductal carcinoma in situ|ductal carcinoma in situ
146573|NCT02391181|Bioequivalence|bioequivalence
146574|NCT02391181|Iron Status|iron status
146575|NCT02391155|follicular flushing|follicular flushing
146576|NCT02391155|IVF|ivf
146577|NCT02391155|poor responders|poor responders
146578|NCT02391155|oocyte retrival|oocyte retrival
146579|NCT02391142|heart failure|heart failure
146580|NCT02391142|cardiac sympathetic nerve block|cardiac sympathetic nerve block
146581|NCT02391142|sympathetic nervous system|sympathetic nervous system
146582|NCT02391090|asthma|asthma
146583|NCT02391090|hypoxia|hypoxia
146584|NCT02391090|forced exhaled nitric oxide|forced exhaled nitric oxide
146585|NCT02391090|inflammation|inflammation
146586|NCT02391077|PrePex|prepex
146587|NCT02391077|Male Circumcision|male circumcision
146588|NCT02391077|Bacterial Load|bacterial load
146589|NCT02391064|cognition|cognition
146590|NCT02391064|brief computerized cognitive assessment|brief computerized cognitive assessment
146591|NCT02391064|impairment prediction|impairment prediction
146592|NCT02391051|prostate cancer|prostate cancer
146593|NCT02391051|focal brachytherapy|focal brachytherapy
146595|NCT02391051|Biological marker|biological marker
146596|NCT02391038|MLN0264|mln0264
146597|NCT02391038|Advanced gastrointestinal carcinoma|advanced gastrointestinal carcinoma
137449|NCT02441777|polarization sensitive coherence tomography|polarization sensitive coherence tomography
137451|NCT02441764|Eribulin Mesylate|eribulin mesylate
137453|NCT02441751|Electrocardiography|electrocardiography
146598|NCT02391025|Metastatic|metastatic
146599|NCT02391025|Prostate Cancer|prostate cancer
146600|NCT02391025|Castrate Resistant|castrate resistant
146601|NCT02391012|Ulcerative colitis|ulcerative colitis
146602|NCT02391012|Crohns disease|crohns disease
146603|NCT02391012|Microbial transplantation|microbial transplantation
146605|NCT02390986|Malignant Neoplasm|malignant neoplasm
146606|NCT02390986|Anti-cancer drug|anti-cancer drug
146607|NCT02390947|Colorectal Cancer|colorectal cancer
146608|NCT02390947|Famitinib|famitinib
146609|NCT02390934|Radium 223|radium 223
146610|NCT02390934|bone metastases|bone metastases
146611|NCT02390908|alcohol use|alcohol use
146612|NCT02390908|hazardous drinking|hazardous drinking
146613|NCT02390908|behavioral intervention|behavioral intervention
146614|NCT02390908|ART adherence|art adherence
146615|NCT02390908|viral load|viral load
146616|NCT02390908|CD4|cd4
146617|NCT02390895|Minimally-invasive endoscopic repair|minimally-invasive endoscopic repair
146618|NCT02390895|fetal surgery|fetal surgery
146619|NCT02390895|outcome|outcome
146620|NCT02390895|Foetus|foetus
146621|NCT02390869|relapse|relapse
146622|NCT02390869|progression|progression
146623|NCT02390804|postoperative pain|postoperative pain
146624|NCT02390804|hysterectomy|hysterectomy
146625|NCT02390804|single-port access laparoscopy|single-port access laparoscopy
146626|NCT02390804|multi-port access laparoscopy|multi-port access laparoscopy
146627|NCT02390804|TLH|tlh
146628|NCT02390778|secondary traumatic stress|secondary traumatic stress
146629|NCT02390778|vicarious trauma|vicarious trauma
146630|NCT02390778|secondary distress|secondary distress
146631|NCT02390765|Stress Response|stress response
146632|NCT02390765|Binge Eating|binge eating
146633|NCT02390765|Eating Behavior|eating behavior
146634|NCT02390765|Obesity|obesity
146635|NCT02390765|Disordered Eating|disordered eating
146636|NCT02390752|Maximum Tolerated Dose|maximum tolerated dose
146637|NCT02390752|Dose Escalation|dose escalation
146638|NCT02390752|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
146639|NCT02390752|Acute Myelogenous Leukemia|acute myelogenous leukemia
146640|NCT02390739|Immunotherapy|immunotherapy
146641|NCT02390739|Gene Therapy|gene therapy
146642|NCT02390739|Metastatic Cancer|metastatic cancer
146643|NCT02390713|hepatectomy|hepatectomy
146644|NCT02390713|post-operative liver failure|post-operative liver failure
146645|NCT02390713|portal vein|portal vein
146646|NCT02390713|portal flow|portal flow
146647|NCT02390713|portal pressure|portal pressure
146648|NCT02390713|modulation|modulation
146649|NCT02390713|surgical device|surgical device
146650|NCT02390700|Rheumatoid Arthritis|rheumatoid arthritis
146651|NCT02390700|Observational|observational
146652|NCT02390700|Golimumab|golimumab
146653|NCT02390700|SIMPONI|simponi
146654|NCT02390700|Intravenous Infusion|intravenous infusion
146655|NCT02390661|seroma|seroma
146656|NCT02390661|accelerated partial breast irradiation (APBI)|accelerated partial breast irradiation (apbi)
146657|NCT02390661|breast lumpectomy|breast lumpectomy
146658|NCT02390661|breast cancer|breast cancer
146659|NCT02390635|Leukemia|leukemia
146660|NCT02390635|Acute myeloid leukemia|acute myeloid leukemia
146661|NCT02390635|AML|aml
146662|NCT02390635|Acute promyelocytic leukemia|acute promyelocytic leukemia
146663|NCT02390635|APL|apl
146664|NCT02390635|Extramedullary leukemia|extramedullary leukemia
146665|NCT02390635|EML|eml
146666|NCT02390635|Whole body magnetic resonance imaging|whole body magnetic resonance imaging
146667|NCT02390635|MRI|mri
146668|NCT02390635|Positron emission tomography/ computed tomography|positron emission tomography/ computed tomography
146669|NCT02390635|PET/CT|pet/ct
146670|NCT02390635|18F-FDG|18f-fdg
146671|NCT02390635|Gadolinium contrast agent|gadolinium contrast agent
146672|NCT02390609|Healthy|healthy
146673|NCT02390609|Ibrutinib|ibrutinib
146674|NCT02390609|Bioavailability|bioavailability
146675|NCT02390596|Kawasaki disease|kawasaki disease
146676|NCT02390596|anti Interleukin 1 treatment|anti interleukin 1 treatment
146677|NCT02390596|anakinra|anakinra
146678|NCT02390596|resistance to IVIg|resistance to ivig
146679|NCT02390596|coronary aneurysms|coronary aneurysms
146876|NCT02389335|IL-2|il-2
146680|NCT02390596|phase II trial|phase ii trial
146681|NCT02390583|Internet dependence|internet dependence
146682|NCT02390583|Sleep disorders|sleep disorders
146683|NCT02390583|pathological gambling|pathological gambling
146684|NCT02390570|Patient Capacity|patient capacity
146685|NCT02390544|children|children
146686|NCT02390544|bone marrow transplant|bone marrow transplant
146687|NCT02390544|pharmacokinetics|pharmacokinetics
146688|NCT02390531|Retinopathy of Prematurity|retinopathy of prematurity
146689|NCT02390531|Bevacizumab|bevacizumab
146690|NCT02390531|ROP|rop
137550|NCT02441075|BMT|bmt
146691|NCT02390505|vitamin C|vitamin c
146692|NCT02390505|CRPS|crps
146693|NCT02390505|Upper limb surgery|upper limb surgery
146694|NCT02390479|Sclerostin|sclerostin
146695|NCT02390479|OPG|opg
146696|NCT02390479|RANKL|rankl
146697|NCT02390453|mild cognitive impairment|mild cognitive impairment
146698|NCT02390453|randomized controlled trial|randomized controlled trial
146699|NCT02390453|cognitive training|cognitive training
146700|NCT02390453|exercise training|exercise training
146701|NCT02390453|cognition|cognition
146702|NCT02390453|physical performance|physical performance
146703|NCT02390453|disability|disability
146704|NCT02390453|mood|mood
146705|NCT02390440|Pain management|pain management
146706|NCT02390440|Exparel|exparel
146707|NCT02390440|Rib fracture|rib fracture
146708|NCT02390427|Metastatic Breast Cancer|metastatic breast cancer
146709|NCT02390427|Advanced Breast Cancer|advanced breast cancer
146710|NCT02390427|Recurrent Breast Cancer|recurrent breast cancer
146711|NCT02390414|Myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
146712|NCT02390388|pudendal block|pudendal block
146713|NCT02390388|Hypospadias|hypospadias
146714|NCT02390388|caudal block|caudal block
146715|NCT02390388|child|child
146716|NCT02390388|analgesia|analgesia
146717|NCT02390336|Osteoarthritis of the hip|osteoarthritis of the hip
146718|NCT02390336|Pain|pain
146719|NCT02390336|Range of Motion|range of motion
146720|NCT02390336|Physical Function|physical function
146721|NCT02390336|Manual Therapy|manual therapy
146722|NCT02390310|male circumcision|male circumcision
146723|NCT02390310|Shang Ring|shang ring
146724|NCT02390310|male circumcision device|male circumcision device
146725|NCT02390310|prevention|prevention
146726|NCT02390310|voluntary medical male circumcision (VMMC)|voluntary medical male circumcision (vmmc)
146727|NCT02390284|RGCD|rgcd
146728|NCT02390284|Glaucoma Suspect|glaucoma suspect
146729|NCT02390232|gut microbiota|gut microbiota
146730|NCT02390232|Non Alcoholic Steato Hepatitis|non alcoholic steato hepatitis
146731|NCT02390232|Steatohepatitis|steatohepatitis
146732|NCT02390232|Escherichia coli|escherichia coli
146733|NCT02390232|colibactin|colibactin
146734|NCT02390206|Stroke|stroke
146735|NCT02390206|Spasticity|spasticity
146945|NCT02389010|Cost|cost
146736|NCT02390206|Botulinum Toxin type A|botulinum toxin type a
146737|NCT02390206|Dysport|dysport
146738|NCT02390193|Chronic kidney disease|chronic kidney disease
146739|NCT02390193|Dialysis|dialysis
146740|NCT02390193|Sleep|sleep
146741|NCT02390193|Pulmonary function|pulmonary function
146742|NCT02390193|Polysomnography|polysomnography
146743|NCT02390193|Upper airway|upper airway
146744|NCT02390128|iodine|iodine
146745|NCT02390128|thyroid|thyroid
146746|NCT02390128|TSH|tsh
146747|NCT02390128|pregnancy|pregnancy
146748|NCT02390128|nutrition|nutrition
146749|NCT02390128|diet|diet
146750|NCT02390102|Anemia|anemia
146751|NCT02390102|Severe aortic stenosis|severe aortic stenosis
146752|NCT02390102|Red blood cell transfusion|red blood cell transfusion
146753|NCT02390102|Erythropoietin|erythropoietin
146754|NCT02390089|Dysphagia|dysphagia
146755|NCT02390089|Cough|cough
146756|NCT02390089|Aspiration pneumonia|aspiration pneumonia
146757|NCT02390024|Mechanical Ventilation|mechanical ventilation
146758|NCT02390024|Asynchronies|asynchronies
146759|NCT02390024|Cognition|cognition
146760|NCT02390011|Advanced Solid Tumor|advanced solid tumor
146761|NCT02389998|Functional Pain|functional pain
146762|NCT02389998|Abdominal Pain|abdominal pain
146763|NCT02389998|Irritable Bowel Syndrome|irritable bowel syndrome
146764|NCT02389998|IBS|ibs
146765|NCT02389998|Functional Dyspepsia|functional dyspepsia
146766|NCT02389998|FGID|fgid
146767|NCT02389998|Functional Gastrointestinal Disorders|functional gastrointestinal disorders
146768|NCT02389959|HHT|hht
146769|NCT02389959|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
146770|NCT02389959|epistaxis|epistaxis
146771|NCT02389959|nose bleeds|nose bleeds
146772|NCT02389959|nasal bleeding|nasal bleeding
146773|NCT02389959|Avastin|avastin
146774|NCT02389959|bevacizumab|bevacizumab
146775|NCT02389946|Drug eluting coronary stents|drug eluting coronary stents
146776|NCT02389946|Sirolimus|sirolimus
146777|NCT02389946|Bioabsorbable polymer|bioabsorbable polymer
146778|NCT02389946|DES|des
146779|NCT02389933|Multiple Patient Program, LCZ696, heart failure, heart failure with reduced ejection fraction, HF-rEF|multiple patient program, lcz696, heart failure, heart failure with reduced ejection fraction, hf-ref
146780|NCT02389894|Embolic Protection Device|embolic protection device
146781|NCT02389894|Stroke|stroke
146877|NCT02389335|TNF α|tnf α
146782|NCT02389894|Brain Infarction|brain infarction
146783|NCT02389894|atheroma|atheroma
146784|NCT02389894|Aortic Valve Replacement|aortic valve replacement
146785|NCT02389881|Drug therapy|drug therapy
146786|NCT02389868|Lovastatin|lovastatin
146787|NCT02389868|Proteome|proteome
146788|NCT02389868|Blood platelets|blood platelets
146789|NCT02389855|Progression|progression
146790|NCT02389855|Quality of Life|quality of life
146791|NCT02389816|Drug therapy|drug therapy
146792|NCT02389790|Crohn's Disease|crohn's disease
146793|NCT02389764|Breast cancer|breast cancer
146794|NCT02389764|Metastatic inflammatory breast cancer|metastatic inflammatory breast cancer
146795|NCT02389764|MIBC|mibc
146798|NCT02389764|BIBF 1120|bibf 1120
146799|NCT02389764|Nintedanib|nintedanib
146800|NCT02389764|Phone call|phone call
146801|NCT02389751|Esophageal Cancer|esophageal cancer
146802|NCT02389751|Esophageal carcinoma|esophageal carcinoma
146803|NCT02389751|Adenocarcinoma or squamous cell carcinoma of the gastroesophageal junction|adenocarcinoma or squamous cell carcinoma of the gastroesophageal junction
146804|NCT02389751|Adenocarcinoma or squamous cell carcinoma of the cervical esophagus|adenocarcinoma or squamous cell carcinoma of the cervical esophagus
146805|NCT02389751|Adenocarcinoma or squamous cell carcinoma of thoracic esophagus|adenocarcinoma or squamous cell carcinoma of thoracic esophagus
146806|NCT02389751|Ganetespib|ganetespib
146807|NCT02389751|Carboplatin|carboplatin
146808|NCT02389751|Paraplatin|paraplatin
146809|NCT02389751|Paclitaxel|paclitaxel
146810|NCT02389751|Taxol|taxol
146811|NCT02389725|peripheral intravenous access|peripheral intravenous access
146812|NCT02389725|tourniquet techniques|tourniquet techniques
146813|NCT02389712|Bipolar Disorder|bipolar disorder
146814|NCT02389712|Mayo Clinic|mayo clinic
146815|NCT02389699|Intermediate and high grade ductal carcinoma in situ （DCIS）|intermediate and high grade ductal carcinoma in situ （dcis）
146816|NCT02389686|Ductal carcinoma in situ （DCIS）|ductal carcinoma in situ （dcis）
146817|NCT02389686|Nipple-sparing mastectomy (NSM)|nipple-sparing mastectomy (nsm)
146818|NCT02389686|Intraoperative radiotherapy (IORT)|intraoperative radiotherapy (iort)
146819|NCT02389686|INTRABEAM|intrabeam
146820|NCT02389673|Intermediate and high grade ductal carcinoma in situ （DCIS）|intermediate and high grade ductal carcinoma in situ （dcis）
146821|NCT02389660|Depression, Blended Cognitive Behavioural Therapy, Internet intervention|depression, blended cognitive behavioural therapy, internet intervention
146822|NCT02389621|Elective invasive procedures|elective invasive procedures
146823|NCT02389608|Transcranial direct current stimulation|transcranial direct current stimulation
146824|NCT02389608|functional electrical stimulation|functional electrical stimulation
146825|NCT02389608|hemiparesis|hemiparesis
146826|NCT02389608|electromyography|electromyography
146827|NCT02389608|balance|balance
146828|NCT02389595|HIV|hiv
146829|NCT02389595|vaccine|vaccine
146830|NCT02389595|T cell|t cell
146831|NCT02389582|platelet function; dabigatran;enoxaparin|platelet function; dabigatran;enoxaparin
146832|NCT02389569|Biomaterial|biomaterial
146833|NCT02389569|Dental caries|dental caries
146834|NCT02389569|Composite|composite
146835|NCT02389543|KPT-330|kpt-330
146836|NCT02389543|Selinexor|selinexor
146837|NCT02389543|Multiple Myeloma|multiple myeloma
146838|NCT02389543|Relapsed/refractory|relapsed/refractory
146839|NCT02389543|Lenalidomide|lenalidomide
146840|NCT02389543|Dexamethasone|dexamethasone
146841|NCT02389543|Karyopharm|karyopharm
146842|NCT02389530|glioma|glioma
146843|NCT02389530|neoplasms|neoplasms
146844|NCT02389504|Exertion|exertion
146845|NCT02389504|Efficacy of Treatment|efficacy of treatment
146846|NCT02389491|high density formula|high density formula
146847|NCT02389491|heart defects|heart defects
146848|NCT02389491|infant|infant
146849|NCT02389478|oropharyngeal|oropharyngeal
146850|NCT02389478|breastmilk|breastmilk
146851|NCT02389478|colostrum|colostrum
146852|NCT02389478|human milk|human milk
146853|NCT02389478|premature infant|premature infant
146854|NCT02389465|Depression|depression
146855|NCT02389465|Geriatric|geriatric
146856|NCT02389426|Multiple Sclerosis|multiple sclerosis
146857|NCT02389426|Cerebral hemodynamics|cerebral hemodynamics
146858|NCT02389426|Cerebral hypoperfusion|cerebral hypoperfusion
146859|NCT02389426|Cerebral circulation|cerebral circulation
146860|NCT02389413|PQ912|pq912
146861|NCT02389413|Glutaminy Cyclase (QC)|glutaminy cyclase (qc)
146862|NCT02389413|QC - Inhibitor|qc - inhibitor
146863|NCT02389400|adult with Langerhans cell histiocytosis|adult with langerhans cell histiocytosis
146864|NCT02389400|newly diagnosed|newly diagnosed
146865|NCT02389400|methotrexate|methotrexate
146866|NCT02389400|cytosine arabinoside|cytosine arabinoside
146867|NCT02389387|Dialysis Facilities|dialysis facilities
146868|NCT02389387|African Americans|african americans
146869|NCT02389387|Racial Disparity|racial disparity
146870|NCT02389387|Kidney Transplantation|kidney transplantation
146871|NCT02389387|Community-based Participatory Research|community-based participatory research
146872|NCT02389387|Coalition|coalition
146873|NCT02389348|Induced blood stage malaria|induced blood stage malaria
146874|NCT02389335|type 1diabetes|type 1diabetes
146875|NCT02389335|IFN γ|ifn γ
146878|NCT02389322|ESAT6|esat6
146879|NCT02389322|CFP10|cfp10
146880|NCT02389322|skin test|skin test
146881|NCT02389322|diagnostic test|diagnostic test
146882|NCT02389309|Solid tumors|solid tumors
146883|NCT02389309|Advanced tumors|advanced tumors
146884|NCT02389309|Temsirolimus|temsirolimus
146885|NCT02389309|CCI-779|cci-779
146886|NCT02389309|Torisel|torisel
146887|NCT02389309|Dasatinib|dasatinib
146888|NCT02389309|BMS-354825|bms-354825
146889|NCT02389309|Sprycel|sprycel
146890|NCT02389309|Cyclophosphamide|cyclophosphamide
146891|NCT02389309|Cytoxan|cytoxan
146892|NCT02389309|Neosar|neosar
146893|NCT02389283|Rheumatoid arthritis|rheumatoid arthritis
146894|NCT02389283|ultrasound joint count|ultrasound joint count
657691|NCT00808431|Obesity|obesity
146901|NCT02389231|interleukine 2|interleukine 2
146902|NCT02389231|warm autoimmune hemolytic anemia|warm autoimmune hemolytic anemia
146903|NCT02389231|CD8 regulatory T cells|cd8 regulatory t cells
146904|NCT02389218|atrial fibrillation|atrial fibrillation
146905|NCT02389218|cryoablation|cryoablation
146906|NCT02389218|catheter ablation|catheter ablation
146907|NCT02389192|Ebola|ebola
146908|NCT02389192|Mono-clonal Antibody|mono-clonal antibody
146909|NCT02389179|Vitamin D Deficiency|vitamin d deficiency
146910|NCT02389153|secondary prevention coronary heart disease|secondary prevention coronary heart disease
146911|NCT02389153|myocardial infarction|myocardial infarction
146912|NCT02389153|cardiovascular risk factors|cardiovascular risk factors
146913|NCT02389153|collaborative care|collaborative care
146914|NCT02389153|quality of life|quality of life
146915|NCT02389153|patients´ satisfaction with treatment|patients´ satisfaction with treatment
146919|NCT02389127|Cirrhosis|cirrhosis
146920|NCT02389127|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
146921|NCT02389127|Glycosylated hemoglobin A1c|glycosylated hemoglobin a1c
146922|NCT02389127|Glucose|glucose
146923|NCT02389101|Lymphoma|lymphoma
146924|NCT02389101|68Ga-DOTANOC PET/CT|68ga-dotanoc pet/ct
146925|NCT02389101|Somatostatin receptor|somatostatin receptor
146926|NCT02389101|MRI|mri
146927|NCT02389101|Diffusion weighted imaging|diffusion weighted imaging
146928|NCT02389101|Early treatment response|early treatment response
146929|NCT02389088|Granulosa Cell|granulosa cell
146930|NCT02389088|Androgens|androgens
146931|NCT02389088|FSH|fsh
146932|NCT02389088|Ovary|ovary
146936|NCT02389049|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
146937|NCT02389049|Kartagener Syndrome|kartagener syndrome
146938|NCT02389023|surgical site infection|surgical site infection
146939|NCT02389023|infrainguinal bypass|infrainguinal bypass
146940|NCT02389023|incisional wound vacuum assisted closure|incisional wound vacuum assisted closure
146941|NCT02389023|Prevena|prevena
146942|NCT02389010|Umbilical Cord Blood|umbilical cord blood
146943|NCT02389010|Diabetic Foot|diabetic foot
146944|NCT02389010|Ulcer|ulcer
146946|NCT02389010|Effectiveness|effectiveness
146947|NCT02389010|Safety|safety
146948|NCT02389010|Platelet Gel|platelet gel
146949|NCT02389010|Cord Blood Platelet Gel|cord blood platelet gel
146950|NCT02389010|Adverse Event|adverse event
146951|NCT02388997|mild asthma|mild asthma
146952|NCT02388997|young adults|young adults
146953|NCT02388997|rhinovirus|rhinovirus
146954|NCT02388971|Drug therapy|drug therapy
146955|NCT02388919|anlotinib|anlotinib
146956|NCT02388919|Cancer|cancer
146957|NCT02388919|NSCLC|nsclc
146958|NCT02388919|Non-small Cell Lung Cancer|non-small cell lung cancer
146959|NCT02388880|ITPR|itpr
146960|NCT02388880|CPP|cpp
146961|NCT02388880|TBI|tbi
146962|NCT02388880|traumatic brain injury|traumatic brain injury
146963|NCT02388880|cerebral perfusion pressure|cerebral perfusion pressure
146964|NCT02388880|intrathoracic pressure regulator|intrathoracic pressure regulator
146965|NCT02388841|Pulmonary embolism, Computed tomographic pulmonary|pulmonary embolism, computed tomographic pulmonary
146966|NCT02388815|Diabetes Mellitus|diabetes mellitus
146967|NCT02388815|Sensing Technology|sensing technology
146968|NCT02388802|Infertility|infertility
146969|NCT02388802|Transplant|transplant
146970|NCT02388802|IVF|ivf
146971|NCT02388802|Hysterectomy|hysterectomy
146972|NCT02388802|Absolute uterine infertility|absolute uterine infertility
146973|NCT02388789|sensory receptors|sensory receptors
146974|NCT02388789|balance control|balance control
146975|NCT02388789|gait|gait
146976|NCT02388789|temperature|temperature
146977|NCT02388776|ROTEM|rotem
146978|NCT02388776|Fibrinogen|fibrinogen
146979|NCT02388763|Contact lenses|contact lenses
146980|NCT02388750|nausea|nausea
146981|NCT02388750|vomiting|vomiting
146982|NCT02388750|radiation|radiation
146983|NCT02388750|anti-emetic drug|anti-emetic drug
146984|NCT02388737|Drug therapy|drug therapy
146985|NCT02388724|Drug therapy|drug therapy
146986|NCT02388711|Dementia|dementia
146987|NCT02388711|Transitional Care|transitional care
146988|NCT02388711|Caregiver|caregiver
146989|NCT02388698|HPV DNA|hpv dna
146990|NCT02388698|PET-CT|pet-ct
146991|NCT02388698|Recurrent cervical cancer|recurrent cervical cancer
146992|NCT02388698|chemoradiation|chemoradiation
146993|NCT02388685|peripheral arterial disease|peripheral arterial disease
146994|NCT02388685|exercise|exercise
146995|NCT02388685|perfusion|perfusion
146996|NCT02388685|energetics|energetics
146997|NCT02388685|magnetic resonance imaging|magnetic resonance imaging
146998|NCT02388685|magnetic resonance spectroscopy|magnetic resonance spectroscopy
137906|NCT02439216|DMD|dmd
146999|NCT02388659|MRS Biomarkers|mrs biomarkers
147000|NCT02388581|Helicobactor pylori, Hp|helicobactor pylori, hp
147001|NCT02388581|mucosa-associated lymphoid tissue-type lymphoma, MALToma|mucosa-associated lymphoid tissue-type lymphoma, maltoma
147002|NCT02388542|cardiovascular disease|cardiovascular disease
147003|NCT02388542|education|education
147004|NCT02388542|peer mentor|peer mentor
147005|NCT02388529|Heart Failure|heart failure
147006|NCT02388529|Bendavia™|bendavia™
147007|NCT02388529|MTP-131|mtp-131
147008|NCT02388516|Bangladesh|bangladesh
147009|NCT02388516|Vitamin D|vitamin d
147010|NCT02388516|Acute Respiratory Infections|acute respiratory infections
147011|NCT02388516|Infancy|infancy
147012|NCT02388516|Pregnancy|pregnancy
147013|NCT02388503|Blood glucose|blood glucose
147014|NCT02388490|Brentuximabvedotin|brentuximabvedotin
147016|NCT02388490|Lymphoma|lymphoma
147017|NCT02388477|rotator cuff repair|rotator cuff repair
147018|NCT02388477|Doxycycline|doxycycline
147019|NCT02388464|Congestive Heart Failure|congestive heart failure
147020|NCT02388464|Bendavia™|bendavia™
147021|NCT02388464|MTP-131|mtp-131
147022|NCT02388451|Mild Cognitive Impairment|mild cognitive impairment
147023|NCT02388438|demineralized bone matrix|demineralized bone matrix
147024|NCT02387333|Radical cystectomy|radical cystectomy
147025|NCT02387333|Urinary diversion|urinary diversion
147026|NCT02387333|Ileal conduit|ileal conduit
147027|NCT02387333|Parastomal hernia|parastomal hernia
147028|NCT02387333|Prophylactic mesh|prophylactic mesh
147029|NCT02387333|Mesh stoma reinforcement technique|mesh stoma reinforcement technique
147030|NCT02387320|Anxiety|anxiety
147031|NCT02387320|Pain|pain
147032|NCT02387320|Nausea|nausea
147033|NCT02387320|Fatigue|fatigue
147034|NCT02387320|Sleep Disturbance|sleep disturbance
147035|NCT02387320|Breast Cancer|breast cancer
147036|NCT02387320|Surgery|surgery
147037|NCT02387294|immunogenicity|immunogenicity
147038|NCT02387294|reduced dos|reduced dos
147039|NCT02387294|Phase III|phase iii
147040|NCT02387294|tolerability|tolerability
147041|NCT02387294|safety|safety
147042|NCT02387281|Freezing of gait|freezing of gait
147043|NCT02387242|Tuberculosis|tuberculosis
147044|NCT02387242|Whole blood Bactericidal Activity|whole blood bactericidal activity
147046|NCT02387242|Rifampicin|rifampicin
147047|NCT02387229|Atrial Fibrillation|atrial fibrillation
147048|NCT02387229|Stroke|stroke
147049|NCT02387229|Neurocognitive decline|neurocognitive decline
147050|NCT02387229|Rivaroxaban|rivaroxaban
147051|NCT02387229|Acetylsalicylic acid|acetylsalicylic acid
147052|NCT02387229|Anticoagulation|anticoagulation
147053|NCT02387216|NSCLC|nsclc
147054|NCT02387216|Non-Small Cell Lung Cancer|non-small cell lung cancer
147055|NCT02387216|heregulin|heregulin
147056|NCT02387216|ErbB3|erbb3
147057|NCT02387216|docetaxel|docetaxel
147058|NCT02387216|pemetrexed|pemetrexed
147059|NCT02387203|Pseudomyxoma Peritonei|pseudomyxoma peritonei
147060|NCT02387203|Appendiceal cancer|appendiceal cancer
147061|NCT02387203|CRS/HIPEC|crs/hipec
147062|NCT02387203|PMP|pmp
147063|NCT02388412|Positron emission tomography|positron emission tomography
147064|NCT02388412|Tissue background ratio|tissue background ratio
147065|NCT02388412|Optical coherence tomography|optical coherence tomography
147066|NCT02388412|Thin cap fibroous atheroma|thin cap fibroous atheroma
147067|NCT02388412|Vulnerability|vulnerability
147068|NCT02388412|Acute coronary syndrome|acute coronary syndrome
147069|NCT02388399|Optical coherence tomography|optical coherence tomography
147070|NCT02388399|Axial Plaque Stress|axial plaque stress
147071|NCT02388399|Wall Shear Stress|wall shear stress
147072|NCT02388399|Vulnerability|vulnerability
147073|NCT02388386|Telemedicine|telemedicine
147074|NCT02388386|Mobile Health|mobile health
147075|NCT02388360|Prostaglandin analogs|prostaglandin analogs
147076|NCT02388360|Corneal biomechanics|corneal biomechanics
147077|NCT02388360|Corneal Hysteresis|corneal hysteresis
147078|NCT02388360|Glaucoma, Open-Angle|glaucoma, open-angle
147079|NCT02388334|Caregivers|caregivers
147080|NCT02388334|Quality of life|quality of life
147081|NCT02388334|Quality of care|quality of care
147082|NCT02388321|Analgesia|analgesia
147083|NCT02388321|pediatrics|pediatrics
147084|NCT02388321|pain management|pain management
147085|NCT02388308|Prostate cancer|prostate cancer
147086|NCT02388308|Image-guided radiotherapy|image-guided radiotherapy
147087|NCT02388308|Ultrasound guidance|ultrasound guidance
147088|NCT02388295|Multiple System Atrophy (MSA), PET imaging, myeloperoxidase (MPO) inhibitor|multiple system atrophy (msa), pet imaging, myeloperoxidase (mpo) inhibitor
147089|NCT02388282|dynamic intrinsic PEEP|dynamic intrinsic peep
147090|NCT02388282|diaphragm echography|diaphragm echography
147091|NCT02388282|respiratory mechanics|respiratory mechanics
147092|NCT02388256|colon|colon
147093|NCT02388256|colorectal|colorectal
147094|NCT02388256|cancer|cancer
147100|NCT02388243|Capacity Building|capacity building
147101|NCT02388243|Primary Health Care|primary health care
147102|NCT02388243|Education, Medical|education, medical
147103|NCT02388243|Education, Nursing|education, nursing
137928|NCT02439112|Pain|pain
137929|NCT02439112|Bone Disease|bone disease
137930|NCT02439086|rectal cancer|rectal cancer
137933|NCT02439086|response|response
147104|NCT02388243|Education, Professional|education, professional
147105|NCT02388243|Community Health Workers|community health workers
147106|NCT02388230|Breast cancer|breast cancer
147107|NCT02388230|Elastography|elastography
147108|NCT02388230|Ultrasound imaging|ultrasound imaging
147109|NCT02388230|Quantification of toxicity|quantification of toxicity
147110|NCT02388230|Side-effects|side-effects
147111|NCT02388217|chronic pain|chronic pain
147112|NCT02388217|cannabis|cannabis
147113|NCT02388217|Approved for cannabis treatment by Israeli ministry of health|approved for cannabis treatment by israeli ministry of health
147114|NCT02388217|Unrelieved chronic pain|unrelieved chronic pain
147115|NCT02388204|Gait|gait
147116|NCT02388204|Locomotion|locomotion
147117|NCT02388204|Freezing|freezing
147118|NCT02388191|Contraception|contraception
147119|NCT02388191|Naproxen|naproxen
147120|NCT02388191|Intrauterine devices|intrauterine devices
147121|NCT02388191|Pain Control|pain control
147122|NCT02388165|Staphylococcal Vaccine|staphylococcal vaccine
147123|NCT02388165|Post-operative Surgical Site Infection|post-operative surgical site infection
147124|NCT02388165|Spinal Surgery|spinal surgery
147125|NCT02388165|MRSA|mrsa
147126|NCT02388165|Staphylococcus aureus|staphylococcus aureus
147127|NCT02388139|acute myocardial infarction|acute myocardial infarction
147128|NCT02388139|renal artery stenosis|renal artery stenosis
147129|NCT02388113|Exercise therapy|exercise therapy
147130|NCT02388113|Time factors|time factors
147131|NCT02388074|Lung Cancer|lung cancer
147132|NCT02388074|Porphyrin|porphyrin
147133|NCT02388074|Fluorescence|fluorescence
147134|NCT02388074|Diagnostic|diagnostic
147135|NCT02388074|Sputum Cytology|sputum cytology
147136|NCT02388074|Early Detection|early detection
147143|NCT02388035|profiles changes|profiles changes
147144|NCT02388035|microorganisms|microorganisms
147145|NCT02388035|cefotaxime|cefotaxime
147147|NCT02388035|Egyptian|egyptian
147148|NCT02388035|effective antibiotics|effective antibiotics
147149|NCT02388009|bioconjugate vaccine|bioconjugate vaccine
147150|NCT02388009|safety|safety
147151|NCT02388009|immunogenicity|immunogenicity
147152|NCT02388009|shigellosis|shigellosis
147153|NCT02387970|Dental implants|dental implants
147154|NCT02387970|Partial edentulism|partial edentulism
147155|NCT02387970|Immediate/delayed provisionalization|immediate/delayed provisionalization
147156|NCT02387957|Wet AMD|wet amd
147157|NCT02387957|subfoveal choroidal neovascularization|subfoveal choroidal neovascularization
147158|NCT02387957|Fovista®|fovista®
147159|NCT02387957|Avastin®|avastin®
147160|NCT02387957|Lucentis®|lucentis®
147161|NCT02387957|Eylea®|eylea®
147162|NCT02387944|Children|children
147163|NCT02387944|Cyanotic congenital heart defect|cyanotic congenital heart defect
147164|NCT02387944|Cardiopulmonary Bypass|cardiopulmonary bypass
147165|NCT02387944|Thromboelastometry|thromboelastometry
147166|NCT02387944|Platelet Function Tests|platelet function tests
147167|NCT02387931|Adolescent|adolescent
147168|NCT02387931|Endometriosis|endometriosis
147169|NCT02387931|Diet|diet
147170|NCT02387931|Nutrition|nutrition
147171|NCT02387931|Pain|pain
147172|NCT02387918|Tonsillectomy|tonsillectomy
147173|NCT02387918|postoperative vomiting (POV)|postoperative vomiting (pov)
147174|NCT02387918|Dexamethasone|dexamethasone
147175|NCT02387918|Acupuncture|acupuncture
147176|NCT02387905|Stereotactic spinal radiosurgery|stereotactic spinal radiosurgery
147177|NCT02387905|Spinal Cord Diseases|spinal cord diseases
147178|NCT02387905|Vertebral body compression fracture|vertebral body compression fracture
147179|NCT02387905|SSRS|ssrs
147180|NCT02387905|Brief Pain Inventory|brief pain inventory
147181|NCT02387905|MD Anderson Symptom Inventory - Spine Tumor|md anderson symptom inventory - spine tumor
147182|NCT02387905|MDASI-SP|mdasi-sp
147183|NCT02387905|Questionnaires|questionnaires
147184|NCT02387905|Survey|survey
147185|NCT02387879|Multiple Myeloma|multiple myeloma
147186|NCT02387879|PASS|pass
147187|NCT02387879|Observational|observational
147188|NCT02387879|Non-interventional|non-interventional
147189|NCT02387879|Relapse|relapse
147190|NCT02387879|Refractory|refractory
147191|NCT02387879|CC-5013|cc-5013
147192|NCT02387879|Lenalidomide|lenalidomide
147193|NCT02387879|Turkey|turkey
147194|NCT02387866|Pharmacokinetic|pharmacokinetic
147195|NCT02387866|Healthy Volunteers|healthy volunteers
147197|NCT02387866|Japanese|japanese
147198|NCT02387866|Caucasian|caucasian
147199|NCT02387866|AG-221|ag-221
147200|NCT02387840|Brain|brain
147201|NCT02387840|Cancer|cancer
147202|NCT02387840|Neurofibromatosis type 1|neurofibromatosis type 1
147203|NCT02387840|NF1|nf1
147204|NCT02387840|Magnetic resonance fingerprinting|magnetic resonance fingerprinting
177780|NCT02220686|PAD|pad
147205|NCT02387840|MRF|mrf
147206|NCT02387827|long bout physical activity|long bout physical activity
147207|NCT02387827|short bout physical activity|short bout physical activity
147208|NCT02387827|Caloric Restriction|caloric restriction
147209|NCT02387775|esophageal cooling device|esophageal cooling device
147210|NCT02387775|post cardiac arrest|post cardiac arrest
147211|NCT02387775|targetted temperature management|targetted temperature management
147212|NCT02387775|therapeutic hypothermia|therapeutic hypothermia
147213|NCT02387775|cooling|cooling
147214|NCT02387775|rewarming|rewarming
147215|NCT02387762|Acalabrutinib|acalabrutinib
147216|NCT02387749|diabetic peripheral neuropathy|diabetic peripheral neuropathy
147217|NCT02387749|mesenchymal stem cells|mesenchymal stem cells
147218|NCT02387736|BPD|bpd
147219|NCT02387736|DBT|dbt
147220|NCT02387736|Dialectical Behaviour Therapy|dialectical behaviour therapy
147221|NCT02387736|Borderline Personality Disorder|borderline personality disorder
147222|NCT02387736|Suicide|suicide
147223|NCT02387736|Non-suicidal self injury|non-suicidal self injury
147224|NCT02387736|NSSI|nssi
147225|NCT02387736|Randomized Control trials|randomized control trials
147226|NCT02387736|treatment|treatment
147227|NCT02387710|arousal threshold|arousal threshold
147228|NCT02387710|phenotype|phenotype
147229|NCT02387710|tiagabine|tiagabine
147230|NCT02387710|slow wave sleep|slow wave sleep
147231|NCT02387684|chronic hepatitis B|chronic hepatitis b
147232|NCT02387684|interferon|interferon
147233|NCT02387684|peginterferon|peginterferon
147234|NCT02387684|HBsAg loss|hbsag loss
147235|NCT02387658|peripheral arterial disease|peripheral arterial disease
147236|NCT02387658|claudication|claudication
147237|NCT02387658|translesional pressure gradient|translesional pressure gradient
147238|NCT02387658|pressure wire|pressure wire
147239|NCT02387658|six minute walk|six minute walk
147240|NCT02387658|superficial femoral artery|superficial femoral artery
147241|NCT02387658|pressure gradient|pressure gradient
147242|NCT02387658|endovascular|endovascular
147243|NCT02387645|Endometrium|endometrium
147244|NCT02387645|Endometrial Neoplasms|endometrial neoplasms
147245|NCT02387645|Early detection|early detection
147246|NCT02387645|Carcinoma of Endometrium|carcinoma of endometrium
147247|NCT02387645|Gynaecological Cancer|gynaecological cancer
147248|NCT02387606|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
147249|NCT02387606|Placebo|placebo
147250|NCT02387606|Antiviral activity|antiviral activity
147251|NCT02387606|JNJ-53718678|jnj-53718678
147252|NCT02387593|Adenoma|adenoma
147253|NCT02387593|Colonoscopy|colonoscopy
147254|NCT02387593|Screening|screening
147255|NCT02387580|Malaria|malaria
147256|NCT02387580|Bioavailability|bioavailability
147257|NCT02387580|Formulation|formulation
147258|NCT02387541|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
147259|NCT02387528|MIndfulness|mindfulness
147260|NCT02387528|Primary Health Care|primary health care
147261|NCT02387463|chronic hepatitis B|chronic hepatitis b
147262|NCT02387463|antiviral therapy|antiviral therapy
147263|NCT02387463|peginterferon|peginterferon
147264|NCT02387463|HBeAg seroconversion|hbeag seroconversion
147265|NCT02387463|HBsAg loss|hbsag loss
147266|NCT02387450|Claudication|claudication
147267|NCT02387450|Maximal walking distance|maximal walking distance
147268|NCT02387450|Morbi-mortality|morbi-mortality
147269|NCT02387437|ARDS|ards
147270|NCT02387437|EIT|eit
147271|NCT02387437|recruitment maneuvers|recruitment maneuvers
147272|NCT02387424|depression|depression
147273|NCT02387424|mindfulness|mindfulness
147274|NCT02387424|pregnancy|pregnancy
147275|NCT02387424|prevention|prevention
147276|NCT02387424|cognitive behavioral therapy|cognitive behavioral therapy
147277|NCT02387411|heart failure|heart failure
147278|NCT02387411|aerobic exercise|aerobic exercise
147279|NCT02387411|strength training|strength training
147280|NCT02387411|cardiopulmonary rehabilitation|cardiopulmonary rehabilitation
147281|NCT02387411|high-intensity exercise training|high-intensity exercise training
147282|NCT02387190|Heart Failure|heart failure
147283|NCT02387190|Lung function test|lung function test
147284|NCT02387190|Telenursing|telenursing
147285|NCT02387190|Morbidity|morbidity
147286|NCT02387190|Mortality|mortality
147287|NCT02387190|Quality of life|quality of life
147288|NCT02387164|Type 1 diabetes|type 1 diabetes
147289|NCT02387164|Islet autoantibodies|islet autoantibodies
147290|NCT02387164|glutamate decarboxylase autoantibodies (GADA)|glutamate decarboxylase autoantibodies (gada)
147291|NCT02387164|Immune tolerance|immune tolerance
147292|NCT02387164|Prediabetes|prediabetes
147293|NCT02387164|Glucose tolerance|glucose tolerance
147294|NCT02387164|glutamate decarboxylase|glutamate decarboxylase
147295|NCT02387164|Prevention|prevention
147296|NCT02387164|Children|children
147297|NCT02387151|Mesenchymal Stromal Cells|mesenchymal stromal cells
147298|NCT02387151|Rejection|rejection
147299|NCT02387112|End stage heart disease|end stage heart disease
147300|NCT02387112|Ventricular assist device|ventricular assist device
147301|NCT02387099|Stage IIIB|stage iiib
147302|NCT02387099|Stage IV|stage iv
147303|NCT02387099|Recurrent|recurrent
147304|NCT02387099|Metastatic|metastatic
147305|NCT02387086|gefitinib|gefitinib
147306|NCT02387086|thalidomide|thalidomide
147307|NCT02387086|NSCLC|nsclc
147308|NCT02387086|EGFR mutation|egfr mutation
147309|NCT02387073|outcome assessment|outcome assessment
147310|NCT02387073|self-reported|self-reported
147311|NCT02387073|patient|patient
147312|NCT02387073|clinical outcome|clinical outcome
147313|NCT02387060|Anesthesia|anesthesia
147314|NCT02387060|Spinal and Epidural|spinal and epidural
147315|NCT02387060|Adverse Effect|adverse effect
147316|NCT02387060|Complications|complications
147317|NCT02387034|Osteoarthritis|osteoarthritis
147318|NCT02387034|Sedentary|sedentary
147319|NCT02387034|Physical activity|physical activity
147320|NCT02387034|Health related quality of life|health related quality of life
147322|NCT02387021|nerve block|nerve block
147323|NCT02387021|Total knee replacement|total knee replacement
147324|NCT02386995|depth of anesthesia monitors|depth of anesthesia monitors
147325|NCT02386995|deep brain stimulation|deep brain stimulation
147326|NCT02386969|Neuropathic Pain|neuropathic pain
147327|NCT02386969|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
147328|NCT02386956|manual therapy|manual therapy
147329|NCT02386956|muscle chains|muscle chains
147330|NCT02386956|Dynamic stretching|dynamic stretching
147331|NCT02386956|Active stretching|active stretching
147332|NCT02386930|Cognitive behavior therapy|cognitive behavior therapy
147333|NCT02386930|Lifestyle modification|lifestyle modification
147334|NCT02386930|HbA1c|hba1c
147335|NCT02386930|Carbohydrates|carbohydrates
147336|NCT02386891|food intake|food intake
147337|NCT02386891|indoor thermal environment|indoor thermal environment
147338|NCT02386878|Orphans and vulnerable children (OVC)|orphans and vulnerable children (ovc)
147339|NCT02386878|Program Evaluation|program evaluation
147340|NCT02386878|HIV Prevention|hiv prevention
147341|NCT02386878|Psychosocial Wellbeing|psychosocial wellbeing
147342|NCT02386878|Adolescents|adolescents
147343|NCT02386852|Ginseng|ginseng
147344|NCT02386852|Ginkgo Biloba|ginkgo biloba
147345|NCT02386852|cardiovascular reactivity|cardiovascular reactivity
147346|NCT02386852|cognition|cognition
147347|NCT02386826|INC280|inc280
147348|NCT02386826|c-MET Inhibitors|c-met inhibitors
147349|NCT02386826|bevacizumab|bevacizumab
147350|NCT02386826|Avastin|avastin
147351|NCT02386826|C-Met proto-oncogene|c-met proto-oncogene
147352|NCT02386800|primary myelofibrosis|primary myelofibrosis
147353|NCT02386800|chronic idiopathic myelofibrosis,|chronic idiopathic myelofibrosis,
147354|NCT02386800|post polycythemia vera myelofibrosis,|post polycythemia vera myelofibrosis,
147355|NCT02386800|post essential thrombocythaemia myelofibrosis.|post essential thrombocythaemia myelofibrosis.
147356|NCT02386787|Ultrasonography|ultrasonography
147357|NCT02386787|Non-elective surgery|non-elective surgery
147358|NCT02386787|Anesthesia|anesthesia
147463|NCT02386072|Betmiga®|betmiga®
147359|NCT02386774|In vivo confocal microscopy|in vivo confocal microscopy
147360|NCT02386774|corneal disease|corneal disease
147361|NCT02386774|Blepharitis|blepharitis
147362|NCT02386774|Lacrimal Apparatus Diseases|lacrimal apparatus diseases
147363|NCT02386774|Microscopy, Confocal|microscopy, confocal
147364|NCT02386748|Cesarean section|cesarean section
147365|NCT02386748|Chewing gums|chewing gums
147366|NCT02386748|Intestinal motility|intestinal motility
147367|NCT02386735|Corticosteroid treatment|corticosteroid treatment
147368|NCT02386735|COPD|copd
147369|NCT02386735|Primary Health Care|primary health care
147370|NCT02386735|Randomized controlled trial|randomized controlled trial
147371|NCT02386722|Adherence of inhaled medication|adherence of inhaled medication
147372|NCT02386722|pharmaceutical care intervention|pharmaceutical care intervention
147373|NCT02386683|Protective mechanical ventilation|protective mechanical ventilation
147374|NCT02386683|ventilator-induced lung injury|ventilator-induced lung injury
147375|NCT02386683|neurosurgery|neurosurgery
147376|NCT02386657|Sickle Cell Disease|sickle cell disease
147377|NCT02386657|Vaso-occlusive crisis|vaso-occlusive crisis
147378|NCT02386657|Emergency management|emergency management
147379|NCT02386631|gait|gait
147380|NCT02386631|orthotics|orthotics
147381|NCT02386631|kinetics|kinetics
147382|NCT02386631|hallux valgus|hallux valgus
147385|NCT02386618|laterally spreading tumors|laterally spreading tumors
147386|NCT02386618|endoscopic mucosal resestion|endoscopic mucosal resestion
147387|NCT02386618|local residual neoplasia|local residual neoplasia
147390|NCT02386553|NURTURE|nurture
147391|NCT02386540|Community Health Workers|community health workers
147392|NCT02386540|Community Health Workers: utilization|community health workers: utilization
147393|NCT02386540|Emergency Service|emergency service
147394|NCT02386540|Primary Health Care/utilization|primary health care/utilization
147395|NCT02386540|Health Services Accessibility|health services accessibility
147396|NCT02386514|sexually transmitted infection|sexually transmitted infection
147397|NCT02386514|gonorrhea|gonorrhea
147398|NCT02386514|chlamydia|chlamydia
147399|NCT02386514|presumptive therapy|presumptive therapy
147400|NCT02386462|laryngeal mask airway|laryngeal mask airway
147401|NCT02386462|circulatory reflexes|circulatory reflexes
147402|NCT02386436|GSK2330811|gsk2330811
147403|NCT02386436|Dose Escalation|dose escalation
147404|NCT02386436|Safety|safety
147405|NCT02386436|First Time in Human|first time in human
147406|NCT02386436|Pharmacodynamics|pharmacodynamics
147407|NCT02386436|Pharmacokinetics|pharmacokinetics
147408|NCT02386423|RLS|rls
147409|NCT02386423|Willis-Ekbom|willis-ekbom
147410|NCT02386384|pregnancy failure|pregnancy failure
147411|NCT02386358|Chronic Chagas Disease|chronic chagas disease
147412|NCT02386358|Randomized Clinical Trial double blind|randomized clinical trial double blind
147413|NCT02386358|Benznidazole vs Placebo|benznidazole vs placebo
147414|NCT02386358|Adult patients|adult patients
147415|NCT02386345|FIRM procedure|firm procedure
147416|NCT02386319|Melatonin|melatonin
147417|NCT02386319|Analgesic|analgesic
147419|NCT02386319|Pharmacokinetic|pharmacokinetic
147420|NCT02386280|Primary Prevention|primary prevention
147421|NCT02386280|Substance-Related Disorders|substance-related disorders
147422|NCT02386280|Family|family
147423|NCT02386254|premorbid|premorbid
147424|NCT02386254|scoring system|scoring system
147425|NCT02386254|ECOG|ecog
147427|NCT02386254|morbidity|morbidity
147428|NCT02386254|mortality|mortality
147429|NCT02386241|brain tumor|brain tumor
147430|NCT02386228|miRNA|mirna
147431|NCT02386228|posthemorrhagic hydrocephalus (PHH)|posthemorrhagic hydrocephalus (phh)
147432|NCT02386215|HIV self-testing|hiv self-testing
147433|NCT02386215|randomized controlled trial|randomized controlled trial
147434|NCT02386215|Kenya|kenya
147435|NCT02386189|Continuity of Patient Care|continuity of patient care
147436|NCT02386189|Health Records, Personal|health records, personal
147437|NCT02386189|Veterans|veterans
147438|NCT02386189|Patient Participation|patient participation
147439|NCT02386189|Chronic Disease|chronic disease
147440|NCT02386137|MR-HIFU|mr-hifu
147441|NCT02386137|HIFU|hifu
147442|NCT02386137|Fibroid treatment|fibroid treatment
147443|NCT02386137|MR Perfusion|mr perfusion
147444|NCT02386137|CEUS perfusion|ceus perfusion
147445|NCT02386137|Diffusion weighted imaging|diffusion weighted imaging
147446|NCT02386137|ARFI|arfi
147447|NCT02386137|Fibroid stiffness|fibroid stiffness
147448|NCT02386124|frailty|frailty
147449|NCT02386124|elderly|elderly
147450|NCT02386124|acute coronary syndrome|acute coronary syndrome
147451|NCT02386124|acute heart failure|acute heart failure
147452|NCT02386124|arrhythmias|arrhythmias
147453|NCT02386111|Sutent|sutent
147454|NCT02386085|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
147455|NCT02386085|Osteopathic Manipulation|osteopathic manipulation
147456|NCT02386085|adverse effects|adverse effects
147457|NCT02386085|side effects|side effects
147458|NCT02386085|undesirable effects|undesirable effects
147459|NCT02386072|Betanis®|betanis®
147460|NCT02386072|Myrbetriq®|myrbetriq®
147461|NCT02386072|Quality of Life|quality of life
147462|NCT02386072|Antimuscarinics|antimuscarinics
147464|NCT02386072|Overactive Bladder|overactive bladder
147465|NCT02386072|Observational|observational
147466|NCT02386059|ondansetron|ondansetron
147467|NCT02386059|dexamethasone|dexamethasone
147468|NCT02386059|vitrectomy|vitrectomy
147469|NCT02386059|local anesthesia|local anesthesia
147470|NCT02386046|Caffeine use|caffeine use
147471|NCT02386046|Normative data|normative data
147472|NCT02385968|Modic|modic
147473|NCT02385968|Microbiology|microbiology
147474|NCT02385968|Immunology|immunology
147475|NCT02385942|u-health|u-health
147476|NCT02385942|chronic wound management|chronic wound management
147477|NCT02385942|pressure ulcer|pressure ulcer
147478|NCT02385929|Head and Neck Cancer|head and neck cancer
147479|NCT02385929|Intervention|intervention
147480|NCT02385929|Rehabilitation|rehabilitation
147481|NCT02385929|Late Effects|late effects
147482|NCT02385929|Dysphagia|dysphagia
147483|NCT02385916|EstroSense|estrosense
147484|NCT02385916|estrogen|estrogen
147485|NCT02385903|Flammacerium|flammacerium
147486|NCT02385903|Ischemic wound|ischemic wound
147487|NCT02385903|Lower limb|lower limb
147488|NCT02385903|Arteriopathy|arteriopathy
147489|NCT02385903|Amputation|amputation
147490|NCT02385903|Dressing|dressing
147491|NCT02385838|Nutrition labelling|nutrition labelling
147492|NCT02385838|Front-of-pack nutrition labels|front-of-pack nutrition labels
147493|NCT02385838|Purchasing intentions|purchasing intentions
657692|NCT00808431|Diabetes|diabetes
147498|NCT02385812|Asbestos|asbestos
147499|NCT02385812|Screening|screening
147500|NCT02385799|Autism Spectrum Disorder|autism spectrum disorder
147501|NCT02385799|Behavior|behavior
147502|NCT02385799|sertraline|sertraline
147503|NCT02385799|treatment|treatment
147504|NCT02385786|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
147505|NCT02385786|depression|depression
147506|NCT02385786|treatment|treatment
147507|NCT02385786|mindfulness meditation|mindfulness meditation
147508|NCT02385786|psychotherapy|psychotherapy
178166|NCT02218905|Age|age
138370|NCT02436226|HCG|hcg
147509|NCT02385773|colostrum|colostrum
147510|NCT02385773|Immunoglobulin Y (IgY)|immunoglobulin y (igy)
147511|NCT02385760|Facial Acne|facial acne
147512|NCT02385747|perimenopausal bleeding|perimenopausal bleeding
147513|NCT02385747|postmenopausal bleeding|postmenopausal bleeding
147514|NCT02385747|hysteroscopy|hysteroscopy
147515|NCT02385747|Steroid receptors|steroid receptors
147516|NCT02385734|Multiple gingival recession|multiple gingival recession
147517|NCT02385734|Concentrated growth factor|concentrated growth factor
147518|NCT02385734|Coronally advanced flap|coronally advanced flap
147519|NCT02385695|Disc Degeneration Disease|disc degeneration disease
147520|NCT02385695|DDD|ddd
147521|NCT02385695|multilevel lumbar Disc Degeneration Disease|multilevel lumbar disc degeneration disease
147527|NCT02385643|alcohol dependence|alcohol dependence
147528|NCT02385643|abstinence|abstinence
147532|NCT02385630|Esophagectomy|esophagectomy
147533|NCT02385630|Gastrectomy|gastrectomy
147534|NCT02385630|Hunger|hunger
147535|NCT02385630|Appetite|appetite
147536|NCT02385630|Glucagon-like Peptide 1|glucagon-like peptide 1
147537|NCT02385630|Peptide YY|peptide yy
147538|NCT02385630|Ghrelin|ghrelin
147539|NCT02385630|Satiety Response|satiety response
147540|NCT02385630|Feeding Behavior|feeding behavior
147541|NCT02385630|Meals|meals
147542|NCT02385630|Postprandial Period|postprandial period
147543|NCT02385617|Glucagon-Like Peptide 1|glucagon-like peptide 1
147544|NCT02385617|Peptide YY|peptide yy
147545|NCT02385617|Ghrelin|ghrelin
147546|NCT02385617|Satiety Response|satiety response
147547|NCT02385617|Appetite|appetite
147548|NCT02385617|Hunger|hunger
147549|NCT02385617|Somatostatin|somatostatin
147550|NCT02385617|Octreotide|octreotide
147551|NCT02385617|Anastomosis, Roux-en-Y|anastomosis, roux-en-y
147552|NCT02385617|Digestive System Surgical Procedures|digestive system surgical procedures
147553|NCT02385617|Pharmacologic Actions|pharmacologic actions
147554|NCT02385617|Physiological Effects of Drugs|physiological effects of drugs
147555|NCT02385617|Endocrine System Diseases|endocrine system diseases
147556|NCT02385617|Enteroendocrine Cells|enteroendocrine cells
147557|NCT02385617|Gastrointestinal Agents|gastrointestinal agents
147558|NCT02385604|Positron-Emission Tomography|positron-emission tomography
147559|NCT02385604|Neoadjuvant Therapy|neoadjuvant therapy
147560|NCT02385604|Chemoradiotherapy|chemoradiotherapy
147561|NCT02385604|Esophagectomy|esophagectomy
147562|NCT02385604|Response Evaluation Criteria in Solid Tumors|response evaluation criteria in solid tumors
147563|NCT02385604|Treatment Outcome|treatment outcome
147564|NCT02385604|Survival|survival
147565|NCT02385604|Recurrence|recurrence
147566|NCT02385604|Disease-Free Survival|disease-free survival
147567|NCT02385604|Progression-Free Survival|progression-free survival
147568|NCT02385604|Prognosis|prognosis
147569|NCT02385604|Neoplasm Grading|neoplasm grading
147570|NCT02385604|Adenocarcinoma|adenocarcinoma
147571|NCT02385604|Squamous Cell Carcinoma|squamous cell carcinoma
147572|NCT02385604|Neoplasm Metastasis|neoplasm metastasis
147573|NCT02385591|physical activity|physical activity
147574|NCT02385591|Latinos|latinos
147575|NCT02385591|overweight|overweight
147576|NCT02385591|SMS|sms
147577|NCT02385591|mHealth|mhealth
147578|NCT02385578|VS (vessel plus surface) classification system|vs (vessel plus surface) classification system
147579|NCT02385578|Magnified endoscopy with narrow band imaging (ME-NBI)|magnified endoscopy with narrow band imaging (me-nbi)
147580|NCT02385578|the rate of detection|the rate of detection
147581|NCT02385552|colonoscopy|colonoscopy
147582|NCT02385552|quality improvement|quality improvement
147583|NCT02385552|adenoma detection rate|adenoma detection rate
147687|NCT02385058|Mebendazole|mebendazole
147584|NCT02385526|Vagus Nerve Stimulation|vagus nerve stimulation
147585|NCT02385526|ASCEND|ascend
147586|NCT02385526|VNS Titration to Improve Tolerance and Accelerate Adaptation|vns titration to improve tolerance and accelerate adaptation
147587|NCT02385513|Immunogenicity|immunogenicity
147588|NCT02385487|Myocardial Infarction|myocardial infarction
147589|NCT02385487|Inflammation|inflammation
147590|NCT02385487|Critical Illness|critical illness
147591|NCT02385487|Necrosis|necrosis
147592|NCT02385487|Sepsis|sepsis
147593|NCT02385487|Respiratory Insufficiency|respiratory insufficiency
147594|NCT02385487|Myocardial Ischemia|myocardial ischemia
147595|NCT02385487|Cardiovascular Diseases|cardiovascular diseases
147596|NCT02385487|Heart Diseases|heart diseases
147597|NCT02385487|Vascular Diseases|vascular diseases
147598|NCT02385474|silver diamine fluoride|silver diamine fluoride
147599|NCT02385474|randomized clinical trial|randomized clinical trial
147600|NCT02385474|caries|caries
147601|NCT02385474|children|children
147602|NCT02385474|fluoride|fluoride
147603|NCT02385448|dienogest|dienogest
147604|NCT02385448|combined oral contraceptive pills|combined oral contraceptive pills
147605|NCT02385448|endometriosis|endometriosis
147606|NCT02385435|caudal block|caudal block
147607|NCT02385422|secondary prophylaxis|secondary prophylaxis
147608|NCT02385422|Propranolol|propranolol
147609|NCT02385422|Carvedilol|carvedilol
147610|NCT02385422|comparative effectiveness research|comparative effectiveness research
147611|NCT02385409|Patient Blood Management|patient blood management
147612|NCT02385409|Preoperative anemia|preoperative anemia
147613|NCT02385409|Hip replacement|hip replacement
147614|NCT02385409|Knee replacement|knee replacement
147615|NCT02385396|Polycystic Ovary Syndrome|polycystic ovary syndrome
147616|NCT02385396|Infertility|infertility
147617|NCT02385396|Myo-inositol|myo-inositol
147618|NCT02385396|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
147619|NCT02385383|Patient Blood Management|patient blood management
147620|NCT02385383|Preoperative anemia|preoperative anemia
147622|NCT02385357|Muscle function|muscle function
147623|NCT02385357|Anaerobic power|anaerobic power
147624|NCT02385357|Muscle damage|muscle damage
147625|NCT02385331|Neutrophils|neutrophils
147626|NCT02385331|necroptosis|necroptosis
147627|NCT02385331|apoptosis|apoptosis
147628|NCT02385305|Pressure support ventilation|pressure support ventilation
147629|NCT02385305|respiratory drive|respiratory drive
147630|NCT02385305|Physiology|physiology
147632|NCT02385279|ACS|acs
147633|NCT02385279|All comers|all comers
147634|NCT02385279|PCI|pci
147635|NCT02385266|Interstitial cystitis with Painful Bladder Syndrome|interstitial cystitis with painful bladder syndrome
147636|NCT02385266|Urological Chronic Pelvic Pain Syndrome|urological chronic pelvic pain syndrome
147637|NCT02385253|Training|training
147638|NCT02385253|Primary Health Care|primary health care
147639|NCT02385253|Skin Cancer|skin cancer
147640|NCT02385253|Primary Care Physicians|primary care physicians
147641|NCT02385253|Surveillance|surveillance
147642|NCT02385253|Education|education
147643|NCT02385214|Malignant|malignant
147644|NCT02385214|Melanoma|melanoma
147645|NCT02385214|Cancer|cancer
147646|NCT02385214|Surgery|surgery
147647|NCT02385188|Extramammary Paget's disease|extramammary paget's disease
147648|NCT02385188|Vulva|vulva
147649|NCT02385188|Genital, female|genital, female
147650|NCT02385188|imiquimod|imiquimod
147651|NCT02385175|Eustachian tube|eustachian tube
147652|NCT02385175|test accuracy|test accuracy
147653|NCT02385175|clinical test|clinical test
147654|NCT02385175|questionnaire|questionnaire
147655|NCT02385162|Mucolipidoses|mucolipidoses
147656|NCT02385162|Metabolic Diseases|metabolic diseases
147657|NCT02385162|Lysosomal Storage Diseases|lysosomal storage diseases
147658|NCT02385149|resilience|resilience
147659|NCT02385149|challenge test|challenge test
147660|NCT02385149|whole grain wheat|whole grain wheat
147661|NCT02385149|metabolic flexibility|metabolic flexibility
147662|NCT02385149|cardio-metabolic|cardio-metabolic
147663|NCT02385149|liver and adipose tissue|liver and adipose tissue
147664|NCT02385136|NSCLC|nsclc
147665|NCT02385136|Radiotherpy|radiotherpy
147666|NCT02385136|Temozolomide|temozolomide
147667|NCT02385123|ex-vivo|ex-vivo
147668|NCT02385123|Influenza|influenza
147669|NCT02385123|plasmablasts|plasmablasts
147670|NCT02385110|Leukemia|leukemia
147671|NCT02385110|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
147672|NCT02385110|HLH|hlh
147673|NCT02385110|Alemtuzumab|alemtuzumab
147674|NCT02385110|CAMPATH-1H|campath-1h
147675|NCT02385110|Campath|campath
147676|NCT02385110|Etoposide|etoposide
147677|NCT02385110|VePesid|vepesid
147678|NCT02385110|Dexamethasone|dexamethasone
147679|NCT02385110|Decadron|decadron
147680|NCT02385110|Methotrexate|methotrexate
147681|NCT02385110|Phone call|phone call
147682|NCT02385071|Healthy|healthy
147683|NCT02385071|Simeprevir|simeprevir
147684|NCT02385071|Bioavailability|bioavailability
147685|NCT02385058|Helminthiasis|helminthiasis
147686|NCT02385058|Amoebiasis|amoebiasis
147688|NCT02385058|Quinfamide|quinfamide
147689|NCT02385058|Mexican population|mexican population
147690|NCT02385019|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
658537|NCT00812994|BDNF|bdnf
147691|NCT02385019|Graft vs host disease|graft vs host disease
147692|NCT02385019|Regulatory T cells|regulatory t cells
147693|NCT02385006|Thromboelastography|thromboelastography
147694|NCT02385006|simulatneous pancreas-kidney transplantation|simulatneous pancreas-kidney transplantation
147695|NCT02384993|Alzheimer's Disease|alzheimer's disease
147696|NCT02384993|Dementia|dementia
147697|NCT02384993|aerobic exercise|aerobic exercise
147698|NCT02384993|physical activity|physical activity
147699|NCT02384993|exercise|exercise
147700|NCT02384993|neuroimaging|neuroimaging
147701|NCT02384980|Intermittent Claudication|intermittent claudication
147702|NCT02384980|Functional Electrical Stimulation|functional electrical stimulation
147703|NCT02384954|Lymphoma|lymphoma
147704|NCT02384954|indolent B Cell|indolent b cell
147705|NCT02384954|non-Hodgkin Lymphoma|non-hodgkin lymphoma
147706|NCT02384954|Cancer|cancer
147707|NCT02384954|Immunotherapy|immunotherapy
147708|NCT02384954|Relapsed|relapsed
147709|NCT02384954|Refractory|refractory
147710|NCT02384954|Rituximab|rituximab
147711|NCT02384954|Interleukin-15|interleukin-15
178418|NCT02217865|CRC|crc
147712|NCT02384954|Absolute Lymphocyte Count|absolute lymphocyte count
147713|NCT02384954|White Blood Cell|white blood cell
147714|NCT02384954|Follicular Lymphoma|follicular lymphoma
147715|NCT02384954|Marginal Zone Lymphoma|marginal zone lymphoma
147716|NCT02384954|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
147717|NCT02384954|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
147718|NCT02384954|anti-CD20|anti-cd20
147719|NCT02384928|Acupuncture|acupuncture
147720|NCT02384928|Pharmacopuncture|pharmacopuncture
147721|NCT02384928|Usual Care|usual care
147722|NCT02384902|glycemic index|glycemic index
147723|NCT02384902|diabetic nephropathy|diabetic nephropathy
147724|NCT02384902|low glycemic load|low glycemic load
147725|NCT02384902|inflammation|inflammation
147726|NCT02384876|pediatric|pediatric
147727|NCT02384876|intraoperative arterial hypotension|intraoperative arterial hypotension
147728|NCT02384876|ephedrine|ephedrine
147729|NCT02384876|general anesthesia|general anesthesia
147730|NCT02384863|Chest Pain|chest pain
147731|NCT02384863|Acute Coronary Syndrome|acute coronary syndrome
147732|NCT02384863|Cardiac|cardiac
147733|NCT02384863|Emergency Department|emergency department
147734|NCT02384863|Cardiac Testing|cardiac testing
147735|NCT02384863|Healthcare Utilization|healthcare utilization
147736|NCT02384863|Patient Centered Outcomes|patient centered outcomes
147737|NCT02384863|Shared Decision Making|shared decision making
147738|NCT02384863|Unnecessary hospital admissions|unnecessary hospital admissions
147739|NCT02384863|Decision Aid|decision aid
147740|NCT02384850|metastatic|metastatic
147741|NCT02384837|national Cather Lad|national cather lad
147742|NCT02384837|Interventional Imaging Training Base|interventional imaging training base
147743|NCT02384811|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
147744|NCT02384811|postoperative radiotherapy|postoperative radiotherapy
147745|NCT02384759|cancer, colorectal,|cancer, colorectal,
147746|NCT02384746|metastatic breast cancer|metastatic breast cancer
147747|NCT02384746|ER-positive|er-positive
147748|NCT02384746|HER2-negative|her2-negative
147749|NCT02384746|Fulvestrant|fulvestrant
147750|NCT02384746|MLN9708|mln9708
147751|NCT02384733|Radiation induced morbidity, recurrence|radiation induced morbidity, recurrence
147752|NCT02384694|cardiorespiratory fitness|cardiorespiratory fitness
147753|NCT02384694|weight|weight
147754|NCT02384694|quality of life|quality of life
147755|NCT02384694|depression|depression
147756|NCT02384694|menopausal symptoms|menopausal symptoms
147757|NCT02384694|exercise barriers|exercise barriers
147758|NCT02384694|executive functions|executive functions
147759|NCT02384681|Speech intelligibility|speech intelligibility
147760|NCT02384681|Short-term memory|short-term memory
147761|NCT02384681|Working memory|working memory
147762|NCT02384681|Perceived mental task load|perceived mental task load
147763|NCT02384668|Cholecalciferol|cholecalciferol
147764|NCT02384668|Vitamin D3|vitamin d3
147765|NCT02384668|Arterial stiffness|arterial stiffness
147766|NCT02384668|Quality of Life|quality of life
147767|NCT02384668|Bone density and geometry|bone density and geometry
147768|NCT02384668|Muscle strength and balance|muscle strength and balance
147769|NCT02384655|Preterms|preterms
147770|NCT02384655|Breastfeeding|breastfeeding
147771|NCT02384655|Lactation|lactation
147772|NCT02384655|Macronutrients|macronutrients
147773|NCT02384642|Adolescent Health|adolescent health
147774|NCT02384642|Democratic Republic of Congo|democratic republic of congo
147775|NCT02384642|Sexual Violence|sexual violence
147776|NCT02384616|Lung Volume Measurements|lung volume measurements
147777|NCT02384616|airway resistance|airway resistance
147778|NCT02384616|general anesthesia|general anesthesia
147779|NCT02384564|Laryngoscopy|laryngoscopy
147780|NCT02384564|Video Laryngoscopy|video laryngoscopy
147781|NCT02384564|Tracheal intubation|tracheal intubation
147782|NCT02384551|GERD|gerd
147783|NCT02384551|diet|diet
147784|NCT02384551|carbohydrate|carbohydrate
147785|NCT02384551|obesity|obesity
147786|NCT02384538|Osteoarthritis|osteoarthritis
147787|NCT02384538|Joint diseases|joint diseases
147788|NCT02384538|Musculoskeletal diseases|musculoskeletal diseases
147789|NCT02384538|Rheumatic diseases|rheumatic diseases
147790|NCT02384538|Arthritis|arthritis
147791|NCT02384538|Osteoarthritis, Hand|osteoarthritis, hand
147792|NCT02384525|Septic AKI|septic aki
147793|NCT02384525|CRRT|crrt
147794|NCT02384525|BIA|bia
147795|NCT02384512|Parkinson's disease|parkinson's disease
147796|NCT02384512|akinesia|akinesia
147797|NCT02384512|Azilect®|azilect®
147798|NCT02384512|Rasagiline|rasagiline
147799|NCT02384512|Combination therapy with L-dopa|combination therapy with l-dopa
147800|NCT02384512|Wearing-off Questionnaire-32|wearing-off questionnaire-32
147801|NCT02384512|Quality of life|quality of life
147802|NCT02384512|Daily practice|daily practice
147803|NCT02384460|Simplex|simplex
147804|NCT02384460|Recessive Dystrophic|recessive dystrophic
147805|NCT02384460|Junctional non-Herlitz|junctional non-herlitz
147806|NCT02384460|Epidermolysis Bullosa|epidermolysis bullosa
147807|NCT02384447|above knee amputation|above knee amputation
147808|NCT02384447|sciatic nerve|sciatic nerve
147809|NCT02384447|ultrasonography|ultrasonography
147810|NCT02384447|histology|histology
147811|NCT02384408|menopause|menopause
147812|NCT02384408|drospirenone|drospirenone
147813|NCT02384408|tibolone|tibolone
147814|NCT02384408|Bcl-2|bcl-2
147815|NCT02384408|steroid receptors|steroid receptors
147816|NCT02384395|Dolutegravir|dolutegravir
147817|NCT02384395|Abacavir|abacavir
147818|NCT02384395|Lamivudine|lamivudine
147819|NCT02384395|acute HIV infection|acute hiv infection
147820|NCT02384395|human leukocyte antigen|human leukocyte antigen
147821|NCT02384395|latent HIV reservoir|latent hiv reservoir
147822|NCT02384395|integrase-based regimen|integrase-based regimen
147823|NCT02384395|viremia|viremia
147824|NCT02384395|antiretroviral therapy|antiretroviral therapy
147825|NCT02384395|fixed dose combination|fixed dose combination
147826|NCT02384382|Cancer of the Prostate|cancer of the prostate
147954|NCT02383472|Light Emitting Diode|light emitting diode
147827|NCT02384356|Non-communicable diseases|non-communicable diseases
147828|NCT02384356|Chronic disease|chronic disease
147829|NCT02384356|Mobile health|mobile health
147830|NCT02384356|Diabetes Mellitus|diabetes mellitus
147831|NCT02384356|Hypertension|hypertension
147832|NCT02384356|Bolivia|bolivia
147833|NCT02384356|Longitudinal survey|longitudinal survey
147834|NCT02384356|Health indicators|health indicators
147835|NCT02384356|Primary care|primary care
147836|NCT02384356|Ambulatory care|ambulatory care
147837|NCT02384343|Dexmedetomidine|dexmedetomidine
147838|NCT02384343|Cesarean section|cesarean section
147839|NCT02384343|Anesthesia, Spinal|anesthesia, spinal
147840|NCT02384343|Anesthesia, Epidural|anesthesia, epidural
147841|NCT02384304|randomized controlled trial|randomized controlled trial
147842|NCT02384304|alcohol|alcohol
147843|NCT02384304|internet|internet
147844|NCT02384304|internet based therapy|internet based therapy
147845|NCT02384304|cognitive behavior therapy|cognitive behavior therapy
147846|NCT02384278|alcohol use disorder|alcohol use disorder
147847|NCT02384278|internet|internet
147848|NCT02384278|cognitive behavior therapy|cognitive behavior therapy
147849|NCT02384278|relapse prevention|relapse prevention
147850|NCT02384265|Diabetes|diabetes
147851|NCT02384265|Disparities|disparities
147852|NCT02384265|Behavioral|behavioral
147853|NCT02384265|Text messaging|text messaging
147854|NCT02384265|Social networks|social networks
147855|NCT02384265|African American|african american
147856|NCT02384265|Female|female
147857|NCT02384252|obese cardiomyopathy|obese cardiomyopathy
147858|NCT02384252|mitochondria|mitochondria
147859|NCT02384252|contractile dysfunction|contractile dysfunction
147860|NCT02384226|mobile application|mobile application
147861|NCT02384226|postpartum|postpartum
147862|NCT02384226|weight loss|weight loss
147863|NCT02384187|Gabapentin|gabapentin
147864|NCT02384187|PONV|ponv
147865|NCT02384187|Adenotonsillectomy|adenotonsillectomy
147866|NCT02384187|Pediatrics|pediatrics
147867|NCT02384174|Aging|aging
147868|NCT02384174|Resistant starch|resistant starch
147869|NCT02384174|Dietary fibre|dietary fibre
147870|NCT02384174|Immune system|immune system
147871|NCT02384174|Bacteria|bacteria
147872|NCT02384174|older subjects|older subjects
147873|NCT02384122|Angiodysplasias|angiodysplasias
147874|NCT02384122|Sandostatin LAR|sandostatin lar
147875|NCT02384122|Gastrointestinal|gastrointestinal
147876|NCT02384122|Somatostatin|somatostatin
147877|NCT02384122|Octreotide|octreotide
147878|NCT02384096|stimulation|stimulation
147879|NCT02384096|implantable|implantable
147880|NCT02384096|pulse generator|pulse generator
147881|NCT02384096|back pain|back pain
147882|NCT02384096|chronic pain|chronic pain
147883|NCT02384096|leg pain|leg pain
147884|NCT02384083|Multiple Myeloma|multiple myeloma
147885|NCT02384083|Pethema|pethema
147886|NCT02384083|Filanesib|filanesib
147887|NCT02384083|Pomalidomide|pomalidomide
147888|NCT02384044|Sensitivity|sensitivity
147889|NCT02383979|Phantom limb pain|phantom limb pain
147890|NCT02383979|Mirror therapy|mirror therapy
147891|NCT02383979|Elective amputation|elective amputation
147892|NCT02383979|Residual limb pain|residual limb pain
147893|NCT02383979|Functional MRI|functional mri
147895|NCT02383953|IBD|ibd
147896|NCT02383953|UC|uc
147897|NCT02383953|CD|cd
147898|NCT02383875|nutrition economics|nutrition economics
147899|NCT02383875|food expenditure|food expenditure
147900|NCT02383875|nutritional quality|nutritional quality
147901|NCT02383875|low income|low income
147902|NCT02383862|Sleep|sleep
147903|NCT02383862|Pain|pain
147904|NCT02383862|Anxiety|anxiety
147905|NCT02383862|Depression|depression
147906|NCT02383862|Fatigue|fatigue
147907|NCT02383862|PROMIS|promis
147908|NCT02383862|primary care|primary care
147909|NCT02383836|Patent Foramen Ovale|patent foramen ovale
147910|NCT02383823|glucose, cholesterol, estrogen, gender, age|glucose, cholesterol, estrogen, gender, age
147911|NCT02383810|Chemotherapy Induced Diarrhea (CID)|chemotherapy induced diarrhea (cid)
147912|NCT02383771|Ticagrelor|ticagrelor
138719|NCT02434172|HIV|hiv
147913|NCT02383771|Aspirin|aspirin
147914|NCT02383771|Peri-operative treatment|peri-operative treatment
147915|NCT02383758|Behavioral Symptoms|behavioral symptoms
147916|NCT02383758|Child Development Disorders, Pervasive|child development disorders, pervasive
147917|NCT02383758|Bowel Incontinence|bowel incontinence
147918|NCT02383758|Constipation|constipation
147919|NCT02383745|Acute EEG|acute eeg
147920|NCT02383745|status epilepticus|status epilepticus
147921|NCT02383745|seizure|seizure
147922|NCT02383706|Sleep Apnea, Obstructive|sleep apnea, obstructive
147923|NCT02383706|Pregnancy|pregnancy
147924|NCT02383706|Obesity, Morbid|obesity, morbid
147925|NCT02383706|Complications, pregnancy|complications, pregnancy
147926|NCT02383693|depression|depression
147927|NCT02383693|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
147928|NCT02383693|tolerability|tolerability
147934|NCT02383654|Autologous Adipose-Tissue Derived Stem Cells (ADSCs)|autologous adipose-tissue derived stem cells (adscs)
147935|NCT02383641|Lipid Metabolism|lipid metabolism
147936|NCT02383641|Inborn Errors|inborn errors
147937|NCT02383641|Cholesterol Ester Storage Disease|cholesterol ester storage disease
147938|NCT02383628|ICG Dye|icg dye
147939|NCT02383628|endoscopic neurosurgery|endoscopic neurosurgery
147940|NCT02383628|tissue perfusion|tissue perfusion
147941|NCT02383602|6,000 Thai MSM and TG from study sites in Bangkok, Chiang Mai, Chonburi and Songkhla|6,000 thai msm and tg from study sites in bangkok, chiang mai, chonburi and songkhla
147942|NCT02383550|Multiple Sclerosis|multiple sclerosis
147943|NCT02383550|Cognition|cognition
147944|NCT02383498|Overall Response Rate|overall response rate
147945|NCT02383498|Immune Activation|immune activation
147946|NCT02383498|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
147947|NCT02383498|T Cell Response|t cell response
147948|NCT02383498|Cross-Over|cross-over
147949|NCT02383485|arterial stiffness|arterial stiffness
147950|NCT02383472|Concussion|concussion
147951|NCT02383472|Mild Traumatic Brain Injury|mild traumatic brain injury
147952|NCT02383472|MTBI|mtbi
147953|NCT02383472|LED|led
147955|NCT02383472|Headache|headache
147956|NCT02383472|Brain Concussion|brain concussion
147957|NCT02383446|Echeclon|echeclon
147958|NCT02383446|Elan|elan
147959|NCT02383446|TTA|tta
147960|NCT02383446|Transtibial Amputee|transtibial amputee
147961|NCT02383394|second trimesteric pregnancy loss|second trimesteric pregnancy loss
147962|NCT02383368|Pharmacokinetics|pharmacokinetics
147963|NCT02383368|ASP4132|asp4132
147964|NCT02383368|Lymphoma|lymphoma
147965|NCT02383368|Refractory Solid Tumors|refractory solid tumors
147966|NCT02383355|Persistent immune activation|persistent immune activation
147967|NCT02383355|Platelet hyperreactivity|platelet hyperreactivity
147968|NCT02383342|Pain Processing|pain processing
147969|NCT02383342|Genetic Factors|genetic factors
147970|NCT02383342|Biomarkers|biomarkers
147971|NCT02383329|malnutrition|malnutrition
147972|NCT02383329|Underweight|underweight
147973|NCT02383329|Oral Nutrition Supplements|oral nutrition supplements
147974|NCT02383329|Children|children
147975|NCT02383316|Insulin sensitivity|insulin sensitivity
147976|NCT02383316|Metabolism|metabolism
147977|NCT02383316|Noonan syndrome|noonan syndrome
147978|NCT02383316|Shp2|shp2
147979|NCT02383303|savings|savings
147980|NCT02383303|assets|assets
147981|NCT02383303|material hardship|material hardship
147982|NCT02383303|poverty|poverty
147983|NCT02383303|Individual Development Account|individual development account
147984|NCT02383264|feeding intolerance|feeding intolerance
147985|NCT02383264|preterm infants|preterm infants
147986|NCT02383264|near infrared spectroscopy|near infrared spectroscopy
147987|NCT02383238|Dapagliflozin|dapagliflozin
147988|NCT02383238|diabetes mellitus|diabetes mellitus
147989|NCT02383238|vascular|vascular
147990|NCT02383225|American Indian|american indian
147991|NCT02383225|Adolescent|adolescent
147992|NCT02383225|Prevention|prevention
147993|NCT02383212|Advanced cancerous growth|advanced cancerous growth
147994|NCT02383173|end of life|end of life
147995|NCT02383173|palliative care|palliative care
147996|NCT02383173|implementation|implementation
147997|NCT02383160|low-intensity pulsed ultrasound|low-intensity pulsed ultrasound
147998|NCT02383160|nonunion|nonunion
147999|NCT02383160|scaphoid|scaphoid
148001|NCT02383147|Aged|aged
148002|NCT02383147|Alpha Rhythm|alpha rhythm
148003|NCT02383147|Auditory Cortex|auditory cortex
148004|NCT02383147|Chronic|chronic
148005|NCT02383147|Electroencephalography|electroencephalography
148006|NCT02383147|Female|female
148007|NCT02383147|Humans|humans
148008|NCT02383147|Male|male
148009|NCT02383147|Neurofeedback|neurofeedback
148010|NCT02383147|Prospective Studies|prospective studies
148011|NCT02383147|Questionnaires|questionnaires
148012|NCT02383147|Tinnitus|tinnitus
148013|NCT02383147|Treatment Outcome|treatment outcome
148014|NCT02383095|Schizophrenia|schizophrenia
148015|NCT02383095|Art-therapy|art-therapy
148016|NCT02383095|Visual organization|visual organization
148017|NCT02383069|Pulmonary rehabilitation|pulmonary rehabilitation
148018|NCT02383069|Asthma|asthma
148019|NCT02383069|Children|children
148020|NCT02383069|Teenager|teenager
148021|NCT02383069|Physical capacity|physical capacity
148022|NCT02383056|wound|wound
148023|NCT02383056|secondary intention healing|secondary intention healing
148024|NCT02383056|lower extremity|lower extremity
148025|NCT02383030|Breast cancer|breast cancer
148026|NCT02383030|Metastatic|metastatic
148027|NCT02383030|HER2 negative|her2 negative
148031|NCT02383017|Multi-ingredient performance supplement, High Intensity Interval Training, Concurrent training|multi-ingredient performance supplement, high intensity interval training, concurrent training
148034|NCT02383004|emergence delirium|emergence delirium
148035|NCT02383004|pediatrics|pediatrics
148036|NCT02383004|general anesthesia|general anesthesia
148037|NCT02382991|Moderately active amputees|moderately active amputees
148038|NCT02382991|C-leg Compact|c-leg compact
148039|NCT02382991|Knee prosthesis|knee prosthesis
148040|NCT02382991|Kenevo|kenevo
148041|NCT02382991|Microprocessor controlled knee|microprocessor controlled knee
148042|NCT02382991|Amputation|amputation
148043|NCT02382991|3C60|3c60
148044|NCT02382991|TGUG|tgug
148045|NCT02382991|LCI|lci
148046|NCT02382991|QUEST|quest
148047|NCT02382991|SF-36|sf-36
148048|NCT02382952|Abdominal surgery|abdominal surgery
148049|NCT02382952|Pelvic surgery|pelvic surgery
148050|NCT02382952|Stoma takedown|stoma takedown
148051|NCT02382952|Bowel resection|bowel resection
148052|NCT02382952|Lysis of abdominal adhesions|lysis of abdominal adhesions
148053|NCT02382926|capacitive electrocardiography|capacitive electrocardiography
148054|NCT02382926|Eulerian Magnification Method|eulerian magnification method
148055|NCT02382900|quadrivalent|quadrivalent
148056|NCT02382900|vaccine|vaccine
148057|NCT02382887|intubation|intubation
148058|NCT02382887|difficult airway|difficult airway
148059|NCT02382887|fiberscopy|fiberscopy
148060|NCT02382887|Airtraq|airtraq
148061|NCT02382887|general anesthesia|general anesthesia
148062|NCT02382874|Idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
148063|NCT02382874|adipose derived mesenchymal stromal cell|adipose derived mesenchymal stromal cell
148064|NCT02382874|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
148065|NCT02382861|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
148066|NCT02382861|Weaning|weaning
148067|NCT02382861|Mechanical ventilation|mechanical ventilation
148068|NCT02382861|Extubation|extubation
148069|NCT02382848|Eating Disorders|eating disorders
148070|NCT02382848|Bulimia Nervosa|bulimia nervosa
148071|NCT02382848|Nightmares|nightmares
148072|NCT02382848|Post Traumatic Stress Disorder|post traumatic stress disorder
148073|NCT02382835|metal-on-metal|metal-on-metal
148074|NCT02382809|Alveolar osteitis|alveolar osteitis
148075|NCT02382809|Third molar|third molar
148076|NCT02382809|Dry socket|dry socket
148077|NCT02382809|Mouthwash|mouthwash
148078|NCT02382809|third molar extraction|third molar extraction
148079|NCT02382783|Rheumatoid Arthritis|rheumatoid arthritis
148080|NCT02382783|Disease Activity|disease activity
148081|NCT02382783|Flare|flare
148082|NCT02382783|Management of Flares|management of flares
148083|NCT02382783|Pfizer|pfizer
148084|NCT02382744|Saphenous Nerve|saphenous nerve
148085|NCT02382744|Nerve Block|nerve block
148086|NCT02382744|Ultrasound guided|ultrasound guided
148087|NCT02382744|Neurostimulation|neurostimulation
148088|NCT02382744|Regional Anesthesia|regional anesthesia
148089|NCT02382744|Ropivacaine|ropivacaine
148090|NCT02382744|Foot Surgery|foot surgery
148097|NCT02382705|capsule endoscopy|capsule endoscopy
148098|NCT02382705|battery life|battery life
148099|NCT02382705|completion rate|completion rate
148100|NCT02382705|diagnostic yield|diagnostic yield
148101|NCT02382640|Drug therapy|drug therapy
148102|NCT02382614|Endobronchial Valve|endobronchial valve
148103|NCT02382614|Minimally Invasive|minimally invasive
148104|NCT02382614|Intrabronchial Valves|intrabronchial valves
148105|NCT02382614|Digital Thoracic Drainage System|digital thoracic drainage system
148106|NCT02382614|Spiration Valve System|spiration valve system
148107|NCT02382614|Prolonged Air Leak|prolonged air leak
148108|NCT02382614|Persistent Air Leak|persistent air leak
148112|NCT02382562|Depression|depression
148113|NCT02382562|Asthma|asthma
148114|NCT02382562|Urticaria|urticaria
148115|NCT02382549|vaccine|vaccine
148116|NCT02382549|peptide|peptide
148117|NCT02382549|dabrafenib|dabrafenib
148118|NCT02382549|trametinib|trametinib
148119|NCT02382549|Montanide ISA-51|montanide isa-51
148120|NCT02382549|MEKINIST|mekinist
148121|NCT02382549|Tafinlar|tafinlar
148122|NCT02382536|Diabetes|diabetes
148123|NCT02382536|Insulin therapy|insulin therapy
148124|NCT02382536|insulin pump|insulin pump
148125|NCT02382536|Infusion sets|infusion sets
148126|NCT02382523|acthar|acthar
148127|NCT02382523|proteinuria|proteinuria
148128|NCT02382523|IgA nephropathy|iga nephropathy
148129|NCT02382484|Hypertension Resistant to Conventional Therapy|hypertension resistant to conventional therapy
148130|NCT02382471|atherosclerotic|atherosclerotic
138918|NCT02433002|Cystatin|cystatin
138919|NCT02433002|Creatinine|creatinine
138920|NCT02433002|Albuminuria|albuminuria
138921|NCT02432989|Exercise Therapy|exercise therapy
138922|NCT02432989|Concussion Management|concussion management
148131|NCT02382471|BDNF|bdnf
148132|NCT02382471|Follistatin|follistatin
148133|NCT02382471|Irisin|irisin
148134|NCT02382432|Anesthesia|anesthesia
148135|NCT02382432|dexmedetomidine|dexmedetomidine
148136|NCT02382432|pethidine|pethidine
148137|NCT02382432|shivering|shivering
148138|NCT02382432|spinal|spinal
148139|NCT02382406|MK-3475|mk-3475
148140|NCT02382406|Pembrolizumab|pembrolizumab
148141|NCT02382406|Carboplatin|carboplatin
148142|NCT02382406|Nab-paclitaxel|nab-paclitaxel
148143|NCT02382393|cognitive assessment|cognitive assessment
148144|NCT02382393|Brain Performance Test|brain performance test
148145|NCT02382393|Lumosity|lumosity
148146|NCT02382393|concurrent validity|concurrent validity
148147|NCT02382393|computerized assessment|computerized assessment
148148|NCT02382380|Magnetic Resonance Imaging|magnetic resonance imaging
148149|NCT02382380|Contrast Agent|contrast agent
148150|NCT02382380|Gadoterate|gadoterate
148151|NCT02382341|ACL|acl
148152|NCT02382341|BIOSURE|biosure
148153|NCT02382341|HEALICOIL|healicoil
148154|NCT02382341|PEEK|peek
148155|NCT02382341|In-Growth|in-growth
148156|NCT02382315|fear of cancer recurrence|fear of cancer recurrence
148157|NCT02382315|psychosocial intervention|psychosocial intervention
148158|NCT02382315|randomized controlled clinical trial|randomized controlled clinical trial
148159|NCT02382302|U-health|u-health
148160|NCT02382302|chronic wound management|chronic wound management
148161|NCT02382289|Radiofrequency|radiofrequency
148162|NCT02382289|monopolar|monopolar
148163|NCT02382289|bipolar|bipolar
148164|NCT02382289|Sacroiliac Joint Arthropathy|sacroiliac joint arthropathy
148165|NCT02382289|three different modalities|three different modalities
148166|NCT02382263|Advanced pancreatic cancer|advanced pancreatic cancer
148167|NCT02382263|Fragile|fragile
148168|NCT02382263|Nab-paclitaxel|nab-paclitaxel
148169|NCT02382237|denutrition in Head and Neck cancer or oesophageal cancer|denutrition in head and neck cancer or oesophageal cancer
148170|NCT02382224|generalized anxiety disorder|generalized anxiety disorder
148171|NCT02382224|anxiety|anxiety
148172|NCT02382224|worry exposure|worry exposure
148173|NCT02382224|treatment|treatment
148174|NCT02382211|CMV|cmv
148175|NCT02382198|droooling, sialorrhea, parkinson's disease, parkinsons|droooling, sialorrhea, parkinson's disease, parkinsons
148176|NCT02382185|Cardiac output|cardiac output
148177|NCT02382120|carbon dioxide|carbon dioxide
148178|NCT02382120|cardiac output|cardiac output
148179|NCT02382120|ventilation|ventilation
148180|NCT02382120|thermodilution|thermodilution
148184|NCT02382094|curative intention|curative intention
148185|NCT02382094|radiation Therapy|radiation therapy
148186|NCT02382094|health related quality of life|health related quality of life
148187|NCT02382055|Eating Disorders|eating disorders
148188|NCT02382055|Psychotherapy|psychotherapy
148189|NCT02382055|Anorexia Nervosa|anorexia nervosa
148190|NCT02382055|Treatment|treatment
148191|NCT02382042|Rural Health|rural health
148192|NCT02382042|Veterans|veterans
148193|NCT02382042|Substance Abuse|substance abuse
148194|NCT02382003|Anxiety|anxiety
148195|NCT02382003|Cognitive bias|cognitive bias
148196|NCT02382003|Telemedicine|telemedicine
148197|NCT02381990|Prostate|prostate
148199|NCT02381990|FUSION|fusion
148200|NCT02381990|Ultrasound|ultrasound
148201|NCT02381990|MRI|mri
148202|NCT02381990|Cancer|cancer
148203|NCT02381990|Cryotherapy|cryotherapy
148204|NCT02381990|Outcomes|outcomes
148205|NCT02381990|Recurrence|recurrence
148206|NCT02381990|QOL, Quality of Life|qol, quality of life
148207|NCT02381990|Urinary function|urinary function
148208|NCT02381990|Sexual Function|sexual function
148209|NCT02381964|cerebral blood flow|cerebral blood flow
148210|NCT02381964|cognitive function|cognitive function
148211|NCT02381964|vitamins|vitamins
148212|NCT02381964|energy expenditure|energy expenditure
148214|NCT02381964|Indirect calorimetry|indirect calorimetry
148215|NCT02381938|inactivity|inactivity
148216|NCT02381938|behavior change|behavior change
148217|NCT02381938|worksite wellness|worksite wellness
148218|NCT02381938|child care|child care
148219|NCT02381925|CT|ct
148220|NCT02381925|Scintigraphy|scintigraphy
148221|NCT02381925|Ultrasound|ultrasound
148222|NCT02381899|chronic lymphocytic leukemia|chronic lymphocytic leukemia
148223|NCT02381899|bendamustine|bendamustine
148224|NCT02381899|rituximab|rituximab
148225|NCT02381886|IDHR132 mutations|idhr132 mutations
148226|NCT02381886|IDH305|idh305
148227|NCT02381886|IDH|idh
148228|NCT02381886|IDH1|idh1
148229|NCT02381886|AML|aml
148230|NCT02381886|Acute Myeloid Leukemia|acute myeloid leukemia
148231|NCT02381886|Leukemia|leukemia
148232|NCT02381886|Myeloid|myeloid
148233|NCT02381886|Acute|acute
148234|NCT02381886|MDS|mds
148235|NCT02381886|Myelodysplastic Syndrome|myelodysplastic syndrome
148236|NCT02381886|Glioma|glioma
148237|NCT02381886|Oligodendroglioma|oligodendroglioma
148238|NCT02381886|Astrocytoma|astrocytoma
148239|NCT02381886|Glioblastoma|glioblastoma
148240|NCT02381886|Cholangiocarcinoma|cholangiocarcinoma
148241|NCT02381886|Solid Tumors|solid tumors
148242|NCT02381873|Arthroplasty|arthroplasty
148785|NCT02378883|AVM|avm
148243|NCT02381873|Replacement|replacement
148244|NCT02381873|Knee|knee
148245|NCT02381873|Osteoarthritis|osteoarthritis
148246|NCT02381847|gastric cancer|gastric cancer
148247|NCT02381847|intraperitoneal chemoperfusion|intraperitoneal chemoperfusion
148248|NCT02381834|Urine Specimen Collection|urine specimen collection
148249|NCT02381834|Infant|infant
148250|NCT02381834|Neonate|neonate
148251|NCT02381834|Bacterial Infection|bacterial infection
148252|NCT02381821|junctional zone|junctional zone
148253|NCT02381821|Implantation|implantation
148254|NCT02381821|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
148255|NCT02381717|ultrasound|ultrasound
148256|NCT02381717|bupivacaine|bupivacaine
148257|NCT02381717|femoral nerve block|femoral nerve block
148258|NCT02381717|pain reduction|pain reduction
148259|NCT02381678|Heart Valve Replacement|heart valve replacement
148260|NCT02381678|Perimount 2900|perimount 2900
148261|NCT02381678|China|china
148262|NCT02381678|Perimount 6900P|perimount 6900p
148263|NCT02381626|HEPA filter|hepa filter
148264|NCT02381626|14-247|14-247
148265|NCT02381613|Fish|fish
148266|NCT02381613|Herring|herring
148267|NCT02381613|Meat|meat
148268|NCT02381613|Beef|beef
148269|NCT02381600|vitamin D|vitamin d
148270|NCT02381600|aging|aging
148271|NCT02381600|cognitive function|cognitive function
148272|NCT02381600|depression|depression
148273|NCT02381600|executive function|executive function
148274|NCT02381574|Lumbar Total Disk Replacement|lumbar total disk replacement
148275|NCT02381522|remote ischemic preconditioning|remote ischemic preconditioning
148276|NCT02381509|inferior vena cava filters|inferior vena cava filters
148277|NCT02381496|ACT-453859|act-453859
148278|NCT02381496|ACT-463036|act-463036
148279|NCT02381496|Setipiprant|setipiprant
148280|NCT02381496|Tolerability|tolerability
148281|NCT02381496|safety|safety
148282|NCT02381496|pharmacodynamics|pharmacodynamics
148283|NCT02381496|pharmacokinetics|pharmacokinetics
148284|NCT02381457|Microdeletion Syndrome|microdeletion syndrome
148285|NCT02381457|Aneuploidy|aneuploidy
148287|NCT02381457|Non-Invasive Prenatal Screening|non-invasive prenatal screening
148288|NCT02381457|DiGeorge Syndrome|digeorge syndrome
148289|NCT02381444|Quality of life|quality of life
148290|NCT02381444|Jejunal Percutaneous Endoscopic Gastrostomy|jejunal percutaneous endoscopic gastrostomy
148291|NCT02381444|Observational Study|observational study
148292|NCT02381444|Levodopa Carbidopa Intestinal Gel|levodopa carbidopa intestinal gel
148293|NCT02381444|Advanced Parkinson's Disease|advanced parkinson's disease
148294|NCT02381431|imaging|imaging
148295|NCT02381431|diagnostic|diagnostic
148296|NCT02381431|pediatrics|pediatrics
148297|NCT02381418|Influenza|influenza
148298|NCT02381418|Vaccine|vaccine
148299|NCT02381418|Committee for Medicinal Products for Human Use (CHMP) criteria|committee for medicinal products for human use (chmp) criteria
148300|NCT02381392|emergency medicine|emergency medicine
148301|NCT02381392|infrared|infrared
148302|NCT02381392|intravenous|intravenous
148303|NCT02381379|CML|cml
148304|NCT02381379|peginterferon|peginterferon
148305|NCT02381379|stop|stop
148306|NCT02381379|BCR-ABL|bcr-abl
148307|NCT02381366|Mesenchymal Stem Cells|mesenchymal stem cells
148308|NCT02381366|Human Umbilical Cord Blood|human umbilical cord blood
148309|NCT02381366|Premature Infants|premature infants
148310|NCT02381366|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
148311|NCT02381366|Chronic Lung Disease|chronic lung disease
148312|NCT02381366|Cell Therapy|cell therapy
148313|NCT02381353|Enucleation|enucleation
148314|NCT02381353|Evisceration|evisceration
148315|NCT02381353|Exparel|exparel
148316|NCT02381353|bupivacaine|bupivacaine
148317|NCT02381340|Obesity|obesity
148318|NCT02381340|Bariatric surgery|bariatric surgery
148319|NCT02381340|Gastric plication|gastric plication
148320|NCT02381340|Minimal invasive surgery|minimal invasive surgery
148321|NCT02381340|gastrointestinal hormones|gastrointestinal hormones
148322|NCT02381340|food-reward|food-reward
148323|NCT02381340|satiety|satiety
148324|NCT02381340|microbiota|microbiota
148325|NCT02381327|Speed of eating|speed of eating
148326|NCT02381327|body weight|body weight
148327|NCT02381327|food intake|food intake
148328|NCT02381314|Other B7-H3 expressing cancers|other b7-h3 expressing cancers
148329|NCT02381301|Biological Markers|biological markers
148330|NCT02381301|Multidetector Computed Tomography|multidetector computed tomography
148331|NCT02381288|Drug therapy|drug therapy
148332|NCT02381262|Fitbit|fitbit
148333|NCT02381249|Esophagectomy|esophagectomy
148334|NCT02381249|Gastrectomy|gastrectomy
148335|NCT02381249|Octreotide|octreotide
148336|NCT02381249|Somatostatin|somatostatin
148337|NCT02381249|Appetite|appetite
148338|NCT02381249|Hunger|hunger
148339|NCT02381249|Glucagon-Like Peptide 1|glucagon-like peptide 1
148340|NCT02381249|Peptide YY|peptide yy
148341|NCT02381249|Reinforcement|reinforcement
148342|NCT02381249|Reward|reward
148343|NCT02381249|Psychological Phenomena and Processes|psychological phenomena and processes
148344|NCT02381249|Gastrointestinal Agents|gastrointestinal agents
148345|NCT02381249|Nutritional Status|nutritional status
148346|NCT02381249|Pancreaticoduodenectomy|pancreaticoduodenectomy
148347|NCT02381249|Whipple Procedure|whipple procedure
148348|NCT02381210|Congo Red Dot Test|congo red dot test
148349|NCT02381197|Congo Red Dot Test|congo red dot test
148350|NCT02381171|myofacial pain|myofacial pain
148351|NCT02381171|neuromodulation|neuromodulation
148352|NCT02381171|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
148353|NCT02381171|electroacupuncture|electroacupuncture
148354|NCT02381158|Wheezing|wheezing
148355|NCT02381158|Children|children
148356|NCT02381145|Polyphenols|polyphenols
148357|NCT02381145|Resveratrol|resveratrol
148358|NCT02381145|Epigallocatechin-gallate|epigallocatechin-gallate
148359|NCT02381145|Insulin sensitivity|insulin sensitivity
148360|NCT02381145|mitochondrial function|mitochondrial function
148361|NCT02381145|lipid oxidation|lipid oxidation
148362|NCT02381145|tissue lipolysis|tissue lipolysis
148363|NCT02381119|dietary services|dietary services
148364|NCT02381119|personalized advice|personalized advice
148365|NCT02381119|biological markers|biological markers
148366|NCT02381106|arterial contractility|arterial contractility
148367|NCT02381106|Uterine contractility|uterine contractility
148368|NCT02381080|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
148369|NCT02381080|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
148370|NCT02381080|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
148371|NCT02381080|Marginal Zone Lymphoma|marginal zone lymphoma
148372|NCT02381080|Mantle Cell Lymphoma|mantle cell lymphoma
148373|NCT02381080|Follicular Lymphoma|follicular lymphoma
148374|NCT02381080|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
148375|NCT02381080|Ibrutinib|ibrutinib
148376|NCT02381080|IMBRUVICA|imbruvica
148377|NCT02381080|PCI-32765|pci-32765
148378|NCT02381080|JNJ-54179060|jnj-54179060
148379|NCT02381067|Cervical Fusion|cervical fusion
148380|NCT02381067|NuCel|nucel
148381|NCT02381067|Amniotic Allograft|amniotic allograft
148382|NCT02381067|Prospective|prospective
148383|NCT02381054|Patient reported outcomes|patient reported outcomes
148384|NCT02381041|Rhinoplasty|rhinoplasty
148385|NCT02381041|Topical Vasonconstrictor|topical vasonconstrictor
148386|NCT02381041|Cocaine|cocaine
148387|NCT02381041|Adrenaline|adrenaline
148388|NCT02381028|Atopic eczema|atopic eczema
148389|NCT02381028|Human milk|human milk
148390|NCT02381028|Topical treatment|topical treatment
148391|NCT02381028|Children|children
148392|NCT02381015|Genetic testing|genetic testing
148393|NCT02381015|Genomic testing|genomic testing
148394|NCT02381015|Chemoprevention|chemoprevention
148395|NCT02381015|Prostate Specific Antigen|prostate specific antigen
148396|NCT02381015|Prostate Cancer|prostate cancer
148397|NCT02381015|Predictive Genetic Testing|predictive genetic testing
148398|NCT02381015|Genetic Counseling|genetic counseling
148399|NCT02381015|Prostate-Specific Antigen|prostate-specific antigen
148400|NCT02381002|Serum ferritin, physical exercise, Diet|serum ferritin, physical exercise, diet
148401|NCT02380989|Ayurveda|ayurveda
148402|NCT02380989|Acute pain|acute pain
148403|NCT02380989|Sports Injury|sports injury
148404|NCT02380963|Soy|soy
148405|NCT02380963|Obesity|obesity
148406|NCT02380963|Weight Loss|weight loss
148407|NCT02380963|Muscle|muscle
148408|NCT02380963|Cardiovascular Disease|cardiovascular disease
148409|NCT02380963|Colorado Diet|colorado diet
148410|NCT02380937|real-time MRI|real-time mri
148411|NCT02380937|electrophysiology study|electrophysiology study
148412|NCT02380937|atrial flutter|atrial flutter
148413|NCT02380937|ablation|ablation
148414|NCT02380937|active tracking|active tracking
148415|NCT02380924|subjects|subjects
148416|NCT02380911|Dyslipidemia|dyslipidemia
148417|NCT02380911|Global cardiovascular risk|global cardiovascular risk
148418|NCT02380911|Statins|statins
148419|NCT02380911|Educational interventions|educational interventions
148420|NCT02380885|severe mental illness|severe mental illness
148421|NCT02380885|social cognition|social cognition
148422|NCT02380885|intervention|intervention
148423|NCT02380872|Gingival recession|gingival recession
148424|NCT02380872|fibrin|fibrin
148425|NCT02380872|connective tissue|connective tissue
148426|NCT02380872|gingival crevicular fluid|gingival crevicular fluid
148427|NCT02380872|matrix metalloproteinase|matrix metalloproteinase
148428|NCT02380872|cytokine|cytokine
148429|NCT02380859|problems of gait and balance|problems of gait and balance
148430|NCT02380820|Mattress|mattress
148431|NCT02380820|Preventing bed sores|preventing bed sores
148432|NCT02380820|Skin pressure|skin pressure
148433|NCT02380807|Paraspinal Muscles|paraspinal muscles
148434|NCT02380807|Trigger Points|trigger points
148435|NCT02380807|Randomized Controlled Trial|randomized controlled trial
148436|NCT02380807|Mobility Limitation|mobility limitation
148437|NCT02380794|Danshen Gegen Capsule|danshen gegen capsule
148438|NCT02380768|Supraglottic airway|supraglottic airway
148439|NCT02380768|Laryngeal mask airway|laryngeal mask airway
148440|NCT02380768|Children|children
148441|NCT02380755|Flow-mediated dilatation|flow-mediated dilatation
148442|NCT02380755|Clomiphene citrate|clomiphene citrate
148443|NCT02380755|sICAM-1|sicam-1
148444|NCT02380755|sVCAM-1|svcam-1
148445|NCT02380755|sE- Selectin|se- selectin
148446|NCT02380755|Endothelial function|endothelial function
148447|NCT02380755|Cardiovascular risk|cardiovascular risk
148448|NCT02380755|Endocrine System Diseases|endocrine system diseases
148449|NCT02380755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
148450|NCT02380755|Estrogen Receptor Modulators|estrogen receptor modulators
148451|NCT02380755|Infertility, Male|infertility, male
148452|NCT02380755|Endothelial Progenitor Cells|endothelial progenitor cells
148453|NCT02380755|Obesity|obesity
148454|NCT02380755|Testosterone|testosterone
148455|NCT02380742|Pessary|pessary
148456|NCT02380742|Pain|pain
148457|NCT02380742|EMLA|emla
148458|NCT02380742|lidocaine|lidocaine
148459|NCT02380742|prilocaine|prilocaine
148460|NCT02380729|Health care delivery|health care delivery
148461|NCT02380729|Human Phenotype Ontology|human phenotype ontology
148462|NCT02380729|Mutation prioritization|mutation prioritization
148463|NCT02380729|Next Generation Sequencing|next generation sequencing
148464|NCT02380729|Mutation detection|mutation detection
148465|NCT02380729|Bioinformatic analysis|bioinformatic analysis
148466|NCT02380729|Quality of life|quality of life
148467|NCT02380703|aggression|aggression
148468|NCT02380703|dementia|dementia
148469|NCT02380703|Alzheimer's disease|alzheimer's disease
148470|NCT02380703|pain|pain
148471|NCT02380703|depression|depression
148472|NCT02380703|caregiver|caregiver
148473|NCT02380703|behavioral health|behavioral health
148474|NCT02380703|counseling|counseling
148475|NCT02380690|self-management|self-management
148476|NCT02380690|peer support|peer support
148477|NCT02380690|social support|social support
148478|NCT02380664|swimmers|swimmers
148479|NCT02380664|adolescent swimmers|adolescent swimmers
148480|NCT02380664|whole-body vibration|whole-body vibration
148481|NCT02380664|bone and bones|bone and bones
148482|NCT02380664|body composition|body composition
148483|NCT02380625|Ebola|ebola
148485|NCT02380625|Adaptive design|adaptive design
148486|NCT02380625|therapeutics|therapeutics
148487|NCT02380612|Second Degree Burn Injuries|second degree burn injuries
148488|NCT02380599|Spinal Manipulation|spinal manipulation
148489|NCT02380599|Mobilization|mobilization
148490|NCT02380599|Autonomic Nervous System|autonomic nervous system
148491|NCT02380573|methylene blue|methylene blue
148492|NCT02380573|fMRI|fmri
148493|NCT02380560|myometrial thickness|myometrial thickness
148494|NCT02380560|Preterm premature rupture of membranes|preterm premature rupture of membranes
148495|NCT02380560|Preterm Labour|preterm labour
148496|NCT02380547|Sonography|sonography
148497|NCT02380547|Diaphragmatic function|diaphragmatic function
148498|NCT02380547|Non invasive ventilation|non invasive ventilation
148499|NCT02380547|Critical care patients|critical care patients
148500|NCT02380547|Extubation after 24 hours of invasive ventilation|extubation after 24 hours of invasive ventilation
148501|NCT02380534|High level of Lp(a)|high level of lp(a)
148502|NCT02380521|Exenatide once weekly|exenatide once weekly
148503|NCT02380521|T2DM|t2dm
148509|NCT02380482|Traumatic brain injury|traumatic brain injury
148510|NCT02380482|Myocardial dysfunction|myocardial dysfunction
148511|NCT02380482|Transthoracic echocardiography|transthoracic echocardiography
148512|NCT02380482|Speckle tracking|speckle tracking
148513|NCT02380469|Caregivers|caregivers
148515|NCT02380469|Information|information
148516|NCT02380469|Intervention|intervention
149334|NCT02376023|Latina|latina
148517|NCT02380469|Randomised trial|randomised trial
148518|NCT02380443|colorectal cancer|colorectal cancer
148519|NCT02380443|KRAS mutant|kras mutant
148520|NCT02380443|BRAF mutant|braf mutant
148521|NCT02380443|metastatic|metastatic
148522|NCT02380443|liver metastasis|liver metastasis
148523|NCT02380443|AlloStim®|allostim®
148524|NCT02380443|cryoablation|cryoablation
148525|NCT02380443|cancer vaccine|cancer vaccine
148526|NCT02380443|immunotherapy|immunotherapy
148527|NCT02380430|Ambulatory surgery|ambulatory surgery
148528|NCT02380430|Pain management|pain management
148529|NCT02380430|Nausea and vomiting management|nausea and vomiting management
148530|NCT02380430|Questionnaire|questionnaire
148531|NCT02380430|Survey|survey
148532|NCT02380430|Management|management
148533|NCT02380404|Edentulous maxilla|edentulous maxilla
148534|NCT02380391|Platelet reactivity|platelet reactivity
148535|NCT02380391|Acute coronary syndrome|acute coronary syndrome
148536|NCT02380391|Antiplatelet treatment|antiplatelet treatment
148537|NCT02380391|Antiretroviral treatment|antiretroviral treatment
148538|NCT02380391|HIV|hiv
148539|NCT02380365|lung transplantation|lung transplantation
148540|NCT02380365|electrocardiography|electrocardiography
148541|NCT02380365|macrolides|macrolides
148542|NCT02380365|QTc interval|qtc interval
148543|NCT02380365|arrhythmia|arrhythmia
148544|NCT02380352|antibiotic stewardship|antibiotic stewardship
148545|NCT02380352|non-inferiority|non-inferiority
148546|NCT02380352|randomized controlled trial|randomized controlled trial
148547|NCT02380313|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
148548|NCT02380313|Enzalutamide|enzalutamide
148549|NCT02380313|Abiraterone|abiraterone
148550|NCT02380313|Dose-Finding|dose-finding
148552|NCT02380287|interleukin-17|interleukin-17
148553|NCT02380287|maximum tolerated dose|maximum tolerated dose
148554|NCT02380287|novel monoclonal antibody|novel monoclonal antibody
148555|NCT02380274|Prostate Cancer|prostate cancer
148556|NCT02380274|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
148557|NCT02380274|Metastatic Prostate Cancer|metastatic prostate cancer
148558|NCT02380222|Systemic mastocytosis|systemic mastocytosis
148559|NCT02380222|Patient-reported outcome (PRO)|patient-reported outcome (pro)
148560|NCT02380209|breast cancer|breast cancer
148561|NCT02380209|CEST MRI|cest mri
148562|NCT02380183|anesthesia|anesthesia
148563|NCT02380183|nerve block|nerve block
148564|NCT02380183|needle guidance|needle guidance
148565|NCT02380170|sepsis|sepsis
148566|NCT02380170|urinary tract infection|urinary tract infection
148567|NCT02380170|resistance|resistance
148568|NCT02380170|pathogens|pathogens
148569|NCT02380170|mortality|mortality
148570|NCT02380170|health economics|health economics
148571|NCT02380157|Blood pressure|blood pressure
148572|NCT02380157|Potassium, Dietary|potassium, dietary
148573|NCT02380157|Renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
148574|NCT02380157|Sympathetic nervous system|sympathetic nervous system
148575|NCT02380144|carotenoid|carotenoid
148576|NCT02380144|bioavailability|bioavailability
148577|NCT02380144|beta-cryptoxanthin|beta-cryptoxanthin
148578|NCT02380144|flavonoid|flavonoid
148579|NCT02380144|hesperidin|hesperidin
148580|NCT02380144|narirutin|narirutin
148581|NCT02380144|randomized cross-over|randomized cross-over
148582|NCT02380144|Pharmacokinetics|pharmacokinetics
148583|NCT02380144|micronutrients|micronutrients
148584|NCT02380144|Oranges/Orange Juice|oranges/orange juice
148585|NCT02380131|XELOX|xelox
148586|NCT02380131|Herceptin|herceptin
148587|NCT02380131|Potentially Resectable Gastric Cancer|potentially resectable gastric cancer
148588|NCT02380118|emergency|emergency
148589|NCT02380118|emergency medicine|emergency medicine
148590|NCT02380118|sedation|sedation
148591|NCT02380118|acute agitation|acute agitation
148597|NCT02380079|Homozygous Sickle Cell Disease S/Beta 0 Thalassemia|homozygous sickle cell disease s/beta 0 thalassemia
148598|NCT02380053|Beta-blocker|beta-blocker
148599|NCT02380053|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
148600|NCT02380027|Prostate biopsy|prostate biopsy
148602|NCT02380027|transrectal|transrectal
148603|NCT02380027|Detection|detection
148604|NCT02380001|Postoperative pain|postoperative pain
148707|NCT02379416|Taxanes|taxanes
148610|NCT02379949|virtual reality exposure therapy|virtual reality exposure therapy
148611|NCT02379949|social phobia|social phobia
148612|NCT02379949|social anxiety disorder|social anxiety disorder
148613|NCT02379949|cognitive behavioral therapy|cognitive behavioral therapy
148614|NCT02379936|Classification|classification
148615|NCT02379936|HIE|hie
148616|NCT02379936|Infections|infections
658988|NCT00806273|debridement|debridement
148617|NCT02379936|Lactate dehydrogenase|lactate dehydrogenase
148618|NCT02379936|Intensive Care|intensive care
148619|NCT02379884|Mechanical ventilation|mechanical ventilation
148620|NCT02379884|Elderly|elderly
148621|NCT02379884|Mortality|mortality
148622|NCT02379884|Health services|health services
148623|NCT02379871|Thoracic Spinal Manipulation, Autonomic Nervous System|thoracic spinal manipulation, autonomic nervous system
148624|NCT02379858|GI tract recovery|gi tract recovery
148625|NCT02379858|hospital discharge|hospital discharge
148626|NCT02379832|preeclampsia|preeclampsia
148627|NCT02379832|preterm birth|preterm birth
148628|NCT02379832|pregnancy|pregnancy
148629|NCT02379832|placenta|placenta
148630|NCT02379832|intra-uterine growth restriction|intra-uterine growth restriction
148631|NCT02379832|fetal growth restriction|fetal growth restriction
148632|NCT02379832|ultrasound|ultrasound
148633|NCT02379832|doppler|doppler
148634|NCT02379832|biomarkers|biomarkers
148635|NCT02379832|serum|serum
148636|NCT02379832|PAPP-A|papp-a
148637|NCT02379832|PlGF|plgf
148638|NCT02379832|sFlt-1|sflt-1
148639|NCT02379832|endoglin|endoglin
148640|NCT02379793|LEO 80185 gel|leo 80185 gel
148641|NCT02379793|calcipotriol|calcipotriol
148642|NCT02379793|betamethasone|betamethasone
148643|NCT02379754|vestibular schwannoma|vestibular schwannoma
148644|NCT02379754|acoustic neuroma|acoustic neuroma
148645|NCT02379754|cerebellopontine angle tumour|cerebellopontine angle tumour
148646|NCT02379754|gentamicin|gentamicin
148647|NCT02379754|rehabilitation|rehabilitation
148648|NCT02379754|postural balance|postural balance
148649|NCT02379741|Antibodies|antibodies
148650|NCT02379741|Antibodies, Monoclonal|antibodies, monoclonal
148651|NCT02379741|Antineoplastic agent|antineoplastic agent
148652|NCT02379741|Physiological effects of drugs|physiological effects of drugs
148653|NCT02379741|Therapeutic uses|therapeutic uses
148654|NCT02379741|Clinical Trial, Phase I|clinical trial, phase i
148655|NCT02379741|Immunotherapy, Active|immunotherapy, active
148656|NCT02379741|CD40 Antigen|cd40 antigen
148657|NCT02379741|Immunologic Factors|immunologic factors
148658|NCT02379741|Injections, Intralesional|injections, intralesional
148659|NCT02379728|positional therapy|positional therapy
148660|NCT02379728|tennis ball technique|tennis ball technique
148662|NCT02379728|supine position|supine position
148663|NCT02379728|supine|supine
148664|NCT02379728|sleep position|sleep position
148665|NCT02379728|low birth weight|low birth weight
148666|NCT02379728|stillbirth|stillbirth
148667|NCT02379728|intrauterine growth restriction|intrauterine growth restriction
148668|NCT02379715|Remifentanil|remifentanil
148669|NCT02379715|smooth induction|smooth induction
148670|NCT02379715|desflurane|desflurane
148671|NCT02379689|psychosocial state|psychosocial state
148672|NCT02379637|N-acetylcysteine|n-acetylcysteine
148673|NCT02379637|adults|adults
148674|NCT02379637|cough and cold|cough and cold
148675|NCT02379572|5-ALA|5-ala
148676|NCT02379572|Intraoperative MRI|intraoperative mri
148677|NCT02379572|Extent of resection|extent of resection
148678|NCT02379559|prostate cancer|prostate cancer
148679|NCT02379559|African-American|african-american
148680|NCT02379559|Metabolic Syndrome|metabolic syndrome
148681|NCT02379559|Exercise|exercise
148682|NCT02379559|Men's Health|men's health
148683|NCT02379546|reflex, oculocardiac|reflex, oculocardiac
148684|NCT02379546|monitoring, intraoperative|monitoring, intraoperative
148685|NCT02379520|recurrent cancer|recurrent cancer
148686|NCT02379520|refractory cancer|refractory cancer
148687|NCT02379520|virus specific T-cells|virus specific t-cells
148688|NCT02379520|gene therapy|gene therapy
148689|NCT02379520|HPV|hpv
148690|NCT02379507|mild to moderate|mild to moderate
148691|NCT02379468|Diabetic|diabetic
148692|NCT02379468|Foot|foot
148693|NCT02379468|Ulcer|ulcer
148694|NCT02379455|Polypharmacy|polypharmacy
148695|NCT02379455|Geriatrics|geriatrics
148696|NCT02379455|Elderly|elderly
148697|NCT02379455|Drug review|drug review
148702|NCT02379429|Specimen Collection|specimen collection
148703|NCT02379429|Urine|urine
148704|NCT02379429|Blood|blood
148705|NCT02379429|Saliva|saliva
148706|NCT02379416|Drug Efflux|drug efflux
148708|NCT02379416|Combination|combination
148709|NCT02379416|Bcr-Abl Kinase Inhibitors|bcr-abl kinase inhibitors
148710|NCT02379416|Neoplasms|neoplasms
148711|NCT02379403|Flavonoid|flavonoid
148712|NCT02379403|Vascular|vascular
148713|NCT02379403|Biomarkers|biomarkers
148714|NCT02379403|Arterial Stiffness|arterial stiffness
148715|NCT02379403|Nutrigenomics|nutrigenomics
148716|NCT02379364|Physiotherapy|physiotherapy
148717|NCT02379364|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
148718|NCT02379364|Manual therapy|manual therapy
148719|NCT02379351|Non-stress Test|non-stress test
148720|NCT02379351|Fetal Monitoring|fetal monitoring
148721|NCT02379351|Telemedicine|telemedicine
148722|NCT02379338|Dopamine D3 receptor|dopamine d3 receptor
148723|NCT02379312|Foams|foams
148724|NCT02379312|Satiety|satiety
148725|NCT02379312|Appetite|appetite
148726|NCT02379247|HER-2 Negative|her-2 negative
148727|NCT02379247|Metastatic Breast Cancer|metastatic breast cancer
148728|NCT02379234|CVVH|cvvh
148729|NCT02379234|Renal replacement therapy|renal replacement therapy
148730|NCT02379234|High fidelity simulation|high fidelity simulation
148731|NCT02379234|Nurse training|nurse training
148732|NCT02379208|Visual Field Tests|visual field tests
148733|NCT02379208|Ocular Hypertension|ocular hypertension
148734|NCT02379208|Glaucoma, Open-Angle|glaucoma, open-angle
148735|NCT02379208|Quality of Life|quality of life
148736|NCT02379208|Glaucoma progression|glaucoma progression
148737|NCT02379208|Early glaucoma|early glaucoma
148738|NCT02379208|Frequency Doubling Technology (FDT)|frequency doubling technology (fdt)
148739|NCT02379208|RareBit|rarebit
148740|NCT02379208|Octopus 900 perimetry|octopus 900 perimetry
148741|NCT02379182|dysphagia|dysphagia
148742|NCT02379182|VitalStim|vitalstim
148743|NCT02379182|electrical stimulation|electrical stimulation
148744|NCT02379169|macular pigment optical density, age related macular degeneration, dry eye, vision|macular pigment optical density, age related macular degeneration, dry eye, vision
148745|NCT02379156|Quadriplegia|quadriplegia
148746|NCT02379156|Spinal Cord Injury|spinal cord injury
148747|NCT02379156|Body Temperature Regulation|body temperature regulation
148748|NCT02379156|Mild Cognitive Impairment|mild cognitive impairment
148749|NCT02379143|SWD, EPA, SAFE PRACTICE|swd, epa, safe practice
148750|NCT02379130|Premature|premature
148751|NCT02379130|Family Nurture Intervention|family nurture intervention
148752|NCT02379091|Drug therapy|drug therapy
148753|NCT02379078|Shared decision-making|shared decision-making
148754|NCT02379078|Priority setting|priority setting
148755|NCT02379078|Patient decision aid|patient decision aid
148756|NCT02379078|Interprofessional care|interprofessional care
148757|NCT02379078|Diabetes mellitus|diabetes mellitus
148758|NCT02379078|Patient education|patient education
148759|NCT02379078|Medical informatics|medical informatics
148760|NCT02379078|Toolkit development|toolkit development
148761|NCT02379078|Study protocol|study protocol
148762|NCT02379078|User-centred design|user-centred design
148763|NCT02379078|Qualitative methods|qualitative methods
148764|NCT02379013|Fatigue|fatigue
148765|NCT02379013|functional MRI|functional mri
148766|NCT02378987|cerebral palsy|cerebral palsy
148767|NCT02378987|language|language
148768|NCT02378987|acoustic|acoustic
148769|NCT02378987|motor speech|motor speech
148770|NCT02378987|follow-up|follow-up
148771|NCT02378974|Cerebral Infarction|cerebral infarction
148772|NCT02378974|Mesenchymal Stem Cells|mesenchymal stem cells
148773|NCT02378974|Stroke|stroke
148774|NCT02378948|Esophagectomy|esophagectomy
148775|NCT02378948|Nutrition|nutrition
148776|NCT02378948|Oral feeding|oral feeding
148777|NCT02378948|Enteral feeding|enteral feeding
148778|NCT02378948|Pulmonary complications|pulmonary complications
148779|NCT02378948|Anastomotic leakage|anastomotic leakage
148780|NCT02378948|Quality of life|quality of life
148781|NCT02378896|Cognitive Behavioral Therapy|cognitive behavioral therapy
148782|NCT02378883|Apollo|apollo
148783|NCT02378883|Onyx|onyx
148784|NCT02378883|arteriovenous malformation|arteriovenous malformation
148786|NCT02378883|Onyx™ Liquid Embolic System|onyx™ liquid embolic system
148787|NCT02378883|Apollo™ Onyx™ Delivery Micro Catheter|apollo™ onyx™ delivery micro catheter
148788|NCT02378883|Brain Diseases|brain diseases
148789|NCT02378870|CRPC|crpc
148790|NCT02378857|Univentricular heart defect|univentricular heart defect
148791|NCT02378857|Fontan circulation|fontan circulation
148792|NCT02378831|diagnosing sleep|diagnosing sleep
148793|NCT02378818|Schizophrenia|schizophrenia
148794|NCT02378818|Negative symptoms|negative symptoms
148795|NCT02378818|Lack of motivation|lack of motivation
148796|NCT02378818|Cognitive characterization|cognitive characterization
148797|NCT02378818|Computational psychiatry|computational psychiatry
148798|NCT02378818|Depression|depression
148799|NCT02378805|Alport syndrome|alport syndrome
148800|NCT02378805|thin basement membrane disease|thin basement membrane disease
148801|NCT02378805|familial benign hematuria|familial benign hematuria
148802|NCT02378792|PINS VNS Refractory Epilepsy|pins vns refractory epilepsy
148803|NCT02378779|Premature ejaculation|premature ejaculation
148804|NCT02378779|general practice|general practice
148805|NCT02378779|sexual dysfunction|sexual dysfunction
148806|NCT02378766|tailored web-based intervention|tailored web-based intervention
148807|NCT02378766|health behavior|health behavior
148808|NCT02378766|hiv comorbidities|hiv comorbidities
148809|NCT02378766|online trial|online trial
148810|NCT02378753|Ebola|ebola
148811|NCT02378753|Sierra Leone|sierra leone
148812|NCT02378753|vaccine|vaccine
148813|NCT02378753|rVSVΔG-ZEBOV|rvsvδg-zebov
148814|NCT02378740|Anesthesia|anesthesia
148815|NCT02378740|Cervical Fusion|cervical fusion
148816|NCT02378740|Quality of Recovery|quality of recovery
148817|NCT02378740|Ketamine Infusion|ketamine infusion
148818|NCT02378714|Smoking Cessation|smoking cessation
148819|NCT02378714|Major Depressive Disorder|major depressive disorder
148820|NCT02378714|Nicotine Dependence|nicotine dependence
148821|NCT02378714|Varenicline|varenicline
148822|NCT02378714|Behavioral Activation Therapy|behavioral activation therapy
148823|NCT02378714|Cigarette Smoking|cigarette smoking
148824|NCT02378701|Leukemia|leukemia
148825|NCT02378701|Myelodysplastic syndrome|myelodysplastic syndrome
148827|NCT02378701|Low- or intermediate-1-risk|low- or intermediate-1-risk
148828|NCT02378701|Chronic Myelomonocytic Leukemia -1|chronic myelomonocytic leukemia -1
148829|NCT02378701|CMML-1|cmml-1
148830|NCT02378701|Quality of Life in Myelodysplasia Scale|quality of life in myelodysplasia scale
148831|NCT02378701|QUALMS-1|qualms-1
148832|NCT02378701|Anemia Subset of FACT|anemia subset of fact
148833|NCT02378701|FACT-An|fact-an
148834|NCT02378701|Questionnaires|questionnaires
148835|NCT02378701|Surveys|surveys
148836|NCT02378688|Crohn's Disease|crohn's disease
148837|NCT02378675|Adipocytokines|adipocytokines
148838|NCT02378662|Peritoneal Dialysis|peritoneal dialysis
148839|NCT02378662|End Stage Renal Disease|end stage renal disease
148840|NCT02378662|Anemia|anemia
148841|NCT02378649|Pulmonary Hypertension|pulmonary hypertension
148842|NCT02378623|paradoxical embolism|paradoxical embolism
148843|NCT02378623|lead thrombus|lead thrombus
148844|NCT02378623|ICD|icd
148845|NCT02378623|Pacemaker|pacemaker
148846|NCT02378623|Cognitive decline|cognitive decline
148847|NCT02378623|Stroke|stroke
148848|NCT02378623|TIA|tia
148849|NCT02378597|Resiliency burnout stress|resiliency burnout stress
148850|NCT02378571|Medication adherence|medication adherence
148851|NCT02378571|Hospital readmissions|hospital readmissions
148852|NCT02378558|Breast Surgery|breast surgery
148853|NCT02378545|Sepsis|sepsis
148854|NCT02378545|Hyperoxia|hyperoxia
148855|NCT02378545|Sepsis Six|sepsis six
148856|NCT02378545|Oxygen delivery|oxygen delivery
148857|NCT02378532|Glioblastoma|glioblastoma
148858|NCT02378532|Chloroquine|chloroquine
148859|NCT02378532|Autophagy|autophagy
148860|NCT02378532|EGFRvIII|egfrviii
148861|NCT02378532|Radiotherapy|radiotherapy
148862|NCT02378532|Temozolomide|temozolomide
148863|NCT02378519|Low back pain,|low back pain,
148864|NCT02378519|neck pain,|neck pain,
148865|NCT02378519|chronic pain|chronic pain
148866|NCT02378519|SSED|ssed
148867|NCT02378519|Pilot project|pilot project
148868|NCT02378519|interactive web-based self-help programme|interactive web-based self-help programme
148869|NCT02378519|CBT-coaching|cbt-coaching
148870|NCT02378519|physiotherapy|physiotherapy
148871|NCT02378493|Antibiogramme|antibiogramme
148872|NCT02378493|Antibiofilmogramme|antibiofilmogramme
148873|NCT02378467|Cystic Fibrosis|cystic fibrosis
148874|NCT02378467|Hypertonic Saline|hypertonic saline
148875|NCT02378467|Inhaled Saline|inhaled saline
148876|NCT02378467|Digestive System Diseases|digestive system diseases
148877|NCT02378467|Genetic Diseases, Inborn|genetic diseases, inborn
148878|NCT02378467|Lung Diseases|lung diseases
148879|NCT02378467|Pancreatic Diseases|pancreatic diseases
148880|NCT02378467|Pathologic Processes|pathologic processes
148881|NCT02378467|Respiratory Tract Diseases|respiratory tract diseases
148882|NCT02378454|Lung Clearance Index|lung clearance index
148883|NCT02378454|Cystic Fibrosis|cystic fibrosis
148884|NCT02378454|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
148885|NCT02378441|volunteers|volunteers
148886|NCT02378428|Neuroblastoma|neuroblastoma
148887|NCT02378415|Depression|depression
148888|NCT02378402|Creatine|creatine
148889|NCT02378402|heart failure|heart failure
148890|NCT02378402|lipid|lipid
148891|NCT02378402|MRS|mrs
148892|NCT02378402|myocardium|myocardium
148893|NCT02378324|Attendance|attendance
148894|NCT02378324|Screening without fee|screening without fee
148895|NCT02378311|Bike|bike
148896|NCT02378311|Bicycle|bicycle
148897|NCT02378311|Scooter|scooter
148898|NCT02378311|Handlebar|handlebar
148899|NCT02378285|recent lateral humeral epicondylitis|recent lateral humeral epicondylitis
148900|NCT02378285|platelet-rich plasma|platelet-rich plasma
148901|NCT02378285|infiltration|infiltration
148902|NCT02378285|tennis elbow|tennis elbow
148903|NCT02378285|ultrasonography|ultrasonography
148904|NCT02378272|Care Manager|care manager
148905|NCT02378272|Primary Care|primary care
148906|NCT02378272|Depressive symptoms|depressive symptoms
148907|NCT02378272|quality of life|quality of life
148908|NCT02378272|return to work|return to work
148909|NCT02378246|Iodine|iodine
148910|NCT02378246|Double-Blind Method|double-blind method
148911|NCT02378246|Randomized Controlled Tria|randomized controlled tria
148912|NCT02378246|Cognitive Development|cognitive development
148913|NCT02378233|Iodine|iodine
148914|NCT02378233|Double-Blind Method|double-blind method
148915|NCT02378233|Randomized Controlled Trial|randomized controlled trial
148916|NCT02378220|Home Care Agencies|home care agencies
148917|NCT02378220|Home Health Care Agencies|home health care agencies
148918|NCT02378220|Home Health Care Nursing|home health care nursing
148919|NCT02378220|Home Health Nurses|home health nurses
148920|NCT02378220|CYP 2D6|cyp 2d6
148921|NCT02378220|CYP 2C9|cyp 2c9
148922|NCT02378220|CYP 2C19|cyp 2c19
148923|NCT02378220|CYP 3A4|cyp 3a4
148924|NCT02378220|CYP 3A5|cyp 3a5
148925|NCT02378194|in stage 3 or 4 steps|in stage 3 or 4 steps
148926|NCT02378168|postconditioning|postconditioning
148927|NCT02378168|six month follow up|six month follow up
148928|NCT02378168|cardiac event|cardiac event
148929|NCT02378168|non-cardiac event|non-cardiac event
148930|NCT02378155|cardioversion|cardioversion
148931|NCT02378155|atrial fibrillation|atrial fibrillation
148932|NCT02378129|Dentin Sensitivity|dentin sensitivity
148933|NCT02378129|Dentin Desensitizing Agents|dentin desensitizing agents
148934|NCT02378129|Glass Ionomer Cements|glass ionomer cements
148935|NCT02378129|Randomized Controlled Trial|randomized controlled trial
148936|NCT02378103|Aortic Dissection|aortic dissection
148937|NCT02378103|Chinese XinJiang Province|chinese xinjiang province
148938|NCT02378077|Obesity|obesity
148939|NCT02378077|Insulin Resistance|insulin resistance
148940|NCT02378064|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
148941|NCT02378064|Positron-Emission Tomography and Computed Tomography|positron-emission tomography and computed tomography
148942|NCT02378064|Plaque, Atherosclerotic|plaque, atherosclerotic
148943|NCT02378064|Renin-Angiotensin System|renin-angiotensin system
148944|NCT02378038|PNT2258|pnt2258
148945|NCT02378038|Richter's Transformation|richter's transformation
148946|NCT02378038|NHL|nhl
148947|NCT02378038|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
148948|NCT02378038|Lymphoma|lymphoma
148949|NCT02378038|DLBCL|dlbcl
139825|NCT02428374|MRI|mri
148950|NCT02378038|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
148951|NCT02378038|Lymphoma, Large B-cell, Diffuse|lymphoma, large b-cell, diffuse
148952|NCT02378038|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
148953|NCT02378038|Lymphoma, B-cell|lymphoma, b-cell
148954|NCT02378025|Chronic Pain|chronic pain
148955|NCT02378025|Veterans|veterans
148956|NCT02378025|Gulf War Illness|gulf war illness
148957|NCT02377973|growth,|growth,
148958|NCT02377973|infancy,|infancy,
148959|NCT02377973|children,|children,
148960|NCT02377973|diet,|diet,
148961|NCT02377973|breastfeeding|breastfeeding
148962|NCT02377973|complementary feeding|complementary feeding
148963|NCT02377973|early life programming|early life programming
148964|NCT02377973|tracking|tracking
148965|NCT02377973|physical activity|physical activity
148972|NCT02377947|The Retro Study|the retro study
148973|NCT02377934|Pulmonary Hypertension|pulmonary hypertension
148974|NCT02377934|Cardiac MRT|cardiac mrt
148975|NCT02377934|Radiotherapy|radiotherapy
148976|NCT02377921|GNE Myopathy|gne myopathy
148977|NCT02377921|GNEM|gnem
148978|NCT02377921|HIBM|hibm
148979|NCT02377921|Nonaka|nonaka
148980|NCT02377921|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
148981|NCT02377921|DMRV|dmrv
148982|NCT02377882|Intra-operative neuromonitoring|intra-operative neuromonitoring
148983|NCT02377882|Neuromuscular blocking agent|neuromuscular blocking agent
148984|NCT02377882|Rocuronium|rocuronium
148985|NCT02377882|Thyroid surgery|thyroid surgery
148986|NCT02377856|acute hepatitis C|acute hepatitis c
148987|NCT02377856|treatment|treatment
148988|NCT02377856|SVR|svr
148989|NCT02377843|vaccine|vaccine
148990|NCT02377843|physician training|physician training
148991|NCT02377843|adolescent health|adolescent health
148992|NCT02377817|positional therapy|positional therapy
148993|NCT02377817|tennis ball technique|tennis ball technique
148994|NCT02377817|sleep in pregnancy|sleep in pregnancy
148995|NCT02377817|supine|supine
148996|NCT02377817|polysomnography|polysomnography
148997|NCT02377817|sleep position|sleep position
148998|NCT02377817|supine position|supine position
148999|NCT02377804|dry needling|dry needling
149000|NCT02377804|spasticity|spasticity
149001|NCT02377804|pain|pain
149002|NCT02377791|tacrolimus|tacrolimus
149003|NCT02377791|Cytochrome P-450 CYP3A|cytochrome p-450 cyp3a
149004|NCT02377791|Kidney transplant|kidney transplant
149005|NCT02377791|FK506|fk506
149006|NCT02377791|Prograf|prograf
149007|NCT02377791|Rejection|rejection
149008|NCT02377791|Gene Polymorphism|gene polymorphism
149009|NCT02377765|Neuromodulation|neuromodulation
149010|NCT02377765|Detrusor overactivity|detrusor overactivity
149011|NCT02377765|Urinary urgency|urinary urgency
149012|NCT02377765|Urgency urinary incontinence|urgency urinary incontinence
149013|NCT02377726|Randomized Controlled Trial|randomized controlled trial
149014|NCT02377726|Alcohol|alcohol
149015|NCT02377726|Internet|internet
149016|NCT02377726|Internet based therapy|internet based therapy
149017|NCT02377726|Cognitive behavioral therapy|cognitive behavioral therapy
149018|NCT02377713|KHK6640|khk6640
149019|NCT02377713|Phase 1|phase 1
149020|NCT02377713|Japanese|japanese
149021|NCT02377713|single dose|single dose
149022|NCT02377713|Alzheimer's disease|alzheimer's disease
149023|NCT02377687|Emergency surgery|emergency surgery
149024|NCT02377687|HRQoL|hrqol
149025|NCT02377687|Elderly|elderly
149026|NCT02377648|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
149027|NCT02377648|Heart Transplant|heart transplant
149028|NCT02377648|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
149029|NCT02377635|Arsenic|arsenic
149030|NCT02377635|Arsenicosis|arsenicosis
149031|NCT02377609|Dry Blood Spot (DBS)|dry blood spot (dbs)
149032|NCT02377609|Validation|validation
149033|NCT02377609|Tacrolimus|tacrolimus
149034|NCT02377609|Bioanalytical assay method cross-validation|bioanalytical assay method cross-validation
149035|NCT02377596|Feeding|feeding
149036|NCT02377596|difficulties|difficulties
149037|NCT02377596|disorders|disorders
149038|NCT02377596|childhood|childhood
149039|NCT02377596|eating|eating
149040|NCT02377557|Dermatologic Agent|dermatologic agent
149041|NCT02377531|early glucose screen, perinatal outcome|early glucose screen, perinatal outcome
149042|NCT02377505|Treatment-Resistant Schizophrenia|treatment-resistant schizophrenia
149043|NCT02377505|Deep Brain Stimulation|deep brain stimulation
149044|NCT02377466|Spontaneous Preterm Labor|spontaneous preterm labor
149045|NCT02377466|GSK221149|gsk221149
149046|NCT02377466|Retosiban|retosiban
149047|NCT02377453|stroke|stroke
149048|NCT02377453|participation|participation
149049|NCT02377453|brain imaging|brain imaging
149050|NCT02377453|biomechanical|biomechanical
149051|NCT02377440|ACE inhibitor|ace inhibitor
149052|NCT02377427|pharmacokinetics|pharmacokinetics
149053|NCT02377427|pediatric|pediatric
149054|NCT02377427|Mepolizumab|mepolizumab
149055|NCT02377427|subcutaneous|subcutaneous
149056|NCT02377427|eosinophilic asthma|eosinophilic asthma
149057|NCT02377427|pharmacodynamics|pharmacodynamics
149058|NCT02377414|Preterm labor|preterm labor
149059|NCT02377414|Retosiban|retosiban
149060|NCT02377414|Pharmacokinetics|pharmacokinetics
149061|NCT02377414|Safety|safety
149062|NCT02377414|Infusion|infusion
149063|NCT02377414|GSK2847065|gsk2847065
149064|NCT02377401|healthy volunteer|healthy volunteer
149065|NCT02377401|Zanamivir|zanamivir
149066|NCT02377401|pharmacokinetics|pharmacokinetics
149067|NCT02377401|intravenous|intravenous
149068|NCT02377388|diabetes mellitus|diabetes mellitus
149069|NCT02377388|platelet function testing|platelet function testing
149070|NCT02377388|acute coronary syndromes|acute coronary syndromes
149071|NCT02377388|saxagliptin|saxagliptin
149072|NCT02377375|Deep Brain Stimulation|deep brain stimulation
149073|NCT02377375|OCD|ocd
149074|NCT02377336|GS-6615|gs-6615
149075|NCT02377336|coronary heart disease|coronary heart disease
149076|NCT02377336|angina pectoris|angina pectoris
149077|NCT02377336|late sodium current|late sodium current
149078|NCT02377336|myocardial ischemia|myocardial ischemia
149079|NCT02377336|coronary artery disease|coronary artery disease
149080|NCT02377336|chronic stable angina|chronic stable angina
149081|NCT02377323|Multiple Sclerosis|multiple sclerosis
149082|NCT02377323|Patient-reported outcomes|patient-reported outcomes
149083|NCT02377323|Employment status|employment status
149084|NCT02377323|Quality of Life|quality of life
149085|NCT02377323|Cognition|cognition
149086|NCT02377323|Rebif|rebif
149087|NCT02377297|dental atraumatic restorative treatment|dental atraumatic restorative treatment
149088|NCT02377297|primary tooth|primary tooth
149089|NCT02377297|occlusal restoration|occlusal restoration
149090|NCT02377297|glass-ionomer cement|glass-ionomer cement
149091|NCT02377271|Bosentan|bosentan
149092|NCT02377245|Juvenile|juvenile
149093|NCT02377245|Inflammatory|inflammatory
149094|NCT02377245|Rheumatism|rheumatism
149095|NCT02377245|Pediatric-Onset inflammatory diseases|pediatric-onset inflammatory diseases
149096|NCT02377206|PET|pet
149097|NCT02377206|[18F]DPA-714|[18f]dpa-714
149098|NCT02377206|cognitive decline|cognitive decline
149100|NCT02377193|luminex method|luminex method
149101|NCT02377193|simulect ATG|simulect atg
149102|NCT02377193|immunosuppression|immunosuppression
149103|NCT02377180|musculoskeletal pain|musculoskeletal pain
149104|NCT02377180|regional anesthesia|regional anesthesia
149105|NCT02377180|diagnostic nerve block|diagnostic nerve block
149106|NCT02377180|intramuscular capsaicin|intramuscular capsaicin
149107|NCT02377180|referred pain|referred pain
149108|NCT02377180|hyperalgesia|hyperalgesia
149109|NCT02377180|experimental pain|experimental pain
149110|NCT02377180|central hypersensitivity|central hypersensitivity
149111|NCT02377180|human experimental pain|human experimental pain
149112|NCT02377154|keratometry|keratometry
149113|NCT02377154|verion|verion
149114|NCT02377154|iol|iol
149115|NCT02377154|intraocular lens|intraocular lens
149116|NCT02377154|iolmaster|iolmaster
149117|NCT02377154|lenstar|lenstar
149118|NCT02377154|pentacam|pentacam
149119|NCT02377154|IOL calculation|iol calculation
149120|NCT02377154|VERION Image Guided System|verion image guided system
149121|NCT02377141|Oesophageal Variceal Bleed|oesophageal variceal bleed
149122|NCT02377141|TIPSS|tipss
658989|NCT00806273|root canal|root canal
149123|NCT02377141|Endoscopic Variceal Band Ligation|endoscopic variceal band ligation
149124|NCT02377141|Decompensated Liver Disease|decompensated liver disease
149126|NCT02377128|focus|focus
149127|NCT02377128|ovarian|ovarian
149128|NCT02377128|reserve|reserve
149129|NCT02377115|Postoperative delirium|postoperative delirium
149130|NCT02377115|Postoperative cognitive decline|postoperative cognitive decline
149131|NCT02377115|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
149132|NCT02377115|Risk assessment|risk assessment
149133|NCT02377115|Tablet computer|tablet computer
149134|NCT02377115|Clinical screening tool|clinical screening tool
149135|NCT02377089|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
149136|NCT02377089|Post-Traumatic Stress Disorder|post-traumatic stress disorder
149137|NCT02377063|colonic flora|colonic flora
149138|NCT02377063|microbiomes|microbiomes
149139|NCT02377050|Nutritional support|nutritional support
149140|NCT02377037|Sitting|sitting
149141|NCT02377037|Standing|standing
149142|NCT02377037|Transitions|transitions
149143|NCT02376998|Thoracic Aorta|thoracic aorta
149144|NCT02376998|Trauma|trauma
149145|NCT02376998|Endovascular|endovascular
149146|NCT02376959|Anxiety|anxiety
149335|NCT02376023|Chile|chile
149147|NCT02376959|Complementary Therapies|complementary therapies
149148|NCT02376959|energy therapies|energy therapies
149149|NCT02376933|vertebral bodies|vertebral bodies
149150|NCT02376933|vertebral fracture|vertebral fracture
149151|NCT02376933|vertebral augmentation|vertebral augmentation
149152|NCT02376933|radiotherapy|radiotherapy
149153|NCT02376933|vertebroplasty|vertebroplasty
149154|NCT02376933|kyphoplasty|kyphoplasty
149155|NCT02376920|occular melanoma|occular melanoma
149156|NCT02376920|melanoma of eye|melanoma of eye
149157|NCT02376920|DecisionDx-UM|decisiondx-um
139934|NCT02427737|Patient satisfaction|patient satisfaction
139935|NCT02427737|Diagnostic Imaging|diagnostic imaging
139937|NCT02427711|blood transfusions|blood transfusions
139938|NCT02427711|Readmission|readmission
149158|NCT02376907|distal malignant biliary obstruction|distal malignant biliary obstruction
149159|NCT02376907|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
149160|NCT02376907|endoscopic ultrasound|endoscopic ultrasound
149161|NCT02376907|gastric outlet obstruction|gastric outlet obstruction
149163|NCT02376881|Erythropoietin -Methanol - Optic Neuropathy|erythropoietin -methanol - optic neuropathy
149164|NCT02376855|Health Services Accessibility|health services accessibility
149165|NCT02376842|severe sepsis infection|severe sepsis infection
149166|NCT02376829|Orthodontic|orthodontic
149167|NCT02376829|Orthodontic Treatment|orthodontic treatment
149168|NCT02376829|Clear Aligners|clear aligners
149169|NCT02376829|Malocclusion|malocclusion
149170|NCT02376816|DMD|dmd
149171|NCT02376816|muscular dystrophy|muscular dystrophy
149172|NCT02376816|dystrophin|dystrophin
149173|NCT02376803|Randomized controlled trial|randomized controlled trial
149174|NCT02376803|Warfarin|warfarin
149175|NCT02376803|Time in therapeutic range|time in therapeutic range
149176|NCT02376803|Bleeding|bleeding
149177|NCT02376803|Thromboembolic|thromboembolic
149178|NCT02376803|Hemorrhage|hemorrhage
149179|NCT02376803|Anticoagulant|anticoagulant
149180|NCT02376803|TTR|ttr
149181|NCT02376803|Chronobiology|chronobiology
149182|NCT02376803|Chronotherapeutic|chronotherapeutic
149183|NCT02376803|Coumadin|coumadin
149184|NCT02376803|INR|inr
149185|NCT02376803|International normalized ratio|international normalized ratio
149186|NCT02376803|RCT|rct
149187|NCT02376790|Psoriatic Arthritis|psoriatic arthritis
149188|NCT02376790|Arthritis, Psoriasis|arthritis, psoriasis
149189|NCT02376790|Etanercept|etanercept
149190|NCT02376790|Enbrel|enbrel
149191|NCT02376790|Methotrexate|methotrexate
149192|NCT02376790|Minimal Disease Activity|minimal disease activity
149193|NCT02376777|Anticoagulants|anticoagulants
149194|NCT02376777|Antithrombins|antithrombins
149195|NCT02376777|Atrial Fibrillation|atrial fibrillation
149196|NCT02376777|Intracranial haemorrhage|intracranial haemorrhage
149197|NCT02376777|Gastrointestinal haemorrhage|gastrointestinal haemorrhage
149198|NCT02376777|Myocardial infarction|myocardial infarction
149199|NCT02376777|Stroke|stroke
149200|NCT02376777|Venous thrombosis|venous thrombosis
149201|NCT02376777|Primary care|primary care
149202|NCT02376751|Cholesteryl Ester Storage Disease|cholesteryl ester storage disease
149203|NCT02376751|Acid lipase disease|acid lipase disease
149204|NCT02376751|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
149205|NCT02376751|LIPA Deficiency|lipa deficiency
149206|NCT02376751|Wolman disease|wolman disease
149207|NCT02376751|Lysosomal Storage Disease|lysosomal storage disease
149208|NCT02376725|Goniosynechialysis|goniosynechialysis
149209|NCT02376712|Acute Kidney Injury|acute kidney injury
149401|NCT02375581|Icotinib|icotinib
149210|NCT02376712|Differential diagnosis|differential diagnosis
149211|NCT02376712|Urinary indices|urinary indices
149212|NCT02376712|Renal Blood Flow|renal blood flow
149213|NCT02376712|Transesophageal Echocardiography|transesophageal echocardiography
149214|NCT02376699|CD40 Antigen|cd40 antigen
149215|NCT02376699|Drug Therapy|drug therapy
149216|NCT02376699|Follicular Lymphoma|follicular lymphoma
149217|NCT02376699|Hodgkin Disease|hodgkin disease
149218|NCT02376699|Immunotherapy|immunotherapy
149219|NCT02376699|Indolent Lymphoma|indolent lymphoma
149220|NCT02376699|Lymphoma|lymphoma
149221|NCT02376699|Lymphoma, B-Cell|lymphoma, b-cell
149222|NCT02376699|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
149223|NCT02376699|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
149224|NCT02376699|Monoclonal Antibody|monoclonal antibody
149225|NCT02376699|Neoplasms|neoplasms
149226|NCT02376699|Neoplasm Metastasis|neoplasm metastasis
149227|NCT02376699|Solid tumor|solid tumor
149228|NCT02376686|sleep Quality|sleep quality
149229|NCT02376686|Depression|depression
149231|NCT02376686|quality of life|quality of life
149232|NCT02376673|Pediatric Health Literacy|pediatric health literacy
149233|NCT02376673|Home Literacy Orientation|home literacy orientation
149234|NCT02376673|safe sleep|safe sleep
149235|NCT02376647|Patients|patients
149236|NCT02376647|ARDS diagnosis|ards diagnosis
149237|NCT02376621|omega-3 based dietary supplements|omega-3 based dietary supplements
149238|NCT02376621|Bioavailability|bioavailability
149239|NCT02376595|Rocuronium|rocuronium
149240|NCT02376595|Pharmacokinetics|pharmacokinetics
140341|NCT02425358|BMC|bmc
149241|NCT02376595|Pharmacodynamics|pharmacodynamics
149242|NCT02376582|HIV/AIDS vaccine|hiv/aids vaccine
149243|NCT02376582|helminth infection|helminth infection
149244|NCT02376582|Impact of co-infection|impact of co-infection
149245|NCT02376556|Dry eye syndrome|dry eye syndrome
149246|NCT02376556|Blepharoplasty|blepharoplasty
149247|NCT02376556|Muller muscle resection surgery|muller muscle resection surgery
149248|NCT02376517|Health Behavior|health behavior
149249|NCT02376517|Melanin Index|melanin index
149250|NCT02376517|Spectrophotometry|spectrophotometry
149251|NCT02376517|Sun Protective Clothing|sun protective clothing
149252|NCT02376517|Education|education
149253|NCT02376517|Primary Prevention|primary prevention
149254|NCT02376439|siblings|siblings
149255|NCT02376439|overweight|overweight
149256|NCT02376439|adolescent|adolescent
149257|NCT02376426|Healthy|healthy
149258|NCT02376426|Ebola viruses|ebola viruses
149259|NCT02376426|Ebola Viral Disease (EVD)|ebola viral disease (evd)
149260|NCT02376426|Filoviruses|filoviruses
149262|NCT02376426|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
149263|NCT02376426|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
149264|NCT02376426|Safety|safety
149265|NCT02376426|Immunogenicity|immunogenicity
149266|NCT02376413|Morbidity|morbidity
149267|NCT02376413|The Breast Cancer Treatment Outcome Scale|the breast cancer treatment outcome scale
149268|NCT02376413|Disease free survival|disease free survival
149269|NCT02376413|Positivity cavity margin rate|positivity cavity margin rate
149270|NCT02376413|Harvard/NSABP/RTOG breast cosmesis grading scale|harvard/nsabp/rtog breast cosmesis grading scale
149271|NCT02376400|Healthy|healthy
149272|NCT02376400|Ebola viruses|ebola viruses
149273|NCT02376400|Ebola Viral Disease (EVD)|ebola viral disease (evd)
149274|NCT02376400|Filoviruses|filoviruses
149275|NCT02376400|Monovalent vaccine|monovalent vaccine
149276|NCT02376400|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
149277|NCT02376400|Modified Vaccinia Virus Ankara - Bavarian Nordic Filo-vector (MVA-BN Filo)|modified vaccinia virus ankara - bavarian nordic filo-vector (mva-bn filo)
149278|NCT02376400|Safety|safety
149279|NCT02376400|Immunogenicity|immunogenicity
149280|NCT02376374|transmission|transmission
149281|NCT02376374|vaccine|vaccine
149282|NCT02376361|Surveillance|surveillance
149283|NCT02376348|VMMC|vmmc
149284|NCT02376348|Adult males|adult males
149285|NCT02376348|HIV Prevention|hiv prevention
149286|NCT02376348|Africa|africa
149287|NCT02376335|Fatigue|fatigue
149288|NCT02376335|Primary Biliary Cirrhosis|primary biliary cirrhosis
149289|NCT02376335|Rituximab|rituximab
149290|NCT02376335|PBC-40|pbc-40
149291|NCT02376296|metastatic prostate cancer|metastatic prostate cancer
149292|NCT02376296|castrate resistant prostate cancer|castrate resistant prostate cancer
149293|NCT02376296|CRPC|crpc
149294|NCT02376296|hormone sensitive prostate cancer|hormone sensitive prostate cancer
149295|NCT02376283|STEMI|stemi
149296|NCT02376283|NSTEMI|nstemi
149297|NCT02376283|PPCI|ppci
149298|NCT02376244|High intensity Interval Exercise training|high intensity interval exercise training
149299|NCT02376244|Cardiac rehabilitation|cardiac rehabilitation
149300|NCT02376244|cardiac revascularisation|cardiac revascularisation
149301|NCT02376244|Percutaneous coronary interventions|percutaneous coronary interventions
149302|NCT02376244|Cardiac surgery|cardiac surgery
149303|NCT02376231|EOC Epithelial ovarian cancer|eoc epithelial ovarian cancer
149304|NCT02376231|Surgery|surgery
149305|NCT02376231|nil macroscopic residual disease|nil macroscopic residual disease
149306|NCT02376231|Stage 3/4 Epithelial Ovarian Cancer requiring surgery|stage 3/4 epithelial ovarian cancer requiring surgery
149307|NCT02376205|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
149308|NCT02376205|Dysphagia|dysphagia
149309|NCT02376192|Microcirculation|microcirculation
149310|NCT02376192|Sidestream Dark Field (SDF) Imaging|sidestream dark field (sdf) imaging
149311|NCT02376192|Spinal Anesthesia|spinal anesthesia
149312|NCT02376192|Phenylephrine|phenylephrine
149313|NCT02376166|Prostate Cancer|prostate cancer
149314|NCT02376140|micronutrient deficiency|micronutrient deficiency
149315|NCT02376140|24-H recall|24-h recall
149316|NCT02376140|West Africa|west africa
149317|NCT02376140|Food consumption|food consumption
149318|NCT02376127|Dynamic Contrast-Enhanced Perfusion|dynamic contrast-enhanced perfusion
149319|NCT02376127|14-203|14-203
149320|NCT02376114|ocular blood flow|ocular blood flow
149321|NCT02376114|ginkgo biloba|ginkgo biloba
149322|NCT02376114|glaucoma|glaucoma
149323|NCT02376114|vasospasm|vasospasm
149324|NCT02376062|Continuing Medical Education|continuing medical education
149325|NCT02376062|Chronic Diseases|chronic diseases
149326|NCT02376062|Nepal|nepal
149327|NCT02376062|Implementation Research|implementation research
149328|NCT02376049|Atopic Dermatitis|atopic dermatitis
149329|NCT02376049|Eczema|eczema
149331|NCT02376036|Normal healthy volunteer|normal healthy volunteer
149332|NCT02376023|Cervical Cancer|cervical cancer
149333|NCT02376023|Women|women
149336|NCT02376023|Text Message|text message
149337|NCT02376023|Technology|technology
149338|NCT02376023|Screening|screening
140162|NCT02426593|CHF|chf
149339|NCT02376023|Cancer Prevention|cancer prevention
149340|NCT02376023|Health Disparities|health disparities
149341|NCT02376023|Mobile Health|mobile health
149342|NCT02376010|atherosclerosis|atherosclerosis
149343|NCT02376010|coronary artery disease|coronary artery disease
149344|NCT02376010|cardiac CT|cardiac ct
149345|NCT02376010|computed tomographic angiography|computed tomographic angiography
149346|NCT02375971|intravitreal ranibizumab|intravitreal ranibizumab
149347|NCT02375971|laser ablation therapy|laser ablation therapy
149348|NCT02375971|retinopathy of prematurity|retinopathy of prematurity
149349|NCT02375971|preterm infants|preterm infants
149350|NCT02375971|RAINBOW|rainbow
149811|NCT02372851|Arsenic|arsenic
149351|NCT02375958|PCA062, Triple Negative Breast Cancer, Head & Neck Cancer, Esophageal Cancer, pCAD, pcadherin, solid-tumors|pca062, triple negative breast cancer, head & neck cancer, esophageal cancer, pcad, pcadherin, solid-tumors
149353|NCT02375945|post operative compression treatment|post operative compression treatment
149354|NCT02375945|compression therapy|compression therapy
149355|NCT02375945|adjustable fulcro wraps|adjustable fulcro wraps
149356|NCT02375945|edema|edema
149357|NCT02375932|Electronic Medical Records|electronic medical records
149358|NCT02375932|Primary Health Care|primary health care
149359|NCT02375932|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
149360|NCT02375919|PERC rule|perc rule
149361|NCT02375919|emergency department|emergency department
149362|NCT02375919|pulmonary embolism|pulmonary embolism
149363|NCT02375906|HDV, hepatitis delta|hdv, hepatitis delta
149364|NCT02375893|Coronary disease|coronary disease
149365|NCT02375893|Bile acids|bile acids
149366|NCT02375893|Gut microbiota|gut microbiota
149367|NCT02375893|Risk factors|risk factors
149368|NCT02375893|Atherosclerosis|atherosclerosis
149369|NCT02375854|preterm|preterm
149370|NCT02375854|acute kidney injury|acute kidney injury
149371|NCT02375854|biomarkers|biomarkers
149372|NCT02375854|chronic kidney disease|chronic kidney disease
149373|NCT02375841|Communication|communication
149374|NCT02375841|Physicians|physicians
149375|NCT02375841|Patients|patients
149376|NCT02375841|Caregivers|caregivers
149377|NCT02375841|15-034|15-034
149378|NCT02375828|Acceptability|acceptability
149379|NCT02375828|Phase 3|phase 3
149380|NCT02375828|Neonatal diabetes|neonatal diabetes
149381|NCT02375815|statin|statin
149382|NCT02375815|decision aid|decision aid
149383|NCT02375802|Stem cells|stem cells
149384|NCT02375789|Migraine Headache|migraine headache
149385|NCT02375789|Cooling|cooling
149386|NCT02375789|Intranasal|intranasal
149387|NCT02375789|Rhinochill|rhinochill
149388|NCT02375724|COPD|copd
149389|NCT02375711|Chronic renal disease|chronic renal disease
149390|NCT02375711|Hepatitis B vaccine|hepatitis b vaccine
149391|NCT02375711|Biological Aging|biological aging
149392|NCT02375685|Uveitis|uveitis
149393|NCT02375685|Non-infectious Uveitis|non-infectious uveitis
149394|NCT02375685|Intermediate Uveitis|intermediate uveitis
149395|NCT02375685|Posterior Uveitis|posterior uveitis
149396|NCT02375685|Behçet's disease uveitis|behçet's disease uveitis
149397|NCT02375672|Pembrolizumab|pembrolizumab
149398|NCT02375672|MK-3475|mk-3475
149399|NCT02375607|Pain management|pain management
149400|NCT02375581|Radiotherapy|radiotherapy
149402|NCT02375568|mesenchymal stem cells|mesenchymal stem cells
149403|NCT02375555|Multiple Myeloma|multiple myeloma
149404|NCT02375516|Drug abuse|drug abuse
149405|NCT02375503|Calcium|calcium
149406|NCT02375503|Vitamin D|vitamin d
149407|NCT02375503|Parathyroid Hormone|parathyroid hormone
149408|NCT02375503|Bone|bone
149409|NCT02375503|Microarchitecture|microarchitecture
149410|NCT02375490|Exercise|exercise
149411|NCT02375490|Eating Behavior|eating behavior
149412|NCT02375490|Preschool Child|preschool child
149413|NCT02375490|Early Childcare Center|early childcare center
149414|NCT02375490|Obesity|obesity
149415|NCT02375490|Physical Literacy|physical literacy
149416|NCT02375477|Clostridium difficile|clostridium difficile
149417|NCT02375477|C. difficile|c. difficile
149418|NCT02375477|adherence|adherence
149419|NCT02375464|neuroendocrine tumor|neuroendocrine tumor
149420|NCT02375464|carcinoid tumor|carcinoid tumor
149421|NCT02375438|nutrition|nutrition
149422|NCT02375438|mitochondrial cytopathy|mitochondrial cytopathy
149423|NCT02375438|malnutrition|malnutrition
149424|NCT02375438|energy intake|energy intake
149425|NCT02375438|nutritional risk|nutritional risk
149426|NCT02375425|BV, HSV|bv, hsv
149427|NCT02375425|contraceptive|contraceptive
149428|NCT02375425|ex vivo challenge model|ex vivo challenge model
149429|NCT02375412|heart rate variability|heart rate variability
149430|NCT02375412|post-operative outcome|post-operative outcome
149431|NCT02375373|Gut Microbiota|gut microbiota
149432|NCT02375347|Gut Microbiota|gut microbiota
149433|NCT02375321|OSA|osa
149434|NCT02375321|Depression|depression
149435|NCT02375321|Quality of Life|quality of life
149436|NCT02375321|CPAP|cpap
149541|NCT02374671|Reading Glasses|reading glasses
180732|NCT02207010|GBM|gbm
149437|NCT02375308|Hypnotherapy; Cognitive Behavioral Therapy; Efficacy|hypnotherapy; cognitive behavioral therapy; efficacy
149438|NCT02375295|struvite|struvite
140251|NCT02425865|UC, IBD|uc, ibd
149439|NCT02375295|infection|infection
149440|NCT02375295|stones|stones
149441|NCT02375295|calculi|calculi
149442|NCT02375295|antibiotics|antibiotics
149443|NCT02375282|ambulation|ambulation
149444|NCT02375282|cardiac rehabilitation|cardiac rehabilitation
149445|NCT02375269|Visceral Surgery|visceral surgery
149446|NCT02375269|Comprehensive Complication Index|comprehensive complication index
149447|NCT02375269|Patient undergoing abdominal surgery|patient undergoing abdominal surgery
149448|NCT02375230|Neonatal Resuscitation|neonatal resuscitation
149449|NCT02375230|Respiratory Function Tests|respiratory function tests
149450|NCT02375230|Neonatal Simulation|neonatal simulation
149451|NCT02375230|Resuscitation Teaching|resuscitation teaching
149453|NCT02375178|local/therapeutic use|local/therapeutic use
149454|NCT02375178|chlorhexidine|chlorhexidine
149455|NCT02375178|dental desinfectants|dental desinfectants
149456|NCT02375178|polyhexamethylene biguanide|polyhexamethylene biguanide
149457|NCT02375178|mouthrinse|mouthrinse
149458|NCT02375152|neurosurgery|neurosurgery
149459|NCT02375152|capsulotomy|capsulotomy
149460|NCT02375113|Obesity prevention|obesity prevention
149461|NCT02375113|Soy supplementation|soy supplementation
149462|NCT02375074|Supported Employment|supported employment
149463|NCT02375074|Vocational Rehabilitation|vocational rehabilitation
149464|NCT02375074|Youth|youth
149465|NCT02375074|Sick leave|sick leave
149466|NCT02375074|Disability|disability
149467|NCT02375074|Coping|coping
149468|NCT02375074|Work|work
149469|NCT02375074|Occupational|occupational
149470|NCT02375074|Labor market participation|labor market participation
149471|NCT02375074|Randomized Controlled Trial|randomized controlled trial
149472|NCT02375061|Best Possible Self|best possible self
149473|NCT02375061|Positive Psychology|positive psychology
149474|NCT02375061|Optimism|optimism
149475|NCT02375061|Positive Technologies|positive technologies
149476|NCT02375061|Future thinking|future thinking
149477|NCT02375061|Pain Catastrophizing|pain catastrophizing
149478|NCT02374983|Gamma Knife Radiosurgery|gamma knife radiosurgery
149479|NCT02374983|Radiation Dosimetry|radiation dosimetry
149480|NCT02374957|leg pain|leg pain
149481|NCT02374957|claudication|claudication
149482|NCT02374931|desmoid|desmoid
149483|NCT02374931|FES-PET|fes-pet
149484|NCT02374931|aggressive fibromatosis|aggressive fibromatosis
149485|NCT02374918|Mild traumatic brain injury|mild traumatic brain injury
149486|NCT02374918|Concussion|concussion
149487|NCT02374918|Sleep problems|sleep problems
149488|NCT02374918|Brain imaging|brain imaging
149489|NCT02374918|fMRI|fmri
149490|NCT02374905|drinksmeter|drinksmeter
149491|NCT02374905|alcohol counselling|alcohol counselling
149492|NCT02374892|Intervention|intervention
149493|NCT02374892|Congenital Heart Disease|congenital heart disease
149494|NCT02374892|Adolescent|adolescent
149495|NCT02374892|Education|education
149496|NCT02374892|Self-management|self-management
149497|NCT02374866|Obesity|obesity
149498|NCT02374866|Morbid Obesity|morbid obesity
149499|NCT02374866|Therapeutic education|therapeutic education
149500|NCT02374840|Pharmacogenomics|pharmacogenomics
149501|NCT02374840|Adverse Drug Reactions|adverse drug reactions
149502|NCT02374840|Pharmacogenetics|pharmacogenetics
149503|NCT02374827|complete salpingectomy|complete salpingectomy
149510|NCT02374801|Severe HF (NYHA Class III or ambulatory IV)|severe hf (nyha class iii or ambulatory iv)
149511|NCT02374801|Stable, optimal drug regimen|stable, optimal drug regimen
149513|NCT02374801|Heart Failure|heart failure
149514|NCT02374775|axial plaque stress|axial plaque stress
149515|NCT02374775|pressure|pressure
149516|NCT02374775|pressure gradient|pressure gradient
149517|NCT02374775|coronary plaque|coronary plaque
149518|NCT02374775|plaque rupture|plaque rupture
149519|NCT02374775|acute coronary syndrome|acute coronary syndrome
149520|NCT02374775|acute myocardial infarction|acute myocardial infarction
149521|NCT02374775|computational fluid dynamics|computational fluid dynamics
149522|NCT02374775|coronary computed tomography angiography|coronary computed tomography angiography
149523|NCT02374775|wall shear stress|wall shear stress
149524|NCT02374762|Arteriovenous Fistula|arteriovenous fistula
149525|NCT02374762|Hemodialysis|hemodialysis
149526|NCT02374762|Vascular Access|vascular access
149527|NCT02374749|Axial Spondyloarthritis|axial spondyloarthritis
149528|NCT02374749|Education|education
149529|NCT02374749|Co-morbidities|co-morbidities
149530|NCT02374749|Nurse|nurse
149531|NCT02374736|recipients|recipients
149532|NCT02374736|Subclinical Antibody-mediated rejection (ABMR)|subclinical antibody-mediated rejection (abmr)
149533|NCT02374736|Intravenous immunoglobulins (IVIg)|intravenous immunoglobulins (ivig)
149534|NCT02374736|Donor-specific antibodies (DSA)|donor-specific antibodies (dsa)
149535|NCT02374723|improve|improve
149536|NCT02374723|vision|vision
149537|NCT02374697|Second opinion|second opinion
149538|NCT02374684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
149539|NCT02374671|Near Vision|near vision
149540|NCT02374671|Reading Vision|reading vision
149542|NCT02374671|Reading|reading
149543|NCT02374671|Readers|readers
149544|NCT02374619|eccentric exercise|eccentric exercise
149545|NCT02374619|pro-oxidants|pro-oxidants
149546|NCT02374619|free radicals|free radicals
149547|NCT02374619|adults|adults
149548|NCT02374619|children|children
149549|NCT02374606|outcomes measures|outcomes measures
149550|NCT02374606|strength measurement|strength measurement
149551|NCT02374606|disease progression|disease progression
149552|NCT02374567|geriatric psychiatry|geriatric psychiatry
149553|NCT02374567|pharmacovigilance|pharmacovigilance
149554|NCT02374554|Respiratory Rate|respiratory rate
149555|NCT02374554|Structured Light Plethysmography|structured light plethysmography
149556|NCT02374554|Capnography|capnography
149563|NCT02374528|Negative pressure wound therapy|negative pressure wound therapy
149564|NCT02374528|wound|wound
149565|NCT02374528|split-thickness skin grafting|split-thickness skin grafting
149566|NCT02374502|Spondylarthropathies|spondylarthropathies
149567|NCT02374502|Motor Activity|motor activity
149568|NCT02374502|Physical Therapists|physical therapists
149569|NCT02374502|Accelerometry|accelerometry
149571|NCT02374476|Refractory VT|refractory vt
149572|NCT02374476|VT Storm|vt storm
149573|NCT02374476|Ventricular Fibrillation|ventricular fibrillation
149574|NCT02374476|V Fib|v fib
149575|NCT02374476|VF|vf
149576|NCT02374463|Balance|balance
149577|NCT02374463|Fall Risk|fall risk
149578|NCT02374463|Older Adults|older adults
149579|NCT02374463|Tai Chi|tai chi
149580|NCT02374463|Multimodal Balance Intervention|multimodal balance intervention
149581|NCT02374450|Malaria|malaria
149582|NCT02374450|Surveillance study|surveillance study
149583|NCT02374450|Adverse Events of Specific Interest (AESI)|adverse events of specific interest (aesi)
149584|NCT02374450|Children|children
149585|NCT02374450|Infants|infants
149586|NCT02374450|Meningitis|meningitis
149587|NCT02374450|Epidemiology|epidemiology
149588|NCT02374450|Serious Adverse Events (SAE)|serious adverse events (sae)
149589|NCT02374450|Africa|africa
149590|NCT02374398|Tranexamic Acid|tranexamic acid
149591|NCT02374398|Blood Loss|blood loss
149592|NCT02374398|Aquamantys System|aquamantys system
149593|NCT02374398|TKA|tka
149594|NCT02374372|hemodialysis|hemodialysis
149595|NCT02374372|beta microglobulin|beta microglobulin
149596|NCT02374372|amyloidosis|amyloidosis
149597|NCT02374307|Falls|falls
149598|NCT02374307|home-care services|home-care services
149599|NCT02374307|older people|older people
149600|NCT02374307|falls-prevention|falls-prevention
149601|NCT02374281|Newborn|newborn
149602|NCT02374281|Neonatal Screening|neonatal screening
149603|NCT02374281|Autonomic Nervous System|autonomic nervous system
149604|NCT02374281|Pain|pain
149605|NCT02374281|non-nutritive sucking|non-nutritive sucking
149606|NCT02374281|sucrose administration|sucrose administration
149607|NCT02374281|nociceptive action|nociceptive action
149608|NCT02374281|Electro acoustical characteristics of crying|electro acoustical characteristics of crying
149609|NCT02374255|Advanced cancer|advanced cancer
149610|NCT02374255|goals of care|goals of care
149611|NCT02374255|quality of care|quality of care
149612|NCT02374255|end of life discussions|end of life discussions
149613|NCT02374242|Brain|brain
149614|NCT02374242|Metastases|metastases
149615|NCT02374242|Immunotherapy|immunotherapy
149616|NCT02374242|Intracranial response|intracranial response
149617|NCT02374242|Nivolumab|nivolumab
149618|NCT02374242|Ipilimumab|ipilimumab
149619|NCT02374242|Biomarkers|biomarkers
149620|NCT02374242|Immune related response criteria|immune related response criteria
149621|NCT02374229|pulmonary hypertension|pulmonary hypertension
149622|NCT02374229|pulmonary artery denervation|pulmonary artery denervation
149623|NCT02374229|mitral valve disease|mitral valve disease
149624|NCT02374216|Dental Implants|dental implants
149625|NCT02374216|Periodontal Bone Loss|periodontal bone loss
149626|NCT02374216|Implant-Supported Dental Prosthesis|implant-supported dental prosthesis
149627|NCT02374216|Dental Prosthesis Failure|dental prosthesis failure
149628|NCT02374203|Critical Illness|critical illness
149629|NCT02374203|Mechanical ventilator|mechanical ventilator
149630|NCT02374203|Indirect Calorimetry|indirect calorimetry
149631|NCT02374164|Drug therapy|drug therapy
149632|NCT02374151|intrauterine pressure catheter|intrauterine pressure catheter
149633|NCT02374151|electrohysterography|electrohysterography
149634|NCT02374138|psychosocial stress|psychosocial stress
149635|NCT02374099|Breast Cancer|breast cancer
149636|NCT02374099|Her2 -|her2 -
149637|NCT02374099|ER+|er+
149638|NCT02374099|CC-486 (ORAL AZACITIDINE)|cc-486 (oral azacitidine)
149639|NCT02374099|Metastatic Breast Cancer|metastatic breast cancer
149640|NCT02374099|Oralazacitidine|oralazacitidine
149641|NCT02374099|Fulvestrant|fulvestrant
149642|NCT02374099|Epigenetics|epigenetics
149643|NCT02374021|rheumatoid arthritis|rheumatoid arthritis
149644|NCT02374008|Peripheral nerve block|peripheral nerve block
180777|NCT02206776|OCD|ocd
149645|NCT02374008|Total knee Arthroplasty|total knee arthroplasty
149646|NCT02374008|Dexamethasone|dexamethasone
149647|NCT02373995|Graves|graves
149648|NCT02373995|Orbithopaty|orbithopaty
149649|NCT02373995|euthyroidism|euthyroidism
149650|NCT02373995|microbiome|microbiome
149651|NCT02373943|vitamin A|vitamin a
149652|NCT02373943|human|human
149653|NCT02373943|bioavailability|bioavailability
149654|NCT02373943|fortified maize|fortified maize
149655|NCT02373943|cross-over|cross-over
149656|NCT02373943|beta-carotene|beta-carotene
149657|NCT02373930|Dolutegravir|dolutegravir
149658|NCT02373930|safety|safety
149659|NCT02373930|Rilpivirine|rilpivirine
149660|NCT02373930|fixed dose combination|fixed dose combination
149661|NCT02373930|relative bioavailability|relative bioavailability
149662|NCT02373865|Diabetes mellitus type 2|diabetes mellitus type 2
149663|NCT02373865|nocturnal hypoglycemia|nocturnal hypoglycemia
149664|NCT02373865|metformin monotherapy|metformin monotherapy
149665|NCT02373800|Induced|induced
149666|NCT02373800|pre-term labor|pre-term labor
149667|NCT02373787|Resorbable|resorbable
149668|NCT02373787|Collagen membrane|collagen membrane
149669|NCT02373787|NobelReplace CC|nobelreplace cc
149670|NCT02373774|infant|infant
149671|NCT02373774|lumbar puncture|lumbar puncture
149672|NCT02373774|patient safety|patient safety
149673|NCT02373774|ultrasound|ultrasound
149674|NCT02373735|stroke volume variation|stroke volume variation
149675|NCT02373735|radical cystectomy|radical cystectomy
149676|NCT02373735|blood loss|blood loss
149677|NCT02373735|postoperative complications|postoperative complications
149678|NCT02373696|Pain|pain
149679|NCT02373696|Caesarean section|caesarean section
149680|NCT02373670|Positive deviance|positive deviance
149681|NCT02373670|Peer mentors|peer mentors
149682|NCT02373657|trachoma|trachoma
149683|NCT02373657|soil transmitted helminths|soil transmitted helminths
149684|NCT02373657|water|water
149685|NCT02373657|hand washing|hand washing
149686|NCT02373592|Diabetic Neuropathies|diabetic neuropathies
149687|NCT02373592|Thermometry|thermometry
149688|NCT02373592|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
149689|NCT02373592|Foot Ulcer|foot ulcer
149690|NCT02373592|Telemedicine|telemedicine
149691|NCT02373579|omega-3 fatty acids|omega-3 fatty acids
149692|NCT02373579|methotrexate|methotrexate
149693|NCT02373579|hepatotoxicity|hepatotoxicity
149694|NCT02373566|burns|burns
149695|NCT02373566|dermal substitute|dermal substitute
149696|NCT02373566|scar quality|scar quality
149697|NCT02373566|reconstruction|reconstruction
149698|NCT02373566|wound healing|wound healing
149699|NCT02373566|wound closure|wound closure
149700|NCT02373553|posture|posture
149701|NCT02373553|postural|postural
149702|NCT02373553|kinetics|kinetics
149703|NCT02373540|spinal cord stimulation|spinal cord stimulation
149704|NCT02373540|chronic pain|chronic pain
149901|NCT02372461|Amoxicillin|amoxicillin
149705|NCT02373540|failed back surgery syndrome|failed back surgery syndrome
149706|NCT02373501|caesarean delivery|caesarean delivery
149707|NCT02373501|uterine incision repair|uterine incision repair
149708|NCT02373488|Constipation|constipation
149709|NCT02373488|connective tissue manipulation|connective tissue manipulation
149710|NCT02373488|abdominal massage|abdominal massage
149711|NCT02373488|bowel movements|bowel movements
149712|NCT02373488|quality of life|quality of life
149713|NCT02373475|spine surgery|spine surgery
149714|NCT02373475|prone position|prone position
149715|NCT02373475|intraoperative lung protective strategies|intraoperative lung protective strategies
149716|NCT02373475|postoperative pulmonary complications|postoperative pulmonary complications
149717|NCT02373449|Ketamine|ketamine
149719|NCT02373449|refractory neuropathic pain|refractory neuropathic pain
149720|NCT02373436|Upper Extremity|upper extremity
149721|NCT02373436|Rehabilitation|rehabilitation
149722|NCT02373397|Wound healing|wound healing
149723|NCT02373397|nerve regeneration|nerve regeneration
149724|NCT02373397|re-epithelialization|re-epithelialization
149725|NCT02373397|corneal epithelium|corneal epithelium
149726|NCT02373397|laser corneal surgery|laser corneal surgery
149727|NCT02373384|Radiolucent renal stones|radiolucent renal stones
149728|NCT02373384|Oral dissolution therapy|oral dissolution therapy
149729|NCT02373384|Systemic chemolysis|systemic chemolysis
149730|NCT02373384|Renal uric acid stones|renal uric acid stones
149731|NCT02373384|Alkalinization|alkalinization
149732|NCT02373358|Complex trauma|complex trauma
149733|NCT02373358|Yoga|yoga
149734|NCT02373345|psychological factors|psychological factors
149735|NCT02373345|functional disability|functional disability
149736|NCT02373345|pain thresholds|pain thresholds
149737|NCT02373345|tolerance thresholds|tolerance thresholds
149738|NCT02373345|motor adaptations|motor adaptations
149739|NCT02373345|natural course|natural course
149740|NCT02373332|platelets|platelets
149741|NCT02373332|12-lipoxygenase|12-lipoxygenase
149742|NCT02373332|fatty acids|fatty acids
149743|NCT02373332|DGLA|dgla
149744|NCT02373332|DHA|dha
140541|NCT02424344|COPD|copd
149745|NCT02373332|EPA|epa
149746|NCT02373332|12-LOX|12-lox
149747|NCT02373319|Cardiovascular risk|cardiovascular risk
149748|NCT02373319|Cholesterol|cholesterol
149749|NCT02373319|Hypertension|hypertension
149750|NCT02373319|Diabetes|diabetes
149751|NCT02373319|Smoking|smoking
149752|NCT02373319|Preventive Medicine|preventive medicine
149753|NCT02373319|Epidemiology|epidemiology
149754|NCT02373319|Public Health|public health
149755|NCT02373319|Diet|diet
149756|NCT02373319|Physical Activity|physical activity
149757|NCT02373306|Risk stratification|risk stratification
149758|NCT02373306|ICD intervention|icd intervention
149759|NCT02373306|occurrence during one-year follow-up after NIPS|occurrence during one-year follow-up after nips
149760|NCT02373293|Acute pancreatitis|acute pancreatitis
149761|NCT02373280|Helicobacter pylori|helicobacter pylori
149762|NCT02373280|tailored therapy|tailored therapy
149763|NCT02373280|eradication|eradication
149764|NCT02373241|Anemia, Sickle Cell|anemia, sickle cell
149765|NCT02373241|Sickle Cell Disease|sickle cell disease
149766|NCT02373241|Kidney Disease|kidney disease
149770|NCT02373241|Antihypertensive Agents|antihypertensive agents
149771|NCT02373241|Blood Pressure|blood pressure
149772|NCT02373111|Anti-aging|anti-aging
149773|NCT02373111|Isoflavones|isoflavones
149774|NCT02373111|Astaxanthine|astaxanthine
149775|NCT02373111|Skin aging|skin aging
149776|NCT02373098|Fingolimod,cytokine,chemokine,RRMS|fingolimod,cytokine,chemokine,rrms
149777|NCT02373085|Asymptomatic Bacteriuria|asymptomatic bacteriuria
149778|NCT02373085|Kidney transplant recipients|kidney transplant recipients
149779|NCT02373085|Pyelonephritis|pyelonephritis
149780|NCT02373072|Pakinson's Disease, Movement Disorders|pakinson's disease, movement disorders
149781|NCT02373033|Folate|folate
149782|NCT02373033|folic acid|folic acid
149783|NCT02373033|intervention trial|intervention trial
149784|NCT02373033|folate status|folate status
149785|NCT02373033|women in childbearing age|women in childbearing age
149786|NCT02373033|food folate|food folate
149787|NCT02372994|chronic disease|chronic disease
149788|NCT02372994|continuity of patient care|continuity of patient care
149789|NCT02372994|patient engagement|patient engagement
149790|NCT02372994|cost effectiveness analysis|cost effectiveness analysis
149791|NCT02372994|user-centred design|user-centred design
149792|NCT02372994|Interdisciplinary Health Team|interdisciplinary health team
149793|NCT02372994|Medical Informatics|medical informatics
149794|NCT02372994|Patient-centred care|patient-centred care
149795|NCT02372942|efficacy|efficacy
149796|NCT02372942|prevention|prevention
149797|NCT02372890|Otorhinolaryngeal Neoplasms|otorhinolaryngeal neoplasms
149798|NCT02372890|Cancer of Head and Neck|cancer of head and neck
149799|NCT02372890|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
149800|NCT02372890|Positron Emission Tomography|positron emission tomography
149801|NCT02372890|PET/CT|pet/ct
149802|NCT02372890|FDG|fdg
149803|NCT02372877|Sickle Cell Disease|sickle cell disease
149804|NCT02372877|Hemoglobin (Hb) S Disease|hemoglobin (hb) s disease
149805|NCT02372877|Hb S Disease|hb s disease
149806|NCT02372877|Congenital Hemolytic Anemia|congenital hemolytic anemia
149807|NCT02372864|Ovariectomy|ovariectomy
149808|NCT02372864|Mindfulness|mindfulness
149809|NCT02372864|Postmenopause|postmenopause
149810|NCT02372864|Hot Flashes|hot flashes
149812|NCT02372851|Household water treatment|household water treatment
149813|NCT02372851|Point of use water treatment|point of use water treatment
149814|NCT02372851|Water Quality|water quality
149815|NCT02372851|Total Urinary Arsenic|total urinary arsenic
149816|NCT02372851|West Bengal|west bengal
149817|NCT02372851|Thermotolerant coliforms|thermotolerant coliforms
149818|NCT02372851|Compliance|compliance
149819|NCT02372851|Diarrhoea|diarrhoea
149820|NCT02372825|Free iliac crest transfer|free iliac crest transfer
149821|NCT02372825|Bone reconstruction|bone reconstruction
149822|NCT02372825|Ankle reconstruction|ankle reconstruction
149823|NCT02372825|Heel reconstruction|heel reconstruction
149824|NCT02372812|effect of dexamethasone|effect of dexamethasone
149825|NCT02372812|general surgery|general surgery
149826|NCT02372812|post operative|post operative
149827|NCT02372786|7% lidocaine / 7% tetracaine cream|7% lidocaine / 7% tetracaine cream
149828|NCT02372786|2,5% lidocaine / 2,5% prilocaine cream|2,5% lidocaine / 2,5% prilocaine cream
149829|NCT02372773|Frontotemporal Dementia|frontotemporal dementia
149830|NCT02372773|MAPT|mapt
149831|NCT02372773|PGRN|pgrn
149832|NCT02372773|C9ORF72|c9orf72
149833|NCT02372760|Bronchoscopic anesthesia lidocaine|bronchoscopic anesthesia lidocaine
149834|NCT02372760|Spray Catheter|spray catheter
149835|NCT02372760|brochoalveolar lavage|brochoalveolar lavage
149836|NCT02372747|Totally laparoscopic gastrectomy|totally laparoscopic gastrectomy
149837|NCT02372747|laparoscopic distal gastrectomy|laparoscopic distal gastrectomy
149838|NCT02372747|Intracorporeal anastomosis|intracorporeal anastomosis
149839|NCT02372747|Delta-Shaped Anastomosis|delta-shaped anastomosis
149840|NCT02372747|Billroth II Anastomosis|billroth ii anastomosis
149841|NCT02372747|Gastric cancer|gastric cancer
149842|NCT02372721|acute kidney injury|acute kidney injury
149843|NCT02372656|Simvastatin, Metformin, Chronic periodontitis|simvastatin, metformin, chronic periodontitis
149844|NCT02372643|clitoris|clitoris
149845|NCT02372643|sexuality|sexuality
149846|NCT02372643|vascularization|vascularization
149847|NCT02372643|doppler|doppler
149848|NCT02372643|ultrasound|ultrasound
149849|NCT02372643|reference|reference
149850|NCT02372643|female|female
149851|NCT02372643|Pilot Projects|pilot projects
149852|NCT02372643|Vagina/ultrasonography|vagina/ultrasonography
149853|NCT02372643|Urethra/ultrasonography|urethra/ultrasonography
149854|NCT02372643|Regional Blood Flow/physiology|regional blood flow/physiology
149855|NCT02372643|Arteries/ultrasonography|arteries/ultrasonography
149856|NCT02372643|Clitoris/ultrasonography|clitoris/ultrasonography
149857|NCT02372643|Reference values|reference values
149858|NCT02372643|Clitoris/blood supply|clitoris/blood supply
149859|NCT02372617|cerebral palsy|cerebral palsy
149860|NCT02372617|hip|hip
149861|NCT02372617|luxation|luxation
149862|NCT02372617|subluxation|subluxation
149863|NCT02372604|Chronic spontaneous urticaria|chronic spontaneous urticaria
149864|NCT02372604|Levocetirizine|levocetirizine
149865|NCT02372604|H1-antihistamine|h1-antihistamine
149866|NCT02372604|Fourfold dosage|fourfold dosage
149867|NCT02372604|Efficacy|efficacy
149868|NCT02372604|Tolerance|tolerance
149869|NCT02372604|UAS7 (Urticaria activity score)|uas7 (urticaria activity score)
149870|NCT02372604|resistant|resistant
149871|NCT02372591|Quantitative Sensory Testing|quantitative sensory testing
149872|NCT02372591|Hydromorphone|hydromorphone
149873|NCT02372591|Buprenorphine|buprenorphine
149874|NCT02372578|Painful diabetic peripheral neuropathy (PDPN)|painful diabetic peripheral neuropathy (pdpn)
149875|NCT02372578|ASP3662|asp3662
149876|NCT02372565|African American|african american
149877|NCT02372565|Women|women
149878|NCT02372565|Physical Activity|physical activity
149879|NCT02372565|Social Media|social media
149880|NCT02372565|Exercise|exercise
149881|NCT02372565|Facebook|facebook
149882|NCT02372565|Text message|text message
149883|NCT02372539|dexamethasone|dexamethasone
149884|NCT02372526|Glucagon-like Peptide-1|glucagon-like peptide-1
149885|NCT02372526|Glucose-dependent insulinotropic peptide|glucose-dependent insulinotropic peptide
149886|NCT02372526|Glucagon|glucagon
149887|NCT02372526|Peptide YY 3-36|peptide yy 3-36
149888|NCT02372526|Ghrelin|ghrelin
149889|NCT02372526|Body Weight|body weight
149890|NCT02372526|Obesity|obesity
149891|NCT02372526|Overnutrition|overnutrition
149892|NCT02372526|Overweight|overweight
149893|NCT02372526|Gastrointestinal Agents|gastrointestinal agents
149894|NCT02372526|GLP-1 secretagogue|glp-1 secretagogue
149895|NCT02372513|Cholesteryl Ester Storage Disease|cholesteryl ester storage disease
149896|NCT02372513|Children|children
149897|NCT02372513|Liver disease|liver disease
149898|NCT02372474|POF|pof
149899|NCT02372474|ESS|ess
149900|NCT02372474|stem cell therapy|stem cell therapy
149902|NCT02372461|Placebo|placebo
149903|NCT02372435|PJI|pji
149904|NCT02372422|Twins|twins
149905|NCT02372422|Twin gestation|twin gestation
149906|NCT02372422|Preterm birth|preterm birth
149907|NCT02372422|Prevention|prevention
149908|NCT02372396|PTSD|ptsd
149909|NCT02372396|Psychotherapy|psychotherapy
149910|NCT02372396|OEF/OIF|oef/oif
149911|NCT02372396|Veterans|veterans
149912|NCT02372383|Cystic Fibrosis|cystic fibrosis
149913|NCT02372383|Pharmacokinetics|pharmacokinetics
149914|NCT02372383|Pharmacodynamics|pharmacodynamics
149915|NCT02372383|Nontuberculous Mycobacteria|nontuberculous mycobacteria
149916|NCT02372383|Treatment|treatment
149917|NCT02372357|chemotherapy|chemotherapy
149918|NCT02372357|stem cell transplantation|stem cell transplantation
149919|NCT02372344|the effect of food timing on PK|the effect of food timing on pk
149920|NCT02372344|the effect of food timing on Safety and Tolerability|the effect of food timing on safety and tolerability
149921|NCT02372344|AZD0585|azd0585
149922|NCT02372344|Japanese|japanese
149923|NCT02372331|pancreaticoduodenectomy|pancreaticoduodenectomy
149924|NCT02372331|ERAS|eras
149925|NCT02372331|Whipple's operation|whipple's operation
149926|NCT02372331|Fast track|fast track
149927|NCT02372318|opiod receptor modulator nalmefene|opiod receptor modulator nalmefene
149928|NCT02372318|cue-reactivity|cue-reactivity
149929|NCT02372318|fMRI|fmri
149930|NCT02372318|resting-state networks|resting-state networks
149931|NCT02372292|cardiorenal syndrome, decompensated heart failure, renal resistivity index, venous impedance index, kidney failure|cardiorenal syndrome, decompensated heart failure, renal resistivity index, venous impedance index, kidney failure
149932|NCT02372279|Embryo development|embryo development
149933|NCT02372279|Implantation|implantation
149934|NCT02372279|In vitro fertilization|in vitro fertilization
149935|NCT02372266|Infant, Newborn|infant, newborn
149936|NCT02372266|hospital discharge|hospital discharge
149937|NCT02372266|Early newborn discharge|early newborn discharge
149938|NCT02372266|Newborn length of stay|newborn length of stay
149939|NCT02372266|Maternity length of stay|maternity length of stay
149940|NCT02372253|verapamil|verapamil
149941|NCT02372253|type 1 diabetes|type 1 diabetes
149942|NCT02372253|diabetes|diabetes
149943|NCT02372253|beta cells|beta cells
149944|NCT02372253|beta cell function|beta cell function
149945|NCT02372253|insulin|insulin
149946|NCT02372214|Endovascular Procedures|endovascular procedures
149947|NCT02372214|3D printing|3d printing
149948|NCT02372214|Simulation|simulation
149949|NCT02372214|Training|training
149950|NCT02372214|Learning curve|learning curve
149951|NCT02372214|Education|education
149952|NCT02372201|irritable bowel disease|irritable bowel disease
149953|NCT02372201|microbiota|microbiota
149954|NCT02372201|hydro colon therapy|hydro colon therapy
149955|NCT02372201|food intolerance|food intolerance
149956|NCT02372175|Dengue|dengue
149957|NCT02372162|Hepatocellular Carcinoma|hepatocellular carcinoma
149958|NCT02372162|Molecular Diagnostics|molecular diagnostics
149959|NCT02372162|Sorafenib|sorafenib
149960|NCT02372162|Therapeutic chemoembolization|therapeutic chemoembolization
149961|NCT02372162|Next-generation sequencing|next-generation sequencing
149962|NCT02372162|Sequence analysis, DNA|sequence analysis, dna
149963|NCT02372162|Sequence analysis, RNA|sequence analysis, rna
149964|NCT02372162|Metabolomics|metabolomics
149965|NCT02372123|Dysmenorrhea|dysmenorrhea
149966|NCT02372123|Primary dysmenorrhea|primary dysmenorrhea
149967|NCT02372123|physiotherapy|physiotherapy
149968|NCT02372123|massage|massage
149969|NCT02372123|connective tissue massage|connective tissue massage
149970|NCT02372123|connective tissue manipulation|connective tissue manipulation
149971|NCT02372084|Hepatic impairment,|hepatic impairment,
149972|NCT02372084|osilodrostat,|osilodrostat,
149973|NCT02372084|LCI699|lci699
149974|NCT02372032|Herniation|herniation
149975|NCT02372032|Discectomy|discectomy
149976|NCT02372032|Ozone|ozone
149977|NCT02372019|Social Anxiety Disorder|social anxiety disorder
149978|NCT02372019|Social Phobia|social phobia
149979|NCT02372019|Reconsolidation|reconsolidation
149980|NCT02372019|Cognitive Bias Modification|cognitive bias modification
149981|NCT02372019|Interpretation Bias|interpretation bias
149982|NCT02371980|Drug therapy|drug therapy
149983|NCT02371928|Shoulder|shoulder
149984|NCT02371928|Instability|instability
149985|NCT02371928|Neuromuscular|neuromuscular
149986|NCT02371928|Physiotherapy|physiotherapy
149987|NCT02371928|Exercise|exercise
149988|NCT02371928|Dislocation|dislocation
149989|NCT02371928|Recurrence|recurrence
149990|NCT02371915|Rural access|rural access
149991|NCT02371915|Telehealth|telehealth
149992|NCT02371902|Elbow pain|elbow pain
149993|NCT02371902|lateral epicondylitis|lateral epicondylitis
149994|NCT02371902|conservative treatment|conservative treatment
149995|NCT02371902|shock wave treatment|shock wave treatment
149996|NCT02371902|therapeutic ultrasound|therapeutic ultrasound
149997|NCT02371850|Bioequivalence|bioequivalence
149998|NCT02371850|Therapeutic Equivalency|therapeutic equivalency
149999|NCT02371824|Magnetic Resonance Imaging|magnetic resonance imaging
150000|NCT02371824|Bone Marrow|bone marrow
150001|NCT02371824|Hip|hip
150002|NCT02371824|Lumbar Vertebrae|lumbar vertebrae
150003|NCT02371785|Peripheral Arterial Disease|peripheral arterial disease
150004|NCT02371785|Critical Limb Ischemia|critical limb ischemia
150005|NCT02371785|Claudication|claudication
150006|NCT02371785|Percutaneous Vascular Intervention|percutaneous vascular intervention
150007|NCT02371785|Peripheral Vascular Intervention|peripheral vascular intervention
150008|NCT02371772|Warfarin|warfarin
150009|NCT02371772|Self Care|self care
150010|NCT02371772|Conventional care|conventional care
150011|NCT02371733|pulmonary arterial hypertension|pulmonary arterial hypertension
150012|NCT02371733|aerobic exercise training|aerobic exercise training
150013|NCT02371733|upper extremity|upper extremity
150014|NCT02371733|exercise capacity|exercise capacity
150022|NCT02371681|Time to Positivity/TTP|time to positivity/ttp
150023|NCT02371681|FDG-PET/CT|fdg-pet/ct
150024|NCT02371668|Influenza A|influenza a
150025|NCT02371668|H1N1|h1n1
150026|NCT02371668|Challenge Model|challenge model
150027|NCT02371668|Human Immunoglobulin and H1N1|human immunoglobulin and h1n1
150028|NCT02371668|Efficacy and Safety in H1N1|efficacy and safety in h1n1
150029|NCT02371655|Bowel cleansing|bowel cleansing
150030|NCT02371655|CTcolonography|ctcolonography
150031|NCT02371655|Bowel preparation|bowel preparation
150032|NCT02371655|Faecal and fluid tagging|faecal and fluid tagging
150033|NCT02371642|Echocardiography|echocardiography
150034|NCT02371629|Anticholinergic|anticholinergic
150035|NCT02371629|Antimuscarinic|antimuscarinic
150036|NCT02371629|Chronic Obstructive Airway Disease|chronic obstructive airway disease
150037|NCT02371629|Chronic Obstructive Lung Disease|chronic obstructive lung disease
150038|NCT02371629|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
150039|NCT02371629|COPD|copd
150040|NCT02371629|LAMA|lama
150041|NCT02371629|Lung Disease|lung disease
150042|NCT02371629|Lung Diseases, Obstructive|lung diseases, obstructive
150043|NCT02371629|Lung Function|lung function
150044|NCT02371629|Muscarinic receptor antagonist|muscarinic receptor antagonist
150045|NCT02371629|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
150046|NCT02371629|Respiratory Tract Diseases|respiratory tract diseases
150047|NCT02371603|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
150048|NCT02371603|GSK1278863|gsk1278863
150049|NCT02371603|Anemia|anemia
150050|NCT02371603|Drug interaction|drug interaction
150051|NCT02371590|cancer|cancer
150052|NCT02371590|lenalidomide|lenalidomide
150053|NCT02371590|obinutuzumab|obinutuzumab
150054|NCT02371590|CLL|cll
150055|NCT02371577|Revlimid|revlimid
150056|NCT02371551|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
150057|NCT02371551|Medical Sonography|medical sonography
150058|NCT02371551|Computed Tomography, X-Ray|computed tomography, x-ray
150059|NCT02371538|stem cell transplant|stem cell transplant
150060|NCT02371538|human breastmilk|human breastmilk
150061|NCT02371525|adherence|adherence
150062|NCT02371525|prevention|prevention
150063|NCT02371512|Mitral Valve Insufficiency|mitral valve insufficiency
150064|NCT02371499|Irritable Bowel Syndrome|irritable bowel syndrome
150065|NCT02371499|Lactobacillus casei dg|lactobacillus casei dg
150066|NCT02371499|microbiota|microbiota
150067|NCT02371486|cesarean section defect|cesarean section defect
150068|NCT02371486|implantation|implantation
150070|NCT02371473|Acetazolamide|acetazolamide
150071|NCT02371473|Central Sleep Apnea|central sleep apnea
150072|NCT02371473|Opium Abuse|opium abuse
150073|NCT02371460|Neonatal Prematurity|neonatal prematurity
150074|NCT02371460|Omega-3 Fatty Acids|omega-3 fatty acids
150075|NCT02371460|Breastfeeding|breastfeeding
150076|NCT02371447|bladder cancer|bladder cancer
150077|NCT02371447|recurrent non-muscle invasive bladder cancer|recurrent non-muscle invasive bladder cancer
150078|NCT02371447|VPM1002BC|vpm1002bc
150079|NCT02371447|BCG therapy|bcg therapy
150085|NCT02371330|Thrombocytopenia|thrombocytopenia
150086|NCT02371330|Neonate|neonate
150087|NCT02371330|PFA-100|pfa-100
150088|NCT02371330|Neo-BAT|neo-bat
150089|NCT02371330|Hemorrhage|hemorrhage
150090|NCT02371317|Randomized clinical trial|randomized clinical trial
150091|NCT02371317|Early medical intervention|early medical intervention
150092|NCT02371317|Intervention studies|intervention studies
150093|NCT02371317|Blood pressure|blood pressure
150094|NCT02371317|Stress Management|stress management
150095|NCT02371304|local therapy|local therapy
150096|NCT02371304|adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
150097|NCT02371304|rectal preserving|rectal preserving
150098|NCT02371291|Memory Flexibility|memory flexibility
150099|NCT02371278|Leucine|leucine
150100|NCT02371278|Protein|protein
150101|NCT02371278|Diet|diet
150102|NCT02371278|Muscle protein synthesis|muscle protein synthesis
150103|NCT02371265|HIV|hiv
150104|NCT02371265|Mozambique|mozambique
150105|NCT02371265|antenatal care|antenatal care
150106|NCT02371265|adherence|adherence
150107|NCT02371265|retention|retention
150108|NCT02371265|pregnancy|pregnancy
150109|NCT02371265|HIV-positive mothers retained in ART after 90 days|hiv-positive mothers retained in art after 90 days
658990|NCT00806312|MiRNA|mirna
150110|NCT02371252|Osteoporosis|osteoporosis
150111|NCT02371252|Bisphosphonates|bisphosphonates
150112|NCT02371252|Alendronate|alendronate
150113|NCT02371252|Bone mineral density|bone mineral density
150114|NCT02371252|Bone markers|bone markers
150115|NCT02371239|Glucose regulation|glucose regulation
150116|NCT02371239|Glucose|glucose
150117|NCT02371239|Lipids|lipids
150118|NCT02371226|MPS I|mps i
150119|NCT02371213|Social Networking|social networking
150120|NCT02371213|Mobile phone|mobile phone
150121|NCT02371213|Antenatal Care|antenatal care
150122|NCT02371213|Health education|health education
150123|NCT02371213|Maternal outcome|maternal outcome
150124|NCT02371213|Neonatal outcome|neonatal outcome
150125|NCT02371174|HER2-Negative Inoperable or Recurrent Breast Cancer|her2-negative inoperable or recurrent breast cancer
150126|NCT02371174|Japan|japan
150127|NCT02371174|Eribulin Mesylate|eribulin mesylate
150128|NCT02371135|Gut Microbiome|gut microbiome
150129|NCT02371135|15-016|15-016
150130|NCT02371083|Pelvic organ prolapse managed by vaginal pessary|pelvic organ prolapse managed by vaginal pessary
150131|NCT02370979|Dolutegravir|dolutegravir
150132|NCT02370979|Proviral HIV-1 DNA|proviral hiv-1 dna
150133|NCT02370979|Reservoir|reservoir
150134|NCT02370953|Toric IOL alignment|toric iol alignment
150135|NCT02370953|VERION digital marker|verion digital marker
150136|NCT02370953|Manual ink-marking|manual ink-marking
150137|NCT02370953|Randomized controlled trial|randomized controlled trial
150138|NCT02370940|Iron bioavailability|iron bioavailability
150139|NCT02370940|phytate|phytate
150140|NCT02370940|serum iron curve|serum iron curve
150141|NCT02370940|hepcidin|hepcidin
150142|NCT02370940|iron status|iron status
150143|NCT02370914|Concussion|concussion
150144|NCT02370888|Lenalidomide|lenalidomide
150145|NCT02370888|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
150146|NCT02370888|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
150147|NCT02370862|Spinal Cord Injury|spinal cord injury
150148|NCT02370862|Neurogenic Bowel|neurogenic bowel
150149|NCT02370862|Bowel Evacuation|bowel evacuation
150150|NCT02370862|Gut Motility|gut motility
150151|NCT02370849|nimotuzumab|nimotuzumab
150152|NCT02370849|gastric adenocarcinoma|gastric adenocarcinoma
150153|NCT02370849|Cisplatin|cisplatin
150154|NCT02370849|S-1|s-1
150155|NCT02370849|epidermal growth factor receptor|epidermal growth factor receptor
150156|NCT02370836|distress|distress
150157|NCT02370823|Osteoarthritis|osteoarthritis
150158|NCT02370823|Knee|knee
150159|NCT02370810|tinnitus treatment, internet-intervention, CBT|tinnitus treatment, internet-intervention, cbt
150160|NCT02370797|IOERT|ioert
150161|NCT02370797|Radiation|radiation
150162|NCT02370797|Single fraction|single fraction
150163|NCT02370797|Lumpectomy|lumpectomy
150164|NCT02370797|Radiation therapy|radiation therapy
150165|NCT02370797|Avera|avera
150166|NCT02370784|early diffuse scleroderma|early diffuse scleroderma
150167|NCT02370784|Raynaud|raynaud
150168|NCT02370758|Quantiferon-CMV|quantiferon-cmv
150169|NCT02370758|Quantiferon-Monitor|quantiferon-monitor
150170|NCT02370758|Solid Organ Transplants|solid organ transplants
150171|NCT02370758|CMV Disease|cmv disease
150172|NCT02370745|Incretin|incretin
150173|NCT02370745|GLP-1|glp-1
150174|NCT02370745|Skeletal muscle metabolism|skeletal muscle metabolism
150175|NCT02370745|Microvascular recruitment|microvascular recruitment
150176|NCT02370745|Amino Acids|amino acids
150177|NCT02370745|Microvascular blood flow|microvascular blood flow
150178|NCT02370732|Alcohol|alcohol
150179|NCT02370732|Bariatric Surgery|bariatric surgery
150180|NCT02370732|Roux en Y Gastric bypass|roux en y gastric bypass
150181|NCT02370732|Alcohol impairment|alcohol impairment
150182|NCT02370732|Alcohol reinforcement|alcohol reinforcement
150183|NCT02370732|Alcohol pharmacokinetics|alcohol pharmacokinetics
150184|NCT02370719|Diabetes mellitus|diabetes mellitus
150185|NCT02370719|Randomized controlled trial|randomized controlled trial
150186|NCT02370719|Primary care|primary care
150187|NCT02370719|Physical activity|physical activity
150188|NCT02370719|Lifestyle|lifestyle
150189|NCT02370719|Blood glucose|blood glucose
150190|NCT02370719|Mobile health|mobile health
150191|NCT02370719|Hb A1c|hb a1c
150192|NCT02370719|Self-management|self-management
150193|NCT02370706|PIM447|pim447
150194|NCT02370706|LGH447|lgh447
150195|NCT02370706|PIM inhibitor|pim inhibitor
150196|NCT02370706|LEE011|lee011
150197|NCT02370706|CDK 4/6 inhibitor|cdk 4/6 inhibitor
150198|NCT02370706|ruxolitinib|ruxolitinib
150199|NCT02370706|INC424|inc424
150200|NCT02370706|Jakavi®|jakavi®
150201|NCT02370706|Jakafi®|jakafi®
150202|NCT02370706|INCB18424|incb18424
150203|NCT02370706|JAK inhibitor|jak inhibitor
150204|NCT02370706|myelofibrosis|myelofibrosis
150205|NCT02370706|PMF|pmf
150206|NCT02370706|PPV-MF|ppv-mf
150207|NCT02370706|PET-MF|pet-mf
150208|NCT02370693|mycophenolate|mycophenolate
150209|NCT02370693|lung scarring|lung scarring
150210|NCT02370680|Antiplatelet|antiplatelet
660335|NCT00811200|kenalog|kenalog
150211|NCT02370680|Antiplatelet therapy|antiplatelet therapy
150212|NCT02370680|platelet turnover|platelet turnover
150213|NCT02370680|high platelet turnover|high platelet turnover
150214|NCT02370680|platelet aggregation|platelet aggregation
150215|NCT02370680|cardiovascular disease|cardiovascular disease
150216|NCT02370680|coronary artery disease|coronary artery disease
150217|NCT02370680|diabetes mellitus|diabetes mellitus
150218|NCT02370667|Exercise|exercise
150219|NCT02370667|Magnetic Resonance Imaging|magnetic resonance imaging
150220|NCT02370654|COPD|copd
150221|NCT02370654|Tai chi|tai chi
150222|NCT02370654|Pulmonary rehabilitation|pulmonary rehabilitation
150223|NCT02370641|urolithin A|urolithin a
150224|NCT02370641|microflora|microflora
150225|NCT02370628|percutaneous vertebroplasty|percutaneous vertebroplasty
150226|NCT02370628|facet block|facet block
150227|NCT02370602|Drug therapy|drug therapy
150228|NCT02370589|Ebola|ebola
150229|NCT02370537|omega-3 carboxylic acid|omega-3 carboxylic acid
150230|NCT02370498|Gastric cancer|gastric cancer
150231|NCT02370498|Gastroesophageal junction cancer|gastroesophageal junction cancer
150232|NCT02370498|PD1|pd1
150233|NCT02370498|PD-1|pd-1
150234|NCT02370498|PDL1|pdl1
150235|NCT02370498|PD-L1|pd-l1
150236|NCT02370472|Ultrasound|ultrasound
150237|NCT02370472|Image|image
150238|NCT02370472|Learning Tool|learning tool
150239|NCT02370472|Ultrasound Guide Procedures|ultrasound guide procedures
150240|NCT02370472|Simulated Setting|simulated setting
150241|NCT02370459|Papillomavirus Vaccines|papillomavirus vaccines
150242|NCT02370459|Immunization|immunization
150243|NCT02370459|Quality Improvement|quality improvement
150244|NCT02370459|Adolescent Health Services|adolescent health services
150245|NCT02370446|Medication Log|medication log
150246|NCT02370446|15-008|15-008
150247|NCT02370433|Spinal Cord Injury|spinal cord injury
150248|NCT02370433|Neurogenic Bowel|neurogenic bowel
150249|NCT02370433|Bowel Evacuation|bowel evacuation
150250|NCT02370420|Platelet-rich plasma|platelet-rich plasma
150251|NCT02370420|Osteoarthritis|osteoarthritis
150252|NCT02370407|surgical education|surgical education
150253|NCT02370407|minimally invasive surgical procedures|minimally invasive surgical procedures
150254|NCT02370407|laparoscopic simulation|laparoscopic simulation
150255|NCT02370407|robotic simulation|robotic simulation
150256|NCT02370407|medical education|medical education
150257|NCT02370394|Intimate Partner Violence|intimate partner violence
150258|NCT02370394|Perinatal Women|perinatal women
150259|NCT02370394|Mental Health|mental health
150260|NCT02370316|metacognition|metacognition
150261|NCT02370316|MRI|mri
150262|NCT02370316|Psychotherapy|psychotherapy
150263|NCT02370251|Fat Emulsions, Intravenous|fat emulsions, intravenous
150469|NCT02369029|NSCLC|nsclc
150264|NCT02370251|Parenteral-Nutrition-Associated Liver Disease|parenteral-nutrition-associated liver disease
150265|NCT02370251|Cholestasis|cholestasis
150266|NCT02370251|Omegaven|omegaven
150267|NCT02370251|Fish Oil|fish oil
150268|NCT02370238|Triple negative metastatic breast cancer|triple negative metastatic breast cancer
150269|NCT02370238|Cancer Stem Cells|cancer stem cells
150270|NCT02370225|sjogren's syndrome|sjogren's syndrome
150271|NCT02370225|aerobic exercise|aerobic exercise
150272|NCT02370225|fatigue|fatigue
150273|NCT02370212|Creatine|creatine
150275|NCT02370212|effects on performance|effects on performance
150276|NCT02370173|PTSD|ptsd
150277|NCT02370173|Stress|stress
150278|NCT02370173|Sleep Problems|sleep problems
150279|NCT02370173|Brain imaging|brain imaging
150280|NCT02370173|fMRI|fmri
150281|NCT02370147|smoking reduction intervention|smoking reduction intervention
150282|NCT02370147|no intention to quit|no intention to quit
150283|NCT02370147|randomized controlled trial|randomized controlled trial
150284|NCT02370147|telephone follow-up intervention|telephone follow-up intervention
150285|NCT02370121|Gymnema Sylvestre|gymnema sylvestre
150286|NCT02370121|Insulin Secretion|insulin secretion
150287|NCT02370121|Insulin Sensitivity|insulin sensitivity
150288|NCT02370121|Central Obesity|central obesity
150289|NCT02370108|electrical muscle stimulation|electrical muscle stimulation
150290|NCT02370108|parkinson's disease|parkinson's disease
150291|NCT02370108|rest tremor|rest tremor
150292|NCT02370108|tremor reduction|tremor reduction
150293|NCT02370095|ARDS|ards
150294|NCT02370095|Acute Lung Injury|acute lung injury
150295|NCT02370095|Acute Respiratory Failure|acute respiratory failure
150296|NCT02370082|lumpectomy|lumpectomy
150297|NCT02370082|breast conserving surgery|breast conserving surgery
150298|NCT02370030|sepsis|sepsis
150299|NCT02370030|citrulline|citrulline
150300|NCT02370030|endothelial|endothelial
150303|NCT02370030|with vs without citrulline|with vs without citrulline
150304|NCT02370017|Autologous Ex vivo-expanded NK cell enriched lymphocytes|autologous ex vivo-expanded nk cell enriched lymphocytes
150305|NCT02370004|Asthma|asthma
150306|NCT02370004|RFST|rfst
150307|NCT02370004|Bronchial Diseases|bronchial diseases
150308|NCT02370004|Respiratory Tract Diseases|respiratory tract diseases
150309|NCT02370004|Lung Diseases, Obstructive|lung diseases, obstructive
150310|NCT02370004|Lung Diseases|lung diseases
150311|NCT02369991|latissimus dorsi flap|latissimus dorsi flap
150312|NCT02369991|bone transport|bone transport
150313|NCT02369991|bone reconstruction|bone reconstruction
150314|NCT02369991|tibia|tibia
150315|NCT02369991|tibial fracture|tibial fracture
150316|NCT02369978|Trypanocidal therapy|trypanocidal therapy
150317|NCT02369978|Benznidazole|benznidazole
150318|NCT02369978|Nifurtimox|nifurtimox
150319|NCT02369978|Polymerase chain reaction|polymerase chain reaction
150320|NCT02369978|Randomized trial|randomized trial
150321|NCT02369965|HIV-1|hiv-1
150322|NCT02369965|AIDS|aids
150323|NCT02369965|Albuvirtide|albuvirtide
150324|NCT02369965|Treatment-experienced|treatment-experienced
150325|NCT02369965|Fusion inhibitor|fusion inhibitor
150326|NCT02369939|anal carcinoma|anal carcinoma
150327|NCT02369939|hyperthermia|hyperthermia
150328|NCT02369939|radiotherapy|radiotherapy
150329|NCT02369939|chemotherapy|chemotherapy
150330|NCT02369939|radiochemotherapy|radiochemotherapy
150331|NCT02369926|multiple sclerosis|multiple sclerosis
150332|NCT02369926|telemedicine|telemedicine
150333|NCT02369926|remote monitoring|remote monitoring
150334|NCT02369926|lisinopril|lisinopril
150335|NCT02369900|Esmolol|esmolol
150336|NCT02369900|Septic Shock|septic shock
150337|NCT02369900|Hypotension|hypotension
150338|NCT02369900|Tachycardia|tachycardia
150339|NCT02369887|MSM/TG who agree to start PrEP|msm/tg who agree to start prep
150340|NCT02369874|Head and Neck cancer; MEDI4736; Tremelimumab|head and neck cancer; medi4736; tremelimumab
150341|NCT02369822|Vitamin C|vitamin c
150342|NCT02369822|convulsions status|convulsions status
150344|NCT02369822|children|children
150345|NCT02369809|Ischemia|ischemia
150346|NCT02369796|Drug therapy|drug therapy
150347|NCT02369770|Stroke|stroke
150348|NCT02369770|Robotics|robotics
150349|NCT02369770|Ankle|ankle
150350|NCT02369770|Active Stretching|active stretching
150351|NCT02369770|Passive Stretching|passive stretching
150352|NCT02369770|Range of Motion|range of motion
141208|NCT02420938|CLL|cll
150353|NCT02369744|Ureteral calculus|ureteral calculus
150354|NCT02369744|Ureterolithiasis|ureterolithiasis
150355|NCT02369744|Ureteral stone|ureteral stone
150356|NCT02369744|Kidney stone|kidney stone
150357|NCT02369744|Medical expulsive therapy|medical expulsive therapy
150358|NCT02369744|tamsulosin|tamsulosin
150359|NCT02369744|silodosin|silodosin
150360|NCT02369744|rapaflo|rapaflo
150361|NCT02369744|flomax|flomax
150362|NCT02369679|upper limb|upper limb
150363|NCT02369679|lymphedema|lymphedema
150364|NCT02369666|Inflammation|inflammation
150365|NCT02369666|Lycopene|lycopene
150366|NCT02369666|Exercise|exercise
150368|NCT02369614|rTMS - repetitive transcranial magnetic stimulation|rtms - repetitive transcranial magnetic stimulation
150369|NCT02369614|CAPS - Clinician Administered PTSD Scale|caps - clinician administered ptsd scale
150370|NCT02369601|amniorrhexis|amniorrhexis
150371|NCT02369601|Ruptured membranes|ruptured membranes
150372|NCT02369601|Alfa-fetoprotein|alfa-fetoprotein
150373|NCT02369562|Dental implants|dental implants
150374|NCT02369562|Periodontal Bone Loss|periodontal bone loss
150375|NCT02369549|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
150376|NCT02369549|Micro-particle curcumin|micro-particle curcumin
150377|NCT02369549|Albuminuria|albuminuria
150378|NCT02369536|NAFLD|nafld
150379|NCT02369536|nutraceutical mixture|nutraceutical mixture
150381|NCT02369510|spinal anesthesia|spinal anesthesia
150382|NCT02369510|epinephrine|epinephrine
150383|NCT02369510|bupivacaine|bupivacaine
150384|NCT02369510|repeat cesarean|repeat cesarean
150385|NCT02369484|Stage IIIb/ IV NSCLC harbouring HER2 exon 20 mutations|stage iiib/ iv nsclc harbouring her2 exon 20 mutations
150386|NCT02369471|Cannabidivarin|cannabidivarin
150387|NCT02369471|CBDV|cbdv
150388|NCT02369471|GWP42006|gwp42006
150389|NCT02369432|Drug carriers|drug carriers
150390|NCT02369432|Polymeric microparticles|polymeric microparticles
150391|NCT02369432|Preferential accumulation in inflamed skin|preferential accumulation in inflamed skin
150392|NCT02369432|Atopic dermatitis|atopic dermatitis
150393|NCT02369432|Pilosebaceous follicles|pilosebaceous follicles
150394|NCT02369432|Selective drug delivery|selective drug delivery
150395|NCT02369432|Drug reservoir|drug reservoir
150396|NCT02369419|frailty|frailty
150397|NCT02369419|Heart failure|heart failure
150398|NCT02369419|cardiac resynchronization therapy|cardiac resynchronization therapy
150399|NCT02369406|Botswana|botswana
150400|NCT02369406|Immunology|immunology
150401|NCT02369406|Antiretroviral Therapy|antiretroviral therapy
150402|NCT02369393|Internet based treatment|internet based treatment
150403|NCT02369393|Depression|depression
150404|NCT02369393|Efficacy|efficacy
150405|NCT02369393|Cost-effectiveness|cost-effectiveness
150406|NCT02369393|Behavioral Activation|behavioral activation
150407|NCT02369393|Self-applied|self-applied
150408|NCT02369393|Ecological Momentary Assessment|ecological momentary assessment
150409|NCT02369393|Physical Activity|physical activity
150410|NCT02369367|Malignant Gliomas|malignant gliomas
150411|NCT02369367|Glioblastoma Multiforme|glioblastoma multiforme
150412|NCT02369367|Gliosarcoma|gliosarcoma
150413|NCT02369367|Anaplastic Astrocytoma|anaplastic astrocytoma
150414|NCT02369367|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
150415|NCT02369367|Anaplastic Oligoastrocytoma|anaplastic oligoastrocytoma
150416|NCT02369367|Camptosar|camptosar
150417|NCT02369367|Irinotecan|irinotecan
150418|NCT02369367|CPT-11|cpt-11
150419|NCT02369367|Lenalidomide|lenalidomide
150420|NCT02369367|Revlimid|revlimid
150421|NCT02369367|CC-5013|cc-5013
150422|NCT02369354|Kidney Transplant|kidney transplant
150423|NCT02369354|African Americans|african americans
150424|NCT02369341|Southern Hemisphere influenza vaccine|southern hemisphere influenza vaccine
150425|NCT02369341|Elderly|elderly
150426|NCT02369341|Seasonal flu|seasonal flu
150427|NCT02369341|Fluarix Tetra|fluarix tetra
150428|NCT02369341|Adults|adults
150429|NCT02369341|Immunogenicity|immunogenicity
150430|NCT02369341|Reactogenicity|reactogenicity
150431|NCT02369341|Influenza|influenza
150432|NCT02369315|child development|child development
150433|NCT02369315|music training|music training
150434|NCT02369315|self-regulation|self-regulation
150435|NCT02369315|exposure to violence|exposure to violence
150436|NCT02369276|neck dissection surgery|neck dissection surgery
150437|NCT02369276|shoulder disability|shoulder disability
150438|NCT02369276|musculoskeletal ultrasonography|musculoskeletal ultrasonography
150439|NCT02369263|Deep Vein Thrombosis|deep vein thrombosis
150440|NCT02369263|DVT|dvt
150441|NCT02369263|Leg Swelling|leg swelling
150442|NCT02369263|Leg Pain|leg pain
150443|NCT02369263|Blood Clot|blood clot
150444|NCT02369250|regeneration|regeneration
150445|NCT02369250|surgical therapy|surgical therapy
150446|NCT02369250|furcation defect|furcation defect
150447|NCT02369211|acetaminophen|acetaminophen
150448|NCT02369172|Herpes|herpes
150449|NCT02369172|volunteers|volunteers
150450|NCT02369172|drug-drug interaction|drug-drug interaction
150451|NCT02369120|patient education|patient education
141253|NCT02420860|ASCT|asct
150452|NCT02369120|pain cognitions|pain cognitions
150453|NCT02369107|acupuncture|acupuncture
150454|NCT02369107|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
150455|NCT02369094|Frailty|frailty
150456|NCT02369094|Frail elderly|frail elderly
150457|NCT02369094|Acupressure|acupressure
150458|NCT02369094|Pragmatic Randomised Controlled Trial|pragmatic randomised controlled trial
150459|NCT02369081|Hypertension|hypertension
150460|NCT02369055|Rehabilitation|rehabilitation
150461|NCT02369029|Phase I|phase i
150462|NCT02369029|Dose escalation|dose escalation
150463|NCT02369029|NUT-midline carcinoma|nut-midline carcinoma
150464|NCT02369029|Acute Leucemia|acute leucemia
150465|NCT02369029|Lymphoma|lymphoma
150466|NCT02369029|Melanoma|melanoma
150467|NCT02369029|Myeloma|myeloma
150468|NCT02369029|HCC|hcc
150470|NCT02369016|indolent Non-Hodgkin lymphoma|indolent non-hodgkin lymphoma
150471|NCT02369016|rituximab-refractory|rituximab-refractory
150472|NCT02369003|Deep Brain Stimulation|deep brain stimulation
150473|NCT02369003|Schwann Cells|schwann cells
150474|NCT02368990|NSCLC|nsclc
150475|NCT02368990|T790M|t790m
150476|NCT02368990|EGFR|egfr
150477|NCT02368990|TKI Resistance|tki resistance
150478|NCT02368990|Non Small Cell Lung Cancer|non small cell lung cancer
150479|NCT02368990|AZD9291|azd9291
150480|NCT02368990|Clovis|clovis
150481|NCT02368977|Colonoscopy|colonoscopy
150482|NCT02368977|Polyps|polyps
150483|NCT02368977|Adenomas|adenomas
150484|NCT02368964|double triggering|double triggering
150485|NCT02368964|Oocyte maturation|oocyte maturation
150486|NCT02368964|GNRH Agonist|gnrh agonist
150487|NCT02368964|hCG|hcg
150488|NCT02368964|IVF treatment|ivf treatment
150489|NCT02368964|immature oocytes|immature oocytes
150490|NCT02368951|Phase 1|phase 1
150491|NCT02368951|Solid Tumors|solid tumors
150492|NCT02368951|FGFR2|fgfr2
150493|NCT02368951|Antibody drug conjugate|antibody drug conjugate
150494|NCT02368938|Cardiovascular risk factors|cardiovascular risk factors
150495|NCT02368938|Prospective study|prospective study
150496|NCT02368938|Mortality|mortality
150497|NCT02368938|Cardiovascular events|cardiovascular events
150498|NCT02368938|Asymptomatic target organ damage|asymptomatic target organ damage
150499|NCT02368938|elderly Chinese|elderly chinese
150500|NCT02368925|Rhytids|rhytids
150501|NCT02368925|Skin Laxity|skin laxity
150502|NCT02368912|Phase 1|phase 1
150503|NCT02368912|ASP1707|asp1707
150806|NCT02367287|Immunology|immunology
150504|NCT02368912|Dose escalation|dose escalation
150505|NCT02368912|Food effect|food effect
150506|NCT02368912|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
150507|NCT02368912|Healthy subjects|healthy subjects
150508|NCT02368912|Single ascending dose|single ascending dose
150509|NCT02368912|Multiple ascending dose|multiple ascending dose
150510|NCT02368899|technology|technology
150511|NCT02368899|information science|information science
150512|NCT02368899|health care|health care
150513|NCT02368873|prevention|prevention
150514|NCT02368847|Aged|aged
150515|NCT02368847|Psychiatric Hospitals|psychiatric hospitals
150516|NCT02368821|cytotrophoblast|cytotrophoblast
150517|NCT02368821|syncytiotrophoblast|syncytiotrophoblast
150518|NCT02368821|placentas|placentas
150519|NCT02368821|intrauterine growth restriction|intrauterine growth restriction
150520|NCT02368821|preeclampsia|preeclampsia
150521|NCT02368821|placenta accrete|placenta accrete
150522|NCT02368808|orphans and vulnerable children|orphans and vulnerable children
150523|NCT02368808|South Africa|south africa
150524|NCT02368808|peer support group|peer support group
150525|NCT02368795|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
150526|NCT02368795|Pancreatic duct stenting|pancreatic duct stenting
150527|NCT02368795|Post-ERCP pancreatitis|post-ercp pancreatitis
150528|NCT02368782|transient evoked otoacoustic emissions|transient evoked otoacoustic emissions
150529|NCT02368782|distortion product otoacoustic emissions|distortion product otoacoustic emissions
150530|NCT02368782|ketamine|ketamine
150531|NCT02368782|propofol|propofol
150532|NCT02368782|child|child
150534|NCT02368704|Endoplasmic Reticulum|endoplasmic reticulum
150535|NCT02368678|Halitosis|halitosis
150536|NCT02368678|Sulfur compounds|sulfur compounds
150537|NCT02368678|Periodontitis|periodontitis
150538|NCT02368678|Periodontal treatment|periodontal treatment
150539|NCT02368600|lifestyle intervention|lifestyle intervention
150540|NCT02368600|gestational diabetes mellitus|gestational diabetes mellitus
150541|NCT02368600|Chinese|chinese
150542|NCT02368600|prevention|prevention
150543|NCT02368587|intracoronary infusion|intracoronary infusion
150544|NCT02368587|intravenous infusion|intravenous infusion
150545|NCT02368587|Wharton's jelly-derived mesenchymal stem cells|wharton's jelly-derived mesenchymal stem cells
150546|NCT02368587|ischemic Cardiomyopathy|ischemic cardiomyopathy
150547|NCT02368587|heart function|heart function
150548|NCT02368548|Pharmaceutical care|pharmaceutical care
150549|NCT02368548|Emergency Service|emergency service
181942|NCT02201524|JAK|jak
150550|NCT02368535|teamwork|teamwork
150551|NCT02368509|sensory test|sensory test
150552|NCT02368509|olfaction|olfaction
150553|NCT02368509|gustation|gustation
150554|NCT02368509|taste|taste
150555|NCT02368509|cancer|cancer
150556|NCT02368496|Long-term parenteral nutrition|long-term parenteral nutrition
150557|NCT02368496|HR-pQCT|hr-pqct
150558|NCT02368496|DXA|dxa
150559|NCT02368496|Bone trophicity|bone trophicity
150560|NCT02368457|Mandibular osteoradionecrosis|mandibular osteoradionecrosis
150561|NCT02368457|Tocopherol|tocopherol
150562|NCT02368457|pentoxifylline|pentoxifylline
150563|NCT02368457|vitamine E|vitamine e
150564|NCT02368457|wounds and injuries|wounds and injuries
150565|NCT02368457|antioxidants|antioxidants
150566|NCT02368457|free radical scavengers|free radical scavengers
150567|NCT02368457|radiation-protective agents|radiation-protective agents
150568|NCT02368457|vasodilatadors agents|vasodilatadors agents
150569|NCT02368457|osteonecrosis|osteonecrosis
150570|NCT02368457|mandible|mandible
150571|NCT02368457|extraoral fistula|extraoral fistula
150572|NCT02368457|exposed bone|exposed bone
150573|NCT02368457|necrotic bone|necrotic bone
150574|NCT02368457|head and neck radiotherapy|head and neck radiotherapy
150575|NCT02368444|Posttraumatic Stress|posttraumatic stress
150576|NCT02368444|Sleep|sleep
150577|NCT02368431|Alcohol Use Disorder|alcohol use disorder
150578|NCT02368431|Alcoholism|alcoholism
150579|NCT02368431|Alcohol Dependence|alcohol dependence
150580|NCT02368431|Zonisamide|zonisamide
150581|NCT02368431|Alcoholic Intoxication|alcoholic intoxication
150582|NCT02368431|Drinking Behaviors|drinking behaviors
150583|NCT02368431|Anticonvulsants|anticonvulsants
150584|NCT02368418|Cardiovascular disease|cardiovascular disease
150585|NCT02368418|Rural health|rural health
150587|NCT02368418|Cohort study|cohort study
150588|NCT02368392|in-hospital cardiac arrest|in-hospital cardiac arrest
150589|NCT02368392|quality of life after cardiac arrest|quality of life after cardiac arrest
150590|NCT02368392|survival after cardiac arrest|survival after cardiac arrest
150591|NCT02368392|resources for cardiac arrest|resources for cardiac arrest
150592|NCT02368379|Metyrapone|metyrapone
150593|NCT02368379|ACTH stimulation test|acth stimulation test
150594|NCT02368314|Deep vein thrombosis|deep vein thrombosis
150595|NCT02368314|Prophylaxis|prophylaxis
150596|NCT02368314|Sodium enoxaparin|sodium enoxaparin
150597|NCT02368288|chronic hepatitic B|chronic hepatitic b
150598|NCT02368288|peginterferon|peginterferon
150599|NCT02368288|HBsAg|hbsag
150600|NCT02368288|entecavir|entecavir
150601|NCT02368262|Cerebral Palsy|cerebral palsy
150602|NCT02368262|Risk factors|risk factors
150603|NCT02368262|Child|child
150604|NCT02368262|urinary incontinence|urinary incontinence
150605|NCT02368236|Early Detection of Cancer|early detection of cancer
150606|NCT02368236|Intervention Studies|intervention studies
150607|NCT02368236|Randomized Controlled Trial|randomized controlled trial
150608|NCT02368236|Colorectal Neoplasms|colorectal neoplasms
150609|NCT02368236|Colonic Neoplasms|colonic neoplasms
150610|NCT02368223|Children|children
150611|NCT02368223|Rehabilitation|rehabilitation
150612|NCT02368223|Telerehabilitation|telerehabilitation
150613|NCT02368223|Upper limb therapy|upper limb therapy
150614|NCT02368197|dialysis fistula|dialysis fistula
150615|NCT02368197|cephalic arch stenosis|cephalic arch stenosis
150616|NCT02368197|balloon angioplasty|balloon angioplasty
150617|NCT02368197|drug eluting balloon|drug eluting balloon
150618|NCT02368184|noninvasive physiologic monitoring|noninvasive physiologic monitoring
150619|NCT02368184|acute decompensated heart failure (ADHF)|acute decompensated heart failure (adhf)
150620|NCT02368158|myocard infarction|myocard infarction
150621|NCT02368158|arrhythmia|arrhythmia
150622|NCT02368158|fitness of driving|fitness of driving
150623|NCT02368145|stroke|stroke
150624|NCT02368145|acute stroke|acute stroke
150625|NCT02368145|post stroke depression|post stroke depression
150626|NCT02368132|Caregivers|caregivers
150627|NCT02368132|Dementia|dementia
150628|NCT02368106|patient registry|patient registry
150629|NCT02368106|radiation oncology|radiation oncology
150630|NCT02368106|technology assessment|technology assessment
150631|NCT02368093|Rheumatoid arthritis|rheumatoid arthritis
150632|NCT02368080|Lung Clearance Index|lung clearance index
150633|NCT02368080|Cystic Fibrosis|cystic fibrosis
150634|NCT02368080|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
150635|NCT02368054|Epinephrine|epinephrine
150636|NCT02368054|Bupivacaine|bupivacaine
150637|NCT02368054|Stroke Volume|stroke volume
150638|NCT02368054|Cardiac Output|cardiac output
150639|NCT02368054|Heart Rate|heart rate
150640|NCT02368054|Hemodynamics|hemodynamics
150641|NCT02368054|Total Peripheral Resistance|total peripheral resistance
150642|NCT02368054|Blood Pressure|blood pressure
150643|NCT02368054|Paracervical block|paracervical block
150644|NCT02368054|LiDCO|lidco
150645|NCT02368054|Adrenaline|adrenaline
150646|NCT02368054|Conization|conization
150647|NCT02368054|PulsCO|pulsco
150648|NCT02368028|Plaque|plaque
150649|NCT02368028|Saliva|saliva
150650|NCT02368028|Dental Caries|dental caries
150651|NCT02368015|Penetration|penetration
150652|NCT02368015|Cefazolin|cefazolin
150653|NCT02368015|Hepatic cyst|hepatic cyst
150654|NCT02368002|obesity|obesity
150655|NCT02368002|diet, reducing|diet, reducing
150656|NCT02367989|Glucose response|glucose response
150657|NCT02367989|Insulin response|insulin response
150658|NCT02367989|Satiety|satiety
150659|NCT02367963|Peer education|peer education
150660|NCT02367963|Comprehensive health intervention|comprehensive health intervention
150661|NCT02367963|Lifestyle|lifestyle
150662|NCT02367963|Adult|adult
150663|NCT02367963|Mid age|mid age
150664|NCT02367963|Male|male
150665|NCT02367963|Female|female
150666|NCT02367963|Human|human
150667|NCT02367963|Clinical trial|clinical trial
150668|NCT02367963|Prevention and control|prevention and control
150669|NCT02367963|Cardiovascular Disease|cardiovascular disease
150670|NCT02367963|Behavior|behavior
150671|NCT02367963|Risk Factors|risk factors
151102|NCT02364427|AKI|aki
150672|NCT02367963|Healthy lifestyle|healthy lifestyle
150673|NCT02367963|Healthy people program|healthy people program
150674|NCT02367963|Peer-group|peer-group
150675|NCT02367937|Phase I drug-drug interaction|phase i drug-drug interaction
150676|NCT02367898|Cognitive Training|cognitive training
150677|NCT02367898|Lumosity|lumosity
150678|NCT02367898|Crossword Puzzles|crossword puzzles
150679|NCT02367885|Prevention|prevention
150680|NCT02367872|Drug therapy|drug therapy
150681|NCT02367859|ameloblastoma|ameloblastoma
150688|NCT02367846|Impact of contraceptives on bone health using 41Ca|impact of contraceptives on bone health using 41ca
150689|NCT02367833|Insulin-like growth factor-1|insulin-like growth factor-1
150690|NCT02367833|Combined oral contraceptive|combined oral contraceptive
150691|NCT02367833|Contraceptive Vaginal Ring|contraceptive vaginal ring
150692|NCT02367833|Transdermal Contraceptive|transdermal contraceptive
150693|NCT02367807|HIV prevention|hiv prevention
150694|NCT02367807|PrEP|prep
150695|NCT02367807|young men who have sex with men|young men who have sex with men
150696|NCT02367807|Truvada|truvada
150697|NCT02367768|trauma blue|trauma blue
150698|NCT02367768|major trauma|major trauma
150699|NCT02367768|cohort study|cohort study
150700|NCT02367768|prognostic factor|prognostic factor
150701|NCT02367768|Healing Time|healing time
150702|NCT02367768|Post Operative|post operative
150703|NCT02367755|cardiopulmonary resuscitation|cardiopulmonary resuscitation
150704|NCT02367755|cardiac arrest|cardiac arrest
150705|NCT02367755|therapeutic hypothermia|therapeutic hypothermia
150706|NCT02367755|propofol|propofol
150707|NCT02367755|lorazepam|lorazepam
150708|NCT02367755|cerebral perfusion|cerebral perfusion
150709|NCT02367755|electroencephalography|electroencephalography
150710|NCT02367742|Diet|diet
150711|NCT02367742|Physical Activity|physical activity
150712|NCT02367742|NAFLD|nafld
150713|NCT02367703|Mini-laparoscopy|mini-laparoscopy
150714|NCT02367703|hysterectomy|hysterectomy
150715|NCT02367703|Benign uterine diseases|benign uterine diseases
150716|NCT02367703|Operative time|operative time
150717|NCT02367690|Diabetes|diabetes
150718|NCT02367690|Foot Ulcers|foot ulcers
150719|NCT02367690|DFU|dfu
150720|NCT02367690|KPT-330|kpt-330
150721|NCT02367690|Selinexor|selinexor
150722|NCT02367690|Karyopharm|karyopharm
150723|NCT02367677|Photo|photo
150724|NCT02367664|Japanese encephalitis|japanese encephalitis
150725|NCT02367664|immunogenicity|immunogenicity
150726|NCT02367664|safety|safety
150727|NCT02367664|vaccine|vaccine
150728|NCT02367651|Soft tissue sarcoma|soft tissue sarcoma
150729|NCT02367651|Pazopanib|pazopanib
150730|NCT02367651|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
150731|NCT02367599|PrEP|prep
150732|NCT02367599|Pre exposure Prophylaxis|pre exposure prophylaxis
150733|NCT02367599|Truvada|truvada
150734|NCT02367599|CCTG|cctg
150735|NCT02367599|595|595
150736|NCT02367599|Vitamin D|vitamin d
150737|NCT02367599|Bone mineral density|bone mineral density
150738|NCT02367521|TBI Depression|tbi depression
150739|NCT02367521|co-morbid psychiatric symptoms|co-morbid psychiatric symptoms
150740|NCT02367508|advance care planning|advance care planning
150741|NCT02367508|coping skills|coping skills
150742|NCT02367508|mindfulness|mindfulness
150743|NCT02367508|meditation|meditation
150744|NCT02367508|cancer|cancer
150745|NCT02367508|adult|adult
150746|NCT02367508|caregivers|caregivers
150747|NCT02367508|oncology providers|oncology providers
150748|NCT02367508|advance directives|advance directives
150749|NCT02367508|anxiety|anxiety
150750|NCT02367508|depression|depression
150751|NCT02367508|quality of life|quality of life
150752|NCT02367508|pilot project|pilot project
150753|NCT02367495|Coronary Restenosis|coronary restenosis
150754|NCT02367495|restenosis|restenosis
150755|NCT02367495|paclitaxel-coated balloon|paclitaxel-coated balloon
150756|NCT02367495|drug-eluting stent|drug-eluting stent
150757|NCT02367495|drug-coated balloon|drug-coated balloon
150758|NCT02367495|coronary angiography|coronary angiography
150759|NCT02367482|rGBM|rgbm
150760|NCT02367482|Recurrent GBM|recurrent gbm
150761|NCT02367482|Recurrent Glioblastoma|recurrent glioblastoma
150762|NCT02367469|recurrent brain tumors|recurrent brain tumors
150763|NCT02367469|brain tumors|brain tumors
150764|NCT02367469|Newly diagnosed brain tumors|newly diagnosed brain tumors
150765|NCT02367456|MDS|mds
150766|NCT02367456|AML|aml
150767|NCT02367456|CMML|cmml
150768|NCT02367443|radiotherapy|radiotherapy
150769|NCT02367443|therapeutic use|therapeutic use
150770|NCT02367443|Radiation|radiation
150771|NCT02367443|non-small cell lung cancer|non-small cell lung cancer
150772|NCT02367443|chemotherapy|chemotherapy
150773|NCT02367417|Revision|revision
150774|NCT02367417|Knee Joint|knee joint
150775|NCT02367417|PMCF|pmcf
150776|NCT02367378|Minimally invasive surgery|minimally invasive surgery
150777|NCT02367365|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
150778|NCT02367365|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
150779|NCT02367365|neovascular lesion morphology|neovascular lesion morphology
151518|NCT02362984|mNIHSS|mnihss
150780|NCT02367365|indocyanine green angiography|indocyanine green angiography
150781|NCT02367365|persistent disease activity|persistent disease activity
150782|NCT02367352|Drug therapy|drug therapy
150783|NCT02367352|dose escalation|dose escalation
150784|NCT02367352|dose expansion|dose expansion
150785|NCT02367339|Critical Care|critical care
150786|NCT02367339|Nursing staff|nursing staff
150787|NCT02367339|Medical staff|medical staff
150788|NCT02367339|Extended-spectrum betalactamase|extended-spectrum betalactamase
150789|NCT02367339|Digestive tract colonization|digestive tract colonization
150790|NCT02367339|Cross-contamination|cross-contamination
150791|NCT02367326|score|score
150792|NCT02367326|inflammatory bowel disease|inflammatory bowel disease
150793|NCT02367326|crohn's disease|crohn's disease
150794|NCT02367326|ulcerative colitis|ulcerative colitis
150795|NCT02367326|clinical response|clinical response
150796|NCT02367326|thiopurines|thiopurines
150797|NCT02367313|Symptomatic Human Rhinovirus Infection|symptomatic human rhinovirus infection
150798|NCT02367313|Moderate to Severe Asthma|moderate to severe asthma
150799|NCT02367313|Antiviral|antiviral
150800|NCT02367313|Cold|cold
150801|NCT02367313|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
150802|NCT02367313|Aviragen Therapeutics|aviragen therapeutics
150803|NCT02367313|Aviragen|aviragen
150804|NCT02367287|Diet|diet
150805|NCT02367287|Phenotype|phenotype
150807|NCT02367287|Microbiota|microbiota
150808|NCT02367287|Metabolomics|metabolomics
150809|NCT02367287|Physical activity|physical activity
150810|NCT02367287|Neuroendocrine system|neuroendocrine system
150816|NCT02367248|Hematoma edema|hematoma edema
150818|NCT02367235|sacrocolpopexy|sacrocolpopexy
150820|NCT02367235|vaginal positioning device|vaginal positioning device
150821|NCT02367209|FD MRI|fd mri
150822|NCT02367209|COPD|copd
150823|NCT02367209|SPECT/CT|spect/ct
150824|NCT02367209|DCE MRI|dce mri
150832|NCT02367183|Crohn's Disease|crohn's disease
150833|NCT02367183|Active Crohn's Disease|active crohn's disease
150834|NCT02367183|GED-0301|ged-0301
150835|NCT02367183|Endoscopic|endoscopic
150836|NCT02367183|Double-Blind|double-blind
150837|NCT02367183|IBD|ibd
150838|NCT02367183|Mongersen|mongersen
150839|NCT02367170|respiratory dysfunction|respiratory dysfunction
150840|NCT02367170|chronic critical illness|chronic critical illness
150841|NCT02367170|diaphragm weakness|diaphragm weakness
150842|NCT02367170|sepsis|sepsis
150843|NCT02367170|ventilator dependance|ventilator dependance
150844|NCT02367118|chronic rhinosinusitis without nasal polyps prednisone|chronic rhinosinusitis without nasal polyps prednisone
150845|NCT02367105|Obesity|obesity
150846|NCT02367105|Hypogonadism|hypogonadism
150847|NCT02367105|Frailty|frailty
150848|NCT02367092|Liver Transplantation|liver transplantation
150849|NCT02367066|patients|patients
150850|NCT02367066|glycaemic control on metformin|glycaemic control on metformin
150851|NCT02367040|Clinical trial, Phase III|clinical trial, phase iii
150852|NCT02367040|Phosphatidylinositol-3-kinase|phosphatidylinositol-3-kinase
150853|NCT02367040|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
150854|NCT02367040|Indolent B-cell non-Hodgkin's lymphoma|indolent b-cell non-hodgkin's lymphoma
150855|NCT02367027|Biological Availability|biological availability
150856|NCT02367027|Relative Bioavailability Trial|relative bioavailability trial
150857|NCT02367014|Mitochondrial Myopathy|mitochondrial myopathy
150858|NCT02367014|Primary Mitochondrial Disease|primary mitochondrial disease
150859|NCT02367014|Bendavia™|bendavia™
150860|NCT02367014|elamipretide|elamipretide
150861|NCT02367001|general practitioner|general practitioner
150862|NCT02367001|screening|screening
150863|NCT02367001|participation|participation
150864|NCT02367001|organized screening|organized screening
150865|NCT02366988|Chronic pancreatitis|chronic pancreatitis
150866|NCT02366988|Clinical Trial|clinical trial
150867|NCT02366988|Bile stricture|bile stricture
150868|NCT02366988|Endoscopy|endoscopy
150869|NCT02366988|Surgery|surgery
150870|NCT02366975|BPH/LUTS|bph/luts
150871|NCT02366975|TRT|trt
150872|NCT02366975|Metabolic Syndrome|metabolic syndrome
150873|NCT02366962|Influenza|influenza
150874|NCT02366962|Vaccine|vaccine
150875|NCT02366962|ASP7374|asp7374
150876|NCT02366949|Phase 1|phase 1
150877|NCT02366949|Solid tumors|solid tumors
150878|NCT02366949|Breast cancer|breast cancer
150879|NCT02366949|Paclitaxel|paclitaxel
150880|NCT02366949|MPS-1 inhibitor|mps-1 inhibitor
150881|NCT02366949|Oncology|oncology
150882|NCT02366884|malignant|malignant
150883|NCT02366884|atavistic chemotherapy|atavistic chemotherapy
150884|NCT02366884|cancer|cancer
150885|NCT02366858|19 gauge|19 gauge
150886|NCT02366858|22 gauge|22 gauge
150887|NCT02366858|core tissue|core tissue
150888|NCT02366806|Breast Cancer|breast cancer
150889|NCT02366806|AJCC Stage 1, 2, 3|ajcc stage 1, 2, 3
150890|NCT02366806|Educational Design|educational design
150891|NCT02366806|Radiation Therapy Treatment|radiation therapy treatment
150892|NCT02366793|accessory mobilization, nerve mobilization.|accessory mobilization, nerve mobilization.
150893|NCT02366780|Lactation|lactation
150894|NCT02366780|Breastmilk|breastmilk
150895|NCT02366780|Macronutrients|macronutrients
150896|NCT02366767|Insulin Infusion Systems|insulin infusion systems
150897|NCT02366767|Continuous Glucose Monitors|continuous glucose monitors
150898|NCT02366754|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
150899|NCT02366741|SCLC|sclc
150900|NCT02366741|Neuro-cognitive function|neuro-cognitive function
150902|NCT02366741|Hippocampal sparing|hippocampal sparing
150903|NCT02366676|Recurrent cystitis|recurrent cystitis
150904|NCT02366676|hyaluronic acid|hyaluronic acid
150905|NCT02366676|chondroitin sulphate|chondroitin sulphate
150906|NCT02366663|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
150907|NCT02366663|autologous stem cell transplantation|autologous stem cell transplantation
150908|NCT02366663|radioimmunotherapy|radioimmunotherapy
150909|NCT02366663|Zevalin|zevalin
150910|NCT02366663|Lymphoma|lymphoma
150911|NCT02366663|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
150912|NCT02366663|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
150913|NCT02366663|Immune System Diseases|immune system diseases
150914|NCT02366663|Immunoproliferative Disorders|immunoproliferative disorders
150915|NCT02366663|Lymphatic Diseases|lymphatic diseases
150916|NCT02366663|Lymphoma, B-Cell|lymphoma, b-cell
150917|NCT02366663|Lymphoproliferative Disorders|lymphoproliferative disorders
150918|NCT02366663|Neoplasms|neoplasms
150919|NCT02366663|Neoplasms by Histologic Type|neoplasms by histologic type
150920|NCT02366663|Antibodies, Monoclonal|antibodies, monoclonal
150921|NCT02366663|Immunologic Factors|immunologic factors
150922|NCT02366663|Pharmacologic Actions|pharmacologic actions
150923|NCT02366663|Physiological Effects of Drugs|physiological effects of drugs
150924|NCT02366637|COPD|copd
150925|NCT02366637|Sputum|sputum
150926|NCT02366546|Adoptive cell transfer|adoptive cell transfer
150927|NCT02366546|Cell therapy|cell therapy
150928|NCT02366546|Immunotherapy|immunotherapy
150929|NCT02366546|NY-ESO-1|ny-eso-1
150930|NCT02366546|Esophageal cancer|esophageal cancer
150931|NCT02366546|Melanoma|melanoma
150932|NCT02366546|Head and neck cancer|head and neck cancer
150933|NCT02366546|Ovarian cancer|ovarian cancer
150934|NCT02366546|Synovial sarcoma|synovial sarcoma
150935|NCT02366546|TCR gene therapy|tcr gene therapy
150936|NCT02366533|Linkage to care|linkage to care
150937|NCT02366533|HIV|hiv
150938|NCT02366533|Efficacy of linkage to care program|efficacy of linkage to care program
150939|NCT02366520|Child|child
150940|NCT02366520|Child Behavior|child behavior
150941|NCT02366520|Dental Anxiety/prevention & control|dental anxiety/prevention & control
150942|NCT02366520|Dental Anxiety/psychology|dental anxiety/psychology
150943|NCT02366520|Cooperative Behavior|cooperative behavior
150944|NCT02366520|Dental Care/psychology*|dental care/psychology*
150945|NCT02366520|Humans|humans
150946|NCT02366520|Videotape Recording|videotape recording
150947|NCT02366507|hypotension|hypotension
150948|NCT02366507|doppler|doppler
150949|NCT02366507|shock|shock
150950|NCT02366494|prostate cancer|prostate cancer
150951|NCT02366494|treatment response|treatment response
150952|NCT02366494|androgen deprivation therapy|androgen deprivation therapy
150953|NCT02366481|Vitamin K|vitamin k
150954|NCT02366481|Vitamin K2|vitamin k2
150955|NCT02366481|Menaquinone-7|menaquinone-7
150956|NCT02366481|Osteocalcin|osteocalcin
150957|NCT02366481|Adults|adults
150958|NCT02366481|Obesity|obesity
150959|NCT02366481|Insulin resistance|insulin resistance
150960|NCT02366481|Insulin sensitivity|insulin sensitivity
150961|NCT02366481|Beta-cell function|beta-cell function
150962|NCT02366481|Prediabetes|prediabetes
150963|NCT02366468|Diabetic macular edema|diabetic macular edema
150964|NCT02366468|Visual impairment|visual impairment
150965|NCT02366442|dual/multitasking|dual/multitasking
150966|NCT02366442|Executive function|executive function
150967|NCT02366442|Affective function|affective function
150968|NCT02366442|Balance|balance
150969|NCT02366416|Exercise, Physical|exercise, physical
150970|NCT02366403|PTSD|ptsd
150971|NCT02366403|Meditation|meditation
150972|NCT02366403|Yoga|yoga
150973|NCT02366403|Cognitive Therapy|cognitive therapy
150974|NCT02366390|Psychoeducative|psychoeducative
150975|NCT02366390|HADS|hads
150976|NCT02366390|COPD|copd
150977|NCT02366390|dyspnea|dyspnea
150978|NCT02366364|NRX-1074|nrx-1074
150979|NCT02366364|NMDA Receptor Modulator|nmda receptor modulator
150980|NCT02366364|Major Depressive Disorder|major depressive disorder
150981|NCT02366364|Glycine Site Modulator|glycine site modulator
150982|NCT02366312|Keratocystic odontogenic tumor|keratocystic odontogenic tumor
150983|NCT02366312|KCOT|kcot
150984|NCT02366273|Diabetes|diabetes
150985|NCT02366273|Psoriasis|psoriasis
150986|NCT02366273|Inflammation|inflammation
150987|NCT02366273|Insulin-resistance|insulin-resistance
150988|NCT02366247|Polyethylene Glycol Thymosin alpha1|polyethylene glycol thymosin alpha1
150989|NCT02366247|Adefovir|adefovir
150990|NCT02366247|Hepatitis B e Antigens positive|hepatitis b e antigens positive
150991|NCT02366208|Polyethylene Glycol Thymosin alpha1|polyethylene glycol thymosin alpha1
150992|NCT02366208|Adefovir|adefovir
150993|NCT02366208|Hepatitis B e Antigens positive|hepatitis b e antigens positive
151002|NCT02366130|Xofigo|xofigo
151003|NCT02366130|Radium-223 chloride|radium-223 chloride
151004|NCT02366130|Radium-223 dichloride|radium-223 dichloride
151005|NCT02366130|Alpharadin|alpharadin
151006|NCT02366130|Denosumab|denosumab
151007|NCT02366130|AMG 162|amg 162
151008|NCT02366130|Prolia|prolia
151009|NCT02366130|Hormone therapy|hormone therapy
151010|NCT02366117|Quirc|quirc
585634|NCT00513474|graft versus host disease|graft versus host disease
151011|NCT02366117|Quality Indiciator in Rehabilitative Care|quality indiciator in rehabilitative care
151012|NCT02366104|Cardiovascular Diseases|cardiovascular diseases
151014|NCT02366104|Primary Prevention|primary prevention
151015|NCT02366052|Histologically confirmed NASH|histologically confirmed nash
151016|NCT02366052|Hepatocyte Injury determined by M30 antigen|hepatocyte injury determined by m30 antigen
151017|NCT02366026|HIV|hiv
151018|NCT02366013|HIV|hiv
151019|NCT02366013|HIV Prevention|hiv prevention
151020|NCT02366013|HIV Vaccine|hiv vaccine
151021|NCT02366013|Healthy|healthy
151022|NCT02366000|Parent-child communication|parent-child communication
151023|NCT02366000|Health risk behaviors|health risk behaviors
151024|NCT02366000|Randomized controlled trial|randomized controlled trial
151025|NCT02365987|interesterified|interesterified
151026|NCT02365987|postprandial|postprandial
151027|NCT02365974|arterial stiffness|arterial stiffness
151028|NCT02365974|resistant hypertension|resistant hypertension
151029|NCT02365974|sympathetic system|sympathetic system
151030|NCT02365974|blood pressure|blood pressure
151031|NCT02365974|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
151032|NCT02365961|Hip Arthroscopy|hip arthroscopy
151033|NCT02365948|Pharmacokinetics|pharmacokinetics
151034|NCT02365948|Certolizumab Pegol|certolizumab pegol
151035|NCT02365948|Healthy Chinese subjects|healthy chinese subjects
151036|NCT02365935|adjuvant chemotherapy|adjuvant chemotherapy
151037|NCT02365922|FTLD, PSP, CBD, PPA, FTD, FTD-ALS, CBS, ALS, svPPA, nfvPPA, oPSP|ftld, psp, cbd, ppa, ftd, ftd-als, cbs, als, svppa, nfvppa, opsp
151038|NCT02365883|Prostate Cancer|prostate cancer
151039|NCT02365883|Transrectal Imaging|transrectal imaging
151040|NCT02365870|Anxiety Disorders|anxiety disorders
151041|NCT02365870|Parkinson Disease|parkinson disease
151042|NCT02365870|rotigotine|rotigotine
151043|NCT02365857|spinal anesthesia|spinal anesthesia
151044|NCT02365857|caesarian section|caesarian section
151045|NCT02365857|Dexmedetomidine|dexmedetomidine
151046|NCT02365844|Narrow Band Imaging|narrow band imaging
151047|NCT02365844|oropharyngeal carcinoma|oropharyngeal carcinoma
151048|NCT02365831|MBC|mbc
151049|NCT02365831|breast|breast
151050|NCT02365831|metastatic|metastatic
151051|NCT02365831|cancer|cancer
151052|NCT02365831|HER2|her2
151053|NCT02365818|Bladder Cancer|bladder cancer
151054|NCT02365805|BRCA 1 levels|brca 1 levels
151055|NCT02365805|HER2 Negative|her2 negative
151056|NCT02365792|Clinical Decision Support|clinical decision support
151057|NCT02365792|Clinical Practice Guidelines|clinical practice guidelines
151058|NCT02365792|Emergency Medical Services|emergency medical services
151059|NCT02365779|salpingectomy|salpingectomy
151060|NCT02365779|optical biopsy|optical biopsy
151061|NCT02365779|Cellvizio®|cellvizio®
151062|NCT02365766|MK-3475|mk-3475
151063|NCT02365766|Gemcitabine|gemcitabine
151064|NCT02365766|Cisplatin|cisplatin
151065|NCT02365766|Pembrolizumab|pembrolizumab
151066|NCT02365766|Neoadjuvant Bladder Cancer|neoadjuvant bladder cancer
151067|NCT02365753|lower transverse cesarean delivery|lower transverse cesarean delivery
151068|NCT02365753|Pregnant women|pregnant women
151069|NCT02365740|Type 1 Diabetes mellitus|type 1 diabetes mellitus
151070|NCT02365740|Gastric Emptying|gastric emptying
151071|NCT02365740|Insulin Infusion Pump|insulin infusion pump
151072|NCT02365701|Functional Dyspepsia|functional dyspepsia
151073|NCT02365688|Open Abdominal Surgical Procedure|open abdominal surgical procedure
151074|NCT02365675|Pemphigus|pemphigus
151075|NCT02365675|Pemphigoid|pemphigoid
151076|NCT02365675|Wound Healing|wound healing
151077|NCT02365675|Itch|itch
151078|NCT02365675|Pain|pain
151079|NCT02365675|Wound dressing|wound dressing
151080|NCT02365675|Topical treatment|topical treatment
151081|NCT02365662|Solid Tumor types likely to exhibit elevated levels of Epidermal Growth Factor Receptor|solid tumor types likely to exhibit elevated levels of epidermal growth factor receptor
151082|NCT02365662|Solid Tumors|solid tumors
151083|NCT02365662|Cancer|cancer
151084|NCT02365662|Oncology|oncology
151085|NCT02365649|Crohn's Disease|crohn's disease
151086|NCT02365623|Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)|pulmonary multi-drug resistant tuberculosis (mdr-tb)
151087|NCT02365623|TMC207|tmc207
151088|NCT02365623|Bedaquiline|bedaquiline
151089|NCT02365610|Cannabidivarin|cannabidivarin
151090|NCT02365610|CBDV|cbdv
151091|NCT02365610|GWP42006|gwp42006
151092|NCT02365597|Urothelial Cancer|urothelial cancer
151093|NCT02365597|JNJ-42756493|jnj-42756493
151094|NCT02365597|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
151095|NCT02364505|caregivers|caregivers
151096|NCT02364492|[C04.588.180]|[c04.588.180]
151097|NCT02364440|skin laxity|skin laxity
151098|NCT02364440|Ultherapy™ System|ultherapy™ system
151099|NCT02364440|rhytids|rhytids
151100|NCT02364427|Pulse wave velocity|pulse wave velocity
151101|NCT02364427|Arterial stiffness|arterial stiffness
151103|NCT02364401|Atrial Fibrillation|atrial fibrillation
151104|NCT02364401|Catheter ablation|catheter ablation
151105|NCT02364388|breast imaging diagnosis|breast imaging diagnosis
151106|NCT02364388|breast ultrasound|breast ultrasound
151107|NCT02364388|Imagio|imagio
151108|NCT02364388|Seno Medical Instruments, Inc.|seno medical instruments, inc.
151109|NCT02364388|Seno|seno
151110|NCT02364388|opto-acoustics|opto-acoustics
151112|NCT02363322|Medical Countermeasures|medical countermeasures
151113|NCT02363322|VHF|vhf
151114|NCT02363322|EVD|evd
151115|NCT02363309|13C|13c
151116|NCT02363309|Stable Isotopes|stable isotopes
151117|NCT02363309|Acetate|acetate
151118|NCT02363309|Breath Tests|breath tests
151119|NCT02363309|Palmitate|palmitate
151120|NCT02363296|Brain Cooling - Selected|brain cooling - selected
151121|NCT02363296|Brain Cooling Helmet|brain cooling helmet
151122|NCT02363296|Repetitive TMS (rTMS)|repetitive tms (rtms)
151123|NCT02365532|drug-induced long QT syndrome|drug-induced long qt syndrome
151124|NCT02365532|DILQTS|dilqts
151125|NCT02365532|prolonged QT|prolonged qt
151126|NCT02365519|LME636|lme636
151127|NCT02365519|dry eye disease|dry eye disease
151128|NCT02365519|efficacy|efficacy
151129|NCT02365519|ocular discomfort|ocular discomfort
151130|NCT02365506|Congenital Long QT Syndrome|congenital long qt syndrome
151131|NCT02365506|LQTS|lqts
151132|NCT02365506|Long QT2 Syndrome|long qt2 syndrome
151133|NCT02365506|LQT2|lqt2
151134|NCT02365506|Sudden Cardiac Death|sudden cardiac death
151135|NCT02365493|Methicillin-Resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
151136|NCT02365467|TEVAR|tevar
151137|NCT02365467|Thoracic Aneurysm|thoracic aneurysm
151138|NCT02365467|Endovascular Aortic Repair|endovascular aortic repair
151139|NCT02365467|Type B Dissection|type b dissection
151140|NCT02365454|TAA|taa
151141|NCT02365441|GIST|gist
151142|NCT02365441|Advanced|advanced
151143|NCT02365428|Maternal welfare|maternal welfare
151144|NCT02365402|chronic hepatitis B|chronic hepatitis b
151145|NCT02365402|peginterferon|peginterferon
151146|NCT02365402|sustained viral response|sustained viral response
151147|NCT02365402|entecavir|entecavir
151148|NCT02365402|HBeAg|hbeag
151149|NCT02365337|Vitamin D|vitamin d
151150|NCT02365337|time lapse monitoring|time lapse monitoring
151151|NCT02365337|embryo|embryo
151152|NCT02365324|culinary skills|culinary skills
151153|NCT02365324|menu planning|menu planning
151154|NCT02365324|grocery shopping|grocery shopping
151155|NCT02365324|children|children
151156|NCT02365324|healthy eating|healthy eating
151157|NCT02365324|physical activity|physical activity
151158|NCT02365272|pharmacokinetics|pharmacokinetics
151159|NCT02365272|aminoglycosides|aminoglycosides
151160|NCT02365246|atopic dermatitis|atopic dermatitis
151161|NCT02365246|immunoadsorption|immunoadsorption
151162|NCT02365233|Type II Diabetes|type ii diabetes
151163|NCT02365233|Nonalcoholic fatty liver|nonalcoholic fatty liver
151164|NCT02365194|Ventral Hernia|ventral hernia
151165|NCT02365194|Prehabilitation|prehabilitation
151166|NCT02365181|Shoulder arthroplasty|shoulder arthroplasty
151167|NCT02365168|Fish allergy|fish allergy
151168|NCT02365155|Frailty|frailty
151169|NCT02365155|Heart failure|heart failure
151170|NCT02365155|Physical activity|physical activity
151171|NCT02365155|Cognitive state|cognitive state
151172|NCT02365142|Knee Osteoarthritis|knee osteoarthritis
151173|NCT02365142|Mesenchimal stem cell|mesenchimal stem cell
151174|NCT02365142|Osteoarthritis|osteoarthritis
151175|NCT02365129|BRITE adipose tissue|brite adipose tissue
151176|NCT02365129|physical activity|physical activity
151177|NCT02365129|Thermogenesis|thermogenesis
151178|NCT02365129|Body Temperature Regulation|body temperature regulation
151179|NCT02365129|Energy Metabolism|energy metabolism
151180|NCT02365116|Peer Mentorship|peer mentorship
151181|NCT02365116|Psychiatric Hospitalization|psychiatric hospitalization
151182|NCT02365116|Suicide Risk|suicide risk
151183|NCT02365103|Anemia, Iron-Deficiency|anemia, iron-deficiency
151184|NCT02365103|Iron, Bioavailability|iron, bioavailability
151185|NCT02365103|Hepcidins|hepcidins
151186|NCT02365103|Intestinal, Absorption|intestinal, absorption
151187|NCT02365103|Isotope Labeling, Stable|isotope labeling, stable
151188|NCT02365077|Adverse Effect of Glucocorticoids|adverse effect of glucocorticoids
151189|NCT02365077|Femur Head Necrosis|femur head necrosis
151190|NCT02365077|Susceptibility|susceptibility
151192|NCT02365025|Sleep patterns|sleep patterns
151193|NCT02365025|Electronic Media Exposure|electronic media exposure
151194|NCT02365025|Parental Intervention|parental intervention
151195|NCT02364934|rocuronium|rocuronium
151196|NCT02364934|sex|sex
151197|NCT02364934|elderly|elderly
151198|NCT02364934|Close-loop infusion system|close-loop infusion system
151199|NCT02364921|venous ulcer|venous ulcer
151200|NCT02364921|wound healing|wound healing
151201|NCT02364921|compression bandages|compression bandages
151202|NCT02364908|systemic lupus erythematosus|systemic lupus erythematosus
151203|NCT02364908|antimalarials|antimalarials
151204|NCT02364908|therapeutic education|therapeutic education
151205|NCT02364908|Coping questionnaire|coping questionnaire
151206|NCT02364908|MASRI questionnaire|masri questionnaire
151207|NCT02364908|morisky medication adherence scale|morisky medication adherence scale
151213|NCT02364869|P-cresyl sulfate|p-cresyl sulfate
151214|NCT02364869|Indoxyl sulfate|indoxyl sulfate
151215|NCT02364869|Intestine|intestine
151216|NCT02364869|Endothelial function|endothelial function
151217|NCT02364856|Autonomic Nervous System|autonomic nervous system
151218|NCT02364856|Cerebral Palsy|cerebral palsy
151220|NCT02364856|Children|children
151221|NCT02364843|Threonine|threonine
151222|NCT02364843|enteral feedings|enteral feedings
151223|NCT02364843|infants|infants
151224|NCT02364843|amino acid|amino acid
151225|NCT02364843|requirements|requirements
151226|NCT02364830|Pimpinella anisum L.|pimpinella anisum l.
151227|NCT02364830|Peppermint oil|peppermint oil
151228|NCT02364830|Irritable Bowel Syndrome|irritable bowel syndrome
151229|NCT02364817|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
151230|NCT02364817|Alcohol Dependence|alcohol dependence
151231|NCT02364817|Adults|adults
151232|NCT02364817|Treatment outcome|treatment outcome
151233|NCT02364817|Mental Health|mental health
151234|NCT02364791|pulmonary resection|pulmonary resection
151235|NCT02364791|chest tube|chest tube
151236|NCT02364791|segmentectomy|segmentectomy
151237|NCT02364791|lobectomy|lobectomy
151238|NCT02364778|CAD|cad
151239|NCT02364765|Maxillofacial Orthognathic Surgery|maxillofacial orthognathic surgery
151240|NCT02364765|Hemoglobin|hemoglobin
151241|NCT02364765|Red Blood Cells|red blood cells
151242|NCT02364765|Hematocrit|hematocrit
151243|NCT02364765|Blood Platelets|blood platelets
151244|NCT02364765|Body Weight|body weight
151245|NCT02364765|Operative Time|operative time
151246|NCT02364765|Age Groups|age groups
151247|NCT02364765|Gender|gender
151248|NCT02364726|Acupuncture|acupuncture
151249|NCT02364726|Paclitaxel|paclitaxel
151250|NCT02364726|15-011|15-011
151251|NCT02364700|stroke, robotics, hand rehabilitation|stroke, robotics, hand rehabilitation
151252|NCT02364674|HRCT|hrct
151253|NCT02364674|High Resolution Computed Tomography scans|high resolution computed tomography scans
151254|NCT02364674|Functional Respiratory Imaging|functional respiratory imaging
151255|NCT02364674|FRI|fri
151256|NCT02364674|Computed Tomography|computed tomography
151257|NCT02364674|CT|ct
151258|NCT02364674|Bronchiolitis Obliterans|bronchiolitis obliterans
151259|NCT02364674|BOS|bos
151260|NCT02364674|Lung Transplant|lung transplant
151261|NCT02364661|Hepatitis B virus|hepatitis b virus
151262|NCT02364661|Metabolovirus|metabolovirus
151269|NCT02364635|Phase I pharmacokinetics and safety study|phase i pharmacokinetics and safety study
151270|NCT02364622|flexible intubating stylet|flexible intubating stylet
151271|NCT02364622|double-lumen endobronchial tube|double-lumen endobronchial tube
151272|NCT02364596|Staphylococcus aureus vaccine|staphylococcus aureus vaccine
151273|NCT02364596|Staphylococcal infection|staphylococcal infection
151274|NCT02364570|CVD|cvd
151275|NCT02364570|Hyperglycemia|hyperglycemia
151276|NCT02364570|Postprandial|postprandial
151277|NCT02364570|Vascular Function|vascular function
151278|NCT02364531|Prostatic Neoplasms|prostatic neoplasms
151279|NCT02364531|Prostate Cancer|prostate cancer
151280|NCT02364531|Metastatic|metastatic
151281|NCT02364531|Observational|observational
151282|NCT02364531|Abiraterone Acetate|abiraterone acetate
151283|NCT02364531|ZYTIGA|zytiga
151284|NCT02364518|Snoring|snoring
151285|NCT02364518|snoreplasy|snoreplasy
151286|NCT02364518|Tranquill|tranquill
151287|NCT02364518|Sutures|sutures
151288|NCT02364336|Chronic Hepatitis B|chronic hepatitis b
151289|NCT02364310|Hypertension|hypertension
151290|NCT02364310|baroreceptor stimulation|baroreceptor stimulation
182806|NCT02197390|Latino|latino
151291|NCT02364310|Hypertension resistant|hypertension resistant
151292|NCT02364297|Bleeding gastric varices|bleeding gastric varices
151293|NCT02364297|Transjugular intrahepatic portosystemic shunt (TIPS)|transjugular intrahepatic portosystemic shunt (tips)
151294|NCT02364297|Injection of adhesives|injection of adhesives
151295|NCT02364271|High-sensitive troponin|high-sensitive troponin
151296|NCT02364271|Coronary Artery Calcium Score|coronary artery calcium score
151297|NCT02364271|TIMI score|timi score
151298|NCT02364271|Heart-type fatty acid binding protein|heart-type fatty acid binding protein
151299|NCT02364271|Major adverse cardiac event|major adverse cardiac event
151300|NCT02364271|HEART score|heart score
151301|NCT02364245|Cerebral Palsy.|cerebral palsy.
151302|NCT02364245|Upper Extremity|upper extremity
151303|NCT02364245|Kinect|kinect
151304|NCT02364245|Virtual reality|virtual reality
151305|NCT02364219|prewarming|prewarming
151306|NCT02364219|perioperative hypothermia|perioperative hypothermia
151307|NCT02364219|microdialysis|microdialysis
151308|NCT02364219|tissue oxygen saturation|tissue oxygen saturation
151309|NCT02364219|cytoreductive surgery|cytoreductive surgery
151310|NCT02364206|newly diagnosed glioblastoma|newly diagnosed glioblastoma
151311|NCT02364206|p38 MAPK inhibitor|p38 mapk inhibitor
151312|NCT02364206|temozolomide|temozolomide
151313|NCT02364206|radiotherapy|radiotherapy
151314|NCT02364193|Intrathoracic blood volume|intrathoracic blood volume
152044|NCT02359877|Volunteers|volunteers
151315|NCT02364193|Extravascular lung water|extravascular lung water
151316|NCT02364154|biomarker|biomarker
151317|NCT02364154|screening|screening
151318|NCT02364154|coloscopy|coloscopy
151319|NCT02364141|stroke|stroke
151320|NCT02364141|upper extremity|upper extremity
151321|NCT02364141|motor learning|motor learning
151322|NCT02364141|rehabilitation|rehabilitation
151323|NCT02364115|Spinal metastases|spinal metastases
151324|NCT02364115|Spinal metastatic disease|spinal metastatic disease
151325|NCT02364115|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
151326|NCT02364115|Response|response
151327|NCT02364115|Bone metastases|bone metastases
151328|NCT02364089|Adrenal Incidentaloma|adrenal incidentaloma
151329|NCT02364089|Subclinical Cushing's syndrome|subclinical cushing's syndrome
151330|NCT02364089|Hypertension|hypertension
151331|NCT02364089|Cardiovascular Risk Factors|cardiovascular risk factors
151332|NCT02364089|Metabolic Syndrome|metabolic syndrome
151333|NCT02364089|Surgery of adrenal tumor|surgery of adrenal tumor
151334|NCT02364063|Urinary incontinence|urinary incontinence
151335|NCT02364063|cerebral palsy|cerebral palsy
151336|NCT02364063|urotherapy|urotherapy
151337|NCT02364063|child|child
151338|NCT02364037|intrauterine device|intrauterine device
151339|NCT02364037|subdermal implant|subdermal implant
151340|NCT02364037|contraceptive counseling|contraceptive counseling
151341|NCT02364024|Colon and rectum carcinoma|colon and rectum carcinoma
151342|NCT02364024|Immune response|immune response
151343|NCT02364024|Biomarker|biomarker
151344|NCT02364024|Prognosis|prognosis
151345|NCT02364011|Biomechanics|biomechanics
151346|NCT02364011|Primary Total Knee Arthroplasty|primary total knee arthroplasty
151347|NCT02364011|TKA Bearings|tka bearings
151348|NCT02364011|Osteoarthritis|osteoarthritis
151349|NCT02364011|Total Knee Replacement|total knee replacement
151350|NCT02363998|detoxification|detoxification
151351|NCT02363998|agonist taper|agonist taper
151352|NCT02363998|methadone step down|methadone step down
151353|NCT02363998|buprenorphine step down|buprenorphine step down
151354|NCT02363998|opioid withdrawal syndrome|opioid withdrawal syndrome
151355|NCT02363959|Hyperbaric Oxygen|hyperbaric oxygen
151356|NCT02363959|Lung Transplantation|lung transplantation
151357|NCT02363959|Central Airway Stenosis|central airway stenosis
151358|NCT02363959|Airway Exudative Plaques|airway exudative plaques
151359|NCT02363959|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
151360|NCT02363959|Post-Lung Transplantation|post-lung transplantation
151361|NCT02363959|Airway Ischemia|airway ischemia
151362|NCT02363959|Endobronchial Biopsy|endobronchial biopsy
151363|NCT02363959|Bronchoscopy|bronchoscopy
151364|NCT02363946|alpha-1 antitrypsin|alpha-1 antitrypsin
151365|NCT02363946|AATD|aatd
151366|NCT02363933|Perampanel|perampanel
151367|NCT02363933|Seizures|seizures
151368|NCT02363920|COPD patients|copd patients
151369|NCT02363907|diabetes mellitus|diabetes mellitus
151370|NCT02363907|pediatric|pediatric
151371|NCT02363907|continuous glucose monitoring system|continuous glucose monitoring system
151372|NCT02363907|CGM|cgm
151373|NCT02363855|Neoplasm Metastasis|neoplasm metastasis
151374|NCT02363855|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
151375|NCT02363855|Castration-resistant prostate cancer (CRPC)|castration-resistant prostate cancer (crpc)
151376|NCT02363842|Pressure Ulcer|pressure ulcer
151377|NCT02363842|Skin IQ MCM coverlet|skin iq mcm coverlet
151378|NCT02363842|Pressure redistribution surfaces|pressure redistribution surfaces
151379|NCT02363829|clinical stages IIA, IIB, IIIA, IIIB, IVA|clinical stages iia, iib, iiia, iiib, iva
151380|NCT02363829|invasive carcinoma|invasive carcinoma
151381|NCT02363829|uterine cervix|uterine cervix
142171|NCT02416843|human|human
142172|NCT02416830|embolization|embolization
142173|NCT02416830|visceral Aneurysms|visceral aneurysms
142174|NCT02416830|Prospective Registry|prospective registry
142175|NCT02416817|Thrombelastography|thrombelastography
142176|NCT02416817|Massive Transfusion|massive transfusion
142195|NCT02416765|Insulin|insulin
151382|NCT02363790|Ventral Hernia|ventral hernia
151383|NCT02363790|Laparoscopic|laparoscopic
151384|NCT02363764|respiratory sampling|respiratory sampling
151385|NCT02363751|Bellini|bellini
151386|NCT02363751|Metastatic|metastatic
151387|NCT02363751|Chemotherapy|chemotherapy
151388|NCT02363751|Bevacizumab|bevacizumab
151389|NCT02363738|Bipolar Disorder|bipolar disorder
151390|NCT02363738|Bipolar Depression|bipolar depression
151391|NCT02363738|Inflammation|inflammation
151393|NCT02363725|Acute myocardial infarction|acute myocardial infarction
151394|NCT02363725|Inflammation|inflammation
151395|NCT02363725|CRP|crp
151396|NCT02363725|Colchicine|colchicine
151397|NCT02363712|Osteoarthritis, knee|osteoarthritis, knee
151398|NCT02363712|therapy|therapy
151399|NCT02363712|shoe|shoe
151400|NCT02363712|Randomized Controlled Trial|randomized controlled trial
151401|NCT02363699|cholelithiasis|cholelithiasis
151402|NCT02363699|Cytokines|cytokines
151403|NCT02363699|under general anesthesia|under general anesthesia
151404|NCT02363673|Autism Spectrum Disorder|autism spectrum disorder
151405|NCT02363673|Children|children
151406|NCT02363673|Homoeopathy|homoeopathy
151407|NCT02363660|HIV-uninfected|hiv-uninfected
151408|NCT02363647|medullary thyroid cancer|medullary thyroid cancer
151409|NCT02363647|thyroid cancer|thyroid cancer
151410|NCT02363647|personalized therapy|personalized therapy
151411|NCT02363647|personalized chemotherapy|personalized chemotherapy
151412|NCT02363647|individualized treatment|individualized treatment
151413|NCT02363647|colon cancer|colon cancer
151414|NCT02363647|colorectal cancer|colorectal cancer
151415|NCT02363634|magnesium status|magnesium status
151416|NCT02363634|sleep quality|sleep quality
151417|NCT02363608|Canine-Assisted|canine-assisted
151418|NCT02363608|15-010|15-010
151419|NCT02363608|post surgery patients|post surgery patients
151420|NCT02363595|Genomic Predictors|genomic predictors
151421|NCT02363595|14-277|14-277
151422|NCT02363569|post coital bleeding|post coital bleeding
151423|NCT02363569|vaginal bleeding|vaginal bleeding
151424|NCT02363556|Cervical Dilation|cervical dilation
151425|NCT02363556|Dilation and Evacuation|dilation and evacuation
151426|NCT02363556|Misoprostol|misoprostol
151427|NCT02363556|Misoprostol-Dilapan|misoprostol-dilapan
151428|NCT02363556|Abortion|abortion
151429|NCT02363530|cataract surgery|cataract surgery
151430|NCT02363530|cornea protect|cornea protect
151431|NCT02363530|xerophthalmia|xerophthalmia
151432|NCT02363530|Corneal clarity|corneal clarity
151433|NCT02363517|Hepatitis|hepatitis
151434|NCT02363517|Viral|viral
151435|NCT02363517|Non-A|non-a
151436|NCT02363517|Non-B|non-b
151437|NCT02363517|Parenterally-Transmitted|parenterally-transmitted
151438|NCT02363504|Magnetic Resonance Imaging|magnetic resonance imaging
151439|NCT02363504|Noradrenaline|noradrenaline
151440|NCT02363504|locus coeruleus|locus coeruleus
151441|NCT02363504|memory|memory
151442|NCT02363465|skin thickness|skin thickness
151443|NCT02363465|high-frequency ultrasound|high-frequency ultrasound
151444|NCT02363452|Aicardi-Goutières syndrome|aicardi-goutières syndrome
151445|NCT02363452|Reverse transcriptase inhibitors|reverse transcriptase inhibitors
151446|NCT02363452|open single study|open single study
151447|NCT02363452|interferon signature|interferon signature
151448|NCT02363426|intravaginal culture|intravaginal culture
151449|NCT02363426|in vitro fertilization|in vitro fertilization
151450|NCT02363426|blastocyst|blastocyst
151451|NCT02363426|pregnancy|pregnancy
151452|NCT02363413|NIV|niv
151453|NCT02363413|Overlap Syndrom|overlap syndrom
151454|NCT02363413|home|home
151455|NCT02363413|hospital|hospital
151456|NCT02363400|Nasopharyngeal carcinoma (NPC)|nasopharyngeal carcinoma (npc)
151457|NCT02363400|Epstein-Barr virus (EBV)|epstein-barr virus (ebv)
151458|NCT02363400|radiotherapy (RT)|radiotherapy (rt)
151459|NCT02363400|Plasma EBV DNA(pEBV DNA)|plasma ebv dna(pebv dna)
151460|NCT02363400|Adjuvant Chemotherapy|adjuvant chemotherapy
151461|NCT02363387|HIV|hiv
151462|NCT02363387|antiretroviral medications|antiretroviral medications
151463|NCT02363387|incentives|incentives
151464|NCT02363374|Rectal cancer stage II|rectal cancer stage ii
151465|NCT02363374|Rectal cancer stage III|rectal cancer stage iii
151466|NCT02363374|Multimodality treatment of locally advanced rectal cancer|multimodality treatment of locally advanced rectal cancer
151467|NCT02363348|L arginine|l arginine
151468|NCT02363348|Preeclampsia|preeclampsia
151469|NCT02363335|GLP-1|glp-1
151470|NCT02363335|Phosphodiesterase Inhibitor|phosphodiesterase inhibitor
151471|NCT02363335|GLP|glp
151472|NCT02363270|Analgesia|analgesia
151473|NCT02363270|ketamine|ketamine
151474|NCT02363257|Smoke free bus policy|smoke free bus policy
151475|NCT02363257|BEST commuters|best commuters
151476|NCT02363257|BEST employee|best employee
151477|NCT02363244|Pap,HPVDNA|pap,hpvdna
151478|NCT02363218|Liver Neoplasms|liver neoplasms
151479|NCT02363218|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
151480|NCT02363218|CyberKnife|cyberknife
151481|NCT02363192|Pharmacy|pharmacy
151482|NCT02363179|Emergency Service, Hospital|emergency service, hospital
151483|NCT02363140|Musculoskeletal System|musculoskeletal system
151484|NCT02363127|Reproductive Techniques|reproductive techniques
151485|NCT02363127|Infertility|infertility
151486|NCT02363127|Reproductive Techniques Assisted|reproductive techniques assisted
151487|NCT02363088|cervical screening|cervical screening
151488|NCT02363088|uptake|uptake
151489|NCT02363088|SMS messages|sms messages
151490|NCT02363088|text messages|text messages
151491|NCT02363088|reminder|reminder
151497|NCT02363075|stabilisation phase|stabilisation phase
151498|NCT02363062|frontotemporal lobar degeneration|frontotemporal lobar degeneration
151499|NCT02363062|genes|genes
151500|NCT02363062|whole exome sequencing|whole exome sequencing
151501|NCT02363049|Colectomy|colectomy
151502|NCT02363049|primary tumor resection|primary tumor resection
151503|NCT02363049|Asymptomatic primary colon cancer|asymptomatic primary colon cancer
151504|NCT02363049|Unresectable synchronous liver metastasis|unresectable synchronous liver metastasis
151513|NCT02362997|Diffuse Large B Cell Lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
151514|NCT02362997|Peripheral T-cell lymphoma (PTCL)|peripheral t-cell lymphoma (ptcl)
151515|NCT02362984|DLBS1033|dlbs1033
585906|NCT00522730|Safety|safety
151516|NCT02362984|acute ischemic stroke|acute ischemic stroke
151519|NCT02362919|Influenza vaccination|influenza vaccination
151520|NCT02362919|Elderly individuals|elderly individuals
151521|NCT02362919|Prospective cohort study|prospective cohort study
151522|NCT02362919|response|response
151523|NCT02362906|pneumonia|pneumonia
151524|NCT02362906|pediatrics|pediatrics
151525|NCT02362893|Hypertension|hypertension
151526|NCT02362893|Adherence|adherence
151527|NCT02362893|Direct Observed Therapy (DOT)|direct observed therapy (dot)
151528|NCT02362893|RCT|rct
151529|NCT02362854|dental implant|dental implant
151530|NCT02362854|laser|laser
151531|NCT02362854|diode laser|diode laser
151532|NCT02362854|peri-implantitis|peri-implantitis
151533|NCT02362854|bacterial count|bacterial count
151534|NCT02362828|Post-Dural Puncture Headache|post-dural puncture headache
151535|NCT02362828|Blood Patch, epidural|blood patch, epidural
151536|NCT02362828|Obstetrics|obstetrics
151537|NCT02362828|European Society of Anaesthesiology (ESA)|european society of anaesthesiology (esa)
151538|NCT02362828|epidemiology|epidemiology
151539|NCT02362828|Accidental Dural Puncture (ADP)|accidental dural puncture (adp)
151540|NCT02362828|Anaesthesia|anaesthesia
151541|NCT02362828|childbirth complication|childbirth complication
151542|NCT02362828|epidural analgesia|epidural analgesia
151543|NCT02362828|postdural puncture headache|postdural puncture headache
151544|NCT02362828|prophylactic epidural blood patch|prophylactic epidural blood patch
151545|NCT02362828|epidural|epidural
151546|NCT02362776|NMR spectroscopy|nmr spectroscopy
151547|NCT02362776|metabolic changes|metabolic changes
151548|NCT02362776|blood plasma|blood plasma
151549|NCT02362776|biomarker|biomarker
151550|NCT02362776|cancer|cancer
151551|NCT02362750|comparative effectiveness|comparative effectiveness
151552|NCT02362750|survivorship|survivorship
151553|NCT02362750|Patient-Centered Outcomes Research|patient-centered outcomes research
151554|NCT02362685|Metabolic myopathies|metabolic myopathies
151555|NCT02362685|Exercise testing|exercise testing
151556|NCT02362685|Blood sample|blood sample
151557|NCT02362685|Muscle biopsy|muscle biopsy
151558|NCT02362685|Genetic analysis|genetic analysis
151559|NCT02362685|Cycloergometer|cycloergometer
151560|NCT02362685|Grip-test|grip-test
151561|NCT02362685|Exercise physiology|exercise physiology
151562|NCT02362685|Muscle physiology|muscle physiology
151563|NCT02362659|non-valvular|non-valvular
151564|NCT02362659|atrial fibrillation|atrial fibrillation
151565|NCT02362659|percutaneous coronary intervention|percutaneous coronary intervention
151574|NCT02362581|Prophylaxis treatment|prophylaxis treatment
151575|NCT02362581|On demand treatment|on demand treatment
151576|NCT02362581|Severe hemophilia A|severe hemophilia a
151577|NCT02362581|Moderate hemophilia A|moderate hemophilia a
151578|NCT02362568|Intubation; Difficult|intubation; difficult
151579|NCT02362555|Ossification of nuchal ligament|ossification of nuchal ligament
151580|NCT02362490|chronic hepatitis B|chronic hepatitis b
151581|NCT02362490|interferon|interferon
151582|NCT02362490|Nucleotide analogues|nucleotide analogues
151583|NCT02362490|HBsAg|hbsag
151584|NCT02362464|Multi-epitope|multi-epitope
151585|NCT02362464|Tarp Peptide|tarp peptide
151586|NCT02362464|Dendritic Cell Vaccine|dendritic cell vaccine
151587|NCT02362464|D0 Prostate Cancer|d0 prostate cancer
151588|NCT02362451|Dendritic Cell Vaccine|dendritic cell vaccine
151589|NCT02362451|Multi Epitope Tarp Peptide|multi epitope tarp peptide
151590|NCT02362451|Autolougous Dendritic Cell|autolougous dendritic cell
151591|NCT02362451|D0 Prostate Cancer|d0 prostate cancer
151592|NCT02362451|Vaccine Therapy|vaccine therapy
151593|NCT02362438|Intrathecal|intrathecal
151594|NCT02362438|AAVp Mediated Gene Transfer|aavp mediated gene transfer
151595|NCT02362438|Phase 1|phase 1
151596|NCT02362438|Safety Study|safety study
151597|NCT02362438|Giant Axonal Neuropathy|giant axonal neuropathy
151598|NCT02362425|Neuromuscular Disease|neuromuscular disease
151599|NCT02362425|Clinical Trial|clinical trial
151600|NCT02362425|Ryanodine Receptor Type 1|ryanodine receptor type 1
151601|NCT02362425|Myopathy|myopathy
151602|NCT02362412|major depressive episodes|major depressive episodes
151603|NCT02362412|FK949E|fk949e
151604|NCT02362412|quetiapine|quetiapine
151605|NCT02362412|bipolar depression|bipolar depression
151606|NCT02362412|bipolar disorder|bipolar disorder
151607|NCT02362373|epilepsy|epilepsy
151608|NCT02362373|contraception|contraception
151609|NCT02362373|drug interaction|drug interaction
151610|NCT02362360|Ostomy|ostomy
151611|NCT02362334|dual Sheimpflug analyzer|dual sheimpflug analyzer
151612|NCT02362334|intraocular lens power|intraocular lens power
151613|NCT02362334|optical low-coherence reflectometry|optical low-coherence reflectometry
151614|NCT02362321|[C10.228.140.300.535.450.400.120]|[c10.228.140.300.535.450.400.120]
151615|NCT02362295|palliative care|palliative care
151616|NCT02362295|vulnerable population|vulnerable population
151617|NCT02362295|qualitative research|qualitative research
151618|NCT02362282|stroke|stroke
151619|NCT02362282|walking|walking
151620|NCT02362282|cognition|cognition
151621|NCT02362282|rehabilitation|rehabilitation
151622|NCT02362256|Opioid detoxification|opioid detoxification
151623|NCT02362256|Opioid antagonist induction|opioid antagonist induction
151624|NCT02362256|Conscious sedation|conscious sedation
151625|NCT02362243|low back pain|low back pain
151626|NCT02362243|low back injury|low back injury
151627|NCT02362243|firefighter|firefighter
151628|NCT02362243|prevention|prevention
151629|NCT02362243|physical fitness|physical fitness
151630|NCT02362243|exercise training|exercise training
151631|NCT02362243|worksite|worksite
151632|NCT02362243|web-based|web-based
151633|NCT02362165|multiple myeloma|multiple myeloma
151634|NCT02362165|cyclophosphamide|cyclophosphamide
151635|NCT02362165|bortezomib|bortezomib
151636|NCT02362165|doxorubicin|doxorubicin
151637|NCT02362165|peripheral neuropathy|peripheral neuropathy
151638|NCT02362152|Actinic keratosis|actinic keratosis
151639|NCT02362152|Solar keratosis|solar keratosis
151640|NCT02362152|Field treatment|field treatment
151641|NCT02362152|Ingenol mebutate|ingenol mebutate
151642|NCT02362152|Picato|picato
151643|NCT02362126|Endoscopic full thickness resection|endoscopic full thickness resection
151644|NCT02362126|EFTR|eftr
151645|NCT02362126|FTRD|ftrd
151646|NCT02362126|OTSC|otsc
151647|NCT02362087|pain|pain
151648|NCT02362061|junctional zone|junctional zone
151649|NCT02362061|implantation|implantation
151650|NCT02362061|three D ultraosund|three d ultraosund
151651|NCT02362061|Assisted Reproductive Technology|assisted reproductive technology
151652|NCT02362061|Pregnancy|pregnancy
151653|NCT02362035|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
151654|NCT02362035|Btk|btk
151655|NCT02362035|B-Cell Malignancies|b-cell malignancies
151656|NCT02362035|Mantle Cell|mantle cell
151657|NCT02362035|Multiple Myeloma|multiple myeloma
151658|NCT02362035|CLL|cll
151659|NCT02362035|SLL|sll
151660|NCT02362035|DLBCL|dlbcl
151661|NCT02362035|Follicular|follicular
151662|NCT02362035|Waldenstrom|waldenstrom
151663|NCT02362035|Burkitt lymphoma|burkitt lymphoma
151664|NCT02362035|marginal zone lymphomas|marginal zone lymphomas
151665|NCT02362035|hairy cell leukemia|hairy cell leukemia
151666|NCT02362035|B cell acute lymphoid leukemia|b cell acute lymphoid leukemia
151667|NCT02362035|Acalabrutinib|acalabrutinib
151668|NCT02362035|ACP-196|acp-196
151669|NCT02362009|Myomas|myomas
151670|NCT02362009|Leiomyomas|leiomyomas
151671|NCT02362009|Fibromas|fibromas
151672|NCT02361970|sepsis|sepsis
151673|NCT02361970|gamma delta T cells|gamma delta t cells
151674|NCT02361970|immunosuppression|immunosuppression
151675|NCT02361944|oxygen|oxygen
151676|NCT02361944|hyperoxia|hyperoxia
151677|NCT02361944|reactive oxygen species|reactive oxygen species
151678|NCT02361944|oxidative stress|oxidative stress
151679|NCT02361944|oxidative damage|oxidative damage
151680|NCT02361944|endothelial function|endothelial function
151681|NCT02361944|vascular reactivity|vascular reactivity
151682|NCT02361944|mitochondrial function|mitochondrial function
151683|NCT02361944|surgery|surgery
151684|NCT02361944|anesthesia|anesthesia
151685|NCT02361944|kidney injury|kidney injury
151686|NCT02361944|renal failure|renal failure
151687|NCT02361944|delirium|delirium
151688|NCT02361944|myocardial injury|myocardial injury
151689|NCT02361944|arrythmia|arrythmia
151690|NCT02361931|accelerating healing|accelerating healing
151691|NCT02361931|diabetic chronic wounds|diabetic chronic wounds
151692|NCT02361931|diabetic patients|diabetic patients
151693|NCT02361931|diabetic chronic ulcers|diabetic chronic ulcers
151694|NCT02361931|Wagner grade II|wagner grade ii
151695|NCT02361931|infection|infection
151696|NCT02361931|necrosis|necrosis
151697|NCT02361931|erythema|erythema
151698|NCT02361931|mild drainage|mild drainage
151699|NCT02361905|fibroid|fibroid
151700|NCT02361905|cellular leiomyomas|cellular leiomyomas
151701|NCT02361905|GnRH analogue|gnrh analogue
151702|NCT02361905|ulipristal acetate|ulipristal acetate
151703|NCT02361892|ovarian reserve|ovarian reserve
151704|NCT02361892|infertility|infertility
151705|NCT02361892|leiomyomas|leiomyomas
151713|NCT02361827|Vitamin D|vitamin d
151714|NCT02361827|IVF outcome|ivf outcome
151715|NCT02361814|flexor tendon|flexor tendon
151716|NCT02361814|finger|finger
151717|NCT02361814|amniotic membrane|amniotic membrane
151718|NCT02361814|allograft|allograft
151719|NCT02361814|tendon injury|tendon injury
151720|NCT02361801|cardiac surgery|cardiac surgery
151721|NCT02361801|dobutamine|dobutamine
151722|NCT02361788|neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
151723|NCT02361788|etiology|etiology
151724|NCT02361788|incidence|incidence
151725|NCT02361788|risk factors|risk factors
151726|NCT02361762|Executive Function|executive function
151727|NCT02361762|Theory of Mind|theory of mind
151728|NCT02361762|Individual Differences|individual differences
151729|NCT02361762|Social Skills|social skills
151730|NCT02361762|Executive Control|executive control
151731|NCT02361710|Vitamin D|vitamin d
151732|NCT02361710|pregnancy rate|pregnancy rate
151733|NCT02361710|eFET|efet
151734|NCT02361697|pediatric multiple sclerosis|pediatric multiple sclerosis
151735|NCT02361697|clinically isolated syndrome in children|clinically isolated syndrome in children
151736|NCT02361697|biomarker|biomarker
151737|NCT02361697|magnetic resonance imaging|magnetic resonance imaging
151738|NCT02361697|diffusion weighted imaging|diffusion weighted imaging
151739|NCT02361684|cost-effectiveness|cost-effectiveness
151740|NCT02361684|blended treatment|blended treatment
151868|NCT02360878|DJBS|djbs
151741|NCT02361684|Internet based treatment|internet based treatment
151742|NCT02361684|Efficacy|efficacy
151743|NCT02361684|Depression|depression
151744|NCT02361684|cognitive behavioural therapy|cognitive behavioural therapy
151745|NCT02361645|nonsteroidal antiinflammatory drugs|nonsteroidal antiinflammatory drugs
151746|NCT02361645|prostaglandin E2|prostaglandin e2
151747|NCT02361645|vitrectomy|vitrectomy
151748|NCT02361606|adolescents|adolescents
151749|NCT02361606|cognitive behavioral internet intervention|cognitive behavioral internet intervention
151750|NCT02361593|endoscopic sclerotherapy, esophageal varices, transparent cap|endoscopic sclerotherapy, esophageal varices, transparent cap
151751|NCT02361567|Post Operative Pain|post operative pain
151752|NCT02361567|Addiction|addiction
151753|NCT02361528|Septic shock|septic shock
151754|NCT02361528|Severe sepsis|severe sepsis
151755|NCT02361528|GM-CSF|gm-csf
151756|NCT02361528|Immunosuppression|immunosuppression
151757|NCT02361528|Hospital-acquired infections|hospital-acquired infections
151758|NCT02361528|ICU-acquired infections|icu-acquired infections
151759|NCT02361528|HLA-DR|hla-dr
151760|NCT02361528|Monocytes|monocytes
151761|NCT02361515|Prostate|prostate
151762|NCT02361515|Hypofractionated radiotherapy|hypofractionated radiotherapy
151763|NCT02361515|Stereotactic irradiation|stereotactic irradiation
151764|NCT02361515|Spacer|spacer
151765|NCT02361515|Rectal and bladder toxicities|rectal and bladder toxicities
151766|NCT02361476|Anaesthesia|anaesthesia
151767|NCT02361476|Children|children
151768|NCT02361476|Clonidine|clonidine
151769|NCT02361476|Sevoflurane|sevoflurane
151770|NCT02361476|Postoperative agitation|postoperative agitation
151771|NCT02361476|Prevention|prevention
151772|NCT02361476|Pharmacokinetics|pharmacokinetics
151773|NCT02361476|Safety|safety
151774|NCT02361463|Laparoscopy;|laparoscopy;
151775|NCT02361463|Training;|training;
151776|NCT02361463|Three-Dimensional|three-dimensional
151777|NCT02361450|Faecal incontinence|faecal incontinence
151778|NCT02361450|Spina Bifida|spina bifida
151779|NCT02361450|Enema|enema
151780|NCT02361450|Constipation|constipation
151781|NCT02361450|Myelomeningocele|myelomeningocele
151782|NCT02361450|Human|human
151783|NCT02361437|diabetes type II|diabetes type ii
151784|NCT02361437|diabetic ulcers|diabetic ulcers
151785|NCT02361424|PXT00864|pxt00864
151786|NCT02361424|mild AD|mild ad
151787|NCT02361424|phase 2a|phase 2a
151788|NCT02361359|Arthroplasty|arthroplasty
151789|NCT02361346|CD20|cd20
151790|NCT02361346|immunotoxin|immunotoxin
151792|NCT02361346|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
151793|NCT02361346|lymphoma|lymphoma
151794|NCT02361346|cancer|cancer
151795|NCT02361346|antibodies|antibodies
151796|NCT02361346|immunotherapy|immunotherapy
151797|NCT02361346|safety|safety
151798|NCT02361346|pharmacokinetics|pharmacokinetics
151799|NCT02361346|maximum tolerated dose|maximum tolerated dose
151800|NCT02361346|MT-3724|mt-3724
151801|NCT02361346|relapsed|relapsed
151802|NCT02361346|refractory|refractory
151803|NCT02361346|leukemia|leukemia
151805|NCT02361346|SLL|sll
151806|NCT02361320|Pancreatic cancer|pancreatic cancer
151807|NCT02361320|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
151808|NCT02361320|PDAC|pdac
151809|NCT02361320|Computed tomography|computed tomography
151810|NCT02361320|CT|ct
151811|NCT02361320|Questionnaire|questionnaire
151812|NCT02361320|Survey|survey
151813|NCT02361268|end-stage renal disease|end-stage renal disease
151814|NCT02361268|hemodialysis|hemodialysis
151815|NCT02361268|yoga|yoga
151816|NCT02361268|mind-body medicine|mind-body medicine
151817|NCT02361268|meditation|meditation
151818|NCT02361242|PXT00864|pxt00864
151819|NCT02361242|mild AD|mild ad
151820|NCT02361242|phase 2a|phase 2a
151821|NCT02361138|SHR3824 Type 2 diabetes mellitus SGLT2|shr3824 type 2 diabetes mellitus sglt2
151822|NCT02361125|Fatigue|fatigue
151823|NCT02361125|Cancer related fatigue|cancer related fatigue
151824|NCT02361125|Methylphenidate|methylphenidate
585907|NCT00522730|Drug tolerance|drug tolerance
151825|NCT02361125|Methylphenidate Hydrochloride|methylphenidate hydrochloride
151826|NCT02361125|Ritalin|ritalin
151827|NCT02361125|Concerta|concerta
151828|NCT02361125|Fatigue evaluations|fatigue evaluations
151829|NCT02361086|castration-resistant prostate cancer|castration-resistant prostate cancer
151830|NCT02361086|CYP17|cyp17
151831|NCT02361086|P450c17a|p450c17a
151832|NCT02361086|lyase|lyase
151833|NCT02361073|Stress-induced cardiomyopathy|stress-induced cardiomyopathy
151834|NCT02361073|ERP|erp
151835|NCT02361034|Safety and pharmacokinetics of drug in healthy volunteers|safety and pharmacokinetics of drug in healthy volunteers
151836|NCT02361021|Critical Care|critical care
151837|NCT02361021|Non invasive ventilation|non invasive ventilation
151838|NCT02361021|Electrical impedance tomography|electrical impedance tomography
151839|NCT02361021|End expiratory lung volume|end expiratory lung volume
151840|NCT02361021|Lung ultrasound score|lung ultrasound score
151841|NCT02361008|Infundibular Ventricular Septal Defect|infundibular ventricular septal defect
151842|NCT02361008|occlusion|occlusion
151843|NCT02361008|TEE-guided|tee-guided
151844|NCT02361008|asymmetric occluder|asymmetric occluder
151845|NCT02361008|surgical repair|surgical repair
151846|NCT02360982|Delirium|delirium
151847|NCT02360982|regional anesthesia|regional anesthesia
151848|NCT02360982|general anesthesia|general anesthesia
151849|NCT02360969|strabismus|strabismus
151850|NCT02360969|surgical procedure|surgical procedure
151851|NCT02360969|anesthesia|anesthesia
151852|NCT02360969|squint|squint
151853|NCT02360969|child|child
151854|NCT02360956|Olmesartan medoxomil|olmesartan medoxomil
151855|NCT02360956|Epicardial adipose tissue|epicardial adipose tissue
151856|NCT02360956|Multidetector Computed Tomography|multidetector computed tomography
151857|NCT02360943|elderly patients|elderly patients
151858|NCT02360943|Pulmonary embolism|pulmonary embolism
151859|NCT02360943|Anticoagulant treatments|anticoagulant treatments
151860|NCT02360930|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
151861|NCT02360930|Pharmacokinetics|pharmacokinetics
151862|NCT02360930|Vincristine|vincristine
151863|NCT02360917|Cognitive Dysfunction|cognitive dysfunction
151864|NCT02360917|Cancer Survivorship|cancer survivorship
151865|NCT02360891|multimodal biomarkers|multimodal biomarkers
151866|NCT02360891|prognosis|prognosis
151867|NCT02360891|endophenotypes|endophenotypes
151869|NCT02360878|Duodenal-jejunal bypass sleeve|duodenal-jejunal bypass sleeve
151870|NCT02360878|Duodenal-jejunal bypass liner|duodenal-jejunal bypass liner
151871|NCT02360878|Endobarrier|endobarrier
151872|NCT02360878|Obesity|obesity
151873|NCT02360878|Type 2 diabetes|type 2 diabetes
151874|NCT02360878|Incretin hormones|incretin hormones
151875|NCT02360878|Postprandial glucose metabolism|postprandial glucose metabolism
151876|NCT02360813|Cognitive remediation therapy|cognitive remediation therapy
151877|NCT02360813|Psychiatric rehabilitation|psychiatric rehabilitation
151878|NCT02360813|Forensic mental health|forensic mental health
151879|NCT02360813|Forensic psychiatry|forensic psychiatry
151880|NCT02360813|Clinical psychology|clinical psychology
151881|NCT02360813|Randomized controlled trial|randomized controlled trial
151882|NCT02360813|Principle driven intervention|principle driven intervention
151883|NCT02360813|Psychological Intervention|psychological intervention
151884|NCT02360813|Cognitive enhancement|cognitive enhancement
151885|NCT02360800|Bleeding|bleeding
151886|NCT02360800|Heart Surgery|heart surgery
151887|NCT02360800|Ascending Aorta Replacement|ascending aorta replacement
151888|NCT02360787|Almonds|almonds
151889|NCT02360787|Energy restriction|energy restriction
151890|NCT02360787|Obesity|obesity
151891|NCT02360787|Body weight|body weight
151892|NCT02360787|Body fat|body fat
151893|NCT02360787|Blood pressure|blood pressure
151894|NCT02360787|Cognitive function|cognitive function
142666|NCT02414204|Arteriovenous Fistulas (AVFS)|arteriovenous fistulas (avfs)
142667|NCT02414204|Hemodialysis Fistula Maturation (HFM)|hemodialysis fistula maturation (hfm)
142671|NCT02414191|Feedback|feedback
151895|NCT02360774|Canagliflozin|canagliflozin
151896|NCT02360774|Obesity|obesity
151897|NCT02360774|Weight Loss|weight loss
151898|NCT02360774|Body Weight|body weight
151899|NCT02360774|Body Weight Changes|body weight changes
151900|NCT02360774|Overweight|overweight
151901|NCT02360774|Sodium-glucose transporter subtype 2 inhibitor|sodium-glucose transporter subtype 2 inhibitor
151902|NCT02360761|Lung cancer;Elderly;Sublobar resection;Lobectomy|lung cancer;elderly;sublobar resection;lobectomy
151903|NCT02360696|Duodenal Eosinophilia|duodenal eosinophilia
151904|NCT02360696|Functional Dyspepsia|functional dyspepsia
151905|NCT02360696|Mucosal Eosinophilia|mucosal eosinophilia
152006|NCT02360085|Hypotension|hypotension
151906|NCT02360683|Subthalamic neurostimulation|subthalamic neurostimulation
151907|NCT02360657|Alzheimer's Disease|alzheimer's disease
151908|NCT02360657|Alzheimer Dementia|alzheimer dementia
151909|NCT02360657|JNJ-54861911|jnj-54861911
151910|NCT02360657|Beta Secretase Inhibitor|beta secretase inhibitor
151912|NCT02360631|quit smoking|quit smoking
151913|NCT02360631|smoking treatment|smoking treatment
151914|NCT02360618|Bladder Cancer|bladder cancer
151915|NCT02360618|Metformin|metformin
151916|NCT02360618|Simvastatin|simvastatin
151917|NCT02360618|Combination Therapy|combination therapy
151918|NCT02360605|colorectal cancer screening|colorectal cancer screening
151919|NCT02360605|low literacy|low literacy
151920|NCT02360605|community clinics|community clinics
151921|NCT02360605|Fecal Immunochemical Test|fecal immunochemical test
151922|NCT02360579|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
151923|NCT02360579|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
151924|NCT02360579|Cellular Immuno-therapy|cellular immuno-therapy
151925|NCT02360579|Cell Therapy|cell therapy
151926|NCT02360579|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
151927|NCT02360579|TIL|til
151928|NCT02360579|LN-144|ln-144
151929|NCT02360579|IL-2|il-2
151930|NCT02360579|Melanoma|melanoma
151931|NCT02360566|Psychosis|psychosis
152249|NCT02358824|Telmisartan|telmisartan
151932|NCT02360566|Schizophrenia|schizophrenia
151933|NCT02360566|Participatory Video|participatory video
151934|NCT02360566|Narrative|narrative
151935|NCT02360540|Pulmonary Embolism|pulmonary embolism
151936|NCT02360540|Diagnostic strategy|diagnostic strategy
151937|NCT02360540|Exclusion|exclusion
151938|NCT02360540|Clinical probability|clinical probability
151939|NCT02360540|Implicit Judgment (Gestalt)|implicit judgment (gestalt)
151940|NCT02360540|PERC|perc
151941|NCT02360501|nasopharyngeal carcinoma|nasopharyngeal carcinoma
151942|NCT02360501|induction chemotherapy|induction chemotherapy
151943|NCT02360501|docetaxel|docetaxel
151944|NCT02360501|xeloda|xeloda
151945|NCT02360475|Vaccine|vaccine
151946|NCT02360475|Immunogenicity|immunogenicity
151947|NCT02360475|Safety|safety
151948|NCT02360475|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
151949|NCT02360475|Reactogenicity|reactogenicity
151950|NCT02360462|Transcranial Direct Current Stimulation|transcranial direct current stimulation
151951|NCT02360462|tDCS|tdcs
151952|NCT02360462|Hallux Valgus|hallux valgus
151953|NCT02360462|Chronic Pain|chronic pain
151954|NCT02360449|Pivotal Response Treatment|pivotal response treatment
151955|NCT02360449|Applied Behavior Analysis|applied behavior analysis
151956|NCT02360449|Peer Initiation|peer initiation
151957|NCT02360449|Social Skills Group|social skills group
151958|NCT02360436|Rett|rett
151959|NCT02360436|MeCP2|mecp2
151960|NCT02360436|Glutathione|glutathione
151961|NCT02360436|Cysteine|cysteine
151962|NCT02360436|ROS|ros
151963|NCT02360384|wireless motility capsule|wireless motility capsule
151964|NCT02360332|Autism|autism
151965|NCT02360332|transition to adulthood|transition to adulthood
151966|NCT02360332|employment|employment
151967|NCT02360332|High School Seniors|high school seniors
151968|NCT02360319|First episode or recent onset|first episode or recent onset
151969|NCT02360293|Exercise|exercise
151970|NCT02360293|App-mediated|app-mediated
151971|NCT02360293|Veterans|veterans
151972|NCT02360280|Depressive Disorder, Treatment-Resistant|depressive disorder, treatment-resistant
151973|NCT02360267|Bipolar Disorder|bipolar disorder
151974|NCT02360267|Pediatric|pediatric
151975|NCT02360267|Offspring|offspring
151976|NCT02360267|Depression|depression
151977|NCT02360267|Mania|mania
151978|NCT02360267|Children of parents who suffer from Bipolar disorder|children of parents who suffer from bipolar disorder
151979|NCT02360228|tACS|tacs
151980|NCT02360228|tDCS|tdcs
151981|NCT02360228|sham|sham
151982|NCT02360228|auditory hallucinations|auditory hallucinations
151983|NCT02360228|Schizophrenia|schizophrenia
151984|NCT02360228|Schizoaffective Disorder|schizoaffective disorder
151985|NCT02360176|single port surgery|single port surgery
151986|NCT02360176|bariatric surgery|bariatric surgery
151987|NCT02360176|sleeve gastrectomy|sleeve gastrectomy
151988|NCT02360176|randomise prospective study|randomise prospective study
151989|NCT02360176|complication rate|complication rate
151990|NCT02360150|cardiac angiography|cardiac angiography
151991|NCT02360150|cardiac MRI|cardiac mri
151992|NCT02360137|carotids|carotids
151993|NCT02360137|plaque|plaque
151994|NCT02360137|characteristics|characteristics
151995|NCT02360137|stroke|stroke
151996|NCT02360111|GVHD Prophylaxis|gvhd prophylaxis
151997|NCT02360111|Cyclophosphamide|cyclophosphamide
151998|NCT02360111|Renal Insufficiency|renal insufficiency
151999|NCT02360111|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
152001|NCT02360098|Emergence from Anesthesia|emergence from anesthesia
152002|NCT02360098|Anterior temporal lobectomy|anterior temporal lobectomy
152003|NCT02360098|Amygdalohippocampectomy|amygdalohippocampectomy
152004|NCT02360098|Anesthesia|anesthesia
152005|NCT02360085|Cervical Myelopathy|cervical myelopathy
152010|NCT02360072|nitric oxide|nitric oxide
152011|NCT02360072|bronchial hyper-responsiveness|bronchial hyper-responsiveness
152012|NCT02360059|Breast cancer|breast cancer
152013|NCT02360059|Neuropathy|neuropathy
152014|NCT02360059|Paclitaxel|paclitaxel
152015|NCT02360059|Metformin|metformin
152016|NCT02360059|Metformin ER|metformin er
152018|NCT02360059|Sugar pill|sugar pill
152019|NCT02360059|Questionnaires|questionnaires
152020|NCT02360059|Sensory tests|sensory tests
152021|NCT02360059|Fine-motor tests|fine-motor tests
152022|NCT02360059|Surveys|surveys
152023|NCT02360020|coronary stent|coronary stent
152024|NCT02360020|outcome|outcome
152025|NCT02360007|opioids|opioids
152027|NCT02360007|interim treatment|interim treatment
152028|NCT02360007|opioid dependence|opioid dependence
152030|NCT02359981|Weight loss, Fitness|weight loss, fitness
152031|NCT02359968|resectable esophageal|resectable esophageal
152032|NCT02359968|junctional cancer|junctional cancer
152033|NCT02359968|FOLFOX|folfox
152034|NCT02359968|paclitaxel-carboplatin|paclitaxel-carboplatin
152035|NCT02359942|Helicobacter pylori infection|helicobacter pylori infection
152036|NCT02359942|Eradication|eradication
152037|NCT02359942|Urea breath test|urea breath test
152038|NCT02359929|graft versus host disease|graft versus host disease
152039|NCT02359929|GVHD|gvhd
152043|NCT02359877|pegylated interferon beta|pegylated interferon beta
152045|NCT02359838|Hematologic Malignancy|hematologic malignancy
152046|NCT02359838|Geriatric Assessment|geriatric assessment
152047|NCT02359838|Geriatric Oncology|geriatric oncology
152048|NCT02359838|Frailty|frailty
152049|NCT02359812|Stroke|stroke
152050|NCT02359812|Hemiplegia|hemiplegia
152051|NCT02359812|Upper extremity|upper extremity
152052|NCT02359812|Muscle hypertonia|muscle hypertonia
152053|NCT02359812|Arm|arm
152054|NCT02359812|Hand|hand
152055|NCT02359799|Cerebral palsy|cerebral palsy
152056|NCT02359799|Ankle|ankle
152057|NCT02359773|Magnetocardiography|magnetocardiography
152058|NCT02359773|Myocardial Infarction|myocardial infarction
152059|NCT02359773|Non-ischaemic chest pain|non-ischaemic chest pain
152060|NCT02359760|Rapid orthodontics|rapid orthodontics
152061|NCT02359760|accelerated orthodontics|accelerated orthodontics
152062|NCT02359760|Piezocision|piezocision
152063|NCT02359760|flapless corticotomies|flapless corticotomies
152064|NCT02359760|minimaly invasive|minimaly invasive
152065|NCT02359747|free gDNA|free gdna
152066|NCT02359747|culture media|culture media
152067|NCT02359734|Patient safety|patient safety
152068|NCT02359734|Medication errors|medication errors
152069|NCT02359734|Smart infusion pump|smart infusion pump
152070|NCT02359721|Colony forming units Antimicrobial agents|colony forming units antimicrobial agents
152071|NCT02359721|Microbial colonization|microbial colonization
152072|NCT02359695|Poor ovarian response|poor ovarian response
152073|NCT02359695|IVF|ivf
152074|NCT02359695|Growth hormone|growth hormone
152075|NCT02359643|Kawasaki disease|kawasaki disease
152076|NCT02359617|continuous glucose sensor|continuous glucose sensor
152077|NCT02359617|subcutaneous insulin infusion|subcutaneous insulin infusion
152078|NCT02359617|closed-loop glucose control|closed-loop glucose control
152079|NCT02359617|type 1 diabetes|type 1 diabetes
152080|NCT02359604|infant|infant
152081|NCT02359604|ppi|ppi
152082|NCT02359604|proton pump inhibitor|proton pump inhibitor
152083|NCT02359604|microbiome|microbiome
152084|NCT02359604|Microbiota|microbiota
152085|NCT02359578|lymphatic system|lymphatic system
152086|NCT02359578|occlusion pressure|occlusion pressure
152087|NCT02359578|Indocyanine Green|indocyanine green
152088|NCT02359526|Chronic Diabetic Macular Edema|chronic diabetic macular edema
152089|NCT02359526|Iluvien|iluvien
152090|NCT02359526|Intra-vitreal injections|intra-vitreal injections
152091|NCT02359526|Pilot study|pilot study
152092|NCT02359513|bulimia|bulimia
152093|NCT02359513|serotoninergic brain activity|serotoninergic brain activity
152094|NCT02359513|fluoxetine|fluoxetine
152095|NCT02359513|serotoninergic antidepressant|serotoninergic antidepressant
142868|NCT02412995|satiety|satiety
152096|NCT02359513|brain serotonin profile|brain serotonin profile
152097|NCT02359513|positon emission tomography|positon emission tomography
152098|NCT02359500|68Ga- DOTATOC|68ga- dotatoc
152099|NCT02359500|Diagnosis|diagnosis
152100|NCT02359500|Somatostatin Receptor-Positive Neuroendocrine Tumors|somatostatin receptor-positive neuroendocrine tumors
152101|NCT02359487|Namibia|namibia
152102|NCT02359487|Alcohol|alcohol
152103|NCT02359487|HIV|hiv
152104|NCT02359487|Sexual risk|sexual risk
152105|NCT02359474|high-risk soft tissue sarcoma|high-risk soft tissue sarcoma
152106|NCT02359474|trabectedin|trabectedin
152107|NCT02359461|Vascular function|vascular function
152108|NCT02359461|Pulsatile cuts|pulsatile cuts
152109|NCT02359461|Type 2 diabetes|type 2 diabetes
152110|NCT02359461|Endothelium|endothelium
152111|NCT02359461|Cardiovascular risk|cardiovascular risk
152112|NCT02359461|Vasomotricity|vasomotricity
152113|NCT02359461|FMD (Flow Mediated Dilatation)|fmd (flow mediated dilatation)
152114|NCT02359435|Helicobacter pylori|helicobacter pylori
152115|NCT02359435|Proton pump inhibitor|proton pump inhibitor
152116|NCT02359435|Eradication|eradication
152117|NCT02359396|Randomized open-label study|randomized open-label study
152118|NCT02359396|Chinese Herbal|chinese herbal
152119|NCT02359396|Constipation/drug therapy|constipation/drug therapy
152120|NCT02359383|pleural disease|pleural disease
152121|NCT02359383|infecTion|infection
152122|NCT02359383|chest physiotherapy|chest physiotherapy
152123|NCT02359370|Laryngoscopy|laryngoscopy
152124|NCT02359370|Tracheal Intubation|tracheal intubation
152125|NCT02359370|Lidocaine|lidocaine
152126|NCT02359370|Magnesium Sulphate|magnesium sulphate
585908|NCT00522743|SGA|sga
152127|NCT02359370|Cardiovascular Physiological Phenomena|cardiovascular physiological phenomena
152128|NCT02359331|Helicobacter pylori|helicobacter pylori
152129|NCT02359331|resistance|resistance
152130|NCT02359331|rescue therapy|rescue therapy
152131|NCT02359318|White spot lesion|white spot lesion
152132|NCT02359318|Resin Infiltration|resin infiltration
152133|NCT02359318|Icon|icon
152134|NCT02359318|Debonding|debonding
152135|NCT02359318|Enamel damages|enamel damages
152136|NCT02359318|Enamel|enamel
152137|NCT02359318|Orthodontics|orthodontics
152138|NCT02359266|Mood|mood
152139|NCT02359266|Vitamin D deficiency|vitamin d deficiency
152140|NCT02359266|Adjuvant treatment|adjuvant treatment
152141|NCT02359253|Stroke|stroke
152142|NCT02359253|Hemiplegia|hemiplegia
152143|NCT02359253|Muscle Spasticity|muscle spasticity
152558|NCT02357134|Dyspnea|dyspnea
152144|NCT02359253|Upper extremity|upper extremity
152145|NCT02359253|Arm|arm
152146|NCT02359253|Hand|hand
152147|NCT02359253|Passive stretching|passive stretching
152148|NCT02359253|Muscle Stretching Exercises|muscle stretching exercises
152149|NCT02359253|Occupational Therapy|occupational therapy
152150|NCT02359253|Physical Therapy|physical therapy
152151|NCT02359227|Chronic Heart Failure|chronic heart failure
152152|NCT02359227|Natriuretic Peptides|natriuretic peptides
152153|NCT02359227|Cenderitide|cenderitide
152154|NCT02359214|Vitamin D|vitamin d
152155|NCT02359214|Cardiovascular disease|cardiovascular disease
152156|NCT02359214|Diabetes|diabetes
152157|NCT02359214|Obesity|obesity
152158|NCT02359214|Cardiometabolic|cardiometabolic
152159|NCT02359214|Bone disease|bone disease
152160|NCT02359201|Nicotine replacement therapy|nicotine replacement therapy
152161|NCT02359201|craving|craving
152162|NCT02359201|Healthy moderately dependant smokers|healthy moderately dependant smokers
152163|NCT02359188|Vagus Nerve Stimulation|vagus nerve stimulation
152164|NCT02359175|Pain|pain
152165|NCT02359175|Pain Measurement|pain measurement
152166|NCT02359175|VAS|vas
152167|NCT02359175|Visual Analog Pain Scale|visual analog pain scale
152168|NCT02359175|Analgesics|analgesics
152169|NCT02359175|Opioid|opioid
152170|NCT02359175|Epidural analgesia|epidural analgesia
152171|NCT02359175|VATS|vats
152172|NCT02359175|Video-assisted Thoracic Surgery|video-assisted thoracic surgery
152173|NCT02359175|Lobectomy|lobectomy
152174|NCT02359175|Wedge Resection|wedge resection
152175|NCT02359175|Segmental Resection|segmental resection
152176|NCT02359162|NK/T-cell lymphoma|nk/t-cell lymphoma
152177|NCT02359162|induction chemotherapy|induction chemotherapy
152178|NCT02359162|survival|survival
152179|NCT02359149|Intravitreal injections|intravitreal injections
152180|NCT02359149|Nurses|nurses
152181|NCT02359149|Physicians|physicians
152182|NCT02359136|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
152183|NCT02359136|Anesthesia, Local|anesthesia, local
152184|NCT02359136|Ropivacaine|ropivacaine
152185|NCT02359136|Randomized controlled trial|randomized controlled trial
152186|NCT02359110|laparoscopy|laparoscopy
152187|NCT02359110|postoperative pain|postoperative pain
152188|NCT02359110|gynecology|gynecology
152189|NCT02359110|gabapentin|gabapentin
152190|NCT02359071|handoff|handoff
152191|NCT02359071|signoff|signoff
152192|NCT02359071|handover|handover
152193|NCT02359071|sign-out|sign-out
152194|NCT02359071|shift change|shift change
152195|NCT02359071|Emergency Department|emergency department
152196|NCT02359045|Omega-3-carboxylic acids,|omega-3-carboxylic acids,
152197|NCT02359045|Phase I,|phase i,
152198|NCT02359045|Healthy Subjects,|healthy subjects,
152199|NCT02359045|Pharmacokinetics,|pharmacokinetics,
152200|NCT02359045|Relative bioavailability|relative bioavailability
152201|NCT02359032|Healthy subjects|healthy subjects
152202|NCT02359032|Pharmacokinetics of ASP6858|pharmacokinetics of asp6858
152203|NCT02359032|ASP6858|asp6858
152204|NCT02359032|Pharmacodynamics of ASP6858|pharmacodynamics of asp6858
152205|NCT02359006|Analgesia|analgesia
152206|NCT02359006|pain analgesia|pain analgesia
152207|NCT02359006|methadone|methadone
152208|NCT02359006|opiates|opiates
152209|NCT02358993|Urinary Tract Infections|urinary tract infections
152210|NCT02358993|Catheter-Related Infections|catheter-related infections
152507|NCT02357459|Pain|pain
152217|NCT02358980|Cast Nephropathy|cast nephropathy
152218|NCT02358980|Acute kidney injury|acute kidney injury
152219|NCT02358980|KIDNEY THERAPY|kidney therapy
152220|NCT02358980|HFR|hfr
152221|NCT02358967|ESRD|esrd
152222|NCT02358967|dyslipidemia|dyslipidemia
152223|NCT02358967|oxidative stress|oxidative stress
152224|NCT02358967|inflammation|inflammation
152225|NCT02358967|Hemodialysis|hemodialysis
152226|NCT02358967|CKD|ckd
152227|NCT02358954|quantitative sensory testing|quantitative sensory testing
152228|NCT02358954|contact heat evoked potentials|contact heat evoked potentials
152229|NCT02358954|vection stimulation|vection stimulation
152230|NCT02358954|3D-turntable|3d-turntable
152231|NCT02358954|Volunteers|volunteers
152232|NCT02358941|ADHD, neurofeedback, computerized cognitive training, school|adhd, neurofeedback, computerized cognitive training, school
152233|NCT02358928|NAFLD|nafld
152234|NCT02358928|Metabolic syndrome|metabolic syndrome
152235|NCT02358928|Hepatic Magnetic Resonance Spectroscopy|hepatic magnetic resonance spectroscopy
152236|NCT02358928|Obesity|obesity
152237|NCT02358902|Transcranial Direct Current Stimulation|transcranial direct current stimulation
152238|NCT02358902|Exercise|exercise
152239|NCT02358902|Fibromyalgia|fibromyalgia
152240|NCT02358876|Parkinson's disease|parkinson's disease
152241|NCT02358876|Deep brain stimulation|deep brain stimulation
152242|NCT02358876|Bradykinesia|bradykinesia
152243|NCT02358850|Tonsillectomy|tonsillectomy
152244|NCT02358850|Adenoidectomy|adenoidectomy
152245|NCT02358837|elastosonography|elastosonography
152371|NCT02358226|Men|men
152246|NCT02358837|comparing conventional sonography with ductosonography|comparing conventional sonography with ductosonography
152247|NCT02358824|Hypertension|hypertension
152248|NCT02358824|CKD-828|ckd-828
152250|NCT02358824|S-amlodipine|s-amlodipine
152251|NCT02358824|Pharmacokinetic|pharmacokinetic
152252|NCT02358811|Obstructive Sleep Apnea|obstructive sleep apnea
152253|NCT02358811|Voxel-Based Morphometry|voxel-based morphometry
152254|NCT02358811|Polysomnography|polysomnography
152255|NCT02358811|Magnetic resonance imaging|magnetic resonance imaging
152256|NCT02358798|Time evolution of respiratory function|time evolution of respiratory function
152257|NCT02358798|Longitudinal multicenter monitoring of large cohorts|longitudinal multicenter monitoring of large cohorts
152258|NCT02358798|Preschool aged children|preschool aged children
152259|NCT02358798|Detection of cystic fibrosis in neonatal period|detection of cystic fibrosis in neonatal period
152260|NCT02358772|stroke|stroke
152261|NCT02358772|thrombolysis|thrombolysis
152262|NCT02358772|STEMO|stemo
152263|NCT02358759|Abnormal zygote fertilization|abnormal zygote fertilization
152264|NCT02358759|3PNs correction|3pns correction
152265|NCT02358759|Giant oocyte management|giant oocyte management
152266|NCT02358759|triploidy fertilization|triploidy fertilization
152267|NCT02358759|Maternal nucleus removal|maternal nucleus removal
152268|NCT02358746|epicardial catheter ablation|epicardial catheter ablation
152269|NCT02358733|POR|por
152270|NCT02358733|IMSI|imsi
152271|NCT02358720|bone metastases|bone metastases
152272|NCT02358707|ibuprofen phonophoresis|ibuprofen phonophoresis
152273|NCT02358707|High performance liquid chromatography|high performance liquid chromatography
152274|NCT02358694|IBS|ibs
152275|NCT02358694|IBS-D|ibs-d
152276|NCT02358694|SBI|sbi
152277|NCT02358681|Intranasal|intranasal
152278|NCT02358681|Ketorolac|ketorolac
152279|NCT02358681|Pediatric|pediatric
152280|NCT02358681|Migraine|migraine
152281|NCT02358681|Headache|headache
152282|NCT02358655|Oral anticoagulant|oral anticoagulant
152283|NCT02358655|Knowledge translation|knowledge translation
152284|NCT02358655|Emergency department|emergency department
152285|NCT02358642|Rate of Pneumonia|rate of pneumonia
152286|NCT02358642|Mortality rate|mortality rate
152287|NCT02358603|Chronotropic Incompetence|chronotropic incompetence
152288|NCT02358603|Heart Failure|heart failure
152296|NCT02358551|Pacemaker|pacemaker
152297|NCT02358551|Axillary Vein|axillary vein
152298|NCT02358551|Subclavian vein|subclavian vein
152299|NCT02358551|Clinical Study|clinical study
152300|NCT02358551|Cardiovascular implantable electronic devices|cardiovascular implantable electronic devices
152301|NCT02358538|PCDH19|pcdh19
152302|NCT02358538|ganaxolone|ganaxolone
152303|NCT02358538|neurosteroid|neurosteroid
152304|NCT02358538|CDKL5|cdkl5
152305|NCT02358538|LGS|lgs
152306|NCT02358538|CSWS|csws
152307|NCT02358512|Intensive Care|intensive care
152308|NCT02358512|Recovery of Function|recovery of function
152309|NCT02358512|Survivors|survivors
152310|NCT02358512|Outcome Assessment (Health Care)|outcome assessment (health care)
152311|NCT02358512|Medical Economics|medical economics
152312|NCT02358499|triazoles|triazoles
152313|NCT02358499|fungi|fungi
152314|NCT02358499|transplantation, hematopoietic stem cell|transplantation, hematopoietic stem cell
152315|NCT02358499|leukemia|leukemia
152316|NCT02358499|pediatrics|pediatrics
152317|NCT02358499|pharmacokinetics|pharmacokinetics
152318|NCT02358499|bone marrow failure syndrome|bone marrow failure syndrome
152319|NCT02358486|Functional Dyspepsia|functional dyspepsia
152320|NCT02358486|Acupuncture|acupuncture
152321|NCT02358486|Functional MRI|functional mri
152322|NCT02358473|Nonsmall Cell Lung Cancer|nonsmall cell lung cancer
152324|NCT02358473|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
152325|NCT02358473|Carcinoma, Non-Small Cell Lung|carcinoma, non-small cell lung
152326|NCT02358473|KW-0761|kw-0761
152327|NCT02358473|Mogamulizumab|mogamulizumab
152328|NCT02358460|neonatal|neonatal
152329|NCT02358460|respiratory|respiratory
152330|NCT02358460|mechanical ventilation|mechanical ventilation
152331|NCT02358447|total knee arthroplasty|total knee arthroplasty
152332|NCT02358447|total knee prothesis|total knee prothesis
152333|NCT02358447|Spectrometry, X-Ray Emission|spectrometry, x-ray emission
152334|NCT02358447|SPECT/CT|spect/ct
152335|NCT02358447|measurement of TKA component position|measurement of tka component position
152336|NCT02358434|Implant|implant
152337|NCT02358421|Rotterdam's diagnostic criteria of PCOS|rotterdam's diagnostic criteria of pcos
152338|NCT02358421|Risk of OHSS|risk of ohss
152339|NCT02358356|midgut|midgut
152340|NCT02358356|pancreatic|pancreatic
152341|NCT02358356|neuroendocrine|neuroendocrine
152342|NCT02358356|advanced|advanced
152343|NCT02358356|unresectable low|unresectable low
152344|NCT02358356|intermediate grade|intermediate grade
152345|NCT02358356|mNETs|mnets
152346|NCT02358356|pNETs|pnets
152347|NCT02358343|Comorbid Depression|comorbid depression
152348|NCT02358343|Major Depressive Disorder|major depressive disorder
152349|NCT02358343|Dysthymia|dysthymia
152350|NCT02358343|Cognitive Behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
152351|NCT02358343|Sertraline|sertraline
152352|NCT02358343|Engagement Interview|engagement interview
152353|NCT02358343|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
152354|NCT02358343|Hemodialysis|hemodialysis
152355|NCT02358317|Autism|autism
152356|NCT02358317|Postural Stability|postural stability
152357|NCT02358317|Exergaming|exergaming
152358|NCT02358317|White Matter|white matter
152359|NCT02358252|Heart Rate Variability|heart rate variability
152360|NCT02358252|orthostatic hypotension|orthostatic hypotension
152361|NCT02358252|stroke|stroke
152362|NCT02358252|integrated intelligent biosensor system|integrated intelligent biosensor system
152363|NCT02358239|dizziness and vertigo|dizziness and vertigo
152364|NCT02358239|emergency department (ED)|emergency department (ed)
152365|NCT02358239|clinical trial|clinical trial
152366|NCT02358239|acupuncture|acupuncture
152367|NCT02358226|Substance-Related Disorders|substance-related disorders
152368|NCT02358226|Human Immunodeficiency Virus|human immunodeficiency virus
152369|NCT02358226|Alcoholism|alcoholism
152370|NCT02358226|South Africa|south africa
152372|NCT02358226|Soccer|soccer
152373|NCT02358226|Vocational Training|vocational training
152374|NCT02358213|reproductibility|reproductibility
152375|NCT02358174|Hemorrhoids|hemorrhoids
152377|NCT02358174|NGAL|ngal
152378|NCT02358174|Matrix Metalloproteinases|matrix metalloproteinases
152379|NCT02358161|Pancreatic cancer|pancreatic cancer
152380|NCT02358161|LDE225|lde225
152381|NCT02358161|Gemcitabine|gemcitabine
152382|NCT02358161|nab paclitaxel|nab paclitaxel
152383|NCT02358148|Acute Coronary Syndrome|acute coronary syndrome
152384|NCT02358148|Chest Pain|chest pain
152385|NCT02358148|ACS|acs
152386|NCT02358148|Risk Stratification Score|risk stratification score
152387|NCT02358148|HEART Score|heart score
152388|NCT02358148|Modified TIMI|modified timi
152389|NCT02358148|Coronary Artery Disease|coronary artery disease
152390|NCT02358148|Risk Factors|risk factors
152391|NCT02358148|Myocardial Infarction|myocardial infarction
152392|NCT02358135|Pragmatic|pragmatic
152393|NCT02358135|Equivalency|equivalency
152394|NCT02358135|Teledermatology|teledermatology
152395|NCT02358109|Cost-Benefit Analysis, Exercise,Women,Diseases/Prevention|cost-benefit analysis, exercise,women,diseases/prevention
152396|NCT02358096|Chronic Kidney Disease|chronic kidney disease
152397|NCT02358096|Type 2 Diabetes|type 2 diabetes
152398|NCT02358096|ASP8232|asp8232
152399|NCT02358070|Hepatocellular Carcinoma|hepatocellular carcinoma
152400|NCT02358057|Deep sedation|deep sedation
152401|NCT02358057|Dexmedetomidine|dexmedetomidine
143214|NCT02411071|HIV-1|hiv-1
152402|NCT02358057|Emergency Service, Hospital|emergency service, hospital
152403|NCT02358031|PD-1|pd-1
152404|NCT02358031|PD-L1|pd-l1
152405|NCT02358018|68Ga-DOTATOC|68ga-dotatoc
152406|NCT02358018|PET/CT scan|pet/ct scan
152407|NCT02358018|14-226|14-226
152408|NCT02357992|Lung cancer|lung cancer
152409|NCT02357992|Non-small cell lung cancer|non-small cell lung cancer
152410|NCT02357992|NSCLC|nsclc
152411|NCT02357992|Squamous cell carcinoma|squamous cell carcinoma
152412|NCT02357992|Adenocarcinoma with or without BAC features|adenocarcinoma with or without bac features
152413|NCT02357992|Large cell carcinoma with or without neuroendocrine features|large cell carcinoma with or without neuroendocrine features
152414|NCT02357992|Neuroendocrine carcinoma|neuroendocrine carcinoma
152415|NCT02357992|Bronchioloalveolar cell carcinoma|bronchioloalveolar cell carcinoma
152416|NCT02357992|Stereotactic radiotherapy (SRT)|stereotactic radiotherapy (srt)
152417|NCT02357992|SRT|srt
152418|NCT02357992|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
152419|NCT02357992|SABR|sabr
152420|NCT02357992|Radiation therapy|radiation therapy
152421|NCT02357992|XRT|xrt
152422|NCT02357979|caries|caries
152423|NCT02357979|prevention|prevention
152424|NCT02357979|laser|laser
152425|NCT02357979|fluoride|fluoride
152426|NCT02357966|Staph|staph
152427|NCT02357966|antibody|antibody
152428|NCT02357940|Eczema|eczema
152429|NCT02357940|Skin Irritation|skin irritation
152430|NCT02357927|fears of recurrence|fears of recurrence
152431|NCT02357927|cancer|cancer
152432|NCT02357927|brief intervention|brief intervention
152433|NCT02357927|telephone counseling|telephone counseling
152434|NCT02357927|following primary cancer treatment|following primary cancer treatment
152435|NCT02357914|Ultrasound|ultrasound
152436|NCT02357914|Shoulder|shoulder
152437|NCT02357914|Spinal Cord Injury|spinal cord injury
152438|NCT02357914|Fluoroscopy|fluoroscopy
152439|NCT02357888|Nicotine replacement therapy|nicotine replacement therapy
152440|NCT02357888|craving|craving
152441|NCT02357862|Cardiovascular Diseases|cardiovascular diseases
152442|NCT02357862|Heart Diseases|heart diseases
152443|NCT02357862|Heart Valve Diseases|heart valve diseases
152444|NCT02357862|Mitral Valve Annuloplasty|mitral valve annuloplasty
152445|NCT02357862|Tricuspid Valve Insufficiency|tricuspid valve insufficiency
152446|NCT02357823|Pneumococcal vaccine|pneumococcal vaccine
152447|NCT02357823|HIV infection|hiv infection
152448|NCT02357823|13-valent Pneumococcal Conjugate Vaccine|13-valent pneumococcal conjugate vaccine
152449|NCT02357823|23-valent Pneumococcal Polysaccharide Vaccine|23-valent pneumococcal polysaccharide vaccine
152450|NCT02357784|Sacral Neuromodulation|sacral neuromodulation
152451|NCT02357784|SNM|snm
152452|NCT02357784|Dual Incontinence|dual incontinence
152453|NCT02357784|Current Perception Threshold Testing|current perception threshold testing
152454|NCT02357784|CPT Testing|cpt testing
152455|NCT02357784|Fecal Incontinence|fecal incontinence
152456|NCT02357784|Urinary Incontinence|urinary incontinence
152457|NCT02357784|Afferent Nerve Sensation|afferent nerve sensation
152458|NCT02357784|InterStim|interstim
152459|NCT02357771|misalignment of the two dental arches|misalignment of the two dental arches
152460|NCT02357771|mal-align teeth|mal-align teeth
152461|NCT02357758|Antibiotic Prophylaxis|antibiotic prophylaxis
152462|NCT02357758|Urinary Microbiota|urinary microbiota
152463|NCT02357745|neopterin|neopterin
152464|NCT02357745|plasma|plasma
152465|NCT02357745|urine|urine
152466|NCT02357745|saliva|saliva
152467|NCT02357745|menopause|menopause
152468|NCT02357745|periodontitis|periodontitis
152469|NCT02357732|Metastatic Melanoma|metastatic melanoma
152470|NCT02357719|Sleep Apnea Syndromes|sleep apnea syndromes
152471|NCT02357719|Polysomnography|polysomnography
152472|NCT02357719|Holter ECG|holter ecg
152473|NCT02357719|Thoracic impedance|thoracic impedance
152474|NCT02357719|Heart rate variability|heart rate variability
152475|NCT02357719|Nasal flow|nasal flow
152476|NCT02357693|nausea, postoperative|nausea, postoperative
152477|NCT02357693|postoperative nausea|postoperative nausea
152478|NCT02357693|postoperative vomiting|postoperative vomiting
152479|NCT02357693|vomiting, postoperative|vomiting, postoperative
152480|NCT02357641|acute coronary disease, echographic strain analysis, cut off|acute coronary disease, echographic strain analysis, cut off
152481|NCT02357602|Participants|participants
152482|NCT02357602|HIV-1 negative|hiv-1 negative
152483|NCT02357589|3D|3d
152484|NCT02357589|laparoscopy|laparoscopy
152485|NCT02357589|cholecystectomy|cholecystectomy
152486|NCT02357563|fibroid|fibroid
152487|NCT02357563|GnRH analogue|gnrh analogue
152488|NCT02357563|ulipristal acetate|ulipristal acetate
152489|NCT02357537|Telemedicine|telemedicine
152490|NCT02357524|Effects on coagulation tests in healthy volunteers|effects on coagulation tests in healthy volunteers
152491|NCT02357511|sensitivity|sensitivity
152492|NCT02357511|specificity|specificity
152493|NCT02357511|novel blood pressure monitor|novel blood pressure monitor
152494|NCT02357511|Saturation|saturation
152495|NCT02357498|pituitary|pituitary
152496|NCT02357498|adenoma|adenoma
152497|NCT02357498|transsphenoidal surgery|transsphenoidal surgery
152498|NCT02357485|ADSC|adsc
152499|NCT02357485|osteoarthritis|osteoarthritis
152500|NCT02357485|knee|knee
152501|NCT02357485|adipose|adipose
152502|NCT02357472|Reproductive aging|reproductive aging
152503|NCT02357472|DHEA|dhea
152504|NCT02357472|poor ovarian responder|poor ovarian responder
152505|NCT02357459|Osteoarthritis|osteoarthritis
152506|NCT02357459|Knee|knee
152508|NCT02357459|Steroid|steroid
152509|NCT02357459|Intra-articular|intra-articular
152510|NCT02357459|Injection|injection
152511|NCT02357420|Diabetes Mellitus|diabetes mellitus
152512|NCT02357420|Delayed Gastric Emptying|delayed gastric emptying
152513|NCT02357420|Vomiting|vomiting
152514|NCT02357420|Gastroparesis|gastroparesis
152515|NCT02357420|Gastrointestinal Motility Disorder|gastrointestinal motility disorder
152516|NCT02357407|fluoroquinolones|fluoroquinolones
152517|NCT02357407|pharmacokinetic|pharmacokinetic
152518|NCT02357407|infections|infections
152519|NCT02357368|HIV-negative|hiv-negative
152520|NCT02357329|fat taste|fat taste
152522|NCT02357329|consumption|consumption
152523|NCT02357329|free fatty acids|free fatty acids
152524|NCT02357316|Taste responses of healthy individuals|taste responses of healthy individuals
152525|NCT02357303|Randomized controlled trial|randomized controlled trial
152526|NCT02357303|Endoscopy|endoscopy
152527|NCT02357303|Gastric mucosa|gastric mucosa
152528|NCT02357303|Simethicone|simethicone
152529|NCT02357303|Acetylcysteine|acetylcysteine
152530|NCT02357290|mania|mania
152531|NCT02357290|temper tantrum|temper tantrum
152532|NCT02357290|irritability|irritability
152533|NCT02357290|mood|mood
152534|NCT02357290|bipolar|bipolar
152535|NCT02357277|Osteoporosis|osteoporosis
152536|NCT02357277|Glucocorticoids|glucocorticoids
152537|NCT02357277|Postmenopausal|postmenopausal
152538|NCT02357238|Uveitis|uveitis
152539|NCT02357238|Infectious|infectious
152540|NCT02357225|Pompe disease|pompe disease
152541|NCT02357225|Pyridostigmine|pyridostigmine
152542|NCT02357212|Non-St elevation acute coronary syndrome|non-st elevation acute coronary syndrome
152543|NCT02357199|Mouth Diseases|mouth diseases
152544|NCT02357199|Renal Insufficiency, Chronic|renal insufficiency, chronic
152545|NCT02357199|Intervention Studies|intervention studies
152546|NCT02357186|Mild head injury - clinical decision rule - Child|mild head injury - clinical decision rule - child
152547|NCT02357173|smoking|smoking
152548|NCT02357173|nicotine|nicotine
152549|NCT02357173|tobacco products|tobacco products
152550|NCT02357173|electronic cigarette|electronic cigarette
152551|NCT02357147|Amatuximab|amatuximab
152552|NCT02357147|Pemetrexed|pemetrexed
152553|NCT02357147|Cisplatin|cisplatin
152554|NCT02357147|Unresectable Malignant Pleural Mesothelioma|unresectable malignant pleural mesothelioma
152555|NCT02357147|ARTEMIS|artemis
152556|NCT02357134|Advanced cancers|advanced cancers
152557|NCT02357134|Primary or secondary lung involvement|primary or secondary lung involvement
152559|NCT02357134|Difficulty breathing|difficulty breathing
152560|NCT02357134|Stationary cycle test|stationary cycle test
152561|NCT02357134|Questionnaires|questionnaires
152562|NCT02357134|Surveys|surveys
152563|NCT02357134|High flow oxygen|high flow oxygen
152564|NCT02357134|High flow air|high flow air
152565|NCT02357134|Low flow oxygen|low flow oxygen
152566|NCT02357134|Low flow air|low flow air
152567|NCT02357108|Supportive Care|supportive care
152568|NCT02357108|treatment options|treatment options
152569|NCT02357108|doctor's compassion|doctor's compassion
152570|NCT02357095|Caesarean Scar Pregnancy|caesarean scar pregnancy
152571|NCT02357095|uterine artery chemo-embolization|uterine artery chemo-embolization
152572|NCT02357095|treatment|treatment
152573|NCT02357030|Gulf War Illness|gulf war illness
152574|NCT02357030|nutrients|nutrients
152575|NCT02357030|methylphenidate|methylphenidate
152576|NCT02357030|mitochondria|mitochondria
152577|NCT02356991|Famitinib|famitinib
152578|NCT02356991|Phase II|phase ii
152579|NCT02356991|NSCLC|nsclc
152580|NCT02356978|Rare disease|rare disease
152581|NCT02356978|Crigler-Najjar disease|crigler-najjar disease
152582|NCT02356978|Paediatric|paediatric
152583|NCT02356978|Experimental device|experimental device
152584|NCT02356965|Third molar extraction|third molar extraction
152585|NCT02356965|Wisdom tooth extraction|wisdom tooth extraction
152586|NCT02356952|Metabolic Syndrome X|metabolic syndrome x
152587|NCT02356952|Low Glycemic Index Mediterranean Diet|low glycemic index mediterranean diet
152588|NCT02356952|Low Glycemic Index Diet|low glycemic index diet
152589|NCT02356952|Randomized Clinical Trial|randomized clinical trial
152590|NCT02356926|Adverse events|adverse events
152591|NCT02356926|Medical errors|medical errors
152592|NCT02356926|Emergency department|emergency department
152593|NCT02356926|Cross checking|cross checking
152594|NCT02356900|interval training|interval training
152595|NCT02356900|hyperbaric oxygen|hyperbaric oxygen
152596|NCT02356900|VO2 max|vo2 max
152597|NCT02356900|altitude|altitude
152598|NCT02356900|exercise performance|exercise performance
152599|NCT02356900|mitochondrial oxidative capacity|mitochondrial oxidative capacity
152600|NCT02356900|mitochondrial biogenesis|mitochondrial biogenesis
152601|NCT02356861|treatment|treatment
152602|NCT02356861|photobiomodulation|photobiomodulation
152603|NCT02356861|Veterans|veterans
152604|NCT02356861|brain-injury|brain-injury
152606|NCT02356861|PTSD|ptsd
152607|NCT02356848|self-care|self-care
152708|NCT02356146|genotype|genotype
152608|NCT02356848|self-monitoring|self-monitoring
152609|NCT02356848|secondary prevention|secondary prevention
152610|NCT02356848|foot ulcer|foot ulcer
152611|NCT02356809|Gene therapy, plasmid, vegf, systemic scleroderma,secondary raynaud's phenomenon|gene therapy, plasmid, vegf, systemic scleroderma,secondary raynaud's phenomenon
152612|NCT02356757|self-care|self-care
152613|NCT02356757|self-monitoring|self-monitoring
152614|NCT02356757|medication adherence|medication adherence
152615|NCT02356757|diet|diet
152616|NCT02356757|physical activity|physical activity
152617|NCT02356757|primary prevention|primary prevention
153015|NCT02354313|ASCT|asct
152618|NCT02356744|Maternal outcome|maternal outcome
152620|NCT02356744|bariatric surgery|bariatric surgery
152621|NCT02356744|Third Trimester|third trimester
152622|NCT02356731|seizures,|seizures,
152623|NCT02356731|quality of life|quality of life
152624|NCT02356640|Celiac plexus neurolysis|celiac plexus neurolysis
152625|NCT02356640|Celiac ganglion neurolysis|celiac ganglion neurolysis
152626|NCT02356640|Pancreatic cancer|pancreatic cancer
152627|NCT02356627|Occupational therapy|occupational therapy
152628|NCT02356627|Adaptive intervention|adaptive intervention
152629|NCT02356627|Home-based|home-based
152630|NCT02356627|Assistive Technology|assistive technology
152631|NCT02356627|Home modification|home modification
152632|NCT02356627|Clinical effectiveness|clinical effectiveness
152633|NCT02356627|Cost-effectiveness|cost-effectiveness
152634|NCT02356627|Cost-utility|cost-utility
152635|NCT02356614|Lap Band|lap band
152637|NCT02356601|Lumbar spine|lumbar spine
152638|NCT02356601|Ultrasound|ultrasound
152639|NCT02356575|surgery|surgery
152640|NCT02356575|chemotherapy|chemotherapy
152641|NCT02356575|radiation|radiation
152642|NCT02356575|Acupuncture|acupuncture
152643|NCT02356575|16-947|16-947
152644|NCT02356562|Hepatitis C|hepatitis c
152645|NCT02356562|Interferon-Free|interferon-free
152646|NCT02356562|Treatment Experienced|treatment experienced
152647|NCT02356562|Chronic Hepatitis C|chronic hepatitis c
152648|NCT02356562|Hepatitis C Virus|hepatitis c virus
152649|NCT02356510|myocardial infarction|myocardial infarction
152650|NCT02356510|TIMI flow|timi flow
152651|NCT02356510|culprit lesion|culprit lesion
152652|NCT02356510|culprit vessel|culprit vessel
152653|NCT02356497|Bone metastases|bone metastases
152654|NCT02356497|Metastatic bone disease|metastatic bone disease
152655|NCT02356497|Multi-trial facility|multi-trial facility
152656|NCT02356458|Mantle cell lymphoma|mantle cell lymphoma
152657|NCT02356458|Relapsed|relapsed
152658|NCT02356458|Refractory|refractory
152659|NCT02356458|Cancer|cancer
152660|NCT02356458|Lymphoma|lymphoma
152661|NCT02356458|Ibrutinib Imbruvica|ibrutinib imbruvica
152662|NCT02356458|Bortezomib Velcade|bortezomib velcade
152663|NCT02356432|non-valvular atrial fibrillation|non-valvular atrial fibrillation
152664|NCT02356432|cerebral microbleeds|cerebral microbleeds
152665|NCT02356432|warfarin|warfarin
152666|NCT02356432|NOACs|noacs
152667|NCT02356432|acute ischemic stroke|acute ischemic stroke
152668|NCT02356406|Radiosurgery|radiosurgery
152669|NCT02356406|Celiac Plexus|celiac plexus
152670|NCT02356406|Pain|pain
152671|NCT02356406|Quality of Life|quality of life
152672|NCT02356393|Desalinated Sea Water|desalinated sea water
152673|NCT02356393|Magnesium|magnesium
152674|NCT02356393|Drinking Water|drinking water
152675|NCT02356367|telemonitoring|telemonitoring
152676|NCT02356367|Adaptive servo-ventilation|adaptive servo-ventilation
152677|NCT02356354|molecular factors|molecular factors
152678|NCT02356354|cutaneous innervation|cutaneous innervation
152679|NCT02356354|skin biopsy|skin biopsy
152680|NCT02356354|post-burn scar|post-burn scar
152681|NCT02356315|Brain|brain
152682|NCT02356315|Brain Stem|brain stem
152683|NCT02356315|Spinal Cord|spinal cord
152684|NCT02356315|Neurophysiology|neurophysiology
152685|NCT02356315|Magnetic Resonance Imaging|magnetic resonance imaging
152686|NCT02356289|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
152687|NCT02356263|stressful events|stressful events
152688|NCT02356263|psychological stress|psychological stress
152689|NCT02356263|life experiences|life experiences
152690|NCT02356250|liver biopsy f 4|liver biopsy f 4
152691|NCT02356237|Episiotomy|episiotomy
152692|NCT02356237|Obstetric Anal Sphincter Injury|obstetric anal sphincter injury
152693|NCT02356224|SHR3824 Type 2 diabetes mellitus SGLT2|shr3824 type 2 diabetes mellitus sglt2
152694|NCT02356211|falls|falls
152695|NCT02356185|Alcohol Drinking|alcohol drinking
152696|NCT02356185|Injecting drug|injecting drug
152697|NCT02356185|Antiretroviral therapy|antiretroviral therapy
152698|NCT02356185|sub-Saharan Africa|sub-saharan africa
152699|NCT02356172|Quality of Life|quality of life
152700|NCT02356172|Depression|depression
152701|NCT02356172|Kallmann Syndrome|kallmann syndrome
152702|NCT02356172|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
152703|NCT02356159|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
152704|NCT02356159|Lymphoma|lymphoma
152705|NCT02356159|Leukemia|leukemia
152706|NCT02356159|Unrelated Donors|unrelated donors
152707|NCT02356146|Kidney transplantation|kidney transplantation
152709|NCT02356146|tacrolimus|tacrolimus
152710|NCT02356146|CYP3A5|cyp3a5
152711|NCT02356133|Near-Infrared Spectroscopy|near-infrared spectroscopy
152712|NCT02356094|glaucoma|glaucoma
152713|NCT02356094|primary open angle glaucoma|primary open angle glaucoma
152714|NCT02356094|cornea|cornea
152715|NCT02356068|liver transplantation, rotem, bleeding, transfusion|liver transplantation, rotem, bleeding, transfusion
152716|NCT02356055|activities of daily living|activities of daily living
152717|NCT02356055|massed practice|massed practice
152718|NCT02356055|occupational therapy|occupational therapy
152719|NCT02356029|Cardiopulmonary Arrest|cardiopulmonary arrest
152720|NCT02356029|Emergency Medical Services|emergency medical services
152722|NCT02356029|Decision Making|decision making
152723|NCT02356029|Emotional Stress|emotional stress
152724|NCT02356029|Burnout, Professional|burnout, professional
152725|NCT02356016|Sarcopenic Obesity|sarcopenic obesity
152726|NCT02356016|community dwelling elderly women|community dwelling elderly women
152727|NCT02356016|electromyostimulation|electromyostimulation
152728|NCT02356016|exercise|exercise
152729|NCT02356016|dietary supplements|dietary supplements
152730|NCT02356003|Tourette Syndrome|tourette syndrome
152731|NCT02356003|Children|children
152732|NCT02356003|Tics|tics
152733|NCT02355977|Chronic periodontitis|chronic periodontitis
152734|NCT02355977|Minocycline|minocycline
152735|NCT02355977|Surface and root planning|surface and root planning
152736|NCT02355977|Pocket depth|pocket depth
152737|NCT02355977|Sulcus bleeding index|sulcus bleeding index
152738|NCT02355977|Prevotella intermedia|prevotella intermedia
152739|NCT02355912|Transfemoral|transfemoral
152740|NCT02355873|heparin-coated|heparin-coated
152741|NCT02355873|surface-treated polyacrylonitrile membrane hemofilter|surface-treated polyacrylonitrile membrane hemofilter
152742|NCT02355873|critical ill|critical ill
152743|NCT02355873|acute kidney injury|acute kidney injury
152744|NCT02355873|chronic kidney disease|chronic kidney disease
152745|NCT02355873|continuous renal replacement therapy|continuous renal replacement therapy
152746|NCT02355834|Fecal Incontinence (FI)|fecal incontinence (fi)
152747|NCT02355834|Inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
152748|NCT02355834|bowel control|bowel control
152749|NCT02355834|Chronic diarrhoea|chronic diarrhoea
152750|NCT02355834|rectal inflammation|rectal inflammation
152751|NCT02355821|cellular aging|cellular aging
152752|NCT02355821|vascular aging|vascular aging
152753|NCT02355821|bone metabolism|bone metabolism
152754|NCT02355821|collagen type 1 C-telopeptide|collagen type 1 c-telopeptide
152755|NCT02355821|nuclear factor kappa-B ligand (RANKL)|nuclear factor kappa-b ligand (rankl)
152756|NCT02355821|pulse wave velocity|pulse wave velocity
152757|NCT02355821|telomerase activity|telomerase activity
152758|NCT02355795|weight change|weight change
152759|NCT02355795|diet|diet
152760|NCT02355795|dietary fat|dietary fat
152761|NCT02355795|feeding design|feeding design
152762|NCT02355782|TMA, aHUS, TTP, stem cell transplant-associated TMA|tma, ahus, ttp, stem cell transplant-associated tma
152763|NCT02355769|heart failure|heart failure
152764|NCT02355769|renal failure|renal failure
152765|NCT02355769|prognosis|prognosis
152766|NCT02355769|impedance cardiography|impedance cardiography
152767|NCT02355717|children, bone|children, bone
152768|NCT02355717|Simple obesity|simple obesity
152769|NCT02355717|cardiovascular disease|cardiovascular disease
152770|NCT02355717|osteoporosis|osteoporosis
152771|NCT02355717|diabetes|diabetes
152772|NCT02355704|Kidney Transplantation|kidney transplantation
152773|NCT02355704|Atorvastatin|atorvastatin
152774|NCT02355704|C-Reactive Protein|c-reactive protein
152775|NCT02355704|Biopsy|biopsy
152776|NCT02355704|Interleukin|interleukin
152777|NCT02355652|Total knee arthroplasty|total knee arthroplasty
152778|NCT02355652|IKS Score|iks score
152779|NCT02355652|cemented, uncemented|cemented, uncemented
152780|NCT02355626|Anxiety|anxiety
152781|NCT02355626|level of anxiety|level of anxiety
152782|NCT02355626|delirium|delirium
152783|NCT02355626|agitation|agitation
152784|NCT02355626|tools for measuring anxiety|tools for measuring anxiety
152785|NCT02355626|neuroendocrine system|neuroendocrine system
152786|NCT02355613|Radiosurgery, brain, metastases|radiosurgery, brain, metastases
152787|NCT02355600|Oocyte|oocyte
152788|NCT02355600|Tamoxifen|tamoxifen
152789|NCT02355600|Fertility preservation|fertility preservation
152790|NCT02355587|melanoma|melanoma
152791|NCT02355587|cutaneous melanoma|cutaneous melanoma
152792|NCT02355587|DecisionDx-Melanoma|decisiondx-melanoma
152793|NCT02355574|melanoma|melanoma
143602|NCT02408887|Screening|screening
143603|NCT02408874|Nanoparticles|nanoparticles
143604|NCT02408874|Inflammatory Response|inflammatory response
143605|NCT02408874|Silver|silver
143606|NCT02408874|Lung Function|lung function
143607|NCT02408874|Lung Microbiome|lung microbiome
143608|NCT02408835|negative pressure wound therapy|negative pressure wound therapy
143609|NCT02408835|lymphadenectomy|lymphadenectomy
143610|NCT02408835|wound healing|wound healing
143611|NCT02408809|Orthopaedic Smoking Cessation Discussion|orthopaedic smoking cessation discussion
143612|NCT02408809|Smoking Cessation|smoking cessation
143613|NCT02408809|Randomized Controlled Trial|randomized controlled trial
143615|NCT02408757|ultrasound|ultrasound
143671|NCT02408445|XXY|xxy
152794|NCT02355574|cutaneous melanoma|cutaneous melanoma
152795|NCT02355574|DecisionDx-Melanoma|decisiondx-melanoma
152796|NCT02355561|Bioavailability|bioavailability
152797|NCT02355561|Healthy Participants|healthy participants
152798|NCT02355561|JNJ-54861911|jnj-54861911
152799|NCT02355561|Food Effect|food effect
152800|NCT02355535|refractory|refractory
152801|NCT02355535|intolerant|intolerant
152802|NCT02355535|solid tumors|solid tumors
152803|NCT02355535|lymphoma|lymphoma
152804|NCT02355522|saline infusion sonohysterography|saline infusion sonohysterography
152805|NCT02355509|Acarbose|acarbose
152806|NCT02355509|Postprandial lipemia|postprandial lipemia
152807|NCT02355509|Cardiovascular risk|cardiovascular risk
152808|NCT02355496|Cost Control|cost control
152809|NCT02355496|Data Display|data display
152810|NCT02355496|Diagnostic Tests, Routine|diagnostic tests, routine
152811|NCT02355496|Physician's Practice Patterns|physician's practice patterns
152812|NCT02355470|Sexual assault|sexual assault
152813|NCT02355470|Alcohol consumption|alcohol consumption
152814|NCT02355470|Intimate partner violence|intimate partner violence
152815|NCT02355457|troponin|troponin
152816|NCT02355457|myocardial infarction|myocardial infarction
152818|NCT02355457|AMI|ami
152819|NCT02355457|biomarker|biomarker
152820|NCT02355457|BACC|bacc
152821|NCT02355457|high-sensitivity|high-sensitivity
152822|NCT02355431|EGFR|egfr
152823|NCT02355431|mutation|mutation
152824|NCT02355405|lung ultrasound|lung ultrasound
152825|NCT02355405|atelectasis|atelectasis
152826|NCT02355405|thoracic computed Tomography|thoracic computed tomography
401968|NCT01232530|Malria, ACT, Safety, Efficacy, pregarnancy|malria, act, safety, efficacy, pregarnancy
152827|NCT02355379|Adjuvant chemotherapy in colonic adenocarcinoma in elderly|adjuvant chemotherapy in colonic adenocarcinoma in elderly
152828|NCT02355366|Offspring|offspring
152829|NCT02355366|significant mood symptoms|significant mood symptoms
152830|NCT02355353|DWI-MRI|dwi-mri
152831|NCT02355353|resectable liver metastases|resectable liver metastases
152832|NCT02355340|Bone mineral density|bone mineral density
152833|NCT02355340|Childhood cancer survivors|childhood cancer survivors
152834|NCT02355314|ICU patients|icu patients
152835|NCT02355314|Doppler-based renal|doppler-based renal
152836|NCT02355301|ICF, impairment, activity, satisfaction, quality of care|icf, impairment, activity, satisfaction, quality of care
152837|NCT02355288|Coronary Artery Disease|coronary artery disease
152838|NCT02355288|Diabetes Mellitus|diabetes mellitus
152839|NCT02355288|Minimally Invasive Cardiac Surgery|minimally invasive cardiac surgery
153046|NCT02354157|control rules|control rules
152840|NCT02355288|Percutaneous Coronary Intervention|percutaneous coronary intervention
152841|NCT02355275|Home Exercise|home exercise
152842|NCT02355275|Resistance Exercise|resistance exercise
152843|NCT02355262|Insurance Coverage|insurance coverage
152844|NCT02355262|Insurance Continuity|insurance continuity
152845|NCT02355249|traditional three incisions|traditional three incisions
152846|NCT02355249|minimally invasive thoracol-laparoscopic esophagectomy|minimally invasive thoracol-laparoscopic esophagectomy
152847|NCT02355249|MIE|mie
152848|NCT02355249|esophageal cancer|esophageal cancer
152849|NCT02355236|Naxozol|naxozol
152850|NCT02355236|LDQ|ldq
152851|NCT02355236|GSRS|gsrs
152852|NCT02355236|Osteoarthritis|osteoarthritis
152853|NCT02355236|Gastroprotective|gastroprotective
152854|NCT02355223|Tuberculosis|tuberculosis
152855|NCT02355223|Infection Control|infection control
152856|NCT02355223|Transmission|transmission
152857|NCT02355197|antioxidants|antioxidants
152858|NCT02355197|Gestational diabetes mellitus|gestational diabetes mellitus
152859|NCT02355197|oxidative stress|oxidative stress
152860|NCT02355158|pain|pain
152861|NCT02355158|diabetic neuropathy|diabetic neuropathy
152862|NCT02355158|pain in feet|pain in feet
152863|NCT02355145|type 2 diabetes, add-on diabetes therapy, rationale|type 2 diabetes, add-on diabetes therapy, rationale
152864|NCT02355132|Medicaid|medicaid
152865|NCT02355132|public insurance|public insurance
152866|NCT02355132|cardiovascular disease|cardiovascular disease
152867|NCT02355132|prevention|prevention
152868|NCT02355132|community health centers|community health centers
152869|NCT02355132|electronic health records|electronic health records
152870|NCT02355132|cancer prevention|cancer prevention
152871|NCT02355080|HIV|hiv
152872|NCT02355080|HCV|hcv
152873|NCT02355067|parenting|parenting
152874|NCT02355067|postpartum depression|postpartum depression
152875|NCT02355067|mothers|mothers
152876|NCT02355067|infants|infants
152877|NCT02355067|depression|depression
152878|NCT02355054|Recurrent|recurrent
152879|NCT02355041|diet|diet
152880|NCT02355041|body weight|body weight
152881|NCT02355041|eating|eating
152882|NCT02355041|meal replacement|meal replacement
152883|NCT02355028|LHA510|lha510
152884|NCT02355028|PoC|poc
152885|NCT02355028|Age-related macular degeneration|age-related macular degeneration
152886|NCT02354976|omega-3 carboxylic acid|omega-3 carboxylic acid
152887|NCT02354963|Poor ovarian response|poor ovarian response
152888|NCT02354963|Salvador/Warts/Hippo pathway|salvador/warts/hippo pathway
152889|NCT02354963|Follicular activation|follicular activation
152890|NCT02354963|Poor ovarian reserve|poor ovarian reserve
152891|NCT02354950|GSK1265744|gsk1265744
152892|NCT02354950|healthy controls|healthy controls
152893|NCT02354950|pharmacokinetic|pharmacokinetic
152894|NCT02354950|Hepatic Impairment|hepatic impairment
152895|NCT02354937|Pharmacokinetics|pharmacokinetics
152896|NCT02354937|GSK1265744|gsk1265744
152897|NCT02354937|Severe Renal Impairment|severe renal impairment
152898|NCT02354911|Immunomodulation|immunomodulation
152899|NCT02354872|Nicotine|nicotine
152900|NCT02354859|Cystic Fibrosis|cystic fibrosis
152901|NCT02354859|Gallium Nitrate|gallium nitrate
152902|NCT02354859|IV Gallium|iv gallium
152903|NCT02354859|Pseudomonas aeruginosa|pseudomonas aeruginosa
152904|NCT02354833|Hypotension|hypotension
152905|NCT02354833|Cesarean Delivery|cesarean delivery
152906|NCT02354833|Phenylephrine|phenylephrine
152907|NCT02354833|Spinal Anesthesia|spinal anesthesia
152908|NCT02354833|Norepinephrine|norepinephrine
152909|NCT02354807|BAT activation|bat activation
152910|NCT02354807|quantitative PET imaging|quantitative pet imaging
152911|NCT02354807|Mirabegron effect on BAT|mirabegron effect on bat
152912|NCT02354794|arginine|arginine
152913|NCT02354794|supplementation|supplementation
152914|NCT02354794|metabolic syndrome|metabolic syndrome
152915|NCT02354794|endothelial function|endothelial function
152916|NCT02354781|DMD|dmd
152917|NCT02354781|muscular dystrophy|muscular dystrophy
152918|NCT02354781|Follistatin|follistatin
152919|NCT02354742|Echocardiography|echocardiography
152920|NCT02354742|EGDT|egdt
152921|NCT02354742|Sepsis|sepsis
152922|NCT02354716|esophagus|esophagus
152923|NCT02354716|upper GI|upper gi
152924|NCT02354716|endoscopy|endoscopy
152925|NCT02354716|endoFLIP|endoflip
152926|NCT02354716|functional luminal imaging|functional luminal imaging
152927|NCT02354716|esophageal stricture|esophageal stricture
152928|NCT02354716|narrow esophagus|narrow esophagus
152929|NCT02354716|narrow caliber esophagus|narrow caliber esophagus
152930|NCT02354716|esophageal narrowing|esophageal narrowing
152931|NCT02354716|eosinophilic esophagitis|eosinophilic esophagitis
152932|NCT02354716|Zenkers diverticulum|zenkers diverticulum
152933|NCT02354716|Schatzki ring|schatzki ring
152934|NCT02354703|alcoholism, treatment, serotonin transporter|alcoholism, treatment, serotonin transporter
152935|NCT02354677|Bronchial epithelium|bronchial epithelium
152936|NCT02354677|COPD|copd
152937|NCT02354677|Repair|repair
152938|NCT02354677|Remodelling|remodelling
152939|NCT02354677|Club Cells|club cells
152940|NCT02354664|respiratory test|respiratory test
152941|NCT02354664|respiratory muscle endurance|respiratory muscle endurance
152942|NCT02354664|spirometry|spirometry
152943|NCT02354651|Pompe disease|pompe disease
152944|NCT02354651|mechanical ventilation|mechanical ventilation
152945|NCT02354651|diaphragm pacing|diaphragm pacing
152946|NCT02354638|Perceptions|perceptions
152947|NCT02354638|Education and evaluate post intervention KAP|education and evaluate post intervention kap
152948|NCT02354625|Schwann cells|schwann cells
152949|NCT02354599|Randomized, double-blind, placebo-controlled, single-dose subcutaneous administration study|randomized, double-blind, placebo-controlled, single-dose subcutaneous administration study
152950|NCT02354586|gBRCAmut|gbrcamut
152951|NCT02354586|BRCA|brca
152952|NCT02354586|PARP inhibitor|parp inhibitor
152953|NCT02354586|HRD|hrd
152954|NCT02354586|Ovarian cancer|ovarian cancer
152955|NCT02354586|Serous Epithelial|serous epithelial
152956|NCT02354586|Fallopian Tube|fallopian tube
152957|NCT02354586|Primary Peritoneal|primary peritoneal
152958|NCT02354560|Erythromycin|erythromycin
152959|NCT02354560|Familial Adenomatous Polyposis (FAP)|familial adenomatous polyposis (fap)
152960|NCT02354560|APC gene|apc gene
152961|NCT02354560|nonsense mutations|nonsense mutations
152962|NCT02354534|cervical dysplasia|cervical dysplasia
152963|NCT02354534|HPV|hpv
152964|NCT02354534|Treatment|treatment
152965|NCT02354534|preinvasive|preinvasive
152966|NCT02354534|cervix|cervix
152967|NCT02354534|vaginal suppository|vaginal suppository
152968|NCT02354534|Johns Hopkins|johns hopkins
152969|NCT02354534|Cornelia Trimble|cornelia trimble
152970|NCT02354534|abnormal pap|abnormal pap
152971|NCT02354534|CIN|cin
152972|NCT02354521|Protein|protein
152973|NCT02354521|Mechanical ventilation|mechanical ventilation
152974|NCT02354521|Children|children
152975|NCT02354521|Outcomes|outcomes
152976|NCT02354508|acromegaly|acromegaly
152977|NCT02354508|GH|gh
152978|NCT02354508|IGF-1|igf-1
152979|NCT02354508|pasireotide LAR|pasireotide lar
152980|NCT02354495|Indirect calorimetry|indirect calorimetry
152981|NCT02354495|Protein|protein
152982|NCT02354495|Mechanical ventilation|mechanical ventilation
152983|NCT02354495|Respiratory failure|respiratory failure
152984|NCT02354469|TBI|tbi
152985|NCT02354469|Mild Traumatic Brain Injury|mild traumatic brain injury
152986|NCT02354469|Post-Concussion Syndrome|post-concussion syndrome
152987|NCT02354469|Recovery of Function|recovery of function
152988|NCT02354469|Motor Activity|motor activity
152989|NCT02354469|Diffusion Tensor Imaging|diffusion tensor imaging
152990|NCT02354469|Neural Injury|neural injury
152991|NCT02354469|Biomarkers|biomarkers
152992|NCT02354456|atrial fibrillation|atrial fibrillation
152993|NCT02354456|epidemiology|epidemiology
152994|NCT02354456|antiocaogulation|antiocaogulation
152995|NCT02354430|pregnancy|pregnancy
152996|NCT02354430|low back pain|low back pain
152997|NCT02354430|sick leave,|sick leave,
152998|NCT02354430|motor activity|motor activity
152999|NCT02354404|Ebola virus|ebola virus
153000|NCT02354404|Filoviridae Infections|filoviridae infections
153001|NCT02354404|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
153002|NCT02354404|Viral Diseases|viral diseases
153003|NCT02354404|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
153004|NCT02354365|PEEP adjustment|peep adjustment
153005|NCT02354365|Tidal Volume|tidal volume
153006|NCT02354365|Driving Pressure|driving pressure
153007|NCT02354365|Compliance|compliance
153008|NCT02354339|Metabolic Syndrome|metabolic syndrome
153009|NCT02354339|Irvingia gabonensis|irvingia gabonensis
153010|NCT02354339|African mango|african mango
153011|NCT02354339|Insulin resistance|insulin resistance
153012|NCT02354313|MANTLE CELL LYMPHOMA (MCL)|mantle cell lymphoma (mcl)
153013|NCT02354313|Lenalidomide (Len)|lenalidomide (len)
153014|NCT02354313|Rituximab|rituximab
153016|NCT02354313|Revlimid|revlimid
153017|NCT02354313|High dose chemotherapy|high dose chemotherapy
153018|NCT02354313|transplant|transplant
153019|NCT02354261|Basal Cell Carcinoma Nevus Syndrome|basal cell carcinoma nevus syndrome
153022|NCT02354261|itraconazole|itraconazole
153023|NCT02354261|basal cell carcinoma|basal cell carcinoma
153024|NCT02354261|locally advanced basal cell carcinoma|locally advanced basal cell carcinoma
153025|NCT02354248|TST|tst
153026|NCT02354248|TMS|tms
153027|NCT02354248|Stroke patients|stroke patients
153028|NCT02354248|EMG|emg
153029|NCT02354235|MT-2412|mt-2412
153030|NCT02354235|MP-513|mp-513
153031|NCT02354235|TA-7284|ta-7284
153032|NCT02354235|Teneligliptin|teneligliptin
153033|NCT02354235|Canagliflozin|canagliflozin
153034|NCT02354222|MT-2412|mt-2412
153035|NCT02354222|MP-513|mp-513
153036|NCT02354222|TA-7284|ta-7284
153037|NCT02354222|Teneligliptin|teneligliptin
153038|NCT02354222|Canagliflozin|canagliflozin
153039|NCT02354183|Commitment strategies|commitment strategies
153040|NCT02354183|Motivation|motivation
153041|NCT02354183|DBT skills|dbt skills
153042|NCT02354183|Self-harm|self-harm
153043|NCT02354183|Brief intervention|brief intervention
153044|NCT02354170|Central Serous Chorioretinopathy, CSC|central serous chorioretinopathy, csc
153045|NCT02354157|children dietary pattern|children dietary pattern
153148|NCT02353585|rivaroxaban|rivaroxaban
153047|NCT02354157|instrumental learning|instrumental learning
153048|NCT02354157|food reinforcement|food reinforcement
153049|NCT02354144|Human papillomavirus|human papillomavirus
153050|NCT02354144|Carrageenan|carrageenan
153051|NCT02354144|Microbicide|microbicide
153052|NCT02354144|Anal HPV infection|anal hpv infection
153053|NCT02354131|Ovarian cancer|ovarian cancer
153054|NCT02354131|Niraparib|niraparib
153055|NCT02354131|Bevacizumab|bevacizumab
153056|NCT02354131|PARP|parp
153057|NCT02354131|Phase 2 randomized|phase 2 randomized
153058|NCT02354105|Axial Spondyloarthritis|axial spondyloarthritis
153059|NCT02354105|Radiographic Axial Spondyloarthritis|radiographic axial spondyloarthritis
153060|NCT02354105|Non-radiographic Axial Spondyloarthritis|non-radiographic axial spondyloarthritis
153061|NCT02354105|Ankylosing spondylitis|ankylosing spondylitis
153062|NCT02354105|Diagnosis|diagnosis
153063|NCT02354105|Cimzia|cimzia
153064|NCT02354105|CZP|czp
143906|NCT02407002|Safety|safety
153065|NCT02354105|Certolizumab Pegol|certolizumab pegol
153066|NCT02354105|CDP870|cdp870
153067|NCT02354092|cervical dilation|cervical dilation
153068|NCT02354092|pain|pain
153069|NCT02354092|paracervical block|paracervical block
153070|NCT02354092|osmotic dilators|osmotic dilators
153071|NCT02354079|Low LDL-C|low ldl-c
153072|NCT02354079|Target Identification|target identification
153073|NCT02354079|Genetic|genetic
153074|NCT02354079|Endocrinology|endocrinology
153075|NCT02354079|Cardiovascular Disease|cardiovascular disease
153076|NCT02354066|Hallux valgus surgery|hallux valgus surgery
153077|NCT02354066|forefoot surgery|forefoot surgery
153078|NCT02354066|brake response time|brake response time
153079|NCT02354066|foot orthoses|foot orthoses
153080|NCT02354053|HIV|hiv
153081|NCT02354053|Triumeq|triumeq
153082|NCT02354053|vulnerable populations|vulnerable populations
153083|NCT02354040|Stroke, Myocardial Infarction, Adherence, Health Literacy, Implementation, Developing Country|stroke, myocardial infarction, adherence, health literacy, implementation, developing country
153084|NCT02354027|SHR3824 metformin drug-drug interaction|shr3824 metformin drug-drug interaction
153085|NCT02354014|Multidrug-Resistant Tuberculosis|multidrug-resistant tuberculosis
153086|NCT02354014|Bedaquiline|bedaquiline
153087|NCT02354014|TMC207|tmc207
153088|NCT02354001|schizophrenia|schizophrenia
153089|NCT02354001|mental illness|mental illness
153090|NCT02354001|serm|serm
153091|NCT02354001|raloxifene|raloxifene
153092|NCT02354001|clinical trial|clinical trial
153093|NCT02353988|AR-positive|ar-positive
153094|NCT02353988|Androgen Antagonists|androgen antagonists
153095|NCT02353988|Bicalutamide|bicalutamide
153096|NCT02353988|TNBC|tnbc
153097|NCT02353988|metastatic|metastatic
153098|NCT02353975|SHR3824|shr3824
153099|NCT02353975|food effect|food effect
153100|NCT02353975|mass|mass
153101|NCT02353975|balance|balance
153102|NCT02353975|Phase I|phase i
153103|NCT02353962|neglect|neglect
153104|NCT02353962|exergames|exergames
153105|NCT02353949|Mild cognitive impairment|mild cognitive impairment
153106|NCT02353949|Alzheimer|alzheimer
153107|NCT02353949|PET|pet
153108|NCT02353949|Amyloid|amyloid
153109|NCT02353949|Frontotemporal|frontotemporal
153110|NCT02353871|Moderate to Severe|moderate to severe
153111|NCT02353858|Rectal Cancer|rectal cancer
153112|NCT02353858|Hyperthermia|hyperthermia
153113|NCT02353858|Radiochemotherapy|radiochemotherapy
153114|NCT02353858|Chemoradiotherapy|chemoradiotherapy
153115|NCT02353858|Deep regional hyperthermia|deep regional hyperthermia
153116|NCT02353858|pathologic complete response|pathologic complete response
153117|NCT02353858|Regression Grade|regression grade
153118|NCT02353858|Locally advanced rectal cancer|locally advanced rectal cancer
153119|NCT02353858|complete response|complete response
153120|NCT02353806|Amlodipine besylate|amlodipine besylate
153121|NCT02353806|Breast milk|breast milk
153122|NCT02353806|Pharmacokinetics|pharmacokinetics
153123|NCT02353806|Chronic hypertension|chronic hypertension
153124|NCT02353806|Pregnancy|pregnancy
153125|NCT02353793|Hypothermia|hypothermia
153126|NCT02353793|(Poly) Trauma|(poly) trauma
153127|NCT02353793|Emergency Room|emergency room
153128|NCT02353793|Warming Blanket|warming blanket
153129|NCT02353780|Rheumatoid arthritis|rheumatoid arthritis
153130|NCT02353780|TNF inhibitors|tnf inhibitors
153131|NCT02353702|Diaphragmatic function|diaphragmatic function
153132|NCT02353702|sniff-test|sniff-test
153133|NCT02353702|pulmonary complications|pulmonary complications
153134|NCT02353702|upper abdominal surgery|upper abdominal surgery
153135|NCT02353663|Rheumatic heart disease|rheumatic heart disease
153136|NCT02353663|Rheumatic fever|rheumatic fever
153137|NCT02353663|Mitral regurgitation|mitral regurgitation
153138|NCT02353663|Aortic regurgitation|aortic regurgitation
153139|NCT02353663|Mitral stenosis|mitral stenosis
153140|NCT02353650|Q10|q10
153141|NCT02353650|ubiquinol|ubiquinol
153142|NCT02353611|tooth|tooth
153143|NCT02353611|bleaching|bleaching
153144|NCT02353585|vitamin K-antagonist|vitamin k-antagonist
153145|NCT02353585|novel oral anticoagulants|novel oral anticoagulants
153146|NCT02353585|apixaban|apixaban
153147|NCT02353585|dabigatran|dabigatran
153149|NCT02353585|edoxaban|edoxaban
153150|NCT02353585|direct oral anticoagulants|direct oral anticoagulants
153151|NCT02353559|acute leukemia|acute leukemia
153152|NCT02353559|traumatic stress|traumatic stress
153153|NCT02353559|quality of life|quality of life
153154|NCT02353559|symptom burden|symptom burden
153155|NCT02353559|psychosocial oncology|psychosocial oncology
153156|NCT02353559|palliative care|palliative care
153157|NCT02353559|intervention|intervention
153158|NCT02353559|hematological malignancies|hematological malignancies
153159|NCT02353559|supportive care|supportive care
153160|NCT02353546|affective symptoms|affective symptoms
153161|NCT02353546|cancer|cancer
153162|NCT02353546|depression|depression
153163|NCT02353546|palliative care|palliative care
153164|NCT02353546|pilot trial|pilot trial
143997|NCT02406274|15-053|15-053
153165|NCT02353546|psychotherapy|psychotherapy
153166|NCT02353533|adenoma|adenoma
153167|NCT02353533|EMR|emr
153168|NCT02353533|FTRD|ftrd
153169|NCT02353533|non- lifting|non- lifting
153170|NCT02353533|colon|colon
153171|NCT02353442|Pain|pain
153172|NCT02353442|Rotator cuff|rotator cuff
153173|NCT02353442|Stretching|stretching
153174|NCT02353442|Mobilization|mobilization
153175|NCT02353442|Scapula|scapula
153176|NCT02353442|Posterior capsule|posterior capsule
153177|NCT02353416|Mediterranean Diet|mediterranean diet
153178|NCT02353416|Low-Glycemic Index|low-glycemic index
153179|NCT02353416|AGEs|ages
153180|NCT02353403|Fructo-oligosaccharides|fructo-oligosaccharides
153181|NCT02353403|Sugar-reduced foods|sugar-reduced foods
153182|NCT02353403|Postprandial glucose response|postprandial glucose response
153183|NCT02353390|presyncope|presyncope
153184|NCT02353390|syncope|syncope
153185|NCT02353390|adolescent|adolescent
153186|NCT02353390|young adult|young adult
153187|NCT02353390|immunization|immunization
153188|NCT02353390|vaccination|vaccination
153189|NCT02353390|water consumption|water consumption
153190|NCT02353364|Advanced maternal age|advanced maternal age
153191|NCT02353364|Aneuploidy|aneuploidy
153192|NCT02353325|Iron deficiency|iron deficiency
153193|NCT02353325|Iron fortification|iron fortification
153194|NCT02353325|Iron encapsulation|iron encapsulation
153195|NCT02353312|Diastolic|diastolic
153196|NCT02353312|Biopterin|biopterin
153197|NCT02353312|Therapeutic Use|therapeutic use
153198|NCT02353312|Drug Therapy|drug therapy
153199|NCT02353312|Quality of Life|quality of life
153200|NCT02353299|Cognition|cognition
153201|NCT02353299|Balance|balance
153202|NCT02353273|WH-1,Diabetic Foot,Ulcer|wh-1,diabetic foot,ulcer
153203|NCT02353234|Phenolics|phenolics
153204|NCT02353234|Aleurone|aleurone
153205|NCT02353234|Bioavailability|bioavailability
153206|NCT02353234|Pharmacokinetics|pharmacokinetics
153207|NCT02353221|Early arthritis|early arthritis
153208|NCT02353221|undiferentiated arthritis|undiferentiated arthritis
153209|NCT02353182|abdominal|abdominal
153210|NCT02353182|lower extremity|lower extremity
153211|NCT02353169|changes in myocardial repolarization in healthy children|changes in myocardial repolarization in healthy children
153212|NCT02353156|Hemorrhoidectomy|hemorrhoidectomy
153312|NCT02352558|Lymphoma|lymphoma
153213|NCT02353156|postoperative pain|postoperative pain
153214|NCT02353156|Sitz bath|sitz bath
153215|NCT02353156|Electronic bidet|electronic bidet
153216|NCT02353143|Acute Myeloid Leukemia|acute myeloid leukemia
153218|NCT02353143|Relapsed|relapsed
153219|NCT02353143|Refractory|refractory
153220|NCT02353143|MEN1112|men1112
153221|NCT02353143|Monoclonal antibody|monoclonal antibody
153222|NCT02353130|autism spectrum disorders|autism spectrum disorders
153223|NCT02353130|memantine|memantine
153225|NCT02353130|sensory testing|sensory testing
153226|NCT02353078|Eosinophilic Esophagitis (EOE)|eosinophilic esophagitis (eoe)
153227|NCT02353065|Colles' Fracture|colles' fracture
153228|NCT02353065|ultrasonography|ultrasonography
153229|NCT02353052|morphology standards|morphology standards
153230|NCT02353013|protein intake|protein intake
153231|NCT02353013|body composition|body composition
153232|NCT02352974|Diamyd|diamyd
153233|NCT02352974|Diabetes|diabetes
153234|NCT02352974|Juvenile Diabetes|juvenile diabetes
153235|NCT02352974|Diabetes Type 1|diabetes type 1
153236|NCT02352974|Type 1 Diabetes|type 1 diabetes
153237|NCT02352974|Autoimmune Diabetes|autoimmune diabetes
153238|NCT02352974|Insulin Dependent Diabetes|insulin dependent diabetes
153239|NCT02352974|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
153240|NCT02352974|rhGAD65|rhgad65
153241|NCT02352974|GAD65|gad65
153242|NCT02352974|GAD-Alum|gad-alum
153243|NCT02352974|Diabetes Mellitus|diabetes mellitus
153244|NCT02352974|Diabetes mellitus Type 1|diabetes mellitus type 1
153245|NCT02352974|Glucose Metabolism Disorders|glucose metabolism disorders
153246|NCT02352974|Metabolic Diseases|metabolic diseases
153247|NCT02352974|Vitamin D|vitamin d
153248|NCT02352961|Unrecognised condition|unrecognised condition
153249|NCT02352922|Laparoscopy|laparoscopy
153250|NCT02352922|Robotic Surgical Procedures|robotic surgical procedures
153251|NCT02352922|Hysterectomy|hysterectomy
153252|NCT02352922|Anesthetics, Local|anesthetics, local
153253|NCT02352922|Bupivacaine|bupivacaine
153254|NCT02352922|Pain, Postoperative|pain, postoperative
153255|NCT02352896|Leigh syndrome|leigh syndrome
153256|NCT02352896|Mitochondrial disorders|mitochondrial disorders
153257|NCT02352896|EPI743|epi743
153258|NCT02352896|Vincerinone|vincerinone
153259|NCT02352870|Feasibility study|feasibility study
153260|NCT02352870|Randomised controlled trial|randomised controlled trial
153261|NCT02352870|Cognitive behavioural therapy|cognitive behavioural therapy
153262|NCT02352870|Psychological distress|psychological distress
153263|NCT02352870|Cognitive illness representations|cognitive illness representations
153264|NCT02352870|Common sense model|common sense model
153265|NCT02352857|Fructo-oligosaccharides|fructo-oligosaccharides
153266|NCT02352857|Sugar-reduced foods|sugar-reduced foods
153267|NCT02352857|Postprandial glucose response|postprandial glucose response
153268|NCT02352805|Extracorporeal circulation, ventricular assist device|extracorporeal circulation, ventricular assist device
153269|NCT02352792|Local control|local control
153270|NCT02352779|Cancer Survivor|cancer survivor
153271|NCT02352766|Thyroid cancer|thyroid cancer
153272|NCT02352766|Thyroid nodules|thyroid nodules
153273|NCT02352766|Palpable nodules|palpable nodules
153275|NCT02352753|Amgen, OI, Bone|amgen, oi, bone
153276|NCT02352740|arginine|arginine
153277|NCT02352740|supplementation|supplementation
153278|NCT02352740|metabolic syndrome|metabolic syndrome
153279|NCT02352740|nitric oxide|nitric oxide
153280|NCT02352727|Nocturnal hypokinesia|nocturnal hypokinesia
153281|NCT02352727|Accelerometers|accelerometers
153282|NCT02352714|Adolescents|adolescents
153283|NCT02352714|Women's Health|women's health
153284|NCT02352714|Contraception|contraception
153285|NCT02352714|Reproduction|reproduction
153286|NCT02352714|Comparative Effectiveness Research|comparative effectiveness research
153287|NCT02352714|Pregnancy Prevention|pregnancy prevention
153288|NCT02352714|Intrauterine Device|intrauterine device
153289|NCT02352701|helicobacter pylori|helicobacter pylori
153290|NCT02352701|ilaprazole|ilaprazole
153291|NCT02352701|eradication|eradication
153292|NCT02352701|triple therapy|triple therapy
153293|NCT02352688|elderly|elderly
153294|NCT02352688|enhanced recovery after surgery|enhanced recovery after surgery
153295|NCT02352662|Congenital Heart Disease|congenital heart disease
153296|NCT02352662|Point-of-care coagulation monitoring|point-of-care coagulation monitoring
153297|NCT02352662|Rotaional Thromboelastometry|rotaional thromboelastometry
153298|NCT02352649|Peripheral nerve injury|peripheral nerve injury
153299|NCT02352649|Neurotmesis|neurotmesis
153300|NCT02352649|Gene therapy|gene therapy
153301|NCT02352649|Plasmid|plasmid
153302|NCT02352649|Nerve regeneration therapy|nerve regeneration therapy
153303|NCT02352610|carpometacarpal joints|carpometacarpal joints
153304|NCT02352597|PCOS|pcos
153305|NCT02352597|Phytoestrogens|phytoestrogens
153306|NCT02352597|ovulation induction|ovulation induction
153307|NCT02352584|QIV|qiv
153308|NCT02352584|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
153309|NCT02352584|Influenza vaccine|influenza vaccine
153310|NCT02352584|Vaccination|vaccination
153311|NCT02352558|Multiple Myeloma|multiple myeloma
153313|NCT02352558|Acute Myeloid Leukemia|acute myeloid leukemia
153314|NCT02352558|Myelo-Dysplastic Syndrome|myelo-dysplastic syndrome
153315|NCT02352558|Chronic Myeloid Leukemia|chronic myeloid leukemia
153316|NCT02352558|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
153317|NCT02352532|Dry Needling|dry needling
153318|NCT02352532|Shear Wave Elastography|shear wave elastography
153319|NCT02352532|Ultrasound|ultrasound
153320|NCT02352493|PNH|pnh
153321|NCT02352493|RNAi therapeutic|rnai therapeutic
153322|NCT02352480|Non Healing Wound|non healing wound
153323|NCT02352467|Non Healing Wound|non healing wound
153324|NCT02352454|Non Healing Wound|non healing wound
153325|NCT02352428|Skin Cancer|skin cancer
153326|NCT02352428|Secondary Prevention|secondary prevention
153327|NCT02352428|Population Screening|population screening
153328|NCT02352402|CABG|cabg
153329|NCT02352402|Ticagrelor|ticagrelor
153330|NCT02352402|Graft|graft
153331|NCT02352402|Patency|patency
153332|NCT02352389|Childhood|childhood
153333|NCT02352389|Cancer|cancer
153334|NCT02352389|Genetic mutations|genetic mutations
153335|NCT02352376|Noninvasive ventilation|noninvasive ventilation
153336|NCT02352376|Heart rate variability|heart rate variability
153337|NCT02352376|Thoracic surgery|thoracic surgery
153338|NCT02352363|Parkinson's Disease|parkinson's disease
153339|NCT02352363|Motor fluctuations|motor fluctuations
153340|NCT02352363|levodopa|levodopa
153341|NCT02352363|inhaled drugs|inhaled drugs
153342|NCT02352363|OFF episodes|off episodes
153343|NCT02352350|Pre-Hospital Cardiac Arrest|pre-hospital cardiac arrest
153344|NCT02352350|Blood Lactate Level|blood lactate level
153345|NCT02352350|Neurological Injury|neurological injury
153346|NCT02352337|cancer|cancer
153347|NCT02352337|pancreatic cancer|pancreatic cancer
153348|NCT02352337|metastatic pancreatic cancer|metastatic pancreatic cancer
153349|NCT02352324|cardiac output|cardiac output
153350|NCT02352324|coronary artery bypass grafting|coronary artery bypass grafting
153351|NCT02352324|minimally invasive hemodynamic monitoring|minimally invasive hemodynamic monitoring
153352|NCT02352324|fluid responsiveness|fluid responsiveness
153353|NCT02352272|sleep extension|sleep extension
153354|NCT02352272|attention|attention
153355|NCT02352272|physical performance|physical performance
153356|NCT02352259|Liver metastases of colorectal cancer Electrochemotherapy|liver metastases of colorectal cancer electrochemotherapy
153357|NCT02352259|Bleomycin|bleomycin
153358|NCT02352259|Electrochemotherapy|electrochemotherapy
153359|NCT02352246|intermittent sprinting|intermittent sprinting
153360|NCT02352246|abdominal fat mass|abdominal fat mass
153361|NCT02352246|type 2 diabetes|type 2 diabetes
153362|NCT02352246|postmenopausal women|postmenopausal women
153363|NCT02352233|retroview colonoscope|retroview colonoscope
153364|NCT02352233|retroflexion colonoscopy|retroflexion colonoscopy
153365|NCT02352233|colonoscopy|colonoscopy
153366|NCT02352207|Neonatal respiratory distress|neonatal respiratory distress
153367|NCT02352207|prenatal lung malformation|prenatal lung malformation
153368|NCT02352207|KRAS mutation|kras mutation
153369|NCT02352207|pregnant woman|pregnant woman
153370|NCT02352194|Multiple Sclerosis, Physical therapy, Physical capacity, Fatigue|multiple sclerosis, physical therapy, physical capacity, fatigue
153371|NCT02352181|Cirrhosis, transplantation, transfusion, Rotem®|cirrhosis, transplantation, transfusion, rotem®
153372|NCT02352168|allergic rhinitis；airway inflammation；hyperreactivity|allergic rhinitis；airway inflammation；hyperreactivity
153373|NCT02352155|haemostasis|haemostasis
153374|NCT02352142|Separation stress|separation stress
153375|NCT02352142|Family Nurture|family nurture
153376|NCT02352142|Maternal Confidence|maternal confidence
153377|NCT02352142|Maternal Competence|maternal competence
153378|NCT02352142|Calming Cycle|calming cycle
153379|NCT02352142|Kangaroo Care|kangaroo care
153380|NCT02352142|Infant Neurodevelopment|infant neurodevelopment
153381|NCT02352142|Infant Psychological Development|infant psychological development
153382|NCT02352142|Post-partum depression|post-partum depression
153383|NCT02352142|Mother-infant Co-regulation|mother-infant co-regulation
153384|NCT02352116|Postoperative Experience|postoperative experience
153385|NCT02352116|Postoperative Behavioral Changes|postoperative behavioral changes
153386|NCT02352116|Maladaptive Behavioral Changes|maladaptive behavioral changes
153387|NCT02352103|prostate cancer|prostate cancer
153388|NCT02352103|Urinary continence|urinary continence
153389|NCT02352103|robotic assisted radical prostatectomy|robotic assisted radical prostatectomy
153390|NCT02352103|Vattikuti Urology Institute (VIP) radical prostatectomy|vattikuti urology institute (vip) radical prostatectomy
153391|NCT02352103|Retzius sparing radical prostatectomy|retzius sparing radical prostatectomy
153392|NCT02352090|Contraception, oral|contraception, oral
153393|NCT02352090|Ethinyl Estradiol|ethinyl estradiol
153394|NCT02352090|Estradiol Valerate|estradiol valerate
153395|NCT02352090|Dienogest|dienogest
153396|NCT02352090|Insulin resistance|insulin resistance
153397|NCT02352090|Chronic inflammation|chronic inflammation
153398|NCT02352090|Coagulation|coagulation
153399|NCT02352051|attention deficit-hyperactivity disorder (ADHD).|attention deficit-hyperactivity disorder (adhd).
153400|NCT02352051|executive functions|executive functions
153401|NCT02352038|malocclusion|malocclusion
153402|NCT02352038|low-level laser therapy|low-level laser therapy
153403|NCT02352025|S-equol|s-equol
153404|NCT02352025|breast cancer|breast cancer
153405|NCT02352025|triple negative|triple negative
153406|NCT02352012|Interventional Treatment|interventional treatment
153407|NCT02352012|Refractory Pneumothorax|refractory pneumothorax
153408|NCT02352012|Bronchoscope|bronchoscope
153409|NCT02351999|Atrial fibrillation|atrial fibrillation
153410|NCT02351999|Transseptal puncture|transseptal puncture
153411|NCT02351999|Atrial fibrillation ablation|atrial fibrillation ablation
153412|NCT02351986|subacromial impingement|subacromial impingement
153413|NCT02351986|physical therapy|physical therapy
153414|NCT02351986|cryotherapy|cryotherapy
153415|NCT02351960|Drug therapy|drug therapy
153416|NCT02351960|GERD|gerd
153417|NCT02351960|Dexlansoprazole|dexlansoprazole
153418|NCT02351947|stroke|stroke
153419|NCT02351947|Cerebrovascular accident|cerebrovascular accident
153420|NCT02351947|rehabilitation|rehabilitation
153421|NCT02351947|motor learning|motor learning
153422|NCT02351947|fMRI|fmri
153423|NCT02351947|plasticity|plasticity
153424|NCT02351934|colorectal surgery|colorectal surgery
153425|NCT02351934|volume status|volume status
153426|NCT02351921|transcranial magnetic stimulation|transcranial magnetic stimulation
153427|NCT02351921|spinal cord injury|spinal cord injury
153428|NCT02351921|motor cortex|motor cortex
153429|NCT02351921|somatosensory cortex|somatosensory cortex
153430|NCT02351895|infection control|infection control
153431|NCT02351895|Prevention of hospital acquired infection|prevention of hospital acquired infection
153432|NCT02351856|laminopathy|laminopathy
153433|NCT02351804|US-guided peripheral nerve block|us-guided peripheral nerve block
153434|NCT02351804|Anesthetics, Local|anesthetics, local
153435|NCT02351804|duration|duration
153436|NCT02351804|Sensation|sensation
153437|NCT02351804|adductor canal block|adductor canal block
153438|NCT02351804|lower limb|lower limb
153439|NCT02351804|Adjuvants, Anesthesia|adjuvants, anesthesia
153440|NCT02351778|Developing Countries|developing countries
153441|NCT02351778|Quality of Life|quality of life
153442|NCT02351778|Mixed Methods|mixed methods
153443|NCT02351778|Validation|validation
153444|NCT02351778|Caregiver Burden|caregiver burden
153445|NCT02351726|aortic valve replacement|aortic valve replacement
153446|NCT02351726|aortic stenosis|aortic stenosis
153447|NCT02351726|aortic steno-insufficiency|aortic steno-insufficiency
153448|NCT02351713|primary prevention|primary prevention
153449|NCT02351687|Moderate Acute Malnutrition|moderate acute malnutrition
153450|NCT02351674|Heart Rate|heart rate
153451|NCT02351674|Percutaneous coronary intervention|percutaneous coronary intervention
185587|NCT02185820|CPD|cpd
153452|NCT02351674|outcome|outcome
153453|NCT02351648|readmission|readmission
153454|NCT02351648|care transition|care transition
153455|NCT02351635|Calprotectin|calprotectin
153456|NCT02351635|Diagnosis|diagnosis
153457|NCT02351609|smoking cessation|smoking cessation
153458|NCT02351609|patient navigation|patient navigation
153459|NCT02351609|financial incentives|financial incentives
153460|NCT02351609|health disparities|health disparities
153461|NCT02351596|Core Stability|core stability
153462|NCT02351596|Balance|balance
153463|NCT02351596|Core Control|core control
153464|NCT02351505|Small Cell Lung Cancer|small cell lung cancer
153465|NCT02351492|Bile duct obstruction|bile duct obstruction
153466|NCT02351492|intraoperative cholangiography|intraoperative cholangiography
153467|NCT02351492|MRCP|mrcp
153468|NCT02351479|hula|hula
153469|NCT02351479|breast cancer|breast cancer
153470|NCT02351479|female|female
153471|NCT02351479|hawaii|hawaii
153472|NCT02351479|physical activity|physical activity
153473|NCT02351479|cervical cancer|cervical cancer
153474|NCT02351479|ovarian cancer|ovarian cancer
153475|NCT02351479|endometrial cancer|endometrial cancer
153476|NCT02351466|Brain Growth and Development|brain growth and development
153477|NCT02351466|Cognition|cognition
153478|NCT02351466|Children|children
153479|NCT02351466|Continuous Glucose Monitoring|continuous glucose monitoring
153480|NCT02351466|MRI|mri
153481|NCT02351466|Functional MRI|functional mri
153482|NCT02351440|duloxetine|duloxetine
153483|NCT02351414|Osteoarthritis|osteoarthritis
153484|NCT02351414|Ankylosis|ankylosis
153485|NCT02351414|Revision procedures|revision procedures
153486|NCT02351414|Correction of functional deformity|correction of functional deformity
153487|NCT02351414|Rheumatoid arthritis|rheumatoid arthritis
153488|NCT02351414|Arthritis|arthritis
153489|NCT02351388|Alzheimer's disease|alzheimer's disease
153490|NCT02351388|Depressive symptoms|depressive symptoms
153491|NCT02351388|Neuropsychiatric symptoms|neuropsychiatric symptoms
153492|NCT02351388|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
153493|NCT02351388|Neuromodulation|neuromodulation
153494|NCT02351388|Transcranial Direct Current Stimulation|transcranial direct current stimulation
153495|NCT02351375|microbiota|microbiota
153496|NCT02351375|small intestine|small intestine
153497|NCT02351375|diet|diet
153498|NCT02351375|feces|feces
153499|NCT02351362|Retention|retention
153500|NCT02351362|Attrition|attrition
153501|NCT02351362|Incentive|incentive
153502|NCT02351362|Pregnant women|pregnant women
153503|NCT02351349|frailty|frailty
153504|NCT02351349|CKD|ckd
153505|NCT02351349|Physical Therapy Modalities|physical therapy modalities
153506|NCT02351349|Elder Nutritional Physiological Phenomena|elder nutritional physiological phenomena
153507|NCT02351336|Threatened preterm birth|threatened preterm birth
153508|NCT02351336|Fetal adrenal gland volume|fetal adrenal gland volume
153509|NCT02351336|Fetal zone enlargement|fetal zone enlargement
153510|NCT02351336|Prediction of preterm birth|prediction of preterm birth
153511|NCT02351297|High protein diet|high protein diet
153512|NCT02351297|Microbiota|microbiota
153513|NCT02351297|Rectal biopsies|rectal biopsies
153514|NCT02351297|Metabolomics|metabolomics
153515|NCT02351297|Bacterial metabolites|bacterial metabolites
153516|NCT02351297|volunteers|volunteers
153517|NCT02351284|HIV, vitamin D, osteoporosis|hiv, vitamin d, osteoporosis
153518|NCT02351258|Pediatrics|pediatrics
153519|NCT02351258|Medical Oncology|medical oncology
153520|NCT02351258|Catheters|catheters
153521|NCT02351258|Infection|infection
153523|NCT02351206|Magnetic Resonance Imaging|magnetic resonance imaging
153524|NCT02351206|Sensitivity and Specificity|sensitivity and specificity
153525|NCT02351180|Chronic lung allograft dysfunction|chronic lung allograft dysfunction
153526|NCT02351180|Community-acquired respiratory viral infection|community-acquired respiratory viral infection
153527|NCT02351167|smoking cessation|smoking cessation
153528|NCT02351167|counseling|counseling
153529|NCT02351167|Genetics and Genomics|genetics and genomics
153530|NCT02351141|Noble Gas MRI|noble gas mri
153531|NCT02351141|Pulmonary Function|pulmonary function
153532|NCT02351141|Quality of Life Questionnaires|quality of life questionnaires
153533|NCT02351128|lanreotide|lanreotide
153534|NCT02351102|Congenital CMV|congenital cmv
153535|NCT02351102|Congenital Cytomegalovirus|congenital cytomegalovirus
153536|NCT02351063|Heart failure|heart failure
153537|NCT02351063|BNP|bnp
153538|NCT02351063|home testing|home testing
153539|NCT02351063|remote monitoring|remote monitoring
153636|NCT02350491|Pregnancy|pregnancy
153540|NCT02351050|sonolysis, brain infarction, coronary angioplasty|sonolysis, brain infarction, coronary angioplasty
153541|NCT02351037|Acute Myeloid Leukemia|acute myeloid leukemia
153542|NCT02351037|AML|aml
153543|NCT02351037|Ibrutinib|ibrutinib
153544|NCT02351037|Cytarabine|cytarabine
153545|NCT02351037|LD-AraC|ld-arac
153546|NCT02351037|Azacitidine|azacitidine
153547|NCT02350985|Migraine|migraine
153548|NCT02350985|Migrainous Vertigo|migrainous vertigo
153549|NCT02350985|Headache Disorders|headache disorders
153550|NCT02350985|Central Nervous System Origin Vertigo|central nervous system origin vertigo
153551|NCT02350985|Paroxysmal Vertigo|paroxysmal vertigo
153552|NCT02350985|Adrenergic beta-Antagonist|adrenergic beta-antagonist
153553|NCT02350985|Vasodilator Agent|vasodilator agent
153554|NCT02350985|Anti Arrhythmia Agent|anti arrhythmia agent
153555|NCT02350985|Serotonin Uptake Inhibitor|serotonin uptake inhibitor
153556|NCT02350985|Antidepressive Agent|antidepressive agent
153557|NCT02350985|Propranolol|propranolol
153558|NCT02350985|Venlafaxine|venlafaxine
153559|NCT02350959|Plaque|plaque
153560|NCT02350959|coronary computed tomography angiography|coronary computed tomography angiography
153561|NCT02350933|tracheal damages|tracheal damages
153562|NCT02350920|IBD|ibd
153563|NCT02350920|Crohn's disease|crohn's disease
153564|NCT02350920|ulcerative colitis|ulcerative colitis
153565|NCT02350920|ACT|act
153566|NCT02350907|antimicrobial resistance|antimicrobial resistance
153567|NCT02350907|point-of-care testing|point-of-care testing
153568|NCT02350907|Neisseria gonorrhoeae|neisseria gonorrhoeae
153569|NCT02350868|without Standard Treatment|without standard treatment
153570|NCT02350855|Nutrition intervention|nutrition intervention
153571|NCT02350855|Palliative care|palliative care
153572|NCT02350855|Public Health|public health
153573|NCT02350855|Quality of life|quality of life
153574|NCT02350855|Tailored food formula|tailored food formula
153575|NCT02350855|Body weight|body weight
153576|NCT02350842|non-Left Bundle Branch Block morphology|non-left bundle branch block morphology
153577|NCT02350842|Triple-site biventricular pacing|triple-site biventricular pacing
153578|NCT02350842|cardiac resynchronization therapy|cardiac resynchronization therapy
153579|NCT02350803|distraction osteogenesis|distraction osteogenesis
153580|NCT02350803|mini plate|mini plate
153581|NCT02350803|Lefort 1 osteotomy|lefort 1 osteotomy
153582|NCT02350790|Robotics|robotics
153583|NCT02350790|Laparoscopy|laparoscopy
153584|NCT02350790|Endometriosis|endometriosis
153585|NCT02350790|Argon|argon
153586|NCT02350790|Gynecology|gynecology
153587|NCT02350777|T-cell Depleted Hematopoietic Stem Cell|t-cell depleted hematopoietic stem cell
153588|NCT02350777|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
153589|NCT02350777|CliniMACS Cell Selection System|clinimacs cell selection system
153590|NCT02350777|14-228|14-228
153591|NCT02350777|HSCT|hsct
153592|NCT02350764|Nivolumab|nivolumab
153593|NCT02350764|Lung|lung
153594|NCT02350764|ipilimumab|ipilimumab
153595|NCT02350764|NSCLC|nsclc
153596|NCT02350764|14-137|14-137
153597|NCT02350751|Influenza, Flu, Flu A, Influenza A|influenza, flu, flu a, influenza a
153598|NCT02350738|Mild cognitive impairment|mild cognitive impairment
153599|NCT02350738|Dementia|dementia
153600|NCT02350738|Cognitive training|cognitive training
153601|NCT02350738|Cognitive rehabilitation|cognitive rehabilitation
153602|NCT02350738|Cognitive therapy|cognitive therapy
153603|NCT02350725|Chronic Fluid Overload|chronic fluid overload
153604|NCT02350712|Recurrent or metastatic squamous cell carcinoma of the head and neck|recurrent or metastatic squamous cell carcinoma of the head and neck
153605|NCT02350712|SCCHN|scchn
153606|NCT02350647|Rotator cuff|rotator cuff
153607|NCT02350647|Ossification|ossification
153608|NCT02350647|Suture anchors|suture anchors
401969|NCT01232504|Allo-HSCT|allo-hsct
153609|NCT02350621|cervical foraminal stenosis minimal invasive foraminotomy|cervical foraminal stenosis minimal invasive foraminotomy
153610|NCT02350582|breast cancer|breast cancer
153611|NCT02350582|telerehabilitation|telerehabilitation
153612|NCT02350582|strength|strength
153614|NCT02350582|quality of life|quality of life
153615|NCT02350569|liver transplant|liver transplant
153616|NCT02350569|hepatitis C|hepatitis c
153617|NCT02350569|Gilead|gilead
153618|NCT02350569|Communicable Diseases|communicable diseases
153619|NCT02350569|Infection|infection
153620|NCT02350569|Liver Diseases|liver diseases
153621|NCT02350569|RNA Virus Infections|rna virus infections
153622|NCT02350543|Aspirin usage|aspirin usage
153623|NCT02350543|Transurethral resection of bladder tumor (TURBT)|transurethral resection of bladder tumor (turbt)
153624|NCT02350530|Colorectal cancer|colorectal cancer
153625|NCT02350530|Metastatic colorectal cancer|metastatic colorectal cancer
153626|NCT02350530|Liver metastases|liver metastases
153627|NCT02350530|Liver resection|liver resection
153628|NCT02350530|Liver ablation|liver ablation
153629|NCT02350530|Conversion therapy|conversion therapy
153630|NCT02350530|FOLFOXIRI|folfoxiri
153631|NCT02350530|Oxaliplatin|oxaliplatin
153632|NCT02350530|Irinotecan|irinotecan
153633|NCT02350530|Fluorouracil|fluorouracil
153634|NCT02350530|Bevacizumab|bevacizumab
153635|NCT02350530|RAS mutation|ras mutation
153637|NCT02350491|miRNA|mirna
153638|NCT02350491|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
153639|NCT02350491|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
153640|NCT02350465|sarcopenia|sarcopenia
153641|NCT02350465|aging|aging
153642|NCT02350465|myosteatosis|myosteatosis
153643|NCT02350465|exercise|exercise
153644|NCT02350465|screening|screening
153645|NCT02350452|laparoscopic surgery|laparoscopic surgery
153646|NCT02350452|diode laser|diode laser
153647|NCT02350452|AMH|amh
153648|NCT02350452|AFC|afc
153649|NCT02350439|Coronary artery disease|coronary artery disease
153650|NCT02350439|Fractional floe reserve|fractional floe reserve
153651|NCT02350400|Drug eluting beads|drug eluting beads
153652|NCT02350400|Irinotecan|irinotecan
153653|NCT02350400|Pharmacogenetics|pharmacogenetics
153654|NCT02350400|Pharmacokinetics|pharmacokinetics
153655|NCT02350374|diabetes|diabetes
153656|NCT02350374|children|children
153657|NCT02350361|endostar|endostar
153658|NCT02350361|angiogenesis|angiogenesis
153659|NCT02350361|EGFR-TKI|egfr-tki
153660|NCT02350361|lung caner|lung caner
153661|NCT02350348|neonates|neonates
153662|NCT02350348|infants|infants
153663|NCT02350348|anaesthesia|anaesthesia
153664|NCT02350348|mortality|mortality
153665|NCT02350348|adverse effects|adverse effects
153666|NCT02350348|Epidemiological Study|epidemiological study
153667|NCT02350348|European Society of Anaesthesiology|european society of anaesthesiology
153668|NCT02350335|aneurysm|aneurysm
153669|NCT02350335|nicotine replacement therapy|nicotine replacement therapy
153670|NCT02350335|cerebral vasospasm|cerebral vasospasm
153671|NCT02350335|outcome|outcome
153672|NCT02350322|Diet|diet
153673|NCT02350322|concentration|concentration
153674|NCT02350322|seafood|seafood
153675|NCT02350322|youths|youths
153676|NCT02350322|Norway|norway
153677|NCT02350322|Nutrient status in blood|nutrient status in blood
153678|NCT02350322|Inflammatory markers|inflammatory markers
153679|NCT02350309|Insomnia Disorder|insomnia disorder
153680|NCT02350309|E2006|e2006
153681|NCT02350309|Multiple Sleep Latency Test|multiple sleep latency test
153682|NCT02350296|headache|headache
153683|NCT02350296|dental pain|dental pain
153684|NCT02350296|neuralgia|neuralgia
153685|NCT02350296|dysmenorrhoea|dysmenorrhoea
153686|NCT02350296|muscular and osteoarticular pain|muscular and osteoarticular pain
153687|NCT02350283|Acute Ischemic Stroke|acute ischemic stroke
153688|NCT02350283|Endovascular therapy|endovascular therapy
153689|NCT02350283|Solitaire|solitaire
153690|NCT02350283|Standard Medical Management|standard medical management
153691|NCT02350270|cognitively healthy individuals|cognitively healthy individuals
153692|NCT02350257|cognitive behavior therapy|cognitive behavior therapy
153693|NCT02350257|child|child
153694|NCT02350257|randomized controlled trial|randomized controlled trial
153695|NCT02350257|internet|internet
153696|NCT02350244|musculoskeletal diseases|musculoskeletal diseases
153697|NCT02350244|eyestrain|eyestrain
153698|NCT02350244|occupational diseases|occupational diseases
153699|NCT02350244|computer work|computer work
153700|NCT02350244|muscle stretching exercise|muscle stretching exercise
153701|NCT02350244|computer software application|computer software application
153702|NCT02350244|MSDs|msds
153703|NCT02350231|preterm birth|preterm birth
153704|NCT02350231|Twin pregnancy|twin pregnancy
153705|NCT02350231|progesterone|progesterone
153706|NCT02350218|Transplantation|transplantation
153707|NCT02350218|Living donor|living donor
153708|NCT02350218|Eglandin|eglandin
153709|NCT02350218|Alprostadil|alprostadil
153710|NCT02350205|Burn wounds|burn wounds
153712|NCT02350205|Skin substitute|skin substitute
153713|NCT02350192|ehealth|ehealth
153714|NCT02350192|intervention|intervention
153715|NCT02350192|effectiveness|effectiveness
153716|NCT02350192|randomized controlled trial|randomized controlled trial
153717|NCT02350166|colorectal cancer|colorectal cancer
153718|NCT02350166|hepatectomy|hepatectomy
153719|NCT02350166|laparoscopic surgery|laparoscopic surgery
153720|NCT02350166|laparotomy|laparotomy
153721|NCT02350166|complications|complications
153722|NCT02350153|Mortality|mortality
153723|NCT02350153|Morbidity|morbidity
153724|NCT02350153|Incidence|incidence
153725|NCT02350153|Prevalence|prevalence
153727|NCT02350140|Prevention of mother-to-child HIV transmission|prevention of mother-to-child hiv transmission
153728|NCT02350140|PMTCT|pmtct
153729|NCT02350140|mobile health (mHealth)|mobile health (mhealth)
153730|NCT02350140|mobile phone|mobile phone
153731|NCT02350140|text messaging|text messaging
153732|NCT02350140|short message services (SMS)|short message services (sms)
153733|NCT02350127|dementia|dementia
153734|NCT02350127|clinical trial|clinical trial
153735|NCT02350127|behavioral intervention|behavioral intervention
153736|NCT02350127|exercise|exercise
153737|NCT02350127|complementary and alternative medicine|complementary and alternative medicine
153738|NCT02350127|cognition|cognition
153739|NCT02350127|function|function
153740|NCT02350127|quality of life|quality of life
153741|NCT02350114|Heart failure|heart failure
153742|NCT02350114|6 Minute Walk Test|6 minute walk test
153743|NCT02350088|fast-track surgery|fast-track surgery
153744|NCT02350075|short implants|short implants
153745|NCT02350075|sinus floor elevation|sinus floor elevation
153746|NCT02350075|randomized controlled trial|randomized controlled trial
153747|NCT02350036|Preeclampsia|preeclampsia
153748|NCT02350036|placental protein 13|placental protein 13
153749|NCT02350036|Uterine artery doppler|uterine artery doppler
153750|NCT02350023|alopecia areata|alopecia areata
153751|NCT02350023|betamethasone|betamethasone
153752|NCT02350023|latanoprost|latanoprost
153753|NCT02350023|topical steroid|topical steroid
153754|NCT02350023|prostaglandin|prostaglandin
153755|NCT02350010|Etiology|etiology
153756|NCT02350010|Prognostic risk factors|prognostic risk factors
153757|NCT02350010|Intracerebral Hemorrhage|intracerebral hemorrhage
153758|NCT02350010|non-invasive imaging|non-invasive imaging
153759|NCT02350010|CT angiography|ct angiography
153760|NCT02349997|central sleep apnea|central sleep apnea
153761|NCT02349997|Cheyne-Stokes respiration|cheyne-stokes respiration
153762|NCT02349997|obstructive sleep apnea|obstructive sleep apnea
153763|NCT02349997|chronic heart failure|chronic heart failure
153764|NCT02349997|fluid shift|fluid shift
153765|NCT02349919|postinfectious cough, postviral cough|postinfectious cough, postviral cough
153766|NCT02349906|non-malignant diseases, allogeneic stem cell transplantation|non-malignant diseases, allogeneic stem cell transplantation
153767|NCT02349854|pruritus|pruritus
153768|NCT02349854|itch|itch
153769|NCT02349854|skin|skin
153770|NCT02349854|scalp|scalp
153771|NCT02349854|seborrheic dermatitis|seborrheic dermatitis
153772|NCT02349828|antiviral|antiviral
153773|NCT02349828|herpes simplex virus|herpes simplex virus
153774|NCT02349828|herpes|herpes
153775|NCT02349828|burn patients|burn patients
153777|NCT02349828|acyclovir|acyclovir
153778|NCT02349815|Drug Utilization Study|drug utilization study
153779|NCT02349802|Auto-injector Device, device-related injection, Auto-injector|auto-injector device, device-related injection, auto-injector
153780|NCT02349789|Gait|gait
153781|NCT02349789|Cerebellum|cerebellum
153782|NCT02349789|Non invasive electrical stimulation|non invasive electrical stimulation
153783|NCT02349789|tDCS|tdcs
153784|NCT02349789|TMS|tms
153785|NCT02349789|Balance|balance
153786|NCT02349763|Dexamethasone|dexamethasone
153787|NCT02349763|Hypersensitivity reaction|hypersensitivity reaction
153788|NCT02349763|Paclitaxel|paclitaxel
153789|NCT02349750|Endometrial Scratch Injury|endometrial scratch injury
153790|NCT02349750|Unexplained infertility|unexplained infertility
153791|NCT02349750|intrauterine insemenation|intrauterine insemenation
153792|NCT02349750|ovulation induction|ovulation induction
153793|NCT02349737|Bioelectrical Impedance Analysis|bioelectrical impedance analysis
153794|NCT02349737|Body composition|body composition
153795|NCT02349737|ICD|icd
153796|NCT02349724|CEA|cea
153797|NCT02349724|CAR T|car t
153798|NCT02349711|probiotic|probiotic
153799|NCT02349711|allergy|allergy
153800|NCT02349711|immune|immune
153801|NCT02349698|CAR T|car t
153802|NCT02349698|Leukemia|leukemia
153803|NCT02349698|Lymphoma|lymphoma
153804|NCT02349685|Helicobacter pylori|helicobacter pylori
153805|NCT02349685|Personalized therapy|personalized therapy
153806|NCT02349685|antimicrobial susceptibility|antimicrobial susceptibility
153807|NCT02349685|rescue therapy|rescue therapy
153808|NCT02349685|culture|culture
153809|NCT02349672|HIE|hie
153810|NCT02349672|Neonates|neonates
153811|NCT02349633|EGFRm - Epidermal Growth Factor Receptor Mutation|egfrm - epidermal growth factor receptor mutation
153812|NCT02349633|Advanced EGFRm (del19 or L858R +/- T790M NSCLC|advanced egfrm (del19 or l858r +/- t790m nsclc
153813|NCT02349581|Anesthetics, Local|anesthetics, local
153814|NCT02349581|Mastectomy|mastectomy
153815|NCT02349581|Neuralgia|neuralgia
153816|NCT02349581|Nerve block|nerve block
153817|NCT02349542|Liposomal Bupivacaine|liposomal bupivacaine
153818|NCT02349542|Simultaneous Bilateral Total Knee Arthroplasty|simultaneous bilateral total knee arthroplasty
153819|NCT02349542|Safety|safety
153820|NCT02349529|Epilepsy|epilepsy
153821|NCT02349529|psychosocial|psychosocial
153822|NCT02349503|Adrenocortical function|adrenocortical function
153823|NCT02349503|Adrenal hyperplasia, Congenital|adrenal hyperplasia, congenital
153824|NCT02349503|21-hydroxylase deficiency|21-hydroxylase deficiency
153825|NCT02349503|Adrenogenital Syndrome|adrenogenital syndrome
153826|NCT02349503|Adolescents|adolescents
153827|NCT02349503|Female|female
153828|NCT02349503|Hyperplasia|hyperplasia
153829|NCT02349503|Adrenal Gland Diseases|adrenal gland diseases
153830|NCT02349503|Congenital Abnormalities|congenital abnormalities
153831|NCT02349503|Adrenocortical Hyperfunction|adrenocortical hyperfunction
153832|NCT02349503|Disorders of Sex Development|disorders of sex development
153833|NCT02349503|Endocrine System Diseases|endocrine system diseases
153834|NCT02349503|Genetic Diseases, Inborn|genetic diseases, inborn
153835|NCT02349503|Gonadal Disorders|gonadal disorders
153836|NCT02349503|Metabolic Diseases|metabolic diseases
153837|NCT02349503|Metabolism, Inborn Errors|metabolism, inborn errors
153838|NCT02349503|Pathologic Processes|pathologic processes
153947|NCT02348749|PET/CT scan|pet/ct scan
153839|NCT02349503|Steroid Metabolism, Inborn Errors|steroid metabolism, inborn errors
153840|NCT02349503|Urogenital Abnormalities|urogenital abnormalities
153841|NCT02349503|Corticotropin Releasing Factor|corticotropin releasing factor
153842|NCT02349490|gastrointestinal hemorrhage|gastrointestinal hemorrhage
153843|NCT02349490|endoscopy|endoscopy
153844|NCT02349490|hemostasis|hemostasis
153845|NCT02349451|Safety|safety
153846|NCT02349451|Efficacy|efficacy
153847|NCT02349451|Methotrexate|methotrexate
153848|NCT02349373|Overuse injury|overuse injury
153849|NCT02349373|Running related injury|running related injury
153850|NCT02349373|Running pattern|running pattern
153851|NCT02349360|safety|safety
153852|NCT02349360|tolerability|tolerability
153853|NCT02349321|physical or sexual intimate partner violence|physical or sexual intimate partner violence
153854|NCT02349321|adolescents|adolescents
153855|NCT02349321|primary prevention|primary prevention
153856|NCT02349321|randomised controlled trial|randomised controlled trial
153857|NCT02349321|school|school
153858|NCT02349321|South Africa|south africa
153859|NCT02349321|parenting|parenting
153860|NCT02349282|muscle strength|muscle strength
153861|NCT02349282|physical performance|physical performance
153862|NCT02349282|vitamin D3|vitamin d3
153863|NCT02349282|Cholecalciferol|cholecalciferol
153864|NCT02349282|Calcifediol|calcifediol
153865|NCT02349269|Atrial fibrillation|atrial fibrillation
153866|NCT02349269|CABG|cabg
153867|NCT02349269|Stroke|stroke
153868|NCT02349256|MUS|mus
153869|NCT02349256|British South Asians|british south asians
153870|NCT02349256|Somatic Symptoms|somatic symptoms
153871|NCT02349256|Qualitative interviews|qualitative interviews
153872|NCT02349243|obese|obese
153873|NCT02349243|weight loss|weight loss
153874|NCT02349243|entacapone|entacapone
153875|NCT02349217|Breast cancer|breast cancer
153876|NCT02349217|Breast cancer survivors|breast cancer survivors
153877|NCT02349217|Breast cancer partners|breast cancer partners
153878|NCT02349217|Mindfulness-Based Relationship Enhancement|mindfulness-based relationship enhancement
153879|NCT02349217|MBRE|mbre
153880|NCT02349217|Standard of care|standard of care
153881|NCT02349217|Pain Assessment|pain assessment
153882|NCT02349217|Questionnaires|questionnaires
153883|NCT02349217|Surveys|surveys
153884|NCT02349217|Neurocognitive Tests|neurocognitive tests
153885|NCT02349217|Cortisol Tests|cortisol tests
153886|NCT02349217|Saliva tests|saliva tests
153887|NCT02349217|Interviews|interviews
153888|NCT02349217|Meditation|meditation
153889|NCT02349217|Yoga|yoga
153890|NCT02349217|Self-help materials|self-help materials
153891|NCT02349204|Simulator|simulator
153892|NCT02349204|Music|music
153893|NCT02349204|Mozart Effect|mozart effect
153894|NCT02349191|Alzheimers|alzheimers
153895|NCT02349191|dementia|dementia
153896|NCT02349191|omental transposition|omental transposition
153897|NCT02349191|neurological|neurological
153898|NCT02349152|Cardiopulmonary bypass|cardiopulmonary bypass
153899|NCT02349152|Heart surgery|heart surgery
153900|NCT02349126|Hepatitis B|hepatitis b
153901|NCT02349126|HBV infection|hbv infection
153902|NCT02349126|Hepatitis B Surface Antigen|hepatitis b surface antigen
153903|NCT02349113|estrogen, aging|estrogen, aging
153904|NCT02349087|EEG|eeg
153905|NCT02349087|cardiac arrest|cardiac arrest
153906|NCT02349087|resuscitation|resuscitation
153907|NCT02349087|seizures|seizures
153912|NCT02349048|Chronic Hepatitis C Virus Genotype 1 Infection|chronic hepatitis c virus genotype 1 infection
153913|NCT02349048|Liver fibrosis|liver fibrosis
153914|NCT02349048|Cirrhosis|cirrhosis
153915|NCT02349048|Simeprevir|simeprevir
153916|NCT02349048|Daclatasvir|daclatasvir
153917|NCT02349048|Sofosbuvir|sofosbuvir
153918|NCT02349035|Transradial amputee|transradial amputee
153919|NCT02349022|[89Zr]Df-IAB2M|[89zr]df-iab2m
153920|NCT02349022|Prostate cancer|prostate cancer
153921|NCT02349022|PET scan|pet scan
153922|NCT02349009|systemic sclerosis|systemic sclerosis
153923|NCT02349009|scleroderma|scleroderma
153924|NCT02348970|mandibular advancement devices ONIRIS®|mandibular advancement devices oniris®
153925|NCT02348970|obstructive sleep apnea and hypopneas|obstructive sleep apnea and hypopneas
153926|NCT02348957|Chronic myeloid leukemia|chronic myeloid leukemia
153927|NCT02348957|Dasatinib|dasatinib
153928|NCT02348957|Any line|any line
153929|NCT02348957|Chronic phase|chronic phase
153930|NCT02348944|Biological markers|biological markers
153931|NCT02348944|Cartilage|cartilage
153932|NCT02348840|Midwives|midwives
153933|NCT02348840|Pregnant Women|pregnant women
153934|NCT02348827|Unipolar depression|unipolar depression
153935|NCT02348827|Family Therapies|family therapies
153936|NCT02348827|Psychoeducation|psychoeducation
153937|NCT02348827|Family psychoeducation|family psychoeducation
153938|NCT02348814|NAFLD, NASH|nafld, nash
153939|NCT02348788|Vivax|vivax
153940|NCT02348788|Malaria|malaria
153941|NCT02348788|artemether-lumefantrine|artemether-lumefantrine
153942|NCT02348788|chloroquine|chloroquine
153943|NCT02348788|RCT|rct
153944|NCT02348749|18F-MFBG Imaging|18f-mfbg imaging
153945|NCT02348749|14-138|14-138
153946|NCT02348749|PET/MR|pet/mr
153948|NCT02348736|airway|airway
153949|NCT02348736|videolaryngoscope|videolaryngoscope
153950|NCT02348697|Cartilage Defect in the Knee|cartilage defect in the knee
153951|NCT02348697|MACT|mact
153952|NCT02348684|Breast Cancer|breast cancer
153953|NCT02348658|Pharmacological therapy|pharmacological therapy
153954|NCT02348645|Pilot projects|pilot projects
153955|NCT02348645|Feasibility studies|feasibility studies
153956|NCT02348645|Intervention studies|intervention studies
153957|NCT02348645|Orthopedics|orthopedics
153958|NCT02348645|Orthopedic Procedures|orthopedic procedures
153959|NCT02348645|Neurosurgical Procedures|neurosurgical procedures
153960|NCT02348645|Neurosurgery|neurosurgery
153961|NCT02348645|Spine|spine
153962|NCT02348645|Spinal Fusion|spinal fusion
153963|NCT02348645|Spondylodesis|spondylodesis
153964|NCT02348645|Spondylosyndesis|spondylosyndesis
153965|NCT02348645|Laminectomy|laminectomy
153966|NCT02348645|Foraminotomy|foraminotomy
153967|NCT02348645|Decompression, surgical|decompression, surgical
153968|NCT02348645|Low Back Pain|low back pain
153969|NCT02348645|Quality of Life|quality of life
153970|NCT02348580|teaching|teaching
153971|NCT02348580|education|education
153972|NCT02348580|active learning|active learning
153973|NCT02348580|time on task|time on task
153974|NCT02348580|financial education|financial education
153975|NCT02348580|social education|social education
153976|NCT02348580|rights based education|rights based education
153977|NCT02348580|primary school|primary school
153978|NCT02348580|life-skills|life-skills
153979|NCT02348567|Health care, accreditation, unannounced survey, cluster randomized controlled trial, quality improvement, organisational development|health care, accreditation, unannounced survey, cluster randomized controlled trial, quality improvement, organisational development
153980|NCT02348554|obesity|obesity
153981|NCT02348554|energy expenditure|energy expenditure
153982|NCT02348554|daily living physical activity|daily living physical activity
153983|NCT02348554|smartphone|smartphone
153984|NCT02348554|accelerometry|accelerometry
153985|NCT02348554|prediction algorithm|prediction algorithm
153986|NCT02348528|Multiple Myeloma|multiple myeloma
153987|NCT02348528|Relapsed|relapsed
153988|NCT02348528|Refractory|refractory
153989|NCT02348528|Lenalidomide|lenalidomide
153990|NCT02348528|Dexamethasone|dexamethasone
153991|NCT02348528|open-label|open-label
153992|NCT02348528|CC-5013-MM-021|cc-5013-mm-021
153993|NCT02348502|HBsAg loss|hbsag loss
153994|NCT02348502|interferon|interferon
153995|NCT02348502|HBV reaction|hbv reaction
153996|NCT02348502|Hepatitis B|hepatitis b
153997|NCT02348489|AML|aml
153998|NCT02348489|Acute Myeloid Leukemia|acute myeloid leukemia
153999|NCT02348489|SGI-110|sgi-110
154000|NCT02348489|DNA Hypomethylating Agen|dna hypomethylating agen
154006|NCT02348424|genitourinary|genitourinary
154007|NCT02348424|Neisseriaceae|neisseriaceae
154008|NCT02348424|pharyngeal|pharyngeal
154009|NCT02348424|Solithromycin|solithromycin
154010|NCT02348411|Medication-refractory|medication-refractory
154011|NCT02348398|Cervical Cancer|cervical cancer
154012|NCT02348398|Recurrent cervical cancer|recurrent cervical cancer
154013|NCT02348398|Squamous cervical cancer|squamous cervical cancer
154014|NCT02348398|Adenocarcinoma of the cervix|adenocarcinoma of the cervix
154015|NCT02348398|Adenosquamous cervical cancer|adenosquamous cervical cancer
154016|NCT02348398|Persistent cervical cancer|persistent cervical cancer
154017|NCT02348398|Pazopanib|pazopanib
154018|NCT02348398|GW786034|gw786034
154019|NCT02348398|Topotecan|topotecan
154020|NCT02348398|Hycamtin|hycamtin
154021|NCT02348385|amphetamine|amphetamine
154022|NCT02348385|cigarette smokers|cigarette smokers
154023|NCT02348359|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
154024|NCT02348359|Platelet Derived Growth Factor (PDGF)|platelet derived growth factor (pdgf)
154026|NCT02348346|self-disinfecting surfaces|self-disinfecting surfaces
154027|NCT02348346|titanium dioxide|titanium dioxide
154028|NCT02348281|triple negative breast cancer|triple negative breast cancer
154029|NCT02348281|androgen receptor|androgen receptor
154030|NCT02348281|bicalutamide|bicalutamide
154031|NCT02348268|Neck Pain|neck pain
154032|NCT02348268|Myofascial release|myofascial release
154033|NCT02348268|Manual therapy|manual therapy
154034|NCT02348242|Intensive care|intensive care
154035|NCT02348242|corneal damage|corneal damage
154036|NCT02348242|prevention|prevention
154037|NCT02348242|nursing protocol|nursing protocol
154038|NCT02348229|Enhanced recovery after surgery|enhanced recovery after surgery
154039|NCT02348229|laparoscopic gastrectomy|laparoscopic gastrectomy
154040|NCT02348229|advanced gastric cancer|advanced gastric cancer
154041|NCT02348229|C-reactive,visceral proteins|c-reactive,visceral proteins
154042|NCT02348177|Human immunideficiency virus|human immunideficiency virus
154043|NCT02348177|Tuberculosis|tuberculosis
154044|NCT02348177|superboosting|superboosting
154045|NCT02348177|lopinavir/ritonavir 1:1|lopinavir/ritonavir 1:1
154046|NCT02348177|Pediatric TB/HIV co-infection|pediatric tb/hiv co-infection
154047|NCT02348164|Carotenoids|carotenoids
154048|NCT02348164|absorption|absorption
154049|NCT02348164|citrus|citrus
154050|NCT02348151|COPD|copd
154051|NCT02348151|SWTi|swti
154052|NCT02348151|Treadmill|treadmill
154053|NCT02348138|Isometric Handgrip|isometric handgrip
154054|NCT02348112|stress urinary incontinence|stress urinary incontinence
154055|NCT02348112|Altis 522|altis 522
154056|NCT02348112|urinary incontinence|urinary incontinence
154057|NCT02348099|Diabetes|diabetes
154058|NCT02348099|Lipohypertrophy|lipohypertrophy
154059|NCT02348099|Ultrasound|ultrasound
154060|NCT02348073|Epilepsy|epilepsy
154061|NCT02348073|Attention Deficit Disorders|attention deficit disorders
154062|NCT02348073|VAYARIN|vayarin
154063|NCT02348073|Children|children
154064|NCT02348073|Polyunsaturated n-3 fatty acid supplementation|polyunsaturated n-3 fatty acid supplementation
154065|NCT02348034|Surgical Site Infection (SSI)|surgical site infection (ssi)
154066|NCT02348034|Negative Pressure Wound Therapy (NPWT)|negative pressure wound therapy (npwt)
154067|NCT02348008|MK-3475|mk-3475
154068|NCT02348008|Pembrolizumab|pembrolizumab
154069|NCT02348008|Bevacizumab|bevacizumab
154070|NCT02347995|Exercise|exercise
154071|NCT02347995|Protein|protein
154072|NCT02347995|Nutrition|nutrition
154073|NCT02347995|Stroke|stroke
154074|NCT02347982|Turkey|turkey
154075|NCT02347982|Epidemiologic|epidemiologic
154076|NCT02347969|antioxidant|antioxidant
154077|NCT02347969|skin radiance|skin radiance
154078|NCT02347969|skin elasticity|skin elasticity
154079|NCT02347969|skin firmness|skin firmness
154080|NCT02347969|skin hydration|skin hydration
154081|NCT02347956|robot surgery|robot surgery
154082|NCT02347956|reduced port|reduced port
154083|NCT02347956|single-site|single-site
154084|NCT02347956|safety|safety
154085|NCT02347956|feasibility|feasibility
154086|NCT02347930|acute kidney injury|acute kidney injury
154087|NCT02347930|ultrasound technology|ultrasound technology
154088|NCT02347904|Esophageal cancer|esophageal cancer
154089|NCT02347904|Adjuvant treatment|adjuvant treatment
154090|NCT02347904|S-1|s-1
154091|NCT02347904|Oxaliplatin|oxaliplatin
154092|NCT02347904|Feasibility|feasibility
154093|NCT02347891|Inflammatory Myositis|inflammatory myositis
154094|NCT02347891|Dermatomyositis|dermatomyositis
154095|NCT02347891|Polymyositis|polymyositis
154096|NCT02347891|Muscle Pain|muscle pain
154097|NCT02347891|Myositis|myositis
154098|NCT02347891|Refractory myositis|refractory myositis
154099|NCT02347878|leukemia|leukemia
154100|NCT02347878|lymphoma|lymphoma
154101|NCT02347878|lumbar puncture|lumbar puncture
154102|NCT02347878|intrathecal treatment|intrathecal treatment
154305|NCT02346591|Gratitude|gratitude
154103|NCT02347878|post-lumbar puncture headache|post-lumbar puncture headache
154104|NCT02347865|osteoporosis post menopausal women|osteoporosis post menopausal women
154105|NCT02347826|coned wires, wire lift,|coned wires, wire lift,
154106|NCT02347826|patient|patient
154107|NCT02347826|discomfort|discomfort
154108|NCT02347813|squamous cell carcinoma|squamous cell carcinoma
154109|NCT02347813|pioglitazone|pioglitazone
154110|NCT02347813|PPARgamma|ppargamma
154111|NCT02347813|skin cancer|skin cancer
154112|NCT02347774|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
154113|NCT02347774|COPD|copd
154114|NCT02347761|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
154115|NCT02347748|Pain|pain
154116|NCT02347748|Anesthesia Recovery Period|anesthesia recovery period
154117|NCT02347748|Postoperative Period|postoperative period
154118|NCT02347748|Adaptation, Psychological|adaptation, psychological
154120|NCT02347748|Stress, Psychological|stress, psychological
154121|NCT02347735|Colorectal carcinoma|colorectal carcinoma
154122|NCT02347735|Anastomotic leakage|anastomotic leakage
154123|NCT02347735|Markers|markers
154124|NCT02347735|Diagnosis|diagnosis
154125|NCT02347722|biomarkers|biomarkers
154126|NCT02347722|diagnosis|diagnosis
154127|NCT02347722|etiology of heart failure|etiology of heart failure
154128|NCT02347709|Diabetic Foot Ulcer|diabetic foot ulcer
154129|NCT02347709|DFU|dfu
154130|NCT02347709|Type 2 Diabetes|type 2 diabetes
154131|NCT02347709|Neuropathy|neuropathy
154132|NCT02347696|Diet|diet
154133|NCT02347696|Physical Activity|physical activity
154134|NCT02347696|Trial|trial
154135|NCT02347696|Lipidomics|lipidomics
154136|NCT02347696|Occidental Diseases|occidental diseases
154137|NCT02347657|Homozygous for the F508del CFTR Mutation|homozygous for the f508del cftr mutation
154138|NCT02347566|COPD|copd
154139|NCT02347566|Physical Activity|physical activity
154140|NCT02347566|Accelerometer|accelerometer
154141|NCT02347540|Heart Failure|heart failure
154142|NCT02347540|Diastolic Dysfunction|diastolic dysfunction
154143|NCT02347540|Pre-Eclampsia|pre-eclampsia
154144|NCT02347540|Endothelial dysfunction|endothelial dysfunction
154145|NCT02347540|Biological Markers|biological markers
154146|NCT02347540|MicroRNAs|micrornas
154147|NCT02347540|Circulating cells|circulating cells
154148|NCT02347488|ETT Holder, bite guard, airway, endotracheal tube|ett holder, bite guard, airway, endotracheal tube
154149|NCT02347462|BiPAP|bipap
154150|NCT02347449|Early-stage Breast cancer, node positive|early-stage breast cancer, node positive
154151|NCT02347449|Prognosis|prognosis
154152|NCT02347449|Oncotype Dx|oncotype dx
154153|NCT02347436|Transurethral Resection of Prostate|transurethral resection of prostate
154154|NCT02347423|Poliomyelitis immunization|poliomyelitis immunization
154155|NCT02347423|primary series|primary series
154156|NCT02347371|Heart transplant|heart transplant
154157|NCT02347371|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
154158|NCT02347371|Chronic rejection|chronic rejection
154159|NCT02347371|Immunosuppressant therapy|immunosuppressant therapy
154160|NCT02347345|HCV, injection drug use|hcv, injection drug use
154161|NCT02347280|clostridium difficile|clostridium difficile
154162|NCT02347280|colitis|colitis
154163|NCT02347280|colon|colon
154164|NCT02347267|Beverages sweetened caloric, no caloric|beverages sweetened caloric, no caloric
154165|NCT02347267|Weight|weight
154166|NCT02347267|Fat percentage|fat percentage
154167|NCT02347267|Body Composition|body composition
154168|NCT02347267|Blood pressure|blood pressure
154169|NCT02347267|Sugar|sugar
154170|NCT02347267|Sodium|sodium
154171|NCT02347267|Dietary intake|dietary intake
154172|NCT02347228|OB318|ob318
154173|NCT02347228|Advanced Solid Malignancies|advanced solid malignancies
154174|NCT02347228|Antrodia cinnamomea|antrodia cinnamomea
154175|NCT02347228|Antrodia camphorata|antrodia camphorata
154176|NCT02347202|Counseling|counseling
154177|NCT02347163|triple neg|triple neg
154178|NCT02347163|breast cancer|breast cancer
154179|NCT02347163|zoledronate|zoledronate
154180|NCT02347163|mevalonate pathway|mevalonate pathway
154181|NCT02347124|smoking cessation|smoking cessation
154182|NCT02347124|oral health care|oral health care
154183|NCT02347124|tobacco quitlines|tobacco quitlines
154184|NCT02347098|plaque|plaque
154185|NCT02347098|LDL|ldl
154186|NCT02347098|statin|statin
154187|NCT02347098|endothelial|endothelial
154188|NCT02347098|apheresis|apheresis
154189|NCT02347098|acute coronary artery syndrome|acute coronary artery syndrome
154190|NCT02347033|Sertraline|sertraline
154191|NCT02347033|Selective Serotonin Reuptake Inhibitor (SSRI)|selective serotonin reuptake inhibitor (ssri)
154192|NCT02347033|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
154193|NCT02347033|Increasing Access to Psychological Therapies (IAPT)|increasing access to psychological therapies (iapt)
154194|NCT02347020|Obesity|obesity
154195|NCT02347020|Metabolic Disorders|metabolic disorders
154196|NCT02347007|Obesity|obesity
154197|NCT02347007|Overweight|overweight
154198|NCT02347007|Body Weight|body weight
154199|NCT02347007|Cardiovascular Diseases|cardiovascular diseases
154200|NCT02347007|Cholesterol|cholesterol
154201|NCT02347007|Almonds|almonds
154202|NCT02347007|Visceral Adiposity|visceral adiposity
154203|NCT02347007|Quality of Life|quality of life
154204|NCT02347007|Hispanic Americans|hispanic americans
154205|NCT02347007|African Continental Ancestry Group|african continental ancestry group
154206|NCT02347007|Metabolic Syndrome X|metabolic syndrome x
154207|NCT02346994|Body Weight|body weight
154208|NCT02346994|Obesity in Adolescence|obesity in adolescence
154209|NCT02346994|Obesity in Childhood|obesity in childhood
154210|NCT02346994|Childhood Onset Obesity|childhood onset obesity
154211|NCT02346994|Childhood Obesity|childhood obesity
154212|NCT02346994|Child Obesity|child obesity
154213|NCT02346994|Adolescent Obesity|adolescent obesity
154214|NCT02346994|Teenagers|teenagers
154215|NCT02346994|Teens|teens
154216|NCT02346994|Youth|youth
154217|NCT02346994|Adolescents|adolescents
154218|NCT02346994|Adolescence|adolescence
154221|NCT02346968|C-terminal fragment of agrin|c-terminal fragment of agrin
154222|NCT02346968|Dialysis|dialysis
154223|NCT02346955|Cancer|cancer
154224|NCT02346955|Oncology|oncology
154225|NCT02346955|cCAM Biotherapeutics Ltd|ccam biotherapeutics ltd
154226|NCT02346955|Immunomodulatory therapy|immunomodulatory therapy
154227|NCT02346955|CM-24|cm-24
154228|NCT02346955|Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 (CEACAM1)|carcinoembryonic antigen-related cell adhesion molecule 1 (ceacam1)
154229|NCT02346955|NSCLC (adenocarcinoma)|nsclc (adenocarcinoma)
154230|NCT02346955|Uveal|uveal
154231|NCT02346955|Acral|acral
154232|NCT02346955|Mucosal|mucosal
154233|NCT02346955|Cutaneous|cutaneous
154234|NCT02346955|Colorectal|colorectal
154235|NCT02346955|Gastric|gastric
154236|NCT02346955|Ovarian|ovarian
154237|NCT02346955|Bladder|bladder
154238|NCT02346955|MK-6018-001|mk-6018-001
154239|NCT02346929|Hematoma block|hematoma block
154240|NCT02346929|distal radius fracture reduction|distal radius fracture reduction
154241|NCT02346929|ultrasound|ultrasound
154242|NCT02346929|ultrasound guided hematoma block|ultrasound guided hematoma block
154243|NCT02346929|traditional hematoma block for analgesia|traditional hematoma block for analgesia
154244|NCT02346929|bupivacaine|bupivacaine
154245|NCT02346929|pain reduction|pain reduction
154246|NCT02346929|wrist fracture|wrist fracture
154247|NCT02346890|Volunteer|volunteer
154248|NCT02346877|Enbrel|enbrel
154249|NCT02346877|Rheumatoid Arthritis|rheumatoid arthritis
154250|NCT02346864|head elevated position|head elevated position
154251|NCT02346864|preterm|preterm
154252|NCT02346864|three-stair-position|three-stair-position
752600|NCT01173276|Intrauterine Insemination|intrauterine insemination
154351|NCT02346396|neuropathic pain|neuropathic pain
154253|NCT02346838|Prediabetes, prebiotics, metabolic endotoxemia|prediabetes, prebiotics, metabolic endotoxemia
154254|NCT02346825|P-CIMT|p-cimt
154255|NCT02346825|Pediatric Constraint Induced Movement Therapy|pediatric constraint induced movement therapy
154256|NCT02346825|Hemiparesis|hemiparesis
154257|NCT02346825|Cerebral Palsy|cerebral palsy
154258|NCT02346825|Infants|infants
154259|NCT02346825|Toddlers|toddlers
154260|NCT02346825|Children|children
154261|NCT02346786|Drinking Water|drinking water
154262|NCT02346786|Mineral water|mineral water
154263|NCT02346786|Sports|sports
154264|NCT02346786|Accident prevention|accident prevention
154265|NCT02346747|Stage III|stage iii
154266|NCT02346747|Stage IV|stage iv
154267|NCT02346747|Ovarian Cancer|ovarian cancer
154268|NCT02346747|Maintenance|maintenance
154269|NCT02346747|Immunotherapy|immunotherapy
154270|NCT02346747|primary peritoneal cancer|primary peritoneal cancer
154271|NCT02346747|fallopian tube cancer|fallopian tube cancer
154272|NCT02346747|endometrioid ovarian cancer|endometrioid ovarian cancer
154273|NCT02346747|high-grade serous ovarian cancer|high-grade serous ovarian cancer
154274|NCT02346734|Multiple Sclerosis|multiple sclerosis
154275|NCT02346734|Telerehablitation|telerehablitation
154276|NCT02346721|Sofosbuvir|sofosbuvir
154277|NCT02346721|SOF/GS-5816|sof/gs-5816
154278|NCT02346721|GS-5816|gs-5816
154279|NCT02346721|Hepatitis C|hepatitis c
154280|NCT02346721|HCV|hcv
154281|NCT02346721|Cirrhosis|cirrhosis
154282|NCT02346721|Velpatasvir|velpatasvir
154283|NCT02346708|Parkinson's|parkinson's
154284|NCT02346708|TMS|tms
154285|NCT02346708|Kluger|kluger
154286|NCT02346695|LV deformation|lv deformation
154287|NCT02346695|Endothelial glycocalyx|endothelial glycocalyx
154288|NCT02346695|Coronary flow reserve|coronary flow reserve
154289|NCT02346682|major depression disorder|major depression disorder
154290|NCT02346682|biochemistry|biochemistry
154291|NCT02346682|TCM diagnosis|tcm diagnosis
154292|NCT02346682|Neurological|neurological
154293|NCT02346682|metabonomics|metabonomics
154294|NCT02346682|neuroimaging|neuroimaging
154295|NCT02346669|Microbiota|microbiota
154296|NCT02346669|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
154297|NCT02346669|Obesity|obesity
154298|NCT02346617|CMV|cmv
154299|NCT02346617|T cell therapy|t cell therapy
154300|NCT02346604|exercise|exercise
154301|NCT02346591|Positive psychology|positive psychology
154302|NCT02346591|Wellbeing|wellbeing
154303|NCT02346591|Stress reduction|stress reduction
154304|NCT02346591|Relaxation|relaxation
154306|NCT02346591|Mobile app|mobile app
154307|NCT02346591|Intervention|intervention
154308|NCT02346591|Altruism|altruism
154309|NCT02346591|Psychological well-being|psychological well-being
154310|NCT02346591|Social well-being|social well-being
154311|NCT02346591|Physical well-being|physical well-being
154312|NCT02346591|Workplace engagement|workplace engagement
154313|NCT02346552|laparoscopic Cholecystectomy|laparoscopic cholecystectomy
154314|NCT02346552|laparoscope holder|laparoscope holder
154315|NCT02346552|Nissen fundoplication|nissen fundoplication
154316|NCT02346552|paraesophageal hernia|paraesophageal hernia
154317|NCT02346552|sleeve surgery|sleeve surgery
154318|NCT02346539|Nicotine|nicotine
154319|NCT02346539|Depression|depression
154320|NCT02346526|Prostate Cancer|prostate cancer
154321|NCT02346526|Castration-resistant prostate cancer|castration-resistant prostate cancer
154322|NCT02346526|Castration-resistant prostate cancer metastatic to bone|castration-resistant prostate cancer metastatic to bone
154323|NCT02346513|Hip Replacement Arthroplasty|hip replacement arthroplasty
154324|NCT02346513|Ceramic on Metal Articulation|ceramic on metal articulation
154325|NCT02346513|Serum level of Cobalt and Chromium|serum level of cobalt and chromium
154326|NCT02346500|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
154327|NCT02346500|Lower urinary tract symptoms|lower urinary tract symptoms
154328|NCT02346500|Photoselective laser vaporization of the prostate|photoselective laser vaporization of the prostate
154329|NCT02346500|Transrectal Ultrasound|transrectal ultrasound
154330|NCT02346487|children|children
154331|NCT02346474|Subcutaneous Fat|subcutaneous fat
154332|NCT02346474|Visceral Fat|visceral fat
154333|NCT02346461|Hereditary Inclusion Body Myopathy (HIBM)|hereditary inclusion body myopathy (hibm)
154334|NCT02346461|Sialic Acid|sialic acid
154335|NCT02346461|GNE Myopathy|gne myopathy
154336|NCT02346461|N-Acetyl-D-mannosamine (ManNAc)|n-acetyl-d-mannosamine (mannac)
154337|NCT02346461|GNE Gene|gne gene
154338|NCT02346448|endoscopic sphincterotomy|endoscopic sphincterotomy
154339|NCT02346448|balloon dilation|balloon dilation
154340|NCT02346448|adverse events|adverse events
154341|NCT02346448|pancreatitis|pancreatitis
154342|NCT02346448|bleeding|bleeding
154343|NCT02346435|small renal mass|small renal mass
154344|NCT02346435|active surveillance|active surveillance
154345|NCT02346422|Heart Failure|heart failure
154346|NCT02346422|Cardiomyopathies|cardiomyopathies
154347|NCT02346422|Heart Diseases|heart diseases
154348|NCT02346422|Cardiovascular Diseases|cardiovascular diseases
154349|NCT02346422|Cardiomegaly|cardiomegaly
154350|NCT02346422|Gene Therapy|gene therapy
145274|NCT02399124|RCC|rcc
154447|NCT02346006|Exercise|exercise
154352|NCT02346396|neurostimulation|neurostimulation
154353|NCT02346396|ambulatory use|ambulatory use
154354|NCT02346396|tDCS|tdcs
154355|NCT02346383|back pain|back pain
154356|NCT02346383|neuromodulation|neuromodulation
154357|NCT02346383|spinal peripheral neuromodulation|spinal peripheral neuromodulation
154358|NCT02346383|spinal cord stimulation|spinal cord stimulation
154359|NCT02346383|postlaminectomy pain syndrome|postlaminectomy pain syndrome
154360|NCT02346370|Recurrent, previously treated, locally advanced or metastatic NSCLC (non small cell lung cancer)|recurrent, previously treated, locally advanced or metastatic nsclc (non small cell lung cancer)
154361|NCT02346357|hip arthroscopy|hip arthroscopy
154362|NCT02346357|analgesia|analgesia
154363|NCT02346344|type 2 diabetes|type 2 diabetes
154364|NCT02346344|beta cell function|beta cell function
154365|NCT02346344|meal tolerance test|meal tolerance test
154366|NCT02346344|maximum stimulation test|maximum stimulation test
154367|NCT02346344|method standardization|method standardization
154368|NCT02346344|insulin secretion|insulin secretion
154369|NCT02346344|prediabetes|prediabetes
154370|NCT02346344|insulin sensitivity|insulin sensitivity
154371|NCT02346318|Radiotherapy|radiotherapy
154372|NCT02346318|Adverse Effect|adverse effect
154373|NCT02346318|Dermatitis or Eczema|dermatitis or eczema
154374|NCT02346292|COPD|copd
154375|NCT02346292|Spirometry|spirometry
154376|NCT02346292|severe and very severe COPD|severe and very severe copd
154377|NCT02346292|COPD exacerbations|copd exacerbations
154378|NCT02346292|therapy schemes|therapy schemes
154379|NCT02346292|therapy changes|therapy changes
154380|NCT02346279|Multiple Sclerosis|multiple sclerosis
154381|NCT02346279|Rehabilitation|rehabilitation
154382|NCT02346279|Questionnaire|questionnaire
154383|NCT02346279|Patient-Reported Outcome|patient-reported outcome
154384|NCT02346279|Responsiveness|responsiveness
154385|NCT02346279|Minimal Important Clinical Difference|minimal important clinical difference
154386|NCT02346266|Stroke|stroke
154387|NCT02346266|Stroke Prevention|stroke prevention
154388|NCT02346266|Children|children
154389|NCT02346266|Education|education
154390|NCT02346240|Certolizumab Pegol|certolizumab pegol
154391|NCT02346240|Cimzia|cimzia
154392|NCT02346240|Psoriasis|psoriasis
154393|NCT02346227|Human Papillomavirus|human papillomavirus
154394|NCT02346227|Uterine cervix|uterine cervix
154395|NCT02346227|Infection|infection
154396|NCT02346227|Antiviral Drug|antiviral drug
154397|NCT02346227|Therapeutic use|therapeutic use
154398|NCT02346214|Gestational Age|gestational age
154495|NCT02345655|Opiate|opiate
154399|NCT02346214|Anterior Lens Capsule Vascularity|anterior lens capsule vascularity
154400|NCT02346214|Preterm|preterm
154401|NCT02346214|Method-comparison|method-comparison
154402|NCT02346188|blood lead, iron, zinc, child, cognition, behavior, Mexico|blood lead, iron, zinc, child, cognition, behavior, mexico
154403|NCT02346175|SHR3824 Type 2 diabetes mellitus SGLT2|shr3824 type 2 diabetes mellitus sglt2
154404|NCT02346162|Pre-pregnancy|pre-pregnancy
154405|NCT02346162|Weight management|weight management
154406|NCT02346136|Tai Chi|tai chi
154407|NCT02346136|Cluster randomized controlled trial|cluster randomized controlled trial
154408|NCT02346136|Intervention|intervention
154409|NCT02346136|Elderly|elderly
154410|NCT02346136|Mobility|mobility
154411|NCT02346136|Health care utilization|health care utilization
154412|NCT02346123|Chagas disease|chagas disease
154413|NCT02346123|Polymorphisms|polymorphisms
154415|NCT02346097|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
154416|NCT02346097|Heart Failure|heart failure
154417|NCT02346097|Ejection Fraction|ejection fraction
154418|NCT02346097|Narrow|narrow
154419|NCT02346097|Pacemaker|pacemaker
154420|NCT02346097|Electrophysiology|electrophysiology
154421|NCT02346097|Electrical activation mapping|electrical activation mapping
154422|NCT02346097|Coronary Sinus|coronary sinus
154423|NCT02346097|Mapping|mapping
154424|NCT02346097|QRS|qrs
154425|NCT02346097|QRS width|qrs width
154426|NCT02346097|Pacing Interval|pacing interval
154427|NCT02346097|Left Ventricular Lead|left ventricular lead
154428|NCT02346097|Cardiac CT|cardiac ct
154429|NCT02346097|Echocardiography|echocardiography
154430|NCT02346097|Myocardial Scintigraphy|myocardial scintigraphy
154431|NCT02346097|6 Minutes Walk Test|6 minutes walk test
154432|NCT02346097|Imaging|imaging
154433|NCT02346097|Left ventricular ejection fraction|left ventricular ejection fraction
154434|NCT02346097|Epicardial veins|epicardial veins
154435|NCT02346097|Resynchronization|resynchronization
154436|NCT02346097|ImagingCRT|imagingcrt
154437|NCT02346097|Optimal electrical resynchronization|optimal electrical resynchronization
154438|NCT02346097|Cardiac computed tomography|cardiac computed tomography
154439|NCT02346071|Bodily distress syndrome|bodily distress syndrome
154440|NCT02346071|Medically unexplained symptoms|medically unexplained symptoms
154441|NCT02346071|Functional somatic symptoms|functional somatic symptoms
154442|NCT02346071|Functional somatic syndromes|functional somatic syndromes
154443|NCT02346071|Treatment|treatment
186807|NCT02179099|OAB|oab
154444|NCT02346071|Acceptance and Commitment Therapy|acceptance and commitment therapy
154445|NCT02346045|hypertension|hypertension
154446|NCT02346032|second line|second line
154448|NCT02346006|Visual Acuity|visual acuity
154449|NCT02346006|Blood Vessels|blood vessels
154450|NCT02346006|Retina|retina
154451|NCT02346006|Choroid|choroid
154452|NCT02345993|formoterol/beclomethasone in asthmatic crisis|formoterol/beclomethasone in asthmatic crisis
154453|NCT02345993|asthmatic crisis treatment|asthmatic crisis treatment
154454|NCT02345967|diabetes mellitus requiring insulin|diabetes mellitus requiring insulin
154455|NCT02345954|Uterus Prolapse|uterus prolapse
154456|NCT02345954|Laparoscopic Sacropexy|laparoscopic sacropexy
154457|NCT02345954|Laparoscopic Hysteropexy|laparoscopic hysteropexy
154458|NCT02345928|Safety|safety
154459|NCT02345928|Efficacy|efficacy
154460|NCT02345928|CNTO 7160|cnto 7160
154461|NCT02345928|Healthy|healthy
154462|NCT02345928|Asthma|asthma
154463|NCT02345928|Atopic Dermatitis|atopic dermatitis
154464|NCT02345876|Dyslexia, Medial olivocochlear system, Maturation, Auditory Processing|dyslexia, medial olivocochlear system, maturation, auditory processing
154465|NCT02345863|CLL|cll
154466|NCT02345850|Acute Leukemia|acute leukemia
154467|NCT02345850|Myelodysplasia|myelodysplasia
154468|NCT02345850|GVHD Prophylaxis|gvhd prophylaxis
154469|NCT02345850|Chronic GVHD|chronic gvhd
154470|NCT02345824|CDK4/6 Inhibitor|cdk4/6 inhibitor
154471|NCT02345824|LEE011|lee011
154472|NCT02345824|Recurrent Glioblastoma|recurrent glioblastoma
154473|NCT02345824|Anaplastic Glioma|anaplastic glioma
154474|NCT02345824|Ribociclib|ribociclib
154475|NCT02345759|CKD patients|ckd patients
154476|NCT02345759|protein-restricted diets|protein-restricted diets
154477|NCT02345759|compliance|compliance
154478|NCT02345759|psychological aspects|psychological aspects
154479|NCT02345707|Cabotegravir|cabotegravir
154480|NCT02345707|Human Immunodeficiency Virus|human immunodeficiency virus
154481|NCT02345707|Bioavailability|bioavailability
154482|NCT02345707|Pharmacokinetics|pharmacokinetics
154483|NCT02345694|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
154484|NCT02345694|Gait|gait
154485|NCT02345694|Posture|posture
154486|NCT02345694|Continuous Positive Airway Pressure|continuous positive airway pressure
154487|NCT02345681|furosemide|furosemide
154488|NCT02345681|under strict conditions|under strict conditions
154489|NCT02345681|normalize|normalize
154490|NCT02345681|ICU patients|icu patients
154491|NCT02345681|fluid balance|fluid balance
154492|NCT02345668|Transdiagnostic Internet-based Protocol|transdiagnostic internet-based protocol
401970|NCT01232504|rhGM-CSF|rhgm-csf
154493|NCT02345668|Treatment as Usual (TAU)|treatment as usual (tau)
154494|NCT02345655|Substances consumption|substances consumption
154496|NCT02345655|Family practice|family practice
154497|NCT02345629|Refractory cancer pain|refractory cancer pain
154498|NCT02345629|Cordotomy|cordotomy
154499|NCT02345629|Sharpness pain sensory testing|sharpness pain sensory testing
154500|NCT02345629|Heat pain sensory testing|heat pain sensory testing
154501|NCT02345629|Symptom questionnaire|symptom questionnaire
154502|NCT02345629|Advanced cancers|advanced cancers
154503|NCT02345629|Pain|pain
154504|NCT02345616|Cardiac surgery|cardiac surgery
154505|NCT02345616|Pulmonary hypertension|pulmonary hypertension
154506|NCT02345616|Nitric oxide|nitric oxide
154507|NCT02345616|Induction anesthesia|induction anesthesia
154508|NCT02345577|Kidney transplantation|kidney transplantation
154509|NCT02345577|Stochastic whole body vibration therapy|stochastic whole body vibration therapy
154510|NCT02345577|Muscle strength|muscle strength
154511|NCT02345577|Intramuscular lipid content|intramuscular lipid content
154512|NCT02345577|Intramyocellular lipid content|intramyocellular lipid content
154513|NCT02345577|Short Physical Performance Battery Test|short physical performance battery test
154514|NCT02345577|Prospective, randomised , double blind,placebo-controlled trial|prospective, randomised , double blind,placebo-controlled trial
154515|NCT02345577|Physical Therapy Modalities|physical therapy modalities
154516|NCT02345551|Exercise|exercise
154517|NCT02345551|Sleep|sleep
154518|NCT02345551|Telemedicine|telemedicine
154519|NCT02345551|Behavior|behavior
154520|NCT02345551|Shift work|shift work
154521|NCT02345512|Falls|falls
154522|NCT02345499|Radical cystectomy|radical cystectomy
154523|NCT02345499|Laparoscopy|laparoscopy
154524|NCT02345486|Pilot Projects|pilot projects
154525|NCT02345486|Plasmalyte A|plasmalyte a
154526|NCT02345486|Ringer's lactate|ringer's lactate
154527|NCT02345486|Sodium Chloride|sodium chloride
154528|NCT02345486|Critical Care|critical care
154529|NCT02345486|"Resuscitation"|"resuscitation"
154530|NCT02345473|Bladder cancer|bladder cancer
154531|NCT02345473|Circulating cancer cells|circulating cancer cells
154532|NCT02345421|LAL D|lal d
154533|NCT02345421|CESD|cesd
154534|NCT02345421|NASH|nash
154535|NCT02345421|NAFLD|nafld
154536|NCT02345421|Wilson's|wilson's
154537|NCT02345421|Niemann Pick|niemann pick
154538|NCT02345421|Familial Hypercholesterolemia|familial hypercholesterolemia
154539|NCT02345395|Brain Aneurysm|brain aneurysm
154540|NCT02345395|Pterional Craniotomy|pterional craniotomy
154541|NCT02345395|MiniPterional Craniotomy|minipterional craniotomy
154542|NCT02345395|Transpalpebral Approach|transpalpebral approach
154543|NCT02345395|Unruptured Brain Aneurysm|unruptured brain aneurysm
154651|NCT02344901|warfarin|warfarin
154544|NCT02345382|Advanced acute leukemia|advanced acute leukemia
154545|NCT02345356|Pharmacogenomics|pharmacogenomics
154546|NCT02345356|Warfarin|warfarin
154547|NCT02345356|Caribbean Hispanics|caribbean hispanics
154548|NCT02345356|Polymorphisms|polymorphisms
154549|NCT02345356|Dosing Algorithm|dosing algorithm
154550|NCT02345278|Immunotherapy|immunotherapy
154551|NCT02345278|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
154552|NCT02345252|HIV|hiv
154553|NCT02345226|HIV|hiv
154554|NCT02345213|DLB|dlb
154555|NCT02345213|Dementia with Lewy bodies|dementia with lewy bodies
154556|NCT02345213|Lewy Body Disease|lewy body disease
154557|NCT02345213|Dementia|dementia
154558|NCT02345213|E2020|e2020
154559|NCT02345213|Donepezil|donepezil
154560|NCT02345213|Aricept|aricept
154561|NCT02345200|dystrophy|dystrophy
154562|NCT02345200|body composition|body composition
154563|NCT02345200|malnutrition|malnutrition
154564|NCT02345174|zirconium|zirconium
154565|NCT02345174|oncology|oncology
154566|NCT02345174|mAb|mab
154567|NCT02345174|receptor occupancy|receptor occupancy
154568|NCT02345174|dose|dose
154569|NCT02345174|PET|pet
154570|NCT02345174|HER3|her3
154571|NCT02345174|89-Zr|89-zr
154572|NCT02345174|biodistribution|biodistribution
154573|NCT02345174|tumours|tumours
154574|NCT02345161|Triple Therapy|triple therapy
154575|NCT02345161|Formoterol|formoterol
154576|NCT02345161|Respiratory|respiratory
154577|NCT02345161|COPD|copd
154578|NCT02345161|Budesonide|budesonide
154579|NCT02345161|Vilanterol|vilanterol
154580|NCT02345161|Fluticasone Furoate|fluticasone furoate
154581|NCT02345161|Umeclidinium|umeclidinium
154582|NCT02345161|Lung Function|lung function
154583|NCT02345148|Healthy|healthy
154584|NCT02345148|Esketamine|esketamine
154585|NCT02345148|JNJ-54135419|jnj-54135419
154586|NCT02345122|At-risk Drinking|at-risk drinking
154587|NCT02345122|Depression|depression
154588|NCT02345122|Anxiety|anxiety
154589|NCT02345122|Alcohol Drinking|alcohol drinking
154590|NCT02345109|weight|weight
154591|NCT02345109|total body water|total body water
154592|NCT02345109|body fat|body fat
154593|NCT02345109|muscle mass|muscle mass
154594|NCT02345109|bone mass|bone mass
154595|NCT02345109|BMI|bmi
154596|NCT02345109|visceral fat|visceral fat
154597|NCT02345109|calories|calories
154598|NCT02345083|Frailty|frailty
154599|NCT02345083|Pre-frailty|pre-frailty
154600|NCT02345083|Fit|fit
154601|NCT02345083|Robust|robust
154602|NCT02345083|Elderly|elderly
154603|NCT02345083|Sociodemography status|sociodemography status
154604|NCT02345083|Functional status|functional status
154605|NCT02345083|Cognitive status|cognitive status
154606|NCT02345083|Nutrition status|nutrition status
154607|NCT02345083|Comorbidity|comorbidity
154608|NCT02345083|Polypharmacy|polypharmacy
154609|NCT02345083|Mortality|mortality
154610|NCT02345083|Depression status|depression status
154611|NCT02345083|Health-related quality of life|health-related quality of life
154612|NCT02345083|Fall incidence|fall incidence
154613|NCT02345083|Hospitality|hospitality
154614|NCT02345057|Diabetic Nephropathy|diabetic nephropathy
154615|NCT02345057|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
154616|NCT02345057|CS-3150|cs-3150
154617|NCT02345057|Japanese|japanese
154618|NCT02345044|Essential hypertension|essential hypertension
154619|NCT02345044|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
154620|NCT02345044|CS-3150|cs-3150
154621|NCT02345044|Japanese|japanese
154622|NCT02345031|hearing loss|hearing loss
154623|NCT02345031|speech-in-noise|speech-in-noise
154624|NCT02345018|Mechano-chemical ablation|mechano-chemical ablation
154625|NCT02345018|Treatment large varicose veins|treatment large varicose veins
154626|NCT02345018|Below-knee and branches|below-knee and branches
154627|NCT02345018|Endovenous|endovenous
154628|NCT02345005|Vascular diseases|vascular diseases
154629|NCT02345005|Aneurysm|aneurysm
154630|NCT02345005|Treatment Efficacy|treatment efficacy
154631|NCT02345005|Medical device|medical device
154632|NCT02345005|Population Register|population register
154633|NCT02344979|NSCLC|nsclc
154634|NCT02344979|Chemotherapy|chemotherapy
154635|NCT02344979|thrombocytopenia|thrombocytopenia
154636|NCT02344979|rhTPO|rhtpo
154637|NCT02344940|operable|operable
154638|NCT02344940|premenopausal|premenopausal
154639|NCT02344940|endocrine therapy|endocrine therapy
154640|NCT02344940|safety|safety
154641|NCT02344940|tamoxifen|tamoxifen
154642|NCT02344940|toremifene|toremifene
154643|NCT02344927|Cancer|cancer
154644|NCT02344927|End-of-life care|end-of-life care
187100|NCT02177526|CT|ct
154645|NCT02344927|Clinically-assisted hydration|clinically-assisted hydration
154646|NCT02344914|dental support|dental support
154647|NCT02344914|second stage of labor|second stage of labor
154648|NCT02344901|non-valvular atrial fibrillation|non-valvular atrial fibrillation
154649|NCT02344901|stroke prevention|stroke prevention
154650|NCT02344901|novel oral anticoagulants|novel oral anticoagulants
154652|NCT02344888|PCOS|pcos
154653|NCT02344888|Clomiphene citrate resistant|clomiphene citrate resistant
154654|NCT02344888|Prednisolone|prednisolone
154655|NCT02344823|cirrhosis|cirrhosis
154656|NCT02344823|erectile dysfunction|erectile dysfunction
154657|NCT02344823|portal hypertension|portal hypertension
154658|NCT02344797|Perioperative|perioperative
154659|NCT02344797|Postoperative Complications/prevention & control|postoperative complications/prevention & control
154660|NCT02344784|ADD|add
154661|NCT02344784|ADHD|adhd
154662|NCT02344784|PPI|ppi
154663|NCT02344771|Endothelial dysfunction|endothelial dysfunction
154664|NCT02344771|General Surgery|general surgery
154665|NCT02344771|Perioperative Care|perioperative care
154666|NCT02344745|Lavender|lavender
154667|NCT02344745|Aromatherapy|aromatherapy
154668|NCT02344745|Urodynamics|urodynamics
154669|NCT02344732|epithelium, cornea, diabetes, vitrectomy, oxygen|epithelium, cornea, diabetes, vitrectomy, oxygen
154670|NCT02344719|cirrhosis|cirrhosis
154671|NCT02344719|portal hypertension|portal hypertension
154672|NCT02344719|taurin|taurin
154673|NCT02344706|Emergency Care, Prehospital|emergency care, prehospital
154674|NCT02344706|Coma|coma
154675|NCT02344706|Electroencephalography|electroencephalography
154676|NCT02344693|Electroencephalography|electroencephalography
154677|NCT02344654|Fluorescence|fluorescence
154678|NCT02344654|Cholangiography|cholangiography
154679|NCT02344654|Indocyanine Green|indocyanine green
154680|NCT02344654|Cholecystectomy, Laparoscopic|cholecystectomy, laparoscopic
154681|NCT02344615|nerve stimulator|nerve stimulator
154682|NCT02344615|ultrasound|ultrasound
154683|NCT02344602|Diabetic Nephropathy|diabetic nephropathy
154684|NCT02344602|Diabetes Mellitus|diabetes mellitus
154685|NCT02344602|Diabetes Complications|diabetes complications
154686|NCT02344602|Uric Acid|uric acid
154687|NCT02344602|Febuxostat|febuxostat
154688|NCT02344602|Uloric|uloric
154689|NCT02344602|Glomerular Filtration Rate|glomerular filtration rate
154690|NCT02344602|Kidney Disease|kidney disease
154691|NCT02344602|Vascular Disease|vascular disease
154692|NCT02344602|Cardiovascular Diseases|cardiovascular diseases
154693|NCT02344602|Endothelial Function|endothelial function
154694|NCT02344602|Arterial Stiffness|arterial stiffness
154695|NCT02344602|Pharmacologic Actions|pharmacologic actions
154696|NCT02344602|Gout Suppressants|gout suppressants
154697|NCT02344602|Therapeutic Uses|therapeutic uses
154698|NCT02344602|Free Radical Scavengers|free radical scavengers
154699|NCT02344602|Antioxidants|antioxidants
154700|NCT02344602|Protective Agents|protective agents
154703|NCT02344602|Flow-mediated Dilation|flow-mediated dilation
154704|NCT02344602|Flow-mediated Constriction|flow-mediated constriction
154705|NCT02344602|Nitroglycerin|nitroglycerin
154706|NCT02344602|Hyperglycemia|hyperglycemia
154707|NCT02344602|Renin-angiotensin-aldosterone System|renin-angiotensin-aldosterone system
154708|NCT02344602|Nitric Oxide|nitric oxide
154709|NCT02344602|cGMP|cgmp
154710|NCT02344602|Oxidative Stress|oxidative stress
154711|NCT02344602|Renal Haemodynamic Function|renal haemodynamic function
154712|NCT02344602|Inulin Clearance|inulin clearance
154713|NCT02344602|PAH Clearance|pah clearance
154714|NCT02344602|Skin Biopsy|skin biopsy
154715|NCT02344602|T1R mRNA Expression|t1r mrna expression
154716|NCT02344602|Cytokines|cytokines
154717|NCT02344602|Chemokines|chemokines
154718|NCT02344589|ACB|acb
154719|NCT02344589|Adductor Canal Block|adductor canal block
154720|NCT02344589|Peripheral Nerve Block|peripheral nerve block
154721|NCT02344576|heart failure|heart failure
154722|NCT02344576|heart-assist devices|heart-assist devices
154723|NCT02344576|decision making|decision making
154724|NCT02344576|decision support techniques|decision support techniques
154725|NCT02344576|hospice care|hospice care
154726|NCT02344576|palliative care|palliative care
154727|NCT02344576|caregivers|caregivers
154728|NCT02344563|volunteers|volunteers
154729|NCT02344550|metastatic breast cancer|metastatic breast cancer
154730|NCT02344550|HER2 negative|her2 negative
154731|NCT02344550|hormone-receptor positive|hormone-receptor positive
154732|NCT02344537|Lyme DIsease|lyme disease
154733|NCT02344537|Kundalini Yoga|kundalini yoga
154734|NCT02344498|Liver cirrhosis|liver cirrhosis
154735|NCT02344498|Antiviral agents|antiviral agents
154736|NCT02344498|Liver diseases|liver diseases
154737|NCT02344472|MBC|mbc
154738|NCT02344472|HER2|her2
154739|NCT02344472|CTC|ctc
154740|NCT02344472|endocrine therapy|endocrine therapy
154741|NCT02344472|Pertuzumab|pertuzumab
154742|NCT02344472|Trastuzumab|trastuzumab
154743|NCT02344472|HER2 therapy|her2 therapy
145624|NCT02396940|3D|3d
154744|NCT02344446|physical therapy intervention|physical therapy intervention
154745|NCT02344433|Family health history|family health history
154746|NCT02344433|Genetic literacy|genetic literacy
154747|NCT02344433|Health literacy|health literacy
154748|NCT02344433|Relational agent|relational agent
154749|NCT02344433|Common chronic conditions|common chronic conditions
154750|NCT02344420|Heart Failure|heart failure
154751|NCT02344420|CRT|crt
154752|NCT02344407|Zaire Ebola Virus Disease|zaire ebola virus disease
154962|NCT02343107|e-coaching|e-coaching
154753|NCT02344394|Atrial Fibrillation|atrial fibrillation
154754|NCT02344394|Anti-Arrhythmia Agents|anti-arrhythmia agents
154755|NCT02344394|Catheter Ablation|catheter ablation
154756|NCT02344394|surgical hybrid ablation|surgical hybrid ablation
154757|NCT02344368|Sucrose|sucrose
154758|NCT02344368|Anesthesia|anesthesia
154759|NCT02344368|Blood specimen collection|blood specimen collection
154760|NCT02344368|Injections, Intravenous|injections, intravenous
154761|NCT02344355|Ascorbic Acid|ascorbic acid
154762|NCT02344355|temozolomide|temozolomide
154763|NCT02344355|radiation|radiation
154764|NCT02344342|telemonitoring|telemonitoring
154766|NCT02344290|Cardiovascular Disease|cardiovascular disease
154767|NCT02344290|Myocardial Infarction|myocardial infarction
154768|NCT02344290|Inflammation|inflammation
154769|NCT02344290|Statin|statin
154770|NCT02344290|Computerized Tomography|computerized tomography
154771|NCT02344290|Cholesterol|cholesterol
154772|NCT02344277|Subcutaneaous Implantable Cardiac Defibrillator|subcutaneaous implantable cardiac defibrillator
154773|NCT02344277|Brugada syndrome|brugada syndrome
154774|NCT02344277|Effectiveness|effectiveness
154775|NCT02344277|Safety|safety
154776|NCT02344264|US guided nerve block|us guided nerve block
154777|NCT02344264|Total hip Arthroplasty|total hip arthroplasty
154778|NCT02344264|NCFL|ncfl
154779|NCT02344264|nervus cutaneous femoralis lateralis|nervus cutaneous femoralis lateralis
154782|NCT02344238|Medication compliance|medication compliance
154783|NCT02344238|Technology|technology
154784|NCT02344238|Drug study|drug study
154785|NCT02344186|diabetes, endoplasmic reticulum stress, obesity, GLP1 analogs|diabetes, endoplasmic reticulum stress, obesity, glp1 analogs
154786|NCT02344160|Total Hip Arthroplasty|total hip arthroplasty
154787|NCT02344160|THA|tha
154788|NCT02344095|recurrent, persistent|recurrent, persistent
154789|NCT02344069|Fibrinogen|fibrinogen
154790|NCT02344056|Having Lunch|having lunch
154791|NCT02344056|Skipping Lunch|skipping lunch
154792|NCT02344030|airway|airway
154793|NCT02344030|videolaryngoscope|videolaryngoscope
154794|NCT02343978|Chronic Constipation|chronic constipation
154795|NCT02343978|CC|cc
154796|NCT02343965|Touch-massage|touch-massage
154797|NCT02343965|anxiety|anxiety
154798|NCT02343965|leukemia|leukemia
154799|NCT02343965|haematology|haematology
154800|NCT02343965|cancerology|cancerology
154801|NCT02343965|supportive care|supportive care
154802|NCT02343965|complementary therapy|complementary therapy
154803|NCT02343952|Pembrolizumab|pembrolizumab
154804|NCT02343952|MK-3475|mk-3475
154805|NCT02343874|Alcohol consumption|alcohol consumption
154806|NCT02343874|Primary health care|primary health care
154807|NCT02343874|health care costs|health care costs
154808|NCT02343874|health service utilization|health service utilization
154809|NCT02343861|Behavioral Research|behavioral research
154810|NCT02343861|Emollients|emollients
154811|NCT02343822|PRP|prp
154812|NCT02343822|Platelet Rich Plasma|platelet rich plasma
154813|NCT02343822|Lateral Epicondylitis|lateral epicondylitis
154814|NCT02343822|Lateral Epicondylopathy|lateral epicondylopathy
154815|NCT02343822|Lateral Epicondylosis|lateral epicondylosis
154816|NCT02343822|Chronic Lateral Epicondylitis|chronic lateral epicondylitis
154817|NCT02343822|PRPLE|prple
154818|NCT02343822|Multiple PRP Injections|multiple prp injections
154819|NCT02343822|Multiple PRP|multiple prp
154820|NCT02343822|Platelet-Rich Plasma|platelet-rich plasma
154822|NCT02343822|Double Blinded Randomized Controlled|double blinded randomized controlled
154823|NCT02343822|Multiple vs Single PRP injections|multiple vs single prp injections
154824|NCT02343822|prp tennis elbow|prp tennis elbow
154825|NCT02343809|Physiotherapy|physiotherapy
154826|NCT02343809|Lateral epicondylitis|lateral epicondylitis
154827|NCT02343809|Manual therapy|manual therapy
154828|NCT02343796|Fiberglass reinforced resins|fiberglass reinforced resins
154829|NCT02343783|Atopic Dermatitis|atopic dermatitis
154830|NCT02343783|Asthma|asthma
154831|NCT02343783|Healthy|healthy
154832|NCT02343783|Skin Blisters|skin blisters
154833|NCT02343783|Adult Participants|adult participants
154834|NCT02343744|Generalized Pustular Psoriasis|generalized pustular psoriasis
154835|NCT02343744|Erythrodermic Psoriasis|erythrodermic psoriasis
154836|NCT02343744|Guselkumab|guselkumab
154837|NCT02343744|CNTO1959|cnto1959
154838|NCT02343731|microbiome|microbiome
154839|NCT02343731|hygiene hypothesis|hygiene hypothesis
154840|NCT02343731|human-animal interaction|human-animal interaction
154841|NCT02343731|microbiota|microbiota
154842|NCT02343731|connections between human-canine microbiome|connections between human-canine microbiome
154843|NCT02343653|Malnutrition|malnutrition
154844|NCT02343653|Muscle mass|muscle mass
154845|NCT02343653|Nutrition|nutrition
154846|NCT02343640|Baseball|baseball
154847|NCT02343640|Ulnar collateral ligament|ulnar collateral ligament
154848|NCT02343614|Intermediate risk|intermediate risk
154849|NCT02343614|Cox-2 inhibitors|cox-2 inhibitors
154850|NCT02343588|Chinese multi-centered school based obesity intervention|chinese multi-centered school based obesity intervention
154851|NCT02343575|Hyperactive delirium|hyperactive delirium
154852|NCT02343575|Mixed delirium|mixed delirium
154853|NCT02343575|Anti-psychotic|anti-psychotic
154854|NCT02343575|Haldol|haldol
154855|NCT02343575|Valproic Acid|valproic acid
154856|NCT02343536|Phase 1|phase 1
154857|NCT02343536|Oral Azacitidine (CC-486)|oral azacitidine (cc-486)
154858|NCT02343536|R-CHOP|r-chop
154859|NCT02343536|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
154860|NCT02343536|Grade 3B Follicular Lymphoma|grade 3b follicular lymphoma
154861|NCT02343536|Follicular Lymphoma|follicular lymphoma
154862|NCT02343536|Transformed Lymphoma|transformed lymphoma
154863|NCT02343523|Wearable device|wearable device
154864|NCT02343523|Wrist-watch|wrist-watch
154865|NCT02343523|Longitudinal monitoring|longitudinal monitoring
154866|NCT02343523|Congestive Heart Failure|congestive heart failure
154867|NCT02343510|Fallopian tubal cancer, high grade serous , ovarian cancer|fallopian tubal cancer, high grade serous , ovarian cancer
154868|NCT02343484|pulsed radiofrequency|pulsed radiofrequency
154869|NCT02343484|gelified ethanol|gelified ethanol
154870|NCT02343471|Whey proteins|whey proteins
154871|NCT02343471|Postprandial lipemia|postprandial lipemia
154872|NCT02343471|Pre-meal|pre-meal
154873|NCT02343471|Type 2 diabetes|type 2 diabetes
154874|NCT02343458|COPD|copd
154875|NCT02343432|Anesthesia|anesthesia
154876|NCT02343432|Adverse Effect|adverse effect
154877|NCT02343432|Spinal|spinal
154878|NCT02343432|Epidural|epidural
154879|NCT02343419|Bronchial Hyperreactivity|bronchial hyperreactivity
154880|NCT02343419|Bronchial Provocation Tests|bronchial provocation tests
154881|NCT02343419|Methacholine Chloride|methacholine chloride
154882|NCT02343419|Respiratory Function Tests|respiratory function tests
154883|NCT02343419|Spirometry|spirometry
154884|NCT02343419|Airway Resistance|airway resistance
154885|NCT02343419|Plethysmography|plethysmography
154886|NCT02343406|European Organization for Research and Treatment of Cancer|european organization for research and treatment of cancer
154887|NCT02343406|Brain Tumor Group|brain tumor group
154888|NCT02343406|Lomustine|lomustine
154889|NCT02343406|Pediatric High Grade Gliomas|pediatric high grade gliomas
154890|NCT02343406|Glioblastoma Multiforme|glioblastoma multiforme
154891|NCT02343406|Pediatric diffuse Intrinsic Pontine Glioma|pediatric diffuse intrinsic pontine glioma
154896|NCT02343406|recurrent glioblastoma|recurrent glioblastoma
154897|NCT02343406|Epithelial Growth Factor|epithelial growth factor
154899|NCT02343406|EORTC|eortc
154900|NCT02343406|Pediatric WHO grade III glioma|pediatric who grade iii glioma
154901|NCT02343406|EGFR amplification|egfr amplification
154902|NCT02343406|Pediatric WHO grade IV glioma|pediatric who grade iv glioma
154903|NCT02343406|Brain Tumor|brain tumor
154904|NCT02343393|Endothelial Dysfunction|endothelial dysfunction
154905|NCT02343393|Biomarkers|biomarkers
154906|NCT02343393|Hydralazine-Isosorbide Dinitrate|hydralazine-isosorbide dinitrate
154907|NCT02343380|diet-induced thermogenesis|diet-induced thermogenesis
154908|NCT02343380|glucose|glucose
154909|NCT02343380|respiratory quotient|respiratory quotient
154910|NCT02343367|Hispanic|hispanic
154911|NCT02343367|overweight|overweight
154912|NCT02343367|families|families
154913|NCT02343367|pediatric|pediatric
154914|NCT02343367|primary care|primary care
154920|NCT02343341|early childhood education|early childhood education
154921|NCT02343341|cardiovascular health|cardiovascular health
154922|NCT02343341|behavior change|behavior change
154923|NCT02343341|community-based|community-based
154924|NCT02343341|family-based|family-based
154925|NCT02343341|prevention|prevention
154926|NCT02343315|low back pain|low back pain
154927|NCT02343315|home exercises|home exercises
154928|NCT02343315|chronic pain|chronic pain
154929|NCT02343315|supervised exercise|supervised exercise
154930|NCT02343315|core stability exercises|core stability exercises
154931|NCT02343315|spinal stabilization exercises|spinal stabilization exercises
154932|NCT02343302|Pancreatic Fistula|pancreatic fistula
154933|NCT02343289|Healthy|healthy
154934|NCT02343289|Pharmacokinetics|pharmacokinetics
154935|NCT02343289|Esketamine|esketamine
154936|NCT02343289|JNJ-54135419|jnj-54135419
154937|NCT02343276|Radial Spasm|radial spasm
154938|NCT02343263|Tonsillectomy|tonsillectomy
154939|NCT02343263|Adenotonsillectomy|adenotonsillectomy
154940|NCT02343263|Pain|pain
154941|NCT02343263|Hemorrhage|hemorrhage
154942|NCT02343237|Fibromyalgia syndrome|fibromyalgia syndrome
154943|NCT02343237|pain|pain
154944|NCT02343237|quality of life|quality of life
154945|NCT02343237|osteopathic treatment|osteopathic treatment
154946|NCT02343211|Paraneoplastic Neurological Syndromes|paraneoplastic neurological syndromes
154947|NCT02343211|Onconeural antibodies|onconeural antibodies
154948|NCT02343211|Cancer|cancer
154949|NCT02343185|diaphragm|diaphragm
154950|NCT02343185|osteopathic treatment|osteopathic treatment
154951|NCT02343185|myofascial release|myofascial release
154952|NCT02343172|Liposarcoma,|liposarcoma,
154953|NCT02343172|MDM2 inhibition,|mdm2 inhibition,
154954|NCT02343172|cdk4 inhibition,|cdk4 inhibition,
154955|NCT02343172|HDM201,|hdm201,
154956|NCT02343172|LEE011|lee011
154957|NCT02343133|Radiation countermeasure|radiation countermeasure
154958|NCT02343133|radiomitigation|radiomitigation
154959|NCT02343107|Obesity|obesity
154960|NCT02343107|Type 2 diabetes|type 2 diabetes
154961|NCT02343107|Metabolic syndrome|metabolic syndrome
154963|NCT02343107|Telehealth|telehealth
154964|NCT02343094|Proteinuria|proteinuria
154965|NCT02343094|Lipocalin 2|lipocalin 2
154966|NCT02343094|Neutrophil gelatinase associated lipocalin|neutrophil gelatinase associated lipocalin
154967|NCT02343094|ELISA|elisa
154968|NCT02343081|brain neoplasm|brain neoplasm
154969|NCT02343081|bioequivalence|bioequivalence
154970|NCT02343081|temozolomide|temozolomide
154971|NCT02342028|sleep apnea|sleep apnea
154972|NCT02342028|intermittent hypoxia|intermittent hypoxia
154973|NCT02342028|regulatory T cell|regulatory t cell
154974|NCT02342028|autoimmunity|autoimmunity
154975|NCT02342002|mifepristone|mifepristone
154976|NCT02342002|misoprostol|misoprostol
154977|NCT02342002|obstetrics|obstetrics
154978|NCT02342002|reproductive health|reproductive health
154979|NCT02342002|pregnancy|pregnancy
154980|NCT02342002|abortion|abortion
154981|NCT02342002|missed abortion|missed abortion
154982|NCT02341989|Chemotherapy, adjuvant|chemotherapy, adjuvant
154983|NCT02341989|Recurrence|recurrence
154984|NCT02341989|Carboplatin|carboplatin
154985|NCT02341989|Bleomycin|bleomycin
154986|NCT02341989|Etoposide|etoposide
154987|NCT02341989|Cisplatin|cisplatin
154988|NCT02341976|whole body vibration|whole body vibration
154989|NCT02341976|pelvic floor muscle|pelvic floor muscle
154990|NCT02341976|urinary incontinence|urinary incontinence
154991|NCT02341976|Urinary sphincter|urinary sphincter
154992|NCT02341950|videogame|videogame
154993|NCT02341950|health|health
154994|NCT02341950|behavior|behavior
154995|NCT02341950|mobile|mobile
154996|NCT02341950|spinal|spinal
154997|NCT02341950|cord|cord
154998|NCT02341950|dysfunction|dysfunction
154999|NCT02341911|triple negative breast cancer|triple negative breast cancer
155000|NCT02341911|fine line chemotherapy|fine line chemotherapy
155001|NCT02341898|nursing home care|nursing home care
155002|NCT02341898|physical restraints|physical restraints
155003|NCT02341898|dementia|dementia
155004|NCT02341898|implementation research|implementation research
155005|NCT02341898|cluster-randomized controlled trial|cluster-randomized controlled trial
155006|NCT02341885|Kidney|kidney
155007|NCT02341885|Renal replacement|renal replacement
155008|NCT02341885|Acute kidney injury|acute kidney injury
155009|NCT02341885|chronic kidney disease|chronic kidney disease
155010|NCT02341885|Epidemiology|epidemiology
155011|NCT02341885|Prevalence|prevalence
155012|NCT02341872|White spot lesions|white spot lesions
155013|NCT02341872|remineralization|remineralization
155014|NCT02341872|QLF|qlf
155015|NCT02341872|antibacterial|antibacterial
155016|NCT02341846|cancer pain|cancer pain
155017|NCT02341833|Anesthetic preconditioning|anesthetic preconditioning
155018|NCT02341833|Sevoflurane|sevoflurane
155019|NCT02341833|Liver transplantation|liver transplantation
155020|NCT02341833|brain-death donors|brain-death donors
155021|NCT02343042|Selinexor|selinexor
155022|NCT02343042|KCP-330|kcp-330
155023|NCT02343042|STOMP|stomp
155024|NCT02343042|Multiple Myeloma|multiple myeloma
155025|NCT02343042|Relapsed/Refractory|relapsed/refractory
155026|NCT02343042|Dexamethasone|dexamethasone
155027|NCT02343042|Pomalidomide|pomalidomide
155028|NCT02343042|Bortezomib|bortezomib
155029|NCT02343042|Karyopharm|karyopharm
155030|NCT02343042|Lenalidomide|lenalidomide
155031|NCT02343042|Daratumumab|daratumumab
155032|NCT02343029|Aerobic Exercise Training|aerobic exercise training
155033|NCT02343029|prevention|prevention
155034|NCT02343029|magnetic resonance spectroscopic imaging|magnetic resonance spectroscopic imaging
155035|NCT02343029|psychometric tests|psychometric tests
155036|NCT02343029|cognition|cognition
155037|NCT02343029|dementia|dementia
155038|NCT02343029|cognitive impairment|cognitive impairment
155039|NCT02343003|cooled radiofrequency ablation|cooled radiofrequency ablation
155040|NCT02343003|knee pain|knee pain
155041|NCT02343003|osteoarthritis|osteoarthritis
155042|NCT02343003|pain management|pain management
155043|NCT02342990|working memory training|working memory training
155044|NCT02342990|home-based training|home-based training
155045|NCT02342990|periventricular leukomalacia|periventricular leukomalacia
155046|NCT02342990|bilateral cerebral palsy|bilateral cerebral palsy
155047|NCT02342990|neuropsychological profile|neuropsychological profile
155048|NCT02342990|high density EEG|high density eeg
187667|NCT02174250|PD|pd
155049|NCT02342990|slow waves activities|slow waves activities
155050|NCT02342977|total hip arthroplasty|total hip arthroplasty
155051|NCT02342964|Cystic fibrosis|cystic fibrosis
155052|NCT02342964|hepatic fibrosis|hepatic fibrosis
155053|NCT02342964|hepatic cirrhosis|hepatic cirrhosis
155054|NCT02342964|non-invasive methods of measurement|non-invasive methods of measurement
155055|NCT02342964|hepatic elasticity|hepatic elasticity
155056|NCT02342951|Cystic fibrosis,|cystic fibrosis,
155057|NCT02342951|lung clearance index,|lung clearance index,
155058|NCT02342951|pulmonary function|pulmonary function
155059|NCT02342938|Epilepsy surgery|epilepsy surgery
155060|NCT02342938|High frequency activity|high frequency activity
155061|NCT02342938|icEEG|iceeg
155062|NCT02342938|fMRI|fmri
155063|NCT02342938|MEG|meg
155064|NCT02342886|Tuberculosis|tuberculosis
155065|NCT02342886|Multi Drug-Resistant Tuberculosis|multi drug-resistant tuberculosis
155066|NCT02342886|Drug-sensitive Tuberculosis|drug-sensitive tuberculosis
155067|NCT02342886|PA-824|pa-824
155068|NCT02342886|Moxifloxacin|moxifloxacin
155069|NCT02342886|Pyrazinamide|pyrazinamide
155070|NCT02342886|Rifampicin|rifampicin
155071|NCT02342886|Isoniazid|isoniazid
155072|NCT02342886|Ethambutol|ethambutol
155073|NCT02342886|HRZE|hrze
155074|NCT02342886|HR|hr
155075|NCT02342886|Pretomanid|pretomanid
155076|NCT02342886|NC-006|nc-006
155077|NCT02342886|STAND|stand
155078|NCT02342873|ultrasound|ultrasound
155079|NCT02342873|nerve stimulator|nerve stimulator
155080|NCT02342860|Water|water
155081|NCT02342860|sanitation|sanitation
155082|NCT02342860|hygiene access in school|hygiene access in school
155083|NCT02342756|ARDS, HFOV|ards, hfov
155084|NCT02342691|Safety and efficacy of BLXA4|safety and efficacy of blxa4
155085|NCT02342665|Non Hodgkin's Lymphomas|non hodgkin's lymphomas
155086|NCT02342626|Prostate|prostate
155087|NCT02342626|Cancer|cancer
155088|NCT02342626|Adenocarcinoma|adenocarcinoma
155089|NCT02342587|Lapatinib|lapatinib
155090|NCT02342561|Infection|infection
155091|NCT02342561|Drape|drape
155092|NCT02342561|Ioban|ioban
155093|NCT02342561|Arthroplasty|arthroplasty
155094|NCT02342561|Knee|knee
155095|NCT02342561|Cylinder Sampling|cylinder sampling
155096|NCT02342561|Bacteria|bacteria
155097|NCT02342548|Huntington; chorea; total motor score; CAG repeat: total functional capacity; motor cognitive and behavioral symptoms|huntington; chorea; total motor score; cag repeat: total functional capacity; motor cognitive and behavioral symptoms
155098|NCT02342522|Cardioprotection|cardioprotection
155099|NCT02342522|STEMI|stemi
155100|NCT02342522|PPCI|ppci
155101|NCT02342522|Myocardial reperfusion injury|myocardial reperfusion injury
155102|NCT02342522|Myocardial infarct size|myocardial infarct size
155103|NCT02342509|et Control|et control
155104|NCT02342509|inhalational sedation|inhalational sedation
155105|NCT02342509|conserve volatile anesthetics|conserve volatile anesthetics
155106|NCT02342470|prevention|prevention
155107|NCT02342470|Recurrent peptic ulcer|recurrent peptic ulcer
155108|NCT02342444|Trauma|trauma
155109|NCT02342444|Surgery|surgery
155110|NCT02342444|Enoxaparin|enoxaparin
155111|NCT02342444|DVTs|dvts
155112|NCT02342444|Thromboembolic events|thromboembolic events
155113|NCT02342431|Thermoregulation|thermoregulation
155114|NCT02342431|Pediatric Anesthesia|pediatric anesthesia
155115|NCT02342431|Cardiac Catheterization|cardiac catheterization
155116|NCT02342405|Oxidative stress|oxidative stress
155117|NCT02342405|Nitrogen oxide|nitrogen oxide
155118|NCT02342405|Reactive oxygen species|reactive oxygen species
155119|NCT02342392|pterygium|pterygium
155120|NCT02342392|ranibizumab|ranibizumab
155121|NCT02342392|anti-VEGF|anti-vegf
155122|NCT02342392|recurrence|recurrence
155123|NCT02342392|vascularity|vascularity
155124|NCT02342392|size|size
155125|NCT02342366|Sodium Oxybate, Altruism, Neurostreroids, Liquid Ecstasy|sodium oxybate, altruism, neurostreroids, liquid ecstasy
155126|NCT02342340|Beans, Lentils, Bioavailability, Phytochemical Absorption|beans, lentils, bioavailability, phytochemical absorption
155127|NCT02342288|Intraoperative ocular pressure|intraoperative ocular pressure
155128|NCT02342275|Infantile hemangioma|infantile hemangioma
155129|NCT02342275|Propranolol|propranolol
155130|NCT02342275|Atenolol|atenolol
155131|NCT02342275|Efficacy|efficacy
155132|NCT02342275|Safety|safety
155133|NCT02342249|Influenza A|influenza a
155134|NCT02342236|Biological Markers|biological markers
155135|NCT02342223|human immunodeficiency virus|human immunodeficiency virus
155136|NCT02342223|facial lipoatrophy|facial lipoatrophy
155137|NCT02342223|facial lipodystrophy|facial lipodystrophy
155138|NCT02342223|hyaluronic acid|hyaluronic acid
155139|NCT02342223|dermal filler|dermal filler
155140|NCT02342223|filler agent|filler agent
155141|NCT02342210|Mindfulness|mindfulness
155142|NCT02342210|Group Therapy|group therapy
155143|NCT02342197|Low responders|low responders
155144|NCT02342197|Minidose long protocol|minidose long protocol
155145|NCT02342197|Microdose flare protocol|microdose flare protocol
155146|NCT02342197|Oocyte yield|oocyte yield
155147|NCT02342171|Ebola Viral Disease|ebola viral disease
155148|NCT02342171|Convalescent Plasma|convalescent plasma
155149|NCT02342171|Developing Countries|developing countries
155150|NCT02342145|beta-Thalassemia major|beta-thalassemia major
155151|NCT02342119|kidney transplantation|kidney transplantation
155152|NCT02342119|race disparities|race disparities
155153|NCT02342119|living donor kidney transplantation|living donor kidney transplantation
155154|NCT02342119|transplant evaluation|transplant evaluation
155155|NCT02342093|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
155156|NCT02342093|Drospirenone|drospirenone
155157|NCT02342093|Oral contraceptive|oral contraceptive
155158|NCT02342080|Rehabilitation|rehabilitation
155159|NCT02342080|Walking|walking
155160|NCT02342080|Robotics|robotics
155161|NCT02342080|Neuronal Plasticity|neuronal plasticity
155162|NCT02342054|Cancer|cancer
155163|NCT02342054|Prostate Cancer|prostate cancer
155164|NCT02342054|Brachytherapy|brachytherapy
155165|NCT02342054|Dose escalation|dose escalation
155166|NCT02342054|High Dose Rate|high dose rate
155167|NCT02342054|MRI-TRUS fusion|mri-trus fusion
155168|NCT02342054|Detection of DILs by MRI|detection of dils by mri
155169|NCT02342054|SINGLE FRACTION|single fraction
155170|NCT02342041|SUVN-G3031|suvn-g3031
155171|NCT02342041|histamine 3 (H3) receptor inverse agonist|histamine 3 (h3) receptor inverse agonist
155172|NCT02342041|first in human|first in human
155173|NCT02342041|safety|safety
155174|NCT02342041|pharmacokinetics|pharmacokinetics
155175|NCT02342041|tolerability|tolerability
155176|NCT02342041|single dose|single dose
155177|NCT02342041|repeat dose|repeat dose
155178|NCT02341820|breast cancer|breast cancer
155179|NCT02341820|breast conserving surgery|breast conserving surgery
155180|NCT02341820|cosmesis|cosmesis
155181|NCT02341807|Choroideremia|choroideremia
155182|NCT02341807|AAV|aav
155183|NCT02341807|Gene therapy|gene therapy
155184|NCT02341807|CHM|chm
155185|NCT02341807|Adeno-associated virus|adeno-associated virus
155186|NCT02341807|Adeno-associated viral vector|adeno-associated viral vector
155187|NCT02341794|intracranial arterial disease|intracranial arterial disease
155188|NCT02341794|dyslipidemia|dyslipidemia
155189|NCT02341794|rosuvastatin|rosuvastatin
155190|NCT02341781|MANTLE CELL LYMPHOMA|mantle cell lymphoma
155191|NCT02341781|Multicenter|multicenter
155192|NCT02341781|Observational|observational
155193|NCT02341781|Lenalidomide (Revlimid®)|lenalidomide (revlimid®)
155194|NCT02341781|Relapsed or progressed|relapsed or progressed
155195|NCT02341781|Ibrutinib|ibrutinib
155196|NCT02341768|clinical and device functional information|clinical and device functional information
155197|NCT02341768|"real world ICD patient population"|"real world icd patient population"
155298|NCT02341326|COPD|copd
155198|NCT02341742|Physical activity|physical activity
155199|NCT02341742|Bone health|bone health
155200|NCT02341742|Pediatrics|pediatrics
155201|NCT02341742|Bone|bone
155202|NCT02341729|semi-urgent CABG|semi-urgent cabg
155203|NCT02341729|reanimation|reanimation
155204|NCT02341729|ticagrelor|ticagrelor
155205|NCT02341729|crushed tablet|crushed tablet
155206|NCT02341716|intermittent claudication|intermittent claudication
155207|NCT02341716|exercise therapy|exercise therapy
155208|NCT02341716|physiotherapy|physiotherapy
155209|NCT02341690|Type 2 diabetes|type 2 diabetes
155210|NCT02341690|Interval Walking Training|interval walking training
155211|NCT02341690|Motivation|motivation
155212|NCT02341677|Prostatic Neoplasms|prostatic neoplasms
155213|NCT02341677|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
155214|NCT02341677|Magnetic Resonance Imaging|magnetic resonance imaging
155215|NCT02341677|Ultrasonography|ultrasonography
155216|NCT02341677|Biopsy|biopsy
155217|NCT02341677|Image Fusion|image fusion
155218|NCT02341664|Mobile Tablet Device|mobile tablet device
155219|NCT02341664|Outpatient Clinic|outpatient clinic
155220|NCT02341664|Tobacco|tobacco
155221|NCT02341664|Health|health
155222|NCT02341664|Barriers|barriers
155223|NCT02341664|Prevention|prevention
155224|NCT02341664|Prescribing Practices|prescribing practices
155225|NCT02341664|Informed Consent|informed consent
155227|NCT02341664|Lipid Panel|lipid panel
155228|NCT02341664|Low Density Lipoprotein-C|low density lipoprotein-c
155229|NCT02341664|Blood Draw|blood draw
155230|NCT02341664|ACC/AHA Guidelines|acc/aha guidelines
155231|NCT02341664|Adult Treatment Panel Guidelines (ATPIII)|adult treatment panel guidelines (atpiii)
155232|NCT02341664|Atherosclerotic Cardiovascular Disease (ASCVD)|atherosclerotic cardiovascular disease (ascvd)
155233|NCT02341664|Cholesterol-lowering therapies|cholesterol-lowering therapies
155234|NCT02341664|Cholesterol Management|cholesterol management
155235|NCT02341664|Cardiovascular Risk|cardiovascular risk
155236|NCT02341664|10-year CVD Risk|10-year cvd risk
155237|NCT02341664|Labs|labs
155238|NCT02341664|Coronary revascularization|coronary revascularization
155239|NCT02341664|Arterial revascularization|arterial revascularization
155240|NCT02341664|Imaging|imaging
155241|NCT02341651|High blood pressure|high blood pressure
155242|NCT02341651|Cardiovascular diseases|cardiovascular diseases
155243|NCT02341651|Antihypertensive agents|antihypertensive agents
155244|NCT02341651|Pharmacological treatment|pharmacological treatment
155245|NCT02341651|Non-pharmacological treatment|non-pharmacological treatment
155246|NCT02341651|Community health care workers|community health care workers
155247|NCT02341651|Treatment algorithm|treatment algorithm
155248|NCT02341651|Public and private healthcare providers|public and private healthcare providers
155249|NCT02341651|Strategy|strategy
155250|NCT02341651|Referral loops|referral loops
155251|NCT02341651|Intervention|intervention
155252|NCT02341612|exercise-induced muscle damage|exercise-induced muscle damage
155253|NCT02341612|skeletal muscle injury recovery|skeletal muscle injury recovery
155254|NCT02341612|cryotherapy|cryotherapy
155255|NCT02341612|recovery of function|recovery of function
155256|NCT02341612|rehabilitation|rehabilitation
155257|NCT02341586|Malaria|malaria
155258|NCT02341586|Cambodia|cambodia
155259|NCT02341586|Iron|iron
155260|NCT02341586|Childbearing Age|childbearing age
155261|NCT02341586|Women|women
155262|NCT02341586|Home Fortification|home fortification
155263|NCT02341573|Traditional Chinese Medicine|traditional chinese medicine
155264|NCT02341573|Randomized Controlled Trial|randomized controlled trial
155265|NCT02341560|NAION|naion
155266|NCT02341495|Azacitidine|azacitidine
155267|NCT02341495|Vidaza|vidaza
155268|NCT02341495|Deferasirox|deferasirox
155269|NCT02341495|Exjade|exjade
155270|NCT02341495|Cholecalciferol|cholecalciferol
155271|NCT02341495|Vitamin D|vitamin d
155272|NCT02341482|Itraconazole|itraconazole
155273|NCT02341482|Healthy Volunteers|healthy volunteers
155274|NCT02341482|Drug-drug interaction|drug-drug interaction
155275|NCT02341482|PF-04958242|pf-04958242
155276|NCT02341469|Burkina Faso|burkina faso
155277|NCT02341469|cluster randomised|cluster randomised
155278|NCT02341469|stepped-wedge|stepped-wedge
155279|NCT02341469|IMCI|imci
155280|NCT02341443|bilateral double mandibular fractures|bilateral double mandibular fractures
155281|NCT02341443|rigid fixation|rigid fixation
155282|NCT02341443|no-rigid fixation|no-rigid fixation
155283|NCT02341443|jaw|jaw
155284|NCT02341430|hernia|hernia
155285|NCT02341430|synthetic mesh|synthetic mesh
401971|NCT01232504|Systemic fungal infection (SFI)|systemic fungal infection (sfi)
585909|NCT00522743|GH|gh
155286|NCT02341417|Chronic Kidney Disease, Dialysis, Secondary Hyperparathyroidism, Pediatric|chronic kidney disease, dialysis, secondary hyperparathyroidism, pediatric
155287|NCT02341391|chondrocyte cells|chondrocyte cells
155288|NCT02341391|Osteoarthritis|osteoarthritis
155289|NCT02341391|gene therapy|gene therapy
155290|NCT02341378|chondrocyte cells|chondrocyte cells
155291|NCT02341378|Osteoarthritis|osteoarthritis
155292|NCT02341378|gene therapy|gene therapy
155293|NCT02341365|Egg donation|egg donation
155294|NCT02341365|vitaminD|vitamind
155295|NCT02341365|ovarian reserve|ovarian reserve
155296|NCT02341365|ovarian stimulation|ovarian stimulation
155300|NCT02341326|Non-smoker|non-smoker
155301|NCT02341313|Hypoglycaemia|hypoglycaemia
155302|NCT02341300|Pregnancy|pregnancy
155303|NCT02341300|Cast-Iron pots|cast-iron pots
155304|NCT02341300|Iron-deficiency anemia|iron-deficiency anemia
155305|NCT02341274|Tacrolimus|tacrolimus
155306|NCT02341274|Drug Formulation|drug formulation
155307|NCT02341274|Absorption|absorption
155308|NCT02341274|Bioavailability|bioavailability
155309|NCT02341274|Healthy Volunteer|healthy volunteer
155310|NCT02341248|Enteral Nutrition|enteral nutrition
155311|NCT02341248|Pediatrics|pediatrics
155312|NCT02341248|Microbiota|microbiota
155313|NCT02341248|Metabolomics|metabolomics
155314|NCT02341235|video game|video game
155315|NCT02341235|narrative|narrative
155316|NCT02341235|story|story
155317|NCT02341235|survivorship|survivorship
155318|NCT02341235|cancer survivor|cancer survivor
155319|NCT02341235|mhealth|mhealth
155320|NCT02341235|physical activity|physical activity
155321|NCT02341235|women|women
155322|NCT02341235|women's health|women's health
155323|NCT02341222|hernia prosthetic surgery|hernia prosthetic surgery
155324|NCT02341222|incisional hernia prosthesis|incisional hernia prosthesis
155325|NCT02341222|prosthesis mesh fixation|prosthesis mesh fixation
155326|NCT02341222|prosthesis mesh biocompatibility|prosthesis mesh biocompatibility
155328|NCT02341209|Sezary Syndrome (SS)|sezary syndrome (ss)
155329|NCT02341209|Mycosis Fungoides (MF)|mycosis fungoides (mf)
155330|NCT02341209|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
155332|NCT02341209|SS|ss
155333|NCT02341131|Schizophrenia|schizophrenia
155334|NCT02341131|Cognitive Remediation|cognitive remediation
155335|NCT02341131|BDNF|bdnf
155336|NCT02341118|BRCA1/2 Mutational Status|brca1/2 mutational status
155337|NCT02341092|Traumatic brain injury|traumatic brain injury
155338|NCT02341079|Total Knee Arthroplasty|total knee arthroplasty
155339|NCT02341079|Osteoarthritis|osteoarthritis
155340|NCT02341079|Femoral Nerve Blockade|femoral nerve blockade
155341|NCT02341079|Liposomal Bupivacaine|liposomal bupivacaine
155342|NCT02341066|Cardiovascular risk score|cardiovascular risk score
155343|NCT02341066|Framingham risk score 2-year|framingham risk score 2-year
155344|NCT02341066|Endothelial dysfunction|endothelial dysfunction
155345|NCT02341066|EndoPAT|endopat
155346|NCT02341066|Rheumatoid arthritis|rheumatoid arthritis
155347|NCT02341053|SMA|sma
155348|NCT02341053|Neuromuscular disability|neuromuscular disability
155349|NCT02341040|wheat allergy|wheat allergy
155350|NCT02341040|food allergy|food allergy
155351|NCT02341040|pediatric|pediatric
155352|NCT02341027|Immediate postpartum contraception|immediate postpartum contraception
155353|NCT02341027|Contraceptive implants|contraceptive implants
155354|NCT02341027|Breastfeeding|breastfeeding
155355|NCT02341027|Jadelle|jadelle
155356|NCT02341027|Lactation|lactation
155357|NCT02341027|Levonorgestrel|levonorgestrel
155358|NCT02341014|Carfilzomib|carfilzomib
155359|NCT02341014|Romidepsin|romidepsin
155360|NCT02341014|Lenalidomide|lenalidomide
155361|NCT02341014|Lymphomas|lymphomas
155362|NCT02341014|14-179|14-179
155363|NCT02341001|Bariatric surgery|bariatric surgery
155364|NCT02341001|Sleeve gastrectomy|sleeve gastrectomy
155365|NCT02341001|Text messaging|text messaging
155366|NCT02341001|Weight loss|weight loss
155367|NCT02341001|BAROS|baros
155368|NCT02341001|Follow-up care|follow-up care
155369|NCT02340975|Gastric Adenocarcinoma|gastric adenocarcinoma
155370|NCT02340975|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
155371|NCT02340975|Immunotherapy|immunotherapy
155372|NCT02340975|Antibodies, Monoclonal|antibodies, monoclonal
155373|NCT02340975|Tremelimumab|tremelimumab
155374|NCT02340975|MEDI4736|medi4736
155375|NCT02340923|DMD|dmd
155376|NCT02340923|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
155377|NCT02340923|EIM|eim
155378|NCT02340910|spasticity|spasticity
155379|NCT02340910|whole body vibration|whole body vibration
155380|NCT02340910|walking|walking
155381|NCT02340871|Neurogenetics|neurogenetics
155382|NCT02340871|genetic testing|genetic testing
155383|NCT02340845|breast,colon, ovary, uterus, cervix, lung|breast,colon, ovary, uterus, cervix, lung
155384|NCT02340845|Treatments|treatments
155385|NCT02340806|epidural bolus|epidural bolus
155386|NCT02340806|pain management|pain management
155387|NCT02340806|labor analgesia|labor analgesia
155388|NCT02340793|Weight loss|weight loss
155389|NCT02340767|Suspicious Occlusal Caries|suspicious occlusal caries
155390|NCT02340754|mindfulness|mindfulness
155391|NCT02340754|meditation|meditation
155392|NCT02340754|stress, psychological|stress, psychological
155393|NCT02340754|quality of life|quality of life
155394|NCT02340754|randomized controlled trial|randomized controlled trial
155395|NCT02340741|carbon dioxide|carbon dioxide
155396|NCT02340741|postoperative cerebrovascular complications|postoperative cerebrovascular complications
155397|NCT02340741|air embolism|air embolism
155398|NCT02340728|Stent Placement|stent placement
155399|NCT02340728|Biliary Obstruction|biliary obstruction
155400|NCT02340728|14-260|14-260
155401|NCT02340715|Anal canal|anal canal
155402|NCT02340715|Brain|brain
155403|NCT02340715|Breast|breast
155404|NCT02340715|Cervix|cervix
155405|NCT02340715|Esophagus|esophagus
155406|NCT02340715|Gynecology|gynecology
155407|NCT02340715|Head and Neck|head and neck
155408|NCT02340715|Lung|lung
155409|NCT02340715|Pancreas|pancreas
155410|NCT02340715|Primary liver or liver metastases|primary liver or liver metastases
155411|NCT02340715|Prostate cancer|prostate cancer
155412|NCT02340715|Sarcoma|sarcoma
155413|NCT02340702|COPD and heart failure|copd and heart failure
155414|NCT02340689|PH|ph
155415|NCT02340689|PH type 1|ph type 1
155416|NCT02340689|Primary Hyperoxaluria|primary hyperoxaluria
155417|NCT02340689|Hyperoxaluria|hyperoxaluria
155418|NCT02340689|Primary Oxalosis|primary oxalosis
155419|NCT02340689|PH type 2|ph type 2
155420|NCT02340689|PH type 3|ph type 3
155421|NCT02340689|Genetic testing for PH|genetic testing for ph
155422|NCT02340689|Genetic testing for Primary Hyperoxaluria|genetic testing for primary hyperoxaluria
155423|NCT02340689|Hereditary study for PH|hereditary study for ph
155424|NCT02340689|Hereditary study for Primary Hyperoxaluria|hereditary study for primary hyperoxaluria
155425|NCT02340689|AGXT|agxt
155426|NCT02340689|GRHPR|grhpr
155427|NCT02340689|HOGA1|hoga1
155429|NCT02340663|dental orthotic|dental orthotic
155430|NCT02340663|bite splint|bite splint
155431|NCT02340663|oral parafunction|oral parafunction
155432|NCT02340663|clenching|clenching
155433|NCT02340663|grinding|grinding
155434|NCT02340650|suspicious bladder lesion, normal bladder tissue|suspicious bladder lesion, normal bladder tissue
155435|NCT02340585|Next Generation Neuroform Stent System|next generation neuroform stent system
155436|NCT02340585|Wide Neck, Intracranial, Saccular Aneurysms|wide neck, intracranial, saccular aneurysms
155437|NCT02340585|Cerebral Aneurysms|cerebral aneurysms
155438|NCT02340572|Healthy Subjects|healthy subjects
155439|NCT02340559|meta-cognition|meta-cognition
155440|NCT02340559|positive symptoms|positive symptoms
155441|NCT02340559|early phases|early phases
155442|NCT02340559|schizophrenia|schizophrenia
155443|NCT02340533|adenomyosis|adenomyosis
155444|NCT02340481|Diarrhea|diarrhea
155445|NCT02340481|Flatulence|flatulence
146288|NCT02392741|Microcirculation|microcirculation
146289|NCT02392741|Pregnancy Outcome|pregnancy outcome
146290|NCT02392741|Obesity|obesity
146291|NCT02392741|Pregnancy|pregnancy
146292|NCT02392715|Inspiratory muscle training|inspiratory muscle training
146293|NCT02392715|General exercise training|general exercise training
146294|NCT02392715|pulmonary rehabilitation|pulmonary rehabilitation
146295|NCT02392715|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
155446|NCT02340481|Abdominal discomfort|abdominal discomfort
155447|NCT02340481|Loperamide hydrochloride|loperamide hydrochloride
155448|NCT02340481|Simethicone|simethicone
155450|NCT02340442|arteriovenous ratio|arteriovenous ratio
155451|NCT02340442|retinal flicker stimulation|retinal flicker stimulation
155452|NCT02340442|Dynamic vessel analyzer|dynamic vessel analyzer
155453|NCT02340416|orthopedic surgeries|orthopedic surgeries
155454|NCT02340416|general anesthesia|general anesthesia
155455|NCT02340403|Neuropathy|neuropathy
155456|NCT02340403|Oxaliplatin|oxaliplatin
155457|NCT02340403|Insula|insula
155458|NCT02340403|choline|choline
155459|NCT02340390|G7 Acetabular System|g7 acetabular system
155460|NCT02340377|core body temperature|core body temperature
155561|NCT02339714|moxibustion|moxibustion
155461|NCT02340377|whole-body hyperthermia|whole-body hyperthermia
155462|NCT02340377|rectal body temperature|rectal body temperature
155463|NCT02340364|Hospital Readmissions|hospital readmissions
155464|NCT02340364|Patient Navigation|patient navigation
155465|NCT02340351|acupuncture|acupuncture
155466|NCT02340351|auricular acupuncture|auricular acupuncture
155467|NCT02340351|NADA|nada
155468|NCT02340351|anxiety|anxiety
155469|NCT02340351|depression|depression
155470|NCT02340299|High Frequency Oscillation Ventilation|high frequency oscillation ventilation
155471|NCT02340299|Nasal Continuous Positive Airway Pressure|nasal continuous positive airway pressure
155472|NCT02340299|Airway Extubation|airway extubation
155473|NCT02340299|Prematurity|prematurity
155474|NCT02340273|tendinopathy|tendinopathy
155475|NCT02340273|ultrasound|ultrasound
155476|NCT02340273|pain|pain
155477|NCT02340273|heat|heat
155478|NCT02340273|strength|strength
155479|NCT02340273|LITUS|litus
155480|NCT02340273|long duration|long duration
155481|NCT02340273|therapeutic ultrasound|therapeutic ultrasound
155482|NCT02340273|tendonopathy|tendonopathy
155483|NCT02340260|Exercise|exercise
155484|NCT02340260|Risk factors|risk factors
155485|NCT02340260|Exercise therapy|exercise therapy
155486|NCT02340260|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
155487|NCT02340208|Non-Small Cell Lung Cancer|non-small cell lung cancer
155488|NCT02340208|Neoplasms|neoplasms
155489|NCT02340208|Immunoconjugate|immunoconjugate
155490|NCT02340208|Tumor microenvironment alkalinization|tumor microenvironment alkalinization
155491|NCT02340195|Kidney impairment|kidney impairment
155492|NCT02340182|gut flora|gut flora
155493|NCT02340182|antibiotics|antibiotics
155494|NCT02340182|systemic immune response|systemic immune response
155495|NCT02340182|Volunteers|volunteers
155496|NCT02340091|facial nasolabial fold wrinkles|facial nasolabial fold wrinkles
155497|NCT02340078|the facial nasolabial fold|the facial nasolabial fold
155498|NCT02340065|colonoscopy|colonoscopy
155499|NCT02340065|adenoma detection rate|adenoma detection rate
155500|NCT02340065|Endocuff-assisted colonoscopy|endocuff-assisted colonoscopy
155501|NCT02340052|postoperative pain treatment|postoperative pain treatment
155502|NCT02340039|Polyphenol|polyphenol
155503|NCT02340039|Fruit|fruit
155504|NCT02340039|Metabolic|metabolic
155505|NCT02340026|Delay in motor skill development|delay in motor skill development
155506|NCT02340000|acute sinusitis|acute sinusitis
155507|NCT02340000|amoxicillin/clavulanate|amoxicillin/clavulanate
155508|NCT02340000|adults|adults
155509|NCT02340000|outcomes|outcomes
155510|NCT02339961|Systemic Sclerosis|systemic sclerosis
155511|NCT02339961|Pulmonary hypertension|pulmonary hypertension
155512|NCT02339961|Lung Doppler Signals|lung doppler signals
155513|NCT02339948|Locally confined|locally confined
155514|NCT02339935|Autism Spectrum Disorder|autism spectrum disorder
155515|NCT02339935|Autism|autism
155516|NCT02339909|Screening|screening
155517|NCT02339909|Incentives|incentives
155518|NCT02339896|rabies|rabies
155519|NCT02339896|modified TRC intradermal rabies vaccine|modified trc intradermal rabies vaccine
155520|NCT02339896|SPEEDA|speeda
155521|NCT02339883|Physiological Measures|physiological measures
155523|NCT02339883|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
155896|NCT02337673|Splenectomy|splenectomy
155524|NCT02339883|Cognitive Testing|cognitive testing
155525|NCT02339857|coronary artery bypass grafting|coronary artery bypass grafting
155526|NCT02339857|saphenous vein|saphenous vein
155527|NCT02339857|grafts|grafts
155528|NCT02339844|glutamate|glutamate
155529|NCT02339844|dopamine|dopamine
155530|NCT02339844|cognition|cognition
155531|NCT02339844|cortical thickness|cortical thickness
155532|NCT02339844|ppi|ppi
155533|NCT02339844|p50|p50
155534|NCT02339831|Knee|knee
155535|NCT02339831|Arthroplasty|arthroplasty
155536|NCT02339831|CPM|cpm
155537|NCT02339831|Camoped|camoped
155538|NCT02339831|Active vs Passive Motion Device|active vs passive motion device
155539|NCT02339805|Minimal residual disease, NGS, NHL, DNA sequencing|minimal residual disease, ngs, nhl, dna sequencing
155540|NCT02339792|COMPREHENSIVE GERIATRIC ASSESSMENT (CGA)|comprehensive geriatric assessment (cga)
155541|NCT02339792|MEDICATION APPROPRIATENESS PRESCRIBING|medication appropriateness prescribing
155542|NCT02339792|DRUG INTERACTIONS|drug interactions
155543|NCT02339792|E-LEARNING|e-learning
155544|NCT02339779|fat grafting|fat grafting
155545|NCT02339779|fat injection|fat injection
155546|NCT02339779|lipoaspirate|lipoaspirate
155547|NCT02339779|fat transfer|fat transfer
155548|NCT02339779|lipofilling|lipofilling
155549|NCT02339779|liposculpturing|liposculpturing
155550|NCT02339779|lipoinjection|lipoinjection
155551|NCT02339779|lipotransfer|lipotransfer
155552|NCT02339779|breast reconstruction|breast reconstruction
155553|NCT02339766|Cesarean|cesarean
155554|NCT02339766|Quadratus Lumborum Block|quadratus lumborum block
155555|NCT02339766|Analgesia|analgesia
155556|NCT02339766|Ultrasonography|ultrasonography
155557|NCT02339727|Omega-3|omega-3
155558|NCT02339727|Omega-6|omega-6
155559|NCT02339714|allergic rhinitis|allergic rhinitis
155560|NCT02339714|acupuncture|acupuncture
155562|NCT02339714|efficacy|efficacy
155563|NCT02339714|safety|safety
155564|NCT02339649|sepsis|sepsis
155565|NCT02339649|septic shock|septic shock
155566|NCT02339649|ICU|icu
155567|NCT02339649|long-term outcome|long-term outcome
155568|NCT02339649|neurocognitive|neurocognitive
155569|NCT02339649|inflammatory|inflammatory
155570|NCT02339649|MRI|mri
155571|NCT02339649|EEG|eeg
155572|NCT02339649|brain imaging|brain imaging
155573|NCT02339649|serum biomarkers|serum biomarkers
155574|NCT02339649|CSF|csf
155575|NCT02339636|subclinical, enthesitis, synovitis|subclinical, enthesitis, synovitis
155576|NCT02339623|Threatened preterm birth - fetal adrenal gland volume|threatened preterm birth - fetal adrenal gland volume
155577|NCT02339610|Osteoarthritis|osteoarthritis
155578|NCT02339610|Post-traumatic Arthritis|post-traumatic arthritis
155579|NCT02339584|OAG|oag
155580|NCT02339584|OHT|oht
155581|NCT02339532|HER2-positive|her2-positive
155582|NCT02339532|non-metastatic|non-metastatic
155583|NCT02339532|TOP2A|top2a
155584|NCT02339519|Laryngeal Masks|laryngeal masks
155585|NCT02339506|stress|stress
155586|NCT02339506|ACTH|acth
155587|NCT02339506|cosyntropin|cosyntropin
155588|NCT02339506|baroreflex sensitivity|baroreflex sensitivity
155589|NCT02339506|cardiovagal|cardiovagal
155590|NCT02339480|Massage therapy|massage therapy
155591|NCT02339480|Simple obesity|simple obesity
155592|NCT02339480|Energy metabolism|energy metabolism
155593|NCT02339480|Mechanism|mechanism
155594|NCT02339467|decreased outdoor walking ability|decreased outdoor walking ability
155595|NCT02339467|Older adult|older adult
155596|NCT02339454|Cardiac Shock wave therapy|cardiac shock wave therapy
155597|NCT02339454|stable angina|stable angina
155598|NCT02339454|exercise tolerance|exercise tolerance
155599|NCT02339441|Systemic sclerosis|systemic sclerosis
155600|NCT02339428|Colonoscopy|colonoscopy
155601|NCT02339428|diagnostic|diagnostic
155602|NCT02339428|diclophenac|diclophenac
155603|NCT02339428|randomized controlled trial|randomized controlled trial
155702|NCT02338973|Interferon Gamma|interferon gamma
155604|NCT02339402|Cystic fibrosis, Myotonic dystrophy, Noonan, Huntingtons|cystic fibrosis, myotonic dystrophy, noonan, huntingtons
155605|NCT02339363|mindfulness|mindfulness
155606|NCT02339363|adolescents|adolescents
155607|NCT02339363|working memory|working memory
155608|NCT02339363|stress|stress
155609|NCT02339363|anxiety|anxiety
155610|NCT02339311|The study focus is on lifestyle changes and patient activation in diabetic patients by regular monthly visit by the CHRs|the study focus is on lifestyle changes and patient activation in diabetic patients by regular monthly visit by the chrs
155611|NCT02339298|Music Therapy|music therapy
155612|NCT02339285|tACS|tacs
155613|NCT02339285|Major Depressive Disorder|major depressive disorder
155614|NCT02339285|MDD|mdd
155615|NCT02339285|mood symptoms|mood symptoms
155616|NCT02339285|sham|sham
155617|NCT02339272|meiosis|meiosis
155618|NCT02339272|synapsis|synapsis
155619|NCT02339272|recombination|recombination
155620|NCT02339272|sperm aneuploidy|sperm aneuploidy
155621|NCT02339259|Rickettsial disease|rickettsial disease
155622|NCT02339259|Febrile|febrile
155623|NCT02339259|Murine typhus|murine typhus
155624|NCT02339259|Scrub typhus|scrub typhus
155625|NCT02339259|Diagnostic test|diagnostic test
155626|NCT02339259|Clinical features|clinical features
155627|NCT02339233|Epidural Stimulation|epidural stimulation
155628|NCT02339220|Constraint-Induced Movement Therapy|constraint-induced movement therapy
155629|NCT02339220|Physical Therapy|physical therapy
155630|NCT02339220|Rehabilitation|rehabilitation
155631|NCT02339220|Occupational Therapy|occupational therapy
155632|NCT02339220|Fitness Training|fitness training
155633|NCT02339220|Recovery of Function|recovery of function
155634|NCT02339220|Neuroplasticity|neuroplasticity
155635|NCT02339220|Exercise Therapy|exercise therapy
155636|NCT02339220|Brain Injuries|brain injuries
155637|NCT02339220|Traumatic Brain Injury|traumatic brain injury
155638|NCT02339220|Physical Therapy Modalities|physical therapy modalities
155639|NCT02339220|Neuroimaging|neuroimaging
155640|NCT02339194|complete denture|complete denture
155641|NCT02339194|quality of life|quality of life
155642|NCT02339194|patient satisfaction|patient satisfaction
155643|NCT02339155|Anthrax Vaccine Adsorbed|anthrax vaccine adsorbed
155644|NCT02339155|Raxibacumab|raxibacumab
155645|NCT02339155|Immunogenicity|immunogenicity
155646|NCT02339103|arteriovenous anastomoses|arteriovenous anastomoses
155647|NCT02339103|accidental hypothermia|accidental hypothermia
155648|NCT02339103|rewarming|rewarming
155649|NCT02339090|VRS-317|vrs-317
155650|NCT02339090|Growth Hormone Deficiency|growth hormone deficiency
155651|NCT02339090|Long Acting Recombinant Growth Hormone|long acting recombinant growth hormone
155652|NCT02339090|Long Acting Growth Hormone|long acting growth hormone
155653|NCT02339090|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
155654|NCT02339090|Growth Hormone Replacement Therapy|growth hormone replacement therapy
155655|NCT02339090|Versartis|versartis
155656|NCT02339090|Xten|xten
155657|NCT02339090|Human Growth Hormone|human growth hormone
155658|NCT02339090|somavaratan|somavaratan
155659|NCT02339090|growth failure|growth failure
155660|NCT02339077|Group B Streptococcus, stillborn|group b streptococcus, stillborn
155661|NCT02339064|Parkinson's disease,|parkinson's disease,
155662|NCT02339064|apomorphine|apomorphine
155663|NCT02339064|Apokyn|apokyn
155664|NCT02339064|dopamine agonist|dopamine agonist
155665|NCT02339064|levodopa|levodopa
155666|NCT02339064|advanced|advanced
155667|NCT02339064|PD|pd
155668|NCT02339064|carbidopa|carbidopa
155669|NCT02339064|pramipexole|pramipexole
155670|NCT02339064|ropinirole|ropinirole
155671|NCT02339064|rotigotine|rotigotine
155672|NCT02339064|MAO-B inhibitors|mao-b inhibitors
155673|NCT02339064|COMT inhibitors|comt inhibitors
155674|NCT02339064|off|off
155675|NCT02339064|dyskinesia|dyskinesia
155676|NCT02339051|Basic Science|basic science
155677|NCT02339038|Community Based Research|community based research
155678|NCT02339038|Hepatitis C Virus and Human Immunodeficiency Virus|hepatitis c virus and human immunodeficiency virus
155679|NCT02339038|Ledipasvir/Sofosbuvir|ledipasvir/sofosbuvir
155680|NCT02339038|Fixed Dose Combination|fixed dose combination
155681|NCT02339038|Sustained Viral Response|sustained viral response
155682|NCT02339025|Cohort|cohort
155683|NCT02339025|Participation|participation
155684|NCT02339025|Biobank|biobank
155685|NCT02339012|Genome Wide Association|genome wide association
155686|NCT02339012|Biomarkers|biomarkers
155687|NCT02339012|Methylation|methylation
155688|NCT02339012|Phenotype|phenotype
155689|NCT02339012|Cytometry|cytometry
155690|NCT02338999|Autoimmunity Pathogenesis|autoimmunity pathogenesis
155691|NCT02338999|Arteriosclerosis|arteriosclerosis
155692|NCT02338999|Adult|adult
155693|NCT02338986|High Titer Antibodies|high titer antibodies
155694|NCT02338986|Convalescent Volunteers|convalescent volunteers
155695|NCT02338986|Apheresis|apheresis
155696|NCT02338986|Males|males
155697|NCT02338986|Quantitative IgG|quantitative igg
155698|NCT02338973|Macular Edema|macular edema
155699|NCT02338973|Rod-Cone Dystrophy|rod-cone dystrophy
155700|NCT02338973|Inherited Retinal Degeneration|inherited retinal degeneration
155701|NCT02338973|Enhanced S-Cone Syndrom|enhanced s-cone syndrom
155703|NCT02338960|HSDD Female|hsdd female
155704|NCT02338960|Sexual Desire Disorder|sexual desire disorder
155705|NCT02338960|decreased desire|decreased desire
155706|NCT02338960|female sexual dysfunction|female sexual dysfunction
155707|NCT02338947|Frailty|frailty
155708|NCT02338947|Cardiopulmonary Bypass|cardiopulmonary bypass
155709|NCT02338947|Coronary artery bypass surgery|coronary artery bypass surgery
155710|NCT02338947|Mortality|mortality
155711|NCT02338947|Morbidity|morbidity
155712|NCT02338921|triple combination therapy|triple combination therapy
155713|NCT02338921|sitagliptin|sitagliptin
155714|NCT02338921|dapagliflozin|dapagliflozin
155715|NCT02338921|lobeglitazone|lobeglitazone
155716|NCT02338908|dry needling|dry needling
155717|NCT02338908|trigger point|trigger point
155718|NCT02338908|eccentric exercise|eccentric exercise
155719|NCT02338895|acute kidney injury, oliguria,renal ultrasound|acute kidney injury, oliguria,renal ultrasound
155720|NCT02338882|Lenses|lenses
155721|NCT02338882|Intraocular|intraocular
155722|NCT02338856|Obesity|obesity
155723|NCT02338830|Twins|twins
155724|NCT02338830|Preterm labor|preterm labor
155725|NCT02338830|Progesterone|progesterone
146604|NCT02390986|Cancer|cancer
155726|NCT02338830|Short cervix|short cervix
155727|NCT02338804|mix vaccine, breast neoplasms, immunotherapy|mix vaccine, breast neoplasms, immunotherapy
155728|NCT02338778|mix vaccine, liver neoplasms, immunotherapy|mix vaccine, liver neoplasms, immunotherapy
155729|NCT02338752|mix vaccine, pancreatic neoplasms, immunotherapy|mix vaccine, pancreatic neoplasms, immunotherapy
155730|NCT02338739|Retention|retention
155731|NCT02338739|Lost to follow up|lost to follow up
155732|NCT02338739|Adaptive strategies|adaptive strategies
155733|NCT02338739|Dynamic regime|dynamic regime
155734|NCT02338739|Sequentially randomized trial|sequentially randomized trial
155735|NCT02338739|Sequential multiple assignment randomized trial|sequential multiple assignment randomized trial
155736|NCT02338739|Engagement in care|engagement in care
155738|NCT02338726|urinary incontinence|urinary incontinence
155739|NCT02338726|pelvic floor|pelvic floor
155740|NCT02338726|quality of life|quality of life
155741|NCT02338726|elderly women|elderly women
155742|NCT02338713|Drug therapy|drug therapy
155743|NCT02338700|mix vaccine, prostate carcinoma, immunotherapy|mix vaccine, prostate carcinoma, immunotherapy
155744|NCT02338687|Calcium|calcium
155745|NCT02338687|Dietary supplements|dietary supplements
155746|NCT02338687|Hypertension, Pregnancy-Induced|hypertension, pregnancy-induced
155747|NCT02338687|Pre-Eclampsia|pre-eclampsia
155748|NCT02338687|Nutritional education|nutritional education
155749|NCT02338687|Diet therapy|diet therapy
155750|NCT02338687|Diet records|diet records
155751|NCT02338687|Hospitalization|hospitalization
155752|NCT02338687|Maternal mortality|maternal mortality
155753|NCT02338635|ER stress|er stress
155754|NCT02338635|Peritoneal Dialysis|peritoneal dialysis
155755|NCT02338622|olaparib|olaparib
155756|NCT02338622|AZD5363|azd5363
155757|NCT02338622|intrapatient dose escalation|intrapatient dose escalation
155758|NCT02338622|advanced solid tumours|advanced solid tumours
155759|NCT02338609|TSC-associated SEGA,|tsc-associated sega,
155760|NCT02338609|height,|height,
155761|NCT02338609|weight,|weight,
155762|NCT02338609|Tanner Stage,|tanner stage,
155763|NCT02338609|growth development,|growth development,
155764|NCT02338609|everolimus,|everolimus,
155765|NCT02338609|RAD001|rad001
155766|NCT02338557|MRP, MIRROR THERAPY, STROKE|mrp, mirror therapy, stroke
155767|NCT02338518|gastric cancer|gastric cancer
155768|NCT02338518|neoadjuvant chemotherapy|neoadjuvant chemotherapy
155769|NCT02338518|efficacy|efficacy
155770|NCT02338518|safety|safety
155771|NCT02338505|Robotic Surgery|robotic surgery
155772|NCT02338505|Telelap-ALFX|telelap-alfx
155773|NCT02338505|Gynecological disease|gynecological disease
155774|NCT02338453|Social Anxiety|social anxiety
155775|NCT02338453|Attention Modification|attention modification
155776|NCT02338453|Dot-Probe|dot-probe
155777|NCT02338453|GCBT|gcbt
155778|NCT02338362|Corticosteroids|corticosteroids
155779|NCT02338362|Bronchodilator Agents|bronchodilator agents
155780|NCT02338362|Intraocular Pressure|intraocular pressure
155781|NCT02338323|Hyperuricemia|hyperuricemia
155782|NCT02338323|Renal Function|renal function
155783|NCT02338323|Chronic kidney disease|chronic kidney disease
155784|NCT02338323|Febuxostat|febuxostat
155785|NCT02338323|Benzbromarone|benzbromarone
155786|NCT02338297|Hepatocellular Carcinoma|hepatocellular carcinoma
155787|NCT02338297|Arterioportal shunts|arterioportal shunts
155788|NCT02338297|Transarterial Chemoembolization|transarterial chemoembolization
155789|NCT02338297|Ethanol|ethanol
155790|NCT02338297|Gelfoam|gelfoam
155791|NCT02338297|Polyvinyl Alcohol Foam Embolization Particles (PVA)|polyvinyl alcohol foam embolization particles (pva)
155792|NCT02338284|increased intracranial pressure|increased intracranial pressure
155793|NCT02338284|optic nerve sheath diameter|optic nerve sheath diameter
155794|NCT02338271|Low back pain|low back pain
155795|NCT02338271|Mesenchymal stromal stem cell|mesenchymal stromal stem cell
155796|NCT02338271|Hyaluronic acid|hyaluronic acid
155797|NCT02338219|postpartum pelvic floor|postpartum pelvic floor
155798|NCT02338206|infertility|infertility
155799|NCT02338193|GDM|gdm
155800|NCT02338193|T2DM|t2dm
155801|NCT02338193|prediabetes|prediabetes
155802|NCT02338180|dental caries|dental caries
155803|NCT02338180|risk assessment|risk assessment
155804|NCT02338180|approximal sealant|approximal sealant
155805|NCT02338180|permanent molar|permanent molar
155806|NCT02338180|preventive dentistry|preventive dentistry
155807|NCT02338180|adolescent|adolescent
155808|NCT02338154|Aortic Valve Replacement|aortic valve replacement
155809|NCT02338154|Aortic Stenosis|aortic stenosis
155810|NCT02338154|EDWARDS INTUITY|edwards intuity
155811|NCT02338141|cervical cancer|cervical cancer
155812|NCT02338141|colposcopy|colposcopy
155813|NCT02338141|human papillomavirus|human papillomavirus
155814|NCT02338141|human immunodeficiency virus|human immunodeficiency virus
155815|NCT02338128|peritoneal dialysis|peritoneal dialysis
155816|NCT02338128|hyperuricemia|hyperuricemia
155817|NCT02338128|cardiovascular|cardiovascular
155818|NCT02338128|Febuxostat|febuxostat
155819|NCT02338089|Uterine contraction|uterine contraction
155820|NCT02338089|Oxytocin desensitization|oxytocin desensitization
155821|NCT02338063|Adolescent Risk Behavior|adolescent risk behavior
155822|NCT02338063|Emotion Regulation|emotion regulation
155823|NCT02338063|Health Promotion|health promotion
155825|NCT02338063|Mental Health|mental health
155827|NCT02338050|Moxetumomab Pasudotox|moxetumomab pasudotox
155828|NCT02338050|Moxe|moxe
155829|NCT02338050|CAT-8015, HA22|cat-8015, ha22
155830|NCT02338024|Enrollment in HIV care|enrollment in hiv care
155831|NCT02338024|Recently detected HIV-positive|recently detected hiv-positive
155832|NCT02338024|specialized health care clinics|specialized health care clinics
155833|NCT02338024|Ukraine|ukraine
155834|NCT02337998|Neurology|neurology
155835|NCT02337998|Sports Medicine|sports medicine
155836|NCT02337972|diabetic macular edema|diabetic macular edema
155837|NCT02337972|Intravitreal injection|intravitreal injection
155838|NCT02337972|conjunctival flora|conjunctival flora
155839|NCT02337959|Healthy Volunteers|healthy volunteers
155840|NCT02337946|Metastatic colorectal cancer, Panitumumab, mFOLFOX6, First-line|metastatic colorectal cancer, panitumumab, mfolfox6, first-line
155841|NCT02337933|Metabolic Syndrome|metabolic syndrome
155842|NCT02337933|Central Obesity|central obesity
155843|NCT02337933|Insulin Sensitivity|insulin sensitivity
155844|NCT02337933|Ursolic Acid|ursolic acid
155845|NCT02337933|Triterpenoid|triterpenoid
155846|NCT02337894|Protein kinetics|protein kinetics
155847|NCT02337894|liver steatosis|liver steatosis
155848|NCT02337868|dose-ranging,double blind,female,healthy,HydroVax,male,Placebo-Controlled,Vaccine,West Nile Virus|dose-ranging,double blind,female,healthy,hydrovax,male,placebo-controlled,vaccine,west nile virus
155849|NCT02337855|Intestinal|intestinal
155850|NCT02337855|Pichia pastoris|pichia pastoris
155851|NCT02337855|S. mansoni|s. mansoni
155852|NCT02337855|Schistosomiasis|schistosomiasis
155853|NCT02337855|Sm-TSP-2/Alhydrogel|sm-tsp-2/alhydrogel
155854|NCT02337855|Sm-TSP-2/Alhydrogel/GLA-AF|sm-tsp-2/alhydrogel/gla-af
155855|NCT02337855|vaccine|vaccine
155856|NCT02337842|NoV, CIN-1, GII4. Norovirus, challenge, FUT-2 gene, HBGA-blocking Ab|nov, cin-1, gii4. norovirus, challenge, fut-2 gene, hbga-blocking ab
155857|NCT02337829|CLL|cll
155858|NCT02337829|SLL|sll
155859|NCT02337829|Btk|btk
155860|NCT02337829|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
155861|NCT02337829|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
155862|NCT02337829|Leukemia|leukemia
155863|NCT02337829|Lymphoma|lymphoma
155864|NCT02337829|Lymphocytic|lymphocytic
155865|NCT02337829|ACP-196|acp-196
155866|NCT02337829|acalabrutinib|acalabrutinib
155867|NCT02337816|Endometriosis|endometriosis
155868|NCT02337816|Metabolomics|metabolomics
155869|NCT02337803|Physical Activity|physical activity
155870|NCT02337790|Hypertension|hypertension
155871|NCT02337790|Heart Failure|heart failure
155872|NCT02337790|Fluids|fluids
155873|NCT02337777|Magnetic Resonance Imaging|magnetic resonance imaging
155874|NCT02337777|Magnetic Resonance Angiography|magnetic resonance angiography
155875|NCT02337777|Diffusion Tensor Imaging|diffusion tensor imaging
155876|NCT02337777|IDEAL|ideal
155877|NCT02337777|T2* mapping|t2* mapping
585910|NCT00522743|GnRHa|gnrha
155883|NCT02337712|Small cell lung cancer|small cell lung cancer
155884|NCT02337712|Radiotherapy|radiotherapy
155885|NCT02337712|Dose fractionation|dose fractionation
155886|NCT02337686|Keytruda|keytruda
155887|NCT02337686|pembrolizumab|pembrolizumab
155888|NCT02337686|immune effector function|immune effector function
155889|NCT02337686|pembrolizumab monotherapy|pembrolizumab monotherapy
155890|NCT02337686|ex vivo T-cell-specific cytokines profiling|ex vivo t-cell-specific cytokines profiling
155891|NCT02337686|immune effector Tcell:Treg ratio|immune effector tcell:treg ratio
155892|NCT02337686|immunological changes|immunological changes
155893|NCT02337686|immune response|immune response
155894|NCT02337673|Postoperative Pulmonary Complication|postoperative pulmonary complication
155897|NCT02337673|Gastric surgery|gastric surgery
155898|NCT02337673|Gastrectomy|gastrectomy
155899|NCT02337673|Pancreatic surgery|pancreatic surgery
155900|NCT02337673|Pancreatectomy|pancreatectomy
155901|NCT02337673|Liver surgery|liver surgery
155902|NCT02337673|Hemihepatectomy|hemihepatectomy
155903|NCT02337673|Cholecystectomy|cholecystectomy
155904|NCT02337673|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
155905|NCT02337673|Hypoxemia|hypoxemia
155906|NCT02337673|Atelectasis|atelectasis
155907|NCT02337673|Pulmonary obstruction|pulmonary obstruction
155908|NCT02337673|Pneumonia|pneumonia
155909|NCT02337673|Pneumothorax|pneumothorax
155910|NCT02337673|Pleural effusion|pleural effusion
155911|NCT02337673|Pulmonary edema|pulmonary edema
155912|NCT02337621|sunken chest|sunken chest
155913|NCT02337621|caved-in chest|caved-in chest
155914|NCT02337621|chest deformity|chest deformity
155915|NCT02337621|sunken sternum|sunken sternum
155916|NCT02337608|moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
155917|NCT02337608|GLPG1205|glpg1205
155918|NCT02337595|CD45RA-depletion|cd45ra-depletion
155919|NCT02337595|TCR-alpha/beta depletion|tcr-alpha/beta depletion
155920|NCT02337595|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
155921|NCT02337595|immune reconstitution|immune reconstitution
155922|NCT02337595|Graft Enhancement, Immunologic|graft enhancement, immunologic
155925|NCT02337452|Hereditary cancer-causing mutation|hereditary cancer-causing mutation
155926|NCT02337452|Gene mutation|gene mutation
155927|NCT02337452|Family member with genetic mutation|family member with genetic mutation
155928|NCT02337452|Questionnaire|questionnaire
155930|NCT02337452|Registry|registry
155931|NCT02337452|Database|database
155932|NCT02337452|Communication|communication
155933|NCT02337413|Constipation|constipation
155934|NCT02337374|Urodynamics|urodynamics
155935|NCT02337374|Midurethral sling|midurethral sling
155936|NCT02337374|Transobturator tape (TOT)|transobturator tape (tot)
155937|NCT02337374|Tension free vaginal tape (TVT)|tension free vaginal tape (tvt)
155940|NCT02337348|coronary stents|coronary stents
155941|NCT02337335|Hemodialyisis|hemodialyisis
155942|NCT02337335|Predictive Model|predictive model
155943|NCT02337335|ESAs|esas
155944|NCT02337335|patients|patients
155945|NCT02337322|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
155947|NCT02337322|HIV-1|hiv-1
155948|NCT02337322|Antiretroviral treatment|antiretroviral treatment
155949|NCT02337322|HIV Advanced Disease|hiv advanced disease
155950|NCT02337322|AIDS|aids
155951|NCT02337322|Dolutegravir|dolutegravir
155952|NCT02337322|Darunavir|darunavir
155953|NCT02337296|Motivational Interviewing|motivational interviewing
155954|NCT02337296|Cognitive Behavioral Therapy|cognitive behavioral therapy
155955|NCT02337296|Cancer|cancer
155956|NCT02337296|Oral Agents|oral agents
155957|NCT02337296|Adherence|adherence
155958|NCT02337270|Tuberculosis|tuberculosis
155959|NCT02337270|Vaccine|vaccine
155960|NCT02337270|Aerosol|aerosol
155961|NCT02337270|Adenovirus|adenovirus
155962|NCT02337270|Immunogenicity|immunogenicity
155968|NCT02337192|Orthodontic, Photochemoterapy|orthodontic, photochemoterapy
155969|NCT02337166|alveolar bone loss|alveolar bone loss
155970|NCT02337166|periodontal attachment loss|periodontal attachment loss
155971|NCT02337153|Orthodontique Bone Stretching|orthodontique bone stretching
155972|NCT02337140|TAVI|tavi
155973|NCT02337140|complete AV-block|complete av-block
155974|NCT02337140|HV-interval|hv-interval
155975|NCT02337140|permanent pacemaker|permanent pacemaker
155976|NCT02337140|valve implantation|valve implantation
155977|NCT02337140|severe|severe
155978|NCT02337140|conduction|conduction
155981|NCT02337101|Brain concussion|brain concussion
155982|NCT02337101|Mild Traumatic Brain Injury|mild traumatic brain injury
155983|NCT02337101|Post-concussion symptoms|post-concussion symptoms
155984|NCT02337101|Therapy|therapy
155985|NCT02337101|Randomised controlled trial|randomised controlled trial
155986|NCT02337101|Cognitive assessment|cognitive assessment
155987|NCT02337088|delayed cord clamping|delayed cord clamping
155988|NCT02337075|condition|condition
155989|NCT02337075|preventing|preventing
155990|NCT02337075|physical activity|physical activity
155991|NCT02337049|Preeclampsia. Cardiovascular Disease (CVD) Risk.|preeclampsia. cardiovascular disease (cvd) risk.
155992|NCT02337036|Liver transplantation|liver transplantation
155993|NCT02337036|Child|child
155994|NCT02337036|Tacrolimus|tacrolimus
155995|NCT02337036|Pharmacokinetic|pharmacokinetic
155996|NCT02337023|Brain scintigraphy|brain scintigraphy
155997|NCT02336997|skin regeneration|skin regeneration
155998|NCT02336997|mechanical stretch|mechanical stretch
155999|NCT02336984|Ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
156000|NCT02336958|cervical plexus|cervical plexus
156001|NCT02336958|regional anesthesia|regional anesthesia
156002|NCT02336958|ultrasound|ultrasound
156003|NCT02336958|carotid surgery|carotid surgery
156004|NCT02336932|vitamin d|vitamin d
156005|NCT02336932|free hormone|free hormone
156006|NCT02336932|surgical stress|surgical stress
156007|NCT02336919|discharge|discharge
156008|NCT02336919|mHealth|mhealth
156009|NCT02336919|telehealth|telehealth
156010|NCT02336919|text messaging|text messaging
156011|NCT02336906|Lower urinary tract dysfunction|lower urinary tract dysfunction
156012|NCT02336906|constipation|constipation
156013|NCT02336893|Communication Barriers|communication barriers
156014|NCT02336893|Total Communication Methods|total communication methods
156015|NCT02336893|Quality Improvement|quality improvement
156016|NCT02336893|Quality of Health Care|quality of health care
156017|NCT02336893|Critical Care|critical care
156018|NCT02336867|Complex anal fistula, clip,|complex anal fistula, clip,
156019|NCT02336854|pharmacokinetics|pharmacokinetics
156020|NCT02336841|Guided Self-Help|guided self-help
156021|NCT02336841|Peer Mentoring|peer mentoring
156022|NCT02336841|Anorexia Nervosa|anorexia nervosa
156023|NCT02336841|Eating Disorders|eating disorders
156024|NCT02336828|MEWS|mews
156025|NCT02336828|deteriorate|deteriorate
156026|NCT02336828|oncology|oncology
156027|NCT02336828|ICU|icu
156028|NCT02336828|predicting outcomes|predicting outcomes
200989|NCT02112682|Completion axillary lymph node dissection|completion axillary lymph node dissection
156029|NCT02336828|MEWS in predicting outcomes in oncology patients|mews in predicting outcomes in oncology patients
156030|NCT02336815|Multiple myeloma|multiple myeloma
146895|NCT02389270|Neurotrophins|neurotrophins
146896|NCT02389270|Nerve Growth Factor|nerve growth factor
146897|NCT02389270|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
146898|NCT02389270|Urinary Biomarkers|urinary biomarkers
146899|NCT02389270|Children|children
146900|NCT02389257|volunteers|volunteers
156031|NCT02336815|Karyopharm|karyopharm
156033|NCT02336815|Selinexor|selinexor
156034|NCT02336815|Refractory|refractory
156035|NCT02336815|Bortezomib|bortezomib
156036|NCT02336815|Carfilzomib|carfilzomib
156037|NCT02336815|Lenalidomide|lenalidomide
156038|NCT02336815|Pomalidomide|pomalidomide
156039|NCT02336815|Dexamethasone|dexamethasone
156040|NCT02336815|STORM|storm
156041|NCT02336815|Daratumumab|daratumumab
156042|NCT02336802|Anxiety|anxiety
156043|NCT02336802|Fear|fear
156044|NCT02336802|Avoidance|avoidance
156045|NCT02336776|Chronic Kidney Disease|chronic kidney disease
156046|NCT02336776|Electrical Stimulation|electrical stimulation
156047|NCT02336737|breast cancer|breast cancer
156048|NCT02336737|sentinel lymph node biopsy|sentinel lymph node biopsy
156049|NCT02336724|gastrointestinal stromal tumor|gastrointestinal stromal tumor
156050|NCT02336724|famitinib|famitinib
156051|NCT02336698|Osteoarthritis|osteoarthritis
156052|NCT02336698|Pain|pain
156053|NCT02336698|Fulranumab|fulranumab
156054|NCT02336698|JNJ-42160443|jnj-42160443
156055|NCT02336698|Monotherapy|monotherapy
156056|NCT02336698|Hip|hip
156057|NCT02336698|Knee|knee
156058|NCT02336698|Joint replacement surgery|joint replacement surgery
156059|NCT02336685|Osteoarthritis|osteoarthritis
156060|NCT02336685|Pain|pain
156061|NCT02336685|Fulranumab|fulranumab
156062|NCT02336685|JNJ-42160443|jnj-42160443
156063|NCT02336685|Adjunctive therapy|adjunctive therapy
156064|NCT02336685|Opioid|opioid
156065|NCT02336685|Hip|hip
156066|NCT02336685|Knee|knee
156067|NCT02336685|Joint replacement surgery|joint replacement surgery
156070|NCT02336633|Huntington disease|huntington disease
156071|NCT02336633|Neurodegenerative disease|neurodegenerative disease
156072|NCT02336633|Volumetric MRI|volumetric mri
156073|NCT02336633|31P MR spectroscopy|31p mr spectroscopy
156074|NCT02336633|metabolism|metabolism
156075|NCT02336633|Caudate atrophy|caudate atrophy
156076|NCT02336620|Severe sepsis, Balanced Salt Solution, Normal Saline|severe sepsis, balanced salt solution, normal saline
156077|NCT02336581|Acceptance and Commitment Therapy|acceptance and commitment therapy
156078|NCT02336581|Mindfulness|mindfulness
156079|NCT02336581|Inpatients|inpatients
156080|NCT02336581|Psychiatric Hospitalization|psychiatric hospitalization
156081|NCT02336568|PTSD, Oxytocin|ptsd, oxytocin
156082|NCT02336542|diagnosis of Tuberculosis|diagnosis of tuberculosis
156083|NCT02336542|ESAT6|esat6
156084|NCT02336542|CFP10|cfp10
156085|NCT02336542|skin test|skin test
156086|NCT02336542|diagnostic test|diagnostic test
156087|NCT02336529|postoperative|postoperative
156088|NCT02336477|non-dystrophic myotonias|non-dystrophic myotonias
156089|NCT02336477|paramyotonia congenita|paramyotonia congenita
156090|NCT02336477|myotonia congenita|myotonia congenita
156091|NCT02336477|Mexiletine|mexiletine
156092|NCT02336477|Randomized clinical trial|randomized clinical trial
156093|NCT02336451|ALK-positive|alk-positive
156094|NCT02336451|NSCLC|nsclc
156095|NCT02336451|brain metastasis|brain metastasis
156195|NCT02335593|Oxidative stress|oxidative stress
156096|NCT02336451|metastatic to the brain and/or to leptomeninges.|metastatic to the brain and/or to leptomeninges.
156097|NCT02336425|Asthma|asthma
156098|NCT02336412|Medication adherence|medication adherence
156099|NCT02336399|HBsAg loss, interferon, HBV reaction|hbsag loss, interferon, hbv reaction
156100|NCT02336386|Bortezomib|bortezomib
156101|NCT02336373|Hemoglobin SC disease|hemoglobin sc disease
156102|NCT02336373|hydroxyurea|hydroxyurea
156103|NCT02336373|quality of life|quality of life
156104|NCT02336373|viscosity|viscosity
156105|NCT02336373|red cell density|red cell density
156106|NCT02336347|Pharmacokinetics|pharmacokinetics
156107|NCT02336347|Healthy Volunteers|healthy volunteers
156108|NCT02336347|deuterated dextromethorphan|deuterated dextromethorphan
156109|NCT02336347|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
156110|NCT02336282|Adult survivor of acute lymphoblastic leukemia|adult survivor of acute lymphoblastic leukemia
156111|NCT02336282|Executive dysfunction|executive dysfunction
156112|NCT02336282|Transcranial direct current stimulation|transcranial direct current stimulation
156113|NCT02336282|Cancer prevention and control|cancer prevention and control
156114|NCT02336269|Pharmacogenomics|pharmacogenomics
156115|NCT02336256|inguinal hernia repair|inguinal hernia repair
156116|NCT02336256|totally extraperitoneal (TEP)|totally extraperitoneal (tep)
156117|NCT02336256|single incision laparoscopic surgery (SILS)|single incision laparoscopic surgery (sils)
188936|NCT02167009|BPH|bph
156118|NCT02336256|plasma total antioxidant status|plasma total antioxidant status
156119|NCT02336243|docosahexaenoic acid|docosahexaenoic acid
156120|NCT02336243|premature birth|premature birth
156121|NCT02336243|placentation disorders|placentation disorders
156122|NCT02336243|preeclampsia|preeclampsia
156123|NCT02336243|fetal growth|fetal growth
156124|NCT02336230|GVHD|gvhd
156125|NCT02336191|living donor liver transplantation|living donor liver transplantation
156126|NCT02336191|graft function|graft function
156127|NCT02336191|thromboelastometry|thromboelastometry
156128|NCT02336165|Glioblastoma|glioblastoma
156129|NCT02336165|Immunotherapy|immunotherapy
156131|NCT02336165|PD-L1|pd-l1
156132|NCT02336165|MEDI4736|medi4736
156133|NCT02336165|Radiation|radiation
156134|NCT02336165|Radiotherapy|radiotherapy
156135|NCT02336165|GBM|gbm
156136|NCT02336100|Diagnostic technique and procedure|diagnostic technique and procedure
156137|NCT02336074|HIV|hiv
156138|NCT02336074|Vaccine|vaccine
156139|NCT02336074|Cure|cure
156140|NCT02336074|Early Intervention|early intervention
156141|NCT02336074|Infection|infection
156142|NCT02336074|Primary infection|primary infection
156143|NCT02336074|Reservoir|reservoir
156144|NCT02336074|Vorinostat|vorinostat
156145|NCT02336074|HDAC|hdac
156146|NCT02336022|general anesthesia|general anesthesia
156147|NCT02336009|wrist arthritis|wrist arthritis
156148|NCT02336009|total wrist arthroplasty|total wrist arthroplasty
156149|NCT02335970|Pain|pain
156150|NCT02335970|Range of motion|range of motion
156151|NCT02335970|Quality of life|quality of life
156152|NCT02335944|non small cell lung cancer,|non small cell lung cancer,
156153|NCT02335944|NSCLC,|nsclc,
156154|NCT02335944|EGF816,|egf816,
156155|NCT02335944|INC280,|inc280,
156156|NCT02335944|tyrosine kinase inhibitor,|tyrosine kinase inhibitor,
156157|NCT02335944|c-MET|c-met
156158|NCT02335918|Opdivo®|opdivo®
156159|NCT02335866|Platelet rich fibrin|platelet rich fibrin
156160|NCT02335866|Gingival Recession|gingival recession
156161|NCT02335853|urinary bladder|urinary bladder
156162|NCT02335853|nerve growth factor|nerve growth factor
156163|NCT02335853|overactive bladder|overactive bladder
156164|NCT02335827|irreversible electroporation|irreversible electroporation
156165|NCT02335827|renal tumor|renal tumor
156166|NCT02335801|heart failure|heart failure
156167|NCT02335801|growth hormone|growth hormone
156168|NCT02335801|testosterone|testosterone
156169|NCT02335801|insulin resistance|insulin resistance
156170|NCT02335801|thyroid hormones|thyroid hormones
156171|NCT02335801|survival|survival
156172|NCT02335788|Therapeutic|therapeutic
156173|NCT02335788|Embolization|embolization
156174|NCT02335736|infertility|infertility
156175|NCT02335684|Heart-assist devices|heart-assist devices
156176|NCT02335684|exercise capacity|exercise capacity
156177|NCT02335671|Early Stage Breast Cancer|early stage breast cancer
156178|NCT02335671|Breast Conserving Surgery|breast conserving surgery
156179|NCT02335671|Breast Cancer Stage I|breast cancer stage i
156180|NCT02335671|Breast Cancer Stage II|breast cancer stage ii
156181|NCT02335645|ACL reconstruction|acl reconstruction
156182|NCT02335645|Running Mechanics|running mechanics
156183|NCT02335645|Physical Therapy|physical therapy
156184|NCT02335645|Knee|knee
156185|NCT02335645|Video Analysis|video analysis
156186|NCT02335645|Body Weight Supported Treadmill|body weight supported treadmill
156187|NCT02335632|Hepatitis|hepatitis
156188|NCT02335632|Probiotics|probiotics
156189|NCT02335632|Lipopolysaccharides|lipopolysaccharides
156190|NCT02335632|Cytokines|cytokines
156191|NCT02335632|Alcoholics|alcoholics
156192|NCT02335593|Hemodialysis patients|hemodialysis patients
156193|NCT02335593|Zinc|zinc
156194|NCT02335593|Anemia|anemia
156196|NCT02335580|Prognosis|prognosis
156197|NCT02335554|Subthreshold|subthreshold
156198|NCT02335554|Employees|employees
156199|NCT02335554|Internet|internet
156200|NCT02335554|Mobile|mobile
156201|NCT02335554|cognitive-behavioral|cognitive-behavioral
156202|NCT02335515|Gastroretentive System|gastroretentive system
156203|NCT02335515|Gastric Retention Time (GRT)|gastric retention time (grt)
156204|NCT02335515|capsule|capsule
156205|NCT02335515|Soctec|soctec
156206|NCT02335515|Gastroenterology|gastroenterology
156207|NCT02335476|optical coherence tomography|optical coherence tomography
156208|NCT02335463|optical coherence tomography|optical coherence tomography
156209|NCT02335450|exercise|exercise
156210|NCT02335450|motivational interviewing|motivational interviewing
156211|NCT02335424|P-D1|p-d1
156212|NCT02335424|PD-1|pd-1
156213|NCT02335424|PD1|pd1
156214|NCT02335424|P-DL1|p-dl1
156215|NCT02335424|PD-L1|pd-l1
156216|NCT02335424|PDL-1|pdl-1
156217|NCT02335424|PDL1|pdl1
156218|NCT02335424|Bladder cancer|bladder cancer
156219|NCT02335411|Gastric cancer|gastric cancer
156220|NCT02335411|Gastroesophageal junction cancer|gastroesophageal junction cancer
156221|NCT02335411|PD1|pd1
156222|NCT02335411|PDL1|pdl1
147095|NCT02388256|neoplasm|neoplasm
147096|NCT02388243|Brief intervention|brief intervention
147097|NCT02388243|Low and middle income countries (LMIC)|low and middle income countries (lmic)
147098|NCT02388243|eLearning|elearning
147099|NCT02388243|Screening|screening
147146|NCT02388035|SBP|sbp
156223|NCT02335398|methadone|methadone
156224|NCT02335398|chronic pain|chronic pain
156225|NCT02335398|noncancer pain|noncancer pain
156226|NCT02335398|cancer pain|cancer pain
156227|NCT02335398|QTc prolongation|qtc prolongation
156228|NCT02335372|Cervical cancer|cervical cancer
156229|NCT02335372|Cervical neoplasia|cervical neoplasia
156230|NCT02335372|Cervical cancer screening|cervical cancer screening
156231|NCT02335372|Colposcopy|colposcopy
156232|NCT02335372|Wide-field white light imaging|wide-field white light imaging
156600|NCT02333214|Aged|aged
156234|NCT02335372|Acetic acid|acetic acid
156235|NCT02335372|Proflavine solution|proflavine solution
156236|NCT02335333|Delayed Graft Function|delayed graft function
156237|NCT02335333|Slow Graft Function|slow graft function
156238|NCT02335333|Renal Transplant|renal transplant
156239|NCT02335333|Extended Criteria Donor|extended criteria donor
156240|NCT02335333|Biomarker of Aging|biomarker of aging
156241|NCT02335333|Kidney Transplant|kidney transplant
156242|NCT02335320|VHC|vhc
156243|NCT02335320|IL28-B|il28-b
156244|NCT02335320|point of care|point of care
156245|NCT02335307|Pain|pain
156246|NCT02335307|CYP2D6|cyp2d6
156247|NCT02335294|Pain|pain
156248|NCT02335294|abdominoplasty|abdominoplasty
156249|NCT02335294|PCA|pca
156250|NCT02335281|Standardized Fecal Microbiota Transplantation|standardized fecal microbiota transplantation
156251|NCT02335281|Inflammatory Bowel Disease|inflammatory bowel disease
156252|NCT02335281|Ulcerative Colitis|ulcerative colitis
156253|NCT02335281|Crohn's Disease|crohn's disease
156254|NCT02335268|MDS classified as IPSS low/int-1|mds classified as ipss low/int-1
156255|NCT02335242|Sildenafil|sildenafil
156256|NCT02335242|Magnetic Resonance Imaging|magnetic resonance imaging
156257|NCT02335242|Dermatology|dermatology
156258|NCT02335242|Pediatrics|pediatrics
156259|NCT02335190|Sacroiliac joint|sacroiliac joint
156260|NCT02335190|Radiofrequency ablation|radiofrequency ablation
156261|NCT02335190|Ultrasound|ultrasound
156262|NCT02335177|Falls|falls
156263|NCT02335177|Elderly|elderly
156264|NCT02335177|Physical activities|physical activities
156265|NCT02335177|Technologies for autonomy|technologies for autonomy
156266|NCT02335177|Impact of intervention|impact of intervention
156267|NCT02335177|autonomy|autonomy
156268|NCT02335177|physical activity program|physical activity program
156269|NCT02335151|Circulating Tumor Cells|circulating tumor cells
156270|NCT02335151|Anesthesia and immunity|anesthesia and immunity
156271|NCT02335151|Cell Search System|cell search system
156273|NCT02335138|MSM|msm
156274|NCT02335138|Couples|couples
156275|NCT02335138|Home Testing|home testing
156276|NCT02335138|Sexual Agreements|sexual agreements
156277|NCT02335112|irreversible electroporation|irreversible electroporation
156278|NCT02335112|Unresectable Head and Neck Neoplasms|unresectable head and neck neoplasms
156279|NCT02335099|hemodialysis|hemodialysis
156280|NCT02335099|vascular access|vascular access
156281|NCT02335099|vascular access patency|vascular access patency
156282|NCT02335099|ticagrelor|ticagrelor
156283|NCT02335099|brilinta|brilinta
156284|NCT02335073|Prognosis|prognosis
156285|NCT02335060|cannabis|cannabis
156286|NCT02335060|Marijuana|marijuana
156287|NCT02335060|THC|thc
156288|NCT02335060|N-acetylcysteine|n-acetylcysteine
156289|NCT02335060|Psychotic Disorders|psychotic disorders
156290|NCT02335047|reliability|reliability
156291|NCT02335047|clinical test|clinical test
156292|NCT02335047|physical therapy|physical therapy
156293|NCT02335034|Osteoarthritis|osteoarthritis
156294|NCT02335034|Knee|knee
156295|NCT02335034|Education|education
156296|NCT02335034|Quality of life|quality of life
156297|NCT02335034|Treatment outcome|treatment outcome
156298|NCT02335034|Musculoskeletal pain|musculoskeletal pain
156299|NCT02334995|solitery rectal ulcer|solitery rectal ulcer
156300|NCT02334995|biofeedback|biofeedback
156301|NCT02334995|dissynergy|dissynergy
156302|NCT02334982|Drug therapy|drug therapy
156303|NCT02334969|ischemic stroke；Naoxintong Capsule|ischemic stroke；naoxintong capsule
156304|NCT02334956|MRI|mri
156305|NCT02334956|Executive Deficits|executive deficits
156306|NCT02334943|Immune Activation|immune activation
156307|NCT02334943|HIV-1 infected subjects|hiv-1 infected subjects
156308|NCT02334943|Undetectable viral load|undetectable viral load
156309|NCT02334943|Causes of Immune Activation in HIV-1 infected patients|causes of immune activation in hiv-1 infected patients
156310|NCT02334943|Forms of Immune Activation|forms of immune activation
147196|NCT02387866|Male|male
156311|NCT02334943|Emergent non-AIDS related comorbidities|emergent non-aids related comorbidities
156312|NCT02334930|propranolol|propranolol
156313|NCT02334930|betablocker|betablocker
156314|NCT02334930|angiogenesis|angiogenesis
156315|NCT02334917|Suture Comparison|suture comparison
156316|NCT02334891|congestive heart failure|congestive heart failure
156317|NCT02334891|heart failure, diastolic|heart failure, diastolic
156318|NCT02334891|heart failure, systolic|heart failure, systolic
156319|NCT02334891|elderly frail|elderly frail
156320|NCT02334891|guideline adherence|guideline adherence
156321|NCT02334878|Stem Cells|stem cells
156322|NCT02334878|Mesenchymal|mesenchymal
156323|NCT02334826|multivessel coronary artery disease|multivessel coronary artery disease
156324|NCT02334826|revascularization|revascularization
156325|NCT02334826|bioresorbable vascular scaffold|bioresorbable vascular scaffold
156326|NCT02334826|percutaneous coronary intervention|percutaneous coronary intervention
156327|NCT02334826|coronary artery bypass grafting|coronary artery bypass grafting
156328|NCT02334800|Palbociclib, PD-0332991, Hepatic Impairment|palbociclib, pd-0332991, hepatic impairment
156329|NCT02334761|Biopsy|biopsy
156330|NCT02334735|Melanoma|melanoma
156331|NCT02334735|Immunotherapy|immunotherapy
156332|NCT02334735|DC Vaccine|dc vaccine
156333|NCT02334735|Adjuvant Therapy|adjuvant therapy
156334|NCT02334735|Immunogenicity|immunogenicity
156335|NCT02334696|Vascular Access|vascular access
156336|NCT02334683|Comparison|comparison
156337|NCT02334683|Botulinum toxin treatments|botulinum toxin treatments
156338|NCT02334683|Ultrasound|ultrasound
156339|NCT02334683|Electrophysiologic|electrophysiologic
156340|NCT02334683|Spasticity|spasticity
156341|NCT02334683|Focal dystonia|focal dystonia
156342|NCT02334670|cryptococcal meningitis|cryptococcal meningitis
156343|NCT02334670|HIV|hiv
156344|NCT02334670|AIDS|aids
156345|NCT02334670|Fluconazole|fluconazole
156346|NCT02334657|non-aneurysmal|non-aneurysmal
156347|NCT02334644|Treatment|treatment
156348|NCT02334644|Natural Health Product|natural health product
156349|NCT02334644|Anxiety|anxiety
156350|NCT02334592|the effect of tanning|the effect of tanning
156351|NCT02334592|vitamin D production|vitamin d production
156352|NCT02334579|Radiation|radiation
156353|NCT02334579|Stereotactic Radiosurgery|stereotactic radiosurgery
156354|NCT02334579|Radiotherapy|radiotherapy
156355|NCT02334579|Prostate Tumor|prostate tumor
156356|NCT02334579|Prostate Surgery|prostate surgery
156357|NCT02334579|CyberKnife|cyberknife
156358|NCT02334566|PTSD|ptsd
156359|NCT02334566|Refugee children mental health|refugee children mental health
156360|NCT02334566|community health care|community health care
156361|NCT02334553|COPD|copd
156362|NCT02334553|Chronic bronchitis|chronic bronchitis
156363|NCT02334553|Cystic fibrosis|cystic fibrosis
156364|NCT02334553|Bronchoconstriction|bronchoconstriction
156365|NCT02334553|Perfluorocarbons|perfluorocarbons
156366|NCT02334553|Carbon dioxide|carbon dioxide
156367|NCT02334527|metastatic urothelial carcinoma (UC)|metastatic urothelial carcinoma (uc)
156368|NCT02334527|LCCC 1406|lccc 1406
156369|NCT02334527|Lineberger|lineberger
156370|NCT02334527|palbociclib|palbociclib
156371|NCT02334514|Influenza|influenza
156372|NCT02334514|Viral shedding|viral shedding
156373|NCT02334514|oseltamivir|oseltamivir
156374|NCT02334514|Polymerase Chain Reaction|polymerase chain reaction
156375|NCT02334501|Healthy Volunteers|healthy volunteers
156376|NCT02334462|Assays|assays
156377|NCT02334462|Antibody|antibody
156378|NCT02334462|Reactogenicity|reactogenicity
156379|NCT02334462|Mosquito|mosquito
156380|NCT02334462|Responses|responses
156381|NCT02334449|healthy volunteers|healthy volunteers
156382|NCT02334410|fractures|fractures
156383|NCT02334410|immobilisation|immobilisation
156384|NCT02334410|paraplegia|paraplegia
156385|NCT02334410|tetraplegia|tetraplegia
156386|NCT02334397|Prenatal Exercise|prenatal exercise
156387|NCT02334397|Prenatal Education|prenatal education
156388|NCT02334397|Pregnancy|pregnancy
156389|NCT02334397|Exercise and Birth Outcomes|exercise and birth outcomes
156390|NCT02334397|Education and Birth Outcomes|education and birth outcomes
156391|NCT02334397|Maternal Quality of Life|maternal quality of life
156392|NCT02334397|Birth Satisfaction|birth satisfaction
156393|NCT02334371|Magnetic Resonance Imaging|magnetic resonance imaging
156394|NCT02334371|Positron-Emission Tomography|positron-emission tomography
156395|NCT02334332|Caregiver|caregiver
156396|NCT02334293|Omegaven|omegaven
156397|NCT02334293|parenteral nutrition|parenteral nutrition
156398|NCT02334293|liver disease|liver disease
156399|NCT02334293|liver injury|liver injury
156402|NCT02334280|Weight loss|weight loss
156403|NCT02334280|Fitness|fitness
156404|NCT02334280|Serious mental illness|serious mental illness
156405|NCT02334280|Health promotion|health promotion
156406|NCT02334254|safety|safety
156407|NCT02334254|rivaroxaban|rivaroxaban
156408|NCT02334254|ticagrel|ticagrel
156409|NCT02334254|triple antithrombotic regimen|triple antithrombotic regimen
156410|NCT02334254|undergoing PCI|undergoing pci
156414|NCT02334202|Adolescent|adolescent
156415|NCT02334202|Obesity/Psychology|obesity/psychology
156416|NCT02334202|Loss of Control Eating|loss of control eating
156417|NCT02334202|Child|child
156418|NCT02334202|Female|female
156419|NCT02334202|Follow-Up Studies|follow-up studies
156420|NCT02334202|Health Behavior|health behavior
156421|NCT02334202|Health Education|health education
156422|NCT02334202|Humans|humans
156423|NCT02334202|Intervention Studies|intervention studies
156424|NCT02334202|Prospective Studies|prospective studies
156425|NCT02334202|Psychotherapy|psychotherapy
156426|NCT02334202|Risk Factors|risk factors
156427|NCT02334202|Weight Loss|weight loss
156428|NCT02334202|Weight Gain|weight gain
156429|NCT02334202|Military|military
156430|NCT02334163|Hepatic Encephalopathy|hepatic encephalopathy
156431|NCT02334163|Nitazoxanide|nitazoxanide
156432|NCT02334163|Serum ammonia|serum ammonia
156433|NCT02334150|combined spinal-epidural analgesia|combined spinal-epidural analgesia
156434|NCT02334150|pelvic floor muscle|pelvic floor muscle
156435|NCT02334150|postpartum electrophysiological function|postpartum electrophysiological function
156436|NCT02334111|Parenting Support for Mothers in Recovery|parenting support for mothers in recovery
156437|NCT02334111|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
156438|NCT02334111|Social Determinants of Health|social determinants of health
156439|NCT02334111|Child Development|child development
156440|NCT02334111|Child Abuse|child abuse
156441|NCT02334111|Child Neglect|child neglect
156442|NCT02334111|Primary Care|primary care
156443|NCT02334098|Aggression|aggression
156444|NCT02334098|Omega-3 supplementation|omega-3 supplementation
156445|NCT02334098|Neurocognition|neurocognition
156446|NCT02334098|Attention|attention
156447|NCT02334098|Antisocial|antisocial
156448|NCT02334059|opioid sparing|opioid sparing
156449|NCT02334059|ketamine|ketamine
156450|NCT02334059|obese|obese
156451|NCT02334059|magnesium|magnesium
156452|NCT02334046|tracheal extubation|tracheal extubation
156453|NCT02334046|remifentanil|remifentanil
156454|NCT02334033|hypertension|hypertension
156455|NCT02334033|blood pressure|blood pressure
156456|NCT02334033|cystatin C|cystatin c
156457|NCT02334033|real-life|real-life
156458|NCT02334033|kidney|kidney
156459|NCT02334020|Mental illness|mental illness
156460|NCT02334020|training|training
156461|NCT02334020|support|support
156462|NCT02334020|Mental Health|mental health
156463|NCT02334007|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
156464|NCT02334007|deep vein thrombosis|deep vein thrombosis
156465|NCT02334007|pulmonary embolism|pulmonary embolism
156466|NCT02334007|lung resection|lung resection
156467|NCT02334007|low molecular weight heparin|low molecular weight heparin
156468|NCT02333968|Cancer pain|cancer pain
156469|NCT02333968|Self-management|self-management
156470|NCT02333968|Randomized controlled trial|randomized controlled trial
156471|NCT02333942|Aging|aging
156472|NCT02333942|Diagnostic Equipment|diagnostic equipment
156473|NCT02333929|rivaroxaban|rivaroxaban
156474|NCT02333929|NOAC|noac
156475|NCT02333929|anti-Xa activity|anti-xa activity
156476|NCT02333929|method comparison|method comparison
156477|NCT02333929|LCMS|lcms
156478|NCT02333903|Obesity|obesity
156479|NCT02333903|Sleeve gastrectomy|sleeve gastrectomy
156480|NCT02333903|Personalized physical activity program|personalized physical activity program
156481|NCT02333903|Body Composition|body composition
156482|NCT02333903|Fat mass|fat mass
156483|NCT02333903|Lean mass|lean mass
156484|NCT02333890|breast|breast
156485|NCT02333851|Type 2 diabetes mellitus treatment|type 2 diabetes mellitus treatment
156486|NCT02333851|Hospitalized patients|hospitalized patients
156487|NCT02333838|Cord Cell Transplantation|cord cell transplantation
156488|NCT02333838|High risk myeloid malignancies|high risk myeloid malignancies
156489|NCT02333799|Tuberculosis|tuberculosis
156490|NCT02333799|MDR-TB|mdr-tb
156491|NCT02333799|XDR-TB|xdr-tb
156492|NCT02333799|Multi-drug resistant|multi-drug resistant
156493|NCT02333799|Extensively drug resistant|extensively drug resistant
156494|NCT02333799|Bedaquiline|bedaquiline
156495|NCT02333799|PA-824|pa-824
156496|NCT02333799|Linezolid|linezolid
156498|NCT02333799|Pretomanid|pretomanid
156499|NCT02333799|TMC-207|tmc-207
156500|NCT02333799|NiX-TB|nix-tb
156501|NCT02333773|irreversible electroporation|irreversible electroporation
156502|NCT02333773|Portal venous tumor emboli|portal venous tumor emboli
156503|NCT02333734|Type 2 diabetes|type 2 diabetes
156504|NCT02333734|Interval training|interval training
156505|NCT02333734|Insulin resistance|insulin resistance
156506|NCT02333734|fat metabolism|fat metabolism
156507|NCT02333721|Stomach Neoplasms|stomach neoplasms
156508|NCT02333721|Laparoscopy|laparoscopy
156509|NCT02333695|SCI, Spinal Cord Injury, Stroke|sci, spinal cord injury, stroke
156510|NCT02333669|Lung fluid absorption disorders|lung fluid absorption disorders
156511|NCT02333669|Neonatal respiratory distress syndrome|neonatal respiratory distress syndrome
156512|NCT02333669|Single nucleotide polymorphism|single nucleotide polymorphism
156513|NCT02333669|SCNN1A|scnn1a
156514|NCT02333630|asthma|asthma
189419|NCT02164604|ROP|rop
156515|NCT02333617|Manual Therapy|manual therapy
156516|NCT02333617|Physical Therapy|physical therapy
156517|NCT02333617|Dry Needling|dry needling
156518|NCT02333617|Gluteus Medius|gluteus medius
156519|NCT02333604|cancer|cancer
156520|NCT02333604|cancer survivor ship|cancer survivor ship
156521|NCT02333604|psychosocial needs|psychosocial needs
156522|NCT02333604|cancer experience|cancer experience
156523|NCT02333604|metastatic breast cancer|metastatic breast cancer
156524|NCT02333604|multiple myeloma|multiple myeloma
156525|NCT02333604|chronic myeloid leukemia|chronic myeloid leukemia
156526|NCT02333604|breast cancer|breast cancer
156527|NCT02333604|Prostate|prostate
156528|NCT02333604|Colon|colon
156529|NCT02333604|Kidney|kidney
156530|NCT02333604|Lung|lung
156531|NCT02333604|Melanoma|melanoma
156532|NCT02333604|Caregiver|caregiver
156533|NCT02333552|Frailty|frailty
156534|NCT02333552|Pre-frailty|pre-frailty
156536|NCT02333552|Robust|robust
156537|NCT02333552|Elderly|elderly
156538|NCT02333552|Sociodemography status|sociodemography status
156539|NCT02333552|Functional status|functional status
156540|NCT02333552|Cognitive status|cognitive status
156541|NCT02333552|Nutrition status|nutrition status
156542|NCT02333552|Comorbidity|comorbidity
156543|NCT02333552|Mortality|mortality
156544|NCT02333552|Depression status|depression status
156545|NCT02333526|ulcerative colitis|ulcerative colitis
156546|NCT02333526|Clostidium difficile-associated colitis|clostidium difficile-associated colitis
156547|NCT02333526|Syndecan-1|syndecan-1
156548|NCT02333526|biomarker|biomarker
156549|NCT02333474|mix vaccine, lung neoplasms, immunotherapy|mix vaccine, lung neoplasms, immunotherapy
156550|NCT02333435|Prostatectomy|prostatectomy
156551|NCT02333435|Omega-3 fatty acids|omega-3 fatty acids
156552|NCT02333435|Quality of life|quality of life
156553|NCT02333435|inflammation|inflammation
156554|NCT02333435|cellular proliferation|cellular proliferation
156555|NCT02333422|NIRS Neurofeedback|nirs neurofeedback
156556|NCT02333422|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
156557|NCT02333422|Near Infrared Spectroscopy|near infrared spectroscopy
156558|NCT02333422|ADHD|adhd
156559|NCT02333409|Cancer of pancreas|cancer of pancreas
156560|NCT02333409|Acupuncture|acupuncture
156561|NCT02333409|Pain|pain
156562|NCT02333396|Navigator|navigator
156563|NCT02333396|Intervention Study|intervention study
156564|NCT02333396|Randomized Controlled Trial|randomized controlled trial
156565|NCT02333396|Pediatric Intensive Care Unit|pediatric intensive care unit
156566|NCT02333396|Decision Making|decision making
156567|NCT02333383|Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score|bath ankylosing spondylitis disease activity index (basdai) score
156568|NCT02333383|EAMs|eams
156569|NCT02333383|Adalimumab|adalimumab
156570|NCT02333370|Advanced breast cancer|advanced breast cancer
156571|NCT02333370|Hormone receptor positive|hormone receptor positive
156572|NCT02333370|HER2-negative|her2-negative
156573|NCT02333370|LEE011,|lee011,
156574|NCT02333370|Letrozole|letrozole
156575|NCT02333370|Tamoxifen|tamoxifen
156576|NCT02333370|Fulvestrant|fulvestrant
156577|NCT02333370|Postmenopausal Asian women|postmenopausal asian women
156578|NCT02333370|Pre and Postmenopausal Japanese women|pre and postmenopausal japanese women
156579|NCT02333344|prosthetic fixation|prosthetic fixation
156580|NCT02333331|Sarcopenia, muscle wasting, elderly, strength, physical function, muscle, gait speed|sarcopenia, muscle wasting, elderly, strength, physical function, muscle, gait speed
585911|NCT00522743|IGF-1|igf-1
156581|NCT02333305|Ataxia with Oculomotor Apraxia type 1|ataxia with oculomotor apraxia type 1
156582|NCT02333305|CoQ10|coq10
156583|NCT02333305|hypoalbuminemia|hypoalbuminemia
156584|NCT02333266|Candida bloodstream infection|candida bloodstream infection
156585|NCT02333266|Detection fungal cells|detection fungal cells
156586|NCT02333266|Fiber-Optic Surface Plasmon Resonance (FO-SPR)|fiber-optic surface plasmon resonance (fo-spr)
156587|NCT02333253|poor responders|poor responders
156588|NCT02333253|GnRH antagonist|gnrh antagonist
156589|NCT02333253|Conventional protocol|conventional protocol
156590|NCT02333240|Pregnancy|pregnancy
156591|NCT02333240|Postnatal Care|postnatal care
156592|NCT02333240|Blood Pressure Monitoring, Home|blood pressure monitoring, home
156593|NCT02333240|Self Care|self care
156594|NCT02333240|Pregnancy Complications, Cardiovascular|pregnancy complications, cardiovascular
156595|NCT02333240|Qualitative Research|qualitative research
156596|NCT02333240|Antihypertensive Agents|antihypertensive agents
156597|NCT02333214|Virtual Reality Therapy|virtual reality therapy
156598|NCT02333214|Video Game|video game
156599|NCT02333214|Physical Exercise|physical exercise
156601|NCT02333214|Frailty|frailty
156602|NCT02333201|Deglutition Disorders|deglutition disorders
156603|NCT02333201|Dysphagia|dysphagia
156604|NCT02333201|Mechanical Ventilation|mechanical ventilation
156605|NCT02333201|Sepsis|sepsis
156606|NCT02333175|Parkinson's disease, Late stage|parkinson's disease, late stage
156607|NCT02333149|Melatonin|melatonin
156608|NCT02333071|HSDD|hsdd
189548|NCT02163967|CES|ces
147494|NCT02385838|Nutritional quality|nutritional quality
147495|NCT02385838|Randomized controlled trial (RCT)|randomized controlled trial (rct)
147496|NCT02385812|Lung Cancer|lung cancer
147497|NCT02385812|Mesothelioma|mesothelioma
156609|NCT02333071|Female Sexual Desire Disorder|female sexual desire disorder
156610|NCT02333058|ALL|all
156611|NCT02333058|AML|aml
156612|NCT02333058|MDS|mds
156613|NCT02333058|JMML|jmml
156614|NCT02333045|HIV-negative|hiv-negative
156615|NCT02333045|Women|women
156616|NCT02333045|At-risk|at-risk
156617|NCT02333019|risk|risk
156618|NCT02333006|Anosognosia|anosognosia
156619|NCT02332993|FPP (Fermented Papaya Preparation)|fpp (fermented papaya preparation)
156620|NCT02332993|Negative Pressure Therapy|negative pressure therapy
156621|NCT02332993|Wound Vac|wound vac
156622|NCT02332993|Wound|wound
156623|NCT02332993|Type II Diabetic|type ii diabetic
156624|NCT02332954|Depression|depression
156625|NCT02332954|Major Depressive Disorder|major depressive disorder
156626|NCT02332954|Cognition|cognition
156627|NCT02332954|Cognitive symptoms|cognitive symptoms
156628|NCT02332954|vortioxetine|vortioxetine
156629|NCT02332954|real life|real life
156630|NCT02332954|naturalistic|naturalistic
156631|NCT02332915|apraxia|apraxia
156632|NCT02332915|aphasia|aphasia
156633|NCT02332915|rehabilitation|rehabilitation
156634|NCT02332915|efficacy|efficacy
156635|NCT02332915|intensity|intensity
156636|NCT02332902|Neurofibroma|neurofibroma
156637|NCT02332902|NF-1|nf-1
156638|NCT02332902|Everolimus|everolimus
156639|NCT02332902|mTOR inhibitor|mtor inhibitor
156640|NCT02332863|Pancreatic cancer|pancreatic cancer
156641|NCT02332863|Image guided radiation therapy|image guided radiation therapy
156642|NCT02332863|Fiducial marker placement|fiducial marker placement
156643|NCT02332863|Endoscopic ultrasound|endoscopic ultrasound
156644|NCT02332850|Relapsed|relapsed
156645|NCT02332850|Refractory|refractory
156771|NCT02332174|tolerability|tolerability
156646|NCT02332837|informed consent, public led trials, shared decision making,|informed consent, public led trials, shared decision making,
156647|NCT02332824|Pharmacological therapy|pharmacological therapy
156648|NCT02332798|Multiple ascending doses|multiple ascending doses
156649|NCT02332798|safety|safety
156650|NCT02332798|tolerability|tolerability
156651|NCT02332798|pharmacokinetics|pharmacokinetics
156652|NCT02332798|cognitive impairment associated with schizophrenia (CIAS)|cognitive impairment associated with schizophrenia (cias)
156653|NCT02332785|Colon Serrated Polyps|colon serrated polyps
156654|NCT02332785|Serrated polyp|serrated polyp
156655|NCT02332785|Hyperplastic polyps above sigmoid colon|hyperplastic polyps above sigmoid colon
156656|NCT02332785|Sessile serrated adenoma|sessile serrated adenoma
156657|NCT02332785|Traditional serrated adenoma|traditional serrated adenoma
156658|NCT02332785|Colonoscopy|colonoscopy
156659|NCT02332785|Endoscopy|endoscopy
156660|NCT02332785|Data collection|data collection
156661|NCT02332785|Data review|data review
156662|NCT02332772|Colon Polyps|colon polyps
156663|NCT02332772|Large polyps|large polyps
156664|NCT02332772|Flat lesions|flat lesions
156665|NCT02332772|Endoscopy|endoscopy
156666|NCT02332772|Colonoscopic resection|colonoscopic resection
156667|NCT02332772|Colonoscopy|colonoscopy
156668|NCT02332772|Data review|data review
156669|NCT02332772|Data collection|data collection
156670|NCT02332668|PD1|pd1
156671|NCT02332668|PD-1|pd-1
156672|NCT02332668|PDL1|pdl1
156673|NCT02332668|PD-L1|pd-l1
156674|NCT02332655|Sturge-Weber syndrome|sturge-weber syndrome
156675|NCT02332655|SWS|sws
156676|NCT02332655|Drug resistant epilepsy|drug resistant epilepsy
156677|NCT02332629|Glucocorticoid|glucocorticoid
156678|NCT02332629|Endothelial barrier|endothelial barrier
156679|NCT02332629|Glycocalyx|glycocalyx
156680|NCT02332629|Knee arthroplasty, total|knee arthroplasty, total
156681|NCT02332616|Glucocorticoid|glucocorticoid
156682|NCT02332616|Complement activation|complement activation
156683|NCT02332616|Knee arthroplasty, total|knee arthroplasty, total
156684|NCT02332603|Glucocorticoid|glucocorticoid
156685|NCT02332603|Glucose homeostasis|glucose homeostasis
156686|NCT02332603|Knee arthroplasty, total|knee arthroplasty, total
156687|NCT02332603|Hip arthroplasty, total|hip arthroplasty, total
156688|NCT02332564|Circulation, Collateral|circulation, collateral
156689|NCT02332564|Coronary Artery Disease|coronary artery disease
156690|NCT02332564|Internal Mammary-Coronary Artery Anastomosis|internal mammary-coronary artery anastomosis
156691|NCT02332564|Ischemia|ischemia
156692|NCT02332538|LASER|laser
156693|NCT02332538|PROSTATE|prostate
156694|NCT02332538|BIPOLAR|bipolar
156695|NCT02332538|HYPERPLASIA|hyperplasia
156696|NCT02332538|VAPORIZATION|vaporization
156697|NCT02332525|Oral Vibrational Stimulation|oral vibrational stimulation
156698|NCT02332525|Cognitive Function|cognitive function
156699|NCT02332525|Mild Cognitive Impairment|mild cognitive impairment
156700|NCT02332525|cognitive normal elderly|cognitive normal elderly
156701|NCT02332512|Non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
156702|NCT02332512|Wild-type EGFR|wild-type egfr
156703|NCT02332512|3rd/4th line treatment|3rd/4th line treatment
156705|NCT02332499|Anlotinib|anlotinib
156706|NCT02332499|Metastatic Colorectal Cancer （mCRC）|metastatic colorectal cancer （mcrc）
156707|NCT02332499|ALTER0703|alter0703
156708|NCT02332447|Tonic-clonic seizures|tonic-clonic seizures
156709|NCT02332447|Naloxone|naloxone
156710|NCT02332447|SUDEP|sudep
156711|NCT02332421|canine retraction|canine retraction
156712|NCT02332421|acceleration of tooth movement|acceleration of tooth movement
156713|NCT02332421|dentoalveolar distraction osteogenesis|dentoalveolar distraction osteogenesis
156714|NCT02332408|vertebral hemangioma|vertebral hemangioma
156715|NCT02332408|conventional radiotherapy|conventional radiotherapy
156716|NCT02332408|Cyber Knife radiotherapy|cyber knife radiotherapy
156717|NCT02332408|randomized trial|randomized trial
156718|NCT02332408|radioablation|radioablation
156719|NCT02332395|pain|pain
156720|NCT02332395|pain catastrophizing|pain catastrophizing
156721|NCT02332395|cesarean section|cesarean section
156723|NCT02332356|Crohn Disease|crohn disease
156724|NCT02332356|Inflammatory Bowel Diseases|inflammatory bowel diseases
156725|NCT02332356|Disease Attributes|disease attributes
156726|NCT02332343|Retina|retina
156727|NCT02332343|Retinal pigment epithelium|retinal pigment epithelium
156728|NCT02332317|Advanced cancer|advanced cancer
156729|NCT02332317|Early integration|early integration
156730|NCT02332317|Palliative rehabilitation|palliative rehabilitation
156731|NCT02332304|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
156732|NCT02332291|Depression|depression
156733|NCT02332291|Geriatrics|geriatrics
156734|NCT02332291|Elderly|elderly
156735|NCT02332291|MRI|mri
156736|NCT02332291|Antidepressants|antidepressants
156737|NCT02332278|Cesarean section|cesarean section
156738|NCT02332278|Early feeding|early feeding
156739|NCT02332265|Food Security|food security
156740|NCT02332265|Microfinance|microfinance
156741|NCT02332265|Village Savings and Loans|village savings and loans
156743|NCT02332265|Quasi-experimental design|quasi-experimental design
156744|NCT02332265|Malawi|malawi
156745|NCT02332265|Structural intervention|structural intervention
156746|NCT02332252|Surgical Wound Infection|surgical wound infection
156747|NCT02332252|Electrocautery|electrocautery
156748|NCT02332252|Scalpel|scalpel
156749|NCT02332239|depression|depression
156750|NCT02332239|violence|violence
156751|NCT02332239|emergency department|emergency department
156752|NCT02332239|text message|text message
156753|NCT02332239|mhealth|mhealth
156754|NCT02332213|Volatile organic compounds|volatile organic compounds
156755|NCT02332213|Nanosensor technology|nanosensor technology
156756|NCT02332213|GC-MS|gc-ms
156757|NCT02332213|Breath-testing|breath-testing
156758|NCT02332213|Digestive cancer|digestive cancer
156759|NCT02332213|Precancerous lesions|precancerous lesions
156760|NCT02332213|Colorectal cancer|colorectal cancer
156761|NCT02332213|Adenoma|adenoma
156762|NCT02332213|Gastric cancer|gastric cancer
156763|NCT02332213|Atrophic gastritis|atrophic gastritis
156764|NCT02332213|OLGIM|olgim
156765|NCT02332200|Spondylolysis|spondylolysis
156766|NCT02332200|Spondylolisthesis|spondylolisthesis
156767|NCT02332200|Low Back Pain|low back pain
156768|NCT02332174|pharmacokinetics|pharmacokinetics
156769|NCT02332174|food effect|food effect
156770|NCT02332174|sex effect|sex effect
156772|NCT02332135|microwave ablation|microwave ablation
156773|NCT02332135|maintenance hemodialysis|maintenance hemodialysis
156774|NCT02332135|mild-to-moderate Secondary Hyperparathyroidism|mild-to-moderate secondary hyperparathyroidism
156775|NCT02332122|COPD|copd
156776|NCT02332122|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
156777|NCT02332122|Aspergillus fumigatus|aspergillus fumigatus
156778|NCT02332122|Bronchiectasis|bronchiectasis
156779|NCT02332122|Sensitization|sensitization
156780|NCT02332122|Vitamin D|vitamin d
156781|NCT02332109|Fuchs endothelial dystrophy|fuchs endothelial dystrophy
156782|NCT02332109|oedema|oedema
156783|NCT02332109|sodium chloride|sodium chloride
156784|NCT02332109|hyaluronan|hyaluronan
156785|NCT02332109|sodium hyaluronate|sodium hyaluronate
156786|NCT02332070|acute kidney injury|acute kidney injury
156787|NCT02332070|coronary angiography|coronary angiography
156788|NCT02332070|cardiac surgery|cardiac surgery
156789|NCT02332070|adverse events|adverse events
156790|NCT02332070|iodinated contrast|iodinated contrast
156791|NCT02332070|Thoracic Surgery|thoracic surgery
156792|NCT02332057|IUD,Diclofenac , Lidocaine|iud,diclofenac , lidocaine
156793|NCT02332031|Sorafenib, levothyroxine, drug interaction, pharmacokinetics, healthy volunteer|sorafenib, levothyroxine, drug interaction, pharmacokinetics, healthy volunteer
156794|NCT02331992|Continuous Positive Airway Pressure|continuous positive airway pressure
156795|NCT02331966|FGF-23|fgf-23
156796|NCT02331966|GROWTH FACTORS RECEPTORS|growth factors receptors
156797|NCT02331966|RECURRENCES|recurrences
156798|NCT02331953|spine surgery|spine surgery
156799|NCT02331953|cerebral oximetry|cerebral oximetry
156800|NCT02331953|postoperative delirium|postoperative delirium
156801|NCT02331940|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
156802|NCT02331940|sleeping oxygen saturation|sleeping oxygen saturation
156803|NCT02331940|sleep quality|sleep quality
156804|NCT02331927|colorectal cancer|colorectal cancer
156805|NCT02331927|marker-driven|marker-driven
156806|NCT02331927|bevacizumab|bevacizumab
156807|NCT02331927|aflibercept|aflibercept
156808|NCT02331927|cytokines|cytokines
156809|NCT02331927|angiogenic factors|angiogenic factors
156810|NCT02331927|CAF|caf
156811|NCT02331914|GIST|gist
156812|NCT02331914|Bio-databank|bio-databank
156813|NCT02331862|urinary tract infection|urinary tract infection
156814|NCT02331862|methylprednisolone|methylprednisolone
156815|NCT02331849|Eosinophilic esophagitis (EoE)|eosinophilic esophagitis (eoe)
156816|NCT02331849|GERD|gerd
156817|NCT02331849|esophageal motility|esophageal motility
156818|NCT02331836|adenoma detection rate|adenoma detection rate
156819|NCT02331836|polyp detection rate|polyp detection rate
156820|NCT02331836|withdrawal time|withdrawal time
156821|NCT02331836|coecal and ileum intubation rate|coecal and ileum intubation rate
156822|NCT02331797|endoscope|endoscope
156823|NCT02331797|microscope|microscope
156824|NCT02331797|transcanal|transcanal
156825|NCT02331719|intracerebral hemorrhage|intracerebral hemorrhage
156826|NCT02331719|subcortical intracerebral hemorrhage|subcortical intracerebral hemorrhage
156827|NCT02331719|ICH|ich
156828|NCT02331719|parafascicular minimally invasive subcortical access|parafascicular minimally invasive subcortical access
156829|NCT02331693|EGFR|egfr
156830|NCT02331693|CAR T cells|car t cells
156831|NCT02331693|glioma|glioma
156832|NCT02331680|Undergoing Hemodialysis|undergoing hemodialysis
156833|NCT02331680|Undergoing Hemodiafiltration|undergoing hemodiafiltration
156834|NCT02331667|Diet|diet
156835|NCT02331667|Vitamin-D|vitamin-d
156836|NCT02331667|Meat|meat
157273|NCT02328885|DLI|dli
156838|NCT02331667|Iodine|iodine
156839|NCT02331667|fatty acid|fatty acid
156840|NCT02331667|Intervention study|intervention study
156841|NCT02331667|Wechsler Preschool and Primary Scale of Intelligence|wechsler preschool and primary scale of intelligence
156842|NCT02331667|Strengths and Difficulties Questionnaire|strengths and difficulties questionnaire
156843|NCT02331667|Nine hole peg test|nine hole peg test
156844|NCT02331654|Chronic pain|chronic pain
156845|NCT02331654|Direct Current Stimulation|direct current stimulation
156846|NCT02331641|hepatectomy|hepatectomy
156847|NCT02331641|hepatic resection|hepatic resection
156848|NCT02331628|TBI Traumatic Brain Injury|tbi traumatic brain injury
156849|NCT02331628|HO Heterotopic Ossification|ho heterotopic ossification
156850|NCT02331628|NHO Neurogenic Heterotopic Ossification|nho neurogenic heterotopic ossification
156851|NCT02331628|ESWT Extracorporeal Shock Wave Therapy|eswt extracorporeal shock wave therapy
156852|NCT02331615|Traumatic Brain Injury|traumatic brain injury
156853|NCT02331615|Executive function difficulties|executive function difficulties
156854|NCT02331615|Transcranial direct current stimulation|transcranial direct current stimulation
156855|NCT02331602|atrial fibrillation|atrial fibrillation
156856|NCT02331602|anticoagulation|anticoagulation
156857|NCT02331602|inflammation|inflammation
156858|NCT02331589|Fatigue|fatigue
156859|NCT02331589|Panax ginseng|panax ginseng
156860|NCT02331589|Chronic hepatitis|chronic hepatitis
156861|NCT02331589|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
156862|NCT02331589|Adiponectin|adiponectin
156863|NCT02331563|dexmedetomidine|dexmedetomidine
156864|NCT02331550|Low-Grade Squamous Intraepithelial Lesions|low-grade squamous intraepithelial lesions
156865|NCT02331524|exercise|exercise
156866|NCT02331524|daily activity|daily activity
156867|NCT02331485|Prevention of wound infection and wound complication|prevention of wound infection and wound complication
156868|NCT02331472|interstitial cystitis|interstitial cystitis
156869|NCT02331472|biomarker|biomarker
156870|NCT02331459|mood|mood
156871|NCT02331459|cognitive state|cognitive state
156872|NCT02331459|physical activity|physical activity
156873|NCT02331459|frailty|frailty
156874|NCT02331394|Chinese herbs|chinese herbs
156875|NCT02331394|lung cancer|lung cancer
156876|NCT02331394|quality of life|quality of life
156877|NCT02331355|amputation, hand, forearm, arm, traumatic, transplantation|amputation, hand, forearm, arm, traumatic, transplantation
156878|NCT02331342|Agreement of NICOM and Innocor|agreement of nicom and innocor
156879|NCT02331329|Accuracy of NICOM|accuracy of nicom
156880|NCT02331329|precision of NICOM|precision of nicom
156881|NCT02331316|obesity|obesity
156882|NCT02331316|diet|diet
156883|NCT02331316|weight|weight
156884|NCT02331316|hunger|hunger
156885|NCT02331316|public led trial|public led trial
156886|NCT02331264|Cardiac Toxicity|cardiac toxicity
156887|NCT02331264|Metal on Metal Hip Implants|metal on metal hip implants
156888|NCT02331186|Obesity|obesity
156889|NCT02331186|Bariatric surgery|bariatric surgery
189926|NCT02162524|obesity|obesity
156890|NCT02331186|Urinary incontinence|urinary incontinence
156891|NCT02331186|Pelvic floor|pelvic floor
156892|NCT02331173|XLRS|xlrs
156893|NCT02331173|RS1|rs1
156894|NCT02331173|maculoschisis|maculoschisis
156895|NCT02331160|Pregnancy|pregnancy
156896|NCT02331160|Breech Presentation|breech presentation
156897|NCT02331160|Version, fetal|version, fetal
156898|NCT02331160|Musculoskeletal Manipulations|musculoskeletal manipulations
156899|NCT02331160|Medicine, Traditional|medicine, traditional
156900|NCT02331134|Tissue|tissue
156901|NCT02331134|Hematopoietic Stem Cell|hematopoietic stem cell
156902|NCT02331134|Melanoma|melanoma
156903|NCT02331134|Squamous Head and Neck Cancer|squamous head and neck cancer
156904|NCT02331121|children|children
156905|NCT02331121|parents|parents
156906|NCT02331121|internet|internet
156907|NCT02331121|video|video
156908|NCT02331121|training|training
156909|NCT02331121|interactive|interactive
156910|NCT02331082|Infant Mortality|infant mortality
156911|NCT02331082|Under-two mortality|under-two mortality
156912|NCT02331082|Maternal Mortality|maternal mortality
156913|NCT02331082|Implementation Research|implementation research
156914|NCT02331082|Health Systems Strengthening|health systems strengthening
156915|NCT02331082|Chronic Disease Management|chronic disease management
156916|NCT02331082|Commuity Health Workers|commuity health workers
156917|NCT02331069|radial neuropathy|radial neuropathy
156918|NCT02331056|Stroke volume variation|stroke volume variation
156919|NCT02331056|fluid responsiveness|fluid responsiveness
156920|NCT02331056|One-lung ventilation|one-lung ventilation
156921|NCT02331056|thoracotomy|thoracotomy
156922|NCT02331030|brachio-axillary|brachio-axillary
156923|NCT02331030|brachio-basilic|brachio-basilic
156924|NCT02331030|interfascial plane block|interfascial plane block
156925|NCT02331030|Pecs II block|pecs ii block
156926|NCT02331030|supraclavicular brachial plexus block|supraclavicular brachial plexus block
156927|NCT02331017|Bimodal|bimodal
156928|NCT02331017|Cochlear Implant|cochlear implant
156929|NCT02331017|Hearing aid|hearing aid
156930|NCT02331017|Auditory Perception|auditory perception
156931|NCT02331004|Frail Elderly|frail elderly
156933|NCT02331004|Upper Extremity|upper extremity
156934|NCT02330991|glioblastoma|glioblastoma
156935|NCT02330991|relapse|relapse
156936|NCT02330991|Temozolomide|temozolomide
156937|NCT02330991|glioblastoma at first relapse|glioblastoma at first relapse
156938|NCT02330965|clinical research|clinical research
156939|NCT02330965|mechanistic studies|mechanistic studies
156940|NCT02330965|blood draw|blood draw
156941|NCT02330965|CSF by lumbar puncture (optional)|csf by lumbar puncture (optional)
156942|NCT02330952|Double-blind method|double-blind method
156943|NCT02330952|Randomized Controlled trials|randomized controlled trials
156944|NCT02330939|Postprandial glycemia|postprandial glycemia
156945|NCT02330939|Momounsaturated fatty acids|momounsaturated fatty acids
156946|NCT02330939|Saturated fatty acids|saturated fatty acids
156947|NCT02330939|Glycemic index|glycemic index
156948|NCT02330939|Glycemic load|glycemic load
156949|NCT02330939|Sensor augmented pump system|sensor augmented pump system
156950|NCT02330926|Combined modality treatment|combined modality treatment
156951|NCT02330926|Diet therapy|diet therapy
156952|NCT02330926|Exercise therapy|exercise therapy
156953|NCT02330926|Ibuprofen|ibuprofen
156954|NCT02330926|Dietary supplements|dietary supplements
156955|NCT02330913|total gastrectomy|total gastrectomy
156956|NCT02330913|intracorporeal|intracorporeal
156957|NCT02330913|totally laparoscopic|totally laparoscopic
156958|NCT02330913|esophagojejunostomy|esophagojejunostomy
156959|NCT02330913|anastomosis|anastomosis
156960|NCT02330900|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
156961|NCT02330900|Electromagnetic interference|electromagnetic interference
156962|NCT02330900|Cell phone|cell phone
156963|NCT02330887|Maternal Mortality|maternal mortality
156964|NCT02330887|Institutional Birth Rate|institutional birth rate
156965|NCT02330887|Neonatal Mortality Rate|neonatal mortality rate
156966|NCT02330887|Preterm Birth|preterm birth
156967|NCT02330887|Stillbirth|stillbirth
660433|NCT00811512|retina|retina
156968|NCT02330887|Infant, Small for Gestational Age|infant, small for gestational age
156969|NCT02330887|Nepal|nepal
156970|NCT02330887|Implementation Research|implementation research
156971|NCT02330887|Global Health|global health
156972|NCT02330874|Risk|risk
156973|NCT02330874|score|score
156974|NCT02330874|readmission|readmission
156975|NCT02330874|ICU|icu
156976|NCT02330861|Coronary Circulation|coronary circulation
156977|NCT02330848|Obesity|obesity
156978|NCT02330848|Walnuts|walnuts
156979|NCT02330848|Endothelial Function|endothelial function
156980|NCT02330848|Adults at risk|adults at risk
156981|NCT02330835|school|school
156982|NCT02330835|bus|bus
156983|NCT02330835|school bus|school bus
156984|NCT02330835|driver|driver
156985|NCT02330835|training|training
156986|NCT02330835|behavior|behavior
156987|NCT02330835|management|management
156988|NCT02330835|interactive|interactive
156989|NCT02330835|computer|computer
156990|NCT02330809|headache|headache
156991|NCT02330809|hunger intensity|hunger intensity
156992|NCT02330809|public led online trial|public led online trial
156993|NCT02330809|water intake|water intake
156994|NCT02330783|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
156995|NCT02330783|Third-line treatment|third-line treatment
156996|NCT02330783|Sorafenib|sorafenib
156997|NCT02330783|Bevacizumab|bevacizumab
156998|NCT02330770|GnRHa trigger|gnrha trigger
156999|NCT02330770|Luteal phase support|luteal phase support
157000|NCT02330770|OHSS|ohss
157001|NCT02330757|Frozen-thawed embryo transfer|frozen-thawed embryo transfer
157002|NCT02330757|FET protocols|fet protocols
157003|NCT02330705|Intrauterine insemination|intrauterine insemination
157004|NCT02330705|IUI|iui
157005|NCT02330705|HCG|hcg
157006|NCT02330679|Major Depression, Neuroimaging, Desvenlafaxine, Machine learning|major depression, neuroimaging, desvenlafaxine, machine learning
157007|NCT02330653|Colitis|colitis
157008|NCT02330653|Fecal Microbiota Transplant|fecal microbiota transplant
157009|NCT02330653|Ulcerative colitis|ulcerative colitis
157010|NCT02330653|inflammatory bowel disease|inflammatory bowel disease
157011|NCT02330640|CABG|cabg
157012|NCT02330640|antiplatelet therapy|antiplatelet therapy
157013|NCT02330640|ticagrelor|ticagrelor
157014|NCT02330614|personality|personality
157015|NCT02330614|bleaching|bleaching
157016|NCT02330588|Obesity|obesity
157017|NCT02330588|Prevention|prevention
157018|NCT02330588|Pediatric|pediatric
157019|NCT02330588|Parents|parents
157020|NCT02330588|Primary Care|primary care
157021|NCT02330588|eHealth|ehealth
157022|NCT02330588|Internet|internet
157023|NCT02330562|Marizomib|marizomib
157024|NCT02330562|Bevacizumab|bevacizumab
157025|NCT02330562|Avastin|avastin
157026|NCT02330562|Grade IV malignant glioma|grade iv malignant glioma
157027|NCT02330562|proteasome inhibitor|proteasome inhibitor
157028|NCT02330562|glioblastoma|glioblastoma
157029|NCT02330562|brain tumor|brain tumor
157030|NCT02330562|malignant glioma|malignant glioma
157031|NCT02330562|brain cancer|brain cancer
157032|NCT02330562|gliosarcoma|gliosarcoma
157034|NCT02330536|Circulatory and Respiratory Physiological Phenomena|circulatory and respiratory physiological phenomena
157035|NCT02330536|Thoracoscopy|thoracoscopy
157036|NCT02330510|Alzheimer's Disease|alzheimer's disease
157037|NCT02330510|White Matter Hyperintensities|white matter hyperintensities
157038|NCT02330510|Vascular Cognitive Impairment|vascular cognitive impairment
157039|NCT02330510|Amyloid Imaging|amyloid imaging
157040|NCT02330510|Transient Ischemic Attack|transient ischemic attack
157041|NCT02330484|Community management， incentives, Medication Adherence|community management， incentives, medication adherence
157042|NCT02330471|conization|conization
157043|NCT02330471|LLETZ|lletz
157044|NCT02330471|cervical dysplasia|cervical dysplasia
157045|NCT02330471|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
157046|NCT02330458|Inflammatory Bowel Disease|inflammatory bowel disease
157047|NCT02330458|Crohn's disease|crohn's disease
157048|NCT02330458|Pediatric IBD|pediatric ibd
157049|NCT02330458|small bowel ultrasound|small bowel ultrasound
157050|NCT02330458|infliximab|infliximab
157051|NCT02330419|Naltrexone|naltrexone
157052|NCT02330406|Dipeptidyl-Peptidase 4 Inhibitors|dipeptidyl-peptidase 4 inhibitors
157053|NCT02330406|LDL Cholesterol|ldl cholesterol
157054|NCT02330406|Glycosylated Hemoglobin|glycosylated hemoglobin
157055|NCT02330406|Diabetes Mellitus|diabetes mellitus
157056|NCT02330406|Coronary Disease|coronary disease
157057|NCT02330380|psoriasis, comparative effects, inflammation|psoriasis, comparative effects, inflammation
157058|NCT02330354|preschool|preschool
157059|NCT02330354|behavior change|behavior change
157060|NCT02330354|social marketing|social marketing
157061|NCT02330354|child care providers|child care providers
157062|NCT02330354|nutrition|nutrition
157063|NCT02330354|child care centers|child care centers
157064|NCT02330354|physical activity|physical activity
157065|NCT02330341|Glucose Intolerance|glucose intolerance
157066|NCT02330341|Artemisia dracunculus|artemisia dracunculus
157067|NCT02330341|Insulin|insulin
157068|NCT02330328|Chest Pain|chest pain
157069|NCT02330328|Telemetry|telemetry
157070|NCT02330315|transcranial direct current stimulation|transcranial direct current stimulation
157071|NCT02330315|transcranial ultrasound|transcranial ultrasound
157072|NCT02330315|non-invasive brain stimulation|non-invasive brain stimulation
157073|NCT02330250|Systemic Lupus Erythematosus|systemic lupus erythematosus
157074|NCT02330250|Pharmaceutical care|pharmaceutical care
157075|NCT02330250|Pharmaceutical services|pharmaceutical services
157076|NCT02330250|Medication adherence|medication adherence
157077|NCT02330224|Blood pressure|blood pressure
157078|NCT02330224|Lipids|lipids
157079|NCT02330224|Cardiovascular|cardiovascular
157080|NCT02330224|Health services|health services
157081|NCT02330224|Hypertension|hypertension
157082|NCT02330211|Colitis|colitis
157083|NCT02330211|Fecal Microbiota Transplant|fecal microbiota transplant
157084|NCT02330211|Crohn's Disease|crohn's disease
157085|NCT02330211|inflammatory bowel disease|inflammatory bowel disease
157086|NCT02330198|self-reported outcome instrument|self-reported outcome instrument
157087|NCT02330185|spinal anesthesia|spinal anesthesia
157088|NCT02330185|ultrasonography|ultrasonography
157089|NCT02330185|anatomical landmark|anatomical landmark
157090|NCT02330159|Pilonidal|pilonidal
157091|NCT02330159|Quality of Life|quality of life
157092|NCT02330133|mid-life women|mid-life women
157093|NCT02330133|unintended pregnancy|unintended pregnancy
157094|NCT02330133|STI/HIV prevention|sti/hiv prevention
157095|NCT02330133|intervention|intervention
157096|NCT02330133|interactive|interactive
157097|NCT02330133|CD-ROM|cd-rom
157098|NCT02330133|multimedia|multimedia
157099|NCT02330133|video|video
157100|NCT02330120|peak airway pressure|peak airway pressure
157101|NCT02330120|airway resistance|airway resistance
157102|NCT02330120|sedation|sedation
157103|NCT02330120|intensive care|intensive care
157104|NCT02330094|aSAH|asah
157106|NCT02330081|pathogen reduction technology|pathogen reduction technology
157107|NCT02330081|whole blood|whole blood
157108|NCT02330081|Platelets|platelets
157109|NCT02330081|Mirasol|mirasol
157110|NCT02330042|Diabetes|diabetes
157111|NCT02330042|OCT|oct
157112|NCT02330042|Angiography|angiography
157113|NCT02330042|Diabetic retinopathy|diabetic retinopathy
157114|NCT02330029|Irritable bowel syndrome,|irritable bowel syndrome,
157115|NCT02330029|Pinaverium|pinaverium
157116|NCT02330029|Herbal medication for IBS,|herbal medication for ibs,
157117|NCT02330029|Tong Xie Yao Fang (Formula for pain and diarrhea)|tong xie yao fang (formula for pain and diarrhea)
157118|NCT02330003|Influenza|influenza
157119|NCT02330003|Influenza vaccine|influenza vaccine
157120|NCT02330003|Split influenza vaccine|split influenza vaccine
157121|NCT02330003|Seasonal influenza vaccine|seasonal influenza vaccine
157122|NCT02329990|phosphorus intake|phosphorus intake
157123|NCT02329977|duodenal-biliary reflux|duodenal-biliary reflux
157124|NCT02329964|Rocuronium|rocuronium
157125|NCT02329964|Sugammadex|sugammadex
157126|NCT02329964|Succinylcholine|succinylcholine
157127|NCT02329964|Cisatracurium|cisatracurium
157128|NCT02329964|Neostigmine|neostigmine
157129|NCT02329964|acceleromyography (TOF-Watch®)|acceleromyography (tof-watch®)
157130|NCT02329912|postoperative ileus|postoperative ileus
157132|NCT02329912|gastrointestinal transit|gastrointestinal transit
157133|NCT02329912|prokinetic drugs|prokinetic drugs
157134|NCT02329886|chronic diseases|chronic diseases
157135|NCT02329886|risk factors|risk factors
157136|NCT02329886|health outcomes|health outcomes
157137|NCT02329873|Acute exacerbation of chronic obstructive pulmonary disease|acute exacerbation of chronic obstructive pulmonary disease
157138|NCT02329873|Older adults|older adults
157139|NCT02329873|Respiratory rehabilitation exercise|respiratory rehabilitation exercise
157140|NCT02329847|Hematologic Neoplasms|hematologic neoplasms
157141|NCT02329847|JNJ54179060|jnj54179060
157142|NCT02329847|Ibrutinib|ibrutinib
157143|NCT02329847|Nivolumab|nivolumab
157144|NCT02329821|lactate|lactate
157145|NCT02329821|hartmann solution|hartmann solution
157146|NCT02329821|hepatocellular carcinoma|hepatocellular carcinoma
157147|NCT02329808|TDM|tdm
157148|NCT02329808|dried blood spot|dried blood spot
157149|NCT02329808|immunosuppressive|immunosuppressive
157150|NCT02329808|antifungal|antifungal
157151|NCT02329769|Duchenne muscular dystrophy|duchenne muscular dystrophy
157152|NCT02329769|DMD|dmd
157153|NCT02329769|BioMarin|biomarin
157154|NCT02329769|PRO044|pro044
157155|NCT02329730|diagnosis of Tuberculosis (TB)|diagnosis of tuberculosis (tb)
157156|NCT02329730|ESAT6|esat6
157157|NCT02329730|CFP10|cfp10
157158|NCT02329730|Phase IIa Clinical Trial|phase iia clinical trial
157159|NCT02329704|IUI/AIH|iui/aih
157160|NCT02329704|Semen preparation|semen preparation
157161|NCT02329704|Semen processing|semen processing
157162|NCT02329704|ICSI/IVF|icsi/ivf
157163|NCT02329704|ART|art
157164|NCT02329704|Density Gradient|density gradient
157165|NCT02329704|Swimming down|swimming down
157166|NCT02329704|hyaluronan affinity testing|hyaluronan affinity testing
157167|NCT02329704|Sperm vitality testin|sperm vitality testin
157168|NCT02329691|safety climate|safety climate
157169|NCT02329691|surgery|surgery
157170|NCT02329678|Apicomarginal defects|apicomarginal defects
157171|NCT02329678|clinical study/trial|clinical study/trial
157172|NCT02329678|collagen membrane|collagen membrane
157173|NCT02329678|guided tissue regeneration|guided tissue regeneration
157174|NCT02329678|endodontic microsurgery|endodontic microsurgery
157175|NCT02329652|Neuroprosthesis|neuroprosthesis
157176|NCT02329652|Functional Electrical Stimulation|functional electrical stimulation
157177|NCT02329639|bevacizumab|bevacizumab
157178|NCT02329639|paclitaxel|paclitaxel
157179|NCT02329639|pharmacogenetics|pharmacogenetics
157180|NCT02329639|breast cancer|breast cancer
157181|NCT02329561|Pharmacokinetics|pharmacokinetics
157182|NCT02329561|Opioid|opioid
157183|NCT02329561|Geriatric|geriatric
157184|NCT02329561|Pharmacodynamics|pharmacodynamics
157185|NCT02329548|Alizarin|alizarin
190359|NCT02160444|CBT|cbt
148091|NCT02382744|Nerve Stimulation|nerve stimulation
148095|NCT02382718|immunotherapy|immunotherapy
148096|NCT02382718|mCyp c 1|mcyp c 1
157186|NCT02329548|Orthostatic|orthostatic
157187|NCT02329548|POTS|pots
157188|NCT02329548|Tilt table testing|tilt table testing
157189|NCT02329548|Syncope|syncope
157190|NCT02329548|Anxiety|anxiety
157191|NCT02329522|Haemodynamics|haemodynamics
157192|NCT02329522|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
157193|NCT02329522|Ultrasonic Cardiac Output Monitor|ultrasonic cardiac output monitor
157194|NCT02329522|severity|severity
157195|NCT02329509|operative procedures|operative procedures
157196|NCT02329483|Infertility|infertility
157197|NCT02329483|Ovulation induction|ovulation induction
157198|NCT02329483|Low-dose step-up protocol|low-dose step-up protocol
157199|NCT02329483|Ovarian high responder|ovarian high responder
157200|NCT02329483|Androgens|androgens
157201|NCT02329483|Androstenedione|androstenedione
157202|NCT02329483|Testosterone|testosterone
157203|NCT02329483|rhFSH|rhfsh
157204|NCT02329457|double-blind, randomized, intradermal, VZVv, HSCT|double-blind, randomized, intradermal, vzvv, hsct
157205|NCT02329431|child mental health, mental health services, Latino families|child mental health, mental health services, latino families
157206|NCT02329340|child safety|child safety
157207|NCT02329340|injury|injury
157208|NCT02329340|prevention|prevention
157209|NCT02329340|computer|computer
157210|NCT02329340|internet|internet
157211|NCT02329327|Factor Xa Inhibitors|factor xa inhibitors
157212|NCT02329327|Major|major
157213|NCT02329327|Bleeding|bleeding
157214|NCT02329327|Anticoagulant|anticoagulant
157215|NCT02329301|malaria|malaria
157216|NCT02329301|malaria, falciparum|malaria, falciparum
157217|NCT02329301|antimalarials|antimalarials
157218|NCT02329262|exercise|exercise
157219|NCT02329262|mentors|mentors
157220|NCT02329262|health education|health education
157221|NCT02329262|obesity|obesity
157222|NCT02329249|smoking cessation|smoking cessation
157223|NCT02329249|coach-supported|coach-supported
157224|NCT02329249|tobacco use cessation|tobacco use cessation
157225|NCT02329249|online|online
157226|NCT02329249|internet-based|internet-based
157227|NCT02329249|tailored|tailored
157228|NCT02329223|Chronic spontaneous uriticaria|chronic spontaneous uriticaria
157229|NCT02329223|Omalizumab|omalizumab
157230|NCT02329197|Infertility|infertility
157231|NCT02329197|Invitro fertilization|invitro fertilization
157232|NCT02329145|renal denervation|renal denervation
157233|NCT02329132|diabetic macular edema|diabetic macular edema
157234|NCT02329132|VEGF|vegf
157235|NCT02329132|ranibizumab|ranibizumab
157236|NCT02329132|oxygen consumption|oxygen consumption
157237|NCT02329054|Ebola Virus Disease|ebola virus disease
157238|NCT02329054|Antivirals|antivirals
157239|NCT02329054|Mortality|mortality
157240|NCT02329054|Viral load|viral load
157241|NCT02329054|Proof-of-concept|proof-of-concept
157242|NCT02329054|Phase II trial|phase ii trial
157243|NCT02329054|Guinea|guinea
157244|NCT02329054|Adults|adults
157245|NCT02329054|Children|children
157246|NCT02329041|videolaryngoscope|videolaryngoscope
157247|NCT02329041|double-lumen tube|double-lumen tube
157248|NCT02329041|intubation|intubation
157249|NCT02329028|Emergency Care, Prehospital|emergency care, prehospital
157250|NCT02329028|Electroencephalography|electroencephalography
157251|NCT02329028|Coma|coma
157252|NCT02329015|stress|stress
157253|NCT02329015|alternative|alternative
157254|NCT02329015|complementary|complementary
157255|NCT02329015|self-regulation|self-regulation
157256|NCT02329002|Retinoblastoma|retinoblastoma
157257|NCT02329002|Second primary tumor|second primary tumor
157258|NCT02329002|Screening|screening
157259|NCT02329002|Magnetic resonance imaging|magnetic resonance imaging
157260|NCT02328989|prematurity|prematurity
157261|NCT02328989|short cervix|short cervix
157262|NCT02328989|twin pregnancy|twin pregnancy
157263|NCT02328989|pessary|pessary
157264|NCT02328963|Cytomegalovirus infection and disease|cytomegalovirus infection and disease
157265|NCT02328963|CMV-seropositive recipients|cmv-seropositive recipients
157266|NCT02328963|Everolimus|everolimus
157267|NCT02328963|preemptive strategy|preemptive strategy
660434|NCT00811512|fold|fold
157268|NCT02328963|mTOR inhibitor|mtor inhibitor
157269|NCT02328898|Polymer free stent|polymer free stent
157270|NCT02328898|percutaneous coronary intervention|percutaneous coronary intervention
157271|NCT02328885|high-risk acute leukemia|high-risk acute leukemia
157272|NCT02328885|graft versus leukemia|graft versus leukemia
157274|NCT02328885|UCBT|ucbt
157275|NCT02328872|screening|screening
157276|NCT02328872|cervical screening|cervical screening
157277|NCT02328872|Human Papillomavirus (HPV)|human papillomavirus (hpv)
157278|NCT02328872|cancer prevention|cancer prevention
157279|NCT02328859|Gait|gait
157280|NCT02328859|Rehabilitation|rehabilitation
157281|NCT02328859|Virtual Reality|virtual reality
157282|NCT02328833|Depression|depression
157283|NCT02328833|Clinical Practice Guideline|clinical practice guideline
157284|NCT02328833|Implementation|implementation
157285|NCT02328833|Primary Care|primary care
157286|NCT02328833|Computerized Guideline|computerized guideline
157287|NCT02328820|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
157288|NCT02328820|Coronary Flow Reserve|coronary flow reserve
157289|NCT02328807|adenocarcinoma|adenocarcinoma
157290|NCT02328807|prostate|prostate
157291|NCT02328807|ENCAGE™|encage™
157292|NCT02328807|focal bipolar radiofrequency ablation|focal bipolar radiofrequency ablation
157293|NCT02328807|radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
157294|NCT02328807|radiotherapy|radiotherapy
157295|NCT02328794|smoking cessation|smoking cessation
157296|NCT02328794|behavioral economics|behavioral economics
157297|NCT02328794|e-cigarettes|e-cigarettes
157299|NCT02328781|vertebral artery stenosis|vertebral artery stenosis
157300|NCT02328781|drug-eluting stent|drug-eluting stent
157301|NCT02328703|Reiki|reiki
157302|NCT02328703|Neuropathic Pain|neuropathic pain
157303|NCT02328703|Military Service Members|military service members
157304|NCT02328703|Extermity Trauma|extermity trauma
157305|NCT02328690|binaural beat technology|binaural beat technology
157306|NCT02328690|sound technology|sound technology
157307|NCT02328690|cardiovascular stress response|cardiovascular stress response
157308|NCT02328690|military|military
157309|NCT02328690|music|music
157310|NCT02328690|anxiety|anxiety
157311|NCT02328690|stress|stress
157312|NCT02328677|Colorectal cancer|colorectal cancer
157313|NCT02328677|rectosigmoid|rectosigmoid
157314|NCT02328677|rectum|rectum
157315|NCT02328677|colon|colon
157316|NCT02328664|Endoscopic resection|endoscopic resection
157317|NCT02328664|Pathology|pathology
157318|NCT02328664|Rescue surgery|rescue surgery
157319|NCT02328651|Mild and Moderate Severe Patients With hand_foot-mouth Disease|mild and moderate severe patients with hand_foot-mouth disease
157320|NCT02328638|ASD|asd
157321|NCT02328625|Scleroderma|scleroderma
157322|NCT02328625|Device|device
157323|NCT02328625|ADRCs|adrcs
157324|NCT02328625|adipose derived regenerative cells|adipose derived regenerative cells
157325|NCT02328625|hand|hand
157326|NCT02328547|fecal microbiota transplantation|fecal microbiota transplantation
157327|NCT02328547|diarrhea-predominant|diarrhea-predominant
157328|NCT02328534|ICSI/IVF|icsi/ivf
157329|NCT02328534|Semen processing|semen processing
157330|NCT02328534|Semen preparation|semen preparation
157331|NCT02328534|Swim down|swim down
157332|NCT02328534|Density gradient|density gradient
157333|NCT02328534|Silica solution|silica solution
157334|NCT02328521|Neointima|neointima
157335|NCT02328521|Tomography, Optical Coherence|tomography, optical coherence
157336|NCT02328521|drug-eluting stents|drug-eluting stents
157337|NCT02328521|Nicorandil|nicorandil
157338|NCT02328508|hyperbaric oxygen therapy|hyperbaric oxygen therapy
157339|NCT02328508|diabetic foot ulcer|diabetic foot ulcer
157340|NCT02328508|wound healing|wound healing
157341|NCT02328508|inflammation|inflammation
157342|NCT02328508|glycemic control|glycemic control
157343|NCT02328508|amputation|amputation
157344|NCT02328508|bacterial infection|bacterial infection
157345|NCT02328508|quality of life|quality of life
157346|NCT02328495|Misoprostol, Office hysteroscopy ,Pain|misoprostol, office hysteroscopy ,pain
157347|NCT02328469|aseptic meningitis|aseptic meningitis
157348|NCT02328469|tick-borne encephalitis|tick-borne encephalitis
157349|NCT02328469|Lyme neuroborreliosis|lyme neuroborreliosis
157350|NCT02328469|inflammation|inflammation
157351|NCT02328469|outcome|outcome
157352|NCT02328443|CYP3A|cyp3a
157353|NCT02328443|Metabolomics|metabolomics
157354|NCT02328404|Vitamin D|vitamin d
157355|NCT02328404|deficiency|deficiency
157356|NCT02328404|hypovitaminosis D|hypovitaminosis d
157357|NCT02328404|Biodal|biodal
157358|NCT02328404|25 hydroxy Vitamin D|25 hydroxy vitamin d
157359|NCT02328404|25hydroxyvitamin D|25hydroxyvitamin d
157360|NCT02328404|25(OH)D|25(oh)d
157361|NCT02328404|PCOS|pcos
157362|NCT02328404|insulin resistance|insulin resistance
157363|NCT02328404|BMI|bmi
157364|NCT02328404|chromium levels|chromium levels
157365|NCT02328404|vitamin D 3|vitamin d 3
157366|NCT02328404|cholecalciferol|cholecalciferol
157367|NCT02328404|50,000 IU|50,000 iu
157368|NCT02328365|Colorectal Cancer|colorectal cancer
157369|NCT02328365|Comorbidity|comorbidity
157370|NCT02328365|Perioperative Care|perioperative care
157371|NCT02328365|Surgery|surgery
157372|NCT02328352|Buckypaper (BP) of Multi-Walled Carbon Nanotubes (MWCNTs)|buckypaper (bp) of multi-walled carbon nanotubes (mwcnts)
157373|NCT02328352|surgical hernia prosthesis|surgical hernia prosthesis
157374|NCT02328352|abdominal wall defects surgery|abdominal wall defects surgery
157375|NCT02328352|prosthesis adhesion|prosthesis adhesion
157376|NCT02328352|disaster preparation and recovery hernia|disaster preparation and recovery hernia
157377|NCT02328352|Abdominal Wall Disaster Surgery|abdominal wall disaster surgery
157378|NCT02328352|Fixation of prosthetic materials in general surgery|fixation of prosthetic materials in general surgery
157379|NCT02328326|Diabetes|diabetes
157380|NCT02328326|diabetes self-management|diabetes self-management
157381|NCT02328326|patient activation|patient activation
157382|NCT02328326|social support|social support
157383|NCT02328313|Cancer|cancer
157384|NCT02328313|Breast Cancer|breast cancer
157385|NCT02328313|Geriatric|geriatric
157386|NCT02328313|Advance Age|advance age
157387|NCT02328313|Exercise|exercise
157388|NCT02328313|Physical Activity|physical activity
157389|NCT02328313|Genetic Marker|genetic marker
157390|NCT02328313|p16|p16
157391|NCT02328313|Chemotherapy|chemotherapy
157392|NCT02328313|Breast Cancer Treatment|breast cancer treatment
157393|NCT02328287|Spinal Fusion|spinal fusion
157394|NCT02328287|Revision Surgery|revision surgery
157395|NCT02328287|Pseudarthrosis|pseudarthrosis
157396|NCT02328287|Cell Therapy|cell therapy
157397|NCT02328287|Bone Graft|bone graft
157398|NCT02328235|skeletal muscle, metabolism, physiology|skeletal muscle, metabolism, physiology
157399|NCT02328222|Early steroid withdrawal|early steroid withdrawal
157400|NCT02328222|Acute allograft rejection|acute allograft rejection
157401|NCT02328222|Mycophenolate|mycophenolate
157402|NCT02328222|Tacrolimus|tacrolimus
157403|NCT02328222|Basiliximab|basiliximab
157404|NCT02328196|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
157405|NCT02328196|Rasch analysis|rasch analysis
157406|NCT02328196|Meal time performance|meal time performance
157407|NCT02328183|polymyxin B|polymyxin b
157408|NCT02328183|carbapenem resistant bacteria|carbapenem resistant bacteria
157409|NCT02328170|immunoglobulin E, food hypersensitivities, child, allergens|immunoglobulin e, food hypersensitivities, child, allergens
157410|NCT02328144|Hemorrhoidectomy|hemorrhoidectomy
157411|NCT02328144|Postoperative pain|postoperative pain
157412|NCT02328144|Metronidazole|metronidazole
157413|NCT02328118|Lucentis|lucentis
157414|NCT02328118|Ranibizumab|ranibizumab
157415|NCT02328118|Triamcinolone Acetonide|triamcinolone acetonide
157416|NCT02328118|Vitrectomy|vitrectomy
157418|NCT02328079|Facial Palsy (acute), Acyclovir, Prednisolone|facial palsy (acute), acyclovir, prednisolone
157419|NCT02328066|NBI|nbi
157420|NCT02328066|NICE classification|nice classification
157421|NCT02328066|deep submucosal invasion|deep submucosal invasion
157422|NCT02328066|Colonic Polyps [C23.300.825.411.235]|colonic polyps [c23.300.825.411.235]
157423|NCT02328066|Colonoscopy [E01.370.372.250.250.200]|colonoscopy [e01.370.372.250.250.200]
157424|NCT02328053|fungal keratitis|fungal keratitis
157425|NCT02328053|collagen cross linking|collagen cross linking
157426|NCT02328040|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
157427|NCT02328040|Closed loop|closed loop
157428|NCT02328040|Artificial Pancreas|artificial pancreas
157429|NCT02328040|Insulin|insulin
157430|NCT02328040|Sitagliptin|sitagliptin
157432|NCT02328014|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
157433|NCT02328014|Btk|btk
157434|NCT02328014|B-Cell Malignancies|b-cell malignancies
157435|NCT02328014|Mantle Cell|mantle cell
157436|NCT02328014|Multiple Myeloma|multiple myeloma
157437|NCT02328014|CLL|cll
157438|NCT02328014|SLL|sll
157439|NCT02328014|DLBCL|dlbcl
157440|NCT02328014|Folicular|folicular
157441|NCT02328014|Waldenstrom|waldenstrom
157442|NCT02328014|B-All|b-all
157443|NCT02327988|cryotherapy|cryotherapy
157444|NCT02327988|laser therapy|laser therapy
157445|NCT02327988|eccentric exercise|eccentric exercise
157446|NCT02327988|delayed onset muscle soreness|delayed onset muscle soreness
157447|NCT02327988|muscle damage|muscle damage
157448|NCT02327988|dynamometry|dynamometry
157449|NCT02327988|electromyography|electromyography
157450|NCT02327923|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
157451|NCT02327923|lidocaine infusion|lidocaine infusion
157452|NCT02327923|Esmolol infusion|esmolol infusion
157453|NCT02327923|Postoperative opioid consumption|postoperative opioid consumption
157454|NCT02327923|Multimodal analgesia|multimodal analgesia
157455|NCT02327910|Elderly patients，|elderly patients，
157456|NCT02327910|General anesthesia，|general anesthesia，
157457|NCT02327910|Transcutaneous partial pressure of carbon dioxide(TcPCO2)，|transcutaneous partial pressure of carbon dioxide(tcpco2)，
157458|NCT02327910|Train-of-four(TOF)，|train-of-four(tof)，
157459|NCT02327910|Extubation|extubation
157460|NCT02327910|，Respiratory events|，respiratory events
157461|NCT02327897|Atopic Asthma|atopic asthma
157462|NCT02327897|Exposures|exposures
157463|NCT02327897|Disease Progression|disease progression
157464|NCT02327884|Genetics|genetics
157465|NCT02327884|Dry Mouth|dry mouth
157466|NCT02327884|Sjogren's Syndrome|sjogren's syndrome
157467|NCT02327884|Gland Dysfuntion|gland dysfuntion
157468|NCT02327884|Induced Pluripotent Stem Cell (iPS) Cell Lines|induced pluripotent stem cell (ips) cell lines
157469|NCT02327871|Therapeutic hypothermia|therapeutic hypothermia
157470|NCT02327871|patients|patients
157471|NCT02327871|Safety, Efficacy|safety, efficacy
157472|NCT02327845|natural history, biomarkers, phenotype, genotype|natural history, biomarkers, phenotype, genotype
157473|NCT02327832|Confirmation|confirmation
157474|NCT02327832|safety|safety
157475|NCT02327793|Perfusion|perfusion
157476|NCT02327793|Blood pressure|blood pressure
157477|NCT02327767|Active Assistance|active assistance
157478|NCT02327767|Resonance|resonance
157479|NCT02327767|Stroke|stroke
157480|NCT02327767|Arm Rehabilitation|arm rehabilitation
157481|NCT02327741|Dual antiplatelet therapy|dual antiplatelet therapy
157482|NCT02327741|clopidogrel|clopidogrel
157483|NCT02327741|percutaneous coronary intervention|percutaneous coronary intervention
157484|NCT02327728|blepharospasm|blepharospasm
157485|NCT02327728|botulinum A|botulinum a
157486|NCT02327728|injection pattern|injection pattern
157487|NCT02327728|tear|tear
157488|NCT02327715|Hepatitis B virus|hepatitis b virus
157489|NCT02327715|Emtricitabine|emtricitabine
157490|NCT02327715|Pregnancy|pregnancy
157491|NCT02327715|Vertical transmission|vertical transmission
157492|NCT02327702|Hepatitis B, chronic|hepatitis b, chronic
157493|NCT02327702|Emtricitabine|emtricitabine
157494|NCT02327702|Pregnancy|pregnancy
157495|NCT02327689|Hepatitis B virus|hepatitis b virus
157496|NCT02327689|Cirrhosis|cirrhosis
157497|NCT02327689|Emtricitabine|emtricitabine
157498|NCT02327689|Adefovir dipivoxil|adefovir dipivoxil
157499|NCT02327676|Hepatitis B, chronic|hepatitis b, chronic
157500|NCT02327676|Emtricitabine|emtricitabine
157501|NCT02327676|Child|child
157502|NCT02327663|Hepatitis B, chronic|hepatitis b, chronic
157503|NCT02327663|Emtricitabine|emtricitabine
157504|NCT02327663|Adefovir dipivixil|adefovir dipivixil
157505|NCT02327663|HBeAg|hbeag
157506|NCT02327637|Preterm Premature Rupture of the Membranes|preterm premature rupture of the membranes
157507|NCT02327637|Bedrest|bedrest
157508|NCT02327637|Physical Activity|physical activity
157509|NCT02327585|Executive function training|executive function training
157510|NCT02327585|child|child
157511|NCT02327559|childbirth|childbirth
157512|NCT02327559|mindfulness|mindfulness
157513|NCT02327559|fear of labor|fear of labor
157514|NCT02327559|labor pain|labor pain
157515|NCT02327559|coping|coping
157516|NCT02327559|self-efficacy|self-efficacy
157517|NCT02327559|childbirth satisfaction|childbirth satisfaction
157518|NCT02327559|depression|depression
157519|NCT02327546|Pharmacokinetics|pharmacokinetics
157520|NCT02327546|Anemia|anemia
157521|NCT02327546|Chronic kidney disease|chronic kidney disease
157522|NCT02327546|CKD|ckd
157523|NCT02327546|Chronic renal insufficiency|chronic renal insufficiency
157524|NCT02327546|Renal impairment|renal impairment
157525|NCT02327546|Ferrous sulfate|ferrous sulfate
157526|NCT02327546|Iron|iron
157527|NCT02327546|Drug-drug interaction|drug-drug interaction
157528|NCT02327546|End stage renal disease|end stage renal disease
157529|NCT02327546|Dialysis|dialysis
157530|NCT02327546|Erythropoietin|erythropoietin
157532|NCT02327546|Hypoxia-induciable factor|hypoxia-induciable factor
157534|NCT02327546|Hypoxia-induciable factor prolyl-hydroxylase inhibitor|hypoxia-induciable factor prolyl-hydroxylase inhibitor
157535|NCT02327546|HIF-PHI|hif-phi
157536|NCT02327533|generalized aggressive periodontitis|generalized aggressive periodontitis
157537|NCT02327533|microarray analysis|microarray analysis
157538|NCT02327520|Clostridium difficile infection|clostridium difficile infection
157539|NCT02327520|burden|burden
157540|NCT02327520|nationwide study|nationwide study
157541|NCT02327520|South East Asia|south east asia
157542|NCT02327520|Thailand|thailand
157543|NCT02327520|Epidemiology|epidemiology
157544|NCT02327520|Outcome Assessment (Health Care) [N04.761.559.590]|outcome assessment (health care) [n04.761.559.590]
157545|NCT02327507|children|children
157546|NCT02327507|fluoridated toothpaste|fluoridated toothpaste
157547|NCT02327507|health education|health education
157548|NCT02327507|Medicaid|medicaid
157549|NCT02327494|Neuromuscular blockade|neuromuscular blockade
157550|NCT02327494|Laparoscopy|laparoscopy
157551|NCT02327494|Oxygen measurements|oxygen measurements
157552|NCT02327481|Stomach Neoplasms Laparoscopy|stomach neoplasms laparoscopy
157553|NCT02327442|chemokine receptor|chemokine receptor
157554|NCT02327442|galium|galium
157555|NCT02327442|dosimetry|dosimetry
157556|NCT02327442|glioma|glioma
157557|NCT02327403|Proteinuria|proteinuria
157558|NCT02327403|Kidney transplantation|kidney transplantation
157559|NCT02327403|Allograft dysfunction|allograft dysfunction
157560|NCT02327403|B7-1|b7-1
157561|NCT02327403|Belatacept|belatacept
157562|NCT02327377|Irritable bowel syndrome|irritable bowel syndrome
157563|NCT02327377|Intervention studies|intervention studies
157564|NCT02327377|Visceral pain|visceral pain
157565|NCT02327377|Chronic pain|chronic pain
157566|NCT02327377|Abdominal pain|abdominal pain
157567|NCT02327377|Dyspepsia|dyspepsia
157568|NCT02327377|Nausea|nausea
157569|NCT02327377|Nociception|nociception
157570|NCT02327377|Parents|parents
157571|NCT02327377|Coping behavior|coping behavior
157572|NCT02327377|Anxiety|anxiety
157573|NCT02327377|Depression|depression
157574|NCT02327377|Catastrophization|catastrophization
157575|NCT02327377|Reinforcement (psychology)|reinforcement (psychology)
157576|NCT02327377|Self efficacy|self efficacy
157577|NCT02327377|Health services overutilization|health services overutilization
157578|NCT02327377|Questionnaires|questionnaires
157579|NCT02327377|Self report|self report
157580|NCT02327377|Health surveys|health surveys
157581|NCT02327377|Prospective studies|prospective studies
157582|NCT02327377|Adolescent health|adolescent health
157583|NCT02327377|Mental health services|mental health services
157584|NCT02327377|Health services accessibility|health services accessibility
157585|NCT02327377|Health diaries|health diaries
157586|NCT02327377|National Institute of Child Health & Human Development (US.)|national institute of child health & human development (us.)
157587|NCT02327377|Telemedicine|telemedicine
157588|NCT02327377|E-Health|e-health
157589|NCT02327377|Web-based intervention|web-based intervention
157590|NCT02327377|Parenting education|parenting education
157591|NCT02327325|Low Back Pain|low back pain
157592|NCT02327325|Exercise|exercise
157593|NCT02327325|Cognitive Behavioral Therapy|cognitive behavioral therapy
157595|NCT02327299|Iron deficiency|iron deficiency
157596|NCT02327299|Iron fortification|iron fortification
157597|NCT02327286|Diabetes Mellitus|diabetes mellitus
157598|NCT02327286|Gestational diabetes|gestational diabetes
157599|NCT02327273|subjects|subjects
157600|NCT02327221|Crohn Disease|crohn disease
157601|NCT02327221|Cell therapy|cell therapy
157602|NCT02327221|Regulatory T lymphocytes|regulatory t lymphocytes
157603|NCT02327221|Treg|treg
157604|NCT02327221|Autologous|autologous
157605|NCT02327221|Antigen specific T regulatory lymphocytes|antigen specific t regulatory lymphocytes
157606|NCT02327208|Military Training|military training
157607|NCT02327208|Whey Protein|whey protein
157608|NCT02327208|Body Composition|body composition
157609|NCT02327182|MT-4666|mt-4666
157610|NCT02327182|α7 nicotinic acetylcholine receptor agonist|α7 nicotinic acetylcholine receptor agonist
157611|NCT02327182|Alzheimer's Disease|alzheimer's disease
157612|NCT02327182|Cognitive function|cognitive function
157613|NCT02327182|Dementia|dementia
157614|NCT02327182|Central Nervous System Agents|central nervous system agents
157615|NCT02327169|Drug therapy|drug therapy
157616|NCT02327156|Dexmedetomidine|dexmedetomidine
157617|NCT02327104|mindfulness|mindfulness
157618|NCT02327104|tobacco dependence|tobacco dependence
157619|NCT02327104|relapse prevention|relapse prevention
157620|NCT02327091|Alfacalcidol|alfacalcidol
157621|NCT02327091|Falls|falls
157622|NCT02327091|Handgrip|handgrip
157623|NCT02327091|Muscle strength|muscle strength
157624|NCT02327091|Sarcopenia|sarcopenia
157625|NCT02327065|EUS|eus
157626|NCT02327065|FNA|fna
157627|NCT02327065|FNB|fnb
157628|NCT02327052|Chagas disease|chagas disease
157629|NCT02327052|longitudinal global strain|longitudinal global strain
157630|NCT02327052|speckle tracking|speckle tracking
157635|NCT02326961|knee|knee
157636|NCT02326961|adipose derived regenerative cells|adipose derived regenerative cells
157637|NCT02326961|ADRC|adrc
157638|NCT02326961|Celution|celution
157639|NCT02326961|arthritis|arthritis
157640|NCT02326948|Gallbladder cancer|gallbladder cancer
157641|NCT02326948|Case-control study|case-control study
157642|NCT02326948|Risk factor|risk factor
157643|NCT02326948|Alcohol consumption|alcohol consumption
157644|NCT02326948|Polypoid lesions of gallbladder|polypoid lesions of gallbladder
157645|NCT02326948|Biliary stone|biliary stone
157647|NCT02326935|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
157648|NCT02326935|Multiple Sclerosis, Chronic Progressive|multiple sclerosis, chronic progressive
157649|NCT02326935|Myelitis|myelitis
157650|NCT02326922|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
157651|NCT02326922|Metraplant-E|metraplant-e
157652|NCT02326922|Levonorgestrel-releasing intrauterine device|levonorgestrel-releasing intrauterine device
157653|NCT02326922|Endometrial decidualization|endometrial decidualization
157654|NCT02326909|Upper Urinary Tract|upper urinary tract
157655|NCT02326909|Optical Coherence Tomography|optical coherence tomography
157656|NCT02326909|Transitional Cell Carcinoma|transitional cell carcinoma
157657|NCT02326909|Urothelial Cell Carcinoma|urothelial cell carcinoma
157658|NCT02326909|Diagnostic accuracy|diagnostic accuracy
157659|NCT02326896|intubation|intubation
157660|NCT02326896|intensive care unit|intensive care unit
157661|NCT02326896|MACOCHA Score|macocha score
157662|NCT02326870|laparoscopic Cholecystectomy|laparoscopic cholecystectomy
157663|NCT02326870|laparoscope holder|laparoscope holder
157664|NCT02326870|gynecological laparoscopy procedures|gynecological laparoscopy procedures
157665|NCT02326870|fundoplication surgery|fundoplication surgery
157666|NCT02326870|laparoscopic adnexal surgery|laparoscopic adnexal surgery
157667|NCT02326870|excision of endometriosis lesion|excision of endometriosis lesion
157668|NCT02326870|diagnostic laparoscopy procedures|diagnostic laparoscopy procedures
157669|NCT02326870|right hemicolectomy|right hemicolectomy
157670|NCT02326870|Diaphragmatic hernia|diaphragmatic hernia
157671|NCT02326857|Distribution of Molecular Profiles in Latin American Women|distribution of molecular profiles in latin american women
157672|NCT02326857|AJCC 7 Clinical Stage II to III|ajcc 7 clinical stage ii to iii
157673|NCT02326857|Breast Cancer Observational Study|breast cancer observational study
157674|NCT02326857|Prospective Cohort|prospective cohort
157675|NCT02326857|Epidemiological, Histological, and Clinical Data|epidemiological, histological, and clinical data
157676|NCT02326844|Germline BRCA1/2 Mutations (gBRCAm)|germline brca1/2 mutations (gbrcam)
157677|NCT02326844|DNA Damaging Agents|dna damaging agents
157678|NCT02326844|FOX03a, 53BP1 and RAD51|fox03a, 53bp1 and rad51
157679|NCT02326818|Dystonia|dystonia
157680|NCT02326818|Botulinum Toxin|botulinum toxin
157681|NCT02326818|Musician's Dystonia|musician's dystonia
157682|NCT02326818|Spasticity|spasticity
157683|NCT02326792|Exercise|exercise
157684|NCT02326792|Training|training
157685|NCT02326792|Low back Pain|low back pain
157686|NCT02326792|Physical Therapy|physical therapy
157687|NCT02326779|esophageal cancer|esophageal cancer
157688|NCT02326779|aspirin|aspirin
157689|NCT02326779|survival|survival
157690|NCT02326740|Pyoderma Gangrenosum|pyoderma gangrenosum
157691|NCT02326740|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
157692|NCT02326727|Epidural Analgesia|epidural analgesia
157693|NCT02326727|Natural Killer Cells|natural killer cells
157694|NCT02326675|Etoposide|etoposide
157695|NCT02326675|Cryotherapy|cryotherapy
157696|NCT02326662|spinal cord injury|spinal cord injury
157697|NCT02326662|neural stem cells|neural stem cells
157698|NCT02326662|paraplegia|paraplegia
157699|NCT02326662|transplantation|transplantation
157700|NCT02326649|cardiac output|cardiac output
157701|NCT02326610|Small for gestational age (SGA)|small for gestational age (sga)
157702|NCT02326610|Human growth hormone (hGH)|human growth hormone (hgh)
157703|NCT02326597|Hydroxyurea|hydroxyurea
157704|NCT02326597|Bone marrow transplant|bone marrow transplant
157705|NCT02326597|Chronic blood transfusion|chronic blood transfusion
157706|NCT02326597|Treatment options for sickle cell disease|treatment options for sickle cell disease
157707|NCT02326597|Decision making|decision making
157708|NCT02326584|Acute Myeloid Leukemia|acute myeloid leukemia
157709|NCT02326584|Antibody-Drug Conjugate|antibody-drug conjugate
157710|NCT02326584|CD33 Antigen|cd33 antigen
157711|NCT02326584|Drug Therapy|drug therapy
157712|NCT02326584|Acute Myelogenous Leukemia|acute myelogenous leukemia
157713|NCT02326571|EEG|eeg
157714|NCT02326571|Cortical Spreading Depression|cortical spreading depression
157715|NCT02326571|Cerebral Hemorrhage|cerebral hemorrhage
157716|NCT02326571|miRNA|mirna
157717|NCT02326571|Reactivity in EEG|reactivity in eeg
157718|NCT02326571|Multimodal monitoring|multimodal monitoring
157719|NCT02326558|zero ischemia|zero ischemia
157720|NCT02326558|microwave|microwave
157721|NCT02326558|ablation|ablation
157722|NCT02326558|enucleation|enucleation
157723|NCT02326558|renal cell carcinoma|renal cell carcinoma
157724|NCT02326545|Video Games|video games
157725|NCT02326545|Child|child
157726|NCT02326545|Adolescent|adolescent
157727|NCT02326532|Rheumatoid Arthritis|rheumatoid arthritis
157728|NCT02326532|Veterans|veterans
157729|NCT02326506|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
157730|NCT02326506|Cardiopulmonary Bypass|cardiopulmonary bypass
157731|NCT02326493|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
157732|NCT02326493|LV lead position|lv lead position
157733|NCT02326493|Device programming|device programming
157734|NCT02326493|Optimization|optimization
157735|NCT02326493|Vectorcardiography|vectorcardiography
157736|NCT02326480|Childhood Obesity|childhood obesity
157737|NCT02326480|Genetics|genetics
157738|NCT02326467|chlorhexidine|chlorhexidine
157739|NCT02326467|safety|safety
157740|NCT02326467|bath|bath
157741|NCT02326467|rash|rash
157742|NCT02326467|infant|infant
157743|NCT02326441|advanced malignancies|advanced malignancies
157744|NCT02326441|refractory therapies|refractory therapies
157745|NCT02326441|phase 1|phase 1
157746|NCT02326428|Stroke|stroke
157747|NCT02326428|Cerebrovascular Accident|cerebrovascular accident
157748|NCT02326428|Brain ischemia|brain ischemia
157749|NCT02326428|Intravenous thrombolysis|intravenous thrombolysis
157750|NCT02326428|Stroke thrombectomy|stroke thrombectomy
157751|NCT02326428|Stent-retriever|stent-retriever
157752|NCT02326415|Acute Appendicitis|acute appendicitis
157753|NCT02326415|Appendectomy|appendectomy
157754|NCT02326415|Fast-Track|fast-track
157755|NCT02326415|Clinical Pathway|clinical pathway
157756|NCT02326402|Circulatory support|circulatory support
157757|NCT02326402|Extracorporeal circulatory support|extracorporeal circulatory support
157758|NCT02326402|Extracorporeal bypass|extracorporeal bypass
157759|NCT02326389|Cognitive functioning|cognitive functioning
157760|NCT02326363|substance abuse|substance abuse
157761|NCT02326363|Mental Health Disorders|mental health disorders
157859|NCT02325713|Bio-availability|bio-availability
157762|NCT02326350|Acute Respiratory Distress syndrome|acute respiratory distress syndrome
157763|NCT02326350|Aspirin|aspirin
157764|NCT02326298|Certolizumab Pegol|certolizumab pegol
157765|NCT02326298|Cimzia|cimzia
157766|NCT02326298|Psoriasis|psoriasis
157767|NCT02326285|induction therapy|induction therapy
157768|NCT02326285|NSCLC|nsclc
157769|NCT02326285|Non-small Cell Lung Cancer|non-small cell lung cancer
157770|NCT02326285|curative surgery|curative surgery
157771|NCT02326272|Certolizumab Pegol|certolizumab pegol
157772|NCT02326272|Cimzia|cimzia
157773|NCT02326272|Psoriasis|psoriasis
157774|NCT02326259|Diabetic Retinopathy|diabetic retinopathy
157775|NCT02326259|Disease Progression|disease progression
157776|NCT02326246|MRI|mri
157777|NCT02326246|active surveillance|active surveillance
157778|NCT02326207|Infant, Newborn|infant, newborn
157779|NCT02326207|Neonatal intensive care unit|neonatal intensive care unit
157780|NCT02326207|Ventilator circuit|ventilator circuit
157781|NCT02326194|Safety,immunogenicity,Ebola|safety,immunogenicity,ebola
157782|NCT02326181|respiratory muscle training|respiratory muscle training
158175|NCT02324166|cefazolin|cefazolin
157783|NCT02326181|respiratory muscle strength|respiratory muscle strength
157784|NCT02326181|respiratory endurance test|respiratory endurance test
157785|NCT02326181|6-minute walking test|6-minute walking test
157786|NCT02326142|Premature Obstetric Labor|premature obstetric labor
157787|NCT02326142|Premature Birth|premature birth
157788|NCT02326103|alcoholic|alcoholic
157789|NCT02326103|hepatitis|hepatitis
157790|NCT02326103|cirrhosis|cirrhosis
157791|NCT02326103|cholesterol metabolites|cholesterol metabolites
157792|NCT02326103|ciprofloxacin|ciprofloxacin
157793|NCT02326077|sonopartogram|sonopartogram
157794|NCT02326077|transperineal ultrasound|transperineal ultrasound
157795|NCT02326077|intrapartum ultrasound|intrapartum ultrasound
157796|NCT02326077|labor|labor
157797|NCT02326077|delivery|delivery
157798|NCT02326077|partogram|partogram
157799|NCT02326077|ultrasound|ultrasound
157800|NCT02326051|Antiphospholipid syndrome|antiphospholipid syndrome
157801|NCT02326051|APS|aps
157802|NCT02326051|LMWH|lmwh
157803|NCT02326038|Memory|memory
157804|NCT02326038|Attention|attention
157805|NCT02326038|MCI|mci
157806|NCT02326038|Ritalin|ritalin
157807|NCT02325999|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
157808|NCT02325999|Laparoscopic Regional Lymph node Dissection|laparoscopic regional lymph node dissection
157809|NCT02325999|early gastric cancer|early gastric cancer
157810|NCT02325999|Disease-free survival|disease-free survival
157811|NCT02325986|radiotherapy|radiotherapy
157812|NCT02325986|esophageal carcinoma|esophageal carcinoma
157813|NCT02325986|chemotherapy|chemotherapy
157814|NCT02325973|STEMI|stemi
157815|NCT02325973|IMR|imr
157816|NCT02325973|FFR|ffr
157817|NCT02325973|microcirculatory|microcirculatory
157819|NCT02325960|insulin glargine|insulin glargine
157820|NCT02325947|Post stroke hand paresis brain injury|post stroke hand paresis brain injury
157821|NCT02325934|Stribild|stribild
157822|NCT02325934|pharmacokinetics|pharmacokinetics
157823|NCT02325934|Crushing|crushing
157824|NCT02325934|Drip feed|drip feed
157825|NCT02325921|Magnetic Resonance Imaging|magnetic resonance imaging
157826|NCT02325921|Diffusion Weighted MRI|diffusion weighted mri
157827|NCT02325921|Diffusion Tensor Imaging|diffusion tensor imaging
157828|NCT02325908|Hemodialysis|hemodialysis
157829|NCT02325908|Estimated Dry Weight|estimated dry weight
157830|NCT02325895|Osteoporosis|osteoporosis
157831|NCT02325895|Dried plum|dried plum
157832|NCT02325895|functional food|functional food
157833|NCT02325869|Acute Coronary Syndrome, Coronary Occlusion, catheter|acute coronary syndrome, coronary occlusion, catheter
157834|NCT02325856|Hemodialysis|hemodialysis
157835|NCT02325856|Body Composition Monitor|body composition monitor
157836|NCT02325830|Functional mitral regurgitation|functional mitral regurgitation
157837|NCT02325830|Secondary mitral regurgitation|secondary mitral regurgitation
157838|NCT02325830|Percutaneous mitral repair|percutaneous mitral repair
157839|NCT02325817|Bifurcation Lesions|bifurcation lesions
157840|NCT02325817|drug eluting balloon|drug eluting balloon
157841|NCT02325817|paclitaxel|paclitaxel
157842|NCT02325817|drug coated balloon|drug coated balloon
157843|NCT02325804|overweight and obesity|overweight and obesity
157844|NCT02325804|adipose tissue|adipose tissue
157845|NCT02325804|weight loss program|weight loss program
157846|NCT02325804|low-calorie diet|low-calorie diet
660435|NCT00811512|fovea|fovea
157847|NCT02325804|circuit-based exercise|circuit-based exercise
157848|NCT02325804|metabolic cardiovascular syndrome|metabolic cardiovascular syndrome
157849|NCT02325765|congential cardiac surgery|congential cardiac surgery
157850|NCT02325765|nuclearsome|nuclearsome
157851|NCT02325765|systemic inflammation response syndrome|systemic inflammation response syndrome
157852|NCT02325752|readmission|readmission
157853|NCT02325752|chronic diseases|chronic diseases
157854|NCT02325739|FGF401, PDR001, PD-1, FGFR4, FGF19, HCC|fgf401, pdr001, pd-1, fgfr4, fgf19, hcc
157855|NCT02325726|Cardiac surgery|cardiac surgery
157856|NCT02325726|Extracorporeal circulation|extracorporeal circulation
157857|NCT02325726|Renal failure|renal failure
157858|NCT02325713|ODT-PZQ|odt-pzq
157860|NCT02325713|Praziquantel|praziquantel
157861|NCT02325713|Cysticide|cysticide
157862|NCT02325713|Pharmacokinetics|pharmacokinetics
157863|NCT02325687|Obstructive Sleep Apnea|obstructive sleep apnea
157864|NCT02325687|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
157865|NCT02325687|Cerebrospinal Fluid|cerebrospinal fluid
157866|NCT02325687|Inflammation|inflammation
157867|NCT02325687|TNF-alpha|tnf-alpha
157868|NCT02325687|Interleukin-6 (IL-6)|interleukin-6 (il-6)
157869|NCT02325687|Interleukin-8 (IL-8)|interleukin-8 (il-8)
157870|NCT02325687|Interleukin-10 (IL-10)|interleukin-10 (il-10)
157871|NCT02325687|Cytokines|cytokines
157872|NCT02325687|Neurotrophins|neurotrophins
157873|NCT02325687|BDNF|bdnf
157874|NCT02325687|Beta-NGF|beta-ngf
157875|NCT02325687|Proteomic Analysis|proteomic analysis
157876|NCT02325674|Lipodystrophy|lipodystrophy
157877|NCT02325674|Metreleptin Registry|metreleptin registry
157878|NCT02325635|Adenoma Detection|adenoma detection
157879|NCT02325635|Adenoma Prediction|adenoma prediction
158176|NCT02324166|lidocaine|lidocaine
157880|NCT02325596|Chronic rhinosinusitis|chronic rhinosinusitis
157881|NCT02325596|microRNA|microrna
157882|NCT02325596|dendritic cell|dendritic cell
157883|NCT02325596|helper T cell|helper t cell
157884|NCT02325583|Intraoral 30% glucose, newborn, MRI|intraoral 30% glucose, newborn, mri
157885|NCT02325544|dissociative seizures,|dissociative seizures,
157886|NCT02325544|psychogenic nonepileptic seizures|psychogenic nonepileptic seizures
157887|NCT02325531|implementation strategies|implementation strategies
157888|NCT02325531|diabetes mellitus|diabetes mellitus
157889|NCT02325531|cardiovascular disease|cardiovascular disease
157890|NCT02325531|community health centers|community health centers
157891|NCT02325531|quality improvement|quality improvement
157892|NCT02325531|translational medical research|translational medical research
157893|NCT02325518|Open-angle glaucoma (OAG)|open-angle glaucoma (oag)
157894|NCT02325518|Ocular hypertension (OHT)|ocular hypertension (oht)
157895|NCT02325518|AZORGA®|azorga®
157896|NCT02325518|COSOPT®|cosopt®
157897|NCT02325492|bariatric surgery|bariatric surgery
157898|NCT02325492|NASH|nash
157899|NCT02325492|ARAMCHOL|aramchol
157900|NCT02325479|Low Molecular Weight (LMWH) Heparin ICSI Enaoxaprin sodium|low molecular weight (lmwh) heparin icsi enaoxaprin sodium
157901|NCT02325466|Peripheral Artery Disease|peripheral artery disease
157902|NCT02325466|Type 2 Diabetes|type 2 diabetes
157903|NCT02325466|Blood Viscosity|blood viscosity
157904|NCT02325466|Ticagrelor|ticagrelor
157905|NCT02325466|Aspirin|aspirin
157906|NCT02325453|Robotic Surgery|robotic surgery
157907|NCT02325453|Laparoscopic Surgery|laparoscopic surgery
157908|NCT02325453|Minimally Invasive Surgery|minimally invasive surgery
157909|NCT02325453|Robotic Gastrectomy|robotic gastrectomy
157910|NCT02325453|Laparoscopic Gastrectomy|laparoscopic gastrectomy
157911|NCT02325453|Open Gastrectomy|open gastrectomy
157912|NCT02325453|Gastric Surgery|gastric surgery
157913|NCT02325440|RRMS (relapsing remitting multiple sclerosis)|rrms (relapsing remitting multiple sclerosis)
157914|NCT02325440|Cluster of differentiation 49d (CD49d)|cluster of differentiation 49d (cd49d)
157915|NCT02325440|immune function|immune function
157916|NCT02325440|disease activity|disease activity
157917|NCT02325427|stroke|stroke
157918|NCT02325427|rehabilitation|rehabilitation
157919|NCT02325427|upper limb|upper limb
157921|NCT02325427|tDCS|tdcs
157922|NCT02325414|Osteoporosis|osteoporosis
157923|NCT02325414|Spinal Cord Injury|spinal cord injury
157924|NCT02325414|Bone Diseases|bone diseases
157925|NCT02325414|Metabolic Bone Diseases|metabolic bone diseases
157926|NCT02325414|Musculoskeletal Diseases|musculoskeletal diseases
157927|NCT02325414|Spinal Cord Diseases|spinal cord diseases
157928|NCT02325414|Central Nervous System Diseases|central nervous system diseases
157929|NCT02325414|Nervous System Diseases|nervous system diseases
157930|NCT02325414|Nervous System|nervous system
157931|NCT02325414|Wounds and Injuries|wounds and injuries
157932|NCT02325414|Bone Density Conservation Agents|bone density conservation agents
157933|NCT02325414|Physiological Effects of Drugs|physiological effects of drugs
157934|NCT02325414|Pharmacologic Actions|pharmacologic actions
157935|NCT02325414|Department of Defense|department of defense
157936|NCT02325388|pressure ulcer|pressure ulcer
157937|NCT02325388|decubitus ulcer|decubitus ulcer
157938|NCT02325388|bed sore|bed sore
157939|NCT02325388|continuous pressure mapping|continuous pressure mapping
157940|NCT02325388|interface pressure imaging|interface pressure imaging
157941|NCT02325375|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
157942|NCT02325375|spinal fluid|spinal fluid
157943|NCT02325375|CD163|cd163
157944|NCT02325362|Cystic fibrosis|cystic fibrosis
157945|NCT02325362|CFTR|cftr
157946|NCT02325362|F508del mutation|f508del mutation
157947|NCT02325362|Miglustat|miglustat
157948|NCT02325362|Total Chloride Secretion|total chloride secretion
157949|NCT02325362|Nasal Potential Difference|nasal potential difference
157950|NCT02325349|Angiogenesis|angiogenesis
157951|NCT02325349|Integrins|integrins
157952|NCT02325349|RGD PET/CT|rgd pet/ct
157953|NCT02325349|FDG PET/CT|fdg pet/ct
157954|NCT02325349|Predictive value|predictive value
158054|NCT02324920|CLS|cls
157955|NCT02325349|Therapeutic response|therapeutic response
157956|NCT02325349|Efficacy|efficacy
157957|NCT02325349|Tolerability|tolerability
157958|NCT02325336|Medication Errors|medication errors
157959|NCT02325336|nurses|nurses
157960|NCT02325336|hospital|hospital
191280|NCT02156102|Skin|skin
157961|NCT02325323|stomach cancer|stomach cancer
157962|NCT02325323|gastric intestinal metaplasia|gastric intestinal metaplasia
157963|NCT02325323|prospective cohort|prospective cohort
157964|NCT02325323|low grade dysplasia|low grade dysplasia
157965|NCT02325323|high grade dysplasia|high grade dysplasia
157966|NCT02325323|prognosis factor|prognosis factor
157967|NCT02325323|gastric cancer risks|gastric cancer risks
157968|NCT02325310|Vaccine strain excretion in breast milk|vaccine strain excretion in breast milk
157969|NCT02325310|Postpartum vaccination|postpartum vaccination
157970|NCT02325310|Breastfeeding women|breastfeeding women
157971|NCT02325310|Measles-mumps-rubella vaccine|measles-mumps-rubella vaccine
157972|NCT02325310|Breast milk|breast milk
157973|NCT02325310|Vaccinology|vaccinology
157974|NCT02325297|Intensive care unit|intensive care unit
157975|NCT02325258|Sepsis diagnosis|sepsis diagnosis
157976|NCT02325258|Sepsis drug therapy|sepsis drug therapy
157977|NCT02325258|Sepsis outcome|sepsis outcome
157978|NCT02325245|Frailty|frailty
157979|NCT02325245|Pre-frailty|pre-frailty
157980|NCT02325245|Metformin|metformin
157981|NCT02325245|Elderly|elderly
157982|NCT02325245|Quality of life|quality of life
157983|NCT02325245|Handgrip|handgrip
157984|NCT02325245|Gait speed|gait speed
157985|NCT02325245|Myostatin|myostatin
157986|NCT02325219|Psoriasis|psoriasis
157987|NCT02325219|CNTO 1959|cnto 1959
157988|NCT02325219|Guselkumab|guselkumab
157989|NCT02325219|Placebo|placebo
157990|NCT02325180|ACT|act
157991|NCT02325180|Plasmodium falciparum|plasmodium falciparum
157992|NCT02325180|malaria|malaria
157993|NCT02325180|efficacy|efficacy
157994|NCT02325180|Indonesia|indonesia
157995|NCT02325167|informal caregivers|informal caregivers
157996|NCT02325167|mental stress|mental stress
157997|NCT02325167|quality of life|quality of life
157998|NCT02325167|psychotherapeutic intervention|psychotherapeutic intervention
157999|NCT02325128|social anxiety|social anxiety
158000|NCT02325128|exposure therapy|exposure therapy
158001|NCT02325128|extinction|extinction
158002|NCT02325128|sleep-dependent memory consolidation|sleep-dependent memory consolidation
158003|NCT02325115|well-being, mental health, schizophrenia, quality of life|well-being, mental health, schizophrenia, quality of life
158004|NCT02325089|Elderly|elderly
158005|NCT02325089|Obstructive Sleep Apnea|obstructive sleep apnea
158006|NCT02325089|Mandibular advancement oral appliance|mandibular advancement oral appliance
158007|NCT02325089|Hypertension|hypertension
158008|NCT02325089|Cardiovascular disease|cardiovascular disease
158009|NCT02325089|Quality of life|quality of life
158010|NCT02325076|Airway Management|airway management
158011|NCT02325076|intubation|intubation
158012|NCT02325076|pulmonary function test|pulmonary function test
158013|NCT02325050|Healthy|healthy
158014|NCT02325050|Ebola viruses|ebola viruses
158015|NCT02325050|Ebola Viral Disease (EVD)|ebola viral disease (evd)
158016|NCT02325050|Filoviruses|filoviruses
158017|NCT02325050|monovalent vaccine|monovalent vaccine
158018|NCT02325050|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
158019|NCT02325050|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
158020|NCT02325050|Safety|safety
158021|NCT02325050|Immunogenicity|immunogenicity
158022|NCT02325024|Sativex|sativex
158023|NCT02325024|GW-1000-02|gw-1000-02
158024|NCT02325024|Nabiximols|nabiximols
158025|NCT02325024|Pharmacokinetics|pharmacokinetics
158026|NCT02325024|Renal Insufficiency|renal insufficiency
158027|NCT02325024|Chronic Kidney Failure|chronic kidney failure
158028|NCT02325011|Sativex|sativex
158029|NCT02325011|GW-1000-02|gw-1000-02
158030|NCT02325011|Nabiximols|nabiximols
158031|NCT02325011|Fluconazole|fluconazole
158032|NCT02325011|Pharmacokinetics|pharmacokinetics
158033|NCT02325011|Drug-drug interaction|drug-drug interaction
158034|NCT02324998|Radical Prostatectomy|radical prostatectomy
158035|NCT02324998|Prostate Cancer|prostate cancer
158036|NCT02324998|PARP inhibition|parp inhibition
158037|NCT02324998|Olaparib|olaparib
158038|NCT02324998|Degarelix|degarelix
158039|NCT02324998|Neoadjuvant|neoadjuvant
158040|NCT02324998|Pharmacodynamics|pharmacodynamics
158041|NCT02324998|Pharmacokinetics|pharmacokinetics
158042|NCT02324998|Biomarkers|biomarkers
158043|NCT02324985|muscle soreness|muscle soreness
158044|NCT02324972|Atopic dermatitis|atopic dermatitis
158045|NCT02324972|Eczema|eczema
158046|NCT02324972|AD|ad
158047|NCT02324972|AQX-1125|aqx-1125
158048|NCT02324972|SHIP1|ship1
158049|NCT02324946|Sleep Apnea Syndromes|sleep apnea syndromes
158050|NCT02324946|Perioperative Period|perioperative period
158051|NCT02324946|Mass Screening|mass screening
158052|NCT02324920|Syncope|syncope
158053|NCT02324920|Closed Loop Stimulation|closed loop stimulation
158055|NCT02324894|screening|screening
158056|NCT02324894|MRI|mri
158057|NCT02324881|smartphone|smartphone
158058|NCT02324881|application|application
158059|NCT02324881|pain management|pain management
158060|NCT02324868|Bandages|bandages
158061|NCT02324868|Catheter|catheter
158062|NCT02324855|Autogenic drainage|autogenic drainage
158063|NCT02324855|Positive expiratory pressure|positive expiratory pressure
158064|NCT02324855|Airway clearance technique|airway clearance technique
158065|NCT02324855|Quality of life|quality of life
158066|NCT02324855|Exacerbations|exacerbations
158067|NCT02324855|Chest physiotherapy|chest physiotherapy
158068|NCT02324829|Total joint replacement|total joint replacement
158069|NCT02324829|Physiotherapy|physiotherapy
158070|NCT02324829|Kalman filtering|kalman filtering
158071|NCT02324829|Kinematic modeling|kinematic modeling
158072|NCT02324829|Hidden Markov model|hidden markov model
158073|NCT02324829|Motion segmentation|motion segmentation
158074|NCT02324790|OSA, Oral Pressure Therapy (OPT)|osa, oral pressure therapy (opt)
158075|NCT02324764|transradial coronary angiography|transradial coronary angiography
158080|NCT02324738|drug interaction|drug interaction
158081|NCT02324725|naltrexone|naltrexone
158082|NCT02324725|neuroimaging|neuroimaging
158083|NCT02324725|heroin|heroin
158084|NCT02324725|addiction|addiction
158085|NCT02324725|dependence|dependence
158086|NCT02324725|opioid|opioid
158087|NCT02324725|Vivitrol®|vivitrol®
158088|NCT02324725|functional magnetic resonance imaging|functional magnetic resonance imaging
158089|NCT02324699|Vedolizumab|vedolizumab
158090|NCT02324699|Corticosteroids|corticosteroids
158091|NCT02324699|Prednisone|prednisone
158092|NCT02324699|Crohn's disease|crohn's disease
158093|NCT02324686|Warfarin|warfarin
158094|NCT02324686|International Normalized Ratio|international normalized ratio
158095|NCT02324686|Vitamin K|vitamin k
158096|NCT02324673|Treatment-resistant seizures|treatment-resistant seizures
158097|NCT02324660|screening procedure|screening procedure
158098|NCT02324660|peak expiratory flow|peak expiratory flow
158099|NCT02324660|respiratory health screening questionnaire|respiratory health screening questionnaire
158100|NCT02324647|Urinary steroid profiling|urinary steroid profiling
158101|NCT02324647|Adrenal incidentaloma|adrenal incidentaloma
158102|NCT02324647|Adrenocortical carcinoma|adrenocortical carcinoma
158103|NCT02324647|cost-effectiveness|cost-effectiveness
158104|NCT02324621|protocol specific|protocol specific
158105|NCT02324595|Ovarian Cancer|ovarian cancer
158106|NCT02324595|Laparoscopy|laparoscopy
158107|NCT02324595|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
158108|NCT02324595|Robotic|robotic
158109|NCT02324595|Interval Debulking Surgery|interval debulking surgery
158110|NCT02324582|Urinary Bladder Neoplasms|urinary bladder neoplasms
158111|NCT02324582|Mycobacterium bovis|mycobacterium bovis
158112|NCT02324582|Programmed Cell Death 1 Receptor|programmed cell death 1 receptor
158114|NCT02324569|Pharmacological therapy|pharmacological therapy
158115|NCT02324556|Rectal Cancer|rectal cancer
158116|NCT02324556|Surgery|surgery
158117|NCT02324556|Laparoscopy|laparoscopy
158118|NCT02324517|response to various potential therapies as managed by lab assays|response to various potential therapies as managed by lab assays
158119|NCT02324478|autonomic nervous system|autonomic nervous system
158120|NCT02324478|heart rate variability|heart rate variability
158121|NCT02324478|laparoscopic surgery|laparoscopic surgery
158122|NCT02324478|general anesthesia|general anesthesia
158123|NCT02324478|photoplethysmography|photoplethysmography
158129|NCT02324426|Parkinson's Disease|parkinson's disease
158130|NCT02324426|Reduced Glutathione|reduced glutathione
158131|NCT02324426|CNS|cns
158132|NCT02324426|Glutathione|glutathione
158133|NCT02324426|Uptake|uptake
158134|NCT02324426|Intranasal|intranasal
158135|NCT02324426|(in)GSH|(in)gsh
158136|NCT02324387|Breast Cancer|breast cancer
158137|NCT02324387|Molecular breast imaging|molecular breast imaging
158138|NCT02324387|MBI|mbi
158139|NCT02324387|Tc99m sestamibi|tc99m sestamibi
158140|NCT02324387|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
158141|NCT02324387|NAC|nac
158142|NCT02324374|colon cancer|colon cancer
158143|NCT02324361|Pediatric|pediatric
158144|NCT02324361|Obesity|obesity
158145|NCT02324361|Intervention|intervention
158146|NCT02324361|Information and Communication Technologies|information and communication technologies
158147|NCT02324361|Social Media|social media
158148|NCT02324361|Text Messaging|text messaging
158149|NCT02324361|Mobile Health|mobile health
158150|NCT02324335|Oral Mucositis|oral mucositis
158151|NCT02324335|Brilacidin|brilacidin
158152|NCT02324335|Chemoradiation|chemoradiation
158153|NCT02324322|Device: Robotic Exoskeleton|device: robotic exoskeleton
158154|NCT02324296|small cell lung cancer|small cell lung cancer
158155|NCT02324296|extended disease|extended disease
158156|NCT02324296|limited disease|limited disease
158157|NCT02324296|chemotherapy|chemotherapy
158158|NCT02324296|cisplatin|cisplatin
158159|NCT02324296|etoposide|etoposide
158160|NCT02324296|ifosfamide|ifosfamide
158161|NCT02324283|one-lung ventilation, oxygenation|one-lung ventilation, oxygenation
158162|NCT02324270|Pain due to ankle sprain|pain due to ankle sprain
158358|NCT02323126|EGF816,|egf816,
158163|NCT02324244|Cytomegalovirus|cytomegalovirus
158164|NCT02324244|critical patient|critical patient
158165|NCT02324244|ICU|icu
149125|NCT02377128|Study|study
158166|NCT02324244|immunocompetent|immunocompetent
158167|NCT02324244|clinical suspicion|clinical suspicion
158168|NCT02324244|risk factors|risk factors
158169|NCT02324218|Diabetes mellitus|diabetes mellitus
158170|NCT02324218|Hepatitis B|hepatitis b
158171|NCT02324218|Incidence|incidence
158172|NCT02324192|Ultrasonography|ultrasonography
158173|NCT02324192|clinical|clinical
158174|NCT02324192|hand|hand
158177|NCT02324153|Post-operative Delirium|post-operative delirium
158178|NCT02324114|Cancer|cancer
158179|NCT02324075|sanitation, toilet, urban, behavior change|sanitation, toilet, urban, behavior change
158180|NCT02324062|Cancer Genetics|cancer genetics
158181|NCT02324062|Multi-gene cancer panel testing|multi-gene cancer panel testing
158182|NCT02324049|MPS IIIB|mps iiib
158183|NCT02324049|Mucopolysaccharidosis|mucopolysaccharidosis
158184|NCT02324049|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
158185|NCT02324049|Sanfilippo Syndrome|sanfilippo syndrome
158186|NCT02324049|Metabolism, Inborn Errors|metabolism, inborn errors
158187|NCT02324049|Metabolic Diseases|metabolic diseases
158188|NCT02324049|Genetic Diseases, Inborn|genetic diseases, inborn
158189|NCT02324049|Carbohydrate Metabolism, Inborn Errors|carbohydrate metabolism, inborn errors
158190|NCT02324049|Connective Tissue Diseases|connective tissue diseases
158191|NCT02324049|Lysosomal Storage Diseases|lysosomal storage diseases
158192|NCT02324049|Mucinoses|mucinoses
158193|NCT02324049|Mucopolysaccharidoses|mucopolysaccharidoses
158194|NCT02324049|Pathologic Processes|pathologic processes
158195|NCT02324023|ultrasound|ultrasound
158196|NCT02324023|perfusion|perfusion
158197|NCT02324023|endoscopic|endoscopic
158198|NCT02324010|gastric emptying|gastric emptying
158199|NCT02324010|glycemia|glycemia
158200|NCT02324010|appetite|appetite
158201|NCT02324010|incretin hormones|incretin hormones
158202|NCT02323997|HPV|hpv
158203|NCT02323997|cervical cancer|cervical cancer
158204|NCT02323997|human papillomavirus|human papillomavirus
158205|NCT02323997|cervical pre-cancer|cervical pre-cancer
158206|NCT02323997|cervical neoplasia|cervical neoplasia
158207|NCT02323945|acute intermittent hypoxia|acute intermittent hypoxia
158208|NCT02323945|incomplete spinal cord injury|incomplete spinal cord injury
158209|NCT02323945|strength|strength
158210|NCT02323945|walking|walking
158211|NCT02323945|breathing|breathing
158212|NCT02323919|myocardial infarction|myocardial infarction
158213|NCT02323919|coronary artery bypass graft (CABG)|coronary artery bypass graft (cabg)
158214|NCT02323919|angioplasty|angioplasty
158216|NCT02323919|cardiac patient|cardiac patient
158217|NCT02323919|physical activity|physical activity
158218|NCT02323906|Hepatocellular|hepatocellular
158219|NCT02323906|Carcinoma|carcinoma
158220|NCT02323906|Phase 1|phase 1
158221|NCT02323906|CC-122|cc-122
158222|NCT02323906|Sorafenib,|sorafenib,
158223|NCT02323906|Nexavar|nexavar
158224|NCT02323906|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
158225|NCT02323906|Unresectable HCCAdvanced,|unresectable hccadvanced,
158226|NCT02323906|Hepatocellular Carcinoma|hepatocellular carcinoma
158227|NCT02323906|liver cancer|liver cancer
158228|NCT02323893|Positron Emission Tomography|positron emission tomography
158229|NCT02323893|Cancer Immunotherapy|cancer immunotherapy
158230|NCT02323867|Transplant|transplant
158231|NCT02323867|Alternative Donor|alternative donor
158232|NCT02323854|primary, recurrent, metastatic lung tumor, ablation|primary, recurrent, metastatic lung tumor, ablation
158233|NCT02323841|cervical cancer|cervical cancer
158234|NCT02323841|neoadjuvant chemotherapy|neoadjuvant chemotherapy
158235|NCT02323841|Adverse Effects|adverse effects
158236|NCT02323815|child acute malnutrition prevention|child acute malnutrition prevention
158237|NCT02323815|behavior change communication|behavior change communication
158238|NCT02323815|lipid-based nutrient supplement|lipid-based nutrient supplement
158239|NCT02323815|screening coverage|screening coverage
158240|NCT02323763|Magnetic Resonance Imaging|magnetic resonance imaging
158241|NCT02323763|Bipolar Disorder|bipolar disorder
158242|NCT02323763|Suicidal Ideation|suicidal ideation
158243|NCT02323698|acute intermittent hypoxia|acute intermittent hypoxia
158244|NCT02323698|incomplete spinal cord injury|incomplete spinal cord injury
158245|NCT02323685|DCI|dci
158246|NCT02323685|Delayed Cerebral Ischemia|delayed cerebral ischemia
158247|NCT02323685|SAH|sah
158248|NCT02323685|Subarachnoid Hemorrhage|subarachnoid hemorrhage
158249|NCT02323685|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
158250|NCT02323685|Cerebral Ischemia|cerebral ischemia
158251|NCT02323685|Brain Ischemia|brain ischemia
158252|NCT02323659|Mycosis Fungoides|mycosis fungoides
158253|NCT02323659|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
158254|NCT02323659|Interferon|interferon
158255|NCT02323659|Methotrexate|methotrexate
158256|NCT02323646|uterine fibroids|uterine fibroids
158257|NCT02323646|leiomyoma|leiomyoma
158258|NCT02323646|fibroid tumor|fibroid tumor
158259|NCT02323646|fibroma|fibroma
158260|NCT02323633|Pediatric Attention Deficit Hyperactivity Disorder|pediatric attention deficit hyperactivity disorder
158261|NCT02323620|Acute myocardial Infarction|acute myocardial infarction
158262|NCT02323620|bone marrow|bone marrow
158263|NCT02323620|stem cells|stem cells
158264|NCT02323620|cardiovascular disease|cardiovascular disease
158265|NCT02323620|mortality|mortality
158266|NCT02323581|Thoracoabdominal|thoracoabdominal
158267|NCT02323581|Aneurysm|aneurysm
158268|NCT02323581|Endovascular|endovascular
158269|NCT02323581|Stent-Graft|stent-graft
158270|NCT02323568|ovarian cancer|ovarian cancer
158271|NCT02323568|quality of life|quality of life
158977|NCT02320110|Leptin|leptin
158272|NCT02323568|remission more than 3 years|remission more than 3 years
158274|NCT02323555|chemotherapy|chemotherapy
158275|NCT02323555|Targeted therapy|targeted therapy
158276|NCT02323555|Day Hospital|day hospital
158277|NCT02323542|Starch|starch
158278|NCT02323542|cereal products|cereal products
158279|NCT02323542|glucose kinetics|glucose kinetics
158280|NCT02323542|blood glucose|blood glucose
158281|NCT02323542|blood insulin|blood insulin
158282|NCT02323529|Orfadin|orfadin
158283|NCT02323529|Nitisinone|nitisinone
158284|NCT02323529|NTBC|ntbc
158285|NCT02323503|CRT-D|crt-d
158286|NCT02323503|replacement|replacement
158287|NCT02323503|primary prevention|primary prevention
158288|NCT02323503|ventricular tachyarrhythmias|ventricular tachyarrhythmias
158289|NCT02323490|meniscus repair|meniscus repair
158290|NCT02323490|bone marrow stimulation|bone marrow stimulation
158291|NCT02323477|cellular therapy|cellular therapy
158292|NCT02323477|chronic ischemic heart disease|chronic ischemic heart disease
158293|NCT02323477|phase 1/2 clinical study|phase 1/2 clinical study
158294|NCT02323477|human umbilical cord multipotent stem cell|human umbilical cord multipotent stem cell
158295|NCT02323477|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
158296|NCT02323477|ischemic heart disease|ischemic heart disease
158297|NCT02323477|bone marrow mononuclear cell|bone marrow mononuclear cell
158298|NCT02323477|allogeneic stem cell transplantation|allogeneic stem cell transplantation
158299|NCT02323438|biomarkers of tobacco exposure|biomarkers of tobacco exposure
158300|NCT02323438|exposure|exposure
158301|NCT02323438|tobacco|tobacco
158302|NCT02323438|nicotine|nicotine
158303|NCT02323438|nicotine gum|nicotine gum
158304|NCT02323438|electronic cigarette|electronic cigarette
158305|NCT02323438|e-cig|e-cig
158306|NCT02323425|stroke|stroke
158307|NCT02323425|Remote ischemic postconditioning|remote ischemic postconditioning
158308|NCT02323425|symptomatic atherosclerotic intracranial arterial stenosis|symptomatic atherosclerotic intracranial arterial stenosis
158310|NCT02323412|Chronic|chronic
158311|NCT02323412|Modic Changes|modic changes
158312|NCT02323412|MRI|mri
158313|NCT02323412|epigenetics|epigenetics
158314|NCT02323412|antibiotics|antibiotics
158315|NCT02323412|randomized placebo controlled trial|randomized placebo controlled trial
158316|NCT02323386|Dynamic RSA|dynamic rsa
158317|NCT02323386|Knee|knee
158318|NCT02323386|Total Knee Arthroplasty|total knee arthroplasty
158319|NCT02323386|Kinematic Analysis|kinematic analysis
158320|NCT02323373|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
158321|NCT02323373|Tranexamic Acid|tranexamic acid
158322|NCT02323373|Drug Administration Routes|drug administration routes
158323|NCT02323360|SBRT|sbrt
158324|NCT02323360|TACE|tace
158325|NCT02323360|TAE|tae
158326|NCT02323321|heart transplant|heart transplant
158327|NCT02323321|heart preservation|heart preservation
158328|NCT02323321|beating heart transplant|beating heart transplant
158329|NCT02323295|Malignant bone tumors|malignant bone tumors
158330|NCT02323282|Dose-response relationship|dose-response relationship
158331|NCT02323282|Drug|drug
158332|NCT02323256|cochlear implant|cochlear implant
158333|NCT02323256|deafness|deafness
158334|NCT02323256|audiometry|audiometry
158335|NCT02323256|speech perception|speech perception
158336|NCT02323256|severe to profound deafness restored with cochlear implantation|severe to profound deafness restored with cochlear implantation
401972|NCT01232478|Cystic Fibrosis|cystic fibrosis
158337|NCT02323243|Detrusor striated sphincter dyssynergia|detrusor striated sphincter dyssynergia
158338|NCT02323243|Temporary urethral stent|temporary urethral stent
158339|NCT02323217|Imidazoline Receptor 2|imidazoline receptor 2
158340|NCT02323217|(4,5-dihydro-1H-imidazol-2-yl)-1-methyl-1H-indole|(4,5-dihydro-1h-imidazol-2-yl)-1-methyl-1h-indole
158341|NCT02323217|BU99008|bu99008
158342|NCT02323217|Radionuclide Imaging|radionuclide imaging
158343|NCT02323217|Molecular Imaging|molecular imaging
158344|NCT02323217|Healthy Volunteers|healthy volunteers
158345|NCT02323217|Alzheimer Disease|alzheimer disease
158346|NCT02323204|posttraumatic stress|posttraumatic stress
158347|NCT02323178|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
158348|NCT02323178|thrombocytopenia|thrombocytopenia
158349|NCT02323178|eltrombopag|eltrombopag
158350|NCT02323152|women|women
158351|NCT02323152|high risk|high risk
158352|NCT02323139|High risk MDS|high risk mds
158353|NCT02323139|Azacitidine|azacitidine
158354|NCT02323139|LDE255|lde255
158355|NCT02323126|Non small cell lung cancer,|non small cell lung cancer,
158356|NCT02323126|NSCLC,|nsclc,
149330|NCT02376049|AD|ad
158357|NCT02323126|EGFR-mutated,|egfr-mutated,
158359|NCT02323126|INC280,|inc280,
158360|NCT02323126|Nivolumab,|nivolumab,
158361|NCT02323126|EGFR-T790M NSCLC,|egfr-t790m nsclc,
158362|NCT02323126|EGFR wild-type (wt),|egfr wild-type (wt),
158363|NCT02323126|cMET positive NSCLC,|cmet positive nsclc,
158364|NCT02323126|cMET negative NSCLC|cmet negative nsclc
158365|NCT02323113|Drug therapy|drug therapy
158366|NCT02323100|cystic fibrosis|cystic fibrosis
158367|NCT02323100|corrector|corrector
158368|NCT02323100|glycerol phenylbutyrate|glycerol phenylbutyrate
158369|NCT02323100|nasal potential difference|nasal potential difference
158370|NCT02323087|Antibiotic resistance|antibiotic resistance
158371|NCT02323087|Point of care tests|point of care tests
158372|NCT02323087|Primary Health Care|primary health care
158374|NCT02323022|cladribine|cladribine
158375|NCT02323022|induction therapy|induction therapy
158376|NCT02323009|Transpulmonary pressure|transpulmonary pressure
158377|NCT02323009|Esophageal balloon|esophageal balloon
158378|NCT02323009|Esophageal pressure monitoring device|esophageal pressure monitoring device
158379|NCT02323009|Cstat|cstat
158380|NCT02323009|Static effective compliance|static effective compliance
158381|NCT02323009|Ventilator weaning|ventilator weaning
158382|NCT02323009|Morbidly Obese Ventilator Dependent Tracheotomized Patients|morbidly obese ventilator dependent tracheotomized patients
158383|NCT02322983|Cerebral Palsy|cerebral palsy
158384|NCT02322983|Dental Care|dental care
158385|NCT02322983|Conscious Sedation|conscious sedation
158386|NCT02322983|Autonomic Nervous System|autonomic nervous system
158387|NCT02322983|Nitrous Oxide|nitrous oxide
158388|NCT02322970|intracranial hypertension|intracranial hypertension
158389|NCT02322970|tcd|tcd
158390|NCT02322970|non invasive|non invasive
158391|NCT02322970|ICP|icp
158392|NCT02322944|acute myocardial infarction|acute myocardial infarction
158393|NCT02322944|quality improvement|quality improvement
158394|NCT02322944|reperfusion therapy|reperfusion therapy
158395|NCT02322905|informal caregivers|informal caregivers
158396|NCT02322905|caregiving|caregiving
158397|NCT02322905|psychotherapy for caregivers|psychotherapy for caregivers
158398|NCT02322905|cancer|cancer
158399|NCT02322905|emotion regulation|emotion regulation
158400|NCT02322905|distress|distress
158401|NCT02322905|inflammation|inflammation
158402|NCT02322892|Thiamine|thiamine
158403|NCT02322892|Vitamin B1|vitamin b1
158404|NCT02322892|Coronary artery bypass grafting|coronary artery bypass grafting
158405|NCT02322892|Cardiac surgery|cardiac surgery
158406|NCT02322892|Lactate|lactate
158407|NCT02322892|Pyruvate dehydrogenase|pyruvate dehydrogenase
158408|NCT02322879|acetaminophen|acetaminophen
158409|NCT02322866|acne|acne
158410|NCT02322853|Metastatic breast cancer|metastatic breast cancer
158411|NCT02322853|p38 map kinase|p38 map kinase
158412|NCT02322853|tamoxifen|tamoxifen
158413|NCT02322853|LY2228820|ly2228820
158414|NCT02322853|Postmenopausal woman with advanced or metastatic breast cancer progressing on aromatase inhibitors (AI)|postmenopausal woman with advanced or metastatic breast cancer progressing on aromatase inhibitors (ai)
158415|NCT02322827|hiv/aids|hiv/aids
158416|NCT02322788|Inhalation, Pharmacodynamic, Patients,|inhalation, pharmacodynamic, patients,
158417|NCT02322775|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases,|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases,
158418|NCT02322762|Type 2 diabetes mellitus|type 2 diabetes mellitus
158419|NCT02322762|Anti-diabetic management patterns|anti-diabetic management patterns
158420|NCT02322749|bioequivalence|bioequivalence
158421|NCT02322749|bioavailability|bioavailability
158422|NCT02322749|pharmacokinetics|pharmacokinetics
158423|NCT02322749|Phase I|phase i
158424|NCT02322749|AZD6244|azd6244
158425|NCT02322749|cancer|cancer
158426|NCT02322736|Metastatic Colorectal Cancer, wild type RAS, Panitumumab, Vectibix, Greece|metastatic colorectal cancer, wild type ras, panitumumab, vectibix, greece
158427|NCT02322723|Adalimumab|adalimumab
158428|NCT02322723|real life|real life
158429|NCT02322723|RA|ra
158430|NCT02322723|Humira|humira
158431|NCT02322723|Rheumatoid Arthritis|rheumatoid arthritis
158432|NCT02322723|effectiveness|effectiveness
158433|NCT02322710|non-inferiority|non-inferiority
158434|NCT02322710|randomized|randomized
158435|NCT02322710|TulleGras|tullegras
158436|NCT02322710|Urgotul|urgotul
158437|NCT02322710|healing|healing
158438|NCT02322710|surgical acute wounds|surgical acute wounds
158439|NCT02322710|pain|pain
158440|NCT02322697|Carnitine|carnitine
158441|NCT02322697|hemodialysis|hemodialysis
158442|NCT02322697|fatty acid|fatty acid
158443|NCT02322697|imaging|imaging
158444|NCT02322697|heart|heart
158445|NCT02322684|Bougie|bougie
158446|NCT02322684|Air-Q|air-q
158447|NCT02322684|Insertion|insertion
158448|NCT02322671|chewable tablet|chewable tablet
158449|NCT02322671|montelukast sodium|montelukast sodium
158450|NCT02322671|healthy adult subjects|healthy adult subjects
158451|NCT02322671|relative bioavailability|relative bioavailability
158452|NCT02322671|GW483100|gw483100
158453|NCT02322593|Gastric Cancer|gastric cancer
158454|NCT02322593|Gastrointestinal Diseases|gastrointestinal diseases
158455|NCT02322593|Gastrointestinal Neoplasms|gastrointestinal neoplasms
158456|NCT02322593|First Line Treatment|first line treatment
158457|NCT02322593|Antineoplastic Agents|antineoplastic agents
158458|NCT02322580|anti-TNF|anti-tnf
158459|NCT02322580|therapeutic drug monitoring|therapeutic drug monitoring
158460|NCT02322580|immunogenicity|immunogenicity
158461|NCT02322554|electronic health records|electronic health records
158462|NCT02322554|Qualified Clinical Data Registry|qualified clinical data registry
158463|NCT02322554|PQRS|pqrs
158464|NCT02322554|quality reporting|quality reporting
158465|NCT02322554|cellular based products|cellular based products
158466|NCT02322554|bioengieered skin|bioengieered skin
158467|NCT02322554|USWR|uswr
158468|NCT02322528|Non-invasive instruments|non-invasive instruments
158469|NCT02322528|Environment|environment
158470|NCT02322528|Wavefront|wavefront
158471|NCT02322528|Placido Disk|placido disk
158472|NCT02322528|Ellipsometer|ellipsometer
158473|NCT02322528|Thermal Imaging|thermal imaging
158474|NCT02322515|Knee|knee
158475|NCT02322515|Proprioception|proprioception
158476|NCT02322515|Electromyography|electromyography
158477|NCT02322515|Taping|taping
158478|NCT02322502|laryngeal mask airway|laryngeal mask airway
158479|NCT02322502|desflurane|desflurane
158480|NCT02322502|sevoflurane|sevoflurane
158481|NCT02322502|propofol|propofol
158482|NCT02322489|microcurent|microcurent
158483|NCT02322489|pain|pain
158484|NCT02322489|flexibility|flexibility
158485|NCT02322463|patients who were admitted to the pediatric ED|patients who were admitted to the pediatric ed
158486|NCT02322411|Stroke|stroke
158487|NCT02322411|Deglutition|deglutition
158488|NCT02322411|Deglutition disorders|deglutition disorders
158489|NCT02322411|Resistance training|resistance training
158490|NCT02322385|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
158491|NCT02322385|PKD 1 gene|pkd 1 gene
158492|NCT02322385|PKD 2 gene|pkd 2 gene
158493|NCT02322385|Truncational mutation|truncational mutation
158494|NCT02322385|Hypomorphic mutation|hypomorphic mutation
158495|NCT02322372|femoral blockade|femoral blockade
158496|NCT02322372|bupivacaine|bupivacaine
158497|NCT02322346|posttonsillectomy pain|posttonsillectomy pain
158498|NCT02322346|levobupivacaine|levobupivacaine
158499|NCT02322320|Multiple Myeloma|multiple myeloma
158500|NCT02322320|Lenalidomide|lenalidomide
158501|NCT02322320|Maintenance Therapy|maintenance therapy
158502|NCT02322320|Progression|progression
158503|NCT02322320|Long-term|long-term
158504|NCT02322320|Anti-Myeloma Agents|anti-myeloma agents
158505|NCT02322320|Hematologic Disorders|hematologic disorders
158506|NCT02322307|Inflammatory Bowel Disease|inflammatory bowel disease
158507|NCT02322307|Crohn's Disease|crohn's disease
158508|NCT02322307|Ulcerative Colitis|ulcerative colitis
158509|NCT02322307|Colitis|colitis
158510|NCT02322307|PRO|pro
158511|NCT02322307|Patient-centric|patient-centric
158512|NCT02322307|HealthPROMISE|healthpromise
158513|NCT02322294|Protein|protein
158514|NCT02322294|mung bean|mung bean
158515|NCT02322294|glucose|glucose
158516|NCT02322294|triglycerides|triglycerides
158517|NCT02322294|insulin|insulin
158518|NCT02322294|body weight,|body weight,
158519|NCT02322294|DXA scan|dxa scan
158520|NCT02322281|cancer|cancer
158521|NCT02322281|metastatic|metastatic
158522|NCT02322281|locally advanced|locally advanced
158523|NCT02322281|lung|lung
158524|NCT02322281|non-small cell lung cancer|non-small cell lung cancer
158525|NCT02322281|NSCLC|nsclc
158526|NCT02322281|epidermal growth factor receptor|epidermal growth factor receptor
158527|NCT02322281|EGFR|egfr
158528|NCT02322281|T790M|t790m
158529|NCT02322281|CO-1686|co-1686
158530|NCT02322281|unresectable|unresectable
158531|NCT02322281|recurrent|recurrent
158532|NCT02322281|EGFR-directed therapy|egfr-directed therapy
158533|NCT02322281|irreversible EGFR inhibitor|irreversible egfr inhibitor
158534|NCT02322281|TIGER|tiger
158535|NCT02322281|Rociletinib|rociletinib
158536|NCT02322268|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
158537|NCT02322268|Cosmos Caudatus|cosmos caudatus
158538|NCT02322268|Ulam Raja|ulam raja
158539|NCT02322268|Metabolomic profiling|metabolomic profiling
158540|NCT02322268|antioxidant|antioxidant
158541|NCT02322255|Natural History Study|natural history study
158542|NCT02322255|Non-interventional Study|non-interventional study
158543|NCT02322255|Observational Study|observational study
158544|NCT02322255|Heterotopic ossification|heterotopic ossification
158545|NCT02322255|Fibrodysplasia Ossificans Progressiva|fibrodysplasia ossificans progressiva
158546|NCT02322255|FOP disease progression|fop disease progression
158547|NCT02322255|FOP flare-up progression|fop flare-up progression
158548|NCT02322255|Clementia|clementia
158549|NCT02322255|Myositosis Ossificans Progressiva|myositosis ossificans progressiva
158550|NCT02322255|Munchmeyer's Disease|munchmeyer's disease
158552|NCT02322255|Palovarotene|palovarotene
158553|NCT02322229|VMT|vmt
158554|NCT02322229|sVMA|svma
158555|NCT02322229|vitrectomy|vitrectomy
158556|NCT02322229|ocriplasmin|ocriplasmin
158557|NCT02322216|Allergies|allergies
158558|NCT02322216|Ocular|ocular
158559|NCT02322203|Niacin|niacin
158560|NCT02322203|Cholesterol|cholesterol
158766|NCT02321267|DME|dme
158561|NCT02322203|High-Density Lipoprotein|high-density lipoprotein
158562|NCT02322203|Low-Density Lipoprotein|low-density lipoprotein
158563|NCT02322203|Lipoproteins|lipoproteins
158564|NCT02322190|Steroid Failure|steroid failure
158565|NCT02322190|Immunomodulation|immunomodulation
158566|NCT02322190|Corticosteroid Therapy|corticosteroid therapy
158567|NCT02322177|Inborn Error of Metabolism|inborn error of metabolism
158568|NCT02322177|Pregnancy|pregnancy
158569|NCT02322177|Methylmalonic Acidemia|methylmalonic acidemia
158570|NCT02322177|Urea Cycle Disorder|urea cycle disorder
158572|NCT02322164|TEMPERATURE|temperature
158573|NCT02322164|Placebo|placebo
158574|NCT02322151|Filgrastim|filgrastim
158575|NCT02322151|Neupogen|neupogen
158576|NCT02322151|Transplant|transplant
158577|NCT02322151|Breast Feeding|breast feeding
158578|NCT02322151|Concentration|concentration
158579|NCT02322125|walking|walking
158580|NCT02322125|locomotion|locomotion
158581|NCT02322125|rehabilitation|rehabilitation
158582|NCT02322112|Dietary Fiber|dietary fiber
158583|NCT02322112|Gastrointestinal Microbiome|gastrointestinal microbiome
158584|NCT02322112|Overweight and Obesity|overweight and obesity
158585|NCT02322112|Personalized Nutrition|personalized nutrition
158586|NCT02322112|Inflammation|inflammation
158587|NCT02322112|Metabolism|metabolism
158588|NCT02322099|human immunodeficiency virus|human immunodeficiency virus
158589|NCT02322099|bone diseases|bone diseases
158590|NCT02322099|osteopenia|osteopenia
158591|NCT02322099|osteoporosis|osteoporosis
158592|NCT02322099|fracture|fracture
158593|NCT02322099|bone turnover|bone turnover
158594|NCT02322099|alendronate|alendronate
158595|NCT02322099|antiretroviral|antiretroviral
158596|NCT02322060|IVA, ovary tissue grafting, POI|iva, ovary tissue grafting, poi
158597|NCT02322034|chronic heart failure|chronic heart failure
158598|NCT02322034|multiple neurohormonal axis disequilibrium|multiple neurohormonal axis disequilibrium
158599|NCT02322034|growth hormone deficiency|growth hormone deficiency
158600|NCT02322034|Insulin-like growth factor-1 (IGF-1)|insulin-like growth factor-1 (igf-1)
158601|NCT02322034|metabolic deficiency syndrome|metabolic deficiency syndrome
158602|NCT02322034|interval training|interval training
158603|NCT02322021|E2609|e2609
158604|NCT02322021|Mild Cognitive Impairment|mild cognitive impairment
158605|NCT02322021|Mild to Moderate Dementia|mild to moderate dementia
158606|NCT02322021|Alzheimer's Disease|alzheimer's disease
158607|NCT02322021|Prodromal Alzheimer's Disease|prodromal alzheimer's disease
158608|NCT02321982|Mohs surgery|mohs surgery
158609|NCT02321982|Preoperative consultation|preoperative consultation
158610|NCT02321969|Chemoprevention|chemoprevention
158611|NCT02321969|Colorectal adenomatous polyp|colorectal adenomatous polyp
158612|NCT02321969|Green tea extract|green tea extract
158613|NCT02321956|ASA class 1,2|asa class 1,2
158614|NCT02321956|age 1-6 years|age 1-6 years
158615|NCT02321956|General anesthesia with ETT|general anesthesia with ett
158616|NCT02321930|Rheumatoid Arthritis|rheumatoid arthritis
158617|NCT02321930|Musculoskeletal Ultrasound|musculoskeletal ultrasound
158618|NCT02321930|Tofacitinib|tofacitinib
158619|NCT02321930|biomarker|biomarker
158620|NCT02321904|Confocal microscopy|confocal microscopy
158621|NCT02321904|Cornea|cornea
158622|NCT02321904|Neuropathy|neuropathy
158623|NCT02321904|Detection|detection
158624|NCT02321904|Diabetes|diabetes
158625|NCT02321839|neovascular age-related macular degeneration|neovascular age-related macular degeneration
158626|NCT02321839|Ranibizumab|ranibizumab
158627|NCT02321839|Treat and extend|treat and extend
158628|NCT02321813|quality of life|quality of life
158629|NCT02321813|colorectal cancer|colorectal cancer
158630|NCT02321813|definitive RCT|definitive rct
158631|NCT02321813|complex intervention|complex intervention
158632|NCT02321800|S-649266|s-649266
158633|NCT02321800|complicated urinary tract infection|complicated urinary tract infection
158634|NCT02321800|cefiderocol|cefiderocol
158635|NCT02321800|acute uncomplicated pyelonephritis|acute uncomplicated pyelonephritis
158636|NCT02321800|Gram-negative pathogens|gram-negative pathogens
158637|NCT02321800|imipenem/cilastatin|imipenem/cilastatin
158638|NCT02321787|Anesthesia, Caudal|anesthesia, caudal
158639|NCT02321787|Ultrasonography|ultrasonography
158640|NCT02321774|Stress|stress
158641|NCT02321774|Virtual Reality|virtual reality
158642|NCT02321774|Wearable Sensor|wearable sensor
158643|NCT02321774|Wellness|wellness
158644|NCT02321761|Amantadine hydrochloride|amantadine hydrochloride
158645|NCT02321761|Rehabilitation|rehabilitation
158646|NCT02321761|Acquired Brain Injury|acquired brain injury
158647|NCT02321761|TBI|tbi
158648|NCT02321748|HSV|hsv
158649|NCT02321748|Herpes|herpes
158650|NCT02321748|volunteers|volunteers
158651|NCT02321748|drug-drug interaction|drug-drug interaction
158652|NCT02321735|Long-Term Survivor|long-term survivor
158653|NCT02321735|Genomic|genomic
158654|NCT02321735|Survivorship|survivorship
158655|NCT02321735|Quality of Life|quality of life
158656|NCT02321722|Colonoscopy|colonoscopy
158657|NCT02321696|physiotherapy|physiotherapy
158658|NCT02321696|manual therapy|manual therapy
158659|NCT02321696|acupuncture|acupuncture
158660|NCT02321696|eccentric exercise|eccentric exercise
158661|NCT02321670|operative technique|operative technique
158662|NCT02321644|CC-90001|cc-90001
158663|NCT02321644|PHARMACOKINETICS|pharmacokinetics
158664|NCT02321644|PHARMACODYNAMICS|pharmacodynamics
158665|NCT02321644|HEALTHY SUBJECTS|healthy subjects
158666|NCT02321644|SINGLE DOSE|single dose
158667|NCT02321644|MULTIPLE DOSE|multiple dose
158668|NCT02321644|PUNCH BIOPSY|punch biopsy
158669|NCT02321631|Malnourished|malnourished
158670|NCT02321631|Head and Neck Cancer|head and neck cancer
158671|NCT02321631|Surgery|surgery
158672|NCT02321618|Hypertension|hypertension
158673|NCT02321618|High Blood Pressure|high blood pressure
158674|NCT02321618|African American men|african american men
158675|NCT02321618|Black men|black men
158676|NCT02321618|barbershop|barbershop
158677|NCT02321605|Best Possible Self|best possible self
158678|NCT02321605|Positive Psychology|positive psychology
158679|NCT02321605|Optimism|optimism
158680|NCT02321605|Positive Technology|positive technology
158681|NCT02321605|Future Thinking|future thinking
158682|NCT02321592|Hodgkin Lymphoma|hodgkin lymphoma
158683|NCT02321592|AFM13|afm13
158684|NCT02321592|Natural Killer Cells|natural killer cells
158685|NCT02321553|metabolic syndrome|metabolic syndrome
158686|NCT02321553|glucose|glucose
158687|NCT02321553|cholesterol|cholesterol
158688|NCT02321553|brown rice|brown rice
158689|NCT02321553|inflammation|inflammation
158690|NCT02321553|oxidative stress|oxidative stress
158691|NCT02321540|Lung Cancer|lung cancer
158692|NCT02321540|Non-small cell lung cancer|non-small cell lung cancer
158693|NCT02321540|NSCLC|nsclc
158694|NCT02321540|Epidermal growth factor receptor mutations|epidermal growth factor receptor mutations
158695|NCT02321540|EGFR|egfr
158696|NCT02321540|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
158697|NCT02321540|Ibrutinib|ibrutinib
158698|NCT02321540|PCI-32765|pci-32765
158699|NCT02321540|Imbruvica|imbruvica
158700|NCT02321527|Breast Cancer|breast cancer
158701|NCT02321527|Microbubble contrast-enhanced ultrasound|microbubble contrast-enhanced ultrasound
158702|NCT02321527|CEUS|ceus
158703|NCT02321527|Sentinel lymph nodes|sentinel lymph nodes
158705|NCT02321527|Perflutren Protein-Type A Microspheres Injectable Suspension|perflutren protein-type a microspheres injectable suspension
158706|NCT02321527|OPTISON™|optison™
158707|NCT02321527|Ultrasound|ultrasound
158708|NCT02321527|Breast biopsy|breast biopsy
158709|NCT02321527|Radioactive seed|radioactive seed
158710|NCT02321527|Phone call|phone call
158711|NCT02321527|Fine needle aspiration|fine needle aspiration
158712|NCT02321527|FNA|fna
158713|NCT02321501|Head and Neck Cancer|head and neck cancer
158714|NCT02321501|Lung Cancer|lung cancer
158715|NCT02321501|Non small cell lung|non small cell lung
158716|NCT02321501|NSCLC|nsclc
158717|NCT02321501|Metastatic|metastatic
158718|NCT02321501|Locally advanced|locally advanced
158719|NCT02321501|Metastatic solid tumors|metastatic solid tumors
158720|NCT02321501|Anaplastic lymphoma kinase|anaplastic lymphoma kinase
158721|NCT02321501|ALK|alk
158722|NCT02321501|Ceritinib|ceritinib
158723|NCT02321501|LDK378|ldk378
158724|NCT02321501|Zykadia|zykadia
158725|NCT02321501|Everolimus|everolimus
158726|NCT02321501|Afinitor|afinitor
158727|NCT02321501|Zortress|zortress
158728|NCT02321501|RAD001|rad001
158729|NCT02321501|Pharmacokinetic|pharmacokinetic
158730|NCT02321501|PK|pk
158731|NCT02321501|Biomarker testing|biomarker testing
158732|NCT02321475|Psycho-emotional symptoms|psycho-emotional symptoms
158733|NCT02321462|preparation|preparation
158734|NCT02321423|Nail Dystrophy|nail dystrophy
158735|NCT02321423|Plantar Keratoderma|plantar keratoderma
158736|NCT02321423|Palmar Keratoderma|palmar keratoderma
158737|NCT02321423|Leukokeratosis|leukokeratosis
158738|NCT02321423|Cysts|cysts
158739|NCT02321423|Pain|pain
158740|NCT02321423|KRT17|krt17
158741|NCT02321423|KRT16|krt16
158742|NCT02321423|KRT6A|krt6a
158743|NCT02321423|KRT6B|krt6b
158744|NCT02321423|KRT6C|krt6c
158745|NCT02321397|oxycodone naloxone combination|oxycodone naloxone combination
158746|NCT02321397|severe chronic and non-malignant pain|severe chronic and non-malignant pain
158747|NCT02321397|Malignant and non-malignant pain that requires around-the clock opioid therapy|malignant and non-malignant pain that requires around-the clock opioid therapy
158748|NCT02321358|Behavior Change|behavior change
158749|NCT02321358|Objectively Measured Physical Activity|objectively measured physical activity
158750|NCT02321358|Survivorship|survivorship
158751|NCT02321345|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
158752|NCT02321345|Hematological Malignancies|hematological malignancies
158753|NCT02321345|Palliative Care|palliative care
158754|NCT02321345|Supportive care|supportive care
158755|NCT02321332|Palmar hyperhidrosis|palmar hyperhidrosis
158756|NCT02321332|Endoscopic thoracic sympathectomy|endoscopic thoracic sympathectomy
158757|NCT02321319|chronic pain|chronic pain
158758|NCT02321319|pediatric|pediatric
158759|NCT02321293|curcumin|curcumin
158760|NCT02321293|lung cancer|lung cancer
158762|NCT02321267|AMD|amd
158763|NCT02321267|PCV|pcv
158764|NCT02321267|RAP|rap
158765|NCT02321267|RVO|rvo
158767|NCT02321267|ERM|erm
158768|NCT02321267|MH|mh
158769|NCT02321267|mCNV|mcnv
158770|NCT02321254|Stroke|stroke
158771|NCT02321254|Upper limb|upper limb
158772|NCT02321254|Robotics|robotics
158773|NCT02321254|Electromyography|electromyography
158774|NCT02321254|Rehabilitation|rehabilitation
158775|NCT02321241|Wet-AMD|wet-amd
158776|NCT02321241|Refractory patients to ranibizumab|refractory patients to ranibizumab
158777|NCT02321241|Real life|real life
158778|NCT02321241|Switch|switch
158779|NCT02321241|Aflibercept|aflibercept
158780|NCT02321228|Salpingectomy|salpingectomy
158781|NCT02321228|Delayed oophorectomy|delayed oophorectomy
158782|NCT02321228|Salpingo-oophorectomy|salpingo-oophorectomy
158783|NCT02321228|Quality of life|quality of life
158784|NCT02321228|Ovarian cancer|ovarian cancer
158785|NCT02321228|BRCA|brca
158786|NCT02321215|AECOPD|aecopd
158787|NCT02321215|COPD|copd
158788|NCT02321215|education|education
158789|NCT02321202|omega-3|omega-3
158790|NCT02321202|Progression|progression
158791|NCT02321202|parenteral nutrition|parenteral nutrition
158792|NCT02321150|Pterygium|pterygium
158793|NCT02321150|Pterygiums|pterygiums
158794|NCT02321150|Pterygia|pterygia
158795|NCT02321150|Graft|graft
158796|NCT02321150|Autograft|autograft
158797|NCT02321150|Excision|excision
158798|NCT02321150|Surgery|surgery
158799|NCT02321150|Eye|eye
158800|NCT02321150|electrocautery|electrocautery
158801|NCT02321150|polyglactin|polyglactin
158802|NCT02321124|Constipation|constipation
158803|NCT02321124|connective tissue manipulation|connective tissue manipulation
158804|NCT02321124|conservative therapy|conservative therapy
158805|NCT02321124|massage|massage
158806|NCT02321124|randomized controlled trial|randomized controlled trial
158807|NCT02321111|Insulin signaling and glucose disposal in muscle|insulin signaling and glucose disposal in muscle
158808|NCT02321111|Hepatic insulin sensitivity|hepatic insulin sensitivity
158809|NCT02321111|TLR4 signaling and inflammatory gene expression|tlr4 signaling and inflammatory gene expression
158810|NCT02321111|Plasma cytokine concentration|plasma cytokine concentration
158811|NCT02321111|Intramyocellular diacylglycerol and ceramide content|intramyocellular diacylglycerol and ceramide content
158812|NCT02321098|Onychomycosis|onychomycosis
158813|NCT02321098|antifungal|antifungal
158814|NCT02321072|oxygen|oxygen
158815|NCT02321072|hypoxia|hypoxia
158816|NCT02321072|hyperoxia|hyperoxia
158817|NCT02321072|critical care|critical care
158818|NCT02321072|intensive care|intensive care
158819|NCT02321059|incisional hernia|incisional hernia
158820|NCT02321059|hernia|hernia
158821|NCT02321059|abdominal wall strength|abdominal wall strength
158822|NCT02321059|validation|validation
158823|NCT02321059|physical activity|physical activity
158824|NCT02321046|Non-Small Cell Lung Cancer, NSCLC, Epidermal growth factor receptor, EGFR|non-small cell lung cancer, nsclc, epidermal growth factor receptor, egfr
158825|NCT02321033|glycemic index|glycemic index
158826|NCT02321033|inactivity|inactivity
158827|NCT02321033|insulin sensitivity|insulin sensitivity
158828|NCT02321033|metabolic flexibility|metabolic flexibility
158829|NCT02321033|arterial stiffness|arterial stiffness
158830|NCT02321033|young men|young men
158831|NCT02320994|stroke|stroke
158832|NCT02320994|aftercare|aftercare
158833|NCT02320981|GERD|gerd
158835|NCT02320981|pH testing|ph testing
158836|NCT02320981|eosinophilic esophagitis|eosinophilic esophagitis
158837|NCT02320981|impedance testing|impedance testing
158838|NCT02320955|autologous bone flap|autologous bone flap
158839|NCT02320955|decompressive craniectomy|decompressive craniectomy
158840|NCT02320955|malignant brain swelling|malignant brain swelling
158841|NCT02320955|patient specific implant|patient specific implant
158842|NCT02320955|bone resorption|bone resorption
158843|NCT02320955|aseptic bone necrosis|aseptic bone necrosis
158844|NCT02320942|Bone Marrow Transplantation|bone marrow transplantation
158845|NCT02320942|Exercise|exercise
158846|NCT02320942|Rehabilitation|rehabilitation
158847|NCT02320942|Cancer|cancer
158848|NCT02320929|irrigation|irrigation
158849|NCT02320929|tenosynovitis|tenosynovitis
158850|NCT02320929|purulent|purulent
158851|NCT02320929|closed-catheter|closed-catheter
158852|NCT02320929|flexor tendon|flexor tendon
158853|NCT02320903|Criminal Justice|criminal justice
158854|NCT02320903|Juvenile Delinquency|juvenile delinquency
158855|NCT02320890|transcranial direct current stimulation|transcranial direct current stimulation
158856|NCT02320890|tDCS|tdcs
158857|NCT02320890|Mild Cognitive Impairment|mild cognitive impairment
158858|NCT02320890|MCI|mci
158859|NCT02320864|muscle strength|muscle strength
158860|NCT02320864|muscle weakness|muscle weakness
158861|NCT02320864|hospitalization|hospitalization
158862|NCT02320864|surgery|surgery
158863|NCT02320864|total knee replacement|total knee replacement
158864|NCT02320851|Somatoform disorder|somatoform disorder
158865|NCT02320851|Functional vertigo/dizziness|functional vertigo/dizziness
158866|NCT02320851|Chronic subjective dizziness|chronic subjective dizziness
158867|NCT02320838|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
158868|NCT02320838|Electric Stimulation Therapy|electric stimulation therapy
158869|NCT02320838|Unmodulated Alternating Currents|unmodulated alternating currents
158870|NCT02320838|Neural Conduction|neural conduction
158871|NCT02320838|Pain Threshold|pain threshold
158872|NCT02320825|Stereotactic Radiosurgery (SRS)|stereotactic radiosurgery (srs)
158873|NCT02320825|Single-Fraction|single-fraction
158874|NCT02320825|Hypofractionated|hypofractionated
158875|NCT02320825|Spinal surgery|spinal surgery
158876|NCT02320825|14-233|14-233
158877|NCT02320799|interpersonal psychotherapy|interpersonal psychotherapy
158878|NCT02320799|HIV|hiv
158879|NCT02320799|women|women
158880|NCT02320799|gender based violence|gender based violence
158881|NCT02320799|mental health|mental health
158882|NCT02320799|africa|africa
158883|NCT02320799|kenya|kenya
158884|NCT02320799|global mental health|global mental health
158885|NCT02320799|HIV treatment adherence|hiv treatment adherence
158886|NCT02320786|Power mobility|power mobility
158887|NCT02320786|Wheelchair skills training|wheelchair skills training
158888|NCT02320786|Spinal Cord Injury|spinal cord injury
158889|NCT02320773|Overactive Bladder|overactive bladder
158890|NCT02320773|Quality of Life|quality of life
158891|NCT02320773|Betanis®|betanis®
158892|NCT02320773|Betmiga®|betmiga®
158893|NCT02320773|Observational|observational
158894|NCT02320773|Myrbetriq®|myrbetriq®
158895|NCT02320747|Volunteers|volunteers
158896|NCT02320734|surgical rating scale|surgical rating scale
158897|NCT02320734|neuromuscular relaxation|neuromuscular relaxation
158898|NCT02320734|Anaesthesia|anaesthesia
158899|NCT02320734|minimally invasive esophagectomy|minimally invasive esophagectomy
158900|NCT02320708|Molar,third; Teeth,wisdom; Pain, Postoperative; Dental Surgery; Third molar extraction|molar,third; teeth,wisdom; pain, postoperative; dental surgery; third molar extraction
158901|NCT02320643|Partially absorbable mesh|partially absorbable mesh
158902|NCT02320617|Lung Neoplasms|lung neoplasms
158903|NCT02320617|diffusion weighted MRI|diffusion weighted mri
158904|NCT02320617|ADC value|adc value
158905|NCT02320617|treatment effect|treatment effect
158906|NCT02320604|Liposomal amphotericin B|liposomal amphotericin b
158907|NCT02320604|AmBisome|ambisome
158908|NCT02320604|Pharmacokinetics|pharmacokinetics
158910|NCT02320604|Bariatric surgery|bariatric surgery
158911|NCT02320578|Neoadjuvant Chemoptherapy|neoadjuvant chemoptherapy
158912|NCT02320578|Laparoscopy 3D|laparoscopy 3d
158913|NCT02320578|Cervical cancer|cervical cancer
158914|NCT02320565|Endometrial Cancer|endometrial cancer
158915|NCT02320565|Laparoscopy 3D|laparoscopy 3d
158916|NCT02320552|Nutritional assessment|nutritional assessment
158917|NCT02320539|MicroRNA|microrna
158918|NCT02320539|Cerebrospinal fluid|cerebrospinal fluid
158919|NCT02320526|Exercise|exercise
158920|NCT02320526|Training|training
158921|NCT02320526|Interval training|interval training
158922|NCT02320526|Systemic inflammation|systemic inflammation
158923|NCT02320526|Glucose disposal|glucose disposal
158924|NCT02320526|Insulin sensitivity|insulin sensitivity
158925|NCT02320526|Glucose effectiveness|glucose effectiveness
158926|NCT02320513|Exercise|exercise
158927|NCT02320461|diabetes mellitus|diabetes mellitus
158928|NCT02320461|cardiovascular diseases|cardiovascular diseases
158929|NCT02320461|cohort studies|cohort studies
158930|NCT02320461|hypertension|hypertension
158931|NCT02320461|obesity|obesity
158932|NCT02320461|smoking|smoking
158933|NCT02320461|social class|social class
158934|NCT02320422|liver transplant|liver transplant
401973|NCT01232478|Adherence|adherence
158935|NCT02320422|medication adherence|medication adherence
158936|NCT02320422|intervention|intervention
158937|NCT02320409|Subjects|subjects
158938|NCT02320383|CLL|cll
158939|NCT02320357|Platelet activation|platelet activation
158940|NCT02320357|CD40 ligand|cd40 ligand
158941|NCT02320357|CD154|cd154
158942|NCT02320357|Interferon alpha|interferon alpha
158943|NCT02320357|clopidogrel|clopidogrel
158944|NCT02320318|Irritable Bowel Syndrome|irritable bowel syndrome
158945|NCT02320318|Colon, irritable|colon, irritable
158946|NCT02320318|Bowel disease|bowel disease
158947|NCT02320318|Diarrhea|diarrhea
158948|NCT02320279|Fetal Heart Rate|fetal heart rate
158949|NCT02320279|Fetal EKG|fetal ekg
158950|NCT02320279|FHR tracing|fhr tracing
158951|NCT02320279|fetal R-waves|fetal r-waves
158952|NCT02320266|Deep Brain Stimulation Surgery|deep brain stimulation surgery
158953|NCT02320253|Diabetes|diabetes
158954|NCT02320253|Obesity|obesity
158955|NCT02320253|Primary Care|primary care
158956|NCT02320253|Lifestyle Intervention|lifestyle intervention
158957|NCT02320240|antidepressants|antidepressants
158958|NCT02320240|acute kidney injury|acute kidney injury
158959|NCT02320240|SNRI|snri
158960|NCT02320240|renal failure|renal failure
158961|NCT02320240|duloxetine|duloxetine
158962|NCT02320240|CNODES|cnodes
158963|NCT02320188|modification of treatment planned|modification of treatment planned
158964|NCT02320188|Exercise|exercise
158965|NCT02320175|family centered rounds|family centered rounds
158966|NCT02320175|patient safety|patient safety
158967|NCT02320175|errors|errors
158968|NCT02320175|adverse events|adverse events
158969|NCT02320175|concordance|concordance
158970|NCT02320175|patient experience|patient experience
158971|NCT02320149|acne|acne
158972|NCT02320123|Terminal Care|terminal care
158973|NCT02320123|Decision Making|decision making
158974|NCT02320123|Communication|communication
158975|NCT02320110|Irisin|irisin
158976|NCT02320110|Adiponectin|adiponectin
158978|NCT02320110|Insulin resistance|insulin resistance
158979|NCT02320110|Body Mass Index|body mass index
158980|NCT02320110|Obesity|obesity
158981|NCT02320110|Metabolic Syndrome|metabolic syndrome
158982|NCT02320110|Lipid Profile|lipid profile
158983|NCT02320110|Diabetes Mellitus|diabetes mellitus
158984|NCT02320084|HT-1|ht-1
158985|NCT02320084|Hereditary Tyrosinemia, Type I|hereditary tyrosinemia, type i
158986|NCT02320084|hypertyrosinemia type 1|hypertyrosinemia type 1
158987|NCT02320084|Orfadin|orfadin
158988|NCT02320084|Long term safety|long term safety
158989|NCT02320084|Hereditary Tyrosinemia Type 1|hereditary tyrosinemia type 1
158990|NCT02320032|Alkermes|alkermes
158991|NCT02320032|Schizophrenia|schizophrenia
158992|NCT02320032|Aripiprazole|aripiprazole
158993|NCT02320032|Aripiprazole lauroxil|aripiprazole lauroxil
158994|NCT02320032|ALKS 9072|alks 9072
158995|NCT02320006|hydrotubation|hydrotubation
158996|NCT02320006|incomplete fallopian tube obstructive infertility|incomplete fallopian tube obstructive infertility
158997|NCT02320006|Acupuncture|acupuncture
158998|NCT02319993|Suan-Zao-Ren Tang|suan-zao-ren tang
158999|NCT02319993|Tian-wang-bu-xin-dan|tian-wang-bu-xin-dan
159000|NCT02319993|Traditional Chinese Medicine|traditional chinese medicine
159001|NCT02319993|Herbs|herbs
159002|NCT02319993|Quality of life|quality of life
159003|NCT02319967|community health worker|community health worker
159004|NCT02319967|emergency|emergency
159005|NCT02319967|asthma|asthma
159006|NCT02319941|Inhibition of Platelet Reactivity|inhibition of platelet reactivity
159007|NCT02319941|ticagrelor|ticagrelor
159008|NCT02319941|clopidogrel|clopidogrel
159009|NCT02319941|Pharmacodynamics|pharmacodynamics
159010|NCT02319941|Pharmacokinetics|pharmacokinetics
159011|NCT02319915|tranexamic acid|tranexamic acid
159012|NCT02319915|knee prosthesis|knee prosthesis
159013|NCT02319915|pharmacokinetic profile|pharmacokinetic profile
159014|NCT02319863|hepatocellular carcinoma|hepatocellular carcinoma
159015|NCT02319863|prognosis|prognosis
159016|NCT02319850|sarcopenia|sarcopenia
159017|NCT02319850|screening|screening
159019|NCT02319850|muscle|muscle
159020|NCT02319850|aging|aging
159021|NCT02319850|ultrasound|ultrasound
159022|NCT02319798|Crohn's disease|crohn's disease
159023|NCT02319798|ulcerative colitis|ulcerative colitis
159024|NCT02319798|Inflammatory bowel disease|inflammatory bowel disease
159025|NCT02319798|IBD|ibd
159026|NCT02319772|Healthy volunteers|healthy volunteers
159027|NCT02319772|Ebola virus|ebola virus
159028|NCT02319772|Filovirus|filovirus
159029|NCT02319759|Psoriatic Arthritis|psoriatic arthritis
159030|NCT02319759|Guselkumab|guselkumab
159031|NCT02319759|Ustekinumab|ustekinumab
159032|NCT02319759|Placebo|placebo
159033|NCT02319694|Basal Ganglia|basal ganglia
159034|NCT02319694|Behavior|behavior
159035|NCT02319694|Behavioral|behavioral
159036|NCT02319694|Brain|brain
159037|NCT02319694|Cognitive|cognitive
159038|NCT02319694|Computer Simulation|computer simulation
159039|NCT02319694|Cues|cues
159040|NCT02319694|Data|data
159041|NCT02319694|Deep Brain Stimulation|deep brain stimulation
159042|NCT02319694|Disease|disease
159043|NCT02319681|Caregivers|caregivers
159044|NCT02319681|Anxiety|anxiety
159045|NCT02319681|Depression|depression
159046|NCT02319655|Epiretinal membrane|epiretinal membrane
159047|NCT02319655|Macular pucker|macular pucker
159048|NCT02319655|Membrane peeling|membrane peeling
159049|NCT02319655|pars plana vitrectomy|pars plana vitrectomy
159050|NCT02319655|Air|air
159051|NCT02319655|balanced salt solution|balanced salt solution
159052|NCT02319655|Intraoperative OCT|intraoperative oct
159053|NCT02319655|Hyporeflectivity|hyporeflectivity
159054|NCT02319655|Retina|retina
159055|NCT02319642|Rheumatoid Arthritis|rheumatoid arthritis
159056|NCT02319642|TNFα antagonist|tnfα antagonist
159057|NCT02319642|Certolizumab pegol|certolizumab pegol
159058|NCT02319642|Chinese patients|chinese patients
159059|NCT02319642|Open-label|open-label
159060|NCT02319629|Morbid obesity,|morbid obesity,
159061|NCT02319629|Cholelithiasis|cholelithiasis
159062|NCT02319629|Bariatric surgery|bariatric surgery
159063|NCT02319629|Ursodiol|ursodiol
159064|NCT02319577|NSCLC|nsclc
159065|NCT02319577|EGFR|egfr
150015|NCT02371694|Lipid|lipid
150016|NCT02371694|Carbohydrate counting|carbohydrate counting
150017|NCT02371694|Adolescent|adolescent
150018|NCT02371694|Continuous glucose monitoring|continuous glucose monitoring
150019|NCT02371694|Insulin requirements|insulin requirements
150020|NCT02371681|HR2E/RIPE|hr2e/ripe
150021|NCT02371681|South Africa|south africa
159066|NCT02319577|vinorelbine|vinorelbine
159067|NCT02319577|gefitinib|gefitinib
159068|NCT02319564|Wheeze|wheeze
159069|NCT02319564|Asthma|asthma
159070|NCT02319564|Randomized Trial|randomized trial
159776|NCT02315638|shRNA|shrna
159071|NCT02319564|Pre-school aged children|pre-school aged children
159072|NCT02319525|lupus nephritis|lupus nephritis
159073|NCT02319525|lupus|lupus
159074|NCT02319525|decision-making|decision-making
159075|NCT02319525|minorities|minorities
159076|NCT02319525|immunosuppressive medications|immunosuppressive medications
159077|NCT02319525|decision-aid|decision-aid
159078|NCT02319525|treatment|treatment
159079|NCT02319525|Decision conflict|decision conflict
159080|NCT02319525|SLE|sle
159081|NCT02319486|Retinoblastoma|retinoblastoma
159082|NCT02319486|carboplatin|carboplatin
159083|NCT02319473|system of care|system of care
159181|NCT02318940|pediatric|pediatric
159084|NCT02319473|acute myocardial infarction|acute myocardial infarction
159085|NCT02319473|registry|registry
159086|NCT02319473|Primary PCI|primary pci
159087|NCT02319473|Fibrinolytic therapy|fibrinolytic therapy
159088|NCT02319460|Vitamin K Reversal Antagonist Therapy of Acute Major Bleeding|vitamin k reversal antagonist therapy of acute major bleeding
159089|NCT02319460|Warfarin Reversal|warfarin reversal
159090|NCT02319447|Living Donation|living donation
159091|NCT02319447|Kidney Transplantation|kidney transplantation
159092|NCT02319421|Alarm fatigue|alarm fatigue
159093|NCT02319395|Parkinson's Disease|parkinson's disease
159094|NCT02319395|Behaviour addiction|behaviour addiction
159095|NCT02319395|Dopamine agonist|dopamine agonist
159096|NCT02319395|Genetic.|genetic.
159097|NCT02319382|Parkinson Disease|parkinson disease
159098|NCT02319382|[18F]DPA-714|[18f]dpa-714
159099|NCT02319382|Positron emission tomography (PET)|positron emission tomography (pet)
159100|NCT02319382|Neuroinflammation|neuroinflammation
159101|NCT02319343|Glucocorticoid|glucocorticoid
159102|NCT02319343|Quadriceps muscle function|quadriceps muscle function
159103|NCT02319343|Knee arthroplasty, total|knee arthroplasty, total
159104|NCT02319330|HIV|hiv
159105|NCT02319330|Adherence|adherence
159106|NCT02319330|Mental health|mental health
159107|NCT02319330|Depression|depression
159108|NCT02319330|Women|women
159109|NCT02319330|Mobile phone technology|mobile phone technology
159110|NCT02319330|eHealth|ehealth
159111|NCT02319330|India|india
159112|NCT02319304|Pelvic Radiotherapy|pelvic radiotherapy
159113|NCT02319304|Rectal Adenocarcinoma|rectal adenocarcinoma
159114|NCT02319265|sepsis|sepsis
159115|NCT02319265|antioxidant|antioxidant
159116|NCT02319265|melatonin|melatonin
159117|NCT02319265|inflammation|inflammation
159118|NCT02319239|Prostate neoplasms|prostate neoplasms
159119|NCT02319239|Urogenital neoplasms|urogenital neoplasms
159120|NCT02319239|Genital neoplasms, male|genital neoplasms, male
159121|NCT02319239|Radiation therapy|radiation therapy
159122|NCT02319239|PSA|psa
159123|NCT02319239|DW-MRI, diffusion weighted MRI|dw-mri, diffusion weighted mri
159124|NCT02319239|Intra-fractional movement|intra-fractional movement
159125|NCT02319239|Hypofractionated radiotherapy|hypofractionated radiotherapy
159126|NCT02319239|Stereotactic|stereotactic
159127|NCT02319239|Toxicity due to radiotherapy|toxicity due to radiotherapy
159128|NCT02319239|Quality of life|quality of life
159129|NCT02319213|Intra-abdominal pressure,|intra-abdominal pressure,
159130|NCT02319213|intraocular pressure,|intraocular pressure,
159131|NCT02319213|abdominal hypertension,|abdominal hypertension,
159132|NCT02319213|laparoscopy,|laparoscopy,
159133|NCT02319213|critical care|critical care
159134|NCT02319200|Chemoprevention|chemoprevention
159135|NCT02319200|Decompensation of cirrhosis|decompensation of cirrhosis
159136|NCT02319200|Hepatocellular Carcinoma|hepatocellular carcinoma
159137|NCT02319200|Death|death
159138|NCT02319200|Efficacy|efficacy
159139|NCT02319200|Safety|safety
159140|NCT02319187|Esophageal Neoplasms|esophageal neoplasms
159141|NCT02319161|intravenous regional anesthesia|intravenous regional anesthesia
159142|NCT02319135|Acute Myeloid Leukemia|acute myeloid leukemia
159143|NCT02319122|Cerebral Palsy|cerebral palsy
159144|NCT02319122|Muscle structure|muscle structure
159145|NCT02319122|Strength training|strength training
159146|NCT02319096|Whole body vibration therapy|whole body vibration therapy
159147|NCT02319096|pelvic floor muscle training|pelvic floor muscle training
159148|NCT02319096|stress urinary incontinence|stress urinary incontinence
159149|NCT02319083|CABG|cabg
159150|NCT02319083|Coronary artery bypass surgery|coronary artery bypass surgery
159151|NCT02319083|Coronary artery bypass grafting|coronary artery bypass grafting
159152|NCT02319083|Coronary surgery|coronary surgery
159153|NCT02319083|Myocardial infarction|myocardial infarction
159154|NCT02319083|Coronary artery disease|coronary artery disease
159155|NCT02319083|Off-pump|off-pump
159156|NCT02319083|EuroSCORE|euroscore
159157|NCT02319070|Cost|cost
159158|NCT02319070|Clinical Outcomes|clinical outcomes
159159|NCT02319070|Quality of Life|quality of life
159160|NCT02319070|On Demand Treatment|on demand treatment
159161|NCT02319070|Secondary Prophylaxis|secondary prophylaxis
159162|NCT02319057|Healthy volunteer study|healthy volunteer study
159163|NCT02319044|Head and neck cancer; SCCHN|head and neck cancer; scchn
159164|NCT02319005|Cardiomyopathy|cardiomyopathy
159165|NCT02319005|Heart Failure|heart failure
159167|NCT02319005|Amyloid|amyloid
159168|NCT02319005|Transthyretin|transthyretin
159169|NCT02319005|TTR|ttr
159170|NCT02319005|RNAi therapeutic|rnai therapeutic
159171|NCT02318953|Telemedicine|telemedicine
159172|NCT02318953|Ambulatory Surgical Procedures|ambulatory surgical procedures
159173|NCT02318953|Postoperative Care|postoperative care
159174|NCT02318953|Cost Effectiveness|cost effectiveness
159175|NCT02318953|Mobile Applications|mobile applications
159176|NCT02318953|Health Services Research|health services research
159177|NCT02318953|Breast Reconstruction|breast reconstruction
159178|NCT02318940|ultrasound guided|ultrasound guided
159179|NCT02318940|femoral vein|femoral vein
159180|NCT02318940|central venous catheter|central venous catheter
159182|NCT02318927|Deep Brain Stimulation|deep brain stimulation
159183|NCT02318914|Pyoderma Gangrenosum|pyoderma gangrenosum
159184|NCT02318914|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
159185|NCT02318888|Small bowel obstruction, Surgery, Colorectal cancer|small bowel obstruction, surgery, colorectal cancer
159186|NCT02318875|Inflammation|inflammation
159187|NCT02318875|swell|swell
159188|NCT02318875|pain|pain
159189|NCT02318875|functional impairment|functional impairment
159190|NCT02318875|stiffness|stiffness
159191|NCT02318862|reflux|reflux
159192|NCT02318862|GERD|gerd
159193|NCT02318862|EGD|egd
159194|NCT02318862|pH testing|ph testing
159195|NCT02318849|designated organ donor, college students|designated organ donor, college students
159196|NCT02318836|hepatic, hepatic impairment, lofexidine|hepatic, hepatic impairment, lofexidine
159197|NCT02318823|social neuroscience|social neuroscience
159198|NCT02318823|emotion|emotion
159199|NCT02318823|face recognition|face recognition
159200|NCT02318823|empathy|empathy
159201|NCT02318823|beer|beer
159202|NCT02318823|alcohol|alcohol
159203|NCT02318823|social cognition|social cognition
159204|NCT02318810|Muscle relaxants|muscle relaxants
159205|NCT02318797|Chronic disease|chronic disease
159206|NCT02318797|Mental Health|mental health
159207|NCT02318797|Behavioral Health|behavioral health
159208|NCT02318797|Community mental health centers|community mental health centers
159209|NCT02318797|Intervention studies|intervention studies
159210|NCT02318797|Mixed methods|mixed methods
159211|NCT02318797|Qualitative research|qualitative research
159212|NCT02318784|neuroendocrine malignancies|neuroendocrine malignancies
159213|NCT02318784|pancreatic neuroendocrine tumors (PNETs)|pancreatic neuroendocrine tumors (pnets)
159214|NCT02318784|gastrointestinal (GI) carcinoids|gastrointestinal (gi) carcinoids
159215|NCT02318784|carfilzomib|carfilzomib
159216|NCT02318784|Kyprolis|kyprolis
159217|NCT02318784|proteasome inhibitors|proteasome inhibitors
159218|NCT02318758|This is a healthy volunteer study.|this is a healthy volunteer study.
159219|NCT02318745|Family Therapy|family therapy
159220|NCT02318745|Substance abuse prevention|substance abuse prevention
159222|NCT02318745|randomized trials|randomized trials
159223|NCT02318745|outcome research|outcome research
159224|NCT02318745|adolescent treatment|adolescent treatment
159225|NCT02318732|violence|violence
159226|NCT02318719|Post-Herpetic Neuralgia|post-herpetic neuralgia
159227|NCT02318719|Developmental Phase III|developmental phase iii
159228|NCT02318706|Diabetic Peripheral Neuropathic Pain|diabetic peripheral neuropathic pain
159229|NCT02318641|oxygen consumption|oxygen consumption
159230|NCT02318641|retinal oximetry|retinal oximetry
159231|NCT02318628|Cardio ankle vascular index|cardio ankle vascular index
159232|NCT02318628|CAVI|cavi
159233|NCT02318628|pulse wave velocity|pulse wave velocity
159234|NCT02318628|PWV|pwv
159235|NCT02318628|Non invasive arterial structure assessment|non invasive arterial structure assessment
159247|NCT02318472|Patient related outcome|patient related outcome
159248|NCT02318472|Heel rise test|heel rise test
159249|NCT02318472|Immobilization|immobilization
159250|NCT02318446|Anti-epileptic drugs|anti-epileptic drugs
159251|NCT02318446|Folic acid|folic acid
159252|NCT02318446|Homocysteine|homocysteine
159253|NCT02318433|DRF|drf
159254|NCT02318433|PTOA|ptoa
159255|NCT02318433|dexamethasone|dexamethasone
159256|NCT02318420|Obstetrics|obstetrics
159257|NCT02318420|Partogram|partogram
159258|NCT02318420|ePartogram|epartogram
192922|NCT02148328|Safety|safety
159259|NCT02318420|eHealth|ehealth
159260|NCT02318420|Low-income|low-income
159261|NCT02318420|Quality of care|quality of care
159262|NCT02318420|Perinatal death|perinatal death
159263|NCT02318420|Maternal death|maternal death
159264|NCT02318420|Cesarean section|cesarean section
159265|NCT02318420|Health information technology|health information technology
159266|NCT02318394|advanced solid tumors; immunotherapy; OX40; immuno-oncology|advanced solid tumors; immunotherapy; ox40; immuno-oncology
159267|NCT02318381|suprascapular nerve|suprascapular nerve
159268|NCT02318381|rotator cuff tear|rotator cuff tear
159269|NCT02318381|suprascapular neuropathy|suprascapular neuropathy
159270|NCT02318381|superior transverse scapular ligament|superior transverse scapular ligament
159271|NCT02318355|hemodilution|hemodilution
159272|NCT02318355|hemorrhage|hemorrhage
159273|NCT02318355|trauma|trauma
159274|NCT02318355|lactate|lactate
159275|NCT02318355|base deficit|base deficit
159276|NCT02318355|randomized control trial|randomized control trial
159377|NCT02317770|lidocaine, esophago-gastro-duodenoscopy|lidocaine, esophago-gastro-duodenoscopy
159277|NCT02318329|FGFR2b, FGFR2, FGFR, bladder neoplasms, esophageal cancer|fgfr2b, fgfr2, fgfr, bladder neoplasms, esophageal cancer
159278|NCT02318316|Exhaled breath condensate|exhaled breath condensate
159279|NCT02318316|allogeneic stem cell transplantation|allogeneic stem cell transplantation
159280|NCT02318316|pulmonary complications|pulmonary complications
159281|NCT02318290|Analgesia|analgesia
159282|NCT02318290|Critical Care|critical care
159283|NCT02318290|Hypnotics and Sedatives|hypnotics and sedatives
159284|NCT02318251|Power, rate of force development|power, rate of force development
159285|NCT02318251|involuntary|involuntary
159286|NCT02318251|reflexive|reflexive
159287|NCT02318238|evaluation|evaluation
159288|NCT02318238|exercise tolerance|exercise tolerance
159289|NCT02318238|healthy children|healthy children
159290|NCT02318238|6MWT|6mwt
159291|NCT02318225|Misoprostol|misoprostol
159292|NCT02318225|Office hysteroscopy|office hysteroscopy
159293|NCT02318225|Pain|pain
159294|NCT02318212|Cervical dilatation|cervical dilatation
159295|NCT02318199|emergence agitation|emergence agitation
159296|NCT02318199|intracranial surgery|intracranial surgery
159297|NCT02318199|general anesthesia|general anesthesia
159298|NCT02318199|incidence|incidence
159299|NCT02318199|risk factor|risk factor
159300|NCT02318186|pharmacokinetic analysis|pharmacokinetic analysis
159301|NCT02318186|remodulin|remodulin
159302|NCT02318186|trepostinil|trepostinil
159303|NCT02318186|pulmonary arterial hypertension|pulmonary arterial hypertension
159304|NCT02318173|Cervical dilatation|cervical dilatation
159305|NCT02318160|Autoimmune Thyroiditis|autoimmune thyroiditis
159306|NCT02318160|Oxidative Status|oxidative status
159307|NCT02318160|Children|children
159308|NCT02318147|Severe acute pancreatitis|severe acute pancreatitis
159309|NCT02318147|Fecal Microbiota Transplantation|fecal microbiota transplantation
159310|NCT02318147|Bacterial Translocation|bacterial translocation
159311|NCT02318147|Infectious Complications|infectious complications
159312|NCT02318134|Severe acute pancreatitis|severe acute pancreatitis
159313|NCT02318134|Fecal Microbiota Transplantation|fecal microbiota transplantation
159314|NCT02318134|Intestinal barrier dysfunction|intestinal barrier dysfunction
159315|NCT02318134|Intestinal flora|intestinal flora
159316|NCT02318121|Labor, prolonged labor, augmentation of labor|labor, prolonged labor, augmentation of labor
159317|NCT02318108|Organizational Innovation|organizational innovation
159318|NCT02318108|Primary Health Care|primary health care
159319|NCT02318095|Cancer of the pancreas|cancer of the pancreas
159320|NCT02318082|Chronic versus Graft Host Disease|chronic versus graft host disease
159321|NCT02318069|immune response|immune response
159322|NCT02318069|TBE-vaccine|tbe-vaccine
159323|NCT02318069|elderly|elderly
159324|NCT02318069|additional doses|additional doses
159325|NCT02318056|hand|hand
159326|NCT02318056|burns|burns
159327|NCT02318056|thermal|thermal
159328|NCT02318056|dressing|dressing
159329|NCT02318056|Aquacel®|aquacel®
159330|NCT02318056|Mepilex® Transfer Ag|mepilex® transfer ag
159331|NCT02318056|Xeroform®|xeroform®
159332|NCT02318056|Bacitracin®|bacitracin®
159333|NCT02318056|partial thickness|partial thickness
159334|NCT02318056|epithelialization|epithelialization
159335|NCT02318056|wound healing|wound healing
159336|NCT02318056|scar|scar
159337|NCT02318056|scarring|scarring
159338|NCT02318043|adenosine monophosphate|adenosine monophosphate
159339|NCT02318043|histamine|histamine
159340|NCT02318043|bronchial provocation test|bronchial provocation test
159341|NCT02318043|asthma symptom score|asthma symptom score
159342|NCT02318043|asthma control|asthma control
159343|NCT02318030|Transplant|transplant
159344|NCT02318030|Adaptive Immunity|adaptive immunity
159346|NCT02318030|Medication Adherence|medication adherence
159347|NCT02318030|Tacrolimus|tacrolimus
159348|NCT02318030|PTLD|ptld
159349|NCT02318017|adhd|adhd
159350|NCT02318017|global network|global network
159351|NCT02318017|eeg|eeg
150343|NCT02369822|EEG|eeg
159352|NCT02318004|telemonitoring|telemonitoring
159353|NCT02317991|gastroesophageal adenocarcinoma|gastroesophageal adenocarcinoma
159354|NCT02317991|nab-paclitaxel|nab-paclitaxel
159355|NCT02317991|Abraxane|abraxane
159356|NCT02317991|ramucirumab|ramucirumab
159357|NCT02317991|Cyramza|cyramza
159358|NCT02317991|GE junction|ge junction
159359|NCT02317913|Kawasaki disease|kawasaki disease
159360|NCT02317913|Epidemiology|epidemiology
159361|NCT02317913|Incidence|incidence
159362|NCT02317913|Coronary arterial lesions|coronary arterial lesions
159363|NCT02317913|Shanghai|shanghai
159364|NCT02317887|Gene Transfer|gene transfer
159365|NCT02317887|X-Linked|x-linked
159366|NCT02317887|Retinoschisis|retinoschisis
159367|NCT02317887|AAV Vector|aav vector
159368|NCT02317848|Diagnosis|diagnosis
159369|NCT02317848|prognostic marker|prognostic marker
159370|NCT02317848|polygraphy|polygraphy
159371|NCT02317848|echocardiography|echocardiography
159372|NCT02317848|ECG|ecg
159373|NCT02317809|Healthy|healthy
159374|NCT02317809|Pergoveris|pergoveris
159375|NCT02317809|Bioequivalence|bioequivalence
159376|NCT02317809|Infertility|infertility
159479|NCT02317367|Breast Cancer|breast cancer
159378|NCT02317757|elderly cancer patients, chemotherapy toxicity|elderly cancer patients, chemotherapy toxicity
159379|NCT02317731|bowel preparation|bowel preparation
159380|NCT02317718|serum vitamin D levels|serum vitamin d levels
159381|NCT02317718|IVF|ivf
159382|NCT02317718|ovarian reserve|ovarian reserve
159383|NCT02317718|25 OHD3|25 ohd3
159384|NCT02317718|pregnancy outcome|pregnancy outcome
159385|NCT02317666|polypharmacy|polypharmacy
159386|NCT02317666|drug burden index|drug burden index
159387|NCT02317666|aged|aged
159388|NCT02317666|medication review|medication review
159389|NCT02317666|cholinergic agents|cholinergic agents
159390|NCT02317640|Testosterone|testosterone
159391|NCT02317640|Electrical Stimulation|electrical stimulation
159392|NCT02317640|Stand Training|stand training
159393|NCT02317614|Incentives|incentives
159394|NCT02317614|Smartphone|smartphone
159395|NCT02317614|Mobile intervention|mobile intervention
159396|NCT02317614|eDOT|edot
159397|NCT02317614|Adherence reinforcement|adherence reinforcement
159398|NCT02317614|Drug users|drug users
159399|NCT02317588|Oxylipins|oxylipins
159400|NCT02317588|Flax oil|flax oil
159401|NCT02317588|Fish oil|fish oil
159402|NCT02317562|Peripheral neuropathy|peripheral neuropathy
159403|NCT02317562|Disimmune disease|disimmune disease
159404|NCT02317562|Neurology chronic disease|neurology chronic disease
159405|NCT02317562|Rare disease|rare disease
159406|NCT02317549|sepsis|sepsis
159407|NCT02317549|septic shock|septic shock
159408|NCT02317549|vasodilatory shock|vasodilatory shock
159409|NCT02317549|circulatory shock|circulatory shock
159410|NCT02317549|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
159411|NCT02317549|SIRS|sirs
159412|NCT02317549|infection|infection
159413|NCT02317549|toxemia|toxemia
159414|NCT02317549|gut barrier breakdown|gut barrier breakdown
159415|NCT02317549|autodigestion|autodigestion
159416|NCT02317549|multiorgan failure|multiorgan failure
159417|NCT02317549|MOF|mof
159418|NCT02317549|multiorgain dysfunction syndrome|multiorgain dysfunction syndrome
159419|NCT02317549|MODS|mods
159420|NCT02317549|hyperlactatemia|hyperlactatemia
159421|NCT02317549|tissue hypoxia|tissue hypoxia
159422|NCT02317536|Muscle function|muscle function
159423|NCT02317536|L-Carnitine|l-carnitine
159424|NCT02317536|Carnipure|carnipure
159425|NCT02317536|DXA|dxa
159426|NCT02317536|anabolism|anabolism
159427|NCT02317536|6 minute walk|6 minute walk
159428|NCT02317536|dynamometry|dynamometry
159429|NCT02317536|muscle biopsy|muscle biopsy
159430|NCT02317523|Dementia|dementia
159431|NCT02317523|Caregiver|caregiver
159432|NCT02317523|Cardiovascular Disease|cardiovascular disease
159433|NCT02317523|Stress|stress
159434|NCT02317523|Depression|depression
159435|NCT02317523|Anxiety|anxiety
159436|NCT02317523|Heart Disease|heart disease
159437|NCT02317523|Carer|carer
159438|NCT02317523|Care Giver|care giver
159439|NCT02317523|Caregiving|caregiving
159440|NCT02317523|Psychotherapy|psychotherapy
159441|NCT02317523|Therapy|therapy
159442|NCT02317523|Behavioral Activation|behavioral activation
159443|NCT02317523|Education|education
159444|NCT02317523|Intervention|intervention
159446|NCT02317523|Cognitive-Behavior Therapy|cognitive-behavior therapy
159447|NCT02317510|Combined anesthesia|combined anesthesia
159448|NCT02317510|General anesthesia|general anesthesia
159449|NCT02317510|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
159450|NCT02317497|Neurocritical care|neurocritical care
159451|NCT02317497|Severe Stroke|severe stroke
159452|NCT02317497|Ischemic stroke|ischemic stroke
159453|NCT02317497|Intracerebral hemorrhage|intracerebral hemorrhage
159454|NCT02317497|Subarachnoid hemorrhage|subarachnoid hemorrhage
159455|NCT02317497|Sedation|sedation
159456|NCT02317497|RASS|rass
159457|NCT02317497|BIS|bis
159458|NCT02317445|helicobacter pylori|helicobacter pylori
159459|NCT02317445|eradication therapy|eradication therapy
159460|NCT02317445|major adverse cardiac events|major adverse cardiac events
159461|NCT02317445|long-term outcome|long-term outcome
159462|NCT02317445|To explore the significance of Hp eradication therapy in preventing major adverse cardiac events (MACE) and upper gastrointestinal bleeding (UGIB).|to explore the significance of hp eradication therapy in preventing major adverse cardiac events (mace) and upper gastrointestinal bleeding (ugib).
159463|NCT02317432|Depression|depression
159464|NCT02317432|Anxiety|anxiety
159465|NCT02317432|Disability|disability
159466|NCT02317432|Ethnic Minority|ethnic minority
159467|NCT02317432|Elders|elders
159468|NCT02317419|Solid Cancers|solid cancers
159469|NCT02317393|Nuclear medicine|nuclear medicine
159470|NCT02317393|Positron emission tomography|positron emission tomography
159471|NCT02317393|avb3 integrin expression|avb3 integrin expression
159472|NCT02317380|Self-Affirmation|self-affirmation
159473|NCT02317380|Weight Loss|weight loss
159474|NCT02317380|Self vs. Other|self vs. other
159475|NCT02317380|Cancer Risk and Prevention|cancer risk and prevention
159476|NCT02317367|Construct Validity|construct validity
159477|NCT02317367|Self-Affirmation|self-affirmation
159478|NCT02317367|Alcohol Consumption|alcohol consumption
159480|NCT02317354|X-Linked|x-linked
159481|NCT02317354|Retinoschisis|retinoschisis
159482|NCT02317341|Fatigue|fatigue
159483|NCT02317341|Ketamine|ketamine
159484|NCT02317341|Cancer|cancer
159485|NCT02317328|Retinal Images|retinal images
159486|NCT02317328|Adaptive Optics|adaptive optics
159487|NCT02317263|MS|ms
159488|NCT02317250|Alzheimer's disease|alzheimer's disease
159489|NCT02317250|Alzheimer disease|alzheimer disease
159490|NCT02317250|MDC|mdc
159491|NCT02317250|Mild Decline in Cognition|mild decline in cognition
159492|NCT02317250|MCI|mci
159493|NCT02317250|Dementia|dementia
159494|NCT02317250|PET|pet
159495|NCT02317250|FDG-PET|fdg-pet
159496|NCT02317250|FDG|fdg
159497|NCT02317250|amyloid|amyloid
159498|NCT02317250|amyloid imaging|amyloid imaging
159499|NCT02317250|CMS|cms
159500|NCT02317250|Coverage with Evidence Development|coverage with evidence development
159501|NCT02317250|CED|ced
159502|NCT02317250|MCI-ID|mci-id
159503|NCT02317224|3-Hole approach|3-hole approach
159504|NCT02317224|extended thymectomy|extended thymectomy
159505|NCT02317224|myasthenia gravis|myasthenia gravis
159506|NCT02317224|safety|safety
159507|NCT02317224|effectiveness|effectiveness
159508|NCT02317198|Elderly|elderly
159509|NCT02317198|P2Y12 inhibitors|p2y12 inhibitors
159510|NCT02317198|clopidogrel|clopidogrel
159511|NCT02317198|ticagrelor|ticagrelor
159512|NCT02317172|Saliva substitute|saliva substitute
159513|NCT02317172|Edible gel|edible gel
159514|NCT02317172|Xerostomia|xerostomia
159515|NCT02317172|Diabetes Mellitus|diabetes mellitus
159516|NCT02317172|Hypertension|hypertension
159517|NCT02317133|Tregs|tregs
159518|NCT02317133|bacterial translocation|bacterial translocation
159519|NCT02317133|cytokines|cytokines
159520|NCT02317107|Gait|gait
159521|NCT02317107|Mild Traumatic Brain Injury|mild traumatic brain injury
159522|NCT02317107|Post-Concussion Syndrome|post-concussion syndrome
159523|NCT02317107|Recovery of Function|recovery of function
159524|NCT02317107|Locomotion|locomotion
159525|NCT02317107|Motor Activity|motor activity
159526|NCT02317068|sick sinus syndrome|sick sinus syndrome
159527|NCT02317068|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
159528|NCT02317068|atrial pacing|atrial pacing
159529|NCT02317068|high atrial base rate pacing|high atrial base rate pacing
159530|NCT02317055|MRI|mri
159531|NCT02317055|Oxygenation|oxygenation
159532|NCT02317055|nirs|nirs
159533|NCT02317029|Cardioversion|cardioversion
159534|NCT02317029|Cardiac Arrythmias|cardiac arrythmias
159535|NCT02317029|Myocardial Injury|myocardial injury
159536|NCT02317029|Defibrillators|defibrillators
159537|NCT02317029|Biomarkers|biomarkers
159538|NCT02317016|oncology|oncology
159539|NCT02317016|cancer|cancer
159540|NCT02317016|non small cell lung cancer|non small cell lung cancer
159541|NCT02317016|anticancer drug|anticancer drug
159542|NCT02317016|pharmacokinetics|pharmacokinetics
159543|NCT02317016|AZD9291|azd9291
159544|NCT02317016|rosuvastatin|rosuvastatin
159545|NCT02317016|EGFR genes|egfr genes
159546|NCT02317003|physical exercise|physical exercise
159547|NCT02317003|sedentarity|sedentarity
159548|NCT02317003|general practice|general practice
159549|NCT02317003|family medicine|family medicine
159550|NCT02317003|pedometer|pedometer
159551|NCT02316977|Reproducibility of Results|reproducibility of results
159552|NCT02316964|AML|aml
159553|NCT02316964|acute myeloid leukemia|acute myeloid leukemia
159554|NCT02316964|decitabine|decitabine
159555|NCT02316951|Postoperative|postoperative
159556|NCT02316951|Pain|pain
159557|NCT02316951|Symptoms|symptoms
159558|NCT02316951|Video recording|video recording
159559|NCT02316951|Orthopedic surgery|orthopedic surgery
402922|NCT01229124|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
150533|NCT02368756|dme|dme
159560|NCT02316938|kidney transplant, renal transplant, biopsy, biopsies, donor specific antibodies|kidney transplant, renal transplant, biopsy, biopsies, donor specific antibodies
159561|NCT02316912|allergy|allergy
159562|NCT02316899|ASP0456|asp0456
159563|NCT02316899|constipation|constipation
159564|NCT02316899|linaclotide|linaclotide
159565|NCT02316899|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
159566|NCT02316886|coronary intervention|coronary intervention
159567|NCT02316886|Vulnerable Plaque|vulnerable plaque
159568|NCT02316886|Insignificant Stenosis|insignificant stenosis
159569|NCT02316886|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
159570|NCT02316886|Everolimus Eluting stent|everolimus eluting stent
159571|NCT02316873|music training, rhythm|music training, rhythm
159572|NCT02316847|Cluster Seizures|cluster seizures
159573|NCT02316847|Seizures|seizures
159574|NCT02316847|Clusters|clusters
159575|NCT02316847|Acute repetitive seizures|acute repetitive seizures
159576|NCT02316834|Fallopian Tube Cancer|fallopian tube cancer
159577|NCT02316834|Ovarian Cancer|ovarian cancer
159578|NCT02316834|Peritoneal Cancer|peritoneal cancer
159579|NCT02316834|BMN 673|bmn 673
159580|NCT02316834|Talazoparib tosylate|talazoparib tosylate
159581|NCT02316821|Diabetes Mellitus|diabetes mellitus
159582|NCT02316821|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
159583|NCT02316821|Diabetic Nephropathies|diabetic nephropathies
159584|NCT02316821|Kidney Diseases|kidney diseases
159679|NCT02316197|Phamacodynamics|phamacodynamics
159585|NCT02316821|Renal Insufficiency, Chronic|renal insufficiency, chronic
159586|NCT02316821|Diabetes Complications|diabetes complications
159587|NCT02316821|Endocrine System Diseases|endocrine system diseases
159588|NCT02316821|Glucose Metabolism Disorders|glucose metabolism disorders
159589|NCT02316821|Metabolic Diseases|metabolic diseases
159590|NCT02316821|Renal Insufficiency|renal insufficiency
159591|NCT02316821|Urologic Diseases|urologic diseases
159592|NCT02316821|bardoxolone methyl|bardoxolone methyl
159593|NCT02316756|Phase 1, Single-Dose Escalation, Double Blind, Placebo-Controlled, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, PF-06648671, Plasma Abeta|phase 1, single-dose escalation, double blind, placebo-controlled, safety, tolerability, pharmacokinetics, pharmacodynamics, pf-06648671, plasma abeta
159594|NCT02316691|Graves Disease|graves disease
159595|NCT02316691|Rituximab|rituximab
159596|NCT02316678|Patient Preference|patient preference
159597|NCT02316665|Type 1 diabetes|type 1 diabetes
159598|NCT02316665|Sleep apnea syndrome|sleep apnea syndrome
159599|NCT02316665|Nocturnal glycemia|nocturnal glycemia
159600|NCT02316665|Continuous glucose monitoring system|continuous glucose monitoring system
159601|NCT02316665|Continuous positive airway pressure|continuous positive airway pressure
159602|NCT02316665|Sleep habits|sleep habits
159603|NCT02316639|Neuromuscular Training|neuromuscular training
159604|NCT02316639|Skeletally Immature|skeletally immature
159605|NCT02316639|Knee Rehabilitation|knee rehabilitation
159606|NCT02316600|elderly|elderly
159607|NCT02316600|Robust volunteers for the first phase;|robust volunteers for the first phase;
159608|NCT02316600|tele-monitoring|tele-monitoring
159609|NCT02316600|self-management|self-management
159610|NCT02316600|Patient 65 and over|patient 65 and over
159611|NCT02316600|Presenting a frailty syndrome for the second phase|presenting a frailty syndrome for the second phase
159612|NCT02316587|Computerized Tomography|computerized tomography
159613|NCT02316587|Magnetic Resonance Imaging|magnetic resonance imaging
159614|NCT02316587|Echocardiography|echocardiography
159615|NCT02316587|Right Heart Catheterization|right heart catheterization
159616|NCT02316574|Alcohol dependence|alcohol dependence
159617|NCT02316574|Cognitive Behavioral Therapy|cognitive behavioral therapy
159618|NCT02316574|Functional neuroimaging|functional neuroimaging
159619|NCT02316535|colorectal cancer|colorectal cancer
159620|NCT02316535|stage II/III|stage ii/iii
159621|NCT02316535|elderly|elderly
159622|NCT02316535|adjuvant chemotherapy|adjuvant chemotherapy
159623|NCT02316535|capecitabine|capecitabine
159624|NCT02316535|non-inferiority|non-inferiority
159625|NCT02316496|Cancer|cancer
159626|NCT02316496|Colorectal|colorectal
159627|NCT02316496|Metastatic|metastatic
159628|NCT02316496|Thrid-line|thrid-line
159629|NCT02316496|Irinotecan|irinotecan
159630|NCT02316496|Cetuximab|cetuximab
159631|NCT02316470|Clostridium difficile|clostridium difficile
159632|NCT02316470|Valneva|valneva
159633|NCT02316470|Phase 2|phase 2
159634|NCT02316470|Healthy adults|healthy adults
159635|NCT02316457|TNBC|tnbc
159636|NCT02316457|Breast Cancer|breast cancer
159637|NCT02316457|Warehouse|warehouse
159638|NCT02316457|Mutanome|mutanome
159639|NCT02316457|RNA|rna
159640|NCT02316457|Vaccine|vaccine
159641|NCT02316444|Hepatitis B vaccine HIV infection|hepatitis b vaccine hiv infection
159642|NCT02316418|Hairstetics™ anchoring system|hairstetics™ anchoring system
159643|NCT02316418|hair extensions|hair extensions
159644|NCT02316392|Helium|helium
159645|NCT02316392|MRI|mri
159646|NCT02316392|Lung transplantation|lung transplantation
159647|NCT02316379|Respiratory|respiratory
159648|NCT02316314|Friedreich's Ataxia|friedreich's ataxia
193419|NCT02146066|GBM|gbm
159649|NCT02316314|Cardiomyopathy|cardiomyopathy
159650|NCT02316301|Misoprostol, pain, office hysteroscopy|misoprostol, pain, office hysteroscopy
159651|NCT02316249|pelvic organ prolapse|pelvic organ prolapse
159652|NCT02316249|Atrophy of Vagina|atrophy of vagina
159653|NCT02316249|Gellhorn pessary|gellhorn pessary
159654|NCT02316249|Ring with support pessary|ring with support pessary
159655|NCT02316249|Estrace cream|estrace cream
159656|NCT02316249|vaginitis with pessary|vaginitis with pessary
159657|NCT02316249|vaginal ulceration with pessary|vaginal ulceration with pessary
159658|NCT02316249|vaginal erosion with pessary|vaginal erosion with pessary
159659|NCT02316249|pessary complications|pessary complications
159660|NCT02316249|vaginal bleeding with pessary|vaginal bleeding with pessary
159661|NCT02316223|asthma|asthma
159662|NCT02316223|high-risk|high-risk
159663|NCT02316223|adult|adult
159664|NCT02316223|elderly|elderly
159665|NCT02316223|care coordination|care coordination
159666|NCT02316223|community health worker|community health worker
159667|NCT02316223|electronic medical record|electronic medical record
159668|NCT02316197|DNA-PK Inhibitor|dna-pk inhibitor
159669|NCT02316197|advanced solid tumors|advanced solid tumors
159670|NCT02316197|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
159671|NCT02316197|Phase I|phase i
159672|NCT02316197|first-in-human|first-in-human
159673|NCT02316197|open-label|open-label
159674|NCT02316197|dose escalation|dose escalation
159675|NCT02316197|dose expansion|dose expansion
159676|NCT02316197|safety profile|safety profile
159677|NCT02316197|tolerability|tolerability
159678|NCT02316197|Pharmacokinetics|pharmacokinetics
159680|NCT02316197|antitumor activity|antitumor activity
159681|NCT02316197|maximum tolerated dose|maximum tolerated dose
159682|NCT02316197|M3814|m3814
159683|NCT02316197|Recommended Phase II dose|recommended phase ii dose
159684|NCT02316197|Avelumab|avelumab
159685|NCT02316184|Alcohol|alcohol
159686|NCT02316158|Burden|burden
159687|NCT02316158|Mental illness|mental illness
159688|NCT02316158|Stress|stress
159689|NCT02316158|Social support|social support
159690|NCT02316145|ADHD|adhd
159691|NCT02316145|Autism spectrum condition|autism spectrum condition
159692|NCT02316145|Tourette's disorder|tourette's disorder
159693|NCT02316145|Internet-based|internet-based
159694|NCT02316145|chat|chat
159695|NCT02316145|coach|coach
159696|NCT02316119|bleeding risk, acute coronary syndrome, platelet agregation,|bleeding risk, acute coronary syndrome, platelet agregation,
159697|NCT02316106|Smoldering multiple myeloma (SMM)|smoldering multiple myeloma (smm)
159698|NCT02316106|Daratumumab|daratumumab
159699|NCT02316080|dental bleaching|dental bleaching
159700|NCT02316080|dentin sensitivity|dentin sensitivity
159701|NCT02316080|biomaterials|biomaterials
159702|NCT02316067|Spinal cord|spinal cord
159703|NCT02316067|Wounds and Injuries|wounds and injuries
159704|NCT02316067|Rehabilitation|rehabilitation
159705|NCT02316054|type 2 diabetes mellitus|type 2 diabetes mellitus
159706|NCT02316054|coronary microvascular disease|coronary microvascular disease
159707|NCT02316054|coronary artery disease|coronary artery disease
159708|NCT02316054|myocardial perfusion imaging|myocardial perfusion imaging
159709|NCT02316054|prognosis|prognosis
159710|NCT02316054|atherosclerosis|atherosclerosis
159711|NCT02316054|myocardial ischemia|myocardial ischemia
159712|NCT02316054|coronary heart disease|coronary heart disease
159713|NCT02316041|Femtosecond laser|femtosecond laser
159714|NCT02316041|Small incision lenticule extraction (SMILE)|small incision lenticule extraction (smile)
159715|NCT02316028|decitabine|decitabine
159716|NCT02316028|colorectal cancer|colorectal cancer
159717|NCT02316028|hepatic arterial infusion|hepatic arterial infusion
159718|NCT02316015|Child, Hospitalized|child, hospitalized
159719|NCT02316015|Nutritional status|nutritional status
159720|NCT02315976|chronic stable angina pectoris|chronic stable angina pectoris
159721|NCT02315976|propatyl nitrate|propatyl nitrate
159722|NCT02315976|Seattle Angina Questionnaire|seattle angina questionnaire
159723|NCT02315911|Tonsillectomy|tonsillectomy
159724|NCT02315911|Adenoidectomy|adenoidectomy
159725|NCT02315911|Adenoidpharyngoplasty|adenoidpharyngoplasty
159727|NCT02315885|healthy volunteers|healthy volunteers
159728|NCT02315885|social drinkers|social drinkers
159730|NCT02315872|Multiple Sclerosis|multiple sclerosis
159731|NCT02315872|Acthar Gel|acthar gel
159732|NCT02315872|ACTH|acth
159733|NCT02315872|Fatigue|fatigue
159734|NCT02315859|suction work|suction work
159735|NCT02315833|Migraine|migraine
159736|NCT02315833|Aura|aura
159737|NCT02315820|Macrosomia|macrosomia
159738|NCT02315820|Induction of labor|induction of labor
159739|NCT02315820|Expectant management|expectant management
159740|NCT02315820|Shoulder dystocia|shoulder dystocia
159741|NCT02315794|aesthetic outcome|aesthetic outcome
159742|NCT02315794|titanium abutment|titanium abutment
159743|NCT02315794|zirconia abutment|zirconia abutment
159744|NCT02315768|CLL|cll
159745|NCT02315768|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
159746|NCT02315768|Ibrutinib|ibrutinib
159747|NCT02315768|Obinutuzumab|obinutuzumab
159748|NCT02315768|Cancer|cancer
159749|NCT02315755|Metastatic renal cell carcinoma, targeted molecular therapy|metastatic renal cell carcinoma, targeted molecular therapy
159750|NCT02315716|Multiple Myeloma|multiple myeloma
159751|NCT02315716|Carfilzomib|carfilzomib
159752|NCT02315703|Healthy|healthy
159753|NCT02315703|Acquired Immuno-Deficiency Syndrome|acquired immuno-deficiency syndrome
159754|NCT02315703|Acquired Immunodeficiency Syndrome Virus|acquired immunodeficiency syndrome virus
159755|NCT02315703|adenovirus serotype 26|adenovirus serotype 26
159756|NCT02315703|Ad26.Mos.HIV|ad26.mos.hiv
159757|NCT02315703|Modified Vaccinia Ankara|modified vaccinia ankara
159758|NCT02315703|Glycoprotein|glycoprotein
159759|NCT02315703|Adjuvant|adjuvant
159760|NCT02315703|Vaccine|vaccine
159761|NCT02315703|Placebo|placebo
159762|NCT02315690|malaria, Swaziland, reactive case detection, focal mass drug administration|malaria, swaziland, reactive case detection, focal mass drug administration
159763|NCT02315677|Epistaxis|epistaxis
159764|NCT02315677|Nasal Intubation|nasal intubation
159765|NCT02315677|Maxillofacial surgery|maxillofacial surgery
159766|NCT02315664|Physical activity|physical activity
159767|NCT02315664|Exercise|exercise
159768|NCT02315664|Osteoarthritis|osteoarthritis
159769|NCT02315664|Knee|knee
159770|NCT02315664|Arthritis|arthritis
159771|NCT02315638|Adeno-associated viral vectors|adeno-associated viral vectors
159772|NCT02315638|Adeno-associated virus|adeno-associated virus
159773|NCT02315638|AAV|aav
159774|NCT02315638|AAV8|aav8
159775|NCT02315638|ddRNAi|ddrnai
159777|NCT02315638|RNAi|rnai
159778|NCT02315638|Hepatitis|hepatitis
159779|NCT02315638|Chronic Hepatitis C|chronic hepatitis c
159781|NCT02315638|CHC|chc
159782|NCT02315638|Genotype 1|genotype 1
159783|NCT02315625|MEN1|men1
159784|NCT02315625|VHL|vhl
159785|NCT02315625|Neoplasm|neoplasm
159786|NCT02315625|NF1|nf1
159787|NCT02315625|mTOR|mtor
159788|NCT02315612|CD-22 Expressing Tumor|cd-22 expressing tumor
159789|NCT02315612|Chimeric Antigen Receptor|chimeric antigen receptor
159790|NCT02315612|Adoptive Immunotherapy|adoptive immunotherapy
159791|NCT02315612|ALL|all
159792|NCT02315612|Lymphoma|lymphoma
159793|NCT02315599|Replication Competent Retrovirus (RCR)|replication competent retrovirus (rcr)
159794|NCT02315599|Replication Competent Lentivirus (RCL)|replication competent lentivirus (rcl)
159795|NCT02315599|T Cell Persistence|t cell persistence
159796|NCT02315586|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
159797|NCT02315586|Apoliprotein A-1|apoliprotein a-1
159798|NCT02315573|Carpal Tunnel Syndrome|carpal tunnel syndrome
159799|NCT02315573|Anesthetics, Local|anesthetics, local
159800|NCT02315573|Pain Perception|pain perception
159801|NCT02315573|Pain Measurement|pain measurement
159802|NCT02315573|Analgesia|analgesia
159803|NCT02315573|Lidocaine|lidocaine
159804|NCT02315573|Bupivacaine|bupivacaine
159805|NCT02315560|bedwetting|bedwetting
159806|NCT02315547|Microbiota|microbiota
159807|NCT02315547|Airway infection|airway infection
159808|NCT02315547|Bronchiectasis|bronchiectasis
159809|NCT02315547|Airway inflammation|airway inflammation
159810|NCT02315547|Oxidative stress|oxidative stress
159811|NCT02315547|Matrix metalloproteinase|matrix metalloproteinase
159812|NCT02315534|GBM|gbm
159813|NCT02315534|Malignant Glioma|malignant glioma
159814|NCT02315521|lower urinary tract obstruction|lower urinary tract obstruction
159815|NCT02315521|posterior urethral valves|posterior urethral valves
159816|NCT02315521|urethral atresia|urethral atresia
159817|NCT02315521|Prune Belly Syndrome|prune belly syndrome
159818|NCT02315521|Megalo-urethra|megalo-urethra
159819|NCT02315521|Fetal renal function|fetal renal function
159820|NCT02315521|Prenatal Diagnosis|prenatal diagnosis
159821|NCT02315521|Ultrasound|ultrasound
159822|NCT02315482|autonomic nervous system|autonomic nervous system
159823|NCT02315482|heart rate variability|heart rate variability
159824|NCT02315482|prostatectomy|prostatectomy
159825|NCT02315482|steep trendelenburg|steep trendelenburg
159826|NCT02315482|pneumoperitoneum|pneumoperitoneum
159827|NCT02315482|Intervention Affecting Autonomic Nervous System|intervention affecting autonomic nervous system
159828|NCT02315456|capsulorhexis|capsulorhexis
159829|NCT02315456|IOL centration|iol centration
159830|NCT02315443|Stroke|stroke
159831|NCT02315443|Ischemia|ischemia
159832|NCT02315443|Prehospital|prehospital
159833|NCT02315443|NA-1|na-1
159834|NCT02315443|Modified Rankin Scale|modified rankin scale
159835|NCT02315417|Pyoderma Gangrenosum|pyoderma gangrenosum
159836|NCT02315417|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
159837|NCT02315404|Obscure gastrointestinal bleeding|obscure gastrointestinal bleeding
159838|NCT02315404|Overt gastrointestinal bleeding|overt gastrointestinal bleeding
159839|NCT02315404|Occult gastrointestinal bleeding|occult gastrointestinal bleeding
159840|NCT02315404|Enteroscopy|enteroscopy
159841|NCT02315378|Anxiety, Acute Trauma|anxiety, acute trauma
159842|NCT02315352|Healthy|healthy
159843|NCT02315352|L-PZQ|l-pzq
159845|NCT02315352|MSC2499550A|msc2499550a
150811|NCT02367287|Nutritional Physiological Phenomena|nutritional physiological phenomena
150812|NCT02367248|Brain hemorrhage|brain hemorrhage
150813|NCT02367248|Cerebral Hemorrhage|cerebral hemorrhage
150814|NCT02367248|Deferoxamine|deferoxamine
150815|NCT02367248|Xingnaojing injection|xingnaojing injection
150819|NCT02367235|Colpassist|colpassist
159846|NCT02315352|Praziquantel|praziquantel
159847|NCT02315326|Ibrutinib,|ibrutinib,
159848|NCT02315326|Imbruvica™|imbruvica™
159849|NCT02315326|Bruton's Tyrosine Kinase (BTK) Inhibitor|bruton's tyrosine kinase (btk) inhibitor
159850|NCT02315326|HD-MTX|hd-mtx
159851|NCT02315326|14-184|14-184
159852|NCT02315300|ECG, CGM, Hypoglycaemia, Sudden Cardiac Death|ecg, cgm, hypoglycaemia, sudden cardiac death
159853|NCT02315287|Triple combination|triple combination
159854|NCT02315287|Metformin|metformin
159855|NCT02315287|Sitagliptin|sitagliptin
159856|NCT02315287|Pioglitazone|pioglitazone
159857|NCT02315287|Lobeglitazone|lobeglitazone
159858|NCT02315274|Type 1 diabetes|type 1 diabetes
159859|NCT02315274|Pregnancy|pregnancy
159860|NCT02315274|Glycemic variability|glycemic variability
159861|NCT02315274|Between visit contact|between visit contact
159862|NCT02315261|Epidural analgesia|epidural analgesia
159863|NCT02315261|Pain score|pain score
159864|NCT02315248|bone density|bone density
159865|NCT02315222|Nutriomics|nutriomics
159866|NCT02315222|Dietary supplements|dietary supplements
159867|NCT02315222|Scaling and root planing|scaling and root planing
159868|NCT02315222|full mouth disinfection|full mouth disinfection
159869|NCT02315209|Inguinal Hernia, Quality of Life, Mesh|inguinal hernia, quality of life, mesh
159870|NCT02315183|Post cardiac surgery|post cardiac surgery
160073|NCT02314247|KPT-330|kpt-330
159871|NCT02315170|diabetic retinopathy|diabetic retinopathy
159872|NCT02315170|age-related macular edema|age-related macular edema
159873|NCT02315157|Partial Response|partial response
159874|NCT02315144|COPD|copd
159875|NCT02315144|bronchodilation|bronchodilation
159876|NCT02315092|Diabetic Foot Ulcers|diabetic foot ulcers
159877|NCT02315092|Bacteria|bacteria
159878|NCT02315092|Fluorescence|fluorescence
159879|NCT02315079|Ocular Inflammation|ocular inflammation
159880|NCT02315079|Matrix Metalloproteinase 9|matrix metalloproteinase 9
159881|NCT02315066|Immunotherapy|immunotherapy
159882|NCT02315066|PF-04518600|pf-04518600
159883|NCT02315066|PF-05082566|pf-05082566
159884|NCT02315066|solid tumors|solid tumors
159885|NCT02315066|tumors|tumors
159886|NCT02315066|neoplasm metastasis|neoplasm metastasis
159887|NCT02315066|Phase 1|phase 1
159888|NCT02315066|hepatocellular carcinoma|hepatocellular carcinoma
159889|NCT02315066|HCC|hcc
159890|NCT02315066|Liver cancer|liver cancer
159891|NCT02315066|melanoma|melanoma
159892|NCT02315066|clear cell renal cell carcinoma|clear cell renal cell carcinoma
159893|NCT02315066|RCC|rcc
159894|NCT02315066|kidney cancer|kidney cancer
159895|NCT02315066|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
159896|NCT02315066|HNSCC|hnscc
159897|NCT02315066|head and neck cancer|head and neck cancer
159898|NCT02315066|cervical cancer|cervical cancer
159899|NCT02315066|cancer of the cervix|cancer of the cervix
159900|NCT02315066|gastric cancer|gastric cancer
159901|NCT02315066|stomach cancer|stomach cancer
159902|NCT02315066|non small cell lung cancer|non small cell lung cancer
159903|NCT02315066|NSCLC|nsclc
159904|NCT02315066|lung cancer|lung cancer
159905|NCT02315066|urothelial bladder carcinoma|urothelial bladder carcinoma
159906|NCT02315066|bladder cancer|bladder cancer
159907|NCT02315066|OX40|ox40
159908|NCT02315066|4-1BB|4-1bb
159909|NCT02315053|NSCLC|nsclc
159910|NCT02315053|CCRT|ccrt
159911|NCT02315053|FDG PET/CT|fdg pet/ct
159912|NCT02315040|Intrauterine insemination (IUI)|intrauterine insemination (iui)
159913|NCT02315040|Insemination method|insemination method
159914|NCT02315040|Slow release insemination (SRI)|slow release insemination (sri)
159915|NCT02315040|EVIE|evie
159916|NCT02315040|Pregnancy rate|pregnancy rate
159917|NCT02315001|Liraglutide|liraglutide
159918|NCT02315001|GLP-1|glp-1
159919|NCT02315001|Ischaemic heart disease|ischaemic heart disease
159920|NCT02315001|Coronary heart disease|coronary heart disease
159921|NCT02315001|Chronic stable angina|chronic stable angina
159922|NCT02314988|Tranexamic acid|tranexamic acid
159923|NCT02314988|Antifibrinolytic|antifibrinolytic
159924|NCT02314988|Perioperative blood loss|perioperative blood loss
159925|NCT02314988|Postoperative drain output|postoperative drain output
159926|NCT02314988|Allogenic transfusion|allogenic transfusion
159927|NCT02314949|T-regulatory cells|t-regulatory cells
159928|NCT02314949|Tolerogenic protocol|tolerogenic protocol
159929|NCT02314949|immunomodulation|immunomodulation
159930|NCT02314936|Constipation|constipation
159931|NCT02314936|Polydextrose|polydextrose
159932|NCT02314936|Dietary Fiber|dietary fiber
159934|NCT02314936|Colonic Transit Time|colonic transit time
159935|NCT02314936|PAC-SYM|pac-sym
159936|NCT02314910|Innervation|innervation
159937|NCT02314910|Jaw Bone|jaw bone
159938|NCT02314910|Implants|implants
159939|NCT02314910|Stereognostic|stereognostic
159940|NCT02314910|Osseoperception|osseoperception
159941|NCT02314871|perioperative analgesia|perioperative analgesia
159942|NCT02314871|minimal residual disease|minimal residual disease
159943|NCT02314871|cancer recurrence|cancer recurrence
159944|NCT02314871|epidural|epidural
159945|NCT02314871|morphine|morphine
159946|NCT02314871|piritramide|piritramide
159947|NCT02314871|colon|colon
159948|NCT02314871|cancer|cancer
159949|NCT02314871|circulating cancer cells|circulating cancer cells
159950|NCT02314871|colon cancer surgery|colon cancer surgery
159951|NCT02314845|Pulmonary Atelectasis|pulmonary atelectasis
159952|NCT02314845|Pulmonary Ventilation|pulmonary ventilation
159953|NCT02314845|Anesthesia, General|anesthesia, general
159954|NCT02314845|Electric Impedance|electric impedance
159955|NCT02314845|Tomography, Spiral Computed|tomography, spiral computed
159956|NCT02314845|Intraoperative Period|intraoperative period
159957|NCT02314832|femoral nerve block|femoral nerve block
159958|NCT02314832|adductor canal block|adductor canal block
159959|NCT02314832|tinetti score|tinetti score
159960|NCT02314832|2- Results to time to up and go (TUG ) test|2- results to time to up and go (tug ) test
159961|NCT02314832|3- Results to Tinetti test|3- results to tinetti test
159962|NCT02314832|4- Ambulation distance|4- ambulation distance
159963|NCT02314832|5- Pain scores at rest and with movement|5- pain scores at rest and with movement
159964|NCT02314819|colorectal cancer|colorectal cancer
159965|NCT02314793|Pharmacokinetics|pharmacokinetics
159966|NCT02314793|ASP2205|asp2205
159967|NCT02314741|poem|poem
159968|NCT02314741|per oral endoscopic myotomy|per oral endoscopic myotomy
159969|NCT02314741|achalasia|achalasia
159970|NCT02314728|Bishop Score|bishop score
159971|NCT02314728|Induction of Labor|induction of labor
159972|NCT02314728|Cervical Ripening|cervical ripening
159973|NCT02314728|Unfavorable Cervix|unfavorable cervix
159974|NCT02314728|Mode of Delivery|mode of delivery
159975|NCT02314728|C-Section|c-section
159976|NCT02314728|Cesarean Section|cesarean section
159977|NCT02314715|Osteoarthritis Knee|osteoarthritis knee
160177|NCT02313519|Infections|infections
159978|NCT02314702|Osteoarthritis|osteoarthritis
159979|NCT02314702|Avascular necrosis|avascular necrosis
159980|NCT02314702|Ankylosis|ankylosis
159981|NCT02314702|Protrusio acetabuli|protrusio acetabuli
159982|NCT02314702|Painful hip dysplasia|painful hip dysplasia
159983|NCT02314702|Rheumatoid arthritis|rheumatoid arthritis
159984|NCT02314702|Correction of functional deformity|correction of functional deformity
159985|NCT02314702|Revision procedures|revision procedures
159986|NCT02314663|hypercholesterolaemia|hypercholesterolaemia
159987|NCT02314663|medication adherence|medication adherence
159988|NCT02314663|primary health care|primary health care
159989|NCT02314637|DPP-IV inhibitor|dpp-iv inhibitor
159990|NCT02314611|osteoarthritis|osteoarthritis
159991|NCT02314611|avascular necrosis|avascular necrosis
159992|NCT02314611|ankylosis|ankylosis
159993|NCT02314611|protrusio acetabuli|protrusio acetabuli
159994|NCT02314611|painful hip dysplasia|painful hip dysplasia
159995|NCT02314611|rheumatoid arthritis|rheumatoid arthritis
159996|NCT02314611|correction of functional deformity|correction of functional deformity
159997|NCT02314611|revision procedures|revision procedures
159998|NCT02314572|Multifocal Intraocular Lens|multifocal intraocular lens
159999|NCT02314572|Binocular Trifocality|binocular trifocality
160000|NCT02314572|Cataract Surgery|cataract surgery
160001|NCT02314572|Spectacle Independence|spectacle independence
160002|NCT02314572|Intermediate Vision|intermediate vision
160003|NCT02314572|Photopic Vision|photopic vision
160004|NCT02314572|Mesopic Vision|mesopic vision
160005|NCT02314572|Scotopic Vision|scotopic vision
160006|NCT02314572|Binocular Vision|binocular vision
160007|NCT02314559|propofol|propofol
160008|NCT02314559|colonoscopy|colonoscopy
160009|NCT02314507|Gua sha|gua sha
160010|NCT02314481|NSCLC|nsclc
160011|NCT02314481|Clonal dominance|clonal dominance
160012|NCT02314481|Clonal evolution|clonal evolution
160013|NCT02314481|Intratumour heterogeneity|intratumour heterogeneity
160014|NCT02314481|Genomic instability|genomic instability
160015|NCT02314481|Drug resistance|drug resistance
160016|NCT02314481|Immunotherapy|immunotherapy
160017|NCT02314481|PDL1|pdl1
160018|NCT02314481|BRAF V600|braf v600
160019|NCT02314481|ALK|alk
160020|NCT02314481|RET|ret
160021|NCT02314481|HER2 amplification|her2 amplification
160022|NCT02314481|MPDL3280A|mpdl3280a
160023|NCT02314481|Vemurafenib|vemurafenib
160024|NCT02314481|Alectinib|alectinib
160025|NCT02314481|T-DM1|t-dm1
160026|NCT02314481|Trastuzumab emtansine|trastuzumab emtansine
160027|NCT02314481|TRACERX|tracerx
160028|NCT02314455|Eosinophilic Esophagitis|eosinophilic esophagitis
160029|NCT02314455|EoE|eoe
160030|NCT02314455|dysphagia|dysphagia
193907|NCT02144038|LGH447,|lgh447,
151013|NCT02366104|Aged|aged
160031|NCT02314442|LDL-C|ldl-c
160032|NCT02314442|RNAi therapeutic|rnai therapeutic
160033|NCT02314416|wounds, stem cells, collagen matrix, maturation|wounds, stem cells, collagen matrix, maturation
160034|NCT02314403|ESRD|esrd
160035|NCT02314390|Depression|depression
160036|NCT02314390|Mindfulness|mindfulness
160037|NCT02314390|MBCT|mbct
160038|NCT02314364|Non-small cell lung cancer|non-small cell lung cancer
160039|NCT02314364|Metastatic|metastatic
160040|NCT02314364|EGFR|egfr
160041|NCT02314364|ALK|alk
160042|NCT02314364|ROS1|ros1
160043|NCT02314364|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
160044|NCT02314351|migraine disorders|migraine disorders
160045|NCT02314351|migraine with aura|migraine with aura
160046|NCT02314351|migraine without aura|migraine without aura
160047|NCT02314351|pain management|pain management
160048|NCT02314351|emergency department|emergency department
160049|NCT02314325|Factor VIII deficiency|factor viii deficiency
160050|NCT02314325|Arthropathy|arthropathy
160051|NCT02314325|MRI|mri
160052|NCT02314325|XRay|xray
160053|NCT02314325|Joint|joint
160054|NCT02314325|HJHS|hjhs
160055|NCT02314312|Kidney transplantation|kidney transplantation
160056|NCT02314312|ECD|ecd
160057|NCT02314299|Macular edema|macular edema
160058|NCT02314299|Macular degeneration|macular degeneration
160059|NCT02314299|MTP-131|mtp-131
160060|NCT02314299|Ocuvia™|ocuvia™
160061|NCT02314286|Rosuvastatin|rosuvastatin
160062|NCT02314286|severe preeclampsia|severe preeclampsia
160063|NCT02314286|48 hours following delivery|48 hours following delivery
160064|NCT02314260|labour induction|labour induction
160065|NCT02314260|cervical length|cervical length
160066|NCT02314260|trans-vaginal assessment of cervical length|trans-vaginal assessment of cervical length
160067|NCT02314260|Bishop score|bishop score
160068|NCT02314247|PTCL|ptcl
160069|NCT02314247|CTCL|ctcl
160070|NCT02314247|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
160071|NCT02314247|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
160072|NCT02314247|Karyopharm|karyopharm
160074|NCT02314247|Selinexor|selinexor
160075|NCT02314221|Exoskeletal-assisted walking|exoskeletal-assisted walking
160076|NCT02314208|spastic paraplegia|spastic paraplegia
160077|NCT02314208|metabolism|metabolism
160078|NCT02314208|oxysterols|oxysterols
160079|NCT02314208|neurogenetics|neurogenetics
160080|NCT02314195|Obsessive Compulsive Disorder|obsessive compulsive disorder
160081|NCT02314195|Music Therapy/methods|music therapy/methods
160082|NCT02314195|Combined Modality Therapy|combined modality therapy
160083|NCT02314195|Anxiety Disorders/therapy|anxiety disorders/therapy
160084|NCT02314182|Rectal adenocarcinoma|rectal adenocarcinoma
160085|NCT02314182|unresectable|unresectable
160086|NCT02314182|surgery|surgery
160087|NCT02314182|chemotherapy|chemotherapy
160088|NCT02314143|dabrafenib|dabrafenib
160089|NCT02314143|MEK|mek
160090|NCT02314143|trametinib|trametinib
160091|NCT02314143|BRAF|braf
160092|NCT02314143|melanoma|melanoma
160093|NCT02314143|Oncology|oncology
160094|NCT02314104|Surgical procedures, Minimally invasive|surgical procedures, minimally invasive
160095|NCT02314104|Nerve block|nerve block
160096|NCT02314104|Anesthetics, Local|anesthetics, local
160097|NCT02314078|Caesarean section|caesarean section
160098|NCT02314078|Emergency|emergency
160099|NCT02314078|Anaesthesia|anaesthesia
160100|NCT02314065|Severe health anxiety|severe health anxiety
160101|NCT02314065|Somatic symptom disorder|somatic symptom disorder
160102|NCT02314065|Illness anxiety disorder|illness anxiety disorder
160103|NCT02314065|Cognitive behavioral therapy|cognitive behavioral therapy
160104|NCT02314065|Internet|internet
160105|NCT02314065|Exposure|exposure
160106|NCT02314013|uncomplicated diverticulitis, economic cost, hospital stay|uncomplicated diverticulitis, economic cost, hospital stay
160107|NCT02313974|Lupus Nephritis Treatment|lupus nephritis treatment
160108|NCT02313974|Renal Biopsy in Lupus|renal biopsy in lupus
160109|NCT02313974|Lupus Flare|lupus flare
160110|NCT02313961|ST elevation myocardial infarction|st elevation myocardial infarction
160111|NCT02313961|Reperfusion injury|reperfusion injury
160112|NCT02313961|Remote ischaemic conditioning|remote ischaemic conditioning
160113|NCT02313909|Rivaroxaban|rivaroxaban
160114|NCT02313909|Xarelto|xarelto
160115|NCT02313909|Aspirin|aspirin
160116|NCT02313909|ASA|asa
160117|NCT02313909|Oral Anticoagulant|oral anticoagulant
160118|NCT02313909|Blood Thinner|blood thinner
160119|NCT02313909|Stroke|stroke
160120|NCT02313909|Ischemic Stroke|ischemic stroke
160121|NCT02313909|Cryptogenic Stroke|cryptogenic stroke
160122|NCT02313909|Embolic stroke of undetermined source|embolic stroke of undetermined source
160123|NCT02313909|ESUS|esus
160124|NCT02313909|Transient Ischemic Attack|transient ischemic attack
160125|NCT02313909|Thromboembolism|thromboembolism
661475|NCT00814970|SFA|sfa
160131|NCT02313870|superpotent topical steroids|superpotent topical steroids
160132|NCT02313870|methotrexate|methotrexate
160133|NCT02313870|safety|safety
160135|NCT02313857|Viral infections post HSCT|viral infections post hsct
160136|NCT02313857|Virus-specific T cells|virus-specific t cells
160137|NCT02313844|BK virus|bk virus
160138|NCT02313844|Virus specific T cells|virus specific t cells
160139|NCT02313844|Viral infections|viral infections
160140|NCT02313831|autonomic nervous system|autonomic nervous system
160141|NCT02313831|ventilatory anaerobic threshold|ventilatory anaerobic threshold
160142|NCT02313831|oxygen consumption|oxygen consumption
160143|NCT02313831|metabolic profile|metabolic profile
160144|NCT02313831|exercise training|exercise training
160145|NCT02313831|expiratory flow limitation|expiratory flow limitation
160146|NCT02313818|Posttraumatic Stress Disorder|posttraumatic stress disorder
160147|NCT02313818|Cognitive Processing Therapy|cognitive processing therapy
160148|NCT02313818|Active Duty Military|active duty military
160149|NCT02313805|Insulin initiation|insulin initiation
160150|NCT02313805|Insulin checklist|insulin checklist
160151|NCT02313792|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
160152|NCT02313792|Palifermin|palifermin
160153|NCT02313740|Influenza|influenza
160154|NCT02313740|Influenza Vaccines|influenza vaccines
160155|NCT02313714|heart failure, heart transplant, electrical stimulation|heart failure, heart transplant, electrical stimulation
160156|NCT02313688|adenocarcinomas of esophagogastric junction|adenocarcinomas of esophagogastric junction
160157|NCT02313688|resection margin|resection margin
160158|NCT02313688|length|length
160159|NCT02313688|prognosis|prognosis
160160|NCT02313675|carpal tunnel syndrome|carpal tunnel syndrome
160161|NCT02313675|opioid analgesics|opioid analgesics
160162|NCT02313675|postoperative pain|postoperative pain
160163|NCT02313675|IV tylenol|iv tylenol
160164|NCT02313675|IV toradol|iv toradol
160165|NCT02313649|liver|liver
160166|NCT02313649|fibrosis|fibrosis
160167|NCT02313649|elastography|elastography
160168|NCT02313649|ShearWave Elastography|shearwave elastography
160169|NCT02313649|ultrasound|ultrasound
160170|NCT02313610|Retreatment Pulmonary Tuberculosis, Qinbudan,|retreatment pulmonary tuberculosis, qinbudan,
160171|NCT02313584|dabigatran|dabigatran
160172|NCT02313571|Epidural Analgesia|epidural analgesia
160173|NCT02313571|Pain|pain
160174|NCT02313558|dentifrice|dentifrice
160175|NCT02313558|gingivitis|gingivitis
160176|NCT02313558|dental plaque|dental plaque
160178|NCT02313519|anastomotic leakage|anastomotic leakage
160179|NCT02313506|Physical activity|physical activity
160180|NCT02313506|Exercise|exercise
160181|NCT02313506|Osteoarthritis|osteoarthritis
160182|NCT02313506|Knee|knee
160183|NCT02313506|Arthritis|arthritis
160184|NCT02313441|remote ischemic preconditioning|remote ischemic preconditioning
160190|NCT02313363|Health care systems|health care systems
160191|NCT02313363|Mobile applications|mobile applications
160192|NCT02313363|Self-care|self-care
160193|NCT02313363|Diabetes mellitus|diabetes mellitus
160194|NCT02313363|Smartphone|smartphone
160195|NCT02313350|Sciatica,|sciatica,
160196|NCT02313350|herniated disc,|herniated disc,
160197|NCT02313350|chemonucleolysis.|chemonucleolysis.
160198|NCT02313337|Administration route|administration route
160199|NCT02313337|Preanesthetic medication|preanesthetic medication
160200|NCT02313337|Sedation|sedation
160201|NCT02313324|Coccydynia|coccydynia
160202|NCT02313324|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
160203|NCT02313324|Disability|disability
160204|NCT02313311|Cleavage pattern, timing parameter, time-lapse|cleavage pattern, timing parameter, time-lapse
160205|NCT02313272|neoplasms|neoplasms
160206|NCT02313272|high-grade glioma|high-grade glioma
160207|NCT02313272|recurrent glioma|recurrent glioma
160208|NCT02313272|glioma|glioma
160209|NCT02313272|Hypofractionated Stereotactic Irradiation (HFSRT)|hypofractionated stereotactic irradiation (hfsrt)
160210|NCT02313272|Bevacizumab|bevacizumab
160211|NCT02313272|Pembrolizumab|pembrolizumab
160212|NCT02313272|recurrent high-grade glioma|recurrent high-grade glioma
160213|NCT02313272|Grade III malignant glioma|grade iii malignant glioma
160214|NCT02313272|Grade IV malignant glioma|grade iv malignant glioma
160215|NCT02313272|brain and nervous system|brain and nervous system
160216|NCT02313220|Obesity|obesity
160217|NCT02313220|Dapagliflozin|dapagliflozin
160218|NCT02313220|Exenatide|exenatide
160219|NCT02313220|Combination treatment|combination treatment
160220|NCT02313220|Type 2 diabetes|type 2 diabetes
160221|NCT02313181|breastfeeding|breastfeeding
160222|NCT02313181|lactation|lactation
160223|NCT02313181|newborn|newborn
160224|NCT02313168|difficult airway; prediction, FRONT score.|difficult airway; prediction, front score.
160225|NCT02313155|Prevention|prevention
160226|NCT02313129|Infertility|infertility
160227|NCT02313129|Rheumatoid Arthritis|rheumatoid arthritis
160228|NCT02313116|Lumpectomy|lumpectomy
160229|NCT02313116|Breast cancer|breast cancer
160230|NCT02313116|Optical coherence tomography|optical coherence tomography
160231|NCT02313116|Tumor margin|tumor margin
160232|NCT02313116|Imaging|imaging
160233|NCT02313103|ESRD|esrd
160234|NCT02313103|End Stage Renal Disease|end stage renal disease
160235|NCT02313103|Normal Healthy Volunteers|normal healthy volunteers
160236|NCT02313103|Renally Impaired|renally impaired
160237|NCT02313077|Healthy|healthy
160238|NCT02313077|Ebola viruses|ebola viruses
160239|NCT02313077|Ebola Viral Disease (EVD)|ebola viral disease (evd)
160240|NCT02313077|Filoviruses|filoviruses
160241|NCT02313077|monovalent vaccine|monovalent vaccine
160242|NCT02313077|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
160243|NCT02313077|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
160244|NCT02313077|Safety|safety
160245|NCT02313077|Immunogenicity|immunogenicity
160246|NCT02313051|metastatic breast cancer, everolimus|metastatic breast cancer, everolimus
160247|NCT02313038|Coronary heart disease|coronary heart disease
160248|NCT02313038|Percutaneous Coronary Intervention|percutaneous coronary intervention
160249|NCT02313038|Drug Eluting Stents|drug eluting stents
160250|NCT02313012|Maximum Tolerated Dose|maximum tolerated dose
160251|NCT02313012|Solid Tumors|solid tumors
160252|NCT02313012|Locally Advanced Tumors|locally advanced tumors
160253|NCT02313012|Metastatic Solid Tumors|metastatic solid tumors
160254|NCT02313012|Relapsed or refractory, BRAFV600 or RAS-mutated solid tumors|relapsed or refractory, brafv600 or ras-mutated solid tumors
160255|NCT02313012|Melanoma|melanoma
160256|NCT02313012|Colorectal Carcinomas Papillary|colorectal carcinomas papillary
160257|NCT02313012|Thyroid carcinomas|thyroid carcinomas
160258|NCT02313012|Pancreatic ductal Adenocarcinomas|pancreatic ductal adenocarcinomas
160259|NCT02313012|Non -small cell lung cancer [NSCLC]|non -small cell lung cancer [nsclc]
160260|NCT02312999|laparotomy|laparotomy
160261|NCT02312999|plasma-Lyte|plasma-lyte
160262|NCT02312999|volulyte|volulyte
160263|NCT02312999|close loop|close loop
160264|NCT02312999|abdominal surgery|abdominal surgery
160265|NCT02312986|infection|infection
160266|NCT02312986|colonization|colonization
160267|NCT02312986|antibiotic resistance|antibiotic resistance
160268|NCT02312973|Chronic kidney disease|chronic kidney disease
160269|NCT02312973|Pharmacokinetics|pharmacokinetics
160270|NCT02312973|Hemodialysis|hemodialysis
160271|NCT02312973|Peritoneal dialysis|peritoneal dialysis
160272|NCT02312973|Erythropoietin|erythropoietin
160273|NCT02312934|Chemo brain|chemo brain
160274|NCT02312934|Chemotherapy-related cognitive impairment|chemotherapy-related cognitive impairment
160275|NCT02312934|CRCI|crci
160276|NCT02312934|Breast cancer|breast cancer
160277|NCT02312934|Chemo fog|chemo fog
160278|NCT02312934|Nicotine|nicotine
160279|NCT02312934|Transdermal nicotine|transdermal nicotine
160280|NCT02312921|managed healthcare|managed healthcare
160281|NCT02312921|child|child
160282|NCT02312921|dental care|dental care
160283|NCT02312908|REM Sleep Behavior Disorder|rem sleep behavior disorder
160284|NCT02312908|Parkinson Disease|parkinson disease
160285|NCT02312908|Placebos|placebos
160286|NCT02312908|Randomized Controlled Trial|randomized controlled trial
160287|NCT02312908|Double-Blind Method|double-blind method
160288|NCT02312908|Clinical Trial|clinical trial
160289|NCT02312869|Mechanical Ventilation|mechanical ventilation
160290|NCT02312869|Burn patients|burn patients
160291|NCT02312843|Mild Cognitive Impairment|mild cognitive impairment
160292|NCT02312843|Cognitive disorders|cognitive disorders
160293|NCT02312843|Prediabetes|prediabetes
160294|NCT02312843|Exercise|exercise
160295|NCT02312817|Carcinoma, Hepatocellular|carcinoma, hepatocellular
160296|NCT02312817|Liver Neoplasms|liver neoplasms
160297|NCT02312817|Liver Disease|liver disease
160298|NCT02312817|Early Detection of Cancer|early detection of cancer
160299|NCT02312817|Comparative Effectiveness Research|comparative effectiveness research
160300|NCT02312791|Radiation|radiation
160301|NCT02312791|Prognosis|prognosis
160302|NCT02312791|Palliative Care|palliative care
160303|NCT02312778|non-specific low back pain|non-specific low back pain
160304|NCT02312778|center of pressure|center of pressure
160305|NCT02312778|spinal lumbar manipulation|spinal lumbar manipulation
160306|NCT02312778|high velocity and low amplitude manipulation|high velocity and low amplitude manipulation
160307|NCT02312778|postural control|postural control
160308|NCT02312752|Intra-epidermal stimulation in healthy control subjects|intra-epidermal stimulation in healthy control subjects
160309|NCT02312739|pain assessment|pain assessment
160310|NCT02312739|pain measurement|pain measurement
160311|NCT02312739|patient satisfaction|patient satisfaction
160312|NCT02312739|anxiety|anxiety
160313|NCT02312739|analgesia and anesthesia|analgesia and anesthesia
160314|NCT02312739|female sterilization|female sterilization
160315|NCT02312726|mixed methods|mixed methods
160316|NCT02312726|visual analog scale|visual analog scale
160317|NCT02312726|verbal rating score|verbal rating score
160318|NCT02312726|pain assessment|pain assessment
160319|NCT02312726|patient satisfaction|patient satisfaction
160320|NCT02312726|contraceptive devices|contraceptive devices
160321|NCT02312726|postpartum|postpartum
160322|NCT02312713|Osteoarthritis|osteoarthritis
160323|NCT02312713|Knee Osteoarthritis|knee osteoarthritis
160324|NCT02312700|empowerment|empowerment
160325|NCT02312700|communication|communication
160326|NCT02312700|shared decision making|shared decision making
160329|NCT02312687|KRN23|krn23
160330|NCT02312674|pancreatic carcinoma|pancreatic carcinoma
160331|NCT02312674|hepatocellular carcinoma|hepatocellular carcinoma
160332|NCT02312674|palliative therapy|palliative therapy
160333|NCT02312674|oral nutritional supplements|oral nutritional supplements
160334|NCT02312674|quality of life|quality of life
160335|NCT02312674|nutritional status|nutritional status
160336|NCT02312661|ovarian cancer|ovarian cancer
160337|NCT02312661|metformin|metformin
160338|NCT02312661|carboplatin|carboplatin
160339|NCT02312661|paclitaxel|paclitaxel
160340|NCT02312648|Functional Capacity|functional capacity
160341|NCT02312648|Physical Exertion|physical exertion
160342|NCT02312648|Patient Care|patient care
160343|NCT02312648|Early mobilization|early mobilization
160344|NCT02312635|cognitive rehabilitation, traumatic brain injury|cognitive rehabilitation, traumatic brain injury
160345|NCT02312596|non-healing wound|non-healing wound
160346|NCT02312596|diabetic foot ulcer|diabetic foot ulcer
160347|NCT02312596|platelet rich plasma|platelet rich plasma
160348|NCT02312583|depression|depression
160349|NCT02312583|cognitive-behavior intervention|cognitive-behavior intervention
160350|NCT02312570|non-healing wounds|non-healing wounds
160351|NCT02312570|pressure ulcer|pressure ulcer
160352|NCT02312570|platelet rich plasma|platelet rich plasma
160353|NCT02312531|HBV|hbv
160354|NCT02312531|Intrauterine infection|intrauterine infection
160355|NCT02312531|hepatitis B immunoglobulin|hepatitis b immunoglobulin
160356|NCT02312531|immune barrier|immune barrier
160357|NCT02312531|virus replication|virus replication
160358|NCT02312531|placenta|placenta
160359|NCT02312518|non-healing wounds|non-healing wounds
160360|NCT02312518|venous stasis|venous stasis
160361|NCT02312518|ulcer|ulcer
160362|NCT02312518|platelet rich plasma|platelet rich plasma
160363|NCT02312505|cardiac output monitoring|cardiac output monitoring
160364|NCT02312505|semi-invasive pulse contour analysis|semi-invasive pulse contour analysis
160365|NCT02312505|transpulmonary thermodilution|transpulmonary thermodilution
160366|NCT02312492|fatty acid kinetics|fatty acid kinetics
160367|NCT02312440|tranexamic acid|tranexamic acid
160368|NCT02312440|blood loss|blood loss
160369|NCT02312440|topical administration|topical administration
160370|NCT02312440|intravenous administration|intravenous administration
160372|NCT02312401|14-172|14-172
160373|NCT02312388|central venous catheters|central venous catheters
160374|NCT02312362|HFDS|hfds
160375|NCT02312362|ab interno|ab interno
160376|NCT02312362|MIGS|migs
160377|NCT02312362|surgery|surgery
160378|NCT02312349|Celiac Disease|celiac disease
160379|NCT02312349|Gluten free elaborated food|gluten free elaborated food
160380|NCT02312336|ST Elevation Myocardial Infarction|st elevation myocardial infarction
160381|NCT02312336|Transcoronary Cooling|transcoronary cooling
160382|NCT02312258|Ixazomib|ixazomib
160383|NCT02312258|Newly diagnosed|newly diagnosed
160384|NCT02312219|HIV|hiv
160385|NCT02312219|Inflammation|inflammation
160386|NCT02312219|Atherosclerosis|atherosclerosis
160387|NCT02312219|Positron-Emission Tomography|positron-emission tomography
160388|NCT02312219|Imaging|imaging
160389|NCT02312219|fluorodeoxyglucose|fluorodeoxyglucose
160390|NCT02312193|hypertension|hypertension
160391|NCT02312193|myogenic tone|myogenic tone
160392|NCT02312167|endomicroscopy|endomicroscopy
160393|NCT02312167|optical biopsy|optical biopsy
160394|NCT02312167|exploratory surgery|exploratory surgery
160395|NCT02312167|resection surgery|resection surgery
160396|NCT02312167|robot-assisted|robot-assisted
160397|NCT02312167|peritoneum carcinosis|peritoneum carcinosis
160398|NCT02312167|inflammatory|inflammatory
160399|NCT02312167|rectum cancer|rectum cancer
160400|NCT02312167|liver cancer|liver cancer
160401|NCT02312167|ovarian cancer|ovarian cancer
160402|NCT02312167|digestive cancer|digestive cancer
160403|NCT02312167|pancreas cancer|pancreas cancer
160404|NCT02312167|duodenum cancer|duodenum cancer
160405|NCT02312128|distal radius fractures|distal radius fractures
160406|NCT02312128|early mobilization|early mobilization
160407|NCT02312128|postoperative treatment|postoperative treatment
160408|NCT02312128|outcome|outcome
160409|NCT02312115|Renal transplant|renal transplant
160410|NCT02312115|Kidney transplant|kidney transplant
160414|NCT02312102|allogeneic stem cell transplantation|allogeneic stem cell transplantation
160415|NCT02312089|Luteal phase support, ICSI, GnRHa|luteal phase support, icsi, gnrha
160416|NCT02312076|Luteal phase support, ICSI, GnRHa|luteal phase support, icsi, gnrha
160418|NCT02312063|sulfonylurea|sulfonylurea
160419|NCT02312037|Relapsed CD33 AML|relapsed cd33 aml
160420|NCT02312037|Refractory CD33 AML|refractory cd33 aml
160421|NCT02312037|Relapsed CD33 APL|relapsed cd33 apl
160422|NCT02312037|Refractory CD33 APL|refractory cd33 apl
160423|NCT02312037|Relapsed CD33 MDS|relapsed cd33 mds
160424|NCT02312037|Refractory CD33 MDS|refractory cd33 mds
160425|NCT02312024|CytoSorb adsorber|cytosorb adsorber
160426|NCT02312024|sepsis|sepsis
160427|NCT02312024|cytokines|cytokines
160428|NCT02312024|hemofiltration|hemofiltration
160429|NCT02312024|hemadsorption|hemadsorption
160430|NCT02312024|inflammation|inflammation
160431|NCT02312011|Myotonic Dystrophy|myotonic dystrophy
160432|NCT02312011|DM1|dm1
160433|NCT02312011|Adult onset|adult onset
160434|NCT02312011|Neuromuscular Disease|neuromuscular disease
160435|NCT02312011|DMPKRx|dmpkrx
160436|NCT02311998|Leukemia|leukemia
160437|NCT02311998|CD22-positive Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia|cd22-positive philadelphia-chromosome positive acute lymphoblastic leukemia
160438|NCT02311998|ALL|all
160439|NCT02311998|Chronic Myeloid Leukemia Lymphoid Blast Phase|chronic myeloid leukemia lymphoid blast phase
160440|NCT02311998|CML|cml
160441|NCT02311998|Bosutinib|bosutinib
160442|NCT02311998|SKI-606|ski-606
160443|NCT02311998|Inotuzumab Ozogamicin|inotuzumab ozogamicin
160444|NCT02311998|CMC-544|cmc-544
160445|NCT02311998|Phone Call|phone call
160446|NCT02311985|Liver cirrhosis|liver cirrhosis
160447|NCT02311985|Blood coagulation|blood coagulation
160448|NCT02311985|Thromboelastography|thromboelastography
160449|NCT02311985|Blood transfusion|blood transfusion
160450|NCT02311985|Catheterization, central venous|catheterization, central venous
160451|NCT02311959|Breast|breast
160452|NCT02311959|Invasive carcinoma|invasive carcinoma
160453|NCT02311959|In situ carcinoma|in situ carcinoma
160454|NCT02311959|Mastectomy|mastectomy
160455|NCT02311959|Nipple areola|nipple areola
160456|NCT02311959|Reconstruction|reconstruction
160457|NCT02311959|Local recurrence|local recurrence
160458|NCT02311946|Palbociclib, Rabeprazole, Proton Pump Inhibitor, Drug Interaction Study, DDI|palbociclib, rabeprazole, proton pump inhibitor, drug interaction study, ddi
160459|NCT02311829|Quality of life, PNES, Epilepsy,|quality of life, pnes, epilepsy,
160460|NCT02311816|Bacterial infection, empiric antibiotic therapy|bacterial infection, empiric antibiotic therapy
160464|NCT02311751|Autism Spectrum Disorder|autism spectrum disorder
160465|NCT02311751|Executive Function|executive function
160466|NCT02311751|rTMS (Repetitive Transcranial Magnetic Stimulation)|rtms (repetitive transcranial magnetic stimulation)
160467|NCT02311751|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
160468|NCT02311751|Healthy Subjects|healthy subjects
160469|NCT02311738|Exercise and Genes in Obese (EGO)|exercise and genes in obese (ego)
160470|NCT02311725|narrative communication|narrative communication
160471|NCT02311725|depression|depression
160472|NCT02311725|antidepressant augmentation|antidepressant augmentation
160473|NCT02311725|primary care|primary care
160474|NCT02311712|Esophageal cancer|esophageal cancer
160475|NCT02311712|Early detection|early detection
160476|NCT02311712|Cytological examination|cytological examination
160477|NCT02311699|Gender|gender
160478|NCT02311699|Physical Violence|physical violence
160479|NCT02311699|Sexual Violence|sexual violence
160480|NCT02311699|HIV|hiv
160481|NCT02311699|AIDS|aids
160482|NCT02311699|Prevention|prevention
160483|NCT02311699|Community Intervention|community intervention
160484|NCT02311699|Ethiopia|ethiopia
160485|NCT02311699|Intimate Partner Violence|intimate partner violence
160486|NCT02311686|Ethanol|ethanol
160487|NCT02311686|Fatty acid ethyl esters|fatty acid ethyl esters
160488|NCT02311686|Ethyl glucoronide|ethyl glucoronide
160489|NCT02311686|Ethyl sulphate|ethyl sulphate
160490|NCT02311686|Pharmacokinetics|pharmacokinetics
160491|NCT02311673|Prader-Willi Syndrome|prader-willi syndrome
160492|NCT02311673|obesity|obesity
160493|NCT02311673|hyperphagia|hyperphagia
160494|NCT02311647|Tamoxifen|tamoxifen
160495|NCT02311647|Uterine cavity|uterine cavity
160496|NCT02311647|endometrium|endometrium
160497|NCT02311634|Electrical pudendal nerve stimulation|electrical pudendal nerve stimulation
160498|NCT02311634|Transvaginal electrical stimulation|transvaginal electrical stimulation
160499|NCT02311634|Urge urinary incontinence|urge urinary incontinence
160500|NCT02311634|Comparative study|comparative study
160501|NCT02311608|acute variceal hemorrhage|acute variceal hemorrhage
160502|NCT02311608|terlipressin|terlipressin
160503|NCT02311608|somatostatin|somatostatin
160504|NCT02311608|octreotide|octreotide
160505|NCT02311608|comparative effectiveness research|comparative effectiveness research
160506|NCT02311595|gastric cancer|gastric cancer
160507|NCT02311595|laparoscope|laparoscope
160508|NCT02311569|JAK2|jak2
160509|NCT02311569|Mirabegron|mirabegron
160510|NCT02311569|Primary myelofibrosis|primary myelofibrosis
160511|NCT02311569|beta-3-mimetic drugs|beta-3-mimetic drugs
160512|NCT02311569|Myeloproliferative neoplasm|myeloproliferative neoplasm
160513|NCT02311569|Essential thrombocythemia|essential thrombocythemia
160514|NCT02311569|Polycythemia vera|polycythemia vera
160515|NCT02311569|Betmiga|betmiga
160516|NCT02311569|JAK2-V617F|jak2-v617f
160517|NCT02311543|Axillary Lymph Node Dissection (ALND)|axillary lymph node dissection (alnd)
160518|NCT02311543|Breast Cancer|breast cancer
160519|NCT02311543|TachoSil®|tachosil®
160520|NCT02311543|Lymphatic Drainage|lymphatic drainage
160521|NCT02311543|Surgical Sealing Patch|surgical sealing patch
160522|NCT02311491|nano crystalline|nano crystalline
151517|NCT02362984|MRS|mrs
160523|NCT02311491|archwire|archwire
160524|NCT02311465|Palliative Care|palliative care
160525|NCT02311439|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
160526|NCT02311439|Chemotherapy|chemotherapy
160527|NCT02311439|Radiotherapy|radiotherapy
200990|NCT02112682|Axillary radiotherapy|axillary radiotherapy
160528|NCT02311426|Rehabilitation; Functional outcome|rehabilitation; functional outcome
160529|NCT02311413|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
160530|NCT02311400|Emotion|emotion
160531|NCT02311400|Self-Affirmation|self-affirmation
160532|NCT02311400|Alcohol Consumption|alcohol consumption
160533|NCT02311387|Incidence|incidence
160534|NCT02311387|Prevalence|prevalence
160535|NCT02311387|Human|human
160536|NCT02311387|Mastomys|mastomys
160537|NCT02311387|Serosurvey|serosurvey
160538|NCT02311374|Human Brain|human brain
160539|NCT02311374|Sleep|sleep
160540|NCT02311374|EEG|eeg
160541|NCT02311374|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
160542|NCT02311374|Apparent Diffusion Coefficient|apparent diffusion coefficient
160543|NCT02311361|Anti-PDL1|anti-pdl1
160544|NCT02311361|Anti-CTLA4|anti-ctla4
160545|NCT02311361|Streostatic Body Radiation Therapy (SBRT)|streostatic body radiation therapy (sbrt)
160546|NCT02311361|Monoclonal Antibody|monoclonal antibody
160547|NCT02311361|Antitumor Immunity|antitumor immunity
160548|NCT02311348|Biopsy|biopsy
160549|NCT02311348|Pain|pain
160550|NCT02311335|Hypertriglyceridemia|hypertriglyceridemia
160551|NCT02311335|Atherosclerosis|atherosclerosis
160552|NCT02311335|Genectic Variants|genectic variants
160553|NCT02311335|Hyperalphalipoproteinemia|hyperalphalipoproteinemia
160554|NCT02311335|Dyslipidemia|dyslipidemia
160555|NCT02311322|Growth Disorder|growth disorder
160556|NCT02311322|Growth|growth
160557|NCT02311322|Exome Sequencing|exome sequencing
160558|NCT02311244|All-cause mortality|all-cause mortality
160559|NCT02311244|Cardiovascular mortality|cardiovascular mortality
160560|NCT02311244|Myocardial infarction|myocardial infarction
160561|NCT02311244|Stroke|stroke
160562|NCT02311244|Dialysis|dialysis
161162|NCT02307721|Naloxone|naloxone
160563|NCT02311218|oral, microbiota, lactobacillus reuteri,|oral, microbiota, lactobacillus reuteri,
160564|NCT02311205|Transarterial Chemoembolization (TACE)|transarterial chemoembolization (tace)
160565|NCT02311205|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
160566|NCT02311205|Metastasis|metastasis
160567|NCT02311205|Sorafenib|sorafenib
160568|NCT02311192|Vitreous Haze|vitreous haze
160569|NCT02311192|Ocular ultrasound|ocular ultrasound
160571|NCT02311192|Uveitis|uveitis
160572|NCT02311179|Prosthesis fixation|prosthesis fixation
160573|NCT02311179|hip arthroplasty|hip arthroplasty
160574|NCT02311166|Hip dysplasia|hip dysplasia
160575|NCT02311166|Soft tissue|soft tissue
160576|NCT02311166|Hip|hip
160577|NCT02311166|Self-report|self-report
160578|NCT02311166|Physical activity|physical activity
160579|NCT02311140|cystic fibrosis|cystic fibrosis
160580|NCT02311140|nasal lavage|nasal lavage
160581|NCT02311140|inflammation|inflammation
160582|NCT02311140|Interleukin (IL)-6|interleukin (il)-6
160583|NCT02311140|IL-8|il-8
160584|NCT02311140|pulmonary function|pulmonary function
160585|NCT02311127|Peripherally Inserted Central Catheters|peripherally inserted central catheters
160586|NCT02311127|Securement device|securement device
160587|NCT02311114|Program Evaluation|program evaluation
160588|NCT02311114|Telehomecare|telehomecare
160589|NCT02311114|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
160590|NCT02311114|Heart Failure|heart failure
160591|NCT02311114|LHINs|lhins
160592|NCT02311114|Local Health Integrative Network|local health integrative network
160593|NCT02311114|OTN|otn
160594|NCT02311114|Ontario Telemedicine Network|ontario telemedicine network
160595|NCT02311101|bladder cancer|bladder cancer
160596|NCT02311101|mitomycin|mitomycin
160597|NCT02311101|BCG|bcg
160598|NCT02311101|intravesical|intravesical
160599|NCT02311101|non-muscle invasive|non-muscle invasive
160600|NCT02311062|training, soccer, eccentric, lengthening, unstable, squatting|training, soccer, eccentric, lengthening, unstable, squatting
661476|NCT00814970|PPA|ppa
160601|NCT02311036|Post Acute Care(PAC)|post acute care(pac)
160602|NCT02311036|Cerebrovascular diseases|cerebrovascular diseases
160603|NCT02311010|transplant|transplant
160604|NCT02311010|immunosuppressive drug|immunosuppressive drug
160605|NCT02310984|Early breast cancer|early breast cancer
160606|NCT02310984|Lumpectomy|lumpectomy
160607|NCT02310984|Breast conserving surgery|breast conserving surgery
160608|NCT02310984|Radiotherapy|radiotherapy
160609|NCT02310984|Cosmesis|cosmesis
160610|NCT02310971|Adenocarcinoma, resected|adenocarcinoma, resected
160611|NCT02310958|Lapraroscopic surgical procedure|lapraroscopic surgical procedure
160612|NCT02310958|infant|infant
160613|NCT02310958|complications|complications
160614|NCT02310958|inguinal hernia|inguinal hernia
160615|NCT02310958|hernia recurrence|hernia recurrence
160616|NCT02310945|pain|pain
194671|NCT02140658|outcome|outcome
160617|NCT02310945|central nervous system sensitization|central nervous system sensitization
160618|NCT02310945|physiotherapy|physiotherapy
160619|NCT02310932|mental health|mental health
160620|NCT02310932|cardiovascular disease|cardiovascular disease
160621|NCT02310932|diabetes|diabetes
160622|NCT02310932|hypertension|hypertension
160623|NCT02310932|high blood pressure|high blood pressure
160624|NCT02310919|Infertility|infertility
160625|NCT02310919|In vitro fertilization|in vitro fertilization
160626|NCT02310919|IVF|ivf
160627|NCT02310906|Duchenne muscular dystrophy|duchenne muscular dystrophy
160628|NCT02310906|Exon Skipping|exon skipping
160629|NCT02310867|hand transplantation, amputation|hand transplantation, amputation
160630|NCT02310854|anterior cruciate ligament rupture|anterior cruciate ligament rupture
160631|NCT02310854|autograft|autograft
160632|NCT02310854|reconstruction|reconstruction
160633|NCT02310854|orthopedic surgery|orthopedic surgery
160634|NCT02310854|dynamic intraligament stabilization|dynamic intraligament stabilization
160635|NCT02310828|Cluster headache|cluster headache
160636|NCT02310828|Migrainous neuralgia|migrainous neuralgia
160637|NCT02310828|Horton's headache|horton's headache
160638|NCT02310828|Histaminic cephalalgia|histaminic cephalalgia
160640|NCT02310802|ICSI|icsi
160641|NCT02310763|Duchenne Muscular Dystrophy, myostatin|duchenne muscular dystrophy, myostatin
160642|NCT02310737|cesarean section|cesarean section
160643|NCT02310737|facial incision|facial incision
160644|NCT02310737|postoperative pain|postoperative pain
160645|NCT02310724|youth onset type 2 diabetes|youth onset type 2 diabetes
160646|NCT02310724|insulin sensitivity|insulin sensitivity
160647|NCT02310724|beta cell function|beta cell function
160648|NCT02310724|macrovascular comorbidities|macrovascular comorbidities
160649|NCT02310724|microvascular comorbidities|microvascular comorbidities
160650|NCT02310711|Breast|breast
160651|NCT02310711|Mastectomy|mastectomy
160652|NCT02310711|Lumpectomy|lumpectomy
160653|NCT02310711|Breast Therapy|breast therapy
160654|NCT02310698|Ultrasound|ultrasound
160655|NCT02310698|Enhanced Mammography|enhanced mammography
160656|NCT02310698|14-240|14-240
160657|NCT02310685|Cardivascular risks (hypertension, sedentary, overweight)|cardivascular risks (hypertension, sedentary, overweight)
160658|NCT02310685|Cardiovascular age|cardiovascular age
160659|NCT02310685|E-health wellness program|e-health wellness program
160660|NCT02310685|Prevention|prevention
160661|NCT02310685|Community pharmacists|community pharmacists
160662|NCT02310685|Lifestyle change|lifestyle change
160663|NCT02310685|Cardiometabolic age|cardiometabolic age
160664|NCT02310672|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
160665|NCT02310633|TBI|tbi
160666|NCT02310633|memory disorder|memory disorder
160667|NCT02310633|injury, brain, traumatic|injury, brain, traumatic
160668|NCT02310633|rehabilitation|rehabilitation
160669|NCT02310607|Post-partum women|post-partum women
160670|NCT02310581|Bunionectomy|bunionectomy
160671|NCT02310568|PF 06372865|pf 06372865
160672|NCT02310568|generalized anxiety disorder|generalized anxiety disorder
160673|NCT02310568|outpatient|outpatient
160674|NCT02310568|safety|safety
160675|NCT02310568|efficacy|efficacy
160676|NCT02310568|suboptimal response|suboptimal response
160677|NCT02310555|Metabolic surgery|metabolic surgery
160678|NCT02310529|Maternal depression|maternal depression
160679|NCT02310529|Interpersonal Psycotherapy|interpersonal psycotherapy
160680|NCT02310503|Mohs Surgery|mohs surgery
160681|NCT02310490|Nasolabial Folds|nasolabial folds
160682|NCT02310477|regorafenib, cohort, metastatic colorectal cancer|regorafenib, cohort, metastatic colorectal cancer
160683|NCT02310438|Music therapy|music therapy
160684|NCT02310438|stroke|stroke
160685|NCT02310438|hemiparesis|hemiparesis
160686|NCT02310438|neurologic music therapy|neurologic music therapy
160687|NCT02310412|INTERCEPT|intercept
160688|NCT02310412|platelet|platelet
160689|NCT02310412|pathogen inactivation|pathogen inactivation
160690|NCT02310412|platelet components stored|platelet components stored
160691|NCT02310412|therapeutic efficacy|therapeutic efficacy
160692|NCT02310399|Auditory Brainstem Implant|auditory brainstem implant
160693|NCT02310399|Deafness|deafness
160694|NCT02310399|Hearing Loss|hearing loss
160695|NCT02310399|ABI|abi
160696|NCT02310386|Fibromyalgia|fibromyalgia
160697|NCT02310386|Electromagnetic field therapy|electromagnetic field therapy
160698|NCT02310386|Randomized controlled trial|randomized controlled trial
160699|NCT02310373|Nicotine-free hookah|nicotine-free hookah
160700|NCT02310373|Waterpipe|waterpipe
160701|NCT02310373|Smoking|smoking
160702|NCT02310373|Sympathetic|sympathetic
160703|NCT02310321|Acute Myeloid Leukemia|acute myeloid leukemia
160704|NCT02310321|Cytarabine|cytarabine
160705|NCT02310321|Idarubicin|idarubicin
160706|NCT02310321|ASP2215|asp2215
160707|NCT02310308|Xylitol|xylitol
160708|NCT02310308|Magnolia|magnolia
160709|NCT02310308|chewing gum|chewing gum
160710|NCT02310295|Diabetic retinopathy|diabetic retinopathy
160711|NCT02310295|Macular edema|macular edema
160712|NCT02310295|Anti-VEGF|anti-vegf
160713|NCT02310295|Triamcinolone|triamcinolone
160714|NCT02310282|Telemedicine|telemedicine
160715|NCT02310282|Emergency medicine|emergency medicine
160716|NCT02310282|Stroke|stroke
160717|NCT02310282|Stroke syndromes|stroke syndromes
160718|NCT02310269|Cushing's disease,|cushing's disease,
160719|NCT02310269|pasireotide s.c.|pasireotide s.c.
160720|NCT02310269|Signifor|signifor
160721|NCT02310256|Mitochondria, muscle|mitochondria, muscle
160722|NCT02310256|Exercise|exercise
160723|NCT02310256|Blood Flow Velocity|blood flow velocity
160724|NCT02310243|Acute myeloid leukemia|acute myeloid leukemia
160725|NCT02310243|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
160726|NCT02310243|MLL-rearranged leukemia|mll-rearranged leukemia
160727|NCT02310243|Palbociclib (PD-0332991-00)|palbociclib (pd-0332991-00)
160728|NCT02310230|Endoscopy, Upper|endoscopy, upper
160729|NCT02310230|Minute Ventilation|minute ventilation
160730|NCT02310230|Tidal Volume|tidal volume
160731|NCT02310230|Respiratory Rate|respiratory rate
160732|NCT02310217|Hypertension|hypertension
160733|NCT02310217|Cognitive impairment|cognitive impairment
160734|NCT02310217|Biomarkers|biomarkers
160735|NCT02310191|ischemic stroke|ischemic stroke
160736|NCT02310191|carotid stenting|carotid stenting
160737|NCT02310191|MRI diffusion weighted imaging|mri diffusion weighted imaging
160738|NCT02310191|Laboratory marker|laboratory marker
160739|NCT02310178|weight loss|weight loss
160740|NCT02310178|sleeve gastrectomy|sleeve gastrectomy
160741|NCT02310178|gastric bypass|gastric bypass
160742|NCT02310178|gastric banding|gastric banding
160743|NCT02310178|bariatric procedures|bariatric procedures
160744|NCT02310178|cohort|cohort
160745|NCT02310178|morbid obesity|morbid obesity
160746|NCT02310178|medical and economical impact|medical and economical impact
160747|NCT02310178|severe obesity|severe obesity
160748|NCT02310165|Paracentesis|paracentesis
160749|NCT02310165|Ascites|ascites
160750|NCT02310152|Child|child
160751|NCT02310152|Adolescent|adolescent
160752|NCT02310152|Parents|parents
160753|NCT02310152|Cognitive Therapy|cognitive therapy
160754|NCT02310152|Cognitive Behavior Therapy|cognitive behavior therapy
160755|NCT02310152|Anxiety|anxiety
160756|NCT02310113|NIRS|nirs
160757|NCT02310113|transfusion|transfusion
160758|NCT02310113|RBC|rbc
160759|NCT02310087|male infertility|male infertility
160760|NCT02310087|spermatogenesis|spermatogenesis
160761|NCT02310087|antioxidants|antioxidants
160762|NCT02310087|DNA damage|dna damage
160763|NCT02310087|mitochondrial membrane potential|mitochondrial membrane potential
160764|NCT02310087|apoptosis|apoptosis
160765|NCT02310061|Dialysis|dialysis
160766|NCT02310061|ESRD|esrd
160767|NCT02310061|lung congestion|lung congestion
160768|NCT02310061|heart failure|heart failure
160769|NCT02310061|LW-US|lw-us
160770|NCT02310009|Exercise|exercise
160771|NCT02310009|IL-1RA|il-1ra
160772|NCT02310009|Beta-cell function|beta-cell function
160773|NCT02310009|Type 2 Diabetes|type 2 diabetes
161066|NCT02308280|Bortezomib|bortezomib
160774|NCT02309996|Randomized Controlled Trial|randomized controlled trial
160775|NCT02309996|Intervention Studies|intervention studies
160776|NCT02309996|Inservice Training|inservice training
160777|NCT02309996|Personnel Management|personnel management
160778|NCT02309996|Work place|work place
160779|NCT02309996|Work accommodation|work accommodation
160780|NCT02309996|Job modification|job modification
160781|NCT02309996|Supervision|supervision
160782|NCT02309996|Administration|administration
160783|NCT02309996|Return to Work|return to work
160784|NCT02309996|Industrial Psychology|industrial psychology
160785|NCT02309996|Human Engineering|human engineering
160786|NCT02309996|Risk Management|risk management
160787|NCT02309996|Organization and Administration|organization and administration
160788|NCT02309996|Work Disability|work disability
160789|NCT02309996|Occupational Diseases|occupational diseases
160790|NCT02309996|Occupational Injury|occupational injury
160791|NCT02309996|Occupational Health|occupational health
160792|NCT02309996|Occupational Exposure|occupational exposure
160793|NCT02309996|Sick Leave|sick leave
160794|NCT02309996|Absenteeism|absenteeism
160795|NCT02309996|Employee Health|employee health
160796|NCT02309983|bone turnover|bone turnover
160797|NCT02309983|muscle atrophy|muscle atrophy
160798|NCT02309983|fiber|fiber
661578|NCT00821275|Leiomyoma|leiomyoma
160799|NCT02309957|Knee Cartilage Repair, Osteochondral Defects, BioMatrix CRD|knee cartilage repair, osteochondral defects, biomatrix crd
160800|NCT02309944|Wound Healing|wound healing
160801|NCT02309944|Obesity|obesity
160802|NCT02309944|Gynecologic Surgery|gynecologic surgery
160803|NCT02309944|Gynecologic Neoplasms|gynecologic neoplasms
160804|NCT02309944|Surgical Complications|surgical complications
160805|NCT02309931|Right hemicolectomy|right hemicolectomy
160806|NCT02309931|Side-to-side anastomosis|side-to-side anastomosis
160807|NCT02309931|Orocecal time|orocecal time
160808|NCT02309931|Antipersitaltic|antipersitaltic
160809|NCT02309931|Isoperistaltic|isoperistaltic
160810|NCT02309931|Laparoscopic colectomy|laparoscopic colectomy
160811|NCT02309931|Right laparoscopic hemicolectomy|right laparoscopic hemicolectomy
160812|NCT02309918|acute HCV Genotype 1 Infection|acute hcv genotype 1 infection
160813|NCT02309918|HCV RNA|hcv rna
160814|NCT02309918|LDV/SOF FDC|ldv/sof fdc
160815|NCT02309905|inmates|inmates
160816|NCT02309905|skin lesion|skin lesion
160817|NCT02309905|telemedicine|telemedicine
160818|NCT02309892|Non-Small Cell Lung Cancer|non-small cell lung cancer
160819|NCT02309892|Neoplasms|neoplasms
160820|NCT02309892|Immunoconjugate|immunoconjugate
160821|NCT02309892|Tumor microenvironment alkalinization|tumor microenvironment alkalinization
160822|NCT02309879|Intravenous lidocaine|intravenous lidocaine
160823|NCT02309879|Magnesium sulphate|magnesium sulphate
160824|NCT02309879|Mastectomy|mastectomy
160826|NCT02309827|Inflammatory bowel disease|inflammatory bowel disease
160827|NCT02309723|Alzheimer's Disease|alzheimer's disease
160828|NCT02309723|Mild Cognitive Impairment|mild cognitive impairment
160829|NCT02309723|Neuroimaging|neuroimaging
160830|NCT02309723|Diagnostic Tool|diagnostic tool
160831|NCT02309697|Development|development
160832|NCT02309697|Assessments|assessments
160833|NCT02309697|Premature birth|premature birth
160834|NCT02309684|Diabetic Foot Ulcer (DFU)|diabetic foot ulcer (dfu)
160835|NCT02309684|Venous Leg Ulcer (VLU)|venous leg ulcer (vlu)
160836|NCT02309658|cervix neoplasm|cervix neoplasm
160837|NCT02309658|hENT1 protein, human|hent1 protein, human
160838|NCT02309658|Chemotherapy|chemotherapy
160839|NCT02309645|fibrin sealant|fibrin sealant
160840|NCT02309645|CSF leak|csf leak
160841|NCT02309619|esophageal cancer|esophageal cancer
160842|NCT02309619|esophagectomy|esophagectomy
160843|NCT02309619|quality of life|quality of life
160844|NCT02309593|osteoarthritis|osteoarthritis
160845|NCT02309593|avascular necrosis|avascular necrosis
160846|NCT02309593|ankylosis|ankylosis
160847|NCT02309593|protrusio acetabuli|protrusio acetabuli
160848|NCT02309593|painful hip dysplasia|painful hip dysplasia
160849|NCT02309593|rheumatoid arthritis|rheumatoid arthritis
160850|NCT02309593|correction of functional deformity|correction of functional deformity
160851|NCT02309593|revision procedures|revision procedures
160852|NCT02309580|Ibrutinib|ibrutinib
160853|NCT02309580|14-227|14-227
160854|NCT02309567|Anti-p53 antibody|anti-p53 antibody
160855|NCT02309567|PET/CT|pet/ct
160856|NCT02309567|Lung Cancer|lung cancer
160858|NCT02309554|Contraception|contraception
160859|NCT02309554|Post coital test|post coital test
160860|NCT02309554|Vaginal|vaginal
160861|NCT02309554|Diaphragm|diaphragm
160862|NCT02309541|middle ear implant|middle ear implant
160863|NCT02309541|feedback manager|feedback manager
160864|NCT02309541|Sound quality|sound quality
160865|NCT02309502|diabetic retinopathy|diabetic retinopathy
160866|NCT02309502|retina|retina
160867|NCT02309502|Laser|laser
160868|NCT02309502|Pascal|pascal
160869|NCT02309489|Family Planning Services|family planning services
160870|NCT02309489|Maternal Health Services|maternal health services
160871|NCT02309489|Breast Feeding|breast feeding
160872|NCT02309489|Contraception|contraception
160873|NCT02309489|Postnatal care|postnatal care
161173|NCT02307630|PET Imaging|pet imaging
160874|NCT02309489|Postpartum contraception|postpartum contraception
160875|NCT02309489|Exclusive breastfeeding|exclusive breastfeeding
160876|NCT02309489|Postpartum Period|postpartum period
160877|NCT02309476|diffuse diabetic macular oedema|diffuse diabetic macular oedema
160878|NCT02309476|Pascal|pascal
160879|NCT02309476|Laser|laser
160880|NCT02309476|DMO|dmo
160881|NCT02309437|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
160882|NCT02309437|Pain|pain
160883|NCT02309437|Oxycodone|oxycodone
160884|NCT02309437|Opioids|opioids
160885|NCT02309437|Oral Mucositis|oral mucositis
160886|NCT02309411|Pediatric|pediatric
160887|NCT02309385|uveitis|uveitis
160888|NCT02309385|acute uveitis|acute uveitis
160889|NCT02309385|anterior uveitis|anterior uveitis
160890|NCT02309385|dexamethasone sodium phosphate|dexamethasone sodium phosphate
160891|NCT02309385|non-infectious uveitis|non-infectious uveitis
160892|NCT02309385|DSP-Visulex|dsp-visulex
160893|NCT02309385|Aciont|aciont
160894|NCT02309346|clindamycin|clindamycin
160895|NCT02309346|septic abortion|septic abortion
160896|NCT02309307|safety and performance|safety and performance
160897|NCT02309294|Patch Test|patch test
160898|NCT02309281|Eylea|eylea
160899|NCT02309268|left atrial appendage closure|left atrial appendage closure
160900|NCT02309255|Secondary coronary prevention|secondary coronary prevention
160901|NCT02309255|Psychosocial factors|psychosocial factors
160902|NCT02309255|Cardiac rehabilitation|cardiac rehabilitation
160903|NCT02309229|sputum colour|sputum colour
160904|NCT02309229|cystic fibrosis|cystic fibrosis
160905|NCT02309229|pollution|pollution
160906|NCT02309190|Transpulmonary pressure - morbid obesity|transpulmonary pressure - morbid obesity
160907|NCT02309177|Pancreatic Cancer|pancreatic cancer
160908|NCT02309177|Breast Cancer|breast cancer
160909|NCT02309177|Metastatic Breast Cancer|metastatic breast cancer
160910|NCT02309177|nab-Paclitaxel|nab-paclitaxel
160911|NCT02309177|Gemcitabine|gemcitabine
160912|NCT02309177|Carboplatin|carboplatin
160913|NCT02309177|Non-Small Cell Lung Cancer|non-small cell lung cancer
160914|NCT02309177|Lung Cancer|lung cancer
160915|NCT02309177|mBC|mbc
160916|NCT02309177|NSCLC|nsclc
160917|NCT02309177|Triple-negative Breast Cancer|triple-negative breast cancer
160918|NCT02309177|Hormone Receptor Positive|hormone receptor positive
160919|NCT02309177|ER+|er+
160920|NCT02309177|PR+|pr+
160921|NCT02309177|TNBC|tnbc
160922|NCT02309177|Nivolumab|nivolumab
160923|NCT02309177|PD-1|pd-1
160924|NCT02309177|Check-point Inhibitor/s|check-point inhibitor/s
160925|NCT02309177|Immune Check-point Inhibitor/s|immune check-point inhibitor/s
160926|NCT02309177|Anti-PD-1|anti-pd-1
160927|NCT02309177|BMS-936558|bms-936558
200991|NCT02112656|Carcinoma|carcinoma
160928|NCT02309125|immediate gradual loading|immediate gradual loading
160929|NCT02309099|Acoustic Neuroma|acoustic neuroma
160930|NCT02309099|Vestibular Schwannoma|vestibular schwannoma
160931|NCT02309099|Meniere's Disease|meniere's disease
160932|NCT02309060|narrative communication|narrative communication
160933|NCT02309060|depression|depression
160934|NCT02309060|primary care|primary care
160935|NCT02309060|treatment development|treatment development
160936|NCT02309034|Overweight|overweight
160937|NCT02309034|Obesity|obesity
160938|NCT02309034|Cardiometabolic risk factors|cardiometabolic risk factors
160939|NCT02309034|Adolescents|adolescents
160940|NCT02309034|Exercise|exercise
160941|NCT02309021|craving|craving
160942|NCT02309008|Pharmacokinetics|pharmacokinetics
160943|NCT02308995|Endometriosis|endometriosis
160944|NCT02308995|Laparoscopy|laparoscopy
160945|NCT02308995|Barbed sutures|barbed sutures
160946|NCT02308982|encephalitis|encephalitis
160947|NCT02308982|meningoencephalitis|meningoencephalitis
160948|NCT02308982|encephalomyelitis|encephalomyelitis
160949|NCT02308982|brain inflammation|brain inflammation
160950|NCT02308982|intravenous immunoglobulin|intravenous immunoglobulin
160951|NCT02308982|randomised controlled trial|randomised controlled trial
160952|NCT02308982|Central Nervous System Diseases|central nervous system diseases
160953|NCT02308982|Central Nervous System Infection|central nervous system infection
160954|NCT02308969|altered state of consciousness|altered state of consciousness
160955|NCT02308969|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
160956|NCT02308969|hallucination|hallucination
160957|NCT02308969|model psychosis|model psychosis
160958|NCT02308969|serotonin receptor|serotonin receptor
160959|NCT02308969|LSD|lsd
160960|NCT02308956|task sharing|task sharing
160961|NCT02308956|task shifting|task shifting
160962|NCT02308956|community mental health care|community mental health care
160963|NCT02308956|primary care|primary care
160964|NCT02308956|Developing country|developing country
160965|NCT02308956|Sub-Saharan Africa|sub-saharan africa
160966|NCT02308956|non-inferiority trial|non-inferiority trial
160967|NCT02308917|IBD|ibd
160968|NCT02308917|Crohn's|crohn's
160969|NCT02308917|Ulcerative|ulcerative
160970|NCT02308917|Colitis|colitis
160971|NCT02308904|Infertility|infertility
160972|NCT02308904|Thalassemia|thalassemia
160973|NCT02308904|Iron overload|iron overload
160974|NCT02308904|Pituitary Iron Load|pituitary iron load
160975|NCT02308904|Oxidative Stress|oxidative stress
160976|NCT02308904|REPRODUCTIVE CAPACITY AND ASSOCIATION TO IRON BURDEN AND CHELATION PATTERNS IN THALASSEMIA MAJOR PATIENTS|reproductive capacity and association to iron burden and chelation patterns in thalassemia major patients
160977|NCT02308891|pancreatitis|pancreatitis
160978|NCT02308891|ERCP|ercp
160979|NCT02308878|Opioid abuse|opioid abuse
160980|NCT02308878|Cognitive Therapy|cognitive therapy
160981|NCT02308878|Executive Function|executive function
160982|NCT02308878|Mobile Health|mobile health
160983|NCT02308878|Rehabilitation|rehabilitation
160984|NCT02308865|Early palliative care|early palliative care
160985|NCT02308865|Lung cancer|lung cancer
160986|NCT02308865|Quality of life|quality of life
160987|NCT02308852|bi-manual , motor skill learning , stroke , chronic patients,neuro-rehabilitative robot|bi-manual , motor skill learning , stroke , chronic patients,neuro-rehabilitative robot
160988|NCT02308839|Aneurysm|aneurysm
160989|NCT02308839|Aorta|aorta
160990|NCT02308839|Abdominal|abdominal
160991|NCT02308800|diabetic foot ulcer|diabetic foot ulcer
160992|NCT02308787|platelet depletion|platelet depletion
160993|NCT02308787|apheresis|apheresis
160994|NCT02308774|osteomyelitis, diabetic foot infection|osteomyelitis, diabetic foot infection
160995|NCT02308735|gestation|gestation
160996|NCT02308735|diabetes|diabetes
160997|NCT02308735|ethanol|ethanol
160998|NCT02308722|Borderline resectable|borderline resectable
160999|NCT02308709|Radiotherapy|radiotherapy
161000|NCT02308709|Pulmonary Functional Imaging|pulmonary functional imaging
161001|NCT02308709|Computed Tomography (CT)|computed tomography (ct)
161002|NCT02308709|Image Registration|image registration
161003|NCT02308709|Functional Image-guided Radiotherapy|functional image-guided radiotherapy
161004|NCT02308696|Older Adults|older adults
161005|NCT02308696|Aging in Place|aging in place
161006|NCT02308683|hscrp|hscrp
161007|NCT02308683|hgba1c|hgba1c
161008|NCT02308683|diabetes mellitus|diabetes mellitus
161009|NCT02308644|Diabetic Retinopathy|diabetic retinopathy
152026|NCT02360007|buprenorphine|buprenorphine
161010|NCT02308644|intravitreal bevacizumab|intravitreal bevacizumab
161011|NCT02308644|Contrast Sensitivity|contrast sensitivity
161012|NCT02308631|Endoscopic, Colostomy, Colopexy|endoscopic, colostomy, colopexy
161013|NCT02308618|Achilles tendon rupture|achilles tendon rupture
161014|NCT02308618|Rehabilitation|rehabilitation
161015|NCT02308618|Immobilization|immobilization
161016|NCT02308618|Muscle architecture|muscle architecture
161017|NCT02308618|Functionality|functionality
161018|NCT02308618|Neuromuscular parameters|neuromuscular parameters
161019|NCT02308618|Weight-Bearing|weight-bearing
161020|NCT02308605|SMARTCap|smartcap
161021|NCT02308592|Pregnancy|pregnancy
161022|NCT02308592|Depression|depression
161023|NCT02308592|Antidepressant Use|antidepressant use
161024|NCT02308592|Decision Aid|decision aid
161025|NCT02308566|Intracranial Embolism|intracranial embolism
161026|NCT02308566|Ultrasonography, Doppler, Transcranial|ultrasonography, doppler, transcranial
161027|NCT02308553|BRAF V600 wildtype|braf v600 wildtype
161028|NCT02308553|cutaneous malignant melanoma|cutaneous malignant melanoma
161029|NCT02308553|nintedanib|nintedanib
161030|NCT02308553|paclitaxel|paclitaxel
161031|NCT02308553|kinase inhibitor|kinase inhibitor
161032|NCT02308527|Children|children
161033|NCT02308527|Young adults|young adults
161034|NCT02308514|cryostimulation|cryostimulation
161035|NCT02308488|prone IMRT to breast, level III & Supraclavicular|prone imrt to breast, level iii & supraclavicular
161036|NCT02308488|acute toxicity of prone IMRT to breast, level III & SCV|acute toxicity of prone imrt to breast, level iii & scv
161037|NCT02308462|children of mentally ill parents|children of mentally ill parents
161038|NCT02308462|family intervention|family intervention
161039|NCT02308462|randomized controlled trial|randomized controlled trial
161040|NCT02308410|Tourniquet|tourniquet
161041|NCT02308410|Postoperative outcome|postoperative outcome
161042|NCT02308410|Total knee arthroplasty|total knee arthroplasty
161043|NCT02308397|non coeliac gluten sensitivity|non coeliac gluten sensitivity
161044|NCT02308397|gluten|gluten
161045|NCT02308397|bread|bread
161046|NCT02308384|iFOBT|ifobt
161047|NCT02308384|FIT|fit
161048|NCT02308384|general practice|general practice
161049|NCT02308384|early diagnosis|early diagnosis
161050|NCT02308371|critically ill pediatric patients|critically ill pediatric patients
161051|NCT02308371|fluid resuscitation|fluid resuscitation
161052|NCT02308358|Osteochondral Defect|osteochondral defect
161053|NCT02308358|Femoral condyle osteochondral defect|femoral condyle osteochondral defect
161054|NCT02308319|Hepatocellular carcinoma, Recurrence|hepatocellular carcinoma, recurrence
161055|NCT02308306|Chronic pain|chronic pain
161056|NCT02308306|Opioid analgesics|opioid analgesics
161057|NCT02308306|Prediction study|prediction study
161058|NCT02308306|Pharmaco-EEG|pharmaco-eeg
161059|NCT02308293|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
161060|NCT02308293|Hypoglycemia unawareness|hypoglycemia unawareness
161061|NCT02308293|Lactate|lactate
161062|NCT02308293|high intensity interval exercise|high intensity interval exercise
161063|NCT02308293|MRS|mrs
161064|NCT02308280|High-risk myeloma|high-risk myeloma
161065|NCT02308280|Non myeloablative allogeneic transplantation|non myeloablative allogeneic transplantation
161067|NCT02308267|Cystic Fibrosis|cystic fibrosis
161068|NCT02308267|Mucosal immunity|mucosal immunity
161069|NCT02308254|Blood pressure|blood pressure
161070|NCT02308254|Gastric emptying|gastric emptying
161071|NCT02308254|Glycemia|glycemia
161072|NCT02308254|Appetite|appetite
161073|NCT02308254|Incretin Hormones|incretin hormones
161074|NCT02308254|Superior mesenteric artery blood low|superior mesenteric artery blood low
161075|NCT02308241|Ribavirin|ribavirin
161076|NCT02308241|Human Papillomavirus (HPV)|human papillomavirus (hpv)
161077|NCT02308241|Recurrent/Metastatic (R/M)|recurrent/metastatic (r/m)
161078|NCT02308241|14-211|14-211
161079|NCT02308228|Aging|aging
161080|NCT02308228|Hypertrophy|hypertrophy
161081|NCT02308228|Metformin|metformin
161082|NCT02308228|Strength|strength
161083|NCT02308228|Muscle|muscle
161084|NCT02308215|Retina|retina
161085|NCT02308215|AMD|amd
161086|NCT02308215|OCT|oct
161087|NCT02308202|PTSD|ptsd
161088|NCT02308202|treatment|treatment
161089|NCT02308202|virtual reality|virtual reality
161090|NCT02308202|doxazosin|doxazosin
161091|NCT02308189|Exercise|exercise
661579|NCT00821275|myomectomy|myomectomy
161092|NCT02308163|Rheumatoid Arthritis|rheumatoid arthritis
161093|NCT02308163|ASP015K|asp015k
161094|NCT02308150|transcatheter aortic valve replacement|transcatheter aortic valve replacement
161095|NCT02308150|asian pacific|asian pacific
161096|NCT02308150|asian|asian
161097|NCT02308111|Primary Biliary Cirrhosis|primary biliary cirrhosis
161098|NCT02308111|PBC|pbc
161099|NCT02308111|Cirrhosis|cirrhosis
161100|NCT02308111|Liver|liver
161101|NCT02308085|Premenopausal|premenopausal
161102|NCT02308085|endocrine responsive|endocrine responsive
161103|NCT02308085|Breast|breast
161104|NCT02308085|Pregnancy|pregnancy
161105|NCT02308072|Squamous Cell Carcinoma|squamous cell carcinoma
161106|NCT02308072|Head and Neck Cancer|head and neck cancer
161107|NCT02308072|Locally Advanced|locally advanced
161108|NCT02308072|Olaparib|olaparib
161109|NCT02308072|Cisplatin|cisplatin
161110|NCT02308072|IMRT|imrt
161111|NCT02308072|Chemoradiotherapy|chemoradiotherapy
161112|NCT02308072|PARP|parp
161113|NCT02308072|HNSCC|hnscc
161114|NCT02307994|infertility|infertility
161115|NCT02307942|Randomized Clinical Trials|randomized clinical trials
161116|NCT02307942|gastric banding|gastric banding
161117|NCT02307942|calorie restriction|calorie restriction
161118|NCT02307942|SPPB|sppb
161119|NCT02307942|physical performance|physical performance
161120|NCT02307942|elderly|elderly
161121|NCT02307916|tympanic membrane perforation|tympanic membrane perforation
161122|NCT02307916|ear drum|ear drum
161123|NCT02307916|hole|hole
161124|NCT02307903|end-stage renal failure (ESRF)|end-stage renal failure (esrf)
161125|NCT02307890|Liver Transplantation|liver transplantation
161126|NCT02307864|Healthy|healthy
161127|NCT02307864|QT interval|qt interval
161128|NCT02307864|QTc interval|qtc interval
161129|NCT02307864|Electrocardiogram|electrocardiogram
161130|NCT02307864|Tramadol hydrochloride|tramadol hydrochloride
161131|NCT02307864|Moxifloxacin|moxifloxacin
161132|NCT02307864|Placebo|placebo
161133|NCT02307838|Multiple Sclerosis, MS, RRMS, relapsing forms of multiple sclerosis, fingolimod, FTY720, Gilenya|multiple sclerosis, ms, rrms, relapsing forms of multiple sclerosis, fingolimod, fty720, gilenya
161134|NCT02307825|Azithromycin|azithromycin
161135|NCT02307825|Endoscopic sinus surgery|endoscopic sinus surgery
161136|NCT02307799|tobacco|tobacco
161137|NCT02307799|spirometry|spirometry
161138|NCT02307799|cohort study|cohort study
161139|NCT02307799|case-control study|case-control study
161140|NCT02307799|prevalence|prevalence
161141|NCT02307773|Upper Gastrointestinal Endoscopy|upper gastrointestinal endoscopy
161142|NCT02307773|Pharyngeal Anesthesia|pharyngeal anesthesia
161143|NCT02307773|Lidocaine|lidocaine
161144|NCT02307773|Belching|belching
161145|NCT02307773|Retching|retching
161146|NCT02307773|Tolerance|tolerance
161147|NCT02307747|infection in ICU|infection in icu
161148|NCT02307734|Lay Health Workers|lay health workers
161149|NCT02307734|Chinese|chinese
161150|NCT02307734|Vietnamese|vietnamese
161151|NCT02307734|Tobacco Use|tobacco use
161152|NCT02307734|Intervention|intervention
161153|NCT02307734|Behavior Change|behavior change
161154|NCT02307734|Social Networks|social networks
161155|NCT02307734|Asians|asians
161156|NCT02307721|Emergency Treatment|emergency treatment
161157|NCT02307721|Morphine Derivates|morphine derivates
161158|NCT02307721|Heroin|heroin
161159|NCT02307721|Antidotes|antidotes
161160|NCT02307721|Administration, Intranasal|administration, intranasal
161161|NCT02307721|Pharmacology|pharmacology
161163|NCT02307721|Healthy volunteers|healthy volunteers
161164|NCT02307695|Saxagliptin|saxagliptin
161165|NCT02307695|Type 1 Diabetes|type 1 diabetes
161166|NCT02307695|Glycemic variability|glycemic variability
161167|NCT02307695|C-Peptide|c-peptide
161168|NCT02307682|AMD|amd
161169|NCT02307682|CNV|cnv
161170|NCT02307682|IVT|ivt
161171|NCT02307643|Systemic lupus erythematosus|systemic lupus erythematosus
161172|NCT02307630|124I-Humanized 3F8|124i-humanized 3f8
161174|NCT02307630|13-147|13-147
161175|NCT02307617|Major depressive disorder|major depressive disorder
161176|NCT02307617|MDD|mdd
161177|NCT02307617|healthy control|healthy control
161178|NCT02307617|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
161179|NCT02307617|SSRI|ssri
161180|NCT02307617|depression|depression
161181|NCT02307617|transcranial magnetic stimulation|transcranial magnetic stimulation
161182|NCT02307617|TMS|tms
161183|NCT02307617|magnetic resonance spectroscopy|magnetic resonance spectroscopy
161184|NCT02307617|MRS|mrs
161185|NCT02307617|adolescent|adolescent
161186|NCT02307617|mild MDD|mild mdd
161187|NCT02307617|mild depression|mild depression
161188|NCT02307617|cortical excitability|cortical excitability
161189|NCT02307617|cortical inhibition|cortical inhibition
161190|NCT02307617|cortical silent period|cortical silent period
161191|NCT02307617|motor threshold|motor threshold
161192|NCT02307617|intracortical facilitation|intracortical facilitation
161193|NCT02307617|intracortical inhibition|intracortical inhibition
161194|NCT02307617|motor cortex|motor cortex
161195|NCT02307617|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
161196|NCT02307617|DLPFC|dlpfc
161197|NCT02307617|thumb twitch|thumb twitch
161198|NCT02307617|gamma aminobutyric acid|gamma aminobutyric acid
161199|NCT02307617|GABA|gaba
161200|NCT02307617|glutamate|glutamate
161201|NCT02307617|single pulse|single pulse
161202|NCT02307617|paired pulse|paired pulse
161203|NCT02307604|Brain tumor|brain tumor
161204|NCT02307604|Biomarkers|biomarkers
161205|NCT02307604|Screening|screening
161206|NCT02307578|Perampanel|perampanel
161207|NCT02307578|Fycompa|fycompa
161208|NCT02307578|Primary Generalized Tonic-Clonic Seizures|primary generalized tonic-clonic seizures
161209|NCT02307578|E2007-G000-332|e2007-g000-332
161210|NCT02307578|E2007|e2007
161211|NCT02307565|Midodrine|midodrine
161212|NCT02307565|Blood pressure|blood pressure
161213|NCT02307565|Orthostatic hypotension|orthostatic hypotension
161214|NCT02307565|Spinal Cord Injury|spinal cord injury
161215|NCT02307565|Sympathetic vascular control|sympathetic vascular control
161216|NCT02307565|Cerebral blood flow velocity|cerebral blood flow velocity
161217|NCT02307565|Cognition function tasks|cognition function tasks
161218|NCT02307565|Quality of Life|quality of life
161219|NCT02307565|MRI|mri
161220|NCT02307565|fMRI|fmri
161221|NCT02307552|Imaging|imaging
161222|NCT02307552|ultrasound|ultrasound
161223|NCT02307552|prostate|prostate
161224|NCT02307552|cancer|cancer
161225|NCT02307552|diagnostic tool|diagnostic tool
161226|NCT02307552|catheter|catheter
161227|NCT02307552|urethra|urethra
161228|NCT02307552|digital rectal exam|digital rectal exam
161229|NCT02307526|Hypotension, Postural|hypotension, postural
161230|NCT02307513|APREMILAST (CC-10004)|apremilast (cc-10004)
161231|NCT02307513|CC-10004|cc-10004
161232|NCT02307513|Efficacy|efficacy
161234|NCT02307513|Phase 3|phase 3
161235|NCT02307513|Behçet's Disease|behçet's disease
161236|NCT02307487|TC-3 Gel|tc-3 gel
161237|NCT02307487|MMC|mmc
161238|NCT02307487|NMIBC|nmibc
161239|NCT02307487|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
161240|NCT02307487|Hydrogel Reverse thermal gelation|hydrogel reverse thermal gelation
161241|NCT02307487|Drug retention|drug retention
161242|NCT02307487|Urinary Bladder Neoplasms|urinary bladder neoplasms
161243|NCT02307487|Urologic Neoplasms|urologic neoplasms
161244|NCT02307487|Urinary Bladder Diseases|urinary bladder diseases
161245|NCT02307487|Urologic Diseases|urologic diseases
161246|NCT02307474|Kidney|kidney
161247|NCT02307474|Renal Cell Carcinoma|renal cell carcinoma
161248|NCT02307474|Cancer|cancer
161249|NCT02307474|Pilot|pilot
161250|NCT02307474|Pazopanib|pazopanib
161251|NCT02307474|stereotactic body radiation therapy|stereotactic body radiation therapy
161252|NCT02307474|SBRT|sbrt
161253|NCT02307461|Phase 1|phase 1
161254|NCT02307461|Bioequivalence|bioequivalence
161255|NCT02307461|Pharmacokinetics|pharmacokinetics
161256|NCT02307461|Food|food
161257|NCT02307461|Healthy Adult|healthy adult
161258|NCT02307435|non union fracture|non union fracture
161259|NCT02307435|bone defect|bone defect
161260|NCT02307435|mesenchymal stem cell|mesenchymal stem cell
161261|NCT02307435|cryopreservation|cryopreservation
161262|NCT02307383|SDD (Selective Digestive Decolonization)|sdd (selective digestive decolonization)
161263|NCT02307383|OXA 48|oxa 48
161264|NCT02307383|carbapenemase|carbapenemase
161265|NCT02307383|probiotics|probiotics
161266|NCT02307331|Total Hip Replacement|total hip replacement
161559|NCT02305784|Chitinase|chitinase
161267|NCT02307318|Radial Artery|radial artery
161268|NCT02307318|Hemostasis|hemostasis
161269|NCT02307318|Angiography|angiography
161270|NCT02307292|Superficial femoral artery|superficial femoral artery
161271|NCT02307292|Self Expanding Stent System|self expanding stent system
161272|NCT02307253|EUS-guided biopsy, EUS-FNB|eus-guided biopsy, eus-fnb
161274|NCT02307188|Atrial Fibrillation|atrial fibrillation
161275|NCT02307188|Atrial Flutter|atrial flutter
161276|NCT02307188|Multipolar Catheter|multipolar catheter
161277|NCT02307188|Atrial Arrhythmia|atrial arrhythmia
161278|NCT02307162|COPD|copd
161279|NCT02307149|melanoma|melanoma
161280|NCT02307149|ipilimumab|ipilimumab
161281|NCT02307149|coxsackievirus A21|coxsackievirus a21
161282|NCT02307149|CAVATAK|cavatak
161283|NCT02307149|CVA21|cva21
161284|NCT02307149|checkpoint inhibitors|checkpoint inhibitors
161285|NCT02307136|intensive care units|intensive care units
161286|NCT02307136|emergency department|emergency department
161287|NCT02307123|Prehospital emergency care (MeSH)|prehospital emergency care (mesh)
161288|NCT02307123|Emergency medical services (MeSH)|emergency medical services (mesh)
161289|NCT02307123|Helicopter emergency medical service, Critical care (MeSH)|helicopter emergency medical service, critical care (mesh)
161290|NCT02307123|Airway management (MeSH)|airway management (mesh)
161291|NCT02307123|Endotracheal intubation (MeSH)|endotracheal intubation (mesh)
161292|NCT02307123|Patient outcome|patient outcome
161293|NCT02307110|Diabetes Mellitus 1|diabetes mellitus 1
161294|NCT02307110|long-term intensified insulin therapy|long-term intensified insulin therapy
161295|NCT02307110|diabetic retinopathy|diabetic retinopathy
161296|NCT02307110|diabetic macular edema|diabetic macular edema
161297|NCT02307097|Randomised Controlled Trial|randomised controlled trial
161298|NCT02307097|Cognitive-Behavioural Bibliotherapy|cognitive-behavioural bibliotherapy
161299|NCT02307097|Social Anxiety Disorder|social anxiety disorder
161300|NCT02307097|Cognitive-Behavioural Therapy|cognitive-behavioural therapy
161301|NCT02307097|IAPT|iapt
161302|NCT02307084|surgical site infection|surgical site infection
161303|NCT02307084|long saphenous vein|long saphenous vein
161304|NCT02307084|coronary artery bypass grafting|coronary artery bypass grafting
152376|NCT02358174|MMP|mmp
161305|NCT02307058|Prostate Cancer|prostate cancer
161306|NCT02307045|Arterial stiffness|arterial stiffness
161307|NCT02307045|Endothelial Glycocalyx|endothelial glycocalyx
161308|NCT02307032|Atrial Fibrillation Relapses Prediction|atrial fibrillation relapses prediction
161309|NCT02307032|P wave Signal Averaged ECG|p wave signal averaged ecg
161310|NCT02307032|P wave Wavelets|p wave wavelets
161311|NCT02307032|Strain|strain
161312|NCT02307032|Tissue Doppler Imaging|tissue doppler imaging
161313|NCT02307019|Caregivers|caregivers
161314|NCT02307019|Apraxias|apraxias
161315|NCT02307019|Stroke|stroke
161316|NCT02307019|Cerebral Stroke|cerebral stroke
161317|NCT02307019|Rehabilitation|rehabilitation
161318|NCT02307019|Pragmatic Clinical Trials as Topic|pragmatic clinical trials as topic
161319|NCT02306993|Sickle Cell Disease (SCD)|sickle cell disease (scd)
161320|NCT02306993|Sickle Cell Trait (SCT)|sickle cell trait (sct)
161321|NCT02306967|oral cancer|oral cancer
161322|NCT02306967|oral dysplasia|oral dysplasia
161323|NCT02306954|Kidney Cancer|kidney cancer
161324|NCT02306954|High Dose IL-2|high dose il-2
161325|NCT02306954|SBRT|sbrt
161326|NCT02306928|Septic shock|septic shock
161327|NCT02306928|Intensive care unit|intensive care unit
161328|NCT02306928|Therapeutic drug monitoring|therapeutic drug monitoring
161329|NCT02306928|Pharmacokinetics|pharmacokinetics
161330|NCT02306928|Critically ill|critically ill
161331|NCT02306915|Lipegfilgrastim, Lonquex, Japanese Bridging|lipegfilgrastim, lonquex, japanese bridging
161332|NCT02306863|Parkinson's Disease|parkinson's disease
161333|NCT02306863|whole-body vibration|whole-body vibration
161334|NCT02306863|WBV|wbv
161335|NCT02306850|immunotherapy|immunotherapy
161336|NCT02306850|PD-1 inhibitor|pd-1 inhibitor
161337|NCT02306850|programmed death 1 inhibitor|programmed death 1 inhibitor
161338|NCT02306850|neoadjuvant|neoadjuvant
161339|NCT02306850|pembrolizumab|pembrolizumab
161340|NCT02306850|MK-3475|mk-3475
161341|NCT02306837|lymphoma, consolidation chemotherapy, auto-HSCT|lymphoma, consolidation chemotherapy, auto-hsct
161342|NCT02306759|analgesia|analgesia
161343|NCT02306759|ketamine|ketamine
161344|NCT02306759|pain|pain
161345|NCT02306746|Enteral nutrition|enteral nutrition
161346|NCT02306746|randomised control trial|randomised control trial
161347|NCT02306746|Critical care|critical care
161348|NCT02306746|Outcome|outcome
161349|NCT02306733|Post partum hemorrhage|post partum hemorrhage
161350|NCT02306733|Ergometrine|ergometrine
161351|NCT02306733|Oxytocin|oxytocin
161352|NCT02306733|Obstetrics|obstetrics
161353|NCT02306694|hemophilia|hemophilia
161354|NCT02306694|bone disease|bone disease
161355|NCT02306694|clinical study|clinical study
161356|NCT02306694|biomarkers|biomarkers
161357|NCT02306668|Dry eye|dry eye
161358|NCT02306655|Coital incontinence|coital incontinence
161359|NCT02306655|Incidence|incidence
161360|NCT02306655|quality of life|quality of life
161361|NCT02306629|Systemic Lupus Erythematosus|systemic lupus erythematosus
161362|NCT02306590|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
161363|NCT02306590|survival time|survival time
161364|NCT02306590|ALS Functional Rating Scale|als functional rating scale
161365|NCT02306590|quality of life|quality of life
161366|NCT02306590|survival|survival
161367|NCT02306577|STRIBILD|stribild
161368|NCT02306577|HIV|hiv
161369|NCT02306577|Illicit dgug user|illicit dgug user
161370|NCT02306564|ICSI|icsi
161371|NCT02306564|cabergoline|cabergoline
161372|NCT02306564|Subendometrial vascularity|subendometrial vascularity
161373|NCT02306551|Offspring|offspring
161374|NCT02306551|Attachment|attachment
161375|NCT02306551|Risk development|risk development
161376|NCT02306551|Resilience|resilience
161377|NCT02306538|edema|edema
161378|NCT02306538|inflammation|inflammation
161379|NCT02306538|scar|scar
161380|NCT02306538|ejection fraction|ejection fraction
161381|NCT02306538|volumes|volumes
161382|NCT02306512|Melanoma In Situ|melanoma in situ
161383|NCT02306512|Lentigo Maligna|lentigo maligna
161384|NCT02306512|Confocal Microscopy|confocal microscopy
161385|NCT02306512|Direct Immunofluorescence|direct immunofluorescence
161386|NCT02306499|VARICOCELE-AZOOSPERMIA-ICSI|varicocele-azoospermia-icsi
161387|NCT02306460|Neurobehavioral Manifestations|neurobehavioral manifestations
161388|NCT02306460|POCD|pocd
161389|NCT02306460|Atrial Fibrillation|atrial fibrillation
161390|NCT02306460|Anti-Arrhythmia|anti-arrhythmia
161391|NCT02306460|Atrial Appendage Closure|atrial appendage closure
161392|NCT02306434|childbirth fear|childbirth fear
161393|NCT02306434|Internet CBT|internet cbt
161394|NCT02306434|counselling|counselling
161395|NCT02306434|antenatal care|antenatal care
161396|NCT02306434|postnatal care|postnatal care
161397|NCT02306434|childbirth|childbirth
161398|NCT02306434|Cognitive behavioural therapy|cognitive behavioural therapy
161399|NCT02306421|RPH with the simplified Milligan-Morgan surgery|rph with the simplified milligan-morgan surgery
161400|NCT02306421|mixed hemorrhoids|mixed hemorrhoids
161401|NCT02306421|the effectiveness and safety|the effectiveness and safety
161402|NCT02306421|A multi center clinical trial|a multi center clinical trial
161403|NCT02306395|endometrial local injury|endometrial local injury
161404|NCT02306395|repeated implatation failure|repeated implatation failure
161405|NCT02306395|embyo transfer|embyo transfer
161406|NCT02306382|endoanal ultrasonography|endoanal ultrasonography
161407|NCT02306382|drainage|drainage
161408|NCT02306382|perianal abscess|perianal abscess
161409|NCT02306382|fistulas|fistulas
161410|NCT02306382|incontience|incontience
161412|NCT02306369|IBS|ibs
161413|NCT02306369|FGID|fgid
161414|NCT02306369|functional abdominal pain|functional abdominal pain
161415|NCT02306369|Adolescents|adolescents
161416|NCT02306369|Children|children
161417|NCT02306369|Treatment|treatment
161418|NCT02306369|CBT|cbt
161419|NCT02306369|Exposure|exposure
161420|NCT02306369|Cognitive Behavior Therapy|cognitive behavior therapy
161421|NCT02306369|Internet|internet
161422|NCT02306369|Computerized|computerized
161423|NCT02306369|Abdominal Pain|abdominal pain
161424|NCT02306369|Functional Pain|functional pain
161425|NCT02306369|Functional Disorders|functional disorders
161426|NCT02306343|rapid acting insulin|rapid acting insulin
161427|NCT02306343|insulin injection|insulin injection
161428|NCT02306343|insulin delivery|insulin delivery
161429|NCT02306343|local heating|local heating
161430|NCT02306343|experimental device|experimental device
161431|NCT02306343|pre and post meal glucose level|pre and post meal glucose level
161432|NCT02306330|Malditof|malditof
161433|NCT02306330|Malditof MS|malditof ms
161434|NCT02306330|matrix-assisted laser desorption ionization-time|matrix-assisted laser desorption ionization-time
161435|NCT02306330|identifying pathogens|identifying pathogens
161436|NCT02306330|randomized diagnostic trial|randomized diagnostic trial
161437|NCT02306304|Abdominal aortic aneurysm|abdominal aortic aneurysm
161438|NCT02306304|Abdominal aortic aneurism|abdominal aortic aneurism
161439|NCT02306304|AAA|aaa
161440|NCT02306304|Screening|screening
161441|NCT02306304|duplex ultra sound|duplex ultra sound
161442|NCT02306304|Israeli Arab men|israeli arab men
161443|NCT02306304|family physician|family physician
161444|NCT02306291|AML|aml
161445|NCT02306291|Acute myeloid leukemia|acute myeloid leukemia
161446|NCT02306291|E-selectin|e-selectin
161447|NCT02306291|relapse refractory|relapse refractory
161448|NCT02306291|elderly newly diagnosed|elderly newly diagnosed
161449|NCT02306291|induction|induction
161450|NCT02306278|gabapentin|gabapentin
161451|NCT02306278|postoperative pain|postoperative pain
161452|NCT02306278|vomiting|vomiting
161453|NCT02306278|nausea|nausea
161454|NCT02306252|Cancer|cancer
161455|NCT02306252|Older Adult|older adult
161456|NCT02306252|Geriatric|geriatric
161457|NCT02306252|Function|function
161458|NCT02306252|Functional Deficit|functional deficit
161459|NCT02306252|Occupational Therapy|occupational therapy
161460|NCT02306252|Physical Therapy|physical therapy
161461|NCT02306252|Supportive Care|supportive care
161462|NCT02306252|Oncology|oncology
161463|NCT02306252|physiology|physiology
161464|NCT02306252|Geriatric Assessment|geriatric assessment
161465|NCT02306252|Health Services for the Aged|health services for the aged
161466|NCT02306252|Physical Therapy Specialty|physical therapy specialty
161467|NCT02306226|TAVI|tavi
161468|NCT02306226|Aortic stenosis|aortic stenosis
161469|NCT02306226|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
161470|NCT02306226|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
161471|NCT02306226|Transfemoral access|transfemoral access
161472|NCT02306200|Aorta|aorta
161473|NCT02306200|Aortic Disease|aortic disease
161474|NCT02306200|Abdominal Aortic Aneurysm (AAA)|abdominal aortic aneurysm (aaa)
161475|NCT02306200|Thoracic Aortic Aneurysm (TAA)|thoracic aortic aneurysm (taa)
161476|NCT02306200|Aortic Stenosis|aortic stenosis
161477|NCT02306200|Aortic Valve Repair (AVR)|aortic valve repair (avr)
161478|NCT02306200|Bicuspid Aortic Valve (BAV)|bicuspid aortic valve (bav)
161479|NCT02306187|The changes of bone mineral density and bone turnover markers|the changes of bone mineral density and bone turnover markers
161480|NCT02306174|Hoarding|hoarding
161481|NCT02306135|Cancer|cancer
161482|NCT02306135|Tumor|tumor
161483|NCT02306135|Everolimus|everolimus
161484|NCT02306135|mTOR|mtor
161485|NCT02306135|Temsirolimus|temsirolimus
161486|NCT02306135|Sirolimus|sirolimus
161487|NCT02306135|Rapamycin|rapamycin
161488|NCT02306122|medication adherence|medication adherence
161489|NCT02306122|choice architecture|choice architecture
161490|NCT02306122|pharmacy home|pharmacy home
161491|NCT02306109|Motor Rehabilitation Treatment|motor rehabilitation treatment
161493|NCT02306109|Motor Disability|motor disability
161494|NCT02306096|prognostic and predictive biomarkers|prognostic and predictive biomarkers
161495|NCT02306096|RNA-sequencing|rna-sequencing
161496|NCT02306096|pathological complete response|pathological complete response
161497|NCT02306096|minimal residual disease|minimal residual disease
161498|NCT02306096|molecular subtype|molecular subtype
161499|NCT02306096|gene expression profiling|gene expression profiling
161500|NCT02306096|mutation screening|mutation screening
161501|NCT02306096|BRCA|brca
152605|NCT02356861|TBI|tbi
161502|NCT02306096|translational research|translational research
161503|NCT02306096|genomics|genomics
161504|NCT02306096|transcriptomics|transcriptomics
161505|NCT02306096|proteomics|proteomics
161506|NCT02306096|metabolomics|metabolomics
161507|NCT02306096|liquid biopsy|liquid biopsy
161508|NCT02306096|circulating tumor cells|circulating tumor cells
161509|NCT02306096|circulating tumor DNA|circulating tumor dna
161510|NCT02306044|Bleeding|bleeding
161511|NCT02306044|Platelet indices|platelet indices
161512|NCT02306044|Platelet aggregometry|platelet aggregometry
161513|NCT02306044|Bleeding questionnaire|bleeding questionnaire
161514|NCT02306031|diclofenac|diclofenac
161515|NCT02306031|macular thickness|macular thickness
161516|NCT02306031|phacoemulsification|phacoemulsification
161517|NCT02306031|OCT(Optical coherence tomography )|oct(optical coherence tomography )
161518|NCT02306031|diabetic|diabetic
161519|NCT02306018|liver transplantation|liver transplantation
161520|NCT02306018|cardiac output|cardiac output
161521|NCT02306005|diabetes mellitus type 1, insulin therapy, lipoproteins, HDL|diabetes mellitus type 1, insulin therapy, lipoproteins, hdl
161522|NCT02305966|advanced arthritis|advanced arthritis
161523|NCT02305966|shoulder|shoulder
161524|NCT02305953|Psoriasis|psoriasis
161525|NCT02305953|Vascular Inflammation|vascular inflammation
161526|NCT02305953|Coronary Atherosclerosis|coronary atherosclerosis
161527|NCT02305953|Ascending aorta|ascending aorta
161528|NCT02305953|PET scan|pet scan
161529|NCT02305953|Cytokine|cytokine
161530|NCT02305953|Chemokine|chemokine
161531|NCT02305927|Vitamin D|vitamin d
161532|NCT02305927|Pregnant women|pregnant women
161533|NCT02305914|acute pancreatitis|acute pancreatitis
161534|NCT02305914|chronic pancreatitis|chronic pancreatitis
161535|NCT02305914|pancreatic cancer|pancreatic cancer
161536|NCT02305914|pancreatic disease-associated portal hypertension|pancreatic disease-associated portal hypertension
161537|NCT02305914|autoimmune pancreatitis|autoimmune pancreatitis
161538|NCT02305914|PaO2/FiO2＜200|pao2/fio2＜200
161539|NCT02305914|diabetes mellitus|diabetes mellitus
161540|NCT02305914|blood lipid|blood lipid
161541|NCT02305914|local complications|local complications
161542|NCT02305914|quality of life|quality of life
161543|NCT02305862|Coronary Arteriosclerosis|coronary arteriosclerosis
161544|NCT02305862|Carotid Atherosclerotic Plaque|carotid atherosclerotic plaque
161545|NCT02305862|Rosuvastatin|rosuvastatin
161546|NCT02305849|ASP015K|asp015k
161547|NCT02305849|Rheumatoid Arthritis|rheumatoid arthritis
161548|NCT02305836|Electroacupuncture|electroacupuncture
161549|NCT02305836|Donepezil|donepezil
161550|NCT02305836|Alzheimer's disease|alzheimer's disease
161551|NCT02305836|Randomized controlled trial|randomized controlled trial
161552|NCT02305823|psychosis|psychosis
161553|NCT02305823|antipsychotic agents|antipsychotic agents
161554|NCT02305823|treatment|treatment
161555|NCT02305823|effectiveness|effectiveness
161556|NCT02305784|Cystic fibrosis|cystic fibrosis
161557|NCT02305784|Pulmonary exacerbation|pulmonary exacerbation
161558|NCT02305784|inflammation|inflammation
161560|NCT02305784|cytokine|cytokine
161561|NCT02305784|Cystic fibrosis related diabetes|cystic fibrosis related diabetes
161562|NCT02305758|fluorouracil|fluorouracil
161563|NCT02305758|irinotecan|irinotecan
161564|NCT02305758|colon cancer|colon cancer
161565|NCT02305758|veliparib|veliparib
161566|NCT02305758|FOLFIRI|folfiri
161567|NCT02305758|previously untreated|previously untreated
161568|NCT02305758|ABT-888|abt-888
161569|NCT02305758|first line|first line
161570|NCT02305758|metastatic colorectal cancer|metastatic colorectal cancer
161571|NCT02305758|PARP inhibitor|parp inhibitor
161572|NCT02305758|5-FU|5-fu
161573|NCT02305758|rectal cancer|rectal cancer
161574|NCT02305758|colorectal cancer|colorectal cancer
161575|NCT02305758|leucovorin|leucovorin
161576|NCT02305732|Chikungunya virus|chikungunya virus
161577|NCT02305732|CHIKV|chikv
161578|NCT02305732|Dengue virus|dengue virus
161579|NCT02305732|DENV|denv
161580|NCT02305732|pathogen inactivation|pathogen inactivation
161581|NCT02305732|platelets|platelets
161582|NCT02305732|Puerto Rico|puerto rico
161583|NCT02305706|insertion|insertion
161584|NCT02305706|patient comfort|patient comfort
161585|NCT02305667|Laryngoscope|laryngoscope
161586|NCT02305667|Macintosh|macintosh
161587|NCT02305667|Glidescope®|glidescope®
662028|NCT00823654|BRCA2|brca2
161591|NCT02305667|double lumen tube|double lumen tube
161592|NCT02305654|Penis cancer|penis cancer
161593|NCT02305654|Chemotherapy|chemotherapy
161594|NCT02305654|Chemoradiotherapy|chemoradiotherapy
161595|NCT02305654|Surgery|surgery
161596|NCT02305654|Phase III|phase iii
161597|NCT02305602|extracellular matrix|extracellular matrix
161598|NCT02305589|postoperative delirium|postoperative delirium
161599|NCT02305589|sugammadex|sugammadex
161600|NCT02305589|cholinesterase inhibitor|cholinesterase inhibitor
161601|NCT02305589|hip fracture surgery|hip fracture surgery
161602|NCT02305550|Nitric Oxide|nitric oxide
152636|NCT02356601|MRI|mri
161603|NCT02305524|endotracheal intubation|endotracheal intubation
161604|NCT02305511|Catheterization|catheterization
161605|NCT02305511|Peripheral|peripheral
161606|NCT02305498|Yoga|yoga
161607|NCT02305498|14-059|14-059
161608|NCT02305485|NeoVas|neovas
161609|NCT02305485|Bioresorbable Coronary Scaffold|bioresorbable coronary scaffold
161610|NCT02305485|Sirolimus|sirolimus
161611|NCT02305485|Randomized Controlled Trial|randomized controlled trial
161612|NCT02305472|NeoVas|neovas
161613|NCT02305472|Bioresorbable Coronary Scaffold|bioresorbable coronary scaffold
161614|NCT02305472|Sirolimus|sirolimus
161615|NCT02305472|Registry Trial|registry trial
161616|NCT02305459|SIRT|sirt
161617|NCT02305459|microcatheter|microcatheter
161618|NCT02305459|primary liver tumor|primary liver tumor
161619|NCT02305459|secondary liver tumor|secondary liver tumor
161620|NCT02305459|radioembolisation|radioembolisation
161621|NCT02305459|QLQ-C30|qlq-c30
161622|NCT02305459|CIRSE|cirse
161623|NCT02305433|elderly|elderly
161624|NCT02305433|functional-based physiotherapy|functional-based physiotherapy
161625|NCT02305433|frailty syndrome|frailty syndrome
161626|NCT02305433|osteoporotic hip fractures|osteoporotic hip fractures
161627|NCT02305433|home-based physiotherapy|home-based physiotherapy
161628|NCT02305433|home-dwelling|home-dwelling
161629|NCT02305433|intervention|intervention
161630|NCT02305433|randomised controlled trial|randomised controlled trial
161631|NCT02305433|costs of social and health care|costs of social and health care
161632|NCT02305433|quality of life|quality of life
161633|NCT02305433|physical functioning|physical functioning
161634|NCT02305433|mobility|mobility
161635|NCT02305433|nutrition|nutrition
161636|NCT02305394|ketamine|ketamine
161637|NCT02305394|Electroconvulsive Therapy|electroconvulsive therapy
161638|NCT02305394|Cognitive Function|cognitive function
161639|NCT02305342|Uncomplicated UTI|uncomplicated uti
161640|NCT02305342|Enoxacin|enoxacin
161641|NCT02305303|Quality of life|quality of life
161642|NCT02305303|post-traumatic stress disorder|post-traumatic stress disorder
161643|NCT02305303|trauma|trauma
161644|NCT02305238|Eylea,|eylea,
161645|NCT02305238|Aflibercept|aflibercept
161646|NCT02305238|Treat and Extend regimen|treat and extend regimen
161647|NCT02305238|Age-related macular degeneration|age-related macular degeneration
161648|NCT02305212|Working Memory|working memory
161649|NCT02305199|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
161650|NCT02305199|Hartmann's solution|hartmann's solution
161655|NCT02305173|dexamethasone|dexamethasone
161656|NCT02305173|pulmonary function|pulmonary function
161657|NCT02305173|spirometry|spirometry
161658|NCT02305173|mastectomy|mastectomy
161659|NCT02305160|Respiratory distress syndrome|respiratory distress syndrome
161660|NCT02305160|Pulmonary surfactant|pulmonary surfactant
161661|NCT02305160|Mortality|mortality
161662|NCT02305160|Prematurity|prematurity
161663|NCT02305147|Parkinson Disease|parkinson disease
161664|NCT02305147|Biomarkers|biomarkers
161665|NCT02305147|Prognostic factors|prognostic factors
161666|NCT02305147|Prodromal features|prodromal features
161667|NCT02305147|Disease progression|disease progression
161668|NCT02305134|Tipepidine, GIRK|tipepidine, girk
161669|NCT02305121|Trochanteric fracture|trochanteric fracture
161670|NCT02305121|Nail|nail
161671|NCT02305121|Fracture reduction|fracture reduction
161672|NCT02305121|Antirotation|antirotation
161673|NCT02305121|trochanteric area with diaphyseal extension|trochanteric area with diaphyseal extension
161674|NCT02305121|trochanteric area with femoral shaft|trochanteric area with femoral shaft
161675|NCT02305043|non-interventional|non-interventional
161676|NCT02305043|advanced gastric cancer|advanced gastric cancer
161677|NCT02305043|Trastuzumab|trastuzumab
161678|NCT02305043|HER2|her2
161679|NCT02304991|Peanut|peanut
161680|NCT02304991|Food Allergy|food allergy
161681|NCT02304978|colorectal cancer|colorectal cancer
161682|NCT02304978|Tissular factor|tissular factor
161683|NCT02304978|TF|tf
161684|NCT02304965|LVAD|lvad
161685|NCT02304952|Lateral epicondylalgia|lateral epicondylalgia
161686|NCT02304952|Pain|pain
161687|NCT02304952|Function|function
161688|NCT02304952|Physiotherapy|physiotherapy
161689|NCT02304952|Quality of Life|quality of life
161690|NCT02304939|Norepinephrine|norepinephrine
161691|NCT02304939|Intensive Care|intensive care
161692|NCT02304939|Changeovers|changeovers
161693|NCT02304939|Smart pumps|smart pumps
161694|NCT02304939|Quick change|quick change
161695|NCT02304939|Double pumping|double pumping
161696|NCT02304939|Shock|shock
161697|NCT02304926|Dyslipidemia|dyslipidemia
161698|NCT02304926|Simvastatin|simvastatin
161699|NCT02304926|Ezetimibe|ezetimibe
161700|NCT02304926|Lipid profile|lipid profile
161701|NCT02304926|Inflammation|inflammation
161702|NCT02304926|Oxidative stress|oxidative stress
161703|NCT02304926|Endothelial function|endothelial function
161704|NCT02304900|cataract|cataract
161705|NCT02304887|Osteoporosis|osteoporosis
161706|NCT02304887|Bone mineral densisty|bone mineral densisty
161707|NCT02304887|Renal function|renal function
161708|NCT02304887|CKD-MBD|ckd-mbd
161709|NCT02304874|Ferritins|ferritins
161710|NCT02304874|Iron Overload|iron overload
161711|NCT02304874|Metabolic Syndrome|metabolic syndrome
161712|NCT02304874|Venesection therapy|venesection therapy
161713|NCT02304874|Volunteers|volunteers
161714|NCT02304861|cataract|cataract
161715|NCT02304861|viscoelastic (OVD) technology|viscoelastic (ovd) technology
161716|NCT02304861|endothelial cell count|endothelial cell count
161717|NCT02304861|endothelial cell pattern|endothelial cell pattern
161718|NCT02304861|central corneal edema|central corneal edema
161719|NCT02304848|Parkinson's Disease|parkinson's disease
161720|NCT02304848|DBS|dbs
161721|NCT02304848|Deep Brain Stimulation|deep brain stimulation
161722|NCT02304848|Subthalamic Nucleus|subthalamic nucleus
161723|NCT02304822|kidney stones|kidney stones
161724|NCT02304822|retrograde intrarenal surgery|retrograde intrarenal surgery
161725|NCT02304822|ciprofloxacin|ciprofloxacin
161726|NCT02304822|prophylaxis|prophylaxis
161727|NCT02304822|systemic inflammatory response syndrome|systemic inflammatory response syndrome
161728|NCT02304809|metastatic or unresectable locally advanced malignancies.|metastatic or unresectable locally advanced malignancies.
161729|NCT02304809|genomic alterations|genomic alterations
161730|NCT02304809|biological vemurafenib targets BRAF|biological vemurafenib targets braf
161731|NCT02304809|genomic.|genomic.
161732|NCT02304796|Anxiety Disorders|anxiety disorders
161733|NCT02304796|Group Psychotherapy|group psychotherapy
161734|NCT02304796|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
161735|NCT02304796|Dance/Movement Therapy|dance/movement therapy
161736|NCT02304796|CBT|cbt
161737|NCT02304796|DMT|dmt
161738|NCT02304796|Unified Protocol|unified protocol
161739|NCT02304783|Renal colic, Piroxicam|renal colic, piroxicam
161740|NCT02304757|differentiated thyroid cancer|differentiated thyroid cancer
161741|NCT02304757|bone mineral density|bone mineral density
161742|NCT02304757|thyroid stimulating hormone suppression|thyroid stimulating hormone suppression
161743|NCT02304731|Physical Exercise, Atmospheric Pollution, Cognition.|physical exercise, atmospheric pollution, cognition.
161744|NCT02304718|GDM|gdm
161745|NCT02304718|pregnancy outcome|pregnancy outcome
161746|NCT02304718|obesity|obesity
161747|NCT02304718|exercise|exercise
161748|NCT02304718|overweight|overweight
161749|NCT02304640|fatigue|fatigue
161750|NCT02304640|chemotherapy|chemotherapy
161751|NCT02304640|breast cancer|breast cancer
161752|NCT02304640|supportive care|supportive care
161753|NCT02304640|Singapore|singapore
161754|NCT02304523|Colonoscopy preparation|colonoscopy preparation
161755|NCT02304523|Bowel cleansing|bowel cleansing
161756|NCT02304523|Colon cleansing|colon cleansing
161757|NCT02304523|Colonoscopy|colonoscopy
161758|NCT02304523|CDFR0612|cdfr0612
161759|NCT02304523|CDFR0613|cdfr0613
161760|NCT02304510|Prevalence|prevalence
161761|NCT02304510|Menorrhagia|menorrhagia
161762|NCT02304497|Diabetes mellitus|diabetes mellitus
161763|NCT02304497|Platelet rich fibrin|platelet rich fibrin
161764|NCT02304497|growth factor|growth factor
161765|NCT02304445|Radiotherapy|radiotherapy
161766|NCT02304445|Chemoembolization|chemoembolization
161767|NCT02304406|prevalence of ALK rearrangement, NSCLC, MENA|prevalence of alk rearrangement, nsclc, mena
161768|NCT02304367|TIO|tio
161769|NCT02304367|ENS|ens
161770|NCT02304367|FGF23|fgf23
161771|NCT02304367|KRN23|krn23
161772|NCT02304354|rheumatoid arthritis|rheumatoid arthritis
161773|NCT02304354|T lymphocytes|t lymphocytes
161774|NCT02304354|rituximab|rituximab
161775|NCT02304341|critical illness|critical illness
161776|NCT02304341|disease progression|disease progression
161777|NCT02304341|child|child
161778|NCT02304341|severity of illness index|severity of illness index
161779|NCT02304341|monitoring|monitoring
161780|NCT02304328|SAH|sah
161781|NCT02304328|WFNS|wfns
161782|NCT02304328|hWFNS|hwfns
161783|NCT02304328|grading|grading
161784|NCT02304315|HBV-related liver transplantation|hbv-related liver transplantation
161785|NCT02304315|Hepatitis B Immuno Globulin|hepatitis b immuno globulin
161786|NCT02304302|Memantine|memantine
161787|NCT02304302|Episodic Memory|episodic memory
161788|NCT02304302|CVLT|cvlt
161789|NCT02304302|Hippocampus dependent memory|hippocampus dependent memory
161790|NCT02304302|Short-term memory|short-term memory
161791|NCT02304263|tenofovir|tenofovir
161792|NCT02304263|aging|aging
161793|NCT02304263|renal function|renal function
161795|NCT02304263|frailty|frailty
161796|NCT02304237|Premature Birth|premature birth
161797|NCT02304237|progesterone|progesterone
161798|NCT02304224|sepsis|sepsis
161799|NCT02304224|melatonin|melatonin
161800|NCT02304224|Human Leukocyte Antigen-DR|human leukocyte antigen-dr
161801|NCT02304224|outcome|outcome
161802|NCT02304211|Microdosing|microdosing
161803|NCT02304211|Phase 0|phase 0
161804|NCT02304211|Exploratory Investigational New Drug (IND)|exploratory investigational new drug (ind)
161805|NCT02304211|Intra-Arterial|intra-arterial
161806|NCT02304211|PET Imaging|pet imaging
161807|NCT02304185|Healthy|healthy
161808|NCT02304185|Acquired Immuno-Deficiency Syndrome|acquired immuno-deficiency syndrome
161809|NCT02304185|Acquired Immunodeficiency Syndrome Virus|acquired immunodeficiency syndrome virus
161810|NCT02304185|Glycoprotein|glycoprotein
161811|NCT02304185|Adjuvant|adjuvant
161812|NCT02304185|Vaccine|vaccine
161813|NCT02304185|Placebo|placebo
161814|NCT02304172|Thyroidectomy|thyroidectomy
161815|NCT02304172|Thunderbeat|thunderbeat
161816|NCT02304159|HCV|hcv
161817|NCT02304159|Genotype 3|genotype 3
161818|NCT02304159|Treatment naive|treatment naive
161819|NCT02304159|Treatment experienced|treatment experienced
161820|NCT02304146|Foam|foam
161821|NCT02304146|UGFS|ugfs
161822|NCT02304146|Stripping|stripping
161823|NCT02304146|Incompetence|incompetence
161824|NCT02304120|proprioception|proprioception
161825|NCT02304120|postural control|postural control
161826|NCT02304120|sensorimotor training|sensorimotor training
161827|NCT02304120|uncontrolled manifold|uncontrolled manifold
161828|NCT02304029|epilepsy|epilepsy
161829|NCT02304029|seizures|seizures
161830|NCT02304003|Shoulder tendinopathy|shoulder tendinopathy
161831|NCT02304003|Subacromial impingement syndrome|subacromial impingement syndrome
161832|NCT02304003|Rotator cuff tendinopathy|rotator cuff tendinopathy
161833|NCT02304003|Supraspinatus tendinopathy|supraspinatus tendinopathy
161834|NCT02303964|Trauma|trauma
161835|NCT02303964|Hemorrhage|hemorrhage
161836|NCT02303964|Plasma|plasma
161837|NCT02303964|Shock|shock
161838|NCT02303964|Polytrauma|polytrauma
200992|NCT02112656|Carcinoma, Hepatocellular|carcinoma, hepatocellular
161839|NCT02303912|relapsed epithelial ovarian cancer,|relapsed epithelial ovarian cancer,
161840|NCT02303912|relapsed fallopian tube cancer|relapsed fallopian tube cancer
161841|NCT02303912|relapsed primary peritoneal cancer.|relapsed primary peritoneal cancer.
161842|NCT02303860|Healthy volunteer study|healthy volunteer study
161843|NCT02303808|Hyperosmolar agents|hyperosmolar agents
161844|NCT02303808|Hypertonic saline|hypertonic saline
161845|NCT02303808|Airway clearance techniques|airway clearance techniques
161846|NCT02303808|Positive Expiratory Pressure|positive expiratory pressure
161847|NCT02303808|Autogenic drainage|autogenic drainage
161848|NCT02303795|bioprosthetic mitral valve|bioprosthetic mitral valve
161849|NCT02303795|valvular heart disease|valvular heart disease
161850|NCT02303795|anticoagulant agents|anticoagulant agents
161851|NCT02303795|NOACs|noacs
161852|NCT02303795|rivaroxaban|rivaroxaban
161853|NCT02303795|warfarin|warfarin
161854|NCT02303769|Lower Urinary Track Syndrome|lower urinary track syndrome
161855|NCT02303769|Harnal|harnal
161856|NCT02303769|Tamsulosin HCL 0.4mg|tamsulosin hcl 0.4mg
161857|NCT02303743|Bowel preparation; colonoscopy; Smartphone application|bowel preparation; colonoscopy; smartphone application
161858|NCT02303730|Diabetes|diabetes
161859|NCT02303730|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
161860|NCT02303717|Left main|left main
161861|NCT02303717|PCI|pci
161862|NCT02303717|DES|des
161863|NCT02303704|Multiperfusion set|multiperfusion set
161864|NCT02303704|Myocardial protection|myocardial protection
161865|NCT02303704|Coronary Artery Bypass Grafting|coronary artery bypass grafting
161866|NCT02303691|anxiety|anxiety
161867|NCT02303691|attention bias modification|attention bias modification
161868|NCT02303691|computer|computer
161869|NCT02303678|D2C7|d2c7
161870|NCT02303678|Randazzo|randazzo
161871|NCT02303678|Bigner|bigner
161872|NCT02303678|Pro00053325|pro00053325
161873|NCT02303678|recurrent malignant glioma|recurrent malignant glioma
161874|NCT02303665|TCM multi-channel therapy|tcm multi-channel therapy
161875|NCT02303665|ART failure|art failure
161876|NCT02303639|implantable cardioverter defibrillator|implantable cardioverter defibrillator
161877|NCT02303639|antiarrhythmic medication|antiarrhythmic medication
161878|NCT02303639|catheter ablation|catheter ablation
161879|NCT02303626|BCX4161|bcx4161
161880|NCT02303626|Prophylaxis|prophylaxis
161881|NCT02303626|Prevention|prevention
161882|NCT02303626|HAE|hae
161883|NCT02303626|Hereditary Angioedema|hereditary angioedema
161884|NCT02303600|Sub-acute cough|sub-acute cough
161885|NCT02303587|Severe mycoplasma pneumoniae|severe mycoplasma pneumoniae
161886|NCT02303587|pneumonia|pneumonia
161887|NCT02303587|children|children
401974|NCT01232478|Problem-Solving|problem-solving
401975|NCT01232478|Adolescents|adolescents
401976|NCT01232478|Education|education
161888|NCT02303574|AZD7986, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Food Effect, First-in-human, Single Ascending Dose, Multiple Ascending Dose, Healthy Subjects|azd7986, safety, tolerability, pharmacokinetics, pharmacodynamics, food effect, first-in-human, single ascending dose, multiple ascending dose, healthy subjects
161889|NCT02303548|Sodium Bicarbonate|sodium bicarbonate
161890|NCT02303535|Congenital heart disease|congenital heart disease
161891|NCT02303535|European Paediatric Cardiac Code Short List|european paediatric cardiac code short list
161892|NCT02303535|Specific Procedure Definitions|specific procedure definitions
161893|NCT02303535|OPCS|opcs
161894|NCT02303535|paediatric|paediatric
161895|NCT02303535|pediatric|pediatric
402923|NCT01229085|Psoriasis, mometasone, salicylic acid.|psoriasis, mometasone, salicylic acid.
161896|NCT02303522|ALL, pediatric, leukemia, childhood, lymphoblastic, lymphoma, acute, Precursor Cell|all, pediatric, leukemia, childhood, lymphoblastic, lymphoma, acute, precursor cell
161897|NCT02303509|Healthy Subjects|healthy subjects
161898|NCT02303509|Mild to moderate Psoriasis|mild to moderate psoriasis
161899|NCT02303509|Subjects|subjects
161900|NCT02303496|platelet rich plasma|platelet rich plasma
161901|NCT02303470|Exercise|exercise
161902|NCT02303457|CO2 laser surgery|co2 laser surgery
161903|NCT02303457|open surgery|open surgery
161904|NCT02303457|multicenter prospective|multicenter prospective
161905|NCT02303457|randomized|randomized
161906|NCT02303457|controlled clinical studies|controlled clinical studies
161907|NCT02303457|T1N0 squamous cell carcinoma of glottis with anterior commissure involved|t1n0 squamous cell carcinoma of glottis with anterior commissure involved
161908|NCT02303444|Progressive radioactive iodine refractory differentiated thyroid carcinoma|progressive radioactive iodine refractory differentiated thyroid carcinoma
161909|NCT02303431|Pediatric|pediatric
161910|NCT02303431|Pharmacokinetics (PK)|pharmacokinetics (pk)
161911|NCT02303431|Pharmacodynamics (PDy)|pharmacodynamics (pdy)
161912|NCT02303431|Anticoagulant|anticoagulant
161913|NCT02303431|Safety|safety
161914|NCT02303418|Obstetrics|obstetrics
161915|NCT02303405|Glucose Control|glucose control
161916|NCT02303405|Inflammation|inflammation
161917|NCT02303379|Training Protocol|training protocol
161918|NCT02303379|Cardiac Rehabilitation|cardiac rehabilitation
161919|NCT02303379|High-Intensity Interval Training|high-intensity interval training
161920|NCT02303379|Continuous Training|continuous training
161921|NCT02303379|Pyramid Training|pyramid training
161922|NCT02303379|Physical Performance|physical performance
161923|NCT02303353|Breast cancer|breast cancer
161924|NCT02303353|Ovarian cancer|ovarian cancer
161932|NCT02303340|Para Thyroid Hormone|para thyroid hormone
161933|NCT02303340|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
161934|NCT02303340|Digital Imaging and Communication in Medicine|digital imaging and communication in medicine
161935|NCT02303275|Heart Failure|heart failure
161936|NCT02303275|Congestive Heart Failure|congestive heart failure
161937|NCT02303275|Lifestyle Change|lifestyle change
161938|NCT02303236|Exercise|exercise
161939|NCT02303197|head and neck cancer|head and neck cancer
161940|NCT02303197|chemoradiotherapy|chemoradiotherapy
161941|NCT02303197|radioactive stomatitis|radioactive stomatitis
161942|NCT02303184|RVO|rvo
161943|NCT02303184|ME|me
161944|NCT02303184|Central Subfield Thickness|central subfield thickness
161945|NCT02303184|OCT|oct
161946|NCT02303184|optical coherence tomography|optical coherence tomography
161947|NCT02303184|cystoid macular edema|cystoid macular edema
161948|NCT02303184|subretinal fluid|subretinal fluid
161949|NCT02303184|Eylea|eylea
161950|NCT02303184|aflibercept|aflibercept
161951|NCT02303184|anti-VEGF|anti-vegf
161952|NCT02303171|Antiphospholipid syndrome|antiphospholipid syndrome
161953|NCT02303171|APS|aps
161954|NCT02303171|Warfarin|warfarin
161955|NCT02303158|Alzheimer's Disease|alzheimer's disease
161956|NCT02303158|Biomarkers|biomarkers
161957|NCT02303158|Depression|depression
161958|NCT02303158|dementia|dementia
161959|NCT02303158|cerebrospinal fluid|cerebrospinal fluid
161960|NCT02303158|neuropsychological|neuropsychological
161961|NCT02303145|Breast Cancer, Survivors|breast cancer, survivors
161962|NCT02303119|LNH|lnh
161963|NCT02303119|CD20+|cd20+
161964|NCT02303119|follicular|follicular
161965|NCT02303106|AUC exposure to lamotrigine|auc exposure to lamotrigine
161966|NCT02303080|whey protein microgels|whey protein microgels
161967|NCT02303080|thermogenesis|thermogenesis
161968|NCT02303067|Cardiac|cardiac
161969|NCT02303067|Computed Tomography|computed tomography
161970|NCT02303067|Coronary Artery Disease|coronary artery disease
161971|NCT02303054|Prostate Cancer|prostate cancer
161972|NCT02303054|Focal Ablation|focal ablation
161973|NCT02303054|MRI-US Fusion Biopsy|mri-us fusion biopsy
161974|NCT02303054|Focal Therapy|focal therapy
161975|NCT02303028|Pediatric|pediatric
161976|NCT02303028|CNS Tumor|cns tumor
161977|NCT02303028|Solid Tumour|solid tumour
161978|NCT02303015|Germ cell cancer|germ cell cancer
161979|NCT02303015|Late toxicity|late toxicity
161980|NCT02303015|Renal impairment|renal impairment
161981|NCT02303015|Cardiovascular disease|cardiovascular disease
161982|NCT02302963|Diabetes Mellitus, Type 1 (T1DM)|diabetes mellitus, type 1 (t1dm)
161983|NCT02302963|Diabetes Assistant (DiAs)|diabetes assistant (dias)
161984|NCT02302963|Artificial Pancreas (AP) System|artificial pancreas (ap) system
161985|NCT02302963|Closed-Loop Control (CLC)|closed-loop control (clc)
161986|NCT02302963|Unified Safety System (USS) Virginia|unified safety system (uss) virginia
161987|NCT02302963|Sensor Augmented Pump (SAP)|sensor augmented pump (sap)
161988|NCT02302963|Low Blood Glucose Index (LBGI)|low blood glucose index (lbgi)
161989|NCT02302963|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
161990|NCT02302963|inControl Diabetes Management Platform|incontrol diabetes management platform
161991|NCT02302950|HIV infection|hiv infection
161992|NCT02302950|raltegravir use|raltegravir use
161994|NCT02302937|Inguinal Hernia|inguinal hernia
161995|NCT02302937|Primary|primary
161996|NCT02302937|laparoscopic surgery|laparoscopic surgery
161997|NCT02302937|single port surgery|single port surgery
161998|NCT02302911|Early intervention|early intervention
161999|NCT02302898|Roux-en-Y Gastric Bypass Surgery|roux-en-y gastric bypass surgery
162000|NCT02302898|Weight Regain|weight regain
162001|NCT02302885|cancer-free 18-60 year old men and women|cancer-free 18-60 year old men and women
162002|NCT02302859|Cancer Prevention|cancer prevention
162003|NCT02302859|Tobacco Use Cessation|tobacco use cessation
162004|NCT02302859|HIV-positive|hiv-positive
162005|NCT02302859|Nicotine patch|nicotine patch
162006|NCT02302859|NRT|nrt
162007|NCT02302859|Questionnaire|questionnaire
162008|NCT02302859|Survey|survey
162009|NCT02302859|Smartphone|smartphone
162010|NCT02302859|Counseling|counseling
162011|NCT02302859|Saliva test|saliva test
162012|NCT02302859|Saliva cotinine test|saliva cotinine test
162013|NCT02302859|Nicotine replacement therapy|nicotine replacement therapy
162014|NCT02302859|Smoking abstinence|smoking abstinence
162015|NCT02302859|Aids|aids
162017|NCT02302846|Acute myeloid leukemia|acute myeloid leukemia
162019|NCT02302846|High-risk myelodysplastic syndrome|high-risk myelodysplastic syndrome
162020|NCT02302846|MDS|mds
162021|NCT02302846|Ixazomib|ixazomib
162022|NCT02302846|MLN9708|mln9708
162023|NCT02302833|Neuroendocrine tumors|neuroendocrine tumors
162024|NCT02302833|Pheochromocytomas|pheochromocytomas
162025|NCT02302833|Paragangliomas|paragangliomas
162026|NCT02302833|Unresectable|unresectable
162027|NCT02302833|Metastatic|metastatic
162028|NCT02302833|Cabozantinib|cabozantinib
162029|NCT02302833|XL-184|xl-184
162030|NCT02302833|XL184|xl184
162031|NCT02302833|Questionnaire|questionnaire
162032|NCT02302833|Survey|survey
162033|NCT02302820|Advance Care Planning|advance care planning
162034|NCT02302820|Nurse Care Coordination|nurse care coordination
162035|NCT02302820|Comparative Effectiveness|comparative effectiveness
162036|NCT02302820|Advance Directive|advance directive
162037|NCT02302820|Decision Aides|decision aides
162038|NCT02302781|Reasons for Dropout|reasons for dropout
162039|NCT02302781|Subfertility|subfertility
162040|NCT02302781|IVF|ivf
162041|NCT02302781|NON IVF|non ivf
162042|NCT02302742|Triple Negative Breast Cancer|triple negative breast cancer
162043|NCT02302742|TNBC|tnbc
162044|NCT02302742|Hereditary Breast and Ovarian Cancer|hereditary breast and ovarian cancer
162045|NCT02302742|HBOC|hboc
162046|NCT02302742|Prospective Registry|prospective registry
162047|NCT02302729|Micronutrient intervention|micronutrient intervention
162048|NCT02302729|Responsive feeding intervention|responsive feeding intervention
162049|NCT02302729|School readiness intervention|school readiness intervention
162050|NCT02302677|bile acids|bile acids
162051|NCT02302677|sleeve gastrectomy|sleeve gastrectomy
162052|NCT02302677|obesity|obesity
162053|NCT02302677|GLP-1|glp-1
162054|NCT02302677|FGF-19|fgf-19
162055|NCT02302664|Achilles|achilles
162056|NCT02302664|Platelet Rich Plasma|platelet rich plasma
162057|NCT02302664|Patient reported outcome measure|patient reported outcome measure
162058|NCT02302664|Orthopaedic trauma|orthopaedic trauma
162059|NCT02302664|Musculoskeletal|musculoskeletal
162060|NCT02302664|Tendon|tendon
162061|NCT02302664|Sports Injury|sports injury
162062|NCT02302664|Heel-Rise Endurance Test|heel-rise endurance test
162063|NCT02302651|high intensity focused ultrasound|high intensity focused ultrasound
162064|NCT02302651|osteoid osteoma|osteoid osteoma
162065|NCT02302651|bone tumor|bone tumor
162066|NCT02302638|single-step media|single-step media
162067|NCT02302638|embryo development|embryo development
162068|NCT02302638|blastocyst formation|blastocyst formation
162069|NCT02302638|embryo utilization|embryo utilization
162070|NCT02302625|Cognitive behavior therapy|cognitive behavior therapy
162071|NCT02302612|chronic conditions|chronic conditions
162072|NCT02302612|complex patients|complex patients
162073|NCT02302612|engagement|engagement
162074|NCT02302612|activation|activation
162075|NCT02302586|Thoracic paravertebral block|thoracic paravertebral block
162076|NCT02302586|Patient controlled analgesia|patient controlled analgesia
162077|NCT02302586|Video Assisted Thoracoscopic Surgery|video assisted thoracoscopic surgery
162078|NCT02302586|Postoperative acute pain|postoperative acute pain
162079|NCT02302586|Chronic pain|chronic pain
162080|NCT02302573|placenta accreta|placenta accreta
162081|NCT02302573|contrast-enhanced unltrasound|contrast-enhanced unltrasound
162082|NCT02302573|pregnancy|pregnancy
162084|NCT02302573|sonovue|sonovue
162085|NCT02302547|HIV-DNA|hiv-dna
162086|NCT02302547|dual therapy|dual therapy
162087|NCT02302547|NRTI|nrti
162088|NCT02302547|virological control|virological control
162089|NCT02302547|truvada®|truvada®
162090|NCT02302534|scoliosis|scoliosis
162091|NCT02302534|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
162092|NCT02302521|MRI|mri
162093|NCT02302508|pharmacokinetics|pharmacokinetics
162094|NCT02302508|drug metabolism|drug metabolism
162095|NCT02302508|platelet reactivity|platelet reactivity
162096|NCT02302508|carboxylesterase|carboxylesterase
162097|NCT02302508|cytochromes p450|cytochromes p450
162098|NCT02302508|type 2 diabetes|type 2 diabetes
162099|NCT02302508|active metabolite|active metabolite
162100|NCT02302495|Carfilzomib weekly|carfilzomib weekly
162101|NCT02302495|and Melphalan and Prednisone|and melphalan and prednisone
162102|NCT02302482|Alzheimer's disease or related disorders|alzheimer's disease or related disorders
162103|NCT02302482|Functional autonomy level|functional autonomy level
162104|NCT02302482|Cognitive function|cognitive function
162105|NCT02302482|Predictive factors|predictive factors
162106|NCT02302469|Lenalidomide|lenalidomide
162107|NCT02302469|Hematology|hematology
162108|NCT02302469|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
162109|NCT02302456|Immediate postpartum hemorrhage|immediate postpartum hemorrhage
162110|NCT02302456|tranexamic acid|tranexamic acid
162111|NCT02302456|prevention|prevention
162112|NCT02302430|Cohesion|cohesion
162113|NCT02302430|Oxytocin|oxytocin
162114|NCT02302430|ROTC|rotc
162115|NCT02302430|Virtual-reality|virtual-reality
162116|NCT02302417|Asthma|asthma
162117|NCT02302417|Asthma-COPD Overlap Syndrome|asthma-copd overlap syndrome
162118|NCT02302417|Clinical Questionnaire|clinical questionnaire
162119|NCT02302417|COPD|copd
162120|NCT02302417|ACOS|acos
162121|NCT02302404|FTIH|ftih
162122|NCT02302404|pharmacodynamics|pharmacodynamics
162123|NCT02302404|pharmacokinetics|pharmacokinetics
162124|NCT02302404|GSK2982772|gsk2982772
162125|NCT02302404|safety|safety
162126|NCT02302404|Repeat dose|repeat dose
162127|NCT02302404|tolerability|tolerability
162128|NCT02302378|Hypotension|hypotension
162129|NCT02302378|Anesthesia, Spinal [E03.155.086.331]|anesthesia, spinal [e03.155.086.331]
162130|NCT02302365|white blood cell depletion|white blood cell depletion
162131|NCT02302365|apheresis|apheresis
162132|NCT02302352|Probiotics|probiotics
162133|NCT02302352|Immune system|immune system
162134|NCT02302339|Advanced melanoma|advanced melanoma
162135|NCT02302339|Unresectable melanoma|unresectable melanoma
162136|NCT02302339|Metastatic melanoma|metastatic melanoma
162137|NCT02302339|Targeted Treatment for melanoma|targeted treatment for melanoma
162138|NCT02302339|GPNMB|gpnmb
162139|NCT02302339|CDX-011|cdx-011
162140|NCT02302339|Glembatumumab vedotin|glembatumumab vedotin
162141|NCT02302339|Antibody-drug-conjugate|antibody-drug-conjugate
162142|NCT02302339|Skin neoplasm|skin neoplasm
162143|NCT02302339|Varlilumab|varlilumab
162144|NCT02302339|CDX-1127|cdx-1127
162145|NCT02302326|reticulum endoplasmic stress|reticulum endoplasmic stress
162146|NCT02302326|Polycystic Ovary Syndrome|polycystic ovary syndrome
162147|NCT02302326|mitochondrial function|mitochondrial function
162148|NCT02302326|insulin resistance|insulin resistance
162149|NCT02302326|inflammation|inflammation
162150|NCT02302326|myoinositol|myoinositol
162151|NCT02302326|metformin|metformin
162152|NCT02302326|oxidative stress|oxidative stress
162153|NCT02302313|healthy volunteers|healthy volunteers
162154|NCT02302313|critical awareness|critical awareness
162155|NCT02302313|hypnosis|hypnosis
162156|NCT02302313|Analgesia Nociception Index|analgesia nociception index
162157|NCT02302313|numerical verbal scale|numerical verbal scale
162158|NCT02302313|Determine the validity of the index (ANI)|determine the validity of the index (ani)
162159|NCT02302313|nociception in critical awareness|nociception in critical awareness
162160|NCT02302300|Cardiac surgery|cardiac surgery
162161|NCT02302300|Preventive non-invasive ventilation|preventive non-invasive ventilation
162162|NCT02302287|Chronic kidney disease|chronic kidney disease
162163|NCT02302287|mediterranean diet|mediterranean diet
162164|NCT02302287|low-protein diet|low-protein diet
162165|NCT02302287|ketoacids|ketoacids
162166|NCT02302287|intestinal microbiota|intestinal microbiota
162167|NCT02302274|Brugada Syndrome|brugada syndrome
162168|NCT02302274|ARVC|arvc
162169|NCT02302274|flecainide|flecainide
162170|NCT02302274|ST elevation|st elevation
162171|NCT02302261|Pulsus paradoxus|pulsus paradoxus
162172|NCT02302235|Glioblastoma multigorme|glioblastoma multigorme
162173|NCT02302235|Ketogenic Diet|ketogenic diet
162174|NCT02302235|radiotherapy|radiotherapy
162175|NCT02302235|chemotherapy|chemotherapy
162176|NCT02302235|safety|safety
162177|NCT02302235|efficiency|efficiency
162178|NCT02302209|oxytocin|oxytocin
162179|NCT02302209|schizophrenia|schizophrenia
162180|NCT02302209|autism spectrum disorder|autism spectrum disorder
162181|NCT02302183|Hypoxemic, Respiratory distress, infant|hypoxemic, respiratory distress, infant
162182|NCT02302157|Cervical spinal cord injury|cervical spinal cord injury
162183|NCT02302157|AST-OPC1|ast-opc1
162184|NCT02302157|SCiStar|scistar
162185|NCT02302157|OPC1|opc1
162186|NCT02302157|Neural cell|neural cell
162187|NCT02302157|Trauma spinal cord|trauma spinal cord
162188|NCT02302157|stemcell transplant|stemcell transplant
162189|NCT02302157|Cervical spine injury|cervical spine injury
162190|NCT02302157|Paralysis|paralysis
162191|NCT02302157|Quadriplegia|quadriplegia
162192|NCT02302157|Tetraplegia|tetraplegia
162193|NCT02302157|Spine injury|spine injury
402924|NCT01229072|Safety|safety
162194|NCT02302157|oligodendrocyte progenitor cell|oligodendrocyte progenitor cell
162195|NCT02302157|Subacute spinal cord injury|subacute spinal cord injury
162196|NCT02302144|Postural Instability (falling)|postural instability (falling)
162197|NCT02302144|Gait Disturbances (e.g., freezing)|gait disturbances (e.g., freezing)
162198|NCT02302144|Bradykinesia (slowness of movement), rigidity|bradykinesia (slowness of movement), rigidity
162199|NCT02302118|esophageal carcinoma|esophageal carcinoma
162200|NCT02302118|kardia carcinoma|kardia carcinoma
162201|NCT02302092|Drug Therapy|drug therapy
162202|NCT02302079|ASP8232|asp8232
162203|NCT02302079|Diabetes Mellitus|diabetes mellitus
162204|NCT02302079|ranibizumab|ranibizumab
162205|NCT02302079|Diabetic Macular Edema|diabetic macular edema
162206|NCT02302066|Drug therapy|drug therapy
162207|NCT02302053|Hair thinning, hair loss, alopecia, women, oral supplement|hair thinning, hair loss, alopecia, women, oral supplement
162208|NCT02302040|Adolescent|adolescent
162209|NCT02302027|withdrawal therapy|withdrawal therapy
162210|NCT02302027|oxygen therapy|oxygen therapy
162211|NCT02302001|Breast augmentation|breast augmentation
162212|NCT02302001|Breast implants|breast implants
162213|NCT02302001|Silicone implants|silicone implants
162214|NCT02302001|Breast surgery|breast surgery
162215|NCT02301975|Adult|adult
162216|NCT02301975|asthma|asthma
162217|NCT02301975|Fluticasone Propionate|fluticasone propionate
162218|NCT02301975|Adolescents|adolescents
162219|NCT02301975|Salmeterol|salmeterol
162220|NCT02301975|Vilanterol|vilanterol
162221|NCT02301975|ELLIPTA|ellipta
162222|NCT02301975|ACCUHALER/DISKUS|accuhaler/diskus
162223|NCT02301975|Non-inferior|non-inferior
162224|NCT02301975|Fluticasone Furoate|fluticasone furoate
162225|NCT02301962|panitumumab|panitumumab
162226|NCT02301962|previously treated|previously treated
162227|NCT02301962|metastatic colorectal cancer|metastatic colorectal cancer
162228|NCT02301962|fully human antibody|fully human antibody
162229|NCT02301962|wild-type KRAS and wild-type NRAS|wild-type kras and wild-type nras
162230|NCT02301949|gastrointestinal bleeding|gastrointestinal bleeding
162231|NCT02301949|vascular malformation|vascular malformation
162232|NCT02301949|thalidomide retreatment|thalidomide retreatment
162233|NCT02301936|Sickle Cell Disease|sickle cell disease
162234|NCT02301936|Gilead|gilead
162235|NCT02301936|Hepatitis C|hepatitis c
162236|NCT02301923|Continuous Positive Airway Pressure|continuous positive airway pressure
162237|NCT02301910|Myocardial Infarction|myocardial infarction
162238|NCT02301910|Fibrinolysis|fibrinolysis
162239|NCT02301910|Fortelyzin|fortelyzin
162240|NCT02301871|MNP|mnp
162241|NCT02301871|MET|met
162242|NCT02301871|Soft tissue mobilization|soft tissue mobilization
162243|NCT02301871|DNF|dnf
162244|NCT02301871|Static Stretching|static stretching
162245|NCT02301858|molecular pathology|molecular pathology
162246|NCT02301858|functional genomics|functional genomics
162247|NCT02301858|lung cancer|lung cancer
162248|NCT02301858|primary tumor|primary tumor
162249|NCT02301858|metastases|metastases
162250|NCT02301845|Respiration, artificial|respiration, artificial
162251|NCT02301832|acute compartment swelling (ACS)|acute compartment swelling (acs)
162252|NCT02301832|near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
162253|NCT02301767|MRI|mri
162254|NCT02301767|Risk Factor|risk factor
162255|NCT02301767|background Parenchymal Enhancement|background parenchymal enhancement
162256|NCT02301767|(IMAGINE) Study|(imagine) study
162257|NCT02301741|chronic low back pain|chronic low back pain
162258|NCT02301728|breast milk|breast milk
162259|NCT02301728|short chain fatty acids|short chain fatty acids
162260|NCT02301728|maternal diet|maternal diet
162261|NCT02301715|Intranasal oxytocin|intranasal oxytocin
162262|NCT02301715|Emotion regulation|emotion regulation
162263|NCT02301715|Attachment|attachment
162264|NCT02301702|Maternal Immunization|maternal immunization
162265|NCT02301702|Tdap|tdap
162266|NCT02301702|Td|td
162267|NCT02301702|Pertussis|pertussis
162268|NCT02301689|Heart failure|heart failure
162269|NCT02301689|Chronic heart failure|chronic heart failure
162270|NCT02301689|Sleep disordered breathing|sleep disordered breathing
162271|NCT02301689|Sleep apnea|sleep apnea
162272|NCT02301689|Positive Airway Pressure|positive airway pressure
162273|NCT02301676|Geriatrics; Cognitive impairment; Interviews, Telephone|geriatrics; cognitive impairment; interviews, telephone
162274|NCT02301650|Hepatitis B virus|hepatitis b virus
162275|NCT02301650|pregnancy|pregnancy
162276|NCT02301650|nucleoside (acid) analogs|nucleoside (acid) analogs
162277|NCT02301650|children|children
162278|NCT02301650|safety|safety
162279|NCT02301624|gMG|gmg
162280|NCT02301624|Myasthenia Gravis|myasthenia gravis
162281|NCT02301624|safety|safety
162282|NCT02301624|efficacy|efficacy
162283|NCT02301598|femtosecond laser|femtosecond laser
162284|NCT02301598|anterior lamellar keratoplasty|anterior lamellar keratoplasty
162285|NCT02301598|atomic-force microscopy|atomic-force microscopy
162286|NCT02301585|shock, septic|shock, septic
162287|NCT02301585|hemodynamics|hemodynamics
162288|NCT02301585|algorithms|algorithms
162289|NCT02301533|HIV infection|hiv infection
162290|NCT02301533|antiretroviral therapy|antiretroviral therapy
162291|NCT02301533|adherence|adherence
162292|NCT02301533|men who have sex with men|men who have sex with men
162293|NCT02301520|Vitamin D|vitamin d
162294|NCT02301520|Iodine|iodine
162295|NCT02301520|Lead|lead
162296|NCT02301520|Thyroid function|thyroid function
162297|NCT02301520|point-of-care test|point-of-care test
162298|NCT02301494|CTCL|ctcl
162299|NCT02301494|Mycosis Fungoides|mycosis fungoides
162300|NCT02301494|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
162301|NCT02301494|MF|mf
162302|NCT02301494|topical therapy|topical therapy
162303|NCT02301494|early stage|early stage
162304|NCT02301455|hypertension treatment|hypertension treatment
162305|NCT02301455|stroke prevention|stroke prevention
162306|NCT02301403|smoking|smoking
162307|NCT02301403|cessation|cessation
162308|NCT02301403|tobacco|tobacco
162309|NCT02301390|INTERVENE|intervene
162310|NCT02301390|Ventricular tachycardia|ventricular tachycardia
162311|NCT02301390|India|india
162312|NCT02301364|Buparlisib (BKM120)|buparlisib (bkm120)
162313|NCT02301364|14-177|14-177
162314|NCT02301338|Videoconferencing|videoconferencing
162315|NCT02301338|Following Surgery|following surgery
162316|NCT02301338|14-213|14-213
162317|NCT02301299|stroke|stroke
162318|NCT02301299|barriers|barriers
162319|NCT02301299|community|community
162320|NCT02301286|Acetylsalicylic acid|acetylsalicylic acid
162321|NCT02301286|Colon cancer|colon cancer
162322|NCT02301286|Survival|survival
162323|NCT02301273|Intensive care unit|intensive care unit
162324|NCT02301273|Physiotherapy|physiotherapy
162325|NCT02301273|Upright position|upright position
162326|NCT02301273|Exercise|exercise
162327|NCT02301273|Long term follow up of ICU survivors|long term follow up of icu survivors
162328|NCT02301260|Processing Speed|processing speed
162329|NCT02301260|Intervention|intervention
162330|NCT02301260|Multiple Sclerosis|multiple sclerosis
162331|NCT02301260|Cognition|cognition
162332|NCT02301247|Multiple Sclerosis, Progressive|multiple sclerosis, progressive
162333|NCT02301247|cognition|cognition
162334|NCT02301247|memory|memory
162335|NCT02301247|treatment|treatment
162336|NCT02301234|Osteoarthritis|osteoarthritis
162337|NCT02301234|Pain|pain
162338|NCT02301234|Fulranumab|fulranumab
162339|NCT02301234|JNJ-42160443|jnj-42160443
162340|NCT02301234|Adjunctive therapy|adjunctive therapy
162341|NCT02301234|Celecoxib|celecoxib
162342|NCT02301234|Hip|hip
162343|NCT02301234|Knee|knee
162344|NCT02301234|Joint replacement surgery|joint replacement surgery
162345|NCT02301221|Fecal Microbiota Transplantation|fecal microbiota transplantation
162346|NCT02301221|Slow Transit Constipation|slow transit constipation
162347|NCT02301221|Colonic motility|colonic motility
162348|NCT02301195|Therapeutic Horseback Riding|therapeutic horseback riding
162349|NCT02301169|Pain|pain
162350|NCT02301143|Pancreatic Neoplasms|pancreatic neoplasms
162351|NCT02301143|Pancreatic Cancer|pancreatic cancer
162352|NCT02301143|Locally advanced pacriatic cancer|locally advanced pacriatic cancer
162353|NCT02301143|nab-Paclitaxel|nab-paclitaxel
162354|NCT02301143|Abraxane|abraxane
162355|NCT02301143|Gemcitabine|gemcitabine
162356|NCT02301143|ABI-007|abi-007
162357|NCT02301130|advanced solid tumors|advanced solid tumors
162358|NCT02301130|solid tumors|solid tumors
162359|NCT02301130|mogamulizumab|mogamulizumab
162360|NCT02301130|MEDI4736 (Durvalumab)|medi4736 (durvalumab)
162368|NCT02301117|Renal Impairment|renal impairment
162369|NCT02301117|Pharmacokinetics|pharmacokinetics
162370|NCT02301117|Advance Solid Tumor|advance solid tumor
162371|NCT02301117|Creatinine Clearance|creatinine clearance
162372|NCT02301117|Kidney Neoplasms|kidney neoplasms
162373|NCT02301117|Renal Tumor|renal tumor
162374|NCT02301117|Kidney|kidney
162375|NCT02301117|Urology|urology
162376|NCT02301117|Pharmacologic Action|pharmacologic action
162377|NCT02301104|Liver Neoplasms|liver neoplasms
162378|NCT02301104|Hepatic|hepatic
162379|NCT02301104|TAS-102|tas-102
162380|NCT02301104|mCRC|mcrc
162381|NCT02301104|Liver Impairment|liver impairment
162382|NCT02301104|Pharmacologic Actions|pharmacologic actions
162383|NCT02301104|Liver Diseases|liver diseases
162384|NCT02301104|Liver|liver
162386|NCT02301104|Advanced Solid Tumor|advanced solid tumor
162387|NCT02301104|Pharmacokinetics|pharmacokinetics
162388|NCT02301091|HCC PVTT TACE RFA|hcc pvtt tace rfa
162389|NCT02301078|Dupuytren disease|dupuytren disease
162390|NCT02301078|needle aponeurotomy|needle aponeurotomy
162391|NCT02301078|collagenase|collagenase
162392|NCT02301065|Viral|viral
162393|NCT02301065|Infection|infection
162394|NCT02301065|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
162395|NCT02301052|hemorrhoids|hemorrhoids
162396|NCT02301052|Allium Ampeloprasum|allium ampeloprasum
162397|NCT02301052|herbal medicine|herbal medicine
162398|NCT02301052|traditional persian medicine|traditional persian medicine
162399|NCT02301000|Clostridium difficile|clostridium difficile
162400|NCT02301000|Intestinal microbiota therapy|intestinal microbiota therapy
162401|NCT02300987|Teratoma,|teratoma,
162402|NCT02300987|Germ Cell tumor,|germ cell tumor,
162403|NCT02300987|incurable teratoma,|incurable teratoma,
162404|NCT02300987|CDK4/6,|cdk4/6,
162405|NCT02300987|LEE011|lee011
162406|NCT02300948|Pregnancy|pregnancy
162407|NCT02300948|Perinatal Vitamins|perinatal vitamins
162408|NCT02300948|folate|folate
162409|NCT02300935|trametinib|trametinib
162410|NCT02300935|nab-paclitaxel|nab-paclitaxel
162411|NCT02300935|Mekinist|mekinist
162412|NCT02300935|Abraxane|abraxane
162413|NCT02300935|unresectable|unresectable
162414|NCT02300935|metastatic|metastatic
162415|NCT02300896|exercise|exercise
162416|NCT02300896|physical fitness|physical fitness
162417|NCT02300896|geriatrics|geriatrics
162418|NCT02300870|Acute rejection, myocardial blood flow|acute rejection, myocardial blood flow
162419|NCT02300831|NSCLC|nsclc
162420|NCT02300831|Lung Cancer|lung cancer
162421|NCT02300831|SELECT-1|select-1
162422|NCT02300831|SELECT-2|select-2
162423|NCT02300831|selumetinib|selumetinib
162424|NCT02300831|biomarker|biomarker
162425|NCT02300831|NIS|nis
162426|NCT02300831|Observational study|observational study
162427|NCT02300831|Disease registry|disease registry
162428|NCT02300831|Clinical Outcomes|clinical outcomes
162429|NCT02300818|Hipertension ocular, Glaucoma, Magnetotherapy, seawater|hipertension ocular, glaucoma, magnetotherapy, seawater
162430|NCT02300805|Endometrial volume , VOCAL , Endometrial , Metrorrhagia|endometrial volume , vocal , endometrial , metrorrhagia
162431|NCT02300792|honey, hepatitis A|honey, hepatitis a
162432|NCT02300779|Colonoscopy|colonoscopy
162433|NCT02300779|Diabetes Mellitus|diabetes mellitus
162434|NCT02300779|Diet|diet
162435|NCT02300779|Polyethylene glycols|polyethylene glycols
162436|NCT02300779|Efficacy|efficacy
162437|NCT02300779|Personal satisfaction|personal satisfaction
162438|NCT02300766|Cerebellar Mutism Syndrome|cerebellar mutism syndrome
162439|NCT02300766|Posterior Fossa Tumor|posterior fossa tumor
162440|NCT02300766|Pediatric cancer|pediatric cancer
162441|NCT02300766|Neurosurgical techniques|neurosurgical techniques
162442|NCT02300727|Mucositis|mucositis
162443|NCT02300727|Neoplasms|neoplasms
162444|NCT02300727|CANCER|cancer
162445|NCT02300727|Curcumin|curcumin
162446|NCT02300727|Drug Therapy|drug therapy
162447|NCT02300727|ANTINEOPLASTIC AGENTS|antineoplastic agents
162448|NCT02300675|therapeutic patient education|therapeutic patient education
162449|NCT02300675|patient adherence|patient adherence
162450|NCT02300675|empowerment|empowerment
162451|NCT02300675|breast cancer|breast cancer
162452|NCT02300675|oral adjuvant endocrine therapy|oral adjuvant endocrine therapy
162453|NCT02300675|side effects|side effects
162454|NCT02300636|Knee joint|knee joint
162455|NCT02300636|Muscle strength|muscle strength
162456|NCT02300636|anterior cruciate ligament|anterior cruciate ligament
162467|NCT02300597|Autism Spectrum Disorders|autism spectrum disorders
162468|NCT02300597|controlled|controlled
162469|NCT02300597|Internet based|internet based
162470|NCT02300597|coaching|coaching
162472|NCT02300558|long QT syndrome|long qt syndrome
162473|NCT02300558|congenital long QT|congenital long qt
162474|NCT02300558|sudden cardiac death|sudden cardiac death
162475|NCT02300532|Malignant Glioma|malignant glioma
162476|NCT02300532|Glioblastoma Multiforme|glioblastoma multiforme
162477|NCT02300519|Haemophilia|haemophilia
162478|NCT02300519|numerical models|numerical models
162479|NCT02300519|thrombin generation|thrombin generation
162480|NCT02300519|volunteers|volunteers
162481|NCT02300519|endogenous thrombin potential|endogenous thrombin potential
162482|NCT02300506|Malignant Glioma|malignant glioma
162483|NCT02300506|Glioblastoma multiforme|glioblastoma multiforme
162484|NCT02300493|among college students|among college students
162485|NCT02300480|pain|pain
162486|NCT02300480|calot's triangle|calot's triangle
162487|NCT02300480|local block|local block
162488|NCT02300480|analgesia|analgesia
162489|NCT02300480|patient controlled intravenous analgesia|patient controlled intravenous analgesia
162490|NCT02300454|in-stent restenosis|in-stent restenosis
162491|NCT02300454|percutaneous coronary intervention|percutaneous coronary intervention
162492|NCT02300454|balloon|balloon
162493|NCT02300428|iron deficiency|iron deficiency
162494|NCT02300389|high risk prostate cancer radiotherapy hypofractionation|high risk prostate cancer radiotherapy hypofractionation
162496|NCT02300376|Bayesian model|bayesian model
162497|NCT02300376|plasma clearance|plasma clearance
162498|NCT02300376|Calcium edetate de sodium|calcium edetate de sodium
162499|NCT02300376|Inulin|inulin
162500|NCT02300337|laryngeal tube|laryngeal tube
162501|NCT02300337|cuff pressure|cuff pressure
162502|NCT02300337|leakage|leakage
162503|NCT02300337|laryngeal mask|laryngeal mask
162504|NCT02300324|bioavailability|bioavailability
162505|NCT02300324|Beneforte|beneforte
162506|NCT02300324|sulforaphane|sulforaphane
162507|NCT02300272|Practice-related learning|practice-related learning
162508|NCT02300272|Sleep|sleep
162509|NCT02300272|Pain|pain
162510|NCT02300272|Circadian Rhythm|circadian rhythm
162511|NCT02300272|Older Adults|older adults
162512|NCT02300246|alveolar socket preservation|alveolar socket preservation
153522|NCT02351206|X-Rays|x-rays
162513|NCT02300246|tooth extraction|tooth extraction
162514|NCT02300246|platelet concentrates|platelet concentrates
162515|NCT02300246|growth factors|growth factors
162516|NCT02300207|Electroacupuncture|electroacupuncture
162517|NCT02300207|Cardiovascular function|cardiovascular function
162518|NCT02300207|Orthostatic tolerance|orthostatic tolerance
162519|NCT02300207|Head-down bed rest|head-down bed rest
162520|NCT02300194|Pain management|pain management
162521|NCT02300168|bariatric surgery; neuromuscular blockade|bariatric surgery; neuromuscular blockade
162522|NCT02300155|Pregnancy|pregnancy
162523|NCT02300155|Morning Sickness|morning sickness
162524|NCT02300155|nausea and vomiting|nausea and vomiting
162525|NCT02300155|hyperemesis gravidarum|hyperemesis gravidarum
162526|NCT02300155|perinatal vitamins|perinatal vitamins
162527|NCT02300142|HSV|hsv
162528|NCT02300142|Herpes|herpes
162529|NCT02300142|genital infection|genital infection
162530|NCT02300142|vaccine|vaccine
162531|NCT02300090|COPD, Exacerbation, respiratory disease, lung disease, breathlessness, dyspnoea, sputum, wheezing, cough|copd, exacerbation, respiratory disease, lung disease, breathlessness, dyspnoea, sputum, wheezing, cough
162532|NCT02300077|fentanyl, morphine|fentanyl, morphine
162533|NCT02300077|methadone|methadone
162534|NCT02300051|Compulsive sexual behavior|compulsive sexual behavior
162535|NCT02300051|Intervention|intervention
162536|NCT02300051|Short term psychodynamic group psychotherapy|short term psychodynamic group psychotherapy
162537|NCT02300051|Sexual addiction|sexual addiction
162538|NCT02300051|Hypersexual behavior|hypersexual behavior
162539|NCT02300012|Anterior cruciate ligament|anterior cruciate ligament
162540|NCT02300012|Performance based investigations|performance based investigations
162541|NCT02299973|irritable bowel syndrome|irritable bowel syndrome
162542|NCT02299973|fecal microbiota transplantation|fecal microbiota transplantation
162543|NCT02299973|bloating|bloating
162544|NCT02299960|EndoPAT|endopat
162545|NCT02299960|NICOM|nicom
162546|NCT02299960|circulating endothelial cells|circulating endothelial cells
162547|NCT02299908|Hernia, Inguinal|hernia, inguinal
162548|NCT02299908|Herniorrhaphy|herniorrhaphy
162549|NCT02299908|Abdominal Wall|abdominal wall
162550|NCT02299908|Analgesia|analgesia
162551|NCT02299908|Pain, Postoperative|pain, postoperative
162552|NCT02299895|setting approach|setting approach
162553|NCT02299895|health promotion|health promotion
162554|NCT02299895|organization|organization
162555|NCT02299895|implementation research|implementation research
162556|NCT02299895|qualitative study|qualitative study
162557|NCT02299895|comparison|comparison
162558|NCT02299882|Posterior spine surgery|posterior spine surgery
162559|NCT02299882|infection|infection
162560|NCT02299882|vancomycin|vancomycin
162561|NCT02299882|surgical wound infection|surgical wound infection
162562|NCT02299856|Magnetic Resonance Imaging|magnetic resonance imaging
162563|NCT02299856|Diagnostic Imaging|diagnostic imaging
162565|NCT02299843|ALPPS|alpps
162566|NCT02299843|hepatectomy|hepatectomy
162567|NCT02299843|morbidity and mortality|morbidity and mortality
162568|NCT02299830|neoplasm|neoplasm
162569|NCT02299830|central airway|central airway
162570|NCT02299830|obstruction|obstruction
162571|NCT02299791|clinic-level interventions|clinic-level interventions
162572|NCT02299791|quality improvement|quality improvement
162573|NCT02299791|translational medical research|translational medical research
162574|NCT02299791|community health centers|community health centers
162575|NCT02299765|Advanced Non-small Cell Lung Cancer (NSCLC)|advanced non-small cell lung cancer (nsclc)
162576|NCT02299765|EGFR Mutation|egfr mutation
162577|NCT02299765|gefitinib|gefitinib
162578|NCT02299765|chemotherapy|chemotherapy
162579|NCT02299739|Herbal Medicine|herbal medicine
162580|NCT02299739|Complementary Therapies|complementary therapies
162581|NCT02299739|Liver Function Tests|liver function tests
162582|NCT02299739|Risk Factors|risk factors
162583|NCT02299726|acute heart failure|acute heart failure
162584|NCT02299726|MRA|mra
162585|NCT02299726|emergency department|emergency department
162586|NCT02299713|acupuncture|acupuncture
162587|NCT02299713|knee pain|knee pain
162588|NCT02299700|Janssen Autism Knowledge Engine|janssen autism knowledge engine
162589|NCT02299700|Autism Spectrum Disorder|autism spectrum disorder
162590|NCT02299661|Hypoxia inducible factor prolyl hydroxylase inhibitor.|hypoxia inducible factor prolyl hydroxylase inhibitor.
162591|NCT02299661|Erythropoietin stimulating agent|erythropoietin stimulating agent
162592|NCT02299661|Chronic renal disease|chronic renal disease
162593|NCT02299661|renal anemia|renal anemia
162594|NCT02299635|PF-03084014|pf-03084014
162595|NCT02299635|Notch Alterations|notch alterations
162596|NCT02299609|C14.280.647.500|c14.280.647.500
162597|NCT02299596|Colorectal neoplasm|colorectal neoplasm
162598|NCT02299596|Physical activity|physical activity
162599|NCT02299583|prevention|prevention
162600|NCT02299583|early intervention|early intervention
162601|NCT02299583|trauma-informed practice|trauma-informed practice
162602|NCT02299570|Clostridium difficile|clostridium difficile
162603|NCT02299570|C diff|c diff
162604|NCT02299570|CDI|cdi
162605|NCT02299570|CDAD|cdad
162606|NCT02299570|Fecal transplant|fecal transplant
162607|NCT02299570|Fecal Microbiota Transplant|fecal microbiota transplant
162608|NCT02299570|Diarrhea|diarrhea
162609|NCT02299570|FMT|fmt
162610|NCT02299570|Microbiota restoration therapy|microbiota restoration therapy
162611|NCT02299570|Microbiota suspension|microbiota suspension
162612|NCT02299570|Fecal bacteriotherapy|fecal bacteriotherapy
162613|NCT02299570|C diff diarrhea|c diff diarrhea
162614|NCT02299505|LDK378|ldk378
162615|NCT02299505|ceritinib|ceritinib
162616|NCT02299505|Alk+|alk+
162617|NCT02299505|Alk positive|alk positive
162618|NCT02299505|NSCLC|nsclc
162619|NCT02299505|lung Cancer|lung cancer
162620|NCT02299492|Mental Health Services|mental health services
162621|NCT02299479|insulin pump|insulin pump
162622|NCT02299479|continuous glucose monitor|continuous glucose monitor
162623|NCT02299479|activity monitor|activity monitor
162624|NCT02299466|parenteral nutrition|parenteral nutrition
162625|NCT02299466|complications|complications
162626|NCT02299466|indications|indications
162627|NCT02299466|long-term administration|long-term administration
162628|NCT02299466|HTPN|htpn
162629|NCT02299453|Telemedicine|telemedicine
162630|NCT02299453|Interpersonal Psychotherapy (IPT)|interpersonal psychotherapy (ipt)
162631|NCT02299440|treatment of acute suicidal ideation|treatment of acute suicidal ideation
162632|NCT02299440|ketamine|ketamine
162633|NCT02299440|low-dose ketamine|low-dose ketamine
162634|NCT02299414|Pregnancy|pregnancy
162635|NCT02299414|Chronic hypertension|chronic hypertension
162636|NCT02299401|Medical abortion|medical abortion
162637|NCT02299401|Induced abortion|induced abortion
162638|NCT02299401|Pregnancy test|pregnancy test
162639|NCT02299401|Semi-quantitative pregnancy test|semi-quantitative pregnancy test
162640|NCT02299388|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
162641|NCT02299388|Hypertension|hypertension
162642|NCT02299388|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
162643|NCT02299388|Endothelial Dysfunction|endothelial dysfunction
162644|NCT02299388|Pulse pressure|pulse pressure
162645|NCT02299388|Renin-angiotensin system|renin-angiotensin system
162646|NCT02299388|heart rate variability|heart rate variability
162647|NCT02299375|Phase II clinical study|phase ii clinical study
162648|NCT02299375|losmapimod|losmapimod
162649|NCT02299375|exacerbations|exacerbations
162650|NCT02299375|COPD|copd
162651|NCT02299375|eosinophil sub-group|eosinophil sub-group
162652|NCT02299362|Early Onset Scoliosis|early onset scoliosis
162653|NCT02299362|EOS|eos
162654|NCT02299362|Pulmonary function|pulmonary function
162655|NCT02299362|Infantile Idiopathic Scoliosis|infantile idiopathic scoliosis
162656|NCT02299362|MCGR|mcgr
162657|NCT02299362|Magnetically controlled growing rods|magnetically controlled growing rods
162658|NCT02299362|Growing rods|growing rods
162659|NCT02299362|Growth friendly spine surgery|growth friendly spine surgery
162660|NCT02299362|Cast|cast
162661|NCT02299310|Chronic kidney disease, Anti-hypertensive drugs|chronic kidney disease, anti-hypertensive drugs
162662|NCT02299297|Alopecia Areata|alopecia areata
162663|NCT02299284|Spastic|spastic
162664|NCT02299284|Hemiplegia|hemiplegia
162665|NCT02299245|telomere|telomere
162666|NCT02299245|telomerase|telomerase
162667|NCT02299245|statin|statin
162668|NCT02299245|percutaneous coronary intervention|percutaneous coronary intervention
162669|NCT02299245|acute coronary syndrome|acute coronary syndrome
162670|NCT02299232|dexmedetomidine|dexmedetomidine
162671|NCT02299232|sedation|sedation
162672|NCT02299232|MRI|mri
162673|NCT02299219|Adolescent|adolescent
162674|NCT02299219|Internet Self-Management|internet self-management
162675|NCT02299219|Managing Cancer|managing cancer
162676|NCT02299193|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
162677|NCT02299193|sleep hygiene|sleep hygiene
162678|NCT02299180|Advanced care planning|advanced care planning
162679|NCT02299180|End of life care|end of life care
162680|NCT02299167|Perianal surgery|perianal surgery
162681|NCT02299167|hyperbaric bupivacaine|hyperbaric bupivacaine
162682|NCT02299167|saddle block|saddle block
162683|NCT02299115|Vigabatrin|vigabatrin
162684|NCT02299115|Prednisolone|prednisolone
162685|NCT02299102|Aspiration Procedures|aspiration procedures
162686|NCT02299102|Bone Marrow|bone marrow
162687|NCT02299102|To compare powered ported bone marrow aspiration procedures to manual standard bone marrow aspiration procedures|to compare powered ported bone marrow aspiration procedures to manual standard bone marrow aspiration procedures
162688|NCT02299089|acromegaly|acromegaly
162689|NCT02299089|neuroendocrine tumour (NET)|neuroendocrine tumour (net)
162690|NCT02299089|carcinoid syndrome|carcinoid syndrome
162691|NCT02299089|octreotide|octreotide
162692|NCT02299089|Sandostatin LAR|sandostatin lar
162693|NCT02299076|Tobacco smoking cessation|tobacco smoking cessation
162694|NCT02299076|Motivation|motivation
162695|NCT02299063|Mitochondria|mitochondria
162696|NCT02299063|Dexmedetomidine|dexmedetomidine
162697|NCT02299063|Heart Defects, Congenital|heart defects, congenital
162698|NCT02299050|Type 2 Diabetes|type 2 diabetes
162699|NCT02299050|T2DM|t2dm
153776|NCT02349828|HSV|hsv
162700|NCT02299050|Cycloset|cycloset
162701|NCT02299050|Glycemic Control|glycemic control
162702|NCT02299050|GLP-1|glp-1
162703|NCT02299024|opioids|opioids
162704|NCT02299024|health literacy|health literacy
162705|NCT02299011|Biomatrix drug eluting stent|biomatrix drug eluting stent
162706|NCT02299011|Orsiro drug eluting stent|orsiro drug eluting stent
162707|NCT02299011|Coronary artery disease|coronary artery disease
162708|NCT02298985|curcumin; schizophrenia; neuroprotection|curcumin; schizophrenia; neuroprotection
162709|NCT02298946|Anti-PD1 Therapy|anti-pd1 therapy
162710|NCT02298946|Anti-Tumor Immunity|anti-tumor immunity
162711|NCT02298946|Liver Metastatic|liver metastatic
162712|NCT02298946|B7-DC Fc Fushion Protein|b7-dc fc fushion protein
162713|NCT02298933|Complement Inhibition|complement inhibition
162714|NCT02298933|Platelet Refractoriness|platelet refractoriness
162715|NCT02298933|Eculizumab|eculizumab
162716|NCT02298907|colorectal cancer|colorectal cancer
162717|NCT02298907|surgery|surgery
162718|NCT02298907|cardiopulmonary exercise testing|cardiopulmonary exercise testing
162719|NCT02298907|perioperative|perioperative
162720|NCT02298907|fitness|fitness
162721|NCT02298894|Low Density Lipoprotein (LDL)|low density lipoprotein (ldl)
162722|NCT02298894|Lipoprotein|lipoprotein
162723|NCT02298894|Nuclear Magnetic Resonance (NMR)|nuclear magnetic resonance (nmr)
162724|NCT02298894|Vertical Auto Profile (VAP)|vertical auto profile (vap)
162725|NCT02298894|Ion mobility|ion mobility
162726|NCT02298894|Apoliproprotein B (ApoB)|apoliproprotein b (apob)
162727|NCT02298881|Dry Eye|dry eye
162728|NCT02298881|Microbiome|microbiome
162729|NCT02298855|Gynaecological cancer|gynaecological cancer
162730|NCT02298855|Nurse-led care|nurse-led care
162731|NCT02298855|Aftercare|aftercare
162732|NCT02298855|Patient self-management|patient self-management
162733|NCT02298855|Quality of life|quality of life
162734|NCT02298855|Relapse free interval|relapse free interval
162735|NCT02298855|Watch and wait|watch and wait
162736|NCT02298842|Healthy Adults|healthy adults
162737|NCT02298829|curvature|curvature
162738|NCT02298829|bend|bend
162739|NCT02298816|Monoclonal gammopathy of undetermined significance (MGUS)|monoclonal gammopathy of undetermined significance (mgus)
162740|NCT02298816|Smoldering multiple myeloma (SMM)|smoldering multiple myeloma (smm)
162741|NCT02298816|Multiple myeloma (MM)|multiple myeloma (mm)
162742|NCT02298816|Waldenstroms Macroglobulinemia (WM)|waldenstroms macroglobulinemia (wm)
162743|NCT02298816|Monoclonal B-cell lymphocytosis (MBL)|monoclonal b-cell lymphocytosis (mbl)
162744|NCT02298816|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
162745|NCT02298816|B-Cell Non-Hodgkin lymphoma (NHL)|b-cell non-hodgkin lymphoma (nhl)
162746|NCT02298816|B-Cell Hematologic Malignancies|b-cell hematologic malignancies
162747|NCT02298816|immunization|immunization
162748|NCT02298816|Vaccination|vaccination
162749|NCT02298816|Influenza, Human|influenza, human
162750|NCT02298816|Pneumonia|pneumonia
162846|NCT02298361|Infant|infant
162751|NCT02298790|Dietary Habits|dietary habits
162752|NCT02298790|Circadian|circadian
162753|NCT02298790|Metabolism|metabolism
162754|NCT02298790|Feeding Behavior|feeding behavior
162755|NCT02298738|Atrial fibrillation, hypertension, vitamin D|atrial fibrillation, hypertension, vitamin d
162756|NCT02298725|Insulin Resistance|insulin resistance
162757|NCT02298725|Obesity|obesity
162758|NCT02298725|US Dietary Guidelines|us dietary guidelines
162759|NCT02298712|Iduronidase|iduronidase
162760|NCT02298712|Lysosomal Storage Diseases|lysosomal storage diseases
162761|NCT02298712|Genetic Diseases, Inborn|genetic diseases, inborn
162762|NCT02298712|Metabolism, Inborn Errors|metabolism, inborn errors
162763|NCT02298699|Lysosomal Storage Diseases|lysosomal storage diseases
162764|NCT02298699|Hereditary Diseases|hereditary diseases
162765|NCT02298686|Inborn Errors of Metabolism|inborn errors of metabolism
162766|NCT02298686|Lysosomal Storage Diseases|lysosomal storage diseases
162767|NCT02298686|Metabolism Errors, Inborn|metabolism errors, inborn
162768|NCT02298673|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
162769|NCT02298673|Hereditary Disease|hereditary disease
162770|NCT02298673|Inborn Genetic Diseases|inborn genetic diseases
162771|NCT02298660|Autonomic Dysreflexia|autonomic dysreflexia
162772|NCT02298660|Spinal Cord Injury|spinal cord injury
162773|NCT02298660|OnabotulinumtoxinA|onabotulinumtoxina
162895|NCT02298270|Neurofibromatosis|neurofibromatosis
162774|NCT02298660|Neurogenic detrusor overactivity|neurogenic detrusor overactivity
162775|NCT02298660|Urodynamics|urodynamics
162776|NCT02298660|Cardiovascular|cardiovascular
162777|NCT02298660|Quality of life|quality of life
162778|NCT02298660|Blood pressure|blood pressure
162779|NCT02298660|Twenty-four hour ambulatory blood pressure monitoring|twenty-four hour ambulatory blood pressure monitoring
162780|NCT02298647|Lysosomal Storage Diseases|lysosomal storage diseases
162781|NCT02298634|Lysosomal Storage Diseases|lysosomal storage diseases
162782|NCT02298634|Lipogranulomatosis|lipogranulomatosis
162783|NCT02298608|Renal mass|renal mass
162784|NCT02298608|Kidney cancer|kidney cancer
162785|NCT02298608|Irreversibel Electroporation|irreversibel electroporation
162786|NCT02298608|Ablation|ablation
197427|NCT02128087|HIV|hiv
162788|NCT02298608|Efficacy|efficacy
162789|NCT02298608|IRE|ire
162790|NCT02298595|Carcinoma|carcinoma
162791|NCT02298595|Squamous|squamous
162792|NCT02298595|Oropharyngeal|oropharyngeal
162793|NCT02298595|HPV|hpv
162794|NCT02298595|Resectable|resectable
162795|NCT02298582|safety|safety
162796|NCT02298582|procedural pain|procedural pain
162797|NCT02298582|intranasal fentanyl|intranasal fentanyl
162798|NCT02298582|elderly|elderly
162799|NCT02298569|patient discharge|patient discharge
162800|NCT02298569|hospital readmission|hospital readmission
162801|NCT02298569|postnatal care|postnatal care
162802|NCT02298569|Home Care Services|home care services
162803|NCT02298569|Cost-Benefit Analysis|cost-benefit analysis
162804|NCT02298569|Personal satisfaction|personal satisfaction
162805|NCT02298569|Community Care Networks|community care networks
162806|NCT02298556|Hypertension|hypertension
162807|NCT02298556|Diabetes Mellitus|diabetes mellitus
162808|NCT02298556|ACE Inhibitors|ace inhibitors
162809|NCT02298556|Calcium Channel Blockers|calcium channel blockers
162810|NCT02298517|Morbid obesity|morbid obesity
162811|NCT02298517|bariatric surgery|bariatric surgery
162812|NCT02298517|Respiratory muscle endurance|respiratory muscle endurance
162813|NCT02298517|Respiratory muscle strength|respiratory muscle strength
162814|NCT02298517|spirometry|spirometry
162815|NCT02298517|physiotherapy|physiotherapy
162816|NCT02298478|Self-help|self-help
162817|NCT02298478|Computer-aided Treatment|computer-aided treatment
162818|NCT02298478|Internet|internet
162819|NCT02298478|Flying phobia|flying phobia
162820|NCT02298478|minimal contact therapies|minimal contact therapies
162821|NCT02298478|Cognitive-Behavioural Treatment|cognitive-behavioural treatment
162822|NCT02298478|Waiting list control group|waiting list control group
162824|NCT02298465|distal ureteric stone|distal ureteric stone
162825|NCT02298465|transgluteal|transgluteal
162826|NCT02298465|supine ESWL|supine eswl
162827|NCT02298439|NAFLD|nafld
162828|NCT02298426|Body Constitution Classification|body constitution classification
162829|NCT02298426|Health Management|health management
162830|NCT02298426|Obese Population|obese population
162831|NCT02298374|Rehabilitation|rehabilitation
162832|NCT02298374|Evaluation studies|evaluation studies
162833|NCT02298374|Home care services|home care services
162834|NCT02298361|Adolescent|adolescent
162835|NCT02298361|Child|child
162836|NCT02298361|Child Health Services/organization & administration*|child health services/organization & administration*
162837|NCT02298361|Child, Preschool|child, preschool
162838|NCT02298361|Cohort Studies|cohort studies
162839|NCT02298361|Community Health Centers/organization & administration|community health centers/organization & administration
162840|NCT02298361|Community Health Centers/standards|community health centers/standards
162841|NCT02298361|Electronic Health Records|electronic health records
162842|NCT02298361|Feasibility Studies|feasibility studies
162843|NCT02298361|Female|female
162844|NCT02298361|Health Services Accessibility/economics|health services accessibility/economics
162845|NCT02298361|Humans|humans
162847|NCT02298361|Infant, Newborn|infant, newborn
162848|NCT02298361|Insurance Coverage|insurance coverage
162849|NCT02298361|Insurance Coverage/statistics & numerical data|insurance coverage/statistics & numerical data
162850|NCT02298361|Insurance Coverage/trends|insurance coverage/trends
162851|NCT02298361|Insurance, Health|insurance, health
162852|NCT02298361|Insurance, Health/legislation & jurisprudence|insurance, health/legislation & jurisprudence
162853|NCT02298361|Insurance, Health/statistics & numerical data|insurance, health/statistics & numerical data
162854|NCT02298361|Insurance, Health/trends|insurance, health/trends
162855|NCT02298361|Logistic Models|logistic models
162856|NCT02298361|Longitudinal Studies|longitudinal studies
162857|NCT02298361|Male|male
162858|NCT02298361|Medicaid|medicaid
162859|NCT02298361|Medicaid/statistics & numerical data|medicaid/statistics & numerical data
162860|NCT02298361|Medicaid/trends|medicaid/trends
162861|NCT02298361|Medicaid/utilization|medicaid/utilization
162862|NCT02298361|Medically Uninsured|medically uninsured
162863|NCT02298361|Medicare/statistics & numerical data|medicare/statistics & numerical data
162864|NCT02298361|Medicare/trends|medicare/trends
162865|NCT02298361|Medicare/utilization|medicare/utilization
162866|NCT02298361|Multivariate Analysis|multivariate analysis
162867|NCT02298361|Oregon|oregon
162868|NCT02298361|Patient Protection and Affordable Care Act|patient protection and affordable care act
162869|NCT02298361|Patient-Centered Care|patient-centered care
162870|NCT02298361|Pediatrics/legislation & jurisprudence|pediatrics/legislation & jurisprudence
162871|NCT02298361|Pediatrics/standards|pediatrics/standards
162872|NCT02298361|Population Surveillance/methods|population surveillance/methods
162873|NCT02298361|Primary Health Care/economics|primary health care/economics
162874|NCT02298361|Quality Assurance, Health Care/legislation & jurisprudence|quality assurance, health care/legislation & jurisprudence
162875|NCT02298361|Quality Assurance, Health Care/methods|quality assurance, health care/methods
162876|NCT02298361|Quality Indicators, Health Care|quality indicators, health care
162877|NCT02298361|Retrospective Studies|retrospective studies
153908|NCT02349061|Systemic Lupus Erythematosus|systemic lupus erythematosus
153909|NCT02349061|Ustekinumab|ustekinumab
153910|NCT02349048|Hepatitis C virus|hepatitis c virus
153911|NCT02349048|Hepatitis C virus genotype 1|hepatitis c virus genotype 1
162878|NCT02298361|Socioeconomic Factors|socioeconomic factors
162879|NCT02298361|United States|united states
162880|NCT02298361|Young Adult|young adult
162881|NCT02298348|Neuroblastoma|neuroblastoma
162882|NCT02298348|NANT|nant
162883|NCT02298348|Sorafenib|sorafenib
162884|NCT02298348|Relapse|relapse
162885|NCT02298335|Prednisone|prednisone
162886|NCT02298335|idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
162887|NCT02298335|prospective|prospective
162888|NCT02298309|TB|tb
162889|NCT02298309|HIV|hiv
162890|NCT02298309|Test and Treat|test and treat
162891|NCT02298309|Linkage|linkage
162892|NCT02298283|Hodgkin lymphoma|hodgkin lymphoma
162893|NCT02298283|HL|hl
162894|NCT02298283|brentuximab vedotin|brentuximab vedotin
162896|NCT02298270|NF I|nf i
162897|NCT02298270|NF 2|nf 2
162898|NCT02298270|Schwannomatosis|schwannomatosis
162899|NCT02298270|Stress Management|stress management
162900|NCT02298270|Resiliency|resiliency
162901|NCT02298270|Skype|skype
162902|NCT02298244|Pulmonary Hypertension|pulmonary hypertension
162903|NCT02298244|Atrial Fibrillation|atrial fibrillation
162904|NCT02298244|Pulmonary Arterial Denervation|pulmonary arterial denervation
162905|NCT02298244|Safety|safety
162906|NCT02298244|Pulmonary Arterial GP Ablation|pulmonary arterial gp ablation
162907|NCT02298231|Traumatic Brain Injury|traumatic brain injury
162908|NCT02298231|Balance|balance
162909|NCT02298231|TBI|tbi
162910|NCT02298231|Veterans|veterans
162911|NCT02298231|Virtual Reality|virtual reality
162912|NCT02298166|Acute myeloid leukemia|acute myeloid leukemia
162913|NCT02298166|FLT3 mutations|flt3 mutations
162914|NCT02298166|Crenolanib|crenolanib
162915|NCT02298166|Relapsed|relapsed
162921|NCT02298127|auricular acupressure|auricular acupressure
162922|NCT02298127|primary care settings|primary care settings
162923|NCT02298127|randomized controlled trial|randomized controlled trial
162924|NCT02298114|electrical stimulation|electrical stimulation
162925|NCT02298114|intensive care unit|intensive care unit
162926|NCT02298114|muscular atrophy|muscular atrophy
162927|NCT02298101|Aerosol delivery|aerosol delivery
162928|NCT02298101|Lung deposition|lung deposition
162929|NCT02298101|SPECT|spect
162930|NCT02298101|subjects|subjects
162931|NCT02298075|Immune thrombocytopenia|immune thrombocytopenia
162932|NCT02298075|Primary|primary
162933|NCT02298075|Thrombopoietin receptor agonist|thrombopoietin receptor agonist
162934|NCT02298062|Kawasaki disease coronary artery lesion, IVIG- resistant, Infliximab|kawasaki disease coronary artery lesion, ivig- resistant, infliximab
162935|NCT02298049|fMRI|fmri
162936|NCT02298049|reward|reward
162937|NCT02298049|satiation|satiation
162938|NCT02298036|Health Anxiety|health anxiety
162939|NCT02298036|Urgent Care|urgent care
162940|NCT02298036|Medically Unexplained|medically unexplained
162941|NCT02298023|adipose derived mesenchymal stem cell|adipose derived mesenchymal stem cell
162942|NCT02298023|allogeneic stem cell|allogeneic stem cell
162943|NCT02298023|Rotator cuff tear|rotator cuff tear
162944|NCT02297997|sarcopenia|sarcopenia
162945|NCT02297997|cetylpyridinium chloride|cetylpyridinium chloride
162946|NCT02297984|Neuroglobin|neuroglobin
162947|NCT02297984|HIF-α|hif-α
162948|NCT02297984|Acute ischemic stroke|acute ischemic stroke
162949|NCT02297984|Prognosis|prognosis
162950|NCT02297932|Exercise|exercise
162951|NCT02297919|Web-based education, Adolescent, Obesity|web-based education, adolescent, obesity
162952|NCT02297906|Intranasal|intranasal
162953|NCT02297906|Ketorolac|ketorolac
162954|NCT02297906|Pharmacokinetics|pharmacokinetics
162955|NCT02297906|Pediatric|pediatric
162956|NCT02297880|low calorie sweetener satiety, intake, hunger|low calorie sweetener satiety, intake, hunger
162957|NCT02297815|antibiotic use|antibiotic use
162958|NCT02297815|effectiveness|effectiveness
162959|NCT02297815|acute respiratory infections|acute respiratory infections
162960|NCT02297815|pediatrics|pediatrics
162961|NCT02297776|cardiac arrest|cardiac arrest
162962|NCT02297776|biomarker|biomarker
162963|NCT02297776|microRNA|microrna
162964|NCT02297776|circRNA|circrna
162965|NCT02297776|NSE|nse
162966|NCT02297776|CPC|cpc
162967|NCT02297750|The focus of the study is double-wire technique versus single wire technique in patients undergoing ERCP with biliary cannulation as the primary objective.|the focus of the study is double-wire technique versus single wire technique in patients undergoing ercp with biliary cannulation as the primary objective.
162968|NCT02297737|Tai Chi|tai chi
162969|NCT02297698|Breast cancer, NeuVax|breast cancer, neuvax
162970|NCT02297685|Transcutaneous electrical nerve stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
162971|NCT02297685|Interferential currents therapy|interferential currents therapy
162972|NCT02297685|Therapeutic exercises|therapeutic exercises
162973|NCT02297685|Low back pain|low back pain
162974|NCT02297685|Rehabilitation|rehabilitation
162975|NCT02297672|breast cancer|breast cancer
162976|NCT02297672|brachytherapy|brachytherapy
162977|NCT02297672|partial breast radiotherapy|partial breast radiotherapy
162978|NCT02297672|palladium 103|palladium 103
162979|NCT02297659|damage control|damage control
162980|NCT02297659|resuscitation|resuscitation
162981|NCT02297659|laparotomy|laparotomy
162982|NCT02297646|Prevention|prevention
162983|NCT02297646|Exercise|exercise
162984|NCT02297646|Health|health
162985|NCT02297646|Endurance|endurance
162986|NCT02297633|COPD|copd
162987|NCT02297633|reactive oxygen metabolites|reactive oxygen metabolites
162988|NCT02297620|SGLT-2 inhibitor|sglt-2 inhibitor
162989|NCT02297620|Elderly patients|elderly patients
162990|NCT02297620|ASP1941|asp1941
162991|NCT02297607|Esophageal Cancer|esophageal cancer
162992|NCT02297607|Esophagectomy|esophagectomy
162993|NCT02297581|Geriatrics [MeSH]|geriatrics [mesh]
162994|NCT02297581|Osteoporotic fractures [MeSH]|osteoporotic fractures [mesh]
162995|NCT02297581|Hip fractures [MeSH]|hip fractures [mesh]
162996|NCT02297581|Cost benefit analysis [MeSH]|cost benefit analysis [mesh]
162997|NCT02297581|Quality of life [MeSH]|quality of life [mesh]
162998|NCT02297581|Mortality [MeSH]|mortality [mesh]
162999|NCT02297581|Complications|complications
163000|NCT02297568|Breast-fed infant|breast-fed infant
163001|NCT02297568|vitamin D supplementation|vitamin d supplementation
163002|NCT02297568|Lactation|lactation
163003|NCT02297555|Obesity|obesity
163004|NCT02297555|Metabolic Syndrome|metabolic syndrome
163005|NCT02297555|ENDOBARRIER®|endobarrier®
163333|NCT02295267|Walnut|walnut
163007|NCT02297529|unresected, Melanoma, expanded access, EU|unresected, melanoma, expanded access, eu
163008|NCT02297490|Environmental Exposure Chamber|environmental exposure chamber
163009|NCT02297490|Specific Immunotherapy|specific immunotherapy
163010|NCT02297490|SIT|sit
163011|NCT02297490|SCIT|scit
163012|NCT02297464|Risk|risk
163013|NCT02297438|breast cancer|breast cancer
163014|NCT02297438|postmenopausal women|postmenopausal women
163015|NCT02297438|estrogen-receptor positive|estrogen-receptor positive
163016|NCT02297438|HER2 negative|her2 negative
163017|NCT02297438|locoregionally recurrent|locoregionally recurrent
163018|NCT02297438|metastatic|metastatic
163143|NCT02296307|CA-125 Antigen/blood*|ca-125 antigen/blood*
163019|NCT02297425|NSCLC, Non-Small Cell Lung Cancer, EGFRm, Epidermal Grown Factor Receptor mutation|nsclc, non-small cell lung cancer, egfrm, epidermal grown factor receptor mutation
163020|NCT02297399|Colonoscopy|colonoscopy
163021|NCT02297399|Diabetes Mellitus|diabetes mellitus
163022|NCT02297399|Polyethylene glycols|polyethylene glycols
163023|NCT02297399|Ascorbate|ascorbate
163024|NCT02297399|Personal satisfaction|personal satisfaction
163025|NCT02297386|[18F] Dihydro-testosterone|[18f] dihydro-testosterone
163026|NCT02297386|PET Scan|pet scan
163027|NCT02297386|MRI|mri
163028|NCT02297386|14-185|14-185
163029|NCT02297360|Hair loss, hair thinning, women, marine protein supplement|hair loss, hair thinning, women, marine protein supplement
163030|NCT02297334|CytoSorb(TM)|cytosorb(tm)
163031|NCT02297334|cytokines|cytokines
163032|NCT02297334|inflammation|inflammation
163033|NCT02297334|cardiac surgery|cardiac surgery
163034|NCT02297334|extracorporeal bypass|extracorporeal bypass
163035|NCT02297321|tattoos|tattoos
163036|NCT02297321|laser|laser
163037|NCT02297321|whitening|whitening
163038|NCT02297321|patch|patch
163039|NCT02297295|Sequelae of; Amputation, Traumatic, Limb, Lower|sequelae of; amputation, traumatic, limb, lower
163040|NCT02297282|Depression|depression
163041|NCT02297282|Behavioural Activation|behavioural activation
163042|NCT02297269|Deep vein thrombosis|deep vein thrombosis
163043|NCT02297269|Surgery|surgery
163044|NCT02297269|gastrointestinal malignancy|gastrointestinal malignancy
163045|NCT02297230|Locally Advanced Breast Cancer|locally advanced breast cancer
163046|NCT02297191|volunteer|volunteer
163047|NCT02297191|pilot study|pilot study
163048|NCT02297191|adults|adults
163049|NCT02297165|anorexic|anorexic
163050|NCT02297165|olfactory stimulation|olfactory stimulation
163051|NCT02297165|autobiographical memories recovery|autobiographical memories recovery
163052|NCT02297152|Premature ejaculation treatment|premature ejaculation treatment
163053|NCT02297152|Sexual dysfunction|sexual dysfunction
163054|NCT02297152|Intravaginal Ejaculatory Latency time|intravaginal ejaculatory latency time
163055|NCT02297152|Masturbation aid|masturbation aid
163056|NCT02297152|Ejaculatory disorders|ejaculatory disorders
163057|NCT02297113|patients|patients
163058|NCT02297113|departement|departement
163059|NCT02297113|requiring Rapid Sequence Intubation (RSI)|requiring rapid sequence intubation (rsi)
163060|NCT02297100|women|women
163061|NCT02297100|interstitial cystitis|interstitial cystitis
163062|NCT02297100|bladder pain syndrome|bladder pain syndrome
163063|NCT02297100|botox|botox
163064|NCT02297100|onabotulinum toxin A|onabotulinum toxin a
163065|NCT02297074|Bread|bread
163066|NCT02297074|Glycemic index|glycemic index
163067|NCT02297074|Glycemic load|glycemic load
163068|NCT02297074|Insulinemic index|insulinemic index
163069|NCT02297074|Satiety|satiety
163070|NCT02297074|Gastrointestinal hormones|gastrointestinal hormones
163071|NCT02297061|Hip fracture|hip fracture
163072|NCT02297061|Thrombelastography|thrombelastography
163073|NCT02297061|Blood loss|blood loss
163074|NCT02297048|Potassium intake|potassium intake
163075|NCT02297048|Progesterone|progesterone
163076|NCT02297048|steroidogenesis|steroidogenesis
163077|NCT02297048|RU486|ru486
163078|NCT02297048|Synachtene test|synachtene test
163079|NCT02297022|Deep Brain Stimulation|deep brain stimulation
163080|NCT02297022|obesity|obesity
163081|NCT02297022|Prader-Willi syndrome|prader-willi syndrome
163082|NCT02296996|BRAF V600|braf v600
163083|NCT02296996|Rechallenge|rechallenge
163084|NCT02296996|Combination|combination
163085|NCT02296996|Dabrafenib|dabrafenib
163086|NCT02296996|Trametinib|trametinib
163087|NCT02296944|Childrens|childrens
163088|NCT02296944|tempanoplasty|tempanoplasty
163089|NCT02296944|tympanic membrane perforation|tympanic membrane perforation
163090|NCT02296944|retrospective|retrospective
163091|NCT02296944|cohort|cohort
163092|NCT02296918|CLL|cll
163093|NCT02296918|SLL|sll
163094|NCT02296918|PLL|pll
163095|NCT02296918|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
163096|NCT02296918|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
163097|NCT02296918|Prolymphocytic Leukemia|prolymphocytic leukemia
163098|NCT02296918|ACP-196|acp-196
163099|NCT02296918|acalabrutinib|acalabrutinib
163100|NCT02296905|Hepatic Impairment|hepatic impairment
163101|NCT02296905|Hepatitis C Virus Infection|hepatitis c virus infection
163437|NCT02294591|Urine|urine
163102|NCT02296892|Remimazolam, midazolam, bronchoscopy, procedural sedation|remimazolam, midazolam, bronchoscopy, procedural sedation
163103|NCT02296853|Severe Hepatic Impairment|severe hepatic impairment
163104|NCT02296840|analgesia|analgesia
163105|NCT02296840|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
163106|NCT02296840|narcotic-containing pain medication|narcotic-containing pain medication
163107|NCT02296788|Gut Microbiota|gut microbiota
163108|NCT02296775|Rheumatoid arthritis|rheumatoid arthritis
163109|NCT02296775|Rituximab|rituximab
163110|NCT02296775|Pharmacokinetics|pharmacokinetics
163111|NCT02296736|computerised tomography (CT) scan|computerised tomography (ct) scan
163112|NCT02296736|diagnostic accuracy|diagnostic accuracy
163113|NCT02296736|Pancreatic head malignancy|pancreatic head malignancy
163114|NCT02296710|mitral valve|mitral valve
163115|NCT02296710|valve surgery|valve surgery
163116|NCT02296710|echocardiography|echocardiography
163117|NCT02296697|Pressure Ulcer|pressure ulcer
163118|NCT02296697|Low Level Laser Therapy|low level laser therapy
163119|NCT02296697|Dressings|dressings
163120|NCT02296632|Telemedicine|telemedicine
163121|NCT02296632|Patient Reported Outcomes|patient reported outcomes
163122|NCT02296593|lactate|lactate
163123|NCT02296593|continuous lactate monitoring|continuous lactate monitoring
163124|NCT02296593|continuous blood glucose monitoring|continuous blood glucose monitoring
163125|NCT02296593|EIRUS|eirus
163126|NCT02296593|blood glucose|blood glucose
163127|NCT02296593|cardiac surgery|cardiac surgery
163128|NCT02296593|central veinous catheter|central veinous catheter
163129|NCT02296593|microdialysis|microdialysis
163130|NCT02296554|SLAP Repair|slap repair
163131|NCT02296554|Biceps Tenodesis|biceps tenodesis
163132|NCT02296528|Feeding Tube Dependent|feeding tube dependent
163133|NCT02296502|DSM Diagnosis|dsm diagnosis
163134|NCT02296450|Quality of Life (QoL)|quality of life (qol)
163135|NCT02296450|Assessment|assessment
163136|NCT02296450|14-236|14-236
163137|NCT02296450|Patients and Survivors|patients and survivors
163138|NCT02296411|Asthma, Anticholinergics|asthma, anticholinergics
163139|NCT02296385|volunteers|volunteers
163140|NCT02296333|Acetaminophen, ondansetron|acetaminophen, ondansetron
163141|NCT02296307|Aged|aged
163142|NCT02296307|Algorithms|algorithms
163144|NCT02296307|Chi-Square Distribution|chi-square distribution
163145|NCT02296307|Early Detection of Cancer*|early detection of cancer*
163146|NCT02296307|Feasibility Studies|feasibility studies
163147|NCT02296307|Female|female
163148|NCT02296307|Humans|humans
163149|NCT02296307|Logistic Models|logistic models
163150|NCT02296307|Mass Screening/methods*|mass screening/methods*
163151|NCT02296307|Middle Aged|middle aged
163152|NCT02296307|Neoplasm Grading|neoplasm grading
163153|NCT02296307|Neoplasm Invasiveness|neoplasm invasiveness
163154|NCT02296307|Neoplasm Staging|neoplasm staging
163155|NCT02296307|Ovarian Neoplasms/diagnosis*|ovarian neoplasms/diagnosis*
163156|NCT02296307|Ovarian Neoplasms/epidemiology|ovarian neoplasms/epidemiology
163157|NCT02296307|Ovarian Neoplasms/immunology|ovarian neoplasms/immunology
163158|NCT02296307|Ovarian Neoplasms/ultrasonography|ovarian neoplasms/ultrasonography
163159|NCT02296307|Pilot Projects|pilot projects
163160|NCT02296307|Predictive Value of Tests|predictive value of tests
163161|NCT02296307|Prevalence|prevalence
163162|NCT02296307|Prognosis|prognosis
163163|NCT02296307|Prospective Studies|prospective studies
163164|NCT02296307|Quebec/epidemiology|quebec/epidemiology
163165|NCT02296307|Tumor Burden|tumor burden
163166|NCT02296294|Bioimpedance Spectroscopy, Body Composition Monitor, Fluid Therapy|bioimpedance spectroscopy, body composition monitor, fluid therapy
163167|NCT02296268|stroke|stroke
163168|NCT02296268|aerobic exercise|aerobic exercise
163169|NCT02296268|screening|screening
163170|NCT02296268|prescription|prescription
163171|NCT02296255|cervical cancer screening|cervical cancer screening
163172|NCT02296255|young women vaccination|young women vaccination
163173|NCT02296255|impact of HPV vaccination on screening|impact of hpv vaccination on screening
163174|NCT02296216|have been treated or not treated by Gamma Knife Radiosurgery|have been treated or not treated by gamma knife radiosurgery
163175|NCT02296203|cetuximab rechallenge|cetuximab rechallenge
163176|NCT02296177|evidence-based intervention|evidence-based intervention
163177|NCT02296177|mammography|mammography
163178|NCT02296177|underserved population|underserved population
163179|NCT02296164|PROVe|prove
163180|NCT02296164|CTCL|ctcl
163181|NCT02296164|Mechlorethamine|mechlorethamine
163182|NCT02296164|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
163183|NCT02296164|Mycosis fungoides cutaneous T-cell lymphoma|mycosis fungoides cutaneous t-cell lymphoma
163184|NCT02296164|Valchlor|valchlor
163185|NCT02296164|Dermatology|dermatology
163186|NCT02296164|MF-CTCL|mf-ctcl
163187|NCT02296164|Mycosis Fungoides|mycosis fungoides
163188|NCT02296164|Oncology|oncology
163189|NCT02296125|Advanced Non-Small Cell Lung Cancer; EGFRm+; AZD9291; TKI; Phase III|advanced non-small cell lung cancer; egfrm+; azd9291; tki; phase iii
163190|NCT02296099|retropubic suburethral sling|retropubic suburethral sling
163191|NCT02296099|stress urinary incontinence|stress urinary incontinence
163192|NCT02296099|liposomal bupivacaine|liposomal bupivacaine
163193|NCT02296086|Geriatrics [MeSH]|geriatrics [mesh]
163195|NCT02296086|China [MeSH]|china [mesh]
163196|NCT02296086|Early ambulation [MeSH]|early ambulation [mesh]
163197|NCT02296086|Immobilization [MeSH]|immobilization [mesh]
163198|NCT02296073|Pediatric intensive care unit|pediatric intensive care unit
163199|NCT02296073|Sedation|sedation
163200|NCT02296073|Dexmedetomidine|dexmedetomidine
163201|NCT02296073|mechanical ventilation|mechanical ventilation
163202|NCT02296047|COPD, central drive, bronchodilators|copd, central drive, bronchodilators
163203|NCT02296021|helicobacter pylori|helicobacter pylori
163204|NCT02296021|berberine-containing quadruple therapy|berberine-containing quadruple therapy
163205|NCT02296021|bismuth-containing quadruple therapy|bismuth-containing quadruple therapy
163206|NCT02296008|high resolution manometry|high resolution manometry
163207|NCT02296008|children|children
163208|NCT02296008|congenital anorectal disorder|congenital anorectal disorder
163209|NCT02296008|surgery|surgery
163210|NCT02295995|Aged|aged
163211|NCT02295995|Exercise|exercise
163212|NCT02295995|Veterans|veterans
163213|NCT02295995|Adherence|adherence
163214|NCT02295995|Clinical Trials, Randomized|clinical trials, randomized
163215|NCT02295982|Laparoscopic nephrectomy|laparoscopic nephrectomy
163216|NCT02295982|one day surgery|one day surgery
163217|NCT02295969|Rhinitis|rhinitis
163218|NCT02295969|Conjunctivitis|conjunctivitis
163219|NCT02295969|Grass pollen|grass pollen
163220|NCT02295969|Sublingual tablet|sublingual tablet
163221|NCT02295969|Allergen immunotherapy|allergen immunotherapy
163222|NCT02295969|Safety|safety
163223|NCT02295956|Pancreatic Cancer|pancreatic cancer
163224|NCT02295956|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
163225|NCT02295956|Preoperative therapy|preoperative therapy
163226|NCT02295956|Questionnaires|questionnaires
163227|NCT02295956|Surveys|surveys
163228|NCT02295956|Exercises|exercises
163229|NCT02295956|Stretching|stretching
163230|NCT02295956|Walking|walking
163231|NCT02295956|Nutrition counseling|nutrition counseling
163232|NCT02295956|Resistance exercise bands|resistance exercise bands
163233|NCT02295956|Phone calls|phone calls
163234|NCT02295956|Booklet|booklet
163235|NCT02295956|Pamphlet|pamphlet
163236|NCT02295930|colorectal cancer,|colorectal cancer,
163237|NCT02295930|bevacizumab|bevacizumab
163238|NCT02295930|cetuximab|cetuximab
163239|NCT02295930|folfoxiri|folfoxiri
163240|NCT02295930|kras wild type|kras wild type
163241|NCT02295904|perineum|perineum
163242|NCT02295904|videoanalysis|videoanalysis
163243|NCT02295865|Psoriasis|psoriasis
163244|NCT02295865|Toreforant|toreforant
163245|NCT02295865|JNJ-38518168|jnj-38518168
163246|NCT02295852|Low-sodium calcium enriched diet|low-sodium calcium enriched diet
163247|NCT02295852|Low-sodium diet|low-sodium diet
163248|NCT02295852|Glucose and lipid metabolims|glucose and lipid metabolims
163249|NCT02295839|Sleep|sleep
163250|NCT02295839|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
163251|NCT02295839|Fatigue|fatigue
163252|NCT02295839|Sleep hygiene|sleep hygiene
163253|NCT02295839|Relaxation|relaxation
163254|NCT02295839|RCT|rct
163255|NCT02295800|HIV|hiv
163256|NCT02295800|PMTCT|pmtct
163257|NCT02295800|Antenatal Care|antenatal care
163258|NCT02295787|Depression|depression
163259|NCT02295787|Suicide|suicide
163260|NCT02295787|Suicidal Ideation|suicidal ideation
163261|NCT02295787|Ketamine|ketamine
163262|NCT02295787|Late-Life|late-life
163263|NCT02295761|motor activity|motor activity
163264|NCT02295761|obesity|obesity
163265|NCT02295761|overweight|overweight
163266|NCT02295761|intervention study|intervention study
163267|NCT02295761|health promotion|health promotion
163268|NCT02295761|lifestyle counseling|lifestyle counseling
163269|NCT02295761|adherence|adherence
163270|NCT02295735|Skin, safety, wounds, intensive care|skin, safety, wounds, intensive care
163271|NCT02295722|eligible for high-dose therapy and stem cell transplantation|eligible for high-dose therapy and stem cell transplantation
163272|NCT02295709|ultrasound|ultrasound
163273|NCT02295709|cervical Transformational Epidural Steroid Injection|cervical transformational epidural steroid injection
163274|NCT02295696|Adults, dialogue tools, outpatient clinic visits|adults, dialogue tools, outpatient clinic visits
163275|NCT02295644|Therapeutic ultrasound|therapeutic ultrasound
163276|NCT02295592|hemorrhoids|hemorrhoids
163277|NCT02295592|The recurrence rate|the recurrence rate
163279|NCT02295592|TSTstarr+|tststarr+
163280|NCT02295566|Nitric Oxide|nitric oxide
163281|NCT02295566|Pseudomonas Aeruginosa|pseudomonas aeruginosa
163282|NCT02295566|Biofilm|biofilm
163283|NCT02295553|Ketamine|ketamine
163284|NCT02295553|Propofol|propofol
163285|NCT02295553|Children|children
163286|NCT02295553|Pediatrics|pediatrics
163287|NCT02295553|Upper endoscopy|upper endoscopy
163288|NCT02295514|Sepsis|sepsis
163289|NCT02295514|Septic shock|septic shock
163290|NCT02295501|Pathogen inactivation|pathogen inactivation
163291|NCT02295501|ebola|ebola
163292|NCT02295501|convalescent plasma|convalescent plasma
163293|NCT02295501|EBOV|ebov
163294|NCT02295501|amotosalen|amotosalen
163295|NCT02295501|Provide access to the potential therapeutic benefit of EBOV convalescent plasma containing antibodies to EBOV.|provide access to the potential therapeutic benefit of ebov convalescent plasma containing antibodies to ebov.
163296|NCT02295488|hymenoptera puncture|hymenoptera puncture
163297|NCT02295462|nursing homes|nursing homes
163298|NCT02295462|person-centered care|person-centered care
163299|NCT02295462|inappropriate prescriptions|inappropriate prescriptions
163300|NCT02295462|cluster-randomised controlled trial|cluster-randomised controlled trial
163301|NCT02295462|antipsychotic drugs|antipsychotic drugs
163302|NCT02295449|Prostate cancer|prostate cancer
163303|NCT02295449|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
163304|NCT02295436|minodronic acid|minodronic acid
163305|NCT02295436|pharmacokinetics|pharmacokinetics
163306|NCT02295436|tolerability|tolerability
163307|NCT02295436|food|food
163308|NCT02295436|age|age
163309|NCT02295436|Chinese subjects|chinese subjects
163310|NCT02295410|Assessment, PTSD, Veterans|assessment, ptsd, veterans
163311|NCT02295397|Food provocation|food provocation
163312|NCT02295397|Matrix effect|matrix effect
163313|NCT02295397|ED05|ed05
163314|NCT02295397|Allergy|allergy
163315|NCT02295397|Proton Pump Inhibitor|proton pump inhibitor
163316|NCT02295384|Polypharmacy|polypharmacy
163317|NCT02295384|Medication Therapy Management|medication therapy management
163318|NCT02295371|Drug therapy|drug therapy
163319|NCT02295371|Patient safety|patient safety
163320|NCT02295371|Polydrug therapy|polydrug therapy
163321|NCT02295319|Discharge|discharge
163322|NCT02295319|Acute Admission Unit|acute admission unit
163323|NCT02295319|Randomized Controlled Trial|randomized controlled trial
163324|NCT02295306|OSA, polysomnography, ExSpiron monitor|osa, polysomnography, exspiron monitor
163325|NCT02295293|Rhus|rhus
163326|NCT02295293|Cholesterol|cholesterol
163327|NCT02295293|Triglycerides|triglycerides
163328|NCT02295293|Lipids|lipids
163329|NCT02295293|Medicine, Traditional|medicine, traditional
163336|NCT02295241|Sarcopenia, muscles, aging|sarcopenia, muscles, aging
163337|NCT02295228|Vitamin D, Vitamin D deficiency, Hip Arthroplasty|vitamin d, vitamin d deficiency, hip arthroplasty
163338|NCT02295215|chagas disease|chagas disease
163339|NCT02295215|exercise|exercise
163340|NCT02295215|baroreflex sensitivity|baroreflex sensitivity
163341|NCT02295163|Stellate ganglion block|stellate ganglion block
163342|NCT02295163|hot flushes|hot flushes
163343|NCT02295163|androgen deprivation therapy|androgen deprivation therapy
163344|NCT02295163|prostate cancer|prostate cancer
163345|NCT02295150|Nadroparin|nadroparin
163346|NCT02295150|Anti-Xa activity|anti-xa activity
163347|NCT02295124|Nausea|nausea
163348|NCT02295111|electro-acupuncture|electro-acupuncture
163349|NCT02295111|chronic pelvic pain|chronic pelvic pain
163350|NCT02295111|patient practitioner interactions|patient practitioner interactions
163351|NCT02295111|TCM health consultation|tcm health consultation
163352|NCT02295111|meridian balanced method acupuncture|meridian balanced method acupuncture
163353|NCT02295085|Cohort, Prospective, Biospecimens|cohort, prospective, biospecimens
163354|NCT02295072|Exercise-based Randomized Controlled Trial|exercise-based randomized controlled trial
163355|NCT02295072|Brain structure|brain structure
163356|NCT02295072|Brain function|brain function
163357|NCT02295072|Cognitive function|cognitive function
163358|NCT02295072|Physical fitness|physical fitness
163359|NCT02295072|Body Mass Index|body mass index
163360|NCT02295072|Cardiovascular disease risk factors|cardiovascular disease risk factors
163361|NCT02295072|Mental health|mental health
163362|NCT02295072|Stress|stress
163363|NCT02295072|Neurology|neurology
163364|NCT02295072|Obesity|obesity
163365|NCT02295072|brain|brain
163366|NCT02295072|risk factors|risk factors
163367|NCT02295072|bone|bone
163368|NCT02295072|bones|bones
163369|NCT02295072|body composition|body composition
163370|NCT02295059|Breast cancer|breast cancer
163371|NCT02295059|ERPR negative|erpr negative
163372|NCT02295059|HER-2/neu overexpression positive or negative|her-2/neu overexpression positive or negative
163373|NCT02295033|Boost versus no boost irradiation of early breast cancer|boost versus no boost irradiation of early breast cancer
163374|NCT02294955|catheter ablation|catheter ablation
163375|NCT02294955|atrial fibrillation|atrial fibrillation
163376|NCT02294942|RNTA06|rnta06
163377|NCT02294942|RANCAD|rancad
163378|NCT02294929|catheter ablation|catheter ablation
163379|NCT02294929|cryoballoon|cryoballoon
163380|NCT02294903|Focal radiofrequency ablation|focal radiofrequency ablation
163381|NCT02294903|Prostate cancer|prostate cancer
163382|NCT02294903|Encage|encage
163383|NCT02294864|focus: pulsed radiofrequency (E02.779.468.599)|focus: pulsed radiofrequency (e02.779.468.599)
163389|NCT02294812|Hearing Loss|hearing loss
163390|NCT02294812|Speech Perception|speech perception
163391|NCT02294812|Cognitive Training|cognitive training
163392|NCT02294812|Cognitive Fitness|cognitive fitness
163393|NCT02294812|Memory, Short-Term|memory, short-term
163394|NCT02294799|Temporomandibular Joint Disorders|temporomandibular joint disorders
163395|NCT02294799|Magnetic Ressonance Imaging|magnetic ressonance imaging
163396|NCT02294799|Complementary Therapy|complementary therapy
163397|NCT02294799|Physical Therapy Modalities.|physical therapy modalities.
163399|NCT02294786|Octreotide|octreotide
163400|NCT02294786|Diarrhoea|diarrhoea
163401|NCT02294786|Phase II|phase ii
163402|NCT02294786|Capecitabine|capecitabine
163403|NCT02294786|Quality of life|quality of life
163404|NCT02294786|Metastatic breast cancer|metastatic breast cancer
163405|NCT02294786|HER2|her2
163406|NCT02294786|Lapatinib|lapatinib
163407|NCT02294786|Diarrhoea diary|diarrhoea diary
163408|NCT02294773|Infertility|infertility
163409|NCT02294773|Intrauterine insemination|intrauterine insemination
163410|NCT02294773|Luteinizing hormone surge|luteinizing hormone surge
163411|NCT02294760|Irritable Bowel Syndrome|irritable bowel syndrome
163412|NCT02294760|Sacral Nerve Stimulation|sacral nerve stimulation
163413|NCT02294760|Symptoms|symptoms
163414|NCT02294760|Quality of Life|quality of life
163415|NCT02294734|functional respiratory capacity|functional respiratory capacity
163416|NCT02294734|High-resolution computed tomography|high-resolution computed tomography
163417|NCT02294734|GSK2269557|gsk2269557
163418|NCT02294734|acute exacerbation of COPD|acute exacerbation of copd
163419|NCT02294734|lung capacity|lung capacity
163420|NCT02294708|macula-off retinal detachment|macula-off retinal detachment
163421|NCT02294708|scleral buckle|scleral buckle
163422|NCT02294708|persistent sub-foveal fluid|persistent sub-foveal fluid
163423|NCT02294708|postoperative postures|postoperative postures
163424|NCT02294708|optical coherence tomography (OCT)|optical coherence tomography (oct)
163425|NCT02294695|Empiric antibiotic therapy|empiric antibiotic therapy
163426|NCT02294682|uncomplicated urogenital gonorrhea|uncomplicated urogenital gonorrhea
163427|NCT02294682|Bacterial Type II Topoisomerase Inhibitors (BTI)|bacterial type ii topoisomerase inhibitors (bti)
163428|NCT02294682|antibiotics|antibiotics
163429|NCT02294682|GSK2140944|gsk2140944
163430|NCT02294682|N. gonorrhoeae|n. gonorrhoeae
163431|NCT02294656|CYSTOID MACULAR EDEMA|cystoid macular edema
163432|NCT02294643|sarpogrelate|sarpogrelate
163433|NCT02294591|Bipolar Disorder|bipolar disorder
163434|NCT02294591|Depression|depression
163435|NCT02294591|Acetylcystein|acetylcystein
163436|NCT02294591|Oxidative Stress|oxidative stress
163438|NCT02294578|Biomarkers|biomarkers
163439|NCT02294578|saliva|saliva
163440|NCT02294578|mRNA|mrna
163441|NCT02294565|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
163442|NCT02294565|Breast Cancer|breast cancer
163443|NCT02294565|Lymphatic Mapping|lymphatic mapping
163444|NCT02294552|Cyclophosphamide|cyclophosphamide
163445|NCT02294552|Leukemia|leukemia
163446|NCT02294552|Lymphoma|lymphoma
163447|NCT02294552|Myelodysplastic Syndromes|myelodysplastic syndromes
163448|NCT02294552|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
163449|NCT02294552|Immunosuppressive Agents|immunosuppressive agents
163450|NCT02294552|Immune System Diseases|immune system diseases
163451|NCT02294552|Busulfan|busulfan
163452|NCT02294552|Fludarabine|fludarabine
163453|NCT02294552|Tacrolimus|tacrolimus
163454|NCT02294552|Mycophenolate mofetil|mycophenolate mofetil
163455|NCT02294552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
163456|NCT02294552|Myeloablative Agonists|myeloablative agonists
163457|NCT02294552|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
163458|NCT02294552|Allogeneic|allogeneic
163459|NCT02294526|Diet|diet
163460|NCT02294526|Sardine|sardine
198377|NCT02123498|ETD|etd
163461|NCT02294526|Type 2 diabetes|type 2 diabetes
163462|NCT02294513|Alzheimer disease|alzheimer disease
163463|NCT02294513|Dementia|dementia
163464|NCT02294513|Hearing loss|hearing loss
163465|NCT02294513|Correction of hearing impairment|correction of hearing impairment
163466|NCT02294513|Hearing aids|hearing aids
163467|NCT02294513|Communication|communication
163468|NCT02294513|Family caregivers|family caregivers
163469|NCT02294513|Third-party disability|third-party disability
163470|NCT02294500|ovarian function|ovarian function
163471|NCT02294500|female|female
163472|NCT02294500|Genital Function|genital function
163473|NCT02294487|influenza|influenza
163474|NCT02294487|pneumococcal|pneumococcal
163475|NCT02294487|pneumonia|pneumonia
163476|NCT02294487|vaccine|vaccine
163477|NCT02294487|immunization|immunization
163478|NCT02294487|#CAImmun|#caimmun
163479|NCT02294487|Immuno-oncology|immuno-oncology
163480|NCT02294487|supportive care|supportive care
163481|NCT02294487|vaccination|vaccination
163482|NCT02294487|meningococcal|meningococcal
163483|NCT02294487|HIB|hib
163484|NCT02294461|Enzalutamide|enzalutamide
163485|NCT02294461|Androgen receptor|androgen receptor
163486|NCT02294461|Prostate cancer|prostate cancer
163487|NCT02294461|Xtandi|xtandi
163488|NCT02294448|Cervical radiculopathy|cervical radiculopathy
163489|NCT02294448|Neck pain|neck pain
163490|NCT02294448|Qishe pill|qishe pill
163491|NCT02294448|raditional Chinese medicine|raditional chinese medicine
163492|NCT02294448|healthy Chinese subject|healthy chinese subject
163493|NCT02294448|Population Pharmacokinetics|population pharmacokinetics
163494|NCT02294448|Personalized Medicine|personalized medicine
163495|NCT02294448|Individualized Medicine|individualized medicine
163496|NCT02294435|Thoracoabdominal Aneurysms|thoracoabdominal aneurysms
163497|NCT02294435|Endovascular|endovascular
163498|NCT02294435|Ps-ide|ps-ide
163499|NCT02294435|Early Feasibility|early feasibility
163500|NCT02294435|Aneurysm|aneurysm
163501|NCT02294435|Aortic Aneurysm, Thoracic|aortic aneurysm, thoracic
163502|NCT02294435|Aortic Aneurysm|aortic aneurysm
163503|NCT02294435|Aortic Diseases|aortic diseases
163504|NCT02294435|Cardiovascular Diseases|cardiovascular diseases
163505|NCT02294435|Vascular Diseases|vascular diseases
163506|NCT02294435|Pararenal aneurysm|pararenal aneurysm
163507|NCT02294435|Juxtarenal aneurysm|juxtarenal aneurysm
163508|NCT02294435|Aortic dissection|aortic dissection
163509|NCT02294435|Short neck infrarenal aneurysm|short neck infrarenal aneurysm
163510|NCT02294435|Type 4 thoracoabdominal|type 4 thoracoabdominal
163511|NCT02294435|TAAA|taaa
163512|NCT02294422|Loss of resistance|loss of resistance
163513|NCT02294422|Pilot balloon|pilot balloon
163514|NCT02294422|Cuff pressure|cuff pressure
163515|NCT02294422|Endotracheal tube|endotracheal tube
163516|NCT02294409|social anxiety|social anxiety
163517|NCT02294409|psychosis|psychosis
163519|NCT02294409|randomized|randomized
163520|NCT02294409|CRT|crt
163521|NCT02294396|Anticholinergic|anticholinergic
163522|NCT02294396|Overactive Bladder (OAB)|overactive bladder (oab)
163523|NCT02294396|Mirabegron|mirabegron
163524|NCT02294396|YM178|ym178
163525|NCT02294383|Pelvic Floor Biomechanics|pelvic floor biomechanics
163526|NCT02294383|Tissue Elasticity|tissue elasticity
163527|NCT02294383|Tactile Imaging|tactile imaging
163528|NCT02294370|type 2 diabetes|type 2 diabetes
163529|NCT02294370|continuous glucose monitoring|continuous glucose monitoring
163530|NCT02294357|carfilzomib|carfilzomib
163531|NCT02294357|proteasome inhibitor|proteasome inhibitor
163532|NCT02294357|multiple myeloma|multiple myeloma
163533|NCT02294357|relapsed/refractory|relapsed/refractory
163534|NCT02294344|double filtration plasmapheresis|double filtration plasmapheresis
163535|NCT02294344|ANCA-Associated Vasculitis|anca-associated vasculitis
163536|NCT02294305|Depression|depression
163537|NCT02294305|Social Anxiety|social anxiety
163538|NCT02294305|Social Phobia|social phobia
163539|NCT02294305|Major Depression|major depression
163540|NCT02294305|Vortioxetine|vortioxetine
163541|NCT02294279|cough, wheeze, dyspnoea|cough, wheeze, dyspnoea
163544|NCT02294214|malaria|malaria
163545|NCT02294214|Spatial Repellents|spatial repellents
163546|NCT02294214|Plasmodium|plasmodium
163547|NCT02294201|Malaria|malaria
163548|NCT02294201|Spatial Repellents|spatial repellents
163549|NCT02294201|Plasmodium|plasmodium
163550|NCT02294188|Malaria|malaria
163551|NCT02294188|Spatial Repellents|spatial repellents
163552|NCT02294188|Plasmodium|plasmodium
163553|NCT02294175|larva|larva
163554|NCT02294175|debridement|debridement
163555|NCT02294175|lower extremity or diabetic foot ulcer|lower extremity or diabetic foot ulcer
163556|NCT02294175|biofilm|biofilm
163557|NCT02294175|infection|infection
163558|NCT02294175|chronic wound|chronic wound
163559|NCT02294149|chemotherapy|chemotherapy
163560|NCT02294149|Omega 3|omega 3
163561|NCT02294136|HIV|hiv
163562|NCT02294136|HCV|hcv
163563|NCT02294136|Adherence|adherence
163564|NCT02294136|Psychiatric|psychiatric
163565|NCT02294136|Behavioral|behavioral
163566|NCT02294136|Intervention|intervention
163567|NCT02294110|failure|failure
163568|NCT02294110|spinal anesthesia|spinal anesthesia
163569|NCT02294071|acetaminophen|acetaminophen
163570|NCT02294071|ibuprofen|ibuprofen
163571|NCT02294058|MS|ms
163572|NCT02294058|RMS|rms
163573|NCT02294058|Multiple Sclerosis|multiple sclerosis
163574|NCT02294058|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
163575|NCT02294045|Knee|knee
163576|NCT02294045|Healthy|healthy
163577|NCT02294045|arthroscopy|arthroscopy
163578|NCT02294045|MRI|mri
163579|NCT02294045|amplification|amplification
163580|NCT02294045|sounds|sounds
163581|NCT02294045|pre-operative|pre-operative
163582|NCT02294045|analyzing|analyzing
163583|NCT02294032|Bcells|bcells
163584|NCT02294032|kidney allograft dysfunction|kidney allograft dysfunction
163585|NCT02294032|antibody mediated rejection|antibody mediated rejection
163586|NCT02294019|ibuprofen 400 mg|ibuprofen 400 mg
163587|NCT02294019|actual use|actual use
163588|NCT02294019|compliance|compliance
163589|NCT02294006|pancreatic|pancreatic
163590|NCT02294006|neuroendocrine|neuroendocrine
163591|NCT02294006|everolimus|everolimus
163592|NCT02294006|metformin|metformin
163593|NCT02294006|octreotide|octreotide
163594|NCT02293941|liver inflammation|liver inflammation
163595|NCT02293928|Hybrid coronary revascularization|hybrid coronary revascularization
163596|NCT02293928|Antiplatelet therapy|antiplatelet therapy
163597|NCT02293928|Aspirin|aspirin
163598|NCT02293928|Clopidogrel|clopidogrel
163599|NCT02293889|Knee osteoarthritis|knee osteoarthritis
163600|NCT02293889|Pain|pain
163601|NCT02293889|Vitamin D|vitamin d
163602|NCT02293889|Physical activity|physical activity
163603|NCT02293889|Pilot study|pilot study
163604|NCT02293889|Qualitative Interview|qualitative interview
163605|NCT02293889|Obesity|obesity
163607|NCT02293876|Corneal Diseases|corneal diseases
163608|NCT02293876|Corneal Ulcer|corneal ulcer
163609|NCT02293876|Nursing Diagnosis|nursing diagnosis
163610|NCT02293876|Intensive Care Units|intensive care units
163611|NCT02293876|Nursing|nursing
163612|NCT02293876|Randomized Clinical Trial|randomized clinical trial
163614|NCT02293824|Infant, Premature|infant, premature
163615|NCT02293824|Caffeine|caffeine
163616|NCT02293824|Pharmacokinetics|pharmacokinetics
163617|NCT02293824|Metabolism|metabolism
163618|NCT02293772|Bedrest|bedrest
163619|NCT02293772|Appetite|appetite
163620|NCT02293759|BPH- LASER- PROSTATE- BLEEDING TENDENCY|bph- laser- prostate- bleeding tendency
163621|NCT02293746|Obstructive Sleep Apnea|obstructive sleep apnea
163622|NCT02293746|OSA|osa
163623|NCT02293746|neurostimulation|neurostimulation
163624|NCT02293746|hypoglossal nerve|hypoglossal nerve
163625|NCT02293746|tongue|tongue
163626|NCT02293746|upper airway stimulation|upper airway stimulation
163627|NCT02293746|surgery|surgery
163628|NCT02293733|Retrospective|retrospective
163630|NCT02293733|mutation|mutation
163631|NCT02293733|TKI|tki
163632|NCT02293733|NSCLC|nsclc
163636|NCT02293694|DMPA-SC: depo medroxyprogesterone acetate sub-cutaneous|dmpa-sc: depo medroxyprogesterone acetate sub-cutaneous
163637|NCT02293694|DMPA-IM: depo medroxyprogesterone acetate intramuscular|dmpa-im: depo medroxyprogesterone acetate intramuscular
163638|NCT02293681|Spondylitis, Ankylosing|spondylitis, ankylosing
163639|NCT02293681|Infliximab|infliximab
163640|NCT02293681|Non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
401977|NCT01232478|Skills Remediation|skills remediation
163641|NCT02293681|Disease-modifying anti-rheumatic drugs|disease-modifying anti-rheumatic drugs
163642|NCT02293668|poor responders|poor responders
163643|NCT02293655|ADHD|adhd
163644|NCT02293655|inattention|inattention
163645|NCT02293655|hyperactivity|hyperactivity
163646|NCT02293655|methylphenidate|methylphenidate
163647|NCT02293642|primary cancers of the breast|primary cancers of the breast
163648|NCT02293642|primary cancers of the kidney|primary cancers of the kidney
163649|NCT02293642|primary cancers of the lung|primary cancers of the lung
163650|NCT02293642|primary cancers of the prostate|primary cancers of the prostate
163651|NCT02293629|Subjects|subjects
163652|NCT02293616|ICU|icu
163653|NCT02293616|Respiratory Failure|respiratory failure
163654|NCT02293616|Weakness|weakness
163655|NCT02293616|Nitrate supplementation|nitrate supplementation
163656|NCT02293603|cardiomyopathy|cardiomyopathy
163657|NCT02293603|cardiosphere-derived stem cells|cardiosphere-derived stem cells
163658|NCT02293603|intracoronary infusion|intracoronary infusion
163659|NCT02293603|adult stem cells|adult stem cells
163660|NCT02293603|heart disease|heart disease
163661|NCT02293603|ventricular dysfunction|ventricular dysfunction
163662|NCT02293603|pathological processes|pathological processes
163663|NCT02293603|cardiovascular diseases|cardiovascular diseases
163664|NCT02293603|heart failure|heart failure
163665|NCT02293590|Certolizumab pegol|certolizumab pegol
163666|NCT02293590|DMARD|dmard
163667|NCT02293590|Joint injection|joint injection
163668|NCT02293590|Glucocorticoids|glucocorticoids
163669|NCT02293564|Erosive Osteoarthritis|erosive osteoarthritis
163670|NCT02293564|Osteoarthritis|osteoarthritis
155297|NCT02341326|Lung|lung
163671|NCT02293564|Osteoarthritis of the Hand|osteoarthritis of the hand
163672|NCT02293538|Symptoms of Contact Lens Related Discomfort|symptoms of contact lens related discomfort
163673|NCT02293512|Tinnitus|tinnitus
163674|NCT02293512|Coping|coping
163675|NCT02293512|Psychoeducational intervention|psychoeducational intervention
163676|NCT02293499|asthma|asthma
163677|NCT02293499|adolescent|adolescent
163678|NCT02293499|intervention|intervention
163679|NCT02293486|Antioxidants|antioxidants
163680|NCT02293486|Protein Carbonylation|protein carbonylation
163681|NCT02293486|Malondialdehyde|malondialdehyde
163682|NCT02293486|Punicaceae|punicaceae
163683|NCT02293486|Athletic Performance|athletic performance
163787|NCT02292979|HL|hl
163684|NCT02293460|Peripheral neuropathy|peripheral neuropathy
163685|NCT02293460|Disimmune disease|disimmune disease
163686|NCT02293460|Neurology Chronic disease|neurology chronic disease
163687|NCT02293460|Rare disease|rare disease
163688|NCT02293447|Uterine|uterine
163689|NCT02293447|Fibroid|fibroid
163690|NCT02293447|Embolization|embolization
163691|NCT02293447|Leiomyoma|leiomyoma
163692|NCT02293447|Lidocaine|lidocaine
163693|NCT02293447|Pain|pain
163694|NCT02293434|Malnutrition|malnutrition
163695|NCT02293434|Status Nutritional Weight|status nutritional weight
163696|NCT02293434|Pediatric intensive care|pediatric intensive care
163697|NCT02293408|MPS IIIB|mps iiib
163698|NCT02293408|Mucopolysaccharidosis|mucopolysaccharidosis
163699|NCT02293408|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
163700|NCT02293408|Sanfilippo Syndrome|sanfilippo syndrome
163701|NCT02293395|Acute Coronary Syndrome|acute coronary syndrome
163702|NCT02293395|Myocardial infarction|myocardial infarction
163703|NCT02293395|Unstable angina|unstable angina
163704|NCT02293395|Acetylsalicylic acid|acetylsalicylic acid
163705|NCT02293395|Rivaroxaban|rivaroxaban
163706|NCT02293395|JNJ-39039039|jnj-39039039
163707|NCT02293395|Bay 59-7939|bay 59-7939
163709|NCT02293395|Clopidogrel|clopidogrel
163710|NCT02293395|Ticagrelor|ticagrelor
163711|NCT02293395|Plavix|plavix
163712|NCT02293395|Brilinta|brilinta
163713|NCT02293395|Effient|effient
163714|NCT02293382|MPS IIIB|mps iiib
163715|NCT02293382|Mucopolysaccharodosis III|mucopolysaccharodosis iii
163716|NCT02293382|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
163717|NCT02293382|Sanfilippo Syndrome|sanfilippo syndrome
163718|NCT02293343|histamine profile|histamine profile
163719|NCT02293343|IgE Antibodies|ige antibodies
163720|NCT02293330|continuous versus intermittent bolus sciatic nerve block|continuous versus intermittent bolus sciatic nerve block
163721|NCT02293317|Influenza Prime universal vaccine M-001 Multimeric|influenza prime universal vaccine m-001 multimeric
163722|NCT02293291|Gulf war illness|gulf war illness
163723|NCT02293278|MVPA|mvpa
163724|NCT02293278|sedentary behaviour|sedentary behaviour
163725|NCT02293278|PA intervention|pa intervention
163726|NCT02293278|preschool|preschool
163727|NCT02293278|gross motor|gross motor
163728|NCT02293278|anthropometrics|anthropometrics
163729|NCT02293278|day care|day care
163730|NCT02293265|mepolizumab|mepolizumab
163731|NCT02293265|omalizumab|omalizumab
163732|NCT02293265|SB-240563|sb-240563
163733|NCT02293265|Severe Asthma|severe asthma
163734|NCT02293265|reslizumab|reslizumab
163735|NCT02293252|Home Telemonitoring|home telemonitoring
163736|NCT02293239|whole-body electromyostimulation|whole-body electromyostimulation
163737|NCT02293239|cachexia|cachexia
163738|NCT02293239|cancer|cancer
163739|NCT02293239|skeletal muscle mass|skeletal muscle mass
163740|NCT02293239|nutrition|nutrition
163741|NCT02293213|Category D|category d
163742|NCT02293213|Category X|category x
163743|NCT02293213|Electronic Medical Records|electronic medical records
163744|NCT02293213|Long Acting Reversible Contraception|long acting reversible contraception
163745|NCT02293187|vitamin D|vitamin d
163746|NCT02293187|muscle performance|muscle performance
163748|NCT02293161|Interleukin-7 Receptor α|interleukin-7 receptor α
163749|NCT02293161|monoclonal antibody|monoclonal antibody
163750|NCT02293148|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
163751|NCT02293148|GSK1278863|gsk1278863
163752|NCT02293148|Anemia|anemia
163753|NCT02293148|QTc|qtc
163754|NCT02293148|erythropoiesis stimulating agent|erythropoiesis stimulating agent
163755|NCT02293135|Type 2 diabetes ; endothelium stimulation|type 2 diabetes ; endothelium stimulation
163756|NCT02293122|Agreement|agreement
163757|NCT02293122|Repeatability|repeatability
163758|NCT02293122|Reproducibility|reproducibility
163759|NCT02293096|Genotype|genotype
163760|NCT02293096|CYP2D6|cyp2d6
163761|NCT02293096|ADRB1|adrb1
163762|NCT02293057|Adolescent|adolescent
163763|NCT02293057|Juvenile Justice|juvenile justice
163764|NCT02293057|Drug Use|drug use
163765|NCT02293057|Marijuana|marijuana
163766|NCT02293057|Gender Responsive|gender responsive
163767|NCT02293057|Girls|girls
163768|NCT02293057|HIV|hiv
163769|NCT02293057|Sexual Risk|sexual risk
163770|NCT02293044|Sensitivity|sensitivity
163771|NCT02293031|maxillofacial bone defects|maxillofacial bone defects
163772|NCT02293031|alveolar ridge atrophy|alveolar ridge atrophy
163773|NCT02293031|gene-activated matrix|gene-activated matrix
163774|NCT02293031|VEGF gene|vegf gene
163775|NCT02293031|DNA plasmid|dna plasmid
163776|NCT02293031|bone gene therapy|bone gene therapy
163777|NCT02293005|Lung Cancer|lung cancer
163778|NCT02293005|Mesothelioma|mesothelioma
163779|NCT02293005|Unresectable malignant pleural mesothelioma|unresectable malignant pleural mesothelioma
163780|NCT02293005|MPM|mpm
163781|NCT02293005|Alisertib|alisertib
163782|NCT02293005|MLN8237|mln8237
163783|NCT02292992|Electrical impedance tomography|electrical impedance tomography
163784|NCT02292992|Nasal Pillow Continuous Positive Airway Pressure(CPAP)|nasal pillow continuous positive airway pressure(cpap)
163785|NCT02292992|High Flow Nasal Cannula|high flow nasal cannula
163786|NCT02292992|extubation|extubation
163788|NCT02292966|Hepatitis C|hepatitis c
163789|NCT02292966|Hepatitis|hepatitis
163790|NCT02292966|Asunaprevir|asunaprevir
163791|NCT02292966|Daclatasvir|daclatasvir
163792|NCT02292966|Beclabuvir|beclabuvir
163793|NCT02292966|Neurocognitive function|neurocognitive function
163794|NCT02292966|Brain metabolites|brain metabolites
163795|NCT02292966|Direct acting antiviral therapy|direct acting antiviral therapy
163796|NCT02292953|ICSI|icsi
163797|NCT02292953|Ovum Pickup|ovum pickup
163798|NCT02292953|Embryo Transfer|embryo transfer
163799|NCT02292940|patient outcome assessment|patient outcome assessment
163800|NCT02292940|electronic health records|electronic health records
163801|NCT02292888|Doppler VTI TEE SV volume responsiveness|doppler vti tee sv volume responsiveness
163802|NCT02292875|Grass Allergy|grass allergy
163803|NCT02292875|Rhinoconjunctivitis|rhinoconjunctivitis
163804|NCT02292875|Environmental Exposure Unit|environmental exposure unit
163805|NCT02292875|Immunotherapy|immunotherapy
163806|NCT02292875|ToleroMune Grass|toleromune grass
163807|NCT02292849|Depression|depression
163808|NCT02292823|STEMI|stemi
163809|NCT02292823|heart attack|heart attack
163811|NCT02292823|Bare Metal Stent|bare metal stent
163812|NCT02292823|myocardial infarction|myocardial infarction
163813|NCT02292823|PCI|pci
163814|NCT02292784|infants|infants
163815|NCT02292784|retosiban|retosiban
163816|NCT02292784|Preterm Labor|preterm labor
163817|NCT02292784|long-term safety follow-up|long-term safety follow-up
163818|NCT02292771|Spontaneous Preterm Labor|spontaneous preterm labor
163819|NCT02292771|retosiban|retosiban
163820|NCT02292771|GSK221149|gsk221149
163821|NCT02292771|atosiban|atosiban
163822|NCT02292745|locally advanced pancreatic cancer|locally advanced pancreatic cancer
163823|NCT02292745|chemotherapy|chemotherapy
163824|NCT02292745|stereotactic radiotherapy|stereotactic radiotherapy
163825|NCT02292732|Pharmacokinetics|pharmacokinetics
163826|NCT02292732|Solid Tumors|solid tumors
163827|NCT02292732|Safety|safety
163828|NCT02292732|Trametinib|trametinib
163829|NCT02292732|MEK Inhibitor|mek inhibitor
163830|NCT02292732|Combined Oral Contraceptive|combined oral contraceptive
163831|NCT02292732|Trametinib's Metabolite M5|trametinib's metabolite m5
163832|NCT02292732|Norethindrone|norethindrone
163833|NCT02292732|Ethinyl Estradiol|ethinyl estradiol
163834|NCT02292719|Hepatitis C Virus|hepatitis c virus
163835|NCT02292719|Genotype 2|genotype 2
163836|NCT02292719|Chronic Hepatitis C|chronic hepatitis c
163837|NCT02292719|Genotype 3|genotype 3
163838|NCT02292719|Non-cirrhotic|non-cirrhotic
163839|NCT02292719|Cirrhotic|cirrhotic
163840|NCT02292706|HCV Cirrhosis registry|hcv cirrhosis registry
163841|NCT02292706|Cirrhosis|cirrhosis
163842|NCT02292706|Hepatitis C|hepatitis c
163843|NCT02292693|intubation|intubation
163845|NCT02292680|environmental exposures|environmental exposures
163846|NCT02292680|neurodevelopmental outcomes|neurodevelopmental outcomes
163847|NCT02292667|Transversus Abdominis Plane Block|transversus abdominis plane block
163848|NCT02292667|Postoperative Pain Management|postoperative pain management
163849|NCT02292667|Open Repair of Aortic Abdominal Aneurysm|open repair of aortic abdominal aneurysm
163850|NCT02292641|Lower Gastrointestinal Tract|lower gastrointestinal tract
163851|NCT02292641|Rectum|rectum
163852|NCT02292641|Diagnostic Imaging|diagnostic imaging
163853|NCT02292641|Magnetic Resonance Imaging|magnetic resonance imaging
163854|NCT02292641|Pelvic Exenteration|pelvic exenteration
163855|NCT02292641|Neoplasms|neoplasms
163856|NCT02292641|Adenocarcinoma|adenocarcinoma
163857|NCT02292641|Carcinoma|carcinoma
163858|NCT02292602|preschool|preschool
163859|NCT02292602|obesity|obesity
163860|NCT02292602|health disparities|health disparities
163861|NCT02292602|intervention|intervention
163862|NCT02292589|Traumatic Brain Injury|traumatic brain injury
163863|NCT02292589|Post concussion syndrome|post concussion syndrome
163864|NCT02292589|Transcranial Direct Current Stimulation|transcranial direct current stimulation
163865|NCT02292589|Neuromodulation|neuromodulation
163866|NCT02292576|volunteers|volunteers
163867|NCT02292563|Nurse; Colonoscopy; Polyp; Adenoma;|nurse; colonoscopy; polyp; adenoma;
163868|NCT02292550|Non-small cell lung cancer,|non-small cell lung cancer,
163869|NCT02292550|ALK translocation,|alk translocation,
163870|NCT02292550|ALK-positive,|alk-positive,
154892|NCT02343406|Children|children
154893|NCT02343406|Epithelial Growth Factor vIII mutation|epithelial growth factor viii mutation
154894|NCT02343406|Antibody Drug Conjugate|antibody drug conjugate
154895|NCT02343406|Temozolomide|temozolomide
154898|NCT02343406|ABT-414|abt-414
163871|NCT02292550|NSCLC,|nsclc,
163872|NCT02292550|LEE011,|lee011,
163873|NCT02292550|CDK4/6 inhibitor,|cdk4/6 inhibitor,
163874|NCT02292550|EML4-ALK|eml4-alk
163875|NCT02292537|Spinal Muscular Atrophy|spinal muscular atrophy
163876|NCT02292537|SMA|sma
163877|NCT02292537|SMN|smn
163878|NCT02292537|SMNRx|smnrx
163879|NCT02292537|ISIS-SMNRx|isis-smnrx
163880|NCT02292537|ISIS-SMN Rx|isis-smn rx
163881|NCT02292537|ISIS 396443|isis 396443
163882|NCT02292537|CHERISH|cherish
163883|NCT02292537|IONIS-SMNRx|ionis-smnrx
163884|NCT02292537|IONIS-SMN Rx|ionis-smn rx
163885|NCT02292511|subjective cognitive impairment|subjective cognitive impairment
163886|NCT02292511|mind-motor intervention|mind-motor intervention
163887|NCT02292511|square-stepping exercise|square-stepping exercise
163888|NCT02292511|older adults|older adults
163889|NCT02292498|imaging, diagnostic|imaging, diagnostic
163890|NCT02292498|feasibility|feasibility
163891|NCT02292485|Lung Cancer Screening|lung cancer screening
163892|NCT02292485|LCS|lcs
163893|NCT02292485|Survey|survey
163894|NCT02292485|Questionnaire|questionnaire
163895|NCT02292485|Texas Academy of Family Physicians|texas academy of family physicians
163896|NCT02292472|masticatory muscles|masticatory muscles
163897|NCT02292446|Polycythemia Vera|polycythemia vera
163898|NCT02292446|Hematologic Diseases|hematologic diseases
163899|NCT02292446|Myeloproliferative Disorders|myeloproliferative disorders
163900|NCT02292446|INC424|inc424
163901|NCT02292446|Ruxolitinib|ruxolitinib
163902|NCT02292433|Phase 1|phase 1
163903|NCT02292433|type 2 diabetes|type 2 diabetes
163904|NCT02292433|monotherapy|monotherapy
163905|NCT02292433|PF-04937319|pf-04937319
163906|NCT02292420|pulse oximetry plethymographic waveform|pulse oximetry plethymographic waveform
163907|NCT02292420|area under curve|area under curve
163908|NCT02292420|amplitude|amplitude
163909|NCT02292394|Depression|depression
163910|NCT02292394|Depressive symptoms|depressive symptoms
163911|NCT02292394|Prevention|prevention
163912|NCT02292394|Caregivers|caregivers
163913|NCT02292394|Telephone intervention|telephone intervention
163914|NCT02292368|Head and Neck Cancer|head and neck cancer
163915|NCT02292368|Xerostomia|xerostomia
163916|NCT02292368|Radiation-induced Xerostomia|radiation-induced xerostomia
163917|NCT02292368|Acupuncture|acupuncture
163918|NCT02292368|Nasopharyngeal cancer|nasopharyngeal cancer
163919|NCT02292368|Radiation therapy|radiation therapy
163920|NCT02292368|XRT|xrt
163921|NCT02292368|Electroencephalogram|electroencephalogram
163922|NCT02292368|EEG|eeg
163923|NCT02292368|Xerostomia questionnaire|xerostomia questionnaire
163924|NCT02292368|XQ|xq
163925|NCT02292368|MD Anderson Symptom Inventory - Head & Neck|md anderson symptom inventory - head & neck
163926|NCT02292368|MDASI-HN|mdasi-hn
163927|NCT02292368|Questionnaires|questionnaires
163928|NCT02292368|Surveys|surveys
163929|NCT02292355|Temporomandibular Joint Disorders|temporomandibular joint disorders
163930|NCT02292355|posture|posture
163931|NCT02292355|pain|pain
163932|NCT02292355|clinical trial|clinical trial
163933|NCT02292355|Pilates|pilates
163934|NCT02292342|Flow mediated dilatation|flow mediated dilatation
163935|NCT02292329|flow-mediated dilation|flow-mediated dilation
163936|NCT02292329|Acai polyphenols|acai polyphenols
163937|NCT02292316|middle-aged and aged adults|middle-aged and aged adults
163938|NCT02292316|fall in the previous year|fall in the previous year
163939|NCT02292303|Zinc/pharmacokinetics|zinc/pharmacokinetics
163940|NCT02292290|Diabetes|diabetes
163941|NCT02292290|Liraglutide|liraglutide
163942|NCT02292290|Ramadan|ramadan
163943|NCT02292290|fasting|fasting
163944|NCT02292277|Ticagrelor|ticagrelor
163945|NCT02292277|Pharmacokinetics|pharmacokinetics
163946|NCT02292277|Platelet Aggregation|platelet aggregation
163947|NCT02292277|Platelet Function Tests|platelet function tests
163948|NCT02292251|Stroke|stroke
163949|NCT02292251|Transcranial direct current stimulation|transcranial direct current stimulation
163950|NCT02292238|Alzheimer's disease|alzheimer's disease
163951|NCT02292238|benfotiamine|benfotiamine
163952|NCT02292238|glucose|glucose
163953|NCT02292238|Amyloid|amyloid
163954|NCT02292225|Phase 1b, CLL/SLL, PI3K|phase 1b, cll/sll, pi3k
163955|NCT02292199|Hypertension|hypertension
163956|NCT02292199|TENS|tens
163957|NCT02292199|Sympathetic and Parasympathetic nervous system|sympathetic and parasympathetic nervous system
163958|NCT02292186|Cardiomyopathy|cardiomyopathy
163959|NCT02292186|Heart Failure|heart failure
163960|NCT02292186|FAC|fac
163961|NCT02292186|Amyloid|amyloid
163962|NCT02292186|Transthyretin|transthyretin
163963|NCT02292186|TTR|ttr
163964|NCT02292186|RNAi therapeutic|rnai therapeutic
163965|NCT02292173|Liver Neoplasms|liver neoplasms
163966|NCT02292173|Liver Diseases|liver diseases
163967|NCT02292173|Digestive System Diseases|digestive system diseases
163968|NCT02292173|Advanced|advanced
163969|NCT02292173|Mitogen-Activated Protein Kinase (MEK) Inhibitor|mitogen-activated protein kinase (mek) inhibitor
163970|NCT02292173|Kinase Inhibitor|kinase inhibitor
163971|NCT02292147|Cerebral anoxia|cerebral anoxia
163972|NCT02292147|Functional outcome|functional outcome
163973|NCT02292134|Sleep quality|sleep quality
163974|NCT02292134|Sleep architecture|sleep architecture
163975|NCT02292134|Intensive care unit|intensive care unit
163976|NCT02292134|Light|light
163977|NCT02292134|Noise|noise
163978|NCT02292134|Earplug|earplug
163979|NCT02292134|Sleep mask|sleep mask
163980|NCT02292121|Obesity|obesity
163981|NCT02292121|Intestinal permeability|intestinal permeability
163982|NCT02292121|Adipose tissue inflammation|adipose tissue inflammation
163983|NCT02292121|Low grade systemic inflammation|low grade systemic inflammation
163984|NCT02292121|Bariatric surgery|bariatric surgery
163985|NCT02292108|Hypnosis|hypnosis
163986|NCT02292108|self-hypnosis|self-hypnosis
163987|NCT02292108|obesity|obesity
163988|NCT02292108|high food impulsiveness|high food impulsiveness
163989|NCT02292095|anesthesia|anesthesia
163990|NCT02292095|transverse abdominis plane block|transverse abdominis plane block
163991|NCT02292095|patient controlled intravenous analgesia|patient controlled intravenous analgesia
163992|NCT02292082|Nerve Block|nerve block
163993|NCT02292082|Rehabilitation|rehabilitation
163994|NCT02292082|Knee Replacement, Total|knee replacement, total
163995|NCT02291991|Safety|safety
163996|NCT02291991|Tolerability|tolerability
163997|NCT02291991|Pharmacokinetics|pharmacokinetics
163998|NCT02291991|Pharmacodynamics|pharmacodynamics
163999|NCT02291991|Immunogenecity|immunogenecity
164000|NCT02291978|back pain|back pain
164001|NCT02291978|facet joint|facet joint
164002|NCT02291978|spine|spine
164003|NCT02291965|hematopoietic cell transplant|hematopoietic cell transplant
164004|NCT02291952|Circadian Misalignment, Forced Desynchrony, Metabolism, Meal-timing, Circadian|circadian misalignment, forced desynchrony, metabolism, meal-timing, circadian
164005|NCT02291926|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
164006|NCT02291926|Mesenchymal Stem Cell|mesenchymal stem cell
164007|NCT02291926|Osteoarthritis|osteoarthritis
164008|NCT02291913|ER-Positive Breast Cancer|er-positive breast cancer
164009|NCT02291913|HER2-Negative Breast Cancer|her2-negative breast cancer
164011|NCT02291913|anti-estrogen therapy|anti-estrogen therapy
164012|NCT02291913|PR-Positive Breast Cancer|pr-positive breast cancer
164013|NCT02291913|Afinitor|afinitor
164014|NCT02291900|avascular necrosis, talus, medial femoral condyle|avascular necrosis, talus, medial femoral condyle
164015|NCT02291874|Diabetes|diabetes
164016|NCT02291874|Ipragliflozin|ipragliflozin
164017|NCT02291874|GLP-1 receptor agonist|glp-1 receptor agonist
164018|NCT02291861|Dyskinesias|dyskinesias
164019|NCT02291861|Movement Disorders|movement disorders
164020|NCT02291861|Central Nervous System Diseases|central nervous system diseases
164021|NCT02291861|Nervous System Diseases|nervous system diseases
164022|NCT02291861|Neurologic Manifestations|neurologic manifestations
164023|NCT02291861|Signs and Symptoms|signs and symptoms
164024|NCT02291848|Multiple Myeloma|multiple myeloma
164025|NCT02291848|Cytotoxic T-lymphocytes|cytotoxic t-lymphocytes
164026|NCT02291809|HIV/AIDS|hiv/aids
164027|NCT02291809|Pediatric|pediatric
164029|NCT02291809|HIV-1 Immunogen|hiv-1 immunogen
164030|NCT02291796|Bezafibrate|bezafibrate
164031|NCT02291796|Hyperfibrinogenemia|hyperfibrinogenemia
164032|NCT02291796|Inflammatory response|inflammatory response
164033|NCT02291796|Acute myocardial infarction|acute myocardial infarction
662029|NCT00823654|08-156|08-156
164034|NCT02291796|Mayor cardiovascular events|mayor cardiovascular events
164035|NCT02291770|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
164036|NCT02291770|Mesenchymal Stromal Cells|mesenchymal stromal cells
164037|NCT02291744|TFS (time to failure of strategy)|tfs (time to failure of strategy)
164038|NCT02291731|Autologous serum eye drops|autologous serum eye drops
164039|NCT02291731|Silicone-hydrogel contact lens|silicone-hydrogel contact lens
164040|NCT02291731|Persistent epithelial defects|persistent epithelial defects
164041|NCT02291731|Corneal epithelial defects|corneal epithelial defects
164042|NCT02291718|Suspected or confirmed|suspected or confirmed
164044|NCT02291718|Computed tomography angiography|computed tomography angiography
164045|NCT02291718|CTA|cta
164046|NCT02291718|Contrast agent|contrast agent
164047|NCT02291718|Radiation dose|radiation dose
164048|NCT02291718|Thoracoabdominal aortic aneurysm|thoracoabdominal aortic aneurysm
164049|NCT02291705|Ultrasound, rectus sheath block, children, inguinal hernia|ultrasound, rectus sheath block, children, inguinal hernia
164050|NCT02291666|Cytochromes p450|cytochromes p450
164051|NCT02291666|drug metabolism|drug metabolism
164052|NCT02291666|pharmacokinetics|pharmacokinetics
164053|NCT02291666|diabetes|diabetes
164054|NCT02291666|probe markers|probe markers
164055|NCT02291614|Amgen|amgen
164056|NCT02291614|Phase 1|phase 1
164057|NCT02291614|Clinical Trial|clinical trial
164058|NCT02291614|Oncology|oncology
164059|NCT02291614|GI adenocarcinoma|gi adenocarcinoma
164060|NCT02291614|Immunotherapy|immunotherapy
164061|NCT02291536|THC and CBD|thc and cbd
164062|NCT02291536|Attentional blink|attentional blink
164063|NCT02291523|Fecal transplant|fecal transplant
164064|NCT02291484|Computed tomography|computed tomography
164065|NCT02291484|Coronary angiography|coronary angiography
164066|NCT02291484|Coronary artery disease|coronary artery disease
164067|NCT02291484|Perfusion imaging|perfusion imaging
164068|NCT02291484|Comparative effectiveness|comparative effectiveness
164069|NCT02291484|Randomized controlled trial|randomized controlled trial
164070|NCT02291484|Cost-effectiveness|cost-effectiveness
164071|NCT02291445|Peppermint oil|peppermint oil
164072|NCT02291445|Menthol|menthol
164073|NCT02291445|Volatile oil|volatile oil
164074|NCT02291445|Plant oil|plant oil
164075|NCT02291445|Visceral pain|visceral pain
164076|NCT02291445|Abdominal pain|abdominal pain
164077|NCT02291445|Irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
164078|NCT02291445|Colonic disease|colonic disease
164079|NCT02291419|ticagrelor|ticagrelor
164080|NCT02291419|non-cardiac surgery|non-cardiac surgery
164081|NCT02291419|elevated troponin|elevated troponin
164082|NCT02291419|myocardial injury|myocardial injury
164083|NCT02291406|Hysterectomy|hysterectomy
164084|NCT02291406|Insulin resistance|insulin resistance
164085|NCT02291406|Metabolism|metabolism
164086|NCT02291380|Chronic Migraine|chronic migraine
164087|NCT02291380|Botulinum Toxin Type A for Injection|botulinum toxin type a for injection
164088|NCT02291354|Fecal Microbiota Transplantation|fecal microbiota transplantation
164089|NCT02291354|Soluble Dietary Fiber|soluble dietary fiber
164090|NCT02291354|Slow Transit Constipation|slow transit constipation
164091|NCT02291315|Triple Stable Isotope|triple stable isotope
164092|NCT02291263|Polio|polio
164093|NCT02291263|Inactivated polio vaccine|inactivated polio vaccine
164094|NCT02291263|IPV|ipv
164095|NCT02291263|oral polio vaccine|oral polio vaccine
164096|NCT02291250|anthocyanin|anthocyanin
164097|NCT02291250|blackcurrant|blackcurrant
164098|NCT02291250|greencurrant|greencurrant
164099|NCT02291250|glucose|glucose
164100|NCT02291250|polyphenol|polyphenol
164101|NCT02291250|post prandial glucose|post prandial glucose
164102|NCT02291237|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
164103|NCT02291237|hcm|hcm
164104|NCT02291237|hocm|hocm
164105|NCT02291237|hypertrophic myocardiopathy|hypertrophic myocardiopathy
164106|NCT02291237|hypertrophic obstructive cardiomyopathies|hypertrophic obstructive cardiomyopathies
164107|NCT02291237|cardiomyopathy|cardiomyopathy
164108|NCT02291237|hypertrophic|hypertrophic
164109|NCT02291237|familial hypertrophic cardiomyopathy|familial hypertrophic cardiomyopathy
164110|NCT02291237|genetic heart disease|genetic heart disease
164111|NCT02291237|echocardiography|echocardiography
164112|NCT02291237|cardiopulmonary exercise testing|cardiopulmonary exercise testing
164113|NCT02291237|exercise Capacity|exercise capacity
164114|NCT02291237|heart failure|heart failure
164115|NCT02291237|angina|angina
164116|NCT02291237|dyspnea|dyspnea
164117|NCT02291237|diastolic dysfunction|diastolic dysfunction
164118|NCT02291237|microvascular ischemia|microvascular ischemia
164119|NCT02291237|late sodium current inhibitor|late sodium current inhibitor
164120|NCT02291237|GS-6615|gs-6615
164121|NCT02291237|late INA|late ina
164122|NCT02291224|dual protection|dual protection
164123|NCT02291224|pregnancy|pregnancy
164124|NCT02291224|reproductive health|reproductive health
164125|NCT02291224|sexually transmitted diseases|sexually transmitted diseases
164126|NCT02291224|condoms|condoms
164127|NCT02291224|contraception|contraception
164128|NCT02291224|adolescent health services|adolescent health services
164129|NCT02291198|colorectal cancer|colorectal cancer
164130|NCT02291198|natural killer cell activity|natural killer cell activity
164131|NCT02291198|screening|screening
164132|NCT02291198|NK cells|nk cells
164133|NCT02291159|stroke|stroke
164134|NCT02291159|spasticity|spasticity
164135|NCT02291159|dry needling|dry needling
164136|NCT02291159|upper motor neuron syndrome|upper motor neuron syndrome
164137|NCT02291159|motor function|motor function
164138|NCT02291146|gardening|gardening
164139|NCT02291146|cooking|cooking
164140|NCT02291146|nutrition education|nutrition education
164141|NCT02291146|Hispanic Americans|hispanic americans
164142|NCT02291133|Primary liver tumors|primary liver tumors
164143|NCT02291133|Bleomycin|bleomycin
164144|NCT02291133|Electrochemotherapy|electrochemotherapy
164145|NCT02291107|Gait orthosis|gait orthosis
164147|NCT02291107|Robotic Rehabilitation|robotic rehabilitation
164148|NCT02291094|Intravenous lidocaine|intravenous lidocaine
164149|NCT02291094|Mastectomy|mastectomy
164150|NCT02291094|Pain|pain
164151|NCT02291081|HIV, AIDS|hiv, aids
164152|NCT02291081|antiretroviral therapy|antiretroviral therapy
164153|NCT02291081|aging|aging
164154|NCT02291081|heart failure|heart failure
164155|NCT02291081|coronary heart disease|coronary heart disease
164156|NCT02291081|myocardial infarction|myocardial infarction
164157|NCT02291081|HIV-associated neurocognitive disorders|hiv-associated neurocognitive disorders
164158|NCT02291042|Bladder|bladder
164159|NCT02291042|Surgery|surgery
164160|NCT02291029|Sjögren's syndrome, CFZ533, ESSDAI|sjögren's syndrome, cfz533, essdai
164161|NCT02291016|COPD|copd
164162|NCT02291016|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
164163|NCT02291003|circadian|circadian
164164|NCT02291003|sleep|sleep
164165|NCT02290977|RT, TACE|rt, tace
164166|NCT02290964|Acute normovolemic hemodilution|acute normovolemic hemodilution
164167|NCT02290964|allogeneic transfusion|allogeneic transfusion
164168|NCT02290938|adolescents|adolescents
164169|NCT02290938|Native American|native american
164170|NCT02290938|alcohol use|alcohol use
164171|NCT02290938|drug use|drug use
164172|NCT02290938|cultural|cultural
164173|NCT02290938|traditional activities|traditional activities
164174|NCT02290938|cultural identification|cultural identification
164175|NCT02290925|biscuit containing Salacia reticulate|biscuit containing salacia reticulate
164176|NCT02290925|randomised controlled trial|randomised controlled trial
164177|NCT02290912|Alzheimer's disease prevention lifestyle intervention|alzheimer's disease prevention lifestyle intervention
164178|NCT02290899|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
164179|NCT02290886|safety evaluation|safety evaluation
164180|NCT02290886|intravenous administration|intravenous administration
164181|NCT02290886|3 doses of autologous MSC|3 doses of autologous msc
164182|NCT02290886|ALS|als
164183|NCT02290834|Chemotherapy related cognitive impairment|chemotherapy related cognitive impairment
164184|NCT02290834|Chemo-brain|chemo-brain
164185|NCT02290808|physical|physical
164186|NCT02290808|activity|activity
164187|NCT02290808|exercise|exercise
164188|NCT02290808|new-parents|new-parents
164189|NCT02290808|intervention|intervention
164190|NCT02290808|theory-based|theory-based
164191|NCT02290795|Vitreopapillary traction|vitreopapillary traction
164192|NCT02290782|toxicity|toxicity
164193|NCT02290782|outcome|outcome
164194|NCT02290782|TARGIT|targit
164195|NCT02290782|quality of life|quality of life
164196|NCT02290782|intraoperative radiotherapy (IORT)|intraoperative radiotherapy (iort)
164197|NCT02290769|Guide wire cannulation ERCP|guide wire cannulation ercp
164198|NCT02290769|Time of cannulation|time of cannulation
164199|NCT02290769|Rapid exchange guide wire|rapid exchange guide wire
164200|NCT02290769|Guide wire|guide wire
164201|NCT02290756|Early child development|early child development
164202|NCT02290756|Link Workers|link workers
164203|NCT02290756|Community Birth attendants|community birth attendants
164204|NCT02290756|Parenting Program|parenting program
164205|NCT02290730|Lower trapezius|lower trapezius
164206|NCT02290730|Kinesio taping|kinesio taping
164207|NCT02290717|ultraviolet therapy|ultraviolet therapy
164208|NCT02290717|non segmental|non segmental
164209|NCT02290717|vitiligo|vitiligo
164210|NCT02290717|topical corticosteroid|topical corticosteroid
164211|NCT02290717|laser|laser
164212|NCT02290717|fractional|fractional
164213|NCT02290717|CO2|co2
164214|NCT02290717|carbon dioxide|carbon dioxide
164215|NCT02290717|UVB|uvb
164216|NCT02290704|oxygen saturation|oxygen saturation
164217|NCT02290704|retinal vessels|retinal vessels
164218|NCT02290704|thyroid associated ophthalmopathy|thyroid associated ophthalmopathy
164219|NCT02290691|Needle Free, Influenza|needle free, influenza
164220|NCT02290678|Pilot Study|pilot study
164221|NCT02290678|Adventure-based Programming|adventure-based programming
164222|NCT02290665|enema|enema
164223|NCT02290652|Sexual function in Orthopaedic patients|sexual function in orthopaedic patients
164224|NCT02290639|Posttraumatic Stress|posttraumatic stress
164225|NCT02290639|Posttraumatic Stress Disorder|posttraumatic stress disorder
164230|NCT02290639|Cognitive Processing Therapy|cognitive processing therapy
164231|NCT02290639|Behavioral Health Optimization Program|behavioral health optimization program
164232|NCT02290639|Behavioral Health Consultant|behavioral health consultant
164233|NCT02290626|Elemental diet|elemental diet
164234|NCT02290626|semi-solid diet|semi-solid diet
164235|NCT02290626|gastric emptying|gastric emptying
164237|NCT02290626|PEG|peg
164238|NCT02290613|pulmonary hypertension|pulmonary hypertension
164239|NCT02290613|systemic sclerosis|systemic sclerosis
164240|NCT02290587|social cognitive|social cognitive
164241|NCT02290587|theory of mind|theory of mind
164242|NCT02290587|cognitive impairment|cognitive impairment
164243|NCT02290587|functional MRI|functional mri
164244|NCT02290587|brain activation network|brain activation network
164245|NCT02290561|Prostatic Neoplasms|prostatic neoplasms
164246|NCT02290561|Therapeutics|therapeutics
164247|NCT02290561|Magnetic Resonance Imaging|magnetic resonance imaging
164248|NCT02290561|Ultrasonography|ultrasonography
164249|NCT02290561|High Intensity Focused Ultrasound|high intensity focused ultrasound
164250|NCT02290561|Image Fusion|image fusion
164251|NCT02290548|high flow nasal cannula|high flow nasal cannula
164252|NCT02290548|extubation failure|extubation failure
402925|NCT01229072|Non-inferiority|non-inferiority
155331|NCT02341209|MF|mf
164253|NCT02290535|obstructive pulmonary disease|obstructive pulmonary disease
164254|NCT02290535|children|children
164255|NCT02290535|teenager|teenager
164256|NCT02290535|EIT (Electrical Impedance Tomography)|eit (electrical impedance tomography)
164263|NCT02290470|Nausea|nausea
164264|NCT02290470|Vomiting|vomiting
164265|NCT02290457|resistance training|resistance training
164266|NCT02290457|trunk muscle strength|trunk muscle strength
164267|NCT02290457|physical fitness|physical fitness
164268|NCT02290457|adolescent|adolescent
164269|NCT02290444|Acute Relapsing Multiple Sclerosis|acute relapsing multiple sclerosis
164270|NCT02290444|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
164271|NCT02290444|Multiple Sclerosis, Chronic Progressive|multiple sclerosis, chronic progressive
164272|NCT02290431|LBH589,|lbh589,
164273|NCT02290431|panobinostat,|panobinostat,
164274|NCT02290431|bortezomib,|bortezomib,
164275|NCT02290431|dexamethasone,|dexamethasone,
164276|NCT02290431|Phase II|phase ii
164277|NCT02290418|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
164278|NCT02290418|Omega-Loop Gastric Bypass|omega-loop gastric bypass
164279|NCT02290418|"Mini-Gastric Bypass"|"mini-gastric bypass"
164280|NCT02290405|insomnia|insomnia
164281|NCT02290405|primary insomnia|primary insomnia
164282|NCT02290405|chronic insomnia|chronic insomnia
164283|NCT02290392|African American|african american
164284|NCT02290392|Environmental Factor|environmental factor
164285|NCT02290392|Transcriptome|transcriptome
164286|NCT02290392|Cardiovascular Disease|cardiovascular disease
164287|NCT02290392|Hypertension|hypertension
164288|NCT02290353|Engagement|engagement
164289|NCT02290353|Motivation|motivation
164290|NCT02290353|Exergaming|exergaming
164291|NCT02290340|Respiratory Syncytial Virus, RSV|respiratory syncytial virus, rsv
164292|NCT02290327|Stress ulcer bleeding|stress ulcer bleeding
164293|NCT02290327|proton pump inhibitors|proton pump inhibitors
164294|NCT02290327|pneumonia|pneumonia
164295|NCT02290327|clostridium difficile infection|clostridium difficile infection
164296|NCT02290262|Heart disease|heart disease
164297|NCT02290262|Phase one rehabilitation|phase one rehabilitation
164298|NCT02290223|Chronic pain|chronic pain
164299|NCT02290223|Analgesics, Opioid|analgesics, opioid
164300|NCT02290223|Cognitive Therapy|cognitive therapy
164301|NCT02290223|Behavior Therapy|behavior therapy
164302|NCT02290223|Mindfulness|mindfulness
164303|NCT02290223|Psychophysiology|psychophysiology
164304|NCT02290223|Biofeedback, Psychology|biofeedback, psychology
164305|NCT02290184|type 2 diabetes|type 2 diabetes
164306|NCT02290184|cardiovascular disease prevention|cardiovascular disease prevention
164307|NCT02290184|lifestyle intervention|lifestyle intervention
164308|NCT02290184|physical activity|physical activity
164309|NCT02290184|weight loss|weight loss
164310|NCT02290184|nutrition|nutrition
164311|NCT02290184|Filipinos|filipinos
164312|NCT02290184|culturally appropriate|culturally appropriate
164313|NCT02290158|treatment outcomes|treatment outcomes
164314|NCT02290158|Malocclusion/therapy|malocclusion/therapy
164315|NCT02290145|docetaxel, cisplatin, 5-FU, cyclinD1|docetaxel, cisplatin, 5-fu, cyclind1
164316|NCT02290132|acute lymphoblastic leukemia|acute lymphoblastic leukemia
164317|NCT02290132|lymphoblastic lymphoma|lymphoblastic lymphoma
164318|NCT02290132|stem-cell transplant|stem-cell transplant
164319|NCT02290132|T-cell lymphoma|t-cell lymphoma
401978|NCT01232465|sperm DNA integrity|sperm dna integrity
164320|NCT02290119|Primary PCL-retaining Total Knee Arthroplasty|primary pcl-retaining total knee arthroplasty
164321|NCT02290119|Intraoperative Sensors|intraoperative sensors
164322|NCT02290119|Ligament Balancing|ligament balancing
164323|NCT02290119|Clinical Outcomes|clinical outcomes
164324|NCT02290106|obesity|obesity
164325|NCT02290106|insulin sensitivity|insulin sensitivity
164326|NCT02290106|statin (HMG-CoA Reductase Inhibitor)|statin (hmg-coa reductase inhibitor)
164327|NCT02290106|fatty liver|fatty liver
164328|NCT02290093|Cathartics|cathartics
164329|NCT02290093|Colonoscopy|colonoscopy
164330|NCT02290093|Polyethylene Glycols|polyethylene glycols
164331|NCT02290093|Elderly|elderly
164332|NCT02290080|acute myocardial infarction (AMI)|acute myocardial infarction (ami)
164333|NCT02290080|acute coronary syndrome (ACS)|acute coronary syndrome (acs)
164334|NCT02290080|ST-segment elevation myocardial infarction (STEMI)|st-segment elevation myocardial infarction (stemi)
164335|NCT02290080|Non ST-segment elevation myocardial infarction (NSTEMI)|non st-segment elevation myocardial infarction (nstemi)
164336|NCT02290080|Ischemic Reperfusion injury (IR-injury)|ischemic reperfusion injury (ir-injury)
164337|NCT02290080|Biomarkers|biomarkers
164338|NCT02290080|Oxygen|oxygen
164339|NCT02290080|Apoptosis|apoptosis
164340|NCT02290080|Fluorescence-activated cell sorting (FACS)|fluorescence-activated cell sorting (facs)
164341|NCT02290080|Flow cytometry|flow cytometry
164342|NCT02290080|Matrix metalloproteinase (MMP)|matrix metalloproteinase (mmp)
164343|NCT02290067|blood glucose monitoring system|blood glucose monitoring system
164344|NCT02290067|system accuracy|system accuracy
164345|NCT02290054|analgesia, epidural|analgesia, epidural
164346|NCT02290054|urinary retention|urinary retention
164347|NCT02290041|mesenchymal stem cells|mesenchymal stem cells
164348|NCT02290041|Virus of human immunodeficiency Infection|virus of human immunodeficiency infection
164349|NCT02290028|CRT-D therapy|crt-d therapy
164350|NCT02290028|quadripolar left ventricular lead|quadripolar left ventricular lead
164351|NCT02290015|Single Photon Emission Computed Tomography; Acupuncture|single photon emission computed tomography; acupuncture
164352|NCT02289989|Atopic dermatitis|atopic dermatitis
164353|NCT02289989|Oregano|oregano
164354|NCT02289989|Atopic Dermatitis Quick (ADQ) score|atopic dermatitis quick (adq) score
164355|NCT02289989|Eczema Area and Severity Index score|eczema area and severity index score
164356|NCT02289989|Reflectance confocal microscopy|reflectance confocal microscopy
164357|NCT02289976|talar avascular necrosis|talar avascular necrosis
164358|NCT02289976|osteochondrosis dissecans|osteochondrosis dissecans
164359|NCT02289976|femoral condyle|femoral condyle
164360|NCT02289950|Ovarian Cancer in in first relapse|ovarian cancer in in first relapse
164361|NCT02289950|Platinum-Sensitive|platinum-sensitive
164362|NCT02289937|Postoperative pain|postoperative pain
164363|NCT02289937|regional anaesthesia|regional anaesthesia
164364|NCT02289937|total hip replacement|total hip replacement
164365|NCT02289937|nervus cutaneous femoral lateralis|nervus cutaneous femoral lateralis
164366|NCT02289924|wet AMD|wet amd
164367|NCT02289911|ultrasound|ultrasound
164368|NCT02289898|1st-line metastatic pancreatic ductal adenocarcinoma|1st-line metastatic pancreatic ductal adenocarcinoma
164369|NCT02289885|trauma|trauma
164370|NCT02289885|examination|examination
164371|NCT02289885|knowledge|knowledge
164372|NCT02289885|paramedic|paramedic
164373|NCT02289820|RSV|rsv
164374|NCT02289820|Older adults|older adults
164375|NCT02289820|MEDI7510|medi7510
164376|NCT02289820|Vaccine|vaccine
164377|NCT02289807|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
164378|NCT02289807|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
164379|NCT02289807|intermediate risk|intermediate risk
164380|NCT02289807|intensity-modulated radiotherapy|intensity-modulated radiotherapy
164381|NCT02289794|Bioconjugate vaccine|bioconjugate vaccine
164382|NCT02289794|Urinary tract infections|urinary tract infections
164383|NCT02289755|Urine Oxalate|urine oxalate
164384|NCT02289755|Nephrolithiasis|nephrolithiasis
164385|NCT02289755|Kidney Stones|kidney stones
164386|NCT02289755|Hyperoxaluria|hyperoxaluria
164387|NCT02289755|Enteric Hyperoxaluria|enteric hyperoxaluria
164388|NCT02289755|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
164389|NCT02289755|Urological Diseases|urological diseases
164390|NCT02289755|Kidney Diseases|kidney diseases
164391|NCT02289742|Dailies AquaComfort Plus® Multifocal (DACP MF)|dailies aquacomfort plus® multifocal (dacp mf)
164392|NCT02289742|Dailies AquaComfort Plus® Toric (DACP Toric)|dailies aquacomfort plus® toric (dacp toric)
164393|NCT02289742|tear film stability|tear film stability
164394|NCT02289742|Non-Invasive Keratograph Break-Up Time (NIK-BUT)|non-invasive keratograph break-up time (nik-but)
164395|NCT02289729|Duodopa|duodopa
164396|NCT02289729|Advanced Parkinson's Disease|advanced parkinson's disease
164397|NCT02289729|Levodopa/Carbidopa intestinal gel|levodopa/carbidopa intestinal gel
164398|NCT02289716|Osteoarthritis|osteoarthritis
164399|NCT02289716|Pain|pain
164400|NCT02289716|Fulranumab|fulranumab
164401|NCT02289716|JNJ-42160443|jnj-42160443
164402|NCT02289716|Monotherapy|monotherapy
164403|NCT02289716|Hip|hip
164404|NCT02289716|Knee|knee
164405|NCT02289716|Joint replacement surgery|joint replacement surgery
164406|NCT02289703|End-Stage Renal Disease|end-stage renal disease
164407|NCT02289703|Healthy|healthy
164410|NCT02289703|JNJ-39039039|jnj-39039039
164412|NCT02289703|Hemodialysis|hemodialysis
164413|NCT02289703|Blood Coagulation|blood coagulation
164414|NCT02289703|Pharmacokinetics|pharmacokinetics
164415|NCT02289690|Veliparib|veliparib
164416|NCT02289690|PARP - Poly (ADP) ribose polymerase|parp - poly (adp) ribose polymerase
164417|NCT02289690|ABT-888|abt-888
164418|NCT02289690|Extensive Stage Smal Cell Lung Cancer|extensive stage smal cell lung cancer
164419|NCT02289677|intubation|intubation
164420|NCT02289677|child|child
164421|NCT02289677|resuscitation|resuscitation
164422|NCT02289677|simulation|simulation
164423|NCT02289677|Endotracheal|endotracheal
164424|NCT02289664|intubation|intubation
164425|NCT02289651|intubation|intubation
164426|NCT02289638|intubation|intubation
164427|NCT02289625|Obstructive Sleep Apnea|obstructive sleep apnea
164428|NCT02289625|cognition|cognition
164429|NCT02289625|neurovascular function|neurovascular function
164430|NCT02289625|brain metabolism|brain metabolism
164431|NCT02289625|exercise training|exercise training
164432|NCT02289612|Risk for Type 2 Diabetes Mellitus|risk for type 2 diabetes mellitus
164433|NCT02289612|Fibre|fibre
164434|NCT02289612|Postprandial Glucose|postprandial glucose
164435|NCT02289612|Postprandial Insulin|postprandial insulin
164436|NCT02289612|Postprandial Acetaminophen|postprandial acetaminophen
164437|NCT02289612|Satiety|satiety
164438|NCT02289599|Healthy Japanese Subjects|healthy japanese subjects
164439|NCT02289599|E2307|e2307
164440|NCT02289599|Pharmacokinetics|pharmacokinetics
164441|NCT02289547|chemotherapy|chemotherapy
155522|NCT02339883|MRI|mri
164442|NCT02289547|stomach neoplasms|stomach neoplasms
164443|NCT02289521|Transcranial Direct Current stimulation|transcranial direct current stimulation
164444|NCT02289521|Executive function|executive function
164445|NCT02289521|Bilingualism|bilingualism
164446|NCT02289521|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
164447|NCT02289508|Heart Failure|heart failure
164448|NCT02289508|Hemodynamics|hemodynamics
164449|NCT02289508|Echocardiography|echocardiography
164450|NCT02289508|Diagnostic techniques and procedures|diagnostic techniques and procedures
164451|NCT02289508|Ultrasonography|ultrasonography
164452|NCT02289508|USCOM|uscom
164453|NCT02289495|Single Dose Escalation|single dose escalation
164454|NCT02289495|Repeat Dose Escalation|repeat dose escalation
164455|NCT02289495|GSK2838232|gsk2838232
164456|NCT02289495|Ritonavir|ritonavir
164457|NCT02289482|Ritonavir|ritonavir
164458|NCT02289482|Safety|safety
164459|NCT02289482|Continuation Single Dose Escalation|continuation single dose escalation
164460|NCT02289482|GSK2838232|gsk2838232
164461|NCT02289456|Phase II, LOCALLY ADVANCED OR METASTATIC NON SMALL|phase ii, locally advanced or metastatic non small
164462|NCT02289456|CELL LUNG CANCER (NSCLC) AND AN|cell lung cancer (nsclc) and an
164463|NCT02289456|EASTERN COOPERATIVE ONCOLOGY GROUP|eastern cooperative oncology group
164464|NCT02289456|PERFORMANCE STATUS OF 2|performance status of 2
164465|NCT02289456|(ABOUND.PS2)|(abound.ps2)
164466|NCT02289456|LOCALLY ADVANCED OR METASTATIC NON SMALL|locally advanced or metastatic non small
164467|NCT02289456|CELL LUNG CANCER (NSCLC) SUBJECTS THAT AE NOT CANDIDATES FOR RADIATION OR CURATIVE SURGERY|cell lung cancer (nsclc) subjects that ae not candidates for radiation or curative surgery
164468|NCT02289443|complete dentures|complete dentures
164469|NCT02289443|10-year follow-up|10-year follow-up
164470|NCT02289443|patient report outcomes|patient report outcomes
164473|NCT02289391|Dexmedetomidine|dexmedetomidine
164474|NCT02289391|Inflammatory factor|inflammatory factor
164475|NCT02289391|Inflammatory mediator|inflammatory mediator
164476|NCT02289391|Cytokines|cytokines
164477|NCT02289391|Asthma|asthma
164478|NCT02289365|Radiodermatitis|radiodermatitis
164479|NCT02289365|Breast cancer|breast cancer
164480|NCT02289365|Radiotherapy|radiotherapy
164481|NCT02289313|obesity prevention|obesity prevention
164482|NCT02289313|CBPR|cbpr
164483|NCT02289313|high risk youth|high risk youth
164484|NCT02289313|school health|school health
164485|NCT02289287|Self-Management|self-management
164486|NCT02289287|Stroke|stroke
164487|NCT02289287|Intervention|intervention
164488|NCT02289287|Group Processes|group processes
164489|NCT02289261|Chronic pain|chronic pain
164490|NCT02289261|Morphine|morphine
164491|NCT02289261|Dexmedetomidine|dexmedetomidine
164492|NCT02289235|Ginger|ginger
164493|NCT02289235|Medicine, traditional|medicine, traditional
164494|NCT02289235|Herbal medicine|herbal medicine
164495|NCT02289222|Relapsed/Refractory|relapsed/refractory
164496|NCT02289222|MK-3475 & Pomalidomide|mk-3475 & pomalidomide
164497|NCT02289222|Immunotherapy|immunotherapy
164498|NCT02289209|head and neck cancer|head and neck cancer
164499|NCT02289209|reirradiation|reirradiation
164500|NCT02289209|MK-3475|mk-3475
164501|NCT02289209|Anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
164502|NCT02289209|Squamous cell carcinoma|squamous cell carcinoma
164503|NCT02289209|Keytruda|keytruda
164504|NCT02289209|pembrolizumab|pembrolizumab
164505|NCT02289196|Vaccine|vaccine
164506|NCT02289183|Stomach Neoplasms|stomach neoplasms
164507|NCT02289183|Laparoscopy|laparoscopy
164508|NCT02289183|Billroth I Operation|billroth i operation
164509|NCT02289170|Chronic low back pain|chronic low back pain
164510|NCT02289170|Heating and cooling combination therapeutic device|heating and cooling combination therapeutic device
164511|NCT02289170|Heating and cooling combination therapy|heating and cooling combination therapy
164512|NCT02289170|Contrast therapy|contrast therapy
164513|NCT02289131|oral care|oral care
164514|NCT02289105|Advance Directive|advance directive
164515|NCT02289105|Active Choice|active choice
164516|NCT02289105|Decision making|decision making
164517|NCT02289053|Colorectal Cancer|colorectal cancer
164518|NCT02289040|Acute Kidney Injury|acute kidney injury
164519|NCT02289040|Microvesicles|microvesicles
164520|NCT02289040|microRNA|microrna
164521|NCT02289040|Paediatric cardiac surgery|paediatric cardiac surgery
164522|NCT02289027|Ebola, Ebolavirus|ebola, ebolavirus
164523|NCT02289014|online intervention|online intervention
164524|NCT02289014|stress management|stress management
164525|NCT02289014|cognitive behavioral therapy|cognitive behavioral therapy
164526|NCT02289014|acceptance and mindfulness based intervention|acceptance and mindfulness based intervention
164527|NCT02289001|patient simulation|patient simulation
164528|NCT02289001|simulation|simulation
164529|NCT02289001|teamwork|teamwork
164530|NCT02289001|interdisciplinary health team|interdisciplinary health team
164531|NCT02289001|healthcare team|healthcare team
164532|NCT02289001|nursing|nursing
164533|NCT02289001|training programs|training programs
164534|NCT02288988|GERD|gerd
164535|NCT02288988|Short Esophagus|short esophagus
402926|NCT01229059|FFA|ffa
164536|NCT02288988|Minimally Invasive Surgery|minimally invasive surgery
164537|NCT02288988|Collis gastroplasty|collis gastroplasty
164538|NCT02288975|hemoadsorption|hemoadsorption
164539|NCT02288975|extracorporeal blood purification|extracorporeal blood purification
164540|NCT02288975|CytoSorb|cytosorb
164541|NCT02288975|hemofiltration|hemofiltration
164542|NCT02288975|SIRS|sirs
164543|NCT02288975|sepsis|sepsis
164544|NCT02288975|septic shock|septic shock
164545|NCT02288975|membranes|membranes
164546|NCT02288975|ICU|icu
164547|NCT02288975|dialysis|dialysis
164548|NCT02288975|adsorption|adsorption
164549|NCT02288962|dopamine agonists|dopamine agonists
164550|NCT02288962|cabergoline|cabergoline
164551|NCT02288949|mechanical ventilation, stratificacion, lung severity|mechanical ventilation, stratificacion, lung severity
164552|NCT02288936|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
164553|NCT02288936|Enzalutamide|enzalutamide
164554|NCT02288936|TMPRSS2-ETS fusion gene|tmprss2-ets fusion gene
164555|NCT02288923|Total knee arthroplasty|total knee arthroplasty
164556|NCT02288923|Femoral nerve block|femoral nerve block
164557|NCT02288923|Local infiltration analgesia|local infiltration analgesia
164558|NCT02288910|Liver Perfusion|liver perfusion
164559|NCT02288910|DynaCT Perfusion|dynact perfusion
164560|NCT02288910|Radioembolization|radioembolization
164561|NCT02288910|Chemoembolization|chemoembolization
164562|NCT02288897|Stage III|stage iii
164563|NCT02288897|Stage IIIB|stage iiib
164564|NCT02288897|Stage IIIC|stage iiic
164565|NCT02288897|Stage IV (M1a)|stage iv (m1a)
164566|NCT02288897|Stage 3|stage 3
164567|NCT02288897|Stage 4|stage 4
164568|NCT02288897|IVM1a|ivm1a
164569|NCT02288897|IV(M1a)|iv(m1a)
164570|NCT02288897|IV-M1a|iv-m1a
164571|NCT02288897|in-transit|in-transit
164572|NCT02288897|in transit|in transit
164573|NCT02288897|intransit|intransit
164574|NCT02288897|satellite|satellite
164575|NCT02288897|recurrent|recurrent
164576|NCT02288884|Complications|complications
164577|NCT02288884|Cesarean Section|cesarean section
164578|NCT02288884|Wound|wound
164579|NCT02288884|Infection (Following Delivery)|infection (following delivery)
164580|NCT02288871|aortic valve replacement|aortic valve replacement
164581|NCT02288871|aortic valve bioprosthesis|aortic valve bioprosthesis
164582|NCT02288871|hemodynamics|hemodynamics
164583|NCT02288858|Hair thinning|hair thinning
164584|NCT02288819|loop diuretics|loop diuretics
164585|NCT02288819|heart failure|heart failure
164586|NCT02288819|natriuresis|natriuresis
164587|NCT02288819|urinary analysis|urinary analysis
164588|NCT02288793|attitudes|attitudes
164589|NCT02288793|knowledge|knowledge
164590|NCT02288793|examination|examination
164591|NCT02288754|DNA in Tumors|dna in tumors
164592|NCT02288741|high-dose chemotherapy|high-dose chemotherapy
164593|NCT02288741|autologous blood stem-cell transplantation|autologous blood stem-cell transplantation
164594|NCT02288741|induction chemotherapy|induction chemotherapy
164595|NCT02288741|elderly patients|elderly patients
164596|NCT02288728|Proximal gastrectomy|proximal gastrectomy
164597|NCT02288728|quality of life|quality of life
164598|NCT02288728|mortality|mortality
164599|NCT02288728|morbidity|morbidity
164600|NCT02288715|cerebral perfusion pressure|cerebral perfusion pressure
164601|NCT02288715|septic encephalopathy|septic encephalopathy
164602|NCT02288676|genomics|genomics
164603|NCT02288676|molecular markers|molecular markers
164604|NCT02288676|genetic mutations|genetic mutations
164605|NCT02288676|high-grade serous cancer|high-grade serous cancer
164606|NCT02288676|ovarian cancer|ovarian cancer
164607|NCT02288676|endometrial cancer|endometrial cancer
164608|NCT02288676|driver mutations|driver mutations
164609|NCT02288676|passenger mutations|passenger mutations
164610|NCT02288676|molecular screening|molecular screening
164611|NCT02288598|Stammering|stammering
164612|NCT02288598|Brain stimulation|brain stimulation
164613|NCT02288585|plant sterols|plant sterols
164614|NCT02288585|blood lipids|blood lipids
164615|NCT02288572|metabolic syndrome X|metabolic syndrome x
164617|NCT02288572|insulin resistance|insulin resistance
164618|NCT02288572|dyslipidemia|dyslipidemia
164619|NCT02288572|probiotic bacteria|probiotic bacteria
164620|NCT02288546|nutritional status|nutritional status
164621|NCT02288546|pesticides|pesticides
164622|NCT02288546|nitrate|nitrate
164623|NCT02288533|Minimally Conscious State|minimally conscious state
164624|NCT02288533|tDCS|tdcs
164625|NCT02288520|Methotrexate|methotrexate
164626|NCT02288520|Therapeutic strategy|therapeutic strategy
164627|NCT02288507|sorafenib, yttrium-90 radioembolization|sorafenib, yttrium-90 radioembolization
164628|NCT02288494|hypoalbuminemia|hypoalbuminemia
164629|NCT02288494|-acid base balance|-acid base balance
164630|NCT02288494|acid base disorders|acid base disorders
164631|NCT02288494|critical ill|critical ill
164632|NCT02288494|Stewart approach|stewart approach
164633|NCT02288494|human albumin infusion|human albumin infusion
164634|NCT02288481|Tuberculosis|tuberculosis
164635|NCT02288481|TBA-354|tba-354
164636|NCT02288481|Pulmonary Tuberculosis|pulmonary tuberculosis
164637|NCT02288481|TB|tb
164638|NCT02288468|Parkinson's Disease|parkinson's disease
164639|NCT02288455|SUI, incontinence, sphincter|sui, incontinence, sphincter
164640|NCT02288429|pharmacokinetics|pharmacokinetics
164641|NCT02288429|cystic fibrosis|cystic fibrosis
164642|NCT02288429|critical illness|critical illness
164643|NCT02288403|Aerobic Exercise|aerobic exercise
164644|NCT02288403|Oxygen Consumption|oxygen consumption
164645|NCT02288403|Blood Pressure|blood pressure
164646|NCT02288390|VAP|vap
164647|NCT02288390|Oral care|oral care
164648|NCT02288390|Chlorhexidine|chlorhexidine
164649|NCT02288390|Miswak (Sewak)|miswak (sewak)
164650|NCT02288377|Lanreotide|lanreotide
164651|NCT02288377|Duodeno-pancreatic neuroendocrine tumours|duodeno-pancreatic neuroendocrine tumours
164652|NCT02288377|Maintenance treatment|maintenance treatment
164653|NCT02288351|Roux-en-Y gastric bypass|roux-en-y gastric bypass
164654|NCT02288325|Fetzima|fetzima
164655|NCT02288325|Relapse-prevention|relapse-prevention
164656|NCT02288325|Placebo-controlled|placebo-controlled
164657|NCT02288299|Instrumental cough assistance|instrumental cough assistance
164658|NCT02288299|positive pressure insufflation maneuver|positive pressure insufflation maneuver
164659|NCT02288299|home mechanical ventilation|home mechanical ventilation
164660|NCT02288299|prospective evaluation|prospective evaluation
164661|NCT02288260|Acute Coronary Syndrome|acute coronary syndrome
164662|NCT02288260|Russian ACS Registry|russian acs registry
164663|NCT02288260|ticagrelor|ticagrelor
164664|NCT02288247|Metastatic|metastatic
164665|NCT02288247|Castration-resistant|castration-resistant
164666|NCT02288247|Docetaxel|docetaxel
164667|NCT02288247|Chemotherapy- Naïve|chemotherapy- naïve
164668|NCT02288247|Enzalutamide|enzalutamide
164669|NCT02288247|Prostate Cancer|prostate cancer
164670|NCT02288247|Chemotherapy Naïve Metastatic Castration Resistant Prostate Cancer|chemotherapy naïve metastatic castration resistant prostate cancer
164671|NCT02288247|Prednisolone|prednisolone
164672|NCT02288247|Xtandi|xtandi
164673|NCT02288247|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
164674|NCT02288234|Registry|registry
164675|NCT02288195|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
164676|NCT02288195|Preoperative radiotherapy|preoperative radiotherapy
164677|NCT02288195|Chemoradiotherapy|chemoradiotherapy
164678|NCT02288195|Capecitabine|capecitabine
164679|NCT02288195|Oxaliplatin|oxaliplatin
164680|NCT02288182|Sinus augmentation procedure|sinus augmentation procedure
164681|NCT02288169|Symptom management|symptom management
164682|NCT02288169|palliative care|palliative care
164683|NCT02288117|PMCF|pmcf
164684|NCT02288117|Post Market Clinical Follow up|post market clinical follow up
164685|NCT02288117|SP-CL|sp-cl
164686|NCT02288117|anatomic stem|anatomic stem
164687|NCT02288104|Interventional Radiology|interventional radiology
164688|NCT02288104|Liver|liver
164689|NCT02288104|Kidney|kidney
164690|NCT02288104|Confocal endomicroscopy|confocal endomicroscopy
164691|NCT02288104|Optical Biopsy|optical biopsy
164692|NCT02288104|Scanner|scanner
164693|NCT02288104|Fluoroscopy|fluoroscopy
164694|NCT02288104|CT|ct
164695|NCT02288104|Computed Tomography|computed tomography
164696|NCT02288104|Radiofrequency Ablation|radiofrequency ablation
164697|NCT02288104|Fluorescein|fluorescein
164698|NCT02288091|ALS|als
164702|NCT02288091|Glutathione|glutathione
164703|NCT02288091|Biomarker|biomarker
164704|NCT02288091|Oxidative stress|oxidative stress
164705|NCT02288091|Oxidative damage|oxidative damage
164706|NCT02288091|proof-of-concept|proof-of-concept
164707|NCT02288078|unresectable colorectal cancer|unresectable colorectal cancer
164708|NCT02288078|regorafenib|regorafenib
164709|NCT02288078|Steroid|steroid
164710|NCT02288078|fatigue and malaise|fatigue and malaise
164711|NCT02288078|Phase 2 randomized, controlled trial (RCT)|phase 2 randomized, controlled trial (rct)
164712|NCT02288052|Handwriting|handwriting
164713|NCT02288052|Motor learning|motor learning
164714|NCT02288039|Pulmonary|pulmonary
164715|NCT02288026|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
164716|NCT02288026|Lung Neoplasms|lung neoplasms
164717|NCT02288026|Carcinoma, Bronchogenic|carcinoma, bronchogenic
164718|NCT02288026|Bronchial Neoplasms|bronchial neoplasms
164719|NCT02288013|Cesarean section|cesarean section
164720|NCT02288013|uterine closure technique|uterine closure technique
164721|NCT02288013|materials used|materials used
164722|NCT02288000|Alzheimer|alzheimer
164723|NCT02288000|Memantine|memantine
164724|NCT02288000|biomarkers|biomarkers
164725|NCT02288000|battery|battery
164726|NCT02288000|cognition|cognition
164727|NCT02288000|imaging|imaging
164728|NCT02288000|neuropsychology|neuropsychology
164729|NCT02287987|Renal function|renal function
164730|NCT02287987|Off-clamp|off-clamp
164731|NCT02287987|Partial nephrectomy|partial nephrectomy
164732|NCT02287987|Robotic|robotic
164733|NCT02287987|Hylar clamping|hylar clamping
164734|NCT02287948|Balance|balance
164735|NCT02287948|Multiple Sclerosis|multiple sclerosis
164736|NCT02287948|Nintendo Wii Fit|nintendo wii fit
164737|NCT02287935|Karydakis procedure|karydakis procedure
164738|NCT02287935|Limberg flap|limberg flap
164739|NCT02287935|recurrent pilonidal sinus|recurrent pilonidal sinus
164740|NCT02287896|RhD-negative pregnant woman|rhd-negative pregnant woman
164741|NCT02287896|anti-RhD antibody|anti-rhd antibody
164742|NCT02287883|Patient activation and engagement|patient activation and engagement
164743|NCT02287883|Patient reported outcomes|patient reported outcomes
164744|NCT02287883|Accountable Care Organizations|accountable care organizations
164745|NCT02287883|Chronic illness|chronic illness
164746|NCT02287883|Vulnerable population|vulnerable population
164747|NCT02287883|Comparison of approaches|comparison of approaches
164748|NCT02287870|Epidural anesthesia|epidural anesthesia
164749|NCT02287870|Chloroprocaine|chloroprocaine
164750|NCT02287870|Lidocaine|lidocaine
164751|NCT02287844|Xylo-oligosaccharides|xylo-oligosaccharides
164752|NCT02287844|Immunonutrition|immunonutrition
164753|NCT02287844|Prebiotics|prebiotics
164754|NCT02287844|Lipopolysaccharides|lipopolysaccharides
164755|NCT02287844|Cytokines|cytokines
164756|NCT02287805|craniosynostosis|craniosynostosis
164757|NCT02287805|simple form|simple form
164758|NCT02287805|complex form|complex form
164759|NCT02287805|diagnostic|diagnostic
164760|NCT02287805|announcement|announcement
164762|NCT02287792|Infective endocarditis|infective endocarditis
164763|NCT02287792|18-FDG PET/CT|18-fdg pet/ct
164764|NCT02287792|Impact|impact
164765|NCT02287792|Patient's management|patient's management
164766|NCT02287792|Diagnostic|diagnostic
164767|NCT02287753|vascular occlusion test|vascular occlusion test
164768|NCT02287753|near infrared spectroscopy|near infrared spectroscopy
164769|NCT02287740|Exercise|exercise
164770|NCT02287714|Instep plantar fasciotomy|instep plantar fasciotomy
164771|NCT02287701|bladder cancer|bladder cancer
164772|NCT02287701|MRI|mri
164773|NCT02287701|PET|pet
164774|NCT02287688|safety of Meningococcal quadrivalent CRM-197 conjugate vaccine|safety of meningococcal quadrivalent crm-197 conjugate vaccine
164775|NCT02287688|Children 2-23 months of age|children 2-23 months of age
164776|NCT02287675|Sentinel Node|sentinel node
164777|NCT02287662|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
164778|NCT02287649|Immune thrombocytopenia|immune thrombocytopenia
164779|NCT02287649|Fc gamma RIIIA V/F158 polymorphism|fc gamma riiia v/f158 polymorphism
164780|NCT02287649|Rituximab|rituximab
164781|NCT02287649|autoreactive B and T cells|autoreactive b and t cells
164782|NCT02287649|ITP|itp
164783|NCT02287610|RA|ra
164784|NCT02287610|Delayed-release prednisone|delayed-release prednisone
164785|NCT02287610|Immediate-release prednisone|immediate-release prednisone
164786|NCT02287610|Non-interventional|non-interventional
164787|NCT02287571|comfort|comfort
164788|NCT02287571|satisfaction|satisfaction
164789|NCT02287558|HHT|hht
164790|NCT02287558|CASE4Z14|case4z14
164791|NCT02287558|Pomalidomide|pomalidomide
164792|NCT02287545|open angle glaucoma|open angle glaucoma
164793|NCT02287545|corneal biomechanics|corneal biomechanics
164794|NCT02287545|trabeculectomy|trabeculectomy
164795|NCT02287506|diagnosis, strategy|diagnosis, strategy
164796|NCT02287480|Ebolavirus Vaccines|ebolavirus vaccines
164797|NCT02287467|Antiviral|antiviral
164808|NCT02287350|moderate acute pain|moderate acute pain
164809|NCT02287350|mild or moderate acute pain|mild or moderate acute pain
164810|NCT02287350|NSAID|nsaid
164811|NCT02287350|nonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drug
164812|NCT02287337|Neck pain|neck pain
164813|NCT02287324|Cervicalgia|cervicalgia
164814|NCT02287311|EBV positive diseases|ebv positive diseases
164815|NCT02287311|cytotoxic T lymphocytes|cytotoxic t lymphocytes
164816|NCT02287285|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
164817|NCT02287285|Gastric Bypass Surgery|gastric bypass surgery
164818|NCT02287285|Exendin9|exendin9
164819|NCT02287272|COPD- cimetidine- drug-drug interaction|copd- cimetidine- drug-drug interaction
164820|NCT02287233|Myelogenous Leukemia|myelogenous leukemia
164821|NCT02287233|Untreated AML|untreated aml
164822|NCT02287233|Treatment Naive AML|treatment naive aml
164823|NCT02287220|Non-Contact Oximetry|non-contact oximetry
164824|NCT02287220|video plethysmography|video plethysmography
164825|NCT02287220|oxygen desaturation|oxygen desaturation
164826|NCT02287168|Peritoneal lavage|peritoneal lavage
164827|NCT02287168|Dissemination|dissemination
164828|NCT02287168|Gastrectomy|gastrectomy
164829|NCT02287168|Cytology|cytology
164830|NCT02287168|Lavage|lavage
164831|NCT02287155|Health Promotion|health promotion
164832|NCT02287155|Intervention Study|intervention study
164833|NCT02287155|Occupational Therapy|occupational therapy
164834|NCT02287155|Rural Population|rural population
164835|NCT02287155|Quality of life|quality of life
164836|NCT02287155|Sense of coherence|sense of coherence
164837|NCT02287129|Potentially R0 - resectable AEG and primary tumor category|potentially r0 - resectable aeg and primary tumor category
164838|NCT02287129|Histologically confirmed AEG I-III|histologically confirmed aeg i-iii
164839|NCT02287129|Functional operability|functional operability
164840|NCT02287129|Intense FDG tracer uptake of the tumor|intense fdg tracer uptake of the tumor
164841|NCT02287116|preterm infants|preterm infants
164842|NCT02287116|CPAP|cpap
164843|NCT02287116|BPD|bpd
155878|NCT02337777|Magnetic ResonanceCine|magnetic resonancecine
155879|NCT02337777|BOLD|bold
155880|NCT02337777|phase contrast|phase contrast
155881|NCT02337777|diffusion-weighted imaging|diffusion-weighted imaging
155882|NCT02337777|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
164844|NCT02287116|invasive mechanical ventilation|invasive mechanical ventilation
164845|NCT02287116|we aimed determine that affect the rate of BPD and death of NCPAP therapy with nasal prongs or nasal mask as the initial treatment for RDS.|we aimed determine that affect the rate of bpd and death of ncpap therapy with nasal prongs or nasal mask as the initial treatment for rds.
164846|NCT02287103|Skipping Breakfast|skipping breakfast
164847|NCT02287038|PTSD|ptsd
164848|NCT02287038|ADHD|adhd
164849|NCT02287038|Comorbidity|comorbidity
164850|NCT02287038|Combat Trauma|combat trauma
164851|NCT02287038|Cognitive Deficit|cognitive deficit
164852|NCT02286986|Epilepsy|epilepsy
164853|NCT02286986|Dravet syndrome|dravet syndrome
164854|NCT02286986|Seizures|seizures
164855|NCT02286986|Intractable Epilepsy|intractable epilepsy
164856|NCT02286986|Medically Refractory Epilepsy|medically refractory epilepsy
164857|NCT02286973|Tranexamic acid|tranexamic acid
164858|NCT02286947|DMD|dmd
164859|NCT02286947|exon 51|exon 51
164860|NCT02286947|dystrophin|dystrophin
164861|NCT02286947|dystrophy|dystrophy
164862|NCT02286947|Eteplirsen|eteplirsen
164863|NCT02286947|Duchenne|duchenne
164864|NCT02286934|Carvedilol|carvedilol
164865|NCT02286934|CYP2D6|cyp2d6
164866|NCT02286934|Isoproterenol Sensitivity Test|isoproterenol sensitivity test
164867|NCT02286921|Testosterone|testosterone
164868|NCT02286921|Enzalutamide|enzalutamide
164869|NCT02286921|Abiraterone|abiraterone
164870|NCT02286921|Androgen Ablative Therapies|androgen ablative therapies
164871|NCT02286921|Bipolar Androgen Therapy|bipolar androgen therapy
164872|NCT02286908|Ejection fraction, Global Strain, Mechanical dispersion|ejection fraction, global strain, mechanical dispersion
164873|NCT02286895|rotavirus|rotavirus
164874|NCT02286895|rotavirus vaccine|rotavirus vaccine
164875|NCT02286895|Mali|mali
164876|NCT02286895|EPI vaccines|epi vaccines
164877|NCT02286882|Single Ascending Dose|single ascending dose
164881|NCT02286869|heart rate variability|heart rate variability
164882|NCT02286869|cardioventilatory coupling|cardioventilatory coupling
164883|NCT02286856|malnutrition, diet intervention, Nutritional Assessment|malnutrition, diet intervention, nutritional assessment
164884|NCT02286843|89Zr-trastuzumab|89zr-trastuzumab
164886|NCT02286843|14-156|14-156
164887|NCT02286830|osteolysis|osteolysis
164888|NCT02286830|zoledronic acid|zoledronic acid
164889|NCT02286830|osteonecrosis|osteonecrosis
164890|NCT02286830|bone markers|bone markers
164891|NCT02286830|low-dose CT|low-dose ct
164892|NCT02286791|Prevention of dementia|prevention of dementia
164893|NCT02286791|Mindful awareness program|mindful awareness program
164894|NCT02286791|Mild cognitive impairment|mild cognitive impairment
164895|NCT02286791|Mindfulness|mindfulness
164897|NCT02286791|Cognitive decline|cognitive decline
164898|NCT02286765|Ulthera System|ulthera system
164899|NCT02286765|Ultherapy|ultherapy
164900|NCT02286739|Total Knee Arthroplasty|total knee arthroplasty
164901|NCT02286739|Rotational Alignment|rotational alignment
164902|NCT02286739|Intraoperative Sensors|intraoperative sensors
164903|NCT02286739|Patient Outcomes|patient outcomes
164904|NCT02286739|Soft Tissue Balance|soft tissue balance
164905|NCT02286726|Leukemia|leukemia
164906|NCT02286726|Acute myeloid leukemia|acute myeloid leukemia
164907|NCT02286726|AML|aml
164908|NCT02286726|CPX-351|cpx-351
164909|NCT02286726|Phone call|phone call
164910|NCT02286713|Lung Cancer Screening|lung cancer screening
164911|NCT02286713|heavy smokers|heavy smokers
164912|NCT02286713|state-based smoking cessation quitlines|state-based smoking cessation quitlines
164913|NCT02286713|patient decision aid|patient decision aid
164914|NCT02286713|low-dose computed tomography|low-dose computed tomography
164915|NCT02286713|LDCT|ldct
164916|NCT02286713|standard educational information|standard educational information
164917|NCT02286700|dermatitis, eczema, itch, moisturizer, amino acid|dermatitis, eczema, itch, moisturizer, amino acid
164918|NCT02286687|Advanced Cancers|advanced cancers
164919|NCT02286687|Germline mutations|germline mutations
164920|NCT02286687|Metastatic cancer|metastatic cancer
164921|NCT02286687|Talazoparib Tosylate|talazoparib tosylate
164922|NCT02286687|BMN 673|bmn 673
164923|NCT02286687|Phone call|phone call
164924|NCT02286674|mYpas|mypas
164925|NCT02286674|anxiety|anxiety
164926|NCT02286674|distraction|distraction
164927|NCT02286674|inhalation induction|inhalation induction
164928|NCT02286648|clinical signs|clinical signs
164929|NCT02286648|child|child
164930|NCT02286648|pulpotomy|pulpotomy
164931|NCT02286583|RTM|rtm
164932|NCT02286583|Female breast cancer|female breast cancer
164933|NCT02286557|Methylphenidate|methylphenidate
155979|NCT02337140|disorders|disorders
155980|NCT02337114|Acceptance and Commitment Therapy|acceptance and commitment therapy
164934|NCT02286557|Multiple Sclerosis|multiple sclerosis
164935|NCT02286557|Cognitive Fatigue|cognitive fatigue
164936|NCT02286544|Myocardial Infarction|myocardial infarction
164937|NCT02286544|Oxygen|oxygen
164938|NCT02286544|Inflammation|inflammation
164939|NCT02286544|Acute coronary syndrome (ACS)|acute coronary syndrome (acs)
164940|NCT02286544|ST-segment elevation myocardial infarction (STEMI)|st-segment elevation myocardial infarction (stemi)
164941|NCT02286544|Reperfusion injury (IR-injury)|reperfusion injury (ir-injury)
164942|NCT02286544|Biomarkers|biomarkers
164943|NCT02286544|Normoxemia|normoxemia
164944|NCT02286544|Salmonella typhi|salmonella typhi
164945|NCT02286544|Vaccine-induced inflammation|vaccine-induced inflammation
164946|NCT02286544|Soluble markers of apoptosis|soluble markers of apoptosis
164947|NCT02286544|Leukocyte subset distribution|leukocyte subset distribution
164948|NCT02286544|Matrix metalloproteinase (MMP)|matrix metalloproteinase (mmp)
164949|NCT02286544|Biological Markers|biological markers
164950|NCT02286531|: Low grade glioma|: low grade glioma
164951|NCT02286531|PET|pet
164952|NCT02286531|FET|fet
164953|NCT02286531|MRI|mri
164954|NCT02286531|Standardized uptake value|standardized uptake value
164955|NCT02286453|Osteoarthritis of The knee|osteoarthritis of the knee
164956|NCT02286453|Benjakul|benjakul
164957|NCT02286453|Alternative Medicine|alternative medicine
164958|NCT02286440|Depression|depression
164959|NCT02286440|Genotyping|genotyping
164960|NCT02286440|Pharmacokinetic|pharmacokinetic
164961|NCT02286440|Pharmacodynamic|pharmacodynamic
164962|NCT02286414|Oral anticoagulants, Geriatrics, General Practitioner, Safety, Misuse|oral anticoagulants, geriatrics, general practitioner, safety, misuse
164963|NCT02286401|myocardial perfusion|myocardial perfusion
164964|NCT02286401|coronary atherosclerosis|coronary atherosclerosis
164965|NCT02286401|coronary blood flow|coronary blood flow
164966|NCT02286401|fractional flow reserve|fractional flow reserve
164967|NCT02286401|coronary flow reserve|coronary flow reserve
164968|NCT02286388|Deep carious lesion|deep carious lesion
164969|NCT02286388|incomplete caries removal|incomplete caries removal
164970|NCT02286388|antibacterial adhesive system|antibacterial adhesive system
164973|NCT02286388|randomized controlled trial|randomized controlled trial
164974|NCT02286375|health-social partnership|health-social partnership
164975|NCT02286375|self-efficacy|self-efficacy
165416|NCT02283359|Stomach|stomach
164976|NCT02286349|Neuromodulation Attention Deficit Hyperactivity Disorder|neuromodulation attention deficit hyperactivity disorder
164977|NCT02286336|minimum effective concentration|minimum effective concentration
164978|NCT02286336|ropivacaine|ropivacaine
164979|NCT02286336|ultrasound-guided supraclavicular block|ultrasound-guided supraclavicular block
164980|NCT02286323|Intubation, Endotracheal|intubation, endotracheal
164981|NCT02286310|Exercise|exercise
164982|NCT02286310|Kinematics|kinematics
164983|NCT02286297|Intubation|intubation
164984|NCT02286284|Early severe preeclampsia|early severe preeclampsia
164985|NCT02286284|Angiogenic factor|angiogenic factor
164986|NCT02286284|Apheresis|apheresis
164987|NCT02286271|Seizure detection|seizure detection
164988|NCT02286258|Inulin|inulin
164989|NCT02286258|Ca-EDTA|ca-edta
164990|NCT02286258|Gd-DOTA|gd-dota
164991|NCT02286258|Chronic kidney disease|chronic kidney disease
164992|NCT02286258|glomerular filtration rate measurement|glomerular filtration rate measurement
164993|NCT02286245|Triage|triage
164995|NCT02286245|Primary Health Care|primary health care
164996|NCT02286245|Emergency Medical Service Communication Systems|emergency medical service communication systems
164997|NCT02286232|Chronic low back pain|chronic low back pain
164998|NCT02286232|stretching exercises|stretching exercises
164999|NCT02286206|Clozapine|clozapine
165000|NCT02286206|Psychotropic Drugs|psychotropic drugs
165001|NCT02286206|Antipsychotic Agents|antipsychotic agents
165002|NCT02286206|Psychotic Disorders|psychotic disorders
165003|NCT02286206|Schizophrenia|schizophrenia
165004|NCT02286206|Adverse Effects|adverse effects
165005|NCT02286206|Drug Monitoring|drug monitoring
165006|NCT02286180|near infrared spectroscopy|near infrared spectroscopy
165007|NCT02286180|NIRS|nirs
165008|NCT02286180|intern|intern
165009|NCT02286167|modified-Atkins diet|modified-atkins diet
165010|NCT02286167|ketogenic diet|ketogenic diet
165011|NCT02286167|central nervous system malignancy|central nervous system malignancy
165012|NCT02286167|glioma|glioma
165013|NCT02286154|Hydroxyurea|hydroxyurea
165014|NCT02286154|Sickle Cell|sickle cell
165015|NCT02286154|Pharmacokinetics|pharmacokinetics
165016|NCT02286154|dynamics|dynamics
165017|NCT02286154|genomics|genomics
165018|NCT02286128|Type 2 diabetes|type 2 diabetes
165019|NCT02286128|RAGE|rage
165020|NCT02286128|osteoblast|osteoblast
165021|NCT02286115|Chronic Pelvic Pain|chronic pelvic pain
165022|NCT02286115|Interstitial Cystitis|interstitial cystitis
165023|NCT02286115|Vulvodynia|vulvodynia
165024|NCT02286115|Dyspareunia|dyspareunia
165025|NCT02286115|Pelvic Floor Dysfunction|pelvic floor dysfunction
165026|NCT02286115|Emotional Processing|emotional processing
165027|NCT02286089|dry-AMD|dry-amd
165028|NCT02286089|Geographic Atrophy|geographic atrophy
165029|NCT02286076|endometrioma|endometrioma
165030|NCT02286076|laparoscopy|laparoscopy
165031|NCT02286076|ovarian reserve|ovarian reserve
165032|NCT02286037|Secondary Hyperalgesia|secondary hyperalgesia
165033|NCT02286037|Method|method
165034|NCT02286037|Pin-prick|pin-prick
165035|NCT02286037|Monofilament|monofilament
165036|NCT02285998|Influenza|influenza
165037|NCT02285985|Adipose tissue|adipose tissue
165038|NCT02285985|Inflammation|inflammation
165039|NCT02285985|.Obesity|.obesity
165040|NCT02285933|stroke|stroke
165041|NCT02285933|physical therapy specialty|physical therapy specialty
165042|NCT02285933|exercise therapy|exercise therapy
165043|NCT02285933|virtual reality|virtual reality
165044|NCT02285933|man-machine systems|man-machine systems
165045|NCT02285933|randomized control trial|randomized control trial
165046|NCT02285933|inpatients|inpatients
165047|NCT02285933|rehabilitation|rehabilitation
165048|NCT02285920|hemodialysis|hemodialysis
165049|NCT02285920|spironolactone|spironolactone
165050|NCT02285920|cardiac fibrosis|cardiac fibrosis
165051|NCT02285920|diastolic function|diastolic function
165052|NCT02285881|diabetes treatment|diabetes treatment
165053|NCT02285881|personalized medicine|personalized medicine
165054|NCT02285881|shared decision making|shared decision making
165055|NCT02285881|goal setting|goal setting
165056|NCT02285868|Orthopedic rehabilitation|orthopedic rehabilitation
165057|NCT02285868|Rehabilitation outcomes|rehabilitation outcomes
165058|NCT02285868|Physical therapy|physical therapy
165059|NCT02285868|Physical therapy outcomes|physical therapy outcomes
165060|NCT02285855|Lung Cancer|lung cancer
165061|NCT02285855|Non small cell lung cancer|non small cell lung cancer
165062|NCT02285855|Stereotactic body radiotherapy|stereotactic body radiotherapy
165063|NCT02285855|SBRT|sbrt
165065|NCT02285855|Radiation therapy|radiation therapy
165066|NCT02285855|Metformin|metformin
165067|NCT02285855|Metformin ER|metformin er
165068|NCT02285855|Placebo|placebo
165069|NCT02285855|Sugar pill|sugar pill
165070|NCT02285855|Lung adenocarcinoma|lung adenocarcinoma
165072|NCT02285855|Genetic mutations|genetic mutations
165073|NCT02285842|osteoarthritis|osteoarthritis
165074|NCT02285842|avascular necrosis|avascular necrosis
165075|NCT02285842|ankylosis|ankylosis
165076|NCT02285842|protrusio acetabuli|protrusio acetabuli
165077|NCT02285842|painful hip dysplasia|painful hip dysplasia
165078|NCT02285842|rheumatoid arthritis|rheumatoid arthritis
165079|NCT02285842|correction of functional deformity|correction of functional deformity
165080|NCT02285842|revision procedures|revision procedures
165081|NCT02285751|high on treatment platelet reactivity|high on treatment platelet reactivity
165082|NCT02285751|acetylsalicylic acid|acetylsalicylic acid
165083|NCT02285751|clopidogrel|clopidogrel
165084|NCT02285751|prasugrel|prasugrel
165085|NCT02285751|ticagrelor|ticagrelor
165086|NCT02285751|critically ill|critically ill
165087|NCT02285751|pharmacokinetic|pharmacokinetic
165088|NCT02285751|pharmacodynamics|pharmacodynamics
165089|NCT02285738|solid tumor, cancer, simvastatin, aspirin, blood clot, VTE, venous thromboembolism|solid tumor, cancer, simvastatin, aspirin, blood clot, vte, venous thromboembolism
165090|NCT02285712|Peripheral venous catheter|peripheral venous catheter
165091|NCT02285712|ultrasound|ultrasound
165092|NCT02285712|nurse|nurse
165093|NCT02285712|Intensive Care Units|intensive care units
165594|NCT02282371|Cetuximab|cetuximab
165096|NCT02285686|biomarkers|biomarkers
165097|NCT02285686|myocardial infarction|myocardial infarction
165098|NCT02285686|critical illness|critical illness
165099|NCT02285673|umbilical cord, mesenchymal stem cell|umbilical cord, mesenchymal stem cell
165100|NCT02285621|Scoliosis|scoliosis
165101|NCT02285621|Spine deformity|spine deformity
165102|NCT02285621|Brace|brace
165104|NCT02285608|Medication adherence|medication adherence
165105|NCT02285608|Patient education|patient education
165106|NCT02285608|Mood disorders|mood disorders
165107|NCT02285608|Economic assessment|economic assessment
165108|NCT02285608|Mixed methods|mixed methods
165109|NCT02285556|drug carving changes during rehabilitation|drug carving changes during rehabilitation
165110|NCT02285556|community|community
165111|NCT02285556|DNA|dna
165112|NCT02285543|TPF induction chemotherapy, randomized, trial,OSCC|tpf induction chemotherapy, randomized, trial,oscc
165113|NCT02285530|head and neck squamous cell carcinoma, GDF15, TPF|head and neck squamous cell carcinoma, gdf15, tpf
165114|NCT02285504|Postpartum depression|postpartum depression
165115|NCT02285465|Healthy volunteers|healthy volunteers
165116|NCT02285465|Pharmacokinetics|pharmacokinetics
165117|NCT02285465|Pharmacodynamics|pharmacodynamics
165118|NCT02285465|ASP3700|asp3700
165119|NCT02285452|physiologcal phenomena|physiologcal phenomena
165120|NCT02285452|.HRV Parameters|.hrv parameters
165121|NCT02285452|respiratory activity|respiratory activity
165122|NCT02285452|thorax wraps|thorax wraps
165123|NCT02285439|Pediatric Oncology|pediatric oncology
165124|NCT02285439|Ras/Raf pathway|ras/raf pathway
165125|NCT02285439|Low-Grade Glioma|low-grade glioma
165126|NCT02285439|MEK inhibitor|mek inhibitor
165127|NCT02285426|i-scan|i-scan
165128|NCT02285426|histology|histology
165129|NCT02285413|Melanoma|melanoma
165130|NCT02285413|Dendritic cells|dendritic cells
165131|NCT02285413|Cisplatin|cisplatin
165132|NCT02285413|Vaccine|vaccine
165133|NCT02285413|Immunotherapy|immunotherapy
165134|NCT02285400|COPD|copd
165135|NCT02285400|CPAP|cpap
165136|NCT02285400|Central Drive|central drive
165137|NCT02285348|Ataxia Telangiectasia|ataxia telangiectasia
165138|NCT02285348|cerebrospinal fluid|cerebrospinal fluid
165139|NCT02285348|inflammation|inflammation
165140|NCT02285348|proteomic analysis|proteomic analysis
165141|NCT02285309|Cardiac Surgery|cardiac surgery
165142|NCT02285309|Diastolic Dysfunction|diastolic dysfunction
165143|NCT02285309|Enoximone|enoximone
165144|NCT02285296|geriatric assessment|geriatric assessment
165145|NCT02285296|Caregivers|caregivers
165146|NCT02285296|Needs Assessment|needs assessment
165147|NCT02285296|oncology nursing|oncology nursing
165148|NCT02285296|frail elderly|frail elderly
165149|NCT02285296|Medical, psychologic and sociologic approach|medical, psychologic and sociologic approach
165150|NCT02285270|Circadian rhythm|circadian rhythm
165151|NCT02285270|Adipose tissue, brown|adipose tissue, brown
165152|NCT02285270|Metabolism|metabolism
165153|NCT02285257|Sepsis, Severe sepsis, septic shock, epidemiology, outcome|sepsis, severe sepsis, septic shock, epidemiology, outcome
165154|NCT02285231|Anti-hyperglycemic effect|anti-hyperglycemic effect
165155|NCT02285192|18F-FDG Injection|18f-fdg injection
165156|NCT02285192|Positron Lymphography|positron lymphography
165157|NCT02285192|Lymphatic Mapping|lymphatic mapping
165158|NCT02285192|sentinel lymph nodes|sentinel lymph nodes
165159|NCT02285192|PET/CT|pet/ct
165160|NCT02285192|14-222|14-222
165161|NCT02285179|GDC-0032|gdc-0032
165162|NCT02285179|Pi3K inhibitor|pi3k inhibitor
165163|NCT02285179|tamoxifen|tamoxifen
165164|NCT02285179|hormone receptor positive|hormone receptor positive
165165|NCT02285179|dose escalation|dose escalation
165166|NCT02285179|RECIST|recist
165167|NCT02285179|pharmacodynamic|pharmacodynamic
165168|NCT02285166|Pharmaocological therapy|pharmaocological therapy
165169|NCT02285153|acetylsalicylic acid|acetylsalicylic acid
165170|NCT02285153|intensive care unit|intensive care unit
165171|NCT02285153|mortality|mortality
165172|NCT02285153|Post mortem examination|post mortem examination
165173|NCT02285153|bleeding|bleeding
165175|NCT02285114|emtricitabine|emtricitabine
165176|NCT02285114|FTC|ftc
165177|NCT02285114|tenofovir|tenofovir
165178|NCT02285114|TDF|tdf
165179|NCT02285114|TAF|taf
165180|NCT02285114|antiretroviral|antiretroviral
165181|NCT02285114|pharmacokinetic|pharmacokinetic
165182|NCT02285114|PK|pk
165183|NCT02285114|adolescents|adolescents
165184|NCT02285114|children|children
165185|NCT02285114|pediatric|pediatric
165186|NCT02285114|Gilead|gilead
165187|NCT02285101|arginine auxotrophic tumors|arginine auxotrophic tumors
165188|NCT02285101|PEG-BCT-100|peg-bct-100
165189|NCT02285101|arginase|arginase
165190|NCT02285075|temocillin|temocillin
165191|NCT02285075|PD/PD|pd/pd
165192|NCT02285075|T>MIC|t>mic
165292|NCT02284191|Acute Medicine|acute medicine
165214|NCT02284932|COPD|copd
165215|NCT02284932|atrophy|atrophy
165216|NCT02284932|muscle|muscle
165217|NCT02284906|Drug therapy|drug therapy
165218|NCT02284867|uterine natural killer cells|uterine natural killer cells
165219|NCT02284867|CD16|cd16
165220|NCT02284867|CD56|cd56
165221|NCT02284867|Preterm labour|preterm labour
165222|NCT02284815|Gluten|gluten
165223|NCT02284815|T1D|t1d
165224|NCT02284815|Remission|remission
165225|NCT02284789|Hemophilia|hemophilia
165226|NCT02284776|Therapeutic education|therapeutic education
165227|NCT02284750|Bifurcation lesion|bifurcation lesion
165228|NCT02284750|Percutaneous coronary intervention|percutaneous coronary intervention
165229|NCT02284737|Pulmonary arterial hypertension|pulmonary arterial hypertension
165230|NCT02284711|salpingectomy, ovarian reserve, coagulation technique|salpingectomy, ovarian reserve, coagulation technique
165231|NCT02284685|Mental Health Services|mental health services
165232|NCT02284646|Ankylosing spondylitis|ankylosing spondylitis
165233|NCT02284646|Physical training program|physical training program
165234|NCT02284633|EGFR mutation|egfr mutation
165235|NCT02284633|Liquid biopsies|liquid biopsies
165236|NCT02284633|Lung cancer|lung cancer
165237|NCT02284633|erlotinib|erlotinib
165238|NCT02284620|anesthesia|anesthesia
165239|NCT02284620|nerve block|nerve block
165240|NCT02284620|infltration|infltration
165241|NCT02284581|MBC|mbc
165242|NCT02284581|metastatic|metastatic
165243|NCT02284581|breast|breast
165244|NCT02284581|observational|observational
165245|NCT02284581|disease management|disease management
165246|NCT02284529|high-risk stage-Ⅱ Colorectal Cancer,Orectalip,oxaliplatin|high-risk stage-ⅱ colorectal cancer,orectalip,oxaliplatin
165247|NCT02284503|MI reduction|mi reduction
165248|NCT02284503|intensive statin treatment|intensive statin treatment
165249|NCT02284503|NSTE-ACS|nste-acs
165250|NCT02284490|Brain Metastases|brain metastases
165251|NCT02284477|Insulin resistance|insulin resistance
165252|NCT02284477|Pulmonary function|pulmonary function
165253|NCT02284477|Phthalates|phthalates
165254|NCT02284464|Kidney transplant|kidney transplant
165255|NCT02284464|Immunosuppression|immunosuppression
165256|NCT02284464|Steroid withdrawal|steroid withdrawal
165257|NCT02284464|Donor specific antibodies|donor specific antibodies
165258|NCT02284451|HIV/AIDS and HIV Testing Knowledge|hiv/aids and hiv testing knowledge
165259|NCT02284438|ETT|ett
165260|NCT02284438|Biofilm|biofilm
165261|NCT02284438|Mechanical ventilation|mechanical ventilation
165262|NCT02284438|Critical illness|critical illness
165263|NCT02284438|Ventilator-associated pneumonia|ventilator-associated pneumonia
165264|NCT02284412|Neostigmine|neostigmine
165265|NCT02284412|Sugammadex|sugammadex
165266|NCT02284399|aneuploidy|aneuploidy
165267|NCT02284399|Trisomy 21|trisomy 21
165268|NCT02284399|NIPT|nipt
165269|NCT02284386|Total knee arthroplasty|total knee arthroplasty
165270|NCT02284360|wound healing|wound healing
165271|NCT02284360|APOSEC™|aposec™
165272|NCT02284360|Safety|safety
165273|NCT02284334|mitochondrial diseases|mitochondrial diseases
165274|NCT02284334|nutrition|nutrition
165275|NCT02284334|glycemic index|glycemic index
165277|NCT02284295|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
165278|NCT02284295|silica dust|silica dust
165279|NCT02284295|aromatic hydrocarbons|aromatic hydrocarbons
165280|NCT02284295|genetic|genetic
165281|NCT02284295|occupational|occupational
165282|NCT02284282|Spinal Morphine|spinal morphine
165283|NCT02284282|Laparoscopic GI-surgery|laparoscopic gi-surgery
165284|NCT02284282|Post-operative pain|post-operative pain
165285|NCT02284243|Bunion|bunion
165286|NCT02284243|Bunionectomy|bunionectomy
165287|NCT02284243|Pain|pain
165288|NCT02284243|Analgesia|analgesia
165289|NCT02284243|dexmedetomidine|dexmedetomidine
165290|NCT02284243|intranasal|intranasal
165291|NCT02284191|Radiology|radiology
165296|NCT02284178|aspiration|aspiration
165297|NCT02284178|suctioning|suctioning
165298|NCT02284178|secretions|secretions
165299|NCT02284178|ventilator-associated events|ventilator-associated events
165300|NCT02284152|bottle feeding|bottle feeding
165301|NCT02284152|feeding behavior|feeding behavior
165302|NCT02284152|infants|infants
165303|NCT02284152|mothers|mothers
165304|NCT02284152|responsive feeding|responsive feeding
165305|NCT02284152|maternal feeding practices|maternal feeding practices
165306|NCT02284152|maternal feeding styles|maternal feeding styles
165307|NCT02284139|EGF ointment|egf ointment
165308|NCT02284139|EGFR inhibitor|egfr inhibitor
401980|NCT01232465|IVF outcome|ivf outcome
165309|NCT02284139|Skin side effect|skin side effect
165310|NCT02284126|Vancomycin|vancomycin
165311|NCT02284126|Anti-Infective Agents, Local|anti-infective agents, local
165312|NCT02284126|Craniotomy|craniotomy
165313|NCT02284126|surgical site infection|surgical site infection
165314|NCT02284126|wound prophylaxis|wound prophylaxis
165315|NCT02284126|Anti-Bacterial Agents|anti-bacterial agents
165316|NCT02284126|Neurosurgical Procedures|neurosurgical procedures
165317|NCT02284126|Administration, Topical|administration, topical
165318|NCT02284126|Antibiotic Prophylaxis|antibiotic prophylaxis
165319|NCT02284126|antibiotics|antibiotics
165320|NCT02284126|prophylaxis|prophylaxis
165321|NCT02284126|neurosurgery|neurosurgery
165322|NCT02284126|Bacterial Infections|bacterial infections
165323|NCT02284126|Central Nervous System Infections|central nervous system infections
165326|NCT02284074|Lipopolysaccharide (LPS)|lipopolysaccharide (lps)
165327|NCT02284074|Biomarkers|biomarkers
165328|NCT02284074|Chemokines|chemokines
165329|NCT02284074|Cytokines|cytokines
165330|NCT02284074|Gene Expression|gene expression
165331|NCT02284074|Nasal Challenge|nasal challenge
165332|NCT02284074|Inflammation|inflammation
165334|NCT02284074|Nasosorption|nasosorption
165335|NCT02284074|Respiratory|respiratory
165336|NCT02284048|Ticagrelor|ticagrelor
165337|NCT02284048|Coronary Flow Reserve|coronary flow reserve
165338|NCT02284009|New-onset type 1 diabetes mellitus|new-onset type 1 diabetes mellitus
165339|NCT02284009|Albiglutide|albiglutide
165340|NCT02283905|amphotericin-B|amphotericin-b
165341|NCT02283905|continuously infused|continuously infused
165342|NCT02283905|voriconazole|voriconazole
165343|NCT02283892|respiratory complaints|respiratory complaints
165344|NCT02283892|dyspnea|dyspnea
165345|NCT02283892|cough|cough
165346|NCT02283892|checklist|checklist
165347|NCT02283879|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
165348|NCT02283879|Mesenchymal Stem Cell|mesenchymal stem cell
165349|NCT02283879|Cerebral hemorrhage|cerebral hemorrhage
165350|NCT02283853|Pediatrics|pediatrics
165351|NCT02283749|NCSLC|ncslc
165352|NCT02283749|lung cancer|lung cancer
165353|NCT02283749|non small cell lung cancer|non small cell lung cancer
165354|NCT02283749|bone metastases|bone metastases
165355|NCT02283749|maintenance|maintenance
165356|NCT02283736|Chronic periodontitis|chronic periodontitis
165357|NCT02283736|Probiotics|probiotics
165358|NCT02283736|Non- surgical treatment|non- surgical treatment
165359|NCT02283723|older adults, goal attainment, optimal aging|older adults, goal attainment, optimal aging
165360|NCT02283710|Pentoxifylline|pentoxifylline
165361|NCT02283710|Aminotransferase|aminotransferase
165362|NCT02283710|Steatohepatitis|steatohepatitis
165363|NCT02283697|hypertension|hypertension
165364|NCT02283697|high blood pressure|high blood pressure
165365|NCT02283697|sodium|sodium
165366|NCT02283697|prevention|prevention
165367|NCT02283697|dietary sodium|dietary sodium
165368|NCT02283697|salt|salt
165369|NCT02283684|LASER|laser
165370|NCT02283684|PROSTATE|prostate
165371|NCT02283684|BIPOLAR|bipolar
165372|NCT02283684|HYPERPLASIA|hyperplasia
165373|NCT02283684|VAPORIZATION|vaporization
165374|NCT02283580|COPD|copd
165375|NCT02283580|Healthy adults|healthy adults
165376|NCT02283580|Resistance training|resistance training
165377|NCT02283580|Elastic bands|elastic bands
165378|NCT02283580|Limb muscle function|limb muscle function
165379|NCT02283580|Volunteers|volunteers
165380|NCT02283554|Periodontal Surgery|periodontal surgery
165381|NCT02283554|Periodontal Regeneration|periodontal regeneration
165382|NCT02283554|Growth factors|growth factors
165383|NCT02283554|Clinical trials|clinical trials
165384|NCT02283541|Gait|gait
165385|NCT02283541|late life depression|late life depression
165386|NCT02283541|mind-body therapies|mind-body therapies
165387|NCT02283515|chronic periodontitis|chronic periodontitis
165388|NCT02283515|local drug delivery|local drug delivery
165389|NCT02283515|rosuvastatin|rosuvastatin
165390|NCT02283515|osseo-differentiation|osseo-differentiation
165391|NCT02283502|Uterine fibroid|uterine fibroid
165392|NCT02283502|magnetic resonance imaging|magnetic resonance imaging
165393|NCT02283502|ultrasound|ultrasound
165395|NCT02283489|Recombinant Human Endostatin Adenovirus|recombinant human endostatin adenovirus
165396|NCT02283489|Head and Neck Malignant Tumor|head and neck malignant tumor
165398|NCT02283489|randomized|randomized
165399|NCT02283489|Endostatin|endostatin
165400|NCT02283489|gene therapy|gene therapy
165401|NCT02283476|efficacy and safety|efficacy and safety
165402|NCT02283437|Bibliotherapy|bibliotherapy
165403|NCT02283437|Problem-solving|problem-solving
165404|NCT02283437|Randomized Controlled Trial|randomized controlled trial
165405|NCT02283437|Schizophrenia Spectrum Disorders|schizophrenia spectrum disorders
165406|NCT02283437|Family Caregivers|family caregivers
165407|NCT02283385|Elder abuse|elder abuse
165408|NCT02283385|Intervention|intervention
165409|NCT02283385|Treatment|treatment
165410|NCT02283385|Detection|detection
165411|NCT02283359|Distal Esophagus|distal esophagus
165412|NCT02283359|Esophageal|esophageal
165414|NCT02283359|Carcinoma|carcinoma
165415|NCT02283359|Adenocarcinoma|adenocarcinoma
165417|NCT02283359|Gastro-esophageal junction|gastro-esophageal junction
165418|NCT02283359|Recurrent|recurrent
165419|NCT02283359|Metastatic|metastatic
165420|NCT02283359|Unresectable|unresectable
165421|NCT02283346|Prostate Cancer|prostate cancer
165422|NCT02283346|HDR brachytherapy|hdr brachytherapy
165423|NCT02283346|hypo fractionated external beam radiotherapy|hypo fractionated external beam radiotherapy
165424|NCT02283346|toxicity|toxicity
165425|NCT02283346|biochemical control|biochemical control
165426|NCT02283333|Behavioral Activation|behavioral activation
165427|NCT02283333|Therapeutic Exposure|therapeutic exposure
165428|NCT02283333|Mental Health|mental health
165429|NCT02283333|Veterans|veterans
165430|NCT02283333|Complicated Grief|complicated grief
165431|NCT02283333|Military|military
165432|NCT02283333|Treatment|treatment
165433|NCT02283333|Cognitive Therapy|cognitive therapy
165434|NCT02283333|Bereavement|bereavement
165435|NCT02283333|Complicated Bereavement|complicated bereavement
165436|NCT02283255|Fontan|fontan
165437|NCT02283255|Exercise|exercise
165438|NCT02283255|Pulmonary Function|pulmonary function
165439|NCT02283255|Aerobic Capacity|aerobic capacity
165440|NCT02283255|Skeletal Muscle|skeletal muscle
165441|NCT02283242|Cholinergic Antagonists|cholinergic antagonists
165442|NCT02283242|Inflammation|inflammation
165443|NCT02283242|Oxidative Stress|oxidative stress
165444|NCT02283229|Plagiocephaly|plagiocephaly
165445|NCT02283229|torticollis|torticollis
165446|NCT02283229|occlusal defect|occlusal defect
165447|NCT02283216|neuromodulation|neuromodulation
165448|NCT02283216|noninvasive|noninvasive
165449|NCT02283216|plasticity|plasticity
165450|NCT02283216|transcranial magnetic stimulation|transcranial magnetic stimulation
165451|NCT02283216|hearing|hearing
165452|NCT02283216|hyperacusis|hyperacusis
165453|NCT02283203|Paracetamol|paracetamol
165454|NCT02283203|Management of fever|management of fever
165455|NCT02283203|Infections|infections
165456|NCT02283190|Asparaginase|asparaginase
165457|NCT02283190|Glutamine|glutamine
165458|NCT02283164|Occupational health|occupational health
165459|NCT02283164|Hazardous material handling|hazardous material handling
165460|NCT02283151|Very Low Carbohydrate Diet|very low carbohydrate diet
165461|NCT02283151|Overweight/obese|overweight/obese
165462|NCT02283138|FLV, VOCAL, PA-RI, preterm fetuses, RDS|flv, vocal, pa-ri, preterm fetuses, rds
165463|NCT02282098|Atrial fibrillation|atrial fibrillation
165464|NCT02282098|Arrhythmias, Cardiac|arrhythmias, cardiac
165465|NCT02282098|Stroke|stroke
165466|NCT02282098|agents, anti inflammatory|agents, anti inflammatory
165467|NCT02282098|D-dimer|d-dimer
165468|NCT02282098|C-reactive protein|c-reactive protein
165469|NCT02282085|Medication Non-Adherence|medication non-adherence
165470|NCT02282085|Antipsychotic|antipsychotic
165471|NCT02282046|type 2 diabetes mellitus|type 2 diabetes mellitus
165472|NCT02282046|dental implant|dental implant
165474|NCT02282007|Quality of life|quality of life
165475|NCT02283099|Ebola virus, vaccination, phase I, healthy volunteers|ebola virus, vaccination, phase i, healthy volunteers
165476|NCT02283086|Quality Improvement|quality improvement
165477|NCT02283086|Physician Feedback|physician feedback
165478|NCT02283073|Diagnosis|diagnosis
165479|NCT02283060|Atripla|atripla
165480|NCT02283060|Stribild|stribild
165482|NCT02283060|Sleep architecture|sleep architecture
165483|NCT02283060|Neuropsychological performance|neuropsychological performance
165484|NCT02283047|cardiovascular risk, obesity, interval training, diet|cardiovascular risk, obesity, interval training, diet
165485|NCT02283021|expression of L-type calcium subunits|expression of l-type calcium subunits
165486|NCT02282995|Functional dyspepsia|functional dyspepsia
165487|NCT02282995|symptom response|symptom response
165488|NCT02282982|Immunoprophylaxis|immunoprophylaxis
165489|NCT02282982|Palivizumab|palivizumab
165490|NCT02282969|Cancer Prevention|cancer prevention
165491|NCT02282969|Smokers|smokers
165492|NCT02282969|Quit smoking|quit smoking
165493|NCT02282969|Interviews|interviews
165494|NCT02282969|Questionnaires|questionnaires
165495|NCT02282969|Surveys|surveys
165496|NCT02282969|Lung cancer screening|lung cancer screening
165497|NCT02282969|Patient decision aid|patient decision aid
165498|NCT02282943|endometriosis|endometriosis
165499|NCT02282943|CO2 laser vapourisation|co2 laser vapourisation
165500|NCT02282943|Harmonic scalpel|harmonic scalpel
165501|NCT02282943|AFS stage I-III|afs stage i-iii
165502|NCT02282930|ACTH|acth
165503|NCT02282930|Acthar|acthar
165504|NCT02282930|IgA|iga
165505|NCT02282930|Progressive|progressive
165506|NCT02282930|Nephropathy|nephropathy
165507|NCT02282930|renal function|renal function
165508|NCT02282917|NF2|nf2
165509|NCT02282917|Vestibular Schwannoma|vestibular schwannoma
165510|NCT02282917|Schwannoma|schwannoma
165511|NCT02282917|Meningioma|meningioma
165512|NCT02282904|Bone Marrow Transplant|bone marrow transplant
165513|NCT02282904|Subablative Conditioning|subablative conditioning
165514|NCT02282904|Graft Versus Host Disease|graft versus host disease
165515|NCT02282904|Non-Myeloablative|non-myeloablative
165516|NCT02282904|Reduced Intensity|reduced intensity
165517|NCT02282891|propofol|propofol
165518|NCT02282891|ketofol|ketofol
165519|NCT02282878|High Sodium Diet|high sodium diet
165520|NCT02282878|Low Sodium Diet|low sodium diet
165521|NCT02282878|MS|ms
165522|NCT02282865|Emergence agitation, Heart rate variability (HRV)|emergence agitation, heart rate variability (hrv)
165523|NCT02282839|Head and neck cancer|head and neck cancer
165524|NCT02282839|Glutamine|glutamine
165525|NCT02282839|Oral mucositis|oral mucositis
165526|NCT02282839|Quality of life|quality of life
165527|NCT02282813|Parathyroid Diseases|parathyroid diseases
165528|NCT02282813|Renal Insufficiency|renal insufficiency
165529|NCT02282813|Kidney Failure, Chronic|kidney failure, chronic
165530|NCT02282813|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
165531|NCT02282813|Vitamin D|vitamin d
165532|NCT02282813|Hyperparathyroidism|hyperparathyroidism
165533|NCT02282813|Kidney Diseases|kidney diseases
165534|NCT02282813|Kidney Failure|kidney failure
165535|NCT02282813|Renal Insufficiency, Chronic|renal insufficiency, chronic
165536|NCT02282787|local anesthesia|local anesthesia
165537|NCT02282787|peribulbar anesthesia|peribulbar anesthesia
165538|NCT02282787|DEXMEDETOMIDINE|dexmedetomidine
165539|NCT02282787|vitreoretinal surgery|vitreoretinal surgery
165540|NCT02282774|Vitreoretinal surgery|vitreoretinal surgery
165541|NCT02282735|neuroblastoma|neuroblastoma
165542|NCT02282735|end-of-life|end-of-life
165543|NCT02282735|decision-making|decision-making
165544|NCT02282735|parent|parent
165545|NCT02282735|child|child
165546|NCT02282735|prognosis|prognosis
165547|NCT02282735|preferences|preferences
165548|NCT02282735|childhood cancer|childhood cancer
165549|NCT02282735|oncology|oncology
165550|NCT02282722|cancer|cancer
165551|NCT02282722|palliative|palliative
165552|NCT02282722|chemotherapy|chemotherapy
165553|NCT02282722|metastatic|metastatic
165554|NCT02282722|colorectal|colorectal
165555|NCT02282722|communication|communication
165556|NCT02282722|informed consent|informed consent
165557|NCT02282722|video|video
165558|NCT02282722|education|education
165559|NCT02282722|oncology|oncology
165560|NCT02282722|patient-centered|patient-centered
165561|NCT02282722|outcomes research|outcomes research
165562|NCT02282709|Immunity|immunity
165563|NCT02282657|extracorporreal|extracorporreal
165564|NCT02282657|CO2 removal|co2 removal
165565|NCT02282657|ARDS|ards
165566|NCT02282657|lung|lung
165567|NCT02282657|Protective ventilation|protective ventilation
165568|NCT02282631|active school travel|active school travel
165569|NCT02282631|active travel|active travel
165570|NCT02282631|incentive scheme|incentive scheme
165571|NCT02282631|children|children
165572|NCT02282631|school|school
165573|NCT02282631|behaviour change|behaviour change
165574|NCT02282618|Cardiac Sympathetic Blockade|cardiac sympathetic blockade
165575|NCT02282592|Metabolic syndrome|metabolic syndrome
165576|NCT02282592|case-control study|case-control study
165577|NCT02282592|Breast cancer|breast cancer
165578|NCT02282566|Muscle protein synthesis|muscle protein synthesis
165579|NCT02282514|autoimmune diseases|autoimmune diseases
165580|NCT02282514|stem cells|stem cells
165581|NCT02282514|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
165582|NCT02282514|Stiff Person Syndrome (SPS)|stiff person syndrome (sps)
165583|NCT02282501|leptin levels|leptin levels
165584|NCT02282501|ghrelin levels|ghrelin levels
165585|NCT02282462|Chest tube|chest tube
165586|NCT02282449|Venous access device|venous access device
165587|NCT02282449|Port catheters|port catheters
165588|NCT02282449|Chemotherapy|chemotherapy
165589|NCT02282410|severe hemophilia A|severe hemophilia a
165590|NCT02282410|moderately severe hemophilia A|moderately severe hemophilia a
165591|NCT02282410|Recombinant Human Coagulation Factor VIII|recombinant human coagulation factor viii
165592|NCT02282410|standard prophylaxis|standard prophylaxis
165593|NCT02282397|Diabetes Mellitus|diabetes mellitus
165595|NCT02282371|BYL719|byl719
165596|NCT02282371|IMRT (Intensity-Modulated Radiation Therapy)|imrt (intensity-modulated radiation therapy)
165597|NCT02282371|14-116|14-116
165598|NCT02282358|Mocetinostat|mocetinostat
165599|NCT02282358|14-106|14-106
165600|NCT02282345|Breast cancer|breast cancer
165601|NCT02282345|BRCA deleterious mutation|brca deleterious mutation
165602|NCT02282345|Invasive adenocarcinoma of the breast|invasive adenocarcinoma of the breast
165603|NCT02282345|BMN 673|bmn 673
165604|NCT02282345|Talazoparib tosylate|talazoparib tosylate
165605|NCT02282319|spinal or intravenous dexmedetomidine|spinal or intravenous dexmedetomidine
165606|NCT02282293|Chemoprevention|chemoprevention
165608|NCT02282293|Uganda|uganda
165609|NCT02282293|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
165610|NCT02282293|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
401981|NCT01232452|lung cancer|lung cancer
165611|NCT02282293|Human Immunodeficiency Virus|human immunodeficiency virus
165612|NCT02282267|Epidermal growth factor receptor|epidermal growth factor receptor
165613|NCT02282267|Droplet digital PCR|droplet digital pcr
165614|NCT02282254|Type 1 diabetes|type 1 diabetes
165615|NCT02282254|Hypoglycemia unawareness|hypoglycemia unawareness
165616|NCT02282254|Nocturnal hypoglycemia|nocturnal hypoglycemia
165617|NCT02282254|Closed-loop strategy|closed-loop strategy
165618|NCT02282254|Artificial pancreas|artificial pancreas
165619|NCT02282254|Glucagon|glucagon
165620|NCT02282254|Hypoglycemia|hypoglycemia
165621|NCT02282254|Insulin|insulin
165622|NCT02282241|Melatonin|melatonin
165623|NCT02282241|Sleep|sleep
165624|NCT02282241|Delirium|delirium
165625|NCT02282215|Fever|fever
165626|NCT02282215|Induction chemotherapy|induction chemotherapy
165627|NCT02282215|Infection|infection
165628|NCT02282215|Leukemia|leukemia
165878|NCT02280811|Immunotherapy|immunotherapy
165629|NCT02282215|Myeloid progenitor cells|myeloid progenitor cells
165630|NCT02282215|Neutropenia|neutropenia
165631|NCT02282202|Sputum|sputum
165632|NCT02282202|Bronchiectasis|bronchiectasis
165633|NCT02282202|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
165634|NCT02282202|Airway clearance therapy|airway clearance therapy
165635|NCT02282202|Oscillatory Positive Expiratory Pressure|oscillatory positive expiratory pressure
165636|NCT02282189|Sputum|sputum
165637|NCT02282189|Airway clearance therapy|airway clearance therapy
165638|NCT02282189|Oscillatory Positive Expiratory Pressure|oscillatory positive expiratory pressure
165639|NCT02282189|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
165640|NCT02282176|Neonates|neonates
165641|NCT02282176|Preterm|preterm
165642|NCT02282176|Azithromycin|azithromycin
165643|NCT02282176|Ureaplasma|ureaplasma
165644|NCT02282176|Chronic Lung disease|chronic lung disease
165645|NCT02282176|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
165646|NCT02282150|Fatigue|fatigue
165647|NCT02282150|Quality of Life|quality of life
165648|NCT02282150|Hydrocortisone|hydrocortisone
165649|NCT02282150|Ecological Momentary Assessments|ecological momentary assessments
165650|NCT02282124|weight|weight
165651|NCT02282124|self-management|self-management
165652|NCT02282124|exercise|exercise
165653|NCT02281994|PEMF|pemf
165654|NCT02281994|odontoid fracture|odontoid fracture
165655|NCT02281994|IDE|ide
165656|NCT02281994|prospective|prospective
165657|NCT02281955|Human Papillomavirus|human papillomavirus
165658|NCT02281955|Oropharynx|oropharynx
165659|NCT02281955|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
165660|NCT02281955|Squamous Cell Carcinoma|squamous cell carcinoma
165661|NCT02281955|Radiation Therapy|radiation therapy
165662|NCT02281955|Chemotherapy|chemotherapy
165663|NCT02281955|p16|p16
165664|NCT02281929|Alcoholic hepatitis|alcoholic hepatitis
165665|NCT02281929|corticotherapy|corticotherapy
165666|NCT02281929|antibiotherapy|antibiotherapy
165667|NCT02281929|survival|survival
165668|NCT02281929|infection|infection
165669|NCT02281929|hepato renal syndrome|hepato renal syndrome
165670|NCT02281916|Crohn disease|crohn disease
165671|NCT02281916|Immunotherapy|immunotherapy
165672|NCT02281916|Helminth antigen|helminth antigen
165673|NCT02281890|neurodevelopmental disability|neurodevelopmental disability
165674|NCT02281877|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
165675|NCT02281877|Gene Expression|gene expression
165676|NCT02281851|Endogenous antioxidants|endogenous antioxidants
165677|NCT02281851|Antioxidant supplements|antioxidant supplements
165678|NCT02281851|Vitamin Supplements|vitamin supplements
165679|NCT02281851|Exercise adaptations|exercise adaptations
165680|NCT02281851|Oxidative stress|oxidative stress
165681|NCT02281851|Redox regulation|redox regulation
165682|NCT02281851|Cycling - exercise|cycling - exercise
165683|NCT02281838|Stroke|stroke
165684|NCT02281838|Hypertension|hypertension
165685|NCT02281825|Attention-Deficit and Hyperactivity Disorder|attention-deficit and hyperactivity disorder
165686|NCT02281825|Anxiety|anxiety
165687|NCT02281825|Impulsivity|impulsivity
165688|NCT02281825|Computer Games|computer games
165689|NCT02281825|Depression|depression
165690|NCT02281812|Ablation Technique|ablation technique
165691|NCT02281812|Breast cancer|breast cancer
165692|NCT02281812|Stage 1|stage 1
165693|NCT02281812|Lumpectomy|lumpectomy
165694|NCT02281799|Azathioprine (AZA)|azathioprine (aza)
165695|NCT02281799|6-mercaptopurine (6-MP)|6-mercaptopurine (6-mp)
165696|NCT02281799|Thiopurine-S-methyltransferase (TPMT)|thiopurine-s-methyltransferase (tpmt)
165697|NCT02281799|Xanthine oxidase (XO)|xanthine oxidase (xo)
165698|NCT02281799|6-thioguanine (6-TGN)|6-thioguanine (6-tgn)
165699|NCT02281799|6-methyl-mercaptopurine (6-MMP)|6-methyl-mercaptopurine (6-mmp)
165700|NCT02281799|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
165701|NCT02281799|acute pancreatitis (AP)|acute pancreatitis (ap)
165702|NCT02281799|inosine triphosphate pyrophosphohydrolase (ITPA)|inosine triphosphate pyrophosphohydrolase (itpa)
165703|NCT02281799|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
401982|NCT01232452|advanced|advanced
165704|NCT02281799|systemic lupus erythematosis (SLE)|systemic lupus erythematosis (sle)
165705|NCT02281799|Crohn's disease (CD)|crohn's disease (cd)
165706|NCT02281799|ulcerative colitis (UC)|ulcerative colitis (uc)
165707|NCT02281760|Histiocytosis|histiocytosis
165708|NCT02281760|Non Langerhans Cell Histiocytosis|non langerhans cell histiocytosis
165709|NCT02281760|BRAF Inhibitor|braf inhibitor
165710|NCT02281747|Biologic Therapy|biologic therapy
165711|NCT02281747|Rheumatoid Arthritis|rheumatoid arthritis
165712|NCT02281747|Arthroplasty|arthroplasty
165713|NCT02281708|normogram|normogram
165714|NCT02281708|recurrence|recurrence
165715|NCT02281708|adjuvant chemotherapy|adjuvant chemotherapy
165716|NCT02281708|disease free survival|disease free survival
165717|NCT02281708|Quality of life|quality of life
165718|NCT02281682|Keratosis, Actinic|keratosis, actinic
165719|NCT02281682|Treatment Outcome|treatment outcome
165720|NCT02281682|cost-effectiveness|cost-effectiveness
165721|NCT02281682|economic evaluation|economic evaluation
165722|NCT02281682|imiquimod|imiquimod
165723|NCT02281682|photodynamic therapy|photodynamic therapy
165724|NCT02281682|topical fluorouracil|topical fluorouracil
165725|NCT02281682|ingenol mebutate|ingenol mebutate
165726|NCT02281643|Coinfection|coinfection
165727|NCT02281643|Buruli ulcer|buruli ulcer
165728|NCT02281643|Tuberculosis|tuberculosis
165729|NCT02281643|Mansonella perstans|mansonella perstans
165730|NCT02281630|Chronic Constipation|chronic constipation
165731|NCT02281630|CC|cc
165732|NCT02281578|Sex Workers|sex workers
165733|NCT02281578|Prevention|prevention
165734|NCT02281565|attitudes|attitudes
165735|NCT02281565|blood donation|blood donation
165736|NCT02281565|blood shortage|blood shortage
165737|NCT02281552|Tofacitinib, CP-690,550, Janis kinase, JAK inhibitor, modified release, Xeljanz|tofacitinib, cp-690,550, janis kinase, jak inhibitor, modified release, xeljanz
165738|NCT02281539|Phantom Limb Pain|phantom limb pain
165739|NCT02281539|Augmented Reality|augmented reality
165740|NCT02281539|Myoelectric control|myoelectric control
165741|NCT02281539|Virtual reality|virtual reality
165742|NCT02281539|electromyography|electromyography
165743|NCT02281539|pattern recognition|pattern recognition
165744|NCT02281539|neurorehabilitation|neurorehabilitation
165745|NCT02281513|Nutrition|nutrition
165746|NCT02281487|tubal carcinoma|tubal carcinoma
165747|NCT02281487|ovarian carcinoma|ovarian carcinoma
165748|NCT02281487|tubectomy|tubectomy
165749|NCT02281487|hysterectomy|hysterectomy
165750|NCT02281487|dysplastic changes|dysplastic changes
165751|NCT02281487|Anti Mullerian Hormone|anti mullerian hormone
165752|NCT02281487|Tubal Intraepithelial Carcinoma|tubal intraepithelial carcinoma
165753|NCT02281487|Salpingectomy|salpingectomy
165754|NCT02281461|PrePex|prepex
165755|NCT02281461|Infants|infants
165756|NCT02281461|Early infants|early infants
165757|NCT02281461|Children|children
165758|NCT02281461|Circumcision|circumcision
165759|NCT02281461|HIV|hiv
165760|NCT02281461|AIDS|aids
165761|NCT02281461|Non surgical|non surgical
165762|NCT02281435|Male Circumcision|male circumcision
165763|NCT02281435|HIV Prevention|hiv prevention
165764|NCT02281435|Screen Failure Subjects|screen failure subjects
165765|NCT02281435|PrePex with Incision|prepex with incision
165766|NCT02281409|Mogamulizumab (KW-0761)|mogamulizumab (kw-0761)
165767|NCT02281409|14-135|14-135
165768|NCT02281396|safety|safety
165769|NCT02281396|rabies vaccine|rabies vaccine
165770|NCT02281396|MRC-5 cell|mrc-5 cell
165771|NCT02281383|Bacillus Calmette-Guérin (BCG)|bacillus calmette-guérin (bcg)
165772|NCT02281383|14-174|14-174
165773|NCT02281370|eltrombopag|eltrombopag
165774|NCT02281370|cyclosporine|cyclosporine
165775|NCT02281370|drug-drug interaction|drug-drug interaction
165776|NCT02281370|pharmacokinetics|pharmacokinetics
165777|NCT02281370|SB-497115|sb-497115
165778|NCT02281357|Asthma|asthma
165779|NCT02281357|Reactive Airways|reactive airways
165780|NCT02281357|Repiratory Tract Disease|repiratory tract disease
165781|NCT02281357|Obstructive Lung Disease|obstructive lung disease
165782|NCT02281357|Lung Diseases|lung diseases
165783|NCT02281344|induced blood stage malaria infection|induced blood stage malaria infection
165784|NCT02281318|Asthma control|asthma control
165785|NCT02281318|Lung function|lung function
165786|NCT02281318|Health-related quality of life|health-related quality of life
165787|NCT02281318|Mepolizumab|mepolizumab
165788|NCT02281318|Severe Eosinophilic asthma|severe eosinophilic asthma
165789|NCT02281292|Diabetic Macular Edema|diabetic macular edema
165790|NCT02281292|Intravitreal|intravitreal
165791|NCT02281292|Retina|retina
165792|NCT02281292|Ophthalmology|ophthalmology
165793|NCT02281292|Lucentis|lucentis
165795|NCT02281253|L-carnitine|l-carnitine
165796|NCT02281253|fibre|fibre
165797|NCT02281253|bakery product|bakery product
165798|NCT02281253|insulin resistance|insulin resistance
165799|NCT02281240|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
165800|NCT02281214|lung cancer, mutations|lung cancer, mutations
165816|NCT02281110|Instantaneous wave free ratio|instantaneous wave free ratio
165817|NCT02281110|Fractional flow reserve|fractional flow reserve
165818|NCT02281097|Postural Orthostatic Tachycardia Syndrome|postural orthostatic tachycardia syndrome
165819|NCT02281097|POTS|pots
165820|NCT02281097|Vagal Stimulation|vagal stimulation
165834|NCT02281032|Palliative Care|palliative care
165835|NCT02281032|Nursing Homes|nursing homes
165836|NCT02281032|interRAI Palliative Care instrument|interrai palliative care instrument
165837|NCT02281032|Older adults|older adults
165838|NCT02280980|Stroke|stroke
165839|NCT02280980|Postural Balance|postural balance
165840|NCT02280980|Oculomotor and Gaze Stability Exercises|oculomotor and gaze stability exercises
165841|NCT02280980|Rehabilitation|rehabilitation
165842|NCT02280980|Physical therapy|physical therapy
165843|NCT02280980|Outpatient|outpatient
165844|NCT02280967|Adolescent|adolescent
165845|NCT02280967|Attitude|attitude
165846|NCT02280967|Condom|condom
165847|NCT02280967|Human Papillomavirus Vaccines|human papillomavirus vaccines
165848|NCT02280967|Primary prevention|primary prevention
165849|NCT02280967|School Health|school health
165850|NCT02280954|Solid Tumor|solid tumor
165851|NCT02280915|female|female
165852|NCT02280915|subjects|subjects
165853|NCT02280902|auto-immune diseases|auto-immune diseases
165854|NCT02280902|inflammatory diseases|inflammatory diseases
165855|NCT02280902|risk factors|risk factors
165856|NCT02280902|infections|infections
165857|NCT02280902|cohort study|cohort study
165858|NCT02280889|quality of life|quality of life
165859|NCT02280889|nevus or scar|nevus or scar
165860|NCT02280889|stigmatization|stigmatization
165861|NCT02280889|scar|scar
165862|NCT02280876|MS|ms
165863|NCT02280876|Demyelinating Autoimmune Diseases|demyelinating autoimmune diseases
165864|NCT02280876|CNS|cns
165865|NCT02280876|Nervous System Diseases|nervous system diseases
165866|NCT02280850|Angina|angina
165867|NCT02280837|GLP-1|glp-1
165868|NCT02280824|Transcaval|transcaval
165869|NCT02280824|TAVR|tavr
165870|NCT02280824|AMPLATZER(R) Occluder|amplatzer(r) occluder
165871|NCT02280811|HPV positive|hpv positive
165872|NCT02280811|Metastatic|metastatic
165873|NCT02280811|Diet|diet
165874|NCT02280811|Screening|screening
165875|NCT02280811|Risk Factors|risk factors
165876|NCT02280811|Colorectal adenoma|colorectal adenoma
165877|NCT02280811|Refractory|refractory
165879|NCT02280811|Reproductive Cancers|reproductive cancers
165880|NCT02280798|ERA|era
165881|NCT02280772|glucomannan|glucomannan
165882|NCT02280772|obesity|obesity
165883|NCT02280772|children|children
165884|NCT02280772|overweight|overweight
165885|NCT02280772|adolescents|adolescents
165886|NCT02280772|treatment|treatment
165887|NCT02280759|diarrhea, gelatin tannate, acute gastroenteritis|diarrhea, gelatin tannate, acute gastroenteritis
165988|NCT02280252|breast|breast
165888|NCT02280733|Qualified Clinical Data Registry|qualified clinical data registry
165889|NCT02280733|Quality Measures|quality measures
165890|NCT02280733|Meaningful Use Stage 2|meaningful use stage 2
165891|NCT02280733|Electronic Health Records|electronic health records
165892|NCT02280733|Clinical Data Research Network|clinical data research network
165893|NCT02280733|Real world data|real world data
165894|NCT02280720|titanium-nitride-oxide-coated stent|titanium-nitride-oxide-coated stent
165895|NCT02280720|everolimus-eluting stent|everolimus-eluting stent
165896|NCT02280720|optical coherence tomography|optical coherence tomography
165897|NCT02280720|strut coverage|strut coverage
165898|NCT02280681|reproductive medicine|reproductive medicine
165899|NCT02280681|artificial gametes|artificial gametes
165900|NCT02280681|patient preference|patient preference
165901|NCT02280681|decision making|decision making
165902|NCT02280668|muscle|muscle
165903|NCT02280668|muscle repair|muscle repair
165904|NCT02280668|tissue repair|tissue repair
165905|NCT02280668|eccentric exercise|eccentric exercise
165906|NCT02280668|force loss|force loss
165907|NCT02280668|icing|icing
165908|NCT02280668|cold therapy|cold therapy
165909|NCT02280668|DOMS|doms
165910|NCT02280668|soreness|soreness
165911|NCT02280668|recovery|recovery
165912|NCT02280655|Blood Transfusions|blood transfusions
165913|NCT02280642|Human papillomavirus|human papillomavirus
165914|NCT02280642|Cervical cancer|cervical cancer
165915|NCT02280642|Genital warts|genital warts
165916|NCT02280642|Vaccine|vaccine
165917|NCT02280642|Immunogenicity|immunogenicity
165918|NCT02280564|motivational interviewing|motivational interviewing
165919|NCT02280564|problem solving skills|problem solving skills
165920|NCT02280564|family communication|family communication
165921|NCT02280564|technology support|technology support
165922|NCT02280564|cell phone system|cell phone system
165923|NCT02280551|adolescent|adolescent
165924|NCT02280551|alcohol|alcohol
165925|NCT02280551|parent|parent
165926|NCT02280551|epidemiology|epidemiology
165927|NCT02280538|Knee Osteoarthritis|knee osteoarthritis
165928|NCT02280538|Intra-Articular Hyaluronic Acid|intra-articular hyaluronic acid
165929|NCT02280538|disease modifying|disease modifying
165930|NCT02280525|Leukemia|leukemia
165931|NCT02280525|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
165932|NCT02280525|CLL|cll
165933|NCT02280525|Natural Killer Cells|natural killer cells
165934|NCT02280525|NK|nk
165935|NCT02280525|Umbilical Cord Blood|umbilical cord blood
165936|NCT02280525|UCB|ucb
165937|NCT02280525|Lenalidomide|lenalidomide
165938|NCT02280525|CC-5013|cc-5013
165939|NCT02280525|Revlimid|revlimid
165940|NCT02280525|Rituximab|rituximab
165941|NCT02280525|Rituxan|rituxan
165942|NCT02280525|Fludarabine|fludarabine
165943|NCT02280525|Fludarabine phosphate|fludarabine phosphate
165944|NCT02280525|Fludara|fludara
165945|NCT02280525|Cyclophosphamide|cyclophosphamide
165946|NCT02280525|Cytoxan|cytoxan
165947|NCT02280525|Neosar|neosar
165948|NCT02280512|noninvasive cardiac output measurement(NICOM)|noninvasive cardiac output measurement(nicom)
165949|NCT02280512|Leg fractures|leg fractures
165950|NCT02280512|Near-Infrared Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
165951|NCT02280512|Intensive care unit(ICU)|intensive care unit(icu)
165952|NCT02280486|saxagliptin|saxagliptin
165953|NCT02280486|glimepiride|glimepiride
165954|NCT02280486|metformin monotherapy|metformin monotherapy
165955|NCT02280421|HSV|hsv
165956|NCT02280421|Herpes|herpes
165957|NCT02280421|volunteers|volunteers
165958|NCT02280421|drug-drug interaction|drug-drug interaction
165959|NCT02280421|transplant|transplant
165960|NCT02280382|splinting|splinting
165961|NCT02280369|posture detection|posture detection
165962|NCT02280369|healthy subjects|healthy subjects
165963|NCT02280356|Radiation Therapy|radiation therapy
165964|NCT02280356|Brachytherapy|brachytherapy
165965|NCT02280356|14-163|14-163
165966|NCT02280343|forced oscillation tecnique|forced oscillation tecnique
165967|NCT02280343|lung function|lung function
165968|NCT02280343|asbestosis|asbestosis
165969|NCT02280330|Iodine Deficiency|iodine deficiency
165970|NCT02280330|Micronutrient Powder|micronutrient powder
165971|NCT02280330|Hypothyroidism|hypothyroidism
165972|NCT02280304|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
165973|NCT02280304|Concussion, Mild|concussion, mild
165974|NCT02280304|Brain Injuries|brain injuries
165975|NCT02280304|Community Integration|community integration
165976|NCT02280304|Meditation|meditation
165977|NCT02280304|Magnetic Resonance Imaging|magnetic resonance imaging
165978|NCT02280278|colon cancer|colon cancer
165979|NCT02280278|cytokine-induced killer cell immunotherapy|cytokine-induced killer cell immunotherapy
165980|NCT02280265|hemophilia A|hemophilia a
165981|NCT02280265|standard prophylaxis|standard prophylaxis
402927|NCT01229059|insulin resistance|insulin resistance
165982|NCT02280265|Recombinant Human Coagulation Factor VIII for injection|recombinant human coagulation factor viii for injection
165983|NCT02280265|ADVATE|advate
165984|NCT02280265|Pediatric|pediatric
165985|NCT02280252|Locally-advanced Breast Cancer|locally-advanced breast cancer
165986|NCT02280252|LABC|labc
165987|NCT02280252|breast cancer|breast cancer
165989|NCT02280252|cancer|cancer
165990|NCT02280252|metastasis|metastasis
165991|NCT02280252|metastatic|metastatic
165992|NCT02280252|tumor|tumor
165993|NCT02280252|radiation|radiation
165994|NCT02280252|radiation therapy|radiation therapy
165995|NCT02280252|radiotherapy|radiotherapy
165996|NCT02280252|paclitaxel|paclitaxel
165997|NCT02280239|Fever|fever
165998|NCT02280239|Acetaminophen|acetaminophen
165999|NCT02280239|Body Temperature Regulation|body temperature regulation
166000|NCT02280239|Critical Illness|critical illness
166001|NCT02280239|Hypotension|hypotension
166002|NCT02280200|claudication|claudication
166003|NCT02280200|ankle foot orthoses|ankle foot orthoses
166004|NCT02280200|community walking exercise|community walking exercise
166005|NCT02280187|InductOs|inductos
166006|NCT02280187|rhBMP-2|rhbmp-2
166007|NCT02280187|Retrospective|retrospective
166008|NCT02280187|France|france
166009|NCT02280187|Fusion|fusion
166010|NCT02280187|real world use|real world use
166011|NCT02280174|Apo B-48|apo b-48
166013|NCT02280174|Linagliptin|linagliptin
166014|NCT02280148|Propofol|propofol
166015|NCT02280148|gastroscopy and colonoscopy|gastroscopy and colonoscopy
166016|NCT02280148|driving simulator|driving simulator
166017|NCT02280148|driving ability|driving ability
166018|NCT02280148|cognitive function|cognitive function
166019|NCT02280148|patients|patients
166020|NCT02280122|activated matrix metalloproteinase 8|activated matrix metalloproteinase 8
166021|NCT02280122|untreated moderate/severe chronic periodontitis|untreated moderate/severe chronic periodontitis
166022|NCT02280122|saliva|saliva
166023|NCT02280122|sensitivity/specificity|sensitivity/specificity
166024|NCT02280109|Tenofovir|tenofovir
166025|NCT02280109|Healthy Volunteers|healthy volunteers
166026|NCT02280109|HIV|hiv
166027|NCT02280109|pharmacokinetics of tenofovir gel and film|pharmacokinetics of tenofovir gel and film
166028|NCT02280096|Cognitive function|cognitive function
166029|NCT02280096|Multiple sclerosis|multiple sclerosis
166030|NCT02280096|4-aminopyridine|4-aminopyridine
166031|NCT02280096|Fatigue|fatigue
166032|NCT02280083|Spasticity, Post-Stroke|spasticity, post-stroke
166033|NCT02280083|Botulinum toxin type A for Injection|botulinum toxin type a for injection
166034|NCT02280083|upper limb spasticity|upper limb spasticity
166035|NCT02280070|resectable rectal cancer|resectable rectal cancer
166037|NCT02280070|mFOLFOX6|mfolfox6
166038|NCT02280070|neoadjuvant|neoadjuvant
166039|NCT02280057|PCOS|pcos
166040|NCT02280057|metformin|metformin
166041|NCT02280057|obesity|obesity
166042|NCT02280057|randomized controlled trial|randomized controlled trial
166043|NCT02280044|Campylobacter jejuni|campylobacter jejuni
166044|NCT02280044|rifaximin|rifaximin
166045|NCT02280044|antibiotic prophylaxis|antibiotic prophylaxis
166046|NCT02280044|dysentery|dysentery
166047|NCT02280044|diarrhea|diarrhea
166048|NCT02280031|Twin Pregnancy|twin pregnancy
166049|NCT02280031|Pregnancy Complications|pregnancy complications
166050|NCT02280018|Healthy|healthy
166051|NCT02280018|JNJ-49122944|jnj-49122944
166052|NCT02280018|Placebo|placebo
166053|NCT02280005|Dialysis|dialysis
166054|NCT02280005|Renal Failure|renal failure
166055|NCT02280005|Wearable|wearable
166056|NCT02280005|Artificial Kidney|artificial kidney
166057|NCT02280005|Hemodialysis|hemodialysis
166058|NCT02279992|Malignant Glioma|malignant glioma
166059|NCT02279992|Brain Neoplasms, Malignant|brain neoplasms, malignant
166060|NCT02279992|Brain metastasis|brain metastasis
166061|NCT02279979|PHP|php
166062|NCT02279979|Cardiogenic Shock|cardiogenic shock
166063|NCT02279979|Percutaneous|percutaneous
166064|NCT02279979|Ventricular Assist|ventricular assist
166065|NCT02279979|Heart Pump|heart pump
166066|NCT02279979|Catheter|catheter
166067|NCT02279979|Thoratec Corporation|thoratec corporation
166068|NCT02279940|rivaroxaban|rivaroxaban
166069|NCT02279940|stroke|stroke
166070|NCT02279940|transient ischemic attack|transient ischemic attack
166071|NCT02279940|ischemia|ischemia
166072|NCT02279927|Ureteroscopy|ureteroscopy
166073|NCT02279901|Obstructive Sleep Apnea|obstructive sleep apnea
166074|NCT02279901|CPAP|cpap
166075|NCT02279901|Continuous positive airway pressure|continuous positive airway pressure
166076|NCT02279901|CPAP compliance|cpap compliance
166077|NCT02279901|Telemedicine|telemedicine
166078|NCT02279901|Automated response mechanisms|automated response mechanisms
166079|NCT02279901|Patient engagement|patient engagement
166080|NCT02279901|OSA|osa
166081|NCT02279888|Pulmonary Artery Pressure Monitoring|pulmonary artery pressure monitoring
166082|NCT02279888|Implantable Hemodynamic Monitor|implantable hemodynamic monitor
166083|NCT02279875|Tuberculosis|tuberculosis
166084|NCT02279875|Drug-Sensitive Tuberculosis|drug-sensitive tuberculosis
157105|NCT02330094|SAH|sah
166085|NCT02279875|Linezolid|linezolid
166086|NCT02279875|HRZE (isoniazid, rifampicin, pyrazinamide, ethambutol)|hrze (isoniazid, rifampicin, pyrazinamide, ethambutol)
166087|NCT02279875|Pulmonary Tuberculosis|pulmonary tuberculosis
166088|NCT02279875|TB|tb
166089|NCT02279849|multi-level intervention|multi-level intervention
166090|NCT02279849|price discounts|price discounts
166091|NCT02279849|communication|communication
166092|NCT02279849|low income population|low income population
166093|NCT02279849|dietary intervention|dietary intervention
166094|NCT02279849|obesity prevention|obesity prevention
166095|NCT02279849|store-based intervention|store-based intervention
166096|NCT02279836|Patients with any indication for colonoscopy in the U.S.A.|patients with any indication for colonoscopy in the u.s.a.
166097|NCT02279823|androgen|androgen
166098|NCT02279823|alopecia|alopecia
166099|NCT02279823|CB-03-01|cb-03-01
166100|NCT02279823|solution|solution
166101|NCT02279823|topical|topical
166102|NCT02279810|organ shortage|organ shortage
166103|NCT02279810|attitudes to organ transplantation|attitudes to organ transplantation
166104|NCT02279797|bone marrow|bone marrow
166105|NCT02279797|attitude|attitude
166106|NCT02279771|colorectal anastomosis|colorectal anastomosis
166107|NCT02279771|anastomotic leak|anastomotic leak
166108|NCT02279771|ileostomy|ileostomy
166109|NCT02279771|complications|complications
166110|NCT02279758|Neuroendocrine Tumors|neuroendocrine tumors
166111|NCT02279758|The Mammalian Target of Rapamycin (mTOR)|the mammalian target of rapamycin (mtor)
166112|NCT02279758|metformin|metformin
166113|NCT02279693|Raypilot dosimetry|raypilot dosimetry
166114|NCT02279693|CBCT (cone beam computed tomography)|cbct (cone beam computed tomography)
166115|NCT02279654|Lenalidomide|lenalidomide
166116|NCT02279654|Revlimid|revlimid
166117|NCT02279654|Transfusion-dependent|transfusion-dependent
166118|NCT02279654|international Prognostic Scoring System (IPSS) low|international prognostic scoring system (ipss) low
166119|NCT02279654|Intermediate-1-risk|intermediate-1-risk
166120|NCT02279654|MDS|mds
166121|NCT02279654|Isolated del(5q)|isolated del(5q)
166122|NCT02279654|Prospective|prospective
166123|NCT02279654|Non-interventional|non-interventional
166124|NCT02279654|Post-authorization safety study (PASS)|post-authorization safety study (pass)
166125|NCT02279654|Disease registry|disease registry
166126|NCT02279628|cesarean section|cesarean section
166127|NCT02279628|spinal anesthesia|spinal anesthesia
166129|NCT02279628|intrathecal morphine|intrathecal morphine
166130|NCT02279628|oral morphine|oral morphine
166131|NCT02279615|Overactive Bladder|overactive bladder
166132|NCT02279615|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
166133|NCT02279615|Combination Therapy|combination therapy
166134|NCT02279615|β3-Adrenoceptor Agonist|β3-adrenoceptor agonist
166135|NCT02279615|Mirabegron|mirabegron
166136|NCT02279615|Myrbetriq|myrbetriq
166137|NCT02279615|α-Adrenoceptor Antagonist|α-adrenoceptor antagonist
166138|NCT02279615|Tamsulosin|tamsulosin
166139|NCT02279615|Flomax|flomax
166140|NCT02279602|Pancreatic|pancreatic
166141|NCT02279602|Gastrointestional|gastrointestional
166142|NCT02279589|hyporesponsiveness|hyporesponsiveness
166143|NCT02279589|vaccination|vaccination
166144|NCT02279589|recommendations|recommendations
166145|NCT02279589|improvement|improvement
166146|NCT02279589|schedule|schedule
166147|NCT02279589|fractional dose|fractional dose
166148|NCT02279589|conjugate polysaccharide vaccine|conjugate polysaccharide vaccine
166149|NCT02279576|Penile squamous cell carcinoma|penile squamous cell carcinoma
166150|NCT02279576|Pazopanib|pazopanib
166151|NCT02279576|Weekly paclitaxel|weekly paclitaxel
166152|NCT02279550|hip fracture, elderly|hip fracture, elderly
166153|NCT02279537|Wet age-related macular Degeneration (Wet-AMD)|wet age-related macular degeneration (wet-amd)
166154|NCT02279537|Naïve patients|naïve patients
166155|NCT02279537|Real life|real life
166156|NCT02279537|Aflibercept|aflibercept
166157|NCT02279524|NASH|nash
166158|NCT02279511|Alzheimer|alzheimer
166159|NCT02279485|Healthy Subjects|healthy subjects
166160|NCT02279485|Bioequivalence|bioequivalence
166161|NCT02279485|Fasted|fasted
166162|NCT02279485|Fed|fed
166163|NCT02279433|Neoplasms|neoplasms
166164|NCT02279433|Lung Neoplasms|lung neoplasms
166165|NCT02279433|Colorectal Neoplasms|colorectal neoplasms
166166|NCT02279433|Neuroendocrine Tumors|neuroendocrine tumors
166167|NCT02279433|Pancreatic Neoplasms|pancreatic neoplasms
166168|NCT02279407|omega-3 carboxylic acid|omega-3 carboxylic acid
166169|NCT02279394|Smoldering myeloma|smoldering myeloma
166170|NCT02279394|Smoldering Multiple Myeloma|smoldering multiple myeloma
166171|NCT02279381|Chlorhexidine|chlorhexidine
166172|NCT02279381|Kangaroo mother care|kangaroo mother care
166173|NCT02279381|RCT|rct
166174|NCT02279342|Coronary artery disease|coronary artery disease
166175|NCT02279342|hyperuricemia|hyperuricemia
166176|NCT02279342|coronary plaque volume|coronary plaque volume
166177|NCT02279342|IVUS|ivus
166178|NCT02279316|Dalcroze eurhythmics|dalcroze eurhythmics
166179|NCT02279316|home exercise|home exercise
166180|NCT02279316|vitamin D|vitamin d
166181|NCT02279316|mild cognitive impairment|mild cognitive impairment
166182|NCT02279316|MCI|mci
166183|NCT02279316|mild dementia|mild dementia
166184|NCT02279290|Childhood trauma|childhood trauma
166185|NCT02279264|ph|ph
166186|NCT02279264|RightSpot Infant|rightspot infant
166187|NCT02279264|Feeding Tube|feeding tube
166188|NCT02279264|RightBio Metrics|rightbio metrics
166191|NCT02279264|NG|ng
166192|NCT02279264|infant|infant
166193|NCT02279251|Anxiety|anxiety
166194|NCT02279251|adolescents|adolescents
166195|NCT02279251|school-based|school-based
166196|NCT02279251|low-intensity CBT|low-intensity cbt
166197|NCT02279225|Phototherapy|phototherapy
166198|NCT02279225|Laser|laser
166199|NCT02279225|Fibromyalgia|fibromyalgia
166200|NCT02279225|DTM/ TMD|dtm/ tmd
166201|NCT02279225|Pain|pain
166202|NCT02279212|Critical illness|critical illness
166203|NCT02279212|pain|pain
166204|NCT02279212|quality of life|quality of life
166205|NCT02279199|hemophilia|hemophilia
166206|NCT02279199|joint health|joint health
166207|NCT02279199|motor development|motor development
166208|NCT02279199|motor proficiency|motor proficiency
166209|NCT02279173|Pediatric|pediatric
166210|NCT02279173|Immune Thrombocytopenia|immune thrombocytopenia
166211|NCT02279173|Amgen|amgen
166212|NCT02279147|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
166213|NCT02279147|Jaundice, Obstructive|jaundice, obstructive
166214|NCT02279147|anti-inflammatory|anti-inflammatory
166215|NCT02279134|StageⅡB-Ⅲ esophageal cancer|stageⅱb-ⅲ esophageal cancer
166216|NCT02279134|adjuvant radiotherapy|adjuvant radiotherapy
166217|NCT02279134|adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
166218|NCT02279121|central venous catheter|central venous catheter
166219|NCT02279121|Taurolidine|taurolidine
166220|NCT02279121|lock-therapy|lock-therapy
166221|NCT02279108|sentinel lymph node|sentinel lymph node
166222|NCT02279108|indocyanine green|indocyanine green
166223|NCT02279108|fluorescence method|fluorescence method
166224|NCT02279108|radioisotope conventional method|radioisotope conventional method
166225|NCT02279108|breast cancer|breast cancer
166226|NCT02279095|Open-label extension study|open-label extension study
166227|NCT02279095|Clinical trial Phase 2|clinical trial phase 2
166228|NCT02279095|Efficacy and safety|efficacy and safety
166229|NCT02279095|Heterotopic ossification|heterotopic ossification
166230|NCT02279095|Fibrodysplasia Ossificans Progressiva|fibrodysplasia ossificans progressiva
166231|NCT02279095|Flare-up|flare-up
166232|NCT02279095|Palovarotene|palovarotene
166233|NCT02279095|Retinoic acid receptor agonist|retinoic acid receptor agonist
166234|NCT02279095|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
166235|NCT02279095|Clementia|clementia
166236|NCT02279095|Myositis Ossificans Progressiva|myositis ossificans progressiva
166237|NCT02279095|Munchmeyer's Disease|munchmeyer's disease
166238|NCT02279095|FOP|fop
166239|NCT02279069|stroke|stroke
166240|NCT02279069|walking|walking
166241|NCT02279069|rehabilitation|rehabilitation
166242|NCT02279043|IUD|iud
166243|NCT02279043|IUC|iuc
166244|NCT02279043|birth control|birth control
166245|NCT02279043|contraception|contraception
166246|NCT02279043|online|online
166247|NCT02279030|ablation|ablation
166248|NCT02279017|Mobile Technology|mobile technology
166249|NCT02279017|Diet and Fitness|diet and fitness
166460|NCT02278003|Propofol|propofol
166250|NCT02279004|Plasma Genotyping|plasma genotyping
166251|NCT02279004|NSCLC|nsclc
166252|NCT02279004|Melanoma|melanoma
166253|NCT02278978|urothelial carcinoma|urothelial carcinoma
166254|NCT02278978|BIBF1120|bibf1120
166257|NCT02278939|diabetes prevention|diabetes prevention
166258|NCT02278939|Filipinos|filipinos
166259|NCT02278939|lifestyle intervention|lifestyle intervention
166260|NCT02278926|Ultrasound|ultrasound
166261|NCT02278926|Lypo-hypertrophy|lypo-hypertrophy
166262|NCT02278913|inpatient|inpatient
166263|NCT02278913|hospital|hospital
166264|NCT02278913|randomized trial|randomized trial
166265|NCT02278913|diabetes|diabetes
166266|NCT02278913|analogs|analogs
166267|NCT02278913|human insulin|human insulin
166268|NCT02278900|communication|communication
166269|NCT02278900|shared decision-making|shared decision-making
166270|NCT02278887|melanoma|melanoma
166271|NCT02278887|TIL treatment|til treatment
166272|NCT02278887|tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
166273|NCT02278887|ipilimumab|ipilimumab
166274|NCT02278887|interleukin 2|interleukin 2
166275|NCT02278887|non-myeloablative|non-myeloablative
166276|NCT02278887|randomization|randomization
166277|NCT02278874|Trisomy 13|trisomy 13
166278|NCT02278874|Trisomy 18|trisomy 18
166279|NCT02278874|Trisomy 21|trisomy 21
166280|NCT02278874|Sex Chromosome Abnormalities|sex chromosome abnormalities
166281|NCT02278874|Monosomy X|monosomy x
166283|NCT02278874|XXY|xxy
166284|NCT02278874|XYY|xyy
166285|NCT02278861|actinic keratosis|actinic keratosis
166286|NCT02278861|tretinoin|tretinoin
166287|NCT02278861|isotretinoin|isotretinoin
166288|NCT02278861|cryotherapy|cryotherapy
166289|NCT02278861|sun protection factor|sun protection factor
166290|NCT02278861|clinical clearance|clinical clearance
166291|NCT02278848|Computerised gait analysis|computerised gait analysis
166292|NCT02278848|Ultrasound measurement of cerebral pulsatility|ultrasound measurement of cerebral pulsatility
166293|NCT02278848|MRI flow|mri flow
166294|NCT02278848|Urinary incontinence scale|urinary incontinence scale
166295|NCT02278848|Subtractive lumbar puncture|subtractive lumbar puncture
166296|NCT02278835|Cardiac valve|cardiac valve
166297|NCT02278809|physical activity|physical activity
166298|NCT02278809|screen time|screen time
166299|NCT02278809|vegetables|vegetables
166300|NCT02278809|fruit|fruit
166301|NCT02278809|snacks|snacks
166302|NCT02278809|softdrink|softdrink
166303|NCT02278809|water|water
166304|NCT02278809|fruit juice|fruit juice
166305|NCT02278809|parenting practices|parenting practices
166306|NCT02278809|online videos|online videos
166307|NCT02278809|intervention mapping protocol|intervention mapping protocol
166308|NCT02278796|Diffuse large B-cell lymphomas (DLBC)|diffuse large b-cell lymphomas (dlbc)
166309|NCT02278796|Follicular lymphomas (FL)|follicular lymphomas (fl)
166310|NCT02278796|Mantle cell lymphomas (MCL)|mantle cell lymphomas (mcl)
166311|NCT02278770|diverticular disease|diverticular disease
166312|NCT02278770|MRI|mri
166313|NCT02278770|visceral and subcutaneous fat|visceral and subcutaneous fat
166314|NCT02278770|adipokines|adipokines
166315|NCT02278757|Metabolic syndrome|metabolic syndrome
166316|NCT02278757|Weight loss|weight loss
166317|NCT02278757|Obesity|obesity
166318|NCT02278757|Hypertension|hypertension
166319|NCT02278757|Dyslipidemia|dyslipidemia
166320|NCT02278744|Single-Fraction Stereotactic Radiosurgery|single-fraction stereotactic radiosurgery
166321|NCT02278744|Salvage Re-Irradiation|salvage re-irradiation
166322|NCT02278744|14-054|14-054
166323|NCT02278731|Physical activity|physical activity
166324|NCT02278731|Rehabilitation|rehabilitation
166325|NCT02278731|Older adults|older adults
166326|NCT02278731|Pilates|pilates
166327|NCT02278731|Proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
166328|NCT02278705|childhood obesity|childhood obesity
166329|NCT02278705|childhood overweight|childhood overweight
166330|NCT02278705|primary care|primary care
166331|NCT02278705|weight management|weight management
166332|NCT02278692|Vitamin K|vitamin k
166333|NCT02278692|Calciphylaxis|calciphylaxis
166334|NCT02278692|Calcific uremic arteriolopathy|calcific uremic arteriolopathy
166335|NCT02278692|Dialysis|dialysis
166336|NCT02278692|End-stage renal disease|end-stage renal disease
166337|NCT02278653|Restaging|restaging
166338|NCT02278653|Watchful Waiting|watchful waiting
166339|NCT02278653|Quality of Life|quality of life
166340|NCT02278653|Manometry|manometry
166341|NCT02278601|Breakthrough pain|breakthrough pain
166342|NCT02278575|antithrombin, Atenativ, preeclampsia, blood flow.|antithrombin, atenativ, preeclampsia, blood flow.
166343|NCT02278549|Spinal kinematics|spinal kinematics
166344|NCT02278536|Trisomy 13|trisomy 13
166345|NCT02278536|Trisomy 18|trisomy 18
166346|NCT02278536|Trisomy 21|trisomy 21
166347|NCT02278536|Sex Chromosome Abnormalities|sex chromosome abnormalities
166348|NCT02278536|Monosomy X|monosomy x
166349|NCT02278536|XXX|xxx
166350|NCT02278536|XXY|xxy
166351|NCT02278536|XYY|xyy
166352|NCT02278510|topotecan|topotecan
166353|NCT02278510|convection-enhanced delivery|convection-enhanced delivery
166354|NCT02278510|CED|ced
166355|NCT02278510|High Grade Glioma|high grade glioma
166356|NCT02278484|sinus infections|sinus infections
166357|NCT02278484|sinusitis|sinusitis
166358|NCT02278484|chronic sinusitis|chronic sinusitis
166359|NCT02278484|rhinosinusitis|rhinosinusitis
166360|NCT02278484|allergic sinusitis|allergic sinusitis
166361|NCT02278484|allergic rhinitis|allergic rhinitis
166362|NCT02278484|chronic rhinosinusitis|chronic rhinosinusitis
166363|NCT02278484|sinus disease in children|sinus disease in children
166364|NCT02278484|sinus balloon dilation|sinus balloon dilation
166365|NCT02278484|balloon dilatation|balloon dilatation
166366|NCT02278484|sinus disease|sinus disease
166367|NCT02278484|pediatric|pediatric
166368|NCT02278471|combination pill|combination pill
166369|NCT02278471|polypill|polypill
166370|NCT02278471|primary prevention|primary prevention
166371|NCT02278445|Systemic Sclerosis|systemic sclerosis
166372|NCT02278445|Pulmonary hypertension|pulmonary hypertension
166373|NCT02278445|Lung Doppler Signals|lung doppler signals
166374|NCT02278432|risk assessment|risk assessment
166375|NCT02278432|pharmacovigilance|pharmacovigilance
166376|NCT02278432|pharmacoepidemiology|pharmacoepidemiology
166377|NCT02278432|drug toxicity|drug toxicity
166378|NCT02278432|adverse drug reaction reporting system|adverse drug reaction reporting system
166379|NCT02278432|omeprazole|omeprazole
166380|NCT02278419|Hepatitis C|hepatitis c
166381|NCT02278419|Simeprevir|simeprevir
166382|NCT02278419|Sofosbuvir|sofosbuvir
166383|NCT02278419|Healthy|healthy
166384|NCT02278406|Parkinson's Disease|parkinson's disease
166385|NCT02278406|Deep brain stimulator|deep brain stimulator
166386|NCT02278406|dbs|dbs
166387|NCT02278393|Japanese healthy volunteers|japanese healthy volunteers
166388|NCT02278393|High LDL-C|high ldl-c
166389|NCT02278393|dairy drinks|dairy drinks
166390|NCT02278393|phytosterols|phytosterols
166391|NCT02278341|ASP1517|asp1517
166392|NCT02278341|FG-4592|fg-4592
166393|NCT02278341|Anemia|anemia
166790|NCT02275845|metformin|metformin
166394|NCT02278341|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
166395|NCT02278341|Erythropoetin Stimulating Agents (ESAs)|erythropoetin stimulating agents (esas)
166396|NCT02278341|Chronic Kidney Disease|chronic kidney disease
166397|NCT02278341|Hematopoetic Agents|hematopoetic agents
166398|NCT02278341|HIF-PH inhibitor|hif-ph inhibitor
166399|NCT02278341|Hemoglobin|hemoglobin
166400|NCT02278341|Dialysis|dialysis
166401|NCT02278341|roxadustat|roxadustat
663582|NCT00829348|Compliance|compliance
166402|NCT02278328|dose titration study|dose titration study
166403|NCT02278328|electrophysiology|electrophysiology
166404|NCT02278315|Multiple Myeloma|multiple myeloma
166405|NCT02278315|Radiopharmaceutical|radiopharmaceutical
166406|NCT02278315|Therapy|therapy
166407|NCT02278315|Phase 1|phase 1
166408|NCT02278263|tranexamic acid|tranexamic acid
166409|NCT02278263|enhanced recovery|enhanced recovery
166410|NCT02278263|arthroplasty|arthroplasty
166411|NCT02278263|perioperative care|perioperative care
166412|NCT02278198|thyroid cancer|thyroid cancer
166413|NCT02278172|vitamin D|vitamin d
166414|NCT02278172|athletes|athletes
166415|NCT02278172|fitness|fitness
166416|NCT02278159|end-stage kidney disease|end-stage kidney disease
166417|NCT02278159|peritoneal dialysis|peritoneal dialysis
166418|NCT02278159|home hemodialysis|home hemodialysis
166419|NCT02278159|technique survival|technique survival
166420|NCT02278159|patient survival|patient survival
166421|NCT02278133|metastatic,|metastatic,
166422|NCT02278133|Colorectal cancer,|colorectal cancer,
166423|NCT02278133|WNT974,|wnt974,
166424|NCT02278133|LGX818,|lgx818,
166425|NCT02278133|cetuximab,|cetuximab,
166426|NCT02278133|BRAF-mutant,|braf-mutant,
166427|NCT02278133|mCRC,|mcrc,
166428|NCT02278133|BRAFV600-mutant,|brafv600-mutant,
166429|NCT02278133|KRAS|kras
166430|NCT02278120|HR-positive|hr-positive
166431|NCT02278120|HER2-negative|her2-negative
166432|NCT02278120|Advanced breast cancer|advanced breast cancer
166433|NCT02278120|Letrozole|letrozole
166434|NCT02278120|Anastrozole|anastrozole
166435|NCT02278120|Tamoxifen|tamoxifen
166436|NCT02278120|Goserelin|goserelin
166438|NCT02278120|CDK4|cdk4
166440|NCT02278120|CDK4/6|cdk4/6
166441|NCT02278120|Phase III|phase iii
166442|NCT02278120|ER-positive|er-positive
166443|NCT02278120|PR-positive|pr-positive
166444|NCT02278120|Premenopausal|premenopausal
166445|NCT02278094|OSAS|osas
166446|NCT02278094|Adult|adult
166447|NCT02278094|Home-based|home-based
166448|NCT02278094|Genioglossus|genioglossus
166449|NCT02278094|Inspiratory muscle|inspiratory muscle
166450|NCT02278094|Exercise|exercise
166451|NCT02278081|Rhinitis (nasal obstruction) and GERD|rhinitis (nasal obstruction) and gerd
166452|NCT02278068|Type 2 diabetes|type 2 diabetes
166453|NCT02278055|Radium-223|radium-223
166454|NCT02278055|14-098|14-098
166455|NCT02278055|Prostate Cancer Clinical Trials Consortium|prostate cancer clinical trials consortium
166456|NCT02278016|procalcitonin|procalcitonin
166457|NCT02278016|interleukin-6|interleukin-6
166458|NCT02278016|agiotensininⅡ|agiotensininⅱ
166459|NCT02278003|Amnesic|amnesic
166461|NCT02278003|12-006|12-006
166462|NCT02277977|sepsis|sepsis
166463|NCT02277977|septic shock|septic shock
166464|NCT02277977|contrast-enhanced ultrasound|contrast-enhanced ultrasound
166465|NCT02277977|microcirculation|microcirculation
166466|NCT02277964|RRMS|rrms
166467|NCT02277964|Natalizumab|natalizumab
166468|NCT02277964|Fingolimod|fingolimod
166469|NCT02277964|Treatment Change|treatment change
166470|NCT02277964|Disease Activity|disease activity
166471|NCT02277925|Pelvic Organ Prolapse|pelvic organ prolapse
166472|NCT02277925|Vaginal mesh exposure rates|vaginal mesh exposure rates
166473|NCT02277925|Vaginal suture exposure rates|vaginal suture exposure rates
166474|NCT02277912|ICH|ich
166475|NCT02277912|Stroke|stroke
166476|NCT02277912|Navigated|navigated
166477|NCT02277912|Placebo|placebo
166478|NCT02277912|TMS|tms
166479|NCT02277899|childhood obesity|childhood obesity
166480|NCT02277899|overweight|overweight
166481|NCT02277899|communication|communication
166482|NCT02277899|primary care|primary care
166483|NCT02277899|weight management|weight management
166484|NCT02277899|communication methods|communication methods
166485|NCT02277899|patient-centered communication|patient-centered communication
166486|NCT02277886|sodium alginate|sodium alginate
166487|NCT02277886|esomeprazole|esomeprazole
166488|NCT02277886|GERD|gerd
166489|NCT02277873|moon|moon
166490|NCT02277873|parturition|parturition
166491|NCT02277873|moon phases|moon phases
166492|NCT02277860|Exercise|exercise
166493|NCT02277847|Idarubicin|idarubicin
202033|NCT02108223|rLH|rlh
166494|NCT02277847|Cytosine arabinoside|cytosine arabinoside
166495|NCT02277847|Efficacy|efficacy
166496|NCT02277847|Safety|safety
166497|NCT02277821|Essential Hypertension|essential hypertension
166498|NCT02277821|Central Blood Pressure|central blood pressure
166499|NCT02277821|Microcirculation|microcirculation
166500|NCT02277821|Endothelium Stimulation|endothelium stimulation
166501|NCT02277808|Pneumocystis|pneumocystis
166502|NCT02277808|Nebulizer|nebulizer
166503|NCT02277808|Pentamidine|pentamidine
166504|NCT02277795|Early infant male circumcision|early infant male circumcision
166505|NCT02277795|HIV|hiv
166506|NCT02277795|Prevention|prevention
166507|NCT02277795|AccuCirc|accucirc
166508|NCT02277795|Kenya|kenya
166509|NCT02277795|Providers|providers
166510|NCT02277795|Parents|parents
166511|NCT02277782|Labor|labor
166512|NCT02277782|Analgesia|analgesia
166513|NCT02277756|high functioning autism|high functioning autism
166514|NCT02277756|endogenous modulation systems|endogenous modulation systems
166515|NCT02277730|Hypotension|hypotension
166516|NCT02277717|cancer|cancer
166517|NCT02277717|metastasis|metastasis
166518|NCT02277717|HER2|her2
166519|NCT02277717|trastuzumab|trastuzumab
166520|NCT02277717|duocarmycin|duocarmycin
166521|NCT02277717|SYD985|syd985
166522|NCT02277717|antibody-drug conjugate|antibody-drug conjugate
166523|NCT02277717|ADC|adc
166524|NCT02277717|trastuzumab vc-seco-DUBA|trastuzumab vc-seco-duba
166525|NCT02277704|PTSD|ptsd
166526|NCT02277704|Military-related PTSD and other related conditions|military-related ptsd and other related conditions
166527|NCT02277691|Pharmacological therapy|pharmacological therapy
166528|NCT02277691|Drug Therapy|drug therapy
166529|NCT02277678|Pruritus|pruritus
166530|NCT02277665|Cannabis Use Disorder|cannabis use disorder
166531|NCT02277665|Tobacco Use|tobacco use
166532|NCT02277665|Treatment|treatment
166533|NCT02277639|Transplant related mortality|transplant related mortality
166534|NCT02277639|Graft versus host disease|graft versus host disease
166535|NCT02277639|Bone marrow transplant|bone marrow transplant
166536|NCT02277613|stem cells|stem cells
166537|NCT02277587|Plenadren|plenadren
166538|NCT02277587|Addison's disease|addison's disease
166539|NCT02277587|Hydrocortisone|hydrocortisone
166540|NCT02277587|Cortisone Acetate|cortisone acetate
166541|NCT02277587|Monocytes|monocytes
166542|NCT02277587|Natural Killer cells|natural killer cells
166543|NCT02277587|Immunological profile|immunological profile
166544|NCT02277587|Inflammation|inflammation
166545|NCT02277574|Rheumatoid arthritis|rheumatoid arthritis
166546|NCT02277574|Arthritis|arthritis
166547|NCT02277574|Joint diseases|joint diseases
166548|NCT02277574|Musculoskeletal diseases|musculoskeletal diseases
166549|NCT02277548|chemotherapy|chemotherapy
166550|NCT02277548|radiation therapy|radiation therapy
166551|NCT02277535|Malnutrition in the ICU (caloric deficit >4000 kcal or 150 g protein deficit) or >48hrs of admission without receiving nutrition|malnutrition in the icu (caloric deficit >4000 kcal or 150 g protein deficit) or >48hrs of admission without receiving nutrition
166552|NCT02277470|pharmacokinetics, Golimumab, IBD|pharmacokinetics, golimumab, ibd
166553|NCT02277444|Methotrexate|methotrexate
166554|NCT02277444|Anti-TNFα Antibody|anti-tnfα antibody
166555|NCT02277444|Golimumab|golimumab
166556|NCT02277444|Pediatric Participants|pediatric participants
166557|NCT02277379|cardiac surgery ; hemorrhage ; transfusion requirements|cardiac surgery ; hemorrhage ; transfusion requirements
166558|NCT02277366|Lung Neoplasms|lung neoplasms
166559|NCT02277366|Bronchoscopy|bronchoscopy
166560|NCT02277366|Early Detection of Cancer|early detection of cancer
166561|NCT02277353|Fluid responsiveness|fluid responsiveness
166563|NCT02277353|Prone Position|prone position
166564|NCT02277353|Stroke Volume Variation|stroke volume variation
166565|NCT02277327|Hospitalization|hospitalization
166566|NCT02277327|Readmissions|readmissions
166567|NCT02277327|Medical complexity|medical complexity
166568|NCT02277301|Pilot study|pilot study
166569|NCT02277301|Randomised Controlled Trial|randomised controlled trial
166570|NCT02277301|Parenting|parenting
166571|NCT02277301|Paediatrics|paediatrics
166572|NCT02277301|Mental Health|mental health
166573|NCT02277275|Branched chain amino acid, high protein diet, weight loss|branched chain amino acid, high protein diet, weight loss
166574|NCT02277262|peritonitis patients|peritonitis patients
166575|NCT02277236|sarcopenia|sarcopenia
166576|NCT02277236|aging|aging
166577|NCT02277236|insulin resistance|insulin resistance
166578|NCT02277236|screening|screening
166579|NCT02277184|Intermediate Risk HNSCC|intermediate risk hnscc
166580|NCT02277184|High Risk HNSCC|high risk hnscc
166581|NCT02277184|Previously Untreated, Locally Advanced HNSCC|previously untreated, locally advanced hnscc
166582|NCT02277184|Undifferentiated carcinoma|undifferentiated carcinoma
166583|NCT02277184|Poorly differentiated carcinoma of the oral cavity|poorly differentiated carcinoma of the oral cavity
166584|NCT02277184|Poorly differentiated carcinoma of the oropharynx|poorly differentiated carcinoma of the oropharynx
166585|NCT02277184|Poorly differentiated carcinoma of the larynx|poorly differentiated carcinoma of the larynx
166586|NCT02277184|Poorly differentiated carcinoma of the hypopharynx|poorly differentiated carcinoma of the hypopharynx
166587|NCT02277158|Rectal cancer|rectal cancer
166588|NCT02277158|S-1|s-1
166589|NCT02277158|Chemoradiotherapy|chemoradiotherapy
166590|NCT02277158|Phase I|phase i
166591|NCT02277145|radiation-induced pulmonary fibrosis|radiation-induced pulmonary fibrosis
166592|NCT02277145|MSCs|mscs
166593|NCT02277132|Fetal growth restriction|fetal growth restriction
166594|NCT02277132|Sildenafil|sildenafil
166595|NCT02277080|Pain, opioids, immune system, endocrine system, quality of life|pain, opioids, immune system, endocrine system, quality of life
166596|NCT02277067|PPH|pph
166597|NCT02277041|PPH|pph
166598|NCT02277002|Cabin Air Filtration|cabin air filtration
166599|NCT02277002|Particulate Matter|particulate matter
166600|NCT02277002|Commuter Exposure|commuter exposure
166601|NCT02277002|Traffic Related Air Pollution|traffic related air pollution
166602|NCT02276989|Chronic Pain|chronic pain
166603|NCT02276989|Compliance Marker|compliance marker
166604|NCT02276989|Narcotic Abuse|narcotic abuse
166605|NCT02276989|Opioid related disorders|opioid related disorders
166606|NCT02276989|Opiate substitution treatment|opiate substitution treatment
166607|NCT02276989|Buprenorphrine|buprenorphrine
166608|NCT02276989|Suboxone|suboxone
166609|NCT02276989|Lyrica|lyrica
166610|NCT02276989|Pregabalin|pregabalin
166611|NCT02276989|Acetazolamide|acetazolamide
166612|NCT02276989|Quinine|quinine
166613|NCT02276989|Compliance|compliance
166614|NCT02276976|crebral white matter lesions|crebral white matter lesions
166615|NCT02276976|brain networks|brain networks
166616|NCT02276976|MRI|mri
166617|NCT02276976|DTI|dti
166618|NCT02276976|fMRI|fmri
166619|NCT02276976|cognitive impairment|cognitive impairment
166620|NCT02276976|gene|gene
166621|NCT02276963|Transverse myelitis, optic neuritis, neuromyelitis optica|transverse myelitis, optic neuritis, neuromyelitis optica
166622|NCT02276950|Cardiac Surgery|cardiac surgery
166623|NCT02276950|Epidemiologic Methods|epidemiologic methods
166624|NCT02276950|Blood Transfusions|blood transfusions
166625|NCT02276937|Recombinant Sendai virus|recombinant sendai virus
166626|NCT02276937|fibroblast growth factor-2|fibroblast growth factor-2
166627|NCT02276937|treadmill|treadmill
166628|NCT02276924|Laser Confocal Microscopy|laser confocal microscopy
166629|NCT02276924|Superior Urinary Tract Tumors|superior urinary tract tumors
166630|NCT02276898|pediatric|pediatric
166631|NCT02276898|lung clearance index|lung clearance index
166632|NCT02276898|Multiple Breath Washout|multiple breath washout
166633|NCT02276898|Hypertonic Saline|hypertonic saline
166634|NCT02276885|breast|breast
166635|NCT02276885|cancer|cancer
166636|NCT02276885|breast cancer|breast cancer
166637|NCT02276885|prone|prone
166638|NCT02276885|partial breast irradiation|partial breast irradiation
166639|NCT02276885|PBI|pbi
166640|NCT02276872|pediatric|pediatric
166641|NCT02276872|treprostinil|treprostinil
166642|NCT02276872|transition|transition
166643|NCT02276872|Remodulin|remodulin
166644|NCT02276859|dual-wave bolus|dual-wave bolus
166645|NCT02276859|square bolus|square bolus
166646|NCT02276859|normal bolus|normal bolus
166647|NCT02276859|standard bolus|standard bolus
166648|NCT02276859|high-protein meal|high-protein meal
166649|NCT02276859|prandial insulin requirement|prandial insulin requirement
166650|NCT02276846|Palpitate-Eluting Balloon|palpitate-eluting balloon
166651|NCT02276846|Bifurcation|bifurcation
166652|NCT02276846|OCT|oct
166653|NCT02276846|Transluminal|transluminal
166654|NCT02276820|Adenovirus|adenovirus
166655|NCT02276820|Virus specific T cells|virus specific t cells
166656|NCT02276820|Viral infections|viral infections
166657|NCT02276807|Depression|depression
166658|NCT02276807|Behavioral Symptoms|behavioral symptoms
166659|NCT02276807|Mental Disorders|mental disorders
166660|NCT02276807|Depressive Disorder|depressive disorder
166661|NCT02276807|suicidal ideation|suicidal ideation
166662|NCT02276807|primary health care|primary health care
166663|NCT02276807|Veterans|veterans
166664|NCT02276794|Low back pain|low back pain
166665|NCT02276794|Thrust manipulation|thrust manipulation
166666|NCT02276794|Spinal manipulation|spinal manipulation
166667|NCT02276794|Joint mobilization|joint mobilization
166668|NCT02276794|Non-thrust manipulation|non-thrust manipulation
166669|NCT02276794|proprioception|proprioception
166670|NCT02276794|Postural stability|postural stability
166671|NCT02276794|Baropodometry|baropodometry
166672|NCT02276781|PAD|pad
166673|NCT02276781|Peripheral Arterial Disease|peripheral arterial disease
166674|NCT02276781|Biomarkers|biomarkers
166675|NCT02276768|rectal distension|rectal distension
166676|NCT02276768|rectal compliance|rectal compliance
166677|NCT02276768|visceral pain|visceral pain
166678|NCT02276768|pain intensity|pain intensity
166679|NCT02276768|barostat|barostat
166680|NCT02276768|distender|distender
166681|NCT02276768|VAS (Visual Analog Scale)|vas (visual analog scale)
166682|NCT02276768|rectal sensory threshold|rectal sensory threshold
166683|NCT02276768|analgesia|analgesia
166684|NCT02276768|trimebutine|trimebutine
166685|NCT02276768|pain management|pain management
166686|NCT02276768|peripheral|peripheral
166687|NCT02276768|colon cancer|colon cancer
166688|NCT02276768|H2S (hydrogen sulfide)|h2s (hydrogen sulfide)
166689|NCT02276729|Upper limb|upper limb
166690|NCT02276729|Rehabilitation|rehabilitation
166691|NCT02276729|Occupational Therapy|occupational therapy
166692|NCT02276729|Mirror Box Therapy|mirror box therapy
166693|NCT02276690|iron deficiency|iron deficiency
166694|NCT02276690|dosage of hepcidin|dosage of hepcidin
166791|NCT02275845|prevention|prevention
166889|NCT02275195|alcohol|alcohol
166695|NCT02276690|usual biomarker (ferritin and transferrin saturation)|usual biomarker (ferritin and transferrin saturation)
166696|NCT02276690|mass spectrometry|mass spectrometry
166697|NCT02276690|immuno-detection|immuno-detection
166698|NCT02276690|anaemia in intensive care unit|anaemia in intensive care unit
166699|NCT02276664|lung cancer prevention|lung cancer prevention
166700|NCT02276560|main tumor ranging from less than 3cm (T1 up to 7cm (T3)|main tumor ranging from less than 3cm (t1 up to 7cm (t3)
166701|NCT02276547|Mitral|mitral
166702|NCT02276547|Regurgitation|regurgitation
166703|NCT02276547|Heart valve|heart valve
166704|NCT02276547|Transcatheter|transcatheter
166705|NCT02276547|Transapical|transapical
166706|NCT02276547|Functional|functional
166707|NCT02276547|Degenerative|degenerative
166708|NCT02276547|Symptomatic, severe mitral valve regurgitation, high risk for open mitral valve surgery|symptomatic, severe mitral valve regurgitation, high risk for open mitral valve surgery
166709|NCT02276495|pain management for total knee arthroplasty|pain management for total knee arthroplasty
166710|NCT02276469|severe mental illness|severe mental illness
166711|NCT02276443|Breast Cancer|breast cancer
166712|NCT02276443|Triple-negative breast cancer|triple-negative breast cancer
166713|NCT02276443|TNBC|tnbc
166714|NCT02276443|Molecular testing|molecular testing
166715|NCT02276443|Standard chemotherapy|standard chemotherapy
166716|NCT02276443|Ultrasound|ultrasound
166717|NCT02276430|Testicular cancer|testicular cancer
166718|NCT02276430|Survivor|survivor
166719|NCT02276430|Cardiovascular disease|cardiovascular disease
166720|NCT02276430|Risk factors|risk factors
166721|NCT02276417|Sepsis|sepsis
166722|NCT02276417|Surgical ICU|surgical icu
166723|NCT02276313|Peripheral|peripheral
166724|NCT02276313|Infrainguinal|infrainguinal
166725|NCT02276313|Drug Releasing Balloon|drug releasing balloon
166726|NCT02276313|Drug Eluting Balloon|drug eluting balloon
166727|NCT02276287|Adherence|adherence
166728|NCT02276287|HAART|haart
166729|NCT02276287|HIV|hiv
166730|NCT02276287|Illness Perception|illness perception
166731|NCT02276287|IPQ-R|ipq-r
166732|NCT02276235|catgut embedding|catgut embedding
166733|NCT02276235|obese women|obese women
166734|NCT02276235|obesity-related hormones|obesity-related hormones
166735|NCT02276222|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
166737|NCT02276157|cholangioscopy|cholangioscopy
166738|NCT02276105|Carpal Tunnel Syndrome|carpal tunnel syndrome
166739|NCT02276105|Quality of Life|quality of life
166740|NCT02276105|EQ-5D|eq-5d
166741|NCT02276105|SF-12|sf-12
166742|NCT02276105|Michigan Hand Questionnaire|michigan hand questionnaire
166743|NCT02276092|Community-acquired pneumonia|community-acquired pneumonia
166744|NCT02276092|Pragmatic study|pragmatic study
166745|NCT02276092|Multi-center|multi-center
166746|NCT02276092|Time-dependent bias|time-dependent bias
166747|NCT02276092|antimicrobial stewardship|antimicrobial stewardship
166748|NCT02276092|prospective audit and feedback|prospective audit and feedback
166749|NCT02276079|Mild Traumatic Brain Injury|mild traumatic brain injury
166750|NCT02276079|Aerobic Exercise|aerobic exercise
166751|NCT02276079|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
166752|NCT02276066|kidney dysfunction|kidney dysfunction
167051|NCT02274233|Chelation|chelation
166753|NCT02276066|chronic critical illness|chronic critical illness
166754|NCT02276066|sepsis|sepsis
166755|NCT02276066|Glomerular filtration rate|glomerular filtration rate
166756|NCT02276053|Epilepsy|epilepsy
166757|NCT02276053|Brain tumor|brain tumor
166758|NCT02276053|lacosamide (LCM)|lacosamide (lcm)
166759|NCT02276053|Anti-Epileptic Drugs (AEDs)|anti-epileptic drugs (aeds)
166760|NCT02276040|Arthroplasty|arthroplasty
166761|NCT02276040|Knee Replacement|knee replacement
166762|NCT02276040|Analgesia|analgesia
166763|NCT02276040|pain|pain
166764|NCT02276027|adenocarcinoma lung cancer,squamous cell lung carcinoma, NSCLC|adenocarcinoma lung cancer,squamous cell lung carcinoma, nsclc
166765|NCT02276014|Beta carotene|beta carotene
166766|NCT02276014|Retinol|retinol
166767|NCT02276001|Adult Volunteers|adult volunteers
166768|NCT02275988|Adult Volunteers|adult volunteers
166769|NCT02275975|Adult Volunteers|adult volunteers
166770|NCT02275962|Adult Volunteers|adult volunteers
166771|NCT02275949|SAH (Subarachnoid Hemorrhage)|sah (subarachnoid hemorrhage)
166772|NCT02275949|Cerebral Vasospasm|cerebral vasospasm
166773|NCT02275949|Acupuncture|acupuncture
166774|NCT02275936|N91115|n91115
166775|NCT02275936|Cavosonstat|cavosonstat
166776|NCT02275910|Solid Tumors|solid tumors
166777|NCT02275910|E7090|e7090
202414|NCT02106702|HIV|hiv
166778|NCT02275897|Lower Segmental Caesarean Section (LSCS)|lower segmental caesarean section (lscs)
166779|NCT02275897|Speed of Injection|speed of injection
166780|NCT02275897|Spinal Anaesthesia|spinal anaesthesia
166781|NCT02275897|Anesthesia|anesthesia
166782|NCT02275884|Parkinson Disease|parkinson disease
166783|NCT02275884|Cacao|cacao
166784|NCT02275884|Biogenic amines|biogenic amines
166785|NCT02275884|Xanthines|xanthines
166786|NCT02275884|Neurodegenerative Diseases|neurodegenerative diseases
166787|NCT02275871|Breast Cancer|breast cancer
166788|NCT02275858|balloon assisted enteroscopy|balloon assisted enteroscopy
166789|NCT02275858|terminal ileum intubation|terminal ileum intubation
166792|NCT02275819|Heart Failure|heart failure
166793|NCT02275819|Exercise|exercise
166794|NCT02275819|Echocardiography|echocardiography
166798|NCT02275741|expanded disability status scale|expanded disability status scale
166799|NCT02275728|Menopause|menopause
166800|NCT02275728|Stress Urinary Incontinence|stress urinary incontinence
166801|NCT02275728|EMG Biofeedback|emg biofeedback
166802|NCT02275728|Pelvic Floor Muscle Training|pelvic floor muscle training
166803|NCT02275728|Quality of life|quality of life
166804|NCT02275728|Physical Therapie|physical therapie
166807|NCT02275702|Dexamethasone|dexamethasone
166808|NCT02275702|Quality of recovery questionnaire|quality of recovery questionnaire
166809|NCT02275702|QoR-40|qor-40
166810|NCT02275702|Lung cancer|lung cancer
166811|NCT02275702|Video-assisted thoracoscopic|video-assisted thoracoscopic
166812|NCT02275689|Rotator cuff|rotator cuff
166813|NCT02275689|Tendinosis|tendinosis
166814|NCT02275689|Impingement|impingement
166815|NCT02275689|radiofrequency|radiofrequency
166816|NCT02275676|Inflammatory bowel disease|inflammatory bowel disease
166817|NCT02275676|Nutritional Status|nutritional status
166818|NCT02275676|Malnutrition|malnutrition
166819|NCT02275676|Resting Energy Expenditure|resting energy expenditure
166820|NCT02275663|relapsed AML|relapsed aml
166821|NCT02275663|refractory AML|refractory aml
166822|NCT02275663|azacytidine|azacytidine
166823|NCT02275650|calcidiol|calcidiol
166824|NCT02275650|25(oh)d|25(oh)d
166825|NCT02275650|nbUVB|nbuvb
166826|NCT02275650|cyp27A1|cyp27a1
166827|NCT02275650|cyp27B1|cyp27b1
166828|NCT02275650|vitamin D|vitamin d
166829|NCT02275637|Implantable Cardioverter-Defibrillators|implantable cardioverter-defibrillators
166830|NCT02275637|Ventricular Fibrillation|ventricular fibrillation
166831|NCT02275637|ventricular Tachycardia|ventricular tachycardia
166832|NCT02275611|oxytocin|oxytocin
166833|NCT02275611|alcohol withdrawal|alcohol withdrawal
166834|NCT02275611|alcohol dependence|alcohol dependence
166835|NCT02275611|alcoholism|alcoholism
166836|NCT02275585|Portal vein|portal vein
167118|NCT02273882|RSV|rsv
166837|NCT02275585|Thrombosis|thrombosis
166838|NCT02275585|Cirrhosis|cirrhosis
166839|NCT02275481|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
166840|NCT02275481|COPD|copd
166841|NCT02275481|Emphysema|emphysema
166842|NCT02275481|Chronic bronchitis|chronic bronchitis
166843|NCT02275468|Chronic Kidney Disease|chronic kidney disease
166844|NCT02275468|eGFR slope|egfr slope
166845|NCT02275468|Herbal medicine Fu-zheng-qu-zhuo Oral liquid|herbal medicine fu-zheng-qu-zhuo oral liquid
166846|NCT02275442|EPICES scale|epices scale
166847|NCT02275442|Precarious situation|precarious situation
166848|NCT02275442|Rural parturient women|rural parturient women
166849|NCT02275442|Access to care|access to care
166850|NCT02275442|Global Initiative for Sentinel E-health Network on Grid|global initiative for sentinel e-health network on grid
166851|NCT02275442|General practice|general practice
166852|NCT02275429|Metabolic Diseases|metabolic diseases
166853|NCT02275429|Athletes|athletes
166854|NCT02275429|Running|running
166855|NCT02275429|Selenium|selenium
166856|NCT02275429|Zinc|zinc
167155|NCT02273726|hemoglobin|hemoglobin
166857|NCT02275429|Iron Metabolism Disorders|iron metabolism disorders
166858|NCT02275429|Water-Electrolyte Imbalance|water-electrolyte imbalance
166859|NCT02275429|Hyperkalemia|hyperkalemia
166860|NCT02275429|Hypernatremia|hypernatremia
166861|NCT02275429|Selenium levels before and after the race|selenium levels before and after the race
166862|NCT02275429|Levels of other electrolytes and markers|levels of other electrolytes and markers
166863|NCT02275390|mental illness|mental illness
166864|NCT02275390|psychoeducation|psychoeducation
166865|NCT02275390|nurse-led clinic|nurse-led clinic
166866|NCT02275390|randomized controlled trial|randomized controlled trial
166867|NCT02275377|Breathing Exercises; Autonomic Control; Blood Pressure.|breathing exercises; autonomic control; blood pressure.
166868|NCT02275351|alopecia|alopecia
166869|NCT02275351|topical|topical
166870|NCT02275351|Samumed|samumed
166871|NCT02275325|Posture|posture
166872|NCT02275325|Unilateral vestibular deafferentation|unilateral vestibular deafferentation
166873|NCT02275325|Medical management|medical management
166874|NCT02275325|Preoperative vestibular rehabilitation|preoperative vestibular rehabilitation
166875|NCT02275325|Neural plasticity|neural plasticity
166876|NCT02275286|sarcoma|sarcoma
166877|NCT02275273|Adnexal Masses|adnexal masses
166878|NCT02275273|Magnetic Resonance Imaging|magnetic resonance imaging
166879|NCT02275273|Anatomopathology|anatomopathology
166880|NCT02275247|Stellate ganglion block|stellate ganglion block
166881|NCT02275247|Aneurysm surgery|aneurysm surgery
166882|NCT02275247|Cognitive recovery|cognitive recovery
166883|NCT02275247|Cerebral vasospasm|cerebral vasospasm
166884|NCT02275234|cardiac arrest|cardiac arrest
166885|NCT02275234|psychological intervention|psychological intervention
166886|NCT02275221|Hepatitis B (HBV)|hepatitis b (hbv)
166887|NCT02275221|Hepatitis C (HCV)|hepatitis c (hcv)
166888|NCT02275195|hepatitis|hepatitis
166890|NCT02275182|Dexmedetomidine|dexmedetomidine
166891|NCT02275169|follicle stimulating hormone treatment|follicle stimulating hormone treatment
166892|NCT02275169|azoospermia nonobstructive|azoospermia nonobstructive
166893|NCT02275169|male infertility|male infertility
166894|NCT02275169|follicle stimulating hormone|follicle stimulating hormone
166895|NCT02275156|Subjects with normal renal function or severe renal impairment (RI) or end stage renal disease (ESRD) receiving hemodialysis|subjects with normal renal function or severe renal impairment (ri) or end stage renal disease (esrd) receiving hemodialysis
166896|NCT02275143|Computed Tomography of Thorax, Abdomen and Pelvis|computed tomography of thorax, abdomen and pelvis
166897|NCT02275143|cancer patients|cancer patients
166898|NCT02275143|coronary angiogram evaluation|coronary angiogram evaluation
166899|NCT02275130|glottic insufficiency|glottic insufficiency
166900|NCT02275130|calcium hydroxyapatite|calcium hydroxyapatite
166901|NCT02275130|augmentation of vocal cords with injection technique|augmentation of vocal cords with injection technique
166902|NCT02275117|Migraine Disorders|migraine disorders
166903|NCT02275117|ALD403|ald403
166904|NCT02275104|Ventricular arrhythmias|ventricular arrhythmias
166905|NCT02275104|Persistent atrial fibrillation|persistent atrial fibrillation
166906|NCT02275104|Ablation guidance|ablation guidance
166907|NCT02275104|Software|software
166908|NCT02275104|MRI (Magnetic resonance imaging)|mri (magnetic resonance imaging)
166909|NCT02275091|Children|children
166910|NCT02275091|Cholesterol|cholesterol
166911|NCT02275078|COPD|copd
166912|NCT02275078|Action Plan|action plan
166913|NCT02275078|Telesystem|telesystem
166914|NCT02275078|New technology|new technology
166915|NCT02275065|HIV-1 Infected|hiv-1 infected
166916|NCT02275065|Adults|adults
166917|NCT02275065|Treatment Naive|treatment naive
166918|NCT02275052|shuttle walk test|shuttle walk test
166919|NCT02275052|umeclidinium|umeclidinium
166920|NCT02275052|beta2-agonist|beta2-agonist
166921|NCT02275052|exercise endurance time|exercise endurance time
166922|NCT02275052|anticholinergic|anticholinergic
166923|NCT02275052|combination product|combination product
166924|NCT02275052|vilanterol|vilanterol
166925|NCT02275052|exercise|exercise
166926|NCT02275052|COPD|copd
166927|NCT02275026|General Anesthesia, Postoperative Delirium, Recovery|general anesthesia, postoperative delirium, recovery
166928|NCT02274974|incisional|incisional
166931|NCT02274974|lidocaine|lidocaine
166932|NCT02274974|epinephrine|epinephrine
166933|NCT02274974|Adverse Reaction to Topical or Infiltrative Lidocaine|adverse reaction to topical or infiltrative lidocaine
166934|NCT02274922|Campylobacter diagnosis,|campylobacter diagnosis,
166935|NCT02274922|immuno-chromatographic test, ELISA, PCR, culture, stool|immuno-chromatographic test, elisa, pcr, culture, stool
166936|NCT02274922|ELISA,|elisa,
166937|NCT02274922|PCR,|pcr,
166938|NCT02274922|culture, stool|culture, stool
166939|NCT02274909|electromyography|electromyography
166940|NCT02274909|aged|aged
166941|NCT02274909|muscle strength|muscle strength
166942|NCT02274909|wavelet analysis|wavelet analysis
166943|NCT02274909|pilates|pilates
166944|NCT02274909|proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
166945|NCT02274857|FIRMap|firmap
166946|NCT02274857|Rotor|rotor
166947|NCT02274857|FIRM-guided procedure|firm-guided procedure
166948|NCT02274857|REAFFIRM|reaffirm
166949|NCT02274805|Brown adipose tissue|brown adipose tissue
166950|NCT02274805|Neck surgery|neck surgery
166951|NCT02274779|Prostate Cancer,Oligometastasis,Radiotherapy,Hormonotherapy|prostate cancer,oligometastasis,radiotherapy,hormonotherapy
166952|NCT02274766|Levodopa-Induced Dyskinesia|levodopa-induced dyskinesia
166954|NCT02274766|Parkinsonism|parkinsonism
166955|NCT02274766|Parkinson's Disease|parkinson's disease
166956|NCT02274727|Biomarker|biomarker
166957|NCT02274727|Stroke|stroke
166958|NCT02274727|Etiology|etiology
166959|NCT02274727|Outcome|outcome
166960|NCT02274675|Stroke|stroke
166961|NCT02274675|Robot-assisted therapy|robot-assisted therapy
166962|NCT02274675|Rehabilitation|rehabilitation
166963|NCT02274623|Bone Neoplasms|bone neoplasms
166964|NCT02274623|Hypocalcemia|hypocalcemia
166965|NCT02274623|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
166966|NCT02274610|docetaxel|docetaxel
166967|NCT02274610|Pharmacokinetic|pharmacokinetic
166968|NCT02274597|hypothermia|hypothermia
166969|NCT02274597|pre-hospital|pre-hospital
166970|NCT02274597|epitympanic|epitympanic
166971|NCT02274597|temperature|temperature
166972|NCT02274584|Hodgkin's lymphoma|hodgkin's lymphoma
166973|NCT02274584|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
166974|NCT02274584|CD30 positive lymphoma|cd30 positive lymphoma
166975|NCT02274584|Peripheral T/Natural Killer (NK) cell lymphoma|peripheral t/natural killer (nk) cell lymphoma
166976|NCT02274519|multiple myeloma|multiple myeloma
166977|NCT02274519|plasma cell disorder|plasma cell disorder
166978|NCT02274519|autologous stem cell transplant|autologous stem cell transplant
166979|NCT02274506|Blood And Marrow Transplantation|blood and marrow transplantation
166980|NCT02274506|Leukemia|leukemia
166981|NCT02274506|Lymphoma|lymphoma
166982|NCT02274506|CD19-specific T cells|cd19-specific t cells
166983|NCT02274506|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
166985|NCT02274506|Biphenotypic leukemia|biphenotypic leukemia
166986|NCT02274506|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
166987|NCT02274506|NHL|nhl
166988|NCT02274506|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
166989|NCT02274506|Small lymphocytic lymphoma|small lymphocytic lymphoma
166990|NCT02274506|Follicular lymphoma|follicular lymphoma
166991|NCT02274506|Mantle cell lymphoma|mantle cell lymphoma
166992|NCT02274506|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
166993|NCT02274506|CLL|cll
166994|NCT02274493|da Vinci® robotic surgical system|da vinci® robotic surgical system
166995|NCT02274493|latissimus dorsi muscle flap harvest procedures|latissimus dorsi muscle flap harvest procedures
166996|NCT02274493|breast reconstruction|breast reconstruction
166997|NCT02274493|scalp reconstruction|scalp reconstruction
166998|NCT02274493|upper extremity reconstruction|upper extremity reconstruction
166999|NCT02274493|lower extremity reconstruction|lower extremity reconstruction
167000|NCT02274480|MRI|mri
167001|NCT02274480|Diffusion Weighted Imaging|diffusion weighted imaging
167002|NCT02274480|14-191|14-191
167003|NCT02274467|Tsui Test|tsui test
167004|NCT02274467|Labour|labour
167005|NCT02274467|Epidural catheter|epidural catheter
167006|NCT02274454|Uterine contraction|uterine contraction
167007|NCT02274454|Oxytocin desensitization|oxytocin desensitization
167008|NCT02274428|intraventricular hemorrhage|intraventricular hemorrhage
167009|NCT02274415|Streptococcus pneumoniae|streptococcus pneumoniae
167010|NCT02274415|Sickle cell disease|sickle cell disease
167011|NCT02274415|Immunogenicity|immunogenicity
167012|NCT02274415|Antibody response|antibody response
167013|NCT02274402|Prednisone|prednisone
167014|NCT02274402|Glucocorticoids|glucocorticoids
167015|NCT02274402|pharmacokinetics|pharmacokinetics
167016|NCT02274389|Pulmonary Multi-drug Resistant Tuberculosis|pulmonary multi-drug resistant tuberculosis
167017|NCT02274389|Bedaquiline|bedaquiline
167018|NCT02274389|Sirturo|sirturo
167019|NCT02274389|Observational|observational
167020|NCT02274389|Prospective|prospective
167021|NCT02274363|Psoriasis|psoriasis
167022|NCT02274363|Plaque|plaque
167023|NCT02274363|Chronic|chronic
167024|NCT02274350|prostate cancer|prostate cancer
167025|NCT02274350|radiation therapy|radiation therapy
167026|NCT02274350|sexual side effects|sexual side effects
167027|NCT02274337|Epidermal Growth Factor Receptor|epidermal growth factor receptor
167028|NCT02274337|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
167029|NCT02274337|T790M mutation|t790m mutation
167030|NCT02274324|parkinson|parkinson
167032|NCT02274324|diet|diet
167033|NCT02274324|proteins|proteins
167034|NCT02274324|amino acids|amino acids
167035|NCT02274311|Acromegaly|acromegaly
167036|NCT02274311|SERM|serm
167037|NCT02274311|Clomiphene|clomiphene
167038|NCT02274285|Tetanus|tetanus
167039|NCT02274285|Diphtheria|diphtheria
167040|NCT02274285|Pertussis|pertussis
167041|NCT02274285|Poliomyelitis|poliomyelitis
167042|NCT02274285|Bacterial meningitis|bacterial meningitis
167043|NCT02274285|DTaP-IPV/Hib Combination vaccine|dtap-ipv/hib combination vaccine
167044|NCT02274272|lactobacillus reuteri|lactobacillus reuteri
167045|NCT02274272|type 2 diabetes|type 2 diabetes
167046|NCT02274246|Segmentation|segmentation
167047|NCT02274246|GIMIAS® program|gimias® program
167048|NCT02274246|Atrial fibrillation|atrial fibrillation
167049|NCT02274246|Left atrial fibrosis|left atrial fibrosis
167050|NCT02274246|Healthy volunteers|healthy volunteers
167052|NCT02274233|Iron Overload|iron overload
167053|NCT02274233|Thalassemia|thalassemia
167054|NCT02274233|Transfusion|transfusion
167055|NCT02274233|Iron Chelation|iron chelation
167056|NCT02274220|systemic inflammation|systemic inflammation
167057|NCT02274220|glucose metabolism|glucose metabolism
167058|NCT02274220|glucose-insulin ratio|glucose-insulin ratio
167059|NCT02274207|Silver dressing|silver dressing
167060|NCT02274207|NPWT|npwt
167061|NCT02274207|DMF|dmf
167062|NCT02274207|foot|foot
167063|NCT02274194|CPAP|cpap
167064|NCT02274194|Nasal mask|nasal mask
167065|NCT02274194|Oronasal mask|oronasal mask
167066|NCT02274194|Mucociliary clearance|mucociliary clearance
167067|NCT02274194|breathing route|breathing route
167068|NCT02274155|Head and Neck Cancer|head and neck cancer
167069|NCT02274155|anti-OX40 antibody|anti-ox40 antibody
167070|NCT02274155|MEDI6469|medi6469
167071|NCT02274155|Immunotherapy|immunotherapy
167072|NCT02274142|dentinal caries|dentinal caries
167073|NCT02274142|occlusal|occlusal
167074|NCT02274142|occluso-proximal|occluso-proximal
167075|NCT02274116|acute intermittent hypoxia|acute intermittent hypoxia
167076|NCT02274116|walking|walking
167077|NCT02274116|spasticity|spasticity
167078|NCT02274116|incomplete spinal cord injury|incomplete spinal cord injury
167079|NCT02274116|breathing|breathing
167080|NCT02274116|strength|strength
167081|NCT02274090|Metformin|metformin
167082|NCT02274090|Pocket depth|pocket depth
167083|NCT02274090|moderate periodontitis|moderate periodontitis
167280|NCT02272855|Phase II|phase ii
167084|NCT02274090|severe periodontitis|severe periodontitis
167085|NCT02274077|length of stay|length of stay
167086|NCT02274077|nausea|nausea
167087|NCT02274077|emesis|emesis
167088|NCT02274077|bowel function|bowel function
167089|NCT02274077|pain scores|pain scores
167090|NCT02274077|narcotic pain medication|narcotic pain medication
167091|NCT02274077|post operative period|post operative period
167092|NCT02274064|Retention|retention
167093|NCT02274064|Blood Donor Motivation|blood donor motivation
167094|NCT02274025|Patient diagnosed with lung cancer|patient diagnosed with lung cancer
167095|NCT02274012|Gastric|gastric
167096|NCT02274012|Gastroesophageal Junction|gastroesophageal junction
167097|NCT02274012|Gastroesophageal Cancer|gastroesophageal cancer
167098|NCT02274012|Esophageal Cancer|esophageal cancer
167099|NCT02274012|Metastatic|metastatic
167100|NCT02274012|HER2 amplified|her2 amplified
167101|NCT02274012|Afatinib|afatinib
167102|NCT02273999|pulsed electromagnetic fields|pulsed electromagnetic fields
167103|NCT02273999|post operative morbidity|post operative morbidity
167104|NCT02273999|third molar|third molar
167105|NCT02273999|extraction|extraction
167106|NCT02273999|pain|pain
167107|NCT02273986|Adult Volunteers|adult volunteers
167108|NCT02273934|Home-based rehabilitation|home-based rehabilitation
167109|NCT02273934|Activities of daily living|activities of daily living
167110|NCT02273934|Restorative care|restorative care
167111|NCT02273934|Reablement|reablement
167112|NCT02273934|Everyday rehabilitation|everyday rehabilitation
167113|NCT02273921|Dementia, Diagnosis, Electroencephalography|dementia, diagnosis, electroencephalography
167114|NCT02273908|Low-Back Pain|low-back pain
167115|NCT02273908|Neuropathic Pain|neuropathic pain
167116|NCT02273908|Pregabalin|pregabalin
167117|NCT02273895|Scopolamine, AD, EEG, MCI|scopolamine, ad, eeg, mci
167119|NCT02273882|RSVH|rsvh
167120|NCT02273882|Infant|infant
167121|NCT02273882|Gestational Age|gestational age
167122|NCT02273882|wGA|wga
167123|NCT02273882|PRETERM|preterm
167124|NCT02273856|Chronic Lymphocytic Leukaemia (CLL)|chronic lymphocytic leukaemia (cll)
167125|NCT02273856|Indolent Non Hodgkin's Lymphoma (iNHL)|indolent non hodgkin's lymphoma (inhl)
167126|NCT02273843|Preterm|preterm
167127|NCT02273843|late-onset sepsis|late-onset sepsis
167128|NCT02273843|Vitamin D|vitamin d
167129|NCT02273843|Dose|dose
167130|NCT02273843|Interleukin-6|interleukin-6
167131|NCT02273843|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
167132|NCT02273830|oxygen therapy|oxygen therapy
167133|NCT02273830|COPD|copd
167134|NCT02273830|exercise|exercise
167135|NCT02273804|Topiramate|topiramate
167136|NCT02273804|Obesity|obesity
167137|NCT02273804|Children|children
167138|NCT02273804|Adolescents|adolescents
167139|NCT02273791|Frozen-thawed embryo transfer|frozen-thawed embryo transfer
167140|NCT02273791|FET protocols|fet protocols
167141|NCT02273739|solid tumor|solid tumor
167142|NCT02273739|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
167143|NCT02273739|ICC|icc
167144|NCT02273739|chondrosarcoma|chondrosarcoma
167145|NCT02273739|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
167146|NCT02273739|AITL|aitl
167147|NCT02273739|IDH|idh
167148|NCT02273739|glioma|glioma
167149|NCT02273739|solid tumor, including intrahepatic cholangiocarcinoma and chondrosarcoma|solid tumor, including intrahepatic cholangiocarcinoma and chondrosarcoma
167150|NCT02273726|Anemia|anemia
167151|NCT02273726|Chronic Kidney Disease|chronic kidney disease
167152|NCT02273726|Dialysis|dialysis
167153|NCT02273726|hemodialysis|hemodialysis
167154|NCT02273726|peritoneal dialysis|peritoneal dialysis
167156|NCT02273726|End stage renal disease|end stage renal disease
167157|NCT02273726|Stable Dialysis|stable dialysis
167158|NCT02273726|erythropoietins|erythropoietins
167159|NCT02273726|erythropoiesis stimulating agent|erythropoiesis stimulating agent
167160|NCT02273713|Esophageal cancer|esophageal cancer
167161|NCT02273713|Metastasized|metastasized
167162|NCT02273713|Nab-paclitaxel|nab-paclitaxel
167163|NCT02273713|Toxicity|toxicity
167164|NCT02273713|First line treatment|first line treatment
167165|NCT02273713|Phase Ib/II|phase ib/ii
167166|NCT02273700|Xarelto®|xarelto®
167167|NCT02273700|protein/peptide profiles|protein/peptide profiles
167168|NCT02273687|diaphragm movement|diaphragm movement
167169|NCT02273687|ultrasound|ultrasound
167170|NCT02273687|emergency room|emergency room
167171|NCT02273674|Borderline Personality Disorder|borderline personality disorder
167172|NCT02273674|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
167173|NCT02273648|national|national
167174|NCT02273648|multicenter|multicenter
167175|NCT02273648|observational registry|observational registry
167176|NCT02273648|Orsiro Drug Eluting Stent|orsiro drug eluting stent
167177|NCT02273648|Stenting Treatment of coronary artery disease|stenting treatment of coronary artery disease
167178|NCT02273648|coronary revascularization|coronary revascularization
167179|NCT02273648|PCI|pci
167180|NCT02273648|STEMI|stemi
167181|NCT02273648|NSTEMI|nstemi
167182|NCT02273648|Ischemia|ischemia
167183|NCT02273648|Angina|angina
167184|NCT02273648|Acute Myocardial Infarction|acute myocardial infarction
167185|NCT02273648|Small Vessels|small vessels
167186|NCT02273648|Chronic Total Occlusion|chronic total occlusion
167187|NCT02273622|hydroxytyrosol|hydroxytyrosol
167188|NCT02273622|dietary supplement|dietary supplement
167189|NCT02273622|gene expression regulation|gene expression regulation
167190|NCT02273609|Atrial fibrillation|atrial fibrillation
167191|NCT02273609|Anticoagulation|anticoagulation
167192|NCT02273609|Vitamin K antagonists|vitamin k antagonists
167193|NCT02273609|INR control|inr control
167194|NCT02273583|of the extremity|of the extremity
167195|NCT02273570|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
167196|NCT02273570|Anemia|anemia
167197|NCT02273570|Vascular Stiffness|vascular stiffness
167198|NCT02273570|Vascular Calcification|vascular calcification
167199|NCT02273323|Flow mediated dilation|flow mediated dilation
167200|NCT02273323|tea|tea
167201|NCT02273323|blood pressure|blood pressure
167202|NCT02273297|Body composition|body composition
167203|NCT02273297|Body size|body size
167204|NCT02273284|Pain, Pediatrics, Botulinum Toxin injections, Buzzy|pain, pediatrics, botulinum toxin injections, buzzy
167205|NCT02273271|FLT-PET|flt-pet
167206|NCT02273271|DWI-MRI|dwi-mri
167207|NCT02273232|Peripheral Arterial Disease|peripheral arterial disease
167208|NCT02273232|Peripheral Vascular Disease|peripheral vascular disease
167209|NCT02273232|Claudication|claudication
167210|NCT02273232|Remote Ischemic Preconditioning|remote ischemic preconditioning
167211|NCT02273232|EQ-5D|eq-5d
167212|NCT02273232|Symptoms free distance|symptoms free distance
167213|NCT02273232|ABI|abi
167214|NCT02273232|micro vessel formation|micro vessel formation
167215|NCT02273219|Uveal|uveal
167216|NCT02273219|Melanoma|melanoma
167217|NCT02273219|Advanced uveal melanoma|advanced uveal melanoma
167218|NCT02273206|Depression|depression
167219|NCT02273206|Breast Cancer Screening|breast cancer screening
167220|NCT02273206|Cervical Cancer Screening|cervical cancer screening
167221|NCT02273206|Colorectal Cancer Screening|colorectal cancer screening
167222|NCT02273154|major depressive disorder|major depressive disorder
167223|NCT02273154|Efficacy and safety of buspirone add-one treatment in patients with major depression disorder|efficacy and safety of buspirone add-one treatment in patients with major depression disorder
167224|NCT02273154|buspirone|buspirone
167225|NCT02273154|paroxetine|paroxetine
167226|NCT02273154|anxiety|anxiety
167227|NCT02273128|Osteoporosis|osteoporosis
167228|NCT02273128|Chronic Periodontitis|chronic periodontitis
167229|NCT02273128|Calcitonin gene Polymorphism|calcitonin gene polymorphism
167230|NCT02273115|induction|induction
167231|NCT02273115|Foley catheter|foley catheter
167232|NCT02273115|oxytocin|oxytocin
167233|NCT02273102|Acute Myelogenous Leukemia|acute myelogenous leukemia
167234|NCT02273102|AML|aml
167235|NCT02273102|Myelodysplastic Syndromes|myelodysplastic syndromes
167236|NCT02273102|MDS|mds
167237|NCT02273102|Tranylcypromine|tranylcypromine
167238|NCT02273102|TCP|tcp
167239|NCT02273102|ATRA|atra
167240|NCT02273102|Tretinoin|tretinoin
167241|NCT02273089|Obstructive sleep apnea|obstructive sleep apnea
167242|NCT02273089|arterial stiffness|arterial stiffness
167243|NCT02273089|CPAP|cpap
167244|NCT02273089|excessive daytime sleepiness|excessive daytime sleepiness
167245|NCT02273089|pulse wave velocity|pulse wave velocity
167246|NCT02273063|PTSD|ptsd
167247|NCT02273063|MDD|mdd
167248|NCT02273063|TMS|tms
167249|NCT02273063|5Hz|5hz
167250|NCT02273050|Type 2 Diabetes Mellitus, Dipeptidyl-Peptidase 4 Inhibitors, Saxagliptin, Metformin, Endocrine System Diseases|type 2 diabetes mellitus, dipeptidyl-peptidase 4 inhibitors, saxagliptin, metformin, endocrine system diseases
167251|NCT02273037|Labour|labour
167252|NCT02273037|Birth asphyxia|birth asphyxia
167253|NCT02273037|Fetal Heart Rate Monitor|fetal heart rate monitor
167254|NCT02273037|Doppler Fetal Heart Rate Monitor|doppler fetal heart rate monitor
167255|NCT02273037|Pinard Horn|pinard horn
167256|NCT02273037|Pediatrics|pediatrics
167257|NCT02273037|Uganda|uganda
167258|NCT02273024|Exercise|exercise
167259|NCT02273024|Quality of Life|quality of life
167260|NCT02273024|Fatigue|fatigue
167261|NCT02273024|Symptoms|symptoms
167262|NCT02273024|Prehabilitation|prehabilitation
167263|NCT02273024|Aerobic Capacity|aerobic capacity
167264|NCT02272998|FGFR, RET, KIT|fgfr, ret, kit
167265|NCT02272985|cerebral blood flow|cerebral blood flow
167266|NCT02272985|hemodialysis|hemodialysis
167267|NCT02272972|"fluoroscopy[MeSH], education, medical[MeSH]"|"fluoroscopy[mesh], education, medical[mesh]"
402928|NCT01229059|mitochondria|mitochondria
167268|NCT02272959|Anxiety/Anxiety disorders, Clinical trials, treatment, cognition, computer/Internet technology|anxiety/anxiety disorders, clinical trials, treatment, cognition, computer/internet technology
167269|NCT02272907|Bariatric Surgery|bariatric surgery
167270|NCT02272907|Laparoscopy|laparoscopy
167271|NCT02272907|Weight Loss Surgery|weight loss surgery
167272|NCT02272907|Staple Line Reinforcement|staple line reinforcement
167273|NCT02272894|Gastric Cancer|gastric cancer
663583|NCT00829348|Chronic|chronic
167274|NCT02272894|D2 Lymphadenectomy|d2 lymphadenectomy
167275|NCT02272894|Superior Mesenteric Vein Lymph Node|superior mesenteric vein lymph node
167276|NCT02272855|HF10|hf10
167277|NCT02272855|HSV-1|hsv-1
167278|NCT02272855|Ipilimumab|ipilimumab
167279|NCT02272855|Oncolytic virus|oncolytic virus
167281|NCT02272855|Stage IIIB melanoma|stage iiib melanoma
167282|NCT02272855|Stage IIIC melanoma|stage iiic melanoma
167283|NCT02272855|Stage IV melanoma|stage iv melanoma
167284|NCT02272855|Unresectable malignant melanoma|unresectable malignant melanoma
167285|NCT02272855|Metastatic malignant melanoma|metastatic malignant melanoma
167286|NCT02272855|Combination treatment|combination treatment
167287|NCT02272855|Intratumoral injection|intratumoral injection
167288|NCT02272842|Nepal|nepal
167289|NCT02272842|Cobalamin|cobalamin
167290|NCT02272842|Neurodevelopment|neurodevelopment
167291|NCT02272842|Stunting|stunting
167292|NCT02272842|Growth|growth
167293|NCT02272790|Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|ovarian, fallopian tube, or primary peritoneal cancer
167294|NCT02272777|Myelogenous|myelogenous
167295|NCT02272777|Chronic|chronic
167296|NCT02272777|BCR-ABL Positive|bcr-abl positive
167297|NCT02272751|cancer survivorship|cancer survivorship
167298|NCT02272751|exercise|exercise
167299|NCT02272751|relaxation|relaxation
167300|NCT02272751|mindfulness|mindfulness
167301|NCT02272725|ultramarathon|ultramarathon
167302|NCT02272725|ibuprofen|ibuprofen
167303|NCT02272725|acute kidney injury|acute kidney injury
167304|NCT02272725|exercise-associated hyponatremia|exercise-associated hyponatremia
167305|NCT02272725|exertion|exertion
167306|NCT02272712|cancer survivor|cancer survivor
167307|NCT02272712|computerized treatment|computerized treatment
167308|NCT02272712|symptom management|symptom management
167309|NCT02272699|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
167310|NCT02272699|Nimotuzumab|nimotuzumab
167311|NCT02272699|Neoadjuvant treatment|neoadjuvant treatment
167312|NCT02272686|Lymphoma|lymphoma
167313|NCT02272686|Blood And Marrow Transplantation|blood and marrow transplantation
167314|NCT02272686|Post Autologous Stem Cell Transplantation|post autologous stem cell transplantation
167316|NCT02272686|B-cell lymphoma|b-cell lymphoma
167317|NCT02272686|Ibrutinib|ibrutinib
167318|NCT02272686|PCI-32765|pci-32765
167319|NCT02272686|Imbruvica|imbruvica
167320|NCT02272660|preemptive analgesia|preemptive analgesia
167321|NCT02272660|parecoxib sodium|parecoxib sodium
167322|NCT02272660|total knee arthroplasty|total knee arthroplasty
167323|NCT02272660|total hip arthroplasty|total hip arthroplasty
167324|NCT02272647|Normal Healthy Volunteers|normal healthy volunteers
167326|NCT02272595|Biologic Markers|biologic markers
167327|NCT02272595|Molecular testing|molecular testing
167328|NCT02272595|Advanced cancers|advanced cancers
167329|NCT02272595|Molecular information|molecular information
167330|NCT02272595|Molecular profiling|molecular profiling
167331|NCT02272595|Genetic Mutation|genetic mutation
167332|NCT02272569|glaucoma|glaucoma
167333|NCT02272569|glaucoma drainage device|glaucoma drainage device
167334|NCT02272569|glaucoma shunt|glaucoma shunt
167335|NCT02272530|Endothelial NO-synthase|endothelial no-synthase
167336|NCT02272530|red blood cell|red blood cell
167337|NCT02272530|erythrocytes|erythrocytes
167338|NCT02272530|Peripheral Blood Mononuclear Cell|peripheral blood mononuclear cell
167339|NCT02272530|cardiovascular disease|cardiovascular disease
167340|NCT02272517|Vortioxetine|vortioxetine
167341|NCT02272517|Cognition|cognition
167342|NCT02272504|HCC|hcc
167343|NCT02272504|AFP|afp
167344|NCT02272504|AFP-L3|afp-l3
167345|NCT02272504|DCP|dcp
167346|NCT02272504|Surveillance|surveillance
167347|NCT02272504|biomarkers|biomarkers
167348|NCT02272478|AML|aml
167349|NCT02272478|MDS|mds
167350|NCT02272465|pre-hospital resuscitation, helicopter, trauma|pre-hospital resuscitation, helicopter, trauma
167450|NCT02272036|Short message service|short message service
167351|NCT02272452|High resolution magic angle spinning Nuclear magnetic resonance|high resolution magic angle spinning nuclear magnetic resonance
167352|NCT02272452|Nuclear magnetic resonance|nuclear magnetic resonance
167353|NCT02272452|Spectroscopy|spectroscopy
167354|NCT02272452|Primary brain tumors|primary brain tumors
167355|NCT02272452|Gliomas|gliomas
167356|NCT02272452|extemporaneous analysis|extemporaneous analysis
167357|NCT02272439|Bisphenol A|bisphenol a
167358|NCT02272439|phthalates|phthalates
167359|NCT02272439|infertility|infertility
167360|NCT02272439|human|human
167361|NCT02272426|Stroke|stroke
167362|NCT02272426|Exercise Training|exercise training
167363|NCT02272426|Cognitive Training|cognitive training
167364|NCT02272426|Quality of Life|quality of life
167365|NCT02272400|image guided radiation therapy|image guided radiation therapy
167366|NCT02272400|partial breast irradiation|partial breast irradiation
167367|NCT02272400|breast cancer|breast cancer
167368|NCT02272400|breast|breast
167369|NCT02272400|cancer|cancer
167370|NCT02272400|breast preservation|breast preservation
167371|NCT02272400|IGRT|igrt
167372|NCT02272400|PBI|pbi
167373|NCT02272374|Hemodialysis|hemodialysis
167374|NCT02272374|Arteriovenous fistula|arteriovenous fistula
167375|NCT02272374|Tunneled cuffed catheter|tunneled cuffed catheter
167376|NCT02272374|Arteriovenous graft|arteriovenous graft
167377|NCT02272374|Elderly|elderly
167378|NCT02272374|Very elderly|very elderly
167379|NCT02272348|Therapeutic education|therapeutic education
167380|NCT02272348|Functional insulin therapy|functional insulin therapy
167381|NCT02272335|Breast Cancer|breast cancer
167382|NCT02272335|Health Disparities|health disparities
167383|NCT02272335|Psychosocial Intervention|psychosocial intervention
167384|NCT02272335|Cancer Survivors|cancer survivors
167385|NCT02272322|Anterior prolapse|anterior prolapse
167386|NCT02272296|Injections, Jet|injections, jet
167387|NCT02272296|pharmacology|pharmacology
167388|NCT02272296|Insulin Aspart|insulin aspart
167389|NCT02272296|Equipment and Supplies|equipment and supplies
167390|NCT02272283|PCI optimization|pci optimization
167391|NCT02272283|Coronary Remodeling|coronary remodeling
167392|NCT02272283|Drug-Eluting Stent|drug-eluting stent
167393|NCT02272283|Optical Coherence Tomography|optical coherence tomography
167394|NCT02272283|Intravascular Ultrasound|intravascular ultrasound
167395|NCT02272283|Strut Coverage|strut coverage
167396|NCT02272283|Strut Apposition|strut apposition
167397|NCT02272283|Vascular Healing Pattern|vascular healing pattern
167398|NCT02272257|Musculoskeletal Pain|musculoskeletal pain
167399|NCT02272257|Physical Therapists|physical therapists
167400|NCT02272257|Drug Prescriptions|drug prescriptions
167401|NCT02272257|Humans|humans
167402|NCT02272257|Physical Therapy Modalities|physical therapy modalities
167403|NCT02272257|Referral and Consultation|referral and consultation
167404|NCT02272257|Workers' Compensation|workers' compensation
167405|NCT02272257|United States|united states
167406|NCT02272257|Primary Care|primary care
167407|NCT02272257|Health Services Research|health services research
167408|NCT02272257|Triage|triage
167409|NCT02272257|Acute|acute
167410|NCT02272257|Cost|cost
167411|NCT02272257|Occupational Health|occupational health
167412|NCT02272244|Colorectal Cancer|colorectal cancer
167413|NCT02272244|Cancer Screening|cancer screening
167414|NCT02272244|Decision Support|decision support
167415|NCT02272244|Navigation|navigation
167416|NCT02272231|women's health|women's health
167417|NCT02272231|vaginosis, bacterial|vaginosis, bacterial
167418|NCT02272231|african americans|african americans
167419|NCT02272205|Hip replacement|hip replacement
167420|NCT02272205|Knee replacement|knee replacement
167421|NCT02272205|Knee infection|knee infection
167422|NCT02272205|Hip infection|hip infection
167423|NCT02272205|Antibiotic prophylaxis|antibiotic prophylaxis
167424|NCT02272192|autism|autism
167425|NCT02272192|autism spectrum disorder|autism spectrum disorder
167426|NCT02272192|intensive intervention|intensive intervention
167427|NCT02272192|early intervention|early intervention
167428|NCT02272192|Early Start Denver Model|early start denver model
167429|NCT02272179|adolescence|adolescence
167430|NCT02272179|suicidality|suicidality
167431|NCT02272179|depression|depression
167432|NCT02272127|EGFR tyrosine kinase inhibitor|egfr tyrosine kinase inhibitor
167433|NCT02272088|physical activity|physical activity
167434|NCT02272088|energy expenditure|energy expenditure
167435|NCT02272088|compensatory mechanisms|compensatory mechanisms
167436|NCT02272088|adolescent|adolescent
167437|NCT02272075|screeening|screeening
167438|NCT02272062|Coronary artery disease|coronary artery disease
167439|NCT02272062|Angina|angina
167440|NCT02272062|Shared decision-making|shared decision-making
167441|NCT02272062|Patient preferences|patient preferences
167442|NCT02272062|Percutaneous coronary intervention|percutaneous coronary intervention
167443|NCT02272062|Coronary artery bypass graft|coronary artery bypass graft
167444|NCT02272049|Respiratory|respiratory
167445|NCT02272036|Colonoscopy|colonoscopy
167446|NCT02272036|Colonoscopy preparation|colonoscopy preparation
167447|NCT02272036|screening|screening
167448|NCT02272036|New media|new media
167449|NCT02272036|SMS|sms
167451|NCT02272023|alcohol|alcohol
167452|NCT02272023|women|women
167453|NCT02272023|motivational interviewing|motivational interviewing
167454|NCT02271984|Healthy|healthy
167455|NCT02271984|Praziquantel|praziquantel
167456|NCT02271984|L-PZQ|l-pzq
167457|NCT02271984|PZQ|pzq
167458|NCT02271984|MSC2499550A|msc2499550a
167459|NCT02271984|Bioavailability|bioavailability
167460|NCT02271984|Pharmacokinetics|pharmacokinetics
167461|NCT02271971|Psoriasis|psoriasis
167462|NCT02271971|Vitamin D|vitamin d
167463|NCT02271971|Metabolic syndrome|metabolic syndrome
167464|NCT02271971|Insulin resistance|insulin resistance
167465|NCT02271971|Cholesterol|cholesterol
167466|NCT02271971|Methotrexate|methotrexate
167467|NCT02271971|Dyslipidemia|dyslipidemia
167468|NCT02271971|PASI|pasi
167469|NCT02271971|Psoriasis Area Severity Index|psoriasis area severity index
167470|NCT02271958|Mifepristone|mifepristone
167471|NCT02271958|Endometriosis|endometriosis
167472|NCT02271945|aggressive lymphoma, DLBCL, NHL|aggressive lymphoma, dlbcl, nhl
167473|NCT02271932|appendicitis|appendicitis
167474|NCT02271932|non-operative management|non-operative management
167475|NCT02271932|children|children
167476|NCT02271932|pediatric|pediatric
167477|NCT02271919|Cancer Prevention|cancer prevention
167478|NCT02271919|Tobacco Use Cessation|tobacco use cessation
167479|NCT02271919|Nicotine replacement therapy|nicotine replacement therapy
167480|NCT02271919|NRT|nrt
167481|NCT02271919|Varenicline|varenicline
167482|NCT02271919|Chantix|chantix
167483|NCT02271919|Nicotine lozenge|nicotine lozenge
167484|NCT02271919|Placebo tablet|placebo tablet
167485|NCT02271919|Placebo patch|placebo patch
167486|NCT02271919|Questionnaire|questionnaire
167487|NCT02271919|Survey|survey
167488|NCT02271919|Counseling|counseling
167489|NCT02271906|Lung Cancer|lung cancer
167490|NCT02271906|Non small cell lung cancer|non small cell lung cancer
167491|NCT02271906|NSCLC|nsclc
167492|NCT02271906|Adenocarcinoma|adenocarcinoma
167493|NCT02271906|Squamous cell carcinoma|squamous cell carcinoma
167494|NCT02271906|BIBW 2992|bibw 2992
167495|NCT02271906|Afatinib|afatinib
167496|NCT02271893|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
167497|NCT02271880|Medication nonadherence|medication nonadherence
167498|NCT02271802|Butyrate|butyrate
167499|NCT02271802|Interorgan metabolism|interorgan metabolism
167500|NCT02271802|Short-chain fatty acids|short-chain fatty acids
167501|NCT02271802|Gut production|gut production
167502|NCT02271776|Insulin Sensitivity|insulin sensitivity
167503|NCT02271763|cricothyroid membrane|cricothyroid membrane
167504|NCT02271763|ultrasound|ultrasound
167505|NCT02271750|IGF, Neurotrophic factors, Dementia, spinal fluid|igf, neurotrophic factors, dementia, spinal fluid
167506|NCT02271737|Newborn|newborn
167507|NCT02271737|infection|infection
167508|NCT02271737|community health|community health
167509|NCT02271724|CIDP|cidp
167510|NCT02271724|MMN|mmn
167511|NCT02271724|Spinal fluid|spinal fluid
167512|NCT02271724|CD163|cd163
167513|NCT02271724|CD19|cd19
167514|NCT02271711|Brain Cancer|brain cancer
167515|NCT02271711|Brain tumor|brain tumor
167516|NCT02271711|Recurrent posterior fossa tumors|recurrent posterior fossa tumors
167517|NCT02271711|Central nervous system|central nervous system
167518|NCT02271711|CNS|cns
167519|NCT02271711|Artificial antigen- presenting cells|artificial antigen- presenting cells
167520|NCT02271711|aAPC|aapc
167521|NCT02271711|Natural killer cells|natural killer cells
167522|NCT02271711|NK|nk
167523|NCT02271711|Ommaya reservoir|ommaya reservoir
167524|NCT02271698|Knee arthroplasty|knee arthroplasty
167525|NCT02271698|Dexamethasone|dexamethasone
167526|NCT02271698|Acute pain|acute pain
167527|NCT02271698|Chronic pain|chronic pain
167528|NCT02271685|Diagnostic Information|diagnostic information
167529|NCT02271685|Risk Perception|risk perception
167530|NCT02271659|Prostate|prostate
167531|NCT02271659|external beam radiotherapy|external beam radiotherapy
167532|NCT02271659|brachytherapy boost|brachytherapy boost
167533|NCT02271659|economical evaluation|economical evaluation
167534|NCT02271646|paravertebral block|paravertebral block
167535|NCT02271646|ultrasound guided|ultrasound guided
167536|NCT02271633|Nitrate|nitrate
167537|NCT02271633|Bioavailability|bioavailability
167538|NCT02271633|Sports|sports
167539|NCT02271620|1 prevalence|1 prevalence
167540|NCT02271620|2 children|2 children
167541|NCT02271620|3 local allergic rhinitis|3 local allergic rhinitis
167542|NCT02271607|moxibustion|moxibustion
167543|NCT02271555|electroconvulsive therapy|electroconvulsive therapy
167544|NCT02271555|sevoflurane|sevoflurane
167545|NCT02271555|remifentanil|remifentanil
167546|NCT02271542|Propofol|propofol
167547|NCT02271542|Polymorphism|polymorphism
167548|NCT02271542|UGT1A9|ugt1a9
167549|NCT02271542|CYP2B6|cyp2b6
167550|NCT02271529|Peripheral Vascular Disease|peripheral vascular disease
167551|NCT02271529|Femoral Artery|femoral artery
167552|NCT02271529|Drug-Eluting Stent|drug-eluting stent
167553|NCT02271490|Assisted Reproductive Technique|assisted reproductive technique
167554|NCT02271490|ICSI|icsi
167555|NCT02271490|Acrosome Reaction|acrosome reaction
167556|NCT02271490|Pregnancy outcome|pregnancy outcome
167557|NCT02271477|Fluid replacement|fluid replacement
167558|NCT02271477|Trans-Thoracic Echocardiography|trans-thoracic echocardiography
167559|NCT02271477|Spinal Anesthesia|spinal anesthesia
167560|NCT02271477|Empirical Volemic Repletion|empirical volemic repletion
167561|NCT02271464|Metastatic colorectal cancer|metastatic colorectal cancer
167562|NCT02271464|Ist line therapy|ist line therapy
167563|NCT02271464|metronimic therapy|metronimic therapy
167564|NCT02271464|bevacizumab|bevacizumab
167565|NCT02271451|concussion|concussion
167566|NCT02271438|Healthy|healthy
158551|NCT02322255|FOP|fop
167567|NCT02271438|Ibrutinib|ibrutinib
167568|NCT02271438|Moxifloxacin|moxifloxacin
167569|NCT02271438|Cardiac Repolarization|cardiac repolarization
167570|NCT02271438|Electrocardiogram|electrocardiogram
167571|NCT02271438|QTc interval|qtc interval
167572|NCT02271399|venous thromboembolism|venous thromboembolism
167573|NCT02271399|total knee arthroplasty|total knee arthroplasty
167574|NCT02271386|Evidence-Based Practice|evidence-based practice
167575|NCT02271386|Provider Education|provider education
167576|NCT02271373|Vision, Ocular|vision, ocular
167577|NCT02271373|Physical activity|physical activity
167578|NCT02271373|Schoolchildren|schoolchildren
167579|NCT02271373|Intervention Studies|intervention studies
167580|NCT02271360|infertility ICSI OHSS Calcium Dobesilate Cabergoline|infertility icsi ohss calcium dobesilate cabergoline
167581|NCT02271334|Asthma|asthma
167582|NCT02271334|Albuterol|albuterol
167583|NCT02271321|dementia|dementia
167584|NCT02271321|white noise|white noise
167585|NCT02271321|agitation|agitation
167586|NCT02271321|saliva cortisol|saliva cortisol
167587|NCT02271308|elastic band resistance training|elastic band resistance training
167588|NCT02271308|nursing home residents|nursing home residents
167589|NCT02271308|muscle strength|muscle strength
167590|NCT02271308|flexibility|flexibility
167591|NCT02271308|quality of life|quality of life
167592|NCT02271308|ease of care|ease of care
167593|NCT02271295|Cirrhosis|cirrhosis
167594|NCT02271295|Child B|child b
167595|NCT02271295|decompensation|decompensation
167596|NCT02271295|mortality|mortality
167597|NCT02271295|portal thrombosis|portal thrombosis
167598|NCT02271295|anticoagulation|anticoagulation
167599|NCT02271269|glaucoma|glaucoma
167600|NCT02271269|medication adherence|medication adherence
167601|NCT02271269|financial incentives|financial incentives
167602|NCT02271269|behavioral economics|behavioral economics
167603|NCT02271256|Functional intimate apparel|functional intimate apparel
167604|NCT02271256|Adolescent Idiopathic scoliosis|adolescent idiopathic scoliosis
167605|NCT02271243|Central line-associated bloodstream infections|central line-associated bloodstream infections
167606|NCT02271243|mucosal barrier injury|mucosal barrier injury
167607|NCT02271243|laboratory-confirmed bloodstream infection|laboratory-confirmed bloodstream infection
167608|NCT02271217|Post stroke|post stroke
167609|NCT02271217|Ischemic stroke|ischemic stroke
167610|NCT02271126|ECMO|ecmo
167611|NCT02271126|Heparin|heparin
167612|NCT02271126|Thromboelastography|thromboelastography
167613|NCT02271126|Bleeding complications|bleeding complications
167614|NCT02271074|HIV|hiv
167615|NCT02271074|Care|care
167616|NCT02271074|Treatment|treatment
167617|NCT02271074|Retention|retention
167618|NCT02271074|Implementation Science|implementation science
167619|NCT02271048|telemedicine|telemedicine
167620|NCT02271048|ultrasonography|ultrasonography
167621|NCT02271048|echocardiography|echocardiography
167622|NCT02271035|VUR|vur
167623|NCT02271022|ACS, Acute Coronary Syndromes|acs, acute coronary syndromes
167624|NCT02271022|NSTEMI|nstemi
167625|NCT02271022|MI, Myocardial Infarction|mi, myocardial infarction
167626|NCT02270996|antibiotic, antimicrobial, stewardship, child|antibiotic, antimicrobial, stewardship, child
167628|NCT02270983|Linaclotide|linaclotide
167629|NCT02270983|Linzess|linzess
167630|NCT02270944|GBS|gbs
167631|NCT02270944|vaccine comparability|vaccine comparability
167632|NCT02270944|Group B Strep|group b strep
167633|NCT02270918|Xa inhibitor|xa inhibitor
167634|NCT02270918|Prothrombin complex concentrate|prothrombin complex concentrate
167635|NCT02270918|anticoagulation|anticoagulation
167636|NCT02270905|meniscus|meniscus
167637|NCT02270905|meniscectomy|meniscectomy
167638|NCT02270905|decellularised|decellularised
167639|NCT02270905|xenograft|xenograft
167640|NCT02270892|Ulthera, Ulthera System, Ultherapy|ulthera, ulthera system, ultherapy
167641|NCT02270866|aphasia|aphasia
167642|NCT02270866|stroke|stroke
167643|NCT02270853|ApneaLink|apnealink
167644|NCT02270853|bronchial carcinoma|bronchial carcinoma
167645|NCT02270853|sleep apnea screening|sleep apnea screening
167646|NCT02270840|cardiac resynchronization therapy|cardiac resynchronization therapy
167647|NCT02270801|recombinant human thrombopoietin|recombinant human thrombopoietin
167648|NCT02270801|immune thrombocytopenia|immune thrombocytopenia
167649|NCT02270801|pregnancy|pregnancy
167650|NCT02270775|Questionnaire|questionnaire
167651|NCT02270775|Translation|translation
167652|NCT02270762|Early Physical Exercise|early physical exercise
167653|NCT02270762|Early Passive Exercise|early passive exercise
167654|NCT02270762|Alveolar Recruitment|alveolar recruitment
167655|NCT02270762|Electrical Impedance Tomography|electrical impedance tomography
167656|NCT02270762|Oxygenation|oxygenation
167657|NCT02270762|Ventilation|ventilation
167658|NCT02270684|Total Knee Arthroplasty|total knee arthroplasty
167659|NCT02270684|Home monitoring|home monitoring
167660|NCT02270671|Social Anxiety|social anxiety
167661|NCT02270671|Social Phobia|social phobia
167662|NCT02270671|Depression|depression
167663|NCT02270671|Attention Bias Modification Training|attention bias modification training
167664|NCT02270658|continuous positive airway pressure|continuous positive airway pressure
167665|NCT02270658|hypertension|hypertension
167666|NCT02270658|sleep apnea|sleep apnea
167667|NCT02270606|Rectum|rectum
167668|NCT02270541|Telemedicine|telemedicine
167669|NCT02270541|Prehospital|prehospital
167670|NCT02270541|Emergency Medicine|emergency medicine
167671|NCT02270541|Stroke|stroke
167672|NCT02270515|Patient-Centered Care|patient-centered care
167673|NCT02270515|Medical Home|medical home
167674|NCT02270502|critically illness|critically illness
167675|NCT02270502|intensive care unit|intensive care unit
167676|NCT02270502|outcome|outcome
167677|NCT02270502|frailty|frailty
167678|NCT02270476|Cystic Fibrosis|cystic fibrosis
167679|NCT02270476|Infant|infant
167680|NCT02270476|Toddler|toddler
167681|NCT02270476|Children|children
167682|NCT02270476|Newborn screening|newborn screening
167683|NCT02270437|total knee arthroplasty|total knee arthroplasty
167684|NCT02270437|cocktail analgesia|cocktail analgesia
167685|NCT02270437|morphine consumption|morphine consumption
167686|NCT02270424|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
167687|NCT02270424|Medicine, Chinese Traditional|medicine, chinese traditional
167688|NCT02270424|Humans|humans
167689|NCT02270424|Treatment Outcome|treatment outcome
167690|NCT02270398|Exercise|exercise
167691|NCT02270398|Balance|balance
167692|NCT02270398|Gait|gait
167693|NCT02270398|Community|community
167694|NCT02270398|Rehabilitation|rehabilitation
167695|NCT02270398|Dual-task|dual-task
167696|NCT02270385|pressure ulcer|pressure ulcer
167697|NCT02270385|nursing home|nursing home
167698|NCT02270372|Advanced breast carcinoma|advanced breast carcinoma
167699|NCT02270372|Advanced ovarian carcinoma|advanced ovarian carcinoma
167700|NCT02270372|MUC1|muc1
167701|NCT02270372|vaccine|vaccine
167702|NCT02270372|Phase 1b|phase 1b
167703|NCT02270359|Myocardial Infarction|myocardial infarction
167704|NCT02270359|CAD|cad
167705|NCT02270346|Allogeneic HSCT, Inspiratory Muscle Training, Exercise Capacity|allogeneic hsct, inspiratory muscle training, exercise capacity
167706|NCT02270333|sarcoidosis|sarcoidosis
167707|NCT02270333|inspiratory muscle strength|inspiratory muscle strength
167708|NCT02270333|exercise capacity|exercise capacity
167709|NCT02270333|quality of life|quality of life
167710|NCT02270320|Tai Chi Chuan|tai chi chuan
167711|NCT02270320|cognitive function|cognitive function
167712|NCT02270320|motor function|motor function
167713|NCT02270320|MRI|mri
167714|NCT02270294|Ischemic stroke|ischemic stroke
167715|NCT02270294|Thai traditional massage|thai traditional massage
167716|NCT02270294|Vascular function|vascular function
167717|NCT02270294|Cerebral blood flow|cerebral blood flow
167718|NCT02270294|Cerebrovascular reactivity|cerebrovascular reactivity
167719|NCT02270268|Irritable bowel syndrome|irritable bowel syndrome
167720|NCT02270268|Gut microbiota|gut microbiota
167721|NCT02270268|Soluble dietary fiber|soluble dietary fiber
167722|NCT02270255|embolization|embolization
167723|NCT02270255|analgesia|analgesia
167724|NCT02270242|PCI|pci
167725|NCT02270242|DAPT|dapt
167726|NCT02270242|ticagrelor|ticagrelor
167727|NCT02270242|aspirin|aspirin
167728|NCT02270216|isolated systolic hypertension|isolated systolic hypertension
167729|NCT02270216|exercise pressor responses|exercise pressor responses
167731|NCT02270203|si joint injury|si joint injury
167732|NCT02270203|si joint treatment|si joint treatment
167733|NCT02270203|si joint inflammation|si joint inflammation
167734|NCT02270203|si joint problems|si joint problems
167735|NCT02270203|si joint symptoms|si joint symptoms
167736|NCT02270203|hypermobile joint|hypermobile joint
167737|NCT02270203|si joint arthritis|si joint arthritis
167738|NCT02270203|si joint pain treatment|si joint pain treatment
167739|NCT02270203|inflamed si joint|inflamed si joint
167740|NCT02270203|si joint sclerosis|si joint sclerosis
167741|NCT02270203|locked si joint|locked si joint
167742|NCT02270203|si joint injuries|si joint injuries
167743|NCT02270203|si joint disease|si joint disease
167744|NCT02270203|si joint infection|si joint infection
167745|NCT02270203|sacroiliac joint pelvic pain|sacroiliac joint pelvic pain
167746|NCT02270203|sacroiliac joint arthritis treatment|sacroiliac joint arthritis treatment
167747|NCT02270203|si joint pain|si joint pain
167748|NCT02270203|si joint injections|si joint injections
167749|NCT02270177|Headache|headache
167750|NCT02270177|Telemedicine|telemedicine
167751|NCT02270177|Videoconsultation|videoconsultation
167752|NCT02270177|Headache-referrals|headache-referrals
167753|NCT02270164|Lipids|lipids
167754|NCT02270164|Cholesterol|cholesterol
168248|NCT02267512|ATG-F|atg-f
167755|NCT02270164|Dietary Supplements|dietary supplements
167756|NCT02270164|Cynara scolymus|cynara scolymus
167757|NCT02270164|Safety|safety
167758|NCT02270151|Atrial fibrillation|atrial fibrillation
167759|NCT02270151|Screening|screening
167760|NCT02270151|Primary care|primary care
167761|NCT02270151|Diagnostic|diagnostic
167762|NCT02270138|physical activity|physical activity
167763|NCT02270138|music|music
167764|NCT02270138|sedentary lifestyle|sedentary lifestyle
158761|NCT02321293|TKI|tki
167765|NCT02270125|nasal mucosa|nasal mucosa
167766|NCT02270125|chronic hypertrophic rhinosinusitis|chronic hypertrophic rhinosinusitis
167767|NCT02270125|mucotomy|mucotomy
167768|NCT02270125|nanoparticles|nanoparticles
167769|NCT02270125|scanning electron microscopy|scanning electron microscopy
167770|NCT02270125|Raman microspectroscopy|raman microspectroscopy
167771|NCT02270125|nasal polyposis|nasal polyposis
167772|NCT02270112|atrial fibrillation|atrial fibrillation
167773|NCT02270112|atrial electrophysiology|atrial electrophysiology
167774|NCT02270112|stroke|stroke
167775|NCT02270112|vascular stiffness|vascular stiffness
167776|NCT02270073|Psychotherapy process|psychotherapy process
167777|NCT02270073|Change mechanisms|change mechanisms
167778|NCT02270073|Mindfulness|mindfulness
167779|NCT02270073|Micro-interventions|micro-interventions
167780|NCT02270073|Mindfulness interventions|mindfulness interventions
167781|NCT02270073|Progressive muscle relaxation|progressive muscle relaxation
167782|NCT02270060|Music Therapy|music therapy
167988|NCT02269085|Carfilzomib|carfilzomib
167783|NCT02270060|Sickle Cell Disease|sickle cell disease
167784|NCT02270060|Pain|pain
167785|NCT02270047|Ad libitum energy intake|ad libitum energy intake
167786|NCT02270047|Appetite sensation|appetite sensation
167787|NCT02270021|Pap smear|pap smear
167788|NCT02270021|Screening|screening
167789|NCT02270021|Women|women
167790|NCT02270021|Human papillomavirus|human papillomavirus
167791|NCT02270021|Cervical precancer|cervical precancer
167792|NCT02270021|Guideline adherence|guideline adherence
167793|NCT02270008|anal incontinence|anal incontinence
167794|NCT02270008|pregnancy-associated pelvic floor disorders|pregnancy-associated pelvic floor disorders
167795|NCT02269995|Hepatocellular|hepatocellular
167796|NCT02269995|Carcinoma|carcinoma
167797|NCT02269969|Aminoglycoside|aminoglycoside
167798|NCT02269969|Pharmacokinetics|pharmacokinetics
167799|NCT02269969|Once daily dosing|once daily dosing
167800|NCT02269943|Metastatic nasopharyngeal carcinoma|metastatic nasopharyngeal carcinoma
167801|NCT02269943|oral azacitidine|oral azacitidine
167802|NCT02269943|oral AZA|oral aza
167803|NCT02269943|CC-486|cc-486
167804|NCT02269943|metastatic|metastatic
167805|NCT02269943|recurrent|recurrent
167806|NCT02269943|nasopharyngeal carcinoma|nasopharyngeal carcinoma
167807|NCT02269943|nasal|nasal
167808|NCT02269943|solid tumors|solid tumors
167809|NCT02269943|locally advanced|locally advanced
167810|NCT02269943|rare head and neck cancer|rare head and neck cancer
167811|NCT02269943|nasopharynx|nasopharynx
167812|NCT02269943|single chemotherapy agent|single chemotherapy agent
167813|NCT02269943|Epstein-Barr Virus (EBV) + nasopharyngeal carcinoma|epstein-barr virus (ebv) + nasopharyngeal carcinoma
167814|NCT02269943|EBV-DN|ebv-dn
167815|NCT02269943|Celgene|celgene
167816|NCT02269943|Sponsor-study|sponsor-study
167817|NCT02269943|oral chemotherapy|oral chemotherapy
167818|NCT02269943|phase 2|phase 2
167819|NCT02269943|oral Vidaza|oral vidaza
167820|NCT02269943|EBV promoter methylation|ebv promoter methylation
167821|NCT02269943|hypomethylation|hypomethylation
167822|NCT02269943|tumor infiltrating lymphocytes (TILs)|tumor infiltrating lymphocytes (tils)
167823|NCT02269943|EBV gene expression|ebv gene expression
167824|NCT02269943|neoplasms|neoplasms
167825|NCT02269917|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
167827|NCT02269917|Darunavir|darunavir
167828|NCT02269917|Cobicistat|cobicistat
167829|NCT02269917|Emtricitabine|emtricitabine
167830|NCT02269917|Tenofovir Alafenamide|tenofovir alafenamide
167831|NCT02269891|Menopausal symptoms|menopausal symptoms
167832|NCT02269891|Peri-menopause|peri-menopause
167833|NCT02269891|Nu Femme|nu femme
167834|NCT02269891|Labisia pumila|labisia pumila
167835|NCT02269891|Eurycoma longifolia|eurycoma longifolia
167836|NCT02269891|Hot flash|hot flash
167837|NCT02269891|Joint pain|joint pain
167838|NCT02269852|seasonal trivalent inactivated influenza vaccine|seasonal trivalent inactivated influenza vaccine
167839|NCT02269852|immunogenicity|immunogenicity
167840|NCT02269852|safety|safety
167841|NCT02269852|cross-reactivity|cross-reactivity
167842|NCT02269852|Northern hemisphere 2013-2014 formulation|northern hemisphere 2013-2014 formulation
167843|NCT02269839|Tinnitus|tinnitus
167844|NCT02269839|rTMS|rtms
167845|NCT02269813|MammaPrint|mammaprint
167846|NCT02269813|BluePrint|blueprint
167847|NCT02269813|TargetPrint|targetprint
167848|NCT02269774|Atrial Fibrillation|atrial fibrillation
167849|NCT02269774|Obstructive Sleep Apnea|obstructive sleep apnea
167850|NCT02269774|Atrial Premature Complexes|atrial premature complexes
167851|NCT02269774|Pulmonary Vein Isolation|pulmonary vein isolation
167852|NCT02269774|Mueller Manoeuvre|mueller manoeuvre
168339|NCT02267148|Fibrosis|fibrosis
167853|NCT02269761|Emergency Departments|emergency departments
167854|NCT02269761|Chest|chest
167855|NCT02269761|Lung|lung
167856|NCT02269761|Cough|cough
167857|NCT02269761|Dyspnea|dyspnea
167858|NCT02269761|Wheezing|wheezing
167859|NCT02269761|Ultrasound|ultrasound
167860|NCT02269761|Ultrasonography|ultrasonography
167861|NCT02269657|Scoliosis|scoliosis
167862|NCT02269657|Postural balance|postural balance
167863|NCT02269657|Lordosis|lordosis
167864|NCT02269657|Kyphosis|kyphosis
167865|NCT02269657|X-rays|x-rays
167866|NCT02269631|Weight loss|weight loss
167867|NCT02269631|Epidemiology|epidemiology
167868|NCT02269631|Nutrition|nutrition
167869|NCT02269618|Telehealth, Home-based, rehabilitation|telehealth, home-based, rehabilitation
167870|NCT02269605|HIV reservoir|hiv reservoir
167871|NCT02269605|Bryostatin|bryostatin
167872|NCT02269592|MGUS|mgus
167873|NCT02269592|Smoldering Myeloma|smoldering myeloma
167874|NCT02269592|Chronic Lymphocytic leukemia|chronic lymphocytic leukemia
167875|NCT02269592|Acute Myeloid Leukemia|acute myeloid leukemia
167876|NCT02269592|Myeloproliferative neoplasms|myeloproliferative neoplasms
167877|NCT02269592|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
167878|NCT02269592|Monoclonal Gammopathy of Undermined Significance|monoclonal gammopathy of undermined significance
167879|NCT02269592|Monoclonal B cell lymphocytosis|monoclonal b cell lymphocytosis
167880|NCT02269592|Smoldering Multiple Myeloma|smoldering multiple myeloma
167881|NCT02269592|Myelodysplastic syndromes|myelodysplastic syndromes
167882|NCT02269579|Newly Diagnosed AML|newly diagnosed aml
167883|NCT02269579|Secondary AML|secondary aml
167884|NCT02269579|Relapsed/Refractory AML|relapsed/refractory aml
167885|NCT02269579|Relapsed/Refractory ALL|relapsed/refractory all
167886|NCT02269566|allergic rhinitis|allergic rhinitis
167887|NCT02269566|immunotherapy|immunotherapy
167888|NCT02269553|Migraine|migraine
167889|NCT02269553|Headache|headache
167890|NCT02269514|adoption|adoption
167891|NCT02269514|electronic cigarettes|electronic cigarettes
167892|NCT02269514|e-cigarettes|e-cigarettes
167893|NCT02269514|combustible cigarettes|combustible cigarettes
167894|NCT02269514|nicotine polacrilex|nicotine polacrilex
167895|NCT02269514|own brand cigarette|own brand cigarette
167896|NCT02269514|subjective measures|subjective measures
167897|NCT02269514|pharmacokinetics|pharmacokinetics
167898|NCT02269514|pharmacodynamics|pharmacodynamics
167899|NCT02269488|Safety|safety
167900|NCT02269488|Tolerability|tolerability
167901|NCT02269488|MEDI3250|medi3250
167902|NCT02269488|Japanese children|japanese children
167903|NCT02269475|Efficacy|efficacy
167904|NCT02269475|Safety|safety
167905|NCT02269475|Tolerability|tolerability
167906|NCT02269475|MEDI3250|medi3250
167907|NCT02269475|Japanese children|japanese children
167908|NCT02269449|transradial intervention|transradial intervention
167909|NCT02269449|radial artery|radial artery
167910|NCT02269410|Bariatric Surgery|bariatric surgery
167911|NCT02269410|Nitrogen Balance|nitrogen balance
167912|NCT02269410|Body composition|body composition
167913|NCT02269410|Protein supplementation|protein supplementation
167914|NCT02269410|Satiety|satiety
167915|NCT02269410|Adherence|adherence
167916|NCT02269397|Epilepsy|epilepsy
167917|NCT02269397|Seizures|seizures
167918|NCT02269397|Diagnosis|diagnosis
167919|NCT02269397|Diagnostic|diagnostic
167920|NCT02269397|Inflammation|inflammation
167921|NCT02269384|Pain|pain
167922|NCT02269384|Memory|memory
167923|NCT02269384|Pressure Pain Threshold|pressure pain threshold
167924|NCT02269384|Electromyography|electromyography
167925|NCT02269384|Heart Rate Variability|heart rate variability
167926|NCT02269319|ABSSSI|absssi
167927|NCT02269319|MRX-I|mrx-i
167928|NCT02269319|Acute Bacterial Skin and Skin Structure Infections|acute bacterial skin and skin structure infections
167929|NCT02269306|PCOS|pcos
167930|NCT02269306|clomiphene citrate|clomiphene citrate
167931|NCT02269306|AMH|amh
167932|NCT02269306|visceral fat area|visceral fat area
167933|NCT02269306|HOMA-IR|homa-ir
167934|NCT02269293|Selinexor (KPT-330)|selinexor (kpt-330)
167935|NCT02269293|Paclitaxel|paclitaxel
167936|NCT02269293|Carboplatin|carboplatin
167937|NCT02269293|14-110|14-110
167938|NCT02269280|Leukemia|leukemia
167939|NCT02269280|Myelodysplastic syndrome|myelodysplastic syndrome
167940|NCT02269280|MDS|mds
167941|NCT02269280|Low or intermediate-1 risk|low or intermediate-1 risk
167942|NCT02269280|Transfusion-dependent|transfusion-dependent
167943|NCT02269280|Transfusion-independent|transfusion-independent
167944|NCT02269280|Best supportive care|best supportive care
167945|NCT02269280|BSC|bsc
167946|NCT02269280|Azacitidine|azacitidine
167947|NCT02269280|5-Azacytidine|5-azacytidine
167948|NCT02269280|5-AZA|5-aza
167949|NCT02269280|Vidaza|vidaza
167950|NCT02269280|5-AZC|5-azc
167951|NCT02269280|AZA-CR|aza-cr
167952|NCT02269280|Ladakamycin|ladakamycin
167953|NCT02269280|NSC-102816|nsc-102816
167954|NCT02269280|Azacytidine|azacytidine
167955|NCT02269280|Decitabine|decitabine
167956|NCT02269280|Dacogen|dacogen
167957|NCT02269254|Comparative Study|comparative study
167958|NCT02269254|Knee Prosthesis|knee prosthesis
167959|NCT02269254|Prosthesis Design|prosthesis design
167960|NCT02269254|Treatment Outcome|treatment outcome
167961|NCT02269254|Follow-Up Studies|follow-up studies
167962|NCT02269254|Arthroplasty, Replacement, Knee/methods|arthroplasty, replacement, knee/methods
167963|NCT02269241|contraception|contraception
167964|NCT02269241|hormonal oral contraceptive agents|hormonal oral contraceptive agents
167965|NCT02269241|hormonal oral contraceptive|hormonal oral contraceptive
167966|NCT02269241|oral contraceptive|oral contraceptive
167967|NCT02269241|drospirenone|drospirenone
167968|NCT02269241|LF111|lf111
167969|NCT02269241|birth control|birth control
167970|NCT02269150|Recipients|recipients
167971|NCT02269150|Transplantation|transplantation
167972|NCT02269137|status epileptics|status epileptics
167973|NCT02269137|prognosis|prognosis
167974|NCT02269137|risk factor|risk factor
167975|NCT02269137|outcome|outcome
167976|NCT02269098|type 2 diabetes|type 2 diabetes
167977|NCT02269098|hyperglycemia|hyperglycemia
167978|NCT02269098|Emergency Department|emergency department
167979|NCT02269098|Patient Education as Topic|patient education as topic
167980|NCT02269098|Drug Therapy|drug therapy
167981|NCT02269085|Lymphoma|lymphoma
167982|NCT02269085|Mantle cell lymphoma|mantle cell lymphoma
167983|NCT02269085|MCL|mcl
167984|NCT02269085|Relapsed or refractory|relapsed or refractory
167985|NCT02269085|Ibrutinib|ibrutinib
167986|NCT02269085|PCI-32765|pci-32765
167987|NCT02269085|Imbruvica|imbruvica
167989|NCT02269072|Natriuretic Peptide|natriuretic peptide
167990|NCT02269046|acupuncture|acupuncture
167991|NCT02269046|moxibustion|moxibustion
167992|NCT02269046|hyperlipidemias|hyperlipidemias
167993|NCT02269046|effectiveness|effectiveness
167994|NCT02269033|Breast cancer|breast cancer
167995|NCT02269033|Patient Navigation|patient navigation
167996|NCT02269033|Health Disparities|health disparities
167997|NCT02269033|Latinas|latinas
167998|NCT02269033|Breast Imaging Reporting and Data System, BI-RADS|breast imaging reporting and data system, bi-rads
167999|NCT02269033|underserved|underserved
168000|NCT02269020|Squamous Cell Carcinoma of the Epi-larynx|squamous cell carcinoma of the epi-larynx
168001|NCT02269007|safety, tolerance, quadrivalent influenza vaccine|safety, tolerance, quadrivalent influenza vaccine
168002|NCT02268994|ferric citrate|ferric citrate
168003|NCT02268994|Chronic kidney disease|chronic kidney disease
168004|NCT02268994|Anemia|anemia
168005|NCT02268981|Oxymizer|oxymizer
168006|NCT02268981|Oxygen conserving device|oxygen conserving device
168007|NCT02268981|Conventional nasal cannula (CNC)|conventional nasal cannula (cnc)
168008|NCT02268981|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
168009|NCT02268968|Topical Lidocaine|topical lidocaine
168010|NCT02268968|Nasal CPAP|nasal cpap
168011|NCT02268968|Pain|pain
168012|NCT02268968|Preterm Infants|preterm infants
168013|NCT02268968|Salivary cortisol|salivary cortisol
168014|NCT02268955|Biliary Colic|biliary colic
168015|NCT02268955|Abdominal pain|abdominal pain
168016|NCT02268955|Intravenous Ibuprofen|intravenous ibuprofen
168017|NCT02268916|diabetes|diabetes
168018|NCT02268916|physical activity|physical activity
168019|NCT02268916|participation|participation
168020|NCT02268903|Pulmonary Embolism|pulmonary embolism
168021|NCT02268903|Right Ventricle failure|right ventricle failure
168022|NCT02268903|Diuretics|diuretics
168023|NCT02268890|Multiple Myeloma|multiple myeloma
168024|NCT02268890|Bortezomib|bortezomib
168025|NCT02268890|Velcade|velcade
168026|NCT02268877|ultrasonography|ultrasonography
168027|NCT02268877|emergency department|emergency department
168028|NCT02268864|Hepatitis C Chronic|hepatitis c chronic
168029|NCT02268864|Simeprevir|simeprevir
168031|NCT02268851|Mantle Cell Lymphoma|mantle cell lymphoma
168032|NCT02268851|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|chronic lymphocytic leukemia/small lymphocytic lymphoma
168033|NCT02268838|E6007|e6007
168034|NCT02268838|Healthy Japanese male subjects|healthy japanese male subjects
168035|NCT02268812|Pain Management|pain management
168036|NCT02268812|Europe|europe
168037|NCT02268812|Intrathecal|intrathecal
168038|NCT02268799|Cardioversion|cardioversion
168039|NCT02268799|High Sensitivity Troponin T (Hs-Trop T)|high sensitivity troponin t (hs-trop t)
168040|NCT02268799|Brain Natriuretic Peptide (BNP)|brain natriuretic peptide (bnp)
168041|NCT02268799|Neutrophil Gelatinase-associated Lipocalin (NGAL)|neutrophil gelatinase-associated lipocalin (ngal)
168042|NCT02268786|Preimplantation Genetic Screening|preimplantation genetic screening
168043|NCT02268786|Blastocyst|blastocyst
168044|NCT02268786|Vitrification|vitrification
168045|NCT02268786|In vitro fertilization|in vitro fertilization
168046|NCT02268786|non-invasive prenatal testing|non-invasive prenatal testing
168047|NCT02268786|next generation sequencing|next generation sequencing
168048|NCT02268747|skin squamous cell cancer panHER inhibitor Dacomitinib|skin squamous cell cancer panher inhibitor dacomitinib
168049|NCT02268734|Sporadic Medullary Thyroid Cancer Vandetanib miRNA|sporadic medullary thyroid cancer vandetanib mirna
168050|NCT02268721|Pilot study|pilot study
168051|NCT02268721|Frail elderly|frail elderly
168052|NCT02268721|Malnutrition|malnutrition
168053|NCT02268721|Functionality|functionality
168054|NCT02268721|Life quality|life quality
168055|NCT02268721|Health care technology|health care technology
168056|NCT02268708|COPD|copd
168057|NCT02268708|Surgery, Thoracic|surgery, thoracic
168058|NCT02268695|Recurrent/Metastatic HNSCC|recurrent/metastatic hnscc
168059|NCT02268695|Taxanes|taxanes
168060|NCT02268682|Educator-Guided|educator-guided
168061|NCT02268682|Patient-Guided|patient-guided
168062|NCT02268682|Standard of Care (Control)|standard of care (control)
168063|NCT02268669|primary angioplasty|primary angioplasty
168064|NCT02268669|post-thrombolysis angioplasty|post-thrombolysis angioplasty
168065|NCT02268669|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
168066|NCT02268643|breast cancer|breast cancer
168067|NCT02268643|screening|screening
168068|NCT02268643|ultrasound|ultrasound
168069|NCT02268643|risk model|risk model
168070|NCT02268630|Post-thrombotic syndrome|post-thrombotic syndrome
168071|NCT02268630|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
168072|NCT02268630|Anticoagulation|anticoagulation
168073|NCT02268630|Rivaroxaban|rivaroxaban
168074|NCT02268617|Treadmill|treadmill
168075|NCT02268617|Walking|walking
168076|NCT02268617|Gait|gait
168077|NCT02268617|Exercise|exercise
168078|NCT02268578|Transcranial Direct Current Stimulation|transcranial direct current stimulation
168079|NCT02268578|TDCS|tdcs
168080|NCT02268578|Memory Dysfunction|memory dysfunction
168081|NCT02268578|Depression|depression
168082|NCT02268565|sleep, insomnia, inflammation, pain|sleep, insomnia, inflammation, pain
168083|NCT02268565|Insomnia symptom induction/placebo|insomnia symptom induction/placebo
168084|NCT02268565|Insomnia symptom induction/aspirin|insomnia symptom induction/aspirin
168085|NCT02268552|Type 1 Spinal Muscular Atrophy|type 1 spinal muscular atrophy
168086|NCT02268539|pilot study|pilot study
168087|NCT02268539|atrial fibrillation|atrial fibrillation
168088|NCT02268539|ablation|ablation
168089|NCT02268539|implanted loop recorder|implanted loop recorder
168090|NCT02268526|Safety, efficacy, pharmacokinetics, CSJ148, HCMV, HCMV viral load,|safety, efficacy, pharmacokinetics, csj148, hcmv, hcmv viral load,
168091|NCT02268526|immunogenicity|immunogenicity
168092|NCT02268513|Cardiovascular Disease|cardiovascular disease
168093|NCT02268513|Social network|social network
168094|NCT02268513|South Asians|south asians
168095|NCT02268487|Early Improvement|early improvement
168096|NCT02268487|Depression|depression
168097|NCT02268487|Antidepressant|antidepressant
168098|NCT02268474|532nm|532nm
168099|NCT02268474|Excel V|excel v
168100|NCT02268474|Cutera|cutera
168101|NCT02268474|Laser|laser
168102|NCT02268474|Laser Light|laser light
168103|NCT02268474|PDL|pdl
168104|NCT02268474|595nm|595nm
168105|NCT02268474|Flash Lamp|flash lamp
168106|NCT02268461|Post-Stroke Spasticity|post-stroke spasticity
168107|NCT02268448|itch atopic dermatitis|itch atopic dermatitis
168108|NCT02268422|Healthy volunteer|healthy volunteer
168109|NCT02268422|crossover|crossover
168110|NCT02268422|open-label|open-label
168111|NCT02268422|randomised|randomised
168112|NCT02268422|bioequivalence|bioequivalence
168113|NCT02268422|pharmacokinetic study|pharmacokinetic study
168114|NCT02268357|Dental Anxiety|dental anxiety
168115|NCT02268357|Tooth Extraction|tooth extraction
168116|NCT02268357|Propranolol|propranolol
168117|NCT02268344|nerve regeneration|nerve regeneration
168118|NCT02268344|spinal accessory nerve|spinal accessory nerve
168119|NCT02268344|shoulder function|shoulder function
168120|NCT02268344|head neck cancer|head neck cancer
168121|NCT02268344|electrical stimulation|electrical stimulation
168122|NCT02268318|Japanese Subjects, High LDL-C, fermented-dairy products, phytosterols|japanese subjects, high ldl-c, fermented-dairy products, phytosterols
168124|NCT02268292|Diabetes|diabetes
168125|NCT02268292|Muscle strength|muscle strength
168126|NCT02268292|Aerobic exercise|aerobic exercise
168127|NCT02268292|Bicycle|bicycle
168128|NCT02268292|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
168129|NCT02268266|brain injury, early rehabilitation, tilt table|brain injury, early rehabilitation, tilt table
168130|NCT02268214|Dapagliflozin|dapagliflozin
168131|NCT02268214|Efficacy|efficacy
168132|NCT02268214|Safety|safety
168133|NCT02268214|Add on to insulin|add on to insulin
168134|NCT02268214|Oral Antidiabetic|oral antidiabetic
168135|NCT02268214|Type 1 diabetes|type 1 diabetes
168136|NCT02268201|immunosuppressive therapy|immunosuppressive therapy
168137|NCT02268201|tacrolimus|tacrolimus
168138|NCT02268188|Cancer Survivors|cancer survivors
168139|NCT02268175|prostate adenocarcinoma|prostate adenocarcinoma
168140|NCT02268175|advanced prostate cancer|advanced prostate cancer
168141|NCT02268175|high risk prostate cancer|high risk prostate cancer
168142|NCT02268162|Lung Neoplasms|lung neoplasms
168143|NCT02268162|Bronchoscopy|bronchoscopy
168144|NCT02268162|Virtual Bronchoscopic Navigation(VBN)|virtual bronchoscopic navigation(vbn)
168145|NCT02268162|Fluoroscopy|fluoroscopy
168146|NCT02268162|Endobronchial Ultrasonography with a Guide Sheath(EBUS-GS)|endobronchial ultrasonography with a guide sheath(ebus-gs)
168147|NCT02268162|Diagnosis|diagnosis
168148|NCT02268123|Male Infertility|male infertility
168149|NCT02268123|Sperm DNA Fragmentation|sperm dna fragmentation
168150|NCT02268123|Sperm Abnormality|sperm abnormality
168151|NCT02268110|diastasis recti|diastasis recti
168152|NCT02268110|physiotherapy|physiotherapy
168153|NCT02268110|exercise therapy|exercise therapy
168154|NCT02268110|abdominal binding|abdominal binding
168155|NCT02268097|patella|patella
168156|NCT02268097|total knee arthroplasty|total knee arthroplasty
168157|NCT02268097|resection|resection
168158|NCT02268084|PTSD|ptsd
168159|NCT02268084|TMS|tms
168160|NCT02268084|EEG|eeg
168161|NCT02268071|Hypertension|hypertension
168162|NCT02268071|Stopping antihypertensive treatment|stopping antihypertensive treatment
168163|NCT02268071|Primary care|primary care
168164|NCT02268071|White coat hypertension|white coat hypertension
168165|NCT02268071|Masked Hypertension|masked hypertension
168166|NCT02268045|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
168168|NCT02268045|Diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
168169|NCT02268032|hormone replacement therapy|hormone replacement therapy
168170|NCT02268019|hypospadias|hypospadias
168171|NCT02268019|dehiscence|dehiscence
168172|NCT02268019|urethral stricture|urethral stricture
168173|NCT02268019|side effects|side effects
168174|NCT02268006|rectal carcinoma|rectal carcinoma
168175|NCT02268006|preoperative radiochemotherapy|preoperative radiochemotherapy
168176|NCT02268006|IMRT|imrt
168177|NCT02268006|SIB|sib
168178|NCT02267980|Electroconvulsive therapy; sevoflurane; ketamine|electroconvulsive therapy; sevoflurane; ketamine
168179|NCT02267954|Calories|calories
168180|NCT02267954|Fast Food Literacy|fast food literacy
168181|NCT02267928|Symptom Assessment|symptom assessment
168182|NCT02267915|Relapsed or refractory patients with mantle-cell lymphoma|relapsed or refractory patients with mantle-cell lymphoma
168183|NCT02267915|Progression after high-dose chemotherapy and autologous HPT|progression after high-dose chemotherapy and autologous hpt
168184|NCT02267902|Volunteers|volunteers
168185|NCT02267889|Ganglionated plexi|ganglionated plexi
168186|NCT02267850|Photobiomodulation|photobiomodulation
168187|NCT02267850|Orthodontic treatment|orthodontic treatment
168188|NCT02267850|Malocclusion|malocclusion
168189|NCT02267850|OrthoPulse™|orthopulse™
168190|NCT02267837|Alignment phase|alignment phase
168191|NCT02267837|Photobiomodulation|photobiomodulation
168192|NCT02267837|Orthodontic treatment|orthodontic treatment
168193|NCT02267837|Malocclusion|malocclusion
168194|NCT02267837|OrthoPulse™|orthopulse™
168195|NCT02267824|Alignment phase|alignment phase
168196|NCT02267824|Photobiomodulation|photobiomodulation
168197|NCT02267824|Orthodontic treatment|orthodontic treatment
168198|NCT02267824|Malocclusion|malocclusion
168199|NCT02267824|OrthoPulse™|orthopulse™
168200|NCT02267811|Photobiomodulation|photobiomodulation
168201|NCT02267811|Orthodontic treatment|orthodontic treatment
168202|NCT02267811|Malocclusion|malocclusion
168203|NCT02267811|OrthoPulse™|orthopulse™
168205|NCT02267798|Rehabilitation|rehabilitation
168206|NCT02267798|Arm motor recovery|arm motor recovery
168207|NCT02267798|biological biomarkers|biological biomarkers
168208|NCT02267785|exercise|exercise
168209|NCT02267785|mild cognitive impairment|mild cognitive impairment
168210|NCT02267785|Parkinson's Disease|parkinson's disease
168211|NCT02267720|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
168212|NCT02267720|Glass ionomer cement|glass ionomer cement
168213|NCT02267720|Occlusal-proximal leasons|occlusal-proximal leasons
168214|NCT02267720|Primary molars|primary molars
168215|NCT02267707|nab®-paclitaxel|nab®-paclitaxel
168216|NCT02267707|ABI-007|abi-007
168217|NCT02267707|Abraxane|abraxane
168218|NCT02267707|Advanced Pancreatic Cancer|advanced pancreatic cancer
168219|NCT02267707|Cholestatic Hyperbilirubinemia|cholestatic hyperbilirubinemia
168220|NCT02267707|Bile Duct Obstruction|bile duct obstruction
168221|NCT02267707|Pancreatic Cancer|pancreatic cancer
168222|NCT02267668|concussion|concussion
168223|NCT02267668|sports concussion|sports concussion
168224|NCT02267668|exercise therapy|exercise therapy
168225|NCT02267655|Inhaled Nitric Oxide (iNO)|inhaled nitric oxide (ino)
168226|NCT02267655|Pulmonary Hypertension (PH)|pulmonary hypertension (ph)
168227|NCT02267655|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
168228|NCT02267655|Long Term Oxygen Therapy (LTOT)|long term oxygen therapy (ltot)
168229|NCT02267655|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
168230|NCT02267629|OCD|ocd
168231|NCT02267616|Levonorgestrel intrauterine device (LNG IUD)|levonorgestrel intrauterine device (lng iud)
168232|NCT02267616|Etonogestrel (ENG) Implant|etonogestrel (eng) implant
168233|NCT02267616|Contraception|contraception
168234|NCT02267564|patellar dislocation|patellar dislocation
168235|NCT02267564|medial patellofemoral ligament|medial patellofemoral ligament
168236|NCT02267564|tibial tubercle transfer|tibial tubercle transfer
168237|NCT02267551|robotic surgery|robotic surgery
168238|NCT02267551|simulation|simulation
168239|NCT02267538|Delirium|delirium
168240|NCT02267538|Cardiac Surgical Procedures|cardiac surgical procedures
168241|NCT02267538|Postoperative Complications|postoperative complications
168242|NCT02267538|Dexmedetomidine|dexmedetomidine
168243|NCT02267538|Prevention|prevention
168244|NCT02267525|Gastroparesis|gastroparesis
168245|NCT02267525|Diabetic|diabetic
168246|NCT02267525|Idiopathic|idiopathic
168247|NCT02267512|Kidney Transplant Patients|kidney transplant patients
168249|NCT02267499|cognitive training|cognitive training
159236|NCT02318615|Breast Neoplasm|breast neoplasm
159237|NCT02318615|Lymphedema|lymphedema
159238|NCT02318615|Autologous flap|autologous flap
159239|NCT02318615|lattismus dorsi flap|lattismus dorsi flap
159243|NCT02318576|Multiple Sclerosis|multiple sclerosis
159246|NCT02318472|Microdialysis|microdialysis
168250|NCT02267499|physical training|physical training
168251|NCT02267499|exercise games|exercise games
168252|NCT02267499|novelty serious games|novelty serious games
168253|NCT02267499|computer training|computer training
168254|NCT02267499|mild cognitive impairment|mild cognitive impairment
168255|NCT02267499|mild dementia|mild dementia
168256|NCT02267499|healthy elderly|healthy elderly
168257|NCT02267486|Alzheimer Dementia, AD|alzheimer dementia, ad
168258|NCT02267486|patients|patients
168259|NCT02267486|cognitive|cognitive
168260|NCT02267460|Peyronie's disease|peyronie's disease
168261|NCT02267460|penile plaque|penile plaque
168262|NCT02267460|penile curvature|penile curvature
168263|NCT02267447|Cardiovascular diseases|cardiovascular diseases
168264|NCT02267447|Clinical prediction rule|clinical prediction rule
168265|NCT02267447|Population projection|population projection
168266|NCT02267447|Risk stratification|risk stratification
168267|NCT02267447|Health behavior|health behavior
168268|NCT02267408|Heart valve prosthesis|heart valve prosthesis
168269|NCT02267408|Anticoagulation|anticoagulation
168270|NCT02267408|Warfarin|warfarin
168271|NCT02267395|Musicians, Injuries|musicians, injuries
168272|NCT02267369|online|online
168273|NCT02267369|social media|social media
168274|NCT02267369|online social network|online social network
168275|NCT02267369|physical activity|physical activity
168276|NCT02267369|message|message
168277|NCT02267330|Gonadal Radiation Exposure|gonadal radiation exposure
168278|NCT02267330|Fluoroscopic Imaging|fluoroscopic imaging
168279|NCT02267330|Trauma Surgery|trauma surgery
168280|NCT02267330|Pelvis fractures|pelvis fractures
168281|NCT02267330|Femur fractures|femur fractures
168282|NCT02267317|Insulin signaling and glucose disposal in muscle|insulin signaling and glucose disposal in muscle
168283|NCT02267317|Hepatic insulin sensitivity|hepatic insulin sensitivity
168284|NCT02267317|TLR4 signaling and inflammatory gene expression|tlr4 signaling and inflammatory gene expression
168285|NCT02267317|Plasma cytokine concentration|plasma cytokine concentration
168286|NCT02267317|Intramyocellular diacylglycerol and ceramide content|intramyocellular diacylglycerol and ceramide content
168287|NCT02267304|volunteers|volunteers
168288|NCT02267291|Cardiac Catheterization|cardiac catheterization
168289|NCT02267291|Echocardiography|echocardiography
168290|NCT02267291|Noninvasive Ventilation|noninvasive ventilation
168291|NCT02267291|Positive-Pressure Respiration|positive-pressure respiration
168292|NCT02267291|Ventricular Function|ventricular function
168293|NCT02267278|Myeloproliferative Diseases|myeloproliferative diseases
168294|NCT02267278|Myelofibrosis|myelofibrosis
168295|NCT02267278|MF|mf
168296|NCT02267278|Primary or post essential thrombocythemia/polycythemia vera|primary or post essential thrombocythemia/polycythemia vera
168297|NCT02267278|Ruxolitinib|ruxolitinib
168298|NCT02267278|Jakafi|jakafi
168299|NCT02267278|INCB018424|incb018424
168300|NCT02267278|INC424|inc424
168301|NCT02267278|Pracinostat|pracinostat
168302|NCT02267278|Questionnaire|questionnaire
168303|NCT02267278|Survey|survey
168304|NCT02267265|educational intervention|educational intervention
168305|NCT02267265|language development|language development
168306|NCT02267265|universal newborn hearing screening|universal newborn hearing screening
168307|NCT02267265|postpartum|postpartum
168308|NCT02267265|parental attachment|parental attachment
168309|NCT02267265|loss to follow-up|loss to follow-up
168310|NCT02267265|hearing loss|hearing loss
168311|NCT02267265|achievement gap|achievement gap
168312|NCT02267265|language gap|language gap
168313|NCT02267265|school readiness|school readiness
168314|NCT02267239|essential oils|essential oils
168315|NCT02267239|chlorhexidine|chlorhexidine
168316|NCT02267239|microscopy, confocal|microscopy, confocal
168317|NCT02267239|immersion|immersion
168318|NCT02267239|antiseptic|antiseptic
168319|NCT02267200|biomarkers，pulmonary arterial hypertension|biomarkers，pulmonary arterial hypertension
168320|NCT02267187|Craniomaxillofacial (CMF)|craniomaxillofacial (cmf)
168321|NCT02267187|Battle-injured (BI)|battle-injured (bi)
168322|NCT02267187|Facial Trauma|facial trauma
168323|NCT02267187|Fat Grafts|fat grafts
168324|NCT02267187|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
168325|NCT02267187|Wounded Warriors|wounded warriors
168326|NCT02267174|Implementation|implementation
168327|NCT02267174|quality improvement|quality improvement
168328|NCT02267174|patient safety|patient safety
168329|NCT02267174|handoffs|handoffs
168330|NCT02267174|intensive care unit|intensive care unit
168331|NCT02267174|postoperative care|postoperative care
168332|NCT02267174|simulation|simulation
168333|NCT02267161|agenesis|agenesis
168334|NCT02267161|corpus callosum|corpus callosum
168335|NCT02267161|prenatal diagnosis|prenatal diagnosis
168336|NCT02267148|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
168337|NCT02267148|Fatty liver|fatty liver
168338|NCT02267148|Steatosis|steatosis
168340|NCT02267148|Liver Stiffness|liver stiffness
168341|NCT02267148|Cirrhosis|cirrhosis
168342|NCT02267148|Genetics|genetics
168343|NCT02267148|Single Nucleotide Polymorphism|single nucleotide polymorphism
168344|NCT02267135|scalp psoriasis, plaque psoriasis, secukinumab, AIN457, biologic, monoclonal antibody, psoriasis, AIN457A|scalp psoriasis, plaque psoriasis, secukinumab, ain457, biologic, monoclonal antibody, psoriasis, ain457a
168345|NCT02267096|lung cancer screening|lung cancer screening
168346|NCT02267083|soft tissue sarcoma|soft tissue sarcoma
168347|NCT02267070|cognitive training|cognitive training
168348|NCT02267070|aerobic exercise|aerobic exercise
168349|NCT02267070|neurotrophic factors|neurotrophic factors
168350|NCT02267070|randomized controlled trial|randomized controlled trial
168351|NCT02267057|Pain measurement|pain measurement
168352|NCT02267057|Pain assessment|pain assessment
168353|NCT02267057|Pain management|pain management
168354|NCT02267057|Analgesia|analgesia
168355|NCT02267057|Analgesics|analgesics
168356|NCT02267057|Depressive symptoms|depressive symptoms
168357|NCT02267057|Alzheimer disease|alzheimer disease
168358|NCT02267057|Vascular dementia|vascular dementia
168359|NCT02267057|Multi-infarct dementia|multi-infarct dementia
168360|NCT02267057|Frontotemporal lobar degeneration|frontotemporal lobar degeneration
168361|NCT02267057|Lewy body disease|lewy body disease
168362|NCT02267031|cognitive dysfunction|cognitive dysfunction
168363|NCT02267031|mechanical ventilation|mechanical ventilation
168364|NCT02267031|hyperoxia|hyperoxia
168365|NCT02267031|hypocapnia|hypocapnia
168366|NCT02267018|nCPAP|ncpap
168464|NCT02266407|Blood Loss|blood loss
168367|NCT02267018|High-Frequency Oscillator Ventilation|high-frequency oscillator ventilation
168368|NCT02267018|Diaphragm Electrical Activity|diaphragm electrical activity
168369|NCT02266979|peritoneal dialysis|peritoneal dialysis
168370|NCT02266979|nursing staff|nursing staff
168371|NCT02266979|nursing activities|nursing activities
168372|NCT02266979|Personnel Downsizing|personnel downsizing
168373|NCT02266953|Dietary services|dietary services
168374|NCT02266953|Public Health Nursing|public health nursing
168375|NCT02266953|Preschool child|preschool child
168376|NCT02266940|pharmacokinetics|pharmacokinetics
168377|NCT02266901|leaks after bariatric surgery|leaks after bariatric surgery
168378|NCT02266901|fistulae after bariatric surgery|fistulae after bariatric surgery
168379|NCT02266901|abdominal abcesses and bariatric surgery|abdominal abcesses and bariatric surgery
168380|NCT02266901|endoscopic drainage of abcesses|endoscopic drainage of abcesses
168381|NCT02266901|percutaneous drainage of abcesses|percutaneous drainage of abcesses
168382|NCT02266901|gastric bypass|gastric bypass
168383|NCT02266901|sleeve gastrectomy|sleeve gastrectomy
168384|NCT02266901|necrotic collection and bariatric surgery|necrotic collection and bariatric surgery
168385|NCT02266888|B cells|b cells
168386|NCT02266888|lung transplant recipient|lung transplant recipient
168387|NCT02266888|rituximab|rituximab
168388|NCT02266888|placebo|placebo
168389|NCT02266888|standard of care|standard of care
168390|NCT02266836|Stroke|stroke
168391|NCT02266836|Cerebrovascular accident|cerebrovascular accident
168392|NCT02266836|Upper Extremity|upper extremity
168393|NCT02266836|Cerebral Infarction|cerebral infarction
168394|NCT02266836|Brain Infarction|brain infarction
168395|NCT02266836|Brain Ischemia|brain ischemia
168396|NCT02266836|Cerebrovascular Disorders|cerebrovascular disorders
168397|NCT02266836|Cardiovascular Diseases|cardiovascular diseases
168398|NCT02266836|Nervous System Diseases|nervous system diseases
168399|NCT02266836|Central Nervous System Diseases|central nervous system diseases
168400|NCT02266784|smoking, smoking cessation, contingency management, ADHD|smoking, smoking cessation, contingency management, adhd
168401|NCT02266771|Negative Pressure Wound Therapy, Wound VAC, Instillation|negative pressure wound therapy, wound vac, instillation
168404|NCT02266758|Pregnancy|pregnancy
168405|NCT02266719|Aortic Aneurysm, Abdominal [C14.907.055.239.075]|aortic aneurysm, abdominal [c14.907.055.239.075]
168406|NCT02266693|Cognitive Behavioural Therapy|cognitive behavioural therapy
168407|NCT02266693|Internet Based|internet based
168408|NCT02266693|CBT|cbt
168409|NCT02266693|Transdiagnostic|transdiagnostic
168410|NCT02266693|MDD|mdd
168411|NCT02266693|PD|pd
168412|NCT02266693|SAD|sad
168413|NCT02266693|GAD|gad
168414|NCT02266693|iCBT|icbt
168415|NCT02266680|Social Anxiety|social anxiety
168416|NCT02266680|Yoga|yoga
168417|NCT02266667|NEMOT device|nemot device
168418|NCT02266667|pediatrics|pediatrics
168419|NCT02266667|surgery|surgery
168420|NCT02266667|progressive scoliosis|progressive scoliosis
168421|NCT02266654|Emergency Medical Services|emergency medical services
168422|NCT02266654|Lactic Acid|lactic acid
168423|NCT02266654|Sepsis|sepsis
168424|NCT02266641|one-carbon metabolism|one-carbon metabolism
168425|NCT02266641|folate|folate
168426|NCT02266641|choline|choline
168427|NCT02266641|DNA methylation|dna methylation
168428|NCT02266641|imprint marker|imprint marker
168429|NCT02266641|cancer risks|cancer risks
168430|NCT02266602|IORT|iort
168431|NCT02266602|Breast Cancer|breast cancer
168432|NCT02266589|coagulopathy|coagulopathy
168433|NCT02266589|hydrocortisone|hydrocortisone
168434|NCT02266589|organ failure|organ failure
169726|NCT02258412|efficacy|efficacy
168435|NCT02266589|hemodynamic improvement induced by hydrocortisone|hemodynamic improvement induced by hydrocortisone
168436|NCT02266563|Traumatic Brain Injury|traumatic brain injury
168437|NCT02266563|Chronic Traumatic Encephalopathy|chronic traumatic encephalopathy
168438|NCT02266563|Mild Cognitive Impairment|mild cognitive impairment
168439|NCT02266563|PET imaging|pet imaging
168440|NCT02266563|tauopathy|tauopathy
168441|NCT02266563|amyloid|amyloid
168442|NCT02266446|anxiety disorders|anxiety disorders
168443|NCT02266446|cognitive bias modification|cognitive bias modification
168444|NCT02266446|primary care|primary care
168445|NCT02266446|attention|attention
168446|NCT02266446|interpretation|interpretation
168447|NCT02266446|computer|computer
168448|NCT02266433|DeQuervains Tenosynovitis|dequervains tenosynovitis
168449|NCT02266433|Lateral Epicondylitis|lateral epicondylitis
168450|NCT02266433|Tennis Elbow|tennis elbow
168451|NCT02266433|Trigger Finger|trigger finger
168452|NCT02266433|Tenosynovitis|tenosynovitis
168453|NCT02266433|Inflammatory Disease|inflammatory disease
168454|NCT02266433|Dexamethasone|dexamethasone
168455|NCT02266433|Ketorolac|ketorolac
168456|NCT02266433|Toradol|toradol
168457|NCT02266420|Triple negative breast cancer|triple negative breast cancer
168458|NCT02266420|immuno-histochemistery|immuno-histochemistery
168459|NCT02266420|genomic profiles|genomic profiles
168460|NCT02266407|Revision TKA|revision tka
168461|NCT02266407|Septic|septic
168462|NCT02266407|Aseptic|aseptic
168463|NCT02266407|Transfusion|transfusion
168466|NCT02266381|MPCNL|mpcnl
168467|NCT02266381|guidance|guidance
168468|NCT02266381|puncture|puncture
168469|NCT02266368|Ureteral stents|ureteral stents
168470|NCT02266368|Double J stent|double j stent
168471|NCT02266368|Antimicoreal coated stent|antimicoreal coated stent
168472|NCT02266368|USSQ|ussq
168474|NCT02266355|Oxaliplatin|oxaliplatin
168475|NCT02266355|Omalizumab|omalizumab
168476|NCT02266329|controlled clinical trial|controlled clinical trial
168477|NCT02266329|randomized controlled clinical trial|randomized controlled clinical trial
168478|NCT02266290|ADHESIVE TAPE|adhesive tape
168479|NCT02266290|ANKLE INJURY|ankle injury
168480|NCT02266290|POSTURAL BALANCE|postural balance
168481|NCT02266290|FUNCTIONAL ANKLE INSTABILITY|functional ankle instability
168482|NCT02266277|electronic health record, utilization|electronic health record, utilization
168483|NCT02266277|randomized controlled trial|randomized controlled trial
168484|NCT02266277|pragmatic clinical trial|pragmatic clinical trial
168485|NCT02266277|influenza, prevention and control|influenza, prevention and control
168486|NCT02266277|pneumococcal vaccines|pneumococcal vaccines
168487|NCT02266277|qualitative research|qualitative research
168488|NCT02266225|Chronic disease management|chronic disease management
168489|NCT02266225|Physical activity|physical activity
168490|NCT02266225|Fall prevention|fall prevention
168491|NCT02266225|Strength and balance exercise|strength and balance exercise
168492|NCT02266199|questionnaire|questionnaire
168493|NCT02266199|quality assurance|quality assurance
168494|NCT02266199|qualitative Verification|qualitative verification
168495|NCT02266199|conservative patients|conservative patients
168496|NCT02266199|interview|interview
168497|NCT02266160|tinnitus|tinnitus
168498|NCT02266160|local anaesthetic|local anaesthetic
168499|NCT02266160|EMLA cream 5%|emla cream 5%
168501|NCT02266134|implementation|implementation
168502|NCT02266134|measurement based care|measurement based care
168503|NCT02266134|standardized|standardized
168504|NCT02266134|tailored|tailored
168505|NCT02266121|Multiple Sclerosis|multiple sclerosis
168506|NCT02266121|MS|ms
168507|NCT02266121|Cognitive deficits|cognitive deficits
168508|NCT02266121|Motor deficits|motor deficits
168509|NCT02266121|Fatigue|fatigue
168510|NCT02266121|Nervous System Diseases|nervous system diseases
168511|NCT02266121|Brain Diseases|brain diseases
168512|NCT02266121|Brain stimulation|brain stimulation
168513|NCT02266121|Working memory|working memory
168514|NCT02266121|Motor learning|motor learning
168515|NCT02266121|Central Nervous System Diseases|central nervous system diseases
168516|NCT02266121|Neuropsychological rehabilitation|neuropsychological rehabilitation
168517|NCT02266108|Sexually Transmitted Infections|sexually transmitted infections
168518|NCT02266108|Female Sex Workers|female sex workers
168519|NCT02266095|Osteoarthritis|osteoarthritis
168520|NCT02266095|Thumb spica splint|thumb spica splint
168521|NCT02266095|Oval-8 splint|oval-8 splint
168522|NCT02266095|Tee-Pee splint|tee-pee splint
168523|NCT02266069|implementation|implementation
168524|NCT02266069|anticipatory care planning|anticipatory care planning
168525|NCT02266069|symptom assessment|symptom assessment
168526|NCT02266069|interdisciplinary collaboration|interdisciplinary collaboration
168527|NCT02266056|deep neuromuscular block|deep neuromuscular block
168528|NCT02266056|sugammadex|sugammadex
168529|NCT02266056|laparoscopic colorectal surgery|laparoscopic colorectal surgery
168530|NCT02266056|hemodynamic change|hemodynamic change
168531|NCT02266043|Upper airway obstruction|upper airway obstruction
168532|NCT02266017|pain|pain
168533|NCT02266017|coping|coping
168534|NCT02266017|mhealth|mhealth
168535|NCT02266017|cancer|cancer
168536|NCT02266004|transcranial direct current stimulation|transcranial direct current stimulation
168537|NCT02266004|neuromodulation|neuromodulation
664075|NCT00831259|PFO|pfo
168538|NCT02265978|Emotional Self-Awareness|emotional self-awareness
168539|NCT02265978|Positive Coping|positive coping
168540|NCT02265978|Help-Seeking|help-seeking
168541|NCT02265926|filtering facepiece respirators|filtering facepiece respirators
168542|NCT02265926|N95 masks|n95 masks
168543|NCT02265926|pandemic response|pandemic response
168544|NCT02265926|pregnant healthcare workers|pregnant healthcare workers
168545|NCT02265900|Positron Emission Tomography|positron emission tomography
168546|NCT02265900|Dopamine|dopamine
168547|NCT02265900|Parkinson's Disease|parkinson's disease
168548|NCT02265887|Pulmonary Hypertension|pulmonary hypertension
168549|NCT02265887|Africa|africa
168550|NCT02265887|Heart Disease|heart disease
168551|NCT02265887|Echocardiography|echocardiography
168552|NCT02265861|Polycystic ovary syndrome; Vascular endothelial growth factor; Angiotensin-Ⅱ; Ovarian hyperstimulation syndrome|polycystic ovary syndrome; vascular endothelial growth factor; angiotensin-ⅱ; ovarian hyperstimulation syndrome
168553|NCT02265848|Spinal cord stimulation|spinal cord stimulation
168554|NCT02265848|Chronic pain|chronic pain
168555|NCT02265848|Chronic low back pain|chronic low back pain
168556|NCT02265848|Radiculopathy|radiculopathy
168557|NCT02265848|Complex Regional Pain Syndrome (CRPS)|complex regional pain syndrome (crps)
168558|NCT02265848|High Frequency stimulation|high frequency stimulation
168559|NCT02265822|melatonin|melatonin
168560|NCT02265822|midazolam|midazolam
168561|NCT02265822|children|children
168562|NCT02265809|Interleukin 2|interleukin 2
168563|NCT02265809|Type 1 diabetes|type 1 diabetes
168564|NCT02265809|T regulatory cells|t regulatory cells
168565|NCT02265809|Adaptive trial|adaptive trial
168566|NCT02265796|deferred percutaneous coronary intervention|deferred percutaneous coronary intervention
168567|NCT02265796|fractional flow reserve|fractional flow reserve
168568|NCT02265783|Focus of Study: Healthy Volunteers|focus of study: healthy volunteers
168569|NCT02265757|Behavioral Intervention|behavioral intervention
168570|NCT02265757|Mild Cognitive Impairment|mild cognitive impairment
168571|NCT02265757|HABIT|habit
168572|NCT02265757|Cognitive Rehabilitation|cognitive rehabilitation
168573|NCT02265757|Multi-Component Intervention|multi-component intervention
168574|NCT02265731|acute myeloid leukemia|acute myeloid leukemia
168575|NCT02265731|small lymphocytic lymphoma|small lymphocytic lymphoma
168576|NCT02265731|relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
168577|NCT02265731|refractory multiple myeloma|refractory multiple myeloma
168578|NCT02265731|refractory small lymphocytic lymphoma|refractory small lymphocytic lymphoma
168579|NCT02265731|relapsed multiple myeloma|relapsed multiple myeloma
168580|NCT02265731|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
168581|NCT02265731|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
168582|NCT02265731|Lymphoproliferative Disorders|lymphoproliferative disorders
168583|NCT02265731|relapsed small lymphocytic lymphoma|relapsed small lymphocytic lymphoma
168584|NCT02265731|Lymphatic Diseases|lymphatic diseases
168585|NCT02265718|Healthy|healthy
168586|NCT02265718|elderly volunteers|elderly volunteers
168587|NCT02265614|PGS|pgs
168588|NCT02265614|blastocyst|blastocyst
168589|NCT02265614|human|human
168590|NCT02265614|IVF|ivf
168591|NCT02265614|vitrification|vitrification
168592|NCT02265614|single embryo transfer|single embryo transfer
168593|NCT02265601|advance care planning|advance care planning
168594|NCT02265601|living wills|living wills
168595|NCT02265601|end of life|end of life
168596|NCT02265601|cancer|cancer
168597|NCT02265588|Inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
168598|NCT02265588|Ulcerative colitis|ulcerative colitis
168599|NCT02265588|Crohn's disease|crohn's disease
168600|NCT02265588|Children|children
168601|NCT02265588|Adolescents|adolescents
168602|NCT02265588|Anxiety|anxiety
168603|NCT02265588|Depression|depression
168604|NCT02265588|Cognitive behavioral therapy|cognitive behavioral therapy
168605|NCT02265562|Hysterectomy|hysterectomy
168606|NCT02265562|Misoprostol|misoprostol
168607|NCT02265562|Blood loss|blood loss
168608|NCT02265549|Metastases,|metastases,
168609|NCT02265549|Neoplasm|neoplasm
168610|NCT02265549|Cerebral|cerebral
168611|NCT02265523|Arthroplasties, Replacement, Knee|arthroplasties, replacement, knee
168612|NCT02265458|Respiratory failure|respiratory failure
168613|NCT02265458|NIV|niv
168614|NCT02265458|Musical intervention|musical intervention
168615|NCT02265445|Carbapenems therapy/ESBL infections/Deescalation|carbapenems therapy/esbl infections/deescalation
168616|NCT02265445|due to ESBL-PE|due to esbl-pe
168617|NCT02265432|Physical activity|physical activity
168618|NCT02265432|Sedentary behavior|sedentary behavior
168619|NCT02265419|hyperinflammation, Cytosorb|hyperinflammation, cytosorb
168620|NCT02265354|Tobacco Smoking Cessation|tobacco smoking cessation
168621|NCT02265354|Computer tailored health communication|computer tailored health communication
168622|NCT02265354|messaging|messaging
168623|NCT02265354|collective intelligence|collective intelligence
168624|NCT02265354|recommender systems|recommender systems
168625|NCT02265354|machine learning|machine learning
168717|NCT02264756|Pragmatic clinical trial|pragmatic clinical trial
168626|NCT02265328|Severe Alcoholic Hepatitis in 'Extremis'|severe alcoholic hepatitis in 'extremis'
168627|NCT02265328|Bovine Colostrum|bovine colostrum
168628|NCT02265328|Glucocorticoids|glucocorticoids
168629|NCT02265276|NAFLD, Diabetes, Glitazone|nafld, diabetes, glitazone
168630|NCT02265250|magnetic resonance imaging|magnetic resonance imaging
168631|NCT02265250|positron emission tomography|positron emission tomography
168632|NCT02265237|Compensated Cirrhosis|compensated cirrhosis
168633|NCT02265237|Hepatitis C|hepatitis c
168634|NCT02265237|Hepatitis C Genotype 4|hepatitis c genotype 4
168635|NCT02265237|Chronic Hepatitis C|chronic hepatitis c
168636|NCT02265198|Pulmonary Contusion|pulmonary contusion
168637|NCT02265198|ARDS|ards
168638|NCT02265198|Respiratory Failure|respiratory failure
168639|NCT02265172|Physiotherapy|physiotherapy
168640|NCT02265172|Orthopaedic|orthopaedic
168641|NCT02265172|Primary care|primary care
168642|NCT02265146|Lipid Core Plaques (LCPs)|lipid core plaques (lcps)
168643|NCT02265146|Vulnerable Plaque|vulnerable plaque
168644|NCT02265146|Near Infrared Spectroscopy|near infrared spectroscopy
168645|NCT02265107|endothelial function|endothelial function
168646|NCT02265107|physical training|physical training
168647|NCT02265107|exercise|exercise
168648|NCT02265107|coronary artery bypass|coronary artery bypass
168649|NCT02265094|Autism Spectrum Disorder|autism spectrum disorder
168650|NCT02265094|Development|development
168651|NCT02265094|Memory|memory
168652|NCT02265094|ERD|erd
168744|NCT02264509|Atherosclerosis|atherosclerosis
168653|NCT02265068|Acute coronary syndrome (ACS), Ticagrelor|acute coronary syndrome (acs), ticagrelor
168654|NCT02265029|fibromyalgia|fibromyalgia
168655|NCT02265029|rheumatism|rheumatism
168656|NCT02265029|fatigue syndrom|fatigue syndrom
168657|NCT02265029|pain|pain
168658|NCT02265029|spa treatment in rheumatology|spa treatment in rheumatology
168659|NCT02265016|coronary artery disease|coronary artery disease
168660|NCT02265016|acute coronary syndrome|acute coronary syndrome
168661|NCT02265016|angina pectoris|angina pectoris
168662|NCT02265016|non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
168663|NCT02265016|red blood cells|red blood cells
168664|NCT02265016|erythrocytes|erythrocytes
168665|NCT02265003|red blood cells|red blood cells
168666|NCT02265003|endothelial function|endothelial function
168667|NCT02265003|nitric oxide pool in red blood cells|nitric oxide pool in red blood cells
168668|NCT02265003|nitric oxide poll in blood plasma|nitric oxide poll in blood plasma
168669|NCT02265003|nitric oxide synthase III - expression|nitric oxide synthase iii - expression
168670|NCT02265003|oxidative status|oxidative status
168671|NCT02265003|nitric oxide signalling|nitric oxide signalling
168672|NCT02264990|cisplatin|cisplatin
168673|NCT02264990|paclitaxel|paclitaxel
168674|NCT02264990|Poly Adenosine diphosphate (ADP)-ribose Polymerase (PARP)|poly adenosine diphosphate (adp)-ribose polymerase (parp)
168675|NCT02264990|Non-squamous|non-squamous
168676|NCT02264990|Non-small cell lung cancer|non-small cell lung cancer
168677|NCT02264990|pemetrexed|pemetrexed
168678|NCT02264990|carboplatin|carboplatin
168679|NCT02264990|Metastatic|metastatic
168680|NCT02264990|veliparib|veliparib
168681|NCT02264964|Hemodialysis|hemodialysis
168682|NCT02264964|End-Stage Kidney Disease|end-stage kidney disease
168683|NCT02264964|Central Venous Catheterization|central venous catheterization
168684|NCT02264964|Digital Subtraction Angiography|digital subtraction angiography
168685|NCT02264951|Short fatty acids|short fatty acids
168686|NCT02264951|2-oleoyl glycerol|2-oleoyl glycerol
168687|NCT02264951|GLP-1 secretion|glp-1 secretion
168688|NCT02264951|C8-diet oil|c8-diet oil
168689|NCT02264951|GIP secretion|gip secretion
168690|NCT02264925|Essential tremor|essential tremor
168691|NCT02264925|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
168692|NCT02264925|Ventral intermediate Thalamus (VIM)|ventral intermediate thalamus (vim)
168693|NCT02264925|Local field potentials (LFPs)|local field potentials (lfps)
168694|NCT02264925|Closed loop therapy|closed loop therapy
168695|NCT02264912|antiplatelets, percutanous coronary intervention, acute coronary syndromes, laboratory efficacy|antiplatelets, percutanous coronary intervention, acute coronary syndromes, laboratory efficacy
168696|NCT02264899|Alzheimer's disease|alzheimer's disease
168697|NCT02264899|Mild Cognitive Impairment|mild cognitive impairment
168698|NCT02264873|Relapse|relapse
168699|NCT02264873|Autologous stem cell transplant|autologous stem cell transplant
168700|NCT02264847|Clomiphene Citrate|clomiphene citrate
168701|NCT02264847|Ovulation trigger|ovulation trigger
168702|NCT02264847|Human chorionic gonadotrophin|human chorionic gonadotrophin
168703|NCT02264834|epidural|epidural
168704|NCT02264834|primiparous patient|primiparous patient
168705|NCT02264834|deambulation|deambulation
168706|NCT02264821|analgesia|analgesia
168707|NCT02264821|caesarean|caesarean
168708|NCT02264821|wound infiltration|wound infiltration
168709|NCT02264821|intrathecal morphine.|intrathecal morphine.
168710|NCT02264795|Cesarean section|cesarean section
168711|NCT02264795|Lidocaine|lidocaine
168712|NCT02264769|pregnancy|pregnancy
168713|NCT02264769|postpartum hemorrhage|postpartum hemorrhage
168714|NCT02264769|Cesarean delivery|cesarean delivery
168715|NCT02264769|carbetocin|carbetocin
168716|NCT02264756|Community-acquired pneumonia|community-acquired pneumonia
168718|NCT02264756|Antimicrobial stewardship|antimicrobial stewardship
168719|NCT02264756|length of stay|length of stay
168720|NCT02264756|stepped-wedge design|stepped-wedge design
168721|NCT02264756|time-dependent bias|time-dependent bias
168723|NCT02264704|Exercise|exercise
168724|NCT02264704|Training|training
168725|NCT02264704|Multiple sclerosis|multiple sclerosis
168726|NCT02264704|Immune response|immune response
168727|NCT02264704|Neurotrophin|neurotrophin
168728|NCT02264704|Cytokine|cytokine
168729|NCT02264704|Fatigue|fatigue
168730|NCT02264678|ATM deficient, ATM proficient, HER2 negative, Breast, Gastric, Head & Neck, Lung|atm deficient, atm proficient, her2 negative, breast, gastric, head & neck, lung
168731|NCT02264652|Refractory|refractory
168732|NCT02264652|Partial|partial
168733|NCT02264652|Epilepsy|epilepsy
168734|NCT02264626|acute respiratory failure|acute respiratory failure
168735|NCT02264626|noninvasive ventilation|noninvasive ventilation
168736|NCT02264626|sedation|sedation
168737|NCT02264626|patient/ventilator interaction|patient/ventilator interaction
168738|NCT02264600|Restless Legs Syndrome, Apelin, Oxidative Stress|restless legs syndrome, apelin, oxidative stress
168739|NCT02264535|Allergy|allergy
168740|NCT02264535|Skin test|skin test
168741|NCT02264535|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
168742|NCT02264509|Arterial Insufficiency|arterial insufficiency
168743|NCT02264509|Human Immunodeficiency Virus|human immunodeficiency virus
168747|NCT02264496|Colorectal cancer|colorectal cancer
168748|NCT02264496|Exercise|exercise
168749|NCT02264496|CPEX|cpex
168750|NCT02264496|Exercise, Physical|exercise, physical
168751|NCT02264496|Exercise, Aerobic|exercise, aerobic
168752|NCT02264496|Surgery|surgery
168753|NCT02264483|Pneumonia in COPD exacerbation|pneumonia in copd exacerbation
168754|NCT02264470|Prediction|prediction
168755|NCT02264470|Falls|falls
168756|NCT02264470|Stroke|stroke
168757|NCT02264457|Lenses, Intraocular|lenses, intraocular
168758|NCT02264444|Cholecystectomy, visualization, single incision|cholecystectomy, visualization, single incision
168759|NCT02264431|Obesity|obesity
168760|NCT02264431|Obstructive Sleep Apnea|obstructive sleep apnea
168761|NCT02264431|Sleep Habits|sleep habits
168762|NCT02264431|Bariatric Surgery|bariatric surgery
168763|NCT02264431|Cohort|cohort
168764|NCT02264418|Solid tumours|solid tumours
168765|NCT02264405|Autoimmune diseases|autoimmune diseases
168766|NCT02264405|Systemic sclerosis|systemic sclerosis
168767|NCT02264405|Autologous Hematopoietic stem cell transplant|autologous hematopoietic stem cell transplant
168768|NCT02264379|Oligometastases|oligometastases
168769|NCT02264379|Prostate Cancer|prostate cancer
168770|NCT02264379|Stereotactic Radiotherapy|stereotactic radiotherapy
168771|NCT02264379|Hypo fractionation|hypo fractionation
168772|NCT02264379|Normal fractionation|normal fractionation
168773|NCT02264353|Obstructive|obstructive
168774|NCT02264353|Sleep Apnea|sleep apnea
168775|NCT02264353|Arousal threshold|arousal threshold
168776|NCT02264353|Donepezil|donepezil
168777|NCT02264340|Tension-type headache|tension-type headache
168778|NCT02264340|relaxation techniques|relaxation techniques
168779|NCT02264340|physiotherapy|physiotherapy
168780|NCT02264327|Motivational Interviewing|motivational interviewing
168781|NCT02264327|Evidence Based Practice|evidence based practice
168782|NCT02264327|Online Simulation|online simulation
168783|NCT02264327|Workforce development|workforce development
168784|NCT02264327|Training|training
168785|NCT02264314|Aged|aged
168786|NCT02264314|Hearing Aids|hearing aids
168792|NCT02264275|Exergame|exergame
168793|NCT02264275|Behavior|behavior
168794|NCT02264275|Video Game|video game
168795|NCT02264275|Inflammatory Bowel Disease|inflammatory bowel disease
168796|NCT02264275|Children|children
168797|NCT02264275|Adolescents|adolescents
168798|NCT02264275|Pediatric|pediatric
168799|NCT02264275|Physical Fitness|physical fitness
168800|NCT02264223|Bioavailability|bioavailability
168801|NCT02264223|Isoflavones|isoflavones
168802|NCT02264223|Plasma|plasma
168803|NCT02264223|Human|human
168804|NCT02264223|Processing|processing
168805|NCT02264223|Cross-over|cross-over
168806|NCT02263950|Cancer|cancer
168807|NCT02263950|Malignant Neoplasm|malignant neoplasm
168808|NCT02263950|Artemether|artemether
168809|NCT02263950|Sublingual|sublingual
168810|NCT02263950|Neoplastic disease|neoplastic disease
168811|NCT02263950|Solid Tumour|solid tumour
159844|NCT02315352|PZQ|pzq
168812|NCT02263950|Anti-cancer drug|anti-cancer drug
168813|NCT02263950|Chemotherapy|chemotherapy
168814|NCT02263950|LON002|lon002
168815|NCT02263885|Parkinson's Disease|parkinson's disease
168816|NCT02263885|ExAblate|exablate
168817|NCT02263885|MRgFUS|mrgfus
168818|NCT02263859|Obstructive Sleep Apnea|obstructive sleep apnea
168819|NCT02263846|Breast cancer|breast cancer
168820|NCT02263846|Menopause|menopause
168821|NCT02263846|Estradiol|estradiol
168822|NCT02263846|Follicle stimulating hormone|follicle stimulating hormone
168823|NCT02263820|Acute Kidney Injury|acute kidney injury
168824|NCT02263820|Acute Renal Failure|acute renal failure
168825|NCT02263807|Patella luxation|patella luxation
168826|NCT02263794|Bronchial Thermoplasty|bronchial thermoplasty
168827|NCT02263755|CHB, cohort, fibroscan|chb, cohort, fibroscan
168828|NCT02263742|Healthcare choice and outcomes|healthcare choice and outcomes
168829|NCT02263742|Peer-led whole health|peer-led whole health
168830|NCT02263742|Mental Illness|mental illness
168831|NCT02263742|Peer Health Navigation|peer health navigation
168832|NCT02263742|Health care Coordination|health care coordination
168833|NCT02263716|Physical Activity|physical activity
168834|NCT02263716|Intensive Care|intensive care
168835|NCT02263716|Activities of Daily Living|activities of daily living
168836|NCT02263716|Delirium|delirium
168837|NCT02263716|Sepsis|sepsis
168838|NCT02263716|Mechanical Ventilation|mechanical ventilation
168839|NCT02263716|Critical Care|critical care
168840|NCT02263716|Critical Illness|critical illness
168841|NCT02263716|Aging|aging
168842|NCT02263716|Accelerometery|accelerometery
168843|NCT02263703|HPV vaccine, children, immunocompromised|hpv vaccine, children, immunocompromised
168844|NCT02263677|diabetes|diabetes
168845|NCT02263677|fatty liver|fatty liver
168846|NCT02263664|microcirculation|microcirculation
168847|NCT02263664|esophagectomy|esophagectomy
168848|NCT02263664|side stream dark field|side stream dark field
168849|NCT02263664|microcirculatory derangements|microcirculatory derangements
168850|NCT02263651|Breast cancer|breast cancer
168851|NCT02263651|Mastectomy|mastectomy
168852|NCT02263651|Seroma|seroma
168853|NCT02263651|Quilting suture|quilting suture
168854|NCT02263638|hereditary haemochromatosis|hereditary haemochromatosis
168855|NCT02263638|rheumatism|rheumatism
168856|NCT02263638|anakinra|anakinra
168857|NCT02263625|Indication|indication
168858|NCT02263625|Differences|differences
168859|NCT02263612|Incisional Hernia|incisional hernia
168860|NCT02263612|Complications|complications
168861|NCT02263612|Long-term|long-term
168862|NCT02263586|Ironman|ironman
168863|NCT02263586|Triathlon|triathlon
168864|NCT02263573|PEP'C-R|pep'c-r
168865|NCT02263573|Endurance parameters|endurance parameters
168866|NCT02263573|Maximal cardio-respiratory function|maximal cardio-respiratory function
168867|NCT02263573|Older seniors|older seniors
168868|NCT02263573|Over 70|over 70
168869|NCT02263547|teriflunomide|teriflunomide
168870|NCT02263547|colestipol hcl|colestipol hcl
168871|NCT02263534|stress urinary incontinence|stress urinary incontinence
168872|NCT02263534|tension free vaginal tape|tension free vaginal tape
168873|NCT02263534|single incision minisling|single incision minisling
168874|NCT02263534|midurethral sling|midurethral sling
168875|NCT02263508|Talimogene Laherparepvec|talimogene laherparepvec
168876|NCT02263508|pembrolizumab|pembrolizumab
168877|NCT02263508|KEYNOTE-034|keynote-034
168878|NCT02263508|MASTERKEY-265|masterkey-265
168879|NCT02263495|HER2-Negative|her2-negative
168880|NCT02263482|muscle training|muscle training
168881|NCT02263482|walking test|walking test
168882|NCT02263482|chronic heart failure|chronic heart failure
168883|NCT02263482|functional capacity|functional capacity
168884|NCT02263443|bowel preparation|bowel preparation
168885|NCT02263443|gynecologic surgery|gynecologic surgery
168886|NCT02263443|laparotomy|laparotomy
168887|NCT02263391|transmission|transmission
168888|NCT02263391|prevention|prevention
168889|NCT02263391|women|women
168894|NCT02263352|Diabetes, Periodontitis, Oxidative stress, Antioxidant|diabetes, periodontitis, oxidative stress, antioxidant
168895|NCT02263339|Exercise|exercise
168896|NCT02263339|MRI|mri
168897|NCT02263313|Safety and efficacy|safety and efficacy
168898|NCT02263313|Combo stent|combo stent
168899|NCT02263313|Late loss thrombosis|late loss thrombosis
168900|NCT02263313|Late loss catch up|late loss catch up
168901|NCT02263300|Fiberoptic Intubation|fiberoptic intubation
168902|NCT02263300|Medical student|medical student
168903|NCT02263300|Virtual larynx|virtual larynx
168904|NCT02263300|Didactic Training|didactic training
168905|NCT02263300|Medical Education|medical education
168906|NCT02263287|Alzheimer Disease|alzheimer disease
168907|NCT02263287|Lewy Body Disease|lewy body disease
168908|NCT02263261|dermal matrix|dermal matrix
168909|NCT02263235|Alzheimer disease (AD)|alzheimer disease (ad)
168910|NCT02263235|diagnosis biomarkers|diagnosis biomarkers
168911|NCT02263235|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
168912|NCT02263235|targeted quantitative proteomics|targeted quantitative proteomics
168913|NCT02263235|mass spectrometry|mass spectrometry
168914|NCT02263235|stable isotope-labelled leucine|stable isotope-labelled leucine
168915|NCT02263183|Metabolic risk|metabolic risk
168916|NCT02263183|Abdominally overweight|abdominally overweight
168917|NCT02263131|Influenza|influenza
168918|NCT02263131|Influenza vaccine|influenza vaccine
168919|NCT02263131|Split influenza vaccine|split influenza vaccine
168920|NCT02263131|Seasonal influenza vaccine|seasonal influenza vaccine
168921|NCT02263118|breastfeeding|breastfeeding
168923|NCT02263118|m-health|m-health
168924|NCT02263118|mHealth|mhealth
168925|NCT02263118|Patojitos|patojitos
168926|NCT02263118|Guatemala|guatemala
168927|NCT02263118|exclusive breastfeeding|exclusive breastfeeding
168928|NCT02263118|mobile|mobile
168929|NCT02263118|eHealth|ehealth
168930|NCT02263118|e-health|e-health
168931|NCT02263105|recurrent high-grade gliomas|recurrent high-grade gliomas
168932|NCT02263105|cisplatin (CDDP)|cisplatin (cddp)
168933|NCT02263105|temozolomide (TMZ)|temozolomide (tmz)
168934|NCT02263092|Cortical excitability|cortical excitability
168935|NCT02263092|Plasticity|plasticity
168936|NCT02263092|Healthy subjects|healthy subjects
168937|NCT02263040|influenza vaccine|influenza vaccine
168938|NCT02263040|adult|adult
168939|NCT02263040|immunogenicity|immunogenicity
168940|NCT02263040|reactogenicity|reactogenicity
168941|NCT02263027|influenza vaccine|influenza vaccine
168942|NCT02263027|adult|adult
168943|NCT02263027|safety|safety
168944|NCT02263027|reactogenicity|reactogenicity
168945|NCT02263014|Breast Cancer|breast cancer
168946|NCT02263014|Contralateral Prophylactic Mastectomy|contralateral prophylactic mastectomy
168947|NCT02263014|Questionnaires|questionnaires
168948|NCT02263014|Surveys|surveys
168949|NCT02263014|Psychosocial|psychosocial
168950|NCT02263001|Auricular therapy|auricular therapy
168951|NCT02263001|Acupuncture|acupuncture
168952|NCT02263001|Acute, sub-acute pain|acute, sub-acute pain
168953|NCT02263001|Auricular Acupuncture Needles|auricular acupuncture needles
168954|NCT02262988|knee|knee
168955|NCT02262988|joint replacement|joint replacement
168956|NCT02262988|total knee|total knee
168957|NCT02262988|cell therapy|cell therapy
168958|NCT02262975|Alzheimer's disease|alzheimer's disease
168959|NCT02262936|Aged|aged
168960|NCT02262936|Deamino Arginine Vasopressin|deamino arginine vasopressin
168961|NCT02262936|Fesoterodine|fesoterodine
168962|NCT02262936|Randomized Controlled Trial|randomized controlled trial
168963|NCT02262910|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
168964|NCT02262910|CRPC|crpc
168965|NCT02262897|small cell lung cancer|small cell lung cancer
168966|NCT02262897|chemotherapy|chemotherapy
168967|NCT02262897|Nab-paclitaxel|nab-paclitaxel
168968|NCT02262871|Cystic fibrosis|cystic fibrosis
168969|NCT02262871|High-flow nasal oxygen cannula|high-flow nasal oxygen cannula
168970|NCT02262871|Non-invasive ventilation|non-invasive ventilation
168971|NCT02262871|Respiratory distress|respiratory distress
168972|NCT02262871|Oxygen therapy|oxygen therapy
168973|NCT02262832|Diabetes|diabetes
168974|NCT02262832|Leptin|leptin
168975|NCT02262832|Lipodystrophy|lipodystrophy
168976|NCT02262832|Hypertriglyceridemia|hypertriglyceridemia
168977|NCT02262819|Skin Blister|skin blister
168978|NCT02262819|Immune Response|immune response
168979|NCT02262819|Suction Device|suction device
168980|NCT02262819|Anti-Microbial|anti-microbial
168981|NCT02262819|Killed Microbe|killed microbe
168982|NCT02262806|Lipodystrophy|lipodystrophy
168983|NCT02262806|Leptin|leptin
168984|NCT02262806|Hypertriglyceridemia|hypertriglyceridemia
168985|NCT02262806|Diabetes|diabetes
169242|NCT02261389|breast cancer|breast cancer
168986|NCT02262767|Phase 1, Randomized, Double Blind, Placebo-Controlled, Single-Dose Escalation, Safety, Tolerability, Pharmacokinetic, PF-06649751, Trimethobenzamide|phase 1, randomized, double blind, placebo-controlled, single-dose escalation, safety, tolerability, pharmacokinetic, pf-06649751, trimethobenzamide
168988|NCT02262728|Simeprevir|simeprevir
168989|NCT02262728|Daclatasvir|daclatasvir
168990|NCT02262728|Sofosbuvir|sofosbuvir
168991|NCT02262728|Decompensated Liver Disease|decompensated liver disease
168992|NCT02262715|Oseltamivir|oseltamivir
168993|NCT02262715|VX-787|vx-787
168994|NCT02262689|GSK2256294|gsk2256294
168995|NCT02262689|normoxic|normoxic
168996|NCT02262689|hypoxic|hypoxic
168997|NCT02262689|Pulmonary artery systolic pressure (PASP)|pulmonary artery systolic pressure (pasp)
168998|NCT02262676|Stroke prevention on Atrial Fibrillation|stroke prevention on atrial fibrillation
168999|NCT02262676|Prevention and Control|prevention and control
169000|NCT02262676|Stroke|stroke
169001|NCT02262507|Brain|brain
169002|NCT02262507|Hearing|hearing
169003|NCT02262507|MTBI|mtbi
169004|NCT02262468|retrospective analysis|retrospective analysis
169005|NCT02262455|Serous tumor|serous tumor
169006|NCT02262455|Granulosa tumor|granulosa tumor
169007|NCT02262455|Clear Cell tumor|clear cell tumor
169008|NCT02262455|Endometrial cancer|endometrial cancer
169009|NCT02262455|Advanced solid tumors|advanced solid tumors
169010|NCT02262455|Adenocarcinoma|adenocarcinoma
169011|NCT02262455|Prostate cancer|prostate cancer
169012|NCT02262455|Head and Neck cancer|head and neck cancer
169013|NCT02262455|Lung cancer|lung cancer
169014|NCT02262455|Non-small cell lung cancer|non-small cell lung cancer
169015|NCT02262455|Small cell lung cancer|small cell lung cancer
169016|NCT02262455|Gastric cancer|gastric cancer
169017|NCT02262455|Kidney cancer|kidney cancer
169018|NCT02262455|Pancreatic cancer|pancreatic cancer
169019|NCT02262455|Breast cancer|breast cancer
169020|NCT02262455|Colorectal cancer|colorectal cancer
169021|NCT02262455|Bladder cancer|bladder cancer
169022|NCT02262455|Esophagus cancer|esophagus cancer
169023|NCT02262455|Liver cancer|liver cancer
169024|NCT02262455|Hepatobiliary cancer|hepatobiliary cancer
169025|NCT02262455|Skin cancer|skin cancer
169026|NCT02262442|flexible bronchoscopy|flexible bronchoscopy
169027|NCT02262442|anaesthetics|anaesthetics
169028|NCT02262442|transcutaneous pCO2|transcutaneous pco2
169029|NCT02262442|capillary pCO2|capillary pco2
169030|NCT02262442|special atomizing set|special atomizing set
169031|NCT02262416|GnRH agonist|gnrh agonist
169033|NCT02262403|Hookworm|hookworm
169034|NCT02262403|Helminths|helminths
169035|NCT02262403|Treg|treg
169036|NCT02262403|Immune regulation|immune regulation
169037|NCT02262403|Vietnam|vietnam
169038|NCT02262403|Allergic diseases|allergic diseases
169039|NCT02262377|Group Medical Visits|group medical visits
169040|NCT02262377|Integrative Medicine|integrative medicine
169041|NCT02262377|Chronic Pain|chronic pain
169042|NCT02262377|Depression|depression
169043|NCT02262377|MBSR|mbsr
169044|NCT02262377|Mindfulness Based Stress Reduction|mindfulness based stress reduction
169045|NCT02262377|Web based|web based
169046|NCT02262377|Virtual Patient Advocate|virtual patient advocate
169047|NCT02262377|Internet Based|internet based
169048|NCT02262351|Atrial Fibrillation|atrial fibrillation
169049|NCT02262351|Screening|screening
169050|NCT02262351|Family Practice|family practice
169051|NCT02262351|Novel screening technologies|novel screening technologies
169052|NCT02262338|MPS II|mps ii
169053|NCT02262338|Hunter Syndrome|hunter syndrome
169054|NCT02262325|Non-small cell|non-small cell
169055|NCT02262325|Lung Cancer|lung cancer
169056|NCT02262325|Chemoradiation|chemoradiation
169057|NCT02262286|Brain Injury|brain injury
169058|NCT02262273|women|women
169059|NCT02262273|platinum sensitive|platinum sensitive
169060|NCT02262273|recurrent|recurrent
169061|NCT02262273|serous|serous
169062|NCT02262273|ovarian cancer|ovarian cancer
169063|NCT02262273|BRCA|brca
169064|NCT02262273|PARP|parp
169065|NCT02262273|Olaparib|olaparib
169066|NCT02262260|Diabetic macular edema, DME, ranibizumab, wait and extend|diabetic macular edema, dme, ranibizumab, wait and extend
169067|NCT02262247|Transoral|transoral
169068|NCT02262247|Oropharynx|oropharynx
169069|NCT02262247|Hypopharynx|hypopharynx
169070|NCT02262247|Endoscopic|endoscopic
169071|NCT02262247|TORS|tors
169072|NCT02262247|Endoscopic Transoral|endoscopic transoral
169073|NCT02262247|Larynx|larynx
169074|NCT02262234|Spinal cord injury|spinal cord injury
169075|NCT02262234|Chronic pain|chronic pain
169076|NCT02262234|Education|education
169077|NCT02262208|Glycemic variability, exercise, diabetes|glycemic variability, exercise, diabetes
169078|NCT02262182|Atelectasis, Respiratory physiotherapy, end expiratory pressure, EzPAP®, cardiac surgery|atelectasis, respiratory physiotherapy, end expiratory pressure, ezpap®, cardiac surgery
169079|NCT02262169|Non-Bleeding Peptic Ulcers, DLBS2411, Ulcer Healing|non-bleeding peptic ulcers, dlbs2411, ulcer healing
169080|NCT02262156|Cognitive Behavioral Therapy|cognitive behavioral therapy
169081|NCT02262156|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
169082|NCT02262156|depression|depression
169083|NCT02262156|epilepsy|epilepsy
169084|NCT02262130|Omalizumab|omalizumab
169085|NCT02262130|Efficacy|efficacy
169086|NCT02262130|Safety|safety
169087|NCT02262117|IVF, pregnancy, immune endometrial profile, personalization of treatment|ivf, pregnancy, immune endometrial profile, personalization of treatment
169088|NCT02262104|Exercise|exercise
169089|NCT02262104|dementia|dementia
169090|NCT02262104|nursing home|nursing home
169091|NCT02262078|Preserved Ejection Fraction|preserved ejection fraction
169092|NCT02262065|implant|implant
169093|NCT02262065|allergy|allergy
169094|NCT02262065|particle|particle
169095|NCT02262065|cytokine|cytokine
169096|NCT02262052|Deep vein thrombosis|deep vein thrombosis
169097|NCT02262052|Diagnostic management|diagnostic management
169098|NCT02262052|Recurrent|recurrent
169099|NCT02262052|MRI|mri
169100|NCT02262052|Ipsilateral|ipsilateral
169101|NCT02262039|living|living
169102|NCT02262039|kidney|kidney
169103|NCT02262039|donors|donors
169104|NCT02262013|Pediatric Obesity|pediatric obesity
169105|NCT02262013|Lifestyle Intervention|lifestyle intervention
169106|NCT02262013|Family-based Intervention|family-based intervention
169107|NCT02262013|Motivational Interviewing|motivational interviewing
169108|NCT02262000|Non Small Cell Lung Cancer|non small cell lung cancer
169109|NCT02262000|Surgically inoperable|surgically inoperable
160126|NCT02313909|Cerebrovascular Disease|cerebrovascular disease
160127|NCT02313883|periodontitis|periodontitis
160128|NCT02313883|taurolidine (PerioSept(r))|taurolidine (periosept(r))
160129|NCT02313883|scaling and root planing|scaling and root planing
160130|NCT02313870|Bullous pemphigoid|bullous pemphigoid
169110|NCT02262000|Radiation Therapy|radiation therapy
169111|NCT02261987|Autogenic drainage|autogenic drainage
169112|NCT02261987|Resistive inspiratory manoeuvre|resistive inspiratory manoeuvre
169113|NCT02261987|Computerized respiratory sounds|computerized respiratory sounds
664076|NCT00831259|embolism|embolism
169114|NCT02261987|Airway clearance techniques|airway clearance techniques
169115|NCT02261987|Mucus clearances|mucus clearances
169116|NCT02261974|Vaginal laxity|vaginal laxity
169117|NCT02261961|resistance exercise|resistance exercise
169118|NCT02261961|Juven|juven
169119|NCT02261961|exercise training|exercise training
169120|NCT02261961|interleukin-1|interleukin-1
169121|NCT02261961|insulin-like growth factor|insulin-like growth factor
169122|NCT02261948|Cardiac Failure|cardiac failure
169123|NCT02261948|Severe Heart Failure|severe heart failure
169124|NCT02261935|Family caregiver|family caregiver
169125|NCT02261935|Home care nursing practice|home care nursing practice
169126|NCT02261935|Palliative care|palliative care
169127|NCT02261935|End of life care|end of life care
169128|NCT02261935|Family caregiver quality of life|family caregiver quality of life
169129|NCT02261935|Family caregiver grief symptoms|family caregiver grief symptoms
169130|NCT02261935|Family caregiver burden|family caregiver burden
169131|NCT02261935|Family caregiver preparedness for caregiving|family caregiver preparedness for caregiving
169132|NCT02261935|Family caregiver perceived social supports|family caregiver perceived social supports
169133|NCT02261935|Family caregiver health status|family caregiver health status
169134|NCT02261935|Family caregiver satisfaction with healthcare provided|family caregiver satisfaction with healthcare provided
169135|NCT02261909|Emergency Medicine|emergency medicine
169136|NCT02261909|diagnosis|diagnosis
169137|NCT02261896|cyst|cyst
169138|NCT02261896|pancreatic cyst|pancreatic cyst
169139|NCT02261896|EUS-FNA|eus-fna
169140|NCT02261896|antibiotic prophylaxis|antibiotic prophylaxis
169141|NCT02261883|PPHN|pphn
169142|NCT02261870|MRI, T2 quantification|mri, t2 quantification
169145|NCT02261857|Pediatrics|pediatrics
169146|NCT02261857|Computer-Aided Design|computer-aided design
169147|NCT02261857|Continuous Positive Airway Pressure|continuous positive airway pressure
169148|NCT02261857|Three-Dimensional Printing|three-dimensional printing
169149|NCT02261857|Additive Manufacturing|additive manufacturing
169150|NCT02261844|Hepatocellular carcinoma|hepatocellular carcinoma
169151|NCT02261844|Metastatic colorectal cancer|metastatic colorectal cancer
169152|NCT02261844|Metabolism|metabolism
169153|NCT02261844|Hepatic function|hepatic function
169154|NCT02261831|bacterial|bacterial
169155|NCT02261831|gut|gut
169156|NCT02261831|type 2 diabetes.|type 2 diabetes.
169157|NCT02261831|16S rDNA gene|16s rdna gene
169158|NCT02261831|intestinal crypt|intestinal crypt
169159|NCT02261818|depression|depression
169160|NCT02261818|aging|aging
169161|NCT02261818|health services|health services
169162|NCT02261792|Postural headache treatment|postural headache treatment
169163|NCT02261792|Spontaneous intracranial hypotension|spontaneous intracranial hypotension
169164|NCT02261792|Epidural blood patch|epidural blood patch
169165|NCT02261792|Trendelenburg position|trendelenburg position
169166|NCT02261792|Head-Down Tilt|head-down tilt
169167|NCT02261792|Blood Patch, Epidural|blood patch, epidural
169168|NCT02261753|epilepsy surgery, outcome, ketogenic diet, ortical dysplasia|epilepsy surgery, outcome, ketogenic diet, ortical dysplasia
169169|NCT02261740|Pelvic Pain|pelvic pain
169170|NCT02261740|Genital Pain|genital pain
169171|NCT02261727|COPD|copd
169172|NCT02261727|Theophylline|theophylline
169173|NCT02261727|Oral corticosteroids|oral corticosteroids
169174|NCT02261727|COPD exacerbations|copd exacerbations
169175|NCT02261714|Pancreatic cancer, resected|pancreatic cancer, resected
169176|NCT02261714|Vaccine|vaccine
169177|NCT02261714|KRAS|kras
169179|NCT02261701|rotator cuff injury|rotator cuff injury
169180|NCT02261701|rehabilitation|rehabilitation
169181|NCT02261701|function|function
169182|NCT02261701|pain|pain
169183|NCT02261701|quality of life|quality of life
169184|NCT02261675|dexmedetomidine|dexmedetomidine
169185|NCT02261675|sevoflurane|sevoflurane
169186|NCT02261675|MAC bar|mac bar
169187|NCT02261675|drug interaction|drug interaction
169188|NCT02261675|anesthesia|anesthesia
169191|NCT02261610|PCT algorithm|pct algorithm
169192|NCT02261610|Antibiotic|antibiotic
169193|NCT02261610|Pulmonary embolism|pulmonary embolism
169194|NCT02261597|insomnia, inflammation, stress|insomnia, inflammation, stress
169195|NCT02261545|n-3 fatty acid|n-3 fatty acid
169196|NCT02261545|Sirt-1|sirt-1
169197|NCT02261545|AdipoR1|adipor1
169198|NCT02261545|AdipoR2|adipor2
169199|NCT02261545|MCP-1|mcp-1
169200|NCT02261545|Adiponectin|adiponectin
169201|NCT02261545|Resistin|resistin
169202|NCT02261545|T2DM|t2dm
169203|NCT02261506|Intensive care|intensive care
169204|NCT02261506|bacteremia|bacteremia
169205|NCT02261506|bloodstream infection|bloodstream infection
169206|NCT02261506|antimicrobial|antimicrobial
169207|NCT02261506|mortality|mortality
169208|NCT02261506|antimicrobial stewardship|antimicrobial stewardship
169209|NCT02261480|Parvovirus B19 Infection|parvovirus b19 infection
169210|NCT02261454|postoperative ileus|postoperative ileus
169211|NCT02261454|gum chewing|gum chewing
169212|NCT02261454|postoperative care|postoperative care
169213|NCT02261454|abdominal surgery|abdominal surgery
169214|NCT02261454|child|child
169215|NCT02261441|Cardiovascular disease|cardiovascular disease
169216|NCT02261441|Hypertension|hypertension
169217|NCT02261441|Diabetes|diabetes
169218|NCT02261441|Smoking|smoking
169219|NCT02261441|Hypercholesterolemia|hypercholesterolemia
169220|NCT02261441|Cardiovascular risk factor|cardiovascular risk factor
169221|NCT02261428|Nasotracheal suction, tracheal access|nasotracheal suction, tracheal access
169222|NCT02261415|blood transfusion|blood transfusion
169223|NCT02261415|blood loss|blood loss
169224|NCT02261415|feasibility|feasibility
169225|NCT02261415|outcome|outcome
169226|NCT02261415|liver resection|liver resection
169227|NCT02261402|Adherence|adherence
169228|NCT02261402|Morisky Medication Adherence Scale|morisky medication adherence scale
169229|NCT02261402|Beliefs about Medicines Questionnaire|beliefs about medicines questionnaire
169230|NCT02261402|Medication Possession Ratio|medication possession ratio
169231|NCT02261402|Medication-Related Problems|medication-related problems
169232|NCT02261402|Pharmacist|pharmacist
169233|NCT02261402|Pharmacist Intervention|pharmacist intervention
169234|NCT02261402|Pharmacy|pharmacy
169235|NCT02261402|Pharmacy Service|pharmacy service
169236|NCT02261402|Pharmacy Practice|pharmacy practice
169237|NCT02261402|Hypertension|hypertension
169238|NCT02261402|Antihypertensive Agents|antihypertensive agents
169239|NCT02261402|Anticoagulants|anticoagulants
169240|NCT02261402|Statins|statins
169241|NCT02261402|Dyslipidemia|dyslipidemia
169343|NCT02260505|Imatinib|imatinib
169246|NCT02261337|Sarcopenia|sarcopenia
169247|NCT02261324|Percutaneous coronary intervention|percutaneous coronary intervention
169248|NCT02261311|Breast|breast
169249|NCT02261220|advanced solid tumors|advanced solid tumors
169250|NCT02261220|durvalumab|durvalumab
169251|NCT02261220|tremelimumab|tremelimumab
169252|NCT02261194|depression|depression
169253|NCT02261194|age-related macular degeneration|age-related macular degeneration
169254|NCT02261194|self-care|self-care
169255|NCT02261194|self-help|self-help
169256|NCT02261181|head neck cancer XONRID radiation induced dermatitis|head neck cancer xonrid radiation induced dermatitis
169257|NCT02261168|Circadian Rhythm|circadian rhythm
169258|NCT02261051|Palliative Care|palliative care
169259|NCT02261051|Hospice|hospice
169260|NCT02261051|End of Life|end of life
169261|NCT02261051|Health Service Utilization|health service utilization
169262|NCT02261051|Quality of Life|quality of life
169263|NCT02261038|total knee arthroplasty|total knee arthroplasty
169264|NCT02261038|total knee prothesis|total knee prothesis
169265|NCT02261038|X-Ray|x-ray
169266|NCT02261038|Kanekasu radiographs|kanekasu radiographs
169267|NCT02261038|femoral component rotation|femoral component rotation
169268|NCT02261038|effects|effects
169269|NCT02261025|aspirin|aspirin
169270|NCT02260908|Trauma|trauma
169271|NCT02260908|Thromboprophylaxis|thromboprophylaxis
169272|NCT02260908|Intracranial haemorrhage|intracranial haemorrhage
169273|NCT02260908|Deep vein thrombosis|deep vein thrombosis
169274|NCT02260856|RCT|rct
169275|NCT02260856|Epiphysiodesis|epiphysiodesis
169276|NCT02260856|Tantalum beads|tantalum beads
169277|NCT02260856|Patient centered outcome data|patient centered outcome data
169278|NCT02260856|Cost effective analysis|cost effective analysis
169279|NCT02260843|Insomnia|insomnia
169280|NCT02260843|Sleeping|sleeping
169281|NCT02260843|Quality|quality
169282|NCT02260817|Prostate Cancer|prostate cancer
169283|NCT02260817|11C Choline|11c choline
169284|NCT02260817|PET Imaging|pet imaging
169286|NCT02260791|Arthritis|arthritis
169287|NCT02260778|Learning Collaborative|learning collaborative
169288|NCT02260778|Treat-to-Target|treat-to-target
169289|NCT02260778|Arthritis, Rheumatoid|arthritis, rheumatoid
169290|NCT02260765|Treatment as Usual = TAU|treatment as usual = tau
169291|NCT02260726|femoroacetabular impingement|femoroacetabular impingement
169292|NCT02260726|morphometry|morphometry
169293|NCT02260726|dynamic|dynamic
169294|NCT02260726|magnetic resonance imaging|magnetic resonance imaging
169295|NCT02260726|ultrasound|ultrasound
169296|NCT02260726|screening|screening
169297|NCT02260726|diagnosis|diagnosis
169298|NCT02260700|Healthy|healthy
169299|NCT02260700|Bioavailability|bioavailability
169300|NCT02260700|Alzheimer's Disease|alzheimer's disease
169301|NCT02260700|JNJ-54861911|jnj-54861911
169302|NCT02260687|Aflibercept|aflibercept
169303|NCT02260687|Anti-VEGF|anti-vegf
169304|NCT02260674|Alzheimer's Disease|alzheimer's disease
169305|NCT02260674|JNJ-54861911|jnj-54861911
169306|NCT02260674|Placebo|placebo
169307|NCT02260661|AZD8835|azd8835
169308|NCT02260661|Fulvestrant|fulvestrant
169309|NCT02260661|Breast Cancer|breast cancer
169310|NCT02260661|PIK3CA Gene Mutation|pik3ca gene mutation
169311|NCT02260622|Restenosis|restenosis
169312|NCT02260622|Critical Limb Ischemia|critical limb ischemia
169313|NCT02260622|Infrainguinal Percutaneous Transluminal Angioplasty|infrainguinal percutaneous transluminal angioplasty
169314|NCT02260622|Rivaroxaban|rivaroxaban
169315|NCT02260622|Clopidogrel|clopidogrel
169316|NCT02260609|Complex Wound|complex wound
169317|NCT02260609|Diabetic Foot Ulcer|diabetic foot ulcer
169318|NCT02260609|DFU|dfu
169319|NCT02260609|GrafixCORE|grafixcore
169320|NCT02260609|Exposed tendon|exposed tendon
169321|NCT02260609|Exposed bone|exposed bone
169322|NCT02260609|Allograft tissue|allograft tissue
169328|NCT02260557|Systemic Sclerosis|systemic sclerosis
169329|NCT02260557|Raynaud's Phenomenon|raynaud's phenomenon
169330|NCT02260531|Metastatic breast cancer and brain metastases|metastatic breast cancer and brain metastases
169331|NCT02260531|HER-2 Positive Breast Cancer|her-2 positive breast cancer
169332|NCT02260531|ER-Positive PR-Positive HER-2 Negative Breast Cancer|er-positive pr-positive her-2 negative breast cancer
169333|NCT02260531|ER-Negative PR-Negative HER2-Negative Breast Cancer|er-negative pr-negative her2-negative breast cancer
169334|NCT02260518|Gestational weight gain|gestational weight gain
169335|NCT02260518|Lifestyle intervention|lifestyle intervention
169336|NCT02260518|Pregnancy|pregnancy
169337|NCT02260518|Postpartum|postpartum
169338|NCT02260518|Physical activity|physical activity
169339|NCT02260518|Nutrition|nutrition
169340|NCT02260505|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
169341|NCT02260505|Non-metastatic|non-metastatic
169342|NCT02260505|KIT +|kit +
169344|NCT02260505|Adjuvant treatment|adjuvant treatment
169345|NCT02260505|High risk of recurrence|high risk of recurrence
169346|NCT02260505|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
169347|NCT02260505|Disease Free Survival|disease free survival
169348|NCT02260505|Overall survival|overall survival
169349|NCT02260505|Time To Secondary Resistance|time to secondary resistance
169350|NCT02260505|Safety profile|safety profile
169351|NCT02260505|Quality of Life during treatment|quality of life during treatment
169352|NCT02260479|skin disinfection|skin disinfection
169353|NCT02260479|bacterial colonization|bacterial colonization
169354|NCT02260479|perioperative|perioperative
169355|NCT02260479|chlorehexidine|chlorehexidine
169356|NCT02260466|Amyloidosis|amyloidosis
169357|NCT02260466|echocardiography|echocardiography
169358|NCT02260466|magnetic resonance imaging|magnetic resonance imaging
169359|NCT02260466|radionuclide imaging|radionuclide imaging
169360|NCT02260427|elective surgery|elective surgery
169361|NCT02260427|undergoing general anesthesia|undergoing general anesthesia
169362|NCT02260427|elderly adult patients|elderly adult patients
169363|NCT02260414|Endogenous Thrombin Potential|endogenous thrombin potential
169364|NCT02260414|Lymphoma|lymphoma
169365|NCT02260414|Multiple Myeloma|multiple myeloma
169366|NCT02260414|tinzaparin|tinzaparin
169367|NCT02260414|thrombin generation|thrombin generation
169368|NCT02260414|Thromboplastin generation tests|thromboplastin generation tests
169370|NCT02260388|neuropathy|neuropathy
169371|NCT02260388|pain|pain
169372|NCT02260388|pain management|pain management
169373|NCT02260375|Mesenchymal stromal cells; liver transplantation; tolerance.|mesenchymal stromal cells; liver transplantation; tolerance.
169374|NCT02260349|Prostatic Neoplasms|prostatic neoplasms
169375|NCT02260349|Prostate cancer|prostate cancer
169376|NCT02260349|surgical margins|surgical margins
169377|NCT02260349|indocyanine green|indocyanine green
169378|NCT02260349|characterization|characterization
169379|NCT02260349|prostatectomy|prostatectomy
169380|NCT02260349|peroperative|peroperative
169381|NCT02260349|detection|detection
169382|NCT02260297|Actigraphy|actigraphy
169383|NCT02260297|overweight and obese adults|overweight and obese adults
169384|NCT02260297|sleep disorders|sleep disorders
169385|NCT02260258|Cardiac Arrest, NMB, Neuromuscular Blockade, Rocuronium|cardiac arrest, nmb, neuromuscular blockade, rocuronium
169386|NCT02260219|Ahmed implant|ahmed implant
169388|NCT02260219|Intraocular pressure|intraocular pressure
169389|NCT02260206|Pericardial Effusion|pericardial effusion
169390|NCT02260206|Colchicine|colchicine
169391|NCT02260206|arrhythmia Recurrence|arrhythmia recurrence
169392|NCT02260206|pericardiocentesis|pericardiocentesis
169393|NCT02260193|anemia|anemia
169394|NCT02260193|end stage renal disease|end stage renal disease
169395|NCT02260193|chronic kidney disease|chronic kidney disease
169396|NCT02260193|CKD|ckd
169397|NCT02260193|dialysis|dialysis
169398|NCT02260193|chronic renal insufficiency|chronic renal insufficiency
169399|NCT02260193|renal impairment|renal impairment
169400|NCT02260193|erythropoietin|erythropoietin
169401|NCT02260193|kidney|kidney
169402|NCT02260193|oral anemia treatment|oral anemia treatment
160411|NCT02312115|DGF|dgf
160412|NCT02312102|myelodysplastic syndrome|myelodysplastic syndrome
160413|NCT02312102|acute myeloid leukemia|acute myeloid leukemia
160417|NCT02312063|DPP-4 inhibitor|dpp-4 inhibitor
169403|NCT02260193|hemoglobin|hemoglobin
169404|NCT02260193|hypoxia-inducible factor|hypoxia-inducible factor
169405|NCT02260193|HIF|hif
169406|NCT02260193|hypoxia-inducible factor propyl-hydroxylase inhibitor|hypoxia-inducible factor propyl-hydroxylase inhibitor
169407|NCT02260193|HIF-PHI|hif-phi
169408|NCT02260193|pharmacokinetics|pharmacokinetics
169409|NCT02260154|Duspatalin|duspatalin
169410|NCT02260154|mebeverine|mebeverine
169411|NCT02260154|cholecystectomy|cholecystectomy
169412|NCT02260154|gastrointestinal spasm|gastrointestinal spasm
169413|NCT02260154|abdominal pain|abdominal pain
169414|NCT02260154|dyspepsia|dyspepsia
169415|NCT02260154|antispasmodics|antispasmodics
665109|NCT00829114|HB sAg|hb sag
169416|NCT02260128|postoperative ileus|postoperative ileus
169417|NCT02260128|chewing gum|chewing gum
169418|NCT02259712|Women|women
169419|NCT02259712|Pelvic floor disorders|pelvic floor disorders
169420|NCT02259712|Urinary incontinence|urinary incontinence
169421|NCT02259712|Fecal incontinence|fecal incontinence
169422|NCT02259712|Physical Therapy Modalities|physical therapy modalities
169423|NCT02259699|Ovarian Cancer|ovarian cancer
169424|NCT02259699|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
169425|NCT02259699|Intravenous chemotherapy|intravenous chemotherapy
169426|NCT02259699|decision making|decision making
169427|NCT02259686|Apelin|apelin
169428|NCT02259686|volunteers|volunteers
169429|NCT02259660|obstructive sleep apnea|obstructive sleep apnea
169430|NCT02259660|osa|osa
169431|NCT02259660|breathing|breathing
169432|NCT02259660|snoring|snoring
169433|NCT02259660|respiratory|respiratory
169434|NCT02259660|exercise|exercise
169435|NCT02259660|inspiratory muscle strength training|inspiratory muscle strength training
169436|NCT02259660|expiratory muscle strength training|expiratory muscle strength training
169437|NCT02259634|Patient Navigation|patient navigation
169438|NCT02259634|Motivational Interviewing|motivational interviewing
169439|NCT02259634|Formerly Incarcerated|formerly incarcerated
169440|NCT02259634|Health Education|health education
169441|NCT02259634|Quality of Life|quality of life
169442|NCT02259634|Healthcare Utilization|healthcare utilization
169443|NCT02259608|Trained innate immunity|trained innate immunity
169444|NCT02259608|Heterologous effects of BCG on immunity|heterologous effects of bcg on immunity
169445|NCT02259595|Hearing Loss|hearing loss
169446|NCT02259595|Sensorineural Hearing Loss|sensorineural hearing loss
169447|NCT02259595|Noise-Induced Hearing Loss|noise-induced hearing loss
169448|NCT02259595|Antioxidant|antioxidant
169449|NCT02259595|NAC|nac
169450|NCT02259595|N-acetylcysteine|n-acetylcysteine
169451|NCT02259595|HPN-07|hpn-07
169452|NCT02259582|Phase 2|phase 2
169453|NCT02259582|histologically|histologically
169454|NCT02259582|confirmed|confirmed
169455|NCT02259582|malignancy|malignancy
169456|NCT02259582|metastatic|metastatic
169457|NCT02259582|pemetrexed|pemetrexed
169458|NCT02259582|carboplatin|carboplatin
169459|NCT02259582|carcinoma|carcinoma
169460|NCT02259582|non small cell lung|non small cell lung
169461|NCT02259582|lung neoplasms|lung neoplasms
169462|NCT02259582|lung diseases|lung diseases
169463|NCT02259569|Gastric insufflation|gastric insufflation
169464|NCT02259569|I-gel|i-gel
169465|NCT02259569|Peak airway pressure|peak airway pressure
169466|NCT02259569|Pressure-controlled ventilation|pressure-controlled ventilation
169467|NCT02259569|Volume-Controlled Ventilation|volume-controlled ventilation
169468|NCT02259569|pediatric patient|pediatric patient
169469|NCT02259543|gingival recession|gingival recession
169470|NCT02259543|soft tissue|soft tissue
169471|NCT02259543|root biomodification|root biomodification
169472|NCT02259543|root coverage|root coverage
169473|NCT02259543|citric acid|citric acid
169474|NCT02259543|tetracycline|tetracycline
169475|NCT02259517|ADHD|adhd
169476|NCT02259517|Intuniv|intuniv
169477|NCT02259517|Non-stimulant|non-stimulant
169478|NCT02259517|Guanfacine extended-release|guanfacine extended-release
169479|NCT02259517|Vyvanse|vyvanse
169480|NCT02259517|Stimulant|stimulant
169481|NCT02259517|Lisdexamfetamine|lisdexamfetamine
169482|NCT02259504|aneurysms|aneurysms
169483|NCT02259491|Wound Healing|wound healing
169484|NCT02259491|Honey|honey
169485|NCT02259491|Skin Grafts|skin grafts
169486|NCT02259491|Free tissue transfer|free tissue transfer
169487|NCT02259478|Intravenous Immunoglobulin (IVIG)|intravenous immunoglobulin (ivig)
169488|NCT02259478|Hemolysis|hemolysis
169489|NCT02259478|Transfusion Medicine|transfusion medicine
169490|NCT02259478|Pharmacovigilance|pharmacovigilance
169491|NCT02259465|microbiota|microbiota
169492|NCT02259465|FODMAP|fodmap
169493|NCT02259465|oligofructose|oligofructose
169494|NCT02259465|Magnetic Resonance Imaging|magnetic resonance imaging
169495|NCT02259465|Metabolomics|metabolomics
169496|NCT02259465|Diet|diet
169497|NCT02259452|Radiation Therapy|radiation therapy
169498|NCT02259413|Hemodialysis|hemodialysis
169499|NCT02259413|End-stage renal disease|end-stage renal disease
169500|NCT02259413|Exercise|exercise
169501|NCT02259413|Symptom Burden|symptom burden
169502|NCT02259400|NIV|niv
169503|NCT02259400|NSIPPV|nsippv
169504|NCT02259400|BiPAP|bipap
169505|NCT02259348|Hematological malignancies|hematological malignancies
169506|NCT02259348|Allogeneic hematopoietic cell transplant|allogeneic hematopoietic cell transplant
169507|NCT02259348|Refractory hematologic malignancy|refractory hematologic malignancy
169508|NCT02259348|Relapsed hematologic malignancy|relapsed hematologic malignancy
169509|NCT02259335|weaning from mechanical ventilation|weaning from mechanical ventilation
169510|NCT02259335|extracorporeal CO2 removal|extracorporeal co2 removal
169511|NCT02259335|post-extubation failure|post-extubation failure
169512|NCT02259322|Bariatric surgery|bariatric surgery
169513|NCT02259322|Weight loss surgery|weight loss surgery
665110|NCT00829114|ICH|ich
169514|NCT02259322|Behavioral weight loss treatment|behavioral weight loss treatment
169515|NCT02259322|Cognitive behavioral therapy|cognitive behavioral therapy
169516|NCT02259322|Behavioral treatment|behavioral treatment
169517|NCT02259322|Obesity|obesity
169518|NCT02259322|Morbid obesity|morbid obesity
169519|NCT02259322|Binge eating|binge eating
169520|NCT02259322|Binge eating disorder|binge eating disorder
169521|NCT02259322|Loss of control eating|loss of control eating
169522|NCT02259322|Overeating|overeating
169523|NCT02259309|misoprostol|misoprostol
169524|NCT02259309|mucosal|mucosal
169525|NCT02259309|cervical|cervical
169526|NCT02259309|immune|immune
169527|NCT02259309|buccal|buccal
169528|NCT02259309|vaginal|vaginal
169529|NCT02259283|achalasia|achalasia
169530|NCT02259283|per oral endoscopic myotoymy|per oral endoscopic myotoymy
169531|NCT02259283|endoscopy|endoscopy
169532|NCT02259270|Acid suppressive therapy|acid suppressive therapy
169533|NCT02259270|Appropriateness|appropriateness
169534|NCT02259270|Long term treatment|long term treatment
169535|NCT02259270|Risk factors|risk factors
169536|NCT02259270|Hospitalisation|hospitalisation
169537|NCT02259270|Non-critically ill|non-critically ill
169538|NCT02259270|Adult|adult
169539|NCT02259257|carotid arteriosclerosis|carotid arteriosclerosis
169540|NCT02259257|contrast-enhanced ultrasound|contrast-enhanced ultrasound
169541|NCT02259257|neovascularization|neovascularization
169542|NCT02259257|quantitative analysis|quantitative analysis
169543|NCT02259257|3D/4D imaging|3d/4d imaging
169545|NCT02259257|Vasa vasorum|vasa vasorum
169546|NCT02259231|RTA 408|rta 408
169547|NCT02259231|RTA 408 Capsules|rta 408 capsules
169548|NCT02259231|Myeloid-derived suppressor cells (MDSDs)|myeloid-derived suppressor cells (mdsds)
169549|NCT02259231|iNOS|inos
169550|NCT02259231|Melanoma|melanoma
169551|NCT02259231|Checkpoint inhibitor|checkpoint inhibitor
169552|NCT02259231|omaveloxolone|omaveloxolone
169553|NCT02259218|Biomarker|biomarker
169554|NCT02259218|Radiation|radiation
169555|NCT02259205|platelet activating factor|platelet activating factor
169556|NCT02259205|inflammatory markers|inflammatory markers
169557|NCT02259205|yogurt|yogurt
169558|NCT02259205|olive oil|olive oil
169559|NCT02259205|platelet aggregation|platelet aggregation
169560|NCT02259205|oxidative stress|oxidative stress
169561|NCT02259205|endothelial damage|endothelial damage
169562|NCT02259205|bioactive lipids|bioactive lipids
169563|NCT02259192|deaf adult|deaf adult
169564|NCT02259192|single-sided|single-sided
169565|NCT02259192|cochlear implant|cochlear implant
169566|NCT02259179|Obesity|obesity
169567|NCT02259179|Overweight|overweight
169568|NCT02259179|Contrave|contrave
169569|NCT02259179|Antiobesity agents|antiobesity agents
169570|NCT02259179|Antiobesity drugs|antiobesity drugs
169571|NCT02259179|Weight loss drug|weight loss drug
169572|NCT02259179|Bioequivalence|bioequivalence
169573|NCT02259179|Pharmacokinetic|pharmacokinetic
169574|NCT02259153|Lipids|lipids
169575|NCT02259153|Non Cholesterol Sterols|non cholesterol sterols
169576|NCT02259153|Oxysterols|oxysterols
169577|NCT02259153|Cholesterol Metabolism|cholesterol metabolism
169578|NCT02259140|cerebral palsy|cerebral palsy
169579|NCT02259140|randomized controlled trial|randomized controlled trial
169580|NCT02259140|hip dislocation|hip dislocation
169581|NCT02259140|hip subluxation|hip subluxation
169582|NCT02259140|patient centered outcomes|patient centered outcomes
169583|NCT02259140|cost effectiveness analysis|cost effectiveness analysis
169584|NCT02259088|DME, macular edema, vision impairment, Chinese, diabetes|dme, macular edema, vision impairment, chinese, diabetes
169585|NCT02259075|Migraine with aura|migraine with aura
169586|NCT02259075|Migraine without aura|migraine without aura
169587|NCT02259075|Headache disorders|headache disorders
169588|NCT02259075|Botulinum Toxin Type A|botulinum toxin type a
169589|NCT02259075|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
169590|NCT02259075|Autonomic Nerve Block|autonomic nerve block
169591|NCT02259036|child anxiety|child anxiety
169593|NCT02259036|fears|fears
169594|NCT02259036|talk therapy|talk therapy
169595|NCT02259023|Stress Perception|stress perception
169596|NCT02259023|Discretionary Calories|discretionary calories
169597|NCT02259023|Health|health
169598|NCT02258997|sickle cell disease|sickle cell disease
169599|NCT02258958|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
169600|NCT02258958|deep venous thrombosis|deep venous thrombosis
169601|NCT02258958|pulmonary embolus|pulmonary embolus
169602|NCT02258958|thoracic surgery|thoracic surgery
169603|NCT02258958|lung resection|lung resection
169604|NCT02258958|incidence|incidence
169605|NCT02258945|Type 1 diabetes|type 1 diabetes
169606|NCT02258945|CSII|csii
169607|NCT02258945|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
169608|NCT02258945|Insulin pump|insulin pump
169609|NCT02258945|Nutrition|nutrition
169610|NCT02258945|Eating behaviours|eating behaviours
169611|NCT02258945|Quality of life|quality of life
169612|NCT02258945|Cardiometabolic risks|cardiometabolic risks
169613|NCT02258945|Liverpool|liverpool
169614|NCT02258945|NHS|nhs
169615|NCT02258945|Metabolomics|metabolomics
169616|NCT02258945|Observational|observational
169617|NCT02258945|Lipoproteins|lipoproteins
169618|NCT02258945|Lipids|lipids
169619|NCT02258945|Food|food
169620|NCT02258945|Food diary|food diary
169621|NCT02258945|Cross-Sectional|cross-sectional
169622|NCT02258932|Type 1 diabetes|type 1 diabetes
169623|NCT02258932|CSII|csii
169624|NCT02258932|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
169625|NCT02258932|Insulin pump|insulin pump
169626|NCT02258932|Nutrition|nutrition
169627|NCT02258932|Eating behaviours|eating behaviours
169628|NCT02258932|Quality of life|quality of life
169629|NCT02258932|Cardiometabolic risks|cardiometabolic risks
169630|NCT02258932|Liverpool|liverpool
169631|NCT02258932|NHS|nhs
169632|NCT02258932|Metabolomics|metabolomics
169633|NCT02258932|Observational|observational
169634|NCT02258932|Lipoproteins|lipoproteins
169635|NCT02258932|Lipids|lipids
169636|NCT02258932|Food|food
169637|NCT02258932|Food diary|food diary
169638|NCT02258932|Longitudinal|longitudinal
169639|NCT02258919|Intracerebral hemorrhage|intracerebral hemorrhage
169640|NCT02258919|Decompressive craniectomy|decompressive craniectomy
169641|NCT02258919|Randomized controlled trial|randomized controlled trial
169642|NCT02258919|Acute stroke|acute stroke
169643|NCT02258893|Nitrogen Dioxide|nitrogen dioxide
169644|NCT02258893|Parts per billion|parts per billion
169645|NCT02258880|Acute Stroke|acute stroke
169646|NCT02258880|Outcome Measures|outcome measures
169647|NCT02258880|Physical Performance|physical performance
169648|NCT02258867|Uveitis|uveitis
169649|NCT02258867|Behcet's Disease Uveitis|behcet's disease uveitis
169650|NCT02258867|Behcet's Disease|behcet's disease
169651|NCT02258854|Uveitis|uveitis
169652|NCT02258854|Non-infectious Uveitis|non-infectious uveitis
169653|NCT02258854|Intermediate Uveitis|intermediate uveitis
169654|NCT02258854|Posterior Uveitis|posterior uveitis
169655|NCT02258854|Panuveitis|panuveitis
169656|NCT02258854|Behçet's disease uveitis|behçet's disease uveitis
169657|NCT02258841|domestic violence|domestic violence
169658|NCT02258841|mental health|mental health
169659|NCT02258841|safety planning|safety planning
169660|NCT02258815|pediatric|pediatric
169661|NCT02258815|haploidentical|haploidentical
169662|NCT02258815|stem cell transplantation|stem cell transplantation
169663|NCT02258802|psychoeducational intervention|psychoeducational intervention
169664|NCT02258802|nutrition intervention|nutrition intervention
169665|NCT02258802|malnutrition|malnutrition
169666|NCT02258802|micronutrient deficiency|micronutrient deficiency
169667|NCT02258802|nutrition transition|nutrition transition
169668|NCT02258789|Stroke, rehabilitation, spatial neglect|stroke, rehabilitation, spatial neglect
169669|NCT02258763|Pneumonia|pneumonia
169670|NCT02258763|Child|child
169671|NCT02258763|Outcome|outcome
169672|NCT02258763|Antibiotics|antibiotics
169673|NCT02258763|Etiology|etiology
169674|NCT02258737|Case management|case management
169675|NCT02258737|psychiatric hospitalization|psychiatric hospitalization
169676|NCT02258737|discharge|discharge
169677|NCT02258724|Adult|adult
169678|NCT02258724|Registry|registry
169679|NCT02258724|Grown-up congenital heart disease|grown-up congenital heart disease
169680|NCT02258711|Bipolar disorder|bipolar disorder
169681|NCT02258711|Psychoeducation|psychoeducation
169682|NCT02258711|Smart-phone monitoring|smart-phone monitoring
169683|NCT02258685|Gut microbiota composition|gut microbiota composition
169684|NCT02258672|Preoperative rehabilitation|preoperative rehabilitation
169685|NCT02258672|Minimally invasive surgery|minimally invasive surgery
169686|NCT02258672|Functional capacity|functional capacity
169687|NCT02258646|Exercise|exercise
169688|NCT02258646|Rehabilitation|rehabilitation
169689|NCT02258646|Telemedicine|telemedicine
169690|NCT02258646|Treatment Outcome|treatment outcome
169691|NCT02258646|Costs and Cost Analysis|costs and cost analysis
169692|NCT02258646|Physical Therapists|physical therapists
169693|NCT02258646|Adaptation, Psychological|adaptation, psychological
169694|NCT02258568|Cigarette Smoking|cigarette smoking
169695|NCT02258568|Pregnancy|pregnancy
169696|NCT02258568|Postpartum smoking relapse|postpartum smoking relapse
169697|NCT02258568|Romania|romania
169698|NCT02258555|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
169699|NCT02258555|Follicular lymphoma (FL)|follicular lymphoma (fl)
169700|NCT02258555|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
169701|NCT02258555|Phosphatidylinositol 3 kinase (PI3K)|phosphatidylinositol 3 kinase (pi3k)
169702|NCT02258555|Marginal Zone Lymphoma (MZL)|marginal zone lymphoma (mzl)
169703|NCT02258542|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
169704|NCT02258529|Cancer|cancer
169705|NCT02258529|Indolent Non-Hodgkin Lymphoma|indolent non-hodgkin lymphoma
169706|NCT02258529|FL|fl
169707|NCT02258529|SLL|sll
169708|NCT02258503|Numerical scale|numerical scale
169709|NCT02258503|Pain in elderly patients admitted in emergency department|pain in elderly patients admitted in emergency department
169710|NCT02258490|chronic myeloid leukemia|chronic myeloid leukemia
169711|NCT02258490|myelodysplastic syndrome|myelodysplastic syndrome
169712|NCT02258490|acute myeloid leukemia|acute myeloid leukemia
169713|NCT02258490|CD34+ cell mobilization therapy|cd34+ cell mobilization therapy
169714|NCT02258490|graft versus host disease|graft versus host disease
169715|NCT02258490|allogeneic hematopoietic stem cell|allogeneic hematopoietic stem cell
169716|NCT02258490|G-CSF|g-csf
169717|NCT02258464|Breast Cancer|breast cancer
169718|NCT02258451|Breast Cancer|breast cancer
169719|NCT02258438|Sedentary Behavior|sedentary behavior
169720|NCT02258425|Homeless Women|homeless women
169721|NCT02258425|Parolees|parolees
169722|NCT02258425|Probationers|probationers
169723|NCT02258425|Community Drug Treatment|community drug treatment
169724|NCT02258425|Recidivism|recidivism
169725|NCT02258412|antimicrobial|antimicrobial
169727|NCT02258412|hand|hand
169728|NCT02258412|hygiene|hygiene
169729|NCT02258412|bacteria|bacteria
169730|NCT02258373|Diabetes Mellitus|diabetes mellitus
169731|NCT02258373|Continuous Glucose Monitoring|continuous glucose monitoring
169732|NCT02258360|Thromboelastometry|thromboelastometry
169733|NCT02258360|Haemostasis|haemostasis
169734|NCT02258360|Hypothermia|hypothermia
169735|NCT02258360|Heart Arrest|heart arrest
169736|NCT02258334|Influenza|influenza
169737|NCT02258334|Fluzone® Quadrivalent, Influenza Vaccine|fluzone® quadrivalent, influenza vaccine
169738|NCT02258334|Fluzone® Intradermal, Influenza Vaccine|fluzone® intradermal, influenza vaccine
169739|NCT02258334|Fluzone® High-Dose, Influenza Vaccine|fluzone® high-dose, influenza vaccine
169740|NCT02258295|Lateral Humeral Epicondylitis|lateral humeral epicondylitis
169741|NCT02258295|Tendinitis|tendinitis
169742|NCT02258295|Tendinosis|tendinosis
169743|NCT02258295|Athletic Injuries|athletic injuries
169744|NCT02258295|Elbow Joint|elbow joint
169745|NCT02258295|Sports Medicine|sports medicine
169746|NCT02258204|Cerebral Infarct|cerebral infarct
169747|NCT02258204|Thrombolysis|thrombolysis
169748|NCT02258204|Tissue-type plasminogen activator|tissue-type plasminogen activator
169749|NCT02258204|Neuroprotection|neuroprotection
169750|NCT02258204|Anesthetic agent|anesthetic agent
169751|NCT02258204|Magnetic resonance imaging|magnetic resonance imaging
169753|NCT02258191|COPD|copd
169754|NCT02258191|telemonitoring|telemonitoring
169755|NCT02258165|ovarian cancer|ovarian cancer
169756|NCT02258165|imaging|imaging
169757|NCT02258165|gated PET/CT scan|gated pet/ct scan
169759|NCT02258152|Parkinson's Disease Dementia|parkinson's disease dementia
169760|NCT02258152|patients taking a cholinesterase inhibitor.|patients taking a cholinesterase inhibitor.
169761|NCT02258126|overweight children|overweight children
169762|NCT02258126|hepatic fat|hepatic fat
169763|NCT02258126|exercise|exercise
169764|NCT02258126|nutritional education program|nutritional education program
169765|NCT02258126|cardiometabolic risk|cardiometabolic risk
169766|NCT02258087|Prostate, Cancer, Brachytherapy, HDR, LDR, monotherapy|prostate, cancer, brachytherapy, hdr, ldr, monotherapy
169767|NCT02258048|Cirrhosis|cirrhosis
169768|NCT02258035|vitamin D binding protein (DBP)|vitamin d binding protein (dbp)
169769|NCT02258022|Wounds and Injuries|wounds and injuries
169770|NCT02258022|Sepsis|sepsis
169771|NCT02257996|Psychoanalytic Psychotherapy|psychoanalytic psychotherapy
169772|NCT02257996|Telepsychology|telepsychology
169773|NCT02257996|Online Therapy|online therapy
169774|NCT02257996|Web conferencing|web conferencing
169775|NCT02257996|RCT|rct
169776|NCT02257996|HIPAA|hipaa
169777|NCT02257983|hearing|hearing
169778|NCT02257983|noise|noise
169779|NCT02257983|oxidative stress|oxidative stress
169780|NCT02257970|Lymphedema|lymphedema
169781|NCT02257970|edema|edema
169782|NCT02257970|swelling|swelling
169783|NCT02257931|infection|infection
169784|NCT02257931|bacteria|bacteria
169785|NCT02257931|gram-negative|gram-negative
169786|NCT02257931|HSCT|hsct
169787|NCT02257931|allogeneic|allogeneic
169788|NCT02257931|autologous|autologous
169789|NCT02257931|recipients, of all ages, for any indications|recipients, of all ages, for any indications
169790|NCT02257918|antibiotic|antibiotic
169791|NCT02257918|antimicrobial|antimicrobial
169792|NCT02257918|AZD0914|azd0914
169793|NCT02257918|Ceftriaxone|ceftriaxone
169794|NCT02257918|drug-resistant|drug-resistant
169795|NCT02257918|sexually transmitted infection|sexually transmitted infection
169796|NCT02257918|urogenital gonorrhoea|urogenital gonorrhoea
169797|NCT02257905|AL Amyloidosis|al amyloidosis
169798|NCT02257905|Amyloidosis|amyloidosis
169799|NCT02257905|allogeneic|allogeneic
169800|NCT02257905|HSCT|hsct
169801|NCT02257892|CTLA4|ctla4
169802|NCT02257892|PI3KCD|pi3kcd
169803|NCT02257892|MAG T1|mag t1
169804|NCT02257892|Rare Immune Disorders|rare immune disorders
169805|NCT02257892|Genetic Testing|genetic testing
169806|NCT02257879|Midazolam|midazolam
169807|NCT02257879|CYP3A|cyp3a
169808|NCT02257879|Loperamide|loperamide
169809|NCT02257866|Autoimmunity|autoimmunity
169810|NCT02257866|Adult and Pediatric Disease|adult and pediatric disease
169811|NCT02257866|Vasculitis|vasculitis
169812|NCT02257866|Rheumatic Disease|rheumatic disease
169813|NCT02257853|Caregiver Stress|caregiver stress
169814|NCT02257853|Cancer Caregivers|cancer caregivers
169815|NCT02257853|Yoga-Based Stress Reduction Intervention|yoga-based stress reduction intervention
169816|NCT02257853|HSCT Caregivers|hsct caregivers
169817|NCT02257827|Hypofractionated schedule|hypofractionated schedule
169818|NCT02257827|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
169819|NCT02257827|Conformal radiotherapy|conformal radiotherapy
169820|NCT02257801|Memory|memory
169821|NCT02257801|Cognition|cognition
169822|NCT02257801|Execute Function|execute function
169823|NCT02257801|Attention|attention
169824|NCT02257801|Mood|mood
169825|NCT02257762|Ready-to-use supplementary food (RUSF)|ready-to-use supplementary food (rusf)
169826|NCT02257762|Lipid-based nutrient supplement (LNS)|lipid-based nutrient supplement (lns)
169827|NCT02257762|Multiple micronutrients (MMN)|multiple micronutrients (mmn)
169828|NCT02257762|Complementary feeding|complementary feeding
169829|NCT02257762|Home fortification|home fortification
169830|NCT02257762|Efficacy/impact|efficacy/impact
169831|NCT02257762|Infant and young child feeding (IYCF)|infant and young child feeding (iycf)
169832|NCT02257762|Cambodia|cambodia
169833|NCT02257762|Cluster randomised controlled trial|cluster randomised controlled trial
169834|NCT02257749|Concussion|concussion
169835|NCT02257749|Persistent Symptoms|persistent symptoms
169836|NCT02257749|Children|children
169837|NCT02257749|Exercise|exercise
169838|NCT02257749|Adolescents|adolescents
169839|NCT02257749|Active Rehabilitation|active rehabilitation
169840|NCT02257749|Education|education
169841|NCT02257736|Prostatic neoplasms|prostatic neoplasms
169842|NCT02257736|JN56021927|jn56021927
169843|NCT02257736|ZYTIGA|zytiga
169844|NCT02257736|Prednisone|prednisone
169845|NCT02257736|Abiraterone acetate|abiraterone acetate
169846|NCT02257736|Apalutamide|apalutamide
169847|NCT02257723|Inpatient care|inpatient care
169848|NCT02257723|Complementary and alternative medicine|complementary and alternative medicine
169849|NCT02257723|Integrated medicine|integrated medicine
169850|NCT02257710|national|national
169851|NCT02257710|Multicenter|multicenter
169852|NCT02257710|Observational registry|observational registry
169853|NCT02257710|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
169854|NCT02257710|Stenting|stenting
169855|NCT02257710|Treatment of coronary artery disease|treatment of coronary artery disease
169856|NCT02257710|Coronary revascularization|coronary revascularization
169857|NCT02257710|Coronary Intervention|coronary intervention
169858|NCT02257710|STEMI|stemi
169859|NCT02257710|NSTEMI|nstemi
169860|NCT02257710|Ischemia|ischemia
169861|NCT02257710|Angina|angina
169862|NCT02257710|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
169863|NCT02257710|Small Vessels|small vessels
169864|NCT02257710|Chronic Total Occlusion|chronic total occlusion
169865|NCT02257684|ALL|all
169866|NCT02257684|LBL|lbl
169867|NCT02257658|Men who have Sex with Men|men who have sex with men
169868|NCT02257658|HIV-positive|hiv-positive
169869|NCT02257658|Syphilis|syphilis
169870|NCT02257658|Contingency Management|contingency management
169871|NCT02257619|Stage IIIb, IV, or Recurrent Non-Small Cell Lung Cancer|stage iiib, iv, or recurrent non-small cell lung cancer
169872|NCT02257593|macronutrient|macronutrient
169873|NCT02257593|malnutrition|malnutrition
169874|NCT02257593|birth weight|birth weight
169875|NCT02257593|protein leverage|protein leverage
169876|NCT02257580|E-Aminocaproic Acid|e-aminocaproic acid
169877|NCT02257580|Bilateral Varus Rotational Osteotomy|bilateral varus rotational osteotomy
169878|NCT02257580|Blood Loss and Transfusion|blood loss and transfusion
169879|NCT02257580|Complications|complications
169880|NCT02257580|Safety|safety
169882|NCT02257541|BGJ398|bgj398
169883|NCT02257541|Imatinib Mesylate|imatinib mesylate
169884|NCT02257541|14-140|14-140
169885|NCT02257502|aflibercept|aflibercept
402929|NCT01229046|presumed sepsis|presumed sepsis
169886|NCT02257502|iodiopathic choroidal neovascularization|iodiopathic choroidal neovascularization
169887|NCT02257502|young patient|young patient
169888|NCT02257476|carfilzomib|carfilzomib
169889|NCT02257476|advanced solid malignancies|advanced solid malignancies
169890|NCT02257476|advanced solid cancers|advanced solid cancers
169891|NCT02257476|prostate|prostate
169892|NCT02257476|bladder|bladder
169893|NCT02257476|colon|colon
169894|NCT02257476|breast|breast
169895|NCT02257476|lung|lung
169896|NCT02257463|COPD|copd
169897|NCT02257463|inspiratory muscle training|inspiratory muscle training
169898|NCT02257463|dyspnea|dyspnea
169899|NCT02257463|Quality of Life|quality of life
169900|NCT02257450|Primary Aldosteronism|primary aldosteronism
169901|NCT02257450|Hyperaldosteronism|hyperaldosteronism
169902|NCT02257437|Ready-to-use supplementary food (RUSF)|ready-to-use supplementary food (rusf)
401983|NCT01232452|non-small cell|non-small cell
169903|NCT02257437|Lipid-based nutrient supplement (LNS)|lipid-based nutrient supplement (lns)
169904|NCT02257437|Multiple micronutrients (MMN)|multiple micronutrients (mmn)
169905|NCT02257437|Complementary feeding|complementary feeding
169906|NCT02257437|Home fortification|home fortification
169907|NCT02257437|Acceptability|acceptability
169908|NCT02257437|Infant and young child feeding (IYCF)|infant and young child feeding (iycf)
169909|NCT02257437|Cambodia|cambodia
169910|NCT02257437|Cross-over studies|cross-over studies
169911|NCT02257411|child|child
169912|NCT02257411|ear based|ear based
169913|NCT02257411|Proseal LMA|proseal lma
169914|NCT02257398|TQTc|tqtc
169915|NCT02257398|Moxifloxacin|moxifloxacin
169916|NCT02257398|GSK2140944|gsk2140944
169917|NCT02257385|indacaterol|indacaterol
169918|NCT02257385|efficacy|efficacy
169919|NCT02257385|FEV1|fev1
169920|NCT02257385|ELLIPTA|ellipta
169921|NCT02257385|non inferiority|non inferiority
169922|NCT02257385|vilanterol|vilanterol
169923|NCT02257385|COPD|copd
169924|NCT02257385|safety|safety
169925|NCT02257385|tiotropium|tiotropium
169926|NCT02257385|umeclidinium bromide|umeclidinium bromide
169927|NCT02257385|GSK573719|gsk573719
169928|NCT02257372|FEV1|fev1
169929|NCT02257372|DPI|dpi
169930|NCT02257372|ICS/LABA|ics/laba
169931|NCT02257372|UMEC|umec
169932|NCT02257372|COPD|copd
169933|NCT02257359|Epelsiban|epelsiban
169934|NCT02257359|Healthy Female Volunteers|healthy female volunteers
169935|NCT02257359|Safety|safety
169936|NCT02257359|Tolerability|tolerability
169937|NCT02257359|Oxytocin|oxytocin
169938|NCT02257359|Pharmacokinetics|pharmacokinetics
169939|NCT02257346|Pregnancy|pregnancy
169940|NCT02257346|Lidocaine|lidocaine
169941|NCT02257346|Quality|quality
169942|NCT02257346|Recovery|recovery
169943|NCT02257333|Retinal Vein Occlusion|retinal vein occlusion
169944|NCT02257333|Atherosclerosis|atherosclerosis
169945|NCT02257333|Risk Factors|risk factors
169946|NCT02257333|Major Adverse Cardiovascular Events|major adverse cardiovascular events
169947|NCT02257307|ROP|rop
169948|NCT02257307|retinopathy|retinopathy
169949|NCT02257307|Referral warranted retinopathy|referral warranted retinopathy
169950|NCT02257281|Sodium lauryl sulfate|sodium lauryl sulfate
169951|NCT02257281|Skin irritants|skin irritants
169952|NCT02257281|inflammation|inflammation
169953|NCT02257281|therapeutic ultrasound|therapeutic ultrasound
169954|NCT02257268|health behavior; risk factors;|health behavior; risk factors;
169955|NCT02257255|cesarean section|cesarean section
169956|NCT02257255|pain, postoperative/diagnosis|pain, postoperative/diagnosis
169957|NCT02257255|pain measurement/methods|pain measurement/methods
169958|NCT02257242|Bendamustine|bendamustine
169959|NCT02257242|Rituximab|rituximab
169960|NCT02257242|Vincristine sulfate|vincristine sulfate
169961|NCT02257242|Vincristine sulfate liposome injection|vincristine sulfate liposome injection
169962|NCT02257242|Phase I|phase i
169963|NCT02257242|Escalation With Overdose Control|escalation with overdose control
169964|NCT02257229|Feet, deformity, correction, management, gait|feet, deformity, correction, management, gait
169965|NCT02257203|Dietary sucrose|dietary sucrose
169966|NCT02257190|Glycemic control|glycemic control
169967|NCT02257190|Exercise|exercise
169968|NCT02257164|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
169969|NCT02257164|femoral nerve block|femoral nerve block
169970|NCT02257164|articular injection and obturator nerve block|articular injection and obturator nerve block
169971|NCT02257151|Volunteers|volunteers
169972|NCT02257138|Leukemia|leukemia
169973|NCT02257138|Myeloproliferative Diseases|myeloproliferative diseases
169974|NCT02257138|Acute Myeloid Leukemia|acute myeloid leukemia
169975|NCT02257138|AML|aml
169976|NCT02257138|Ruxolitinib|ruxolitinib
169977|NCT02257138|Jakafi|jakafi
169978|NCT02257138|INCB018424|incb018424
169979|NCT02257138|INC424|inc424
169980|NCT02257138|Decitabine|decitabine
169981|NCT02257138|Dacogen|dacogen
169982|NCT02257138|Post myeloproliferative neoplasm|post myeloproliferative neoplasm
169983|NCT02257138|Post MPN-AML|post mpn-aml
169984|NCT02257125|rehabilitation|rehabilitation
169985|NCT02257125|virtual reality|virtual reality
169986|NCT02257125|stroke|stroke
169987|NCT02257125|upper extremity|upper extremity
169988|NCT02257125|arm|arm
169989|NCT02257125|feedback|feedback
169990|NCT02257125|reward|reward
169991|NCT02257060|Endocardial Ablation|endocardial ablation
169992|NCT02257060|Atrial Flutter|atrial flutter
169993|NCT02257060|Cavotricuspid Isthmus|cavotricuspid isthmus
169994|NCT02256995|Pregnancy|pregnancy
169995|NCT02256995|Preeclampsia|preeclampsia
169996|NCT02256995|Eclampsia|eclampsia
169997|NCT02256995|Proteinuria|proteinuria
169998|NCT02256982|unresectable intrahepatic cholangiocarcinoma|unresectable intrahepatic cholangiocarcinoma
169999|NCT02256982|resectable intrahepatic cholangiocarcinoma|resectable intrahepatic cholangiocarcinoma
170000|NCT02256956|Pharmacogenetics of Amitriptyline|pharmacogenetics of amitriptyline
170001|NCT02256943|Pharmacogenetics of Amitriptyline|pharmacogenetics of amitriptyline
170002|NCT02256904|Alignment|alignment
170003|NCT02256904|Kinematic|kinematic
170004|NCT02256904|knee|knee
170005|NCT02256904|satisfaction|satisfaction
170006|NCT02256904|function|function
170007|NCT02256904|survivorship|survivorship
170008|NCT02256891|Rotator cuff tear|rotator cuff tear
170009|NCT02256891|Rotator cuff injury|rotator cuff injury
170010|NCT02256891|Shoulder pain|shoulder pain
170011|NCT02256891|Shoulder injury|shoulder injury
170012|NCT02256865|Sleep Restriction|sleep restriction
170013|NCT02256865|Insulin Resistance|insulin resistance
170014|NCT02256865|Testosterone|testosterone
170015|NCT02256865|Cortisol|cortisol
170016|NCT02256839|Tuberculosis|tuberculosis
170017|NCT02256839|TB|tb
170018|NCT02256683|atrial fibrillation|atrial fibrillation
170019|NCT02256683|atrial flutter|atrial flutter
170020|NCT02256683|Atrial-Appendage Thrombus|atrial-appendage thrombus
170021|NCT02256683|Thrombus resolution|thrombus resolution
170022|NCT02256683|Dabigatran|dabigatran
170023|NCT02256683|Phenprocoumon|phenprocoumon
170024|NCT02256683|Transesophageal Echocardiography|transesophageal echocardiography
170025|NCT02256670|Hormone Receptor Positive|hormone receptor positive
170026|NCT02256618|neonatal encephalopathy|neonatal encephalopathy
170027|NCT02256618|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
170028|NCT02256618|newborn infants|newborn infants
170029|NCT02256618|neonates|neonates
170030|NCT02256618|umbilical cord blood cells|umbilical cord blood cells
170031|NCT02256592|inflammation|inflammation
170032|NCT02256592|microbiome|microbiome
170033|NCT02256592|immune activation|immune activation
170034|NCT02256592|fecal microbiota transplantation|fecal microbiota transplantation
170035|NCT02256592|dysbiosis|dysbiosis
170036|NCT02256579|TDF:Tenofovir, Urine beta2microglobulin|tdf:tenofovir, urine beta2microglobulin
170331|NCT02255032|microneedle|microneedle
170037|NCT02256566|cognitive training|cognitive training
170038|NCT02256566|depression|depression
170039|NCT02256566|bipolar depression|bipolar depression
170040|NCT02256566|anxiety|anxiety
170041|NCT02256566|ptsd|ptsd
170042|NCT02256566|generalized anxiety|generalized anxiety
170043|NCT02256566|social phobia|social phobia
170044|NCT02256514|therapeutic vaccine|therapeutic vaccine
170045|NCT02256501|Dilated cardiomyopathy pediatric heart failure cell therapy|dilated cardiomyopathy pediatric heart failure cell therapy
170046|NCT02256449|Coronary artery disease; angioplasty; bioresorbable device|coronary artery disease; angioplasty; bioresorbable device
170047|NCT02256436|P-D1|p-d1
170048|NCT02256436|PD-1|pd-1
170049|NCT02256436|PD1|pd1
170050|NCT02256436|P-DL1|p-dl1
170051|NCT02256436|PD-L1|pd-l1
170052|NCT02256436|PDL-1|pdl-1
170053|NCT02256436|PDL1|pdl1
170054|NCT02256436|Bladder cancer|bladder cancer
170055|NCT02256423|Ibuprofen|ibuprofen
170056|NCT02256423|healthy volunteer study|healthy volunteer study
170057|NCT02256423|pharmacokinetics|pharmacokinetics
170058|NCT02256410|low back pain|low back pain
170059|NCT02256410|chronic pain|chronic pain
170060|NCT02256410|sensitization|sensitization
170061|NCT02256410|treatment|treatment
170062|NCT02256410|trigger points|trigger points
170063|NCT02256397|Asthma|asthma
170064|NCT02256384|Respiration Rate|respiration rate
170065|NCT02256384|Respiratory Acoustic Monitor|respiratory acoustic monitor
170066|NCT02256384|postoperative|postoperative
170067|NCT02256371|Neuropathic pain|neuropathic pain
170068|NCT02256371|Hypnosis|hypnosis
170069|NCT02256371|Relaxation|relaxation
170070|NCT02256358|child, ketamine, midazolam|child, ketamine, midazolam
170071|NCT02256319|Deep brain stimulation|deep brain stimulation
170072|NCT02256319|Dexmedetomidine|dexmedetomidine
170073|NCT02256319|Propofol|propofol
170074|NCT02256293|Type 1 Diabetes|type 1 diabetes
170075|NCT02256280|Neuromuscular blockade|neuromuscular blockade
170076|NCT02256280|Thoracic surgery|thoracic surgery
170077|NCT02256254|Oxidative stress|oxidative stress
170078|NCT02256254|Simvastatin|simvastatin
170079|NCT02256228|Analgesia|analgesia
170080|NCT02256228|Local infiltration analgesia|local infiltration analgesia
170081|NCT02256228|Pain, relief|pain, relief
170082|NCT02256228|Pain, Postoperative|pain, postoperative
170083|NCT02256228|Intra-peritoneal analgesia|intra-peritoneal analgesia
170084|NCT02256228|Ropivacaine|ropivacaine
170086|NCT02256228|Therapeutic Uses|therapeutic uses
170087|NCT02256228|Analgesics, Non-Narcotic|analgesics, non-narcotic
170088|NCT02256228|Analgesics|analgesics
170089|NCT02256228|Opioids|opioids
170090|NCT02256228|Morphine|morphine
170091|NCT02256228|Pain|pain
170092|NCT02256228|Postoperative Complications|postoperative complications
170093|NCT02256228|Physiological Effects of Drugs|physiological effects of drugs
170094|NCT02256228|Anesthetics, Local|anesthetics, local
170095|NCT02256228|Anesthetic|anesthetic
170096|NCT02256228|Cytoreductive|cytoreductive
170097|NCT02256228|Surgery|surgery
170098|NCT02256228|Cancer|cancer
170099|NCT02256215|Vitamin D|vitamin d
170100|NCT02256163|Thoracic Aortic Aneurysm (TAA)|thoracic aortic aneurysm (taa)
170101|NCT02256163|gene|gene
170102|NCT02256163|familial TAA|familial taa
170103|NCT02256163|blood collection|blood collection
170104|NCT02256137|Frailty phenotype|frailty phenotype
170105|NCT02256137|Physical fitness|physical fitness
170106|NCT02256137|Childhood cancer|childhood cancer
170107|NCT02256137|Late onset of chronic health conditions|late onset of chronic health conditions
170108|NCT02256137|Physical frailty|physical frailty
170109|NCT02256124|Neurofibromatosis type 1|neurofibromatosis type 1
170110|NCT02256124|NF1|nf1
170111|NCT02256124|Cognition|cognition
170112|NCT02256124|Learning problems|learning problems
170113|NCT02256124|Lamotrigine|lamotrigine
170114|NCT02256124|Transcranial magnetic stimulation|transcranial magnetic stimulation
170115|NCT02256124|TMS|tms
170116|NCT02256098|Comparative Study|comparative study
170117|NCT02256098|Knee Prosthesis|knee prosthesis
170118|NCT02256098|Prosthesis Design|prosthesis design
170119|NCT02256098|Treatment Outcome|treatment outcome
170120|NCT02256098|Follow-Up Studies|follow-up studies
170121|NCT02256098|Arthroplasty, Replacement, Knee/methods|arthroplasty, replacement, knee/methods
170122|NCT02256085|Dissociative|dissociative
170123|NCT02256085|Dissociation|dissociation
170124|NCT02256085|Depersonalization|depersonalization
170125|NCT02256085|Depersonalization Disorder|depersonalization disorder
170126|NCT02256085|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
170127|NCT02256085|TMS|tms
170128|NCT02256085|DPD|dpd
170129|NCT02256085|rTMS|rtms
170130|NCT02256085|Behavioral Symptoms|behavioral symptoms
170131|NCT02256072|aging, geriatrics, aging in place, home services|aging, geriatrics, aging in place, home services
170132|NCT02256033|Mild hepatic impairment|mild hepatic impairment
170133|NCT02256033|Healthy volunteer|healthy volunteer
170134|NCT02256033|Istradefylline|istradefylline
170135|NCT02256020|Wheel-chair dependent, music aerobic exercise, depression, insomnia|wheel-chair dependent, music aerobic exercise, depression, insomnia
170926|NCT02251678|Interleuken|interleuken
170136|NCT02256007|Videogames; stroke|videogames; stroke
170137|NCT02255981|macular, degeneration, acupuncture, visual acuity, OCT|macular, degeneration, acupuncture, visual acuity, oct
170138|NCT02255968|Normal Volunteers|normal volunteers
170139|NCT02255968|Safety|safety
170140|NCT02255968|Pharmacokinetics|pharmacokinetics
170141|NCT02255955|naproxen sodium codeine|naproxen sodium codeine
170142|NCT02255955|paracetamol codeine|paracetamol codeine
170143|NCT02255955|disk surgery|disk surgery
170144|NCT02255929|Benign Essential Tremor|benign essential tremor
170145|NCT02255929|Tremor|tremor
170146|NCT02255929|Neurologic Manifestations|neurologic manifestations
170147|NCT02255929|Nervous System Diseases|nervous system diseases
170148|NCT02255929|Movement Disorders|movement disorders
170149|NCT02255929|Central Nervous System Diseases|central nervous system diseases
170150|NCT02255916|oncology|oncology
170151|NCT02255916|psychology|psychology
170152|NCT02255916|cancer|cancer
170153|NCT02255916|music|music
170154|NCT02255916|sound-bed|sound-bed
170155|NCT02255877|Bi lateral knee surgery|bi lateral knee surgery
170156|NCT02255877|uni compartmental|uni compartmental
170157|NCT02255864|Stents|stents
170158|NCT02255864|Angioplasty|angioplasty
170159|NCT02255864|Coronary Vessels|coronary vessels
170160|NCT02255864|Coronary Artery Disease|coronary artery disease
170161|NCT02255864|Angina Pectoris|angina pectoris
170162|NCT02255864|Myocardial Ischemia|myocardial ischemia
170163|NCT02255864|Myocardial Infarction|myocardial infarction
170164|NCT02255864|Myocardial Revascularization|myocardial revascularization
170165|NCT02255851|selected for TAVR by heart team consensus|selected for tavr by heart team consensus
170166|NCT02255851|treated with CE-Marked TAVR devices|treated with ce-marked tavr devices
170167|NCT02255799|traumatic brain injury|traumatic brain injury
170168|NCT02255799|TBI|tbi
170169|NCT02255799|brain injury|brain injury
170170|NCT02255799|memory|memory
170171|NCT02255799|verbal memory deficits|verbal memory deficits
170172|NCT02255799|memory problems|memory problems
170173|NCT02255799|cognition|cognition
170174|NCT02255799|cognitive impairment|cognitive impairment
170175|NCT02255799|neuropsychiatric symptoms|neuropsychiatric symptoms
170176|NCT02255799|donepezil|donepezil
170177|NCT02255799|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
170178|NCT02255786|Group Therapy|group therapy
170179|NCT02255786|Parents|parents
170180|NCT02255786|Autism|autism
170181|NCT02255786|Quality of Life|quality of life
170182|NCT02255773|Head and Neck Cancer|head and neck cancer
170183|NCT02255773|HNC|hnc
170184|NCT02255773|Moderate to severe fatigue|moderate to severe fatigue
170185|NCT02255773|Computerized tasks|computerized tasks
170186|NCT02255773|Questionnaires|questionnaires
170187|NCT02255773|Surveys|surveys
170188|NCT02255773|Disease-free adult males|disease-free adult males
170189|NCT02255773|Cancer survivors|cancer survivors
170190|NCT02255760|MEDI3902, Safety, Pharmacokinetics|medi3902, safety, pharmacokinetics
170191|NCT02255747|infants and children with constipation|infants and children with constipation
170192|NCT02255734|Volunteers|volunteers
170193|NCT02255695|posture|posture
170194|NCT02255695|child|child
170195|NCT02255695|prevention|prevention
170196|NCT02255695|muscle strength|muscle strength
170197|NCT02255695|muscle stretching exercises|muscle stretching exercises
170198|NCT02255695|exercise therapy|exercise therapy
170199|NCT02255695|disease management|disease management
170200|NCT02255695|musculoskeletal pain|musculoskeletal pain
170201|NCT02255695|adolescent|adolescent
170202|NCT02255695|spinal curvatures|spinal curvatures
170203|NCT02255682|physical activity|physical activity
170204|NCT02255682|statin therapy|statin therapy
170205|NCT02255682|diabetes mellitus|diabetes mellitus
170206|NCT02255682|cardiovascular disease|cardiovascular disease
170207|NCT02255682|Q10-supplementation|q10-supplementation
170208|NCT02255643|motor cortex stimulation|motor cortex stimulation
170209|NCT02255643|chronic neuropathic pain|chronic neuropathic pain
170210|NCT02255630|salbutamol|salbutamol
170211|NCT02255630|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
170212|NCT02255630|anaerobic power|anaerobic power
170213|NCT02255604|Allergic Rhinitis|allergic rhinitis
170214|NCT02255604|Allergen immunotherapy|allergen immunotherapy
170215|NCT02255591|Hip surgery anesthesia|hip surgery anesthesia
170216|NCT02255591|Perioperative analgesia|perioperative analgesia
170217|NCT02255565|Quillivant|quillivant
170218|NCT02255552|DMD, Duchenne, Eteplirsen, dystrophy, dystrophin, exon 51|dmd, duchenne, eteplirsen, dystrophy, dystrophin, exon 51
170219|NCT02255500|Total knee arthroplasty|total knee arthroplasty
170220|NCT02255487|surgical device|surgical device
170221|NCT02255487|surgical irrigation device|surgical irrigation device
170222|NCT02255487|surgical site infection prophylaxis|surgical site infection prophylaxis
170223|NCT02255474|pediatrics|pediatrics
170224|NCT02255474|refractive error - myopia|refractive error - myopia
170225|NCT02255474|contact lenses|contact lenses
170226|NCT02255474|intervention|intervention
170227|NCT02255435|RTA 408|rta 408
170228|NCT02255435|RTA 408 Capsules|rta 408 capsules
170229|NCT02255435|Oxidative Stress|oxidative stress
170230|NCT02255435|Mitochondrial dysfunction|mitochondrial dysfunction
170231|NCT02255435|omaveloxolone|omaveloxolone
170232|NCT02255422|omaveloxolone|omaveloxolone
170233|NCT02255422|RTA 408 capsules|rta 408 capsules
170234|NCT02255422|mitochondrial myopathies|mitochondrial myopathies
170235|NCT02255383|Osteoarthritis|osteoarthritis
170236|NCT02255383|Rheumatoid Arthritis|rheumatoid arthritis
170237|NCT02255383|Traumatic Arthritis|traumatic arthritis
170238|NCT02255383|Polyarthritis|polyarthritis
170239|NCT02255383|Total Knee Arthroplasty|total knee arthroplasty
170240|NCT02255370|Curcumin. Crohn's disease. Post-operative recurrence. Thiopurines . Rutgeerts endoscopic score|curcumin. crohn's disease. post-operative recurrence. thiopurines . rutgeerts endoscopic score
170241|NCT02255357|Oxytocin|oxytocin
170242|NCT02255357|Vasopressin|vasopressin
170243|NCT02255357|Cocaine|cocaine
170244|NCT02255344|Acute Coronary Syndromes|acute coronary syndromes
170245|NCT02255344|Risk Model|risk model
170246|NCT02255344|National Registry|national registry
170247|NCT02255344|Comprehensive Care Program|comprehensive care program
170248|NCT02255344|Major Cardiovascular Events|major cardiovascular events
170249|NCT02255331|Arthroplasty|arthroplasty
170250|NCT02255331|Replacement|replacement
170251|NCT02255331|Hip|hip
170252|NCT02255318|Taurolock®|taurolock®
170253|NCT02255318|infections related to chambers implantable catheter|infections related to chambers implantable catheter
170254|NCT02255318|patients with cancer receiving parenteral nutrition|patients with cancer receiving parenteral nutrition
170255|NCT02255305|CDI|cdi
170256|NCT02255305|C difficile|c difficile
170257|NCT02255305|C diff|c diff
170258|NCT02255305|Clostridium difficile|clostridium difficile
170259|NCT02255253|Telmisartan|telmisartan
170260|NCT02255253|Hydrochlorothiazide|hydrochlorothiazide
170261|NCT02255253|Efficacy|efficacy
170262|NCT02255253|hypertension|hypertension
170263|NCT02255253|high sodium intake|high sodium intake
170264|NCT02255240|breast cancer|breast cancer
170265|NCT02255240|cancer|cancer
170266|NCT02255240|survivorship|survivorship
170267|NCT02255240|cancer survivor|cancer survivor
170268|NCT02255240|physical activity|physical activity
170269|NCT02255240|video game|video game
170270|NCT02255240|women|women
170271|NCT02255240|women's health|women's health
170272|NCT02255227|vaccination|vaccination
170273|NCT02255227|randomized|randomized
170274|NCT02255227|anti-pneumococcal|anti-pneumococcal
170275|NCT02255227|Pneumo 23|pneumo 23
170276|NCT02255227|Prevenar 13|prevenar 13
170277|NCT02255227|Chronic Inflammatory Bowel Disease|chronic inflammatory bowel disease
170278|NCT02255188|Haemostas, prosthesis|haemostas, prosthesis
170279|NCT02255175|Reproductive Affective Disorder|reproductive affective disorder
170280|NCT02255175|Depression|depression
170281|NCT02255175|Perimenopause|perimenopause
170282|NCT02255175|Estrogen|estrogen
170283|NCT02255175|Estradiol treatment|estradiol treatment
170284|NCT02255175|Mood Disorders|mood disorders
170285|NCT02255175|Estrogen Replacement Therapy|estrogen replacement therapy
170286|NCT02255175|Sex Steroids|sex steroids
170287|NCT02255175|Depressive disorder|depressive disorder
170288|NCT02255175|Mental Disorders|mental disorders
170289|NCT02255175|Estradiol|estradiol
170290|NCT02255175|Hormones|hormones
170291|NCT02255175|Physiological effects of drugs|physiological effects of drugs
170292|NCT02255175|Reproductive Control Agents|reproductive control agents
170293|NCT02255162|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
170294|NCT02255162|Acute Myelocytic Leukemia|acute myelocytic leukemia
170295|NCT02255162|Acute Myelogenous Leukemia|acute myelogenous leukemia
170296|NCT02255162|Acute Granulocytic Leukemia|acute granulocytic leukemia
170297|NCT02255162|Acute Non-Lymphocytic Leukemia|acute non-lymphocytic leukemia
170298|NCT02255136|Interleukin|interleukin
170299|NCT02255136|Immunoglobulin|immunoglobulin
170300|NCT02255136|Homeopathy|homeopathy
170301|NCT02255136|Allergic Rhinitis|allergic rhinitis
170302|NCT02255136|Asthma|asthma
170303|NCT02255110|Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma|locally advanced unresectable or metastatic soft tissue sarcoma
170304|NCT02255110|TH-302|th-302
170305|NCT02255110|Doxorubicin|doxorubicin
170306|NCT02255110|Evofosfamide|evofosfamide
170307|NCT02255097|PD-1|pd-1
170308|NCT02255097|PD1|pd1
170309|NCT02255097|PD-L1|pd-l1
170310|NCT02255097|PDL1|pdl1
170311|NCT02255084|Cervical cancer screening|cervical cancer screening
170312|NCT02255084|High Risk Human papillomavirus Infection|high risk human papillomavirus infection
170313|NCT02255084|vaginal self-sampling|vaginal self-sampling
170314|NCT02255084|pap smear|pap smear
170315|NCT02255084|general practitioner|general practitioner
170316|NCT02255071|GERD|gerd
170317|NCT02255071|Neiguan|neiguan
170318|NCT02255071|Acupressure|acupressure
170319|NCT02255071|P6|p6
170320|NCT02255032|uveitis|uveitis
170321|NCT02255032|macular edema|macular edema
170322|NCT02255032|UME|ume
170323|NCT02255032|posterior uveitis|posterior uveitis
170324|NCT02255032|anterior uveitis|anterior uveitis
170325|NCT02255032|panuveitis|panuveitis
170326|NCT02255032|intermediate uveitis|intermediate uveitis
170327|NCT02255032|noninfectious uveitis|noninfectious uveitis
170328|NCT02255032|triamcinolone acetonide|triamcinolone acetonide
170329|NCT02255032|suprachoroidal space|suprachoroidal space
170330|NCT02255032|injection|injection
170332|NCT02255032|intravitreal injection|intravitreal injection
170333|NCT02255032|corticosteroid|corticosteroid
170334|NCT02255032|CME|cme
170335|NCT02255032|choroid|choroid
170336|NCT02255032|retina|retina
170337|NCT02255032|microinjection|microinjection
170338|NCT02255032|SCS|scs
170339|NCT02255006|volunteer|volunteer
170340|NCT02255006|BMI(25 kg/m2)|bmi(25 kg/m2)
170341|NCT02254980|Total hip arthroplasty|total hip arthroplasty
170342|NCT02254980|Cemented acetabular cup|cemented acetabular cup
170343|NCT02254980|Vitamin-E|vitamin-e
170344|NCT02254980|Radiostereometry|radiostereometry
170345|NCT02254980|Fixation of cemented acetabular component in total hip arthroplasty|fixation of cemented acetabular component in total hip arthroplasty
170346|NCT02254967|Aged|aged
170347|NCT02254967|Fidaxomicin|fidaxomicin
170348|NCT02254967|Clostridium Difficile|clostridium difficile
170349|NCT02254967|Vancomycin|vancomycin
170350|NCT02254954|glioblastoma|glioblastoma
170351|NCT02254941|Metastatic Colon Cancer|metastatic colon cancer
170352|NCT02254941|Monoclonal antibodies|monoclonal antibodies
170353|NCT02254941|Chemotherapy|chemotherapy
170354|NCT02254941|First line|first line
170355|NCT02254928|poor ovarian response|poor ovarian response
170356|NCT02254928|controlled ovarian stimulation|controlled ovarian stimulation
170357|NCT02254928|randomised clinical trial|randomised clinical trial
170358|NCT02254928|corifollitropin alfa|corifollitropin alfa
170359|NCT02254928|recombinant follicle-stimulating hormone (rFSH)|recombinant follicle-stimulating hormone (rfsh)
170360|NCT02254928|human menopausal gonadotropin (HMG)|human menopausal gonadotropin (hmg)
170361|NCT02254915|Synergo|synergo
170362|NCT02254915|RITE|rite
170363|NCT02254915|SHTC|shtc
170364|NCT02254915|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
170365|NCT02254915|NMIBC|nmibc
170366|NCT02254915|Superficial Bladder Cancer|superficial bladder cancer
170367|NCT02254915|Urothelial Cell Cancer|urothelial cell cancer
170490|NCT02254200|exercise|exercise
170368|NCT02254915|Transitional Cell Cancer|transitional cell cancer
170369|NCT02254915|Mitomycin|mitomycin
170370|NCT02254902|sedentary lifestyle|sedentary lifestyle
170371|NCT02254902|physical activity|physical activity
161411|NCT02306369|ICBT|icbt
170372|NCT02254902|Somali women|somali women
170373|NCT02254902|prevention|prevention
170374|NCT02254876|Stroke|stroke
170375|NCT02254876|Hemiplegia|hemiplegia
170376|NCT02254876|Painful shoulder Syndrome|painful shoulder syndrome
170377|NCT02254876|NeuroMuscolar Taping|neuromuscolar taping
170378|NCT02254863|Adrenoleukodystrophy|adrenoleukodystrophy
170379|NCT02254863|Batten Disease|batten disease
170380|NCT02254863|Hunter Syndrome|hunter syndrome
170381|NCT02254863|Krabbe|krabbe
170382|NCT02254863|Metachromatic Leukodystrophy|metachromatic leukodystrophy
170383|NCT02254863|ALD|ald
170384|NCT02254863|MLD|mld
170385|NCT02254863|PMD|pmd
170386|NCT02254850|Mesoglycan|mesoglycan
170387|NCT02254850|Metabolic Syndrome|metabolic syndrome
170388|NCT02254850|Flow Mediated Dilation|flow mediated dilation
170389|NCT02254824|Xuezhikang|xuezhikang
170390|NCT02254824|atorvastatin|atorvastatin
170391|NCT02254785|poor prognosis|poor prognosis
170392|NCT02254785|castrate-resistant prostate cancer|castrate-resistant prostate cancer
170393|NCT02254785|cabazitaxel|cabazitaxel
170394|NCT02254785|abiraterone|abiraterone
170395|NCT02254785|enzalutamide|enzalutamide
170396|NCT02254733|CBSST|cbsst
170397|NCT02254733|Schizoaffective Disorder|schizoaffective disorder
170398|NCT02254733|Psychotic Disorder|psychotic disorder
170399|NCT02254733|Cognitive Behavioral Therapy|cognitive behavioral therapy
170400|NCT02254733|Social Skills Training|social skills training
170401|NCT02254733|Assertive Community Treatment|assertive community treatment
170402|NCT02254694|sagittal balance|sagittal balance
170403|NCT02254694|posture|posture
170404|NCT02254694|lumbar lordosis|lumbar lordosis
170405|NCT02254694|high heeled shoes|high heeled shoes
170406|NCT02254681|low-dose radiotherapy|low-dose radiotherapy
170407|NCT02254681|gemcitabine|gemcitabine
170408|NCT02254681|cisplatin|cisplatin
170409|NCT02254681|cholangiocarcinoma|cholangiocarcinoma
170410|NCT02254668|intima|intima
170411|NCT02254668|thickness|thickness
170412|NCT02254668|transplantation|transplantation
170413|NCT02254668|cardiology|cardiology
170414|NCT02254668|immunosuppression|immunosuppression
170415|NCT02254655|puerarin|puerarin
170416|NCT02254655|rheumatoid arthritis|rheumatoid arthritis
170417|NCT02254655|atherosclerosis|atherosclerosis
170418|NCT02254655|carotid intima-media thickness|carotid intima-media thickness
170419|NCT02254629|Fecal microflora|fecal microflora
170420|NCT02254629|IBS|ibs
170421|NCT02254629|Sequential treatment|sequential treatment
170422|NCT02254629|Probiotic|probiotic
170423|NCT02254629|Laxative|laxative
170424|NCT02254616|Stroke Rehabilitation|stroke rehabilitation
170425|NCT02254616|Hybrid therapy|hybrid therapy
170426|NCT02254616|Mirror Therapy|mirror therapy
170427|NCT02254616|Transcranial Direct Current Stimulation|transcranial direct current stimulation
170428|NCT02254603|Obesity, ayuveda yoga exercise, acupuncture.|obesity, ayuveda yoga exercise, acupuncture.
170429|NCT02254590|IEDL|iedl
170525|NCT02253680|Compression bandages|compression bandages
170430|NCT02254590|irrigation endoscopic decompressive laminotomy|irrigation endoscopic decompressive laminotomy
170431|NCT02254590|irrigation endoscopic decompression|irrigation endoscopic decompression
170432|NCT02254590|minimally invasive spine surgery|minimally invasive spine surgery
170433|NCT02254590|endoscopic decompression|endoscopic decompression
170434|NCT02254590|spinal stenosis|spinal stenosis
170435|NCT02254577|Infertility|infertility
170436|NCT02254577|Progesterone|progesterone
170437|NCT02254577|ART|art
170438|NCT02254577|IVF|ivf
170439|NCT02254577|FET|fet
170440|NCT02254577|FBT|fbt
170441|NCT02254577|Frozen Embryo Transfer|frozen embryo transfer
170442|NCT02254551|relapsed multiple myeloma|relapsed multiple myeloma
170443|NCT02254551|refractory multiple myeloma|refractory multiple myeloma
170444|NCT02254551|LDE225|lde225
170445|NCT02254551|Sonidegib|sonidegib
170446|NCT02254551|bortezomib|bortezomib
170447|NCT02254551|smoothened (SMO) inhibitors|smoothened (smo) inhibitors
170448|NCT02254551|Velcade|velcade
170449|NCT02254473|Knee|knee
170450|NCT02254473|Osteoarthritis|osteoarthritis
170451|NCT02254447|relative bio-availability|relative bio-availability
170452|NCT02254447|fasting|fasting
170453|NCT02254447|GW615775|gw615775
170454|NCT02254447|Candesartan cilexetil|candesartan cilexetil
170455|NCT02254447|ATACAND|atacand
170456|NCT02254434|single-dose|single-dose
170457|NCT02254434|fasting|fasting
170458|NCT02254434|eltrombopag 50 mg|eltrombopag 50 mg
170459|NCT02254434|pharmacokinetic|pharmacokinetic
170460|NCT02254434|healthy volunteers|healthy volunteers
170461|NCT02254434|Open-label|open-label
170462|NCT02254421|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
170463|NCT02254421|Antiviral|antiviral
170464|NCT02254421|Hematopoietic Cell Transplant (HCT)|hematopoietic cell transplant (hct)
170465|NCT02254421|Lower respiratory tract infection|lower respiratory tract infection
170466|NCT02254408|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
170467|NCT02254408|Antiviral|antiviral
170468|NCT02254408|Hematopoietic Cell Transplant (HCT)|hematopoietic cell transplant (hct)
161492|NCT02306109|Intensive versus standard|intensive versus standard
170469|NCT02254408|Upper respiratory tract infection|upper respiratory tract infection
170470|NCT02254382|diastolic heart failure|diastolic heart failure
170471|NCT02254356|drug-eluting stent, paclitaxel-eluting stent, peripheral artery disease, peripheral vascular disease, superficial femoral artery, popliteal artery|drug-eluting stent, paclitaxel-eluting stent, peripheral artery disease, peripheral vascular disease, superficial femoral artery, popliteal artery
170472|NCT02254343|stroke rehabilitation|stroke rehabilitation
170473|NCT02254343|robot-assisted therapy|robot-assisted therapy
170474|NCT02254330|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
170475|NCT02254317|Impaired Glucose Tolerance|impaired glucose tolerance
170476|NCT02254317|Oral Glucose Tolerance Test|oral glucose tolerance test
170477|NCT02254317|Grape Seed Extract|grape seed extract
170478|NCT02254304|Relapsing multiple sclerosis|relapsing multiple sclerosis
170479|NCT02254304|Clinically isolated syndrome|clinically isolated syndrome
170481|NCT02254304|CIS|cis
170482|NCT02254304|RebiSmart™|rebismart™
170483|NCT02254304|Rebif®|rebif®
170484|NCT02254304|Interferon beta-1a|interferon beta-1a
170485|NCT02254252|Slow coronary flow phenomenon|slow coronary flow phenomenon
170486|NCT02254252|Angina pectoris|angina pectoris
170487|NCT02254252|chest pain|chest pain
170488|NCT02254252|nicroandil|nicroandil
170489|NCT02254213|Intra-individual stability, EEG|intra-individual stability, eeg
170491|NCT02254200|fat oxidation|fat oxidation
170492|NCT02254200|indirect calorimetry|indirect calorimetry
170493|NCT02254200|insulin sensitivity|insulin sensitivity
170494|NCT02254200|weight management|weight management
170495|NCT02253810|Dysplasia, Congenital Hip|dysplasia, congenital hip
170496|NCT02253810|Osteotomy|osteotomy
170497|NCT02253810|Blood Transfusion|blood transfusion
170498|NCT02253810|Tranexamic Acid|tranexamic acid
170499|NCT02253758|Magnetic Resonance Imaging|magnetic resonance imaging
170500|NCT02253758|Electroencephalography|electroencephalography
170501|NCT02253758|Conscious Sedation|conscious sedation
170502|NCT02253758|Deep Sedation|deep sedation
170503|NCT02253758|Arousal|arousal
170504|NCT02253758|Consciousness|consciousness
170505|NCT02253745|ADHD|adhd
170506|NCT02253745|Attention Deficit/ Hyperactivity Disorder|attention deficit/ hyperactivity disorder
170507|NCT02253732|MicroRNAs|micrornas
170508|NCT02253732|exercise|exercise
170509|NCT02253732|skeletal muscle|skeletal muscle
170510|NCT02253732|metabolism|metabolism
170511|NCT02253719|cervical neoplasia|cervical neoplasia
170512|NCT02253719|cervical cancer'|cervical cancer'
170513|NCT02253719|visual inspection acetic acid|visual inspection acetic acid
170514|NCT02253719|cryotherapy|cryotherapy
170515|NCT02253706|bronchoscopy|bronchoscopy
170516|NCT02253706|hypoxia|hypoxia
170517|NCT02253706|oxygen supplementation|oxygen supplementation
170518|NCT02253706|safety|safety
170519|NCT02253693|Hemophilia A|hemophilia a
170520|NCT02253693|Hemophilic arthropathy|hemophilic arthropathy
170521|NCT02253693|Accelerometry|accelerometry
170522|NCT02253680|Osteoarthritis|osteoarthritis
170523|NCT02253680|Total knee replacement|total knee replacement
170524|NCT02253680|Enhanced recovery|enhanced recovery
170526|NCT02253667|Palliative care|palliative care
170527|NCT02253667|Lung disease|lung disease
170528|NCT02253667|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
170529|NCT02253667|High-flow oxygen nasal cannula|high-flow oxygen nasal cannula
170530|NCT02253667|Dyspnoea|dyspnoea
170531|NCT02253667|Opioids|opioids
170532|NCT02253654|Chronic Kidney Disease|chronic kidney disease
170533|NCT02253654|Anemia|anemia
170534|NCT02253654|Hemodialysis|hemodialysis
170535|NCT02253654|Red Blood Cell Transfusion|red blood cell transfusion
170536|NCT02253641|African American, Women|african american, women
170537|NCT02253641|Weight Loss|weight loss
170538|NCT02253628|Coffee|coffee
170539|NCT02253628|Gastrin|gastrin
170540|NCT02253628|Alpha-amylase|alpha-amylase
170541|NCT02253628|Cortisol|cortisol
170542|NCT02253628|Self-reported gastrointestinal symptoms|self-reported gastrointestinal symptoms
170543|NCT02253628|Self-reported stress|self-reported stress
170544|NCT02253628|Blood pressure|blood pressure
170545|NCT02253615|Aging|aging
170546|NCT02253615|Resistance training|resistance training
170547|NCT02253615|Muscle strength|muscle strength
170548|NCT02253615|Functional performance|functional performance
170549|NCT02253615|Postural balance|postural balance
170550|NCT02253602|Esophageal Neoplasms|esophageal neoplasms
170551|NCT02253602|Lymph Nodes|lymph nodes
170552|NCT02253602|USPIO|uspio
170553|NCT02253602|Magnetic Resonance Imaging|magnetic resonance imaging
170554|NCT02253576|infant|infant
170555|NCT02253576|bronchiolitis|bronchiolitis
170556|NCT02253576|hypertonic saline|hypertonic saline
170557|NCT02253537|Tuberculosis|tuberculosis
170558|NCT02253537|TB|tb
170559|NCT02253524|Metoclopramide|metoclopramide
170560|NCT02253524|Dimenhydrinate|dimenhydrinate
170561|NCT02253524|emergency medicine|emergency medicine
170562|NCT02253511|Hepatocellular carcinoma|hepatocellular carcinoma
161588|NCT02305667|King Vision™|king vision™
161589|NCT02305667|Airtraq®|airtraq®
161590|NCT02305667|intubation|intubation
170563|NCT02253511|Hepotectomy|hepotectomy
170564|NCT02253511|Recurrence-free survival|recurrence-free survival
170565|NCT02253511|Overall survival|overall survival
170566|NCT02253485|Mother-to-child transmission|mother-to-child transmission
170567|NCT02253446|Dysmenorrhea|dysmenorrhea
170569|NCT02253446|Diclofenac Sodium|diclofenac sodium
170570|NCT02253446|Emergency department|emergency department
170571|NCT02253433|asthma|asthma
170572|NCT02253433|environmental triggers|environmental triggers
170573|NCT02253433|home-based intervention|home-based intervention
170574|NCT02253433|asthma home visits|asthma home visits
170575|NCT02253420|Phase 1|phase 1
170576|NCT02253420|Advanced solid tumor|advanced solid tumor
170577|NCT02253420|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
170578|NCT02253420|PI3 Kinase inhibitor|pi3 kinase inhibitor
170579|NCT02253420|Drug-drug Interaction|drug-drug interaction
170580|NCT02253394|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
170581|NCT02253394|Ambrisentan|ambrisentan
170582|NCT02253394|Spironolactone|spironolactone
170583|NCT02253394|Selective Endothelin A (ETA) inhibition|selective endothelin a (eta) inhibition
170584|NCT02253394|Aldosterone antagonism|aldosterone antagonism
170585|NCT02253394|Cardiac output (CO)|cardiac output (co)
170586|NCT02253394|Right ventricular (RV) function|right ventricular (rv) function
170587|NCT02253394|Heart failure|heart failure
170588|NCT02253394|Quality of life|quality of life
170589|NCT02253394|Pro-inflammatory cytokine|pro-inflammatory cytokine
170590|NCT02253394|Interleukin-6 (IL-6)|interleukin-6 (il-6)
170591|NCT02253394|Troponin-I|troponin-i
170592|NCT02253394|N-terminal pro-brain natriuretic peptide (NT-BNP)|n-terminal pro-brain natriuretic peptide (nt-bnp)
170593|NCT02253394|Collagen metabolism|collagen metabolism
170594|NCT02253394|N-terminal procollagen type I|n-terminal procollagen type i
170595|NCT02253394|Collagen III|collagen iii
170596|NCT02253394|Echocardiography|echocardiography
170597|NCT02253394|WHO Functional Class|who functional class
170598|NCT02253394|Cardiopulmonary Exercise Test with Innocor|cardiopulmonary exercise test with innocor
170599|NCT02253394|Peak oxygen consumption (pVO2)|peak oxygen consumption (pvo2)
170600|NCT02253394|Liver function markers (AST/ALT)|liver function markers (ast/alt)
170601|NCT02253394|Renal function markers (creatinine and potassium)|renal function markers (creatinine and potassium)
170602|NCT02253381|lateral decubitus position|lateral decubitus position
170603|NCT02253381|hypotension|hypotension
170604|NCT02253381|cesarean section|cesarean section
170605|NCT02253329|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
170606|NCT02253329|Ageing|ageing
170607|NCT02253329|Protein ingestion|protein ingestion
170608|NCT02253316|Multiple Myeloma|multiple myeloma
170609|NCT02253316|Autologous Stem Cell Transplantation|autologous stem cell transplantation
170610|NCT02253316|Ixazomib|ixazomib
170611|NCT02253316|Lenalidomide|lenalidomide
170612|NCT02253316|Dexamethasone|dexamethasone
170613|NCT02253277|CML, Ph+ ALL|cml, ph+ all
170614|NCT02253251|Breast Cancer|breast cancer
170615|NCT02253251|Cancer Risk|cancer risk
170616|NCT02253251|Family Breast and Ovarian Cancer|family breast and ovarian cancer
170617|NCT02253251|Genetic Cancer Risk|genetic cancer risk
170618|NCT02253251|Cancer Treatment|cancer treatment
170619|NCT02253251|Familial multiple primary cancer risk|familial multiple primary cancer risk
170620|NCT02253238|Head and Neck Cancer|head and neck cancer
170621|NCT02253238|Dehydration|dehydration
170622|NCT02253238|Sensor-based home monitoring|sensor-based home monitoring
170623|NCT02253238|Radiation therapy|radiation therapy
170624|NCT02253238|RT|rt
170625|NCT02253238|XRT|xrt
170626|NCT02253238|Oropharyngeal cancer|oropharyngeal cancer
170627|NCT02253238|Hypopharyngeal cancer|hypopharyngeal cancer
170628|NCT02253238|Nasopharyngeal cancer|nasopharyngeal cancer
170629|NCT02253238|Salivary gland cancer|salivary gland cancer
170630|NCT02253238|Oral cavity cancer|oral cavity cancer
170631|NCT02253238|Questionnaires|questionnaires
170632|NCT02253238|Surveys|surveys
170633|NCT02253238|Quality of life|quality of life
170634|NCT02253238|QOL|qol
170635|NCT02253238|Phone calls|phone calls
170636|NCT02253238|Self-monitoring devices|self-monitoring devices
170637|NCT02253238|CYberinfrastructure for COmparative effectiveness REsearch|cyberinfrastructure for comparative effectiveness research
170638|NCT02253238|CYCORE|cycore
170639|NCT02253238|Emergency room visits|emergency room visits
170640|NCT02253238|ER|er
170641|NCT02253238|Emergency room visits with hospitalization|emergency room visits with hospitalization
170642|NCT02253238|ERHV|erhv
170643|NCT02253225|Bipolar Disorder|bipolar disorder
170644|NCT02253225|Major Depression|major depression
170645|NCT02253225|Rumination|rumination
170646|NCT02253225|Self Processing|self processing
170647|NCT02253173|VVA|vva
170648|NCT02253173|Painful Sex|painful sex
170649|NCT02253173|Postmenopausal|postmenopausal
170650|NCT02253160|MNCs|mncs
170651|NCT02253160|Mononuclear Cells|mononuclear cells
170652|NCT02253160|Apheresis|apheresis
170653|NCT02253160|Spectra Optia|spectra optia
170654|NCT02253134|Syncopal events|syncopal events
170655|NCT02253134|Palpitation events|palpitation events
170656|NCT02253121|COPD|copd
170657|NCT02253121|acute exacerbation|acute exacerbation
170658|NCT02253121|glucocorticoid therapy|glucocorticoid therapy
170659|NCT02253121|hyperglycemia|hyperglycemia
170660|NCT02253108|DES|des
170661|NCT02253108|Angina pectoris|angina pectoris
170663|NCT02253108|Optical coherence tomography|optical coherence tomography
170664|NCT02253108|Stent thrombosis|stent thrombosis
170665|NCT02253056|Fasting|fasting
170666|NCT02253056|Caloric Restriction|caloric restriction
170667|NCT02253056|Focus is to observe effects of fasting in healthy volunteers.|focus is to observe effects of fasting in healthy volunteers.
170668|NCT02253043|Alzheimer's Disease|alzheimer's disease
170669|NCT02253030|AMD|amd
170670|NCT02253030|OCT|oct
170671|NCT02253030|Angiography|angiography
665112|NCT00829114|IRB|irb
170672|NCT02253030|Macular degeneration|macular degeneration
170673|NCT02253017|Therapeutic strategies|therapeutic strategies
170674|NCT02253017|Pediatrics|pediatrics
170675|NCT02253017|Cataract|cataract
170676|NCT02253017|Surgery|surgery
170677|NCT02253017|Intra-ocular lens|intra-ocular lens
170678|NCT02252991|Breast cancer|breast cancer
170679|NCT02252991|Fatigue|fatigue
170680|NCT02252991|Physical activity|physical activity
170681|NCT02252965|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
170682|NCT02252965|Metformin XR|metformin xr
170683|NCT02252965|Metformin IR|metformin ir
170684|NCT02252952|Sugar Sweetened Beverages, Diet Beverages, ectopic fat, Functional MRI|sugar sweetened beverages, diet beverages, ectopic fat, functional mri
170685|NCT02252926|Anesthetics, Local|anesthetics, local
170686|NCT02252926|Bupivacaine|bupivacaine
170687|NCT02252926|Lozenge|lozenge
170688|NCT02252926|Administration, Topical|administration, topical
170689|NCT02252900|Brain damages|brain damages
170691|NCT02252900|infectious endocarditis|infectious endocarditis
170692|NCT02252887|Gemcitabine,|gemcitabine,
170693|NCT02252887|Trastuzumab|trastuzumab
170694|NCT02252887|Pertuzumab|pertuzumab
170695|NCT02252887|14-124|14-124
170696|NCT02252874|balance|balance
170697|NCT02252874|visual function|visual function
170698|NCT02252874|community-dwelling older adults|community-dwelling older adults
170699|NCT02252874|action video-game|action video-game
170700|NCT02252822|Eating Disorders|eating disorders
170701|NCT02252822|Self Help|self help
170702|NCT02252822|Anonymous CBT|anonymous cbt
170703|NCT02252809|inflammation endotoxin anti-TNF corticosteroids|inflammation endotoxin anti-tnf corticosteroids
170704|NCT02252796|Non-small Cell Lung Cancer|non-small cell lung cancer
170705|NCT02252796|Radiotherapy Therapy|radiotherapy therapy
170706|NCT02252783|Coronary Artery Disease|coronary artery disease
170707|NCT02252783|Myocardial Ischemia|myocardial ischemia
170708|NCT02252783|Coronary Disease|coronary disease
170709|NCT02252783|Heart Diseases|heart diseases
170710|NCT02252783|Cardiovascular Diseases|cardiovascular diseases
170711|NCT02252783|Arteriosclerosis|arteriosclerosis
170712|NCT02252783|Arterial Occlusive Diseases|arterial occlusive diseases
170713|NCT02252783|Vascular Diseases|vascular diseases
170714|NCT02252770|ASA|asa
170715|NCT02252770|ASLD|asld
170716|NCT02252770|UCD|ucd
170717|NCT02252757|mHealth, hypertension, atherosclerotic disease, diabetes, obesity, metabolic syndrome, cardiotoxins, cardiomyopathy, dsypnea|mhealth, hypertension, atherosclerotic disease, diabetes, obesity, metabolic syndrome, cardiotoxins, cardiomyopathy, dsypnea
170718|NCT02252744|dry eye disease|dry eye disease
170719|NCT02252744|rheumatoid arthritis|rheumatoid arthritis
170720|NCT02252731|Phase I|phase i
170721|NCT02252731|FG-4592|fg-4592
170722|NCT02252731|Warfarin|warfarin
170723|NCT02252731|Pharmacokinetics|pharmacokinetics
170724|NCT02252731|Pharmacodynamics|pharmacodynamics
170725|NCT02252705|Pulmonary arterial hypertension|pulmonary arterial hypertension
170726|NCT02252705|Mortality|mortality
170727|NCT02252705|Survival|survival
170728|NCT02252692|Bioavailability|bioavailability
170729|NCT02252692|pharmacokinetics|pharmacokinetics
170730|NCT02252692|enalapril|enalapril
170731|NCT02252692|enalaprilat|enalaprilat
170732|NCT02252679|Bone Turnover Markers|bone turnover markers
170733|NCT02252679|Calcium Isotopes|calcium isotopes
170734|NCT02252666|MS|ms
170735|NCT02252666|balance|balance
170736|NCT02252666|standing|standing
170737|NCT02252666|control|control
170738|NCT02252666|movement|movement
170739|NCT02252653|Cardiomyopathy|cardiomyopathy
170740|NCT02252653|Heart Failure|heart failure
170741|NCT02252653|FAC|fac
170742|NCT02252653|Amyloid|amyloid
170743|NCT02252653|Transthyretin (TTR)|transthyretin (ttr)
170744|NCT02252640|Plasmodium Falciparum|plasmodium falciparum
170745|NCT02252640|Malaria|malaria
170746|NCT02252640|Vaccine|vaccine
170747|NCT02252640|Plasmodium|plasmodium
170748|NCT02252640|Falciparum|falciparum
170749|NCT02252614|naproxen sodium+codein, paracetamol+codein,lumbar disc surgery|naproxen sodium+codein, paracetamol+codein,lumbar disc surgery
170750|NCT02252601|Cystic Fibrosis|cystic fibrosis
170751|NCT02252601|Hearing Loss|hearing loss
170752|NCT02252601|High Frequency Digit Triplet Test|high frequency digit triplet test
170753|NCT02252588|COPD|copd
170754|NCT02252588|Bacteria|bacteria
170755|NCT02252562|Hand hygiene|hand hygiene
170756|NCT02252562|Hospital acquired infections (HAI)|hospital acquired infections (hai)
170757|NCT02252562|Healthcare acquired infections (HCAI)|healthcare acquired infections (hcai)
170758|NCT02252536|alcohol use disorder|alcohol use disorder
170759|NCT02252536|alcoholism|alcoholism
170760|NCT02252536|alcohol dependence|alcohol dependence
170761|NCT02252536|drinking alcohol|drinking alcohol
170762|NCT02252523|Feasibility study|feasibility study
170763|NCT02252497|hip arthroplasty|hip arthroplasty
170764|NCT02252497|Tranexamic acid|tranexamic acid
170765|NCT02252497|randomized control trial|randomized control trial
170766|NCT02252484|prostate cancer|prostate cancer
170767|NCT02252484|prostatectomy|prostatectomy
170768|NCT02252484|weight loss|weight loss
170769|NCT02252484|prevent weight gain|prevent weight gain
170770|NCT02252471|alcohol-exposed pregnancy|alcohol-exposed pregnancy
170771|NCT02252471|nicotine-exposed pregnancy|nicotine-exposed pregnancy
170772|NCT02252471|tobacco-exposed pregnancy|tobacco-exposed pregnancy
170773|NCT02252471|alcohol|alcohol
170774|NCT02252471|contraception|contraception
170775|NCT02252471|smoking|smoking
170776|NCT02252471|pregnancy|pregnancy
170778|NCT02252471|prevention|prevention
170779|NCT02252458|Opioid induced hyperalgesia|opioid induced hyperalgesia
170780|NCT02252458|Fentanyl|fentanyl
170781|NCT02252432|KETAMINE|ketamine
170782|NCT02252432|METHADONE|methadone
170783|NCT02252432|POSTOPERATIVE PAIN|postoperative pain
170784|NCT02252432|OPIOID REQUIREMENTS|opioid requirements
170785|NCT02252432|Length of hospital stay|length of hospital stay
170786|NCT02252432|Perioperative outcomes|perioperative outcomes
170787|NCT02252419|Postoperative Period|postoperative period
170788|NCT02252419|Anesthesia, General|anesthesia, general
170789|NCT02252419|Intubation, Intratracheal|intubation, intratracheal
170790|NCT02252419|Dexamethasone|dexamethasone
170791|NCT02252419|Acetaminophen|acetaminophen
170792|NCT02252406|Stable Angina|stable angina
170793|NCT02252406|Metabolic Syndrome|metabolic syndrome
170794|NCT02252406|Women|women
170795|NCT02252406|Biomarkers|biomarkers
170796|NCT02252367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors
170797|NCT02252367|BPH/LUTS|bph/luts
170798|NCT02252354|Drug therapy|drug therapy
170799|NCT02252341|smoking|smoking
170800|NCT02252341|inflammation|inflammation
170801|NCT02252341|oxidative stress|oxidative stress
170802|NCT02252341|NAC|nac
170803|NCT02252341|treatment|treatment
170804|NCT02252328|Uveitis|uveitis
170805|NCT02252328|Simvastatin|simvastatin
170806|NCT02252328|Visual acuity|visual acuity
170807|NCT02252328|Corticosteroids|corticosteroids
170808|NCT02252328|Immunosuppression|immunosuppression
170809|NCT02252302|Exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
170810|NCT02252302|Air pollution|air pollution
170811|NCT02252302|Exercise|exercise
170812|NCT02252302|Inhaled beta-2-agonist|inhaled beta-2-agonist
170813|NCT02252302|Cognitive Function|cognitive function
170814|NCT02252289|Asthma|asthma
170815|NCT02252289|children|children
170816|NCT02252289|fluctuation analysis|fluctuation analysis
170817|NCT02252289|exacerbations|exacerbations
170818|NCT02252276|Manual therapy|manual therapy
170819|NCT02252276|proprioception|proprioception
170820|NCT02252276|exercises|exercises
170821|NCT02252276|ankle sprain|ankle sprain
170822|NCT02252250|rectal cancer|rectal cancer
170823|NCT02252250|laparoscopic|laparoscopic
170824|NCT02252250|NOTES|notes
170825|NCT02252237|Prednisone|prednisone
170826|NCT02252237|Prednisolone|prednisolone
170827|NCT02252237|Methylprednisolone|methylprednisolone
170828|NCT02252237|Glucocorticoids|glucocorticoids
170829|NCT02252237|pharmacokinetics|pharmacokinetics
170830|NCT02252211|EphA2 positive cancer|epha2 positive cancer
170831|NCT02252211|DS-8895a monoclonal antibody|ds-8895a monoclonal antibody
170832|NCT02252172|Multiple Myeloma|multiple myeloma
170833|NCT02252172|Daratumumab|daratumumab
170834|NCT02252172|JNJ-54767414|jnj-54767414
170835|NCT02252172|Lenalidomide|lenalidomide
170836|NCT02252172|Dexamethasone|dexamethasone
170837|NCT02252159|Polycythemia|polycythemia
170838|NCT02252159|Polycythemia Vera|polycythemia vera
170839|NCT02252159|Hematologic Diseases|hematologic diseases
170840|NCT02252159|Myeloproliferative Disorders|myeloproliferative disorders
170841|NCT02252159|Bone Marrow Diseases|bone marrow diseases
170842|NCT02252159|Hydroxyurea|hydroxyurea
170843|NCT02252159|Antineoplastic Agents|antineoplastic agents
170844|NCT02252159|Therapeutic Uses|therapeutic uses
170845|NCT02252159|Pharmacologic Actions|pharmacologic actions
170846|NCT02252159|Antisickling Agents|antisickling agents
170847|NCT02252159|Hematologic Agents|hematologic agents
170848|NCT02252159|Enzyme Inhibitors|enzyme inhibitors
170849|NCT02252159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
170850|NCT02252159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors
170851|NCT02252146|DLBCL|dlbcl
170852|NCT02252146|MYD88 L265P|myd88 l265p
170853|NCT02252146|Lymphoma|lymphoma
170854|NCT02252146|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
170855|NCT02252146|Idera|idera
170856|NCT02252146|IMO 8400|imo 8400
170857|NCT02252133|Contact lenses|contact lenses
170858|NCT02252133|Myopia|myopia
170859|NCT02252107|Decitabine|decitabine
170860|NCT02252107|Hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
170861|NCT02252107|Conditioning|conditioning
170862|NCT02252107|AML|aml
170863|NCT02252081|metformin|metformin
170864|NCT02252081|cardiovascular disease|cardiovascular disease
170865|NCT02252081|Chronic Kidney Disease|chronic kidney disease
170866|NCT02252081|Metabolic Syndrome|metabolic syndrome
170867|NCT02252042|Squamous cell carcinoma|squamous cell carcinoma
170868|NCT02252042|Head and neck carcinoma|head and neck carcinoma
170870|NCT02252042|PD-1|pd-1
170871|NCT02252042|PDL1|pdl1
170872|NCT02252042|PD-L1|pd-l1
170873|NCT02252029|Rotavirus|rotavirus
170874|NCT02252029|Vaccine|vaccine
170875|NCT02252003|Children|children
170876|NCT02252003|Pain|pain
170877|NCT02252003|Pain scale evaluation|pain scale evaluation
170878|NCT02251964|IMID|imid
170879|NCT02251964|Interstitial Pneumonitis|interstitial pneumonitis
170880|NCT02251964|rituximab|rituximab
170881|NCT02251964|Immuno PET|immuno pet
170882|NCT02251964|PET/CT|pet/ct
170883|NCT02251951|Cancer|cancer
170884|NCT02251951|Stomach|stomach
170885|NCT02251951|Gastro-Esophageal Junction|gastro-esophageal junction
170886|NCT02251951|Salvage treatment|salvage treatment
170887|NCT02251951|Nab-paclitaxel|nab-paclitaxel
170888|NCT02251925|infertility froze emberyo transfer hormone replacement|infertility froze emberyo transfer hormone replacement
170889|NCT02251912|Alcohol dependence|alcohol dependence
170890|NCT02251912|Alcohol|alcohol
170891|NCT02251912|Oxytocin|oxytocin
170892|NCT02251912|Intranasal administration|intranasal administration
170893|NCT02251847|cholesterol|cholesterol
170894|NCT02251834|Healthcare Disparities|healthcare disparities
170895|NCT02251834|stroke|stroke
170896|NCT02251834|Hispanic Americans|hispanic americans
170897|NCT02251834|community health worker|community health worker
170898|NCT02251834|Mobile Health|mobile health
170899|NCT02251834|Transient Ischemic Attack (TIA)|transient ischemic attack (tia)
170900|NCT02251834|hypertension|hypertension
170901|NCT02251834|Randomized Controlled Trial|randomized controlled trial
170902|NCT02251834|high cholesterol|high cholesterol
170903|NCT02251834|behavioral|behavioral
170904|NCT02251834|exercise|exercise
170905|NCT02251834|diabetes|diabetes
170906|NCT02251834|diet|diet
170907|NCT02251808|Parkinson's Disease, Deep brain stimulation|parkinson's disease, deep brain stimulation
170908|NCT02251743|ADHD|adhd
170909|NCT02251743|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
170910|NCT02251743|neurofeedback|neurofeedback
170911|NCT02251743|EEG|eeg
170912|NCT02251730|radiation therapy,Smoking pattern,head and neck cancer|radiation therapy,smoking pattern,head and neck cancer
170913|NCT02251717|renal transplant|renal transplant
170914|NCT02251704|Malaria|malaria
170915|NCT02251704|MTI|mti
170916|NCT02251704|Surveillance study|surveillance study
170917|NCT02251704|Africa|africa
170918|NCT02251704|RTSS, adjuvant|rtss, adjuvant
170919|NCT02251704|Epidemiology|epidemiology
170920|NCT02251691|Compliance|compliance
170921|NCT02251678|Plaque|plaque
170922|NCT02251678|Psoriasis|psoriasis
170923|NCT02251678|Biomarkers|biomarkers
170924|NCT02251678|CRP|crp
170925|NCT02251678|αTNF|αtnf
170927|NCT02251665|Acute ischemic stroke|acute ischemic stroke
170928|NCT02251665|Acute intracerebral hemorrhage|acute intracerebral hemorrhage
170929|NCT02251665|Transient ischemic attack|transient ischemic attack
170931|NCT02251639|Oral cancer|oral cancer
170932|NCT02251639|Pre-cancer|pre-cancer
170933|NCT02251639|Widefield Fluorescence Imaging|widefield fluorescence imaging
170934|NCT02251639|VELScope|velscope
170935|NCT02251639|Point Spectroscopy System|point spectroscopy system
170936|NCT02251639|Oral brush biopsy|oral brush biopsy
170937|NCT02251639|Questionnaire|questionnaire
170938|NCT02251639|Survey|survey
170939|NCT02251639|Diagnostic aid|diagnostic aid
170940|NCT02251639|Screening|screening
170941|NCT02251626|MGH|mgh
170942|NCT02251626|Burn patient|burn patient
170943|NCT02251626|Adult|adult
170944|NCT02251626|CoQ10|coq10
170945|NCT02251626|Ubiquinol|ubiquinol
170946|NCT02251600|Pediatric|pediatric
170947|NCT02251600|Adolescent|adolescent
170948|NCT02251600|Deflazacort|deflazacort
170949|NCT02251561|contact lenses|contact lenses
170950|NCT02251561|contact lens solution|contact lens solution
170951|NCT02251561|corneal staining|corneal staining
170952|NCT02251561|fluorescein|fluorescein
170953|NCT02251548|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
170954|NCT02251548|Leukemia|leukemia
170955|NCT02251535|kinematic analysis|kinematic analysis
161993|NCT02302950|women|women
170956|NCT02251535|femoral rollback|femoral rollback
170957|NCT02251535|mobile bearing|mobile bearing
170958|NCT02251535|cruciate retaining Primary Total Knee Arthroplasty|cruciate retaining primary total knee arthroplasty
170959|NCT02251496|Malnutrition|malnutrition
170960|NCT02251496|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
170961|NCT02251496|Nutrition Therapy|nutrition therapy
170962|NCT02251496|Oral Nutrition Supplement|oral nutrition supplement
170963|NCT02251496|Food|food
170964|NCT02251483|DIBS|dibs
170965|NCT02251483|SIBO|sibo
170966|NCT02251470|stroke|stroke
170967|NCT02251470|balance|balance
170969|NCT02251470|home-based exercises|home-based exercises
170970|NCT02251470|Wii|wii
170971|NCT02251470|postural balance|postural balance
170972|NCT02251470|Nintendo|nintendo
170973|NCT02251470|balance board|balance board
170974|NCT02251470|Wii-Fit|wii-fit
170975|NCT02251470|home|home
170976|NCT02251470|feasibility|feasibility
170977|NCT02251457|Myotonia Congenita|myotonia congenita
170978|NCT02251457|ranolazine|ranolazine
170979|NCT02251457|Ohio State|ohio state
170980|NCT02251457|Open Label|open label
170981|NCT02251457|Paramyotonia Congenita|paramyotonia congenita
170982|NCT02251457|Myotonic Dystrophy 1|myotonic dystrophy 1
170983|NCT02251431|diabetes mellitus|diabetes mellitus
170984|NCT02251431|chronic kidney disease|chronic kidney disease
170985|NCT02251431|diastolic function|diastolic function
170986|NCT02251431|cardiac fibrosis|cardiac fibrosis
170987|NCT02251431|cardiac strain|cardiac strain
170988|NCT02251431|cardiac biomarker|cardiac biomarker
170989|NCT02251431|renal biomarker|renal biomarker
170990|NCT02251418|Foot ulcer, diabetic|foot ulcer, diabetic
170991|NCT02251418|ESWT (Extracorporeal Shockwave Therapy)|eswt (extracorporeal shockwave therapy)
170992|NCT02251418|Endocrinology|endocrinology
170993|NCT02251418|Dermatology|dermatology
170994|NCT02251418|Wound healing|wound healing
170995|NCT02251418|Ischemia|ischemia
170996|NCT02251418|Neovascularization, Physiologic|neovascularization, physiologic
170997|NCT02251418|Pain management|pain management
170998|NCT02251405|Melamine|melamine
170999|NCT02251405|Melamine tableware|melamine tableware
171000|NCT02251392|chamomilla|chamomilla
171001|NCT02251392|matricaria|matricaria
171002|NCT02251392|chamomile|chamomile
171003|NCT02251392|chamomila|chamomila
171004|NCT02251392|recutita|recutita
171005|NCT02251392|Breast Neoplasms|breast neoplasms
171006|NCT02251392|head and neck neoplasms|head and neck neoplasms
171007|NCT02251392|radiotherapy|radiotherapy
171008|NCT02251366|Age-Related Macular Degeneration|age-related macular degeneration
171009|NCT02251353|breast cancer, intervention to metastasis|breast cancer, intervention to metastasis
171010|NCT02251314|BRAF mutant melanoma|braf mutant melanoma
171011|NCT02251314|circulation tumour DNA|circulation tumour dna
171012|NCT02251314|tumour heterogeneity|tumour heterogeneity
171013|NCT02251314|liquid biopsy|liquid biopsy
171014|NCT02251288|H7N9 pandemic|h7n9 pandemic
171015|NCT02251288|inactivated influenza vaccine (pIIV)|inactivated influenza vaccine (piiv)
171016|NCT02251288|live attenuated influenza vaccine (pLAIV)|live attenuated influenza vaccine (plaiv)
171017|NCT02251288|MF59 adjuvant|mf59 adjuvant
171018|NCT02251275|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
171019|NCT02251262|Pacemaker|pacemaker
171020|NCT02251262|Endocarditis|endocarditis
171021|NCT02251262|18FDG-PET-CT|18fdg-pet-ct
171022|NCT02251262|Diagnostic accuracy|diagnostic accuracy
171023|NCT02251262|Pacing or defibrillation lead|pacing or defibrillation lead
171024|NCT02251236|Stribild|stribild
171025|NCT02251236|Genvoya|genvoya
171026|NCT02251236|elvitegravir|elvitegravir
171027|NCT02251236|Cerebrospinal Fluid|cerebrospinal fluid
171029|NCT02251093|mycosis|mycosis
171030|NCT02251093|vulvovaginal candidiasis|vulvovaginal candidiasis
171031|NCT02251093|lcr35|lcr35
171032|NCT02251093|Lcr Regenerans®|lcr regenerans®
171033|NCT02251080|adherence|adherence
171034|NCT02251080|internet-based|internet-based
171035|NCT02251054|Overactive Bladder|overactive bladder
171036|NCT02251054|Multimedia|multimedia
171037|NCT02251054|Behavioral Therapy|behavioral therapy
171038|NCT02251041|Liver|liver
171039|NCT02251041|Transplantation|transplantation
171040|NCT02251041|Ischemia-reperfusion|ischemia-reperfusion
171041|NCT02251041|Effectiveness|effectiveness
171042|NCT02251028|whiplash, prevention, pain, cognitive-behavioural therapy|whiplash, prevention, pain, cognitive-behavioural therapy
171043|NCT02251015|Postural balance|postural balance
171044|NCT02251015|Temporomandibular disorders|temporomandibular disorders
171045|NCT02251015|splints|splints
171046|NCT02250989|Endothelial disfunction|endothelial disfunction
171047|NCT02250989|Intercellular Adhesion Molecule-1|intercellular adhesion molecule-1
171048|NCT02250989|Vascular Cell Adhesion Molecule-1|vascular cell adhesion molecule-1
171049|NCT02250989|8-epi-prostaglandin F2alpha|8-epi-prostaglandin f2alpha
171050|NCT02250989|Nitric Oxide|nitric oxide
171051|NCT02250989|Plasminogen Activator Inhibitor 1|plasminogen activator inhibitor 1
162083|NCT02302573|MRI|mri
171052|NCT02250989|Endothelin-1|endothelin-1
171053|NCT02250989|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
171054|NCT02250989|Glucose|glucose
171055|NCT02250989|Insulin|insulin
171056|NCT02250989|C-peptide|c-peptide
171057|NCT02250989|C-reactive protein|c-reactive protein
171058|NCT02250989|3-nitrotyrosine|3-nitrotyrosine
171059|NCT02250963|Dobutamine Stress Echocardiography|dobutamine stress echocardiography
171060|NCT02250963|Computed tomography coronary angiography|computed tomography coronary angiography
171061|NCT02250950|self-determination theory|self-determination theory
171062|NCT02250950|motivational interviewing|motivational interviewing
171063|NCT02250950|exercise|exercise
171064|NCT02250950|physical activity|physical activity
171065|NCT02250937|Acute Myeloid Leukemia|acute myeloid leukemia
171067|NCT02250937|Myelodysplastic Syndrome|myelodysplastic syndrome
171068|NCT02250937|MDS|mds
171069|NCT02250937|Stem Cell Transplantation|stem cell transplantation
171070|NCT02250937|Busulfan|busulfan
171071|NCT02250937|Busulfex|busulfex
171072|NCT02250937|Myleran|myleran
171073|NCT02250937|Fludarabine|fludarabine
171074|NCT02250937|Fludarabine Phosphate|fludarabine phosphate
171075|NCT02250937|Fludara|fludara
171076|NCT02250937|Cladribine|cladribine
171077|NCT02250937|Leustatin|leustatin
171078|NCT02250937|2-CdA|2-cda
171079|NCT02250937|G-CSF|g-csf
171080|NCT02250937|Filgrastim|filgrastim
171081|NCT02250937|Neupogen|neupogen
171082|NCT02250937|Methotrexate|methotrexate
171083|NCT02250911|Caregivers of patients|caregivers of patients
171084|NCT02250911|CCC = Care for the Cancer Caregivers|ccc = care for the cancer caregivers
171085|NCT02250911|MCP-C = Meaning-Centered Psychotherapy for Cancer Caregivers|mcp-c = meaning-centered psychotherapy for cancer caregivers
171086|NCT02250911|14-208|14-208
171087|NCT02250898|Post Breast Surgery|post breast surgery
171088|NCT02250898|Myofascial Massage|myofascial massage
171089|NCT02250898|Pain|pain
171090|NCT02250898|Mobility Limitations|mobility limitations
171091|NCT02250885|Selinexor|selinexor
171092|NCT02250885|phase 2|phase 2
171093|NCT02250885|Gabrail|gabrail
171094|NCT02250872|Cisplatin|cisplatin
171095|NCT02250872|Nephrotoxicity|nephrotoxicity
171096|NCT02250872|Gemigliptin|gemigliptin
171097|NCT02250872|DPP4 inhibitor|dpp4 inhibitor
171098|NCT02250846|EGFR mutations|egfr mutations
171099|NCT02250846|asymptomatic brain metastases|asymptomatic brain metastases
171100|NCT02250846|EGFR-TKI|egfr-tki
171101|NCT02250846|Erlotinib|erlotinib
171102|NCT02250833|Hypertension|hypertension
171103|NCT02250833|CKD-828|ckd-828
171104|NCT02250833|Telmisartan|telmisartan
171105|NCT02250833|S-amlodipine|s-amlodipine
171106|NCT02250833|Pharmacokinetic|pharmacokinetic
171107|NCT02250820|Pediatric|pediatric
171108|NCT02250820|Sedation|sedation
171109|NCT02250820|Transthoracic echocardiography|transthoracic echocardiography
171110|NCT02250820|TTE|tte
171111|NCT02250820|Dexmedetomidine|dexmedetomidine
171112|NCT02250820|Pentobarbital|pentobarbital
171113|NCT02250807|Chronic hepatitis C|chronic hepatitis c
171114|NCT02250807|Genotype 4 chronic hepatitis C|genotype 4 chronic hepatitis c
171115|NCT02250807|Simeprevir|simeprevir
171116|NCT02250807|Sofosbuvir|sofosbuvir
171117|NCT02250794|diabetes mellitus|diabetes mellitus
171118|NCT02250794|inpatient management|inpatient management
171119|NCT02250794|metformin|metformin
171120|NCT02250794|sitagliptin|sitagliptin
171121|NCT02250768|GM-CSF, repeated implantation failure|gm-csf, repeated implantation failure
171122|NCT02250755|MRI perfusion|mri perfusion
171123|NCT02250755|therapeutic response|therapeutic response
171124|NCT02250755|chemotherapy|chemotherapy
171125|NCT02250755|brain metastases|brain metastases
171126|NCT02250742|ultrasound imaging|ultrasound imaging
171127|NCT02250742|acupuncture|acupuncture
171128|NCT02250742|back muscles|back muscles
171129|NCT02250742|spine|spine
171130|NCT02250742|muscle strength|muscle strength
171131|NCT02250729|anaphylaxis|anaphylaxis
171132|NCT02250729|pholcodine|pholcodine
171133|NCT02250729|neuromuscular blocking agents|neuromuscular blocking agents
171134|NCT02250716|CIN1|cin1
171135|NCT02250716|HIV seropositive women|hiv seropositive women
171136|NCT02250716|Cryotherapy|cryotherapy
171137|NCT02250703|Premedication|premedication
171138|NCT02250690|idiopathic PD|idiopathic pd
171139|NCT02250690|Hoehn and Yahr stage I to III|hoehn and yahr stage i to iii
171140|NCT02250690|stable medication usage|stable medication usage
171141|NCT02250690|age 40 to 80 years|age 40 to 80 years
171142|NCT02250690|absence of cognitive impairment|absence of cognitive impairment
171143|NCT02250677|physical activity|physical activity
171144|NCT02250677|Statin therapy|statin therapy
171145|NCT02250677|cardiovascular disease|cardiovascular disease
171146|NCT02250677|diabetes mellitus|diabetes mellitus
171147|NCT02250664|Biomarkers of exposure|biomarkers of exposure
171148|NCT02250664|Compensatory smoking|compensatory smoking
171149|NCT02250664|Nicotine dependence|nicotine dependence
171150|NCT02250664|Reduced nicotine cigarettes|reduced nicotine cigarettes
171151|NCT02250664|Tobacco withdrawal|tobacco withdrawal
171152|NCT02250664|Women|women
171153|NCT02250664|Health disparities|health disparities
171154|NCT02250664|Vulnerable populations|vulnerable populations
171155|NCT02250612|SYL040012|syl040012
171156|NCT02250612|bamosiran|bamosiran
171157|NCT02250612|siRNA|sirna
171158|NCT02250612|RNAi|rnai
171159|NCT02250612|Glaucoma|glaucoma
171160|NCT02250612|Ocular hypertension|ocular hypertension
171161|NCT02250599|Metastatic Nasopharyngeal Carcinoma|metastatic nasopharyngeal carcinoma
171162|NCT02250599|treatment|treatment
171163|NCT02250586|concerned significant other|concerned significant other
171164|NCT02250586|internet-delivered cognitive-behavioral therapy,|internet-delivered cognitive-behavioral therapy,
171165|NCT02250586|treatment-refusing problem gambler|treatment-refusing problem gambler
171167|NCT02250534|Compensatory smoking|compensatory smoking
171168|NCT02250534|Nicotine dependence|nicotine dependence
171169|NCT02250534|Reduced nicotine cigarettes|reduced nicotine cigarettes
171170|NCT02250534|Tobacco withdrawal|tobacco withdrawal
171171|NCT02250534|Women|women
171172|NCT02250534|Health disparities|health disparities
171173|NCT02250534|Vulnerable populations|vulnerable populations
171174|NCT02250521|BMI < 50 kg/m2|bmi < 50 kg/m2
171175|NCT02250521|Mallampatti class: III-IV|mallampatti class: iii-iv
171176|NCT02250521|Reduced mouth opening < 4 cm|reduced mouth opening < 4 cm
171177|NCT02250521|Neck circumference > 40 cm for females and > 43 cm for males|neck circumference > 40 cm for females and > 43 cm for males
171178|NCT02250521|Thyromental distance < 6 cm|thyromental distance < 6 cm
171179|NCT02250521|Ratio of the patient's height to thyromental distance ≥ 23.5|ratio of the patient's height to thyromental distance ≥ 23.5
171180|NCT02250521|Sternomental distance < 12 cm|sternomental distance < 12 cm
171181|NCT02250443|Inclusion Body Myositis (IBM)|inclusion body myositis (ibm)
171182|NCT02250430|acne|acne
171183|NCT02250365|stroke, acute|stroke, acute
171184|NCT02250365|upper extremity|upper extremity
171185|NCT02250365|rehabilitation|rehabilitation
171186|NCT02250365|electric stimulation therapy|electric stimulation therapy
171187|NCT02250339|Child Mental Health|child mental health
171188|NCT02250339|Parenting|parenting
171189|NCT02250339|Family Issues|family issues
171190|NCT02250326|Cancer of the lung|cancer of the lung
171191|NCT02250326|lung neoplasm|lung neoplasm
171192|NCT02250326|NSCLC - non-small cell lung cancer|nsclc - non-small cell lung cancer
171193|NCT02250326|Nonsquamou|nonsquamou
171194|NCT02250326|squamous|squamous
171195|NCT02250326|squamous NSCLC|squamous nsclc
171196|NCT02250326|Tumor|tumor
171197|NCT02250326|locally advanced NSCLC|locally advanced nsclc
171198|NCT02250326|metastatic NSCLC|metastatic nsclc
171199|NCT02250326|advanced lung cancer|advanced lung cancer
171200|NCT02250326|metastatic lung cancer|metastatic lung cancer
171201|NCT02250326|non-squamous NSCLC|non-squamous nsclc
171202|NCT02250326|lung cancer|lung cancer
171203|NCT02250326|Abraxane|abraxane
171204|NCT02250326|ABI-007|abi-007
171205|NCT02250326|nab-paclitaxel|nab-paclitaxel
171206|NCT02250326|albumin-bound paclitaxel|albumin-bound paclitaxel
171207|NCT02250326|taxanes|taxanes
171208|NCT02250326|CC-486|cc-486
171209|NCT02250326|oral azacitidine|oral azacitidine
171210|NCT02250326|azacitidine|azacitidine
171211|NCT02250326|second line treatment of lung cancer|second line treatment of lung cancer
171212|NCT02250326|second line treatment|second line treatment
171213|NCT02250326|Celgene|celgene
171214|NCT02250326|abound.2L|abound.2l
171497|NCT02248688|Obesity|obesity
171215|NCT02250326|third line treatment|third line treatment
171216|NCT02250326|durvalumab|durvalumab
171217|NCT02250326|immunotherapy|immunotherapy
171218|NCT02250326|MEDI4736|medi4736
171219|NCT02250313|prostate cancer|prostate cancer
171220|NCT02250287|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
171221|NCT02250287|magnetic resonance imaging parameters|magnetic resonance imaging parameters
171416|NCT02249143|Prematurity|prematurity
171222|NCT02250287|magnetic resonance elastography|magnetic resonance elastography
171223|NCT02250287|apparent diffusion coefficient|apparent diffusion coefficient
171224|NCT02250287|blood oxygen level determinations|blood oxygen level determinations
171225|NCT02250287|diffusion weighted imaging|diffusion weighted imaging
171226|NCT02250274|Immune response to influenza vaccine|immune response to influenza vaccine
171227|NCT02250274|PCR confirmed Influenza A virus|pcr confirmed influenza a virus
171228|NCT02250274|PCR confirmed Influenza B virus|pcr confirmed influenza b virus
171229|NCT02250261|walking|walking
171230|NCT02250261|cycling|cycling
171231|NCT02250261|intervention|intervention
171232|NCT02250261|physical activity|physical activity
171233|NCT02250261|environment|environment
171234|NCT02250261|promotion|promotion
171235|NCT02250248|Degenerative disc disease|degenerative disc disease
171236|NCT02250248|Lumbar spine|lumbar spine
171237|NCT02250209|Gastric Cancer|gastric cancer
171238|NCT02250209|HER2-positive|her2-positive
171239|NCT02250209|Trastuzumab|trastuzumab
171240|NCT02250209|XELOX|xelox
171241|NCT02250209|Stage III|stage iii
171242|NCT02250209|D2 Gastrectomy|d2 gastrectomy
171243|NCT02250196|Bowel preparation|bowel preparation
171244|NCT02250196|Polyethylene glycol with ascorbic acid|polyethylene glycol with ascorbic acid
171245|NCT02250196|Sodium picosulfate with magnesium citrate|sodium picosulfate with magnesium citrate
171246|NCT02250183|Medihoney|medihoney
171247|NCT02250183|Santyl|santyl
171248|NCT02250183|Burns|burns
171249|NCT02250144|Patellofemoral pain syndrome|patellofemoral pain syndrome
171250|NCT02250144|Feet orthoses|feet orthoses
171251|NCT02250144|KOOS|koos
171252|NCT02250131|cardiopulmonary bypass|cardiopulmonary bypass
171253|NCT02250118|pleural|pleural
171254|NCT02250118|effusion|effusion
171255|NCT02250118|breast|breast
171256|NCT02250118|cancer|cancer
171257|NCT02250092|Cerebral Palsy|cerebral palsy
171258|NCT02250092|Hemiparesis|hemiparesis
171259|NCT02250092|Stroke|stroke
171260|NCT02250092|Non-Invasive Brain Stimulation|non-invasive brain stimulation
171261|NCT02250092|Transcranial Direct Current Stimulation|transcranial direct current stimulation
171262|NCT02250092|Constraint-Induced Movement Therapy|constraint-induced movement therapy
171263|NCT02250092|Diffusion Tensor Imaging|diffusion tensor imaging
171264|NCT02250092|Congenital Hemiparesis|congenital hemiparesis
171265|NCT02250053|stage II and stage III colon cancer survivors, who have completed curative treatment i.e., surgical resection and chemotherapy for their colon cancer|stage ii and stage iii colon cancer survivors, who have completed curative treatment i.e., surgical resection and chemotherapy for their colon cancer
171267|NCT02250040|Rehabilitation|rehabilitation
171268|NCT02250040|Physiotherapy|physiotherapy
171269|NCT02250040|Functional Recovery|functional recovery
171270|NCT02250027|acute bronchitis|acute bronchitis
171271|NCT02250027|acute exacerbations of chronic bronchitis|acute exacerbations of chronic bronchitis
171273|NCT02249962|prospective|prospective
171274|NCT02249962|cohort|cohort
171275|NCT02249936|Volunteers|volunteers
171276|NCT02249923|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
171277|NCT02249923|Pulmonary Vascular Disease (PVD)|pulmonary vascular disease (pvd)
171278|NCT02249923|Registry|registry
171279|NCT02249923|Pediatric|pediatric
171280|NCT02249884|radiodermatitis|radiodermatitis
171281|NCT02249884|head and neck neoplasms|head and neck neoplasms
171282|NCT02249884|Breast Neoplasms|breast neoplasms
171283|NCT02249884|Urea|urea
171284|NCT02249884|Matricaria|matricaria
171285|NCT02249884|chamomilla|chamomilla
171286|NCT02249884|chamomile|chamomile
171287|NCT02249858|cervical spine|cervical spine
171288|NCT02249858|OMT|omt
171289|NCT02249858|HVLA|hvla
171290|NCT02249858|ultrasound|ultrasound
171291|NCT02249845|dehydration|dehydration
171292|NCT02249845|children|children
171293|NCT02249845|gastroenteritis|gastroenteritis
171294|NCT02249832|stroke|stroke
171295|NCT02249832|CVA|cva
171296|NCT02249832|cerebrovascular accident|cerebrovascular accident
171297|NCT02249832|cerebral stroke|cerebral stroke
171298|NCT02249832|robotic therapy|robotic therapy
171299|NCT02249832|anklebot|anklebot
171300|NCT02249832|physical therapy|physical therapy
171301|NCT02249819|stroke|stroke
171302|NCT02249819|aphasia|aphasia
171303|NCT02249819|CVA|cva
171304|NCT02249819|apraxia|apraxia
171305|NCT02249819|cerebrovascular accident|cerebrovascular accident
171306|NCT02249819|cerebral stroke|cerebral stroke
171307|NCT02249819|speech therapy|speech therapy
171308|NCT02249819|aphasia therapy|aphasia therapy
171309|NCT02249819|non-invasive brain stimulation|non-invasive brain stimulation
171310|NCT02249819|transcranial direct current stimulation|transcranial direct current stimulation
171311|NCT02249819|tDCS|tdcs
171498|NCT02248688|Weight Loss|weight loss
171312|NCT02249806|Pulmonary Hypertension|pulmonary hypertension
171313|NCT02249806|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
171314|NCT02249806|Pulmonary arterial hypertension|pulmonary arterial hypertension
171315|NCT02249806|Outcome|outcome
171316|NCT02249793|circadian|circadian
171317|NCT02249793|oscillation|oscillation
171318|NCT02249793|clock|clock
171319|NCT02249793|human|human
171320|NCT02249793|social behavior|social behavior
171321|NCT02249793|cell phone with internet access (so-called smartphone)|cell phone with internet access (so-called smartphone)
171322|NCT02249793|social sensing|social sensing
171323|NCT02249793|behavioral feature|behavioral feature
171324|NCT02249793|Ginger.io|ginger.io
171325|NCT02249793|blood pressure|blood pressure
171326|NCT02249793|metabolism|metabolism
171327|NCT02249793|metabolomics|metabolomics
171328|NCT02249793|gut bacteria|gut bacteria
171329|NCT02249793|microbiome|microbiome
171330|NCT02249780|Parathyroid gland angiography|parathyroid gland angiography
171331|NCT02249780|Parathyroid gland indocyanine green angiography|parathyroid gland indocyanine green angiography
171332|NCT02249780|Parathyroid gland indocyanine green fluoroscopy|parathyroid gland indocyanine green fluoroscopy
171333|NCT02249754|Nutrition education|nutrition education
171334|NCT02249754|Maternal counselling|maternal counselling
171335|NCT02249754|Complementary feeding|complementary feeding
171336|NCT02249754|Infant growth|infant growth
171337|NCT02249754|Micronutrients|micronutrients
171338|NCT02249754|Tanzania|tanzania
171339|NCT02249715|Parkinson|parkinson
171340|NCT02249715|TMS|tms
171341|NCT02249715|BNA|bna
208342|NCT02079402|ICU|icu
171342|NCT02249702|trabectedin|trabectedin
171343|NCT02249702|uterine leiomyosarcoma|uterine leiomyosarcoma
171344|NCT02249676|Autologous mesenchymal stem cells|autologous mesenchymal stem cells
171345|NCT02249676|neuromyelitis optica|neuromyelitis optica
171346|NCT02249676|treatment|treatment
171347|NCT02249663|Bioequivalence|bioequivalence
171348|NCT02249650|metastatic colorectal cancer|metastatic colorectal cancer
171349|NCT02249650|TSB-9-W1|tsb-9-w1
171350|NCT02249624|Twin to twin transfusion syndrome|twin to twin transfusion syndrome
171351|NCT02249624|Developmental disabilities|developmental disabilities
171352|NCT02249624|Magnetic resonance imaging|magnetic resonance imaging
171353|NCT02249611|Physical activity|physical activity
171354|NCT02249611|mobile activity sensor and feedback system|mobile activity sensor and feedback system
171355|NCT02249611|self-management of health|self-management of health
171356|NCT02249572|Vestibular schwannoma|vestibular schwannoma
171357|NCT02249572|Radiosurgery|radiosurgery
171358|NCT02249572|Neurosurgery|neurosurgery
171359|NCT02249572|Randomized|randomized
171360|NCT02249533|Spot Light|spot light
171361|NCT02249533|High School RIO|high school rio
171362|NCT02249533|Concussion|concussion
171363|NCT02249533|Injury Prevention|injury prevention
171364|NCT02249533|Football|football
171365|NCT02249533|Pop Warner|pop warner
171366|NCT02249533|High School|high school
171367|NCT02249533|Middle School|middle school
171368|NCT02249520|Magnetic Resonance Imaging|magnetic resonance imaging
171370|NCT02249520|Positron Emission Tomography|positron emission tomography
171371|NCT02249520|PET|pet
171372|NCT02249520|PET-MR|pet-mr
171373|NCT02249520|mMR|mmr
171374|NCT02249507|Resistant Hypertension|resistant hypertension
171375|NCT02249507|Aerobic Exercise|aerobic exercise
171376|NCT02249494|Nutritional Knowledge|nutritional knowledge
171377|NCT02249494|Nutritional Counseling|nutritional counseling
171378|NCT02249481|Anaesthetic|anaesthetic
171379|NCT02249481|total knee replacement|total knee replacement
171380|NCT02249481|Femoral nerve catheter|femoral nerve catheter
171381|NCT02249481|Adductor canal catheter|adductor canal catheter
171382|NCT02249429|Non Hodgkin Lymphoma|non hodgkin lymphoma
171383|NCT02249377|Baker's Cyst|baker's cyst
171384|NCT02249325|group B Streptococcus colonization|group b streptococcus colonization
171385|NCT02249325|Probiotic|probiotic
171386|NCT02249325|Pregnancy|pregnancy
171387|NCT02249299|ADHD,|adhd,
171388|NCT02249299|Cannabis,|cannabis,
171389|NCT02249299|Sativex,|sativex,
171390|NCT02249299|Endocannabinoid,|endocannabinoid,
171391|NCT02249299|Cognition|cognition
171392|NCT02249286|Child Centered Counseling|child centered counseling
171393|NCT02249286|Home based food production|home based food production
171394|NCT02249286|Nutrition|nutrition
171395|NCT02249286|Health|health
171396|NCT02249286|IYCF|iycf
171397|NCT02249260|Exercise, cardiac rehabilitation, quality of life|exercise, cardiac rehabilitation, quality of life
171398|NCT02249234|Scrotal pain|scrotal pain
171399|NCT02249234|Botox|botox
171400|NCT02249221|Influenza vaccine|influenza vaccine
171401|NCT02249221|Vaccination|vaccination
171402|NCT02249221|cell-culture based influenza vaccine|cell-culture based influenza vaccine
171403|NCT02249221|cell culture derived influenza vaccine|cell culture derived influenza vaccine
171404|NCT02249221|CCIV|cciv
171405|NCT02249208|Breast Cancer|breast cancer
171406|NCT02249208|Sentinel Lymph Node|sentinel lymph node
171407|NCT02249208|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
171408|NCT02249208|Clinically Node-Positive with biopsy-proven cN1|clinically node-positive with biopsy-proven cn1
171409|NCT02249208|False-negative Rate|false-negative rate
171410|NCT02249195|ECG loop recorder, pregnant women, arrhythmias|ecg loop recorder, pregnant women, arrhythmias
171411|NCT02249169|IBS|ibs
171412|NCT02249156|Health economics|health economics
171413|NCT02249156|Financial incentives|financial incentives
171414|NCT02249156|Health care spending|health care spending
171415|NCT02249143|Continuous positive airway pressure|continuous positive airway pressure
171417|NCT02249143|Respiratory distress syndrome|respiratory distress syndrome
171418|NCT02249143|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
171419|NCT02249078|Crohn's Disease|crohn's disease
171420|NCT02249013|Ovarian Cancer|ovarian cancer
171421|NCT02248974|End-Stage Heart Failure|end-stage heart failure
171422|NCT02248974|Left Ventricular Assist Device|left ventricular assist device
171423|NCT02248974|Decision Aid|decision aid
171424|NCT02248974|Medical Decision-Making|medical decision-making
171425|NCT02248948|Omega-3|omega-3
171426|NCT02248948|ADHD|adhd
171427|NCT02248948|Quality of Life|quality of life
171428|NCT02248948|Inattention|inattention
171429|NCT02248948|Hyperactivity|hyperactivity
171430|NCT02248935|Robotic Assisted Laparoscopic Sacrocolpopexy|robotic assisted laparoscopic sacrocolpopexy
171431|NCT02248935|Y Mesh|y mesh
171432|NCT02248935|Pelvic Organ Prolapse|pelvic organ prolapse
402930|NCT01229033|Atrial fibrillation|atrial fibrillation
402931|NCT01229033|ablation|ablation
402932|NCT01229033|atrial flutter|atrial flutter
402933|NCT01229020|Emphysema|emphysema
162495|NCT02300376|GFR|gfr
171433|NCT02248922|Cystic Fibrosis, Pseudomonas aeruginosa, Lung Clearance Index, Multiple Breath Washout, Inhaled Tobramycin, Inhaled Antibiotics.|cystic fibrosis, pseudomonas aeruginosa, lung clearance index, multiple breath washout, inhaled tobramycin, inhaled antibiotics.
171434|NCT02248909|COPD, Primary Care, Spirometry, Risk factors|copd, primary care, spirometry, risk factors
171435|NCT02248870|femoral neck|femoral neck
171436|NCT02248857|UMS|ums
171437|NCT02248857|medication schedule|medication schedule
171438|NCT02248857|diabetes|diabetes
171439|NCT02248857|drug labeling|drug labeling
171440|NCT02248831|Dyspnea|dyspnea
171441|NCT02248831|Acute decompensated heart failure|acute decompensated heart failure
171442|NCT02248831|Doppler ultrasound|doppler ultrasound
171443|NCT02248831|Lung Doppler signals|lung doppler signals
171444|NCT02248805|colon cancer|colon cancer
171445|NCT02248805|colorectal carcinoma|colorectal carcinoma
171446|NCT02248805|stage IV colorectal cancer|stage iv colorectal cancer
171447|NCT02248779|Diabetes Risk|diabetes risk
171448|NCT02248779|14-202|14-202
171449|NCT02248753|Atrial fibrillation|atrial fibrillation
171450|NCT02248753|Electrical cardioversion|electrical cardioversion
171451|NCT02248753|Pharmacological cardioversion|pharmacological cardioversion
171452|NCT02248753|Rhythm control|rhythm control
171453|NCT02248753|Rate control|rate control
171454|NCT02248740|chronic venous insufficiency|chronic venous insufficiency
171455|NCT02248740|varicose vein|varicose vein
171456|NCT02248740|small saphenous vein|small saphenous vein
171457|NCT02248701|Testosterone|testosterone
171458|NCT02248701|Testosterone enanthate|testosterone enanthate
171459|NCT02248701|Testosterone undecanoate|testosterone undecanoate
171460|NCT02248701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
171461|NCT02248701|Methyltestosterone|methyltestosterone
171462|NCT02248701|Androgens|androgens
171463|NCT02248701|Hormones|hormones
171464|NCT02248701|Hormone Substitutes, and Hormone Antagonists|hormone substitutes, and hormone antagonists
171465|NCT02248701|Physiologic Effects of Drugs|physiologic effects of drugs
171466|NCT02248701|Pharmacologic Actions|pharmacologic actions
171467|NCT02248701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
171468|NCT02248701|Antineoplastic Agents|antineoplastic agents
171469|NCT02248701|Therapeutic Uses|therapeutic uses
171470|NCT02248701|Anabolic Agents|anabolic agents
171471|NCT02248701|Testosterone Replacement Therapy|testosterone replacement therapy
171472|NCT02248701|Dual Energy X ray Absorptiometry|dual energy x ray absorptiometry
171473|NCT02248701|Lean Tissue Mass|lean tissue mass
171474|NCT02248701|Body Composition|body composition
171475|NCT02248701|Lipid and Glucose profile|lipid and glucose profile
171476|NCT02248701|Muscle Strength|muscle strength
171477|NCT02248701|5-alpha Reductase|5-alpha reductase
171478|NCT02248701|Muscle Mass|muscle mass
171479|NCT02248701|Bone Mineral Density|bone mineral density
171480|NCT02248701|Adipose Tissue|adipose tissue
171481|NCT02248701|Body Fat|body fat
171482|NCT02248701|Density, Bone|density, bone
171483|NCT02248701|Bone Formation|bone formation
171484|NCT02248701|Bone Resorption|bone resorption
171485|NCT02248701|Bone Density Conservation Agents|bone density conservation agents
171486|NCT02248701|Magnetic Resonance Imaging|magnetic resonance imaging
171487|NCT02248701|Muscle, Skeletal|muscle, skeletal
171488|NCT02248701|Bone and Bones|bone and bones
171489|NCT02248701|Gait|gait
171490|NCT02248701|Walking|walking
171491|NCT02248701|Locomotion|locomotion
171492|NCT02248701|Motor Activity|motor activity
171493|NCT02248688|Bariatric Embolization|bariatric embolization
171494|NCT02248688|Gastric Artery Emboliziation|gastric artery emboliziation
171495|NCT02248688|Left Gastric Artery Embolization|left gastric artery embolization
171496|NCT02248688|Morbid Obesity|morbid obesity
171499|NCT02248688|Ghrelin|ghrelin
171500|NCT02248688|Embolization|embolization
171501|NCT02248675|sleep disorders|sleep disorders
171502|NCT02248675|insomnia|insomnia
171503|NCT02248675|suicidal ideation|suicidal ideation
171504|NCT02248675|Depression|depression
171505|NCT02248675|Depressive disorders|depressive disorders
171506|NCT02248675|PTSD|ptsd
171507|NCT02248675|anxiety disorders|anxiety disorders
171508|NCT02248675|suicide|suicide
171509|NCT02248675|cognitive behavioral therapy|cognitive behavioral therapy
171511|NCT02248662|PCORI|pcori
171512|NCT02248662|ductal carcinoma in situ|ductal carcinoma in situ
171513|NCT02248662|radiation|radiation
171514|NCT02248662|oncology|oncology
171515|NCT02248662|patient-centered|patient-centered
171516|NCT02248662|decision aid|decision aid
171517|NCT02248662|decision-making|decision-making
171518|NCT02248649|Parkinson's disease|parkinson's disease
171519|NCT02248649|Exercise therapy|exercise therapy
171520|NCT02248649|Mild cognitive impairment|mild cognitive impairment
171521|NCT02248636|Alzheimer's disease|alzheimer's disease
171522|NCT02248636|Cholinesterase inhibitor|cholinesterase inhibitor
171523|NCT02248636|Discontinuation|discontinuation
171524|NCT02248623|Anaesthesia|anaesthesia
171525|NCT02248623|Isolated forearm test|isolated forearm test
171526|NCT02248623|Responsiveness|responsiveness
171527|NCT02248623|Laryngoscopy|laryngoscopy
171528|NCT02248623|Intubation|intubation
171529|NCT02248610|Pulmonary embolism|pulmonary embolism
171530|NCT02248610|PE|pe
171531|NCT02248610|Deep vein thrombosis|deep vein thrombosis
171532|NCT02248610|DVT|dvt
171533|NCT02248610|Rivaroxaban|rivaroxaban
171534|NCT02248610|Venous thromboembolism|venous thromboembolism
171535|NCT02248610|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
171536|NCT02248610|Post thrombotic limb syndrome|post thrombotic limb syndrome
171537|NCT02248610|Root cause analysis|root cause analysis
171538|NCT02248571|breast cancer|breast cancer
171539|NCT02248571|advanced|advanced
171540|NCT02248571|inoperable|inoperable
171541|NCT02248571|metastatic|metastatic
171542|NCT02248571|HER2/neu-negative|her2/neu-negative
171543|NCT02248571|hormone receptor positive|hormone receptor positive
171544|NCT02248571|HR+|hr+
171545|NCT02248571|female|female
171546|NCT02248571|postmenopausal|postmenopausal
171547|NCT02248558|Contest|contest
171548|NCT02248558|Crowdsourcing|crowdsourcing
171549|NCT02248558|Innovation|innovation
171550|NCT02248558|Randomized controlled trial|randomized controlled trial
171552|NCT02248558|Social entrepreneurship|social entrepreneurship
171553|NCT02248545|Non-Celiac Wheat Sensitivity|non-celiac wheat sensitivity
171554|NCT02248545|Autoimmune diseases|autoimmune diseases
171555|NCT02248545|Anti-nuclear antibodies|anti-nuclear antibodies
171556|NCT02248545|Celiac disease|celiac disease
171557|NCT02248545|Irritable bowel syndrome|irritable bowel syndrome
171558|NCT02248519|Gastric cancer|gastric cancer
171559|NCT02248519|Gastrectomy|gastrectomy
171560|NCT02248519|Laparoscopy|laparoscopy
171561|NCT02248506|Candidiasis|candidiasis
171562|NCT02248493|Pain, Postoperative|pain, postoperative
171563|NCT02248493|Paracetamol|paracetamol
171564|NCT02248493|Administration, Intravenous|administration, intravenous
171565|NCT02248493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
171566|NCT02248493|Child|child
171567|NCT02248493|Adolescent|adolescent
171568|NCT02248467|Testosterone replacement therapy|testosterone replacement therapy
171569|NCT02248428|multiple myeloma|multiple myeloma
171570|NCT02248428|Clarithromycin|clarithromycin
171571|NCT02248428|CTd|ctd
171572|NCT02248415|Cardioplegic Solutions|cardioplegic solutions
171573|NCT02248415|Myocardial Ischemia|myocardial ischemia
171574|NCT02248389|carcinoma, renal cell|carcinoma, renal cell
171575|NCT02248389|ablation|ablation
171576|NCT02248389|laparoscopic surgery|laparoscopic surgery
171577|NCT02248389|high intensity focused ultrasound|high intensity focused ultrasound
171578|NCT02248376|Uterine synechiae Scraping surgery Natural miscarriage|uterine synechiae scraping surgery natural miscarriage
171579|NCT02248363|Rehabilitation|rehabilitation
171580|NCT02248363|Effectiveness|effectiveness
171581|NCT02248363|Determinants|determinants
171582|NCT02248363|Prediction|prediction
171583|NCT02248350|prostate cancer|prostate cancer
171584|NCT02248350|physical activity|physical activity
171585|NCT02248350|exercise|exercise
171586|NCT02248350|intervention|intervention
171587|NCT02248350|side effects|side effects
171588|NCT02248350|androgen deprivation therapy|androgen deprivation therapy
171589|NCT02248337|Colon preparation; Colonoscopy; Inflammatory bowel disease|colon preparation; colonoscopy; inflammatory bowel disease
171590|NCT02248324|Age-related macular degeneration, genetic polymorphisms|age-related macular degeneration, genetic polymorphisms
171591|NCT02248298|Ablative fractional laser|ablative fractional laser
171592|NCT02248298|Actinic keratosis|actinic keratosis
171593|NCT02248298|Efficacy|efficacy
171594|NCT02248298|Photodynamic therapy|photodynamic therapy
171595|NCT02248298|Short incubation time|short incubation time
171596|NCT02248285|multiplex|multiplex
171597|NCT02248285|polymerase chain reaction|polymerase chain reaction
171598|NCT02248285|PCR|pcr
171599|NCT02248285|BioFire Diagnostics|biofire diagnostics
171600|NCT02248285|Infectious gastroenteritis|infectious gastroenteritis
171601|NCT02248285|Diarrheal disease|diarrheal disease
171602|NCT02248285|Emergency department|emergency department
171603|NCT02248285|rapid diagnostics|rapid diagnostics
171604|NCT02248285|FilmArray|filmarray
171605|NCT02248285|FilmArray GI Panel|filmarray gi panel
171606|NCT02248272|Polycystic ovary syndrome|polycystic ovary syndrome
171607|NCT02248272|Type 2 Diabetes|type 2 diabetes
171608|NCT02248272|Hyperinsulinemia|hyperinsulinemia
171609|NCT02248272|Meal frequency|meal frequency
171610|NCT02248246|Hemostasis|hemostasis
171611|NCT02248246|Harmonic ACE®+7 Shears|harmonic ace®+7 shears
171612|NCT02248246|Laparoscopic|laparoscopic
171613|NCT02248246|Inferior mesenteric artery|inferior mesenteric artery
171614|NCT02248246|Inferior mesenteric vein|inferior mesenteric vein
171615|NCT02248246|Observational|observational
171616|NCT02248233|nimodipine|nimodipine
171617|NCT02248233|acute massive cerebral infarction|acute massive cerebral infarction
171618|NCT02248233|Cerebral Infarction|cerebral infarction
171619|NCT02248233|optimal therapeutic time window|optimal therapeutic time window
171620|NCT02248233|optimal dose|optimal dose
171621|NCT02248233|multi-center|multi-center
171622|NCT02248194|Dysfunction uterine bleeding|dysfunction uterine bleeding
171623|NCT02248194|Hysteroscopic endometrial ablation|hysteroscopic endometrial ablation
171624|NCT02248194|Tactile endometrial ablation|tactile endometrial ablation
171625|NCT02248194|Hysteroscopic difficulties|hysteroscopic difficulties
171626|NCT02248194|Quality of life|quality of life
171627|NCT02248194|Satisfaction|satisfaction
171628|NCT02248090|Phase 1|phase 1
171629|NCT02248090|Safety|safety
171630|NCT02248090|Tolerability|tolerability
171631|NCT02248090|Pharmacokinetics|pharmacokinetics
171632|NCT02248090|Ascending Doses|ascending doses
171633|NCT02248090|Estrogen Receptor Positive|estrogen receptor positive
171634|NCT02248090|Her2 Negative|her2 negative
171635|NCT02248090|Advanced Breast Cancer|advanced breast cancer
171636|NCT02248064|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
171637|NCT02248064|Long term oxygen therapy|long term oxygen therapy
171638|NCT02248064|Auto-titrating oxygen system|auto-titrating oxygen system
171639|NCT02248064|Intelligent oxygen therapy|intelligent oxygen therapy
171640|NCT02248064|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
171641|NCT02248025|Fluid responsiveness|fluid responsiveness
171642|NCT02248025|capillary refill time|capillary refill time
171643|NCT02248025|microcirculation|microcirculation
171644|NCT02248025|circulatory failure|circulatory failure
171645|NCT02248025|passive leg raising|passive leg raising
171646|NCT02248012|Gastroenteropancreatic|gastroenteropancreatic
171647|NCT02248012|Neuroendocrine carcinoma|neuroendocrine carcinoma
171648|NCT02248012|Chemotherapy|chemotherapy
171649|NCT02247999|Cervical Cancer|cervical cancer
171650|NCT02247999|HIV/AIDS|hiv/aids
171651|NCT02247999|HPV|hpv
171652|NCT02247999|Biomarkers|biomarkers
171653|NCT02247999|Screening|screening
171654|NCT02247986|Conduct Disorder|conduct disorder
171655|NCT02247986|Methylphenidate|methylphenidate
171656|NCT02247986|Disruptive Behavior Disorders|disruptive behavior disorders
171657|NCT02247947|CPR|cpr
171658|NCT02247934|Primary sclerosing cholangitis|primary sclerosing cholangitis
171659|NCT02247934|PSC|psc
171660|NCT02247921|caregiver delivered rehabilitation|caregiver delivered rehabilitation
171661|NCT02247921|nurse-organized service|nurse-organized service
171662|NCT02247921|disabled stroke patients|disabled stroke patients
171663|NCT02247908|Cigarette smoking|cigarette smoking
171664|NCT02247908|Smoke|smoke
171665|NCT02247908|Smoking|smoking
171666|NCT02247908|Tobacco Use|tobacco use
171667|NCT02247895|ICU Acquired weakness|icu acquired weakness
171668|NCT02247895|Critical illness|critical illness
171669|NCT02247895|Mechanical ventilation|mechanical ventilation
171670|NCT02247882|Osteoarthritis|osteoarthritis
171671|NCT02247882|Patient Education|patient education
171672|NCT02247882|Aquatic Exercise|aquatic exercise
171673|NCT02247882|kinetic|kinetic
171674|NCT02247869|HL|hl
171675|NCT02247869|Hodgkin Lymphoma|hodgkin lymphoma
171676|NCT02247869|First line therapy|first line therapy
171677|NCT02247856|nebulizers,|nebulizers,
171678|NCT02247856|noninvasive ventilation|noninvasive ventilation
171679|NCT02247856|COPD|copd
171680|NCT02247856|scintigraphy,|scintigraphy,
171681|NCT02247856|aerosol|aerosol
171682|NCT02247843|Sickle Cell Disease (SCD)|sickle cell disease (scd)
171683|NCT02247843|Gene Therapy|gene therapy
171684|NCT02247843|Lentiviral Vector|lentiviral vector
171685|NCT02247843|Beta Globin|beta globin
171686|NCT02247830|Radiodermatitis|radiodermatitis
171687|NCT02247830|Head and neck neoplasms|head and neck neoplasms
171688|NCT02247830|Radiotherapy|radiotherapy
171689|NCT02247830|Urea|urea
171690|NCT02247830|Matricaria|matricaria
171691|NCT02247830|Breast Neoplasms|breast neoplasms
171692|NCT02247830|chamomilla|chamomilla
171693|NCT02247830|chamomile|chamomile
171694|NCT02247778|clavicle|clavicle
171695|NCT02247778|surgical intervention|surgical intervention
171696|NCT02247778|mini-incision|mini-incision
171697|NCT02247778|plate osteosynthesis|plate osteosynthesis
171698|NCT02247752|hepatitis|hepatitis
171699|NCT02247752|HBV|hbv
171700|NCT02247752|chronic hepatitis|chronic hepatitis
171701|NCT02247752|HCC|hcc
171702|NCT02247752|cirrhosis|cirrhosis
171703|NCT02247752|quantitative HBsAg|quantitative hbsag
171704|NCT02247752|HBsAg inactive carriers|hbsag inactive carriers
171705|NCT02247739|HAE|hae
171706|NCT02247739|Hereditary Angioedema|hereditary angioedema
171707|NCT02247739|Prophylaxis|prophylaxis
171708|NCT02247726|RSV|rsv
171709|NCT02247726|Third Trimester|third trimester
171710|NCT02247726|Maternal Immunization|maternal immunization
171711|NCT02247713|PET|pet
171712|NCT02247713|radiotherapy|radiotherapy
171713|NCT02247713|international|international
171714|NCT02247713|NSCLC|nsclc
171715|NCT02247713|overall survival|overall survival
171716|NCT02247713|low and middle income countries|low and middle income countries
171717|NCT02247700|Pediatrics|pediatrics
171718|NCT02247700|ARDS|ards
171719|NCT02247700|ARF|arf
171720|NCT02247700|ALI|ali
171721|NCT02247700|Respiratory|respiratory
171722|NCT02247700|Mechanical ventilation|mechanical ventilation
171723|NCT02247700|Ventilation|ventilation
171724|NCT02247700|Noninvasive monitoring|noninvasive monitoring
171725|NCT02247700|electrical impedance tomography|electrical impedance tomography
171726|NCT02247700|EIT|eit
171727|NCT02247687|HIV-1|hiv-1
171728|NCT02247687|antiretroviral treatment|antiretroviral treatment
171729|NCT02247687|viral load|viral load
171730|NCT02247674|Stroke, Cerebrovascular accident, Rehabilitation, Upper extremity|stroke, cerebrovascular accident, rehabilitation, upper extremity
171731|NCT02247661|Femoral neck fracture,surgical approach, limp, abductor strenght, trochanteric pain|femoral neck fracture,surgical approach, limp, abductor strenght, trochanteric pain
171732|NCT02247648|tramadol|tramadol
171733|NCT02247648|shoulder surgery|shoulder surgery
171734|NCT02247648|pain|pain
171735|NCT02247648|interscalen block|interscalen block
171736|NCT02247648|BUPRENORPHINE/HYDROMORPHONE [VA Drug Interaction]|buprenorphine/hydromorphone [va drug interaction]
171737|NCT02247635|Treatment adherence|treatment adherence
171738|NCT02247635|Behavioral model of health care|behavioral model of health care
171739|NCT02247635|Healthy lifestyle|healthy lifestyle
171740|NCT02247635|Chronic metabolic diseases|chronic metabolic diseases
171741|NCT02247635|Metabolic syndrome|metabolic syndrome
171743|NCT02247622|telomeres|telomeres
171744|NCT02247622|PSC|psc
171746|NCT02247609|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
171747|NCT02247609|Burkitt lymphoma|burkitt lymphoma
171748|NCT02247609|diffused large B cell lymphoma|diffused large b cell lymphoma
171749|NCT02247609|B cell malignancy|b cell malignancy
171750|NCT02247596|Resveratrol|resveratrol
171751|NCT02247596|obesity|obesity
171752|NCT02247596|insulin resistance|insulin resistance
171753|NCT02247596|energy expenditure|energy expenditure
171754|NCT02247596|diabetes|diabetes
171755|NCT02247570|Vestibular Rehabilitation|vestibular rehabilitation
171756|NCT02247570|PTSD|ptsd
171757|NCT02247570|DSM-IV|dsm-iv
171758|NCT02247557|IC/PBS|ic/pbs
171759|NCT02247557|VAS|vas
171760|NCT02247557|Botulinum Toxin A|botulinum toxin a
171761|NCT02247557|Lipotoxin|lipotoxin
171762|NCT02247544|STS, leiomyosarcoma, liposarcoma, trabectedin|sts, leiomyosarcoma, liposarcoma, trabectedin
171763|NCT02247518|Male|male
171764|NCT02247518|Volunteers|volunteers
171765|NCT02247492|International|international
171766|NCT02247492|Multicenter|multicenter
171767|NCT02247492|Observational registry|observational registry
171768|NCT02247492|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
171769|NCT02247492|Stenting|stenting
171770|NCT02247492|Treatment of coronary artery disease|treatment of coronary artery disease
171771|NCT02247492|Coronary revascularization|coronary revascularization
171772|NCT02247492|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
171773|NCT02247492|STEMI|stemi
171774|NCT02247492|NSTEMI|nstemi
171775|NCT02247492|Ischemia|ischemia
171776|NCT02247492|Angina|angina
171777|NCT02247492|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
171778|NCT02247492|Small Vessels|small vessels
171779|NCT02247492|Chronic Total Occlusion (CTO|chronic total occlusion (cto
171780|NCT02247466|Neuromuscular Blockade|neuromuscular blockade
171781|NCT02247466|Laparoscopy|laparoscopy
171782|NCT02247453|lung cancer|lung cancer
171783|NCT02247453|clinical trial|clinical trial
171784|NCT02247453|screening|screening
171785|NCT02247453|microRNA|microrna
171786|NCT02247453|biomarkers|biomarkers
171787|NCT02247440|HCV|hcv
171788|NCT02247440|HIV|hiv
171789|NCT02247440|Thailand|thailand
171790|NCT02247440|pegylated interferon|pegylated interferon
171791|NCT02247440|ribavirin|ribavirin
171792|NCT02247427|Heart failure|heart failure
171793|NCT02247427|Super responder|super responder
171794|NCT02247414|Cirrhosis|cirrhosis
171795|NCT02247414|Hypertension|hypertension
171796|NCT02247414|venous thrombosis|venous thrombosis
171797|NCT02247414|Warfarin|warfarin
171798|NCT02247414|Splenectomy|splenectomy
171799|NCT02247414|Azygoportal Disconnection|azygoportal disconnection
171800|NCT02247414|Laparoscopy|laparoscopy
171801|NCT02247401|Genotype 4|genotype 4
171802|NCT02247401|non-responder|non-responder
171803|NCT02247401|treatment experienced|treatment experienced
171804|NCT02247401|HCV|hcv
171805|NCT02247401|naive|naive
171806|NCT02247401|relapser|relapser
171807|NCT02247401|hepatitis infection|hepatitis infection
171808|NCT02247401|compensated cirrhosis|compensated cirrhosis
171809|NCT02247401|hepatitis c|hepatitis c
171810|NCT02247401|Cirrhosis|cirrhosis
171811|NCT02247401|Egypt|egypt
171812|NCT02247401|null responder|null responder
171813|NCT02247401|partial responder|partial responder
171814|NCT02247388|Alcohol Dependence|alcohol dependence
171815|NCT02247388|Alcoholism|alcoholism
171816|NCT02247388|AB-CASI|ab-casi
171817|NCT02247388|Emergency Department|emergency department
171818|NCT02247362|Safety|safety
171819|NCT02247362|Immunogenicity|immunogenicity
171820|NCT02247336|colorectal cancer|colorectal cancer
171821|NCT02247336|early detection of cancer|early detection of cancer
171822|NCT02247297|Pancreatic stone protein (PSP)|pancreatic stone protein (psp)
171823|NCT02247297|premature rupture of membranes (PPROM)|premature rupture of membranes (pprom)
171824|NCT02247297|amniotic infection syndrome (AIS)|amniotic infection syndrome (ais)
171825|NCT02247297|hemolysis, elevated liver enzymes, and low platelets (HELLP)|hemolysis, elevated liver enzymes, and low platelets (hellp)
171826|NCT02247297|preeclampsia|preeclampsia
171827|NCT02247297|pregnancy|pregnancy
171828|NCT02247271|peer coaches|peer coaches
171829|NCT02247245|CHF|chf
171830|NCT02247245|AF|af
171831|NCT02247245|SR|sr
171832|NCT02247245|HFREF|hfref
171833|NCT02247245|CRT|crt
171834|NCT02247219|Health education|health education
171835|NCT02247219|Health services research|health services research
171836|NCT02247206|Tourette Syndrome|tourette syndrome
171837|NCT02247206|tic disorders|tic disorders
171838|NCT02247206|behavior therapy|behavior therapy
171839|NCT02247206|web-based videoconferencing|web-based videoconferencing
171840|NCT02247206|VoIP|voip
171841|NCT02247193|Botulinum Toxin|botulinum toxin
171842|NCT02247193|Botox|botox
171843|NCT02247193|Craniofacial deformity|craniofacial deformity
171844|NCT02247167|obstructive sleep apnoea, oxidative stress, FMD|obstructive sleep apnoea, oxidative stress, fmd
171845|NCT02247128|Transcatheter Aortic Valve Implantation (TAVI)|transcatheter aortic valve implantation (tavi)
171846|NCT02247128|Transcatheter Aortic Valve Replacement (TAVR)|transcatheter aortic valve replacement (tavr)
171847|NCT02247128|Aortic Valve Disease|aortic valve disease
171849|NCT02247128|Myocardial Infarction|myocardial infarction
171850|NCT02247128|Ischemic stroke|ischemic stroke
171851|NCT02247128|Bleeding|bleeding
171852|NCT02247128|Thrombosis|thrombosis
171853|NCT02247128|Myocardial Ischemia|myocardial ischemia
171854|NCT02247128|Heart Diseases|heart diseases
171855|NCT02247128|Cardiovascular Diseases|cardiovascular diseases
171856|NCT02247128|Vascular Diseases|vascular diseases
171857|NCT02247128|Embolism and Thrombosis|embolism and thrombosis
171858|NCT02247128|Aspirin|aspirin
171859|NCT02247128|Clopidogrel|clopidogrel
171860|NCT02247128|Prasugrel|prasugrel
171861|NCT02247128|Ticagrelor|ticagrelor
171862|NCT02247128|Antithrombotic treatment|antithrombotic treatment
171863|NCT02247128|Oral anticoagulation|oral anticoagulation
171864|NCT02247128|Warfarin|warfarin
171865|NCT02247128|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
171866|NCT02247128|Genetic Testing|genetic testing
171867|NCT02247128|Cytochrome P450 2C19 (CYP2C19)|cytochrome p450 2c19 (cyp2c19)
171868|NCT02247128|Prostaglandin-endoperoxide synthase 2(PTGS2)|prostaglandin-endoperoxide synthase 2(ptgs2)
171869|NCT02247115|endoscopic ultrasound|endoscopic ultrasound
171870|NCT02247115|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
171871|NCT02247115|competency|competency
171872|NCT02247089|Night Shift work|night shift work
171873|NCT02247089|Stress|stress
171874|NCT02247089|Autonomic nervous system (ANS)|autonomic nervous system (ans)
171875|NCT02247089|Heart rate variability (HRV)|heart rate variability (hrv)
171876|NCT02247089|Pre-ejection period (PEP)|pre-ejection period (pep)
171877|NCT02247089|Inflammation|inflammation
171878|NCT02247089|Pro-inflammatory cytokines|pro-inflammatory cytokines
171879|NCT02247089|Massage Therapy|massage therapy
171880|NCT02247050|Costs and Cost Analysis|costs and cost analysis
171881|NCT02247050|Professional Practice|professional practice
171882|NCT02247050|Attitude of Health Personnel|attitude of health personnel
171883|NCT02247050|Health Knowledge, Attitudes, and Practice|health knowledge, attitudes, and practice
171884|NCT02247050|Decision Making|decision making
171885|NCT02247050|Practice Guidelines as Topic|practice guidelines as topic
171886|NCT02247050|Physician-Patient Relations|physician-patient relations
171887|NCT02247050|Physician's Role|physician's role
171888|NCT02247050|Health Care|health care
171889|NCT02247050|Quality of Health Care|quality of health care
171890|NCT02247050|Quality Assurance|quality assurance
171891|NCT02247050|Physicians, Primary Care|physicians, primary care
171892|NCT02247050|Evidence-Based Medicine|evidence-based medicine
171893|NCT02247050|Evidence-Based Practice|evidence-based practice
171894|NCT02247050|Decision Support Systems, Clinical|decision support systems, clinical
171895|NCT02247050|Reminder Systems|reminder systems
171896|NCT02247050|Judgment|judgment
171897|NCT02247050|Cognition|cognition
171898|NCT02247050|Patient Care|patient care
171899|NCT02247050|Health Services Misuse|health services misuse
171900|NCT02247050|Unnecessary Procedures|unnecessary procedures
171901|NCT02247050|Prescribing Patterns, Physician|prescribing patterns, physician
171902|NCT02247050|Inappropriate Prescribing|inappropriate prescribing
171903|NCT02247050|Over Prescribing|over prescribing
171904|NCT02247050|Low Back Pain|low back pain
171905|NCT02247050|Sinusitis|sinusitis
171906|NCT02247050|Infections, Upper Respiratory|infections, upper respiratory
171907|NCT02247050|Generalized Headache|generalized headache
171908|NCT02247050|Imaging, Diagnostic|imaging, diagnostic
171909|NCT02247050|Antibiotics|antibiotics
171910|NCT02247050|Humans|humans
171911|NCT02247050|Overuse of Low-Value Services|overuse of low-value services
171912|NCT02247050|Pragmatic Trial|pragmatic trial
171913|NCT02247050|Stepped Wedge Design|stepped wedge design
171914|NCT02247050|Cluster Randomized Trial|cluster randomized trial
171915|NCT02247050|Choosing Wisely|choosing wisely
171916|NCT02247037|Triple Negative Breast Cancer|triple negative breast cancer
171917|NCT02247037|Patient Derived Xenograft|patient derived xenograft
171918|NCT02247037|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
171919|NCT02247037|Therapeutic Resistance|therapeutic resistance
171920|NCT02247011|bone mineral density|bone mineral density
171921|NCT02247011|25(OH)D|25(oh)d
171922|NCT02246985|Processed foods|processed foods
171923|NCT02246985|Carotenoids in plasma, urine and faeces|carotenoids in plasma, urine and faeces
171924|NCT02246985|alpha-carotene|alpha-carotene
171925|NCT02246985|beta-carotene|beta-carotene
171926|NCT02246985|Vitamin A|vitamin a
171927|NCT02246985|Lycopene|lycopene
171928|NCT02246985|Gut absorption|gut absorption
171929|NCT02246985|Bread|bread
171930|NCT02246985|Mayonnaise|mayonnaise
171931|NCT02246985|Bioavailability|bioavailability
171932|NCT02246985|Fruits and Vegetables|fruits and vegetables
171933|NCT02246985|Inflammation|inflammation
171934|NCT02246985|Oxidative Stress|oxidative stress
171935|NCT02246972|PTSD|ptsd
171936|NCT02246972|Military sexual trauma|military sexual trauma
171937|NCT02246972|Veterans|veterans
172231|NCT02245672|Asthma|asthma
171938|NCT02246972|Women in the military|women in the military
171939|NCT02246972|Sexual assault|sexual assault
171940|NCT02246946|pleural effusion|pleural effusion
171942|NCT02246946|respiratory therapy|respiratory therapy
171943|NCT02246946|intermittent positive-pressure breathing|intermittent positive-pressure breathing
171944|NCT02246946|lung function|lung function
171945|NCT02246946|pulmonary complications|pulmonary complications
171946|NCT02246920|Bioequivalence|bioequivalence
171947|NCT02246920|Allergic Rhinitis|allergic rhinitis
171948|NCT02246907|Health related quality of life|health related quality of life
171949|NCT02246855|Subjects|subjects
171950|NCT02246842|Volunteers|volunteers
171951|NCT02246829|wet AMD, SD-OCT, intravitreal injection, central retinal thickness,|wet amd, sd-oct, intravitreal injection, central retinal thickness,
171952|NCT02246816|Short Bowel Syndrome|short bowel syndrome
171953|NCT02246816|SBS|sbs
171954|NCT02246816|Chronic Diarrhea|chronic diarrhea
171955|NCT02246816|Short Bowel|short bowel
171956|NCT02246816|Short Gut|short gut
171957|NCT02246816|Short Gut Syndrome|short gut syndrome
171958|NCT02246816|Anti-Diarrheal|anti-diarrheal
171959|NCT02246816|Opium Tincture|opium tincture
171960|NCT02246816|loperamide|loperamide
171961|NCT02246816|diphenoxylate|diphenoxylate
171962|NCT02246816|ileostomies|ileostomies
171963|NCT02246816|tincture of opium|tincture of opium
171964|NCT02246816|DTO|dto
171965|NCT02246816|codeine|codeine
171966|NCT02246816|morphine|morphine
171967|NCT02246816|opiate|opiate
171968|NCT02246803|paroxysmal atrial fibrillation, CABG, pulmonary vein isolation|paroxysmal atrial fibrillation, cabg, pulmonary vein isolation
171969|NCT02246790|ablation, CABG|ablation, cabg
171970|NCT02246790|Long-standing persistent Atrial Fibrillation|long-standing persistent atrial fibrillation
171971|NCT02246777|Glaucoma|glaucoma
171972|NCT02246764|Ocular hypertension.|ocular hypertension.
171973|NCT02246764|Glaucoma|glaucoma
171974|NCT02246751|postural control|postural control
171975|NCT02246751|Targeted Training|targeted training
171976|NCT02246751|cerebral palsy|cerebral palsy
171977|NCT02246751|sensorimotor control|sensorimotor control
171978|NCT02246751|trunk segments|trunk segments
171979|NCT02246725|Colorectal Neoplasms|colorectal neoplasms
171980|NCT02246725|Depression|depression
171981|NCT02246725|Intestinal Neoplasms|intestinal neoplasms
171982|NCT02246725|Gastrointestinal Neoplasms|gastrointestinal neoplasms
171983|NCT02246725|Digestive System Neoplasms|digestive system neoplasms
171984|NCT02246725|Digestive System Diseases|digestive system diseases
171985|NCT02246725|Gastrointestinal Diseases|gastrointestinal diseases
171986|NCT02246725|Intestinal Diseases|intestinal diseases
171987|NCT02246725|Palliative chemotherapy|palliative chemotherapy
171988|NCT02246725|Palliative care|palliative care
171989|NCT02246725|Palliative treatment|palliative treatment
171990|NCT02246725|Quality of life|quality of life
171991|NCT02246725|Quality of life for relatives|quality of life for relatives
171992|NCT02246725|Survival|survival
171993|NCT02246712|tramadol|tramadol
171994|NCT02246712|pharmacokinetics|pharmacokinetics
171995|NCT02246712|enantiomers|enantiomers
171996|NCT02246712|metabolism|metabolism
171997|NCT02246712|diabetes|diabetes
171998|NCT02246699|obesity|obesity
171999|NCT02246699|overweight|overweight
172000|NCT02246699|chitosan|chitosan
172001|NCT02246699|fungal chitosan|fungal chitosan
172002|NCT02246699|weight management|weight management
172003|NCT02246686|Iberogast N|iberogast n
172004|NCT02246686|Mild to moderate ulcerative colitis|mild to moderate ulcerative colitis
172005|NCT02246686|add-on therapy|add-on therapy
172006|NCT02246686|efficacy|efficacy
172007|NCT02246660|Peripheral Artery Disease|peripheral artery disease
172008|NCT02246660|Peripheral Arterial Disease|peripheral arterial disease
172010|NCT02246634|Colorectal Neoplasms|colorectal neoplasms
172011|NCT02246634|Neoplasm Metastases|neoplasm metastases
172012|NCT02246634|Magnetic Resonance Imaging|magnetic resonance imaging
172013|NCT02246634|Diffusion Weighted MRI|diffusion weighted mri
172014|NCT02246634|Hepatic Neoplasms|hepatic neoplasms
172015|NCT02246634|Tumors|tumors
172016|NCT02246634|Neoplasms, Rectal|neoplasms, rectal
172017|NCT02246621|MONARCH 3|monarch 3
172018|NCT02246595|Sepsis|sepsis
172019|NCT02246595|Severe Sepsis|severe sepsis
172020|NCT02246595|Septic Shock|septic shock
172021|NCT02246595|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
172022|NCT02246595|Organ Dysfunction|organ dysfunction
172023|NCT02246582|Type 1 Diabetes|type 1 diabetes
172024|NCT02246582|Type 2 Diabetes|type 2 diabetes
172025|NCT02246582|Enlite 3|enlite 3
172026|NCT02246569|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
172027|NCT02246569|endoscopic lung volume reduction|endoscopic lung volume reduction
172028|NCT02246569|RePneu®Coils|repneu®coils
172029|NCT02246569|physical capacity|physical capacity
172030|NCT02246569|quality of life|quality of life
172031|NCT02246556|Amblyopia|amblyopia
172032|NCT02246556|Dichoptic|dichoptic
172033|NCT02246556|Virtual reality|virtual reality
172034|NCT02246556|Stereopsis|stereopsis
172035|NCT02246556|Stereo vision|stereo vision
172036|NCT02246556|Visual acuity|visual acuity
172037|NCT02246556|Binocular|binocular
172038|NCT02246543|Appetite|appetite
172039|NCT02246543|Gut Hormones|gut hormones
172041|NCT02246543|Energy Density|energy density
172042|NCT02246543|Gastric Emptying|gastric emptying
172043|NCT02246465|Hypertrophic scar|hypertrophic scar
172044|NCT02246465|Cicatrix|cicatrix
172045|NCT02246465|Scar prevention|scar prevention
172046|NCT02246465|Scar revision|scar revision
172047|NCT02246452|Children and adolescents|children and adolescents
172048|NCT02246452|Cancer|cancer
172049|NCT02246452|Malnutrition|malnutrition
172050|NCT02246452|BMI percentile|bmi percentile
172051|NCT02246452|BMI-SDS|bmi-sds
172052|NCT02246439|Gastroenteritis|gastroenteritis
172053|NCT02246439|Gastritis|gastritis
172054|NCT02246439|Vomiting|vomiting
172055|NCT02246439|Nausea|nausea
172056|NCT02246439|Diarrhea|diarrhea
172057|NCT02246413|BMI|bmi
172058|NCT02246413|Depressive symptoms|depressive symptoms
172059|NCT02246413|Integrated therapy|integrated therapy
172060|NCT02246413|Cardiometabolic risk|cardiometabolic risk
172061|NCT02246413|Self-regulation|self-regulation
172062|NCT02246413|Behavior change|behavior change
172063|NCT02246413|Precision medicine|precision medicine
172064|NCT02246413|Lifestyle|lifestyle
172065|NCT02246400|eCMP|ecmp
172066|NCT02246400|eHealth|ehealth
172067|NCT02246400|mHealth|mhealth
172068|NCT02246400|Lifestyle intervention|lifestyle intervention
172069|NCT02246400|Cardiometabolic risk reduction|cardiometabolic risk reduction
172070|NCT02246400|PAMF|pamf
172071|NCT02246387|Pelvic Organ Prolapse|pelvic organ prolapse
172072|NCT02246387|Gynecologic Surgery Procedures|gynecologic surgery procedures
172073|NCT02246387|Treatment Outcome|treatment outcome
172074|NCT02246374|Parkinson's Disease|parkinson's disease
172075|NCT02246374|ExAblate|exablate
172076|NCT02246374|MRgFUS|mrgfus
172077|NCT02246361|Ankle sprain|ankle sprain
172078|NCT02246361|Infectious colitis|infectious colitis
172079|NCT02246361|Diverticulitis|diverticulitis
172080|NCT02246361|Pyelonephritis|pyelonephritis
172081|NCT02246361|Prostatitis|prostatitis
172082|NCT02246361|Pneumonitis|pneumonitis
172083|NCT02246361|Patient Information Leaflet (PIL)|patient information leaflet (pil)
172084|NCT02246361|Doctor Patient Communication|doctor patient communication
172085|NCT02246361|Adherence|adherence
172086|NCT02246361|Satisfaction|satisfaction
172087|NCT02246361|Scale|scale
172088|NCT02246361|Doctor Patient Communication scale|doctor patient communication scale
172089|NCT02246361|Adherence scale|adherence scale
172090|NCT02246361|Satisfaction scale|satisfaction scale
172091|NCT02246348|Systemic Sclerosis|systemic sclerosis
172092|NCT02246348|Pulmonary hypertension|pulmonary hypertension
172093|NCT02246348|Lung Doppler signals|lung doppler signals
172094|NCT02246322|Pancreatic cancer|pancreatic cancer
172095|NCT02246322|Neuroendocrine tumors|neuroendocrine tumors
172096|NCT02246322|Lymphadenopathies|lymphadenopathies
172097|NCT02246322|GIST|gist
172098|NCT02246322|Gastrointestinal wall neoplasia|gastrointestinal wall neoplasia
172099|NCT02246309|Infertility|infertility
172100|NCT02246309|Embryo Culture|embryo culture
172101|NCT02246309|Laboratory Technique|laboratory technique
172102|NCT02246296|severe acute malnutrition|severe acute malnutrition
172103|NCT02246296|wasting|wasting
172104|NCT02246296|kwashiorkor|kwashiorkor
172105|NCT02246296|nutrition|nutrition
172106|NCT02246296|feeding|feeding
172107|NCT02246296|milk|milk
172108|NCT02246283|schizophrenia|schizophrenia
172109|NCT02246283|elderly|elderly
172110|NCT02246283|lifelong|lifelong
172111|NCT02246283|quality of life|quality of life
172112|NCT02246283|register|register
172113|NCT02246283|questionaire|questionaire
402934|NCT01229020|COPD|copd
172114|NCT02246218|Urea Cycle Disorder|urea cycle disorder
172116|NCT02246218|Buphenyl|buphenyl
172117|NCT02246218|Glycerol Phenylbutyrate|glycerol phenylbutyrate
172118|NCT02246218|Ravicti|ravicti
172119|NCT02246218|Hyperammonemia|hyperammonemia
172120|NCT02246218|Sodium Phenylbutyrate|sodium phenylbutyrate
172121|NCT02246218|GPB|gpb
172122|NCT02246218|HPN-100|hpn-100
172123|NCT02246205|pancreaticoduodenectomy|pancreaticoduodenectomy
172124|NCT02246205|delayed gastric emptying|delayed gastric emptying
172125|NCT02246205|Roux en-Y reconstruction|roux en-y reconstruction
172126|NCT02246179|Fractional laser|fractional laser
172127|NCT02246179|Topical anesthesia|topical anesthesia
172128|NCT02246179|Drug delivery|drug delivery
172129|NCT02246153|Laparoscopic gastrectomy|laparoscopic gastrectomy
172130|NCT02246153|Advanced gastric cancer|advanced gastric cancer
172131|NCT02246153|Elderly patients|elderly patients
172132|NCT02246153|Morbidity|morbidity
172133|NCT02246153|Mortality|mortality
172134|NCT02246127|advanced pNET|advanced pnet
172135|NCT02246127|everolimus|everolimus
172136|NCT02246127|STZ-5FU|stz-5fu
172137|NCT02246127|treatment sequence|treatment sequence
172138|NCT02246114|Pregnancy|pregnancy
172139|NCT02246114|Smoking|smoking
172140|NCT02246114|Smoking cessation|smoking cessation
172141|NCT02246101|cardiac disease|cardiac disease
172142|NCT02246101|cardiopulmonary disease|cardiopulmonary disease
172144|NCT02246101|albuminuria|albuminuria
172145|NCT02246101|cardiovascular disease|cardiovascular disease
172146|NCT02246101|CVD|cvd
172147|NCT02246101|particulate matter|particulate matter
172148|NCT02246088|Osteoarthritis, Central Nervous System Sensitization|osteoarthritis, central nervous system sensitization
172149|NCT02246075|Alzheimer's disease|alzheimer's disease
172150|NCT02246075|Cognition|cognition
172151|NCT02246075|Alpha-7 nAChR|alpha-7 nachr
172152|NCT02246062|Anxiety|anxiety
172153|NCT02246062|Anesthesia|anesthesia
172154|NCT02246062|Evaluation|evaluation
172155|NCT02246062|Preoperative care|preoperative care
172156|NCT02246062|Child|child
172157|NCT02246049|Metastatic colorectal cancer, bevacizumab, FOLFOXIRI|metastatic colorectal cancer, bevacizumab, folfoxiri
172158|NCT02246010|diarrhea|diarrhea
172159|NCT02246010|developing world|developing world
172160|NCT02246010|lactose-free diet|lactose-free diet
172161|NCT02246010|Clinical trial|clinical trial
172162|NCT02245997|Reduced-dose Radiotherapy|reduced-dose radiotherapy
172163|NCT02245997|14-186|14-186
172164|NCT02245984|clinical competence, nursing process, nursing student|clinical competence, nursing process, nursing student
172165|NCT02245945|HIV|hiv
172166|NCT02245945|prevention|prevention
172167|NCT02245932|Pulmonary disease, Chronic Obstructive|pulmonary disease, chronic obstructive
172168|NCT02245932|Cardiovascular diseases|cardiovascular diseases
172169|NCT02245932|Metabolism|metabolism
172170|NCT02245932|Resveratrol|resveratrol
172171|NCT02245919|Low Back Pain|low back pain
172172|NCT02245919|Chronic Pain|chronic pain
172173|NCT02245919|Cognitive Behavioral Therapy|cognitive behavioral therapy
172174|NCT02245919|Primary Health Care|primary health care
172175|NCT02245919|Physical Therapy|physical therapy
172176|NCT02245906|Brazilian fruit peel|brazilian fruit peel
172177|NCT02245906|Functional food|functional food
172178|NCT02245906|Cardiometabolic risk|cardiometabolic risk
172179|NCT02245906|Metabolic syndrome|metabolic syndrome
172180|NCT02245906|Inflammation|inflammation
172181|NCT02245906|Appetite|appetite
172182|NCT02245906|Gut hormone|gut hormone
172183|NCT02245880|cervical spine|cervical spine
172184|NCT02245880|intubating laryngeal mask airway|intubating laryngeal mask airway
172185|NCT02245880|Glidescope videolaryngoscope|glidescope videolaryngoscope
172186|NCT02245880|collar|collar
172187|NCT02245867|Amyloidosis|amyloidosis
172188|NCT02245867|Relapse|relapse
172189|NCT02245867|Refractory|refractory
172190|NCT02245854|diminutive polyps|diminutive polyps
172191|NCT02245854|small polyps|small polyps
172192|NCT02245854|cold snare polypectomy|cold snare polypectomy
172193|NCT02245854|complications|complications
172194|NCT02245854|bleeding|bleeding
172195|NCT02245841|dermatomyositis|dermatomyositis
172196|NCT02245841|Acthar gel|acthar gel
172197|NCT02245828|healthy subjects, inhaled|healthy subjects, inhaled
172198|NCT02245815|Necrotizing enterocolitis|necrotizing enterocolitis
172199|NCT02245815|Probiotics|probiotics
172200|NCT02245815|Secreting IgA|secreting iga
172201|NCT02245815|Preterm newborns|preterm newborns
172202|NCT02245802|Bleeding peptic ulcer|bleeding peptic ulcer
172203|NCT02245802|Prediction model|prediction model
172204|NCT02245802|Mortality|mortality
172299|NCT02245230|Hypertension|hypertension
172205|NCT02245802|Prediction of in-hospital mortality for bleeding peptic ulcer|prediction of in-hospital mortality for bleeding peptic ulcer
172206|NCT02245776|Incurable Neurological Disorders|incurable neurological disorders
172207|NCT02245776|Autologous mononuclear cell therapy|autologous mononuclear cell therapy
172208|NCT02245776|Stem cells|stem cells
172209|NCT02245750|hysteroscopy - recurrent implantation failure|hysteroscopy - recurrent implantation failure
172210|NCT02245737|Alzheimer's disease|alzheimer's disease
209419|NCT02074839|IDH|idh
172211|NCT02245737|Dementia|dementia
172212|NCT02245737|Brain Diseases|brain diseases
172213|NCT02245737|Neurogenerative Diseases|neurogenerative diseases
172214|NCT02245737|Central Nervous System Diseases|central nervous system diseases
172215|NCT02245737|Nervous System Diseases|nervous system diseases
172216|NCT02245737|Mental Disorders|mental disorders
172217|NCT02245737|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
172218|NCT02245737|Tauopathies|tauopathies
172219|NCT02245724|Mental retardation|mental retardation
172220|NCT02245724|Autologous mononuclear cell therapy|autologous mononuclear cell therapy
172221|NCT02245724|Stem cell|stem cell
172222|NCT02245711|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
172223|NCT02245711|Autologous Bone Marrow Mononuclear cell therapy|autologous bone marrow mononuclear cell therapy
172224|NCT02245711|Stem Cell|stem cell
172225|NCT02245698|Chronic Stroke|chronic stroke
172226|NCT02245698|Subacute stroke|subacute stroke
172227|NCT02245698|Autologous Bone Marrow Mononuclear Cell therapy|autologous bone marrow mononuclear cell therapy
172228|NCT02245698|Stem cell|stem cell
172229|NCT02245685|Substitution Therapy|substitution therapy
172230|NCT02245685|Specialized Care Center for Addicts|specialized care center for addicts
172232|NCT02245672|fluticasone|fluticasone
172233|NCT02245672|salmeterol|salmeterol
172234|NCT02245672|CRC749|crc749
172236|NCT02245672|Advair|advair
172237|NCT02245672|FEV1|fev1
172238|NCT02245672|MGR001|mgr001
172239|NCT02245620|Skeletal muscle dysfunction, MTP-131, Bendavia™|skeletal muscle dysfunction, mtp-131, bendavia™
172240|NCT02245620|elamipretide|elamipretide
172241|NCT02245607|Psychotic Disorders|psychotic disorders
172242|NCT02245607|Cognitive Training|cognitive training
172243|NCT02245607|Mental Disorders|mental disorders
172244|NCT02245607|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
172245|NCT02245594|Gastrointestinal motility|gastrointestinal motility
172246|NCT02245594|Motility Tracking System (MTS)|motility tracking system (mts)
172247|NCT02245594|Transit time|transit time
172248|NCT02245594|Sleep pattern|sleep pattern
172249|NCT02245568|Dementia|dementia
172250|NCT02245568|Alzheimer Disease|alzheimer disease
172251|NCT02245568|bvFTD|bvftd
172252|NCT02245568|Frontotemporal Dementia|frontotemporal dementia
172253|NCT02245568|Neurodegenerative Diseases|neurodegenerative diseases
172254|NCT02245568|Brain Diseases|brain diseases
172255|NCT02245568|Cognitive Disorders|cognitive disorders
172256|NCT02245516|Intraretinal Fluid|intraretinal fluid
172257|NCT02245516|Subretinal Fluid|subretinal fluid
172258|NCT02245516|Retinal Vein Occlusion|retinal vein occlusion
172259|NCT02245516|Diabetic Macular Edema|diabetic macular edema
172260|NCT02245477|Serum VEGF, FGR|serum vegf, fgr
172261|NCT02245425|Neck pain|neck pain
172262|NCT02245425|Thoracic spine manipulation|thoracic spine manipulation
172263|NCT02245425|Range of Motion|range of motion
172264|NCT02245425|Disability|disability
172265|NCT02245399|Weight loss|weight loss
172266|NCT02245399|Diabetes|diabetes
172267|NCT02245399|Cardiovascular disease (CVD) risk|cardiovascular disease (cvd) risk
172268|NCT02245399|Weight loss diet|weight loss diet
172269|NCT02245399|mediterranean type diet|mediterranean type diet
172270|NCT02245399|Canola oil|canola oil
172271|NCT02245399|Low-carbohydrate diet|low-carbohydrate diet
172272|NCT02245399|Glycemic index|glycemic index
172273|NCT02245373|Depression|depression
172274|NCT02245373|Primary Care|primary care
172275|NCT02245373|Cost-effectiveness|cost-effectiveness
172276|NCT02245373|Pharmacological treatment|pharmacological treatment
172277|NCT02245373|Watchful-waiting or Active Monitoring.|watchful-waiting or active monitoring.
172278|NCT02245360|GRAZAX|grazax
172280|NCT02245347|Tuberculosis|tuberculosis
172281|NCT02245347|MDR TB|mdr tb
172282|NCT02245347|Drug resistant TB|drug resistant tb
172283|NCT02245321|hemoglobin recovery|hemoglobin recovery
172284|NCT02245321|iron recovery|iron recovery
172285|NCT02245321|iron supplements|iron supplements
172286|NCT02245308|Tobacco use cessation|tobacco use cessation
172287|NCT02245308|Homelessness|homelessness
172288|NCT02245308|Veterans|veterans
172289|NCT02245295|Bronchial endoscopy|bronchial endoscopy
172290|NCT02245295|ultrasound|ultrasound
172291|NCT02245295|EBUS|ebus
172292|NCT02245295|anesthesia|anesthesia
172293|NCT02245295|lung cancer|lung cancer
172294|NCT02245295|diagnosis including staging|diagnosis including staging
172295|NCT02245256|delirium|delirium
172296|NCT02245256|incidence|incidence
172297|NCT02245256|dexmedetomidine|dexmedetomidine
172298|NCT02245243|Hepatic Impairment, single dose, intravenous|hepatic impairment, single dose, intravenous
172300|NCT02245230|Autonomic Nervous System|autonomic nervous system
172301|NCT02245230|Renin-Angiotensin System|renin-angiotensin system
172302|NCT02245230|Angiotensin (1-7)|angiotensin (1-7)
172303|NCT02245230|Ganglionic Blockers|ganglionic blockers
172304|NCT02245230|Trimethaphan|trimethaphan
172305|NCT02245230|Blood Pressure|blood pressure
172306|NCT02245230|Hemodynamics|hemodynamics
172307|NCT02245191|Vasopressor|vasopressor
172308|NCT02245191|Cesarian delivery|cesarian delivery
172309|NCT02245191|Hypotension|hypotension
172310|NCT02245191|Maternal cardiac output|maternal cardiac output
172311|NCT02245191|Uteroplacental blood flow|uteroplacental blood flow
172312|NCT02245191|Cerebral fetal blood flow|cerebral fetal blood flow
172313|NCT02245191|Preeclampsia|preeclampsia
172314|NCT02245165|Nitric oxide|nitric oxide
172315|NCT02245165|Nitric oxide synthase|nitric oxide synthase
172316|NCT02245165|Gastrointestinal motility|gastrointestinal motility
172317|NCT02245165|Gut peptide hormones|gut peptide hormones
172318|NCT02245152|child acute malnutrition|child acute malnutrition
172319|NCT02245152|prevention|prevention
172320|NCT02245152|behavior change communication|behavior change communication
172321|NCT02245152|lipid-based nutrient supplement|lipid-based nutrient supplement
172322|NCT02245152|screening coverage|screening coverage
172323|NCT02245139|diarrhea|diarrhea
172324|NCT02245139|vomiting|vomiting
172326|NCT02245139|abdominal pain|abdominal pain
172327|NCT02245139|oliguria|oliguria
172328|NCT02245126|Pain, Visual analogue scale|pain, visual analogue scale
172329|NCT02245087|atorvastatin|atorvastatin
172330|NCT02245087|coronary artery disease|coronary artery disease
172331|NCT02245087|myocardial infarction|myocardial infarction
172332|NCT02245087|stroke|stroke
172333|NCT02245087|revascularization|revascularization
172334|NCT02245074|Infantile asthma|infantile asthma
172335|NCT02245074|Induced sputum|induced sputum
172336|NCT02245074|Phenotypes|phenotypes
172337|NCT02245074|Eosinophils|eosinophils
172338|NCT02245074|Neutrophils|neutrophils
172339|NCT02245061|pharmacoresistant focal epilepsy|pharmacoresistant focal epilepsy
172340|NCT02245061|cortical excitability|cortical excitability
172341|NCT02245061|paired pulses|paired pulses
172342|NCT02245061|TMS|tms
172343|NCT02245061|SEEG|seeg
172344|NCT02245061|DES|des
172345|NCT02245048|Cardiovascular Risk Stratification|cardiovascular risk stratification
172346|NCT02245048|Carotid intima-media thickness (CIMT)|carotid intima-media thickness (cimt)
172347|NCT02245048|Stress echocardiography (SE)|stress echocardiography (se)
172348|NCT02245035|Glutathione|glutathione
172349|NCT02245035|Dairy consumption|dairy consumption
172350|NCT02245035|Brain|brain
172351|NCT02245035|Humans|humans
172352|NCT02245022|HIV|hiv
172353|NCT02245022|Prevention of mother to child transmission|prevention of mother to child transmission
172354|NCT02245022|Africa|africa
172355|NCT02245022|Uganda|uganda
172356|NCT02245022|Pharmacokinetics|pharmacokinetics
172357|NCT02245022|Pregnancy|pregnancy
172358|NCT02245022|Breastfeeding|breastfeeding
172359|NCT02244996|Retinitis pigmentosa|retinitis pigmentosa
172360|NCT02244996|Lycium barbarum|lycium barbarum
172361|NCT02244996|Antioxidation|antioxidation
172362|NCT02244996|Visual field|visual field
172363|NCT02244996|Electroretinogram|electroretinogram
172364|NCT02244970|Mindfulness|mindfulness
172365|NCT02244970|Depressive mood|depressive mood
172366|NCT02244970|anxiety|anxiety
172367|NCT02244970|early psychosis|early psychosis
172368|NCT02244944|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
172369|NCT02244944|NAFLD|nafld
172370|NCT02244931|Spinal cord injuries, paraplegic, manual wheelchairs, assisting propelling device|spinal cord injuries, paraplegic, manual wheelchairs, assisting propelling device
172371|NCT02244905|Positive Deviance|positive deviance
172372|NCT02244905|Infection Control|infection control
172373|NCT02244905|Healthcare-Associated Infections|healthcare-associated infections
172374|NCT02244905|Staff Engagement|staff engagement
172375|NCT02244905|Cluster Randomized Controlled Trial|cluster randomized controlled trial
172376|NCT02244892|Disability glare|disability glare
172377|NCT02244892|Corneal scar|corneal scar
172378|NCT02244892|Corneal haze|corneal haze
172379|NCT02244892|Scheimpflug densitometry|scheimpflug densitometry
172380|NCT02244892|Contrast sensitivity|contrast sensitivity
172381|NCT02244879|resveratrol|resveratrol
172382|NCT02244879|type 2 diabetes mellitus|type 2 diabetes mellitus
172383|NCT02244879|inflammation|inflammation
172384|NCT02244879|insulin resistance|insulin resistance
172385|NCT02244879|body composition|body composition
172386|NCT02244879|bone mass|bone mass
172387|NCT02244866|IVF|ivf
172388|NCT02244866|LH supplementation|lh supplementation
172389|NCT02244866|ovarian stimulation|ovarian stimulation
172390|NCT02244866|poor responder|poor responder
172391|NCT02244840|Bidet, Sitz bath, Anal resting pressure|bidet, sitz bath, anal resting pressure
172392|NCT02244814|glucose|glucose
172393|NCT02244814|insulin resistance|insulin resistance
172394|NCT02244814|dietary carbohydrate|dietary carbohydrate
172395|NCT02244814|dietary fat|dietary fat
172396|NCT02244814|adiposity|adiposity
172495|NCT02244411|14-164|14-164
172397|NCT02244814|Air displacement plethysmography|air displacement plethysmography
172398|NCT02244814|Dual X-ray Absorptiometry|dual x-ray absorptiometry
172399|NCT02244814|continuous glucose monitoring|continuous glucose monitoring
172400|NCT02244775|osteo-arthritis|osteo-arthritis
172401|NCT02244775|post traumatic arthritis|post traumatic arthritis
172402|NCT02244736|Arterial stiffness|arterial stiffness
172403|NCT02244736|Endothelial glycocalyx|endothelial glycocalyx
172404|NCT02244736|Coronary flow reserve|coronary flow reserve
172405|NCT02244723|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
172406|NCT02244723|diagnosis|diagnosis
172407|NCT02244710|Circulating Endothelial Cells|circulating endothelial cells
172408|NCT02244710|Endothelial Progenitor Cells|endothelial progenitor cells
172409|NCT02244710|Acute coronary syndrome (ACS)|acute coronary syndrome (acs)
172410|NCT02244710|Ticagrelor|ticagrelor
172411|NCT02244697|Stridor|stridor
172412|NCT02244697|Vocal Cord Paralysis (VCP)|vocal cord paralysis (vcp)
172413|NCT02244697|Ultrasound (US)|ultrasound (us)
172414|NCT02244684|Folate|folate
172415|NCT02244684|Folic Acid|folic acid
172416|NCT02244684|One-Carbon Nutrients|one-carbon nutrients
172417|NCT02244684|Epigenetics|epigenetics
172418|NCT02244684|Pregnancy|pregnancy
172419|NCT02244684|Fetal Health|fetal health
172443|NCT02244606|Candidemia|candidemia
172444|NCT02244606|SCY-078|scy-078
172445|NCT02244606|Micafungin|micafungin
172446|NCT02244606|Fluconazole|fluconazole
172447|NCT02244606|Echinocandin|echinocandin
172448|NCT02244593|breast cancer survivors|breast cancer survivors
172449|NCT02244593|FAST MRI|fast mri
172450|NCT02244593|mammography screening|mammography screening
172451|NCT02244580|Subtyping of Invasive breast cancer|subtyping of invasive breast cancer
172452|NCT02244567|PCOS|pcos
172453|NCT02244554|tattoo removal|tattoo removal
172454|NCT02244554|Q-switched laser|q-switched laser
172455|NCT02244554|Nd:YAG laser|nd:yag laser
172456|NCT02244554|nanosecond laser|nanosecond laser
172457|NCT02244554|picosecond laser|picosecond laser
172458|NCT02244554|laser therapy|laser therapy
172460|NCT02244554|pulsed-laser|pulsed-laser
172461|NCT02244554|laser treatment|laser treatment
172462|NCT02244554|remove tattoo|remove tattoo
172463|NCT02244554|tattoo clearing|tattoo clearing
172464|NCT02244554|tattoo lightening|tattoo lightening
172465|NCT02244554|tattoo lighten|tattoo lighten
172466|NCT02244554|resistant tattoo|resistant tattoo
172467|NCT02244515|children|children
172468|NCT02244502|Ovarian Carcinoma|ovarian carcinoma
172469|NCT02244502|Treatment|treatment
172470|NCT02244502|Minimal toxicity|minimal toxicity
172471|NCT02244502|TTFields|ttfields
172472|NCT02244502|Tumor Treating Fields|tumor treating fields
172473|NCT02244502|Novocure|novocure
172474|NCT02244502|Paclitaxel|paclitaxel
172475|NCT02244502|Weekly paclitaxel|weekly paclitaxel
172476|NCT02244476|mouth feel|mouth feel
172477|NCT02244476|acoustic tribology|acoustic tribology
172478|NCT02244476|vibration spectrum|vibration spectrum
172479|NCT02244476|sensory perception|sensory perception
172480|NCT02244463|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
172481|NCT02244463|Thyroid Cancer|thyroid cancer
172482|NCT02244450|Neonatal screening|neonatal screening
172483|NCT02244450|severe combined immunodeficiency|severe combined immunodeficiency
172484|NCT02244450|T-cell Receptor Excision Circle|t-cell receptor excision circle
172485|NCT02244437|altitude, altitude illnesses, headache|altitude, altitude illnesses, headache
172487|NCT02244424|Obesity|obesity
172488|NCT02244424|Adolescent|adolescent
172489|NCT02244424|Social media|social media
172490|NCT02244424|Prevention|prevention
172491|NCT02244411|EQUAL|equal
172492|NCT02244411|Exercise|exercise
172493|NCT02244411|Diet|diet
172494|NCT02244411|Physical activity|physical activity
172496|NCT02244385|vascular disease|vascular disease
172497|NCT02244385|pregnancy|pregnancy
172498|NCT02244385|chronic hypertension|chronic hypertension
172499|NCT02244385|diabetes|diabetes
172501|NCT02244372|Cordyceps sinensis mycelium culture extract(Paecilomyces hepiali, CBG-CS-2)|cordyceps sinensis mycelium culture extract(paecilomyces hepiali, cbg-cs-2)
172502|NCT02244372|immunity|immunity
172503|NCT02244359|Shared Decision making|shared decision making
172504|NCT02244359|Patient Centred care|patient centred care
172505|NCT02244359|Interprofessionalism|interprofessionalism
172506|NCT02244359|Home care|home care
172507|NCT02244359|Frail elderly|frail elderly
172508|NCT02244164|Type 2 Diabetes|type 2 diabetes
172509|NCT02244164|Incretinomimetics|incretinomimetics
172510|NCT02244164|DPP-4 inhibitors|dpp-4 inhibitors
172511|NCT02244164|Pancreas|pancreas
172512|NCT02244164|PanIN|panin
172513|NCT02244164|RMN|rmn
172514|NCT02244164|Lipasemia|lipasemia
172515|NCT02244151|ovulation induction,oocyte maturation timing and collection|ovulation induction,oocyte maturation timing and collection
172516|NCT02244138|Adolescent|adolescent
172517|NCT02244138|Screening|screening
172518|NCT02244138|Primary Care|primary care
172519|NCT02244138|Computer Decision Support Systems|computer decision support systems
172521|NCT02244125|Multiple Myeloma|multiple myeloma
172522|NCT02244125|Relapse|relapse
172523|NCT02244125|Refractory|refractory
172524|NCT02244125|PCD|pcd
172525|NCT02244125|IFM/DFCI 2009|ifm/dfci 2009
172526|NCT02244125|Transplantation|transplantation
172527|NCT02244125|Autologous|autologous
172528|NCT02244125|Pomalidomide|pomalidomide
172529|NCT02244125|Immunoglobulin|immunoglobulin
172530|NCT02244125|Ig|ig
209789|NCT02072941|Aging|aging
163542|NCT02294240|Pregnant, malnourished, energy dense biscuits, low birth weight|pregnant, malnourished, energy dense biscuits, low birth weight
163543|NCT02294227|AIN457, psoriatic arthritis, chronic inflammatory disease, loading regimen, secukinumab, self-injection|ain457, psoriatic arthritis, chronic inflammatory disease, loading regimen, secukinumab, self-injection
172531|NCT02244125|Free light Chain|free light chain
172532|NCT02244099|Controlled substance prescribing|controlled substance prescribing
172533|NCT02244099|Controlled substance treatment agreements|controlled substance treatment agreements
172534|NCT02244099|Opioid use|opioid use
172535|NCT02244086|obstetric pain, bupivacaine, analgesic efficacy|obstetric pain, bupivacaine, analgesic efficacy
172536|NCT02244073|blood glucose target|blood glucose target
172537|NCT02244073|ICU|icu
172538|NCT02244073|insulin|insulin
172539|NCT02244073|hypoglycemia|hypoglycemia
172540|NCT02244073|hyperglycemia|hyperglycemia
172541|NCT02244073|glycated hemoglobin|glycated hemoglobin
172542|NCT02244060|Vignette|vignette
172543|NCT02244060|Priming effect|priming effect
172544|NCT02244021|HD|hd
172545|NCT02244021|Hodgkin's Lymphoma|hodgkin's lymphoma
172546|NCT02244021|RELAPSED-REFRACTORY|relapsed-refractory
172547|NCT02244008|Mobilization|mobilization
172548|NCT02244008|Joint Range of Motion|joint range of motion
172549|NCT02244008|Ankle|ankle
172550|NCT02244008|Manual Therapy|manual therapy
172551|NCT02243995|Training program|training program
172552|NCT02243995|Resistance training|resistance training
172553|NCT02243995|Endurance training|endurance training
172554|NCT02243995|Muscle strength|muscle strength
172555|NCT02243995|Exercise capacity|exercise capacity
172556|NCT02243995|Fatigue|fatigue
172557|NCT02243995|Quality of life|quality of life
172798|NCT02242955|Relapse|relapse
172558|NCT02243982|Parkinson, dementia, FDDNP, tau, beta-amyloid|parkinson, dementia, fddnp, tau, beta-amyloid
172559|NCT02243969|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
172560|NCT02243969|Alpha-linolenic acid|alpha-linolenic acid
172561|NCT02243969|Blood pressure|blood pressure
172562|NCT02243969|Vascular function|vascular function
172563|NCT02243943|Neuromuscular block|neuromuscular block
172564|NCT02243943|neuromuscular reversal|neuromuscular reversal
172565|NCT02243943|postoperative conditions|postoperative conditions
172566|NCT02243943|respiratory failure|respiratory failure
172567|NCT02243930|Sigmoidoscopy with or without cap|sigmoidoscopy with or without cap
172568|NCT02243930|Pain during sigmoidoscopy|pain during sigmoidoscopy
172569|NCT02243930|Sigmoidoscopy and time|sigmoidoscopy and time
172570|NCT02243904|Autonomic nervous function|autonomic nervous function
172571|NCT02243904|Blood pressure|blood pressure
172572|NCT02243904|Cardiovascular regulation|cardiovascular regulation
172573|NCT02243904|Lead|lead
172574|NCT02243904|Occupational exposure|occupational exposure
172575|NCT02243904|Renal function|renal function
172576|NCT02243852|Growth Hormone Deficiency (GHD)|growth hormone deficiency (ghd)
172577|NCT02243852|Growth Hormone Replacement Therapy|growth hormone replacement therapy
172578|NCT02243852|Fibroblast Growth Factor 21 (FGF21)|fibroblast growth factor 21 (fgf21)
172579|NCT02243852|Visceral Fat|visceral fat
172580|NCT02243852|Subcutaneous Fat|subcutaneous fat
172581|NCT02243839|Prosthetic valve|prosthetic valve
172582|NCT02243839|Thrombosis|thrombosis
172583|NCT02243839|Surgery|surgery
172584|NCT02243839|Thrombolytic therapy|thrombolytic therapy
172585|NCT02243839|Transesophageal echocardiography|transesophageal echocardiography
172586|NCT02243826|Lumbar puncture|lumbar puncture
172587|NCT02243826|Adults|adults
172588|NCT02243826|Nitrous oxide|nitrous oxide
172589|NCT02243826|Procedural pain|procedural pain
172590|NCT02243826|Procedural anxiety|procedural anxiety
172591|NCT02243813|Psilocybin|psilocybin
172592|NCT02243813|Pharmacologic Actions|pharmacologic actions
172593|NCT02243813|Psychotropic Drugs|psychotropic drugs
172594|NCT02243800|Vitamin D|vitamin d
172595|NCT02243800|Rheumatoid arthritis|rheumatoid arthritis
172596|NCT02243800|Cholecalciferol|cholecalciferol
172597|NCT02243774|Vaccination|vaccination
172598|NCT02243774|Immunization|immunization
172599|NCT02243774|Randomized Controlled Trial|randomized controlled trial
172600|NCT02243774|Prevention & Control|prevention & control
172601|NCT02243774|Preventive Measures|preventive measures
172602|NCT02243774|Health Promotion|health promotion
172603|NCT02243774|Medicare|medicare
172604|NCT02243774|Intention Prompts|intention prompts
172606|NCT02243761|Concurrent Disorders|concurrent disorders
172607|NCT02243761|Mental Health|mental health
172608|NCT02243761|Addictions|addictions
172609|NCT02243761|Caregiver Burden|caregiver burden
172610|NCT02243722|laryngeal electromyography|laryngeal electromyography
172611|NCT02243722|intrinsic laryngeal muscles|intrinsic laryngeal muscles
172612|NCT02243722|recurrent laryngeal nerve|recurrent laryngeal nerve
402935|NCT01229020|lung sounds|lung sounds
172613|NCT02243722|superior laryngeal nerve|superior laryngeal nerve
172614|NCT02243722|laryngeal sensation|laryngeal sensation
172615|NCT02243722|tone language|tone language
172616|NCT02243709|Stress, alcohol craving, alcohol use disorders|stress, alcohol craving, alcohol use disorders
172617|NCT02243670|opioid addiction|opioid addiction
172618|NCT02243670|opioid substitution therapy|opioid substitution therapy
172619|NCT02243670|addiction|addiction
172620|NCT02243670|buprenorphine maintenance treatment|buprenorphine maintenance treatment
172621|NCT02243670|opioid dependence|opioid dependence
172622|NCT02243670|substitution treatment|substitution treatment
172623|NCT02243670|noncompliance|noncompliance
172624|NCT02243670|opiate addiction|opiate addiction
172625|NCT02243670|Zubzolv® maintenance|zubzolv® maintenance
172626|NCT02243670|adherence monitoring|adherence monitoring
172627|NCT02243670|directly observed therapy|directly observed therapy
172628|NCT02243670|medication adherence|medication adherence
172629|NCT02243670|adherence|adherence
172630|NCT02243670|mobile|mobile
172631|NCT02243670|electronic monitoring|electronic monitoring
172632|NCT02243670|wireless|wireless
172633|NCT02243670|mobile device|mobile device
172634|NCT02243670|artificial intelligence|artificial intelligence
172635|NCT02243670|facial recognition|facial recognition
172636|NCT02243670|computer vision|computer vision
172637|NCT02243670|visual confirmation|visual confirmation
172638|NCT02243670|sublingual buprenorphine/naloxone|sublingual buprenorphine/naloxone
172639|NCT02243670|nonadherence|nonadherence
172640|NCT02243657|ASP3652|asp3652
172642|NCT02243657|Gender|gender
172643|NCT02243657|Pharmacokinetics|pharmacokinetics
172644|NCT02243657|Pharmacodynamics|pharmacodynamics
172645|NCT02243657|Phase 1|phase 1
172646|NCT02243657|Multiple Ascending Doses (MAD)|multiple ascending doses (mad)
172647|NCT02243644|parenchymal neurocysticercosis upto five lesions|parenchymal neurocysticercosis upto five lesions
172648|NCT02243631|ATP|atp
172649|NCT02243631|Probenecid|probenecid
172650|NCT02243631|Chondrocalcinosis|chondrocalcinosis
172651|NCT02243527|Exercise|exercise
172652|NCT02243514|Hypertension|hypertension
172657|NCT02243514|Nerve remodeling|nerve remodeling
172658|NCT02243488|Menstruation|menstruation
172660|NCT02243488|Menstrual Hygiene Management|menstrual hygiene management
172661|NCT02243488|Girls Education|girls education
172662|NCT02243488|Absenteeism|absenteeism
172663|NCT02243488|Access to Education|access to education
172664|NCT02243488|Menstrual Health Education|menstrual health education
172665|NCT02243488|Reusable Sanitary Product|reusable sanitary product
172666|NCT02243462|Shivering|shivering
172667|NCT02243462|Hypothermia|hypothermia
172668|NCT02243462|Postoperative|postoperative
172669|NCT02243462|Temperature|temperature
172670|NCT02243462|Forced air warmer|forced air warmer
172671|NCT02243449|mechanical ventilation|mechanical ventilation
172672|NCT02243449|weaning|weaning
172673|NCT02243449|elderly|elderly
172674|NCT02243449|critically ill|critically ill
172675|NCT02243449|screening|screening
172676|NCT02243449|spontaneous breathing trial|spontaneous breathing trial
172677|NCT02243449|invasive ventilation|invasive ventilation
172678|NCT02243436|CLASSICAL HODGKIN LYMPHOMA|classical hodgkin lymphoma
172679|NCT02243436|HODGKIN LYMPHOMA|hodgkin lymphoma
172680|NCT02243436|LYMPHOMA|lymphoma
172681|NCT02243436|HL|hl
172682|NCT02243423|Aortocaval compression|aortocaval compression
172683|NCT02243423|Cesarean Section|cesarean section
172684|NCT02243423|Spinal Anesthesia|spinal anesthesia
172685|NCT02243423|Phenylephrine|phenylephrine
172686|NCT02243384|Early Hepatocellular Carcinoma|early hepatocellular carcinoma
172687|NCT02243384|Laparoscopic Hepatectomy|laparoscopic hepatectomy
172688|NCT02243384|Radiofrequency Ablation|radiofrequency ablation
172689|NCT02243384|Micrometastases|micrometastases
172690|NCT02243358|Pancreatic, cancer|pancreatic, cancer
172691|NCT02243345|decompression|decompression
172692|NCT02243345|recompression|recompression
172693|NCT02243345|delayed|delayed
172694|NCT02243345|late|late
172695|NCT02243332|Knee|knee
172696|NCT02243332|Pain|pain
172697|NCT02243332|Joint|joint
172698|NCT02243332|Rehabilitation|rehabilitation
172699|NCT02243332|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
172700|NCT02243332|Anterior Knee Pain Syndrome|anterior knee pain syndrome
172701|NCT02243332|Knee Pain|knee pain
172702|NCT02243332|Quadriceps|quadriceps
172703|NCT02243306|pharmacokinetics|pharmacokinetics
172704|NCT02243306|Chronic kidney disease|chronic kidney disease
172705|NCT02243306|peritoneal dialysis|peritoneal dialysis
172706|NCT02243306|hemoglobin|hemoglobin
172707|NCT02243306|Anemia|anemia
172708|NCT02243306|GSK1278863|gsk1278863
172709|NCT02243306|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
172710|NCT02243306|erythropoiesis stimulating agents|erythropoiesis stimulating agents
172711|NCT02243293|Hepatitis C Virus|hepatitis c virus
665113|NCT00829114|IU|iu
172712|NCT02243293|Hepatitis C Genotype 4|hepatitis c genotype 4
172713|NCT02243293|Hepatitis C|hepatitis c
172714|NCT02243293|HCV|hcv
172818|NCT02242890|LARC|larc
172715|NCT02243293|Hepatitis C Genotype 5|hepatitis c genotype 5
163747|NCT02293187|falls|falls
172716|NCT02243293|interferon free|interferon free
172717|NCT02243293|Hepatitis C Genotype 2|hepatitis c genotype 2
172718|NCT02243293|Hepatitis C Genotype 3|hepatitis c genotype 3
172719|NCT02243293|Hepatitis C Genotype 6|hepatitis c genotype 6
172720|NCT02243293|Chronic Hepatitis C|chronic hepatitis c
172721|NCT02243280|HCV GT4|hcv gt4
172722|NCT02243280|Hepatitis C virus|hepatitis c virus
172723|NCT02243280|HCV GT1|hcv gt1
172724|NCT02243280|HCV|hcv
172725|NCT02243280|Compensated Cirrhosis|compensated cirrhosis
172726|NCT02243280|HCV GT6|hcv gt6
172727|NCT02243280|Hepatitis C Genotype 4 (GT 4)|hepatitis c genotype 4 (gt 4)
172728|NCT02243280|Hepatitis C Genotype 1 (GT1)|hepatitis c genotype 1 (gt1)
172729|NCT02243280|RBV|rbv
172730|NCT02243280|Cirrhotic|cirrhotic
172731|NCT02243280|Hepatitis C|hepatitis c
172732|NCT02243280|Interferon (IFN) Free|interferon (ifn) free
172733|NCT02243280|IFN free|ifn free
172734|NCT02243280|HCV GT5|hcv gt5
172735|NCT02243280|Chronic Hepatitis C|chronic hepatitis c
172736|NCT02243280|Ribavirin|ribavirin
172737|NCT02243280|Child Pugh A|child pugh a
172738|NCT02243280|Hepatitis C Genotype 5 (GT 5)|hepatitis c genotype 5 (gt 5)
172739|NCT02243280|Hepatitis C Genotype 6 (GT 6)|hepatitis c genotype 6 (gt 6)
172740|NCT02243280|ABT-493|abt-493
172741|NCT02243280|ABT-530|abt-530
172742|NCT02243280|glecaprevir|glecaprevir
172743|NCT02243280|pibrentasvir|pibrentasvir
172744|NCT02243267|Colon Cancer Colon Cancer Prevention|colon cancer colon cancer prevention
172745|NCT02243241|Healthy volunteers|healthy volunteers
172746|NCT02243241|Opioid|opioid
172747|NCT02243241|ECG|ecg
172748|NCT02243241|QTcI|qtci
172749|NCT02243228|granulocyte-macrophage colony stimulating factor(GM-CSF)|granulocyte-macrophage colony stimulating factor(gm-csf)
172750|NCT02243228|Autoimmune pulmonary alveolar proteinosis (PAP)|autoimmune pulmonary alveolar proteinosis (pap)
172751|NCT02243215|Laparoscopy|laparoscopy
172752|NCT02243215|Training|training
172753|NCT02243215|Off-site|off-site
172754|NCT02243215|Box trainer|box trainer
172755|NCT02243215|Virtual Reality Simulator|virtual reality simulator
172756|NCT02243202|Obesity|obesity
172757|NCT02243202|Overweight|overweight
172758|NCT02243202|Canagliflozin|canagliflozin
172759|NCT02243202|Phentermine|phentermine
172760|NCT02243202|INVOKANA®|invokana®
172761|NCT02243189|Healthy|healthy
172762|NCT02243189|Asthma|asthma
172763|NCT02243189|JNJ-43260295|jnj-43260295
172764|NCT02243189|Nasal Allergen Challenge|nasal allergen challenge
172765|NCT02243176|Saxagliptin|saxagliptin
172766|NCT02243176|Acarbose|acarbose
172767|NCT02243176|Type 2 Diabetes|type 2 diabetes
172768|NCT02243176|Metformin|metformin
172769|NCT02243124|Anemia|anemia
172770|NCT02243124|Transfusion|transfusion
172771|NCT02243124|AML|aml
172772|NCT02243124|MDS|mds
172773|NCT02243124|CLL|cll
172774|NCT02243124|p53|p53
172775|NCT02243124|erythropoiesis|erythropoiesis
172776|NCT02243111|Systemic sclerosis, pulmonary hypertension|systemic sclerosis, pulmonary hypertension
172777|NCT02243072|Insulin Dependent Diabetes Mellitus|insulin dependent diabetes mellitus
172778|NCT02243072|family therapy|family therapy
172779|NCT02243072|adolescents|adolescents
172780|NCT02243072|regimen adherence|regimen adherence
172781|NCT02243072|metabolic control|metabolic control
172782|NCT02243059|Magnetic Resonance Imaging|magnetic resonance imaging
172783|NCT02243059|Gadofosveset trisodium|gadofosveset trisodium
172784|NCT02243059|Nodal imaging|nodal imaging
172785|NCT02243033|Prostate cancer|prostate cancer
172786|NCT02243033|Focal therapy|focal therapy
172787|NCT02243033|Laser therapy|laser therapy
172788|NCT02243033|Transrectal|transrectal
172789|NCT02243033|MRI-guided|mri-guided
172790|NCT02243007|Resectable pancreatic cancer|resectable pancreatic cancer
172791|NCT02243007|Pancreatic Ductal Carcinoma|pancreatic ductal carcinoma
172792|NCT02242968|Licensed Vaccines|licensed vaccines
172793|NCT02242968|Blood Draw|blood draw
172794|NCT02242968|Investigational Vaccines|investigational vaccines
172795|NCT02242968|Healthy Volunteers|healthy volunteers
172796|NCT02242968|Eligibility Screening|eligibility screening
172797|NCT02242955|Alcohol-dependence|alcohol-dependence
172799|NCT02242955|Detoxification|detoxification
172800|NCT02242955|Diazepam|diazepam
172801|NCT02242955|Benzodiazepines|benzodiazepines
172802|NCT02242955|Anxiety|anxiety
172803|NCT02242929|Nodular Basal Cell Carcinoma|nodular basal cell carcinoma
172804|NCT02242929|Treatment|treatment
172805|NCT02242929|Imiquimod|imiquimod
172806|NCT02242929|Curettage|curettage
172807|NCT02242929|Surgery|surgery
172808|NCT02242916|reccurent Head and Neck tumors|reccurent head and neck tumors
172809|NCT02242916|re-irradiation|re-irradiation
172810|NCT02242916|photon|photon
172811|NCT02242916|proton|proton
172812|NCT02242916|carbon-ion|carbon-ion
172813|NCT02242890|intrauterine contraception (IUC)|intrauterine contraception (iuc)
172814|NCT02242890|social networks|social networks
172815|NCT02242890|social influence|social influence
172816|NCT02242890|diffusion of innovation|diffusion of innovation
210165|NCT02071160|HIE|hie
172817|NCT02242890|intrauterine device (IUD)|intrauterine device (iud)
172819|NCT02242799|Malaria|malaria
172820|NCT02242799|HIV|hiv
172821|NCT02242799|Dolutegravir|dolutegravir
172822|NCT02242799|Artemisinin|artemisinin
172823|NCT02242799|Pharmacokinetics|pharmacokinetics
172824|NCT02242799|Interactions|interactions
172825|NCT02242773|Prostate Cancer|prostate cancer
172826|NCT02242773|Active Surveillance|active surveillance
172827|NCT02242773|MRI-Guided Biopsy|mri-guided biopsy
172828|NCT02242773|Multi-parametric MRI|multi-parametric mri
172829|NCT02242773|MP-MRI|mp-mri
172830|NCT02242760|acne|acne
172831|NCT02242747|actinic keratosis|actinic keratosis
172832|NCT02242747|field cancerization|field cancerization
172833|NCT02242747|ingenol mebutate|ingenol mebutate
172834|NCT02242747|5-fluorouracil|5-fluorouracil
172835|NCT02242747|tolerability|tolerability
172836|NCT02242747|safety|safety
172837|NCT02242695|vulvovaginal candidiasis|vulvovaginal candidiasis
172838|NCT02242695|vulvovaginal candidosis|vulvovaginal candidosis
172839|NCT02242695|mycotic vaginal infection|mycotic vaginal infection
172840|NCT02242695|dequalinium chloride|dequalinium chloride
172841|NCT02242695|Fluomizin|fluomizin
172842|NCT02242695|clotrimazole|clotrimazole
172843|NCT02242695|canesten|canesten
172844|NCT02242656|Short Bowel Syndrome|short bowel syndrome
172845|NCT02242656|SBS|sbs
172846|NCT02242656|Chronic Diarrhea|chronic diarrhea
172847|NCT02242656|Short Bowel|short bowel
172848|NCT02242656|Short Gut|short gut
172849|NCT02242656|Short Gut Syndrome|short gut syndrome
172850|NCT02242656|Anti-Diarrheal|anti-diarrheal
172851|NCT02242656|Opium Tincture|opium tincture
172852|NCT02242656|loperamide|loperamide
172853|NCT02242656|diphenoxylate|diphenoxylate
172854|NCT02242656|ileostomies|ileostomies
172855|NCT02242656|tincture of opium|tincture of opium
172859|NCT02242656|opiate|opiate
172860|NCT02242643|Fluzone Quadrivalent|fluzone quadrivalent
172861|NCT02242643|Comparator|comparator
172862|NCT02242643|Children|children
172863|NCT02242643|Seasonal influenza|seasonal influenza
172864|NCT02242643|Safety|safety
172865|NCT02242643|Immunogenicity|immunogenicity
172866|NCT02242630|Subacromial bursitis|subacromial bursitis
172867|NCT02242630|Triamcinolone|triamcinolone
172868|NCT02242630|Methylprednisolone|methylprednisolone
172869|NCT02242630|Shoulder pain|shoulder pain
172870|NCT02242617|Adherence|adherence
172871|NCT02242617|CPAP|cpap
172872|NCT02242617|Oral Appliance|oral appliance
172873|NCT02242617|Mandibular Advancement Splints|mandibular advancement splints
172874|NCT02242617|Preference|preference
172875|NCT02242591|Knee surgery|knee surgery
172876|NCT02242591|Saphenous nerve|saphenous nerve
172877|NCT02242591|Perineural block|perineural block
172878|NCT02242591|Adductor Canal Block|adductor canal block
172879|NCT02242591|Postoperative Pain|postoperative pain
172880|NCT02242591|Mobilization|mobilization
172881|NCT02242578|Negative symptoms|negative symptoms
172882|NCT02242565|HIV prevention|hiv prevention
172883|NCT02242565|ShangRing|shangring
172884|NCT02242565|adverse events|adverse events
172885|NCT02242565|wound healing|wound healing
172886|NCT02242565|voluntary medical male circumcision (VMMC)|voluntary medical male circumcision (vmmc)
172887|NCT02242565|medical device|medical device
172888|NCT02242565|Zambia|zambia
172889|NCT02242526|hiatal hernia, recurrence, biologic mesh, synthetic mesh|hiatal hernia, recurrence, biologic mesh, synthetic mesh
172890|NCT02242513|Pulsed mode radiofrequency|pulsed mode radiofrequency
172891|NCT02242513|Plantar Fasciitis|plantar fasciitis
172892|NCT02242513|Ultrasound-guided|ultrasound-guided
172893|NCT02242500|Gingival recession/surgery|gingival recession/surgery
172894|NCT02242500|Collagen/therapeutic use|collagen/therapeutic use
172895|NCT02242500|Root coverage|root coverage
172896|NCT02242500|Treatment outcome|treatment outcome
172897|NCT02242487|Parkinson's Disease|parkinson's disease
172898|NCT02242487|Motor fluctuations|motor fluctuations
172899|NCT02242487|levodopa|levodopa
172900|NCT02242487|inhaled drugs|inhaled drugs
172901|NCT02242487|OFF episodes|off episodes
172902|NCT02242474|Rheumatoid arthritis|rheumatoid arthritis
172903|NCT02242474|Surgical Wound Infection|surgical wound infection
172904|NCT02242474|Surgical Site Infection|surgical site infection
172905|NCT02242474|Antirheumatic Agents|antirheumatic agents
172906|NCT02242474|Perioperative Care|perioperative care
172907|NCT02242474|Anti-TNF|anti-tnf
172908|NCT02242474|Anti-TNF-alpha|anti-tnf-alpha
172909|NCT02242461|COPD, Rhodiola L., clinical trial, biomarkers, spirometry|copd, rhodiola l., clinical trial, biomarkers, spirometry
172910|NCT02242448|Healthy Volunteer|healthy volunteer
172911|NCT02242448|Contrast|contrast
172912|NCT02242409|Metastatic pancreatic cancer|metastatic pancreatic cancer
172913|NCT02242409|Second Line treatment|second line treatment
172914|NCT02242409|Gemcitabine|gemcitabine
172915|NCT02242409|Nab-paclitaxel|nab-paclitaxel
172916|NCT02242188|Breastfeeding|breastfeeding
172917|NCT02242188|Iron supplementation|iron supplementation
172918|NCT02242188|Psychomotor development|psychomotor development
172919|NCT02242188|Safety|safety
172920|NCT02242188|infants|infants
172921|NCT02242162|phrenic nerves magnetic stimulations|phrenic nerves magnetic stimulations
172922|NCT02242149|Fat liver|fat liver
172923|NCT02242149|Diabetes|diabetes
172924|NCT02242149|Diacerein|diacerein
172925|NCT02242149|Transient elastography|transient elastography
172926|NCT02242149|Treatment|treatment
172927|NCT02242136|Posttraumatic Stress Disorder|posttraumatic stress disorder
172928|NCT02242136|Aggressive Behavior|aggressive behavior
172929|NCT02242136|Appetitive Aggression|appetitive aggression
172930|NCT02242136|Treatment|treatment
172931|NCT02242136|FORNET|fornet
172932|NCT02242123|Celiac Disease|celiac disease
172933|NCT02242123|Gluten-free diet|gluten-free diet
172934|NCT02242123|EmA assay|ema assay
172935|NCT02242123|Duodenal culture medium|duodenal culture medium
172936|NCT02242110|Nightmares|nightmares
172937|NCT02242110|Sleep|sleep
172938|NCT02242110|PTSD|ptsd
172939|NCT02242110|Exposure, Relaxation, and Rescripting Therapy|exposure, relaxation, and rescripting therapy
172940|NCT02242071|Motor Neuron Disease|motor neuron disease
172941|NCT02242071|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
172942|NCT02242071|Autologous Mononuclear Cell therapy|autologous mononuclear cell therapy
172943|NCT02242071|Stem cells|stem cells
172944|NCT02242032|dry eye disease|dry eye disease
172945|NCT02241993|glucose sensor|glucose sensor
172946|NCT02241993|Inter-sensor distance|inter-sensor distance
172947|NCT02241967|total knee arthroplasty|total knee arthroplasty
172948|NCT02241967|pain|pain
172949|NCT02241967|post-surgical pain|post-surgical pain
172950|NCT02241967|opioid|opioid
172951|NCT02241967|transcranial direct current stimulation|transcranial direct current stimulation
172952|NCT02241967|tDCS|tdcs
172953|NCT02241967|brain stimulation|brain stimulation
172954|NCT02241967|total hip arthroplasty|total hip arthroplasty
172955|NCT02241967|TKA|tka
172956|NCT02241967|THA|tha
172957|NCT02241928|Muscular Dystrophy|muscular dystrophy
172958|NCT02241928|Autologous Mononuclear cell therapy|autologous mononuclear cell therapy
172959|NCT02241928|Stem Cell|stem cell
172960|NCT02241889|diabetes|diabetes
172961|NCT02241889|closed-loop|closed-loop
172962|NCT02241889|bi-hormonal|bi-hormonal
172963|NCT02241889|exercise|exercise
172964|NCT02241863|bipolar disorders|bipolar disorders
172965|NCT02241863|medication adherence|medication adherence
172966|NCT02241863|psychological intervention|psychological intervention
172967|NCT02241863|multifaceted intervention|multifaceted intervention
172968|NCT02241850|High Intensity Training|high intensity training
172969|NCT02241850|Genetic Polymorphisms|genetic polymorphisms
172970|NCT02241850|Genome Wide association study|genome wide association study
172971|NCT02241850|Single Nucleotide Polymorphism genotype|single nucleotide polymorphism genotype
172972|NCT02241850|Subjects|subjects
172973|NCT02241837|heart failure|heart failure
172974|NCT02241837|percutaneous|percutaneous
172975|NCT02241837|interventional cardiology|interventional cardiology
172976|NCT02241837|apical remodeling|apical remodeling
172977|NCT02241837|LV dilatation|lv dilatation
172978|NCT02241837|akinesis|akinesis
172979|NCT02241837|dyskinesis|dyskinesis
172980|NCT02241837|myocardial infarction|myocardial infarction
172981|NCT02241824|Lumbar Orthosis|lumbar orthosis
172982|NCT02241824|Lumbar brace|lumbar brace
172983|NCT02241811|Diabetic|diabetic
172984|NCT02241811|Foot|foot
172985|NCT02241811|Wound|wound
173108|NCT02241278|preemptive analgesia|preemptive analgesia
172986|NCT02241811|Sodium pentaborate pentahydrate|sodium pentaborate pentahydrate
172987|NCT02241811|Hydrogel|hydrogel
172988|NCT02241798|epilepsy|epilepsy
172989|NCT02241798|oxygen saturation|oxygen saturation
172990|NCT02241798|transcutaneous carbon dioxide|transcutaneous carbon dioxide
172991|NCT02241798|sudep|sudep
172992|NCT02241798|pre-oxygenation|pre-oxygenation
172993|NCT02241733|exercise|exercise
172994|NCT02241733|pulmonary rehabilitation|pulmonary rehabilitation
173778|NCT02238002|SS-OCT|ss-oct
172999|NCT02241681|Medium Chain Triglycerides|medium chain triglycerides
173000|NCT02241681|Medium Chain Triglycerides metabolites|medium chain triglycerides metabolites
173001|NCT02241681|Peptamen 1.5|peptamen 1.5
173002|NCT02241668|Brain tumor|brain tumor
173003|NCT02241668|3'-Deoxy-3'-18f-Fluorothymidine|3'-deoxy-3'-18f-fluorothymidine
173004|NCT02241668|Fluoro-L-Thymidine Positron Emission Tomography|fluoro-l-thymidine positron emission tomography
173005|NCT02241668|FLT PET|flt pet
173006|NCT02241668|Magnetic resonance imaging|magnetic resonance imaging
173007|NCT02241668|MRI|mri
173008|NCT02241655|Anesthesia|anesthesia
173009|NCT02241655|Electroencephalography|electroencephalography
173010|NCT02241655|Burst suppression|burst suppression
173011|NCT02241655|Surgery|surgery
173012|NCT02241655|Delirium|delirium
173013|NCT02241655|Falls|falls
173014|NCT02241655|Health related quality of life|health related quality of life
401984|NCT01232413|Thorough QT (TQT)|thorough qt (tqt)
173015|NCT02241642|Percutaneous vascular closure device|percutaneous vascular closure device
164043|NCT02291718|TAA|taa
173016|NCT02241642|vascular closure device|vascular closure device
173017|NCT02241642|Large hole closure device|large hole closure device
173018|NCT02241629|motion sickness|motion sickness
173019|NCT02241603|Insulin resistance|insulin resistance
173020|NCT02241603|Consummatory Reward|consummatory reward
173021|NCT02241577|peri-implantitis|peri-implantitis
173022|NCT02241577|dental implants|dental implants
173023|NCT02241577|randomized controlled trial|randomized controlled trial
173024|NCT02241577|non-surgical periodontal treatment|non-surgical periodontal treatment
173025|NCT02241577|will be defined by the presence of alveolar bone loss of at least 3mm, pocket depth of at least 5mm and bleeding on probing.|will be defined by the presence of alveolar bone loss of at least 3mm, pocket depth of at least 5mm and bleeding on probing.
173026|NCT02241564|Immunosuppression|immunosuppression
173027|NCT02241551|Borderline|borderline
173028|NCT02241551|Resectable|resectable
173029|NCT02241551|Pancreatic|pancreatic
173030|NCT02241551|Cancer|cancer
173031|NCT02241551|Neoadjuvant|neoadjuvant
173032|NCT02241551|Chemotheraphy|chemotheraphy
173033|NCT02241551|Gemcitabine|gemcitabine
173034|NCT02241551|Nab-Paclitaxel|nab-paclitaxel
173035|NCT02241551|mFOFIRINOX|mfofirinox
173036|NCT02241551|Sterotatic Body Radiation Therapy|sterotatic body radiation therapy
173037|NCT02241538|Pilates-based exercises|pilates-based exercises
173038|NCT02241525|Pulmonary|pulmonary
173039|NCT02241525|Thromboembolic|thromboembolic
173040|NCT02241525|Lung|lung
173041|NCT02241512|post-ERCP pancreatitis|post-ercp pancreatitis
173042|NCT02241512|pediatric|pediatric
173043|NCT02241512|ibuprofen|ibuprofen
173044|NCT02241499|Digestive System Diseases|digestive system diseases
173045|NCT02241499|Esophageal cancer|esophageal cancer
173046|NCT02241499|Intestinal Neoplasms|intestinal neoplasms
173047|NCT02241499|Gastrointestinal Neoplasms|gastrointestinal neoplasms
173048|NCT02241499|Digestive System Neoplasms|digestive system neoplasms
173050|NCT02241499|Fluorouracil|fluorouracil
173051|NCT02241499|Metabolic response|metabolic response
173052|NCT02241499|Oxaliplatin|oxaliplatin
173053|NCT02241499|Radiotherapy|radiotherapy
173054|NCT02241486|Burn pain|burn pain
173055|NCT02241486|Procedural pain|procedural pain
173056|NCT02241486|Sublingual fentanyl|sublingual fentanyl
173057|NCT02241486|Morphine|morphine
173058|NCT02241473|gait|gait
173059|NCT02241473|physical activity|physical activity
173060|NCT02241473|energy cost|energy cost
173061|NCT02241473|efficiency|efficiency
173062|NCT02241460|Premature Ejaculation|premature ejaculation
173063|NCT02241460|Lidocaine|lidocaine
173064|NCT02241447|aortic valve Stenosis|aortic valve stenosis
173065|NCT02241447|Echo|echo
173066|NCT02241447|TAVI|tavi
173067|NCT02241447|SAVR|savr
173068|NCT02241447|referral|referral
173069|NCT02241434|Duchenne muscular dystrophy|duchenne muscular dystrophy
173070|NCT02241434|Autologous Bone marrow Mononuclear cell therapy|autologous bone marrow mononuclear cell therapy
173071|NCT02241434|Stem Cells|stem cells
173072|NCT02241421|Impaired glucose tolerance|impaired glucose tolerance
173073|NCT02241421|Glucose Metabolism Disorders|glucose metabolism disorders
173074|NCT02241421|Metabolic Diseases|metabolic diseases
173075|NCT02241421|Endocrine System Diseases|endocrine system diseases
173076|NCT02241421|Hyperinsulinism|hyperinsulinism
173077|NCT02241421|Lipid metabolism|lipid metabolism
173078|NCT02241421|Anti Bacterial Agents|anti bacterial agents
173079|NCT02241421|Gastro Intestinal Tract|gastro intestinal tract
173080|NCT02241395|Cerebral Palsy|cerebral palsy
173081|NCT02241395|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
173082|NCT02241395|stem cell|stem cell
173086|NCT02241356|Down syndrome|down syndrome
173087|NCT02241356|visual functions|visual functions
173088|NCT02241356|bifocals|bifocals
173089|NCT02241356|children|children
173090|NCT02241356|visual acuity at near|visual acuity at near
173091|NCT02241343|Artificially and reversibly achieved with a blood pressure cuff|artificially and reversibly achieved with a blood pressure cuff
173092|NCT02241330|Zinc|zinc
173093|NCT02241330|deficiency|deficiency
173094|NCT02241330|biofortification|biofortification
173095|NCT02241330|wheat|wheat
173096|NCT02241317|Diabetes mellitus|diabetes mellitus
173097|NCT02241317|Hypoglycaemia|hypoglycaemia
173098|NCT02241317|staff training|staff training
173099|NCT02241317|Education|education
173100|NCT02241317|blood glucose|blood glucose
173101|NCT02241304|electromyography|electromyography
173102|NCT02241304|neuromuscular blockade|neuromuscular blockade
173103|NCT02241291|Percutaneous Coronary Intervention|percutaneous coronary intervention
173104|NCT02241291|Registries|registries
173105|NCT02241278|colon surgery|colon surgery
173106|NCT02241278|ketamine|ketamine
173107|NCT02241278|patient-controlled-analgesia|patient-controlled-analgesia
173109|NCT02241265|asthma|asthma
173110|NCT02241265|thermoplasty|thermoplasty
173111|NCT02241252|ECG|ecg
173112|NCT02241252|QT interval|qt interval
173113|NCT02241252|Sotalol|sotalol
173114|NCT02241252|Dofetilide|dofetilide
173115|NCT02241252|iPhone|iphone
173116|NCT02241226|wellbeing|wellbeing
173117|NCT02241226|meditation|meditation
173118|NCT02241226|Ayurveda|ayurveda
173119|NCT02241226|yoga|yoga
173120|NCT02241226|herbs|herbs
173121|NCT02241226|health|health
173122|NCT02241226|longevity|longevity
173123|NCT02241226|individuals|individuals
173124|NCT02241213|Stroke|stroke
173125|NCT02241213|Aphasia|aphasia
173126|NCT02241213|Broca|broca
173127|NCT02241187|PEGPH20|pegph20
173128|NCT02241187|Cetuximab|cetuximab
173129|NCT02241187|14-039|14-039
173130|NCT02241174|Atopic Dermatitis|atopic dermatitis
173131|NCT02241161|skin eythema|skin eythema
173132|NCT02241161|rejuvenating cream|rejuvenating cream
173133|NCT02241161|rejuvenating serum|rejuvenating serum
173134|NCT02241161|antioxidant serum|antioxidant serum
173135|NCT02241135|Rav G protein|rav g protein
173136|NCT02241135|rabies|rabies
173137|NCT02241135|VNT|vnt
173138|NCT02241135|immunogenicity|immunogenicity
173139|NCT02241135|PrEP vaccination|prep vaccination
173140|NCT02241135|mRNA|mrna
173141|NCT02241135|CV7201|cv7201
173142|NCT02241122|prostate cancer|prostate cancer
173143|NCT02241122|PSA|psa
173144|NCT02241122|MRI|mri
173145|NCT02241122|biopsy|biopsy
173146|NCT02241122|biomarker|biomarker
173147|NCT02241109|aortic stenosis progression|aortic stenosis progression
173148|NCT02241109|aortic valve sclerosis progression|aortic valve sclerosis progression
173149|NCT02241109|calcification propensity|calcification propensity
173150|NCT02241070|mindfulness meditation|mindfulness meditation
173151|NCT02241070|mental health promotion|mental health promotion
173152|NCT02241070|worker|worker
173153|NCT02241057|temperature profile|temperature profile
173154|NCT02241057|air activated 3-cell patch|air activated 3-cell patch
173155|NCT02241057|adhesion|adhesion
173156|NCT02241044|argon plasma coagulation, bleeding peptic ulcer|argon plasma coagulation, bleeding peptic ulcer
173157|NCT02241031|Megakaryocytic Progenitor Products|megakaryocytic progenitor products
173158|NCT02241031|Hematological Diseases|hematological diseases
173159|NCT02241031|Thrombocytopenia|thrombocytopenia
173160|NCT02241018|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
173161|NCT02241018|Mesenchymal Stem Cells|mesenchymal stem cells
173162|NCT02241018|CD25 Monoclonal Antibody|cd25 monoclonal antibody
173163|NCT02241018|Acute Graft-versus-host disease|acute graft-versus-host disease
173164|NCT02241005|Health-care associated infection|health-care associated infection
173165|NCT02241005|Skin integrity|skin integrity
173166|NCT02241005|Antimicrobial resistance|antimicrobial resistance
173167|NCT02240992|Poor Graft Function|poor graft function
173168|NCT02240992|Delayed platelet engraftment|delayed platelet engraftment
173169|NCT02240992|Peripheral Blood Stem Cell|peripheral blood stem cell
173170|NCT02240992|Mesenchymal Stem Cells|mesenchymal stem cells
173171|NCT02240992|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
173172|NCT02240979|arterial waveform|arterial waveform
173173|NCT02240979|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
173174|NCT02240979|echocardiography|echocardiography
173175|NCT02240979|intrinsic frequency measures of cardiac function|intrinsic frequency measures of cardiac function
173176|NCT02240966|Testicular Neoplasms|testicular neoplasms
173177|NCT02240966|Hypogonadism|hypogonadism
173178|NCT02240966|Metabolic Syndrome|metabolic syndrome
173179|NCT02240966|Treatment related late effects|treatment related late effects
173180|NCT02240953|Anticoagulation|anticoagulation
173181|NCT02240953|Prosthetic Heart Valves|prosthetic heart valves
173182|NCT02240953|Acetylsalicylic acid|acetylsalicylic acid
173183|NCT02240953|Warfarin|warfarin
173184|NCT02240953|Thrombosis|thrombosis
173185|NCT02240940|Heart Failure|heart failure
173186|NCT02240940|Volume Reduction|volume reduction
173187|NCT02240940|Pressure Reduction|pressure reduction
173188|NCT02240940|Ischemic Heart Failure|ischemic heart failure
173189|NCT02240940|LAD Infarct|lad infarct
173192|NCT02240927|Pregnancy|pregnancy
173193|NCT02240927|Warfarin|warfarin
173194|NCT02240927|Thrombosis|thrombosis
173195|NCT02240914|Iliac Vein Obstruction|iliac vein obstruction
173196|NCT02240914|May-Thurner Syndrome|may-thurner syndrome
173197|NCT02240914|Cockett Syndrome|cockett syndrome
173198|NCT02240914|Vascular Ultrasound|vascular ultrasound
173199|NCT02240914|IVUS|ivus
173200|NCT02240901|Laryngeal mask airway|laryngeal mask airway
173201|NCT02240901|endotracheal intubation|endotracheal intubation
173202|NCT02240901|postoperative pulmonary complications|postoperative pulmonary complications
173203|NCT02240901|elderly patients|elderly patients
173204|NCT02240888|pneumococcal|pneumococcal
173205|NCT02240888|vaccination|vaccination
173206|NCT02240888|antibody|antibody
173207|NCT02240888|response|response
173208|NCT02240888|immunosuppressive|immunosuppressive
173209|NCT02240888|treatment|treatment
173210|NCT02240888|inflammatory|inflammatory
173211|NCT02240888|rheumatic|rheumatic
173212|NCT02240888|disease|disease
173213|NCT02240875|Ebola|ebola
173214|NCT02240875|Zaire|zaire
173215|NCT02240849|Neck pain|neck pain
164226|NCT02290639|Military|military
164227|NCT02290639|Primary Care|primary care
164228|NCT02290639|Cognitive Behavioral Therapy|cognitive behavioral therapy
164229|NCT02290639|Prolonged Exposure|prolonged exposure
164236|NCT02290626|GER|ger
173216|NCT02240849|functional pillow|functional pillow
173217|NCT02240849|sleep|sleep
173218|NCT02240849|cervical lordosis|cervical lordosis
173219|NCT02240823|Erectile Function|erectile function
173220|NCT02240823|Mesenchymal Stromal Cells|mesenchymal stromal cells
173221|NCT02240823|Stem Cell|stem cell
173222|NCT02240797|Anorexia Nervosa|anorexia nervosa
173223|NCT02240797|Neuroimaging|neuroimaging
173224|NCT02240797|Positron emission tomography (PET)|positron emission tomography (pet)
173225|NCT02240797|[11C]PKAB|[11c]pkab
173226|NCT02240784|Porphyria|porphyria
173227|NCT02240784|AIP|aip
173228|NCT02240784|VP|vp
173229|NCT02240784|HCP|hcp
173230|NCT02240784|Variegate|variegate
173231|NCT02240784|Coproporphyria|coproporphyria
173232|NCT02240771|Transarterial chemotherapy|transarterial chemotherapy
173233|NCT02240771|Thalidomide|thalidomide
173234|NCT02240771|Capecitabine|capecitabine
173235|NCT02240758|glioma, confocal laser endomicroscopy|glioma, confocal laser endomicroscopy
173236|NCT02240745|Echocardiography, Stress|echocardiography, stress
173237|NCT02240745|Echocardiography, Three-Dimensional|echocardiography, three-dimensional
173238|NCT02240745|Coronary Artery Disease|coronary artery disease
173239|NCT02240745|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
173240|NCT02240745|Coronary Circulation|coronary circulation
173241|NCT02240615|Epiphora|epiphora
173242|NCT02240615|Lacrimal Stent|lacrimal stent
173243|NCT02240615|Lacrimal System|lacrimal system
173244|NCT02240602|acute pain|acute pain
173245|NCT02240602|postoperative|postoperative
173246|NCT02240602|surgery|surgery
173247|NCT02240589|Traumatic Brain Injury|traumatic brain injury
173248|NCT02240589|Memantine|memantine
173249|NCT02240589|Memory|memory
173250|NCT02240576|surgery for nasal fracture|surgery for nasal fracture
173251|NCT02240563|autoimmune thyroiditis|autoimmune thyroiditis
173252|NCT02240563|LLLT|lllt
173253|NCT02240563|safety|safety
173254|NCT02240563|ultrasound|ultrasound
173255|NCT02240550|Open Inguinal Hernia|open inguinal hernia
173257|NCT02240537|MM|mm
173258|NCT02240537|MDS|mds
173259|NCT02240537|sMM|smm
173260|NCT02240524|Gastric adenocarcinoma|gastric adenocarcinoma
173261|NCT02240524|HIPEC|hipec
173262|NCT02240524|Paclitaxel|paclitaxel
173263|NCT02240524|Oxaliplatin|oxaliplatin
173264|NCT02240524|Capecitabine|capecitabine
173265|NCT02240511|Body Composition|body composition
173266|NCT02240511|Amino Acids Supplementation|amino acids supplementation
173267|NCT02240511|Resistance Exercise|resistance exercise
173268|NCT02240498|Abscess|abscess
173269|NCT02240498|Drainage|drainage
173270|NCT02240485|Pathological gambling|pathological gambling
173271|NCT02240485|Treatment|treatment
173272|NCT02240485|Marital relationship|marital relationship
173274|NCT02240459|crossover study|crossover study
173275|NCT02240459|placebo controlled|placebo controlled
173276|NCT02240459|double blind|double blind
173277|NCT02240459|overactive bladder|overactive bladder
173278|NCT02240420|Type 2 diabetes prevention in the post-partum|type 2 diabetes prevention in the post-partum
173279|NCT02240420|Behavior change among Latinas,|behavior change among latinas,
173280|NCT02240420|Health Coaching, Motivational interviewing techniques|health coaching, motivational interviewing techniques
173281|NCT02240407|Pompe Disease|pompe disease
173282|NCT02240407|Gene Therapy|gene therapy
173283|NCT02240407|Repeated dosing|repeated dosing
173284|NCT02240407|Immune modulation|immune modulation
173285|NCT02240394|TCD Traumatic brain injury increased intracranial pressure|tcd traumatic brain injury increased intracranial pressure
173286|NCT02240368|Depth anesthesia monitors|depth anesthesia monitors
173287|NCT02240368|Children anesthesia|children anesthesia
173288|NCT02240368|Bispectral monitor|bispectral monitor
173289|NCT02240368|Entropy monitor|entropy monitor
173290|NCT02240342|Ovarian reserve|ovarian reserve
173291|NCT02240342|Poor response|poor response
173292|NCT02240342|Follicle recruitment|follicle recruitment
173293|NCT02240342|Bone marrow transplant|bone marrow transplant
173294|NCT02240329|respiratory|respiratory
173295|NCT02240329|cough|cough
173296|NCT02240303|pain|pain
173297|NCT02240303|mobility|mobility
173298|NCT02240303|brain|brain
173299|NCT02240303|cognition|cognition
173300|NCT02240290|C14|c14
173301|NCT02240290|Dosimetry|dosimetry
173302|NCT02240290|Mass balance|mass balance
173303|NCT02240290|ADME|adme
173304|NCT02240277|Septic Shock|septic shock
173305|NCT02240277|Meropenem|meropenem
173306|NCT02240277|Ciprofloxacin|ciprofloxacin
173307|NCT02240277|Pharmacokinetics|pharmacokinetics
173308|NCT02240264|Omega-3 fatty acids|omega-3 fatty acids
173309|NCT02240264|Cognitive function|cognitive function
173310|NCT02240264|Academic performance|academic performance
173311|NCT02240264|Mental health|mental health
173312|NCT02240264|Eye tracking|eye tracking
173313|NCT02240264|Krill oil|krill oil
173314|NCT02240264|LCPUFA|lcpufa
173315|NCT02240251|Inferior Vena Cava Filter|inferior vena cava filter
173316|NCT02240251|IVC Filter|ivc filter
173317|NCT02240251|IVC filter removal|ivc filter removal
173318|NCT02240251|Excimer Laser|excimer laser
173319|NCT02240225|COPD;SRI;Reliability;validity;|copd;sri;reliability;validity;
173320|NCT02240212|second line treatment|second line treatment
173321|NCT02240212|oncology|oncology
173322|NCT02240212|AKT inhibitor|akt inhibitor
173323|NCT02240212|paclitaxel|paclitaxel
173324|NCT02240212|HER2 (ErbB2) negative advanced gastric cancer|her2 (erbb2) negative advanced gastric cancer
173325|NCT02240212|Afuresertib|afuresertib
173326|NCT02240186|Microprocessor-controlled knee|microprocessor-controlled knee
173327|NCT02240186|prosthesis|prosthesis
173328|NCT02240186|amputation|amputation
173329|NCT02240173|antipsychotic Jobelyn schizophrenia sorghum bicolor|antipsychotic jobelyn schizophrenia sorghum bicolor
173330|NCT02240160|Sativex|sativex
173331|NCT02240160|Pharmacokinetics|pharmacokinetics
173332|NCT02240160|Oral pH|oral ph
173333|NCT02240147|adult congenital heart disease|adult congenital heart disease
173334|NCT02240147|exercise capacity|exercise capacity
173335|NCT02240147|exercise training|exercise training
173336|NCT02240147|physical activity|physical activity
173337|NCT02240121|Crohn's Disease|crohn's disease
173338|NCT02240121|Rifaximin|rifaximin
173339|NCT02240121|Clinical remission with endoscopic response|clinical remission with endoscopic response
173340|NCT02240121|Inflammatory Bowel Disease|inflammatory bowel disease
173341|NCT02240108|Crohn's Disease|crohn's disease
173342|NCT02240108|Rifaximin|rifaximin
173343|NCT02240108|Clinical remission with endoscopic response|clinical remission with endoscopic response
173344|NCT02240108|Inflammatory Bowel Disease|inflammatory bowel disease
173345|NCT02240082|Shiftwork|shiftwork
173346|NCT02240082|Sleep disruption|sleep disruption
173347|NCT02240082|Stress|stress
173348|NCT02240030|Parkinson's Disease|parkinson's disease
173349|NCT02240030|Motor fluctuations|motor fluctuations
173350|NCT02240030|levodopa|levodopa
173351|NCT02240030|inhaled drugs|inhaled drugs
173352|NCT02240030|OFF episodes|off episodes
173353|NCT02240017|Urothelial cancer, renal function impaired.|urothelial cancer, renal function impaired.
173354|NCT02239991|Point of care|point of care
173586|NCT02238925|MDS|mds
173355|NCT02239991|perioperative hemostasis|perioperative hemostasis
173357|NCT02239991|bleeding risk|bleeding risk
173358|NCT02239991|end-stage liver disease|end-stage liver disease
173359|NCT02239991|hepatic coagulopathy|hepatic coagulopathy
173360|NCT02239991|whole blood coagulation|whole blood coagulation
173361|NCT02239978|Parkinson Disease|parkinson disease
173362|NCT02239978|Posture Balance|posture balance
173363|NCT02239978|Learning|learning
173364|NCT02239978|Dopamine|dopamine
173365|NCT02239965|Neuromuscular blockade|neuromuscular blockade
173366|NCT02239965|Neuromuscular monitoring|neuromuscular monitoring
173367|NCT02239965|Focus group interview|focus group interview
173368|NCT02239965|Clinical observation|clinical observation
173369|NCT02239939|older adults, body composition, weight loss, muscle mass|older adults, body composition, weight loss, muscle mass
173370|NCT02239926|IBS-D|ibs-d
173371|NCT02239913|Cocaine|cocaine
173372|NCT02239913|Pharmacotherapy|pharmacotherapy
173373|NCT02239913|Phentermine|phentermine
173374|NCT02239913|Topiramate|topiramate
173375|NCT02239913|Self-Administration|self-administration
173376|NCT02239900|Liver Cancer|liver cancer
173377|NCT02239900|Lung Cancer|lung cancer
173378|NCT02239900|Adrenal Gland|adrenal gland
173379|NCT02239900|Metastasis|metastasis
173380|NCT02239900|Advanced Solid Malignancies|advanced solid malignancies
173381|NCT02239900|Ipilimumab|ipilimumab
173382|NCT02239900|Yervoy|yervoy
173383|NCT02239900|BMS-734016|bms-734016
173384|NCT02239900|MDX010|mdx010
173385|NCT02239900|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
173386|NCT02239900|SBRT|sbrt
173387|NCT02239900|XRT|xrt
173388|NCT02239887|LAA occlusion|laa occlusion
173389|NCT02239887|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
173390|NCT02239887|Percutaneous|percutaneous
173391|NCT02239887|Oral Anticoagulation|oral anticoagulation
173392|NCT02239887|Occluder|occluder
173393|NCT02239887|WAVECREST|wavecrest
173394|NCT02239874|mammographic breast density, breast disease, breast tissue|mammographic breast density, breast disease, breast tissue
173395|NCT02239861|Rhabdomyosarcoma|rhabdomyosarcoma
173396|NCT02239861|cytotoxic T lymphocytes|cytotoxic t lymphocytes
173397|NCT02239822|Electrodes, Implanted|electrodes, implanted
173398|NCT02239822|Electric Stimulation Therapy|electric stimulation therapy
173399|NCT02239809|Electrodes, Implanted|electrodes, implanted
173400|NCT02239809|Electric Stimulation Therapy|electric stimulation therapy
173401|NCT02239796|transcutaneous posterior tibial nerve stimulation|transcutaneous posterior tibial nerve stimulation
173402|NCT02239796|Randomised controlled trial|randomised controlled trial
164408|NCT02289703|Rivaroxaban|rivaroxaban
164409|NCT02289703|BAY 59-7939|bay 59-7939
164411|NCT02289703|Xarelto|xarelto
173403|NCT02239796|Feasibility|feasibility
173404|NCT02239783|osteoarthritis|osteoarthritis
173405|NCT02239783|avascular necrosis|avascular necrosis
173406|NCT02239783|ankylosis|ankylosis
173407|NCT02239783|protrusio acetabuli|protrusio acetabuli
173408|NCT02239783|painful hip dysplasia|painful hip dysplasia
173409|NCT02239783|rheumatoid arthritis|rheumatoid arthritis
401985|NCT01232413|ASP1941|asp1941
173410|NCT02239783|correction of functional deformity|correction of functional deformity
173411|NCT02239783|revision procedures|revision procedures
173412|NCT02239770|Nicotine|nicotine
173413|NCT02239770|Random Delivery|random delivery
173414|NCT02239770|Smoking Cessation|smoking cessation
173415|NCT02239770|Plasma Nicotine|plasma nicotine
173416|NCT02239770|Oral Film|oral film
173615|NCT02238808|Estradiol|estradiol
173417|NCT02239757|Transradial Approach, Primary PCI, ST-segment elevation myocardial infarction|transradial approach, primary pci, st-segment elevation myocardial infarction
173418|NCT02239744|air pollution|air pollution
173419|NCT02239744|air purification|air purification
173420|NCT02239744|intervention|intervention
173421|NCT02239744|randomized controlled trial|randomized controlled trial
173422|NCT02239744|cardiovascular health|cardiovascular health
173423|NCT02239744|pulmonary health|pulmonary health
173424|NCT02239731|EGFRI|egfri
173425|NCT02239731|Epidermal Growth Factor Receptor Inhibition|epidermal growth factor receptor inhibition
173426|NCT02239731|Skin toxicity|skin toxicity
173427|NCT02239731|Topical|topical
173428|NCT02239731|Doxycycline|doxycycline
173429|NCT02239731|Foam|foam
173430|NCT02239731|Phase II|phase ii
173431|NCT02239731|Cetuximab|cetuximab
173432|NCT02239731|Panitumumab|panitumumab
173433|NCT02239731|Vectibix|vectibix
173434|NCT02239731|Erbitux|erbitux
173435|NCT02239731|Rash|rash
173436|NCT02239718|Resin bonded bridges|resin bonded bridges
173437|NCT02239718|Clinical trial|clinical trial
173438|NCT02239718|Prospective|prospective
173439|NCT02239718|Survival|survival
173440|NCT02239718|Oral health related quality of life|oral health related quality of life
173441|NCT02239705|Trans pulmonary thermodilution|trans pulmonary thermodilution
173442|NCT02239705|Hemodynamic|hemodynamic
173443|NCT02239679|Actinic Keratosis|actinic keratosis
173444|NCT02239666|Dermatology, plaque psoriasis, biologic treatment, biologic naive|dermatology, plaque psoriasis, biologic treatment, biologic naive
173445|NCT02239614|dengue fever|dengue fever
173446|NCT02239614|dengue|dengue
173447|NCT02239601|Physical Therapy|physical therapy
173448|NCT02239601|Physiotherapy|physiotherapy
173449|NCT02239601|Breast Cancer|breast cancer
173450|NCT02239601|Chemotherapy Induced Peripheral Neuropathy (CIPN)|chemotherapy induced peripheral neuropathy (cipn)
173451|NCT02239601|Nerve gliding exercises|nerve gliding exercises
173452|NCT02239601|Nerve Entrapment|nerve entrapment
173453|NCT02239575|Assorted cancers (oncology)|assorted cancers (oncology)
173454|NCT02239562|sPIF|spif
173455|NCT02239562|synthetic PreImplantation Factor|synthetic preimplantation factor
173456|NCT02239562|Autoimmune|autoimmune
173457|NCT02239562|Liver|liver
173458|NCT02239562|Hepatitis|hepatitis
173459|NCT02239549|Colonic Polyps|colonic polyps
173460|NCT02239549|Polypectomy|polypectomy
173461|NCT02239536|neoplastic colorectal polyp|neoplastic colorectal polyp
173462|NCT02239536|hot snare polypectomy|hot snare polypectomy
173463|NCT02239536|hot snare polypectomy after saline injection|hot snare polypectomy after saline injection
173464|NCT02239523|Pathologic fracture|pathologic fracture
173465|NCT02239523|Insufficiency fracture|insufficiency fracture
173466|NCT02239523|Secondary fracture|secondary fracture
173467|NCT02239523|Fracture with bone fragility|fracture with bone fragility
173468|NCT02239523|Osteoporosis|osteoporosis
173469|NCT02239523|Bone loss|bone loss
173470|NCT02239523|Osteopenia|osteopenia
173471|NCT02239523|Metabolic Bone Disease|metabolic bone disease
173472|NCT02239523|Fragility fracture|fragility fracture
173473|NCT02239510|constipation|constipation
173474|NCT02239510|bowel habits|bowel habits
173475|NCT02239497|postoperatory pain|postoperatory pain
173476|NCT02239497|orthopaedic surgery|orthopaedic surgery
173477|NCT02239497|femoral block|femoral block
173478|NCT02239432|Adenocarcinoma of the Lung|adenocarcinoma of the lung
173479|NCT02239432|Adenocarcinoma, Bronchiolo-Alveolar|adenocarcinoma, bronchiolo-alveolar
173480|NCT02239419|Critical Limb Ischemia|critical limb ischemia
173481|NCT02239419|Limb Ischemia|limb ischemia
173482|NCT02239419|Wound Care|wound care
173982|NCT02237118|measured|measured
173483|NCT02239419|Hemodialysis|hemodialysis
173484|NCT02239419|Dialysis|dialysis
173485|NCT02239419|Skin Ulceration|skin ulceration
173486|NCT02239406|metal on metal total hip|metal on metal total hip
173487|NCT02239406|avasuclar necrosis|avasuclar necrosis
173488|NCT02239406|acetabular revision|acetabular revision
173489|NCT02239406|bone vascularity|bone vascularity
173490|NCT02239393|Multiple Sclerosis|multiple sclerosis
173491|NCT02239393|Mesenchymal Stem Cells|mesenchymal stem cells
173493|NCT02239380|Lorazepam|lorazepam
173494|NCT02239380|Status Epilepticus|status epilepticus
173495|NCT02239341|hospitalized|hospitalized
173496|NCT02239341|activity restriction|activity restriction
173497|NCT02239341|bed rest|bed rest
173498|NCT02239341|antepartum|antepartum
173499|NCT02239341|pregnant|pregnant
173500|NCT02239341|high risk|high risk
173501|NCT02239328|Lung cancer|lung cancer
173502|NCT02239328|esophageal cancer|esophageal cancer
173503|NCT02239315|Breast cancers|breast cancers
173504|NCT02239315|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
173505|NCT02239315|RNA Disruption Assay™ (RDA) score|rna disruption assay™ (rda) score
173506|NCT02239315|Pathological Complete Response (pCR)|pathological complete response (pcr)
173507|NCT02239315|Fine Needle Aspiration Biopsy|fine needle aspiration biopsy
173508|NCT02239302|Obstructed defaecation syndrome|obstructed defaecation syndrome
173509|NCT02239302|Transperineal Ultrasound|transperineal ultrasound
173510|NCT02239302|Endovaginal Ultrasound|endovaginal ultrasound
173511|NCT02239302|Evacuation Proctography|evacuation proctography
173512|NCT02239289|Low back pain|low back pain
173513|NCT02239289|Rehabilitation|rehabilitation
173514|NCT02239289|Biofeedback|biofeedback
173515|NCT02239289|Electromyography|electromyography
173516|NCT02239289|Kinematic|kinematic
173517|NCT02239276|Stiripentol|stiripentol
173518|NCT02239276|Dravet syndrome|dravet syndrome
173519|NCT02239276|Epilepsy|epilepsy
173520|NCT02239276|Epileptic Encephalopathies|epileptic encephalopathies
173521|NCT02239250|Child health|child health
173522|NCT02239250|Pneumonia|pneumonia
173523|NCT02239250|Diarrhoea|diarrhoea
173524|NCT02239250|Household air pollution|household air pollution
173525|NCT02239250|PM2.5|pm2.5
173526|NCT02239250|Stove intervention|stove intervention
173527|NCT02239250|Biomass fuel|biomass fuel
173528|NCT02239250|Monitoring and evaluation|monitoring and evaluation
173529|NCT02239250|Water filter|water filter
173530|NCT02239250|Compliance|compliance
173531|NCT02239250|Thermotolerant coliforms|thermotolerant coliforms
173532|NCT02239250|Rwanda|rwanda
173533|NCT02239224|FSHD|fshd
173534|NCT02239211|BUTEO|buteo
173535|NCT02239211|Primary sclerosing cholangitis|primary sclerosing cholangitis
173536|NCT02239211|PSC|psc
173537|NCT02239211|VAP-1|vap-1
173538|NCT02239211|BTT1023|btt1023
173539|NCT02239211|Human monoclonal antibody|human monoclonal antibody
173540|NCT02239198|HDL|hdl
173541|NCT02239198|nutrition bar|nutrition bar
173542|NCT02239185|Laparoscopy|laparoscopy
173543|NCT02239185|purse string|purse string
173544|NCT02239185|hernial sac|hernial sac
173545|NCT02239159|transcutaneous electric acupoint stimulation|transcutaneous electric acupoint stimulation
173546|NCT02239159|elderly patients|elderly patients
173550|NCT02239107|laparoscopic drilling|laparoscopic drilling
173551|NCT02239107|clomiphene citrate|clomiphene citrate
173552|NCT02239107|n acetyl cysteine|n acetyl cysteine
173553|NCT02239107|insulin resistance|insulin resistance
173554|NCT02239094|Bipolar Disorder|bipolar disorder
173555|NCT02239094|depression|depression
173556|NCT02239094|Bipolar depression|bipolar depression
173557|NCT02239081|Pharmacokinetics|pharmacokinetics
173558|NCT02239081|Safety|safety
173559|NCT02239068|CT, sedation, oral contrast|ct, sedation, oral contrast
173560|NCT02239055|Borderline Personality Disorder|borderline personality disorder
173561|NCT02239055|Mentalization Based Treatment|mentalization based treatment
173562|NCT02239055|MBT Skills Training|mbt skills training
173563|NCT02239055|Staff Nurse Perceptions|staff nurse perceptions
173564|NCT02239055|Acute Mental Health|acute mental health
173565|NCT02239042|Gingival recessions|gingival recessions
173566|NCT02239029|Platelet rich plasma|platelet rich plasma
173567|NCT02239029|Osteoarthritis of knee|osteoarthritis of knee
173568|NCT02239029|Balance|balance
173569|NCT02239029|Strength|strength
173570|NCT02239016|Sickle cell disease|sickle cell disease
173571|NCT02239016|Hgb SS|hgb ss
173572|NCT02239016|Hgb SC|hgb sc
173573|NCT02239016|Sβ-Thalassemia|sβ-thalassemia
173574|NCT02238977|depression|depression
173575|NCT02238977|ESRD|esrd
173576|NCT02238977|hemodialysis|hemodialysis
173577|NCT02238951|care coordination, mobile health, chemotherapy, technology|care coordination, mobile health, chemotherapy, technology
173578|NCT02238938|piecemeal polypectomy|piecemeal polypectomy
173579|NCT02238938|piecemeal endoscopic mucosal resection (EMR)|piecemeal endoscopic mucosal resection (emr)
173580|NCT02238938|endoscopic submucosal dissection (ESD)|endoscopic submucosal dissection (esd)
173581|NCT02238938|endoscopic en-bloc resection|endoscopic en-bloc resection
173582|NCT02238925|Newly Diagnosed AML|newly diagnosed aml
173583|NCT02238925|Secondary AML|secondary aml
173584|NCT02238925|Relapsed/Refractory AML|relapsed/refractory aml
173585|NCT02238925|Relapsed/Refractory ALL|relapsed/refractory all
173587|NCT02238912|tinea|tinea
173588|NCT02238886|Quality of Life|quality of life
173589|NCT02238886|Enteral nutrition|enteral nutrition
173590|NCT02238886|Nutrition Therapy|nutrition therapy
173591|NCT02238886|Parenteral nutrition, total|parenteral nutrition, total
164616|NCT02288572|obesity|obesity
173592|NCT02238873|lymphoma|lymphoma
173593|NCT02238873|neutropenia|neutropenia
173594|NCT02238873|pegfilgrastim|pegfilgrastim
173595|NCT02238860|Hepatitis B|hepatitis b
173596|NCT02238860|cirrhosis|cirrhosis
173597|NCT02238860|Entacavir|entacavir
173598|NCT02238860|enofovir|enofovir
173599|NCT02238847|Pancreatic|pancreatic
173600|NCT02238847|Pancreatic Cancer|pancreatic cancer
665114|NCT00829114|mg|mg
173601|NCT02238847|Preoperative Biliary Drainage|preoperative biliary drainage
173602|NCT02238847|Neoadjuvant Therapy|neoadjuvant therapy
173603|NCT02238834|Phase I|phase i
173604|NCT02238834|Safety and tolerability|safety and tolerability
173605|NCT02238834|Pharmacokinetic|pharmacokinetic
173606|NCT02238834|Randomized|randomized
173607|NCT02238834|Double Blind|double blind
173608|NCT02238834|Placebo-Controlled|placebo-controlled
173609|NCT02238834|Single- & Multiple Dose Escalation|single- & multiple dose escalation
173610|NCT02238834|FP-025|fp-025
173611|NCT02238834|MMP-12 inhibitor|mmp-12 inhibitor
173612|NCT02238821|resectable colorectal cancer|resectable colorectal cancer
173613|NCT02238808|ER+ breast cancer|er+ breast cancer
173614|NCT02238808|Luminal A|luminal a
173616|NCT02238795|Purpura fulminans, Sepsis, Epidemiology, Morbidity, Therapy|purpura fulminans, sepsis, epidemiology, morbidity, therapy
173617|NCT02238782|bioavailability|bioavailability
173618|NCT02238782|pharmacokinetics|pharmacokinetics
173619|NCT02238782|I phase|i phase
173620|NCT02238782|AZD6244|azd6244
173621|NCT02238782|cancer|cancer
173622|NCT02238769|Hepatocellular Carcinoma, 18F-FluoroethylCholine PET|hepatocellular carcinoma, 18f-fluoroethylcholine pet
173623|NCT02238730|Depression|depression
173624|NCT02238730|Depressive Disorder|depressive disorder
173625|NCT02238730|Treatment Resistant Depressive Disorder|treatment resistant depressive disorder
173626|NCT02238730|Bipolar Disorder|bipolar disorder
173627|NCT02238730|Major Depressive Disorder|major depressive disorder
173628|NCT02238730|Electroconvulsive therapy|electroconvulsive therapy
173629|NCT02238717|Pain|pain
173630|NCT02238717|evoked pain|evoked pain
173631|NCT02238717|healthy volunteer|healthy volunteer
173632|NCT02238717|pharmacodynamics|pharmacodynamics
173633|NCT02238704|Adherence|adherence
173634|NCT02238704|Calcium supplementation|calcium supplementation
173635|NCT02238704|Prevention of preeclampsia|prevention of preeclampsia
173636|NCT02238704|Adherence to calcium supplementation|adherence to calcium supplementation
173637|NCT02238691|PEEP|peep
173638|NCT02238691|Air insufflation|air insufflation
173639|NCT02238691|Mask ventilation|mask ventilation
173640|NCT02238691|Esophageal manometry|esophageal manometry
173641|NCT02238691|Esophageal impedance|esophageal impedance
173642|NCT02238652|Nursing homes|nursing homes
173643|NCT02238652|Dementia|dementia
173644|NCT02238652|Quality of Life|quality of life
173645|NCT02238652|Geriatrics|geriatrics
173646|NCT02238652|Aged|aged
173647|NCT02238652|Activities of Daily Living|activities of daily living
173648|NCT02238652|Pain|pain
173649|NCT02238652|Pain management|pain management
173650|NCT02238652|Advance Care Planning|advance care planning
173651|NCT02238652|Patient Safety|patient safety
173652|NCT02238652|Costs and Cost Analysis|costs and cost analysis
173653|NCT02238652|Medication Errors|medication errors
173654|NCT02238652|Medical Order Entry Systems|medical order entry systems
173655|NCT02238652|Medication Reconciliation|medication reconciliation
173656|NCT02238652|Medication Therapy Management|medication therapy management
173657|NCT02238652|Depression|depression
173658|NCT02238652|Psychotropic Drugs|psychotropic drugs
173659|NCT02238652|Informed Consent|informed consent
173660|NCT02238652|Presumed Consent|presumed consent
173661|NCT02238652|Anxiety|anxiety
173662|NCT02238652|Apathy|apathy
173663|NCT02238652|Hospitalization|hospitalization
173664|NCT02238652|Mortality|mortality
173665|NCT02238639|Venous thromboembolism|venous thromboembolism
173666|NCT02238639|COPD exacerbations|copd exacerbations
173667|NCT02238639|Anticoagulation|anticoagulation
173668|NCT02238639|Mortality|mortality
173669|NCT02238626|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
173670|NCT02238626|pharmacotherapy|pharmacotherapy
173671|NCT02238626|intervention|intervention
173672|NCT02238626|prospective|prospective
173673|NCT02238626|safety endpoint|safety endpoint
173674|NCT02238626|preliminary efficacy|preliminary efficacy
173675|NCT02238626|ibudilast|ibudilast
173676|NCT02238613|Radioactive stents|radioactive stents
173677|NCT02238613|Brachytherapy|brachytherapy
173678|NCT02238613|Biliary obstruction|biliary obstruction
173679|NCT02238613|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
173777|NCT02238002|narrow angle|narrow angle
173680|NCT02238613|Cholangiocarcinoma of the Extrahepatic Bile Duct|cholangiocarcinoma of the extrahepatic bile duct
173681|NCT02238613|ampullary carcinoma|ampullary carcinoma
173682|NCT02238587|Gandoerma Spores Powder Capsules, head-and-neck cancer.|gandoerma spores powder capsules, head-and-neck cancer.
173683|NCT02238561|non-invasive|non-invasive
173684|NCT02238561|measurement of oxygen|measurement of oxygen
173685|NCT02238561|consumption|consumption
173686|NCT02238561|delivery|delivery
173687|NCT02238561|post-operative complications|post-operative complications
173688|NCT02238548|immunity|immunity
173689|NCT02238548|vaccination|vaccination
173691|NCT02238522|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
173692|NCT02238522|B-prolymphocytic leukemia|b-prolymphocytic leukemia
173693|NCT02238522|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
173694|NCT02238522|follicular lymphoma|follicular lymphoma
173695|NCT02238522|mantle cell lymphoma|mantle cell lymphoma
173696|NCT02238522|marginal zone lymphoma|marginal zone lymphoma
173697|NCT02238522|small lymphocytic lymphoma|small lymphocytic lymphoma
173698|NCT02238522|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
173699|NCT02238522|unclassifiable lymphoma|unclassifiable lymphoma
173700|NCT02238522|T-cell lymphoma|t-cell lymphoma
173701|NCT02238522|Richter's syndrome|richter's syndrome
173702|NCT02238522|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
173703|NCT02238509|Breast cancer|breast cancer
173704|NCT02238509|HER2 Positive|her2 positive
173705|NCT02238509|HER2+|her2+
173706|NCT02238509|MBC|mbc
173707|NCT02238509|Metastatic|metastatic
173708|NCT02238509|Metastatic breast cancer|metastatic breast cancer
173709|NCT02238509|Chemotherapy|chemotherapy
173710|NCT02238509|Lapatinib|lapatinib
173711|NCT02238509|Trastuzumab|trastuzumab
173712|NCT02238509|anti HER2 therapies|anti her2 therapies
173713|NCT02238496|Glioblastoma|glioblastoma
173714|NCT02238496|Anaplastic Astrocytoma|anaplastic astrocytoma
173715|NCT02238496|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
173716|NCT02238496|Mixed Glioma|mixed glioma
173717|NCT02238496|akt-Oncogene Protein|akt-oncogene protein
173718|NCT02238496|mTOR Protein|mtor protein
173719|NCT02238496|Glioma|glioma
173720|NCT02238496|Brain Neoplasms|brain neoplasms
173721|NCT02238496|Brain Tumor, Recurrent|brain tumor, recurrent
173722|NCT02238483|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
173723|NCT02238483|COPD patients|copd patients
173724|NCT02238483|Exacerbations|exacerbations
173725|NCT02238483|ICS|ics
173726|NCT02238483|LABA|laba
173727|NCT02238470|Ischemic stroke|ischemic stroke
173728|NCT02238470|Intracerebral hemorrhage|intracerebral hemorrhage
173729|NCT02238470|Subdural hemorrhage|subdural hemorrhage
173730|NCT02238470|Microbleed|microbleed
173731|NCT02238470|Leukoaraiosis|leukoaraiosis
173732|NCT02238470|Oral anticoagulants|oral anticoagulants
173733|NCT02238457|Heart failure|heart failure
173734|NCT02238457|Losartan|losartan
173735|NCT02238444|Warfarin|warfarin
173736|NCT02238444|Portal Vein|portal vein
173737|NCT02238444|Anticoagulants|anticoagulants
173738|NCT02238444|Cirrhosis|cirrhosis
173739|NCT02238444|Hypertension|hypertension
173740|NCT02238444|Venous Thrombosis|venous thrombosis
173741|NCT02238444|Splenectomy|splenectomy
173742|NCT02238431|Lucrin depot,|lucrin depot,
173743|NCT02238431|frozen embryo transfer,|frozen embryo transfer,
173744|NCT02238431|artificial cycle,|artificial cycle,
173745|NCT02238431|pregnancy,|pregnancy,
173746|NCT02238431|cancellation|cancellation
173747|NCT02238418|Vitamin D, Calciuria, Paediatrics, Nephrology|vitamin d, calciuria, paediatrics, nephrology
173748|NCT02238392|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
173749|NCT02238392|pulmonary vein isolation|pulmonary vein isolation
173750|NCT02238392|adenosine|adenosine
173751|NCT02238392|AF terminatin|af terminatin
173752|NCT02238379|Intranasal oxytocin|intranasal oxytocin
173753|NCT02238379|Social perception|social perception
173754|NCT02238379|EEG/ERP|eeg/erp
173755|NCT02238340|Postoperatory pain|postoperatory pain
173756|NCT02238340|Oxycodone|oxycodone
173757|NCT02238327|Antiretroviral therapy|antiretroviral therapy
173758|NCT02238327|pulmonary function|pulmonary function
173759|NCT02238327|biomarkers|biomarkers
173760|NCT02238301|Intrauterine growth restriction|intrauterine growth restriction
173761|NCT02238301|BOLD effect|bold effect
173762|NCT02238288|anticoagulation|anticoagulation
173763|NCT02238288|extraction|extraction
173764|NCT02238288|epsilon amino caproic|epsilon amino caproic
173765|NCT02238054|Cardiology|cardiology
173766|NCT02238054|Intracoronary angioplasty|intracoronary angioplasty
173767|NCT02238054|Bioresorbable stent|bioresorbable stent
173768|NCT02238041|Glucose monitoring|glucose monitoring
173769|NCT02238041|Intensive care unit|intensive care unit
173770|NCT02238028|Heart rate variability|heart rate variability
173771|NCT02238028|Blood pressure|blood pressure
173772|NCT02238028|Circulating biomarkers|circulating biomarkers
173773|NCT02238028|Respirator|respirator
173774|NCT02238028|Fine particulate matter|fine particulate matter
173775|NCT02238015|cataract ,tear film,SS-OCT|cataract ,tear film,ss-oct
173776|NCT02238002|shallow anterior chamber|shallow anterior chamber
173779|NCT02237989|knee osteoarthritis, native collagen type 2, paracetamol|knee osteoarthritis, native collagen type 2, paracetamol
173780|NCT02237937|Depression, Affective Disorder|depression, affective disorder
173781|NCT02237924|nasopharyngeal carcinoma|nasopharyngeal carcinoma
173782|NCT02237924|endostar|endostar
173783|NCT02237924|IMRT|imrt
173784|NCT02237924|chemoradiation|chemoradiation
173785|NCT02237911|total knee replacement|total knee replacement
173786|NCT02237911|rehabilitation|rehabilitation
173787|NCT02237911|exercise program|exercise program
173788|NCT02237911|total knee arthroplasty|total knee arthroplasty
173789|NCT02237898|Tobacco cessation|tobacco cessation
173790|NCT02237885|Military Veterans|military veterans
173791|NCT02237872|Brown Adipose Tissue|brown adipose tissue
173792|NCT02237859|cdiff|cdiff
173793|NCT02237859|vancomycin|vancomycin
173794|NCT02237859|infection|infection
173795|NCT02237859|clostridium difficile|clostridium difficile
173796|NCT02237846|osteoarthritis|osteoarthritis
173797|NCT02237846|knee|knee
173798|NCT02237846|stem cells|stem cells
173799|NCT02237846|mesenchymal|mesenchymal
173800|NCT02237846|umbilical cord|umbilical cord
173801|NCT02237833|septic shock|septic shock
173802|NCT02237833|cerebral oximetry|cerebral oximetry
173803|NCT02237833|vasopressor|vasopressor
173804|NCT02237833|norepinephrine|norepinephrine
173805|NCT02237807|Fed Conditions|fed conditions
173806|NCT02237781|AMH|amh
173807|NCT02237781|IVF|ivf
173808|NCT02237781|ovarian stimulation|ovarian stimulation
173809|NCT02237768|Fasting conditions|fasting conditions
173810|NCT02237755|Clomiphene citrate|clomiphene citrate
173811|NCT02237755|IVF|ivf
173812|NCT02237755|Pregnancy Rates|pregnancy rates
173813|NCT02237755|Ovarian Reserve|ovarian reserve
173814|NCT02237729|healthy subjects|healthy subjects
173815|NCT02237729|immunology|immunology
173816|NCT02237729|PK|pk
173817|NCT02237729|Phase 1|phase 1
173818|NCT02237729|bioequivalence|bioequivalence
173819|NCT02237729|biosimilarity|biosimilarity
173820|NCT02237729|adalimumab|adalimumab
173821|NCT02237729|single dose.|single dose.
173822|NCT02237703|Post-traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
173823|NCT02237703|Positron emission tomography (PET)|positron emission tomography (pet)
173824|NCT02237703|Neuroimaging|neuroimaging
173825|NCT02237703|Kappa opioid receptor (KOR)|kappa opioid receptor (kor)
173826|NCT02237677|Post-traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
173827|NCT02237677|Trauma|trauma
173828|NCT02237677|Neuroimaging|neuroimaging
173829|NCT02237677|Positron emission tomography (PET)|positron emission tomography (pet)
173830|NCT02237677|[11C]OMAR|[11c]omar
173831|NCT02237677|Endocannabinoid|endocannabinoid
173832|NCT02237664|Thoracoscopy|thoracoscopy
173833|NCT02237664|Patient-controlled analgesia|patient-controlled analgesia
173834|NCT02237664|Paravertebral analgesia|paravertebral analgesia
173835|NCT02237651|anesthesia|anesthesia
173836|NCT02237651|bronchosocopy|bronchosocopy
173837|NCT02237651|lung transplantation|lung transplantation
173838|NCT02237638|VEGF|vegf
173839|NCT02237638|Vaccine|vaccine
173840|NCT02237638|Angiogenesis|angiogenesis
173841|NCT02237625|Hypophosphatasia|hypophosphatasia
173842|NCT02237625|HPP|hpp
173843|NCT02237599|SSEP|ssep
173844|NCT02237599|neuropraxia|neuropraxia
173845|NCT02237599|intraoperative|intraoperative
173846|NCT02237599|automated|automated
173847|NCT02237586|Plasmodium falciparum malaria|plasmodium falciparum malaria
173848|NCT02237586|Malaria|malaria
173849|NCT02237586|PfSPZ Challenge|pfspz challenge
173850|NCT02237586|Controlled Human Malaria Infection (CHMI)|controlled human malaria infection (chmi)
173851|NCT02237586|Sickle Cell Trait|sickle cell trait
173852|NCT02237586|Sporozoites|sporozoites
173853|NCT02237573|general practice|general practice
173854|NCT02237573|viral infections|viral infections
173855|NCT02237573|consultation reports|consultation reports
173856|NCT02237573|drug prescription|drug prescription
173857|NCT02237560|MCI|mci
173858|NCT02237560|Exergaming|exergaming
173859|NCT02237560|Cognition|cognition
173860|NCT02237560|Exercise|exercise
173861|NCT02237560|Older Adults|older adults
173862|NCT02237547|spinal cord injury|spinal cord injury
173863|NCT02237547|mesenchymal|mesenchymal
173864|NCT02237547|bone marrow|bone marrow
173865|NCT02237547|mononuclear cells|mononuclear cells
173866|NCT02237547|stem cells|stem cells
173867|NCT02237547|umbilical cord|umbilical cord
173868|NCT02237534|Lanthanum|lanthanum
173869|NCT02237534|Calcium Carbonate|calcium carbonate
173870|NCT02237534|Vascular Calcification|vascular calcification
173871|NCT02237521|Incretin hormones|incretin hormones
173872|NCT02237521|End-stage renal disease|end-stage renal disease
173873|NCT02237521|ESRD|esrd
173874|NCT02237521|GLP-1|glp-1
173875|NCT02237521|GIP|gip
173876|NCT02237521|Insulin|insulin
173877|NCT02237521|Glucagon|glucagon
173878|NCT02237469|Breast cancer|breast cancer
173879|NCT02237469|Breast conserving surgery.|breast conserving surgery.
173880|NCT02237469|Radiotherapy.|radiotherapy.
173881|NCT02237469|Treatment planning.|treatment planning.
173882|NCT02237469|Prone.|prone.
173887|NCT02237456|Optical coherence tomography|optical coherence tomography
173888|NCT02237456|Stent|stent
173889|NCT02237456|Bioresorbable stents|bioresorbable stents
173890|NCT02237443|Patient Safety|patient safety
164896|NCT02286791|Elderly|elderly
173891|NCT02237430|Coronary angiography (CAG)|coronary angiography (cag)
173892|NCT02237417|MRI|mri
173893|NCT02237417|Imaging|imaging
173894|NCT02237417|Antipsychotic|antipsychotic
173895|NCT02237404|Follow-Up studies|follow-up studies
173896|NCT02237404|Biological Pacemakers|biological pacemakers
173897|NCT02237404|Telemedicine|telemedicine
173898|NCT02237404|Efficiency|efficiency
173899|NCT02237391|High Frequency Emergency Department Visits|high frequency emergency department visits
173900|NCT02237391|Healthcare Utilization|healthcare utilization
173901|NCT02237391|Chronic Pain|chronic pain
173902|NCT02237391|Interdisciplinary|interdisciplinary
173903|NCT02237378|FDG lung and RV uptake|fdg lung and rv uptake
173904|NCT02237365|neurological disability|neurological disability
173905|NCT02237365|tuberculous meningitis (TBM)|tuberculous meningitis (tbm)
173906|NCT02237365|safety|safety
173907|NCT02237365|aspirin|aspirin
173908|NCT02237365|efficacy|efficacy
173909|NCT02237352|Diabetes mellitus|diabetes mellitus
173910|NCT02237352|Diabetic nephropathy|diabetic nephropathy
173911|NCT02237352|Social Factors|social factors
173912|NCT02237352|Biological Factors|biological factors
173913|NCT02237352|VEGF-A|vegf-a
173914|NCT02237352|Tenascin C|tenascin c
173915|NCT02237352|Disease characterization|disease characterization
173916|NCT02237352|Mechanisms|mechanisms
173917|NCT02237352|Kidney|kidney
173918|NCT02237352|Chronic kidney disease|chronic kidney disease
173919|NCT02237352|Secondary nephropathy|secondary nephropathy
173920|NCT02237352|South America|south america
173921|NCT02237352|Hispanics|hispanics
173922|NCT02237352|Ecuador|ecuador
173923|NCT02237352|Biomarkers|biomarkers
173924|NCT02237339|Allopurinol|allopurinol
173925|NCT02237339|Cardiac MRI (CMR)|cardiac mri (cmr)
173926|NCT02237339|Flow mediated dilatation (FMD)|flow mediated dilatation (fmd)
173927|NCT02237339|Pulse wave analysis (PWA)|pulse wave analysis (pwa)
173928|NCT02237339|Endothelial function|endothelial function
173929|NCT02237339|Scar|scar
173930|NCT02237339|Hypertrophy|hypertrophy
173931|NCT02237339|Hypertension|hypertension
173932|NCT02237326|Visual Inspection with Acetic Acid|visual inspection with acetic acid
173933|NCT02237326|Visual Inspection with Lugol's Iodine|visual inspection with lugol's iodine
173934|NCT02237326|Cervical Intraepithelial neoplasia|cervical intraepithelial neoplasia
173935|NCT02237326|Cervical Cancer Screening|cervical cancer screening
173936|NCT02237326|HIV infected women|hiv infected women
173940|NCT02237300|Bulimia nervosa|bulimia nervosa
173941|NCT02237300|Binge eating disorder|binge eating disorder
173942|NCT02237300|Food craving|food craving
173943|NCT02237300|Anxiety|anxiety
173944|NCT02237300|Bingeing|bingeing
173945|NCT02237300|Cue Exposure Therapy|cue exposure therapy
173946|NCT02237300|Virtual Reality|virtual reality
173947|NCT02237274|Fontan circulation|fontan circulation
173948|NCT02237274|High altitude exposure|high altitude exposure
173949|NCT02237261|Newly diagnosed symptomatic multiple myeloma|newly diagnosed symptomatic multiple myeloma
173950|NCT02237248|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
173951|NCT02237248|Functional Movement Screen|functional movement screen
173952|NCT02237248|Y Balance Test|y balance test
173953|NCT02237235|Schizophrenia|schizophrenia
173954|NCT02237235|Schizoaffective disorder|schizoaffective disorder
173955|NCT02237235|Cognition|cognition
173956|NCT02237235|Magnesium|magnesium
173957|NCT02237235|Imaging|imaging
173958|NCT02237235|Negative symptoms|negative symptoms
173959|NCT02237222|Outcome Assessment|outcome assessment
173960|NCT02237222|Gait|gait
173961|NCT02237222|Neuromuscular Diseases|neuromuscular diseases
173962|NCT02237222|Psychometrics|psychometrics
173963|NCT02237222|Clinical Assessment Tools|clinical assessment tools
173964|NCT02237196|cat-allergic|cat-allergic
173965|NCT02237196|cat immunotherapy|cat immunotherapy
173966|NCT02237196|anti-thymic stromal lymphopoietin (anti-TSLP)|anti-thymic stromal lymphopoietin (anti-tslp)
173967|NCT02237170|Sipuleucel-T|sipuleucel-t
173968|NCT02237170|Castration Resistant Prostate Cancer|castration resistant prostate cancer
173969|NCT02237170|Provenge|provenge
173970|NCT02237157|pancreatic cancer|pancreatic cancer
173971|NCT02237157|unresectable|unresectable
173972|NCT02237157|gemcitabine|gemcitabine
173973|NCT02237157|device|device
173974|NCT02237157|local delivery|local delivery
173975|NCT02237157|chemoembolization|chemoembolization
173976|NCT02237131|Endometriosis|endometriosis
173977|NCT02237131|Oral contraceptives|oral contraceptives
173978|NCT02237131|Laparoscopy|laparoscopy
173979|NCT02237118|Acute|acute
173980|NCT02237118|wound|wound
173981|NCT02237118|management|management
173983|NCT02237118|Visual analoge scale|visual analoge scale
173984|NCT02237066|OCT|oct
173985|NCT02237066|PTA|pta
173986|NCT02237066|Balloon|balloon
173987|NCT02237053|Energy expenditure|energy expenditure
173988|NCT02237053|Glucagon|glucagon
173989|NCT02237053|Octreotide|octreotide
173990|NCT02237053|Weight loss|weight loss
173991|NCT02237040|Children|children
173992|NCT02237040|mandible|mandible
211688|NCT02064101|EMG|emg
165064|NCT02285855|XRT|xrt
173993|NCT02237040|condylar fracture|condylar fracture
173994|NCT02237040|conservative treatment|conservative treatment
173995|NCT02237040|functional treatment|functional treatment
173996|NCT02237027|HIV|hiv
173997|NCT02237027|Early treatment as prevention (TasP)|early treatment as prevention (tasp)
173998|NCT02237027|Pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
173999|NCT02237027|antiretroviral treatment|antiretroviral treatment
174000|NCT02237027|prevention|prevention
174001|NCT02237027|feasibility|feasibility
174002|NCT02237027|female sex workers|female sex workers
174003|NCT02237027|Benin|benin
174004|NCT02237027|West Africa|west africa
174005|NCT02237001|meniscal|meniscal
174006|NCT02237001|meniscus|meniscus
174007|NCT02237001|repair|repair
174008|NCT02237001|knee|knee
174009|NCT02237001|arthroscopy knee|arthroscopy knee
174010|NCT02237001|horizontal|horizontal
174011|NCT02236988|Apremilast|apremilast
174012|NCT02236988|Healthy male subjects|healthy male subjects
174013|NCT02236988|Pharmacokinetics|pharmacokinetics
174014|NCT02236949|pediatric pain|pediatric pain
174015|NCT02236949|intervention sustainability|intervention sustainability
174016|NCT02236936|Squamous Cell Carcinoma|squamous cell carcinoma
174017|NCT02236936|Head and neck|head and neck
174018|NCT02236936|SCCHN|scchn
174019|NCT02236936|Parenteral nutrition|parenteral nutrition
174020|NCT02236936|Larynx|larynx
174021|NCT02236936|Hypopharynx|hypopharynx
174022|NCT02236936|Cavum oris|cavum oris
174023|NCT02236936|Radiotherapy|radiotherapy
174024|NCT02236936|Cetuximab|cetuximab
174025|NCT02236936|Cisplatin|cisplatin
174026|NCT02236923|cardiovascular|cardiovascular
174027|NCT02236923|surgery|surgery
174028|NCT02236923|ascending aorta|ascending aorta
174029|NCT02236923|aortic dissection|aortic dissection
174030|NCT02236910|somatostatin receptor positive tumour|somatostatin receptor positive tumour
174031|NCT02236884|rectal cancer|rectal cancer
174032|NCT02236884|no scar|no scar
174033|NCT02236884|NOTES|notes
174034|NCT02236884|TaTME|tatme
174035|NCT02236884|feasibility|feasibility
174036|NCT02236884|safety|safety
174037|NCT02236871|Adolescents|adolescents
174038|NCT02236871|Dairy|dairy
174039|NCT02236871|Bone|bone
174040|NCT02236858|COPD|copd
174041|NCT02236845|Insomnia, medical device, sleep latency|insomnia, medical device, sleep latency
174042|NCT02236806|Breast cancer|breast cancer
174043|NCT02236806|Adjuvant chemotherapy|adjuvant chemotherapy
174044|NCT02236806|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
174045|NCT02236806|Cardioprotection|cardioprotection
174046|NCT02236806|Anthracyclines|anthracyclines
174047|NCT02236780|in vitro fertilisation|in vitro fertilisation
174048|NCT02236780|environmental conditions|environmental conditions
174049|NCT02236780|pregnancy|pregnancy
174050|NCT02236780|live birth rate|live birth rate
174051|NCT02236754|dihydrotetrabenazine|dihydrotetrabenazine
174052|NCT02236754|beta cell mass|beta cell mass
174053|NCT02236754|diabetes mellitus|diabetes mellitus
174054|NCT02236702|Major Depressive Disorder|major depressive disorder
174055|NCT02236702|Anhedonia|anhedonia
174056|NCT02236702|Positron Emission Tomography (PET)|positron emission tomography (pet)
174057|NCT02236702|Kappa Opioid Receptor (KOR)|kappa opioid receptor (kor)
174058|NCT02236676|motor learning TBI|motor learning tbi
174059|NCT02236663|Intimate Partner Violence|intimate partner violence
174060|NCT02236663|Dating Violence|dating violence
174061|NCT02236663|Relationships|relationships
174062|NCT02236663|Safety Planning|safety planning
174063|NCT02236663|College|college
174064|NCT02236663|Student|student
174065|NCT02236663|App|app
174066|NCT02236650|Parental Resilience|parental resilience
174067|NCT02236650|Parental Stress|parental stress
174068|NCT02236650|Family Adaptation|family adaptation
174069|NCT02236650|Autistic Disorder|autistic disorder
174070|NCT02236650|Behavior|behavior
174071|NCT02236650|Child Behavior|child behavior
174072|NCT02236650|Child Development Disorders|child development disorders
174073|NCT02236650|Pervasive Developmental Disabilities|pervasive developmental disabilities
174074|NCT02236650|Caregivers|caregivers
174075|NCT02236650|Parents|parents
174076|NCT02236650|Parenting|parenting
174077|NCT02236650|Primary Health Care|primary health care
174078|NCT02236637|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
174079|NCT02236637|Registry|registry
174080|NCT02236637|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
174081|NCT02236611|COPD|copd
174082|NCT02236611|inhaler ease of use|inhaler ease of use
174083|NCT02236611|glycopyrronium|glycopyrronium
174084|NCT02236611|umeclidinium|umeclidinium
174085|NCT02236611|novel dry powder inhaler|novel dry powder inhaler
174392|NCT02235363|SMAS|smas
174086|NCT02236611|long-acting muscarinic antagonist|long-acting muscarinic antagonist
174087|NCT02236611|inhaler errors|inhaler errors
174088|NCT02236598|borderline hypokalemia|borderline hypokalemia
174089|NCT02236598|glucose tolerance|glucose tolerance
165103|NCT02285621|3D|3d
174090|NCT02236598|insulin secretion|insulin secretion
174091|NCT02236598|insulin sensitivity|insulin sensitivity
174092|NCT02236598|fasting glucose|fasting glucose
174093|NCT02236598|African American|african american
174094|NCT02236585|uterine artery embolization, epidural , patient-controlled analgesia|uterine artery embolization, epidural , patient-controlled analgesia
174095|NCT02236572|Postmenopausal|postmenopausal
174096|NCT02236572|ER-positive, PR-positive, HER2-negative|er-positive, pr-positive, her2-negative
174097|NCT02236572|Low and intermediate risk|low and intermediate risk
174098|NCT02236559|high flow therapy|high flow therapy
174099|NCT02236559|high flow nasal cannula|high flow nasal cannula
174100|NCT02236559|acute respiratory failure|acute respiratory failure
665115|NCT00829114|mm3|mm3
174109|NCT02236520|salt stores|salt stores
174110|NCT02236494|alcoholism|alcoholism
174111|NCT02236494|dangerous behavior|dangerous behavior
174112|NCT02236494|aged|aged
174113|NCT02236494|emergency medicine|emergency medicine
174114|NCT02236455|complementary medicine|complementary medicine
174115|NCT02236455|state anxiety|state anxiety
174116|NCT02236455|acute pain|acute pain
174117|NCT02236455|self-efficacy|self-efficacy
174118|NCT02236455|surgery|surgery
174119|NCT02236455|medical music intervention|medical music intervention
174120|NCT02236455|nature therapy|nature therapy
174121|NCT02236455|relaxation technique|relaxation technique
174122|NCT02236442|Cephalalgia|cephalalgia
174123|NCT02236442|Headache|headache
174124|NCT02236442|Migraine|migraine
174125|NCT02236442|Pain|pain
174126|NCT02236442|Global|global
174127|NCT02236442|Treatment|treatment
174128|NCT02236442|Oxygen|oxygen
174129|NCT02236442|Emergency|emergency
174238|NCT02235974|task oriented training|task oriented training
174130|NCT02236442|Treatment of cephalalgia in emergency department|treatment of cephalalgia in emergency department
174131|NCT02236429|bacterial vaginitis|bacterial vaginitis
174132|NCT02236429|vaginal flora|vaginal flora
174133|NCT02236429|microbiome|microbiome
174134|NCT02236416|Dementia|dementia
174135|NCT02236416|Prevention|prevention
174136|NCT02236416|Physical Activity|physical activity
174137|NCT02236403|Blepharitis , Demodex, Ivermectin, Metronidazole|blepharitis , demodex, ivermectin, metronidazole
174138|NCT02236390|Nightmare|nightmare
174139|NCT02236390|PTSD|ptsd
174140|NCT02236390|Sleep|sleep
174141|NCT02236390|Emotion Regulation|emotion regulation
174142|NCT02236390|Exposure Relaxation and Rescripting Therapy|exposure relaxation and rescripting therapy
174143|NCT02236390|Cognitive Processing Therapy|cognitive processing therapy
174144|NCT02236377|ERRT|errt
174145|NCT02236377|Nightmares|nightmares
174146|NCT02236377|Sleep|sleep
174147|NCT02236377|Trauma|trauma
174148|NCT02236377|PTSD|ptsd
174149|NCT02236351|patching|patching
174150|NCT02236351|pediatric ophthalmology|pediatric ophthalmology
174151|NCT02236338|chronic venous insufficiency|chronic venous insufficiency
174152|NCT02236338|varicose vein|varicose vein
174153|NCT02236338|greater saphenous vein|greater saphenous vein
174154|NCT02236299|Right Coronary Artery|right coronary artery
174155|NCT02236299|Percutaneous Coronary Intervention|percutaneous coronary intervention
174156|NCT02236299|Diastolic Dysfunction|diastolic dysfunction
174157|NCT02236299|Glucagon-like peptide-1|glucagon-like peptide-1
174158|NCT02236299|GLP-1|glp-1
174159|NCT02236299|Stunning|stunning
174160|NCT02236299|Cardioprotection|cardioprotection
174161|NCT02236286|freezing of gait (FOG)|freezing of gait (fog)
174162|NCT02236286|balance|balance
174163|NCT02236286|gait|gait
174164|NCT02236286|exercise|exercise
174165|NCT02236273|Human papillomavirus|human papillomavirus
174166|NCT02236273|vaccination|vaccination
174167|NCT02236273|text message|text message
174168|NCT02236273|reminder|reminder
174169|NCT02236247|ivabradine|ivabradine
174170|NCT02236247|heart rate|heart rate
174171|NCT02236247|heart failure|heart failure
174172|NCT02236234|HIV|hiv
174173|NCT02236234|HPV|hpv
174174|NCT02236234|Clinical trial|clinical trial
174175|NCT02236234|outcome|outcome
174185|NCT02236143|Healthy|healthy
174186|NCT02236130|pediatric regional|pediatric regional
174187|NCT02236117|heart rate variability|heart rate variability
174188|NCT02236117|children|children
174189|NCT02236117|progressive test|progressive test
174190|NCT02236104|neuromuscular disorders|neuromuscular disorders
174191|NCT02236104|mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
174192|NCT02236104|respiratory parameters|respiratory parameters
174193|NCT02236104|plethysmography opto electronic|plethysmography opto electronic
174194|NCT02236104|Vital capacity|vital capacity
174195|NCT02236091|cerebral palsy|cerebral palsy
174196|NCT02236091|stroke|stroke
174197|NCT02236091|traumatic brain injury|traumatic brain injury
174198|NCT02236065|Umbilical cord blood|umbilical cord blood
174199|NCT02236065|Granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
174200|NCT02236065|Brain injury|brain injury
174201|NCT02236065|Neurodegenerative disorder|neurodegenerative disorder
174202|NCT02236065|Efficacy|efficacy
174203|NCT02236065|Safety|safety
174204|NCT02236052|Influenza|influenza
174205|NCT02236052|Human|human
174206|NCT02236052|RNA Virus Infections|rna virus infections
174207|NCT02236052|Immunologic|immunologic
174208|NCT02236052|Immunogenic Factors|immunogenic factors
174209|NCT02236052|Physiological Effects of Drugs|physiological effects of drugs
174210|NCT02236052|Virus diseases|virus diseases
174211|NCT02236052|Orthomyxoviridae Infections|orthomyxoviridae infections
174212|NCT02236052|Infection|infection
174213|NCT02236039|Diesel exhaust|diesel exhaust
174214|NCT02236039|Air pollution|air pollution
174215|NCT02236039|Airway responsivness|airway responsivness
174216|NCT02236026|Nestorone use as an IV solution on heart rate;|nestorone use as an iv solution on heart rate;
174217|NCT02236026|Abnormality in Heart Rate or Rhythm, Unspecified as to Time of Onset|abnormality in heart rate or rhythm, unspecified as to time of onset
174218|NCT02236013|ASP2215|asp2215
174219|NCT02236013|Acute Myeloid Leukemia|acute myeloid leukemia
174220|NCT02236013|Idarubicin|idarubicin
174221|NCT02236013|Cytarabine|cytarabine
174222|NCT02236000|NSABP|nsabp
174223|NCT02236000|Trastuzumab Emtansine|trastuzumab emtansine
174224|NCT02236000|T DM1|t dm1
174225|NCT02236000|Neratinib|neratinib
174226|NCT02236000|Metastatic Breast Cancer|metastatic breast cancer
174227|NCT02236000|HER2 positive|her2 positive
174228|NCT02236000|Dose Escalation|dose escalation
174229|NCT02235974|stroke|stroke
174230|NCT02235974|critical periods|critical periods
174231|NCT02235974|sensitive periods|sensitive periods
174232|NCT02235974|hemiparesis|hemiparesis
174233|NCT02235974|upper extremity|upper extremity
174234|NCT02235974|physical rehabilitation|physical rehabilitation
174235|NCT02235974|arm therapy|arm therapy
174236|NCT02235974|occupational therapy|occupational therapy
174237|NCT02235974|physical therapy|physical therapy
174545|NCT02234583|pain|pain
174239|NCT02235974|patient focused|patient focused
174240|NCT02235974|arm function|arm function
174241|NCT02235974|hand function|hand function
174242|NCT02235974|neurorehabilitation|neurorehabilitation
174243|NCT02235974|motor learning|motor learning
174244|NCT02235974|motor control|motor control
174245|NCT02235974|motor function|motor function
174246|NCT02235974|motor recovery|motor recovery
174247|NCT02235974|skill acquisition|skill acquisition
174248|NCT02235974|skill training|skill training
174249|NCT02235948|arsenic induced health problem|arsenic induced health problem
174250|NCT02235948|modifying effects|modifying effects
174251|NCT02235948|folic acid|folic acid
174252|NCT02235948|oxidative damage|oxidative damage
174253|NCT02235948|clinical trial|clinical trial
174254|NCT02235922|Aged|aged
174255|NCT02235922|Exercise|exercise
174256|NCT02235922|Cognition|cognition
174257|NCT02235922|Functional capacity|functional capacity
174258|NCT02235909|Pediatric Hypertension|pediatric hypertension
174259|NCT02235909|High Blood Pressure|high blood pressure
174260|NCT02235909|Hypertension|hypertension
174261|NCT02235909|Pediatric|pediatric
174262|NCT02235909|Primary Hypertension|primary hypertension
174263|NCT02235909|Secondary Hypertension|secondary hypertension
174264|NCT02235896|risk factors, African American, lipids, blood pressure|risk factors, african american, lipids, blood pressure
174265|NCT02235883|Coronary artery disease|coronary artery disease
174266|NCT02235883|FFR|ffr
174267|NCT02235883|diagnosis|diagnosis
174268|NCT02235883|computational model|computational model
174269|NCT02235883|non-invasive|non-invasive
174270|NCT02235870|Weight Loss|weight loss
174271|NCT02235870|Obesity|obesity
174272|NCT02235870|BMI|bmi
174273|NCT02235857|pediatric, renal transplantation, recurrence, drug-resistant|pediatric, renal transplantation, recurrence, drug-resistant
174274|NCT02235844|Mesenchymal|mesenchymal
174275|NCT02235844|Stem Cells|stem cells
174276|NCT02235844|Umbilical Cord|umbilical cord
174277|NCT02235844|Duchenne's|duchenne's
174278|NCT02235844|Muscular Dystrophy|muscular dystrophy
174279|NCT02235831|DACP MF|dacp mf
174280|NCT02235831|DAILIES AquaComfort Plus® Multifocal|dailies aquacomfort plus® multifocal
174281|NCT02235831|presbyopia|presbyopia
174282|NCT02235831|visual performance|visual performance
174283|NCT02235818|tennis elbow, treatment, lateral epicondylitis, immediate effects|tennis elbow, treatment, lateral epicondylitis, immediate effects
174284|NCT02235805|Metabolic Syndrome|metabolic syndrome
174285|NCT02235805|Obesity|obesity
174286|NCT02235805|Magnesium Supplementation|magnesium supplementation
174287|NCT02235805|Vascular Stiffness|vascular stiffness
174288|NCT02235805|Vascular Function|vascular function
174289|NCT02235779|ILD|ild
174290|NCT02235779|Pulmonary fibrosis|pulmonary fibrosis
174291|NCT02235779|Cryobiopsy|cryobiopsy
174292|NCT02235779|Transbronchial|transbronchial
174293|NCT02235766|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
174294|NCT02235766|Satellite Tele-Echocardiography|satellite tele-echocardiography
174295|NCT02235740|Open label|open label
174296|NCT02235740|carfilzomib|carfilzomib
174297|NCT02235740|Phase I|phase i
174298|NCT02235740|clinical activity|clinical activity
174299|NCT02235740|pharmacokinetics|pharmacokinetics
174300|NCT02235740|afuresertib|afuresertib
165333|NCT02284074|Nasal|nasal
174301|NCT02235740|relapsed|relapsed
174302|NCT02235740|refractory|refractory
174303|NCT02235740|safety|safety
174304|NCT02235740|multiple myeloma|multiple myeloma
174305|NCT02235714|Airway inflammation|airway inflammation
174306|NCT02235714|Tetraplegia|tetraplegia
174307|NCT02235714|Asthma|asthma
174308|NCT02235714|Exhaled breath condensate|exhaled breath condensate
174309|NCT02235714|Spirometry|spirometry
174310|NCT02235714|Pulmonary Function Testing|pulmonary function testing
174311|NCT02235701|soft tissue sarcoma|soft tissue sarcoma
174312|NCT02235701|aldoxorubicin|aldoxorubicin
174313|NCT02235701|ifosfamide|ifosfamide
174314|NCT02235701|mesna|mesna
174315|NCT02235701|phase 1|phase 1
174316|NCT02235701|INNO-206|inno-206
174317|NCT02235688|aldoxorubicin|aldoxorubicin
174318|NCT02235688|INNO-206|inno-206
174319|NCT02235688|solid tumors|solid tumors
174320|NCT02235688|gemcitabine|gemcitabine
174321|NCT02235688|phase 1|phase 1
174322|NCT02235675|Angioplasty|angioplasty
174323|NCT02235675|Peripheral Artery Disease|peripheral artery disease
174324|NCT02235675|Critical Limb Ischemia|critical limb ischemia
174325|NCT02235675|CLI|cli
174326|NCT02235675|PAD|pad
174327|NCT02235662|HIV|hiv
174328|NCT02235662|LNG|lng
174329|NCT02235662|IVR|ivr
174330|NCT02235662|Contraception|contraception
174331|NCT02235662|Prevention|prevention
174332|NCT02235623|Laparoscopic Surgery|laparoscopic surgery
174333|NCT02235623|Orchiopexy|orchiopexy
174334|NCT02235610|Lung Transplantation|lung transplantation
174335|NCT02235610|Ex Vivo Lung Perfusion|ex vivo lung perfusion
174336|NCT02235610|EVLP|evlp
174337|NCT02235597|patient access|patient access
174338|NCT02235597|patient centered care|patient centered care
174339|NCT02235597|scheduling|scheduling
174340|NCT02235597|access barriers|access barriers
174341|NCT02235597|improve efficiency|improve efficiency
174342|NCT02235597|decision making tools|decision making tools
174343|NCT02235597|underserved|underserved
174344|NCT02235584|Incretin hormones|incretin hormones
174345|NCT02235584|GLP-1|glp-1
174346|NCT02235584|GIP|gip
174347|NCT02235584|Dexamethasone|dexamethasone
174348|NCT02235558|Acute Ischemic Stoke|acute ischemic stoke
174349|NCT02235558|Thrombectomy|thrombectomy
174350|NCT02235558|Intraarterial Pharmacotherapy|intraarterial pharmacotherapy
174351|NCT02235558|Neuroprotection|neuroprotection
174352|NCT02235545|HV Lead|hv lead
174353|NCT02235545|ICD|icd
174354|NCT02235545|CRT-D System|crt-d system
174355|NCT02235545|Treatment of Heart Failure|treatment of heart failure
174356|NCT02235545|Treamtent of life-threatening ventricular tachyarrhythmia|treamtent of life-threatening ventricular tachyarrhythmia
174357|NCT02235545|Optisure|optisure
174358|NCT02235532|clinical trial|clinical trial
174359|NCT02235532|oral hygiene|oral hygiene
174360|NCT02235532|Gingivitis|gingivitis
174361|NCT02235532|Aloevera|aloevera
174362|NCT02235532|Toothpaste|toothpaste
174363|NCT02235532|anti-inflammatory agents|anti-inflammatory agents
174364|NCT02235493|HPP|hpp
174365|NCT02235493|Soft Bones|soft bones
174366|NCT02235493|low Alkaline Phosphatase|low alkaline phosphatase
174367|NCT02235493|genetic metabolic disorder|genetic metabolic disorder
174368|NCT02235493|alkaline phosphatase|alkaline phosphatase
174369|NCT02235493|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
174370|NCT02235493|rickets|rickets
174371|NCT02235493|osteomalacia|osteomalacia
174372|NCT02235467|autism|autism
174373|NCT02235467|videomodeling|videomodeling
174374|NCT02235467|behavioral therapy|behavioral therapy
174375|NCT02235467|parental training|parental training
174376|NCT02235454|glaucoma|glaucoma
174377|NCT02235454|OCT|oct
174378|NCT02235454|spectral domain optical coherence tomography|spectral domain optical coherence tomography
174379|NCT02235441|Gastrointestinal malignancy|gastrointestinal malignancy
174380|NCT02235441|Cardiopulmonary fitness|cardiopulmonary fitness
174381|NCT02235441|Chemoradiation therapy|chemoradiation therapy
174382|NCT02235376|Critical Care|critical care
174383|NCT02235376|Brain injured patients|brain injured patients
174384|NCT02235376|Mechanical Ventilation|mechanical ventilation
174385|NCT02235376|Weaning|weaning
174386|NCT02235376|Extubation|extubation
174387|NCT02235376|Prognostic score|prognostic score
174388|NCT02235376|Clinical examination|clinical examination
174389|NCT02235363|face lift|face lift
174390|NCT02235363|thread lift|thread lift
174391|NCT02235363|retaining ligament|retaining ligament
174393|NCT02235350|Adult|adult
174394|NCT02235350|Male|male
174395|NCT02235350|Female|female
174396|NCT02235350|Neuronal Plasticity|neuronal plasticity
174397|NCT02235350|Imitative Behavior/physiology|imitative behavior/physiology
174398|NCT02235350|Magnetic Resonance Imaging|magnetic resonance imaging
174399|NCT02235350|Psychomotor Disorders/rehabilitation|psychomotor disorders/rehabilitation
174400|NCT02235350|Follow-up Studies|follow-up studies
174401|NCT02235350|Video Recording|video recording
174402|NCT02235350|Physical Therapy Modalities|physical therapy modalities
165413|NCT02283359|Gastric|gastric
174403|NCT02235350|Recovery of Function|recovery of function
174404|NCT02235350|Action Observation Treatment|action observation treatment
174405|NCT02235350|Mirror Neuron System|mirror neuron system
174406|NCT02235350|Stroke/rehabilitation|stroke/rehabilitation
174407|NCT02235350|Upper Limb|upper limb
174408|NCT02235337|Concussion|concussion
174409|NCT02235337|Sports related concussion|sports related concussion
174410|NCT02235337|mTBI|mtbi
174411|NCT02235337|Vitamin B|vitamin b
174412|NCT02235337|Riboflavin|riboflavin
174413|NCT02235311|Proton pump inhibitor|proton pump inhibitor
174414|NCT02235311|Upper gastrointestinal bleed|upper gastrointestinal bleed
174415|NCT02235311|Ulcer healing|ulcer healing
174416|NCT02235298|epicardial fat|epicardial fat
174417|NCT02235298|diabetes|diabetes
174418|NCT02235298|dapagliflozin|dapagliflozin
174419|NCT02235285|capsular contracture|capsular contracture
174420|NCT02235285|reoperation|reoperation
174421|NCT02235285|breast augmentation|breast augmentation
174422|NCT02235246|perioperative intravenous magnesium|perioperative intravenous magnesium
174423|NCT02235246|endoscopic submucosal dissection|endoscopic submucosal dissection
174424|NCT02235220|Bruxism|bruxism
174425|NCT02235207|sedentary work|sedentary work
174426|NCT02235207|musculoskeletal pain|musculoskeletal pain
174427|NCT02235207|neuromuscular exercise|neuromuscular exercise
174428|NCT02235207|physical fitness|physical fitness
174429|NCT02235207|quality of life|quality of life
174430|NCT02235207|work ability|work ability
174431|NCT02235181|Twin Pregnancy|twin pregnancy
174432|NCT02235181|Prevention of Preterm birth|prevention of preterm birth
174433|NCT02235181|Short Cervix|short cervix
174434|NCT02235181|Arabin cervical pessary|arabin cervical pessary
174435|NCT02235116|Number of patients|number of patients
174436|NCT02235116|full body skin exam|full body skin exam
174437|NCT02235116|Survey|survey
174438|NCT02235116|preferences|preferences
174439|NCT02235090|Spinal muscular atrophy|spinal muscular atrophy
174440|NCT02235090|Neuromuscular disorders|neuromuscular disorders
174441|NCT02235090|Outcome measures|outcome measures
174442|NCT02235090|Visit-free clinical trial design|visit-free clinical trial design
174443|NCT02235077|Heart Failure|heart failure
174444|NCT02235077|Heart Diseases|heart diseases
174445|NCT02235077|Cardiovascular Diseases|cardiovascular diseases
174446|NCT02235077|Spironolactone|spironolactone
174447|NCT02235077|Aldactone|aldactone
174448|NCT02235025|mild COPD|mild copd
174449|NCT02235025|dyspnea|dyspnea
174450|NCT02235025|exercise|exercise
174451|NCT02235025|respiratory mechanics|respiratory mechanics
174452|NCT02235012|Schizophrenia|schizophrenia
174453|NCT02235012|Ketamine|ketamine
174454|NCT02235012|Cognitive biases|cognitive biases
174455|NCT02235012|Uncertainty|uncertainty
174456|NCT02234999|Pharmacokinetics, Healthy Subjects|pharmacokinetics, healthy subjects
174457|NCT02234986|Advanced Fibrolamellar Carcinoma|advanced fibrolamellar carcinoma
174458|NCT02234947|type 1 diabetes|type 1 diabetes
174459|NCT02234947|pancreas volume|pancreas volume
174460|NCT02234934|Gene Therapy|gene therapy
174461|NCT02234934|X-Linked Chronic Granulomatous Disease (X-CGD)|x-linked chronic granulomatous disease (x-cgd)
174462|NCT02234934|Lentiviral Vector|lentiviral vector
174463|NCT02234921|Prostate|prostate
174464|NCT02234921|Adenocarcinoma|adenocarcinoma
174465|NCT02234921|Metastatic|metastatic
174466|NCT02234921|DRibble|dribble
174467|NCT02234921|Immunotherapy|immunotherapy
174468|NCT02234921|Microbiome|microbiome
174469|NCT02234908|Tuberculosis|tuberculosis
174470|NCT02234908|Drug-resistant tuberculosis|drug-resistant tuberculosis
174471|NCT02234908|Incentives|incentives
174472|NCT02234908|Symptom screening|symptom screening
174473|NCT02234895|osteoarthritis|osteoarthritis
174475|NCT02234895|biomechanics|biomechanics
174476|NCT02234895|treatment|treatment
174477|NCT02234895|symptoms|symptoms
174478|NCT02234869|Peginterferon Beta-1a|peginterferon beta-1a
174479|NCT02234869|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
174480|NCT02234869|RMS|rms
174481|NCT02234869|flu-like symptoms|flu-like symptoms
174482|NCT02234856|Hysterectomy|hysterectomy
174483|NCT02234856|Laparoscopy|laparoscopy
174484|NCT02234856|Surgical assessment|surgical assessment
174485|NCT02234856|Education|education
174486|NCT02234843|Pediatric|pediatric
174487|NCT02234830|PCI|pci
174488|NCT02234804|Coronary angiography (CAG)|coronary angiography (cag)
174489|NCT02234804|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
174490|NCT02234804|OCT|oct
174491|NCT02234804|Stent|stent
174492|NCT02234778|critical limb ischemia|critical limb ischemia
174618|NCT02234284|Health Disparities|health disparities
174493|NCT02234778|autologous stromal vascular fraction|autologous stromal vascular fraction
174495|NCT02234765|OSAS|osas
174496|NCT02234765|Sleep apnea|sleep apnea
174497|NCT02234765|Management|management
174498|NCT02234765|Primary Care|primary care
174499|NCT02234765|Sleep Unit|sleep unit
174500|NCT02234765|Cost-Effectiveness|cost-effectiveness
174501|NCT02234765|ESS|ess
174502|NCT02234752|Schizophrenia|schizophrenia
174503|NCT02234752|Schizoaffective Disorder|schizoaffective disorder
174504|NCT02234752|Cognition|cognition
174505|NCT02234752|Cognitive Impairment|cognitive impairment
174506|NCT02234752|Galantamine|galantamine
174507|NCT02234752|Memantine|memantine
174508|NCT02234739|voriconazole|voriconazole
174509|NCT02234739|COPD|copd
174510|NCT02234739|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
174511|NCT02234739|efficacy|efficacy
174512|NCT02234739|safety|safety
174513|NCT02234726|child health|child health
174514|NCT02234726|child development|child development
174515|NCT02234726|malnutrition|malnutrition
174516|NCT02234726|stunting|stunting
174517|NCT02234726|community-based health services|community-based health services
174518|NCT02234687|post-traumatic stress disorder|post-traumatic stress disorder
174519|NCT02234674|Pulsating suit|pulsating suit
174520|NCT02234674|lymphedema|lymphedema
174521|NCT02234674|leg volume|leg volume
174522|NCT02234661|Low income|low income
174523|NCT02234661|Education|education
174524|NCT02234661|Poverty|poverty
174525|NCT02234661|Children|children
174526|NCT02234661|Parents|parents
174527|NCT02234661|Head Start|head start
174528|NCT02234648|Vascular Function|vascular function
174529|NCT02234648|tart Montmorency cherries|tart montmorency cherries
174530|NCT02234648|Arterial Stiffness|arterial stiffness
174531|NCT02234648|Blood Flow|blood flow
174532|NCT02234635|visual acuity|visual acuity
174533|NCT02234635|objective visual quality|objective visual quality
174534|NCT02234635|multifocal intraocular lens|multifocal intraocular lens
174535|NCT02234635|tear-film quality dynamics|tear-film quality dynamics
174536|NCT02234622|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
174537|NCT02234622|Yoga|yoga
174538|NCT02234622|Veterans|veterans
174539|NCT02234609|dentistry|dentistry
174540|NCT02234609|dental caries|dental caries
174541|NCT02234609|atraumatic restorative Treatment|atraumatic restorative treatment
174542|NCT02234609|effectiveness|effectiveness
174543|NCT02234596|Nintedanib|nintedanib
174544|NCT02234596|14-094|14-094
174546|NCT02234583|fibromyalgia|fibromyalgia
174547|NCT02234570|neurocysticercosis|neurocysticercosis
174548|NCT02234570|pork tapeworm|pork tapeworm
174549|NCT02234570|Taenia solium|taenia solium
174550|NCT02234557|Motor Control|motor control
174551|NCT02234557|Attention|attention
174552|NCT02234557|Cognitive Control|cognitive control
174553|NCT02234544|vitamin D|vitamin d
174554|NCT02234544|absorption|absorption
174555|NCT02234544|ezetimibe|ezetimibe
174556|NCT02234531|Virtual Reality,|virtual reality,
174557|NCT02234531|Enhanced Feedback,|enhanced feedback,
174558|NCT02234531|Stroke,|stroke,
174559|NCT02234531|Rehabilitation,|rehabilitation,
174560|NCT02234531|Motor Learning|motor learning
174561|NCT02234505|prosthetics|prosthetics
174562|NCT02234505|amputation|amputation
174563|NCT02234505|gait stability|gait stability
174564|NCT02234505|step variability|step variability
174565|NCT02234505|load cell|load cell
174566|NCT02234492|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
174567|NCT02234492|Statin therapy|statin therapy
174568|NCT02234492|Cardiovascular disease (CVD)|cardiovascular disease (cvd)
174569|NCT02234492|Coronary Flow Reserve (CFR)|coronary flow reserve (cfr)
174570|NCT02234492|Positron Emission Tomography (PET)|positron emission tomography (pet)
174571|NCT02234492|Myocardial contrast echocardiography (MCE)|myocardial contrast echocardiography (mce)
174572|NCT02234479|Breast Cancer|breast cancer
174800|NCT02233465|hernia|hernia
174573|NCT02234479|Radiation Dermatitis|radiation dermatitis
174574|NCT02234466|Quality of Recovery (QOR40)|quality of recovery (qor40)
174575|NCT02234466|Breast Surgery|breast surgery
174576|NCT02234466|Clinically significant Nausea and Vomiting|clinically significant nausea and vomiting
174577|NCT02234466|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
174579|NCT02234453|chemotherapy|chemotherapy
174580|NCT02234453|home|home
174581|NCT02234453|blood count|blood count
174582|NCT02234453|remote|remote
174583|NCT02234427|aspirin, atherosclerosis|aspirin, atherosclerosis
174584|NCT02234414|vertebral fracture assessment (vfa)|vertebral fracture assessment (vfa)
174585|NCT02234414|vitamin D|vitamin d
174586|NCT02234401|Cystic Fibrosis|cystic fibrosis
174587|NCT02234401|Noninvasive ventilation|noninvasive ventilation
174588|NCT02234401|Non invasive ventilation|non invasive ventilation
174589|NCT02234401|Acute respiratory exacerbation|acute respiratory exacerbation
174590|NCT02234401|Bi level pressure support|bi level pressure support
174591|NCT02234388|connective tissue disease|connective tissue disease
174592|NCT02234388|registry|registry
174593|NCT02234388|hospital for special surgery|hospital for special surgery
174594|NCT02234375|Pulmonary embolism|pulmonary embolism
174595|NCT02234375|Contrast|contrast
174596|NCT02234375|Computed tomography|computed tomography
174597|NCT02234375|Gadolinium|gadolinium
174598|NCT02234349|bile acids|bile acids
174599|NCT02234349|pancreas kidney transplantation|pancreas kidney transplantation
174600|NCT02234349|incretins|incretins
174601|NCT02234349|intestinal flora|intestinal flora
174602|NCT02234336|Echocardiography|echocardiography
174603|NCT02234336|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
174620|NCT02234284|Chronic Disease Model|chronic disease model
174621|NCT02234245|Follow-Up studies|follow-up studies
174622|NCT02234245|Biological Pacemakers|biological pacemakers
174623|NCT02234245|Telemedicine|telemedicine
174624|NCT02234245|Efficiency|efficiency
174625|NCT02234232|Hemodialysis|hemodialysis
174626|NCT02234232|Exercise, aerobic|exercise, aerobic
174627|NCT02234232|Exercise, resistance|exercise, resistance
174628|NCT02234232|Intradialytic|intradialytic
174629|NCT02234232|Randomized Controlled Trial|randomized controlled trial
174631|NCT02234232|Quality of life|quality of life
174632|NCT02234232|Physical performance|physical performance
174633|NCT02234206|Hypospermatogenesis, Low Sperm Count, Oligozoospermia|hypospermatogenesis, low sperm count, oligozoospermia
174634|NCT02234193|wound healing|wound healing
174641|NCT02234115|Prostate Neoplasm Cancer Carcinoma|prostate neoplasm cancer carcinoma
174642|NCT02234076|Posttraumatic Stress Disorder|posttraumatic stress disorder
174643|NCT02234076|Depression|depression
174644|NCT02234076|Treatment|treatment
174645|NCT02234076|VRET|vret
174646|NCT02234063|Hypertension|hypertension
174647|NCT02234063|Chronic Kidney Disease|chronic kidney disease
174648|NCT02234063|End Stage Renal Disease|end stage renal disease
174649|NCT02234063|APOL1|apol1
174650|NCT02234063|Genomics|genomics
174651|NCT02234063|Genetics|genetics
174652|NCT02234063|Community-engaged|community-engaged
174660|NCT02234037|AML|aml
174661|NCT02233998|Plaque|plaque
174662|NCT02233998|Bleeding|bleeding
174663|NCT02233998|Gums|gums
174664|NCT02233998|Gingiva|gingiva
174665|NCT02233998|Gingival Inflammation|gingival inflammation
174666|NCT02233998|Gingival Bleeding|gingival bleeding
174667|NCT02233985|bronchiolitis|bronchiolitis
174668|NCT02233985|hypertonic|hypertonic
174669|NCT02233985|saline|saline
174670|NCT02233985|salbutamol|salbutamol
174671|NCT02233972|Pharmacokinetics|pharmacokinetics
174672|NCT02233972|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
174673|NCT02233946|Substance Abuse|substance abuse
174674|NCT02233946|Prevention|prevention
174675|NCT02233946|Youth|youth
174676|NCT02233946|Alcohol|alcohol
174677|NCT02233946|Drugs|drugs
174678|NCT02233933|radiation proctitis|radiation proctitis
174679|NCT02233933|bleeding|bleeding
174680|NCT02233933|therapy|therapy
174681|NCT02233868|Imaging Studies|imaging studies
174682|NCT02233868|Alcoholism|alcoholism
174683|NCT02233868|Inflammation|inflammation
174684|NCT02233855|Seizures|seizures
174685|NCT02233855|Cestode|cestode
174686|NCT02233855|Hydrocephalus|hydrocephalus
174687|NCT02233855|Taenia Solium|taenia solium
174688|NCT02233855|Helminth|helminth
174689|NCT02233842|Qualitative Data|qualitative data
174690|NCT02233842|Questionnaire|questionnaire
174691|NCT02233829|C-11 Raclopride|c-11 raclopride
174692|NCT02233829|015 PET|015 pet
174693|NCT02233829|Circadian Rhythm|circadian rhythm
174694|NCT02233816|Influenza|influenza
174695|NCT02233816|Human|human
174799|NCT02233465|parastomal|parastomal
174696|NCT02233816|RNA Virus Infections|rna virus infections
174697|NCT02233816|Immunologic|immunologic
174698|NCT02233816|Immunogenic Factors|immunogenic factors
174699|NCT02233816|Physiological Effects of Drugs|physiological effects of drugs
174700|NCT02233816|Virus diseases|virus diseases
174701|NCT02233816|Orthomyxoviridae Infections|orthomyxoviridae infections
174702|NCT02233816|Infection|infection
174705|NCT02233803|efficacy|efficacy
174706|NCT02233803|budesonide/formoterol fumarate 400/12 mcg|budesonide/formoterol fumarate 400/12 mcg
174708|NCT02233803|Asthma|asthma
174709|NCT02233803|pharmacodynamics|pharmacodynamics
174710|NCT02233790|Myocardial infarction|myocardial infarction
174711|NCT02233790|No-Reflow Phenomenon|no-reflow phenomenon
174712|NCT02233790|Ticagrelor|ticagrelor
174713|NCT02233790|Clopidogrel|clopidogrel
174714|NCT02233790|Single-Photon Emission Computerized Tomography|single-photon emission computerized tomography
174715|NCT02233777|Pregabalin|pregabalin
174716|NCT02233777|Bioequivalence|bioequivalence
174717|NCT02233777|Bioavailability|bioavailability
174718|NCT02233777|Pharmacokinetic|pharmacokinetic
174719|NCT02233777|Antiepileptic|antiepileptic
174720|NCT02233764|iron|iron
174721|NCT02233764|zinc|zinc
174722|NCT02233764|pearl millet|pearl millet
174723|NCT02233764|India|india
174724|NCT02233764|children|children
174725|NCT02233764|trial|trial
174726|NCT02233764|randomized|randomized
174727|NCT02233751|Healthy Adult Males|healthy adult males
174728|NCT02233738|Alcoholism|alcoholism
174729|NCT02233738|Substance-related disorders|substance-related disorders
174730|NCT02233738|Dual Diagnosis|dual diagnosis
174731|NCT02233725|Prostatic Neoplasms|prostatic neoplasms
174732|NCT02233725|Magnetic Resonance Imaging|magnetic resonance imaging
174733|NCT02233725|MRI / Ultrasound Fusion|mri / ultrasound fusion
174734|NCT02233725|Contrast-Enhanced Ultrasound (CEUS)|contrast-enhanced ultrasound (ceus)
174735|NCT02233712|gastric cancer, stomach neoplasms,|gastric cancer, stomach neoplasms,
174736|NCT02233673|Obesity|obesity
174737|NCT02233673|Pregnancy|pregnancy
174738|NCT02233647|cocaine|cocaine
174739|NCT02233647|phendimetrazine|phendimetrazine
174740|NCT02233647|pharmacotherapy|pharmacotherapy
174741|NCT02233634|Coronary Angiography|coronary angiography
174742|NCT02233634|Magnetic Resonance Imaging|magnetic resonance imaging
174743|NCT02233634|Oxygen|oxygen
174744|NCT02233634|Hyperoxia|hyperoxia
174745|NCT02233634|Carbon Dioxide|carbon dioxide
174746|NCT02233634|Apnea|apnea
174747|NCT02233634|Hyperventilation|hyperventilation
174748|NCT02233608|Prostate cancer|prostate cancer
174749|NCT02233608|Radical prostatectomy|radical prostatectomy
174750|NCT02233608|Pelvic floor muscle exercises|pelvic floor muscle exercises
174751|NCT02233608|Pfilates|pfilates
174752|NCT02233608|Hypopressives|hypopressives
174753|NCT02233608|Urinary Incontinence|urinary incontinence
174754|NCT02233595|MRI|mri
174755|NCT02233595|PET|pet
174756|NCT02233595|rectal cancer|rectal cancer
174757|NCT02233595|adjuvant chemotherapy|adjuvant chemotherapy
174758|NCT02233582|altitude|altitude
174759|NCT02233582|mountain sickness|mountain sickness
174760|NCT02233582|ibuprofen|ibuprofen
174761|NCT02233582|hypoxia|hypoxia
174762|NCT02233569|Laparoscopic hernia repair|laparoscopic hernia repair
174763|NCT02233569|Ventral hernia|ventral hernia
174764|NCT02233569|Incisional hernia|incisional hernia
174765|NCT02233569|IPOM|ipom
174766|NCT02233556|event-related potential|event-related potential
174767|NCT02233556|mismatch negativity|mismatch negativity
174768|NCT02233556|NMDA|nmda
174769|NCT02233556|Glutamate|glutamate
174770|NCT02233543|COPD|copd
174771|NCT02233543|QVA149|qva149
174772|NCT02233543|nocturnal oxygen levels|nocturnal oxygen levels
174773|NCT02233543|combination bronchodilator|combination bronchodilator
174774|NCT02233530|Dementia|dementia
174775|NCT02233530|Cognitive Stimulation Therapy|cognitive stimulation therapy
174776|NCT02233530|Quality of life|quality of life
174777|NCT02233530|Cognitive impairment|cognitive impairment
174778|NCT02233530|Africa|africa
174779|NCT02233530|Tanzania|tanzania
174780|NCT02233530|Nigeria|nigeria
176368|NCT02226445|Outpatients|outpatients
174781|NCT02233530|Low- and Middle-income countries|low- and middle-income countries
174782|NCT02233530|Non-pharmacological intervention|non-pharmacological intervention
174783|NCT02233530|Task-shifting|task-shifting
174784|NCT02233530|Cognitive screening|cognitive screening
174785|NCT02233517|Veterans|veterans
174786|NCT02233517|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
174787|NCT02233517|Aggression|aggression
174788|NCT02233517|Anger|anger
174789|NCT02233517|Posttraumatic Stress Disorder|posttraumatic stress disorder
174790|NCT02233517|Combat Disorders|combat disorders
174791|NCT02233491|PTDM|ptdm
174792|NCT02233491|kidney transplant|kidney transplant
175002|NCT02232412|regional cerebral oxygen saturation|regional cerebral oxygen saturation
175003|NCT02232412|tissue oxygenation|tissue oxygenation
174793|NCT02233491|lifestyle intervention|lifestyle intervention
174794|NCT02233491|diet|diet
174795|NCT02233491|exercise|exercise
174796|NCT02233478|Pomegranate polyphenols|pomegranate polyphenols
174797|NCT02233478|Soy Protein|soy protein
174798|NCT02233478|Ellagitannins|ellagitannins
174801|NCT02233465|mesh|mesh
174802|NCT02233465|parastomal hernia-repair with mesh|parastomal hernia-repair with mesh
174803|NCT02233452|Neuropathic pain|neuropathic pain
174804|NCT02233452|Methadone|methadone
174805|NCT02233452|Ketamine|ketamine
174806|NCT02233452|Multimodal analgesia|multimodal analgesia
174807|NCT02233439|galactagogues|galactagogues
174808|NCT02233439|herbs|herbs
174809|NCT02233439|breastfeeding|breastfeeding
174810|NCT02233439|supplements|supplements
174811|NCT02233439|Silybum marianum|silybum marianum
174812|NCT02233439|Galega officinalis|galega officinalis
174813|NCT02233426|allergic rhinitis|allergic rhinitis
174814|NCT02233426|nasal steroid|nasal steroid
174815|NCT02233426|hypertonic saline|hypertonic saline
174816|NCT02233426|eosinophil|eosinophil
174817|NCT02233426|symptom score|symptom score
174818|NCT02233413|Traumatic brain injury|traumatic brain injury
174819|NCT02233413|TBI|tbi
174820|NCT02233413|Low-level light therapy|low-level light therapy
174821|NCT02233413|LLLT|lllt
174822|NCT02233413|LLLT helmet|lllt helmet
174823|NCT02233400|Acetaminophen|acetaminophen
174824|NCT02233400|Gastric Bypass|gastric bypass
174825|NCT02233400|Sleeve Gastrectomy|sleeve gastrectomy
174826|NCT02233400|Pain|pain
174827|NCT02233400|Cost|cost
174828|NCT02233387|cervix cancer|cervix cancer
174829|NCT02233387|[18F] HX4 PET imaging|[18f] hx4 pet imaging
174830|NCT02233387|hypoxia|hypoxia
174831|NCT02233387|phase II trial|phase ii trial
174832|NCT02233374|Rectal Cancer|rectal cancer
174833|NCT02233374|Magnetic Resonance Imaging|magnetic resonance imaging
174834|NCT02233374|Positron Emission Tomography|positron emission tomography
174835|NCT02233374|pathologic complete response|pathologic complete response
165803|NCT02281175|Benzodiazepine withdrawal|benzodiazepine withdrawal
165804|NCT02281175|PASSE-65+ program|passe-65+ program
165805|NCT02281175|Psychosocial (non-pharmacological) intervention|psychosocial (non-pharmacological) intervention
165806|NCT02281175|Cognitive-Behavioral Therapy (CBT)|cognitive-behavioral therapy (cbt)
165807|NCT02281175|Older adults|older adults
165808|NCT02281149|breast cancer|breast cancer
165809|NCT02281149|radiotherapy|radiotherapy
165810|NCT02281149|intensity modulation|intensity modulation
165811|NCT02281149|toxicity|toxicity
165812|NCT02281136|Actinic keratosis|actinic keratosis
165813|NCT02281110|Diagnostic coronary catheterization|diagnostic coronary catheterization
165814|NCT02281110|Multi-vessel coronary disease|multi-vessel coronary disease
165815|NCT02281110|Percutaneous Coronary Intervention|percutaneous coronary intervention
174836|NCT02233374|Diffusion-weighted magnetic resonance imaging|diffusion-weighted magnetic resonance imaging
174837|NCT02233374|Microstructural Imaging|microstructural imaging
174838|NCT02233374|FDG PET|fdg pet
174839|NCT02233361|Hearing rehabilitation|hearing rehabilitation
174840|NCT02233361|Elderly|elderly
174841|NCT02233361|Hearing aid use|hearing aid use
174842|NCT02233322|ADHR|adhr
174843|NCT02233322|Rickets|rickets
174844|NCT02233322|Hypophosphatemia|hypophosphatemia
174845|NCT02233296|pharmacokinetics|pharmacokinetics
174846|NCT02233283|LH pulsatility|lh pulsatility
174847|NCT02233283|Insulin sensitivity|insulin sensitivity
174848|NCT02233283|Metabolism|metabolism
174849|NCT02233283|hypercaloric feeding|hypercaloric feeding
174850|NCT02233257|Adrenoleukodystrophy|adrenoleukodystrophy
174851|NCT02233257|Lorenzo's oil|lorenzo's oil
174852|NCT02233257|erucic acid|erucic acid
174853|NCT02233244|Drug Interaction|drug interaction
174854|NCT02233205|microbubble|microbubble
174855|NCT02233205|chemotherapy|chemotherapy
174856|NCT02233205|alimentary|alimentary
174857|NCT02233192|PrEP|prep
174858|NCT02233192|conception|conception
174859|NCT02233192|HIV|hiv
174860|NCT02233192|serodiscordant|serodiscordant
174861|NCT02233179|Diabetic foot ulcer|diabetic foot ulcer
174862|NCT02233153|Senior|senior
174863|NCT02233153|Elderly|elderly
174864|NCT02233153|Acute Care|acute care
174865|NCT02233153|Emergency Surgery|emergency surgery
174866|NCT02233140|Diabetes|diabetes
174867|NCT02233140|Ankle equinus|ankle equinus
176671|NCT02225275|CC-5013|cc-5013
174868|NCT02233140|ankle dorsiflexion|ankle dorsiflexion
174869|NCT02233140|dynamic plantar pressure|dynamic plantar pressure
174870|NCT02233140|shockwave therapy|shockwave therapy
174871|NCT02233127|Birth cohort|birth cohort
174872|NCT02233127|Pakistan|pakistan
174873|NCT02233127|Child mortality|child mortality
174874|NCT02233088|Prediabetic State|prediabetic state
174875|NCT02233088|Hypertension|hypertension
174876|NCT02233088|Enlarged Waist Elevated Triglycerides|enlarged waist elevated triglycerides
174877|NCT02233088|HDL Cholesterol, Low Serum|hdl cholesterol, low serum
174878|NCT02233062|Crohn's Disease|crohn's disease
174879|NCT02233062|semen quality|semen quality
174880|NCT02233062|enteral nutrition|enteral nutrition
174881|NCT02233062|CDAI score higher than 150|cdai score higher than 150
174882|NCT02233049|Children|children
174883|NCT02233049|adolescents|adolescents
174884|NCT02233049|young adults|young adults
174885|NCT02233049|newly diagnosed|newly diagnosed
174886|NCT02233036|Young Adults|young adults
174887|NCT02233036|Transfer|transfer
174888|NCT02233036|Chronic Disease|chronic disease
174889|NCT02232997|Chronic kidney disease|chronic kidney disease
174890|NCT02232997|contrast induced nephropathy|contrast induced nephropathy
174891|NCT02232997|diabetes mellitus|diabetes mellitus
174892|NCT02232997|congestive heart failure|congestive heart failure
174893|NCT02232997|hypertension|hypertension
174894|NCT02232984|Heart Failure|heart failure
174895|NCT02232984|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
174896|NCT02232984|CRT-D|crt-d
174897|NCT02232984|Quadripolar pacing|quadripolar pacing
174898|NCT02232971|glucagon|glucagon
174899|NCT02232971|insulin pump|insulin pump
174900|NCT02232971|artificial pancreas|artificial pancreas
174901|NCT02232971|closed-loop|closed-loop
174902|NCT02232958|Hyperbaric Oxygen|hyperbaric oxygen
174903|NCT02232958|Small Vessel Disease of the Brain|small vessel disease of the brain
174904|NCT02232958|Impaired Brain Circuit Connections|impaired brain circuit connections
174905|NCT02232945|influenza A (H1N1,H3N2)|influenza a (h1n1,h3n2)
174906|NCT02232945|influenza B virus|influenza b virus
174907|NCT02232932|Hilar cholangiocarcinoma|hilar cholangiocarcinoma
174908|NCT02232932|Liver transplantation|liver transplantation
174909|NCT02232932|Radiochemotherapy|radiochemotherapy
174911|NCT02232906|Chronic kidney disease|chronic kidney disease
174913|NCT02232906|non-dialysis-dependent|non-dialysis-dependent
174915|NCT02232906|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
174916|NCT02232906|Ferric carboxymaltose|ferric carboxymaltose
174917|NCT02232906|Iron|iron
174918|NCT02232893|Gastrointestinal Quality of Life Index (GIQLI)|gastrointestinal quality of life index (giqli)
174919|NCT02232893|Abdominal Discomfort|abdominal discomfort
174920|NCT02232893|Abdominal Bloating|abdominal bloating
174921|NCT02232893|Laparoscopic colectomy|laparoscopic colectomy
174922|NCT02232893|Postoperative ileus (POI)|postoperative ileus (poi)
174923|NCT02232880|hypertension|hypertension
174924|NCT02232880|inflammation|inflammation
174925|NCT02232867|rehabilitation|rehabilitation
174926|NCT02232867|stroke|stroke
174927|NCT02232867|walking|walking
174928|NCT02232867|interlimb connections|interlimb connections
174929|NCT02232854|Depression|depression
174930|NCT02232841|Electrical impedance tomography|electrical impedance tomography
174931|NCT02232841|lung imaging|lung imaging
174932|NCT02232789|Mephedrone|mephedrone
174933|NCT02232789|3,4-methylenedioxymethamphetamine|3,4-methylenedioxymethamphetamine
174934|NCT02232789|Abuse liability|abuse liability
174935|NCT02232789|Human Pharmacology|human pharmacology
174936|NCT02232776|Losartan|losartan
174937|NCT02232776|Ig A nephropathy|ig a nephropathy
174938|NCT02232776|children|children
174939|NCT02232776|proteinuria|proteinuria
174940|NCT02232763|Losartan|losartan
174941|NCT02232763|children|children
174942|NCT02232763|proteinuria|proteinuria
174943|NCT02232737|Biomarkers of exposure|biomarkers of exposure
174944|NCT02232737|Compensatory smoking|compensatory smoking
174945|NCT02232737|Nicotine dependence|nicotine dependence
174946|NCT02232737|Reduced nicotine cigarettes|reduced nicotine cigarettes
174947|NCT02232737|Tobacco withdrawal|tobacco withdrawal
174948|NCT02232737|Women|women
174949|NCT02232737|Health disparaties|health disparaties
174950|NCT02232737|Vulnerable populations|vulnerable populations
174951|NCT02232724|Prostate Cancer|prostate cancer
174952|NCT02232724|Staging|staging
174953|NCT02232724|PET/CT|pet/ct
174954|NCT02232711|multiplex, polymerase chain reaction, PCR, BioFire, respiratory infection, infectious disease, point of care, CLIA waived, rapid diagnostics|multiplex, polymerase chain reaction, pcr, biofire, respiratory infection, infectious disease, point of care, clia waived, rapid diagnostics
174955|NCT02232698|Sensing Technology|sensing technology
174956|NCT02232698|Type 1 Diabetes,|type 1 diabetes,
174957|NCT02232685|Prostate cancer|prostate cancer
174958|NCT02232685|Staging|staging
174959|NCT02232685|PET/CT|pet/ct
174960|NCT02232672|Prostate Cancer|prostate cancer
174961|NCT02232672|Staging|staging
174962|NCT02232672|PET/CT|pet/ct
174963|NCT02232659|SynCardia|syncardia
174964|NCT02232659|Total Artificial Heart|total artificial heart
174965|NCT02232659|Biventricular heart failure|biventricular heart failure
176672|NCT02225275|Revlimid|revlimid
174966|NCT02232659|Ineligible for cardiac transplant|ineligible for cardiac transplant
174967|NCT02232568|Patient blood management|patient blood management
174968|NCT02232568|RBC transfusion|rbc transfusion
174969|NCT02232568|Restrictive transfusion strategy|restrictive transfusion strategy
174970|NCT02232529|modified release formulation|modified release formulation
174971|NCT02232529|pharmacokinetics|pharmacokinetics
174972|NCT02232490|AFP|afp
174973|NCT02232490|alpha-fetoprotein|alpha-fetoprotein
174974|NCT02232490|cancer vaccine|cancer vaccine
174975|NCT02232490|cirrhosis|cirrhosis
174976|NCT02232490|hepatitis|hepatitis
174977|NCT02232490|HCC|hcc
174978|NCT02232490|hepatocellular carcinoma|hepatocellular carcinoma
174979|NCT02232490|immunotherapy|immunotherapy
174980|NCT02232490|liver tumor|liver tumor
174981|NCT02232490|Cholangiocarcinoma|cholangiocarcinoma
174982|NCT02232464|Adult ADHD|adult adhd
174983|NCT02232464|diffusion spectrum imaging|diffusion spectrum imaging
174984|NCT02232464|resting-state fMRI|resting-state fmri
174985|NCT02232464|frontostriatal circuitries|frontostriatal circuitries
174986|NCT02232464|frontoparietal circuitries|frontoparietal circuitries
174987|NCT02232464|executive function|executive function
174988|NCT02232451|loop|loop
174989|NCT02232451|ERCP|ercp
174990|NCT02232451|cannulation|cannulation
174991|NCT02232451|biliary|biliary
174992|NCT02232451|wire|wire
174993|NCT02232438|Depression|depression
174994|NCT02232438|Psychotherapy|psychotherapy
174995|NCT02232438|Anxiety|anxiety
174996|NCT02232438|Cancer|cancer
174997|NCT02232412|Anemia|anemia
174998|NCT02232412|NIRS|nirs
174999|NCT02232412|Near Infrared Spectroscopy|near infrared spectroscopy
175000|NCT02232412|RBC transfusion|rbc transfusion
175001|NCT02232412|critical ill|critical ill
175007|NCT02232373|FODMAPs|fodmaps
175008|NCT02232373|microbiota|microbiota
175009|NCT02232373|oligofructose|oligofructose
175010|NCT02232373|IBS|ibs
212931|NCT02058563|Safety|safety
175011|NCT02232373|Irritable bowel syndrome|irritable bowel syndrome
175012|NCT02232360|Atherosclerotic plaque|atherosclerotic plaque
175013|NCT02232360|Virtual histology intravascular ultrasound|virtual histology intravascular ultrasound
175014|NCT02232360|Plaque composition|plaque composition
175015|NCT02232360|Rosuvastatin|rosuvastatin
175016|NCT02232360|Fenofibrate|fenofibrate
175017|NCT02232360|Coronary artery disease|coronary artery disease
175018|NCT02232347|traumatic brain injury|traumatic brain injury
175019|NCT02232347|ketamine|ketamine
175020|NCT02232347|microdialysis|microdialysis
175021|NCT02232347|PtiO2|ptio2
175022|NCT02232347|glutamate|glutamate
175023|NCT02232334|Idiopathic Gastroparesis, Nausea, Vomiting, Abdominal Pain, Gastrectomy, Osteopathy, Gastroparesis Cardinal Symptom Index, GCSI|idiopathic gastroparesis, nausea, vomiting, abdominal pain, gastrectomy, osteopathy, gastroparesis cardinal symptom index, gcsi
175024|NCT02232295|Upper extremity, motor imagery, mirror therapy|upper extremity, motor imagery, mirror therapy
175029|NCT02232269|Coffee|coffee
175030|NCT02232269|Grapefruit Juice|grapefruit juice
175031|NCT02232269|Felodipine|felodipine
175032|NCT02232269|Calcium Channel Blocker|calcium channel blocker
175033|NCT02232269|Hemodynamics|hemodynamics
175034|NCT02232269|CYP3A4|cyp3a4
175035|NCT02232256|Chronic non-cancer pain|chronic non-cancer pain
175036|NCT02232256|Insomnia|insomnia
175037|NCT02232256|California poppy|california poppy
175038|NCT02232256|Eschscholzia californica|eschscholzia californica
175039|NCT02232256|Pain|pain
175040|NCT02232256|Sleep quality|sleep quality
175041|NCT02232243|Cancer|cancer
175042|NCT02232243|Surgery|surgery
175043|NCT02232243|Hydroxychloroquine|hydroxychloroquine
175044|NCT02232217|Children|children
175045|NCT02232217|Sleep|sleep
175046|NCT02232217|Obesity|obesity
175047|NCT02232204|insomnia|insomnia
175048|NCT02232204|implantable cardioverter defibrillator|implantable cardioverter defibrillator
175049|NCT02232204|cardiac arrhythmia|cardiac arrhythmia
175050|NCT02232204|cognitive behavioral treatment|cognitive behavioral treatment
175051|NCT02232178|unilateral inguinal hernioplasty|unilateral inguinal hernioplasty
175052|NCT02232165|acute spinal cord injury|acute spinal cord injury
175053|NCT02232165|hemodynamic therapy|hemodynamic therapy
175054|NCT02232165|functional outcome|functional outcome
175055|NCT02232126|Hospital readmissions|hospital readmissions
175056|NCT02232126|Randomized controlled trial|randomized controlled trial
175057|NCT02232126|Older adults|older adults
175058|NCT02232126|Care transitions|care transitions
175059|NCT02232126|Social work|social work
175060|NCT02232113|malnutrition, inflammation, and anemia (MIA) syndrome,|malnutrition, inflammation, and anemia (mia) syndrome,
175061|NCT02232113|hemodialysis,|hemodialysis,
175062|NCT02232113|erythropoietin stimulating agent (ESA),|erythropoietin stimulating agent (esa),
175063|NCT02232113|cost-effectiveness,|cost-effectiveness,
175064|NCT02232113|pharmacokinetics,|pharmacokinetics,
175065|NCT02232113|endothelial dysfunction|endothelial dysfunction
175066|NCT02232100|Attentional bias modification|attentional bias modification
175067|NCT02232100|Chronic pain|chronic pain
175068|NCT02232100|Visual-probe task|visual-probe task
175069|NCT02232100|Internet-delivered therapy|internet-delivered therapy
175176|NCT02231710|Shwachman Diamond Syndrome|shwachman diamond syndrome
175070|NCT02232087|long-acting beta agonist (LABA)|long-acting beta agonist (laba)
175071|NCT02232087|corticosteroid|corticosteroid
175072|NCT02232087|pMDI|pmdi
175073|NCT02232087|inhaler|inhaler
175074|NCT02232074|Patient Navigation|patient navigation
175075|NCT02232074|Medical Legal Partnership|medical legal partnership
175076|NCT02232074|Healthcare Disparities|healthcare disparities
175077|NCT02232061|multiple sclerosis, fingolimod,|multiple sclerosis, fingolimod,
175078|NCT02232035|diazepam|diazepam
175079|NCT02232035|active phase|active phase
175080|NCT02232022|Stroke|stroke
175081|NCT02232022|Ischemic stroke|ischemic stroke
175082|NCT02232022|Atrial fibrillation|atrial fibrillation
175083|NCT02232022|Insertable cardiac monitor|insertable cardiac monitor
175084|NCT02232022|Non-cryptogenic|non-cryptogenic
175085|NCT02232009|Neonate|neonate
175086|NCT02232009|Infant|infant
175087|NCT02231983|Clinical Characteristics|clinical characteristics
175088|NCT02231983|Genetic Profiles|genetic profiles
175089|NCT02231970|Obesity|obesity
175090|NCT02231970|Endoscopic sleeve gastroplasty|endoscopic sleeve gastroplasty
175091|NCT02231970|Weight loss|weight loss
175092|NCT02231892|Repetitive TMS (rTMS)|repetitive tms (rtms)
175093|NCT02231892|Parameter Development|parameter development
175094|NCT02231892|Cognitive Tasks|cognitive tasks
175095|NCT02231892|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
175096|NCT02231879|Infections|infections
175097|NCT02231879|Hypogammaglobulinemia|hypogammaglobulinemia
175098|NCT02231879|CXCR4|cxcr4
175099|NCT02231879|Myelokathexis|myelokathexis
175100|NCT02231879|Warts|warts
175101|NCT02231866|Filovirus|filovirus
175102|NCT02231866|Healthy|healthy
175103|NCT02231866|Ebola Hemorrhagic Fever|ebola hemorrhagic fever
175104|NCT02231866|Immunity|immunity
175105|NCT02231866|Ebola Virus|ebola virus
175106|NCT02231853|BK Virus|bk virus
175107|NCT02231853|Cytotoxic T Cells|cytotoxic t cells
175108|NCT02231853|EBV|ebv
175109|NCT02231853|Adenovirus|adenovirus
175110|NCT02231853|CMV|cmv
175112|NCT02231840|Alcohol Use|alcohol use
175113|NCT02231840|Alcohol|alcohol
175114|NCT02231840|Alcohol Dependence|alcohol dependence
175115|NCT02231840|Genetics|genetics
175116|NCT02231827|subjects|subjects
175117|NCT02231814|Crohn's disease|crohn's disease
175118|NCT02231814|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
175119|NCT02231814|Diet|diet
175120|NCT02231814|Enteral Nutrition|enteral nutrition
175121|NCT02231801|Preterm|preterm
175122|NCT02231801|Kangaroo Care|kangaroo care
175123|NCT02231801|Skin-to-Skin|skin-to-skin
175124|NCT02231801|Vital Sign|vital sign
175125|NCT02231801|Heart Rate|heart rate
175126|NCT02231801|Respiratory Rate|respiratory rate
175127|NCT02231801|Oxygen Saturation|oxygen saturation
175128|NCT02231788|Telminuvo|telminuvo
175129|NCT02231788|Telmitrend|telmitrend
175130|NCT02231788|Hypertension|hypertension
175131|NCT02231788|24hr ABPM|24hr abpm
175132|NCT02231788|Telmisartan|telmisartan
175133|NCT02231788|S-amlodipine|s-amlodipine
175134|NCT02231775|Neoadjuvant|neoadjuvant
175135|NCT02231775|Dabrafenib|dabrafenib
175136|NCT02231775|Tafinlar|tafinlar
175137|NCT02231775|GSK2118436|gsk2118436
175138|NCT02231775|Trametinib|trametinib
175139|NCT02231775|GSK1120212|gsk1120212
175140|NCT02231775|Combination therapy|combination therapy
175141|NCT02231775|Surgery|surgery
175142|NCT02231775|Adjuvant therapy|adjuvant therapy
175143|NCT02231775|Melanoma|melanoma
175144|NCT02231736|Type 2 Diabetes|type 2 diabetes
175145|NCT02231736|Chromosomal damage|chromosomal damage
175146|NCT02231736|Micronuclei|micronuclei
175147|NCT02231736|DNA damage|dna damage
175148|NCT02231736|HbA1c|hba1c
175149|NCT02231736|Comet Assay|comet assay
175150|NCT02231736|Glycemic control|glycemic control
175151|NCT02231723|Digestive System Neoplasms|digestive system neoplasms
175152|NCT02231723|Endocrine Gland Neoplasms|endocrine gland neoplasms
175153|NCT02231723|Pancreatic neoplasms|pancreatic neoplasms
175154|NCT02231723|Pancreatic cancer, adult|pancreatic cancer, adult
175155|NCT02231723|Pancreatic cancer|pancreatic cancer
175156|NCT02231723|Pancreas cancer|pancreas cancer
175157|NCT02231723|Pancreatic diseases|pancreatic diseases
175158|NCT02231723|Adenoma, Islet Cell|adenoma, islet cell
175159|NCT02231723|Carcinoma, Islet Cell|carcinoma, islet cell
175160|NCT02231723|Carcinoma, Pancreatic Ductal|carcinoma, pancreatic ductal
175161|NCT02231723|Gemcitabine|gemcitabine
175162|NCT02231723|Gemzar|gemzar
175163|NCT02231723|Nab-paclitaxel|nab-paclitaxel
175164|NCT02231723|Paclitaxel|paclitaxel
175165|NCT02231723|Abraxane|abraxane
175166|NCT02231723|Oxaliplatin|oxaliplatin
175167|NCT02231723|Leucovorin|leucovorin
175168|NCT02231723|Irinotecan|irinotecan
175169|NCT02231723|Fluorouracil|fluorouracil
175170|NCT02231723|5-FU|5-fu
175171|NCT02231723|MM-398|mm-398
175172|NCT02231710|Severe Combined Immune Deficiency|severe combined immune deficiency
175173|NCT02231710|Congenital T-cell Defect|congenital t-cell defect
175174|NCT02231710|Congenital T-cell Deficiency|congenital t-cell deficiency
175175|NCT02231710|Chronic Granulomatous Disease|chronic granulomatous disease
175177|NCT02231710|Diamond Blackfan Anemia|diamond blackfan anemia
175178|NCT02231710|Dyskeratosis Congenita|dyskeratosis congenita
175179|NCT02231710|Fanconi Anemia|fanconi anemia
175180|NCT02231710|Sickle Cell Disease|sickle cell disease
175181|NCT02231710|Thalassemia|thalassemia
175182|NCT02231710|Mucopolysaccharidosis|mucopolysaccharidosis
175183|NCT02231710|Sphingolipidoses|sphingolipidoses
175184|NCT02231697|XLMTM|xlmtm
175185|NCT02231645|Parkinson's disease|parkinson's disease
175186|NCT02231645|Deep brain stimulation|deep brain stimulation
175187|NCT02231645|Subthalamic nucleus|subthalamic nucleus
175188|NCT02231645|decision-making|decision-making
175189|NCT02231645|cognition|cognition
175190|NCT02231645|behavior|behavior
175191|NCT02231632|Poliomyelitis|poliomyelitis
175192|NCT02231632|Vaccine|vaccine
175193|NCT02231632|Safety|safety
175194|NCT02231632|efficacy|efficacy
175195|NCT02231619|feasibility|feasibility
175196|NCT02231619|self assessment|self assessment
175197|NCT02231619|medical abortion|medical abortion
175198|NCT02231619|low sensitivity urine pregnancy test|low sensitivity urine pregnancy test
175199|NCT02231619|South Africa|south africa
175200|NCT02231606|Myopia Prevalence|myopia prevalence
175201|NCT02231606|Proportion of Purchase of free Spectacles|proportion of purchase of free spectacles
175202|NCT02231606|Proportion of Purchase of update Spectacles|proportion of purchase of update spectacles
175203|NCT02231606|Proportion of Wearing Spectacles|proportion of wearing spectacles
175204|NCT02231580|Neurodegenerative genetic disorder|neurodegenerative genetic disorder
175205|NCT02231567|hip replacement|hip replacement
175206|NCT02231567|neurocognitive rehabilitation|neurocognitive rehabilitation
175207|NCT02231567|WOMAC questionnaire|womac questionnaire
175208|NCT02231554|low back pain|low back pain
175209|NCT02231554|quality of life|quality of life
175210|NCT02231554|rehabilitation|rehabilitation
175211|NCT02231554|exercise|exercise
175213|NCT02231541|Magnetic Fields|magnetic fields
175215|NCT02231541|Visual Analogue scale|visual analogue scale
175216|NCT02231528|anesthesia|anesthesia
175217|NCT02231528|central venous catheter|central venous catheter
175218|NCT02231528|jugular vein|jugular vein
175219|NCT02231528|ultrasound guidance|ultrasound guidance
175220|NCT02231502|Bioavailability in healthy individuals|bioavailability in healthy individuals
175221|NCT02231489|Healthy|healthy
175222|NCT02231489|JNJ-42756493|jnj-42756493
175223|NCT02231489|JNJ-61818549|jnj-61818549
175224|NCT02231463|ultrasound|ultrasound
175225|NCT02231450|AE58054|ae58054
175226|NCT02231450|Hepatic impairment|hepatic impairment
175227|NCT02231411|Delayed Cord Clamping|delayed cord clamping
175228|NCT02231411|Pulmonary Ventilation|pulmonary ventilation
175229|NCT02231398|Cardiovascular disease|cardiovascular disease
175230|NCT02231398|Pregnant women|pregnant women
175231|NCT02231398|Nulliparity|nulliparity
175232|NCT02231398|Pregnancy outcomes|pregnancy outcomes
175233|NCT02231398|Pregnancy complications|pregnancy complications
175234|NCT02231398|Sleep disordered breathing|sleep disordered breathing
175235|NCT02231385|Colorectal cancer|colorectal cancer
175236|NCT02231385|Serrated adenomas|serrated adenomas
175237|NCT02231385|Screening|screening
175238|NCT02231385|Adenoma detection rate|adenoma detection rate
175239|NCT02231385|Polypectomy|polypectomy
175240|NCT02231307|sublingual immunotherapy|sublingual immunotherapy
175241|NCT02231307|birch pollen|birch pollen
175242|NCT02231307|allergic rhinitis / rhinoconjunctivitis|allergic rhinitis / rhinoconjunctivitis
175243|NCT02231307|efficacy|efficacy
175244|NCT02231281|HIV Infections|hiv infections
175245|NCT02231281|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
175246|NCT02231281|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
175247|NCT02231281|Immune System Diseases|immune system diseases
175248|NCT02231281|Lentivirus Infections|lentivirus infections
175249|NCT02231281|Retroviridae Infections|retroviridae infections
175250|NCT02231281|Virus Diseases|virus diseases
175251|NCT02231281|RNA Virus Infections|rna virus infections
175252|NCT02231281|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
175253|NCT02231281|Slow Virus Diseases|slow virus diseases
175254|NCT02231281|Therapeutic Uses|therapeutic uses
175255|NCT02231281|Pharmacologic Actions|pharmacologic actions
175256|NCT02231281|Antiretroviral therapy|antiretroviral therapy
175257|NCT02231281|Early therapy|early therapy
175259|NCT02231242|children|children
175260|NCT02231242|cerebral palsy|cerebral palsy
175261|NCT02231242|bone marrow stem cells|bone marrow stem cells
175262|NCT02231242|intrathecal autologous total nucleated cells|intrathecal autologous total nucleated cells
175263|NCT02231242|quadriparesis|quadriparesis
175264|NCT02231229|Pulmonary tuberculosis|pulmonary tuberculosis
175265|NCT02231229|Mycobacterium tuberculosis (MTB)|mycobacterium tuberculosis (mtb)
175266|NCT02231229|Drug Resistance (DR)|drug resistance (dr)
175267|NCT02231229|Isoniazid (INH or H)|isoniazid (inh or h)
175268|NCT02231229|Rifampicin (RIF or RMP or R)|rifampicin (rif or rmp or r)
175269|NCT02231229|Pyrazinamide (PZA or Z)|pyrazinamide (pza or z)
175270|NCT02231229|Ethambutol (EMB or E)|ethambutol (emb or e)
175271|NCT02231229|Fast-TB|fast-tb
175272|NCT02231229|Isoniazid, Rifampicin, Pyrazinamide (HRZ)|isoniazid, rifampicin, pyrazinamide (hrz)
176076|NCT02227992|Coagulants|coagulants
175273|NCT02231229|Isoniazid, Rifampicin, Pyrazinamide, Ethambutol (HRZE)|isoniazid, rifampicin, pyrazinamide, ethambutol (hrze)
175274|NCT02231229|drug susceptibility testing (DST)|drug susceptibility testing (dst)
175275|NCT02231229|Acid-Fast Bacilli (AFB+)|acid-fast bacilli (afb+)
175276|NCT02231229|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
175277|NCT02231216|rhinoseptoplasty|rhinoseptoplasty
175278|NCT02231203|fish oil|fish oil
175279|NCT02231203|omega-3 fatty acids|omega-3 fatty acids
175280|NCT02231203|postoperative inflammatory response|postoperative inflammatory response
175281|NCT02231203|erythrocyte function|erythrocyte function
175282|NCT02231190|muscle soreness|muscle soreness
175283|NCT02231190|Muscle damage and recovery|muscle damage and recovery
175284|NCT02231190|muscle function|muscle function
175285|NCT02231190|eccentric exercise|eccentric exercise
175286|NCT02231151|CPR quality assessment|cpr quality assessment
175287|NCT02231151|Visual CPR assessment|visual cpr assessment
175288|NCT02231151|Position relative to patient|position relative to patient
175289|NCT02231138|Abelmoschus manihot|abelmoschus manihot
175290|NCT02231138|Chronic Kidney Disease|chronic kidney disease
175291|NCT02231138|proteinuria|proteinuria
175292|NCT02231138|efficacy|efficacy
175293|NCT02231138|safety|safety
175294|NCT02231125|Abelmoschus manihot|abelmoschus manihot
175295|NCT02231125|IgA Nephropathy|iga nephropathy
175296|NCT02231125|proteinuria|proteinuria
175297|NCT02231125|efficacy|efficacy
175298|NCT02231125|safety|safety
175299|NCT02231112|Korean|korean
175300|NCT02231112|Left side|left side
175301|NCT02231099|recurrent pelvic organ prolapse|recurrent pelvic organ prolapse
175302|NCT02231099|mesh|mesh
175303|NCT02231086|Chemotherapy, Adjuvant|chemotherapy, adjuvant
175304|NCT02231086|Laparoscopy|laparoscopy
175305|NCT02231086|Peritoneal Lavage|peritoneal lavage
175306|NCT02231086|HIPEC|hipec
175307|NCT02231073|Freezing of gait|freezing of gait
175308|NCT02231073|Idiopathic Parkinson's disease|idiopathic parkinson's disease
175309|NCT02231073|Exercise|exercise
175310|NCT02231073|parkinsonism|parkinsonism
175311|NCT02231060|Outcome Prediction|outcome prediction
175312|NCT02231060|Anoxic-Ischemic Encephalopathy|anoxic-ischemic encephalopathy
175313|NCT02231060|Coma|coma
175314|NCT02231060|Vegetative State|vegetative state
175315|NCT02231060|Minimally Conscious State|minimally conscious state
175316|NCT02231060|Chronic Disorders of Consciousness|chronic disorders of consciousness
175317|NCT02231047|Diarrhea|diarrhea
175318|NCT02231047|Pneumonia|pneumonia
175319|NCT02231047|Child, Preschool|child, preschool
175320|NCT02231047|Infant|infant
175321|NCT02231047|Dietary Supplements|dietary supplements
175322|NCT02231047|Colostrums|colostrums
175323|NCT02231047|Developing Countries|developing countries
175324|NCT02229994|Dyspnea|dyspnea
175325|NCT02229994|Self-administered questionnaire|self-administered questionnaire
175326|NCT02229994|Chronic respiratory disease|chronic respiratory disease
175327|NCT02229994|COPD|copd
175328|NCT02229994|Diffuse interstitial lung diseases|diffuse interstitial lung diseases
175329|NCT02229994|Pulmonary arterial hypertension|pulmonary arterial hypertension
175330|NCT02229994|Cystic fibrosis|cystic fibrosis
175331|NCT02229981|Lymphoma|lymphoma
175332|NCT02229981|B-cell Lymphomas|b-cell lymphomas
175333|NCT02229981|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
175334|NCT02229981|Lymphosarcoma|lymphosarcoma
175335|NCT02229981|Kaposi's Sarcoma-associated Herpesvirus|kaposi's sarcoma-associated herpesvirus
175336|NCT02229981|KHSV|khsv
175337|NCT02229981|Human Immunodeficiency Virus|human immunodeficiency virus
175339|NCT02229981|Epstein-Barr Virus|epstein-barr virus
175340|NCT02229981|EBV|ebv
175341|NCT02229981|Kaposi sarcoma|kaposi sarcoma
175342|NCT02229968|craniosynostosis|craniosynostosis
175343|NCT02229968|craniofacial|craniofacial
175344|NCT02229968|amicar|amicar
175345|NCT02229968|epsilon aminocaproic acid|epsilon aminocaproic acid
175346|NCT02229968|ε-aminocaproic acid|ε-aminocaproic acid
175347|NCT02229955|Dry Eye Syndromes|dry eye syndromes
175348|NCT02229942|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
175349|NCT02229942|Myalgic Encephalitis (ME)|myalgic encephalitis (me)
175350|NCT02229942|Rituximab|rituximab
175351|NCT02229942|B-lymphocyte depletion|b-lymphocyte depletion
175352|NCT02229942|B-cell depletion|b-cell depletion
175353|NCT02229929|Pruritus|pruritus
175354|NCT02229929|uremic pruritus|uremic pruritus
175355|NCT02229929|kappa opioid|kappa opioid
175356|NCT02229929|CR845|cr845
175357|NCT02229916|Testicular Neoplasms|testicular neoplasms
175358|NCT02229916|Testicular Cancer|testicular cancer
175359|NCT02229916|Cohort Study|cohort study
175360|NCT02229903|OCD|ocd
175361|NCT02229864|Absorb™ BVS|absorb™ bvs
175362|NCT02229864|Angioplasty|angioplasty
175363|NCT02229864|Bioabsorbable|bioabsorbable
175364|NCT02229864|BVS|bvs
175365|NCT02229864|Coronary Artery Disease|coronary artery disease
175366|NCT02229864|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
175367|NCT02229864|Coronary artery restenosis|coronary artery restenosis
175368|NCT02229864|Coronary artery stenosis|coronary artery stenosis
175369|NCT02229864|Coronary scaffold|coronary scaffold
175370|NCT02229864|Coronary Stent|coronary stent
175371|NCT02229864|Drug eluting stents|drug eluting stents
175372|NCT02229864|Everolimus|everolimus
175373|NCT02229864|Myocardial ischemia|myocardial ischemia
175374|NCT02229864|Stent thrombosis|stent thrombosis
175375|NCT02229864|Stents|stents
175376|NCT02231021|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
175377|NCT02231021|alogliptin|alogliptin
175378|NCT02231021|pioglitazone|pioglitazone
175379|NCT02231021|DPP4 inhibitor|dpp4 inhibitor
175380|NCT02231021|thiazolidinedione|thiazolidinedione
175381|NCT02231008|SMS|sms
175382|NCT02230969|peginterferon|peginterferon
175383|NCT02230969|relapsing|relapsing
175384|NCT02230969|pegylated|pegylated
175385|NCT02230969|Subcutaneous|subcutaneous
175386|NCT02230969|Injectable|injectable
175387|NCT02230969|Multiple Sclerosis|multiple sclerosis
175388|NCT02230943|rheumatoid|rheumatoid
175389|NCT02230943|arthritis|arthritis
175390|NCT02230943|osteoarthritis|osteoarthritis
175391|NCT02230943|gout|gout
175392|NCT02230930|Parkinson's disease|parkinson's disease
175393|NCT02230930|Apomorphine|apomorphine
175394|NCT02230930|Infusion|infusion
175395|NCT02230930|Skin reactions|skin reactions
175396|NCT02230930|Subcutaneous nodules|subcutaneous nodules
175397|NCT02230930|Hydrocortisone|hydrocortisone
175399|NCT02230930|Dilution|dilution
175400|NCT02230904|Rotigotine patch|rotigotine patch
175401|NCT02230904|Neupro|neupro
175402|NCT02230904|Parkinson's Disease|parkinson's disease
175403|NCT02230891|heart failure|heart failure
175404|NCT02230891|biomarkers|biomarkers
175405|NCT02230891|troponin|troponin
175406|NCT02230891|BNP|bnp
175407|NCT02230891|carvedilol|carvedilol
175408|NCT02230891|spironolactone|spironolactone
175409|NCT02230891|prevention|prevention
175410|NCT02230878|JNJ-42847922|jnj-42847922
175411|NCT02230878|Phase 1|phase 1
175412|NCT02230878|Healthy|healthy
175413|NCT02230878|Placebo|placebo
175414|NCT02230865|Funnel chest (Pectus excavatum)|funnel chest (pectus excavatum)
175415|NCT02230852|Telemedicine|telemedicine
175416|NCT02230852|Prehospital|prehospital
175417|NCT02230852|Emergency Medicine|emergency medicine
175418|NCT02230852|Stroke|stroke
175419|NCT02230839|insulin resistance|insulin resistance
175420|NCT02230839|muscle|muscle
175421|NCT02230839|health education|health education
175422|NCT02230839|exercise|exercise
175423|NCT02230826|Arthroplasty|arthroplasty
175424|NCT02230826|Hip Replacement|hip replacement
175425|NCT02230826|Acetabular cup|acetabular cup
175426|NCT02230826|Femoral stem|femoral stem
175427|NCT02230813|Cohort Study,|cohort study,
175428|NCT02230813|Cellulitis,|cellulitis,
175429|NCT02230813|Skin and Soft Tissue Infection,|skin and soft tissue infection,
175430|NCT02230813|Emergency Department,|emergency department,
175431|NCT02230813|Clinical Prediction Rule|clinical prediction rule
175432|NCT02230787|Pilot study|pilot study
175433|NCT02230787|randomized clinical trial|randomized clinical trial
175434|NCT02230787|periodontal disease|periodontal disease
175435|NCT02230787|gingival recession|gingival recession
175436|NCT02230787|Emdogain|emdogain
175437|NCT02230787|connective tissue|connective tissue
175438|NCT02230787|wound healing|wound healing
175439|NCT02230787|inflammation|inflammation
175440|NCT02230774|hydration|hydration
175441|NCT02230774|cognitive function|cognitive function
175442|NCT02230774|doctors|doctors
175443|NCT02230774|nurses|nurses
175444|NCT02230774|Nurses and Doctors oncall|nurses and doctors oncall
175445|NCT02230761|steatoblepharon|steatoblepharon
175446|NCT02230761|blepharoptosis|blepharoptosis
175447|NCT02230761|dermatochalasis|dermatochalasis
175448|NCT02230761|blepharoplasty|blepharoplasty
175449|NCT02230761|periorbital|periorbital
175450|NCT02230761|orbital|orbital
175451|NCT02230761|eyelid|eyelid
175452|NCT02230761|eyebags|eyebags
175453|NCT02230761|eye bags|eye bags
175454|NCT02230748|LAA|laa
175455|NCT02230748|LAA-Occluder|laa-occluder
175456|NCT02230748|Atrial Fibrillation|atrial fibrillation
175457|NCT02230748|AF|af
175458|NCT02230735|Robotic|robotic
175459|NCT02230735|Hysterectomy|hysterectomy
175460|NCT02230735|Uterosacral|uterosacral
175461|NCT02230735|Bupivacaine|bupivacaine
175462|NCT02230735|Robotic hysterectomy pain control|robotic hysterectomy pain control
175463|NCT02230722|opioids|opioids
175464|NCT02230722|chronic pain|chronic pain
175465|NCT02230722|collaborative care|collaborative care
175466|NCT02230709|Neck pain|neck pain
175467|NCT02230709|Myofascial pain syndrome|myofascial pain syndrome
175468|NCT02230709|Soreness|soreness
175469|NCT02230683|Liver Cirrhosis|liver cirrhosis
175470|NCT02230683|Hepatic Cirrhosis|hepatic cirrhosis
175471|NCT02230683|Portal Hypertension|portal hypertension
175472|NCT02230670|Liver Cirrhosis|liver cirrhosis
175473|NCT02230670|Hepatic Cirrhosis|hepatic cirrhosis
175474|NCT02230605|Delirium|delirium
175475|NCT02230605|Post Operative Delirium|post operative delirium
175476|NCT02230605|PD|pd
175477|NCT02230605|POD|pod
175478|NCT02230605|Anesthesia|anesthesia
175479|NCT02230605|Anesthesiology|anesthesiology
175480|NCT02230605|Post Operative Recovery|post operative recovery
175481|NCT02230605|Post Anesthesia Care Unit|post anesthesia care unit
175482|NCT02230605|PACU|pacu
175483|NCT02230605|Cognition|cognition
175484|NCT02230605|Cognitive Impairment|cognitive impairment
175485|NCT02230605|Memory|memory
175486|NCT02230605|Thinking|thinking
175487|NCT02230605|Confusion Assessment Method|confusion assessment method
175488|NCT02230605|CAM|cam
175489|NCT02230605|Neurobics|neurobics
175490|NCT02230605|Neuroplasticity|neuroplasticity
175491|NCT02230605|Lumosity|lumosity
175492|NCT02230605|Brain Games|brain games
175493|NCT02230605|Cognitive Exercise|cognitive exercise
175494|NCT02230605|Cognitive Training|cognitive training
175495|NCT02230605|Perioperative Cognitive Protection|perioperative cognitive protection
175496|NCT02230605|Cognitive Reserve|cognitive reserve
175497|NCT02230605|Neurobics Trial|neurobics trial
175498|NCT02230605|Surgery|surgery
175499|NCT02230605|Elderly Patients|elderly patients
175500|NCT02230592|PET|pet
175501|NCT02230592|Metabolic Glutamate Receptors|metabolic glutamate receptors
175502|NCT02230592|Brain Imaging|brain imaging
175503|NCT02230579|safety|safety
175504|NCT02230579|tolerability|tolerability
175505|NCT02230579|malaria|malaria
175506|NCT02230566|MPS 7|mps 7
175507|NCT02230566|Sly Syndrome|sly syndrome
175508|NCT02230566|Mucopolysaccharidosis|mucopolysaccharidosis
175509|NCT02230566|MPS VII|mps vii
175510|NCT02230566|Enzyme Replacement Therapy|enzyme replacement therapy
175511|NCT02230566|Mucopolysaccharidosis type 7|mucopolysaccharidosis type 7
175512|NCT02230566|rare disease|rare disease
175513|NCT02230566|lysosomal storage disease|lysosomal storage disease
175514|NCT02230566|metabolic disorder|metabolic disorder
175515|NCT02230514|Nonunion fracture|nonunion fracture
175516|NCT02230514|Long bones|long bones
175517|NCT02230514|Pseudoarthrosis|pseudoarthrosis
175518|NCT02230514|Cell therapy|cell therapy
175519|NCT02230514|Tissue engineering|tissue engineering
175520|NCT02230514|Mesenchymal stromal cells|mesenchymal stromal cells
175521|NCT02230488|Inpatient Diabetes Management|inpatient diabetes management
175522|NCT02230488|Prevent <31 day readmission in patients with Diabetes|prevent <31 day readmission in patients with diabetes
175523|NCT02230488|CDEs role in transition of care of inpatients with diabetes|cdes role in transition of care of inpatients with diabetes
175524|NCT02230475|Allergic Rhinitis|allergic rhinitis
175525|NCT02230475|NMR|nmr
175526|NCT02230462|patient satisfaction|patient satisfaction
175527|NCT02230462|Mohs surgery|mohs surgery
175528|NCT02230436|Pancreatectomy|pancreatectomy
175529|NCT02230436|Time of drain removal|time of drain removal
175530|NCT02230423|Functional nasal surgery|functional nasal surgery
175531|NCT02230423|Empty Nose Syndrome (ENS)|empty nose syndrome (ens)
175532|NCT02230410|Barrett's|barrett's
175533|NCT02230410|high grade dysplasia|high grade dysplasia
175534|NCT02230410|ablation|ablation
175535|NCT02230410|cyrotherapy|cyrotherapy
175536|NCT02230397|skin aging|skin aging
175537|NCT02230397|anti-aging cream|anti-aging cream
175538|NCT02230397|wrinkles|wrinkles
175539|NCT02230384|Attempt at Smoking Cessation|attempt at smoking cessation
175540|NCT02230384|Schizophrenia or Schizoaffective disorder|schizophrenia or schizoaffective disorder
175541|NCT02230384|Novel nicotinergic drug|novel nicotinergic drug
175542|NCT02230371|Myofascial pain|myofascial pain
175543|NCT02230371|TMD|tmd
175544|NCT02230371|5-HT3|5-ht3
175545|NCT02230371|Granisetron|granisetron
175546|NCT02230371|Placebo-controlled|placebo-controlled
175547|NCT02230371|Patients|patients
175548|NCT02230371|Randomized|randomized
175549|NCT02230371|Double-blind|double-blind
175550|NCT02230358|carotid endarterectomy|carotid endarterectomy
175551|NCT02230358|cardiac output|cardiac output
175552|NCT02230358|trans-cranial Doppler|trans-cranial doppler
175553|NCT02230358|CEA|cea
175554|NCT02230358|regional anesthesia|regional anesthesia
175555|NCT02230358|general anesthesia|general anesthesia
175556|NCT02230345|Probiotic|probiotic
175557|NCT02230345|Yoghourt|yoghourt
175558|NCT02230345|Inflammation|inflammation
175559|NCT02230345|Metabolomics|metabolomics
175560|NCT02230319|Cryotherapy|cryotherapy
175561|NCT02230319|Cold therapy|cold therapy
175562|NCT02230319|Peripheral Neuropathy|peripheral neuropathy
175563|NCT02230319|Paclitaxel|paclitaxel
175564|NCT02230319|Breast Cancer|breast cancer
175565|NCT02230319|Symptom management|symptom management
175566|NCT02230319|Prevention|prevention
175567|NCT02230293|ambulatory care,|ambulatory care,
175568|NCT02230293|hypertension,|hypertension,
175569|NCT02230293|health personnel,|health personnel,
175570|NCT02230293|clinical trial|clinical trial
175571|NCT02230280|Mobile health technology|mobile health technology
175572|NCT02230280|Multiple chronic conditions|multiple chronic conditions
175573|NCT02230280|Older adults|older adults
175574|NCT02230280|Home and community care|home and community care
175575|NCT02230280|Effectiveness|effectiveness
175576|NCT02230280|Cost analysis|cost analysis
175577|NCT02230280|Interprofessional Stroke Rehabilitation|interprofessional stroke rehabilitation
175578|NCT02230267|boot camp|boot camp
175579|NCT02230267|exercise|exercise
175580|NCT02230267|balance training|balance training
175581|NCT02230267|fall prevention|fall prevention
175582|NCT02230267|falling|falling
175583|NCT02230267|strength training|strength training
175584|NCT02230254|Coronary Artery Disease|coronary artery disease
175585|NCT02230241|Dyslipidaemia|dyslipidaemia
175586|NCT02230241|LDL-C goals|ldl-c goals
175587|NCT02230241|Guidelines|guidelines
175588|NCT02230215|Total Knee Replacement|total knee replacement
175589|NCT02230215|Visionaire|visionaire
175590|NCT02230189|Asthma|asthma
175591|NCT02230189|Allergen challenge|allergen challenge
175592|NCT02230163|Chikungunya virus|chikungunya virus
175593|NCT02230163|Human anti-CHIKV hyperimmune intravenous immunoglobulins|human anti-chikv hyperimmune intravenous immunoglobulins
175594|NCT02230163|Neonates|neonates
175595|NCT02230150|Adhesion, Knowledge, Nursing|adhesion, knowledge, nursing
175596|NCT02230137|adolescents|adolescents
175597|NCT02230137|type 1 diabetes|type 1 diabetes
175598|NCT02230137|poorly controlled|poorly controlled
175599|NCT02230137|SMS|sms
175600|NCT02230137|Improve glycaemic control|improve glycaemic control
175601|NCT02230137|HbA1c reduction|hba1c reduction
175701|NCT02229474|Tanzania|tanzania
175602|NCT02230137|poorly controlled type 1 diabetic adolescents|poorly controlled type 1 diabetic adolescents
175603|NCT02230124|Hydrocephalus|hydrocephalus
175605|NCT02230111|Caloric restriction|caloric restriction
175606|NCT02230111|Cognitive dietary restraint|cognitive dietary restraint
175607|NCT02230111|Eating behaviours|eating behaviours
175608|NCT02230111|Food habits|food habits
665116|NCT00829114|PCR|pcr
175609|NCT02230111|Appetite sensations|appetite sensations
175610|NCT02230111|Stress|stress
175611|NCT02230111|Weight management|weight management
175612|NCT02230098|remote ischemic conditioning|remote ischemic conditioning
175613|NCT02230098|ischemic heart disease|ischemic heart disease
175614|NCT02230072|myelomeningocele|myelomeningocele
175615|NCT02230072|MMC|mmc
175616|NCT02230072|NTD|ntd
175617|NCT02230072|neural|neural
175618|NCT02230072|defect|defect
175619|NCT02230072|Spina bifida|spina bifida
175620|NCT02230072|Neural Tube Defect|neural tube defect
175621|NCT02230059|Prostatic Neoplasms|prostatic neoplasms
175622|NCT02230059|observational Study|observational study
175623|NCT02230059|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
175624|NCT02230046|Healthy,|healthy,
175625|NCT02230046|Abiraterone Acetate,|abiraterone acetate,
175626|NCT02230046|Bioequivalence.|bioequivalence.
175627|NCT02230033|JNJ-56021927|jnj-56021927
175628|NCT02230033|Itraconazole|itraconazole
175629|NCT02230033|Gemfibrozil|gemfibrozil
175630|NCT02229708|Pregnancy|pregnancy
175631|NCT02229708|Weight control|weight control
175632|NCT02229708|Behavioral|behavioral
175633|NCT02229708|technology-based intervention|technology-based intervention
175634|NCT02229695|Trauma|trauma
175635|NCT02229695|Sepsis|sepsis
175636|NCT02229695|Temporary abdominal closure|temporary abdominal closure
175637|NCT02229695|Bogota bag|bogota bag
175638|NCT02229695|Vacuum assisted closure|vacuum assisted closure
175639|NCT02229682|extranodal NK/T-cell lymphoma,nasal-type,|extranodal nk/t-cell lymphoma,nasal-type,
175640|NCT02229682|radiotherapy,|radiotherapy,
175641|NCT02229682|intensity-modulated radiation treatment,|intensity-modulated radiation treatment,
175642|NCT02229682|asparaginase-based chemotherapy,|asparaginase-based chemotherapy,
175643|NCT02229682|loco-regional control,|loco-regional control,
175644|NCT02229682|survival|survival
175645|NCT02229656|olaparib|olaparib
175646|NCT02229656|radiotherapy|radiotherapy
175647|NCT02229656|Laryngeal SCC|laryngeal scc
175648|NCT02229656|oropharyngeal SCC|oropharyngeal scc
175649|NCT02229643|Traumatic brain injury|traumatic brain injury
175650|NCT02229643|Neuroglobin|neuroglobin
175651|NCT02229643|Nogo-A|nogo-a
175652|NCT02229643|Prognosis|prognosis
175653|NCT02229630|intra-uterine growth restriction|intra-uterine growth restriction
175654|NCT02229630|MRI|mri
175655|NCT02229630|apparent diffusion coefficient|apparent diffusion coefficient
175656|NCT02229617|Intramuscular testosterone|intramuscular testosterone
175657|NCT02229617|Subcutaneous testosterone|subcutaneous testosterone
175658|NCT02229604|electroacupuncture|electroacupuncture
175659|NCT02229604|diminished ovarian reserve|diminished ovarian reserve
175660|NCT02229604|cohort study|cohort study
175661|NCT02229578|Burn pain|burn pain
175662|NCT02229578|lidocaine|lidocaine
175663|NCT02229578|donor site pain|donor site pain
175664|NCT02229578|Narcotic use|narcotic use
175665|NCT02229565|prostate cancer|prostate cancer
175666|NCT02229565|prostate biopsy|prostate biopsy
175667|NCT02229565|prostatectomy|prostatectomy
175668|NCT02229526|Fish oil supplementation|fish oil supplementation
175669|NCT02229526|RCT|rct
175670|NCT02229526|High risk pregnancies|high risk pregnancies
175671|NCT02229526|Twin pregnancy|twin pregnancy
175672|NCT02229526|Preterm birth|preterm birth
175673|NCT02229526|Intrauterine growth retardation|intrauterine growth retardation
175674|NCT02229526|Pregnancy induced hypertension|pregnancy induced hypertension
175675|NCT02229513|postpartum hemorrhage|postpartum hemorrhage
175676|NCT02229513|uterine atony|uterine atony
175677|NCT02229513|cesarean section|cesarean section
175678|NCT02229513|cesarean hysterectomy|cesarean hysterectomy
175679|NCT02229513|acute blood loss anemia|acute blood loss anemia
175680|NCT02229513|uterotonics|uterotonics
175681|NCT02229513|obstetric hemorrhage|obstetric hemorrhage
175682|NCT02229513|severe hemorrhage|severe hemorrhage
175683|NCT02229513|blood transfusion|blood transfusion
175684|NCT02229513|obstetric emergencies|obstetric emergencies
175685|NCT02229513|obstetrics|obstetrics
175686|NCT02229513|massive hemorrhage|massive hemorrhage
175687|NCT02229513|hemorrhage|hemorrhage
175688|NCT02229513|uterine cooling|uterine cooling
175689|NCT02229500|Propionate|propionate
175690|NCT02229500|Microbiome|microbiome
175691|NCT02229500|Dietary Fibre|dietary fibre
175692|NCT02229500|Short chain fatty acids|short chain fatty acids
175693|NCT02229487|Prediabetes|prediabetes
175694|NCT02229487|Short sleepers|short sleepers
175695|NCT02229487|GLP-1|glp-1
175696|NCT02229474|Dementia|dementia
175697|NCT02229474|Cognitive Stimulation Therapy|cognitive stimulation therapy
175698|NCT02229474|Quality of life|quality of life
175699|NCT02229474|Cognitive impairment|cognitive impairment
175700|NCT02229474|Africa|africa
175702|NCT02229474|Nigeria|nigeria
175703|NCT02229474|Low- and Middle-income countries|low- and middle-income countries
175704|NCT02229474|Non-pharmacological intervention|non-pharmacological intervention
175705|NCT02229474|Task-shifting|task-shifting
175706|NCT02229474|Cognitive screening|cognitive screening
213821|NCT02054650|OMT|omt
175707|NCT02229448|Immunoglobulin G|immunoglobulin g
175708|NCT02229448|focus|focus
175709|NCT02229448|study|study
175710|NCT02229448|detect|detect
175711|NCT02229448|patients|patients
175712|NCT02229435|Chronic kidney disease|chronic kidney disease
175713|NCT02229435|Urological care|urological care
175714|NCT02229435|Nephrological care|nephrological care
175715|NCT02229409|adults|adults
175716|NCT02229396|Diabetes Mellitus|diabetes mellitus
175718|NCT02229396|Dapagliflozin|dapagliflozin
175719|NCT02229396|Diabetes medication|diabetes medication
175720|NCT02229396|Treatment efficacy|treatment efficacy
175721|NCT02229396|Placebo|placebo
175722|NCT02229396|Metabolism|metabolism
175723|NCT02229396|Cardiovascular metabolic|cardiovascular metabolic
175724|NCT02229383|Diabetes Mellitus|diabetes mellitus
175725|NCT02229383|Exenatide|exenatide
175726|NCT02229383|Diabetes drug|diabetes drug
175727|NCT02229383|Treatment efficacy|treatment efficacy
175728|NCT02229383|Placebo|placebo
175729|NCT02229383|Metabolism|metabolism
175730|NCT02229383|Cardiovascilar metabolic|cardiovascilar metabolic
175731|NCT02229370|extracranial|extracranial
175732|NCT02229370|carotid|carotid
175733|NCT02229370|artery|artery
175734|NCT02229370|aneurysm|aneurysm
175735|NCT02229370|registry|registry
175736|NCT02229370|CAR|car
175737|NCT02229357|H5N2 Vaccine|h5n2 vaccine
175738|NCT02229344|colitis, ulcerative|colitis, ulcerative
175739|NCT02229344|MOSAIK|mosaik
175740|NCT02229344|REMICADE|remicade
175741|NCT02229344|Infliximab|infliximab
175742|NCT02229331|haemophilia|haemophilia
175743|NCT02229331|arthropathy|arthropathy
175744|NCT02229331|pediatrics|pediatrics
175745|NCT02229331|ankle|ankle
175746|NCT02229331|biomechanics|biomechanics
175747|NCT02229305|Anxiety|anxiety
175748|NCT02229305|Trauma|trauma
175749|NCT02229305|Depression|depression
175750|NCT02229305|Problem Behavior|problem behavior
175751|NCT02229305|evidence-based treatments|evidence-based treatments
175752|NCT02229279|Surgical Procedures, Operative|surgical procedures, operative
175753|NCT02229266|AML|aml
175754|NCT02229266|high-risk AML|high-risk aml
175755|NCT02229266|acute myeloid leukemia|acute myeloid leukemia
175756|NCT02229266|NK cells|nk cells
175757|NCT02229266|haploidentical natural killer cells|haploidentical natural killer cells
175758|NCT02229266|immunotherapy|immunotherapy
175759|NCT02229240|Albiglutide|albiglutide
175760|NCT02229240|Add-on to basal-bolus insulin therapy|add-on to basal-bolus insulin therapy
175761|NCT02229240|Glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
175762|NCT02229240|Type 2 diabetes mellitus|type 2 diabetes mellitus
175763|NCT02229227|switch study|switch study
175764|NCT02229227|albiglutide|albiglutide
175765|NCT02229227|glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
175766|NCT02229227|Type 2 diabetes mellitus|type 2 diabetes mellitus
175767|NCT02229227|basal-bolus insulin therapy|basal-bolus insulin therapy
175768|NCT02229214|Renal function|renal function
175769|NCT02229214|Glomerular Filtration Rate|glomerular filtration rate
175770|NCT02229214|Kidney function|kidney function
175771|NCT02229214|Qsymia|qsymia
175772|NCT02229214|Iohexol|iohexol
175773|NCT02229214|Serum Creatinine|serum creatinine
175774|NCT02229214|Creatinine clearance|creatinine clearance
175775|NCT02229214|Renal Clearance|renal clearance
175776|NCT02229214|VI-0521|vi-0521
175777|NCT02229214|Healthy volunteers|healthy volunteers
175778|NCT02229201|propofol|propofol
175779|NCT02229201|sevoflurane|sevoflurane
175780|NCT02229201|Interleukin 6|interleukin 6
175781|NCT02229201|Interleukin 10|interleukin 10
175782|NCT02229188|Depression; mood; cognitive training|depression; mood; cognitive training
176367|NCT02226445|Adults|adults
175783|NCT02229175|Diabetic Macular Edema|diabetic macular edema
175784|NCT02229175|Diabetic Retinopathy|diabetic retinopathy
175785|NCT02229175|Type 1 Diabetes|type 1 diabetes
175786|NCT02229175|Type 2 Diabetes|type 2 diabetes
175787|NCT02229175|Macular Edema|macular edema
175788|NCT02229175|bevacizumab|bevacizumab
175789|NCT02229175|intravitreal injection|intravitreal injection
175790|NCT02229175|Avastin|avastin
175791|NCT02229175|PASCAL Endpoint Management (EpM) system|pascal endpoint management (epm) system
175792|NCT02229175|Subthreshold focal laser treatments|subthreshold focal laser treatments
175793|NCT02229162|umbilical cord|umbilical cord
175794|NCT02229162|cesarean section|cesarean section
175795|NCT02229162|Blood Loss, Surgical|blood loss, surgical
175796|NCT02229149|breast cancer|breast cancer
175797|NCT02229149|metastatic breast cancer|metastatic breast cancer
175798|NCT02229149|HER2+ breast cancer|her2+ breast cancer
175799|NCT02229136|Mouth sores from chemotherapy|mouth sores from chemotherapy
175800|NCT02229136|mouth sores|mouth sores
175801|NCT02229136|hormone receptor-positive metastatic breast cancer|hormone receptor-positive metastatic breast cancer
175900|NCT02228694|Safety|safety
175802|NCT02229136|metastatic breast cancer|metastatic breast cancer
175803|NCT02229123|seizures|seizures
175804|NCT02229123|neonates|neonates
175805|NCT02229123|anticonvulsants treatment|anticonvulsants treatment
166795|NCT02275741|Vaccine|vaccine
166796|NCT02275741|Antibody response|antibody response
166797|NCT02275741|relaps rate|relaps rate
175806|NCT02229123|levetiracetam|levetiracetam
175807|NCT02229123|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
175808|NCT02229123|electroencephalography|electroencephalography
175809|NCT02229110|type 2 diabetes mellitus|type 2 diabetes mellitus
175810|NCT02229110|e-Health|e-health
175811|NCT02229110|allocation of care|allocation of care
175812|NCT02229110|clinical inertia|clinical inertia
175813|NCT02229110|quality of care|quality of care
175814|NCT02229110|patient satisfaction|patient satisfaction
175815|NCT02229097|type 1 diabetes|type 1 diabetes
175816|NCT02229071|Donafenib|donafenib
175817|NCT02229071|HCC|hcc
175818|NCT02229071|Advanced|advanced
175819|NCT02229071|inoperable|inoperable
175820|NCT02229071|Phase 1B|phase 1b
175821|NCT02229058|Gastric Cancer|gastric cancer
175822|NCT02229058|Albumin Bound Paclitaxel|albumin bound paclitaxel
175823|NCT02229058|S-1|s-1
175824|NCT02229058|First Line|first line
175825|NCT02229045|gastric caner|gastric caner
175826|NCT02229045|Albumin Bound Paclitaxel|albumin bound paclitaxel
175827|NCT02229045|5-FU/CF|5-fu/cf
175828|NCT02229045|taxanes naive|taxanes naive
175829|NCT02229032|Dravet Syndrome|dravet syndrome
175830|NCT02229032|cannabidiol therapy|cannabidiol therapy
175831|NCT02229032|Charlotte's Web|charlotte's web
175832|NCT02229019|Volunteers|volunteers
175833|NCT02229019|Mealtime assistance|mealtime assistance
175834|NCT02229019|Older adults|older adults
175835|NCT02229019|Nutrition|nutrition
175836|NCT02229019|Nursing|nursing
175837|NCT02229006|Aortic aneurysm, abdominal|aortic aneurysm, abdominal
175838|NCT02229006|Sodium Fluoride|sodium fluoride
175839|NCT02229006|Positron Emission Tomography|positron emission tomography
175840|NCT02228980|Influenza|influenza
175841|NCT02228980|Trivalent influenza vaccine|trivalent influenza vaccine
175842|NCT02228980|Sanofi Pasteur Shenzhen trivalent influenza vaccine|sanofi pasteur shenzhen trivalent influenza vaccine
175843|NCT02228967|Alcohol Use|alcohol use
175844|NCT02228967|SBIRT|sbirt
175845|NCT02228967|Military|military
175846|NCT02228967|Health Behavior|health behavior
175847|NCT02228967|Emergency Room|emergency room
175848|NCT02228967|Health Promotion|health promotion
175849|NCT02228967|Formative Research|formative research
175850|NCT02228967|Randomized Trial|randomized trial
175851|NCT02228954|Clear-cell metastatic renal cell carcinoma|clear-cell metastatic renal cell carcinoma
175852|NCT02228954|Positron-Emission Tomography|positron-emission tomography
175853|NCT02228928|Peripheral Nerve Injury|peripheral nerve injury
175854|NCT02228928|Postherpetic Neuralgia|postherpetic neuralgia
175855|NCT02228889|Hernia|hernia
175856|NCT02228889|Abdominal wall reconstruction|abdominal wall reconstruction
175857|NCT02228889|Abdominal wall defect|abdominal wall defect
175858|NCT02228889|Porcine mesh|porcine mesh
175859|NCT02228889|Component separation|component separation
175860|NCT02228889|Abdominal wall tumor|abdominal wall tumor
175861|NCT02228889|Desmoid|desmoid
175862|NCT02228863|Stroke|stroke
175863|NCT02228863|Spasticity|spasticity
175864|NCT02228850|Secondary Raynaud's Phenomenon|secondary raynaud's phenomenon
175865|NCT02228850|Secondary Raynaud's Disease|secondary raynaud's disease
175866|NCT02228850|Scleroderma|scleroderma
175867|NCT02228850|Raynaud's Disease secondary to systemic sclerosis|raynaud's disease secondary to systemic sclerosis
175868|NCT02228850|CREST|crest
175869|NCT02228850|Apricus Biosciences|apricus biosciences
175870|NCT02228850|laser doppler|laser doppler
175871|NCT02228850|thermography|thermography
175872|NCT02228824|Smoking|smoking
175873|NCT02228824|Non-daily smokers|non-daily smokers
175874|NCT02228824|Ecological Momentary Assessment|ecological momentary assessment
175875|NCT02228824|Biomarkers|biomarkers
175876|NCT02228798|anticoagulant|anticoagulant
175877|NCT02228798|atrial fibrillation|atrial fibrillation
175878|NCT02228798|surgery|surgery
175879|NCT02228798|oral anticoagulant|oral anticoagulant
175880|NCT02228798|discontinue|discontinue
175881|NCT02228798|DOAC|doac
175882|NCT02228798|NOAC|noac
175883|NCT02228798|blood thinner|blood thinner
175884|NCT02228798|interruption|interruption
175885|NCT02228772|Acute lymphoblastic Leukemia|acute lymphoblastic leukemia
175886|NCT02228772|Lymphoblastic lymphoma|lymphoblastic lymphoma
175887|NCT02228772|B-cell Adult Acute Lymphoblastic Leukemia|b-cell adult acute lymphoblastic leukemia
175888|NCT02228772|T-cell Adult Acute Lymphoblastic Leukemia|t-cell adult acute lymphoblastic leukemia
175889|NCT02228759|Ambulatory home regional|ambulatory home regional
175890|NCT02228759|adductor canal block|adductor canal block
175891|NCT02228759|Postoperative pain|postoperative pain
175892|NCT02228759|total knee arthroplasty|total knee arthroplasty
175893|NCT02228759|Home regional|home regional
175894|NCT02228759|Fast track arthroplasty|fast track arthroplasty
175895|NCT02228720|Chronic Sinusitis|chronic sinusitis
175896|NCT02228720|Endoscopic Sinus Surgery|endoscopic sinus surgery
175897|NCT02228694|ADC|adc
166953|NCT02274766|LID|lid
175898|NCT02228694|Pre installation|pre installation
175899|NCT02228694|Post installation|post installation
175901|NCT02228694|Time|time
175902|NCT02228668|AVANT|avant
175903|NCT02228668|GERCOR|gercor
175904|NCT02228668|Follow up|follow up
175905|NCT02228668|Colon cancer|colon cancer
175906|NCT02228668|Bevacizumab|bevacizumab
175907|NCT02228668|Overall survival|overall survival
175908|NCT02228655|Chronic Kidney Disease|chronic kidney disease
175909|NCT02228655|CKD|ckd
175910|NCT02228655|Anemia of Chronic Illness|anemia of chronic illness
175911|NCT02228642|Type 1 diabetes|type 1 diabetes
175912|NCT02228642|Type 2 diabetes|type 2 diabetes
175913|NCT02228642|Hypoglycemia|hypoglycemia
175914|NCT02228642|Cognition disorders|cognition disorders
175915|NCT02228642|Inpatient|inpatient
175916|NCT02228629|Diabetes|diabetes
175917|NCT02228629|Foot complications|foot complications
175918|NCT02228629|plantar keratoma|plantar keratoma
175919|NCT02228629|plantar pressure|plantar pressure
175920|NCT02228616|Constipation|constipation
175921|NCT02228616|Chronic constipation|chronic constipation
175922|NCT02228616|Prucalopride|prucalopride
175923|NCT02228616|Women|women
175924|NCT02228603|exercise therapy|exercise therapy
175925|NCT02228603|rehabilitation|rehabilitation
175926|NCT02228590|Parkinson's Disease|parkinson's disease
175927|NCT02228564|Lack of perfusion in the extremities|lack of perfusion in the extremities
175928|NCT02228564|Atherosclerosis|atherosclerosis
175929|NCT02228564|Intermittent claudication|intermittent claudication
175930|NCT02228564|BOLSTER|bolster
175931|NCT02228551|Augmented renal clearance|augmented renal clearance
175932|NCT02228551|non-critically ill|non-critically ill
175933|NCT02228551|surgery|surgery
175934|NCT02228551|prevalence|prevalence
175935|NCT02228551|risk factors|risk factors
175936|NCT02228538|total knee arthroplasty|total knee arthroplasty
175937|NCT02228538|osteoarthritis|osteoarthritis
175938|NCT02228525|Selinexor (KPT-330)|selinexor (kpt-330)
175939|NCT02228525|Selective Inhibitor of Nuclear Export (SINE)|selective inhibitor of nuclear export (sine)
175940|NCT02228525|14-005|14-005
175941|NCT02228512|HHV8|hhv8
175942|NCT02228512|PEL|pel
175943|NCT02228512|Immune Modulation|immune modulation
175944|NCT02228512|CC-4047|cc-4047
175945|NCT02228512|IMiD|imid
175946|NCT02228499|asthma|asthma
175947|NCT02228499|academics|academics
175948|NCT02228499|GPA|gpa
175949|NCT02228499|attendance|attendance
175950|NCT02228447|Adolescent|adolescent
175951|NCT02228447|Randomized controlled trial|randomized controlled trial
175952|NCT02228447|Eating behavior|eating behavior
175953|NCT02228447|Physical Activity|physical activity
175954|NCT02228447|Sedentary lifestyle|sedentary lifestyle
175955|NCT02228434|Childhood obesity, intervention, effectiveness, comparison|childhood obesity, intervention, effectiveness, comparison
175956|NCT02228408|hemodialysis|hemodialysis
175957|NCT02228408|ESRD|esrd
175958|NCT02228408|Cardiovascular Disease|cardiovascular disease
175959|NCT02228408|Isosorbide Dinitrate|isosorbide dinitrate
175960|NCT02228408|Hydralazine|hydralazine
175961|NCT02228395|Single ascending doses|single ascending doses
175962|NCT02228395|pharmacokinetics|pharmacokinetics
175963|NCT02228395|safety|safety
175964|NCT02228395|tolerability|tolerability
175965|NCT02228395|healthy volunteers|healthy volunteers
175966|NCT02228395|cognitive impairment associated with schizophrenia (CIAS)|cognitive impairment associated with schizophrenia (cias)
175967|NCT02228382|Bosutinib|bosutinib
175968|NCT02228382|Chronic Myeloid Leukemia|chronic myeloid leukemia
175969|NCT02228382|CML|cml
175970|NCT02228382|Leukemia|leukemia
175971|NCT02228382|Myelogenous|myelogenous
175972|NCT02228382|Chronic|chronic
175973|NCT02228382|BC-ABL Positive|bc-abl positive
175974|NCT02228369|Non Small Cell Lung Cancer, EGFR, Tyrosine kinase inhibitor,EGFR mutation positive, Brain Metastasis, Leptomeningeal Metastasis|non small cell lung cancer, egfr, tyrosine kinase inhibitor,egfr mutation positive, brain metastasis, leptomeningeal metastasis
175975|NCT02228356|Neoplasm Metastasis|neoplasm metastasis
175976|NCT02228356|oligometastatic cancer|oligometastatic cancer
175977|NCT02228356|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
175978|NCT02228356|SBRT|sbrt
175979|NCT02228356|Real-time Tumor Tracking (RTTT)|real-time tumor tracking (rttt)
175980|NCT02228356|ITV|itv
175981|NCT02228356|Internal Target Volume|internal target volume
175982|NCT02228356|Respiratory Motion Management|respiratory motion management
175983|NCT02228356|Image-guided Radiotherapy|image-guided radiotherapy
175984|NCT02228356|IGRT|igrt
175985|NCT02228330|Transurethral resection of bladder tumors|transurethral resection of bladder tumors
175986|NCT02228330|Obturator nerve reflex|obturator nerve reflex
175987|NCT02228330|Obturator nerve block|obturator nerve block
175988|NCT02228317|Emergency Medical Dispatch|emergency medical dispatch
175989|NCT02228317|Telemedicine|telemedicine
175990|NCT02228317|Emergency Medical Services|emergency medical services
175991|NCT02228317|Pre-hospital|pre-hospital
175992|NCT02228304|Wet AMD|wet amd
175993|NCT02228304|Wet Age Related Macular Degeneration|wet age related macular degeneration
166984|NCT02274506|ALL|all
175994|NCT02228304|Recurrent CNV Secondary to AMD|recurrent cnv secondary to amd
175995|NCT02228304|Active subfoveal CNV|active subfoveal cnv
175996|NCT02228291|Polyphenols|polyphenols
175997|NCT02228291|Endothelial function|endothelial function
175998|NCT02228291|Gut barrier function|gut barrier function
175999|NCT02228278|Pediatric|pediatric
176000|NCT02228278|Obesity|obesity
176001|NCT02228278|Overweight|overweight
176002|NCT02228278|Texting|texting
176003|NCT02228278|Text message|text message
176004|NCT02228278|SMS|sms
176005|NCT02228278|Diet|diet
176006|NCT02228278|Weight Loss|weight loss
176007|NCT02228278|Nutrition|nutrition
176008|NCT02228278|Physical activity|physical activity
176009|NCT02228278|BMI z-score|bmi z-score
176010|NCT02228278|BMI|bmi
176011|NCT02228252|Proteins|proteins
176012|NCT02228252|Postprandial lipemia|postprandial lipemia
176013|NCT02228252|Pre-meal|pre-meal
176014|NCT02228252|Metabolic syndrome|metabolic syndrome
176015|NCT02228239|Healthy|healthy
176016|NCT02228239|Esketamine|esketamine
176017|NCT02228239|Mirtazapine|mirtazapine
176018|NCT02228239|Psychomotor.|psychomotor.
176019|NCT02228226|Arthroscopic Bankart repair|arthroscopic bankart repair
176020|NCT02228226|Bone hole|bone hole
176021|NCT02228226|Ossification|ossification
176022|NCT02228226|Suture anchor|suture anchor
176023|NCT02228226|Shoulder dislocation|shoulder dislocation
176024|NCT02228213|multiple sclerosis|multiple sclerosis
176025|NCT02228213|SPMS|spms
176026|NCT02228200|Oncology Nursing|oncology nursing
176027|NCT02228200|Advanced Practice Nursing|advanced practice nursing
176028|NCT02228200|Nurse-led care|nurse-led care
176029|NCT02228200|Chemotherapy|chemotherapy
176030|NCT02228174|Abnormal Uterine Bleeding associated with fibroids|abnormal uterine bleeding associated with fibroids
176031|NCT02228174|AUB-L|aub-l
176032|NCT02228174|Fibroids|fibroids
176033|NCT02228174|Heavy menstrual bleeding|heavy menstrual bleeding
176034|NCT02228174|HMB|hmb
176035|NCT02228174|Myoma|myoma
176036|NCT02228174|Menorrhagia|menorrhagia
176037|NCT02228161|Yoga|yoga
176038|NCT02228161|Work-related Stress,|work-related stress,
176039|NCT02228161|Stress Adaptation.|stress adaptation.
176040|NCT02228148|Post linguistically deafness, severe to profound deafness|post linguistically deafness, severe to profound deafness
176041|NCT02228122|Chronic wounds|chronic wounds
176042|NCT02228122|Biofilms|biofilms
176043|NCT02228122|Bacteria|bacteria
176044|NCT02228096|Chronic myeloid leukemia and relapsed/refractory Philadelphia chromosome positive acute lymphoblastic leukemia|chronic myeloid leukemia and relapsed/refractory philadelphia chromosome positive acute lymphoblastic leukemia
176045|NCT02228096|Pharmaceuticals|pharmaceuticals
176046|NCT02228096|Philadelphia chromosome positive|philadelphia chromosome positive
176047|NCT02228096|Acute Lymphoid Leukemia (ALL)|acute lymphoid leukemia (all)
176048|NCT02228096|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
176049|NCT02228083|dental|dental
176050|NCT02228083|epinephrine|epinephrine
176051|NCT02228083|local anesthetic|local anesthetic
176052|NCT02228083|lidocaine|lidocaine
176053|NCT02228083|cardiac arrhythmias|cardiac arrhythmias
176054|NCT02228083|procedure|procedure
176055|NCT02228070|strabismus|strabismus
176056|NCT02228070|oculomotor palsy|oculomotor palsy
176057|NCT02228070|abducens palsy|abducens palsy
176058|NCT02228070|trochlear palsy|trochlear palsy
176059|NCT02228057|arterial patency|arterial patency
176060|NCT02228057|upper extremity|upper extremity
176061|NCT02228057|anastomosis|anastomosis
176062|NCT02228057|sensibility|sensibility
176063|NCT02228057|pain|pain
176064|NCT02228057|cold intolerance|cold intolerance
176065|NCT02228044|suicide|suicide
176066|NCT02228044|alcohol|alcohol
176067|NCT02228044|marijuana|marijuana
176068|NCT02228044|HIV|hiv
176069|NCT02228044|prevention|prevention
176070|NCT02228044|adolescent|adolescent
176071|NCT02228031|Mirror neurons|mirror neurons
176072|NCT02228031|Imitation|imitation
176073|NCT02228031|Oxytocin|oxytocin
176074|NCT02227992|Fibrin Sealant|fibrin sealant
176075|NCT02227992|Hemostatics|hemostatics
176077|NCT02227966|Mild Cognitive Impairment|mild cognitive impairment
176078|NCT02227966|MCI|mci
176079|NCT02227966|tDCS|tdcs
176080|NCT02227966|transcranial Direct Current Stimulation|transcranial direct current stimulation
176081|NCT02227953|Alzheimer's Disease|alzheimer's disease
176082|NCT02227953|AD|ad
176083|NCT02227953|tDCS|tdcs
176084|NCT02227953|transcranial direct current stimulation|transcranial direct current stimulation
176085|NCT02227927|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
176086|NCT02227927|GERD|gerd
176087|NCT02227927|Gastroparesis|gastroparesis
176088|NCT02227927|Domperidone|domperidone
176089|NCT02227888|CF|cf
176090|NCT02227888|F508Del|f508del
176091|NCT02227888|Cavosonstat|cavosonstat
176092|NCT02227888|N91115|n91115
176093|NCT02227849|insulin resistance|insulin resistance
176094|NCT02227836|Allergy Patch testing|allergy patch testing
214347|NCT02052206|3D|3d
176095|NCT02227836|Eosinophilic Esophagitis|eosinophilic esophagitis
176096|NCT02227836|EoE|eoe
176097|NCT02227823|spinal muscular atrophy type 3|spinal muscular atrophy type 3
176098|NCT02227823|electromyography|electromyography
176099|NCT02227823|fatigability|fatigability
176100|NCT02227823|decrement|decrement
176101|NCT02227810|Prolong mechanical ventilator,|prolong mechanical ventilator,
176102|NCT02227810|Electrical stimulation,|electrical stimulation,
176103|NCT02227810|Activities of daily life,|activities of daily life,
176104|NCT02227810|Hospitalization outcomes.|hospitalization outcomes.
176105|NCT02227797|stem cell transplant|stem cell transplant
176106|NCT02227797|hematopoietic stem cell transplant|hematopoietic stem cell transplant
176107|NCT02227797|fungal infection|fungal infection
176108|NCT02227797|voriconazole|voriconazole
176109|NCT02227797|pediatric|pediatric
176110|NCT02227719|after augmentation|after augmentation
176111|NCT02227719|procedure|procedure
176112|NCT02227706|Fibrin Sealant|fibrin sealant
176113|NCT02227706|Hemostatics|hemostatics
176114|NCT02227706|Coagulants|coagulants
176115|NCT02227693|Thrombocytopenia|thrombocytopenia
176116|NCT02227693|Chronic Liver Disease|chronic liver disease
176117|NCT02227680|music therapy|music therapy
176118|NCT02227680|massage therapy|massage therapy
176119|NCT02227667|MEDI4736|medi4736
176121|NCT02227654|Ovary|ovary
176122|NCT02227654|Cancer|cancer
176123|NCT02227654|Morphology|morphology
176124|NCT02227654|Surgery|surgery
176125|NCT02227641|CMV|cmv
176126|NCT02227641|Cytomegalovirus|cytomegalovirus
176127|NCT02227641|EBV|ebv
176128|NCT02227641|Epstein Barr Virus|epstein barr virus
176129|NCT02227641|virus|virus
176130|NCT02227641|T cell|t cell
176131|NCT02227641|adoptive transfer|adoptive transfer
176132|NCT02227641|transplantation|transplantation
176133|NCT02227641|allogeneic|allogeneic
176134|NCT02227589|adolescent,|adolescent,
176135|NCT02227589|alcohol abuse|alcohol abuse
176136|NCT02227589|depression,|depression,
176137|NCT02227589|cognitive behavior therapy|cognitive behavior therapy
176138|NCT02227589|cannabis abuse|cannabis abuse
176139|NCT02227576|glioblastoma, thrombocytopenia, temozolomide, chemotherapy|glioblastoma, thrombocytopenia, temozolomide, chemotherapy
176140|NCT02227563|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
176141|NCT02227563|left superior temporal gyrus|left superior temporal gyrus
176142|NCT02227563|auditory hallucinations|auditory hallucinations
176143|NCT02227563|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
176144|NCT02227550|Atrilal fibrillation|atrilal fibrillation
176145|NCT02227550|anticoagulation|anticoagulation
176146|NCT02227550|prevention of peri-procedural complication|prevention of peri-procedural complication
176147|NCT02227550|catheter ablation|catheter ablation
176148|NCT02227537|Adolescence Idiopathic Scoliosis|adolescence idiopathic scoliosis
176149|NCT02227537|nighttime Bracing|nighttime bracing
176150|NCT02227537|Providence|providence
176151|NCT02227524|Multiple Sclerosis|multiple sclerosis
176152|NCT02227524|Walking|walking
176153|NCT02227524|Gait|gait
176154|NCT02227511|fruit, nuts, liver fat, insulin, glucose|fruit, nuts, liver fat, insulin, glucose
176155|NCT02227511|Focus of the study is to compare the often given advice to eat fruit, containing large amount of glucose and fructose, with nuts that are more rich in fat.|focus of the study is to compare the often given advice to eat fruit, containing large amount of glucose and fructose, with nuts that are more rich in fat.
176156|NCT02227485|Gingivitis|gingivitis
176157|NCT02227485|Diabetes mellitus|diabetes mellitus
176158|NCT02227485|Medicine, Traditional|medicine, traditional
176159|NCT02227485|Herbal medicine|herbal medicine
176160|NCT02227485|Punica granatum|punica granatum
176161|NCT02227446|Surgical site infection risk prevention|surgical site infection risk prevention
176162|NCT02227446|Bacterial species type and antibacterial sensitives|bacterial species type and antibacterial sensitives
176163|NCT02227433|Hodgkin Lymphoma, Elderly Patients, brentuximab vedotin (BV)|hodgkin lymphoma, elderly patients, brentuximab vedotin (bv)
176164|NCT02227407|SCI|sci
176165|NCT02227407|SMA|sma
176166|NCT02227407|Paralysis|paralysis
176167|NCT02227394|Asthma|asthma
176168|NCT02227394|Functional Respiratory Imaging|functional respiratory imaging
176169|NCT02227394|Computational Fluid Dynamic|computational fluid dynamic
176170|NCT02227368|Myocardial Infarction|myocardial infarction
176171|NCT02227368|Peripheral Arterial disease|peripheral arterial disease
176172|NCT02227368|Mycardial Ischemia|mycardial ischemia
176173|NCT02227368|Heart Diseases|heart diseases
176174|NCT02227368|Cardiovascular Diseases|cardiovascular diseases
176175|NCT02227368|Vascular Diseases|vascular diseases
176176|NCT02227368|Altherosclerosis|altherosclerosis
176177|NCT02227368|Arteriosclerosis|arteriosclerosis
176178|NCT02227368|Arterial Occlusive Diseases|arterial occlusive diseases
176179|NCT02227368|Peripheral Vascular Diseases|peripheral vascular diseases
176180|NCT02227368|Ticagrelor|ticagrelor
176181|NCT02227368|Ticlopidine|ticlopidine
176182|NCT02227368|Platelet Aggregation inhibitors|platelet aggregation inhibitors
176183|NCT02227368|Hematologic Agents|hematologic agents
176184|NCT02227368|Therapeutic Uses|therapeutic uses
176185|NCT02227368|Pharmacologic Actions|pharmacologic actions
176186|NCT02227368|Purinegic P2Y Receptor Antagonists|purinegic p2y receptor antagonists
176187|NCT02227368|Purinegic P2 Receptor Antagonists|purinegic p2 receptor antagonists
176188|NCT02227368|Purinergic Antagonists|purinergic antagonists
176189|NCT02227368|Purinergic Agents|purinergic agents
665117|NCT00829114|SAE|sae
176190|NCT02227368|Neurotransmitter Agents|neurotransmitter agents
176191|NCT02227368|Molecular Mechanisms of Pharmacological Actions|molecular mechanisms of pharmacological actions
176393|NCT02226367|military|military
176192|NCT02227368|Physiological Effects of Drugs|physiological effects of drugs
176193|NCT02227368|Fibrinolytic Agents|fibrinolytic agents
176194|NCT02227368|Crardiovascular Agents|crardiovascular agents
176195|NCT02227355|Parkinson's Disease|parkinson's disease
176196|NCT02227355|Neupro®|neupro®
176197|NCT02227355|Rotigotine|rotigotine
176198|NCT02227355|Transdermal patch|transdermal patch
176199|NCT02227355|NEUPART|neupart
176200|NCT02227355|Levodopa|levodopa
176201|NCT02227355|Noninterventional|noninterventional
176202|NCT02227355|Combination therapy|combination therapy
176203|NCT02227329|Home parenteral Nutrition|home parenteral nutrition
176204|NCT02227329|Quality of Life|quality of life
176205|NCT02227329|infection prevention|infection prevention
176206|NCT02227329|CRBSI|crbsi
176207|NCT02227329|Ethanol lock therapy|ethanol lock therapy
176208|NCT02227316|Uterine Fibroid Embolization|uterine fibroid embolization
176209|NCT02227316|Pain|pain
176210|NCT02227316|UFE|ufe
176211|NCT02227316|Fibroids|fibroids
176212|NCT02227316|Adenomyosis|adenomyosis
176213|NCT02227316|Bleeding|bleeding
176214|NCT02227316|IV Acetaminophen|iv acetaminophen
176215|NCT02227316|IV Ibuprofen|iv ibuprofen
176216|NCT02227316|Menorrhagia|menorrhagia
176217|NCT02227316|Leiomyoma|leiomyoma
176218|NCT02227316|Patient Satisfaction|patient satisfaction
176219|NCT02227290|Tinea Corporis|tinea corporis
176220|NCT02227290|Ringworm|ringworm
176221|NCT02227277|HIV|hiv
176222|NCT02227277|HIV-1|hiv-1
176223|NCT02227277|Pegintron|pegintron
176224|NCT02227277|Peg-IFN-α2b|peg-ifn-α2b
176225|NCT02227277|Viral suppression|viral suppression
176226|NCT02227277|ART cessation|art cessation
176227|NCT02227277|Immune function|immune function
176228|NCT02227277|Innate immunity|innate immunity
176229|NCT02227277|Toxicity|toxicity
176230|NCT02227277|Immune-based therapy|immune-based therapy
176231|NCT02227277|Treatment interruption|treatment interruption
176232|NCT02227277|HIV Cure|hiv cure
176233|NCT02227277|HIV Eradication|hiv eradication
176234|NCT02227277|BEAT-HIV|beat-hiv
176235|NCT02227277|HIV Cure Trial|hiv cure trial
176236|NCT02227277|Cure Trial|cure trial
176237|NCT02227264|Primary hyperparathyroidism|primary hyperparathyroidism
176238|NCT02227264|Calcimimetic Agents|calcimimetic agents
176239|NCT02227264|Parathyroid adenomectomy|parathyroid adenomectomy
176240|NCT02227251|Diffuse large B-cell Lymphoma|diffuse large b-cell lymphoma
176241|NCT02227251|DLBCL|dlbcl
176242|NCT02227251|Karyopharm|karyopharm
176243|NCT02227251|KPT-330|kpt-330
176244|NCT02227251|selinexor|selinexor
176245|NCT02227238|integrase inhibitor|integrase inhibitor
176246|NCT02227238|non-inferiority|non-inferiority
176247|NCT02227238|dolutegravir|dolutegravir
176248|NCT02227238|lopinavir/ritonavir|lopinavir/ritonavir
176249|NCT02227238|second-line treatment|second-line treatment
176250|NCT02227238|HIV-1|hiv-1
176251|NCT02227238|antiretroviral therapy-experienced|antiretroviral therapy-experienced
176252|NCT02227225|Postoperative Delirium|postoperative delirium
176253|NCT02227186|Influenza vaccination rates|influenza vaccination rates
176254|NCT02227147|Neurotrophic Keratitis|neurotrophic keratitis
176255|NCT02227108|pediatric cancer,pediatric acute lymphoblastic leukemia, lymphoblastic lymphoma, B-cell leukemia, ALL, moxetumomab pasudotox, CD22|pediatric cancer,pediatric acute lymphoblastic leukemia, lymphoblastic lymphoma, b-cell leukemia, all, moxetumomab pasudotox, cd22
176256|NCT02227082|radiotherapy|radiotherapy
176257|NCT02227082|olaparib|olaparib
176258|NCT02227082|breast cancer|breast cancer
176259|NCT02227082|locally advanced breast cancer|locally advanced breast cancer
176260|NCT02227056|Acquired pediatric brain injury|acquired pediatric brain injury
176261|NCT02227056|Methylphenidate|methylphenidate
176262|NCT02227056|Traumatic brain injury|traumatic brain injury
176263|NCT02227056|Cerebrovascular event|cerebrovascular event
176264|NCT02227056|Hypoxic ischemic brain injury|hypoxic ischemic brain injury
176265|NCT02227056|Function (ecologic)|function (ecologic)
176267|NCT02227004|Magnetic Resonance Imaging|magnetic resonance imaging
176268|NCT02227004|pacemakers|pacemakers
176269|NCT02227004|ICD|icd
176270|NCT02226965|PNT2258|pnt2258
176271|NCT02226965|DLBCL|dlbcl
176272|NCT02226965|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
176273|NCT02226965|NHL|nhl
176274|NCT02226965|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
176275|NCT02226965|Lymphoma|lymphoma
176276|NCT02226913|Buffered|buffered
176277|NCT02226913|inferior alveolar nerve block|inferior alveolar nerve block
176278|NCT02226913|irreversible pulpitis|irreversible pulpitis
176279|NCT02226913|local anesthesia|local anesthesia
167315|NCT02272686|SCT|sct
176280|NCT02226913|sodium bicarbonate|sodium bicarbonate
176281|NCT02226900|Multivessel Coronary Artery Disease|multivessel coronary artery disease
176282|NCT02226900|Hybrid Revascularization|hybrid revascularization
176283|NCT02226887|Loop ileostomy|loop ileostomy
176284|NCT02226887|Eventration|eventration
176285|NCT02226874|Dose Estimation|dose estimation
176286|NCT02226874|Dose Reconstruction|dose reconstruction
176287|NCT02226874|Methods|methods
176288|NCT02226874|Fallout|fallout
176289|NCT02226874|Radiation Exposure|radiation exposure
176290|NCT02226861|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
176291|NCT02226861|MDS|mds
176292|NCT02226861|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
176293|NCT02226861|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
176294|NCT02226861|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
176295|NCT02226848|Endothelial Progenitor Cells|endothelial progenitor cells
176296|NCT02226848|Angiogenesis|angiogenesis
176297|NCT02226848|Traumatic Brain Injury|traumatic brain injury
176298|NCT02226835|OCT|oct
176299|NCT02226835|Alzheimer's Disease|alzheimer's disease
176300|NCT02226835|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
176301|NCT02226822|Type 2 diabetes mellitus|type 2 diabetes mellitus
176302|NCT02226809|Muscle relaxants|muscle relaxants
176303|NCT02226809|Postoperative complications, respiratory|postoperative complications, respiratory
176304|NCT02226809|General anesthesia|general anesthesia
176305|NCT02226809|Postanesthesia care unit|postanesthesia care unit
176306|NCT02226809|Neuromuscular block reversal|neuromuscular block reversal
176307|NCT02226796|Broca's Aphasia|broca's aphasia
176308|NCT02226796|Transcranial Direct Current Stimulation|transcranial direct current stimulation
176309|NCT02226783|Phase I|phase i
176310|NCT02226783|Healthy subjects|healthy subjects
176311|NCT02226783|PK|pk
176312|NCT02226783|PD|pd
176313|NCT02226757|NSCLC|nsclc
176314|NCT02226757|HER2-expression|her2-expression
176315|NCT02226757|EGFR-mutation|egfr-mutation
176316|NCT02226757|Trastuzumab|trastuzumab
176317|NCT02226757|Paclitaxel|paclitaxel
176318|NCT02226744|breathing|breathing
176319|NCT02226744|mind-body practices|mind-body practices
176320|NCT02226744|yoga|yoga
176321|NCT02226744|meditation|meditation
176322|NCT02226731|Immediate postpartum hemorrhage|immediate postpartum hemorrhage
176323|NCT02226731|Intrauterine balloon tamponade|intrauterine balloon tamponade
176324|NCT02226705|Rhinocerebral Mucormycosis|rhinocerebral mucormycosis
176325|NCT02226705|Surgery|surgery
176326|NCT02226705|Fungal Infection|fungal infection
176327|NCT02226705|Survival|survival
176328|NCT02226692|chronic low back pain|chronic low back pain
176329|NCT02226692|prognostic factors|prognostic factors
176330|NCT02226692|disabling low back pain|disabling low back pain
176331|NCT02226692|lumbar muscle activity|lumbar muscle activity
176332|NCT02226692|start back screening tool|start back screening tool
176333|NCT02226692|physical evaluation|physical evaluation
176334|NCT02226679|crossover|crossover
176335|NCT02226679|rollover study|rollover study
176336|NCT02226679|open label|open label
176337|NCT02226666|MRI|mri
176338|NCT02226666|Eovist|eovist
176339|NCT02226666|MultiHance|multihance
176340|NCT02226601|drowsiness|drowsiness
176341|NCT02226601|loopiness|loopiness
176342|NCT02226601|nausea|nausea
176343|NCT02226575|Sense of coherence|sense of coherence
176344|NCT02226549|hepatitis C|hepatitis c
176345|NCT02226549|Gilead|gilead
176346|NCT02226549|GS-9451|gs-9451
176347|NCT02226536|Posture|posture
176348|NCT02226536|Vertigo|vertigo
176349|NCT02226536|glucose metabolism|glucose metabolism
176350|NCT02226536|diet|diet
176351|NCT02226536|scales|scales
176352|NCT02226536|dinamic posturography|dinamic posturography
176353|NCT02226523|immunomagnetic reduction|immunomagnetic reduction
176354|NCT02226523|acute coronary syndrome|acute coronary syndrome
176355|NCT02226523|serum biomarkers|serum biomarkers
176356|NCT02226484|Gastroesophageal reflux disease|gastroesophageal reflux disease
176357|NCT02226484|GERD|gerd
176358|NCT02226484|Acid reflux|acid reflux
176359|NCT02226484|Reflux|reflux
176360|NCT02226484|Quercetin|quercetin
176361|NCT02226458|Autism|autism
176362|NCT02226458|Mitochondrial Disorders|mitochondrial disorders
176363|NCT02226458|EPI-743|epi-743
176364|NCT02226458|EPI743|epi743
176365|NCT02226458|Rett syndrome|rett syndrome
176366|NCT02226458|Angelman syndrome|angelman syndrome
176369|NCT02226432|Barthel Scale|barthel scale
176370|NCT02226432|Disability|disability
176371|NCT02226432|Modified Ashworth Scale|modified ashworth scale
176372|NCT02226432|Right Arm|right arm
176373|NCT02226432|Neuromodulation|neuromodulation
176374|NCT02226432|Spasticity|spasticity
176375|NCT02226432|Stroke|stroke
176376|NCT02226419|Fatty acid oxidation disorder|fatty acid oxidation disorder
176377|NCT02226419|Primary carnitine deficiency|primary carnitine deficiency
176378|NCT02226419|Exercise|exercise
176379|NCT02226419|L-carnitine treatment|l-carnitine treatment
176380|NCT02226419|Stable isotopes|stable isotopes
176381|NCT02226419|Carnitine transporter deficiency|carnitine transporter deficiency
176382|NCT02226406|Early Physical Exercise|early physical exercise
176383|NCT02226406|Alveolar Recruitment|alveolar recruitment
176384|NCT02226406|Electrical Impedance Tomography|electrical impedance tomography
176385|NCT02226406|Oxygenation|oxygenation
176386|NCT02226406|Ventilation|ventilation
176387|NCT02226393|Toddlers; Preschoolers; PTSD|toddlers; preschoolers; ptsd
176388|NCT02226367|prazosin|prazosin
176389|NCT02226367|alcohol use disorders|alcohol use disorders
176390|NCT02226367|posttraumatic stress disorder|posttraumatic stress disorder
176391|NCT02226367|PTSD|ptsd
176392|NCT02226367|combat trauma|combat trauma
176394|NCT02226367|alpha-1 adrenoreceptor antagonist|alpha-1 adrenoreceptor antagonist
176395|NCT02226354|Dietary vegetable oil|dietary vegetable oil
176396|NCT02226354|Stearidonic acid|stearidonic acid
176397|NCT02226354|Tissue|tissue
176398|NCT02226354|Fatty Acid|fatty acid
176399|NCT02226354|composition|composition
176400|NCT02226341|Lupus|lupus
176401|NCT02226341|Lupus Nephritis|lupus nephritis
176402|NCT02226341|ACTHar|acthar
176403|NCT02226341|Columbia|columbia
176404|NCT02226341|Rheumatology|rheumatology
176405|NCT02226341|CUMC|cumc
176406|NCT02226341|Autoimmune|autoimmune
176407|NCT02226341|SLE|sle
176408|NCT02226341|Proliferative Lupus Nephritis|proliferative lupus nephritis
176409|NCT02226315|noninvasive prenatal testing|noninvasive prenatal testing
176410|NCT02226302|Endometrial cancer|endometrial cancer
176411|NCT02226302|Obesity|obesity
176412|NCT02226289|bevacizumab|bevacizumab
176413|NCT02226289|refractory|refractory
176414|NCT02226289|colorectal cancer|colorectal cancer
176415|NCT02226289|metastatic|metastatic
176416|NCT02226263|Necrotizing enterocolitis|necrotizing enterocolitis
176417|NCT02226263|Probiotics|probiotics
176418|NCT02226263|Preterm newborns|preterm newborns
176419|NCT02226250|sugar-based beverage|sugar-based beverage
176420|NCT02226250|Time Influence|time influence
176421|NCT02226237|urinary incontinence|urinary incontinence
176422|NCT02226237|erectile dysfunction|erectile dysfunction
176423|NCT02226237|Retropubic Prostatectomy|retropubic prostatectomy
176424|NCT02226237|Physiotherapy|physiotherapy
176425|NCT02226224|gastrointestinal neoplasms|gastrointestinal neoplasms
176426|NCT02226224|endosonography|endosonography
176427|NCT02226224|in vitro|in vitro
176428|NCT02226224|Staging|staging
176429|NCT02226198|LDL-C|ldl-c
176430|NCT02226198|HoFH|hofh
176431|NCT02226198|Hyperlipidemia|hyperlipidemia
176432|NCT02226172|Primary myelofibrosis|primary myelofibrosis
176433|NCT02226172|Secondary myelofibrosis|secondary myelofibrosis
176434|NCT02226172|PMF|pmf
176435|NCT02226172|PET-MF|pet-mf
176436|NCT02226172|PPV-MF|ppv-mf
176437|NCT02226172|Ruxolitinib resistant or intolerant|ruxolitinib resistant or intolerant
176438|NCT02226172|previously treated myelofibrosis|previously treated myelofibrosis
176439|NCT02226172|smoothened inhibitor|smoothened inhibitor
176440|NCT02226172|oral|oral
176441|NCT02226172|single agent.|single agent.
176442|NCT02226159|cervical|cervical
176443|NCT02226159|radicular pain|radicular pain
176444|NCT02226159|transforaminal epidural steroid injections|transforaminal epidural steroid injections
176445|NCT02226146|Pemphigoid Bullous|pemphigoid bullous
176446|NCT02226146|Bullous|bullous
176447|NCT02226146|Blisters|blisters
176448|NCT02226146|SKIN DISEASES|skin diseases
176449|NCT02226146|BP|bp
176450|NCT02226120|LCZ696, chronic heart failure, open-label study, ARNI|lcz696, chronic heart failure, open-label study, arni
176451|NCT02226107|Lay health worker|lay health worker
176452|NCT02226107|Patient navigation|patient navigation
176453|NCT02226107|Screening colonoscopy|screening colonoscopy
176454|NCT02226107|Colon cancer|colon cancer
176455|NCT02226107|Training|training
176456|NCT02226107|Hispanic|hispanic
176457|NCT02226107|Latino|latino
176458|NCT02226094|intra-ocular pressure|intra-ocular pressure
176459|NCT02226094|primary open-angle glaucoma|primary open-angle glaucoma
176460|NCT02226094|intra ocular pressure|intra ocular pressure
176461|NCT02226094|primary open angle glaucoma|primary open angle glaucoma
176462|NCT02226094|glaucoma|glaucoma
176463|NCT02226094|deep wave trabeculoplasty|deep wave trabeculoplasty
176464|NCT02226094|ocular hypertension|ocular hypertension
176465|NCT02226081|breast lesion|breast lesion
176466|NCT02226081|ultrasound|ultrasound
176467|NCT02226081|BI-RADS|bi-rads
176468|NCT02226081|women|women
176469|NCT02226081|malignancy|malignancy
176470|NCT02226068|Atopic dermatitis|atopic dermatitis
176471|NCT02226068|Ciclosporine|ciclosporine
176472|NCT02226068|Extracorporal photopheresis|extracorporal photopheresis
176473|NCT02226055|Chronic kidney disease of unknown origin|chronic kidney disease of unknown origin
176474|NCT02226055|Chronic kidney disease of unknown aetiology|chronic kidney disease of unknown aetiology
176475|NCT02226055|Sri Lanka|sri lanka
176476|NCT02226055|CKDu|ckdu
176477|NCT02226055|Arterial stiffness|arterial stiffness
176478|NCT02226055|Cardiovascular risk|cardiovascular risk
176479|NCT02226055|North Central Province|north central province
176480|NCT02226029|MRI, fat fraction, stomach, lipid emulsion|mri, fat fraction, stomach, lipid emulsion
176481|NCT02226016|ptosis|ptosis
176482|NCT02226016|blepharochalasis|blepharochalasis
176483|NCT02226016|dermatochalasis|dermatochalasis
176484|NCT02225990|stroke|stroke
665118|NCT00829114|ULN|uln
176485|NCT02225990|stroke rehabilitation|stroke rehabilitation
176486|NCT02225990|stroke therapy|stroke therapy
176487|NCT02225964|APOEε4|apoeε4
176488|NCT02225938|Intensive Care|intensive care
176489|NCT02225938|Recovery|recovery
176490|NCT02225938|Long term outcome|long term outcome
176491|NCT02225938|Function|function
176492|NCT02225925|brachytherapy|brachytherapy
176493|NCT02225886|Renal anaemia|renal anaemia
176494|NCT02225886|Intravenous ascorbic acid|intravenous ascorbic acid
176495|NCT02225886|Intravenous iron administration|intravenous iron administration
176496|NCT02225860|ADPKD|adpkd
176497|NCT02225860|Copeptin|copeptin
176498|NCT02225860|Vasopressin|vasopressin
176499|NCT02225860|Diet|diet
176500|NCT02225860|Water|water
176501|NCT02225847|Gardening|gardening
176502|NCT02225847|Therapeutic Horticulture|therapeutic horticulture
176503|NCT02225847|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
176504|NCT02225847|Psychometric Assessment|psychometric assessment
176505|NCT02225847|Stress|stress
176506|NCT02225847|Depression|depression
176507|NCT02225847|Anxiety|anxiety
176508|NCT02225847|Quality of Life|quality of life
176509|NCT02225847|Wellness|wellness
176510|NCT02225834|Atorvastatin, ischemic stroke, cytokines|atorvastatin, ischemic stroke, cytokines
176511|NCT02225821|Implant Removal|implant removal
176512|NCT02225821|Antibiotic Prophylaxis|antibiotic prophylaxis
176513|NCT02225821|Postoperative wound infection|postoperative wound infection
176514|NCT02225821|Orthopedics|orthopedics
176515|NCT02225808|CBT|cbt
176516|NCT02225808|autism|autism
176517|NCT02225808|anxiety|anxiety
176518|NCT02225808|treatment|treatment
176519|NCT02225808|fMRI|fmri
176520|NCT02225795|Crohn's Disease|crohn's disease
176521|NCT02225795|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
176522|NCT02225795|Children|children
176523|NCT02225795|Young Adults|young adults
176524|NCT02225782|Alteplase; Hemodialysis Catheter; Occlusion; Renal Failure|alteplase; hemodialysis catheter; occlusion; renal failure
176525|NCT02225769|fever|fever
176526|NCT02225769|point-of-care tests|point-of-care tests
176527|NCT02225769|clinical algorithms|clinical algorithms
176528|NCT02225769|electronic support|electronic support
176529|NCT02225769|host biomarkers|host biomarkers
176530|NCT02225756|Drug therapy|drug therapy
176531|NCT02225756|Prevention and control|prevention and control
176532|NCT02225756|Healing|healing
176533|NCT02225756|Tissue regeneration|tissue regeneration
176534|NCT02225756|Therapy|therapy
176535|NCT02225743|Hypothermia|hypothermia
176536|NCT02225743|Total Hip Joint Prosthesis|total hip joint prosthesis
176537|NCT02225743|Total Knee Joint Prosthesis|total knee joint prosthesis
176538|NCT02225717|Preterm labor|preterm labor
176539|NCT02225717|cervicovaginal secretions|cervicovaginal secretions
176540|NCT02225717|markers of fetal membranes remodelling|markers of fetal membranes remodelling
176541|NCT02225717|Multiplex test|multiplex test
176542|NCT02225691|type 1 diabetes|type 1 diabetes
176543|NCT02225691|type 2 diabetes|type 2 diabetes
176544|NCT02225691|paired testing|paired testing
176545|NCT02225678|healthy volunteers|healthy volunteers
176546|NCT02225678|asthma|asthma
176547|NCT02225678|sputum eosinophils|sputum eosinophils
176548|NCT02225639|ADHD|adhd
176549|NCT02225639|Adult|adult
176550|NCT02225613|Cruciate ligament injury|cruciate ligament injury
176551|NCT02225613|Balance control|balance control
176552|NCT02225613|Rehabilitation|rehabilitation
176553|NCT02225613|Spa therapy|spa therapy
176554|NCT02225613|Sport|sport
176555|NCT02225600|Borderline Personality Disorder|borderline personality disorder
176556|NCT02225600|BPD|bpd
176557|NCT02225600|Intranasal oxytocin|intranasal oxytocin
176558|NCT02225574|Leukemia|leukemia
176559|NCT02225574|Advanced phase chronic myeloid leukemia|advanced phase chronic myeloid leukemia
176560|NCT02225574|refractory chronic phase chronic myeloid leukemia|refractory chronic phase chronic myeloid leukemia
176561|NCT02225574|CML|cml
176562|NCT02225574|Accelerated phase|accelerated phase
176563|NCT02225574|(AP)|(ap)
176564|NCT02225574|Blast phase|blast phase
176565|NCT02225574|(BP)|(bp)
176566|NCT02225574|Philadelphia-positive acute leukemia|philadelphia-positive acute leukemia
176567|NCT02225574|MEK-162|mek-162
176568|NCT02225574|Nilotinib|nilotinib
176569|NCT02225574|AMN107|amn107
176570|NCT02225574|Tasigna|tasigna
176571|NCT02225574|Questionnaires|questionnaires
176572|NCT02225574|Surveys|surveys
176573|NCT02225561|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
176574|NCT02225561|Nitroprusside|nitroprusside
176575|NCT02225561|Transthoracic|transthoracic
176576|NCT02225561|Impedances|impedances
176577|NCT02225535|low back pain|low back pain
176578|NCT02225535|telehealth|telehealth
176579|NCT02225535|videoconferencing|videoconferencing
176580|NCT02225535|access to physical therapy|access to physical therapy
176581|NCT02225535|interprofessional care|interprofessional care
176582|NCT02225535|rural health|rural health
176583|NCT02225522|Intensive Care Units, Neonatal|intensive care units, neonatal
176584|NCT02225522|Infant, Newborn|infant, newborn
665119|NCT00829114|WB|wb
176585|NCT02225522|Genetic Diseases, Inborn|genetic diseases, inborn
176586|NCT02225509|Thyroid cancer|thyroid cancer
176587|NCT02225509|Thyroid cancer diagnostic|thyroid cancer diagnostic
176588|NCT02225509|Thyroid nodule|thyroid nodule
176589|NCT02225509|Fine needle aspiration biopsy|fine needle aspiration biopsy
176590|NCT02225509|Indeterminate cytological result|indeterminate cytological result
176591|NCT02225509|Molecular diagnostic|molecular diagnostic
176592|NCT02225509|Transcriptomics|transcriptomics
176593|NCT02225509|Molecular signature|molecular signature
176594|NCT02225496|Oropharyngeal cancer|oropharyngeal cancer
176595|NCT02225496|Oropharynx|oropharynx
176596|NCT02225496|Human papilloma virus|human papilloma virus
176597|NCT02225496|HPV positive|hpv positive
176598|NCT02225496|Squamous cell carcinoma|squamous cell carcinoma
176599|NCT02225496|SCC|scc
176600|NCT02225496|Transoral robotic surgery|transoral robotic surgery
176601|NCT02225496|TORS|tors
176602|NCT02225496|Intuitive Surgical da Vinci Surgical System|intuitive surgical da vinci surgical system
176603|NCT02225496|Modified barium swallow|modified barium swallow
176604|NCT02225496|MBS|mbs
176605|NCT02225496|Questionnaires|questionnaires
176606|NCT02225496|Surveys|surveys
176607|NCT02225496|Speech and swallowing function|speech and swallowing function
176608|NCT02225470|Locally Recurrent or Metastatic Breast Cancer|locally recurrent or metastatic breast cancer
176609|NCT02225457|insulin resistance|insulin resistance
176610|NCT02225457|type 2 diabetes|type 2 diabetes
176611|NCT02225457|obesity|obesity
176612|NCT02225457|polyphenols|polyphenols
176613|NCT02225457|adipose tissue|adipose tissue
176614|NCT02225457|overfeeding|overfeeding
176615|NCT02225444|degenerative lumbosacral spine disease|degenerative lumbosacral spine disease
176616|NCT02225444|posterolateral fusion evaluation|posterolateral fusion evaluation
176617|NCT02225444|OsteoAMP growth factor|osteoamp growth factor
176618|NCT02225444|autograft|autograft
176619|NCT02225431|Contrast-induced nephropathy|contrast-induced nephropathy
176620|NCT02225431|Contrast-Induced acute kidney injury|contrast-induced acute kidney injury
176621|NCT02225431|Contrast media|contrast media
176622|NCT02225431|Angiography|angiography
176623|NCT02225431|Coronary percutaneous intervention|coronary percutaneous intervention
176624|NCT02225418|Laparoscopic|laparoscopic
176625|NCT02225418|Cholecystectomy|cholecystectomy
176626|NCT02225418|Postoperative|postoperative
176627|NCT02225418|Pain|pain
176628|NCT02225418|Quadratus lumborum|quadratus lumborum
176629|NCT02225418|Ultrasound|ultrasound
176630|NCT02225405|Lung Cancer|lung cancer
176631|NCT02225405|Non-small Cell Lung Cancers|non-small cell lung cancers
176632|NCT02225405|NCLC|nclc
176633|NCT02225405|Chemotherapy|chemotherapy
176634|NCT02225405|Nintedanib|nintedanib
176635|NCT02225405|BIBF 1120|bibf 1120
176636|NCT02225405|Cisplatin|cisplatin
176637|NCT02225405|Platinol-AQ|platinol-aq
176638|NCT02225405|Platinol|platinol
176639|NCT02225405|CDDP|cddp
176640|NCT02225405|Docetaxel|docetaxel
176641|NCT02225405|Taxotere|taxotere
176642|NCT02225392|Bronchial thermoplasty|bronchial thermoplasty
176643|NCT02225392|Severe asthma|severe asthma
176644|NCT02225379|Type 1 Diabetes|type 1 diabetes
176645|NCT02225379|Hypoglycemia detection|hypoglycemia detection
176646|NCT02225379|Non-invasive sensor|non-invasive sensor
176647|NCT02225379|Nocturnal hypoglycemia|nocturnal hypoglycemia
176648|NCT02225366|Melanoma|melanoma
176649|NCT02225366|Metastatic|metastatic
176650|NCT02225366|Antimicrobial peptide|antimicrobial peptide
176651|NCT02225366|LL37|ll37
176652|NCT02225366|Photographs|photographs
176653|NCT02225353|Cervical Pessaries|cervical pessaries
176654|NCT02225353|Progesterone|progesterone
176655|NCT02225314|Parkinson's Disease|parkinson's disease
176656|NCT02225314|Mild Cognitive Impairment|mild cognitive impairment
176657|NCT02225301|Child maltreatment|child maltreatment
176658|NCT02225301|Child Care|child care
176659|NCT02225301|Knowledge|knowledge
176660|NCT02225301|Attitude|attitude
176661|NCT02225288|Healthy Subjects|healthy subjects
176662|NCT02225288|Japanese|japanese
176663|NCT02225288|Males|males
176664|NCT02225275|Leukemia|leukemia
176665|NCT02225275|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
176666|NCT02225275|CLL|cll
176667|NCT02225275|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
176668|NCT02225275|SLL|sll
176669|NCT02225275|Recurrent|recurrent
176670|NCT02225275|Lenalidomide|lenalidomide
176673|NCT02225275|Obinutuzumab|obinutuzumab
176674|NCT02225275|GA101|ga101
176675|NCT02225275|Gazyva|gazyva
176676|NCT02225262|Prostate cancer|prostate cancer
176677|NCT02225262|CyberKnife|cyberknife
176678|NCT02225262|Stereotactic|stereotactic
176679|NCT02225262|Radiation|radiation
176680|NCT02225236|executive functioning|executive functioning
176681|NCT02225236|metacognition|metacognition
176682|NCT02225236|self-regulation|self-regulation
176683|NCT02225236|preschoolers|preschoolers
176684|NCT02225223|metastatic lesions|metastatic lesions
176685|NCT02225223|vertebral body|vertebral body
176686|NCT02225223|ablation|ablation
176687|NCT02225223|radiation|radiation
176688|NCT02225223|targeted radio-frequency ablation|targeted radio-frequency ablation
176689|NCT02225223|radio-frequency targeted vertebral augmentation|radio-frequency targeted vertebral augmentation
176690|NCT02225223|radiofrequency kyphoplasty|radiofrequency kyphoplasty
176691|NCT02225223|spine|spine
176692|NCT02225223|vertebral augmentation|vertebral augmentation
176693|NCT02225223|kyphoplasty|kyphoplasty
176694|NCT02225223|spinal ablation|spinal ablation
176695|NCT02225223|pain|pain
176696|NCT02225223|quality of life|quality of life
176697|NCT02225223|spinal tumors|spinal tumors
176698|NCT02225210|Dexmedetomidine ,Delirium ,Haemodynamic, Mechanical ventilation|dexmedetomidine ,delirium ,haemodynamic, mechanical ventilation
176699|NCT02225197|Perioptic|perioptic
176700|NCT02225197|Stereotactic|stereotactic
176701|NCT02225197|Radiation|radiation
176702|NCT02225197|Benign brain tumor|benign brain tumor
176703|NCT02225197|Optic apparatus|optic apparatus
176704|NCT02225184|Opioid Dependence|opioid dependence
176705|NCT02225184|OPRM1|oprm1
176706|NCT02225184|Outcome|outcome
176707|NCT02225184|Treatment|treatment
176708|NCT02225171|Genetic Knowledge|genetic knowledge
176709|NCT02225171|Genetic Testing|genetic testing
176710|NCT02225158|Immunity|immunity
176711|NCT02225158|Co-Infection|co-infection
176712|NCT02225158|Parasite|parasite
176713|NCT02225158|Mycobacteria|mycobacteria
176714|NCT02225145|Bone Marrow Transplant|bone marrow transplant
176715|NCT02225145|Fertility|fertility
176716|NCT02225145|Ovary|ovary
176717|NCT02225132|Hydroxyurea|hydroxyurea
176718|NCT02225132|Sickle Cell Disease|sickle cell disease
176719|NCT02225132|Fetal Hemoglobin Induction|fetal hemoglobin induction
176720|NCT02225119|Retinal Images|retinal images
176721|NCT02225119|Retinal Pigment Epithelium|retinal pigment epithelium
176722|NCT02225106|Dopamine Receptors|dopamine receptors
176723|NCT02225106|Methylphenidate|methylphenidate
176724|NCT02225106|Traumatic Brain Injury|traumatic brain injury
176725|NCT02225106|C-11 Raclopride|c-11 raclopride
176726|NCT02225106|Dopamine Release|dopamine release
176727|NCT02225093|Safety|safety
176728|NCT02225093|Dextromethorphan|dextromethorphan
176729|NCT02225093|CYP2D6|cyp2d6
176730|NCT02225093|Phase 1|phase 1
176731|NCT02225093|Prostate cancer|prostate cancer
176732|NCT02225093|CYP1A2|cyp1a2
176733|NCT02225093|Pharmacokinetics|pharmacokinetics
176734|NCT02225093|Drug-drug interactions|drug-drug interactions
176735|NCT02225093|Caffeine|caffeine
176736|NCT02225093|Enzalutamide|enzalutamide
176737|NCT02225067|Patients|patients
176738|NCT02225067|Volunteers|volunteers
176739|NCT02225054|duration of analgesia|duration of analgesia
176740|NCT02225041|intensive care|intensive care
176741|NCT02225041|critical care|critical care
176742|NCT02225041|child|child
176743|NCT02225041|family|family
176744|NCT02225041|survivors|survivors
176745|NCT02225028|physical activity|physical activity
176746|NCT02225028|physical fitness|physical fitness
176747|NCT02225028|exercise program|exercise program
176748|NCT02225028|telephone coaching|telephone coaching
176749|NCT02225028|motivational counseling|motivational counseling
176750|NCT02225028|stretching|stretching
176751|NCT02225028|fitness improvement|fitness improvement
176752|NCT02225028|exercise coaching|exercise coaching
176753|NCT02225028|toning|toning
176755|NCT02225028|spinal cord injury|spinal cord injury
176756|NCT02225028|home-based|home-based
176757|NCT02225028|home exercise|home exercise
176758|NCT02225015|Cancer|cancer
176759|NCT02225015|Breast cancer|breast cancer
176760|NCT02225015|Ovarian cancer|ovarian cancer
176761|NCT02225015|BRCA Mutation|brca mutation
176762|NCT02225015|BRCA1 Gene Mutation|brca1 gene mutation
176763|NCT02225015|BRCA2 Gene Mutation|brca2 gene mutation
176764|NCT02225015|Telephone genetic counselling|telephone genetic counselling
176765|NCT02225015|Cancer prevention|cancer prevention
176766|NCT02225002|relapsed|relapsed
176767|NCT02225002|refractory to standard therapy|refractory to standard therapy
176768|NCT02225002|no effective therapy exists|no effective therapy exists
176769|NCT02224976|exercise training|exercise training
176770|NCT02224963|Aging,|aging,
176771|NCT02224963|Macular Degeneration,|macular degeneration,
176772|NCT02224963|Preparation for Future Care,|preparation for future care,
176773|NCT02224963|Psychological Well-being,|psychological well-being,
176774|NCT02224963|Problem Solving|problem solving
176775|NCT02224963|Prevention|prevention
176776|NCT02224963|Mental Health Promotion|mental health promotion
176777|NCT02224950|Atopic dermatitis|atopic dermatitis
176778|NCT02224950|eczema|eczema
176779|NCT02224950|alternative therapy|alternative therapy
176780|NCT02224950|complementary therapy|complementary therapy
176781|NCT02224950|moisturizer|moisturizer
176782|NCT02224937|Melatonin|melatonin
176783|NCT02224937|Cognitive parameters|cognitive parameters
176784|NCT02224937|pharmacodynamic|pharmacodynamic
176785|NCT02224937|pharmacokinetics|pharmacokinetics
401986|NCT01233648|heart failure|heart failure
401987|NCT01233648|CRT-D|crt-d
176786|NCT02224924|Experimental: autologous blood patch injection (ABPI)|experimental: autologous blood patch injection (abpi)
176787|NCT02224924|Experimental: BioSentry (formerly known as Bio-Seal) hydrogel Tract Plug|experimental: biosentry (formerly known as bio-seal) hydrogel tract plug
176788|NCT02224924|14-141|14-141
176789|NCT02224911|focal therapy|focal therapy
176790|NCT02224911|prostate cancer treatment|prostate cancer treatment
176791|NCT02224911|laser treatment|laser treatment
176792|NCT02224885|Interventional radiology|interventional radiology
176793|NCT02224885|Lung|lung
176794|NCT02224885|Liver|liver
176795|NCT02224885|Confocal endomicroscopy|confocal endomicroscopy
176796|NCT02224885|Optical biopsy|optical biopsy
176797|NCT02224885|Scanner|scanner
176798|NCT02224885|Fluoroscopy|fluoroscopy
176799|NCT02224885|CT|ct
176800|NCT02224885|Computed Tomography|computed tomography
176801|NCT02224885|Radiofrequency Ablation|radiofrequency ablation
176802|NCT02224885|Fluorescein|fluorescein
176803|NCT02224872|bone marrow transplant|bone marrow transplant
176804|NCT02224872|thymoglobulin|thymoglobulin
176805|NCT02224872|cyclophosphamide|cyclophosphamide
176806|NCT02224872|fludarabine|fludarabine
176807|NCT02224872|tacrolimus|tacrolimus
176808|NCT02224872|Mycophenolic Acid Mofetil|mycophenolic acid mofetil
176809|NCT02224872|chemotherapy|chemotherapy
176811|NCT02224872|haploidentical|haploidentical
176812|NCT02224833|appropriateness|appropriateness
176813|NCT02224833|elderly|elderly
176814|NCT02224833|polypharmacy|polypharmacy
176815|NCT02224833|primary care|primary care
176816|NCT02224820|transplantation|transplantation
176817|NCT02224820|sensitised patients|sensitised patients
176818|NCT02224820|HLA-antibodies|hla-antibodies
176819|NCT02224807|breast cancer|breast cancer
176820|NCT02224807|diet|diet
176821|NCT02224807|exercise|exercise
176822|NCT02224807|weight loss|weight loss
176823|NCT02224794|abdominal|abdominal
176824|NCT02224794|aortic|aortic
176825|NCT02224794|aneurysm|aneurysm
176826|NCT02224755|Heart Failure|heart failure
176827|NCT02224755|Left Ventricular Assist Device|left ventricular assist device
176828|NCT02224755|Ventricular Dysfunction|ventricular dysfunction
176829|NCT02224755|Cardiomyopathy|cardiomyopathy
176830|NCT02224755|Heart Disease|heart disease
176831|NCT02224755|Cardiovascular Disease|cardiovascular disease
176832|NCT02224755|Heart-assist devices|heart-assist devices
176833|NCT02224755|Thoratec Corporation|thoratec corporation
176834|NCT02224703|Cannabidiol|cannabidiol
176835|NCT02224703|CBD|cbd
176836|NCT02224703|GWP42003-P|gwp42003-p
176837|NCT02224690|Cannabidiol|cannabidiol
176838|NCT02224690|CBD|cbd
176839|NCT02224690|Epidiolex|epidiolex
176840|NCT02224690|GWP42003-P|gwp42003-p
176841|NCT02224677|CFM|cfm
176842|NCT02224677|facial asymmetry|facial asymmetry
176843|NCT02224677|skin tag|skin tag
176844|NCT02224677|facial tag|facial tag
176845|NCT02224677|missing ear|missing ear
176846|NCT02224677|small ear|small ear
176847|NCT02224677|anotia|anotia
176848|NCT02224677|microtia|microtia
176849|NCT02224677|epibulbar dermoid|epibulbar dermoid
176850|NCT02224677|coloboma|coloboma
176851|NCT02224677|macrostomia|macrostomia
176852|NCT02224677|lateral cleft|lateral cleft
176853|NCT02224677|infant|infant
176854|NCT02224677|toddler|toddler
176855|NCT02224677|baby|baby
176856|NCT02224677|neurodevelopment|neurodevelopment
176857|NCT02224677|cognition|cognition
176858|NCT02224677|socialization|socialization
176859|NCT02224638|skin ulcers|skin ulcers
176860|NCT02224612|Pediatric Face Masks|pediatric face masks
176861|NCT02224612|children|children
176862|NCT02224573|Cannabidiol|cannabidiol
176863|NCT02224573|CBD|cbd
176864|NCT02224573|GWP42003-P|gwp42003-p
176865|NCT02224560|Cannabidiol|cannabidiol
176866|NCT02224560|CBD|cbd
176867|NCT02224560|Epidiolex|epidiolex
176868|NCT02224560|GWP42003-P|gwp42003-p
176869|NCT02224547|non-small cell lung cancer|non-small cell lung cancer
176870|NCT02224547|lung carcinoma|lung carcinoma
176871|NCT02224547|NSCLC|nsclc
176872|NCT02224534|ST elevation myocardial infarction.|st elevation myocardial infarction.
176873|NCT02224534|Ticagrelor|ticagrelor
176874|NCT02224534|Left ventricular remodeling|left ventricular remodeling
176875|NCT02224534|Platelet reactivity|platelet reactivity
176876|NCT02224521|FLAP inhibitor|flap inhibitor
176877|NCT02224521|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
176878|NCT02224521|COPD|copd
176879|NCT02224521|Bioavailability|bioavailability
176880|NCT02224469|Brain-Computer Interface|brain-computer interface
176881|NCT02224469|Motor Cortex|motor cortex
402936|NCT01229020|vibration response imaging|vibration response imaging
176882|NCT02224469|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
176883|NCT02224469|Quality of Life|quality of life
176884|NCT02224456|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
176885|NCT02224456|hepatocellular carcinoma|hepatocellular carcinoma
176886|NCT02224456|chronic hepatitis B|chronic hepatitis b
176887|NCT02224456|Cirrhosis|cirrhosis
176888|NCT02224443|Dexmedetomidine,postoperative cognitive dysfunction|dexmedetomidine,postoperative cognitive dysfunction
176889|NCT02224430|biomarker of relapse|biomarker of relapse
176890|NCT02224430|schizophrenia|schizophrenia
176891|NCT02224430|schizoaffective disorder|schizoaffective disorder
176892|NCT02224430|on-body sensors|on-body sensors
176893|NCT02224430|smartphone|smartphone
176894|NCT02224430|observational|observational
176895|NCT02224417|Diabetes|diabetes
176896|NCT02224417|Treatment medication adherence|treatment medication adherence
176897|NCT02224417|Physical activity|physical activity
176898|NCT02224417|Financial incentives|financial incentives
176899|NCT02224417|Outcome incentives|outcome incentives
176900|NCT02224417|Process incentives|process incentives
176901|NCT02224417|HbA1c|hba1c
176902|NCT02224391|Smoking Cessation|smoking cessation
176903|NCT02224391|Attentional bias modification|attentional bias modification
176904|NCT02224391|ABM|abm
176905|NCT02224391|Smartphone|smartphone
176906|NCT02224391|Nicotine replacement therapy|nicotine replacement therapy
176907|NCT02224391|Nicotine patch|nicotine patch
176908|NCT02224391|NRT|nrt
176909|NCT02224391|Questionnaires|questionnaires
176910|NCT02224391|Surveys|surveys
176911|NCT02224391|Saliva collection|saliva collection
176912|NCT02224391|Cotinine level|cotinine level
176913|NCT02224391|Counseling sessions|counseling sessions
176914|NCT02224391|Electroencephalography|electroencephalography
176916|NCT02224378|fluid responsiveness|fluid responsiveness
176917|NCT02224378|atrial fibrillation|atrial fibrillation
176918|NCT02224378|passive leg raising|passive leg raising
176919|NCT02224378|central venous pressure|central venous pressure
176920|NCT02224378|valvular heart surgery|valvular heart surgery
176921|NCT02224365|Diabetes|diabetes
176922|NCT02224365|Arterial Stiffness|arterial stiffness
176923|NCT02224365|Blood Pressure|blood pressure
176924|NCT02224365|Endothelial Function|endothelial function
176925|NCT02224365|Body Composition|body composition
176926|NCT02224365|Glycemic Control|glycemic control
176927|NCT02224365|Apples|apples
176928|NCT02224365|Functional Foods|functional foods
176929|NCT02224365|Polyphenols|polyphenols
176930|NCT02224365|Fiber|fiber
176931|NCT02224352|Electric Stimulation|electric stimulation
176932|NCT02224352|Respiration|respiration
176933|NCT02224352|Abdominal wall|abdominal wall
176934|NCT02224352|Lung Diseases|lung diseases
176935|NCT02224352|Respiratory Tract Diseases|respiratory tract diseases
176936|NCT02224352|COPD|copd
176937|NCT02224339|Atherosclerosis|atherosclerosis
176938|NCT02224339|carotid plaque|carotid plaque
176939|NCT02224339|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
176940|NCT02224339|Major Adverse Cardiovascular Events|major adverse cardiovascular events
176941|NCT02224326|Alzheimer´s disease|alzheimer´s disease
176942|NCT02224326|early diagnosis|early diagnosis
176943|NCT02224326|evoked potentials|evoked potentials
176944|NCT02224326|near-infrared spectroscopy|near-infrared spectroscopy
176945|NCT02224313|vaginal cytokine|vaginal cytokine
176946|NCT02224287|Urolithiasis|urolithiasis
176947|NCT02224287|Kidney Stones|kidney stones
176948|NCT02224287|Ureteroscopy|ureteroscopy
176949|NCT02224287|Fluoroscopy|fluoroscopy
176950|NCT02224274|Antiplatelet Therapy|antiplatelet therapy
176951|NCT02224274|Cardiac Arrest|cardiac arrest
176952|NCT02224274|Therapeutic hypothermia|therapeutic hypothermia
176953|NCT02224274|Myocardial infarction (STEMI and NSTEMI)|myocardial infarction (stemi and nstemi)
176954|NCT02224261|Axillary web syndrome|axillary web syndrome
176955|NCT02224261|cording|cording
176956|NCT02224261|physical therapy|physical therapy
176957|NCT02224261|breast cancer|breast cancer
176958|NCT02224248|cardiorespiratory fitness|cardiorespiratory fitness
176959|NCT02224248|exercise tolerance|exercise tolerance
176960|NCT02224248|exercise test|exercise test
176961|NCT02224248|health behavior|health behavior
176962|NCT02224248|motor activity|motor activity
176963|NCT02224248|motivation|motivation
176964|NCT02224248|intention|intention
176965|NCT02224248|self-rated health|self-rated health
176966|NCT02224235|Stable angina|stable angina
176967|NCT02224235|PCI|pci
176968|NCT02224235|Percutaneous Coronary Intervention|percutaneous coronary intervention
176969|NCT02224209|Carotid artery stenosis|carotid artery stenosis
176970|NCT02224209|High risk of hyperperfusion|high risk of hyperperfusion
176971|NCT02224209|Staged angioplasty|staged angioplasty
176972|NCT02224209|Routine single-stage stenting|routine single-stage stenting
176973|NCT02224196|manual ventilation|manual ventilation
176974|NCT02224196|pressure-controlled ventilation|pressure-controlled ventilation
176975|NCT02224196|peak airway pressure|peak airway pressure
176976|NCT02224196|antral area|antral area
176977|NCT02224183|low back pain|low back pain
176978|NCT02224183|yoga|yoga
215460|NCT02047357|LTP|ltp
176979|NCT02224183|education|education
176980|NCT02224183|Veterans|veterans
176981|NCT02224183|cost-effectiveness|cost-effectiveness
176982|NCT02224183|military|military
176983|NCT02224183|back pain|back pain
176984|NCT02224170|Dexamethasone|dexamethasone
176985|NCT02224170|Lidocaine|lidocaine
176986|NCT02224170|Quality of Recovery|quality of recovery
665120|NCT00829114|COC|coc
176987|NCT02224170|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
176988|NCT02224144|Kidney Transplantation|kidney transplantation
176989|NCT02224144|Calcitriol|calcitriol
176990|NCT02224144|Bone Mineral Density|bone mineral density
176991|NCT02224144|Bone Mass and Strength|bone mass and strength
176992|NCT02224144|Vascular Calcifications|vascular calcifications
176993|NCT02224144|Hyperparathyroidism|hyperparathyroidism
176994|NCT02224144|Parathyroid Hormone|parathyroid hormone
176995|NCT02224131|platelet function test|platelet function test
176996|NCT02224131|stent;|stent;
176997|NCT02224118|Healthy|healthy
176998|NCT02224118|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
176999|NCT02224118|CNTO 3649|cnto 3649
177000|NCT02224092|heart health|heart health
177001|NCT02224092|general well-being|general well-being
177002|NCT02224066|Aortic stenosis|aortic stenosis
177003|NCT02224066|TAVI|tavi
177004|NCT02224066|TAVR|tavr
177507|NCT02221726|Healthy|healthy
177005|NCT02224066|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
177006|NCT02224066|Ticagrelor|ticagrelor
177007|NCT02224066|Antiplatelet reactivity|antiplatelet reactivity
200993|NCT02112656|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
177233|NCT02223052|MM|mm
177008|NCT02224053|oncology, cancer, non small cell lung cancer, anticancer druge, omeprazole, healthy volunteer|oncology, cancer, non small cell lung cancer, anticancer druge, omeprazole, healthy volunteer
177009|NCT02224001|tip plasty|tip plasty
177010|NCT02224001|septal cartilage|septal cartilage
177011|NCT02223988|Patients|patients
177012|NCT02223988|mechanical|mechanical
177013|NCT02223988|ventilation|ventilation
177014|NCT02223988|tracheostomy|tracheostomy
177015|NCT02223975|Spectrum Analysis, vibrational|spectrum analysis, vibrational
177016|NCT02223975|Spectrum Analysis, infrared|spectrum analysis, infrared
177017|NCT02223975|Spectrum Analysis, Raman|spectrum analysis, raman
177018|NCT02223975|Spectrum Analysis|spectrum analysis
177019|NCT02223975|Fourier transform infrared spectroscopy|fourier transform infrared spectroscopy
177020|NCT02223975|Raman probe|raman probe
177021|NCT02223975|Optical|optical
177022|NCT02223975|Diagnosis|diagnosis
177023|NCT02223975|Cancer|cancer
177024|NCT02223975|Multivariate analysis|multivariate analysis
177025|NCT02223975|Vulval Intraepithelial Neoplasia|vulval intraepithelial neoplasia
177026|NCT02223975|Vulvar Neoplasm|vulvar neoplasm
177027|NCT02223975|Vulva|vulva
177028|NCT02223975|Vulvar Diseases|vulvar diseases
177029|NCT02223962|physical activity|physical activity
177030|NCT02223962|COPD|copd
177031|NCT02223962|activity monitors|activity monitors
177032|NCT02223949|Obesity|obesity
177033|NCT02223949|Labor complications|labor complications
177034|NCT02223949|Induction of labor|induction of labor
177035|NCT02223949|Mechanical cervical ripening|mechanical cervical ripening
177036|NCT02223936|nuchal translucency, neurological developpment, anxiety, depression, prenatal diagnosis, normal karyotype|nuchal translucency, neurological developpment, anxiety, depression, prenatal diagnosis, normal karyotype
177037|NCT02223923|Phase 1|phase 1
177038|NCT02223923|Maximimum tolerated dose|maximimum tolerated dose
177039|NCT02223923|ATR Inhibitor|atr inhibitor
177040|NCT02223923|Radiotherapy|radiotherapy
177041|NCT02223910|brain computer interface|brain computer interface
177042|NCT02223910|neurofeedback|neurofeedback
177043|NCT02223910|functional connectivity|functional connectivity
177044|NCT02223897|Liver transplantation|liver transplantation
177045|NCT02223897|Biliary complication|biliary complication
177046|NCT02223897|mesenchymal stem cells|mesenchymal stem cells
177047|NCT02223884|Malignant melanoma, second-line treatment, docetaxel, carboplatin|malignant melanoma, second-line treatment, docetaxel, carboplatin
177048|NCT02223871|Malaria|malaria
177049|NCT02223871|ACT-451840|act-451840
177050|NCT02223858|Health Status Disparities|health status disparities
177051|NCT02223858|Arthritis|arthritis
177052|NCT02223858|Psychology|psychology
177053|NCT02223858|Pain Management|pain management
177054|NCT02223858|Affect|affect
177055|NCT02223845|Music, Anxiety, IVF|music, anxiety, ivf
177056|NCT02223832|ACT-128800|act-128800
177057|NCT02223832|Safety|safety
177058|NCT02223832|Tolerability|tolerability
177059|NCT02223832|Pharmacokinetics|pharmacokinetics
177060|NCT02223819|Crizotinib|crizotinib
177061|NCT02223819|14-063|14-063
177062|NCT02223806|Postpartum hemorrhage|postpartum hemorrhage
177063|NCT02223806|Uterine tonus assessment|uterine tonus assessment
177064|NCT02223806|Active management of third stage of labor|active management of third stage of labor
177065|NCT02223793|Vascular screening|vascular screening
177066|NCT02223793|Cardiovascular risk factors|cardiovascular risk factors
177067|NCT02223793|Blood pressure|blood pressure
177068|NCT02223793|Lipids|lipids
177069|NCT02223793|Lifestyle|lifestyle
177070|NCT02223793|Identifying unknown risk|identifying unknown risk
177071|NCT02223793|Low socioeconomic status|low socioeconomic status
177072|NCT02223793|low threshold|low threshold
177073|NCT02223780|COPD|copd
177074|NCT02223780|palliative care|palliative care
177075|NCT02223767|TMS|tms
177076|NCT02223767|VR|vr
177077|NCT02223767|Exposure therapy|exposure therapy
177078|NCT02223767|TMS augmentations of exposure therapy|tms augmentations of exposure therapy
177079|NCT02223741|Cerebral palsy|cerebral palsy
177080|NCT02223741|GMFM-66|gmfm-66
177081|NCT02223741|PEDI|pedi
177082|NCT02223702|Aggressive periodontitis|aggressive periodontitis
177083|NCT02223702|amoxicillin|amoxicillin
177084|NCT02223702|metronidazole|metronidazole
177085|NCT02223702|moxifloxacin|moxifloxacin
177086|NCT02223702|nonsurgical periodontal debridement.|nonsurgical periodontal debridement.
177087|NCT02223689|SkinAffix|skinaffix
177088|NCT02223676|Pharmacy|pharmacy
177089|NCT02223676|Length-of-stay|length-of-stay
177090|NCT02223676|Emergency Department|emergency department
177091|NCT02223650|Intermittent Exotropia|intermittent exotropia
177092|NCT02223650|IXT|ixt
177093|NCT02223650|overminus|overminus
177094|NCT02223624|eccentric|eccentric
177095|NCT02223624|exercise|exercise
177096|NCT02223624|heart disease|heart disease
177097|NCT02223624|chronic heart failure|chronic heart failure
177098|NCT02223624|rehabilitation|rehabilitation
177099|NCT02223611|Stage Ⅱ-ⅢA NSCLC S1 capsule Completely resection|stage ⅱ-ⅲa nsclc s1 capsule completely resection
177100|NCT02223598|Lymphoid Hematological Malignancies|lymphoid hematological malignancies
177101|NCT02223585|Gut microbial|gut microbial
177102|NCT02223585|response|response
177103|NCT02223585|to protein-based|to protein-based
177104|NCT02223585|diet|diet
177105|NCT02223585|challenges|challenges
177106|NCT02223585|population|population
177107|NCT02223533|analgesia|analgesia
177108|NCT02223533|post-operative|post-operative
177109|NCT02223533|wound catheter infusion|wound catheter infusion
177110|NCT02223533|laparoscopic colon surgery|laparoscopic colon surgery
177111|NCT02223520|Staphylococcus aureus|staphylococcus aureus
177112|NCT02223520|Infection|infection
177113|NCT02223520|Colonization|colonization
177114|NCT02223520|Transmission|transmission
177115|NCT02223520|Neonate|neonate
177116|NCT02223468|Intestinal Microbiota|intestinal microbiota
177117|NCT02223468|Liver Transplant|liver transplant
177118|NCT02223468|Acute Rejection|acute rejection
177119|NCT02223468|Infection|infection
177120|NCT02223455|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
177121|NCT02223455|Infection Control (IC)|infection control (ic)
177122|NCT02223455|Hospital-associated infections (HAI)|hospital-associated infections (hai)
177123|NCT02223455|Hand Hygiene (HH)|hand hygiene (hh)
177124|NCT02223455|Compliance|compliance
177125|NCT02223455|Health Care Workers (HCWs)|health care workers (hcws)
177126|NCT02223442|chronic pain|chronic pain
177127|NCT02223442|central analgesic drugs|central analgesic drugs
177128|NCT02223442|adherence to therapy|adherence to therapy
177129|NCT02223442|side effects|side effects
177130|NCT02223442|quality of life|quality of life
177131|NCT02223442|MOR-NRI drugs|mor-nri drugs
177132|NCT02223429|Paternal nurturance|paternal nurturance
177133|NCT02223429|Oxytocin|oxytocin
177134|NCT02223429|Vasopressin|vasopressin
177135|NCT02223429|fMRI|fmri
177136|NCT02223429|Neurobiology|neurobiology
177137|NCT02223416|female|female
177138|NCT02223416|volunteers|volunteers
177139|NCT02223403|Nitrate-rich beetroot juice|nitrate-rich beetroot juice
177140|NCT02223403|heart failure|heart failure
177141|NCT02223403|exercise performance|exercise performance
177142|NCT02223403|oxygen consumption|oxygen consumption
177143|NCT02223390|South Africa|south africa
177144|NCT02223390|HIV|hiv
177145|NCT02223390|Mental health|mental health
177146|NCT02223390|Trauma|trauma
177147|NCT02223390|Women|women
177148|NCT02223351|HSV|hsv
177149|NCT02223351|HIV|hiv
177150|NCT02223351|Herpes|herpes
177151|NCT02223351|volunteers|volunteers
177152|NCT02223351|drug-drug interaction|drug-drug interaction
177153|NCT02223325|Elderly|elderly
177154|NCT02223325|Prognosis|prognosis
177155|NCT02223299|Depression|depression
177156|NCT02223299|SSRI|ssri
177157|NCT02223299|Nutritional Supplements|nutritional supplements
177158|NCT02223299|Beck Depression Scale|beck depression scale
177159|NCT02223299|L-tyrosine|l-tyrosine
177160|NCT02223299|L-tryptophan|l-tryptophan
177161|NCT02223273|stroke,|stroke,
177162|NCT02223273|quality improvement|quality improvement
177163|NCT02223247|solid tumors|solid tumors
177164|NCT02223247|cancer|cancer
177165|NCT02223221|In Vitro Fertilization|in vitro fertilization
177166|NCT02223221|Intracytoplasmic Sperm Injections|intracytoplasmic sperm injections
177167|NCT02223221|Infertility, Female|infertility, female
177168|NCT02223221|Abortion, Habitual|abortion, habitual
177169|NCT02223221|recurrent pregnancy loss|recurrent pregnancy loss
168167|NCT02268045|DLBCL|dlbcl
177170|NCT02223221|comprehensive chromosome screening|comprehensive chromosome screening
177171|NCT02223221|preimplantation genetic screening|preimplantation genetic screening
177172|NCT02223221|SNP array|snp array
177173|NCT02223208|PTCL|ptcl
177174|NCT02223208|PTCL-NOS|ptcl-nos
177175|NCT02223208|AITL|aitl
177176|NCT02223208|ALCL|alcl
177177|NCT02223195|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
177178|NCT02223195|Saliva|saliva
177179|NCT02223182|Milk Allergy,|milk allergy,
177180|NCT02223182|Viaskin Milk,|viaskin milk,
665617|NCT00837499|Breast|breast
177181|NCT02223182|Specific Immunotherapy,|specific immunotherapy,
177182|NCT02223182|Epicutaneous ImmunoTherapy (EPIT)|epicutaneous immunotherapy (epit)
177183|NCT02223182|IgE-Mediated Cow's Milk Allergy|ige-mediated cow's milk allergy
177184|NCT02223169|Blood Pressure|blood pressure
177185|NCT02223169|Hypertension|hypertension
177186|NCT02223169|Cardiovascular disease|cardiovascular disease
177187|NCT02223143|Lipid lowering therapy|lipid lowering therapy
177189|NCT02223130|Discrimination|discrimination
177190|NCT02223130|Coping|coping
177191|NCT02223130|Medical Mistrust|medical mistrust
177192|NCT02223130|HIV Outcomes|hiv outcomes
177193|NCT02223130|Cognitive Behavioral Therapy|cognitive behavioral therapy
177194|NCT02223091|complementary therapies|complementary therapies
177195|NCT02223091|consultants|consultants
177196|NCT02223091|medical oncology|medical oncology
177197|NCT02223091|breast-cancer|breast-cancer
177198|NCT02223091|education|education
177199|NCT02223052|CC-486|cc-486
177200|NCT02223052|Oral Azacitidine|oral azacitidine
177201|NCT02223052|Soli Tumor Malignancy|soli tumor malignancy
177608|NCT02221245|Chemo-naive|chemo-naive
177202|NCT02223052|Hematological Malignancy|hematological malignancy
177203|NCT02223052|Leukemia|leukemia
177204|NCT02223052|Lymphoma|lymphoma
177205|NCT02223052|Multiple Myeloma|multiple myeloma
177206|NCT02223052|Acute Myeloid Leukemia|acute myeloid leukemia
177207|NCT02223052|Myelodysplastic Syndromes|myelodysplastic syndromes
177209|NCT02223052|Melanoma|melanoma
177210|NCT02223052|Breast Cancer|breast cancer
177211|NCT02223052|Metastatic Breast Cancer|metastatic breast cancer
177212|NCT02223052|Non-Small Cell Lung Cancer|non-small cell lung cancer
177213|NCT02223052|Small Cell Lung Cancer|small cell lung cancer
177214|NCT02223052|Renal Cell Carcinoma|renal cell carcinoma
177215|NCT02223052|Glioblastoma Multiforme|glioblastoma multiforme
177216|NCT02223052|Brain Cancer|brain cancer
177217|NCT02223052|Kidney Cancer|kidney cancer
177218|NCT02223052|Lung cancer|lung cancer
177219|NCT02223052|Blood Cancer|blood cancer
177220|NCT02223052|Thyroid Cancer|thyroid cancer
177221|NCT02223052|Bone Cancer|bone cancer
177222|NCT02223052|Bone Metastasis|bone metastasis
177223|NCT02223052|Testicular Cancer|testicular cancer
177224|NCT02223052|Prostate Cancer|prostate cancer
177225|NCT02223052|Bladder Cancer|bladder cancer
177226|NCT02223052|Ovarian Cancer|ovarian cancer
177227|NCT02223052|Skin Cancer|skin cancer
177228|NCT02223052|Cancer general|cancer general
177229|NCT02223052|Survival|survival
177230|NCT02223052|Chemotherapy|chemotherapy
177231|NCT02223052|Targeted Therapy|targeted therapy
177232|NCT02223052|Genitourinary|genitourinary
177234|NCT02223052|MDS|mds
177235|NCT02223052|AML|aml
177236|NCT02223052|NHL|nhl
177237|NCT02223052|HL|hl
177238|NCT02223052|MBC|mbc
177239|NCT02223052|NSCLC|nsclc
177240|NCT02223052|SCLC|sclc
177241|NCT02223052|GBM|gbm
177242|NCT02223039|Psoriasis|psoriasis
177243|NCT02223039|Dermatology|dermatology
177244|NCT02223039|Monoclonal antibody|monoclonal antibody
177245|NCT02222935|Balance training|balance training
177246|NCT02222935|low back pain|low back pain
177247|NCT02222935|balance test|balance test
177248|NCT02222935|routine back exercise|routine back exercise
177249|NCT02222922|ADC|adc
177250|NCT02222922|PF-06647020|pf-06647020
177251|NCT02222922|solid tumors|solid tumors
177252|NCT02222922|tumors|tumors
177253|NCT02222922|neoplasm metastasis|neoplasm metastasis
177254|NCT02222922|TNBC|tnbc
177255|NCT02222922|triple negative breast cancer|triple negative breast cancer
177256|NCT02222922|NSCLC|nsclc
177257|NCT02222922|non small cell lung cancer|non small cell lung cancer
177258|NCT02222922|advanced metastatic breast cancer|advanced metastatic breast cancer
177259|NCT02222922|ovarian cancer|ovarian cancer
177260|NCT02222922|OVCA|ovca
177261|NCT02222909|Community Based Organization|community based organization
177262|NCT02222909|Reverse Innovation|reverse innovation
177263|NCT02222909|Social Services|social services
177264|NCT02222909|Referral|referral
177265|NCT02222909|Chronic disease|chronic disease
177266|NCT02222870|Influenza|influenza
177267|NCT02222870|Influenza virus vaccine|influenza virus vaccine
177268|NCT02222870|Quadrivalent Influenza Virus Vaccine (No Preservative)|quadrivalent influenza virus vaccine (no preservative)
177269|NCT02222870|Fluzone®|fluzone®
177270|NCT02222857|Acute retinal necrosis|acute retinal necrosis
177271|NCT02222857|Retinal detachment|retinal detachment
177272|NCT02222857|Laser photocoagulation|laser photocoagulation
177273|NCT02222857|Vitrectomy|vitrectomy
177274|NCT02222844|Cancer|cancer
177275|NCT02222844|Colorectal Neoplasms|colorectal neoplasms
177276|NCT02222844|Colon, Sigmoid|colon, sigmoid
177277|NCT02222844|Magnetic Resonance Imaging|magnetic resonance imaging
177278|NCT02222844|General Surgery|general surgery
177279|NCT02222844|Postoperative Complications|postoperative complications
177280|NCT02222831|IVF|ivf
177281|NCT02222831|Embryo Quality|embryo quality
177282|NCT02222831|Time Lapse Culture|time lapse culture
177283|NCT02222831|Preimplantation factor|preimplantation factor
177284|NCT02222805|Cord clamping|cord clamping
177285|NCT02222805|Iron deficiency|iron deficiency
177286|NCT02222805|Anemia|anemia
177287|NCT02222805|Iron|iron
177288|NCT02222805|Hyperbilirubinemia|hyperbilirubinemia
177289|NCT02222805|Jaundice|jaundice
177290|NCT02222805|Neurodevelopment|neurodevelopment
177291|NCT02222792|Staphylococci, Streptococci, P acnes and Gram-negative bacteria|staphylococci, streptococci, p acnes and gram-negative bacteria
177292|NCT02222740|Safety|safety
177293|NCT02222740|Tolerability|tolerability
177294|NCT02222740|Pharmacokinetics|pharmacokinetics
177295|NCT02222714|ischemic stroke|ischemic stroke
177296|NCT02222714|stroke|stroke
177297|NCT02222714|APC|apc
177298|NCT02222714|3K3A|3k3a
177299|NCT02222714|3K3A-APC|3k3a-apc
177300|NCT02222714|activated protein C|activated protein c
177301|NCT02222714|RHAPSODY|rhapsody
177302|NCT02222701|composite|composite
177303|NCT02222701|dental|dental
177304|NCT02222701|longevity|longevity
177305|NCT02222688|cancer|cancer
177306|NCT02222688|CLL|cll
177307|NCT02222662|Massage|massage
177308|NCT02222662|effectiveness|effectiveness
177309|NCT02222662|autism|autism
177310|NCT02222662|parent stress|parent stress
177311|NCT02222649|Elderly|elderly
177312|NCT02222649|vitamin D insufficiency|vitamin d insufficiency
177313|NCT02222649|High dose vitamin D3 supplementation|high dose vitamin d3 supplementation
177314|NCT02222649|Polymorphism of the VDR gene|polymorphism of the vdr gene
177315|NCT02222636|The efficacy and safety of intranasal dexmedetomidine|the efficacy and safety of intranasal dexmedetomidine
177316|NCT02222623|insulin|insulin
177317|NCT02222623|basal|basal
177318|NCT02222623|diabetes|diabetes
177319|NCT02222623|hospital|hospital
177320|NCT02222623|glucose|glucose
177321|NCT02222623|hypoglycemia|hypoglycemia
177322|NCT02222623|glargine|glargine
177323|NCT02222623|NPH|nph
177324|NCT02222623|neutral protamine hagedorn|neutral protamine hagedorn
177325|NCT02222610|Radiation Retinopathy|radiation retinopathy
177326|NCT02222597|head injury|head injury
177327|NCT02222597|infrascanner|infrascanner
177328|NCT02222597|intracranial hemorrhage|intracranial hemorrhage
177329|NCT02222584|inflammatory bowel disease|inflammatory bowel disease
177330|NCT02222584|physical activity|physical activity
177331|NCT02222584|disease activity|disease activity
177332|NCT02222584|quality of life|quality of life
177333|NCT02222558|hypogonadism|hypogonadism
177334|NCT02222558|Gonadal Disorders|gonadal disorders
177335|NCT02222558|Endocrine System Diseases|endocrine system diseases
177336|NCT02222558|Testosterone|testosterone
177337|NCT02222558|Testosterone enanthate|testosterone enanthate
177338|NCT02222558|Testosterone undecanoate|testosterone undecanoate
177339|NCT02222558|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
177340|NCT02222558|Methyltestosterone|methyltestosterone
177341|NCT02222558|Androgens|androgens
177342|NCT02222558|Hormones|hormones
177343|NCT02222558|Hormones,|hormones,
177344|NCT02222558|Hormone Substitutes,|hormone substitutes,
177345|NCT02222558|Hormone Antagonists|hormone antagonists
177346|NCT02222558|Physiological Effects of Drugs|physiological effects of drugs
177347|NCT02222558|Pharmacologic Actions|pharmacologic actions
177348|NCT02222558|Therapeutic Uses|therapeutic uses
177349|NCT02222558|Anabolic Agents|anabolic agents
177350|NCT02222558|dihydrotestosterone|dihydrotestosterone
177351|NCT02222545|TMA, aHUS, HSCT-associated TMA, TTP|tma, ahus, hsct-associated tma, ttp
177352|NCT02222532|tetronine|tetronine
177353|NCT02222532|congenital heart disease|congenital heart disease
177354|NCT02222532|cardiopulmonary bypass|cardiopulmonary bypass
177355|NCT02222532|euthyroid sick syndrome|euthyroid sick syndrome
177356|NCT02222519|statins|statins
177357|NCT02222519|nondepolarizing muscle relaxants|nondepolarizing muscle relaxants
177358|NCT02222519|rocuronium|rocuronium
177359|NCT02222519|myalgia|myalgia
177360|NCT02222493|Phase 3|phase 3
177361|NCT02222493|infliximab|infliximab
177362|NCT02222493|rheumatoid arthritis|rheumatoid arthritis
177363|NCT02222480|Patients|patients
177364|NCT02222480|with mild|with mild
177365|NCT02222480|moderate|moderate
177366|NCT02222480|essential|essential
177367|NCT02222441|Palbociclib|palbociclib
177368|NCT02222441|Modafinil|modafinil
177369|NCT02222441|Pioglitazone|pioglitazone
177370|NCT02222441|Pharmacokinetics|pharmacokinetics
177371|NCT02222441|Drug-Drug Interaction Study|drug-drug interaction study
177372|NCT02222441|Healthy Volunteers|healthy volunteers
177373|NCT02222441|CYP3A Inducers|cyp3a inducers
177374|NCT02222415|Muscle mass|muscle mass
177375|NCT02222415|Strength|strength
177376|NCT02222415|Cross-sectional area|cross-sectional area
177377|NCT02222415|Protein|protein
177378|NCT02222402|Quality of Life|quality of life
177379|NCT02222402|Exercise|exercise
177380|NCT02222402|Functional Capacity|functional capacity
177381|NCT02222376|Diabetic ulcer, diabetic foot|diabetic ulcer, diabetic foot
177382|NCT02222363|Phase I|phase i
177383|NCT02222363|Iron chelator|iron chelator
666562|NCT00844961|IBS|ibs
177384|NCT02222363|Refractory advanced solid tumors|refractory advanced solid tumors
177385|NCT02222363|Dose escalation study|dose escalation study
177386|NCT02222363|Safety and tolerability|safety and tolerability
177387|NCT02222363|Tumor response by RECIST 1.1|tumor response by recist 1.1
177388|NCT02222363|Progression-free survival|progression-free survival
177389|NCT02222363|Overall survival Pharmacokinetics|overall survival pharmacokinetics
177390|NCT02222350|type 2 diabetes mellitus|type 2 diabetes mellitus
177391|NCT02222337|behavioral intervention|behavioral intervention
177392|NCT02222337|quality of life|quality of life
177393|NCT02222337|breast cancer|breast cancer
177394|NCT02222337|Latina|latina
177395|NCT02222337|caregiver|caregiver
177396|NCT02222337|PCORI|pcori
177397|NCT02222324|QTc Interval|qtc interval
177398|NCT02222324|Healthy Subjects|healthy subjects
177399|NCT02222272|cml|cml
177400|NCT02222272|chronic myeloid leukemia|chronic myeloid leukemia
177401|NCT02222272|dasatinib|dasatinib
177402|NCT02222272|nilotinib|nilotinib
177403|NCT02222272|tki|tki
177404|NCT02222272|second generation tki|second generation tki
177405|NCT02222272|2nd generation tki|2nd generation tki
177406|NCT02222259|Geriatric Oncology|geriatric oncology
177407|NCT02222259|Quality of Life|quality of life
177408|NCT02222259|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
177409|NCT02222259|Functional Status|functional status
177410|NCT02222259|Chemotherapy|chemotherapy
177411|NCT02222259|Older Adults|older adults
177412|NCT02222246|Sickle Cell Disease|sickle cell disease
177413|NCT02222246|Emergency Department|emergency department
177414|NCT02222246|Vaso-occlusive Crisis|vaso-occlusive crisis
177415|NCT02222246|Pain Management|pain management
177416|NCT02222246|Pilot Project|pilot project
177417|NCT02222207|neovascular Age-related Macular Degeneration|neovascular age-related macular degeneration
177418|NCT02222194|Lung cancer|lung cancer
177419|NCT02222194|Surgery|surgery
177420|NCT02222194|Videomediastinoscopy|videomediastinoscopy
177421|NCT02222181|elderly, medication adherence,pharmaceutical care|elderly, medication adherence,pharmaceutical care
177422|NCT02222155|ANCA-associated vasculitis|anca-associated vasculitis
177423|NCT02222155|complement|complement
177424|NCT02222155|vasculitis|vasculitis
177425|NCT02222155|C5aR|c5ar
177426|NCT02222142|Ischemic heart disease|ischemic heart disease
177427|NCT02222142|Off pump coronary artery bypass graft|off pump coronary artery bypass graft
177428|NCT02222142|Isoflurane|isoflurane
177429|NCT02222142|Propofol|propofol
177430|NCT02222129|Randomized controlled trial|randomized controlled trial
177431|NCT02222129|anesthetics-local|anesthetics-local
177432|NCT02222129|bupivacaine|bupivacaine
177433|NCT02222129|analgesia|analgesia
177434|NCT02222129|Pain, Postoperative|pain, postoperative
177435|NCT02222116|STEMI|stemi
177436|NCT02222116|BMS|bms
177437|NCT02222116|DES|des
177438|NCT02222116|mesh|mesh
177439|NCT02222090|patients with atrial fibrillation (AF) recommend the use of novel oral anticoagulants (NOACs) in patients with non-valvular AF|patients with atrial fibrillation (af) recommend the use of novel oral anticoagulants (noacs) in patients with non-valvular af
177440|NCT02222077|Central blood pressure|central blood pressure
177441|NCT02222077|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
177442|NCT02222077|Target-organ damage|target-organ damage
177443|NCT02222077|Adolescents and young adults|adolescents and young adults
177444|NCT02222051|neck pain|neck pain
177445|NCT02222051|chronic pain|chronic pain
177446|NCT02221986|Interdisciplinary rehabilitation|interdisciplinary rehabilitation
177447|NCT02221986|Neurooncology|neurooncology
177448|NCT02221986|Physiotherapy|physiotherapy
177449|NCT02221986|Occupational therapy|occupational therapy
177450|NCT02221986|Neurorehabilitation|neurorehabilitation
177451|NCT02221986|Glioma|glioma
177452|NCT02221960|Recurrent or metastatic solid tumors, MEDI6383, OX40|recurrent or metastatic solid tumors, medi6383, ox40
177453|NCT02221947|Alzheimer's|alzheimer's
177454|NCT02221947|bryostatin|bryostatin
177455|NCT02221947|PKC epsilon|pkc epsilon
177456|NCT02221934|Pain|pain
177457|NCT02221934|Chronic|chronic
177458|NCT02221934|Amputation|amputation
177459|NCT02221934|Phantom Pain|phantom pain
177460|NCT02221934|Stump Pain|stump pain
177461|NCT02221908|Systolic Blood pressure < 100 mm Hg|systolic blood pressure < 100 mm hg
177462|NCT02221895|postpartum appointment|postpartum appointment
177463|NCT02221895|breastfeeding|breastfeeding
177464|NCT02221895|postpartum contraception|postpartum contraception
402937|NCT01229007|Hemophilia A|hemophilia a
177465|NCT02221895|postpartum cervical cancer screening|postpartum cervical cancer screening
177466|NCT02221895|postpartum depression screening|postpartum depression screening
177467|NCT02221856|Conventional orthodontic treatment|conventional orthodontic treatment
177468|NCT02221856|Motion View|motion view
177469|NCT02221843|sun behavior|sun behavior
177470|NCT02221843|immunosuppression|immunosuppression
177471|NCT02221843|skin neoplasms|skin neoplasms
177472|NCT02221843|sunbit|sunbit
177473|NCT02221843|uv sensor|uv sensor
177474|NCT02221843|uv dosimeter|uv dosimeter
177475|NCT02221843|solar radiation|solar radiation
177476|NCT02221843|uv exposition|uv exposition
177477|NCT02221843|uv index|uv index
177478|NCT02221804|Physical Inactivity|physical inactivity
177479|NCT02221804|Skeletal Muscle|skeletal muscle
177480|NCT02221804|Cachexia|cachexia
177481|NCT02221791|Flavan-3-ol|flavan-3-ol
177482|NCT02221791|Flavonoids|flavonoids
177483|NCT02221791|Epicatechin|epicatechin
177485|NCT02221791|Chocolate|chocolate
177486|NCT02221791|Endothelial function|endothelial function
177487|NCT02221791|Bioavailability|bioavailability
177488|NCT02221778|Carcinoma, Hepatocellular|carcinoma, hepatocellular
177489|NCT02221778|SBRT|sbrt
177490|NCT02221765|Obesity|obesity
177491|NCT02221765|Overnutrition|overnutrition
177492|NCT02221765|Nutrition Disorders|nutrition disorders
177493|NCT02221765|Overweight|overweight
177494|NCT02221765|Body Weight|body weight
177495|NCT02221765|Signs and Symptoms|signs and symptoms
177496|NCT02221752|iron deficiency|iron deficiency
177497|NCT02221752|iron deficiency anemia|iron deficiency anemia
177498|NCT02221752|infant|infant
177499|NCT02221752|pregnancy|pregnancy
177500|NCT02221739|lung cancer|lung cancer
177501|NCT02221739|NSCLC|nsclc
177502|NCT02221739|lung|lung
177503|NCT02221739|cancer|cancer
177504|NCT02221739|radiation|radiation
177505|NCT02221739|immunotherapy|immunotherapy
177506|NCT02221739|metastatic|metastatic
177508|NCT02221726|JNJ-35685-AAA-G-023|jnj-35685-aaa-g-023
177509|NCT02221726|Placebo|placebo
177510|NCT02221726|Transdermal delivery device system|transdermal delivery device system
177515|NCT02221700|Chemotherapy Induced Peripheral Neuropathy|chemotherapy induced peripheral neuropathy
177517|NCT02221700|Symptom reduction|symptom reduction
177518|NCT02221700|Massage|massage
177519|NCT02221700|Symptom questionnaires|symptom questionnaires
177520|NCT02221700|Surveys|surveys
177521|NCT02221700|Leg function and balance tests|leg function and balance tests
177522|NCT02221687|synbiotic formula|synbiotic formula
177523|NCT02221687|infant formula|infant formula
177524|NCT02221687|diarrhea|diarrhea
177525|NCT02221674|Post-surgical pain|post-surgical pain
177526|NCT02221674|Opioid|opioid
177527|NCT02221661|Alzheimer|alzheimer
177528|NCT02221661|cognitive impairment|cognitive impairment
177529|NCT02221661|blood test|blood test
177530|NCT02221648|Back|back
177531|NCT02221648|Pain|pain
177532|NCT02221648|Muscle|muscle
177533|NCT02221635|Schizoaffective Disorder|schizoaffective disorder
177534|NCT02221635|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
177535|NCT02221622|Alzheimer's disease|alzheimer's disease
177536|NCT02221622|Mild Cognitive Impairment|mild cognitive impairment
177537|NCT02221622|Dementia|dementia
177538|NCT02221622|Regenerative therapeutic|regenerative therapeutic
177539|NCT02221609|Low Back Pain, Mechanical Low Back Pain, Low Back Ache, Low Backache, Lower Back Pain, Lumbago|low back pain, mechanical low back pain, low back ache, low backache, lower back pain, lumbago
177540|NCT02221596|Vitamin D|vitamin d
177541|NCT02221596|25(OH)D|25(oh)d
177542|NCT02221596|Aerobic training|aerobic training
177543|NCT02221596|Near-infrared spectroscopy|near-infrared spectroscopy
177544|NCT02221596|Diffuse correlation spectroscopy|diffuse correlation spectroscopy
177546|NCT02221583|End stage renal disease|end stage renal disease
177547|NCT02221583|Renal transplant candidate|renal transplant candidate
177548|NCT02221583|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
177549|NCT02221583|Immunosuppressants|immunosuppressants
177550|NCT02221544|Parkinson's disease, rTMS, Freezing of Gait|parkinson's disease, rtms, freezing of gait
177551|NCT02221518|OCD|ocd
177552|NCT02221518|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
177553|NCT02221505|LOP628,|lop628,
177554|NCT02221505|cKit,|ckit,
177555|NCT02221505|ADC,|adc,
177556|NCT02221505|Antibody drug conjugates,|antibody drug conjugates,
177557|NCT02221505|maytansine|maytansine
177558|NCT02221466|diabetes|diabetes
177559|NCT02221466|foot|foot
177560|NCT02221466|wounds|wounds
177561|NCT02221466|nitric oxide|nitric oxide
177562|NCT02221466|endothelium|endothelium
177563|NCT02221466|infection|infection
177564|NCT02221466|biological markers|biological markers
177565|NCT02221466|observational study|observational study
177566|NCT02221466|hyperbaric oxygen|hyperbaric oxygen
177567|NCT02221466|ulcers|ulcers
177568|NCT02221466|cytokines|cytokines
177569|NCT02221466|inflammation|inflammation
177570|NCT02221453|Diabetic Macular Edema|diabetic macular edema
177571|NCT02221453|Ocular Cytokines|ocular cytokines
177572|NCT02221453|Triamcinolone Acetonide|triamcinolone acetonide
177573|NCT02221427|First time mothers|first time mothers
177574|NCT02221427|Labour progression|labour progression
177575|NCT02221427|Prolonged labour|prolonged labour
177576|NCT02221427|Oxytocin|oxytocin
177577|NCT02221427|Mode of delivery|mode of delivery
177578|NCT02221427|Maternal birth outcome|maternal birth outcome
177579|NCT02221427|Neonatal birth outcome|neonatal birth outcome
177580|NCT02221349|Sensitivity|sensitivity
177581|NCT02221336|Bipolar disorder|bipolar disorder
177582|NCT02221336|Daily electronic monitoring|daily electronic monitoring
177583|NCT02221336|Smartphones|smartphones
177584|NCT02221336|Subjective and objective smartphone data|subjective and objective smartphone data
177585|NCT02221336|Feedback loop|feedback loop
177586|NCT02221310|targeted therapy|targeted therapy
177587|NCT02221310|leukemia|leukemia
177588|NCT02221310|MDS|mds
177589|NCT02221310|immune therapy|immune therapy
177590|NCT02221284|Pharmacological therapy|pharmacological therapy
177591|NCT02221258|Rheumatoid Arthritis|rheumatoid arthritis
177592|NCT02221258|Rheumatic Disease|rheumatic disease
177593|NCT02221258|RA|ra
177594|NCT02221258|Stem cell|stem cell
177595|NCT02221258|Cell therapy|cell therapy
177596|NCT02221258|furestem|furestem
177597|NCT02221258|Umbilical cord Blood|umbilical cord blood
177598|NCT02221258|hUCB-MSC|hucb-msc
177599|NCT02221258|UCB-MSC|ucb-msc
177600|NCT02221245|Esophageal cancer|esophageal cancer
177601|NCT02221245|Cancer Stem Cell|cancer stem cell
177602|NCT02221245|CSC|csc
177603|NCT02221245|Wnt|wnt
177604|NCT02221245|Hegdehog|hegdehog
177606|NCT02221245|Signaling|signaling
177607|NCT02221245|Pathway|pathway
177609|NCT02221232|ZuraPrep|zuraprep
177610|NCT02221232|Antimicrobial|antimicrobial
177611|NCT02221232|Bio-Science Laboratories|bio-science laboratories
177612|NCT02221232|Zurex Pharma|zurex pharma
177613|NCT02221232|Surgical/Patient preoperative skin preparation|surgical/patient preoperative skin preparation
177614|NCT02221219|infant|infant
177615|NCT02221219|brain injury|brain injury
177616|NCT02221219|renal|renal
177617|NCT02221219|indomethacin|indomethacin
177618|NCT02221206|Mini-Screw implant anchorage|mini-screw implant anchorage
177619|NCT02221206|retraction of maxillary incisors|retraction of maxillary incisors
177620|NCT02221180|Bioequivalence|bioequivalence
177621|NCT02221180|Metformin|metformin
177622|NCT02221180|Canagliflozin|canagliflozin
177623|NCT02221180|Healthy|healthy
177624|NCT02221167|breastfeeding|breastfeeding
177625|NCT02221167|donor milk|donor milk
177626|NCT02221167|formula|formula
177627|NCT02221167|exclusive breastfeeding|exclusive breastfeeding
177628|NCT02221167|newborn|newborn
177629|NCT02221154|in vitro fertilization|in vitro fertilization
177630|NCT02221154|ovarian hyperstimulation|ovarian hyperstimulation
177631|NCT02221154|pregnancy|pregnancy
177632|NCT02221115|Google Glass device|google glass device
177633|NCT02221115|Evaluation|evaluation
177634|NCT02221115|patient's|patient's
177635|NCT02221115|response|response
177636|NCT02221115|to new technology|to new technology
177637|NCT02221115|clinical setting|clinical setting
177638|NCT02221102|edoxaban|edoxaban
177639|NCT02221102|aspirin|aspirin
177640|NCT02221102|new oral anticoagulant|new oral anticoagulant
177641|NCT02221102|TIA|tia
177642|NCT02221102|acute minor ischemic stroke|acute minor ischemic stroke
177643|NCT02221089|Effect of Retaron on imparied retinal vascular reactivity after LPS administration in healthy subjects|effect of retaron on imparied retinal vascular reactivity after lps administration in healthy subjects
177644|NCT02221076|Cellvizio|cellvizio
177645|NCT02221076|Endomicroscopy|endomicroscopy
177646|NCT02221076|Robot-assisted procedure|robot-assisted procedure
177647|NCT02221076|Cervix cancer|cervix cancer
177648|NCT02221076|Endocervix cancer|endocervix cancer
177649|NCT02221076|Endometrium cancer|endometrium cancer
177650|NCT02221076|Ovarian cancer|ovarian cancer
177651|NCT02221076|Tubal cancer|tubal cancer
177652|NCT02221076|Colposcopy|colposcopy
177653|NCT02221076|Hysteroscopy|hysteroscopy
177654|NCT02221063|thiamin|thiamin
177655|NCT02221063|thiamin diphosphate|thiamin diphosphate
177656|NCT02221063|beriberi|beriberi
177657|NCT02221063|Cambodia|cambodia
177658|NCT02221063|fish sauce|fish sauce
177659|NCT02221063|fortification|fortification
177660|NCT02221063|pregnancy|pregnancy
177661|NCT02221063|breastfeeding|breastfeeding
177662|NCT02221063|childbearing age|childbearing age
177663|NCT02221037|PaO2/FiO2|pao2/fio2
177664|NCT02221037|Peri-operative lung injury|peri-operative lung injury
177665|NCT02221037|EVLWI|evlwi
177666|NCT02221037|ARDS|ards
177667|NCT02221037|PVPI|pvpi
177668|NCT02221037|SOFA scores|sofa scores
177669|NCT02221037|GSK2862277|gsk2862277
177670|NCT02221037|Oesophagectomy|oesophagectomy
177671|NCT02221024|Peripheral intravenous catheter|peripheral intravenous catheter
177672|NCT02221024|Peripheral intravenous lock|peripheral intravenous lock
177673|NCT02221024|Normal saline|normal saline
177674|NCT02221024|Patency|patency
177675|NCT02221024|Management|management
177676|NCT02221024|of peripheral|of peripheral
177677|NCT02221024|intravenous catheter|intravenous catheter
177678|NCT02221011|Shock wave|shock wave
177679|NCT02221011|Spasticity|spasticity
177680|NCT02221011|Effect|effect
177681|NCT02220998|Hepatitis C|hepatitis c
177682|NCT02220998|HCV|hcv
177683|NCT02220998|cirrhosis|cirrhosis
177684|NCT02220998|Sofosbuvir|sofosbuvir
177685|NCT02220998|Sovaldi|sovaldi
177686|NCT02220998|SOF/VEL|sof/vel
177687|NCT02220998|GS-5816|gs-5816
177688|NCT02220998|GS-7977|gs-7977
177689|NCT02220998|liver|liver
177690|NCT02220998|Treatment naive|treatment naive
177691|NCT02220998|Treatment Experience|treatment experience
177692|NCT02220998|genotype 2|genotype 2
177693|NCT02220972|Epilepsy|epilepsy
177694|NCT02220972|Partial Onset Seizures|partial onset seizures
177695|NCT02220972|Insomnia|insomnia
177696|NCT02220959|morbid obesity surgery|morbid obesity surgery
177697|NCT02220959|walk test|walk test
177698|NCT02220959|exercise|exercise
177699|NCT02220946|Vaginal Electrical Stimulation|vaginal electrical stimulation
177700|NCT02220933|Multiple Sclerosis|multiple sclerosis
177701|NCT02220933|MS|ms
177702|NCT02220933|EDSS|edss
177703|NCT02220920|insulin resistance|insulin resistance
177704|NCT02220907|MT-2412|mt-2412
177705|NCT02220907|MP-513|mp-513
177706|NCT02220907|TA-7284|ta-7284
177707|NCT02220907|Teneligliptin|teneligliptin
177708|NCT02220907|Canagliflozin|canagliflozin
177709|NCT02220894|PD-1|pd-1
177710|NCT02220894|PD1|pd1
177711|NCT02220894|PD-L1|pd-l1
177712|NCT02220894|PDL1|pdl1
177713|NCT02220881|Hallux valgus, Mold making silicone toe separator, Toe separator|hallux valgus, mold making silicone toe separator, toe separator
177714|NCT02220868|HIV|hiv
177715|NCT02220868|HCV|hcv
177716|NCT02220868|DAA|daa
177717|NCT02220829|alpha-blocker|alpha-blocker
177718|NCT02220829|symptomatic urinary problems|symptomatic urinary problems
177719|NCT02220829|radiation therapy|radiation therapy
177720|NCT02220829|prostate cancer|prostate cancer
177721|NCT02220816|Attention|attention
177722|NCT02220816|Competitive|competitive
177723|NCT02220816|Training|training
177724|NCT02220803|Acetazolamide|acetazolamide
177725|NCT02220803|Zonegran|zonegran
177726|NCT02220803|Obstructive Sleep apnea|obstructive sleep apnea
177727|NCT02220803|Apnea|apnea
177728|NCT02220803|Respiration Disorders|respiration disorders
177729|NCT02220803|Sleep Disorders|sleep disorders
177730|NCT02220803|Cardiovascular|cardiovascular
177731|NCT02220803|Hypertension|hypertension
177732|NCT02220803|Carbonic Anhydrase|carbonic anhydrase
177733|NCT02220803|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors
177734|NCT02220803|Enzyme Inhibitors|enzyme inhibitors
177735|NCT02220803|Sulfonamides|sulfonamides
177736|NCT02220803|Therapeutic Uses|therapeutic uses
177737|NCT02220803|Pharmacologic Actions|pharmacologic actions
177738|NCT02220803|Vascular stifness|vascular stifness
177739|NCT02220790|IPFN|ipfn
177740|NCT02220790|Pediatric|pediatric
177741|NCT02220790|Fungal|fungal
177742|NCT02220790|Biomarker Assays|biomarker assays
177743|NCT02220790|Candida|candida
177744|NCT02220790|Pediatric ICU patient|pediatric icu patient
177745|NCT02220777|MTD (Maximum Tolerated Dose)|mtd (maximum tolerated dose)
177746|NCT02220777|Food effect|food effect
177747|NCT02220777|Postmenopausal subjects|postmenopausal subjects
177748|NCT02220777|Vasectomized subjects|vasectomized subjects
177749|NCT02220777|FIH (First In Humans)|fih (first in humans)
177750|NCT02220777|SAD (Single Ascending Dose)|sad (single ascending dose)
177751|NCT02220777|DDI (Drug-Drug Interaction)|ddi (drug-drug interaction)
177752|NCT02220764|prospective study|prospective study
177753|NCT02220764|chipping|chipping
177754|NCT02220764|survival rate|survival rate
177755|NCT02220764|fracture resistance|fracture resistance
177756|NCT02220764|zirconia|zirconia
177757|NCT02220751|Periodontal Attachment Loss|periodontal attachment loss
177758|NCT02220751|Genes|genes
177759|NCT02220751|Saliva|saliva
177760|NCT02220751|Diagnosis|diagnosis
177761|NCT02220738|Alzheimer's Disease|alzheimer's disease
177762|NCT02220725|Andexanet alpha|andexanet alpha
177763|NCT02220725|Anticoagulation|anticoagulation
177764|NCT02220725|Antidote|antidote
177765|NCT02220725|Rivaroxaban|rivaroxaban
177766|NCT02220725|Anti-fXa inhibitor|anti-fxa inhibitor
177767|NCT02220725|PRT4445|prt4445
177768|NCT02220725|Xarelto|xarelto
177769|NCT02220725|Reversal agent|reversal agent
177770|NCT02220712|Aripiprazole|aripiprazole
177771|NCT02220712|Deltoid|deltoid
177772|NCT02220699|Ostoporosis|ostoporosis
177773|NCT02220699|Primary Prevention|primary prevention
177774|NCT02220699|Health Promotion|health promotion
177775|NCT02220699|General Practice|general practice
177776|NCT02220699|Secondary screening|secondary screening
177777|NCT02220699|Patients at increased risk of osteoporosis|patients at increased risk of osteoporosis
177778|NCT02220686|VAPOR|vapor
177779|NCT02220686|smoking cessation|smoking cessation
177781|NCT02220621|Intrauterine adhesion|intrauterine adhesion
177782|NCT02220621|crosslinked hyaluronan gel|crosslinked hyaluronan gel
216497|NCT02043080|HIV|hiv
168722|NCT02264704|MS|ms
177783|NCT02220621|hysteroscopy|hysteroscopy
177784|NCT02220621|clinical trial|clinical trial
177785|NCT02220608|Multiple Myeloma|multiple myeloma
177786|NCT02220608|G-CSF|g-csf
177787|NCT02220608|Bortezomib|bortezomib
177788|NCT02220595|Stenting|stenting
177789|NCT02220595|Endarterectomy|endarterectomy
177790|NCT02220595|Cognition|cognition
177791|NCT02220582|Cardiac Magnetic Resonance (CMR)|cardiac magnetic resonance (cmr)
177792|NCT02220582|Cardiovascular Diseases|cardiovascular diseases
177793|NCT02220582|socio-environmental factors|socio-environmental factors
177794|NCT02220582|Contextual factors|contextual factors
177795|NCT02220543|Cognitive behavioral therapy|cognitive behavioral therapy
177796|NCT02220543|Primary health care|primary health care
177797|NCT02220543|Physical Therapy|physical therapy
177798|NCT02220530|Sedation.|sedation.
177799|NCT02220530|Colonoscopy quality.|colonoscopy quality.
177800|NCT02220530|Scientific and technical quality.|scientific and technical quality.
177801|NCT02220530|Perceived quality (patient's satisfaction).|perceived quality (patient's satisfaction).
177802|NCT02220530|Safety|safety
177803|NCT02220517|MRI/US fusion-guided prostate biopsy|mri/us fusion-guided prostate biopsy
177804|NCT02220517|MR-guided in-bore prostate biopsy|mr-guided in-bore prostate biopsy
177805|NCT02220517|prostate cancer|prostate cancer
177806|NCT02220504|Treatment|treatment
177807|NCT02220504|Maintenance|maintenance
177808|NCT02220478|hip|hip
177809|NCT02220478|Signature|signature
177810|NCT02220465|sedentary|sedentary
177811|NCT02220465|smoking|smoking
177812|NCT02220465|cue reactivity|cue reactivity
177813|NCT02220465|physical activity|physical activity
177814|NCT02220439|rotavirus|rotavirus
177815|NCT02220439|immunogenicity|immunogenicity
177816|NCT02220439|enteric vaccine|enteric vaccine
177817|NCT02220439|vaccine immunogenicity|vaccine immunogenicity
177823|NCT02220413|Breastmilk|breastmilk
177824|NCT02220413|Lactogenesis|lactogenesis
177825|NCT02220413|Obesity|obesity
177826|NCT02220400|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
177827|NCT02220400|Ketamine|ketamine
177828|NCT02220400|Surgery|surgery
177829|NCT02220387|occupational COPD|occupational copd
177830|NCT02220387|phenotype|phenotype
177831|NCT02220387|genetic|genetic
177839|NCT02220335|pulmonary hypertension|pulmonary hypertension
177840|NCT02220335|pulmonary arterial denervation|pulmonary arterial denervation
177841|NCT02220335|left heart failure|left heart failure
177842|NCT02220335|6-min walk distance|6-min walk distance
177843|NCT02220322|cortical thickness|cortical thickness
177845|NCT02220309|Anxiety|anxiety
177846|NCT02220309|Depression|depression
177847|NCT02220309|Social Anxiety Disorder|social anxiety disorder
177848|NCT02220309|Bipolar disorder II|bipolar disorder ii
177849|NCT02220309|PTSD|ptsd
177850|NCT02220309|GAD|gad
177851|NCT02220309|Phobia|phobia
177852|NCT02220283|Acute kidney injury,aortic dissection|acute kidney injury,aortic dissection
177853|NCT02220257|diabetes mellitus type 1|diabetes mellitus type 1
177854|NCT02220257|remission, honeymoon|remission, honeymoon
177855|NCT02220257|microangiopathy|microangiopathy
177856|NCT02220244|multiple sclerosis (MS)|multiple sclerosis (ms)
177857|NCT02220244|optic neuritis|optic neuritis
177858|NCT02220244|visual defect|visual defect
177859|NCT02220244|visual loss|visual loss
177860|NCT02220244|relapsing remitting multiple sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
177861|NCT02220244|primary progressive multiple sclerosis (PPMS)|primary progressive multiple sclerosis (ppms)
177862|NCT02220244|secondary progressive multiple sclerosis (SPMS)|secondary progressive multiple sclerosis (spms)
177863|NCT02220231|mediastinal mass, one-lung ventilation, capnothorax, transesophageal echocardiography|mediastinal mass, one-lung ventilation, capnothorax, transesophageal echocardiography
177864|NCT02220218|Healthy|healthy
177865|NCT02220218|Metformin|metformin
177866|NCT02220218|Canagliflozin|canagliflozin
177867|NCT02220218|JNJ-28431754|jnj-28431754
177868|NCT02220205|IUD|iud
177869|NCT02220205|training|training
177870|NCT02220205|simulation|simulation
177871|NCT02220192|cervical neoplasia|cervical neoplasia
177872|NCT02220192|cervix|cervix
177873|NCT02220192|high-grade dysplasia|high-grade dysplasia
177874|NCT02220192|LEEP (loop electrosurgical excision procedure)|leep (loop electrosurgical excision procedure)
177875|NCT02220192|precancerous cells|precancerous cells
177876|NCT02220192|colposcopy|colposcopy
177877|NCT02220166|Celiac Disease|celiac disease
177878|NCT02220166|Gluten|gluten
177879|NCT02220166|Gluten free diet|gluten free diet
177880|NCT02220166|Triticum monococcum|triticum monococcum
177881|NCT02220153|Monoclonal antibody|monoclonal antibody
177882|NCT02220153|subjects|subjects
177883|NCT02220153|First in human|first in human
177884|NCT02220127|Brain|brain
177885|NCT02220127|Neoplasm Micrometastasis|neoplasm micrometastasis
177886|NCT02220127|Gamma Knife Radiosurgery|gamma knife radiosurgery
177887|NCT02220114|Infantile spasms|infantile spasms
177888|NCT02220114|vigabatrin|vigabatrin
177889|NCT02220114|soluble tablets|soluble tablets
177890|NCT02220114|acceptability|acceptability
177891|NCT02220114|adherence|adherence
177892|NCT02220114|pharmacokinetics|pharmacokinetics
177893|NCT02220101|hypothermia|hypothermia
177894|NCT02220101|core temperature|core temperature
177895|NCT02220101|temperature measurement methods|temperature measurement methods
177896|NCT02220088|Hepatocellular Carcinoma|hepatocellular carcinoma
177897|NCT02220088|TACE|tace
177898|NCT02220088|TACE failure|tace failure
177899|NCT02220088|TACE refractoriness|tace refractoriness
177900|NCT02220088|BCLC B|bclc b
177901|NCT02220075|fiberoptic, LMA, caudal block|fiberoptic, lma, caudal block
177902|NCT02220036|Diabetic nephropathy|diabetic nephropathy
177903|NCT02220036|Renal function|renal function
178198|NCT02218775|Anhedonia|anhedonia
177904|NCT02220036|Insulin resistance|insulin resistance
177905|NCT02220036|Metabolic profile|metabolic profile
177906|NCT02220036|Serum magnesium level|serum magnesium level
177907|NCT02220010|Post operative pancreatic fistulas|post operative pancreatic fistulas
177908|NCT02220010|Pancreatic stenting|pancreatic stenting
177909|NCT02219997|Cataract|cataract
177910|NCT02219997|Intraocular lens (IOL)|intraocular lens (iol)
177911|NCT02219997|AcrySof|acrysof
177912|NCT02219984|Anticoagulation|anticoagulation
177913|NCT02219984|vitamin K antagonists|vitamin k antagonists
177914|NCT02219984|Warfarin|warfarin
177915|NCT02219984|low molecular weight heparin|low molecular weight heparin
177916|NCT02219984|fondaparinux|fondaparinux
177917|NCT02219984|antithrombotics|antithrombotics
177918|NCT02219984|Direct oral anticoagulants|direct oral anticoagulants
177919|NCT02219984|dabigatran|dabigatran
177920|NCT02219984|rivaroxaban|rivaroxaban
177921|NCT02219984|apixaban|apixaban
177922|NCT02219984|edoxaban|edoxaban
177923|NCT02219984|atrial fibrillation|atrial fibrillation
177924|NCT02219984|venous thromboembolism|venous thromboembolism
177925|NCT02219971|Healthy|healthy
177926|NCT02219958|Hypertension|hypertension
177927|NCT02219945|pulmonary tuberculosis; electronic nose; diagnostic accuracy|pulmonary tuberculosis; electronic nose; diagnostic accuracy
177928|NCT02219932|Fampridine|fampridine
177929|NCT02219919|Carpal Tunnel Syndrome|carpal tunnel syndrome
177930|NCT02219919|Pain|pain
177931|NCT02219919|Sensitivity|sensitivity
177932|NCT02219919|Pain Thresholds|pain thresholds
177933|NCT02219919|Sensitization|sensitization
177934|NCT02219919|Physical Therapy|physical therapy
177935|NCT02219893|Peritoneal Carcinomatosis|peritoneal carcinomatosis
177936|NCT02219893|Peritoneal Metastasis|peritoneal metastasis
177937|NCT02219893|Colorectal Cancer|colorectal cancer
177938|NCT02219893|Cytoreductive surgery|cytoreductive surgery
177939|NCT02219893|HIPEC|hipec
177940|NCT02219893|Intraperitoneal treatment|intraperitoneal treatment
177941|NCT02219893|Immunotoxin|immunotoxin
177942|NCT02219893|MOC31PE|moc31pe
177943|NCT02219880|Kava|kava
177944|NCT02219880|Anxiety|anxiety
177945|NCT02219880|Generalized Anxiety Disorder|generalized anxiety disorder
177946|NCT02219880|Psychiatric|psychiatric
177947|NCT02219880|Anxiolytic|anxiolytic
177948|NCT02219880|GABA|gaba
177949|NCT02219880|Kavalactones|kavalactones
177950|NCT02219867|ketamine|ketamine
177951|NCT02219867|MDD|mdd
177952|NCT02219841|Obesity, low-calorie diet, exercise, atrial fibrillation|obesity, low-calorie diet, exercise, atrial fibrillation
177953|NCT02219828|pericarditis|pericarditis
177954|NCT02219828|recurrent pericarditis|recurrent pericarditis
177955|NCT02219828|corticosteroids|corticosteroids
177956|NCT02219828|anakinra|anakinra
177957|NCT02219815|Preoperative Care|preoperative care
177958|NCT02219815|Exercise Therapy|exercise therapy
177959|NCT02219815|Cardiac Surgery|cardiac surgery
177960|NCT02219815|Frailty|frailty
177961|NCT02219802|Coronary artery disease|coronary artery disease
177962|NCT02219802|Acute myocardial infarction|acute myocardial infarction
177963|NCT02219802|Drug-coated balloon|drug-coated balloon
177964|NCT02219802|Drug-eluting stent|drug-eluting stent
177965|NCT02219776|Infection,|infection,
177966|NCT02219776|Proprionbacterium Acne,|proprionbacterium acne,
177967|NCT02219776|Shoulder,|shoulder,
177968|NCT02219776|skin preparation|skin preparation
177969|NCT02219750|premix insuiln, basal-plus insulin|premix insuiln, basal-plus insulin
177970|NCT02219711|MGCD516|mgcd516
177971|NCT02219711|MET|met
177972|NCT02219711|AXL|axl
177973|NCT02219711|RET|ret
177974|NCT02219711|TRK|trk
177975|NCT02219711|NTRK|ntrk
177976|NCT02219711|DDR2|ddr2
177977|NCT02219711|KDR|kdr
177978|NCT02219711|VEGFR|vegfr
177979|NCT02219711|PDGFRA|pdgfra
177980|NCT02219711|KIT|kit
177981|NCT02219711|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
177982|NCT02219711|NSCLC|nsclc
177983|NCT02219711|Non-small cell lung cancer|non-small cell lung cancer
177984|NCT02219711|Head and neck cancer|head and neck cancer
177985|NCT02219711|Renal cell carcinoma|renal cell carcinoma
177986|NCT02219711|Prostate cancer|prostate cancer
177987|NCT02219711|Phase 1|phase 1
177988|NCT02219711|CBL|cbl
177989|NCT02219672|Triptolide wilfordii HIV-1 reservoir acute hiv infection|triptolide wilfordii hiv-1 reservoir acute hiv infection
177990|NCT02219659|sedation strategy|sedation strategy
168922|NCT02263118|rural|rural
177991|NCT02219659|mechanical ventilation|mechanical ventilation
177992|NCT02219659|ventilator weaning|ventilator weaning
177993|NCT02219646|T2DM|t2dm
177994|NCT02219646|ED|ed
177995|NCT02219620|creative arts|creative arts
177996|NCT02219620|older adults|older adults
177997|NCT02219620|intervention study|intervention study
177998|NCT02219594|gemstone CT|gemstone ct
177999|NCT02219594|320-detector row spiral CT|320-detector row spiral ct
178000|NCT02219594|optical coherence tomography(OCT)|optical coherence tomography(oct)
178001|NCT02219594|in-stent restenosis|in-stent restenosis
178002|NCT02219594|coronary heart disease|coronary heart disease
178003|NCT02219581|Osteoarthritis|osteoarthritis
178004|NCT02219581|Postoperative pain|postoperative pain
178394|NCT02218008|Alkermes|alkermes
178005|NCT02219581|Total knee arthroplasty|total knee arthroplasty
178006|NCT02219581|Orthopaedics|orthopaedics
178007|NCT02219581|Inflammation|inflammation
178008|NCT02219568|obscure gastrointestinal bleeding, CT enterography|obscure gastrointestinal bleeding, ct enterography
178009|NCT02219555|Carpal tunnel|carpal tunnel
178010|NCT02219542|cytokine Transversus Abdominis Plane Block|cytokine transversus abdominis plane block
178011|NCT02219503|Hepatitis C|hepatitis c
178012|NCT02219503|Chronic Hepatitis C|chronic hepatitis c
178013|NCT02219503|Compensated Cirrhosis|compensated cirrhosis
178014|NCT02219503|Cirrhotic|cirrhotic
178015|NCT02219503|Hepatitis C Genotype 1b|hepatitis c genotype 1b
178016|NCT02219503|Hepatitis C Virus|hepatitis c virus
178017|NCT02219503|Interferon-Free|interferon-free
178307|NCT02218294|BioCryst|biocryst
178018|NCT02219503|Child Pugh A|child pugh a
178019|NCT02219503|Ribavirin-Free|ribavirin-free
178020|NCT02219490|Non responder|non responder
178021|NCT02219490|Null responder|null responder
178022|NCT02219490|Treatment-Experienced|treatment-experienced
178023|NCT02219490|Cirrhosis|cirrhosis
178024|NCT02219490|Relapser|relapser
178025|NCT02219490|Hepatitis C Genotype 1|hepatitis c genotype 1
178026|NCT02219490|Compensated Cirrhosis|compensated cirrhosis
178028|NCT02219477|Cirrhosis|cirrhosis
178029|NCT02219477|Hepatitis C|hepatitis c
178030|NCT02219477|Child-Pugh B|child-pugh b
178031|NCT02219477|Hepatitis C Genotype 4|hepatitis c genotype 4
178032|NCT02219477|Interferon-Free|interferon-free
178033|NCT02219477|Hepatitis C Genotype 1|hepatitis c genotype 1
178034|NCT02219477|Chronic Hepatitis C|chronic hepatitis c
178035|NCT02219477|Decompensated Cirrhosis|decompensated cirrhosis
178036|NCT02219477|Hepatitis C Virus|hepatitis c virus
178037|NCT02219464|nasopharyngeal catheter|nasopharyngeal catheter
178038|NCT02219464|nasal cannula|nasal cannula
178039|NCT02219451|Chronic heart failure|chronic heart failure
178040|NCT02219451|exercise training|exercise training
178041|NCT02219451|Sympathetic modulation|sympathetic modulation
178042|NCT02219451|arterial baroreflex control|arterial baroreflex control
178043|NCT02219425|Infertility|infertility
178044|NCT02219425|Endometrium|endometrium
178045|NCT02219425|Endometrial biopsy|endometrial biopsy
178046|NCT02219425|Gene expression|gene expression
178047|NCT02219412|ticagrelor|ticagrelor
178048|NCT02219412|platelet aggregation rate|platelet aggregation rate
178049|NCT02219412|ADP antagonist|adp antagonist
178050|NCT02219412|antiplatelet therapy|antiplatelet therapy
178051|NCT02219399|Pregnancy|pregnancy
178052|NCT02219399|DHA|dha
178053|NCT02219399|Gestational Length|gestational length
178054|NCT02219399|Cognitive Development|cognitive development
178055|NCT02219386|Myofascial pain syndromes,physiotherapy,muscle stretching exercises,neck pain,dry needling|myofascial pain syndromes,physiotherapy,muscle stretching exercises,neck pain,dry needling
178056|NCT02219360|acute|acute
178057|NCT02219360|exacerbation|exacerbation
178058|NCT02219360|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
178059|NCT02219347|rheumatoid arthritis|rheumatoid arthritis
178060|NCT02219347|biological markers|biological markers
178061|NCT02219347|remission|remission
178062|NCT02219347|ultrasonography|ultrasonography
178063|NCT02219347|microarray|microarray
178064|NCT02219347|survival analysis|survival analysis
178065|NCT02219347|T cell|t cell
178066|NCT02219334|Children|children
178067|NCT02219334|Nasal suction devices|nasal suction devices
178068|NCT02219334|Suctioning|suctioning
178069|NCT02219321|Pain, Opioid dependence, Lidocaine infusion|pain, opioid dependence, lidocaine infusion
178070|NCT02219308|Contraception|contraception
178071|NCT02219308|Pain|pain
178072|NCT02219308|Intrauterine Device|intrauterine device
178073|NCT02219308|Paracervical Block|paracervical block
178074|NCT02219295|SGLT1 (sodium dependent glucose transporter)|sglt1 (sodium dependent glucose transporter)
178075|NCT02219295|Glut-transporters|glut-transporters
178076|NCT02219295|taste receptors genes|taste receptors genes
178077|NCT02219295|sweet taste receptor T1R2T1R3|sweet taste receptor t1r2t1r3
178078|NCT02219295|bitter taste receptors of the hTAS2gene family|bitter taste receptors of the htas2gene family
178079|NCT02219282|laryngeal mask airway, edentulate geriatric patients|laryngeal mask airway, edentulate geriatric patients
178080|NCT02219269|contraception|contraception
178081|NCT02219269|family planning|family planning
402938|NCT01229007|Children|children
178082|NCT02219269|complex medical conditions|complex medical conditions
178083|NCT02219256|Drug therapy|drug therapy
178084|NCT02219243|Social Anxiety Disorder|social anxiety disorder
178085|NCT02219243|Cognitive Training|cognitive training
178086|NCT02219243|Interpretation Modification Program|interpretation modification program
178087|NCT02219204|Acupuncture|acupuncture
178088|NCT02219204|Herbal treatment|herbal treatment
178089|NCT02219191|Puerarin tablet|puerarin tablet
178090|NCT02219191|rheumatoid arthritis|rheumatoid arthritis
178091|NCT02219191|metabolism syndrome|metabolism syndrome
178092|NCT02219165|Paediatrics|paediatrics
178093|NCT02219165|Toxic Shock Syndrome|toxic shock syndrome
178094|NCT02219165|Intravenous human immunoglobulin|intravenous human immunoglobulin
178095|NCT02219165|feasibility|feasibility
178096|NCT02219139|Edentulous|edentulous
178097|NCT02219139|Roxolid|roxolid
178098|NCT02219139|SLAclive surface|slaclive surface
178099|NCT02219139|Titanium/zirconium|titanium/zirconium
178100|NCT02219113|Damage of articular cartilage|damage of articular cartilage
178101|NCT02219113|Cartilage degeneration|cartilage degeneration
178102|NCT02219113|Intraarticular injection|intraarticular injection
178103|NCT02219113|ADRC|adrc
178104|NCT02219113|Adipose-derived regenerative cells|adipose-derived regenerative cells
178105|NCT02219113|Adipose tissue|adipose tissue
178106|NCT02219113|Stem cells|stem cells
178107|NCT02219087|Total knee arthroplasty|total knee arthroplasty
178108|NCT02219087|Total joint arthroplasty|total joint arthroplasty
178109|NCT02219087|Knee replacement|knee replacement
178110|NCT02219087|Osteoarthritis of the knee|osteoarthritis of the knee
178111|NCT02219061|Measles|measles
178409|NCT02217878|ticagrelor|ticagrelor
178112|NCT02219061|Meningitis C|meningitis c
178113|NCT02219061|waning|waning
178114|NCT02219061|Geometric Mean Titer|geometric mean titer
178115|NCT02219061|China|china
178116|NCT02219048|Asthma|asthma
178117|NCT02219048|Staged withdrawal of background therapy|staged withdrawal of background therapy
178311|NCT02218294|ADME|adme
178119|NCT02219022|Rheumatoid arthritis|rheumatoid arthritis
178120|NCT02219022|Progressive resistance exercise|progressive resistance exercise
178121|NCT02219022|Pain|pain
178122|NCT02219022|Functional capacity|functional capacity
178123|NCT02219022|Quality of life|quality of life
178124|NCT02219022|Muscle strength|muscle strength
178125|NCT02219009|OPC-14597 Digital|opc-14597 digital
178126|NCT02219009|Aripiprazole|aripiprazole
178127|NCT02219009|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
178128|NCT02219009|Treatment Adherence|treatment adherence
178129|NCT02219009|Ingestible Event Marker|ingestible event marker
178130|NCT02218996|Anxiety|anxiety
178131|NCT02218996|Children|children
178132|NCT02218996|Adolescent|adolescent
178133|NCT02218996|Effectiveness|effectiveness
178134|NCT02218996|Outpatient|outpatient
178135|NCT02218983|trauma|trauma
178136|NCT02218983|echo|echo
178137|NCT02218983|echocardiogram|echocardiogram
178138|NCT02218983|ultrasound|ultrasound
178139|NCT02218983|inferior vena cava collapsibility|inferior vena cava collapsibility
178140|NCT02218970|rehabilitation|rehabilitation
178141|NCT02218970|strength training|strength training
178142|NCT02218970|muscle strength|muscle strength
178143|NCT02218970|physical fitness|physical fitness
178144|NCT02218957|Bariatric surgery|bariatric surgery
178145|NCT02218957|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
178146|NCT02218931|Pre-eclampsia|pre-eclampsia
178147|NCT02218931|Gestational diabetes|gestational diabetes
178148|NCT02218931|Stillbirth|stillbirth
178149|NCT02218931|Small for gestational age|small for gestational age
178150|NCT02218931|Admission to neonatal intensive care unit|admission to neonatal intensive care unit
178151|NCT02218931|Obesity|obesity
178152|NCT02218931|Raised Lipids|raised lipids
178153|NCT02218931|High Blood Pressure|high blood pressure
178154|NCT02218931|Cardiovascular risk|cardiovascular risk
178155|NCT02218931|Insulin resistance|insulin resistance
178156|NCT02218931|Mediterranean dietary pattern|mediterranean dietary pattern
178157|NCT02218931|Dietary interventions|dietary interventions
178158|NCT02218918|Ground walk|ground walk
178159|NCT02218918|treadmill walk|treadmill walk
178160|NCT02218918|Functional walk capacity|functional walk capacity
178161|NCT02218918|COPD|copd
178162|NCT02218918|Quality of Life|quality of life
178163|NCT02218905|Correlation|correlation
178164|NCT02218905|Sit to stand repetitions|sit to stand repetitions
178165|NCT02218905|Anthropometric variables|anthropometric variables
178167|NCT02218905|Height|height
178168|NCT02218905|weight|weight
178169|NCT02218905|Gender|gender
178170|NCT02218905|Regression|regression
178171|NCT02218866|Bariatric surgery|bariatric surgery
178172|NCT02218866|Obesity|obesity
178173|NCT02218866|Neuropathy|neuropathy
178174|NCT02218853|Bipolar disorder|bipolar disorder
178175|NCT02218853|Psychosis|psychosis
178176|NCT02218853|Schizophrenia|schizophrenia
178177|NCT02218840|cigar smoker|cigar smoker
178178|NCT02218840|smoking|smoking
178179|NCT02218840|behavioral pharmacology|behavioral pharmacology
178180|NCT02218840|smoking topography|smoking topography
178181|NCT02218827|Dry Eye|dry eye
178182|NCT02218827|Inflammatory reaction|inflammatory reaction
178183|NCT02218827|steroids|steroids
178184|NCT02218814|Femoral Nerve Block|femoral nerve block
178185|NCT02218814|Adductor Canal Nerve Block|adductor canal nerve block
178186|NCT02218801|Liver metastasis|liver metastasis
178187|NCT02218801|Colorectal carcinoma|colorectal carcinoma
178188|NCT02218801|Unresectable|unresectable
178189|NCT02218801|Borderline resectable|borderline resectable
178190|NCT02218801|Initially unresectable|initially unresectable
178191|NCT02218788|Nasolabial folds|nasolabial folds
178192|NCT02218788|Marionette lines|marionette lines
178193|NCT02218788|Cheek bones|cheek bones
178194|NCT02218788|Jaw lines|jaw lines
178195|NCT02218775|Kappa opioid receptor|kappa opioid receptor
178196|NCT02218775|Mu opioid receptor|mu opioid receptor
178197|NCT02218775|LY2456302|ly2456302
178199|NCT02218775|Mood and Anxiety Spectrum Disorders|mood and anxiety spectrum disorders
178200|NCT02218762|Fluticasone propionate/salmeterol in a capsule-based inhaler|fluticasone propionate/salmeterol in a capsule-based inhaler
178201|NCT02218762|replicated cross-over design|replicated cross-over design
178202|NCT02218762|Respiratory|respiratory
178203|NCT02218762|asthma|asthma
178204|NCT02218762|safety|safety
178205|NCT02218762|pharmacokinetics|pharmacokinetics
178206|NCT02218762|Fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
178207|NCT02218762|pharmacodynamics|pharmacodynamics
178208|NCT02218762|Fluticasone propionate/salmeterol in a multi-dose dry powder inhaler|fluticasone propionate/salmeterol in a multi-dose dry powder inhaler
178209|NCT02218736|Anhedonia|anhedonia
178210|NCT02218736|Mood and Anxiety Spectrum Disorders|mood and anxiety spectrum disorders
178211|NCT02218736|CERC-501 (investigational product)|cerc-501 (investigational product)
178212|NCT02218736|Kappa Opioid Receptor (KOR)|kappa opioid receptor (kor)
178213|NCT02218723|healthy volunteer|healthy volunteer
178214|NCT02218723|Asthma|asthma
178215|NCT02218723|inhaled corticosteroid|inhaled corticosteroid
178217|NCT02218723|ELLIPTA DPI|ellipta dpi
178218|NCT02218723|Fluticasone furoate|fluticasone furoate
178219|NCT02218697|Immunogenicity|immunogenicity
178220|NCT02218697|Influsplit Tetra (Fluarix Tetra) 2014/2015 season|influsplit tetra (fluarix tetra) 2014/2015 season
178221|NCT02218697|Safety|safety
178222|NCT02218697|Adults|adults
178223|NCT02218697|Pneumovax 23/Pneumovax|pneumovax 23/pneumovax
178224|NCT02218697|Co-administration|co-administration
178225|NCT02218697|Elderly|elderly
178226|NCT02218697|Seasonal influenza|seasonal influenza
178227|NCT02218697|Pneumococcal infection|pneumococcal infection
178228|NCT02218632|Galactosaemia|galactosaemia
178229|NCT02218632|Dysglycosylation|dysglycosylation
178230|NCT02218632|Diet|diet
178231|NCT02218619|type 1 diabetes (T1D)|type 1 diabetes (t1d)
178232|NCT02218619|endoplasmic reticulum (ER) stress|endoplasmic reticulum (er) stress
178233|NCT02218619|induced pluripotential stem (iPS) cells|induced pluripotential stem (ips) cells
178234|NCT02218619|Tauroursodeoxycholic Acid (TUDCA)|tauroursodeoxycholic acid (tudca)
178235|NCT02218606|Abiraterone Acetate|abiraterone acetate
178236|NCT02218606|CABAZITAXEL|cabazitaxel
178237|NCT02218606|CASTRATION RESISTANT|castration resistant
178238|NCT02218606|14-046|14-046
178239|NCT02218606|Prostate Cancer Clinical Trials Consortium|prostate cancer clinical trials consortium
178240|NCT02218580|massage therapy|massage therapy
178241|NCT02218580|juvenile arthritis|juvenile arthritis
178242|NCT02218580|pain|pain
178243|NCT02218554|BRONJ|bronj
178244|NCT02218528|subjects|subjects
178245|NCT02218515|Autogenous bone graft|autogenous bone graft
178246|NCT02218515|Chronic periodontitis|chronic periodontitis
178247|NCT02218515|Enamel matrix derivatives|enamel matrix derivatives
178248|NCT02218515|Gingival crevicular fluid|gingival crevicular fluid
178249|NCT02218515|Periodontal flap surgery|periodontal flap surgery
178250|NCT02218502|Ovarian cancer|ovarian cancer
178251|NCT02218502|Diagnosis|diagnosis
178252|NCT02218502|Risk of Malignancy Index|risk of malignancy index
178253|NCT02218502|RMI|rmi
178254|NCT02218502|Ultrasound|ultrasound
178255|NCT02218502|Simple ultrasound-based rules|simple ultrasound-based rules
178256|NCT02218502|DW-MRI|dw-mri
178257|NCT02218502|Subjective assessment|subjective assessment
178258|NCT02218489|Pain|pain
178259|NCT02218489|Corticosteroid|corticosteroid
178260|NCT02218489|Meibomian Gland Disease|meibomian gland disease
178261|NCT02218489|Blepharitis|blepharitis
178262|NCT02218489|Eyelid|eyelid
178263|NCT02218489|Ocular Discomfort|ocular discomfort
178264|NCT02218463|Vulvar disease, adhesions, topical therapy|vulvar disease, adhesions, topical therapy
178265|NCT02218463|Labial adhesions prepubertal girls|labial adhesions prepubertal girls
178266|NCT02218463|Labial agglutination|labial agglutination
178267|NCT02218463|Labial fusion|labial fusion
178268|NCT02218437|Mesenchymal Stem Cells (MSC)|mesenchymal stem cells (msc)
178269|NCT02218437|Umbilical Cord|umbilical cord
178270|NCT02218437|thymocyte globulin (ATG)|thymocyte globulin (atg)
178271|NCT02218437|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
178272|NCT02218398|airway resistance|airway resistance
178273|NCT02218398|lung compliance|lung compliance
178274|NCT02218398|Duration of mechanical ventilation|duration of mechanical ventilation
178275|NCT02218385|Nipple Aspirate Fluid|nipple aspirate fluid
178276|NCT02218385|Breast Health Screening|breast health screening
178277|NCT02218385|Cytology|cytology
178278|NCT02218372|Clostridium difficile-associated Diarrhea (CDAD)|clostridium difficile-associated diarrhea (cdad)
178279|NCT02218372|vancomycin|vancomycin
178280|NCT02218372|Clostridium difficile infection|clostridium difficile infection
178281|NCT02218372|fidaxomicin|fidaxomicin
178282|NCT02218359|Gram-negative pneumonia|gram-negative pneumonia
178283|NCT02218359|Aerosol antibiotics|aerosol antibiotics
178284|NCT02218359|Mechanical ventilation|mechanical ventilation
178285|NCT02218359|Amikacin|amikacin
178286|NCT02218359|Fosfomycin|fosfomycin
178287|NCT02218359|Pneumonia, Bacterial|pneumonia, bacterial
178288|NCT02218359|Pneumonia|pneumonia
178289|NCT02218359|Bacterial Infections|bacterial infections
178290|NCT02218359|Lung Diseases|lung diseases
178291|NCT02218359|Respiratory Tract Diseases|respiratory tract diseases
178292|NCT02218359|Respiratory Tract Infections|respiratory tract infections
178293|NCT02218359|Anti-Bacterial Agents|anti-bacterial agents
178294|NCT02218359|Anti-Infective Agents|anti-infective agents
178295|NCT02218359|Therapeutic Uses|therapeutic uses
178296|NCT02218359|Pharmacologic Actions|pharmacologic actions
178297|NCT02218359|MRSA|mrsa
178298|NCT02218346|Healthy volunteers|healthy volunteers
178299|NCT02218320|HIV|hiv
178300|NCT02218320|Gut-associated lymphoid tissue|gut-associated lymphoid tissue
178301|NCT02218320|raltegravir|raltegravir
178302|NCT02218320|Isentress|isentress
178303|NCT02218320|dolutegravir|dolutegravir
178304|NCT02218320|Tivicay|tivicay
178305|NCT02218320|pharmacodynamics|pharmacodynamics
178306|NCT02218294|BCX4161|bcx4161
178308|NCT02218294|hereditary angioedema|hereditary angioedema
178309|NCT02218294|mass balance|mass balance
178310|NCT02218294|kallikrein inhibitor|kallikrein inhibitor
178312|NCT02218268|type I diabetes|type i diabetes
178313|NCT02218268|healthy|healthy
178314|NCT02218268|children|children
178315|NCT02218268|adolescents|adolescents
178316|NCT02218268|young adults|young adults
178317|NCT02218255|In Vitro Fertilization|in vitro fertilization
178318|NCT02218242|Lung|lung
178319|NCT02218242|Cancer|cancer
178320|NCT02218242|Ultrasound|ultrasound
178321|NCT02218242|Staging|staging
178322|NCT02218229|shock wave|shock wave
178323|NCT02218229|carpal tunnel syndrome|carpal tunnel syndrome
178324|NCT02218216|Mild Traumatic Brain Injury|mild traumatic brain injury
178325|NCT02218203|chronic pain|chronic pain
178326|NCT02218203|central neuropathic pain|central neuropathic pain
178327|NCT02218203|spinal cord injury|spinal cord injury
178328|NCT02218203|dextromethorphan|dextromethorphan
178329|NCT02218203|lidocaine|lidocaine
178330|NCT02218203|combination therapy|combination therapy
178331|NCT02218203|analgesia|analgesia
178332|NCT02218190|Alvimopan|alvimopan
178333|NCT02218190|Ileus|ileus
178334|NCT02218190|Posterior spinal fusion|posterior spinal fusion
178335|NCT02218177|wet Age Related Macular Degeneration|wet age related macular degeneration
178336|NCT02218177|Ranibizumab|ranibizumab
178337|NCT02218177|Aflibercept|aflibercept
178338|NCT02218177|Combination Photodynamic Therapy|combination photodynamic therapy
178339|NCT02218177|Cytokine analysis|cytokine analysis
178340|NCT02218164|metastatic|metastatic
178341|NCT02218164|cutaneous|cutaneous
178342|NCT02218164|skin cancer|skin cancer
178343|NCT02218151|Hematopoietic|hematopoietic
178344|NCT02218151|Stem Cell|stem cell
178345|NCT02218151|Transplant|transplant
178346|NCT02218151|patient-centered|patient-centered
178347|NCT02218151|Microbiota|microbiota
178348|NCT02218151|GVHD|gvhd
178349|NCT02218138|Adolescent|adolescent
178350|NCT02218138|Diabetes|diabetes
178351|NCT02218138|Depression|depression
178352|NCT02218138|Obesity|obesity
178353|NCT02218138|Stress|stress
178354|NCT02218125|Healthy|healthy
178355|NCT02218125|Human immunodeficiency virus type 1 (HIV-1) infection|human immunodeficiency virus type 1 (hiv-1) infection
178356|NCT02218125|Acquired immunodeficiency syndrome (AIDS)|acquired immunodeficiency syndrome (aids)
178357|NCT02218125|recombinant adenovirus (rAd) vector-based vaccines|recombinant adenovirus (rad) vector-based vaccines
178358|NCT02218125|Vaccination|vaccination
178359|NCT02218125|Ad26.ENVA.01|ad26.enva.01
178360|NCT02218125|Recombinant|recombinant
178361|NCT02218125|Modified Vaccinia Ankara (MVA) vector-based vaccines|modified vaccinia ankara (mva) vector-based vaccines
178362|NCT02218112|Blood pressure|blood pressure
178363|NCT02218112|Obesity|obesity
178364|NCT02218112|Glomerular filtration rate|glomerular filtration rate
178365|NCT02218112|Renal Sodium handling|renal sodium handling
178366|NCT02218099|Phase 1|phase 1
178367|NCT02218099|ASP8232|asp8232
178368|NCT02218099|Single dose|single dose
178369|NCT02218099|Multiple doses|multiple doses
178370|NCT02218086|postural control|postural control
178371|NCT02218086|postural balance|postural balance
178372|NCT02218086|slackline|slackline
178373|NCT02218073|Healthy|healthy
217243|NCT02039726|AML|aml
178374|NCT02218073|JNJ-42756493|jnj-42756493
178375|NCT02218073|JNJ-61818549|jnj-61818549
178376|NCT02218073|Isotope|isotope
401988|NCT01233609|retinitis pigmentosa|retinitis pigmentosa
178377|NCT02218047|Pegylated-Proline-interferon alpha-2b (AOP2014)|pegylated-proline-interferon alpha-2b (aop2014)
178378|NCT02218047|Polycythemia Vera|polycythemia vera
178379|NCT02218047|PROUD-PV|proud-pv
178380|NCT02218047|CONTINUATION-PV|continuation-pv
178381|NCT02218047|AOP Orphan|aop orphan
178382|NCT02218047|Polycythemia|polycythemia
178383|NCT02218047|Hematologic Diseases|hematologic diseases
178384|NCT02218047|Myeloproliferative Disorders|myeloproliferative disorders
178385|NCT02218047|Bone Marrow Diseases|bone marrow diseases
178386|NCT02218047|Interferon-alpha|interferon-alpha
178387|NCT02218047|Peginterferon alfa-2b|peginterferon alfa-2b
178388|NCT02218021|Alkermes|alkermes
178389|NCT02218021|ALKS 33|alks 33
178390|NCT02218021|ALKS 5461|alks 5461
178391|NCT02218021|Samidorphan|samidorphan
178392|NCT02218008|Major depressive disorder (MDD)|major depressive disorder (mdd)
178393|NCT02218008|depression|depression
178395|NCT02218008|ALKS 5461|alks 5461
178396|NCT02218008|samidorphan|samidorphan
178397|NCT02217995|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
178398|NCT02217995|Mindfulness|mindfulness
178399|NCT02217969|Anesthesia|anesthesia
178400|NCT02217969|Hypotension|hypotension
178401|NCT02217930|TQT|tqt
178402|NCT02217917|Healthy subjects|healthy subjects
178403|NCT02217917|Randomized|randomized
178404|NCT02217917|Double-blind|double-blind
178405|NCT02217917|Single ascending dose|single ascending dose
178406|NCT02217917|Multiple ascending dose|multiple ascending dose
178407|NCT02217878|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
178408|NCT02217878|non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
178411|NCT02217878|pharmacokinetics|pharmacokinetics
178412|NCT02217878|pharmacodynamics|pharmacodynamics
178413|NCT02217878|drug interactions|drug interactions
178415|NCT02217878|Multiple Electrode Aggregometry|multiple electrode aggregometry
178416|NCT02217878|VerifyNow|verifynow
178417|NCT02217865|Colorectal Cancer|colorectal cancer
178419|NCT02217865|Curative resection of colorectal cancer|curative resection of colorectal cancer
178420|NCT02217865|Caregivers|caregivers
178421|NCT02217865|Interviews|interviews
178422|NCT02217865|Focus groups|focus groups
178423|NCT02217865|Questionnaires|questionnaires
178424|NCT02217865|Surveys|surveys
178425|NCT02217852|hypertension|hypertension
178426|NCT02217852|Tibetan|tibetan
178427|NCT02217852|Nitrendipine|nitrendipine
178428|NCT02217852|hydrochlorothiazide|hydrochlorothiazide
178429|NCT02217852|captopril|captopril
178430|NCT02217852|Beijing hypotensive No.0|beijing hypotensive no.0
178431|NCT02217774|Computer-Aided Design/instrumentation|computer-aided design/instrumentation
178432|NCT02217774|Cone-Beam Computed Tomography|cone-beam computed tomography
178433|NCT02217774|Dental Implant|dental implant
178434|NCT02217774|MGuide|mguide
178435|NCT02217761|Pharmacokinetics|pharmacokinetics
178436|NCT02217761|Antifungal Agents|antifungal agents
178437|NCT02217735|Parkinson's Disease|parkinson's disease
178438|NCT02217735|Caregivers|caregivers
178439|NCT02217735|Expressive Writing|expressive writing
178440|NCT02217735|Complementary Medicine|complementary medicine
178441|NCT02217735|Cortisol|cortisol
178442|NCT02217696|Electroencephalography (EEG)|electroencephalography (eeg)
178443|NCT02217696|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
178444|NCT02217696|Multimodal Neuroimaging|multimodal neuroimaging
178445|NCT02217696|Development|development
178446|NCT02217696|Prediction|prediction
178447|NCT02217696|Intervention|intervention
178448|NCT02217683|Catheterization, Swan-Ganz|catheterization, swan-ganz
178449|NCT02217683|Cardiac Surgical Procedures|cardiac surgical procedures
178450|NCT02217683|Blood Transfusion|blood transfusion
178451|NCT02217683|Nitric Oxide|nitric oxide
178452|NCT02217657|Smart-Touch|smart-touch
178453|NCT02217657|Contact force|contact force
178454|NCT02217605|NAFLD|nafld
178455|NCT02217605|Oral Fructose Challenge|oral fructose challenge
178456|NCT02217605|31P MRS|31p mrs
178457|NCT02217605|Liver|liver
178458|NCT02217605|Subjects|subjects
178459|NCT02217579|Weight loss|weight loss
178460|NCT02217579|Appetite|appetite
178461|NCT02217579|Overweight|overweight
178462|NCT02217579|Obesity|obesity
178463|NCT02217579|Dietary fiber|dietary fiber
178464|NCT02217579|Dietary protein|dietary protein
178465|NCT02217566|Prostatic neoplasms|prostatic neoplasms
178466|NCT02217566|Diethylstilbestrol therapy|diethylstilbestrol therapy
178467|NCT02217566|Abiraterone acetate|abiraterone acetate
178468|NCT02217566|Prednisone|prednisone
178469|NCT02217566|Androgen deprivation therapy|androgen deprivation therapy
178470|NCT02217553|platelet|platelet
178471|NCT02217553|P-selectin|p-selectin
178472|NCT02217553|platelet-fibrinogen binding|platelet-fibrinogen binding
402939|NCT01228994|smoking cessation treatment|smoking cessation treatment
178473|NCT02217553|platelet-monocye aggregate formation|platelet-monocye aggregate formation
178474|NCT02217553|vitamin D|vitamin d
178475|NCT02217540|Shoulder, disability evaluation, physiotherapy modalities|shoulder, disability evaluation, physiotherapy modalities
666563|NCT00844961|CBT|cbt
178477|NCT02217501|peripheral arterial disease, antiplatelet therapy|peripheral arterial disease, antiplatelet therapy
178478|NCT02217462|pregnancy|pregnancy
178479|NCT02217462|gestational weight gain|gestational weight gain
178480|NCT02217462|dietary intake|dietary intake
178481|NCT02217462|food reward|food reward
178482|NCT02217423|Physical Therapy Modalities|physical therapy modalities
178483|NCT02217423|Respiration Disorders|respiration disorders
178484|NCT02217423|Respiratory Therapy|respiratory therapy
178485|NCT02217410|renal, de novo,|renal, de novo,
178486|NCT02217397|Apnea-hyponea Index, CPAP, Obstructive Sleep Apnea, Oral Appliance|apnea-hyponea index, cpap, obstructive sleep apnea, oral appliance
178487|NCT02217384|Microbiome|microbiome
178488|NCT02217384|DNA sequencing|dna sequencing
178489|NCT02217384|Leptin|leptin
178490|NCT02217384|Adiponectin|adiponectin
178491|NCT02217384|Insulin|insulin
178492|NCT02217384|IGF-I|igf-i
178493|NCT02217371|ADHD Patient|adhd patient
178494|NCT02217371|Healthy subjects|healthy subjects
178495|NCT02217371|Sleepiness|sleepiness
178496|NCT02217371|PSG|psg
178497|NCT02217371|MWT|mwt
178498|NCT02217371|EEG|eeg
178499|NCT02217371|cognitive tests|cognitive tests
178500|NCT02217358|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
178501|NCT02217358|NBI endoscopy|nbi endoscopy
178502|NCT02217358|videoendoscopy|videoendoscopy
178503|NCT02217358|white light endoscopy|white light endoscopy
178504|NCT02217358|magnifying endoscopy|magnifying endoscopy
178505|NCT02217358|direct laryngoscopy|direct laryngoscopy
178506|NCT02217332|Sinusitis|sinusitis
178507|NCT02217332|Rhinosinusitis|rhinosinusitis
178508|NCT02217332|CRS|crs
178509|NCT02217332|CRSwNP|crswnp
178510|NCT02217332|CSNP-E|csnp-e
178511|NCT02217332|Nasal polyps|nasal polyps
178512|NCT02217332|Nasal polyposis|nasal polyposis
178513|NCT02217332|Eosinophilia|eosinophilia
178514|NCT02217332|Asthma|asthma
178515|NCT02217319|Volatile Anesthetic|volatile anesthetic
178516|NCT02217319|Cardioprotection|cardioprotection
178517|NCT02217319|Lung surgery|lung surgery
178518|NCT02217319|non cardiac surgery|non cardiac surgery
178519|NCT02217293|Pulsed radiofrequency|pulsed radiofrequency
178520|NCT02217293|Ultrasound-guided|ultrasound-guided
178521|NCT02217293|Carpal tunnel syndrome|carpal tunnel syndrome
178522|NCT02217280|Cervical Radiculopathy|cervical radiculopathy
178523|NCT02217267|Peripheral neuropathy|peripheral neuropathy
178524|NCT02217215|Spectroscopy|spectroscopy
178526|NCT02217202|knee replacement|knee replacement
178527|NCT02217202|knee arthroplasty|knee arthroplasty
178528|NCT02217202|revision|revision
178529|NCT02217202|high risk|high risk
178530|NCT02217189|Zinc supplementation.|zinc supplementation.
178531|NCT02217189|Oxidative stress.|oxidative stress.
178532|NCT02217189|Superoxide radical scavengers.|superoxide radical scavengers.
178533|NCT02217189|Asthenospermia.|asthenospermia.
178534|NCT02217189|Oxido-sensitive index.|oxido-sensitive index.
178535|NCT02217137|Dry Eye|dry eye
178536|NCT02217137|Rheumatoid Arthritis|rheumatoid arthritis
178537|NCT02217137|Systemic Lupus Erythematosus|systemic lupus erythematosus
178538|NCT02217137|Tear cytokines and immune response|tear cytokines and immune response
178539|NCT02217124|apple|apple
178540|NCT02217124|high fiber|high fiber
178541|NCT02217124|body composition|body composition
178542|NCT02217124|children|children
178543|NCT02217111|vocal fold nodules|vocal fold nodules
178544|NCT02217111|pediatric|pediatric
178545|NCT02217111|voice therapy|voice therapy
178546|NCT02217111|acoustic|acoustic
178547|NCT02217111|aerodynamic|aerodynamic
178548|NCT02217111|quality of life|quality of life
178549|NCT02217111|Adventures in Voice|adventures in voice
178550|NCT02217098|ART|art
178551|NCT02217098|Occlusal|occlusal
178552|NCT02217098|Occlusoproximal|occlusoproximal
178553|NCT02217098|Primary teeth|primary teeth
178554|NCT02217085|Colorectal Cancer Screening|colorectal cancer screening
178555|NCT02217085|Colon Cancer Screening|colon cancer screening
178556|NCT02217085|Polyps|polyps
178557|NCT02217085|Colonoscopy|colonoscopy
178558|NCT02217072|academic performance|academic performance
178559|NCT02217072|cognitive development|cognitive development
178560|NCT02217072|children in care|children in care
178561|NCT02217072|prevention of school failure|prevention of school failure
178562|NCT02217059|Emergency Medical Services|emergency medical services
178563|NCT02217059|Emergency Care|emergency care
178564|NCT02217059|Hypertension|hypertension
178565|NCT02217059|BpTRU|bptru
178566|NCT02217059|Blood pressure|blood pressure
178567|NCT02217046|Infection|infection
178568|NCT02217046|prevention|prevention
178569|NCT02217046|cardiac devices|cardiac devices
178570|NCT02217033|Breast Cancer|breast cancer
178571|NCT02217033|Stage I breast cancer|stage i breast cancer
178572|NCT02217033|Stage II breast cancer|stage ii breast cancer
217451|NCT02038764|T1D|t1d
178573|NCT02217033|Water study|water study
178574|NCT02217033|'R'|'r'
178575|NCT02217033|Electro-kinetically altered beverage|electro-kinetically altered beverage
178576|NCT02217033|altered beverage|altered beverage
178577|NCT02217033|Insomnia|insomnia
178578|NCT02217033|Fatigue|fatigue
178579|NCT02217033|Depression|depression
178580|NCT02217033|Adjuvant chemotherapy|adjuvant chemotherapy
178581|NCT02217020|Rectal Cancer|rectal cancer
178582|NCT02217020|Locally advanced rectal cancer|locally advanced rectal cancer
178583|NCT02217020|Neoadjuvant|neoadjuvant
178584|NCT02217020|chemotherapy|chemotherapy
178585|NCT02217020|FOLFOXIRI|folfoxiri
178586|NCT02217007|Tourette|tourette
178587|NCT02217007|Tourette's|tourette's
178588|NCT02217007|tic|tic
178589|NCT02216994|Intestinal dysganglinosis|intestinal dysganglinosis
178590|NCT02216994|Hirschsprung disease|hirschsprung disease
178591|NCT02216994|Hirschsprung disease allied disorders|hirschsprung disease allied disorders
178592|NCT02216994|diagnostic scoring system|diagnostic scoring system
178593|NCT02216994|Prospective study|prospective study
178594|NCT02216981|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
178595|NCT02216981|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
178596|NCT02216981|Intensive therapy|intensive therapy
178597|NCT02216981|Intensive treatment|intensive treatment
178598|NCT02216981|Treatment Resistant|treatment resistant
178599|NCT02216968|vegetables|vegetables
178600|NCT02216968|Head Start|head start
178601|NCT02216968|preschool|preschool
178602|NCT02216968|children|children
178603|NCT02216968|theater|theater
178604|NCT02216968|puppet|puppet
178605|NCT02216942|Endodontics|endodontics
178606|NCT02216942|Deciduous teeth|deciduous teeth
178607|NCT02216942|Iodoform pastes|iodoform pastes
178608|NCT02216942|Treatment Refusal|treatment refusal
178609|NCT02216929|intubation|intubation
178610|NCT02216929|intensive care|intensive care
178611|NCT02216929|withholding treatment|withholding treatment
178612|NCT02216929|cancer|cancer
178613|NCT02216929|terminal care|terminal care
178614|NCT02216929|APACHE|apache
178615|NCT02216903|Atrial fibrillation, sleep apnea|atrial fibrillation, sleep apnea
178616|NCT02216890|Renal Cell Carcinoma|renal cell carcinoma
178617|NCT02216890|Mantle-Cell Lymphoma|mantle-cell lymphoma
178618|NCT02216890|Diffuse, Large B-Cell, Lymphoma|diffuse, large b-cell, lymphoma
178619|NCT02216890|Follicular Lymphoma, Grade 3|follicular lymphoma, grade 3
178620|NCT02216890|Antibody-Drug Conjugate|antibody-drug conjugate
178621|NCT02216890|CD70 Antigen|cd70 antigen
178622|NCT02216890|Drug Therapy|drug therapy
178623|NCT02216877|Chronic Kidney Disease|chronic kidney disease
178624|NCT02216877|Hypomagnesemia|hypomagnesemia
178625|NCT02216851|hyaluronic acid|hyaluronic acid
178626|NCT02216851|no-treatment control|no-treatment control
178627|NCT02216851|enhancement|enhancement
178628|NCT02216812|Finger stiffness|finger stiffness
178629|NCT02216812|Range of motion|range of motion
178630|NCT02216812|Distal radius fracture|distal radius fracture
178631|NCT02216812|Vitamin C|vitamin c
178632|NCT02216799|Parenteral nutrition|parenteral nutrition
178633|NCT02216799|Hyperglycemia|hyperglycemia
178634|NCT02216799|Glargine insulin|glargine insulin
178635|NCT02216799|Regular insulin|regular insulin
178636|NCT02216773|Liver hypertrophy|liver hypertrophy
178637|NCT02216773|Liver resection|liver resection
178638|NCT02216773|Liver metastases|liver metastases
178639|NCT02216773|Portal vein ligation|portal vein ligation
178640|NCT02216773|Portal vein embolization|portal vein embolization
178641|NCT02216773|Radiofrequency splitting|radiofrequency splitting
178642|NCT02216760|Monomorphic Ventricular Tachycardia|monomorphic ventricular tachycardia
178643|NCT02216760|Myocardial infarction|myocardial infarction
178644|NCT02216760|Dilated cardiomyopathy|dilated cardiomyopathy
178645|NCT02216760|Catheter ablation|catheter ablation
178646|NCT02216760|Substrate mapping|substrate mapping
178647|NCT02216760|Ripple Conduction channels|ripple conduction channels
178648|NCT02216747|Idiopathic Nephrotic syndrome relapse|idiopathic nephrotic syndrome relapse
178649|NCT02216734|HIV/AIDS|hiv/aids
178650|NCT02216734|Prevention of mother-to-child transmission|prevention of mother-to-child transmission
178651|NCT02216734|Mother support groups|mother support groups
178652|NCT02216734|Retention-in-care|retention-in-care
178653|NCT02216734|Male participation|male participation
178654|NCT02216734|Anti-retroviral treatment|anti-retroviral treatment
178655|NCT02216734|Infants|infants
178656|NCT02216721|bone mineral density|bone mineral density
178657|NCT02216721|bone turnover markers|bone turnover markers
178658|NCT02216721|primary aldosteronism treatment|primary aldosteronism treatment
178659|NCT02216708|Severe malnutrition|severe malnutrition
178660|NCT02216708|severe dehydration|severe dehydration
178661|NCT02216708|cholera|cholera
178662|NCT02216695|acute kidney injury|acute kidney injury
178663|NCT02216695|epidemiology|epidemiology
178664|NCT02216695|mortality|mortality
178665|NCT02216682|Acetaminophen|acetaminophen
178666|NCT02216682|Total knee replacement|total knee replacement
178667|NCT02216682|Numeric rating scale|numeric rating scale
178668|NCT02216669|Solid tumors|solid tumors
178669|NCT02216669|Head and Neck Neoplasms|head and neck neoplasms
178670|NCT02216643|Stroke|stroke
178671|NCT02216643|Ischemic Stroke|ischemic stroke
178672|NCT02216643|Thrombectomy|thrombectomy
178673|NCT02216643|Reperfusion Therapy|reperfusion therapy
178674|NCT02216643|Treatment|treatment
178675|NCT02216630|COPD|copd
178676|NCT02216604|Exercise|exercise
178677|NCT02216604|Pediatric oncology|pediatric oncology
178678|NCT02216604|Physical Performance|physical performance
178679|NCT02216604|Quality of Life|quality of life
178680|NCT02216604|Feasibility|feasibility
178681|NCT02216604|during primary|during primary
178682|NCT02216604|anticancer treatment|anticancer treatment
178683|NCT02216591|HIV|hiv
178684|NCT02216591|Medication Adherence|medication adherence
178685|NCT02216591|Working Memory|working memory
178686|NCT02216578|tyrosine kinase inhibitor|tyrosine kinase inhibitor
178687|NCT02216578|progressed|progressed
178688|NCT02216578|(GIST)|(gist)
178689|NCT02216565|Stroke|stroke
178690|NCT02216565|Endovascular treatment|endovascular treatment
178691|NCT02216565|Tandem carotid occlusions|tandem carotid occlusions
178692|NCT02216565|Fibrinolysis|fibrinolysis
178693|NCT02216552|Pediatrics|pediatrics
178694|NCT02216552|Adolescents|adolescents
178695|NCT02216552|NAFLD|nafld
178696|NCT02216552|Spectroscopy|spectroscopy
178697|NCT02216552|Type 2 diabetes|type 2 diabetes
178698|NCT02216539|All terminal|all terminal
178699|NCT02216539|leading|leading
178700|NCT02216539|indication|indication
178701|NCT02216539|lung transplantation|lung transplantation
178702|NCT02216526|Skin health|skin health
178703|NCT02216526|Nursing|nursing
178704|NCT02216526|Long-term care|long-term care
178705|NCT02216513|subarachnoid hemorrhage|subarachnoid hemorrhage
178706|NCT02216513|SAH|sah
178707|NCT02216513|DFO|dfo
178708|NCT02216513|cerebral autoregulation|cerebral autoregulation
178709|NCT02216513|delayed cerebral ischemia|delayed cerebral ischemia
178710|NCT02216500|Ketogenic Therapy|ketogenic therapy
178711|NCT02216500|Ketogenic Diet|ketogenic diet
178712|NCT02216487|mCRC|mcrc
178713|NCT02216487|colorectal cancer|colorectal cancer
178714|NCT02216448|Arthroscopy skills|arthroscopy skills
178715|NCT02216448|Knee|knee
178716|NCT02216448|Virtual reality|virtual reality
178717|NCT02216448|Simulator|simulator
178718|NCT02216422|Chronic Hepatitis C|chronic hepatitis c
178719|NCT02216422|Hepatitis C|hepatitis c
178720|NCT02216422|Hepatitis C Virus|hepatitis c virus
178721|NCT02216422|Hepatitis C Genotype 1b|hepatitis c genotype 1b
178722|NCT02216422|Interferon-Free|interferon-free
178723|NCT02216396|dementia|dementia
178724|NCT02216396|care home|care home
178725|NCT02216396|agitation|agitation
178726|NCT02216396|coping|coping
178727|NCT02216383|Post partum haemorrhage|post partum haemorrhage
178728|NCT02216383|Active Management of Third Stage of Labour|active management of third stage of labour
178729|NCT02216383|Carbetocin|carbetocin
178730|NCT02216383|Syntocinon|syntocinon
178731|NCT02216383|Syntometrine|syntometrine
178732|NCT02216383|Birth experience|birth experience
178733|NCT02216383|Labour|labour
178734|NCT02216370|Cryptogenic stroke /TIA|cryptogenic stroke /tia
178735|NCT02216370|Atrial Fibrillation|atrial fibrillation
178736|NCT02216370|Implantable Loop Recorder|implantable loop recorder
178737|NCT02216370|Genetic Mutation|genetic mutation
178738|NCT02216357|Samster's triad|samster's triad
178739|NCT02216357|Acetylsalicylic acid triad|acetylsalicylic acid triad
178740|NCT02216357|Widal's triad|widal's triad
178741|NCT02216357|Francis' triad|francis' triad
178742|NCT02216357|Aspirin triad|aspirin triad
178743|NCT02216357|Aspirin-induced asthma and rhinitis (AIAR)|aspirin-induced asthma and rhinitis (aiar)
178744|NCT02216344|Patient safety monitors|patient safety monitors
178745|NCT02216331|tuberculosis|tuberculosis
178746|NCT02216331|PK|pk
178747|NCT02216331|TMC207|tmc207
178748|NCT02216331|bedaquiline|bedaquiline
178749|NCT02216331|rifapentine|rifapentine
178750|NCT02216331|rifampicin|rifampicin
178751|NCT02216331|drug drug interaction|drug drug interaction
178752|NCT02216318|sleep|sleep
178753|NCT02216318|circadian|circadian
178754|NCT02216318|melatonine|melatonine
178755|NCT02216318|pupil response|pupil response
178756|NCT02216305|HAL-RAR|hal-rar
178757|NCT02216305|Hemorrhoids|hemorrhoids
178758|NCT02216305|Hemorrhoid artery ligation|hemorrhoid artery ligation
178759|NCT02216305|Anal repair|anal repair
178760|NCT02216305|Quality of Life|quality of life
178761|NCT02216305|Postoperative Complications|postoperative complications
178762|NCT02216292|preterm single donor milk|preterm single donor milk
178763|NCT02216292|human milk|human milk
178764|NCT02216292|very lo birth weight infants|very lo birth weight infants
178765|NCT02216292|enteral feedings|enteral feedings
178766|NCT02216292|NEC|nec
178767|NCT02216279|Pulmonary|pulmonary
178768|NCT02216279|Hypertension|hypertension
178769|NCT02216279|PH|ph
178770|NCT02216279|PulmoBind|pulmobind
178771|NCT02216279|Imaging|imaging
169758|NCT02258152|PDD|pdd
178772|NCT02216266|Delirium|delirium
178773|NCT02216266|CAM-ICU|cam-icu
178774|NCT02216253|Urinary tract infection|urinary tract infection
178775|NCT02216253|Pelvic organ prolapse|pelvic organ prolapse
178776|NCT02216253|Urinary incontinence|urinary incontinence
666660|NCT00845416|T cell|t cell
178780|NCT02216253|Placebo|placebo
178781|NCT02216227|MRSA|mrsa
178782|NCT02216227|surgical site infection|surgical site infection
178786|NCT02216175|Cow's milk allergy|cow's milk allergy
178787|NCT02216175|Desensitisation|desensitisation
178788|NCT02216175|Safety|safety
178789|NCT02216162|oncogeriatrics|oncogeriatrics
178790|NCT02216162|adjuvant endocrine therapy|adjuvant endocrine therapy
178791|NCT02216162|compliance|compliance
178792|NCT02216162|elderly|elderly
178793|NCT02216162|Taï Chi|taï chi
178794|NCT02216162|Physical training|physical training
178795|NCT02216149|fluoropyrimidine|fluoropyrimidine
178796|NCT02216149|S-1|s-1
178797|NCT02216149|Teysuno|teysuno
178798|NCT02216149|oxaliplatin|oxaliplatin
178799|NCT02216149|coronary artery flow|coronary artery flow
178800|NCT02216149|coronary artery dysfunction|coronary artery dysfunction
178801|NCT02216149|gastrointestinal tract cancer|gastrointestinal tract cancer
178802|NCT02216136|Mastectomy|mastectomy
178803|NCT02216136|Breast Cancer|breast cancer
178804|NCT02216136|Reconstruction|reconstruction
178805|NCT02216136|Lumpectomy|lumpectomy
178806|NCT02216136|Breast Conservation Therapy|breast conservation therapy
178807|NCT02216123|Tafenoquine|tafenoquine
178808|NCT02216123|Plasmodium vivax|plasmodium vivax
178809|NCT02216123|Hemolysis|hemolysis
178810|NCT02216123|Primaquine|primaquine
178811|NCT02216123|Chloroquine|chloroquine
178812|NCT02216123|Glucose-6-phosphate dehydrogenase (G6PD)|glucose-6-phosphate dehydrogenase (g6pd)
178813|NCT02216123|Relapse|relapse
178814|NCT02216110|Endoscopic submucosal dissection|endoscopic submucosal dissection
178815|NCT02216110|Gastrectomy|gastrectomy
178816|NCT02216110|Survival|survival
178817|NCT02216110|Outcome|outcome
178818|NCT02216045|Hepatitis C ,Chronic Hepatitis C ,camel milk|hepatitis c ,chronic hepatitis c ,camel milk
178819|NCT02216019|cardiac surgery|cardiac surgery
178820|NCT02216019|infectious complication|infectious complication
178821|NCT02216006|Atelectasis|atelectasis
178822|NCT02216006|Fresh gas flow|fresh gas flow
178823|NCT02216006|Prevention|prevention
178824|NCT02216006|Oxygenation|oxygenation
178825|NCT02216006|Anaesthesia|anaesthesia
178826|NCT02215993|Ticagrelor|ticagrelor
178827|NCT02215993|Prasugrel|prasugrel
178828|NCT02215993|VerifyNow|verifynow
178829|NCT02215993|Acute coronary syndrome|acute coronary syndrome
178830|NCT02215980|Multiple myeloma|multiple myeloma
178831|NCT02215980|Diagnosis|diagnosis
178832|NCT02215980|Elderly and unfit patients|elderly and unfit patients
178833|NCT02215980|Lenalidomide plus steroids|lenalidomide plus steroids
178834|NCT02215967|Immunotherapy|immunotherapy
178835|NCT02215967|Anti-BCMA-CAR|anti-bcma-car
178836|NCT02215967|Gene Therapy|gene therapy
178837|NCT02215967|Adoptive T Cell Therapy|adoptive t cell therapy
178838|NCT02215967|Plasma Cell Malignancy|plasma cell malignancy
178839|NCT02215915|Percutaneous coronary intervention|percutaneous coronary intervention
178840|NCT02215915|Drug-eluting stent|drug-eluting stent
178841|NCT02215915|Intravascular ultrasound|intravascular ultrasound
178842|NCT02215902|ESRD|esrd
178843|NCT02215902|Hepatitis C|hepatitis c
178844|NCT02215889|Liver metastases|liver metastases
178845|NCT02215889|Transplantation|transplantation
178846|NCT02215876|Her 2-negative breast cancer|her 2-negative breast cancer
178847|NCT02215876|neoadjuvant doxorubicin/cyclophosphamide followed by Eribulin chemotherapy|neoadjuvant doxorubicin/cyclophosphamide followed by eribulin chemotherapy
178848|NCT02215863|Immunogenicity, Safety, MF59, Influenza vaccine, Pneumococcal vaccine|immunogenicity, safety, mf59, influenza vaccine, pneumococcal vaccine
178849|NCT02215837|Gastric cancer|gastric cancer
178850|NCT02215837|D-CIK|d-cik
178851|NCT02215837|Autologous tumor lysate|autologous tumor lysate
178852|NCT02215811|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
178853|NCT02215785|Funtional constipation|funtional constipation
178854|NCT02215785|Kiwifruit|kiwifruit
178855|NCT02215785|Health promotion|health promotion
178856|NCT02215707|PfSPZ Vaccine|pfspz vaccine
178857|NCT02215707|Plasmodium falciparum|plasmodium falciparum
178858|NCT02215707|Malaria|malaria
178859|NCT02215707|Controlled Human Malaria Infection (CHMI)|controlled human malaria infection (chmi)
178860|NCT02215694|Apolipoprotein A-V|apolipoprotein a-v
178861|NCT02215694|LDL particle size|ldl particle size
178862|NCT02215694|probiotic|probiotic
178863|NCT02215694|triglyceride|triglyceride
178864|NCT02215681|otitis media with effusion|otitis media with effusion
178865|NCT02215681|acupuncture|acupuncture
178866|NCT02215681|inflammatory markers|inflammatory markers
178867|NCT02215655|phosphate binder adherence|phosphate binder adherence
178868|NCT02215655|autonomous motivation|autonomous motivation
178869|NCT02215629|Leukemia|leukemia
178870|NCT02215629|Acute Leukemia|acute leukemia
178871|NCT02215629|Relapsed Leukemia|relapsed leukemia
178872|NCT02215629|Refractory Leukemia|refractory leukemia
178873|NCT02215629|Acute Myeloid Leukemia|acute myeloid leukemia
178874|NCT02215629|B-Cell Acute Lymphoblastic Leukemia|b-cell acute lymphoblastic leukemia
178875|NCT02215590|Postural balance|postural balance
178876|NCT02215590|Motor Learning and Motor Control|motor learning and motor control
178877|NCT02215590|Community integration|community integration
178878|NCT02215590|Quality of life|quality of life
178879|NCT02215590|Functional ambulation|functional ambulation
178880|NCT02215577|cancer, colorectal|cancer, colorectal
178881|NCT02215577|hepatectomy|hepatectomy
178882|NCT02215577|portal vein|portal vein
178883|NCT02215577|embolization|embolization
178884|NCT02215577|two-stage|two-stage
178885|NCT02215564|Bordetella pertussis|bordetella pertussis
178886|NCT02215564|Carriage rates in young adults|carriage rates in young adults
178887|NCT02215551|laminectomy|laminectomy
178888|NCT02215538|ADHD|adhd
178889|NCT02215538|adult|adult
178890|NCT02215538|WRAADDS|wraadds
178891|NCT02215538|OROS MPH|oros mph
178892|NCT02215538|emotional dysregulation|emotional dysregulation
178895|NCT02215525|Herbal therapy|herbal therapy
178896|NCT02215499|JZP-386, Xyrem, sodium oxybate|jzp-386, xyrem, sodium oxybate
178897|NCT02215486|Head massage therapy|head massage therapy
178898|NCT02215486|Massage therapy|massage therapy
178899|NCT02215486|Autonomic nervous system (ANS)|autonomic nervous system (ans)
178900|NCT02215486|Heart rate variability (HRV)|heart rate variability (hrv)
178901|NCT02215486|Pre-ejection period (PEP)|pre-ejection period (pep)
178902|NCT02215473|gingivitis|gingivitis
178903|NCT02215473|periodontitis|periodontitis
178904|NCT02215473|mouth rinse|mouth rinse
178905|NCT02215473|bacteremia|bacteremia
178906|NCT02215447|NAB-paclitaxel|nab-paclitaxel
178907|NCT02215447|Gastrointestinal Neuroendocrine Carcinomas|gastrointestinal neuroendocrine carcinomas
178908|NCT02215447|phase II|phase ii
178909|NCT02215447|carboplatin|carboplatin
178910|NCT02215434|Libido; Sexual Dysfunction; testosterone|libido; sexual dysfunction; testosterone
178911|NCT02215421|vegetables|vegetables
178912|NCT02215421|dietary intake|dietary intake
178913|NCT02215421|preschoolers|preschoolers
178914|NCT02215421|parents|parents
178915|NCT02215421|video game|video game
178916|NCT02215408|Diabetes|diabetes
178917|NCT02215408|Hyperlipidemia|hyperlipidemia
178918|NCT02215408|Hypertension|hypertension
178919|NCT02215408|Cardiovascular Disease|cardiovascular disease
178920|NCT02215395|Nestorone|nestorone
178921|NCT02215395|miconazole nitrate|miconazole nitrate
178922|NCT02215382|two reversal methods|two reversal methods
178923|NCT02215382|changes in IOP|changes in iop
178924|NCT02215382|heart rate|heart rate
178925|NCT02215382|blood pressure|blood pressure
178926|NCT02215382|tracheal extubation|tracheal extubation
178927|NCT02215330|Central serous chorioretinopathy|central serous chorioretinopathy
178928|NCT02215330|Eplerenone|eplerenone
178929|NCT02215330|Photodynamic Therapy|photodynamic therapy
178930|NCT02215330|Macula|macula
178931|NCT02215330|Retina|retina
178932|NCT02215317|Sleep Apnea|sleep apnea
178933|NCT02215317|Stent|stent
178934|NCT02215317|Coronary Artery Disease|coronary artery disease
178935|NCT02215317|Percutaneous Coronary Intervention|percutaneous coronary intervention
178936|NCT02215304|Dietary supplementation|dietary supplementation
178937|NCT02215304|Probiotics|probiotics
178938|NCT02215304|Safety/Efficiency|safety/efficiency
178939|NCT02215304|Healthy infants|healthy infants
178940|NCT02215291|Undergoing Esophagogastroduodenoscopy (EGD) or endoscopy|undergoing esophagogastroduodenoscopy (egd) or endoscopy
178941|NCT02215278|iron biofortification|iron biofortification
178942|NCT02215278|lpa bean|lpa bean
178943|NCT02215278|stable iron isotope study|stable iron isotope study
178944|NCT02215278|phytic acid|phytic acid
178945|NCT02215265|Human papillomavirus HPV positive oropharyngeal cancer|human papillomavirus hpv positive oropharyngeal cancer
178946|NCT02215239|health lifestyle|health lifestyle
178947|NCT02215239|health promotion|health promotion
178948|NCT02215239|occupational health|occupational health
178949|NCT02215239|Work site health promotion|work site health promotion
178950|NCT02215226|Group B Streptococcus, early onset disease, late onset disease, anticapsular antibodies, serotype specific|group b streptococcus, early onset disease, late onset disease, anticapsular antibodies, serotype specific
178951|NCT02215213|Vitamin D|vitamin d
178952|NCT02215213|pregnancy|pregnancy
178953|NCT02215213|Pakistan|pakistan
178954|NCT02215200|Type 1 Diabetes TrialNet|type 1 diabetes trialnet
178955|NCT02215174|Rosuvastatin|rosuvastatin
178956|NCT02215174|PK|pk
178957|NCT02215174|Interethnic|interethnic
178958|NCT02215174|Morbid obese|morbid obese
178959|NCT02215135|Corifollitropin alfa|corifollitropin alfa
178960|NCT02215135|polycystic ovarian syndrome (PCOS)|polycystic ovarian syndrome (pcos)
178961|NCT02215135|controlled ovarian hyperstimulation (COS)|controlled ovarian hyperstimulation (cos)
178962|NCT02215135|GnRH antagonist protocol|gnrh antagonist protocol
178963|NCT02215135|Ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
178964|NCT02215122|Fluticasone Propionate|fluticasone propionate
178965|NCT02215122|Salmeterol|salmeterol
402940|NCT01228994|baclofen|baclofen
178966|NCT02215122|Pharmacokinetics|pharmacokinetics
178967|NCT02215122|Healthy Subjects|healthy subjects
178969|NCT02215122|CRC749|crc749
178970|NCT02215122|Dry Powder Inhaler|dry powder inhaler
178971|NCT02215122|generic|generic
178972|NCT02215122|Advair Diskus|advair diskus
178973|NCT02215122|Seretide Accuhaler|seretide accuhaler
178974|NCT02215096|enzalutamide|enzalutamide
178975|NCT02215096|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
178976|NCT02215096|GSK2636771|gsk2636771
178977|NCT02215096|PI3K-beta|pi3k-beta
178978|NCT02215096|PTEN deficiency|pten deficiency
178979|NCT02215083|peripheral neuropathy|peripheral neuropathy
178980|NCT02215083|breast cancer|breast cancer
178981|NCT02215083|taxane induced peripheral neuropathy|taxane induced peripheral neuropathy
178982|NCT02215083|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
178983|NCT02215070|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
178984|NCT02215070|Acute Myeloid Leukemia|acute myeloid leukemia
178985|NCT02215070|Acute Lymphoid Leukemia|acute lymphoid leukemia
178986|NCT02215070|Acute Non-Lymphocytic Leukemia|acute non-lymphocytic leukemia
178987|NCT02215070|Myelodysplastic Syndrome|myelodysplastic syndrome
178988|NCT02215070|Chronic Myeloid Leukemia|chronic myeloid leukemia
178989|NCT02215070|Lymphoma|lymphoma
178990|NCT02215057|topical anesthesia|topical anesthesia
178991|NCT02215057|intracameral lidocaine|intracameral lidocaine
178992|NCT02215057|implantable collamer lens|implantable collamer lens
178993|NCT02214875|Retention|retention
178994|NCT02214862|Unclassifiable Parkinsonism, [F18]-FDDNP-PET, Tauopathy, PSP,MSA|unclassifiable parkinsonism, [f18]-fddnp-pet, tauopathy, psp,msa
178995|NCT02214849|Breastfeeding|breastfeeding
178996|NCT02214849|Breastfeeding peer counseling|breastfeeding peer counseling
178997|NCT02214849|Exclusive breastfeeding|exclusive breastfeeding
178998|NCT02214849|Formula supplementation|formula supplementation
178999|NCT02214849|Mobile health|mobile health
179000|NCT02214849|WIC program|wic program
179001|NCT02214836|kidney stones|kidney stones
179002|NCT02214836|ultrasound imaging|ultrasound imaging
179003|NCT02214836|ureter stones|ureter stones
179004|NCT02214810|Bupivacaine|bupivacaine
179005|NCT02214810|multimodal|multimodal
179006|NCT02214810|exparel|exparel
179007|NCT02214810|open reduction|open reduction
179008|NCT02214810|internal fixation|internal fixation
179009|NCT02214810|post-surgical pain control|post-surgical pain control
179010|NCT02214797|Presbyopia|presbyopia
179011|NCT02214797|Refractive Error|refractive error
179012|NCT02214797|Contact Lenses|contact lenses
179013|NCT02214784|Stress urinary Incontinence|stress urinary incontinence
179014|NCT02214784|SUI|sui
179016|NCT02214771|Clostridium difficile infection CDI|clostridium difficile infection cdi
179017|NCT02214771|Observational|observational
179018|NCT02214771|Fidaxomicin recurrence|fidaxomicin recurrence
179019|NCT02214771|France|france
179020|NCT02214758|Home care clients, nutrition, oral health, medication|home care clients, nutrition, oral health, medication
179021|NCT02214745|Israeli Arab population|israeli arab population
179022|NCT02214745|Israeli/ethnology|israeli/ethnology
179023|NCT02214732|Pregnancy|pregnancy
179024|NCT02214732|Postpartum|postpartum
179153|NCT02214212|Red Light Therapy|red light therapy
179025|NCT02214732|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
179026|NCT02214732|Depression|depression
179027|NCT02214732|Anxiety|anxiety
179028|NCT02214732|Stress|stress
179029|NCT02214732|MBCT|mbct
179030|NCT02214732|Actigraphy|actigraphy
179031|NCT02214719|type 1 diabetes, insulin therapy, bolus calculator|type 1 diabetes, insulin therapy, bolus calculator
179032|NCT02214693|patients|patients
179033|NCT02214680|Pupil diameter|pupil diameter
179034|NCT02214680|Brimonidine|brimonidine
179035|NCT02214680|Timolol|timolol
179036|NCT02214680|Combigan|combigan
179037|NCT02214667|Jail|jail
179038|NCT02214667|co-occurring disorders|co-occurring disorders
179039|NCT02214667|implementation|implementation
179040|NCT02214667|acceptability|acceptability
179041|NCT02214667|feasibility|feasibility
179042|NCT02214667|fidelity|fidelity
179043|NCT02214628|Wet AMD|wet amd
179044|NCT02214628|Choroidal neovascularization|choroidal neovascularization
179045|NCT02214628|Fovista®|fovista®
179046|NCT02214628|E10030|e10030
179047|NCT02214628|Avastin®|avastin®
179048|NCT02214628|Eylea®|eylea®
179049|NCT02214602|non muscle invasive bladder cancer|non muscle invasive bladder cancer
179050|NCT02214602|intermediate and high risk|intermediate and high risk
179051|NCT02214602|immediate single instillation|immediate single instillation
179052|NCT02214602|Intravesical chemotherapy|intravesical chemotherapy
179053|NCT02214602|Disease prevention|disease prevention
179054|NCT02214576|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
179055|NCT02214576|intubation, intratracheal|intubation, intratracheal
179056|NCT02214576|Oxygen Inhalation Therapy|oxygen inhalation therapy
179057|NCT02214576|Positive-Pressure Respiration|positive-pressure respiration
179058|NCT02214576|laryngoscopy|laryngoscopy
179059|NCT02214563|Vitamin D|vitamin d
179060|NCT02214563|Cholecalciferol|cholecalciferol
179061|NCT02214563|Hepcidins|hepcidins
179062|NCT02214563|Renal Dialysis|renal dialysis
179063|NCT02214550|Cystitis, Interstitial|cystitis, interstitial
179064|NCT02214550|Dysmenorrhea|dysmenorrhea
179065|NCT02214550|Migraine Disorders|migraine disorders
179066|NCT02214550|Cross Organ Sensitization|cross organ sensitization
179067|NCT02214550|Pelvic Pain|pelvic pain
179068|NCT02214550|Endometriosis|endometriosis
179069|NCT02214550|Contraceptives, Oral|contraceptives, oral
179070|NCT02214550|Birth Control Pills|birth control pills
179071|NCT02214550|Painful Bladder Syndrome|painful bladder syndrome
179072|NCT02214550|Visceral Pain|visceral pain
179073|NCT02214550|Chronic Pain|chronic pain
179074|NCT02214524|perioperative hypothermia|perioperative hypothermia
179075|NCT02214524|Tympanic temperature|tympanic temperature
179076|NCT02214524|Blood loss|blood loss
179077|NCT02214524|Blood Coagulation Disorders|blood coagulation disorders
179078|NCT02214524|Major surgery|major surgery
179079|NCT02214511|major depressive disorder|major depressive disorder
179080|NCT02214511|social rejection|social rejection
179081|NCT02214511|rapid facial reaction|rapid facial reaction
179082|NCT02214511|facial mimicry|facial mimicry
179083|NCT02214511|prosocial behavior|prosocial behavior
179084|NCT02214511|inflammation|inflammation
179085|NCT02214511|self esteem|self esteem
179086|NCT02214498|Dipper|dipper
179087|NCT02214498|Non-dipper|non-dipper
179088|NCT02214498|Chronopharmacology|chronopharmacology
179089|NCT02214485|frailty|frailty
179090|NCT02214485|exercise|exercise
179091|NCT02214485|intervention|intervention
179092|NCT02214472|Rumination síndrome|rumination síndrome
179093|NCT02214472|Regurgitation|regurgitation
179094|NCT02214472|Vomiting|vomiting
179095|NCT02214472|Biofeedback|biofeedback
179096|NCT02214472|Electromyography|electromyography
179097|NCT02214472|Abdominal accommodation|abdominal accommodation
179098|NCT02214459|mHealth|mhealth
179099|NCT02214459|Hypertension|hypertension
179100|NCT02214459|Mobile|mobile
179101|NCT02214459|smartphone|smartphone
179102|NCT02214459|diet|diet
179103|NCT02214459|lifestyle|lifestyle
179104|NCT02214459|bluetooth|bluetooth
179105|NCT02214459|physical acitvity|physical acitvity
179106|NCT02214459|behavior change|behavior change
179107|NCT02214459|motivational interviewing|motivational interviewing
179108|NCT02214446|truth telling|truth telling
179109|NCT02214446|hope|hope
179110|NCT02214446|quality of life|quality of life
179111|NCT02214446|care burden|care burden
179112|NCT02214446|children with cancer|children with cancer
179113|NCT02214433|Antibiotic|antibiotic
179114|NCT02214433|Antibiotic Resistant Bacterial Infection|antibiotic resistant bacterial infection
179115|NCT02214381|breast cancer|breast cancer
179116|NCT02214381|elderly|elderly
179117|NCT02214329|Postural Balance|postural balance
179118|NCT02214329|Gait|gait
179119|NCT02214329|Fall risk|fall risk
179120|NCT02214303|Allergic asthma|allergic asthma
179121|NCT02214303|Allergic rhinitis|allergic rhinitis
179122|NCT02214303|Healthy subjects|healthy subjects
179123|NCT02214290|Cardiovascular|cardiovascular
179124|NCT02214290|Caffeine|caffeine
179125|NCT02214290|L-citrulline|l-citrulline
179126|NCT02214290|Arterial Function|arterial function
179127|NCT02214290|Hemodynamics|hemodynamics
179128|NCT02214290|Blood Pressure|blood pressure
179129|NCT02214290|Pulse Wave Velocity|pulse wave velocity
179130|NCT02214290|Pulse Wave Analysis|pulse wave analysis
179131|NCT02214277|Embolic Protection|embolic protection
179132|NCT02214277|Edwards SAPIEN THV|edwards sapien thv
179133|NCT02214277|Edwards SAPIEN XT|edwards sapien xt
179134|NCT02214277|TAVR|tavr
179135|NCT02214277|Transfemoral|transfemoral
179136|NCT02214277|Transapical|transapical
179137|NCT02214277|Heart Valve Diseases|heart valve diseases
179138|NCT02214277|Heart Diseases|heart diseases
179139|NCT02214277|TAVI|tavi
179140|NCT02214277|Aortic Stenosis|aortic stenosis
179141|NCT02214277|Aortic Valve|aortic valve
179142|NCT02214277|Transcatheter Heart Valve|transcatheter heart valve
179143|NCT02214251|Parkinson's disease|parkinson's disease
179144|NCT02214251|freezing of gait|freezing of gait
179145|NCT02214251|movement disorders|movement disorders
179146|NCT02214251|neuroscience|neuroscience
179147|NCT02214251|neural|neural
179148|NCT02214251|mechanism|mechanism
179149|NCT02214212|traumatic brain injury|traumatic brain injury
179151|NCT02214212|Sleep|sleep
179152|NCT02214212|Bright White Light Therapy|bright white light therapy
179154|NCT02214212|Recovery|recovery
179155|NCT02214212|Central Nervous System Diseases|central nervous system diseases
179156|NCT02214212|Brain Diseases|brain diseases
179157|NCT02214212|Nervous System Diseases|nervous system diseases
179158|NCT02214212|Signs and Symptoms|signs and symptoms
179159|NCT02214212|Rehabilitation|rehabilitation
179160|NCT02214212|Actigraphy|actigraphy
179161|NCT02214199|Shoulder Pain|shoulder pain
179162|NCT02214199|Shoulder Impingement Syndrome|shoulder impingement syndrome
179163|NCT02214199|Exercise therapy|exercise therapy
179164|NCT02214199|Randomized Controlled Trial|randomized controlled trial
179165|NCT02214186|Pre-Eclampsia|pre-eclampsia
179166|NCT02214186|Acute Kidney Injury|acute kidney injury
179167|NCT02214186|Fluid Therapy|fluid therapy
179168|NCT02214186|Anesthesia, Spinal|anesthesia, spinal
179169|NCT02214173|HIV, BRM4, hydrolyzed rice bran, metabolic syndrome|hiv, brm4, hydrolyzed rice bran, metabolic syndrome
179170|NCT02214160|Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)|long-chain fatty acid oxidation disorders (lc-faod)
179171|NCT02214160|carnitine palmitoyltransferase (CPT I or CPT II) deficiency|carnitine palmitoyltransferase (cpt i or cpt ii) deficiency
179172|NCT02214160|very long chain acyl-CoA dehydrogenase (VLCAD) deficiency|very long chain acyl-coa dehydrogenase (vlcad) deficiency
179173|NCT02214160|long-chain 3-hydroxy-acyl-CoA dehydrogenase (LCHAD) deficiency|long-chain 3-hydroxy-acyl-coa dehydrogenase (lchad) deficiency
179174|NCT02214160|trifunctional protein (TFP) deficiency|trifunctional protein (tfp) deficiency
179175|NCT02214160|carnitine-acylcarnitine translocase (CACT) deficiency|carnitine-acylcarnitine translocase (cact) deficiency
179176|NCT02214160|Triheptanoin|triheptanoin
179177|NCT02214160|UX007|ux007
179179|NCT02214147|Alisertib|alisertib
179180|NCT02214147|MLN8237|mln8237
179181|NCT02214147|Relapsed/refractory lymphoma|relapsed/refractory lymphoma
179182|NCT02214134|Lung cancer|lung cancer
179183|NCT02214134|Malignant pleural mesothelioma|malignant pleural mesothelioma
179184|NCT02214134|Thymic malignancy|thymic malignancy
179185|NCT02214134|Biomarkers|biomarkers
179186|NCT02214134|Screening|screening
179187|NCT02214121|sickle cell anemia|sickle cell anemia
179188|NCT02214121|paediatric|paediatric
179189|NCT02214108|BMI|bmi
179190|NCT02214108|Obesity|obesity
179191|NCT02214108|overweight|overweight
179192|NCT02214108|child|child
179193|NCT02214108|Physical activity|physical activity
179194|NCT02214095|Cytokines|cytokines
179195|NCT02214095|interleukin-1β|interleukin-1β
179196|NCT02214095|chronic periodontitis|chronic periodontitis
179197|NCT02214095|host modulation|host modulation
179198|NCT02214095|glucosamine sulphate.|glucosamine sulphate.
179199|NCT02214056|mobile screening team|mobile screening team
179200|NCT02214056|feasibility|feasibility
179303|NCT02213757|Urinalysis|urinalysis
179201|NCT02214030|Femoral compression device|femoral compression device
179202|NCT02214030|manual compression|manual compression
179203|NCT02214030|arterial hemostasis|arterial hemostasis
179204|NCT02214030|coronary intervention|coronary intervention
179205|NCT02214030|coronary artery disease|coronary artery disease
179206|NCT02214017|diabetes|diabetes
179207|NCT02214017|telemedicine|telemedicine
179208|NCT02214017|glycemia|glycemia
179209|NCT02214017|lipids|lipids
179210|NCT02214017|blood pressure|blood pressure
179211|NCT02214004|Breast cancer|breast cancer
179212|NCT02214004|HER2|her2
179214|NCT02214004|Postmenopausal|postmenopausal
179215|NCT02214004|Trastuzumab|trastuzumab
179216|NCT02214004|Letrozole|letrozole
179217|NCT02214004|Neoadjuvant endocrine treatment|neoadjuvant endocrine treatment
179218|NCT02213991|Breast Cancer|breast cancer
179219|NCT02213991|Breast Conservative Surgery|breast conservative surgery
179220|NCT02213991|Intraoperative Radiotherapy|intraoperative radiotherapy
179221|NCT02213991|Local Toxicity|local toxicity
179222|NCT02213991|Whole breast radiotherapy|whole breast radiotherapy
179223|NCT02213965|Intravenous Catheter|intravenous catheter
179224|NCT02213965|Vasofix safety|vasofix safety
179225|NCT02213965|Introcan safety|introcan safety
179226|NCT02213952|Ulcer|ulcer
179227|NCT02213952|Platelet-Rich Plasma|platelet-rich plasma
179228|NCT02213939|Myocardial revascularization|myocardial revascularization
179229|NCT02213939|Cytosorb|cytosorb
179230|NCT02213939|Inflammatory response|inflammatory response
179231|NCT02213939|Cardiopulmonary bypass|cardiopulmonary bypass
179232|NCT02213926|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
179233|NCT02213926|Btk|btk
179234|NCT02213926|Mantle Cell Lymphoma|mantle cell lymphoma
179235|NCT02213926|MCL|mcl
179236|NCT02213926|ACP-196|acp-196
179237|NCT02213926|Acalabrutinib|acalabrutinib
179238|NCT02213926|ACE-LY-004|ace-ly-004
179239|NCT02213900|delirium|delirium
179240|NCT02213900|confusion|confusion
179241|NCT02213900|surgery|surgery
179242|NCT02213900|cognitive Impairment|cognitive impairment
179243|NCT02213900|post-traumatic Stress disorder|post-traumatic stress disorder
179244|NCT02213900|depression|depression
179245|NCT02213900|anxiety|anxiety
179246|NCT02213887|Drug Interactions|drug interactions
179247|NCT02213887|Pantoprazole|pantoprazole
179248|NCT02213887|Proton Pump Inhibitors|proton pump inhibitors
179249|NCT02213887|Psychotropic Drugs|psychotropic drugs
179250|NCT02213887|Antipsychotic Agents|antipsychotic agents
179251|NCT02213887|Aripiprazole|aripiprazole
179252|NCT02213887|Asenapine|asenapine
179253|NCT02213887|Clozapine|clozapine
179254|NCT02213887|Lurasidone|lurasidone
179255|NCT02213887|Olanzapine|olanzapine
179256|NCT02213887|9-hydroxy-risperidone|9-hydroxy-risperidone
179257|NCT02213887|Quetiapine|quetiapine
179258|NCT02213887|Risperidone|risperidone
179259|NCT02213887|Ziprasidone|ziprasidone
179260|NCT02213887|Valproic Acid|valproic acid
179261|NCT02213887|Lithium|lithium
179262|NCT02213887|Gastrins|gastrins
218346|NCT02034448|AKI|aki
179263|NCT02213887|Psychotic Disorders|psychotic disorders
179264|NCT02213887|Gastroesophageal Reflux|gastroesophageal reflux
179265|NCT02213874|Pregnant Women|pregnant women
179266|NCT02213874|Women's Health|women's health
179267|NCT02213874|Contraception|contraception
179268|NCT02213874|Trust in Health Care|trust in health care
179269|NCT02213861|CTCL|ctcl
179270|NCT02213861|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
179271|NCT02213861|Early-stage|early-stage
179272|NCT02213861|SHAPE|shape
179273|NCT02213861|SHP-141|shp-141
179274|NCT02213861|topical|topical
179275|NCT02213861|Histone deacetylase inhibitor|histone deacetylase inhibitor
179276|NCT02213861|CAILS|cails
179277|NCT02213861|mSWAT|mswat
179278|NCT02213861|mycosis fungoides|mycosis fungoides
179400|NCT02213341|Peanut Allergy|peanut allergy
179279|NCT02213848|Neuromuscular blockade reversal|neuromuscular blockade reversal
179280|NCT02213848|TOF ratio|tof ratio
179281|NCT02213848|Calcium chloride|calcium chloride
179282|NCT02213835|Crohn's disease and Ulcerative colitis|crohn's disease and ulcerative colitis
179283|NCT02213822|genome|genome
179284|NCT02213822|transcriptome|transcriptome
179285|NCT02213822|molecular|molecular
179286|NCT02213822|proteome|proteome
179287|NCT02213822|oncogenic mutations|oncogenic mutations
179288|NCT02213822|sequencing|sequencing
179289|NCT02213822|solid tumor|solid tumor
179290|NCT02213822|hematological malignancy|hematological malignancy
179291|NCT02213822|cancer|cancer
179292|NCT02213822|analysis|analysis
179293|NCT02213822|genetic|genetic
179294|NCT02213822|mutation|mutation
179295|NCT02213796|meropenem, early phase, severe sepsis and septic shock, critically ill, population pharmacokinetics|meropenem, early phase, severe sepsis and septic shock, critically ill, population pharmacokinetics
179296|NCT02213783|Imipenem|imipenem
179297|NCT02213783|Febrile neutropenia|febrile neutropenia
179298|NCT02213783|Gram-negative infection|gram-negative infection
179299|NCT02213783|Pharmacodynamic|pharmacodynamic
179300|NCT02213783|Monte Carlo Simulation|monte carlo simulation
179301|NCT02213757|Hematuria|hematuria
179302|NCT02213757|Menopause|menopause
179304|NCT02213744|HER2-positive|her2-positive
179305|NCT02213744|HER2+|her2+
179306|NCT02213744|HER2|her2
179307|NCT02213744|Locally Advanced Breast Cancer|locally advanced breast cancer
179308|NCT02213744|Metastatic Breast Cancer|metastatic breast cancer
179309|NCT02213744|trastuzumab|trastuzumab
179310|NCT02213744|Herceptin|herceptin
179311|NCT02213744|pertuzumab|pertuzumab
179312|NCT02213744|ado-trastuzumab emtansine|ado-trastuzumab emtansine
179313|NCT02213744|TDM-1|tdm-1
179314|NCT02213744|Perjeta|perjeta
179315|NCT02213744|Kadcyla|kadcyla
179316|NCT02213731|Atrial Fibrillation|atrial fibrillation
179317|NCT02213731|Persistent Atrial Fibrillation|persistent atrial fibrillation
179318|NCT02213731|Cryoablation|cryoablation
179319|NCT02213731|Cryoballoon|cryoballoon
179320|NCT02213731|Pulmonary Vein Isolation|pulmonary vein isolation
179321|NCT02213718|Desflurane|desflurane
179322|NCT02213718|myocardial function|myocardial function
179323|NCT02213718|Coronary Artery Bypass Surgery|coronary artery bypass surgery
179324|NCT02213705|SYSTEMIC SCLERODERMA|systemic scleroderma
179325|NCT02213705|TRANSPLANTATION|transplantation
179326|NCT02213705|ALLOGENEIC MESENCHYMAL STEM CELLS|allogeneic mesenchymal stem cells
179327|NCT02213705|ADULT|adult
179328|NCT02213692|Liver Resection|liver resection
179329|NCT02213692|Harmonic Scalpel|harmonic scalpel
179330|NCT02213692|Crush-clamping|crush-clamping
179331|NCT02213692|A Prospective Randomized Study|a prospective randomized study
179332|NCT02213679|Creatine|creatine
179333|NCT02213679|Guanidinoacetic acid|guanidinoacetic acid
179334|NCT02213679|Intervention|intervention
179335|NCT02213679|Fatigue|fatigue
179336|NCT02213679|Muscle strength|muscle strength
179337|NCT02213666|Atrial fibrillation ablation|atrial fibrillation ablation
179338|NCT02213666|Intracardiac echocardiography|intracardiac echocardiography
179339|NCT02213666|Thrombus|thrombus
179340|NCT02213666|Left atrial appendage|left atrial appendage
179341|NCT02213666|Right atrial appendage|right atrial appendage
179342|NCT02213653|Functional iron deficiency|functional iron deficiency
179343|NCT02213653|Metastatic|metastatic
179344|NCT02213640|Neurologic neglect syndrome|neurologic neglect syndrome
179345|NCT02213640|post stroke|post stroke
179346|NCT02213640|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
179347|NCT02213640|prismatic adaptation|prismatic adaptation
179348|NCT02213627|Corifollitropin alfa, recombinant FSH, HP-hMG, apoptosis, oocyte donation|corifollitropin alfa, recombinant fsh, hp-hmg, apoptosis, oocyte donation
179349|NCT02213601|Yoga|yoga
666952|NCT00846495|Migraine|migraine
179350|NCT02213601|Complementary and Alternative Medicine Interventions|complementary and alternative medicine interventions
179351|NCT02213601|Treatment|treatment
179352|NCT02213601|Postpartum Depression|postpartum depression
179353|NCT02213588|Antioxidant|antioxidant
179354|NCT02213575|Resistent Hypertension|resistent hypertension
179355|NCT02213536|Metastatic brain cancer|metastatic brain cancer
179356|NCT02213536|Whole brain radiotherapy|whole brain radiotherapy
179357|NCT02213536|Scalp sparing whole brain radiotherapy|scalp sparing whole brain radiotherapy
179358|NCT02213536|Prophylactic whole brain radiotherapy|prophylactic whole brain radiotherapy
179359|NCT02213523|antioxidant|antioxidant
179360|NCT02213510|pacemaker|pacemaker
179361|NCT02213510|implantable cardioverter defibrillator|implantable cardioverter defibrillator
179362|NCT02213510|ICD|icd
179363|NCT02213510|surgical wound closure|surgical wound closure
179364|NCT02213510|sutures|sutures
179365|NCT02213510|Zipline|zipline
179366|NCT02213510|Zips|zips
179367|NCT02213510|CIED|cied
179368|NCT02213510|cardiovascular implantable electronic devices|cardiovascular implantable electronic devices
179369|NCT02213510|arrhythmia|arrhythmia
179370|NCT02213497|Patients with esophageal cancer to be treated with concurrent preoperative chemoradiation with carboplatin and paclitaxel.|patients with esophageal cancer to be treated with concurrent preoperative chemoradiation with carboplatin and paclitaxel.
179371|NCT02213484|aortopathy syndrome|aortopathy syndrome
179372|NCT02213484|aortic aneurysm|aortic aneurysm
179373|NCT02213484|aortic dissection|aortic dissection
179374|NCT02213484|connective tissue disorder|connective tissue disorder
179375|NCT02213458|Pragmatic Clinical Trial|pragmatic clinical trial
179376|NCT02213458|Family Caregivers|family caregivers
179377|NCT02213458|Patient Care Management|patient care management
179378|NCT02213432|influenza vaccine|influenza vaccine
179379|NCT02213432|cancer|cancer
179380|NCT02213419|Cystic Tumors of the Pancreas|cystic tumors of the pancreas
179381|NCT02213419|Endoscopic Ultrasound|endoscopic ultrasound
179382|NCT02213419|Ethanol|ethanol
179383|NCT02213393|undernutrition|undernutrition
179384|NCT02213393|nutritional status|nutritional status
179385|NCT02213393|elderly patients|elderly patients
179386|NCT02213393|protein|protein
179387|NCT02213393|enriched products|enriched products
179388|NCT02213393|recovery|recovery
179389|NCT02213393|physical function|physical function
179390|NCT02213393|quality of life|quality of life
180006|NCT02210221|TBI|tbi
179391|NCT02213393|activities of daily living|activities of daily living
179392|NCT02213380|delirium|delirium
179393|NCT02213380|general anesthesia|general anesthesia
179394|NCT02213380|regional anesthesia|regional anesthesia
179395|NCT02213380|elderly patient|elderly patient
179396|NCT02213380|hip fracture|hip fracture
179397|NCT02213354|Influenza, H7N9, Elderly, Vaccine, MF59 Adjuvant|influenza, h7n9, elderly, vaccine, mf59 adjuvant
179398|NCT02213341|Milk Allergy|milk allergy
179399|NCT02213341|Egg Allergy|egg allergy
179401|NCT02213341|Infant Vaccination|infant vaccination
179402|NCT02213315|Healthy Volunteers, Rheumatoid Arthritis, mavrilimumab|healthy volunteers, rheumatoid arthritis, mavrilimumab
179403|NCT02213302|premedication|premedication
179404|NCT02213302|preoperative anxiety|preoperative anxiety
179405|NCT02213302|salivary cortisol level|salivary cortisol level
179407|NCT02213289|Gastric|gastric
179408|NCT02213289|Esophagogastric|esophagogastric
179409|NCT02213276|Glucose infusion|glucose infusion
179410|NCT02213276|Bone markers|bone markers
179411|NCT02213276|Inflammatory markers|inflammatory markers
179412|NCT02213263|rituximab|rituximab
179413|NCT02213263|follicular lymphoma|follicular lymphoma
179414|NCT02213263|Non-Hodgkin lymphoma|non-hodgkin lymphoma
179415|NCT02213263|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
179416|NCT02213224|Perindopril,Telmisartan, Efficacy, NAFLD|perindopril,telmisartan, efficacy, nafld
179417|NCT02213211|Malawi|malawi
179418|NCT02213211|Case management|case management
179419|NCT02213211|Rapid diagnostic tests|rapid diagnostic tests
179420|NCT02213211|Artemether lumefantrine|artemether lumefantrine
179421|NCT02213211|School children|school children
179422|NCT02213211|School health services|school health services
179423|NCT02213211|Attendance|attendance
179424|NCT02213211|Anaemia|anaemia
179425|NCT02213211|Parasitic diseases|parasitic diseases
179426|NCT02213198|Serious mental illness transitions shared decision making|serious mental illness transitions shared decision making
179427|NCT02213185|Sterile water injections|sterile water injections
179428|NCT02213185|Pain|pain
179429|NCT02213185|VAS|vas
179430|NCT02213185|Complementary method|complementary method
179431|NCT02213172|IBS|ibs
179432|NCT02213172|Probiotic|probiotic
179433|NCT02213172|Constipation|constipation
179434|NCT02213172|Bifidobacterium longum|bifidobacterium longum
179435|NCT02213172|Lactobacillus paracasei|lactobacillus paracasei
179436|NCT02213172|Lallemand Health Solutions|lallemand health solutions
179437|NCT02213159|Dexmedetomidine|dexmedetomidine
179438|NCT02213159|bariatric surgery|bariatric surgery
179439|NCT02213159|postoperative pain|postoperative pain
179440|NCT02213159|morphine consumption|morphine consumption
179441|NCT02213159|Quality of recovery|quality of recovery
179442|NCT02213133|Squamous|squamous
179443|NCT02213133|SCC|scc
179444|NCT02213133|Carcinoma|carcinoma
179445|NCT02213133|KPT-330|kpt-330
179446|NCT02213133|SINE|sine
179447|NCT02213133|Selinexor|selinexor
179448|NCT02213133|Karyopharm|karyopharm
179449|NCT02213133|Karyopharm Therapeutics|karyopharm therapeutics
179450|NCT02213133|Lung|lung
179451|NCT02213133|Head|head
179452|NCT02213133|Neck|neck
179453|NCT02213133|Esophageal|esophageal
179454|NCT02213120|Vertigo, Dizziness|vertigo, dizziness
179455|NCT02213107|prostate|prostate
179456|NCT02213094|preeclampsia|preeclampsia
179457|NCT02213094|pregnancy-induced hypertension|pregnancy-induced hypertension
179458|NCT02213094|nicotinamide|nicotinamide
179459|NCT02213081|Endometriosis|endometriosis
179460|NCT02213081|chronic pelvic pain|chronic pelvic pain
179461|NCT02213081|dysmenorrhea|dysmenorrhea
179462|NCT02213081|dyschezia|dyschezia
179463|NCT02213081|bleeding|bleeding
179464|NCT02213081|ulipristal|ulipristal
179465|NCT02213081|progesterone|progesterone
179466|NCT02213068|Kidney|kidney
179467|NCT02213068|Renal|renal
179468|NCT02213068|Transplant|transplant
179469|NCT02213068|EBV|ebv
179470|NCT02213068|Immunosuppressants|immunosuppressants
179471|NCT02213068|Belatacept|belatacept
179472|NCT02213055|Lice|lice
179473|NCT02213042|biomarker|biomarker
179474|NCT02213042|Lapatinib|lapatinib
179475|NCT02213042|Prosigna|prosigna
179476|NCT02213042|ErbB2|erbb2
179477|NCT02213042|PAM50|pam50
179478|NCT02213042|HER2|her2
179479|NCT02213042|HER2-overexpressing metastatic breast cancer|her2-overexpressing metastatic breast cancer
179480|NCT02213042|HER2-enriched|her2-enriched
179481|NCT02213042|Trastuzumab|trastuzumab
179482|NCT02213029|epelsiban|epelsiban
179483|NCT02213029|pharmacokinetics|pharmacokinetics
179484|NCT02213029|patient reported pain / discomfort|patient reported pain / discomfort
179485|NCT02213029|pharmacodynamics|pharmacodynamics
179486|NCT02213029|oxytocin infusions|oxytocin infusions
179487|NCT02213029|Uterine contractions|uterine contractions
179488|NCT02213016|Stimulation magnetic transcranial, major depression, cognitive impairment|stimulation magnetic transcranial, major depression, cognitive impairment
179489|NCT02213003|islet transplantation|islet transplantation
179490|NCT02212990|Fever|fever
179491|NCT02212990|Antipyretics|antipyretics
179492|NCT02212990|Acetaminophen|acetaminophen
179493|NCT02212990|Ibuprofen|ibuprofen
179494|NCT02212990|Influenza vaccine|influenza vaccine
179495|NCT02212990|Influenza|influenza
179496|NCT02212990|Body temperature changes|body temperature changes
179497|NCT02212990|Signs and symptoms|signs and symptoms
179498|NCT02212977|Port Catheter|port catheter
179499|NCT02212977|Octyl 2-cyanoacrylate|octyl 2-cyanoacrylate
179500|NCT02212977|2-octylcyanoacrylate|2-octylcyanoacrylate
179501|NCT02212964|Radiation Injury|radiation injury
179502|NCT02212964|Radiation Necrosis|radiation necrosis
179503|NCT02212964|Ultra-high field MRI|ultra-high field mri
179504|NCT02212964|Susceptibility Weighted Imaging|susceptibility weighted imaging
179505|NCT02212964|Post-treatment radiographic imaging change|post-treatment radiographic imaging change
179506|NCT02212912|acute ischemic stroke, performance measure, acute treatment|acute ischemic stroke, performance measure, acute treatment
179507|NCT02212899|Spinal Surgery|spinal surgery
179508|NCT02212899|Spinal Fusion|spinal fusion
179509|NCT02212899|Deformity Correction|deformity correction
179510|NCT02212899|Spinal Instrumentation|spinal instrumentation
179511|NCT02212886|Glatiramer acetate|glatiramer acetate
179512|NCT02212886|Copaxone|copaxone
179513|NCT02212886|Multiple sclerosis|multiple sclerosis
179514|NCT02212886|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
179515|NCT02212886|RRMS|rrms
179516|NCT02212886|GA Depot|ga depot
179517|NCT02212886|Monthly injection|monthly injection
179518|NCT02212873|school based intervention|school based intervention
179519|NCT02212873|overweight|overweight
179520|NCT02212873|obese|obese
179521|NCT02212873|BMI z score|bmi z score
179522|NCT02212873|fat mass|fat mass
179523|NCT02212860|neoadjuvant|neoadjuvant
179524|NCT02212860|radiation|radiation
179525|NCT02212860|breast|breast
179526|NCT02212860|cancer|cancer
179527|NCT02212860|hypofractionation|hypofractionation
179528|NCT02212860|stereotactic|stereotactic
179529|NCT02212860|preoperative|preoperative
179530|NCT02212834|Breast|breast
179531|NCT02212834|Cancer|cancer
179532|NCT02212834|Surveillance|surveillance
179533|NCT02212834|Imaging|imaging
179534|NCT02212834|Comparative|comparative
179535|NCT02212834|Effectiveness|effectiveness
179536|NCT02212808|Cluster-randomized crossover trial|cluster-randomized crossover trial
179537|NCT02212808|Antimicrobial stewardship|antimicrobial stewardship
179538|NCT02212808|Community hospitals|community hospitals
179539|NCT02212808|Feasibility|feasibility
179540|NCT02212795|healthy|healthy
179541|NCT02212782|Healthy|healthy
179542|NCT02212769|healthy|healthy
179543|NCT02212756|healthy|healthy
179544|NCT02212717|Acute cholecystitis|acute cholecystitis
179545|NCT02212717|EUS-guided gallbladder drainage|eus-guided gallbladder drainage
179546|NCT02212717|Percutaneous cholecystostomy|percutaneous cholecystostomy
179547|NCT02212704|vestibular|vestibular
179548|NCT02212704|proprioception|proprioception
179549|NCT02212704|spatial orientation|spatial orientation
179550|NCT02212704|bayesian|bayesian
179551|NCT02212691|Sickle Cell|sickle cell
179552|NCT02212652|Bariatric surgery|bariatric surgery
179553|NCT02212652|Vitamin D deficiency|vitamin d deficiency
218690|NCT02033070|RFA|rfa
170480|NCT02254304|RMS|rms
179554|NCT02212652|Vitamin D insufficiency|vitamin d insufficiency
179555|NCT02212652|Adverse surgical outcomes|adverse surgical outcomes
179556|NCT02212652|Clinical outcomes|clinical outcomes
179557|NCT02212639|Kaposi' s sarcoma|kaposi' s sarcoma
179558|NCT02212639|Digoxin|digoxin
179559|NCT02212613|Major Depressive Disorder|major depressive disorder
179560|NCT02212613|Mental Disorders, nonpsychotic episode, antipsychotic|mental disorders, nonpsychotic episode, antipsychotic
179561|NCT02212613|Mood Disorder, psychotic disorder|mood disorder, psychotic disorder
179562|NCT02212587|inhaled antibiotics|inhaled antibiotics
179563|NCT02212574|Wnt|wnt
179564|NCT02212574|Medulloblastoma|medulloblastoma
179565|NCT02212574|Chemotherapy|chemotherapy
179566|NCT02212548|SpaceOAR Hydrogel Image Guided Modulated Radiotherapy|spaceoar hydrogel image guided modulated radiotherapy
179567|NCT02212535|Sickle cell disease|sickle cell disease
179568|NCT02212535|Open monocenter study|open monocenter study
179569|NCT02212535|Phase I/II|phase i/ii
179570|NCT02212535|hematopoietic stem cells|hematopoietic stem cells
179571|NCT02212535|Plerixafor|plerixafor
179572|NCT02212522|Diabetes Mellitus|diabetes mellitus
179573|NCT02212522|Insulin-Dependent|insulin-dependent
179574|NCT02212522|Genome-Wide Association Study|genome-wide association study
179575|NCT02212522|Environment-Wide Association Study|environment-wide association study
179576|NCT02212522|Predisposition|predisposition
179577|NCT02212522|Complications|complications
179578|NCT02212483|Asthma|asthma
179579|NCT02212483|Medical Indoor Environment Counselors|medical indoor environment counselors
179580|NCT02212483|Pediatric|pediatric
179581|NCT02212483|Environment|environment
179582|NCT02212483|Clinical effectiveness|clinical effectiveness
179583|NCT02212483|Economical impact|economical impact
179584|NCT02212444|plantar fasciitis|plantar fasciitis
179585|NCT02212444|dynamic elastomeric fabric orthoses (DEFO)|dynamic elastomeric fabric orthoses (defo)
179586|NCT02212444|feasibility|feasibility
179587|NCT02212444|Physiotherapy|physiotherapy
179588|NCT02212444|Musculoskeletal|musculoskeletal
180804|NCT02206555|biomedical|biomedical
179589|NCT02212431|Cystic Fibrosis|cystic fibrosis
179590|NCT02212431|Cysteamine|cysteamine
179591|NCT02212431|Pharmacokinetics|pharmacokinetics
179592|NCT02212405|Deep rTMS|deep rtms
179593|NCT02212405|Insular cortex|insular cortex
179594|NCT02212405|PET|pet
179595|NCT02212405|[11C]-PHNO|[11c]-phno
179596|NCT02212392|acute pancreatitis|acute pancreatitis
179597|NCT02212379|Raltegravir|raltegravir
179598|NCT02212379|Etravirine|etravirine
179599|NCT02212379|aged, 45 and over|aged, 45 and over
179600|NCT02212379|Viral load|viral load
179601|NCT02212379|Efficacy|efficacy
179602|NCT02212379|Safety|safety
179603|NCT02212366|TDCS|tdcs
179604|NCT02212366|Depression|depression
179605|NCT02212366|Brain Stimulation|brain stimulation
179606|NCT02212366|Memory|memory
179613|NCT02212327|Na+ MRI|na+ mri
179614|NCT02212327|salt stores|salt stores
179615|NCT02212314|Response Inhibition, Williams Syndrome|response inhibition, williams syndrome
179616|NCT02212275|ASD|asd
179617|NCT02212275|autism|autism
179618|NCT02212275|typical development|typical development
179619|NCT02212275|sensory testing|sensory testing
179620|NCT02212275|the cortical metric|the cortical metric
179621|NCT02212249|soluble VE-cadherin|soluble ve-cadherin
179622|NCT02212249|antibody|antibody
179623|NCT02212249|systemic slerosis|systemic slerosis
179624|NCT02212236|Distress|distress
179625|NCT02212236|Depression|depression
179626|NCT02212236|Anxiety|anxiety
179627|NCT02212236|Stress|stress
179628|NCT02212236|Coping|coping
179629|NCT02212236|Illness perceptions|illness perceptions
179630|NCT02212236|Stem cell transplantation|stem cell transplantation
179631|NCT02212236|Bone marrow transplantation|bone marrow transplantation
179632|NCT02212223|Vitamin D|vitamin d
179633|NCT02212223|Serum 25-hydroxyvitamin D (25OHD)|serum 25-hydroxyvitamin d (25ohd)
179634|NCT02212223|Dietary supplement|dietary supplement
179635|NCT02212223|Ethnicity|ethnicity
179636|NCT02212223|Immigrant|immigrant
179637|NCT02212197|prostate cancer|prostate cancer
179638|NCT02212197|leuprolide|leuprolide
179639|NCT02212184|Diaphragm|diaphragm
179640|NCT02212184|COPD|copd
179641|NCT02212184|Musculoskeletal Manipulations|musculoskeletal manipulations
179642|NCT02212184|Ultrasonography|ultrasonography
179643|NCT02212184|Optoelectronic Plethysmography.|optoelectronic plethysmography.
179644|NCT02212158|Type 1 diabetes|type 1 diabetes
179645|NCT02212158|adolescents|adolescents
179646|NCT02212158|HA1c|ha1c
179647|NCT02212158|psychological intervention|psychological intervention
179648|NCT02212145|prevention|prevention
179649|NCT02212145|cardiovascular disease|cardiovascular disease
179650|NCT02212145|risk factors|risk factors
179651|NCT02212132|metamemory|metamemory
179652|NCT02212132|memory complaints|memory complaints
179653|NCT02212132|performance mnemonic|performance mnemonic
179654|NCT02212132|cancer|cancer
179655|NCT02212119|Dementia|dementia
179656|NCT02212119|Paratonia|paratonia
179657|NCT02212119|Caregiver Burden|caregiver burden
179658|NCT02212119|Botulinum toxin|botulinum toxin
179659|NCT02212093|Pneumonia, mechanical ventilation, ICU, mortality|pneumonia, mechanical ventilation, icu, mortality
179660|NCT02212041|electronic cigarettes|electronic cigarettes
179661|NCT02212041|smoking|smoking
179662|NCT02212041|schizophrenia|schizophrenia
179663|NCT02212041|serious mental illness|serious mental illness
179664|NCT02212028|ST-elevation myocardial infarction|st-elevation myocardial infarction
179665|NCT02212028|prasugrel|prasugrel
179666|NCT02212028|pharmacodynamic|pharmacodynamic
179667|NCT02212028|pharmacokinetic|pharmacokinetic
179668|NCT02212002|Group B Streptococcus|group b streptococcus
179669|NCT02212002|Intrapartum Antibiotic Prophylaxis|intrapartum antibiotic prophylaxis
179670|NCT02212002|term infants|term infants
179671|NCT02212002|vaginal delivery|vaginal delivery
179672|NCT02212002|gut microbiota|gut microbiota
179673|NCT02212002|feeding|feeding
179674|NCT02212002|molecular analysis|molecular analysis
179675|NCT02212002|real-time PCR|real-time pcr
179676|NCT02211846|Pharmacokinetics|pharmacokinetics
179677|NCT02211846|Mirabegron|mirabegron
179678|NCT02211846|Neurogenic detrusor overactivity (NDO)|neurogenic detrusor overactivity (ndo)
179679|NCT02211846|Overactive bladder (OAB)|overactive bladder (oab)
179680|NCT02211820|Encephalopathy|encephalopathy
179681|NCT02211820|Imaging Studies|imaging studies
179682|NCT02211820|Dementia|dementia
179683|NCT02211820|Cerebellar Cortical Atrophy|cerebellar cortical atrophy
179684|NCT02211794|Total Knee Arthroplasty|total knee arthroplasty
179685|NCT02211794|degenerative joint disease|degenerative joint disease
179686|NCT02211781|Tribal Communities|tribal communities
179687|NCT02211781|Radiation|radiation
179688|NCT02211781|Cancer|cancer
179689|NCT02211768|Genetic Analysis|genetic analysis
179690|NCT02211768|Biopsy|biopsy
179691|NCT02211768|FDG-PET|fdg-pet
179692|NCT02211768|FLT-PET|flt-pet
179693|NCT02211755|Purine Nucleoside Inhibitor|purine nucleoside inhibitor
179694|NCT02211755|Proteasome Inhibitor|proteasome inhibitor
179695|NCT02211755|Combination Treatment|combination treatment
179696|NCT02211755|Solid Tumors|solid tumors
179697|NCT02211742|dapagliflozin|dapagliflozin
179698|NCT02211742|fasting glucose|fasting glucose
179699|NCT02211742|postprandial glucose excursion|postprandial glucose excursion
179993|NCT02210286|dementia|dementia
179700|NCT02211742|euglycemic hyperinsulinemic clamp|euglycemic hyperinsulinemic clamp
179701|NCT02211742|euglycemic oral glucose tolerance test|euglycemic oral glucose tolerance test
179703|NCT02211703|Epidemiology|epidemiology
179704|NCT02211703|Tympanic temperature|tympanic temperature
179705|NCT02211651|adipose tissue|adipose tissue
179706|NCT02211651|placenta|placenta
179707|NCT02211651|pregnancy|pregnancy
179708|NCT02211651|umbilical cord|umbilical cord
179709|NCT02211638|Drug Therapy|drug therapy
179711|NCT02211625|Pharmacodynamics (PD)|pharmacodynamics (pd)
179712|NCT02211625|Pharmacokinetics (PK)|pharmacokinetics (pk)
179713|NCT02211612|Overfeeding|overfeeding
179714|NCT02211612|Weight gain|weight gain
179715|NCT02211612|Liver fat|liver fat
179716|NCT02211612|Pancreatic fat|pancreatic fat
179717|NCT02211612|Ectopic fat|ectopic fat
179718|NCT02211612|Skeletal muscle|skeletal muscle
179719|NCT02211612|Adipose tissue|adipose tissue
179720|NCT02211612|Gene expression|gene expression
179721|NCT02211612|DNA methylation|dna methylation
179722|NCT02211612|Palmitate|palmitate
179723|NCT02211612|Linoleic acid|linoleic acid
179724|NCT02211612|Saturated fat|saturated fat
179725|NCT02211612|Polyunsaturated fat|polyunsaturated fat
179726|NCT02211612|Metabolism|metabolism
179727|NCT02211612|Insulin sensitivity|insulin sensitivity
179728|NCT02211599|protein|protein
179729|NCT02211599|carbohydrate|carbohydrate
179730|NCT02211599|lipid|lipid
179731|NCT02211599|oxidation|oxidation
179732|NCT02211599|fat|fat
179733|NCT02211599|sugar|sugar
179734|NCT02211599|juice|juice
179735|NCT02211599|obesity|obesity
179736|NCT02211586|insulin glargine|insulin glargine
179737|NCT02211586|subcutaneous injections|subcutaneous injections
179738|NCT02211586|sleep respiratory quotient|sleep respiratory quotient
179739|NCT02211573|Autonomic Nervous System, Body composition, Oxygen Uptake,|autonomic nervous system, body composition, oxygen uptake,
179740|NCT02211573|Water Based Physical Training.|water based physical training.
179741|NCT02211534|Pulsed Electromagnetic Energy Fields|pulsed electromagnetic energy fields
667060|NCT00846937|Ileostoma|ileostoma
179742|NCT02211534|Total Knee Arthroplasty|total knee arthroplasty
179743|NCT02211534|Pain Intensity|pain intensity
179744|NCT02211521|Osteoarthritis, platelet-rich plasma, hyaluronic acid|osteoarthritis, platelet-rich plasma, hyaluronic acid
179745|NCT02211508|fibromyalgia|fibromyalgia
179746|NCT02211508|pain|pain
179747|NCT02211508|stimulation|stimulation
179748|NCT02211482|HIV-1 infected patients|hiv-1 infected patients
179749|NCT02211482|dual therapy|dual therapy
179750|NCT02211456|Endocardial pacing|endocardial pacing
179751|NCT02211456|Multi site pacing|multi site pacing
179752|NCT02211443|Full human anti-EGFR monoclonal antibody (SCT200) ;|full human anti-egfr monoclonal antibody (sct200) ;
179753|NCT02211443|metastatic colorectal cancer （mCRC）;|metastatic colorectal cancer （mcrc）;
170690|NCT02252900|MRI|mri
179754|NCT02211443|Escalating doses ;|escalating doses ;
179755|NCT02211443|single dose and multiple doses;|single dose and multiple doses;
179756|NCT02211443|safety, tolerability and pharmacokinetics.|safety, tolerability and pharmacokinetics.
179757|NCT02211430|smoking cessation|smoking cessation
179758|NCT02211430|pregnancy|pregnancy
179759|NCT02211430|postpartum|postpartum
179760|NCT02211430|intervention|intervention
179761|NCT02211391|Nighttime Eating|nighttime eating
179762|NCT02211391|Protein|protein
179763|NCT02211391|Obesity|obesity
179764|NCT02211391|Lipolysis|lipolysis
179765|NCT02211391|Metabolism|metabolism
179766|NCT02211378|stress|stress
179767|NCT02211378|performance|performance
179768|NCT02211378|cortisol|cortisol
179769|NCT02211365|Hypertension|hypertension
179771|NCT02211352|blood pressure, ginseng|blood pressure, ginseng
179772|NCT02211339|Social skills|social skills
179773|NCT02211339|Social communication|social communication
179774|NCT02211339|Cognitive communication|cognitive communication
179775|NCT02211339|Traumatic brain injury|traumatic brain injury
179776|NCT02211339|Acquired brain injury|acquired brain injury
179777|NCT02211339|Communication partner training|communication partner training
179778|NCT02211339|Peer partner training|peer partner training
179779|NCT02211339|Peer mentoring|peer mentoring
179780|NCT02211339|Rating scales|rating scales
179781|NCT02211339|Rehabilitation|rehabilitation
179782|NCT02211326|AF or DVT|af or dvt
179783|NCT02211326|Age Over 18 Years, Acquired|age over 18 years, acquired
179784|NCT02211300|glucose monitoring|glucose monitoring
179785|NCT02211300|OptiScanner|optiscanner
179786|NCT02211287|Dementia|dementia
179787|NCT02211287|Decision-making|decision-making
179788|NCT02211287|Communication|communication
179789|NCT02211287|Advance Care Planning|advance care planning
179790|NCT02211274|Quality of Life|quality of life
179791|NCT02211274|Nursing Homes|nursing homes
179792|NCT02211274|Housing for the Elderly|housing for the elderly
179793|NCT02211274|Homes for the Aged|homes for the aged
179794|NCT02211261|first in human|first in human
179795|NCT02211261|single dose|single dose
179796|NCT02211261|multiple dose|multiple dose
179797|NCT02211261|escalation|escalation
179798|NCT02211261|safety study|safety study
179799|NCT02211261|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
179800|NCT02211248|Cardiac Frequency Variability|cardiac frequency variability
179801|NCT02211248|multidisciplinary care|multidisciplinary care
179802|NCT02211248|clinical trial|clinical trial
179803|NCT02211235|Cystic Fibrosis|cystic fibrosis
179804|NCT02211235|Healthy Controls|healthy controls
179806|NCT02211235|Cystic Fibrosis Related Diabetes (CFRD)|cystic fibrosis related diabetes (cfrd)
179807|NCT02211235|CFRD|cfrd
179808|NCT02211222|Thyroid Cancer|thyroid cancer
179809|NCT02211222|Radioiodine-Refractory|radioiodine-refractory
179810|NCT02211222|Differentiated|differentiated
179811|NCT02211183|Massive Rotator Cuff Tear|massive rotator cuff tear
179812|NCT02211183|Sub-acromial spacer|sub-acromial spacer
179813|NCT02211183|Best repair of rotator cuff|best repair of rotator cuff
179814|NCT02211105|GastroEsophageal Reflux Disease|gastroesophageal reflux disease
179815|NCT02211105|Transoral Incisionless Fundoplication|transoral incisionless fundoplication
179816|NCT02211105|Laparoscopic Nissen Fundoplication|laparoscopic nissen fundoplication
179817|NCT02211092|Family Caregivers|family caregivers
179818|NCT02211092|Advanced Cancer|advanced cancer
179819|NCT02211092|Palliative Care|palliative care
179820|NCT02211092|Support|support
179821|NCT02211092|Self Care|self care
179822|NCT02211092|Physical Activity|physical activity
179823|NCT02211079|Healthy|healthy
179824|NCT02211079|JNJ-54861911|jnj-54861911
179825|NCT02211079|Caffeine|caffeine
179826|NCT02211079|Midazolam|midazolam
179827|NCT02211079|Tolbutamide|tolbutamide
179828|NCT02211079|Cytochrome P450 3A4|cytochrome p450 3a4
179829|NCT02211079|Cytochrome P450 2C9|cytochrome p450 2c9
179830|NCT02211079|Cytochrome P450 1A2|cytochrome p450 1a2
179831|NCT02211079|Alzheimer's disease|alzheimer's disease
179832|NCT02211053|Organ donation|organ donation
179833|NCT02211053|Brain dead|brain dead
179834|NCT02211053|Levothyroxine|levothyroxine
179835|NCT02211040|Intervention Mapping Protocol|intervention mapping protocol
179836|NCT02211040|physical activity|physical activity
179837|NCT02211040|fruit intake|fruit intake
179838|NCT02211040|vegetable intake|vegetable intake
179839|NCT02211040|computer tailoring|computer tailoring
179840|NCT02211040|eHealth|ehealth
179841|NCT02211040|self-regulation|self-regulation
179842|NCT02211040|goal setting|goal setting
179843|NCT02211040|problem solving|problem solving
179844|NCT02211040|general practice|general practice
179845|NCT02211027|Squamous Cell Carcinoma|squamous cell carcinoma
179846|NCT02211027|Head & Neck Cancer|head & neck cancer
179847|NCT02211027|Vaccine|vaccine
179848|NCT02211027|Carcinoma|carcinoma
179849|NCT02211027|Immunization|immunization
179850|NCT02211027|Autologous Tumor|autologous tumor
179851|NCT02211014|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
179852|NCT02211014|Btk|btk
179853|NCT02211014|Multiple Myeloma|multiple myeloma
179854|NCT02211014|MM|mm
179855|NCT02211014|ACP-196|acp-196
179856|NCT02211014|acalabrutinib|acalabrutinib
179857|NCT02211001|Exercise Movement Techniques|exercise movement techniques
179858|NCT02211001|Exercise Therapy|exercise therapy
179859|NCT02211001|Physical Therapy Modalities.|physical therapy modalities.
179860|NCT02210988|Acupuncture therapy, Acute stroke, Randomized controlled trials|acupuncture therapy, acute stroke, randomized controlled trials
179861|NCT02210975|GERD|gerd
179862|NCT02210975|LES|les
179863|NCT02210975|Sleeve Gastrectomy|sleeve gastrectomy
179864|NCT02210975|Electrical Stimulation Therapy|electrical stimulation therapy
179865|NCT02210962|early psychosis|early psychosis
179866|NCT02210962|chronic schizophrenia|chronic schizophrenia
179867|NCT02210962|first episode psychosis|first episode psychosis
179868|NCT02210962|omega-3 and omega-6 essential fatty acids|omega-3 and omega-6 essential fatty acids
179869|NCT02210962|relapse prevention|relapse prevention
179870|NCT02210962|efficacy|efficacy
179871|NCT02210949|Blood transfusion|blood transfusion
179872|NCT02210949|Erythropoietin|erythropoietin
179873|NCT02210949|Iron suppletion|iron suppletion
179874|NCT02210923|Baroreflex|baroreflex
179875|NCT02210923|Electrical stimulation|electrical stimulation
179876|NCT02210923|Carotid body|carotid body
179877|NCT02210923|Chemoreceptors|chemoreceptors
179878|NCT02210923|Resistant hypertension|resistant hypertension
179879|NCT02210910|Massive Rotator Cuff Tear, Sub-acromial spacer, Best repair of rotator cuff|massive rotator cuff tear, sub-acromial spacer, best repair of rotator cuff
179880|NCT02210884|Vitamin D supplementation|vitamin d supplementation
179881|NCT02210884|Lactation|lactation
179882|NCT02210884|25 hydroxyvitamin D|25 hydroxyvitamin d
179883|NCT02210884|Breast feeding|breast feeding
179884|NCT02210845|Diabetes|diabetes
179885|NCT02210845|Supervised Exercise|supervised exercise
179886|NCT02210845|Weight loss|weight loss
179887|NCT02210832|smoking|smoking
179888|NCT02210832|pregnancy|pregnancy
179889|NCT02210832|cessation|cessation
179890|NCT02210832|incentives|incentives
179891|NCT02210819|Thromboembolism|thromboembolism
179892|NCT02210819|Embolism and Thrombosis|embolism and thrombosis
179893|NCT02210819|Vascular Diseases|vascular diseases
179894|NCT02210819|Cardiovascular Diseases|cardiovascular diseases
179895|NCT02210819|Thrombosis|thrombosis
179896|NCT02210806|Asthma|asthma
179901|NCT02210793|Transepithelial PRK|transepithelial prk
179902|NCT02210793|Dry eye|dry eye
179903|NCT02210793|Schirmer test|schirmer test
179904|NCT02210793|Tear break up time|tear break up time
179905|NCT02210793|Dry eye after advanced surface ablation technique|dry eye after advanced surface ablation technique
179906|NCT02210754|Nicotine|nicotine
179907|NCT02210754|Pharmacokinetics|pharmacokinetics
179908|NCT02210754|Pharmacodynamics|pharmacodynamics
179909|NCT02210754|blu e-cigs|blu e-cigs
179910|NCT02210754|Tolerability|tolerability
179911|NCT02210754|Safety|safety
179912|NCT02210754|Smoke urge|smoke urge
179913|NCT02210741|immune repertoire|immune repertoire
179914|NCT02210741|Graves' disease|graves' disease
179920|NCT02210663|Breast cancer|breast cancer
179921|NCT02210663|PARP|parp
179922|NCT02210663|Primary peritoneal cancer|primary peritoneal cancer
179923|NCT02210663|Fallopian tube|fallopian tube
179924|NCT02210663|Ovarian cancer|ovarian cancer
179925|NCT02210663|veliparib|veliparib
179926|NCT02210663|ABT-888|abt-888
179927|NCT02210663|BRCA|brca
179928|NCT02210650|kidney stone|kidney stone
179929|NCT02210637|Appointments and Schedules|appointments and schedules
179930|NCT02210637|Outpatient Clinics, Hospital/Economics|outpatient clinics, hospital/economics
179931|NCT02210637|Emergency Department|emergency department
179932|NCT02210637|Hospitalization|hospitalization
179933|NCT02210637|Mortality|mortality
179934|NCT02210624|Anoxic Brain Injury|anoxic brain injury
179935|NCT02210624|Autologous bone marrow derived stem cell|autologous bone marrow derived stem cell
179936|NCT02210624|stoke|stoke
179937|NCT02210598|labor, induced|labor, induced
179938|NCT02210598|catheter|catheter
179939|NCT02210598|oxytocin|oxytocin
179940|NCT02210598|Cesarean section|cesarean section
179941|NCT02210572|Intestinal microbiota|intestinal microbiota
179942|NCT02210572|Intestinal gas|intestinal gas
179943|NCT02210572|Dietary intervention|dietary intervention
179944|NCT02210572|Low-FODMAPs diet|low-fodmaps diet
179945|NCT02210572|Prebiotics|prebiotics
179946|NCT02210559|locally|locally
179947|NCT02210559|advanced|advanced
179948|NCT02210559|pancreatic|pancreatic
179949|NCT02210559|cancer|cancer
179950|NCT02210559|unresectable|unresectable
179951|NCT02210559|pancreatic cancer|pancreatic cancer
179952|NCT02210546|breast cancer|breast cancer
179953|NCT02210546|intermediate risk|intermediate risk
179954|NCT02210507|vitamin A|vitamin a
179955|NCT02210507|retinol|retinol
179956|NCT02210507|carotenoids|carotenoids
179957|NCT02210481|vitrectomy,|vitrectomy,
179958|NCT02210481|macular thinning,|macular thinning,
179959|NCT02210481|retinal detachment,|retinal detachment,
179960|NCT02210481|epimacular membrane,|epimacular membrane,
179961|NCT02210481|intravitreal glucose,|intravitreal glucose,
179963|NCT02210468|Osteoarthritis|osteoarthritis
179964|NCT02210468|Protease Inhibitors|protease inhibitors
179965|NCT02210468|Alpha-2-macroglobulin|alpha-2-macroglobulin
179966|NCT02210468|Autologous treatment|autologous treatment
179967|NCT02210468|APIC-CF|apic-cf
179968|NCT02210468|Pain due to Mild to Moderate osteoarthritis (OA) of the knee|pain due to mild to moderate osteoarthritis (oa) of the knee
179969|NCT02210455|FASD|fasd
179970|NCT02210455|pFAS|pfas
179971|NCT02210455|ARND|arnd
179972|NCT02210455|Fetal Alcohol Syndrome|fetal alcohol syndrome
179973|NCT02210455|Partial Fetal Alcohol Syndrome|partial fetal alcohol syndrome
179974|NCT02210455|Alcohol Related Neurodevelopmental Disorder|alcohol related neurodevelopmental disorder
179975|NCT02210455|Static Encephalopathy (Alcohol Exposed)|static encephalopathy (alcohol exposed)
179976|NCT02210455|Neurobehavioural Disorder (Alcohol Exposed)|neurobehavioural disorder (alcohol exposed)
179977|NCT02210442|educational games|educational games
179978|NCT02210442|clinical practice guideline|clinical practice guideline
179979|NCT02210442|family medicine|family medicine
179980|NCT02210442|primary health care|primary health care
179981|NCT02210442|cluster clinical trial|cluster clinical trial
179982|NCT02210429|Supraclavicular Block|supraclavicular block
179983|NCT02210429|Supraclavicular Catheter|supraclavicular catheter
179984|NCT02210429|Pediatric Anesthesia|pediatric anesthesia
179985|NCT02210429|Regional Anesthesia|regional anesthesia
179986|NCT02210429|Supracondylar Elbow Fracture|supracondylar elbow fracture
179987|NCT02210390|Psycho-education, Bipolar , cultural adaptation, Pakistan|psycho-education, bipolar , cultural adaptation, pakistan
179988|NCT02210377|Auto-moxibusition, intra-dialytic hypotension, hemodialysis|auto-moxibusition, intra-dialytic hypotension, hemodialysis
179989|NCT02210325|gonorrhea|gonorrhea
179990|NCT02210325|chlamydia|chlamydia
179991|NCT02210325|solithromycin|solithromycin
179992|NCT02210299|Healthy young children (2-6 months ; 12-18 months)|healthy young children (2-6 months ; 12-18 months)
179994|NCT02210286|magnesium|magnesium
179995|NCT02210286|learning|learning
179997|NCT02210286|Alzheimer's disease|alzheimer's disease
179998|NCT02210273|Stress Urinary Incontinence|stress urinary incontinence
179999|NCT02210273|SUI|sui
180000|NCT02210260|Cancer|cancer
180001|NCT02210260|Colorectal|colorectal
180002|NCT02210260|Pain relief|pain relief
180003|NCT02210234|wheat bran|wheat bran
180004|NCT02210234|healthy immunity|healthy immunity
180005|NCT02210234|T cells|t cells
180007|NCT02210195|Cannabis Treatment|cannabis treatment
180008|NCT02210195|Alcohol Treatment|alcohol treatment
180009|NCT02210195|Alcohol-Related Disorders|alcohol-related disorders
180010|NCT02210195|Cannabis-Related Disorders|cannabis-related disorders
180011|NCT02210195|Substance-Related Disorders|substance-related disorders
180012|NCT02210195|Emend|emend
180013|NCT02210195|NK1 receptor antagonist|nk1 receptor antagonist
180014|NCT02210195|Alcohol|alcohol
180015|NCT02210195|Cannabis|cannabis
180016|NCT02210195|aprepitant|aprepitant
180017|NCT02210182|Hepatocellular carcinoma|hepatocellular carcinoma
180018|NCT02210182|Oral Pentamidine|oral pentamidine
180019|NCT02210182|Endo-exonuclease|endo-exonuclease
180020|NCT02210156|Respiratory tract infection|respiratory tract infection
180021|NCT02210156|Incidence|incidence
180022|NCT02210156|Dietary supplements|dietary supplements
180023|NCT02210156|Micronutrients|micronutrients
180024|NCT02210156|Plant extracts|plant extracts
180025|NCT02210117|Kidney Cancer|kidney cancer
180026|NCT02210117|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
180027|NCT02210117|mRCC|mrcc
180028|NCT02210117|Cytoreductive Nephrectomy|cytoreductive nephrectomy
180029|NCT02210117|Presurgical therapy|presurgical therapy
180030|NCT02210117|Nivolumab|nivolumab
180031|NCT02210117|BMS-936558|bms-936558
180032|NCT02210117|Bevacizumab|bevacizumab
180033|NCT02210117|Avastin|avastin
180034|NCT02210117|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
180035|NCT02210117|fhuMab-VEGF|fhumab-vegf
180036|NCT02210117|Ipilimumab|ipilimumab
180037|NCT02210117|Yervoy|yervoy
180038|NCT02210117|BMS-734016|bms-734016
180039|NCT02210117|MDX010|mdx010
180040|NCT02210104|Melanoma|melanoma
180041|NCT02210104|Sarcoma|sarcoma
180042|NCT02210104|Mixed round cell liposarcoma|mixed round cell liposarcoma
180043|NCT02210104|Advanced|advanced
180044|NCT02210104|Metastatic|metastatic
180045|NCT02210104|Immunotherapy|immunotherapy
180046|NCT02210104|Ipilimumab|ipilimumab
180047|NCT02210104|Yervoy|yervoy
180048|NCT02210104|BMS-734016|bms-734016
180049|NCT02210104|MDX010|mdx010
180050|NCT02210104|Cyclophosphamide|cyclophosphamide
180051|NCT02210104|Cytoxan|cytoxan
180052|NCT02210104|Neosar|neosar
180053|NCT02210104|CD4+T Cells|cd4+t cells
180054|NCT02210078|Blood And Marrow Transplantation|blood and marrow transplantation
180055|NCT02210078|Infection|infection
180056|NCT02210078|Cytomegalovirus|cytomegalovirus
180057|NCT02210078|CMV|cmv
180058|NCT02210078|Stem cell transplant|stem cell transplant
180059|NCT02210078|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
219311|NCT02029989|CMM|cmm
171028|NCT02251236|HIV|hiv
180060|NCT02210078|HSCT|hsct
180061|NCT02210078|Human Leukocyte Antigen|human leukocyte antigen
180062|NCT02210078|HLA|hla
180063|NCT02210078|Cytotoxic T-Lymphocytes|cytotoxic t-lymphocytes
180064|NCT02210078|CTL|ctl
180065|NCT02210065|Leukemia|leukemia
180066|NCT02210065|Lymphoma|lymphoma
180067|NCT02210065|Blood And Marrow Transplantation|blood and marrow transplantation
180068|NCT02210065|Hematological malignancies|hematological malignancies
180069|NCT02210065|Cytotoxic T cells|cytotoxic t cells
180070|NCT02210065|CTL|ctl
180071|NCT02210065|Cytomegalovirus|cytomegalovirus
180072|NCT02210065|CMV|cmv
180073|NCT02210065|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
180074|NCT02210065|HSCT|hsct
180075|NCT02210052|radiofrequency ablation|radiofrequency ablation
180076|NCT02210039|SECM|secm
180077|NCT02210039|Esophagus|esophagus
180078|NCT02210039|Imaging|imaging
180079|NCT02210026|bubble nasal continuous positive airway pressure (Bn-CPAP)|bubble nasal continuous positive airway pressure (bn-cpap)
180080|NCT02210026|work of breathing|work of breathing
180081|NCT02210026|pressure-rate products|pressure-rate products
180082|NCT02210013|AMH, AFC, aging, ethnicity|amh, afc, aging, ethnicity
180083|NCT02210000|repeat dose|repeat dose
180084|NCT02210000|phase II|phase ii
180085|NCT02210000|GCSI-DD|gcsi-dd
180086|NCT02210000|pharmacodynamics|pharmacodynamics
180087|NCT02210000|gastroparesis|gastroparesis
180088|NCT02210000|type 1 and type 2 diabetes mellitus|type 1 and type 2 diabetes mellitus
180089|NCT02210000|camicinal|camicinal
180090|NCT02210000|GSK962040|gsk962040
180091|NCT02210000|symptoms|symptoms
180092|NCT02210000|gut motility|gut motility
180093|NCT02209974|emphysema|emphysema
180094|NCT02209974|CRP|crp
180095|NCT02209974|interleukin-8|interleukin-8
180096|NCT02209974|dynamic hyperinflation|dynamic hyperinflation
180097|NCT02209935|pediatric|pediatric
180098|NCT02209935|acute neurologic disease|acute neurologic disease
180099|NCT02209935|critical care|critical care
180100|NCT02209935|rehabilitation|rehabilitation
180101|NCT02209935|outcome|outcome
180102|NCT02209922|tDCS, stroke, postural control|tdcs, stroke, postural control
180103|NCT02209909|preoperative aspirin use|preoperative aspirin use
180104|NCT02209909|platelet activation|platelet activation
180105|NCT02209909|off pump coronary artery bypass|off pump coronary artery bypass
180106|NCT02209896|Peripheral Neuropathic Pain|peripheral neuropathic pain
180107|NCT02209896|PNP|pnp
181211|NCT02204891|Flatulence|flatulence
180108|NCT02209883|sevoflurane, anesthesia, washout time,COPD|sevoflurane, anesthesia, washout time,copd
180109|NCT02209870|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
180111|NCT02209870|electronic checklist|electronic checklist
180112|NCT02209857|Breastcancer|breastcancer
180113|NCT02209857|Adjuvant chemotherapy|adjuvant chemotherapy
180114|NCT02209857|70-gene expression profile|70-gene expression profile
180115|NCT02209857|MammaPrint|mammaprint
180116|NCT02209818|Low level laser therapy|low level laser therapy
180117|NCT02209818|Elastomeric separator|elastomeric separator
180118|NCT02209818|Placebo|placebo
180119|NCT02209818|Visual analog scale|visual analog scale
180120|NCT02209818|Laser irradiation|laser irradiation
180121|NCT02209766|Safety|safety
180122|NCT02209766|Tolerability|tolerability
180123|NCT02209766|Pharmacokinetics|pharmacokinetics
180124|NCT02209766|Pharmacodynamics|pharmacodynamics
180125|NCT02209766|D5884|d5884
180126|NCT02209766|Japanese|japanese
180127|NCT02209766|Caucasian|caucasian
180128|NCT02209740|renal toxicity, HIV, antiretroviral, outcome|renal toxicity, hiv, antiretroviral, outcome
180129|NCT02209675|hepatitis C recurrence|hepatitis c recurrence
180130|NCT02209675|Rejection|rejection
180131|NCT02209675|Liver Transplantation|liver transplantation
180132|NCT02209675|Liver biopsy|liver biopsy
180133|NCT02209662|APIC-PRP|apic-prp
180134|NCT02209662|Chronic Wounds|chronic wounds
180135|NCT02209662|Diabetic foot ulcer|diabetic foot ulcer
180136|NCT02209636|hyperphosphatemia|hyperphosphatemia
180137|NCT02209636|vascular dysfunction|vascular dysfunction
180138|NCT02209636|chronic kidney disease|chronic kidney disease
180139|NCT02209636|cardiovascular disease|cardiovascular disease
180140|NCT02209636|endothelial dysfunction|endothelial dysfunction
180141|NCT02209610|Heart Failure|heart failure
180142|NCT02209597|Major Depressive Disorder|major depressive disorder
180143|NCT02209597|MDD|mdd
180144|NCT02209597|bupropion XL|bupropion xl
180145|NCT02209597|Wellbutrin XL|wellbutrin xl
180146|NCT02209571|Breath Tests|breath tests
180147|NCT02209545|fibroids, leiomyomata, blood loss, misoprostol|fibroids, leiomyomata, blood loss, misoprostol
180148|NCT02209532|Lymph node mapping|lymph node mapping
180149|NCT02209532|Endometrial cancer|endometrial cancer
180150|NCT02209532|Uterine cancer|uterine cancer
180151|NCT02209532|Cervical cancer|cervical cancer
180152|NCT02209519|bacterial vaginosis|bacterial vaginosis
180153|NCT02209519|recurrence|recurrence
180154|NCT02209519|male partner|male partner
180155|NCT02209506|MLN3126|mln3126
180156|NCT02209493|Dietary intervention|dietary intervention
180157|NCT02209493|Hypercholesterolemic adults|hypercholesterolemic adults
180158|NCT02209493|Vegetable intake|vegetable intake
180159|NCT02209493|Functional food|functional food
180160|NCT02209493|Prevention|prevention
180161|NCT02209467|walking|walking
180162|NCT02209467|postural balance|postural balance
180163|NCT02209467|falls|falls
180164|NCT02209454|Dexketoprofen|dexketoprofen
180165|NCT02209454|Bioavailability|bioavailability
180166|NCT02209454|Comparative|comparative
180167|NCT02209454|Pharmacokinetic|pharmacokinetic
180168|NCT02209441|sorafenib, gastric cancer, FOLFOX4|sorafenib, gastric cancer, folfox4
180169|NCT02209428|Temozolomide|temozolomide
180170|NCT02209428|IDH mutation|idh mutation
180171|NCT02209428|Low grade glioma|low grade glioma
180172|NCT02209389|breast cancer|breast cancer
180173|NCT02209389|cancer associated auto antibodies|cancer associated auto antibodies
180174|NCT02209389|breast cancer blood test|breast cancer blood test
180175|NCT02209363|Parkinson's disease|parkinson's disease
180177|NCT02209363|CPAP|cpap
180178|NCT02209363|cognition|cognition
180179|NCT02209311|Alveolar Bone Loss|alveolar bone loss
180180|NCT02209311|Alveolar Bone Atrophy|alveolar bone atrophy
180181|NCT02209311|Dental Implantation|dental implantation
180182|NCT02209311|Bone Tissue Reconstruction|bone tissue reconstruction
180183|NCT02209311|Sinus Lift|sinus lift
180184|NCT02209311|Autologous Multipotent Mesenchymal Stem Cell|autologous multipotent mesenchymal stem cell
180185|NCT02209311|Autologous MMSCs|autologous mmscs
180186|NCT02209311|Synthetic Tricalcium Phosphate|synthetic tricalcium phosphate
180187|NCT02209311|Tissue Engineered Construction|tissue engineered construction
180188|NCT02209311|Oral Mucosa|oral mucosa
180189|NCT02209285|Older adults|older adults
180190|NCT02209285|Home and community care|home and community care
180191|NCT02209285|Effectiveness|effectiveness
180192|NCT02209285|Cost analysis|cost analysis
180193|NCT02209285|Stroke|stroke
180194|NCT02209285|TIA|tia
180195|NCT02209285|Hypertension|hypertension
180196|NCT02209285|Cardiovascular disease|cardiovascular disease
180197|NCT02209220|Obstructive sleep apnea|obstructive sleep apnea
180198|NCT02209220|Treatment compliance|treatment compliance
180199|NCT02209220|Automatic positive airway pressure|automatic positive airway pressure
180200|NCT02209220|Continuous positive airway pressure|continuous positive airway pressure
180201|NCT02209220|Bariatric surgery|bariatric surgery
180202|NCT02209207|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
180203|NCT02209207|endurance training|endurance training
180204|NCT02209207|interval training|interval training
180205|NCT02209207|continuous training|continuous training
180206|NCT02209207|walking training|walking training
180207|NCT02209194|aneurysms|aneurysms
180208|NCT02209194|vascular disease|vascular disease
180209|NCT02209194|E-liac Stent Graft|e-liac stent graft
180210|NCT02209194|E-liac Stent Graft System|e-liac stent graft system
180211|NCT02209194|iliac aneurysm|iliac aneurysm
180212|NCT02209194|branched stent graft|branched stent graft
180213|NCT02209194|self expanding stent graft|self expanding stent graft
180214|NCT02209181|dental pain|dental pain
180215|NCT02209181|post-surgical dental pain|post-surgical dental pain
180216|NCT02209168|AMH, ACF, VIT D, Ethnicity|amh, acf, vit d, ethnicity
180217|NCT02209142|Major depression|major depression
180218|NCT02209129|digital breast tomosynthesis|digital breast tomosynthesis
180219|NCT02209116|ADHD|adhd
180220|NCT02209116|QB Test|qb test
180221|NCT02209116|Activity|activity
180222|NCT02209116|Attention|attention
180223|NCT02209116|Children|children
180224|NCT02209116|Clinical Decision Making|clinical decision making
180225|NCT02209103|Polyphenols|polyphenols
180226|NCT02209103|Orange|orange
180227|NCT02209103|Sleep|sleep
180228|NCT02209103|Fatigue|fatigue
180229|NCT02209090|occiput-posterior|occiput-posterior
180230|NCT02209090|occipitoposterior|occipitoposterior
180231|NCT02209090|labour|labour
180232|NCT02209064|Subxiphoid|subxiphoid
180233|NCT02209064|Access|access
180234|NCT02209051|Diabetic Foot Ulcers|diabetic foot ulcers
180235|NCT02209051|AMNIOEXCEL|amnioexcel
180236|NCT02209051|Wagner Grade 1 or 2 foot ulcers|wagner grade 1 or 2 foot ulcers
180237|NCT02209051|Wound|wound
180238|NCT02209051|Foot health|foot health
180239|NCT02209051|Ulcer|ulcer
180240|NCT02209051|Foot Ulcer|foot ulcer
180241|NCT02209051|Diabetic Foot|diabetic foot
180242|NCT02209051|Foot Diseases|foot diseases
180243|NCT02209051|Skin Diseases|skin diseases
180244|NCT02209051|Leg Ulcer|leg ulcer
180245|NCT02209051|Skin Ulcer|skin ulcer
180246|NCT02209051|Diabetic Angiopathies|diabetic angiopathies
180247|NCT02209051|Vascular Diseases|vascular diseases
180248|NCT02209051|Cardiovascular Diseases|cardiovascular diseases
180249|NCT02209051|Diabetes Complications|diabetes complications
180250|NCT02209051|Diabetes Mellitus|diabetes mellitus
180251|NCT02209051|Endocrine System Diseases|endocrine system diseases
180252|NCT02209051|Diabetic Neuropathies|diabetic neuropathies
180253|NCT02209038|end stage renal disease|end stage renal disease
180254|NCT02209038|hemodialysis|hemodialysis
180255|NCT02209038|dialysis|dialysis
180256|NCT02209025|Atherosclerosis|atherosclerosis
180257|NCT02209025|Cholesterol|cholesterol
180258|NCT02209025|Cholesterol, HDL|cholesterol, hdl
180259|NCT02209025|Apolipoprotein A-I|apolipoprotein a-i
180260|NCT02209025|Theobromine|theobromine
180261|NCT02209012|Actinic Keratosis|actinic keratosis
180262|NCT02208999|medullary neurostimulation|medullary neurostimulation
180263|NCT02208999|pain|pain
180264|NCT02208999|Precision|precision
180265|NCT02208999|rechargeable|rechargeable
180266|NCT02208999|implantable|implantable
180267|NCT02208986|GnRH antagonist|gnrh antagonist
180268|NCT02208986|GnRH agonist trigger|gnrh agonist trigger
180269|NCT02208986|Oocyte donor|oocyte donor
180270|NCT02208973|Adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
180271|NCT02208973|adenosine receptor modulator|adenosine receptor modulator
180272|NCT02208973|Asthma|asthma
180273|NCT02208973|COPD|copd
180274|NCT02208960|Neurodevelopment|neurodevelopment
180275|NCT02208960|Neonatal kit|neonatal kit
180276|NCT02208960|Kenya|kenya
180277|NCT02208960|Cluster Randomized Controlled Trial|cluster randomized controlled trial
180278|NCT02208960|Chlorhexidine|chlorhexidine
180279|NCT02208960|ThermoSpot|thermospot
180280|NCT02208947|advance care planning|advance care planning
180281|NCT02208947|decision making|decision making
180282|NCT02208947|patient engagement|patient engagement
180283|NCT02208947|patient education|patient education
180284|NCT02208947|financial incentives|financial incentives
180285|NCT02208947|behavioral economics|behavioral economics
180286|NCT02208934|PDE10 inhibitor|pde10 inhibitor
180287|NCT02208934|Huntington's disease|huntington's disease
180288|NCT02208934|phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
180289|NCT02208934|psychiatric disorders|psychiatric disorders
180290|NCT02208921|Type 2 Diabetes|type 2 diabetes
180291|NCT02208908|Oral care|oral care
180292|NCT02208908|cancer|cancer
180293|NCT02208908|palliative|palliative
180294|NCT02208908|training|training
180295|NCT02208895|pleural|pleural
180296|NCT02208895|glucose|glucose
180297|NCT02208895|glucometer|glucometer
180298|NCT02208895|i-STAT|i-stat
180299|NCT02208869|familial hypercholesterolemia|familial hypercholesterolemia
180300|NCT02208869|cholesterol|cholesterol
180301|NCT02208869|prevention|prevention
180302|NCT02208869|registry|registry
180303|NCT02208869|atherosclerosis|atherosclerosis
180304|NCT02208869|treatment|treatment
180305|NCT02208869|prevalence|prevalence
180306|NCT02208830|bronchiectasis|bronchiectasis
180307|NCT02208830|functional capacity|functional capacity
180308|NCT02208830|lung functional|lung functional
180309|NCT02208817|capillary refill|capillary refill
180310|NCT02208817|paediatric early warning score|paediatric early warning score
180311|NCT02208817|photoplethysmography|photoplethysmography
180312|NCT02208804|Colorectal Cancer Liver Metastases|colorectal cancer liver metastases
180313|NCT02208791|Kidney Transplantation|kidney transplantation
180314|NCT02208791|Graft Rejection|graft rejection
180315|NCT02208791|Immunossupression|immunossupression
180316|NCT02208778|Osteoarthritis|osteoarthritis
180317|NCT02208778|Chronic Pain|chronic pain
180318|NCT02208778|Pain relief|pain relief
180319|NCT02208765|Coronary Circulation|coronary circulation
180320|NCT02208765|Coronary Artery Disease|coronary artery disease
180321|NCT02208765|Myocardial perfusion imaging|myocardial perfusion imaging
180322|NCT02208765|Prognosis|prognosis
180323|NCT02208752|rotator cuff tears|rotator cuff tears
180324|NCT02208752|ultrasound measure|ultrasound measure
180325|NCT02208752|pain|pain
180326|NCT02208752|range of motion|range of motion
180327|NCT02208752|muscle force|muscle force
180328|NCT02208739|Chronic periodontitis|chronic periodontitis
180329|NCT02208739|periodontal pathogens|periodontal pathogens
180330|NCT02208739|inflammatory mediators|inflammatory mediators
180331|NCT02208739|Non surgical periodontal therapy|non surgical periodontal therapy
180332|NCT02208739|Oral hygiene instructions|oral hygiene instructions
180333|NCT02208739|Polymerase chain reaction|polymerase chain reaction
180334|NCT02208739|Elisa|elisa
180335|NCT02208726|anxiety|anxiety
180336|NCT02208726|students|students
180337|NCT02208726|examinations|examinations
180338|NCT02208726|Homeopathy|homeopathy
401989|NCT01233609|valproic acid|valproic acid
401990|NCT01233609|visual field|visual field
667458|NCT00840502|pregnancy|pregnancy
180342|NCT02208687|Self-Management|self-management
180343|NCT02208687|Rehabilitation|rehabilitation
180344|NCT02208687|Physical therapy|physical therapy
180345|NCT02208687|Occupational therapy|occupational therapy
180346|NCT02208687|Group intervention|group intervention
180347|NCT02208687|Exercise|exercise
180348|NCT02208674|chronic kidney disease|chronic kidney disease
180349|NCT02208674|albuminuria|albuminuria
180350|NCT02208674|hypertension|hypertension
180351|NCT02208674|dyslipidemia|dyslipidemia
180352|NCT02208674|cardiovascular disease|cardiovascular disease
180353|NCT02208674|pragmatic trial|pragmatic trial
180354|NCT02208674|cluster randomized trial|cluster randomized trial
171272|NCT02250001|HCV|hcv
180355|NCT02208661|Morquio A syndrome|morquio a syndrome
180356|NCT02208661|Mucopolysaccharidosis IV A|mucopolysaccharidosis iv a
180357|NCT02208661|Psychological health|psychological health
180358|NCT02208648|coronary calcification|coronary calcification
180359|NCT02208648|Computed Tomography|computed tomography
180360|NCT02208648|Coronary artery calcium|coronary artery calcium
180361|NCT02208648|calcium scores|calcium scores
180362|NCT02208648|post-operative mortality|post-operative mortality
180363|NCT02208635|Zinc Absorption|zinc absorption
180364|NCT02208635|Biofortification|biofortification
180365|NCT02208635|Maize|maize
180366|NCT02208635|Zambia|zambia
180367|NCT02208635|Stable isotopes of Zn|stable isotopes of zn
180368|NCT02208622|Zinc absorption|zinc absorption
180369|NCT02208622|Iron Absorption|iron absorption
180370|NCT02208622|Whey Protein|whey protein
180371|NCT02208622|Mexico|mexico
180372|NCT02208622|Stable isotopes|stable isotopes
180373|NCT02208609|Zinc Absorption|zinc absorption
180374|NCT02208609|Maize|maize
180375|NCT02208609|Amaranth|amaranth
180376|NCT02208609|Guatemala|guatemala
180377|NCT02208609|Stable isotopes of Zn|stable isotopes of zn
180378|NCT02208583|Molecular phenotypic；CRPC; personalized treatment|molecular phenotypic；crpc; personalized treatment
180379|NCT02208570|Hypotension during anesthesia induction|hypotension during anesthesia induction
180380|NCT02208557|Incisional hernia|incisional hernia
180381|NCT02208557|prevention|prevention
180382|NCT02208557|laparotomy closure|laparotomy closure
180383|NCT02208557|absorbable mesh|absorbable mesh
180384|NCT02208544|Thyroid Nodule|thyroid nodule
180385|NCT02208544|Indeterminate Cytology|indeterminate cytology
180386|NCT02208544|FDG-PET/CT|fdg-pet/ct
180387|NCT02208544|Diagnostic Thyroid Surgery|diagnostic thyroid surgery
180388|NCT02208544|Efficacy|efficacy
180389|NCT02208544|Cost-Effectiveness|cost-effectiveness
180390|NCT02208544|Quality-of-Life|quality-of-life
180391|NCT02208544|Thyroidectomy|thyroidectomy
180397|NCT02208518|Endoscopic Ultrasound elastography|endoscopic ultrasound elastography
180398|NCT02208518|Quantitative elastography|quantitative elastography
180399|NCT02208518|Qualitative elastography|qualitative elastography
180400|NCT02208518|Endoscopic Ultrasound|endoscopic ultrasound
180401|NCT02208518|Elastography|elastography
180402|NCT02208492|Levetiracetam, Carabamazepine|levetiracetam, carabamazepine
180403|NCT02208479|cardiac surgery|cardiac surgery
180404|NCT02208479|diaphragm dysfunction|diaphragm dysfunction
180405|NCT02208479|mechanical ventilation weaning|mechanical ventilation weaning
180406|NCT02208479|respiratory paralysis|respiratory paralysis
180407|NCT02208479|muscle weakness|muscle weakness
180408|NCT02208479|cardiac bypass|cardiac bypass
180409|NCT02208479|valvular surgery|valvular surgery
180410|NCT02208479|respiratory insufficiency|respiratory insufficiency
180411|NCT02208466|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
180412|NCT02208466|rTMS|rtms
180415|NCT02208453|Massive Rotator Cuff Tear|massive rotator cuff tear
180416|NCT02208453|Local anesthesia|local anesthesia
180417|NCT02208453|Sub-acromial spacer|sub-acromial spacer
180418|NCT02208440|Massive Rotator Cuff Tear, Sub-acromial spacer, Best repair of rotator cuff|massive rotator cuff tear, sub-acromial spacer, best repair of rotator cuff
180419|NCT02208427|isoniazid, LTBI, rifapentine, TST|isoniazid, ltbi, rifapentine, tst
180420|NCT02208414|Food Allergies|food allergies
180421|NCT02208388|Computed tomography perfusion|computed tomography perfusion
180422|NCT02208388|Fractional flow reserve|fractional flow reserve
180423|NCT02208375|Breast Cancer|breast cancer
180424|NCT02208375|Malignant Female Reproductive System Neoplasm|malignant female reproductive system neoplasm
180425|NCT02208375|Recurrent endometrial cancer|recurrent endometrial cancer
180426|NCT02208375|Recurrent endometrial adenocarcinoma|recurrent endometrial adenocarcinoma
180427|NCT02208375|Triple negative breast cancer|triple negative breast cancer
180428|NCT02208375|Ovarian cancer|ovarian cancer
180429|NCT02208375|Primary peritoneal cancer|primary peritoneal cancer
180430|NCT02208375|Fallopian tube cancer|fallopian tube cancer
180431|NCT02208375|Olaparib|olaparib
180432|NCT02208375|AZD2014|azd2014
180433|NCT02208375|AZD5363|azd5363
180434|NCT02208349|intubation, video laryngoscopy, direct laryngoscopy, prehospital, emergency medical services|intubation, video laryngoscopy, direct laryngoscopy, prehospital, emergency medical services
180435|NCT02208323|Hypoxia|hypoxia
180436|NCT02208323|Respiratory Distress|respiratory distress
180437|NCT02208310|Crohn's disease|crohn's disease
180438|NCT02208310|Vitamin D deficiency|vitamin d deficiency
180439|NCT02208284|Single Ascending Dose|single ascending dose
180440|NCT02208284|healthy subjects|healthy subjects
180441|NCT02208284|Hyperlipidemia|hyperlipidemia
180442|NCT02208284|Lipid Metabolism Disorders|lipid metabolism disorders
180443|NCT02208284|Metabolic Diseases|metabolic diseases
180444|NCT02208271|tissue necrosis|tissue necrosis
180445|NCT02208271|metal on metal total hip|metal on metal total hip
180446|NCT02208271|biomarker|biomarker
180447|NCT02208258|fecal incontinence, consure medical, semi formed stool, stool management system|fecal incontinence, consure medical, semi formed stool, stool management system
180448|NCT02208232|IOL rotation|iol rotation
180449|NCT02208219|Stroke|stroke
180450|NCT02208219|Paresis|paresis
180451|NCT02208219|Upper extremity|upper extremity
180452|NCT02208219|Motor deficits|motor deficits
180453|NCT02208219|Music Therapy|music therapy
180454|NCT02208219|Neurorehabilitation|neurorehabilitation
180455|NCT02208206|Neuropathic pain|neuropathic pain
180456|NCT02208206|Phenotype|phenotype
180457|NCT02208206|Genotype|genotype
180458|NCT02208206|Biomarkers|biomarkers
180459|NCT02208206|HIV|hiv
180460|NCT02208206|Diabetes mellitus|diabetes mellitus
180461|NCT02208206|Breast cancer|breast cancer
180462|NCT02208206|Genomics|genomics
180463|NCT02208206|Quantitative sensory testing|quantitative sensory testing
180464|NCT02208193|Alzheimer disease Art Healing gardens Discourse analysis|alzheimer disease art healing gardens discourse analysis
180465|NCT02208180|Return of results|return of results
180466|NCT02208180|Genomics|genomics
180467|NCT02208167|Antigen Expanded Specific T Cell Therapy|antigen expanded specific t cell therapy
180468|NCT02208167|HXTC|hxtc
180469|NCT02208167|Antiretroviral Therapy|antiretroviral therapy
180470|NCT02208167|Acute HIV infection|acute hiv infection
180471|NCT02208167|Chronic HIV infection|chronic hiv infection
180472|NCT02208167|Leukapheresis|leukapheresis
180473|NCT02208154|ICU acquired bacteraemia|icu acquired bacteraemia
180474|NCT02208154|colonization|colonization
180475|NCT02208154|decolonization|decolonization
180476|NCT02208154|selective decontamination|selective decontamination
180477|NCT02208154|multidrug resistant bacteria|multidrug resistant bacteria
180478|NCT02208141|children|children
180479|NCT02208141|obesity|obesity
180480|NCT02208141|adipose tissue dysfunction|adipose tissue dysfunction
180481|NCT02208141|inflammation|inflammation
180482|NCT02208141|macrophage infiltration|macrophage infiltration
180483|NCT02208141|insulin resistance|insulin resistance
180484|NCT02208141|dyslipidemia|dyslipidemia
180485|NCT02208128|Renal cell carcinoma|renal cell carcinoma
180486|NCT02208128|Biomarkers|biomarkers
180487|NCT02208128|Molecular modifications|molecular modifications
180488|NCT02208115|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
180489|NCT02208115|Exercise|exercise
180490|NCT02208115|Appetite|appetite
180491|NCT02208102|atrial fibrillation, catheter ablation, blood-biomarkers|atrial fibrillation, catheter ablation, blood-biomarkers
180492|NCT02208089|Keratoconus|keratoconus
180493|NCT02208089|Corneal collagen cross-linking|corneal collagen cross-linking
180494|NCT02208089|Photorefractive keratectomy|photorefractive keratectomy
180495|NCT02208076|Growth disorders|growth disorders
180496|NCT02208076|Saizen|saizen
180497|NCT02208076|Easypod|easypod
180498|NCT02208076|Growth hormone|growth hormone
180499|NCT02208076|Pediatric subject|pediatric subject
180500|NCT02208063|Bacteremia|bacteremia
180501|NCT02208063|Staphylococcus aureus|staphylococcus aureus
180502|NCT02208050|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
180503|NCT02208050|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
180504|NCT02208050|Multiple Sclerosis|multiple sclerosis
180505|NCT02208050|Upper limb function|upper limb function
180506|NCT02208050|Mobility|mobility
180507|NCT02208050|Fampridine|fampridine
180508|NCT02208050|DASH|dash
180509|NCT02208050|AMSQ|amsq
180510|NCT02208050|MSWS-12|msws-12
180511|NCT02208050|MSIS-29|msis-29
180512|NCT02208050|SF-36|sf-36
180513|NCT02208050|9HPT|9hpt
180514|NCT02208050|25FTW|25ftw
180515|NCT02208050|JTT|jtt
180516|NCT02208037|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
180517|NCT02208037|Acute Myelogenous Leukemia|acute myelogenous leukemia
180518|NCT02208037|Mantel-Cell Lymphoma|mantel-cell lymphoma
180519|NCT02208037|Hematopoietic Transplant|hematopoietic transplant
180520|NCT02208037|GVHD Prophylaxis|gvhd prophylaxis
180521|NCT02207998|osteoarthritis, physiotherapy, homeopathy, complex|osteoarthritis, physiotherapy, homeopathy, complex
180522|NCT02207985|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
180523|NCT02207985|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
180524|NCT02207972|Pregnant|pregnant
180525|NCT02207972|labor|labor
180526|NCT02207972|Epidural|epidural
180527|NCT02207959|Gastric cancer|gastric cancer
180528|NCT02207959|Neoplasia|neoplasia
180529|NCT02207959|Endoscopic imaging|endoscopic imaging
180530|NCT02207959|In vivo imaging|in vivo imaging
180531|NCT02207933|anterioposterior|anterioposterior
180532|NCT02207933|weight|weight
180533|NCT02207933|shifting|shifting
180534|NCT02207933|training|training
180535|NCT02207933|patient|patient
180536|NCT02207894|Haemophilia A, factor VIII, development of inhibitor|haemophilia a, factor viii, development of inhibitor
180537|NCT02207881|herpes labialis|herpes labialis
180538|NCT02207881|cold sore|cold sore
180539|NCT02207829|COPD|copd
180540|NCT02207829|inhaler critical errors|inhaler critical errors
180541|NCT02207829|double-dummy|double-dummy
180542|NCT02207829|novel dry powder inhaler|novel dry powder inhaler
180543|NCT02207829|inhaler preference|inhaler preference
180544|NCT02207829|tiotropium|tiotropium
180545|NCT02207829|umeclidinium|umeclidinium
180546|NCT02207829|long-acting muscarinic antagonist|long-acting muscarinic antagonist
180547|NCT02207816|Infants|infants
180548|NCT02207816|Efficacy|efficacy
180549|NCT02207816|Children|children
180550|NCT02207816|Malaria|malaria
180551|NCT02207816|Plasmodium falciparum|plasmodium falciparum
180552|NCT02207816|Safety|safety
180553|NCT02207816|Surveillance|surveillance
180554|NCT02207816|Immunogenicity|immunogenicity
180555|NCT02207816|RTS,S/AS01E|rts,s/as01e
180556|NCT02207816|Africa|africa
180557|NCT02207803|Brain Injuries|brain injuries
180558|NCT02207803|Caregivers|caregivers
180559|NCT02207803|Intervention Studies|intervention studies
180560|NCT02207803|Latin America|latin america
180561|NCT02207790|Clinical Trial, Phase I|clinical trial, phase i
180562|NCT02207790|Healthy Volunteers|healthy volunteers
180563|NCT02207777|Obesity|obesity
180564|NCT02207777|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
180565|NCT02207777|Type 2 Diabetes|type 2 diabetes
180566|NCT02207777|Sleeve Gastrectomy (SG)|sleeve gastrectomy (sg)
180567|NCT02207777|Biliopancreatic Diversion with Duodenal switch (BPD)|biliopancreatic diversion with duodenal switch (bpd)
180568|NCT02207777|Laparoscopic Adjustable Gastric Banding (LAGB)|laparoscopic adjustable gastric banding (lagb)
180569|NCT02207751|Chronic Kidney Disease|chronic kidney disease
180570|NCT02207751|Peritoneal Dialysis Access|peritoneal dialysis access
180571|NCT02207751|Peritoneal Dialysis Catheter|peritoneal dialysis catheter
180572|NCT02207751|Catheter Function|catheter function
180573|NCT02207738|acne|acne
180574|NCT02207738|acne scar|acne scar
180575|NCT02207738|microneedling radiofrequency|microneedling radiofrequency
180576|NCT02207738|bipolar radiofrequency|bipolar radiofrequency
180577|NCT02207725|Andexanet alpha|andexanet alpha
180578|NCT02207725|Anticoagulation|anticoagulation
180579|NCT02207725|Antidote|antidote
180580|NCT02207725|Apixaban|apixaban
180581|NCT02207725|Anti-fXa inhibitor|anti-fxa inhibitor
180582|NCT02207725|PRT4445|prt4445
180583|NCT02207725|Eliquis|eliquis
180584|NCT02207725|Reversal agent|reversal agent
180585|NCT02207712|Diabetes|diabetes
180586|NCT02207712|Macular Oedema|macular oedema
180587|NCT02207712|Diabetic retinopathy|diabetic retinopathy
180588|NCT02207712|Noctura|noctura
180589|NCT02207686|CNS hemangioblastoma|cns hemangioblastoma
180590|NCT02207686|Renal Cell Carcinoma|renal cell carcinoma
180591|NCT02207686|VHL germline mutation|vhl germline mutation
180592|NCT02207686|VHL somatic mutation|vhl somatic mutation
180593|NCT02207686|Tumor development|tumor development
180594|NCT02207673|epilepsy surgery|epilepsy surgery
180595|NCT02207673|biomarker|biomarker
180596|NCT02207673|high frequency oscillations (HFOs)|high frequency oscillations (hfos)
180597|NCT02207673|acute electrocorticography (aECoG)|acute electrocorticography (aecog)
180598|NCT02207660|cisplatin|cisplatin
180599|NCT02207660|Cervical cancer|cervical cancer
180600|NCT02207660|metastasis|metastasis
180601|NCT02207660|recurrence|recurrence
180602|NCT02207634|High cholesterol|high cholesterol
180603|NCT02207634|Treatment for high cholesterol|treatment for high cholesterol
180604|NCT02207634|Lowering cholesterol|lowering cholesterol
180605|NCT02207634|Lowering high cholesterol|lowering high cholesterol
180606|NCT02207634|Hypercholesterolemia|hypercholesterolemia
180607|NCT02207621|Glaucoma|glaucoma
180608|NCT02207608|BCG|bcg
180609|NCT02207608|hyaluronic acid|hyaluronic acid
180610|NCT02207608|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
180611|NCT02207608|non bacterial cystitis|non bacterial cystitis
180612|NCT02207582|depression; trns|depression; trns
180613|NCT02207556|AL amyloidosis|al amyloidosis
180614|NCT02207556|amyloidosis|amyloidosis
180615|NCT02207556|light chain amyloidosis|light chain amyloidosis
180616|NCT02207543|Cancer|cancer
180617|NCT02207543|Palliative care|palliative care
180618|NCT02207543|home|home
180619|NCT02207530|Head and neck cancer; SCCHN|head and neck cancer; scchn
180620|NCT02207517|convergence insufficiency|convergence insufficiency
180621|NCT02207517|vision therapy|vision therapy
180622|NCT02207517|reading|reading
180623|NCT02207517|attention|attention
180624|NCT02207504|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
180625|NCT02207491|Glaucoma|glaucoma
180626|NCT02207478|Electromagnetic navigation bronchoscopy with a guide sheath|electromagnetic navigation bronchoscopy with a guide sheath
180627|NCT02207478|Transbronchial lung biopsy|transbronchial lung biopsy
180628|NCT02207478|Peripheral lung lesions|peripheral lung lesions
180629|NCT02207478|Solitary pulmonary nodule|solitary pulmonary nodule
180630|NCT02207452|Hyperpolarised helium-3|hyperpolarised helium-3
180631|NCT02207452|Lung Imaging|lung imaging
180632|NCT02207452|Magnetic Resonance Imaging|magnetic resonance imaging
180633|NCT02207426|Healthy volunteers|healthy volunteers
180634|NCT02207413|Quadrivalent influenza vaccine|quadrivalent influenza vaccine
180635|NCT02207413|Safety|safety
180636|NCT02207413|Children|children
180637|NCT02207413|Adults|adults
180638|NCT02207413|Immunogenicity|immunogenicity
180639|NCT02207322|Hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
171551|NCT02248558|China|china
180640|NCT02207322|autologous stem cell transplant|autologous stem cell transplant
180641|NCT02207322|allogeneic stem cell transplant|allogeneic stem cell transplant
180642|NCT02207309|high-risk soft tissue sarcoma|high-risk soft tissue sarcoma
180643|NCT02207309|pazopanib|pazopanib
180644|NCT02207309|retroperitoneal soft tissue sarcoma|retroperitoneal soft tissue sarcoma
180645|NCT02207309|visceral soft tissue sarcoma|visceral soft tissue sarcoma
180646|NCT02207309|votrient|votrient
180647|NCT02207270|Angina|angina
180648|NCT02207270|Coronary artery disease|coronary artery disease
180649|NCT02207270|Costs|costs
180650|NCT02207270|Cost minimization|cost minimization
180651|NCT02207270|Percutaneous coronary intervention|percutaneous coronary intervention
180652|NCT02207270|Randomized trial|randomized trial
180653|NCT02207270|Risk score|risk score
180654|NCT02207270|Same day discharge|same day discharge
180655|NCT02207270|Unstable angina|unstable angina
180656|NCT02207257|PER977|per977
180657|NCT02207257|anticoagulation reversal|anticoagulation reversal
180658|NCT02207257|pharmacokinetics|pharmacokinetics
180659|NCT02207257|edoxaban|edoxaban
180660|NCT02207257|whole blood clotting time|whole blood clotting time
180661|NCT02207257|D-dimer|d-dimer
180662|NCT02207257|prothrombin fragments 1 and 2|prothrombin fragments 1 and 2
180663|NCT02207257|tissue factor pathway inhibitor|tissue factor pathway inhibitor
180664|NCT02207257|prothrombin time|prothrombin time
180665|NCT02207244|Psoriasis|psoriasis
180666|NCT02207244|Plaque-type psoriasis|plaque-type psoriasis
180667|NCT02207244|Guselkumab|guselkumab
180668|NCT02207244|Adalimumab|adalimumab
180669|NCT02207244|CNTO 1959|cnto 1959
180670|NCT02207244|Monoclonal antibody|monoclonal antibody
180671|NCT02207231|Psoriasis|psoriasis
180672|NCT02207231|Plaque-type psoriasis|plaque-type psoriasis
180673|NCT02207231|Guselkumab|guselkumab
180674|NCT02207231|Adalimumab|adalimumab
180675|NCT02207231|CNTO 1959|cnto 1959
180676|NCT02207231|Monoclonal antibody|monoclonal antibody
180677|NCT02207192|obesity, lung volumes, postural changes|obesity, lung volumes, postural changes
180678|NCT02207179|Intraoperative|intraoperative
180679|NCT02207179|Cancer margin|cancer margin
180680|NCT02207179|Spectroscopy|spectroscopy
180681|NCT02207179|Polarization|polarization
180682|NCT02207166|hypertension|hypertension
180683|NCT02207166|device|device
180684|NCT02207166|errors|errors
180685|NCT02207166|human factor engineering|human factor engineering
180686|NCT02207166|usability engineering|usability engineering
180687|NCT02207153|Chronic Hemodialysis|chronic hemodialysis
180688|NCT02207153|Chronic Peritoneal Dialysis|chronic peritoneal dialysis
180689|NCT02207127|obstructive sleep apnea|obstructive sleep apnea
180690|NCT02207127|sleep apnea|sleep apnea
180691|NCT02207114|Sepsis|sepsis
180692|NCT02207114|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
180693|NCT02207114|Antibiotic use|antibiotic use
180694|NCT02207114|Intensive Care Unit|intensive care unit
180695|NCT02207101|Young athletes|young athletes
180696|NCT02207101|Cardiac endurance|cardiac endurance
180697|NCT02207101|Herbal|herbal
180698|NCT02207101|Ejection Fraction|ejection fraction
180700|NCT02207101|Cardiovascular Injury|cardiovascular injury
180701|NCT02207088|Compensated Cirrhosis|compensated cirrhosis
180702|NCT02207088|dialysis|dialysis
180703|NCT02207088|Hepatitis C Virus|hepatitis c virus
180704|NCT02207088|Severe Renal Impairment|severe renal impairment
180705|NCT02207088|Renal impairment|renal impairment
180706|NCT02207088|cirrhosis|cirrhosis
180707|NCT02207088|Chronic Hepatitis C|chronic hepatitis c
180708|NCT02207088|Hepatitis C|hepatitis c
180709|NCT02207088|End-stage renal disease|end-stage renal disease
180710|NCT02207088|Hepatitis C Genotype 1|hepatitis c genotype 1
180711|NCT02207088|renal disease|renal disease
180712|NCT02207075|SPMS|spms
180713|NCT02207075|Myelin Water Fraction|myelin water fraction
180714|NCT02207075|activated microglia|activated microglia
180715|NCT02207036|Tobacco|tobacco
180716|NCT02207036|cigarettes|cigarettes
180717|NCT02207036|cessation|cessation
180718|NCT02207036|intervention|intervention
180719|NCT02207036|young adults|young adults
180720|NCT02207036|Internet|internet
180721|NCT02207036|social media|social media
180722|NCT02207036|mobile health|mobile health
180723|NCT02207023|Stroke|stroke
180724|NCT02207023|Telehealth|telehealth
180725|NCT02207023|Rehabilitation|rehabilitation
180726|NCT02207023|Stroke Coach|stroke coach
180727|NCT02207023|Randomized controlled trial|randomized controlled trial
180728|NCT02207023|Lifestyle behaviours|lifestyle behaviours
180729|NCT02207023|Secondary prevention|secondary prevention
180730|NCT02207023|Chronic disease self-management|chronic disease self-management
180731|NCT02207010|Glioblastoma|glioblastoma
180733|NCT02207010|first recurrence|first recurrence
180734|NCT02206997|perioperative hypothermia|perioperative hypothermia
180735|NCT02206997|prewarming|prewarming
180736|NCT02206997|treatment guideline|treatment guideline
180737|NCT02206958|Toileting disability|toileting disability
180738|NCT02206958|Functional urinary incontinence|functional urinary incontinence
180739|NCT02206958|Urinary incontinence|urinary incontinence
180740|NCT02206958|Frailty|frailty
180741|NCT02206958|Physical activity|physical activity
180742|NCT02206932|Hepatitis C|hepatitis c
180743|NCT02206932|HIV|hiv
180744|NCT02206932|Simeprevir|simeprevir
180745|NCT02206932|Sofosbuvir|sofosbuvir
180746|NCT02206919|Flow mediated dilation|flow mediated dilation
180747|NCT02206919|Magnetic Resonance Imaging MRI|magnetic resonance imaging mri
180748|NCT02206919|Diabetes|diabetes
180749|NCT02206919|Endothelial dysfunction|endothelial dysfunction
180750|NCT02206919|Popliteal artery|popliteal artery
180751|NCT02206919|Atherosclerosis|atherosclerosis
180752|NCT02206919|Cardiovascular disease|cardiovascular disease
180753|NCT02206919|Vascular disease|vascular disease
180754|NCT02206906|Medication Adherence|medication adherence
180755|NCT02206906|Incentives|incentives
180756|NCT02206906|Real-time Medication Monitoring|real-time medication monitoring
180757|NCT02206880|Thoracic Surgery|thoracic surgery
180758|NCT02206880|Delirium|delirium
180759|NCT02206880|Cardiopulmonary Bypass|cardiopulmonary bypass
180760|NCT02206880|Intensive Care|intensive care
180761|NCT02206854|Pharmakokinetic|pharmakokinetic
180762|NCT02206854|capsules|capsules
180763|NCT02206854|R-Flurbiprofen|r-flurbiprofen
180764|NCT02206841|fibrosis|fibrosis
180765|NCT02206841|markers|markers
180766|NCT02206828|HERNIA|hernia
180767|NCT02206828|SYMCHRO|symchro
180768|NCT02206828|SOFRADIM|sofradim
180769|NCT02206828|REGISTRY|registry
180770|NCT02206828|SYMBOTEX|symbotex
180771|NCT02206802|Alopecia|alopecia
180772|NCT02206802|Androgenetic Alopecia|androgenetic alopecia
180773|NCT02206802|Female Pattern Hair Loss|female pattern hair loss
180774|NCT02206802|Hair Loss|hair loss
180775|NCT02206802|Minoxidil|minoxidil
180776|NCT02206802|Hair Thinning|hair thinning
180778|NCT02206750|Controlled Human exposure study|controlled human exposure study
180779|NCT02206750|Air Pollution|air pollution
180780|NCT02206750|Cardiovascular|cardiovascular
180781|NCT02206750|Social factors|social factors
180782|NCT02206750|Cognitive function|cognitive function
180783|NCT02206724|Metastatic prostate cancer|metastatic prostate cancer
180784|NCT02206698|Intraabdominal Injury|intraabdominal injury
180785|NCT02206698|CT Abdomen and Pelvis|ct abdomen and pelvis
180786|NCT02206698|Pediatric trauma|pediatric trauma
180787|NCT02206698|blunt abdominal injury|blunt abdominal injury
180788|NCT02206698|blunt trauma|blunt trauma
180789|NCT02206698|clinical prediction model|clinical prediction model
180790|NCT02206633|dehydration|dehydration
180791|NCT02206607|Phase 1|phase 1
180792|NCT02206607|bioavailability|bioavailability
180793|NCT02206607|type 2 diabetes mellitus|type 2 diabetes mellitus
180794|NCT02206607|PF-04937319|pf-04937319
180795|NCT02206581|dehydration|dehydration
180796|NCT02206568|diabetes mellitus|diabetes mellitus
180797|NCT02206568|phase 1|phase 1
180798|NCT02206568|insulin lispro|insulin lispro
180799|NCT02206568|male subjects|male subjects
180800|NCT02206555|HIV|hiv
180801|NCT02206555|prevention|prevention
180802|NCT02206555|prophylaxis|prophylaxis
180803|NCT02206555|antiretroviral|antiretroviral
180805|NCT02206555|bio-behavioural|bio-behavioural
180806|NCT02206555|evaluation|evaluation
180807|NCT02206555|demonstration study|demonstration study
180808|NCT02206542|acupuncture,frozen shoulder,robot,sonography,MRI|acupuncture,frozen shoulder,robot,sonography,mri
180809|NCT02206529|obesity|obesity
180810|NCT02206529|child|child
180811|NCT02206529|weight management|weight management
180812|NCT02206529|behavioral|behavioral
180813|NCT02206529|social networks|social networks
180814|NCT02206529|social support|social support
180815|NCT02206503|LENALIDOMIDE|lenalidomide
180816|NCT02206503|BIOCHEMICAL PROGRESSION|biochemical progression
180817|NCT02206503|RELAPSED/REFRACTORY MM|relapsed/refractory mm
180818|NCT02206503|WITHOUT CRAB|without crab
180819|NCT02206490|Gulf War Illness|gulf war illness
180820|NCT02206490|treatment|treatment
180821|NCT02206490|dextromethorphan|dextromethorphan
180822|NCT02206490|naltrexone|naltrexone
180823|NCT02206477|breast capsular contructure|breast capsular contructure
180824|NCT02206477|dimethyl sulfoxide|dimethyl sulfoxide
180825|NCT02206477|radiotherapy|radiotherapy
180826|NCT02206477|breast reconstruction|breast reconstruction
180827|NCT02206464|A/Anhui/1/2013 (H7N9)|a/anhui/1/2013 (h7n9)
180828|NCT02206464|Antibody Response|antibody response
180829|NCT02206464|Avian Influenza|avian influenza
180830|NCT02206464|A/Shanghai/2/2013 (H7N9)|a/shanghai/2/2013 (h7n9)
180831|NCT02206464|Immunogenicity|immunogenicity
180832|NCT02206451|Assay|assay
180833|NCT02206451|Infection|infection
180834|NCT02206451|Direct Skin Feed|direct skin feed
180835|NCT02206451|Midgut|midgut
180836|NCT02206451|Parasite|parasite
180837|NCT02206438|supraglottic airway devices|supraglottic airway devices
180838|NCT02206438|the classic laryngeal mask airway|the classic laryngeal mask airway
402941|NCT01228994|Smoking cessation counselling|smoking cessation counselling
180839|NCT02206438|the self-pressurised air-Q intubating laryngeal airway in adult patients|the self-pressurised air-q intubating laryngeal airway in adult patients
180840|NCT02206438|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway in adult patients|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway in adult patients
180841|NCT02206425|multiple myeloma|multiple myeloma
180842|NCT02206425|Relapsed/refractory|relapsed/refractory
180843|NCT02206425|Ixazomib|ixazomib
180844|NCT02206425|Proteasome inhibitor|proteasome inhibitor
180845|NCT02206425|Oral|oral
180846|NCT02206412|high mobility group box 1|high mobility group box 1
180847|NCT02206412|prognostic biomarker|prognostic biomarker
180848|NCT02206412|off-pump coronary artery bypass graft|off-pump coronary artery bypass graft
180849|NCT02206412|patients|patients
180850|NCT02206373|creatinine|creatinine
180851|NCT02206373|glomerular filtration rate|glomerular filtration rate
180852|NCT02206373|renal insufficiency, chronic|renal insufficiency, chronic
180853|NCT02206360|Pancreatic Cancer|pancreatic cancer
180854|NCT02206360|Pancreatic Cancer Screening|pancreatic cancer screening
180855|NCT02206360|Pancreas Cancer|pancreas cancer
180856|NCT02206360|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
180857|NCT02206360|Pancreatic Adenocarcinoma screening|pancreatic adenocarcinoma screening
180858|NCT02206360|Familial Pancreatic Cancer|familial pancreatic cancer
180859|NCT02206360|BRCA 1/2|brca 1/2
180860|NCT02206360|HNPCC|hnpcc
180861|NCT02206360|Lynch Syndrome|lynch syndrome
180862|NCT02206360|Hereditary Pancreatitis|hereditary pancreatitis
180863|NCT02206360|FAMMM|fammm
180864|NCT02206360|Familial atypical multiple mole melanoma|familial atypical multiple mole melanoma
180865|NCT02206360|Peutz Jeghers Syndrome|peutz jeghers syndrome
180867|NCT02206360|Magnetic Resonance Imaging|magnetic resonance imaging
180868|NCT02206360|EUS|eus
180869|NCT02206360|Endoscopic Ultrasound|endoscopic ultrasound
180870|NCT02206360|Early detection|early detection
180871|NCT02206360|Screening|screening
180872|NCT02206308|Chimeric anti-CD20 monoclonal antibody(SCT400)|chimeric anti-cd20 monoclonal antibody(sct400)
180873|NCT02206308|escalating doses|escalating doses
180874|NCT02206308|safety|safety
180875|NCT02206308|pharmacokinetics and pharmacodynamics|pharmacokinetics and pharmacodynamics
180876|NCT02206295|selexipag|selexipag
180877|NCT02206295|ACT-333679|act-333679
180878|NCT02206243|Benign prostatic hyperplasia|benign prostatic hyperplasia
180879|NCT02206243|BPH|bph
180880|NCT02206230|glioblastoma|glioblastoma
180881|NCT02206230|radiotherapy|radiotherapy
180882|NCT02206230|hypofractionated radiotherapy|hypofractionated radiotherapy
180883|NCT02206204|Selexipag|selexipag
180884|NCT02206204|ACT-333679|act-333679
180885|NCT02206152|Diabetes|diabetes
180886|NCT02206152|Hypoglycemia|hypoglycemia
180887|NCT02206152|Unawareness|unawareness
180888|NCT02206152|HAAF|haaf
180889|NCT02206126|Obstructive sleep apnea|obstructive sleep apnea
180890|NCT02206126|Weight loss|weight loss
180891|NCT02206126|Obesity|obesity
180892|NCT02206126|Sympathetic activity|sympathetic activity
180893|NCT02206126|Metabolic profile|metabolic profile
180894|NCT02206126|Endothelial function|endothelial function
180895|NCT02206113|Standing workstation|standing workstation
180896|NCT02206100|PER977|per977
180897|NCT02206100|enoxaparin|enoxaparin
180898|NCT02206100|anticoagulation reversal|anticoagulation reversal
180899|NCT02206100|whole blood clotting time|whole blood clotting time
180901|NCT02206087|heparin|heparin
180902|NCT02206087|anticoagulation reversal|anticoagulation reversal
180903|NCT02206087|whole blood clotting time|whole blood clotting time
180904|NCT02206048|Cervix Carcinoma|cervix carcinoma
180905|NCT02206048|Cervical adenocarcinoma in situ|cervical adenocarcinoma in situ
180906|NCT02206048|AIS|ais
180907|NCT02206048|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
180908|NCT02206048|CIN|cin
180909|NCT02206048|microinvasive carcinoma of the cervix|microinvasive carcinoma of the cervix
180910|NCT02206048|cold knife cone of the cervix|cold knife cone of the cervix
180911|NCT02206048|CKC|ckc
180912|NCT02206048|High-Resolution Microendoscopy|high-resolution microendoscopy
180913|NCT02206048|HRME|hrme
180914|NCT02206048|Proflavine|proflavine
180915|NCT02206022|Central Venous Catheter|central venous catheter
180916|NCT02206022|Remifentanil|remifentanil
180917|NCT02206022|local anesthesia|local anesthesia
180918|NCT02206022|pain|pain
180919|NCT02205996|Type 2 diabetes|type 2 diabetes
180920|NCT02205996|Hypoglycaemia|hypoglycaemia
180921|NCT02205996|Platelets|platelets
180922|NCT02205996|Inflammation|inflammation
180923|NCT02205983|enrolling|enrolling
180924|NCT02205983|adult|adult
180925|NCT02205983|volunteers|volunteers
180926|NCT02205970|TENS|tens
180927|NCT02205970|Dysmenorrhea|dysmenorrhea
180928|NCT02205970|analgesia|analgesia
180929|NCT02205970|interactive|interactive
180930|NCT02205957|anesthesiology and intensive care, quality, training|anesthesiology and intensive care, quality, training
180931|NCT02205944|chronic kidney disease|chronic kidney disease
180932|NCT02205944|hemodialysis|hemodialysis
180933|NCT02205944|vascular access|vascular access
180934|NCT02205944|arteriovenous fistula|arteriovenous fistula
180935|NCT02205944|forearm exercise|forearm exercise
180936|NCT02205931|Epilepsy|epilepsy
180937|NCT02205931|Ketogenic diet|ketogenic diet
180938|NCT02205931|Antiepileptic drugs|antiepileptic drugs
180939|NCT02205931|Randomised controlled trial|randomised controlled trial
180940|NCT02205905|PER977|per977
180941|NCT02205905|metabolic disposition|metabolic disposition
180942|NCT02205905|mass balance|mass balance
180943|NCT02205905|metabolites|metabolites
180944|NCT02205905|radiolabeled|radiolabeled
180945|NCT02205892|natural product|natural product
180946|NCT02205892|clinical trial|clinical trial
180947|NCT02205879|pregabalin|pregabalin
180948|NCT02205879|patients|patients
180949|NCT02205879|treatment|treatment
180950|NCT02205853|Oncology Service Hospital|oncology service hospital
180951|NCT02205853|Patient-centred|patient-centred
180952|NCT02205853|Exercise|exercise
180953|NCT02205853|Neoplasms|neoplasms
180954|NCT02205853|Rehabilitation|rehabilitation
180955|NCT02205853|Qualitative Research|qualitative research
180956|NCT02205853|Health Plan Implementation|health plan implementation
180957|NCT02205853|Quality of Health Care|quality of health care
180958|NCT02205853|Guidelines|guidelines
180959|NCT02205853|Quality of Life|quality of life
180960|NCT02205827|whole blood clotting time|whole blood clotting time
180961|NCT02205814|Osteoarthritis, Knee|osteoarthritis, knee
180962|NCT02205814|Arthritis|arthritis
180963|NCT02205814|WOMAC|womac
180964|NCT02205814|Injections, intra-articular|injections, intra-articular
180965|NCT02205814|Fasitibant|fasitibant
180966|NCT02205814|MEN 16132|men 16132
180967|NCT02205762|Langerhans cell histiocytosis|langerhans cell histiocytosis
180968|NCT02205749|biobanks|biobanks
180969|NCT02205749|informed consent|informed consent
180970|NCT02205749|health literacy|health literacy
180971|NCT02205736|Breast health education|breast health education
180972|NCT02205736|Latino women|latino women
180973|NCT02205736|Group education|group education
180974|NCT02205736|Breast cancer|breast cancer
180975|NCT02205723|Asthma|asthma
180976|NCT02205723|Asthma exacerbations|asthma exacerbations
180977|NCT02205723|Pediatric|pediatric
180978|NCT02205697|Fruit|fruit
180979|NCT02205697|Vegetable|vegetable
180980|NCT02205684|Physical activity|physical activity
180981|NCT02205684|Exercise|exercise
180982|NCT02205684|High intensity training|high intensity training
180983|NCT02205684|Schizophrenia|schizophrenia
180984|NCT02205684|Symptoms|symptoms
180985|NCT02205684|Well-being|well-being
180986|NCT02205684|Cognition|cognition
180987|NCT02205684|Hippocampal volume|hippocampal volume
180988|NCT02205684|Neuroplasticity|neuroplasticity
180990|NCT02205684|Substance use|substance use
180991|NCT02205684|Metabolic indices|metabolic indices
180992|NCT02205671|caregiving|caregiving
180993|NCT02205671|chronic illness|chronic illness
180994|NCT02205671|patient education|patient education
180995|NCT02205671|self management|self management
180996|NCT02205658|Sensory Processing|sensory processing
180997|NCT02205658|Autism|autism
180998|NCT02205645|medial|medial
180999|NCT02205645|meniscus|meniscus
181000|NCT02205645|scaffold|scaffold
181001|NCT02205645|repair|repair
181003|NCT02205645|injury|injury
181004|NCT02205619|Residual cementum|residual cementum
181212|NCT02204891|Diarrhea|diarrhea
181005|NCT02205619|root surface instrumentation|root surface instrumentation
181006|NCT02205619|ultrasonic scaling|ultrasonic scaling
181007|NCT02205619|air polishing with glycine|air polishing with glycine
181008|NCT02205593|psoriasis|psoriasis
181009|NCT02205593|atopic dermatitis|atopic dermatitis
181010|NCT02205593|eczema|eczema
181011|NCT02205593|patient education|patient education
181012|NCT02205593|stress reduction|stress reduction
181013|NCT02205593|quality of life|quality of life
181014|NCT02205554|Analgesia|analgesia
181015|NCT02205554|Pharmacokinetics|pharmacokinetics
181016|NCT02205554|Treatment|treatment
181017|NCT02205541|Eculizumab|eculizumab
181018|NCT02205541|Shiga-toxin|shiga-toxin
181019|NCT02205541|hemolytic and uremic syndrome|hemolytic and uremic syndrome
181020|NCT02205541|pediatric|pediatric
181021|NCT02205476|Phase 2|phase 2
181022|NCT02205476|open-label|open-label
181023|NCT02205476|safety|safety
181024|NCT02205476|hypertrophic scar revision surgery|hypertrophic scar revision surgery
181025|NCT02205463|Esophagus|esophagus
181026|NCT02205463|Gastroesophageal Junction|gastroesophageal junction
181027|NCT02205463|Stomach|stomach
181028|NCT02205463|Gastric|gastric
181029|NCT02205463|Cancer|cancer
181030|NCT02205463|HER2|her2
181031|NCT02205463|Metastatic|metastatic
181032|NCT02205463|Adenocarcinoma|adenocarcinoma
181033|NCT02205450|Prader-Willi Syndrome|prader-willi syndrome
181034|NCT02205450|Growth Hormone|growth hormone
181035|NCT02205450|Children|children
181036|NCT02205437|Schizophrenia|schizophrenia
181037|NCT02205437|Psychosis|psychosis
181038|NCT02205437|Antipsychotics|antipsychotics
181039|NCT02205437|Treatment response|treatment response
181040|NCT02205437|Metabolic side effects|metabolic side effects
181041|NCT02205437|Gene expression|gene expression
181043|NCT02205437|Genes|genes
181044|NCT02205424|Ischaemic stroke|ischaemic stroke
181045|NCT02205424|Alzheimer's disease|alzheimer's disease
181046|NCT02205424|Brain volume|brain volume
181047|NCT02205424|Cortical thickness|cortical thickness
181048|NCT02205424|Magnetic Resonance Imaging|magnetic resonance imaging
181049|NCT02205411|heart assist device|heart assist device
181050|NCT02205411|ventricular assist device|ventricular assist device
181051|NCT02205398|INC280|inc280
181052|NCT02205398|c-MET inhibitor|c-met inhibitor
181053|NCT02205398|cetuximab|cetuximab
181054|NCT02205398|metastatic colorectal cancer|metastatic colorectal cancer
181055|NCT02205398|head and neck|head and neck
181056|NCT02205398|squamous cell carcinoma|squamous cell carcinoma
181057|NCT02205398|resistance to cetuximab/panitumumab|resistance to cetuximab/panitumumab
181058|NCT02205385|Neuroma|neuroma
181059|NCT02205385|Amputee|amputee
181060|NCT02205385|Amputation Stump|amputation stump
181061|NCT02205385|Assessment, Pain|assessment, pain
181062|NCT02205372|Diabetic Nephropathy|diabetic nephropathy
181063|NCT02205359|AdaptivCRT|adaptivcrt
181064|NCT02205359|aCRT|acrt
181065|NCT02205346|obstructive sleep apnea|obstructive sleep apnea
181066|NCT02205333|Advanced Solid tumors|advanced solid tumors
181067|NCT02205333|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
181068|NCT02205333|programmed death 1|programmed death 1
181069|NCT02205333|programmed dealth ligand 1|programmed dealth ligand 1
181070|NCT02205333|cytotoxic T-lymphocyte-associated antigen-4|cytotoxic t-lymphocyte-associated antigen-4
181071|NCT02205333|OX40 ligand|ox40 ligand
181072|NCT02205320|Pegfilgrastim|pegfilgrastim
181073|NCT02205320|Pharmacokinetics|pharmacokinetics
181074|NCT02205320|Pharmacodynamics|pharmacodynamics
181075|NCT02205320|Healthy volunteers|healthy volunteers
181076|NCT02205307|Rectal cancer|rectal cancer
181077|NCT02205307|Rectal neoplasm|rectal neoplasm
181078|NCT02205307|Colorectal surgery|colorectal surgery
181079|NCT02205307|Anastomosis|anastomosis
181080|NCT02205294|Osteopathic treatment|osteopathic treatment
181081|NCT02205294|Deep Vein Thrombosis|deep vein thrombosis
181082|NCT02205294|Proximal Leg DVT|proximal leg dvt
181083|NCT02205281|Overweight|overweight
181084|NCT02205281|Obese|obese
181085|NCT02205281|Pregnancy|pregnancy
181086|NCT02205281|Weight Gain|weight gain
181087|NCT02205281|Weight Loss|weight loss
181088|NCT02205268|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
181089|NCT02205268|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
181090|NCT02205268|Biofeedback|biofeedback
181091|NCT02205268|Neurofeedback Training|neurofeedback training
181092|NCT02205268|Prefrontal Cortex|prefrontal cortex
181093|NCT02205268|Near infrared spectroscopy|near infrared spectroscopy
181094|NCT02205255|AECOPD|aecopd
181095|NCT02205255|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
181096|NCT02205255|Acute exacerbation|acute exacerbation
181097|NCT02205255|Hospitalization|hospitalization
181098|NCT02205255|Azithromycin|azithromycin
181099|NCT02205255|Macrolides|macrolides
181100|NCT02205255|Randomized Controlled Trial|randomized controlled trial
181101|NCT02205255|Placebo|placebo
181102|NCT02205255|Economic Impact|economic impact
181103|NCT02205255|Cost-effectiveness|cost-effectiveness
181104|NCT02205255|EQ5D|eq5d
181105|NCT02205242|AECOPD|aecopd
181511|NCT02203396|Levamisole|levamisole
181106|NCT02205242|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
181107|NCT02205242|Acute exacerbation|acute exacerbation
181108|NCT02205242|Hospitalization|hospitalization
181109|NCT02205242|Azithromycin|azithromycin
181110|NCT02205242|Macrolides|macrolides
181111|NCT02205242|Randomized Controlled Trial|randomized controlled trial
181112|NCT02205242|Placebo|placebo
181113|NCT02205242|Physical Activity|physical activity
181114|NCT02205242|PRO-Active|pro-active
181115|NCT02205242|Activity Monitor|activity monitor
181116|NCT02205216|tDCS|tdcs
181117|NCT02205216|FOG|fog
181118|NCT02205216|Freezing of Gait|freezing of gait
181119|NCT02205216|Parkinson|parkinson
181120|NCT02205216|Rehabilitation|rehabilitation
181121|NCT02205203|Anxiety|anxiety
181122|NCT02205203|Social Anxiety|social anxiety
181123|NCT02205203|Social Phobia|social phobia
181124|NCT02205203|Separation Anxiety|separation anxiety
181125|NCT02205203|Generalized Anxiety|generalized anxiety
181126|NCT02205203|GAD|gad
181127|NCT02205203|Phobia|phobia
181128|NCT02205203|Panic|panic
181129|NCT02205203|Agoraphobia|agoraphobia
181130|NCT02205203|Obsessive Compulsive Disorder|obsessive compulsive disorder
181131|NCT02205203|OCD|ocd
181132|NCT02205203|Child|child
181133|NCT02205203|Adolescent|adolescent
181134|NCT02205203|Smartphone|smartphone
181135|NCT02205203|Teen|teen
181136|NCT02205203|Youth|youth
181137|NCT02205190|Fimasartan|fimasartan
181138|NCT02205177|Anxiety|anxiety
181139|NCT02205177|Social Anxiety|social anxiety
181140|NCT02205177|Social Phobia|social phobia
181141|NCT02205177|Separation Anxiety|separation anxiety
181142|NCT02205177|Generalized Anxiety|generalized anxiety
181143|NCT02205177|GAD|gad
181144|NCT02205177|Phobia|phobia
181145|NCT02205177|Panic|panic
181146|NCT02205177|Agoraphobia|agoraphobia
181147|NCT02205177|Obsessive Compulsive Disorder|obsessive compulsive disorder
181148|NCT02205177|OCD|ocd
181149|NCT02205177|Child|child
181150|NCT02205177|Adolescent|adolescent
181151|NCT02205177|Smartphone|smartphone
181152|NCT02205177|Teen|teen
181153|NCT02205177|Youth|youth
181154|NCT02205164|palonosetron|palonosetron
181155|NCT02205164|aprepitant|aprepitant
181156|NCT02205164|CINV|cinv
181157|NCT02205164|AML|aml
181158|NCT02205164|multiple-days|multiple-days
181159|NCT02205151|Fimasartan|fimasartan
181160|NCT02205138|Spinal Fusion|spinal fusion
181161|NCT02205138|Lumbar Interbody Fusion|lumbar interbody fusion
181162|NCT02205138|Degenerative Disc Disease|degenerative disc disease
181163|NCT02205138|Cell Therapy|cell therapy
181164|NCT02205138|Bone Graft|bone graft
181165|NCT02205125|polyp|polyp
181166|NCT02205125|colon|colon
181167|NCT02205125|polypectomy|polypectomy
181168|NCT02205125|snare|snare
181169|NCT02205112|intravenous nemonoxacin|intravenous nemonoxacin
181170|NCT02205112|community-acquired pneumonia|community-acquired pneumonia
181171|NCT02205099|Schizophrenia|schizophrenia
181172|NCT02205047|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
181173|NCT02205034|Prader Willi|prader willi
181174|NCT02205008|advanced gastric cancer|advanced gastric cancer
181175|NCT02205008|serosal invasion|serosal invasion
181176|NCT02205008|peritoneal recurrence|peritoneal recurrence
181177|NCT02205008|intraperitoneal chemotherapy|intraperitoneal chemotherapy
181178|NCT02204995|Osteoarthritis|osteoarthritis
181179|NCT02204995|Thumb|thumb
181180|NCT02204995|LRTI|lrti
181181|NCT02204995|Trapeziectomy|trapeziectomy
181182|NCT02204982|Phase 3, Follicular Lymphoma, FL, PI3K|phase 3, follicular lymphoma, fl, pi3k
181183|NCT02204956|Smoking cessation|smoking cessation
181184|NCT02204956|Tobacco use cessation|tobacco use cessation
181185|NCT02204956|Psychiatric comorbidity|psychiatric comorbidity
181186|NCT02204930|Haemostat|haemostat
181187|NCT02204930|Liver surgery|liver surgery
181188|NCT02204930|Primary liver cancer|primary liver cancer
181189|NCT02204930|Metastatic liver cancer|metastatic liver cancer
181286|NCT02204527|diabetes mellitus|diabetes mellitus
181190|NCT02204930|Benign liver disease such as adenoma|benign liver disease such as adenoma
181191|NCT02204930|Hepatitis-related or alcoholic-related liver cirrhosis|hepatitis-related or alcoholic-related liver cirrhosis
181192|NCT02204930|Living donation for liver transplant|living donation for liver transplant
181193|NCT02204917|Ultrasound|ultrasound
181194|NCT02204917|Ultrasound Contrast Agents|ultrasound contrast agents
181195|NCT02204917|Optison|optison
181196|NCT02204917|contrast enhanced Voiding Urosonography|contrast enhanced voiding urosonography
181197|NCT02204917|ceVUS|cevus
181198|NCT02204917|Vesicoureteral Reflux|vesicoureteral reflux
181199|NCT02204917|Children|children
181200|NCT02204917|Kidney|kidney
181201|NCT02204917|Bladder|bladder
181202|NCT02204917|Urethra|urethra
181203|NCT02204917|Voiding Cystourethrography|voiding cystourethrography
181204|NCT02204917|VCUG|vcug
181205|NCT02204917|Safety|safety
181206|NCT02204917|Urinary tract|urinary tract
181207|NCT02204904|X-linked Adrenoleukodystrophy|x-linked adrenoleukodystrophy
181208|NCT02204904|Hematopoietic Stem Cells|hematopoietic stem cells
181210|NCT02204891|Abdominal discomfort|abdominal discomfort
181213|NCT02204891|Bacterial overgrowth|bacterial overgrowth
181214|NCT02204891|Cytokines|cytokines
181215|NCT02204865|Sleep-Disordered Breathing|sleep-disordered breathing
181216|NCT02204865|Sleep Apnoea|sleep apnoea
181217|NCT02204865|Heart failure|heart failure
181218|NCT02204839|T1DM, Exercise, Hypoglycaemia|t1dm, exercise, hypoglycaemia
181219|NCT02204826|Effects of Korean Red Ginseng on semen parameters in male infertility patients: a randomized, placebo-controlled, double-blind clinical study|effects of korean red ginseng on semen parameters in male infertility patients: a randomized, placebo-controlled, double-blind clinical study
181220|NCT02204813|Gastric Bypass|gastric bypass
181221|NCT02204813|RYGB|rygb
181222|NCT02204813|GLP-1|glp-1
181223|NCT02204813|Xenin|xenin
181224|NCT02204813|Insulin Secretion|insulin secretion
181225|NCT02204813|Glucose Homeostasis|glucose homeostasis
181226|NCT02204813|Vertical Sleeve|vertical sleeve
181227|NCT02204813|Lap Band|lap band
181228|NCT02204800|Tumor growth rate in maximal dimension, biomarker assessment based on driver gene alterations (specifically CRG)|tumor growth rate in maximal dimension, biomarker assessment based on driver gene alterations (specifically crg)
181229|NCT02204774|aortic aneurysm|aortic aneurysm
181230|NCT02204774|obstructive sleep apnea|obstructive sleep apnea
181231|NCT02204735|Meal Time|meal time
181232|NCT02204735|Weight Loss|weight loss
181233|NCT02204735|Circadian Rhythm|circadian rhythm
181234|NCT02204709|obese|obese
181235|NCT02204709|obesity|obesity
181236|NCT02204709|metabolic syndrome|metabolic syndrome
181237|NCT02204709|omega-3 fatty acids|omega-3 fatty acids
181238|NCT02204709|fish|fish
181239|NCT02204696|sleep apnea|sleep apnea
181240|NCT02204696|obstructive sleep apnea|obstructive sleep apnea
181241|NCT02204696|sleepiness|sleepiness
181242|NCT02204696|quality of life|quality of life
181244|NCT02204683|Neovascularization|neovascularization
181245|NCT02204683|macular degeneration|macular degeneration
181246|NCT02204683|wet macular degeneration|wet macular degeneration
181247|NCT02204683|vitrectomy|vitrectomy
181248|NCT02204670|Irisin|irisin
181249|NCT02204670|Obesity|obesity
181250|NCT02204670|Exercise|exercise
181251|NCT02204670|Myokine|myokine
181252|NCT02204670|Impaired Glucose Tolerance|impaired glucose tolerance
181253|NCT02204657|Continuous glucose monitoring in GDM|continuous glucose monitoring in gdm
181254|NCT02204631|Head and Neck Cancer|head and neck cancer
181255|NCT02204618|single sided deafness|single sided deafness
181256|NCT02204618|Asymmetrical hearing loss|asymmetrical hearing loss
181257|NCT02204618|Cost-utility|cost-utility
181258|NCT02204618|Tinnitus|tinnitus
181259|NCT02204618|Cochlear implants|cochlear implants
181260|NCT02204618|Bone conduction device|bone conduction device
181261|NCT02204618|Dichotic hearing|dichotic hearing
181262|NCT02204618|Squelch effect.|squelch effect.
181263|NCT02204605|patients|patients
181264|NCT02204605|puzzling|puzzling
181265|NCT02204605|conditions|conditions
181266|NCT02204579|Autosomal Dominant Hypocalcemia|autosomal dominant hypocalcemia
181267|NCT02204579|Hypocalcemia|hypocalcemia
181268|NCT02204579|ADH|adh
181269|NCT02204579|Hypoparathyroidism|hypoparathyroidism
181270|NCT02204566|OFDI|ofdi
181271|NCT02204566|RF Ablation|rf ablation
181272|NCT02204566|Atrial Fibrillation|atrial fibrillation
181273|NCT02204566|Imaging|imaging
181274|NCT02204566|Esophagus|esophagus
181275|NCT02204553|Multiple Myeloma|multiple myeloma
181276|NCT02204553|Panobinostat|panobinostat
181277|NCT02204553|LBH589|lbh589
181278|NCT02204553|Expanded Access|expanded access
181279|NCT02204553|EAP, ETP|eap, etp
181280|NCT02204553|Expanded Treatment|expanded treatment
181281|NCT02204553|Bortezomib|bortezomib
181282|NCT02204553|HDAC|hdac
181283|NCT02204553|histone deacetylace inhibitor|histone deacetylace inhibitor
181284|NCT02204540|Webcams, video monitoring, compliance, adherence|webcams, video monitoring, compliance, adherence
181285|NCT02204527|hypertension|hypertension
181287|NCT02204527|vitamin D|vitamin d
181288|NCT02204501|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
181289|NCT02204501|Aviragen Therapeutics|aviragen therapeutics
181290|NCT02204501|Aviragen|aviragen
181291|NCT02204488|Osteoarthritis|osteoarthritis
181293|NCT02204488|Total joint arthroplasty|total joint arthroplasty
181294|NCT02204488|Trapeziectomy|trapeziectomy
181295|NCT02204462|PET|pet
181296|NCT02204462|Positron Emission Tomography|positron emission tomography
181297|NCT02204462|Breast Cancer|breast cancer
181298|NCT02204462|Imaging|imaging
181299|NCT02204449|cardiac rehabilitation|cardiac rehabilitation
181300|NCT02204449|peer mentorship|peer mentorship
181301|NCT02204449|healthcare utilization|healthcare utilization
181302|NCT02204449|continuity of cardiac care|continuity of cardiac care
181303|NCT02204436|hyperpigmentation|hyperpigmentation
181304|NCT02204436|depigmenting treatment|depigmenting treatment
181305|NCT02204436|hand|hand
181306|NCT02204423|Upper extremity dysfunction|upper extremity dysfunction
181307|NCT02204423|Trans-Radial Percutaneous Coronary Interventions|trans-radial percutaneous coronary interventions
181308|NCT02204410|ADHD|adhd
181309|NCT02204410|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
181310|NCT02204410|DESR|desr
181408|NCT02203890|Inflammation|inflammation
181311|NCT02204410|Deficient Emotional Self-Regulation|deficient emotional self-regulation
181312|NCT02204410|Emotional Dysregulation|emotional dysregulation
181313|NCT02204410|Omega-3 Fatty Acids|omega-3 fatty acids
181314|NCT02204410|Fish Oil|fish oil
181315|NCT02204397|Type 1 Diabetes mellitus|type 1 diabetes mellitus
181316|NCT02204397|INGAP|ingap
181317|NCT02204397|Ustekinumab|ustekinumab
181318|NCT02204384|Dietary fiber|dietary fiber
181319|NCT02204384|Dietary Supplements|dietary supplements
181320|NCT02204384|Type 2 diabetes|type 2 diabetes
181321|NCT02204384|Postprandial Period|postprandial period
181322|NCT02204384|Plasma insulin|plasma insulin
181323|NCT02204384|Plasma glucose|plasma glucose
181324|NCT02204384|Area Under Curve|area under curve
181325|NCT02204384|Soluble fiber|soluble fiber
181326|NCT02204371|Pazopanib|pazopanib
181327|NCT02204371|hereditary haemorrhagic telangiectasia|hereditary haemorrhagic telangiectasia
181328|NCT02204371|bleeding|bleeding
181329|NCT02204319|provoked or non-provoked vulvar vestibulitis|provoked or non-provoked vulvar vestibulitis
181330|NCT02204319|low level laser light device|low level laser light device
181331|NCT02204293|Adult-Onset Still´s Disease|adult-onset still´s disease
181332|NCT02204293|Canakinumab|canakinumab
181333|NCT02204293|Joint involvement|joint involvement
181334|NCT02204293|AOSD|aosd
181335|NCT02204280|UbA52;diabetic nephropathy ;diabetic;ELISA|uba52;diabetic nephropathy ;diabetic;elisa
181336|NCT02204267|Stroke|stroke
181337|NCT02204267|atrial fibrillation|atrial fibrillation
181338|NCT02204267|ECG|ecg
181339|NCT02204241|Multiple myeloma|multiple myeloma
181340|NCT02204241|Diagnosis|diagnosis
181341|NCT02204241|CCyd|ccyd
181342|NCT02204228|osteoarthritis|osteoarthritis
181343|NCT02204228|rheumatoid arthritis|rheumatoid arthritis
181344|NCT02204228|post traumatic arthritis|post traumatic arthritis
181345|NCT02204228|avascular necrosis|avascular necrosis
181346|NCT02204228|severe fractures|severe fractures
181347|NCT02204215|Weakness|weakness
181348|NCT02204215|Mechanical Ventilation|mechanical ventilation
181349|NCT02204215|Acupuncture Therapy|acupuncture therapy
181350|NCT02204202|acute lung transplant rejection|acute lung transplant rejection
181351|NCT02204202|neutrophilic lung inflammation|neutrophilic lung inflammation
181352|NCT02204202|positron emission tomography imaging|positron emission tomography imaging
181353|NCT02204202|[18F] fluorodeoxyglucose|[18f] fluorodeoxyglucose
181354|NCT02204202|[18F] ISO-1|[18f] iso-1
181355|NCT02204189|acute pancreatitis|acute pancreatitis
181356|NCT02204189|gastrointestinal dysfunction|gastrointestinal dysfunction
181357|NCT02204189|TongFuSan|tongfusan
181358|NCT02204189|ShenQue acupoint|shenque acupoint
181359|NCT02204150|Optical Coherence Tomography|optical coherence tomography
181360|NCT02204150|Barrett's Esophagus|barrett's esophagus
181361|NCT02204150|Esophagus|esophagus
181362|NCT02204150|Imaging|imaging
181363|NCT02204124|Whipple procedure|whipple procedure
181364|NCT02204111|Palliative Treatment|palliative treatment
181365|NCT02204111|Trabectedin|trabectedin
181366|NCT02204111|Patient Reported Outcome|patient reported outcome
181367|NCT02204085|Refractory acute myeloid leukemia|refractory acute myeloid leukemia
181368|NCT02204085|Relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
181369|NCT02204020|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
181370|NCT02204020|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
181371|NCT02204020|allogeneic|allogeneic
181372|NCT02204020|5-azacytidine (5-aza)|5-azacytidine (5-aza)
181373|NCT02204020|hematopoietic|hematopoietic
181374|NCT02204020|transplantation|transplantation
181375|NCT02204020|transplant|transplant
181376|NCT02204020|graft-versus-tumor|graft-versus-tumor
181377|NCT02204020|graft-versus-host disease (GVHD)|graft-versus-host disease (gvhd)
181378|NCT02204020|epigenetic|epigenetic
181379|NCT02204020|maintenance|maintenance
181380|NCT02204020|hypomethylation|hypomethylation
181381|NCT02204020|relapse|relapse
181382|NCT02204007|Acetabular Shell|acetabular shell
181383|NCT02204007|Total Hip Arthroplasty|total hip arthroplasty
181384|NCT02204007|3D imaging|3d imaging
181385|NCT02203994|extracorporal shock wave therapy (ESWT)|extracorporal shock wave therapy (eswt)
181386|NCT02203994|spasticity|spasticity
181387|NCT02203994|spinal cord injury|spinal cord injury
181388|NCT02203981|normal Eyes|normal eyes
181389|NCT02203968|Fibrinogen replacement|fibrinogen replacement
181390|NCT02203968|Trauma coagulopathy|trauma coagulopathy
181391|NCT02203968|Hypofibrinogenemia|hypofibrinogenemia
181392|NCT02203968|Early trauma coagulopathy|early trauma coagulopathy
181393|NCT02203968|Haemorrhage|haemorrhage
181394|NCT02203968|Fibrinogen concentrate|fibrinogen concentrate
181395|NCT02203968|Feasibility trial|feasibility trial
181396|NCT02203968|Clinical trials|clinical trials
181397|NCT02203942|Bacterial Vaginosis|bacterial vaginosis
181398|NCT02203942|Vulvovaginal Candidiasis|vulvovaginal candidiasis
181399|NCT02203942|Trichomoniasis|trichomoniasis
181400|NCT02203929|Macular Holes|macular holes
181401|NCT02203929|Progression|progression
181402|NCT02203916|Drug therapy|drug therapy
181403|NCT02203890|Growth|growth
181404|NCT02203890|Hematology|hematology
181405|NCT02203890|Hydration|hydration
181406|NCT02203890|Oxidation|oxidation
181407|NCT02203890|Infection|infection
181409|NCT02203890|Guatemalan children|guatemalan children
181410|NCT02203851|BI 655066|bi 655066
181411|NCT02203851|risankizumab|risankizumab
181412|NCT02203838|Schizophrenia|schizophrenia
181413|NCT02203838|Schizophrenic|schizophrenic
181414|NCT02203838|Schizophrenias|schizophrenias
181415|NCT02203838|Risperidone|risperidone
181416|NCT02203838|Long-acting Risperidone|long-acting risperidone
181417|NCT02203838|Atrigel|atrigel
181418|NCT02203838|Subcutaneous|subcutaneous
181419|NCT02203825|Acute Myeloid Leukemia|acute myeloid leukemia
181420|NCT02203825|NKG2D|nkg2d
181421|NCT02203825|Multiple Myeloma|multiple myeloma
181422|NCT02203825|Cell Therapy|cell therapy
181423|NCT02203799|Peanut Allergy|peanut allergy
181424|NCT02203799|Anaphylaxis|anaphylaxis
181425|NCT02203799|Desensitization|desensitization
181426|NCT02203799|Food Allergy|food allergy
181427|NCT02203799|Oral Immunotherapy|oral immunotherapy
181428|NCT02203786|amphetamine|amphetamine
181429|NCT02203786|d1 and d2 receptors|d1 and d2 receptors
181430|NCT02203786|dopamine antagonists|dopamine antagonists
181431|NCT02203786|pathological gambling|pathological gambling
181432|NCT02203786|priming|priming
181433|NCT02203786|reinforcement|reinforcement
181435|NCT02203773|ABT-199|abt-199
181436|NCT02203773|Untreated AML|untreated aml
181437|NCT02203773|Acute Myelogenous Leukemia|acute myelogenous leukemia
181438|NCT02203773|Treatment Naive AML|treatment naive aml
172325|NCT02245139|fever|fever
181439|NCT02203773|GDC-0199|gdc-0199
181440|NCT02203773|Myelogenous Leukemia|myelogenous leukemia
181441|NCT02203760|Relapsed or metastatic uterine leiomyosarcomas or carcinosarcomas|relapsed or metastatic uterine leiomyosarcomas or carcinosarcomas
181442|NCT02203734|Pregnancy|pregnancy
181443|NCT02203734|Depression|depression
181444|NCT02203734|Massage|massage
181445|NCT02203708|BPD (Borderline Personality Disorder)|bpd (borderline personality disorder)
181446|NCT02203708|Mother/child|mother/child
181447|NCT02203695|Salvage Radiation Therapy (SRT)|salvage radiation therapy (srt)
181448|NCT02203695|Enzalutamide|enzalutamide
181449|NCT02203682|Graves' orbitopathy|graves' orbitopathy
181450|NCT02203682|Graves´ ophthalmopathy|graves´ ophthalmopathy
181451|NCT02203682|Thyroid eye disease|thyroid eye disease
181452|NCT02203682|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
181453|NCT02203682|Doxycycline|doxycycline
181454|NCT02203682|EUGOGO|eugogo
181455|NCT02203682|CAS|cas
181456|NCT02203669|breast reconstruction|breast reconstruction
181457|NCT02203669|occupational therapy|occupational therapy
181458|NCT02203669|physical therapy|physical therapy
181459|NCT02203669|upper extremity morbidity|upper extremity morbidity
181460|NCT02203656|intervention studies|intervention studies
181461|NCT02203656|nutrition|nutrition
181462|NCT02203656|exercise|exercise
181463|NCT02203656|testosterone|testosterone
181464|NCT02203656|patient readmission|patient readmission
181465|NCT02203630|Septic shock|septic shock
181466|NCT02203630|Vasopressor Agents|vasopressor agents
181467|NCT02203630|Phenylephrine|phenylephrine
181468|NCT02203630|Norepinephrine|norepinephrine
181469|NCT02203630|Tachycardia|tachycardia
181470|NCT02203630|Heart Rate|heart rate
181471|NCT02203630|Arrhythmia|arrhythmia
181472|NCT02203630|Catecholamine|catecholamine
181473|NCT02203617|anticipatory guidance|anticipatory guidance
181474|NCT02203617|baby books|baby books
181475|NCT02203617|safety|safety
181476|NCT02203591|surgical skin prep|surgical skin prep
181477|NCT02203591|CHG|chg
181478|NCT02203591|IPA|ipa
181479|NCT02203552|Breast Cancer|breast cancer
181480|NCT02203539|circadian rhythm|circadian rhythm
181481|NCT02203539|light exposure|light exposure
181482|NCT02203539|exercise capacity|exercise capacity
181483|NCT02203539|endurance|endurance
181484|NCT02203539|strength|strength
181485|NCT02203539|reaction|reaction
181486|NCT02203526|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
181487|NCT02203526|ABC DLBCL|abc dlbcl
181488|NCT02203526|Lymphoma in Brain and CNS|lymphoma in brain and cns
181489|NCT02203526|Diffuse Large B-Cell Lymphomas in CNS|diffuse large b-cell lymphomas in cns
181490|NCT02203513|p53 Dysfunction|p53 dysfunction
181491|NCT02203513|Cell Cycle Arrest|cell cycle arrest
181492|NCT02203513|Checkpoint Kinases|checkpoint kinases
181493|NCT02203513|DNA Damage Repair Pathways|dna damage repair pathways
181494|NCT02203513|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
181495|NCT02203461|ART, HIV, insulin resistance|art, hiv, insulin resistance
181496|NCT02203435|code blue|code blue
181497|NCT02203435|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
181498|NCT02203435|APACHE|apache
181499|NCT02203422|Immune Thrombocytopenia|immune thrombocytopenia
181500|NCT02203422|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
181501|NCT02203422|Cyclosporin A|cyclosporin a
181502|NCT02203409|liver tumor|liver tumor
181503|NCT02203409|Two stage hepatectomy|two stage hepatectomy
181504|NCT02203409|Hypertrophy|hypertrophy
181505|NCT02203409|laparoscopy|laparoscopy
181506|NCT02203409|ALPPS|alpps
181507|NCT02203396|SAA|saa
181508|NCT02203396|Immunosuppressive treatment|immunosuppressive treatment
181510|NCT02203396|Cyclosporine|cyclosporine
181512|NCT02203383|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
181513|NCT02203383|Central Sleep Apnoea|central sleep apnoea
181514|NCT02203383|Sleep Disordered Breathing|sleep disordered breathing
181515|NCT02203383|Heart Failure|heart failure
181516|NCT02203383|Hypercapnic Ventilatory Response|hypercapnic ventilatory response
181517|NCT02203357|hepatitis B|hepatitis b
181518|NCT02203357|hepatitis B vaccine|hepatitis b vaccine
181519|NCT02203357|immunogenicity|immunogenicity
181520|NCT02203357|adults|adults
181521|NCT02203318|cryptorchidism, undescended testis, hypertrophy of contralateral testis|cryptorchidism, undescended testis, hypertrophy of contralateral testis
181522|NCT02203305|Unilateral hearing loss|unilateral hearing loss
181523|NCT02203305|Single Sided Deafness|single sided deafness
181524|NCT02203305|Asymmetric hearing loss|asymmetric hearing loss
181525|NCT02203292|Traumatic Brain Injury|traumatic brain injury
181526|NCT02203292|Blood Transfusion|blood transfusion
181527|NCT02203279|Chair-side hard relining|chair-side hard relining
181528|NCT02203279|complete denture|complete denture
181529|NCT02203279|patients' satisfaction|patients' satisfaction
181530|NCT02203279|supporting tissues|supporting tissues
181531|NCT02203279|autopolymerized reline resins|autopolymerized reline resins
181532|NCT02203279|heat cured relining material|heat cured relining material
172420|NCT02244658|chemotherapy-induced thrombocytopenia|chemotherapy-induced thrombocytopenia
172421|NCT02244658|recombinant human thrombopoietin|recombinant human thrombopoietin
172422|NCT02244658|acute myelocytic leukemia|acute myelocytic leukemia
172423|NCT02244645|Low back pain, physical therapy, yoga.|low back pain, physical therapy, yoga.
172436|NCT02244619|Hip replacement|hip replacement
172437|NCT02244619|Knee replacement|knee replacement
172438|NCT02244619|randomized trial|randomized trial
172439|NCT02244619|acetaminophen|acetaminophen
172440|NCT02244619|post-op pain management|post-op pain management
172441|NCT02244606|Invasive Candidiasis|invasive candidiasis
172442|NCT02244606|Invasive Candida infections|invasive candida infections
181533|NCT02203266|Medication Adherence|medication adherence
181534|NCT02203266|Patient Compliance|patient compliance
181535|NCT02203253|solid tumor|solid tumor
181536|NCT02203253|chemotherapy-induced delayed nausea and vomiting|chemotherapy-induced delayed nausea and vomiting
181537|NCT02203253|thalidomide|thalidomide
181538|NCT02203253|prevention|prevention
181539|NCT02203240|Cacao|cacao
181540|NCT02203240|Polyphenols|polyphenols
181541|NCT02203240|Prediabetic State|prediabetic state
181542|NCT02203240|Blood Glucose|blood glucose
181543|NCT02203240|Glucose Intolerance|glucose intolerance
181544|NCT02203240|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
181545|NCT02203240|Obesity|obesity
181546|NCT02203240|Muscle, Skeletal|muscle, skeletal
181547|NCT02203240|Endotoxins|endotoxins
181548|NCT02203240|Gut Permeability|gut permeability
181549|NCT02203240|Incretins|incretins
181550|NCT02203240|Metabolic Flexibility|metabolic flexibility
181551|NCT02203227|Dietary supplements|dietary supplements
181552|NCT02203227|Cotinine level|cotinine level
181553|NCT02203227|Malondialdehyde|malondialdehyde
181554|NCT02203227|Chronic smokers|chronic smokers
181555|NCT02203227|Hyperlipidemia|hyperlipidemia
181556|NCT02203214|Ligamys|ligamys
181557|NCT02203214|ACL|acl
181558|NCT02203214|healing|healing
181559|NCT02203201|Not-celiac gluten sensitivity|not-celiac gluten sensitivity
181560|NCT02203201|Celiac Disease|celiac disease
181561|NCT02203201|Gluten-free diet|gluten-free diet
181562|NCT02203201|EMA assay|ema assay
181563|NCT02203201|Duodenal culture medium|duodenal culture medium
181564|NCT02203175|propofol|propofol
181565|NCT02203175|pretreatment|pretreatment
181566|NCT02203175|mixture|mixture
181567|NCT02203162|cough|cough
181568|NCT02203162|cough reflex sensitivity|cough reflex sensitivity
181569|NCT02203162|electronic cigarette|electronic cigarette
181570|NCT02203162|capsaicin|capsaicin
181571|NCT02203136|Bladder cancer|bladder cancer
181572|NCT02203136|Muscle invasive bladder cancer|muscle invasive bladder cancer
181573|NCT02203136|MIBC|mibc
181574|NCT02203136|Biopsy specimen molecular profiling|biopsy specimen molecular profiling
181575|NCT02203136|Bladder surgery|bladder surgery
181576|NCT02203136|Magnetic resonance imaging|magnetic resonance imaging
181577|NCT02203136|MRI|mri
181578|NCT02203136|Trans urethral resection of bladder|trans urethral resection of bladder
181579|NCT02203110|simultaneous bacterial and viral pneumonia|simultaneous bacterial and viral pneumonia
181986|NCT02201381|AML|aml
181580|NCT02203097|Target controlled infusion|target controlled infusion
181581|NCT02203097|propofol|propofol
181582|NCT02203097|cerebral vasoreactivity|cerebral vasoreactivity
181583|NCT02203097|arterial stiffness|arterial stiffness
181584|NCT02203097|Transcranial Doppler|transcranial doppler
181585|NCT02203097|SphygmoCor|sphygmocor
181586|NCT02203084|Cystic Fibrosis|cystic fibrosis
181587|NCT02203084|Diabetes Mellitus Type I|diabetes mellitus type i
181588|NCT02203084|Chronic Renal Insufficiency|chronic renal insufficiency
181589|NCT02203084|The influence of socioeconomic variables upon outcome in children with three chronic medical diseases.|the influence of socioeconomic variables upon outcome in children with three chronic medical diseases.
181590|NCT02203071|sports|sports
181591|NCT02203071|injury|injury
181592|NCT02203071|knee|knee
181593|NCT02203071|pain|pain
181594|NCT02203071|cartilage|cartilage
181595|NCT02203058|Inspiratory capacity|inspiratory capacity
181596|NCT02203058|Positive-pressure respiration|positive-pressure respiration
181597|NCT02203058|Exercise|exercise
181598|NCT02203058|Activities of daily living|activities of daily living
181599|NCT02203058|COPD.|copd.
181600|NCT02203045|Total Knee Arthroplasty|total knee arthroplasty
181601|NCT02203032|Psoriasis|psoriasis
181602|NCT02203032|Plaque-type psoriasis|plaque-type psoriasis
221364|NCT02019342|MAP|map
172520|NCT02244125|Myeloma|myeloma
181603|NCT02203032|Guselkumab|guselkumab
181604|NCT02203032|Ustekinumab|ustekinumab
181605|NCT02203032|CNTO 1959|cnto 1959
181606|NCT02203032|Monoclonal antibody|monoclonal antibody
181607|NCT02203019|Dexmedetomidine|dexmedetomidine
181608|NCT02203019|Propofol|propofol
181609|NCT02203019|Sepsis|sepsis
181610|NCT02203019|Mechanical Ventilation|mechanical ventilation
181611|NCT02203019|Respiratory Failure|respiratory failure
181612|NCT02203006|HIV,|hiv,
181613|NCT02203006|infection,|infection,
181614|NCT02203006|cohort|cohort
181615|NCT02202967|Aspirin|aspirin
181616|NCT02202967|Intestinal bleeding|intestinal bleeding
181617|NCT02202967|Misoprostol|misoprostol
181618|NCT02202967|NSAIDs|nsaids
181619|NCT02202967|Small intestine|small intestine
181620|NCT02202967|Video capsule endoscopy|video capsule endoscopy
181621|NCT02202954|Stroke|stroke
181622|NCT02202954|Muscle Spasticity|muscle spasticity
181623|NCT02202954|Rehabilitation|rehabilitation
181624|NCT02202928|Colorectal cancer|colorectal cancer
181625|NCT02202928|DC-CIK|dc-cik
181626|NCT02202928|Autologous tumor lysate|autologous tumor lysate
181627|NCT02202902|Cushing's syndrome|cushing's syndrome
181628|NCT02202902|cardiac steatosis|cardiac steatosis
181629|NCT02202902|intramyocardial triglyceride content|intramyocardial triglyceride content
181630|NCT02202902|1H magnetic resonance spectroscopy and cardiac magnetic resonance imaging|1h magnetic resonance spectroscopy and cardiac magnetic resonance imaging
181631|NCT02202902|Left Ventricularly hypertrophy|left ventricularly hypertrophy
181632|NCT02202889|Adolescents|adolescents
181633|NCT02202889|Bone mass|bone mass
181634|NCT02202889|Calcium|calcium
181635|NCT02202889|Perceived milk intolerance|perceived milk intolerance
181636|NCT02202889|lactose maldigestion|lactose maldigestion
181637|NCT02202863|Dietary intervention|dietary intervention
181638|NCT02202863|Wine grape pomace flour|wine grape pomace flour
181639|NCT02202863|Metabolic Syndrome|metabolic syndrome
181640|NCT02202863|Oxidative stress|oxidative stress
181641|NCT02202863|Antioxidants|antioxidants
181642|NCT02202863|Fiber|fiber
181643|NCT02202785|Drug therapy|drug therapy
181644|NCT02202772|Urothelial|urothelial
181645|NCT02202772|Cisplatin|cisplatin
181646|NCT02202772|Gemcitabine|gemcitabine
181647|NCT02202772|Cabazitaxel|cabazitaxel
181648|NCT02202772|Bladder|bladder
181649|NCT02202772|Carcinoma|carcinoma
181650|NCT02202772|Bacillus Calmette-Guerin|bacillus calmette-guerin
181651|NCT02202772|Intravesical|intravesical
181652|NCT02202772|Recurrent|recurrent
181653|NCT02202772|Non-muscle|non-muscle
181654|NCT02202772|Invasive|invasive
181655|NCT02202772|Cancer|cancer
181656|NCT02202759|Drug therapy|drug therapy
181657|NCT02202746|Breast cancer|breast cancer
181658|NCT02202746|Metastatic breast cancer|metastatic breast cancer
181659|NCT02202746|MBC|mbc
181660|NCT02202746|HER2 positive|her2 positive
181661|NCT02202746|HER2+|her2+
181662|NCT02202746|Estrogen receptor positive|estrogen receptor positive
181663|NCT02202746|ER+|er+
181664|NCT02202746|Triple negative|triple negative
181665|NCT02202746|FGFR1|fgfr1
181666|NCT02202746|11q|11q
181667|NCT02202746|FGF aberrant|fgf aberrant
181668|NCT02202746|Biomarker negative|biomarker negative
181669|NCT02202746|FGF non-aberrant|fgf non-aberrant
181670|NCT02202733|cooking skills|cooking skills
181671|NCT02202733|eating out|eating out
181672|NCT02202733|foods prepared away from home|foods prepared away from home
181673|NCT02202720|Sevoflurane|sevoflurane
181674|NCT02202720|RASS score|rass score
181675|NCT02202720|Sedation|sedation
181676|NCT02202720|Minimal alveolar concentration (MAC)|minimal alveolar concentration (mac)
181677|NCT02202694|CBT, Psychosis, cultural adaptation, Pakistan|cbt, psychosis, cultural adaptation, pakistan
181678|NCT02202681|Duodenum|duodenum
181679|NCT02202681|Optical Frequency Domain Imaging (OFDI)|optical frequency domain imaging (ofdi)
181987|NCT02201381|CML|cml
181680|NCT02202681|Optical Coherence Tomography|optical coherence tomography
181681|NCT02202681|Imaging|imaging
181682|NCT02202681|Celiac Disease|celiac disease
181683|NCT02202668|Foot ulcer, diabetic|foot ulcer, diabetic
181684|NCT02202668|Spectrum analysis, Raman|spectrum analysis, raman
181685|NCT02202655|non- small cell lung cancer;|non- small cell lung cancer;
181686|NCT02202655|lymphocyte subsets|lymphocyte subsets
181687|NCT02202616|COPD,|copd,
181688|NCT02202616|QVA149,|qva149,
181689|NCT02202616|Tiotropium,|tiotropium,
181690|NCT02202616|FDC,|fdc,
181691|NCT02202616|GlycOpyrronium With IndacatERol,|glycopyrronium with indacaterol,
181692|NCT02202616|POWER|power
181693|NCT02202590|SECM|secm
181694|NCT02202590|Esophagus|esophagus
181695|NCT02202590|Eosinophilic Esophagitis|eosinophilic esophagitis
181696|NCT02202590|Allergy|allergy
181697|NCT02202577|Surgical site infection|surgical site infection
181698|NCT02202577|Surgical site antisepsis|surgical site antisepsis
181699|NCT02202577|Cesarean Delivery|cesarean delivery
181700|NCT02202564|hepatocellular carcinoma|hepatocellular carcinoma
181701|NCT02202564|liver transplantation|liver transplantation
181702|NCT02202564|adenovirus-thymidine kinase|adenovirus-thymidine kinase
181703|NCT02202564|gene therapy|gene therapy
181704|NCT02202551|Levodopa Induced Dyskinesia|levodopa induced dyskinesia
181706|NCT02202551|Parkinsonism|parkinsonism
181707|NCT02202551|Parkinson's Disease|parkinson's disease
181708|NCT02202538|SCI|sci
181709|NCT02202538|Indego|indego
181710|NCT02202538|Walking|walking
181711|NCT02202499|pharmacotherapy|pharmacotherapy
181712|NCT02202473|Oxymatrine Capsules, lamivudine, chronic Hepatitis B|oxymatrine capsules, lamivudine, chronic hepatitis b
181713|NCT02202447|EC1169|ec1169
181714|NCT02202447|prostate cancer|prostate cancer
181715|NCT02202447|EC0652|ec0652
181716|NCT02202421|Autism|autism
181717|NCT02202421|Applied Behavior Analysis|applied behavior analysis
181718|NCT02202395|Hydroxytriptolide|hydroxytriptolide
181719|NCT02202395|Rheumatoid Arthritis|rheumatoid arthritis
181720|NCT02202395|Methotrexate|methotrexate
181721|NCT02202395|T8|t8
181722|NCT02202395|LTS|lts
181723|NCT02202369|Multimodal Analgesia|multimodal analgesia
181724|NCT02202369|Pain Management|pain management
181725|NCT02202356|RSV|rsv
181726|NCT02202356|Respiratory Syncytial Virus|respiratory syncytial virus
181727|NCT02202343|Nutrition|nutrition
181728|NCT02202343|Food|food
181729|NCT02202343|Security|security
181730|NCT02202343|School|school
181731|NCT02202343|Health|health
181732|NCT02202317|Liver Cancer|liver cancer
181733|NCT02202317|Hepatic Tumors|hepatic tumors
181734|NCT02202317|Primary Liver Tumors|primary liver tumors
181735|NCT02202317|Metastastic Liver Tumors|metastastic liver tumors
181736|NCT02202317|Yttrium-90|yttrium-90
181737|NCT02202317|Y-90|y-90
181738|NCT02202291|Raynaud's phenomenon, Vasospasm, Genetics|raynaud's phenomenon, vasospasm, genetics
181739|NCT02202278|ovarian hyperstimulation|ovarian hyperstimulation
181740|NCT02202278|Oxidative Stress|oxidative stress
181741|NCT02202278|IMA|ima
181742|NCT02202278|OHSS|ohss
181743|NCT02202278|ICSI|icsi
181744|NCT02202278|long agonist protocol|long agonist protocol
181745|NCT02202278|TAC|tac
181746|NCT02202278|TOS|tos
181747|NCT02202278|OSI|osi
181748|NCT02202278|MDA|mda
181749|NCT02202265|Heart Diseases|heart diseases
181750|NCT02202252|Patient comfort|patient comfort
181751|NCT02202252|Drains|drains
181752|NCT02202252|Breast cancer|breast cancer
181753|NCT02202252|Modified radical mastectomy|modified radical mastectomy
181754|NCT02202252|Seroma|seroma
181755|NCT02202200|Melanoma|melanoma
181756|NCT02202200|BRAF mutated|braf mutated
181757|NCT02202174|supraglottic airway|supraglottic airway
181758|NCT02202174|children|children
181759|NCT02202174|safety|safety
181760|NCT02202174|efficacy|efficacy
181761|NCT02202161|pharmacokinetic|pharmacokinetic
181762|NCT02202161|intestinal bile acid transporter inhibitor|intestinal bile acid transporter inhibitor
181763|NCT02202161|metformin|metformin
181764|NCT02202161|sitagliptin|sitagliptin
181765|NCT02202161|GSK2330672|gsk2330672
181766|NCT02202161|pharmacodynamic|pharmacodynamic
181767|NCT02202148|Fibroscan|fibroscan
181768|NCT02202148|alcohol dependence|alcohol dependence
181769|NCT02202148|alcohol withdrawal|alcohol withdrawal
181770|NCT02202148|controlled attenuation parameter|controlled attenuation parameter
181771|NCT02202148|BDNF|bdnf
181772|NCT02202135|complicated skin and soft tissue infections (cSSTI)|complicated skin and soft tissue infections (cssti)
181773|NCT02202135|skin infection|skin infection
181774|NCT02202135|ceftaroline|ceftaroline
181775|NCT02202135|wound infection|wound infection
181776|NCT02202135|cellulitis|cellulitis
181777|NCT02202135|burn infection|burn infection
181778|NCT02202135|bacterial infection|bacterial infection
181779|NCT02202135|vancomycin|vancomycin
181780|NCT02202122|Femoral Neck Fractures|femoral neck fractures
181781|NCT02202122|Obstructive Sleep Apnea|obstructive sleep apnea
181782|NCT02202122|Perioperative Complications|perioperative complications
181783|NCT02202109|Screen|screen
181784|NCT02202109|self-sampler|self-sampler
181785|NCT02202109|cervical, cancer|cervical, cancer
181786|NCT02202109|women|women
181787|NCT02202109|community health workers|community health workers
181788|NCT02202109|Hispanic/ Latinas|hispanic/ latinas
181789|NCT02202109|Haitian|haitian
181790|NCT02202109|Focus of study is cervical cancer|focus of study is cervical cancer
181791|NCT02202083|Oxytocin|oxytocin
181792|NCT02202083|Cook Balloon|cook balloon
181793|NCT02202070|onabotulinumtoxinA|onabotulinumtoxina
181794|NCT02202070|Temporomandibular Joint Disorders|temporomandibular joint disorders
181795|NCT02202070|Bruxism|bruxism
181796|NCT02202070|Temporomandibular Joint Dysfunction Syndrome|temporomandibular joint dysfunction syndrome
182010|NCT02201303|Neutrophils|neutrophils
181797|NCT02202070|Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint|myofascial pain dysfunction syndrome, temporomandibular joint
181798|NCT02202057|respiratory sensation|respiratory sensation
181799|NCT02202057|somatosensation|somatosensation
181800|NCT02202057|resistive load|resistive load
181801|NCT02202057|magnitude estimation|magnitude estimation
181802|NCT02202044|Bladder Cancer|bladder cancer
181803|NCT02202018|Knowledge Translation|knowledge translation
181804|NCT02202018|Chronic Kidney Disease|chronic kidney disease
181805|NCT02202018|Dialysis|dialysis
181806|NCT02202018|Home dialysis|home dialysis
181807|NCT02202018|Cluster randomized trial|cluster randomized trial
181808|NCT02202005|Bioequivalence|bioequivalence
181809|NCT02201979|breast|breast
181810|NCT02201979|ptosis|ptosis
181811|NCT02201979|sagging|sagging
181812|NCT02201979|implant|implant
181813|NCT02201979|lift|lift
181814|NCT02201966|low back pain|low back pain
181815|NCT02201966|pediatric|pediatric
181816|NCT02201966|gymnasts|gymnasts
181817|NCT02201953|Sofosbuvir|sofosbuvir
181818|NCT02201953|Velpatasvir|velpatasvir
181819|NCT02201953|SOF/VEL|sof/vel
181820|NCT02201953|GS-5816|gs-5816
181821|NCT02201953|Hepatitis C|hepatitis c
181822|NCT02201953|HCV|hcv
181823|NCT02201953|Cirrhosis|cirrhosis
181824|NCT02201953|Genotype 3|genotype 3
181825|NCT02201940|Sofosbuvir|sofosbuvir
181826|NCT02201940|SOF/VEL|sof/vel
181827|NCT02201940|Velpatasvir|velpatasvir
181828|NCT02201940|Hepatitis C|hepatitis c
181829|NCT02201940|HCV|hcv
181830|NCT02201940|cirrhosis|cirrhosis
181831|NCT02201927|galvanic vestibular stimulation|galvanic vestibular stimulation
181832|NCT02201927|right parietal lobe lesion|right parietal lobe lesion
181833|NCT02201927|egocentric space|egocentric space
181834|NCT02201901|Sofosbuvir|sofosbuvir
181835|NCT02201901|Velpatasvir|velpatasvir
181836|NCT02201901|SOF/VEL|sof/vel
181837|NCT02201901|GS-5816|gs-5816
181838|NCT02201901|Hepatitis C|hepatitis c
181839|NCT02201901|HCV|hcv
181840|NCT02201901|Cirrhosis|cirrhosis
181841|NCT02201901|CPT-B|cpt-b
181842|NCT02201888|Schizophrenia|schizophrenia
181843|NCT02201888|Rehabilitation|rehabilitation
181844|NCT02201888|Cognition|cognition
181845|NCT02201875|hypoxia|hypoxia
181846|NCT02201875|exercise|exercise
181847|NCT02201875|periodic breathing|periodic breathing
181848|NCT02201875|hypercapnia|hypercapnia
181849|NCT02201875|apneas|apneas
181850|NCT02201875|cardiac failure|cardiac failure
181851|NCT02201862|Aneuploidy|aneuploidy
181852|NCT02201862|Down Syndrome|down syndrome
181853|NCT02201862|amniocentesis|amniocentesis
181854|NCT02201862|chronic villus sampling|chronic villus sampling
181855|NCT02201862|Trisomy|trisomy
181856|NCT02201862|non-invasive prenatal testing|non-invasive prenatal testing
181857|NCT02201862|Chromosome disorders|chromosome disorders
181858|NCT02201849|Alkermes|alkermes
181859|NCT02201849|ALKS 8700|alks 8700
181860|NCT02201810|smoking cessation|smoking cessation
181861|NCT02201810|quit line|quit line
181862|NCT02201810|nicotine replacement therapy|nicotine replacement therapy
181863|NCT02201810|tobacco intervention|tobacco intervention
181864|NCT02201797|Reproducibility of Results|reproducibility of results
181865|NCT02201797|Liver neoplasm|liver neoplasm
181866|NCT02201797|Neoplasm metastasis|neoplasm metastasis
181867|NCT02201797|Regional Perfusion|regional perfusion
181868|NCT02201797|Perfusion Magnetic Resonance Imaging|perfusion magnetic resonance imaging
181869|NCT02201784|Subarachnoid block|subarachnoid block
181870|NCT02201784|intrathecal|intrathecal
181871|NCT02201784|spinal anesthesia|spinal anesthesia
181872|NCT02201784|isobaric|isobaric
181873|NCT02201784|levobupivacaine|levobupivacaine
181874|NCT02201784|ropivacaine|ropivacaine
181875|NCT02201771|CABG|cabg
181876|NCT02201771|Antiplatelet|antiplatelet
181877|NCT02201771|Ticagrelor|ticagrelor
181878|NCT02201758|Inflammatory Bowel Disease (IBD), ulcerative colitis (UC), flaxseed lignan-enriched complex (FLC)|inflammatory bowel disease (ibd), ulcerative colitis (uc), flaxseed lignan-enriched complex (flc)
181879|NCT02201732|Incomplete miscarriage|incomplete miscarriage
181880|NCT02201732|Hysteroscopy|hysteroscopy
181881|NCT02201732|curettage, pregnancy|curettage, pregnancy
181882|NCT02201732|RCT|rct
181883|NCT02201719|Adenomyosis|adenomyosis
181884|NCT02201719|Dysmenorrhea|dysmenorrhea
181885|NCT02201719|Chronic pelvic pain|chronic pelvic pain
181886|NCT02201719|Infertility|infertility
181887|NCT02201719|Sensitivity histology|sensitivity histology
181988|NCT02201381|Leukemea|leukemea
181888|NCT02201719|womens health|womens health
181889|NCT02201719|junction zone|junction zone
181890|NCT02201706|Retinal detachment|retinal detachment
181891|NCT02201706|silicone oil|silicone oil
181892|NCT02201706|retinectomy|retinectomy
181893|NCT02201693|Crohn's disease,|crohn's disease,
181894|NCT02201693|pediatric GETAID (Therapeutic study group of inflammatory bowel diseases of the child),|pediatric getaid (therapeutic study group of inflammatory bowel diseases of the child),
181895|NCT02201693|enteral nutrition,|enteral nutrition,
181896|NCT02201693|randomized multicenter study|randomized multicenter study
181897|NCT02201680|anxiety|anxiety
181898|NCT02201680|preoperative|preoperative
181899|NCT02201667|non-ST elevation acute coronary syndrome|non-st elevation acute coronary syndrome
181900|NCT02201667|myocardial perfusion|myocardial perfusion
181901|NCT02201667|magnetic Resonance Imaging|magnetic resonance imaging
181902|NCT02201667|antiplatelet|antiplatelet
181903|NCT02201641|Indirect pulp capping|indirect pulp capping
181908|NCT02201641|calcium silicate cements|calcium silicate cements
181909|NCT02201641|glass ionomer cements|glass ionomer cements
181910|NCT02201641|caries|caries
181911|NCT02201628|Oesophageal|oesophageal
181912|NCT02201628|Nasopharyngeal|nasopharyngeal
181913|NCT02201628|temperature|temperature
181914|NCT02201628|Intubation, endotracheal|intubation, endotracheal
181915|NCT02201628|Pediatric|pediatric
181916|NCT02201628|Anesthesia|anesthesia
181917|NCT02201628|Hypothermia|hypothermia
181918|NCT02201615|Perineal Massage; Episiotomy; Perineal Laceration|perineal massage; episiotomy; perineal laceration
181919|NCT02201602|sulphonylureas|sulphonylureas
181920|NCT02201602|gliclazide|gliclazide
181921|NCT02201602|glibenclamide|glibenclamide
181922|NCT02201589|Lesions in the ascending thoracic aorta|lesions in the ascending thoracic aorta
181923|NCT02201576|Chronic antibody-mediated rejection,|chronic antibody-mediated rejection,
181924|NCT02201576|transplant rejection, kidney transplantation,|transplant rejection, kidney transplantation,
181925|NCT02201576|proteasome inhibitor,|proteasome inhibitor,
181926|NCT02201576|anti-HLA antibodies,|anti-hla antibodies,
181927|NCT02201576|immunosuppressive agents|immunosuppressive agents
181928|NCT02201563|Adverse radiation effects (ARE)|adverse radiation effects (are)
181929|NCT02201563|Radiosurgery|radiosurgery
181930|NCT02201563|Brain metastases|brain metastases
181931|NCT02201563|Minocycline|minocycline
181932|NCT02201537|Ultrasound functional imaging|ultrasound functional imaging
181933|NCT02201537|Chronic kidney Nephropathy|chronic kidney nephropathy
181934|NCT02201524|Phase 2|phase 2
181935|NCT02201524|randomized|randomized
181936|NCT02201524|double-blind|double-blind
181937|NCT02201524|placebo|placebo
181938|NCT02201524|plaque|plaque
181939|NCT02201524|psoriasis|psoriasis
181940|NCT02201524|safety|safety
181941|NCT02201524|efficacy|efficacy
181943|NCT02201524|janus kinase|janus kinase
181944|NCT02201524|moderate|moderate
181945|NCT02201524|severe|severe
181946|NCT02201511|relative bioavailbility|relative bioavailbility
181947|NCT02201511|food effect|food effect
181948|NCT02201511|pharmacokinetics|pharmacokinetics
181949|NCT02201511|ALTERATION OF COGNITIVE FUNCTIONS|alteration of cognitive functions
181955|NCT02201472|liver|liver
181956|NCT02201472|mre|mre
181957|NCT02201472|mri|mri
181958|NCT02201472|neonatal|neonatal
181959|NCT02201472|mr touch|mr touch
181960|NCT02201459|Peg-IFN, nilotinib, MR4.5, CML, chronic phase, first-line|peg-ifn, nilotinib, mr4.5, cml, chronic phase, first-line
181961|NCT02201433|breastfeeding|breastfeeding
181962|NCT02201433|fathers|fathers
181963|NCT02201433|preterm newborns|preterm newborns
181964|NCT02201433|partner influence|partner influence
181965|NCT02201394|Antiplatelet|antiplatelet
181966|NCT02201394|Ticagrelor|ticagrelor
181967|NCT02201394|Platelets|platelets
181968|NCT02201394|Thrombosis|thrombosis
181969|NCT02201394|Coronary artery disease|coronary artery disease
181970|NCT02201394|Coronary artery disease.|coronary artery disease.
181971|NCT02201381|Cancer|cancer
181972|NCT02201381|Cancer Treatments|cancer treatments
181973|NCT02201381|Cancer Palliative Care|cancer palliative care
181974|NCT02201381|Metabolic|metabolic
181975|NCT02201381|Metabolism|metabolism
181976|NCT02201381|Existing Medicines|existing medicines
181977|NCT02201381|Licensed Medicines|licensed medicines
181978|NCT02201381|Real World|real world
181979|NCT02201381|Breast Cancer|breast cancer
181980|NCT02201381|Triple Negative Breast Cancer|triple negative breast cancer
181981|NCT02201381|Colon Cancer|colon cancer
181982|NCT02201381|Prostrate Cancer|prostrate cancer
181983|NCT02201381|Brain Cancer|brain cancer
181984|NCT02201381|Ovarian Cancer|ovarian cancer
181985|NCT02201381|Pancreatic Cancer|pancreatic cancer
181989|NCT02201381|Metformin|metformin
181990|NCT02201381|Statins|statins
181991|NCT02201381|Mebendazole|mebendazole
181992|NCT02201381|Doxycycline|doxycycline
181993|NCT02201381|Ibuprofen|ibuprofen
181994|NCT02201381|Metastatic|metastatic
181995|NCT02201368|Triglycerides; Lipid Metabolism; Fatty Acids.|triglycerides; lipid metabolism; fatty acids.
181996|NCT02201355|Head and Neck cancer|head and neck cancer
181997|NCT02201342|Fontan|fontan
181998|NCT02201342|Pharmacokinetics|pharmacokinetics
181999|NCT02201342|Pharmacodynamics|pharmacodynamics
182000|NCT02201342|Exercise capacity|exercise capacity
182001|NCT02201342|Maximal Oxygen Consumption|maximal oxygen consumption
182002|NCT02201342|Vascular function|vascular function
182003|NCT02201342|EndoPAT|endopat
182004|NCT02201342|Myocardial performance|myocardial performance
182005|NCT02201316|Healthy adult human subjects|healthy adult human subjects
667645|NCT00841165|Hyperbaric|hyperbaric
182006|NCT02201316|Mosapride citrate anhydrous|mosapride citrate anhydrous
182007|NCT02201316|Bioequivalence|bioequivalence
182008|NCT02201316|Dyspepsia|dyspepsia
182009|NCT02201303|CD11b|cd11b
182011|NCT02201303|CXCL1|cxcl1
182012|NCT02201303|Danirixin|danirixin
182013|NCT02201303|Respiratory Syncytial Virus|respiratory syncytial virus
182014|NCT02201303|Children|children
182015|NCT02201303|CXCR2|cxcr2
182016|NCT02201290|Chronic immune thrombocytopenic purpura, ITP, eltrombopag olamine, thrombopoietin receptor agonist, pediatrics|chronic immune thrombocytopenic purpura, itp, eltrombopag olamine, thrombopoietin receptor agonist, pediatrics
182017|NCT02201277|IVC|ivc
182018|NCT02201277|IVC Filter|ivc filter
182019|NCT02201277|Filter|filter
182020|NCT02201277|Option|option
182021|NCT02201277|Denali|denali
182022|NCT02201277|filter tilt|filter tilt
182023|NCT02201277|filter migration|filter migration
182024|NCT02201277|filter fracture|filter fracture
182025|NCT02201277|filter thrombus|filter thrombus
182026|NCT02201277|filter penetration|filter penetration
182027|NCT02201264|myocardial infarction|myocardial infarction
182028|NCT02201264|Angioplasty|angioplasty
182029|NCT02201264|Stent|stent
182030|NCT02201251|Epilepsy|epilepsy
182031|NCT02201251|Topiramate|topiramate
182032|NCT02201251|Levetiracetam|levetiracetam
182033|NCT02201251|Pediatric|pediatric
182034|NCT02201212|TSC1|tsc1
182035|NCT02201212|TSC2|tsc2
182036|NCT02201212|Tuberous Sclerosis Complex|tuberous sclerosis complex
182037|NCT02201212|MTOR|mtor
182038|NCT02201186|honey enema for pouchitis|honey enema for pouchitis
182039|NCT02201160|NAFLD|nafld
182040|NCT02201160|Fatty acid composition|fatty acid composition
182041|NCT02201160|Omega 3 supplementation|omega 3 supplementation
182042|NCT02201160|Metabolism|metabolism
182043|NCT02201134|Cardiac arrest|cardiac arrest
182044|NCT02201134|Therapeutic hypothermia|therapeutic hypothermia
182045|NCT02201134|Sevoflurane|sevoflurane
182046|NCT02201134|Sedation|sedation
182047|NCT02201134|Patient resuscitated from cardiac arrest|patient resuscitated from cardiac arrest
182048|NCT02201134|Requiring sedation|requiring sedation
182049|NCT02201134|Adult patients|adult patients
182050|NCT02201134|Patient covered by french health care system|patient covered by french health care system
182051|NCT02201095|caesarean section|caesarean section
182052|NCT02201095|perioperative hypothermia|perioperative hypothermia
182053|NCT02201095|active warming|active warming
182054|NCT02201095|forced air warming|forced air warming
182055|NCT02201095|conduction mattress warming|conduction mattress warming
182056|NCT02201095|thermal comfort|thermal comfort
182057|NCT02201095|Prevention of|prevention of
182058|NCT02201069|nutrition|nutrition
182059|NCT02201069|physical activity|physical activity
182060|NCT02201069|sleep|sleep
182061|NCT02201069|weight loss|weight loss
182062|NCT02201056|Drug Therapy|drug therapy
182063|NCT02201043|ankylosing spondylitis|ankylosing spondylitis
182064|NCT02201043|thalidomide|thalidomide
182065|NCT02200952|OHSS|ohss
182066|NCT02200952|Oocytes triggering|oocytes triggering
182067|NCT02200952|GnRh agonist triggering|gnrh agonist triggering
182068|NCT02200952|Luteal phase supplementation|luteal phase supplementation
182069|NCT02200952|recombinant LH|recombinant lh
182070|NCT02200900|High flow nasal cannula|high flow nasal cannula
182071|NCT02200900|Continuous Positive Airway Pressure|continuous positive airway pressure
182072|NCT02200900|Respiratory physiology|respiratory physiology
182073|NCT02200887|Dyskinesia|dyskinesia
182074|NCT02200887|Slow Wave Sleep|slow wave sleep
182075|NCT02200874|disease related malnutrition|disease related malnutrition
182076|NCT02200874|influence of Nutrition Support Team|influence of nutrition support team
182077|NCT02200874|length of hospital stay|length of hospital stay
182078|NCT02200874|quality of life|quality of life
182079|NCT02200874|body composition|body composition
182080|NCT02200874|health care costs|health care costs
182081|NCT02200861|sedation,|sedation,
182082|NCT02200861|tooth extraction,|tooth extraction,
182083|NCT02200848|Lenalidomide|lenalidomide
182084|NCT02200848|Ibrutinib|ibrutinib
182085|NCT02200848|Rituximab|rituximab
182086|NCT02200848|CLL|cll
182087|NCT02200848|SLL|sll
182088|NCT02200835|aortic dissection|aortic dissection
182380|NCT02199327|Mitomycin C|mitomycin c
182089|NCT02200835|Chinese patients|chinese patients
182090|NCT02200835|gender differences|gender differences
182091|NCT02200822|neurohumoral blocker therapy|neurohumoral blocker therapy
182092|NCT02200822|renin-angiotensin-aldosterone system (RAAS)|renin-angiotensin-aldosterone system (raas)
182093|NCT02200822|RAAS-blocker|raas-blocker
182094|NCT02200822|beta blocker|beta blocker
182095|NCT02200822|spironolactone|spironolactone
182096|NCT02200822|angiotensin converting enzyme inhibitor (ACE-I)|angiotensin converting enzyme inhibitor (ace-i)
182097|NCT02200822|angiotensin receptor blocker (ARB)|angiotensin receptor blocker (arb)
182098|NCT02200822|cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
182099|NCT02200822|heart failure|heart failure
182100|NCT02200822|dyssynchrony|dyssynchrony
182101|NCT02200822|left bundle branch block|left bundle branch block
182102|NCT02200809|MR-guided therapy|mr-guided therapy
182103|NCT02200809|Focal laser ablation|focal laser ablation
182104|NCT02200809|Prostate cancer|prostate cancer
182105|NCT02200796|Dietary Protein|dietary protein
182107|NCT02200796|Food Intake|food intake
182108|NCT02200796|Thermic Effect of Food|thermic effect of food
182109|NCT02200796|Diet Induced Thermogenesis|diet induced thermogenesis
182110|NCT02200783|Cardiac catheterization|cardiac catheterization
402942|NCT01228968|obesity|obesity
182111|NCT02200783|Radiation Protection|radiation protection
182112|NCT02200783|Radial artery|radial artery
182113|NCT02200783|Femoral artery|femoral artery
182114|NCT02200770|NMO, NMOSD, Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorders, autoimmune, demyelination, MEDI-551, monoclonal antibody, Devic's syndrome, B-cell|nmo, nmosd, neuromyelitis optica, neuromyelitis optica spectrum disorders, autoimmune, demyelination, medi-551, monoclonal antibody, devic's syndrome, b-cell
182115|NCT02200744|Procedural sedation|procedural sedation
182116|NCT02200744|emergency department|emergency department
182118|NCT02200744|propofol|propofol
182119|NCT02200744|recall assessment|recall assessment
182120|NCT02200731|Childhood cancer|childhood cancer
182121|NCT02200731|Psychosocial intervention|psychosocial intervention
182122|NCT02200731|Family|family
182123|NCT02200731|Siblings|siblings
182124|NCT02200731|Childhood cancer survivors|childhood cancer survivors
182125|NCT02200731|Cogntive Behavioural|cogntive behavioural
182126|NCT02200731|Manualized|manualized
182127|NCT02200718|Multiple Sclerosis Pediatric MS NeuroVax Vaccine Therapeutic|multiple sclerosis pediatric ms neurovax vaccine therapeutic
182128|NCT02200705|cryoablation, cryotherapy, breast cancer|cryoablation, cryotherapy, breast cancer
182129|NCT02200692|plasma transfusion|plasma transfusion
182130|NCT02200692|allergic transfusion reaction|allergic transfusion reaction
182131|NCT02200692|transfusion reaction|transfusion reaction
182132|NCT02200692|blood transfusion|blood transfusion
182133|NCT02200692|Solvent detergent plasma|solvent detergent plasma
182134|NCT02200679|Autism spectrum disorders|autism spectrum disorders
182135|NCT02200679|Prevalence|prevalence
182136|NCT02200679|Diagnosis|diagnosis
182137|NCT02200679|Screen|screen
182138|NCT02200679|Risk Factor|risk factor
182139|NCT02200679|SRS|srs
182140|NCT02200679|ASRS|asrs
182141|NCT02200666|Type 2 diabetes mellitus|type 2 diabetes mellitus
182142|NCT02200666|Diabetes|diabetes
182143|NCT02200666|Forxiga|forxiga
182144|NCT02200666|Long-term use|long-term use
182145|NCT02200627|Type 2 diabetes mellitus|type 2 diabetes mellitus
182146|NCT02200627|Diabetes|diabetes
182147|NCT02200627|Forxiga|forxiga
182148|NCT02200627|Elderly|elderly
182149|NCT02200601|Seipher Wellness|seipher wellness
182150|NCT02200601|algorithm|algorithm
182151|NCT02200601|secure samples of SGC waveform|secure samples of sgc waveform
182152|NCT02200601|volunteers|volunteers
182153|NCT02200601|validation|validation
182154|NCT02200601|heart health algorithm|heart health algorithm
182155|NCT02200588|psychosis|psychosis
182156|NCT02200588|schizophrenia|schizophrenia
182157|NCT02200549|pulmonary rehabilitation|pulmonary rehabilitation
182158|NCT02200549|inspiratory muscle training|inspiratory muscle training
182159|NCT02200549|exercise training|exercise training
182160|NCT02200523|EEG|eeg
182161|NCT02200523|electrode|electrode
182162|NCT02200510|Anemia, Sickle Cell|anemia, sickle cell
182163|NCT02200510|Transition to Adult Care|transition to adult care
182164|NCT02200510|Self Care|self care
182165|NCT02200510|Personal Electronic Health Records|personal electronic health records
182166|NCT02200510|Adolescent|adolescent
182167|NCT02200510|Young Adult|young adult
182168|NCT02200510|Disease Management|disease management
182169|NCT02200510|Physician-Patient Relations|physician-patient relations
182170|NCT02200484|obesity|obesity
182171|NCT02200484|adolescents, females|adolescents, females
182172|NCT02200484|child development|child development
182173|NCT02200484|weight loss programs|weight loss programs
182174|NCT02200484|child rearing|child rearing
182175|NCT02200484|parenting|parenting
182176|NCT02200471|Cosmetic dermatology|cosmetic dermatology
182177|NCT02200471|near-infrared|near-infrared
182178|NCT02200471|patient preference|patient preference
182179|NCT02200471|physician preference|physician preference
182180|NCT02200445|Ulcerative colitis|ulcerative colitis
182181|NCT02200445|Inflammatory bowel disease|inflammatory bowel disease
182182|NCT02200445|Interleukin 2|interleukin 2
182183|NCT02200445|Interleukin-2|interleukin-2
182184|NCT02200445|IL-2|il-2
182185|NCT02200445|Regulatory T Cells|regulatory t cells
182186|NCT02200445|Tregs|tregs
182187|NCT02200445|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
182188|NCT02200432|Smoking Cessation|smoking cessation
182189|NCT02200432|Persuasive Communication Tailoring|persuasive communication tailoring
182190|NCT02200432|Health Behavior Change|health behavior change
182191|NCT02200432|Patient decision support|patient decision support
182192|NCT02200419|Rotem|rotem
182193|NCT02200419|Point of care coagulation tests|point of care coagulation tests
182194|NCT02200419|Cardiac surgery|cardiac surgery
182195|NCT02200419|Vascular surgery|vascular surgery
182196|NCT02200419|Cardiopulmonary bypass|cardiopulmonary bypass
182197|NCT02200419|Blood products|blood products
182198|NCT02200419|Transfusion|transfusion
182199|NCT02200419|Viscoelastic coagulation|viscoelastic coagulation
182200|NCT02200406|Desvenlafaxine|desvenlafaxine
182201|NCT02200406|Opioid-dependent|opioid-dependent
182202|NCT02200406|Addiction|addiction
182203|NCT02200406|Depression|depression
182204|NCT02200406|Methadone|methadone
182205|NCT02200406|Comorbidity|comorbidity
182206|NCT02200393|Spinal cord injury|spinal cord injury
182207|NCT02200393|Tetraplegia|tetraplegia
182208|NCT02200393|Ventilator|ventilator
182209|NCT02200367|Primary health care|primary health care
182210|NCT02200367|Computer communication network|computer communication network
182211|NCT02200367|Depression|depression
182212|NCT02200328|Clostridium difficile infection|clostridium difficile infection
182213|NCT02200328|Diarrhea|diarrhea
182215|NCT02200328|Metronidazole|metronidazole
182216|NCT02200315|Stomach neoplasms|stomach neoplasms
182217|NCT02200315|Surgical site infection|surgical site infection
182218|NCT02200315|Laparoscopic gastrectomy|laparoscopic gastrectomy
182219|NCT02200315|Antimicrobial prophylaxis|antimicrobial prophylaxis
182220|NCT02200289|Birth cohort|birth cohort
182221|NCT02200289|Ghana|ghana
182222|NCT02200289|Biomass|biomass
182223|NCT02200289|Cook stove|cook stove
182224|NCT02200289|Oxidative stress|oxidative stress
182225|NCT02200289|Lung development|lung development
182226|NCT02200263|ocular albinism (OA)|ocular albinism (oa)
182227|NCT02200263|oculocutaneous albinism (OCA)|oculocutaneous albinism (oca)
182228|NCT02200263|macular pigment|macular pigment
182229|NCT02200263|visual function|visual function
182230|NCT02200237|EV71 Vaccine|ev71 vaccine
182231|NCT02200211|Amblyopia|amblyopia
182232|NCT02200198|undernutrition|undernutrition
182233|NCT02200198|abdominal surgery|abdominal surgery
182234|NCT02200198|respiratory muscles|respiratory muscles
182235|NCT02200198|muscles strength|muscles strength
182236|NCT02200198|pulmonary complication|pulmonary complication
182237|NCT02200198|perioperative care|perioperative care
182238|NCT02200185|post traumatic pain|post traumatic pain
182239|NCT02200185|titrated morphine|titrated morphine
182240|NCT02200185|nebulised morphine|nebulised morphine
182241|NCT02200172|Cancer|cancer
182242|NCT02200172|Melatonin|melatonin
182243|NCT02200172|Delirium|delirium
182244|NCT02200172|Feasibility Studies|feasibility studies
182245|NCT02200172|Palliative Care|palliative care
182246|NCT02200159|Sedation|sedation
182247|NCT02200159|Dexmedetomidine|dexmedetomidine
182248|NCT02200159|ICU|icu
182249|NCT02200159|Delirium|delirium
182250|NCT02200146|sarcoidosis|sarcoidosis
182251|NCT02200146|treatment|treatment
182252|NCT02200146|lung|lung
182253|NCT02200146|glucocorticoids|glucocorticoids
182254|NCT02200146|hydroxychloroquine|hydroxychloroquine
182255|NCT02200133|Hematopoietic cell transplant (HCT) survivors|hematopoietic cell transplant (hct) survivors
182256|NCT02200133|Survivorship Care Plan|survivorship care plan
182257|NCT02200107|Osteoarthritis Knee|osteoarthritis knee
182258|NCT02200107|Self Care|self care
182259|NCT02200107|Treatment Outcome|treatment outcome
182260|NCT02200107|Patient Education as Topic|patient education as topic
182261|NCT02200107|Physical Therapy Modalities|physical therapy modalities
182262|NCT02200081|Extensive disease|extensive disease
182263|NCT02200081|After first line therapy|after first line therapy
182264|NCT02200081|Immuno therapy|immuno therapy
182265|NCT02200068|Perceived Efficacy of Patient Physician Interactions|perceived efficacy of patient physician interactions
182266|NCT02200068|Patient Reported Outcomes|patient reported outcomes
182267|NCT02200068|Personal Health Record|personal health record
182268|NCT02200055|Electrical Bioimpedance|electrical bioimpedance
182269|NCT02200055|Major Intra-abdominal Surgical Procedures|major intra-abdominal surgical procedures
182270|NCT02200055|Total Body Volume|total body volume
182271|NCT02200055|Fluid Resuscitation|fluid resuscitation
182272|NCT02200029|Intrahepatic Cholestasis|intrahepatic cholestasis
182273|NCT02200016|Postoperative pain|postoperative pain
182274|NCT02200016|Regional anesteshia|regional anesteshia
182275|NCT02200016|Nerve catheters|nerve catheters
182276|NCT02200016|Sciatic nerve catheters|sciatic nerve catheters
182277|NCT02200003|attention bias modification, anxiety, event-related potentials|attention bias modification, anxiety, event-related potentials
182381|NCT02199327|Interferon alfa 2b|interferon alfa 2b
182278|NCT02199990|cognitive function; propofol; etomidate;|cognitive function; propofol; etomidate;
182279|NCT02199977|Malaria|malaria
182280|NCT02199977|Antimalarial subsidy|antimalarial subsidy
182408|NCT02199262|music|music
182281|NCT02199977|Malaria rapid diagnostic test (RDT)|malaria rapid diagnostic test (rdt)
182282|NCT02199977|public-private partnership|public-private partnership
182283|NCT02199964|Dry eye|dry eye
182284|NCT02199964|environmental stress|environmental stress
182285|NCT02199964|artificial tears|artificial tears
182286|NCT02199964|cyclosporin|cyclosporin
182287|NCT02199964|Restasis|restasis
182288|NCT02199951|Uncomplicated Malaria|uncomplicated malaria
182289|NCT02199951|dihydroartemisinin|dihydroartemisinin
182290|NCT02199951|piperaquine|piperaquine
182291|NCT02199925|Autism|autism
182292|NCT02199925|Autism spectrum|autism spectrum
182293|NCT02199925|Autism children|autism children
182294|NCT02199912|cachexia|cachexia
182295|NCT02199912|nutrition|nutrition
182296|NCT02199912|cancer|cancer
182297|NCT02199912|colorectal tumor|colorectal tumor
182298|NCT02199834|diabetes|diabetes
182299|NCT02199834|peer support|peer support
402943|NCT01228942|ovarian cancer|ovarian cancer
182300|NCT02199834|personalized feedback report|personalized feedback report
182301|NCT02199795|stroke|stroke
182302|NCT02199795|hemiplegia|hemiplegia
182303|NCT02199795|footdrop|footdrop
182304|NCT02199795|electrical stimulation|electrical stimulation
182305|NCT02199769|Clinical decision support|clinical decision support
182306|NCT02199769|Diabetes screening|diabetes screening
182307|NCT02199756|Uterine contractions|uterine contractions
182308|NCT02199756|Indomethacin|indomethacin
182309|NCT02199756|Nanovectors|nanovectors
182310|NCT02199743|schizophrenia|schizophrenia
182311|NCT02199743|schizoaffective|schizoaffective
182312|NCT02199743|cognition|cognition
182313|NCT02199743|lurasidone|lurasidone
182314|NCT02199743|Latuda|latuda
182315|NCT02199717|Physical Activity|physical activity
182316|NCT02199717|Accelerometer|accelerometer
182317|NCT02199717|Exercise|exercise
182318|NCT02199717|Obesity|obesity
182319|NCT02199717|BMI|bmi
182320|NCT02199704|Parenting|parenting
182321|NCT02199704|Psychosis|psychosis
182322|NCT02199704|Schizophrenia|schizophrenia
182323|NCT02199704|Delusions|delusions
182324|NCT02199704|Hallucinations|hallucinations
182325|NCT02199691|Meningitis|meningitis
182326|NCT02199691|Meningococcal Meningitis|meningococcal meningitis
182327|NCT02199691|MenACYW conjugate vaccine|menacyw conjugate vaccine
182328|NCT02199691|MENVEO vaccine|menveo vaccine
182329|NCT02199691|Adacel®|adacel®
182330|NCT02199691|GARDASIL®|gardasil®
182331|NCT02199639|Haemophilia|haemophilia
182332|NCT02199639|Arthropathy|arthropathy
182333|NCT02199639|Range of Movement|range of movement
182334|NCT02199639|Strength|strength
182335|NCT02199639|Proprioception|proprioception
182336|NCT02199639|Gait|gait
182337|NCT02199639|Quality of Life|quality of life
182338|NCT02199613|HIV|hiv
182339|NCT02199613|antiretroviral therapy|antiretroviral therapy
182340|NCT02199587|Medical clown|medical clown
182341|NCT02199587|Growth hormone|growth hormone
182342|NCT02199587|Precocious puberty|precocious puberty
182343|NCT02199548|Adolescent|adolescent
182344|NCT02199548|Decision-making|decision-making
182345|NCT02199548|Social network|social network
182346|NCT02199535|operating room,|operating room,
182347|NCT02199535|risk factors|risk factors
182348|NCT02199535|anesthesiologists|anesthesiologists
182349|NCT02199509|Levetiracetam|levetiracetam
182350|NCT02199509|Cranial Dystonia|cranial dystonia
182351|NCT02199509|Oromandibular Dystonia|oromandibular dystonia
182352|NCT02199496|Malabsorption|malabsorption
182353|NCT02199496|Enteropathy|enteropathy
182354|NCT02199496|Diarrhea|diarrhea
182355|NCT02199496|IL-23|il-23
182356|NCT02199496|IL-12|il-12
182357|NCT02199483|Energy Expenditure|energy expenditure
182358|NCT02199483|Behavioral Weight Loss Treatment|behavioral weight loss treatment
182359|NCT02199483|Neurocognitive Function|neurocognitive function
182360|NCT02199483|Weight Loss|weight loss
182361|NCT02199470|β-CELLS,|β-cells,
182362|NCT02199470|MIXED MEAL TEST,|mixed meal test,
182363|NCT02199470|C-PEPTİDE|c-peptide
182364|NCT02199431|Lu AF11167|lu af11167
182365|NCT02199431|Interaction|interaction
182366|NCT02199405|Spondylosis, Massage Therapy, Exercise Therapy ,Treatment Efficacy|spondylosis, massage therapy, exercise therapy ,treatment efficacy
182367|NCT02199392|P-glycoprotein|p-glycoprotein
182368|NCT02199392|Healthy Volunteers|healthy volunteers
182369|NCT02199379|renal impairment|renal impairment
182370|NCT02199379|disease severity|disease severity
182371|NCT02199366|Cardiac MRI|cardiac mri
182372|NCT02199366|Radiation|radiation
182373|NCT02199366|Proton Radiation|proton radiation
182374|NCT02199366|Breast Cancer|breast cancer
182375|NCT02199353|Activities of daily living, Occupational Therapy, Dementia|activities of daily living, occupational therapy, dementia
182376|NCT02199340|Exercise testing|exercise testing
182377|NCT02199340|Children|children
182378|NCT02199340|Exercise capacity|exercise capacity
182379|NCT02199327|Conjunctival-corneal intraepithelial neoplasia|conjunctival-corneal intraepithelial neoplasia
182382|NCT02199314|intra|intra
182383|NCT02199314|operative|operative
182384|NCT02199314|neurophysiologic|neurophysiologic
182385|NCT02199314|monitoring|monitoring
182386|NCT02199314|transcranial|transcranial
182387|NCT02199314|motor|motor
182388|NCT02199314|evoked|evoked
182389|NCT02199314|potential|potential
182390|NCT02199314|anesthesia|anesthesia
182391|NCT02199314|pulses|pulses
182392|NCT02199301|Kidney transplantation|kidney transplantation
182393|NCT02199301|Tolerance induction|tolerance induction
182394|NCT02199301|Immunosuppression withdrawal|immunosuppression withdrawal
182395|NCT02199301|Bone marrow transplantation|bone marrow transplantation
182396|NCT02199301|Transplantation conditioning|transplantation conditioning
182397|NCT02199301|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
182398|NCT02199301|Living donor|living donor
182399|NCT02199301|Haplotype|haplotype
182400|NCT02199301|Immune tolerance|immune tolerance
182401|NCT02199275|Non-urgent surgery|non-urgent surgery
182402|NCT02199275|General anesthesia|general anesthesia
182403|NCT02199275|Enterocyte damage|enterocyte damage
182509|NCT02198911|Satiation|satiation
182404|NCT02199275|Intestinal fatty acid-binding protein|intestinal fatty acid-binding protein
182405|NCT02199262|Intensive care unit|intensive care unit
182406|NCT02199262|Incidents|incidents
182407|NCT02199262|prevention|prevention
182409|NCT02199262|reflexology|reflexology
182410|NCT02199249|open anatomic reduction|open anatomic reduction
182411|NCT02199249|syndesmosis screw fixation, syndesmosis Tightrope fixation|syndesmosis screw fixation, syndesmosis tightrope fixation
182412|NCT02199236|High-Dose-Rate Brachytherapy|high-dose-rate brachytherapy
182413|NCT02199236|oral capecitabine|oral capecitabine
182414|NCT02199236|infusional 5-FU|infusional 5-fu
182415|NCT02199236|Questionnaires|questionnaires
182416|NCT02199236|14-104|14-104
182417|NCT02199210|Massive transfusion protocols|massive transfusion protocols
182418|NCT02199210|Self-regulatory learning|self-regulatory learning
182419|NCT02199210|Forethought|forethought
182420|NCT02199210|Clinical expertise|clinical expertise
182421|NCT02199210|Simulation|simulation
182422|NCT02199210|Education|education
182423|NCT02199184|Leukemia|leukemia
182424|NCT02199184|Burkitt leukemia|burkitt leukemia
182425|NCT02199184|Burkitt-like leukemia/lymphoma|burkitt-like leukemia/lymphoma
182426|NCT02199184|Newly diagnosed|newly diagnosed
182427|NCT02199184|Relapsed/refractory|relapsed/refractory
182428|NCT02199184|Ofatumumab|ofatumumab
182429|NCT02199184|Arzerra|arzerra
182430|NCT02199184|Etoposide|etoposide
182431|NCT02199184|VePesid|vepesid
182432|NCT02199184|Doxorubicin|doxorubicin
182433|NCT02199184|Doxorubicin Hydrochloride|doxorubicin hydrochloride
182434|NCT02199184|Adriamycin PFS|adriamycin pfs
182435|NCT02199184|Adriamycin RDF|adriamycin rdf
182436|NCT02199184|Adriamycin|adriamycin
182437|NCT02199184|Rubex|rubex
182438|NCT02199184|Vincristine|vincristine
182439|NCT02199184|Cyclophosphamide|cyclophosphamide
182440|NCT02199184|Cytoxan|cytoxan
182441|NCT02199184|Neosar|neosar
182442|NCT02199184|Prednisone|prednisone
182443|NCT02199184|Rituximab|rituximab
182444|NCT02199184|Rituxan|rituxan
182445|NCT02199184|DA-EPOCH|da-epoch
182446|NCT02199184|Pegfilgrastim|pegfilgrastim
182447|NCT02199184|Neulasta|neulasta
182448|NCT02199184|PEG-G-CSF|peg-g-csf
182449|NCT02199184|G-CSF|g-csf
182450|NCT02199184|Filgrastim|filgrastim
182451|NCT02199184|Neupogen|neupogen
182452|NCT02199184|Phone calls|phone calls
182453|NCT02199171|hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) carboplatin|hyperthermic intraoperative intraperitoneal chemotherapy (hipec) carboplatin
182454|NCT02199171|intraperitoneal (IP) chemotherapy|intraperitoneal (ip) chemotherapy
182455|NCT02199171|cytoreductive surgery|cytoreductive surgery
182456|NCT02199158|iridoplasty|iridoplasty
182457|NCT02199158|angle|angle
182458|NCT02199158|glaucoma|glaucoma
182459|NCT02199158|anterior chamber|anterior chamber
182460|NCT02199158|laser treatment|laser treatment
182461|NCT02199132|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
182462|NCT02199119|children|children
182463|NCT02199119|television|television
182464|NCT02199119|exercise|exercise
182465|NCT02199119|food intake|food intake
182466|NCT02199119|appetite|appetite
182467|NCT02199119|satiation|satiation
182468|NCT02199093|MeSH terms:|mesh terms:
182469|NCT02199093|Apraxias|apraxias
182470|NCT02199093|Apraxia, Ideomotor|apraxia, ideomotor
182471|NCT02199093|Stroke|stroke
182472|NCT02199093|Cerebral Stroke|cerebral stroke
182473|NCT02199093|Rehabilitation|rehabilitation
182474|NCT02199093|Occupational therapy|occupational therapy
182475|NCT02199093|Treatment Outcome|treatment outcome
182476|NCT02199093|Activities of Daily Living|activities of daily living
182477|NCT02199054|Snack Foods|snack foods
182478|NCT02199054|Safflower Oil|safflower oil
182480|NCT02199054|Postmenopausal women|postmenopausal women
182481|NCT02199054|Metabolic Syndrome|metabolic syndrome
182482|NCT02199041|Cord Blood|cord blood
182483|NCT02199041|Haploidentical|haploidentical
182484|NCT02199041|Reduced Intensity Regimen|reduced intensity regimen
182485|NCT02199028|hyaluronidase|hyaluronidase
182486|NCT02199028|infusion sets|infusion sets
182487|NCT02199028|insulin pump|insulin pump
182488|NCT02199028|Continuous glucose monitor|continuous glucose monitor
182489|NCT02199015|Dysarthria|dysarthria
182490|NCT02199015|Electrical Stimulation|electrical stimulation
182491|NCT02199015|Lateral Cord Stimulation|lateral cord stimulation
182492|NCT02199015|Spasticity|spasticity
182493|NCT02199015|Treatment|treatment
182494|NCT02199002|acid pocket|acid pocket
182495|NCT02199002|GERD|gerd
182496|NCT02199002|Barrett|barrett
182497|NCT02198963|Skin irritation potential of RUT058-60.|skin irritation potential of rut058-60.
182498|NCT02198950|sepsis|sepsis
182499|NCT02198950|diagnosis|diagnosis
182500|NCT02198950|biomarker|biomarker
182501|NCT02198937|smokers|smokers
182502|NCT02198937|non-smokers|non-smokers
182503|NCT02198924|sequential administration|sequential administration
182504|NCT02198924|pain control|pain control
182505|NCT02198924|inflammation control|inflammation control
182506|NCT02198924|function recovery|function recovery
182507|NCT02198911|Habituation|habituation
182508|NCT02198911|Orosensory cues|orosensory cues
182510|NCT02198885|FAST|fast
182511|NCT02198885|Thoracoabdominal Trauma|thoracoabdominal trauma
182512|NCT02198885|Prehospital care|prehospital care
182513|NCT02198885|ultrasound|ultrasound
182514|NCT02198885|NanoMaxx Ultrasound|nanomaxx ultrasound
182515|NCT02198885|RP-Xpress|rp-xpress
182516|NCT02198872|Autonomic Nervous System, Body composition, Oxygen Uptake,|autonomic nervous system, body composition, oxygen uptake,
182517|NCT02198872|Water Based Physical Training, Land Based Physical Training.|water based physical training, land based physical training.
182518|NCT02198859|Prostate Cancer|prostate cancer
182519|NCT02198859|Lithium|lithium
182520|NCT02198859|Androgen|androgen
182522|NCT02198833|Urinary Tract Infection|urinary tract infection
182523|NCT02198833|Bacteriuria|bacteriuria
182524|NCT02198833|Transurethral Foley Catheter|transurethral foley catheter
182525|NCT02198833|Suprapubic Foley Catheter|suprapubic foley catheter
182526|NCT02198833|Spinal Cord injury|spinal cord injury
182527|NCT02198820|Femoral Neck Fractures|femoral neck fractures
182528|NCT02198820|Perioperative Care|perioperative care
182529|NCT02198820|Perioperative Period|perioperative period
182530|NCT02198820|Postoperative Complications|postoperative complications
182531|NCT02198794|Dyskinesias|dyskinesias
182532|NCT02198794|Movement Disorders|movement disorders
182533|NCT02198794|Central Nervous System Diseases|central nervous system diseases
182534|NCT02198794|Nervous System Diseases|nervous system diseases
182535|NCT02198794|Neurologic Manifestations|neurologic manifestations
182536|NCT02198794|Signs and Symptoms|signs and symptoms
182537|NCT02198781|atrial fibrilation|atrial fibrilation
182538|NCT02198781|atrial-ventricula|atrial-ventricula
182539|NCT02198781|right ventricle|right ventricle
182540|NCT02198781|left ventricle|left ventricle
182541|NCT02198781|surrogate marker|surrogate marker
182542|NCT02198781|ventricular dysfunction|ventricular dysfunction
182543|NCT02198781|pacing|pacing
182544|NCT02198768|ankle fracture|ankle fracture
182545|NCT02198768|ankle fracture-dislocation|ankle fracture-dislocation
182546|NCT02198768|prospective|prospective
182547|NCT02198768|observational|observational
182548|NCT02198755|high resolution ultrasound|high resolution ultrasound
182549|NCT02198755|osteomyelitis|osteomyelitis
182550|NCT02198716|Percutaneous coronary intervention|percutaneous coronary intervention
182551|NCT02198716|Elderly|elderly
182552|NCT02198716|Angina|angina
182553|NCT02198703|Probiotics|probiotics
182554|NCT02198703|AB-Life|ab-life
182555|NCT02198703|LDL-cholesterol|ldl-cholesterol
182556|NCT02198703|Hypercholesterolemia|hypercholesterolemia
182557|NCT02198690|Mammography, Older women, decision making|mammography, older women, decision making
182558|NCT02198664|Characterized Peanut Allergen|characterized peanut allergen
182559|NCT02198664|Peanut|peanut
182560|NCT02198664|OIT|oit
182561|NCT02198664|Oral Desensitization|oral desensitization
182562|NCT02198664|Peanut Allergen|peanut allergen
182563|NCT02198664|Peanut-Allergic Children|peanut-allergic children
182564|NCT02198664|Children|children
182565|NCT02198664|Peanut-Allergic Adults|peanut-allergic adults
182566|NCT02198651|Magnetic Resonance Imaging|magnetic resonance imaging
182567|NCT02198651|Taper|taper
182568|NCT02198651|Anti-rheumatic drugs|anti-rheumatic drugs
182569|NCT02198651|Arthritis|arthritis
182570|NCT02198651|Rheumatoid Arthritis|rheumatoid arthritis
182571|NCT02198651|Drug Level|drug level
182572|NCT02198651|Flare|flare
182573|NCT02198651|Ultrasound|ultrasound
182574|NCT02198651|Reduced dose|reduced dose
182575|NCT02198651|Remission|remission
182576|NCT02198651|Adalimumab|adalimumab
182577|NCT02198651|Biomarker|biomarker
182578|NCT02198638|Influenza|influenza
182579|NCT02198638|Vaccination rate|vaccination rate
182580|NCT02198638|Hospital acquired infection|hospital acquired infection
182581|NCT02198625|Moderate FiO2|moderate fio2
182582|NCT02198625|Protective lung ventilation|protective lung ventilation
182583|NCT02198625|Postoperative pulmonary complications|postoperative pulmonary complications
182681|NCT02198066|Sternal wound infection|sternal wound infection
182584|NCT02198625|Positive end-expiratory pressure|positive end-expiratory pressure
182585|NCT02198625|recruitment maneuvers|recruitment maneuvers
182586|NCT02198599|Multiple sclerosis|multiple sclerosis
182587|NCT02198599|Stroke|stroke
182588|NCT02198599|Nursing|nursing
182589|NCT02198599|Mobility|mobility
182590|NCT02198599|Rehabilitation|rehabilitation
182591|NCT02198586|Alzheimer's, MRI, APOE|alzheimer's, mri, apoe
182592|NCT02198573|malaria|malaria
182593|NCT02198573|K13|k13
182594|NCT02198573|pfmrp1|pfmrp1
182595|NCT02198573|Myanmar|myanmar
182596|NCT02198560|Normal (Eyes without pathologies)|normal (eyes without pathologies)
182597|NCT02198547|Local anesthetic adjuvant,|local anesthetic adjuvant,
182598|NCT02198547|Magnesium solfatus,|magnesium solfatus,
182599|NCT02198547|Sciatic block|sciatic block
182600|NCT02198534|visual acuity|visual acuity
182601|NCT02198534|Landolt C|landolt c
182602|NCT02198534|ETDRS charts|etdrs charts
182603|NCT02198534|Freiburg Visual Acuity Test|freiburg visual acuity test
222599|NCT02014935|pain,|pain,
182604|NCT02198534|FrACT|fract
182605|NCT02198534|Comparison|comparison
182606|NCT02198534|acceptance|acceptance
184059|NCT02191956|Early Onset|early onset
182607|NCT02198534|Test retest reliability|test retest reliability
182608|NCT02198534|duration|duration
182609|NCT02198534|questionnaire|questionnaire
200994|NCT02112656|Neoplasms by Histologic Type|neoplasms by histologic type
182610|NCT02198521|Patients undergoing staged bilateral open Carpal Tunnel Release (CTR) have no difference in overall pain intensity of pain between sides.|patients undergoing staged bilateral open carpal tunnel release (ctr) have no difference in overall pain intensity of pain between sides.
182611|NCT02198482|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
182612|NCT02198482|Volasertib|volasertib
182613|NCT02198482|High-risk Myelodysplastic Syndrome (MDS)|high-risk myelodysplastic syndrome (mds)
182614|NCT02198469|actinic cheilitis|actinic cheilitis
182615|NCT02198469|Er:YAG ablative fractional laser|er:yag ablative fractional laser
182616|NCT02198469|methyl aminolevulinate photodynamic therapy|methyl aminolevulinate photodynamic therapy
182617|NCT02198456|pulmonary arterial hypertension|pulmonary arterial hypertension
182618|NCT02198430|Haemophilia|haemophilia
182619|NCT02198430|Arthropathy|arthropathy
182620|NCT02198430|Range of motion|range of motion
182621|NCT02198430|Strength|strength
182622|NCT02198430|Proprioception|proprioception
182623|NCT02198430|Gait|gait
182624|NCT02198430|Quality of Life.|quality of life.
182625|NCT02198417|Polycystic Ovary Syndrome|polycystic ovary syndrome
182626|NCT02198417|PCOS|pcos
182627|NCT02198417|Acne|acne
182628|NCT02198417|Infertility|infertility
182629|NCT02198417|Irregular menses|irregular menses
182630|NCT02198417|Irregular period|irregular period
182631|NCT02198417|Mitochondria|mitochondria
182632|NCT02198417|Metabolism|metabolism
182633|NCT02198378|premixed nitrous oxide and oxygen|premixed nitrous oxide and oxygen
182634|NCT02198378|pain|pain
182635|NCT02198378|prehospital setting|prehospital setting
182636|NCT02198378|acute coronary syndrome|acute coronary syndrome
182637|NCT02198365|mRNA,|mrna,
182638|NCT02198365|DNA,|dna,
182639|NCT02198365|integrated HPV DNA|integrated hpv dna
182640|NCT02198365|human papillomavirus,|human papillomavirus,
182641|NCT02198365|cervical neoplasia|cervical neoplasia
182642|NCT02198300|dedicated bifurcation stent|dedicated bifurcation stent
182643|NCT02198300|sirolimus eluting stent|sirolimus eluting stent
182644|NCT02198261|alopecia|alopecia
182645|NCT02198261|androgenetic alopecia|androgenetic alopecia
182646|NCT02198261|hair loss|hair loss
182647|NCT02198261|minoxidil|minoxidil
182648|NCT02198261|5% minoxidil foam|5% minoxidil foam
182649|NCT02198261|male pattern hair loss|male pattern hair loss
182650|NCT02198209|liraglutide|liraglutide
182651|NCT02198209|GLP-1|glp-1
182652|NCT02198209|liver glucokinase|liver glucokinase
182653|NCT02198170|Healthy Volunteers|healthy volunteers
182654|NCT02198157|duration of second stage|duration of second stage
182655|NCT02198157|urinary catheterization|urinary catheterization
182656|NCT02198157|epidural anaesthesia|epidural anaesthesia
182657|NCT02198144|Hypertension|hypertension
182658|NCT02198144|High Blood Pressure|high blood pressure
182659|NCT02198144|African American Men|african american men
182660|NCT02198144|Black Men|black men
182661|NCT02198118|breast cancer|breast cancer
182662|NCT02198118|physiotherapy|physiotherapy
182663|NCT02198118|radiotherapy|radiotherapy
182664|NCT02198105|PAD|pad
182665|NCT02198105|femoropoliteal stenosis/occlusion|femoropoliteal stenosis/occlusion
182666|NCT02198105|cutting-balloon|cutting-balloon
182667|NCT02198105|drug-coated-balloon|drug-coated-balloon
182668|NCT02198092|familial adenomatous polyposis|familial adenomatous polyposis
182669|NCT02198092|multiple adenomatous polyposis|multiple adenomatous polyposis
182670|NCT02198092|lynch syndrome|lynch syndrome
182671|NCT02198092|hnpcc|hnpcc
182672|NCT02198092|colorectal cancer|colorectal cancer
182673|NCT02198092|genetic syndrome|genetic syndrome
182674|NCT02198092|epigenomics|epigenomics
182675|NCT02198092|septin9|septin9
182676|NCT02198079|non-tuberculous mycobacteria|non-tuberculous mycobacteria
182677|NCT02198079|Pediatrics|pediatrics
182678|NCT02198079|Cystic Fibrosis|cystic fibrosis
182679|NCT02198066|Sternotomy incision|sternotomy incision
182680|NCT02198066|Silver dressing|silver dressing
182682|NCT02198040|Elbow|elbow
182683|NCT02198040|Joint disease|joint disease
182684|NCT02198040|Hemophilia|hemophilia
182685|NCT02198040|Physiotherapy modalities|physiotherapy modalities
182686|NCT02198027|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
182687|NCT02198027|postoperative analgesia|postoperative analgesia
182688|NCT02198027|peritubal block|peritubal block
182689|NCT02198027|pain|pain
182690|NCT02198027|Visual Analog Pain Scale|visual analog pain scale
182691|NCT02198014|Knee|knee
182692|NCT02198014|Joint disease|joint disease
182693|NCT02198014|Haemophilia|haemophilia
182694|NCT02198014|Physiotherapy modalities|physiotherapy modalities
182695|NCT02198001|Platelets|platelets
182696|NCT02198001|fibrin|fibrin
182697|NCT02198001|growth factors|growth factors
222717|NCT02014519|Adults|adults
182698|NCT02198001|bisphosphonates|bisphosphonates
182699|NCT02198001|tooth extraction|tooth extraction
182700|NCT02197988|Surgery|surgery
182701|NCT02197988|Abdominal|abdominal
182702|NCT02197988|Epidural Anesthesia|epidural anesthesia
182703|NCT02197988|Transversus Abdominis Plane Block|transversus abdominis plane block
182704|NCT02197988|TAP block|tap block
182705|NCT02197975|Healthy Volunteers|healthy volunteers
182706|NCT02197962|Osteoarthritis|osteoarthritis
182707|NCT02197962|Radial shockwaves|radial shockwaves
182708|NCT02197936|Peristalsis|peristalsis
182709|NCT02197936|ultrasound|ultrasound
182710|NCT02197923|Menorrhagia|menorrhagia
182711|NCT02197923|Dysmenorrhea|dysmenorrhea
182712|NCT02197923|Pelvic pain|pelvic pain
182713|NCT02197923|expression profiling|expression profiling
182714|NCT02197923|uterine biopsies|uterine biopsies
182715|NCT02197923|serum hormones|serum hormones
182716|NCT02197897|Tamoxifen citrate|tamoxifen citrate
182717|NCT02197897|Bladder Cancer|bladder cancer
182718|NCT02197884|Healthy|healthy
182719|NCT02197884|JNJ-54861911|jnj-54861911
182720|NCT02197884|Cytochrome P450 3A4 inhibitor|cytochrome p450 3a4 inhibitor
182721|NCT02197884|Itraconazole|itraconazole
182722|NCT02197884|Clarithromycin|clarithromycin
182723|NCT02197884|Alzheimer's disease|alzheimer's disease
182724|NCT02197871|COPD|copd
182725|NCT02197871|malnutrition|malnutrition
182726|NCT02197871|nutrition supplementation|nutrition supplementation
182727|NCT02197858|invasive arterial pressure|invasive arterial pressure
182728|NCT02197858|extended hemodynamic monitoring|extended hemodynamic monitoring
182729|NCT02197858|propofol|propofol
182730|NCT02197858|remifentanil|remifentanil
182731|NCT02197845|sickle cell disease|sickle cell disease
182732|NCT02197845|hydroxyurea|hydroxyurea
182733|NCT02197845|patient navigator|patient navigator
182734|NCT02197845|community health worker|community health worker
182735|NCT02197845|public health worker|public health worker
182736|NCT02197845|fetal hemoglobin|fetal hemoglobin
182737|NCT02197845|health services research|health services research
182738|NCT02197832|Frozen thawed embryo transfer|frozen thawed embryo transfer
182739|NCT02197832|Endometrial injury|endometrial injury
182740|NCT02197832|Ongoing pregnancy rates|ongoing pregnancy rates
182741|NCT02197780|Diagnostic accuracy|diagnostic accuracy
182742|NCT02197780|Fecal biomarker|fecal biomarker
182743|NCT02197780|Clinical Decision Rule|clinical decision rule
182744|NCT02197780|Cohort Study|cohort study
182745|NCT02197767|fibrillary GN|fibrillary gn
182746|NCT02197767|rituximab|rituximab
182747|NCT02197767|Rituxan|rituxan
182748|NCT02197767|MabThera|mabthera
182749|NCT02197767|Zytux|zytux
182750|NCT02197754|pharmacokinetics|pharmacokinetics
182751|NCT02197754|polyphenol metabolites|polyphenol metabolites
182752|NCT02197754|lean individuals|lean individuals
182753|NCT02197754|obese individuals|obese individuals
182754|NCT02197728|hysterectomy, uterine manipulator, thermal damage, laparoscopy, colpotomy|hysterectomy, uterine manipulator, thermal damage, laparoscopy, colpotomy
182755|NCT02197715|Pregnancy|pregnancy
182756|NCT02197715|Contraceptive Methods|contraceptive methods
182757|NCT02197715|Family Planning Services|family planning services
182758|NCT02197702|RCT|rct
182759|NCT02197702|asthma|asthma
182760|NCT02197702|pediatric|pediatric
182761|NCT02197702|virus|virus
182762|NCT02197702|corticosteroid|corticosteroid
182763|NCT02197689|Personalized Medication Management|personalized medication management
182764|NCT02197689|Medication Adherence|medication adherence
182765|NCT02197689|SMS Medication Reminder|sms medication reminder
182766|NCT02197663|acupuncture|acupuncture
182767|NCT02197663|stroke|stroke
182768|NCT02197663|Randomized Controlled Trial|randomized controlled trial
182769|NCT02197650|ALL L-asparaginase encapsulated erythrocytes|all l-asparaginase encapsulated erythrocytes
182770|NCT02197624|Non-heme iron absorption; HFE|non-heme iron absorption; hfe
182771|NCT02197611|Haemophilia|haemophilia
182772|NCT02197611|Adherence of Treatment|adherence of treatment
182773|NCT02197611|Knowledge of Illness|knowledge of illness
182774|NCT02197611|Medical-patient Relationship|medical-patient relationship
182775|NCT02197611|Illness Behavior|illness behavior
182776|NCT02197611|Treatment Difficulties.|treatment difficulties.
182777|NCT02197598|nalmefene, alcohol consumption, liver effects|nalmefene, alcohol consumption, liver effects
182778|NCT02197585|Male patients|male patients
182779|NCT02197585|Age > 18 year|age > 18 year
182780|NCT02197585|Primary hernia|primary hernia
182781|NCT02197585|glue|glue
182782|NCT02197572|Drug therapy|drug therapy
182900|NCT02196961|Merkel cell carcinoma|merkel cell carcinoma
182783|NCT02197559|Ischemic Stroke, restenosis,bare-metal stents, drug -eluting stents|ischemic stroke, restenosis,bare-metal stents, drug -eluting stents
182784|NCT02197546|Injection pain|injection pain
182785|NCT02197546|local anesthesia|local anesthesia
182786|NCT02197546|acupuncture|acupuncture
182787|NCT02197481|BiClamp forceps hepatectomy|biclamp forceps hepatectomy
182788|NCT02197481|Clamp crushing technique|clamp crushing technique
182789|NCT02197481|Liver parenchyma transection|liver parenchyma transection
182790|NCT02197481|Randomized controlled trial|randomized controlled trial
182791|NCT02197468|Gut microbiome|gut microbiome
182792|NCT02197468|Necrotizing enterocolitis|necrotizing enterocolitis
182793|NCT02197468|Antibiotics|antibiotics
182794|NCT02197429|Vulvodynia|vulvodynia
182795|NCT02197429|Acupuncture|acupuncture
182796|NCT02197429|Provoked Vestibulodynia|provoked vestibulodynia
182797|NCT02197429|Vulvar Vestibulitis|vulvar vestibulitis
182798|NCT02197429|Vulvar Pain|vulvar pain
182799|NCT02197429|Dyspareunia|dyspareunia
182800|NCT02197429|Female Sexual Function|female sexual function
182801|NCT02197403|Dexmedetomidine|dexmedetomidine
182802|NCT02197403|Sedation|sedation
182803|NCT02197403|Paradoxical excitement response|paradoxical excitement response
182804|NCT02197403|Alcohol drinkers|alcohol drinkers
182805|NCT02197390|Childhood obesity|childhood obesity
182807|NCT02197390|Hispanic|hispanic
182808|NCT02197377|Laryngeal mask airway, edentulous geriatric patient|laryngeal mask airway, edentulous geriatric patient
182809|NCT02197364|Interstitial Lung Disease|interstitial lung disease
182810|NCT02197364|Diagnosis|diagnosis
182811|NCT02197364|Krebs Von Den Lungen-6|krebs von den lungen-6
182812|NCT02197351|stomach neoplasms|stomach neoplasms
182813|NCT02197351|narrow band imaging|narrow band imaging
182814|NCT02197351|gastroscopy|gastroscopy
182815|NCT02197338|cholangiopancreatography, endoscopic retrograde|cholangiopancreatography, endoscopic retrograde
182816|NCT02197325|NSTEMI and STEMI|nstemi and stemi
182817|NCT02197312|yttrium-oxide|yttrium-oxide
182818|NCT02197312|Y-TZP|y-tzp
182819|NCT02197312|bridge|bridge
182820|NCT02197312|NobelProcera|nobelprocera
182821|NCT02197312|Shaded Zirconia|shaded zirconia
182822|NCT02197273|Total knee arthroplasty|total knee arthroplasty
182823|NCT02197273|Total shoulder arthroplasty|total shoulder arthroplasty
182824|NCT02197273|Total hip arthroplasty|total hip arthroplasty
182825|NCT02197273|Total joint arthroplasty|total joint arthroplasty
182826|NCT02197273|Hip replacement|hip replacement
182827|NCT02197273|Knee replacement|knee replacement
182828|NCT02197273|Shoulder replacement|shoulder replacement
182829|NCT02197260|Periodontitis|periodontitis
182830|NCT02197260|amoxicillin|amoxicillin
182831|NCT02197260|metronidazole|metronidazole
182832|NCT02197260|case management|case management
182833|NCT02197247|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, rifampicin, CYP P450 inducer, EGFR genes|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, rifampicin, cyp p450 inducer, egfr genes
182834|NCT02197234|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, simvastatin, EGFR genes|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, simvastatin, egfr genes
182835|NCT02197208|Frozen-thawed embryo transfer|frozen-thawed embryo transfer
182836|NCT02197208|natural cycle|natural cycle
182837|NCT02197208|spontaneous ovulation|spontaneous ovulation
182838|NCT02197208|hCG induced natural cycles|hcg induced natural cycles
182839|NCT02197182|Bacterial Vaginosis (BV)|bacterial vaginosis (bv)
182840|NCT02197182|Amsel's criteria|amsel's criteria
182841|NCT02197182|Pap smear|pap smear
182842|NCT02197169|Brain|brain
182843|NCT02197169|Brain Cancer|brain cancer
182844|NCT02197169|Brain Neoplasms|brain neoplasms
182845|NCT02197169|Central Nervous System Diseases|central nervous system diseases
182846|NCT02197169|Central Nervous System Neoplasms|central nervous system neoplasms
182847|NCT02197169|CNS|cns
182848|NCT02197169|Conditionally Replication-Competent Adenovirus|conditionally replication-competent adenovirus
182849|NCT02197169|DNX-2401|dnx-2401
182850|NCT02197169|Delta-24-RGD|delta-24-rgd
182851|NCT02197169|Glioma|glioma
182852|NCT02197169|Glioblastoma|glioblastoma
182853|NCT02197169|Gliosarcoma|gliosarcoma
182854|NCT02197169|Interferon gamma|interferon gamma
182855|NCT02197169|Malignant brain tumor|malignant brain tumor
182856|NCT02197169|Neoplasms, Neuroepithelial|neoplasms, neuroepithelial
182857|NCT02197169|Neuroectodermal Tumors|neuroectodermal tumors
182858|NCT02197169|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
182859|NCT02197169|Neoplasms by Histologic Type|neoplasms by histologic type
182860|NCT02197169|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
182861|NCT02197169|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
182862|NCT02197169|Nervous System Diseases|nervous system diseases
182863|NCT02197169|Alcyone Lifesciences|alcyone lifesciences
182864|NCT02197169|AMC™|amc™
182865|NCT02197169|Cannula|cannula
182866|NCT02197169|Alcyone MEMS Cannula (AMC™) System|alcyone mems cannula (amc™) system
182867|NCT02197143|esomeprazole|esomeprazole
182868|NCT02197143|ranitidine|ranitidine
182869|NCT02197143|hydrotalcid|hydrotalcid
183166|NCT02195778|UAE|uae
182870|NCT02197143|treatment of dyspepsia|treatment of dyspepsia
182871|NCT02197143|emergancy medicine|emergancy medicine
182872|NCT02197130|Huntington; chorea; total motor score; CAG repeat: total functional capacity; motor cognitive and behavioral symptoms|huntington; chorea; total motor score; cag repeat: total functional capacity; motor cognitive and behavioral symptoms
182873|NCT02197117|ST-segment elevation myocardial infarction (STEMI); thrombolysis, remote ischemic conditioning, myocardial infarct size, cardioprotection|st-segment elevation myocardial infarction (stemi); thrombolysis, remote ischemic conditioning, myocardial infarct size, cardioprotection
182874|NCT02197065|hip fracture|hip fracture
182875|NCT02197065|myocardial ischemia|myocardial ischemia
182876|NCT02197065|statin|statin
182877|NCT02197065|surgery|surgery
182878|NCT02197065|troponin|troponin
182879|NCT02197065|complication|complication
182880|NCT02197065|arthroplasty|arthroplasty
182881|NCT02197065|hip|hip
182882|NCT02197065|knee|knee
182883|NCT02197065|orthopedic|orthopedic
182884|NCT02197065|atorvastatin|atorvastatin
182885|NCT02197065|cardiovascular|cardiovascular
182886|NCT02197039|Peptic ulcer hemorrhage, second-look endoscopy|peptic ulcer hemorrhage, second-look endoscopy
182887|NCT02197000|BRCA mutation|brca mutation
182888|NCT02197000|Breast cancer|breast cancer
182889|NCT02197000|Estrogen metabolism|estrogen metabolism
182890|NCT02197000|3,3-Diindolylmethane|3,3-diindolylmethane
182891|NCT02197000|Breast density|breast density
182892|NCT02196987|Pain|pain
182893|NCT02196987|Catheter|catheter
182894|NCT02196987|Urethra|urethra
182895|NCT02196987|Urination|urination
182896|NCT02196974|bronchoscopy|bronchoscopy
182897|NCT02196974|lung nodule|lung nodule
182898|NCT02196974|diagnosis|diagnosis
182899|NCT02196974|cryobiopsy|cryobiopsy
182901|NCT02196961|Adjuvant|adjuvant
182902|NCT02196961|Nivolumab|nivolumab
182903|NCT02196961|Ipilimumab|ipilimumab
182904|NCT02196948|Supraspinatus, tendinopathy, pain, disability, EPTE|supraspinatus, tendinopathy, pain, disability, epte
182905|NCT02196935|Cholangitis|cholangitis
182906|NCT02196935|Choledocholithiasis|choledocholithiasis
182907|NCT02196935|Gastrointestinal Neoplasms|gastrointestinal neoplasms
182908|NCT02196935|Medically underserved area|medically underserved area
182909|NCT02196935|Anesthesia|anesthesia
182910|NCT02196922|Chronic Heart Failure|chronic heart failure
182911|NCT02196922|Telehealth|telehealth
182912|NCT02196922|Self Management|self management
182913|NCT02196909|HIBM|hibm
182914|NCT02196909|GNE|gne
182915|NCT02196870|Airway pressure stress index|airway pressure stress index
182916|NCT02196870|Transpulmonary pressure stress index|transpulmonary pressure stress index
182917|NCT02196870|Acute Respiratory Failure|acute respiratory failure
182918|NCT02196870|Chest wall elastance|chest wall elastance
182919|NCT02196870|Lung stress|lung stress
182920|NCT02196857|Leukemia|leukemia
182921|NCT02196857|Acute myeloid leukemia|acute myeloid leukemia
182922|NCT02196857|AML|aml
182923|NCT02196857|High risk myelodysplastic syndrome|high risk myelodysplastic syndrome
182924|NCT02196857|MDS|mds
182925|NCT02196857|FLT3-ITD mutation|flt3-itd mutation
182926|NCT02196857|Azacytidine|azacytidine
182927|NCT02196857|5-Azacytidine|5-azacytidine
182928|NCT02196857|5-AZA|5-aza
182929|NCT02196857|Vidaza|vidaza
182930|NCT02196857|5-AZC|5-azc
182931|NCT02196857|AZA-CR|aza-cr
182932|NCT02196857|Ladakamycin|ladakamycin
182933|NCT02196857|NSC-102816|nsc-102816
182934|NCT02196857|Sorafenib|sorafenib
182935|NCT02196857|Nexavar|nexavar
182936|NCT02196857|BAY 43-9006|bay 43-9006
182937|NCT02196844|Lung cancer|lung cancer
182938|NCT02196844|Hatha Yoga|hatha yoga
182939|NCT02196844|Questionnaires|questionnaires
182940|NCT02196844|Surveys|surveys
182941|NCT02196844|Walk Test|walk test
182942|NCT02196844|Caregiver|caregiver
182943|NCT02196831|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
182944|NCT02196831|Nonalcoholic fatty liver disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
182945|NCT02196831|Nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
182946|NCT02196831|Growth hormone releasing hormone|growth hormone releasing hormone
182947|NCT02196831|tesamorelin|tesamorelin
182948|NCT02196805|bioequivalence|bioequivalence
182949|NCT02196805|imported PROBUCOL table|imported probucol table
182950|NCT02196805|Lorelco|lorelco
182951|NCT02196805|marketed PROBUCOL tablet|marketed probucol tablet
182952|NCT02196805|Chang Tai|chang tai
182953|NCT02196792|Joint Diseases|joint diseases
182954|NCT02196792|Musculoskeletal Diseases|musculoskeletal diseases
182955|NCT02196792|radiostereometric analysis|radiostereometric analysis
182956|NCT02196792|Total hip arthroplasty|total hip arthroplasty
182957|NCT02196779|Abdominoplasty|abdominoplasty
182958|NCT02196779|circulation|circulation
182959|NCT02196779|skin|skin
182960|NCT02196779|dissection|dissection
182961|NCT02196779|laser|laser
182962|NCT02196779|fluorescence|fluorescence
182963|NCT02196779|imaging|imaging
182964|NCT02196753|Positron emission tomography combined with computed tomography|positron emission tomography combined with computed tomography
182965|NCT02196753|PET CT|pet ct
182966|NCT02196753|Cardiovascular Implantable Electronic Device|cardiovascular implantable electronic device
667646|NCT00841165|Oxygen|oxygen
182967|NCT02196753|Infective endocarditis|infective endocarditis
182968|NCT02196753|Generator pocket infection|generator pocket infection
182969|NCT02196753|Fever of unknown origin|fever of unknown origin
182970|NCT02196740|periapical periodontitis,primary teeth|periapical periodontitis,primary teeth
182971|NCT02196727|Postoperative pain|postoperative pain
182972|NCT02196727|Multimodal analgesia|multimodal analgesia
182973|NCT02196727|Bascom Cleft Lift|bascom cleft lift
182974|NCT02196727|Day-case.|day-case.
182975|NCT02196714|Japanese Healthy Volunteers|japanese healthy volunteers
182976|NCT02196701|methotrexate|methotrexate
182977|NCT02196701|adalimumab|adalimumab
182978|NCT02196701|biologic|biologic
182979|NCT02196701|psoriasis|psoriasis
182980|NCT02196701|Tumor necrosis factor (TNF)-α inhibitor|tumor necrosis factor (tnf)-α inhibitor
182981|NCT02196688|subjects with mCRC who failed at least 2nd line therapy|subjects with mcrc who failed at least 2nd line therapy
182982|NCT02196610|End-Stage Renal Disease,|end-stage renal disease,
182983|NCT02196610|arterial or vascular stiffness,|arterial or vascular stiffness,
182984|NCT02196610|hemodialysis,|hemodialysis,
182985|NCT02196610|Pulse wave velocity|pulse wave velocity
182986|NCT02196610|Renal insufficiency,|renal insufficiency,
182987|NCT02196610|tonometry|tonometry
182988|NCT02196597|anorectal manometry|anorectal manometry
182989|NCT02196571|GDM|gdm
182990|NCT02196571|Exercise|exercise
182991|NCT02196571|Diabetes|diabetes
182992|NCT02196571|Pregnancy|pregnancy
182993|NCT02196558|Rheumatoid Arthritis|rheumatoid arthritis
182994|NCT02196558|Japanese subjects|japanese subjects
182995|NCT02196532|retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
182996|NCT02196532|optical coherence tomography|optical coherence tomography
182997|NCT02196532|migraine|migraine
182998|NCT02196506|OPC-34712|opc-34712
182999|NCT02196506|brexpiprazole|brexpiprazole
183000|NCT02196506|Major Depressive Disorder|major depressive disorder
183001|NCT02196506|Adjunctive Treatment|adjunctive treatment
183002|NCT02196506|Anxious Distress|anxious distress
183003|NCT02196493|Productive|productive
183004|NCT02196493|Cough|cough
183005|NCT02196493|Bronchitis|bronchitis
183006|NCT02196493|Azithromycin|azithromycin
183007|NCT02196467|myoblast|myoblast
183008|NCT02196467|transplantation|transplantation
183009|NCT02196467|strength|strength
183010|NCT02196467|tacrolimus|tacrolimus
183011|NCT02196467|immunosuppression|immunosuppression
183012|NCT02196454|HPV vaccine|hpv vaccine
183013|NCT02196454|vaccination|vaccination
183014|NCT02196454|immunization|immunization
183015|NCT02196454|video|video
183016|NCT02196454|health education|health education
183017|NCT02196454|communication|communication
183018|NCT02196441|deep topical fornix nerve block|deep topical fornix nerve block
183019|NCT02196441|topical anesthesia|topical anesthesia
183020|NCT02196441|implantable contact lens procedure|implantable contact lens procedure
183021|NCT02196428|Ambient Assisted Living (AAL)|ambient assisted living (aal)
183022|NCT02196428|Telemonitoring|telemonitoring
183023|NCT02196428|Teleconsultation|teleconsultation
183024|NCT02196415|Hindfoot Alignment|hindfoot alignment
183025|NCT02196415|Rearfoot|rearfoot
183026|NCT02196415|Malalignment|malalignment
183027|NCT02196415|biplanar radiography|biplanar radiography
183028|NCT02196415|3D measurement|3d measurement
183029|NCT02196376|Postural orthostatic syndrome|postural orthostatic syndrome
183030|NCT02196376|orthostatic intolerance|orthostatic intolerance
183031|NCT02196376|autonomic dysfunction|autonomic dysfunction
183032|NCT02196350|personalized treatment|personalized treatment
183033|NCT02196350|prevention|prevention
183034|NCT02196350|improved diagnosis|improved diagnosis
183035|NCT02196337|Iodine deficiency|iodine deficiency
183036|NCT02196324|Prurigo Nodularis|prurigo nodularis
183037|NCT02196324|Atopic Dermatitis|atopic dermatitis
183038|NCT02196324|Lichen-simplex chronicus|lichen-simplex chronicus
183039|NCT02196311|Supracondylar humerus fractures, external fixation, open reduction, and internal fixation.|supracondylar humerus fractures, external fixation, open reduction, and internal fixation.
183040|NCT02196298|physical therapy|physical therapy
183041|NCT02196298|gait|gait
183042|NCT02196298|pediatric rehabilitation|pediatric rehabilitation
183043|NCT02196298|gross motor function|gross motor function
183044|NCT02196298|participation|participation
183045|NCT02196285|Double|double
183046|NCT02196285|Viral|viral
183047|NCT02196285|Vaccine|vaccine
183048|NCT02196285|Measles|measles
183049|NCT02196285|Rubella|rubella
183050|NCT02196285|Safety|safety
183051|NCT02196285|Efficacy|efficacy
183052|NCT02196285|Imunogenicity|imunogenicity
183053|NCT02196259|Pre-Post|pre-post
183054|NCT02196233|Trigger Finger|trigger finger
183055|NCT02196233|Prospective Clinical Research|prospective clinical research
183056|NCT02196233|Randomized|randomized
183057|NCT02196233|Questionnaires|questionnaires
183058|NCT02196233|Transverse|transverse
183059|NCT02196233|Longitudinal|longitudinal
183060|NCT02196207|Severe Hemophilia A|severe hemophilia a
183061|NCT02196207|Previously Untreated Patients|previously untreated patients
668335|NCT00850265|Asthma|asthma
183062|NCT02196207|Hemophilia Inhibitor Formation|hemophilia inhibitor formation
183063|NCT02196207|Long-Acting Factor VIII|long-acting factor viii
183064|NCT02196207|Prophylaxis|prophylaxis
183065|NCT02196155|plantar fasciitis|plantar fasciitis
183066|NCT02196155|Botulinum toxin A|botulinum toxin a
183067|NCT02196155|Cortisone|cortisone
183068|NCT02196155|RCT|rct
183069|NCT02196142|Cortisol|cortisol
183070|NCT02196142|Alcohol Craving|alcohol craving
183071|NCT02196142|Alcohol Dependence|alcohol dependence
183072|NCT02196129|low back pain|low back pain
183073|NCT02196129|pharmacoacupuncture|pharmacoacupuncture
183074|NCT02196129|sinbaro-3|sinbaro-3
183075|NCT02196116|Alzheimer disease|alzheimer disease
183076|NCT02196116|amyloid load|amyloid load
183077|NCT02196116|educational level|educational level
183078|NCT02196116|cognitive performances|cognitive performances
183079|NCT02196103|TOLAC|tolac
183080|NCT02196103|PROM|prom
183081|NCT02196103|Previous Cesarian section|previous cesarian section
184365|NCT02190591|pregnant|pregnant
183082|NCT02196103|Mechanical cervical ripening|mechanical cervical ripening
183083|NCT02196090|OCD, Exposure and Response Prevention, Vagal Stimulation|ocd, exposure and response prevention, vagal stimulation
183084|NCT02196077|Budesonide and formoterol inhalation aerosol|budesonide and formoterol inhalation aerosol
183085|NCT02196064|HIV HCV antiretroviral|hiv hcv antiretroviral
183086|NCT02196051|Insulin resistance|insulin resistance
183087|NCT02196051|Exercise|exercise
183088|NCT02196051|de novo lipogenesis|de novo lipogenesis
183089|NCT02196051|NAFLD|nafld
183090|NCT02196051|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
183091|NCT02196038|heart failure|heart failure
183092|NCT02196025|Insomnia|insomnia
183093|NCT02196012|overweight|overweight
183094|NCT02196012|obesity|obesity
183095|NCT02196012|Technology|technology
183096|NCT02196012|College Students|college students
183097|NCT02195986|vaginal dryness|vaginal dryness
183098|NCT02195986|vaginal and/or vulvar irritation/itching|vaginal and/or vulvar irritation/itching
183099|NCT02195986|dysuria|dysuria
183100|NCT02195986|vaginal pain and bleeding associated with sexual activity|vaginal pain and bleeding associated with sexual activity
183101|NCT02195986|vaginal atrophy|vaginal atrophy
183102|NCT02195973|ovarian cancer|ovarian cancer
183103|NCT02195973|platinum resistant|platinum resistant
183104|NCT02195973|LED225|led225
183105|NCT02195973|Sonidegib|sonidegib
183106|NCT02195973|Paclitaxel|paclitaxel
183107|NCT02195960|skin toxicity, radiotherapy, antioxidants|skin toxicity, radiotherapy, antioxidants
183108|NCT02195947|Growth hormone|growth hormone
183109|NCT02195947|IVF/ICSI|ivf/icsi
183110|NCT02195947|Poor responder|poor responder
183111|NCT02195947|Antagonist protocol|antagonist protocol
183112|NCT02195934|Cardiovascular disease, blood orange juice, anthocyanins|cardiovascular disease, blood orange juice, anthocyanins
183113|NCT02195895|Teriparatide|teriparatide
183114|NCT02195895|Alendronate|alendronate
183115|NCT02195895|Alendronic Acid|alendronic acid
183116|NCT02195895|Osteoporosis|osteoporosis
183117|NCT02195895|Bone Fracture|bone fracture
183118|NCT02195895|Bone Loss|bone loss
183119|NCT02195895|Spinal Cord Injury|spinal cord injury
183120|NCT02195895|Bone Diseases|bone diseases
183121|NCT02195895|Metabolic Bone Diseases|metabolic bone diseases
183122|NCT02195895|Musculoskeletal Diseases|musculoskeletal diseases
183123|NCT02195895|Spinal Cord Diseases|spinal cord diseases
183124|NCT02195895|Central Nervous System Diseases|central nervous system diseases
183125|NCT02195895|Nervous System Diseases|nervous system diseases
183126|NCT02195895|Nervous System|nervous system
183127|NCT02195895|Wounds and Injuries|wounds and injuries
183128|NCT02195895|Bone Density Conservation Agents|bone density conservation agents
183129|NCT02195895|Physiological Effects of Drugs|physiological effects of drugs
183130|NCT02195895|Pharmacologic Actions|pharmacologic actions
183131|NCT02195882|strength training|strength training
183132|NCT02195882|scapular stabilization|scapular stabilization
183133|NCT02195882|kayakers.|kayakers.
183134|NCT02195869|PCYC1129|pcyc1129
183135|NCT02195869|PCYC1129CA|pcyc1129ca
183136|NCT02195869|1129|1129
183137|NCT02195869|Ibrutinib|ibrutinib
183138|NCT02195869|PCI32765|pci32765
183139|NCT02195869|IMBRUVICA|imbruvica
183140|NCT02195869|Pharmacyclics|pharmacyclics
183141|NCT02195869|PCYC|pcyc
183142|NCT02195869|GVHD|gvhd
183143|NCT02195869|Steroid dependent|steroid dependent
183144|NCT02195869|refractory|refractory
183145|NCT02195869|chronic|chronic
183146|NCT02195869|graft versus host disease|graft versus host disease
183147|NCT02195869|chronic graft versus host disease|chronic graft versus host disease
183148|NCT02195869|immunology|immunology
183149|NCT02195856|Diabetes|diabetes
183150|NCT02195856|Nitrate|nitrate
183151|NCT02195856|Nitrite|nitrite
183152|NCT02195856|Hepatic|hepatic
183153|NCT02195856|MRI|mri
183154|NCT02195856|Incretin|incretin
183155|NCT02195856|Insulin|insulin
183156|NCT02195856|Glucose|glucose
183157|NCT02195843|CRT-D|crt-d
183158|NCT02195843|Heart Failure|heart failure
183159|NCT02195843|Middle East|middle east
183160|NCT02195843|Quadripolar|quadripolar
183161|NCT02195830|Sepsis|sepsis
183162|NCT02195830|ultrasound|ultrasound
183163|NCT02195830|inferior vena cava collapsibility|inferior vena cava collapsibility
183164|NCT02195778|Health Literacy|health literacy
183165|NCT02195778|Adult|adult
183167|NCT02195778|Disease|disease
183168|NCT02195778|Age|age
183169|NCT02195765|Chronic Periodontitis|chronic periodontitis
183170|NCT02195765|Periodontal disease|periodontal disease
174101|NCT02236559|noninvasive ventilation|noninvasive ventilation
174102|NCT02236546|fluorodeoxyglucose|fluorodeoxyglucose
174103|NCT02236546|FDG|fdg
174104|NCT02236546|PET/CT|pet/ct
174105|NCT02236546|melanoma|melanoma
174106|NCT02236546|imaging biomarkers|imaging biomarkers
174107|NCT02236546|cancer imaging|cancer imaging
174108|NCT02236520|Na+ MRI|na+ mri
183171|NCT02195752|Compounded pain cream|compounded pain cream
183172|NCT02195752|Ordinary care|ordinary care
183173|NCT02195752|Compounding|compounding
183174|NCT02195752|Topical treatment|topical treatment
183175|NCT02195752|Analgesia|analgesia
183176|NCT02195739|smoking|smoking
183177|NCT02195739|smoking cessation|smoking cessation
183178|NCT02195739|cardiovascular disease|cardiovascular disease
183179|NCT02195739|pharmacological intervention|pharmacological intervention
183180|NCT02195739|UK primary care population|uk primary care population
183181|NCT02195739|nicotine replacement therapy|nicotine replacement therapy
183182|NCT02195700|Dyskinesias|dyskinesias
183183|NCT02195700|Movement Disorders|movement disorders
183184|NCT02195700|Central Nervous System Diseases|central nervous system diseases
183185|NCT02195700|Nervous System Diseases|nervous system diseases
183186|NCT02195700|Neurologic Manifestations|neurologic manifestations
183187|NCT02195700|Signs and Symptoms|signs and symptoms
183188|NCT02195661|Epilepsy|epilepsy
183189|NCT02195661|Electroencephalogram|electroencephalogram
183190|NCT02195661|children|children
183191|NCT02195661|sedation|sedation
183192|NCT02195648|Tension-Type Headache|tension-type headache
183193|NCT02195648|Physical Therapy Modalities|physical therapy modalities
183194|NCT02195648|Musculoskeletal Manipulations|musculoskeletal manipulations
183195|NCT02195648|Sub-occipital muscle inhibition technique|sub-occipital muscle inhibition technique
183196|NCT02195609|Vasomotor Symptoms Associated With Menopause|vasomotor symptoms associated with menopause
183197|NCT02195609|Menopause|menopause
183198|NCT02195609|Hot Flashes|hot flashes
183199|NCT02195609|Postmenopausal Women|postmenopausal women
183200|NCT02195596|Alzheimer disease, exercise, cognition|alzheimer disease, exercise, cognition
183201|NCT02195570|contingency management|contingency management
183202|NCT02195570|smoking cessation|smoking cessation
183203|NCT02195570|prenatal tobacco exposure|prenatal tobacco exposure
183204|NCT02195570|maternal smoking|maternal smoking
183205|NCT02195531|Adherence|adherence
183206|NCT02195518|Chronic Hepatitis B|chronic hepatitis b
183207|NCT02195518|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
183208|NCT02195518|Failure of multiple NAs treatment|failure of multiple nas treatment
183209|NCT02195479|Multiple Myeloma|multiple myeloma
183210|NCT02195479|Bortezomib|bortezomib
183211|NCT02195479|Velcade|velcade
183212|NCT02195479|Melphalan|melphalan
183213|NCT02195479|Prednisone|prednisone
183214|NCT02195479|Daratumumab|daratumumab
183215|NCT02195453|Non-small cell lung cancer|non-small cell lung cancer
183216|NCT02195453|FACT-L scale|fact-l scale
183217|NCT02195453|Yangzhengxiaoji|yangzhengxiaoji
183218|NCT02195440|Hepatitis C virus, cirrhosis|hepatitis c virus, cirrhosis
183219|NCT02194842|metastatic|metastatic
183220|NCT02194842|prostate cancer|prostate cancer
183221|NCT02194816|Parkinson's Disease|parkinson's disease
183223|NCT02194816|Complementary and Alternative|complementary and alternative
183224|NCT02194816|CAM|cam
183225|NCT02194790|Chronic Kidney Disease|chronic kidney disease
183226|NCT02194790|Diabetic Nephropathy|diabetic nephropathy
183227|NCT02194790|Integrated Chronic Kidney Disease Care|integrated chronic kidney disease care
183228|NCT02194725|Stress and Coping Model|stress and coping model
183229|NCT02194725|Coping|coping
183230|NCT02194712|circulating anodic antigen|circulating anodic antigen
183231|NCT02195414|NeoVas|neovas
183232|NCT02195414|Bioresorbable scaffold|bioresorbable scaffold
183233|NCT02195414|Sirolimus|sirolimus
183234|NCT02195414|First-in-Man|first-in-man
183235|NCT02195401|autism, cleanroom, immune dysregulation, toxins|autism, cleanroom, immune dysregulation, toxins
183236|NCT02195388|Arterial stiffness,|arterial stiffness,
183237|NCT02195388|endothelial function,|endothelial function,
183238|NCT02195388|autonomic nervous system,|autonomic nervous system,
183239|NCT02195388|acute coronary syndrome,|acute coronary syndrome,
183240|NCT02195388|arterial hypertension,|arterial hypertension,
183241|NCT02195388|pulse wave velocity,|pulse wave velocity,
183242|NCT02195388|augmentation index,|augmentation index,
183243|NCT02195388|arterial stiffness index,|arterial stiffness index,
183244|NCT02195388|heart rate variability,|heart rate variability,
183245|NCT02195388|heart rate turbulence,|heart rate turbulence,
183246|NCT02195388|vascular endothelial growth factor,|vascular endothelial growth factor,
183247|NCT02195388|asymmetric dimethylarginine|asymmetric dimethylarginine
183248|NCT02195375|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
183249|NCT02195375|FEV1 ≤ 50%|fev1 ≤ 50%
183250|NCT02195349|Tuberculin Purified Protein Derivative|tuberculin purified protein derivative
183251|NCT02195349|Delayed Type Hypersensitivity|delayed type hypersensitivity
183252|NCT02195349|Biopsy|biopsy
183253|NCT02195349|Induration|induration
183254|NCT02195349|First time in human|first time in human
183255|NCT02195349|T-cells|t-cells
183256|NCT02195349|LAG-3|lag-3
183257|NCT02195349|safety|safety
183258|NCT02195349|GSK2831781|gsk2831781
183259|NCT02195349|psoriasis|psoriasis
183356|NCT02194946|End-Stage Renal Disease,|end-stage renal disease,
183260|NCT02195323|autologous bone marrow mesenchymal stem cells chronic kidney disease|autologous bone marrow mesenchymal stem cells chronic kidney disease
183261|NCT02195310|Sternotomy|sternotomy
183262|NCT02195310|Surgical site Occurences|surgical site occurences
183263|NCT02195310|Negative Pressure Wound Therapy|negative pressure wound therapy
183264|NCT02195310|Surgical Site Infection|surgical site infection
183265|NCT02195297|cellulitis|cellulitis
183266|NCT02195297|anticellulitis|anticellulitis
183267|NCT02195284|Inhaler preference|inhaler preference
183268|NCT02195284|Overall inhaler error|overall inhaler error
183269|NCT02195284|DISKUS/ACCUHALER|diskus/accuhaler
183270|NCT02195284|MDI|mdi
183271|NCT02195284|TURBUHALER|turbuhaler
183272|NCT02195284|ELLIPTA|ellipta
183273|NCT02195284|Ease of use|ease of use
183274|NCT02195284|Critical inhaler error|critical inhaler error
183275|NCT02195271|Melatonin|melatonin
183276|NCT02195271|Transcranial Direct Current Stimulation|transcranial direct current stimulation
183277|NCT02195271|Neuroplasticity|neuroplasticity
183278|NCT02195271|Analgesia|analgesia
183279|NCT02195271|Pain|pain
183280|NCT02195245|CO2 filter|co2 filter
183281|NCT02195245|anesthesia|anesthesia
183282|NCT02195245|device|device
183283|NCT02195232|Venous Thromboembolic Events in Cancer Patients|venous thromboembolic events in cancer patients
183284|NCT02195232|Thromboembolism of Vein in Colorectal Cancer|thromboembolism of vein in colorectal cancer
183285|NCT02195232|Thromboembolism of Vein in Pancreatic Cancer|thromboembolism of vein in pancreatic cancer
183286|NCT02195232|Thromboembolism of Vein in Non-small Cell Lung Cancer|thromboembolism of vein in non-small cell lung cancer
183287|NCT02195219|conservative|conservative
183288|NCT02195219|treatment|treatment
183289|NCT02195219|surgical|surgical
183290|NCT02195219|Acromioclavicular|acromioclavicular
183291|NCT02195219|Joint|joint
183292|NCT02195219|dislocation|dislocation
183293|NCT02195206|Hyperpolarized gas magnetic resonance imaging|hyperpolarized gas magnetic resonance imaging
183294|NCT02195206|Hyperpolarized Xenon-129 magnetic resonance imaging|hyperpolarized xenon-129 magnetic resonance imaging
183295|NCT02195206|Lung Imaging|lung imaging
183296|NCT02195206|Healthy Adults|healthy adults
183297|NCT02195193|Health Services Research|health services research
183298|NCT02195193|Acute Coronary Syndromes|acute coronary syndromes
183299|NCT02195193|Depression|depression
183300|NCT02195193|Integrated care|integrated care
183301|NCT02195180|Pancreas|pancreas
183302|NCT02195180|adenocarcinoma|adenocarcinoma
183303|NCT02195180|cancer|cancer
183304|NCT02195180|asparaginase|asparaginase
183305|NCT02195180|erythrocytes|erythrocytes
183306|NCT02195180|red blood cell|red blood cell
183307|NCT02195180|Encapsulation|encapsulation
183308|NCT02195180|folfox|folfox
183309|NCT02195180|gemcitabine|gemcitabine
183310|NCT02195154|18F-DTBZ|18f-dtbz
183311|NCT02195141|Preoperative Chemoradiotherapy|preoperative chemoradiotherapy
183312|NCT02195141|Locally Advanced Rectal Cancer|locally advanced rectal cancer
183313|NCT02195141|boost|boost
183314|NCT02195141|IMRT|imrt
183315|NCT02195102|transcatheter aortic valve Replacement|transcatheter aortic valve replacement
183316|NCT02195089|Treatment of Cervical Intraepithelial Neoplasia(CIN3)|treatment of cervical intraepithelial neoplasia(cin3)
183317|NCT02195076|Lung cancer|lung cancer
183318|NCT02195076|Breast Cancer|breast cancer
183319|NCT02195076|Biosensors|biosensors
183320|NCT02195076|Volatile Organic Compounds|volatile organic compounds
183321|NCT02195076|Odor|odor
183322|NCT02195076|Urine Sample|urine sample
183323|NCT02195076|Exhaled Breath Samples|exhaled breath samples
183324|NCT02195063|Pain management|pain management
183325|NCT02195063|Scar care|scar care
183326|NCT02195063|Wound care|wound care
183327|NCT02195063|UDT|udt
183328|NCT02195063|Urinary drug testing|urinary drug testing
183329|NCT02195037|Delayed Cord Clamping|delayed cord clamping
183330|NCT02195024|pacemaker|pacemaker
183331|NCT02195024|magnetic resonance imaging|magnetic resonance imaging
183332|NCT02195024|MRI conditional|mri conditional
183333|NCT02195024|pacemaker leads|pacemaker leads
183334|NCT02195011|Regorafenib|regorafenib
183335|NCT02195011|90Y|90y
183336|NCT02195011|Radioembolization|radioembolization
183337|NCT02195011|SIR-Spheres Microspheres|sir-spheres microspheres
183338|NCT02195011|Metastatic Colorectal Cancer|metastatic colorectal cancer
183339|NCT02195011|Liver Metastases|liver metastases
183340|NCT02195011|SIRT|sirt
183341|NCT02195011|Refractory|refractory
183342|NCT02194985|Fabry disease|fabry disease
183343|NCT02194985|Lysosomal storage disease|lysosomal storage disease
183344|NCT02194985|migalastat HCl|migalastat hcl
183345|NCT02194985|AT1001|at1001
183346|NCT02194972|constipation|constipation
183347|NCT02194972|colon transit time|colon transit time
183348|NCT02194972|gut microbiota|gut microbiota
183349|NCT02194972|soluble dietary fiber|soluble dietary fiber
183350|NCT02194972|disturbance of gut microbiota in constipation|disturbance of gut microbiota in constipation
183351|NCT02194959|Patient Navigation|patient navigation
183352|NCT02194959|Screening Colonoscopy|screening colonoscopy
183353|NCT02194959|Colorectal Cancer Screening|colorectal cancer screening
183354|NCT02194959|African Americans|african americans
183355|NCT02194946|Chronic Kidney Disease,|chronic kidney disease,
183357|NCT02194946|Traditional Chinese Medicine,|traditional chinese medicine,
183358|NCT02194946|dialysis initiation.|dialysis initiation.
183359|NCT02194933|Schizophrenia|schizophrenia
183360|NCT02194933|Mental Disorders, Antipsychotic,|mental disorders, antipsychotic,
183361|NCT02194933|Psychotic disorder, Impulsivity|psychotic disorder, impulsivity
183362|NCT02194907|Emotional Aging|emotional aging
183363|NCT02194907|Neurofeedback|neurofeedback
183466|NCT02194439|Immune Reconstitution|immune reconstitution
183364|NCT02194894|Acetaminophen, Non-alcoholic Fatty Liver Disease (NAFLD)|acetaminophen, non-alcoholic fatty liver disease (nafld)
183365|NCT02194881|Cystic fibrosis|cystic fibrosis
183366|NCT02194881|CFTR|cftr
183367|NCT02194881|G551D mutation|g551d mutation
183368|NCT02194881|Novel treatments|novel treatments
183369|NCT02194881|Potentiator|potentiator
183370|NCT02194881|Ivacaftor|ivacaftor
183371|NCT02194868|Allogeneic hematopoietic stem cell transplantation,|allogeneic hematopoietic stem cell transplantation,
183372|NCT02194868|Immunoregulatory T lymphocytes,|immunoregulatory t lymphocytes,
183373|NCT02194868|acute graft versus host disease|acute graft versus host disease
183374|NCT02194855|rocuronium|rocuronium
183375|NCT02194855|cisatracurium|cisatracurium
183376|NCT02194855|pharmacokinetic|pharmacokinetic
183377|NCT02194686|cilostazol|cilostazol
183378|NCT02194686|progenitor cells|progenitor cells
183379|NCT02194686|cardiovascular disease|cardiovascular disease
183380|NCT02194686|risk factors|risk factors
183381|NCT02194686|angiogenesis|angiogenesis
183382|NCT02194686|biological markers|biological markers
183383|NCT02194686|endothelial function|endothelial function
183384|NCT02194660|Fractures Liaison Service|fractures liaison service
183385|NCT02194660|Osteoporosis|osteoporosis
183386|NCT02194660|Fracture|fracture
183387|NCT02194660|Medication adherence|medication adherence
183388|NCT02194647|Osteoporosis|osteoporosis
183389|NCT02194647|Medication Monitoring|medication monitoring
183390|NCT02194647|Education|education
183391|NCT02194647|Adherence|adherence
183392|NCT02194647|Management|management
183393|NCT02194595|type 2 diabetes|type 2 diabetes
183394|NCT02194595|beta-cell function|beta-cell function
183395|NCT02194595|GLP-1|glp-1
183396|NCT02194595|insulin|insulin
183397|NCT02194582|FSGS|fsgs
183398|NCT02194582|NS|ns
183399|NCT02194582|Kidney disease|kidney disease
183400|NCT02194582|Kidney failure|kidney failure
183401|NCT02194582|Renal disease|renal disease
183402|NCT02194582|nephrotic syndrome|nephrotic syndrome
183403|NCT02194582|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
183404|NCT02194582|familial kidney disease|familial kidney disease
183405|NCT02194582|minimal change disease|minimal change disease
183406|NCT02194582|proteinuria|proteinuria
183407|NCT02194543|Cataract|cataract
183408|NCT02194543|HD 3D|hd 3d
183409|NCT02194543|Microscope|microscope
183410|NCT02194530|Peanut allergy|peanut allergy
183411|NCT02194530|Allergic/atopic individuals|allergic/atopic individuals
183412|NCT02194530|Non allergic individuals|non allergic individuals
183413|NCT02194530|Allergic individuals receiving xolair therapy|allergic individuals receiving xolair therapy
183414|NCT02194517|diabetes|diabetes
183415|NCT02194517|diet control toolset|diet control toolset
183416|NCT02194517|food exchanges|food exchanges
183417|NCT02194517|CHO|cho
183418|NCT02194517|FP|fp
183419|NCT02194504|Metabolic health|metabolic health
183420|NCT02194504|Phenotyping|phenotyping
183421|NCT02194504|Abdominal obesity|abdominal obesity
183422|NCT02194504|Abdominal adiposity|abdominal adiposity
183423|NCT02194504|Liver fat|liver fat
183424|NCT02194504|Belly fat|belly fat
183425|NCT02194491|[11C]AS2471907|[11c]as2471907
183426|NCT02194491|ASP3662|asp3662
183427|NCT02194491|Positron Emission Tomography (PET)|positron emission tomography (pet)
183428|NCT02194491|Brain enzyme occupancy|brain enzyme occupancy
183429|NCT02194478|Stress|stress
183430|NCT02194478|Meditation|meditation
183431|NCT02194478|Mind body|mind body
183432|NCT02194439|Acute Graft Versus Host Disease|acute graft versus host disease
183433|NCT02194439|Affect|affect
183434|NCT02194439|Anti-inflammatory|anti-inflammatory
183435|NCT02194439|Anti-inflammatory Agents|anti-inflammatory agents
183436|NCT02194439|Antigen-Presenting Cells|antigen-presenting cells
183437|NCT02194439|Alloantigen|alloantigen
183438|NCT02194439|Allogeneic|allogeneic
183439|NCT02194439|Allograft rejection|allograft rejection
183440|NCT02194439|Allograft Tolerance|allograft tolerance
183441|NCT02194439|Antigens|antigens
183442|NCT02194439|Autoimmunity|autoimmunity
183443|NCT02194439|Biomarkers|biomarkers
183444|NCT02194439|Biospecimen Repository|biospecimen repository
183445|NCT02194439|BMT|bmt
183446|NCT02194439|Bone Marrow Transplantation|bone marrow transplantation
183447|NCT02194439|Cell Transplantation|cell transplantation
183448|NCT02194439|Cells|cells
183449|NCT02194439|Clonal Expansion|clonal expansion
183450|NCT02194439|Complex|complex
183451|NCT02194439|Cytokine|cytokine
183452|NCT02194439|Data|data
183453|NCT02194439|Development|development
183454|NCT02194439|Environment|environment
183455|NCT02194439|Failure (biologic function)|failure (biologic function)
183456|NCT02194439|Genomics|genomics
183457|NCT02194439|Graft-vs-Host Disease|graft-vs-host disease
183458|NCT02194439|Graft-vs-Leukemia|graft-vs-leukemia
183459|NCT02194439|GVHD|gvhd
183460|NCT02194439|GVL|gvl
183461|NCT02194439|Hematopoietic|hematopoietic
183462|NCT02194439|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
183463|NCT02194439|HCT|hct
183464|NCT02194439|HSCT|hsct
183465|NCT02194439|IL-33 Receptor|il-33 receptor
183575|NCT02193984|Diabetes|diabetes
183467|NCT02194439|Immune Response|immune response
183468|NCT02194439|Inflammatory|inflammatory
183469|NCT02194439|Modeling|modeling
183470|NCT02194439|Novel|novel
183471|NCT02194439|Novel therapeutics|novel therapeutics
183472|NCT02194439|Outcome|outcome
183473|NCT02194439|Pathway interactions|pathway interactions
183474|NCT02194439|Peptides|peptides
183475|NCT02194439|Prevent|prevent
183476|NCT02194439|Process|process
183477|NCT02194439|Production|production
183478|NCT02194439|Proteomics|proteomics
183479|NCT02194439|Regulatory T-Lymphocyte|regulatory t-lymphocyte
183480|NCT02194439|Response|response
183481|NCT02194439|Role|role
183482|NCT02194439|Signal|signal
183483|NCT02194439|ST2|st2
183484|NCT02194439|Transduction|transduction
183485|NCT02194439|T-cell response|t-cell response
183486|NCT02194439|T-cell Activation|t-cell activation
183487|NCT02194439|T-Lymphocytes|t-lymphocytes
183488|NCT02194439|Tissues|tissues
183489|NCT02194400|RSLV-132|rslv-132
183490|NCT02194400|Systemic Lupus Erythematosus|systemic lupus erythematosus
183491|NCT02194400|Lupus|lupus
183492|NCT02194400|SLE|sle
183493|NCT02194400|Resolve|resolve
183494|NCT02194387|Breast Cancer|breast cancer
183495|NCT02194387|Ovarian Cancer|ovarian cancer
183496|NCT02194387|Triple negative breast cancer|triple negative breast cancer
183497|NCT02194387|TNBC|tnbc
183498|NCT02194387|BRCA-positive survivor|brca-positive survivor
183499|NCT02194387|High-grade serous ovarian cancer|high-grade serous ovarian cancer
183500|NCT02194387|HGSOC|hgsoc
183501|NCT02194387|Female biological relative of a BRCA positive TNBC or HGSOC survivor|female biological relative of a brca positive tnbc or hgsoc survivor
183502|NCT02194387|Cancer survivors|cancer survivors
183503|NCT02194387|Employees at MD Anderson|employees at md anderson
183504|NCT02194387|Multi-phase Optimization Strategy|multi-phase optimization strategy
183505|NCT02194387|MOST|most
183506|NCT02194387|Energy balance interventions|energy balance interventions
183507|NCT02194387|EB|eb
183508|NCT02194387|Telephone Coaching|telephone coaching
183509|NCT02194387|Text Messaging|text messaging
183510|NCT02194387|Resistance Training|resistance training
183511|NCT02194387|Daily Self-Monitoring|daily self-monitoring
183512|NCT02194387|Weekly Self-Monitoring|weekly self-monitoring
183513|NCT02194387|Email Coaching|email coaching
183514|NCT02194387|Questionnaires|questionnaires
183515|NCT02194387|Surveys|surveys
183516|NCT02194374|Leukemia|leukemia
183517|NCT02194374|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
183518|NCT02194374|CLL|cll
183519|NCT02194374|Small lymphocytic lymphoma|small lymphocytic lymphoma
183520|NCT02194374|SLL|sll
183521|NCT02194374|B cell|b cell
183522|NCT02194374|ROR1-specific T cells|ror1-specific t cells
183523|NCT02194374|Fludarabine|fludarabine
183524|NCT02194374|Fludarabine Phosphate|fludarabine phosphate
183525|NCT02194374|Fludara|fludara
183526|NCT02194374|Cyclophosphamide|cyclophosphamide
183527|NCT02194374|Cytoxan|cytoxan
183528|NCT02194374|Neosar|neosar
183529|NCT02194374|Rituximab|rituximab
183530|NCT02194374|Rituxan|rituxan
183531|NCT02194374|Bendamustine|bendamustine
183532|NCT02194374|Bendamustine Hydrochloride|bendamustine hydrochloride
183533|NCT02194374|Bendamustine HCL|bendamustine hcl
183534|NCT02194374|CEP-18083|cep-18083
183535|NCT02194374|SDX-105|sdx-105
183536|NCT02194374|Treanda|treanda
183537|NCT02194231|Mesothelioma|mesothelioma
183538|NCT02194231|MPM|mpm
183539|NCT02194231|Trabectedin|trabectedin
183540|NCT02194192|prevention of hypotension|prevention of hypotension
183541|NCT02194192|spinal anesthesia|spinal anesthesia
183542|NCT02194192|cesarean section|cesarean section
183543|NCT02194192|ephedrine|ephedrine
183544|NCT02194192|ondansetron|ondansetron
183545|NCT02194140|ultrasound|ultrasound
183546|NCT02194140|iodinated contrast material|iodinated contrast material
183547|NCT02194140|computed tomography|computed tomography
183548|NCT02194114|Chronic Renal Failure|chronic renal failure
183549|NCT02194114|End-Stage Renal Disease|end-stage renal disease
183550|NCT02194114|Nitrogen Balance|nitrogen balance
183551|NCT02194114|Dietary Protein Intake|dietary protein intake
183554|NCT02194101|goal-directed therapy|goal-directed therapy
183555|NCT02194062|Chronic rhinosinusitis with polyps|chronic rhinosinusitis with polyps
183556|NCT02194062|Nasal steroids|nasal steroids
183557|NCT02194062|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
183558|NCT02194062|SNOT-22|snot-22
183559|NCT02194062|Lund-Kennedy|lund-kennedy
183560|NCT02194036|Ownership of body|ownership of body
183561|NCT02194036|Bodily and mental balance|bodily and mental balance
183562|NCT02194036|Learning|learning
183563|NCT02194036|Body image|body image
183564|NCT02194036|Sensations|sensations
183565|NCT02194036|Expectations|expectations
183566|NCT02194023|chlorhexidine digluconate|chlorhexidine digluconate
183567|NCT02194023|gingivitis|gingivitis
183568|NCT02194023|cetylpyridinium chloride|cetylpyridinium chloride
183569|NCT02194023|mouthrinse|mouthrinse
183570|NCT02194023|dental plaque|dental plaque
183571|NCT02194023|de novo|de novo
183572|NCT02194023|in vivo|in vivo
183576|NCT02193984|Peer support|peer support
183577|NCT02193984|Hispanic|hispanic
183578|NCT02193984|Latino|latino
183579|NCT02193971|Acute coronary syndrome|acute coronary syndrome
183580|NCT02193971|Drug eluting stent|drug eluting stent
183581|NCT02193971|Everolimus|everolimus
183582|NCT02193971|Prasugrel|prasugrel
183583|NCT02193958|Acute Myeloid Leukemia|acute myeloid leukemia
183584|NCT02193958|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
183585|NCT02193958|Myelodysplastic Syndrome|myelodysplastic syndrome
183586|NCT02193932|EEG triggered|eeg triggered
183587|NCT02193932|fMRI|fmri
183588|NCT02193932|epilepsy|epilepsy
183590|NCT02193919|psoriasis|psoriasis
183591|NCT02193906|Cognitive training|cognitive training
183592|NCT02193906|Multiple sclerosis|multiple sclerosis
183593|NCT02193906|Cognitive deficits|cognitive deficits
183594|NCT02193893|cell-based therapy|cell-based therapy
183595|NCT02193893|autologous bone marrow-derived stem/progenitor cells|autologous bone marrow-derived stem/progenitor cells
183596|NCT02193893|stem cell infusion, stem cell transplantation|stem cell infusion, stem cell transplantation
183597|NCT02193893|biological therapy with neurotrophic factors|biological therapy with neurotrophic factors
183598|NCT02193893|bioactive neurotrophic factors|bioactive neurotrophic factors
183599|NCT02193867|LIPA|lipa
183600|NCT02193867|Wolman Disease|wolman disease
183601|NCT02193867|Wolman Phenotype|wolman phenotype
183602|NCT02193867|Acid Lipase Deficiency|acid lipase deficiency
183603|NCT02193867|Acid Cholesteryl Hydrolase|acid cholesteryl hydrolase
183604|NCT02193867|Acid Lipase Disease Deficiency, type 2|acid lipase disease deficiency, type 2
183605|NCT02193867|Cholesteryl Ester Storage Disease (CESD)|cholesteryl ester storage disease (cesd)
183606|NCT02193867|Cholesteryl Ester Hydrolase Deficiency|cholesteryl ester hydrolase deficiency
183607|NCT02193867|Early Onset Lysosomal Acid Lipase Deficiency (Wolman Disease)|early onset lysosomal acid lipase deficiency (wolman disease)
183608|NCT02193867|LAL Deficiency|lal deficiency
183609|NCT02193867|Late Onset Lysosomal Acid Lipase Deficiency (CESD)|late onset lysosomal acid lipase deficiency (cesd)
183610|NCT02193867|Wolman Disease (early onset LAL Deficiency)|wolman disease (early onset lal deficiency)
183611|NCT02193867|Related Disorders:|related disorders:
183612|NCT02193867|Non-alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
183613|NCT02193867|Non-alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
183614|NCT02193867|Alcoholic Liver Disease|alcoholic liver disease
183615|NCT02193867|Cryptogenic Cirrhosis|cryptogenic cirrhosis
183616|NCT02193867|Niemann-Pick Disease (NPD) Type C|niemann-pick disease (npd) type c
183617|NCT02193867|Chanarin Dorfman Syndrome|chanarin dorfman syndrome
183618|NCT02193854|Telemedicine|telemedicine
183619|NCT02193854|Mobile phone|mobile phone
183620|NCT02193854|Rural physicians|rural physicians
183621|NCT02193854|Mongolia|mongolia
183622|NCT02193841|Simple bone cyst|simple bone cyst
183623|NCT02193841|Unicameral bone cyst|unicameral bone cyst
183624|NCT02193828|Dupuytren's nodules|dupuytren's nodules
183625|NCT02193815|psoriasis|psoriasis
183626|NCT02193815|plaque|plaque
183627|NCT02193815|vulgaris|vulgaris
183628|NCT02193815|phase 1|phase 1
183629|NCT02193815|randomized|randomized
183630|NCT02193815|double-blind|double-blind
183631|NCT02193815|topical|topical
183632|NCT02193815|safety|safety
183633|NCT02193802|Crohn's disease|crohn's disease
183634|NCT02193802|small bowel (SB)|small bowel (sb)
183635|NCT02193802|capsule endoscopy|capsule endoscopy
183636|NCT02193802|ileocolonoscopy|ileocolonoscopy
183637|NCT02193802|anti-TNF-alpha antibodies|anti-tnf-alpha antibodies
183638|NCT02193789|Anastomosis site structure|anastomosis site structure
183639|NCT02193789|Stent insertion|stent insertion
183640|NCT02193789|Stent migration|stent migration
183641|NCT02193776|Tuberculosis|tuberculosis
183642|NCT02193776|Multi Drug-Resistant Tuberculosis|multi drug-resistant tuberculosis
174604|NCT02234336|cardiomyopathy|cardiomyopathy
174605|NCT02234336|magnetic resonance imaging|magnetic resonance imaging
174606|NCT02234336|contrast|contrast
174607|NCT02234323|prophylaxis treatment|prophylaxis treatment
174608|NCT02234323|Hemophilia A|hemophilia a
174609|NCT02234323|Hemophilia|hemophilia
174610|NCT02234323|episodic treatment|episodic treatment
174611|NCT02234310|prophylaxis treatment|prophylaxis treatment
174612|NCT02234310|episodic treatment|episodic treatment
174613|NCT02234297|Glioma|glioma
174614|NCT02234297|Tumor Paint|tumor paint
174615|NCT02234297|BLZ100|blz100
174616|NCT02234284|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
174617|NCT02234284|Health Coaching|health coaching
174619|NCT02234284|Self-management|self-management
183643|NCT02193776|Drug-Sensitive Tuberculosis|drug-sensitive tuberculosis
183644|NCT02193776|Pa-824|pa-824
183645|NCT02193776|Bedaquiline|bedaquiline
183646|NCT02193776|Moxifloxacin|moxifloxacin
183647|NCT02193776|Pyrazinamide|pyrazinamide
183648|NCT02193776|Nitroimidazole|nitroimidazole
183649|NCT02193776|Quinolone|quinolone
183650|NCT02193776|Pretomanid|pretomanid
183651|NCT02193776|NC-005|nc-005
183652|NCT02193763|pediatric|pediatric
183653|NCT02193763|lumbar puncture|lumbar puncture
183654|NCT02193763|ultrasonography|ultrasonography
183655|NCT02193763|efficacy|efficacy
183656|NCT02193750|Crohn's Disease|crohn's disease
183657|NCT02193724|Heritable Retinoblastoma|heritable retinoblastoma
183658|NCT02193724|Familial Retinoblastoma|familial retinoblastoma
183659|NCT02193724|Pluripotent Stem Cells|pluripotent stem cells
183660|NCT02193698|POEMS syndrome|poems syndrome
183661|NCT02193698|lenalidomide|lenalidomide
183662|NCT02193685|(HAEC) Hirschsprung Associated Entrocolistis|(haec) hirschsprung associated entrocolistis
183663|NCT02193685|(HD) Hirschsprung Disease|(hd) hirschsprung disease
183664|NCT02193685|(IBD) Inflammatory Bowel Disease|(ibd) inflammatory bowel disease
183665|NCT02193685|Children|children
183666|NCT02193672|Advanced cancers|advanced cancers
183667|NCT02193672|PET/CT|pet/ct
183668|NCT02193672|Positron emission tomography / computed tomography|positron emission tomography / computed tomography
183669|NCT02193672|[18F]Fluciclatide|[18f]fluciclatide
183670|NCT02193672|Chemotherapy|chemotherapy
183671|NCT02193672|Phone calls|phone calls
183672|NCT02193659|breakfast cereal|breakfast cereal
183673|NCT02193659|omega-3|omega-3
183674|NCT02193659|cholesterol|cholesterol
183675|NCT02193659|lipidic profile|lipidic profile
183676|NCT02193659|consumption|consumption
183677|NCT02193659|acceptability|acceptability
183678|NCT02193646|Colonoscopy|colonoscopy
183679|NCT02193646|Adenoma|adenoma
183680|NCT02193646|ADR|adr
183681|NCT02193646|Screening Colon Cancer|screening colon cancer
183682|NCT02193620|Analgesic|analgesic
183683|NCT02193620|Narcotics|narcotics
183684|NCT02193620|Opioids|opioids
183685|NCT02193620|Pain relief after surgery|pain relief after surgery
183686|NCT02193607|Occult stress incontinence|occult stress incontinence
183687|NCT02193607|Pelvic Organ Prolapse|pelvic organ prolapse
183688|NCT02193607|Surgical Intervention|surgical intervention
183689|NCT02193607|TVT-O(Tension-free vaginal tape-obturator)|tvt-o(tension-free vaginal tape-obturator)
183690|NCT02193607|Improved Reconstructive Pelvic Surgery|improved reconstructive pelvic surgery
183691|NCT02193607|Combined Surgery|combined surgery
183692|NCT02193607|Two-step Approach|two-step approach
183693|NCT02193607|Prophylactic Incontinence Procedure|prophylactic incontinence procedure
183694|NCT02193607|Randomized Controlled Trial|randomized controlled trial
183695|NCT02193594|Preoperative concurrent chemoradiotherapy|preoperative concurrent chemoradiotherapy
183696|NCT02193594|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
183697|NCT02193594|Gastroesophageal junction adenocarcinoma|gastroesophageal junction adenocarcinoma
183698|NCT02193568|Supratentorial Glioma|supratentorial glioma
183699|NCT02193568|Craniotomy|craniotomy
183700|NCT02193555|Presbyopia|presbyopia
183701|NCT02193555|Refractive error correction|refractive error correction
183702|NCT02193555|Contact lenses|contact lenses
183703|NCT02193542|regional anesthesia|regional anesthesia
183704|NCT02193542|general anesthesia|general anesthesia
183705|NCT02193542|obstetric|obstetric
183706|NCT02193529|sleeve gastrectomy, dietary intake, morbid obesity.|sleeve gastrectomy, dietary intake, morbid obesity.
183707|NCT02193503|cancer|cancer
183708|NCT02193503|solid tumors|solid tumors
183709|NCT02193503|gene therapy|gene therapy
183710|NCT02193503|cell therapy|cell therapy
183711|NCT02193503|encapsulation|encapsulation
183712|NCT02193490|DNase, Pulmozyme, dry eye disease, treatment|dnase, pulmozyme, dry eye disease, treatment
183713|NCT02193464|inflammatory bowel disease, registry, incidence, Korea|inflammatory bowel disease, registry, incidence, korea
183714|NCT02193451|Lower urinary tract symptoms|lower urinary tract symptoms
183715|NCT02193451|Male LUTS|male luts
183716|NCT02193451|Voiding dysfunction|voiding dysfunction
183717|NCT02193451|Benign prostate obstruction|benign prostate obstruction
183718|NCT02193451|Detrusor underactivity|detrusor underactivity
183719|NCT02193438|Heart rate variability|heart rate variability
183720|NCT02193438|Resting energy expenditure|resting energy expenditure
183721|NCT02193438|Facial thermography|facial thermography
183722|NCT02193438|Blood pressure|blood pressure
183723|NCT02193438|Spices ingestion|spices ingestion
183724|NCT02193425|Brain|brain
183725|NCT02193425|Connectivity|connectivity
183726|NCT02193425|PET|pet
183727|NCT02193425|fcMRI|fcmri
183728|NCT02193425|18FDG|18fdg
183729|NCT02193412|analgesia nociception index|analgesia nociception index
183730|NCT02193412|heart rate variability|heart rate variability
183731|NCT02193412|autonomic nervous system|autonomic nervous system
183732|NCT02193412|specificity|specificity
183733|NCT02193412|systemic venous return|systemic venous return
183734|NCT02193412|pulse pressure variation|pulse pressure variation
183735|NCT02193412|Intraoperative Monitoring|intraoperative monitoring
183736|NCT02193399|Stem cell transplantation|stem cell transplantation
183737|NCT02193399|Fatigue|fatigue
183738|NCT02193399|Physiotherapy|physiotherapy
183739|NCT02193399|Quality of Life|quality of life
183740|NCT02193399|Cancer|cancer
183741|NCT02193399|Psychosocial aspects|psychosocial aspects
183742|NCT02193386|Cerebral Palsy|cerebral palsy
183743|NCT02193386|Physical Therapy|physical therapy
183744|NCT02193386|gait analysis|gait analysis
183745|NCT02193386|gross motor function|gross motor function
183746|NCT02193373|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
183747|NCT02193373|Autonomic Nervous System|autonomic nervous system
183748|NCT02193373|Heart Rate Variability|heart rate variability
183749|NCT02193373|Sub-Occipital Release|sub-occipital release
183750|NCT02193373|Rib-Raising|rib-raising
183751|NCT02193373|Stellate Ganglion Release|stellate ganglion release
183752|NCT02193360|Inflammation|inflammation
183753|NCT02193360|PBC|pbc
183754|NCT02193347|Immunotherapy|immunotherapy
183755|NCT02193347|Adult|adult
183756|NCT02193334|Hepatocyte Growth Factor|hepatocyte growth factor
183757|NCT02193334|HGF|hgf
183758|NCT02193334|KP-100IT|kp-100it
183759|NCT02193334|Intrathecal injection|intrathecal injection
183760|NCT02193321|Atrial Fibrillation|atrial fibrillation
183761|NCT02193321|Amniotic Membrane|amniotic membrane
183762|NCT02193295|Weight Reduction|weight reduction
183763|NCT02193295|Caloric Restriction|caloric restriction
183764|NCT02193295|Euglycemic Hyperinsulinemic Clamp|euglycemic hyperinsulinemic clamp
183765|NCT02193295|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
183766|NCT02193269|Abstinent cocaine users|abstinent cocaine users
183767|NCT02193269|minocycline|minocycline
183768|NCT02193269|antibiotic|antibiotic
183769|NCT02193256|varenicline|varenicline
183770|NCT02193256|prazosin|prazosin
183771|NCT02193256|cigarette smoking|cigarette smoking
183772|NCT02193256|alcohol drinking|alcohol drinking
183773|NCT02193256|sleep|sleep
183774|NCT02193256|dreams|dreams
183775|NCT02193243|Congenital Heart Disease|congenital heart disease
183776|NCT02193243|Six Minute Walk Test|six minute walk test
183777|NCT02193243|Exercise Testing|exercise testing
183778|NCT02193243|Peak oxygen uptake|peak oxygen uptake
183779|NCT02193230|Atopic dermatitis, Feasibility, Adherence to treatment|atopic dermatitis, feasibility, adherence to treatment
183780|NCT02193204|Alcohol dependence|alcohol dependence
183781|NCT02193204|Stress|stress
183782|NCT02193204|Cytokines|cytokines
183783|NCT02193204|Depressive Symptomatology|depressive symptomatology
183784|NCT02193191|Plerixafor|plerixafor
183785|NCT02193191|13-229|13-229
183786|NCT02193152|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
183787|NCT02193152|NSCLC|nsclc
183788|NCT02193152|Pazopanib|pazopanib
183789|NCT02193126|Long term foster care|long term foster care
183790|NCT02193126|child abuse and neglect|child abuse and neglect
183791|NCT02193126|trauma|trauma
183792|NCT02193113|Diabetic Macular Edema|diabetic macular edema
183793|NCT02193113|DME|dme
183794|NCT02193113|Plasma Kallikrein inhibitor|plasma kallikrein inhibitor
183795|NCT02193113|KVD001|kvd001
183796|NCT02193113|KVD001-001|kvd001-001
183797|NCT02193113|Intravitreal|intravitreal
183798|NCT02193113|IVT|ivt
183799|NCT02193113|Diabetes mellitus|diabetes mellitus
183800|NCT02193087|Drug therapy|drug therapy
183801|NCT02193074|Spinal Muscular Atrophy|spinal muscular atrophy
183802|NCT02193074|SMA|sma
183803|NCT02193074|SMN|smn
183804|NCT02193074|SMNRx|smnrx
183805|NCT02193074|ISIS-SMNRx|isis-smnrx
183806|NCT02193074|ISIS-SMN Rx|isis-smn rx
183807|NCT02193074|ISIS 396443|isis 396443
183808|NCT02193074|IONIS-SMNRx|ionis-smnrx
183809|NCT02193074|IONIS-SMN Rx|ionis-smn rx
183810|NCT02193074|Spinraza|spinraza
183811|NCT02193074|ENDEAR|endear
183812|NCT02193061|Rotavirus|rotavirus
183813|NCT02193061|immunological behavior|immunological behavior
183814|NCT02193061|Rotarix|rotarix
183815|NCT02193061|RotaTeq|rotateq
183816|NCT02193061|vaccine interchangeability|vaccine interchangeability
183817|NCT02193035|Microparticles|microparticles
183818|NCT02193035|Severe aortic stenosis|severe aortic stenosis
183819|NCT02193035|Calcified aortic stenosis|calcified aortic stenosis
183820|NCT02193035|transcatheter aortic valve replacement|transcatheter aortic valve replacement
183821|NCT02193022|Bangladesh, PKDL, Visceral Leishmaniasis, Children, Miltefosine|bangladesh, pkdl, visceral leishmaniasis, children, miltefosine
183822|NCT02192996|VLBW preterm|vlbw preterm
183823|NCT02192996|GUT microbiota|gut microbiota
183824|NCT02192996|probiotics supplementation|probiotics supplementation
183825|NCT02192996|immune compounds|immune compounds
183826|NCT02192970|Retinal detachment|retinal detachment
183827|NCT02192970|Proliferative vitreoretinopathy|proliferative vitreoretinopathy
183828|NCT02192957|cardioversion|cardioversion
183829|NCT02192957|electrical cardioversion|electrical cardioversion
183830|NCT02192957|atrial fibrillation|atrial fibrillation
183831|NCT02192957|cardioversion protocol|cardioversion protocol
183832|NCT02192944|ECG|ecg
183833|NCT02192944|Pharmacokinetic profile|pharmacokinetic profile
183834|NCT02192892|Young children|young children
183835|NCT02192892|Acceptability|acceptability
183836|NCT02192892|Food intake|food intake
183837|NCT02192892|Energy dense porridge|energy dense porridge
183838|NCT02192879|thoracic epidural|thoracic epidural
183839|NCT02192879|continuous paravertebral catheter|continuous paravertebral catheter
183841|NCT02192879|liver resection|liver resection
183842|NCT02192879|pain management|pain management
183843|NCT02192853|Diabetes Mellitus|diabetes mellitus
183844|NCT02192853|Glucagon-like peptide 1|glucagon-like peptide 1
183845|NCT02192853|Dipeptidyl peptidase 4|dipeptidyl peptidase 4
183846|NCT02192853|Dipeptidyl peptidase 4 inhibitor|dipeptidyl peptidase 4 inhibitor
183847|NCT02192853|sitagliptin|sitagliptin
183848|NCT02192853|Enzyme activity|enzyme activity
183849|NCT02192840|provisional T stenting|provisional t stenting
183850|NCT02192840|dedicated bifurcation stent|dedicated bifurcation stent
183851|NCT02192827|Pediatric|pediatric
183852|NCT02192827|Asthma|asthma
183853|NCT02192827|Exacerbation|exacerbation
183854|NCT02192827|Dexamethasone|dexamethasone
183855|NCT02192827|Peak flow|peak flow
183856|NCT02192814|Lacosamide|lacosamide
183858|NCT02192814|Epilepsy|epilepsy
183859|NCT02192814|Partial-onset seizures|partial-onset seizures
183860|NCT02192814|iv|iv
183861|NCT02192801|Classic Bladder Exstrophy|classic bladder exstrophy
183862|NCT02192801|Renal function|renal function
183863|NCT02192801|GFR|gfr
183864|NCT02192801|Proteinuria|proteinuria
183865|NCT02192788|SBRT|sbrt
183866|NCT02192788|Oligometastases|oligometastases
183867|NCT02192788|Prostate Cancer|prostate cancer
183868|NCT02192775|Measles virus|measles virus
183869|NCT02192775|Sodium Iodide Symporter|sodium iodide symporter
183870|NCT02192775|Cyclophosphamide|cyclophosphamide
183871|NCT02192775|Refractory multiple myeloma|refractory multiple myeloma
183872|NCT02192749|autism|autism
183873|NCT02192749|umbilical cord|umbilical cord
183874|NCT02192749|mesenchymal|mesenchymal
183875|NCT02192749|stem cells|stem cells
183876|NCT02192736|asthma|asthma
183877|NCT02192736|umbilical cord|umbilical cord
183878|NCT02192736|mesenchymal|mesenchymal
183879|NCT02192736|stem cells|stem cells
183880|NCT02192736|trophic factors|trophic factors
183881|NCT02192710|outpatient surgery|outpatient surgery
183882|NCT02192710|anaesthesia|anaesthesia
183883|NCT02192710|midazolam|midazolam
183884|NCT02192710|electronic tab|electronic tab
183885|NCT02192697|safety|safety
183886|NCT02192697|pharmacokinetics|pharmacokinetics
183887|NCT02192697|tolerability|tolerability
183888|NCT02192697|ASP8273|asp8273
183889|NCT02192697|Non-small Cell Lung Cancer|non-small cell lung cancer
183890|NCT02192697|T790M resistance mutation|t790m resistance mutation
183891|NCT02192697|NSCLC|nsclc
183892|NCT02192697|Epidermal Growth Factor Receptor mutations|epidermal growth factor receptor mutations
183893|NCT02192697|irreversible EGFR inhibitor|irreversible egfr inhibitor
183894|NCT02192697|antitumor activity|antitumor activity
183895|NCT02192697|EGFR|egfr
183896|NCT02192684|obstructive sleep apnea|obstructive sleep apnea
183897|NCT02192684|insulin sensitivity|insulin sensitivity
183898|NCT02192684|cardiovascular risk|cardiovascular risk
183899|NCT02192684|positive airway pressure therapy|positive airway pressure therapy
183900|NCT02192671|hepatocellular carcinoma|hepatocellular carcinoma
183901|NCT02192671|radiofrequency ablation|radiofrequency ablation
183902|NCT02192671|hepatic resection|hepatic resection
183903|NCT02192671|portal hypertension|portal hypertension
183904|NCT02192671|Milan criteria|milan criteria
183905|NCT02192671|randomized critical trial|randomized critical trial
183906|NCT02192619|APL|apl
174910|NCT02232919|Deep Brain Stimulation|deep brain stimulation
183907|NCT02192619|acute promyelocytic leukemia|acute promyelocytic leukemia
183908|NCT02192619|AML M3|aml m3
183909|NCT02192606|Laparoscopy|laparoscopy
183910|NCT02192606|3D Visual System|3d visual system
183911|NCT02192606|Total Hysterectomy|total hysterectomy
183912|NCT02192567|Advanced solid malignant tumor|advanced solid malignant tumor
183913|NCT02192567|phase 1|phase 1
183914|NCT02192567|oncology|oncology
183915|NCT02192554|OPC-34712|opc-34712
183916|NCT02192554|brexpiprazole|brexpiprazole
183917|NCT02192554|Dementia|dementia
183918|NCT02192554|Alzheimer's Disease|alzheimer's disease
183919|NCT02192554|Cognitive Disorders|cognitive disorders
183920|NCT02192554|Memory|memory
183921|NCT02192554|Agitation|agitation
183922|NCT02192541|Urothelial Carcinomas|urothelial carcinomas
183923|NCT02192541|Non-Squamous Non-Small Cell Lung Carcinomas|non-squamous non-small cell lung carcinomas
183924|NCT02192541|Refractory Gastrointestinal Carcinomas|refractory gastrointestinal carcinomas
183925|NCT02192541|Hsp90 Inhibitor|hsp90 inhibitor
183926|NCT02192541|Sarcomas|sarcomas
183927|NCT02192528|vitamin D|vitamin d
183928|NCT02192528|25-hydroxyvitamin D|25-hydroxyvitamin d
183929|NCT02192528|1,25-dihydroxyvitamin D|1,25-dihydroxyvitamin d
183930|NCT02192528|MACCE|macce
183931|NCT02192528|mortality|mortality
183932|NCT02192528|cardiac|cardiac
183933|NCT02192528|cerebrovascular|cerebrovascular
183934|NCT02192515|Healthy Subjects|healthy subjects
183935|NCT02192515|Japanese Adult|japanese adult
183936|NCT02192489|Chronic Cutaneous Sarcoidosis|chronic cutaneous sarcoidosis
183937|NCT02192489|Cutaneous Sarcoidosis|cutaneous sarcoidosis
183938|NCT02192489|Skin Sarcoidosis|skin sarcoidosis
183939|NCT02192489|Sarcoidosis|sarcoidosis
183940|NCT02192476|Stroke, subluxation|stroke, subluxation
183941|NCT02192450|Diabetes Mellitus|diabetes mellitus
183942|NCT02192450|Hypoglycaemia|hypoglycaemia
183943|NCT02192450|Glucose Metabolism Disorders|glucose metabolism disorders
183944|NCT02192450|Metabolic Diseases|metabolic diseases
183945|NCT02192450|Endocrine System Diseases|endocrine system diseases
183946|NCT02192450|Autoimmune Diseases|autoimmune diseases
183947|NCT02192450|Insulin|insulin
183948|NCT02192450|Hypoglycaemic Agents|hypoglycaemic agents
183949|NCT02192450|Physiological Effetcs of Drugs|physiological effetcs of drugs
183950|NCT02192437|methionine|methionine
183951|NCT02192437|cysteine|cysteine
183952|NCT02192437|sulfur amino acid restriction|sulfur amino acid restriction
183953|NCT02192424|beta-cell function,|beta-cell function,
183954|NCT02192424|type 2 diabetes,|type 2 diabetes,
183955|NCT02192424|intermittent insulin|intermittent insulin
183956|NCT02192411|lidocaine|lidocaine
183957|NCT02192411|tumescent|tumescent
183958|NCT02192411|endovenous|endovenous
183959|NCT02192411|laser|laser
183960|NCT02192411|pain|pain
183961|NCT02192398|Pain|pain
183962|NCT02192398|Pain management|pain management
183963|NCT02192398|Neck|neck
183964|NCT02192398|Back|back
183965|NCT02192372|creatinine|creatinine
183966|NCT02192372|glomerular filtration rate|glomerular filtration rate
183967|NCT02192372|metabolic syndrome|metabolic syndrome
183968|NCT02192346|metastatic|metastatic
183969|NCT02192346|refractory|refractory
183970|NCT02192346|progressive|progressive
183971|NCT02192320|Atorvastatin|atorvastatin
183972|NCT02192320|Atorvastatin and Dexamethasone|atorvastatin and dexamethasone
183973|NCT02192320|Chronic Subdural Hematoma|chronic subdural hematoma
183974|NCT02192320|conservative treatment|conservative treatment
183975|NCT02192307|Sensitivity|sensitivity
183976|NCT02192294|Bosutinib|bosutinib
200995|NCT02112656|Neoplasms|neoplasms
183977|NCT02192294|absolute bioavailability|absolute bioavailability
183978|NCT02192281|Physical activity|physical activity
183979|NCT02192281|Recess|recess
183980|NCT02192281|Accelerometer|accelerometer
183981|NCT02192281|Play|play
183982|NCT02192255|diabetes type 2|diabetes type 2
183983|NCT02192255|primary care|primary care
183984|NCT02192255|chronic disease care improvement|chronic disease care improvement
183985|NCT02192255|adherence, randomized trial|adherence, randomized trial
183986|NCT02192255|BP control|bp control
183987|NCT02192255|lipid control|lipid control
183988|NCT02192255|glucose control|glucose control
183989|NCT02192255|natural language processing.|natural language processing.
183990|NCT02192242|acute ischemic pain|acute ischemic pain
183991|NCT02192242|model|model
183992|NCT02192242|S100|s100
183993|NCT02192242|interleukine 6|interleukine 6
183994|NCT02192216|Body composition|body composition
183995|NCT02192216|Chemotherapy|chemotherapy
183996|NCT02192216|Muscle mass|muscle mass
183997|NCT02192216|Muscle function|muscle function
183998|NCT02192216|Exercise|exercise
183999|NCT02192177|Apoptosis|apoptosis
184000|NCT02192177|intrahepatic cholestasis|intrahepatic cholestasis
184001|NCT02192177|obstetric outcomes|obstetric outcomes
184002|NCT02192164|plaque psoriasis|plaque psoriasis
184003|NCT02192164|smoking|smoking
184004|NCT02192164|etanercept|etanercept
224463|NCT02006875|balance|balance
184005|NCT02192151|Analgesic|analgesic
184006|NCT02192151|Narcotics|narcotics
184007|NCT02192151|Opioids|opioids
184008|NCT02192151|Non-scheduled substanse|non-scheduled substanse
184009|NCT02192138|Pleural effusion|pleural effusion
184010|NCT02192138|Pleural fluid|pleural fluid
184011|NCT02192138|Thoracentesis|thoracentesis
184012|NCT02192138|Intrapleural pressure|intrapleural pressure
184013|NCT02192138|Pleural manometry|pleural manometry
184014|NCT02192125|stroke|stroke
184015|NCT02192125|rehabilitation|rehabilitation
184016|NCT02192125|balance|balance
184017|NCT02192125|training|training
184018|NCT02192125|posture|posture
184019|NCT02192086|Kidney transplantation|kidney transplantation
184020|NCT02192060|Biofilm|biofilm
184021|NCT02192060|Triclosan|triclosan
184022|NCT02192060|Crossover|crossover
184023|NCT02192060|Clinical trial|clinical trial
184024|NCT02192034|Colonoscopy|colonoscopy
184025|NCT02192034|Colon cancer|colon cancer
184026|NCT02192034|screening|screening
184027|NCT02192034|navigation|navigation
184028|NCT02192021|CTCL|ctcl
184029|NCT02192021|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
184030|NCT02192021|Mycosis Fungoides|mycosis fungoides
184031|NCT02192008|Challenge|challenge
184032|NCT02192008|Re-challenge|re-challenge
184033|NCT02192008|Controlled Infection|controlled infection
184034|NCT02192008|Enteric fever|enteric fever
184035|NCT02191982|Cancer|cancer
184036|NCT02191982|Chemotherapy|chemotherapy
184037|NCT02191982|Fatigue|fatigue
184038|NCT02191982|Elderly|elderly
184039|NCT02191982|Geriatric|geriatric
184040|NCT02191982|Any Cancer|any cancer
184041|NCT02191982|Cancer Treatment|cancer treatment
184042|NCT02191982|Weakness|weakness
184043|NCT02191982|Tiredness|tiredness
184044|NCT02191969|Chemotherapy|chemotherapy
184045|NCT02191969|Adjuvant Chemotherapy|adjuvant chemotherapy
184046|NCT02191969|Cancer Therapy|cancer therapy
184047|NCT02191969|Fatigue|fatigue
184048|NCT02191969|Physical Activity|physical activity
184049|NCT02191969|Physical Function|physical function
184050|NCT02191969|Tiredness|tiredness
184051|NCT02191969|Colon Cancer|colon cancer
184052|NCT02191969|Rectal Cancer|rectal cancer
184053|NCT02191969|Walk With Ease|walk with ease
184054|NCT02191969|Colorectal Cancer|colorectal cancer
184055|NCT02191969|Geriatric Assessment|geriatric assessment
184056|NCT02191969|Geriatric|geriatric
184057|NCT02191969|Elderly|elderly
184058|NCT02191956|Disruptive behavior disorders|disruptive behavior disorders
184060|NCT02191956|Young Children|young children
184061|NCT02191956|Parenting|parenting
184062|NCT02191956|Behavioral Parent Training|behavioral parent training
184063|NCT02191943|caries|caries
184064|NCT02191943|proximal|proximal
184065|NCT02191943|non-cavitated|non-cavitated
184066|NCT02191943|fluoridation|fluoridation
184067|NCT02191878|Liver Cancer|liver cancer
184068|NCT02191878|Liver Neoplasms|liver neoplasms
184069|NCT02191878|Liver Epithelial Neoplasms|liver epithelial neoplasms
184070|NCT02191878|Liver Cancer, malignant|liver cancer, malignant
184071|NCT02191839|cardiac surgery|cardiac surgery
184072|NCT02191839|alpha 1 antitrypsin|alpha 1 antitrypsin
184073|NCT02191839|inflammation|inflammation
184074|NCT02191839|post operative bleeding|post operative bleeding
184075|NCT02191839|organ function|organ function
184076|NCT02191826|Transthyretin|transthyretin
184077|NCT02191826|TTR|ttr
184078|NCT02191826|Amyloidosis|amyloidosis
184079|NCT02191826|SOM0226|som0226
184080|NCT02191826|Familiar Amyloid Polyneuropathy|familiar amyloid polyneuropathy
184081|NCT02191774|Medical abortion|medical abortion
184082|NCT02191774|Home abortion|home abortion
184083|NCT02191683|Anaemia|anaemia
184084|NCT02191683|Pregnancy|pregnancy
184085|NCT02191683|Foetal programming|foetal programming
184086|NCT02191683|Epigenetics|epigenetics
184087|NCT02191683|Non-communicable diseases|non-communicable diseases
184088|NCT02191683|Tanzania|tanzania
184089|NCT02191657|HIV|hiv
184090|NCT02191657|deferiprone|deferiprone
184091|NCT02191657|iron chelation|iron chelation
184092|NCT02191631|OCD|ocd
184093|NCT02191631|adolescents|adolescents
184094|NCT02191631|pediatric|pediatric
184095|NCT02191631|internet|internet
184096|NCT02191631|online|online
184097|NCT02191631|CBT|cbt
184098|NCT02191618|Aneurysm|aneurysm
184099|NCT02191618|Intracranial Aneurysm|intracranial aneurysm
184100|NCT02191618|Vascular Diseases|vascular diseases
184101|NCT02191618|Cardiovascular Diseases|cardiovascular diseases
184102|NCT02191618|Intracranial Arterial Diseases|intracranial arterial diseases
184103|NCT02191618|Cerebrovascular Disorders|cerebrovascular disorders
184104|NCT02191618|Brain Diseases|brain diseases
184105|NCT02191618|Central Nervous System Diseases|central nervous system diseases
184106|NCT02191618|Nervous System Diseases|nervous system diseases
184107|NCT02191605|Computerized Brief Intervention|computerized brief intervention
184108|NCT02191592|Tinnitus|tinnitus
184109|NCT02191592|EMA|ema
184110|NCT02191592|Bothersome|bothersome
224623|NCT02006030|ADI|adi
184111|NCT02191566|Stomach Cancer|stomach cancer
184112|NCT02191553|mindfulness meditation|mindfulness meditation
184113|NCT02191553|alpha rhythm|alpha rhythm
184114|NCT02191553|EEG|eeg
184115|NCT02191553|brain mapping|brain mapping
184116|NCT02191553|emotion|emotion
184117|NCT02191553|attention|attention
184118|NCT02191527|PMTCT|pmtct
184119|NCT02191527|HIV|hiv
184120|NCT02191527|Syphilis|syphilis
184121|NCT02191527|Anemia during pregnancy|anemia during pregnancy
184122|NCT02191527|Point of care diagnostics|point of care diagnostics
184123|NCT02191514|Prehospital|prehospital
184124|NCT02191514|EMS|ems
184125|NCT02191514|EMD|emd
184126|NCT02191514|Stroke|stroke
184127|NCT02191514|Dispatch|dispatch
184128|NCT02191501|Obesity Treatment|obesity treatment
184129|NCT02191501|Endoscopy|endoscopy
184130|NCT02191501|Pyloric Suturing|pyloric suturing
184131|NCT02191501|Pyloric restriction|pyloric restriction
184132|NCT02191488|Fluorescence|fluorescence
184133|NCT02191488|Brain Tumors|brain tumors
184134|NCT02191488|Brain Metastases|brain metastases
184135|NCT02191488|Malignant Glioma|malignant glioma
184136|NCT02191488|Brain Lesions|brain lesions
184137|NCT02191475|sepsis shock|sepsis shock
184138|NCT02191475|Tigecycline|tigecycline
184139|NCT02191475|Piperacillin / tazobactam|piperacillin / tazobactam
184140|NCT02191475|Abdominal infection|abdominal infection
184141|NCT02191462|Pharmacokinetics|pharmacokinetics
184142|NCT02191462|Niagen|niagen
184143|NCT02191462|Nicotinamide riboside|nicotinamide riboside
184144|NCT02191436|Haemophilia|haemophilia
184145|NCT02191436|Adherence|adherence
184146|NCT02191436|Family Functioning|family functioning
184147|NCT02191436|Quality of Life|quality of life
184148|NCT02191436|Anxiety|anxiety
184149|NCT02191436|Illness Behavior|illness behavior
184150|NCT02191436|Coping Strategies|coping strategies
184151|NCT02191423|postpartum Depression|postpartum depression
184152|NCT02191423|Diadic psychotherapy|diadic psychotherapy
184153|NCT02191423|Oxytocin|oxytocin
184154|NCT02191423|fMRI|fmri
184155|NCT02191423|attachment|attachment
184156|NCT02191423|empathy|empathy
184285|NCT02191046|nasal irrigation device|nasal irrigation device
184157|NCT02191410|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
184158|NCT02191410|one-lung ventilation|one-lung ventilation
184159|NCT02191410|continuous positive-airway ventilation|continuous positive-airway ventilation
184160|NCT02191410|high-frequency positive-pressure ventilation|high-frequency positive-pressure ventilation
184161|NCT02191410|stroke volume variation|stroke volume variation
184162|NCT02191410|fluid responsiveness|fluid responsiveness
184568|NCT02189811|Pakistan|pakistan
184163|NCT02191397|Escitalopram|escitalopram
184164|NCT02191397|Major depressive disorder|major depressive disorder
184165|NCT02191397|Non-inferiority|non-inferiority
184166|NCT02191397|Bupropion|bupropion
184167|NCT02191371|oxygenation|oxygenation
184168|NCT02191371|microcirculation|microcirculation
184169|NCT02191371|one-lung ventilation|one-lung ventilation
184170|NCT02191371|thoracic surgery|thoracic surgery
184171|NCT02191358|Cytochrome drug interactions|cytochrome drug interactions
184172|NCT02191358|Drug-drug interaction|drug-drug interaction
184173|NCT02191358|Drug-gene interaction|drug-gene interaction
184174|NCT02191358|Drug-drug-gene interaction|drug-drug-gene interaction
184175|NCT02191358|Drug Metabolism|drug metabolism
184176|NCT02191358|Elderly|elderly
184177|NCT02191358|Geriatric medicine|geriatric medicine
184178|NCT02191358|Geriatrics|geriatrics
184179|NCT02191358|Personalized medicine|personalized medicine
184180|NCT02191358|Pharmacist|pharmacist
184181|NCT02191358|Pharmacogenetics|pharmacogenetics
184182|NCT02191358|Pharmacogenomics|pharmacogenomics
184183|NCT02191358|Pharmacokinetics|pharmacokinetics
184184|NCT02191358|Polymorphism|polymorphism
184185|NCT02191358|Polypharmacy|polypharmacy
184186|NCT02191358|Precision medicine|precision medicine
184187|NCT02191358|Seniors|seniors
184188|NCT02191358|YouScript|youscript
184189|NCT02191358|CYP2C9|cyp2c9
184190|NCT02191358|CYP2C19|cyp2c19
184191|NCT02191358|CYP2D6|cyp2d6
184192|NCT02191358|CYP3A4|cyp3a4
184193|NCT02191358|CYP3A5|cyp3a5
184194|NCT02191358|VKORC1|vkorc1
184195|NCT02191358|Amitriptyline|amitriptyline
184196|NCT02191358|Aripiprazole|aripiprazole
184197|NCT02191358|Atomoxetine|atomoxetine
184198|NCT02191358|Carvedilol|carvedilol
184199|NCT02191358|Celecoxib|celecoxib
184200|NCT02191358|Citalopram|citalopram
184201|NCT02191358|Clobazam|clobazam
184202|NCT02191358|Clomipramine|clomipramine
184203|NCT02191358|Clopidogrel|clopidogrel
184204|NCT02191358|Clozapine|clozapine
184205|NCT02191358|Codeine|codeine
184206|NCT02191358|Desipramine|desipramine
184207|NCT02191358|Dextromethorphan|dextromethorphan
184208|NCT02191358|Diazepam|diazepam
184209|NCT02191358|Doxepin|doxepin
184210|NCT02191358|Escitalopram|escitalopram
184211|NCT02191358|Esomeprazole|esomeprazole
184212|NCT02191358|Fesoterodine|fesoterodine
184213|NCT02191358|Flecainide|flecainide
184214|NCT02191358|Fluoxetine|fluoxetine
184215|NCT02191358|Flurbiprofen|flurbiprofen
184216|NCT02191358|Fluvoxamine|fluvoxamine
184217|NCT02191358|Haloperidol|haloperidol
184218|NCT02191358|Hydrocodone|hydrocodone
184219|NCT02191358|Ibuprofen|ibuprofen
184220|NCT02191358|Iloperidone|iloperidone
184221|NCT02191358|Imipramine|imipramine
184222|NCT02191358|Indomethacin|indomethacin
184223|NCT02191358|Meloxicam|meloxicam
184224|NCT02191358|Metoprolol|metoprolol
184225|NCT02191358|Mexiletine|mexiletine
184226|NCT02191358|Nortriptyline|nortriptyline
184227|NCT02191358|Omeprazole|omeprazole
184228|NCT02191358|Oxycodone|oxycodone
184229|NCT02191358|Paroxetine|paroxetine
184230|NCT02191358|Perphenazine|perphenazine
184231|NCT02191358|Phenobarbital|phenobarbital
184232|NCT02191358|Phenytoin|phenytoin
184233|NCT02191358|Pimozide|pimozide
184234|NCT02191358|Piroxicam|piroxicam
184235|NCT02191358|Proguanil|proguanil
184236|NCT02191358|Propafenone|propafenone
184237|NCT02191358|Propranolol|propranolol
184238|NCT02191358|Risperidone|risperidone
184239|NCT02191358|Sertraline|sertraline
184240|NCT02191358|Tetrabenazine|tetrabenazine
184241|NCT02191358|Thioridazine|thioridazine
184242|NCT02191358|Timolol|timolol
184243|NCT02191358|Tolterodine|tolterodine
184244|NCT02191358|Torsemide|torsemide
184245|NCT02191358|Tramadol|tramadol
184246|NCT02191358|Trimipramine|trimipramine
184247|NCT02191358|Venlafaxine|venlafaxine
184248|NCT02191358|Voriconazole|voriconazole
184249|NCT02191358|Vortioxetine|vortioxetine
184250|NCT02191345|guided imagery|guided imagery
184251|NCT02191345|burnout|burnout
184252|NCT02191345|compassion fatigue|compassion fatigue
184253|NCT02191345|state anxiety|state anxiety
184254|NCT02191267|CTE|cte
184255|NCT02191267|Positron Emission Topography|positron emission topography
184256|NCT02191267|Tau|tau
184257|NCT02191267|Beta-amyloid|beta-amyloid
184258|NCT02191267|Magnetic Resonance Imaging|magnetic resonance imaging
184259|NCT02191267|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
184260|NCT02191267|Diffusion Tensor Imaging|diffusion tensor imaging
184261|NCT02191150|Anaemia, Chronic Kidney Disease, Switching, Aranesp, Darbepoetin Alfa, Epoetin Alfa Biosimilars, Haemodialysis.|anaemia, chronic kidney disease, switching, aranesp, darbepoetin alfa, epoetin alfa biosimilars, haemodialysis.
184262|NCT02191137|Pulmonary Hypertension,Riociguat,Living with Pulmonary Hypertension Questionnaire|pulmonary hypertension,riociguat,living with pulmonary hypertension questionnaire
184263|NCT02191124|Measurement-based care|measurement-based care
184264|NCT02191124|Unipolar depression|unipolar depression
184265|NCT02191124|Outpatients|outpatients
184266|NCT02191111|Pharmacist|pharmacist
184267|NCT02191111|Pharmacy practice|pharmacy practice
184268|NCT02191111|Patient care|patient care
184269|NCT02191111|Community pharmacy|community pharmacy
184270|NCT02191111|Hypertension|hypertension
184271|NCT02191111|Diabetes|diabetes
184272|NCT02191111|Dyslipidemia|dyslipidemia
184273|NCT02191111|Pharmaceutical care|pharmaceutical care
184274|NCT02191098|HIV|hiv
184275|NCT02191098|ART|art
184276|NCT02191072|urticaria,omalizumab|urticaria,omalizumab
184277|NCT02191059|Non Small Cell Lung Cancer|non small cell lung cancer
184278|NCT02191059|Wild Type EGFR|wild type egfr
184279|NCT02191059|Icotinib|icotinib
184280|NCT02191059|Second-line Treatment|second-line treatment
184281|NCT02191046|nasal irrigation|nasal irrigation
184282|NCT02191046|sinusitis|sinusitis
184283|NCT02191046|children|children
184284|NCT02191046|buffered hypertonic saline|buffered hypertonic saline
184286|NCT02191033|cigarette smoking|cigarette smoking
184287|NCT02191033|tobacco use cessation products|tobacco use cessation products
184288|NCT02191020|Total Glucosides of Paeony(TGP)|total glucosides of paeony(tgp)
184289|NCT02191020|Acitretin Capsules|acitretin capsules
184290|NCT02191020|Psoriasis Vulgaris|psoriasis vulgaris
184291|NCT02190994|Hydrocortisone|hydrocortisone
184292|NCT02190994|Pituitary adenomas|pituitary adenomas
184293|NCT02190994|Replacement therapy|replacement therapy
184294|NCT02190981|Small bowel obstruction|small bowel obstruction
184295|NCT02190981|Ultrasound|ultrasound
184296|NCT02190981|Emergency department|emergency department
184297|NCT02190968|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
184298|NCT02190968|Internet interventions|internet interventions
184299|NCT02190968|Residual depressive symptoms|residual depressive symptoms
184300|NCT02190968|Depressive relapse prevention|depressive relapse prevention
184301|NCT02190903|delirium|delirium
184302|NCT02190903|hip fracture|hip fracture
184303|NCT02190903|general anesthesia|general anesthesia
184304|NCT02190903|spinal anesthesia|spinal anesthesia
184305|NCT02190903|postoperative complications|postoperative complications
184306|NCT02190877|Heart Failure|heart failure
184307|NCT02190877|Impedance|impedance
184308|NCT02190877|Fluids|fluids
184309|NCT02190851|urinary disorders|urinary disorders
184310|NCT02190851|Parkinson's disease|parkinson's disease
184311|NCT02190838|Melanoma|melanoma
184312|NCT02190838|Melatonin|melatonin
184313|NCT02190838|Metformin|metformin
184314|NCT02190838|Dacarbazine|dacarbazine
184315|NCT02190812|wrist muscle strength|wrist muscle strength
184316|NCT02190799|Corona Virus|corona virus
184317|NCT02190799|Convalescent plasma|convalescent plasma
184318|NCT02190799|Serology|serology
184319|NCT02190786|Hyperuricemia|hyperuricemia
184320|NCT02190773|Chronic Periodontitis, Aggressive Periodontitis, RANKL/OPG ratio, Gingival crevicular fluid|chronic periodontitis, aggressive periodontitis, rankl/opg ratio, gingival crevicular fluid
184321|NCT02190747|Intervention study|intervention study
184322|NCT02190747|Clinical trial Phase 2|clinical trial phase 2
184323|NCT02190747|Efficacy and safety|efficacy and safety
184324|NCT02190747|Heterotopic ossification|heterotopic ossification
184325|NCT02190747|Flare-up|flare-up
184326|NCT02190747|Palovarotene|palovarotene
184327|NCT02190747|Retinoic acid receptor agonist|retinoic acid receptor agonist
184328|NCT02190747|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
184329|NCT02190747|Clementia|clementia
184330|NCT02190747|Myositis Ossificans Progressiva|myositis ossificans progressiva
184331|NCT02190747|Munchmeyer's Disease|munchmeyer's disease
184332|NCT02190747|FOP|fop
184333|NCT02190734|Stroke|stroke
184334|NCT02190734|Pusher Syndrome|pusher syndrome
184335|NCT02190734|Lateropulsion|lateropulsion
184336|NCT02190734|Pushing Behaviors|pushing behaviors
184337|NCT02190734|Burke Lateropulsion Scale|burke lateropulsion scale
184338|NCT02190721|Neutropenia|neutropenia
184339|NCT02190708|PQ912|pq912
184340|NCT02190708|Midazolam|midazolam
184341|NCT02190708|Omeprazole|omeprazole
184342|NCT02190708|Pharmacokinetics|pharmacokinetics
184343|NCT02190708|Drug Interaction|drug interaction
668336|NCT00850265|Formoterol|formoterol
184344|NCT02190682|postoperative|postoperative
184345|NCT02190682|chronic|chronic
184346|NCT02190682|pain|pain
184347|NCT02190682|software|software
184348|NCT02190656|Rectal cancer|rectal cancer
184349|NCT02190656|Anterior Resection Syndrome|anterior resection syndrome
184350|NCT02190656|Functional outcomes|functional outcomes
184351|NCT02190643|Smoking|smoking
184352|NCT02190643|HIV|hiv
184353|NCT02190643|Latino|latino
184354|NCT02190643|Cessation|cessation
184355|NCT02190643|Nicotine patch|nicotine patch
184356|NCT02190617|Asthma|asthma
184357|NCT02190617|Guidelines|guidelines
184358|NCT02190617|Community Health Worker|community health worker
184359|NCT02190604|FEV1- Forced Expiratory volume|fev1- forced expiratory volume
184360|NCT02190604|LCI - Lung Clearance Index|lci - lung clearance index
184361|NCT02190604|CFTR - cystic fibrosis transmembrane conductance regulator|cftr - cystic fibrosis transmembrane conductance regulator
184362|NCT02190604|cystic fibrosis|cystic fibrosis
184363|NCT02190604|allergic bronchopulmonary aspergillosis|allergic bronchopulmonary aspergillosis
184364|NCT02190591|epidural|epidural
184366|NCT02190591|Cesarean Section|cesarean section
184367|NCT02190591|forceps|forceps
184368|NCT02190591|vaginal|vaginal
184369|NCT02190565|pregnancy, lactation, food supplement, anaemia|pregnancy, lactation, food supplement, anaemia
184370|NCT02190552|Brain|brain
184371|NCT02190552|Brain Clot|brain clot
184372|NCT02190552|Brain Diseases|brain diseases
184373|NCT02190552|Brain Infarction|brain infarction
184374|NCT02190552|Cerebral Ischemia|cerebral ischemia
184375|NCT02190552|Cerebrovascular Disorders|cerebrovascular disorders
184376|NCT02190552|EmboTrap® Revascularization Device|embotrap® revascularization device
184377|NCT02190552|EmboTrap|embotrap
184378|NCT02190552|Ischemia|ischemia
184379|NCT02190552|Ischemic|ischemic
184380|NCT02190552|Ischemic Stroke|ischemic stroke
184381|NCT02190552|Mechanical Thrombectomy|mechanical thrombectomy
184382|NCT02190552|Neurovascular Intervention|neurovascular intervention
184383|NCT02190552|Revascularization|revascularization
184384|NCT02190552|Stent Retriever|stent retriever
184385|NCT02190552|Stroke|stroke
184386|NCT02190552|Vascular Diseases|vascular diseases
184387|NCT02190539|Breast cancer|breast cancer
184388|NCT02190539|complementary medicine|complementary medicine
184389|NCT02190539|homeopathy|homeopathy
184390|NCT02190539|quality of life|quality of life
184391|NCT02190526|mesalamine|mesalamine
184392|NCT02190526|amitriptyline|amitriptyline
184393|NCT02190526|Severity of Illness Index|severity of illness index
184394|NCT02190500|stroke|stroke
184395|NCT02190500|tpa|tpa
184396|NCT02190500|emergency medical service|emergency medical service
184397|NCT02190500|ems|ems
184398|NCT02190500|mobile|mobile
184399|NCT02190500|ct scan|ct scan
184400|NCT02190474|fibromyalgia|fibromyalgia
184401|NCT02190474|juvenile fibromyalgia|juvenile fibromyalgia
184402|NCT02190474|juvenile primary fibromyalgia syndrome (JPFS)|juvenile primary fibromyalgia syndrome (jpfs)
184403|NCT02190474|adolescent pain|adolescent pain
184404|NCT02190474|mindfulness|mindfulness
184405|NCT02190474|MBSR|mbsr
184406|NCT02190461|Early Respiratory Rehabilitation|early respiratory rehabilitation
184407|NCT02190461|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
184408|NCT02190461|Re-admitted patients|re-admitted patients
184409|NCT02190461|Open clinical trial|open clinical trial
184410|NCT02190461|Exacerbations|exacerbations
184411|NCT02190448|galactogogue|galactogogue
184412|NCT02190448|lactation|lactation
184413|NCT02190448|milk production|milk production
184414|NCT02190448|breastfeeding|breastfeeding
184415|NCT02190435|Computer-assisted navigation|computer-assisted navigation
184416|NCT02190435|ADAPT|adapt
184417|NCT02190435|Intramedullary nail|intramedullary nail
184418|NCT02190435|Intertrochanteric femur fracture|intertrochanteric femur fracture
184419|NCT02190422|reproductive technologies, assisted|reproductive technologies, assisted
184420|NCT02190422|echocardiography|echocardiography
184421|NCT02190422|cardiology|cardiology
184422|NCT02190422|pediatrics|pediatrics
184423|NCT02190409|Dental Implant,|dental implant,
184424|NCT02190396|Calcium|calcium
184425|NCT02190396|Vitamin D|vitamin d
184426|NCT02190396|Placental calcification.|placental calcification.
184427|NCT02190383|Tic-Disorder, Tourette-Disorder, Habit Reversal Training|tic-disorder, tourette-disorder, habit reversal training
184428|NCT02190370|Tic-Disorder, Tourette-Disorder, Resources activation|tic-disorder, tourette-disorder, resources activation
184429|NCT02190357|Cirrhosis|cirrhosis
184430|NCT02190344|Eight|eight
184431|NCT02190344|Channel|channel
184432|NCT02190344|Paddle|paddle
184433|NCT02190344|Coil|coil
184434|NCT02190344|MRI|mri
184435|NCT02190344|Prostate|prostate
184436|NCT02190344|Healthy Male|healthy male
184437|NCT02190331|Detraining|detraining
184438|NCT02190331|Neck|neck
184439|NCT02190331|Exercise|exercise
184440|NCT02190331|Posture|posture
184441|NCT02190331|Rehabilitation|rehabilitation
184442|NCT02190318|peritoneal dialysis；|peritoneal dialysis；
668541|NCT00851006|Depression|depression
184443|NCT02190318|residual renal function；|residual renal function；
184444|NCT02190318|RAAS|raas
184445|NCT02190279|Prostate Specific Membrane Antigen|prostate specific membrane antigen
184446|NCT02190279|Radiolabeled PET Agent|radiolabeled pet agent
184447|NCT02190279|Imaging|imaging
184448|NCT02190279|NaF|naf
184449|NCT02190266|Extrapulmonary|extrapulmonary
184450|NCT02190266|Immunodeficiency|immunodeficiency
184451|NCT02190266|Genetics|genetics
184452|NCT02190266|Infection|infection
184453|NCT02190266|Fungal|fungal
184454|NCT02190253|Renal Threshold|renal threshold
184455|NCT02190253|Liver Transplant|liver transplant
184456|NCT02190253|Transplantation|transplantation
184457|NCT02190253|Hepatitis E|hepatitis e
184458|NCT02190240|Complementary and Alternative Medicine|complementary and alternative medicine
184459|NCT02190240|Integrative Medicine|integrative medicine
184460|NCT02190240|Pain Management|pain management
184461|NCT02190227|Breast Cancer|breast cancer
184462|NCT02190227|Chemotherapy|chemotherapy
184463|NCT02190227|Neoadjuvant|neoadjuvant
184464|NCT02190227|RNA Disruption Assay|rna disruption assay
184465|NCT02190227|Biopsies|biopsies
184466|NCT02190227|Response|response
184467|NCT02190214|Hyperthyroidism|hyperthyroidism
184468|NCT02190214|Hypothyroidism|hypothyroidism
184469|NCT02190214|Autoimmune thyroid disorders|autoimmune thyroid disorders
184470|NCT02190214|Iodine deficiency|iodine deficiency
184471|NCT02190214|Genetic susceptibility|genetic susceptibility
184472|NCT02190201|videolaryngoscope|videolaryngoscope
184473|NCT02190201|double lumen intubation|double lumen intubation
184474|NCT02190188|wedge insoles,|wedge insoles,
184475|NCT02190188|knee brace,|knee brace,
184476|NCT02190188|orthotic device|orthotic device
184477|NCT02190188|goal|goal
184478|NCT02190162|Patients undergoing tonsillectomy with or without adenoidectomy|patients undergoing tonsillectomy with or without adenoidectomy
184479|NCT02190149|Factor VIII Deficiency|factor viii deficiency
184480|NCT02190149|Factor FIX Deficiency|factor fix deficiency
184481|NCT02190136|obesity|obesity
184482|NCT02190136|protein-rich whole foods diet|protein-rich whole foods diet
184483|NCT02190136|aerobic fitness|aerobic fitness
184484|NCT02190136|resistance training|resistance training
184485|NCT02190136|stretching/yoga training|stretching/yoga training
184486|NCT02190136|glycemia|glycemia
184487|NCT02190136|mood state|mood state
184488|NCT02190123|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
184489|NCT02190123|Oral antiplatelets (ticagrelor, prasugrel, clopidogrel) (OAP)|oral antiplatelets (ticagrelor, prasugrel, clopidogrel) (oap)
184490|NCT02190123|Treatment persistence.|treatment persistence.
184491|NCT02190110|Pulmonary embolism|pulmonary embolism
184492|NCT02190110|diagnosis|diagnosis
184493|NCT02190110|emergency medicine|emergency medicine
184494|NCT02190110|ultrasonography|ultrasonography
184495|NCT02190097|PCOS|pcos
184496|NCT02190097|insulin sensitivity|insulin sensitivity
184497|NCT02190097|paleolithic diet|paleolithic diet
184498|NCT02190084|apathy|apathy
184499|NCT02190084|Alzheimer's|alzheimer's
184500|NCT02190084|executive function|executive function
184501|NCT02190071|EUS-FNA|eus-fna
184502|NCT02190071|cytopathology|cytopathology
184503|NCT02190071|slide smear|slide smear
184504|NCT02190058|safety|safety
184505|NCT02190058|pharmacokinetics|pharmacokinetics
184506|NCT02190058|DS-1971a|ds-1971a
184507|NCT02190045|Balance|balance
184508|NCT02190045|gait|gait
184509|NCT02190045|Wii-Fit|wii-fit
184510|NCT02190019|Mild Cognitive Impairment|mild cognitive impairment
184511|NCT02190019|apathy|apathy
184512|NCT02190019|executive function|executive function
184513|NCT02190006|Polycystic ovarian syndrome|polycystic ovarian syndrome
184514|NCT02190006|Follicle output rate|follicle output rate
184515|NCT02190006|preovulatory count|preovulatory count
184516|NCT02190006|ICSI|icsi
184517|NCT02189993|Mortality|mortality
184518|NCT02189993|Long term follow-up|long term follow-up
184519|NCT02189993|Parenteral Nutrition, Total|parenteral nutrition, total
184520|NCT02189980|Nausea|nausea
184521|NCT02189980|Post-operative|post-operative
184522|NCT02189967|non-small cell lung cancer|non-small cell lung cancer
184523|NCT02189967|radiotherapy|radiotherapy
184524|NCT02189967|accelerated fractionation|accelerated fractionation
184525|NCT02189967|conventional fractionation|conventional fractionation
184526|NCT02189967|postoperative|postoperative
184527|NCT02189954|elderly; laryngeal masks; postoperative complications|elderly; laryngeal masks; postoperative complications
184528|NCT02189941|Deferiprone|deferiprone
184529|NCT02189941|Deferiprone sustained-release tablets|deferiprone sustained-release tablets
184530|NCT02189941|Pharmacokinetics|pharmacokinetics
184531|NCT02189902|Vitamin D|vitamin d
184532|NCT02189889|Active preoperative anemia management|active preoperative anemia management
184533|NCT02189889|Erythrocyte transfusion|erythrocyte transfusion
184534|NCT02189889|RBC transfusion|rbc transfusion
184535|NCT02189889|Red cell transfusion|red cell transfusion
184536|NCT02189889|Transfusion in cardiac surgery|transfusion in cardiac surgery
184537|NCT02189889|Anemia treatment with erythropoietin|anemia treatment with erythropoietin
668542|NCT00851006|Females|females
184538|NCT02189889|Anemic cardiac surgery patients|anemic cardiac surgery patients
184539|NCT02189889|Erythrocyte stimulating agent (ESA)|erythrocyte stimulating agent (esa)
184540|NCT02189889|Iron deficiency anemia|iron deficiency anemia
184542|NCT02189889|Feraheme|feraheme
184543|NCT02189876|HIV Prevention|hiv prevention
184544|NCT02189876|Behavioral Intervention|behavioral intervention
184545|NCT02189876|Condom Use|condom use
184546|NCT02189876|African American|african american
184547|NCT02189876|Sexually Transmitted Disease|sexually transmitted disease
184548|NCT02189876|Sexually Transmitted Infection|sexually transmitted infection
184549|NCT02189876|Internet|internet
184550|NCT02189863|Driving Simulator|driving simulator
184551|NCT02189863|Air Optix Aqua|air optix aqua
184552|NCT02189863|AOAMF|aoamf
184553|NCT02189850|colonoscopy|colonoscopy
184554|NCT02189850|pediatric|pediatric
184555|NCT02189837|Raised cholesterol|raised cholesterol
184556|NCT02189837|Cholesterol|cholesterol
184557|NCT02189837|Elevated Cholesterol|elevated cholesterol
184558|NCT02189837|Hyperlipidemias|hyperlipidemias
184559|NCT02189837|Dyslipidemias|dyslipidemias
184560|NCT02189837|Lipid Metabolism Disorders|lipid metabolism disorders
184561|NCT02189837|Metabolic Diseases|metabolic diseases
184562|NCT02189811|IPV|ipv
184563|NCT02189811|OPV|opv
184564|NCT02189811|tOPV|topv
184565|NCT02189811|bOPV|bopv
184566|NCT02189811|Polio|polio
184567|NCT02189811|Endgame|endgame
184569|NCT02189798|Cochlear Implant|cochlear implant
184570|NCT02189798|HiRes™ 90K Advantage implant|hires™ 90k advantage implant
184571|NCT02189798|Cochlear Implantation|cochlear implantation
184572|NCT02189798|HiFocus™ Mid-Scala electrode|hifocus™ mid-scala electrode
184573|NCT02189798|Listening Benefits|listening benefits
184574|NCT02189798|Adults|adults
184575|NCT02189798|Cochlear Implant Benefit|cochlear implant benefit
184576|NCT02189798|Electrical Stimulation|electrical stimulation
184577|NCT02189798|Electro-Acoustic Stimulation (EAS)|electro-acoustic stimulation (eas)
184578|NCT02189785|social|social
184579|NCT02189785|rejection|rejection
184580|NCT02189785|acceptance|acceptance
184581|NCT02189785|PET|pet
184582|NCT02189785|opioid|opioid
184583|NCT02189785|fMRI|fmri
184584|NCT02189785|reward|reward
184585|NCT02189785|exclusion|exclusion
184586|NCT02189772|ADHD|adhd
184587|NCT02189772|Inattention|inattention
184588|NCT02189772|MDX|mdx
184589|NCT02189759|Hypothermia|hypothermia
184590|NCT02189759|Hyperthermia|hyperthermia
184591|NCT02189759|Kangaroo Mother Care|kangaroo mother care
184592|NCT02189759|Newborn|newborn
184593|NCT02189746|Hypothermia|hypothermia
184594|NCT02189746|Newborn|newborn
184595|NCT02189746|Hyperthermia|hyperthermia
184596|NCT02189746|Kangaroo mother care|kangaroo mother care
184597|NCT02189720|Amifampridine Phosphate|amifampridine phosphate
184598|NCT02189720|Amifampridine|amifampridine
184599|NCT02189720|3,4-Diaminopyridine Phosphate|3,4-diaminopyridine phosphate
184600|NCT02189720|3,4-Diaminopyridine|3,4-diaminopyridine
184601|NCT02189720|3,4-DAP|3,4-dap
184602|NCT02189720|LEMS|lems
184603|NCT02189720|CMS|cms
184604|NCT02189720|Lambert-Eaton Myasthenic Syndrome|lambert-eaton myasthenic syndrome
184605|NCT02189720|Congenital Myasthenic Syndrome|congenital myasthenic syndrome
184606|NCT02189720|Neuromuscular disorders|neuromuscular disorders
184607|NCT02189720|Neuromuscular|neuromuscular
184608|NCT02189720|eye movement|eye movement
184609|NCT02189720|electromyography|electromyography
184610|NCT02189720|EMG|emg
184611|NCT02189720|Expanded Access|expanded access
184612|NCT02189720|Firdapse®|firdapse®
184613|NCT02189720|Downbeat Nystagmus|downbeat nystagmus
184614|NCT02189707|Gastrointestinal disorder|gastrointestinal disorder
184615|NCT02189707|Constipation|constipation
184616|NCT02189707|Probiotics|probiotics
184617|NCT02189707|Dietary supplement|dietary supplement
184618|NCT02189694|Type 1 diabetes|type 1 diabetes
184619|NCT02189694|Hypoglycemia|hypoglycemia
184620|NCT02189694|Insulin|insulin
184621|NCT02189694|Glucagon|glucagon
184622|NCT02189694|Closed-loop system|closed-loop system
184623|NCT02189694|Artificial pancreas|artificial pancreas
184624|NCT02189681|spinal anaesthesia|spinal anaesthesia
184625|NCT02189681|ultrasound|ultrasound
184626|NCT02189681|paramedian|paramedian
184627|NCT02189668|Appendicitis|appendicitis
184628|NCT02189668|Non-operative|non-operative
184629|NCT02189668|Children|children
184630|NCT02189668|Appendicolith|appendicolith
184631|NCT02189668|fecalith|fecalith
184632|NCT02189668|Pediatrics|pediatrics
184633|NCT02189655|shivering spinal anesthesia|shivering spinal anesthesia
184634|NCT02189629|Acne vulgaris|acne vulgaris
184635|NCT02189629|Safety|safety
184636|NCT02189629|Face|face
184637|NCT02189629|Trunk|trunk
184638|NCT02189616|asthma management|asthma management
184639|NCT02189616|SMS reminder|sms reminder
184640|NCT02189616|SMS consultation|sms consultation
184641|NCT02189603|hepatitis E|hepatitis e
184642|NCT02189603|Immunogenicity|immunogenicity
184643|NCT02189603|vaccine|vaccine
184647|NCT02189590|fiberoptic guided tracheal intubation|fiberoptic guided tracheal intubation
184649|NCT02189590|i-gel|i-gel
184650|NCT02189577|Chronic Obstructive Pulmonary disease|chronic obstructive pulmonary disease
184651|NCT02189577|COPD|copd
184652|NCT02189538|Infections, Enteral nutrition, SIRS, critically ill|infections, enteral nutrition, sirs, critically ill
184653|NCT02189525|traumatic brain injury|traumatic brain injury
184654|NCT02189525|sports head injury|sports head injury
184655|NCT02189525|sports concussion|sports concussion
184656|NCT02189512|brain-death organ donors|brain-death organ donors
184657|NCT02189512|intestinal manipulation|intestinal manipulation
184658|NCT02189512|monocytes|monocytes
184659|NCT02189499|Stents|stents
184660|NCT02189499|Angioplasty|angioplasty
184661|NCT02189499|Coronary Vessels|coronary vessels
184662|NCT02189499|Coronary Artery Disease|coronary artery disease
184663|NCT02189499|Angina Pectoris|angina pectoris
184664|NCT02189499|Myocardial Ischemia|myocardial ischemia
184665|NCT02189499|Myocardial Infarction|myocardial infarction
184666|NCT02189499|Myocardial Revascularization|myocardial revascularization
184667|NCT02189486|Prostate Cancer|prostate cancer
184668|NCT02189486|Radical Prostatectomy|radical prostatectomy
184669|NCT02189486|Prostate biopsy|prostate biopsy
184670|NCT02189486|Upgrading|upgrading
184671|NCT02189486|Upgrading Reference set|upgrading reference set
185477|NCT02186236|urine|urine
184672|NCT02189473|metastatic epidural spinal cord compression|metastatic epidural spinal cord compression
184673|NCT02189473|motor function|motor function
184674|NCT02189473|ambulatory status|ambulatory status
184675|NCT02189473|pain|pain
184676|NCT02189473|quality of life|quality of life
184677|NCT02189473|overall survival|overall survival
184678|NCT02189473|local control|local control
184679|NCT02189473|toxicity|toxicity
184680|NCT02189460|Cognition|cognition
184681|NCT02189447|Keratoconus|keratoconus
184682|NCT02189447|Ectasia|ectasia
184683|NCT02189447|Corneal Cross-linking|corneal cross-linking
184684|NCT02189421|peroral cholangioscopy|peroral cholangioscopy
184685|NCT02189421|ultra-slim upper endoscope|ultra-slim upper endoscope
184686|NCT02189421|multibending endoscope|multibending endoscope
184687|NCT02189408|Platelet rich plasma|platelet rich plasma
184688|NCT02189408|Autologous conditioned plasma|autologous conditioned plasma
184689|NCT02189408|Outerbridge|outerbridge
184690|NCT02189395|Type 2 diabetes|type 2 diabetes
184691|NCT02189395|Uncontrolled blood glucose|uncontrolled blood glucose
184692|NCT02189395|insulin|insulin
184693|NCT02189395|glargine|glargine
184694|NCT02189395|NPH|nph
184695|NCT02189382|Sensitivity|sensitivity
184696|NCT02189356|Pregnancy-related low back and pelvic pain|pregnancy-related low back and pelvic pain
184698|NCT02189356|nurse|nurse
184699|NCT02189343|Multiple Myeloma|multiple myeloma
184700|NCT02189343|Relapsed and Refractory|relapsed and refractory
184701|NCT02189343|Refractory Disease|refractory disease
184702|NCT02189343|Progressive Disease|progressive disease
184703|NCT02189343|Pomalidomide|pomalidomide
184704|NCT02189343|Dexamethasone|dexamethasone
184705|NCT02189343|Proteasome Inhibitor|proteasome inhibitor
184706|NCT02189343|Ricolinostat|ricolinostat
184707|NCT02189304|Healthy volunteers|healthy volunteers
184708|NCT02189291|Indwelling catheter|indwelling catheter
184709|NCT02189291|Hospital stay|hospital stay
184710|NCT02189291|Urinary tract infection|urinary tract infection
184711|NCT02189291|Sacrocolpopexy|sacrocolpopexy
184716|NCT02189265|Live birth [MeSH]|live birth [mesh]
184717|NCT02189265|Infant [MeSH]|infant [mesh]
184718|NCT02189265|Infant, newborn [MeSH]|infant, newborn [mesh]
184719|NCT02189265|Second-hand smoke|second-hand smoke
184720|NCT02189265|Tobacco smoke pollution [MeSH]|tobacco smoke pollution [mesh]
184721|NCT02189265|Smoke-free|smoke-free
184722|NCT02189265|Smoke-free policy [MeSH]|smoke-free policy [mesh]
184723|NCT02189226|probe-based confocal laser endomicroscopy (pCLE), early gastric cancer (EGC), endoscopic submucosal dissection (ESD), margin|probe-based confocal laser endomicroscopy (pcle), early gastric cancer (egc), endoscopic submucosal dissection (esd), margin
184724|NCT02189213|anxiety|anxiety
184725|NCT02189213|SSRI|ssri
184726|NCT02189213|biomarker|biomarker
184727|NCT02189213|sleep|sleep
184728|NCT02189213|children|children
184729|NCT02189213|adolescents|adolescents
184730|NCT02189213|young adults|young adults
184731|NCT02189200|nutritional counseling|nutritional counseling
184732|NCT02189200|oat bran|oat bran
184733|NCT02189200|dyslipidemia|dyslipidemia
184734|NCT02189200|cardiovascular disease|cardiovascular disease
184735|NCT02189187|Weight Loss|weight loss
184736|NCT02189187|Body Weight Changes|body weight changes
184737|NCT02189187|Body Weight|body weight
184738|NCT02189187|Magnetic Resonance Imaging|magnetic resonance imaging
184739|NCT02189187|Emotions|emotions
184740|NCT02189187|Emotion regulation|emotion regulation
184741|NCT02189187|Health Behavior|health behavior
184742|NCT02189187|Eating behavior|eating behavior
184743|NCT02189174|Solid tumor,|solid tumor,
184744|NCT02189174|breast cancer,|breast cancer,
184745|NCT02189174|lung cancer,|lung cancer,
184746|NCT02189174|endometrial cancer|endometrial cancer
184747|NCT02189161|anal intraepithelial neoplasia|anal intraepithelial neoplasia
184748|NCT02189161|AIN|ain
184749|NCT02189161|Radiofrequency Ablation|radiofrequency ablation
184750|NCT02189161|RFA|rfa
184751|NCT02189148|Prediction|prediction
184752|NCT02189148|Preeclampsia|preeclampsia
184753|NCT02189148|Preterm birth|preterm birth
184754|NCT02189148|Pregnancy|pregnancy
184755|NCT02189148|Placenta|placenta
184756|NCT02189148|Intra-uterine growth restriction|intra-uterine growth restriction
184757|NCT02189148|fetal growth restriction|fetal growth restriction
184758|NCT02189148|Ultrasound|ultrasound
184759|NCT02189148|Doppler|doppler
184760|NCT02189148|Biomarkers|biomarkers
184761|NCT02189148|PAPP-A|papp-a
184762|NCT02189148|Placental growth factor (PlGF)|placental growth factor (plgf)
184763|NCT02189109|glioblastoma|glioblastoma
184764|NCT02189109|multiforme|multiforme
184765|NCT02189109|radiation|radiation
184766|NCT02189109|radiation therapy|radiation therapy
184767|NCT02189096|Sepsis|sepsis
184768|NCT02189096|National Early Warning Score|national early warning score
184769|NCT02189096|Lactate|lactate
184770|NCT02189083|Leiomyoma|leiomyoma
184771|NCT02189083|Medicine, Chinese Traditional|medicine, chinese traditional
184772|NCT02189083|Randomized Controlled Trial|randomized controlled trial
184773|NCT02189070|Follow-up|follow-up
184774|NCT02189070|Percutaneous coronary intervention|percutaneous coronary intervention
184775|NCT02189070|Patient preference|patient preference
184776|NCT02189070|DUTCH PEERS|dutch peers
184777|NCT02189070|TWENTE|twente
184778|NCT02189057|Bipolar|bipolar
184779|NCT02189057|Unipolar|unipolar
184780|NCT02189057|Genotyping|genotyping
184781|NCT02189057|Pharmacokinetic|pharmacokinetic
184782|NCT02189057|Pharmacodynamic|pharmacodynamic
184783|NCT02189044|aged;|aged;
184784|NCT02189044|breathing exercises;|breathing exercises;
184785|NCT02189044|muscle strength.|muscle strength.
184786|NCT02189031|Upper limb Amputee|upper limb amputee
184787|NCT02189031|Targeted Muscle Reinnervation|targeted muscle reinnervation
184788|NCT02189031|Prosthetic|prosthetic
184789|NCT02189018|Peripheral arterial disease|peripheral arterial disease
184790|NCT02189018|Endovascular|endovascular
184791|NCT02189018|Exercise|exercise
184792|NCT02189018|Perfusion|perfusion
184793|NCT02189018|Functional capacity|functional capacity
184794|NCT02189005|High blood sugar|high blood sugar
184795|NCT02189005|High HbA1C|high hba1c
184796|NCT02189005|hyperglycemia|hyperglycemia
184797|NCT02189005|Pre-Diabetes|pre-diabetes
184798|NCT02189005|Natural Supplement for Diabetes|natural supplement for diabetes
184800|NCT02188992|Immune activation|immune activation
184801|NCT02188992|Systemic Inflammation|systemic inflammation
184802|NCT02188992|Emergency Medicine|emergency medicine
184803|NCT02188992|Critical Care|critical care
184804|NCT02188979|airway|airway
184805|NCT02188979|equipment - laryngoscopes|equipment - laryngoscopes
184806|NCT02188979|intubation - tracheal|intubation - tracheal
184807|NCT02188979|obesity.|obesity.
184808|NCT02188966|Geographic Information System|geographic information system
184809|NCT02188966|Emergency Care Information Systems|emergency care information systems
184810|NCT02188966|Telemedicine|telemedicine
184811|NCT02188966|Emergency Hospital Service|emergency hospital service
184812|NCT02188953|aflatoxin|aflatoxin
184813|NCT02188953|Kenya|kenya
184814|NCT02188940|Asthma|asthma
184815|NCT02188940|Obesity|obesity
184816|NCT02188940|Clinical control|clinical control
184817|NCT02188940|Exercise|exercise
184818|NCT02188940|Weight-loss|weight-loss
184819|NCT02188927|Advanced notification letter|advanced notification letter
184820|NCT02188927|Standard invitation|standard invitation
184821|NCT02188927|Participation rate|participation rate
184822|NCT02188927|Colonoscopy|colonoscopy
184823|NCT02188927|Screening|screening
184824|NCT02188927|Colorectal Neoplasms|colorectal neoplasms
184825|NCT02188927|Digestive System Diseases|digestive system diseases
184826|NCT02188914|Inhalant use disorder|inhalant use disorder
184827|NCT02188914|Positron emission tomography|positron emission tomography
184828|NCT02188914|Magnetic Resonance Imaging|magnetic resonance imaging
184829|NCT02188914|Executive functions assessment|executive functions assessment
184830|NCT02188914|Transcriptome|transcriptome
184831|NCT02188901|HCC|hcc
184832|NCT02188901|Sonazoid|sonazoid
184833|NCT02188901|Ultrasonography|ultrasonography
184834|NCT02188901|Screening|screening
184835|NCT02188888|septic shock|septic shock
184836|NCT02188888|esmolol|esmolol
184837|NCT02188888|tachycardia|tachycardia
184838|NCT02188888|betablockers|betablockers
184839|NCT02188875|Fitbit One|fitbit one
184840|NCT02188875|wearable sensor|wearable sensor
184841|NCT02188875|wearable device|wearable device
184842|NCT02188875|web-based intervention|web-based intervention
184843|NCT02188875|SMS text messages|sms text messages
184844|NCT02188875|randomized controlled trial|randomized controlled trial
184845|NCT02188875|physical activity|physical activity
184846|NCT02188875|behavioral intervention|behavioral intervention
184847|NCT02188875|text message prompts|text message prompts
184848|NCT02188875|text messaging|text messaging
184849|NCT02188875|technology|technology
184850|NCT02188875|exercise|exercise
184851|NCT02188862|Rheumatic heart disease|rheumatic heart disease
184852|NCT02188862|Acute rheumatic fever|acute rheumatic fever
184853|NCT02188862|Group A streptococcal disease|group a streptococcal disease
184854|NCT02188862|Streptococcus pyogenes|streptococcus pyogenes
184855|NCT02188862|Genetics|genetics
184856|NCT02188862|Oceania|oceania
184857|NCT02188849|creatine|creatine
184858|NCT02188849|resistance training|resistance training
184859|NCT02188849|older women|older women
184860|NCT02188849|muscle strength|muscle strength
184861|NCT02188823|prediabetes|prediabetes
184862|NCT02188823|obesity|obesity
184863|NCT02188823|mindful eating|mindful eating
184864|NCT02188823|positive affect|positive affect
184865|NCT02188823|low carbohydrate|low carbohydrate
184866|NCT02188823|ketogenic|ketogenic
184867|NCT02188823|diet|diet
184868|NCT02188810|PAL|pal
184869|NCT02188810|fluviral|fluviral
184870|NCT02188810|healthy volunteer|healthy volunteer
184871|NCT02188810|adjuvant|adjuvant
184872|NCT02188810|TH1 immune response|th1 immune response
184873|NCT02188797|homeless|homeless
184874|NCT02188797|young adults|young adults
184875|NCT02188797|substance use|substance use
184876|NCT02188797|HIV risk|hiv risk
184877|NCT02188797|sexual risk behavior|sexual risk behavior
184878|NCT02188797|group motivational interviewing|group motivational interviewing
184879|NCT02188771|Moderate to Severe OA|moderate to severe oa
184880|NCT02188771|VAS score of ≥ 5|vas score of ≥ 5
184881|NCT02188771|grade III-IV Kellgren Lawrence of OA|grade iii-iv kellgren lawrence of oa
184882|NCT02188771|subjects who failed conservative treatment|subjects who failed conservative treatment
184883|NCT02188771|subjects who candidates for total knee replacement (TKR)|subjects who candidates for total knee replacement (tkr)
184884|NCT02188771|subject 45 and 75 years old|subject 45 and 75 years old
184885|NCT02188771|subject is experiencing pain in the intended study knee with a VAS score of ≥ 5|subject is experiencing pain in the intended study knee with a vas score of ≥ 5
184886|NCT02188771|subject has a Body Mass Index (BMI) between 18.5 and 35|subject has a body mass index (bmi) between 18.5 and 35
184887|NCT02188758|iron|iron
184888|NCT02188758|hepcidin-25|hepcidin-25
184889|NCT02188758|pulmonary exacerbation|pulmonary exacerbation
184890|NCT02188758|interleukin-6|interleukin-6
184891|NCT02188745|metastatic|metastatic
184892|NCT02188745|locally advanced|locally advanced
184893|NCT02188745|ER+|er+
184894|NCT02188745|Estrogen therapy|estrogen therapy
184895|NCT02188745|Estradiol therapy|estradiol therapy
184902|NCT02188719|Donor-Alloantigen-Reactive Regulatory T Cell Therapy|donor-alloantigen-reactive regulatory t cell therapy
184903|NCT02188719|Tregs|tregs
184904|NCT02188719|Cell- and Tissue-Based Therapy|cell- and tissue-based therapy
184905|NCT02188719|Immunotherapy, Adoptive|immunotherapy, adoptive
184906|NCT02188719|Liver Transplantation|liver transplantation
184907|NCT02188706|Leukemia|leukemia
184908|NCT02188706|Acute myeloid leukemia|acute myeloid leukemia
184909|NCT02188706|AML|aml
184910|NCT02188706|Myelodysplastic syndrome|myelodysplastic syndrome
184911|NCT02188706|MDS|mds
184912|NCT02188706|Relapsed or refractory|relapsed or refractory
184913|NCT02188706|Decitabine|decitabine
184914|NCT02188706|Dacogen|dacogen
184915|NCT02188706|Carboplatin|carboplatin
184916|NCT02188706|Paraplatin|paraplatin
184917|NCT02188706|Arsenic Trioxide|arsenic trioxide
184918|NCT02188706|ATO|ato
184919|NCT02188706|Trisenox|trisenox
184920|NCT02188680|fructose test|fructose test
184921|NCT02188667|Chronic Noncancer Pain|chronic noncancer pain
184922|NCT02188667|Musculoskeletal Pain|musculoskeletal pain
184923|NCT02188667|Neuropathic Pain|neuropathic pain
184924|NCT02188667|Headache Pain|headache pain
184925|NCT02188654|psoriatic arthritis|psoriatic arthritis
184926|NCT02188654|inflammation|inflammation
184927|NCT02188654|metabolic syndrome|metabolic syndrome
184928|NCT02188654|metformin|metformin
184929|NCT02188641|Psoriatic arthritis|psoriatic arthritis
184930|NCT02188641|inflammation|inflammation
184931|NCT02188641|obesity|obesity
184932|NCT02188641|diet|diet
184933|NCT02188641|exercise|exercise
184934|NCT02188628|Motor recovery, robotics, stroke rehabilitation|motor recovery, robotics, stroke rehabilitation
184935|NCT02188615|Squamous Cell Esophageal Carcinoma|squamous cell esophageal carcinoma
184936|NCT02188615|minimally invasive esophagectomy|minimally invasive esophagectomy
184937|NCT02188615|laparoscopy|laparoscopy
184938|NCT02188615|thoracoscopy|thoracoscopy
184939|NCT02188576|Craniofacial Surgery|craniofacial surgery
184940|NCT02188576|tranexamic acid|tranexamic acid
184941|NCT02188576|Antifibrinolytic|antifibrinolytic
184942|NCT02188563|Smoking cessation|smoking cessation
184943|NCT02188563|Head and neck neoplasms|head and neck neoplasms
184944|NCT02188563|Lung neoplasms|lung neoplasms
184945|NCT02188563|Thoracic neoplasms|thoracic neoplasms
184946|NCT02188563|Radiation|radiation
184947|NCT02188550|relapse or refractory or persistent epithelial ovarian fallopian tube|relapse or refractory or persistent epithelial ovarian fallopian tube
184948|NCT02188550|primary peritoneal carcinoma or endometrial cancer|primary peritoneal carcinoma or endometrial cancer
184949|NCT02188537|Myeloma|myeloma
184950|NCT02188537|proteasome inhibitor-nonresponsive myeloma|proteasome inhibitor-nonresponsive myeloma
184951|NCT02188537|Nelfinavir|nelfinavir
184952|NCT02188537|bortezomib|bortezomib
184953|NCT02188537|bortezomib-sensitizing drug|bortezomib-sensitizing drug
184954|NCT02188524|balance, exercise, compensatory stepping, tai chi|balance, exercise, compensatory stepping, tai chi
184955|NCT02188511|E-Cigarettes|e-cigarettes
184956|NCT02188511|Lung|lung
184957|NCT02188511|Non-Smokers|non-smokers
184958|NCT02188511|Lung Biology|lung biology
184959|NCT02188472|Oxidative Stress|oxidative stress
184960|NCT02188472|antibiotics|antibiotics
184961|NCT02188446|Radical cystectomy|radical cystectomy
184962|NCT02188446|Bladder cancer|bladder cancer
184963|NCT02188446|Smoking cessation|smoking cessation
184964|NCT02188446|Alcohol cessation|alcohol cessation
184965|NCT02188446|Postoperative complications|postoperative complications
185065|NCT02188043|Motivational Intervention|motivational intervention
184966|NCT02188433|Effectiveness of quit immediately (QI) and cut down to quit (CDTQ) interventions in achieving smoking abstinence|effectiveness of quit immediately (qi) and cut down to quit (cdtq) interventions in achieving smoking abstinence
184968|NCT02188420|TMS|tms
184969|NCT02188420|Stroke|stroke
184970|NCT02188420|Paired Associative Stimulation|paired associative stimulation
184971|NCT02188420|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
184972|NCT02188407|thoracotomy|thoracotomy
184973|NCT02188407|one-lung ventilation (OLV)|one-lung ventilation (olv)
184974|NCT02188407|total intravenous anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
185186|NCT02187549|Knee|knee
184975|NCT02188407|volatile induced and maintained anaesthesia (VIMA)|volatile induced and maintained anaesthesia (vima)
184976|NCT02188407|cytokines|cytokines
184977|NCT02188407|interleukine (IL)|interleukine (il)
184978|NCT02188394|migraine,|migraine,
184979|NCT02188394|pressure pain,|pressure pain,
184980|NCT02188394|anesthetic blocks|anesthetic blocks
184981|NCT02188394|patients|patients
184982|NCT02188381|Resistant Hypertension|resistant hypertension
184983|NCT02188381|Uncontrolled Hypertension|uncontrolled hypertension
184984|NCT02188368|Pomalidomide|pomalidomide
184985|NCT02188368|Lenalidomide refractory|lenalidomide refractory
184986|NCT02188368|multiple myeloma|multiple myeloma
184987|NCT02188355|Ultimaster|ultimaster
184988|NCT02188355|registry|registry
184990|NCT02188355|DAPT|dapt
184991|NCT02188329|Early care and education|early care and education
184992|NCT02188329|ECE|ece
184993|NCT02188329|workforce|workforce
184994|NCT02188329|child care|child care
184995|NCT02188329|caregivers|caregivers
184996|NCT02188329|home-based providers|home-based providers
184997|NCT02188329|center-based providers|center-based providers
184998|NCT02188316|Cold forceps polypectomy|cold forceps polypectomy
184999|NCT02188316|Diminutive colorectal polyp|diminutive colorectal polyp
185000|NCT02188316|Hot biopsy forceps electrocauterization|hot biopsy forceps electrocauterization
185001|NCT02188316|Jumbo forceps.|jumbo forceps.
185002|NCT02188290|Haploidentical donor|haploidentical donor
185003|NCT02188290|Unrelated donor|unrelated donor
185004|NCT02188290|Umbilical cord blood|umbilical cord blood
185005|NCT02188290|Graft versus host disease|graft versus host disease
185006|NCT02188290|Transplant-related mortality|transplant-related mortality
185007|NCT02188290|Hematologic malignancy|hematologic malignancy
185008|NCT02188290|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
185009|NCT02188251|Activamp|activamp
225706|NCT02000947|IMTC|imtc
185010|NCT02188251|Gynostemma pentaphyllum|gynostemma pentaphyllum
185011|NCT02188251|Body weight|body weight
185012|NCT02188251|Fat Loss|fat loss
185013|NCT02188251|Metabolic markers|metabolic markers
185014|NCT02188251|Overweight participants|overweight participants
185015|NCT02188251|DXA|dxa
185016|NCT02188251|AMPK|ampk
185017|NCT02188238|saliva|saliva
185018|NCT02188238|protein|protein
185019|NCT02188238|oral health|oral health
185020|NCT02188238|film|film
185021|NCT02188238|pellicle|pellicle
185022|NCT02188225|Hot flash|hot flash
185023|NCT02188225|Acupuncture|acupuncture
185024|NCT02188225|Fluoxetine|fluoxetine
185025|NCT02188225|Quality of life|quality of life
185027|NCT02188199|Knee|knee
185028|NCT02188199|Hip replacement|hip replacement
185029|NCT02188199|Knee replacement|knee replacement
185030|NCT02188199|Total Joint|total joint
185031|NCT02188186|triple combination|triple combination
185032|NCT02188186|metformin|metformin
185033|NCT02188186|sitagliptin|sitagliptin
185034|NCT02188186|thiazolidinedione|thiazolidinedione
185035|NCT02188160|Pain|pain
185036|NCT02188160|Corticosteroid|corticosteroid
185037|NCT02188160|Dry Eye|dry eye
185038|NCT02188160|Hyperemia|hyperemia
185039|NCT02188160|Ocular Discomfort|ocular discomfort
185040|NCT02188147|Syncope|syncope
185041|NCT02188147|Sudden Cardiac Arrest|sudden cardiac arrest
185042|NCT02188147|Sudden Cardiac Death|sudden cardiac death
185043|NCT02188147|Cardiac Arrest|cardiac arrest
185044|NCT02188147|Emergency Service|emergency service
185045|NCT02188147|Emergency Department|emergency department
185046|NCT02188147|Ambulatory Electrocardiography|ambulatory electrocardiography
185047|NCT02188147|Holter|holter
185048|NCT02188147|Holter Electrocardiography|holter electrocardiography
185049|NCT02188147|Holter Monitoring|holter monitoring
185050|NCT02188134|Adverse events,|adverse events,
185051|NCT02188134|adverse drug reactions,|adverse drug reactions,
185052|NCT02188134|medication error,|medication error,
185053|NCT02188134|noncompliance|noncompliance
185054|NCT02188108|quality of life|quality of life
185055|NCT02188108|QOL|qol
185056|NCT02188108|urolithiasis|urolithiasis
185057|NCT02188108|nephrolithiasis|nephrolithiasis
185058|NCT02188108|kidney stones|kidney stones
185059|NCT02188108|patient-reported outcomes|patient-reported outcomes
185060|NCT02188069|Non-atherosclerotic Coronary Artery Disease|non-atherosclerotic coronary artery disease
185061|NCT02188056|Venous|venous
185062|NCT02188056|Thromboembolic|thromboembolic
185063|NCT02188056|Pulmonary embolism|pulmonary embolism
185064|NCT02188043|Alcohol use disorder|alcohol use disorder
185066|NCT02188043|Health expenditures|health expenditures
185067|NCT02188043|efficacy study|efficacy study
185068|NCT02188030|musculoskeletal symptom|musculoskeletal symptom
185069|NCT02188030|industrial workers|industrial workers
185070|NCT02188030|physical-activity program|physical-activity program
185071|NCT02188030|resistance training|resistance training
185072|NCT02188030|randomized controlled trial|randomized controlled trial
185073|NCT02188017|prednisone, methotrexate, sarcoidosis, azathioprine|prednisone, methotrexate, sarcoidosis, azathioprine
185074|NCT02188004|HPV|hpv
185075|NCT02188004|genital warts|genital warts
185076|NCT02187991|metastatic breast cancer|metastatic breast cancer
185077|NCT02187991|Human Epidermal Growth Factor Receptor 2-negative (HER2-) breast cancer|human epidermal growth factor receptor 2-negative (her2-) breast cancer
185078|NCT02187991|Estrogen Receptor-positive (ER+) breast cancer|estrogen receptor-positive (er+) breast cancer
185079|NCT02187991|Triple Negative breast cancer|triple negative breast cancer
185080|NCT02187991|alisertib|alisertib
185081|NCT02187991|paclitaxel|paclitaxel
185082|NCT02187978|Early total enteral feeding (ETEF)|early total enteral feeding (etef)
185083|NCT02187978|Conventional enteral feeding (CEF)|conventional enteral feeding (cef)
185084|NCT02187978|VLBW infants|vlbw infants
185086|NCT02187978|Preterm infants|preterm infants
185087|NCT02187926|Drug therapy|drug therapy
185088|NCT02187900|Tripterygium Wilfordii HOOK. f.|tripterygium wilfordii hook. f.
185089|NCT02187900|Mycophenolate mofetil|mycophenolate mofetil
185090|NCT02187887|alcohol|alcohol
185091|NCT02187887|young adult veterans|young adult veterans
185092|NCT02187887|brief intervention|brief intervention
185093|NCT02187887|online|online
185094|NCT02187887|perceived norms|perceived norms
185095|NCT02187835|complexity|complexity
185096|NCT02187835|electroencephalogram|electroencephalogram
185097|NCT02187835|entropy|entropy
185098|NCT02187835|negative symptoms|negative symptoms
185099|NCT02187835|schizophrenia.|schizophrenia.
185100|NCT02187822|Brain|brain
185101|NCT02187822|Advanced solid tumors|advanced solid tumors
185102|NCT02187822|Fractionated Stereotactic Radiotherapy (FSRT)|fractionated stereotactic radiotherapy (fsrt)
185103|NCT02187822|Brain lesions|brain lesions
185104|NCT02187822|Primary solid malignancy|primary solid malignancy
185105|NCT02187796|HIV|hiv
185106|NCT02187796|Dementia|dementia
185107|NCT02187796|HAND|hand
185108|NCT02187796|COGNISION System|cognision system
185109|NCT02187796|ERP|erp
225841|NCT02000362|CD|cd
185110|NCT02187796|event-related potentials|event-related potentials
185111|NCT02187783|Solid malignancy,|solid malignancy,
185112|NCT02187783|Hematologic malignancy,|hematologic malignancy,
185113|NCT02187783|Mutations,|mutations,
185114|NCT02187783|Amplifications,|amplifications,
185115|NCT02187783|Signature,|signature,
185116|NCT02187783|CDK4,|cdk4,
185117|NCT02187783|CDK6,|cdk6,
185118|NCT02187783|CDK4/6,|cdk4/6,
185119|NCT02187783|Cyclin D1,|cyclin d1,
185120|NCT02187783|CCND1,|ccnd1,
185121|NCT02187783|Cyclin D3,|cyclin d3,
185122|NCT02187783|CCND3,|ccnd3,
185123|NCT02187783|p16 mutation,|p16 mutation,
185124|NCT02187783|CDKN2A,|cdkn2a,
185125|NCT02187783|LEE011,|lee011,
185126|NCT02187783|Breast cancer,|breast cancer,
185127|NCT02187783|Ovarian cancer,|ovarian cancer,
185128|NCT02187783|Lymphoma,|lymphoma,
185129|NCT02187783|Mesothelioma,|mesothelioma,
185130|NCT02187783|Pancreatic neuroendocrine,|pancreatic neuroendocrine,
185131|NCT02187783|Leukemia|leukemia
185132|NCT02187783|Tumor|tumor
185133|NCT02187757|Dyslipidemia|dyslipidemia
185134|NCT02187757|High cholesterol|high cholesterol
185135|NCT02187757|High LDL|high ldl
185136|NCT02187757|Triglycerides|triglycerides
185137|NCT02187744|Biosimilars|biosimilars
185138|NCT02187744|Non-inferiority|non-inferiority
185139|NCT02187744|Neoadjuvant Setting|neoadjuvant setting
185140|NCT02187744|Early Breast Cancer|early breast cancer
185141|NCT02187744|PK|pk
185142|NCT02187744|Phase 3|phase 3
185143|NCT02187744|Trastuzumab|trastuzumab
185144|NCT02187744|Herceptin|herceptin
185145|NCT02187744|HER2 Positive|her2 positive
185146|NCT02187731|Multiple Myeloma|multiple myeloma
185147|NCT02187731|Functional Imaging|functional imaging
185148|NCT02187731|PET/CT|pet/ct
185149|NCT02187731|Diffusion Weighted MRI|diffusion weighted mri
185150|NCT02187718|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
185151|NCT02187718|Local Anaesthesia|local anaesthesia
185152|NCT02187692|schizophrenia;|schizophrenia;
185153|NCT02187692|meta-cognition;|meta-cognition;
185154|NCT02187692|general functioning;|general functioning;
185155|NCT02187692|positive symptoms;|positive symptoms;
185156|NCT02187692|insight;|insight;
185157|NCT02187679|Tourette Syndrome|tourette syndrome
185158|NCT02187679|Tourette's Syndrome|tourette's syndrome
185159|NCT02187679|Chronic Vocal Tic|chronic vocal tic
185160|NCT02187679|Vocal Tic|vocal tic
185161|NCT02187666|Cervical|cervical
185162|NCT02187666|Lumbar|lumbar
185163|NCT02187666|Spine|spine
185164|NCT02187666|Spinal Disease|spinal disease
185165|NCT02187653|IOM|iom
185166|NCT02187653|IONM|ionm
185167|NCT02187653|Intraoperative Monitoring|intraoperative monitoring
185476|NCT02186236|blood|blood
185174|NCT02187640|Psychiatric in-patients|psychiatric in-patients
185176|NCT02187640|Self-administered acupressure program|self-administered acupressure program
185177|NCT02187640|Sham control group|sham control group
185178|NCT02187614|Acute Renal colic|acute renal colic
185179|NCT02187614|Acute Ureteric Colic|acute ureteric colic
185180|NCT02187614|Renal or Ureteral Calculi|renal or ureteral calculi
185181|NCT02187614|Urolithiasis|urolithiasis
185182|NCT02187614|Kidney or Ureteral stones|kidney or ureteral stones
185183|NCT02187601|CLD|cld
185184|NCT02187549|Hyaluronic Acid|hyaluronic acid
185185|NCT02187549|Osteoarthritis|osteoarthritis
185187|NCT02187549|Hyaluronan|hyaluronan
185188|NCT02187549|Viscoelastic|viscoelastic
185189|NCT02187549|Hydrogel|hydrogel
185190|NCT02187510|Hemodynamics|hemodynamics
185191|NCT02187510|Premature Infant|premature infant
185192|NCT02187510|Umbilical cord|umbilical cord
185193|NCT02187510|Milking|milking
185194|NCT02187510|Delayed clamping|delayed clamping
185195|NCT02187471|pain|pain
185196|NCT02187471|fibromyalgia|fibromyalgia
185203|NCT02186392|Depression|depression
185204|NCT02186392|Anxiety|anxiety
185205|NCT02186392|Stroke|stroke
185206|NCT02186392|Cerebral Infarction|cerebral infarction
185207|NCT02186392|Sleep disorders|sleep disorders
185208|NCT02186392|Circadian Rhythm disorders|circadian rhythm disorders
185209|NCT02186392|Circadian Light|circadian light
185210|NCT02186392|Light therapy|light therapy
185211|NCT02186392|Melatonin|melatonin
185212|NCT02186392|Sleep|sleep
185213|NCT02186392|Sleep apnea|sleep apnea
185214|NCT02186392|Coagulation disturbances|coagulation disturbances
185215|NCT02186392|Bone metabolism|bone metabolism
185216|NCT02186392|Rehabilitation|rehabilitation
185217|NCT02186392|Mood disorders|mood disorders
185218|NCT02186392|Mental disorders|mental disorders
185219|NCT02186392|Neurologic Manifestations|neurologic manifestations
185220|NCT02186392|Signs and Symptoms Cerebrovascular Disorders|signs and symptoms cerebrovascular disorders
185221|NCT02186392|Brain Diseases|brain diseases
185222|NCT02186392|Vascular Disease|vascular disease
185223|NCT02186392|Brain Infarction|brain infarction
185224|NCT02186392|Brain Ischemia|brain ischemia
185225|NCT02186379|Obesity|obesity
185226|NCT02186379|Obesity Prevention|obesity prevention
185227|NCT02186379|Childhood obesity prevention|childhood obesity prevention
185228|NCT02186379|Rapid Eating Style|rapid eating style
185229|NCT02186366|Anxiety Disorders, Massage Therapy, Treatment Efficacy|anxiety disorders, massage therapy, treatment efficacy
185230|NCT02186353|Whole grains|whole grains
185231|NCT02186353|Food processing|food processing
185232|NCT02186353|Cardiometabolic risk factors|cardiometabolic risk factors
185233|NCT02186327|Integrative Health Coaching|integrative health coaching
185234|NCT02186314|atrial fibrillation, heart failure, pacemaker|atrial fibrillation, heart failure, pacemaker
185235|NCT02187445|Sickle Cell Disease|sickle cell disease
185236|NCT02187445|Budesonide inhalation suspension|budesonide inhalation suspension
185237|NCT02187445|Acute Chest Syndrome|acute chest syndrome
185238|NCT02187419|Sleep|sleep
185239|NCT02187419|Menopause|menopause
185240|NCT02187419|Hypnosis|hypnosis
185241|NCT02187419|Relaxation|relaxation
185242|NCT02187419|Hypnotic Relaxation Therapy|hypnotic relaxation therapy
185243|NCT02187419|Hot Flash|hot flash
185244|NCT02187406|athletic tape|athletic tape
185245|NCT02187406|tennis|tennis
185246|NCT02187406|warm-up exercise|warm-up exercise
185247|NCT02187393|Epithelial cell function of cells from individuals with various genotypes|epithelial cell function of cells from individuals with various genotypes
185248|NCT02187302|nanopharmaceutical,|nanopharmaceutical,
185249|NCT02187289|NCSG|ncsg
185250|NCT02187289|Compression bandages|compression bandages
185251|NCT02187289|devices|devices
185252|NCT02187289|Night time compression|night time compression
185253|NCT02187289|Breast cancer treatment side effects|breast cancer treatment side effects
185254|NCT02187289|Compression therapy|compression therapy
185255|NCT02187289|Reid Sleeve|reid sleeve
185256|NCT02187289|Comprefit|comprefit
185257|NCT02187289|Medassist|medassist
185258|NCT02187289|Tribute|tribute
185259|NCT02187289|Comprilan|comprilan
185260|NCT02187276|Predictive factors of response|predictive factors of response
185261|NCT02187276|mild and moderate|mild and moderate
185262|NCT02187276|Alzheimer disease|alzheimer disease
185263|NCT02187276|mixed dementia|mixed dementia
185264|NCT02187276|APOE|apoe
185265|NCT02187276|polymorphisms of CYP 2D6|polymorphisms of cyp 2d6
185266|NCT02187263|hereditary cardiomyopathy,|hereditary cardiomyopathy,
185267|NCT02187263|inflammatory cardiomyopathy,|inflammatory cardiomyopathy,
185268|NCT02187263|registry,|registry,
185269|NCT02187263|biomaterial,|biomaterial,
185270|NCT02187263|clinical trial|clinical trial
185271|NCT02187263|Patients|patients
185272|NCT02187250|PCOS|pcos
185273|NCT02187250|PDE-4 inhibitor|pde-4 inhibitor
185274|NCT02187250|roflumilast|roflumilast
185275|NCT02187250|liraglutide|liraglutide
185276|NCT02187250|metformin|metformin
185277|NCT02187250|obesity|obesity
185278|NCT02187224|Alcohol Dependence|alcohol dependence
185279|NCT02187224|Post-Traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
185280|NCT02187224|Progesterone|progesterone
185281|NCT02187211|Alcohol Dependence|alcohol dependence
185282|NCT02187211|Minocycline|minocycline
185283|NCT02187198|Opioid Dependence|opioid dependence
185284|NCT02187198|Buprenorphine|buprenorphine
185285|NCT02187185|Inflammatory biomarkers|inflammatory biomarkers
185286|NCT02187185|Periodontitis|periodontitis
185287|NCT02187172|Psoriasis|psoriasis
185288|NCT02187172|Cardiovascular Disease|cardiovascular disease
185289|NCT02187172|Vascular Inflammation|vascular inflammation
185290|NCT02187172|Lipid Biomarkers|lipid biomarkers
185291|NCT02187172|FDG-PET/CT|fdg-pet/ct
185292|NCT02187159|pain|pain
185293|NCT02187159|fibromyalgia|fibromyalgia
185294|NCT02187146|Vitamin D|vitamin d
185295|NCT02187146|Infertility|infertility
185296|NCT02187146|IVF|ivf
185297|NCT02187146|ART|art
185298|NCT02187133|Relapsed|relapsed
185299|NCT02187133|Refractory|refractory
185300|NCT02187120|Wounds and Injuries|wounds and injuries
185301|NCT02187120|Acute Coagulopathy|acute coagulopathy
185302|NCT02187120|Tranexamic Acid|tranexamic acid
185303|NCT02187120|Emergency Medical Services|emergency medical services
185305|NCT02187107|AIDS|aids
185306|NCT02187107|TMC114|tmc114
185307|NCT02187107|Ritonavir|ritonavir
185308|NCT02187107|Norvir|norvir
185309|NCT02187107|Darunavir|darunavir
185310|NCT02187081|HCC|hcc
185311|NCT02187081|RFA|rfa
185312|NCT02187081|Sorafenib|sorafenib
185313|NCT02187081|Tumor recurrence|tumor recurrence
185314|NCT02187081|Overall survival|overall survival
185315|NCT02187068|Anaesthetics iv|anaesthetics iv
185316|NCT02187068|Dexmedetomidine|dexmedetomidine
185317|NCT02187068|Pharmacokinetic|pharmacokinetic
185318|NCT02187042|sunitinib|sunitinib
185319|NCT02187042|call center|call center
185320|NCT02187042|management of patients|management of patients
185321|NCT02187042|nurses|nurses
185322|NCT02187042|metastatic renal carcinoma|metastatic renal carcinoma
185323|NCT02187029|Hyperuricemia|hyperuricemia
185324|NCT02187029|gout|gout
185325|NCT02187029|serum uric acid|serum uric acid
185326|NCT02187016|Gingivitis|gingivitis
185327|NCT02187016|plaque|plaque
185328|NCT02187016|interproximal cleaning|interproximal cleaning
226104|NCT01999114|ECG|ecg
185329|NCT02187016|dental floss|dental floss
185330|NCT02187003|Sickle Cell Anemia|sickle cell anemia
185331|NCT02187003|Sickle Cell Disease|sickle cell disease
185332|NCT02187003|Sickle Cell Disorders|sickle cell disorders
185333|NCT02187003|pain crisis|pain crisis
185334|NCT02187003|vaso-occlusive crisis|vaso-occlusive crisis
185335|NCT02187003|rivipansel|rivipansel
185336|NCT02187003|GMI-1070|gmi-1070
185337|NCT02187003|selectin inhibitor|selectin inhibitor
185338|NCT02187003|SCD|scd
185339|NCT02187003|VOC|voc
185340|NCT02186977|immunogenicity|immunogenicity
185341|NCT02186977|safety|safety
185342|NCT02186977|proof of concept|proof of concept
185343|NCT02186951|ventilator-associated pneumonia|ventilator-associated pneumonia
185344|NCT02186951|cardiac arrests with shockable rhythm|cardiac arrests with shockable rhythm
185345|NCT02186951|Mild therapeutic hypothermia|mild therapeutic hypothermia
185346|NCT02186951|preventive antibiotics|preventive antibiotics
185347|NCT02186938|head and neck cancer|head and neck cancer
185348|NCT02186938|patients requiring a free flap surgery|patients requiring a free flap surgery
185349|NCT02186925|Kidney Cancer|kidney cancer
185350|NCT02186925|Prostate Cancer|prostate cancer
185351|NCT02186925|Bladder Cancer|bladder cancer
185352|NCT02186912|edentulous|edentulous
185353|NCT02186912|Nobel Active|nobel active
185354|NCT02186912|Nobel Procera|nobel procera
185355|NCT02186912|IBO|ibo
185356|NCT02186912|CAD/CAM|cad/cam
185357|NCT02186886|Ulcerative Colitis|ulcerative colitis
185358|NCT02186886|Golimumab|golimumab
185359|NCT02186886|Physiological Intermolecular Modification Spectroscopy|physiological intermolecular modification spectroscopy
185360|NCT02186886|PIMS|pims
185361|NCT02186873|Ankylosing Spondylitis|ankylosing spondylitis
185362|NCT02186873|Golimumab|golimumab
185363|NCT02186873|SIMPONI|simponi
185364|NCT02186834|Relapsed|relapsed
185365|NCT02186834|Refractory|refractory
185366|NCT02186834|Myeloma|myeloma
185367|NCT02186821|hematological malignancy|hematological malignancy
185368|NCT02186821|solid tumor malignancy|solid tumor malignancy
185369|NCT02186821|mutation|mutation
185370|NCT02186821|translocation|translocation
185371|NCT02186821|rearrangement|rearrangement
185372|NCT02186821|amplification|amplification
185373|NCT02186821|ALK|alk
185374|NCT02186821|ROS1|ros1
185375|NCT02186821|NSCLC|nsclc
185376|NCT02186821|B-cell lymphoma|b-cell lymphoma
185377|NCT02186795|Arthroplasty|arthroplasty
185378|NCT02186795|Replacement, Hip|replacement, hip
185379|NCT02186782|Clomiphene citrate|clomiphene citrate
185380|NCT02186782|Estradiol|estradiol
185381|NCT02186782|Endometrial thickness|endometrial thickness
185382|NCT02186756|Fibromyalgia|fibromyalgia
185383|NCT02186756|Complementary Therapies|complementary therapies
185384|NCT02186756|Biofeedback|biofeedback
185385|NCT02186756|Randomized controlled trial|randomized controlled trial
185386|NCT02186756|Relaxation Therapy|relaxation therapy
185387|NCT02186743|Irritable Bowel Syndrome|irritable bowel syndrome
185388|NCT02186743|IBS|ibs
185389|NCT02186743|Diet|diet
185390|NCT02186743|Food sensitivity|food sensitivity
185391|NCT02186730|Computerised Cognitive Behaviour Therapy|computerised cognitive behaviour therapy
185392|NCT02186730|Adolescents|adolescents
185393|NCT02186730|Depression|depression
185394|NCT02186730|Low Mood|low mood
185395|NCT02186704|Atrial Fibrillation|atrial fibrillation
185396|NCT02186704|Implantable Defibrillators|implantable defibrillators
185397|NCT02186704|Implanted Electrodes|implanted electrodes
185398|NCT02186691|pulmonary valve replacement|pulmonary valve replacement
185399|NCT02186691|tetralogy of Fallot|tetralogy of fallot
185400|NCT02186652|obese|obese
185401|NCT02186652|children|children
185402|NCT02186652|adolescents|adolescents
185403|NCT02186652|GERD|gerd
185404|NCT02186652|pharmacokinetic|pharmacokinetic
185405|NCT02186639|exhaled breath|exhaled breath
185406|NCT02186639|volatile organic compounds (VOCs)|volatile organic compounds (vocs)
185407|NCT02186639|SESI-MS|sesi-ms
185408|NCT02186626|West Nile Virus, vaccine|west nile virus, vaccine
185409|NCT02186613|Breast Feeding|breast feeding
185410|NCT02186613|Telephone|telephone
185411|NCT02186613|Education|education
185412|NCT02186613|Primary Health Care|primary health care
185413|NCT02186600|Low bone mass|low bone mass
185414|NCT02186600|Post-menopausal women|post-menopausal women
185415|NCT02186600|Bone mineral density|bone mineral density
185416|NCT02186600|Bone structure|bone structure
185417|NCT02186600|Bone turnover|bone turnover
185418|NCT02186600|Bone-loading exercises|bone-loading exercises
185419|NCT02186600|Optimal calcium and vitamin D|optimal calcium and vitamin d
185420|NCT02186600|risedronate|risedronate
185421|NCT02186574|Non-Hodgkin|non-hodgkin
185422|NCT02186574|Lymphoma|lymphoma
185423|NCT02186574|Hepatitis B|hepatitis b
185424|NCT02186574|Tenofovir|tenofovir
185425|NCT02186574|Viread|viread
185426|NCT02186561|intracranial aneurysm|intracranial aneurysm
185427|NCT02186561|brain aneurysm|brain aneurysm
185428|NCT02186522|Sepsis|sepsis
185429|NCT02186522|Septic shock|septic shock
185430|NCT02186522|Critical care|critical care
185431|NCT02186522|Immune dysfunction|immune dysfunction
185432|NCT02186522|Inflammatory markers|inflammatory markers
185433|NCT02186522|Neutrophil|neutrophil
185434|NCT02186522|Monocyte|monocyte
185435|NCT02186522|Tregs|tregs
185436|NCT02186470|Breast Cancer|breast cancer
185437|NCT02186470|Early Stage Breast Cancer|early stage breast cancer
185438|NCT02186457|Pancreatoduodenectomy|pancreatoduodenectomy
185439|NCT02186457|Whipple|whipple
185440|NCT02186444|newly diagnosed prostate cancer|newly diagnosed prostate cancer
185441|NCT02186444|prostate|prostate
185442|NCT02186431|Contact lenses|contact lenses
185443|NCT02186301|cancer|cancer
185444|NCT02186301|metastatic|metastatic
185445|NCT02186301|locally advanced|locally advanced
185446|NCT02186301|lung|lung
185447|NCT02186301|non-small cell lung cancer|non-small cell lung cancer
185448|NCT02186301|NSCLC|nsclc
185449|NCT02186301|epidermal growth factor receptor|epidermal growth factor receptor
185450|NCT02186301|EGFR|egfr
185451|NCT02186301|T790M|t790m
185452|NCT02186301|CO-1686|co-1686
185453|NCT02186301|unresectable|unresectable
185454|NCT02186301|recurrent|recurrent
185455|NCT02186301|EGFR-directed therapy|egfr-directed therapy
185456|NCT02186301|irreversible EGFR inhibitor|irreversible egfr inhibitor
185457|NCT02186301|TIGER|tiger
185458|NCT02186301|rociletinib|rociletinib
185459|NCT02186288|Critical Care|critical care
185460|NCT02186288|High-flow nasal cannula oxygen|high-flow nasal cannula oxygen
185461|NCT02186288|Electrical impedance tomography|electrical impedance tomography
185462|NCT02186288|End expiratory lung volume|end expiratory lung volume
185463|NCT02186288|End expiratory lung impedance|end expiratory lung impedance
185464|NCT02186288|Diaphragmatic ultrasound|diaphragmatic ultrasound
185465|NCT02186275|Crohn|crohn
185466|NCT02186275|vitamin D|vitamin d
185467|NCT02186275|remission|remission
185468|NCT02186275|inflammation|inflammation
185469|NCT02186275|tolerance|tolerance
185470|NCT02186262|Glioma|glioma
185472|NCT02186262|Rotating frame relaxation|rotating frame relaxation
185474|NCT02186262|treatment response|treatment response
185475|NCT02186236|Detection of Oncogenic Tumor Mutations|detection of oncogenic tumor mutations
185478|NCT02186236|14-114|14-114
185479|NCT02186223|Pulmonary Embolism|pulmonary embolism
185480|NCT02186223|PE|pe
185481|NCT02186223|DVT|dvt
185482|NCT02186223|Deep Vein Thrombosis|deep vein thrombosis
185483|NCT02186223|VTE|vte
185484|NCT02186223|Venous Thromboembolism|venous thromboembolism
185485|NCT02186223|prophylaxis|prophylaxis
185486|NCT02186223|thromboprophylaxis|thromboprophylaxis
185487|NCT02186223|contraindications to thromboprophylaxis|contraindications to thromboprophylaxis
185488|NCT02186223|prophylactic|prophylactic
185489|NCT02186223|prevention|prevention
185490|NCT02186223|Inferior vena cava filter|inferior vena cava filter
185491|NCT02186223|IVC filter|ivc filter
185492|NCT02186223|filter|filter
185493|NCT02186223|prevention of pulmonary embolism|prevention of pulmonary embolism
185494|NCT02186223|trauma|trauma
185495|NCT02186223|critically-ill|critically-ill
185496|NCT02186210|microcirculation|microcirculation
185497|NCT02186210|off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
185498|NCT02186210|tissue oxygen saturation|tissue oxygen saturation
185499|NCT02186210|vascular occlusion test|vascular occlusion test
185500|NCT02186210|recovery slope|recovery slope
185501|NCT02186197|Volume Responsiveness|volume responsiveness
185502|NCT02186184|Myopia progression|myopia progression
185503|NCT02186184|Orthokeratology|orthokeratology
185504|NCT02186171|Osteoporosis in men|osteoporosis in men
185505|NCT02186158|Pneumonia|pneumonia
185506|NCT02186158|Elderly|elderly
185507|NCT02186158|Ascorbic acid|ascorbic acid
185508|NCT02186158|Vitamin C|vitamin c
185509|NCT02186158|Hospitalized patient|hospitalized patient
185511|NCT02186132|neostigmine|neostigmine
185512|NCT02186132|atropine|atropine
185513|NCT02186132|dosage|dosage
185514|NCT02186093|Coronary Artery Disease|coronary artery disease
185515|NCT02186093|Angina, Stable|angina, stable
185516|NCT02186093|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
185517|NCT02186093|Coronary Angiography|coronary angiography
185518|NCT02186080|diabetes mellitus|diabetes mellitus
185519|NCT02186080|metabolic endotoxemia|metabolic endotoxemia
185520|NCT02186080|gemigliptin|gemigliptin
185521|NCT02186080|DPP-4 inhibitor|dpp-4 inhibitor
185522|NCT02186067|Hypertension|hypertension
185523|NCT02186067|Uncontrolled Hypertension|uncontrolled hypertension
185524|NCT02186054|Abdominal-Pelvic MRI (magnetic resonance image)|abdominal-pelvic mri (magnetic resonance image)
185525|NCT02186054|T2W (T2 weighted)|t2w (t2 weighted)
185526|NCT02186054|FSE Flex (recently developed MRI pulse sequence)|fse flex (recently developed mri pulse sequence)
185527|NCT02186054|Enhanced single shot FSE (fast spin echo).|enhanced single shot fse (fast spin echo).
185528|NCT02186028|oral daily supplementation with vitamin D for 6 months|oral daily supplementation with vitamin d for 6 months
185529|NCT02186015|Metastatic Breast Cancer|metastatic breast cancer
185530|NCT02186015|MBC|mbc
185531|NCT02186015|Vitamin D Supplementation|vitamin d supplementation
185532|NCT02186015|Symptom Management|symptom management
185533|NCT02186002|ACT-451840|act-451840
185534|NCT02186002|Safety|safety
185535|NCT02186002|Tolerability|tolerability
185536|NCT02186002|Pharmacokinetics|pharmacokinetics
185537|NCT02185989|Critical Illness/*rehabilitation|critical illness/*rehabilitation
185538|NCT02185989|Humans|humans
185539|NCT02185989|*Intensive Care Units|*intensive care units
185540|NCT02185989|Muscle Weakness/diagnosis/*etiology/physiopathology/prevention & control|muscle weakness/diagnosis/*etiology/physiopathology/prevention & control
185541|NCT02185989|Polyneuropathies/diagnosis/*etiology/physiopathology|polyneuropathies/diagnosis/*etiology/physiopathology
185551|NCT02185950|Burn|burn
185552|NCT02185950|Skin graft|skin graft
185553|NCT02185950|Elasticity|elasticity
185554|NCT02185950|Skin|skin
185555|NCT02185950|Physical therapy modalities|physical therapy modalities
185556|NCT02185937|imatinib|imatinib
185557|NCT02185937|gastrectomy|gastrectomy
185558|NCT02185937|gastrointestinal stromal tumor|gastrointestinal stromal tumor
185559|NCT02185937|pharmacokinetics|pharmacokinetics
185560|NCT02185924|PARECOXIB|parecoxib
185561|NCT02185924|CONTINUOUS FEMORAL BLOCK|continuous femoral block
185562|NCT02185911|chronic kidney disease,|chronic kidney disease,
185563|NCT02185911|anaemia correction/maintenance,|anaemia correction/maintenance,
185564|NCT02185911|non dialysis,|non dialysis,
185565|NCT02185898|electronic cigarettes|electronic cigarettes
185566|NCT02185898|e-cigarettes|e-cigarettes
185567|NCT02185898|combustible cigarettes|combustible cigarettes
185568|NCT02185898|second-hand smoke|second-hand smoke
185569|NCT02185898|environmental tobacco smoke|environmental tobacco smoke
185570|NCT02185898|tobacco-burning|tobacco-burning
185571|NCT02185885|Ischemic stroke|ischemic stroke
185572|NCT02185885|Embolic stroke|embolic stroke
185671|NCT02185599|cervical cancer|cervical cancer
185573|NCT02185885|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
185574|NCT02185885|Cardiac Bypass Surgery|cardiac bypass surgery
185575|NCT02185885|Cardiac Anaesthesia|cardiac anaesthesia
185576|NCT02185872|Exercise|exercise
185577|NCT02185872|Physical Fitness|physical fitness
185578|NCT02185872|Body Composition, Beneficial|body composition, beneficial
185579|NCT02185859|Lidocaine|lidocaine
185580|NCT02185859|Magnesium|magnesium
185581|NCT02185859|Mastectomy|mastectomy
185582|NCT02185859|Functional Recovery|functional recovery
185583|NCT02185846|Fed condition|fed condition
185584|NCT02185833|Fasting condition|fasting condition
185585|NCT02185820|Multiple myeloma|multiple myeloma
185586|NCT02185820|Relapsed and/or refractory|relapsed and/or refractory
185588|NCT02185807|cataract|cataract
185589|NCT02185807|surgery|surgery
185590|NCT02185807|consent process|consent process
185591|NCT02185807|video-assisted|video-assisted
185592|NCT02185794|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
185593|NCT02185794|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
185594|NCT02185794|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
185595|NCT02185794|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
185596|NCT02185794|HCV|hcv
185597|NCT02185794|Sustained Virologic Response|sustained virologic response
185598|NCT02185794|Direct Acting Antiviral|direct acting antiviral
185599|NCT02185794|Combination Therapy|combination therapy
185600|NCT02185794|Open Label|open label
185601|NCT02185794|Hepatitis|hepatitis
185602|NCT02185794|Hepatitis, Chronic|hepatitis, chronic
185603|NCT02185794|Hepatitis C|hepatitis c
185604|NCT02185794|Hepatitis C, Chronic|hepatitis c, chronic
185605|NCT02185794|Liver Diseases|liver diseases
185606|NCT02185794|Digestive System Diseases|digestive system diseases
185607|NCT02185794|Hepatitis, Viral, Human|hepatitis, viral, human
185608|NCT02185794|Virus Diseases|virus diseases
185609|NCT02185794|Enterovirus Infections|enterovirus infections
185610|NCT02185794|Picornaviridae Infections|picornaviridae infections
185611|NCT02185794|RNA Virus Infections|rna virus infections
185612|NCT02185794|Flaviviridae Infections|flaviviridae infections
185614|NCT02185794|Anti-Infective Agents|anti-infective agents
185615|NCT02185794|Therapeutic Uses|therapeutic uses
185616|NCT02185794|Pharmacologic Actions|pharmacologic actions
185617|NCT02185794|Antimetabolites|antimetabolites
185618|NCT02185794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
185625|NCT02185768|Liver cancer|liver cancer
185626|NCT02185755|Internet-Based Glucose Monitoring System|internet-based glucose monitoring system
185627|NCT02185755|Type 2 Diabetes|type 2 diabetes
185628|NCT02185742|HIV|hiv
185629|NCT02185742|jail|jail
185630|NCT02185742|detainee|detainee
185631|NCT02185742|Linkage and Retention|linkage and retention
185632|NCT02185742|Treatment as Prevention|treatment as prevention
185633|NCT02185742|Strength Based Case Management|strength based case management
185634|NCT02185742|releases|releases
185635|NCT02185729|Intravenous Feeding|intravenous feeding
185636|NCT02185729|Lipid Emulsions, Intravenous|lipid emulsions, intravenous
185637|NCT02185716|Transversus abdominis plane block|transversus abdominis plane block
185638|NCT02185716|levobupivacaine|levobupivacaine
185639|NCT02185690|Lung cancer|lung cancer
185640|NCT02185690|Non small cell lung cancer|non small cell lung cancer
185641|NCT02185690|non squamous|non squamous
185642|NCT02185690|pemetrexed|pemetrexed
185643|NCT02185690|carboplatin|carboplatin
185644|NCT02185690|binimetinib|binimetinib
185645|NCT02185690|chemotherapy|chemotherapy
185646|NCT02185690|combination chemotherapy|combination chemotherapy
185647|NCT02185690|Phase 1|phase 1
185648|NCT02185690|Princess Margaret Cancer Centre|princess margaret cancer centre
185649|NCT02185690|carcinoma|carcinoma
185650|NCT02185677|dysexecutive syndrome|dysexecutive syndrome
185651|NCT02185677|multiple system atrophy|multiple system atrophy
185652|NCT02185677|imaging study|imaging study
185653|NCT02185664|internal jugular vein|internal jugular vein
185654|NCT02185664|landmark|landmark
185655|NCT02185664|ultrasound|ultrasound
185656|NCT02185664|static|static
185657|NCT02185664|cardiac surgery|cardiac surgery
185658|NCT02185651|Pompe Disease|pompe disease
185659|NCT02185651|Enzyme Replacement Therapy|enzyme replacement therapy
185660|NCT02185651|Infusion Associated Reaction|infusion associated reaction
185661|NCT02185638|obesity|obesity
185662|NCT02185638|herbal bioactive compounds|herbal bioactive compounds
185663|NCT02185638|appetite|appetite
185664|NCT02185638|GLP-1|glp-1
185665|NCT02185638|ghrelin|ghrelin
185666|NCT02185638|CCK|cck
185667|NCT02185599|colposcopy|colposcopy
185668|NCT02185599|CIN|cin
185669|NCT02185599|cervical neoplasia|cervical neoplasia
185670|NCT02185599|cervical dysplasia|cervical dysplasia
185672|NCT02185599|CIN2+|cin2+
185673|NCT02185573|Bulk fill|bulk fill
185674|NCT02185573|SonicFill|sonicfill
185675|NCT02185573|resin composite application|resin composite application
185676|NCT02185573|class II restoration|class ii restoration
185677|NCT02185560|Sorafenib|sorafenib
185678|NCT02185560|Differentiated Thyroid Carcinoma,|differentiated thyroid carcinoma,
185679|NCT02185560|Japan|japan
185680|NCT02185560|Post Marketing Surveillance|post marketing surveillance
185681|NCT02185560|Drug Use Investigation|drug use investigation
185682|NCT02185547|women|women
185683|NCT02185534|Clopidogrel, Zyllt, Plavix, Phase I, Healthy Subjects, Pharmacokinetics, Bioequivalence|clopidogrel, zyllt, plavix, phase i, healthy subjects, pharmacokinetics, bioequivalence
185684|NCT02185521|Hemodynamics|hemodynamics
185685|NCT02185521|Medical Informatics|medical informatics
185686|NCT02185508|IONM|ionm
185687|NCT02185508|Lumbar Disk Disease|lumbar disk disease
185688|NCT02185508|Degenerative Spine Disease|degenerative spine disease
185689|NCT02185508|Radiculopathy|radiculopathy
185690|NCT02185508|Intraoperative Neurophysiological Monitoring|intraoperative neurophysiological monitoring
185691|NCT02185508|Somatosensory Evoked Potentials|somatosensory evoked potentials
185692|NCT02185508|Electromyography|electromyography
185693|NCT02185482|Psychological counselling|psychological counselling
185694|NCT02185482|Randomized single blind study|randomized single blind study
185695|NCT02185482|Depression|depression
185696|NCT02185482|Diabetes|diabetes
185697|NCT02185469|Corneal Endothelial Cell Loss|corneal endothelial cell loss
185698|NCT02185469|pneumatic retinopexy|pneumatic retinopexy
185699|NCT02185469|vitrectomy|vitrectomy
185700|NCT02185443|SBRT|sbrt
185701|NCT02185443|radiation|radiation
185702|NCT02185443|Neoplasm Metastasis|neoplasm metastasis
185703|NCT02185443|Colorectal Neoplasms|colorectal neoplasms
185704|NCT02185443|Anal Canal|anal canal
185705|NCT02185443|Neuroendocrine Tumors|neuroendocrine tumors
185706|NCT02185417|Hypertension|hypertension
185707|NCT02185417|Diuretic|diuretic
185708|NCT02185417|Comparative Effectiveness Research|comparative effectiveness research
185709|NCT02185417|Point of Care Research|point of care research
185710|NCT02185391|Coronary Disease|coronary disease
185711|NCT02185391|Audience Response System|audience response system
185712|NCT02185365|T1-rho MRI|t1-rho mri
185713|NCT02185365|dGEMRIC MRI|dgemric mri
185864|NCT02184676|T cells|t cells
185718|NCT02185352|Breast Cancer|breast cancer
185719|NCT02185352|Chemotherapy|chemotherapy
185720|NCT02185352|Whole Brain Radiotherapy|whole brain radiotherapy
185721|NCT02185339|Respiratory mechanics|respiratory mechanics
185722|NCT02185339|Respiratory function test|respiratory function test
185723|NCT02185339|Hemodynamics|hemodynamics
185724|NCT02185326|Poor responders|poor responders
185725|NCT02185326|Poor ovarian response|poor ovarian response
185726|NCT02185326|IVF/ICSI|ivf/icsi
185727|NCT02185326|Microflare protocol|microflare protocol
185728|NCT02185326|Growth hormone|growth hormone
185729|NCT02185326|Oral contraceptive pills|oral contraceptive pills
185730|NCT02185300|GSK1349572|gsk1349572
185731|NCT02185300|granule|granule
185732|NCT02185300|pediatric|pediatric
185733|NCT02185300|CONTREX mineral water|contrex mineral water
185734|NCT02185300|free-acid|free-acid
185735|NCT02185300|chelating|chelating
185736|NCT02185300|cations|cations
185737|NCT02185300|divalent|divalent
185738|NCT02185300|dolutegravir|dolutegravir
185739|NCT02185300|dispersible tablet|dispersible tablet
185740|NCT02185300|relative bioavailability|relative bioavailability
185741|NCT02185274|Transsexualism|transsexualism
185742|NCT02185274|Cross-sex hormone treatment|cross-sex hormone treatment
185743|NCT02185274|Sex hormones|sex hormones
185744|NCT02185274|Mood|mood
185745|NCT02185274|Stress|stress
185746|NCT02185274|Cortisol|cortisol
185747|NCT02185274|Cardiovascular|cardiovascular
185748|NCT02185274|Metabolome|metabolome
185749|NCT02185261|Relapse|relapse
185750|NCT02185261|Minimal residual disease|minimal residual disease
185751|NCT02185261|Graft-versus-host disease|graft-versus-host disease
185752|NCT02185261|Acute leukemia|acute leukemia
185753|NCT02185261|Interferon Alfa-2b|interferon alfa-2b
185754|NCT02185248|Pediatric Obesity|pediatric obesity
185755|NCT02185248|Body Mass Index|body mass index
185756|NCT02185248|Weight Perception|weight perception
185757|NCT02185248|Counseling|counseling
185758|NCT02185248|Health Behavior|health behavior
185759|NCT02185235|Electrical stimulation|electrical stimulation
185760|NCT02185235|Biofeedback|biofeedback
185761|NCT02185222|Vitamin D|vitamin d
185762|NCT02185222|Cholecalciferol|cholecalciferol
185763|NCT02185222|25-hydroxyvitamin D|25-hydroxyvitamin d
185764|NCT02185222|Memory complaint|memory complaint
185765|NCT02185222|Subjective memory complaint|subjective memory complaint
185766|NCT02185222|Mild cognitive impairment|mild cognitive impairment
185767|NCT02185222|Preventive therapy|preventive therapy
185768|NCT02185222|Cognitive disorders|cognitive disorders
185769|NCT02185196|Vitamin D,|vitamin d,
185770|NCT02185196|Severe pneumonia,|severe pneumonia,
185771|NCT02185196|Under-five children,|under-five children,
185772|NCT02185196|Randomised|randomised
185773|NCT02185196|Controlled|controlled
185774|NCT02185196|Trial (RCT)|trial (rct)
185775|NCT02185196|Morbidity|morbidity
185776|NCT02185170|Prostate|prostate
185777|NCT02185170|Cancer|cancer
185778|NCT02185170|Medical Device|medical device
185779|NCT02185170|Fluorescence|fluorescence
185780|NCT02185157|elderly|elderly
185781|NCT02185157|dual-task training|dual-task training
185782|NCT02185157|aerobic training|aerobic training
185783|NCT02185157|gait|gait
185784|NCT02185157|cognition|cognition
185785|NCT02185144|HIV, mental health, substance abuse|hiv, mental health, substance abuse
185786|NCT02185131|Major Depressive Disorder|major depressive disorder
185787|NCT02185131|Alcohol Use Disorder|alcohol use disorder
185788|NCT02185092|exacerbations|exacerbations
185789|NCT02185092|COPD|copd
185790|NCT02185092|pneumonia|pneumonia
185791|NCT02185092|probiotic|probiotic
185792|NCT02185079|labor|labor
185793|NCT02185079|epidural|epidural
185794|NCT02185040|Lupus, Systemic Lupus, SLE|lupus, systemic lupus, sle
185795|NCT02185027|Oral anticoagulants|oral anticoagulants
185796|NCT02185027|Surgery|surgery
185797|NCT02185027|Haemorrhage|haemorrhage
185798|NCT02185027|Emergency|emergency
185799|NCT02185014|Crohn's Disease|crohn's disease
185800|NCT02185001|Medial patellofemoral ligament|medial patellofemoral ligament
185801|NCT02185001|MPFL|mpfl
185802|NCT02185001|Repair|repair
185803|NCT02185001|Patellar dislocation|patellar dislocation
185804|NCT02185001|Knee|knee
185805|NCT02184988|Glabellar Lines|glabellar lines
185806|NCT02184988|Botulinum purifies neurotoxin, Type A (DWP-450)|botulinum purifies neurotoxin, type a (dwp-450)
185807|NCT02184975|cold knife conization|cold knife conization
185808|NCT02184975|lateral hemostatic sutures|lateral hemostatic sutures
185809|NCT02184975|cervix|cervix
185811|NCT02184949|Coronary angioplasty|coronary angioplasty
185812|NCT02184949|Percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
185813|NCT02184949|PTCA|ptca
185970|NCT02184208|ARDS|ards
185814|NCT02184936|CT Angiography, CT Perfusion, Ischemic Stroke, Collaterals|ct angiography, ct perfusion, ischemic stroke, collaterals
185815|NCT02184910|atrophic gastritis, pepsinogen, Helicobacter pylori|atrophic gastritis, pepsinogen, helicobacter pylori
186033|NCT02183935|Diabetes|diabetes
185816|NCT02184884|off-pump coronary artery bypass surgery, clopidogrel responsiveness, ischemic outcome|off-pump coronary artery bypass surgery, clopidogrel responsiveness, ischemic outcome
185817|NCT02184871|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
185818|NCT02184871|RNAseq|rnaseq
185819|NCT02184871|risk factors|risk factors
185820|NCT02184871|asbestos|asbestos
185821|NCT02184845|single tooth implant|single tooth implant
185822|NCT02184845|supported restoration(s)|supported restoration(s)
185823|NCT02184845|maxillary lateral incisor|maxillary lateral incisor
185824|NCT02184845|mandibular central incisor|mandibular central incisor
185825|NCT02184845|lateral incisor|lateral incisor
185826|NCT02184845|areas of the mouth|areas of the mouth
185827|NCT02184819|coronary artery bypass graft|coronary artery bypass graft
185828|NCT02184819|left ventricular dysfunction|left ventricular dysfunction
185829|NCT02184819|low cardiac output syndrome|low cardiac output syndrome
185830|NCT02184819|levosimendan|levosimendan
185831|NCT02184819|mortality|mortality
185832|NCT02184819|inotropic agents|inotropic agents
185839|NCT02184793|mechanical ventilation|mechanical ventilation
185840|NCT02184793|semirecumbent position|semirecumbent position
185841|NCT02184793|electronic monitoring device|electronic monitoring device
185843|NCT02184780|General Anaesthesia|general anaesthesia
185844|NCT02184780|Infants|infants
185845|NCT02184780|Epidural|epidural
185846|NCT02184780|Spinal|spinal
185847|NCT02184780|Anxiety and depression|anxiety and depression
185848|NCT02184754|Magnetic endoscope imaging|magnetic endoscope imaging
185849|NCT02184754|single-balloon-enteroscopy|single-balloon-enteroscopy
185850|NCT02184741|IVIG|ivig
185851|NCT02184741|Unexplained Recurrent miscarriage|unexplained recurrent miscarriage
185852|NCT02184741|Recurrent abortion|recurrent abortion
185853|NCT02184741|Intravenous immunoglobulin|intravenous immunoglobulin
185854|NCT02184728|end-tidal CO2|end-tidal co2
185855|NCT02184728|capnometer|capnometer
185856|NCT02184715|virtual reality system, children, developmental delay|virtual reality system, children, developmental delay
185857|NCT02184676|Type 1 diabetes|type 1 diabetes
185858|NCT02184676|risk assessment|risk assessment
185859|NCT02184676|immunological marker|immunological marker
185860|NCT02184676|children|children
185861|NCT02184676|relatives|relatives
185862|NCT02184676|autoantibodies|autoantibodies
185863|NCT02184676|lymphocytes|lymphocytes
185865|NCT02184676|epitopes|epitopes
185866|NCT02184676|Children born to mother/father with type 1 diabetes and their parents|children born to mother/father with type 1 diabetes and their parents
185867|NCT02184663|Unresectable|unresectable
185868|NCT02184663|Pancreatic cancer|pancreatic cancer
185869|NCT02184663|GERCOR|gercor
185870|NCT02184663|Adapted physical activity (APA)|adapted physical activity (apa)
185871|NCT02184663|Quality of life|quality of life
185872|NCT02184663|Fatigue|fatigue
185873|NCT02184650|Premature infants|premature infants
185874|NCT02184650|Nutritional status|nutritional status
185875|NCT02184650|Polyunsaturated fatty acids status|polyunsaturated fatty acids status
185876|NCT02184637|Malaria|malaria
185877|NCT02184637|Artemisinin-based Combination Therapies (ACT)|artemisinin-based combination therapies (act)
185878|NCT02184624|BREEZHALER|breezhaler
185879|NCT02184624|DISKUS/ACCUHALER|diskus/accuhaler
185880|NCT02184624|MDI|mdi
185881|NCT02184624|Inhaler preference|inhaler preference
185882|NCT02184624|Overall inhaler error|overall inhaler error
185883|NCT02184624|HANDIHALER|handihaler
185884|NCT02184624|Ease of use|ease of use
185885|NCT02184624|TURBUHALER|turbuhaler
185886|NCT02184624|ELLIPTA|ellipta
185887|NCT02184624|Critical inhaler error|critical inhaler error
185895|NCT02184598|ADHD|adhd
185896|NCT02184598|Cognitive training|cognitive training
185897|NCT02184598|fMRI|fmri
185898|NCT02184598|Cognitive function|cognitive function
185899|NCT02184585|bioavailability|bioavailability
185900|NCT02184585|crossover design|crossover design
185901|NCT02184585|healthy male volunteers|healthy male volunteers
185902|NCT02184585|tamsulosin hydrochloride|tamsulosin hydrochloride
185903|NCT02184585|Dutasteride|dutasteride
185904|NCT02184572|Rubella|rubella
185905|NCT02184572|Healthy children|healthy children
185906|NCT02184572|Measles|measles
185907|NCT02184572|Safety|safety
185908|NCT02184572|Mumps|mumps
185909|NCT02184572|12 to 15 months|12 to 15 months
185910|NCT02184572|Immunogenicity|immunogenicity
185911|NCT02184507|insulin resistance|insulin resistance
185912|NCT02184507|blood glucose|blood glucose
185913|NCT02184507|CABG|cabg
185914|NCT02184507|oxidative stress|oxidative stress
185915|NCT02184494|Parkinson's Disease|parkinson's disease
185916|NCT02184494|Multiple Sclerosis|multiple sclerosis
185917|NCT02184494|Fatigue|fatigue
185918|NCT02184494|Resting Energy Expenditure|resting energy expenditure
185919|NCT02184494|Whole Body Vibration|whole body vibration
185920|NCT02184494|Exercise|exercise
185921|NCT02184494|Blood Lactate|blood lactate
185922|NCT02184481|Depression|depression
185923|NCT02184481|Anxiety|anxiety
185925|NCT02184481|Rumination|rumination
185926|NCT02184481|Cognitive training|cognitive training
185927|NCT02184481|Executive functioning|executive functioning
185928|NCT02184468|Cardiac Arrest|cardiac arrest
185929|NCT02184468|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
185930|NCT02184468|Firefighters|firefighters
185931|NCT02184468|Police|police
185932|NCT02184468|Defibrillators|defibrillators
185933|NCT02184468|Survival|survival
185934|NCT02184455|Diabetic|diabetic
185935|NCT02184455|Chronic Ulcer|chronic ulcer
185936|NCT02184455|Wound Healing|wound healing
185937|NCT02184455|Leg|leg
185938|NCT02184442|SAPIEN|sapien
185939|NCT02184442|TAVR|tavr
185940|NCT02184442|THV|thv
185941|NCT02184442|Aortic Stenosis|aortic stenosis
185942|NCT02184442|Heart Valve Disease|heart valve disease
185943|NCT02184442|Aortic Valve|aortic valve
185944|NCT02184442|Retroflex|retroflex
185945|NCT02184442|Ascendra|ascendra
185946|NCT02184429|First in human|first in human
185947|NCT02184429|single ascending dose study|single ascending dose study
185948|NCT02184429|multiple ascending dose study|multiple ascending dose study
185949|NCT02184429|safety and tolerability|safety and tolerability
185950|NCT02184429|pharmacokinetics|pharmacokinetics
185951|NCT02184429|food effect|food effect
185952|NCT02184429|Parkinson's Disease|parkinson's disease
185953|NCT02184416|Inlyta|inlyta
185954|NCT02184416|axitinib|axitinib
185955|NCT02184416|Sutent|sutent
185956|NCT02184416|sunitinib|sunitinib
185957|NCT02184416|renal|renal
185958|NCT02184390|Internet|internet
185959|NCT02184390|Education|education
185960|NCT02184377|quantitative laryngeal electromyography|quantitative laryngeal electromyography
185961|NCT02184377|cricothyroid muscle|cricothyroid muscle
185962|NCT02184377|unilateral vocal fold paralysis|unilateral vocal fold paralysis
185963|NCT02184377|superior laryngeal nerve|superior laryngeal nerve
185964|NCT02184377|lexical tone|lexical tone
185965|NCT02184377|Mandarin|mandarin
185973|NCT02184195|BRCA, metastatic adenocarcinoma pancreas, maintenance olaparib monotherapy, first line platinum chemotherapy, pancreatic cancer, PARP inhibitor|brca, metastatic adenocarcinoma pancreas, maintenance olaparib monotherapy, first line platinum chemotherapy, pancreatic cancer, parp inhibitor
185975|NCT02184169|neonatal|neonatal
185976|NCT02184169|cardiac disease|cardiac disease
185977|NCT02184169|congenital heart disease|congenital heart disease
185978|NCT02184169|volumetric oxygen consumption|volumetric oxygen consumption
185979|NCT02184117|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
185980|NCT02184117|Adenosine|adenosine
185981|NCT02184117|Contrast Media|contrast media
185982|NCT02184104|caffeine|caffeine
185983|NCT02184104|pharmacokinetics|pharmacokinetics
185984|NCT02184104|pharmacodynamics|pharmacodynamics
185985|NCT02182999|Hallux valgus surgery|hallux valgus surgery
185986|NCT02182999|wound infiltration|wound infiltration
185987|NCT02182999|pain|pain
185988|NCT02182986|Biomarkers|biomarkers
185989|NCT02182986|Post-Transplant Lymphoproliferative Disorders (PTLDs)|post-transplant lymphoproliferative disorders (ptlds)
185990|NCT02182973|neonatal abstinence syndrome, infant opiate withdrawal|neonatal abstinence syndrome, infant opiate withdrawal
185991|NCT02182947|Pediatric|pediatric
185992|NCT02182947|Inflammatory Bowel Disease|inflammatory bowel disease
185993|NCT02182947|capsule endoscopy|capsule endoscopy
185994|NCT02182947|MRI|mri
185995|NCT02182947|Crohn's Disease|crohn's disease
185996|NCT02182947|Indeterminant Colitis|indeterminant colitis
185997|NCT02182947|Small bowel Crohn's Disease|small bowel crohn's disease
185998|NCT02182908|Aneurysm of abdominal aorta|aneurysm of abdominal aorta
185999|NCT02182908|18F-fluorodesoxyglucose (FDG-F18)|18f-fluorodesoxyglucose (fdg-f18)
186000|NCT02182843|Cellentra ACDF|cellentra acdf
186001|NCT02184026|nightmare|nightmare
186002|NCT02184026|PTSD|ptsd
186003|NCT02184026|trauma|trauma
186004|NCT02184026|children|children
186005|NCT02184026|Children Age 8 to 13|children age 8 to 13
186006|NCT02184013|Atrial fibrillation|atrial fibrillation
186007|NCT02184013|Catheter ablation|catheter ablation
186008|NCT02184013|Delayed gadolinium enhanced MRI|delayed gadolinium enhanced mri
186009|NCT02184013|C-metahydroxyepherdrine (HED) PET scan|c-metahydroxyepherdrine (hed) pet scan
186010|NCT02184013|ECGI mapping|ecgi mapping
186011|NCT02184013|Atrial Fibrosis|atrial fibrosis
186012|NCT02184013|Atrial sympathetic denervation|atrial sympathetic denervation
186013|NCT02184000|strain elastography|strain elastography
186014|NCT02184000|hepatopathy|hepatopathy
186015|NCT02184000|liver fibrosis|liver fibrosis
186016|NCT02183987|Knowledge Translation|knowledge translation
186017|NCT02183987|Chronic Kidney Disease|chronic kidney disease
186018|NCT02183987|Dialysis|dialysis
186019|NCT02183987|Intent-to-defer|intent-to-defer
186020|NCT02183987|Early dialysis|early dialysis
186021|NCT02183987|Cluster randomized trial|cluster randomized trial
186022|NCT02183974|otitis media with effusion|otitis media with effusion
186023|NCT02183974|Laryngopharyngeal Reflux|laryngopharyngeal reflux
186024|NCT02183961|otitis media with effusion|otitis media with effusion
186025|NCT02183961|peptest|peptest
186026|NCT02183961|restech|restech
186027|NCT02183961|oropharyngeal pH monitoring|oropharyngeal ph monitoring
186028|NCT02183961|laryngopharyngeal reflux|laryngopharyngeal reflux
186029|NCT02183948|treatment|treatment
186030|NCT02183948|mask face exoressions|mask face exoressions
186031|NCT02183948|genier|genier
186032|NCT02183935|Obesity|obesity
186034|NCT02183935|Metabolic syndrome|metabolic syndrome
186035|NCT02183935|Gut hormones|gut hormones
186036|NCT02183935|Adipokines|adipokines
186037|NCT02183935|Appetite|appetite
186038|NCT02183935|Adolescent|adolescent
186039|NCT02183896|Femoroacetabular impingement (FAI)|femoroacetabular impingement (fai)
186040|NCT02183896|Chondral lesions|chondral lesions
186041|NCT02183896|Hip|hip
186042|NCT02183896|Microfracture|microfracture
186043|NCT02183896|Platelet-rich plasma (PRP)|platelet-rich plasma (prp)
186044|NCT02183883|Non-small cell lung cancer|non-small cell lung cancer
186045|NCT02183883|NSCLC|nsclc
186046|NCT02183883|Afatinib|afatinib
186047|NCT02183883|Intra-tumour heterogeneity|intra-tumour heterogeneity
186048|NCT02183883|Clonal dominance|clonal dominance
186049|NCT02183883|Drug resistance|drug resistance
186050|NCT02183883|EGFR|egfr
186051|NCT02183883|HER2|her2
186052|NCT02183883|Phase 2|phase 2
186053|NCT02183870|lung cancer|lung cancer
186054|NCT02183870|adenocarcinoma|adenocarcinoma
186055|NCT02183870|NSCLC|nsclc
186056|NCT02183870|ROS1|ros1
186057|NCT02183870|ROS1 translocation|ros1 translocation
186058|NCT02183870|crizotinib|crizotinib
186059|NCT02183870|phase II|phase ii
186060|NCT02183857|children|children
186061|NCT02183857|congenital heart disease|congenital heart disease
186062|NCT02183844|Medical Informatics|medical informatics
186063|NCT02183844|Patient-Centered|patient-centered
186064|NCT02183844|Healthcare Preferences|healthcare preferences
186065|NCT02183844|Health Education|health education
186066|NCT02183844|Quality Improvement|quality improvement
186067|NCT02183844|Weight Loss|weight loss
186068|NCT02183844|Personal Satisfaction|personal satisfaction
186069|NCT02183844|Humans|humans
186070|NCT02183844|Cognition|cognition
186071|NCT02183844|Body Weight|body weight
186072|NCT02183818|Smoking|smoking
186073|NCT02183818|COPD|copd
186074|NCT02183818|Non-Smokers|non-smokers
186075|NCT02183818|Smokers|smokers
186076|NCT02183805|triple negative breast cancer|triple negative breast cancer
186077|NCT02183805|autologous hematopoietic stem-cell transplantation|autologous hematopoietic stem-cell transplantation
186078|NCT02183779|post-occlusive hyperaemia|post-occlusive hyperaemia
186079|NCT02183779|laser-speckle contrast imaging|laser-speckle contrast imaging
186080|NCT02183779|epoxyeicosatrienoic acid|epoxyeicosatrienoic acid
186081|NCT02183779|nitrous oxide|nitrous oxide
186082|NCT02183753|LAIV|laiv
186083|NCT02183753|Flumist|flumist
186084|NCT02183753|wood smoke|wood smoke
186085|NCT02183740|Education|education
186086|NCT02183740|Nurses|nurses
186087|NCT02183740|Nursing homes|nursing homes
186088|NCT02183740|Fecal incontinence|fecal incontinence
186089|NCT02183740|Cluster-randomized controlled trial|cluster-randomized controlled trial
186090|NCT02183727|ACL|acl
186091|NCT02183727|knee injury|knee injury
186092|NCT02183727|anterior cruciate ligament|anterior cruciate ligament
186093|NCT02183597|Magnetic Resonance Imaging|magnetic resonance imaging
186094|NCT02183597|Data Accuracy|data accuracy
186095|NCT02183597|Reproducibility of Results|reproducibility of results
186096|NCT02183597|Diagnosis|diagnosis
186097|NCT02183558|PCOS|pcos
186098|NCT02183558|GDM|gdm
186099|NCT02183558|OGTT|ogtt
186100|NCT02183558|Glucose metabolism|glucose metabolism
186101|NCT02183519|Cough|cough
186102|NCT02183519|Reflex|reflex
186103|NCT02183519|Voluntary|voluntary
186104|NCT02183519|Healthy older adults|healthy older adults
186105|NCT02183519|Parkinson's disease|parkinson's disease
186106|NCT02183519|Respiratory kinematics|respiratory kinematics
186107|NCT02183519|Cueing|cueing
186108|NCT02183454|intracoronary stent|intracoronary stent
186109|NCT02183454|drug eluting stent|drug eluting stent
186110|NCT02183454|sirolimus|sirolimus
186111|NCT02183454|endothelial progenitor cells|endothelial progenitor cells
186112|NCT02183272|Depression|depression
186113|NCT02183272|Suicidal Ideation|suicidal ideation
186114|NCT02183272|Ketamine|ketamine
186115|NCT02183272|Emergency Department|emergency department
186116|NCT02183207|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
186117|NCT02183207|Introducer method|introducer method
186118|NCT02182817|General Anaesthesia|general anaesthesia
186119|NCT02182817|Neurocognitive Development|neurocognitive development
186120|NCT02182817|Behaviour|behaviour
186121|NCT02182804|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
186122|NCT02182804|Narrow Band Imaging|narrow band imaging
186123|NCT02182804|Lugol Chromoendoscopy|lugol chromoendoscopy
186124|NCT02182804|Esophageal Neoplasm|esophageal neoplasm
186125|NCT02182804|Head and Neck Cancer|head and neck cancer
186126|NCT02182687|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
186127|NCT02182687|Orthotopic liver transplant|orthotopic liver transplant
186128|NCT02182687|Bridge to transplant|bridge to transplant
186129|NCT02182687|stereotactic body radiation therapy (SBRT)|stereotactic body radiation therapy (sbrt)
186130|NCT02182687|trans-arterial chemoembolization (TACE)|trans-arterial chemoembolization (tace)
186131|NCT02182596|Acute Myeloid Leukemia|acute myeloid leukemia
186132|NCT02182596|First relapsing AML|first relapsing aml
186133|NCT02182466|Colon capsule endoscopy|colon capsule endoscopy
186134|NCT02182466|Colonoscopy|colonoscopy
186135|NCT02182466|Screening colonoscopy|screening colonoscopy
186136|NCT02182440|SA-AKI|sa-aki
186137|NCT02182440|Sepsis|sepsis
186138|NCT02182440|AKI|aki
186139|NCT02182440|Recombinant Alkaline Phosphatase|recombinant alkaline phosphatase
186140|NCT02182440|recAP|recap
186141|NCT02182167|Drug Induced Hepatitis (DIH)|drug induced hepatitis (dih)
186142|NCT02182167|Toxic Liver|toxic liver
186143|NCT02182167|Drug Induced Liver Injury (DILI)|drug induced liver injury (dili)
186144|NCT02182115|Staphylococcus aureus infection|staphylococcus aureus infection
186145|NCT02182115|Decolonization|decolonization
186146|NCT02182115|Surgical site infection|surgical site infection
186147|NCT02181894|Infant|infant
186148|NCT02181894|Newborn|newborn
186149|NCT02181894|Neonate|neonate
186150|NCT02181894|Intubation|intubation
186151|NCT02181894|Neonatal resuscitation|neonatal resuscitation
186152|NCT02181842|Pharmacological therapy|pharmacological therapy
186153|NCT02181829|Whole Lung IMRT|whole lung imrt
186154|NCT02181829|14-075|14-075
186155|NCT02181816|Pharmacological therapy|pharmacological therapy
186156|NCT02181790|psoriasis|psoriasis
186157|NCT02181790|palmoplantar|palmoplantar
186158|NCT02181790|acitretin|acitretin
186159|NCT02181790|retinoids|retinoids
186160|NCT02181790|laser treatment|laser treatment
186161|NCT02181777|Psychosis|psychosis
186162|NCT02181777|Schizophrenia|schizophrenia
186163|NCT02181777|Social Skills|social skills
186164|NCT02181777|Therapy|therapy
186165|NCT02181764|XLH|xlh
186166|NCT02181751|Child Sexual Abuse|child sexual abuse
186167|NCT02181751|CSA|csa
186168|NCT02181751|Treatment|treatment
186169|NCT02181751|Prevention|prevention
186170|NCT02181751|PTSD|ptsd
186171|NCT02181751|Post Traumatic Stress Disorder|post traumatic stress disorder
186172|NCT02181751|Depression|depression
186173|NCT02181751|Anxiety|anxiety
186174|NCT02181751|Quality of Life|quality of life
186175|NCT02181751|Attachment|attachment
186176|NCT02181751|Cognitive Behavioural Therapy|cognitive behavioural therapy
186177|NCT02181751|Group Therapy|group therapy
186178|NCT02181725|Chronic Pain|chronic pain
186179|NCT02181725|Adolescent|adolescent
186180|NCT02181725|Graded Exposure|graded exposure
186181|NCT02181712|Bronchiolitis obliterans|bronchiolitis obliterans
186182|NCT02181712|lung transplant|lung transplant
186183|NCT02181712|mesenchymal stem cell|mesenchymal stem cell
186184|NCT02181712|cell therapy|cell therapy
186185|NCT02181686|Heart Failure|heart failure
186186|NCT02181686|Iperia ICD family|iperia icd family
186187|NCT02181686|Sentus QP left ventricular lead|sentus qp left ventricular lead
186188|NCT02181686|Quadripolar CRT-D system|quadripolar crt-d system
186189|NCT02181673|Psoriatic arthritis|psoriatic arthritis
186190|NCT02181673|Golimumab|golimumab
186191|NCT02181673|Simponi|simponi
186192|NCT02181660|AML|aml
186193|NCT02181660|Acute myeloid leukemia|acute myeloid leukemia
186194|NCT02181660|ASP2215|asp2215
186195|NCT02181634|Advanced Cholangiocarcinoma|advanced cholangiocarcinoma
186196|NCT02181634|Metastatic Cholangiocarcinoma|metastatic cholangiocarcinoma
186197|NCT02181634|CCA|cca
186198|NCT02181634|Bile Duct Cancer|bile duct cancer
186199|NCT02181634|Nab-Paclitaxel|nab-paclitaxel
186200|NCT02181634|Abraxane®|abraxane®
186201|NCT02181634|Gemcitabine|gemcitabine
186202|NCT02181634|Gemzar®|gemzar®
186203|NCT02181608|Alcohol Dependence|alcohol dependence
186204|NCT02181608|Fear Conditioning|fear conditioning
186205|NCT02181608|Stress|stress
186206|NCT02181608|Alcohol|alcohol
186207|NCT02181595|Reading|reading
186208|NCT02181595|FACIT-SP|facit-sp
186209|NCT02181595|Primary Ovarian Insufficiency|primary ovarian insufficiency
186210|NCT02181582|Health Humans|health humans
186211|NCT02181582|Receptor Occupancy|receptor occupancy
186212|NCT02181569|Addiction Severity Index|addiction severity index
186213|NCT02181569|Addiction|addiction
186214|NCT02181569|Sleep Measures|sleep measures
186215|NCT02181569|Sleep Disorders|sleep disorders
186216|NCT02181556|colorectal cancer|colorectal cancer
186217|NCT02181556|Metastatic|metastatic
186218|NCT02181543|Clonidine|clonidine
186219|NCT02181543|Psychomotor agitation|psychomotor agitation
186220|NCT02181543|Anesthesia recovery period|anesthesia recovery period
186221|NCT02181543|Tonsillectomy|tonsillectomy
186222|NCT02181543|Child, preschool|child, preschool
186223|NCT02181478|Total Body Irradiation|total body irradiation
186224|NCT02181478|Human Mesenchymal Stromal Cells|human mesenchymal stromal cells
186225|NCT02181478|hMSC|hmsc
186226|NCT02181478|Cyclophosphamide|cyclophosphamide
186227|NCT02181478|Fludarabine|fludarabine
186228|NCT02181478|Dimethyl Sulfoxide|dimethyl sulfoxide
186229|NCT02181478|DMSO|dmso
186230|NCT02181478|Cyclosporine|cyclosporine
186231|NCT02181478|Mycophenolate Mofetil|mycophenolate mofetil
186232|NCT02181478|MMF|mmf
186233|NCT02181478|Granulocyte- Colony Stimulating Factor|granulocyte- colony stimulating factor
186234|NCT02181478|G-CSF|g-csf
186235|NCT02181478|GVHD|gvhd
186236|NCT02181478|Cancer|cancer
186237|NCT02181478|feasibility|feasibility
186238|NCT02181452|liver|liver
186239|NCT02181452|fibrosis|fibrosis
186240|NCT02181452|ShearWave Elastography|shearwave elastography
186241|NCT02181452|ultrasound|ultrasound
186242|NCT02181426|Knee Arthroscopy|knee arthroscopy
186243|NCT02181413|Drug therapy|drug therapy
186244|NCT02181413|TOURMALINE|tourmaline
186245|NCT02181413|ixazomib|ixazomib
186246|NCT02181400|diabetic retinopathy|diabetic retinopathy
186247|NCT02181400|diabetic macular edema|diabetic macular edema
186248|NCT02181400|diabetic macular oedema|diabetic macular oedema
186249|NCT02181400|near infrared light therapy|near infrared light therapy
186250|NCT02181387|labor pain|labor pain
186251|NCT02181387|acetaminophen|acetaminophen
186252|NCT02181374|atrial fibrillation|atrial fibrillation
186253|NCT02181374|NT-proBNP|nt-probnp
186254|NCT02181374|Cardioembolic Stroke|cardioembolic stroke
186255|NCT02181361|atrial fibrillation|atrial fibrillation
186256|NCT02181361|cardioembolic stroke|cardioembolic stroke
186257|NCT02181361|Hirudin|hirudin
186258|NCT02181361|aspirin|aspirin
186259|NCT02181361|warfarin|warfarin
177188|NCT02223130|HIV|hiv
186260|NCT02181348|Vitamin E, Hemoglobin, mild anemia|vitamin e, hemoglobin, mild anemia
186261|NCT02181296|Shoulder arthroscopy|shoulder arthroscopy
186262|NCT02181296|Interscalene block|interscalene block
186263|NCT02181296|Drug concentration|drug concentration
186264|NCT02181296|0.1% ropivacaine or 0.2% ropivacaine|0.1% ropivacaine or 0.2% ropivacaine
186265|NCT02181283|alcohol|alcohol
186266|NCT02181283|prescribed drugs|prescribed drugs
186267|NCT02181283|National Guard|national guard
186268|NCT02181270|NAFLD|nafld
186269|NCT02181270|obesity|obesity
186270|NCT02181270|ck18|ck18
186271|NCT02181270|blood lipids|blood lipids
186272|NCT02181270|high intensity exercise training|high intensity exercise training
186273|NCT02181270|individuals|individuals
186274|NCT02181270|>5% liver fat|>5% liver fat
186275|NCT02181257|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
186276|NCT02181257|Lung Transplantation|lung transplantation
186277|NCT02181257|Extracorporeal Photopheresis|extracorporeal photopheresis
186278|NCT02181257|Methoxsalen|methoxsalen
186279|NCT02181244|egg|egg
186280|NCT02181244|oatmeal|oatmeal
186281|NCT02181244|atherogenic dyslipidemia|atherogenic dyslipidemia
186282|NCT02181244|glycosylated hemoglobin|glycosylated hemoglobin
186283|NCT02181244|inflammatory markers|inflammatory markers
186284|NCT02181231|depression|depression
186285|NCT02181231|older adult|older adult
186286|NCT02181231|buprenorphine|buprenorphine
186287|NCT02181231|Effexor XR|effexor xr
186288|NCT02181231|treatment resistant|treatment resistant
186289|NCT02181231|venlafaxine|venlafaxine
186290|NCT02181231|Saint Louis|saint louis
186291|NCT02181231|late life|late life
186292|NCT02181231|major depression|major depression
186293|NCT02181192|biochemical recurrence|biochemical recurrence
186294|NCT02181192|prostate carcinoma|prostate carcinoma
186295|NCT02181192|prostate cancer|prostate cancer
186296|NCT02181192|PSA|psa
186297|NCT02181192|postoperative|postoperative
186298|NCT02181192|radiotherapy|radiotherapy
186299|NCT02181192|imaging diagnostic|imaging diagnostic
186300|NCT02181192|PET/CT|pet/ct
186301|NCT02181192|social economic aspects|social economic aspects
186302|NCT02181192|quality of life|quality of life
186303|NCT02181179|yoga|yoga
186304|NCT02181179|exercise intervention|exercise intervention
186305|NCT02181179|smoking|smoking
186306|NCT02181179|stress|stress
186307|NCT02181179|mind-body|mind-body
186308|NCT02181179|intervention|intervention
186309|NCT02181166|Breast Neoplasms|breast neoplasms
186310|NCT02181166|Mastectomy|mastectomy
186311|NCT02181166|Myofascial pain syndromes|myofascial pain syndromes
186312|NCT02181166|Physical Therapy Modalities|physical therapy modalities
186313|NCT02181153|inflammatory bowel disease|inflammatory bowel disease
186314|NCT02181153|siblings|siblings
186315|NCT02181140|fine needle aspiration|fine needle aspiration
186316|NCT02181140|core biopsy|core biopsy
186317|NCT02181140|endoscopic ultrasound|endoscopic ultrasound
186318|NCT02181140|space occupying process mediastinal, perigastral, perihilar|space occupying process mediastinal, perigastral, perihilar
186319|NCT02181140|suspect lymph nodes mediastinal, perigastral or perihilar|suspect lymph nodes mediastinal, perigastral or perihilar
186320|NCT02181140|diagnostic accuracy of EUS guided core biopsy|diagnostic accuracy of eus guided core biopsy
186321|NCT02181127|bionic pancreas|bionic pancreas
186322|NCT02181127|artificial pancreas|artificial pancreas
186323|NCT02181127|insulin|insulin
186324|NCT02181127|glucagon|glucagon
186325|NCT02181127|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
186326|NCT02181127|outpatient|outpatient
186327|NCT02181127|insulin pump|insulin pump
186328|NCT02181127|glucagon pump|glucagon pump
186329|NCT02181114|Coaching|coaching
186330|NCT02181114|Educational Materials|educational materials
186331|NCT02181114|Expert System|expert system
186332|NCT02181114|Living Donor Kidney Transplant|living donor kidney transplant
186334|NCT02181088|Plasmodium falciparum|plasmodium falciparum
186335|NCT02181088|RH5|rh5
186336|NCT02181075|ThermoDox|thermodox
186337|NCT02181075|High Intensity Focused Ultrasound|high intensity focused ultrasound
186338|NCT02181075|Lyso thermosensitive Liposomal|lyso thermosensitive liposomal
186339|NCT02181075|Non invasive drug delivery|non invasive drug delivery
186340|NCT02181075|Hepatic metastatic disease|hepatic metastatic disease
186341|NCT02181075|Liver tumour(s)|liver tumour(s)
186342|NCT02181075|Targeted Release of Chemotherapy|targeted release of chemotherapy
186343|NCT02181062|Stroke|stroke
186344|NCT02181062|Stroke prevention|stroke prevention
186345|NCT02181062|older adults|older adults
186346|NCT02181062|self efficacy|self efficacy
186347|NCT02181062|walking|walking
186348|NCT02181062|minorities|minorities
186349|NCT02181062|minority older adults|minority older adults
186350|NCT02181062|hypertension|hypertension
186351|NCT02181062|high blood pressure|high blood pressure
186352|NCT02181062|elderly|elderly
186353|NCT02181062|sedentary lifestyle|sedentary lifestyle
186354|NCT02181049|Childhood cancer survivors|childhood cancer survivors
186355|NCT02181049|Cardiac|cardiac
186356|NCT02181049|Vascular|vascular
186357|NCT02181049|Cardiovascular|cardiovascular
186358|NCT02181049|Late-sequelae|late-sequelae
186359|NCT02181036|Family work shop|family work shop
186360|NCT02181036|speech developmental delays|speech developmental delays
186361|NCT02181036|children|children
186362|NCT02181023|COPD|copd
186363|NCT02181023|Hyperinflation|hyperinflation
186364|NCT02181023|Aclidinium|aclidinium
186365|NCT02181023|Glycopyrronium|glycopyrronium
186366|NCT02181023|Volume distribution|volume distribution
186367|NCT02181023|Anticholinergic|anticholinergic
186368|NCT02181023|Pharmacokinetics|pharmacokinetics
186369|NCT02181023|Single Breath Nitrogen Test|single breath nitrogen test
186370|NCT02181023|Phase III|phase iii
186371|NCT02181010|African American|african american
186372|NCT02181010|Adolescents|adolescents
186373|NCT02181010|Urban|urban
186374|NCT02181010|Food Desert|food desert
186375|NCT02181010|Food Insecurity|food insecurity
186376|NCT02181010|Obesity|obesity
186377|NCT02181010|Baltimore City|baltimore city
186378|NCT02181010|Peer mentors|peer mentors
186379|NCT02181010|Multi level|multi level
186380|NCT02181010|Policy|policy
186381|NCT02181010|Caregivers|caregivers
186382|NCT02181010|Systems|systems
186383|NCT02181010|Agent Based Model|agent based model
186384|NCT02181010|Systems Dynamic Model|systems dynamic model
186385|NCT02181010|Corner Store|corner store
186386|NCT02181010|Carryout|carryout
186387|NCT02181010|Recreation Center|recreation center
186388|NCT02181010|Text Messaging|text messaging
186389|NCT02181010|Social Media|social media
186390|NCT02181010|Mapping|mapping
186391|NCT02180997|α1-blockers|α1-blockers
186392|NCT02180997|antimuscarinic agent|antimuscarinic agent
186393|NCT02180984|Binge Eating|binge eating
186394|NCT02180984|Obesity|obesity
186395|NCT02180984|TMS|tms
186396|NCT02180984|Neuroimage|neuroimage
186397|NCT02180984|Neuromodulation|neuromodulation
186398|NCT02180984|Biomarkers|biomarkers
186399|NCT02180984|Eating Disorders|eating disorders
186400|NCT02180984|Cognition|cognition
186401|NCT02180984|Endocrine|endocrine
186402|NCT02180984|Hormones|hormones
186403|NCT02180984|BDNF|bdnf
186404|NCT02180984|Inflammatory biomarkers|inflammatory biomarkers
186405|NCT02180971|Multi-detector computed tomography angiography|multi-detector computed tomography angiography
186406|NCT02180971|Coronary vessel distensibility|coronary vessel distensibility
186407|NCT02180971|Coronary spasm|coronary spasm
186408|NCT02180958|cerebral arteriovenous malformations|cerebral arteriovenous malformations
186409|NCT02180958|cAVM|cavm
186410|NCT02180958|ONYX|onyx
186411|NCT02180945|dAVF|davf
186412|NCT02180945|Arteriovenous fistula|arteriovenous fistula
186413|NCT02180945|ONYX|onyx
186414|NCT02180919|Telemonitoring|telemonitoring
186415|NCT02180919|COPD|copd
186416|NCT02180919|Heart failure|heart failure
186417|NCT02180919|Exacerbation|exacerbation
186418|NCT02180919|Respiratory failure|respiratory failure
186419|NCT02180919|Prevention|prevention
186420|NCT02180919|Self monitoring|self monitoring
186421|NCT02180906|Fasciitis|fasciitis
186422|NCT02180906|Gangrene|gangrene
186423|NCT02180906|Fasciitis, Necrotizing|fasciitis, necrotizing
186424|NCT02180906|Soft Tissue Infections|soft tissue infections
186425|NCT02180906|Fournier's Gangrene|fournier's gangrene
186426|NCT02180906|Streptococcal septic shock syndrome|streptococcal septic shock syndrome
186427|NCT02180906|Flesh eating bacteria|flesh eating bacteria
186428|NCT02180906|Meleneys ulcer|meleneys ulcer
186429|NCT02180906|Wounds and Injuries|wounds and injuries
186430|NCT02180906|Streptococcus pyogenes|streptococcus pyogenes
186431|NCT02180906|Staphylococcus aureus|staphylococcus aureus
186432|NCT02180906|Immunopathogenesis|immunopathogenesis
186433|NCT02180906|Soft Tissue Infections/blood|soft tissue infections/blood
186434|NCT02180906|Necrosis/blood|necrosis/blood
186435|NCT02180906|Necrosis/diagnosis|necrosis/diagnosis
186436|NCT02180906|Necrosis/mortality|necrosis/mortality
668544|NCT00851019|Exercise|exercise
186437|NCT02180906|Necrosis/surgery|necrosis/surgery
186438|NCT02180906|Prognosis|prognosis
186439|NCT02180906|Risk Factors|risk factors
186440|NCT02180906|Bacterial Infections|bacterial infections
186441|NCT02180906|Infection|infection
186442|NCT02180906|Skin Diseases, Bacterial|skin diseases, bacterial
186443|NCT02180906|Observational study|observational study
186444|NCT02180906|Biological markers|biological markers
186445|NCT02180880|Neuralgia|neuralgia
186446|NCT02180880|Spinal cord|spinal cord
186447|NCT02180880|Oxcarbazepine|oxcarbazepine
186448|NCT02180880|Pregabalin|pregabalin
186449|NCT02180880|Drug therapy|drug therapy
186450|NCT02180880|Algorithms|algorithms
186451|NCT02180854|Early warning score|early warning score
186452|NCT02180854|Rapid response systems|rapid response systems
186453|NCT02180854|Medical emergency team|medical emergency team
186455|NCT02180841|hypertension|hypertension
186456|NCT02180841|HDL-C|hdl-c
186457|NCT02180841|cholesterol efflux|cholesterol efflux
186458|NCT02180841|cardiovascular disease|cardiovascular disease
186459|NCT02180815|Obstructive Sleep Apnea|obstructive sleep apnea
227473|NCT01993043|ROP|rop
186460|NCT02180815|Obstructive Sleep Apnea due to primary tongue base closure|obstructive sleep apnea due to primary tongue base closure
186461|NCT02180815|Minimally invasive surgery|minimally invasive surgery
186462|NCT02180815|ReVENT Sleep Apnea System|revent sleep apnea system
186463|NCT02180815|Tongue implants|tongue implants
186464|NCT02180802|obese adolescents|obese adolescents
186465|NCT02180802|BMI ≥ 95th percentile for age and gender|bmi ≥ 95th percentile for age and gender
186466|NCT02180789|tamsulosin,|tamsulosin,
186467|NCT02180789|benign prostatic hyperplasia,|benign prostatic hyperplasia,
187066|NCT02177695|SWOG|swog
186468|NCT02180789|α1-adrenoceptor antagonists|α1-adrenoceptor antagonists
186469|NCT02180763|Primary Immunodeficiency, PID|primary immunodeficiency, pid
186470|NCT02180750|Children|children
186471|NCT02180750|HIV|hiv
186472|NCT02180750|orphans|orphans
186473|NCT02180737|dexmedetomedine|dexmedetomedine
186474|NCT02180737|sedation|sedation
186475|NCT02180737|interventional radiology|interventional radiology
186476|NCT02180724|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
186477|NCT02180724|Btk|btk
186478|NCT02180724|Waldenström Macroglobulinemia|waldenström macroglobulinemia
186479|NCT02180724|WM|wm
186480|NCT02180724|Waldenström|waldenström
186481|NCT02180724|Macroglobulinemia|macroglobulinemia
186482|NCT02180711|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
186483|NCT02180711|Btk|btk
186484|NCT02180711|Follicular Lymphoma|follicular lymphoma
186485|NCT02180711|FL|fl
186486|NCT02180711|acalabrutinib|acalabrutinib
186487|NCT02180711|ACP-196|acp-196
186488|NCT02180672|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
186489|NCT02180672|OSA|osa
186490|NCT02180672|sleep apnea|sleep apnea
186491|NCT02180672|nasal steroids|nasal steroids
186492|NCT02180672|corticosteroids|corticosteroids
186493|NCT02180646|GLP-1|glp-1
186494|NCT02180646|GIP|gip
186495|NCT02180646|second meal phenomena|second meal phenomena
186496|NCT02180646|type 2 diabetes|type 2 diabetes
186497|NCT02180633|Idiopathic Macular Hole|idiopathic macular hole
186498|NCT02180620|GIP|gip
186499|NCT02180620|GLP-1|glp-1
186500|NCT02180620|exercise timing|exercise timing
186501|NCT02180620|resistance exercise|resistance exercise
186502|NCT02180620|glucose concentrations|glucose concentrations
186503|NCT02180607|depression|depression
186504|NCT02180607|social|social
186505|NCT02180607|rejection|rejection
186506|NCT02180607|acceptance|acceptance
186507|NCT02180607|fMRI|fmri
186508|NCT02180607|reward|reward
186509|NCT02180607|exclusion|exclusion
186510|NCT02180581|Infections|infections
186511|NCT02180581|Allergy|allergy
186512|NCT02180581|Immune function|immune function
186513|NCT02180581|Microbiota|microbiota
186514|NCT02180581|Infant|infant
186515|NCT02180568|Ground-glass-opacity (GGO)|ground-glass-opacity (ggo)
186516|NCT02180568|Lung localization|lung localization
186517|NCT02180568|Lipiodol|lipiodol
186518|NCT02180568|Hook wire|hook wire
186519|NCT02180568|Video assisted thoracic surgery (VATS)|video assisted thoracic surgery (vats)
186520|NCT02180542|stroke|stroke
186521|NCT02180542|Ischemic stroke|ischemic stroke
186522|NCT02180542|Cerebral infarction|cerebral infarction
186523|NCT02180542|recurrent stroke|recurrent stroke
186524|NCT02180542|atrial fibrillation|atrial fibrillation
186525|NCT02180542|premature atrial complexes|premature atrial complexes
186526|NCT02180542|heart rhythm monitoring|heart rhythm monitoring
186527|NCT02180542|left atrial function|left atrial function
186528|NCT02180542|carotid artery|carotid artery
186529|NCT02180542|plaque morphology|plaque morphology
186530|NCT02180529|methylphenidate, elderly, mild cognitive impairment|methylphenidate, elderly, mild cognitive impairment
186531|NCT02180464|psoriasis, topical|psoriasis, topical
186532|NCT02180438|HIV-2|hiv-2
186533|NCT02180425|acne|acne
186535|NCT02180425|tretinoin|tretinoin
186536|NCT02180425|isotretinoin|isotretinoin
186537|NCT02180412|Acute porphyria|acute porphyria
186538|NCT02180412|Hemin|hemin
186539|NCT02180399|Sepsis|sepsis
186540|NCT02180399|Capillary blood lactate|capillary blood lactate
186541|NCT02180399|Serial measurement of capillary|serial measurement of capillary
186542|NCT02180386|Audiovisual distraction|audiovisual distraction
186543|NCT02180386|Pediatric dentistry|pediatric dentistry
186544|NCT02180360|Capoeira training|capoeira training
186545|NCT02180360|Range of motion|range of motion
186546|NCT02180360|Flexibility|flexibility
186547|NCT02180360|beginners|beginners
186548|NCT02180347|Pediatrics|pediatrics
186549|NCT02180347|Contact lenses|contact lenses
186550|NCT02180334|Gastric Emptying|gastric emptying
186551|NCT02180334|Gastrointestinal Motility|gastrointestinal motility
186552|NCT02180334|Incretins|incretins
186553|NCT02180334|Glucagon-Like Peptide 1|glucagon-like peptide 1
186554|NCT02180334|Diabetes Mellitus|diabetes mellitus
186555|NCT02180321|Tranexamic acid|tranexamic acid
186556|NCT02180321|pharmacokinetics|pharmacokinetics
186557|NCT02180321|craniosynostosis|craniosynostosis
186558|NCT02180308|Head cancer|head cancer
186559|NCT02180308|Neck cancer|neck cancer
177484|NCT02221791|Cocoa|cocoa
186560|NCT02180308|MRI|mri
186561|NCT02180308|PET|pet
186562|NCT02180282|Acne Treatment|acne treatment
186563|NCT02180269|Healthy|healthy
186564|NCT02180269|JNJ-54861911|jnj-54861911
186565|NCT02180269|Alzheimer's disease|alzheimer's disease
186566|NCT02180256|IVF|ivf
186567|NCT02180256|ICSI|icsi
186568|NCT02180256|Embryo transfer|embryo transfer
186569|NCT02180256|Assisted reproduction|assisted reproduction
186570|NCT02180256|Endometrial injury|endometrial injury
186571|NCT02180256|Endometrial scratching|endometrial scratching
186572|NCT02180243|meditation|meditation
186573|NCT02180243|acupuncture|acupuncture
186574|NCT02180243|Gulf War Veterans' Illness|gulf war veterans' illness
186575|NCT02180243|Gulf War health education|gulf war health education
186576|NCT02180243|iRest yoga|irest yoga
186577|NCT02180230|Short implants|short implants
186578|NCT02180230|prospective multicenter study|prospective multicenter study
186579|NCT02180230|maxilla & mandible|maxilla & mandible
186580|NCT02180217|LCI699|lci699
186581|NCT02180217|Cushing's disease|cushing's disease
186582|NCT02180204|Cerebral Infarction|cerebral infarction
186583|NCT02180204|Ischemic Stroke|ischemic stroke
186584|NCT02180204|Thrombolysis|thrombolysis
186585|NCT02180191|Gut microbiota|gut microbiota
186586|NCT02180178|microvascular disease|microvascular disease
186587|NCT02180178|coronary artery disease|coronary artery disease
186588|NCT02180178|Coronary artery disease, with or without microvascular dysfuntion|coronary artery disease, with or without microvascular dysfuntion
186589|NCT02180152|Perinatal outcomes|perinatal outcomes
186590|NCT02180113|Cirrhotic patients|cirrhotic patients
186591|NCT02180113|Fibroscan|fibroscan
186592|NCT02180113|Liver Stiffness Measurement|liver stiffness measurement
186593|NCT02180113|Oesophageal Varices|oesophageal varices
186594|NCT02180113|Portal Hypertension|portal hypertension
186595|NCT02180113|Spleen Stiffness Measurement|spleen stiffness measurement
186596|NCT02180087|Cardiac surgery|cardiac surgery
186597|NCT02180087|Post-operative pain|post-operative pain
186598|NCT02180087|Kétoprofène|kétoprofène
186599|NCT02180087|Minimum analgesic dose|minimum analgesic dose
186600|NCT02180087|Morphin consumption|morphin consumption
186601|NCT02180087|Morphin secondary effects|morphin secondary effects
186602|NCT02180087|Patient comfort and satisfaction|patient comfort and satisfaction
186603|NCT02180087|Renal fonction|renal fonction
186604|NCT02180074|Hydrogen Sulfide Pools,|hydrogen sulfide pools,
186605|NCT02180061|PD1|pd1
186606|NCT02180061|PD-1|pd-1
186607|NCT02180061|PDL1|pdl1
186608|NCT02180061|PD-L1|pd-l1
186609|NCT02180035|diet therapy|diet therapy
186610|NCT02180035|symbiotic|symbiotic
186611|NCT02180035|dyslipidemia|dyslipidemia
186612|NCT02180035|gastrointestinal symptoms|gastrointestinal symptoms
186613|NCT02180035|body composition|body composition
186614|NCT02180035|adherence|adherence
186615|NCT02180035|HIV|hiv
186616|NCT02180035|HAART|haart
186617|NCT02180022|Quercetin|quercetin
186618|NCT02180022|Endothelial function|endothelial function
186619|NCT02180022|Onion peel extract|onion peel extract
186620|NCT02180022|volunteers|volunteers
186621|NCT02179996|Vaccination|vaccination
186622|NCT02179996|Very preterm-born infants|very preterm-born infants
186623|NCT02179996|Hib immunisation|hib immunisation
186624|NCT02179996|Pertussis immunisation|pertussis immunisation
186625|NCT02179983|Bronchiectasis|bronchiectasis
186626|NCT02179983|rehabilitation|rehabilitation
186627|NCT02179983|exercise|exercise
186628|NCT02179983|exacerbations|exacerbations
186629|NCT02179970|Advanced pancreatic cancer|advanced pancreatic cancer
186630|NCT02179970|Advanced ovarian cancer|advanced ovarian cancer
186631|NCT02179970|Advanced colorectal cancer|advanced colorectal cancer
186632|NCT02179970|Metastatic pancreatic cancer|metastatic pancreatic cancer
186633|NCT02179970|Metastatic ovarian cancer|metastatic ovarian cancer
186774|NCT02179255|DOR|dor
186634|NCT02179970|Metastatic colorectal cancer|metastatic colorectal cancer
186635|NCT02179957|Stenoses|stenoses
186636|NCT02179957|Ischaemia|ischaemia
186637|NCT02179957|haemodynamics|haemodynamics
186638|NCT02179957|fractional flow reserve (FFR)|fractional flow reserve (ffr)
186639|NCT02179957|computed tomography (CT)|computed tomography (ct)
186640|NCT02179957|cardiac|cardiac
186641|NCT02179944|medication abortion|medication abortion
186642|NCT02179944|serum hCG|serum hcg
186643|NCT02179918|Advanced Solid Tumors|advanced solid tumors
186645|NCT02179905|Heart rate variability|heart rate variability
186646|NCT02179905|Fatty acid|fatty acid
186647|NCT02179892|anesthesia|anesthesia
186648|NCT02179892|surgery|surgery
186649|NCT02179892|pain|pain
186650|NCT02179879|labor,epidural,analgesia|labor,epidural,analgesia
186651|NCT02179853|Kawasaki disease|kawasaki disease
186652|NCT02179853|Anakinra|anakinra
186653|NCT02179853|IL-1|il-1
186654|NCT02179840|Cerebral microvascular circulation|cerebral microvascular circulation
186655|NCT02179840|Cerebral autoregulation|cerebral autoregulation
186656|NCT02179814|bulimia nervosa|bulimia nervosa
186657|NCT02179814|dopamine|dopamine
186658|NCT02179814|reward|reward
186659|NCT02179814|catechol-O-methyltransferase|catechol-o-methyltransferase
186660|NCT02179814|gene|gene
186661|NCT02179814|catecholamines|catecholamines
186662|NCT02179814|alpha-methyl-para-tyrosine|alpha-methyl-para-tyrosine
186663|NCT02179814|magnetic resonance imaging|magnetic resonance imaging
186664|NCT02179801|Abdominal aortic aneurysm|abdominal aortic aneurysm
186665|NCT02179801|AAA|aaa
186666|NCT02179801|Screening|screening
186667|NCT02179788|lactation|lactation
186668|NCT02179788|breastfeeding|breastfeeding
186669|NCT02179788|human milk|human milk
186670|NCT02179788|insulin|insulin
186671|NCT02179788|metformin|metformin
186672|NCT02179788|prediabetes|prediabetes
186673|NCT02179788|pre-diabetes|pre-diabetes
186674|NCT02179788|insulin resistance|insulin resistance
186675|NCT02179762|cancer survivor|cancer survivor
186676|NCT02179762|prostate cancer|prostate cancer
186677|NCT02179762|exercise|exercise
186678|NCT02179762|Active surveillance|active surveillance
186679|NCT02179762|EASE|ease
186680|NCT02179749|Alcohol-Related Disorders|alcohol-related disorders
186681|NCT02179749|Substance-Related Disorders|substance-related disorders
186682|NCT02179749|Mental Disorders|mental disorders
186683|NCT02179749|Mifepristone|mifepristone
186684|NCT02179749|Glucocorticoid Antagonists|glucocorticoid antagonists
186685|NCT02179749|Alcohol Treatment|alcohol treatment
186686|NCT02179749|Alcohol|alcohol
186687|NCT02179736|Correction of moderate to severe nasolabial folds|correction of moderate to severe nasolabial folds
186688|NCT02179723|wound healing|wound healing
186689|NCT02179723|cosmetic results|cosmetic results
186690|NCT02179723|trocar incision|trocar incision
186691|NCT02179710|adherence|adherence
186692|NCT02179710|cystic fibrosis|cystic fibrosis
186693|NCT02179710|adolescents|adolescents
186694|NCT02179710|adults|adults
186695|NCT02179697|Groups:|groups:
186696|NCT02179697|Group 1 (2 Treatment Arms (Randomized between 2 treatments))|group 1 (2 treatment arms (randomized between 2 treatments))
186697|NCT02179697|Treatment 1: Surgery + Bracing|treatment 1: surgery + bracing
186698|NCT02179697|Treatment 2: Bracing Alone|treatment 2: bracing alone
186699|NCT02179697|Group 2|group 2
186700|NCT02179697|The patient will decide which group is best for themselves.|the patient will decide which group is best for themselves.
186701|NCT02179684|Cranial Nerve fascial paresis|cranial nerve fascial paresis
186702|NCT02179671|Lung cancer; NSCLC|lung cancer; nsclc
186703|NCT02179658|Clostridium|clostridium
186704|NCT02179658|Infections|infections
186705|NCT02179658|Difficile|difficile
186706|NCT02179658|Vancomycin|vancomycin
186707|NCT02179658|Fidaxomicin|fidaxomicin
186708|NCT02179632|disclosure|disclosure
186709|NCT02179632|conflicts of interest|conflicts of interest
186710|NCT02179632|trust|trust
186711|NCT02179632|patient doctor relationship|patient doctor relationship
186712|NCT02179593|Maxillary expansion|maxillary expansion
186713|NCT02179593|Orthognathic surgery|orthognathic surgery
186714|NCT02179593|Symmetry|symmetry
186715|NCT02179593|Palatal expansion technique|palatal expansion technique
186716|NCT02179593|Maxilla abnormality|maxilla abnormality
186717|NCT02179580|Traditional Chinese Medicine|traditional chinese medicine
186718|NCT02179580|Clinical trial|clinical trial
186719|NCT02179580|Good Clinical Practice|good clinical practice
186720|NCT02179567|Metastatic NSCLC|metastatic nsclc
186721|NCT02179567|Elderly|elderly
186722|NCT02179567|1st Line|1st line
186723|NCT02179567|Bevacizumab-based treatment|bevacizumab-based treatment
186724|NCT02179541|Otitis media with effusion, viscosity, RGB (red-green-blue).|otitis media with effusion, viscosity, rgb (red-green-blue).
186725|NCT02179515|Immune Response|immune response
186726|NCT02179515|Maximum Tolerated Dose|maximum tolerated dose
186727|NCT02179515|Vaccine Therapy|vaccine therapy
186728|NCT02179515|Increased Expression of Brachyury|increased expression of brachyury
186729|NCT02179515|Immunotherapy|immunotherapy
186730|NCT02179489|Peritoneal carcinomatosis|peritoneal carcinomatosis
186731|NCT02179489|HIPEC|hipec
186732|NCT02179489|controlled clinical trial|controlled clinical trial
668545|NCT00851019|Video game|video game
186733|NCT02179489|colorectal cancer|colorectal cancer
186734|NCT02179476|Facet joint|facet joint
186735|NCT02179476|facet joint pain|facet joint pain
186736|NCT02179476|facet joint disease|facet joint disease
186737|NCT02179476|lumbar pain|lumbar pain
186738|NCT02179476|back pain|back pain
186739|NCT02179463|Gastric Cancer|gastric cancer
186740|NCT02179463|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
186741|NCT02179463|Response Evaluation|response evaluation
186743|NCT02179437|Propofol|propofol
186744|NCT02179437|Postoperative pain|postoperative pain
186745|NCT02179437|Liver resection surgery|liver resection surgery
186746|NCT02179437|Retrospective study|retrospective study
186747|NCT02179424|smoking cessation interventions|smoking cessation interventions
186748|NCT02179398|Fever without source|fever without source
186749|NCT02179398|Antibiotic prescription|antibiotic prescription
186750|NCT02179398|Serious bacterial infection|serious bacterial infection
186751|NCT02179385|Type 2 diabetes|type 2 diabetes
186752|NCT02179385|Type II diabetes|type ii diabetes
227861|NCT01991002|BMI|bmi
186753|NCT02179359|Stem Cell Transplant|stem cell transplant
186754|NCT02179346|cartilage defect|cartilage defect
186755|NCT02179346|hip|hip
186756|NCT02179346|impingement|impingement
186757|NCT02179320|Myofascial Pain Syndrome|myofascial pain syndrome
186758|NCT02179320|Dry needling|dry needling
186759|NCT02179320|Clinical Trial|clinical trial
186760|NCT02179307|muscle hypertrophy|muscle hypertrophy
186761|NCT02179307|strength|strength
186762|NCT02179307|resistance training|resistance training
186763|NCT02179307|exercise|exercise
186764|NCT02179307|physical fitness|physical fitness
186765|NCT02179307|health|health
186766|NCT02179307|physical conditioning|physical conditioning
186767|NCT02179294|Pain relief|pain relief
186768|NCT02179294|Labour|labour
186769|NCT02179294|Child birth|child birth
186770|NCT02179294|Anaesthetics|anaesthetics
186771|NCT02179268|Antidepressants|antidepressants
186772|NCT02179268|bone mineral density|bone mineral density
186773|NCT02179268|bone turnover markers|bone turnover markers
186775|NCT02179255|Premature Ovarian Failure (POF)|premature ovarian failure (pof)
186776|NCT02179255|Ovarian Failure|ovarian failure
186777|NCT02179255|Human Growth Hormone|human growth hormone
186778|NCT02179242|cardiac rehab|cardiac rehab
186779|NCT02179242|heart failure|heart failure
186780|NCT02179242|KCCQ|kccq
186781|NCT02179242|6 minute walk test|6 minute walk test
186782|NCT02179242|readmission|readmission
186783|NCT02179229|Kidney transplantation|kidney transplantation
186784|NCT02179229|pCresol|pcresol
186785|NCT02179229|Immunosuppressant drugs|immunosuppressant drugs
186786|NCT02179216|Orthostatic hypotension in the elderly|orthostatic hypotension in the elderly
186787|NCT02179216|Efficacity of Hydration|efficacity of hydration
186788|NCT02179216|Difference between hydratation and venous contention|difference between hydratation and venous contention
186789|NCT02179177|Vaso-occlusive crisis|vaso-occlusive crisis
186790|NCT02179177|Reduction in hospitalizations|reduction in hospitalizations
186791|NCT02179177|Sickle Cell Disease|sickle cell disease
186792|NCT02179151|Prader-Willi Syndrome|prader-willi syndrome
186793|NCT02179151|Obesity|obesity
186794|NCT02179151|Hyperphagia|hyperphagia
186795|NCT02179125|COPD|copd
186796|NCT02179125|Endobronchial treatment|endobronchial treatment
186797|NCT02179112|Surgery|surgery
186798|NCT02179112|Specialties, Surgical|specialties, surgical
186799|NCT02179112|Geography, Medical|geography, medical
186800|NCT02179112|Developing Countries|developing countries
186801|NCT02179112|Developed Countries|developed countries
186802|NCT02179112|Laparotomy|laparotomy
186803|NCT02179112|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
186804|NCT02179112|Treatment Outcome|treatment outcome
186805|NCT02179112|Quality of Health Care|quality of health care
186806|NCT02179099|overactive bladder|overactive bladder
186808|NCT02179099|urgency|urgency
186809|NCT02179099|botulinum toxin|botulinum toxin
186810|NCT02179099|BTX|btx
186811|NCT02179099|botox|botox
186812|NCT02179099|intravesical|intravesical
186813|NCT02179099|TheraCoat|theracoat
186814|NCT02179099|TCGel|tcgel
186815|NCT02179099|TC-3 Gel|tc-3 gel
186816|NCT02179060|Sudden cardiac arrest, RhinoChill -cooling, MRI|sudden cardiac arrest, rhinochill -cooling, mri
186817|NCT02179047|SYNTAX ,NGAL,Cystatin C,Galectin-3,Copeptin.MR-ProANP,sST2.|syntax ,ngal,cystatin c,galectin-3,copeptin.mr-proanp,sst2.
186818|NCT02179034|tobacco|tobacco
186819|NCT02179034|electronic cigarettes|electronic cigarettes
186820|NCT02179034|menthol|menthol
186821|NCT02179034|flavors|flavors
186822|NCT02179021|Thromboelastometry|thromboelastometry
186823|NCT02179021|Haemostasis|haemostasis
186824|NCT02179021|Hypothermia|hypothermia
186825|NCT02179021|Heart arrest|heart arrest
186826|NCT02179008|Santen|santen
186827|NCT02179008|Eye|eye
186828|NCT02179008|Glaucoma|glaucoma
186829|NCT02179008|Ocular hypertension|ocular hypertension
186830|NCT02178982|mechanical ventilation|mechanical ventilation
186831|NCT02178982|ARDS|ards
186987|NCT02178098|LDL|ldl
186832|NCT02178982|Ventilator strategy|ventilator strategy
186834|NCT02178943|Molecular Diagnostics|molecular diagnostics
186835|NCT02178943|Heart Transplantation|heart transplantation
186836|NCT02178943|Risk Factors|risk factors
186837|NCT02178943|Prognosis|prognosis
186838|NCT02178930|HIV|hiv
186839|NCT02178930|cardiovascular disease|cardiovascular disease
186840|NCT02178930|self-management|self-management
186841|NCT02178930|HIV co-morbidities|hiv co-morbidities
186842|NCT02178930|self-efficacy|self-efficacy
187140|NCT02177084|PTNS|ptns
186843|NCT02178930|coronary heart disease risk|coronary heart disease risk
186844|NCT02178930|quality of life|quality of life
186845|NCT02178904|Ischemia|ischemia
186846|NCT02178904|Dual Energy Computed Tomography|dual energy computed tomography
186847|NCT02178904|Computed Tomographic Perfusion|computed tomographic perfusion
186848|NCT02178904|Fractional Flow Rate|fractional flow rate
186849|NCT02178904|Invasive Coronary Angiography|invasive coronary angiography
186850|NCT02178904|Coronary Artery Stenosis|coronary artery stenosis
186851|NCT02178891|short implants|short implants
186852|NCT02178891|Nobel Biocare|nobel biocare
186853|NCT02178891|partially edentulous|partially edentulous
186854|NCT02178891|maxilla or mandible|maxilla or mandible
186855|NCT02178878|Labor pain and progress, variation, genetic|labor pain and progress, variation, genetic
186856|NCT02178865|translocation|translocation
186857|NCT02178839|Non Alcoholic Fatty Liver Disease(NAFLD)|non alcoholic fatty liver disease(nafld)
186858|NCT02178839|β- glucan|β- glucan
186859|NCT02178839|Appetite|appetite
186860|NCT02178839|Insulin Resistance|insulin resistance
186861|NCT02178826|Nocturnal Enuresis|nocturnal enuresis
186862|NCT02178826|Rapid Maxillary Expansion|rapid maxillary expansion
186863|NCT02178826|Orthodontics|orthodontics
186864|NCT02178826|Polysomnography|polysomnography
186865|NCT02178826|Quality of life|quality of life
186866|NCT02178813|Minocycline|minocycline
186867|NCT02178813|Neuroprotection|neuroprotection
186868|NCT02178813|Stroke|stroke
186869|NCT02178787|cerebral blood flow|cerebral blood flow
186870|NCT02178787|near infrared spectroscopy|near infrared spectroscopy
186871|NCT02178787|transcranial Doppler|transcranial doppler
186872|NCT02178787|diabetes mellitus|diabetes mellitus
186873|NCT02178787|cerebral autoregulation|cerebral autoregulation
186874|NCT02178774|Near-Infrared Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
186875|NCT02178774|spinal anesthesia|spinal anesthesia
186876|NCT02178774|cesarean section|cesarean section
186877|NCT02178761|Erectile dysfunction|erectile dysfunction
186878|NCT02178761|Lower Urinary Tract Symptoms|lower urinary tract symptoms
186879|NCT02178761|Peripheral Arterial Disease|peripheral arterial disease
186880|NCT02178761|Angioplasty|angioplasty
186881|NCT02178761|Multidetector Computed Tomography|multidetector computed tomography
186882|NCT02178748|Tuberculosis|tuberculosis
186883|NCT02178748|Phase II|phase ii
186884|NCT02178748|MVA85A|mva85a
186885|NCT02178748|Schistosoma mansoni|schistosoma mansoni
186886|NCT02178735|pelvic organ prolapse, vaginal mesh, urodynamic studies|pelvic organ prolapse, vaginal mesh, urodynamic studies
186887|NCT02178709|Pancreatic|pancreatic
186888|NCT02178709|Cancer|cancer
186889|NCT02178709|Resectable|resectable
186890|NCT02178683|TACROLIMUS|tacrolimus
186891|NCT02178683|MYCOPHENOLATE MOFETIL|mycophenolate mofetil
186892|NCT02178683|FLUDARABINE|fludarabine
186893|NCT02178683|HLA-MATCHED|hla-matched
186894|NCT02178683|MIS-MATCHED|mis-matched
186895|NCT02178657|Stroke|stroke
186896|NCT02178657|Cell therapy|cell therapy
186897|NCT02178657|Bone marrow|bone marrow
186898|NCT02178605|rhBMP-2|rhbmp-2
186899|NCT02178605|arthrodesis|arthrodesis
186900|NCT02178605|cervical|cervical
186901|NCT02178592|integrase inhibitor|integrase inhibitor
186902|NCT02178592|Mycobacterium tuberculosis|mycobacterium tuberculosis
186903|NCT02178592|rifampicin-sensitive|rifampicin-sensitive
186904|NCT02178592|dolutegravir|dolutegravir
186905|NCT02178592|antiretroviral therapy-naïve|antiretroviral therapy-naïve
186906|NCT02178592|HIV-1 infection|hiv-1 infection
186907|NCT02178592|efavirenz|efavirenz
186908|NCT02178592|co-infection|co-infection
186909|NCT02178579|Heart Failure|heart failure
186910|NCT02178579|Cardiac Toxicity|cardiac toxicity
186911|NCT02178579|Multiple Myeloma|multiple myeloma
186912|NCT02178579|Bortezomib|bortezomib
186913|NCT02178579|Carfilzomib|carfilzomib
186914|NCT02178566|COPD|copd
186915|NCT02178566|Trepostinil|trepostinil
186916|NCT02178566|Pulmonary Rehabilitation|pulmonary rehabilitation
186917|NCT02178553|Thoracotomy|thoracotomy
186918|NCT02178553|Pain|pain
186919|NCT02178540|Human factors, TOBI® Podhaler™, Instructions For use, IFU, CF patients|human factors, tobi® podhaler™, instructions for use, ifu, cf patients
186920|NCT02178527|Geriatrics|geriatrics
186921|NCT02178527|Accidental Falls|accidental falls
186922|NCT02178527|Podiatry|podiatry
186923|NCT02178527|Exercise Therapy|exercise therapy
186924|NCT02178527|Orthotic Devices|orthotic devices
186925|NCT02178527|Foot|foot
186926|NCT02178501|OMEGA-3 PUFA|omega-3 pufa
186927|NCT02178501|type 2 diabetes|type 2 diabetes
186928|NCT02178501|cardiovascular diseases|cardiovascular diseases
186929|NCT02178475|NHL|nhl
186930|NCT02178475|Breast Cancer|breast cancer
186931|NCT02178423|children, ultrasound, central catheter|children, ultrasound, central catheter
186932|NCT02178410|Atrial Fibrillation|atrial fibrillation
186933|NCT02178410|Vitamin D3|vitamin d3
186934|NCT02178410|Omega-3 fatty acids|omega-3 fatty acids
186935|NCT02178410|Fish oil|fish oil
186936|NCT02178397|erlotinib|erlotinib
186937|NCT02178397|lung cancer|lung cancer
186938|NCT02178397|EGFR mutation|egfr mutation
186939|NCT02178384|Loading Forces|loading forces
186940|NCT02178384|Removable partial dentures|removable partial dentures
186941|NCT02178384|Bilateral distal extension|bilateral distal extension
186942|NCT02178371|Upper extremity|upper extremity
186943|NCT02178371|Physical therapy modalities|physical therapy modalities
186944|NCT02178358|transforming growth factor beta (TGF-β)|transforming growth factor beta (tgf-β)
186946|NCT02178345|14-126|14-126
186947|NCT02178332|Children|children
186948|NCT02178332|socio-emotional|socio-emotional
186949|NCT02178332|socio-emotional skills|socio-emotional skills
186950|NCT02178332|psychiatric symptoms|psychiatric symptoms
186951|NCT02178332|SDQ|sdq
186952|NCT02178332|Finland|finland
186953|NCT02178332|School|school
186954|NCT02178332|School community|school community
186955|NCT02178332|Teacher|teacher
186956|NCT02178332|Whole school approach|whole school approach
186957|NCT02178332|Intervention|intervention
186958|NCT02178332|Effectiveness study|effectiveness study
186959|NCT02178332|Cluster randomised trial|cluster randomised trial
186960|NCT02178319|portal hypertension|portal hypertension
186961|NCT02178319|Randomized clinical trial|randomized clinical trial
186962|NCT02178319|laparoscopic|laparoscopic
186963|NCT02178319|open|open
186964|NCT02178267|Newborn, preterm, probiotic, resistant microorganisms|newborn, preterm, probiotic, resistant microorganisms
186965|NCT02178254|Pseudomonas aeruginosa, ZTI-101, phosphonic acid derivative, Monurol, fosfomycin tromethamine|pseudomonas aeruginosa, zti-101, phosphonic acid derivative, monurol, fosfomycin tromethamine
186966|NCT02178228|Anastomotic Leaks|anastomotic leaks
187169|NCT02176889|Probiotic|probiotic
186967|NCT02178228|Bowel Resection|bowel resection
186968|NCT02178228|Postoperative Complication|postoperative complication
186969|NCT02178215|atopic dermatitis|atopic dermatitis
186970|NCT02178215|skin barrier function|skin barrier function
186971|NCT02178215|transepidermal water loss|transepidermal water loss
186972|NCT02178215|skin pH|skin ph
186973|NCT02178215|stratum corneum hydration|stratum corneum hydration
186974|NCT02178215|sebum|sebum
186975|NCT02178215|wrinkle|wrinkle
186976|NCT02178202|Harmonic technique, Low Back Pain, McKenzie exercise, Pain, Disability|harmonic technique, low back pain, mckenzie exercise, pain, disability
186977|NCT02178189|prenatal opioid exposure|prenatal opioid exposure
186978|NCT02178189|infant|infant
186979|NCT02178189|weight gain|weight gain
186980|NCT02178189|infant formula|infant formula
186981|NCT02178150|Magnesium|magnesium
186982|NCT02178150|Insulin Resistance|insulin resistance
186983|NCT02178150|Lipid profile|lipid profile
186984|NCT02178150|Sex hormones|sex hormones
186985|NCT02178150|Inflammatory factors|inflammatory factors
186986|NCT02178111|episiotomy, vaginal delivery, randomized, perineum|episiotomy, vaginal delivery, randomized, perineum
186988|NCT02178098|Cholesterol|cholesterol
186989|NCT02178085|glaucoma|glaucoma
186990|NCT02178085|phase-contrast MRI|phase-contrast mri
186991|NCT02178085|blood flow|blood flow
186992|NCT02178085|cerebrospinal fluid|cerebrospinal fluid
186993|NCT02178072|HNSCC|hnscc
186994|NCT02178059|Healthy volunteers, pharmacokinetic, inhalation|healthy volunteers, pharmacokinetic, inhalation
186995|NCT02178046|Gingivitis|gingivitis
186996|NCT02178033|adenoma detection rate, screening colonoscopy|adenoma detection rate, screening colonoscopy
186997|NCT02178020|Knee Arthroplasty|knee arthroplasty
186998|NCT02178020|Osteolysis|osteolysis
186999|NCT02178020|Radiolucent Lines|radiolucent lines
187000|NCT02177994|Elective Cesarean Section|elective cesarean section
187001|NCT02177994|Antibiotic prophylaxis|antibiotic prophylaxis
187002|NCT02177994|Timing of Antibiotic prophylaxis|timing of antibiotic prophylaxis
187003|NCT02177994|post cesarean section infection|post cesarean section infection
187004|NCT02177981|Remote Ischemic Preconditioning|remote ischemic preconditioning
187005|NCT02177981|Coronary Artery Bypass Grafting|coronary artery bypass grafting
187006|NCT02177981|Diffusion Weighted Magnetic Resonance Imaging|diffusion weighted magnetic resonance imaging
187007|NCT02177981|Resting State Functional Magnetic Resonance Imaging|resting state functional magnetic resonance imaging
187008|NCT02177981|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
187009|NCT02177968|fall|fall
187010|NCT02177968|elderly|elderly
187011|NCT02177968|characteristics|characteristics
187012|NCT02177955|Third Molar|third molar
187013|NCT02177955|Anty-anxiety drugs|anty-anxiety drugs
187014|NCT02177955|hemodynamic|hemodynamic
187015|NCT02177955|Benzodiazepines|benzodiazepines
187016|NCT02177929|Spinal cord injury,|spinal cord injury,
187017|NCT02177929|adaptive sport,|adaptive sport,
187018|NCT02177929|dynamometry,|dynamometry,
187019|NCT02177929|electromyography,|electromyography,
187020|NCT02177929|force platform.|force platform.
187021|NCT02177916|lung transplantation|lung transplantation
187022|NCT02177903|hypothermia|hypothermia
187023|NCT02177903|surgical site infection|surgical site infection
187024|NCT02177903|opioid usage|opioid usage
187025|NCT02177903|blood loss|blood loss
187026|NCT02177903|pain severity|pain severity
187027|NCT02177903|anxiety|anxiety
187028|NCT02177903|Length of Stay|length of stay
187029|NCT02177877|Epilepsy|epilepsy
187030|NCT02177877|Seizures|seizures
187031|NCT02177877|Wrist accelerometer|wrist accelerometer
187032|NCT02177877|Epilepsy diary|epilepsy diary
187033|NCT02177877|Seizure detection|seizure detection
187034|NCT02177877|Biosensor|biosensor
187444|NCT02175420|BCG|bcg
187035|NCT02177851|Iron bio-availability|iron bio-availability
187036|NCT02177851|Hepcidin|hepcidin
187037|NCT02177851|Iron absorption|iron absorption
187038|NCT02177812|Oncology|oncology
187039|NCT02177812|LSD1|lsd1
187040|NCT02177812|GSK2879552|gsk2879552
187041|NCT02177812|Acute myeloid leukemia|acute myeloid leukemia
187042|NCT02177799|Gastroenteritis|gastroenteritis
228194|NCT01989312|local|local
187043|NCT02177799|Hospitalized|hospitalized
187044|NCT02177799|Children|children
187045|NCT02177786|Diabetic Kidney Disease|diabetic kidney disease
187046|NCT02177786|Gilead|gilead
187047|NCT02177760|SCID|scid
187048|NCT02177760|severe combined immunodeficiency|severe combined immunodeficiency
187049|NCT02177760|maternal engraftment|maternal engraftment
187050|NCT02177760|aGVHD prophylaxis|agvhd prophylaxis
187051|NCT02177760|sirolimus|sirolimus
187052|NCT02177734|Adjuvant|adjuvant
187053|NCT02177734|Safety|safety
187054|NCT02177734|Influenza|influenza
187055|NCT02177734|H7N9|h7n9
187056|NCT02177734|Immunogenicity|immunogenicity
187057|NCT02177734|Adults|adults
187058|NCT02177721|Raxibacumab|raxibacumab
187059|NCT02177721|anthrax|anthrax
187060|NCT02177721|anti-toxin|anti-toxin
187061|NCT02177695|Bladder Cancer|bladder cancer
187062|NCT02177695|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
187063|NCT02177695|Coexpression Extrapolation|coexpression extrapolation
187064|NCT02177695|COXEN|coxen
187065|NCT02177695|S1314|s1314
187067|NCT02177682|AKT inhibitor|akt inhibitor
187068|NCT02177682|Afuresertib|afuresertib
187069|NCT02177682|multiple myeloma|multiple myeloma
187070|NCT02177669|Normal, healthy individuals without ocular disease|normal, healthy individuals without ocular disease
187071|NCT02177669|Ages 20-89|ages 20-89
187072|NCT02177669|English speaking|english speaking
187073|NCT02177669|Visual acuity better than 20/25|visual acuity better than 20/25
187074|NCT02177656|heart failure|heart failure
187075|NCT02177656|self-care|self-care
187076|NCT02177656|self-care maintenance|self-care maintenance
187077|NCT02177656|self-care management|self-care management
187078|NCT02177656|self-efficacy|self-efficacy
187079|NCT02177656|quality of life|quality of life
187080|NCT02177656|symptoms|symptoms
187081|NCT02177643|Diabetes|diabetes
187082|NCT02177643|Diacerein|diacerein
187083|NCT02177630|myocarditis, myocardial inflammation, imaging, magnetic resonance|myocarditis, myocardial inflammation, imaging, magnetic resonance
187084|NCT02177617|Cervical Dystonia|cervical dystonia
187085|NCT02177617|Botox|botox
187086|NCT02177578|Subventricular Zone|subventricular zone
187087|NCT02177578|progenitor cell|progenitor cell
187088|NCT02177578|radiation therapy|radiation therapy
187089|NCT02177578|temozolomide|temozolomide
187090|NCT02177565|Non-union|non-union
187091|NCT02177565|fracture|fracture
187092|NCT02177565|bone marrow stem cells|bone marrow stem cells
187093|NCT02177552|Esophageal cancer|esophageal cancer
187094|NCT02177552|Gastric cancer|gastric cancer
187095|NCT02177539|cycloplegia|cycloplegia
187096|NCT02177539|refraction in children|refraction in children
187097|NCT02177539|cycloplegic agents|cycloplegic agents
187098|NCT02177539|cycloplegic schemes|cycloplegic schemes
187099|NCT02177539|cyclopentolate|cyclopentolate
187102|NCT02177513|Cannabis|cannabis
187103|NCT02177513|Pharmacodynamics|pharmacodynamics
187104|NCT02177513|Marijuana|marijuana
187105|NCT02177513|Cannabinoids|cannabinoids
187106|NCT02177513|Vaporized|vaporized
187107|NCT02177474|depressive symptoms|depressive symptoms
187108|NCT02177474|perceived social support|perceived social support
187109|NCT02177474|coronary heart disease|coronary heart disease
187110|NCT02177474|peer support|peer support
187111|NCT02177474|women|women
187112|NCT02177279|Wheat bran cereals, bran phytochemicals, phytochemicals bioavailability|wheat bran cereals, bran phytochemicals, phytochemicals bioavailability
187113|NCT02177240|GlideScope®|glidescope®
187114|NCT02177240|GlideRite®|gliderite®
187115|NCT02177240|Flex-it®|flex-it®
187116|NCT02177240|Difficult intubation|difficult intubation
187117|NCT02177227|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
187118|NCT02177227|Attune|attune
187119|NCT02177227|Primary Total Knee Prosthesis|primary total knee prosthesis
187120|NCT02177227|TruMatch|trumatch
187121|NCT02177188|Hypovolaemic shock|hypovolaemic shock
187122|NCT02177188|Monitoring|monitoring
187123|NCT02177188|Haemorrhage|haemorrhage
187124|NCT02177188|Transthoracic Echocardiography|transthoracic echocardiography
187125|NCT02177175|Carvedilol|carvedilol
187126|NCT02177175|Anthracycline|anthracycline
187127|NCT02177175|HER2|her2
187128|NCT02177175|14-099|14-099
187129|NCT02177136|PSC|psc
187130|NCT02177123|glaucoma shunt|glaucoma shunt
187131|NCT02177123|glaucoma drainage device|glaucoma drainage device
187132|NCT02177110|advanced melanoma|advanced melanoma
187133|NCT02177110|metastatic melanoma|metastatic melanoma
187134|NCT02177110|fresh frozen tissue|fresh frozen tissue
187135|NCT02177110|FFPE tissue|ffpe tissue
187136|NCT02177097|Pain|pain
187137|NCT02177097|Infection|infection
187138|NCT02177097|Inflammation|inflammation
187139|NCT02177097|Prosthesis|prosthesis
187141|NCT02177084|rectal cancer|rectal cancer
187142|NCT02177084|low anterior resection syndrome|low anterior resection syndrome
187143|NCT02177071|CROHN DISEASE|crohn disease
187144|NCT02177071|INFLIXIMAB|infliximab
187145|NCT02177071|COMBINATION THERAPY|combination therapy
187146|NCT02177071|steroid free remission|steroid free remission
187147|NCT02177071|anti-metabolites|anti-metabolites
187148|NCT02177058|Nursing homes|nursing homes
187149|NCT02177058|Hospitalizations|hospitalizations
187150|NCT02177032|Rabies vaccines|rabies vaccines
187151|NCT02177032|intradermal|intradermal
187152|NCT02177032|human rabies immunoglobulins|human rabies immunoglobulins
187153|NCT02177019|frequent headaches|frequent headaches
187154|NCT02177019|personalized health plan|personalized health plan
187155|NCT02176993|Acute stroke|acute stroke
187156|NCT02176993|Therapeutic Hypothermia|therapeutic hypothermia
187157|NCT02176980|HCV|hcv
187158|NCT02176980|hepatitis C|hepatitis c
187159|NCT02176980|alcohol|alcohol
187160|NCT02176980|integrated care|integrated care
187161|NCT02176941|Telomere Length|telomere length
187162|NCT02176941|Arterial Aging|arterial aging
187163|NCT02176941|Endothelial Progenitor Cells|endothelial progenitor cells
187164|NCT02176941|Inflammation|inflammation
187165|NCT02176941|Atherosclerosis|atherosclerosis
187166|NCT02176889|Lactospore|lactospore
187167|NCT02176889|Bacillus coagulans|bacillus coagulans
187168|NCT02176889|Safety|safety
187170|NCT02176889|Healthy Adults|healthy adults
187171|NCT02176889|Tolerability|tolerability
187172|NCT02176876|rheumatoid arthritis|rheumatoid arthritis
187173|NCT02176876|RA|ra
187174|NCT02176876|GS-5745|gs-5745
187175|NCT02176876|MMP9|mmp9
187176|NCT02176876|phase 1|phase 1
187177|NCT02176863|FORCE|force
187178|NCT02176863|post-polio syndrome|post-polio syndrome
187179|NCT02176863|Flebogamma|flebogamma
187180|NCT02176863|Immune Globulin Intravenous|immune globulin intravenous
187181|NCT02176863|IGIV|igiv
187182|NCT02176837|subarachnoid hemorrhage|subarachnoid hemorrhage
187183|NCT02176837|vasospasm|vasospasm
187184|NCT02176837|nitrite|nitrite
187185|NCT02176837|sodium nitrite|sodium nitrite
187186|NCT02176811|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
187187|NCT02176811|Betatrophin|betatrophin
187188|NCT02176785|Sleep|sleep
187189|NCT02176785|Transcranial Electric Stimulation|transcranial electric stimulation
187190|NCT02176720|Glioma|glioma
187191|NCT02176720|Glioblastoma|glioblastoma
187192|NCT02176720|Glioblastoma multiforme|glioblastoma multiforme
187193|NCT02176720|GBM|gbm
187194|NCT02176720|Recurrence|recurrence
187195|NCT02176720|PET|pet
187196|NCT02176720|FDOPA|fdopa
187197|NCT02176707|Lung Function|lung function
187198|NCT02176707|Exercise Capacity|exercise capacity
187199|NCT02176694|persistent asthma|persistent asthma
187200|NCT02176694|adherence|adherence
187201|NCT02176694|text message reminders|text message reminders
187202|NCT02176655|Delayed Alcohol Induced Headache|delayed alcohol induced headache
187203|NCT02176642|Urinary Urge Incontinence|urinary urge incontinence
187204|NCT02176642|Posterior Tibial Nerve Stimulation|posterior tibial nerve stimulation
187205|NCT02176642|PTNS|ptns
187206|NCT02176642|Neuromodulation|neuromodulation
187207|NCT02176642|Oxybutynin|oxybutynin
187208|NCT02176642|Anticholinergic Medication|anticholinergic medication
187209|NCT02176629|Virtual Reality|virtual reality
187210|NCT02176629|mild cognitive impairment|mild cognitive impairment
187211|NCT02176629|Alzheimer's disease|alzheimer's disease
187212|NCT02176603|phenylketonuria, endothelial dysfunction, CKD|phenylketonuria, endothelial dysfunction, ckd
187213|NCT02176590|PATHS Social Emotional Learning|paths social emotional learning
187214|NCT02176590|Coping Power|coping power
187215|NCT02176590|Power PATH|power path
187216|NCT02176590|Head Start|head start
187217|NCT02176486|Drug therapy|drug therapy
187218|NCT02176473|Depression|depression
187219|NCT02176460|Knee Osteoarthritis|knee osteoarthritis
187220|NCT02176460|Double-blind|double-blind
187221|NCT02176460|placebo-controlled|placebo-controlled
187222|NCT02176460|randomized|randomized
187223|NCT02176460|colchicine|colchicine
187224|NCT02176434|End stage renal disease|end stage renal disease
187225|NCT02176434|Transplantation|transplantation
187226|NCT02176434|Tolerance|tolerance
187227|NCT02176408|Major Depressive Disorder|major depressive disorder
187228|NCT02176408|Depression|depression
187229|NCT02176408|MDD|mdd
187230|NCT02176408|Exercise|exercise
187231|NCT02176408|Physical Activity|physical activity
187232|NCT02176408|Treatment|treatment
187233|NCT02176408|Behavioral Activation|behavioral activation
187234|NCT02176395|Acute Ischemic Stroke|acute ischemic stroke
187235|NCT02176395|Randomized Controlled Trial|randomized controlled trial
187236|NCT02176395|Traditional Chinese Medicine|traditional chinese medicine
187237|NCT02176395|Proteomics|proteomics
187238|NCT02176369|Non small cell lung cancer (NSCLC)|non small cell lung cancer (nsclc)
187239|NCT02176369|Lung tumor in advanced phase|lung tumor in advanced phase
187240|NCT02176343|Cataract|cataract
187241|NCT02176343|Intraocular lens|intraocular lens
187242|NCT02176343|ACRYSOF IQ ReSTOR + 2.5 D Multifocal Toric IOL|acrysof iq restor + 2.5 d multifocal toric iol
187243|NCT02176330|Randomised Controlled Trial|randomised controlled trial
187244|NCT02176330|Virtual Clinic|virtual clinic
187245|NCT02176330|ePAQ-PF|epaq-pf
187246|NCT02176330|Pelvic Floor Disorders|pelvic floor disorders
187247|NCT02176330|Economic Analysis|economic analysis
187248|NCT02176317|Autism Spectrum Disorder|autism spectrum disorder
187249|NCT02176317|ASD|asd
187250|NCT02176317|Umbilical cord blood|umbilical cord blood
187251|NCT02176317|Autologous cord blood|autologous cord blood
187252|NCT02176317|cord blood|cord blood
187253|NCT02176304|knee|knee
187254|NCT02176304|arthritis|arthritis
187255|NCT02176304|injections|injections
187256|NCT02176304|corticosteroids|corticosteroids
187257|NCT02176291|Buprenorphine|buprenorphine
187258|NCT02176291|Receptors, opioid|receptors, opioid
187259|NCT02176291|Receptors, opioid kappa and mu|receptors, opioid kappa and mu
187260|NCT02176278|Diabetic Kidney Disease|diabetic kidney disease
187261|NCT02176278|Diabetes|diabetes
187262|NCT02176278|Asian|asian
187263|NCT02176278|Joint Asia Diabetes Evaluation (JADE) Program|joint asia diabetes evaluation (jade) program
187264|NCT02176265|CAD|cad
187265|NCT02176265|PCI|pci
187266|NCT02176265|bioactive coronary stent|bioactive coronary stent
187267|NCT02176265|OCT|oct
187268|NCT02176226|Major Depressive Disorder|major depressive disorder
187269|NCT02176226|Anxiety Disorders|anxiety disorders
187270|NCT02176226|Behavior Therapy|behavior therapy
187271|NCT02176226|Technology Assisted|technology assisted
187272|NCT02176226|Mobile Phone|mobile phone
187273|NCT02176226|Cellular Phone|cellular phone
187274|NCT02176226|Smartphone|smartphone
187275|NCT02176226|App|app
187276|NCT02176213|Relapsed|relapsed
187277|NCT02176213|Refractory|refractory
187278|NCT02176213|Multiple Myeloma|multiple myeloma
187279|NCT02176213|Pomalidomide|pomalidomide
187280|NCT02176213|Cyclophosphamide|cyclophosphamide
187281|NCT02176213|Dexamethasone|dexamethasone
187282|NCT02176174|Ethnic group|ethnic group
187283|NCT02176174|Cardiovascular disease|cardiovascular disease
187284|NCT02176174|Atherosclerosis|atherosclerosis
187285|NCT02176161|Prostate Cancer|prostate cancer
187286|NCT02176161|Prostate Cancer Recurrent|prostate cancer recurrent
187287|NCT02176148|cutaneous lupus|cutaneous lupus
187288|NCT02176148|systemic lupus|systemic lupus
187289|NCT02176148|systemic therapy|systemic therapy
187290|NCT02176148|medication|medication
187291|NCT02176135|HIV|hiv
187292|NCT02176135|HAART suppressed|haart suppressed
187293|NCT02176135|Auranofin|auranofin
187294|NCT02176135|HIV latent reservoir|hiv latent reservoir
187295|NCT02176057|trachoma|trachoma
187296|NCT02176044|Nitric Oxide|nitric oxide
187297|NCT02176044|Sodium Nitroprusside|sodium nitroprusside
187298|NCT02176044|Spatial Working Memory|spatial working memory
187299|NCT02176044|Psychosis|psychosis
187300|NCT02176044|Schizophrenia|schizophrenia
187301|NCT02176031|Graft Versus Host Disease|graft versus host disease
187302|NCT02176018|Episodic Migraine|episodic migraine
187303|NCT02176018|Migraine|migraine
187304|NCT02176018|Headache|headache
187305|NCT02175979|postoperative ileus|postoperative ileus
187306|NCT02175979|anastomotic leak|anastomotic leak
187307|NCT02175979|colorectal surgery|colorectal surgery
187308|NCT02175979|inflammation|inflammation
187309|NCT02175953|caregiver burden|caregiver burden
187310|NCT02175953|stress|stress
187311|NCT02175953|depression|depression
187312|NCT02175953|dementia|dementia
187313|NCT02175927|Helicobacter pylori|helicobacter pylori
187314|NCT02175927|Treatment Failure|treatment failure
187315|NCT02175927|second-line therapy|second-line therapy
187316|NCT02175914|Erythromycin|erythromycin
187317|NCT02175914|Familial Adenomatous Polyposis (FAP).|familial adenomatous polyposis (fap).
187318|NCT02175914|APC gene|apc gene
187319|NCT02175914|nonsense mutations|nonsense mutations
187320|NCT02175901|helicobacter pylori eradication|helicobacter pylori eradication
187321|NCT02175901|antibiotic|antibiotic
187322|NCT02175888|Iron bio availability|iron bio availability
187323|NCT02175888|Hepcidin|hepcidin
187324|NCT02175888|Iron absorption|iron absorption
187325|NCT02175875|ticagrelor|ticagrelor
187326|NCT02175875|platelet function test|platelet function test
187327|NCT02175875|comatose|comatose
187328|NCT02175875|PCI|pci
187329|NCT02175875|naso-gastric tube|naso-gastric tube
187330|NCT02175862|Helicopter Emergency Medical Service|helicopter emergency medical service
187331|NCT02175862|Trauma|trauma
187332|NCT02175862|Early retirement|early retirement
187333|NCT02175862|ISS|iss
187334|NCT02175862|Quality of life|quality of life
187335|NCT02175849|Multi-Drug Resistant Tuberculosis|multi-drug resistant tuberculosis
187336|NCT02175849|Social Network Analysis|social network analysis
187337|NCT02175836|Arrhythmic Sudden Cardiac Death|arrhythmic sudden cardiac death
187338|NCT02175836|Heart Failure|heart failure
187339|NCT02175836|Risk Stratification|risk stratification
187340|NCT02175836|Autonomic Nervous System|autonomic nervous system
187341|NCT02175836|Heart Rate|heart rate
187342|NCT02175836|Repolarization|repolarization
187343|NCT02175823|Cancer survivors|cancer survivors
187344|NCT02175823|circadian rhythm|circadian rhythm
187345|NCT02175823|Elderly Patients|elderly patients
187346|NCT02175823|frailty|frailty
187347|NCT02175810|Obesity|obesity
187348|NCT02175810|Bariatric surgery|bariatric surgery
187349|NCT02175810|physical activity|physical activity
187350|NCT02175810|cardiopulmonary exercise test|cardiopulmonary exercise test
187351|NCT02175797|Pacemaker, leads and MRI exam|pacemaker, leads and mri exam
187352|NCT02175784|Blood glucose|blood glucose
187353|NCT02175784|insulin|insulin
187354|NCT02175784|ipragliflozin|ipragliflozin
187355|NCT02175784|SGLT2 inhibitor|sglt2 inhibitor
187356|NCT02175732|Type 1 Diabetes|type 1 diabetes
187357|NCT02175732|Distress|distress
187358|NCT02175719|Torticollis|torticollis
187359|NCT02175719|rimabotulinumtoxinB|rimabotulinumtoxinb
187360|NCT02175693|Torticollis|torticollis
187361|NCT02175693|rimabotulinumtoxinB|rimabotulinumtoxinb
187362|NCT02175680|HIV-1|hiv-1
187363|NCT02175680|HIV|hiv
187364|NCT02175680|Treatment Substitution|treatment substitution
187365|NCT02175680|PRO 140|pro 140
187366|NCT02175680|PRO140|pro140
187367|NCT02175680|CytoDyn|cytodyn
187368|NCT02175680|Amarex|amarex
187369|NCT02175667|Global postural reeducation|global postural reeducation
187370|NCT02175667|Stabilometry|stabilometry
187371|NCT02175667|Postural Sway|postural sway
187372|NCT02175667|Range of motion|range of motion
187373|NCT02175667|Personality traits|personality traits
187470|NCT02175251|GAF|gaf
187374|NCT02175654|metastatic colorectal cancer|metastatic colorectal cancer
187375|NCT02175654|RAS/BRAF mutation|ras/braf mutation
187376|NCT02175654|Regorafenib|regorafenib
187377|NCT02175654|FOLFOXIRI|folfoxiri
187378|NCT02175654|Bevacizumab|bevacizumab
187379|NCT02175641|Healthy lifestyle Intervention|healthy lifestyle intervention
187380|NCT02175641|Serious Mental Illness|serious mental illness
187381|NCT02175641|Effectiveness trial|effectiveness trial
187382|NCT02175641|Supportive housing|supportive housing
187383|NCT02175641|Racial and Ethnic Health Disparities|racial and ethnic health disparities
187384|NCT02175628|Ultrasound|ultrasound
187385|NCT02175628|Breast|breast
187386|NCT02175628|Angiography|angiography
187387|NCT02175615|CYCLOSPORINE|cyclosporine
187388|NCT02175615|ACUTE GRAFT VERSUS HOST DISEASE|acute graft versus host disease
187389|NCT02175615|PROPHYLAXIS|prophylaxis
187390|NCT02175615|CHILDREN|children
187391|NCT02175615|HAEMATOPOIETIC STEM CELL TRANSPLANT|haematopoietic stem cell transplant
187392|NCT02175589|Familial Mediterranean Fever|familial mediterranean fever
187393|NCT02175589|Monozygous|monozygous
187394|NCT02175589|MEFV|mefv
187395|NCT02175589|Colchicine|colchicine
187396|NCT02175589|Serum Amyloid A|serum amyloid a
187397|NCT02175563|Chest|chest
187398|NCT02175563|Compression|compression
187399|NCT02175550|partially edentulous|partially edentulous
187400|NCT02175550|maxilla|maxilla
187401|NCT02175550|implants|implants
187402|NCT02175550|Conical connection|conical connection
187403|NCT02175550|Nobel Biocare|nobel biocare
187404|NCT02175550|NobelReplace|nobelreplace
187405|NCT02175550|Immediate loading|immediate loading
187406|NCT02175550|One- stage surgery|one- stage surgery
187407|NCT02175550|Two- stage surgery|two- stage surgery
187408|NCT02175550|supported restoration|supported restoration
187409|NCT02175550|patients|patients
187410|NCT02175537|Diabetes Mellitus, Type II|diabetes mellitus, type ii
187411|NCT02175537|Disease management|disease management
187412|NCT02175537|Obesity|obesity
187413|NCT02175537|Social Network|social network
187414|NCT02175537|Chronic disease|chronic disease
187415|NCT02175537|Prevention and control|prevention and control
187416|NCT02175537|Education|education
187417|NCT02175524|nut chewing|nut chewing
187418|NCT02175511|Home Blood Pressure|home blood pressure
187419|NCT02175511|Computerized physician order entry (CPOE)|computerized physician order entry (cpoe)
187420|NCT02175511|Telemonitoring|telemonitoring
187421|NCT02175511|Hypertension|hypertension
187422|NCT02175498|Homoeopathy Similimum female infertility|homoeopathy similimum female infertility
187423|NCT02175472|Parkinson's disease|parkinson's disease
187424|NCT02175472|Light therapy|light therapy
187425|NCT02175472|Circadian rhythm|circadian rhythm
187426|NCT02175446|Breast cancer|breast cancer
187427|NCT02175446|HER2Negative|her2negative
187428|NCT02175446|Second line treatment|second line treatment
187429|NCT02175446|HER2-|her2-
187430|NCT02175446|MBC|mbc
187431|NCT02175446|Metastatic|metastatic
187432|NCT02175446|Metastatic breast cancer|metastatic breast cancer
187433|NCT02175446|bevacizumab|bevacizumab
187434|NCT02175446|eribulin|eribulin
187435|NCT02175446|Human Epidermal Growth Factor Receptor 2-Negative|human epidermal growth factor receptor 2-negative
187436|NCT02175433|Refractory or relapsed chronic lymphocytic leukemia (CLL) prolymphocytic leukemia (PLL)|refractory or relapsed chronic lymphocytic leukemia (cll) prolymphocytic leukemia (pll)
187437|NCT02175433|Relapsed lymphoid malignancy|relapsed lymphoid malignancy
187438|NCT02175433|Refractory lymphoid malignancy|refractory lymphoid malignancy
187439|NCT02175433|Pharmacokinetics of AGS67E|pharmacokinetics of ags67e
187440|NCT02175433|hairy cell leukemia (HCL)|hairy cell leukemia (hcl)
187441|NCT02175433|AGS67C|ags67c
187442|NCT02175433|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
187443|NCT02175433|AGS67E|ags67e
187445|NCT02175420|Salmonella|salmonella
187446|NCT02175420|Trained immunity|trained immunity
187447|NCT02175420|Non-specific effect vaccines|non-specific effect vaccines
187448|NCT02175407|Healthy subjects|healthy subjects
187449|NCT02175407|ASP1707|asp1707
187450|NCT02175407|Itraconazole|itraconazole
187451|NCT02175381|Metastatic NSCLC|metastatic nsclc
187452|NCT02175381|Elderly|elderly
187453|NCT02175381|1st Line|1st line
187454|NCT02175381|Platinum-based treatment|platinum-based treatment
187455|NCT02175368|total etch protocol|total etch protocol
187456|NCT02175368|direct filling therapy|direct filling therapy
187457|NCT02175329|CAD/CAM, three-unit posterior bridges, zirconia framework|cad/cam, three-unit posterior bridges, zirconia framework
187458|NCT02175277|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
187459|NCT02175277|Darbepoetin alfa|darbepoetin alfa
187460|NCT02175277|low risk MDS|low risk mds
187461|NCT02175277|intermediate-1 risk MDS|intermediate-1 risk mds
187462|NCT02175277|International Prognostic Scoring System (IPSS)|international prognostic scoring system (ipss)
187463|NCT02175264|Isolated non syndromic CDH|isolated non syndromic cdh
187464|NCT02175251|rTMS|rtms
187465|NCT02175251|Schizophrenia|schizophrenia
187466|NCT02175251|high frequency rTMS|high frequency rtms
187467|NCT02175251|low frequency rTMS|low frequency rtms
187468|NCT02175251|AHRS|ahrs
187469|NCT02175251|SAPS SANS PANSS|saps sans panss
187471|NCT02175251|UKU|uku
187472|NCT02175225|Brain hemorrhage|brain hemorrhage
187473|NCT02175225|Cerebral hemorrhage|cerebral hemorrhage
187474|NCT02175225|Bleeding in the brain|bleeding in the brain
187475|NCT02175225|Deferoxamine|deferoxamine
187476|NCT02175225|iDEF trial|idef trial
187477|NCT02175212|Patients with prostate adenocarcinoma|patients with prostate adenocarcinoma
187478|NCT02175199|Contact lens|contact lens
187479|NCT02175199|Vision care|vision care
187480|NCT02175199|Daily wear|daily wear
187481|NCT02175199|Color contact lens|color contact lens
187482|NCT02175186|Gastritis|gastritis
187483|NCT02175186|Gastroduodenal Ulcer|gastroduodenal ulcer
187484|NCT02175186|Percutaneous Coronary Revascularization|percutaneous coronary revascularization
187485|NCT02175186|Dual Antiplatelet Therapy|dual antiplatelet therapy
187486|NCT02175173|Epileptic encephalopathy, Lennox-Gastaut type|epileptic encephalopathy, lennox-gastaut type
187487|NCT02175160|Driver reaction time|driver reaction time
187488|NCT02175134|tuberculosis|tuberculosis
187489|NCT02175134|peritonitis|peritonitis
187490|NCT02175134|laparoscopy|laparoscopy
187491|NCT02175108|Cerebral palsy|cerebral palsy
187492|NCT02175108|Adolescents|adolescents
187493|NCT02175108|Adults|adults
187494|NCT02175108|Diet|diet
187495|NCT02175108|Activity|activity
187496|NCT02175108|Metabolic Syndrome|metabolic syndrome
187497|NCT02175095|regorafenib|regorafenib
187498|NCT02175095|fluorothymidine|fluorothymidine
187499|NCT02175095|positron emission tomography|positron emission tomography
187500|NCT02175095|metastatic colorectal cancer|metastatic colorectal cancer
187501|NCT02175082|Parkinson Disease|parkinson disease
187502|NCT02175082|Exercise|exercise
187503|NCT02175082|Rehabilitation|rehabilitation
187504|NCT02175082|Physical Therapy|physical therapy
187505|NCT02175082|Cycling|cycling
187506|NCT02175069|Shoulder surgery|shoulder surgery
187507|NCT02175056|First In Human|first in human
187508|NCT02175056|CAPS, SoJIA, AOSD, Bechet Disease, Rheumatoid arthritis|caps, sojia, aosd, bechet disease, rheumatoid arthritis
187509|NCT02175043|atrial fibrillation, catheter ablation, recurrence|atrial fibrillation, catheter ablation, recurrence
187510|NCT02175030|Emergency contraception|emergency contraception
187511|NCT02175030|Levonorgestrel IUD|levonorgestrel iud
187512|NCT02175030|Copper IUD|copper iud
187513|NCT02175017|ONO-4538|ono-4538
187514|NCT02175017|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
187515|NCT02175004|FAP|fap
187516|NCT02175004|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
187517|NCT02175004|TTR|ttr
187518|NCT02175004|Transthyretin|transthyretin
187519|NCT02175004|Amyloidosis|amyloidosis
187520|NCT02174978|Malaria vaccine|malaria vaccine
187521|NCT02174952|Parenting interventions|parenting interventions
187522|NCT02174952|ADHD|adhd
669010|NCT00839332|Pancreas|pancreas
187523|NCT02174952|Family functioning|family functioning
187524|NCT02174952|Parent Training|parent training
187525|NCT02174939|cilostazol|cilostazol
187526|NCT02174939|progenitor cells|progenitor cells
187527|NCT02174939|coronary artery disease|coronary artery disease
187528|NCT02174939|myocardial infarction|myocardial infarction
187529|NCT02174939|angiogenesis|angiogenesis
187530|NCT02174939|biological markers|biological markers
187531|NCT02174939|endothelial function|endothelial function
187532|NCT02174913|Awakening time|awakening time
187533|NCT02174913|Bispectral index|bispectral index
187534|NCT02174913|clinical signs|clinical signs
187535|NCT02174913|neurophysiologic monitoring|neurophysiologic monitoring
187536|NCT02174913|spine surgery|spine surgery
187537|NCT02174900|G6PD deficiency|g6pd deficiency
187538|NCT02174900|safety|safety
187539|NCT02174900|transmission|transmission
187540|NCT02174887|pancreatic adenocarcinoma|pancreatic adenocarcinoma
187541|NCT02174887|liver metastases|liver metastases
187542|NCT02174861|Chronic Migraine|chronic migraine
187543|NCT02174848|Pantothenate Kinase-Associated Neurodegeneration|pantothenate kinase-associated neurodegeneration
187544|NCT02174848|PKAN|pkan
187545|NCT02174848|Neurodegeneration with Brain Iron Accumulation|neurodegeneration with brain iron accumulation
187546|NCT02174848|NBIA|nbia
187547|NCT02174848|Deferiprone|deferiprone
187548|NCT02174848|Ferriprox|ferriprox
187549|NCT02174835|Pharmacokinetics|pharmacokinetics
187550|NCT02174835|Healthy Volunteers|healthy volunteers
187551|NCT02174835|deuterated dextromethorphan|deuterated dextromethorphan
187552|NCT02174835|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
187553|NCT02174822|Drug-drug interaction|drug-drug interaction
187554|NCT02174822|Pharmacokinetics|pharmacokinetics
187555|NCT02174822|Healthy Volunteers|healthy volunteers
187556|NCT02174822|deuterated dextromethorphan|deuterated dextromethorphan
187557|NCT02174822|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
187558|NCT02174809|Pregnancy|pregnancy
187559|NCT02174809|Gestational Weight Gain|gestational weight gain
187560|NCT02174809|Primary Care|primary care
187561|NCT02174809|Guidelines|guidelines
187562|NCT02174796|Pectus excavatum|pectus excavatum
187563|NCT02174796|cardiac output|cardiac output
187564|NCT02174796|transthoracic impedancemetry|transthoracic impedancemetry
187565|NCT02174783|Weight Loss|weight loss
187566|NCT02174783|Diet, Mediterranean|diet, mediterranean
187567|NCT02174783|Diet, Reducing|diet, reducing
187568|NCT02174783|protein sparing modified diet|protein sparing modified diet
187569|NCT02174744|Pain in elderly patients having communication disorders|pain in elderly patients having communication disorders
187570|NCT02174744|Numerical scale|numerical scale
187571|NCT02174744|Algoplus® scale|algoplus® scale
187572|NCT02174744|Doloplus® scale|doloplus® scale
187573|NCT02174731|Renal,|renal,
187574|NCT02174731|CKD,|ckd,
187575|NCT02174731|Epoetin alfa,|epoetin alfa,
187576|NCT02174731|Roxadustat,|roxadustat,
187577|NCT02174731|dialysis,|dialysis,
187578|NCT02174731|anemia|anemia
187579|NCT02174718|Cholecalciferol|cholecalciferol
187580|NCT02174718|Transdermal patch|transdermal patch
187581|NCT02174705|vaccination|vaccination
187582|NCT02174705|pain management|pain management
187583|NCT02174705|sucrose|sucrose
187584|NCT02174705|rotavirus|rotavirus
187585|NCT02174666|Aglycones|aglycones
187586|NCT02174666|Isoflavones|isoflavones
187587|NCT02174666|Red clover|red clover
187588|NCT02174666|Osteopenia|osteopenia
187589|NCT02174666|Menopause|menopause
187590|NCT02174666|Bone turnover|bone turnover
187591|NCT02174666|Bone mineral density|bone mineral density
187592|NCT02174640|Coffee|coffee
187593|NCT02174640|Polyphenolics|polyphenolics
187594|NCT02174627|Renal,|renal,
187595|NCT02174627|CKD,|ckd,
187596|NCT02174627|Roxadustat,|roxadustat,
187597|NCT02174627|anemia,|anemia,
187598|NCT02174627|non-dialysis|non-dialysis
187599|NCT02174614|Cocaine use disorder|cocaine use disorder
187600|NCT02174601|bowel preparation|bowel preparation
187601|NCT02174601|coolprep|coolprep
187602|NCT02174601|colonoscopy|colonoscopy
187603|NCT02174601|prediction model|prediction model
187604|NCT02174588|sedation, propofol, midazolam|sedation, propofol, midazolam
187605|NCT02174575|Hepatectomy|hepatectomy
187606|NCT02174562|Type 2 diabetes|type 2 diabetes
187607|NCT02174562|Mild Cognitive Impairment|mild cognitive impairment
187608|NCT02174549|Hypoxia|hypoxia
187609|NCT02174549|Embolization|embolization
187610|NCT02174549|Tirapazamine|tirapazamine
187611|NCT02174549|Hepatocellular carcinoma|hepatocellular carcinoma
187612|NCT02174523|pharmacokinetic|pharmacokinetic
187613|NCT02174523|lurasidone|lurasidone
187614|NCT02174523|multiple dose|multiple dose
187615|NCT02174510|pharmacokinetic|pharmacokinetic
187616|NCT02174510|lurasidone|lurasidone
187617|NCT02174510|single dose|single dose
187618|NCT02174497|Pediatric Colonoscopy|pediatric colonoscopy
187619|NCT02174497|Bowel Preparation|bowel preparation
187620|NCT02174497|Safety|safety
187621|NCT02174497|Tolerability|tolerability
187622|NCT02174484|Pacemaker|pacemaker
187623|NCT02174484|Remote monitoring|remote monitoring
187624|NCT02174484|Remote follow-up|remote follow-up
187625|NCT02174484|Home monitoring|home monitoring
187626|NCT02174484|Periodic IEGM|periodic iegm
187627|NCT02174484|Intracardiac electrogram|intracardiac electrogram
187628|NCT02174471|Aortic Stenosis|aortic stenosis
187629|NCT02174471|Aortic Valve Replacement|aortic valve replacement
187634|NCT02174458|Bariatric surgery; Body contouring; Quality of life|bariatric surgery; body contouring; quality of life
187635|NCT02174445|Patients with CML in chronic phase|patients with cml in chronic phase
187636|NCT02174445|Imatinib|imatinib
187637|NCT02174445|Nilotinib|nilotinib
187638|NCT02174432|Itch|itch
187639|NCT02174432|Chronic Itch|chronic itch
187640|NCT02174432|Nalbupine|nalbupine
187641|NCT02174419|Itch|itch
187642|NCT02174419|Chronic Itch|chronic itch
187643|NCT02174419|nalbuphine|nalbuphine
187644|NCT02174406|Ultrasound|ultrasound
187645|NCT02174406|Digital Breast Tomosynthesis|digital breast tomosynthesis
187646|NCT02174406|14-119|14-119
187647|NCT02174367|Chronic plaque psoriasis|chronic plaque psoriasis
187648|NCT02174367|Liver fibrosis|liver fibrosis
187649|NCT02174367|Fatty liver disease|fatty liver disease
187650|NCT02174367|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
187651|NCT02174367|Transient elastography|transient elastography
187652|NCT02174367|Fibroscan|fibroscan
187653|NCT02174367|Procollagen-3 N-Terminal peptide|procollagen-3 n-terminal peptide
187654|NCT02174367|Alanine aminotransferase|alanine aminotransferase
187655|NCT02174367|Liver function tests|liver function tests
187656|NCT02174354|Psoriasis|psoriasis
187657|NCT02174354|Methotrexate|methotrexate
187658|NCT02174354|Methotrexate Polyglutamates|methotrexate polyglutamates
187659|NCT02174354|Injury of Liver|injury of liver
187660|NCT02174341|Chikungunya fever|chikungunya fever
187661|NCT02174341|Chikungunya Virus|chikungunya virus
187662|NCT02174328|See incidence of Pre-Eclampsia in acetylsalicylic acid group|see incidence of pre-eclampsia in acetylsalicylic acid group
187663|NCT02174328|See incidence of Pre-Eclampsia in placebo group|see incidence of pre-eclampsia in placebo group
187664|NCT02174289|Heart Failure|heart failure
187665|NCT02174289|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
187666|NCT02174289|Transseptal left ventricular endocardial lead|transseptal left ventricular endocardial lead
187668|NCT02174237|Phase 1, safety, tolerability, PK, PD|phase 1, safety, tolerability, pk, pd
187669|NCT02174224|Violence|violence
187670|NCT02174224|At-risk youth|at-risk youth
187671|NCT02174224|Intentional Injury|intentional injury
187672|NCT02174224|Violence Intervention|violence intervention
187673|NCT02174224|Youth|youth
187674|NCT02174224|recidivism|recidivism
187675|NCT02174198|Immediate implant|immediate implant
187676|NCT02174198|bone graft|bone graft
187677|NCT02174198|immediate restoration|immediate restoration
187678|NCT02174185|bladder cancer|bladder cancer
187679|NCT02174185|conduit diversion|conduit diversion
187680|NCT02174185|orthotopic neobladder|orthotopic neobladder
187681|NCT02174185|health-related quality of life|health-related quality of life
187682|NCT02174185|validated questionnaire|validated questionnaire
187683|NCT02174146|leptin|leptin
187684|NCT02174146|visfatin|visfatin
187685|NCT02174146|chronic periodontitis|chronic periodontitis
187686|NCT02174146|diabetes mellitus|diabetes mellitus
187687|NCT02174146|non-surgical periodontal therapy|non-surgical periodontal therapy
187688|NCT02174133|left ventricular assist device|left ventricular assist device
187689|NCT02174133|endothelial function|endothelial function
187690|NCT02174133|microvascular perfusion|microvascular perfusion
187691|NCT02174133|microparticles|microparticles
187692|NCT02174107|Health economics|health economics
187693|NCT02174107|Percutaneous vertebroplasty|percutaneous vertebroplasty
187694|NCT02174107|Radiation therapy|radiation therapy
187695|NCT02174107|Painful spine metastases|painful spine metastases
187696|NCT02174081|mechanical ventilation, ARDS, Ventilator strategy, outcome|mechanical ventilation, ards, ventilator strategy, outcome
187697|NCT02174068|Paracetamol|paracetamol
187698|NCT02174068|Nefopam|nefopam
187699|NCT02174068|Pharmacokinetic|pharmacokinetic
187700|NCT02174068|Drug interaction|drug interaction
187701|NCT02174055|Depression|depression
187702|NCT02174055|14-101|14-101
187703|NCT02174029|Atrophy|atrophy
187704|NCT02174029|Ventilator|ventilator
187705|NCT02174029|Induced|induced
187706|NCT02174029|Diaphragm|diaphragm
187707|NCT02174029|Dysfunction|dysfunction
187708|NCT02174016|Intensive Care Units|intensive care units
187709|NCT02174016|Pediatric|pediatric
187710|NCT02174003|whole body hyperthermia|whole body hyperthermia
187711|NCT02174003|depression|depression
187712|NCT02174003|fibromyalgia|fibromyalgia
187713|NCT02174003|rheumatoid arthritis|rheumatoid arthritis
669985|NCT00855725|fMRI|fmri
187714|NCT02174003|perimenopausal symptoms|perimenopausal symptoms
187715|NCT02174003|open treatment|open treatment
187716|NCT02173990|adenocarcinoma|adenocarcinoma
187717|NCT02173990|colon and/or rectum|colon and/or rectum
187718|NCT02173977|GnRH Agonist|gnrh agonist
187722|NCT02173964|positron emission tomography|positron emission tomography
187723|NCT02173964|computed tomography|computed tomography
187724|NCT02173964|bowel|bowel
187725|NCT02173964|pinaverium bromide|pinaverium bromide
187726|NCT02173951|young minimally transfused beta thalassemia major|young minimally transfused beta thalassemia major
187727|NCT02173951|labile plasma iron (LPI)|labile plasma iron (lpi)
187728|NCT02173951|Transferrin saturation (TSAT)|transferrin saturation (tsat)
187729|NCT02173951|Deferiprone|deferiprone
187730|NCT02173951|Transfusional iron loading rate|transfusional iron loading rate
187731|NCT02173951|Transfusion units|transfusion units
187732|NCT02173938|Smokers|smokers
187733|NCT02173938|outpatient|outpatient
187734|NCT02173938|Tobacco Dependence Treatment Program|tobacco dependence treatment program
187735|NCT02173873|Age related macular degeneration|age related macular degeneration
187736|NCT02173873|central retinal vein occlusion|central retinal vein occlusion
187737|NCT02173860|Coronary artery disease|coronary artery disease
187738|NCT02173860|Valvular heart disease|valvular heart disease
187739|NCT02173860|Fractional flow reserve|fractional flow reserve
187740|NCT02173860|Coronary artery bypass surgery|coronary artery bypass surgery
187933|NCT02172690|Laparoscopic Staging|laparoscopic staging
187741|NCT02173860|Coronary graft failure or patency|coronary graft failure or patency
187742|NCT02173847|anvil-shaped corneal graft|anvil-shaped corneal graft
187743|NCT02173847|penetrating keratoplasty|penetrating keratoplasty
187744|NCT02173847|femtosecond laser|femtosecond laser
187745|NCT02173847|laser welding|laser welding
187746|NCT02173834|Brown Adipose Tissue|brown adipose tissue
187747|NCT02173834|Weight|weight
187748|NCT02173834|Sympathetic Nervous System|sympathetic nervous system
187749|NCT02173756|chemotherapy|chemotherapy
187750|NCT02173756|mucositis|mucositis
187751|NCT02173756|systemic opioids|systemic opioids
187752|NCT02173756|morphine|morphine
187753|NCT02173743|plasma, calcific tendinitis, rotator cuff, PRP|plasma, calcific tendinitis, rotator cuff, prp
187754|NCT02173704|Meningitis|meningitis
187755|NCT02173704|Infants|infants
187756|NCT02173704|Meningococcal B Recombinant Vaccine|meningococcal b recombinant vaccine
187757|NCT02173626|Mindfulness|mindfulness
187758|NCT02173613|infection lung elderly patients|infection lung elderly patients
187759|NCT02173600|Cardiovascular risk|cardiovascular risk
187760|NCT02173600|Primary prevention|primary prevention
187761|NCT02173600|Intensive dietary counselling|intensive dietary counselling
187762|NCT02173600|Physical exercise|physical exercise
187763|NCT02173587|Anti-inflammation, Rheumatoid arthritis, Thick shell mussel lipid extract, Chinese|anti-inflammation, rheumatoid arthritis, thick shell mussel lipid extract, chinese
187764|NCT02173574|Hepatitis C Virus, Viral, Antiviral, Infection, Infectious disease, alisporivir, EDP239, DEB025|hepatitis c virus, viral, antiviral, infection, infectious disease, alisporivir, edp239, deb025
187765|NCT02173561|Posttraumatic Stress Disorder|posttraumatic stress disorder
187766|NCT02173561|Cognitive Processing Therapy|cognitive processing therapy
187767|NCT02173561|combat|combat
187768|NCT02173561|military|military
187770|NCT02173561|group therapy|group therapy
187771|NCT02173548|heart failure|heart failure
187772|NCT02173548|HFpEF|hfpef
187773|NCT02173548|diastole|diastole
187774|NCT02173548|diastolic heart failure|diastolic heart failure
187775|NCT02173548|inflammation|inflammation
187776|NCT02173548|interleukin-1|interleukin-1
187777|NCT02173548|C-reactive protein|c-reactive protein
187778|NCT02173522|Prostate cancer|prostate cancer
187779|NCT02173522|Prostate artery embolization|prostate artery embolization
187780|NCT02173522|Robot-assisted laparoscopic radical prostatectomy|robot-assisted laparoscopic radical prostatectomy
187781|NCT02173496|Wet age-related macular degeneration|wet age-related macular degeneration
187782|NCT02173496|Assessment modalities for preclinical, pre-symptomatic ARMD|assessment modalities for preclinical, pre-symptomatic armd
187783|NCT02173457|Chiglitazar|chiglitazar
187784|NCT02173457|Sitagliptin|sitagliptin
187785|NCT02173457|diabetes|diabetes
187786|NCT02173457|type 2 diabetes|type 2 diabetes
187787|NCT02173444|in-vitro fertilization|in-vitro fertilization
187788|NCT02173444|ovarian stimulation|ovarian stimulation
187789|NCT02173431|BMI|bmi
187790|NCT02173431|Pressure|pressure
187791|NCT02173431|Bedsore|bedsore
187792|NCT02173418|Postoperative pain|postoperative pain
187793|NCT02173418|Acute postoperative pain|acute postoperative pain
187794|NCT02173418|Chronic postoperative pain|chronic postoperative pain
187795|NCT02173418|Shoulder pain|shoulder pain
187796|NCT02173418|Thoracotomy|thoracotomy
187797|NCT02173418|Thoracoscopy|thoracoscopy
187798|NCT02173405|Myofascial Pain Syndromes|myofascial pain syndromes
187799|NCT02173405|Pelvic pain|pelvic pain
187800|NCT02173405|Trigger points + injections|trigger points + injections
187801|NCT02173405|Myofascial Trigger Point Pain|myofascial trigger point pain
187802|NCT02173405|Trigger Point Pain, Myofascial|trigger point pain, myofascial
187803|NCT02173405|Botulinum Toxins, Type A|botulinum toxins, type a
187804|NCT02173405|Botulinum Neurotoxin A|botulinum neurotoxin a
187805|NCT02173405|Botulinum Toxin Type A|botulinum toxin type a
187806|NCT02173405|Clostridium botulinum A Toxin|clostridium botulinum a toxin
187807|NCT02173405|Clostridium Botulinum Toxin Type A|clostridium botulinum toxin type a
187809|NCT02173379|Absorb™ BVS|absorb™ bvs
187810|NCT02173379|Angioplasty|angioplasty
187811|NCT02173379|Bioabsorbable|bioabsorbable
187812|NCT02173379|BVS|bvs
187813|NCT02173379|Coronary Artery Disease|coronary artery disease
187814|NCT02173379|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
187815|NCT02173379|Coronary artery restenosis|coronary artery restenosis
187816|NCT02173379|Coronary artery stenosis|coronary artery stenosis
187817|NCT02173379|Coronary scaffold|coronary scaffold
187818|NCT02173379|Coronary Stent|coronary stent
187819|NCT02173379|Drug eluting stents|drug eluting stents
187820|NCT02173379|Everolimus|everolimus
187821|NCT02173379|Myocardial ischemia|myocardial ischemia
187822|NCT02173379|Stent thrombosis|stent thrombosis
187823|NCT02173379|Stents|stents
187824|NCT02173353|Ultrasound use during radiation therapy for Pancreas cancer|ultrasound use during radiation therapy for pancreas cancer
187825|NCT02173314|Long term foster care|long term foster care
187826|NCT02173314|child abuse and neglect|child abuse and neglect
229230|NCT01984450|BMAC|bmac
178777|NCT02216253|Stress urinary incontinence|stress urinary incontinence
178778|NCT02216253|Mixed Urinary incontinence|mixed urinary incontinence
178779|NCT02216253|L-methionine|l-methionine
187827|NCT02173262|Breast|breast
187934|NCT02172690|Cytology|cytology
187828|NCT02173236|Dental Implant Platform Switching|dental implant platform switching
187829|NCT02173236|Early Dental Implant Loading|early dental implant loading
187830|NCT02173210|Premature birth|premature birth
187831|NCT02173210|Premature delivery|premature delivery
187832|NCT02173210|Metabolomics|metabolomics
187833|NCT02173210|Microbiota|microbiota
187834|NCT02173210|Genetics|genetics
187835|NCT02173210|17 hydroxyprogesterone caproate|17 hydroxyprogesterone caproate
187836|NCT02173197|Occupational Therapy|occupational therapy
187837|NCT02173197|Complex patients|complex patients
187838|NCT02173197|Occupational performance problem|occupational performance problem
187839|NCT02173197|Rehabilitation Complexity Scale|rehabilitation complexity scale
187840|NCT02173184|bacterial vaginosis|bacterial vaginosis
187841|NCT02173184|Gynevac Lactobacillus vaccine|gynevac lactobacillus vaccine
187842|NCT02173171|Melanoma|melanoma
187843|NCT02173145|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
187844|NCT02173145|cough|cough
187845|NCT02173145|immunomodulation|immunomodulation
187846|NCT02173145|macrolide|macrolide
187847|NCT02173119|Hepatocellular|hepatocellular
187848|NCT02173119|Carcinoma|carcinoma
187849|NCT02173119|HCC|hcc
187850|NCT02173119|lipiodol|lipiodol
187851|NCT02173093|Neuroblastoma|neuroblastoma
187857|NCT02173080|autosomal dominant polycystic liver disease|autosomal dominant polycystic liver disease
187858|NCT02173080|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
187859|NCT02173080|quality of life|quality of life
187860|NCT02173080|patient reported outcome tool|patient reported outcome tool
187861|NCT02173067|Diabetes mellitus|diabetes mellitus
187862|NCT02173067|Epinephrine|epinephrine
187863|NCT02173067|Anesthesia, Dental|anesthesia, dental
187864|NCT02173067|lidocaine|lidocaine
187865|NCT02173067|Ambulatory Surgical Procedures|ambulatory surgical procedures
187866|NCT02173054|Acne|acne
187867|NCT02173054|Moisturizer|moisturizer
187868|NCT02173054|Efficacy|efficacy
187869|NCT02173054|Irritation|irritation
187870|NCT02173041|Prevention and Awareness Groups (PAG),|prevention and awareness groups (pag),
187871|NCT02173041|Substance Use Disorder,|substance use disorder,
187872|NCT02173041|Community based intervention|community based intervention
187873|NCT02173028|Beta Blocker Intolerance;|beta blocker intolerance;
187874|NCT02173028|Remote Patient Management system;|remote patient management system;
187875|NCT02173028|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
187876|NCT02173015|accidental falls|accidental falls
187877|NCT02173015|older adults|older adults
187878|NCT02173015|long-term care|long-term care
187879|NCT02173015|nursing home|nursing home
187880|NCT02173015|postural balance|postural balance
187881|NCT02173002|Telemedicine|telemedicine
187882|NCT02173002|Patient empowerment|patient empowerment
187883|NCT02173002|Integrated care|integrated care
187884|NCT02172989|Near-infrared fluorescence|near-infrared fluorescence
187885|NCT02172989|Indocyanine green, ICG|indocyanine green, icg
187886|NCT02172989|Radio-guided surgery|radio-guided surgery
187887|NCT02172989|breast cancer|breast cancer
187888|NCT02172976|pancreas cancer|pancreas cancer
187889|NCT02172976|neoadjuvant chemotherapy|neoadjuvant chemotherapy
187890|NCT02172976|Folfirinox|folfirinox
187891|NCT02172976|gemcitabine|gemcitabine
187892|NCT02172963|Stem Cell Transplantation|stem cell transplantation
187893|NCT02172963|Decidual Stromal Cells|decidual stromal cells
187894|NCT02172937|Stem Cell Transplantation|stem cell transplantation
187895|NCT02172937|Decidual Stromal Cells|decidual stromal cells
187896|NCT02172924|Stem Cell Transplantation|stem cell transplantation
187897|NCT02172924|Decidual Stromal Cells|decidual stromal cells
187903|NCT02172885|Mesenchymal stem cell based therapy|mesenchymal stem cell based therapy
187904|NCT02172885|cell infusion|cell infusion
187905|NCT02172872|Newly diagnosed|newly diagnosed
187907|NCT02172872|Elderly|elderly
187908|NCT02172872|Decitabine|decitabine
187909|NCT02172872|Transplant|transplant
187910|NCT02172859|lumiVida™, cognition, mood, sleep, tryptophane|lumivida™, cognition, mood, sleep, tryptophane
187911|NCT02172820|cardiac rehabilitation|cardiac rehabilitation
187912|NCT02172820|contingency management|contingency management
187913|NCT02172768|pharmacokinetics|pharmacokinetics
187914|NCT02172768|alternate dosing|alternate dosing
187915|NCT02172768|micafungin|micafungin
187916|NCT02172755|Eslicarbazepine acetate|eslicarbazepine acetate
187917|NCT02172755|BIA 2-093|bia 2-093
187918|NCT02172742|Eslicarbazepine acetate|eslicarbazepine acetate
187919|NCT02172742|BIA 2-093|bia 2-093
187920|NCT02172729|adductor canal block|adductor canal block
187921|NCT02172729|healthy volunteers|healthy volunteers
178894|NCT02215525|UVA|uva
187922|NCT02172729|US-guided peripheral nerve block|us-guided peripheral nerve block
187923|NCT02172729|lower limb|lower limb
187924|NCT02172729|duration|duration
187925|NCT02172729|Muscle Strength|muscle strength
187926|NCT02172729|Anesthetics, Local|anesthetics, local
187927|NCT02172729|Sensation|sensation
187928|NCT02172703|TBI|tbi
187929|NCT02172703|SAH|sah
187930|NCT02172703|ICP|icp
187931|NCT02172703|non invasive measurement|non invasive measurement
187932|NCT02172690|Gastric Cancer|gastric cancer
188030|NCT02171819|H5N1|h5n1
187935|NCT02172690|Peritoneal Metastases|peritoneal metastases
187936|NCT02172664|noncarious cervical lesions|noncarious cervical lesions
187937|NCT02172664|dental adhesive|dental adhesive
187938|NCT02172664|retention|retention
187939|NCT02172664|enamel margin discoloration|enamel margin discoloration
187940|NCT02172664|self etch|self etch
187941|NCT02172664|selective etch procedures|selective etch procedures
187942|NCT02172651|Vitamin D|vitamin d
187943|NCT02172651|Stage I-III colon cancer|stage i-iii colon cancer
187944|NCT02172651|Stage IV colon cancer|stage iv colon cancer
187945|NCT02172651|Resectable liver metastases|resectable liver metastases
187946|NCT02172638|Enhanced Recovery After Surgery|enhanced recovery after surgery
187950|NCT02172638|Gynecologic surgery|gynecologic surgery
187951|NCT02172638|Gynecology oncology|gynecology oncology
187952|NCT02172638|Median length of stay|median length of stay
187953|NCT02172638|Readmission rate|readmission rate
187954|NCT02172638|Surgery related complications|surgery related complications
187955|NCT02172638|Cost|cost
187956|NCT02172625|Athletic performance|athletic performance
187957|NCT02172625|Running|running
187958|NCT02172625|Dietary supplementation|dietary supplementation
187959|NCT02172625|Quality of life|quality of life
187960|NCT02172625|Running performance|running performance
187961|NCT02172625|oxidative damage|oxidative damage
187962|NCT02172612|Anticholinergic drugs|anticholinergic drugs
187963|NCT02172599|sit-stand workstation|sit-stand workstation
187964|NCT02172599|workplace|workplace
187965|NCT02172599|multi-component intervention|multi-component intervention
187966|NCT02172599|randomised control trial design|randomised control trial design
187967|NCT02172599|physical activity|physical activity
187968|NCT02172599|sitting|sitting
187969|NCT02172599|sedentary behaviour|sedentary behaviour
187970|NCT02172599|process evaluation|process evaluation
187971|NCT02172599|health|health
187972|NCT02172365|Chronic myeloid leukemia|chronic myeloid leukemia
187973|NCT02172365|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
187974|NCT02172365|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
187975|NCT02172365|TKI failure|tki failure
187976|NCT02172183|cognitive-behavioral therapy, adolescents, ADHD.|cognitive-behavioral therapy, adolescents, adhd.
187977|NCT02172092|Diabetes|diabetes
187978|NCT02172092|Ketoacidosis|ketoacidosis
187979|NCT02172092|fluid shift|fluid shift
187980|NCT02172079|shoulder impingement, manual therapy, pain, motion.|shoulder impingement, manual therapy, pain, motion.
187981|NCT02172066|Posttraumatic Stress Disorder|posttraumatic stress disorder
187982|NCT02172066|Childhood maltreatment|childhood maltreatment
187983|NCT02172053|Workplace|workplace
187984|NCT02172053|Industrial workers|industrial workers
187985|NCT02172053|Resistance exercise|resistance exercise
187986|NCT02172053|Fatigue|fatigue
187987|NCT02172053|Occupational risk|occupational risk
187988|NCT02172053|Physical therapy|physical therapy
187989|NCT02172040|High blood pressure|high blood pressure
187990|NCT02172040|Systolic blood pressure|systolic blood pressure
187991|NCT02172040|Diastolic blood pressure|diastolic blood pressure
187992|NCT02172040|Antihypertensive|antihypertensive
187993|NCT02172014|Mechanical Ventilation|mechanical ventilation
187994|NCT02172014|Sedation|sedation
187995|NCT02172014|Fentanyl|fentanyl
187996|NCT02172014|Midazolam|midazolam
187997|NCT02172014|Comfort behavior scale|comfort behavior scale
187998|NCT02172001|IDA|ida
187999|NCT02172001|Iron deficiency|iron deficiency
188000|NCT02172001|iron deficiency anemia and who are intolerant or unresponsive to oral iron therapy|iron deficiency anemia and who are intolerant or unresponsive to oral iron therapy
188001|NCT02171988|Postural Orthostatic Tachycardia Syndrome|postural orthostatic tachycardia syndrome
188002|NCT02171988|propranolol|propranolol
188003|NCT02171988|bisoprolol|bisoprolol
188004|NCT02171988|pyridostigmine|pyridostigmine
188005|NCT02171975|Spinal anaesthesia|spinal anaesthesia
188006|NCT02171975|Ultrasound pre-procedure guided|ultrasound pre-procedure guided
188007|NCT02171975|Paramedian spinal|paramedian spinal
188008|NCT02171962|Zilver® PTX® Drug-Eluting Peripheral Stent|zilver® ptx® drug-eluting peripheral stent
188009|NCT02171962|Above-the-Knee Femoropopliteal Artery|above-the-knee femoropopliteal artery
188011|NCT02171949|Chronic hepatitis|chronic hepatitis
188012|NCT02171949|Hepatic cirrhosis|hepatic cirrhosis
188013|NCT02171936|Pain|pain
188014|NCT02171936|Precariousness|precariousness
188015|NCT02171936|EPICES Score|epices score
188016|NCT02171936|CETD|cetd
178968|NCT02215122|MGR001|mgr001
188017|NCT02171923|depression|depression
188018|NCT02171910|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
188019|NCT02171910|Sedation|sedation
188020|NCT02171871|EFFECTS,|effects,
188021|NCT02171871|PASSIVE SMOKING ,|passive smoking ,
188022|NCT02171871|RESPIRATORY SYSTEM MECHANICS,|respiratory system mechanics,
188023|NCT02171871|DIFFERENT BODY POSITIONS.|different body positions.
188024|NCT02171858|Stroke|stroke
188025|NCT02171858|National Institutes of Health Stroke Scale|national institutes of health stroke scale
188026|NCT02171858|Serum high sensitivity C-Reactive Protein|serum high sensitivity c-reactive protein
188027|NCT02171845|Male foetuses of 10 to 37 weeks|male foetuses of 10 to 37 weeks
188028|NCT02171819|Influenza|influenza
188029|NCT02171819|Avian|avian
188031|NCT02171819|Vaccine|vaccine
188032|NCT02171390|Hypogonadism|hypogonadism
188033|NCT02171390|Endothelial dysfunction|endothelial dysfunction
188034|NCT02171390|Insulin resistance|insulin resistance
188035|NCT02171390|Inflammation|inflammation
188036|NCT02171390|Testosterone replacement therapy|testosterone replacement therapy
188141|NCT02170961|MMP3|mmp3
188041|NCT02171364|Atrial fibrillation, Virtual ablation, electrocardiography, electroanatomical mapping data|atrial fibrillation, virtual ablation, electrocardiography, electroanatomical mapping data
188042|NCT02171351|sympathetic nerve reactivity|sympathetic nerve reactivity
188043|NCT02171351|neuromuscular electrostimulation|neuromuscular electrostimulation
188045|NCT02171338|Antibiotic therapy|antibiotic therapy
188046|NCT02171338|Lower respiratory tract diseases|lower respiratory tract diseases
188047|NCT02171325|irinotecan|irinotecan
188048|NCT02171325|Small Cell Lung Cancer|small cell lung cancer
188049|NCT02171312|Dizziness|dizziness
188050|NCT02171312|Imbalance|imbalance
188051|NCT02171286|KRAS|kras
188052|NCT02171286|EGFR|egfr
188053|NCT02171286|BRAF|braf
188054|NCT02171286|NRAS and HRAS|nras and hras
188055|NCT02171286|PIK3CA|pik3ca
188056|NCT02171286|RAS-RAF-MEK-MAPK|ras-raf-mek-mapk
188057|NCT02171286|HER2|her2
188058|NCT02171286|IDH1 and IDH2|idh1 and idh2
188059|NCT02171286|ALK|alk
188060|NCT02171286|TP53|tp53
188061|NCT02171286|c-KIT|c-kit
188062|NCT02171286|STAT1&3|stat1&3
188063|NCT02171286|PDGFRA|pdgfra
188064|NCT02171286|Metastatic colorectal cancer|metastatic colorectal cancer
188065|NCT02171286|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
188066|NCT02171286|Advanced melanoma|advanced melanoma
188067|NCT02171286|Gastrointestingal Struma Tumor|gastrointestingal struma tumor
188068|NCT02171286|Candidate genes implicated as potential prognostic and predictive biomarkers in patients with solid tumours|candidate genes implicated as potential prognostic and predictive biomarkers in patients with solid tumours
188069|NCT02171286|Circulating Tumor DNA|circulating tumor dna
188070|NCT02171273|Sleep|sleep
188071|NCT02171273|Aging|aging
188072|NCT02171273|Metabolism|metabolism
188073|NCT02171273|Circadian|circadian
188074|NCT02171273|Genetic|genetic
188075|NCT02171273|Alertness|alertness
188076|NCT02171260|Tumors|tumors
188077|NCT02171260|Lymphomas|lymphomas
188078|NCT02171260|Solid Tumors|solid tumors
188079|NCT02171260|Pediatric|pediatric
188080|NCT02171247|coronary computed tomographic angiography|coronary computed tomographic angiography
188081|NCT02171247|contrast|contrast
188082|NCT02171234|Epilepsy|epilepsy
188083|NCT02171234|BIA 2-093|bia 2-093
188084|NCT02171234|Eslicarbazepine acetate|eslicarbazepine acetate
188085|NCT02171221|Refractory or relapsed tumors|refractory or relapsed tumors
188086|NCT02171221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
188087|NCT02171221|Fluorouracil|fluorouracil
188088|NCT02171195|Eslicarbazepine acetate|eslicarbazepine acetate
188089|NCT02171195|BIA 2-093|bia 2-093
188090|NCT02171195|Epilepsy|epilepsy
188091|NCT02171182|Qutenza|qutenza
188092|NCT02171182|8% capsaicin patch|8% capsaicin patch
188093|NCT02171182|Non-interventional|non-interventional
188094|NCT02171182|Post-operative peripheral neuropathic pain|post-operative peripheral neuropathic pain
188095|NCT02171182|Observational|observational
188096|NCT02171182|Czech Republic|czech republic
188097|NCT02171143|ASP2409|asp2409
188098|NCT02171143|Rheumatoid Arthritis|rheumatoid arthritis
188099|NCT02171143|methotrexate|methotrexate
188100|NCT02171130|Diabetes Mellitus|diabetes mellitus
188101|NCT02171130|Hypoglycemia|hypoglycemia
188102|NCT02171130|Glucagon|glucagon
188103|NCT02171130|Anti-glucagon Antibody|anti-glucagon antibody
188104|NCT02171130|Immunogenicity|immunogenicity
188105|NCT02171117|Acute Myeloid Leukemia|acute myeloid leukemia
188106|NCT02171117|microtransplantation|microtransplantation
188107|NCT02171117|elderly patients|elderly patients
188108|NCT02171117|HLA-mismatched|hla-mismatched
188110|NCT02171117|Peripheral|peripheral
188111|NCT02171117|stem cell|stem cell
188112|NCT02171117|infusion|infusion
188113|NCT02171104|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
188114|NCT02171104|bone marrow transplantation|bone marrow transplantation
179150|NCT02214212|TBI|tbi
188115|NCT02171104|IMD|imd
188116|NCT02171104|AMACRD|amacrd
188117|NCT02171104|MNGIE|mngie
188118|NCT02171104|HDLS|hdls
188119|NCT02171104|OP|op
188120|NCT02171104|ALD|ald
188121|NCT02171091|endotracheal|endotracheal
188122|NCT02171091|intubation|intubation
188123|NCT02171091|airway|airway
188124|NCT02171091|inflammation|inflammation
188125|NCT02171078|Breast Cancer|breast cancer
188126|NCT02171078|Breast Neoplasms|breast neoplasms
188127|NCT02171078|Health Services Research|health services research
188128|NCT02171078|Surveillance|surveillance
188129|NCT02171078|Diagnostic Imaging|diagnostic imaging
188130|NCT02171078|Magnetic Resonance Imaging|magnetic resonance imaging
188131|NCT02171078|Mammography|mammography
188132|NCT02171078|Toxicity|toxicity
188133|NCT02171078|Adverse Effects|adverse effects
188134|NCT02171078|Side Effects|side effects
188135|NCT02171078|Recurrence|recurrence
188136|NCT02171065|NIRS/IVUS|nirs/ivus
188137|NCT02171065|multimodality imaging|multimodality imaging
188138|NCT02171065|PROSPECT|prospect
188139|NCT02170961|Acute heart failure|acute heart failure
188140|NCT02170961|RAAS|raas
188142|NCT02170961|MMP12|mmp12
188143|NCT02170961|Polymorphysm|polymorphysm
188144|NCT02170948|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
188145|NCT02170948|nerve block|nerve block
188146|NCT02170948|ankle block|ankle block
188147|NCT02170948|dexmedetomidine|dexmedetomidine
188148|NCT02170948|Precedex|precedex
188149|NCT02170948|ankle surgery|ankle surgery
188150|NCT02170948|forefoot surgery|forefoot surgery
188151|NCT02170948|duration|duration
188152|NCT02170948|anesthetic duration following ankle block for forefoot surgery|anesthetic duration following ankle block for forefoot surgery
188153|NCT02170883|asthma|asthma
188154|NCT02170883|mHealth|mhealth
188155|NCT02170883|cluster randomized controlled trial|cluster randomized controlled trial
188156|NCT02170883|pharmacy practice|pharmacy practice
188157|NCT02170883|pharmacist|pharmacist
188158|NCT02170857|Hyaluronic acid|hyaluronic acid
188159|NCT02170857|infra-bony defects|infra-bony defects
188160|NCT02170857|chronic periodontitis|chronic periodontitis
188161|NCT02170857|experimental|experimental
188162|NCT02170857|radiographic|radiographic
188163|NCT02170857|clinical|clinical
188164|NCT02170857|periodontal surgical treatment|periodontal surgical treatment
188165|NCT02170857|open flap curettage|open flap curettage
188166|NCT02170818|Education|education
188167|NCT02170818|Curriculum|curriculum
188168|NCT02170818|Anesthesiology|anesthesiology
188169|NCT02170818|Operating Rooms|operating rooms
188170|NCT02170779|multiple sclerosis|multiple sclerosis
188171|NCT02170779|spasticity|spasticity
188172|NCT02170779|stretching|stretching
188173|NCT02170779|exercise|exercise
188174|NCT02170779|rehabilitation|rehabilitation
188175|NCT02170714|Acute severe colitis|acute severe colitis
188176|NCT02170714|Children|children
188177|NCT02170714|Infliximab|infliximab
188178|NCT02170714|colectomy|colectomy
188179|NCT02170688|IV contrast|iv contrast
188180|NCT02170688|contrast dosing|contrast dosing
188181|NCT02170662|male pattern hair loss|male pattern hair loss
188182|NCT02170662|androgenetic alopecia|androgenetic alopecia
188183|NCT02170662|bimatoprost|bimatoprost
188184|NCT02170649|BIA 2-093|bia 2-093
188185|NCT02170649|Eslicarbazepine acetate|eslicarbazepine acetate
188186|NCT02170558|Trabecular Metal|trabecular metal
188187|NCT02170558|Metal reduction CT|metal reduction ct
188188|NCT02170558|TM- Ardis|tm- ardis
188189|NCT02170545|avascular necrosis|avascular necrosis
188190|NCT02170545|humeral head fracture|humeral head fracture
188191|NCT02170545|proximal arm fracture|proximal arm fracture
188192|NCT02170545|arthroplasty|arthroplasty
188193|NCT02170532|asthma|asthma
188194|NCT02170519|pulmonary hypertension|pulmonary hypertension
188195|NCT02170493|Insole Sensor|insole sensor
188196|NCT02170493|Optimial Limb Loading|optimial limb loading
188197|NCT02170493|42IIIB|42iiib
188198|NCT02170493|IIIC|iiic
188199|NCT02170493|Lower Extremity Fractures|lower extremity fractures
188200|NCT02170467|Intestinal permeability - Anorexia nervosa- Re feeding - auto-antibodies α-MSH|intestinal permeability - anorexia nervosa- re feeding - auto-antibodies α-msh
188201|NCT02170454|neuromodulation|neuromodulation
188202|NCT02170454|swallowing|swallowing
188203|NCT02170454|magnetic stimulation|magnetic stimulation
188204|NCT02170454|healthy subjects|healthy subjects
188205|NCT02170441|Tuberculosis|tuberculosis
188206|NCT02170441|Multi-drug resistant tuberculosis|multi-drug resistant tuberculosis
188411|NCT02169505|HL|hl
188207|NCT02170441|Extensively drug-resistant tuberculosis|extensively drug-resistant tuberculosis
188208|NCT02170441|Drug-resistant tuberculosis|drug-resistant tuberculosis
188209|NCT02170441|Mycobacterial Growth Indicator Tube Drug Susceptibility Test|mycobacterial growth indicator tube drug susceptibility test
188210|NCT02170441|Line Probe Assay|line probe assay
188211|NCT02170441|Microscopic Observation Drug Susceptibility Assay|microscopic observation drug susceptibility assay
188212|NCT02170441|Pyrosequencing|pyrosequencing
229743|NCT01982396|HIV|hiv
179178|NCT02214160|C7|c7
188213|NCT02170428|growth,|growth,
188214|NCT02170428|infancy,|infancy,
188215|NCT02170428|children,|children,
188216|NCT02170428|diet,|diet,
188217|NCT02170428|breastfeeding|breastfeeding
188218|NCT02170428|complementary feeding|complementary feeding
188219|NCT02170428|early life programming|early life programming
188220|NCT02170428|tracking|tracking
188221|NCT02170428|physical activity|physical activity
188222|NCT02170415|Persistent post-surgical pain|persistent post-surgical pain
188223|NCT02170415|Breast surgery|breast surgery
188224|NCT02170415|Complex intervention|complex intervention
188225|NCT02170415|Pain treatment|pain treatment
188226|NCT02170376|Parkinson's disease (PD)|parkinson's disease (pd)
188227|NCT02170376|BIA 9-1067|bia 9-1067
188228|NCT02170376|Opicapone|opicapone
188229|NCT02170363|Heart Failure|heart failure
188230|NCT02170363|Ventricular Dysfunction|ventricular dysfunction
188231|NCT02170363|Cardiomyopathies|cardiomyopathies
188232|NCT02170363|Heart Disease|heart disease
188233|NCT02170363|Cardiovascular Disease|cardiovascular disease
188234|NCT02170363|Heart-assist devices|heart-assist devices
188235|NCT02170311|Z-213, Ferric carboxymaltose, Iron, Iron-deficiency-anemia|z-213, ferric carboxymaltose, iron, iron-deficiency-anemia
188236|NCT02170298|ADHD|adhd
188237|NCT02170298|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
188238|NCT02170298|Vyvanse|vyvanse
188239|NCT02170298|Lisdexamfetamine|lisdexamfetamine
188240|NCT02170285|perinatal stroke|perinatal stroke
188241|NCT02170285|hemiparetic cerebral palsy|hemiparetic cerebral palsy
188242|NCT02170285|brain stimulation|brain stimulation
188243|NCT02170285|tDCS|tdcs
188244|NCT02170285|constraint-induced movement therapy|constraint-induced movement therapy
188245|NCT02170285|hand arm bimanual intensive therapy|hand arm bimanual intensive therapy
188246|NCT02170259|Tension-type headache|tension-type headache
188247|NCT02170259|Depression|depression
188248|NCT02170259|Anxiety|anxiety
188249|NCT02170259|Manual therapy|manual therapy
188250|NCT02170259|Spinal manipulation|spinal manipulation
188251|NCT02170259|Patients diagnosed with tension-type headache|patients diagnosed with tension-type headache
188252|NCT02170246|Acute HIV infection|acute hiv infection
188253|NCT02170246|Central nervous system|central nervous system
188254|NCT02170246|Antiretroviral therapy|antiretroviral therapy
188255|NCT02170246|Telmisartan|telmisartan
188256|NCT02170246|Cerebrospinal fluid|cerebrospinal fluid
188257|NCT02170220|Drug therapy|drug therapy
188258|NCT02170207|Pharmacological therapy|pharmacological therapy
188259|NCT02170194|smart phone apps|smart phone apps
188260|NCT02170194|subthreshold PTSD|subthreshold ptsd
188261|NCT02170194|resilience enhancement|resilience enhancement
188262|NCT02170194|military veterans|military veterans
188263|NCT02170194|natural disasters|natural disasters
188264|NCT02170194|terrorism|terrorism
188265|NCT02170194|shootings|shootings
188266|NCT02170194|fMRI|fmri
188267|NCT02170194|physiology|physiology
188268|NCT02170181|SBRT|sbrt
188269|NCT02170181|prostate cancer|prostate cancer
188270|NCT02170181|lung cancer|lung cancer
188271|NCT02170181|bladder cancer|bladder cancer
188272|NCT02170181|kidney cancer|kidney cancer
188273|NCT02170181|oligometastatic disease|oligometastatic disease
188274|NCT02170168|Community health services|community health services
188275|NCT02170168|Models, organizational|models, organizational
188276|NCT02170168|Referral and consultation|referral and consultation
188277|NCT02170168|Palliative medicine|palliative medicine
188278|NCT02170168|Terminal care|terminal care
188279|NCT02170142|MRI|mri
188280|NCT02170142|perinatal brain|perinatal brain
188281|NCT02170142|development, neonates|development, neonates
188282|NCT02170103|segment elevation myocardial infarctions (STEMIs),|segment elevation myocardial infarctions (stemis),
188283|NCT02170103|sonothrombolysis|sonothrombolysis
188284|NCT02170103|reperfusion|reperfusion
188285|NCT02170103|percutaneous intervention (PCI),|percutaneous intervention (pci),
188286|NCT02170103|antithrombotic therapy,|antithrombotic therapy,
188287|NCT02170103|antiplatelet therapy,|antiplatelet therapy,
188288|NCT02170090|adjuvant chemotherapy|adjuvant chemotherapy
188289|NCT02170090|cholangiocarcinoma|cholangiocarcinoma
670365|NCT00856804|Thalidomide|thalidomide
188290|NCT02170090|muscle invasive gall bladder carcinoma|muscle invasive gall bladder carcinoma
188291|NCT02170090|translational research|translational research
188292|NCT02170090|multidisciplinary|multidisciplinary
188293|NCT02170090|AIO, DGAV, DGVS|aio, dgav, dgvs
188294|NCT02170077|Epilepsy|epilepsy
188295|NCT02170077|BIA 2-093|bia 2-093
188296|NCT02170064|Epilepsy|epilepsy
188297|NCT02170064|BIA 2-093|bia 2-093
188298|NCT02170051|negative symptoms|negative symptoms
188299|NCT02170051|cognition|cognition
188301|NCT02170051|defeatist attitudes|defeatist attitudes
188302|NCT02170051|psychosocial treatment|psychosocial treatment
188303|NCT02170038|Drug Kinetics|drug kinetics
188304|NCT02170025|Cystic fibrosis|cystic fibrosis
188305|NCT02170025|delta F508|delta f508
188306|NCT02170025|Safety|safety
188307|NCT02170025|Tolerability|tolerability
188308|NCT02170025|Sweat Chloride|sweat chloride
188309|NCT02170025|Pharmacokinetics|pharmacokinetics
188310|NCT02170012|Multiple dose|multiple dose
188311|NCT02170012|safety|safety
188312|NCT02170012|tolerability|tolerability
188313|NCT02170012|PK|pk
188314|NCT02169973|Healthy|healthy
188315|NCT02169973|Positron Emission Tomography|positron emission tomography
188316|NCT02169973|11C-MK-3168|11c-mk-3168
188317|NCT02169973|JNJ-42165279|jnj-42165279
188318|NCT02169973|Human Brain|human brain
188319|NCT02169895|Parkinson's disease (PD)|parkinson's disease (pd)
188320|NCT02169895|Opicapone|opicapone
188321|NCT02169895|Bia 9-1067|bia 9-1067
188322|NCT02169882|Tuberculous meningitis|tuberculous meningitis
188323|NCT02169882|Rifampicin|rifampicin
188324|NCT02169882|Dose finding study|dose finding study
188325|NCT02169882|Pharmacokinetics|pharmacokinetics
188326|NCT02169869|intrauterine device, postpartum, contraception, Mirena, Paragard, intrauterine system|intrauterine device, postpartum, contraception, mirena, paragard, intrauterine system
188327|NCT02169856|Cholecystectomy|cholecystectomy
188328|NCT02169856|Laparoscopic|laparoscopic
188329|NCT02169856|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
188330|NCT02169843|Dexmedetomidine,|dexmedetomidine,
188331|NCT02169843|agitation,|agitation,
188332|NCT02169843|AFPS,|afps,
188333|NCT02169843|NRS,|nrs,
188334|NCT02169843|mean arterial pressure|mean arterial pressure
188335|NCT02169843|heart rate(HR)|heart rate(hr)
188433|NCT02169453|Opicapone|opicapone
188336|NCT02169830|vestibular migraines, nortriptyline and topiramate|vestibular migraines, nortriptyline and topiramate
188337|NCT02169791|hematologic malignancies|hematologic malignancies
188338|NCT02169778|Weight loss|weight loss
188339|NCT02169778|Intermittent energy restriction|intermittent energy restriction
188340|NCT02169778|Metabolic compensation|metabolic compensation
188341|NCT02169778|Diet therapy|diet therapy
188342|NCT02169765|Hepatocellular Carcinoma|hepatocellular carcinoma
188343|NCT02169765|Liver Cancer|liver cancer
188344|NCT02169752|Pre-Pulmonary Atrial Hypertension|pre-pulmonary atrial hypertension
188345|NCT02169739|ischemic preconditioning|ischemic preconditioning
188346|NCT02169739|remote ischemic preconditioning|remote ischemic preconditioning
188347|NCT02169739|ischemic stroke|ischemic stroke
188348|NCT02169739|white matter disease|white matter disease
188349|NCT02169739|cerebral small vessel disease|cerebral small vessel disease
188350|NCT02169739|cognitive decline|cognitive decline
188351|NCT02169739|leukoaraiosis|leukoaraiosis
188352|NCT02169739|diffusion tensor imaging|diffusion tensor imaging
188353|NCT02169739|white matter hyper intensity score|white matter hyper intensity score
188354|NCT02169739|European scale of age-related white matter change|european scale of age-related white matter change
188355|NCT02169713|Healthy subjects|healthy subjects
188356|NCT02169713|Mirabegron|mirabegron
188357|NCT02169713|Solifenacin|solifenacin
188358|NCT02169713|Tamsulosin HCl|tamsulosin hcl
188359|NCT02169700|Ischemic compression|ischemic compression
188360|NCT02169700|Myofascial trigger points|myofascial trigger points
188361|NCT02169700|Post-needling soreness|post-needling soreness
188362|NCT02169687|Thyroid, HIFU, hyperfunctioning, autonomous|thyroid, hifu, hyperfunctioning, autonomous
188363|NCT02169674|Hepatitis B|hepatitis b
188364|NCT02169674|Vaccine|vaccine
188365|NCT02169674|Immunogenicity|immunogenicity
188366|NCT02169661|Oxidative stress|oxidative stress
188367|NCT02169661|Lipid peroxides|lipid peroxides
188368|NCT02169661|Phytochemicals|phytochemicals
188369|NCT02169661|Ready meals|ready meals
188370|NCT02169661|Beetroot|beetroot
188371|NCT02169661|Blood pressure|blood pressure
188372|NCT02169648|macular edema|macular edema
188373|NCT02169648|branch retinal vein occlusion|branch retinal vein occlusion
188374|NCT02169648|central retinal vein occlusion|central retinal vein occlusion
188375|NCT02169648|ranibizumab|ranibizumab
188376|NCT02169648|cytokines|cytokines
188377|NCT02169648|visual acuity|visual acuity
188378|NCT02169648|central macular thickness|central macular thickness
188379|NCT02169635|macular buckle|macular buckle
188380|NCT02169635|high myopia|high myopia
188381|NCT02169635|posterior staphyloma|posterior staphyloma
188382|NCT02169609|Neuroblastoma|neuroblastoma
188383|NCT02169609|Immunotherapy|immunotherapy
188384|NCT02169609|Dinutuximab|dinutuximab
188385|NCT02169596|Acute Coronary Syndrome|acute coronary syndrome
188386|NCT02169596|Nitric oxide|nitric oxide
188387|NCT02169596|Ticagrelor|ticagrelor
188388|NCT02169596|Antiplatelet agents|antiplatelet agents
188389|NCT02169596|Endothelial function|endothelial function
188390|NCT02169583|GSK1325756|gsk1325756
188391|NCT02169583|Safety|safety
188392|NCT02169583|Bioavailability|bioavailability
188393|NCT02169583|Pharmacokinetics|pharmacokinetics
188394|NCT02169570|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
188395|NCT02169570|Pulmonary Tuberculosis|pulmonary tuberculosis
188396|NCT02169570|Vitamin D|vitamin d
188397|NCT02169570|Calcium|calcium
188398|NCT02169531|Diabetes Mellitus Type 2|diabetes mellitus type 2
188399|NCT02169531|Hyperglycemia|hyperglycemia
188400|NCT02169531|Immunotherapy|immunotherapy
188401|NCT02169531|Autologous|autologous
188402|NCT02169518|PON1 activity|pon1 activity
188403|NCT02169518|HDL functionality|hdl functionality
188404|NCT02169518|LDL oxidation|ldl oxidation
188405|NCT02169518|Diabetes Mellitus Type 1|diabetes mellitus type 1
188406|NCT02169518|Obesity|obesity
188407|NCT02169518|Diabetes Mellitus Type 2|diabetes mellitus type 2
188408|NCT02169518|Bariatric Surgery|bariatric surgery
188409|NCT02169505|Lymphoma|lymphoma
188410|NCT02169505|Hodgkin lymphoma|hodgkin lymphoma
188412|NCT02169505|CD30 positive Hodgkin Lymphoma|cd30 positive hodgkin lymphoma
188413|NCT02169505|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
188414|NCT02169505|ALCL|alcl
188415|NCT02169505|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
188416|NCT02169505|ASCT|asct
188417|NCT02169505|Graft-versus-host disease|graft-versus-host disease
188418|NCT02169505|GVHD|gvhd
188419|NCT02169505|Brentuximab Vedotin|brentuximab vedotin
188420|NCT02169505|SGN-35|sgn-35
188421|NCT02169505|Adcetris|adcetris
188422|NCT02169492|Thrombectomy|thrombectomy
188423|NCT02169492|Stroke|stroke
188424|NCT02169492|ReVive SE|revive se
188425|NCT02169479|Parkinson's disease (PD)|parkinson's disease (pd)
188426|NCT02169479|Opicapone|opicapone
188427|NCT02169479|BIA 9-1067|bia 9-1067
188428|NCT02169466|Parkinson's disease (PD)|parkinson's disease (pd)
188429|NCT02169466|Opicapone|opicapone
188430|NCT02169466|BIA 9-1067|bia 9-1067
188431|NCT02169453|Parkinson's disease (PD)|parkinson's disease (pd)
188432|NCT02169453|BIA 9-1067|bia 9-1067
188434|NCT02169440|Parkinson's disease (PD)|parkinson's disease (pd)
188435|NCT02169440|BIA 9-1067|bia 9-1067
188436|NCT02169440|Opicapone|opicapone
188437|NCT02169427|Parkinson's disease (PD)|parkinson's disease (pd)
188438|NCT02169427|BIA 9-1067|bia 9-1067
188439|NCT02169427|Opicapone|opicapone
188440|NCT02169414|Parkinson's disease (PD)|parkinson's disease (pd)
188441|NCT02169414|BIA 9-1067|bia 9-1067
188442|NCT02169414|Opicapone|opicapone
188443|NCT02169388|Gut microflora|gut microflora
188444|NCT02169388|colorectal cancer|colorectal cancer
188445|NCT02169388|Chemotherapy|chemotherapy
188446|NCT02169388|Immunity|immunity
188447|NCT02169388|Nutrition|nutrition
188448|NCT02169362|Burns|burns
188449|NCT02169362|Thermal burns|thermal burns
188450|NCT02169362|Second degree burns|second degree burns
188451|NCT02169362|Partial thickness burns|partial thickness burns
188452|NCT02169362|Deep partial thickness burns|deep partial thickness burns
188453|NCT02169362|Acute burns|acute burns
188454|NCT02169362|Burn wounds|burn wounds
188455|NCT02169336|Bunion|bunion
188456|NCT02169336|Bunionectomy|bunionectomy
188457|NCT02169336|Pain|pain
188458|NCT02169336|Analgesia|analgesia
188459|NCT02169336|dexmedetomidine|dexmedetomidine
188460|NCT02169336|intranasal|intranasal
188461|NCT02169323|Non-eosinophilic Asthma|non-eosinophilic asthma
188462|NCT02169323|Inhaled corticosteroids|inhaled corticosteroids
188463|NCT02169323|Step-down|step-down
188464|NCT02169310|Traumatic Brain Injury|traumatic brain injury
188465|NCT02169310|Decision-Making|decision-making
188466|NCT02169310|Dopaminergic Network|dopaminergic network
188467|NCT02169310|Brain Imaging|brain imaging
188468|NCT02169310|Non-Invasive Brain Stimulation|non-invasive brain stimulation
188469|NCT02169297|Pain Management|pain management
188470|NCT02169297|Anesthesia: Nerve Block|anesthesia: nerve block
188471|NCT02169258|coronary artery disease|coronary artery disease
188472|NCT02169258|peripheral artery disease|peripheral artery disease
188473|NCT02169258|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
188474|NCT02169258|coronary angiography|coronary angiography
188475|NCT02169258|revascularization|revascularization
188476|NCT02169258|gene polymorphisms|gene polymorphisms
188477|NCT02169258|microRNAs|micrornas
188478|NCT02169232|Awake intubation|awake intubation
188479|NCT02169232|Videolaryngoscope|videolaryngoscope
188480|NCT02169232|Fiberoptic|fiberoptic
188481|NCT02169206|Frozen shoulder|frozen shoulder
188482|NCT02169206|scapulothoracic angle|scapulothoracic angle
188483|NCT02169206|scapulohumeral angle|scapulohumeral angle
188484|NCT02169206|acromiohumeral distance|acromiohumeral distance
188485|NCT02169206|center equator distance|center equator distance
188486|NCT02169206|shoulder radiography|shoulder radiography
188487|NCT02169193|microaspiration|microaspiration
188488|NCT02169193|mechanical ventilation|mechanical ventilation
188489|NCT02169193|enteral feeding|enteral feeding
188490|NCT02169193|99m technetium|99m technetium
188491|NCT02169193|pepsin|pepsin
188492|NCT02169180|Ibrutinib|ibrutinib
188493|NCT02169180|IMBRUVICA|imbruvica
188494|NCT02169180|PCI-32765|pci-32765
188495|NCT02169180|JNJ-54179060|jnj-54179060
188496|NCT02169180|Lymphoma, Mantle-cell|lymphoma, mantle-cell
188497|NCT02169167|Diabetes complications|diabetes complications
188498|NCT02169167|Diabetic foot|diabetic foot
188499|NCT02169167|Foot ulcer|foot ulcer
188500|NCT02169167|Wound healing|wound healing
188501|NCT02169167|Wound infection|wound infection
188502|NCT02169141|pharmacokinetics|pharmacokinetics
188503|NCT02169141|pharmacodynamics|pharmacodynamics
188504|NCT02169141|MDR-TB|mdr-tb
188505|NCT02169141|Levofloxacin|levofloxacin
188506|NCT02169141|Capreomycin|capreomycin
188507|NCT02169102|Low power laser|low power laser
188508|NCT02169102|Pulpitis|pulpitis
188509|NCT02169102|Pain|pain
188510|NCT02169076|Ventricular Assist Device, Cardiac Resynchronization Therapy|ventricular assist device, cardiac resynchronization therapy
188511|NCT02169050|Vitamin D deficiency|vitamin d deficiency
188512|NCT02169050|Inflammation|inflammation
188513|NCT02169050|Obesity|obesity
188514|NCT02169037|Rotor|rotor
188515|NCT02169037|FIRM|firm
188516|NCT02169037|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
188517|NCT02169037|Atrial tachyarrhythmia|atrial tachyarrhythmia
188518|NCT02169037|Ablation|ablation
188519|NCT02169037|Contact mapping|contact mapping
188520|NCT02169037|Clinical trial|clinical trial
188521|NCT02169037|Signal processing.|signal processing.
188522|NCT02169024|prenatal care|prenatal care
188523|NCT02169024|group care|group care
188524|NCT02169024|Expect With Me|expect with me
188525|NCT02169024|evaluation studies|evaluation studies
188526|NCT02169024|group prenatal care|group prenatal care
188527|NCT02169011|Breast reconstruction|breast reconstruction
188528|NCT02169011|Breast cancer|breast cancer
188529|NCT02168998|Medical clown|medical clown
188530|NCT02168998|Pediatric emergency medicine|pediatric emergency medicine
188531|NCT02168985|Child violence|child violence
188532|NCT02168985|HIV AIDS conflicted couples|hiv aids conflicted couples
188533|NCT02168985|Intimate partner violence|intimate partner violence
188534|NCT02168985|Tanzania|tanzania
188535|NCT02168985|Marriage counseling|marriage counseling
188536|NCT02168985|Child maltreatment|child maltreatment
188537|NCT02168985|Couples communication|couples communication
188538|NCT02168972|atrial fibrillation|atrial fibrillation
188540|NCT02168972|radiofrequency RF ablation|radiofrequency rf ablation
188541|NCT02168972|left atrium anatomical and electrophysiological mapping|left atrium anatomical and electrophysiological mapping
188542|NCT02168959|Femoral Nerve Block|femoral nerve block
188543|NCT02168959|Pain Control|pain control
188544|NCT02168959|Tibial Plateau Fracture|tibial plateau fracture
188545|NCT02168959|Prospective|prospective
188546|NCT02168959|Randomized|randomized
188547|NCT02168933|psoriasis|psoriasis
188548|NCT02168933|nail|nail
188549|NCT02168933|laser|laser
188550|NCT02168933|excimer|excimer
188551|NCT02168933|treatment|treatment
188552|NCT02168920|Alzeheimer|alzeheimer
188553|NCT02168894|Peripheral neuropathy|peripheral neuropathy
188554|NCT02168894|Chemotherapy-Induced Peripheral Neuropathy|chemotherapy-induced peripheral neuropathy
188555|NCT02168894|Cancer Survivors|cancer survivors
188556|NCT02168894|Acupuncture|acupuncture
188557|NCT02168894|Electrical stimulation|electrical stimulation
188558|NCT02168894|Nerve function tests|nerve function tests
188559|NCT02168894|Hand function tests|hand function tests
188560|NCT02168894|Balance tests|balance tests
188561|NCT02168894|Questionnaires|questionnaires
188562|NCT02168894|Surveys|surveys
188563|NCT02168881|labour|labour
188564|NCT02168881|induction|induction
188565|NCT02168881|misoprostol|misoprostol
188566|NCT02168881|dinoprostone|dinoprostone
188567|NCT02168868|Autoimmune Diseases|autoimmune diseases
188568|NCT02168868|Child Development Disorders, Pervasive|child development disorders, pervasive
188569|NCT02168868|Inflammation|inflammation
188570|NCT02168868|Risk Factors|risk factors
188571|NCT02168855|Smoking cessation|smoking cessation
188572|NCT02168855|Non-daily smokers|non-daily smokers
188573|NCT02168855|Ecological Momentary Assessment|ecological momentary assessment
188574|NCT02168855|nicotine replacement therapy|nicotine replacement therapy
188575|NCT02168842|Parkinson|parkinson
188576|NCT02168842|Parkinson Disease|parkinson disease
188577|NCT02168842|Parkinson's Disease|parkinson's disease
188578|NCT02168829|AF ablation|af ablation
188579|NCT02168829|Anticoagulation AF ablation|anticoagulation af ablation
188580|NCT02168829|Stroke prevention|stroke prevention
188581|NCT02168816|Osteomyelitis|osteomyelitis
188582|NCT02168816|Diabetes|diabetes
188583|NCT02168816|Foot Infection|foot infection
188584|NCT02168803|abnormal cholesterol|abnormal cholesterol
670366|NCT00856804|Hepatitis C|hepatitis c
188585|NCT02168790|amniotic membrane holder, aminiotic membrane transplantation|amniotic membrane holder, aminiotic membrane transplantation
188586|NCT02168777|Patients with Cancer|patients with cancer
188587|NCT02168751|one lung ventilation|one lung ventilation
188588|NCT02168751|inflammatory response|inflammatory response
188589|NCT02168751|thoracic surgery|thoracic surgery
188590|NCT02168738|nutrition|nutrition
188591|NCT02168725|briciclib|briciclib
188592|NCT02168725|Dose escalation|dose escalation
188593|NCT02168725|Maximum tolerated dose|maximum tolerated dose
188594|NCT02168712|Coronary Heart Disease|coronary heart disease
188595|NCT02168712|Interval exercise training|interval exercise training
188596|NCT02168712|Continuous exercise training|continuous exercise training
188597|NCT02168712|Quality of life|quality of life
230312|NCT01979692|CLM|clm
188598|NCT02168712|Safety|safety
188599|NCT02168699|children|children
188600|NCT02168699|infants|infants
188601|NCT02168699|musculocutaneous nerve|musculocutaneous nerve
188602|NCT02168699|ultrasonography|ultrasonography
188603|NCT02168686|alpha1-antitrypsin deficiency|alpha1-antitrypsin deficiency
188604|NCT02168686|alpha1AT|alpha1at
188605|NCT02168686|A1AT|a1at
188606|NCT02168686|ADVM-043|advm-043
188607|NCT02168686|gene therapy|gene therapy
188608|NCT02168686|gene transfer vector|gene transfer vector
188609|NCT02168673|COPD|copd
188610|NCT02168673|Cigarette Smoke|cigarette smoke
188611|NCT02168673|Smoker|smoker
188612|NCT02168673|Nonsmoker|nonsmoker
188613|NCT02168673|ODF2|odf2
188614|NCT02168673|Cilia|cilia
188615|NCT02168660|Obesity|obesity
188616|NCT02168660|Insulin Resistance|insulin resistance
188617|NCT02168660|Vitamin D Deficiency|vitamin d deficiency
188618|NCT02168660|Children|children
188619|NCT02168660|Adolescents|adolescents
188620|NCT02168647|Excessive gestational weight gain|excessive gestational weight gain
188621|NCT02168647|Insulin resistance|insulin resistance
188622|NCT02168647|Physical activity|physical activity
188623|NCT02168647|Behavioral prenatal lifestyle intervention|behavioral prenatal lifestyle intervention
188624|NCT02168647|Reduced carbohydrate intake|reduced carbohydrate intake
188625|NCT02168647|Self-determination theory|self-determination theory
188626|NCT02168647|Motivational interviewing|motivational interviewing
188627|NCT02168621|Chronic periodontitis|chronic periodontitis
188628|NCT02168621|Non-surgical therapy|non-surgical therapy
188629|NCT02168621|Ultrasonic debridement|ultrasonic debridement
188630|NCT02168621|Scaling and root planing|scaling and root planing
188631|NCT02168608|hepatic ischemia reperfusion injury|hepatic ischemia reperfusion injury
188632|NCT02168608|ischemia precondition|ischemia precondition
188633|NCT02168608|remote ischemia precondition|remote ischemia precondition
188634|NCT02168608|anti-inflammation|anti-inflammation
188635|NCT02168595|healthy volunteers, GMI-1271|healthy volunteers, gmi-1271
188636|NCT02168582|Physical Therapy Modalities|physical therapy modalities
188637|NCT02168582|Prognosis|prognosis
188638|NCT02168582|Patient Selection|patient selection
188639|NCT02168569|treatment|treatment
188640|NCT02168569|artemisin-based combinations|artemisin-based combinations
188641|NCT02168569|children|children
188642|NCT02168556|Urodynamics, Anxiety|urodynamics, anxiety
188643|NCT02168517|Obesity|obesity
188644|NCT02168517|Pain|pain
188645|NCT02168517|Fertility|fertility
188646|NCT02168478|Neo-Synalar|neo-synalar
188647|NCT02168478|Patch Test|patch test
188648|NCT02168478|Sodium lauryl sulfate|sodium lauryl sulfate
188649|NCT02168478|Saline|saline
188650|NCT02168478|Presensitization|presensitization
188651|NCT02168465|self-efficacy|self-efficacy
188652|NCT02168465|self-management|self-management
188653|NCT02168465|web-based intervention research|web-based intervention research
188654|NCT02168452|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
188655|NCT02168452|Indocyanine green (ICG)|indocyanine green (icg)
188656|NCT02168452|Radioisotope (RI)|radioisotope (ri)
188657|NCT02168452|Near infrared fluorescence camera|near infrared fluorescence camera
188658|NCT02168439|Dexmedetomidine|dexmedetomidine
188659|NCT02168439|Midazolam|midazolam
188660|NCT02168413|cortical excitability|cortical excitability
188661|NCT02168413|robotized TMS|robotized tms
188662|NCT02168413|EEG|eeg
188663|NCT02168413|EMG|emg
188664|NCT02168387|atelectasis|atelectasis
188665|NCT02168387|continuous high frequency oscillator|continuous high frequency oscillator
188666|NCT02168387|acetylcysteine|acetylcysteine
188667|NCT02168387|dornase alfa|dornase alfa
188668|NCT02168374|Glass ionomer cement|glass ionomer cement
188669|NCT02168374|Indirect pulp therapy|indirect pulp therapy
188670|NCT02168361|cirrhosis|cirrhosis
188671|NCT02168322|growth factors|growth factors
188672|NCT02168322|periodontal regeneration|periodontal regeneration
188673|NCT02168322|modefied perforated membranes|modefied perforated membranes
188674|NCT02168296|Pharmacokinetics|pharmacokinetics
188675|NCT02168296|Blood glucose|blood glucose
188676|NCT02168296|subjects|subjects
188677|NCT02168283|cardiovascular disease|cardiovascular disease
188678|NCT02168283|hypertension|hypertension
188679|NCT02168257|Nasal Cannula|nasal cannula
188680|NCT02168244|psoriasis|psoriasis
188681|NCT02168244|biologics|biologics
188682|NCT02168244|subcutaneous|subcutaneous
188683|NCT02168244|pain|pain
188684|NCT02168244|heat|heat
188685|NCT02168244|ice|ice
188686|NCT02168231|Complex abdominal wall hernia|complex abdominal wall hernia
188687|NCT02168231|Biologic mesh|biologic mesh
188688|NCT02168231|Strattice|strattice
188689|NCT02168218|protein synthesis|protein synthesis
188690|NCT02168218|intrahepatic fat|intrahepatic fat
188691|NCT02168218|lean body mass|lean body mass
188692|NCT02168218|IGF1|igf1
188693|NCT02168218|energy metabolism|energy metabolism
188694|NCT02168205|Healthy volunteer|healthy volunteer
188695|NCT02168205|Pharmacokinetics|pharmacokinetics
188697|NCT02168205|Pomalidomide|pomalidomide
188698|NCT02168205|Food effect|food effect
188699|NCT02168205|smoker|smoker
188700|NCT02168192|Breaking bad news skills|breaking bad news skills
188701|NCT02168192|Communications skills|communications skills
188702|NCT02168192|Medical education|medical education
188703|NCT02168192|Obstetrics|obstetrics
188704|NCT02168192|Simulation|simulation
188705|NCT02168166|Neurological Disorders|neurological disorders
188706|NCT02168166|Neuroscience|neuroscience
188707|NCT02168166|Neuropsychology|neuropsychology
188708|NCT02168166|EEG|eeg
188709|NCT02168166|Cognitive remediation|cognitive remediation
188710|NCT02168166|Cognitive Response|cognitive response
188711|NCT02168153|Chiropractic Manipulative Therapy|chiropractic manipulative therapy
188712|NCT02168153|Reaction Times|reaction times
188713|NCT02168153|Response Times|response times
188714|NCT02168153|Special Forces|special forces
188715|NCT02168153|Biomechanical Assessments|biomechanical assessments
188716|NCT02168114|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
188717|NCT02168114|Exercise|exercise
188718|NCT02168114|Optical Imaging|optical imaging
188719|NCT02168114|Magnetic Resonance|magnetic resonance
188720|NCT02168101|MLN9708|mln9708
188721|NCT02168101|allogeneic stem cell transplant|allogeneic stem cell transplant
188722|NCT02168101|multiple myeloma|multiple myeloma
188723|NCT02168101|ixazomib|ixazomib
188724|NCT02168101|autologous stem cell transplant|autologous stem cell transplant
188725|NCT02168088|Sudden unexplained death|sudden unexplained death
188726|NCT02168062|Supportive Therapy|supportive therapy
188727|NCT02168062|Androgen Deprivation Therapy|androgen deprivation therapy
188728|NCT02168049|cardiac, respiratory, monitoring|cardiac, respiratory, monitoring
188729|NCT02168036|lung disease|lung disease
188730|NCT02168036|mediastinal lymph node|mediastinal lymph node
188731|NCT02168036|bronchoscopy|bronchoscopy
188732|NCT02168036|Endobronchial-Guided Transbronchial Needle Aspiration|endobronchial-guided transbronchial needle aspiration
188733|NCT02168023|surgical site infection|surgical site infection
188734|NCT02168023|dialkylcarbamoylchloride impregnated dressing|dialkylcarbamoylchloride impregnated dressing
188735|NCT02168023|caesarean section|caesarean section
188736|NCT02168023|wound dehiscence|wound dehiscence
188737|NCT02167984|esophageal swallow|esophageal swallow
188738|NCT02167984|gastroesophageal reflux|gastroesophageal reflux
188739|NCT02167984|esophageal impedance|esophageal impedance
188740|NCT02167984|newborn|newborn
188741|NCT02167984|preterm|preterm
188742|NCT02167971|traumatic brain injury|traumatic brain injury
188743|NCT02167971|diffuse axonal injury|diffuse axonal injury
188744|NCT02167971|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
188745|NCT02167971|neuromodulation|neuromodulation
188746|NCT02167971|cognitive rehabilitation|cognitive rehabilitation
188747|NCT02167945|Naïve|naïve
188748|NCT02167945|Hepatitis C|hepatitis c
188749|NCT02167945|Non responder|non responder
188750|NCT02167945|Relapser|relapser
188751|NCT02167945|Null responder|null responder
188752|NCT02167945|Treatment-Experienced|treatment-experienced
188753|NCT02167945|Cirrhosis|cirrhosis
188754|NCT02167945|Hepatitis C Genotype 1|hepatitis c genotype 1
188755|NCT02167945|Compensated Cirrhosis|compensated cirrhosis
188756|NCT02167945|Hepatitis C Virus|hepatitis c virus
188757|NCT02167932|Breast Cancer|breast cancer
188758|NCT02167932|Walk With Ease|walk with ease
188759|NCT02167932|Physical Activity|physical activity
188760|NCT02167932|Walking|walking
188761|NCT02167932|Younger Women|younger women
188762|NCT02167932|Cancer|cancer
188763|NCT02167932|p16|p16
188764|NCT02167932|Aging|aging
188765|NCT02167932|Biomarkers|biomarkers
188766|NCT02167932|Biomarkers of Aging|biomarkers of aging
188767|NCT02167932|Chemotherapy|chemotherapy
188768|NCT02167932|Chemotherapy Treatment|chemotherapy treatment
188769|NCT02167932|Adjuvant Chemotherapy|adjuvant chemotherapy
188770|NCT02167932|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
188771|NCT02167919|Prostate|prostate
188772|NCT02167919|Men|men
188773|NCT02167919|Hyperplasia|hyperplasia
188774|NCT02167893|Pharmacological therapy|pharmacological therapy
188775|NCT02167867|body contouring|body contouring
188776|NCT02167867|circumference reduction|circumference reduction
188777|NCT02167867|body shaping|body shaping
188778|NCT02167867|low level laser|low level laser
188779|NCT02167854|LJM716|ljm716
188780|NCT02167854|BYL719 [Alpelisib]|byl719 [alpelisib]
188781|NCT02167854|TRASTUZUMAB|trastuzumab
188782|NCT02167854|HER2+|her2+
188783|NCT02167854|14-057|14-057
188784|NCT02167841|Breech presentation,|breech presentation,
188785|NCT02167841|External cephalic version,|external cephalic version,
188786|NCT02167841|Maternal posture,|maternal posture,
188787|NCT02167841|Pregnancy,|pregnancy,
188788|NCT02167841|Caesarean section.|caesarean section.
188789|NCT02167828|HIV|hiv
188790|NCT02167828|AIDS|aids
188791|NCT02167828|treatment adherence|treatment adherence
188792|NCT02167828|social network|social network
188793|NCT02167802|severe infection, pediatrics, sub-optimal care, term care|severe infection, pediatrics, sub-optimal care, term care
179770|NCT02211365|CVD|cvd
188794|NCT02167789|HF, diagnosis|hf, diagnosis
188795|NCT02167763|contraception|contraception
188796|NCT02167763|IUD|iud
188797|NCT02167763|copper|copper
188798|NCT02167750|cognitive|cognitive
188799|NCT02167750|phytochmicals|phytochmicals
188800|NCT02167750|caffeine|caffeine
188801|NCT02167750|cognitive performance after ingestion of test beverage|cognitive performance after ingestion of test beverage
188802|NCT02167737|Accident Prevention|accident prevention
188803|NCT02167737|Accidental Falls|accidental falls
188804|NCT02167737|Geriatric Health Services|geriatric health services
188805|NCT02167737|Gender Differences|gender differences
188806|NCT02167698|Pediatric acute respiratory distress syndrome|pediatric acute respiratory distress syndrome
188807|NCT02167698|Mechanical ventilation|mechanical ventilation
188808|NCT02167698|Airway pressure release ventilation|airway pressure release ventilation
188809|NCT02167698|Conventional low-tidal volume ventilation|conventional low-tidal volume ventilation
188810|NCT02167672|total abdominal hysterectomy, total laparoscopic hysterectomy, vaginal hysterectomy|total abdominal hysterectomy, total laparoscopic hysterectomy, vaginal hysterectomy
188811|NCT02167659|Lymphedema|lymphedema
188812|NCT02167659|Breast cancer|breast cancer
188813|NCT02167659|Bioimpedance Spectroscopy|bioimpedance spectroscopy
188814|NCT02167659|L-Dex|l-dex
188815|NCT02167646|Soft tissue defect|soft tissue defect
188816|NCT02167646|dorsal branch of the digital nerve|dorsal branch of the digital nerve
188817|NCT02167646|dorsal branch of the digital artery|dorsal branch of the digital artery
188818|NCT02167646|dorsal digital flap|dorsal digital flap
188819|NCT02167633|Radiosurgery|radiosurgery
188820|NCT02167633|Laminectomy|laminectomy
188821|NCT02167633|Radiotherapy|radiotherapy
188822|NCT02167633|Spinal Cord Compression|spinal cord compression
188823|NCT02167633|Neoplasm Metastasis|neoplasm metastasis
188824|NCT02167633|Randomized Controlled Trial|randomized controlled trial
188825|NCT02167607|Purple Potatoes|purple potatoes
188826|NCT02167607|Polyphenolics|polyphenolics
189924|NCT02162537|Cisplatin|cisplatin
188827|NCT02167581|Maxillofacial surgery|maxillofacial surgery
188828|NCT02167581|Epithelial odontogenic tumours|epithelial odontogenic tumours
188829|NCT02167568|corpus callosum agenesis/dysgenesis|corpus callosum agenesis/dysgenesis
188830|NCT02167568|mental deficiency/ Intellectual deficiency|mental deficiency/ intellectual deficiency
188831|NCT02167568|genetic and phenotypic characterization|genetic and phenotypic characterization
188832|NCT02167555|Wild Blueberries|wild blueberries
188833|NCT02167555|Polyphenolics|polyphenolics
188834|NCT02167542|Severe hypoxemic respiratory failure|severe hypoxemic respiratory failure
188835|NCT02167542|Fiberoptic bronchoscopy|fiberoptic bronchoscopy
188836|NCT02167542|Noninvasive possitive pressure ventilation|noninvasive possitive pressure ventilation
188837|NCT02167542|Continuous positive airway pressure|continuous positive airway pressure
188838|NCT02167529|Quality of life-Thyroidectomy-Morbidity|quality of life-thyroidectomy-morbidity
188839|NCT02167516|Xinfeng capsule|xinfeng capsule
188840|NCT02167516|Knee osteoarthritis|knee osteoarthritis
188841|NCT02167516|Randomized controlled trials|randomized controlled trials
188842|NCT02167516|Double-blind|double-blind
188843|NCT02167490|BC; conservative surgery; SNB; AD; axillary US imaging|bc; conservative surgery; snb; ad; axillary us imaging
188844|NCT02167477|Intubation, Endotracheal|intubation, endotracheal
188845|NCT02167464|Hypertension|hypertension
188846|NCT02167451|stem cell transplant|stem cell transplant
188847|NCT02167451|GVHD prevention|gvhd prevention
188848|NCT02167438|Cesarean|cesarean
188849|NCT02167438|Section|section
188850|NCT02167438|second|second
188851|NCT02167438|stage|stage
188852|NCT02167438|labor|labor
188853|NCT02167425|People who Inject Drugs|people who inject drugs
188854|NCT02167425|HIV|hiv
188855|NCT02167425|Methadone|methadone
188856|NCT02167425|Sub Saharan Africa|sub saharan africa
188857|NCT02167425|Tanzania|tanzania
188858|NCT02167425|Implementation Science|implementation science
188859|NCT02167412|POTS|pots
188860|NCT02167412|Syncope|syncope
188861|NCT02167386|Men who have sex with men (MSM)|men who have sex with men (msm)
188862|NCT02167386|Black/African-American|black/african-american
188863|NCT02167360|adult patients|adult patients
188864|NCT02167360|B-cell ALL|b-cell all
188865|NCT02167360|chemo-refractory|chemo-refractory
188866|NCT02167360|relapsed after allogeneic SCT|relapsed after allogeneic sct
670762|NCT00858351|Biofeedback|biofeedback
188867|NCT02167360|ineligible for allogeneic SCT|ineligible for allogeneic sct
188868|NCT02167347|CBT, Psychosis, cultural adaptation, Pakistan|cbt, psychosis, cultural adaptation, pakistan
188869|NCT02167334|panendoscopy|panendoscopy
188870|NCT02167334|preoxygenation|preoxygenation
188871|NCT02167334|non invasive ventilation|non invasive ventilation
188872|NCT02167295|betel nut|betel nut
188873|NCT02167295|dependence|dependence
188874|NCT02167295|withdraw|withdraw
188875|NCT02167295|deprivation test|deprivation test
188876|NCT02167269|enclosed afferent reservoir|enclosed afferent reservoir
188877|NCT02167269|Jackson Rees system|jackson rees system
188878|NCT02167269|anesthesia breathing circuit|anesthesia breathing circuit
188879|NCT02167269|spontaneous breathing|spontaneous breathing
188880|NCT02167269|pediatric anesthesia|pediatric anesthesia
188881|NCT02167230|Coronary Artery Disease|coronary artery disease
188882|NCT02167230|Percutaneous Coronary Intervention|percutaneous coronary intervention
188883|NCT02167230|Bifurcation|bifurcation
188884|NCT02167230|Jailed-balloon technique|jailed-balloon technique
188885|NCT02167217|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
188886|NCT02167217|Corticosteroids|corticosteroids
188887|NCT02167217|Infants|infants
188888|NCT02167217|Young Children|young children
188889|NCT02167217|Toddlers|toddlers
188890|NCT02167165|Atrial Fibrillation|atrial fibrillation
188891|NCT02167165|Digoxin|digoxin
188892|NCT02167165|SNP|snp
188893|NCT02167139|Rheumatoid Arthritis, Adalimumab|rheumatoid arthritis, adalimumab
188894|NCT02167126|Athletic Performance;|athletic performance;
188895|NCT02167126|Muscle Strength;|muscle strength;
188896|NCT02167126|Isometric Contraction;|isometric contraction;
188897|NCT02167126|Kinesio Taping|kinesio taping
188898|NCT02167100|HIV|hiv
188899|NCT02167100|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
188900|NCT02167100|Patient Care|patient care
188901|NCT02167100|Patient Care Management|patient care management
188902|NCT02167100|Lost to Follow-Up|lost to follow-up
188903|NCT02167087|Sentinel node mapping|sentinel node mapping
188904|NCT02167087|lymphatic mapping|lymphatic mapping
188905|NCT02167087|lymphatic metastasis|lymphatic metastasis
188906|NCT02167087|Aberrant lymphatic drainage|aberrant lymphatic drainage
188907|NCT02167087|indocyanine green|indocyanine green
188908|NCT02167087|ICG|icg
188909|NCT02167087|near infrared|near infrared
188910|NCT02167087|colon cancer|colon cancer
188911|NCT02167087|laparoscopic surgery|laparoscopic surgery
188912|NCT02167074|Diagnostic accuracy|diagnostic accuracy
188913|NCT02167074|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
188914|NCT02167074|EUS-FNA|eus-fna
188915|NCT02167074|Endoscopic Ultrasound-Guided Fine Needle Biopsy|endoscopic ultrasound-guided fine needle biopsy
188916|NCT02167074|EUS-FNB|eus-fnb
188917|NCT02167074|Pancreatic mass|pancreatic mass
188918|NCT02167074|Lymph node|lymph node
190217|NCT02161185|open-label|open-label
188919|NCT02167048|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
188920|NCT02167048|Executive Function|executive function
188921|NCT02167048|Methylphenidate|methylphenidate
188922|NCT02167048|Psychostimulants|psychostimulants
188923|NCT02167048|Adolescent|adolescent
188924|NCT02167048|Child|child
188925|NCT02167048|Working Memory|working memory
188926|NCT02167048|Prefrontal Cortex|prefrontal cortex
188927|NCT02167048|Attention|attention
188928|NCT02167048|Cognitive Function|cognitive function
188929|NCT02167048|Inhibition|inhibition
188930|NCT02167035|Open-Angle Glaucoma|open-angle glaucoma
188931|NCT02167035|Ocular Hypertension|ocular hypertension
188932|NCT02167022|intense therapy|intense therapy
188933|NCT02167022|brain plasticity|brain plasticity
188934|NCT02167022|Perception-Action approach|perception-action approach
188935|NCT02167009|ARTERY EMBOLIZATION|artery embolization
188937|NCT02166970|Hilar tumor|hilar tumor
188938|NCT02166970|Metal stent|metal stent
188939|NCT02166970|Single|single
188940|NCT02166970|Multiple|multiple
188941|NCT02166957|Esophageal disruption|esophageal disruption
188942|NCT02166957|anterograde-retrograde endoscopy|anterograde-retrograde endoscopy
188943|NCT02166957|rendez-vous technique|rendez-vous technique
188944|NCT02166957|NOTES|notes
188945|NCT02166957|recanalization|recanalization
188946|NCT02166957|dilatations|dilatations
188947|NCT02166957|Stenting|stenting
188948|NCT02166957|radiation therapy|radiation therapy
188949|NCT02166957|head and neck carcinoma|head and neck carcinoma
188950|NCT02166944|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
188951|NCT02166944|ALS functional ration scale|als functional ration scale
188952|NCT02166944|TAR-DNA-binding protein-43|tar-dna-binding protein-43
188953|NCT02166944|tamoxifen|tamoxifen
188954|NCT02166944|mTOR|mtor
188955|NCT02166931|Essence of Chicken|essence of chicken
188956|NCT02166931|stress|stress
188957|NCT02166931|cognitive function|cognitive function
188958|NCT02166918|Schizophrenia|schizophrenia
188959|NCT02166918|Real-Life Functioning|real-life functioning
188960|NCT02166918|Schizophrenia Endophenotypes|schizophrenia endophenotypes
188961|NCT02166892|Childhood obesity|childhood obesity
188962|NCT02166892|Plate|plate
188963|NCT02166892|Food consumption|food consumption
188964|NCT02166879|Obstructive Sleep Apnea-Hypopnea Syndrome|obstructive sleep apnea-hypopnea syndrome
188965|NCT02166879|Obstructive sleep apnea|obstructive sleep apnea
188967|NCT02166879|Chart review|chart review
188968|NCT02166879|Questionnaire|questionnaire
188969|NCT02166879|Survey|survey
188970|NCT02166853|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
188971|NCT02166853|Sevoflurane|sevoflurane
188972|NCT02166853|Mechanical ventilation|mechanical ventilation
188973|NCT02166853|Intensive Care Unit (ICU)|intensive care unit (icu)
188974|NCT02166853|Prospective study|prospective study
188975|NCT02166853|Lung injury|lung injury
188976|NCT02166853|Gas exchange|gas exchange
188977|NCT02166853|Inflammation|inflammation
188978|NCT02166853|Receptor for advanced glycation end-produts (RAGE)|receptor for advanced glycation end-produts (rage)
188979|NCT02166853|sRAGE|srage
188980|NCT02166827|TMS|tms
188981|NCT02166827|Cognitive Stimulation|cognitive stimulation
188982|NCT02166827|NeuroAD|neuroad
188983|NCT02166801|Cerebral palsy|cerebral palsy
188984|NCT02166801|Children|children
188985|NCT02166801|Early Intervention|early intervention
188986|NCT02166801|Communication|communication
188987|NCT02166801|Gross motor function|gross motor function
188988|NCT02166801|Hand function|hand function
188989|NCT02166788|metastatic melanoma|metastatic melanoma
188990|NCT02166788|groin lymph nodes|groin lymph nodes
188991|NCT02166788|surgery|surgery
188992|NCT02166788|lymphadenectomy|lymphadenectomy
188993|NCT02166762|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
188994|NCT02166762|Biventricular implantable cardioverter defibrillators|biventricular implantable cardioverter defibrillators
188995|NCT02166762|Heart failure|heart failure
188996|NCT02166762|Cardiomyopathy|cardiomyopathy
188997|NCT02166762|QLV|qlv
188998|NCT02166762|LV lead placement|lv lead placement
188999|NCT02166762|Arrhythmia|arrhythmia
189000|NCT02166749|Hysterectomy, long term follow up, subjective outcome|hysterectomy, long term follow up, subjective outcome
189001|NCT02166736|Instantaneous wave Free Ratio|instantaneous wave free ratio
189002|NCT02166736|Fractional Flow Reserve|fractional flow reserve
189003|NCT02166723|persistent atrial fibrillation|persistent atrial fibrillation
189004|NCT02166723|Cryoballoon ablation|cryoballoon ablation
189005|NCT02166710|Knee arthroplasty|knee arthroplasty
189006|NCT02166710|Adductor canal block|adductor canal block
189007|NCT02166710|Quadriceps strength|quadriceps strength
189008|NCT02166697|Pharmacological therapy|pharmacological therapy
189009|NCT02166684|Do-it-yourself devices|do-it-yourself devices
189010|NCT02166684|User-experiences|user-experiences
189011|NCT02166684|Health behavior|health behavior
189012|NCT02166684|Self-measurement|self-measurement
189013|NCT02166684|Methodology, Evaluation|methodology, evaluation
189014|NCT02166684|Personal health records|personal health records
189015|NCT02166684|Blood Glucose Self-Monitoring|blood glucose self-monitoring
189016|NCT02166684|Self Blood Pressure Monitoring|self blood pressure monitoring
189017|NCT02166658|Patients with breast or lung cancer and recurrent or progressive brain|patients with breast or lung cancer and recurrent or progressive brain
189018|NCT02166658|metastases|metastases
189019|NCT02166645|patient positioning|patient positioning
189020|NCT02166645|premature infant|premature infant
189021|NCT02166645|mechanical ventilation|mechanical ventilation
189022|NCT02166645|airway extubation|airway extubation
189023|NCT02166632|Knee arthroplasty|knee arthroplasty
189024|NCT02166632|Exparel|exparel
189025|NCT02166632|Bupivacaine liposome|bupivacaine liposome
189026|NCT02166632|Total knee replacement|total knee replacement
189027|NCT02166632|Pain control|pain control
189028|NCT02166619|Stroke|stroke
189029|NCT02166619|Rehabilitation|rehabilitation
189030|NCT02166619|Electric stimulation therapy|electric stimulation therapy
189031|NCT02166619|Neuroplasticity|neuroplasticity
189032|NCT02166567|intracytoplasmic sperm injection|intracytoplasmic sperm injection
189033|NCT02166567|Male infertility|male infertility
189034|NCT02166567|apoptosis|apoptosis
189035|NCT02166567|flow cytometry and sorting|flow cytometry and sorting
189036|NCT02166567|DNA fragmentation|dna fragmentation
189037|NCT02166554|Adhesions|adhesions
189038|NCT02166554|Hyaluronan|hyaluronan
189039|NCT02166554|Gynaecological surgery|gynaecological surgery
189040|NCT02166554|Clinical outcomes|clinical outcomes
189041|NCT02166541|cerebral palsy, spastic, diplegic,|cerebral palsy, spastic, diplegic,
189042|NCT02166541|children,|children,
189043|NCT02166541|intervention study,|intervention study,
189044|NCT02166541|manipulation, spinal|manipulation, spinal
189045|NCT02166541|randomized controlled trial|randomized controlled trial
189046|NCT02166528|female pelvic floor dysfunction|female pelvic floor dysfunction
189047|NCT02166528|pelvic organ prolaps|pelvic organ prolaps
189048|NCT02166528|urinary incontinence|urinary incontinence
189049|NCT02166528|massively parallel sequencing|massively parallel sequencing
189050|NCT02166515|cervical cancer|cervical cancer
189051|NCT02166515|ovarian cancer|ovarian cancer
189052|NCT02166515|endometrial cancer|endometrial cancer
189053|NCT02166515|high-throughput sequencing|high-throughput sequencing
189054|NCT02166502|pediatric|pediatric
189055|NCT02166502|HIV|hiv
189056|NCT02166502|prevention|prevention
189057|NCT02166502|prophylaxis|prophylaxis
189058|NCT02166502|nevirapine|nevirapine
189059|NCT02166489|autologous mesenchymal stem cells|autologous mesenchymal stem cells
189060|NCT02166489|polycystic kidney disease|polycystic kidney disease
189061|NCT02166489|intravenous injection|intravenous injection
189062|NCT02166489|CRF|crf
189063|NCT02166450|Denture stomatitis|denture stomatitis
189064|NCT02166450|Dentures|dentures
189065|NCT02166450|Denture wearers|denture wearers
189066|NCT02166437|osteoporosis|osteoporosis
189067|NCT02166437|BMD|bmd
189068|NCT02166437|teriparatide|teriparatide
189069|NCT02166437|bisphosphonate|bisphosphonate
189070|NCT02166437|denosmab|denosmab
189071|NCT02166424|Pregnancy|pregnancy
189072|NCT02166424|Depression|depression
189073|NCT02166424|omega-3 fatty acids|omega-3 fatty acids
200996|NCT02112656|Adenocarcinoma|adenocarcinoma
189074|NCT02166411|Myomectomy ,Laparoscopy , Barbed sutures|myomectomy ,laparoscopy , barbed sutures
189075|NCT02166398|Amlodipine basylate, Losartan potassium|amlodipine basylate, losartan potassium
189076|NCT02166359|Icodextrin|icodextrin
189077|NCT02166359|Triglyceride|triglyceride
189078|NCT02166346|Transverse myelitis|transverse myelitis
189079|NCT02166333|vitamin D|vitamin d
189081|NCT02166333|high risk of falling|high risk of falling
189082|NCT02166333|insufficient or deficient serum vitamin D levels|insufficient or deficient serum vitamin d levels
189083|NCT02166333|10-29 ng/ml|10-29 ng/ml
189084|NCT02166307|formaldehyde; Maillard Reaction; cross-linkage; human aging|formaldehyde; maillard reaction; cross-linkage; human aging
189085|NCT02166294|Foot|foot
189086|NCT02166294|Ulcer|ulcer
189087|NCT02166294|Diabetes|diabetes
189088|NCT02166294|Amputation|amputation
189089|NCT02166294|Limb salvage|limb salvage
189090|NCT02166281|Insomnia|insomnia
189091|NCT02166281|Anxiety|anxiety
189092|NCT02166281|Depression|depression
189093|NCT02166281|Restless leg syndrome|restless leg syndrome
189094|NCT02166281|Aromatase inhibitor|aromatase inhibitor
189095|NCT02166281|Body composition|body composition
189096|NCT02166268|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
189097|NCT02166268|Allergic rhinitis|allergic rhinitis
189098|NCT02166268|Allergy|allergy
189099|NCT02166268|Grass pollen|grass pollen
189100|NCT02166242|non-small cell lung cancer|non-small cell lung cancer
189101|NCT02166242|thioredoxin reductase|thioredoxin reductase
189102|NCT02166216|Prolonged high intensity exercise|prolonged high intensity exercise
189103|NCT02166216|Healthy subjects|healthy subjects
189104|NCT02166216|Cardiovascular risk markers|cardiovascular risk markers
189105|NCT02166216|Troponin|troponin
189106|NCT02166216|Leisure sports athletes|leisure sports athletes
189107|NCT02166216|Cycling|cycling
189108|NCT02166216|CT coronary angiography|ct coronary angiography
189109|NCT02166216|Outcomes|outcomes
189110|NCT02166190|Pancreatic|pancreatic
189111|NCT02166190|cholangiocarcinoma|cholangiocarcinoma
190526|NCT02159807|pregnant|pregnant
189112|NCT02166190|radiofrequency ablation|radiofrequency ablation
189113|NCT02166164|Pain|pain
189114|NCT02166164|Secondary hyperalgesia|secondary hyperalgesia
189115|NCT02166164|thermal sensitization|thermal sensitization
189116|NCT02166164|Catastrophization|catastrophization
189117|NCT02166164|Anxiety|anxiety
189118|NCT02166125|gastric bypass|gastric bypass
189119|NCT02166125|sleeve gastrectomy|sleeve gastrectomy
189120|NCT02166125|esophageal stent|esophageal stent
189121|NCT02166125|suturing|suturing
189122|NCT02166112|Hernia of Abdominal Wall|hernia of abdominal wall
189123|NCT02166112|Biologic implant|biologic implant
189124|NCT02166112|Infected Hernioplasty Mesh|infected hernioplasty mesh
189125|NCT02166047|Hepatitis B|hepatitis b
189126|NCT02166047|HBV|hbv
189127|NCT02166047|GS-9620|gs-9620
189128|NCT02166047|TLR-7 Agonist|tlr-7 agonist
189129|NCT02166034|children|children
189130|NCT02166034|fruit|fruit
189131|NCT02166034|vegetable|vegetable
189132|NCT02166034|diet|diet
189133|NCT02166034|school|school
189134|NCT02166034|garden|garden
189135|NCT02166021|Multiple Sclerosis (MS)|multiple sclerosis (ms)
189136|NCT02166021|Stem Cells|stem cells
189137|NCT02166008|Repamipide|repamipide
189138|NCT02166008|Dual antiplatelet|dual antiplatelet
189139|NCT02166008|Peptic ulcer|peptic ulcer
189140|NCT02165995|Brain Tumor|brain tumor
189141|NCT02165995|Glioma|glioma
189142|NCT02165995|Tumor resection|tumor resection
189143|NCT02165995|Navigated Transcranial Magnetic Stimulation|navigated transcranial magnetic stimulation
189144|NCT02165995|nTMS|ntms
189145|NCT02165995|Brain mapping|brain mapping
189146|NCT02165995|Motor function|motor function
189147|NCT02165995|Speech function|speech function
189148|NCT02165995|Speech mapping|speech mapping
189149|NCT02165969|tumor|tumor
189150|NCT02165969|inflammatory process|inflammatory process
189151|NCT02165969|fracture|fracture
189152|NCT02165969|defect|defect
189153|NCT02165956|Cereals|cereals
189154|NCT02165956|Obesity|obesity
189155|NCT02165956|Complementary Feeding|complementary feeding
189156|NCT02165930|Bioavailability|bioavailability
189157|NCT02165930|oxycodone|oxycodone
189158|NCT02165930|ethanol interaction|ethanol interaction
189159|NCT02165930|healthy volunteers|healthy volunteers
189160|NCT02165917|Endometriosis|endometriosis
189161|NCT02165917|Adhesions|adhesions
189162|NCT02165917|Hyalobarrier®|hyalobarrier®
189163|NCT02165917|Hyaluronic acid|hyaluronic acid
189164|NCT02165917|Antiadhesion agent|antiadhesion agent
189165|NCT02165917|Adhesionbarrier|adhesionbarrier
189166|NCT02165917|Pregnancy rate|pregnancy rate
189167|NCT02165904|Analyze clinical efficacy of subarachnoid administration of|analyze clinical efficacy of subarachnoid administration of
402944|NCT01228942|fallopian tube cancer|fallopian tube cancer
180176|NCT02209363|OSA|osa
189168|NCT02165904|"autologous BMSC expanded in vitro"|"autologous bmsc expanded in vitro"
189169|NCT02165878|Chronic kidney disease(CKD)|chronic kidney disease(ckd)
189170|NCT02165865|hand transplantation|hand transplantation
189171|NCT02165865|hand allotransplantation|hand allotransplantation
189172|NCT02165865|upper extremity transplantation|upper extremity transplantation
189173|NCT02165865|upper extremity amputation|upper extremity amputation
189174|NCT02165865|hand amputation|hand amputation
189175|NCT02165865|vascularized composite allotransplantation|vascularized composite allotransplantation
189176|NCT02165865|composite tissue allotransplantation|composite tissue allotransplantation
189177|NCT02165865|variance component analysis (VCA)|variance component analysis (vca)
189178|NCT02165865|composite tissue allograft (CTA)|composite tissue allograft (cta)
189179|NCT02165852|ampulla of Vater|ampulla of vater
189180|NCT02165852|adenoma|adenoma
189181|NCT02165852|papillectomy|papillectomy
189182|NCT02165852|injection|injection
189183|NCT02165852|non-injection|non-injection
189184|NCT02165826|Drug therapy|drug therapy
189185|NCT02165774|sacral neuromodulation, neurogenic lower urinary tract dysfunction|sacral neuromodulation, neurogenic lower urinary tract dysfunction
189186|NCT02165761|Hemodialysis|hemodialysis
189187|NCT02165761|End Stage Renal Disease|end stage renal disease
189188|NCT02165761|Vascular Graft|vascular graft
189189|NCT02165722|Influenza|influenza
189190|NCT02165722|HPV|hpv
189191|NCT02165722|Tdap|tdap
189192|NCT02165722|MCV|mcv
189193|NCT02165722|vaccination|vaccination
189194|NCT02165722|adolescents|adolescents
189195|NCT02165696|compression bandage, manual lymphatic drainage, lymphedema, breast cancer, qualitative research.|compression bandage, manual lymphatic drainage, lymphedema, breast cancer, qualitative research.
189196|NCT02165683|Cancer|cancer
189197|NCT02165683|Pediatric|pediatric
189198|NCT02165683|PET Scan|pet scan
189199|NCT02165670|Ischemic heart disesase|ischemic heart disesase
189497|NCT02164305|Kinematics|kinematics
189200|NCT02165670|Myocardial infarction|myocardial infarction
189201|NCT02165670|Angina pectoris|angina pectoris
189202|NCT02165657|Excimer laser|excimer laser
189203|NCT02165657|UVB|uvb
189204|NCT02165657|Psoriasis|psoriasis
189205|NCT02165644|Subarachnoid Hemorrhage|subarachnoid hemorrhage
189206|NCT02165644|Vasospasm|vasospasm
189207|NCT02165644|Acetazolamide|acetazolamide
189208|NCT02165618|frailty|frailty
189209|NCT02165618|geriatric, elderly|geriatric, elderly
189210|NCT02165618|polypharmacy|polypharmacy
189211|NCT02165605|external beam radiotherapy|external beam radiotherapy
189212|NCT02165605|breast cancer|breast cancer
189213|NCT02165592|Hemophilia|hemophilia
189214|NCT02165592|Arthropathy|arthropathy
189215|NCT02165592|Range of Motion|range of motion
189216|NCT02165592|Strength|strength
189217|NCT02165592|Proprioception|proprioception
189218|NCT02165592|Gait|gait
189219|NCT02165592|Quality of Life|quality of life
189220|NCT02165579|procalcitonin|procalcitonin
189221|NCT02165579|biomarkers|biomarkers
189222|NCT02165579|Osteomyelitis|osteomyelitis
189223|NCT02165579|diabetes|diabetes
189224|NCT02165579|foot ulcer(s)|foot ulcer(s)
189225|NCT02165579|Infectious Disease Society of America stage 3 infection|infectious disease society of america stage 3 infection
189226|NCT02165566|intensive insulin therapy|intensive insulin therapy
189227|NCT02165566|critical care patients|critical care patients
189228|NCT02165566|blood glucose concentration>180 mg/dl|blood glucose concentration>180 mg/dl
189229|NCT02165553|Hibiscus sabdariffa calyces|hibiscus sabdariffa calyces
189230|NCT02165553|Blood Pressure|blood pressure
189231|NCT02165553|Vascular Function|vascular function
189232|NCT02165553|Inflammation|inflammation
189233|NCT02165553|Cardiometabolic risk markers|cardiometabolic risk markers
189234|NCT02165553|Systemic antioxidant capacity|systemic antioxidant capacity
189235|NCT02165540|Doula|doula
189236|NCT02165540|Pain management|pain management
189237|NCT02165540|Miscarriage|miscarriage
189238|NCT02165540|Abortion|abortion
189239|NCT02165514|spinal curvatures|spinal curvatures
189240|NCT02165488|ketamine|ketamine
189241|NCT02165488|abuse|abuse
189242|NCT02165488|abdominal discomfort|abdominal discomfort
189243|NCT02165488|cholangiopathy|cholangiopathy
189244|NCT02165462|Haemophilia|haemophilia
189245|NCT02165462|Arthropathy|arthropathy
189246|NCT02165462|Bilateral deficit phenomenon|bilateral deficit phenomenon
189247|NCT02165462|Proprioception|proprioception
189248|NCT02165449|ketamine|ketamine
670763|NCT00858351|Relaxation|relaxation
189249|NCT02165449|major depression|major depression
189251|NCT02165449|gene expression|gene expression
189252|NCT02165423|pediatric|pediatric
189253|NCT02165423|solid organ transplant|solid organ transplant
189254|NCT02165423|parents|parents
189255|NCT02165423|heart|heart
189256|NCT02165423|kidney|kidney
189257|NCT02165423|liver|liver
189258|NCT02165410|Autism, mental retardation, Magnetic Resonance Imaging|autism, mental retardation, magnetic resonance imaging
189259|NCT02165397|Ibrutinib|ibrutinib
189260|NCT02165397|Pharmacyclics|pharmacyclics
189261|NCT02165397|PCYC|pcyc
189262|NCT02165397|Lymphoma|lymphoma
189263|NCT02165397|Btk inhibitor|btk inhibitor
189264|NCT02165397|WM|wm
189265|NCT02165397|Rituximab|rituximab
189266|NCT02165397|Rituxan|rituxan
189267|NCT02165397|Waldenström's|waldenström's
189268|NCT02165397|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
189269|NCT02165397|non-Hodgkin lymphoma|non-hodgkin lymphoma
189270|NCT02165397|NHL|nhl
189271|NCT02165384|tympanostomy|tympanostomy
189272|NCT02165384|myringotomy|myringotomy
189274|NCT02165384|ear tubes|ear tubes
189275|NCT02165384|ear infection|ear infection
189276|NCT02165358|BMD|bmd
189277|NCT02165358|LGMD2I|lgmd2i
189278|NCT02165358|Calf enlargement|calf enlargement
189279|NCT02165358|Muscular dystrophy|muscular dystrophy
189280|NCT02165358|MRI|mri
189281|NCT02165306|epilepsy|epilepsy
189282|NCT02165280|Pelvic Organ Prolapse|pelvic organ prolapse
189283|NCT02165280|Surgery|surgery
189284|NCT02165254|physical activity|physical activity
189285|NCT02165254|coronary heart disease|coronary heart disease
189286|NCT02165254|exercise|exercise
189287|NCT02165254|affect|affect
189288|NCT02165254|mind/body therapies|mind/body therapies
189289|NCT02165254|stress, psychological|stress, psychological
189290|NCT02165241|Hypertension|hypertension
189291|NCT02165241|Cardiac remodeling|cardiac remodeling
189292|NCT02165241|Immune system|immune system
189293|NCT02165202|HIV Pre-exposure Prophylaxis;|hiv pre-exposure prophylaxis;
189294|NCT02165202|long-acting injectable;|long-acting injectable;
189295|NCT02165202|HIV PrEP;|hiv prep;
189296|NCT02165202|biomedical HIV prevention research|biomedical hiv prevention research
189297|NCT02165189|Simeprevir|simeprevir
189298|NCT02165189|Sofosbuvir|sofosbuvir
189299|NCT02165189|Ribavirin|ribavirin
189300|NCT02165189|Hepatitits C|hepatitits c
189301|NCT02165189|Hepatitis C virus ribonucleic acid|hepatitis c virus ribonucleic acid
189302|NCT02165176|cannabis|cannabis
189303|NCT02165176|toxicology|toxicology
189304|NCT02165176|intoxication|intoxication
189305|NCT02165150|Elastic Band|elastic band
189306|NCT02165150|Institutional Elders|institutional elders
189307|NCT02165150|Functional Fitness|functional fitness
189308|NCT02165150|Sleep Quality|sleep quality
189309|NCT02165150|Depression|depression
189310|NCT02165137|trauma|trauma
189311|NCT02165137|major trauma|major trauma
189312|NCT02165137|multiple trauma|multiple trauma
189313|NCT02165137|outcome|outcome
189314|NCT02165137|quality|quality
189315|NCT02165137|process Management|process management
189316|NCT02165137|emergency room|emergency room
189317|NCT02165137|trauma center|trauma center
189318|NCT02165124|Obesity|obesity
189319|NCT02165124|Morbid Obesity|morbid obesity
189320|NCT02165124|Bariatric Surgery|bariatric surgery
189321|NCT02165124|Embolization|embolization
189322|NCT02165124|Minimally Invasive|minimally invasive
189323|NCT02165124|Weight Loss|weight loss
189324|NCT02165111|Scleroderma, Systemic|scleroderma, systemic
189325|NCT02165111|Raynaud Disease|raynaud disease
189326|NCT02165111|Botulinum Toxins, Type A|botulinum toxins, type a
189327|NCT02165085|Biomarkers|biomarkers
189328|NCT02165085|Ehlers-Danlos syndrome, vascular type|ehlers-danlos syndrome, vascular type
189329|NCT02165085|Pathophysiology|pathophysiology
189330|NCT02165072|Inferior vena cava|inferior vena cava
189331|NCT02165072|Kidney injury|kidney injury
189332|NCT02165072|Ultrasound|ultrasound
189333|NCT02165059|Nausea|nausea
189334|NCT02165059|Vomiting|vomiting
189335|NCT02165059|Functional dyspepsia|functional dyspepsia
189336|NCT02165059|Bloating|bloating
189337|NCT02165059|Regurgitation|regurgitation
189338|NCT02165059|Retching|retching
189339|NCT02165020|Prostate|prostate
189340|NCT02165020|Hypofractionated radiotherapy|hypofractionated radiotherapy
189341|NCT02165020|Hyaluronic acid|hyaluronic acid
189342|NCT02165020|Spacer|spacer
189343|NCT02165020|Rectum toxicity|rectum toxicity
189344|NCT02165020|Rectal toxicities after hypofractionated irradiation and injection of hyaluronic acid in patients with low- to intermediate-risk Prostate Cancer|rectal toxicities after hypofractionated irradiation and injection of hyaluronic acid in patients with low- to intermediate-risk prostate cancer
189345|NCT02164994|Astigmatism, arcuate incisions, astigmatic keratotomy|astigmatism, arcuate incisions, astigmatic keratotomy
189346|NCT02164968|Device investigation|device investigation
189347|NCT02164955|Pomalidomide|pomalidomide
189348|NCT02164955|Multiple Myeloma|multiple myeloma
189349|NCT02164955|Relapsed, Refractory|relapsed, refractory
189350|NCT02164955|Observational|observational
189351|NCT02164955|Imnovid|imnovid
189352|NCT02164955|Registry|registry
189353|NCT02164955|Post-approval|post-approval
189354|NCT02164955|Safety|safety
189355|NCT02164929|TAP block|tap block
189356|NCT02164929|Paravertebral block|paravertebral block
189357|NCT02164929|Epidural|epidural
189358|NCT02164929|Laparoscopic colectomy|laparoscopic colectomy
189359|NCT02164916|BRAF Mutant|braf mutant
189360|NCT02164916|Metastatic|metastatic
189361|NCT02164903|Quality of Life|quality of life
189362|NCT02164903|Chronic Myeloid Leukemia|chronic myeloid leukemia
189363|NCT02164903|Imatinib|imatinib
180339|NCT02208713|FSHD muscle derived stem cell adipose derived mesenchymal stem cell intramuscular injection|fshd muscle derived stem cell adipose derived mesenchymal stem cell intramuscular injection
180340|NCT02208687|Social Participation|social participation
180341|NCT02208687|Fatigue|fatigue
180413|NCT02208466|TMS|tms
189364|NCT02164903|Dasatinib|dasatinib
189365|NCT02164877|Dietary fiber|dietary fiber
189366|NCT02164851|shock, emergencies, inflammation, infection|shock, emergencies, inflammation, infection
189367|NCT02164851|pathologic process|pathologic process
189368|NCT02164799|Shock|shock
189369|NCT02164799|Predicting diagnosis|predicting diagnosis
189370|NCT02164799|Predicting adverse outcomes|predicting adverse outcomes
189371|NCT02164786|Acute severe disease|acute severe disease
189372|NCT02164786|Intensive care unit|intensive care unit
189373|NCT02164786|adult|adult
189374|NCT02164786|cohort study|cohort study
189375|NCT02164786|metabolomics|metabolomics
189376|NCT02164786|NMR|nmr
189377|NCT02164786|High Performance Liquid Chromatography|high performance liquid chromatography
189378|NCT02164773|sevoflurane|sevoflurane
189379|NCT02164773|pediatric|pediatric
189380|NCT02164773|lower abdominal surgery|lower abdominal surgery
189381|NCT02164773|caudal|caudal
189382|NCT02164773|magnesium sulfate|magnesium sulfate
189383|NCT02164773|Magnesium Sulfate Causing Adverse Effects in Therapeutic Use|magnesium sulfate causing adverse effects in therapeutic use
189384|NCT02164773|Agitation States as Acute Reaction to Exceptional Stress|agitation states as acute reaction to exceptional stress
189385|NCT02164760|burns|burns
189386|NCT02164760|dermal substitute|dermal substitute
189387|NCT02164760|scar quality|scar quality
189388|NCT02164760|reconstruction|reconstruction
189389|NCT02164760|wound healing|wound healing
189390|NCT02164760|wound closure|wound closure
189391|NCT02164734|surfactant|surfactant
189392|NCT02164721|Heart failure|heart failure
189393|NCT02164721|Chemotherapy-induced cardiomyopathy|chemotherapy-induced cardiomyopathy
189394|NCT02164721|Cardiac resynchronization therapy|cardiac resynchronization therapy
189395|NCT02164708|mindfulness meditation, mental health, self-criticism|mindfulness meditation, mental health, self-criticism
189396|NCT02164682|Hypospadias repair|hypospadias repair
189397|NCT02164682|Caudal block|caudal block
189398|NCT02164682|Postoperative complications|postoperative complications
189399|NCT02164669|Inflammation|inflammation
189400|NCT02164669|Coronary artery bypass graft|coronary artery bypass graft
189401|NCT02164669|Magnetic Resonance Imaging|magnetic resonance imaging
189402|NCT02164643|Alzheimer's disease|alzheimer's disease
189403|NCT02164643|Mild Cognitive Impairment|mild cognitive impairment
189404|NCT02164630|Temporomandibular Joint Disorder|temporomandibular joint disorder
189405|NCT02164630|TMD|tmd
189406|NCT02164630|Hope|hope
189407|NCT02164630|Resilience|resilience
189408|NCT02164630|Cognitive Behavior Therapy|cognitive behavior therapy
189409|NCT02164617|Dementia|dementia
189410|NCT02164617|Wheelchair-bound seniors|wheelchair-bound seniors
189411|NCT02164617|Long-term care facilities|long-term care facilities
189412|NCT02164617|Elastic band exercise|elastic band exercise
189413|NCT02164617|Functional fitness|functional fitness
189414|NCT02164617|Daily life function|daily life function
189415|NCT02164617|Depression|depression
189416|NCT02164617|Problem behaviors|problem behaviors
189417|NCT02164604|ranibizumab|ranibizumab
189418|NCT02164604|intravitreal therapy|intravitreal therapy
189420|NCT02164604|Plus disease|plus disease
189421|NCT02164604|stage 3 plus|stage 3 plus
189422|NCT02164591|gastroparesis|gastroparesis
189423|NCT02164591|gastric electrical stimulator|gastric electrical stimulator
189424|NCT02164591|GES|ges
189425|NCT02164591|vomiting|vomiting
189426|NCT02164591|nausea|nausea
189427|NCT02164591|bloating|bloating
189428|NCT02164591|postprandial fullness|postprandial fullness
189429|NCT02164591|epigastric pain|epigastric pain
189430|NCT02164552|PCOS|pcos
189431|NCT02164552|vitamin D|vitamin d
189432|NCT02164552|insulin resistance|insulin resistance
189433|NCT02164552|glycemic control|glycemic control
189434|NCT02164539|GSK573719|gsk573719
189435|NCT02164539|asthma|asthma
189436|NCT02164539|UMEC|umec
189437|NCT02164539|FF|ff
189438|NCT02164539|GSK2829332|gsk2829332
189439|NCT02164539|persistent obstruction|persistent obstruction
189440|NCT02164539|GW685698|gw685698
189441|NCT02164539|Fluticasone Furoate|fluticasone furoate
189442|NCT02164539|COPD|copd
189443|NCT02164539|umeclidinium bromide|umeclidinium bromide
189444|NCT02164526|Pulmonary Hypertension|pulmonary hypertension
189445|NCT02164526|Left Heart Disease|left heart disease
189446|NCT02164526|Heart failure|heart failure
189447|NCT02164526|Registry|registry
189448|NCT02164526|China|china
189449|NCT02164513|COPD|copd
189450|NCT02164513|umeclidinium|umeclidinium
189451|NCT02164513|fluticasone furoate|fluticasone furoate
189452|NCT02164513|vilanterol|vilanterol
189453|NCT02164513|triple therapy|triple therapy
189454|NCT02164513|exacerbation|exacerbation
189455|NCT02164487|B1 adolescents Eating disorders Thaimine|b1 adolescents eating disorders thaimine
189456|NCT02164461|Adenocarcinoma|adenocarcinoma
189457|NCT02164461|Carcinoma|carcinoma
189458|NCT02164461|Carcinoma, Squamous Cell|carcinoma, squamous cell
189459|NCT02164461|Uterine Cervical Neoplasms|uterine cervical neoplasms
189460|NCT02164461|Small Cell Lung Carcinoma|small cell lung carcinoma
189461|NCT02164461|Carcinoma, Small Cell|carcinoma, small cell
189462|NCT02164461|Carcinoma, Adenosquamous|carcinoma, adenosquamous
189463|NCT02164461|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
189464|NCT02164461|Neoplasms by Histologic Type|neoplasms by histologic type
189465|NCT02164461|Neoplasms|neoplasms
189466|NCT02164461|Neoplasms, Squamous Cell|neoplasms, squamous cell
189467|NCT02164461|Uterine Neoplasms|uterine neoplasms
189468|NCT02164461|Genital Neoplasms, Female|genital neoplasms, female
189469|NCT02164461|Urogenital Neoplasms|urogenital neoplasms
189470|NCT02164461|Neoplasms by Site|neoplasms by site
189471|NCT02164461|Uterine Cervical Diseases|uterine cervical diseases
189472|NCT02164461|Uterine Diseases|uterine diseases
189473|NCT02164461|Genital Diseases, Female|genital diseases, female
189474|NCT02164448|dexmedetomidine|dexmedetomidine
189475|NCT02164448|postoperative bowel movement|postoperative bowel movement
189476|NCT02164448|laparoscopic gastrectomy|laparoscopic gastrectomy
189477|NCT02164435|Uncontrolled hypertension|uncontrolled hypertension
189478|NCT02164435|Renal denervation|renal denervation
189479|NCT02164435|Renal artery|renal artery
189480|NCT02164422|Alcohol|alcohol
189481|NCT02164422|Drinkers|drinkers
189482|NCT02164422|Guanfacine|guanfacine
189483|NCT02164383|Smoking Cessation|smoking cessation
189484|NCT02164383|Smoking|smoking
189485|NCT02164383|Nicotine|nicotine
189486|NCT02164357|Ischaemic Stroke|ischaemic stroke
189487|NCT02164357|Main artery occlusion|main artery occlusion
189488|NCT02164357|Endovascular treatment|endovascular treatment
189489|NCT02164357|Intravenous Thrombolytic Therapy|intravenous thrombolytic therapy
189490|NCT02164344|HIV|hiv
189491|NCT02164344|Gut|gut
189492|NCT02164344|probiotics|probiotics
189493|NCT02164344|immune activation|immune activation
189494|NCT02164305|Rotator cuff muscle|rotator cuff muscle
189495|NCT02164305|Excitability|excitability
189496|NCT02164305|Proprioception|proprioception
189498|NCT02164305|Muscle activity|muscle activity
189499|NCT02164305|Electromyography|electromyography
189500|NCT02164292|Liver tumor|liver tumor
189501|NCT02164292|ALPPS|alpps
189502|NCT02164292|Two-stage hepatectomy|two-stage hepatectomy
189503|NCT02164292|Morbidity|morbidity
189504|NCT02164292|Hypertrophy|hypertrophy
189505|NCT02164279|Microalbuminuria|microalbuminuria
189506|NCT02164279|diabetic nephropathy|diabetic nephropathy
189507|NCT02164279|type I diabetes|type i diabetes
189508|NCT02164279|early predictive urinary biomarkers|early predictive urinary biomarkers
189509|NCT02164240|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
189510|NCT02164227|anxiety|anxiety
189511|NCT02164227|breathing exercise|breathing exercise
189512|NCT02164227|labour|labour
189513|NCT02164201|Type A Aortic Dissection (where the use of BioFoam is limited to the anastomotic site)|type a aortic dissection (where the use of biofoam is limited to the anastomotic site)
189515|NCT02164188|Well-being|well-being
189516|NCT02164188|Functional magnetic resonance imaging|functional magnetic resonance imaging
189517|NCT02164188|Positive psychology|positive psychology
189518|NCT02164175|HeRO Graft|hero graft
189519|NCT02164162|Parkinson's disease, Lokomat, gait training, rehabilitation.|parkinson's disease, lokomat, gait training, rehabilitation.
189520|NCT02164149|Colon cancer|colon cancer
189521|NCT02164149|Quality of surgery|quality of surgery
189522|NCT02164149|Length of tumour feeding artery|length of tumour feeding artery
189523|NCT02164123|Autonomic effects|autonomic effects
189524|NCT02164123|spinal mobilization|spinal mobilization
189525|NCT02164123|clinical trial|clinical trial
189526|NCT02164097|ICE|ice
189527|NCT02164097|ODSH|odsh
189528|NCT02164097|platelet recovery|platelet recovery
189529|NCT02164097|recurrent solid tumor|recurrent solid tumor
189530|NCT02164084|acne|acne
189531|NCT02164071|Haematological malignancy|haematological malignancy
189532|NCT02164071|Elderly|elderly
189533|NCT02164071|Health Status|health status
189534|NCT02164071|Scale validation|scale validation
189535|NCT02164058|Myocardial infarction|myocardial infarction
189536|NCT02164058|STEMI|stemi
189537|NCT02164058|ST elevation MI|st elevation mi
189538|NCT02164058|Acute MI|acute mi
189539|NCT02164019|Pathologic Fractures|pathologic fractures
189540|NCT02164019|hip replacements|hip replacements
189541|NCT02164019|12-287|12-287
189542|NCT02164006|Hodgkin's|hodgkin's
189543|NCT02163980|dexmedetomidine|dexmedetomidine
670764|NCT00858351|Diabetic|diabetic
189557|NCT02163941|PTSD|ptsd
189558|NCT02163941|empathy|empathy
189559|NCT02163941|meditation|meditation
189560|NCT02163941|compassion|compassion
189561|NCT02163941|inflammation|inflammation
189562|NCT02163941|oxytocin|oxytocin
189563|NCT02163941|fMRI|fmri
189564|NCT02163928|Antioxidants|antioxidants
189565|NCT02163928|Carotenoids|carotenoids
189566|NCT02163928|Diet|diet
189567|NCT02163915|Drug therapy|drug therapy
189568|NCT02163889|Candida|candida
189569|NCT02163889|Blood culture|blood culture
189570|NCT02163889|Antifungal therapy|antifungal therapy
189571|NCT02163889|Sepsis|sepsis
189572|NCT02163876|spine|spine
189573|NCT02163876|injury|injury
189574|NCT02163876|trauma|trauma
189575|NCT02163876|spine injury|spine injury
189576|NCT02163876|cervical spine injury|cervical spine injury
189577|NCT02163876|cervical spine|cervical spine
189578|NCT02163876|stemcells transplantation|stemcells transplantation
189579|NCT02163863|Peripheral arterial disease (PAD)|peripheral arterial disease (pad)
189580|NCT02163863|Peripheral vascular disease (PVD)|peripheral vascular disease (pvd)
189581|NCT02163863|Biomimetic stent|biomimetic stent
189582|NCT02163863|Helical centerline|helical centerline
189583|NCT02163837|sleep quality|sleep quality
189585|NCT02163837|daytime sleepiness|daytime sleepiness
189586|NCT02163837|actigraphy|actigraphy
189587|NCT02163837|quality of life|quality of life
189588|NCT02163824|postsurgical|postsurgical
189589|NCT02163824|postoperative|postoperative
189590|NCT02163824|ocular|ocular
189591|NCT02163824|cataract|cataract
189592|NCT02163824|inflammation|inflammation
189593|NCT02163824|pain|pain
189594|NCT02163824|corticosteroid|corticosteroid
189595|NCT02163811|Self-management|self-management
189596|NCT02163811|Functional status|functional status
189597|NCT02163811|Depression|depression
189598|NCT02163798|Tai Chi|tai chi
189599|NCT02163798|Walking|walking
189600|NCT02163798|Physical activity|physical activity
189601|NCT02163798|Randomized controlled trial|randomized controlled trial
189602|NCT02163798|Chinese population|chinese population
189603|NCT02163798|Exercise|exercise
189604|NCT02163798|Body composition|body composition
189605|NCT02163798|Cardiovascular risk factor|cardiovascular risk factor
189606|NCT02163798|Energy expenditure|energy expenditure
189607|NCT02163798|Fitness|fitness
189608|NCT02163798|SF-12|sf-12
189609|NCT02163785|Inferior rectal cancer|inferior rectal cancer
189610|NCT02163785|Abdominoperineal resection|abdominoperineal resection
189611|NCT02163785|Miles operation|miles operation
189612|NCT02163785|Supine Miles operation|supine miles operation
189613|NCT02163785|Prone Miles operation|prone miles operation
189614|NCT02163785|Total mesorectal excision|total mesorectal excision
189615|NCT02163785|Circumferential radial margin|circumferential radial margin
189616|NCT02163746|Hidradenitis suppurativa|hidradenitis suppurativa
189617|NCT02163733|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, EGFR sensitivity mutation, food effect|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, egfr sensitivity mutation, food effect
189618|NCT02163720|ovarian cancer|ovarian cancer
189619|NCT02163720|fallopian tube or primary peritoneal|fallopian tube or primary peritoneal
189620|NCT02163720|relapse|relapse
189621|NCT02163720|platinum-sensitive|platinum-sensitive
189622|NCT02163720|Yondelis®-Caelyx®|yondelis®-caelyx®
189623|NCT02163707|Psilocybin|psilocybin
189624|NCT02163707|Pharmacokinetics|pharmacokinetics
189639|NCT02163668|Yoga|yoga
189640|NCT02163668|Bone turnover markers|bone turnover markers
189641|NCT02163668|Bone strength|bone strength
189642|NCT02163668|Bone mineral density|bone mineral density
189643|NCT02163655|preeclampsia, very high blood pressure, diuretics|preeclampsia, very high blood pressure, diuretics
189644|NCT02163642|Bronchiectasis|bronchiectasis
189645|NCT02163642|Immunity|immunity
189646|NCT02163629|Psychotherapeutic intervention|psychotherapeutic intervention
189647|NCT02163629|stress management|stress management
189648|NCT02163629|cardiac transplantation|cardiac transplantation
189649|NCT02163629|quality of life|quality of life
189650|NCT02163616|Primary postpartum hemorrhage|primary postpartum hemorrhage
189652|NCT02163616|uterine atony|uterine atony
189653|NCT02163616|high fever|high fever
189654|NCT02163616|hyperpyrexia|hyperpyrexia
189655|NCT02163616|shock index|shock index
189656|NCT02163590|Spinal mobilisation|spinal mobilisation
189657|NCT02163590|Pressure pain threshold|pressure pain threshold
189658|NCT02163590|Thoracic spine|thoracic spine
189659|NCT02163577|X-linked hypophosphatemia|x-linked hypophosphatemia
189660|NCT02163577|XLH|xlh
189661|NCT02163577|FGF23|fgf23
189662|NCT02163577|KRN23|krn23
189663|NCT02163564|Adolescent|adolescent
189664|NCT02163564|Depression|depression
189665|NCT02163564|Insomnia|insomnia
189666|NCT02163551|dyspnea|dyspnea
189667|NCT02163551|respiratory sensation|respiratory sensation
189668|NCT02163551|event-related potentials|event-related potentials
189669|NCT02163551|spinal cord injury|spinal cord injury
189670|NCT02163538|energy device|energy device
189671|NCT02163538|laparoscopic|laparoscopic
189672|NCT02163538|hysterectomy|hysterectomy
189673|NCT02163538|enseal|enseal
189674|NCT02163538|ligasure|ligasure
189675|NCT02163538|raw tlx|raw tlx
189676|NCT02163525|Fibroids|fibroids
189677|NCT02163525|Myomas|myomas
189678|NCT02163525|leiomyomata|leiomyomata
189679|NCT02163525|menorrhagia|menorrhagia
189680|NCT02163525|Acessa Procedure|acessa procedure
189681|NCT02163525|Radiofrequency Ablation (RFA)|radiofrequency ablation (rfa)
189682|NCT02163525|GFA|gfa
189683|NCT02163525|Acessa|acessa
189684|NCT02163512|Hepatic cirrhosis|hepatic cirrhosis
189685|NCT02163512|Ascites|ascites
189686|NCT02163512|Beta blockers treatment|beta blockers treatment
189687|NCT02163486|I-gel|i-gel
189688|NCT02163486|oropharyngeal leak pressure|oropharyngeal leak pressure
189689|NCT02163486|head position|head position
189690|NCT02163460|ventral hernia|ventral hernia
189691|NCT02163460|seroma|seroma
189692|NCT02163460|drainage|drainage
189693|NCT02163460|infection|infection
189694|NCT02163447|Chemoprevention|chemoprevention
189695|NCT02163447|Malaria|malaria
189696|NCT02163447|Uganda|uganda
189824|NCT02162862|Physical Illness|physical illness
189697|NCT02163447|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
189698|NCT02163447|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
189700|NCT02163434|nausea|nausea
189701|NCT02163434|vomiting|vomiting
189702|NCT02163434|hyperemesis|hyperemesis
189703|NCT02163434|treatment|treatment
189704|NCT02163434|gabapentin|gabapentin
189705|NCT02163434|metoclopramide|metoclopramide
189706|NCT02163434|safety|safety
189707|NCT02163421|Drug therapy|drug therapy
189708|NCT02163408|MRI|mri
189709|NCT02163408|Plaque Characterization|plaque characterization
189710|NCT02163395|Ceramic implant|ceramic implant
189711|NCT02163382|Nava|nava
189712|NCT02163382|Non Invasive Ventilation|non invasive ventilation
189713|NCT02163356|neuroblastoma|neuroblastoma
189714|NCT02163356|recurrent|recurrent
189715|NCT02163356|resistant|resistant
189716|NCT02163343|Serum metal ion levels|serum metal ion levels
189717|NCT02163343|Cathcart/Corail hemiarthroplasty|cathcart/corail hemiarthroplasty
189718|NCT02163343|Hip replacement|hip replacement
189719|NCT02163291|advanced gastric cancer|advanced gastric cancer
189720|NCT02163291|neoadjuvant chemotherapy|neoadjuvant chemotherapy
189721|NCT02163291|safety|safety
189722|NCT02163291|feasibility|feasibility
189723|NCT02163278|DBPR108|dbpr108
189724|NCT02163278|DPP4|dpp4
189725|NCT02163278|Diabetes|diabetes
189726|NCT02163278|Glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
189727|NCT02163278|Incretins|incretins
189728|NCT02163239|FloShield|floshield
189729|NCT02163239|MID|mid
189730|NCT02163239|Minimally invasive surgery|minimally invasive surgery
189731|NCT02163239|Minimally Invasive devices|minimally invasive devices
189732|NCT02163239|Robot-assisted Laparoscopic Surgery|robot-assisted laparoscopic surgery
189733|NCT02163239|Single-site Laparoscopic Surgery|single-site laparoscopic surgery
189734|NCT02163239|Single Incision Laparoscopic Surgery|single incision laparoscopic surgery
189735|NCT02163239|Cannula|cannula
189736|NCT02163239|Blunt Obturator|blunt obturator
189737|NCT02163239|Cholecystectomy|cholecystectomy
189738|NCT02163239|Benign hysterectomy|benign hysterectomy
189739|NCT02163239|Salpingo-oophorectomy|salpingo-oophorectomy
189740|NCT02163226|Bone metastases|bone metastases
189741|NCT02163226|Hypofractionated Radiation Therapy|hypofractionated radiation therapy
189742|NCT02163226|Standard Radiation Therapy|standard radiation therapy
189743|NCT02163226|XRT|xrt
189744|NCT02163226|Pain control|pain control
189745|NCT02163226|Palliation of symptoms|palliation of symptoms
189746|NCT02163226|Questionnaire|questionnaire
189747|NCT02163226|Survey|survey
189748|NCT02163213|diarrhea|diarrhea
189749|NCT02163213|irritable bowel syndrome|irritable bowel syndrome
189750|NCT02163200|Bedsores|bedsores
189751|NCT02163200|pressure|pressure
189753|NCT02163187|Neuromodulation (SNM)|neuromodulation (snm)
189754|NCT02163187|sphincter preservation|sphincter preservation
189755|NCT02163187|rectal polyp|rectal polyp
189756|NCT02163187|InterStimTM|interstimtm
189757|NCT02163187|14-100|14-100
189758|NCT02163174|neonatal|neonatal
189759|NCT02163174|pentoxifylline|pentoxifylline
189760|NCT02163174|randomized controlled trial|randomized controlled trial
189761|NCT02163161|Phase I|phase i
189762|NCT02163161|Open Label|open label
189763|NCT02163161|Single dose|single dose
189764|NCT02163161|Crossover|crossover
189765|NCT02163161|Bioavailability|bioavailability
189766|NCT02163161|Fasting|fasting
189767|NCT02163161|Fed|fed
189768|NCT02163161|PF-04965842|pf-04965842
189769|NCT02163161|Healthy|healthy
189770|NCT02163122|Cat Allergy|cat allergy
189771|NCT02163122|Feld1|feld1
189772|NCT02163109|Oxygen consumption|oxygen consumption
189773|NCT02163109|Pulmonary gas exchange|pulmonary gas exchange
189774|NCT02163109|Cardiac output|cardiac output
189775|NCT02163070|whey protein|whey protein
189776|NCT02163070|malnutrition|malnutrition
189777|NCT02163070|oxidative stress|oxidative stress
189778|NCT02163070|hemodialysis|hemodialysis
189779|NCT02163057|Head and neck squamous cell cancer|head and neck squamous cell cancer
189780|NCT02163057|Papillomavirus|papillomavirus
231796|NCT01973127|TMS|tms
189781|NCT02163031|heart transplant|heart transplant
189782|NCT02163031|radial approach|radial approach
189783|NCT02163031|catheterization|catheterization
189784|NCT02163005|GDL contrast agent|gdl contrast agent
189785|NCT02162992|Antibodies, Antinuclear|antibodies, antinuclear
189786|NCT02162992|SS-A antigen|ss-a antigen
189787|NCT02162992|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
189788|NCT02162992|Atrioventricular Block|atrioventricular block
189789|NCT02162992|Sudden death|sudden death
189790|NCT02162979|Parkinson's disease|parkinson's disease
189791|NCT02162979|PD|pd
189792|NCT02162979|dyskinesia|dyskinesia
189793|NCT02162979|treatment|treatment
189794|NCT02162979|motor complications|motor complications
189795|NCT02162966|colistin|colistin
189796|NCT02162966|ICU|icu
189797|NCT02162966|critical care|critical care
189798|NCT02162953|eye disease|eye disease
189799|NCT02162953|retinal|retinal
189800|NCT02162953|best1|best1
189801|NCT02162940|low back pain|low back pain
189802|NCT02162940|epidural steroid injection|epidural steroid injection
189804|NCT02162940|quality of life|quality of life
189805|NCT02162927|muscular strength|muscular strength
189806|NCT02162927|muscular endurance|muscular endurance
189807|NCT02162927|muscular power|muscular power
189808|NCT02162927|rowing|rowing
189809|NCT02162927|CrossFit|crossfit
189810|NCT02162927|dietary nitrate|dietary nitrate
189811|NCT02162914|Intra-hepatic|intra-hepatic
189812|NCT02162914|Hilar|hilar
189813|NCT02162914|Locally Advanced|locally advanced
189814|NCT02162914|Non Resectable|non resectable
189815|NCT02162914|Metastatic|metastatic
189816|NCT02162914|Regorafenib|regorafenib
189817|NCT02162914|Placebo|placebo
189818|NCT02162901|Diabetes prevention|diabetes prevention
189819|NCT02162875|Schistosoma mansoni|schistosoma mansoni
189820|NCT02162875|treatment|treatment
189821|NCT02162875|school children|school children
189822|NCT02162875|adults|adults
189823|NCT02162862|Inflammatory Bowel Disease|inflammatory bowel disease
189825|NCT02162862|Wellbutrin|wellbutrin
189826|NCT02162849|Tobacco Use Cessation|tobacco use cessation
189827|NCT02162849|Smoking Cessation|smoking cessation
189828|NCT02162849|Cancer Prevention|cancer prevention
189829|NCT02162849|Behavioral Counseling|behavioral counseling
189830|NCT02162849|Nicotine Replacement Therapy|nicotine replacement therapy
189832|NCT02162849|Nicotine patch|nicotine patch
189833|NCT02162849|Placebo patch|placebo patch
189834|NCT02162849|Placebo pill|placebo pill
189835|NCT02162849|Sugar pill|sugar pill
189836|NCT02162849|Varenicline|varenicline
189837|NCT02162849|Chantix|chantix
189838|NCT02162849|Questionnaires|questionnaires
189839|NCT02162849|Surveys|surveys
189840|NCT02162849|Saliva test|saliva test
189841|NCT02162836|Prostatic Neoplasms, Castration-Resistant|prostatic neoplasms, castration-resistant
189842|NCT02162836|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
189843|NCT02162836|Prostate Cancer|prostate cancer
189844|NCT02162836|Androgen Receptor|androgen receptor
189845|NCT02162836|JNJ-56021927|jnj-56021927
189847|NCT02162810|hypospadias|hypospadias
189848|NCT02162797|HIV|hiv
189849|NCT02162797|AIDS|aids
189850|NCT02162797|zinc|zinc
189851|NCT02162797|zinc supplement|zinc supplement
189852|NCT02162797|immunological deficiency|immunological deficiency
189853|NCT02162771|Advanced Follicular Lymphoma|advanced follicular lymphoma
189854|NCT02162758|Drug therapy|drug therapy
189855|NCT02162745|Bronchiolitis|bronchiolitis
189856|NCT02162745|Normal saline solution|normal saline solution
189857|NCT02162745|Hypertonic solution|hypertonic solution
189858|NCT02162745|Nasal irrigation|nasal irrigation
189859|NCT02162680|local anesthesia|local anesthesia
189860|NCT02162680|intravenous catheter|intravenous catheter
189861|NCT02162654|neuroprotection|neuroprotection
189862|NCT02162654|ischemic preconditioning|ischemic preconditioning
189863|NCT02162654|cerebral aneurysm|cerebral aneurysm
189864|NCT02162628|Pelvic Floor Disorder|pelvic floor disorder
189865|NCT02162628|Pelvic Organ Prolapse|pelvic organ prolapse
189866|NCT02162628|Sexual Dysfunction|sexual dysfunction
189867|NCT02162628|Mesh|mesh
189868|NCT02162628|POP|pop
189869|NCT02162628|Transvaginal|transvaginal
189870|NCT02162628|Total Repair|total repair
189871|NCT02162628|Uterine Prolapse|uterine prolapse
189872|NCT02162628|Cystocele|cystocele
189873|NCT02162628|Rectocele|rectocele
189874|NCT02162628|Enterocele|enterocele
189875|NCT02162628|Vaginal Vault Prolapse|vaginal vault prolapse
189876|NCT02162628|Native Tissue Repair|native tissue repair
189877|NCT02162628|Repair Augmented with Mesh|repair augmented with mesh
189878|NCT02162628|Pathological Conditions, Anatomical|pathological conditions, anatomical
189879|NCT02162628|Exair Prolapse Repair System|exair prolapse repair system
189880|NCT02162628|Vaginal Mesh|vaginal mesh
189881|NCT02162628|Transvaginal Mesh|transvaginal mesh
189882|NCT02162615|Pelvic Floor Disorder|pelvic floor disorder
189883|NCT02162615|Pelvic Organ Prolapse|pelvic organ prolapse
231873|NCT01972737|Vaccine|vaccine
180866|NCT02206360|MRI|mri
189884|NCT02162615|Sexual Dysfunction|sexual dysfunction
189885|NCT02162615|Mesh|mesh
189886|NCT02162615|POP|pop
189887|NCT02162615|Transvaginal|transvaginal
189888|NCT02162615|Anterior|anterior
189889|NCT02162615|Posterior|posterior
189890|NCT02162615|Apical|apical
189891|NCT02162615|Uterine Prolapse|uterine prolapse
189892|NCT02162615|Cystocele|cystocele
189893|NCT02162615|Rectocele|rectocele
189894|NCT02162615|Enterocele|enterocele
189895|NCT02162615|Vaginal Vault Prolapse|vaginal vault prolapse
189896|NCT02162615|Native Tissue Repair|native tissue repair
189897|NCT02162615|Repair Augmented with Mesh|repair augmented with mesh
189898|NCT02162615|Pathological Conditions, Anatomical|pathological conditions, anatomical
189899|NCT02162615|Restorelle Direct Fix|restorelle direct fix
189900|NCT02162615|Vaginal Mesh|vaginal mesh
189901|NCT02162615|Transvaginal Mesh|transvaginal mesh
189902|NCT02162576|asthma|asthma
189903|NCT02162576|asthma control|asthma control
189904|NCT02162576|healthcare utilization costs|healthcare utilization costs
189905|NCT02162576|community hotspots|community hotspots
189906|NCT02162576|public health research|public health research
189907|NCT02162563|Colorectal cancer|colorectal cancer
189908|NCT02162563|Chemotherapy|chemotherapy
189909|NCT02162563|Anti-EGFR|anti-egfr
189910|NCT02162563|Liver metastases|liver metastases
189911|NCT02162563|R0 R1 liver resection|r0 r1 liver resection
189912|NCT02162563|Resectability of liver|resectability of liver
189913|NCT02162563|Liver expert panel|liver expert panel
189914|NCT02162550|Type 2 Diabetes|type 2 diabetes
189915|NCT02162550|Cardiovascular Disease|cardiovascular disease
189916|NCT02162550|Hyperglycemia|hyperglycemia
189917|NCT02162550|Carotid Plaque|carotid plaque
189918|NCT02162550|Endothelial function|endothelial function
189919|NCT02162550|Incretins|incretins
189920|NCT02162550|Atherosclerosis|atherosclerosis
189921|NCT02162537|Strategy|strategy
189922|NCT02162537|Radiotherapy|radiotherapy
189923|NCT02162537|Chemotherapy|chemotherapy
189925|NCT02162524|aerobic exercise|aerobic exercise
189927|NCT02162524|energy balance|energy balance
189928|NCT02162511|Haplocompatible|haplocompatible
189929|NCT02162511|Stem cell transplant|stem cell transplant
189930|NCT02162511|Borderline organ function|borderline organ function
189931|NCT02162511|Alternative donor stem cell transplant|alternative donor stem cell transplant
189932|NCT02162498|Peer support|peer support
189933|NCT02162498|Adherence|adherence
189934|NCT02162498|Exclusive breastfeeding|exclusive breastfeeding
189935|NCT02162498|Early infant diagnosis|early infant diagnosis
189936|NCT02162498|Stigma and disclosure|stigma and disclosure
189937|NCT02162472|videocapillaroscopy, psoriasis, systemic agent|videocapillaroscopy, psoriasis, systemic agent
189938|NCT02162459|Adolescent|adolescent
189939|NCT02162459|supplements|supplements
189940|NCT02162459|strength|strength
189941|NCT02162459|whey protein|whey protein
189942|NCT02162459|bench press strength|bench press strength
189943|NCT02162459|squat strength|squat strength
189944|NCT02162420|severe aplastic anemia|severe aplastic anemia
189945|NCT02162420|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
189946|NCT02162381|Humphrey visual fields|humphrey visual fields
189947|NCT02162381|methylphenidate|methylphenidate
189948|NCT02162381|attention deficit disorder|attention deficit disorder
189949|NCT02162381|MoCa questionnaire|moca questionnaire
585912|NCT00522756|Kidney Failure, Acute|kidney failure, acute
189950|NCT02162368|laryngeal mask, prone position, spine surgery|laryngeal mask, prone position, spine surgery
189951|NCT02162342|upper extremity|upper extremity
189952|NCT02162342|muscle activity|muscle activity
189953|NCT02162342|kinematics|kinematics
189954|NCT02162342|motion capture|motion capture
189955|NCT02162342|Electromyography|electromyography
189956|NCT02162329|Breast Cancer|breast cancer
189957|NCT02162329|Cognitive function|cognitive function
189958|NCT02162329|Questionnaires|questionnaires
189960|NCT02162329|Electroencephalography|electroencephalography
189961|NCT02162329|EEG|eeg
189962|NCT02162329|Magnetic resonance imaging|magnetic resonance imaging
189963|NCT02162329|fMRI|fmri
189964|NCT02162329|Tibetan meditation|tibetan meditation
189965|NCT02162329|Quality of life|quality of life
189966|NCT02162329|QOL|qol
189967|NCT02162303|Atherosclerosis|atherosclerosis
189968|NCT02162303|Vascular|vascular
189969|NCT02162303|Cardiovascular|cardiovascular
189970|NCT02162303|Coronary artery disease|coronary artery disease
189971|NCT02162303|Imaging|imaging
189972|NCT02162303|PET|pet
189973|NCT02162303|Scan|scan
189974|NCT02162303|anti-inflammatory|anti-inflammatory
189975|NCT02162277|To decrease|to decrease
189976|NCT02162277|number|number
189977|NCT02162277|osteoporotic|osteoporotic
189978|NCT02162277|patients in|patients in
189979|NCT02162277|Kami-Ina area|kami-ina area
189980|NCT02162277|Nagano prefecture|nagano prefecture
189981|NCT02162264|Alzheimer's Disease|alzheimer's disease
189982|NCT02162264|donepezil hydrochloride|donepezil hydrochloride
189983|NCT02162251|Alzheimer's Disease|alzheimer's disease
189984|NCT02162251|donepezil hydrochloride|donepezil hydrochloride
189985|NCT02162238|zinc|zinc
189986|NCT02162238|diet|diet
189987|NCT02162238|water|water
189988|NCT02162238|morbidity|morbidity
189989|NCT02162238|growth|growth
189990|NCT02162225|Erythrocyte Deformability|erythrocyte deformability
189991|NCT02162225|Platelet Activation|platelet activation
189992|NCT02162225|Platelet Aggregation|platelet aggregation
189993|NCT02162225|Nitrite|nitrite
189994|NCT02162225|Sickle Cell Anemia|sickle cell anemia
189995|NCT02162225|Diet Therapy|diet therapy
189996|NCT02162199|Antibiotic|antibiotic
189997|NCT02162199|Antibiotic Resistant Bacterial Infection|antibiotic resistant bacterial infection
189998|NCT02162186|Arthroplasty, Replacement, Hip/methods|arthroplasty, replacement, hip/methods
189999|NCT02162186|Hip Joint/physiopathology|hip joint/physiopathology
190000|NCT02162186|Hip Joint/radiography|hip joint/radiography
190001|NCT02162186|Hip Joint/surgery|hip joint/surgery
190002|NCT02162186|Hip Prosthesis|hip prosthesis
190003|NCT02162186|Outcome Assessment (Health Care)|outcome assessment (health care)
190004|NCT02162186|Female|female
190005|NCT02162186|Male|male
190006|NCT02162186|Adult|adult
200997|NCT02112656|Liver Neoplasms|liver neoplasms
190007|NCT02162173|Familial adenomatous polyposis syndrome|familial adenomatous polyposis syndrome
190009|NCT02162173|Ampullary polyp|ampullary polyp
190010|NCT02162173|Narrow band imaging endoscopy|narrow band imaging endoscopy
190011|NCT02162173|Confocal laser endomicroscopy|confocal laser endomicroscopy
190012|NCT02162160|probiotic|probiotic
190013|NCT02162160|post-menopausal|post-menopausal
190014|NCT02162160|atrophic vaginitis|atrophic vaginitis
190015|NCT02162147|patient safety|patient safety
190016|NCT02162147|pediatrics|pediatrics
190017|NCT02162147|emergency medicine|emergency medicine
190018|NCT02162134|cholecystectomy|cholecystectomy
190019|NCT02162134|laparoscopic|laparoscopic
190020|NCT02162134|postoperative|postoperative
190021|NCT02162134|ileus|ileus
190022|NCT02162134|chewing gum|chewing gum
190023|NCT02162095|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
190024|NCT02162095|Coronary artery disease|coronary artery disease
190025|NCT02162095|Coronary calcium score|coronary calcium score
190026|NCT02162043|Glaucoma|glaucoma
190027|NCT02162043|Perimetry|perimetry
190028|NCT02162043|Diagnostic self-evaluation|diagnostic self-evaluation
190029|NCT02162043|Screening|screening
190030|NCT02162043|Visual fields|visual fields
190031|NCT02162017|Acute ischemic stroke|acute ischemic stroke
190032|NCT02162017|Acute intracerebral haemorrhage|acute intracerebral haemorrhage
190033|NCT02162017|Head position|head position
190034|NCT02162017|Lying flat head position|lying flat head position
190035|NCT02162017|Sitting up head position|sitting up head position
190037|NCT02162017|Disability|disability
190038|NCT02162017|Clinical trial|clinical trial
190039|NCT02162004|Type 1 diabetes|type 1 diabetes
190040|NCT02162004|Continuous Glucose Monitoring|continuous glucose monitoring
190041|NCT02162004|Insulin pump|insulin pump
190042|NCT02162004|Sensor-augmented pump|sensor-augmented pump
190043|NCT02162004|Continuous correction of high blood glucose|continuous correction of high blood glucose
190044|NCT02161991|aprepitant|aprepitant
190045|NCT02161991|non-small cell lung cancer|non-small cell lung cancer
190046|NCT02161978|antiangiogenic|antiangiogenic
190047|NCT02161978|cancer|cancer
190048|NCT02161978|vascular|vascular
190049|NCT02161978|biomarker|biomarker
190050|NCT02161978|tyrosine kinase inhibitor|tyrosine kinase inhibitor
190051|NCT02161965|Anticoagulation|anticoagulation
190052|NCT02161965|Coronary and peripheral calcification|coronary and peripheral calcification
190053|NCT02161965|Arterial stiffness|arterial stiffness
190054|NCT02161965|Biomarker|biomarker
190055|NCT02161952|Fibrosis, necroinflammation, hepatitis C chronic|fibrosis, necroinflammation, hepatitis c chronic
190056|NCT02161926|Obesity|obesity
190057|NCT02161926|dietary restrictions|dietary restrictions
190058|NCT02161926|metabolism|metabolism
190059|NCT02161926|nutrition|nutrition
190060|NCT02161926|elderly|elderly
190061|NCT02161874|edentulism|edentulism
190062|NCT02161874|dental implants|dental implants
190063|NCT02161874|clinical study|clinical study
190064|NCT02161874|endosseous|endosseous
190065|NCT02161874|randomized|randomized
190066|NCT02161874|crestal bone level|crestal bone level
190068|NCT02161874|Nanotite Certain|nanotite certain
190069|NCT02161874|Nanotite Certain Prevail|nanotite certain prevail
190070|NCT02161874|Tapered|tapered
190071|NCT02161861|tripeptide FEE|tripeptide fee
190072|NCT02161861|fertilization rates|fertilization rates
190073|NCT02161861|embryos|embryos
190074|NCT02161861|oocytes|oocytes
190075|NCT02161835|Congenital myotonia|congenital myotonia
190076|NCT02161835|Myotonia congenita|myotonia congenita
190077|NCT02161835|Thomsons disease|thomsons disease
190078|NCT02161835|Becker type|becker type
190079|NCT02161835|Training|training
190080|NCT02161835|Exercise|exercise
190081|NCT02161822|locally advanced rectal cancer, neoadjuvant chemoradiation|locally advanced rectal cancer, neoadjuvant chemoradiation
190082|NCT02161809|MVPA|mvpa
190083|NCT02161809|Healthy Eating|healthy eating
190084|NCT02161809|children|children
190085|NCT02161809|childhood obesity|childhood obesity
190086|NCT02161796|Phase 1|phase 1
190087|NCT02161796|FG-4592|fg-4592
190088|NCT02161796|Age/gender comparison|age/gender comparison
190089|NCT02161783|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
190090|NCT02161770|oncology, cancer, neoplasm, anticancer drug, pharmacokinetics, area under curve, AZD9291, solid tumour, mild hepatic impairment, moderate hepatic impairment|oncology, cancer, neoplasm, anticancer drug, pharmacokinetics, area under curve, azd9291, solid tumour, mild hepatic impairment, moderate hepatic impairment
190091|NCT02161757|Asthma|asthma
190092|NCT02161757|Reactive Airways|reactive airways
190093|NCT02161757|Respiratory Tract Disease|respiratory tract disease
190094|NCT02161757|Obstructive Lung Disease|obstructive lung disease
190095|NCT02161757|Lung Diseases|lung diseases
190096|NCT02161744|Adipose derived stem cells|adipose derived stem cells
190097|NCT02161744|Stromal vascular fraction cells|stromal vascular fraction cells
190098|NCT02161744|Pulmonary Function Tests|pulmonary function tests
190099|NCT02161744|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
190100|NCT02161718|Alkermes|alkermes
190101|NCT02161718|Schizophrenia|schizophrenia
190102|NCT02161718|Alcohol Use Disorder|alcohol use disorder
190103|NCT02161718|ALKS 3831|alks 3831
190104|NCT02161705|Immediate breast reconstruction|immediate breast reconstruction
190105|NCT02161705|pain control|pain control
190106|NCT02161705|post mastectomy pain control|post mastectomy pain control
190107|NCT02161679|Antibody drug conjugate|antibody drug conjugate
190108|NCT02161679|IMMU-132|immu-132
190109|NCT02161679|Triple-negative breast cancer|triple-negative breast cancer
190110|NCT02161679|Safety and tolerability|safety and tolerability
190111|NCT02161679|Progression Free Survival (PFS)|progression free survival (pfs)
190112|NCT02161666|Obesity|obesity
190113|NCT02161666|Gastric Bypass|gastric bypass
190114|NCT02161666|Bariatric Surgery|bariatric surgery
190115|NCT02161666|Incretin Function|incretin function
190116|NCT02161666|Islet Function|islet function
190117|NCT02161653|Severe alcoholic hepatitis|severe alcoholic hepatitis
190118|NCT02161653|survival|survival
190119|NCT02161653|oxidative stress|oxidative stress
190120|NCT02161627|spinal cord stimulation|spinal cord stimulation
190121|NCT02161627|automatic control|automatic control
190122|NCT02161614|hormone replacement therapy|hormone replacement therapy
190123|NCT02161614|Dopplervelocimetry|dopplervelocimetry
190124|NCT02161614|Flow-mediated dilation|flow-mediated dilation
190125|NCT02161614|menopause|menopause
190126|NCT02161614|Estradiol valerate|estradiol valerate
190127|NCT02161601|Cricoid pressure|cricoid pressure
190128|NCT02161601|Rapid Sequence Induction|rapid sequence induction
190129|NCT02161562|chronic spontaneous urticaria, CSU, chronic idiopathic urticaria, CIU, hives, angioedema, itch|chronic spontaneous urticaria, csu, chronic idiopathic urticaria, ciu, hives, angioedema, itch
190130|NCT02161523|mast cells, lung cancer, cancer associated fibroblasts (CAF)|mast cells, lung cancer, cancer associated fibroblasts (caf)
190131|NCT02161497|Medical History Taking|medical history taking
190132|NCT02161497|Electronic Health Records|electronic health records
190133|NCT02161497|Pediatrics|pediatrics
190134|NCT02161497|Parents|parents
190135|NCT02161484|Peripheral Nerve Block|peripheral nerve block
190136|NCT02161484|Total Hip Replacement|total hip replacement
190137|NCT02161471|Atria, Heart|atria, heart
190138|NCT02161471|Function, Atrial|function, atrial
190139|NCT02161471|Heart Defects, Congenital|heart defects, congenital
190140|NCT02161471|Cardiovascular Abnormalities|cardiovascular abnormalities
190141|NCT02161471|Congenital Abnormalities|congenital abnormalities
190142|NCT02161471|Tetralogy, Fallot|tetralogy, fallot
190143|NCT02161471|Transposition of Great Arteries|transposition of great arteries
190144|NCT02161471|Coarctation of the Aorta|coarctation of the aorta
190145|NCT02161458|Escitalopram|escitalopram
190146|NCT02161458|Amyloid Beta|amyloid beta
190147|NCT02161458|Cerebrospinal Fluid|cerebrospinal fluid
190148|NCT02161445|impedance|impedance
190149|NCT02161445|pep|pep
190150|NCT02161445|tevg|tevg
190151|NCT02161445|dyspnea|dyspnea
190152|NCT02161445|AHF|ahf
190153|NCT02161445|BNP|bnp
190154|NCT02161419|Small Cell Lung Carcinoma,|small cell lung carcinoma,
190155|NCT02161419|First line|first line
190156|NCT02161419|Extensive disease|extensive disease
190157|NCT02161419|Small cell lung cancer|small cell lung cancer
190158|NCT02161406|Scleroderma|scleroderma
190159|NCT02161393|Physical Activity|physical activity
190160|NCT02161393|Pulmonary Rehabilitation|pulmonary rehabilitation
190161|NCT02161393|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
190162|NCT02161380|Gene therapy|gene therapy
190163|NCT02161380|Mitochondrial Genes|mitochondrial genes
190164|NCT02161380|Leber's|leber's
190165|NCT02161380|AAV2 Viral vectors|aav2 viral vectors
190166|NCT02161367|colorectal surgery|colorectal surgery
190167|NCT02161367|postoperative ileus|postoperative ileus
190168|NCT02161367|simethicone|simethicone
190169|NCT02161367|randomized controlled trial|randomized controlled trial
190170|NCT02161367|double blind|double blind
190171|NCT02161367|pilot study|pilot study
190172|NCT02161367|anti-foaming agent|anti-foaming agent
190173|NCT02161367|abdominal pain|abdominal pain
190174|NCT02161367|abdominal distention|abdominal distention
190175|NCT02161367|nausea vomiting|nausea vomiting
190176|NCT02161367|flatus|flatus
190177|NCT02161367|bowel movement|bowel movement
190178|NCT02161367|placebo|placebo
190179|NCT02161367|postoperative complications|postoperative complications
190180|NCT02161367|polydimethylsiloxane|polydimethylsiloxane
190181|NCT02161367|hydrated silica gel|hydrated silica gel
190182|NCT02161367|gas bubbles|gas bubbles
190183|NCT02161367|intestinal tract|intestinal tract
190184|NCT02161354|Dental Pain|dental pain
190185|NCT02161354|Acute Pain|acute pain
190186|NCT02161354|Mild Pain|mild pain
190187|NCT02161354|Moderate Pain|moderate pain
190188|NCT02161341|Bacterial microbiome|bacterial microbiome
190189|NCT02161341|Gene expression|gene expression
190190|NCT02161315|SAID, Progestogens, nSAID-resistanced, LSBC|said, progestogens, nsaid-resistanced, lsbc
190191|NCT02161302|Endometriosis|endometriosis
190192|NCT02161302|Transcranial Direct Current Stimulation|transcranial direct current stimulation
190193|NCT02161302|tDCS|tdcs
190194|NCT02161302|Near Infrared Spectroscopy|near infrared spectroscopy
190195|NCT02161302|NIRS|nirs
190196|NCT02161302|Chronic Pelvic Pain|chronic pelvic pain
190197|NCT02161289|100 HIV-negagtve MSM|100 hiv-negagtve msm
190198|NCT02161263|LASIK|lasik
190199|NCT02161263|Satisfaction|satisfaction
190200|NCT02161237|Acute rejection|acute rejection
190201|NCT02161237|Advagraf|advagraf
190202|NCT02161237|Renal function|renal function
190203|NCT02161224|Phase 1|phase 1
190204|NCT02161224|FG-4592|fg-4592
190205|NCT02161224|Single dose|single dose
190206|NCT02161224|Moderate hepatic impairment|moderate hepatic impairment
190207|NCT02161211|alcohol|alcohol
190208|NCT02161211|anxiety|anxiety
190209|NCT02161198|Panax ginseng CA|panax ginseng ca
190210|NCT02161198|ginsan|ginsan
190211|NCT02161198|polysaccharide|polysaccharide
190212|NCT02161198|immunity|immunity
190213|NCT02161198|natural killer cell|natural killer cell
190214|NCT02161185|Epilepsy|epilepsy
190215|NCT02161185|seizure cluster|seizure cluster
190216|NCT02161185|acute repetitive seizures|acute repetitive seizures
190218|NCT02161185|intranasal Midazolam|intranasal midazolam
190219|NCT02161185|USL261|usl261
190220|NCT02161185|Upsher-Smith|upsher-smith
190221|NCT02161172|Mild traumatic brain injury|mild traumatic brain injury
190222|NCT02161172|Cognitive outcome|cognitive outcome
190223|NCT02161172|Psychological outcome|psychological outcome
190224|NCT02161133|Veterans|veterans
190225|NCT02161133|neuropsychology|neuropsychology
190226|NCT02161133|fatigue|fatigue
190227|NCT02161133|Chronic Multisymptom Illness|chronic multisymptom illness
190228|NCT02161133|Gulf War Illness|gulf war illness
190229|NCT02161133|behavioral treatment|behavioral treatment
190230|NCT02161120|IBS, irritable bowel syndrome, functional gastrointestinal disorder, diet, bread, rye, FODMAP, microbiota|ibs, irritable bowel syndrome, functional gastrointestinal disorder, diet, bread, rye, fodmap, microbiota
190231|NCT02161107|Grass|grass
190232|NCT02161107|Allergy|allergy
190233|NCT02161107|rhinoconjunctivitis|rhinoconjunctivitis
190234|NCT02161107|rhinitis|rhinitis
190235|NCT02161107|asthma|asthma
190236|NCT02161094|Community management incentives|community management incentives
190237|NCT02161081|Myocardial ischemia|myocardial ischemia
190238|NCT02161081|Coronary artery disease|coronary artery disease
190239|NCT02161081|Myocardial CT perfusion|myocardial ct perfusion
190240|NCT02161081|Modified scan protocol|modified scan protocol
190241|NCT02161081|Diagnostic performance|diagnostic performance
190242|NCT02161081|Radiation dose|radiation dose
190243|NCT02161068|ADPKD|adpkd
190244|NCT02161068|Chart Review|chart review
190245|NCT02161068|PKD Genotyping|pkd genotyping
190246|NCT02161055|Insulin|insulin
190247|NCT02161055|Hyperglycemia|hyperglycemia
190248|NCT02161055|Postoperative Mortality|postoperative mortality
190249|NCT02161055|Intensive insulin therapy|intensive insulin therapy
190250|NCT02161055|Non-intensive insulin therapy|non-intensive insulin therapy
190251|NCT02161055|Brain Injuries|brain injuries
190252|NCT02161055|Wounds and Injuries|wounds and injuries
190253|NCT02161055|Craniocerebral Trauma|craniocerebral trauma
190254|NCT02161055|Trauma, Nervous System|trauma, nervous system
190255|NCT02161042|Blood transfusion|blood transfusion
190256|NCT02161042|Storage Lesion|storage lesion
190257|NCT02161042|Endothelial dysfunction|endothelial dysfunction
190258|NCT02161042|Nitric Oxide|nitric oxide
190259|NCT02161029|Gastric tumor|gastric tumor
190260|NCT02161003|Fecal Incontinence|fecal incontinence
190261|NCT02161003|Posterior Sagittal Ano-rectoplasty|posterior sagittal ano-rectoplasty
190262|NCT02161003|Mesenchymal Stem Cell|mesenchymal stem cell
190263|NCT02160990|Obesity|obesity
190264|NCT02160977|Surgical procedures|surgical procedures
190265|NCT02160977|Minimally invasive|minimally invasive
190266|NCT02160977|Arthroplasty|arthroplasty
190267|NCT02160977|Knee|knee
190268|NCT02160964|Inferior Vena Cava|inferior vena cava
190269|NCT02160951|Multiple Myeloma,|multiple myeloma,
190270|NCT02160951|Phase I,|phase i,
190271|NCT02160951|PIM,|pim,
190272|NCT02160951|Japanese patients,|japanese patients,
190273|NCT02160951|LGH447|lgh447
190274|NCT02160938|microarray|microarray
190275|NCT02160938|prenatal|prenatal
190276|NCT02160938|copy number variant|copy number variant
190277|NCT02160938|CNV|cnv
190278|NCT02160938|microdeletion|microdeletion
190279|NCT02160938|microduplication|microduplication
190280|NCT02160938|genetic|genetic
190281|NCT02160899|High Lipoprotein(a)|high lipoprotein(a)
190282|NCT02160847|children|children
190283|NCT02160847|pediatric obesity|pediatric obesity
190284|NCT02160847|parent training|parent training
190285|NCT02160847|home-based|home-based
190286|NCT02160847|nutrition|nutrition
190287|NCT02160847|physical activity|physical activity
190288|NCT02160847|parent-child interaction|parent-child interaction
190289|NCT02160847|parenting|parenting
190290|NCT02160834|Sedentary behavior|sedentary behavior
190291|NCT02160834|Physical activity|physical activity
190292|NCT02160834|Obesity|obesity
190293|NCT02160834|Mobile health|mobile health
190294|NCT02160834|Smartphone|smartphone
190295|NCT02160834|Time spent sedentary|time spent sedentary
190296|NCT02160821|Transversus Abdominis Plane Block|transversus abdominis plane block
190297|NCT02160821|Caudal Epidural|caudal epidural
190298|NCT02160821|Pediatric Pain control|pediatric pain control
190299|NCT02160821|Pain control for Lower Abdominal Surgery|pain control for lower abdominal surgery
190300|NCT02160795|Periconceptional|periconceptional
190301|NCT02160795|Folic Acid|folic acid
190302|NCT02160795|Leukemia|leukemia
190303|NCT02160795|Childhood Cancer|childhood cancer
190304|NCT02160769|Tear Lipid Thickness|tear lipid thickness
190305|NCT02160769|Pterygium surgery|pterygium surgery
190306|NCT02160756|Healthy|healthy
190307|NCT02160756|JNJ-56021927|jnj-56021927
190308|NCT02160756|JNJ-56142060|jnj-56142060
190309|NCT02160756|ARN-509|arn-509
190310|NCT02160730|Cushings disease|cushings disease
190311|NCT02160730|R-roscovitine|r-roscovitine
190312|NCT02160717|Turner Syndrome|turner syndrome
190313|NCT02160717|Diabetes|diabetes
190314|NCT02160704|Sperm density|sperm density
190315|NCT02160704|Testosterone|testosterone
190316|NCT02160704|Hypogonadism|hypogonadism
190317|NCT02160652|Ureteral Obstruction|ureteral obstruction
190318|NCT02160652|HYDRONEPHROSIS|hydronephrosis
190319|NCT02160652|nephrostomy tube|nephrostomy tube
190320|NCT02160639|diabetes self management education|diabetes self management education
190321|NCT02160639|diabetes self management support|diabetes self management support
190322|NCT02160639|type 2 diabetes|type 2 diabetes
190323|NCT02160626|Seborrheic keratosis|seborrheic keratosis
190324|NCT02160626|A101|a101
190325|NCT02160613|Osteoprotegerin|osteoprotegerin
190326|NCT02160613|Biomarker|biomarker
190327|NCT02160613|Chronic periodontitis|chronic periodontitis
190328|NCT02160613|Open flap debridement|open flap debridement
190329|NCT02160561|mechanical|mechanical
190330|NCT02160561|ventilation|ventilation
190331|NCT02160561|acute|acute
190332|NCT02160561|respiratory|respiratory
190333|NCT02160561|failure|failure
190334|NCT02160548|Organophosphate, insectiside, Salbutamol, Atropine|organophosphate, insectiside, salbutamol, atropine
190335|NCT02160535|Mild Traumatic Brain Injury|mild traumatic brain injury
190336|NCT02160535|Concussion|concussion
190337|NCT02160535|Post Concussive Headache|post concussive headache
190338|NCT02160522|Intubation|intubation
190339|NCT02160522|cuff|cuff
190340|NCT02160522|cuffed|cuffed
190341|NCT02160522|endotracheal|endotracheal
190342|NCT02160522|tube|tube
190343|NCT02160522|pressure|pressure
190344|NCT02160522|pediatric|pediatric
190345|NCT02160522|child|child
190346|NCT02160522|children|children
190347|NCT02160522|emergency|emergency
190348|NCT02160509|real time, ultrasonography, handheld|real time, ultrasonography, handheld
190349|NCT02160496|Weight Loss|weight loss
190350|NCT02160496|Obesity|obesity
190351|NCT02160496|Overweight|overweight
190352|NCT02160496|Diet, Reducing|diet, reducing
190353|NCT02160496|Lipids|lipids
190354|NCT02160483|Chronic pelvic pain|chronic pelvic pain
190355|NCT02160483|Endometriosis|endometriosis
190356|NCT02160457|Cerebral palsy|cerebral palsy
190357|NCT02160457|Instrumented gait analysis|instrumented gait analysis
190358|NCT02160457|Gait Deviation Index|gait deviation index
190360|NCT02160444|Parent Training|parent training
190361|NCT02160444|Anxiety Disorders in Children|anxiety disorders in children
190362|NCT02160431|Children|children
190363|NCT02160431|OCD|ocd
190364|NCT02160431|CBT|cbt
190365|NCT02160431|Neuropsychological profiles|neuropsychological profiles
190366|NCT02160405|Iron levels|iron levels
190367|NCT02160392|HIV|hiv
190368|NCT02160392|female|female
190369|NCT02160392|genital tract|genital tract
190370|NCT02160379|roux-en-Y-gastric bypass|roux-en-y-gastric bypass
190371|NCT02160379|brain responses to food|brain responses to food
190372|NCT02160379|gastrointestinal hormones|gastrointestinal hormones
190373|NCT02160379|bile acids|bile acids
190374|NCT02160366|Advanced Cancers|advanced cancers
190375|NCT02160366|Molecular profiling|molecular profiling
190376|NCT02160366|Biomarker data|biomarker data
190377|NCT02160366|Data analysis|data analysis
190378|NCT02160366|Tumor marker|tumor marker
190379|NCT02160340|Posterior Vitreous Detachment|posterior vitreous detachment
190380|NCT02160340|Vitreomacular Traction|vitreomacular traction
190381|NCT02160340|Vitreous|vitreous
190382|NCT02160314|stress urinary incontinence, SUI, pessary|stress urinary incontinence, sui, pessary
190383|NCT02160301|pain|pain
190384|NCT02160301|postoperative|postoperative
190385|NCT02160301|multimodal|multimodal
190386|NCT02160301|satisfaction|satisfaction
190387|NCT02160301|narcotic|narcotic
190388|NCT02160288|Botox|botox
190389|NCT02160288|obstructed defecation syndrome|obstructed defecation syndrome
190390|NCT02160288|ODS|ods
190391|NCT02160288|Outlet-Type Constipation|outlet-type constipation
190392|NCT02160288|injection|injection
190393|NCT02160275|Artificial pancreas|artificial pancreas
190394|NCT02160275|Bi-hormonal closed loop|bi-hormonal closed loop
190395|NCT02160275|Diabetes Type 1|diabetes type 1
190396|NCT02160249|Schizophrenia|schizophrenia
190397|NCT02160249|Psychotic disorders|psychotic disorders
190398|NCT02160249|Schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder or schizophreniform disorder) using DSM-IV criteria|schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder or schizophreniform disorder) using dsm-iv criteria
190399|NCT02160236|dexketoprofen trometamol|dexketoprofen trometamol
190400|NCT02160236|tenoxicam|tenoxicam
190401|NCT02160236|postoperative pain|postoperative pain
190402|NCT02160223|sugammadex|sugammadex
190403|NCT02160223|neostigmine|neostigmine
190404|NCT02160223|obstructive sleep apnea|obstructive sleep apnea
190405|NCT02160197|Ankle Fractures|ankle fractures
190406|NCT02160197|Fracture Fixation|fracture fixation
190407|NCT02160197|Early Ambulation|early ambulation
190408|NCT02160197|Fracture Healing|fracture healing
190409|NCT02160197|Return to Work|return to work
190410|NCT02160171|Decision Support Algorithm|decision support algorithm
190411|NCT02160171|Neonatal Seizures|neonatal seizures
190412|NCT02160171|EEG|eeg
190413|NCT02160158|Fesoterodine|fesoterodine
190414|NCT02160158|SR3|sr3
190415|NCT02160158|SR4|sr4
190416|NCT02160158|bioavailability|bioavailability
190417|NCT02160158|pharmacokinetics|pharmacokinetics
190418|NCT02160158|sprinkle|sprinkle
190419|NCT02160158|applesauce|applesauce
190420|NCT02160145|Chronic Kidney Disease|chronic kidney disease
190421|NCT02160145|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
190422|NCT02160119|Autism Spectrum Disorders|autism spectrum disorders
190423|NCT02160119|Emotion|emotion
190424|NCT02160119|Attention|attention
190425|NCT02160119|Event-related potential|event-related potential
190426|NCT02160119|Functional neuroimaging|functional neuroimaging
190427|NCT02160119|Diffusion Tensor Imaging|diffusion tensor imaging
190428|NCT02160119|Development|development
190429|NCT02160106|Cancer|cancer
190430|NCT02160106|advanced solid tumors|advanced solid tumors
190431|NCT02160106|metastatic|metastatic
190432|NCT02160106|phase I|phase i
190433|NCT02160106|transforming growth factor beta|transforming growth factor beta
190434|NCT02160106|TGF-β|tgf-β
190435|NCT02160106|first-in-human|first-in-human
190436|NCT02160106|TEW-7197|tew-7197
190437|NCT02160106|activin receptor-like kinase 5|activin receptor-like kinase 5
190438|NCT02160106|ALK5|alk5
190439|NCT02160106|Smad2|smad2
190440|NCT02160106|Smad3|smad3
190441|NCT02160106|phospho-Smad|phospho-smad
190442|NCT02160106|phospho Smad|phospho smad
190443|NCT02160106|psmad|psmad
190444|NCT02160106|serine / threonine kinase inhibitor|serine / threonine kinase inhibitor
190445|NCT02160106|pharmacokinetics|pharmacokinetics
190446|NCT02160106|MedPacto|medpacto
190447|NCT02160106|National OncoVenture|national oncoventure
190448|NCT02160093|sarcopenia|sarcopenia
190449|NCT02160093|frailty|frailty
190450|NCT02160093|chronic disease control|chronic disease control
190451|NCT02160093|aging psychology|aging psychology
190452|NCT02160080|Boceprevir;|boceprevir;
190453|NCT02160080|Liver pre-transplant|liver pre-transplant
190454|NCT02160067|Healthy Volunteers|healthy volunteers
190455|NCT02160067|Pharmacokinetics|pharmacokinetics
190456|NCT02160054|tacrolimus|tacrolimus
190457|NCT02160054|cyclosporine|cyclosporine
190458|NCT02160054|Graceptor®|graceptor®
190459|NCT02160054|kidney transplantation|kidney transplantation
190460|NCT02160041|Solid tumor malignancy|solid tumor malignancy
190461|NCT02160041|hematologic malignancy|hematologic malignancy
190462|NCT02160041|mutation|mutation
190463|NCT02160041|translocations|translocations
190464|NCT02160041|amplifications,|amplifications,
190465|NCT02160041|fusions|fusions
190466|NCT02160041|signature|signature
190467|NCT02160041|FGFR|fgfr
190468|NCT02160041|ligand|ligand
190469|NCT02160041|BGJ398|bgj398
190470|NCT02160028|Information|information
190471|NCT02160028|Pain|pain
190472|NCT02160028|Stress|stress
190473|NCT02160028|Fear|fear
190474|NCT02160028|Placebo analgesia|placebo analgesia
190475|NCT02160002|Incubator Weaning|incubator weaning
190476|NCT02160002|Moderately Preterm Infants|moderately preterm infants
190477|NCT02160002|Growth Velocity|growth velocity
190478|NCT02159976|Helicobacter pylori|helicobacter pylori
190479|NCT02159963|FSHD|fshd
190480|NCT02159963|HIT|hit
190481|NCT02159963|Training|training
190482|NCT02159963|Exercise|exercise
190483|NCT02159963|10-20-30 interval training|10-20-30 interval training
190484|NCT02159937|cancer|cancer
190485|NCT02159937|in vitro|in vitro
190486|NCT02159937|peptides|peptides
190487|NCT02159937|dendritic cells|dendritic cells
190488|NCT02159924|Smartphone measurements|smartphone measurements
190489|NCT02159924|Orientation|orientation
190490|NCT02159924|Range of motion|range of motion
190491|NCT02159924|Median nerve neurodynamic test|median nerve neurodynamic test
190492|NCT02159924|Posture|posture
190493|NCT02159924|Thoracic spine|thoracic spine
190494|NCT02159924|Shoulder girdle|shoulder girdle
190495|NCT02159911|Cervical|cervical
190496|NCT02159911|Hysteroscopy|hysteroscopy
190497|NCT02159911|Misoprostol|misoprostol
190498|NCT02159911|Oral|oral
190499|NCT02159898|Esophageal Cancer|esophageal cancer
190500|NCT02159898|Dysphagia|dysphagia
190501|NCT02159898|Regurgitation|regurgitation
190502|NCT02159885|obstructive sleep apnea|obstructive sleep apnea
190503|NCT02159885|adherence|adherence
190504|NCT02159885|telemedicine|telemedicine
190505|NCT02159885|auto-titrating continuous positive airway pressure|auto-titrating continuous positive airway pressure
190506|NCT02159872|Leukemia|leukemia
190507|NCT02159872|Myelodysplastic Syndrome|myelodysplastic syndrome
190508|NCT02159872|MDS|mds
190509|NCT02159872|Omacetaxine|omacetaxine
190510|NCT02159872|Synribo|synribo
190511|NCT02159872|Homoharringtonine|homoharringtonine
190512|NCT02159859|ertapenem|ertapenem
190513|NCT02159859|pharmacokinetic|pharmacokinetic
190514|NCT02159859|pharmacodynamics|pharmacodynamics
190515|NCT02159859|hemodialysis|hemodialysis
190516|NCT02159859|requires hemodialysis three times a week|requires hemodialysis three times a week
190517|NCT02159846|Herbs|herbs
190518|NCT02159846|Diabetes Mellitus|diabetes mellitus
190519|NCT02159846|HbA1c|hba1c
190520|NCT02159846|Lipid Profile|lipid profile
190521|NCT02159833|Food allergy|food allergy
190522|NCT02159833|Diagnosis|diagnosis
190523|NCT02159807|Pain control|pain control
190524|NCT02159807|labor|labor
190525|NCT02159807|epidural|epidural
190527|NCT02159794|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
190528|NCT02159794|Aortic valve stenosis|aortic valve stenosis
190529|NCT02159794|Severe aortic stenosis|severe aortic stenosis
190530|NCT02159768|tracheal intubation|tracheal intubation
190531|NCT02159742|Adult subjects|adult subjects
190532|NCT02159742|history|history
190533|NCT02159742|treatment|treatment
190534|NCT02159742|photodynamic therapy|photodynamic therapy
190535|NCT02159716|Subjects|subjects
190536|NCT02159703|T1-2 N2 M0,|t1-2 n2 m0,
190537|NCT02159703|stage IVa SCCA|stage iva scca
190538|NCT02159703|oropharynx|oropharynx
190539|NCT02159703|negative for PNI,|negative for pni,
190540|NCT02159703|negative surgical margins|negative surgical margins
190541|NCT02159690|prostate cancer|prostate cancer
190542|NCT02159690|prostatectomy|prostatectomy
190543|NCT02159690|localized prostate cancer|localized prostate cancer
190544|NCT02159677|EIM|eim
190545|NCT02159664|didgeridoo|didgeridoo
190546|NCT02159664|sleep apnea|sleep apnea
190547|NCT02159664|drug induced sleep endoscopy|drug induced sleep endoscopy
190548|NCT02159651|tacrolimus|tacrolimus
190549|NCT02159651|interstitial pneumonia|interstitial pneumonia
190551|NCT02159638|Diabetes Mellitus|diabetes mellitus
190552|NCT02159638|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
190553|NCT02159638|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
190554|NCT02159638|Endocrine System Diseases|endocrine system diseases
190555|NCT02159638|Blood glucose|blood glucose
190556|NCT02159638|Blood Glucose, Self-Monitoring|blood glucose, self-monitoring
190557|NCT02159625|Abdominal Compression Elastic Support|abdominal compression elastic support
190558|NCT02159625|Hemodialysis|hemodialysis
190559|NCT02159625|hypotension|hypotension
190560|NCT02159625|occurrence rate|occurrence rate
190561|NCT02159612|FSHD|fshd
190562|NCT02159612|MRI|mri
190563|NCT02159612|Disease progression|disease progression
190564|NCT02159586|gastroparesis|gastroparesis
190565|NCT02159586|gastric electrical stimulator|gastric electrical stimulator
190566|NCT02159586|GES|ges
190567|NCT02159586|vomiting|vomiting
190568|NCT02159586|nausea|nausea
190569|NCT02159586|bloating|bloating
190570|NCT02159586|postprandial fullness|postprandial fullness
190571|NCT02159586|epigastric pain|epigastric pain
190572|NCT02159547|migraine, emergency department, dexketoprofen, placebo|migraine, emergency department, dexketoprofen, placebo
190573|NCT02159521|deep vein thrombosis|deep vein thrombosis
190574|NCT02159521|post-thrombotic syndrome|post-thrombotic syndrome
190575|NCT02159521|chronic deep vein thrombosis|chronic deep vein thrombosis
181509|NCT02203396|ATG|atg
190576|NCT02159508|nutritional status|nutritional status
190577|NCT02159508|nutritional intervention|nutritional intervention
190578|NCT02159508|handgrip strength|handgrip strength
190579|NCT02159508|patient-generated subjective global assessment|patient-generated subjective global assessment
190580|NCT02159508|chemoradiotherapy|chemoradiotherapy
190581|NCT02159508|survival|survival
190582|NCT02159469|Hypogonadism|hypogonadism
190583|NCT02159469|Testosterone enanthate|testosterone enanthate
190584|NCT02159443|Hu14.18K322A|hu14.18k322a
190585|NCT02159443|Human anti-human antibodies (HAHA)|human anti-human antibodies (haha)
190586|NCT02159443|Pretreatment anti-therapeutic antibodies (PATA)|pretreatment anti-therapeutic antibodies (pata)
190587|NCT02159417|Evolution of the sport, HbA1C, IMC|evolution of the sport, hba1c, imc
190588|NCT02159391|Accident Prevention|accident prevention
190589|NCT02159391|Alcohol Drinking|alcohol drinking
190590|NCT02159391|Substance-Related Disorders|substance-related disorders
190591|NCT02159391|Motivational Interviewing|motivational interviewing
190592|NCT02159391|Adult|adult
190593|NCT02159391|Humans|humans
190594|NCT02159391|Intervention Studies|intervention studies
190595|NCT02159391|Recurrence|recurrence
190596|NCT02159391|Risk Factors|risk factors
190597|NCT02159391|Trauma Centers|trauma centers
190598|NCT02159391|Wounds and Injuries/epidemiology|wounds and injuries/epidemiology
190599|NCT02159391|Wounds and Injuries/etiology*|wounds and injuries/etiology*
190600|NCT02159391|Wounds and Injuries/prevention & control*|wounds and injuries/prevention & control*
190601|NCT02159378|Gestational Diabetes|gestational diabetes
190602|NCT02159378|Fructosamines|fructosamines
190603|NCT02159378|Insulin treatment|insulin treatment
190604|NCT02159339|DNA methylation|dna methylation
190605|NCT02159313|Biological Availability|biological availability
190606|NCT02159300|Fibromyalgia|fibromyalgia
190607|NCT02159300|Pain|pain
190608|NCT02159287|ischemic stroke|ischemic stroke
190609|NCT02159287|atrial fibrillation|atrial fibrillation
190610|NCT02159287|bridging therapy|bridging therapy
190611|NCT02159274|Late symptoms|late symptoms
190612|NCT02159274|Shoulder function|shoulder function
190613|NCT02159274|Cosmetic results|cosmetic results
190614|NCT02159274|EORTC|eortc
190615|NCT02159274|Lymphoedema|lymphoedema
190616|NCT02159261|Personal Satisfaction|personal satisfaction
190617|NCT02159248|pancreatic, gemcitabine, radiation, tolfenamic acid|pancreatic, gemcitabine, radiation, tolfenamic acid
190618|NCT02159235|cadmium|cadmium
190619|NCT02159235|lead|lead
190620|NCT02159235|mercury|mercury
190621|NCT02159235|zinc|zinc
190622|NCT02159235|endostatin|endostatin
190623|NCT02159235|angiostatin|angiostatin
190624|NCT02159235|VEGF|vegf
190625|NCT02159235|CAD|cad
190626|NCT02159235|osteopontin|osteopontin
190627|NCT02159209|Acute Kidney Injury|acute kidney injury
190628|NCT02159209|Adverse Drug Reaction|adverse drug reaction
190629|NCT02159209|Acute Kidney Failure|acute kidney failure
190630|NCT02159209|Kidney|kidney
190631|NCT02159209|Kidneys|kidneys
190632|NCT02159196|mechanical ventilation|mechanical ventilation
190633|NCT02159196|nebulisation|nebulisation
190634|NCT02159196|respiratory failure|respiratory failure
190635|NCT02159170|Use of NGF injection as a model of non-inflammatory neuropathic pain in healthy subjects|use of ngf injection as a model of non-inflammatory neuropathic pain in healthy subjects
190636|NCT02159157|breast cancer, exercise|breast cancer, exercise
190637|NCT02159144|Brown adipose tissue|brown adipose tissue
190638|NCT02159144|Subcutaneous white adipose tissue|subcutaneous white adipose tissue
190639|NCT02159144|White adipose tissue|white adipose tissue
190640|NCT02159131|ethinyl estradiol|ethinyl estradiol
190641|NCT02159131|GSK1265744|gsk1265744
190642|NCT02159131|pharmacokinetics|pharmacokinetics
190643|NCT02159131|oral contraceptive|oral contraceptive
190644|NCT02159131|oral contraceptive containing levonorgestrel and ethinyl estradiol|oral contraceptive containing levonorgestrel and ethinyl estradiol
190645|NCT02159131|levonorgestrel|levonorgestrel
190646|NCT02159118|bone marrow aspiration|bone marrow aspiration
190647|NCT02159118|bone marrow biopsy|bone marrow biopsy
190648|NCT02159118|OnControl|oncontrol
190649|NCT02159118|powered bone marrow aspiration and biopsy device|powered bone marrow aspiration and biopsy device
190650|NCT02159118|standard manual bone marrow aspiration and biopsy device|standard manual bone marrow aspiration and biopsy device
190651|NCT02159105|postpartum hemorrhage|postpartum hemorrhage
190652|NCT02159105|postsurgical bleeding|postsurgical bleeding
190653|NCT02159105|abdominal ultrasound|abdominal ultrasound
190654|NCT02159105|FAST scan|fast scan
190655|NCT02159105|non-invasive hemoglobin measurement|non-invasive hemoglobin measurement
190656|NCT02159092|Waterpipe|waterpipe
190657|NCT02159092|Smoking cessation|smoking cessation
190658|NCT02159092|Contingency management|contingency management
190659|NCT02159092|Dependence|dependence
190660|NCT02159079|Sepsis|sepsis
190661|NCT02159079|Severe Sepsis|severe sepsis
190662|NCT02159079|Septic Shock|septic shock
190663|NCT02159079|Conservative Fluid Management|conservative fluid management
190664|NCT02159079|Fluid Balance|fluid balance
190665|NCT02159079|Fluid Restriction|fluid restriction
190666|NCT02159066|Melanoma|melanoma
190667|NCT02159053|AIN457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection|ain457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection
190668|NCT02159040|Int-2 MDS|int-2 mds
190669|NCT02159027|Human Immunodeficiency Virus|human immunodeficiency virus
190670|NCT02159027|AIDS Dementia Complex|aids dementia complex
190671|NCT02159014|Physical activity intervention|physical activity intervention
190672|NCT02159014|Aerobic dance|aerobic dance
190673|NCT02159014|Nutritional intervention|nutritional intervention
190674|NCT02159014|Online participation|online participation
190675|NCT02159014|Primary Care settings|primary care settings
190676|NCT02159014|General Practice Physical Activity Questionnaire GPPAQ|general practice physical activity questionnaire gppaq
190677|NCT02159014|Qrisk2|qrisk2
190678|NCT02159014|QDS Diabetes|qds diabetes
190679|NCT02159001|clozapine|clozapine
190680|NCT02159001|ECT|ect
190681|NCT02159001|PANSS|panss
190682|NCT02159001|schizoaffective disorder|schizoaffective disorder
190683|NCT02159001|schizophrenia|schizophrenia
190684|NCT02159001|treatment|treatment
190685|NCT02158988|Gastric cancer|gastric cancer
190686|NCT02158988|cancer of the esophagogastric junction|cancer of the esophagogastric junction
190687|NCT02158988|peritoneal carcinomatosis|peritoneal carcinomatosis
190688|NCT02158988|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
190689|NCT02158988|HIPEC|hipec
190690|NCT02158962|Partner abuse|partner abuse
190691|NCT02158962|Abuse African Caribbean women|abuse african caribbean women
190692|NCT02158962|Intimate Partner Violence|intimate partner violence
190693|NCT02158949|alcohol|alcohol
190694|NCT02158949|mHealth|mhealth
190695|NCT02158949|SBIRT|sbirt
190696|NCT02158936|thrombocytopenia|thrombocytopenia
190697|NCT02158936|myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
190698|NCT02158936|thrombopoietin|thrombopoietin
190699|NCT02158936|azacitidine|azacitidine
190700|NCT02158936|Eltrombopag|eltrombopag
190701|NCT02158923|ventilation|ventilation
190702|NCT02158923|lung|lung
190703|NCT02158923|lung complications|lung complications
190704|NCT02158923|postoperative complications|postoperative complications
190705|NCT02158923|perioperative lung protective ventilation|perioperative lung protective ventilation
190706|NCT02158910|Alzheimer's disease|alzheimer's disease
190707|NCT02158884|Major extremity trauma|major extremity trauma
190708|NCT02158884|wounded warriors|wounded warriors
190709|NCT02158884|IDEO|ideo
190710|NCT02158884|return to run|return to run
190711|NCT02158871|Education|education
190712|NCT02158871|Early intervention|early intervention
190713|NCT02158871|Workplace|workplace
190714|NCT02158871|Stigma|stigma
190715|NCT02158871|Mental Health Literacy|mental health literacy
190716|NCT02158858|Phase 1|phase 1
190717|NCT02158858|Oncology|oncology
190718|NCT02158858|BET Inhibitor|bet inhibitor
190719|NCT02158845|endometriosis|endometriosis
190720|NCT02158845|blood coagulation|blood coagulation
190721|NCT02158845|levonorgestrel|levonorgestrel
190722|NCT02158845|GnRH agonist|gnrh agonist
190723|NCT02158845|progesterone-releasing intrauterine device|progesterone-releasing intrauterine device
190724|NCT02158832|Lymphoedema|lymphoedema
190725|NCT02158832|Edema|edema
190726|NCT02158832|Oedema|oedema
190727|NCT02158832|Cancer|cancer
190728|NCT02158832|Breast Cancer|breast cancer
190729|NCT02158819|Visionaire|visionaire
190820|NCT02158416|transfusion|transfusion
190730|NCT02158819|Health Economics|health economics
673433|NCT00862615|Ageing|ageing
190731|NCT02158819|Degenerative arthritis|degenerative arthritis
190732|NCT02158819|total knee arthroplasty|total knee arthroplasty
190733|NCT02158806|Venous ulcer, varicose ulcer, gravitational ulcer, aspirin|venous ulcer, varicose ulcer, gravitational ulcer, aspirin
190734|NCT02158793|face transplant|face transplant
190735|NCT02158793|Craniomaxillofacial Allotransplantation|craniomaxillofacial allotransplantation
190736|NCT02158793|facial disfigurement|facial disfigurement
190737|NCT02158793|facial trauma|facial trauma
190738|NCT02158754|coronary artery disease|coronary artery disease
190739|NCT02158754|gene expression score|gene expression score
190740|NCT02158754|Corus CAD|corus cad
190741|NCT02158754|coronary artery disease diagnosis|coronary artery disease diagnosis
190742|NCT02158754|coronary artery disease economics|coronary artery disease economics
190743|NCT02158741|Self-Management|self-management
190744|NCT02158741|Home Visits|home visits
190745|NCT02158702|Relapsed Myeloma Patients|relapsed myeloma patients
190746|NCT02158702|Relapsed after use of Bortezomib and Lenalidomide|relapsed after use of bortezomib and lenalidomide
190747|NCT02158702|Pomalidomide and Dexamethasone|pomalidomide and dexamethasone
190748|NCT02158702|Efficacy and Safety|efficacy and safety
190749|NCT02158689|Poor responders|poor responders
190750|NCT02158689|letrozole|letrozole
190751|NCT02158689|human menopausal gonadotropin|human menopausal gonadotropin
190752|NCT02158676|Roux-en-y gastric bypass|roux-en-y gastric bypass
190753|NCT02158676|Inflammatory markers|inflammatory markers
190754|NCT02158676|Nutritional status|nutritional status
190755|NCT02158676|Fatty acids|fatty acids
190757|NCT02158676|Prebiotic|prebiotic
190758|NCT02158676|Synbiotic|synbiotic
190759|NCT02158663|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
190760|NCT02158663|TMS|tms
190761|NCT02158663|PTSD|ptsd
190762|NCT02158650|informed consent|informed consent
190763|NCT02158650|video-based|video-based
190764|NCT02158637|PRO-CTCAE|pro-ctcae
190765|NCT02158637|Patient-Reported Outcomes|patient-reported outcomes
190766|NCT02158637|Common Terminology Criteria for Adverse Events|common terminology criteria for adverse events
190767|NCT02158637|Questionnaire|questionnaire
190768|NCT02158637|Adverse Events|adverse events
190769|NCT02158637|Symptoms|symptoms
190770|NCT02158611|Individual Counseling service|individual counseling service
190771|NCT02158611|Group Counseling service|group counseling service
190772|NCT02158585|Lamotrigine|lamotrigine
190773|NCT02158585|Lamictal|lamictal
190774|NCT02158585|Anticonvulsant|anticonvulsant
190775|NCT02158585|Ménière's disease|ménière's disease
190776|NCT02158585|Vertigo attack|vertigo attack
190777|NCT02158585|Dizziness|dizziness
190778|NCT02158585|Vestibular disorder|vestibular disorder
190779|NCT02158572|prevention of pregnancy|prevention of pregnancy
190780|NCT02158546|Major Depressive Disorder|major depressive disorder
190781|NCT02158546|Depression|depression
190782|NCT02158546|Alkermes|alkermes
190783|NCT02158546|ALKS 5461|alks 5461
190784|NCT02158546|Samidorphan|samidorphan
190785|NCT02158533|Major Depressive Disorder|major depressive disorder
190786|NCT02158533|Depression|depression
190787|NCT02158533|Alkermes|alkermes
190788|NCT02158533|ALKS 5461|alks 5461
190789|NCT02158533|Samidorphan|samidorphan
190790|NCT02158507|metastatic|metastatic
190791|NCT02158507|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
190792|NCT02158507|Veliparib|veliparib
190793|NCT02158507|Lapatinib|lapatinib
190794|NCT02158507|estrogen receptor (ER) negative|estrogen receptor (er) negative
190795|NCT02158507|progesterone receptor (PR) negative|progesterone receptor (pr) negative
190796|NCT02158507|human epidermal growth factor receptor 2 (HER-2-Neu) negative|human epidermal growth factor receptor 2 (her-2-neu) negative
190797|NCT02158494|Cranial Nerve Noninvasive Neuromodulation|cranial nerve noninvasive neuromodulation
190798|NCT02158494|Portable Neuromodulation Stimulator (PoNS)|portable neuromodulation stimulator (pons)
190799|NCT02158494|Balance and Gait Training|balance and gait training
190800|NCT02158494|Breathing Awareness Training|breathing awareness training
190801|NCT02158481|Vascular function|vascular function
190802|NCT02158481|Dietary ingredients|dietary ingredients
190803|NCT02158481|Acute glucose load|acute glucose load
190804|NCT02158481|Oxidative stress|oxidative stress
190805|NCT02158468|STEMI, reperfusion, preconditioning, postconditioning, reperfusion injury, myocardial salvage|stemi, reperfusion, preconditioning, postconditioning, reperfusion injury, myocardial salvage
190806|NCT02158455|CABG|cabg
190901|NCT02158026|ICSI|icsi
190807|NCT02158455|Saphenous vein|saphenous vein
190808|NCT02158455|Radial artery|radial artery
190809|NCT02158442|Diabetes|diabetes
190810|NCT02158442|Lower limb infection|lower limb infection
190811|NCT02158442|Significant wound infections|significant wound infections
190812|NCT02158442|Intravenous antibiotics|intravenous antibiotics
190813|NCT02158442|Timentin|timentin
190814|NCT02158429|substance use disorders|substance use disorders
190815|NCT02158429|pregnancy|pregnancy
190816|NCT02158429|maternal attachment|maternal attachment
190817|NCT02158429|paternal attachment|paternal attachment
190818|NCT02158429|three dimensional ultrasound|three dimensional ultrasound
190819|NCT02158416|platelet|platelet
190821|NCT02158416|ThromboLUX|thrombolux
190822|NCT02158416|corrected count increment|corrected count increment
190823|NCT02158416|thrombocytopenic|thrombocytopenic
190824|NCT02158403|HeartMate II|heartmate ii
190825|NCT02158403|heart assist device|heart assist device
190826|NCT02158403|pump thrombosis|pump thrombosis
190827|NCT02158403|hypercoagulable disorder|hypercoagulable disorder
190828|NCT02158403|thrombus|thrombus
190829|NCT02158403|Thoratec Corporation|thoratec corporation
190830|NCT02158390|Down syndrome|down syndrome
190831|NCT02158390|Language intervention|language intervention
190832|NCT02158390|Communication intervention|communication intervention
190833|NCT02158377|Dental implants|dental implants
190834|NCT02158377|Trabecular Metal dental implants|trabecular metal dental implants
190835|NCT02158377|TSV dental implants|tsv dental implants
190836|NCT02158377|Zimmer Dental|zimmer dental
190837|NCT02158377|Implant stability|implant stability
190838|NCT02158377|Implant stability quotient (ISQ)|implant stability quotient (isq)
190839|NCT02158377|Resonance Frequency Analysis (RFA)|resonance frequency analysis (rfa)
190840|NCT02158364|Pharmacological therapy|pharmacological therapy
190841|NCT02158351|Simple steatosis (SS)|simple steatosis (ss)
190842|NCT02158351|Non-alcoholic steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
190843|NCT02158351|Gut microbiota (GM)|gut microbiota (gm)
190844|NCT02158351|Non alcoholic fatty liver disease (NAFLD)|non alcoholic fatty liver disease (nafld)
190845|NCT02158338|asthma|asthma
190846|NCT02158338|maternal bonding|maternal bonding
190847|NCT02158338|maternal bonding disruptions|maternal bonding disruptions
190848|NCT02158338|mother-infant interaction|mother-infant interaction
190849|NCT02158312|neuroplasticity|neuroplasticity
190850|NCT02158273|Alcohol|alcohol
190851|NCT02158273|Relapse|relapse
190852|NCT02158260|Capsule endoscopy|capsule endoscopy
190853|NCT02158260|Patient position changing|patient position changing
190854|NCT02158234|squamous cell carcinoma|squamous cell carcinoma
190855|NCT02158234|head and neck cancer|head and neck cancer
190856|NCT02158234|paranasal sinuses|paranasal sinuses
190857|NCT02158234|nasal cavity|nasal cavity
190858|NCT02158234|nasopharynx|nasopharynx
190859|NCT02158234|oropharynx|oropharynx
190860|NCT02158234|oral cavity|oral cavity
190861|NCT02158234|larynx|larynx
190862|NCT02158234|hypopharynx|hypopharynx
190863|NCT02158234|salivary glands|salivary glands
190864|NCT02158234|cervical lymph nodes|cervical lymph nodes
190865|NCT02158208|before any treatment|before any treatment
190866|NCT02158208|at the diagnosis|at the diagnosis
190867|NCT02158182|Hepatic Encephalopathy|hepatic encephalopathy
190868|NCT02158182|Acute Variceal Bleeding|acute variceal bleeding
190869|NCT02158182|Cirrhosis|cirrhosis
190870|NCT02158130|Physical Inactivity|physical inactivity
190871|NCT02158130|Aerobic Exercise Detraining|aerobic exercise detraining
190872|NCT02158130|Body Weight|body weight
190873|NCT02158130|Energy Expenditure|energy expenditure
190874|NCT02158130|Metabolic Syndrome|metabolic syndrome
190875|NCT02158117|Emergency Treatment|emergency treatment
190876|NCT02158117|Morphine Derivates|morphine derivates
190877|NCT02158117|Heroin|heroin
190878|NCT02158117|Antidotes|antidotes
190879|NCT02158117|Administration, Intranasal|administration, intranasal
190880|NCT02158091|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
190881|NCT02158078|Diabetes Mellitus|diabetes mellitus
190882|NCT02158078|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
190883|NCT02158078|Glucose Metabolism Disorders|glucose metabolism disorders
190884|NCT02158078|Metabolic Diseases|metabolic diseases
190885|NCT02158078|Endocrine System Diseases|endocrine system diseases
190886|NCT02158078|Insulin|insulin
190887|NCT02158078|Continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
190888|NCT02158078|Insulin pumps|insulin pumps
190889|NCT02158065|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
190890|NCT02158065|physical activity|physical activity
190891|NCT02158065|PROactive|proactive
190892|NCT02158065|telecoaching|telecoaching
190893|NCT02158052|HLA matched|hla matched
190894|NCT02158052|bone marrow transplantation|bone marrow transplantation
190895|NCT02158052|kidney transplantation|kidney transplantation
190896|NCT02158039|Intraductal Papillary Mucinous Neoplasm|intraductal papillary mucinous neoplasm
190897|NCT02158039|Mucinous Cystic Neoplasm|mucinous cystic neoplasm
190898|NCT02158039|Endoscopic Ultrasound|endoscopic ultrasound
190899|NCT02158039|Ethanol|ethanol
190900|NCT02158026|Follicular sensitivity index|follicular sensitivity index
190903|NCT02157987|telangietasia hereditary hemorragic|telangietasia hereditary hemorragic
190904|NCT02157987|epistaxis|epistaxis
190905|NCT02157987|safety|safety
190906|NCT02157987|quality of life|quality of life
190907|NCT02157987|bevacizumab|bevacizumab
190908|NCT02157987|spray|spray
190909|NCT02157948|postmenopausal osteoporosis|postmenopausal osteoporosis
190910|NCT02157948|osteoporosis|osteoporosis
190911|NCT02157948|postmenopausal|postmenopausal
190912|NCT02157948|denosumab|denosumab
190913|NCT02157948|women|women
190914|NCT02157935|COPD, turbuhaler, pMDI|copd, turbuhaler, pmdi
190915|NCT02157922|Cystic fibrosis|cystic fibrosis
190916|NCT02157922|mucolytic|mucolytic
190917|NCT02157922|mucociliary clearance|mucociliary clearance
190918|NCT02157922|lung clearance|lung clearance
190919|NCT02157909|Lens fit|lens fit
190920|NCT02157909|contact lenses|contact lenses
190921|NCT02157909|myopia|myopia
190922|NCT02157896|Acute ischemic stroke|acute ischemic stroke
190923|NCT02157896|Vascular endothelial growth factor|vascular endothelial growth factor
190924|NCT02157896|Endostatin|endostatin
190925|NCT02157883|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, intraconazole, EGFR sensitivity mutation|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, intraconazole, egfr sensitivity mutation
190926|NCT02157870|Ovary|ovary
190927|NCT02157870|ovarian cancer|ovarian cancer
190928|NCT02157870|biologic therapy|biologic therapy
190929|NCT02157870|platinum-resistant|platinum-resistant
190930|NCT02157870|platinum-refractory ovarian cancer|platinum-refractory ovarian cancer
190931|NCT02157870|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
190932|NCT02157870|paclitaxel|paclitaxel
190933|NCT02157870|tgDCC-E1A|tgdcc-e1a
190934|NCT02157870|E1A|e1a
190935|NCT02157870|Taxol|taxol
190936|NCT02157857|NSCLC, SCLC, lung cancer, EBUS-TBNA|nsclc, sclc, lung cancer, ebus-tbna
190937|NCT02157844|Obstructive Sleep Apnea|obstructive sleep apnea
190938|NCT02157844|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
190939|NCT02157844|Obesity|obesity
190940|NCT02157844|Hepatic fat metabolism|hepatic fat metabolism
181904|NCT02201641|reversible pulpitis|reversible pulpitis
181905|NCT02201641|periapical radiolucency|periapical radiolucency
181906|NCT02201641|periapical radiographs|periapical radiographs
181907|NCT02201641|cone beam computed tomography|cone beam computed tomography
190941|NCT02157844|fat digestion|fat digestion
190942|NCT02157844|whole body protein synthesis|whole body protein synthesis
190943|NCT02157844|protein digestion|protein digestion
190944|NCT02157844|amino acid metabolism|amino acid metabolism
190945|NCT02157844|adipose tissue fat metabolism|adipose tissue fat metabolism
190946|NCT02157844|lipolysis|lipolysis
190947|NCT02157831|Subjects with Clinical Benefit After a Single Infusion of CP - 870, 893|subjects with clinical benefit after a single infusion of cp - 870, 893
190948|NCT02157805|Meat processes|meat processes
190949|NCT02157805|Amino acids bioavailability|amino acids bioavailability
190950|NCT02157805|Digestion rate|digestion rate
190951|NCT02157805|Protein synthesis|protein synthesis
190952|NCT02157805|Aging|aging
190953|NCT02157805|Sarcopenia|sarcopenia
190954|NCT02157792|Solid Tumor|solid tumor
190955|NCT02157792|Advanced Solid Tumor|advanced solid tumor
190956|NCT02157779|Veterans|veterans
190957|NCT02157779|Anger|anger
190958|NCT02157779|Cognitive Behavioral Therapy|cognitive behavioral therapy
190959|NCT02157779|Treatment|treatment
190960|NCT02157766|Mental Health|mental health
190961|NCT02157766|Asthma|asthma
190962|NCT02157766|Mindfulness|mindfulness
190963|NCT02157766|Compassion|compassion
190964|NCT02157766|Meditation|meditation
190965|NCT02157753|Osteoporotic fracture|osteoporotic fracture
190966|NCT02157753|treatment for osteoporosis|treatment for osteoporosis
190967|NCT02157753|adherence and compliance|adherence and compliance
190968|NCT02157701|Dietary herbs|dietary herbs
190969|NCT02157701|Polyherbal capsule|polyherbal capsule
190970|NCT02157701|Functional exercise capacity|functional exercise capacity
190971|NCT02157701|Joint health|joint health
190972|NCT02157688|folliculitis decalvans|folliculitis decalvans
190973|NCT02157688|Staphylococcus Aureus|staphylococcus aureus
190974|NCT02157688|antibiotics|antibiotics
190975|NCT02157675|Delayed onset muscle soreness|delayed onset muscle soreness
190976|NCT02157675|Muscle damage|muscle damage
190977|NCT02157675|Eccentric exercise|eccentric exercise
190978|NCT02157636|Phase 1|phase 1
190979|NCT02157636|Oncology|oncology
190980|NCT02157636|BET Inhibitor|bet inhibitor
190981|NCT02157623|Basal Cell Nevus Syndrome|basal cell nevus syndrome
190982|NCT02157623|Gorlin's Syndrome|gorlin's syndrome
190983|NCT02157610|Cervical Cancer|cervical cancer
190984|NCT02157610|Cervical Cancer Survivors|cervical cancer survivors
190985|NCT02157610|Smoking Cessation|smoking cessation
190986|NCT02157610|Motivation And Problem-Solving|motivation and problem-solving
190987|NCT02157610|MAPS|maps
190988|NCT02157610|Saliva test|saliva test
190989|NCT02157610|Self help materials|self help materials
190990|NCT02157610|Pamphlets|pamphlets
190991|NCT02157610|Texas Quitline|texas quitline
190992|NCT02157610|Nicotine patch|nicotine patch
190993|NCT02157610|Questionnaires|questionnaires
190994|NCT02157610|Surveys|surveys
190995|NCT02157610|Telephone counseling sessions|telephone counseling sessions
190996|NCT02157571|prulifloxacin|prulifloxacin
190997|NCT02157571|AECB|aecb
190998|NCT02157571|Levofloxacin|levofloxacin
190999|NCT02157545|muscle relaxants|muscle relaxants
191000|NCT02157545|pyridostigmine|pyridostigmine
191001|NCT02157545|pharmacodynamics|pharmacodynamics
191002|NCT02157545|potency|potency
191003|NCT02157532|Severe stroke|severe stroke
191004|NCT02157532|IV tPA|iv tpa
191005|NCT02157532|mechanical thrombectomy|mechanical thrombectomy
191006|NCT02157519|Oral Chemotherapy|oral chemotherapy
191007|NCT02157519|Cancer|cancer
191008|NCT02157506|Acute Heart failure|acute heart failure
191009|NCT02157506|Hemodynamics|hemodynamics
191010|NCT02157506|Pharmacokinetics|pharmacokinetics
191011|NCT02157506|Renal Function|renal function
191012|NCT02157493|American Indian|american indian
191013|NCT02157493|Adolescents|adolescents
191014|NCT02157493|Entrepreneurship|entrepreneurship
191015|NCT02157493|Paraprofessional|paraprofessional
191016|NCT02157493|Life skills|life skills
191017|NCT02157480|glucose profile|glucose profile
191018|NCT02157480|continuous glucose monitoring|continuous glucose monitoring
191019|NCT02157480|electrostimulation|electrostimulation
191020|NCT02157441|Postpartum Hemorrhage|postpartum hemorrhage
191021|NCT02157441|Placenta Previa|placenta previa
191022|NCT02157441|uterine cavity|uterine cavity
191023|NCT02157402|Adolescent|adolescent
191025|NCT02157376|Upper GI bleeding|upper gi bleeding
191026|NCT02157376|Seriously ill patients|seriously ill patients
191027|NCT02157350|Eye Diseases|eye diseases
191028|NCT02157350|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
191029|NCT02157350|Retinal Vessel Geometry|retinal vessel geometry
191030|NCT02157350|Retinal Oxymetry|retinal oxymetry
191031|NCT02157350|Retina Ischemia|retina ischemia
191032|NCT02157350|Panretinal Photocoagulation|panretinal photocoagulation
191033|NCT02157350|Lasers, Semiconductor|lasers, semiconductor
191034|NCT02157350|Fluorescein Angiography|fluorescein angiography
191035|NCT02157337|aortic surgery|aortic surgery
191036|NCT02157337|postoperative acute kidney injury|postoperative acute kidney injury
191037|NCT02157337|statin|statin
191038|NCT02157337|the patient undergoing aortic surgery|the patient undergoing aortic surgery
191039|NCT02157324|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
191041|NCT02157311|HIV-1|hiv-1
191042|NCT02157311|simplification,|simplification,
191043|NCT02157311|treatment discontinuation|treatment discontinuation
191044|NCT02157311|virological success|virological success
191045|NCT02157311|four days a week|four days a week
191046|NCT02157298|Japanese patients with type 2 diabetes with inadequate glycemic control on insulin|japanese patients with type 2 diabetes with inadequate glycemic control on insulin
191047|NCT02157285|Unintended pregnancy in adolescence|unintended pregnancy in adolescence
191048|NCT02157285|LARC|larc
191049|NCT02157285|contraception|contraception
191050|NCT02157272|Antiphospholipid|antiphospholipid
191051|NCT02157272|Syndrome|syndrome
191052|NCT02157272|Rivaroxaban|rivaroxaban
191053|NCT02157272|Warfarin|warfarin
191054|NCT02157272|Thrombosis|thrombosis
191055|NCT02157272|Treatment|treatment
191056|NCT02157246|hypoxia|hypoxia
191057|NCT02157246|rectal cancer|rectal cancer
191058|NCT02157207|antioxidants|antioxidants
191059|NCT02157207|Caucasians|caucasians
191060|NCT02157207|healthy|healthy
191061|NCT02157207|African Americans|african americans
191062|NCT02157207|vascular|vascular
191063|NCT02157207|aging|aging
191064|NCT02157207|racial differences|racial differences
191065|NCT02157181|HCL variant|hcl variant
191066|NCT02157181|HCL relapse|hcl relapse
191067|NCT02157181|Risk stratified|risk stratified
191068|NCT02157168|Affordable Care Act|affordable care act
191069|NCT02157168|Medically underserved minorities|medically underserved minorities
191070|NCT02157168|Community health workers|community health workers
191071|NCT02157168|Health disparities among Mexican origin|health disparities among mexican origin
191072|NCT02157142|Severe aortic stenosis|severe aortic stenosis
191073|NCT02157142|Aortic valve stenosis|aortic valve stenosis
191074|NCT02157142|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
191075|NCT02157129|Tracheostomy|tracheostomy
191076|NCT02157129|inflammation|inflammation
191077|NCT02157129|mucous congestion|mucous congestion
191078|NCT02157129|inhalation therapy|inhalation therapy
191079|NCT02157129|phospholipids|phospholipids
191080|NCT02157116|Dose-Dense Chemotherapy|dose-dense chemotherapy
191081|NCT02157103|GBM|gbm
191082|NCT02157103|Glioblastoma|glioblastoma
191083|NCT02157103|Bevacizumab|bevacizumab
191084|NCT02157103|Avastin|avastin
191085|NCT02157103|Subcutaneous|subcutaneous
191086|NCT02157090|HSL of lips|hsl of lips
191087|NCT02157090|perioral skin|perioral skin
191088|NCT02157090|duration of HSL symptoms not more than three days|duration of hsl symptoms not more than three days
191089|NCT02157090|not acyclovir or other cold sore therapies|not acyclovir or other cold sore therapies
191090|NCT02157077|Eye diseases|eye diseases
191091|NCT02157077|Vision Impairment and Blindness|vision impairment and blindness
191092|NCT02157077|Eyes and Vision|eyes and vision
191093|NCT02157077|Seniors|seniors
191094|NCT02157077|Neovascular Age-Related Macular Degeneration (AMD)|neovascular age-related macular degeneration (amd)
191095|NCT02157077|Retinal Disease|retinal disease
191096|NCT02157038|whiplash|whiplash
191097|NCT02157038|neck pain|neck pain
191098|NCT02157038|chronic pain|chronic pain
191099|NCT02157038|motor vehicle accident|motor vehicle accident
191100|NCT02157038|car accident|car accident
191102|NCT02157038|DNA|dna
191103|NCT02157038|RNA|rna
191104|NCT02157025|Humphrey visual fields|humphrey visual fields
191105|NCT02157025|perimetry|perimetry
191106|NCT02157025|pediatrics|pediatrics
191107|NCT02156973|cardiac computed tomography|cardiac computed tomography
191108|NCT02156973|Image quality|image quality
191109|NCT02156947|Power Doppler sonography|power doppler sonography
191110|NCT02156947|cholecystitis, adhesion|cholecystitis, adhesion
191111|NCT02156934|autologous stress urinary incontinence muscle derived cells|autologous stress urinary incontinence muscle derived cells
191112|NCT02156908|cognitive remediation|cognitive remediation
191113|NCT02156895|Korean PMS of Axitinib|korean pms of axitinib
191114|NCT02156895|Metastatic RCC ; 2nd line only|metastatic rcc ; 2nd line only
191115|NCT02156882|TB|tb
191116|NCT02156882|Tuberculosis|tuberculosis
191117|NCT02156882|MaTuTU - Maputo Tuberculosis Trial Unit|matutu - maputo tuberculosis trial unit
191118|NCT02156882|Clinical Trial Capacity Development|clinical trial capacity development
191119|NCT02156869|Prostate cancer|prostate cancer
191120|NCT02156869|Screening|screening
191121|NCT02156869|Decision aids|decision aids
191122|NCT02156856|hemodynamic monitoring|hemodynamic monitoring
191123|NCT02156856|cardiac output|cardiac output
191124|NCT02156856|cardiac surgery|cardiac surgery
191125|NCT02156843|Diabetic Kidney Disease|diabetic kidney disease
191126|NCT02156843|Nephropathy|nephropathy
182106|NCT02200796|Satiety|satiety
191127|NCT02156843|Diabetic Nephropathy|diabetic nephropathy
191128|NCT02156843|Kidney Disease|kidney disease
191129|NCT02156843|Type 2 Diabetes|type 2 diabetes
191130|NCT02156817|Amplitude integrated electroencephalogram|amplitude integrated electroencephalogram
191131|NCT02156817|Heart rate variability|heart rate variability
191132|NCT02156817|Respiratory rate variability|respiratory rate variability
191133|NCT02156817|Preterm Infants|preterm infants
191134|NCT02156817|Length of Hospital Stay|length of hospital stay
191135|NCT02156791|Seasonal allergic rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
191136|NCT02156791|Grass pollen|grass pollen
191137|NCT02156791|Allergen specific immunotherapy|allergen specific immunotherapy
191138|NCT02156778|Post-Stroke Disease Management|post-stroke disease management
191139|NCT02156778|Post-Stroke Complication|post-stroke complication
191140|NCT02156778|Risk Factor Control|risk factor control
191141|NCT02156778|Quality-of-Life|quality-of-life
191142|NCT02156765|Atrial Fibrillation|atrial fibrillation
191143|NCT02156765|Screening|screening
191144|NCT02156765|Stroke patients|stroke patients
191145|NCT02156739|Liver Neoplasms|liver neoplasms
191146|NCT02156739|Liver lesions|liver lesions
191147|NCT02156739|Benign liver lesions|benign liver lesions
191148|NCT02156739|Malignant liver lesions|malignant liver lesions
191149|NCT02156739|Contrast-Enhanced Magnetic Resonance Imaging|contrast-enhanced magnetic resonance imaging
191150|NCT02156739|MRI|mri
191151|NCT02156739|Gadoxetate|gadoxetate
191152|NCT02156739|Eovist|eovist
191153|NCT02156739|Gadopentetate Dimeglumine|gadopentetate dimeglumine
191154|NCT02156739|Magnevist|magnevist
191155|NCT02156726|chronic lymphocytic leukemia|chronic lymphocytic leukemia
191156|NCT02156726|fludarabine|fludarabine
191157|NCT02156726|rituximab|rituximab
191158|NCT02156726|elderly|elderly
191159|NCT02156726|comorbid|comorbid
191160|NCT02156726|FCR|fcr
191161|NCT02156726|CIRS|cirs
191162|NCT02156713|Hemiparesis|hemiparesis
191163|NCT02156713|Occupational Therapy|occupational therapy
191164|NCT02156700|shear wave elastography|shear wave elastography
191165|NCT02156700|haemangiomas|haemangiomas
191166|NCT02156700|metastases|metastases
191167|NCT02156700|hepatocellular carcinoma|hepatocellular carcinoma
191168|NCT02156700|focal nodular hyperplasia|focal nodular hyperplasia
191169|NCT02156700|cholangiocellular carcinoma|cholangiocellular carcinoma
191170|NCT02156674|Maroteaux-Lamy Syndrome|maroteaux-lamy syndrome
191171|NCT02156674|mucopolysaccharide VI|mucopolysaccharide vi
191172|NCT02156674|MPS VI|mps vi
191313|NCT02155972|CGI|cgi
191173|NCT02156648|Invasive ductal|invasive ductal
191174|NCT02156648|HER2-neu positive|her2-neu positive
191175|NCT02156635|Rehabilitation|rehabilitation
191176|NCT02156635|Direct Current Stimulation|direct current stimulation
191177|NCT02156635|Acute Stroke|acute stroke
191179|NCT02156622|Depression|depression
191180|NCT02156622|Measurement-based care|measurement-based care
191181|NCT02156622|Outcomes|outcomes
191182|NCT02156622|Viral load|viral load
191183|NCT02156609|HeartMate PHP|heartmate php
191184|NCT02156609|HeartMate PHP CE Mark|heartmate php ce mark
191185|NCT02156609|Percutaneous coronary intervention|percutaneous coronary intervention
191186|NCT02156609|PCI|pci
191187|NCT02156609|Percutaneous ventricular assist|percutaneous ventricular assist
191188|NCT02156609|Thoratec Corporation|thoratec corporation
191189|NCT02156596|renal colic|renal colic
191190|NCT02156596|nebulised morphine|nebulised morphine
191191|NCT02156596|Intravenous NSAID|intravenous nsaid
191192|NCT02156583|Ventricular Assist Device|ventricular assist device
191193|NCT02156583|Skeletal Muscle|skeletal muscle
191194|NCT02156583|Frailty|frailty
191195|NCT02156583|Older adults|older adults
191196|NCT02156570|Hepatitis C|hepatitis c
191197|NCT02156570|Acute/early chronic|acute/early chronic
191198|NCT02156570|Recently acquired|recently acquired
585913|NCT00522756|Cardiac Surgical Procedures|cardiac surgical procedures
191199|NCT02156570|Directly acting antiviral therapy|directly acting antiviral therapy
191200|NCT02156570|Sofosbuvir|sofosbuvir
191201|NCT02156570|Ribavirin|ribavirin
191202|NCT02156531|Anxiety|anxiety
191203|NCT02156531|Youth Anxiety|youth anxiety
191204|NCT02156531|CBM|cbm
191205|NCT02156531|Cognitive Bias Modification|cognitive bias modification
191206|NCT02156531|Adolescents|adolescents
191207|NCT02156505|stent|stent
191208|NCT02156505|gastric outlet obstruction|gastric outlet obstruction
191209|NCT02156505|restenosis|restenosis
191210|NCT02156479|CMV|cmv
191211|NCT02156479|T-Track CMV|t-track cmv
191212|NCT02156479|allo-HSCT|allo-hsct
191213|NCT02156479|CMI|cmi
191214|NCT02156466|Psoriasis|psoriasis
191215|NCT02156466|MSB0010841|msb0010841
191216|NCT02156466|Anti-IL17A/F Nanobody|anti-il17a/f nanobody
191217|NCT02156466|M1095|m1095
191218|NCT02156453|Functional recovery|functional recovery
191219|NCT02156453|Total knee arthroplasty|total knee arthroplasty
191220|NCT02156440|Ostearthritis|ostearthritis
191221|NCT02156440|Knee|knee
191222|NCT02156440|SierraSil|sierrasil
191223|NCT02156414|Prostatectomy|prostatectomy
182214|NCT02200328|Flagyl|flagyl
191224|NCT02156414|Extended Lymphadenectomy|extended lymphadenectomy
191225|NCT02156414|Pelvic lymph node dissection|pelvic lymph node dissection
191226|NCT02156414|Prostatic Neoplasm|prostatic neoplasm
191227|NCT02156414|Prospective Studies|prospective studies
191228|NCT02156401|Venous thromboembolism|venous thromboembolism
191229|NCT02156401|Deep vein thrombosis|deep vein thrombosis
191230|NCT02156401|Pulmonary embolism|pulmonary embolism
191231|NCT02156401|Cohort study/epidemiology|cohort study/epidemiology
191232|NCT02156401|Outcome|outcome
191233|NCT02156401|Prognosis|prognosis
191234|NCT02156375|Healthy|healthy
191235|NCT02156375|Ustekinumab|ustekinumab
191236|NCT02156375|STELARA®|stelara®
191237|NCT02156362|Thyroid carcinoma|thyroid carcinoma
191238|NCT02156362|predictive factors|predictive factors
191239|NCT02156362|refractory|refractory
191240|NCT02156362|Differentiated|differentiated
191241|NCT02156362|follicular origin|follicular origin
191242|NCT02156349|Diabetes|diabetes
191243|NCT02156336|Diabetic Peripheral Neuropathic Pain|diabetic peripheral neuropathic pain
191244|NCT02156336|Ranexa|ranexa
191245|NCT02156336|Ranolazine|ranolazine
191246|NCT02156336|Neurology|neurology
191247|NCT02156284|Fear; Thoracic Surgery; Nursing Care; Preoperative Care|fear; thoracic surgery; nursing care; preoperative care
191248|NCT02156271|Insomnia|insomnia
191249|NCT02156258|Imaging|imaging
191250|NCT02156258|Mammography|mammography
191251|NCT02156232|hepatic encephalopathy (HE)|hepatic encephalopathy (he)
191252|NCT02156232|vericeal bleeding|vericeal bleeding
191253|NCT02156232|spontaneous portosystemic shunts (SPSS)|spontaneous portosystemic shunts (spss)
191254|NCT02156232|transjugular intrahepatic portosystemic shunt (TIPS)|transjugular intrahepatic portosystemic shunt (tips)
191255|NCT02156232|embolization|embolization
191256|NCT02156180|exhaled breath|exhaled breath
191257|NCT02156180|volatile organic compounds|volatile organic compounds
191258|NCT02156180|surgery|surgery
191259|NCT02156180|chemotherapy|chemotherapy
191260|NCT02156180|radiotherapy|radiotherapy
191261|NCT02156167|Otosclerosis, cochlear implant, acoustic stimulation|otosclerosis, cochlear implant, acoustic stimulation
191262|NCT02156141|Kennedy's disease|kennedy's disease
191263|NCT02156141|Spinal and bulbar muscular atrophy|spinal and bulbar muscular atrophy
191264|NCT02156141|High Intensity Training|high intensity training
191265|NCT02156141|High Intensity Interval Training|high intensity interval training
191266|NCT02156141|HIT|hit
191267|NCT02156141|HIIT|hiit
191268|NCT02156141|Training|training
191269|NCT02156141|Exercise|exercise
191270|NCT02156141|10-20-30|10-20-30
191271|NCT02156128|Cognitive therapy|cognitive therapy
191272|NCT02156115|Lymphangiomatosis|lymphangiomatosis
191273|NCT02156115|Lymphangiogenesis|lymphangiogenesis
191274|NCT02156115|Smooth Muscle Cell|smooth muscle cell
191275|NCT02156115|Vascular Anomalies|vascular anomalies
191276|NCT02156102|Genetic Disorders|genetic disorders
191277|NCT02156102|Sickle Cell Disease|sickle cell disease
191278|NCT02156102|African American|african american
191279|NCT02156102|Leg Ulcers|leg ulcers
191281|NCT02156089|fMRI|fmri
191282|NCT02156089|Reward Processing|reward processing
191283|NCT02156089|Nutrition|nutrition
191284|NCT02156089|Omega-3 Fatty Acids|omega-3 fatty acids
191285|NCT02156089|ADHD|adhd
191286|NCT02156063|Recurrent Pregnancy Loss|recurrent pregnancy loss
191287|NCT02156063|Recurrent Miscarriage|recurrent miscarriage
191288|NCT02156063|Miscarriage|miscarriage
191289|NCT02156063|Pregnancy Loss|pregnancy loss
191290|NCT02156063|Repeated Pregnancy Loss|repeated pregnancy loss
191291|NCT02156037|Hispanic|hispanic
191292|NCT02156037|clinical decision support|clinical decision support
191293|NCT02156037|diabetes|diabetes
191294|NCT02156037|Hba1c|hba1c
191487|NCT02155192|C0743T12|c0743t12
191295|NCT02156037|psychosocial|psychosocial
191296|NCT02156024|clinical trials|clinical trials
673637|NCT00863356|HemCon|hemcon
191297|NCT02156024|Gastrodia and Uncaria Drink|gastrodia and uncaria drink
191298|NCT02156011|In vivo knee joint kinematics|in vivo knee joint kinematics
191299|NCT02156011|In vivo knee joint loading|in vivo knee joint loading
191300|NCT02156011|Video-fluoroscopy|video-fluoroscopy
191301|NCT02156011|Instrumented implants|instrumented implants
191302|NCT02156011|Optical motion capture|optical motion capture
191303|NCT02156011|Ground reaction forces|ground reaction forces
191304|NCT02156011|Electromyography|electromyography
191305|NCT02155998|prostate adenocarcinoma, locally advanced prostate cancer with high and very high risk of recurrence, adjuvant endocrine treatment, prostate specific antigen|prostate adenocarcinoma, locally advanced prostate cancer with high and very high risk of recurrence, adjuvant endocrine treatment, prostate specific antigen
191306|NCT02155972|Bipolar|bipolar
191307|NCT02155972|Depression|depression
191308|NCT02155972|Probiotic|probiotic
191309|NCT02155972|ALIGN|align
191310|NCT02155972|HAMD|hamd
191311|NCT02155972|STAI|stai
191312|NCT02155972|YMRS|ymrs
191315|NCT02155972|WHOQOL-BREF|whoqol-bref
191316|NCT02155972|C-SSRS|c-ssrs
191317|NCT02155972|TSES|tses
191318|NCT02155959|astigmatism|astigmatism
191319|NCT02155959|cataract|cataract
191320|NCT02155959|toric|toric
191321|NCT02155959|lens|lens
191322|NCT02155946|Aging|aging
191323|NCT02155946|Alzheimer's Disease/Dementia|alzheimer's disease/dementia
191324|NCT02155946|Cognitive Disorders|cognitive disorders
191325|NCT02155946|Imaging|imaging
191326|NCT02155946|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
191327|NCT02155946|Neurology|neurology
191328|NCT02155946|Physical Medicine & Rehabilitation|physical medicine & rehabilitation
191329|NCT02155946|transcranial direct current stimulation|transcranial direct current stimulation
191330|NCT02155920|Ependymoma|ependymoma
191331|NCT02155920|Anaplastic Ependymoma|anaplastic ependymoma
191332|NCT02155894|Rheumatoid arthritis, treat to target, telemedicine|rheumatoid arthritis, treat to target, telemedicine
191333|NCT02155881|Drug therapy|drug therapy
191334|NCT02155868|Cerebral near-infrared spectroscopy monitoring|cerebral near-infrared spectroscopy monitoring
191335|NCT02155868|Postoperative complications|postoperative complications
191336|NCT02155868|Cardiac surgery|cardiac surgery
191337|NCT02155855|type 1 diabetes, home glucose monitor, upload, cloud|type 1 diabetes, home glucose monitor, upload, cloud
191338|NCT02155842|exercise therapy|exercise therapy
191339|NCT02155829|PTSD|ptsd
191340|NCT02155829|TBI|tbi
191341|NCT02155829|Riluzole|riluzole
191342|NCT02155829|Rilutek|rilutek
191343|NCT02155829|augmentation|augmentation
191344|NCT02155829|supplement|supplement
191345|NCT02155829|double blinded|double blinded
191346|NCT02155829|clinical trial|clinical trial
191347|NCT02155829|placebo|placebo
191348|NCT02155829|RCT|rct
191349|NCT02155829|Randomized Control Trial|randomized control trial
191350|NCT02155816|inflammation|inflammation
191351|NCT02155816|lipoproteins|lipoproteins
191352|NCT02155816|omega 3|omega 3
191353|NCT02155816|omega 7|omega 7
191354|NCT02155803|Sarcoidosis-Associated Calcium Dysregulation|sarcoidosis-associated calcium dysregulation
191355|NCT02155803|Sarcoidosis-Associated hypercalciuria|sarcoidosis-associated hypercalciuria
191356|NCT02155803|hypercalcemia|hypercalcemia
191357|NCT02155803|hypercalciuria|hypercalciuria
191358|NCT02155803|nephrocalcinosis|nephrocalcinosis
191359|NCT02155803|nephrolithiasis|nephrolithiasis
191360|NCT02155803|interstitial nephritis|interstitial nephritis
191361|NCT02155803|glomerulonephritis|glomerulonephritis
191362|NCT02155803|acute kidney disease|acute kidney disease
191363|NCT02155803|chronic kidney disease|chronic kidney disease
191364|NCT02155790|safety, performance, hypertension, renal denervation|safety, performance, hypertension, renal denervation
191365|NCT02155777|BRCA1|brca1
191366|NCT02155777|BRCA2|brca2
191367|NCT02155777|Risk-reducing surgery|risk-reducing surgery
191372|NCT02155764|socket preservation|socket preservation
191373|NCT02155764|ridge preservation|ridge preservation
191375|NCT02155764|tricalcium phosphate|tricalcium phosphate
191376|NCT02155764|octacalcium phosphate|octacalcium phosphate
191377|NCT02155764|xenograft|xenograft
191378|NCT02155764|bio oss|bio oss
191379|NCT02155751|Obesity prevention|obesity prevention
191380|NCT02155751|Nutrition and exercise in pregnancy|nutrition and exercise in pregnancy
191381|NCT02155751|Postpartum|postpartum
191382|NCT02155751|Maternal obesity risk|maternal obesity risk
191383|NCT02155738|IV acetaminophen|iv acetaminophen
191384|NCT02155738|Postoperative pain|postoperative pain
191385|NCT02155738|Pelvic organ prolapse surgery|pelvic organ prolapse surgery
191386|NCT02155738|Pelvic organ prolapse repair|pelvic organ prolapse repair
191387|NCT02155725|PPH|pph
191388|NCT02155725|fibrinogen|fibrinogen
191389|NCT02155725|vaginal delivery|vaginal delivery
191488|NCT02155192|Psoriasis|psoriasis
585914|NCT00522756|Sodium Bicarbonate|sodium bicarbonate
191396|NCT02155686|Home heath care|home heath care
191397|NCT02155686|Medico-economics|medico-economics
191404|NCT02155647|Carcinoma, Merkel Cell|carcinoma, merkel cell
191406|NCT02155647|avelumab|avelumab
191407|NCT02155647|Bavencio|bavencio
191408|NCT02155647|anti PD-L1|anti pd-l1
191409|NCT02155647|JAVELIN Merkel 200|javelin merkel 200
191410|NCT02155634|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
191411|NCT02155634|Multiple Myeloma|multiple myeloma
191412|NCT02155634|Lenalidomide|lenalidomide
191413|NCT02155634|Revlimid|revlimid
191414|NCT02155634|Phase III|phase iii
191415|NCT02155634|Phase IIIb|phase iiib
191416|NCT02155634|Plasma Cell Dyscrasia|plasma cell dyscrasia
191417|NCT02155621|cancer genomics|cancer genomics
191418|NCT02155621|precision medicine|precision medicine
191419|NCT02155621|metastatic cancer|metastatic cancer
191420|NCT02155621|clinical decision-making|clinical decision-making
191421|NCT02155608|ADHD|adhd
191422|NCT02155608|neuromodulation|neuromodulation
191423|NCT02155608|trigeminal nerve stimulation|trigeminal nerve stimulation
191424|NCT02155608|cognition|cognition
191425|NCT02155582|Solid tumors|solid tumors
191426|NCT02155569|Cesarean, extraperitoneal|cesarean, extraperitoneal
191427|NCT02155569|Cesarean|cesarean
191428|NCT02155569|Pain|pain
402945|NCT01228942|primary peritoneal cancer|primary peritoneal cancer
233864|NCT01964170|ASP3550|asp3550
182479|NCT02199054|Soy|soy
191429|NCT02155517|TCI,Schnider Model, Cortinez Model, BIS, Cardiac Output.|tci,schnider model, cortinez model, bis, cardiac output.
191430|NCT02155504|Healthy volunteers|healthy volunteers
191431|NCT02155504|Pharmacokinetics|pharmacokinetics
191432|NCT02155504|ASP3700|asp3700
191433|NCT02155504|Itraconazole|itraconazole
191434|NCT02155504|Drug-drug interaction|drug-drug interaction
191435|NCT02155491|venous, thromboembolism, embolism, DVT, Pulmonary Embolism, thrombosis|venous, thromboembolism, embolism, dvt, pulmonary embolism, thrombosis
191436|NCT02155465|Ruxolitinib|ruxolitinib
191437|NCT02155465|Erlotinib|erlotinib
191438|NCT02155465|EGFR-mutant|egfr-mutant
191439|NCT02155465|14-043|14-043
191440|NCT02155452|ALA|ala
191441|NCT02155452|Malignant gliomas|malignant gliomas
191442|NCT02155439|Prospective, randomized controlled trial - pilot study|prospective, randomized controlled trial - pilot study
191443|NCT02155413|Acute pain|acute pain
191444|NCT02155413|Audit|audit
191445|NCT02155413|Safety|safety
191446|NCT02155413|Tolerability|tolerability
191447|NCT02155400|perioperative hypothermia|perioperative hypothermia
191448|NCT02155400|thermal compression|thermal compression
191449|NCT02155400|forced air warming|forced air warming
191450|NCT02155387|EVLW|evlw
191451|NCT02155387|EVLWI|evlwi
191452|NCT02155387|PVPI|pvpi
191453|NCT02155387|MICS|mics
191454|NCT02155374|Glucocorticoid induced hyperglycemia, insulin, chemotherapy|glucocorticoid induced hyperglycemia, insulin, chemotherapy
191455|NCT02155361|Diabetes mellitus|diabetes mellitus
191456|NCT02155361|Diabetes complications|diabetes complications
191457|NCT02155361|Pain|pain
191458|NCT02155309|scopolamine|scopolamine
191459|NCT02155309|motion|motion
191460|NCT02155309|sickness|sickness
191461|NCT02155296|positive youth development|positive youth development
191462|NCT02155296|restorative practices|restorative practices
191463|NCT02155296|school climate|school climate
191464|NCT02155296|social competency|social competency
191465|NCT02155283|Chronic Low Back Pain|chronic low back pain
191466|NCT02155283|Mild-to-Moderate Chronic Low Back Pain|mild-to-moderate chronic low back pain
191467|NCT02155283|Continuous Passive Motion Devices|continuous passive motion devices
191468|NCT02155270|Cataract|cataract
191469|NCT02155270|Incision|incision
191470|NCT02155270|Precut|precut
191471|NCT02155270|Corneal|corneal
191472|NCT02155270|OCT|oct
191473|NCT02155270|Intraoperative OCT|intraoperative oct
191476|NCT02155270|Clear corneal incision|clear corneal incision
191477|NCT02155257|Osteoarthritis|osteoarthritis
191478|NCT02155244|CBDS|cbds
191479|NCT02155244|ERCP|ercp
191480|NCT02155244|Dindo-Clavien classification|dindo-clavien classification
191481|NCT02155231|Male with history of anal sex with men or previous participants of the MSM VCT study|male with history of anal sex with men or previous participants of the msm vct study
191482|NCT02155218|Magnetic Resonance Angiography|magnetic resonance angiography
191483|NCT02155218|Contrast Media|contrast media
191484|NCT02155192|CNTO1959PSO2001|cnto1959pso2001
191485|NCT02155192|C0743T08|c0743t08
191486|NCT02155192|C0743T09|c0743t09
191489|NCT02155192|Pharmacogenomics|pharmacogenomics
191490|NCT02155166|Levonorgestrel-releasing intrauterine system|levonorgestrel-releasing intrauterine system
191491|NCT02155166|anesthesia|anesthesia
191492|NCT02155166|pain|pain
191493|NCT02155166|nulliparous|nulliparous
191494|NCT02155140|enteral feeding|enteral feeding
191495|NCT02155140|Discharged|discharged
191496|NCT02155140|surgical resection of an upper gastrointestinal malignancy|surgical resection of an upper gastrointestinal malignancy
191497|NCT02155140|Nutritional supplementation via a jejunostomy|nutritional supplementation via a jejunostomy
191498|NCT02155127|chronic kidney disease|chronic kidney disease
191499|NCT02155127|physical function|physical function
191500|NCT02155114|Hepcidins|hepcidins
191501|NCT02155114|Homeostasis|homeostasis
191502|NCT02155114|Iron/administration & dosage|iron/administration & dosage
191503|NCT02155114|Biological Markers/blood|biological markers/blood
191504|NCT02155101|Efficacy|efficacy
191505|NCT02155101|Safety|safety
191506|NCT02155101|Darunavir|darunavir
191507|NCT02155101|HIV-1 RNA level|hiv-1 rna level
191508|NCT02155101|Cameroon|cameroon
191509|NCT02155088|Locally Advanced|locally advanced
191510|NCT02155088|Metastatic|metastatic
191511|NCT02155088|Recurrent|recurrent
191512|NCT02155088|Pancreas|pancreas
191513|NCT02155075|Breast neoplasm|breast neoplasm
191514|NCT02155075|Breast implants|breast implants
191515|NCT02155075|Mammography|mammography
191516|NCT02155075|Breast imaging|breast imaging
191517|NCT02155075|Imaging augmented breast|imaging augmented breast
191518|NCT02155062|Nutritional biomarker|nutritional biomarker
191519|NCT02155062|Dietary assessment|dietary assessment
191520|NCT02155062|Whole grain|whole grain
191521|NCT02155062|Wheat|wheat
191522|NCT02155062|Rye|rye
191523|NCT02155062|Alkylresorcinol|alkylresorcinol
191524|NCT02155062|Urine|urine
191525|NCT02155049|TED|ted
191526|NCT02155049|Prostaglandin Analogues|prostaglandin analogues
191527|NCT02155036|exercise|exercise
191528|NCT02155036|rehabilitation|rehabilitation
191529|NCT02155036|kidney function|kidney function
191530|NCT02155036|cardiovascular disease risk|cardiovascular disease risk
191531|NCT02155010|Dexmedetomidine|dexmedetomidine
191532|NCT02155010|Spinal anesthesia|spinal anesthesia
191533|NCT02154971|HIV Seropositivity|hiv seropositivity
191534|NCT02154971|Audiometry|audiometry
191535|NCT02154971|Hearing Loss|hearing loss
191536|NCT02154958|Follicular output rate|follicular output rate
191537|NCT02154958|IVF|ivf
191538|NCT02154958|ICSI|icsi
191539|NCT02154932|Myomectomy, Misoprostol|myomectomy, misoprostol
191540|NCT02154906|periodontal disease|periodontal disease
191541|NCT02154906|periodontitis|periodontitis
191542|NCT02154893|Ultrasound|ultrasound
191543|NCT02154893|Laser|laser
191544|NCT02154893|Therapeutic exercise|therapeutic exercise
191545|NCT02154893|Rehabilitation|rehabilitation
191546|NCT02154893|Osteoarthritis|osteoarthritis
191547|NCT02154880|HIV|hiv
191548|NCT02154880|lung|lung
191549|NCT02154880|aging|aging
191550|NCT02154867|IBS-D|ibs-d
191551|NCT02154867|FMT|fmt
191552|NCT02154867|metagenomics|metagenomics
191553|NCT02154867|gut microbiome|gut microbiome
191554|NCT02154854|Renal|renal
191555|NCT02154854|Transplantation|transplantation
191556|NCT02154854|Tacrolimus|tacrolimus
191557|NCT02154854|Arterial stiffness|arterial stiffness
191558|NCT02154854|Vascular fibrose plasma markers|vascular fibrose plasma markers
191559|NCT02154841|Postoperative|postoperative
191560|NCT02154841|nutrition|nutrition
191561|NCT02154841|taste|taste
191562|NCT02154841|perception|perception
191563|NCT02154841|preference|preference
191564|NCT02154841|choice|choice
191565|NCT02154828|Children|children
191566|NCT02154828|aged|aged
191567|NCT02154828|3 to 6 years|3 to 6 years
191568|NCT02154815|End Stage Renal Disease|end stage renal disease
191569|NCT02154815|Renal transplantation|renal transplantation
191570|NCT02154815|Dialysis|dialysis
191571|NCT02154815|Pre-emptive transplantation|pre-emptive transplantation
191572|NCT02154815|Psychological adjustment|psychological adjustment
191573|NCT02154815|Quality of life.|quality of life.
191574|NCT02154776|LEE011,|lee011,
191575|NCT02154776|buparlisib,|buparlisib,
191576|NCT02154776|letrozole,|letrozole,
191577|NCT02154776|HR +,|hr +,
191578|NCT02154776|HER2 - negative,|her2 - negative,
191579|NCT02154776|post-menopausal,|post-menopausal,
191581|NCT02154776|CDK 4/6,|cdk 4/6,
191582|NCT02154776|PI3K,|pi3k,
191583|NCT02154776|MTD|mtd
191584|NCT02154763|Bariatric surgery|bariatric surgery
191585|NCT02154763|Bariatrics|bariatrics
191586|NCT02154763|Local anesthetic|local anesthetic
191587|NCT02154763|Ropivacaine|ropivacaine
191588|NCT02154763|Intraperitoneal|intraperitoneal
191589|NCT02154750|Atrioventricular delay|atrioventricular delay
191590|NCT02154750|AV delay|av delay
191591|NCT02154750|Pacemaker|pacemaker
191592|NCT02154750|Sick Sinus Syndrome|sick sinus syndrome
191593|NCT02154750|Bradycardia|bradycardia
191594|NCT02154750|PR interval|pr interval
191595|NCT02154750|Atrioventricular block|atrioventricular block
191601|NCT02154737|Gemcitabine|gemcitabine
191602|NCT02154737|Gemzar|gemzar
191603|NCT02154737|erlotinib|erlotinib
191604|NCT02154737|Tarceva|tarceva
191605|NCT02154711|mitochondrial disease|mitochondrial disease
191606|NCT02154711|magnetic resonance imaging|magnetic resonance imaging
191607|NCT02154711|magnetic resonance spectroscopy|magnetic resonance spectroscopy
191608|NCT02154711|creatine|creatine
191609|NCT02154711|phosphocreatine|phosphocreatine
191610|NCT02154685|Smoking|smoking
191611|NCT02154685|Nicotine|nicotine
191612|NCT02154685|Addiction|addiction
191613|NCT02154685|Cessation|cessation
191614|NCT02154620|Distal radius fracture|distal radius fracture
191615|NCT02154620|wrist fracture|wrist fracture
191616|NCT02154620|volar plate|volar plate
191617|NCT02154620|surgical treatment|surgical treatment
191618|NCT02154620|plaster immobilisation|plaster immobilisation
191619|NCT02154607|oral lichen planus|oral lichen planus
191620|NCT02154607|recurrence|recurrence
191621|NCT02154607|Treatment|treatment
191622|NCT02154607|cancer|cancer
191623|NCT02154607|Primary disease Management|primary disease management
191624|NCT02154594|Acacia|acacia
191625|NCT02154594|Chlorhexidine|chlorhexidine
191626|NCT02154594|Gingivitis|gingivitis
191627|NCT02154594|Orthodontic appliances.|orthodontic appliances.
191628|NCT02154581|Dental implants|dental implants
191629|NCT02154581|Esthetic score|esthetic score
191630|NCT02154581|Immediate implants|immediate implants
191631|NCT02154581|Gingival biotype|gingival biotype
191632|NCT02154568|Hyperpolarized gas MRI|hyperpolarized gas mri
191633|NCT02154542|Nava|nava
191634|NCT02154542|Mechanical ventilation|mechanical ventilation
191635|NCT02154477|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
191636|NCT02154464|Morphine-sparing|morphine-sparing
191637|NCT02154464|Paracetamol|paracetamol
191638|NCT02154464|Obesity|obesity
191639|NCT02154464|Gastric banding|gastric banding
191645|NCT02154412|Respiration|respiration
191646|NCT02154412|Motor control|motor control
191647|NCT02154412|Blood Pressure|blood pressure
191648|NCT02154412|Orthostatic Hypotension|orthostatic hypotension
191649|NCT02154386|bone augmentation|bone augmentation
191650|NCT02154386|tooth extraction|tooth extraction
191651|NCT02154386|dental implant|dental implant
191652|NCT02154360|HIV infection|hiv infection
191653|NCT02154360|NK-1R antagonists|nk-1r antagonists
191654|NCT02154360|aprepitant|aprepitant
191655|NCT02154360|ritonavir boosting|ritonavir boosting
191656|NCT02154347|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
191657|NCT02154347|HbA1c|hba1c
191658|NCT02154334|Allergic Rhinitis|allergic rhinitis
191659|NCT02154334|Healthy|healthy
191660|NCT02154334|Esketamine|esketamine
191661|NCT02154334|Mometasone|mometasone
191662|NCT02154334|Oxymetazoline|oxymetazoline
191663|NCT02154334|Phase 1|phase 1
191664|NCT02154308|Influenza|influenza
191665|NCT02154308|Influenza vaccine|influenza vaccine
191666|NCT02154308|Split influenza vaccine|split influenza vaccine
191667|NCT02154308|Seasonal influenza vaccine|seasonal influenza vaccine
191668|NCT02154282|hepatic encephalopathy|hepatic encephalopathy
191669|NCT02154282|covert hepatic encephalopathy|covert hepatic encephalopathy
191670|NCT02154282|cirrhosis|cirrhosis
191671|NCT02154269|Chagas disease|chagas disease
191672|NCT02154269|G-CSF|g-csf
191673|NCT02154269|Cell therapy|cell therapy
191674|NCT02154256|walking|walking
191675|NCT02154256|incentives|incentives
191676|NCT02154256|exercise|exercise
191677|NCT02154256|habits|habits
191678|NCT02154230|weight loss|weight loss
191679|NCT02154230|sulphate-bicarbonate-calcium water|sulphate-bicarbonate-calcium water
191680|NCT02154230|gut microbiota|gut microbiota
191681|NCT02154230|body composition|body composition
191682|NCT02154230|bile salts|bile salts
191683|NCT02154191|Lumbosacral Region|lumbosacral region
191684|NCT02154191|Sedentary Lifestyle|sedentary lifestyle
191685|NCT02154191|Surgical Procedure, Operative|surgical procedure, operative
191686|NCT02154178|empiric antifungal therapy|empiric antifungal therapy
191687|NCT02154178|biomarkers|biomarkers
191688|NCT02154178|invasive fungal infection|invasive fungal infection
191689|NCT02154178|Candida|candida
191690|NCT02154165|Neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
191691|NCT02154165|Phototherapy|phototherapy
191692|NCT02154165|Light emitting diodes|light emitting diodes
191695|NCT02154152|Bed wetting|bed wetting
191696|NCT02154152|Primary Enuresis|primary enuresis
191697|NCT02154152|Frequency|frequency
191698|NCT02154152|Efficacy|efficacy
191699|NCT02154152|Homoeopathic Medicine|homoeopathic medicine
191700|NCT02154152|Causticum 200c|causticum 200c
191702|NCT02154113|Syneron|syneron
191703|NCT02154113|Velashape|velashape
191704|NCT02154113|ELOS|elos
191705|NCT02154113|Ultrashape|ultrashape
191706|NCT02154100|Metabolic Syndrome|metabolic syndrome
191707|NCT02154100|Arterial Stiffness|arterial stiffness
191708|NCT02154100|Blood Pressure|blood pressure
191709|NCT02154100|Endothelial Function|endothelial function
191710|NCT02154100|Tart Cherries|tart cherries
191711|NCT02154087|Venous leg ulcer|venous leg ulcer
191712|NCT02154087|Ulcer|ulcer
191713|NCT02154087|Venous stasis|venous stasis
191714|NCT02154087|Compression|compression
191715|NCT02154074|Dexmedetomidine perioperative blood glucose and insulin|dexmedetomidine perioperative blood glucose and insulin
191716|NCT02154061|Flu Vaccine, Intestinal Microbiome, Antibiotics|flu vaccine, intestinal microbiome, antibiotics
191717|NCT02154035|Viral Suppression|viral suppression
191718|NCT02154035|Functional Cure|functional cure
191719|NCT02154022|PK|pk
191720|NCT02154009|Autonomic Nervous System|autonomic nervous system
191721|NCT02154009|Catecholamines|catecholamines
191722|NCT02154009|Dysautonomia|dysautonomia
191723|NCT02154009|Parasympathetic Cholinergic System|parasympathetic cholinergic system
191724|NCT02154009|Sympathetic Adrenergic System|sympathetic adrenergic system
191725|NCT02153996|Malaria Immunity Longevity|malaria immunity longevity
191726|NCT02153983|Obesity|obesity
191727|NCT02153983|Colchicine|colchicine
191728|NCT02153983|Inflammation|inflammation
191729|NCT02153983|Metabolic Syndrome|metabolic syndrome
191730|NCT02153983|Dyslipidemia|dyslipidemia
191731|NCT02153970|Clinical Outcomes Measures|clinical outcomes measures
191732|NCT02153970|Proxy Reported Outcome|proxy reported outcome
191733|NCT02153970|Pediatric|pediatric
191734|NCT02153970|Neuromuscular Disease|neuromuscular disease
191735|NCT02153970|Cerebral Palsy|cerebral palsy
191736|NCT02153957|Exercise|exercise
191737|NCT02153957|Memory|memory
191738|NCT02153957|BDNF|bdnf
191739|NCT02153957|Zamzee|zamzee
191740|NCT02153957|QOL|qol
191741|NCT02153944|Startle|startle
191742|NCT02153944|Induced-Threat|induced-threat
191743|NCT02153944|Memory|memory
191744|NCT02153944|Stimulant|stimulant
191745|NCT02153944|Cognitive Interference|cognitive interference
191746|NCT02153931|Children's Tumor Foundation|children's tumor foundation
191747|NCT02153931|Social Support|social support
191748|NCT02153931|Online|online
191749|NCT02153931|Anxiety|anxiety
191750|NCT02153931|Depression|depression
191751|NCT02153918|Surgery|surgery
191752|NCT02153918|Neoadjuvant|neoadjuvant
191753|NCT02153918|CD8 Cell Infiltrate Response|cd8 cell infiltrate response
191754|NCT02153918|CD4 Cell Infiltrate Response|cd4 cell infiltrate response
191755|NCT02153918|Vaccine|vaccine
191756|NCT02153905|Tumor Regression|tumor regression
191757|NCT02153905|Immunotherapy|immunotherapy
191758|NCT02153905|Metastatic Cancer|metastatic cancer
191759|NCT02153905|Gene Therapy|gene therapy
191760|NCT02153892|Functional Mitral Regurgitation|functional mitral regurgitation
191761|NCT02153892|Heart Failure|heart failure
191762|NCT02153892|Ventricular Reshaping|ventricular reshaping
191763|NCT02153879|HDL|hdl
191764|NCT02153879|Niacin|niacin
191765|NCT02153879|Fenofibrate|fenofibrate
191766|NCT02153879|Diabetes|diabetes
191767|NCT02153879|Metabolomics|metabolomics
191768|NCT02153866|rotavirus vaccine|rotavirus vaccine
191769|NCT02153840|Stable Plaque Psoriasis|stable plaque psoriasis
191770|NCT02153827|Shoulder|shoulder
191771|NCT02153827|Eccentric Training|eccentric training
191772|NCT02153827|Subacromial Impingement Syndrome|subacromial impingement syndrome
191773|NCT02153814|Infertility|infertility
191774|NCT02153814|In vitro fertilization|in vitro fertilization
191775|NCT02153814|Endometrial injury|endometrial injury
191776|NCT02153801|High Ligation, Low ligation, Genito-urinary function, laparoscopy, rectal cancer, aterior resection, Total mesorectal Excision, anastomotic leak.|high ligation, low ligation, genito-urinary function, laparoscopy, rectal cancer, aterior resection, total mesorectal excision, anastomotic leak.
191777|NCT02153788|Insomnia|insomnia
191778|NCT02153788|HIV|hiv
191779|NCT02153775|Progressive muscle relaxation|progressive muscle relaxation
191780|NCT02153775|Cigarette|cigarette
191781|NCT02153775|Smoking|smoking
191782|NCT02153775|Craving|craving
191783|NCT02153762|Atopic Dermatitis|atopic dermatitis
191784|NCT02153762|AD|ad
191785|NCT02153723|Treatment trial|treatment trial
191788|NCT02153697|solar lentigines|solar lentigines
191789|NCT02153697|Q-switches Laser|q-switches laser
191790|NCT02153697|bleaching cream|bleaching cream
191791|NCT02153684|smoking|smoking
191792|NCT02153684|small airway dysfunction|small airway dysfunction
191793|NCT02153684|mild COPD|mild copd
191794|NCT02153684|dyspnea|dyspnea
191795|NCT02153684|exercise|exercise
191796|NCT02153684|clinical outcomes|clinical outcomes
191797|NCT02153671|LAIV H5N2|laiv h5n2
191798|NCT02153671|Influenza vaccine|influenza vaccine
191799|NCT02153671|Russia|russia
191800|NCT02153658|PrePex|prepex
191801|NCT02153658|Odor|odor
191802|NCT02153658|Cleaning technique|cleaning technique
191803|NCT02153658|Male Circumcision|male circumcision
191805|NCT02153658|AIDS|aids
191806|NCT02153658|Chlorhexidine|chlorhexidine
191807|NCT02153658|Soap|soap
191808|NCT02153645|Parkinson's Disease|parkinson's disease
191809|NCT02153645|Levodopa Induced Dyskinesias (LID)|levodopa induced dyskinesias (lid)
191810|NCT02153645|Dyskinesias|dyskinesias
191811|NCT02153645|Parkinsonism|parkinsonism
191812|NCT02153632|Parkinson's Disease|parkinson's disease
191813|NCT02153632|Levodopa Induced Dyskinesia (LID)|levodopa induced dyskinesia (lid)
191814|NCT02153632|LID|lid
191815|NCT02153632|Parkinsonism|parkinsonism
191816|NCT02153632|Dyskinesia|dyskinesia
191817|NCT02153619|Grief|grief
191818|NCT02153619|bereavement|bereavement
191819|NCT02153619|questionnaires|questionnaires
191820|NCT02153619|therapy sessions|therapy sessions
191821|NCT02153619|14-102|14-102
191822|NCT02153606|Glycerin Suppositories|glycerin suppositories
191823|NCT02153606|Enteral Nutrition|enteral nutrition
191824|NCT02153606|Enterocolitis, Necrotizing|enterocolitis, necrotizing
191825|NCT02153606|Infant, Premature|infant, premature
191826|NCT02153606|Meconium|meconium
191827|NCT02153593|Clinical trial|clinical trial
191828|NCT02153593|Randomized|randomized
191829|NCT02153593|Fibrin glue|fibrin glue
191830|NCT02153593|Tranexamic acid|tranexamic acid
191831|NCT02153593|Blood loss|blood loss
191832|NCT02153567|Functional dyspepsia|functional dyspepsia
191833|NCT02153567|symptom response|symptom response
191834|NCT02153567|postprandial fullness|postprandial fullness
191835|NCT02153567|Anxiety|anxiety
191836|NCT02153567|Depression|depression
191837|NCT02153528|Bangladesh|bangladesh
191838|NCT02153528|Rimfapicin|rimfapicin
191839|NCT02153515|Finger prick with diabetic lancet|finger prick with diabetic lancet
191840|NCT02153515|Fingerprick|fingerprick
191841|NCT02153515|Fresh|fresh
191842|NCT02153515|Your own blood|your own blood
191843|NCT02153515|autologous blood|autologous blood
191844|NCT02153515|Dry eyes|dry eyes
191845|NCT02153515|Sjogren's disease with dry eyes|sjogren's disease with dry eyes
192726|NCT02149342|HAL|hal
191846|NCT02153515|Persistent corneal epithelial defects|persistent corneal epithelial defects
191847|NCT02153515|Chronic corneal ulcers|chronic corneal ulcers
191848|NCT02153463|Tourette Syndrome|tourette syndrome
191849|NCT02153463|Persistent Tic Disorder|persistent tic disorder
191850|NCT02153463|Physical Activity|physical activity
191851|NCT02153463|Quality of Life|quality of life
191852|NCT02153450|pancreatic cancer|pancreatic cancer
191853|NCT02153450|Radiation|radiation
191854|NCT02153450|Metformin|metformin
191855|NCT02153450|Pancreatic Adenocarcinomas|pancreatic adenocarcinomas
191856|NCT02153411|Asthma control|asthma control
191857|NCT02153398|Gastric ulcer (GU)|gastric ulcer (gu)
191858|NCT02153398|Duodenal ulcer (DU)|duodenal ulcer (du)
191859|NCT02153398|Anastomotic ulcer (AU)|anastomotic ulcer (au)
191860|NCT02153398|Non-erosive reflux esophagitis disease (NERD)|non-erosive reflux esophagitis disease (nerd)
191861|NCT02153398|Reflux esophagitis (RE)|reflux esophagitis (re)
191862|NCT02153398|Zollinger-Ellison syndrome|zollinger-ellison syndrome
191863|NCT02153385|Yoga, heart rate variability, stress, mood, women|yoga, heart rate variability, stress, mood, women
191864|NCT02153372|large bone defect, bone marrow-derived mononuclear cells|large bone defect, bone marrow-derived mononuclear cells
191865|NCT02153359|asthma|asthma
191866|NCT02153359|HEPA|hepa
191867|NCT02153359|air pollutants|air pollutants
191868|NCT02153359|lung function|lung function
191869|NCT02153359|home environment|home environment
191870|NCT02153359|respiratory symptoms|respiratory symptoms
191871|NCT02153359|diet|diet
191872|NCT02153346|indirect cost|indirect cost
191873|NCT02153346|asthma|asthma
191874|NCT02153333|Human rotavirus (HRV) vaccine|human rotavirus (hrv) vaccine
191875|NCT02153333|Serologic response|serologic response
191876|NCT02153333|Porcine circovirus type 1 (PCV-1)|porcine circovirus type 1 (pcv-1)
191877|NCT02153333|Laboratory evaluations|laboratory evaluations
191878|NCT02153320|HBsAg|hbsag
191879|NCT02153320|Persistence of the immune response|persistence of the immune response
191880|NCT02153320|Adjuvants|adjuvants
191881|NCT02153294|low tidal volume|low tidal volume
191882|NCT02153294|high tidal volume|high tidal volume
191883|NCT02153294|protective ventilation|protective ventilation
191884|NCT02153294|ARDS|ards
191885|NCT02153281|Depression|depression
191886|NCT02153281|Positron Emission Tomography (PET)|positron emission tomography (pet)
191887|NCT02153281|MAO-B|mao-b
191888|NCT02153268|Safety|safety
191889|NCT02153268|efficacy|efficacy
191890|NCT02153268|BonoFill|bonofill
191891|NCT02153268|bone filler|bone filler
191892|NCT02153268|autologous adipose tissue derived cells (HATDCs)|autologous adipose tissue derived cells (hatdcs)
191893|NCT02153268|Bone augmentation|bone augmentation
191894|NCT02153268|sinus augmentation|sinus augmentation
191895|NCT02153268|Bone grafting after removal of cysts from jaws|bone grafting after removal of cysts from jaws
191897|NCT02153255|Mucopolysaccharidosis|mucopolysaccharidosis
191898|NCT02153255|Galactosamine-6-Sulfatase|galactosamine-6-sulfatase
191899|NCT02153255|GALNS|galns
191900|NCT02153242|Pacing|pacing
191903|NCT02153229|Histological diagnosis of MPM|histological diagnosis of mpm
191904|NCT02153229|epitheliod subtype|epitheliod subtype
191905|NCT02153229|limited to the hemithorax|limited to the hemithorax
191906|NCT02153229|macroscopically complete resection of the tumor|macroscopically complete resection of the tumor
191907|NCT02153203|Autism spectrum disorder|autism spectrum disorder
191908|NCT02153203|Problem behavior|problem behavior
191909|NCT02153190|Type 1 Diabetes,|type 1 diabetes,
191910|NCT02153190|T1DM,|t1dm,
191911|NCT02153190|Artificial Pancreas|artificial pancreas
191912|NCT02153177|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
191913|NCT02153177|RCT|rct
191914|NCT02153177|rotator cuff tear|rotator cuff tear
191915|NCT02153177|NSAIDs|nsaids
191916|NCT02153177|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
191917|NCT02153177|rotator cuff repair|rotator cuff repair
191918|NCT02153164|Enthalpy|enthalpy
191919|NCT02153164|Trendelenberg position|trendelenberg position
191920|NCT02153164|Mechanical ventilation|mechanical ventilation
191921|NCT02153138|vegetarian diet|vegetarian diet
191922|NCT02153138|vegan|vegan
191923|NCT02153138|cardiovascular diseases|cardiovascular diseases
191924|NCT02153138|endothelial function|endothelial function
191925|NCT02153138|carotid intima-media thickness|carotid intima-media thickness
191926|NCT02153112|Drug therapy|drug therapy
191927|NCT02153099|Drug therapy|drug therapy
191928|NCT02153086|Pharmacological therapy|pharmacological therapy
191929|NCT02153073|Pharmacological therapy|pharmacological therapy
191930|NCT02153060|immune thrombocytopenia|immune thrombocytopenia
191931|NCT02153060|dexamethasone|dexamethasone
191932|NCT02153060|efficacy|efficacy
191933|NCT02153060|safety|safety
191934|NCT02153047|Smoking cessation|smoking cessation
191935|NCT02153047|Spirometry|spirometry
191936|NCT02153047|Primary health care|primary health care
191937|NCT02153034|Buruli ulcer|buruli ulcer
191938|NCT02153034|Mycobacterium ulcerans disease|mycobacterium ulcerans disease
191939|NCT02153034|M. ulcerans disease|m. ulcerans disease
191940|NCT02153021|anthropometric parameters;|anthropometric parameters;
191941|NCT02153021|biochemical parameters;|biochemical parameters;
191942|NCT02153021|inflammatory markers|inflammatory markers
191943|NCT02153021|neuropeptide markers|neuropeptide markers
191944|NCT02153021|phototherapy|phototherapy
191945|NCT02153008|Strep throat|strep throat
191946|NCT02152956|AML|aml
191947|NCT02152956|leukemia|leukemia
191948|NCT02152956|myelogenous|myelogenous
191949|NCT02152956|myeloid|myeloid
191950|NCT02152956|refractory|refractory
191951|NCT02152956|MDS|mds
191952|NCT02152956|Myelodysplastic|myelodysplastic
191953|NCT02152943|Breast Cancer|breast cancer
191954|NCT02152943|Advanced Metastatic Breast Cancer|advanced metastatic breast cancer
191955|NCT02152943|Solid Tumors|solid tumors
191956|NCT02152943|Advanced Solid Tumors|advanced solid tumors
191957|NCT02152943|Everolimus|everolimus
191958|NCT02152943|Afinitor|afinitor
191959|NCT02152943|Zortress|zortress
191960|NCT02152943|RAD001|rad001
191961|NCT02152943|Trastuzumab|trastuzumab
191962|NCT02152943|Herceptin|herceptin
191963|NCT02152943|Letrozole|letrozole
191964|NCT02152943|Femara|femara
191965|NCT02152930|Fish oil supplements|fish oil supplements
191966|NCT02152930|Supervised Exercise Training|supervised exercise training
191967|NCT02152930|Walking distance|walking distance
191968|NCT02152930|Hemorheological factors|hemorheological factors
191969|NCT02152930|Cardiovascular risk|cardiovascular risk
191970|NCT02152904|Peptic ulcer bleeding|peptic ulcer bleeding
191971|NCT02152904|rebleeding|rebleeding
191972|NCT02152904|mortality|mortality
191973|NCT02152904|nationwide|nationwide
191976|NCT02152878|transcranial direct current stimulation|transcranial direct current stimulation
191977|NCT02152878|non invasive brain stimulation|non invasive brain stimulation
191978|NCT02152878|bipolar disorder|bipolar disorder
191979|NCT02152878|depression|depression
191980|NCT02152865|medication|medication
191981|NCT02152852|Type 2 Diabetes|type 2 diabetes
191982|NCT02152826|Sensitivity|sensitivity
191983|NCT02152813|Electrical stimulation, exercise, stroke , rehabilitation|electrical stimulation, exercise, stroke , rehabilitation
191984|NCT02152787|emergence agitation|emergence agitation
191985|NCT02152787|propofol|propofol
191986|NCT02152787|strabismus surgery|strabismus surgery
191987|NCT02152787|children|children
191988|NCT02152787|elective strabismus surgery|elective strabismus surgery
191989|NCT02152761|bimagrumab,|bimagrumab,
191990|NCT02152761|BYM338,|bym338,
191991|NCT02152761|hip fracture,|hip fracture,
191992|NCT02152761|elderly,|elderly,
191993|NCT02152761|controlled clinical trial,|controlled clinical trial,
191994|NCT02152761|randomized,|randomized,
191995|NCT02152761|muscle wasting (atrophy)|muscle wasting (atrophy)
191996|NCT02152748|glioblastoma|glioblastoma
191997|NCT02152748|morphological and molecular changes|morphological and molecular changes
191998|NCT02152748|progression|progression
191999|NCT02152748|therapy-resistance|therapy-resistance
192000|NCT02152722|Breath test|breath test
192001|NCT02152722|Volatile Organic Compounds|volatile organic compounds
192002|NCT02152722|VOC|voc
192003|NCT02152722|oxidative stress|oxidative stress
192004|NCT02152722|radiation biodosimetry|radiation biodosimetry
192005|NCT02152722|metabolomics|metabolomics
192006|NCT02152722|GCxGC TOF-MS|gcxgc tof-ms
192007|NCT02152709|Safety|safety
192008|NCT02152709|Immunogenicity|immunogenicity
192009|NCT02152709|Vaccine|vaccine
192010|NCT02152709|Hepatitis B|hepatitis b
192011|NCT02152657|Spinal cord injury|spinal cord injury
192012|NCT02152657|Stem cell transplantation|stem cell transplantation
192013|NCT02152657|Mesenchymal stem cell|mesenchymal stem cell
192014|NCT02152644|amyloidosis-carpal tunnel|amyloidosis-carpal tunnel
192015|NCT02152631|Therapy, Platinum, Kras +|therapy, platinum, kras +
192016|NCT02152618|Serious emotional disturbance|serious emotional disturbance
192017|NCT02152618|foster care|foster care
192018|NCT02152618|child protective services|child protective services
192019|NCT02152605|SGRQ|sgrq
192020|NCT02152605|vilanterol|vilanterol
192021|NCT02152605|long-acting beta2-agonist|long-acting beta2-agonist
192022|NCT02152605|long-acting muscarinic antagonist|long-acting muscarinic antagonist
192023|NCT02152605|COPD|copd
192024|NCT02152605|umeclidinium|umeclidinium
192025|NCT02152592|Postoperative pain|postoperative pain
192026|NCT02152592|Ambulatory surgery|ambulatory surgery
192027|NCT02152592|NSAIDS|nsaids
192028|NCT02152592|CR Oxycodone|cr oxycodone
192029|NCT02152592|Compliance to study medication|compliance to study medication
192030|NCT02152579|Stable Angina|stable angina
192031|NCT02152553|Biomarker|biomarker
192032|NCT02152553|Glucocorticoids|glucocorticoids
192033|NCT02152553|Metabolism|metabolism
192034|NCT02152553|Pharmacology|pharmacology
192035|NCT02152553|Metabolomics|metabolomics
192036|NCT02152540|TBI|tbi
192037|NCT02152540|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
192038|NCT02152540|magnetic resonance imaging functional|magnetic resonance imaging functional
192039|NCT02152540|Quality of life|quality of life
192040|NCT02152540|Executive Function|executive function
192041|NCT02152540|Veterans|veterans
192042|NCT02152501|obese|obese
192043|NCT02152501|overweight|overweight
192044|NCT02152501|exercise|exercise
192045|NCT02152501|energy expenditure differences|energy expenditure differences
192046|NCT02152501|relative reinforcing values (RRV)|relative reinforcing values (rrv)
192047|NCT02152501|food|food
192048|NCT02152501|physical activity|physical activity
192049|NCT02152501|biological|biological
192050|NCT02152501|neurobehavioral|neurobehavioral
192051|NCT02152501|behavioral|behavioral
192052|NCT02152488|cerebral blood flow|cerebral blood flow
192053|NCT02152488|position|position
192054|NCT02152488|cervical spine|cervical spine
192055|NCT02152475|Blue-LED|blue-led
192056|NCT02152475|Curcumin|curcumin
192057|NCT02152475|PDT|pdt
192058|NCT02152475|Oral disinfection|oral disinfection
192059|NCT02152462|exergaming|exergaming
192060|NCT02152462|breast cancer|breast cancer
192061|NCT02152462|African American women|african american women
192062|NCT02152462|obesity|obesity
192063|NCT02152423|enoxaparin|enoxaparin
192064|NCT02152423|Enoxamed|enoxamed
192065|NCT02152423|lovenox|lovenox
192066|NCT02152423|anti Xa|anti xa
192067|NCT02152423|acute coronary syndrome|acute coronary syndrome
192068|NCT02152410|acupuncture|acupuncture
192069|NCT02152410|renal colic|renal colic
192070|NCT02152358|Cytomegalovirus|cytomegalovirus
192071|NCT02152358|Herpes simplex virus|herpes simplex virus
192072|NCT02152358|ICU|icu
192073|NCT02152358|mechanical ventilation|mechanical ventilation
192074|NCT02152358|mortality|mortality
192075|NCT02152358|ventilator-free days|ventilator-free days
192076|NCT02152358|PCR|pcr
192077|NCT02152345|kidney|kidney
192078|NCT02152345|renal|renal
192079|NCT02152345|transplant|transplant
192080|NCT02152345|belatacept|belatacept
192081|NCT02152345|delayed graft function|delayed graft function
192082|NCT02152345|thymoglobulin|thymoglobulin
192083|NCT02152345|tacrolimus|tacrolimus
192084|NCT02152345|kidney function|kidney function
192085|NCT02152345|immunosuppression|immunosuppression
192086|NCT02152345|NGAL|ngal
192087|NCT02152332|JNJ-54861912|jnj-54861912
192088|NCT02152332|RSC-385896|rsc-385896
192089|NCT02152332|MTS-0385896A|mts-0385896a
192090|NCT02152332|Phase 1|phase 1
192091|NCT02152332|Moxifloxacin|moxifloxacin
192092|NCT02152332|Placebo|placebo
192093|NCT02152332|Healthy|healthy
192094|NCT02152319|Parkinson's disease|parkinson's disease
192095|NCT02152319|Telemedicine|telemedicine
192096|NCT02152319|Telehealth|telehealth
192097|NCT02152319|Kinesia|kinesia
192098|NCT02152319|Tremor|tremor
192099|NCT02152319|Bradykinesia|bradykinesia
192100|NCT02152319|Dyskinesia|dyskinesia
192101|NCT02152306|Fimasartan|fimasartan
192102|NCT02152306|Fimasartan and Amlodipine|fimasartan and amlodipine
192103|NCT02152306|Antihypertension|antihypertension
192104|NCT02152267|Temporomandibular|temporomandibular
192105|NCT02152267|Musculoskeletal Diseases|musculoskeletal diseases
192106|NCT02152267|Electrical Stimulation of the Brain|electrical stimulation of the brain
192107|NCT02152267|Prefrontal Cortex|prefrontal cortex
192108|NCT02152254|Metastatic Cancer|metastatic cancer
192109|NCT02152254|Molecular Profiling|molecular profiling
192110|NCT02152254|Genomic alteration analysis of the tumor|genomic alteration analysis of the tumor
192111|NCT02152254|Advanced Cancer Therapy|advanced cancer therapy
192112|NCT02152254|Gene mutations|gene mutations
192113|NCT02152254|Tumor biopsy|tumor biopsy
192114|NCT02152254|Personalized medicine|personalized medicine
192115|NCT02152241|IBD|ibd
192116|NCT02152241|Crohn|crohn
192117|NCT02152241|Colitis|colitis
192118|NCT02152241|Function|function
192119|NCT02152176|pain|pain
192120|NCT02152176|analgesia|analgesia
192121|NCT02152176|morphine|morphine
192122|NCT02152176|PCA|pca
192123|NCT02152176|Nurse|nurse
192124|NCT02152163|Assessing the efficacy of IV Ibuprofen for Treatment of Pain in Orthopedic Trauma Patients|assessing the efficacy of iv ibuprofen for treatment of pain in orthopedic trauma patients
192125|NCT02152150|iron|iron
192126|NCT02152150|anemia|anemia
192127|NCT02152150|bio-fortification|bio-fortification
192128|NCT02152150|children|children
192129|NCT02152150|India|india
192130|NCT02152124|Acromegaly|acromegaly
192131|NCT02152124|Acromegaly treatment|acromegaly treatment
192132|NCT02152124|Long-acting somatostatin analogs|long-acting somatostatin analogs
192133|NCT02152124|Pegvisomant|pegvisomant
192134|NCT02152124|Insulin sensitivity|insulin sensitivity
192135|NCT02152124|Gut hormones|gut hormones
192136|NCT02152124|Lipid metabolism|lipid metabolism
192137|NCT02152124|Adipokines|adipokines
192138|NCT02152111|Obesity|obesity
192139|NCT02152111|Coconut flour|coconut flour
192140|NCT02152111|Diet quality|diet quality
192141|NCT02152111|Cardiovascular risk factor|cardiovascular risk factor
192142|NCT02152085|Walking|walking
192143|NCT02152085|Mobility|mobility
192144|NCT02152085|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
192145|NCT02152085|Multiple sclerosis|multiple sclerosis
192146|NCT02152059|Small cell lung cancer|small cell lung cancer
192147|NCT02152059|BIBF1120|bibf1120
192148|NCT02152059|nintedanib|nintedanib
192149|NCT02152059|platinum-sensitive|platinum-sensitive
192150|NCT02152033|Substance Abuse|substance abuse
192151|NCT02152033|Continuing Care|continuing care
192152|NCT02152033|Recovery|recovery
192153|NCT02152033|Substance Abuse Treatment|substance abuse treatment
192154|NCT02152033|Parent|parent
192155|NCT02152033|Family|family
234733|NCT01960348|FAP|fap
192156|NCT02152033|Young Adult|young adult
192157|NCT02152007|pachyonychia congenita|pachyonychia congenita
192158|NCT02151994|BIA 5-1058|bia 5-1058
192159|NCT02151994|hypertension|hypertension
192160|NCT02151994|chronic heart failure|chronic heart failure
192161|NCT02151994|cardiovascular disorders|cardiovascular disorders
192162|NCT02151981|Advanced Non-Small Cell Lung Cancer; T790M Mutation Positive|advanced non-small cell lung cancer; t790m mutation positive
192163|NCT02151942|elective endovascular AAA repair|elective endovascular aaa repair
192164|NCT02151929|myocardial infarction|myocardial infarction
192165|NCT02151929|primary PCI|primary pci
192166|NCT02151929|stent|stent
192167|NCT02151916|dental caries|dental caries
192168|NCT02151916|early childhood caries|early childhood caries
192169|NCT02151916|topical fluorides|topical fluorides
192170|NCT02151916|fluoride varnish|fluoride varnish
192171|NCT02151903|NHL|nhl
192172|NCT02151903|Immunocytokine|immunocytokine
192173|NCT02151903|Lymphoma|lymphoma
192174|NCT02151903|Non-Hodgkin|non-hodgkin
192175|NCT02151903|B-cell|b-cell
192176|NCT02151903|IL (interleukin)|il (interleukin)
192177|NCT02151890|POF|pof
192178|NCT02151890|ESS|ess
192179|NCT02151890|stem cell|stem cell
192180|NCT02151877|Ischemia/reperfusion injury|ischemia/reperfusion injury
192181|NCT02151864|liver cancer|liver cancer
192182|NCT02151864|cirrhosis|cirrhosis
192183|NCT02151864|Child-Pugh A|child-pugh a
192184|NCT02151864|Hedgehog|hedgehog
192185|NCT02151851|Rheumatoid Arthritis|rheumatoid arthritis
192186|NCT02151851|TNFα antagonist|tnfα antagonist
192187|NCT02151851|Certolizumab Pegol|certolizumab pegol
192188|NCT02151851|Chinese patients|chinese patients
192189|NCT02151838|HIV-infected pregnant women who request HAART from the TRCSPMTCT|hiv-infected pregnant women who request haart from the trcspmtct
192190|NCT02151825|Gut microbiota|gut microbiota
192191|NCT02151825|Probiotics|probiotics
192192|NCT02151825|Prebiotics|prebiotics
192193|NCT02151825|Synbiotic|synbiotic
192194|NCT02151825|Bifidobacterium lactis BB-12|bifidobacterium lactis bb-12
192195|NCT02151825|Lactobacillus acidophilus LA-5|lactobacillus acidophilus la-5
192196|NCT02151825|Lactobacillus casei 431|lactobacillus casei 431
192197|NCT02151825|Inulin|inulin
192198|NCT02151825|GOS|gos
192199|NCT02151825|Body Weight|body weight
192200|NCT02151825|Overweight|overweight
192201|NCT02151825|Adiposity|adiposity
192202|NCT02151825|Obesity|obesity
192203|NCT02151825|ANGPTL4|angptl4
192204|NCT02151786|Pharmacological therapy|pharmacological therapy
192205|NCT02151773|Pharmacological therapy|pharmacological therapy
192206|NCT02151760|Metastatic Prostate Cancer|metastatic prostate cancer
192207|NCT02151747|breast neoplasms, BRCA1, Sanger, NGS, Next generation sequencing|breast neoplasms, brca1, sanger, ngs, next generation sequencing
192208|NCT02151721|Vorinostat|vorinostat
192209|NCT02151721|Gefitinib|gefitinib
192210|NCT02151721|BIM polymorphism|bim polymorphism
192211|NCT02151721|EGFR-TKI resistance|egfr-tki resistance
585915|NCT00522756|Sodium Chloride|sodium chloride
192212|NCT02151708|accommodation, emptying,motilitone|accommodation, emptying,motilitone
192213|NCT02151682|chronic pain|chronic pain
192214|NCT02151682|opioid|opioid
192215|NCT02151669|Mediterranean diet|mediterranean diet
192216|NCT02151669|Smoking/tobacco|smoking/tobacco
192217|NCT02151669|Spirometry|spirometry
192218|NCT02151656|Schizophrenia|schizophrenia
192219|NCT02151656|Mental disorders|mental disorders
192220|NCT02151656|Antipsychotic Drugs|antipsychotic drugs
192221|NCT02151643|Dialysis Dependent Chronic Kidney Disease|dialysis dependent chronic kidney disease
192222|NCT02151630|wart|wart
192223|NCT02151630|verruca vulgaris|verruca vulgaris
192224|NCT02151630|topical therapy|topical therapy
192225|NCT02151630|pyruvic acid|pyruvic acid
192226|NCT02151630|salicylic acid|salicylic acid
192227|NCT02151617|Multiple dose|multiple dose
192228|NCT02151617|safety|safety
192229|NCT02151617|tolerability|tolerability
192230|NCT02151617|PK|pk
192231|NCT02151591|Quit smoking|quit smoking
192232|NCT02151591|Quit drinking|quit drinking
192233|NCT02151578|Impact of home management of malaria and pneumonia on child mortality|impact of home management of malaria and pneumonia on child mortality
192234|NCT02151578|home management of malaria and pneumonia|home management of malaria and pneumonia
192235|NCT02151565|back pain|back pain
192236|NCT02151565|sciatica|sciatica
192237|NCT02151565|electrotherapy|electrotherapy
192238|NCT02151565|HTEMS|htems
192239|NCT02151565|TENS|tens
192240|NCT02151552|lung inflammation|lung inflammation
192241|NCT02151552|positron emission tomography|positron emission tomography
192242|NCT02151552|inducible nitric oxide synthase|inducible nitric oxide synthase
192243|NCT02151513|Cancer-associated pain|cancer-associated pain
192244|NCT02151513|Immune function|immune function
192245|NCT02151500|Medically Unexplained Symptoms (MUPS)|medically unexplained symptoms (mups)
192246|NCT02151500|Somatoform disorders|somatoform disorders
193135|NCT02147496|Appetite|appetite
192247|NCT02151500|Chronic pain|chronic pain
192248|NCT02151500|Somatic symptoms|somatic symptoms
192249|NCT02151500|Emotional processing|emotional processing
192250|NCT02151500|Primary Care|primary care
192251|NCT02151487|Supraclavicular block|supraclavicular block
192252|NCT02151487|Ropivacaine|ropivacaine
192253|NCT02151487|Dexamethasone|dexamethasone
192254|NCT02151487|Clonidine|clonidine
192255|NCT02151461|Diabetes|diabetes
192256|NCT02151461|Type 2 Diabetes|type 2 diabetes
192257|NCT02151435|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
192258|NCT02151435|Biomarkers|biomarkers
192259|NCT02151435|Forced Vital Capacity|forced vital capacity
192260|NCT02151435|Diffusion Capacity for Carbon Monoxide|diffusion capacity for carbon monoxide
192261|NCT02151435|Prognosis|prognosis
192262|NCT02151422|Adults|adults
192263|NCT02151422|age 18-65|age 18-65
192264|NCT02151422|physician-diagnosed|physician-diagnosed
192265|NCT02151422|persistent asthma|persistent asthma
192266|NCT02151396|ADHD, hyperactivity, inattention, working memory|adhd, hyperactivity, inattention, working memory
192267|NCT02151383|Acute heart failure,|acute heart failure,
192268|NCT02151383|RELAX−AHF−PEDIATRIC PK|relax−ahf−pediatric pk
192269|NCT02151357|first in man|first in man
192270|NCT02151357|dose escalating|dose escalating
192271|NCT02151357|MTD|mtd
192272|NCT02151357|DLT|dlt
192273|NCT02151331|Chronic care model|chronic care model
192274|NCT02151331|Mood disorders|mood disorders
192275|NCT02151331|Adaptive implementation|adaptive implementation
192276|NCT02151279|Shrimp allergy|shrimp allergy
192277|NCT02151279|Chitosan|chitosan
192278|NCT02151279|fining agent|fining agent
192279|NCT02151266|Heart failure|heart failure
192280|NCT02151266|Exercise|exercise
192281|NCT02151266|Cognitive training|cognitive training
192282|NCT02151253|Nocturia|nocturia
192283|NCT02151253|Daytime sleepiness|daytime sleepiness
192284|NCT02151240|herpes zoster, Foscarnet Sodium, Acyclovir, Postherpetic neuralgia|herpes zoster, foscarnet sodium, acyclovir, postherpetic neuralgia
192285|NCT02151227|Meta-Analysis|meta-analysis
192286|NCT02151227|Metabolic Syndrome|metabolic syndrome
192287|NCT02151227|Magnesium|magnesium
192288|NCT02151227|Dose Response Effect|dose response effect
192289|NCT02151227|Systematic Review|systematic review
192290|NCT02151214|Palliative Phase of Cancer|palliative phase of cancer
192291|NCT02151214|Quality of life|quality of life
192292|NCT02151214|Parenteral nutrition|parenteral nutrition
192293|NCT02151214|Undernutrition|undernutrition
192294|NCT02151201|pregnancy vaccination influenza education|pregnancy vaccination influenza education
200998|NCT02112656|Digestive System Neoplasms|digestive system neoplasms
200999|NCT02112656|Neoplasms by Site|neoplasms by site
201000|NCT02112656|Digestive System Diseases|digestive system diseases
192295|NCT02151149|NSCLC advanced non-small cell lung cancer squamous adenocarcinoma large cell carcinoma lung cancer elderly first line treatment abraxane carbo nab-paclitaxel|nsclc advanced non-small cell lung cancer squamous adenocarcinoma large cell carcinoma lung cancer elderly first line treatment abraxane carbo nab-paclitaxel
192296|NCT02151136|Sucrose|sucrose
192297|NCT02151136|Pain|pain
192298|NCT02151123|Colonic Neoplasms|colonic neoplasms
192299|NCT02151123|Colon Cancer|colon cancer
192300|NCT02151123|Microbiome|microbiome
192301|NCT02151110|Healthy Male|healthy male
192302|NCT02151110|Healthy Female of non child bearing potential|healthy female of non child bearing potential
192303|NCT02151097|Prostatectomy|prostatectomy
192304|NCT02151097|Prostate cancer|prostate cancer
192305|NCT02151097|Cerenkov Luminescence Imaging|cerenkov luminescence imaging
192306|NCT02151084|randomized|randomized
192307|NCT02151084|selumetinib|selumetinib
192308|NCT02151084|tablets|tablets
192309|NCT02151084|cisplatin|cisplatin
192310|NCT02151084|gemcitabine|gemcitabine
192311|NCT02151084|non-resectable|non-resectable
192312|NCT02151084|recurrent|recurrent
192313|NCT02151084|metstatic|metstatic
192314|NCT02151071|Breast Cancer|breast cancer
192315|NCT02151071|Mastectomy, Segmental|mastectomy, segmental
192316|NCT02151071|Breast Conserving Surgery|breast conserving surgery
192317|NCT02151071|Cerenkov Luminescence Imaging|cerenkov luminescence imaging
192318|NCT02151071|Beta particle detection|beta particle detection
192319|NCT02151058|Staining|staining
192320|NCT02151058|Intensity|intensity
192321|NCT02151058|Area|area
192322|NCT02151045|Epidural infiltration of Corticoids|epidural infiltration of corticoids
192323|NCT02151045|L3-L4 stage|l3-l4 stage
192324|NCT02151045|On contact of disco radicular conflict|on contact of disco radicular conflict
192325|NCT02151045|Scan control|scan control
192326|NCT02151032|Colorectal Cancer|colorectal cancer
192327|NCT02151032|Colorectal cancer screening|colorectal cancer screening
192328|NCT02151032|Multimedia|multimedia
192329|NCT02151032|Booklet|booklet
192330|NCT02151032|Pamphlet|pamphlet
192331|NCT02151032|Audio CD|audio cd
192332|NCT02151032|Video with animated images|video with animated images
192333|NCT02151032|Video with non-moving images|video with non-moving images
192334|NCT02151032|Questionnaires|questionnaires
192335|NCT02151032|Surveys|surveys
192336|NCT02151006|DHEA|dhea
192337|NCT02151006|IVF|ivf
192338|NCT02151006|ICSI|icsi
192339|NCT02150993|Africa|africa
192340|NCT02150993|Antiretroviral Treatment|antiretroviral treatment
192341|NCT02150993|HIV-2|hiv-2
192342|NCT02150993|firsts line ART|firsts line art
192343|NCT02150993|Adults|adults
192344|NCT02150980|Fractures|fractures
192345|NCT02150980|burden of fractures|burden of fractures
192346|NCT02150980|orthopaedic fractures|orthopaedic fractures
192347|NCT02150980|orthopaedic injuries|orthopaedic injuries
192348|NCT02150980|orthopaedic trauma|orthopaedic trauma
192349|NCT02150980|observational study|observational study
192350|NCT02150980|outcomes of fracture care|outcomes of fracture care
192351|NCT02150980|epidemiology|epidemiology
192352|NCT02150967|cholangiocarcinoma,|cholangiocarcinoma,
192353|NCT02150967|FGFR2 gene fusion,|fgfr2 gene fusion,
192354|NCT02150967|FGFR genetic alteration|fgfr genetic alteration
192355|NCT02150954|induction of labor|induction of labor
192356|NCT02150954|pitocin|pitocin
192357|NCT02150954|foley bulb|foley bulb
192358|NCT02150941|Upper gastrointestinal tract|upper gastrointestinal tract
192359|NCT02150941|Endoscopy|endoscopy
192360|NCT02150941|Endoscopic Hemostasis|endoscopic hemostasis
192361|NCT02150915|Acupoints|acupoints
192362|NCT02150915|Acupuncture therapy|acupuncture therapy
192363|NCT02150915|Median nerve|median nerve
192364|NCT02150915|Biomechanics|biomechanics
192365|NCT02150902|Catheter ablation for atrial fibrillation|catheter ablation for atrial fibrillation
192366|NCT02150902|treatment for atrial fibrillation|treatment for atrial fibrillation
192367|NCT02150902|comparison of catheter ablation techniques for atrial fibrillation|comparison of catheter ablation techniques for atrial fibrillation
192368|NCT02150889|insulin resistance|insulin resistance
192369|NCT02150889|lipid metabolism|lipid metabolism
192370|NCT02150889|diabetes|diabetes
192371|NCT02150876|DES|des
192372|NCT02150876|SDF|sdf
192373|NCT02150876|MACE|mace
192374|NCT02150876|SYNERGY|synergy
192375|NCT02150863|actinic keratosis|actinic keratosis
192376|NCT02150863|field cancerization|field cancerization
192377|NCT02150863|organ transplant patients|organ transplant patients
192378|NCT02150850|Femoral Fractures|femoral fractures
192379|NCT02150850|Subtrochanteric Fractures|subtrochanteric fractures
192380|NCT02150850|Osteoporotic Fractures|osteoporotic fractures
192381|NCT02150850|Fractures, Spontaneous|fractures, spontaneous
192382|NCT02150850|Stress Fractures|stress fractures
192383|NCT02150850|Bone Fractures|bone fractures
192384|NCT02150850|Hip Fractures|hip fractures
192385|NCT02150850|Osteoporosis|osteoporosis
192386|NCT02150837|Obesity|obesity
192387|NCT02150837|Weight Loss|weight loss
192388|NCT02150837|Meal replacements|meal replacements
192389|NCT02150837|Weight maintenance|weight maintenance
192390|NCT02150798|Diet Therapy|diet therapy
192391|NCT02150798|Diet, Carbohydrate Restricted|diet, carbohydrate restricted
192392|NCT02150798|Fatty Acids, Omega 3|fatty acids, omega 3
192393|NCT02150798|Oximetry|oximetry
192394|NCT02150798|phase angle|phase angle
192395|NCT02150798|Triglycerides, blood|triglycerides, blood
192396|NCT02150798|Lipids, blood|lipids, blood
192397|NCT02150798|Hand Strength|hand strength
192398|NCT02150798|Body Composition|body composition
192399|NCT02150798|Electric Impedance|electric impedance
192400|NCT02150785|Thrombolysis|thrombolysis
192401|NCT02150785|Safety of Streptokinase|safety of streptokinase
585916|NCT00522756|Prevention and control|prevention and control
192402|NCT02150785|tissue plasminogen activator tPA|tissue plasminogen activator tpa
192403|NCT02150785|Stroke treatment|stroke treatment
192404|NCT02150759|Dexmedetomidine|dexmedetomidine
192405|NCT02150759|Ketamine|ketamine
192406|NCT02150759|Pain|pain
192407|NCT02150746|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
192408|NCT02150746|Pancreatic cancer|pancreatic cancer
192409|NCT02150746|PDAC|pdac
192410|NCT02150746|Circulating tumor cells|circulating tumor cells
192411|NCT02150720|Hip fractures|hip fractures
192412|NCT02150720|Clinical Trial|clinical trial
192413|NCT02150720|Randomized|randomized
192414|NCT02150720|Fibrin glue|fibrin glue
192415|NCT02150720|Tranexamic acid|tranexamic acid
192416|NCT02150720|Blood loss|blood loss
192417|NCT02150681|preconception|preconception
192418|NCT02150681|pregnancy|pregnancy
192419|NCT02150681|postpartum|postpartum
192420|NCT02150681|women|women
192421|NCT02150668|ADHD|adhd
192422|NCT02150668|Homework|homework
192423|NCT02150668|School|school
192424|NCT02150668|Organization|organization
192425|NCT02150668|Time-management|time-management
192426|NCT02150616|Pulmonary hypertension|pulmonary hypertension
192427|NCT02150616|Interstitial lung disease|interstitial lung disease
192428|NCT02150616|Pulmonary fibrosis|pulmonary fibrosis
192429|NCT02150603|Heart defects, congenital|heart defects, congenital
192430|NCT02150603|Patient-reported outcomes|patient-reported outcomes
192431|NCT02150603|Health status|health status
192432|NCT02150603|Factors, psychosocial|factors, psychosocial
192433|NCT02150603|Health behavior|health behavior
192434|NCT02150603|Quality of life|quality of life
192435|NCT02150603|Sense of coherence|sense of coherence
192436|NCT02150603|Illness perceptions|illness perceptions
192437|NCT02150603|Depression|depression
192438|NCT02150603|Anxiety|anxiety
192439|NCT02150590|airway disease|airway disease
192440|NCT02150590|bronchitis|bronchitis
192441|NCT02150590|emphysema|emphysema
192442|NCT02150590|lung|lung
192443|NCT02150577|Screening|screening
192444|NCT02150577|Mood Stabilizers|mood stabilizers
192445|NCT02150577|Computer delivered psychotherapy|computer delivered psychotherapy
192446|NCT02150577|Peer Support|peer support
192447|NCT02150577|Telepsychiatry|telepsychiatry
192448|NCT02150577|Implementation|implementation
192449|NCT02150577|Rural|rural
192450|NCT02150564|Malignant gliomas|malignant gliomas
192451|NCT02150564|Sono RCT|sono rct
192452|NCT02150551|Crohn disease|crohn disease
192453|NCT02150551|ulcerative colitis|ulcerative colitis
192454|NCT02150551|mesenchymal stromal cells|mesenchymal stromal cells
192455|NCT02150551|inflammatory bowel diseases|inflammatory bowel diseases
192456|NCT02150538|Cardiac Resynchronization therapy|cardiac resynchronization therapy
192457|NCT02150538|Minimized Right ventricular pacing|minimized right ventricular pacing
192458|NCT02150538|Prolonged AV conduction|prolonged av conduction
192459|NCT02150525|breast cancer|breast cancer
192460|NCT02150525|vaginal dryness|vaginal dryness
192461|NCT02150525|dyspareunia|dyspareunia
192462|NCT02150525|genital irritation|genital irritation
192463|NCT02150512|Septic shock|septic shock
192464|NCT02150512|Critically ill patients|critically ill patients
192465|NCT02150512|Transpulmonary thermodilution|transpulmonary thermodilution
192466|NCT02150512|Fluid resuscitation|fluid resuscitation
192467|NCT02150499|Acute Asthma exacerbation|acute asthma exacerbation
192468|NCT02150473|rheumatoid Arthritis|rheumatoid arthritis
192469|NCT02150460|ophthalmic surgery, peribulbar local anaesthesia|ophthalmic surgery, peribulbar local anaesthesia
192470|NCT02150447|Gastric cancer bleeding|gastric cancer bleeding
192471|NCT02150447|Proton pump inhibitor|proton pump inhibitor
192472|NCT02150434|Oxygen therapy|oxygen therapy
192473|NCT02150434|Hypoxemia|hypoxemia
192474|NCT02150434|COPD|copd
192475|NCT02150434|Closed-loop|closed-loop
192476|NCT02150434|Automated titration,|automated titration,
192477|NCT02150382|hypertension|hypertension
192478|NCT02150382|rural|rural
192479|NCT02150382|China|china
192480|NCT02150382|protocol-based treatment|protocol-based treatment
192481|NCT02150343|Cat allergy|cat allergy
192482|NCT02150343|Rhinoconjunctivitis|rhinoconjunctivitis
192483|NCT02150330|Dehydroepiandrosterone|dehydroepiandrosterone
192484|NCT02150330|DHEAS|dheas
192485|NCT02150330|Gene expression of cumulus cells.|gene expression of cumulus cells.
192486|NCT02150330|Folliculogenesis.|folliculogenesis.
192487|NCT02150330|Oocyte maturation.|oocyte maturation.
192488|NCT02150330|Ovarian hyper-stimulation protocol.|ovarian hyper-stimulation protocol.
192489|NCT02150330|Artificial reproduction technology.|artificial reproduction technology.
192490|NCT02150317|Carcinoma, Hepatocellular|carcinoma, hepatocellular
192491|NCT02150317|Chemoembolization, Therapeutic|chemoembolization, therapeutic
192492|NCT02150317|Sorafenib|sorafenib
192493|NCT02150278|Driving|driving
192494|NCT02150278|Alcohol consumption|alcohol consumption
192495|NCT02150278|Risk perception|risk perception
192496|NCT02150252|Clinical trial|clinical trial
192497|NCT02150252|Ischemic stroke|ischemic stroke
192498|NCT02150252|Bu-Yang-Huan-Wu Tang (BYHWT）|bu-yang-huan-wu tang (byhwt）
192499|NCT02150252|Gait parameter|gait parameter
192500|NCT02150252|Quality of life|quality of life
192501|NCT02150239|pain|pain
192502|NCT02150239|postoperative|postoperative
192503|NCT02150213|Adrenocortical Adenoma,|adrenocortical adenoma,
192504|NCT02150213|Endometrial Stromal sarcomas|endometrial stromal sarcomas
192505|NCT02150213|BGG492|bgg492
192506|NCT02150187|Androgenetic Alopecia|androgenetic alopecia
192507|NCT02150187|Male|male
192508|NCT02150187|Baldness|baldness
192509|NCT02150187|hair loss pattern|hair loss pattern
192510|NCT02150174|Schizophrenia|schizophrenia
192511|NCT02150174|Episodic memory deficits|episodic memory deficits
192512|NCT02150148|breast cancer|breast cancer
192513|NCT02150148|prostate cancer|prostate cancer
192514|NCT02150148|colorectal cancer|colorectal cancer
192515|NCT02150148|small intestine cancer|small intestine cancer
192516|NCT02150148|thyroid cancer|thyroid cancer
192517|NCT02150148|Hodgkin lymphoma|hodgkin lymphoma
192518|NCT02150148|non-Hodgkin lymphoma|non-hodgkin lymphoma
192519|NCT02150148|endometrial cancer|endometrial cancer
192520|NCT02150148|kidney cancer|kidney cancer
192521|NCT02150148|cervical cancer|cervical cancer
192522|NCT02150148|diet|diet
192523|NCT02150148|exercise|exercise
192524|NCT02150148|physical activity|physical activity
192525|NCT02150148|garden|garden
192526|NCT02150135|Pancreatic cancer|pancreatic cancer
192527|NCT02150135|Quality of life|quality of life
192528|NCT02150135|Pain|pain
192529|NCT02150122|Vitamin D|vitamin d
192530|NCT02150122|Serum 25-hydroxyvitamin D (25OHD)|serum 25-hydroxyvitamin d (25ohd)
192531|NCT02150122|Adolescents|adolescents
192532|NCT02150096|chronic non-specific low back pain|chronic non-specific low back pain
192533|NCT02150096|clinical trial|clinical trial
192534|NCT02150096|disability|disability
192535|NCT02150096|women|women
192536|NCT02150083|midurethral sling|midurethral sling
192537|NCT02150083|voiding study|voiding study
192538|NCT02150083|voiding trial|voiding trial
192539|NCT02150083|retrograde voiding trial|retrograde voiding trial
192540|NCT02150070|Healthy subjects|healthy subjects
192541|NCT02150070|ASP2408|asp2408
192542|NCT02150070|Rheumatoid arthritis|rheumatoid arthritis
192543|NCT02150070|Safety and Tolerability|safety and tolerability
192544|NCT02150070|Pharmacokinetics|pharmacokinetics
192545|NCT02150057|knee osteoarthritis unicompartmental unloading brace|knee osteoarthritis unicompartmental unloading brace
192546|NCT02150031|prevention and control|prevention and control
192547|NCT02150031|chlorhexidine|chlorhexidine
192548|NCT02150031|therapeutic irrigation|therapeutic irrigation
192549|NCT02150031|mouthwashes|mouthwashes
192550|NCT02150031|culture|culture
192551|NCT02150018|- Critical Care|- critical care
192552|NCT02150018|Non invasive ventilation|non invasive ventilation
192553|NCT02150018|Electrical impedance tomography|electrical impedance tomography
192554|NCT02150018|End expiratory lung volume|end expiratory lung volume
192555|NCT02150018|End expiratory lung impedance|end expiratory lung impedance
192556|NCT02150005|periodontal diseases|periodontal diseases
192557|NCT02150005|cardiovascular diseases|cardiovascular diseases
192558|NCT02150005|periodontitis treatment|periodontitis treatment
192559|NCT02149992|gestational diabetes|gestational diabetes
192560|NCT02149992|myoinositol|myoinositol
192561|NCT02149979|Incision|incision
192562|NCT02149979|Wound Closure|wound closure
192563|NCT02149979|Laser Tissue Soldering|laser tissue soldering
192564|NCT02149966|safety and tolerability|safety and tolerability
192565|NCT02149966|pharmacokinetic study|pharmacokinetic study
192566|NCT02149953|Pregnancy|pregnancy
192567|NCT02149953|Glycine requirements|glycine requirements
192568|NCT02149953|Indicator Amino Acid Oxidation (IAAO) method|indicator amino acid oxidation (iaao) method
192569|NCT02149953|Stable isotopes|stable isotopes
192570|NCT02149940|Elderly|elderly
192571|NCT02149940|Frailty|frailty
192572|NCT02149940|Polypharmacy|polypharmacy
192573|NCT02149940|Medication review|medication review
192574|NCT02149940|Clinical pharmacy services|clinical pharmacy services
192575|NCT02149927|EEG|eeg
192576|NCT02149927|fMRI|fmri
192577|NCT02149927|connectivity|connectivity
192578|NCT02149927|sevoflurane|sevoflurane
192579|NCT02149914|Ryodoraku|ryodoraku
192580|NCT02149914|Meridian energy|meridian energy
192581|NCT02149914|Heart rate variability|heart rate variability
192582|NCT02149914|Autonomic Nervous System|autonomic nervous system
192583|NCT02149914|GERD|gerd
192584|NCT02149901|Pure Autonomic Failure|pure autonomic failure
192585|NCT02149901|Multiple System Atrophy|multiple system atrophy
192586|NCT02149901|Pseudoephedrine|pseudoephedrine
192587|NCT02149901|Water|water
192588|NCT02149901|Osmopressor|osmopressor
192589|NCT02149888|HIV|hiv
192590|NCT02149888|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
192591|NCT02149888|PrEP|prep
192592|NCT02149888|Human Immunodeficiency Virus|human immunodeficiency virus
192593|NCT02149875|Acute ischemic stroke|acute ischemic stroke
192594|NCT02149875|Dl-3-n-butylphthalide|dl-3-n-butylphthalide
192595|NCT02149875|Cerebrolysin|cerebrolysin
192596|NCT02149862|Bladder cancer|bladder cancer
192597|NCT02149862|Diagnostic|diagnostic
192598|NCT02149862|Infrared|infrared
192599|NCT02149862|Spectrum|spectrum
192600|NCT02149862|Urina|urina
192601|NCT02149862|Patients with an indication of partial or total bladder resection|patients with an indication of partial or total bladder resection
192602|NCT02149862|or|or
192603|NCT02149862|"Lithiasic patients should be operated a urinary calculation, without catheter double J"|"lithiasic patients should be operated a urinary calculation, without catheter double j"
192604|NCT02149849|Ipsilateral shoulder pain|ipsilateral shoulder pain
192605|NCT02149849|Surgical positioning|surgical positioning
192606|NCT02149849|Lung cancer|lung cancer
192607|NCT02149849|Thoracotomy|thoracotomy
192608|NCT02149849|Video assisted thoracic surgery|video assisted thoracic surgery
192609|NCT02149836|major depressive disorder|major depressive disorder
192610|NCT02149836|depression|depression
192611|NCT02149836|treatment resistent depression|treatment resistent depression
192612|NCT02149823|Oxytocin, Social Cognition|oxytocin, social cognition
192613|NCT02149823|Borderline Personality Disorder|borderline personality disorder
192614|NCT02149823|Schizotypal Personality Disorder|schizotypal personality disorder
192615|NCT02149823|Social Cognition|social cognition
192616|NCT02149823|BPD|bpd
192617|NCT02149823|SPD|spd
192618|NCT02149823|MASC|masc
192619|NCT02149810|MDD|mdd
192620|NCT02149784|Metastasis colorectal cancer|metastasis colorectal cancer
192621|NCT02149784|Chemotherapy|chemotherapy
192622|NCT02149784|Resection of primary tumor|resection of primary tumor
192623|NCT02149771|hepatocellular carcinoma|hepatocellular carcinoma
192624|NCT02149771|portal vein tumor thrombosis|portal vein tumor thrombosis
192625|NCT02149771|stents|stents
192626|NCT02149771|chemoembolization|chemoembolization
192627|NCT02149758|Cyclooxygenase two inhibitors|cyclooxygenase two inhibitors
192628|NCT02149758|Etoricoxib|etoricoxib
192629|NCT02149758|Periodontitis|periodontitis
192630|NCT02149758|Superoxide dismutase|superoxide dismutase
235361|NCT01957072|BMI|bmi
183552|NCT02194101|oxygen delivery|oxygen delivery
193238|NCT02147015|Doses|doses
183553|NCT02194101|proximal femoral fracture|proximal femoral fracture
192631|NCT02149758|Saliva|saliva
192632|NCT02149732|Limbal stem cell deficiency|limbal stem cell deficiency
192633|NCT02149732|Cultivated oral mucosal cell sheet transplantation|cultivated oral mucosal cell sheet transplantation
192634|NCT02149732|Ocular surface reconstruction|ocular surface reconstruction
192635|NCT02149719|Peanut allergy|peanut allergy
192636|NCT02149719|Desensitisation|desensitisation
192637|NCT02149719|Safety|safety
192638|NCT02149706|Secondary Progress Multiple Sclerosis|secondary progress multiple sclerosis
192639|NCT02149706|SPMS|spms
192640|NCT02149706|Multiple Sclerosis|multiple sclerosis
192641|NCT02149706|NeuroVax|neurovax
192642|NCT02149693|Flipped classroom|flipped classroom
192643|NCT02149693|High-fidelity simulation|high-fidelity simulation
192644|NCT02149693|Medical education reform|medical education reform
192645|NCT02149693|Medical teamwork|medical teamwork
192646|NCT02149693|Resuscitation training|resuscitation training
192647|NCT02149680|Post-dural puncture headache|post-dural puncture headache
192648|NCT02149680|epidural blood patch|epidural blood patch
192649|NCT02149680|labour analgesia|labour analgesia
192650|NCT02149680|epidural analgesia|epidural analgesia
192651|NCT02149667|osteoarthritis|osteoarthritis
192652|NCT02149667|avascular necrosis|avascular necrosis
192653|NCT02149667|ankylosis|ankylosis
192654|NCT02149667|protrusio acetabuli|protrusio acetabuli
192655|NCT02149667|painful hip dysplasia|painful hip dysplasia
192656|NCT02149667|rheumatoid arthritis|rheumatoid arthritis
192657|NCT02149667|correction of functional deformity|correction of functional deformity
192658|NCT02149667|revision procedures|revision procedures
192659|NCT02149654|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
192660|NCT02149654|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
192788|NCT02148952|Maternal Morbidity|maternal morbidity
192661|NCT02149654|Engager transcatheter aortic valve implantation system|engager transcatheter aortic valve implantation system
192662|NCT02149654|Engager bioprosthesis|engager bioprosthesis
192663|NCT02149615|idiopathic intracranial hypertension|idiopathic intracranial hypertension
192664|NCT02149615|optic disc swelling|optic disc swelling
192665|NCT02149615|antiacne medication|antiacne medication
192666|NCT02149615|isotretinoin|isotretinoin
192667|NCT02149602|involvement of bilateral parapharyngeal spaces|involvement of bilateral parapharyngeal spaces
192668|NCT02149589|ARDS|ards
192669|NCT02149589|PEEP|peep
192670|NCT02149589|Recruitment manoeuvres|recruitment manoeuvres
192671|NCT02149589|Lung Morphology|lung morphology
192672|NCT02149576|Retrospective Review|retrospective review
192673|NCT02149576|Pilot Study|pilot study
192674|NCT02149576|Early Stage NSCLC|early stage nsclc
192675|NCT02149576|Post-Surgical Surveillance|post-surgical surveillance
192676|NCT02149576|Re-intervention Rates|re-intervention rates
192677|NCT02149550|Plasmodium falciparum|plasmodium falciparum
192678|NCT02149550|malaria|malaria
192679|NCT02149537|sickle cell disease|sickle cell disease
192680|NCT02149537|sickle cell anemia|sickle cell anemia
192681|NCT02149537|hydroxyurea|hydroxyurea
192682|NCT02149537|Nigeria|nigeria
192683|NCT02149537|low income country|low income country
192684|NCT02149537|middle income country|middle income country
192685|NCT02149537|developing country|developing country
192686|NCT02149524|HER2 Positive Breast Cancer|her2 positive breast cancer
192687|NCT02149524|Trastuzumab|trastuzumab
192688|NCT02149524|Biosimilar|biosimilar
192689|NCT02149498|Parkinson|parkinson
192691|NCT02149498|BNA|bna
192692|NCT02149485|PGD,|pgd,
192693|NCT02149485|follow up|follow up
192694|NCT02149459|Radiotherapy|radiotherapy
192695|NCT02149459|Ketosis|ketosis
192696|NCT02149459|Metformin|metformin
192697|NCT02149459|Magnetic Resonance Imaging|magnetic resonance imaging
192698|NCT02149459|Metabolome|metabolome
192699|NCT02149459|Insulin|insulin
192700|NCT02149459|recurrent brain tumors|recurrent brain tumors
192701|NCT02149459|gliomas|gliomas
192702|NCT02149459|glioblastomas|glioblastomas
192703|NCT02149459|astrocytomas|astrocytomas
192704|NCT02149446|Left sided pancreatic resections|left sided pancreatic resections
192705|NCT02149446|Distal pancreatic resections|distal pancreatic resections
192706|NCT02149446|Reinforced staple line|reinforced staple line
192707|NCT02149446|Post operative pancreatic fistula|post operative pancreatic fistula
192708|NCT02149433|Pneumocystis Jiroveci|pneumocystis jiroveci
192709|NCT02149433|Steroids|steroids
192710|NCT02149433|Infants|infants
192711|NCT02149420|primary Sjögren's syndrome, pharmacodynamics|primary sjögren's syndrome, pharmacodynamics
192712|NCT02149394|Thirst|thirst
192713|NCT02149394|Ice|ice
192714|NCT02149394|Water|water
192715|NCT02149394|Perioperative Nursing|perioperative nursing
192716|NCT02149394|Recovery Room|recovery room
192717|NCT02149381|Depression|depression
192718|NCT02149381|treatment as usual|treatment as usual
192719|NCT02149381|CBASP|cbasp
192720|NCT02149381|befriending|befriending
192721|NCT02149355|teeth position|teeth position
192722|NCT02149355|jaw alignment|jaw alignment
192723|NCT02149342|Actinic keratoses|actinic keratoses
192724|NCT02149342|Daylight-PDT|daylight-pdt
192725|NCT02149342|Hexylaminolaevulinate|hexylaminolaevulinate
192727|NCT02149342|Methylaminolaevulinate|methylaminolaevulinate
192728|NCT02149342|MAL|mal
192729|NCT02149342|Hyperspectral imaging|hyperspectral imaging
192730|NCT02149329|fever|fever
192731|NCT02149329|neutropenia|neutropenia
192732|NCT02149329|febrile neutropenia|febrile neutropenia
192733|NCT02149329|carbapenem|carbapenem
192734|NCT02149329|imipenem|imipenem
192735|NCT02149329|meropenem|meropenem
192736|NCT02149329|antibiotic stewardship|antibiotic stewardship
192737|NCT02149329|hematology|hematology
192738|NCT02149329|oncology|oncology
192739|NCT02149290|Heart Failure|heart failure
192740|NCT02149290|Six minute walk test|six minute walk test
192741|NCT02149277|Infertility|infertility
192742|NCT02149277|IVF|ivf
192743|NCT02149277|Embryo transfer|embryo transfer
192744|NCT02149251|Pre-genetic diagnosis|pre-genetic diagnosis
192745|NCT02149251|ICSI|icsi
192746|NCT02149238|flavanols|flavanols
192747|NCT02149238|cardiovascular effects|cardiovascular effects
192748|NCT02149238|nutrition-nutrition interaction|nutrition-nutrition interaction
192749|NCT02149225|Actively personalized peptide vaccinations|actively personalized peptide vaccinations
192750|NCT02149225|Newly diagnosed Glioblastoma|newly diagnosed glioblastoma
192751|NCT02149225|Concurrent to first line temozolomide maintenance therapy|concurrent to first line temozolomide maintenance therapy
192752|NCT02149212|Iliac|iliac
192753|NCT02149212|Vein|vein
192754|NCT02149212|Stent|stent
192755|NCT02149160|Histone deacetylase inhibitor|histone deacetylase inhibitor
192756|NCT02149160|Frontotemporal dementia|frontotemporal dementia
192757|NCT02149160|Granulin|granulin
192758|NCT02149147|physical activity|physical activity
192759|NCT02149147|environmental factors|environmental factors
192760|NCT02149147|variety|variety
192761|NCT02149147|MVPA|mvpa
192762|NCT02149095|treprostinil|treprostinil
192763|NCT02149082|Intracranial hematoma|intracranial hematoma
192764|NCT02149082|traumatic brain injury|traumatic brain injury
192765|NCT02149082|Near infrared spectroscopy|near infrared spectroscopy
192766|NCT02149082|NIRS|nirs
192767|NCT02149056|Platelets/Lymphocytes Rate;Serological Index;|platelets/lymphocytes rate;serological index;
192768|NCT02149043|inflammatory bowel disease|inflammatory bowel disease
192769|NCT02149043|ulcerative colitis|ulcerative colitis
192770|NCT02149043|thermography|thermography
192771|NCT02149043|endoscopy|endoscopy
192772|NCT02149043|CRP|crp
192773|NCT02149017|amyloid plaque|amyloid plaque
192774|NCT02149017|Positron-Emission Tomography|positron-emission tomography
192775|NCT02149017|radiopharmaceuticals|radiopharmaceuticals
192776|NCT02149004|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
192777|NCT02149004|Prevention|prevention
192778|NCT02149004|Long-term life|long-term life
192779|NCT02149004|Cure|cure
192780|NCT02149004|Cohort|cohort
192782|NCT02148965|clinical trials|clinical trials
192783|NCT02148965|pregnancy|pregnancy
192784|NCT02148965|hypertension|hypertension
192785|NCT02148965|cohort studies|cohort studies
192786|NCT02148952|Maternal Health|maternal health
192787|NCT02148952|Maternal Death|maternal death
192789|NCT02148952|Stillbirth|stillbirth
192790|NCT02148952|Neonatal Mortality|neonatal mortality
192791|NCT02148952|Quality Improvement|quality improvement
192895|NCT02148445|nicotine|nicotine
192792|NCT02148952|Resource Limited Settings|resource limited settings
192793|NCT02148952|Checklist|checklist
192794|NCT02148952|Safe Childbirth|safe childbirth
192795|NCT02148939|ischemic stroke|ischemic stroke
192796|NCT02148939|Antiplatelet Effects|antiplatelet effects
192797|NCT02148939|aspirin|aspirin
192798|NCT02148939|metamizole|metamizole
192799|NCT02148939|dipyrone|dipyrone
192800|NCT02148900|Marfan syndrome|marfan syndrome
192801|NCT02148900|blood test|blood test
192802|NCT02148900|aortic root size|aortic root size
192803|NCT02148900|Marfan related disorders|marfan related disorders
192804|NCT02148874|pregnant|pregnant
192805|NCT02148874|flu shot|flu shot
192806|NCT02148874|influenza|influenza
192807|NCT02148874|vaccine|vaccine
192808|NCT02148848|Osteoporosis|osteoporosis
192809|NCT02148848|Femoral neck fracture|femoral neck fracture
192810|NCT02148848|hemiarthroplasty|hemiarthroplasty
192811|NCT02148835|Omega-3 Index|omega-3 index
192812|NCT02148835|Bioavailability|bioavailability
192813|NCT02148835|Eicosapentaenoic acid|eicosapentaenoic acid
192814|NCT02148835|Docosahexaenoic acid|docosahexaenoic acid
192815|NCT02148835|Fortified food|fortified food
192816|NCT02148822|Visceral leishmaniasis|visceral leishmaniasis
192817|NCT02148822|kala azar|kala azar
192818|NCT02148822|malnutrition|malnutrition
192819|NCT02148822|stunting|stunting
192820|NCT02148822|thinness|thinness
192821|NCT02148822|Leishmania donovani|leishmania donovani
192822|NCT02148796|Wheezing|wheezing
192823|NCT02148796|Lower respiratory tract illness|lower respiratory tract illness
192824|NCT02148796|Asthma|asthma
192825|NCT02148796|Atopy|atopy
192826|NCT02148783|Traumatic brain injury|traumatic brain injury
192827|NCT02148783|Attention deficit and memory problems|attention deficit and memory problems
192828|NCT02148783|Methylphenidate|methylphenidate
192829|NCT02148783|Dopamine receptor imaging|dopamine receptor imaging
192830|NCT02148783|Motivation and reward|motivation and reward
192831|NCT02148783|Positron emission tomography|positron emission tomography
192832|NCT02148783|Transcranial magnetic stimulation|transcranial magnetic stimulation
192833|NCT02148770|rt-fmri|rt-fmri
192834|NCT02148770|self-control|self-control
192835|NCT02148770|eating behaviour|eating behaviour
192836|NCT02148770|overweight|overweight
192837|NCT02148770|neurofeedback|neurofeedback
192838|NCT02148757|DVT|dvt
192839|NCT02148731|Colon cancer|colon cancer
192840|NCT02148731|Elderly patients|elderly patients
192841|NCT02148718|Crohn's Disease|crohn's disease
192842|NCT02148705|fire/flame|fire/flame
192843|NCT02148705|scalds|scalds
192844|NCT02148705|contact|contact
192845|NCT02148679|Heart Failure|heart failure
192846|NCT02148679|Diet|diet
192847|NCT02148653|Cardiometabolic risk|cardiometabolic risk
192848|NCT02148653|Diet|diet
192849|NCT02148653|Dietary prevention|dietary prevention
192850|NCT02148653|Functional diet|functional diet
192851|NCT02148653|Functional foods|functional foods
192852|NCT02148653|Metabolic Syndrome|metabolic syndrome
192853|NCT02148653|Overweight|overweight
192854|NCT02148627|antibody|antibody
192855|NCT02148627|autoimmune|autoimmune
192856|NCT02148601|Fecal microbiota transplantation|fecal microbiota transplantation
192857|NCT02148601|Recurrent C. difficile infection|recurrent c. difficile infection
192858|NCT02148601|Colonoscopy|colonoscopy
192859|NCT02148601|Randomized clinical trial|randomized clinical trial
192860|NCT02148588|Central Post Stroke Pain|central post stroke pain
192861|NCT02148588|Nerve block|nerve block
192862|NCT02148575|Palliative Care|palliative care
192863|NCT02148575|Self-management|self-management
192864|NCT02148575|Breast Cancer|breast cancer
192865|NCT02148549|Borderline resectable pancreatic cancer|borderline resectable pancreatic cancer
192866|NCT02148549|R0 resection|r0 resection
192867|NCT02148549|Resection rate|resection rate
192868|NCT02148549|Optimal schedule|optimal schedule
192869|NCT02148523|Medication Adherence|medication adherence
192870|NCT02148523|High Blood Pressure|high blood pressure
192871|NCT02148523|Diabetes|diabetes
192872|NCT02148523|Statins|statins
192873|NCT02148510|human|human
192874|NCT02148510|sleep apnea|sleep apnea
192875|NCT02148510|adults|adults
192876|NCT02148510|oral appliance|oral appliance
192877|NCT02148510|efficacy|efficacy
192878|NCT02148510|safety|safety
192879|NCT02148510|polygraphy|polygraphy
192880|NCT02148510|bruxism|bruxism
192881|NCT02148510|cost|cost
192882|NCT02148497|volunteers|volunteers
192883|NCT02148484|PTSD|ptsd
192884|NCT02148484|Cognitive Behavioral Treatment|cognitive behavioral treatment
192885|NCT02148484|Child Sexual Abuse|child sexual abuse
192886|NCT02148471|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
192887|NCT02148471|Steatosis|steatosis
192888|NCT02148471|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
192889|NCT02148458|Intermittent fasting|intermittent fasting
192890|NCT02148458|Mediterranean diet|mediterranean diet
192891|NCT02148458|overweight|overweight
192892|NCT02148458|Calorie restriction|calorie restriction
192893|NCT02148445|smoking cessation|smoking cessation
192894|NCT02148445|tobacco use cessation products|tobacco use cessation products
192896|NCT02148432|sleep apnea syndrome, fiberoptic bronchoscopy, IV sedation|sleep apnea syndrome, fiberoptic bronchoscopy, iv sedation
192897|NCT02148419|quality of life|quality of life
192898|NCT02148419|maltreatment|maltreatment
192899|NCT02148419|neglect|neglect
192900|NCT02148419|childhood|childhood
192901|NCT02148406|Yoga|yoga
192902|NCT02148406|Mind-body therapies|mind-body therapies
192903|NCT02148406|Fatigue|fatigue
192904|NCT02148406|Colorectal cancer|colorectal cancer
192905|NCT02148406|Depressive symptoms|depressive symptoms
192906|NCT02148380|Lung adenocarcinoma,EGFR mutation, chemotherapy, gefitinib|lung adenocarcinoma,egfr mutation, chemotherapy, gefitinib
192907|NCT02148367|Traumatic brain injury|traumatic brain injury
192908|NCT02148367|Endothelial progenitor cells|endothelial progenitor cells
192909|NCT02148367|Cerebrovascular reactivity|cerebrovascular reactivity
192910|NCT02148367|Angiogenesis|angiogenesis
192911|NCT02148354|Depression|depression
192912|NCT02148354|Self-applied treatment|self-applied treatment
192913|NCT02148354|Internet|internet
192914|NCT02148354|Support by the therapist|support by the therapist
193164|NCT02147379|Euthymic|euthymic
192915|NCT02148354|Cognitive-Behavioural Treatment|cognitive-behavioural treatment
192916|NCT02148354|Positive Psychology|positive psychology
192917|NCT02148354|Behavioral Activation|behavioral activation
192918|NCT02148328|Healthy participants|healthy participants
192919|NCT02148328|Immunogenicity|immunogenicity
183840|NCT02192879|PCA|pca
192920|NCT02148328|Influenza|influenza
192921|NCT02148328|Prevention|prevention
192923|NCT02148315|physical activity|physical activity
192924|NCT02148315|children|children
192925|NCT02148315|school|school
192926|NCT02148315|garden|garden
192927|NCT02148302|Venous Leg Ulcerations|venous leg ulcerations
192928|NCT02148302|Epidermal Grafts|epidermal grafts
192929|NCT02148302|Chronic wounds|chronic wounds
192930|NCT02148302|Clinical trial|clinical trial
192931|NCT02148302|Protease levels in chronic wounds|protease levels in chronic wounds
192932|NCT02148289|COPD, beetroot, dietary nitrate, nitric oxide|copd, beetroot, dietary nitrate, nitric oxide
192933|NCT02148276|Social harm detection|social harm detection
192934|NCT02148276|Instrument development|instrument development
192935|NCT02148276|HIV-related clinical trials|hiv-related clinical trials
192936|NCT02148276|Substance abuse|substance abuse
192937|NCT02148276|Research participation|research participation
192938|NCT02148263|Contact Lenses|contact lenses
192939|NCT02148263|Neophytes|neophytes
192940|NCT02148263|Contact Lens Adaptation|contact lens adaptation
192941|NCT02148263|Randomized|randomized
192942|NCT02148250|Type 2 diabetes|type 2 diabetes
192943|NCT02148250|Insulin resistance|insulin resistance
192944|NCT02148250|High insulin requirements|high insulin requirements
192945|NCT02148250|U 500|u 500
192946|NCT02148237|Breastfeeding duration|breastfeeding duration
192947|NCT02148237|Puerto Rican mothers|puerto rican mothers
192948|NCT02148237|WIC program|wic program
192949|NCT02148237|Home-based individual breastfeeding consultation|home-based individual breastfeeding consultation
192950|NCT02148224|glycemic index|glycemic index
192951|NCT02148224|body composition|body composition
192952|NCT02148211|Fluarix Quadrivalent|fluarix quadrivalent
192953|NCT02148211|Fluarix|fluarix
192954|NCT02148211|FluLaval|flulaval
192955|NCT02148211|FluLaval Quadrivalent|flulaval quadrivalent
192956|NCT02148211|Pregnancy Registry|pregnancy registry
192957|NCT02148211|Pregnancy outcome|pregnancy outcome
192958|NCT02148185|Crohn's disease|crohn's disease
192959|NCT02148172|Knee|knee
192960|NCT02148172|plyometrics|plyometrics
192961|NCT02148172|motor learning|motor learning
192962|NCT02148172|psychological factors|psychological factors
192963|NCT02148159|anorexia|anorexia
192964|NCT02148159|cachexia|cachexia
192965|NCT02148159|cancer|cancer
192966|NCT02148159|unintentional weigh loss|unintentional weigh loss
192967|NCT02148159|gastrointestinal tract|gastrointestinal tract
192968|NCT02148159|adults|adults
192969|NCT02148146|short bowel syndrome|short bowel syndrome
192970|NCT02148146|intestinal failure|intestinal failure
192971|NCT02148146|total parenteral nutrition associated cholestasis|total parenteral nutrition associated cholestasis
192972|NCT02148133|Thrombocytopenia|thrombocytopenia
192973|NCT02148133|Eltrombopag|eltrombopag
192974|NCT02148133|Aplastic Anemia (AA)|aplastic anemia (aa)
192975|NCT02148133|Thrombopoietin|thrombopoietin
192977|NCT02148094|AIDS|aids
192978|NCT02148094|India|india
192979|NCT02148094|Prevention|prevention
192980|NCT02148094|Female sex workers|female sex workers
192981|NCT02148094|PrEP|prep
192982|NCT02148094|Pre-exposure prophylaxis|pre-exposure prophylaxis
192984|NCT02148094|Tenofovir|tenofovir
192985|NCT02148081|pediatrics, critical illness, recovery, function, health|pediatrics, critical illness, recovery, function, health
192986|NCT02148068|Obesity|obesity
192987|NCT02148068|Bariatric Surgery|bariatric surgery
192991|NCT02148055|fetal MRI|fetal mri
192992|NCT02148055|autopsy|autopsy
192993|NCT02148042|Anorexia|anorexia
192994|NCT02148042|Generalized anxiety|generalized anxiety
192995|NCT02148042|Fear|fear
192996|NCT02148029|Deep vein thrombosis|deep vein thrombosis
192997|NCT02148029|Post thrombotic syndrome|post thrombotic syndrome
192998|NCT02148029|Thrombus resolution|thrombus resolution
192999|NCT02148016|Corneal disorders|corneal disorders
193000|NCT02148016|Chemical injury|chemical injury
193001|NCT02148016|Pterygium|pterygium
193002|NCT02148016|Refractive error|refractive error
193003|NCT02148016|Myopia|myopia
193004|NCT02148016|Hyperopia|hyperopia
193005|NCT02148016|Cornea|cornea
193006|NCT02148016|Monocular|monocular
193007|NCT02148016|Transparent|transparent
193008|NCT02148016|Transplantation|transplantation
193009|NCT02148016|Visual function|visual function
193010|NCT02147990|cancer|cancer
193011|NCT02147990|metastatic|metastatic
193012|NCT02147990|locally advanced|locally advanced
193013|NCT02147990|lung|lung
193014|NCT02147990|non-small cell lung cancer|non-small cell lung cancer
193015|NCT02147990|NSCLC|nsclc
193016|NCT02147990|epidermal growth factor receptor|epidermal growth factor receptor
193017|NCT02147990|EGFR|egfr
193018|NCT02147990|T790M|t790m
193019|NCT02147990|CO-1686|co-1686
193020|NCT02147990|unresectable|unresectable
193021|NCT02147990|recurrent|recurrent
193022|NCT02147990|EGFR-directed therapy|egfr-directed therapy
193023|NCT02147990|irreversible EGFR inhibitor|irreversible egfr inhibitor
193024|NCT02147990|TIGER|tiger
193025|NCT02147990|Rociletinib|rociletinib
193026|NCT02147977|Renal Dialysis|renal dialysis
193027|NCT02147977|Arrhythmias Cardiac|arrhythmias cardiac
193028|NCT02147977|Death Sudden Cardiac|death sudden cardiac
193029|NCT02147977|Fatty Acids Omega 3|fatty acids omega 3
193030|NCT02147964|intratesticular androgens|intratesticular androgens
193031|NCT02147964|testosterone|testosterone
193032|NCT02147964|dutasteride|dutasteride
193033|NCT02147964|gonadotropin suppression|gonadotropin suppression
193034|NCT02147964|male contraception|male contraception
193035|NCT02147964|spermatogenesis|spermatogenesis
193036|NCT02147951|Melanoma|melanoma
193042|NCT02147925|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
193043|NCT02147925|Glucagon-like peptide-1 receptor agonists|glucagon-like peptide-1 receptor agonists
193044|NCT02147925|Diabetes mellitus, type 2|diabetes mellitus, type 2
193045|NCT02147912|Depression|depression
193046|NCT02147912|COPD|copd
193047|NCT02147912|Aerobic Exercise|aerobic exercise
193048|NCT02147912|Anxiety|anxiety
193049|NCT02147912|Quality of life|quality of life
193050|NCT02147912|neurocognitive functioning|neurocognitive functioning
193051|NCT02147886|Bioblast, Randomized, parallel-group, and dose-controlled|bioblast, randomized, parallel-group, and dose-controlled
193052|NCT02147873|MDS|mds
193053|NCT02147873|CMML|cmml
193054|NCT02147873|myelodysplastic syndrome|myelodysplastic syndrome
193055|NCT02147873|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
193056|NCT02147873|TL32711|tl32711
193057|NCT02147873|TL32711-0094|tl32711-0094
193058|NCT02147873|azacitidine|azacitidine
193059|NCT02147873|birinapant|birinapant
193060|NCT02147873|higher risk|higher risk
193061|NCT02147873|naive|naive
193062|NCT02147873|double blind|double blind
193063|NCT02147873|placebo|placebo
193064|NCT02147873|placebo controlled|placebo controlled
193065|NCT02147873|randomized|randomized
193066|NCT02147860|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
193067|NCT02147860|Artificial Pancreas Project (APP)|artificial pancreas project (app)
193068|NCT02147860|Diabetes Assistant (DiAs)|diabetes assistant (dias)
193069|NCT02147860|Closed-Loop Control (CLC)|closed-loop control (clc)
193070|NCT02147860|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
193071|NCT02147860|Insulin Pump|insulin pump
193072|NCT02147847|Presbycusis|presbycusis
193073|NCT02147847|Hearing In Noise|hearing in noise
193074|NCT02147847|Hearing Impairment|hearing impairment
193075|NCT02147847|Hearing Loss|hearing loss
193076|NCT02147847|Aging|aging
193077|NCT02147847|Plasticity|plasticity
193078|NCT02147847|Video Games|video games
193079|NCT02147847|Perceptual Learning|perceptual learning
193080|NCT02147834|deferred percutaneous coronary intervention|deferred percutaneous coronary intervention
193081|NCT02147834|fractional flow reserve|fractional flow reserve
193082|NCT02147795|Patient Blood Management|patient blood management
193083|NCT02147795|Red Blood Cell Transfusion Practice|red blood cell transfusion practice
193084|NCT02147795|Patient Safety|patient safety
193085|NCT02147795|Anemia|anemia
193086|NCT02147795|Clinical Outcome|clinical outcome
193087|NCT02147795|perioperative care|perioperative care
193088|NCT02147782|chronic renal insufficient, renal osteodystrophy, bone mineral density, bone turnover, kidney function|chronic renal insufficient, renal osteodystrophy, bone mineral density, bone turnover, kidney function
193089|NCT02147769|cerebral autoregulation|cerebral autoregulation
193091|NCT02147769|near-infrared spectroscopy|near-infrared spectroscopy
193092|NCT02147756|Skin pigmentation, skin texture disorders, fractional laser, CO2, fractional CO2, Syneron, Solta.|skin pigmentation, skin texture disorders, fractional laser, co2, fractional co2, syneron, solta.
193093|NCT02147743|Adolescents|adolescents
193094|NCT02147743|Family-Based treatment|family-based treatment
193095|NCT02147743|Multidimensional Family Therapy|multidimensional family therapy
193096|NCT02147730|chronic pain|chronic pain
193097|NCT02147717|preterm newborns|preterm newborns
193098|NCT02147717|Transfontanellar ultrafast doppler|transfontanellar ultrafast doppler
193099|NCT02147717|Acupuncture|acupuncture
193100|NCT02147717|perioperative pain|perioperative pain
193101|NCT02147717|surgery of the ductus arteriosus|surgery of the ductus arteriosus
193102|NCT02147665|Hookah|hookah
193103|NCT02147665|waterpipe|waterpipe
193104|NCT02147665|smoking|smoking
193105|NCT02147665|sympathetic|sympathetic
193106|NCT02147652|moderate dementia|moderate dementia
193107|NCT02147652|severe dementia|severe dementia
193108|NCT02147652|Alzheimer's disease|alzheimer's disease
193109|NCT02147652|Vascular dementia|vascular dementia
193110|NCT02147652|agitation|agitation
193111|NCT02147652|personalized music therapy|personalized music therapy
193112|NCT02147626|preeclampsia|preeclampsia
193113|NCT02147626|cardiovascular disease|cardiovascular disease
193114|NCT02147626|health behaviors|health behaviors
193115|NCT02147626|behavioral intervention|behavioral intervention
193116|NCT02147626|web-based|web-based
193117|NCT02147626|Hypertension|hypertension
193118|NCT02147626|Post-partum Weight Retention|post-partum weight retention
193119|NCT02147600|adalimumab|adalimumab
193120|NCT02147600|biologicals|biologicals
193121|NCT02147600|immunogenicity|immunogenicity
193122|NCT02147574|slow-transit constipation|slow-transit constipation
193123|NCT02147574|laparoscope Sub-total Colectomy|laparoscope sub-total colectomy
193124|NCT02147574|anti-peristaltic anastomosis|anti-peristaltic anastomosis
193125|NCT02147522|community health worker|community health worker
193126|NCT02147522|promotoras|promotoras
193127|NCT02147522|self-care behaviors activation|self-care behaviors activation
193128|NCT02147522|depression|depression
193129|NCT02147522|low-income patients|low-income patients
193130|NCT02147522|safety-net care|safety-net care
193131|NCT02147509|Dry eye|dry eye
193132|NCT02147509|Therapeutic bandage contact lenses|therapeutic bandage contact lenses
193133|NCT02147509|The quality of life|the quality of life
193134|NCT02147496|Food intake|food intake
193136|NCT02147496|Blood glucose|blood glucose
193137|NCT02147496|Insulin|insulin
193138|NCT02147496|Dairy|dairy
193139|NCT02147496|Milk|milk
193140|NCT02147483|Mindfulness|mindfulness
193141|NCT02147483|Alcohol use disorders|alcohol use disorders
193142|NCT02147470|cirrhosis of the liver|cirrhosis of the liver
193143|NCT02147470|Acute kidney injury|acute kidney injury
193144|NCT02147457|Prematurity|prematurity
193145|NCT02147457|Extremely low birth weight|extremely low birth weight
193146|NCT02147457|Phenotyping|phenotyping
193147|NCT02147444|Rivaroxaban|rivaroxaban
193148|NCT02147444|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
193149|NCT02147444|NOAC|noac
193150|NCT02147444|Xa inhibitor|xa inhibitor
193151|NCT02147418|Head and neck cancer|head and neck cancer
193152|NCT02147418|Throat cancer|throat cancer
193153|NCT02147418|Human papillomavirus|human papillomavirus
193154|NCT02147418|HPV|hpv
193155|NCT02147418|Exosome|exosome
193156|NCT02147418|Diagnostic|diagnostic
193157|NCT02147418|Early Detection|early detection
193158|NCT02147405|FDG PET/CT Scan|fdg pet/ct scan
193159|NCT02147405|Lymph Node Biopsy|lymph node biopsy
193160|NCT02147405|Apheresis|apheresis
193161|NCT02147392|PET Imaging|pet imaging
193162|NCT02147379|Bipolar Disorder|bipolar disorder
193163|NCT02147379|Cognition|cognition
193165|NCT02147379|Lurasidone|lurasidone
193166|NCT02147366|Hypertension,ambulatory pressure,autonomic function,music|hypertension,ambulatory pressure,autonomic function,music
193167|NCT02147353|External Genital Warts|external genital warts
193168|NCT02147353|Sinecatechins|sinecatechins
193169|NCT02147353|Cryotherapy|cryotherapy
193170|NCT02147340|Heart Failure patients|heart failure patients
193171|NCT02147340|Remote Patient Management|remote patient management
193172|NCT02147340|External Sensors|external sensors
193173|NCT02147327|vitamin D|vitamin d
193174|NCT02147327|cord blood|cord blood
193175|NCT02147327|neonatal sepsis|neonatal sepsis
193176|NCT02147327|neonatal morbidity|neonatal morbidity
193177|NCT02147314|diabetes|diabetes
193178|NCT02147314|glucometer|glucometer
193179|NCT02147314|Yofimeter|yofimeter
193180|NCT02147314|diabetes monitoring|diabetes monitoring
193181|NCT02147275|hypertension|hypertension
193182|NCT02147275|cerebral oxygen saturation|cerebral oxygen saturation
193183|NCT02147275|near-infrared spectroscopy|near-infrared spectroscopy
193184|NCT02147275|cognitive function|cognitive function
193185|NCT02147262|chronic atrophic acrodermatitis|chronic atrophic acrodermatitis
193186|NCT02147262|Lyme borreliosis|lyme borreliosis
193187|NCT02147262|molecular characteristics|molecular characteristics
193188|NCT02147262|outcome|outcome
193189|NCT02147249|erythema migrans|erythema migrans
193190|NCT02147249|Lyme borreliosis|lyme borreliosis
193191|NCT02147249|inflammation|inflammation
193192|NCT02147249|outcome|outcome
193193|NCT02147236|autism|autism
193194|NCT02147236|pervasive developmental disorders|pervasive developmental disorders
193195|NCT02147236|social skills intervention|social skills intervention
193196|NCT02147223|flavanols|flavanols
193197|NCT02147223|sex-related cardiovascular effects|sex-related cardiovascular effects
193198|NCT02147210|Chronic transplant glomerulopathy|chronic transplant glomerulopathy
193199|NCT02147210|antibody mediated rejection|antibody mediated rejection
193200|NCT02147210|Ephrin-B1|ephrin-b1
193201|NCT02147184|SSRI|ssri
193202|NCT02147184|serotonin transporter|serotonin transporter
193204|NCT02147184|pQCT|pqct
193205|NCT02147184|bone mass|bone mass
193206|NCT02147184|adolescents|adolescents
193207|NCT02147171|Retinal ageing, macular pigment, visual function|retinal ageing, macular pigment, visual function
193208|NCT02147145|GIST|gist
193209|NCT02147145|endoscopy|endoscopy
193210|NCT02147145|endoscopic ultrasound|endoscopic ultrasound
193211|NCT02147132|Cigarette|cigarette
193212|NCT02147132|Methadone|methadone
193213|NCT02147132|Smoking|smoking
193214|NCT02147132|Cessation|cessation
193215|NCT02147132|Varenicline|varenicline
193216|NCT02147132|Nicotine|nicotine
193217|NCT02147106|Neuroendocrine tumor|neuroendocrine tumor
193218|NCT02147106|Videoconsultation|videoconsultation
193219|NCT02147106|Feasibility|feasibility
193220|NCT02147080|prevention or control|prevention or control
193221|NCT02147067|microvascular angina|microvascular angina
193222|NCT02147067|coronary microvascular disease|coronary microvascular disease
193223|NCT02147067|coronary physiology|coronary physiology
193224|NCT02147067|ranolazine|ranolazine
193225|NCT02147054|Organophosphate poisoning|organophosphate poisoning
193226|NCT02147054|Intermediate syndrome|intermediate syndrome
193227|NCT02147054|Rocuronium|rocuronium
193228|NCT02147041|diabetes mellitus|diabetes mellitus
193229|NCT02147041|hyperlipidemia|hyperlipidemia
193230|NCT02147041|green tea|green tea
193231|NCT02147041|epigallocatechin gallate|epigallocatechin gallate
193232|NCT02147028|whole brain RT|whole brain rt
193233|NCT02147028|hippocampal sparing|hippocampal sparing
193234|NCT02147028|neurocognitive function|neurocognitive function
193235|NCT02147015|Acute Exacerbations|acute exacerbations
193236|NCT02147015|Corticosteroids|corticosteroids
193237|NCT02147015|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
193239|NCT02147002|Chronic Kidney Disease|chronic kidney disease
193240|NCT02147002|Cardiovascular Complications|cardiovascular complications
193241|NCT02146989|Cerebral Palsy|cerebral palsy
193242|NCT02146989|child|child
193243|NCT02146989|upper extremity|upper extremity
193244|NCT02146989|strength, reproducibility|strength, reproducibility
193245|NCT02146976|postoperative|postoperative
193246|NCT02146976|sleep quality|sleep quality
193247|NCT02146976|propofol|propofol
193248|NCT02146976|sevoflurane|sevoflurane
193249|NCT02146950|LCS-12|lcs-12
193250|NCT02146950|Intrauterine Device (IUD)|intrauterine device (iud)
193251|NCT02146950|Intrauterine System (IUS)|intrauterine system (ius)
193252|NCT02146950|Levonorgestrel|levonorgestrel
193253|NCT02146950|Pearl Index|pearl index
193254|NCT02146950|Hormonal Contraception|hormonal contraception
193255|NCT02146937|active surveillance|active surveillance
193256|NCT02146937|MRI/transrectal ultrasound fusion guided biopsy|mri/transrectal ultrasound fusion guided biopsy
193257|NCT02146937|biopsy|biopsy
193258|NCT02146911|Smoking Cessation Medication|smoking cessation medication
193259|NCT02146911|Smoking Treatment|smoking treatment
193260|NCT02146911|Tobacco Treatment|tobacco treatment
193261|NCT02146911|Quitting Smoking|quitting smoking
193262|NCT02146911|Bupropion|bupropion
193263|NCT02146911|Varenicline|varenicline
193264|NCT02146911|Efficacy|efficacy
193265|NCT02146911|Pharmacogenetics of Smoking Treatment|pharmacogenetics of smoking treatment
193266|NCT02146911|Genetics analysis|genetics analysis
193267|NCT02146911|Smoking Personality|smoking personality
193268|NCT02146911|Dependence|dependence
193269|NCT02146911|Addiction|addiction
193270|NCT02146911|Cigarettes|cigarettes
193271|NCT02146911|Primary Care Physicians|primary care physicians
193272|NCT02146911|Biochemical Confirmation|biochemical confirmation
193273|NCT02146898|spinal anesthesia|spinal anesthesia
193274|NCT02146898|hypotension|hypotension
193275|NCT02146898|pregnancy|pregnancy
193276|NCT02146872|Coronary Artery Disease|coronary artery disease
193277|NCT02146872|Myocardial Infarction|myocardial infarction
193278|NCT02146872|Atherosclerosis|atherosclerosis
585917|NCT00522769|binge eating|binge eating
193279|NCT02146872|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
193280|NCT02146872|Sequence Analysis, DNA|sequence analysis, dna
193281|NCT02146872|Genetic Testing|genetic testing
193282|NCT02146872|Genetic Linkage|genetic linkage
193283|NCT02146859|residual neuromuscular blockade|residual neuromuscular blockade
193285|NCT02146833|castrate-resistant prostate cancer|castrate-resistant prostate cancer
193286|NCT02146833|prostate cancer|prostate cancer
193287|NCT02146833|Karyopharm|karyopharm
193288|NCT02146833|KPT-330|kpt-330
193289|NCT02146833|selinexor|selinexor
193290|NCT02146820|Pigmented Lesions, Skin Pigment, Picosecond Laser, Syneron|pigmented lesions, skin pigment, picosecond laser, syneron
193291|NCT02146807|Tattoos, Picosecond Laser, Syneron|tattoos, picosecond laser, syneron
193293|NCT02146742|Japanese subjects|japanese subjects
193294|NCT02146742|Safety|safety
193295|NCT02146742|Pharmacokinetics|pharmacokinetics
193296|NCT02146742|Pharmacodynamics|pharmacodynamics
193297|NCT02146729|Randomized|randomized
193298|NCT02146729|Thoracolumbar fractures|thoracolumbar fractures
193299|NCT02146729|Spine Trauma|spine trauma
193300|NCT02146729|Percutaneous Pedicle Screw Fixation|percutaneous pedicle screw fixation
193301|NCT02146729|Functional Outcome|functional outcome
193302|NCT02146716|RESC, alcohol withdrawal syndrome|resc, alcohol withdrawal syndrome
193303|NCT02146703|biliary tract neoplasm|biliary tract neoplasm
193304|NCT02146703|gemcitabine|gemcitabine
193305|NCT02146703|S-1|s-1
193306|NCT02146690|pathology|pathology
193307|NCT02146690|newborn|newborn
193308|NCT02146690|osteopathic manipulative treatment|osteopathic manipulative treatment
193309|NCT02146690|pain|pain
193310|NCT02146677|prematurity|prematurity
193311|NCT02146677|newborns|newborns
193312|NCT02146677|pain|pain
193313|NCT02146677|cost|cost
193314|NCT02146664|Acute NSTEMI|acute nstemi
193315|NCT02146664|DLBS1033|dlbs1033
193316|NCT02146664|SPECT|spect
193317|NCT02146664|Infarct size|infarct size
193318|NCT02146664|Left ventricular function|left ventricular function
193319|NCT02146638|post operative analgesia, morphine, fentanyl|post operative analgesia, morphine, fentanyl
193320|NCT02146573|Intensive Care Units, Pediatric|intensive care units, pediatric
193321|NCT02146573|Communication|communication
193322|NCT02146573|Health personnel|health personnel
193323|NCT02146573|Decision making|decision making
193324|NCT02146573|Critical Care|critical care
193325|NCT02146573|Length of Stay|length of stay
193326|NCT02146573|Iatrogenic Disease|iatrogenic disease
193327|NCT02146560|Surgery|surgery
193328|NCT02146560|Non-cardiac|non-cardiac
193329|NCT02146560|Elective|elective
193330|NCT02146560|Adult|adult
193331|NCT02146560|Patients|patients
193332|NCT02146560|Troponin|troponin
193333|NCT02146560|Myocardial|myocardial
193334|NCT02146560|Injury|injury
193335|NCT02146560|Postoperative|postoperative
193336|NCT02146560|Recovery|recovery
193337|NCT02146560|Outcome|outcome
193338|NCT02146547|depot, oral, antipsychotics, paliperidone, aripiprazole|depot, oral, antipsychotics, paliperidone, aripiprazole
193339|NCT02146521|z-axis limited CT|z-axis limited ct
193340|NCT02146521|computed tomography|computed tomography
193341|NCT02146521|CT|ct
193342|NCT02146521|abdominal non-traumatic pain and tenderness|abdominal non-traumatic pain and tenderness
193343|NCT02146521|emergency patients|emergency patients
193344|NCT02146508|Esophageal cancer|esophageal cancer
193345|NCT02146508|Radiofrequency, catheter ablation|radiofrequency, catheter ablation
193346|NCT02146508|Endoscopic mucosal resection|endoscopic mucosal resection
193347|NCT02146508|Esophageal squamous dysplasia|esophageal squamous dysplasia
193348|NCT02146508|Cancer prevention|cancer prevention
193349|NCT02146482|back pain|back pain
193350|NCT02146482|low back pain|low back pain
193351|NCT02146482|sit-stand workstation|sit-stand workstation
193352|NCT02146482|standing desk|standing desk
193353|NCT02146469|varicella vaccination|varicella vaccination
193354|NCT02146443|Manual dexterity|manual dexterity
193355|NCT02146443|hand to eye coordination|hand to eye coordination
193356|NCT02146443|stress|stress
193357|NCT02146443|fatigue|fatigue
193358|NCT02146430|pain|pain
193359|NCT02146430|fibromyalgia|fibromyalgia
193360|NCT02146417|Low pressure pneumoperitoneum|low pressure pneumoperitoneum
193361|NCT02146417|Deep neuromuscular block|deep neuromuscular block
193362|NCT02146404|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
193363|NCT02146404|Hypoglycemia unawareness|hypoglycemia unawareness
193364|NCT02146404|1H MRS|1h mrs
193365|NCT02146404|Lactate|lactate
193366|NCT02146352|Pancreatic pseudocyst|pancreatic pseudocyst
193367|NCT02146339|nutrition|nutrition
193368|NCT02146339|milk|milk
193369|NCT02146339|polar lipids|polar lipids
193370|NCT02146339|cardiometabolic risk|cardiometabolic risk
193371|NCT02146300|birch pollen|birch pollen
193372|NCT02146300|allergy|allergy
193373|NCT02146300|breathing|breathing
193374|NCT02146300|pattern|pattern
193375|NCT02146300|exposure|exposure
193376|NCT02146287|cycled light|cycled light
193377|NCT02146287|preterm infants|preterm infants
193378|NCT02146287|infant neurodevelopment|infant neurodevelopment
193380|NCT02146274|PROSPER|prosper
193381|NCT02146274|Stroke|stroke
193382|NCT02146274|Ischemic Stroke|ischemic stroke
193383|NCT02146261|Volunteers|volunteers
193384|NCT02146261|Japanese|japanese
193385|NCT02146261|Males|males
193386|NCT02146248|hysterosalpingography, DMPA, combined oral contraceptive, tubal patency|hysterosalpingography, dmpa, combined oral contraceptive, tubal patency
193387|NCT02146235|Music Therapy|music therapy
193388|NCT02146235|Pulmonary Disease|pulmonary disease
193389|NCT02146235|COPD|copd
193390|NCT02146235|Music Visualization|music visualization
193391|NCT02146235|Therapeutic Singing|therapeutic singing
193392|NCT02146235|Wind-playing|wind-playing
193393|NCT02146235|Lung Condition|lung condition
193394|NCT02146196|Heart failure|heart failure
193395|NCT02146196|robotic assisted gait therapy|robotic assisted gait therapy
193396|NCT02146183|Stevio glycosides|stevio glycosides
193397|NCT02146183|sport|sport
193398|NCT02146183|glycogen|glycogen
193399|NCT02146170|Sample Acquisition|sample acquisition
193400|NCT02146170|Generic and Epigenetic Alterations|generic and epigenetic alterations
193401|NCT02146170|Mig6 Expression|mig6 expression
193402|NCT02146170|Proteomic Analysis|proteomic analysis
193403|NCT02146170|Genomic Analysis|genomic analysis
193404|NCT02146144|Idiopathic epimacular membrane|idiopathic epimacular membrane
193405|NCT02146144|internal limiting membrane peeling|internal limiting membrane peeling
193406|NCT02146144|microscotomas|microscotomas
193407|NCT02146131|Peripheral pulmonary lesions|peripheral pulmonary lesions
193408|NCT02146131|Solitary pulmonary lesions|solitary pulmonary lesions
193409|NCT02146131|Multiple pulmonary lesions|multiple pulmonary lesions
193410|NCT02146118|Erlotinib|erlotinib
193411|NCT02146118|Silybin-phytosome|silybin-phytosome
193412|NCT02146118|EGFR mutant lung adenocarcinoma|egfr mutant lung adenocarcinoma
193413|NCT02146092|lung resection|lung resection
193414|NCT02146092|incentive spirometry|incentive spirometry
193415|NCT02146092|physiotherapy|physiotherapy
193416|NCT02146092|quality improvement|quality improvement
193417|NCT02146092|outcomes|outcomes
193418|NCT02146092|post operative complications|post operative complications
193420|NCT02146066|Brain tumor|brain tumor
193421|NCT02146066|glioblastoma|glioblastoma
193422|NCT02146066|Brain tumor WHO grade IV|brain tumor who grade iv
193423|NCT02146053|healthy participants|healthy participants
193424|NCT02146053|gastrointestinal side-effects associated with oral iron|gastrointestinal side-effects associated with oral iron
193425|NCT02146040|anticoagulation|anticoagulation
193426|NCT02146040|atrial fibrillation|atrial fibrillation
193427|NCT02146040|cardioversion|cardioversion
193428|NCT02146040|complications|complications
193429|NCT02146040|hemorrhage|hemorrhage
193430|NCT02146040|medications|medications
193431|NCT02146040|thromboembolism|thromboembolism
193433|NCT02146040|stroke|stroke
193434|NCT02146040|treatment|treatment
193435|NCT02146027|HIV|hiv
193436|NCT02146027|Lactobacillus casei Shirota|lactobacillus casei shirota
193437|NCT02146027|NK cell|nk cell
193438|NCT02146027|CD4|cd4
193439|NCT02146027|Lymphocyte|lymphocyte
193440|NCT02146027|Cell activation|cell activation
193441|NCT02146027|Antiretroviral therapy|antiretroviral therapy
193442|NCT02146027|Immune discordants|immune discordants
193443|NCT02146014|cigarette smoking, smoking|cigarette smoking, smoking
193444|NCT02146001|sedentary behavior|sedentary behavior
193445|NCT02146001|physical activity|physical activity
193446|NCT02146001|older adults|older adults
193447|NCT02145988|DLBS1033|dlbs1033
193448|NCT02145988|Peripheral arterial disease|peripheral arterial disease
193449|NCT02145988|Ankle-brachial index|ankle-brachial index
193450|NCT02145975|Severe postoperative pain|severe postoperative pain
193451|NCT02145975|Morphine|morphine
193452|NCT02145975|Fentanyl|fentanyl
193453|NCT02145975|Time to titration of pain|time to titration of pain
193454|NCT02145975|Pain and PACU|pain and pacu
193455|NCT02145975|Anesthesiology|anesthesiology
193456|NCT02145962|diabetic foot ulcer healing|diabetic foot ulcer healing
193457|NCT02145962|magnetic therapy|magnetic therapy
193458|NCT02145962|safety and efficacy|safety and efficacy
193459|NCT02145962|wound care|wound care
193460|NCT02145949|aging|aging
193461|NCT02145949|clinical|clinical
193462|NCT02145949|translational|translational
193463|NCT02145949|functional mobility|functional mobility
193464|NCT02145949|total knee arthroplasty|total knee arthroplasty
193466|NCT02145923|Hodgkin Lymphoma|hodgkin lymphoma
193467|NCT02145923|Non-Hodgkin's Lymphomas|non-hodgkin's lymphomas
193468|NCT02145923|Allogeneic Mesenchymal Stem Cell Transplantation|allogeneic mesenchymal stem cell transplantation
193469|NCT02145923|Autologous Peripheral Blood Stem Cell Transplantation|autologous peripheral blood stem cell transplantation
193470|NCT02145923|Neutropenic Enterocolitis|neutropenic enterocolitis
193471|NCT02145923|Myeloablative Chemotherapy|myeloablative chemotherapy
193472|NCT02145923|Bone Marrow Aplasia|bone marrow aplasia
193473|NCT02145897|CLI|cli
193474|NCT02145884|hemangioma|hemangioma
193475|NCT02145884|birthmark|birthmark
193476|NCT02145884|strawberry hemangioma|strawberry hemangioma
193477|NCT02145884|timolol|timolol
193478|NCT02145871|Radical Cystectomy|radical cystectomy
193479|NCT02145871|Perioperative Fluid Management|perioperative fluid management
193480|NCT02145871|EV1000|ev1000
193481|NCT02145871|14-069|14-069
201001|NCT02112656|Liver Diseases|liver diseases
201002|NCT02112656|Doxorubicin|doxorubicin
201003|NCT02112656|Antibiotics, Antineoplastic|antibiotics, antineoplastic
201004|NCT02112656|Antineoplastic Agents|antineoplastic agents
193482|NCT02145858|Chest tube, chest drainage, chest tube clogging, retained blood complications, hemothorax, tamponade, heart surgery, pleural effusion, intensive care|chest tube, chest drainage, chest tube clogging, retained blood complications, hemothorax, tamponade, heart surgery, pleural effusion, intensive care
193483|NCT02145845|critical limb ischemia|critical limb ischemia
193484|NCT02145845|wound healing|wound healing
193486|NCT02145832|TINN|tinn
193487|NCT02145832|Pharmacokinetic|pharmacokinetic
193488|NCT02145832|Neonates|neonates
193489|NCT02145832|Antifungal|antifungal
193490|NCT02145832|Fluconazole|fluconazole
193491|NCT02145832|Micafungin|micafungin
193492|NCT02145806|Urinary incontinence|urinary incontinence
193493|NCT02145806|Validation study|validation study
193494|NCT02145806|Pregnant women|pregnant women
193495|NCT02145806|Postpartum period|postpartum period
193496|NCT02145793|primary care|primary care
193497|NCT02145793|pediatrics|pediatrics
193498|NCT02145793|parenting|parenting
193499|NCT02145793|education|education
193500|NCT02145780|Overfeeding|overfeeding
193501|NCT02145780|Fat distribution|fat distribution
193502|NCT02145780|Subcutaneous and visceral adipose tissue|subcutaneous and visceral adipose tissue
193503|NCT02145780|Insulin sensitivity|insulin sensitivity
193504|NCT02145780|Insulin resistance|insulin resistance
193505|NCT02145780|Peripheral and hepatic insulin sensitivity|peripheral and hepatic insulin sensitivity
193506|NCT02145780|Stable isotopes|stable isotopes
193507|NCT02145780|Lipid oxidation|lipid oxidation
193508|NCT02145780|Energy expenditure|energy expenditure
193509|NCT02145780|Muscle and subcutaneous adipose tissue gene expression|muscle and subcutaneous adipose tissue gene expression
193510|NCT02145754|erythema migrans|erythema migrans
193511|NCT02145754|Lyme borreliosis|lyme borreliosis
193512|NCT02145754|Borrelia burgdorferi|borrelia burgdorferi
193513|NCT02145754|skin culture|skin culture
193514|NCT02145754|culture media|culture media
193515|NCT02145728|Non-specific chronic low back pain|non-specific chronic low back pain
193516|NCT02145728|Cognitive functional therapy|cognitive functional therapy
193517|NCT02145728|Exercise classes|exercise classes
193518|NCT02145702|ESRD|esrd
193519|NCT02145702|Kidney Failure|kidney failure
193520|NCT02145702|Exercise|exercise
193521|NCT02145702|Cognitive impairment|cognitive impairment
193522|NCT02145637|Cancer, Lung cancer, Head and neck squamous cell carcinoma, Afatinib, Ruxolitinib, EGFR, JAK, STAT|cancer, lung cancer, head and neck squamous cell carcinoma, afatinib, ruxolitinib, egfr, jak, stat
193523|NCT02145624|pertussis|pertussis
193524|NCT02145624|maternal vaccination|maternal vaccination
193525|NCT02145624|maternal immunisation|maternal immunisation
193526|NCT02145624|immune response|immune response
193527|NCT02145611|hypertension, diabetes, endothelial function|hypertension, diabetes, endothelial function
193528|NCT02145598|Multiple Myeloma|multiple myeloma
193529|NCT02145598|Revlimid|revlimid
193530|NCT02145598|Lenalidomide maintenance|lenalidomide maintenance
193531|NCT02145585|Cardiac surgery|cardiac surgery
193532|NCT02145585|Robotic pharmacological anesthesia|robotic pharmacological anesthesia
193533|NCT02145585|Anesthesia|anesthesia
193534|NCT02145546|Pacing dependent|pacing dependent
193535|NCT02145546|Atrial Fibrillation|atrial fibrillation
193536|NCT02145546|Amiodarone|amiodarone
193537|NCT02145546|Propafenone|propafenone
193538|NCT02145546|Sotalol|sotalol
193539|NCT02145546|AF burden|af burden
193540|NCT02145533|MMP|mmp
193541|NCT02145533|NGAL|ngal
193542|NCT02145533|Arterial Aneurysms|arterial aneurysms
193543|NCT02145520|bronchiolitis|bronchiolitis
193544|NCT02145507|Leukoreduction|leukoreduction
193545|NCT02145507|Red Blood Cell post-leukoreduction recovery|red blood cell post-leukoreduction recovery
193546|NCT02145507|Packed red blood cell post storage hemolysis|packed red blood cell post storage hemolysis
193547|NCT02145507|Red blood cell recovery|red blood cell recovery
193548|NCT02145507|Plasma clotting factors|plasma clotting factors
193549|NCT02145507|2,3-DPG rejuvenation|2,3-dpg rejuvenation
193550|NCT02145494|SBRT (stereotactic body radiotherapy)|sbrt (stereotactic body radiotherapy)
193551|NCT02145494|Focal boost|focal boost
193552|NCT02145494|Prostate|prostate
193553|NCT02145481|coronary artery disease|coronary artery disease
193554|NCT02145481|decision quality|decision quality
193555|NCT02145481|decision making|decision making
193556|NCT02145481|survey|survey
193557|NCT02145481|measure development|measure development
193558|NCT02145481|patient-centered care|patient-centered care
193559|NCT02145481|cardiology|cardiology
193560|NCT02145481|heart disease|heart disease
193561|NCT02145468|Myocardial infarction|myocardial infarction
193562|NCT02145468|Acute coronary syndrome|acute coronary syndrome
193563|NCT02145468|Cardiovascular disease|cardiovascular disease
193564|NCT02145468|p38 mitogen-activated protein kinase (MAPK) inhibitor|p38 mitogen-activated protein kinase (mapk) inhibitor
193565|NCT02145468|NSTEMI|nstemi
193566|NCT02145468|Losmapimod|losmapimod
193567|NCT02145468|STEMI|stemi
193568|NCT02145455|Arthroplasty, Replacement, Knee/methods|arthroplasty, replacement, knee/methods
193569|NCT02145455|Knee Joint/physiopathology|knee joint/physiopathology
193570|NCT02145455|Knee Joint/radiography|knee joint/radiography
193571|NCT02145455|Knee Joint/surgery|knee joint/surgery
193573|NCT02145455|Outcome Assessment (Health Care)|outcome assessment (health care)
193574|NCT02145455|Female|female
193575|NCT02145455|Male|male
193576|NCT02145455|Adult|adult
193577|NCT02145442|Impaired fasting glucose|impaired fasting glucose
193578|NCT02145442|Prediabetes|prediabetes
193579|NCT02145442|Obesity|obesity
193580|NCT02145442|Overweight|overweight
193581|NCT02145442|Insulin sensitivity|insulin sensitivity
193582|NCT02145442|Weight loss|weight loss
193583|NCT02145442|Nutritional supplement|nutritional supplement
193584|NCT02145442|Waist|waist
193585|NCT02145442|Body composition|body composition
193586|NCT02145429|Prevention of depression and anxiety disorder|prevention of depression and anxiety disorder
193587|NCT02145429|Depression Prevention|depression prevention
193588|NCT02145416|Imaging|imaging
193589|NCT02145416|Chemoradiotherapy|chemoradiotherapy
193590|NCT02145403|Allogeneic Transplantation|allogeneic transplantation
193591|NCT02145403|Carfilzomib|carfilzomib
193592|NCT02145403|Relapse|relapse
193593|NCT02145403|Graft-Versus-Host Disease|graft-versus-host disease
193594|NCT02145403|Multiple Myeloma|multiple myeloma
193595|NCT02145403|Lymphoma|lymphoma
193596|NCT02145403|Leukemia|leukemia
193597|NCT02145390|Bladder Cancer|bladder cancer
193598|NCT02145390|Bladder Carcinoma|bladder carcinoma
193599|NCT02145390|Transition Cell Cancer|transition cell cancer
193601|NCT02145390|Muscle Invasive Bladder Carcinoma|muscle invasive bladder carcinoma
193602|NCT02145377|Cholera|cholera
193603|NCT02145377|Vaccine|vaccine
193604|NCT02145377|Mali|mali
193605|NCT02145364|Ulthera System®|ulthera system®
193606|NCT02145364|Ultherapy®|ultherapy®
193607|NCT02145364|Ulthera, Inc.|ulthera, inc.
193608|NCT02145351|HFpEF|hfpef
402946|NCT01228929|Dry Eye|dry eye
184541|NCT02189889|EPO|epo
193609|NCT02145351|Heart failure|heart failure
193610|NCT02145351|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
193611|NCT02145351|Chronotropic incompetence|chronotropic incompetence
193612|NCT02145338|Urinary tract infection|urinary tract infection
193613|NCT02145338|Clean intermittent self-catheterisation|clean intermittent self-catheterisation
193614|NCT02145338|Antibiotic prophylaxis|antibiotic prophylaxis
193615|NCT02145325|Kidney transplant|kidney transplant
193616|NCT02145325|Regulatory T cells|regulatory t cells
193617|NCT02145325|Leukopheresis|leukopheresis
193618|NCT02145325|Immune cells|immune cells
193619|NCT02145325|Stem Cells|stem cells
193620|NCT02145325|Tolerance|tolerance
193621|NCT02145273|Maternal Depression|maternal depression
193622|NCT02145273|Interpersonal Psychotherapy|interpersonal psychotherapy
193623|NCT02145273|School Readiness|school readiness
193624|NCT02145260|Hemodialysis|hemodialysis
193625|NCT02145260|Hypotension|hypotension
193626|NCT02145260|Hospitalization|hospitalization
193627|NCT02145208|BPH|bph
193628|NCT02145195|Vitamin D|vitamin d
193629|NCT02145195|Children|children
193630|NCT02145195|Supplements|supplements
193631|NCT02145195|Cardiometabolic markers|cardiometabolic markers
193632|NCT02145195|Immune defense|immune defense
193633|NCT02145195|Bone turnover|bone turnover
193634|NCT02145195|Muscle strength|muscle strength
193635|NCT02145182|DGF|dgf
193636|NCT02145182|Dialysis|dialysis
193637|NCT02145182|Kidney|kidney
193638|NCT02145182|Kidney Transplantation|kidney transplantation
193639|NCT02145182|eGFR|egfr
193640|NCT02145182|Complement|complement
193641|NCT02145182|Eculizumab|eculizumab
193642|NCT02145169|procedural sedation|procedural sedation
193643|NCT02145169|emergence reaction|emergence reaction
193644|NCT02145169|nitrous oxide|nitrous oxide
193645|NCT02145169|ketamine|ketamine
193646|NCT02145156|HPV vaccination|hpv vaccination
193647|NCT02145156|Tailored health messaging|tailored health messaging
193648|NCT02145143|Radioiodine (RAI) Incorporation|radioiodine (rai) incorporation
193649|NCT02145143|Vemurafenib|vemurafenib
193650|NCT02145143|14-031|14-031
193651|NCT02145130|Skin|skin
193652|NCT02145130|Tissue-engineering|tissue-engineering
193653|NCT02145130|Autologous|autologous
193654|NCT02145130|Dermis|dermis
193655|NCT02145130|Epidermis|epidermis
193656|NCT02145117|MBSR|mbsr
193657|NCT02145117|fMRI|fmri
193658|NCT02145117|PTH|pth
193659|NCT02145091|Psilocybin|psilocybin
193660|NCT02145091|Hallucinogens|hallucinogens
193661|NCT02145091|Pharmacologic Actions|pharmacologic actions
193662|NCT02145091|Central Nervous System Agents|central nervous system agents
193663|NCT02145091|Therapeutic Uses|therapeutic uses
193664|NCT02145091|Psychotropic Drugs|psychotropic drugs
193665|NCT02145065|paclitaxel coated balloon|paclitaxel coated balloon
193666|NCT02145065|restenosis|restenosis
193667|NCT02145065|Femoropopliteal artery disease|femoropopliteal artery disease
193668|NCT02145052|Fascial closure|fascial closure
193669|NCT02145052|Interrupted suture|interrupted suture
193670|NCT02145052|Running suture|running suture
193671|NCT02145052|Continuous suture|continuous suture
193672|NCT02145039|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
193673|NCT02145039|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
193674|NCT02145039|Burkitt's lymphoma|burkitt's lymphoma
193675|NCT02145039|Natural killer cell malignancies|natural killer cell malignancies
193676|NCT02145039|Chronic myelogenous leukemia|chronic myelogenous leukemia
193677|NCT02145039|Myelodysplastic syndrome|myelodysplastic syndrome
193678|NCT02145039|Large-cell lymphoma|large-cell lymphoma
193679|NCT02145039|Hodgkin lymphoma|hodgkin lymphoma
193680|NCT02145039|Multiple myeloma|multiple myeloma
193681|NCT02145039|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
193682|NCT02145039|Small lymphocytic lymphoma (SLL)|small lymphocytic lymphoma (sll)
193683|NCT02145039|Marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
193684|NCT02145039|Follicular lymphoma|follicular lymphoma
193685|NCT02145039|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
193686|NCT02145039|Mantle-cell lymphoma|mantle-cell lymphoma
193687|NCT02145039|Prolymphocytic leukemia|prolymphocytic leukemia
193688|NCT02145039|Refractory leukemia|refractory leukemia
193690|NCT02145039|Bone marrow failure syndromes|bone marrow failure syndromes
193691|NCT02145039|Myeloproliferative syndromes|myeloproliferative syndromes
193692|NCT02145013|portal hypertension, hepatocellular carcinoma, resection|portal hypertension, hepatocellular carcinoma, resection
193693|NCT02145000|Rotavirus|rotavirus
193694|NCT02145000|Gastroenteritis|gastroenteritis
193695|NCT02145000|Diarrhea|diarrhea
193696|NCT02145000|Vaccine|vaccine
193697|NCT02145000|Niger|niger
193698|NCT02144974|Total pelvic exenteration.|total pelvic exenteration.
193699|NCT02144961|breast reconstruction|breast reconstruction
193700|NCT02144961|Deep Inferior Epigastric Artery Perforator (DIEP)|deep inferior epigastric artery perforator (diep)
193701|NCT02144961|Indocyanine Green Angiography (IGA)|indocyanine green angiography (iga)
193702|NCT02144961|autologous tissue transfer|autologous tissue transfer
236793|NCT01950351|XRT|xrt
184644|NCT02189603|safety|safety
184645|NCT02189590|supraglottic airway|supraglottic airway
184646|NCT02189590|children|children
184648|NCT02189590|air-Q|air-q
193703|NCT02144948|diabetes|diabetes
193704|NCT02144935|pediatrics|pediatrics
193705|NCT02144922|Hypertension|hypertension
193706|NCT02144922|Statin|statin
193707|NCT02144909|Diabetes self management|diabetes self management
193708|NCT02144909|support group|support group
193709|NCT02144909|semi structured support group|semi structured support group
193710|NCT02144883|telephone counseling|telephone counseling
193711|NCT02144870|Tic-Disorder, Tourette-Disorder, Habit Reversal Training, Resources activation|tic-disorder, tourette-disorder, habit reversal training, resources activation
193712|NCT02144844|Antepartum depressive symptoms|antepartum depressive symptoms
193713|NCT02144844|Antepartum depression|antepartum depression
193714|NCT02144844|Cognitive behavioral intervention|cognitive behavioral intervention
193715|NCT02144844|Feasibility|feasibility
193716|NCT02144844|randomized clinical trial|randomized clinical trial
193717|NCT02144831|TIA|tia
193718|NCT02144831|stroke prevention|stroke prevention
193719|NCT02144831|ASA|asa
193720|NCT02144831|clopidogrel|clopidogrel
193721|NCT02144831|dual antiplatelet treatment|dual antiplatelet treatment
193722|NCT02144753|IBS-C|ibs-c
193723|NCT02144753|Constipation|constipation
193724|NCT02144753|IBS|ibs
193725|NCT02144740|Flow-mediated dilation|flow-mediated dilation
193726|NCT02144688|Human Immunodeficiency Virus|human immunodeficiency virus
193727|NCT02144688|HIV|hiv
193728|NCT02144688|Cognitive symptoms|cognitive symptoms
193729|NCT02144688|Cognitive evaluation|cognitive evaluation
193730|NCT02144688|Neuropsychological testing|neuropsychological testing
193731|NCT02144688|Quality of life|quality of life
193732|NCT02144688|Anxiety|anxiety
193733|NCT02144688|Viral load|viral load
193734|NCT02144688|Antiretroviral|antiretroviral
193735|NCT02144688|Cerebrospinal fluid|cerebrospinal fluid
193736|NCT02144688|Lumbar puncture|lumbar puncture
193737|NCT02144688|Magnetic resonance imaging|magnetic resonance imaging
193738|NCT02144688|MRI|mri
193739|NCT02144649|Prostate Cancer|prostate cancer
193740|NCT02144649|Tangerine Juice|tangerine juice
193741|NCT02144649|Tomato Juice|tomato juice
193742|NCT02144623|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
193743|NCT02144623|Valproate|valproate
193744|NCT02144623|Cluster of differentiation antigen 20|cluster of differentiation antigen 20
193745|NCT02144623|Lymphomas|lymphomas
193746|NCT02144623|B-cell lymphomas|b-cell lymphomas
193747|NCT02144623|Translational research|translational research
193748|NCT02144623|Monoclonal antibodies|monoclonal antibodies
193749|NCT02144610|CLI|cli
193750|NCT02144597|morbid obesity|morbid obesity
193751|NCT02144597|gastric bypass|gastric bypass
193752|NCT02144597|bariatrics|bariatrics
193753|NCT02144597|diet|diet
193754|NCT02144597|caloric restriction|caloric restriction
193755|NCT02144597|liver fat|liver fat
193756|NCT02144597|appetite|appetite
193757|NCT02144584|ischemic stroke|ischemic stroke
193758|NCT02144584|memantine|memantine
193759|NCT02144584|upper extremity weakness|upper extremity weakness
193760|NCT02144584|motor recovery|motor recovery
193761|NCT02144558|Sperm parameters|sperm parameters
193762|NCT02144558|Spinal cord injuries|spinal cord injuries
193763|NCT02144558|Oxidative stress|oxidative stress
193764|NCT02144558|Inflammatory syndrome|inflammatory syndrome
193765|NCT02144545|Surgery|surgery
193766|NCT02144545|Morbid Obesity|morbid obesity
193767|NCT02144545|Bariatric surgery|bariatric surgery
193768|NCT02144545|Sleeve gastrectomy|sleeve gastrectomy
193770|NCT02144545|Distance from pylorus|distance from pylorus
193771|NCT02144545|Hormones|hormones
193772|NCT02144545|Gastric remanent|gastric remanent
193773|NCT02144532|Ehlers-Danlos syndrome|ehlers-danlos syndrome
193774|NCT02144532|hypermobility|hypermobility
193775|NCT02144532|Compression garment|compression garment
193776|NCT02144532|pain|pain
193777|NCT02144532|isokinetic evaluation|isokinetic evaluation
193778|NCT02144506|Elderly, home-based exercises programm|elderly, home-based exercises programm
193779|NCT02144493|common bile duct stones|common bile duct stones
193780|NCT02144493|diverticulum|diverticulum
193781|NCT02144480|coronary bypass surgery|coronary bypass surgery
193782|NCT02144480|rehabilitation|rehabilitation
193783|NCT02144480|exercise training|exercise training
193784|NCT02144480|platelet activation|platelet activation
193785|NCT02144480|cardiopulmonary fitness|cardiopulmonary fitness
193786|NCT02144467|Multiple-MRI, Gene, Cognition|multiple-mri, gene, cognition
193787|NCT02144454|Cardiovascular disease|cardiovascular disease
193788|NCT02144454|Fatty acids|fatty acids
193789|NCT02144454|Vascular function|vascular function
193790|NCT02144454|Blood pressure|blood pressure
193791|NCT02144454|Plasma lipids|plasma lipids
193792|NCT02144454|Insulin resistance|insulin resistance
193793|NCT02144454|Endothelial activation|endothelial activation
193794|NCT02144441|Diabetes Mellitus|diabetes mellitus
193795|NCT02144441|Insulin|insulin
193796|NCT02144441|Self Administration|self administration
193797|NCT02144441|Patient Satisfaction|patient satisfaction
193798|NCT02144441|Glucose|glucose
193799|NCT02144441|Hypoglycemia|hypoglycemia
193800|NCT02144441|Hyperglycemia|hyperglycemia
193801|NCT02144415|abuse liability|abuse liability
193802|NCT02144415|recreational drug user|recreational drug user
193803|NCT02144415|stimulant|stimulant
193804|NCT02144415|d-amphetamine|d-amphetamine
193805|NCT02144415|ADHD|adhd
193806|NCT02144389|Arachidonic acid|arachidonic acid
193807|NCT02144389|Bilharzia|bilharzia
193808|NCT02144389|Mansoni|mansoni
193809|NCT02144389|Schistosomiasis|schistosomiasis
193810|NCT02144389|Polyunsaturated fatty acid|polyunsaturated fatty acid
193811|NCT02144376|Constipation|constipation
193812|NCT02144376|psyllium|psyllium
193813|NCT02144376|ispaghula|ispaghula
193814|NCT02144376|Magnetic Resonance Imaging|magnetic resonance imaging
193815|NCT02144376|MRI|mri
193816|NCT02144376|microbiota|microbiota
193817|NCT02144363|Preterm|preterm
193818|NCT02144363|RDS|rds
193819|NCT02144363|Mechanical Ventilation|mechanical ventilation
193820|NCT02144363|Extubation failure|extubation failure
193821|NCT02144350|hyperbaric oxygen|hyperbaric oxygen
193822|NCT02144337|Physical activity|physical activity
193823|NCT02144337|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
193824|NCT02144337|Children|children
193825|NCT02144337|Intervention|intervention
193826|NCT02144324|Maxillary protraction|maxillary protraction
193827|NCT02144324|Modified Tandem Appliance|modified tandem appliance
193828|NCT02144324|Face mask therapy|face mask therapy
193829|NCT02144324|Class III malocclusion|class iii malocclusion
193830|NCT02144324|Maxillary deficiency|maxillary deficiency
193831|NCT02144311|MRI|mri
193832|NCT02144311|FDG PET/CT|fdg pet/ct
193833|NCT02144311|histologic heterogeneity|histologic heterogeneity
193834|NCT02144311|14-061|14-061
193835|NCT02144298|microcirculation|microcirculation
193836|NCT02144298|coronary artery bypass grafting|coronary artery bypass grafting
193837|NCT02144298|cold blood cardioplegia|cold blood cardioplegia
193838|NCT02144298|cristalloid cardioplegia|cristalloid cardioplegia
193839|NCT02144285|Renal dialysis|renal dialysis
193840|NCT02144272|Antibody|antibody
193841|NCT02144272|Tumor Necrosis Factor alpha|tumor necrosis factor alpha
193842|NCT02144272|Interleukin-17|interleukin-17
193843|NCT02144233|Pain|pain
193844|NCT02144233|Temporomandibular joint disorders|temporomandibular joint disorders
193845|NCT02144233|Occlusal adjustment|occlusal adjustment
193846|NCT02144233|Therapy|therapy
193847|NCT02144233|Randomized clinical trial|randomized clinical trial
193848|NCT02144233|Mastication|mastication
193849|NCT02144233|Habitual chewing side|habitual chewing side
193850|NCT02144233|Handedness preference|handedness preference
193851|NCT02144233|Hemimandibular retrognathia|hemimandibular retrognathia
193852|NCT02144220|Telemedicine|telemedicine
193853|NCT02144220|Virtual care visit|virtual care visit
193854|NCT02144220|Remote visit|remote visit
193855|NCT02144220|Video-conferencing|video-conferencing
193856|NCT02144194|Oral Vinorelbine|oral vinorelbine
193857|NCT02144194|Oral Chemotherapy|oral chemotherapy
673729|NCT00863746|Sorafenib|sorafenib
193858|NCT02144194|Metastatic Breast Cancer|metastatic breast cancer
193859|NCT02144194|Advanced Breast Cancer|advanced breast cancer
193860|NCT02144194|Maintenance treatment|maintenance treatment
193861|NCT02144181|Ulthera® System|ulthera® system
193862|NCT02144181|Ultherapy® Treatment|ultherapy® treatment
193863|NCT02144181|Ulthera, Inc.|ulthera, inc.
193864|NCT02144168|Prebiotics|prebiotics
193865|NCT02144168|diarrhoea|diarrhoea
193866|NCT02144168|Enteral nutrition|enteral nutrition
193868|NCT02144168|Bifidobacteria|bifidobacteria
193869|NCT02144168|SCFA|scfa
193870|NCT02144155|Oxytocin|oxytocin
193871|NCT02144142|Microbiome|microbiome
193872|NCT02144142|Atopic dermatitis|atopic dermatitis
193873|NCT02144142|Eczema|eczema
193874|NCT02144142|Bacteriotherapy|bacteriotherapy
193875|NCT02144129|Whole Body Electromyostimulation|whole body electromyostimulation
193876|NCT02144129|Inflammatory Bowel Disease|inflammatory bowel disease
193877|NCT02144129|Lean Body Mass|lean body mass
193878|NCT02144129|Muscle Strength|muscle strength
193879|NCT02144116|dance-movement therapy|dance-movement therapy
193880|NCT02144116|balance|balance
193881|NCT02144116|Fibromyalgia|fibromyalgia
193882|NCT02144103|Glaucomatous Neurodegeneration|glaucomatous neurodegeneration
193883|NCT02144103|Retinal Degeneration|retinal degeneration
193884|NCT02144103|Primary Open-Angle Glaucoma|primary open-angle glaucoma
193885|NCT02144103|Optic Neuropathy|optic neuropathy
193886|NCT02144103|Intraocular pressure|intraocular pressure
193887|NCT02144103|Retinal ganglion cell degeneration|retinal ganglion cell degeneration
193888|NCT02144103|Optic nerve atrophy|optic nerve atrophy
193889|NCT02144103|Subtenon injection|subtenon injection
193890|NCT02144103|Glaucomatous damage|glaucomatous damage
193891|NCT02144103|ADRC|adrc
193892|NCT02144103|Adipose-derived regenerative cells|adipose-derived regenerative cells
193893|NCT02144103|Fat tissue|fat tissue
193894|NCT02144103|Stem cells|stem cells
193895|NCT02144090|Angiography|angiography
193896|NCT02144090|Angioplasty|angioplasty
193897|NCT02144090|Coronary artery disease|coronary artery disease
193898|NCT02144090|Diagnostic|diagnostic
193899|NCT02144090|Fractional flow reserve|fractional flow reserve
193900|NCT02144077|Photodynamic Therapy|photodynamic therapy
193901|NCT02144077|PDT|pdt
193902|NCT02144077|non-aggressive BCC|non-aggressive bcc
193903|NCT02144064|Aspirin, heparin, pregnancy, recurrent pregnancy loss|aspirin, heparin, pregnancy, recurrent pregnancy loss
193904|NCT02144051|solid tumor, prostate cancer, breast cancer, bladder cancer, ovarian cancer, gastric cancer, salivary duct cancer|solid tumor, prostate cancer, breast cancer, bladder cancer, ovarian cancer, gastric cancer, salivary duct cancer
193905|NCT02144038|multiple myeloma,|multiple myeloma,
194035|NCT02143557|modified breast milk|modified breast milk
193906|NCT02144038|relapsed and refractory,|relapsed and refractory,
193908|NCT02144038|pan-PIM inhibitor,|pan-pim inhibitor,
193909|NCT02144038|PIM Kinase,|pim kinase,
193910|NCT02144038|BYL719,|byl719,
193911|NCT02144038|PI3K inhibitor|pi3k inhibitor
193912|NCT02144025|Ocular Graft-Versus-Host-Disease|ocular graft-versus-host-disease
193913|NCT02144025|Topical Cyclosporine|topical cyclosporine
193914|NCT02143986|sepsis|sepsis
193915|NCT02143986|Macrophagic activation syndrome|macrophagic activation syndrome
193916|NCT02143986|Ferritin|ferritin
193917|NCT02143986|Still's disease|still's disease
193918|NCT02143973|Uremic|uremic
193919|NCT02143973|Pruritus|pruritus
193920|NCT02143973|Itch|itch
193921|NCT02143973|Chronic Itch|chronic itch
193922|NCT02143973|Nalbuphine|nalbuphine
193923|NCT02143960|Syneron|syneron
193924|NCT02143960|Velashape|velashape
193925|NCT02143960|ELOS|elos
193926|NCT02143960|Zeltiq|zeltiq
193927|NCT02143960|Cryolipolysis|cryolipolysis
193928|NCT02143947|Orthoses|orthoses
193929|NCT02143947|Foot|foot
193930|NCT02143947|Kinematics|kinematics
193931|NCT02143947|EMG|emg
193932|NCT02143947|Biomechanics|biomechanics
193933|NCT02143934|Plasmodium vivax|plasmodium vivax
193934|NCT02143934|Hypnozoites|hypnozoites
193935|NCT02143934|Primaquine|primaquine
193936|NCT02143934|Liver-stage|liver-stage
193937|NCT02143934|Blood-stage|blood-stage
193938|NCT02143934|Plasmodium falciparum|plasmodium falciparum
193939|NCT02143921|NGO zinc scale|ngo zinc scale
193940|NCT02143921|compliance with WHO zinc treatment recommendations|compliance with who zinc treatment recommendations
193941|NCT02143908|Diarrhea|diarrhea
193942|NCT02143908|L-lysine supplementation|l-lysine supplementation
193943|NCT02143908|immune status|immune status
193944|NCT02143908|adults|adults
193945|NCT02143908|Bangladesh|bangladesh
193946|NCT02143908|aged 18-45 years|aged 18-45 years
193947|NCT02143908|urban community|urban community
193948|NCT02143882|Live attenuated influenza vaccine|live attenuated influenza vaccine
193949|NCT02143882|fluenz|fluenz
193950|NCT02143882|pandemrix|pandemrix
193951|NCT02143882|pandemic influenza vaccine|pandemic influenza vaccine
193952|NCT02143882|immunogenicity|immunogenicity
193953|NCT02143869|Gastrointestinal cancer|gastrointestinal cancer
193954|NCT02143869|Lung cancer|lung cancer
193959|NCT02143830|cytopenia|cytopenia
193960|NCT02143830|myelodysplasia|myelodysplasia
193961|NCT02143830|AML|aml
193962|NCT02143830|bone marrow transplant|bone marrow transplant
193963|NCT02143830|cytoreductive regimen|cytoreductive regimen
193964|NCT02143830|T-cell reduction|t-cell reduction
193965|NCT02143817|whole body vibration training|whole body vibration training
193966|NCT02143817|L-citrulline|l-citrulline
193967|NCT02143817|hypertension|hypertension
193968|NCT02143817|obesity|obesity
193969|NCT02143817|arterial function|arterial function
193970|NCT02143817|arterial stiffness|arterial stiffness
193971|NCT02143817|autonomic function|autonomic function
193972|NCT02143817|endothelial function|endothelial function
193973|NCT02143804|Oncolytic virus|oncolytic virus
193974|NCT02143804|GMCSF|gmcsf
193975|NCT02143804|pRb|prb
193976|NCT02143804|PDL1|pdl1
193977|NCT02143804|Immunotherapy|immunotherapy
193978|NCT02143804|Adenovirus|adenovirus
193980|NCT02143791|Burst stimulation|burst stimulation
193981|NCT02143778|MBT|mbt
193982|NCT02143778|CSPH|csph
193983|NCT02143778|HVPG|hvpg
193984|NCT02143765|Mitiglinide|mitiglinide
193985|NCT02143765|Acarbose|acarbose
193986|NCT02143765|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
193987|NCT02143752|Smoking|smoking
193988|NCT02143752|Tobacco|tobacco
193989|NCT02143752|Addiction|addiction
193990|NCT02143752|Mindfulness|mindfulness
193991|NCT02143752|Meditation|meditation
193992|NCT02143739|asthma|asthma
193993|NCT02143713|Dyspareunia|dyspareunia
193994|NCT02143713|Endometriosis-associated pain|endometriosis-associated pain
193995|NCT02143713|Dysmenorrhea (DYS)|dysmenorrhea (dys)
193996|NCT02143713|Elagolix|elagolix
193997|NCT02143713|Gonadotropin-releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
237151|NCT01948453|CAD|cad
193998|NCT02143713|Non-menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
193999|NCT02143700|exacerbation|exacerbation
194000|NCT02143700|cognitive|cognitive
194001|NCT02143700|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
194002|NCT02143687|Pulmonary hypertension|pulmonary hypertension
194003|NCT02143687|Interstitial lung disease|interstitial lung disease
194004|NCT02143687|Pulmonary fibrosis|pulmonary fibrosis
194005|NCT02143674|Stretching exercise muscle|stretching exercise muscle
194006|NCT02143674|Elderly|elderly
194007|NCT02143674|Techniques and exercise|techniques and exercise
194008|NCT02143674|Physiotherapy|physiotherapy
194009|NCT02143648|uremic|uremic
194010|NCT02143648|pruritus|pruritus
194011|NCT02143648|itch|itch
194012|NCT02143648|chronic itch|chronic itch
194013|NCT02143648|nalbuphine|nalbuphine
194014|NCT02143635|HDM201,TP53wt, p53, MDM2, HDM2, advanced tumors, BLRM (Bayesian logistic regression model)|hdm201,tp53wt, p53, mdm2, hdm2, advanced tumors, blrm (bayesian logistic regression model)
194015|NCT02143622|Head and neck cancer|head and neck cancer
194016|NCT02143609|airway disease|airway disease
194017|NCT02143609|bronchitis|bronchitis
194018|NCT02143609|emphysema|emphysema
194019|NCT02143609|lung|lung
194020|NCT02143596|stroke|stroke
194021|NCT02143596|dehydration|dehydration
194022|NCT02143596|prognosis|prognosis
194023|NCT02143583|rhinoconjunctivitis|rhinoconjunctivitis
194024|NCT02143583|birch pollen|birch pollen
194025|NCT02143583|desensitization|desensitization
194026|NCT02143583|allergen immunotherapy|allergen immunotherapy
194027|NCT02143570|Urinary Bladder, Overactive|urinary bladder, overactive
194028|NCT02143570|Darifenacin|darifenacin
194029|NCT02143570|Physiotherapy|physiotherapy
194030|NCT02143570|Quality of Life|quality of life
194031|NCT02143557|breast milk|breast milk
194032|NCT02143557|infants|infants
194033|NCT02143557|chylothorax|chylothorax
194034|NCT02143557|cardiac surgery|cardiac surgery
194036|NCT02143544|Intra-aortic balloon counterpulsation|intra-aortic balloon counterpulsation
194037|NCT02143544|Cardiac surgery|cardiac surgery
194038|NCT02143544|High-risk patients|high-risk patients
194039|NCT02143518|Human Hookworm|human hookworm
194040|NCT02143518|Necator americanus|necator americanus
194041|NCT02143518|Hookworm|hookworm
194042|NCT02143518|Hookworm Disease|hookworm disease
194043|NCT02143518|Iron-deficiency anemia|iron-deficiency anemia
194044|NCT02143518|Soil-transmitted helminth infection|soil-transmitted helminth infection
194045|NCT02143518|Neglected Tropical Disease|neglected tropical disease
194046|NCT02143518|Na-GST-1|na-gst-1
194047|NCT02143518|CpG|cpg
194053|NCT02143466|Phase I|phase i
194054|NCT02143466|Safety|safety
194055|NCT02143466|Tolerability|tolerability
194056|NCT02143466|Efficacy|efficacy
194057|NCT02143466|Anti-tumour|anti-tumour
194058|NCT02143466|AZD9291|azd9291
194059|NCT02143466|AZD6094|azd6094
194060|NCT02143466|MEDI4736|medi4736
194061|NCT02143466|Osimertinib|osimertinib
194062|NCT02143466|Savolitinib|savolitinib
194063|NCT02143466|Selumetinib|selumetinib
194064|NCT02143466|Durvalumab|durvalumab
194065|NCT02143466|Ascending Doses|ascending doses
194066|NCT02143466|Expansion cohorts|expansion cohorts
194067|NCT02143466|EGFR|egfr
194068|NCT02143466|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
194069|NCT02143466|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
194070|NCT02143453|exercise|exercise
194071|NCT02143453|overweight|overweight
194072|NCT02143453|children|children
194073|NCT02143427|social skills training,|social skills training,
194074|NCT02143427|computer based,|computer based,
194075|NCT02143427|social competence training,|social competence training,
194076|NCT02143427|Oppositional Defiant Disorder|oppositional defiant disorder
194077|NCT02143427|peer related aggressive behavior|peer related aggressive behavior
194078|NCT02143427|randomized controlled trial|randomized controlled trial
194079|NCT02143388|Local advanced|local advanced
194080|NCT02143388|high risk|high risk
194081|NCT02143388|nasopharyngeal carcinoma|nasopharyngeal carcinoma
194082|NCT02143362|Intraoperative wake up|intraoperative wake up
194083|NCT02143362|Closed loop of target controlled infusion|closed loop of target controlled infusion
194084|NCT02143362|Dexmedetomidine|dexmedetomidine
194085|NCT02143362|Propofol|propofol
194087|NCT02143349|herbal remedies|herbal remedies
194088|NCT02143349|metabolic disorders|metabolic disorders
194089|NCT02143336|Surgical site infections|surgical site infections
194090|NCT02143336|Skin closure techniques|skin closure techniques
194091|NCT02143336|Colorectal surgery|colorectal surgery
194092|NCT02143323|GST, DILI, biomarker|gst, dili, biomarker
194093|NCT02143297|Sleep Apnea/Hypopnea Syndrome|sleep apnea/hypopnea syndrome
194094|NCT02143297|Pulse Oximetry|pulse oximetry
194095|NCT02143297|Nonlinear Dynamics|nonlinear dynamics
194096|NCT02143297|Fourier Analysis|fourier analysis
194097|NCT02143297|Neural Networks (Computer)|neural networks (computer)
194098|NCT02143271|Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis|secondary hyperparathyroidism in patients receiving peritoneal dialysis
185026|NCT02188199|Hip|hip
194099|NCT02143258|stenting venous sinus|stenting venous sinus
194100|NCT02143258|intracranial hypertension|intracranial hypertension
194101|NCT02143258|quality of life|quality of life
194102|NCT02143258|headache|headache
194103|NCT02143258|visual impairment|visual impairment
194104|NCT02143232|knee replacement|knee replacement
194105|NCT02143232|hip replacement|hip replacement
194106|NCT02143232|patient monitor|patient monitor
194107|NCT02143219|Pancreatic metastatic cancer|pancreatic metastatic cancer
194108|NCT02143219|FOLFIRINOX|folfirinox
194109|NCT02143219|toxicity|toxicity
194110|NCT02143219|efficacy|efficacy
194111|NCT02143206|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
194112|NCT02143206|Pain|pain
194113|NCT02143206|Arthritis|arthritis
194114|NCT02143206|Dyspnea|dyspnea
194115|NCT02143206|Exercise|exercise
194116|NCT02143206|Aerobic|aerobic
194117|NCT02143193|Breastfeeding|breastfeeding
194118|NCT02143193|Newborn|newborn
194119|NCT02143193|Formula|formula
194120|NCT02143193|Temperature|temperature
194121|NCT02143193|Initial Bath|initial bath
194122|NCT02143180|real-time tissue elastography|real-time tissue elastography
194123|NCT02143180|hepatic fibrosis|hepatic fibrosis
194124|NCT02143154|vancomycin, GBS|vancomycin, gbs
194125|NCT02143141|postoperative pain|postoperative pain
194126|NCT02143141|narcotic side effects|narcotic side effects
194127|NCT02143128|score|score
194128|NCT02143128|postoperative|postoperative
194129|NCT02143128|pain|pain
194130|NCT02143128|nausea|nausea
194131|NCT02143128|mental status|mental status
194132|NCT02143128|tool|tool
194133|NCT02143115|Colorectal cancer surveillance|colorectal cancer surveillance
194134|NCT02143089|CCSWI|ccswi
194135|NCT02143076|Medication Adherence|medication adherence
194136|NCT02143076|Hydroxyurea|hydroxyurea
194137|NCT02143050|Unresectable melanoma Stage IIIC and Stage IV BRAF V600E+|unresectable melanoma stage iiic and stage iv braf v600e+
194138|NCT02143024|depression|depression
194139|NCT02143024|family|family
194140|NCT02143024|primary health care|primary health care
194141|NCT02143011|sugar|sugar
194142|NCT02143011|sucrose|sucrose
194143|NCT02143011|fruit juice|fruit juice
194144|NCT02143011|orange juice|orange juice
194145|NCT02143011|metabolism|metabolism
194146|NCT02143011|immune cell aging|immune cell aging
194147|NCT02143011|lipids|lipids
194148|NCT02142998|GERD|gerd
194149|NCT02142998|Laparoscopic|laparoscopic
194150|NCT02142998|sleeve|sleeve
194151|NCT02142998|gastrectomy|gastrectomy
194152|NCT02142972|Low back pain|low back pain
194153|NCT02142972|Oswestry questionnaire|oswestry questionnaire
194154|NCT02142972|Post-partum Depression|post-partum depression
194155|NCT02142972|Pelvic pain|pelvic pain
194156|NCT02142959|RTA 408|rta 408
194157|NCT02142959|RTA 408 Lotion|rta 408 lotion
194158|NCT02142959|Breast cancer|breast cancer
194159|NCT02142959|Radiation therapy|radiation therapy
673827|NCT00864279|Cetirizine|cetirizine
194160|NCT02142959|Radiation dermatitis|radiation dermatitis
194161|NCT02142959|Oxidative stress|oxidative stress
194162|NCT02142959|Inflammation|inflammation
194163|NCT02142959|omaveloxolone|omaveloxolone
194164|NCT02142933|colonization|colonization
194165|NCT02142933|screening|screening
194166|NCT02142933|group B streptococci|group b streptococci
194167|NCT02142933|extended-spectrum beta-lactamase|extended-spectrum beta-lactamase
194168|NCT02142933|enterobacteriaceae|enterobacteriaceae
194169|NCT02142920|Healthy Volunteers|healthy volunteers
194170|NCT02142907|Breast conservative surgery|breast conservative surgery
194171|NCT02142907|boost radiation|boost radiation
194172|NCT02142907|acute toxicity|acute toxicity
194173|NCT02142907|cosmesis|cosmesis
194174|NCT02142907|local control|local control
194175|NCT02142894|Tuberculosis|tuberculosis
194177|NCT02142868|Expanded Access|expanded access
194178|NCT02142868|Advanced Breast Cancer|advanced breast cancer
194179|NCT02142855|volunteers|volunteers
194180|NCT02142855|young (18-30 y)|young (18-30 y)
194181|NCT02142855|older (65-75 y)|older (65-75 y)
194182|NCT02142855|age groups|age groups
194183|NCT02142842|Adipose stem cell|adipose stem cell
194184|NCT02142842|Platelet rich plasma|platelet rich plasma
194185|NCT02142842|Knee Osteoarthritis|knee osteoarthritis
194186|NCT02142842|Injured cartilage|injured cartilage
194187|NCT02142829|bariatric surgery, postoperative pain|bariatric surgery, postoperative pain
194188|NCT02142777|S-equol|s-equol
194189|NCT02142777|COX activity|cox activity
194190|NCT02142764|Multiple Sclerosis|multiple sclerosis
194191|NCT02142764|CD8+ T-cells|cd8+ t-cells
194192|NCT02142764|Class I Major Histocompatibility Complex (MHC)|class i major histocompatibility complex (mhc)
194193|NCT02142764|pentamers|pentamers
194194|NCT02142751|Escherichia coli|escherichia coli
194195|NCT02142751|Extended-spectrum β-lactamases (ESBLs)|extended-spectrum β-lactamases (esbls)
194196|NCT02142751|Bacteremia|bacteremia
194197|NCT02142751|Urinary tract infection|urinary tract infection
194198|NCT02142751|Bloodstream infection|bloodstream infection
194199|NCT02142751|Fosfomycin|fosfomycin
194200|NCT02142751|Meropenem|meropenem
194201|NCT02142751|Pharmacokinetics|pharmacokinetics
194202|NCT02142751|intestinal colonization|intestinal colonization
194203|NCT02142751|Recurrence|recurrence
194204|NCT02142751|multidrug resistance E.coli|multidrug resistance e.coli
194205|NCT02142751|Ceftriaxone|ceftriaxone
194206|NCT02142738|PD-1|pd-1
194207|NCT02142738|PD1|pd1
194208|NCT02142738|PD-L1|pd-l1
194209|NCT02142738|PDL1|pdl1
194210|NCT02142712|Ischemic Stroke|ischemic stroke
194211|NCT02142712|Brain Edema|brain edema
194212|NCT02142712|Diphenhydramine|diphenhydramine
194213|NCT02142712|Dextromethorphan|dextromethorphan
194214|NCT02142712|Famotidine|famotidine
194215|NCT02142699|Acute kidney injury|acute kidney injury
194216|NCT02142699|Cardiac surgery|cardiac surgery
194217|NCT02142699|Ischaemia reperfusion injury|ischaemia reperfusion injury
194218|NCT02142699|hemearginate|hemearginate
194219|NCT02142686|Hysteroscopy|hysteroscopy
194220|NCT02142686|Filling pressures|filling pressures
194221|NCT02142673|Operative hysteroscopy|operative hysteroscopy
194222|NCT02142673|Filling pressure|filling pressure
194223|NCT02142660|Adhesion barrier system|adhesion barrier system
194224|NCT02142660|Bariatric surgery|bariatric surgery
194225|NCT02142647|infant growth|infant growth
194226|NCT02142647|dietary protein|dietary protein
194227|NCT02142647|body composition|body composition
194228|NCT02142647|gut microbiome|gut microbiome
194229|NCT02142608|Prostate cancer|prostate cancer
194230|NCT02142608|Ultrasound Imaging|ultrasound imaging
194231|NCT02142595|dexmedetomidine|dexmedetomidine
194232|NCT02142595|midazolam|midazolam
194233|NCT02142595|sleep quality|sleep quality
194234|NCT02142595|delirium|delirium
194235|NCT02142582|Home Parenteral Nutrition|home parenteral nutrition
194236|NCT02142582|Compliance|compliance
194237|NCT02142582|Short Bowel Syndrome|short bowel syndrome
194238|NCT02142582|Oral Rehydration Solution|oral rehydration solution
194239|NCT02142569|Monacolin K|monacolin k
194240|NCT02142569|Cholesterol|cholesterol
194241|NCT02142569|Tocotrienol-enriched fraction of palm oil (TRF)|tocotrienol-enriched fraction of palm oil (trf)
194242|NCT02142569|Chinese Red Yeast Rice (CRYR|chinese red yeast rice (cryr
194243|NCT02142530|NHL|nhl
194244|NCT02142530|DLBCL|dlbcl
194245|NCT02142530|PTCL|ptcl
194246|NCT02142530|Marginal zone lymphoma|marginal zone lymphoma
194247|NCT02142530|lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
194248|NCT02142530|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
194249|NCT02142517|pancreaticoduodenectomy, pancreatic fistula|pancreaticoduodenectomy, pancreatic fistula
194250|NCT02142504|Drug therapy|drug therapy
194251|NCT02142491|Egg allergy|egg allergy
194252|NCT02142491|live attenuated influenza vaccine|live attenuated influenza vaccine
194253|NCT02142478|physical activity|physical activity
194254|NCT02142478|behaviour change|behaviour change
194255|NCT02142478|exercise referral|exercise referral
194256|NCT02142478|self-determination theory|self-determination theory
194257|NCT02142478|mixed-method|mixed-method
194258|NCT02142478|evaluation|evaluation
194259|NCT02142478|qualitative|qualitative
194260|NCT02142452|Pregnancy|pregnancy
194261|NCT02142452|Obesity/Overweight|obesity/overweight
194262|NCT02142452|postpartum|postpartum
194263|NCT02142452|mobile health|mobile health
194264|NCT02142452|cardiovascular disease|cardiovascular disease
194265|NCT02142439|Anorexia|anorexia
194267|NCT02142439|Physical activity|physical activity
194268|NCT02142439|Treatment|treatment
194269|NCT02142426|wound chronic|wound chronic
194270|NCT02142413|Stroke|stroke
194271|NCT02142413|Atrial fibrillation|atrial fibrillation
194272|NCT02142413|Holter ECG|holter ecg
194273|NCT02142413|cardiac MRI|cardiac mri
194274|NCT02142335|B-Raf, inoperable stage III melanoma, metastatic stage IV melanoma,|b-raf, inoperable stage iii melanoma, metastatic stage iv melanoma,
194275|NCT02142296|Pigment Epithelial Detachment|pigment epithelial detachment
194276|NCT02142296|Age-related Macular degeneration|age-related macular degeneration
194277|NCT02142283|Mechanical thrombectomy|mechanical thrombectomy
194278|NCT02142283|Acute ischemic stroke|acute ischemic stroke
194279|NCT02142283|Wake up stroke|wake up stroke
194280|NCT02142283|Late presenting stroke|late presenting stroke
194281|NCT02142257|Obesity|obesity
194282|NCT02142257|Gastric Bypass|gastric bypass
194283|NCT02142257|Aspiration Therapy|aspiration therapy
194284|NCT02142257|AspireAssist|aspireassist
194285|NCT02142244|Sentinel node biopsy|sentinel node biopsy
194286|NCT02142244|Near infra red light|near infra red light
194287|NCT02142244|Indocyanine green|indocyanine green
194288|NCT02142244|micrometastasis|micrometastasis
194289|NCT02142231|acupuncture|acupuncture
194290|NCT02142231|test anxiety|test anxiety
194291|NCT02142231|neuroenhancer|neuroenhancer
194292|NCT02142231|placebo|placebo
194293|NCT02142179|Asthma|asthma
194294|NCT02142179|Knowledge|knowledge
194295|NCT02142179|School-Based Service|school-based service
194296|NCT02142179|Adolescents|adolescents
194297|NCT02142166|aneurysmal subarachnoid hemorrhage (ASH)|aneurysmal subarachnoid hemorrhage (ash)
194298|NCT02142166|biomarker|biomarker
194299|NCT02142153|First in man|first in man
194300|NCT02142153|Antifungal|antifungal
194301|NCT02142153|Intravenous infusion|intravenous infusion
194302|NCT02142153|Healthy volunteers|healthy volunteers
194303|NCT02142140|Treatment of ADHD|treatment of adhd
194304|NCT02142140|Long-term treatment follow-up|long-term treatment follow-up
194305|NCT02142127|GFT505|gft505
194306|NCT02142127|Mass balance|mass balance
194307|NCT02142127|Pharmacokinetics|pharmacokinetics
194308|NCT02142127|Metabolites|metabolites
194309|NCT02142127|Healthy subjects|healthy subjects
194310|NCT02142127|Healthy male volunteers|healthy male volunteers
194311|NCT02142114|Intravitreal injection|intravitreal injection
194312|NCT02142114|Needle size|needle size
194313|NCT02142114|Pain|pain
194314|NCT02142114|Intraocular pressure|intraocular pressure
194315|NCT02142114|Pain following an Intravitreal injection|pain following an intravitreal injection
194316|NCT02142101|Gut Microbiota|gut microbiota
194317|NCT02142101|Polycystic kidney disease|polycystic kidney disease
194318|NCT02142101|Chronic kidney disease|chronic kidney disease
194319|NCT02142101|Uremic metabolites|uremic metabolites
194320|NCT02142088|Glycaemic Control|glycaemic control
194321|NCT02142088|Glucose Monitoring|glucose monitoring
194322|NCT02142088|Intravascular Glucose Monitoring|intravascular glucose monitoring
194323|NCT02142075|Pharmacokinetics|pharmacokinetics
194324|NCT02142062|Venous outflow obstruction|venous outflow obstruction
194325|NCT02142062|Iliac Vein|iliac vein
194326|NCT02142062|Common Femoral Vein|common femoral vein
194327|NCT02142062|Iliac Compression|iliac compression
194328|NCT02142049|DLBCL|dlbcl
194329|NCT02142049|ABC|abc
194330|NCT02142049|GCB|gcb
194331|NCT02142049|Primary Mediastinal B-cell lymphoma|primary mediastinal b-cell lymphoma
194332|NCT02142049|Pharmacyclics|pharmacyclics
194333|NCT02142049|Lenalidomide|lenalidomide
194334|NCT02142049|lymphoma|lymphoma
194335|NCT02142049|Rituximab|rituximab
194336|NCT02142049|EPOCH|epoch
194337|NCT02142036|Metastatic disease|metastatic disease
194338|NCT02142036|Metastasis|metastasis
194339|NCT02142036|Targeted therapy|targeted therapy
194340|NCT02142036|Solid tumor|solid tumor
194341|NCT02142036|Personalized medicine|personalized medicine
194342|NCT02142036|N-of-1 trial|n-of-1 trial
194343|NCT02141997|efficacy|efficacy
194344|NCT02141997|Methotrexate|methotrexate
194345|NCT02141997|safety|safety
194346|NCT02141984|Korean regulatory required Postmarketing Surveillance|korean regulatory required postmarketing surveillance
194347|NCT02141971|Down syndrome|down syndrome
194348|NCT02141971|Alzheimer's disease|alzheimer's disease
194349|NCT02141971|biomarkers|biomarkers
194350|NCT02141971|amyloid|amyloid
194351|NCT02141971|tau|tau
194352|NCT02141945|Cancer|cancer
194353|NCT02141945|Colon Cancer|colon cancer
194354|NCT02141945|Colorectal Cancer|colorectal cancer
194355|NCT02141945|Neoplasm|neoplasm
194356|NCT02141945|Colorectal Neoplasm|colorectal neoplasm
194357|NCT02141945|Intestinal Neoplasms|intestinal neoplasms
194358|NCT02141945|Gastrointestinal Neoplasms|gastrointestinal neoplasms
194359|NCT02141945|Digestive System Neoplasms|digestive system neoplasms
194360|NCT02141945|Neoplasms by Site|neoplasms by site
194361|NCT02141945|Neoplasms|neoplasms
194362|NCT02141945|Colonic Diseases|colonic diseases
194363|NCT02141945|Digestive System Diseases|digestive system diseases
194364|NCT02141945|Gastrointestinal Diseases|gastrointestinal diseases
194365|NCT02141945|Intestinal Diseases|intestinal diseases
194366|NCT02141945|Rectal Diseases|rectal diseases
194367|NCT02141932|Hand-held|hand-held
194368|NCT02141932|Ultrasound|ultrasound
194369|NCT02141932|Diagnosis|diagnosis
194370|NCT02141932|Cardiovascular|cardiovascular
194371|NCT02141932|Carotid artery stenosis|carotid artery stenosis
194372|NCT02141919|renal cancer|renal cancer
194373|NCT02141880|Obesity|obesity
194374|NCT02141867|Surgery|surgery
194375|NCT02141867|Mortality|mortality
194376|NCT02141841|intrathecal;|intrathecal;
194377|NCT02141841|bupivacaine;|bupivacaine;
194378|NCT02141841|concentration;|concentration;
194379|NCT02141828|Leukemia|leukemia
194380|NCT02141828|Advanced hematologic malignancies|advanced hematologic malignancies
194381|NCT02141828|Epizyme|epizyme
194382|NCT02141828|Phase 1b|phase 1b
194383|NCT02141828|MLL gene|mll gene
194384|NCT02141828|11q23|11q23
194385|NCT02141828|Ambiguous lineage|ambiguous lineage
194387|NCT02141828|AML|aml
194388|NCT02141828|Acute leukemias|acute leukemias
194389|NCT02141828|MLL-r|mll-r
194390|NCT02141763|Psoriatic Arthritis|psoriatic arthritis
194391|NCT02141724|Neuromuscular|neuromuscular
194392|NCT02141724|Wheelchair|wheelchair
194393|NCT02141724|Pain|pain
194394|NCT02141724|Bedsore|bedsore
194395|NCT02141724|Trouble postural|trouble postural
194396|NCT02141711|Drug therapy|drug therapy
194397|NCT02141698|Drug therapy|drug therapy
194398|NCT02141685|in vitro fertilization|in vitro fertilization
194399|NCT02141685|assisted reproduction techniques|assisted reproduction techniques
194400|NCT02141685|noninvasive imaging of embryos|noninvasive imaging of embryos
194401|NCT02141685|time lapse imaging of embryos|time lapse imaging of embryos
194402|NCT02141685|traditional morphological grading of embryos|traditional morphological grading of embryos
194403|NCT02141685|prediction of blastocysts|prediction of blastocysts
194404|NCT02141685|infertility|infertility
194405|NCT02141685|preimplantation genetic diagnosis|preimplantation genetic diagnosis
194406|NCT02141685|array-Comparative Genomic Hybridization|array-comparative genomic hybridization
194407|NCT02141672|lupus nephritis|lupus nephritis
194408|NCT02141672|calcineurin inhibitors|calcineurin inhibitors
194409|NCT02141672|voclosporin|voclosporin
194410|NCT02141646|adolescent risky sexual behavior, MI, BST|adolescent risky sexual behavior, mi, bst
194411|NCT02141633|smokers|smokers
194412|NCT02141633|airway blood flow|airway blood flow
194413|NCT02141633|fluticasone|fluticasone
194414|NCT02141633|echocardiogram|echocardiogram
194415|NCT02141607|shock|shock
194416|NCT02141607|heart failure|heart failure
194417|NCT02141607|inflammation|inflammation
194418|NCT02141607|biomarkers|biomarkers
194419|NCT02141607|cardiovascular instability|cardiovascular instability
194420|NCT02141607|metabolic pathways|metabolic pathways
194421|NCT02141607|proteolysis|proteolysis
194422|NCT02141581|Intramuscular inactivated trivalent influenza vaccine|intramuscular inactivated trivalent influenza vaccine
194423|NCT02141581|Intradermal inactivated trivalent influenza vaccine|intradermal inactivated trivalent influenza vaccine
194424|NCT02141581|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
194425|NCT02141581|Young adults|young adults
194426|NCT02141568|Cost-effective|cost-effective
194427|NCT02141568|Unexplained Medical Symptoms|unexplained medical symptoms
194428|NCT02141568|Frequent Attenders|frequent attenders
194429|NCT02141555|misoprostol, early pregnancy loss, missed abortion|misoprostol, early pregnancy loss, missed abortion
194430|NCT02141542|Metastatic Melanoma|metastatic melanoma
194431|NCT02141529|Intraarticular|intraarticular
194432|NCT02141529|pulsed radiofrequency|pulsed radiofrequency
194433|NCT02141529|osteoarthritis|osteoarthritis
194434|NCT02141516|Meningitis|meningitis
194435|NCT02141516|vaccination|vaccination
194436|NCT02141516|complement deficiency|complement deficiency
194437|NCT02141516|asplenia|asplenia
194438|NCT02141516|splenic dysfunction|splenic dysfunction
194439|NCT02141503|Biomarkers|biomarkers
194440|NCT02141503|Alpha-Manosidosis|alpha-manosidosis
194441|NCT02141490|Lymph Node|lymph node
194442|NCT02141490|Biopsy|biopsy
194443|NCT02141490|Metastatic Nodes|metastatic nodes
194444|NCT02141490|Imaging Agent|imaging agent
194445|NCT02141477|Leukemia|leukemia
194446|NCT02141477|Acute Myelogenous Leukemia|acute myelogenous leukemia
194447|NCT02141477|AML|aml
194448|NCT02141477|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
194449|NCT02141477|MDS|mds
194450|NCT02141477|Omacetaxine|omacetaxine
194451|NCT02141477|Synribo|synribo
194452|NCT02141477|Homoharringtonine|homoharringtonine
194453|NCT02141477|Decitabine|decitabine
194454|NCT02141477|Dacogen|dacogen
194455|NCT02141451|DLBCL|dlbcl
194456|NCT02141438|Radium-223|radium-223
194457|NCT02141438|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
194458|NCT02141438|CRPC|crpc
194459|NCT02141438|Phase IV|phase iv
194460|NCT02141438|Safety study|safety study
194461|NCT02141425|Healthy volunteers|healthy volunteers
194462|NCT02141425|ASP015K|asp015k
194463|NCT02141412|optimal dose of dexmedetomidine|optimal dose of dexmedetomidine
194464|NCT02141412|prevent shivering|prevent shivering
194465|NCT02141412|improve quality of emergence|improve quality of emergence
194466|NCT02141412|anesthesia|anesthesia
194467|NCT02141412|without delay|without delay
194468|NCT02141412|recovery|recovery
194469|NCT02141386|Multiple Sclerosis|multiple sclerosis
194470|NCT02141386|Cognitive remediation|cognitive remediation
194471|NCT02141386|Plasticity-based, adaptive, computerized cognitive remediation|plasticity-based, adaptive, computerized cognitive remediation
194472|NCT02141386|Cognitive impairment|cognitive impairment
194473|NCT02141373|seroma|seroma
194474|NCT02141373|axillary|axillary
194475|NCT02141373|dissection|dissection
194476|NCT02141360|Mild Traumatic Brain Injury|mild traumatic brain injury
194477|NCT02140281|Phase I, Healthy Volunteers|phase i, healthy volunteers
194478|NCT02140268|Phase I|phase i
194479|NCT02140268|Healthy|healthy
194480|NCT02140268|Pharmacokinetics|pharmacokinetics
194481|NCT02140255|HIV Remission|hiv remission
194482|NCT02140242|AML|aml
194483|NCT02140242|leukemia|leukemia
194484|NCT02140242|induction treatment|induction treatment
194485|NCT02140242|daunorubicin|daunorubicin
194486|NCT02140242|7+3|7+3
194487|NCT02140229|Rheumatoid Arthritis|rheumatoid arthritis
194488|NCT02140229|Remission,|remission,
194489|NCT02140229|DAS28,|das28,
194490|NCT02140229|ACR/EULAR,|acr/eular,
194491|NCT02140229|RAPID, Randomized study,|rapid, randomized study,
194492|NCT02140229|Longitudinal follow-up|longitudinal follow-up
194493|NCT02140216|Blood transfusion|blood transfusion
194494|NCT02140216|Immune|immune
194495|NCT02140216|Surgery|surgery
194496|NCT02140203|Metabolic Syndrome|metabolic syndrome
185471|NCT02186262|MRI|mri
194497|NCT02140203|Waist circumference|waist circumference
194498|NCT02140203|blood pressure|blood pressure
194499|NCT02140203|triglyceride|triglyceride
194500|NCT02140203|HDL|hdl
194501|NCT02140177|Screening|screening
194502|NCT02140177|Adults|adults
194503|NCT02140177|Medical Inpatients|medical inpatients
194504|NCT02140177|Suicide|suicide
194505|NCT02140164|Cystoid Macular Edema|cystoid macular edema
194506|NCT02140164|Minocycline|minocycline
194507|NCT02140164|Microglia|microglia
194508|NCT02140164|Retinitis Pigmentosa|retinitis pigmentosa
194509|NCT02140151|amd|amd
194510|NCT02140151|non-exudative macular degeneration|non-exudative macular degeneration
194511|NCT02140151|exudative macular degeneration|exudative macular degeneration
194512|NCT02140151|age-related macular degeneration|age-related macular degeneration
194513|NCT02140151|ranibizumab|ranibizumab
194514|NCT02140151|anti-VEGF|anti-vegf
194515|NCT02141321|IUD|iud
194516|NCT02141321|Misoprostol|misoprostol
194517|NCT02141321|Rectal administration|rectal administration
194518|NCT02141308|Retina|retina
194519|NCT02141308|Optical coherence tomography|optical coherence tomography
194520|NCT02141308|Imaging|imaging
194521|NCT02141282|Oncology|oncology
194522|NCT02141282|Cancer of the blood and bone marrow|cancer of the blood and bone marrow
194523|NCT02141282|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
194524|NCT02141269|Transthoracic echocardiogram|transthoracic echocardiogram
194525|NCT02141269|Hand-held Echocardiography|hand-held echocardiography
194526|NCT02141256|elderly|elderly
194527|NCT02141256|protein enrichment|protein enrichment
194528|NCT02141256|undernutrition|undernutrition
194529|NCT02141217|Odontogenic (Dental) Infections|odontogenic (dental) infections
194530|NCT02141217|Dental infections, periapical abscess|dental infections, periapical abscess
194531|NCT02141217|Bacterial infection|bacterial infection
194532|NCT02141204|HRV|hrv
194533|NCT02141204|Liquid vaccine|liquid vaccine
194534|NCT02141204|Human rotavirus vaccine|human rotavirus vaccine
194535|NCT02141191|cystic fibrosis|cystic fibrosis
194536|NCT02141191|hypertonic saline|hypertonic saline
194537|NCT02141191|nebulizer|nebulizer
194538|NCT02141191|nasal cannula|nasal cannula
194539|NCT02141165|sleep apnea|sleep apnea
194540|NCT02141165|portable monitor|portable monitor
194541|NCT02141165|primary care|primary care
194542|NCT02141165|cost-effectiveness|cost-effectiveness
194543|NCT02141165|OSAS|osas
194544|NCT02141139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
194545|NCT02141139|Inflammation|inflammation
194546|NCT02141139|Perioperative Period|perioperative period
194547|NCT02141126|Older adults|older adults
194548|NCT02141126|Strength training|strength training
194549|NCT02141126|Muscle mass|muscle mass
194550|NCT02141126|Function|function
194551|NCT02141126|Inpatients|inpatients
194552|NCT02141100|thioguanine|thioguanine
194553|NCT02141100|mercaptopurine|mercaptopurine
194554|NCT02141100|methotrexate|methotrexate
194555|NCT02141048|Parenting programme|parenting programme
194556|NCT02141048|Randomised controlled trial|randomised controlled trial
194557|NCT02141048|South Africa|south africa
194558|NCT02141048|Positive parenting|positive parenting
194559|NCT02141048|Child behaviour problems|child behaviour problems
194560|NCT02141048|Implementation fidelity|implementation fidelity
194561|NCT02141048|Low- and middle-income country|low- and middle-income country
194562|NCT02141035|Acetyl-l-carnitine|acetyl-l-carnitine
194563|NCT02141035|Carpal tunnel syndrome|carpal tunnel syndrome
194564|NCT02141035|Motor unit number estimation|motor unit number estimation
194565|NCT02141035|Compression neuropathy|compression neuropathy
194566|NCT02141022|Multiple Sclerosis|multiple sclerosis
194567|NCT02141022|Cognition|cognition
194568|NCT02141022|Cognitive Remediation|cognitive remediation
194569|NCT02141022|Gilenya|gilenya
194570|NCT02141022|Computerized Cognitive Exercise|computerized cognitive exercise
194571|NCT02141009|Vaccination, prevnar, PCV13|vaccination, prevnar, pcv13
194572|NCT02140996|MUC-1 vector vaccine; epithelial cancers; immunotherapy; safety; antigen specific vaccine, dendritic cell activation|muc-1 vector vaccine; epithelial cancers; immunotherapy; safety; antigen specific vaccine, dendritic cell activation
194573|NCT02140983|Insulin Resistance|insulin resistance
194574|NCT02140983|Family History of Dementia|family history of dementia
194575|NCT02140983|Cognition|cognition
194576|NCT02140970|ureteral stent|ureteral stent
194577|NCT02140970|stent pain|stent pain
194579|NCT02140970|NSAID|nsaid
194580|NCT02140970|ibuprofen|ibuprofen
194581|NCT02140970|placebo|placebo
194582|NCT02140970|ureteropelvic junction obstruction|ureteropelvic junction obstruction
194583|NCT02140970|urolithiasis|urolithiasis
194584|NCT02140957|Toddler Bottle Use|toddler bottle use
194585|NCT02140957|Educational Intervention|educational intervention
194586|NCT02140957|Pediatrics|pediatrics
194587|NCT02140957|Iron Deficiency|iron deficiency
194588|NCT02140944|Cord blood transplantation|cord blood transplantation
194589|NCT02140944|CCR5Δ32|ccr5δ32
194590|NCT02140944|HIV cure|hiv cure
194591|NCT02140931|Cell therapy|cell therapy
185542|NCT02185976|preoperative anxiety|preoperative anxiety
185543|NCT02185976|paediatric patients|paediatric patients
185544|NCT02185976|Cartoon|cartoon
185545|NCT02185963|Diabetes|diabetes
185546|NCT02185963|Dyslipidemia|dyslipidemia
185547|NCT02185963|HDL function|hdl function
185548|NCT02185963|Cholesterol efflux|cholesterol efflux
185549|NCT02185963|MCA assay|mca assay
185550|NCT02185963|MCP-1|mcp-1
194592|NCT02140931|Autologous|autologous
194593|NCT02140918|Fludrocortisone|fludrocortisone
194594|NCT02140918|Mineralocorticoids|mineralocorticoids
194595|NCT02140918|Hemodynamics|hemodynamics
194596|NCT02140918|Pharmacokinetics|pharmacokinetics
194597|NCT02140905|Hemodialysis|hemodialysis
194598|NCT02140905|Heart failure|heart failure
194599|NCT02140905|Impedance|impedance
194600|NCT02140905|Fluids|fluids
194601|NCT02140879|pregnancy|pregnancy
194602|NCT02140879|inflammation|inflammation
194603|NCT02140879|infant assessment|infant assessment
194604|NCT02140853|MDR gram-negative bacilli|mdr gram-negative bacilli
194605|NCT02140853|Mortality|mortality
194606|NCT02140853|Therapy|therapy
194607|NCT02140840|TMTB|tmtb
194608|NCT02140840|Mekinist|mekinist
194609|NCT02140840|Trametinib|trametinib
194610|NCT02140840|relapse|relapse
194611|NCT02140840|refractory|refractory
194612|NCT02140840|response rate|response rate
194613|NCT02140827|bowel preparation|bowel preparation
194614|NCT02140827|instant messaging program|instant messaging program
194615|NCT02140814|PKD|pkd
194616|NCT02140814|niacinamide|niacinamide
194617|NCT02140814|Vitamin B3|vitamin b3
194618|NCT02140814|Vitamin B|vitamin b
194619|NCT02140801|Percutaneous coronary intervention|percutaneous coronary intervention
194620|NCT02140801|Drug-eluting stent|drug-eluting stent
194621|NCT02140801|Thrombosis|thrombosis
194622|NCT02140788|schizophrenia|schizophrenia
194623|NCT02140788|schizo-affective disorder|schizo-affective disorder
194624|NCT02140775|HIV|hiv
194625|NCT02140775|AIDS|aids
194626|NCT02140775|Fatigue|fatigue
194627|NCT02140775|armodafinil|armodafinil
194628|NCT02140775|Unemployment|unemployment
194730|NCT02140112|T. suis ova|t. suis ova
194629|NCT02140762|Meningitis ABCWY|meningitis abcwy
194630|NCT02140762|adolescents|adolescents
194631|NCT02140762|accination|accination
194632|NCT02140762|meningococcal disease|meningococcal disease
194633|NCT02140749|Bifidobacteria|bifidobacteria
194634|NCT02140749|Bristol Stool Scale|bristol stool scale
194635|NCT02140749|Constipation|constipation
194636|NCT02140749|Diet|diet
194637|NCT02140749|Fructooligosacchardes|fructooligosacchardes
194638|NCT02140749|Microbiota|microbiota
194639|NCT02140749|Oligofructose|oligofructose
194640|NCT02140736|Chemotherapy-induced anemia|chemotherapy-induced anemia
194641|NCT02140736|Epoetin biosimilar|epoetin biosimilar
194642|NCT02140723|preoperative short course radiotherapy|preoperative short course radiotherapy
194643|NCT02140723|delay of surgery|delay of surgery
194644|NCT02140723|rectal cancer|rectal cancer
194645|NCT02140723|TP53|tp53
194646|NCT02140723|predictive marker|predictive marker
194647|NCT02140723|MRT imaging|mrt imaging
194648|NCT02140710|premature infant|premature infant
194649|NCT02140710|visceral osteopathy|visceral osteopathy
194650|NCT02140710|alternative medicine|alternative medicine
194651|NCT02140710|meconium passage|meconium passage
194652|NCT02140710|enteral feedings|enteral feedings
194653|NCT02140710|hospital stay|hospital stay
194654|NCT02140684|Real-world|real-world
194655|NCT02140684|observational|observational
194656|NCT02140684|Nitric oxide|nitric oxide
194657|NCT02140684|Inhaled corticosteroid|inhaled corticosteroid
194658|NCT02140684|UK|uk
194659|NCT02140671|asthma management|asthma management
194660|NCT02140671|anti-inflammatory therapy|anti-inflammatory therapy
194661|NCT02140671|compliance|compliance
194662|NCT02140671|hospital admission|hospital admission
194663|NCT02140671|educations|educations
194664|NCT02140671|self-management|self-management
194665|NCT02140671|guidelines|guidelines
194666|NCT02140671|exacerbations|exacerbations
194667|NCT02140671|diagnostic accuracy|diagnostic accuracy
194668|NCT02140671|symptom control|symptom control
194669|NCT02140658|ischemic stroke|ischemic stroke
194670|NCT02140658|Statins Medication Compliance|statins medication compliance
194672|NCT02140632|Carpal tunnel syndrome|carpal tunnel syndrome
194673|NCT02140632|Local steroid injection|local steroid injection
194674|NCT02140632|Wrist splinting|wrist splinting
194675|NCT02140619|ischemic stroke|ischemic stroke
194676|NCT02140619|Medication Compliance|medication compliance
194677|NCT02140619|outcome|outcome
194678|NCT02140606|AML|aml
194679|NCT02140606|phase1|phase1
194680|NCT02140606|MTD|mtd
194681|NCT02140606|Cafusertib|cafusertib
194682|NCT02140580|Minimally-invasive surfactant therapy|minimally-invasive surfactant therapy
194683|NCT02140541|Asthma|asthma
194684|NCT02140541|Blood eosinophils|blood eosinophils
194685|NCT02140541|Sputum eosinophils|sputum eosinophils
194686|NCT02140541|Clinical predictor|clinical predictor
194687|NCT02140541|UK primary care|uk primary care
194688|NCT02140541|Global Initiative for Asthma (GINA)|global initiative for asthma (gina)
194689|NCT02140528|Allogenic adipose derived mesenchymal stem cell tibial fracture|allogenic adipose derived mesenchymal stem cell tibial fracture
194690|NCT02140515|Gonal-F Luveris Assisted Reproductive Technology Hypogonadotropic Hypogonadism|gonal-f luveris assisted reproductive technology hypogonadotropic hypogonadism
194691|NCT02140502|Enterobacterial Infections|enterobacterial infections
194692|NCT02140502|Prostate cancer|prostate cancer
194694|NCT02140502|Incidence of fluoroquinolone resistant enteric bacteria|incidence of fluoroquinolone resistant enteric bacteria
194695|NCT02140476|Thyroid goiter|thyroid goiter
194696|NCT02140476|Papillary thyroid cancer|papillary thyroid cancer
194697|NCT02140476|Bipolar device|bipolar device
194698|NCT02140476|Sealing and cutting device|sealing and cutting device
194699|NCT02140476|Thyroidectomy|thyroidectomy
194700|NCT02140450|intraocular pressure, intravitreal injection, short term|intraocular pressure, intravitreal injection, short term
194701|NCT02140437|Fulvestrant|fulvestrant
194702|NCT02140437|Anastrozole|anastrozole
194703|NCT02140437|Luminal A-like|luminal a-like
194704|NCT02140437|Postmenopausal|postmenopausal
194705|NCT02140437|Advanced breast cancer|advanced breast cancer
194706|NCT02140424|type 1 diabetes|type 1 diabetes
194707|NCT02140424|osteoporosis|osteoporosis
194708|NCT02140424|children|children
194709|NCT02140398|infertility|infertility
194710|NCT02140398|PCOS|pcos
194711|NCT02140398|scratching|scratching
194712|NCT02140398|endometrial receptivity|endometrial receptivity
194713|NCT02140372|colchicine|colchicine
194714|NCT02140372|platelet activity|platelet activity
194715|NCT02140372|neutrophil|neutrophil
194716|NCT02140359|homelessness|homelessness
194717|NCT02140359|housing first|housing first
194718|NCT02140359|social networks|social networks
194719|NCT02140359|drug abuse|drug abuse
194720|NCT02140359|alcohol use|alcohol use
194721|NCT02140359|HIV|hiv
194722|NCT02140333|erlotinib|erlotinib
194723|NCT02140333|EGFR mutation|egfr mutation
194724|NCT02140307|Health Promotion|health promotion
194725|NCT02140307|Prevention|prevention
194726|NCT02140307|Relaxation Response|relaxation response
194727|NCT02140307|Meditation|meditation
194728|NCT02140307|Cortisol|cortisol
194729|NCT02140125|ASP2408|asp2408
194731|NCT02140112|Trichuris suis ova|trichuris suis ova
194732|NCT02140112|Autism Spectrum Disorder|autism spectrum disorder
194733|NCT02140112|ASD|asd
194734|NCT02140099|Mental health|mental health
194735|NCT02140099|Violence|violence
194736|NCT02140099|Substance use|substance use
194737|NCT02140099|Adolescent|adolescent
194738|NCT02140099|Prevention|prevention
194739|NCT02140086|asthma|asthma
194740|NCT02140086|Buteyko|buteyko
194741|NCT02140086|remedial breathing|remedial breathing
194742|NCT02140086|children|children
194743|NCT02140073|GERD|gerd
194744|NCT02140073|Omez|omez
194745|NCT02140073|Omez DSR|omez dsr
194746|NCT02140073|heartburn|heartburn
194747|NCT02140073|esophagitis|esophagitis
194748|NCT02140073|omeprazole|omeprazole
194749|NCT02140073|omeprazole+domperidone|omeprazole+domperidone
194750|NCT02140060|Glaucoma|glaucoma
194751|NCT02140060|Ocular|ocular
194752|NCT02140060|Hypertension|hypertension
194753|NCT02140060|OAG|oag
194754|NCT02140060|POAG|poag
194755|NCT02140060|OHT|oht
194756|NCT02140047|Haemophilus influenza type b|haemophilus influenza type b
194757|NCT02140047|Hib|hib
194758|NCT02140034|Extensive Peritoneal Lavage|extensive peritoneal lavage
194759|NCT02140034|Overall Survival|overall survival
194760|NCT02140034|Disease Free Survival|disease free survival
194761|NCT02140034|Peritoneal Recurrence Rate|peritoneal recurrence rate
194762|NCT02140034|T3 and T4 Gastric Cancer|t3 and t4 gastric cancer
194763|NCT02140021|Malignant Female Reproductive System Neoplasm|malignant female reproductive system neoplasm
194764|NCT02140021|Gynecological Cancer|gynecological cancer
194765|NCT02140021|High-grade dysplasia|high-grade dysplasia
194766|NCT02140021|Carcinoma of the cervix|carcinoma of the cervix
194767|NCT02140021|Carcinoma of the vagina|carcinoma of the vagina
194768|NCT02140021|Carcinoma of the vulva|carcinoma of the vulva
194769|NCT02140021|Invasive squamous cell carcinoma|invasive squamous cell carcinoma
194770|NCT02140021|Anal pap test|anal pap test
194771|NCT02140021|Anoscopy|anoscopy
194772|NCT02140008|supraglottic airway devices|supraglottic airway devices
194773|NCT02140008|the i-gel|the i-gel
194774|NCT02140008|the self-pressurised air-Q intubating laryngeal airway,|the self-pressurised air-q intubating laryngeal airway,
194775|NCT02140008|children|children
194776|NCT02139995|transfusion|transfusion
194777|NCT02139995|trigger|trigger
194778|NCT02139995|critically-ill|critically-ill
194779|NCT02139982|hemodynamics|hemodynamics
194780|NCT02139982|anaesthetics|anaesthetics
194781|NCT02139982|brachial plexus|brachial plexus
194782|NCT02139982|peripheral nerves|peripheral nerves
194976|NCT02138968|Exercise|exercise
194784|NCT02139982|sympathetic nervous system|sympathetic nervous system
194785|NCT02139982|dose-response relationship|dose-response relationship
194786|NCT02139943|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
194787|NCT02139943|Canagliflozin|canagliflozin
194788|NCT02139943|Continuous Glucose Monitoring|continuous glucose monitoring
194790|NCT02139930|nicotine reduction|nicotine reduction
194791|NCT02139917|transitional palliative care|transitional palliative care
194792|NCT02139917|end stage renal failure|end stage renal failure
194793|NCT02139904|Mesothelioma|mesothelioma
194794|NCT02139904|Vinorelbine|vinorelbine
194795|NCT02139904|BRCA1|brca1
194796|NCT02139891|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
194797|NCT02139891|non responders|non responders
194798|NCT02139891|MultiPoint Pacing (MPP)|multipoint pacing (mpp)
194799|NCT02139813|Obesity -|obesity -
194800|NCT02139813|Bariatric surgery|bariatric surgery
194801|NCT02139813|Gastric bypass|gastric bypass
194802|NCT02139800|Neonatal resuscitation|neonatal resuscitation
194803|NCT02139800|Extreme Low Gestational Age Newborn (ELGAN)|extreme low gestational age newborn (elgan)
194804|NCT02139800|Delivery Room|delivery room
194805|NCT02139800|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
194806|NCT02139800|Positive pressure ventilation (PPV)|positive pressure ventilation (ppv)
194807|NCT02139800|Sustained inflation|sustained inflation
194808|NCT02139787|Hypertension, obesity|hypertension, obesity
194809|NCT02139787|Dietary behaviors|dietary behaviors
194810|NCT02139787|Physical activity behaviors|physical activity behaviors
194811|NCT02139787|Radio story, entertainment health education|radio story, entertainment health education
194812|NCT02139787|Immigrants|immigrants
194813|NCT02139787|Somali, Latino, Hmong|somali, latino, hmong
194814|NCT02139787|Families with 3-18 year old children|families with 3-18 year old children
194815|NCT02139774|Prostate Cancer|prostate cancer
194816|NCT02139774|Elderly|elderly
194817|NCT02139774|Geriatric|geriatric
194818|NCT02139774|Radiation|radiation
194819|NCT02139774|Arthritis|arthritis
194820|NCT02139774|Exercise|exercise
194821|NCT02139774|Walking|walking
194822|NCT02139774|Endocrine Therapy|endocrine therapy
194823|NCT02139774|Androgen Deprivation Therapy|androgen deprivation therapy
194824|NCT02139774|Active Surveillance|active surveillance
194825|NCT02139774|Men|men
194826|NCT02139761|Cocaine|cocaine
194827|NCT02139761|Treatment|treatment
194828|NCT02139748|Dental Implants|dental implants
194829|NCT02139748|Alveolar Bone Grafting|alveolar bone grafting
194918|NCT02139267|Neoplasm|neoplasm
194830|NCT02139748|Acellular Dermis|acellular dermis
194831|NCT02139735|Temporomandibular Joint Disorders,|temporomandibular joint disorders,
194832|NCT02139735|Ultrasonics,|ultrasonics,
194833|NCT02139735|Electromyography,|electromyography,
194834|NCT02139735|Pain Measurement,|pain measurement,
194835|NCT02139735|Muscle Stretching Exercise|muscle stretching exercise
194836|NCT02139722|hepatitis B|hepatitis b
194837|NCT02139722|hepatitis C|hepatitis c
194838|NCT02139722|screening|screening
194839|NCT02139722|Asian Americans|asian americans
194840|NCT02139722|mobile technology|mobile technology
194841|NCT02139657|Rabies|rabies
194842|NCT02139657|Rabies virus|rabies virus
194843|NCT02139657|Rhabdoviridae|rhabdoviridae
194844|NCT02139657|Rabies immune globulin|rabies immune globulin
194845|NCT02139657|Rabies antibodies|rabies antibodies
194846|NCT02139657|Passive rabies immunization|passive rabies immunization
194847|NCT02139644|fluticasone propionate|fluticasone propionate
194848|NCT02139644|multidose dry powder inhaler|multidose dry powder inhaler
194849|NCT02139631|hemodynamic|hemodynamic
194850|NCT02139631|mechanical ventilation|mechanical ventilation
194851|NCT02139631|respiration with positive pressure|respiration with positive pressure
194852|NCT02139618|Randomized-controlled-trial|randomized-controlled-trial
194853|NCT02139618|Methyl-Aminolevulinate|methyl-aminolevulinate
194854|NCT02139618|Daylight|daylight
194855|NCT02139618|Photodynamic-therapy|photodynamic-therapy
194856|NCT02139605|D2 versus D3 Lymphadenectomy|d2 versus d3 lymphadenectomy
194857|NCT02139592|Pharmacological therapy|pharmacological therapy
194858|NCT02139579|chemotherapy|chemotherapy
194859|NCT02139579|EGFR-TKI resistance|egfr-tki resistance
194860|NCT02139579|Bevacizumab|bevacizumab
194861|NCT02139553|Rhythmic versus discrete movements|rhythmic versus discrete movements
194862|NCT02139553|Rehabilitation|rehabilitation
194863|NCT02139540|Treatment|treatment
194864|NCT02139527|arthroplasty|arthroplasty
194865|NCT02139527|spinal|spinal
194866|NCT02139527|CHARITE|charite
194867|NCT02139527|PRODISC-L|prodisc-l
194868|NCT02139527|PRODISC|prodisc
194869|NCT02139527|disc|disc
194870|NCT02139527|replacement|replacement
194871|NCT02139527|lumbar|lumbar
194872|NCT02139514|Social Skills|social skills
194873|NCT02139514|Adults|adults
194874|NCT02139501|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
194875|NCT02139501|Dose and frequency|dose and frequency
185833|NCT02184819|cardiac mechanical assist devices|cardiac mechanical assist devices
185834|NCT02184819|renal replacement therapy|renal replacement therapy
185835|NCT02184819|mechanical ventilation duration|mechanical ventilation duration
185836|NCT02184819|ICU stay|icu stay
185837|NCT02184806|Ovarian tissue transplantation|ovarian tissue transplantation
185838|NCT02184806|Cryopreserved ovarian tissue|cryopreserved ovarian tissue
185842|NCT02184780|Neurodevelopment|neurodevelopment
194876|NCT02139501|Immune Thrombocytopenia|immune thrombocytopenia
194877|NCT02139488|Esophageal cancer|esophageal cancer
194878|NCT02139488|Chemoradiation|chemoradiation
194879|NCT02139475|bowel cleansing, colorectal cancer surgery|bowel cleansing, colorectal cancer surgery
194880|NCT02139462|FBT, fidelity, training|fbt, fidelity, training
194881|NCT02139449|CRT, heart failure, ICD|crt, heart failure, icd
194882|NCT02139423|Congenital cytomegalovirus infection|congenital cytomegalovirus infection
194883|NCT02139423|newborn universal hearing screening|newborn universal hearing screening
194884|NCT02139410|sarcopenia|sarcopenia
194885|NCT02139410|mortality|mortality
194886|NCT02139384|procalcitonin|procalcitonin
194887|NCT02139384|community acquired pneumonia|community acquired pneumonia
194888|NCT02139384|pneumonia score|pneumonia score
194889|NCT02139371|Positron Emission Tomography|positron emission tomography
194890|NCT02139371|Uroplasminogen Plasminogen Activator Receptor|uroplasminogen plasminogen activator receptor
194891|NCT02139371|Breast cancer|breast cancer
194892|NCT02139371|Prostate cancer|prostate cancer
194893|NCT02139371|Urinary bladder cancer|urinary bladder cancer
194894|NCT02139371|Biodistribution|biodistribution
194895|NCT02139371|Radiation exposure|radiation exposure
194896|NCT02139358|Breast - Female|breast - female
194897|NCT02139358|Metastatic|metastatic
194899|NCT02139345|Osteoarthritis|osteoarthritis
194900|NCT02139345|Rheumatoid arthritis|rheumatoid arthritis
194901|NCT02139345|Post-traumatic arthritis|post-traumatic arthritis
194902|NCT02139345|Avascular necrosis|avascular necrosis
194903|NCT02139345|AVN|avn
194904|NCT02139332|Attachment theory|attachment theory
194905|NCT02139332|Parent- child relationship|parent- child relationship
194906|NCT02139332|Child mental health|child mental health
194907|NCT02139332|Behavioral health|behavioral health
194908|NCT02139293|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion
194909|NCT02139280|Cyclophosphamide|cyclophosphamide
194910|NCT02139280|Hematopoietic|hematopoietic
194911|NCT02139280|Stem Cell|stem cell
194912|NCT02139280|Mobilization|mobilization
194913|NCT02139280|Hematologic Malignancy|hematologic malignancy
194914|NCT02139267|CIN3|cin3
194915|NCT02139267|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
194916|NCT02139267|High-Risk HPV|high-risk hpv
194917|NCT02139267|HPV Infection|hpv infection
194919|NCT02139267|Precancerous Diseases|precancerous diseases
194920|NCT02139267|Uterine Diseases|uterine diseases
194921|NCT02139267|Genital Diseases, Female|genital diseases, female
194922|NCT02139254|Gestational Diabetes|gestational diabetes
194923|NCT02139254|HbA1c|hba1c
194924|NCT02139254|Glucose|glucose
194925|NCT02139254|First Trimenon|first trimenon
194926|NCT02139228|Haemophilus influenzae type b|haemophilus influenzae type b
194927|NCT02139228|persistency|persistency
194928|NCT02139228|children|children
194929|NCT02139228|CRM197|crm197
194930|NCT02139228|anti-PRP antibody|anti-prp antibody
194931|NCT02139202|Acute|acute
194932|NCT02139202|Myocardial|myocardial
194933|NCT02139202|Infarction|infarction
194934|NCT02139202|AMI|ami
194935|NCT02139176|couple HIV testing and counseling|couple hiv testing and counseling
194936|NCT02139176|disclosure|disclosure
194937|NCT02139176|discordant|discordant
194938|NCT02139176|HIV|hiv
194939|NCT02139176|Malawi|malawi
194940|NCT02139163|Community acquired pneumonia|community acquired pneumonia
194941|NCT02139163|CAP|cap
194942|NCT02139163|CAPNETZ|capnetz
194943|NCT02139163|age ≥18|age ≥18
194944|NCT02139163|infiltrate on chest X-ray|infiltrate on chest x-ray
194945|NCT02139163|cough or production of purulent sputum|cough or production of purulent sputum
194946|NCT02139163|pathologic lung auscultation|pathologic lung auscultation
194947|NCT02139163|fever|fever
194948|NCT02139150|FLT PET Imaging|flt pet imaging
194949|NCT02139150|3'deoxy-3' [18F] fluorothymidine ([18F] FLT)|3'deoxy-3' [18f] fluorothymidine ([18f] flt)
194950|NCT02139150|CT|ct
194951|NCT02139150|scans|scans
194952|NCT02139150|14-050|14-050
194953|NCT02139098|sleep architecture|sleep architecture
194954|NCT02139098|conditioning of pharmacological responses|conditioning of pharmacological responses
194955|NCT02139098|insomnia|insomnia
194956|NCT02139085|varicose veins|varicose veins
194957|NCT02139085|catheter ablation|catheter ablation
194958|NCT02139085|Catheter Ablation, Electrical|catheter ablation, electrical
194959|NCT02139085|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
194960|NCT02139072|Anticoagulation|anticoagulation
194961|NCT02139072|International normalized ratio|international normalized ratio
194962|NCT02139072|Warfarin|warfarin
194963|NCT02139059|anuria|anuria
194964|NCT02139059|children|children
194965|NCT02139059|ureteroscopy|ureteroscopy
194966|NCT02139059|initial urinary drainage|initial urinary drainage
194967|NCT02139059|ureteric stones|ureteric stones
194968|NCT02139046|Drug therapy|drug therapy
194969|NCT02139033|Dry Eye, Dry Eye Syndrome, Retaine, KCS, Keratoconjunctivitis sicca|dry eye, dry eye syndrome, retaine, kcs, keratoconjunctivitis sicca
194970|NCT02139020|Targeted therapies|targeted therapies
194971|NCT02139020|Plasma samples|plasma samples
194972|NCT02138981|Hepatocellular Carcinoma|hepatocellular carcinoma
194973|NCT02138981|Milan Criteria|milan criteria
194974|NCT02138968|Pre-frailty|pre-frailty
194975|NCT02138968|Frail|frail
194977|NCT02138968|Nutritional assessment|nutritional assessment
194978|NCT02138968|Functional capacity|functional capacity
194979|NCT02138942|automated vascular filling|automated vascular filling
194980|NCT02138942|Learning Intravenous Resuscitator (LIR)|learning intravenous resuscitator (lir)
194981|NCT02138942|General Surgery|general surgery
194982|NCT02138942|Fluid Therapy|fluid therapy
194983|NCT02138929|Esophageal Cancer|esophageal cancer
194984|NCT02138929|Advanced adenocarcinoma of the esophagus|advanced adenocarcinoma of the esophagus
194985|NCT02138929|Advanced adenocarcinoma of the gastroesophageal junction|advanced adenocarcinoma of the gastroesophageal junction
194986|NCT02138929|GEJ|gej
194987|NCT02138929|Metastatic|metastatic
194988|NCT02138929|Everolimus|everolimus
194989|NCT02138929|Afinitor|afinitor
194990|NCT02138929|Zortress|zortress
194991|NCT02138929|RAD001|rad001
194992|NCT02138929|LDE 225|lde 225
194993|NCT02138916|Obstructive Lung Diseases|obstructive lung diseases
194994|NCT02138916|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
194995|NCT02138916|Lung Disease|lung disease
194996|NCT02138916|Bronchial Diseases|bronchial diseases
194997|NCT02138916|COPD Exacerbation|copd exacerbation
194998|NCT02138916|Respiratory Tract Diseases|respiratory tract diseases
194999|NCT02138903|weaning|weaning
195000|NCT02138903|Cardiac|cardiac
195001|NCT02138903|Echocardiography|echocardiography
195002|NCT02138903|Mechanical Ventilation|mechanical ventilation
195003|NCT02138890|Autologous Protein Solution|autologous protein solution
195004|NCT02138890|APS|aps
195005|NCT02138890|Osteoarthritis|osteoarthritis
195006|NCT02138890|Intra Articular Injection|intra articular injection
195007|NCT02138877|Pelviureteric junction obstruction|pelviureteric junction obstruction
195008|NCT02138877|pyeloplasty|pyeloplasty
195009|NCT02138877|Neonate affected by hydronephrosis|neonate affected by hydronephrosis
195010|NCT02138877|obstructive uropathy|obstructive uropathy
195011|NCT02138877|urinary stent|urinary stent
195012|NCT02138864|carbon monoxide intoxication|carbon monoxide intoxication
195013|NCT02138864|Parkinsonism|parkinsonism
195014|NCT02138864|18F-DTBZ AV-133|18f-dtbz av-133
195015|NCT02138838|Chronic Kidney Disease, Secondary Hyperparathyroidism, Dialysis, Pediatric|chronic kidney disease, secondary hyperparathyroidism, dialysis, pediatric
195016|NCT02138812|Phase 1|phase 1
195017|NCT02138812|Solid tumors|solid tumors
195018|NCT02138812|Breast cancer|breast cancer
195019|NCT02138812|Paclitaxel|paclitaxel
195020|NCT02138812|MPS-1 inhibitor|mps-1 inhibitor
195021|NCT02138812|Taxanes|taxanes
195022|NCT02138799|Phase I|phase i
195023|NCT02138799|Pharmacokinetics|pharmacokinetics
195024|NCT02138799|Safety|safety
195025|NCT02138799|Drug-drug interactions|drug-drug interactions
195026|NCT02138799|Enzalutamide|enzalutamide
195027|NCT02138799|Rifampin|rifampin
195028|NCT02138799|CYP3A4|cyp3a4
195029|NCT02138799|CYP2D8|cyp2d8
195030|NCT02138799|Enzyme induction|enzyme induction
195031|NCT02138786|Richter's Transformation|richter's transformation
195032|NCT02138786|Richter's Syndrome|richter's syndrome
195033|NCT02138786|Karyopharm|karyopharm
195034|NCT02138786|selinexor|selinexor
195035|NCT02138786|KPT-330|kpt-330
195036|NCT02138786|SIRRT|sirrt
195037|NCT02138786|CLL|cll
195038|NCT02138773|prolonged release formulation|prolonged release formulation
195039|NCT02138773|adrenergic blocker|adrenergic blocker
195040|NCT02138773|Bioequivalence|bioequivalence
195041|NCT02138760|prostate cancer|prostate cancer
195042|NCT02138760|prostate biopsy|prostate biopsy
195043|NCT02138760|magnetic resonance imaging guidance|magnetic resonance imaging guidance
195044|NCT02138760|detection rates|detection rates
195045|NCT02138760|performance|performance
195046|NCT02138747|Overactive bladder (OAB)|overactive bladder (oab)
195047|NCT02138747|tolterodine ER|tolterodine er
195048|NCT02138747|mirabegron|mirabegron
195049|NCT02138734|antitumor|antitumor
195050|NCT02138734|BCG|bcg
195051|NCT02138734|bladder cancer|bladder cancer
195052|NCT02138734|cancer|cancer
195053|NCT02138734|immunotherapy|immunotherapy
195054|NCT02138734|instillation|instillation
195055|NCT02138734|interleukin-15|interleukin-15
195056|NCT02138734|intravesical|intravesical
195057|NCT02138734|naive|naive
195058|NCT02138734|non-muscle invasive|non-muscle invasive
195059|NCT02138734|transitional cell carcinoma|transitional cell carcinoma
195060|NCT02138721|Metastatic Prostate Cancer|metastatic prostate cancer
195061|NCT02138721|Prostatectomy|prostatectomy
195062|NCT02138708|Pulmonary arterial hypertension,|pulmonary arterial hypertension,
195063|NCT02138708|congenital heart disease,|congenital heart disease,
195064|NCT02138708|heart shunt,|heart shunt,
195065|NCT02138708|acetylcholine|acetylcholine
195066|NCT02138708|Pharmacological test of pulmonary vascular reactivity (acetylcholine) in|pharmacological test of pulmonary vascular reactivity (acetylcholine) in
195067|NCT02138695|atrial fibrillation|atrial fibrillation
195068|NCT02138695|catheter ablation|catheter ablation
195069|NCT02138695|recurrence|recurrence
195070|NCT02138682|DaT-SPECT scan|dat-spect scan
195071|NCT02138682|Parkinson's|parkinson's
195072|NCT02138682|Diagnostic|diagnostic
195073|NCT02138669|Cornea|cornea
195074|NCT02138669|Keratoconus|keratoconus
195075|NCT02138669|Steep cornea|steep cornea
195076|NCT02138656|Crying|crying
195077|NCT02138656|Chiropractic|chiropractic
195078|NCT02138656|Infant|infant
195079|NCT02138656|pediatric|pediatric
195080|NCT02138656|Infantile colic|infantile colic
195081|NCT02138656|Clinical Trial|clinical trial
195082|NCT02138643|Achalasia|achalasia
195083|NCT02138643|Megaesophagus|megaesophagus
195084|NCT02138643|Peropal endoscopic myotomy(POEM)|peropal endoscopic myotomy(poem)
195085|NCT02138643|Laparoscopic Heller myotomy|laparoscopic heller myotomy
195086|NCT02138630|Exercise|exercise
195087|NCT02138617|Colon Cancer|colon cancer
195088|NCT02138617|Irinotecan|irinotecan
195089|NCT02138617|FOLFIRI|folfiri
195090|NCT02138617|Genotyping|genotyping
195091|NCT02138617|UGT1A1|ugt1a1
195092|NCT02138604|chest pain|chest pain
195093|NCT02138604|myocardial ischemia|myocardial ischemia
195094|NCT02138604|acute myocardial dysfunction|acute myocardial dysfunction
195095|NCT02138604|plethesmography|plethesmography
195096|NCT02138604|non invasive dP/dt|non invasive dp/dt
195097|NCT02138591|vitamin d deficiency|vitamin d deficiency
195098|NCT02138591|cathelicidin antimicrobial peptide|cathelicidin antimicrobial peptide
195099|NCT02138591|resistin, human|resistin, human
195100|NCT02138591|protein, human|protein, human
195101|NCT02138591|1,25-dihydroxy-16,23-diene vitamin D3|1,25-dihydroxy-16,23-diene vitamin d3
195102|NCT02138591|Cholecalciferol|cholecalciferol
195103|NCT02138591|Nutritional Status|nutritional status
195104|NCT02138591|length of stay|length of stay
195105|NCT02138539|hyperpigmentation|hyperpigmentation
195106|NCT02138539|melasma|melasma
195107|NCT02138539|sun spots|sun spots
195108|NCT02138539|dark spots|dark spots
195109|NCT02138526|cancer|cancer
195110|NCT02138526|pazopanib|pazopanib
195111|NCT02138526|food|food
195112|NCT02138526|pharmacokinetics|pharmacokinetics
195113|NCT02138513|Mindfulness|mindfulness
195114|NCT02138513|MBCT|mbct
195115|NCT02138513|Cancer|cancer
195116|NCT02138513|Oncology|oncology
195117|NCT02138513|E-health|e-health
195118|NCT02138513|Cost-effectiveness|cost-effectiveness
195119|NCT02138500|PF-06372865|pf-06372865
195120|NCT02138500|phase 1|phase 1
195121|NCT02138500|open-label|open-label
195122|NCT02138500|GABA-A receptor occupancy|gaba-a receptor occupancy
195123|NCT02138500|positron emission tomography|positron emission tomography
195124|NCT02138500|healthy subjects|healthy subjects
195125|NCT02138487|pelvic organ prolapse|pelvic organ prolapse
195126|NCT02138487|reconstructive pelvic surgery|reconstructive pelvic surgery
195127|NCT02138487|postoperative restrictions|postoperative restrictions
195128|NCT02138487|patient satisfaction|patient satisfaction
195129|NCT02138474|Lacticum acidum homaccord|lacticum acidum homaccord
195130|NCT02138474|homeopathy|homeopathy
195131|NCT02138474|chronic tension-type headaches|chronic tension-type headaches
195132|NCT02138461|glaucoma|glaucoma
195133|NCT02138461|bimatoprost|bimatoprost
195134|NCT02138461|latanoprost|latanoprost
195135|NCT02138461|tolerability|tolerability
195136|NCT02138448|Cancer Screenings|cancer screenings
195137|NCT02138448|Health Information Technology|health information technology
195138|NCT02138448|Patient Health Record|patient health record
195139|NCT02138448|Preventive Services|preventive services
195140|NCT02138422|colorectal cancer|colorectal cancer
195141|NCT02138383|advanced pancreatic cancer|advanced pancreatic cancer
195142|NCT02138383|pancreas|pancreas
195143|NCT02138383|malignant neoplasm|malignant neoplasm
195144|NCT02138383|endocrine system|endocrine system
195145|NCT02138357|Restless Legs Syndrome|restless legs syndrome
195146|NCT02138357|Willis Ekbom Disease|willis ekbom disease
195147|NCT02138357|Twitchy Legs|twitchy legs
195148|NCT02138357|Periodic Limb Movements|periodic limb movements
195149|NCT02138357|Leg Movements|leg movements
195150|NCT02138357|Augmentation|augmentation
195151|NCT02138357|Requip|requip
195152|NCT02138357|ropinirole|ropinirole
195153|NCT02138357|Mirapex|mirapex
195154|NCT02138357|pramipexole|pramipexole
195155|NCT02138357|gabapentin|gabapentin
195156|NCT02138357|Horizant|horizant
195157|NCT02138357|Neupro|neupro
195158|NCT02138357|rotigotine|rotigotine
195159|NCT02138331|Diabetes Mellitus Type 1|diabetes mellitus type 1
195160|NCT02138331|Microvesicles|microvesicles
195161|NCT02138331|Exosomes|exosomes
195162|NCT02138331|Cord Blood|cord blood
195163|NCT02138331|Mesenchymal Stem Cells|mesenchymal stem cells
195164|NCT02138305|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
195165|NCT02138305|Instantaneous Wave Free Ratio (iFR)|instantaneous wave free ratio (ifr)
195166|NCT02138305|Coronary Flow Reserve (CFR)|coronary flow reserve (cfr)
195167|NCT02138305|Hyperemic Stenosis Resistance Index (HSR)|hyperemic stenosis resistance index (hsr)
195168|NCT02138305|Hyperemic microvascular resistance (HMR)|hyperemic microvascular resistance (hmr)
195169|NCT02138305|Wave intensity analysis (WIA)|wave intensity analysis (wia)
195170|NCT02138305|Myocardial Perfusion|myocardial perfusion
195171|NCT02138305|SPY NIRF Regional Myocardial Perfusion Analysis|spy nirf regional myocardial perfusion analysis
195172|NCT02138253|liver transplant|liver transplant
195173|NCT02138253|hepatitis C|hepatitis c
195174|NCT02138253|liver fibrosis|liver fibrosis
195175|NCT02138253|hepatic fibrosis|hepatic fibrosis
195176|NCT02138253|liver cirrhosis|liver cirrhosis
195177|NCT02138253|hepatic cirrhosis|hepatic cirrhosis
195178|NCT02138227|Organ donation request|organ donation request
195179|NCT02138227|Family decision makers|family decision makers
195180|NCT02138227|Communication|communication
195181|NCT02138201|diffusion tensor imaging fiber tracking|diffusion tensor imaging fiber tracking
195182|NCT02138201|magnetic resonance Imaging|magnetic resonance imaging
195183|NCT02138201|spinal cord injury|spinal cord injury
195184|NCT02138201|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
195185|NCT02138175|bleeding|bleeding
195186|NCT02138175|blood loss|blood loss
195187|NCT02138175|hemoglobin|hemoglobin
195188|NCT02138175|hemoglobin monitoring|hemoglobin monitoring
195189|NCT02138175|noninvasive monitoring|noninvasive monitoring
195190|NCT02138162|Phase 1|phase 1
195191|NCT02138162|Pharmacokinetics|pharmacokinetics
195192|NCT02138162|Safety|safety
195193|NCT02138162|Severe hepatic impairment|severe hepatic impairment
195194|NCT02138162|Enzalutamide|enzalutamide
195195|NCT02138149|spinal cord injury|spinal cord injury
195196|NCT02138149|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
195197|NCT02138149|nerve growth factor|nerve growth factor
195198|NCT02138149|neurogenic detrusor overactivity|neurogenic detrusor overactivity
195199|NCT02138149|urodynamics|urodynamics
195200|NCT02138123|dense cataract|dense cataract
195201|NCT02138123|phacoemulsification|phacoemulsification
195202|NCT02138123|lens-shell technique|lens-shell technique
195203|NCT02138123|intraocular lens|intraocular lens
195204|NCT02138110|Spinal Cord Injury (SCI)|spinal cord injury (sci)
195205|NCT02138110|Complete (AIS A) Traumatic Acute Spinal Cord Injury|complete (ais a) traumatic acute spinal cord injury
195206|NCT02138071|low back pain|low back pain
195207|NCT02138071|lumbar pain|lumbar pain
195208|NCT02138058|compulsive buying, compulsive shopping, topiramate|compulsive buying, compulsive shopping, topiramate
195209|NCT02138045|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
195210|NCT02138045|Diabetic Neuropathy|diabetic neuropathy
195211|NCT02138045|Liraglutide|liraglutide
195212|NCT02138032|message framing|message framing
195213|NCT02138032|smoking cessation|smoking cessation
195313|NCT02137460|Imaging|imaging
195214|NCT02138032|peripheral artery disease|peripheral artery disease
195215|NCT02138019|corneal ulcers|corneal ulcers
195216|NCT02138019|conjunctival closure in strabismus surgery|conjunctival closure in strabismus surgery
195217|NCT02138019|surgery for retinal detachment|surgery for retinal detachment
195218|NCT02138019|cataract surgery|cataract surgery
195219|NCT02138019|mucous membrane grafting|mucous membrane grafting
195220|NCT02137954|cancer|cancer
195221|NCT02137954|pain|pain
195222|NCT02137941|Stress|stress
195223|NCT02137941|occupations|occupations
195224|NCT02137941|biomarkers|biomarkers
195225|NCT02137941|firefighters|firefighters
195226|NCT02137928|Retinoblastoma|retinoblastoma
195227|NCT02137928|carboplatin|carboplatin
195228|NCT02137915|AMD|amd
195229|NCT02137902|Tobacco dependence|tobacco dependence
195230|NCT02137902|Cardiovascular disease|cardiovascular disease
195231|NCT02137902|Risk behaviors|risk behaviors
195232|NCT02137902|Smoking|smoking
195233|NCT02137902|Physical activity|physical activity
195234|NCT02137902|Alaska Native people|alaska native people
195235|NCT02137889|CLL|cll
195236|NCT02137876|B cells|b cells
195237|NCT02137876|Thymoglubulin|thymoglubulin
195238|NCT02137876|humoral rejections|humoral rejections
195239|NCT02137876|transplant|transplant
195240|NCT02137876|rATG|ratg
195241|NCT02137863|Contrast induced nephropathy|contrast induced nephropathy
195242|NCT02137863|Diabetes Mellitus|diabetes mellitus
195243|NCT02137863|Dexmedetomidine|dexmedetomidine
195244|NCT02137837|Metastatic breast cancer|metastatic breast cancer
195245|NCT02137837|Invasive breast carcinoma|invasive breast carcinoma
195246|NCT02137837|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
195247|NCT02137837|HER2-negative breast cancer|her2-negative breast cancer
195248|NCT02137837|Stage IV breast cancer|stage iv breast cancer
195249|NCT02137837|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
195250|NCT02137811|cancer|cancer
195251|NCT02137811|CorrectChemo|correctchemo
195252|NCT02137811|assay|assay
195253|NCT02137811|lab test|lab test
195254|NCT02137811|MICK assay|mick assay
195255|NCT02137811|apoptosis|apoptosis
195256|NCT02137811|increase survival|increase survival
195257|NCT02137811|increase response rates|increase response rates
195258|NCT02137811|decrease time to progression|decrease time to progression
195259|NCT02137811|chemotherapy|chemotherapy
195260|NCT02137811|cancer treatment|cancer treatment
195261|NCT02137798|fluoroscopy exposure|fluoroscopy exposure
195262|NCT02137798|paroxysmal atrial fibrillation Ablation|paroxysmal atrial fibrillation ablation
195263|NCT02137798|fluoroscopy|fluoroscopy
195264|NCT02137798|Atrial Fibrillation Ablation|atrial fibrillation ablation
195265|NCT02137785|Actinic Keratosis|actinic keratosis
195266|NCT02137759|Glioblastoma|glioblastoma
195267|NCT02137746|Prostate Cancer|prostate cancer
195268|NCT02137746|Radical Prostatectomy|radical prostatectomy
195269|NCT02137720|Diabetes|diabetes
195270|NCT02137720|Treatment Adherence|treatment adherence
195271|NCT02137720|Self-management|self-management
195272|NCT02137720|Emotional Distress|emotional distress
195273|NCT02137720|Diabetes-related Distress|diabetes-related distress
195274|NCT02137707|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
195275|NCT02137707|Gilenya|gilenya
195276|NCT02137707|Fingolimod|fingolimod
195277|NCT02137694|Papillomavirus|papillomavirus
195278|NCT02137694|Vaginal auto-takings|vaginal auto-takings
195279|NCT02137694|Urinary test|urinary test
195280|NCT02137681|immune thrombocytopenia|immune thrombocytopenia
195281|NCT02137681|rituximab|rituximab
195282|NCT02137681|efficacy|efficacy
195283|NCT02137681|safety|safety
195284|NCT02137642|constipation|constipation
195285|NCT02137629|Myelodysplastic syndromes|myelodysplastic syndromes
195286|NCT02137629|Vidaza|vidaza
195287|NCT02137629|Observational study|observational study
195288|NCT02137629|Korea|korea
195289|NCT02137616|psychosis|psychosis
195290|NCT02137616|syndrome|syndrome
195291|NCT02137616|risk|risk
195292|NCT02137616|antipsychotic|antipsychotic
195293|NCT02137603|Suppurative appendicitis, appendicitis, pediatric|suppurative appendicitis, appendicitis, pediatric
195294|NCT02137590|Spanish Black Radish|spanish black radish
195295|NCT02137590|Phase I detoxification enzymes|phase i detoxification enzymes
195296|NCT02137590|Phase II detoxification enzymes|phase ii detoxification enzymes
195297|NCT02137590|Acetaminophen|acetaminophen
195298|NCT02137577|drug eluting balloon catheter|drug eluting balloon catheter
195299|NCT02137551|adherence|adherence
195300|NCT02137551|healthcare costs|healthcare costs
195301|NCT02137551|appointment based model|appointment based model
195302|NCT02137551|accountable care organization|accountable care organization
195303|NCT02137512|Artificial Pancreas|artificial pancreas
195304|NCT02137486|stable angina|stable angina
195305|NCT02137486|high angulated bifurcation|high angulated bifurcation
195306|NCT02137486|SYNTAX|syntax
195307|NCT02137486|DES|des
195308|NCT02137486|BMS|bms
195309|NCT02137460|Alzheimer's disease|alzheimer's disease
195310|NCT02137460|Early diagnosis|early diagnosis
195311|NCT02137460|Prediction|prediction
195312|NCT02137460|Biomarker|biomarker
195314|NCT02137447|Prevena|prevena
195315|NCT02137447|faster healing time|faster healing time
195316|NCT02137447|surgical site infection|surgical site infection
195317|NCT02137434|Acute calcium|acute calcium
195318|NCT02137434|Dietary calcium|dietary calcium
195319|NCT02137434|Supplementary calcium|supplementary calcium
195320|NCT02137434|Postprandial metabolism|postprandial metabolism
195321|NCT02137421|Coronary artery disease|coronary artery disease
195322|NCT02137421|Metabolic syndrome|metabolic syndrome
195323|NCT02137421|Resveratrol|resveratrol
195324|NCT02137421|β-catenin|β-catenin
195325|NCT02137421|Wnt signaling|wnt signaling
195326|NCT02137421|FOXO|foxo
195327|NCT02137421|MnSOD|mnsod
195328|NCT02137408|Chronic hypertension in pregnancy|chronic hypertension in pregnancy
195329|NCT02137408|Pre-term delivery|pre-term delivery
195330|NCT02137408|Preeclampsia|preeclampsia
195331|NCT02137408|Endothelial Health|endothelial health
675684|NCT00877474|PM01183|pm01183
195332|NCT02137408|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
195333|NCT02137395|Children, Dexamethasone, Sugammadex,|children, dexamethasone, sugammadex,
195334|NCT02137382|maldigestion of dietary macronutrients (pancreas not producing enough enzymes for digestion of fat, sugars and proteins) in Cystic Fibrosis|maldigestion of dietary macronutrients (pancreas not producing enough enzymes for digestion of fat, sugars and proteins) in cystic fibrosis
195335|NCT02137369|MDD|mdd
195336|NCT02137369|Major Depressive Disorder|major depressive disorder
195337|NCT02137369|Treatment|treatment
195338|NCT02137369|Antidepressants|antidepressants
195339|NCT02137369|Lexapro|lexapro
195340|NCT02137369|Talk therapy|talk therapy
195341|NCT02137356|rectal cancer|rectal cancer
195342|NCT02137356|rectal adenocarcinoma|rectal adenocarcinoma
195343|NCT02137356|Selinexor|selinexor
195344|NCT02137356|capecitabine|capecitabine
195345|NCT02137356|chemoradiation|chemoradiation
195346|NCT02137356|radiation|radiation
195347|NCT02137356|radiotherapy|radiotherapy
195348|NCT02137356|neoadjuvant|neoadjuvant
195349|NCT02137356|locally advanced rectal cancer|locally advanced rectal cancer
195350|NCT02137343|Gastric Cancer|gastric cancer
195351|NCT02137343|First Line Treatment Gastroesophageal Junction (GEJ)|first line treatment gastroesophageal junction (gej)
195352|NCT02137343|Gastroesophageal Junction Cancer (GEJ)|gastroesophageal junction cancer (gej)
195353|NCT02137343|GEJ Cancer|gej cancer
195354|NCT02137330|Obalon swallowable intragastric balloons|obalon swallowable intragastric balloons
195355|NCT02137330|Severe obesity|severe obesity
195356|NCT02137330|Children|children
195357|NCT02137317|Pesticides|pesticides
195358|NCT02137317|Personal protective equipment|personal protective equipment
195359|NCT02137317|Developing countries|developing countries
195360|NCT02137317|Tropical Climate|tropical climate
195361|NCT02137304|cough help|cough help
195362|NCT02137304|in-exsufflation|in-exsufflation
195363|NCT02137304|neuromuscular disease|neuromuscular disease
195364|NCT02137304|cough assistance optimization|cough assistance optimization
195365|NCT02137304|efficient cough flow|efficient cough flow
196458|NCT02132091|Antioxidant|antioxidant
195366|NCT02137291|Video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
195367|NCT02137291|Lung isolation device|lung isolation device
195368|NCT02137291|One-lung ventilation|one-lung ventilation
195369|NCT02137291|Double lumen endotracheal tube|double lumen endotracheal tube
195370|NCT02137291|Bronchial blocker|bronchial blocker
195371|NCT02137278|Syncope|syncope
195372|NCT02137278|Presyncope|presyncope
195373|NCT02137278|Vasoactive drugs|vasoactive drugs
195374|NCT02137278|Hypotension|hypotension
195375|NCT02137278|Carotid sinus massage|carotid sinus massage
195376|NCT02137278|Tilt table test|tilt table test
195377|NCT02137265|Azoospermia|azoospermia
195378|NCT02137265|Hypogonadism|hypogonadism
195379|NCT02137265|Clomiphene|clomiphene
195380|NCT02137252|Invasive Breast Cancer (Stage I-III)|invasive breast cancer (stage i-iii)
195381|NCT02137252|Ductal Carcinoma in Situ|ductal carcinoma in situ
195382|NCT02137252|Lobular Carcinoma in Situ|lobular carcinoma in situ
195383|NCT02137252|Lobular Carcinoma|lobular carcinoma
195384|NCT02137252|Fatigue Related to Cancer Treatment|fatigue related to cancer treatment
195385|NCT02137213|Opioid-induced constipation|opioid-induced constipation
195386|NCT02137213|Methadone|methadone
195387|NCT02137213|Naloxone|naloxone
195388|NCT02137187|Atrial fibrillation|atrial fibrillation
195389|NCT02137187|Heart failure|heart failure
195390|NCT02137187|Catheter ablation|catheter ablation
195391|NCT02137187|Cardiac resynchronization therapy|cardiac resynchronization therapy
195392|NCT02137187|Implantable defibrillator|implantable defibrillator
195393|NCT02137148|Vascular Access|vascular access
195394|NCT02137148|Sonic Window|sonic window
195395|NCT02137148|Ultrasound|ultrasound
195396|NCT02137135|chronic postoperative pain|chronic postoperative pain
195397|NCT02137135|menstrual cycle|menstrual cycle
195398|NCT02137122|Volunteers|volunteers
195399|NCT02137109|Pediatric|pediatric
195400|NCT02137096|Recurrent nasopharynx carcinoma|recurrent nasopharynx carcinoma
195401|NCT02137083|Chemotherapy|chemotherapy
195402|NCT02137083|Endocrine therapy|endocrine therapy
195403|NCT02137083|Docetaxel|docetaxel
195404|NCT02137083|Fulvestrant|fulvestrant
675799|NCT00877864|diabetes|diabetes
195405|NCT02137070|Weightloss and brain function|weightloss and brain function
195406|NCT02137070|Effects of bariatric surgery on brain function|effects of bariatric surgery on brain function
195407|NCT02137070|Reduced glucose insulin changes and brain function|reduced glucose insulin changes and brain function
195408|NCT02137057|Heart Rate Variability|heart rate variability
195409|NCT02137057|spinal anesthesia|spinal anesthesia
195410|NCT02137057|DM|dm
195411|NCT02137057|cardiac autonomic dysfunction|cardiac autonomic dysfunction
195412|NCT02137044|multiple sclerosis|multiple sclerosis
195413|NCT02137044|pain|pain
195414|NCT02137044|depression|depression
195415|NCT02137018|hernia|hernia
195416|NCT02137018|incisional hernia|incisional hernia
195417|NCT02137018|device|device
195418|NCT02137018|pig|pig
195419|NCT02137005|walking|walking
195420|NCT02137005|gait disorders, neurologic|gait disorders, neurologic
195421|NCT02137005|health status|health status
195422|NCT02137005|cognition|cognition
195423|NCT02137005|quality of life|quality of life
195424|NCT02137005|Transition to Adult Care|transition to adult care
195425|NCT02136953|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
195426|NCT02136953|Exercise|exercise
195427|NCT02136953|Cognitive Behavior Therapy|cognitive behavior therapy
195428|NCT02136953|Cognitive Behavioral Therapy|cognitive behavioral therapy
195429|NCT02136953|Treatment Efficacy|treatment efficacy
195430|NCT02136953|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
195431|NCT02136914|Levodopa Induced Dyskinesia|levodopa induced dyskinesia
195432|NCT02136914|LID|lid
195433|NCT02136914|Parkinsonism|parkinsonism
195434|NCT02136901|NuSurface|nusurface
195435|NCT02136901|Meniscus|meniscus
195436|NCT02136901|Prosthesis|prosthesis
195437|NCT02136901|KOOS|koos
195438|NCT02136888|Ponesimod|ponesimod
195439|NCT02136888|Safety|safety
195440|NCT02136875|COPD|copd
195441|NCT02136875|COPD exacerbation|copd exacerbation
195442|NCT02136862|Alport syndrome|alport syndrome
195443|NCT02136862|kidney disease|kidney disease
195444|NCT02136849|severe intellectual disability, genetic, de novo exome|severe intellectual disability, genetic, de novo exome
195445|NCT02136836|Genes, erbB-2|genes, erbb-2
195446|NCT02136836|Prognosis|prognosis
195447|NCT02136823|Spinal Cord Injury|spinal cord injury
195448|NCT02136810|Hypertension|hypertension
195449|NCT02136810|Perioperative Care|perioperative care
195450|NCT02136797|CMVpp65 Specific T-cells|cmvpp65 specific t-cells
195451|NCT02136797|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
195452|NCT02136797|14-070|14-070
195453|NCT02136784|pain|pain
195454|NCT02136784|cold presser test|cold presser test
195455|NCT02136784|buprenorphine|buprenorphine
195456|NCT02136784|opioids|opioids
195457|NCT02136758|lifestyle modification|lifestyle modification
195458|NCT02136758|diet|diet
195459|NCT02136758|exercise|exercise
195460|NCT02136758|cardiovascular disease|cardiovascular disease
195461|NCT02136758|gene expression|gene expression
195462|NCT02136758|obesity|obesity
196459|NCT02132091|Aging|aging
195463|NCT02136745|Irritable Bowel Syndrome|irritable bowel syndrome
195464|NCT02136745|Inflammatory Bowel Disease|inflammatory bowel disease
195465|NCT02136745|mind body|mind body
195466|NCT02136745|intervention|intervention
195467|NCT02136745|group|group
195468|NCT02136745|Relaxation Response|relaxation response
195469|NCT02136745|genomic effects|genomic effects
195470|NCT02136732|chronic conditions|chronic conditions
195471|NCT02136732|multimorbid|multimorbid
195472|NCT02136719|Uterine massage|uterine massage
195473|NCT02136719|vaginal birth|vaginal birth
195474|NCT02136719|postpartum haemorrhage|postpartum haemorrhage
195475|NCT02136706|Stable coronary artery disease|stable coronary artery disease
195476|NCT02136693|obstructed defecation|obstructed defecation
195477|NCT02136693|STARR|starr
195478|NCT02136693|constipation|constipation
195479|NCT02136693|incontinence|incontinence
195480|NCT02136693|psyllium|psyllium
195481|NCT02136680|HIV disease|hiv disease
195482|NCT02136680|palliative care|palliative care
195483|NCT02136680|educational intervention|educational intervention
195484|NCT02136667|Preeclampsia|preeclampsia
195485|NCT02136667|Cardiovascular disease (CVD) risk|cardiovascular disease (cvd) risk
195486|NCT02136654|diabetes|diabetes
195487|NCT02136654|ethnicity|ethnicity
195488|NCT02136654|South Asian|south asian
195489|NCT02136654|diabetes management|diabetes management
195490|NCT02136641|Anesthesia|anesthesia
195491|NCT02136641|Spinal Anesthesia|spinal anesthesia
195492|NCT02136641|Conscious Sedation|conscious sedation
195493|NCT02136641|Operating Rooms.|operating rooms.
195494|NCT02136628|RTL Technique|rtl technique
195495|NCT02136615|hyperbaric oxygenation|hyperbaric oxygenation
195496|NCT02136615|insulin sensitivity|insulin sensitivity
195497|NCT02136615|human|human
195498|NCT02136615|inflammation|inflammation
195499|NCT02136615|adipose tissue|adipose tissue
195500|NCT02136563|Chronic kidney disease|chronic kidney disease
195501|NCT02136563|Erythropoiesis stimulating agent response index|erythropoiesis stimulating agent response index
195502|NCT02136563|Hyporesponsive anemia to erythropoiesis stimulating agent|hyporesponsive anemia to erythropoiesis stimulating agent
195503|NCT02136563|Observational study|observational study
195504|NCT02136550|smoking|smoking
195505|NCT02136550|smoking cessation|smoking cessation
195506|NCT02136550|mucociliary clearance|mucociliary clearance
195507|NCT02136550|proteomics|proteomics
195508|NCT02136550|miRNA|mirna
195509|NCT02136498|smoking cessation|smoking cessation
195510|NCT02136498|varenicline|varenicline
195511|NCT02136498|adherence|adherence
195512|NCT02136472|Subfertility|subfertility
195513|NCT02136472|Metabolic syndrome|metabolic syndrome
195514|NCT02136472|Plasma volume|plasma volume
195515|NCT02136472|Intima media thickness|intima media thickness
195516|NCT02136472|Flow mediated dilatation|flow mediated dilatation
195517|NCT02136459|Thyroidectomy|thyroidectomy
195518|NCT02136459|Endotracheal tube|endotracheal tube
195519|NCT02136459|Voice|voice
195520|NCT02136459|Complications|complications
195521|NCT02136459|Patients undergoing elective thyroidectomy|patients undergoing elective thyroidectomy
195522|NCT02136446|Paravertebral block|paravertebral block
195523|NCT02136446|Mastectomy|mastectomy
195524|NCT02136446|Post-operative pain|post-operative pain
195525|NCT02136446|Echogenic|echogenic
195526|NCT02136446|Peripheral nerve block catheter|peripheral nerve block catheter
195527|NCT02136433|Hand|hand
195528|NCT02136433|Rehabilitation|rehabilitation
195529|NCT02136433|Stroke|stroke
195530|NCT02136433|Brain-injury|brain-injury
195531|NCT02136433|Tablet|tablet
195532|NCT02136407|Vitamin D|vitamin d
195533|NCT02136407|vitamin D deficiency|vitamin d deficiency
195534|NCT02136407|parathyroid hormone|parathyroid hormone
195535|NCT02136381|Lifestyle, interventions, retirement|lifestyle, interventions, retirement
195536|NCT02136368|older adults|older adults
195537|NCT02136368|multiple-modality exercise|multiple-modality exercise
195538|NCT02136368|mind-motor exercise|mind-motor exercise
195539|NCT02136368|self-reported cognitive complaints|self-reported cognitive complaints
195540|NCT02136368|global cognitive functioning|global cognitive functioning
195541|NCT02136368|mobility|mobility
195542|NCT02136368|vascular function|vascular function
195543|NCT02136368|sensorimotor function|sensorimotor function
195544|NCT02136368|brain imaging|brain imaging
195545|NCT02136368|community-based research|community-based research
195546|NCT02136368|subjective cognitive complaints|subjective cognitive complaints
195547|NCT02136342|no available effective treatment|no available effective treatment
195548|NCT02136316|Healthy volunteers|healthy volunteers
195549|NCT02136316|ASP7962|asp7962
195550|NCT02136316|pharmacokinetics|pharmacokinetics
195551|NCT02136290|Weight loss|weight loss
195552|NCT02136277|colorectal surgery|colorectal surgery
195553|NCT02136277|cardiac output|cardiac output
195554|NCT02136264|hypertension|hypertension
195555|NCT02136264|dietary intervention|dietary intervention
195556|NCT02136264|personalized nutrition|personalized nutrition
195557|NCT02136264|randomized controlled trial|randomized controlled trial
195558|NCT02136251|Total Shoulder Arthroplasty|total shoulder arthroplasty
195559|NCT02136251|Glenoid anchor peg component fixation|glenoid anchor peg component fixation
195560|NCT02136251|Autologous bone grafting|autologous bone grafting
195562|NCT02136238|transradial|transradial
195563|NCT02136238|prosthesis|prosthesis
195564|NCT02136238|terminal device|terminal device
195565|NCT02136225|youth|youth
195566|NCT02136225|gun|gun
195567|NCT02136225|access|access
195568|NCT02136225|home|home
195569|NCT02136186|home telemonitoring|home telemonitoring
195570|NCT02136186|readmission|readmission
195571|NCT02136186|high risk|high risk
195572|NCT02136160|elementary school|elementary school
195573|NCT02136160|children|children
195574|NCT02136160|health promotion|health promotion
195575|NCT02136160|teachers|teachers
195576|NCT02136160|prevention|prevention
195577|NCT02136147|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
195578|NCT02136147|Neuropsychiatry|neuropsychiatry
195579|NCT02136147|Drug therapy|drug therapy
195580|NCT02136147|Pharmacogenetics|pharmacogenetics
195581|NCT02136147|Child Psychiatry|child psychiatry
195582|NCT02136134|Multiple Myeloma|multiple myeloma
195583|NCT02136134|Plasmacytoma|plasmacytoma
195584|NCT02136134|Refractory Multiple Myeloma|refractory multiple myeloma
195585|NCT02136134|Relapsed Multiple Myeloma|relapsed multiple myeloma
195586|NCT02136134|Daratumumab|daratumumab
195587|NCT02136134|VELCADE|velcade
195588|NCT02136108|Chronic pain|chronic pain
195589|NCT02136108|Complementary and alternative therapies|complementary and alternative therapies
195590|NCT02136108|Mobile health|mobile health
195591|NCT02136108|Medicaid|medicaid
195592|NCT02136108|Patient navigation|patient navigation
195593|NCT02136095|Fluorescent cholangiography|fluorescent cholangiography
195594|NCT02136095|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
195595|NCT02136082|HIV|hiv
195596|NCT02136082|Women|women
195597|NCT02136082|Children|children
195598|NCT02136082|Nutrition|nutrition
195599|NCT02136056|Sick-leave|sick-leave
195600|NCT02136056|Return to work|return to work
195601|NCT02136056|Self-management|self-management
195602|NCT02136056|Self-efficacy|self-efficacy
195721|NCT02135458|therapeutic education|therapeutic education
195603|NCT02136056|Quality of Life and Well-being|quality of life and well-being
195604|NCT02136056|Motivation|motivation
195605|NCT02136030|Cryptococcal meningitis|cryptococcal meningitis
195606|NCT02136017|AEFI|aefi
195607|NCT02136017|influenza vaccine|influenza vaccine
195608|NCT02136004|arteriotomy|arteriotomy
195609|NCT02136004|vessel closure|vessel closure
195610|NCT02136004|femoral access site|femoral access site
195611|NCT02135978|Spinal Cord Injury|spinal cord injury
195612|NCT02135978|Shoulder Pain|shoulder pain
195613|NCT02135978|Exercise|exercise
195614|NCT02135952|Periodontitis|periodontitis
195615|NCT02135952|Diabetes|diabetes
195616|NCT02135926|Cerebral Stroke, Stroke, Acute, Brain Infarction|cerebral stroke, stroke, acute, brain infarction
195617|NCT02135913|Obese|obese
195623|NCT02135887|Stage III Colorectal Cancer|stage iii colorectal cancer
195625|NCT02135887|MB-6|mb-6
195626|NCT02135874|Leukemia|leukemia
195627|NCT02135874|Mixed Phenotype Acute Leukemia|mixed phenotype acute leukemia
195628|NCT02135874|MPAL|mpal
195629|NCT02135874|Newly Diagnosed|newly diagnosed
195630|NCT02135874|Relapsed|relapsed
195631|NCT02135874|Clofarabine|clofarabine
195632|NCT02135874|Clofarex|clofarex
195633|NCT02135874|Clolar|clolar
195634|NCT02135874|Idarubicin|idarubicin
195635|NCT02135874|Idamycin|idamycin
195636|NCT02135874|Cytarabine|cytarabine
195637|NCT02135874|Ara-C|ara-c
195638|NCT02135874|Cytosar|cytosar
195639|NCT02135874|DepoCyt|depocyt
195640|NCT02135874|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
195641|NCT02135874|Vincristine|vincristine
195642|NCT02135874|Rituximab|rituximab
195643|NCT02135874|Rituxan|rituxan
195644|NCT02135874|Dexamethasone|dexamethasone
195645|NCT02135874|Decadron|decadron
195646|NCT02135861|Acute decompensated heart failure|acute decompensated heart failure
195647|NCT02135861|heart failure|heart failure
195648|NCT02135861|MRI|mri
195649|NCT02135861|trpV4 channel inhibitors|trpv4 channel inhibitors
195650|NCT02135861|pulmonary oedema|pulmonary oedema
195651|NCT02135822|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
195652|NCT02135822|gemcitabine|gemcitabine
195653|NCT02135822|advanced pancreatic cancer|advanced pancreatic cancer
195654|NCT02135796|Septic Shock|septic shock
195655|NCT02135796|Severe Sepsis|severe sepsis
195656|NCT02135796|ICU|icu
195657|NCT02135770|heparin|heparin
195658|NCT02135770|sepsis|sepsis
195659|NCT02135770|inflammation|inflammation
195660|NCT02135744|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
195661|NCT02135744|COPD|copd
195662|NCT02135744|Readmissions|readmissions
195663|NCT02135718|ELLIPTA|ellipta
195664|NCT02135718|Asthma|asthma
195665|NCT02135718|Inhaler preference|inhaler preference
195666|NCT02135718|Fluticasone furoate|fluticasone furoate
195667|NCT02135718|ELLIPTA inhaler|ellipta inhaler
195668|NCT02135718|Dry Powder Inhaler|dry powder inhaler
195676|NCT02135666|Long-term follow-up|long-term follow-up
195677|NCT02135666|Persistence|persistence
195678|NCT02135666|Hepatitis A|hepatitis a
195679|NCT02135666|Antibody|antibody
195680|NCT02135666|Immunity|immunity
195681|NCT02135666|Hepatitis B|hepatitis b
195682|NCT02135666|Combination vaccine|combination vaccine
195683|NCT02135666|Adult|adult
195684|NCT02135601|colonoscopy|colonoscopy
195685|NCT02135601|water|water
195686|NCT02135601|adenoma|adenoma
195687|NCT02135601|pain|pain
195688|NCT02135575|premenopausal|premenopausal
195689|NCT02135575|postmenopausal|postmenopausal
195690|NCT02135575|cardiovascular|cardiovascular
195691|NCT02135575|exercise training|exercise training
195692|NCT02135575|vascular function|vascular function
195693|NCT02135575|cardiac function|cardiac function
195694|NCT02135575|cardiac morphology|cardiac morphology
195695|NCT02135575|health|health
195696|NCT02135562|endometrial cancer|endometrial cancer
195697|NCT02135562|survivor|survivor
195698|NCT02135562|obesity|obesity
195699|NCT02135562|diet|diet
195700|NCT02135562|high protein|high protein
195701|NCT02135562|protein-sparing modified fast intervention|protein-sparing modified fast intervention
195702|NCT02135562|PSMF|psmf
195703|NCT02135523|ovarian cancer|ovarian cancer
195704|NCT02135523|involved-field radiation therapy|involved-field radiation therapy
195705|NCT02135523|progression free survival|progression free survival
195706|NCT02135484|Prostate Cancer|prostate cancer
195707|NCT02135484|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
195708|NCT02135484|Castrate resistant prostate cancer|castrate resistant prostate cancer
195709|NCT02135484|CRPC|crpc
195710|NCT02135484|Skeletal metastases|skeletal metastases
195711|NCT02135484|Alpharadin|alpharadin
195712|NCT02135484|Xofigo|xofigo
195713|NCT02135484|Radium-223 chloride|radium-223 chloride
195714|NCT02135484|Radium-223 dichloride|radium-223 dichloride
195715|NCT02135471|gingival recession|gingival recession
195716|NCT02135471|dental enamel proteins|dental enamel proteins
195717|NCT02135471|acellular dermal matrix graft|acellular dermal matrix graft
195718|NCT02135471|tobacco|tobacco
195719|NCT02135458|Heart failure|heart failure
195720|NCT02135458|Telemonitoring|telemonitoring
195722|NCT02135458|care network|care network
195723|NCT02135458|hospitalization|hospitalization
195724|NCT02135445|Drug therapy|drug therapy
195725|NCT02135432|Chronic Obstructive pulmonary disease, Ivacaftor|chronic obstructive pulmonary disease, ivacaftor
195726|NCT02135406|Adult|adult
195727|NCT02135406|18 years or older|18 years or older
195728|NCT02135406|multiple myeloma|multiple myeloma
195729|NCT02135406|poor prognosis|poor prognosis
195730|NCT02135406|relapsed/progressive disease|relapsed/progressive disease
195731|NCT02135406|within one year of first autologous stem cell transplantation|within one year of first autologous stem cell transplantation
195732|NCT02135367|PRP|prp
195733|NCT02135367|growth factors|growth factors
195734|NCT02135367|Viscosupplementation|viscosupplementation
195735|NCT02135367|injections|injections
195736|NCT02135367|chondropathy|chondropathy
195737|NCT02135367|randomized controlled trial|randomized controlled trial
195738|NCT02135354|AECOPD|aecopd
195739|NCT02135354|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
195740|NCT02135354|Acute exacerbation|acute exacerbation
195741|NCT02135354|Hospitalization|hospitalization
195742|NCT02135354|Azithromycin|azithromycin
195743|NCT02135354|Macrolides|macrolides
195744|NCT02135354|Randomized Controlled Trial|randomized controlled trial
195745|NCT02135354|Placebo|placebo
195746|NCT02135341|Detrusor Overactivity|detrusor overactivity
195747|NCT02135341|Impaired Contractility|impaired contractility
195748|NCT02135341|Botulinum Toxin A (BoNT-A)|botulinum toxin a (bont-a)
195749|NCT02135328|Type 2 diabetes|type 2 diabetes
195750|NCT02135328|Dietary behaviors|dietary behaviors
195751|NCT02135328|Physical activity behaviors|physical activity behaviors
195752|NCT02135328|Radio story, entertainment health education|radio story, entertainment health education
195753|NCT02135328|Immigrants|immigrants
195754|NCT02135328|Somali, Latino, Hmong|somali, latino, hmong
195755|NCT02135328|Families with 3-18 year old children|families with 3-18 year old children
195756|NCT02135315|Acute Coronary Syndrome, arterial pressure|acute coronary syndrome, arterial pressure
195757|NCT02135302|hepatic|hepatic
195758|NCT02135250|Traditional Chinese Medicine|traditional chinese medicine
195759|NCT02135211|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
195760|NCT02135211|multiple risk factor|multiple risk factor
195761|NCT02135211|lifestyle intervention|lifestyle intervention
195762|NCT02135211|health behavior|health behavior
195763|NCT02135211|lifestyle risk reduction|lifestyle risk reduction
195764|NCT02135211|health related quality of life|health related quality of life
195765|NCT02135198|GABA modulator|gaba modulator
195766|NCT02135198|AZD7325|azd7325
195767|NCT02135198|Short interval intracortical inhibition|short interval intracortical inhibition
195768|NCT02135198|volunteers|volunteers
195769|NCT02135146|Hypotension|hypotension
195770|NCT02135146|Kidney injury|kidney injury
195771|NCT02135133|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
195772|NCT02135133|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
195773|NCT02135107|Gastroesophageal reflux disease|gastroesophageal reflux disease
195774|NCT02135094|trapezius|trapezius
195775|NCT02135094|upper back|upper back
195776|NCT02135094|muscle pain|muscle pain
195777|NCT02135094|pain relief|pain relief
195778|NCT02135094|ultrasound|ultrasound
195779|NCT02135094|double blind|double blind
195781|NCT02135094|ZetrOZ|zetroz
195782|NCT02135094|muscle|muscle
195783|NCT02135094|LITUS|litus
195784|NCT02135094|low intensity therapeutic ultrasound|low intensity therapeutic ultrasound
195785|NCT02135081|Single ventricle|single ventricle
195786|NCT02135081|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
195787|NCT02135081|Congenital heart lesion|congenital heart lesion
195788|NCT02135081|Right or left ventricle|right or left ventricle
195789|NCT02135081|Cerebral blood flow|cerebral blood flow
195790|NCT02135081|Pulmonary blood flow|pulmonary blood flow
195791|NCT02135081|Staged Fontan reconstruction|staged fontan reconstruction
195792|NCT02135081|hemi Fontan/bidirectional Glenn stages|hemi fontan/bidirectional glenn stages
195793|NCT02135068|type 1 diabetes|type 1 diabetes
195794|NCT02135068|closed loop insulin delivery systems|closed loop insulin delivery systems
195795|NCT02135068|exercise|exercise
195796|NCT02135068|hypoglycemia|hypoglycemia
195797|NCT02135055|organ function|organ function
195798|NCT02135055|sedation|sedation
195799|NCT02135029|Hyperlipidemia|hyperlipidemia
195800|NCT02135029|statin intolerance|statin intolerance
195801|NCT02135016|effect-site concentration|effect-site concentration
195802|NCT02135016|propofol|propofol
195803|NCT02135016|thoracic epidural anesthesia|thoracic epidural anesthesia
195804|NCT02134990|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
195805|NCT02134990|Docetaxel|docetaxel
195806|NCT02134977|Pharmacological therapy|pharmacological therapy
195807|NCT02134964|Safety|safety
195808|NCT02134964|Tolerability|tolerability
195809|NCT02134964|Pharmacokinetics|pharmacokinetics
195810|NCT02134964|Dose escalation|dose escalation
195811|NCT02134964|Randomized|randomized
195812|NCT02134964|Healthy volunteers|healthy volunteers
195813|NCT02134964|OLT1177|olt1177
195814|NCT02134964|Olatec|olatec
195815|NCT02134899|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
195816|NCT02134899|cyst|cyst
195817|NCT02134899|kidney|kidney
195818|NCT02134899|liver|liver
195819|NCT02134899|kidney transplantation|kidney transplantation
195820|NCT02134899|IF/TA|if/ta
195821|NCT02134899|fibrosis|fibrosis
195822|NCT02134899|DSA|dsa
195823|NCT02134899|mTOR inhibitors|mtor inhibitors
195824|NCT02134899|calcineurin inhibitors|calcineurin inhibitors
195825|NCT02134873|Pain|pain
195826|NCT02134873|Pain management|pain management
195827|NCT02134873|Hospitalized|hospitalized
195828|NCT02134873|Infants|infants
195829|NCT02134873|Sucrose|sucrose
195830|NCT02134847|Resident|resident
195831|NCT02134847|Fatigue|fatigue
195832|NCT02134847|Sleep deprivation|sleep deprivation
195833|NCT02134847|medical errors|medical errors
195834|NCT02134808|Major Depressive Disorder|major depressive disorder
195835|NCT02134808|Creatine|creatine
195836|NCT02134808|Brain Chemistry|brain chemistry
195837|NCT02134808|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
195838|NCT02134808|Treatment Resistance|treatment resistance
195839|NCT02134808|Selective Serotonin Reuptake Inhibitor (SSRI) Resistance|selective serotonin reuptake inhibitor (ssri) resistance
195840|NCT02134795|Parkinson's disease|parkinson's disease
195841|NCT02134782|Randomized Controlled Trial, yoga, children, chemotherapy, haematopoietic stem cell transplantation, fatigue, quality of life|randomized controlled trial, yoga, children, chemotherapy, haematopoietic stem cell transplantation, fatigue, quality of life
195842|NCT02134769|catheter-related bloodstream infections|catheter-related bloodstream infections
195843|NCT02134756|Supplement impact|supplement impact
195844|NCT02134756|Performance|performance
195845|NCT02134756|Fatigue|fatigue
195846|NCT02134743|dental implant|dental implant
195847|NCT02134743|Surface energy|surface energy
195848|NCT02134743|Hydrophilicity|hydrophilicity
195849|NCT02134743|Contact angle|contact angle
195850|NCT02134743|Titanium implant roughness|titanium implant roughness
195851|NCT02134743|Surface conditioning|surface conditioning
195852|NCT02134730|FRIENDS for life|friends for life
195853|NCT02134730|universal prevention|universal prevention
195854|NCT02134730|school children|school children
195855|NCT02134730|anxiety|anxiety
195856|NCT02134717|sarcoidosis|sarcoidosis
195857|NCT02134717|CCR5 inhibition|ccr5 inhibition
195858|NCT02134717|maraviroc|maraviroc
195859|NCT02134691|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
195860|NCT02134691|Prolonged Exposure (PE)|prolonged exposure (pe)
195861|NCT02134678|self-system therapy|self-system therapy
195862|NCT02134678|cognitive therapy|cognitive therapy
195863|NCT02134678|depression|depression
195864|NCT02134678|psychotherapy|psychotherapy
195975|NCT02134275|obesity|obesity
195865|NCT02134678|mechanisms of action|mechanisms of action
195866|NCT02134665|Vancomycin|vancomycin
195867|NCT02134665|severe acute pancreatitis|severe acute pancreatitis
195868|NCT02134665|Creatinine clearance|creatinine clearance
195869|NCT02134652|Ultrasonography|ultrasonography
195870|NCT02134652|World Health|world health
195871|NCT02134626|Portal Hypertension|portal hypertension
195872|NCT02134626|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
195873|NCT02134626|Esophageal Varices|esophageal varices
195874|NCT02134626|Liver Cirrhosis|liver cirrhosis
195875|NCT02134626|Simvastatin|simvastatin
195876|NCT02134626|Nitric oxide|nitric oxide
195877|NCT02134626|HVPG|hvpg
195878|NCT02134613|99mTc-anti-TNF|99mtc-anti-tnf
195879|NCT02134613|Inflammation|inflammation
195880|NCT02134613|Psoriatic arthritis|psoriatic arthritis
195881|NCT02134613|Rheumatoid arthritis|rheumatoid arthritis
195882|NCT02134600|Omega-3 fatty acids|omega-3 fatty acids
195885|NCT02134600|Docosahexaenoic acid|docosahexaenoic acid
195886|NCT02134600|Eicosapentaenoic acid|eicosapentaenoic acid
195887|NCT02134600|Childhood cancer|childhood cancer
195888|NCT02134600|Body composition|body composition
195889|NCT02134600|Inflammation|inflammation
195890|NCT02134600|Neuropsychiatric symptoms|neuropsychiatric symptoms
195891|NCT02134587|Health knowledge, attitudes, practices.|health knowledge, attitudes, practices.
195892|NCT02134587|Adverse drug reaction reporting systems.|adverse drug reaction reporting systems.
195893|NCT02134587|Pharmacovigilance. Product Surveillance, Postmarketing.|pharmacovigilance. product surveillance, postmarketing.
195894|NCT02134587|Drug-related side effects and adverse reactions.|drug-related side effects and adverse reactions.
195895|NCT02134574|Lymphoma,|lymphoma,
195896|NCT02134574|leukemia,|leukemia,
195897|NCT02134574|multiple myeloma,|multiple myeloma,
195898|NCT02134574|hodgkin disease|hodgkin disease
195899|NCT02134522|non alcoholic fatty liver|non alcoholic fatty liver
195900|NCT02134522|childhood obesity|childhood obesity
195901|NCT02134522|Sleep Apnea|sleep apnea
195902|NCT02134509|Cigarette smoking|cigarette smoking
195903|NCT02134496|hip|hip
195904|NCT02134496|knee|knee
195905|NCT02134496|arthroplasty|arthroplasty
195906|NCT02134496|spinal|spinal
195907|NCT02134496|anesthesia|anesthesia
195908|NCT02134483|Parathyroid|parathyroid
195909|NCT02134483|Permanent hypocalcemia|permanent hypocalcemia
195910|NCT02134483|Transplantation|transplantation
195911|NCT02134470|saliva|saliva
195912|NCT02134470|blood|blood
195913|NCT02134470|urine|urine
195914|NCT02134444|Dizziness|dizziness
195915|NCT02134444|Vertigo|vertigo
195916|NCT02134444|Vestibular Diseases|vestibular diseases
195917|NCT02134444|Vestibular Neuritis|vestibular neuritis
195918|NCT02134444|Labyrinth Diseases|labyrinth diseases
195919|NCT02134444|Ear Diseases|ear diseases
195920|NCT02134444|Vestibular rehabilitation|vestibular rehabilitation
195921|NCT02134444|Telerehabilitation|telerehabilitation
195922|NCT02134444|Gaze control|gaze control
195923|NCT02134444|Balance|balance
195924|NCT02134431|HIV|hiv
195925|NCT02134431|tenofovir|tenofovir
195926|NCT02134431|miocrobicide|miocrobicide
195927|NCT02134431|endoscopy (colonoscopy, sigmoidoscopy)|endoscopy (colonoscopy, sigmoidoscopy)
195928|NCT02134431|adolescents|adolescents
195929|NCT02134431|pediatrics|pediatrics
195930|NCT02134418|Schizophrenia|schizophrenia
195931|NCT02134418|Irony|irony
195932|NCT02134418|Hemispheric processing|hemispheric processing
195933|NCT02134418|Theory of mind|theory of mind
195934|NCT02134405|functional dyspepsia|functional dyspepsia
195935|NCT02134405|symptoms|symptoms
195936|NCT02134405|proton pump inhibitor|proton pump inhibitor
195937|NCT02134405|gastritis|gastritis
195938|NCT02134392|C-diff|c-diff
195939|NCT02134392|Clostridium difficile|clostridium difficile
195940|NCT02134392|Fecal Transplant|fecal transplant
195941|NCT02134392|FMT|fmt
195942|NCT02134392|Fecal Microbiota Transplant|fecal microbiota transplant
195943|NCT02134379|Thoracic Impedance|thoracic impedance
195944|NCT02134379|Diagnostic Marker|diagnostic marker
195945|NCT02134379|Bed Rest Test|bed rest test
195946|NCT02134379|Transthoracic Impedance|transthoracic impedance
195947|NCT02134379|Heart Failure|heart failure
195948|NCT02134379|HF|hf
195949|NCT02134366|Epilepsia Partialis Continua|epilepsia partialis continua
195950|NCT02134366|Kojewnikov's Epilepsy|kojewnikov's epilepsy
195951|NCT02134366|Epilepsy|epilepsy
195952|NCT02134366|Clobazam|clobazam
195953|NCT02134366|Focal Motor Epilepsy|focal motor epilepsy
195954|NCT02134366|Partial Motor Seizure|partial motor seizure
195955|NCT02134340|IGF1R|igf1r
195956|NCT02134314|ESRD|esrd
195957|NCT02134314|CKD|ckd
195958|NCT02134314|Kidney Transplant|kidney transplant
195959|NCT02134314|ECD|ecd
195960|NCT02134314|delayed graft function|delayed graft function
195961|NCT02134301|oritavancin|oritavancin
195962|NCT02134301|pediatrics|pediatrics
195963|NCT02134301|gram positive|gram positive
195964|NCT02134301|bacterial infection|bacterial infection
195965|NCT02134301|Confirmed|confirmed
195966|NCT02134301|Suspected|suspected
196065|NCT02134002|cocaine|cocaine
195968|NCT02134288|Kidney Transplant|kidney transplant
195969|NCT02134288|immunosuppressive therapy|immunosuppressive therapy
195970|NCT02134288|Delayed Graft Function|delayed graft function
195971|NCT02134288|Belatacept|belatacept
195972|NCT02134275|whole body vibration training|whole body vibration training
195973|NCT02134275|young adult|young adult
195974|NCT02134275|weight gain|weight gain
195976|NCT02134275|randomized clinical trial|randomized clinical trial
195977|NCT02134262|Anti-CD19 CAR Expressing T cells Therapy|anti-cd19 car expressing t cells therapy
195978|NCT02134262|CD19 CAR Gene-Transduced Lymphocyte|cd19 car gene-transduced lymphocyte
195979|NCT02134262|Adoptive Immunotherapy|adoptive immunotherapy
195980|NCT02134262|Genetically Engineered Lymphocyte Therapy|genetically engineered lymphocyte therapy
195981|NCT02134262|Retroviral Vector|retroviral vector
195982|NCT02134262|Burkitt Lymphoma|burkitt lymphoma
195983|NCT02134262|Lymphoma|lymphoma
195984|NCT02134262|Lymphoma, Follicular|lymphoma, follicular
195985|NCT02134262|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
195986|NCT02134262|Lymphomatoid Granulomatosis|lymphomatoid granulomatosis
195987|NCT02134262|Lymphoma, B-Cell|lymphoma, b-cell
195988|NCT02134262|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
195989|NCT02134262|Lymphoma, Large-Cell, Immunoblastic|lymphoma, large-cell, immunoblastic
195990|NCT02134262|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
195991|NCT02134262|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
195992|NCT02134262|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
195993|NCT02134262|Neoplasms by Histologic Type|neoplasms by histologic type
195994|NCT02134262|Neoplasms|neoplasms
195995|NCT02134262|Neoplasms, Experimental|neoplasms, experimental
195996|NCT02134262|Immune System Diseases|immune system diseases
195997|NCT02134249|infertility|infertility
195998|NCT02134249|ICSI|icsi
195999|NCT02134249|OHSS|ohss
196000|NCT02134249|Diosmin|diosmin
196001|NCT02134249|Cabergoline|cabergoline
196002|NCT02134210|PsO|pso
196003|NCT02134197|Oncology|oncology
196004|NCT02134197|Solid tumors|solid tumors
196005|NCT02134197|Antibody drug conjugate|antibody drug conjugate
196006|NCT02134197|Maximum tolerated dose|maximum tolerated dose
196007|NCT02134171|Thrombotic microangiopathy,|thrombotic microangiopathy,
196008|NCT02134171|haemolytic uremic syndrome,|haemolytic uremic syndrome,
196009|NCT02134171|thrombotic thrombocytopenic purpura,|thrombotic thrombocytopenic purpura,
196010|NCT02134171|ADAMTS13,|adamts13,
196011|NCT02134171|troponin,|troponin,
196012|NCT02134171|plasma exchange.|plasma exchange.
196013|NCT02134158|tDCS, gait disorders, equilibrium, hemiplegic, stroke|tdcs, gait disorders, equilibrium, hemiplegic, stroke
196014|NCT02134145|Mobile Health|mobile health
196015|NCT02134145|mHealth|mhealth
196016|NCT02134145|Technology|technology
196017|NCT02134132|Platelet gel|platelet gel
196018|NCT02134132|diabetic foot ulcer|diabetic foot ulcer
196019|NCT02134132|umbilical cord blood|umbilical cord blood
196020|NCT02134119|dietary supplement|dietary supplement
196021|NCT02134119|endurance athletes|endurance athletes
196022|NCT02134119|VO2max|vo2max
196023|NCT02134119|red blood cells|red blood cells
196024|NCT02134106|Multicenter|multicenter
196025|NCT02134106|Open-label|open-label
196026|NCT02134106|Randomized|randomized
196027|NCT02134106|Controlled|controlled
196029|NCT02134106|antibiotic|antibiotic
196030|NCT02134106|drug-resistant|drug-resistant
196031|NCT02134106|Gram-negative|gram-negative
196032|NCT02134106|bacteria|bacteria
196033|NCT02134080|Tourette Syndrome|tourette syndrome
196034|NCT02134080|FAAH-Inhibitor|faah-inhibitor
187101|NCT02177526|MRI|mri
196035|NCT02134080|Tics|tics
196036|NCT02134080|Tic Disorders|tic disorders
196037|NCT02134067|advanced solid tumors|advanced solid tumors
196038|NCT02134067|tumor|tumor
196039|NCT02134067|Dose Escalation|dose escalation
196040|NCT02134067|TAS-119|tas-119
196041|NCT02134067|Taxane|taxane
196042|NCT02134067|Paclitaxel|paclitaxel
196043|NCT02134067|Aurora A kinase inhibitor|aurora a kinase inhibitor
196044|NCT02134067|AurA|aura
196045|NCT02134054|Therapeutic drug monitoring|therapeutic drug monitoring
196046|NCT02134054|Biological treatment|biological treatment
196047|NCT02134054|IBD|ibd
196048|NCT02134041|traumatic brain injury|traumatic brain injury
196049|NCT02134041|Alzheimer disease|alzheimer disease
196050|NCT02134015|Carcinoma|carcinoma
196051|NCT02134015|Non-Small-Cell Lung|non-small-cell lung
196052|NCT02134015|Lung Neoplasms|lung neoplasms
196053|NCT02134015|Bronchogenic|bronchogenic
196054|NCT02134015|Bronchial Neoplasms|bronchial neoplasms
196055|NCT02134015|Respiratory Tract Neoplasms|respiratory tract neoplasms
196056|NCT02134015|Thoracic Neoplasms|thoracic neoplasms
196057|NCT02134015|Neoplasms by Site|neoplasms by site
196058|NCT02134015|Neoplasms|neoplasms
196059|NCT02134015|Lung Diseases|lung diseases
196060|NCT02134015|Respiratory Tract Diseases|respiratory tract diseases
196061|NCT02134015|Erlotinib|erlotinib
196062|NCT02134015|Therapeutic Uses|therapeutic uses
196063|NCT02134015|Pharmacologic Actions|pharmacologic actions
196064|NCT02134015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
196066|NCT02134002|disulfiram|disulfiram
196067|NCT02134002|beta-dopamine hydroxylase|beta-dopamine hydroxylase
196068|NCT02133989|Carotid stenosis|carotid stenosis
196070|NCT02133989|Clopidogrel resistance|clopidogrel resistance
196071|NCT02133989|Stroke, ischemic|stroke, ischemic
196072|NCT02133976|chronic low back pain|chronic low back pain
196073|NCT02133976|psychosocial interventions|psychosocial interventions
196074|NCT02133976|mechanisms|mechanisms
196075|NCT02133963|depression|depression
196076|NCT02133963|postpartum depression|postpartum depression
196077|NCT02133963|pregnancy|pregnancy
196078|NCT02133963|perinatal depression|perinatal depression
196079|NCT02133963|sleep|sleep
196080|NCT02133963|life stress|life stress
196081|NCT02133950|preimplantation genetic diagnosis|preimplantation genetic diagnosis
196082|NCT02133950|cryopreservation|cryopreservation
196083|NCT02133950|pregnancy|pregnancy
196084|NCT02133924|Graft vs Host Disease|graft vs host disease
196085|NCT02133924|Graft vs Host Reaction|graft vs host reaction
196086|NCT02133924|allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
196087|NCT02133924|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
196088|NCT02133924|adverse effects|adverse effects
196089|NCT02133898|Depression|depression
196090|NCT02133898|MTHFR|mthfr
196091|NCT02133898|L-methylfolate|l-methylfolate
196092|NCT02133885|Resistent Hypertension|resistent hypertension
196093|NCT02133885|Systolic Blood Pressure|systolic blood pressure
196094|NCT02133872|Resistent Hypertension|resistent hypertension
196095|NCT02133846|4RT, CBS, PSP, CBD, TPI-287|4rt, cbs, psp, cbd, tpi-287
196096|NCT02133820|Healthy Volunteer|healthy volunteer
196097|NCT02133820|Pharmacokinetics|pharmacokinetics
196098|NCT02133807|Lipoprotein(a);|lipoprotein(a);
196099|NCT02133807|Lp(a) immunoadsorption;|lp(a) immunoadsorption;
196100|NCT02133807|Apheresis;|apheresis;
196101|NCT02133807|Coronary atherosclerosis;|coronary atherosclerosis;
196102|NCT02133807|Carotid Atherosclerosis;|carotid atherosclerosis;
196103|NCT02133807|Intima-media thickness;|intima-media thickness;
196104|NCT02133807|Regression;|regression;
196105|NCT02133807|Quantitative Coronary Angiography;|quantitative coronary angiography;
196106|NCT02133807|Intravascular Ultrasound;|intravascular ultrasound;
196107|NCT02133807|Virtual Histology;|virtual histology;
196108|NCT02133807|Plaque;|plaque;
196109|NCT02133807|Atorvastatin;|atorvastatin;
196110|NCT02133794|Hip fracture|hip fracture
196111|NCT02133794|Tomosynthesis|tomosynthesis
196112|NCT02133794|X-ray|x-ray
196113|NCT02133794|Emergency room|emergency room
196114|NCT02133781|Inactivated influenza vaccine|inactivated influenza vaccine
196212|NCT02133352|pulmonary hypertension|pulmonary hypertension
196115|NCT02133781|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
196116|NCT02133781|Child identical twins|child identical twins
196117|NCT02133781|Young and elderly adults|young and elderly adults
196118|NCT02133742|Axitinib and MK-3475|axitinib and mk-3475
196119|NCT02133742|patients with advanced Renal Cell Cancer.|patients with advanced renal cell cancer.
196120|NCT02133716|pain|pain
196121|NCT02133716|premature infant|premature infant
196122|NCT02133716|sucrose|sucrose
196123|NCT02133716|breastfeeding|breastfeeding
196124|NCT02133716|expressed breast milk|expressed breast milk
196125|NCT02133716|PIPP|pipp
196126|NCT02133703|Genetic counseling|genetic counseling
196127|NCT02133703|genetic testing|genetic testing
196128|NCT02133703|BRCA1|brca1
196129|NCT02133703|BRCA2|brca2
196130|NCT02133703|Hereditary breast cancer|hereditary breast cancer
196131|NCT02133703|Hereditary ovarian cancer|hereditary ovarian cancer
196132|NCT02133690|rotavirus|rotavirus
196133|NCT02133690|rotavirus vaccine|rotavirus vaccine
196134|NCT02133690|BRV-PV|brv-pv
196135|NCT02133677|lung cancer and breast cancer patients with brain metastases|lung cancer and breast cancer patients with brain metastases
196136|NCT02133664|multiple sclerosis|multiple sclerosis
196137|NCT02133664|cognition|cognition
196138|NCT02133664|clinical trial|clinical trial
196139|NCT02133664|thiotic acid|thiotic acid
196140|NCT02133664|Omega-3 fatty acids|omega-3 fatty acids
196141|NCT02133651|Clostridium difficile|clostridium difficile
196142|NCT02133651|Intestinal Microbiota Transplantation|intestinal microbiota transplantation
196143|NCT02133651|Diarrhea|diarrhea
196144|NCT02133651|Fecal Microbiota Transplant|fecal microbiota transplant
196145|NCT02133638|Delirium|delirium
196146|NCT02133638|Hypoxic Brain Damage|hypoxic brain damage
196147|NCT02133638|Propofol|propofol
196148|NCT02133638|S100b protein|s100b protein
196149|NCT02133638|Sevoflurane|sevoflurane
196150|NCT02133625|Advanced solid tumor|advanced solid tumor
196151|NCT02133625|Metastatic solid tumor|metastatic solid tumor
196152|NCT02133612|esophageal cancer|esophageal cancer
196153|NCT02133612|adjuvant chemotherapy|adjuvant chemotherapy
196154|NCT02133612|esophageal surgery|esophageal surgery
196155|NCT02133612|paclitaxel|paclitaxel
196156|NCT02133612|cisplatin|cisplatin
196157|NCT02133586|Air pollution|air pollution
196159|NCT02133586|Nitrogen dioxide|nitrogen dioxide
196160|NCT02133586|Lung function|lung function
196161|NCT02133586|Cytokines|cytokines
196162|NCT02133573|progesterone|progesterone
196163|NCT02133573|congenital heart disease|congenital heart disease
196164|NCT02133573|periventricular leucomalacia|periventricular leucomalacia
196166|NCT02133573|cardiac surgery|cardiac surgery
196167|NCT02133573|neurodevelopmental disability|neurodevelopmental disability
196168|NCT02133573|fetus|fetus
196169|NCT02133573|fetal neuroprotection|fetal neuroprotection
196170|NCT02133560|Sickle cell|sickle cell
196171|NCT02133560|Thalassemia|thalassemia
196172|NCT02133560|Adherence|adherence
196173|NCT02133547|Nitric Oxide|nitric oxide
196174|NCT02133547|Nose|nose
196175|NCT02133547|Healthy Volunteers|healthy volunteers
196176|NCT02133547|Kartagener Syndrome|kartagener syndrome
196177|NCT02133547|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
196178|NCT02133534|Chronic kidney disease|chronic kidney disease
196179|NCT02133534|High cholesterol|high cholesterol
196180|NCT02133521|DLBS1033|dlbs1033
196181|NCT02133521|Acute ischemic stroke|acute ischemic stroke
196182|NCT02133521|NIHSS|nihss
196183|NCT02133521|Barthel Index|barthel index
196184|NCT02133495|lower eyelid|lower eyelid
196185|NCT02133495|retraction|retraction
196186|NCT02133469|Effectiveness|effectiveness
196187|NCT02133469|Prevenar|prevenar
196188|NCT02133469|nasopharyngeal carriage|nasopharyngeal carriage
196189|NCT02133469|vaccine serotype|vaccine serotype
196190|NCT02133456|safety|safety
196191|NCT02133456|influenza vaccine|influenza vaccine
196192|NCT02133456|post-marketing|post-marketing
196193|NCT02133443|Mechanical ventilation|mechanical ventilation
196194|NCT02133443|Acute respiratory failure|acute respiratory failure
196195|NCT02133443|Weaning|weaning
196196|NCT02133443|Pressure support ventilation|pressure support ventilation
196197|NCT02133443|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
196198|NCT02133430|Postoperative delirium|postoperative delirium
196199|NCT02133417|Quantitative Transmission Ultrasound|quantitative transmission ultrasound
196200|NCT02133417|QTUS|qtus
196201|NCT02133404|secondary hyperparathyroidism(SHPT)|secondary hyperparathyroidism(shpt)
196202|NCT02133404|Chronic kidney disease(CKD)|chronic kidney disease(ckd)
196203|NCT02133404|Mineral bone disease(MBD)|mineral bone disease(mbd)
196204|NCT02133391|Accountable Care Organization|accountable care organization
196205|NCT02133391|Comparative Effectiveness Research|comparative effectiveness research
196206|NCT02133391|Immunization/statistics & numerical data|immunization/statistics & numerical data
196207|NCT02133391|Medicaid|medicaid
196208|NCT02133391|Reminder Systems/economics|reminder systems/economics
196209|NCT02133391|Reminder Systems/statistics & numerical data|reminder systems/statistics & numerical data
196210|NCT02133378|Bleeding|bleeding
196211|NCT02133378|Hemostatic|hemostatic
196213|NCT02133352|diastolic dyfunction|diastolic dyfunction
196214|NCT02133326|Analgesia|analgesia
196215|NCT02133326|Third Molar Extraction|third molar extraction
196216|NCT02133326|Ibuprofen|ibuprofen
196217|NCT02133326|Acetaminophen|acetaminophen
196218|NCT02133326|Pain Medicine|pain medicine
196219|NCT02133326|Nonsteroidal|nonsteroidal
196220|NCT02133326|Anti-inflammatory|anti-inflammatory
196221|NCT02133313|Peritoneal Dialysis|peritoneal dialysis
196222|NCT02133313|Peritoneal Fibrosis|peritoneal fibrosis
196223|NCT02133313|Glucose Transporters|glucose transporters
196224|NCT02133274|Neoplasms|neoplasms
196225|NCT02133274|Early Palliative Care|early palliative care
196226|NCT02133274|Psychosocial Intervention|psychosocial intervention
196227|NCT02133274|Symptoms|symptoms
196228|NCT02133274|Quality of life|quality of life
196229|NCT02133274|Depression|depression
196230|NCT02133248|donor specific antibodies|donor specific antibodies
196231|NCT02133248|B cells|b cells
196232|NCT02133248|antibody mediated rejection|antibody mediated rejection
196233|NCT02133248|kidney transplant|kidney transplant
196234|NCT02133248|desensitization|desensitization
196235|NCT02133235|endobronchial blocker|endobronchial blocker
196236|NCT02133235|lung separation|lung separation
196237|NCT02133235|vedio-assisted thoracic operation|vedio-assisted thoracic operation
196238|NCT02133209|migraine|migraine
196239|NCT02133209|headache|headache
196240|NCT02133209|meditation|meditation
196241|NCT02133209|mindfulness based stress reduction|mindfulness based stress reduction
196242|NCT02133209|MBSR|mbsr
196243|NCT02133196|Metastatic|metastatic
196244|NCT02133196|Non-Small Cell Lung Cancer|non-small cell lung cancer
196245|NCT02133196|NSCLC|nsclc
196246|NCT02133196|Lung Cancer|lung cancer
196247|NCT02133170|BIPOLAR DISORDER|bipolar disorder
196248|NCT02133170|DEPRESSIVE SYMPTOMS|depressive symptoms
196249|NCT02133170|MINDFULNESS|mindfulness
196250|NCT02133170|PSYCHOEDUCATION|psychoeducation
196251|NCT02133170|BIPOLAR PATIENTS WITH DEPRESSIVE SYMPTOMS|bipolar patients with depressive symptoms
196252|NCT02133157|tumor|tumor
196253|NCT02133144|NAFLD|nafld
196254|NCT02133144|insulin resistance|insulin resistance
196255|NCT02133144|metabolic syndrome|metabolic syndrome
196256|NCT02133144|de novo lipogenesis|de novo lipogenesis
196257|NCT02133144|overfeeding|overfeeding
196258|NCT02133118|Type 2 diabetes|type 2 diabetes
196259|NCT02133118|New-user design|new-user design
196260|NCT02133118|Weight trajectory|weight trajectory
196261|NCT02133118|Add-on therapy|add-on therapy
196262|NCT02133118|Sulphonylureas.|sulphonylureas.
196263|NCT02133105|Heart failure|heart failure
196264|NCT02133105|Renal failure|renal failure
196265|NCT02133105|Inotropic drugs|inotropic drugs
196266|NCT02133105|Levosimendan|levosimendan
196267|NCT02133105|Dobutamine|dobutamine
196268|NCT02133092|Respiratory syncytial virus|respiratory syncytial virus
196270|NCT02133092|Lower respiratory tract infection|lower respiratory tract infection
196271|NCT02133092|LRTI|lrti
196272|NCT02133092|Acute respiratory infection|acute respiratory infection
196273|NCT02133092|Belgian children|belgian children
196274|NCT02133066|Ultrasound|ultrasound
196275|NCT02133066|Lumbar Puncture|lumbar puncture
196276|NCT02133066|Spinal Tap|spinal tap
196277|NCT02133066|Pediatric|pediatric
196278|NCT02133066|Infant|infant
196279|NCT02133066|Bedside Ultrasonography|bedside ultrasonography
196280|NCT02133053|Allergic Rhinitis|allergic rhinitis
196281|NCT02133053|Ectoine|ectoine
196282|NCT02133053|bitop|bitop
196283|NCT02133053|Ectoin|ectoin
196284|NCT02133040|Brown Adipose Tissue|brown adipose tissue
196285|NCT02133027|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
196286|NCT02133014|pancreatitis|pancreatitis
196287|NCT02133014|laparoscopic|laparoscopic
196288|NCT02133014|drainage|drainage
196289|NCT02133014|surgery|surgery
196290|NCT02133001|Major Depressive Disorder|major depressive disorder
196291|NCT02133001|Esketamine|esketamine
196292|NCT02133001|Intranasal esketamine|intranasal esketamine
196293|NCT02133001|Placebo|placebo
196294|NCT02132975|prostate|prostate
196295|NCT02132975|cancer|cancer
196296|NCT02132923|Respiratory syncytial virus|respiratory syncytial virus
196297|NCT02132923|RSV|rsv
196298|NCT02132923|Lower respiratory tract infection|lower respiratory tract infection
196299|NCT02132923|LRTI|lrti
196300|NCT02132923|Acute respiratory infection|acute respiratory infection
196301|NCT02132923|Japanese children|japanese children
196302|NCT02132897|Antiepileptic|antiepileptic
196303|NCT02132897|Carbamazepine|carbamazepine
196304|NCT02132897|Bio-equivalence|bio-equivalence
196305|NCT02132897|Fed|fed
196306|NCT02132897|Crossover|crossover
196307|NCT02132832|marijuana|marijuana
196308|NCT02132832|attentional bias|attentional bias
196309|NCT02132832|stress|stress
196310|NCT02132832|buspirone|buspirone
196311|NCT02132819|transfusion|transfusion
196312|NCT02132819|feeding|feeding
196313|NCT02132819|TRAGI|tragi
196314|NCT02132819|NEC|nec
196315|NCT02132806|class II furcation involvement|class ii furcation involvement
196316|NCT02132806|piezoelectric surgery|piezoelectric surgery
196317|NCT02132806|regeneration|regeneration
196318|NCT02132806|biomaterial|biomaterial
196319|NCT02132793|technology|technology
196320|NCT02132793|mobile|mobile
196321|NCT02132793|anger management|anger management
196322|NCT02132793|anger|anger
196323|NCT02132793|PTSD|ptsd
196324|NCT02132793|veterans|veterans
196325|NCT02132767|Heart surgery|heart surgery
196326|NCT02132767|Cardiac surgery|cardiac surgery
196327|NCT02132767|Coronary artery bypass|coronary artery bypass
196328|NCT02132767|Mitral valve surgery|mitral valve surgery
196329|NCT02132767|Aortic valve surgery|aortic valve surgery
196330|NCT02132767|Atrial fibrillation|atrial fibrillation
196331|NCT02132767|Atrial flutter|atrial flutter
196332|NCT02132767|Cardiac arrhythmia|cardiac arrhythmia
196333|NCT02132767|Valve surgery|valve surgery
196334|NCT02132741|OCT; hypertension; CKD|oct; hypertension; ckd
196335|NCT02132728|flaxseed|flaxseed
196336|NCT02132728|lignans|lignans
196337|NCT02132728|inflammation|inflammation
196338|NCT02132728|Nutrition|nutrition
196339|NCT02132728|enterolactone|enterolactone
196340|NCT02132728|enterodiol|enterodiol
196341|NCT02132689|Moderate Risk Acute Pulmonary Embolism|moderate risk acute pulmonary embolism
196342|NCT02132676|Self-Management|self-management
196343|NCT02132676|Patient Care Management|patient care management
196344|NCT02132676|Peer Group|peer group
196345|NCT02132676|Disease Management|disease management
196346|NCT02132676|Health Plan Implementation|health plan implementation
196347|NCT02132676|Diabetes Mellitus|diabetes mellitus
196348|NCT02132650|Rehabilitation|rehabilitation
196349|NCT02132650|Walking|walking
196350|NCT02132650|Motor skills disorders|motor skills disorders
196351|NCT02132650|Electromyography|electromyography
196352|NCT02132598|Lung Cancer|lung cancer
196353|NCT02132598|Non Small Cell|non small cell
196354|NCT02132598|Brain metastases|brain metastases
196355|NCT02132598|c-MET|c-met
196356|NCT02132520|Hemiparesis|hemiparesis
196357|NCT02132520|Stroke|stroke
196358|NCT02132520|Rehabilitation|rehabilitation
196359|NCT02132520|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
196360|NCT02132520|Electroencephalography|electroencephalography
196361|NCT02132520|Functional Neuroimaging|functional neuroimaging
196362|NCT02132520|Brain-Computer Interface|brain-computer interface
196363|NCT02132507|epilepsy|epilepsy
196365|NCT02132507|EEG|eeg
196367|NCT02132481|Smartphones|smartphones
196368|NCT02132481|Mobile phones|mobile phones
196369|NCT02132481|Substance use disorder|substance use disorder
196370|NCT02132481|Recovery Support Services|recovery support services
196371|NCT02132481|Ecological Momentary Assessment (EMA)|ecological momentary assessment (ema)
196372|NCT02132481|Ecological Momentary Intervention (EMI)|ecological momentary intervention (emi)
196373|NCT02132481|Randomized field experiment|randomized field experiment
196374|NCT02132481|Effectiveness|effectiveness
196375|NCT02132481|Post-Discharge|post-discharge
196376|NCT02132468|PNET|pnet
196377|NCT02132468|GI-NET|gi-net
196378|NCT02132468|neuroendocrine|neuroendocrine
196379|NCT02132468|carcinoid|carcinoid
196380|NCT02132455|Screening colonoscopy|screening colonoscopy
196381|NCT02132455|Surveillance colonoscopy|surveillance colonoscopy
196382|NCT02132442|Children|children
196383|NCT02132442|Adolescents|adolescents
196384|NCT02132442|Adults|adults
196385|NCT02132442|Type 2 diabetes|type 2 diabetes
196386|NCT02132442|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
196387|NCT02132442|Vitamin D deficiency|vitamin d deficiency
196388|NCT02132429|Migraine|migraine
196389|NCT02132416|Prospective study|prospective study
196390|NCT02132416|Surgical management|surgical management
196391|NCT02132416|Unstable thoracic cage injuries|unstable thoracic cage injuries
196392|NCT02132416|Trauma|trauma
196393|NCT02132416|Ventilator support|ventilator support
196394|NCT02132403|pancreatic cancer|pancreatic cancer
196395|NCT02132403|adenocarcinoma of the pancreas (PDAC)|adenocarcinoma of the pancreas (pdac)
196396|NCT02132403|mixed adenocarcinoma of the pancreas|mixed adenocarcinoma of the pancreas
196397|NCT02132403|locally advanced|locally advanced
196398|NCT02132403|recurrent|recurrent
196399|NCT02132403|metastatic|metastatic
196400|NCT02132390|Breast cancer|breast cancer
196401|NCT02132390|Chemotherapy induced amenorrhea|chemotherapy induced amenorrhea
196402|NCT02132390|Goserelin|goserelin
196403|NCT02132364|stroke|stroke
196404|NCT02132364|hypertension|hypertension
196405|NCT02132364|secondary prevention|secondary prevention
196406|NCT02132364|educational program|educational program
196407|NCT02132338|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
196408|NCT02132338|Prevention|prevention
196409|NCT02132338|Health Education|health education
196410|NCT02132325|Pancreatic Cancer|pancreatic cancer
196411|NCT02132325|Dignity Therapy|dignity therapy
196412|NCT02132325|Palliative Care|palliative care
196413|NCT02132325|Advanced Lung Cancer|advanced lung cancer
196414|NCT02132325|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
196415|NCT02132312|Cataract|cataract
196416|NCT02132312|Lens replacement|lens replacement
196417|NCT02132312|pediatric|pediatric
196419|NCT02132299|Plasmodium falciparum malaria|plasmodium falciparum malaria
196420|NCT02132299|PfSPZ Vaccine|pfspz vaccine
196421|NCT02132299|PfSPZ Challenge|pfspz challenge
196422|NCT02132299|Controlled human malaria infection (CHMI)|controlled human malaria infection (chmi)
196423|NCT02132286|Functional magnetic resonance neuroimaging|functional magnetic resonance neuroimaging
196424|NCT02132286|Serotonin transporter gene polymorphism|serotonin transporter gene polymorphism
196425|NCT02132286|Amygdala|amygdala
196426|NCT02132286|Antidepressant|antidepressant
196427|NCT02132286|Quetiapine|quetiapine
196428|NCT02132286|Citalopram|citalopram
196429|NCT02132286|imaging biomarker|imaging biomarker
196430|NCT02132260|Naftifine|naftifine
196431|NCT02132260|Naftin®|naftin®
196432|NCT02132260|Tinea pedis|tinea pedis
196433|NCT02132247|Minor athletic injuries|minor athletic injuries
196434|NCT02132247|Pain|pain
196435|NCT02132247|Diclofenac|diclofenac
196436|NCT02132247|Topical|topical
196437|NCT02132221|Chronic non cancer pain|chronic non cancer pain
196438|NCT02132221|Long term opioid therapy|long term opioid therapy
196439|NCT02132221|Side effects|side effects
196440|NCT02132221|risks|risks
196441|NCT02132221|function|function
196442|NCT02132221|negative benefit/risk ratio|negative benefit/risk ratio
196443|NCT02132143|Lung adenocarcinoma|lung adenocarcinoma
196444|NCT02132143|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
196445|NCT02132143|Sequential chemoradiotherapy|sequential chemoradiotherapy
196446|NCT02132143|Progression-free survival|progression-free survival
196447|NCT02132130|gene therapy|gene therapy
196448|NCT02132130|hearing loss|hearing loss
196449|NCT02132130|balance|balance
196450|NCT02132130|vestibular|vestibular
196451|NCT02132130|cochlear implant|cochlear implant
196452|NCT02132104|Intrauterine adhesions|intrauterine adhesions
196453|NCT02132104|Asherman Syndrome|asherman syndrome
196454|NCT02132104|Amnion graft|amnion graft
196455|NCT02132091|Sirtuins|sirtuins
196456|NCT02132091|Calorie Restriction|calorie restriction
196457|NCT02132091|Intermittent Fasting|intermittent fasting
196460|NCT02132091|Metabolism|metabolism
196461|NCT02132091|Mitochondria|mitochondria
196462|NCT02132091|Oxidative Stress|oxidative stress
196463|NCT02132078|Lung transplant recipients|lung transplant recipients
196464|NCT02132078|diverticulitis|diverticulitis
196465|NCT02132078|immunosuppression|immunosuppression
196470|NCT02132052|Parkinson's Disease|parkinson's disease
196472|NCT02132039|Tai Chi, dementia, caregivers|tai chi, dementia, caregivers
196473|NCT02132026|Aortic Stenosis|aortic stenosis
196474|NCT02132026|Denosumab|denosumab
196475|NCT02132026|Alendronic Acid|alendronic acid
196476|NCT02132026|Osteoporosis|osteoporosis
196477|NCT02131987|Dislocation|dislocation
196478|NCT02131987|Hemiarthroplasty|hemiarthroplasty
196479|NCT02131987|Femoral neck fracture|femoral neck fracture
196480|NCT02131987|Femoral offset|femoral offset
196481|NCT02131987|Leg length difference|leg length difference
196482|NCT02131987|Wiberg angle|wiberg angle
196483|NCT02131974|intubation, pediatric, endotracheal, cuffed ETT|intubation, pediatric, endotracheal, cuffed ett
196484|NCT02131961|diabetic foot|diabetic foot
196485|NCT02131961|foot ulcer|foot ulcer
196486|NCT02131961|foot wound|foot wound
196487|NCT02131961|plantar ulcer|plantar ulcer
196488|NCT02131961|plantar wound|plantar wound
196489|NCT02131961|contact cast|contact cast
196490|NCT02131961|collagenase|collagenase
196491|NCT02131948|Insulin resistance|insulin resistance
196492|NCT02131948|Brain insulin action|brain insulin action
196493|NCT02131948|Type 2 Diabetes|type 2 diabetes
196494|NCT02131909|unilateral cerebral palsy|unilateral cerebral palsy
196495|NCT02131909|children|children
196496|NCT02131909|upper-limb|upper-limb
196497|NCT02131909|mirror therapy|mirror therapy
196498|NCT02131909|bimanual coordination|bimanual coordination
196499|NCT02131909|kinematics analysis|kinematics analysis
196500|NCT02131896|Type 1 Diabetes|type 1 diabetes
196501|NCT02131896|Newly diagnosed|newly diagnosed
196502|NCT02131896|Lipid profile|lipid profile
196503|NCT02131896|Mediterranean diet|mediterranean diet
196504|NCT02131883|Health Anxiety|health anxiety
196505|NCT02131883|Hypochondriasis|hypochondriasis
196506|NCT02131883|Illness Anxiety Disorder|illness anxiety disorder
196507|NCT02131883|Somatic Symptom Disorder|somatic symptom disorder
196508|NCT02131883|Personality Disorders|personality disorders
196509|NCT02131883|Cognitive Behavioral Therapy|cognitive behavioral therapy
196510|NCT02131883|Group-CBT|group-cbt
196511|NCT02131883|Illness Perception|illness perception
196512|NCT02131883|Cost-effectiveness|cost-effectiveness
196513|NCT02131870|iron absorption|iron absorption
196514|NCT02131870|healthy females|healthy females
196515|NCT02131870|child bearing age|child bearing age
196516|NCT02131857|Mindfulness|mindfulness
196517|NCT02131857|stress reduction|stress reduction
196518|NCT02131844|colorectal surgery|colorectal surgery
196519|NCT02131844|postoperative recovery|postoperative recovery
196520|NCT02131844|early mobilization|early mobilization
196521|NCT02131831|telomere|telomere
196522|NCT02131831|telomerase|telomerase
196523|NCT02131831|cirrhosis|cirrhosis
196524|NCT02131818|amoxicillin|amoxicillin
196525|NCT02131818|postpartum infections|postpartum infections
196526|NCT02131818|puerperal infection|puerperal infection
196527|NCT02131805|skin|skin
196528|NCT02131805|Brachytherapy|brachytherapy
196529|NCT02131805|14-001|14-001
196530|NCT02131779|prostate cancer disparities|prostate cancer disparities
196531|NCT02131779|African American|african american
196532|NCT02131779|Spiritually based intervention|spiritually based intervention
196533|NCT02131779|Men's Health|men's health
196534|NCT02131779|Informed Decision Making|informed decision making
196535|NCT02131779|Community Based Participatory Research|community based participatory research
240391|NCT01933503|MAD|mad
196536|NCT02131779|Health Communication|health communication
196537|NCT02131779|Health Information Technology|health information technology
196538|NCT02131779|Community Health Advisors|community health advisors
196792|NCT02130674|glutamine|glutamine
196539|NCT02131766|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
196540|NCT02131766|Artificial Pancreas Project (APP)|artificial pancreas project (app)
196541|NCT02131766|Diabetes Assistant (DiAs)|diabetes assistant (dias)
196542|NCT02131766|Closed-Loop Control (CLC)|closed-loop control (clc)
196543|NCT02131753|hairy cell leukemia|hairy cell leukemia
196544|NCT02131753|untreated|untreated
196545|NCT02131753|cladribine subcutaneous|cladribine subcutaneous
196546|NCT02131740|corneal|corneal
196547|NCT02131740|eye rubbing|eye rubbing
196548|NCT02131727|hand hygiene|hand hygiene
196549|NCT02131727|communicable diseases|communicable diseases
196550|NCT02131727|respiratory tract infections|respiratory tract infections
196551|NCT02131727|primary prevention|primary prevention
196552|NCT02131727|employees|employees
196553|NCT02131714|pressure pain threshold|pressure pain threshold
196554|NCT02131714|temporomandibular disorder syndrome|temporomandibular disorder syndrome
196555|NCT02131714|therapeutic exercise|therapeutic exercise
196558|NCT02131701|Physical fitness|physical fitness
196559|NCT02131701|Family history of type 2 diabetes|family history of type 2 diabetes
196560|NCT02131701|Prescription of exercise|prescription of exercise
196561|NCT02131688|safety;malignant lymphoma;|safety;malignant lymphoma;
196562|NCT02131675|C-peptide|c-peptide
196563|NCT02131675|type 1 diabetes|type 1 diabetes
196564|NCT02131662|Uterine fibroids|uterine fibroids
196565|NCT02131649|Prostate Cancer|prostate cancer
196567|NCT02131649|MRI|mri
196568|NCT02131649|Fluorocholine|fluorocholine
196569|NCT02131649|Radiotherapy|radiotherapy
196570|NCT02131649|Prostatectomy|prostatectomy
196571|NCT02131610|Sleep apnea|sleep apnea
196572|NCT02131610|Obstructive sleep apnea|obstructive sleep apnea
196573|NCT02131610|Subclinical atherosclerosis|subclinical atherosclerosis
196574|NCT02131610|Epigenetics|epigenetics
196575|NCT02131610|T cells|t cells
196576|NCT02131597|Leukemia|leukemia
196577|NCT02131597|Myelodysplastic syndrome|myelodysplastic syndrome
196578|NCT02131597|MDS|mds
196579|NCT02131597|Higher risk|higher risk
196580|NCT02131597|SGI-110|sgi-110
196581|NCT02131584|Leukemia|leukemia
196582|NCT02131584|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
196583|NCT02131584|CLL|cll
196584|NCT02131584|Fatigue|fatigue
196585|NCT02131584|Brief Fatigue Inventory|brief fatigue inventory
196586|NCT02131584|BFI|bfi
196587|NCT02131584|Questionnaires|questionnaires
196588|NCT02131584|Surveys|surveys
196589|NCT02131584|Ruxolitinib|ruxolitinib
196590|NCT02131584|Jakafi|jakafi
196591|NCT02131584|INCB018424|incb018424
196592|NCT02131584|INC424|inc424
196593|NCT02131571|HIV|hiv
196594|NCT02131571|bone|bone
196595|NCT02131571|fractures|fractures
196596|NCT02131571|vitamin D|vitamin d
196597|NCT02131571|biomarkers|biomarkers
196598|NCT02131558|Endometrial cancer|endometrial cancer
196599|NCT02131558|Sentinel lymph node|sentinel lymph node
196600|NCT02131558|Indocyanine green|indocyanine green
196601|NCT02131558|Near infrared imaging|near infrared imaging
196602|NCT02131545|quetiapine|quetiapine
675800|NCT00877864|exercise|exercise
196603|NCT02131545|pharmacokinetics|pharmacokinetics
196604|NCT02131545|dementia|dementia
196605|NCT02131545|delirium|delirium
196606|NCT02131545|palliative care|palliative care
196607|NCT02131532|Post-stroke fatigue|post-stroke fatigue
196608|NCT02131532|Psychological intervention|psychological intervention
196609|NCT02131532|Feasibility|feasibility
196610|NCT02131506|Advanced HER2 positive Breast Cancer|advanced her2 positive breast cancer
196611|NCT02131506|pretreated breast cancer|pretreated breast cancer
196612|NCT02131506|advanced disease|advanced disease
196613|NCT02131454|asthma and COPD treatment|asthma and copd treatment
196614|NCT02131454|inhalation techniques|inhalation techniques
196615|NCT02131454|training of inhalation|training of inhalation
196616|NCT02131428|Heart Failure|heart failure
196617|NCT02131428|Depression|depression
196619|NCT02131415|schizophrenia|schizophrenia
196620|NCT02131415|real-life|real-life
196621|NCT02131415|long-acting injectable|long-acting injectable
196622|NCT02131415|Reliam|reliam
196623|NCT02131389|Hip|hip
196624|NCT02131389|Arthroplasty|arthroplasty
196625|NCT02131389|Arthroplasties|arthroplasties
196626|NCT02131389|Prosthesis|prosthesis
196627|NCT02131389|Iconacy|iconacy
196628|NCT02131389|Osteoarthritis|osteoarthritis
196629|NCT02131389|Arthritis|arthritis
196630|NCT02131389|THA|tha
196631|NCT02131389|THR|thr
196632|NCT02131389|DJD|djd
196633|NCT02131376|carcinoma, renal cell|carcinoma, renal cell
196634|NCT02131376|partial nephrectomy|partial nephrectomy
196635|NCT02131376|kidney function test|kidney function test
196636|NCT02131376|robotics|robotics
196637|NCT02131324|Psoriasis|psoriasis
196638|NCT02131311|single use|single use
196639|NCT02131311|disposable|disposable
196640|NCT02131311|pessary|pessary
196641|NCT02131311|stress urinary incontinence|stress urinary incontinence
196642|NCT02131311|sui|sui
196643|NCT02131298|Palbociclib|palbociclib
196644|NCT02131298|Itraconazole|itraconazole
196645|NCT02131298|Pharmacokinetics|pharmacokinetics
196646|NCT02131298|Drug-Drug Interaction Study|drug-drug interaction study
196647|NCT02131298|Healthy Volunteers|healthy volunteers
196648|NCT02131285|Rehabilitation,|rehabilitation,
196649|NCT02131285|Balance,|balance,
196650|NCT02131285|Sensory strategies,|sensory strategies,
196651|NCT02131285|Multiple Sclerosis,|multiple sclerosis,
196652|NCT02131285|Postural control|postural control
196653|NCT02131220|No-Reflow Phenomenon|no-reflow phenomenon
196654|NCT02131194|Cataract|cataract
196655|NCT02131194|Nutritional Supplement|nutritional supplement
196656|NCT02131181|Delirium, postoperative delirium, elderly|delirium, postoperative delirium, elderly
196657|NCT02131142|ischemic heart disease|ischemic heart disease
196658|NCT02131142|CAD|cad
196659|NCT02131129|schizophrenia|schizophrenia
196762|NCT02130804|Salsalate|salsalate
196660|NCT02131129|schizophreniform disorder|schizophreniform disorder
196661|NCT02131129|schizoaffective disorder|schizoaffective disorder
196667|NCT02131116|schizoaffective disorder|schizoaffective disorder
196668|NCT02131116|cognition|cognition
196669|NCT02131116|metacognition|metacognition
196671|NCT02131116|first episode psychosis|first episode psychosis
196672|NCT02131116|psychosis|psychosis
196673|NCT02131103|Pharmacoinvasive strategy|pharmacoinvasive strategy
196674|NCT02131090|Epidural|epidural
196675|NCT02131090|Catheter|catheter
196676|NCT02131090|Fixation|fixation
196677|NCT02131090|Device|device
196678|NCT02131090|Intrapartum|intrapartum
196679|NCT02131077|Lateral Epicondylitis|lateral epicondylitis
196680|NCT02131051|ectoine|ectoine
196681|NCT02131051|allergic rhinitis|allergic rhinitis
196682|NCT02131051|bitop|bitop
196683|NCT02131038|Ectoine|ectoine
196684|NCT02131038|bitop|bitop
196685|NCT02131038|Allergic Rhinitis|allergic rhinitis
196686|NCT02131012|Macular edema|macular edema
196687|NCT02130999|Non-24|non-24
196688|NCT02130999|absolute bioavailability|absolute bioavailability
196689|NCT02130999|tasimelteon|tasimelteon
196690|NCT02130999|Hetlioz™|hetlioz™
196691|NCT02130986|procalcitonin (PCT)|procalcitonin (pct)
196692|NCT02130986|lower respiratory tract infection (LRTI)|lower respiratory tract infection (lrti)
196693|NCT02130986|antibiotic exposure|antibiotic exposure
196694|NCT02130986|antibiotic decision making|antibiotic decision making
196695|NCT02130986|community acquired pneumonia (CAP)|community acquired pneumonia (cap)
196696|NCT02130986|chronic obstructive pulmonary disease (COPD) exacerbation|chronic obstructive pulmonary disease (copd) exacerbation
196697|NCT02130986|acute asthma exacerbation|acute asthma exacerbation
196698|NCT02130986|acute bronchitis|acute bronchitis
196699|NCT02130986|procalcitonin guideline|procalcitonin guideline
196707|NCT02130960|Reliability|reliability
196708|NCT02130960|Obese|obese
196709|NCT02130960|Energy Expenditure|energy expenditure
196710|NCT02130960|Resting Energy Expenditure|resting energy expenditure
196711|NCT02130960|Resting Metabolic Rate|resting metabolic rate
196712|NCT02130947|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
196713|NCT02130947|Prostate Cancer|prostate cancer
196714|NCT02130947|mCRPC|mcrpc
196715|NCT02130947|Pilot Study|pilot study
196716|NCT02130947|UNC Lineberger|unc lineberger
196717|NCT02130947|Exercise|exercise
196718|NCT02130934|Childhood cancer|childhood cancer
196719|NCT02130934|anthracyclines|anthracyclines
196720|NCT02130934|cardiotoxicity|cardiotoxicity
196721|NCT02130934|cardiac MRI|cardiac mri
196722|NCT02130934|cumulative does of at least 150 mg/m2 of anthracyclines|cumulative does of at least 150 mg/m2 of anthracyclines
196723|NCT02130934|Ventricular function|ventricular function
196724|NCT02130921|Stigma|stigma
196725|NCT02130921|HIV|hiv
196726|NCT02130921|CHWs|chws
196727|NCT02130921|PLH|plh
196728|NCT02130921|Injecting Drug Users|injecting drug users
196729|NCT02130921|FM|fm
196730|NCT02130895|prescribing|prescribing
196731|NCT02130895|STOPP Criteria|stopp criteria
196732|NCT02130895|potentially inappropriate prescribing|potentially inappropriate prescribing
196733|NCT02130895|clinical decision support|clinical decision support
196734|NCT02130895|Electronic Medical Records|electronic medical records
196735|NCT02130895|primary care|primary care
196736|NCT02130882|Interleukin-5|interleukin-5
196737|NCT02130882|Monoclonal Antibody|monoclonal antibody
196738|NCT02130882|Treatment|treatment
196739|NCT02130869|Autologous stem cell transplantation|autologous stem cell transplantation
196740|NCT02130869|Natural killer cells|natural killer cells
196741|NCT02130856|Neonatal mortality|neonatal mortality
196742|NCT02130856|Neonatal kit|neonatal kit
196743|NCT02130856|Pakistan|pakistan
196744|NCT02130856|Randomized Control Trial|randomized control trial
196745|NCT02130856|Chlorhexidine|chlorhexidine
196746|NCT02130856|ThermoSpot|thermospot
196747|NCT02130856|Birth|birth
196748|NCT02130843|URINARY INCONTINENCE|urinary incontinence
240589|NCT01932502|Onfi|onfi
187769|NCT02173561|CPT|cpt
196749|NCT02130843|URODYNAMICS|urodynamics
196750|NCT02130843|URINARY RETENTION|urinary retention
196751|NCT02130843|URINARY CATHETERIZATION|urinary catheterization
196752|NCT02130830|hemorrhoids|hemorrhoids
196753|NCT02130830|Rubber band ligation|rubber band ligation
196754|NCT02130830|pain|pain
196755|NCT02130817|Renal Transplant|renal transplant
196756|NCT02130817|Kidney Transplant|kidney transplant
196757|NCT02130817|Mean flourescent Intensity|mean flourescent intensity
196758|NCT02130817|Delayed Graft Function|delayed graft function
196759|NCT02130817|Antagonist of Thymocyte Cell Activation|antagonist of thymocyte cell activation
196760|NCT02130804|Obesity|obesity
196761|NCT02130804|Adipose tissue inflammation|adipose tissue inflammation
196764|NCT02130765|Monomorphic Ventricular Tachycardia|monomorphic ventricular tachycardia
196766|NCT02130765|Non-ischemic|non-ischemic
196767|NCT02130765|Catheter Ablation|catheter ablation
196768|NCT02130752|Stomach Neoplasms|stomach neoplasms
196769|NCT02130752|Operative Time|operative time
196770|NCT02130752|Gastrectomy|gastrectomy
196771|NCT02130752|Surgical Hemorrhage|surgical hemorrhage
196772|NCT02130752|Mortality|mortality
196773|NCT02130752|Morbidity|morbidity
196774|NCT02130739|Anesthesia|anesthesia
196775|NCT02130739|Epidural|epidural
196776|NCT02130739|Thoracic Nerves|thoracic nerves
196777|NCT02130739|Horner syndrome|horner syndrome
196778|NCT02130726|Gastric cancer|gastric cancer
196779|NCT02130726|Minimally-invasive|minimally-invasive
196780|NCT02130726|Oncological quality of resection|oncological quality of resection
196781|NCT02130700|mCRPC|mcrpc
196782|NCT02130700|metastatic|metastatic
196783|NCT02130700|castration-resistant prostate cancer|castration-resistant prostate cancer
196784|NCT02130687|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
196785|NCT02130687|Hypertension|hypertension
196786|NCT02130687|Angiotensin Converting Enzyme Inhibitors|angiotensin converting enzyme inhibitors
196787|NCT02130687|Dipeptidyl Peptidase IV Inhibitors|dipeptidyl peptidase iv inhibitors
196788|NCT02130687|Sitagliptin|sitagliptin
196789|NCT02130687|Aprepitant|aprepitant
196790|NCT02130687|Ramipril|ramipril
196791|NCT02130674|traumatic brain injury|traumatic brain injury
196793|NCT02130674|microdialysis|microdialysis
196794|NCT02130674|metabolism|metabolism
196795|NCT02130661|drug interaction|drug interaction
196796|NCT02130661|healthy volunteer|healthy volunteer
196797|NCT02130661|rilapladib|rilapladib
196798|NCT02130661|SB-659032|sb-659032
196799|NCT02130661|Alzheimer's disease|alzheimer's disease
196800|NCT02130661|itraconazole|itraconazole
196801|NCT02130648|Non-invasive Prenatal Diagnosis (NIPD)|non-invasive prenatal diagnosis (nipd)
196802|NCT02130648|Cystic Fibrosis|cystic fibrosis
196803|NCT02130648|Quantitative real time MEMO-PCR|quantitative real time memo-pcr
196804|NCT02130635|PI3Kd|pi3kd
196805|NCT02130635|Pharmacodynamics|pharmacodynamics
196806|NCT02130635|dry powder inhaler|dry powder inhaler
196807|NCT02130635|GSK2269557|gsk2269557
196808|NCT02130635|safety|safety
196809|NCT02130635|COPD subjects|copd subjects
196810|NCT02130622|Diabetic Gastroparesis|diabetic gastroparesis
196811|NCT02130622|Promethazine|promethazine
196812|NCT02130570|Adverse events|adverse events
196813|NCT02130570|Readmissions|readmissions
585918|NCT00522769|adolescent girls|adolescent girls
196814|NCT02130570|Patient Centered Medical Home (PCMH)|patient centered medical home (pcmh)
196815|NCT02130570|Accountable Care Organizations (ACO)|accountable care organizations (aco)
196816|NCT02130570|Medication reconciliation|medication reconciliation
196817|NCT02130570|Discharge Advocate|discharge advocate
196818|NCT02130570|Patient engagement|patient engagement
196819|NCT02130570|Transitions of care|transitions of care
196820|NCT02130570|Transitions coach|transitions coach
196821|NCT02130570|Pharmacist intervention|pharmacist intervention
196822|NCT02130557|Leukemia|leukemia
196823|NCT02130557|Myelogenous|myelogenous
196824|NCT02130557|Chronic|chronic
196825|NCT02130557|BCR-ABL Positive|bcr-abl positive
196826|NCT02130557|Bosutinib|bosutinib
196827|NCT02130557|Leukemia, Myeloid|leukemia, myeloid
196828|NCT02130557|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
196829|NCT02130557|Philadelphia Chromosome|philadelphia chromosome
196830|NCT02130557|Neoplasms by Histologic Type|neoplasms by histologic type
196831|NCT02130557|Bone Marrow Diseases|bone marrow diseases
196832|NCT02130557|Hematologic Diseases|hematologic diseases
196833|NCT02130557|Translocation, Genetic|translocation, genetic
196834|NCT02130557|Pathologic Processes|pathologic processes
196835|NCT02130557|Imatinib|imatinib
196836|NCT02130557|Therapeutic Uses|therapeutic uses
196837|NCT02130557|Pharmacologic Actions|pharmacologic actions
196838|NCT02130557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
196843|NCT02130453|Ischemia|ischemia
196844|NCT02130453|Coronary artery disease|coronary artery disease
196845|NCT02130453|Nuclear stress test|nuclear stress test
196846|NCT02130453|Stress Echocardiogram|stress echocardiogram
196847|NCT02130453|Echocardiography strain measurement|echocardiography strain measurement
196848|NCT02130453|Ultrasound cardiac imaging|ultrasound cardiac imaging
196849|NCT02130453|ReSTE|reste
196850|NCT02130453|SPECT|spect
196851|NCT02130453|Regadenoson|regadenoson
196852|NCT02130440|nasal obstruction|nasal obstruction
196853|NCT02130440|sneezing|sneezing
196854|NCT02130440|itching|itching
196855|NCT02130440|rhinorrhea|rhinorrhea
196856|NCT02130440|respiratory infections|respiratory infections
196857|NCT02130440|wheezing|wheezing
196858|NCT02130427|Adult subjects|adult subjects
196859|NCT02130427|NSCLC|nsclc
196860|NCT02130414|Cyclosporine|cyclosporine
196861|NCT02130414|Healthy Volunteers|healthy volunteers
196862|NCT02130414|Immunosuppressive Agents|immunosuppressive agents
196863|NCT02130414|CyCol|cycol
196864|NCT02130414|Pharmacokinetics|pharmacokinetics
196865|NCT02130401|neuromodulation|neuromodulation
196866|NCT02130401|caloric vestibular stimulation|caloric vestibular stimulation
196867|NCT02130401|Type 2 Diabetes|type 2 diabetes
196868|NCT02130362|Adalimumab|adalimumab
196869|NCT02130362|Crohn's|crohn's
196870|NCT02130362|Crohn's Disease|crohn's disease
196871|NCT02130362|Registry|registry
196872|NCT02130362|Gastrointestinal Diseases|gastrointestinal diseases
196873|NCT02130362|Inflammatory Bowel Diseases|inflammatory bowel diseases
196875|NCT02130349|Crohns Disease|crohns disease
196876|NCT02130349|Ulcerative Colitis|ulcerative colitis
196877|NCT02130349|Cohort|cohort
196878|NCT02130349|Biobank|biobank
196879|NCT02130349|Population based|population based
196880|NCT02130349|IBDSL|ibdsl
196881|NCT02130336|Metabolic syndrome|metabolic syndrome
196882|NCT02130336|Metabolic risk factors|metabolic risk factors
196883|NCT02130336|High-intensity interval training|high-intensity interval training
196884|NCT02130336|Moderate-intensity exercise|moderate-intensity exercise
196885|NCT02130323|Cervical intraepithelial neoplasia, Imiquimod|cervical intraepithelial neoplasia, imiquimod
196886|NCT02130310|Chronic ulcers|chronic ulcers
196887|NCT02130310|Venous ulcers|venous ulcers
196888|NCT02130297|Mohs|mohs
196889|NCT02130297|scar|scar
196890|NCT02130297|post excision|post excision
196891|NCT02130297|CO2 laser|co2 laser
196892|NCT02130297|laser|laser
196893|NCT02130297|skin cancer|skin cancer
196894|NCT02130297|resurfacing|resurfacing
196895|NCT02130271|Sciatica|sciatica
196896|NCT02130271|PET scan|pet scan
196897|NCT02130271|MRI|mri
196898|NCT02130271|Inflammation|inflammation
196899|NCT02130271|Epidural Steroid Injection (ESI)|epidural steroid injection (esi)
196900|NCT02130258|Radicular|radicular
196901|NCT02130258|Pain|pain
196902|NCT02130258|Epidural Steroid Injection|epidural steroid injection
196903|NCT02130245|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
196904|NCT02130245|Acute cholecystitis|acute cholecystitis
196905|NCT02130245|Early|early
196906|NCT02130245|Delayed|delayed
196907|NCT02130232|Gestational weight gain|gestational weight gain
196908|NCT02130232|Lifestyle|lifestyle
196909|NCT02130232|Intervention|intervention
196910|NCT02130219|ICP, intracranial hypertension, Vittamed 205|icp, intracranial hypertension, vittamed 205
196911|NCT02130206|Plaque, Saliva, Cavities|plaque, saliva, cavities
196912|NCT02130193|Efficacy|efficacy
196913|NCT02130193|Danirixin|danirixin
196914|NCT02130193|EXACT-PRO|exact-pro
196915|NCT02130193|COPD|copd
196916|NCT02130193|Safety|safety
196917|NCT02130193|RD|rd
196918|NCT02130193|CXCR2 inhibitor|cxcr2 inhibitor
196919|NCT02130193|EXACT-RS|exact-rs
196920|NCT02130193|PK|pk
196921|NCT02130193|HCRU exacerbations|hcru exacerbations
196922|NCT02130193|PD|pd
196923|NCT02130167|Myopia progression|myopia progression
196924|NCT02130167|Low concentration atropine|low concentration atropine
196925|NCT02130154|Brown adipose Tissue|brown adipose tissue
196926|NCT02130154|Ageing|ageing
196927|NCT02130154|Sympathetic Nervous Stimulation|sympathetic nervous stimulation
196928|NCT02130154|Obesity|obesity
196929|NCT02130141|cocoa|cocoa
196930|NCT02130141|dark chocolate|dark chocolate
196931|NCT02130141|hypertension|hypertension
196932|NCT02130141|blood pressure monitoring, ambulatory|blood pressure monitoring, ambulatory
196933|NCT02130141|flavanols|flavanols
196934|NCT02130102|technology acceptance|technology acceptance
196935|NCT02130102|ambient assisted living|ambient assisted living
196936|NCT02130102|independent living|independent living
196937|NCT02130102|quality of life|quality of life
196938|NCT02130102|socioeconomic impact|socioeconomic impact
196939|NCT02130102|usability of information and communication technologies|usability of information and communication technologies
196940|NCT02130063|IDA|ida
196941|NCT02130063|Iron deficiency|iron deficiency
196942|NCT02130063|iron deficiency anaemia and who are intolerant or unresponsive to oral iron therapy|iron deficiency anaemia and who are intolerant or unresponsive to oral iron therapy
196943|NCT02130050|Obstructive Sleep Apnea|obstructive sleep apnea
196944|NCT02130050|Continuous Positive Airway Pressure|continuous positive airway pressure
196945|NCT02130050|Cardiovascular disease|cardiovascular disease
196946|NCT02130050|Polysomnography|polysomnography
196947|NCT02130050|Metabolomic|metabolomic
187906|NCT02172872|AML|aml
196948|NCT02130037|APPLICATION|application
196949|NCT02130037|SMARTPHONE|smartphone
196950|NCT02130037|BULIMIA|bulimia
196951|NCT02130037|B.E.D|b.e.d
196952|NCT02130037|BINGE EATING DISORDER|binge eating disorder
196953|NCT02130024|Age-related macular degeneration, ranibizumab, aflibercept, geographic atrophy, inject and extend|age-related macular degeneration, ranibizumab, aflibercept, geographic atrophy, inject and extend
196954|NCT02129998|Infertility|infertility
196955|NCT02129998|IVF/ICSI|ivf/icsi
196956|NCT02129998|Progesterone|progesterone
196957|NCT02129998|Preimplantation Factor (PIF)|preimplantation factor (pif)
196958|NCT02129985|the newly onset type 2 diabetes|the newly onset type 2 diabetes
196959|NCT02129985|short-term insulin treatment|short-term insulin treatment
196960|NCT02129985|exenatide sequential therapy|exenatide sequential therapy
196961|NCT02129985|beta cell function|beta cell function
196962|NCT02129985|glycaemic remission|glycaemic remission
196963|NCT02129972|Inflammatory Bowel Disease, colon lesions, colon capsule endoscopy|inflammatory bowel disease, colon lesions, colon capsule endoscopy
196964|NCT02129959|laparoscopic cholecystectomy, laparoscopic gastrectomy, laparoscopic colectomy, laparoscopic appendectomy, laparoscopic|laparoscopic cholecystectomy, laparoscopic gastrectomy, laparoscopic colectomy, laparoscopic appendectomy, laparoscopic
196965|NCT02129959|assisted vaginal hysterectomy, robot-assisted laparoscopic radical prostatectomy|assisted vaginal hysterectomy, robot-assisted laparoscopic radical prostatectomy
196966|NCT02129946|Type 2 Diabetes|type 2 diabetes
196967|NCT02129946|Resistant Starch|resistant starch
196968|NCT02129946|Postprandial Glucose|postprandial glucose
196969|NCT02129946|Postprandial Insulin|postprandial insulin
196970|NCT02129946|Satiety|satiety
196972|NCT02129933|HGD|hgd
196973|NCT02129933|Esophagus|esophagus
196974|NCT02129920|Stroke|stroke
196975|NCT02129920|Cerebral Infarction|cerebral infarction
196976|NCT02129920|Atrial Fibrillation|atrial fibrillation
196977|NCT02129920|Arrhythmias, Cardiac|arrhythmias, cardiac
196978|NCT02129920|Heart Diseases|heart diseases
196979|NCT02129920|Cardiovascular Diseases|cardiovascular diseases
196980|NCT02129920|Cerebrovascular Disorders|cerebrovascular disorders
196981|NCT02129920|Brain Diseases|brain diseases
196982|NCT02129920|Central Nervous System Diseases|central nervous system diseases
196983|NCT02129920|Nervous System Diseases|nervous system diseases
196984|NCT02129920|Vascular Diseases|vascular diseases
196985|NCT02129920|Brain Infarction|brain infarction
196986|NCT02129920|Brain Ischemia|brain ischemia
196987|NCT02129920|Anticoagulants|anticoagulants
196988|NCT02129920|Hematologic Agents|hematologic agents
196989|NCT02129920|Therapeutic Uses|therapeutic uses
196990|NCT02129907|Anemias|anemias
196991|NCT02129907|Iron-Deficiency|iron-deficiency
196992|NCT02129907|thrombin|thrombin
196993|NCT02129894|cesarean section|cesarean section
196994|NCT02129894|postoperative pain|postoperative pain
196995|NCT02129894|pregnancy|pregnancy
196996|NCT02129894|abdominal binder|abdominal binder
196997|NCT02129868|Type 1 diabetes|type 1 diabetes
196998|NCT02129868|Closed-loop glucose control|closed-loop glucose control
196999|NCT02129868|Artificial Pancreas|artificial pancreas
197000|NCT02129868|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
197001|NCT02129868|Continuous glucose monitoring|continuous glucose monitoring
197002|NCT02129842|AFib|afib
197003|NCT02129842|AF|af
197004|NCT02129842|ablation|ablation
197005|NCT02129842|EndoPAT|endopat
586023|NCT00523185|lorazepam|lorazepam
197006|NCT02129842|Endothelial dysfunction|endothelial dysfunction
197008|NCT02129829|Cirrhosis|cirrhosis
197009|NCT02129829|HBV|hbv
197010|NCT02129829|HIV|hiv
197011|NCT02129829|HCV|hcv
197012|NCT02129816|Female|female
197013|NCT02129816|Postmenopause|postmenopause
197014|NCT02129803|Cystic Fibrosis, high flow 20 liters per minute (LPM) humidification therapy|cystic fibrosis, high flow 20 liters per minute (lpm) humidification therapy
197015|NCT02129790|Bipolar Disorder|bipolar disorder
197016|NCT02129790|Suicidal|suicidal
197017|NCT02129790|Depression|depression
197018|NCT02129790|Self-harm|self-harm
197019|NCT02129790|Psychosocial intervention|psychosocial intervention
197020|NCT02129777|Drug therapy|drug therapy
197021|NCT02129751|able to swallow medications without difficulty|able to swallow medications without difficulty
197022|NCT02129751|bupropion hydrobromide|bupropion hydrobromide
197023|NCT02129699|NSCLC|nsclc
197024|NCT02129699|stage IV|stage iv
197025|NCT02129686|Chemotherapy-induced peripheral neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
197026|NCT02129686|Acupuncture|acupuncture
197027|NCT02129686|Early-Stage Breast Carcinoma|early-stage breast carcinoma
197028|NCT02129686|Stage I Breast Cancer|stage i breast cancer
197029|NCT02129686|Stage II Breast Cancer|stage ii breast cancer
197030|NCT02129686|Stage III Breast Cancer|stage iii breast cancer
197031|NCT02129673|Glaucoma|glaucoma
197032|NCT02129673|Intra-ocular pressure|intra-ocular pressure
197033|NCT02129673|Slow Release|slow release
197034|NCT02129673|Controlled release|controlled release
197035|NCT02129647|Neurofibromatosis Type 2|neurofibromatosis type 2
197036|NCT02129647|Vestibular Schwannomas|vestibular schwannomas
197037|NCT02129647|Axitinib|axitinib
197038|NCT02129634|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
197039|NCT02129634|Limb-salvage|limb-salvage
197040|NCT02129634|Randomized Controlled Trial|randomized controlled trial
197041|NCT02129634|Paclitaxel|paclitaxel
197042|NCT02129621|Lipocalin|lipocalin
197043|NCT02129621|mineralocorticoid receptor|mineralocorticoid receptor
197044|NCT02129608|overweight|overweight
197045|NCT02129608|obese|obese
197046|NCT02129608|central adiposity|central adiposity
197047|NCT02129608|Laser|laser
197048|NCT02129608|lorcaserin|lorcaserin
197049|NCT02129608|low level laser therapy|low level laser therapy
197050|NCT02129608|belviq|belviq
197051|NCT02129595|Resveratrol|resveratrol
197052|NCT02129595|Diabetes Mellitus|diabetes mellitus
197053|NCT02129595|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
197054|NCT02129595|Insulin Resistance|insulin resistance
197055|NCT02129595|Glucose Metabolism Disorders|glucose metabolism disorders
197056|NCT02129595|Metabolic Diseases|metabolic diseases
197057|NCT02129595|Endocrine System Diseases|endocrine system diseases
197058|NCT02129595|Hyperinsulinism|hyperinsulinism
197059|NCT02129595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
197060|NCT02129595|Analgesics, Non-Narcotic|analgesics, non-narcotic
197061|NCT02129595|Analgesics|analgesics
197062|NCT02129595|Sensory System Agents|sensory system agents
197063|NCT02129595|Peripheral Nervous System Agents|peripheral nervous system agents
197064|NCT02129595|Physiological Effects of Drugs|physiological effects of drugs
197065|NCT02129595|Pharmacologic Actions|pharmacologic actions
197066|NCT02129595|Anti-Inflammatory Agents|anti-inflammatory agents
197067|NCT02129595|Therapeutic Uses|therapeutic uses
197068|NCT02129595|Antirheumatic Agents|antirheumatic agents
197069|NCT02129595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
197070|NCT02129595|Antineoplastic Agents|antineoplastic agents
197071|NCT02129595|Antioxidants|antioxidants
197072|NCT02129595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
197073|NCT02129595|Protective Agents|protective agents
197074|NCT02129595|Enzyme Inhibitors|enzyme inhibitors
197075|NCT02129595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
197076|NCT02129595|Hematologic Agents|hematologic agents
197077|NCT02129595|Antimutagenic Agents|antimutagenic agents
197078|NCT02129595|Anticarcinogenic Agents|anticarcinogenic agents
197079|NCT02129595|Central Nervous System Agents|central nervous system agents
197080|NCT02129595|Brown Adipose Tissue|brown adipose tissue
197081|NCT02129556|Metastatic|metastatic
197082|NCT02129556|Breast|breast
197083|NCT02129556|trastuzumab-resistant|trastuzumab-resistant
197084|NCT02129556|PD-L1 expressing|pd-l1 expressing
197085|NCT02129556|HER2-positive|her2-positive
197086|NCT02129543|SCT|sct
197087|NCT02129543|Stem Cell Transplantation|stem cell transplantation
197088|NCT02129543|Stem Cell Transplant|stem cell transplant
197089|NCT02129530|Community Mobilization|community mobilization
197090|NCT02129530|HIV|hiv
197091|NCT02129530|Intimate Partner Violence|intimate partner violence
197092|NCT02129530|Gender Norms|gender norms
197093|NCT02129504|root coverage|root coverage
197094|NCT02129504|gingival recession|gingival recession
197095|NCT02129504|periodontal surgery|periodontal surgery
197096|NCT02129491|stroke|stroke
197097|NCT02129491|Congenital stroke|congenital stroke
197098|NCT02129491|neonatal|neonatal
197099|NCT02129491|hemiplegia|hemiplegia
197100|NCT02129478|olanzapine|olanzapine
197101|NCT02129478|pediatrics|pediatrics
197102|NCT02129478|chemotherapy-induced nausea|chemotherapy-induced nausea
197103|NCT02129478|chemotherapy-induced vomiting|chemotherapy-induced vomiting
197104|NCT02129465|Cytomegalovirus|cytomegalovirus
197105|NCT02129465|CMV|cmv
197106|NCT02129465|pregnancy|pregnancy
197107|NCT02129465|transmission|transmission
197108|NCT02129452|Alzheimer disease|alzheimer disease
197109|NCT02129452|Dementia|dementia
197110|NCT02129452|Neurodegenerative Diseases|neurodegenerative diseases
197111|NCT02129452|Tauopathies|tauopathies
197112|NCT02129452|Amyloid beta Peptides|amyloid beta peptides
197113|NCT02129452|Amyloid Plaque|amyloid plaque
197114|NCT02129452|MicroRNAs|micrornas
197115|NCT02129452|Early Diagnosis|early diagnosis
197116|NCT02129439|Antisense oligonucleotide|antisense oligonucleotide
197117|NCT02129439|Colitis Ulcerosa|colitis ulcerosa
197118|NCT02129439|Ulcerative colitis|ulcerative colitis
197119|NCT02129439|Phase II|phase ii
197120|NCT02129439|Transcription factor GATA-3|transcription factor gata-3
197121|NCT02129439|intrarectal application|intrarectal application
197122|NCT02129439|proof-of-concept|proof-of-concept
197123|NCT02129426|Sedation|sedation
197124|NCT02129426|MRI|mri
197125|NCT02129413|Aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
197126|NCT02129413|Subarachnoid hemorrhage|subarachnoid hemorrhage
197127|NCT02129413|Cerebral vasospasm|cerebral vasospasm
197128|NCT02129413|Ruptured aneurysm|ruptured aneurysm
197129|NCT02129413|Delayed Cerebral Ischemia|delayed cerebral ischemia
197130|NCT02129413|Delayed Ischemic Deficit|delayed ischemic deficit
197131|NCT02129413|Delayed ischemic neurological deficit|delayed ischemic neurological deficit
197433|NCT02128087|Uganda|uganda
197132|NCT02129413|Neurostimulation|neurostimulation
197133|NCT02129413|Carotid body|carotid body
197134|NCT02129400|Xenon-inhalation|xenon-inhalation
197135|NCT02129400|Erythropoetin|erythropoetin
197136|NCT02129400|Pharmakokinetic|pharmakokinetic
197137|NCT02129400|Pharmacodynamic|pharmacodynamic
197138|NCT02129400|Hemodynamic parameters|hemodynamic parameters
197139|NCT02129400|Inflammatory parameters|inflammatory parameters
197140|NCT02129400|Growth factors|growth factors
197141|NCT02129400|Oxidative stress parameters|oxidative stress parameters
197142|NCT02129387|Nicotine|nicotine
197143|NCT02129387|Smoking Progression|smoking progression
197144|NCT02129387|EEG|eeg
197145|NCT02129387|Young adults|young adults
197146|NCT02129387|Light smokers|light smokers
197147|NCT02129387|rs1051730 genotype|rs1051730 genotype
197148|NCT02129374|Spondylolysis|spondylolysis
197149|NCT02129374|Lumbar spine|lumbar spine
197150|NCT02129374|Young population|young population
197151|NCT02129374|Direct repair|direct repair
197152|NCT02129374|Union rate|union rate
197153|NCT02129374|Functional outcome|functional outcome
197154|NCT02129361|traumatic brain injury|traumatic brain injury
197155|NCT02129348|Alzheimer's disease|alzheimer's disease
197156|NCT02129348|psychosis|psychosis
197157|NCT02129348|agitation|agitation
197158|NCT02129348|aggression|aggression
197159|NCT02129348|Lithium|lithium
197160|NCT02129348|delusions|delusions
197161|NCT02129348|hallucinations|hallucinations
197162|NCT02129335|glioblastoma|glioblastoma
197163|NCT02129335|partner|partner
197164|NCT02129335|stress|stress
197165|NCT02129335|exercise|exercise
197166|NCT02129335|outcome|outcome
197167|NCT02129309|COPD|copd
197168|NCT02129309|Apelin|apelin
197169|NCT02129309|agonist|agonist
197170|NCT02129309|antagonist|antagonist
197171|NCT02129296|Morbid obesity|morbid obesity
197172|NCT02129296|Gastric balloon|gastric balloon
197173|NCT02129296|Weight loss|weight loss
197174|NCT02129296|Tolerance|tolerance
197175|NCT02129296|Safety|safety
197176|NCT02129283|physicians, nurses, ICU, end-of-life, simulation training|physicians, nurses, icu, end-of-life, simulation training
197177|NCT02129270|Fractures of the distal radius|fractures of the distal radius
197178|NCT02129270|Hematoma block|hematoma block
197179|NCT02129270|Lidocaine|lidocaine
197180|NCT02129244|MDR-TB|mdr-tb
197181|NCT02129244|HIV|hiv
197182|NCT02129244|Nurse Case Management (NCM)|nurse case management (ncm)
197183|NCT02129231|ezetimibe/simvastatin|ezetimibe/simvastatin
197184|NCT02129231|rosuvastatin|rosuvastatin
197185|NCT02129231|diabetic polyneuropathy|diabetic polyneuropathy
197186|NCT02129231|oxidative stress|oxidative stress
197187|NCT02129231|mitochondrial dysfunction|mitochondrial dysfunction
197188|NCT02129205|solid tumors|solid tumors
197189|NCT02129205|triple negative breast cancer|triple negative breast cancer
197190|NCT02129205|PF-06650808|pf-06650808
197191|NCT02129205|Phase 1|phase 1
197192|NCT02129153|Randomized controlled trial|randomized controlled trial
197193|NCT02129153|Population, School Age|population, school age
197194|NCT02129140|hernia repair|hernia repair
197195|NCT02129140|ventral incisional hernia|ventral incisional hernia
197196|NCT02129140|biologic mesh|biologic mesh
197197|NCT02129140|hernia graft|hernia graft
197198|NCT02129088|Healthy|healthy
197199|NCT02129088|Esketamine|esketamine
197200|NCT02129088|Phase 1|phase 1
197201|NCT02129088|Placebo|placebo
197202|NCT02129088|Elderly|elderly
197203|NCT02129088|Adult|adult
197204|NCT02129036|Ovarian cancer|ovarian cancer
197205|NCT02129036|Clear cell carcinoma|clear cell carcinoma
197206|NCT02129036|Paclitaxel-platinum|paclitaxel-platinum
197207|NCT02129036|Chemotherapy|chemotherapy
197208|NCT02129036|response to chemotherapy|response to chemotherapy
197209|NCT02129036|survival of clear cell ovarian carcinoma|survival of clear cell ovarian carcinoma
197210|NCT02129036|Prognostic factors|prognostic factors
197211|NCT02129023|Exergame|exergame
197212|NCT02129023|user health|user health
197213|NCT02129023|exercise|exercise
197214|NCT02129010|subarachnoid hemorrhage|subarachnoid hemorrhage
197215|NCT02129010|terson syndrome|terson syndrome
197216|NCT02129010|CSF-proteines|csf-proteines
197217|NCT02129010|phospho-tau|phospho-tau
197218|NCT02129010|beta-amyloid|beta-amyloid
197219|NCT02128997|obesity, cesarean section, wound complication|obesity, cesarean section, wound complication
197220|NCT02128984|Malnutrition|malnutrition
197221|NCT02128984|Dietary supplement|dietary supplement
197222|NCT02128984|Nutritional supplement|nutritional supplement
197223|NCT02128984|Symbiotic formula|symbiotic formula
197224|NCT02128984|DHA|dha
197225|NCT02128984|Cystic Fibrosis|cystic fibrosis
197226|NCT02128984|Failure to Thrive|failure to thrive
197227|NCT02128971|Iron supplement study|iron supplement study
197228|NCT02128958|Hepatocellular Carcinoma|hepatocellular carcinoma
197229|NCT02128958|Child-Pugh Class B Cirrhosis|child-pugh class b cirrhosis
197230|NCT02128945|PET|pet
197231|NCT02128945|Chronic lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
197232|NCT02128945|Diffuse Large B Cells Lymphoma (DLBCL)|diffuse large b cells lymphoma (dlbcl)
197233|NCT02128945|Fludarabine|fludarabine
197434|NCT02128087|Adherence|adherence
197234|NCT02128919|Schizophrenia|schizophrenia
197235|NCT02128919|Cigarette smoking|cigarette smoking
197236|NCT02128919|Cognition|cognition
197237|NCT02128919|Craving|craving
197238|NCT02128919|MATRICS|matrics
197239|NCT02128906|ERCC1|ercc1
197240|NCT02128906|squamous cell carcinoma|squamous cell carcinoma
197241|NCT02128906|oropharynx|oropharynx
197242|NCT02128906|larynx|larynx
197243|NCT02128906|hypopharynx|hypopharynx
197244|NCT02128906|p16|p16
197245|NCT02128906|radiotherapy|radiotherapy
197246|NCT02128906|docetaxel|docetaxel
197247|NCT02128906|cetuximab|cetuximab
197248|NCT02128906|cisplatin|cisplatin
197249|NCT02128906|EGFR|egfr
197250|NCT02128906|Biomarker|biomarker
197251|NCT02128906|efficacy|efficacy
197252|NCT02128906|head and neck|head and neck
197253|NCT02128906|tongue|tongue
197254|NCT02128906|throat|throat
197255|NCT02128893|Isavuconazole|isavuconazole
197256|NCT02128893|Esomeprazole|esomeprazole
197257|NCT02128893|BAL4815|bal4815
197258|NCT02128893|BAL8728|bal8728
197259|NCT02128893|Healthy Subjects|healthy subjects
197260|NCT02128880|AEP, drinking, contraception, FASD, Internet interventions|aep, drinking, contraception, fasd, internet interventions
197261|NCT02128867|gastro-esophageal reflux|gastro-esophageal reflux
197263|NCT02128867|GER|ger
197264|NCT02128867|airway clearance techniques|airway clearance techniques
197265|NCT02128854|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
201005|NCT02112656|Therapeutic Uses|therapeutic uses
197266|NCT02128854|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
197267|NCT02128854|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
197268|NCT02128854|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
197269|NCT02128854|Diabetes Mellitus, Type II|diabetes mellitus, type ii
197270|NCT02128854|African Americans|african americans
197271|NCT02128854|Blacks|blacks
197272|NCT02128854|Non-Hispanic Blacks|non-hispanic blacks
197273|NCT02128854|Randomized Control Trial|randomized control trial
197274|NCT02128854|Controlled Clinical Trial|controlled clinical trial
197275|NCT02128854|Behavioral Research|behavioral research
197276|NCT02128854|Behavioral Medicine|behavioral medicine
197277|NCT02128841|rivaroxaban|rivaroxaban
197278|NCT02128841|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
197279|NCT02128841|anticoagulants|anticoagulants
197280|NCT02128841|Factor Xa/antagonists & inhibitors|factor xa/antagonists & inhibitors
197281|NCT02128828|AIDS Dementia Complex|aids dementia complex
197282|NCT02128828|HIV-1-Associated Cognitive Motor Complex|hiv-1-associated cognitive motor complex
197283|NCT02128828|Human Immunodeficiency Virus|human immunodeficiency virus
197284|NCT02128815|adults|adults
197285|NCT02128815|coaching|coaching
197286|NCT02128815|type 2 diabetes|type 2 diabetes
197287|NCT02128802|Obesity|obesity
197288|NCT02128802|Renal failure|renal failure
197289|NCT02128802|Gastric bypass|gastric bypass
197290|NCT02128789|Older Adults|older adults
197291|NCT02128789|Caregivers|caregivers
197292|NCT02128789|Aging|aging
197293|NCT02128789|Support|support
197294|NCT02128776|Children|children
197295|NCT02128776|Chronic illnesses|chronic illnesses
197296|NCT02128724|Lung cancer|lung cancer
197297|NCT02128724|BKM120|bkm120
197298|NCT02128724|Hypoxia|hypoxia
197299|NCT02128724|Misonidazole|misonidazole
197300|NCT02128724|Radiotherapy|radiotherapy
197301|NCT02128711|lung|lung
197302|NCT02128711|cystic fibrosis|cystic fibrosis
197303|NCT02128711|bacteria|bacteria
197304|NCT02128711|positive diagnosis of CF,|positive diagnosis of cf,
197305|NCT02128698|Bariatric surgery|bariatric surgery
197306|NCT02128698|Protein supplementation|protein supplementation
197307|NCT02128698|Physical activity|physical activity
197308|NCT02128698|Muscle mass|muscle mass
197309|NCT02128698|Weight loss|weight loss
197310|NCT02128698|Physical fitness|physical fitness
197311|NCT02128698|Muscle strength|muscle strength
197312|NCT02128685|Threatened miscarriage|threatened miscarriage
197313|NCT02128685|Dydrogesterone|dydrogesterone
197314|NCT02128685|Randomized controlled trial|randomized controlled trial
197315|NCT02128646|Pain Management|pain management
197316|NCT02128646|Exparel|exparel
197317|NCT02128646|Abdominal Hernia Repair|abdominal hernia repair
197318|NCT02128646|Laparoscopic Surgery|laparoscopic surgery
197319|NCT02128633|Dentin hypersensitivity|dentin hypersensitivity
197320|NCT02128633|Dentin Sensitivities|dentin sensitivities
197321|NCT02128620|Sexually transmitted diseases|sexually transmitted diseases
197322|NCT02128620|Internet|internet
197323|NCT02128620|Education|education
197324|NCT02128620|Appointments and Schedules|appointments and schedules
197325|NCT02128607|low back pain|low back pain
197326|NCT02128607|manual therapy|manual therapy
197327|NCT02128607|Mulligan|mulligan
197328|NCT02128607|sustained natural apophyseal glide (SNAG)|sustained natural apophyseal glide (snag)
197329|NCT02128607|Kinematic spine model|kinematic spine model
197330|NCT02128568|Depression/therapy;|depression/therapy;
197331|NCT02128568|Developing Countries;|developing countries;
197332|NCT02128568|Interpersonal Relations;|interpersonal relations;
197333|NCT02128568|Life Change Events;|life change events;
198024|NCT02125318|anagrelide|anagrelide
197334|NCT02128568|Psychotherapy, Group;|psychotherapy, group;
197335|NCT02128568|Resilience, Psychological;|resilience, psychological;
197336|NCT02128568|Sierra Leone;|sierra leone;
197337|NCT02128568|Survivors/psychology;|survivors/psychology;
197338|NCT02128568|Social Adjustment;|social adjustment;
197339|NCT02128568|Social Behavior;|social behavior;
197340|NCT02128568|War|war
197341|NCT02128555|ankle arthritis|ankle arthritis
197342|NCT02128555|osteoarthritis|osteoarthritis
197343|NCT02128555|total ankle replacement|total ankle replacement
197344|NCT02128555|arthrodesis|arthrodesis
197345|NCT02128555|quality of life|quality of life
197346|NCT02128555|musculoskeletal|musculoskeletal
197347|NCT02128542|Veterans HCV|veterans hcv
197348|NCT02128529|COPD|copd
197349|NCT02128490|Drug therapy|drug therapy
197350|NCT02128477|Myocardial infarction|myocardial infarction
197351|NCT02128477|Repolarization instability|repolarization instability
197352|NCT02128477|Ventricular fibrillation|ventricular fibrillation
197353|NCT02128464|Knee Osteoarthritis|knee osteoarthritis
197354|NCT02128464|Total Knee Arthroplasty|total knee arthroplasty
197355|NCT02128464|Customized Cutting Block|customized cutting block
197356|NCT02128464|Conventional Intramedullary Cutting Guide|conventional intramedullary cutting guide
197357|NCT02128451|meperdine ,fentanyl, clonidine, orthopedic surgery .|meperdine ,fentanyl, clonidine, orthopedic surgery .
197358|NCT02128425|Colorectal cancer|colorectal cancer
197359|NCT02128425|Metastatic colorectal cancer|metastatic colorectal cancer
197360|NCT02128425|FOLFOXIRI|folfoxiri
197361|NCT02128425|FOLFOX|folfox
197362|NCT02128425|Oxaliplatin|oxaliplatin
197363|NCT02128425|irinotecan|irinotecan
197364|NCT02128425|Leucovorin|leucovorin
197366|NCT02128412|Patients scheduled to undergo coronary angioplasty and stenting because of symptoms related to a single de novo coronary artery stenoses|patients scheduled to undergo coronary angioplasty and stenting because of symptoms related to a single de novo coronary artery stenoses
197367|NCT02128399|antimicrobial stewardship|antimicrobial stewardship
197368|NCT02128360|Low ovarian reserve|low ovarian reserve
197369|NCT02128360|Poor responder|poor responder
197370|NCT02128360|Infertility|infertility
197371|NCT02128347|Hemodialysis, Home|hemodialysis, home
197372|NCT02128347|Peritoneal Dialysis|peritoneal dialysis
197373|NCT02128347|Telemedicine|telemedicine
197374|NCT02128334|Uro-Oncologists|uro-oncologists
197375|NCT02128334|PSA|psa
197376|NCT02128334|Eligard|eligard
197377|NCT02128334|prostate carcinoma|prostate carcinoma
197378|NCT02128321|Isavuconazole|isavuconazole
197379|NCT02128321|Repaglinide|repaglinide
197380|NCT02128321|Caffeine|caffeine
197381|NCT02128321|BAL4815|bal4815
197382|NCT02128321|BAL8728|bal8728
197383|NCT02128321|Healthy Subjects|healthy subjects
197384|NCT02128308|Antituberculosis agents|antituberculosis agents
197385|NCT02128308|Pharmacokinetics|pharmacokinetics
197386|NCT02128295|Breast pumps, breast milk, expression, term infants|breast pumps, breast milk, expression, term infants
197387|NCT02128282|Cholangiocarcinoma|cholangiocarcinoma
197388|NCT02128282|Bile duct cancer|bile duct cancer
197389|NCT02128282|Biliary tract cancer|biliary tract cancer
197390|NCT02128269|Antiphospholipid (aPL)-positive|antiphospholipid (apl)-positive
197391|NCT02128269|Antiphospholid syndrome (APS)|antiphospholid syndrome (aps)
197392|NCT02128256|Osteomyelitis|osteomyelitis
197393|NCT02128256|Bone substitute|bone substitute
197395|NCT02128256|Gentamicin|gentamicin
197396|NCT02128230|High risk|high risk
197397|NCT02128230|Carfilzomib|carfilzomib
197398|NCT02128191|Patent ductus arteriosus|patent ductus arteriosus
197399|NCT02128191|Ibuprofen|ibuprofen
197400|NCT02128191|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
197401|NCT02128178|Morbid obesity|morbid obesity
197402|NCT02128178|Laparoscopic surgery|laparoscopic surgery
197403|NCT02128178|Compression ultrasonography|compression ultrasonography
197404|NCT02128178|Pulmonary embolism|pulmonary embolism
197405|NCT02128178|Bleeding|bleeding
197406|NCT02128165|gastric balloon|gastric balloon
197407|NCT02128165|morbid obesity|morbid obesity
197408|NCT02128152|stroke|stroke
197409|NCT02128152|exoskeleton|exoskeleton
197410|NCT02128152|Ekso|ekso
197411|NCT02128152|ambulation|ambulation
197412|NCT02128152|robotics|robotics
197413|NCT02128139|Infective endocarditis|infective endocarditis
197414|NCT02128139|Developing country|developing country
197415|NCT02128139|Global health|global health
197416|NCT02128139|Cardiac surgery|cardiac surgery
197417|NCT02128139|Heart valve disease|heart valve disease
197418|NCT02128139|Bacteremia|bacteremia
197419|NCT02128126|Advanced or recurrent cervical cancer|advanced or recurrent cervical cancer
197420|NCT02128126|HPV16 positive|hpv16 positive
197421|NCT02128126|No curative treatment options|no curative treatment options
197422|NCT02128113|RTA 408|rta 408
197423|NCT02128113|Cataract surgery|cataract surgery
197424|NCT02128113|Corneal Endothelial Cells|corneal endothelial cells
197425|NCT02128113|omaveloxolone|omaveloxolone
197426|NCT02128100|Pancreatic Cancer|pancreatic cancer
197428|NCT02128087|Antiretroviral (ARV)|antiretroviral (arv)
197429|NCT02128087|co-trimoxazole|co-trimoxazole
197430|NCT02128087|SMS|sms
197431|NCT02128087|mobile Health (mHealth)|mobile health (mhealth)
197432|NCT02128087|Adolescents|adolescents
197435|NCT02128035|radiation protection|radiation protection
197436|NCT02128035|interventional cardiologist|interventional cardiologist
197437|NCT02128035|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
197438|NCT02128035|angiography|angiography
197439|NCT02128035|lead shield|lead shield
197440|NCT02128022|Glucagon-Like Peptide 1|glucagon-like peptide 1
197441|NCT02128022|Angina Pectoris|angina pectoris
197442|NCT02128022|Percutaneous Coronary Intervention|percutaneous coronary intervention
197443|NCT02128022|Ischemic Preconditioning|ischemic preconditioning
197444|NCT02128022|Myocardial Reperfusion Injury|myocardial reperfusion injury
197445|NCT02127996|Angina Pectoris|angina pectoris
197446|NCT02127996|Percutaneous Coronary Intervention|percutaneous coronary intervention
197447|NCT02127996|Myocardial Infarction|myocardial infarction
197448|NCT02127996|Glucagon-Like Peptide 1|glucagon-like peptide 1
197449|NCT02127996|Reperfusion Injury|reperfusion injury
197450|NCT02127983|TB, HIV, case finding, access, informal providers|tb, hiv, case finding, access, informal providers
197451|NCT02127957|cystic fibrosis|cystic fibrosis
197452|NCT02127957|exercise|exercise
197453|NCT02127957|Cystic fibrosis related diabetes|cystic fibrosis related diabetes
197454|NCT02127918|Electrical status epilepticus in sleep|electrical status epilepticus in sleep
197455|NCT02127918|Continuous spikes and waves during sleep|continuous spikes and waves during sleep
197456|NCT02127918|Children|children
197457|NCT02127918|Electroencephalogram|electroencephalogram
197458|NCT02127918|Neuropsychology|neuropsychology
197459|NCT02127918|Development|development
197460|NCT02127918|Antiepileptic drugs|antiepileptic drugs
197461|NCT02127918|Clobazam|clobazam
197462|NCT02127918|Seizures|seizures
197463|NCT02127905|Fanconi Anemia|fanconi anemia
197464|NCT02127905|compassionate treatment|compassionate treatment
197466|NCT02127905|HSCT|hsct
197467|NCT02127905|unrelated|unrelated
197468|NCT02127905|bone marrow transplantation|bone marrow transplantation
197469|NCT02127905|PBSC|pbsc
197470|NCT02127905|peripheral blood|peripheral blood
197471|NCT02127905|CD34+|cd34+
197472|NCT02127892|Severe Combined Immune Deficiency|severe combined immune deficiency
197473|NCT02127892|SCID|scid
197474|NCT02127892|HLA-matched unrelated donor|hla-matched unrelated donor
197475|NCT02127892|unrelated|unrelated
197476|NCT02127892|MUD|mud
197477|NCT02127892|bone marrow|bone marrow
197478|NCT02127892|cord blood|cord blood
197479|NCT02127892|haplo-identical|haplo-identical
197480|NCT02127892|peripheral blood|peripheral blood
197481|NCT02127892|CD34+ selection|cd34+ selection
197482|NCT02127892|T cell depletion|t cell depletion
197483|NCT02127892|HSCT|hsct
197484|NCT02127892|BMT|bmt
197485|NCT02127892|CliniMACS|clinimacs
197486|NCT02127879|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
197487|NCT02127879|Schizophrenia|schizophrenia
197488|NCT02127879|Negative symptoms|negative symptoms
197489|NCT02127879|Intensive|intensive
586024|NCT00523185|diazepam|diazepam
197490|NCT02127879|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
197491|NCT02127866|Asthma, anticholinergics|asthma, anticholinergics
197492|NCT02127853|serial cataract surgery|serial cataract surgery
197493|NCT02127853|hyperalgesia|hyperalgesia
197494|NCT02127853|gabapentin|gabapentin
197495|NCT02127853|central sensitization|central sensitization
197496|NCT02127840|primary aldosteronism|primary aldosteronism
197497|NCT02127840|adrenal adenoma|adrenal adenoma
197498|NCT02127840|arterial hypertension|arterial hypertension
197499|NCT02127814|induced diarrhea|induced diarrhea
197500|NCT02127814|Clostridium difficile toxicity|clostridium difficile toxicity
197501|NCT02127788|Haematology|haematology
197502|NCT02127788|Micafungin|micafungin
197503|NCT02127788|Observational study|observational study
197504|NCT02127788|Prophylaxis|prophylaxis
197505|NCT02127788|Invasive Fungal Infection|invasive fungal infection
197506|NCT02127788|France|france
197507|NCT02127762|Pain|pain
197508|NCT02127762|Quality of Life|quality of life
197509|NCT02127762|Glycemic Control|glycemic control
197510|NCT02127762|diabetic neuropathy|diabetic neuropathy
197511|NCT02127762|mindfulness|mindfulness
197512|NCT02127762|stress reduction|stress reduction
197513|NCT02127762|adult|adult
197514|NCT02127762|chronic pain|chronic pain
197515|NCT02127762|depression|depression
197516|NCT02127762|cortisol|cortisol
197517|NCT02127749|antibiotics|antibiotics
197518|NCT02127749|gut microbiota|gut microbiota
197519|NCT02127749|endotoxemia|endotoxemia
197520|NCT02127749|innate immunity|innate immunity
197521|NCT02127723|cellulite|cellulite
197522|NCT02127710|AZD6094|azd6094
197523|NCT02127710|Savolitinib|savolitinib
197524|NCT02127710|Papillary Renal Cell Cancer|papillary renal cell cancer
402947|NCT01228929|Non-invasive instruments|non-invasive instruments
197525|NCT02127697|Asthma, poorly controlled asthma, LAMA, Long-Acting Muscarinic Antagonist, Glycopyrronium, Glycopyrronium bromide, Anticholinergic|asthma, poorly controlled asthma, lama, long-acting muscarinic antagonist, glycopyrronium, glycopyrronium bromide, anticholinergic
197526|NCT02127684|diabetic macular edema|diabetic macular edema
197527|NCT02127645|RADIOTHERAPY|radiotherapy
197528|NCT02127645|TRANSANAL ENDOSCOPIC MICROSURGERY|transanal endoscopic microsurgery
197529|NCT02127645|LOCAL EXCISION|local excision
197530|NCT02127632|laryngeal mask Supreme|laryngeal mask supreme
197531|NCT02127632|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
197532|NCT02127632|Laryngeal mask during surgery|laryngeal mask during surgery
197533|NCT02127619|knee prosthesis|knee prosthesis
197534|NCT02127619|total knee replacement|total knee replacement
197535|NCT02127619|total knee arthroplasty|total knee arthroplasty
197536|NCT02127619|prospective study|prospective study
197537|NCT02127619|Therapeutic level IV|therapeutic level iv
197538|NCT02127593|Norgestimate|norgestimate
197539|NCT02127593|Ethinyl estradiol|ethinyl estradiol
197540|NCT02127593|Norgestrel|norgestrel
197541|NCT02127593|Norelgestromin|norelgestromin
197542|NCT02127593|Ortho cyclen|ortho cyclen
197543|NCT02127593|Phase 1|phase 1
197544|NCT02127593|Healthy Women|healthy women
197545|NCT02127580|THV|thv
197546|NCT02127580|BAV|bav
197547|NCT02127580|pre-dilation|pre-dilation
197548|NCT02127580|Aortic valve stenosis|aortic valve stenosis
197549|NCT02127567|medical writing, reporting, randomized controlled trial|medical writing, reporting, randomized controlled trial
197550|NCT02127541|Localisation of Insulinoma|localisation of insulinoma
197551|NCT02127541|beta-cell imaging|beta-cell imaging
197552|NCT02127541|exendin-4|exendin-4
197553|NCT02127541|68Ga-DOTA-exendin-4 PET/CT|68ga-dota-exendin-4 pet/ct
197554|NCT02127541|111In-DOTA-exendin-4 SPECT/CT|111in-dota-exendin-4 spect/ct
197555|NCT02127515|Down, trisomy 21|down, trisomy 21
197556|NCT02127515|NIPT|nipt
197557|NCT02127515|Amniocentesis|amniocentesis
197558|NCT02127515|miscarriage|miscarriage
197559|NCT02127515|invasive|invasive
197560|NCT02127515|prenatal|prenatal
197561|NCT02127515|screening.|screening.
197562|NCT02127489|Bupivacaine, caudal, rectal midazolam, children|bupivacaine, caudal, rectal midazolam, children
197564|NCT02127463|Dry AMD|dry amd
197565|NCT02127463|Non-Exudative AMD|non-exudative amd
197566|NCT02127463|MC-1101|mc-1101
197567|NCT02127450|Enterobacteriaceae|enterobacteriaceae
197568|NCT02127450|non-susceptible to carbapenem|non-susceptible to carbapenem
197569|NCT02127450|carbapenemases|carbapenemases
197570|NCT02127450|prevalence|prevalence
197571|NCT02127450|screening algorithm|screening algorithm
197572|NCT02127437|Autosomal dominant polycystic kidney disease,|autosomal dominant polycystic kidney disease,
197573|NCT02127437|Glomerular filtration rate,|glomerular filtration rate,
197574|NCT02127437|Somatostatin,|somatostatin,
197575|NCT02127437|lanreotide|lanreotide
197576|NCT02127424|Nurse|nurse
197577|NCT02127424|Nursing|nursing
197578|NCT02127424|Screening|screening
197579|NCT02127424|HIV|hiv
197580|NCT02127424|Emergency Service Hospital|emergency service hospital
197581|NCT02127411|Mindfulness|mindfulness
197582|NCT02127411|Benzodiazepines|benzodiazepines
197583|NCT02127411|Sleep|sleep
197584|NCT02127411|Dependence|dependence
197585|NCT02127411|Relapse Prevention|relapse prevention
197586|NCT02127398|C. difficile colitis|c. difficile colitis
197587|NCT02127398|fecal microbiota transplantation|fecal microbiota transplantation
197588|NCT02127372|non-small cell|non-small cell
197589|NCT02127372|lung cancer|lung cancer
197590|NCT02127359|Metastatic|metastatic
197591|NCT02127346|Chronic Periodontitis|chronic periodontitis
197592|NCT02127346|Vitamin D concentration|vitamin d concentration
197593|NCT02127346|Calcium concentration|calcium concentration
197594|NCT02127333|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
197595|NCT02127333|Coronary artery disease|coronary artery disease
197596|NCT02127333|Endothelial function|endothelial function
197597|NCT02127307|Myocardial sympathetic innervation|myocardial sympathetic innervation
197598|NCT02127307|Heart failure (HF)|heart failure (hf)
197599|NCT02127307|Nuclear imaging|nuclear imaging
197600|NCT02127307|Radiopharmaceutical|radiopharmaceutical
197601|NCT02127294|Foramen Ovale, Patent|foramen ovale, patent
197602|NCT02127294|migraine|migraine
197603|NCT02127294|transcatheter patent foramen ovale closure|transcatheter patent foramen ovale closure
197604|NCT02127294|contrast-enhanced transcranial Doppler|contrast-enhanced transcranial doppler
197605|NCT02127294|Transthoracic Echocardiography|transthoracic echocardiography
197606|NCT02127281|Revision total knee arthroplasty|revision total knee arthroplasty
197607|NCT02127281|Revision total hip arthroplasty|revision total hip arthroplasty
197608|NCT02127281|Negative pressure wound therapy system (NPWT)|negative pressure wound therapy system (npwt)
197609|NCT02127281|Drainage|drainage
197610|NCT02127255|chemotherapy|chemotherapy
197611|NCT02127255|nausea|nausea
197612|NCT02127255|vomiting|vomiting
197613|NCT02127255|cancer|cancer
197614|NCT02127242|hepatolithiasis|hepatolithiasis
197615|NCT02127242|ureteroscope|ureteroscope
197616|NCT02127242|air-pressure ballistic lithotripsy|air-pressure ballistic lithotripsy
197617|NCT02127242|hepatectomy|hepatectomy
197618|NCT02127229|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
197619|NCT02127229|disposable accessory cost|disposable accessory cost
197620|NCT02127229|endoscopy cost analysis|endoscopy cost analysis
197621|NCT02127216|Mobile Health|mobile health
197622|NCT02127216|Diabetes|diabetes
197623|NCT02127216|Self-Care of Diabetes|self-care of diabetes
197624|NCT02127203|oxidative stress|oxidative stress
197625|NCT02127203|periodontal disease|periodontal disease
197626|NCT02127203|nitric oxide|nitric oxide
197627|NCT02127190|nitro-fatty acids|nitro-fatty acids
197628|NCT02127190|anti-inflammatory|anti-inflammatory
197629|NCT02127190|Nrf2 activation|nrf2 activation
197630|NCT02127190|contrast induced AKI|contrast induced aki
197631|NCT02127177|obstructive sleep apnea|obstructive sleep apnea
197632|NCT02127177|coronary heart disease|coronary heart disease
197633|NCT02127177|continuous positive airway pressure|continuous positive airway pressure
197634|NCT02127177|lipid profiles|lipid profiles
197635|NCT02127177|high-sensitivity C-reactive protein|high-sensitivity c-reactive protein
197636|NCT02127138|unprotected distal left main bifurcation lesion|unprotected distal left main bifurcation lesion
197637|NCT02127138|Percutaneous coronary intervention|percutaneous coronary intervention
197638|NCT02127138|clinical study|clinical study
197735|NCT02126618|diuresis|diuresis
197639|NCT02127138|Active Transfer of Plaque （ATP）|active transfer of plaque （atp）
197640|NCT02127138|Provisional T Stenting|provisional t stenting
197641|NCT02127112|Ridge Augmentation|ridge augmentation
197642|NCT02127112|Bone regeneration|bone regeneration
197643|NCT02127112|Guided Bone Regeneration|guided bone regeneration
197644|NCT02127112|Partially Edentulous|partially edentulous
197646|NCT02127099|obstructive|obstructive
197647|NCT02127099|sleep|sleep
197648|NCT02127099|apnea|apnea
197649|NCT02127099|operation|operation
197650|NCT02127086|Acute pain severity|acute pain severity
197651|NCT02127086|Non-communicative patients|non-communicative patients
197652|NCT02127086|PAIN algorithm|pain algorithm
197653|NCT02127086|Multi-dimensional Pain Assessment Tool (MOPAT)|multi-dimensional pain assessment tool (mopat)
197654|NCT02127073|Breast cancer|breast cancer
197655|NCT02127073|Ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
197656|NCT02127073|Oxytocin|oxytocin
197657|NCT02127060|vitamin C|vitamin c
197658|NCT02127060|effectiveness|effectiveness
197659|NCT02127060|pain management|pain management
197660|NCT02127060|posterior lumbar interbody fusion|posterior lumbar interbody fusion
197661|NCT02127034|Healthy subjects|healthy subjects
197662|NCT02127034|Mirabegron|mirabegron
197663|NCT02127034|Solifenacin|solifenacin
197664|NCT02127034|Digoxin|digoxin
197665|NCT02127021|Pancreaticoduodenectomy|pancreaticoduodenectomy
197666|NCT02127021|Nutritional Status|nutritional status
197667|NCT02127021|Quality of Life|quality of life
197668|NCT02127021|Biochemical Marker|biochemical marker
197669|NCT02127008|epidural fat|epidural fat
197670|NCT02127008|resection|resection
197671|NCT02127008|spinal stenosis|spinal stenosis
197672|NCT02127008|lumbar spine|lumbar spine
197673|NCT02126995|Fragile X Syndrome, Fra(X) Syndrome, FRAXA Syndrome|fragile x syndrome, fra(x) syndrome, fraxa syndrome
197674|NCT02126982|clopidogrel besylate|clopidogrel besylate
586025|NCT00523198|Cortisol|cortisol
197682|NCT02126943|pulmonary arterial hypertension|pulmonary arterial hypertension
197683|NCT02126930|anti-infectious treatment|anti-infectious treatment
197685|NCT02126930|pharmaceutical consultation|pharmaceutical consultation
197686|NCT02126917|Phase 1|phase 1
197687|NCT02126917|Alcohol|alcohol
197688|NCT02126917|Hydrocodone Bitartrate|hydrocodone bitartrate
197689|NCT02126917|Pharmacokinetics|pharmacokinetics
197690|NCT02126891|Cardiac functions|cardiac functions
197691|NCT02126891|Endurance training|endurance training
197692|NCT02126891|Senior athletes|senior athletes
197693|NCT02126852|residual paralysis,neuromuscular blockade,acceleromyography,electromyography|residual paralysis,neuromuscular blockade,acceleromyography,electromyography
197694|NCT02126813|Postoperative urinary retention|postoperative urinary retention
197695|NCT02126813|Fast-track total hip (THA) and knee arthroplasty (TKA)|fast-track total hip (tha) and knee arthroplasty (tka)
197696|NCT02126813|Urinary bladder volume|urinary bladder volume
197697|NCT02126800|breast cancer|breast cancer
197698|NCT02126787|Anxiety disorders|anxiety disorders
197699|NCT02126787|Depressive disorders|depressive disorders
197700|NCT02126787|Personality disorders|personality disorders
197701|NCT02126787|Psychodynamic psychotherapy|psychodynamic psychotherapy
197702|NCT02126787|Cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
197703|NCT02126787|Group psychotherapy|group psychotherapy
197704|NCT02126787|Day treatment|day treatment
197705|NCT02126774|epilepsy|epilepsy
197706|NCT02126774|focal epilepsy|focal epilepsy
197707|NCT02126761|Influenza|influenza
197708|NCT02126761|elderly|elderly
197709|NCT02126761|adjuvant|adjuvant
197710|NCT02126748|bronchiolitis|bronchiolitis
197711|NCT02126748|Wang score|wang score
197712|NCT02126748|Sa02|sa02
197713|NCT02126748|airway clearance techniques|airway clearance techniques
402948|NCT01228929|MGD|mgd
241890|NCT01926418|HIV|hiv
197714|NCT02126748|intrapulmonary percussive ventilation|intrapulmonary percussive ventilation
197715|NCT02126748|assisted autogenic drainage|assisted autogenic drainage
197716|NCT02126722|Helicobacter pylori|helicobacter pylori
197717|NCT02126722|Gastritis|gastritis
197718|NCT02126709|Povidone Iodine|povidone iodine
197719|NCT02126709|Safety|safety
197720|NCT02126709|Efficacy|efficacy
197721|NCT02126709|Acne treatment|acne treatment
197722|NCT02126696|Anti-retroviral Therapy|anti-retroviral therapy
197723|NCT02126696|Lesotho|lesotho
197724|NCT02126696|Southern Africa|southern africa
197725|NCT02126696|Comorbidity|comorbidity
197726|NCT02126696|Virologic failure|virologic failure
197727|NCT02126683|Hashimoto's thyroiditis|hashimoto's thyroiditis
197728|NCT02126683|Plaquenil|plaquenil
197729|NCT02126657|Acne scars|acne scars
197730|NCT02126657|70% Glycolic acid peel|70% glycolic acid peel
197731|NCT02126644|Photoaging|photoaging
197732|NCT02126644|70% glycolic acid peel|70% glycolic acid peel
197733|NCT02126618|Lower urinary tract symptoms|lower urinary tract symptoms
197734|NCT02126618|urodynamic studies|urodynamic studies
197736|NCT02126605|diabetes alert dogs|diabetes alert dogs
197737|NCT02126605|hypoglycemia|hypoglycemia
197746|NCT02126566|striae distensiae|striae distensiae
197747|NCT02126553|Leukemia|leukemia
197748|NCT02126553|Acute myeloid leukemia|acute myeloid leukemia
197749|NCT02126553|AML|aml
197750|NCT02126553|Remission|remission
197751|NCT02126553|Lenalidomide|lenalidomide
197752|NCT02126553|CC-5013|cc-5013
197753|NCT02126553|Revlimid|revlimid
197754|NCT02126540|Peripheral Arterial Disease|peripheral arterial disease
197755|NCT02126540|Atherectomy|atherectomy
197756|NCT02126540|Optical Coherence Tomography|optical coherence tomography
197757|NCT02126514|Beta secretase inhibitor|beta secretase inhibitor
197758|NCT02126514|Alzheimer disease|alzheimer disease
197759|NCT02126501|weaning|weaning
197760|NCT02126501|NCPAP|ncpap
197761|NCT02126501|Preterm|preterm
197762|NCT02126501|sudden wean|sudden wean
197763|NCT02126501|gradual pressure off wean|gradual pressure off wean
197764|NCT02126488|treadmill training|treadmill training
197765|NCT02126488|generalization|generalization
197766|NCT02126488|retention|retention
197767|NCT02126475|"parkinson patients ON"|"parkinson patients on"
197768|NCT02126475|"parkinson patients OFF"|"parkinson patients off"
197769|NCT02126475|time estimation|time estimation
197770|NCT02126475|anticipation|anticipation
197771|NCT02126462|Human Hookworm|human hookworm
197772|NCT02126462|Necator americanus|necator americanus
197773|NCT02126462|Hookworm|hookworm
197774|NCT02126462|Hookworm Disease|hookworm disease
197775|NCT02126462|Iron-deficiency anemia|iron-deficiency anemia
197776|NCT02126462|Soil-transmitted helminth infection|soil-transmitted helminth infection
197777|NCT02126462|Neglected Tropical Disease|neglected tropical disease
197778|NCT02126462|Na-APR-1|na-apr-1
197779|NCT02126462|Na-GST-1|na-gst-1
197780|NCT02126436|phantom limb pain|phantom limb pain
197781|NCT02126436|phantom limb sensation|phantom limb sensation
197782|NCT02126436|acupuncture|acupuncture
197783|NCT02126436|randomised controlled trial|randomised controlled trial
197784|NCT02126423|Drug Resistance, Microbial|drug resistance, microbial
197785|NCT02126410|sarcopenia|sarcopenia
197786|NCT02126410|sleep duration|sleep duration
197787|NCT02126410|body composition|body composition
197788|NCT02126410|skeletal muscle|skeletal muscle
197789|NCT02126397|endometrial polyp|endometrial polyp
197790|NCT02126397|resection of endometrial polyps|resection of endometrial polyps
197791|NCT02126397|hysteroscopy|hysteroscopy
197792|NCT02126397|bipolar electrode Versapoint|bipolar electrode versapoint
197793|NCT02126397|Laser Diode|laser diode
197794|NCT02126384|Immunology|immunology
197795|NCT02126384|human|human
197796|NCT02126384|B-lymphocytes subsets|b-lymphocytes subsets
197797|NCT02126384|Antibody-Producing Cells|antibody-producing cells
197798|NCT02126384|23 valent pneumococcal capsular polysaccharide vaccine|23 valent pneumococcal capsular polysaccharide vaccine
197799|NCT02126332|Severe acute pancreatitis|severe acute pancreatitis
197800|NCT02126332|Epidural analgesia|epidural analgesia
197801|NCT02126332|Acute respiratory failure|acute respiratory failure
197802|NCT02126332|Mechanical ventilation|mechanical ventilation
197803|NCT02126332|Intensive Care Unit (ICU)|intensive care unit (icu)
197804|NCT02126319|Cognitive-affective preparation|cognitive-affective preparation
197805|NCT02126319|prostate cancer counseling|prostate cancer counseling
197806|NCT02126280|proinflammatory cytokines|proinflammatory cytokines
197807|NCT02126280|anti-inflammatory cytokines|anti-inflammatory cytokines
197808|NCT02126280|human monocytes|human monocytes
197809|NCT02126280|activation|activation
197810|NCT02126280|biomarkers|biomarkers
197811|NCT02126280|asymptomatic atherosclerosis|asymptomatic atherosclerosis
197812|NCT02126267|periodontal disease|periodontal disease
197813|NCT02126267|therapy|therapy
197814|NCT02126267|anti-bacterial agents|anti-bacterial agents
197815|NCT02126267|Randomized Controlled Trials|randomized controlled trials
197816|NCT02126241|Heart Failure|heart failure
402949|NCT01228929|Environment|environment
197817|NCT02126241|Cardiac Resyncronization Therapy|cardiac resyncronization therapy
197818|NCT02126241|Optimization|optimization
197819|NCT02126241|Non-invasive cardiac system|non-invasive cardiac system
197820|NCT02126241|Impedance measured cardiac output|impedance measured cardiac output
197821|NCT02126228|antibiotics, cesarean|antibiotics, cesarean
197822|NCT02126215|magnetic resonance imaging|magnetic resonance imaging
197823|NCT02126215|carbon dioxide|carbon dioxide
197824|NCT02126215|abdominal aortic aneurysm|abdominal aortic aneurysm
197825|NCT02126215|post-op delirium|post-op delirium
197826|NCT02126202|Elderly|elderly
197827|NCT02126202|Octogenarians|octogenarians
197829|NCT02126202|Myocardial infarction|myocardial infarction
197830|NCT02126202|NSTEMI|nstemi
197831|NCT02126202|Unstable angina pectoris|unstable angina pectoris
197832|NCT02126189|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
197833|NCT02126189|Human Papillomavirus|human papillomavirus
197834|NCT02126189|Aetiology|aetiology
197835|NCT02126189|prevalence|prevalence
197836|NCT02126189|risk factors|risk factors
197837|NCT02126189|clinical outcome|clinical outcome
197838|NCT02126163|Excessive Drinking|excessive drinking
197839|NCT02126163|Hazardous Drinking|hazardous drinking
197840|NCT02126137|HCV|hcv
197841|NCT02126137|Ezetimibe|ezetimibe
197842|NCT02126137|Cholesterol|cholesterol
197843|NCT02126137|Host|host
197844|NCT02126124|Brainsway, dTMS, Deep Transcranial Magnetic Stimulation, Smoking Cessation|brainsway, dtms, deep transcranial magnetic stimulation, smoking cessation
197845|NCT02126098|ANCA-associated vasculitis|anca-associated vasculitis
197846|NCT02126098|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
197847|NCT02126098|Microscopic polyangiitis|microscopic polyangiitis
197848|NCT02126098|Wegner's granulomatosis|wegner's granulomatosis
197849|NCT02126098|Eosinphilic granulomatosis with polyangiitis|eosinphilic granulomatosis with polyangiitis
197850|NCT02126085|ischemic stroke|ischemic stroke
197851|NCT02126085|recanalisation|recanalisation
197852|NCT02126085|sedation|sedation
197853|NCT02126072|Ethanol|ethanol
197854|NCT02126072|Alcohol|alcohol
197855|NCT02126072|Consumption|consumption
197856|NCT02126072|Gut wall integrity|gut wall integrity
197857|NCT02126072|Endotoxemia|endotoxemia
197858|NCT02126059|dementia|dementia
197859|NCT02126059|behavioral and psychological symptoms|behavioral and psychological symptoms
197860|NCT02126059|quality of life|quality of life
197861|NCT02126046|Cord Blood Transplant|cord blood transplant
197862|NCT02126046|Haploidentical HSCT|haploidentical hsct
197863|NCT02126046|Thalassemia major|thalassemia major
197864|NCT02126033|celiac|celiac
197865|NCT02126033|telomere|telomere
197866|NCT02126033|telomerase|telomerase
197867|NCT02126020|Keratoprosthesis|keratoprosthesis
197868|NCT02126020|corneal melt|corneal melt
197869|NCT02126020|keratolysis|keratolysis
197870|NCT02126020|Tumor necrosis factor alpha|tumor necrosis factor alpha
197871|NCT02126020|infliximab|infliximab
197872|NCT02126020|matrix metalloproteinase|matrix metalloproteinase
197873|NCT02126007|fatigue|fatigue
197874|NCT02126007|HIV|hiv
197875|NCT02126007|behavioral intervention|behavioral intervention
197876|NCT02126007|sleep|sleep
197877|NCT02125981|limaprost alfadex|limaprost alfadex
197878|NCT02125981|cervical myelopathy|cervical myelopathy
197879|NCT02125981|surgery|surgery
197880|NCT02125968|chronic low back pain|chronic low back pain
197881|NCT02125968|video game|video game
197882|NCT02125968|therapeutic effects|therapeutic effects
197883|NCT02125955|Pediatric|pediatric
197884|NCT02125955|Overweight|overweight
197885|NCT02125955|Obesity|obesity
197886|NCT02125955|Gut microbiota|gut microbiota
197887|NCT02125955|Adiposity|adiposity
197888|NCT02125955|Prebiotic|prebiotic
197889|NCT02125955|Dietary fiber|dietary fiber
197890|NCT02125942|Borderline Personality Disorder|borderline personality disorder
197891|NCT02125877|Iron overload|iron overload
197892|NCT02125877|Chelation|chelation
197893|NCT02125877|Thalassemia|thalassemia
197894|NCT02125877|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
197895|NCT02125877|Transfusional hemisiderosis|transfusional hemisiderosis
197896|NCT02125877|Deferasirox|deferasirox
197897|NCT02125877|ICL670|icl670
197898|NCT02125877|Dispersible tablet|dispersible tablet
197899|NCT02125877|Film-coated tablet|film-coated tablet
197900|NCT02125864|AMD|amd
197901|NCT02125864|VEGF|vegf
197902|NCT02125864|Aflibercept|aflibercept
197903|NCT02125851|slurry|slurry
197904|NCT02125851|splenda|splenda
197905|NCT02125851|sucralose|sucralose
197906|NCT02125851|budesonide|budesonide
197907|NCT02125851|mucosal contact time|mucosal contact time
197908|NCT02125838|laryngeal mask Supreme|laryngeal mask supreme
197909|NCT02125838|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
197910|NCT02125838|Laryngeal mask during surgery|laryngeal mask during surgery
197911|NCT02125812|Aggressive Periodontitis|aggressive periodontitis
197912|NCT02125812|antimicrobial(s)|antimicrobial(s)
197913|NCT02125812|microbiology|microbiology
197914|NCT02125773|PrEP|prep
197915|NCT02125773|Risk score|risk score
197916|NCT02125773|Self-perception|self-perception
242097|NCT01925417|MRT|mrt
197917|NCT02125760|Respiratory muscle training|respiratory muscle training
197918|NCT02125760|stroke|stroke
197919|NCT02125760|rehabilitation|rehabilitation
197920|NCT02125747|Respiratory muscle training; high-intensity training|respiratory muscle training; high-intensity training
197921|NCT02125721|cystinuria|cystinuria
197922|NCT02125721|D-penicillamine (Cuprimine®)|d-penicillamine (cuprimine®)
197923|NCT02125721|tiopronin (Thiola®)|tiopronin (thiola®)
197924|NCT02125708|preterm prelabor rupture of membranes|preterm prelabor rupture of membranes
197925|NCT02125708|Ovula Ring|ovula ring
197926|NCT02125708|body-core-temperature|body-core-temperature
197927|NCT02125708|biomarkers|biomarkers
197928|NCT02125708|Single pregnancies|single pregnancies
197929|NCT02125708|PPROM|pprom
197930|NCT02125708|gestation week 22 and 27|gestation week 22 and 27
197931|NCT02125682|HDL|hdl
197932|NCT02125682|Hyperlipidemia|hyperlipidemia
197933|NCT02125682|Diabetes|diabetes
197934|NCT02125682|Inflammation|inflammation
197935|NCT02125669|basal cell carcinoma|basal cell carcinoma
197936|NCT02125669|laser surgery|laser surgery
197937|NCT02125669|pulsed dye laser|pulsed dye laser
197938|NCT02125669|randomized controlled trial|randomized controlled trial
197939|NCT02125643|Exercise-induced muscle damage|exercise-induced muscle damage
197940|NCT02125643|Caffeine|caffeine
197941|NCT02125643|Maximal voluntary strength|maximal voluntary strength
197942|NCT02125630|Metastatic breast carcer|metastatic breast carcer
197943|NCT02125630|Bone metastasis|bone metastasis
197944|NCT02125630|surgery|surgery
197945|NCT02125617|Castration-resistant prostate cancer|castration-resistant prostate cancer
197946|NCT02125617|Abiraterone|abiraterone
197947|NCT02125617|Biomarker|biomarker
197948|NCT02125617|Urokinase Plasminogen Activator Receptor|urokinase plasminogen activator receptor
197949|NCT02125617|Plasma|plasma
197950|NCT02125617|Predictive markers|predictive markers
197951|NCT02125604|Gastrointestinal event|gastrointestinal event
197952|NCT02125591|Mild Traumatic Brain Injury|mild traumatic brain injury
197953|NCT02125565|Arterial|arterial
197954|NCT02125565|Blood|blood
197955|NCT02125565|Gas|gas
197956|NCT02125565|Needle|needle
197957|NCT02125565|Pain|pain
197958|NCT02125565|Local|local
197959|NCT02125565|Anaesthesia|anaesthesia
197960|NCT02125565|Anaesthetic|anaesthetic
197961|NCT02125552|vascular access device|vascular access device
197962|NCT02125552|ultrasonography|ultrasonography
197963|NCT02125539|Online adolescent substance abuse relapse prevention program|online adolescent substance abuse relapse prevention program
197964|NCT02125526|Acute myocardial infarction|acute myocardial infarction
197965|NCT02125526|Persisting ischemia|persisting ischemia
197966|NCT02125526|No reflow|no reflow
197967|NCT02125526|Intra-aortic balloon pump|intra-aortic balloon pump
197968|NCT02125526|Exhausted autoregulation|exhausted autoregulation
197969|NCT02125513|neoadjuvant chemotherapy|neoadjuvant chemotherapy
197970|NCT02125513|ovarian cancer|ovarian cancer
197971|NCT02125513|fallopian tube carcinoma|fallopian tube carcinoma
197972|NCT02125513|peritoneal carcinoma|peritoneal carcinoma
197973|NCT02125513|randomized study|randomized study
197974|NCT02125500|HCV/HIV coinfection|hcv/hiv coinfection
197975|NCT02125500|HCV genotype 1|hcv genotype 1
197976|NCT02125487|Clinical Breast Examination|clinical breast examination
197977|NCT02125487|Breast Cancer detection|breast cancer detection
197978|NCT02125487|Breast Simulator|breast simulator
197979|NCT02125487|Hybrid Simulation|hybrid simulation
197980|NCT02125487|Patient Simulation|patient simulation
197981|NCT02125487|Standardized Patient|standardized patient
197982|NCT02125487|Medical student education|medical student education
197983|NCT02125487|Health Communication|health communication
197984|NCT02125487|Communication Barriers|communication barriers
197985|NCT02125487|Cultural competency|cultural competency
197986|NCT02125487|Cultural|cultural
197987|NCT02125487|Middle East|middle east
197988|NCT02125487|Lebanon|lebanon
197989|NCT02125474|Neuroendocrine Tumors|neuroendocrine tumors
197990|NCT02125474|Lutetium|lutetium
197991|NCT02125474|Treatment Outcome|treatment outcome
197992|NCT02125461|Locally advanced|locally advanced
197993|NCT02125461|Unresectable Non-Small Cell Lung Cancer|unresectable non-small cell lung cancer
197994|NCT02125461|MEDI4736|medi4736
197995|NCT02125461|PD-L1|pd-l1
197996|NCT02125461|Stage III Non-Small Cell Lung Cancer|stage iii non-small cell lung cancer
197997|NCT02125461|Chemoradiation|chemoradiation
197998|NCT02125461|Immune-mediated cancer therapy|immune-mediated cancer therapy
197999|NCT02125448|Esophageal cancer|esophageal cancer
198000|NCT02125448|MRI|mri
198001|NCT02125448|PET-CT|pet-ct
198002|NCT02125448|Response assessment|response assessment
198003|NCT02125435|Healthy subjects|healthy subjects
198004|NCT02125435|ASP2408|asp2408
198005|NCT02125435|pharmacokinetics|pharmacokinetics
198006|NCT02125396|hepatocellular carcinoma|hepatocellular carcinoma
198007|NCT02125396|liver cancer|liver cancer
198008|NCT02125396|transarterial chemoembolization|transarterial chemoembolization
198009|NCT02125396|radiotherapy|radiotherapy
198010|NCT02125396|adjuvant therapy|adjuvant therapy
198011|NCT02125383|Parkinson's disease|parkinson's disease
198012|NCT02125383|Transcranial direct current stimulation|transcranial direct current stimulation
198013|NCT02125357|sequencing|sequencing
198014|NCT02125357|abiraterone|abiraterone
198015|NCT02125357|enzalutamide|enzalutamide
198016|NCT02125357|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
198017|NCT02125357|randomized|randomized
198018|NCT02125331|Blood Pressure|blood pressure
198019|NCT02125318|myeloproliferative neoplasm|myeloproliferative neoplasm
198020|NCT02125318|chronic myelogenous leukemia|chronic myelogenous leukemia
198021|NCT02125318|polycythemia vera|polycythemia vera
198022|NCT02125318|primary myelofibrosis|primary myelofibrosis
198023|NCT02125318|essential thrombocythemia|essential thrombocythemia
198025|NCT02125318|thrombocytosis|thrombocytosis
198026|NCT02125318|GALE-401|gale-401
198027|NCT02125305|Metformin|metformin
198028|NCT02125305|Pharmacokinetics/ Pharmacodynamics|pharmacokinetics/ pharmacodynamics
198130|NCT02124707|Carboplatin|carboplatin
198029|NCT02125214|consciousness, anesthesia, electroencephalogram, microstate, long-range dependency|consciousness, anesthesia, electroencephalogram, microstate, long-range dependency
198030|NCT02125201|intranasal fentanyl|intranasal fentanyl
198031|NCT02125201|newborn|newborn
198032|NCT02125162|BCX4161|bcx4161
198033|NCT02125162|BioCryst|biocryst
198034|NCT02125162|hereditary angioedema|hereditary angioedema
198035|NCT02125162|relative bioavailability|relative bioavailability
198036|NCT02125162|kallikrein inhibitor|kallikrein inhibitor
198037|NCT02125149|pregnancy|pregnancy
198038|NCT02125149|obese|obese
198039|NCT02125136|unresectable|unresectable
198040|NCT02125136|borderline resectable|borderline resectable
198041|NCT02125110|neurotoxicants|neurotoxicants
198042|NCT02125110|MRI|mri
198043|NCT02125110|developing brain|developing brain
198044|NCT02125097|Intracranial Aneurysm Treatment|intracranial aneurysm treatment
198045|NCT02125097|Endovascular Therapy|endovascular therapy
198046|NCT02125084|Metastatic Prostate Cancer|metastatic prostate cancer
198047|NCT02125084|Castrate-resistant|castrate-resistant
198048|NCT02125084|Enzalutamide|enzalutamide
198049|NCT02125084|Everolimus|everolimus
198050|NCT02125058|intracutaneous sutures|intracutaneous sutures
198051|NCT02125058|transcutaneous sutures|transcutaneous sutures
198052|NCT02125058|dermatological surgery|dermatological surgery
198053|NCT02125058|facial area|facial area
198055|NCT02125045|cardiovascular risk factors|cardiovascular risk factors
198056|NCT02125045|endothelial dysfunction|endothelial dysfunction
198065|NCT02125006|Painful Neuropathy|painful neuropathy
198066|NCT02125006|Chronic Pain|chronic pain
198067|NCT02125006|fMRI|fmri
198068|NCT02125006|Disability|disability
198069|NCT02125006|Quality of Life|quality of life
198070|NCT02125006|Cytokines|cytokines
198071|NCT02125006|Cortisol|cortisol
198072|NCT02124993|Gastrectomy|gastrectomy
198073|NCT02124980|Opioid Substitution Treatment|opioid substitution treatment
198074|NCT02124980|Cognitive Behavioral Therapy|cognitive behavioral therapy
198075|NCT02124980|Mobile Health|mobile health
198076|NCT02124928|stroke|stroke
198077|NCT02124928|biomarkers|biomarkers
198078|NCT02124928|vulnerable plaque|vulnerable plaque
198079|NCT02124928|carotid endarterectomy|carotid endarterectomy
198080|NCT02124928|carotid artery disease|carotid artery disease
198081|NCT02124915|prosthetic socket|prosthetic socket
198082|NCT02124915|amputee|amputee
198083|NCT02124889|bariatric surgery|bariatric surgery
198084|NCT02124889|multivitamin|multivitamin
198085|NCT02124889|weight loss|weight loss
198086|NCT02124889|adherence|adherence
198087|NCT02124876|amputee|amputee
198088|NCT02124876|prosthetics|prosthetics
198089|NCT02124837|lunch breaks, recovery, nature, park walking, relaxation|lunch breaks, recovery, nature, park walking, relaxation
198090|NCT02124811|Schizophrenia|schizophrenia
198091|NCT02124811|Clozapine|clozapine
198092|NCT02124811|Minocycline|minocycline
198093|NCT02124798|Subcutaneous|subcutaneous
198094|NCT02124798|Autoinjector|autoinjector
198095|NCT02124798|Belimumab|belimumab
198096|NCT02124798|Real-Life Use Study|real-life use study
198097|NCT02124798|Reliability|reliability
198098|NCT02124785|Long-term persistence|long-term persistence
198099|NCT02124785|Havrix|havrix
198100|NCT02124785|Hepatitis A|hepatitis a
198107|NCT02124746|Primary Myelofibrosis|primary myelofibrosis
198108|NCT02124746|Post Polycythemia Vera Myelofibrosis|post polycythemia vera myelofibrosis
198109|NCT02124746|Post Essential Thrombocythemia Myelofibrosis|post essential thrombocythemia myelofibrosis
198110|NCT02124746|Polycythemia Vera|polycythemia vera
198111|NCT02124746|Essential Thrombocythemia|essential thrombocythemia
198112|NCT02124746|blood disorders|blood disorders
198113|NCT02124733|Actinic Keratosis|actinic keratosis
198114|NCT02124733|Actinic Keratoses|actinic keratoses
198115|NCT02124733|AK|ak
198116|NCT02124733|PDT|pdt
198117|NCT02124733|Photodynamic Therapy|photodynamic therapy
198118|NCT02124733|Blue Light Therapy|blue light therapy
198119|NCT02124733|ALA|ala
198120|NCT02124733|aminolevulinic acid|aminolevulinic acid
198121|NCT02124733|Levulan|levulan
198122|NCT02124720|Autism spectrum disorders|autism spectrum disorders
198123|NCT02124720|Stereotypy|stereotypy
198124|NCT02124720|Repetitive behavior|repetitive behavior
198125|NCT02124707|Head and neck cancer|head and neck cancer
198126|NCT02124707|Squamous cell carcinoma|squamous cell carcinoma
198127|NCT02124707|Metastatic|metastatic
198128|NCT02124707|Recurrent|recurrent
198129|NCT02124707|Phase II|phase ii
198131|NCT02124707|Paclitaxel|paclitaxel
198132|NCT02124707|Cetuximab|cetuximab
198133|NCT02124694|historical trauma and unresolved grief|historical trauma and unresolved grief
198134|NCT02124694|complicated grief|complicated grief
198135|NCT02124694|prolonged grief|prolonged grief
198136|NCT02124694|interpersonal conflicts|interpersonal conflicts
198137|NCT02124694|depression|depression
198138|NCT02124694|American Indians|american indians
198428|NCT02123290|vivax|vivax
198139|NCT02124694|interpersonal psychotherapy|interpersonal psychotherapy
198140|NCT02124694|traumatic grief|traumatic grief
198141|NCT02124694|posttraumatic stress disorder|posttraumatic stress disorder
198142|NCT02124668|Xtandi|xtandi
198143|NCT02124668|MDV3100|mdv3100
198144|NCT02124668|Progressive Castration-Resistant Prostate Cancer|progressive castration-resistant prostate cancer
198145|NCT02124668|Enzalutamide|enzalutamide
198146|NCT02124655|Biofilms|biofilms
198147|NCT02124655|Chlorhexidine|chlorhexidine
198148|NCT02124655|Microscopy, confocal|microscopy, confocal
198149|NCT02124655|Dental plaque|dental plaque
198150|NCT02124655|Mouthwashes|mouthwashes
198151|NCT02124642|Folate requirements|folate requirements
198152|NCT02124642|Pregnancy|pregnancy
198153|NCT02124642|Folic acid|folic acid
198154|NCT02124642|DNA methylation|dna methylation
198155|NCT02124642|Folate biomarkers|folate biomarkers
198156|NCT02124616|spinal muscular atrophy|spinal muscular atrophy
198157|NCT02124616|Muscular dystrophy|muscular dystrophy
198158|NCT02124616|Muscle diseases|muscle diseases
198159|NCT02124616|myasthenic syndromes|myasthenic syndromes
198160|NCT02124616|Polyneuropathies|polyneuropathies
198161|NCT02124616|Myopathies|myopathies
198162|NCT02124603|cataract|cataract
198163|NCT02124603|prophylaxis|prophylaxis
198164|NCT02124603|susceptibility|susceptibility
198165|NCT02124590|Carnitine|carnitine
198167|NCT02124590|Exercise|exercise
198168|NCT02124590|Exercise Intensity|exercise intensity
198169|NCT02124590|Insulin Sensitivity|insulin sensitivity
198170|NCT02124564|Lacosamide|lacosamide
198171|NCT02124564|Epilepsy|epilepsy
198172|NCT02124564|Focal, Partial-Onset Seizures with or without secondary generalization|focal, partial-onset seizures with or without secondary generalization
198173|NCT02124564|Monotherapy|monotherapy
198174|NCT02124551|Goal-directed fluid therapy|goal-directed fluid therapy
198175|NCT02124512|obese|obese
198176|NCT02124512|insulin resistance|insulin resistance
198177|NCT02124512|metabolic syndrome|metabolic syndrome
198178|NCT02124499|anesthesia recovery period|anesthesia recovery period
198179|NCT02124499|postoperative complications|postoperative complications
198180|NCT02124499|pain|pain
198181|NCT02124499|pain measurement|pain measurement
198182|NCT02124499|postoperative nausea and vomiting|postoperative nausea and vomiting
198183|NCT02124499|quality of life|quality of life
198184|NCT02124499|genetic association study|genetic association study
198185|NCT02124486|IIH|iih
198186|NCT02124486|Weight loss|weight loss
198187|NCT02124486|Bariatric surgery|bariatric surgery
198188|NCT02124473|Resistant hypertension|resistant hypertension
198189|NCT02124473|Homeopathy|homeopathy
198190|NCT02124473|Blood pressure|blood pressure
198191|NCT02124473|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
198192|NCT02124460|Pediatric|pediatric
198193|NCT02124460|Obesity|obesity
198194|NCT02124460|Overweight|overweight
198195|NCT02124460|Intervention|intervention
198196|NCT02124434|Laparoscopic Sleeve Gastrectomy surgery|laparoscopic sleeve gastrectomy surgery
198197|NCT02124421|Ovarian cancer|ovarian cancer
198198|NCT02124421|Cytoreductive surgery|cytoreductive surgery
198199|NCT02124421|Hyperthermic Intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
198200|NCT02124421|Systemic chemotherapy|systemic chemotherapy
198201|NCT02124421|Primary peritoneal carcinoma|primary peritoneal carcinoma
198202|NCT02124421|Fallopian Tube cancer|fallopian tube cancer
198203|NCT02124421|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
198204|NCT02124421|IV/IP chemotherapy|iv/ip chemotherapy
198205|NCT02124421|IV chemotherapy|iv chemotherapy
198206|NCT02124382|liver failure|liver failure
198207|NCT02124382|liver malignancy|liver malignancy
198208|NCT02124382|metabolic diseases|metabolic diseases
198209|NCT02124382|Pediatric liver transplanted recipients and their healthy donors|pediatric liver transplanted recipients and their healthy donors
198210|NCT02124369|Pancreatic cancer|pancreatic cancer
198211|NCT02124369|locally advanced|locally advanced
198212|NCT02124369|unresectable|unresectable
198213|NCT02124343|Neutrophil|neutrophil
198214|NCT02124343|Exercise|exercise
198215|NCT02124343|COPD|copd
198216|NCT02124343|Pulmonary Rehabilitation|pulmonary rehabilitation
198217|NCT02124330|Montmorillonite, proteic diet, in vitro and in vivo models|montmorillonite, proteic diet, in vitro and in vivo models
198218|NCT02124317|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
198219|NCT02124317|S-1|s-1
198220|NCT02124317|advanced pancreatic cancer|advanced pancreatic cancer
198221|NCT02124317|objective response rate|objective response rate
198222|NCT02124304|Sternocleidomastoid|sternocleidomastoid
198223|NCT02124304|Neck pain|neck pain
198224|NCT02124304|EMG|emg
198225|NCT02124304|Perceived Exertion|perceived exertion
198226|NCT02124304|Thera-Band|thera-band
198227|NCT02124304|Cervical Paraspinals|cervical paraspinals
198228|NCT02124291|In Vitro Fertilization|in vitro fertilization
198229|NCT02124291|Vitrification|vitrification
198230|NCT02124291|Frozen Embryo|frozen embryo
198231|NCT02124291|Assisted Hatching|assisted hatching
198232|NCT02124291|Pregnancy Rate|pregnancy rate
198233|NCT02124278|Single ascending dose|single ascending dose
198234|NCT02124278|Safety and tolerability in healthy subjects|safety and tolerability in healthy subjects
198235|NCT02124265|Oral Rehydration Therapy|oral rehydration therapy
198236|NCT02124252|cervical cancer screening|cervical cancer screening
198237|NCT02124252|human papillomavirus testing|human papillomavirus testing
198238|NCT02124252|Kenya|kenya
198239|NCT02124252|implementation science|implementation science
198240|NCT02124226|Chronic severe asthma, immunomodulation, methotrexate, steroids, omalizumab|chronic severe asthma, immunomodulation, methotrexate, steroids, omalizumab
198241|NCT02124213|Receptor Occupancy|receptor occupancy
198242|NCT02124213|PET|pet
198243|NCT02124213|D1 Receptor Agonist|d1 receptor agonist
198244|NCT02124174|acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
198245|NCT02124174|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
198246|NCT02124161|Pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
198247|NCT02124161|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
198248|NCT02124161|invasive pneumococcal disease|invasive pneumococcal disease
198249|NCT02124161|flu vaccine|flu vaccine
198250|NCT02124148|cancer|cancer
198251|NCT02124135|Nutrition|nutrition
198252|NCT02124122|Focus|focus
198253|NCT02124122|safety|safety
198254|NCT02124109|Rheumatic Fever|rheumatic fever
198255|NCT02124109|Acquired Heart Disease|acquired heart disease
198379|NCT02123498|LPR|lpr
198256|NCT02124109|Rheumatic Heart Disease|rheumatic heart disease
198257|NCT02124109|Endomyocardial Fibrosis|endomyocardial fibrosis
198258|NCT02124096|Zoonotic|zoonotic
198259|NCT02124096|Influenza|influenza
198260|NCT02124096|Infections|infections
198261|NCT02124096|Ohio|ohio
198262|NCT02124096|Fairs|fairs
198263|NCT02124083|Niemann Pick Disease, Type C1|niemann pick disease, type c1
198264|NCT02124083|Phase I, Phase 2|phase i, phase 2
198265|NCT02124083|Vorinostat|vorinostat
198266|NCT02124070|Cystinosis|cystinosis
198267|NCT02124070|Myopathy|myopathy
198268|NCT02124070|Recombiant Growth Hormone|recombiant growth hormone
198269|NCT02124057|Liver|liver
198270|NCT02124057|Motor Neuron Disease|motor neuron disease
198271|NCT02124044|Coinfection|coinfection
198272|NCT02124044|HCV Genotype 1b|hcv genotype 1b
198273|NCT02124044|Interferon Free therapy|interferon free therapy
198274|NCT02124044|Liver Biopsy|liver biopsy
198275|NCT02124044|Virological Response|virological response
198276|NCT02124031|Osteoarthritis|osteoarthritis
198277|NCT02124031|Rheumatoid Arthritis|rheumatoid arthritis
198278|NCT02124031|Disability|disability
198279|NCT02124031|Joint function|joint function
198280|NCT02124018|Myocardial infarction|myocardial infarction
198281|NCT02124018|Risk stratification|risk stratification
198282|NCT02124018|Sudden cardiac death|sudden cardiac death
198283|NCT02124018|Preserved ejection fraction|preserved ejection fraction
198284|NCT02124018|Programmed ventricular stimulation|programmed ventricular stimulation
198285|NCT02124005|Knee surgery|knee surgery
198286|NCT02124005|Femoral block|femoral block
198287|NCT02124005|Bupivacaine|bupivacaine
198288|NCT02124005|Ultrasound|ultrasound
198289|NCT02123966|Chronic Graft-versus-Host-Disease|chronic graft-versus-host-disease
198290|NCT02123966|Oral mucosal disease|oral mucosal disease
198291|NCT02123953|Drug therapy|drug therapy
198292|NCT02123940|Weaning from mechanical ventilation|weaning from mechanical ventilation
198293|NCT02123940|Lung ultrasound|lung ultrasound
198294|NCT02123940|Nasal humidified high flow therapy|nasal humidified high flow therapy
198295|NCT02123940|Weaning failure|weaning failure
198296|NCT02123940|Postextubation distress|postextubation distress
198297|NCT02123927|Drug therapy|drug therapy
198298|NCT02123914|Exercise training|exercise training
198299|NCT02123914|Allergic rhinitis|allergic rhinitis
198300|NCT02123914|Vitamin C|vitamin c
198301|NCT02123914|Cytokine|cytokine
198302|NCT02123914|Rhinitis symptoms|rhinitis symptoms
198303|NCT02123901|Mind and body Exercise|mind and body exercise
198304|NCT02123901|Flow mediated dilation|flow mediated dilation
198305|NCT02123901|Diabetes|diabetes
198306|NCT02123888|Prostate|prostate
198307|NCT02123888|Lung|lung
198308|NCT02123862|Prostate Cancer|prostate cancer
198309|NCT02123862|Breast Cancer|breast cancer
189250|NCT02165449|imaging|imaging
198310|NCT02123862|Colorectal Cancer|colorectal cancer
198311|NCT02123862|Colon Cancer|colon cancer
198312|NCT02123862|Rectal Cancer|rectal cancer
198313|NCT02123862|Cancer|cancer
198314|NCT02123862|Solid Tumor|solid tumor
198315|NCT02123862|Metastatic|metastatic
198316|NCT02123862|Circulating Tumor Cells|circulating tumor cells
198317|NCT02123810|fatigue|fatigue
198318|NCT02123810|motor skills|motor skills
198319|NCT02123810|cardiopulmonary resuscitation|cardiopulmonary resuscitation
198320|NCT02123784|Rotator Cuff Tear|rotator cuff tear
198321|NCT02123784|Rotator Cuff Repair|rotator cuff repair
198322|NCT02123784|Biomarker|biomarker
198323|NCT02123784|Predictive factors|predictive factors
198324|NCT02123784|Skeletal Muscle|skeletal muscle
198325|NCT02123784|Tendon|tendon
198326|NCT02123784|Subacromial Bursa|subacromial bursa
198327|NCT02123771|Focus of Study : HELICOBACTER PYLORI INFECTIONS|focus of study : helicobacter pylori infections
198328|NCT02123758|Prostatic Neoplasms|prostatic neoplasms
198329|NCT02123758|Metastatic Castration-Resistant Prostate Cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
198330|NCT02123758|Prostate cancer|prostate cancer
198331|NCT02123758|Abiraterone Acetate (ZYTIGA)|abiraterone acetate (zytiga)
198332|NCT02123758|Prednisone|prednisone
198333|NCT02123758|JNJ-56021927|jnj-56021927
198334|NCT02123745|infiltration|infiltration
198335|NCT02123745|extravasation|extravasation
198336|NCT02123745|peripheral intravenous therapy|peripheral intravenous therapy
198337|NCT02123732|Diabetes|diabetes
198338|NCT02123732|Diabetes Mellitus|diabetes mellitus
198339|NCT02123732|Herbal|herbal
198340|NCT02123732|food supplement|food supplement
198341|NCT02123693|Osteopathic manipulative treatment|osteopathic manipulative treatment
198342|NCT02123693|Low back pain|low back pain
198343|NCT02123693|Dynamic MRI|dynamic mri
198344|NCT02123680|expectation|expectation
198345|NCT02123680|chronic illness|chronic illness
198346|NCT02123680|trajectory|trajectory
586125|NCT00523562|obese humans|obese humans
198347|NCT02123628|diabetic foot osteomyelitis, antibiotic treatment duration|diabetic foot osteomyelitis, antibiotic treatment duration
198348|NCT02123615|Primary Immunodeficiency|primary immunodeficiency
198349|NCT02123615|Subdermal bloodless space|subdermal bloodless space
198350|NCT02123615|Subdermal injection|subdermal injection
198351|NCT02123615|Subcutaneous injection|subcutaneous injection
201006|NCT02112656|Pharmacologic Actions|pharmacologic actions
198352|NCT02123615|Injectable electromyography needle|injectable electromyography needle
198353|NCT02123615|Electrical stimulation|electrical stimulation
198354|NCT02123615|MRI with Gadolinium|mri with gadolinium
198355|NCT02123602|patellofemoral pain syndrome|patellofemoral pain syndrome
198356|NCT02123602|abdominal muscles|abdominal muscles
198357|NCT02123576|Hepatorenal syndrome|hepatorenal syndrome
198358|NCT02123576|Renal failure|renal failure
198359|NCT02123576|Pentoxyfylline|pentoxyfylline
198360|NCT02123576|Liver transplantation|liver transplantation
198361|NCT02123576|Cirrhosis|cirrhosis
198362|NCT02123550|deep|deep
198363|NCT02123550|venous|venous
198364|NCT02123550|thrombosis|thrombosis
198365|NCT02123550|Doppler|doppler
198366|NCT02123550|ultrasound|ultrasound
198367|NCT02123550|plastic|plastic
198368|NCT02123550|surgery|surgery
198369|NCT02123550|thromboembolism|thromboembolism
198370|NCT02123550|prevention|prevention
198371|NCT02123537|Bioness L300 Foot Drop System|bioness l300 foot drop system
198372|NCT02123537|Functional electrical stimulation|functional electrical stimulation
198373|NCT02123524|Superficial Vein Thrombosis|superficial vein thrombosis
198374|NCT02123498|ear pressure|ear pressure
198375|NCT02123498|ear fullness|ear fullness
198376|NCT02123498|ear pain|ear pain
198378|NCT02123498|laryngopharyngeal reflux|laryngopharyngeal reflux
198380|NCT02123498|gastroesophageal reflux disease|gastroesophageal reflux disease
198381|NCT02123498|GERD|gerd
198382|NCT02123498|nasopharyngeal reflux|nasopharyngeal reflux
198383|NCT02123498|acid reflux|acid reflux
198384|NCT02123485|Depression,|depression,
198385|NCT02123485|ECT,|ect,
198386|NCT02123485|rTMS,|rtms,
198387|NCT02123485|Right prefrontal,|right prefrontal,
198388|NCT02123485|antidepressive efficacy|antidepressive efficacy
198389|NCT02123485|Inflammation markers|inflammation markers
198391|NCT02123433|Streptococcus pneumoniae|streptococcus pneumoniae
198392|NCT02123433|13-valent conjugate pneumococcal vaccine|13-valent conjugate pneumococcal vaccine
198393|NCT02123433|Vaccine|vaccine
198394|NCT02123433|Immunological Response|immunological response
198395|NCT02123433|Pneumococcal Carriage|pneumococcal carriage
198396|NCT02123420|Platform Switching vs Regular Platform|platform switching vs regular platform
198397|NCT02123407|Advanced Gastric Cancer|advanced gastric cancer
198398|NCT02123407|Carbon Nanoparticles|carbon nanoparticles
198399|NCT02123407|Lymph Nodes|lymph nodes
198400|NCT02123394|Low Back Pain|low back pain
198401|NCT02123394|Mechanical Low Back Pain|mechanical low back pain
198402|NCT02123394|Low Back Ache|low back ache
198403|NCT02123394|Low Backache|low backache
198404|NCT02123394|Lower Back Pain|lower back pain
198405|NCT02123394|Lumbago|lumbago
198406|NCT02123381|tumor tissue and serum biomarkers|tumor tissue and serum biomarkers
198407|NCT02123381|cetuximab|cetuximab
198408|NCT02123381|preoperative radiotherapy|preoperative radiotherapy
198409|NCT02123381|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
198410|NCT02123368|Osteoarthritis|osteoarthritis
198411|NCT02123368|Mesenchimal stem cell|mesenchimal stem cell
198412|NCT02123368|Knee|knee
198413|NCT02123342|health|health
198414|NCT02123342|older adults|older adults
198415|NCT02123342|mobile phone|mobile phone
198416|NCT02123329|Qatar|qatar
198417|NCT02123329|Pharmacy|pharmacy
198418|NCT02123329|Pharmacist|pharmacist
198419|NCT02123329|Smoking cessation|smoking cessation
198420|NCT02123316|local allergic rhinitis|local allergic rhinitis
198421|NCT02123316|subcutaneous immunotherapy|subcutaneous immunotherapy
198422|NCT02123316|house dust mite allergy|house dust mite allergy
198423|NCT02123316|Dermatophagoides pteronyssinus allergy|dermatophagoides pteronyssinus allergy
198424|NCT02123303|Hypotension, Orthostatic Hypotension|hypotension, orthostatic hypotension
198425|NCT02123290|Plasmodium|plasmodium
198426|NCT02123290|falciparum|falciparum
198427|NCT02123290|malaria|malaria
198429|NCT02123290|DSM265|dsm265
198430|NCT02123290|pharmacokinetics|pharmacokinetics
198431|NCT02123290|adult|adult
198432|NCT02123251|Incentives,|incentives,
198433|NCT02123251|Diabetes,|diabetes,
198434|NCT02123251|Medicaid,|medicaid,
198435|NCT02123251|Health behavior,|health behavior,
198436|NCT02123251|Cost effectiveness|cost effectiveness
198437|NCT02123225|STOP-BANG|stop-bang
198438|NCT02123225|Obstructive sleep apnea (OSA)|obstructive sleep apnea (osa)
198439|NCT02123225|total knee arthroplasty (TKA)|total knee arthroplasty (tka)
198440|NCT02123225|portable monitoring|portable monitoring
198441|NCT02123225|sleep medicine|sleep medicine
198442|NCT02123225|unattended sleep study|unattended sleep study
198443|NCT02123225|postoperative sleep study|postoperative sleep study
198444|NCT02123212|Hepatitis C|hepatitis c
586126|NCT00523575|Elderly|elderly
198445|NCT02123212|Chronic Hepatitis C|chronic hepatitis c
198446|NCT02123212|Screening|screening
198447|NCT02123199|COPD|copd
198448|NCT02123186|Newborn Screening , spinal muscular atrophy|newborn screening , spinal muscular atrophy
198449|NCT02123173|one lung ventilation,|one lung ventilation,
198450|NCT02123173|cardiac output|cardiac output
198451|NCT02123173|fluid responsiveness|fluid responsiveness
198452|NCT02123160|Depression|depression
198453|NCT02123160|Dyadic therapy|dyadic therapy
198454|NCT02123160|Behavioral Problems|behavioral problems
198455|NCT02123160|Child parent therapy|child parent therapy
198456|NCT02123160|Affect regulation|affect regulation
198457|NCT02123160|Immune markers|immune markers
198458|NCT02123160|Cortisol|cortisol
198459|NCT02123121|Aging|aging
198460|NCT02123121|Biogenesis|biogenesis
198461|NCT02123121|Cell Respiration|cell respiration
198462|NCT02123121|Elderly|elderly
198463|NCT02123121|Enzymes|enzymes
198464|NCT02123121|Mitochondria|mitochondria
198465|NCT02123121|Mitochondrial DNA|mitochondrial dna
198466|NCT02123121|Muscle Fatigue|muscle fatigue
198467|NCT02123121|Physical Function|physical function
198468|NCT02123121|Resveratrol|resveratrol
198469|NCT02123108|Simulect, Myfortic, OLT, Renal Dysfunction, Liver Transplant, Orthotopic Liver Transplantation|simulect, myfortic, olt, renal dysfunction, liver transplant, orthotopic liver transplantation
198470|NCT02123082|Urolithiasis|urolithiasis
198471|NCT02123082|Kidney stones|kidney stones
198472|NCT02123082|Ureteral Obstruction|ureteral obstruction
198473|NCT02123082|Ureteroscopes|ureteroscopes
198474|NCT02123082|Ureteroscopies|ureteroscopies
198475|NCT02123069|Autonomic nervous system|autonomic nervous system
198476|NCT02123069|Blood pressure|blood pressure
198477|NCT02123069|Blood vessels|blood vessels
198478|NCT02123069|Physiological effects of drugs|physiological effects of drugs
198479|NCT02123069|Vascular stiffness|vascular stiffness
198480|NCT02123056|reflex fainting|reflex fainting
198481|NCT02123056|vasovagal syncope|vasovagal syncope
198482|NCT02123056|metoprolol|metoprolol
198483|NCT02123056|randomized clinical trial|randomized clinical trial
198484|NCT02123056|quality of life|quality of life
198485|NCT02123043|rehabilitation|rehabilitation
198486|NCT02123043|wheelchair|wheelchair
198487|NCT02123043|older adults|older adults
198488|NCT02123043|manual wheelchair|manual wheelchair
198489|NCT02123043|motor learning|motor learning
198490|NCT02123043|biomechanics|biomechanics
198491|NCT02123043|gross mechanical efficiency|gross mechanical efficiency
198492|NCT02123030|Lung cancer|lung cancer
198493|NCT02123030|pulmonary disease|pulmonary disease
198494|NCT02123017|Bowel Evacuation|bowel evacuation
198495|NCT02123017|Colonoscopy Preparation|colonoscopy preparation
198496|NCT02123004|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
198497|NCT02123004|Percutaneous Coronary Intervention|percutaneous coronary intervention
198498|NCT02122991|spinal cord injury|spinal cord injury
198499|NCT02122991|autonomic dysreflexia|autonomic dysreflexia
198500|NCT02122991|baroreceptor integrity|baroreceptor integrity
198501|NCT02122991|sympathetic integrity|sympathetic integrity
198502|NCT02122991|vagal integrity|vagal integrity
198503|NCT02122991|autonomic integrity|autonomic integrity
198504|NCT02122991|arterial stiffness|arterial stiffness
198505|NCT02122991|cognitive function|cognitive function
198506|NCT02122991|traumatic brain injury|traumatic brain injury
198507|NCT02122991|cerebral blood flow|cerebral blood flow
198508|NCT02122978|psoriasis|psoriasis
198509|NCT02122978|dermatology|dermatology
198510|NCT02122978|mindfulness|mindfulness
198511|NCT02122978|self-compassion|self-compassion
198512|NCT02122952|Gene Transfer|gene transfer
198513|NCT02122952|Gene Therapy|gene therapy
198514|NCT02122952|Adeno-associated virus|adeno-associated virus
198515|NCT02122952|Survival Motor Neuron|survival motor neuron
198516|NCT02122952|SMN|smn
198517|NCT02122952|AAV9|aav9
198518|NCT02122926|Transitions in care|transitions in care
198519|NCT02122926|discharge intervention|discharge intervention
198520|NCT02122926|RCT|rct
198521|NCT02122926|readmission rates|readmission rates
198522|NCT02122926|medication adherence|medication adherence
198523|NCT02122926|glycemic control|glycemic control
198524|NCT02122926|ED visits|ed visits
198525|NCT02122926|medication reconciliation|medication reconciliation
198921|NCT02121145|Vivotif|vivotif
198526|NCT02122926|Coleman Transitions Coach|coleman transitions coach
198527|NCT02122926|telemonitoring; hypoglycemic events|telemonitoring; hypoglycemic events
198528|NCT02122913|TRK|trk
198529|NCT02122913|TRKA|trka
198530|NCT02122913|TRKB|trkb
198531|NCT02122913|TRKC|trkc
198532|NCT02122913|NTRK1|ntrk1
198533|NCT02122913|NTRK2|ntrk2
198534|NCT02122913|NTRK3|ntrk3
198535|NCT02122913|larotrectinib|larotrectinib
198536|NCT02122913|NTRK fusion positive|ntrk fusion positive
198537|NCT02122913|NTRK gene rearrangements|ntrk gene rearrangements
198538|NCT02122913|NTRK1 fusion|ntrk1 fusion
198539|NCT02122913|NTRK2 fusion|ntrk2 fusion
198540|NCT02122913|NTRK3 fusion|ntrk3 fusion
198541|NCT02122913|NTRK1 gene rearrangement|ntrk1 gene rearrangement
675915|NCT00878540|mirtazapine|mirtazapine
198542|NCT02122913|NTRK2 gene rearrangement|ntrk2 gene rearrangement
198543|NCT02122913|NTRK3 gene rearrangement|ntrk3 gene rearrangement
198544|NCT02122913|ETV6-NTRK3|etv6-ntrk3
198545|NCT02122913|fusion|fusion
198546|NCT02122913|tumors|tumors
198547|NCT02122913|solid tumors|solid tumors
198548|NCT02122913|CNS tumors|cns tumors
198549|NCT02122913|central nervous system tumors|central nervous system tumors
198550|NCT02122913|TRK fusion|trk fusion
198551|NCT02122913|ETV6|etv6
198552|NCT02122913|ETV6 fusion|etv6 fusion
198553|NCT02122913|ETV6 gene rearrangement|etv6 gene rearrangement
198554|NCT02122913|solid CNS tumor|solid cns tumor
198555|NCT02122913|Advanced CNS tumor|advanced cns tumor
198556|NCT02122913|Primary CNS tumor|primary cns tumor
198557|NCT02122913|Metastatic CNS tumor|metastatic cns tumor
198558|NCT02122913|LOXO-101|loxo-101
198559|NCT02122887|jewish, arab, israel, teenagers|jewish, arab, israel, teenagers
198560|NCT02122874|Percutaneous neurostimulation; dermatome T7, type 2 diabetes|percutaneous neurostimulation; dermatome t7, type 2 diabetes
198561|NCT02122861|Melanoma|melanoma
198562|NCT02122848|Heart failure|heart failure
198563|NCT02122848|Exercise tolerance|exercise tolerance
198564|NCT02122848|Noninvasive ventilation|noninvasive ventilation
198565|NCT02122835|exercise|exercise
198566|NCT02122835|aerobic exercise|aerobic exercise
198567|NCT02122822|supratentoria glioma|supratentoria glioma
198568|NCT02122809|Chiauranib, advanced solid tumors, phase 1 study|chiauranib, advanced solid tumors, phase 1 study
198569|NCT02122796|Breast Cancer|breast cancer
198570|NCT02122796|Mastectomy|mastectomy
198571|NCT02122796|Acupuncture|acupuncture
198572|NCT02122770|Drug Therapy|drug therapy
198573|NCT02122731|antihypertensive therapy|antihypertensive therapy
198574|NCT02122731|amiloride|amiloride
198575|NCT02122731|add-on|add-on
198576|NCT02122731|resistant hypertension|resistant hypertension
198577|NCT02122731|blood pressure control|blood pressure control
198578|NCT02122731|type 2 diabetes mellitus,|type 2 diabetes mellitus,
198579|NCT02122731|microalbuminuria.|microalbuminuria.
198580|NCT02122705|Remifentanil|remifentanil
198581|NCT02122705|Labour analgesia|labour analgesia
198582|NCT02122666|Metabolic Syndrome|metabolic syndrome
198583|NCT02122666|Pre-diabetes|pre-diabetes
198584|NCT02122666|impaired glucose tolerance|impaired glucose tolerance
198585|NCT02122666|Phospholipids|phospholipids
198586|NCT02122653|Fatigue|fatigue
198587|NCT02122653|aging|aging
198588|NCT02122653|transcranial magnetic stimulation|transcranial magnetic stimulation
198589|NCT02122653|interpolated|interpolated
198590|NCT02122653|twitch technique|twitch technique
198591|NCT02122627|Vitamin D, COPD, immunomodulation, physical function, pulmonary function|vitamin d, copd, immunomodulation, physical function, pulmonary function
198592|NCT02122614|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
198593|NCT02122614|COPD|copd
198594|NCT02122614|Pulmonary rehabilitation|pulmonary rehabilitation
198595|NCT02122614|Physical activity|physical activity
189544|NCT02163980|caudal block|caudal block
189545|NCT02163980|children|children
189546|NCT02163980|children (1-6 years) undergoing ambulatory orchipexy|children (1-6 years) undergoing ambulatory orchipexy
189547|NCT02163967|cranial electrical stimulation|cranial electrical stimulation
189549|NCT02163967|heart rate variability|heart rate variability
189550|NCT02163967|parasympathetic|parasympathetic
189551|NCT02163967|Vagal|vagal
189552|NCT02163954|platelet|platelet
189553|NCT02163954|ticagrelor|ticagrelor
189554|NCT02163954|clopidogrel|clopidogrel
189555|NCT02163954|end stage renal disease|end stage renal disease
189556|NCT02163954|hemodialysis|hemodialysis
198596|NCT02122614|Exercise|exercise
198597|NCT02122588|serous and endometrioid ovarian, peritoneal, fallopian tube cancer, hereditary ovarian cancer, BRCA (breast cancer gene) mutation, genetic testing|serous and endometrioid ovarian, peritoneal, fallopian tube cancer, hereditary ovarian cancer, brca (breast cancer gene) mutation, genetic testing
198598|NCT02122575|Inflammasome|inflammasome
198599|NCT02122575|Fasting|fasting
198600|NCT02122575|Sirt3|sirt3
198601|NCT02122562|Ketamine|ketamine
198602|NCT02122562|Major Depression|major depression
198603|NCT02122562|Alcohol|alcohol
198604|NCT02122562|Alcohol Clamp|alcohol clamp
198605|NCT02122562|NMDA Antagonist|nmda antagonist
198606|NCT02122549|In-Hospital Cardiac Arrest|in-hospital cardiac arrest
198607|NCT02122549|Telemetry|telemetry
198608|NCT02122523|Image guided surgery|image guided surgery
198609|NCT02122510|Analgesia, casarean section, TAP block|analgesia, casarean section, tap block
198610|NCT02122497|abdominal aortic aneurysm|abdominal aortic aneurysm
198611|NCT02122497|aortic occlusive disease|aortic occlusive disease
198612|NCT02122497|cardiovascular biomarkers|cardiovascular biomarkers
198613|NCT02122497|open surgical repair|open surgical repair
198614|NCT02122497|endovascular aortic repair|endovascular aortic repair
198615|NCT02122484|reperfusion damage|reperfusion damage
198617|NCT02122471|Constipation|constipation
198618|NCT02122471|Chronic Constipation|chronic constipation
198619|NCT02122471|Synergy|synergy
198620|NCT02122471|Plecanatide|plecanatide
198621|NCT02122458|hearing impairment|hearing impairment
198622|NCT02122458|post-traumatic stress disorder|post-traumatic stress disorder
198623|NCT02122458|traumatic brain injury|traumatic brain injury
198624|NCT02122458|auditory processing disorder|auditory processing disorder
198625|NCT02122445|Gluteus Maximum|gluteus maximum
198626|NCT02122445|Gluteus Medius|gluteus medius
198627|NCT02122445|TFL|tfl
198628|NCT02122445|EMG|emg
198629|NCT02122445|Flexion-Response Phenomenon|flexion-response phenomenon
198630|NCT02122445|Thera-Band|thera-band
198631|NCT02122445|kinesiology tape|kinesiology tape
198632|NCT02122432|teledermatology|teledermatology
198633|NCT02122432|dermatology|dermatology
198634|NCT02122432|general practice|general practice
198635|NCT02122432|organization of care|organization of care
198636|NCT02122406|Rheumatoid Arthritis|rheumatoid arthritis
198637|NCT02122406|Depression|depression
198638|NCT02122406|Anxiety|anxiety
198639|NCT02122406|DAS28|das28
198640|NCT02122406|HADS|hads
198641|NCT02122380|Growth Hormone|growth hormone
198642|NCT02122380|Dipeptidyl Peptidase 4|dipeptidyl peptidase 4
198643|NCT02122380|Polycystic Ovary Syndrome|polycystic ovary syndrome
198644|NCT02122328|Twin twin transfusion syndrome|twin twin transfusion syndrome
198646|NCT02122302|Altered gastrointestinal anatomy|altered gastrointestinal anatomy
198647|NCT02122302|Chronic pancreatic disease|chronic pancreatic disease
198648|NCT02122302|Chronic pancreatic pain|chronic pancreatic pain
198649|NCT02122302|Patient self-assessment|patient self-assessment
198650|NCT02122302|Online assessment|online assessment
198651|NCT02122289|Exacerbation, QoL|exacerbation, qol
198652|NCT02122276|Spinal cord injury|spinal cord injury
198653|NCT02122276|Passive motion|passive motion
198654|NCT02122276|Fatigue index|fatigue index
198655|NCT02122276|Hypertonia|hypertonia
198656|NCT02122250|Diabetes|diabetes
198657|NCT02122250|Health literacy|health literacy
198658|NCT02122250|web intervention|web intervention
198659|NCT02122224|satiety|satiety
198660|NCT02122224|satiation|satiation
198661|NCT02122224|diet quality|diet quality
198662|NCT02122224|memory|memory
198663|NCT02122224|obesity|obesity
198664|NCT02122224|protein|protein
198665|NCT02122224|fiber|fiber
198666|NCT02122211|Sperm motility|sperm motility
198667|NCT02122198|Cognitive impairment|cognitive impairment
198668|NCT02122198|Executive function|executive function
243111|NCT01920737|ALL|all
198669|NCT02122198|Arterial stiffness|arterial stiffness
198670|NCT02122198|Endothelial function|endothelial function
198671|NCT02122198|Menopause|menopause
198672|NCT02122198|Women's health|women's health
198673|NCT02122198|Hormone therapy|hormone therapy
198674|NCT02122198|functional MRI|functional mri
198675|NCT02122159|safety|safety
198676|NCT02122159|tolerability|tolerability
198677|NCT02122159|RPE cellular therapy|rpe cellular therapy
198679|NCT02122146|ADC|adc
198680|NCT02122146|PF-06664178|pf-06664178
198681|NCT02122146|solid tumors|solid tumors
198682|NCT02122146|tumors|tumors
198683|NCT02122146|neoplasm metastasis|neoplasm metastasis
198684|NCT02122146|NSCLC|nsclc
198685|NCT02122146|non small cell lung cancer|non small cell lung cancer
198686|NCT02122146|OVCA|ovca
198687|NCT02122146|ovarian cancer|ovarian cancer
198688|NCT02122146|Phase 1|phase 1
198689|NCT02122146|breast cancer|breast cancer
198690|NCT02122133|IC aneurysms, coil embolization, PC 400, radiation exposure,|ic aneurysms, coil embolization, pc 400, radiation exposure,
198691|NCT02122120|enteral nutrition, tube feeding, nutritional support|enteral nutrition, tube feeding, nutritional support
198692|NCT02122107|Treatment Exposure|treatment exposure
198693|NCT02122107|Smoking History|smoking history
198694|NCT02122107|14-071|14-071
198695|NCT02122068|Meditation|meditation
198696|NCT02122068|Mindfulness|mindfulness
198697|NCT02122068|Caregiver|caregiver
198698|NCT02122068|Dementia|dementia
198699|NCT02122068|Depression|depression
198700|NCT02122055|combined sedation|combined sedation
198701|NCT02122029|Lifestyle intervention|lifestyle intervention
198702|NCT02122029|Bariatric surgery|bariatric surgery
198703|NCT02122029|Weight management|weight management
198704|NCT02122029|Physical activity|physical activity
198705|NCT02122016|Ventilator weaning|ventilator weaning
198706|NCT02122016|Protocols|protocols
198707|NCT02122016|Computer driven weaning|computer driven weaning
198708|NCT02122016|Decision Making, Computer-Assisted|decision making, computer-assisted
198709|NCT02122016|Therapy, Computer-Assisted|therapy, computer-assisted
198710|NCT02122016|Respiration, Artificial|respiration, artificial
198711|NCT02122003|sorafenib|sorafenib
198712|NCT02122003|pazopanib|pazopanib
198713|NCT02122003|cross-resistance|cross-resistance
198714|NCT02122003|TKI|tki
198715|NCT02122003|mRCC|mrcc
198716|NCT02121990|(IP) Cisplatin|(ip) cisplatin
198717|NCT02121990|IV/IP Paclitaxel|iv/ip paclitaxel
198718|NCT02121990|IV Bevacizumab|iv bevacizumab
198719|NCT02121990|Oral Olaparib (AZD2281)|oral olaparib (azd2281)
198720|NCT02121990|Optimally Debulked|optimally debulked
198721|NCT02121990|Stage II/III|stage ii/iii
198722|NCT02121990|Ovary|ovary
198723|NCT02121990|Pertoneum|pertoneum
198724|NCT02121990|10-220|10-220
198725|NCT02121964|unilateral primary total hip arthroplasty|unilateral primary total hip arthroplasty
198726|NCT02121964|bilateral primary total hip arthroplasty|bilateral primary total hip arthroplasty
198727|NCT02121964|Arthritis|arthritis
198728|NCT02121964|Orthopedic Disorders|orthopedic disorders
198729|NCT02121964|Orthopedics|orthopedics
198730|NCT02121964|Surgery,|surgery,
198731|NCT02121964|Orthopedic|orthopedic
198732|NCT02121964|arthroplasty|arthroplasty
198733|NCT02121964|hip|hip
198734|NCT02121964|osteoarthritis|osteoarthritis
198735|NCT02121964|capsulectomy|capsulectomy
198736|NCT02121964|capsulotomy|capsulotomy
198737|NCT02121951|Percutaneous Nephrostomy|percutaneous nephrostomy
198738|NCT02121951|Quadtatus Lumborum Block|quadtatus lumborum block
198739|NCT02121951|Cancer|cancer
198740|NCT02121951|Monitored Anaesthesia Care|monitored anaesthesia care
198741|NCT02121938|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
198742|NCT02121938|Microbiome|microbiome
198743|NCT02121925|Registry|registry
198744|NCT02121899|Registry|registry
198745|NCT02121873|breast cancer, nipple aspirate, ductal lavage, hyperplasia|breast cancer, nipple aspirate, ductal lavage, hyperplasia
198746|NCT02121860|Hepatic Impairment|hepatic impairment
198747|NCT02121860|Pharmacokinetics|pharmacokinetics
198748|NCT02121860|Pharmacodynamics|pharmacodynamics
198749|NCT02121808|Morbid Obesity|morbid obesity
198750|NCT02121808|Bariatric Surgery Candidate|bariatric surgery candidate
198751|NCT02121808|Pre-Oxygenation|pre-oxygenation
198752|NCT02121808|Functional Residual Capacity|functional residual capacity
198753|NCT02121795|HIV|hiv
198754|NCT02121795|HIV-1 Positive|hiv-1 positive
198755|NCT02121795|Virologically-suppressed|virologically-suppressed
198756|NCT02121782|QIV|qiv
198757|NCT02121782|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
198758|NCT02121782|Influenza vaccine|influenza vaccine
198759|NCT02121782|Vaccination|vaccination
198760|NCT02121769|cholestasis|cholestasis
198761|NCT02121769|short bowel syndrome|short bowel syndrome
198762|NCT02121756|Dipyridamole|dipyridamole
198763|NCT02121756|HIV|hiv
198764|NCT02121756|Immune Markers|immune markers
198765|NCT02121756|Immune Activation|immune activation
198766|NCT02121756|Inflammation|inflammation
198767|NCT02121743|strattice|strattice
243221|NCT01920360|VAS|vas
189752|NCT02163200|hip|hip
198768|NCT02121743|colostomy|colostomy
198769|NCT02121743|parastomal hernia|parastomal hernia
198770|NCT02121730|grafting kidney|grafting kidney
198771|NCT02121730|Cancer|cancer
198772|NCT02121717|Chiglitazar,diabetes,type 2 diabetes|chiglitazar,diabetes,type 2 diabetes
198773|NCT02121704|Sedation|sedation
198774|NCT02121704|Colonoscopy|colonoscopy
198775|NCT02121704|Propofol|propofol
198776|NCT02121704|Scope guide|scope guide
198777|NCT02121691|Cancer|cancer
198778|NCT02121691|Obesity|obesity
198779|NCT02121691|Body Mass Index|body mass index
198780|NCT02121678|Resistance training|resistance training
198781|NCT02121678|Aerobic exercise|aerobic exercise
198782|NCT02121678|Isokinetic muscle strength|isokinetic muscle strength
198783|NCT02121678|Bicycle ergometry test|bicycle ergometry test
198784|NCT02121678|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
198785|NCT02121652|lung cancer survivors|lung cancer survivors
198786|NCT02121652|insomnia treatment|insomnia treatment
198787|NCT02121652|cognitive behavioral therapy|cognitive behavioral therapy
198788|NCT02121639|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
198789|NCT02121639|AZD5363|azd5363
198790|NCT02121639|Docetaxel|docetaxel
198791|NCT02121639|Prednisolone|prednisolone
198792|NCT02121626|Cancer|cancer
198793|NCT02121626|Chemotheraphy|chemotheraphy
198794|NCT02121626|Small Bowel Bacterial Overgrowth|small bowel bacterial overgrowth
198795|NCT02121626|Bile Acid Malabsorption|bile acid malabsorption
198796|NCT02121626|Pancreatic Insufficiency|pancreatic insufficiency
198797|NCT02121626|Carbohydrate Malabsorption|carbohydrate malabsorption
198798|NCT02121626|Anorexia|anorexia
198799|NCT02121626|Borborygmi|borborygmi
198800|NCT02121626|Bloating|bloating
198801|NCT02121626|Constipation|constipation
198802|NCT02121626|Diarrhoea|diarrhoea
198803|NCT02121626|Mucositis|mucositis
198804|NCT02121626|Dysphagia|dysphagia
198805|NCT02121626|Early satiety|early satiety
198806|NCT02121626|Frequency of defaecation|frequency of defaecation
198807|NCT02121626|Incontinence|incontinence
198808|NCT02121626|Mucus discharge|mucus discharge
198809|NCT02121626|Nausea|nausea
198810|NCT02121626|Nocturnal defaecation|nocturnal defaecation
198811|NCT02121626|Pain|pain
198812|NCT02121626|Reflux|reflux
198813|NCT02121626|Regurgitation|regurgitation
198814|NCT02121626|Steatorrhoea|steatorrhoea
198815|NCT02121626|Tenesmus|tenesmus
198816|NCT02121626|Urgency of defaecation|urgency of defaecation
198819|NCT02121626|Wind.|wind.
198820|NCT02121600|Fluorocholine (FCH)|fluorocholine (fch)
198821|NCT02121600|Positron Emission Tomography (PET)|positron emission tomography (pet)
198822|NCT02121600|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
198823|NCT02121587|Musculoskeletal Pain, Osteopathy, Mindfulness|musculoskeletal pain, osteopathy, mindfulness
198824|NCT02121574|Surgery|surgery
198825|NCT02121574|thermometers|thermometers
198826|NCT02121574|Hypothermia|hypothermia
198827|NCT02121574|anesthesia|anesthesia
198828|NCT02121574|temperature|temperature
198829|NCT02121561|Shame|shame
198830|NCT02121548|Screen|screen
198831|NCT02121548|cervical, cancer|cervical, cancer
198832|NCT02121548|HPV|hpv
198833|NCT02121548|women|women
198834|NCT02121548|community health workers|community health workers
198835|NCT02121548|Hispanic/ Latinas|hispanic/ latinas
198837|NCT02121496|Depression|depression
198838|NCT02121496|Development|development
198839|NCT02121496|Infant sleep|infant sleep
198840|NCT02121470|AKI|aki
198841|NCT02121470|Acute Kidney Injury|acute kidney injury
198842|NCT02121470|Renal failure|renal failure
198843|NCT02121470|NGAL|ngal
198844|NCT02121470|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
198845|NCT02121470|lipocalin-2|lipocalin-2
198846|NCT02121470|siderocalin|siderocalin
198847|NCT02121470|Intensive care|intensive care
198848|NCT02121470|ICU|icu
198849|NCT02121470|Critical care|critical care
198850|NCT02121457|cognitive performance|cognitive performance
198852|NCT02121457|brazil nuts|brazil nuts
198853|NCT02121457|oxidative stress|oxidative stress
198854|NCT02121444|RRMS|rrms
198855|NCT02121444|CIS|cis
198856|NCT02121366|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
198857|NCT02121366|Insulinoma|insulinoma
198858|NCT02121366|Ethanol|ethanol
198859|NCT02121366|Ablation Techniques|ablation techniques
198860|NCT02121353|Age related macular degeneration|age related macular degeneration
198861|NCT02121353|AMD|amd
198862|NCT02121353|Wet AMD|wet amd
198863|NCT02121353|Eye conditions|eye conditions
198864|NCT02121353|CFT|cft
198865|NCT02121353|OCT|oct
198866|NCT02121353|CNV|cnv
198867|NCT02121353|FA|fa
198868|NCT02121353|Ocular|ocular
198869|NCT02121353|Eye|eye
198870|NCT02121353|Disorder of the eye|disorder of the eye
198871|NCT02121340|Depression|depression
198872|NCT02121340|Health disparities|health disparities
243406|NCT01919723|PCI|pci
198873|NCT02121340|African American|african american
198874|NCT02121340|Geriatric|geriatric
198876|NCT02121314|TB|tb
198877|NCT02121314|bioavailability|bioavailability
198878|NCT02121314|HRZE|hrze
198879|NCT02121314|fasting|fasting
198880|NCT02121314|fed|fed
198881|NCT02121301|Dry Eye|dry eye
198882|NCT02121301|Dry Eye Syndrome|dry eye syndrome
198883|NCT02121301|SkQ1|skq1
198884|NCT02121301|KCS|kcs
198885|NCT02121301|Keratoconjunctivitis|keratoconjunctivitis
198886|NCT02121288|Peripheral Artery Disease|peripheral artery disease
198887|NCT02121288|Myocardial Blood Flow|myocardial blood flow
198888|NCT02121288|Cardiac Blood Flow|cardiac blood flow
198889|NCT02121236|CBCT|cbct
198890|NCT02121236|Ultrasonic diagnosis|ultrasonic diagnosis
198891|NCT02121236|Benign radiolucent lesions|benign radiolucent lesions
198892|NCT02121236|Histopathology|histopathology
198893|NCT02121223|acute ST segment elevated myocardial infarction|acute st segment elevated myocardial infarction
198894|NCT02121223|primary percutaneous intervention|primary percutaneous intervention
198895|NCT02121223|Stent Incomplete Apposition|stent incomplete apposition
198896|NCT02121197|Macular Diabetic Edema|macular diabetic edema
198897|NCT02121197|Ozurdex|ozurdex
198898|NCT02121197|Retrospective|retrospective
198899|NCT02121197|European|european
198900|NCT02121197|Intra-vitreal injections|intra-vitreal injections
198901|NCT02121184|Oxytocin|oxytocin
198902|NCT02121184|Labor, Obstetric|labor, obstetric
198903|NCT02121184|Non-reassuring fetal heart rate|non-reassuring fetal heart rate
198904|NCT02121184|Epidural|epidural
198905|NCT02121158|CSP 592|csp 592
198906|NCT02121158|ICD|icd
198907|NCT02121158|cardiovascular|cardiovascular
198908|NCT02121158|heart|heart
198909|NCT02121158|aging|aging
198910|NCT02121158|chronic diseases|chronic diseases
198911|NCT02121158|multi-site trial|multi-site trial
198912|NCT02121158|investigational device|investigational device
198913|NCT02121158|cardiomyopathy|cardiomyopathy
198914|NCT02121158|coronary artery disease|coronary artery disease
198915|NCT02121158|congestive heart failure|congestive heart failure
198916|NCT02121158|myocardial infarction|myocardial infarction
198917|NCT02121158|I-70|i-70
198918|NCT02121158|I70|i70
198919|NCT02121158|elderly|elderly
198920|NCT02121158|defibrillator|defibrillator
198922|NCT02121145|Typherix|typherix
199318|NCT02119585|atelectasis|atelectasis
198923|NCT02121145|Salmonella Typhi|salmonella typhi
198924|NCT02121145|non-typhoid Salmonella|non-typhoid salmonella
198925|NCT02121145|Salmonella Paratyphi|salmonella paratyphi
198926|NCT02121145|enzyme-linked immunospot assay|enzyme-linked immunospot assay
198927|NCT02121145|Plasmablast|plasmablast
198928|NCT02121132|Overweight|overweight
198929|NCT02121132|Obesity|obesity
198930|NCT02121119|Peripheral nerve block|peripheral nerve block
198931|NCT02121119|Lidocaine|lidocaine
198932|NCT02121119|Bupivacaine|bupivacaine
198933|NCT02121093|vibration|vibration
198934|NCT02121093|physiotherapy|physiotherapy
198935|NCT02121093|cortex|cortex
198936|NCT02121093|muscles|muscles
198937|NCT02121067|postpartum|postpartum
198938|NCT02121067|contraception|contraception
198939|NCT02121067|intrauterine device|intrauterine device
198940|NCT02121067|intrauterine system|intrauterine system
198941|NCT02121067|mirena|mirena
198942|NCT02121067|uterine involution|uterine involution
198943|NCT02121054|Antiplatelet Agents|antiplatelet agents
198944|NCT02121054|Drug Resistance|drug resistance
198945|NCT02121041|Hypertension|hypertension
198946|NCT02121041|Blood Pressure|blood pressure
198947|NCT02121041|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
198948|NCT02121028|Intracranial Atherosclerotic Disease|intracranial atherosclerotic disease
198949|NCT02121028|Stroke|stroke
198950|NCT02121028|Transient Ischemic Attack|transient ischemic attack
198951|NCT02121028|Imaging|imaging
198952|NCT02121015|Postpartum Depression|postpartum depression
198953|NCT02121015|Depression Prevention|depression prevention
198954|NCT02121015|Supportive Accountability|supportive accountability
198960|NCT02120989|partner-assisted|partner-assisted
198961|NCT02120976|Safety|safety
198962|NCT02120976|Tolerability|tolerability
198963|NCT02120976|Pharmacokinetics|pharmacokinetics
198964|NCT02120976|Food-effect|food-effect
198965|NCT02120976|Diabetes|diabetes
198966|NCT02120963|Fatigue|fatigue
198967|NCT02120963|Rheumatoid Arthritis|rheumatoid arthritis
198968|NCT02120963|Physical Therapy|physical therapy
198969|NCT02120963|Person-Centred Care|person-centred care
198971|NCT02120937|amygdala|amygdala
198972|NCT02120937|mindfulness|mindfulness
198973|NCT02120937|mood|mood
198974|NCT02120937|emotion|emotion
198975|NCT02120937|bipolar disorder|bipolar disorder
198976|NCT02120937|parental bipolar disorder|parental bipolar disorder
198977|NCT02120937|adolescence|adolescence
198978|NCT02120924|Moderate facial rosacea|moderate facial rosacea
198979|NCT02120924|Azelaic acid|azelaic acid
198980|NCT02120924|Rosacea|rosacea
243498|NCT01919450|PET|pet
198981|NCT02120911|Her2+|her2+
198982|NCT02120911|Resectable esophageal carcinoma|resectable esophageal carcinoma
198983|NCT02120911|Pertuzumab|pertuzumab
198984|NCT02120911|Trastuzumab|trastuzumab
198985|NCT02120898|Actinic Keratosis|actinic keratosis
198986|NCT02120898|Imiquimod|imiquimod
198987|NCT02120898|Zyclara|zyclara
198988|NCT02120885|Gastric cancer|gastric cancer
198989|NCT02120885|minimally invasive gastrectomy|minimally invasive gastrectomy
198990|NCT02120885|Physical activity intervention|physical activity intervention
198991|NCT02120859|PCI|pci
198992|NCT02120859|Drug-eluting balloon (DEB)|drug-eluting balloon (deb)
198993|NCT02120859|Fractional flow reserve (FFR)|fractional flow reserve (ffr)
198994|NCT02120846|Stroke|stroke
198995|NCT02120846|Flywheel resistance exercise|flywheel resistance exercise
198996|NCT02120846|Muscle function|muscle function
198997|NCT02120846|Cognitive function|cognitive function
198998|NCT02120833|Atopic Dermatitis|atopic dermatitis
198999|NCT02120820|massage|massage
199000|NCT02120820|multisensory environment|multisensory environment
199001|NCT02120820|challenging behaviours|challenging behaviours
199002|NCT02120820|relaxation|relaxation
199003|NCT02120807|Certolizumab|certolizumab
199004|NCT02120807|Cisplatin|cisplatin
199005|NCT02120807|Pemetrexed|pemetrexed
199006|NCT02120807|thoracic|thoracic
199007|NCT02120807|13-063|13-063
199008|NCT02120794|Type 1 diabetes|type 1 diabetes
199009|NCT02120794|Pediatric|pediatric
199010|NCT02120794|Threshold Suspend|threshold suspend
199011|NCT02120794|Sensor augmented pump|sensor augmented pump
199012|NCT02120768|Barrier resection|barrier resection
199013|NCT02120768|Local recurrence|local recurrence
199014|NCT02120768|Complication|complication
199015|NCT02120742|Road traffic injury prevention|road traffic injury prevention
199016|NCT02120742|Helmet use|helmet use
199017|NCT02120742|mHealth intervention|mhealth intervention
199018|NCT02120729|Pharmacogenetics|pharmacogenetics
199019|NCT02120729|CYP2D6 Mutations|cyp2d6 mutations
199020|NCT02120729|Major Depressive Disorder|major depressive disorder
199021|NCT02120729|Psychiatric Inpatients|psychiatric inpatients
199022|NCT02120729|Length of Stay|length of stay
199023|NCT02120729|30 Day Readmission Rate|30 day readmission rate
199024|NCT02120729|Psychiatric hospital inpatients|psychiatric hospital inpatients
199025|NCT02120716|HIV|hiv
199026|NCT02120716|STIs|stis
199027|NCT02120716|Health Check Up|health check up
199028|NCT02120716|Intervention|intervention
199029|NCT02120703|Pregabalin|pregabalin
199030|NCT02120703|gabapentin|gabapentin
199031|NCT02120703|microdiscectomy|microdiscectomy
199032|NCT02120703|pain|pain
199033|NCT02120690|pain|pain
199034|NCT02120690|fibromyagia|fibromyagia
199035|NCT02120690|TNS|tns
199036|NCT02120677|skin cancer|skin cancer
199037|NCT02120677|basal cell carcinoma|basal cell carcinoma
199038|NCT02120651|Fibrin monomer|fibrin monomer
199039|NCT02120651|Tympanoplasty|tympanoplasty
199040|NCT02120651|Hemostatic sponge|hemostatic sponge
199041|NCT02120638|Multidrug Resistant Tuberculosis|multidrug resistant tuberculosis
199042|NCT02120638|Pyrazinamide|pyrazinamide
199043|NCT02120625|radiofrequency ablation|radiofrequency ablation
199044|NCT02120625|neurotomy|neurotomy
199045|NCT02120625|facet joint|facet joint
199046|NCT02120625|medial branch|medial branch
199047|NCT02120625|low back pain|low back pain
199048|NCT02120612|Opioid Dependence|opioid dependence
199049|NCT02120612|Addiction|addiction
199050|NCT02120612|Naloxone|naloxone
199051|NCT02120612|Naloxone Education|naloxone education
199052|NCT02120612|Opiate Overdose Knowledge Scale|opiate overdose knowledge scale
199053|NCT02120612|OOKS|ooks
199054|NCT02120586|Elderly|elderly
199055|NCT02120586|Institutionalization|institutionalization
199056|NCT02120586|Sarcopenia|sarcopenia
199057|NCT02120586|Strength training|strength training
199058|NCT02120586|Muscle mass|muscle mass
199059|NCT02120586|Muscle strength|muscle strength
199060|NCT02120586|Physical performance|physical performance
199061|NCT02120573|Cardiac Arrest|cardiac arrest
199062|NCT02120573|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
199063|NCT02120573|Training|training
199064|NCT02120560|Atrial Fibrillation Ablation|atrial fibrillation ablation
199065|NCT02120560|Cerebrothromboemboli|cerebrothromboemboli
199066|NCT02120560|Neurocognitive Function|neurocognitive function
199067|NCT02120547|Liver Insufficiency|liver insufficiency
199068|NCT02120547|Hepatic impairment|hepatic impairment
199069|NCT02120534|soluble CD14 ,serum CD88,sepsis , SIRS.|soluble cd14 ,serum cd88,sepsis , sirs.
199070|NCT02120521|Sepsis and SIRS, ICU|sepsis and sirs, icu
199071|NCT02120508|stroke|stroke
199072|NCT02120508|aphasia|aphasia
199073|NCT02120508|rTMS|rtms
199074|NCT02120508|Functional MRI|functional mri
199075|NCT02120508|Speech training|speech training
199076|NCT02120495|condylectomy|condylectomy
199077|NCT02120495|TMJ function|tmj function
199078|NCT02120495|intraoral approach|intraoral approach
199079|NCT02120482|ABO isoagglutinins|abo isoagglutinins
190067|NCT02161874|T3|t3
199080|NCT02120482|ABO incompatible transplantation|abo incompatible transplantation
199081|NCT02120482|immunoadsorption|immunoadsorption
199082|NCT02120482|membrane filtration|membrane filtration
199083|NCT02120482|plasmapheresis|plasmapheresis
199084|NCT02120443|infiltration|infiltration
199085|NCT02120443|extravasation|extravasation
199086|NCT02120443|peripheral intravenous therapy|peripheral intravenous therapy
199087|NCT02120430|Early childhood|early childhood
199088|NCT02120430|Audiovisual materials|audiovisual materials
199089|NCT02120430|Parent-child interaction|parent-child interaction
199090|NCT02120430|Parenting programs|parenting programs
199091|NCT02120430|Timing|timing
199092|NCT02120417|Breast Cancer|breast cancer
199093|NCT02120404|septic shock, hemodynamic tolerance, esmolol|septic shock, hemodynamic tolerance, esmolol
199094|NCT02120378|miscarriage|miscarriage
199095|NCT02120378|fetal viability|fetal viability
199096|NCT02120378|prematurity|prematurity
199097|NCT02120365|Alcoholism|alcoholism
199098|NCT02120365|Heavy Drinking|heavy drinking
199099|NCT02120365|Perampanel|perampanel
199100|NCT02120352|bi-monthly|bi-monthly
199101|NCT02120352|GSK744|gsk744
199102|NCT02120352|injectable|injectable
199103|NCT02120352|long acting|long acting
199104|NCT02120352|maintenance|maintenance
199105|NCT02120352|abacavir|abacavir
199106|NCT02120352|every other month|every other month
199107|NCT02120352|rilpivirine|rilpivirine
199108|NCT02120352|HIV-1 infection|hiv-1 infection
199109|NCT02120352|integrase inhibitor|integrase inhibitor
199110|NCT02120352|TMC278 LA|tmc278 la
199112|NCT02120352|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
199113|NCT02120352|LA|la
199114|NCT02120352|once monthly|once monthly
199115|NCT02120352|GSK1265744|gsk1265744
199116|NCT02120352|induction|induction
199117|NCT02120352|treatment satisfication|treatment satisfication
199118|NCT02120352|once daily|once daily
199119|NCT02120352|lamivudine|lamivudine
199120|NCT02120352|adherence|adherence
199121|NCT02120352|TMC278|tmc278
199122|NCT02120352|therapy-naive|therapy-naive
199123|NCT02120339|Hypertension|hypertension
199124|NCT02120339|PAH|pah
199125|NCT02120326|Chronic migraine, tDCS, Transcranial direct current stimulation|chronic migraine, tdcs, transcranial direct current stimulation
199126|NCT02120313|rehabilitation|rehabilitation
199519|NCT02118740|Preclinical|preclinical
199132|NCT02120287|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
199133|NCT02120287|Glioblastoma|glioblastoma
199134|NCT02120287|Brain Cancer|brain cancer
199135|NCT02120287|Brain Tumor|brain tumor
199136|NCT02120287|Radiosurgery|radiosurgery
199137|NCT02120274|RNA Virus Infections|rna virus infections
199138|NCT02120274|Flaviviridae Infections|flaviviridae infections
199139|NCT02120274|Hepatitis C|hepatitis c
199140|NCT02120274|Hepatitis C, Chronic|hepatitis c, chronic
199141|NCT02120274|Vitamin D|vitamin d
199142|NCT02120274|Cholecalciferol|cholecalciferol
199143|NCT02120274|Vitamin B 12|vitamin b 12
199144|NCT02120261|Myofascial Pain Syndrome|myofascial pain syndrome
199145|NCT02120261|trigger point injection|trigger point injection
199146|NCT02120248|WIC|wic
199147|NCT02120248|Oregon|oregon
199148|NCT02120248|Breastfeeding|breastfeeding
199149|NCT02120248|Peer Counseling|peer counseling
199150|NCT02120248|Exclusive Breastfeeding|exclusive breastfeeding
199151|NCT02120235|Lysosomal storage disorders|lysosomal storage disorders
199152|NCT02120235|LSD|lsd
199153|NCT02120235|Gaucher disease|gaucher disease
199154|NCT02120235|Fabry disease|fabry disease
199155|NCT02120235|Pompe disease|pompe disease
199156|NCT02120235|Niemann-Pick disease|niemann-pick disease
199157|NCT02120222|melanoma|melanoma
199279|NCT02119689|Diabetes|diabetes
199158|NCT02120209|assessment; falls; older adults; prediction scale; standardized declaration|assessment; falls; older adults; prediction scale; standardized declaration
199159|NCT02120183|Caregivers|caregivers
199160|NCT02120183|Quality of life|quality of life
199161|NCT02120183|Neoplasms|neoplasms
199162|NCT02120183|Psychotherapy, group|psychotherapy, group
199163|NCT02120183|Family|family
199164|NCT02120183|Adaptation, psychological|adaptation, psychological
199165|NCT02120183|Psycho-educational support group therapy|psycho-educational support group therapy
199166|NCT02120183|Cancer patients|cancer patients
199167|NCT02120170|Hemoclip, Heparin bridging therapy, colon polypectomy, warfarin|hemoclip, heparin bridging therapy, colon polypectomy, warfarin
199168|NCT02120157|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
199169|NCT02120157|Acute myeloid leukemia|acute myeloid leukemia
199170|NCT02120157|Juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
199171|NCT02120157|Treatment related leukemia|treatment related leukemia
199172|NCT02120157|Biphenotypic leukemia|biphenotypic leukemia
199173|NCT02120131|third molar surgery, periodontal probing depth , flap design|third molar surgery, periodontal probing depth , flap design
199174|NCT02120118|Treatment failure|treatment failure
199175|NCT02120105|Renal aminoaciduria|renal aminoaciduria
199176|NCT02120105|cystinuria|cystinuria
199177|NCT02120105|D-penicillamine|d-penicillamine
199178|NCT02120105|renal tubular transport|renal tubular transport
199179|NCT02120105|inborn errors|inborn errors
199180|NCT02120105|tiopronin|tiopronin
199181|NCT02120105|urolithiasis|urolithiasis
199182|NCT02120092|ACS, Acute coronary syndrome|acs, acute coronary syndrome
199183|NCT02120079|Dry Eye|dry eye
199184|NCT02120066|Submacular hemorrhage|submacular hemorrhage
199185|NCT02120066|Vitrectomy|vitrectomy
199186|NCT02120066|tissue- plasminogen activator|tissue- plasminogen activator
199187|NCT02120053|Immediate complete denture|immediate complete denture
199188|NCT02120053|Alveolar ridge resorption|alveolar ridge resorption
199189|NCT02120053|Alveolar bone loss|alveolar bone loss
199190|NCT02120053|Bone substitute material|bone substitute material
199191|NCT02120053|Edentulism|edentulism
199192|NCT02120027|Irritable Bowel Syndrome|irritable bowel syndrome
199193|NCT02120027|Colon, irritable|colon, irritable
199194|NCT02120027|Bowel disease|bowel disease
199195|NCT02120027|Diarrhea|diarrhea
199201|NCT02120001|Medical Devices|medical devices
199202|NCT02120001|Ventilator-Associated Pneumonia (VAP)|ventilator-associated pneumonia (vap)
199203|NCT02120001|Ventilator-Associated Events (VAE)|ventilator-associated events (vae)
199204|NCT02120001|Endotracheal Tube|endotracheal tube
199205|NCT02120001|Microbial Diversity|microbial diversity
199206|NCT02120001|Drug-Resistance|drug-resistance
199207|NCT02120001|biofilms|biofilms
199208|NCT02120001|endotracheal intubation|endotracheal intubation
199209|NCT02120001|mechanical ventilation|mechanical ventilation
199210|NCT02119988|TIPS|tips
199211|NCT02119988|Embolization|embolization
199212|NCT02119988|Variceal rebleeding|variceal rebleeding
199213|NCT02119975|Rumination|rumination
199214|NCT02119975|Working memory|working memory
199215|NCT02119975|Depression|depression
199216|NCT02119975|Anxiety|anxiety
199217|NCT02119975|Working memory training|working memory training
199218|NCT02119975|Overgeneral memories|overgeneral memories
199219|NCT02119962|burnout|burnout
199220|NCT02119962|working memory|working memory
199221|NCT02119962|working memory training|working memory training
199222|NCT02119962|cognitive behavioral therapy|cognitive behavioral therapy
199223|NCT02119962|executive control|executive control
199224|NCT02119949|Substance abuse|substance abuse
199225|NCT02119949|Addiction|addiction
199226|NCT02119949|Working memory|working memory
199227|NCT02119949|Craving|craving
199228|NCT02119949|Impulsivity|impulsivity
199229|NCT02119949|Attention control|attention control
199230|NCT02119936|Stress|stress
199231|NCT02119936|Anxiety|anxiety
199232|NCT02119936|Mental Health|mental health
199233|NCT02119936|Mental Health Services|mental health services
199234|NCT02119936|Maternal Mental Health|maternal mental health
199235|NCT02119923|Depression|depression
199236|NCT02119923|Anxiety|anxiety
199237|NCT02119923|Working memory|working memory
199238|NCT02119923|Rumination|rumination
199239|NCT02119923|Cognitive training|cognitive training
199240|NCT02119923|Executive functioning|executive functioning
199241|NCT02119910|pediatric feeding disorders|pediatric feeding disorders
199242|NCT02119910|behavioral intervention|behavioral intervention
199243|NCT02119910|treatment manual|treatment manual
199244|NCT02119910|feeding|feeding
199245|NCT02119910|food refusal|food refusal
199246|NCT02119910|diet|diet
199247|NCT02119897|Oropharyngeal Mucositis|oropharyngeal mucositis
199248|NCT02119897|Myeloablative Hematopoietic Cell Transplantation|myeloablative hematopoietic cell transplantation
199249|NCT02119897|Low Level Light Therapy|low level light therapy
199250|NCT02119884|Gastric and Esophageal Varices|gastric and esophageal varices
199251|NCT02119884|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
199252|NCT02119884|Terlipressin|terlipressin
199253|NCT02119884|Octreotide|octreotide
199254|NCT02119871|Cerebral air emboli, heart surgery|cerebral air emboli, heart surgery
199255|NCT02119845|Chronic kidney disease|chronic kidney disease
199256|NCT02119845|Arteriovenous fistula (AVF)|arteriovenous fistula (avf)
199257|NCT02119845|Hemodialysis|hemodialysis
199258|NCT02119845|Vascular access|vascular access
199259|NCT02119845|Endovascular AVF (EndoAVF)|endovascular avf (endoavf)
199260|NCT02119832|Chronic kidney disease|chronic kidney disease
199261|NCT02119832|Arteriovenous fistula|arteriovenous fistula
199262|NCT02119832|Hemodialysis|hemodialysis
199263|NCT02119832|Vascular access|vascular access
199264|NCT02119819|Weight loss|weight loss
199265|NCT02119806|cardiac surgery, benzodiazepines, delirium|cardiac surgery, benzodiazepines, delirium
199266|NCT02119767|Atherosclerosis|atherosclerosis
199268|NCT02119754|Ulcer|ulcer
199269|NCT02119754|Infected|infected
199270|NCT02119754|Infection|infection
199271|NCT02119741|Interdental papilla|interdental papilla
199272|NCT02119741|hyaluronic acid|hyaluronic acid
199273|NCT02119741|esthetic zone|esthetic zone
199274|NCT02119741|black triangles|black triangles
199275|NCT02119715|Breast Cancer|breast cancer
199276|NCT02119715|Neutropenia|neutropenia
199277|NCT02119715|Febrile Neutropenia|febrile neutropenia
199278|NCT02119702|HIV/AIDS, perinatal HIV infection|hiv/aids, perinatal hiv infection
199280|NCT02119689|Retinopathy|retinopathy
199281|NCT02119676|Metastatic Colorectal Cancer|metastatic colorectal cancer
199282|NCT02119676|Colon Cancer|colon cancer
199283|NCT02119676|Ruxolitinib|ruxolitinib
199284|NCT02119676|adenocarcinoma|adenocarcinoma
199285|NCT02119676|regorafenib|regorafenib
199286|NCT02119676|Jakavi ®|jakavi ®
199287|NCT02119676|Jakafi ®|jakafi ®
199288|NCT02119676|Stivarga ®|stivarga ®
199289|NCT02119663|Metastatic pancreatic cancer|metastatic pancreatic cancer
199290|NCT02119650|Non small cell lung cancer|non small cell lung cancer
199291|NCT02119637|Emotion|emotion
199292|NCT02119637|Tactile Discrimination|tactile discrimination
199293|NCT02119637|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
199294|NCT02119637|Somatosensory|somatosensory
199295|NCT02119637|Somatosensory Cortex|somatosensory cortex
199296|NCT02119624|Neural Networks|neural networks
199297|NCT02119624|Alcoholism|alcoholism
199298|NCT02119624|fMRI|fmri
199299|NCT02119624|Reward|reward
199300|NCT02119624|Addiction|addiction
199301|NCT02119611|Deep Brain Stimulation|deep brain stimulation
199302|NCT02119611|Movement Disorders|movement disorders
199303|NCT02119611|Parkinson's Disease|parkinson's disease
199304|NCT02119611|Dystonia|dystonia
199305|NCT02119611|Essential Tremor|essential tremor
199306|NCT02119598|Prehospital care|prehospital care
199307|NCT02119598|Telemedicine|telemedicine
199308|NCT02119598|Ambulance-based telemedicine|ambulance-based telemedicine
199309|NCT02119585|orthotopic liver transplantation|orthotopic liver transplantation
199310|NCT02119585|ischemia reperfusion syndrome|ischemia reperfusion syndrome
199311|NCT02119585|cytokines|cytokines
199312|NCT02119585|respiratory system elastance|respiratory system elastance
199313|NCT02119585|lung elastance|lung elastance
199314|NCT02119585|chest wall elastance|chest wall elastance
199315|NCT02119585|shunt|shunt
199316|NCT02119585|dead space|dead space
199317|NCT02119585|acute respiratory failure|acute respiratory failure
199319|NCT02119585|pleural effusion|pleural effusion
199320|NCT02119572|diabetes,peer support|diabetes,peer support
199321|NCT02119559|Circulating Tumor Cells|circulating tumor cells
199322|NCT02119559|Treatment Efficiency|treatment efficiency
199323|NCT02119559|Biomarker|biomarker
199324|NCT02119546|Mild CognitIve impairment|mild cognitive impairment
199325|NCT02119546|Alzheimer's disease|alzheimer's disease
199326|NCT02119546|Cognitive function|cognitive function
199327|NCT02119546|Exercise training|exercise training
199328|NCT02119533|brain injury|brain injury
199329|NCT02119533|concussion|concussion
199330|NCT02119533|post traumatic stress|post traumatic stress
199331|NCT02119520|Periodontitis|periodontitis
199332|NCT02119520|Surgery|surgery
199333|NCT02119520|Growth Factors|growth factors
199334|NCT02119520|Statins|statins
199335|NCT02119507|Dental caries|dental caries
199336|NCT02119507|Curodont Repair|curodont repair
199337|NCT02119507|P11-4|p11-4
199338|NCT02119494|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
199339|NCT02119494|phenotypes|phenotypes
199340|NCT02119494|categories|categories
199341|NCT02119494|stage|stage
199342|NCT02119494|GOLD|gold
199343|NCT02119494|treatment|treatment
586127|NCT00523575|Osteoporosis|osteoporosis
199344|NCT02119481|Mindfulness stress reduction training|mindfulness stress reduction training
199345|NCT02119481|Expressive writing condition|expressive writing condition
199346|NCT02119481|Waiting list control condition|waiting list control condition
199347|NCT02119442|Eisenmenger Syndrome, Pulmonary Arterial Hyptertension|eisenmenger syndrome, pulmonary arterial hyptertension
199348|NCT02119429|Blood pressure|blood pressure
199349|NCT02119429|Pre-menopausal|pre-menopausal
199350|NCT02119429|Supplementation|supplementation
199351|NCT02119416|Cardiovascular influences|cardiovascular influences
199352|NCT02119416|caffeine|caffeine
199353|NCT02119416|healthy children|healthy children
199354|NCT02119403|Minimal Sedation nitrous oxide|minimal sedation nitrous oxide
199355|NCT02119390|adolescents|adolescents
199356|NCT02119390|young adults|young adults
199357|NCT02119390|medication adherence|medication adherence
199358|NCT02119377|trans|trans
199359|NCT02119377|transsexual|transsexual
199360|NCT02119377|transgender|transgender
199361|NCT02119377|sistergirl|sistergirl
199362|NCT02119377|brotherboy|brotherboy
199363|NCT02119377|androgynous|androgynous
199364|NCT02119377|genderqueer|genderqueer
199365|NCT02119364|cerebral palsy|cerebral palsy
199366|NCT02119364|working memory|working memory
199367|NCT02119364|cognitive training|cognitive training
199368|NCT02119351|peripheral intravenous catheters|peripheral intravenous catheters
199369|NCT02119351|blood exposure|blood exposure
199370|NCT02119351|blood control|blood control
199371|NCT02119351|IV catheter insertion|iv catheter insertion
199372|NCT02119338|5-ala|5-ala
199373|NCT02119338|5-aminolevulinic acid|5-aminolevulinic acid
199374|NCT02119338|fluorescence-guided surgery|fluorescence-guided surgery
199375|NCT02119338|glioma|glioma
199376|NCT02119338|astrocytoma|astrocytoma
199377|NCT02119338|glioblastoma|glioblastoma
199378|NCT02119338|oligodendroglioma|oligodendroglioma
199379|NCT02119338|recurrence of glioma|recurrence of glioma
199380|NCT02119325|fibre|fibre
199381|NCT02119325|overweight|overweight
199382|NCT02119325|impaired fasting glucose|impaired fasting glucose
199383|NCT02119312|Malaria|malaria
199384|NCT02119312|Plasmodium|plasmodium
199385|NCT02119312|Plasmodium falciparum|plasmodium falciparum
199386|NCT02119312|Clinical Trials|clinical trials
199387|NCT02119312|Vaccine Study|vaccine study
199388|NCT02119312|Drug Study|drug study
199389|NCT02119312|Malaria Clinical Trials Center|malaria clinical trials center
199390|NCT02119312|Seattle BioMed|seattle biomed
199391|NCT02119312|Center for Infectious Disease Research|center for infectious disease research
199392|NCT02119286|long acting beta2- receptor agonist|long acting beta2- receptor agonist
199393|NCT02119286|long acting muscarininc receptor antagonist|long acting muscarininc receptor antagonist
199394|NCT02119286|dry powder inhaler|dry powder inhaler
199395|NCT02119286|safety|safety
199396|NCT02119286|COPD|copd
199397|NCT02119286|inhaled corticosteroid|inhaled corticosteroid
199398|NCT02119286|efficacy|efficacy
199399|NCT02119286|fluticasone furoate/vilanterol|fluticasone furoate/vilanterol
199400|NCT02119286|umeclidinium bromide|umeclidinium bromide
199401|NCT02119273|CRSsNP|crssnp
199402|NCT02119273|Steroids|steroids
199403|NCT02119273|Corticosteroids|corticosteroids
199404|NCT02119273|Endoscopic|endoscopic
199405|NCT02119273|Surgery|surgery
199406|NCT02119273|Perioperative|perioperative
199407|NCT02119260|First Time in Human|first time in human
199408|NCT02119260|TRPV4 inhibitor|trpv4 inhibitor
199409|NCT02119260|Heart failure|heart failure
199410|NCT02119247|systemic availability , pharmacokinetics, COPD|systemic availability , pharmacokinetics, copd
199411|NCT02119195|composite|composite
199412|NCT02119195|sealant|sealant
199413|NCT02119195|longevity|longevity
199414|NCT02119182|Traumatic Brain Injury|traumatic brain injury
199415|NCT02119182|Biomarkers|biomarkers
199416|NCT02119182|Neuroimaging|neuroimaging
199417|NCT02119182|Psychological Health|psychological health
199518|NCT02118740|Spinal Cord Injury|spinal cord injury
199418|NCT02119182|Comparative Effectiveness Research|comparative effectiveness research
199419|NCT02119156|treatment holiday|treatment holiday
199421|NCT02119156|belimumab|belimumab
199422|NCT02119156|Lymphostat-B|lymphostat-b
199423|NCT02119156|rebound|rebound
199424|NCT02119156|SELENA SLEDAI|selena sledai
199425|NCT02119156|Systemic Lupus Erythematosus|systemic lupus erythematosus
199426|NCT02119156|immunogenicity|immunogenicity
199427|NCT02119143|common cold, immunity, oxidative stress|common cold, immunity, oxidative stress
199428|NCT02119130|cluster randomized trial|cluster randomized trial
199429|NCT02119130|interferon-gamma|interferon-gamma
199430|NCT02119130|tuberculin test|tuberculin test
199431|NCT02119130|operational comparison|operational comparison
199432|NCT02119130|cost effectiveness|cost effectiveness
199433|NCT02119130|qualitative evaluation|qualitative evaluation
199434|NCT02119117|mtDNA|mtdna
199435|NCT02119117|aneuploidy|aneuploidy
199436|NCT02119117|IVF|ivf
199437|NCT02119117|blastocyst|blastocyst
199438|NCT02119117|COQ10|coq10
199439|NCT02119091|QT prolongation|qt prolongation
199440|NCT02119091|Chinese|chinese
199441|NCT02119091|Caucasian|caucasian
199442|NCT02119091|Moxifloxacin|moxifloxacin
199443|NCT02119078|Geriatrics|geriatrics
199444|NCT02119078|Acute Care for Elders|acute care for elders
199445|NCT02119078|Geriatric syndromes|geriatric syndromes
199446|NCT02119078|Delirium|delirium
199447|NCT02119078|Falls|falls
199448|NCT02119078|Polypharmacy|polypharmacy
199449|NCT02119065|Yttrium-90 Radioembolization|yttrium-90 radioembolization
199450|NCT02119065|hepatic malignancy|hepatic malignancy
199451|NCT02119065|hepatic metastatic disease|hepatic metastatic disease
199452|NCT02119039|Cross-linking|cross-linking
199453|NCT02119039|RGTA OTR4120 (CACICOL20)|rgta otr4120 (cacicol20)
199454|NCT02119026|metastatic colorectal cancer|metastatic colorectal cancer
199460|NCT02118974|Robot-assisted|robot-assisted
199461|NCT02118974|Laparoscopy|laparoscopy
199462|NCT02118961|Diphtheria|diphtheria
199463|NCT02118961|Tetanus|tetanus
199464|NCT02118961|Pertussis|pertussis
199465|NCT02118961|DTaP vaccine|dtap vaccine
199466|NCT02118961|Adolescents|adolescents
199467|NCT02118948|abuse|abuse
199468|NCT02118948|sexual behavior|sexual behavior
199469|NCT02118948|sexual risk reduction|sexual risk reduction
199470|NCT02118948|behavioral intervention|behavioral intervention
199471|NCT02118896|Tacrolimus|tacrolimus
199472|NCT02118896|FK506E|fk506e
199474|NCT02118896|Advagraf|advagraf
199475|NCT02118896|Kidney Transplantation|kidney transplantation
199476|NCT02118896|Renal Transplantation|renal transplantation
199477|NCT02118896|Heart Transplantation|heart transplantation
199478|NCT02118883|exercise|exercise
199479|NCT02118883|hydration|hydration
199480|NCT02118883|dehydration|dehydration
199481|NCT02118883|rehydration|rehydration
199482|NCT02118883|alkaline water|alkaline water
199483|NCT02118883|blood viscosity|blood viscosity
199484|NCT02118883|plasma osmolality|plasma osmolality
199485|NCT02118883|bioimpedance|bioimpedance
199486|NCT02118870|ACS patients|acs patients
199487|NCT02118870|Older than 18 years|older than 18 years
199488|NCT02118870|PCI|pci
199489|NCT02118870|Combo stent|combo stent
199490|NCT02118857|Microorganisms and foods|microorganisms and foods
199491|NCT02118857|Fecal microbiota|fecal microbiota
199492|NCT02118857|Salivary microbiota|salivary microbiota
199493|NCT02118844|bariatric surgery|bariatric surgery
199494|NCT02118844|surgical conditions|surgical conditions
199495|NCT02118844|deep neuromuscular blockade|deep neuromuscular blockade
199496|NCT02118831|macular degeneration|macular degeneration
199497|NCT02118831|diabetic macular edema|diabetic macular edema
199498|NCT02118831|vein occlusion|vein occlusion
199499|NCT02118831|vascular endothelial growth factor|vascular endothelial growth factor
199500|NCT02118805|ALS|als
199501|NCT02118805|Myasthenia Gravis|myasthenia gravis
199502|NCT02118805|Myopathy|myopathy
199503|NCT02118805|Stroke|stroke
199504|NCT02118805|Parkinson's Disease|parkinson's disease
199505|NCT02118805|Bulbar|bulbar
199506|NCT02118805|Orofacial|orofacial
199507|NCT02118805|Ultrasound|ultrasound
199508|NCT02118805|Electrical Impedance Myography|electrical impedance myography
199509|NCT02118792|atopic dermatitis|atopic dermatitis
199510|NCT02118779|Myotonic Dystrophy Type 1|myotonic dystrophy type 1
199511|NCT02118779|DM1|dm1
199512|NCT02118779|Physical Exercise|physical exercise
199513|NCT02118779|Cognitive Behavioural Therapy|cognitive behavioural therapy
199514|NCT02118779|Biomarkers|biomarkers
199515|NCT02118766|atopic dermatitis|atopic dermatitis
199516|NCT02118753|ischemia-reperfusion injury|ischemia-reperfusion injury
199517|NCT02118740|Autologous Stem Cells|autologous stem cells
199520|NCT02118727|ALS|als
199521|NCT02118727|FTD|ftd
199522|NCT02118727|Tau|tau
199523|NCT02118727|pNF-H/C3|pnf-h/c3
199524|NCT02118714|Kidney Diseases|kidney diseases
199525|NCT02118714|Urologic Diseases|urologic diseases
199526|NCT02118714|Diabetes Complications|diabetes complications
199527|NCT02118714|Diabetes Mellitus|diabetes mellitus
199528|NCT02118714|Endocrine System Diseases|endocrine system diseases
199529|NCT02118714|Diabetic Nephropathies|diabetic nephropathies
199530|NCT02118701|Shared decision making|shared decision making
199531|NCT02118701|Dementia|dementia
199532|NCT02118701|Long-term care|long-term care
199533|NCT02118701|Nursing home|nursing home
199534|NCT02118701|Care plan|care plan
199535|NCT02118636|Joint pain|joint pain
199536|NCT02118636|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
199537|NCT02118636|Estrogen|estrogen
199538|NCT02118636|Androgen|androgen
199539|NCT02118623|Bipolar Disorder|bipolar disorder
199540|NCT02118623|Bipolar|bipolar
199541|NCT02118623|Online intervention|online intervention
199542|NCT02118623|Internet intervention|internet intervention
199543|NCT02118623|Self help|self help
199545|NCT02118545|Liver Resection|liver resection
199546|NCT02118545|Liver Dysfunction|liver dysfunction
199547|NCT02118545|Liver Regeneration|liver regeneration
199548|NCT02118545|Postoperative Outcome|postoperative outcome
199549|NCT02118532|Atherosclerosis|atherosclerosis
199550|NCT02118532|Superficial Femoral Artery|superficial femoral artery
199554|NCT02118519|Chondrogenesis|chondrogenesis
199555|NCT02118519|orthopedics|orthopedics
199556|NCT02118506|Primary Parkinsonism.|primary parkinsonism.
199557|NCT02118506|Rehabilitation.|rehabilitation.
199558|NCT02118506|Biomechanics.|biomechanics.
199559|NCT02118506|Neurological gait disorders.|neurological gait disorders.
199560|NCT02118493|Benign Biliary Stenosis|benign biliary stenosis
199561|NCT02118493|Laser Excision|laser excision
199562|NCT02118480|Parkinson disease, cognitive rehabilitation, REHACOP|parkinson disease, cognitive rehabilitation, rehacop
199563|NCT02118467|Shock|shock
199564|NCT02118467|Vasopressor agents|vasopressor agents
199565|NCT02118467|Norepinephrine|norepinephrine
199566|NCT02118467|Epinephrine|epinephrine
199567|NCT02118467|Phenylephrine|phenylephrine
199568|NCT02118467|Vasopressin|vasopressin
199569|NCT02118467|Atrial fibrillation|atrial fibrillation
199570|NCT02118467|Tachyarrhythmia|tachyarrhythmia
199571|NCT02118454|Medication adherence|medication adherence
199572|NCT02118454|Self-management|self-management
199573|NCT02118454|Depression|depression
199574|NCT02118454|Coping|coping
199575|NCT02118454|Social support|social support
199576|NCT02118454|Mobile health|mobile health
199577|NCT02118454|Antiretroviral treatment|antiretroviral treatment
199578|NCT02118428|whole blood|whole blood
199579|NCT02118428|transfusion|transfusion
199580|NCT02118428|Plasmodium|plasmodium
199581|NCT02118428|Malaria|malaria
199582|NCT02118428|Pathogen Reduction Technology|pathogen reduction technology
199583|NCT02118428|Whole blood transfusion|whole blood transfusion
199584|NCT02118415|not eligible for surgery|not eligible for surgery
199585|NCT02118415|efficacy of immunotherapy following RCTx|efficacy of immunotherapy following rctx
199586|NCT02118376|obesity; fat distribution; inflammation|obesity; fat distribution; inflammation
199587|NCT02118363|upper limb|upper limb
199588|NCT02118363|lower limb|lower limb
199589|NCT02118363|monitoring|monitoring
199590|NCT02118363|assessment|assessment
190550|NCT02159651|prograf|prograf
199591|NCT02118363|sensor|sensor
199592|NCT02118337|select advanced malignancies|select advanced malignancies
199593|NCT02118324|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
199594|NCT02118324|ALL|all
199595|NCT02118324|fitness intervention|fitness intervention
199596|NCT02118311|Acute Leukemias|acute leukemias
199597|NCT02118311|Burkitt's Lymphoma|burkitt's lymphoma
199598|NCT02118311|Natural Killer Cell Malignancies|natural killer cell malignancies
199599|NCT02118311|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
199600|NCT02118311|Myelodysplastic Syndrome|myelodysplastic syndrome
199601|NCT02118311|Large-Cell Lymphoma|large-cell lymphoma
199602|NCT02118311|Hodgkin Lymphoma|hodgkin lymphoma
199603|NCT02118311|Multiple Myeloma|multiple myeloma
199604|NCT02118311|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
199605|NCT02118311|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
199606|NCT02118311|Marginal Zone B-Cell Lymphoma|marginal zone b-cell lymphoma
199607|NCT02118311|Follicular Lymphoma:|follicular lymphoma:
199608|NCT02118311|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
199609|NCT02118311|Mantle-Cell Lymphoma|mantle-cell lymphoma
199610|NCT02118311|Prolymphocytic Leukemia|prolymphocytic leukemia
199611|NCT02118285|Ovarian cancer|ovarian cancer
199612|NCT02118285|Fallopian cancer|fallopian cancer
199613|NCT02118285|Primary peritoneal cancer|primary peritoneal cancer
199614|NCT02118259|Multidisciplinary review of drug prescriptions|multidisciplinary review of drug prescriptions
199714|NCT02117856|Randomized Clinical Trial|randomized clinical trial
199622|NCT02118233|unilateral|unilateral
199623|NCT02118207|SCUBA diving|scuba diving
199624|NCT02118207|Exercise|exercise
199625|NCT02118207|Microparticles|microparticles
199626|NCT02118207|Repetitive diving|repetitive diving
199627|NCT02118207|Endothelial function|endothelial function
199628|NCT02118194|paraplegia|paraplegia
199629|NCT02118194|paralysis|paralysis
199630|NCT02118194|robotics|robotics
199631|NCT02118194|walking|walking
199632|NCT02118194|immobilization|immobilization
199633|NCT02118168|HIV|hiv
199634|NCT02118168|HAART|haart
199635|NCT02118168|Tat Protein|tat protein
199636|NCT02118129|Vitamin D|vitamin d
199637|NCT02118129|Intervention|intervention
199638|NCT02118129|Behaviour|behaviour
199639|NCT02118129|Mobile app|mobile app
199640|NCT02118116|ASIST, gatekeeper, suicide, intervention, First Nations, Aboriginal, educational, prevention, safety|asist, gatekeeper, suicide, intervention, first nations, aboriginal, educational, prevention, safety
199641|NCT02118103|Lumbosacral Region|lumbosacral region
199642|NCT02118103|Psychomotor Performance|psychomotor performance
199643|NCT02118103|Manipulation, Spinal|manipulation, spinal
199644|NCT02118090|malaria|malaria
199645|NCT02118090|Plasmodium vivax|plasmodium vivax
199646|NCT02118090|drug resistance|drug resistance
199647|NCT02118090|chloroquine|chloroquine
199648|NCT02118090|Cambodia|cambodia
199649|NCT02118064|G17DT|g17dt
199650|NCT02118064|irinotecan|irinotecan
199651|NCT02118064|Colorectal Cancer|colorectal cancer
199652|NCT02118051|Infertility|infertility
199653|NCT02118051|IVF|ivf
199654|NCT02118051|Corifollitropin Alfa treatment|corifollitropin alfa treatment
199655|NCT02118051|Ovarian stimulation|ovarian stimulation
199656|NCT02118038|Postpartum haemorrhage|postpartum haemorrhage
199657|NCT02118038|Sulprostone|sulprostone
199658|NCT02118038|Cardiac impact|cardiac impact
199659|NCT02118038|Emotional impact|emotional impact
199660|NCT02118038|Cardiac magnetic imaging resonance|cardiac magnetic imaging resonance
199661|NCT02118025|Off-pump bypass graft surgery|off-pump bypass graft surgery
199662|NCT02118025|Mini extracorporeal circulation bypass surgery|mini extracorporeal circulation bypass surgery
199663|NCT02118012|Chlorcyclizine HCL|chlorcyclizine hcl
199664|NCT02118012|Direct Acting Antivirals|direct acting antivirals
199665|NCT02118012|Ribavirin|ribavirin
199666|NCT02118012|Hepatitis C|hepatitis c
199667|NCT02117999|corneal cross-linking|corneal cross-linking
199668|NCT02117999|transepithelial corneal cross-linking|transepithelial corneal cross-linking
199669|NCT02117999|iontophoresis|iontophoresis
199670|NCT02117999|progressive keratoconus|progressive keratoconus
199671|NCT02117986|critically ill patients|critically ill patients
199672|NCT02117986|colistin dosing|colistin dosing
199673|NCT02117986|multidrug resistant bacteria|multidrug resistant bacteria
199674|NCT02117960|atherosclerotic|atherosclerotic
199675|NCT02117960|BMP-4|bmp-4
199676|NCT02117960|YKL40|ykl40
199677|NCT02117960|HSP70|hsp70
199678|NCT02117960|HSP27|hsp27
199679|NCT02117947|child secondhand smoke|child secondhand smoke
199680|NCT02117947|maternal smoking|maternal smoking
199681|NCT02117947|tobacco|tobacco
199682|NCT02117947|nicotine|nicotine
199683|NCT02117947|behavioral counseling|behavioral counseling
199684|NCT02117947|low-income|low-income
199685|NCT02117947|underserved|underserved
199695|NCT02117921|Mind Body Syndrome|mind body syndrome
199696|NCT02117921|MBS|mbs
199697|NCT02117921|Chronic Pain|chronic pain
199698|NCT02117908|prevention|prevention
199699|NCT02117908|radiofrequency treatment|radiofrequency treatment
199700|NCT02117908|lung cancer ablation|lung cancer ablation
199701|NCT02117895|Distal Pancreatectomy|distal pancreatectomy
199702|NCT02117895|Celiac Plexus|celiac plexus
199703|NCT02117895|Resection|resection
199704|NCT02117895|Pancreatic Cancer|pancreatic cancer
199705|NCT02117895|Body and Tail|body and tail
199706|NCT02117882|lateral approach, bone augmentation , sinus floor elevation|lateral approach, bone augmentation , sinus floor elevation
199707|NCT02117869|Grapefruit juice|grapefruit juice
199708|NCT02117856|Implant-Supported Denture|implant-supported denture
199709|NCT02117856|Single-Implant Denture|single-implant denture
199710|NCT02117856|Patient Satisfaction|patient satisfaction
199711|NCT02117856|Edentulous Mandible|edentulous mandible
199712|NCT02117856|Dental Implants|dental implants
199713|NCT02117856|Standard of Care|standard of care
199720|NCT02117830|Androxal|androxal
199721|NCT02117804|Discharge Planning|discharge planning
199722|NCT02117804|Decision Support|decision support
199723|NCT02117791|Riociguat, Adempas, sGC stimulator, CTEPH, Japan, PMS|riociguat, adempas, sgc stimulator, cteph, japan, pms
199724|NCT02117765|T1D|t1d
199725|NCT02117765|ustekinumab|ustekinumab
199726|NCT02117765|new-onset|new-onset
199727|NCT02117765|diabetes|diabetes
199728|NCT02117726|Sedation;|sedation;
199729|NCT02117726|ARDS;|ards;
199730|NCT02117726|Mechanical ventilation|mechanical ventilation
199731|NCT02117726|Hypnotics|hypnotics
199732|NCT02117726|Antianxiety Drugs|antianxiety drugs
199733|NCT02117726|Causing|causing
199734|NCT02117726|Adverse Effects|adverse effects
199735|NCT02117726|Therapeutic Use|therapeutic use
199736|NCT02117700|fatty liver|fatty liver
199737|NCT02117700|obesity|obesity
199738|NCT02117700|children|children
199739|NCT02117700|oxidative stress|oxidative stress
199740|NCT02117700|antioxidants|antioxidants
199741|NCT02117674|colonoscopy|colonoscopy
199742|NCT02117674|adenoma detection rate|adenoma detection rate
199743|NCT02117674|full spectrum colonoscopy|full spectrum colonoscopy
199744|NCT02117674|right colon retroflexion|right colon retroflexion
199745|NCT02117674|feasibility|feasibility
199746|NCT02117661|L-carnitine|l-carnitine
199747|NCT02117661|Metabolic syndrome|metabolic syndrome
199748|NCT02117661|Atherosclerosis|atherosclerosis
199749|NCT02117661|Coronary artery disease|coronary artery disease
199750|NCT02117661|Carotid|carotid
199751|NCT02117661|Plaque|plaque
199752|NCT02117661|Cardiovascular disease|cardiovascular disease
199753|NCT02117661|Heart disease|heart disease
199754|NCT02117661|Vascular disease|vascular disease
199755|NCT02117648|advanced cancer|advanced cancer
199756|NCT02117648|metastatic cancer|metastatic cancer
199761|NCT02117609|Elderly|elderly
199762|NCT02117609|Nursing home|nursing home
199763|NCT02117609|Functional impairment|functional impairment
199764|NCT02117609|High-protein oral supplement|high-protein oral supplement
199765|NCT02117596|Pediatric|pediatric
199766|NCT02117596|Renal|renal
199771|NCT02117583|oxycodone|oxycodone
199772|NCT02117570|Clostridium difficile|clostridium difficile
199773|NCT02117570|vaccine|vaccine
199774|NCT02117557|Single-incision|single-incision
199775|NCT02117557|Laparoscopy|laparoscopy
199873|NCT02117076|Horizant|horizant
199776|NCT02117557|Colorectal Cancer|colorectal cancer
199777|NCT02117544|Contact lens|contact lens
199778|NCT02117544|Presbyopia|presbyopia
199779|NCT02117544|Multifocal|multifocal
199780|NCT02117518|type 1 diabetes|type 1 diabetes
199781|NCT02117518|autoreactive T cells|autoreactive t cells
199782|NCT02117518|beta cell peptides|beta cell peptides
199783|NCT02117518|genetically modified T cells|genetically modified t cells
199784|NCT02117518|mRNA electroporation|mrna electroporation
199785|NCT02117505|Biological Availability|biological availability
199786|NCT02117505|JNJ-39220675|jnj-39220675
199787|NCT02117505|Healthy|healthy
199788|NCT02117505|Phase 1|phase 1
199789|NCT02117492|hysterectomy|hysterectomy
199790|NCT02117492|vaginal cuff|vaginal cuff
199791|NCT02117479|Metastatic pancreatic cancer|metastatic pancreatic cancer
199792|NCT02117479|Metastatic pancreatic adenocarcinoma that is recurrent|metastatic pancreatic adenocarcinoma that is recurrent
199793|NCT02117466|cetuximab|cetuximab
199794|NCT02117466|PET-imaging|pet-imaging
199795|NCT02117453|ANCA vasculitis|anca vasculitis
199796|NCT02117453|Statin|statin
199797|NCT02117453|Subclinical markers of atherosclerosis|subclinical markers of atherosclerosis
199798|NCT02117453|Cardiovascular events|cardiovascular events
199799|NCT02117453|Myocardial infarction|myocardial infarction
199800|NCT02117453|Stroke|stroke
199801|NCT02117453|Arterial revascularization|arterial revascularization
199802|NCT02117453|Unstable angina|unstable angina
199803|NCT02117453|Death|death
199804|NCT02117440|Lung Cancer|lung cancer
199805|NCT02117440|Lung Neoplasms|lung neoplasms
199806|NCT02117414|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
199807|NCT02117388|Older adults|older adults
199808|NCT02117388|insomnia|insomnia
199809|NCT02117388|CBT-I (cognitive behavioral therapy-insomnia)|cbt-i (cognitive behavioral therapy-insomnia)
199810|NCT02117388|Behavioral Therapy|behavioral therapy
199811|NCT02117388|SRT (sleep restriction therapy)|srt (sleep restriction therapy)
190756|NCT02158676|Glucose|glucose
199812|NCT02117388|Cognitive Therapy|cognitive therapy
199813|NCT02117375|multiple sclerosis|multiple sclerosis
199814|NCT02117375|spinal cord|spinal cord
199816|NCT02117375|longitudinal study|longitudinal study
199817|NCT02117375|disability|disability
199818|NCT02117362|Melanoma|melanoma
199819|NCT02117362|Ipilimumab|ipilimumab
199820|NCT02117362|Yervoy|yervoy
199821|NCT02117362|Galectin|galectin
199822|NCT02117362|GR-MD-02|gr-md-02
199823|NCT02117362|galactoarabino-rhamnogalacturonate|galactoarabino-rhamnogalacturonate
199824|NCT02117362|galectin-3 inhibitor|galectin-3 inhibitor
199825|NCT02117362|Providence Health & Services|providence health & services
199826|NCT02117362|Earle A. Chiles Research Institute|earle a. chiles research institute
199827|NCT02117362|Robert W. Franz Cancer Center|robert w. franz cancer center
199828|NCT02117362|Immunotherapy|immunotherapy
199829|NCT02117349|surgical hemostasis|surgical hemostasis
199830|NCT02117349|bleeding|bleeding
199831|NCT02117349|fibrin sealant|fibrin sealant
199832|NCT02117349|fibrinogen|fibrinogen
199833|NCT02117349|thrombin|thrombin
199834|NCT02117349|spray dried|spray dried
199835|NCT02117323|corneal opacities|corneal opacities
199836|NCT02117323|Optical coherence tomography|optical coherence tomography
199837|NCT02117284|positron emission tomography (PET)|positron emission tomography (pet)
199838|NCT02117284|Rubidium-82|rubidium-82
199839|NCT02117284|myocardial perfusion imaging|myocardial perfusion imaging
199840|NCT02117284|automated elution system|automated elution system
199841|NCT02117284|controlled radioactivity delivery|controlled radioactivity delivery
199842|NCT02117271|obstructive sleep apnea|obstructive sleep apnea
199843|NCT02117271|treatment|treatment
199844|NCT02117271|placebo|placebo
199845|NCT02117271|appearance|appearance
199846|NCT02117271|skin quality|skin quality
199847|NCT02117258|Z-360, Pancreatic cancer, Pancreatic Adenocarcinoma|z-360, pancreatic cancer, pancreatic adenocarcinoma
199848|NCT02117245|Food effect on MGCD265 bioavailability in healthy volunteers|food effect on mgcd265 bioavailability in healthy volunteers
199849|NCT02117232|colonoscopy|colonoscopy
199850|NCT02117232|cecal intubation|cecal intubation
199851|NCT02117232|carbon dioxide insufflation|carbon dioxide insufflation
199852|NCT02117219|Myelodysplastic syndrome|myelodysplastic syndrome
199853|NCT02117219|MDS|mds
199854|NCT02117206|L-arginine|l-arginine
199855|NCT02117180|functional gastrointestinal disorders|functional gastrointestinal disorders
199856|NCT02117180|FGID|fgid
199857|NCT02117180|children|children
199858|NCT02117180|FODMAP|fodmap
199859|NCT02117154|Continuous Glucose Monitoring System|continuous glucose monitoring system
199861|NCT02117154|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
199862|NCT02117141|Food Effect|food effect
199863|NCT02117141|Pharmacokinetics|pharmacokinetics
199864|NCT02117128|Tranexamic Acid|tranexamic acid
199865|NCT02117128|Antifibrinolytic|antifibrinolytic
199866|NCT02117128|Blood transfusion|blood transfusion
199867|NCT02117128|Total knee arthroplasty|total knee arthroplasty
199868|NCT02117076|Restless leg syndrome|restless leg syndrome
199869|NCT02117076|RLS|rls
199870|NCT02117076|gabapentin|gabapentin
199871|NCT02117076|gabapentin enacarbil|gabapentin enacarbil
199872|NCT02117076|Neurontin|neurontin
199874|NCT02117050|Multiple Sclerosis|multiple sclerosis
199875|NCT02117050|Rebif ®|rebif ®
199876|NCT02117050|Tecfidera ™|tecfidera ™
199877|NCT02117050|treatment change|treatment change
199878|NCT02117024|lung|lung
199879|NCT02117024|cancer|cancer
199880|NCT02117024|gp96|gp96
199881|NCT02117024|vaccine|vaccine
199882|NCT02117024|immunotherapy|immunotherapy
199883|NCT02117024|Heat Biologics|heat biologics
199884|NCT02117024|cyclophosphamide|cyclophosphamide
199885|NCT02117024|vinorelbine|vinorelbine
199886|NCT02117024|erlotinib|erlotinib
199887|NCT02117024|gemcitabine|gemcitabine
199888|NCT02117024|paclitaxel|paclitaxel
199889|NCT02117024|docetaxel|docetaxel
199890|NCT02117024|pemetrexed|pemetrexed
199891|NCT02116998|GEN-004|gen-004
199892|NCT02116998|Aluminum hydroxide|aluminum hydroxide
199893|NCT02116998|Vaccine|vaccine
199894|NCT02116998|Streptococcus pneumoniae|streptococcus pneumoniae
199895|NCT02116998|Pneumococcal Infections|pneumococcal infections
199896|NCT02116998|Strep pneumoniae|strep pneumoniae
199897|NCT02116998|Pneumonia|pneumonia
199898|NCT02116985|Dual-Loop TCI|dual-loop tci
199899|NCT02116985|NI|ni
199900|NCT02116985|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
199901|NCT02116972|Osteoarthritis|osteoarthritis
199902|NCT02116972|Knee|knee
199903|NCT02116972|pain|pain
199904|NCT02116972|steroid|steroid
199905|NCT02116972|intra-articular|intra-articular
199906|NCT02116972|injection|injection
199907|NCT02116959|Systemic|systemic
199908|NCT02116959|Chemotherapy|chemotherapy
199909|NCT02116959|Melphalan|melphalan
199910|NCT02116933|Autologous Fat Grafting|autologous fat grafting
199911|NCT02116933|Breast Augmentation|breast augmentation
199912|NCT02116933|Stromal Vascular Fraction|stromal vascular fraction
199913|NCT02116933|Adipose Derived Stem Cell|adipose derived stem cell
199914|NCT02116920|CIN|cin
199915|NCT02116920|HPV DNA|hpv dna
199916|NCT02116920|mRNA E6/E7|mrna e6/e7
199917|NCT02116920|CIN triage|cin triage
199918|NCT02116920|Cervix Biopsy|cervix biopsy
199924|NCT02116894|PF-03446962|pf-03446962
199925|NCT02116894|regorafenib|regorafenib
199926|NCT02116881|Incisional hernia|incisional hernia
199927|NCT02116881|colorectal surgery|colorectal surgery
199928|NCT02116881|bowel obstruction|bowel obstruction
199929|NCT02116868|Pupillometry|pupillometry
199930|NCT02116868|Pupillary reflex|pupillary reflex
199931|NCT02116868|Analgesia|analgesia
199932|NCT02116868|Laparoscopic surgery|laparoscopic surgery
199933|NCT02116868|Total intravenous anesthesia|total intravenous anesthesia
199934|NCT02116868|Target controlled infusion|target controlled infusion
199935|NCT02116803|solid tumors,|solid tumors,
199936|NCT02116803|TKI258|tki258
199937|NCT02116790|acute|acute
199938|NCT02116790|pain|pain
199939|NCT02116764|Hematopoietic (Stem) Cell Transplantation|hematopoietic (stem) cell transplantation
199940|NCT02116764|Primary Immune Deficiency Consortium|primary immune deficiency consortium
199941|NCT02116751|HIV, antiretroviral, toxicity, eGFR, tubular disease, BMD|hiv, antiretroviral, toxicity, egfr, tubular disease, bmd
199942|NCT02116738|flap|flap
199943|NCT02116738|pilonidal sinus|pilonidal sinus
199944|NCT02116738|vas|vas
199945|NCT02116738|recurrence|recurrence
199946|NCT02116712|LAM|lam
199947|NCT02116712|saracatinib|saracatinib
199948|NCT02116712|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
199949|NCT02116699|oropharyngeal|oropharyngeal
199950|NCT02116699|colostrum|colostrum
199951|NCT02116699|mother's milk|mother's milk
199952|NCT02116699|premature|premature
199953|NCT02116699|neonate|neonate
199954|NCT02116699|infection|infection
199955|NCT02116699|necrotizing enterocolitis|necrotizing enterocolitis
199956|NCT02116699|ventilator-associated pneumonia|ventilator-associated pneumonia
199957|NCT02116699|breastmilk|breastmilk
199958|NCT02116699|human milk|human milk
199959|NCT02116699|late-onset sepsis|late-onset sepsis
199960|NCT02116699|microbiome|microbiome
199961|NCT02116699|antioxidant|antioxidant
199962|NCT02116699|enteral feeds|enteral feeds
199963|NCT02116686|chronic heart failure|chronic heart failure
199964|NCT02116686|Polysomnography|polysomnography
199965|NCT02116686|Sleep Apnea Syndromes|sleep apnea syndromes
199966|NCT02116686|Electrocardiogram|electrocardiogram
199967|NCT02116673|Head injury|head injury
199968|NCT02116673|Concussion|concussion
199970|NCT02116673|Emergency department|emergency department
199971|NCT02116647|Gender discrimination|gender discrimination
199972|NCT02116647|Psychoanalysis|psychoanalysis
199973|NCT02116647|Randomized controlled trial|randomized controlled trial
199974|NCT02116621|Musculoskeletal pain|musculoskeletal pain
199975|NCT02116621|Chronic pain|chronic pain
199976|NCT02116621|Patient centered outcomes research|patient centered outcomes research
199977|NCT02116621|Physician patient relationship|physician patient relationship
199978|NCT02116621|Mobile applications|mobile applications
199979|NCT02116595|volunteers|volunteers
199985|NCT02116569|Multiple Myeloma|multiple myeloma
199986|NCT02116569|Daratumumab|daratumumab
199987|NCT02116569|JNJ-54767414|jnj-54767414
199988|NCT02116569|Phase 1|phase 1
199989|NCT02116569|Relapse|relapse
199990|NCT02116569|Refractory|refractory
199991|NCT02116556|Alcoholic Hepatitis|alcoholic hepatitis
199992|NCT02116556|Bacterial Infections|bacterial infections
199993|NCT02116556|Acute-on-Chronic Liver Failure|acute-on-chronic liver failure
199994|NCT02116543|Hepatitis C|hepatitis c
199996|NCT02116517|obese women|obese women
199997|NCT02116517|high LDL-C|high ldl-c
199998|NCT02116504|Rheumatoid arthritis|rheumatoid arthritis
199999|NCT02116504|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
200000|NCT02116504|Biopharmaceutical|biopharmaceutical
200001|NCT02116504|Immunogenicity|immunogenicity
200002|NCT02116504|Anti-Drug Antibody|anti-drug antibody
200003|NCT02116504|Prediction|prediction
200004|NCT02116478|plantar fasciitis|plantar fasciitis
200005|NCT02116478|gastrocnemius recession|gastrocnemius recession
200006|NCT02116439|Violence|violence
200007|NCT02116426|copeptin|copeptin
200008|NCT02116426|troponin HS|troponin hs
200009|NCT02116413|fluid challenge|fluid challenge
200010|NCT02116413|fluid resuscitation|fluid resuscitation
200011|NCT02116400|Suicidal ideation|suicidal ideation
200012|NCT02116387|Proprioception|proprioception
200013|NCT02116348|Cerebral palsy children|cerebral palsy children
200014|NCT02116348|Cerebrolysin|cerebrolysin
200015|NCT02116348|Sleep questionnaire|sleep questionnaire
200016|NCT02116348|Quality of life|quality of life
200017|NCT02116348|Bayley III scale|bayley iii scale
200018|NCT02116335|arterial stiffness|arterial stiffness
200019|NCT02116335|flow-mediated dilation|flow-mediated dilation
200494|NCT02114593|Children|children
200020|NCT02116335|endothelial function|endothelial function
200021|NCT02116335|pulse wave velocity|pulse wave velocity
200022|NCT02116335|inflammation|inflammation
200023|NCT02116335|oxidative stress|oxidative stress
200024|NCT02116335|Nitric Oxide|nitric oxide
200025|NCT02116335|Cold Pressor Test|cold pressor test
200026|NCT02116335|physio flow|physio flow
200027|NCT02116335|Bosentan|bosentan
200028|NCT02116335|Endothelin Receptor|endothelin receptor
200029|NCT02116335|Endothelin-1|endothelin-1
200030|NCT02116335|BMI|bmi
200031|NCT02116335|stress|stress
200032|NCT02116335|blood pressure|blood pressure
200033|NCT02116283|smoking|smoking
200034|NCT02116283|healthy|healthy
200035|NCT02116283|smartphone|smartphone
200036|NCT02116270|Renal Failure|renal failure
200037|NCT02116270|Dialysis|dialysis
200038|NCT02116270|Biological Aging|biological aging
200039|NCT02116257|Nausea|nausea
200040|NCT02116257|Vomiting|vomiting
200041|NCT02116244|Dry Eye|dry eye
200042|NCT02116244|Civamide|civamide
200043|NCT02116244|Zucapsaicin|zucapsaicin
200044|NCT02116244|Neuropeptides|neuropeptides
200045|NCT02116244|TRPV-1|trpv-1
200046|NCT02116231|Nasopharyngeal neoplasm;IMRT; Concurrent chemotherapy|nasopharyngeal neoplasm;imrt; concurrent chemotherapy
200047|NCT02116218|Traditional Chinese Medicine|traditional chinese medicine
200048|NCT02116218|acupuncture|acupuncture
200049|NCT02116218|complementary alternative medicine|complementary alternative medicine
200050|NCT02116218|cancer pain|cancer pain
200051|NCT02116218|emergency department|emergency department
200052|NCT02116205|Hantaan virus|hantaan virus
200053|NCT02116205|Puumala virus|puumala virus
200054|NCT02116205|HFRS|hfrs
200055|NCT02116192|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
200056|NCT02116192|Adolescent|adolescent
200057|NCT02116179|Human Immunodeficiency Virus|human immunodeficiency virus
200058|NCT02116179|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
200059|NCT02116179|Hepatitis C|hepatitis c
200060|NCT02116179|Hispanic|hispanic
200061|NCT02116179|Criminal Justice|criminal justice
200062|NCT02116166|aging|aging
200063|NCT02116166|sarcopenia|sarcopenia
200064|NCT02116166|mitochondria|mitochondria
200065|NCT02116166|skeletal muscle|skeletal muscle
200066|NCT02116166|inflammation|inflammation
200067|NCT02116153|Cardiac Troponin T|cardiac troponin t
200068|NCT02116153|Micro-RNA|micro-rna
200069|NCT02116153|Sensitivity|sensitivity
200070|NCT02116153|Specificity|specificity
200071|NCT02116140|positron emission tomography|positron emission tomography
200072|NCT02116140|[11C]hydroxyephedrine (HED)|[11c]hydroxyephedrine (hed)
200073|NCT02116140|[11C]acetate|[11c]acetate
200074|NCT02116140|Adaptive Servoventilation (ASV)|adaptive servoventilation (asv)
200075|NCT02116140|Myocardial Energetics|myocardial energetics
200076|NCT02116140|work-metabolic index (WMI)|work-metabolic index (wmi)
200077|NCT02116140|Myocardial sympathetic neuron (SN) presynaptic function continuous positive airway pressure|myocardial sympathetic neuron (sn) presynaptic function continuous positive airway pressure
200078|NCT02116140|heart rate variability|heart rate variability
200079|NCT02116140|overnight polysomnogram|overnight polysomnogram
200080|NCT02116140|Plasma Norepinephrine|plasma norepinephrine
200081|NCT02116140|Urine Normetanephrine|urine normetanephrine
200082|NCT02116140|Quality of Life|quality of life
200083|NCT02116127|Depression|depression
200084|NCT02116127|Pregnancy|pregnancy
200085|NCT02116127|Transcranial Direct Current Stimulation|transcranial direct current stimulation
200086|NCT02116114|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
200087|NCT02116101|Intestinal Health|intestinal health
200088|NCT02116101|Prebiotics|prebiotics
200089|NCT02116101|Blood Lipid|blood lipid
200090|NCT02116088|Externalizing problem behavior, teacher training, teacher coaching, primary school, elementary school, continuing professional development, advanced training|externalizing problem behavior, teacher training, teacher coaching, primary school, elementary school, continuing professional development, advanced training
200091|NCT02116049|Disclosure, intervention|disclosure, intervention
200093|NCT02116049|prevention|prevention
200094|NCT02116049|Disclosure Intervention|disclosure intervention
200095|NCT02116049|Attention Control Case Management|attention control case management
200096|NCT02116036|Antiphospholipid Antibody Syndrome|antiphospholipid antibody syndrome
200097|NCT02116036|Rivaroxaban|rivaroxaban
200098|NCT02116036|Thromboembolism|thromboembolism
200099|NCT02116036|Bleeding|bleeding
200100|NCT02116036|Feasibility|feasibility
200101|NCT02116023|Satiety, beverage, crossover|satiety, beverage, crossover
200102|NCT02116010|Wound Infection in burned patient|wound infection in burned patient
200103|NCT02115971|chronic|chronic
200104|NCT02115971|functional|functional
200105|NCT02115971|instability|instability
200106|NCT02115971|ankle|ankle
200107|NCT02115945|chronic postoperative pain|chronic postoperative pain
200108|NCT02115945|total knee arthroplasty|total knee arthroplasty
200109|NCT02115945|femoral block|femoral block
200110|NCT02115945|We aimed to compare the effects of epidural and femoral block on acute and chronic postoperative pain.|we aimed to compare the effects of epidural and femoral block on acute and chronic postoperative pain.
200111|NCT02115932|Diabetes Mellitus|diabetes mellitus
200112|NCT02115932|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
244865|NCT01912950|IPL|ipl
191040|NCT02157324|Btk|btk
200113|NCT02115932|Diabetes Complications|diabetes complications
200114|NCT02115932|Diabetic Foot|diabetic foot
200115|NCT02115932|Diabetic Neuropathies|diabetic neuropathies
200116|NCT02115932|Gait|gait
200117|NCT02115932|Balance, Postural|balance, postural
200118|NCT02115932|Muscle Strength|muscle strength
200119|NCT02115932|Exercise Therapy|exercise therapy
200120|NCT02115932|Physical Therapy Modalities|physical therapy modalities
200121|NCT02115932|Endocrine System Diseases|endocrine system diseases
200122|NCT02115932|Peripheral Nervous System Diseases|peripheral nervous system diseases
200123|NCT02115932|Metabolic Diseases|metabolic diseases
200124|NCT02115932|Glucose Metabolism Diseases|glucose metabolism diseases
200125|NCT02115932|Quality of Life|quality of life
200126|NCT02115932|Training|training
200127|NCT02115919|condyloma|condyloma
200128|NCT02115919|HIV|hiv
200129|NCT02115893|Nitrate|nitrate
200130|NCT02115893|Performance|performance
200131|NCT02115893|Sports|sports
200132|NCT02115880|Depression|depression
200133|NCT02115880|Prevention|prevention
200134|NCT02115880|Adolescent|adolescent
200135|NCT02115880|Child|child
200136|NCT02115880|Randomised Controlled Trial|randomised controlled trial
200137|NCT02115880|Risk|risk
200138|NCT02115880|Cognitive behavioural therapy|cognitive behavioural therapy
200139|NCT02115880|Group-based therapy|group-based therapy
200140|NCT02115867|diverticular disease|diverticular disease
200141|NCT02115867|diverticulitis|diverticulitis
200142|NCT02115867|diverticulosis|diverticulosis
200143|NCT02115854|usefullness of labial biopsy to distinguish between tuberculosis and sarcoidosis|usefullness of labial biopsy to distinguish between tuberculosis and sarcoidosis
200144|NCT02115841|Transcutaneous Nerve Stimulation|transcutaneous nerve stimulation
200145|NCT02115841|serial reaction time task|serial reaction time task
200146|NCT02115841|functional near infrared spectroscopy|functional near infrared spectroscopy
200147|NCT02115841|transcranial magnetic stimulation|transcranial magnetic stimulation
200148|NCT02115828|Vismodegib|vismodegib
200149|NCT02115828|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
200150|NCT02115828|Accessible Metastatic Lesions for Tumor Biopsy|accessible metastatic lesions for tumor biopsy
200151|NCT02115815|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
200152|NCT02115815|MEDI7510|medi7510
200153|NCT02115789|cicatrix|cicatrix
200154|NCT02115789|Demonstrate|demonstrate
200155|NCT02115789|that there|that there
200156|NCT02115789|is no perception of superiority|is no perception of superiority
200157|NCT02115776|bacteremia|bacteremia
200158|NCT02115776|prophylaxis|prophylaxis
200159|NCT02115776|antibiotics|antibiotics
200160|NCT02115776|dentistry|dentistry
200161|NCT02115763|physically active,|physically active,
200162|NCT02115763|18-35 year old men|18-35 year old men
200163|NCT02115750|CHS-0214|chs-0214
200164|NCT02115750|Enbrel|enbrel
200165|NCT02115750|RA|ra
200166|NCT02115750|Biosimilar|biosimilar
200167|NCT02115750|Etanercept|etanercept
200168|NCT02115724|Low childhood SES|low childhood ses
200169|NCT02115724|Early Life Stress|early life stress
200170|NCT02115724|Endothelial function|endothelial function
200171|NCT02115724|Flow mediated dilation|flow mediated dilation
200172|NCT02115724|Cardiovascular disease|cardiovascular disease
200173|NCT02115724|Subcutaneous adipose arterioles|subcutaneous adipose arterioles
200174|NCT02115711|India|india
200175|NCT02115711|Cardiovascular risk factors|cardiovascular risk factors
200176|NCT02115711|Community health workers|community health workers
200177|NCT02115711|Hypertension|hypertension
200178|NCT02115711|Diabetes|diabetes
200179|NCT02115711|Smoking|smoking
200180|NCT02115698|Sarcopenia|sarcopenia
200181|NCT02115698|Frailty|frailty
200182|NCT02115698|Ageing|ageing
200183|NCT02115698|Protein supplementation|protein supplementation
200184|NCT02115698|Protein quality|protein quality
200185|NCT02115698|Exercise training|exercise training
200186|NCT02115698|Muscle protein turnover|muscle protein turnover
200187|NCT02115685|spinal cord injury|spinal cord injury
200188|NCT02115685|sympathetic nervous system|sympathetic nervous system
200189|NCT02115685|locomotor training|locomotor training
200190|NCT02115685|exercise|exercise
200191|NCT02115672|Chronic myeloid leukemia|chronic myeloid leukemia
200192|NCT02115672|imatinib|imatinib
200193|NCT02115672|CXCR4 antagonist|cxcr4 antagonist
200194|NCT02115672|BL-8040|bl-8040
200195|NCT02115659|ADPKD|adpkd
200196|NCT02115659|triptolide|triptolide
200197|NCT02115646|burn|burn
200198|NCT02115646|scar|scar
200199|NCT02115620|Heart failure|heart failure
200200|NCT02115620|Cardiac failure|cardiac failure
200201|NCT02115620|Congestive Heart Failure|congestive heart failure
200202|NCT02115620|Cardiomyopathy|cardiomyopathy
200203|NCT02115620|Myocardial Failure|myocardial failure
200204|NCT02115620|Telemedicine|telemedicine
200205|NCT02115620|Telehealth|telehealth
200206|NCT02115620|Remote Consultation|remote consultation
200207|NCT02115607|Breast cancer|breast cancer
200208|NCT02115607|Interstitial fluid pressure|interstitial fluid pressure
200209|NCT02115607|Angiogenesis|angiogenesis
200798|NCT02113397|Sputum|sputum
200210|NCT02115607|Contrast enhanced ultrasound imaging|contrast enhanced ultrasound imaging
200211|NCT02115607|Subharmonic imaging|subharmonic imaging
200212|NCT02115607|Subharmonic pressure estimation|subharmonic pressure estimation
200213|NCT02115594|metastatic breast cancer|metastatic breast cancer
200214|NCT02115594|estrogen receptor|estrogen receptor
200215|NCT02115594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
200216|NCT02115594|Histone Deacetylases|histone deacetylases
200217|NCT02115594|HDAC inhibitors|hdac inhibitors
200218|NCT02115594|selective estrogen receptor modulator|selective estrogen receptor modulator
200219|NCT02115594|estrogen receptor modulator, selective|estrogen receptor modulator, selective
200220|NCT02115594|Estrogen receptor modulators, selective|estrogen receptor modulators, selective
200221|NCT02115581|Coenzyme O10|coenzyme o10
200222|NCT02115581|Children|children
200223|NCT02115581|Idiopathic Dilated Cardiomyopathy|idiopathic dilated cardiomyopathy
200224|NCT02115555|type 1|type 1
200225|NCT02115555|diabetes|diabetes
200226|NCT02115555|adolescents|adolescents
200227|NCT02115555|heath information technology|heath information technology
200228|NCT02115542|biliary|biliary
200229|NCT02115542|liver|liver
200230|NCT02115542|Refractory Advanced Biliary Cancers|refractory advanced biliary cancers
200231|NCT02115542|gallbladder cancer|gallbladder cancer
200232|NCT02115542|carcinoma|carcinoma
200233|NCT02115542|intra-hepatic biliary system|intra-hepatic biliary system
200234|NCT02115542|extra-hepatic biliary system|extra-hepatic biliary system
200235|NCT02115542|gall bladder|gall bladder
200236|NCT02115542|unresectable|unresectable
200237|NCT02115542|locally advanced|locally advanced
200238|NCT02115542|metastatic disease|metastatic disease
200239|NCT02115542|Bile Duct Diseases|bile duct diseases
200240|NCT02115542|Gallbladder Diseases|gallbladder diseases
200241|NCT02115542|regorafenib|regorafenib
200242|NCT02115542|stivarga|stivarga
200243|NCT02115542|Bay 73-4506|bay 73-4506
200244|NCT02115542|multikinase inhibitor|multikinase inhibitor
200245|NCT02115516|Malaria|malaria
200246|NCT02115516|Plasmodium falciparum malaria|plasmodium falciparum malaria
200247|NCT02115516|Antimalarial chemoprophylaxis|antimalarial chemoprophylaxis
200248|NCT02115516|PfSPZ Challenge|pfspz challenge
401991|NCT01233596|congenital nasolacrimal duct obstruction|congenital nasolacrimal duct obstruction
200249|NCT02115516|Cryopreserved Plasmodium Falciparum Sporozoites|cryopreserved plasmodium falciparum sporozoites
200250|NCT02115516|PfSPZ-CVac|pfspz-cvac
200251|NCT02115490|Alveolar bone|alveolar bone
200252|NCT02115490|Bisphosphonates|bisphosphonates
200253|NCT02115490|Cone-beam CT|cone-beam ct
200254|NCT02115490|Osteoporosis|osteoporosis
200255|NCT02115477|Uterus cancer|uterus cancer
200256|NCT02115477|Hysterectomy|hysterectomy
200257|NCT02115477|Lymphadenectomy|lymphadenectomy
200258|NCT02115477|Lymphedema|lymphedema
200259|NCT02115464|Metformin|metformin
200260|NCT02115464|Non-small cell lung cancer|non-small cell lung cancer
200261|NCT02115464|Locally advanced|locally advanced
200262|NCT02115464|Chemo-radiotherapy|chemo-radiotherapy
200263|NCT02115464|Lung cancer treatment|lung cancer treatment
200264|NCT02114476|GDM|gdm
200265|NCT02114476|implant|implant
200266|NCT02114476|diabetes mellitus|diabetes mellitus
200267|NCT02114476|metabolic syndrome|metabolic syndrome
200268|NCT02114463|Local analgesia system|local analgesia system
200269|NCT02114463|Ropivacaine|ropivacaine
200270|NCT02114463|Analgesic efficacy after operation|analgesic efficacy after operation
200271|NCT02114463|Postoperative|postoperative
200272|NCT02114450|Stroke|stroke
200273|NCT02114450|Paresis|paresis
200274|NCT02114450|Gait rehabilitation|gait rehabilitation
200275|NCT02114450|Human-Machine Interaction|human-machine interaction
200276|NCT02114450|Wearable Robotic Devices|wearable robotic devices
200277|NCT02114437|Closed-Loop TCI|closed-loop tci
200278|NCT02114437|NI|ni
200279|NCT02114437|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
200280|NCT02114424|Positional Obstructive sleep apnea syndrome (POSAS)|positional obstructive sleep apnea syndrome (posas)
200281|NCT02114424|Obstructive sleep apnea syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
200282|NCT02114424|Apnea-Hypnea Index (AHI)|apnea-hypnea index (ahi)
200283|NCT02114424|Sleep questionnaire|sleep questionnaire
200284|NCT02114424|Positional sleep apnea belt|positional sleep apnea belt
200285|NCT02114424|Adverse events|adverse events
200286|NCT02114424|Compliance|compliance
200287|NCT02114385|Prevention|prevention
200288|NCT02114372|Alzheimer's disease|alzheimer's disease
200289|NCT02114372|Asymptomatic at risk for Alzheimer's disease|asymptomatic at risk for alzheimer's disease
200290|NCT02114372|Retinal diagnosis for Alzheimer's disease|retinal diagnosis for alzheimer's disease
200291|NCT02114359|gastric cancer, elderly, chemotherapy|gastric cancer, elderly, chemotherapy
200292|NCT02114346|Computed Tomography Angiogram|computed tomography angiogram
200293|NCT02114346|Side Effects|side effects
200294|NCT02114346|Contrast-Induced Nephropathy|contrast-induced nephropathy
200295|NCT02114346|Prevention|prevention
245116|NCT01911689|MRI|mri
200296|NCT02114333|Shingles vaccine|shingles vaccine
200297|NCT02114333|Immune response|immune response
200298|NCT02114333|Zoster vaccine|zoster vaccine
200299|NCT02114320|Endoscopic ultrasonography|endoscopic ultrasonography
200300|NCT02114320|Biliary drainage|biliary drainage
200301|NCT02114320|Metal stent|metal stent
200302|NCT02114307|electrical stimulation|electrical stimulation
200303|NCT02114307|venous insufficiency|venous insufficiency
200304|NCT02114307|post thrombotic syndrome|post thrombotic syndrome
200305|NCT02114307|varicose veins|varicose veins
200306|NCT02115399|Dermatitis|dermatitis
200307|NCT02115399|Staphylococcus|staphylococcus
200308|NCT02115399|Staphylococcus aureus|staphylococcus aureus
200309|NCT02115399|Dermatitis, Atopic|dermatitis, atopic
200310|NCT02115399|Non-atopic controls|non-atopic controls
200311|NCT02115386|Ph+ CML, chronic myeloid leukemia|ph+ cml, chronic myeloid leukemia
200312|NCT02115373|Hepatocellular Carcinoma|hepatocellular carcinoma
200313|NCT02115373|c-Met inhibitor|c-met inhibitor
200314|NCT02115373|Phase 1b|phase 1b
200315|NCT02115373|Sorafenib|sorafenib
200316|NCT02115373|MSC2156119J|msc2156119j
200317|NCT02115360|epidural calcitonin|epidural calcitonin
200318|NCT02115360|amputation|amputation
200319|NCT02115360|postoperative pain|postoperative pain
200320|NCT02115360|Later Complication|later complication
200321|NCT02115334|Developmental delay|developmental delay
200322|NCT02115334|Early Intervention|early intervention
200323|NCT02115334|Home programs|home programs
200324|NCT02115334|Preschool activities|preschool activities
200325|NCT02115295|Leukemia|leukemia
200326|NCT02115295|Acute Myeloid Leukemia|acute myeloid leukemia
200327|NCT02115295|AML|aml
200328|NCT02115295|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
200329|NCT02115295|HR MDS|hr mds
200330|NCT02115295|Myeloid Blast Phase of Chronic Myeloid Leukemia|myeloid blast phase of chronic myeloid leukemia
200331|NCT02115295|CML|cml
200332|NCT02115295|Acute Biphenotypic Leukemia|acute biphenotypic leukemia
200333|NCT02115295|Cladribine|cladribine
200334|NCT02115295|Leustatin|leustatin
200335|NCT02115295|2-CdA|2-cda
200336|NCT02115295|Cytarabine|cytarabine
200337|NCT02115295|Ara-C|ara-c
200338|NCT02115295|Cytosar|cytosar
200339|NCT02115295|DepoCyt|depocyt
200340|NCT02115295|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
200341|NCT02115295|Idarubicin|idarubicin
200342|NCT02115295|Idamycin|idamycin
200343|NCT02115295|Phone calls|phone calls
200344|NCT02115269|Indoprocaf|indoprocaf
200345|NCT02115269|Indomethacin|indomethacin
200346|NCT02115269|Caffeine|caffeine
200347|NCT02115269|Prochlorperazine|prochlorperazine
200348|NCT02115269|Migraine with Aura|migraine with aura
200349|NCT02115269|Migraine without Aura|migraine without aura
200350|NCT02115269|Tension-Type Headache|tension-type headache
200351|NCT02115256|External Cephalic Version|external cephalic version
200352|NCT02115256|breech|breech
200353|NCT02115230|Heart Failure|heart failure
200354|NCT02115230|Heart Failure, Diastolic|heart failure, diastolic
200355|NCT02115230|Hypertension|hypertension
200356|NCT02115230|Renal Denervation|renal denervation
200357|NCT02115230|Irrigated Radiofrequency Catheter|irrigated radiofrequency catheter
200358|NCT02115217|Kinestiotaping|kinestiotaping
200359|NCT02115217|Basketball players|basketball players
200360|NCT02115217|Effect of kinesiotaping|effect of kinesiotaping
200361|NCT02115217|on postural stability|on postural stability
200362|NCT02115191|2-octylcyanoacrylate|2-octylcyanoacrylate
200363|NCT02115191|Urethrocutaneous fistulas.|urethrocutaneous fistulas.
200365|NCT02115191|Recurrence.|recurrence.
200366|NCT02115178|Hemodynamic changes|hemodynamic changes
200367|NCT02115178|Spinal anesthesia|spinal anesthesia
200368|NCT02115178|Patient position|patient position
200369|NCT02115178|Impedance cardiography|impedance cardiography
200370|NCT02115152|Capecitabine|capecitabine
200371|NCT02115152|Neoadjuvant therapy|neoadjuvant therapy
200372|NCT02115152|Early Breast Cancer|early breast cancer
200373|NCT02115139|melanoma|melanoma
200374|NCT02115139|brain|brain
200375|NCT02115139|metastases|metastases
200376|NCT02115139|Patients with melanoma and brain metastases|patients with melanoma and brain metastases
200377|NCT02115113|Liver transplantation, everolimus, CNI-minimization, CNI-elimination, renal function|liver transplantation, everolimus, cni-minimization, cni-elimination, renal function
200378|NCT02115100|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
200379|NCT02115100|Persistent atrial fibrillation|persistent atrial fibrillation
200380|NCT02115100|Out of range hypertension|out of range hypertension
200381|NCT02115100|Signs of sympathetic overdrive|signs of sympathetic overdrive
200382|NCT02115087|laparotomy|laparotomy
200383|NCT02115087|levobupivacaine|levobupivacaine
200384|NCT02115087|patient controlled analgesia|patient controlled analgesia
200385|NCT02115074|Low-grade gliomas|low-grade gliomas
200386|NCT02115074|high-grade gliomas|high-grade gliomas
200387|NCT02115074|optico-chiasmatic|optico-chiasmatic
200388|NCT02115074|relapsed|relapsed
200389|NCT02115074|refractory|refractory
402950|NCT01228929|Thermal Imaging|thermal imaging
200390|NCT02115061|Gastric varices,coil,cyanoacrylate,treating gastric varices.|gastric varices,coil,cyanoacrylate,treating gastric varices.
200391|NCT02115035|Multiple Myeloma|multiple myeloma
200392|NCT02115022|pancreatic cancer|pancreatic cancer
200393|NCT02115022|resectability|resectability
200394|NCT02115022|endosonography (EUS)|endosonography (eus)
200395|NCT02115022|multidetection computer tomography (MDCT)|multidetection computer tomography (mdct)
200396|NCT02115022|staging|staging
200397|NCT02115009|sacroiliac joint lumbopelvic ,chronic low back pain|sacroiliac joint lumbopelvic ,chronic low back pain
200398|NCT02114996|mechanical ventilation|mechanical ventilation
200399|NCT02114996|ischemic stroke|ischemic stroke
200400|NCT02114983|deep vein thrombosis|deep vein thrombosis
200401|NCT02114983|diagnostic accuracy|diagnostic accuracy
200402|NCT02114983|general practitioner|general practitioner
200403|NCT02114983|test|test
200404|NCT02114983|compression ultrasonography|compression ultrasonography
200405|NCT02114983|ultrasound|ultrasound
200406|NCT02114970|Older Adults|older adults
200407|NCT02114970|Informed Consent|informed consent
200408|NCT02114970|Technology|technology
200409|NCT02114970|Tablet-delivered|tablet-delivered
200410|NCT02114957|bio-availability|bio-availability
200411|NCT02114957|decursin|decursin
200412|NCT02114957|decursinol angelate|decursinol angelate
200413|NCT02114957|decursinol|decursinol
200414|NCT02114957|subjects|subjects
200415|NCT02114944|Do-not-intubate|do-not-intubate
200416|NCT02114944|DNI|dni
200417|NCT02114944|Palliative treatment|palliative treatment
200418|NCT02114944|Acute respiratory failure|acute respiratory failure
200419|NCT02114944|Acute on chronic respiratory failure|acute on chronic respiratory failure
200420|NCT02114944|Hypoxia|hypoxia
200421|NCT02114944|Respiratory acidosis|respiratory acidosis
200422|NCT02114944|Hypercarbia|hypercarbia
200423|NCT02114944|Non invasive ventilation|non invasive ventilation
200424|NCT02114944|NIV|niv
200425|NCT02114944|CPAP|cpap
200426|NCT02114944|Oxygen-therapy|oxygen-therapy
200427|NCT02114944|High-flow oxygen therapy|high-flow oxygen therapy
200428|NCT02114931|arthritis|arthritis
200429|NCT02114931|rheumatoid|rheumatoid
200430|NCT02114918|obsessive compulsive disorder|obsessive compulsive disorder
200431|NCT02114918|children|children
200432|NCT02114918|adolescents|adolescents
200433|NCT02114918|attention bias modification|attention bias modification
200434|NCT02114905|Tourette's|tourette's
200435|NCT02114905|Tic Disorder|tic disorder
200436|NCT02114905|CBIT|cbit
200437|NCT02114905|Dissemination|dissemination
200438|NCT02114905|Occupational Therapist|occupational therapist
200439|NCT02114892|metabolic syndrome|metabolic syndrome
200440|NCT02114892|central obesity|central obesity
200441|NCT02114892|resveratrol|resveratrol
200442|NCT02114892|insulin secretion|insulin secretion
200443|NCT02114892|insulin sensitivity|insulin sensitivity
200444|NCT02114879|Physical Therapy|physical therapy
200445|NCT02114879|Occupational Therapy|occupational therapy
200446|NCT02114879|Rehabilitation|rehabilitation
200447|NCT02114879|Older adults|older adults
200448|NCT02114879|Depression|depression
200449|NCT02114879|Physical Functioning|physical functioning
200450|NCT02114827|Multiple Myeloma|multiple myeloma
200451|NCT02114814|Diabetes|diabetes
200452|NCT02114814|Hispanic|hispanic
200453|NCT02114814|Adult|adult
200454|NCT02114814|Family Member|family member
200455|NCT02114801|Cerebral Palsy;|cerebral palsy;
200456|NCT02114801|Toothbrushing;|toothbrushing;
200457|NCT02114801|Dental Plaque|dental plaque
200458|NCT02114775|mild traumatic brain injury|mild traumatic brain injury
200459|NCT02114775|growth hormone|growth hormone
200460|NCT02114775|fatigue|fatigue
200461|NCT02114775|sildenafil|sildenafil
200462|NCT02114775|neurology|neurology
200463|NCT02114762|otitis media|otitis media
200464|NCT02114762|eustachian tube|eustachian tube
200465|NCT02114762|eustachian tube dysfunction|eustachian tube dysfunction
200466|NCT02114762|eustachian tube function testing|eustachian tube function testing
200467|NCT02114749|Healthy volunteers|healthy volunteers
200468|NCT02114749|Physiological variables : respiration and circulation|physiological variables : respiration and circulation
200469|NCT02114736|Stroke|stroke
200470|NCT02114736|Muscle spasticity|muscle spasticity
200471|NCT02114736|Stiff knee gait|stiff knee gait
200472|NCT02114736|Botulinum toxin|botulinum toxin
200473|NCT02114736|Tenotomy|tenotomy
200474|NCT02114723|Mediacal Taping concept|mediacal taping concept
200475|NCT02114723|Neuromuscular bandage|neuromuscular bandage
200476|NCT02114723|Physiotherapy techniques|physiotherapy techniques
200477|NCT02114723|Kinesio Tape|kinesio tape
200478|NCT02114710|coagulopathy|coagulopathy
200479|NCT02114710|hydrocortisone|hydrocortisone
200480|NCT02114710|organ failure|organ failure
200481|NCT02114697|Cancer survivorship, cardiovascular disease, stroke, TIA|cancer survivorship, cardiovascular disease, stroke, tia
200482|NCT02114658|Anaplastic and medullary thyroid carcinoma|anaplastic and medullary thyroid carcinoma
200483|NCT02114658|Thyroid Neoplasms|thyroid neoplasms
200484|NCT02114645|Luteal phase support,GnRH agonist,ART cycles|luteal phase support,gnrh agonist,art cycles
191390|NCT02155699|UHR, Remediation, Exercise, Intervention, Psychosis|uhr, remediation, exercise, intervention, psychosis
191391|NCT02155686|Elderly|elderly
191392|NCT02155686|Prevention|prevention
191393|NCT02155686|Multiple chronic disease|multiple chronic disease
191394|NCT02155686|Telemonitoring|telemonitoring
191395|NCT02155686|Geriatric teleexpertise|geriatric teleexpertise
191405|NCT02155647|MSB0010718C|msb0010718c
200485|NCT02114632|ADHD, attention deficit/hyperactivity disorder, attention deficit disorder, inattention, cognitive skills, children, polyunsaturated fatty acids, PUFA|adhd, attention deficit/hyperactivity disorder, attention deficit disorder, inattention, cognitive skills, children, polyunsaturated fatty acids, pufa
200486|NCT02114619|radioiodine therapy|radioiodine therapy
200487|NCT02114619|Graves' disease|graves' disease
200488|NCT02114619|Hyperthyroidism|hyperthyroidism
200489|NCT02114619|calculated dose|calculated dose
200490|NCT02114606|Eosinophilic Esophagitis|eosinophilic esophagitis
200491|NCT02114606|EoE|eoe
200492|NCT02114606|Cytosponge|cytosponge
200493|NCT02114593|Mental Health|mental health
200495|NCT02114593|Parent support program|parent support program
200496|NCT02114593|Somali families|somali families
200497|NCT02114593|Sweden|sweden
200498|NCT02114580|mild cognitive impairment|mild cognitive impairment
200499|NCT02114580|exercise|exercise
200500|NCT02114580|brain plasticity|brain plasticity
200501|NCT02114580|FMRI|fmri
200502|NCT02114567|AECOPD|aecopd
200503|NCT02114567|work of breathing|work of breathing
200504|NCT02114567|patient-ventilator synchrony|patient-ventilator synchrony
200505|NCT02114554|MELAS|melas
200506|NCT02114554|MIDD|midd
200507|NCT02114554|Heteroplasmy|heteroplasmy
200508|NCT02114528|Ventricular Tachycardia|ventricular tachycardia
200509|NCT02114528|Ventricular Arrhythmia|ventricular arrhythmia
200510|NCT02114528|Anti-arrhythmic drugs|anti-arrhythmic drugs
200511|NCT02114528|Catheter Ablation|catheter ablation
200512|NCT02114528|ICD Shocks|icd shocks
200513|NCT02114515|Patient Navigators|patient navigators
200514|NCT02114515|Readmissions|readmissions
200515|NCT02114515|Peer Coaching|peer coaching
200516|NCT02114502|Myeloma|myeloma
200517|NCT02114502|Multiple myeloma|multiple myeloma
200518|NCT02114502|MM|mm
200519|NCT02114502|Refractory|refractory
200520|NCT02114502|Relapsed|relapsed
200521|NCT02114502|Stem Cell Transplant|stem cell transplant
200522|NCT02114502|SCT|sct
200523|NCT02114502|Carfilzomib|carfilzomib
200524|NCT02114502|SAHA|saha
200525|NCT02114502|Vorinostat|vorinostat
200526|NCT02114502|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
200527|NCT02114502|MSK-390|msk-390
200528|NCT02114502|Zolinza|zolinza
200529|NCT02114502|Gemcitabine|gemcitabine
200530|NCT02114502|Gemcitabine Hydrochloride|gemcitabine hydrochloride
200531|NCT02114502|Gemzar|gemzar
200532|NCT02114502|Busulfan|busulfan
200533|NCT02114502|Busulfex|busulfex
200534|NCT02114502|Myleran|myleran
200535|NCT02114502|Palifermin|palifermin
200536|NCT02114502|Kepivance|kepivance
200537|NCT02114502|Dexamethasone|dexamethasone
200538|NCT02114502|Decadron|decadron
200539|NCT02114502|Melphalan|melphalan
200540|NCT02114502|Alkeran|alkeran
200541|NCT02114502|Caphosol|caphosol
200542|NCT02114502|Glutamine|glutamine
200543|NCT02114502|Enterex|enterex
200544|NCT02114502|Glutapak-10|glutapak-10
200545|NCT02114502|NutreStore|nutrestore
200546|NCT02114502|Resource|resource
200547|NCT02114502|GlutaSolve|glutasolve
200548|NCT02114502|Sympt-X G.I.|sympt-x g.i.
200549|NCT02114502|Sympt-X|sympt-x
200550|NCT02114502|Pyridoxine|pyridoxine
200551|NCT02114489|AOH|aoh
200552|NCT02114489|ibandronate|ibandronate
200553|NCT02114294|Patellofemoral pain syndrome|patellofemoral pain syndrome
200554|NCT02114294|Anterior knee pain|anterior knee pain
200555|NCT02114294|Randomised controlled trial|randomised controlled trial
200556|NCT02114294|Exercise intervention|exercise intervention
200557|NCT02114294|Hip strengthening|hip strengthening
200558|NCT02114294|Quadriceps based training|quadriceps based training
200559|NCT02114294|Anterior knee pain score|anterior knee pain score
200560|NCT02114281|Oral Health|oral health
200561|NCT02114281|Periodontitis|periodontitis
200562|NCT02114281|Tooth cavities|tooth cavities
200563|NCT02114281|Saliva|saliva
200564|NCT02114281|Halitosis|halitosis
200565|NCT02114281|Mucosa|mucosa
200566|NCT02114281|Chronic kidney disease|chronic kidney disease
200567|NCT02114281|Inflammation|inflammation
200568|NCT02114281|Nutrition|nutrition
200569|NCT02114268|Respiratory Syncytial Virus, RSV|respiratory syncytial virus, rsv
200570|NCT02114255|Influenza|influenza
200571|NCT02114255|Trained immunity|trained immunity
200572|NCT02114255|BCG|bcg
402951|NCT01228916|tobacco|tobacco
200573|NCT02114242|Parkinson's disease|parkinson's disease
200574|NCT02114242|multiple system atrophy|multiple system atrophy
200575|NCT02114242|progressive supranuclear palsy|progressive supranuclear palsy
200576|NCT02114242|alpha-synuclein|alpha-synuclein
200577|NCT02114229|Alisertib|alisertib
200578|NCT02114229|MLN8237|mln8237
200579|NCT02114229|AT/RT|at/rt
200580|NCT02114229|MRT|mrt
200581|NCT02114190|Overweight Adolescents|overweight adolescents
200582|NCT02114190|Mindful Eating and Living|mindful eating and living
200583|NCT02114190|Family Systems|family systems
200584|NCT02114190|Body-Mass Index|body-mass index
200585|NCT02114190|Mindfulness|mindfulness
200586|NCT02114177|Hepatitis C Virus Infection|hepatitis c virus infection
200587|NCT02114177|Simeprevir|simeprevir
200588|NCT02114177|Sofosbuvir|sofosbuvir
200589|NCT02114177|HCV|hcv
200590|NCT02114177|Cirrhosis|cirrhosis
200591|NCT02114164|AirSeal|airseal
200592|NCT02114164|Trocar|trocar
200593|NCT02114164|Carbon Dioxide Exchange and Absorption|carbon dioxide exchange and absorption
200594|NCT02114151|Hepatitis C Virus Infection|hepatitis c virus infection
200595|NCT02114151|Simeprevir|simeprevir
200596|NCT02114151|Sofosbuvir|sofosbuvir
200597|NCT02114151|HCV|hcv
200598|NCT02114151|Cirrhosis|cirrhosis
200599|NCT02114138|postoperative acute kidney injury|postoperative acute kidney injury
200600|NCT02114138|pAKI|paki
200601|NCT02114138|stress injury on the kidney|stress injury on the kidney
200602|NCT02114138|chronic kidney disease|chronic kidney disease
200604|NCT02114125|Physical activity|physical activity
200605|NCT02114125|Cognitive training|cognitive training
200606|NCT02114112|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
200607|NCT02114112|Continuous positive airway pressure pressure|continuous positive airway pressure pressure
200608|NCT02114112|Preterms|preterms
200609|NCT02114099|Kawasaki Disease|kawasaki disease
200610|NCT02114099|Aneurysm, Coronary|aneurysm, coronary
200611|NCT02114086|Observational Study|observational study
200612|NCT02114086|intraoperative Radiation of Breast Cancer|intraoperative radiation of breast cancer
200613|NCT02114086|early and late effects of radiation|early and late effects of radiation
200614|NCT02114086|cosmesis and quality of life|cosmesis and quality of life
200615|NCT02114073|glaucoma|glaucoma
200616|NCT02114073|trabeculectomy|trabeculectomy
200617|NCT02114073|cyclosporine|cyclosporine
200618|NCT02114073|betamethasone|betamethasone
200619|NCT02114060|HSV|hsv
200620|NCT02114060|Herpes|herpes
200621|NCT02114060|genital infection|genital infection
200622|NCT02114060|vaccine|vaccine
200623|NCT02114034|Severe asthma,|severe asthma,
200624|NCT02114034|child,|child,
200625|NCT02114034|outcome,|outcome,
200626|NCT02114021|Syndrome incidence after intubation|syndrome incidence after intubation
200627|NCT02114021|Betamethasone gel|betamethasone gel
200628|NCT02114021|lidocaine jelly|lidocaine jelly
200629|NCT02114021|sore throat|sore throat
200630|NCT02114021|cough|cough
200631|NCT02114021|hoarseness of voice|hoarseness of voice
200632|NCT02114008|Gastric emptying.|gastric emptying.
200633|NCT02114008|Residual gastric volume.|residual gastric volume.
200634|NCT02114008|Preoperative fasting.|preoperative fasting.
200635|NCT02114008|Morbid Obesity.|morbid obesity.
200636|NCT02114008|Diabetes.|diabetes.
200637|NCT02113995|Obesity, Morbid|obesity, morbid
200638|NCT02113995|Insulin Resistance|insulin resistance
200639|NCT02113995|Acute-Phase Reaction|acute-phase reaction
200640|NCT02113995|Gastroplasty|gastroplasty
200641|NCT02113995|Length of Stay|length of stay
200642|NCT02113995|Protocols|protocols
200643|NCT02113995|Randomized Controlled Trial.|randomized controlled trial.
200644|NCT02113969|Pelvic Organ Prolapse|pelvic organ prolapse
200645|NCT02113969|Quality of Life|quality of life
200646|NCT02113969|Symptoms|symptoms
200647|NCT02113969|Pessary|pessary
200648|NCT02113969|Treatment|treatment
200649|NCT02113956|HIV Prevention|hiv prevention
200650|NCT02113956|Adolescent Men who Have Sex with Men (AMSM)|adolescent men who have sex with men (amsm)
200651|NCT02113956|Text-Messaging|text-messaging
201007|NCT02112643|Thyroid eye disease|thyroid eye disease
200652|NCT02113956|Information-Motivation-Behavioral Skills(IMB)Model|information-motivation-behavioral skills(imb)model
200653|NCT02113917|infant, adolescent and adult Hemophagocytic Syndrome|infant, adolescent and adult hemophagocytic syndrome
200654|NCT02113917|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
200655|NCT02113904|Netherton syndrome|netherton syndrome
200656|NCT02113904|Adalimumab|adalimumab
200657|NCT02113904|TNF-alpha|tnf-alpha
200658|NCT02113904|Orphan genetic syndrome|orphan genetic syndrome
200754|NCT02113566|DOMS|doms
200659|NCT02113891|Antibody-mediated rejection|antibody-mediated rejection
200660|NCT02113891|Complement blockade|complement blockade
200661|NCT02113891|Eculizumab|eculizumab
200662|NCT02113891|Kidney transplantation|kidney transplantation
200663|NCT02113878|Carcinoma, Squamous Cell of Head and Neck|carcinoma, squamous cell of head and neck
200664|NCT02113878|Human Papillomavirus Positive Oropharyngeal Carcinoma|human papillomavirus positive oropharyngeal carcinoma
200665|NCT02113878|Hypopharyngeal Cancer|hypopharyngeal cancer
200666|NCT02113878|Early Invasive Cervical Squamous Cell Carcinoma|early invasive cervical squamous cell carcinoma
200667|NCT02113878|Carcinoma of Larynx|carcinoma of larynx
200668|NCT02113878|Cancer of Nasopharynx|cancer of nasopharynx
200669|NCT02113852|Non small cell Lung Cancer|non small cell lung cancer
200670|NCT02113852|Heavy smokers|heavy smokers
200671|NCT02113852|Treatment naive patients|treatment naive patients
200672|NCT02113839|Dyspnea perception|dyspnea perception
200673|NCT02113839|COPD|copd
200674|NCT02113839|Exacerbations|exacerbations
200675|NCT02113839|CO2 rebreathing test|co2 rebreathing test
200676|NCT02113826|Pazopanib|pazopanib
200677|NCT02113826|Alveolar soft part sarcoma|alveolar soft part sarcoma
200678|NCT02113813|irreversible EGFR inhibitor|irreversible egfr inhibitor
200679|NCT02113813|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
200680|NCT02113813|Midazolam|midazolam
200681|NCT02113813|T790M resistance mutation|t790m resistance mutation
200682|NCT02113813|EGFR|egfr
200683|NCT02113813|NSCLC|nsclc
200684|NCT02113813|naquotinib|naquotinib
200685|NCT02113813|Epidermal Growth Factor Receptor mutations|epidermal growth factor receptor mutations
200686|NCT02113813|ASP8273|asp8273
200687|NCT02113787|epilepsy|epilepsy
200688|NCT02113787|anticonvulsants|anticonvulsants
200689|NCT02113787|generic drugs|generic drugs
200690|NCT02113748|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
200691|NCT02113748|Downhill walking|downhill walking
200692|NCT02113748|exercise|exercise
200693|NCT02113735|ARDS|ards
200694|NCT02113735|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
200695|NCT02113735|Acthar|acthar
200696|NCT02113735|ACTH|acth
200697|NCT02113735|H.P. Acthar Gel|h.p. acthar gel
200698|NCT02113722|Sudden cardiac death|sudden cardiac death
200699|NCT02113722|Ganglionectomy|ganglionectomy
200700|NCT02113722|Ventricular arrhythmia|ventricular arrhythmia
200701|NCT02113722|Cardiac surgery|cardiac surgery
200702|NCT02113722|Implanted cardiac defibrillator|implanted cardiac defibrillator
200703|NCT02113709|Amblyopia|amblyopia
200704|NCT02113709|Strabismus|strabismus
200705|NCT02113709|Occlusion therapy|occlusion therapy
200706|NCT02113709|Visual improvement|visual improvement
200707|NCT02113696|morbid obesity|morbid obesity
200708|NCT02113696|BMI at or above 4O kg/m2|bmi at or above 4o kg/m2
200709|NCT02113696|ingestion of omega 3|ingestion of omega 3
200710|NCT02113696|inflammatory cytokines|inflammatory cytokines
200711|NCT02113696|biochemical factors|biochemical factors
200712|NCT02113696|anthropometric factors|anthropometric factors
200713|NCT02113683|colo-rectal cancer|colo-rectal cancer
200714|NCT02113683|stomach cancer|stomach cancer
200715|NCT02113683|melanoma|melanoma
200716|NCT02113683|MMS test|mms test
200717|NCT02113683|therapy monitoring|therapy monitoring
200718|NCT02113683|Sarcoma|sarcoma
200719|NCT02113670|stress urinary incontinence|stress urinary incontinence
200720|NCT02113670|abdominal leak point pressure|abdominal leak point pressure
200721|NCT02113670|urodynamic study|urodynamic study
200722|NCT02113657|Prostate cancer|prostate cancer
200723|NCT02113657|Castration-resistant prostate cancer|castration-resistant prostate cancer
200724|NCT02113657|CRPC|crpc
200725|NCT02113657|Metastatic|metastatic
200726|NCT02113657|Hormone therapy treatment|hormone therapy treatment
200727|NCT02113657|Androgen deprivation therapy|androgen deprivation therapy
200728|NCT02113657|gonadotropin-releasing hormone|gonadotropin-releasing hormone
200729|NCT02113657|GnRH|gnrh
200730|NCT02113657|Ipilimumab|ipilimumab
200731|NCT02113657|Yervoy|yervoy
200732|NCT02113657|BMS-734016|bms-734016
200733|NCT02113657|MDX010|mdx010
200734|NCT02113631|Hepatitis C treatment,|hepatitis c treatment,
200735|NCT02113631|Boceprevir,|boceprevir,
200736|NCT02113631|Telaprevir,|telaprevir,
200737|NCT02113631|Safety|safety
200738|NCT02113631|Effectiveness|effectiveness
200739|NCT02113631|Head-to-head trial|head-to-head trial
200740|NCT02113618|Cognitive function, alcohol dependence, working memory|cognitive function, alcohol dependence, working memory
200741|NCT02113605|Functional gastrointestinal disorders|functional gastrointestinal disorders
200742|NCT02113605|FGID|fgid
200743|NCT02113605|Recurrent abdominal pain|recurrent abdominal pain
200744|NCT02113605|Abdominal pain|abdominal pain
200745|NCT02113605|pain-predominant functional gastrointestinal disorders|pain-predominant functional gastrointestinal disorders
200746|NCT02113605|Pediatric pain|pediatric pain
200747|NCT02113592|Pain management|pain management
200748|NCT02113592|Opioid use|opioid use
200749|NCT02113592|Pragmatic|pragmatic
200750|NCT02113592|Collaborative care|collaborative care
200751|NCT02113592|Primary care|primary care
200752|NCT02113579|Tooth Sensitivity|tooth sensitivity
200753|NCT02113566|Delayed onset muscle soreness|delayed onset muscle soreness
200755|NCT02113540|coronary angiography|coronary angiography
200756|NCT02113540|chronic stable angina|chronic stable angina
200758|NCT02113527|Electrogastrography|electrogastrography
200759|NCT02113527|Functional dyspepsia|functional dyspepsia
200760|NCT02113527|Gastric emptying|gastric emptying
200761|NCT02113527|Gastrointestinal peptides|gastrointestinal peptides
200762|NCT02113527|Rome III criteria|rome iii criteria
200763|NCT02113514|Appalachian|appalachian
200764|NCT02113514|abnormal pap test|abnormal pap test
200765|NCT02113501|HGT1|hgt1
200766|NCT02113501|high risk bladder cancer|high risk bladder cancer
200767|NCT02113501|substaging|substaging
200768|NCT02113501|repeat transurethral resection (reTUR)|repeat transurethral resection (retur)
200769|NCT02113501|lamina propria|lamina propria
200770|NCT02113475|CDT|cdt
200771|NCT02113475|PCDT|pcdt
200772|NCT02113475|DVT|dvt
200773|NCT02113475|PTS|pts
200774|NCT02113475|Quality of Life|quality of life
200775|NCT02113462|Chronic kidney disease|chronic kidney disease
200776|NCT02113462|Endothelial dysfunction|endothelial dysfunction
200777|NCT02113462|Inflammation|inflammation
200778|NCT02113462|Insulin resistance|insulin resistance
200779|NCT02113462|Tg/hdl ratio|tg/hdl ratio
200780|NCT02113449|Carbon Dioxide, Allergy symptoms|carbon dioxide, allergy symptoms
200781|NCT02113436|FP/SLM|fp/slm
200782|NCT02113436|Asthma|asthma
200783|NCT02113436|Infant|infant
200784|NCT02113436|Efficacy|efficacy
200785|NCT02113436|Safety|safety
200786|NCT02113423|superiority, re-irradiation, IMRT, recurrent T1-2 NPC|superiority, re-irradiation, imrt, recurrent t1-2 npc
200787|NCT02113410|osteoarthritis|osteoarthritis
200788|NCT02113410|Older adults|older adults
200789|NCT02113410|Sit 'N' Chair Yoga|sit 'n' chair yoga
200790|NCT02113410|Pain|pain
200791|NCT02113410|Physical Function|physical function
200792|NCT02113410|Balance|balance
200793|NCT02113410|Fatigue|fatigue
200794|NCT02113410|Depression|depression
200795|NCT02113410|Life Satisfaction|life satisfaction
200796|NCT02113397|Cystic fibrosis|cystic fibrosis
200797|NCT02113397|Microbiome|microbiome
200799|NCT02113397|Tobramycin|tobramycin
200800|NCT02113397|Colistimethate|colistimethate
200801|NCT02113384|Rectal cancer|rectal cancer
200802|NCT02113384|Locally advanced rectal cancer|locally advanced rectal cancer
200803|NCT02113384|Peritoneal carcinomatosis|peritoneal carcinomatosis
200804|NCT02113384|Exfoliated peritoneal cells|exfoliated peritoneal cells
200805|NCT02113384|Peritoneal lavage|peritoneal lavage
200806|NCT02113371|Injury Prevention|injury prevention
200807|NCT02113371|Health Promotion|health promotion
200808|NCT02113371|Well being|well being
200809|NCT02113371|Safety|safety
200810|NCT02113371|Nutrition|nutrition
200811|NCT02113371|Physical Activity|physical activity
200812|NCT02113371|Sleep|sleep
200813|NCT02113371|Stress|stress
200814|NCT02113358|fluid therapy|fluid therapy
200815|NCT02113358|neurosurgery|neurosurgery
200816|NCT02113345|metamemory|metamemory
200817|NCT02113345|memory|memory
200818|NCT02113345|mild cognitive impairment|mild cognitive impairment
200819|NCT02113332|Insulin injections|insulin injections
200820|NCT02113332|Overweight|overweight
200821|NCT02113332|Inadequate glycaemic control|inadequate glycaemic control
200822|NCT02113319|Core Binding Factors|core binding factors
200823|NCT02113319|Acute Myelogenous Leukemia refractory to conventional chemotherapy|acute myelogenous leukemia refractory to conventional chemotherapy
200824|NCT02113319|molecular relapse|molecular relapse
200825|NCT02113293|phase I study|phase i study
200826|NCT02113293|tolerability|tolerability
200827|NCT02113293|safety|safety
200828|NCT02113293|CyclASol®|cyclasol®
200829|NCT02113293|eye drops|eye drops
200830|NCT02113267|esophagitis|esophagitis
200831|NCT02113267|eosinophils|eosinophils
200832|NCT02113267|allergy|allergy
200833|NCT02113267|inflammation|inflammation
200834|NCT02113267|corticosteroids|corticosteroids
200835|NCT02113254|corn|corn
200836|NCT02113254|macular pigment|macular pigment
200837|NCT02113254|lutein|lutein
200838|NCT02113254|zeaxanthin|zeaxanthin
200839|NCT02113254|Age Macular Degeneration|age macular degeneration
200841|NCT02113241|metabolic syndrome|metabolic syndrome
200842|NCT02113241|forxiga|forxiga
200843|NCT02113241|dapagliflozin|dapagliflozin
200844|NCT02113241|insulin secretion|insulin secretion
200845|NCT02113241|insulin sensitivity|insulin sensitivity
200846|NCT02113228|Energy metabolism|energy metabolism
200847|NCT02113228|Stable isotopes|stable isotopes
200848|NCT02113228|Short bowel syndrome|short bowel syndrome
200849|NCT02113228|Doubly labeled water|doubly labeled water
200851|NCT02113215|lipid metabolism|lipid metabolism
200852|NCT02113215|very low density lipoproteins|very low density lipoproteins
200853|NCT02113202|Optical imaging|optical imaging
200854|NCT02113202|Fluorescence endoscopy|fluorescence endoscopy
200855|NCT02113202|Near infrared fluorescence|near infrared fluorescence
200856|NCT02113202|Familial Adenomatous Polyposis|familial adenomatous polyposis
200857|NCT02113202|IRDye800CW|irdye800cw
200858|NCT02113202|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
200859|NCT02113202|Gastrointestinal endoscopy|gastrointestinal endoscopy
200860|NCT02113189|gait|gait
200861|NCT02113189|Parkinson's disease|parkinson's disease
200862|NCT02113176|SAH|sah
200863|NCT02113163|Type 2 diabetes|type 2 diabetes
200864|NCT02113163|T2DM|t2dm
200865|NCT02113163|hypertriglyceridemia|hypertriglyceridemia
200866|NCT02113163|severe hypertriglyceridemia|severe hypertriglyceridemia
200867|NCT02113163|dyslipidemia|dyslipidemia
200868|NCT02113163|triglycerides|triglycerides
200869|NCT02113163|lipids|lipids
200870|NCT02113163|omega-3 fatty acids|omega-3 fatty acids
200871|NCT02113163|EPA|epa
200872|NCT02113163|ethyl-EPA|ethyl-epa
200873|NCT02113163|Metformin|metformin
200874|NCT02113163|Glucophage|glucophage
200875|NCT02113163|Lovaza|lovaza
200876|NCT02113163|Vascepa|vascepa
200877|NCT02113163|Epanova|epanova
200878|NCT02113163|Astra Zeneca|astra zeneca
200879|NCT02113163|Amarin|amarin
200880|NCT02113163|GSK|gsk
200881|NCT02113150|troponin t,cystatin-c,ketamine,remifentanil|troponin t,cystatin-c,ketamine,remifentanil
200882|NCT02113137|halitosis|halitosis
200883|NCT02113137|chlorine dioxide|chlorine dioxide
200884|NCT02113137|tongue cleaning|tongue cleaning
200885|NCT02113124|Chronic Brain Injury|chronic brain injury
200886|NCT02113124|Traumatic brain injury (TBI)|traumatic brain injury (tbi)
200887|NCT02113124|Amino Acids|amino acids
200888|NCT02113124|Microbiome|microbiome
200889|NCT02113098|Stroke|stroke
200890|NCT02113098|Gait|gait
200891|NCT02113098|Rehabilitation|rehabilitation
200892|NCT02113085|Adolescents, foster care, self-determination|adolescents, foster care, self-determination
200893|NCT02113072|wheezing, immune system, cytokines, probiotics, infants.|wheezing, immune system, cytokines, probiotics, infants.
200894|NCT02113059|Liver regeneration|liver regeneration
200895|NCT02113059|liver dysfunction|liver dysfunction
200896|NCT02113059|platelets|platelets
200897|NCT02113059|plasma|plasma
200898|NCT02113059|serum|serum
200899|NCT02113059|platelet activation|platelet activation
200900|NCT02113059|morbidity|morbidity
200901|NCT02113059|mortality|mortality
200902|NCT02113059|Growth factors|growth factors
200903|NCT02113059|Postoperative clinical outcome|postoperative clinical outcome
200904|NCT02113046|pancreas|pancreas
200905|NCT02113046|pancreatico-jejunal anastomosis|pancreatico-jejunal anastomosis
200906|NCT02113046|postoperative pancreatic fistulae|postoperative pancreatic fistulae
200907|NCT02113007|Lymphoma; CNS; rituximab; temozolomide|lymphoma; cns; rituximab; temozolomide
200908|NCT02112994|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
200909|NCT02112994|Lysosomal Storage Disease|lysosomal storage disease
200910|NCT02112994|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
200911|NCT02112994|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
200912|NCT02112994|Acid lipase disease|acid lipase disease
200913|NCT02112994|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
200914|NCT02112994|LAL Deficiency|lal deficiency
200915|NCT02112994|LIPA Deficiency|lipa deficiency
200916|NCT02112994|Wolman disease|wolman disease
200917|NCT02112994|Additional relevant MeSH terms:|additional relevant mesh terms:
200918|NCT02112994|Cholesterol Ester Storage Disease|cholesterol ester storage disease
200919|NCT02112994|Metabolic Diseases|metabolic diseases
200920|NCT02112994|Lipidoses|lipidoses
200921|NCT02112994|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
200922|NCT02112994|Metabolism, Inborn Errors|metabolism, inborn errors
200923|NCT02112994|Genetic Diseases, Inborn|genetic diseases, inborn
200924|NCT02112994|Lysosomal Storage Diseases|lysosomal storage diseases
200925|NCT02112994|Lipid Metabolism Disorders|lipid metabolism disorders
200926|NCT02112994|Infant, Newborn, Diseases|infant, newborn, diseases
200927|NCT02112981|CORONARY ARTERIOSCLEROSIS|coronary arteriosclerosis
200928|NCT02112968|Myopia|myopia
200929|NCT02112968|Hyperopia|hyperopia
200930|NCT02112968|Presbyopia|presbyopia
200931|NCT02112968|Supracor|supracor
200932|NCT02112968|Zyoptix|zyoptix
200933|NCT02112968|Proscan|proscan
200934|NCT02112968|LASIK|lasik
200935|NCT02112955|Stroke|stroke
200936|NCT02112955|Disease management|disease management
200937|NCT02112955|Self efficacy|self efficacy
200938|NCT02112955|Quality of life|quality of life
200939|NCT02112955|Community integration|community integration
200940|NCT02112942|Hepatitis C virus|hepatitis c virus
200941|NCT02112942|HCV|hcv
200942|NCT02112929|Magnetic Resonance Imaging|magnetic resonance imaging
200943|NCT02112929|Lung Diseases|lung diseases
200944|NCT02112890|Mexico|mexico
200945|NCT02112890|Adolescents|adolescents
200946|NCT02112890|Hepatitis|hepatitis
201029|NCT02112578|Vertigo, Meclizine, dimenhydrinate, Peripheral Origin|vertigo, meclizine, dimenhydrinate, peripheral origin
201030|NCT02112526|de Novo Activated B-cell (ABC) Subtype of Diffuse Large B-Cell Lymphoma|de novo activated b-cell (abc) subtype of diffuse large b-cell lymphoma
201031|NCT02112526|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
201032|NCT02112526|Novo Activated B-cell (ABC)|novo activated b-cell (abc)
201033|NCT02112526|Novo Activated B-cell|novo activated b-cell
201035|NCT02112526|DLBCL|dlbcl
201036|NCT02112526|Lymphoma|lymphoma
201037|NCT02112526|B-Cell|b-cell
201038|NCT02112526|Immunoproliferative Disorders|immunoproliferative disorders
201039|NCT02112526|Immune System Diseases|immune system diseases
201040|NCT02112487|pulmonary arterial hypertension|pulmonary arterial hypertension
201041|NCT02112487|PAH-SYMPACT|pah-sympact
201042|NCT02112487|PAH|pah
201043|NCT02112487|psychometric instrument|psychometric instrument
201044|NCT02112474|Failed Back Surgery Syndrome|failed back surgery syndrome
201045|NCT02112474|Neuropathic pain|neuropathic pain
201046|NCT02112474|Leg Pain|leg pain
201047|NCT02112474|Chronic Pain|chronic pain
201048|NCT02112474|Spinal Cord Stimulation|spinal cord stimulation
201049|NCT02112474|Neurostimulation|neurostimulation
201050|NCT02112461|end of life care|end of life care
201051|NCT02112448|congenital heart disease, pediatric cardiothoracic surgery|congenital heart disease, pediatric cardiothoracic surgery
201052|NCT02112435|obstructive sleep apnea|obstructive sleep apnea
201053|NCT02112435|mandibular advancement splint|mandibular advancement splint
201054|NCT02112435|active mandibular advancement splint|active mandibular advancement splint
201055|NCT02112435|oral appliance|oral appliance
201056|NCT02112422|Parturients|parturients
201057|NCT02112409|Adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
201058|NCT02112409|scoliosis corrective surgery|scoliosis corrective surgery
201059|NCT02112409|autologous blood transfusion|autologous blood transfusion
201060|NCT02112409|cell salvage|cell salvage
201061|NCT02112409|acute normovolemic hemodilution|acute normovolemic hemodilution
201062|NCT02112409|hemoglobin level|hemoglobin level
201063|NCT02112396|CRAFT|craft
201064|NCT02112396|Concerned Significant Others|concerned significant others
201065|NCT02112396|Contingency management|contingency management
201066|NCT02112396|Reinforcement|reinforcement
201067|NCT02112396|Family Intervention|family intervention
201068|NCT02112383|Procrastination|procrastination
201069|NCT02112383|Cognitive behavior therapy|cognitive behavior therapy
201070|NCT02112383|Internet interventions|internet interventions
201071|NCT02112383|Group intervention|group intervention
201072|NCT02112383|Students|students
201073|NCT02112383|Randomized controlled trial|randomized controlled trial
201074|NCT02112370|Ropivacaine|ropivacaine
201075|NCT02112370|Epinephrine|epinephrine
201076|NCT02112370|Endoscopy|endoscopy
201077|NCT02112370|Robotics|robotics
201078|NCT02112370|Thyroidectomy|thyroidectomy
201079|NCT02112357|molecular profiling|molecular profiling
201080|NCT02112357|genetic sequencing|genetic sequencing
201081|NCT02112357|personalised medicine|personalised medicine
201082|NCT02112357|gastrointestinal cancer|gastrointestinal cancer
201083|NCT02112331|Preterm newborns|preterm newborns
201084|NCT02112331|Gastric lipolysis|gastric lipolysis
201085|NCT02112331|Physical treatments|physical treatments
201086|NCT02112331|Human milk|human milk
201087|NCT02112305|Magnesium sulphate nebulized|magnesium sulphate nebulized
201088|NCT02112279|Microbiota|microbiota
201089|NCT02112279|c-difficile|c-difficile
201090|NCT02112279|colonoscopy|colonoscopy
201091|NCT02112279|stool transplant|stool transplant
201092|NCT02112266|depression|depression
201093|NCT02112266|online therapy|online therapy
201094|NCT02112266|cognitive behavioural therapy|cognitive behavioural therapy
201095|NCT02112266|quality of life|quality of life
201096|NCT02112266|alexithymia|alexithymia
201097|NCT02112266|therapy expectation and satisfaction|therapy expectation and satisfaction
201098|NCT02112253|Tourette's syndrome|tourette's syndrome
201099|NCT02112253|Deep brain stimulation|deep brain stimulation
201100|NCT02112253|Stereotactic surgery|stereotactic surgery
201101|NCT02112253|Globus pallidus interna|globus pallidus interna
201102|NCT02112253|Tics|tics
201103|NCT02112240|sentinel lymph node|sentinel lymph node
201104|NCT02112240|lymphatic mapping|lymphatic mapping
201105|NCT02112240|rectal tumor|rectal tumor
201106|NCT02112227|Heart Failure|heart failure
201107|NCT02112227|Transitional Care|transitional care
201108|NCT02112227|Knowledge Translation|knowledge translation
201109|NCT02112227|Outcomes|outcomes
201110|NCT02112214|Helicobacter pylori treatment|helicobacter pylori treatment
201111|NCT02112214|Gastric cancer|gastric cancer
201112|NCT02112214|Screening|screening
201113|NCT02112175|Multiple Myeloma|multiple myeloma
201114|NCT02112175|Lenalidomide|lenalidomide
201115|NCT02112175|Revlimid|revlimid
201117|NCT02112175|Melphalan|melphalan
201118|NCT02112175|Prednisone|prednisone
201119|NCT02112175|Velcade|velcade
201120|NCT02112175|Placebo|placebo
201121|NCT02112149|Body Composition|body composition
201122|NCT02112149|Exercise|exercise
201123|NCT02112149|Survivorship|survivorship
201124|NCT02112136|Autosomal Dominant Polycystic Kidney Disease (ADPKD)|autosomal dominant polycystic kidney disease (adpkd)
201125|NCT02112136|Renal cysts|renal cysts
201126|NCT02112136|Chronic Kidney Diseases|chronic kidney diseases
201127|NCT02112136|Genetic|genetic
201128|NCT02112123|icariin|icariin
201129|NCT02112123|pharmacokinetics|pharmacokinetics
201130|NCT02112123|healthy participants|healthy participants
201131|NCT02112097|Plaque Psoriasis.|plaque psoriasis.
201132|NCT02112097|Subdermal bloodless space|subdermal bloodless space
201133|NCT02112097|Subdermal injection|subdermal injection
201134|NCT02112097|Subcutaneous injection|subcutaneous injection
201135|NCT02112097|Injectable electromyography needle|injectable electromyography needle
201136|NCT02112097|Electrical stimulation|electrical stimulation
201137|NCT02112097|MRI with Gadolinium|mri with gadolinium
201138|NCT02112071|Exercise|exercise
201139|NCT02112071|Diabetic kidney disease|diabetic kidney disease
402952|NCT01228916|smoking|smoking
201140|NCT02112071|vascular function|vascular function
201141|NCT02112071|physical function|physical function
201142|NCT02112032|melanoma|melanoma
201143|NCT02112032|advanced|advanced
201144|NCT02112019|Sjögren's Syndrome|sjögren's syndrome
201145|NCT02112019|Sialoendoscopy|sialoendoscopy
201146|NCT02112019|Saliva|saliva
201147|NCT02112019|Dry Mouth|dry mouth
201148|NCT02112006|hand surgery|hand surgery
201149|NCT02112006|wrist surgery|wrist surgery
201150|NCT02112006|finger surgery|finger surgery
201151|NCT02112006|anesthesia|anesthesia
201152|NCT02112006|regional anesthesia|regional anesthesia
201153|NCT02112006|postoperative pain|postoperative pain
201154|NCT02111993|Defibrillation testing|defibrillation testing
201155|NCT02111993|Upper Limit of Vulnerability|upper limit of vulnerability
201156|NCT02111993|ULV|ulv
201157|NCT02111993|DFT|dft
201158|NCT02111993|ICD|icd
201159|NCT02111993|implantable cardioverter defibrillator|implantable cardioverter defibrillator
201160|NCT02111993|cardiomyopathy|cardiomyopathy
201161|NCT02111993|cardiac arrhythmia|cardiac arrhythmia
201162|NCT02111993|cardiac device testing|cardiac device testing
201163|NCT02111980|CIED|cied
201164|NCT02111980|pacemaker|pacemaker
201165|NCT02111980|implantable cardioverter defibrillator|implantable cardioverter defibrillator
201166|NCT02111980|ICD|icd
201167|NCT02111980|radiofrequency|radiofrequency
201168|NCT02111980|cardiac device programming|cardiac device programming
201169|NCT02111980|RF sponge detection|rf sponge detection
201170|NCT02111980|RF assure|rf assure
201171|NCT02111980|cardiac internal electronic devices|cardiac internal electronic devices
201172|NCT02111980|temporary pacing|temporary pacing
201173|NCT02111980|pulmonary thromboendarterectomy|pulmonary thromboendarterectomy
201174|NCT02111980|pacing interference|pacing interference
201175|NCT02111980|Arrhythmia|arrhythmia
201176|NCT02111954|prostate cancer|prostate cancer
201177|NCT02111954|primary|primary
201178|NCT02111954|recurrence|recurrence
201179|NCT02111954|F-18-FCH PET/CT|f-18-fch pet/ct
201180|NCT02111954|Ga-68-NODAGA-MJ9 PET/CT|ga-68-nodaga-mj9 pet/ct
201181|NCT02111915|Maternal depression|maternal depression
201182|NCT02111902|Cardiovascular Disease|cardiovascular disease
201183|NCT02111902|Obesity|obesity
201184|NCT02111902|Physical Activity|physical activity
201185|NCT02111902|Vitamin D deficiency|vitamin d deficiency
201186|NCT02111902|African Americans|african americans
201187|NCT02111876|ICU, COPD, OHS, OSA, heart failure|icu, copd, ohs, osa, heart failure
201188|NCT02111863|Skin Cancer|skin cancer
201189|NCT02111863|Metastatic Melanoma|metastatic melanoma
201190|NCT02111863|Adoptive Cell Therapy|adoptive cell therapy
201191|NCT02111863|Immunotherapy|immunotherapy
201192|NCT02111863|Clinical Response|clinical response
201193|NCT02111850|Gene Therapy|gene therapy
201194|NCT02111850|Tumor Regression|tumor regression
201195|NCT02111850|Immunotherapy|immunotherapy
201196|NCT02111850|Adoptive Cell Therapy|adoptive cell therapy
201197|NCT02111824|Lung Cancer|lung cancer
201198|NCT02111824|Peripheral lung lesions|peripheral lung lesions
201199|NCT02111824|Lung biopsy|lung biopsy
201200|NCT02111824|Minimally invasive|minimally invasive
201201|NCT02111824|multimodality image-guided intervention system|multimodality image-guided intervention system
201202|NCT02111824|MIMIG|mimig
201203|NCT02111824|Indocyanine green|indocyanine green
201204|NCT02111824|ICG|icg
201205|NCT02111811|Depression|depression
201206|NCT02111811|Treatment Outcome|treatment outcome
201207|NCT02111811|Delivery of Healthcare, Integrated|delivery of healthcare, integrated
201208|NCT02111811|Employment|employment
201209|NCT02111811|Rehabilitation|rehabilitation
201210|NCT02111798|substance abuse treatment|substance abuse treatment
201211|NCT02111798|cocaine dependence|cocaine dependence
201212|NCT02111798|contingency management; abstinence incentives|contingency management; abstinence incentives
201213|NCT02111798|medication-enhanced behavioral therapy|medication-enhanced behavioral therapy
201214|NCT02111785|Dexamethasone|dexamethasone
201215|NCT02111785|Burr hole craniostomy|burr hole craniostomy
201216|NCT02111785|Chronic subdural hematoma|chronic subdural hematoma
201217|NCT02111746|Postoperative pain|postoperative pain
201218|NCT02111746|sternotomy|sternotomy
201219|NCT02111746|laparotomy|laparotomy
201220|NCT02111746|thoracotomy|thoracotomy
5668|NCT03254953|technology|technology
201221|NCT02111746|mini-thoracotomy|mini-thoracotomy
201222|NCT02111746|truncal surgical incisions|truncal surgical incisions
201223|NCT02111746|local anaesthetics|local anaesthetics
201224|NCT02111746|bupivacaine|bupivacaine
201226|NCT02111720|Disclosure|disclosure
201228|NCT02111720|Intervention|intervention
201229|NCT02111694|infant|infant
201230|NCT02111694|intake|intake
201231|NCT02111694|satiation|satiation
201232|NCT02111694|mother|mother
201233|NCT02111694|feeding practices|feeding practices
201234|NCT02111694|bottle feeding|bottle feeding
201235|NCT02111694|formula feeding|formula feeding
201336|NCT02111304|children|children
201236|NCT02111694|maternal responsiveness|maternal responsiveness
201237|NCT02111694|infant cues|infant cues
201238|NCT02111681|Calypso-based Deep Inspiration Breath Hold (DIBH)|calypso-based deep inspiration breath hold (dibh)
201239|NCT02111681|radiation treatments|radiation treatments
201240|NCT02111681|13-174|13-174
201241|NCT02111668|Aorta|aorta
201242|NCT02111668|Dilatation|dilatation
201243|NCT02111668|Marfan syndrome|marfan syndrome
201244|NCT02111668|Genetic|genetic
201245|NCT02111668|Fbn1|fbn1
201246|NCT02111655|Thrombosis|thrombosis
201247|NCT02111655|Arteriovenous fistulae|arteriovenous fistulae
201248|NCT02111655|Hemodialysis|hemodialysis
201249|NCT02111655|Doppler ultrasound|doppler ultrasound
201250|NCT02111655|Vascular access blood flow|vascular access blood flow
201251|NCT02111655|Surveillance|surveillance
201252|NCT02111642|Pelvic organ prolapse|pelvic organ prolapse
201253|NCT02111642|Stress urinary incontinence|stress urinary incontinence
201254|NCT02111642|Midurethral sling|midurethral sling
201255|NCT02111642|Patient satisfaction|patient satisfaction
201256|NCT02111629|Vaginosis, bacterial; Candidiasis, vulvovaginal|vaginosis, bacterial; candidiasis, vulvovaginal
201257|NCT02111616|cancer survivorship care|cancer survivorship care
201258|NCT02111616|provider communication|provider communication
201259|NCT02111616|provider care coordination|provider care coordination
201260|NCT02111590|Immunoglobulins, Intravenous|immunoglobulins, intravenous
201261|NCT02111590|Immunoglobulins, Subcutaneous|immunoglobulins, subcutaneous
201262|NCT02111577|Immunotherapy|immunotherapy
201263|NCT02111577|Metastatic|metastatic
201264|NCT02111577|Castrate Resistant|castrate resistant
201265|NCT02111577|Prostate Cancer|prostate cancer
201266|NCT02111577|Biological|biological
201267|NCT02111577|Vaccine|vaccine
201268|NCT02111564|Heart Failure|heart failure
201269|NCT02111564|Respiratory Insufficiency|respiratory insufficiency
201270|NCT02111564|Stroke Acute|stroke acute
201271|NCT02111564|Infectious Diseases|infectious diseases
201272|NCT02111564|Rheumatic Diseases|rheumatic diseases
201273|NCT02111564|Medically ill Patient|medically ill patient
201274|NCT02111564|Rivaroxaban|rivaroxaban
201275|NCT02111564|Thromboembolism|thromboembolism
201276|NCT02111564|Prophylactic Anti-Coagulation|prophylactic anti-coagulation
201277|NCT02111551|Autism|autism
201278|NCT02111551|Nicotinic agonist|nicotinic agonist
201279|NCT02111551|Cognition|cognition
201280|NCT02111551|P50|p50
201281|NCT02111551|Alpha 7|alpha 7
201282|NCT02111499|psoriasis plaque test|psoriasis plaque test
201283|NCT02111499|topical application|topical application
201284|NCT02111499|atrophy measure|atrophy measure
201285|NCT02111486|Breakfast|breakfast
201286|NCT02111486|Satiety|satiety
201287|NCT02111486|Fibre|fibre
201288|NCT02111486|Glucose|glucose
201289|NCT02111486|Gastric emptying|gastric emptying
201290|NCT02111473|endothelial dysfunction|endothelial dysfunction
201291|NCT02111473|bone mineral metabolism|bone mineral metabolism
201292|NCT02111473|testosteron replacement treatment|testosteron replacement treatment
201293|NCT02111460|Initially|initially
201294|NCT02111460|Untreated|untreated
201295|NCT02111460|Distant metastatic|distant metastatic
201296|NCT02111447|children|children
201297|NCT02111447|sevoflurane|sevoflurane
201298|NCT02111447|isoflurane|isoflurane
201299|NCT02111447|propofol|propofol
201300|NCT02111447|anesthesia|anesthesia
201302|NCT02111447|delirium|delirium
201303|NCT02111434|visceral adiposity index|visceral adiposity index
201304|NCT02111434|triglycerides / hdl cholesterol ratio|triglycerides / hdl cholesterol ratio
201305|NCT02111434|testosterone|testosterone
201306|NCT02111421|dexmedetomidine|dexmedetomidine
201307|NCT02111421|parturient|parturient
201308|NCT02111421|nonpregnant women|nonpregnant women
201309|NCT02111421|sedation|sedation
201310|NCT02111408|Sleep apnea syndromes|sleep apnea syndromes
201311|NCT02111408|Autonomic nervous system +/- disease|autonomic nervous system +/- disease
201312|NCT02111408|Depression|depression
201313|NCT02111408|Peripheral arterial disease|peripheral arterial disease
201314|NCT02111382|Low back pain|low back pain
201315|NCT02111382|osteopathic manipulations|osteopathic manipulations
201316|NCT02111382|electroencephalography|electroencephalography
201317|NCT02111369|Essential Tremor|essential tremor
201318|NCT02111369|Essential Vocal Tremor|essential vocal tremor
201319|NCT02111369|Essential Voice Tremor|essential voice tremor
201320|NCT02111343|auditory processing disorder|auditory processing disorder
201321|NCT02111343|central auditory processing disorder|central auditory processing disorder
201322|NCT02111343|auditory processing|auditory processing
201323|NCT02111343|auditory training|auditory training
201324|NCT02111330|Adenosine A2a receptor antagonist|adenosine a2a receptor antagonist
201325|NCT02111330|adenosine receptor modulator|adenosine receptor modulator
201326|NCT02111330|Cancer|cancer
201327|NCT02111317|ASP015K|asp015k
201328|NCT02111317|Pharmacokinetics|pharmacokinetics
201329|NCT02111317|Healthy Subjects|healthy subjects
201330|NCT02111304|cholera|cholera
201331|NCT02111304|diarrhea|diarrhea
201332|NCT02111304|secretory diarrhea|secretory diarrhea
201333|NCT02111304|ORS|ors
201334|NCT02111304|V. cholerae O1|v. cholerae o1
201335|NCT02111304|iOWH032|iowh032
201337|NCT02111304|pharmacokinetic|pharmacokinetic
201338|NCT02111304|Bangladesh|bangladesh
201339|NCT02111291|Diabetic Foot Ulcers|diabetic foot ulcers
201340|NCT02111278|Manipulation|manipulation
201341|NCT02111278|Lumbar|lumbar
201342|NCT02111278|Low Back Pain|low back pain
201343|NCT02111278|Manual Therapy|manual therapy
201344|NCT02111278|Adolescents|adolescents
201345|NCT02111252|Drug Therapy|drug therapy
201346|NCT02111239|DIEP|diep
201347|NCT02111239|DIEP flap|diep flap
201348|NCT02111239|Breast reconstruction|breast reconstruction
201349|NCT02111239|Breast Cancer|breast cancer
201350|NCT02111239|CTA|cta
201351|NCT02111239|MRA|mra
201352|NCT02111226|hypertension|hypertension
201353|NCT02111226|cardiovascular disease|cardiovascular disease
201354|NCT02111226|diabetes|diabetes
201355|NCT02111226|chronic disease management|chronic disease management
201356|NCT02111213|physical activity|physical activity
201357|NCT02111213|Intervention|intervention
201358|NCT02111213|Attitude to Computers|attitude to computers
201359|NCT02111200|urea cycle disorders|urea cycle disorders
201360|NCT02111187|LDE225|lde225
201361|NCT02111187|High risk localized prostate cancer|high risk localized prostate cancer
201362|NCT02111187|Pre-surgical|pre-surgical
201363|NCT02111174|Neuropathy|neuropathy
201364|NCT02111174|Peripheral neuropathy|peripheral neuropathy
201365|NCT02111174|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
201366|NCT02111161|Randomised controlled trial (RCT)|randomised controlled trial (rct)
201367|NCT02111161|Immunoglobulin|immunoglobulin
201368|NCT02111161|Patient Reported Outcome|patient reported outcome
201369|NCT02111161|Health-Related Quality of Life|health-related quality of life
201370|NCT02111161|Short Form-36 (SF-36)|short form-36 (sf-36)
201371|NCT02111148|rupture of membranes, nitrazine, urea, creatinine|rupture of membranes, nitrazine, urea, creatinine
201372|NCT02111122|excessive daytime sleepiness|excessive daytime sleepiness
201373|NCT02111122|Parkinson`s Disease|parkinson`s disease
201374|NCT02111122|sleep-wake disturbances|sleep-wake disturbances
201375|NCT02111122|Sodium Oxybate|sodium oxybate
201376|NCT02111109|Microcirculation|microcirculation
201377|NCT02111109|Trauma|trauma
201378|NCT02111109|Haemorrhage|haemorrhage
201379|NCT02111109|Shock|shock
201380|NCT02111070|Influenza|influenza
201381|NCT02111070|Influenza vaccine|influenza vaccine
201382|NCT02111070|Split influenza vaccine|split influenza vaccine
201383|NCT02111057|Rheumatoid Arthritis|rheumatoid arthritis
201384|NCT02111057|Total Hip Replacement|total hip replacement
201385|NCT02111057|Flare|flare
201386|NCT02111057|Perioperative Outcomes|perioperative outcomes
201489|NCT02110537|Atrial fibrillation|atrial fibrillation
201387|NCT02111044|de novo or partial responder to somatostatin analogues|de novo or partial responder to somatostatin analogues
201388|NCT02111031|CELLSEARCH|cellsearch
201389|NCT02111031|CTC|ctc
201390|NCT02111031|metastatic breast cancer|metastatic breast cancer
201391|NCT02111031|Registry|registry
201392|NCT02111031|mBC|mbc
201393|NCT02111005|apoptosis|apoptosis
201394|NCT02111005|periodontal disease|periodontal disease
201395|NCT02111005|smoking|smoking
201396|NCT02110979|Patient Decision Aid|patient decision aid
201397|NCT02110979|Shared Decision Making|shared decision making
201398|NCT02110966|Anaesthetic effect|anaesthetic effect
201399|NCT02110966|Inferior alveolar nerve block|inferior alveolar nerve block
201400|NCT02110966|Local tramadol|local tramadol
201401|NCT02110966|Mepivacaine|mepivacaine
201402|NCT02110966|Symptomatic irreversible pulpitis.|symptomatic irreversible pulpitis.
201403|NCT02110927|Abdominal fat|abdominal fat
201404|NCT02110927|Metabolic syndrome|metabolic syndrome
201405|NCT02110927|Microcurrent|microcurrent
201406|NCT02110927|Aerobic exercise|aerobic exercise
201407|NCT02110927|Lipolysis|lipolysis
201408|NCT02110914|Feasibility study|feasibility study
201409|NCT02110914|Coaching|coaching
675917|NCT00878540|depression|depression
201410|NCT02110914|Health related quality of life|health related quality of life
201411|NCT02110914|Adherence|adherence
201412|NCT02110901|radiocephalic|radiocephalic
201413|NCT02110901|arteriovenous fistula|arteriovenous fistula
201414|NCT02110901|AVF|avf
201415|NCT02110901|hemodialysis|hemodialysis
201416|NCT02110901|PRT-201|prt-201
201417|NCT02110901|vascular access|vascular access
201418|NCT02110901|kidney|kidney
201419|NCT02110901|renal|renal
201420|NCT02110901|vonapanitase|vonapanitase
201421|NCT02110901|PATENCY-1|patency-1
201422|NCT02110875|Healthy Volunteers|healthy volunteers
201423|NCT02110849|Prostate|prostate
201424|NCT02110849|Proton Therapy|proton therapy
201426|NCT02110810|post-ERCP Acute Pancreatitis|post-ercp acute pancreatitis
201427|NCT02110810|Indomethacin|indomethacin
201428|NCT02110810|NSAIDs|nsaids
201429|NCT02110797|RETT syndrome|rett syndrome
201430|NCT02110797|MECP2|mecp2
201431|NCT02110797|Osteoporosis|osteoporosis
201432|NCT02110797|RANK-ligand|rank-ligand
201433|NCT02110797|osteoprotegerin|osteoprotegerin
201434|NCT02110784|Artemisinin based Combination Therapies|artemisinin based combination therapies
201435|NCT02110784|eurartesim|eurartesim
201931|NCT02108626|Withdrawal|withdrawal
201436|NCT02110784|Dihydroartemisinin/Piperaquine|dihydroartemisinin/piperaquine
201437|NCT02110771|schizophrenia|schizophrenia
201438|NCT02110771|social cognition|social cognition
201439|NCT02110771|facial affects recognition|facial affects recognition
201440|NCT02110771|cognitive remediation|cognitive remediation
201441|NCT02110758|Patient Care Management|patient care management
201442|NCT02110758|Patient Care Planning|patient care planning
201443|NCT02110758|Patient-Centered Care|patient-centered care
201444|NCT02110758|Patient Care Team|patient care team
201445|NCT02110758|Advance Care Planning|advance care planning
201446|NCT02110758|Delivery of Health Care|delivery of health care
201447|NCT02110758|Evidence-based Practice|evidence-based practice
201448|NCT02110758|Health Care Costs|health care costs
201449|NCT02110758|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
201450|NCT02110758|Quality of Health Care|quality of health care
201451|NCT02110758|Neoplasms|neoplasms
201452|NCT02110758|Medical Oncology|medical oncology
201453|NCT02110719|narcotic use|narcotic use
201454|NCT02110719|pain|pain
201455|NCT02110719|constipation|constipation
201456|NCT02110719|nausea|nausea
201457|NCT02110706|Myasthenia Gravis|myasthenia gravis
201458|NCT02110706|Rituximab|rituximab
201459|NCT02110693|Substance Use|substance use
201460|NCT02110693|Substance Use Disorder|substance use disorder
201461|NCT02110693|Screening|screening
201462|NCT02110693|Brief Assessment|brief assessment
201463|NCT02110680|overactive bladder|overactive bladder
201464|NCT02110680|transcutaneous electric stimulation|transcutaneous electric stimulation
201465|NCT02110680|posterior tibial nerve stimulation|posterior tibial nerve stimulation
201466|NCT02110667|Prostate cancer|prostate cancer
201467|NCT02110667|Prostatectomy|prostatectomy
201468|NCT02110667|Ultrasound|ultrasound
201469|NCT02110667|TPUS|tpus
201470|NCT02110654|chronic rhinosinusitis|chronic rhinosinusitis
201471|NCT02110654|asthma|asthma
201472|NCT02110654|montelukast|montelukast
201473|NCT02110654|surgery|surgery
201474|NCT02110654|treatment outcomes|treatment outcomes
201475|NCT02110641|Breast Cancer|breast cancer
201476|NCT02110641|Survivorship|survivorship
201477|NCT02110641|Weight Loss|weight loss
201478|NCT02110628|total gastrectomy|total gastrectomy
201479|NCT02110628|pouch|pouch
201480|NCT02110628|roux-en-y|roux-en-y
201481|NCT02110628|quality of life|quality of life
201482|NCT02110602|Nutrition|nutrition
201483|NCT02110589|seizures|seizures
201484|NCT02110550|endocrown|endocrown
201485|NCT02110550|marginal adaptation|marginal adaptation
201486|NCT02110550|anatomic form|anatomic form
201487|NCT02110550|retention loss|retention loss
201488|NCT02110550|IPS.emmax crowns|ips.emmax crowns
201490|NCT02110537|Acupuncture|acupuncture
201491|NCT02110537|Recurrence|recurrence
201492|NCT02110537|Electrical cardioversion|electrical cardioversion
201493|NCT02110524|Peripheral Arterial Disease|peripheral arterial disease
201494|NCT02110498|Pancreatic cyst|pancreatic cyst
201495|NCT02110498|IPMN|ipmn
201496|NCT02110498|SCA|sca
201497|NCT02110498|SPN|spn
201498|NCT02110498|MCN|mcn
201499|NCT02110498|pancreatic cystic neoplasm|pancreatic cystic neoplasm
201500|NCT02110485|Appendicitis|appendicitis
201501|NCT02110485|Pediatric|pediatric
201502|NCT02110485|Children|children
201503|NCT02110485|Non-operative|non-operative
201504|NCT02110485|Antibiotics alone|antibiotics alone
201505|NCT02110472|Emmetropic presbyopes|emmetropic presbyopes
201506|NCT02110472|Presbyopic|presbyopic
201507|NCT02110459|POL7080|pol7080
201508|NCT02110459|Pharmacokinetics|pharmacokinetics
201509|NCT02110446|Sjögren's syndrome|sjögren's syndrome
201510|NCT02110446|SS-1|ss-1
201511|NCT02110446|Gan-Lu-Yin|gan-lu-yin
201512|NCT02110446|Sang-Ju-Yin|sang-ju-yin
201513|NCT02110446|Xuefu-Zhuyu-Decoction|xuefu-zhuyu-decoction
201514|NCT02110433|chronic heart failure|chronic heart failure
201515|NCT02110433|BNP|bnp
201516|NCT02110433|telemedicine|telemedicine
201517|NCT02110433|telemonitoring|telemonitoring
201518|NCT02110433|weight|weight
201519|NCT02110433|education|education
201520|NCT02110433|self management|self management
201521|NCT02110433|cost effectiveness|cost effectiveness
201522|NCT02110420|Safety|safety
201523|NCT02110420|Pharmacokinetics|pharmacokinetics
201524|NCT02110420|Healthy Subjects|healthy subjects
201525|NCT02110420|First-in-Human|first-in-human
201526|NCT02110407|healthy young adults|healthy young adults
201527|NCT02110407|tDCS|tdcs
201528|NCT02110407|LOCATO task|locato task
201529|NCT02110407|visual-spatial learning|visual-spatial learning
201530|NCT02110394|observational|observational
201531|NCT02110394|chronic lymphocytic leukemia|chronic lymphocytic leukemia
201532|NCT02110394|bendamustine|bendamustine
201533|NCT02110381|High blood pressure|high blood pressure
201534|NCT02110355|Metastatic melanoma|metastatic melanoma
201535|NCT02110342|PF-04449913|pf-04449913
201536|NCT02110342|[14C]PF-04449913|[14c]pf-04449913
201537|NCT02110342|Human ADME|human adme
201538|NCT02110342|Radiolabel|radiolabel
201539|NCT02110342|Mass Balance|mass balance
201540|NCT02110342|Pharmacokinetics|pharmacokinetics
201541|NCT02110329|colorectal cancer|colorectal cancer
201542|NCT02110329|stage II and III|stage ii and iii
201543|NCT02110329|somatic quantitative molecular alterations|somatic quantitative molecular alterations
201544|NCT02110329|Qantitative Multiplex Pcr of Short fluorescent Fragments method (QMPSF)|qantitative multiplex pcr of short fluorescent fragments method (qmpsf)
201545|NCT02110290|quality of life|quality of life
201546|NCT02110290|adaptive sports|adaptive sports
201547|NCT02110290|therapeutic recreation|therapeutic recreation
201548|NCT02110290|mental health|mental health
201549|NCT02110277|Ovarian Cancer|ovarian cancer
201550|NCT02110277|Epithelial ovarian cancer|epithelial ovarian cancer
201551|NCT02110264|Opioid Use|opioid use
201552|NCT02110264|Incarceration|incarceration
201553|NCT02110264|Vivitrol|vivitrol
201554|NCT02110264|Patient Navigator|patient navigator
201555|NCT02110264|Drug Education|drug education
201556|NCT02110238|osteoarthritis|osteoarthritis
201557|NCT02110238|knee pain|knee pain
201558|NCT02110238|Supartz|supartz
201559|NCT02110238|Euflexxa|euflexxa
201560|NCT02110238|HA|ha
201561|NCT02110238|hyaluronic acid|hyaluronic acid
201562|NCT02110225|Cone-Rod Degenerations|cone-rod degenerations
201563|NCT02110225|Cone-Rod Dystrophy|cone-rod dystrophy
201564|NCT02110225|Cone-Rod Dystrophy 2|cone-rod dystrophy 2
201565|NCT02110225|Cone-Rod Retinal Dystrophy|cone-rod retinal dystrophy
201566|NCT02110225|Pigmentary Retinopathy|pigmentary retinopathy
201567|NCT02110225|Retinal Cone-Rod Dystrophy|retinal cone-rod dystrophy
201568|NCT02110225|Rod Cone Dystrophies|rod cone dystrophies
201569|NCT02110225|Rod-Cone Dystrophy|rod-cone dystrophy
201570|NCT02110225|Tapetoretinal Degeneration|tapetoretinal degeneration
201571|NCT02110212|Cataract|cataract
201572|NCT02110212|Surgery, cataract extraction|surgery, cataract extraction
201573|NCT02110212|Optical devices, laser|optical devices, laser
201574|NCT02110186|lumbar disc herniation|lumbar disc herniation
201575|NCT02110186|dynamic stabilization|dynamic stabilization
201576|NCT02110186|discectomy with posterior dynamic stabilization|discectomy with posterior dynamic stabilization
201577|NCT02110186|discectomy alone|discectomy alone
201578|NCT02110186|discectomy with internal fixation and fusion|discectomy with internal fixation and fusion
201579|NCT02110069|KHE|khe
201580|NCT02110069|Vascular anomaly|vascular anomaly
201581|NCT02110069|Kasabach-Merritt Syndrome|kasabach-merritt syndrome
201582|NCT02110069|Tufted angioma|tufted angioma
201583|NCT02110069|hemangioendothelioma|hemangioendothelioma
201584|NCT02110056|healthy older adults|healthy older adults
201585|NCT02110056|tDCS|tdcs
201586|NCT02110056|LOCATO task|locato task
201587|NCT02110056|visual-spatial learning|visual-spatial learning
201588|NCT02110043|mild cognitive impairment (MCI)|mild cognitive impairment (mci)
201589|NCT02110043|tDCS|tdcs
201590|NCT02110043|LOCATO task|locato task
201591|NCT02110043|visual-spatial learning|visual-spatial learning
201592|NCT02110030|Transcutaneous electrical nerve stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
201593|NCT02110030|Ultrasound|ultrasound
201594|NCT02110030|Interferential current therapy|interferential current therapy
201595|NCT02110030|Rehabilitation|rehabilitation
201596|NCT02110030|Shoulder pain|shoulder pain
201597|NCT02110017|Ecological task|ecological task
201598|NCT02110017|fMRI|fmri
201599|NCT02110017|Schizophrenia|schizophrenia
201600|NCT02110017|Social Cognition|social cognition
201601|NCT02109978|Diabetes|diabetes
201602|NCT02109978|Type 2 diabetes|type 2 diabetes
201603|NCT02109978|Diabetes therapy response|diabetes therapy response
201604|NCT02109978|Diabetes progression|diabetes progression
201605|NCT02109939|MDD|mdd
201606|NCT02109939|Pharmacogenomic|pharmacogenomic
201607|NCT02109939|Pharmacogenomic Testing|pharmacogenomic testing
201608|NCT02109939|Pharmacogenomics|pharmacogenomics
201609|NCT02109939|Genetic Testing|genetic testing
201610|NCT02109939|Genetics|genetics
201611|NCT02109939|Major Depressive Disorder|major depressive disorder
201612|NCT02109939|GeneSight|genesight
201613|NCT02109939|Assurex|assurex
201614|NCT02109939|AssureRx|assurerx
201615|NCT02109939|Psychotropic|psychotropic
201616|NCT02109939|Randomized|randomized
201617|NCT02109939|Double Blind|double blind
201618|NCT02109939|Placebo Controlled|placebo controlled
201619|NCT02109913|Breast Cancer|breast cancer
201620|NCT02109913|metastatic|metastatic
201621|NCT02109913|hormone receptor positive|hormone receptor positive
201622|NCT02109913|everolimus|everolimus
201623|NCT02109913|biomarker|biomarker
201624|NCT02109887|Pneumocystis jiroveci, cytomegalovirus, co-infection|pneumocystis jiroveci, cytomegalovirus, co-infection
201625|NCT02109861|Multiple Myeloma|multiple myeloma
201626|NCT02109861|Phase 0 study|phase 0 study
201627|NCT02109861|Microdose study|microdose study
201628|NCT02109861|Micro array|micro array
201629|NCT02109861|Gene expression profiling|gene expression profiling
201630|NCT02109848|keratoconus|keratoconus
201631|NCT02109848|post-keratoplasty|post-keratoplasty
201632|NCT02109835|Diabetes|diabetes
201633|NCT02109835|coronary artery disease|coronary artery disease
201634|NCT02109835|Cardiac computed tomography|cardiac computed tomography
201635|NCT02109835|Computed tomographics coronary angiography|computed tomographics coronary angiography
202133|NCT02107794|Aid|aid
201636|NCT02109835|Plaque progression|plaque progression
201637|NCT02109822|Cystic Fibrosis|cystic fibrosis
201638|NCT02109822|Pulmonary Exacerbation|pulmonary exacerbation
201639|NCT02109822|Lung Infection|lung infection
201640|NCT02109822|Cystic Fibrosis Foundation|cystic fibrosis foundation
201641|NCT02109822|Cystic Fibrosis Foundation National Patient Registry|cystic fibrosis foundation national patient registry
201642|NCT02109796|tDCS|tdcs
201643|NCT02109796|Stroke|stroke
201644|NCT02109796|Force|force
201645|NCT02109796|Spasticity|spasticity
201646|NCT02109796|Gait|gait
201648|NCT02109796|Isokinetic|isokinetic
201649|NCT02109783|Athletes|athletes
201650|NCT02109783|Ergogenic aids|ergogenic aids
201651|NCT02109783|Caffeine|caffeine
201652|NCT02109783|Nutrigenomics|nutrigenomics
201653|NCT02109783|Genotype|genotype
201654|NCT02109770|22q|22q
201655|NCT02109770|DiGeorge|digeorge
201656|NCT02109770|Angelman|angelman
201657|NCT02109770|Cri du chat|cri du chat
201658|NCT02109770|Miller Dieker|miller dieker
201659|NCT02109770|1p36|1p36
201660|NCT02109770|Phelan McDermid|phelan mcdermid
201661|NCT02109770|Prader Willi|prader willi
201662|NCT02109770|Wolf Hirschorn|wolf hirschorn
201663|NCT02109770|Smith Magenis|smith magenis
201664|NCT02109770|Trisomy 21|trisomy 21
201665|NCT02109770|Down syndrome|down syndrome
201666|NCT02109770|Trisomy 18|trisomy 18
201667|NCT02109770|Edwards syndrome|edwards syndrome
201668|NCT02109770|Trisomy 13|trisomy 13
201669|NCT02109770|Patau syndrome|patau syndrome
201670|NCT02109770|Monosomy X|monosomy x
201671|NCT02109770|Turner syndrome|turner syndrome
201672|NCT02109770|XXY|xxy
201673|NCT02109770|Klinefelter syndrome|klinefelter syndrome
201674|NCT02109770|XXX|xxx
201675|NCT02109770|XYY|xyy
201676|NCT02109757|Hearing conservation|hearing conservation
201677|NCT02109757|Personal attenuation rating|personal attenuation rating
201678|NCT02109757|earplug|earplug
201679|NCT02109731|Obstructive Sleep Apnea Syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
201680|NCT02109731|Sleep Apnea|sleep apnea
201681|NCT02109718|Burns|burns
201682|NCT02109718|Dressings|dressings
201683|NCT02109718|Outpatient Management|outpatient management
201684|NCT02109718|Petrolatum Jelly|petrolatum jelly
201685|NCT02109718|Superficial Partial Thickness Burns|superficial partial thickness burns
201686|NCT02109718|Less than or equal to 10% Total Body Surface Area|less than or equal to 10% total body surface area
201687|NCT02109692|dystrophinopathies|dystrophinopathies
201688|NCT02109692|muscle dystrophies|muscle dystrophies
201689|NCT02109692|dystromirs|dystromirs
201690|NCT02109692|longitudinal study|longitudinal study
201691|NCT02109692|miRNA|mirna
201692|NCT02109653|NSCLC,|nsclc,
201693|NCT02109653|Non-Small Cell Lung Cancer,|non-small cell lung cancer,
201694|NCT02109653|BRAF V600,|braf v600,
201695|NCT02109653|LGX818|lgx818
201696|NCT02109640|Colorectal|colorectal
201697|NCT02109640|Surgery|surgery
201698|NCT02109640|Laparoscopic|laparoscopic
201699|NCT02109640|Analgesia|analgesia
201700|NCT02109640|Enhanced Recovery|enhanced recovery
201701|NCT02109640|Targinact|targinact
201702|NCT02109627|Acute Myeloid Leukemia|acute myeloid leukemia
201703|NCT02109627|Ficlatuzumab|ficlatuzumab
201704|NCT02109627|High Dose Cytarabine|high dose cytarabine
201705|NCT02109627|antibody|antibody
201706|NCT02109614|lipoprotein(a)|lipoprotein(a)
201707|NCT02109614|aortic stenosis|aortic stenosis
201708|NCT02109601|Patient Portals|patient portals
201709|NCT02109601|Personal Health Records|personal health records
201710|NCT02109601|Patient Engagement|patient engagement
201711|NCT02109601|Mobile Health|mobile health
201712|NCT02109601|Tablet Computers|tablet computers
201713|NCT02109575|Acute Rejection|acute rejection
201714|NCT02109575|Cardiac Biomarkers|cardiac biomarkers
201715|NCT02109575|Cardiac Catheterization|cardiac catheterization
201716|NCT02109575|Cardiomyopathy|cardiomyopathy
201717|NCT02109575|Cell-Free DNA|cell-free dna
201718|NCT02109575|Congenital Heart Defect|congenital heart defect
201719|NCT02109575|Congenital Heart Disease|congenital heart disease
201720|NCT02109575|Coronary Angiogram|coronary angiogram
201721|NCT02109575|Donor Specific DNA|donor specific dna
201722|NCT02109575|Donor Specific Cell-Free DNA|donor specific cell-free dna
201723|NCT02109575|Endomyocardial Biopsy|endomyocardial biopsy
201724|NCT02109575|Heart Failure|heart failure
201725|NCT02109575|Heart Transplant Failure|heart transplant failure
201726|NCT02109575|Heart Transplant|heart transplant
201727|NCT02109575|Heart Transplant Rejection|heart transplant rejection
201728|NCT02109562|Schizophrenia|schizophrenia
201729|NCT02109562|Schizophrenic|schizophrenic
201730|NCT02109562|Schizophrenias|schizophrenias
201731|NCT02109562|Risperidone|risperidone
201732|NCT02109536|Colonoscopy|colonoscopy
201733|NCT02109536|Looping|looping
201734|NCT02109536|Loop recognition|loop recognition
201735|NCT02109536|magnetic endoscopic imager|magnetic endoscopic imager
201736|NCT02109471|corneal opacities|corneal opacities
201737|NCT02109471|Optical coherence tomography|optical coherence tomography
201738|NCT02109458|Lung nodule biopsy|lung nodule biopsy
201739|NCT02109432|Pedal Desk|pedal desk
201740|NCT02109432|Physical Activity|physical activity
201741|NCT02109432|Workplace|workplace
201742|NCT02109432|Energy Expenditure|energy expenditure
201743|NCT02109419|computerized assessments|computerized assessments
201744|NCT02109419|mood|mood
201745|NCT02109419|life space|life space
201746|NCT02109419|cognition|cognition
201747|NCT02109393|Rehabilitation|rehabilitation
201748|NCT02109393|Robot-assisted walking training|robot-assisted walking training
201749|NCT02109393|Treadmill|treadmill
201750|NCT02109393|Lokomat|lokomat
201751|NCT02109367|ovarian cancer|ovarian cancer
201752|NCT02109367|ovarian mass|ovarian mass
201753|NCT02109367|CA-125|ca-125
201755|NCT02109367|culdocentesis|culdocentesis
201756|NCT02109367|biomarker(s)|biomarker(s)
201757|NCT02109354|HIV infection|hiv infection
201758|NCT02109354|Vaccine|vaccine
201759|NCT02109341|mPC|mpc
201760|NCT02109328|Bladder cancer|bladder cancer
201761|NCT02109328|Urothelial cancer|urothelial cancer
201762|NCT02109328|Alisertib|alisertib
201763|NCT02109328|Phase 2|phase 2
201764|NCT02109328|Advanced disease|advanced disease
201765|NCT02109289|Anti-Tumor necrosis factor alpha|anti-tumor necrosis factor alpha
201766|NCT02109289|18-FluoroDeoxyGlucose Positron Emission Tomography|18-fluorodeoxyglucose positron emission tomography
201767|NCT02109289|High-sensitivity C- Reactive protein|high-sensitivity c- reactive protein
201768|NCT02109276|Fuch's endothelial dystrophy|fuch's endothelial dystrophy
201769|NCT02109276|Aspheric intraocular lens|aspheric intraocular lens
201770|NCT02109276|Higher Order Aberrations|higher order aberrations
201771|NCT02109276|Contrast Sensitivity|contrast sensitivity
201772|NCT02109263|Breast-feeding|breast-feeding
201773|NCT02109263|Saccharose|saccharose
201774|NCT02109263|Breast-feeding newborn|breast-feeding newborn
201775|NCT02109263|cortical pain responses|cortical pain responses
201776|NCT02109263|near infrared spectroscopy (NIRS)|near infrared spectroscopy (nirs)
201777|NCT02109263|Salivary rate cortisol|salivary rate cortisol
201778|NCT02109263|heel lance|heel lance
201779|NCT02109250|Medullary Thyroid Cancer (MTC) vandetanib caprelsa|medullary thyroid cancer (mtc) vandetanib caprelsa
201780|NCT02109237|Lung transplantation|lung transplantation
201781|NCT02109237|Bronchiolitis obliterans|bronchiolitis obliterans
201782|NCT02109198|Mild Traumatic Brain Injury|mild traumatic brain injury
201783|NCT02109185|seasonal allergic rhinitis|seasonal allergic rhinitis
201784|NCT02109185|grass/tree/ragweed allergies|grass/tree/ragweed allergies
201785|NCT02109185|nasal congestion/stuffiness|nasal congestion/stuffiness
201786|NCT02109185|rhinnorea|rhinnorea
201787|NCT02109185|nasal itching|nasal itching
201788|NCT02109185|sneezing|sneezing
201789|NCT02109172|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
201790|NCT02109172|COPD|copd
201791|NCT02109146|TACE|tace
201792|NCT02109146|Postoperation|postoperation
201793|NCT02109133|deep neuromuscular blockade|deep neuromuscular blockade
201794|NCT02109133|intraocular pressure|intraocular pressure
201795|NCT02109107|body contouring|body contouring
201796|NCT02109107|body shaping|body shaping
201797|NCT02109107|circumference reduction|circumference reduction
201798|NCT02109094|insulin|insulin
201799|NCT02109094|metabolomics|metabolomics
201800|NCT02109081|dexamethasone|dexamethasone
201801|NCT02109081|delirium|delirium
201802|NCT02109081|postoperative cognitive dysfunction|postoperative cognitive dysfunction
201803|NCT02109081|postoperative|postoperative
201804|NCT02109081|elderly|elderly
201805|NCT02109068|Breast Cancer|breast cancer
201806|NCT02109068|Survivorship|survivorship
201807|NCT02109068|Weight Loss|weight loss
201808|NCT02109055|Cardiovascular Diseases|cardiovascular diseases
201809|NCT02109055|Thoracic Surgery|thoracic surgery
201810|NCT02109055|Exercise Therapy|exercise therapy
201811|NCT02109016|FGFR1 amplification|fgfr1 amplification
201812|NCT02109016|FGF alteration|fgf alteration
201813|NCT02109016|VEGF alteration|vegf alteration
201814|NCT02109016|PDGF alteration|pdgf alteration
201815|NCT02109016|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
201816|NCT02109016|VEGFR inhibitor|vegfr inhibitor
201817|NCT02109016|FGFR inhibitor|fgfr inhibitor
201818|NCT02109016|PDGFR inhibitor|pdgfr inhibitor
201819|NCT02109016|VEGFR-FGFR inhibitor|vegfr-fgfr inhibitor
201820|NCT02109003|tracheal cuff|tracheal cuff
201821|NCT02109003|cuff overinflation|cuff overinflation
201822|NCT02109003|cuff underinflation|cuff underinflation
751893|NCT01171092|autologous|autologous
201823|NCT02108990|borderline personality disorder|borderline personality disorder
201825|NCT02108990|social pain|social pain
201826|NCT02108977|Remote Consultation|remote consultation
201827|NCT02108977|Teleconsultation|teleconsultation
201828|NCT02108977|Videoconferencing|videoconferencing
201829|NCT02108977|Genetic Counseling|genetic counseling
201830|NCT02108977|Costs and Cost Analysis|costs and cost analysis
201831|NCT02108977|Comparative Effectiveness Research|comparative effectiveness research
201832|NCT02108977|Telehealth|telehealth
201833|NCT02108964|NSCLC|nsclc
402953|NCT01228916|secondhand smoke|secondhand smoke
201834|NCT02108964|Non-small Cell Lung Cancer EGFRmut|non-small cell lung cancer egfrmut
201835|NCT02108964|EGFR TKIs (EGF816)|egfr tkis (egf816)
201836|NCT02108964|acquired T790M mutation|acquired t790m mutation
201837|NCT02108964|de novo T790M mutation|de novo t790m mutation
201838|NCT02108964|EGFR TKI activating mutation (i.e. L858R or ex19del)|egfr tki activating mutation (i.e. l858r or ex19del)
201839|NCT02108964|Treatment naive advanced NSCLC with EGFR activating mutations|treatment naive advanced nsclc with egfr activating mutations
201840|NCT02108964|Locally advanced NSCLC (Stage IIIB NSCLC not amenable to definitive multi-modality therapy including surgery)|locally advanced nsclc (stage iiib nsclc not amenable to definitive multi-modality therapy including surgery)
201841|NCT02108964|Metastatic NSCLC refers to Stage IV NSCLC|metastatic nsclc refers to stage iv nsclc
201842|NCT02108964|1st line|1st line
201843|NCT02108951|CML|cml
201844|NCT02108951|Ph-CML|ph-cml
201845|NCT02108951|leukaemia|leukaemia
201846|NCT02108951|leukemia|leukemia
201847|NCT02108951|chronic myeloid leukemia|chronic myeloid leukemia
201848|NCT02108951|chronic myeloid leukaemia|chronic myeloid leukaemia
201849|NCT02108951|TKI intolerance|tki intolerance
201850|NCT02108951|tyrosine kinase inhibitor|tyrosine kinase inhibitor
201851|NCT02108951|tyrosine kinase inhibitor intolerance|tyrosine kinase inhibitor intolerance
201852|NCT02108912|stroke|stroke
201853|NCT02108912|gait|gait
201854|NCT02108912|cardiovascular|cardiovascular
201855|NCT02108899|Schizophrenia|schizophrenia
201856|NCT02108899|Episodic memory deficits|episodic memory deficits
201857|NCT02108886|preterm labor|preterm labor
201858|NCT02108886|montelukast|montelukast
201859|NCT02108886|uterine contractions|uterine contractions
201860|NCT02108873|Appointments and Schedules|appointments and schedules
201861|NCT02108873|Outpatient Clinics, Hospital/economics|outpatient clinics, hospital/economics
201862|NCT02108860|Granulomatosis with polyangiitis (Wegener's)|granulomatosis with polyangiitis (wegener's)
201863|NCT02108860|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
201864|NCT02108860|GPA|gpa
201865|NCT02108860|Wegener's granulomatosis|wegener's granulomatosis
201866|NCT02108860|Wegener granulomatosis|wegener granulomatosis
201867|NCT02108860|Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis|anti neutrophil cytoplasmic antibody associated vasculitis
201868|NCT02108860|ANCA Associated Vasculitis|anca associated vasculitis
201869|NCT02108860|AAV|aav
201870|NCT02108860|Vasculitis|vasculitis
201871|NCT02108860|Systemic vasculitis|systemic vasculitis
201872|NCT02108860|Systemic inflammatory disease|systemic inflammatory disease
201873|NCT02108860|Lung Diseases|lung diseases
201874|NCT02108860|Respiratory Tract Diseases|respiratory tract diseases
201875|NCT02108860|Vascular Diseases|vascular diseases
201876|NCT02108860|Abatacept|abatacept
201877|NCT02108860|CTLA4-Ig|ctla4-ig
201878|NCT02108860|Immunosuppressive agent|immunosuppressive agent
201879|NCT02108860|Prednisone|prednisone
201880|NCT02108860|Glucocorticoids|glucocorticoids
201881|NCT02108860|Glucocorticoid|glucocorticoid
201882|NCT02108860|Corticosteroid|corticosteroid
201883|NCT02108860|Corticosteroids|corticosteroids
201884|NCT02108860|Treatment|treatment
201885|NCT02108860|Pharmacologic Actions|pharmacologic actions
201886|NCT02108860|Therapeutic Uses|therapeutic uses
201887|NCT02108860|Anti Inflammatory Agents|anti inflammatory agents
201888|NCT02108847|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
201889|NCT02108847|Pain, Postoperative|pain, postoperative
201890|NCT02108847|Nerve Block|nerve block
201891|NCT02108847|Anesthesia, Regional|anesthesia, regional
201892|NCT02108847|Fascia Iliaca Block|fascia iliaca block
201893|NCT02108847|Ultrasound Guided|ultrasound guided
201894|NCT02108834|chronic postsurgery pain|chronic postsurgery pain
201895|NCT02108834|acute pain|acute pain
201896|NCT02108821|Inflammatory Bowel Diseases (IBD)|inflammatory bowel diseases (ibd)
201897|NCT02108821|Crohn's Disease (CD)|crohn's disease (cd)
201898|NCT02108821|Ulcerative Colitis (UC)|ulcerative colitis (uc)
201899|NCT02108808|FFR|ffr
201900|NCT02108808|adenosine|adenosine
201901|NCT02108808|Ticagrelor|ticagrelor
201902|NCT02108769|Yoga|yoga
201903|NCT02108769|Yogic breathing|yogic breathing
201904|NCT02108769|Saliva|saliva
201905|NCT02108769|Proteomics|proteomics
201906|NCT02108769|Lipdomics|lipdomics
201907|NCT02108769|Nerve growth factor|nerve growth factor
201908|NCT02108769|Thirumanthiram|thirumanthiram
201909|NCT02108717|Telemedicine|telemedicine
201910|NCT02108717|appendicitis|appendicitis
201911|NCT02108717|remote consultation|remote consultation
201912|NCT02108704|Parkinson's Disease|parkinson's disease
201913|NCT02108704|Helicobacter pylori infection|helicobacter pylori infection
201914|NCT02108678|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
201915|NCT02108678|Depression|depression
201916|NCT02108678|Illness Management|illness management
201917|NCT02108678|Behavioral Treatment|behavioral treatment
201918|NCT02108678|Impairment|impairment
201919|NCT02108652|anti-PD-L1|anti-pd-l1
201920|NCT02108652|PD-L1|pd-l1
201921|NCT02108652|MPDL3280A|mpdl3280a
201922|NCT02108652|PD-1|pd-1
201923|NCT02108652|bladder cancer|bladder cancer
201924|NCT02108652|atezolizumab|atezolizumab
201925|NCT02108652|Tecentriq|tecentriq
201926|NCT02108626|Electronic Cigarettes|electronic cigarettes
201927|NCT02108626|Lozenge|lozenge
201928|NCT02108626|Nicotine|nicotine
201929|NCT02108626|Tobacco|tobacco
201930|NCT02108626|Dependence|dependence
201932|NCT02108613|Androgen deprivation therapy|androgen deprivation therapy
201933|NCT02108613|Supportive care|supportive care
201934|NCT02108613|Quality of life|quality of life
201935|NCT02108600|Kidney transplantation|kidney transplantation
201936|NCT02108600|Inflammation|inflammation
201937|NCT02108561|Breast Cancer Heterogeneity Her2|breast cancer heterogeneity her2
201938|NCT02108548|ASP7657|asp7657
201939|NCT02108548|Pharmacokinetics|pharmacokinetics
201940|NCT02108548|Pharmacodynamics|pharmacodynamics
201941|NCT02108548|Healthy Subjects|healthy subjects
201942|NCT02108548|First in man|first in man
201943|NCT02108548|Safety|safety
201944|NCT02108535|burns|burns
201945|NCT02108535|dressings|dressings
201946|NCT02108535|silver sulfadiazine|silver sulfadiazine
201947|NCT02108535|silver compounds|silver compounds
201948|NCT02108535|cost|cost
201949|NCT02108522|CMV infection|cmv infection
201950|NCT02108522|EBV infection|ebv infection
201951|NCT02108522|HHV6 virus infection|hhv6 virus infection
201952|NCT02108522|BK virus infection|bk virus infection
201953|NCT02108522|Adenovirus infection|adenovirus infection
201954|NCT02108522|JC virus infection|jc virus infection
201955|NCT02108522|allogeneic stem cell transplant|allogeneic stem cell transplant
201956|NCT02108522|Virus Specific T cells|virus specific t cells
201957|NCT02108509|Chronic Pancreatitis|chronic pancreatitis
201958|NCT02108509|Osteopenia|osteopenia
201959|NCT02108509|Osteoporosis|osteoporosis
201960|NCT02108509|Hypogonadism|hypogonadism
201961|NCT02108509|Opioid medications|opioid medications
201962|NCT02108470|Oral Health Related Quality of Life (OHRQoL)|oral health related quality of life (ohrqol)
201963|NCT02108470|Oral Health Impact Profile (OHIP)|oral health impact profile (ohip)
201964|NCT02108470|Dentist-Patient Relations|dentist-patient relations
201965|NCT02108470|patients' participation.|patients' participation.
201966|NCT02108470|patients' satisfaction with the consultation.|patients' satisfaction with the consultation.
201967|NCT02108457|concurrent chemotherapy|concurrent chemotherapy
201968|NCT02108444|hepatitis|hepatitis
201969|NCT02108444|hepatitis B|hepatitis b
201970|NCT02108444|lymphoma|lymphoma
201971|NCT02108444|Hematologic Diseases|hematologic diseases
201972|NCT02108431|urinary diversion|urinary diversion
201973|NCT02108431|urethral catheter|urethral catheter
201974|NCT02108431|suprapubic tube|suprapubic tube
201975|NCT02108431|radical prostatectomy|radical prostatectomy
201976|NCT02108431|robotic surgery|robotic surgery
201977|NCT02108431|discomfort|discomfort
201978|NCT02108431|pain|pain
201979|NCT02108405|critically ill patient.|critically ill patient.
201980|NCT02108392|PXE|pxe
201981|NCT02108392|phenotype|phenotype
201982|NCT02108392|eye|eye
201983|NCT02108392|biomarkers|biomarkers
201984|NCT02108366|severe|severe
201985|NCT02108366|influenza A|influenza a
201986|NCT02108366|celecoxib|celecoxib
201987|NCT02108353|Type 2 Diabetes|type 2 diabetes
201988|NCT02108353|metabolic control|metabolic control
201989|NCT02108353|Metabolomics|metabolomics
201990|NCT02108353|Circadian Rhythm|circadian rhythm
201991|NCT02108353|Melatonin|melatonin
201992|NCT02108353|Biomarker|biomarker
201993|NCT02108353|Clock Gene|clock gene
201994|NCT02108353|PBMC|pbmc
201995|NCT02108353|Cardiovascular function|cardiovascular function
201996|NCT02108353|Epigenetic modification|epigenetic modification
201997|NCT02108353|Lifestyle Intervention|lifestyle intervention
201998|NCT02108340|Appendicitis|appendicitis
201999|NCT02108340|Diagnosis|diagnosis
202000|NCT02108340|Microwave radiometry|microwave radiometry
202001|NCT02108340|Ultrasonography|ultrasonography
202002|NCT02108327|Blood loss|blood loss
202003|NCT02108327|total knee arthroplasty|total knee arthroplasty
202004|NCT02108327|hot knife|hot knife
202005|NCT02108327|cold knife|cold knife
202006|NCT02108327|unipolar electrocautery|unipolar electrocautery
202007|NCT02108327|surgical blade|surgical blade
202008|NCT02108301|chronic hepatitis C-virus infection|chronic hepatitis c-virus infection
202009|NCT02108301|renal transplantation|renal transplantation
202010|NCT02108301|glucose tolerance|glucose tolerance
202011|NCT02108301|immunosuppression|immunosuppression
202012|NCT02107222|COPD|copd
202013|NCT02107222|Exacerbation|exacerbation
202014|NCT02107222|invasive ventilation|invasive ventilation
202015|NCT02107222|CO2-Removal|co2-removal
202016|NCT02107196|Irritable Bowel Syndrome|irritable bowel syndrome
202017|NCT02107196|Colon, irritable|colon, irritable
202018|NCT02107196|Bowel disease|bowel disease
202019|NCT02107196|Diarrhea|diarrhea
202020|NCT02107183|Oxygen therapy|oxygen therapy
202021|NCT02107183|Extubation|extubation
202022|NCT02107183|Weaning|weaning
202023|NCT02107183|Reintubation|reintubation
202024|NCT02107183|Acute respiratory failure|acute respiratory failure
202025|NCT02107144|trimetazidine|trimetazidine
202026|NCT02107144|microcirculation|microcirculation
202027|NCT02107144|stenting|stenting
202028|NCT02107144|pressure wire|pressure wire
202029|NCT02108236|acupuncture|acupuncture
202030|NCT02108236|chinese traditional medicine|chinese traditional medicine
202031|NCT02108223|ICSI|icsi
202032|NCT02108223|Suboptimal Ovarian Response|suboptimal ovarian response
202034|NCT02108210|Chronic fatigue syndrome|chronic fatigue syndrome
202035|NCT02108210|Cytokines|cytokines
202036|NCT02108210|Interleukin-1|interleukin-1
202037|NCT02108210|Fatigue|fatigue
202038|NCT02108210|Anakinra|anakinra
202039|NCT02108184|helicobacter eradication rates|helicobacter eradication rates
202040|NCT02108171|intranasal|intranasal
202041|NCT02108171|dexmedetomidine|dexmedetomidine
202042|NCT02108171|early recovery|early recovery
202043|NCT02108171|suspension laryngoscopy|suspension laryngoscopy
202044|NCT02108145|cholangiocarcinoma|cholangiocarcinoma
202045|NCT02108145|jaundice|jaundice
202046|NCT02108145|metal stent|metal stent
202047|NCT02108145|PTBS|ptbs
202048|NCT02108132|hemophilia|hemophilia
202049|NCT02108132|mesenchymal stem cells|mesenchymal stem cells
202050|NCT02108132|in-vitro transdifferentiation|in-vitro transdifferentiation
202051|NCT02108106|safety and tolerability|safety and tolerability
202052|NCT02108106|pharmacokinetic study|pharmacokinetic study
202053|NCT02108080|Alcohol|alcohol
202054|NCT02108080|Adolescents|adolescents
202055|NCT02108080|Adults|adults
202056|NCT02108054|fMRI|fmri
202057|NCT02108054|Alcoholism|alcoholism
202058|NCT02108054|Phenotype|phenotype
202059|NCT02108054|Imaging|imaging
202060|NCT02108041|Physicians|physicians
202061|NCT02108041|Pharmacogenetic Testing|pharmacogenetic testing
202062|NCT02108041|Decision-Making|decision-making
202063|NCT02108041|Communicative Behaviors|communicative behaviors
202064|NCT02108028|Advance Care Planning Guide|advance care planning guide
202065|NCT02108028|End-of-Life|end-of-life
202066|NCT02108015|Transmembrane AMPA Receptor Regulatory Protein|transmembrane ampa receptor regulatory protein
202067|NCT02108015|Glutamate Receptors|glutamate receptors
202068|NCT02108015|Healthy Volunteers|healthy volunteers
202069|NCT02108002|Missense Mutations|missense mutations
202070|NCT02108002|Hemangioblastoma|hemangioblastoma
202071|NCT02108002|Histone Deacytelase Inhibitors|histone deacytelase inhibitors
202072|NCT02108002|Von Hippel-Lindau Disease|von hippel-lindau disease
202073|NCT02107989|Epilepsy|epilepsy
202074|NCT02107989|MRI|mri
202075|NCT02107989|fMRI|fmri
202076|NCT02107989|MEG|meg
202077|NCT02107976|Diabetes|diabetes
202078|NCT02107976|Red Blood Cells|red blood cells
202079|NCT02107976|Vitamin C|vitamin c
202080|NCT02107976|Plasma Vitamin C Levels|plasma vitamin c levels
202081|NCT02107963|GD2-Expressing Tumors|gd2-expressing tumors
202082|NCT02107963|Anti-GD2 Chimeric Antigen Receptor|anti-gd2 chimeric antigen receptor
202083|NCT02107963|Osteosarcoma|osteosarcoma
202084|NCT02107963|Adoptive Immunotherapy|adoptive immunotherapy
202085|NCT02107963|Sarcomas|sarcomas
202086|NCT02107950|Ovarian|ovarian
202087|NCT02107950|Platinum Sensitive|platinum sensitive
202088|NCT02107950|Epithelial|epithelial
202089|NCT02107937|serous|serous
202090|NCT02107937|endometrioid|endometrioid
202091|NCT02107937|mucinous|mucinous
202092|NCT02107937|epithelial ovarian cancer|epithelial ovarian cancer
202093|NCT02107924|Total|total
202094|NCT02107924|Knee|knee
202095|NCT02107924|Replacment|replacment
202096|NCT02107924|Infection|infection
202097|NCT02107924|Stimulan|stimulan
202098|NCT02107911|men who have sex with men|men who have sex with men
202099|NCT02107911|non-occupational post exposure prophylaxis|non-occupational post exposure prophylaxis
202100|NCT02107911|HIV infection|hiv infection
202101|NCT02107859|Cystic fibrosis|cystic fibrosis
676216|NCT00879775|Confusion|confusion
202102|NCT02107859|Nonsense mutation|nonsense mutation
202103|NCT02107859|Premature stop codon|premature stop codon
202104|NCT02107859|PTC124|ptc124
202105|NCT02107859|Ataluren|ataluren
202106|NCT02107820|Bladder training|bladder training
202107|NCT02107820|Percutaneous Tibial nerve stimulation|percutaneous tibial nerve stimulation
202108|NCT02107820|Overactive bladder|overactive bladder
202109|NCT02107820|Randomised controlled study|randomised controlled study
202110|NCT02107807|Influenza,|influenza,
202111|NCT02107807|H5N1|h5n1
202112|NCT02107807|aH5N1|ah5n1
202113|NCT02107807|H5N1 vaccine|h5n1 vaccine
202114|NCT02107807|Pandemic Influenza vaccine|pandemic influenza vaccine
202115|NCT02107807|MF59|mf59
202116|NCT02107807|Adjuvant|adjuvant
202117|NCT02107807|Avian flu|avian flu
202118|NCT02107807|Underlying Immunosuppressive|underlying immunosuppressive
202119|NCT02107807|immunosuppressive conditions|immunosuppressive conditions
202120|NCT02107807|Pandemic vaccine|pandemic vaccine
202121|NCT02107807|Adjuvanted vaccine|adjuvanted vaccine
202122|NCT02107794|Grave's|grave's
202123|NCT02107794|Disease|disease
202124|NCT02107794|Thyroid|thyroid
202125|NCT02107794|Hyperthyroidism|hyperthyroidism
202126|NCT02107794|Thyroidectomy|thyroidectomy
247343|NCT01901016|HIV|hiv
192988|NCT02148068|Roux-en-y Gastric Bypass|roux-en-y gastric bypass
192989|NCT02148068|Sleeve Gastrectomy|sleeve gastrectomy
192990|NCT02148055|spontaneous intrauterine death|spontaneous intrauterine death
202127|NCT02107794|Radioactive|radioactive
202128|NCT02107794|Iodine|iodine
202129|NCT02107794|Antithyroid|antithyroid
202130|NCT02107794|Shared|shared
202131|NCT02107794|Decision|decision
202132|NCT02107794|Making|making
202134|NCT02107794|Evidence|evidence
202135|NCT02107794|Based|based
202136|NCT02107794|Endocrinology|endocrinology
202137|NCT02107794|Mayo|mayo
202138|NCT02107794|Clinic|clinic
202139|NCT02107781|Open abdomen|open abdomen
202140|NCT02107781|abdominal compartment pressure|abdominal compartment pressure
202141|NCT02107768|Stroke|stroke
202142|NCT02107768|Exercise|exercise
202143|NCT02107768|Randomized trial|randomized trial
202144|NCT02107768|Quality of Life|quality of life
202145|NCT02107755|oligometastatic melanoma|oligometastatic melanoma
202146|NCT02107755|melanoma|melanoma
202147|NCT02107742|Injections|injections
202148|NCT02107742|Time factors|time factors
202149|NCT02107742|Pain|pain
202150|NCT02107742|Healthy volunteers|healthy volunteers
202151|NCT02107742|Lidocaine|lidocaine
202152|NCT02107729|Injections|injections
202153|NCT02107729|Pain|pain
202154|NCT02107729|Healthy volunteers|healthy volunteers
202155|NCT02107729|Lidocaine|lidocaine
202156|NCT02107716|Pain|pain
202157|NCT02107716|Injections|injections
202158|NCT02107716|Lidocaine|lidocaine
202159|NCT02107716|Healthy volunteers|healthy volunteers
202160|NCT02107703|MONARCH 2|monarch 2
202161|NCT02107690|Injections|injections
202162|NCT02107690|Temperature|temperature
202163|NCT02107690|Pain|pain
202164|NCT02107690|Healthy volunteers|healthy volunteers
202165|NCT02107690|Lidocaine|lidocaine
202166|NCT02107664|Radiotherapy|radiotherapy
202167|NCT02107664|Cachexia|cachexia
202168|NCT02107664|Inflammation|inflammation
202169|NCT02107664|Depression|depression
202170|NCT02107651|Bleeding|bleeding
202171|NCT02107651|Anticoagulation|anticoagulation
202172|NCT02107638|Parkinson's Disease|parkinson's disease
202173|NCT02107638|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
202174|NCT02107638|Falls|falls
202175|NCT02107638|Balance|balance
202176|NCT02107638|Motor function|motor function
202177|NCT02107625|Defecation|defecation
202178|NCT02107625|Abdominal pain|abdominal pain
202179|NCT02107612|Mini-Dental Implant|mini-dental implant
202180|NCT02107612|Implant-Supported Dental Prosthesis|implant-supported dental prosthesis
202181|NCT02107612|Minimally Invasive Surgical procedures|minimally invasive surgical procedures
202182|NCT02107612|Overdentures|overdentures
202183|NCT02107612|Aged|aged
202184|NCT02107586|biceps tenodesis|biceps tenodesis
202185|NCT02107586|biceps tenotomy|biceps tenotomy
202186|NCT02107586|biceps tendonitis|biceps tendonitis
202187|NCT02107586|biceps inflammation|biceps inflammation
202188|NCT02107586|shoulder surgery|shoulder surgery
202189|NCT02107573|Randomized Controlled Trial|randomized controlled trial
202190|NCT02107573|Rotator Cuff Tear|rotator cuff tear
202191|NCT02107573|Suprascapular Nerve|suprascapular nerve
202192|NCT02107573|Decompression|decompression
202193|NCT02107573|Shoulder Surgery|shoulder surgery
202194|NCT02107560|Cholangitis|cholangitis
202195|NCT02107560|Bacteremia|bacteremia
202196|NCT02107560|Endotoxemia|endotoxemia
202197|NCT02107560|Blood|blood
202198|NCT02107560|Bile|bile
202199|NCT02107547|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
202200|NCT02107547|Type 2 SLAP lesions|type 2 slap lesions
202201|NCT02107547|labral tear|labral tear
202202|NCT02107547|biceps tenodesis|biceps tenodesis
202203|NCT02107547|shoulder surgery|shoulder surgery
202204|NCT02107547|RCT|rct
202205|NCT02107547|Comparison between two alternative surgical procedures|comparison between two alternative surgical procedures
202206|NCT02107534|parent training|parent training
202207|NCT02107534|homework|homework
202208|NCT02107534|parenting stress|parenting stress
202209|NCT02107521|sperm morphology|sperm morphology
202210|NCT02107521|ICSI|icsi
202211|NCT02107521|IMSI|imsi
202212|NCT02107521|implantation|implantation
202213|NCT02107521|pregnancy|pregnancy
202214|NCT02107508|activity energy expenditure|activity energy expenditure
202215|NCT02107508|body composition|body composition
202216|NCT02107495|CHF|chf
202217|NCT02107469|Diabetic Polyneuropathy|diabetic polyneuropathy
202218|NCT02107469|Diabetic|diabetic
202219|NCT02107469|Polyneuropathy|polyneuropathy
202220|NCT02107469|Ayurvedic|ayurvedic
202221|NCT02107469|Ayurveda|ayurveda
202222|NCT02107469|Neuralgia|neuralgia
202223|NCT02107469|Diabetic Neuralgia|diabetic neuralgia
202224|NCT02107469|Sida cordifolia|sida cordifolia
202225|NCT02107469|Phyllanthus Niruri|phyllanthus niruri
202226|NCT02107469|Phyllanthus Amarus|phyllanthus amarus
202227|NCT02107469|Extracts|extracts
202228|NCT02107469|Extract|extract
202229|NCT02107469|Crude Herb|crude herb
202230|NCT02107469|Crude|crude
202231|NCT02107469|Herb|herb
202232|NCT02107469|Herbal|herbal
202233|NCT02107469|Herbal Extract|herbal extract
202234|NCT02107469|Decoction|decoction
202235|NCT02107469|Churna|churna
202236|NCT02107469|Powder|powder
202237|NCT02107469|Bala|bala
202238|NCT02107469|Bhumyamalaki|bhumyamalaki
202239|NCT02107469|Tamalaki|tamalaki
202240|NCT02107456|Dry Needling, Myofascial trigger point, Upper trapezius|dry needling, myofascial trigger point, upper trapezius
202241|NCT02107430|Immunotherapy|immunotherapy
202242|NCT02107430|Prostate Cancer|prostate cancer
202243|NCT02107430|Biological, Vaccine|biological, vaccine
202244|NCT02107417|chemotherapy|chemotherapy
202245|NCT02107417|pain|pain
202246|NCT02107417|paresthesia|paresthesia
202247|NCT02107417|Physiotherapy|physiotherapy
202248|NCT02107417|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
202249|NCT02107404|Immunotherapy|immunotherapy
202250|NCT02107404|Prostate Cancer|prostate cancer
202251|NCT02107404|Biological|biological
202252|NCT02107404|Vaccine|vaccine
202253|NCT02107391|Immunotherapy|immunotherapy
202254|NCT02107391|Prostate Cancer|prostate cancer
202255|NCT02107391|Biological|biological
202256|NCT02107391|Vaccine|vaccine
202257|NCT02107391|Androgen Deprivation Therapy|androgen deprivation therapy
202258|NCT02107378|Immunotherapy|immunotherapy
202259|NCT02107378|Serous|serous
202260|NCT02107378|Relapsed|relapsed
202261|NCT02107378|Platinum resistant (pt)|platinum resistant (pt)
202262|NCT02107378|Ovarian Cancer (OvCa)|ovarian cancer (ovca)
202263|NCT02107378|Biological|biological
202264|NCT02107378|Vaccine|vaccine
202265|NCT02107365|Hepatitis C|hepatitis c
202266|NCT02107365|HCV infection|hcv infection
202267|NCT02107365|HCV genotype 4|hcv genotype 4
202268|NCT02107365|Non-responders HCV infected patients|non-responders hcv infected patients
202269|NCT02107365|Asunaprevir|asunaprevir
202270|NCT02107365|Daclatasvir|daclatasvir
202271|NCT02107365|Pegylated Interferon|pegylated interferon
202272|NCT02107365|Ribavirin|ribavirin
202273|NCT02107352|Anti-craving medication|anti-craving medication
202274|NCT02107352|Inhibition|inhibition
202275|NCT02107352|Attentional Bias|attentional bias
202276|NCT02107352|Event-Related Potentials|event-related potentials
202277|NCT02107352|Relapse|relapse
202278|NCT02107339|methadone|methadone
202279|NCT02107339|hydromorphone|hydromorphone
202280|NCT02107339|acute postoperative pain|acute postoperative pain
202281|NCT02107339|chronic persistent surgical pain|chronic persistent surgical pain
202282|NCT02107326|Type 1 diabetes|type 1 diabetes
202283|NCT02107326|HbA1C|hba1c
202284|NCT02107326|Quality of Life|quality of life
202285|NCT02107326|Hypoglycaemia|hypoglycaemia
202286|NCT02107326|Self-management|self-management
202287|NCT02107326|Telemedicine|telemedicine
202288|NCT02107300|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
202289|NCT02107274|Azithromycin|azithromycin
202290|NCT02107274|Bronchiectasis|bronchiectasis
202291|NCT02107274|Macrolide|macrolide
202292|NCT02107274|Inflammation|inflammation
202293|NCT02107274|Pulmonary|pulmonary
202294|NCT02107261|Musician's Dystonia|musician's dystonia
202295|NCT02107248|Arthroplasty|arthroplasty
202296|NCT02107248|Replacement|replacement
202297|NCT02107248|Hip|hip
202298|NCT02107248|Posterolateral surgery|posterolateral surgery
202299|NCT02107248|Precautions|precautions
202300|NCT02107235|Chemoradiotherapy|chemoradiotherapy
202301|NCT02107235|cisplatin|cisplatin
202302|NCT02107118|Stem cells|stem cells
202303|NCT02107118|cardiovascular disease|cardiovascular disease
202304|NCT02107118|erectile dysfunction|erectile dysfunction
202305|NCT02107105|Rectal cancer|rectal cancer
202306|NCT02107105|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
202307|NCT02107105|Quality of Life|quality of life
202308|NCT02107105|QOL|qol
202309|NCT02107105|Post surgery|post surgery
202310|NCT02107105|Pre-surgery|pre-surgery
202311|NCT02107105|Questionnaires|questionnaires
202312|NCT02107105|Surveys|surveys
202313|NCT02107079|melatonin|melatonin
202314|NCT02107079|bioavailability|bioavailability
202315|NCT02107079|pharmacokinetics|pharmacokinetics
202316|NCT02107066|exercise|exercise
202317|NCT02107066|physical activity|physical activity
202318|NCT02107066|ovarian cancer|ovarian cancer
202319|NCT02107066|quality of life|quality of life
202320|NCT02107066|fatigue|fatigue
202321|NCT02107066|weight|weight
202322|NCT02107053|Oxidative stress,|oxidative stress,
202323|NCT02107053|hemodialysis,|hemodialysis,
202324|NCT02107053|pomegranate juice,|pomegranate juice,
202325|NCT02107053|dietary supplement|dietary supplement
202326|NCT02107053|patients|patients
202327|NCT02107001|Lung ultrasound|lung ultrasound
202328|NCT02107001|Community acquired p neumonia (CAP)|community acquired p neumonia (cap)
202329|NCT02107001|Pleuritis|pleuritis
202330|NCT02107001|Pulmonary embolism|pulmonary embolism
202331|NCT02107001|Lung Cancer|lung cancer
202332|NCT02106988|Lymphoma|lymphoma
202333|NCT02106988|NK cell lymphoma-nasal type|nk cell lymphoma-nasal type
202334|NCT02106988|Radiation therapy|radiation therapy
202335|NCT02106988|XRT|xrt
202336|NCT02106988|Dexamethasone|dexamethasone
202337|NCT02106988|Decadron|decadron
202338|NCT02106988|Etoposide|etoposide
202339|NCT02106988|VePesid|vepesid
202340|NCT02106988|Ifosfamide|ifosfamide
202341|NCT02106988|Ifex|ifex
202342|NCT02106988|Mesna|mesna
202343|NCT02106988|Mesnex|mesnex
202344|NCT02106988|Carboplatin|carboplatin
202345|NCT02106988|Paraplatin|paraplatin
202346|NCT02106962|hemodialysis|hemodialysis
202347|NCT02106962|fistula|fistula
202348|NCT02106962|clotting|clotting
202349|NCT02106962|tranexamic acid|tranexamic acid
202350|NCT02106962|bacitracin|bacitracin
202351|NCT02106949|suicide attempt, SMS monitoring, recurrence, phone, prevention control, tertiary healthcare|suicide attempt, sms monitoring, recurrence, phone, prevention control, tertiary healthcare
202352|NCT02106936|Focal Hand Dystonia|focal hand dystonia
202353|NCT02106936|Depotentiation|depotentiation
202354|NCT02106936|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
202355|NCT02106936|Rapid Paired Associative Stimulation|rapid paired associative stimulation
202356|NCT02106936|Healthy Volunteer|healthy volunteer
202357|NCT02106910|Barrett's Esophagus|barrett's esophagus
202358|NCT02106910|Radiofrequency Ablation|radiofrequency ablation
202359|NCT02106884|Pancreatic cancer|pancreatic cancer
202360|NCT02106884|Locally advanced|locally advanced
202361|NCT02106884|Metastatic|metastatic
202362|NCT02106871|cancer|cancer
202363|NCT02106871|pancreas|pancreas
202364|NCT02106871|cholangiocarcinoma|cholangiocarcinoma
202365|NCT02106871|fatigue|fatigue
202366|NCT02106871|sildenafil|sildenafil
202367|NCT02106871|lean mass|lean mass
202368|NCT02106871|muscle|muscle
202369|NCT02106858|Stivarga / Regorafenib / Metastatic Colorectal Cancer / Metastatic or unresectable locally advanced GIST (Gastrointestinal stromal tumors)|stivarga / regorafenib / metastatic colorectal cancer / metastatic or unresectable locally advanced gist (gastrointestinal stromal tumors)
202370|NCT02106845|Regorafenib|regorafenib
202371|NCT02106845|Probe substrates|probe substrates
202372|NCT02106845|Pharmacokinetics|pharmacokinetics
202373|NCT02106845|Cancer|cancer
202374|NCT02106845|Safety|safety
202375|NCT02106845|Advanced solid malignant tumors|advanced solid malignant tumors
202376|NCT02106832|Ciprofloxacin|ciprofloxacin
202377|NCT02106832|Dry Powder for Inhalation|dry powder for inhalation
202378|NCT02106832|Exacerbation|exacerbation
202379|NCT02106832|Bronchiectasis|bronchiectasis
202380|NCT02106819|Cerebellar Ataxia|cerebellar ataxia
202381|NCT02106819|Emotions|emotions
202382|NCT02106819|Affective Prosody|affective prosody
202383|NCT02106819|Facial Expression|facial expression
202384|NCT02106819|Magnetic Resonance Imaging|magnetic resonance imaging
202385|NCT02106806|Oxidative stress|oxidative stress
202386|NCT02106806|Zinc|zinc
202387|NCT02106806|Chemotherapy|chemotherapy
202388|NCT02106806|Colorectal cancer|colorectal cancer
202389|NCT02106793|Chronic Rhinosinusitis|chronic rhinosinusitis
202390|NCT02106793|Mitomicin C|mitomicin c
202391|NCT02106793|Postoperative nasal synerchia|postoperative nasal synerchia
202392|NCT02106780|Phase 1|phase 1
202393|NCT02106780|Healthy subjects|healthy subjects
202394|NCT02106780|Excretion|excretion
202395|NCT02106780|14C-labeled ASP1707|14c-labeled asp1707
202396|NCT02106767|rosuvastatin|rosuvastatin
202397|NCT02106767|rifampin|rifampin
202398|NCT02106767|pharmacokinetics|pharmacokinetics
202399|NCT02106767|drug interaction|drug interaction
202400|NCT02106767|healthy volunteer|healthy volunteer
202504|NCT02106390|Meningitis|meningitis
202401|NCT02106767|drug transporter|drug transporter
202402|NCT02106767|Asian|asian
202403|NCT02106767|White|white
202404|NCT02106741|Pain|pain
202405|NCT02106741|Acupressure|acupressure
202406|NCT02106741|Symptoms|symptoms
202407|NCT02106741|Fatigue|fatigue
202408|NCT02106741|Self-administered|self-administered
202409|NCT02106728|Eating Disorders|eating disorders
202410|NCT02106728|Family Therapy|family therapy
202411|NCT02106728|Multi-Family Therapy|multi-family therapy
202412|NCT02106728|Bulimia Nervosa|bulimia nervosa
202413|NCT02106728|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
202415|NCT02106702|detention|detention
202416|NCT02106702|substance abuse|substance abuse
202417|NCT02106689|infertility, superovulation, gonadotropins, needle free injection system|infertility, superovulation, gonadotropins, needle free injection system
202418|NCT02106676|polycystic ovary Syndrome|polycystic ovary syndrome
202419|NCT02106676|hyperandrogenism|hyperandrogenism
202420|NCT02106676|cordblood|cordblood
202421|NCT02106676|androgens|androgens
202422|NCT02106663|atrial fibrillation|atrial fibrillation
202423|NCT02106663|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
202425|NCT02106663|arrhythmia|arrhythmia
202426|NCT02106663|atrial fibrillation ablation|atrial fibrillation ablation
193284|NCT02146846|cml|cml
202427|NCT02106663|circumferential ablation|circumferential ablation
202428|NCT02106663|CPVA|cpva
202429|NCT02106663|segmental ablation|segmental ablation
202430|NCT02106663|PVI|pvi
202431|NCT02106663|pulmonary vein isolation|pulmonary vein isolation
202432|NCT02106650|Relapsed PTCL|relapsed ptcl
202433|NCT02106650|Refractory PTCL|refractory ptcl
202434|NCT02106637|ACS|acs
202435|NCT02106637|Cessation|cessation
202436|NCT02106624|mechanical ventilation|mechanical ventilation
202437|NCT02106611|MRI|mri
202438|NCT02106611|stress echo|stress echo
202439|NCT02106611|Clinical Assessment|clinical assessment
202440|NCT02106611|14-017|14-017
202441|NCT02106598|Sentinel Lymph Node Mapping|sentinel lymph node mapping
202442|NCT02106598|Intraoperative Sentinel|intraoperative sentinel
202443|NCT02106598|Head and Neck Melanoma|head and neck melanoma
202847|NCT02105077|surgery|surgery
202444|NCT02106598|Targeted Silica Nanoparticles|targeted silica nanoparticles
202445|NCT02106598|cRGDY-PEG-Cy5.5-C dots|crgdy-peg-cy5.5-c dots
202446|NCT02106598|13-249|13-249
202447|NCT02106585|Safety|safety
202448|NCT02106585|Tolerability|tolerability
202449|NCT02106585|Pharmacokinetics|pharmacokinetics
202450|NCT02106585|Food-effect|food-effect
202451|NCT02106585|Diabetes|diabetes
202452|NCT02106572|superficial bladder cancer|superficial bladder cancer
202453|NCT02106572|viscum album extract|viscum album extract
202454|NCT02106572|mistletoe extract|mistletoe extract
202455|NCT02106572|abnobaVISCUM|abnobaviscum
202456|NCT02106572|recurrence rate|recurrence rate
202457|NCT02106559|Pleural Photodynamic Therapy|pleural photodynamic therapy
202458|NCT02106559|Pleural Malignancy|pleural malignancy
202459|NCT02106559|PDT|pdt
202460|NCT02106546|carboplatin|carboplatin
202461|NCT02106546|Randomized|randomized
202462|NCT02106546|veliparib|veliparib
202463|NCT02106546|Advanced|advanced
202464|NCT02106546|Metastatic|metastatic
202465|NCT02106546|Overall Survival|overall survival
202466|NCT02106546|Squamous|squamous
202467|NCT02106546|placebo controlled|placebo controlled
202468|NCT02106546|ABT-888|abt-888
202469|NCT02106546|Poly Adenosine diphosphate (ADP)-ribose Polymerase (PARP)|poly adenosine diphosphate (adp)-ribose polymerase (parp)
202470|NCT02106546|non-small cell lung cancer|non-small cell lung cancer
202471|NCT02106546|paclitaxel|paclitaxel
202472|NCT02106533|Coronary artery disease|coronary artery disease
202473|NCT02106533|Exercise|exercise
202474|NCT02106533|Ventilatory efficiency|ventilatory efficiency
202475|NCT02106520|Epistaxis|epistaxis
202476|NCT02106520|Bevacizumab|bevacizumab
202477|NCT02106507|Apalutamide|apalutamide
202478|NCT02106507|RAD001|rad001
202479|NCT02106507|Everolimus|everolimus
202480|NCT02106507|Castration-resistant|castration-resistant
202481|NCT02106507|13-025|13-025
202482|NCT02106507|ARN-509|arn-509
202483|NCT02106494|Highly emetogenic chemotherapy (HEC)|highly emetogenic chemotherapy (hec)
202484|NCT02106494|Chemotherapy-Induced Nausea and Vomiting (CINV)|chemotherapy-induced nausea and vomiting (cinv)
202485|NCT02106481|TKA|tka
202486|NCT02106481|TKR|tkr
202487|NCT02106481|Knee OA|knee oa
202488|NCT02106481|pain management|pain management
202489|NCT02106481|Femoral Nerve Catheter|femoral nerve catheter
202490|NCT02106481|Single Shot Femoral Nerve Blocks|single shot femoral nerve blocks
202491|NCT02106468|Oral Lichen Planus|oral lichen planus
202492|NCT02106468|Corticosteroid|corticosteroid
202493|NCT02106468|Omega -3|omega -3
202494|NCT02106455|Pharmacological theapy|pharmacological theapy
202495|NCT02106442|Pharmacological therapy|pharmacological therapy
202496|NCT02106429|Vascular Surgery|vascular surgery
202497|NCT02106416|prostate cancer|prostate cancer
202498|NCT02106416|bladder cancer|bladder cancer
202499|NCT02106416|MRI|mri
202500|NCT02106416|PET|pet
202501|NCT02106416|perfusion|perfusion
202502|NCT02106390|Central Nervous System Diseases|central nervous system diseases
202503|NCT02106390|Nervous System Diseases|nervous system diseases
202505|NCT02106377|(DES)|(des)
202506|NCT02106338|follow-up to 10-0008, Clostridium difficile, dose-escalating, CRS3123|follow-up to 10-0008, clostridium difficile, dose-escalating, crs3123
202507|NCT02106325|Ketamine|ketamine
202508|NCT02106325|Ketlar|ketlar
202509|NCT02106325|Depression|depression
202510|NCT02106325|Antidepressants|antidepressants
202511|NCT02106325|Treatment|treatment
202512|NCT02106325|Acute|acute
202513|NCT02106312|Radiotherapy|radiotherapy
202514|NCT02106312|Myxoid liposarcoma|myxoid liposarcoma
202515|NCT02106312|Soft tissue sarcoma|soft tissue sarcoma
202516|NCT02106286|Cardiopulmonary exercise test|cardiopulmonary exercise test
202518|NCT02106286|abdominal aortic aneurysm|abdominal aortic aneurysm
202519|NCT02106286|anaerobic threshold|anaerobic threshold
202520|NCT02106286|fitness|fitness
202521|NCT02106286|beta-blockers|beta-blockers
202522|NCT02106273|LMA|lma
202523|NCT02106273|Bronchial blocker|bronchial blocker
202524|NCT02106260|safety|safety
202525|NCT02106260|pharmacokinetics (PK)|pharmacokinetics (pk)
202526|NCT02106260|pharmacodynamics (PD)|pharmacodynamics (pd)
202527|NCT02106260|CLS003|cls003
202528|NCT02106234|contrast induced nephropathy|contrast induced nephropathy
193379|NCT02146287|infant sleep|infant sleep
202529|NCT02106234|prophylactic intravenous hydration|prophylactic intravenous hydration
202530|NCT02106234|intravenous normal saline|intravenous normal saline
202531|NCT02106234|acute kidney injury|acute kidney injury
202532|NCT02106221|Care coordination|care coordination
202533|NCT02106221|nurse care management|nurse care management
202534|NCT02106221|practice facilitation|practice facilitation
202535|NCT02106221|health information technology|health information technology
202536|NCT02106182|Benign prostatic hyperplasia|benign prostatic hyperplasia
202537|NCT02106182|Nocturia|nocturia
202538|NCT02106182|Silodosin|silodosin
202540|NCT02106169|Food allergy|food allergy
202541|NCT02106169|Children and families|children and families
202542|NCT02106169|Therapeutic education|therapeutic education
202543|NCT02106169|Quality of life|quality of life
202544|NCT02106130|Mosapride citrate|mosapride citrate
202545|NCT02106130|Rebamipide|rebamipide
202546|NCT02106130|pharmacokinetic drug drug interaction|pharmacokinetic drug drug interaction
202547|NCT02106130|oral administration|oral administration
202548|NCT02106130|healthy male subjects|healthy male subjects
202549|NCT02106104|Type 2 diabetes mellitus|type 2 diabetes mellitus
202550|NCT02106104|Diabetic kidney disease|diabetic kidney disease
202551|NCT02106104|Diabetic nephropathy|diabetic nephropathy
202552|NCT02106104|Renoprotection|renoprotection
202553|NCT02106104|DPP-4 inhibitors|dpp-4 inhibitors
202554|NCT02106104|Linagliptin|linagliptin
202555|NCT02106104|SU derivatives|su derivatives
202556|NCT02106104|Glimepiride|glimepiride
202557|NCT02106078|Bipolar Disorder|bipolar disorder
202558|NCT02106078|Bipolar|bipolar
202559|NCT02106078|Online Intervention|online intervention
202560|NCT02106078|Internet intervention|internet intervention
202561|NCT02106078|Self-Help|self-help
202562|NCT02106065|Dementia|dementia
202563|NCT02106065|Caregivers|caregivers
202564|NCT02106065|Neurodegenerative Diseases|neurodegenerative diseases
202565|NCT02106065|Brain Diseases|brain diseases
202566|NCT02106065|Cost of Illness|cost of illness
202567|NCT02106065|Stress, Psychological|stress, psychological
202568|NCT02106065|Depression|depression
202569|NCT02106065|Vital Statistics|vital statistics
202570|NCT02106065|Mortality|mortality
202571|NCT02106065|Behavioral Symptoms|behavioral symptoms
202572|NCT02106065|Residential Facilities|residential facilities
202573|NCT02106065|Emergency Medical Services|emergency medical services
202574|NCT02106065|Long-Term Care|long-term care
202575|NCT02106052|cognitive function|cognitive function
202576|NCT02106052|cognitive impairment|cognitive impairment
202577|NCT02106052|cognitive intervention|cognitive intervention
202578|NCT02106052|cognitive improvement|cognitive improvement
202579|NCT02106052|information processing speed|information processing speed
202580|NCT02106052|exercise training program|exercise training program
202581|NCT02106052|aerobic exercise|aerobic exercise
202582|NCT02106052|stretching and toning|stretching and toning
202583|NCT02106052|Multiple sclerosis|multiple sclerosis
202584|NCT02106052|executive function|executive function
202585|NCT02106039|diabetes mellitus|diabetes mellitus
202586|NCT02106039|tuberculosis|tuberculosis
202587|NCT02106039|management|management
202588|NCT02106039|randomized controlled trial|randomized controlled trial
202589|NCT02106026|Breastfeeding|breastfeeding
202590|NCT02106026|Nursing|nursing
202591|NCT02106026|Patient Education as Topic|patient education as topic
202592|NCT02106026|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
202593|NCT02106026|Hispanic Americans.|hispanic americans.
202594|NCT02106013|HDL|hdl
202595|NCT02106013|Carotid artery intima-media thickness|carotid artery intima-media thickness
202596|NCT02106013|Cholesterol efflux capacity|cholesterol efflux capacity
202597|NCT02106013|Antioxidant effect of HDL|antioxidant effect of hdl
202598|NCT02106013|Susceptibility to oxidation of HDL|susceptibility to oxidation of hdl
202599|NCT02106013|Anti-inflammatory effect of HDL|anti-inflammatory effect of hdl
202801|NCT02105298|Anesthesia|anesthesia
202600|NCT02106013|Platelet aggregation inhibition by HDL|platelet aggregation inhibition by hdl
202601|NCT02106000|Post Partum|post partum
202602|NCT02106000|Inhaled Oxytocin|inhaled oxytocin
202603|NCT02106000|Inhalation Profiles|inhalation profiles
202604|NCT02105987|Abacavir/dolutegravir/lamivudine|abacavir/dolutegravir/lamivudine
202605|NCT02105987|Fixed-dose combination|fixed-dose combination
202606|NCT02105987|Once daily|once daily
202607|NCT02105987|Trii|trii
202608|NCT02105987|Single-tablet regimen|single-tablet regimen
202609|NCT02105974|COPD|copd
202610|NCT02105974|Fluticasone Furoate (FF)|fluticasone furoate (ff)
202611|NCT02105974|Vilanterol (VI)|vilanterol (vi)
202612|NCT02105974|Dry Powder Inhaler|dry powder inhaler
202613|NCT02105961|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
202614|NCT02105961|exacerbations|exacerbations
202615|NCT02105961|SB240563|sb240563
202616|NCT02105961|mepolizumab|mepolizumab
202617|NCT02105961|eosinophils|eosinophils
202618|NCT02105948|eosinophils|eosinophils
202619|NCT02105948|SB240563|sb240563
202620|NCT02105948|exacerbations|exacerbations
202621|NCT02105948|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
202622|NCT02105948|mepolizumab|mepolizumab
202623|NCT02105922|Frailty|frailty
202624|NCT02105922|Ageing|ageing
202625|NCT02105922|Protein supplementation|protein supplementation
202626|NCT02105922|Protein quality|protein quality
202627|NCT02105922|Exercise training|exercise training
202628|NCT02105922|Sarcopenia|sarcopenia
202629|NCT02105896|dental bonding|dental bonding
202630|NCT02105857|knee mobilazation|knee mobilazation
202631|NCT02105857|TKA|tka
202632|NCT02105857|joint replacement|joint replacement
202633|NCT02105857|rehabilitation|rehabilitation
202634|NCT02105844|atrial fibrillation|atrial fibrillation
202635|NCT02105844|dementia|dementia
202636|NCT02105844|cognitive dysfunction|cognitive dysfunction
202637|NCT02105844|stroke|stroke
202638|NCT02105844|Magnetic resonance imaging|magnetic resonance imaging
202639|NCT02105831|left ventricular assist device|left ventricular assist device
202640|NCT02105831|contrast ultrasound|contrast ultrasound
202641|NCT02105831|perfusion imaging|perfusion imaging
202642|NCT02105818|Self-reported questionnaire|self-reported questionnaire
202643|NCT02105818|Swallowing disorders|swallowing disorders
202644|NCT02105818|Systemic sclerosis|systemic sclerosis
202645|NCT02105818|Drug therapy|drug therapy
202646|NCT02105818|Adherence to medication regime|adherence to medication regime
202647|NCT02105818|Coping strategy|coping strategy
202648|NCT02105818|Pharmaceutical care|pharmaceutical care
202649|NCT02105818|Patient safety|patient safety
202650|NCT02105818|Patient oriented care|patient oriented care
202651|NCT02105805|intention weight loss|intention weight loss
202652|NCT02105805|heart failure|heart failure
202653|NCT02105805|6-minute walk test|6-minute walk test
202654|NCT02105792|Diabetes|diabetes
202655|NCT02105792|Type 2 diabetes|type 2 diabetes
202656|NCT02105792|Diabetes therapy response|diabetes therapy response
202657|NCT02105792|Diabetes progression|diabetes progression
202658|NCT02105766|Sickle Cell Disease|sickle cell disease
202659|NCT02105766|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
202660|NCT02105766|Pentostatin (Nipent)|pentostatin (nipent)
202661|NCT02105766|Cyclophosphamide|cyclophosphamide
202662|NCT02105766|Alemtuzumab (Campath)|alemtuzumab (campath)
202663|NCT02105740|BEHAVIORAL|behavioral
202664|NCT02105740|HYPNOSIS|hypnosis
202665|NCT02105740|ANXIETY|anxiety
202666|NCT02105740|DEPRESSION|depression
202667|NCT02105727|Dietary sodium|dietary sodium
202668|NCT02105727|Urinary sodium excretion|urinary sodium excretion
202669|NCT02105727|Urinary iodine excretion|urinary iodine excretion
202670|NCT02105714|Diarrhoea|diarrhoea
202671|NCT02105714|Abdominal pain|abdominal pain
202672|NCT02105714|Bacterial|bacterial
202673|NCT02105714|Protozoal|protozoal
202674|NCT02105714|Helminth|helminth
202675|NCT02105675|Immunotherapy|immunotherapy
202676|NCT02105675|Metastatic|metastatic
202677|NCT02105675|Castrate Resistant|castrate resistant
202678|NCT02105675|Prostate Cancer|prostate cancer
202679|NCT02105675|Biological|biological
202680|NCT02105675|Vaccine|vaccine
202681|NCT02105649|cerebral palsy|cerebral palsy
202682|NCT02105649|standing|standing
202683|NCT02105649|strengthening|strengthening
202684|NCT02105623|Coronary Arteriosclerosis|coronary arteriosclerosis
202685|NCT02105623|rosuvastatin|rosuvastatin
202686|NCT02105610|volatile anesthetics|volatile anesthetics
202687|NCT02105610|desflurane|desflurane
202688|NCT02105610|isoflurane|isoflurane
202689|NCT02105610|sevoflurane|sevoflurane
202690|NCT02105610|TIVA|tiva
202691|NCT02105610|cardiac surgery|cardiac surgery
202692|NCT02105610|mortality|mortality
202693|NCT02105610|anesthesia|anesthesia
202694|NCT02105610|intensive care|intensive care
202695|NCT02105597|Diabetes mellitus|diabetes mellitus
202696|NCT02105597|Medication adherence|medication adherence
202697|NCT02105597|Compliance|compliance
202698|NCT02105597|Mobile health|mobile health
202699|NCT02105571|Body Weight|body weight
202700|NCT02105571|Nutrition|nutrition
202802|NCT02105259|Test|test
202701|NCT02105571|Physical Activity|physical activity
202702|NCT02105571|Sleep|sleep
202703|NCT02105571|Health Promotion|health promotion
202704|NCT02105571|Stress|stress
202705|NCT02105571|Safety|safety
202706|NCT02105558|trial of labor after cesarean|trial of labor after cesarean
202707|NCT02105558|vaginal birth after cesarean|vaginal birth after cesarean
202708|NCT02105558|epidural vs combined spinal epidural|epidural vs combined spinal epidural
202709|NCT02105545|cancer|cancer
202710|NCT02105545|oncology|oncology
202711|NCT02105545|malignant|malignant
202712|NCT02105545|malignancy|malignancy
202713|NCT02105545|genetics|genetics
202714|NCT02105545|genomics|genomics
202715|NCT02105545|exome|exome
202717|NCT02105545|RNA|rna
202718|NCT02105545|sequencing|sequencing
202719|NCT02105545|epigenetic|epigenetic
202720|NCT02105545|clinically actionable findings|clinically actionable findings
202721|NCT02105545|CAF|caf
202722|NCT02105545|secondary findings|secondary findings
202723|NCT02105545|SF|sf
202724|NCT02105545|single nucleotide variants|single nucleotide variants
202725|NCT02105545|SNV|snv
202726|NCT02105545|bioinformatics|bioinformatics
202727|NCT02105545|genotype|genotype
202728|NCT02105545|The American College of Medical Genetics and Genomics|the american college of medical genetics and genomics
202729|NCT02105545|ACMG|acmg
202730|NCT02105532|Transfusion in gastrointestinal bleeding|transfusion in gastrointestinal bleeding
202731|NCT02105519|trivalent influenza vaccine, chronic kidney disease|trivalent influenza vaccine, chronic kidney disease
202733|NCT02105506|Stomach|stomach
202734|NCT02105506|Resection|resection
202735|NCT02105506|Esophageal disease requiring surgery|esophageal disease requiring surgery
202736|NCT02105506|Gastric disease requiring surgery|gastric disease requiring surgery
202737|NCT02105493|Nitroglycerin|nitroglycerin
202738|NCT02105493|Radial Artery Occlusion|radial artery occlusion
202739|NCT02105493|Transradial Catheterization|transradial catheterization
202740|NCT02105480|Computer aided auscultation (CAA)|computer aided auscultation (caa)
202741|NCT02105480|Phonocardiogram analysis|phonocardiogram analysis
202742|NCT02105480|Murmur detection|murmur detection
202743|NCT02105480|Heart auscultation|heart auscultation
202744|NCT02105441|cochlear implant|cochlear implant
202745|NCT02105428|Polycystic Ovarian Syndrome (PCOS)|polycystic ovarian syndrome (pcos)
202746|NCT02105428|Insulin Resistance|insulin resistance
202747|NCT02105428|Overweight, Obese Women|overweight, obese women
202748|NCT02105428|Protein Metabolism|protein metabolism
202749|NCT02105428|Post Translational Modifications|post translational modifications
202750|NCT02105415|Critical care|critical care
202751|NCT02105415|Emergent|emergent
202752|NCT02105415|Etomidate|etomidate
202753|NCT02105415|Hemodynamics|hemodynamics
202754|NCT02105415|Intensive care unit|intensive care unit
202755|NCT02105415|Intubation|intubation
202756|NCT02105415|Ketamine-Propofol admixture|ketamine-propofol admixture
202757|NCT02105402|Speech sound disorders|speech sound disorders
202758|NCT02105402|Randomized Controlled Trial|randomized controlled trial
202759|NCT02105402|Speech intelligibility|speech intelligibility
202760|NCT02105402|PROMPT treatment|prompt treatment
202761|NCT02105402|Developmental motor speech disorders|developmental motor speech disorders
202762|NCT02105402|Children|children
202763|NCT02105402|Functional outcomes|functional outcomes
202764|NCT02105402|Treatment efficacy|treatment efficacy
202765|NCT02105389|fatigue|fatigue
202766|NCT02105389|quality of life|quality of life
202767|NCT02105389|chemotherapy|chemotherapy
202768|NCT02105389|haematopoietic stem cell transplantation|haematopoietic stem cell transplantation
202769|NCT02105389|children|children
202770|NCT02105389|pilot|pilot
202771|NCT02105389|yoga|yoga
202772|NCT02105376|depression|depression
202773|NCT02105376|cranial nerve stimulation|cranial nerve stimulation
202774|NCT02105376|trigeminal stimulation|trigeminal stimulation
202775|NCT02105350|MEK162|mek162
202776|NCT02105350|Gemcitabine|gemcitabine
202777|NCT02105350|Oxaliplatin|oxaliplatin
202778|NCT02105350|Non-resectable|non-resectable
202779|NCT02105350|Recurrent or metastatic|recurrent or metastatic
202780|NCT02105324|bionic pancreas|bionic pancreas
202781|NCT02105324|artificial pancreas|artificial pancreas
202782|NCT02105324|insulin|insulin
202783|NCT02105324|glucagon|glucagon
202784|NCT02105324|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
202785|NCT02105324|outpatient|outpatient
202786|NCT02105324|insulin pump|insulin pump
202787|NCT02105324|pediatrics|pediatrics
202788|NCT02105324|children|children
202789|NCT02105324|camp|camp
202790|NCT02105324|summer camp|summer camp
202791|NCT02105311|Intraocular pressure|intraocular pressure
202792|NCT02105311|Selective laser trabeculoplasty|selective laser trabeculoplasty
202793|NCT02105311|Travoprost|travoprost
202794|NCT02105311|Ocular surface disease|ocular surface disease
202795|NCT02105311|Glaucoma symptom scale|glaucoma symptom scale
202796|NCT02105298|Fluids|fluids
202797|NCT02105298|Intraoperative|intraoperative
202798|NCT02105298|Respiratory|respiratory
202799|NCT02105298|Outcomes|outcomes
202800|NCT02105298|Surgery|surgery
202803|NCT02105259|psychodynamic|psychodynamic
202804|NCT02105259|Internet-delivered psychodynamic treatment|internet-delivered psychodynamic treatment
202805|NCT02105259|patients with social anxiety disorder|patients with social anxiety disorder
202806|NCT02105246|Cardiac rehabilitation|cardiac rehabilitation
202807|NCT02105246|home based care|home based care
202808|NCT02105246|secondary prevention|secondary prevention
202809|NCT02105246|efficacy|efficacy
202810|NCT02105246|6 minute walk rates.|6 minute walk rates.
202811|NCT02105233|ultrasonography|ultrasonography
202812|NCT02105233|ultrasonics|ultrasonics
202814|NCT02105233|surgery|surgery
202815|NCT02105220|Respiratory mechanics|respiratory mechanics
202816|NCT02105220|Esophageal pressure|esophageal pressure
202817|NCT02105220|Functional residual capacity|functional residual capacity
202818|NCT02105220|positive end-expiratory pressure|positive end-expiratory pressure
202819|NCT02105194|cerebral decompression illness|cerebral decompression illness
202820|NCT02105181|benign biliary stricture|benign biliary stricture
202821|NCT02105181|anastomotic biliary stricture after liver transplantation|anastomotic biliary stricture after liver transplantation
202822|NCT02105181|chronic pancreatitis|chronic pancreatitis
202823|NCT02105181|biliary surgical procedure|biliary surgical procedure
202824|NCT02105181|fully covered metal stent|fully covered metal stent
202825|NCT02105155|Liver transplantation,|liver transplantation,
202826|NCT02105155|Conversion (Prograf® to Advagraf®),|conversion (prograf® to advagraf®),
202827|NCT02105155|Prograf® ,|prograf® ,
202828|NCT02105155|Advagraf® ,|advagraf® ,
202832|NCT02105142|Interventions|interventions
202833|NCT02105142|Primary care|primary care
202834|NCT02105142|Pediatric|pediatric
202835|NCT02105090|Upper gastrointestinal tract|upper gastrointestinal tract
202836|NCT02105090|Endoscopy|endoscopy
202837|NCT02105090|Lozenge|lozenge
202838|NCT02105090|Articaine|articaine
202839|NCT02105090|Dyspepsia|dyspepsia
202840|NCT02105090|Hematemesis|hematemesis
202841|NCT02105090|Abdominal pain|abdominal pain
202842|NCT02105090|Heartburn|heartburn
202843|NCT02105077|xenon|xenon
202844|NCT02105077|doping|doping
202845|NCT02105077|anesthesia|anesthesia
202846|NCT02105077|mass spectrometry|mass spectrometry
202848|NCT02105038|distal radius fracture|distal radius fracture
202849|NCT02105038|steering|steering
202850|NCT02105038|steering wheel spinner knob|steering wheel spinner knob
202851|NCT02105025|insertion time|insertion time
202852|NCT02105012|Mild|mild
202853|NCT02105012|moderate persistent|moderate persistent
202854|NCT02105012|Adult|adult
202855|NCT02104986|non seminomateous malignant germ cell tumour (NSMGCT)|non seminomateous malignant germ cell tumour (nsmgct)
202856|NCT02104986|Dose De-escalation|dose de-escalation
202857|NCT02104986|Chemotherapy|chemotherapy
202858|NCT02104960|Skin Surface Microscopy|skin surface microscopy
202859|NCT02104960|Skin Aging|skin aging
202860|NCT02104960|PROOF|proof
202861|NCT02104895|Breast cancer|breast cancer
202862|NCT02104895|Early breast cancer|early breast cancer
202863|NCT02104895|Adjuvant breast cancer|adjuvant breast cancer
202864|NCT02104895|Accelerated partial breast irradiation|accelerated partial breast irradiation
202865|NCT02104895|Intensity modulated radiotherapy|intensity modulated radiotherapy
202866|NCT02104882|Glioblastoma Multiforme|glioblastoma multiforme
202867|NCT02104882|High-Grade Glioma|high-grade glioma
202868|NCT02104882|Malignant Glioma|malignant glioma
202869|NCT02104882|IORT|iort
202870|NCT02104869|Influenza vaccine|influenza vaccine
202871|NCT02104856|Asthma|asthma
202872|NCT02104856|Bronchial Thermoplasty|bronchial thermoplasty
202873|NCT02104856|Registry|registry
202874|NCT02104856|Device|device
202875|NCT02104856|Alair|alair
202876|NCT02104830|empegfilgrastim|empegfilgrastim
202877|NCT02104830|pegylated filgrastim|pegylated filgrastim
202878|NCT02104830|neutropenia|neutropenia
202879|NCT02104830|febrile neutropenia|febrile neutropenia
202880|NCT02104830|chemotherapy-associated neutropenia|chemotherapy-associated neutropenia
202881|NCT02104830|breast cancer|breast cancer
202882|NCT02104830|docetaxel|docetaxel
202883|NCT02104830|doxorubicin|doxorubicin
202884|NCT02104817|omega-3 carboxylic acid|omega-3 carboxylic acid
202885|NCT02104804|Type 2 Diabetes Mellitus, Insulin, Dipeptidyl-Peptidase 4 Inhibitors, Metformin,saxagliptin,Endocrine System Diseases|type 2 diabetes mellitus, insulin, dipeptidyl-peptidase 4 inhibitors, metformin,saxagliptin,endocrine system diseases
202886|NCT02104791|Procalcitonin|procalcitonin
202887|NCT02104791|intra-amniotic subclinical infection.|intra-amniotic subclinical infection.
202888|NCT02104752|Curcumin|curcumin
202889|NCT02104752|Turmeric|turmeric
202890|NCT02104752|Schizophrenia|schizophrenia
202891|NCT02104752|Cognition|cognition
202892|NCT02104752|Psychosis|psychosis
202893|NCT02104739|prediabetes|prediabetes
202894|NCT02104739|diabetes mellitus type 2|diabetes mellitus type 2
202895|NCT02104739|exenatide|exenatide
202896|NCT02104739|saxagliptin|saxagliptin
202897|NCT02104739|exenatide ER|exenatide er
676416|NCT00880399|randomized|randomized
202904|NCT02104687|MAP, mean arterial pressure|map, mean arterial pressure
202905|NCT02104687|CVP, central venous pressure|cvp, central venous pressure
202906|NCT02104622|spinal cord injury|spinal cord injury
202907|NCT02104622|exoskeleton|exoskeleton
202908|NCT02104622|ambulation|ambulation
202909|NCT02104622|walking|walking
202910|NCT02104622|robotics|robotics
202911|NCT02104609|Obesity|obesity
202912|NCT02104609|Emergency contraception|emergency contraception
202913|NCT02104609|Levonorgestrel emergency contraception|levonorgestrel emergency contraception
202914|NCT02104583|VT|vt
202915|NCT02104583|VF|vf
202916|NCT02104583|Ventricular Tachycardia|ventricular tachycardia
202917|NCT02104583|Ventricular Fibrillation|ventricular fibrillation
202918|NCT02104583|shock|shock
202919|NCT02104583|ATP|atp
202920|NCT02104570|Fatigue|fatigue
202921|NCT02104570|Proprioception|proprioception
202922|NCT02104570|Shoulder|shoulder
202923|NCT02104557|Sayana|sayana
202924|NCT02104557|Pregnancy|pregnancy
202925|NCT02104557|Contraception|contraception
202926|NCT02104557|Endometriosis-associated pain|endometriosis-associated pain
202927|NCT02104557|PMS|pms
202928|NCT02104557|Post Marketing Surveillance|post marketing surveillance
202929|NCT02104544|DHA intake;|dha intake;
202930|NCT02104544|Plasma;|plasma;
202931|NCT02104544|Erythrocyte;|erythrocyte;
202933|NCT02104518|glucose-6-phosphate dehydrogenase|glucose-6-phosphate dehydrogenase
202934|NCT02104518|point-of-care diagnostic testing|point-of-care diagnostic testing
202935|NCT02104492|multiple sclerosis|multiple sclerosis
202936|NCT02104492|respiratory muscle strength|respiratory muscle strength
202937|NCT02104492|maximal inspiratory pressure (MIP)|maximal inspiratory pressure (mip)
202938|NCT02104492|maximal expiratory pressure (MEP)|maximal expiratory pressure (mep)
202939|NCT02104492|respiratory muscle endurance|respiratory muscle endurance
202940|NCT02104492|quality of life|quality of life
202941|NCT02104492|qualitative research|qualitative research
202942|NCT02104466|acupuncture|acupuncture
202943|NCT02104466|pain|pain
202944|NCT02104466|neuropathy|neuropathy
202945|NCT02104453|airway maneuver|airway maneuver
202946|NCT02104440|Cytopenia|cytopenia
202947|NCT02104414|Liposomal Bupivacaine|liposomal bupivacaine
202948|NCT02104414|Exparel|exparel
202949|NCT02104375|wave reflection|wave reflection
202950|NCT02104375|augmentation Index|augmentation index
202951|NCT02104375|heart rate variability|heart rate variability
202952|NCT02104375|arterial stiffness|arterial stiffness
202953|NCT02104349|spine surgery|spine surgery
202954|NCT02104349|post op pain management|post op pain management
202955|NCT02104336|Pearson|pearson
202956|NCT02104336|EPI743|epi743
202957|NCT02104336|EPI-743|epi-743
202958|NCT02104336|Vincerinone|vincerinone
202959|NCT02104336|Mitochondrial disorder|mitochondrial disorder
202960|NCT02104336|Mitochondrial disease|mitochondrial disease
202961|NCT02104323|Neurofibromatosis Type 2|neurofibromatosis type 2
202962|NCT02104323|Vestibular Schwannoma|vestibular schwannoma
202963|NCT02104323|Other NF2-related tumors|other nf2-related tumors
202964|NCT02104310|malignant glioma|malignant glioma
202965|NCT02104310|FDOPA|fdopa
202966|NCT02104310|PET CT|pet ct
202967|NCT02104310|radiation therapy|radiation therapy
202968|NCT02104297|Nasal septum operation|nasal septum operation
202969|NCT02104297|agitation|agitation
202970|NCT02104284|Bronchial provocation test|bronchial provocation test
202971|NCT02104284|Mannitol|mannitol
202972|NCT02104284|Methacholine|methacholine
202973|NCT02104284|Bronchial hyperreactivity|bronchial hyperreactivity
202974|NCT02104284|Sensitivity and specificity|sensitivity and specificity
202975|NCT02104271|chronic radiation proctitis|chronic radiation proctitis
202976|NCT02104271|argon plasma coagulation|argon plasma coagulation
202977|NCT02104271|rectal bleeding|rectal bleeding
202978|NCT02104258|Hamstring|hamstring
202979|NCT02104258|Muscle|muscle
202980|NCT02104258|Injury|injury
202981|NCT02104258|Treatment|treatment
202982|NCT02104258|Rehabilitation|rehabilitation
202983|NCT02104245|Non Cystic Fibrosis Bronchiectasis, Pulmaquin, Ciprofloxacin, Pseudomonas aeruginosa|non cystic fibrosis bronchiectasis, pulmaquin, ciprofloxacin, pseudomonas aeruginosa
202984|NCT02104232|Maternal depression|maternal depression
202985|NCT02104219|Hypophosphatasia|hypophosphatasia
202986|NCT02104219|HPP|hpp
202987|NCT02104219|bone disease|bone disease
202988|NCT02104219|Soft Bones|soft bones
202989|NCT02104219|low Alkaline Phosphatase|low alkaline phosphatase
202990|NCT02104219|genetic metabolic disorder|genetic metabolic disorder
202991|NCT02104219|alkaline phosphatase|alkaline phosphatase
202992|NCT02104219|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
202993|NCT02104219|rickets|rickets
202994|NCT02104219|osteomalacia|osteomalacia
202995|NCT02104193|brain metastases|brain metastases
202996|NCT02104193|simvastatin|simvastatin
202997|NCT02104193|radiation therapy|radiation therapy
202998|NCT02104180|non-inferiority|non-inferiority
202999|NCT02104180|randomized|randomized
203000|NCT02104180|TulleGras|tullegras
203001|NCT02104180|Urgotul|urgotul
203002|NCT02104180|pain|pain
203003|NCT02104180|venous leg ulcer|venous leg ulcer
203004|NCT02104180|healing|healing
203005|NCT02104167|DDD|ddd
203006|NCT02104167|degenerative disc disease|degenerative disc disease
203007|NCT02104167|cervical spine|cervical spine
203008|NCT02104167|fusion rate|fusion rate
203009|NCT02104141|DDD|ddd
203010|NCT02104141|lumbar spine|lumbar spine
203011|NCT02104141|fusion rate|fusion rate
203012|NCT02104141|degenerative disc disease|degenerative disc disease
203013|NCT02104128|Anhedonia|anhedonia
203014|NCT02104128|Dopamine|dopamine
203015|NCT02104128|Bupropion|bupropion
203016|NCT02104128|fMRI|fmri
203017|NCT02104128|emotional processing|emotional processing
203018|NCT02104128|reward|reward
203019|NCT02104115|Stomach|stomach
203020|NCT02104115|Small bowel|small bowel
203021|NCT02104115|Colon|colon
203022|NCT02104115|MRI|mri
203023|NCT02104115|Function|function
203024|NCT02104115|Gastrointestinal volumes|gastrointestinal volumes
203025|NCT02104102|Elderly|elderly
203026|NCT02104102|mirror therapy|mirror therapy
203027|NCT02104102|hands|hands
248514|NCT01895257|PFS|pfs
203028|NCT02104089|Thoracoabdominal aortic aneurysm|thoracoabdominal aortic aneurysm
203029|NCT02104089|Endovascular|endovascular
203030|NCT02104089|Fenestration|fenestration
203031|NCT02104089|Branch|branch
203032|NCT02104089|Off-the-shelf|off-the-shelf
203033|NCT02104076|Bile Duct Obstructions|bile duct obstructions
203034|NCT02104076|Biliary Stases|biliary stases
203035|NCT02104076|Biliary Tract|biliary tract
203036|NCT02104076|Stents|stents
203037|NCT02104024|Kidney|kidney
203038|NCT02104024|Pancreas|pancreas
203039|NCT02104024|Transplant|transplant
203040|NCT02104024|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
203041|NCT02104011|Angiomyolipomas in tuberous sclerosis|angiomyolipomas in tuberous sclerosis
203042|NCT02104011|Beta-blockers|beta-blockers
203043|NCT02104011|Anti-angiogenic therapies|anti-angiogenic therapies
203044|NCT02103998|extremely low gestational age neonate|extremely low gestational age neonate
203045|NCT02103998|hypothyroxinemia of prematurity|hypothyroxinemia of prematurity
203046|NCT02103998|brain development|brain development
203047|NCT02103998|cerebral palsy|cerebral palsy
203048|NCT02103998|cognitive dealy|cognitive dealy
203049|NCT02103985|Healthy|healthy
203050|NCT02103985|JNJ-39823277|jnj-39823277
203051|NCT02103985|JNJ-40917006|jnj-40917006
203052|NCT02103985|Pharmacokinetics|pharmacokinetics
203346|NCT02102542|efficacy|efficacy
203053|NCT02103972|All subjects of any ethnicity aged from 4 to 30 months with atopic dermatitis skin symptoms with a SCORAD equal or above 20|all subjects of any ethnicity aged from 4 to 30 months with atopic dermatitis skin symptoms with a scorad equal or above 20
203054|NCT02103946|serratus|serratus
203055|NCT02103946|paravertebral|paravertebral
203056|NCT02103946|breast|breast
203057|NCT02103946|cancer|cancer
203058|NCT02103946|axilla|axilla
203059|NCT02103907|balance|balance
203060|NCT02103907|knee|knee
203061|NCT02103907|osteoarthritis|osteoarthritis
203062|NCT02103907|physical function|physical function
203063|NCT02103894|Alzheimer's disease (AD)|alzheimer's disease (ad)
203064|NCT02103894|Parkinson's disease (PD)|parkinson's disease (pd)
203065|NCT02103894|Progressive supranuclear palsy (PSP)|progressive supranuclear palsy (psp)
203066|NCT02103894|Chronic traumatic encephalopathy (CTE)|chronic traumatic encephalopathy (cte)
203067|NCT02103894|Frontal temporal dementia (FTD)|frontal temporal dementia (ftd)
203068|NCT02103894|Pick's disease|pick's disease
203069|NCT02103894|tauopathies|tauopathies
203070|NCT02103881|Agitation|agitation
203071|NCT02103881|Ketamine|ketamine
203072|NCT02103881|Haloperidol|haloperidol
203073|NCT02103881|Emergency Medical Services|emergency medical services
203074|NCT02103881|Feeling of restlessness|feeling of restlessness
203075|NCT02103881|Increased motor activity|increased motor activity
203076|NCT02103868|Tobacco cessation|tobacco cessation
203077|NCT02103868|Zari worker|zari worker
203078|NCT02103868|Behavior therapy|behavior therapy
203079|NCT02103868|Qualitative Research|qualitative research
203080|NCT02103868|Mumbai|mumbai
203081|NCT02103855|pancreas transplantation|pancreas transplantation
203082|NCT02103855|immunosuppression|immunosuppression
203083|NCT02103855|belatacept|belatacept
203084|NCT02103829|Cigarette smoking|cigarette smoking
203085|NCT02103829|Tobacco smoking|tobacco smoking
203086|NCT02103829|Smoking, Tobacco|smoking, tobacco
203087|NCT02103803|concussion|concussion
203088|NCT02103803|sports-related concussion|sports-related concussion
203089|NCT02103803|mild traumatic brain injury (mTBI)|mild traumatic brain injury (mtbi)
203090|NCT02103803|eye tracking|eye tracking
203091|NCT02103803|oculometrics|oculometrics
203092|NCT02103777|high dose of caffeine|high dose of caffeine
203093|NCT02103777|low dose of caffeine|low dose of caffeine
203094|NCT02103777|prevention|prevention
203095|NCT02103764|Anovulatory Dysfunctional Uterine Bleeding|anovulatory dysfunctional uterine bleeding
203096|NCT02103764|cyclic desogestrel|cyclic desogestrel
203097|NCT02103764|cyclic medroxyprogesterone acetate|cyclic medroxyprogesterone acetate
203098|NCT02103764|lipid metabolism|lipid metabolism
203099|NCT02103764|glucose metabolism|glucose metabolism
676417|NCT00880399|efficacy|efficacy
203100|NCT02103764|endometrial histology changing|endometrial histology changing
203101|NCT02103751|biomarkers|biomarkers
203102|NCT02103751|HPHCs|hphcs
203103|NCT02103751|CVD|cvd
203104|NCT02103751|smoking|smoking
203105|NCT02103751|Smokers|smokers
203106|NCT02103751|non-smokers|non-smokers
203107|NCT02103738|Lucentis|lucentis
203108|NCT02103738|Ranibizumab|ranibizumab
203109|NCT02103738|Treat and Extend|treat and extend
203110|NCT02103738|wetAMD|wetamd
203111|NCT02103738|Age related macular degeneration|age related macular degeneration
203112|NCT02103699|Hepatitis C virus|hepatitis c virus
203113|NCT02103699|Simeprevir|simeprevir
203114|NCT02103699|Ribonucleic acid|ribonucleic acid
203115|NCT02103699|Sustained virologic response|sustained virologic response
203116|NCT02103686|Neuropathic pain|neuropathic pain
203117|NCT02103686|pregabalin|pregabalin
203118|NCT02103660|contraceptive implant|contraceptive implant
203119|NCT02103660|Depo-Medroxyprogesterone Acetate|depo-medroxyprogesterone acetate
193955|NCT02143869|Bioelectrical Impedance analysis|bioelectrical impedance analysis
193956|NCT02143869|Body composition|body composition
193957|NCT02143869|Perioperative|perioperative
193958|NCT02143830|marrow aplasia|marrow aplasia
203120|NCT02103660|Hormonal Contraception|hormonal contraception
203121|NCT02103660|progestin|progestin
203122|NCT02103647|Neuropathic pain|neuropathic pain
203123|NCT02103647|pregabalin|pregabalin
203124|NCT02103634|breast cancer|breast cancer
203125|NCT02103634|FDG PET/CT|fdg pet/ct
203126|NCT02103634|MRI|mri
203127|NCT02103634|NaF PET/MRI|naf pet/mri
203128|NCT02103634|NaF PET/CT|naf pet/ct
203129|NCT02103608|at Home Photo depilation device, Silk'n.|at home photo depilation device, silk'n.
203130|NCT02103556|Constipation|constipation
203131|NCT02103556|Rome III criteria|rome iii criteria
203132|NCT02103556|Hemodialysis|hemodialysis
203133|NCT02103491|Half-ironman|half-ironman
203134|NCT02103491|Triathlon|triathlon
203135|NCT02103491|Salt|salt
203136|NCT02103491|Exercise|exercise
203137|NCT02103491|Performance|performance
203138|NCT02103478|Myelodysplastic Syndrome|myelodysplastic syndrome
203139|NCT02103478|MDS|mds
203140|NCT02103465|Parkinson's Disease|parkinson's disease
203141|NCT02103465|treatment|treatment
203142|NCT02103465|old patients|old patients
203143|NCT02103465|Rotigotine|rotigotine
203144|NCT02103439|Hepatitis C|hepatitis c
203145|NCT02103439|Cepeginterferon alfa|cepeginterferon alfa
203146|NCT02103439|Peginterferon|peginterferon
203147|NCT02103439|Treatment|treatment
203148|NCT02103426|Cytomegalovirus|cytomegalovirus
203149|NCT02103426|ASP0113|asp0113
203150|NCT02103426|CMV-seropositive|cmv-seropositive
203151|NCT02103426|Healthy subjects|healthy subjects
203152|NCT02103426|CMV-seronegative|cmv-seronegative
203153|NCT02103426|Dialysis|dialysis
203154|NCT02103374|weaned tobacco|weaned tobacco
203155|NCT02103374|Has not submitted an exacerbation in the past 3 months|has not submitted an exacerbation in the past 3 months
203156|NCT02103361|autoimmune disease|autoimmune disease
203157|NCT02103361|pregnancy|pregnancy
203158|NCT02103361|psoriasis|psoriasis
203159|NCT02103361|Stelara|stelara
203160|NCT02103361|ustekinumab|ustekinumab
203161|NCT02103361|birth outcome|birth outcome
203162|NCT02103361|malformation|malformation
203163|NCT02103361|birth defect|birth defect
203164|NCT02103361|psoriatic arthritis|psoriatic arthritis
203165|NCT02103361|Crohn's Disease|crohn's disease
203166|NCT02103348|Severe asthma|severe asthma
203167|NCT02103348|Sputum|sputum
203168|NCT02103348|Mucolysis|mucolysis
203169|NCT02103335|Myeloma|myeloma
203170|NCT02103335|Multiple Myeloma|multiple myeloma
203171|NCT02103335|Pomalidomide|pomalidomide
203172|NCT02103335|Marizomib|marizomib
203173|NCT02103335|Low dose Dexamethasone|low dose dexamethasone
203174|NCT02103335|Relapsed|relapsed
203175|NCT02103335|Refractory|refractory
203176|NCT02103309|Soft contact lenses|soft contact lenses
203177|NCT02103309|DACP|dacp
203178|NCT02103283|Diabetic Macular Edema|diabetic macular edema
203179|NCT02103244|pharmacokinetics|pharmacokinetics
203180|NCT02103244|safety|safety
203181|NCT02103231|Preterm birth|preterm birth
203182|NCT02103231|Hypertension|hypertension
203183|NCT02103231|Exercise capacity|exercise capacity
203184|NCT02103231|Cardiovascular risk|cardiovascular risk
203185|NCT02103218|HIV|hiv
203186|NCT02103218|risky sex prevention|risky sex prevention
203187|NCT02103218|intervention|intervention
203188|NCT02103205|Lactoferrin|lactoferrin
203189|NCT02103205|Infant formula|infant formula
203190|NCT02103205|Iron|iron
203191|NCT02103179|Extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
203192|NCT02103179|ECC|ecc
203193|NCT02103179|VEGF signaling|vegf signaling
203194|NCT02103140|Breast Cancer|breast cancer
203195|NCT02103140|Obesity|obesity
203196|NCT02103140|African American female|african american female
203197|NCT02103140|exergaming|exergaming
203198|NCT02103101|polymorphism|polymorphism
203199|NCT02103101|ABCB1|abcb1
203200|NCT02103101|P-glycoprotein|p-glycoprotein
203201|NCT02103101|oral anticoagulant|oral anticoagulant
203202|NCT02103101|dabigatran|dabigatran
203203|NCT02103101|apixaban|apixaban
203204|NCT02103101|rivaroxaban|rivaroxaban
203205|NCT02103101|hemorrhagic complication|hemorrhagic complication
203206|NCT02103101|thrombo-embolism|thrombo-embolism
203207|NCT02103101|serious adverse event|serious adverse event
203208|NCT02103088|Prostate cancer|prostate cancer
203209|NCT02103088|Intervention|intervention
203210|NCT02103088|Rehabilitation|rehabilitation
203211|NCT02103088|Couple|couple
203212|NCT02103088|Sexology|sexology
203213|NCT02103088|Urology|urology
203214|NCT02103088|Late effects|late effects
203215|NCT02103075|spinocerebellar ataxia (SCA)|spinocerebellar ataxia (sca)
203216|NCT02103075|motor evoked potential (MEP)|motor evoked potential (mep)
203217|NCT02103075|Neuromuscular electrical stimulation (NMES)|neuromuscular electrical stimulation (nmes)
203218|NCT02103075|silent period|silent period
203219|NCT02103075|cerebellum|cerebellum
203220|NCT02103062|Metastatic Colorectal Cancer|metastatic colorectal cancer
203221|NCT02103062|nab®Paclitaxel|nab®paclitaxel
203222|NCT02103062|Response Evaluation in Solid Tumors|response evaluation in solid tumors
203223|NCT02103062|Progression Free Survival|progression free survival
203224|NCT02103062|Overall Survival|overall survival
203225|NCT02103062|Duration of Response|duration of response
203226|NCT02103062|RAS|ras
203227|NCT02103036|Low Back Pain|low back pain
203228|NCT02103036|Core stability exercise|core stability exercise
203229|NCT02103036|Back school|back school
203230|NCT02103036|TENS|tens
203231|NCT02103036|Infra- red light|infra- red light
203232|NCT02102997|DTS|dts
203233|NCT02102997|Stents|stents
203234|NCT02102997|Stent|stent
203235|NCT02102997|DES|des
203236|NCT02102997|Drug eluting|drug eluting
203237|NCT02102997|Drug Eluting Stent (DES)|drug eluting stent (des)
203238|NCT02102997|Drug eluting stents|drug eluting stents
203239|NCT02102997|Endothelial Progenitor Cell (EPC)|endothelial progenitor cell (epc)
203240|NCT02102997|Endothelial progenitor cell capturing|endothelial progenitor cell capturing
203241|NCT02102997|Sirolimus|sirolimus
203242|NCT02102997|Sirolimus eluting|sirolimus eluting
203243|NCT02102997|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
203244|NCT02102997|PCI|pci
203245|NCT02102997|Registry|registry
203246|NCT02102997|Registries|registries
203247|NCT02102997|Multi center|multi center
203248|NCT02102997|Multi centre|multi centre
203345|NCT02102542|glycopyrrolate|glycopyrrolate
203249|NCT02102984|distal malignancy of the extra-hepatic biliary tract|distal malignancy of the extra-hepatic biliary tract
203250|NCT02102984|metallic biliary stents|metallic biliary stents
203251|NCT02102984|covered biliary stents|covered biliary stents
203252|NCT02102984|uncovered biliary stents|uncovered biliary stents
203253|NCT02102971|liver|liver
203254|NCT02102971|ischemia|ischemia
203255|NCT02102971|reperfusion|reperfusion
203256|NCT02102958|diabetes|diabetes
203257|NCT02102958|visual impairment|visual impairment
203258|NCT02102958|foot care|foot care
203259|NCT02102958|diabetes self-management education|diabetes self-management education
203260|NCT02102945|Computed tomography|computed tomography
203261|NCT02102945|Perfusion imaging|perfusion imaging
203262|NCT02102945|Coma|coma
203263|NCT02102945|Heart arrest|heart arrest
203264|NCT02102945|Brain death|brain death
203265|NCT02102906|Adult|adult
203266|NCT02102906|Humans|humans
203267|NCT02102906|Conversion disorder|conversion disorder
203268|NCT02102906|Somatoform Disorders/therapy|somatoform disorders/therapy
203269|NCT02102906|Nervous System Disorders/therapy|nervous system disorders/therapy
203270|NCT02102893|for Gastroentero-Pancreatic Neuroendocrine Tumors in Taiwan|for gastroentero-pancreatic neuroendocrine tumors in taiwan
203271|NCT02102880|Genetic Association Studies|genetic association studies
203272|NCT02102867|HIV|hiv
203273|NCT02102867|STI|sti
203274|NCT02102867|Primary Prevention|primary prevention
203275|NCT02102867|Topical Microbicides|topical microbicides
203276|NCT02102867|User Experience|user experience
203277|NCT02102867|Drug Delivery Systems|drug delivery systems
203278|NCT02102854|kidney transplantation|kidney transplantation
203279|NCT02102854|acute rejection|acute rejection
203280|NCT02102854|rabbit antithymocyte globulin|rabbit antithymocyte globulin
203281|NCT02102828|DVT|dvt
203282|NCT02102828|Total Knee Arthroplasty|total knee arthroplasty
203283|NCT02102815|total knee arthroplasty|total knee arthroplasty
203284|NCT02102815|pain control|pain control
203285|NCT02102815|dexamethasone|dexamethasone
203286|NCT02102815|steroids|steroids
203287|NCT02102802|PTSD|ptsd
203288|NCT02102802|MDMA|mdma
203289|NCT02102802|Brain activity|brain activity
203290|NCT02102802|fMRI|fmri
203291|NCT02102802|Heart rate variability|heart rate variability
203292|NCT02102802|Physiological correlate|physiological correlate
203293|NCT02102776|Primary Pterygium|primary pterygium
203294|NCT02102776|Mitomycin C|mitomycin c
203295|NCT02102776|Amniotic membrane transplantation|amniotic membrane transplantation
203296|NCT02102776|Conjunctival autograft|conjunctival autograft
203297|NCT02102776|Multi-center randomized clinical trial|multi-center randomized clinical trial
203298|NCT02102763|Overweight|overweight
203299|NCT02102763|Obesity|obesity
203300|NCT02102763|Dietary intake|dietary intake
203700|NCT02100930|13-260|13-260
203301|NCT02102763|Physical activity levels|physical activity levels
203302|NCT02102763|Blood pressure levels|blood pressure levels
203303|NCT02102763|Family perceptions|family perceptions
203304|NCT02102737|insulin resistance|insulin resistance
203305|NCT02102737|Scintigraphy|scintigraphy
203306|NCT02102737|Hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
203307|NCT02102724|African Americans|african americans
203308|NCT02102724|Older Adults|older adults
203309|NCT02102711|VITAMIN A|vitamin a
203310|NCT02102711|BLOOD CONCENTRATION|blood concentration
203311|NCT02102711|retinopathy of prematurity|retinopathy of prematurity
203312|NCT02102698|Tourette's Syndrome|tourette's syndrome
203313|NCT02102698|Ecopipam|ecopipam
203314|NCT02102698|D1 Receptor|d1 receptor
203315|NCT02102698|Phase 2|phase 2
203316|NCT02102685|VAC Therapy|vac therapy
203317|NCT02102685|Neck Abscess|neck abscess
203318|NCT02102685|Traditional Therapy|traditional therapy
203319|NCT02102685|Wound Healing|wound healing
203320|NCT02102659|Nutritional Assessment|nutritional assessment
203321|NCT02102659|Oral Epithelial Cell|oral epithelial cell
203322|NCT02102659|Apoptosis|apoptosis
203323|NCT02102633|bosutinib|bosutinib
203324|NCT02102633|dabigatran|dabigatran
203325|NCT02102633|drug interaction|drug interaction
203326|NCT02102633|p-glycoprotein|p-glycoprotein
203327|NCT02102633|pharmacokinetics|pharmacokinetics
203328|NCT02102620|intra-articular injection|intra-articular injection
203329|NCT02102620|corticosteroid|corticosteroid
203330|NCT02102620|osteoarthritis|osteoarthritis
203331|NCT02102620|Interphalangeal joint|interphalangeal joint
203332|NCT02102607|intrathecal; ropivacaine; motor blockade; local anesthetics|intrathecal; ropivacaine; motor blockade; local anesthetics
203333|NCT02102594|Myasthenia Gravis|myasthenia gravis
203334|NCT02102594|Systemic Lupus Erythematosus|systemic lupus erythematosus
203335|NCT02102594|Rheumatoid Arthritis|rheumatoid arthritis
203336|NCT02102594|proteasome inhibitor|proteasome inhibitor
203337|NCT02102594|Bortezomib|bortezomib
203338|NCT02102594|Velcade|velcade
203339|NCT02102594|antibody-mediated autoimmune disease|antibody-mediated autoimmune disease
203340|NCT02102581|Tourniquet|tourniquet
203341|NCT02102581|Total knee arthroplasty|total knee arthroplasty
203342|NCT02102581|Blood loss|blood loss
203343|NCT02102581|Limb swelling|limb swelling
203344|NCT02102581|Limb circumference|limb circumference
203347|NCT02102542|antisialagogue|antisialagogue
203348|NCT02102529|pain|pain
203349|NCT02102529|quality of life|quality of life
203350|NCT02102516|Post operative pain management|post operative pain management
203351|NCT02102490|Endocrine Therapy, Taxane, MONARCH 1|endocrine therapy, taxane, monarch 1
203352|NCT02102477|Prostatic neoplasms|prostatic neoplasms
203353|NCT02102477|Locally advanced|locally advanced
203354|NCT02102477|Radiotherapy|radiotherapy
203355|NCT02102477|Surgery|surgery
203356|NCT02102477|Mortality|mortality
203357|NCT02102451|Interferon-free|interferon-free
203358|NCT02102451|Direct acting antiviral (DAA)|direct acting antiviral (daa)
203359|NCT02102451|Treatment as prevention|treatment as prevention
203360|NCT02102451|Surveillance|surveillance
203361|NCT02102451|Feasibility|feasibility
203362|NCT02102438|Elderly patients|elderly patients
203363|NCT02102438|Localized HER2+ Breast Cancer|localized her2+ breast cancer
203364|NCT02102438|Omission of anthracyclines|omission of anthracyclines
203365|NCT02102438|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
203366|NCT02102438|Adjuvant chemotherapy|adjuvant chemotherapy
203367|NCT02102438|Safety information|safety information
203368|NCT02102425|Peritoneal Dialysis|peritoneal dialysis
203369|NCT02102425|Exit site infection|exit site infection
203370|NCT02102425|Exit site care|exit site care
203371|NCT02102425|Bandage|bandage
203372|NCT02102425|Prevention|prevention
203373|NCT02102425|Guidelines|guidelines
203374|NCT02102412|crc|crc
203375|NCT02102412|colonoscopy|colonoscopy
203376|NCT02102412|colon cancer|colon cancer
203377|NCT02102399|Voice training|voice training
203378|NCT02102399|Education|education
203379|NCT02102399|Voice|voice
203380|NCT02102399|Faculty|faculty
203381|NCT02102386|elective|elective
203382|NCT02102386|carotid endarterectomy surgery|carotid endarterectomy surgery
203383|NCT02102373|colonoscopy, pediatric, preparation, diet|colonoscopy, pediatric, preparation, diet
203384|NCT02102360|microsurgery, furcation defects, periodontal disease, enamel matrix proteins, bone substitutes|microsurgery, furcation defects, periodontal disease, enamel matrix proteins, bone substitutes
203385|NCT02102347|Physical Therapy Modalities|physical therapy modalities
203386|NCT02102347|osteoarthritis|osteoarthritis
203387|NCT02102334|Osteoarthritis, hip,|osteoarthritis, hip,
203388|NCT02102334|radiograpghic measurements|radiograpghic measurements
203389|NCT02102334|femoral offset|femoral offset
203390|NCT02102334|leg length discrepancy|leg length discrepancy
203391|NCT02102334|cup anteversion|cup anteversion
203392|NCT02102334|cup inclination|cup inclination
203393|NCT02102321|hookworm|hookworm
203394|NCT02102321|albendazole|albendazole
203395|NCT02102321|iron supplementation|iron supplementation
203396|NCT02102321|democratic republic of congo|democratic republic of congo
203397|NCT02102321|subsistence farmers|subsistence farmers
203398|NCT02102321|randomized control trial|randomized control trial
203399|NCT02102321|neglected tropical disease|neglected tropical disease
203400|NCT02102321|helminths|helminths
203401|NCT02102295|Gingivitis|gingivitis
203402|NCT02102295|antioxidant|antioxidant
203403|NCT02102295|dentifrice|dentifrice
203404|NCT02102295|Ascorbic Acid Derivative|ascorbic acid derivative
248969|NCT01893320|AML|aml
194266|NCT02142439|Bulimia|bulimia
203405|NCT02102295|L ascorbic acid 2 phosphate magnesium salt|l ascorbic acid 2 phosphate magnesium salt
203406|NCT02102282|Pregnancy|pregnancy
203407|NCT02102282|Breast Cancer|breast cancer
203408|NCT02102282|Chemotherapy|chemotherapy
203409|NCT02102282|Surgery|surgery
203410|NCT02102282|Obstetric managment|obstetric managment
203411|NCT02102256|deafness|deafness
203412|NCT02102256|congenital|congenital
203413|NCT02102256|pediatric|pediatric
203414|NCT02102256|device|device
203415|NCT02102243|hypertension|hypertension
203416|NCT02102243|blood pressure|blood pressure
203417|NCT02102243|sympathetic nerve activity|sympathetic nerve activity
203418|NCT02102243|vascular oxidative stress|vascular oxidative stress
203419|NCT02102243|nitric oxide|nitric oxide
203420|NCT02102243|nitric oxide synthase (eNOS)|nitric oxide synthase (enos)
203421|NCT02102243|endothelium|endothelium
203422|NCT02102243|endothelial dysfunction|endothelial dysfunction
203423|NCT02102243|endothelial cell protein expression|endothelial cell protein expression
203424|NCT02102243|microvascular blood flow|microvascular blood flow
203425|NCT02102243|flow mediated dilation|flow mediated dilation
203426|NCT02102243|endothelial cell collection|endothelial cell collection
203427|NCT02102243|microbubbles|microbubbles
203428|NCT02102243|Definity|definity
203429|NCT02102230|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
203430|NCT02102230|marijuana abuse|marijuana abuse
203431|NCT02102230|Veterans|veterans
203432|NCT02102217|Major Abdominal Surgery|major abdominal surgery
203433|NCT02102217|C-reactive protein|c-reactive protein
203434|NCT02102217|Computed Tomography|computed tomography
203435|NCT02102217|Quality Control|quality control
203436|NCT02102217|Postoperative complications|postoperative complications
203437|NCT02102204|Secondary Hyperparathyroidism (SHPT), chrominc kidney disease (CKD), hemodialysis|secondary hyperparathyroidism (shpt), chrominc kidney disease (ckd), hemodialysis
203438|NCT02102178|oncological pain|oncological pain
203439|NCT02102178|therapeutic activities|therapeutic activities
203440|NCT02102178|occupational therapy.|occupational therapy.
203441|NCT02102165|Aurora|aurora
203442|NCT02102165|breast cancer|breast cancer
203443|NCT02102165|metastatic|metastatic
203444|NCT02102165|molecular screening|molecular screening
203445|NCT02102165|targeted gene sequencing|targeted gene sequencing
203446|NCT02102165|molecular aberrations|molecular aberrations
203447|NCT02102165|exploratory|exploratory
203448|NCT02102165|biomarker|biomarker
203449|NCT02102152|Tobramycin Podhaler|tobramycin podhaler
203450|NCT02102152|bronchiectasis|bronchiectasis
203451|NCT02102152|chronic infection|chronic infection
203452|NCT02102152|Pseudomonas Aeruginosa|pseudomonas aeruginosa
203453|NCT02102126|Renal denervation therapy|renal denervation therapy
203454|NCT02102126|Aortic blood pressure|aortic blood pressure
203455|NCT02102126|Blood pressure variability|blood pressure variability
203456|NCT02102126|Arterial stiffness|arterial stiffness
203457|NCT02102126|Target organ damage|target organ damage
203458|NCT02102126|Biomarker|biomarker
203459|NCT02102100|menthol, electronic cigarette, nicotine, smoking, tobacco|menthol, electronic cigarette, nicotine, smoking, tobacco
203460|NCT02102074|colon and rectal tumors|colon and rectal tumors
203461|NCT02102074|colon cancer markers|colon cancer markers
203462|NCT02102061|overweight|overweight
203463|NCT02102061|exercise|exercise
203464|NCT02102061|nutrition|nutrition
203465|NCT02102061|philosophy|philosophy
203467|NCT02102048|diabetes|diabetes
203468|NCT02102048|glucose metabolism|glucose metabolism
203469|NCT02102048|antiretroviral therapy|antiretroviral therapy
203470|NCT02102048|ritonavir|ritonavir
203471|NCT02102048|atazanavir|atazanavir
203472|NCT02102035|defect|defect
203473|NCT02102035|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
203474|NCT02102035|dorsal digital island flap|dorsal digital island flap
203475|NCT02102035|sensory reconstruction.|sensory reconstruction.
203476|NCT02102022|argininosuccinate synthetase|argininosuccinate synthetase
203477|NCT02102022|arginine|arginine
203478|NCT02102022|arginine deiminase|arginine deiminase
203479|NCT02102009|Malnutrition|malnutrition
203480|NCT02102009|Dietary supplement|dietary supplement
203481|NCT02102009|Nutritional supplement|nutritional supplement
203482|NCT02102009|Complete enteral formula|complete enteral formula
203483|NCT02102009|COPD|copd
203484|NCT02101996|stable isotopes|stable isotopes
203485|NCT02101996|triacylglycerol|triacylglycerol
203486|NCT02101983|Acute myeloid leukemia|acute myeloid leukemia
203487|NCT02101983|outpatient consolidation treatment|outpatient consolidation treatment
203488|NCT02101970|Breast cancer risk|breast cancer risk
203489|NCT02101970|DHA|dha
203490|NCT02101970|Omega-3 Fatty Acids|omega-3 fatty acids
203491|NCT02101970|EPA|epa
203492|NCT02101970|Weight Loss|weight loss
203493|NCT02101931|Bladder Cancer|bladder cancer
203494|NCT02101931|Laser Diagnosis|laser diagnosis
203495|NCT02101931|Amino levulinic Acid|amino levulinic acid
203496|NCT02101931|Photodynamic Detection|photodynamic detection
194386|NCT02141828|ALL|all
203497|NCT02101931|spectra of urine|spectra of urine
203498|NCT02101892|migraine|migraine
203499|NCT02101892|Amitriptyline|amitriptyline
203500|NCT02101892|pain modulation|pain modulation
203501|NCT02101892|pain psychophysics|pain psychophysics
203502|NCT02101892|pain neurophysiology|pain neurophysiology
203503|NCT02101892|preventive treatment|preventive treatment
203504|NCT02101866|Bioavailability Study|bioavailability study
203505|NCT02101866|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
203506|NCT02101866|Aviragen Therapeutics|aviragen therapeutics
203507|NCT02101866|Aviragen|aviragen
203508|NCT02101840|Substance-Related Disorders|substance-related disorders
203509|NCT02101840|Prescription Drug Misuse|prescription drug misuse
203510|NCT02101840|Analgesics, Opioid|analgesics, opioid
203511|NCT02101840|Oxycodone|oxycodone
203512|NCT02101840|Randomized Controlled Trial|randomized controlled trial
203513|NCT02101840|Cross-Over Studies|cross-over studies
203514|NCT02101840|Placebo|placebo
203515|NCT02101840|Healthy Volunteers|healthy volunteers
203516|NCT02101801|environment, recycled wastewater, carbamazepine|environment, recycled wastewater, carbamazepine
203517|NCT02101762|Foley|foley
203518|NCT02101762|Catheters|catheters
203519|NCT02101762|CAUTI|cauti
203520|NCT02101762|ERASE CAUTI|erase cauti
203521|NCT02101749|trivalent inactivated influenza vaccine|trivalent inactivated influenza vaccine
203522|NCT02101736|Ages 16 or greater|ages 16 or greater
203523|NCT02101736|Cabozantinib|cabozantinib
203524|NCT02101736|XL184|xl184
203525|NCT02101736|Plexiform Neurofibromas|plexiform neurofibromas
203526|NCT02101736|Neurofibromatosis|neurofibromatosis
203527|NCT02101736|Pathogenetic NF1 Mutations|pathogenetic nf1 mutations
203528|NCT02101736|Cometriq|cometriq
203529|NCT02101736|NF1|nf1
203530|NCT02101723|Zinc absorption|zinc absorption
203531|NCT02101723|Micronutrient supplement|micronutrient supplement
203532|NCT02101723|Microbiome|microbiome
203533|NCT02101723|Kenya|kenya
203534|NCT02101723|Complementary foods|complementary foods
203535|NCT02101723|Home fortification|home fortification
203536|NCT02101710|Bioequivalence|bioequivalence
203537|NCT02101710|Isosorbide 5-mononitrate|isosorbide 5-mononitrate
203538|NCT02101710|Elantan|elantan
203539|NCT02101710|Imdur|imdur
203540|NCT02101710|Korean|korean
203541|NCT02101710|Healthy|healthy
203542|NCT02101697|reduce|reduce
203543|NCT02101697|Indian health providers|indian health providers
203544|NCT02101684|Orteronel, Granulosa Cell Tumour|orteronel, granulosa cell tumour
203545|NCT02101671|agitation|agitation
203546|NCT02101671|anaesthesia|anaesthesia
203547|NCT02101671|laparoscopy|laparoscopy
203548|NCT02101671|surgery|surgery
203549|NCT02101671|delirium|delirium
203550|NCT02101671|sedation|sedation
203551|NCT02101671|emergence|emergence
203552|NCT02101671|steep|steep
203553|NCT02101671|trendelemburg|trendelemburg
203554|NCT02101671|position|position
203555|NCT02101671|delayed|delayed
203556|NCT02101671|Confusion|confusion
203557|NCT02101671|Disorientation|disorientation
203558|NCT02101645|Bioimpedance|bioimpedance
203559|NCT02101645|Venous ulcer|venous ulcer
203560|NCT02101645|Edema|edema
203561|NCT02101645|LIDC|lidc
203562|NCT02101645|Electrical stimulation|electrical stimulation
203563|NCT02101632|TMD|tmd
203564|NCT02101632|bee venom|bee venom
203565|NCT02101632|muscle tension|muscle tension
203566|NCT02101632|muscle pain|muscle pain
203567|NCT02101619|aortic stenosis|aortic stenosis
203568|NCT02101619|myocardial tissue|myocardial tissue
203569|NCT02101619|echocardiography|echocardiography
203570|NCT02101619|MRI|mri
203571|NCT02101606|Acute Stroke|acute stroke
203572|NCT02101606|Cerebral Stroke|cerebral stroke
203573|NCT02101606|Brain Ischemia|brain ischemia
203574|NCT02101606|Perfusion Imaging|perfusion imaging
203575|NCT02101606|MRI, Diffusion Weighted|mri, diffusion weighted
203576|NCT02101606|MRI, Perfusion Weighted|mri, perfusion weighted
203577|NCT02101593|argininosuccinate synthetase|argininosuccinate synthetase
203578|NCT02101593|arginine|arginine
203579|NCT02101593|arginine deiminase|arginine deiminase
203580|NCT02101580|argininosuccinate synthetase|argininosuccinate synthetase
203581|NCT02101580|arginine|arginine
203582|NCT02101580|arginine deiminase|arginine deiminase
203583|NCT02101567|Postpartum hemorrhage, Cesarean section, Uterotonics|postpartum hemorrhage, cesarean section, uterotonics
203584|NCT02101554|Pediatric|pediatric
203585|NCT02101554|pain indication|pain indication
203586|NCT02101554|controlled release morphine|controlled release morphine
203587|NCT02101541|Atrial fibrillation|atrial fibrillation
203588|NCT02101541|Arrhythmias, Cardiac|arrhythmias, cardiac
203589|NCT02101541|Heart diseases|heart diseases
203590|NCT02101541|Cardiovascular diseases|cardiovascular diseases
203591|NCT02101541|Pathological processes|pathological processes
203592|NCT02101528|Strength in PD patients|strength in pd patients
203593|NCT02101528|Isokinetic muscle strength|isokinetic muscle strength
204106|NCT02099162|Stenting|stenting
203594|NCT02101515|randomized controlled trial|randomized controlled trial
203595|NCT02101515|labor complications|labor complications
203596|NCT02101515|cesarean section|cesarean section
203597|NCT02101515|second stage|second stage
203598|NCT02101502|Healthcare,educational effectiveness, institutional capacity|healthcare,educational effectiveness, institutional capacity
203600|NCT02101489|Stress urinary incontinence|stress urinary incontinence
203601|NCT02101476|Pain|pain
203602|NCT02101463|aortic|aortic
203603|NCT02101463|sm-FBSG|sm-fbsg
203604|NCT02101463|aneurysms|aneurysms
203605|NCT02101463|fenestrated|fenestrated
203606|NCT02101463|stent-grafts|stent-grafts
203607|NCT02101463|Vascular|vascular
203608|NCT02101463|Endovascular|endovascular
203609|NCT02101450|extra-abdominal|extra-abdominal
203610|NCT02101450|intra-abdominal|intra-abdominal
203611|NCT02101450|removal of placenta|removal of placenta
203612|NCT02101450|cesarean section|cesarean section
203613|NCT02101450|bleeding|bleeding
203614|NCT02101424|Overdose|overdose
203615|NCT02101424|Emergency Department|emergency department
203616|NCT02101424|Supplemental Oxygen|supplemental oxygen
203617|NCT02101424|Pulse Oximeter|pulse oximeter
203618|NCT02101424|Capnography|capnography
203619|NCT02101398|tDCS|tdcs
203620|NCT02101398|Stroke|stroke
203621|NCT02101398|Aphasia|aphasia
203622|NCT02101398|Naming|naming
203623|NCT02101385|Genomically-Directed Therapy|genomically-directed therapy
203624|NCT02101385|DNA Sequencing|dna sequencing
203625|NCT02101385|RNA Sequencing|rna sequencing
203626|NCT02101372|first episode psychosis|first episode psychosis
203627|NCT02101372|psychoeducation|psychoeducation
203628|NCT02101372|group therapy|group therapy
203629|NCT02101333|TAKAYASU ARTERITIS|takayasu arteritis
203630|NCT02101333|STEROID SPARING|steroid sparing
203631|NCT02101333|TOCILIZUMAB|tocilizumab
203632|NCT02101333|EFFICACY|efficacy
203633|NCT02101333|SAFETY|safety
203634|NCT02101320|surgery|surgery
203635|NCT02101320|nuclear medicine|nuclear medicine
203636|NCT02101320|Lymphoscintigraphy|lymphoscintigraphy
203637|NCT02101320|Gamma Camera|gamma camera
203638|NCT02101320|SNOLL|snoll
203639|NCT02101320|breast cancer|breast cancer
203640|NCT02101294|carpal tunnel syndrome|carpal tunnel syndrome
203641|NCT02101294|repetitive stress disorder|repetitive stress disorder
203642|NCT02101281|Dry Eye|dry eye
203643|NCT02101255|Dental caries|dental caries
203644|NCT02101255|Curodont Repair|curodont repair
203645|NCT02101255|P11-4|p11-4
203646|NCT02101242|Near-infrared-Spectroscopy|near-infrared-spectroscopy
203647|NCT02101229|Glycemic control algorithm|glycemic control algorithm
203648|NCT02101229|closed loop|closed loop
203649|NCT02101229|artificial pancreas|artificial pancreas
203650|NCT02101216|bioequivalence|bioequivalence
203651|NCT02101216|pharmacokinetics|pharmacokinetics
203652|NCT02101216|psoriasis|psoriasis
203653|NCT02101203|HSDD|hsdd
203654|NCT02101190|BIA 9-1067|bia 9-1067
203655|NCT02101190|Opicapone|opicapone
203656|NCT02101190|catechol-O-methyltransferase (COMT)|catechol-o-methyltransferase (comt)
203657|NCT02101177|Viral Hepatitis C|viral hepatitis c
203658|NCT02101177|Genotype 4|genotype 4
203659|NCT02101177|SVR|svr
203660|NCT02101177|Egyptian National Program|egyptian national program
203661|NCT02101151|Type 2 diabetes mellitus|type 2 diabetes mellitus
203662|NCT02101151|vitamin D|vitamin d
203663|NCT02101151|cholecalciferol|cholecalciferol
203664|NCT02101151|obesity|obesity
203665|NCT02101138|Corticosteroids|corticosteroids
203666|NCT02101138|Eosinophilia|eosinophilia
203667|NCT02101099|Colonoscopy|colonoscopy
203668|NCT02101099|Force|force
203669|NCT02101099|Monitor|monitor
203670|NCT02101099|Endoscopist|endoscopist
203671|NCT02101099|Conscious|conscious
203672|NCT02101099|Sedation|sedation
203673|NCT02101099|Propofol|propofol
203674|NCT02101086|umbilical cord blood|umbilical cord blood
203675|NCT02101086|premature|premature
203676|NCT02101086|autologous transfusion|autologous transfusion
203677|NCT02101086|allogeneic transfusion|allogeneic transfusion
203678|NCT02101060|exercise|exercise
203679|NCT02101060|aging|aging
203680|NCT02101060|aerobic capacity|aerobic capacity
203681|NCT02101060|cardiac function|cardiac function
203682|NCT02101060|inflammation|inflammation
203683|NCT02101047|cesarean section|cesarean section
203684|NCT02101047|hypotension|hypotension
203685|NCT02101047|phenylephrine|phenylephrine
203686|NCT02100982|Multimorbidity|multimorbidity
203687|NCT02100982|Communication|communication
203688|NCT02100982|Primary Care|primary care
203689|NCT02100982|Mental Health|mental health
203690|NCT02100969|MG|mg
203691|NCT02100969|Hizentra|hizentra
203692|NCT02100969|autoimmune neuromuscular disorder|autoimmune neuromuscular disorder
203693|NCT02100956|chronic pain|chronic pain
203694|NCT02100956|neuropathic pain|neuropathic pain
203695|NCT02100943|Obstructive Sleep Apnea|obstructive sleep apnea
203696|NCT02100930|Anti-GD2 3F8 Monoclonal Antibody|anti-gd2 3f8 monoclonal antibody
203697|NCT02100930|oral isotretinoin|oral isotretinoin
203698|NCT02100930|GM-CSF|gm-csf
203699|NCT02100930|Sargramostim|sargramostim
203701|NCT02100917|Bioequivalence|bioequivalence
203702|NCT02100917|Biosimilarity|biosimilarity
203703|NCT02100917|Similarity|similarity
203704|NCT02100917|Pharmacokinetics|pharmacokinetics
203705|NCT02100917|Phase I|phase i
203706|NCT02100917|Trastuzumab|trastuzumab
203707|NCT02100917|Healthy Male Volunteers|healthy male volunteers
203708|NCT02100917|Single-dose|single-dose
203709|NCT02100917|HER-2|her-2
203710|NCT02100917|Oncology|oncology
203711|NCT02100904|Fibroids|fibroids
203712|NCT02100904|Radiofrequency ablation|radiofrequency ablation
203713|NCT02100891|Ewing Sarcoma|ewing sarcoma
203714|NCT02100891|Neuroblastoma|neuroblastoma
203715|NCT02100891|Rhabdomyosarcoma|rhabdomyosarcoma
203716|NCT02100891|Osteosarcoma|osteosarcoma
203717|NCT02100891|CNS tumors|cns tumors
203718|NCT02100891|Brain Tumors|brain tumors
203719|NCT02100839|hypercholesterolemia|hypercholesterolemia
203720|NCT02100839|apolipoprotein E|apolipoprotein e
203721|NCT02100839|First in Human|first in human
203722|NCT02100839|Apolipoprotein E (ApoE)|apolipoprotein e (apoe)
203723|NCT02100839|Apolipoprotein E Mimetic (AEM)|apolipoprotein e mimetic (aem)
203724|NCT02100800|COPD|copd
203725|NCT02100800|Emphysema|emphysema
203726|NCT02100800|MRI|mri
203727|NCT02100800|UTE|ute
203728|NCT02100800|Quantification|quantification
203729|NCT02100800|CT|ct
203730|NCT02100787|tear osmolarity|tear osmolarity
203731|NCT02100787|keratitis sicca|keratitis sicca
203732|NCT02100787|ocular surface disease|ocular surface disease
203733|NCT02100787|TheraTears|theratears
203735|NCT02100774|postprandial period|postprandial period
203736|NCT02100774|genetic variants|genetic variants
203737|NCT02100774|single nucleotide polymorphisms|single nucleotide polymorphisms
203738|NCT02100774|vitamin|vitamin
203739|NCT02100774|carotenoid|carotenoid
203740|NCT02100774|lutein|lutein
203741|NCT02100774|lycopene|lycopene
203742|NCT02100774|tocopherol|tocopherol
203743|NCT02100774|cholecalciferol|cholecalciferol
203744|NCT02100761|Voriconazole|voriconazole
203745|NCT02100761|Invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
203746|NCT02100761|Therapeutic drug monitoring|therapeutic drug monitoring
203747|NCT02100761|CYP genetic polymorphism|cyp genetic polymorphism
203748|NCT02100761|Efficacy|efficacy
203749|NCT02100761|Safety|safety
203750|NCT02100748|moderate to severe acute pain|moderate to severe acute pain
203751|NCT02100748|bunionectomy|bunionectomy
203752|NCT02100735|sedatives|sedatives
203753|NCT02100735|analgesics|analgesics
203754|NCT02100735|protocol|protocol
203755|NCT02100735|mechanical ventilation|mechanical ventilation
203756|NCT02100735|analgosedation|analgosedation
203757|NCT02100683|Occluder|occluder
203758|NCT02100657|multiple myeloma|multiple myeloma
203759|NCT02100657|plitidepsin|plitidepsin
203760|NCT02100657|APLIDIN|aplidin
203761|NCT02100618|Adolescents|adolescents
203762|NCT02100618|Adults|adults
203763|NCT02100618|Immunogenicity|immunogenicity
203764|NCT02100618|6.5 years|6.5 years
203765|NCT02100618|Safety|safety
203766|NCT02100618|Antibody persistence|antibody persistence
203767|NCT02100618|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
203768|NCT02100605|Nasal|nasal
203769|NCT02100605|Congestion|congestion
203770|NCT02100605|Decongestion|decongestion
203771|NCT02100605|Hypertonic|hypertonic
203772|NCT02100605|Saline solution|saline solution
203773|NCT02100592|brain injury|brain injury
203774|NCT02100592|coma|coma
203775|NCT02100592|intensive care|intensive care
203776|NCT02100592|early rehabilitation|early rehabilitation
203777|NCT02100566|Advance Directive|advance directive
203778|NCT02100553|Postmenopausal Women|postmenopausal women
203779|NCT02100553|Obese|obese
203780|NCT02100553|Non-obese|non-obese
203781|NCT02100553|Drug Interaction with Itraconazole|drug interaction with itraconazole
203782|NCT02100553|Pharmacokinetic|pharmacokinetic
203783|NCT02100540|PMS|pms
203784|NCT02100540|hot flashes|hot flashes
203785|NCT02100527|safety|safety
203786|NCT02100527|tolerability|tolerability
203787|NCT02100527|pharmacokinetics|pharmacokinetics
203788|NCT02100527|oral dosing|oral dosing
203789|NCT02100527|moderate to severe acne vulgaris|moderate to severe acne vulgaris
203790|NCT02100514|Primary hyperlipidemia or mixed dyslipidemia|primary hyperlipidemia or mixed dyslipidemia
203791|NCT02100514|high risk of cardiovascular events|high risk of cardiovascular events
203792|NCT02100514|multiple cardiovascular disease risk factors.|multiple cardiovascular disease risk factors.
203793|NCT02100501|Seizure control through dietary therapy in pediatric intractable epilepsy patients.|seizure control through dietary therapy in pediatric intractable epilepsy patients.
676418|NCT00880399|placebo|placebo
203795|NCT02100488|Postprandial glucose control|postprandial glucose control
203796|NCT02100488|Glucose variability|glucose variability
203797|NCT02100462|Hypertension|hypertension
203798|NCT02100462|Platelet activation|platelet activation
203799|NCT02100462|Platelet aggregation|platelet aggregation
203800|NCT02100462|Chlorthalidone|chlorthalidone
203801|NCT02100449|Atelectasis|atelectasis
203802|NCT02100449|Pneumonia|pneumonia
203803|NCT02100449|Lung ultrasound|lung ultrasound
203805|NCT02100436|children|children
203806|NCT02100436|H3N2|h3n2
203807|NCT02100436|H3N2v|h3n2v
203808|NCT02100436|influenza|influenza
203809|NCT02100436|pediatric|pediatric
203810|NCT02100436|unadjuvanted|unadjuvanted
203811|NCT02100436|vaccine|vaccine
203812|NCT02100410|Contact Lens|contact lens
203813|NCT02100410|Toric|toric
203814|NCT02100397|Enteric fever|enteric fever
203815|NCT02100397|Paratyphoid|paratyphoid
203816|NCT02100397|Salmonella Paratyphi|salmonella paratyphi
203817|NCT02100397|Challenge study|challenge study
203818|NCT02100397|Human model of infection|human model of infection
203819|NCT02100384|peri implant|peri implant
203820|NCT02100384|Maintenance|maintenance
203821|NCT02100384|Ultrasonic|ultrasonic
203822|NCT02100384|Scalers|scalers
203823|NCT02100371|BMS-833923|bms-833923
203824|NCT02100371|CA194002|ca194002
203825|NCT02100358|acute cholecystitis|acute cholecystitis
203826|NCT02100332|Drug Therapy|drug therapy
203827|NCT02100319|Pharmacological therapy|pharmacological therapy
203828|NCT02100293|magnesium sulfate, rocuronium|magnesium sulfate, rocuronium
203829|NCT02100280|Neuromuscular blockade|neuromuscular blockade
203830|NCT02100280|Sugammadex|sugammadex
203831|NCT02100280|Laparoscopic surgery|laparoscopic surgery
203832|NCT02100280|IL-6|il-6
203833|NCT02100241|Young adult|young adult
203834|NCT02100241|Muscle Stretching Exercises|muscle stretching exercises
203835|NCT02100241|Range of Motion, Articular|range of motion, articular
203836|NCT02100228|apixaban|apixaban
203837|NCT02100228|oral anticoagulant|oral anticoagulant
203838|NCT02100228|non-valvular atrial fibrillation|non-valvular atrial fibrillation
203839|NCT02100228|cardioversion|cardioversion
203840|NCT02100215|simulation|simulation
203841|NCT02100215|competence|competence
203842|NCT02100215|self-efficacy|self-efficacy
203843|NCT02100215|novice nurses|novice nurses
203844|NCT02100202|Dietary supplements|dietary supplements
203845|NCT02100202|Cotinine level|cotinine level
203846|NCT02100202|Malondialdehyde|malondialdehyde
203847|NCT02100202|Chronic smokers|chronic smokers
203848|NCT02100202|Hyperlipidemia|hyperlipidemia
203849|NCT02100176|Rehabilitation treatment|rehabilitation treatment
203851|NCT02100150|Concussion|concussion
203852|NCT02100124|reproductive life planning|reproductive life planning
203853|NCT02100124|action planning|action planning
203854|NCT02100124|contraceptive use|contraceptive use
203855|NCT02100124|unintended pregnancy|unintended pregnancy
203856|NCT02100098|Ankle fracture|ankle fracture
203857|NCT02100098|Nerve block|nerve block
203858|NCT02100098|Postoperative pain|postoperative pain
203859|NCT02100098|Pain profile|pain profile
203860|NCT02100098|Rebound pain|rebound pain
203861|NCT02100085|Phase 1 follow up|phase 1 follow up
203862|NCT02100085|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
203863|NCT02100085|Adult|adult
203864|NCT02100085|Safety|safety
203865|NCT02100085|Efficacy|efficacy
203866|NCT02100059|meniscectomy|meniscectomy
203867|NCT02100059|arthroscopic partial meniscectomy|arthroscopic partial meniscectomy
203868|NCT02100059|meniscus|meniscus
203869|NCT02100046|Ethosuximide|ethosuximide
203870|NCT02100046|Neuropathic pain|neuropathic pain
203871|NCT02100046|Pain|pain
203872|NCT02100046|Quality of life|quality of life
203873|NCT02100046|Neuropathic Pain diagnostic questionnaire ≥ 4|neuropathic pain diagnostic questionnaire ≥ 4
203874|NCT02100046|Analgesic treatment failure for at least 3 months|analgesic treatment failure for at least 3 months
203875|NCT02100020|physical activity|physical activity
203876|NCT02100020|exercise guidelines|exercise guidelines
203877|NCT02100020|multiple sclerosis|multiple sclerosis
203878|NCT02100007|solid tumors|solid tumors
203879|NCT02100007|relapsed|relapsed
203880|NCT02100007|advanced|advanced
203881|NCT02100007|metastatic|metastatic
203882|NCT02100007|small cell lung cancer|small cell lung cancer
203883|NCT02100007|ovarian cancer|ovarian cancer
203884|NCT02100007|refractory|refractory
203885|NCT02099994|HIV|hiv
203886|NCT02099994|vaccine|vaccine
203887|NCT02099981|Diabetes|diabetes
203888|NCT02099981|Diabetic|diabetic
203889|NCT02099981|Retinopathy|retinopathy
203890|NCT02099981|Ophthalmology|ophthalmology
203891|NCT02099981|Eye|eye
203892|NCT02099981|Eyes|eyes
203893|NCT02099955|spinal cord injury|spinal cord injury
203894|NCT02099955|vitamin D deficiency|vitamin d deficiency
203895|NCT02099955|pulmonary function|pulmonary function
203896|NCT02099955|metabolic diseases|metabolic diseases
203905|NCT02099929|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
203906|NCT02099916|DHEA, pregnancy, ovarian reserve, AMH|dhea, pregnancy, ovarian reserve, amh
203907|NCT02099903|Heart Failure|heart failure
203908|NCT02099903|Heart Failure, Systolic|heart failure, systolic
203909|NCT02099903|Chagas Disease|chagas disease
203910|NCT02099903|Chagas Cardiomyopathy|chagas cardiomyopathy
203911|NCT02099903|Renal Denervation|renal denervation
203912|NCT02099903|Irrigated Radiofrequency Catheter|irrigated radiofrequency catheter
203913|NCT02099890|Chronic Inflammation|chronic inflammation
203914|NCT02099890|Spinal Cord Injury|spinal cord injury
203915|NCT02099890|Anti-inflammatory Diet|anti-inflammatory diet
203916|NCT02099890|Neuropathic Pain|neuropathic pain
203918|NCT02099890|Cognitive Impairment|cognitive impairment
203919|NCT02099890|Somatic Nerve Function|somatic nerve function
203920|NCT02099890|Autonomic Nerve Function|autonomic nerve function
203921|NCT02099877|µ-opioid receptor polymorphism|µ-opioid receptor polymorphism
203922|NCT02099877|Opioids|opioids
203923|NCT02099877|Opioid analgesia|opioid analgesia
203924|NCT02099877|Labor analgesia|labor analgesia
203925|NCT02099838|Pioglitazone|pioglitazone
203926|NCT02099838|Metformin|metformin
203927|NCT02099838|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
203928|NCT02099825|adult male|adult male
203929|NCT02099825|anxiety|anxiety
203930|NCT02099825|public speaking|public speaking
203931|NCT02099825|healthy controls|healthy controls
203932|NCT02099825|exposure therapy|exposure therapy
203933|NCT02099825|social anxiety|social anxiety
203934|NCT02099825|mifepristone|mifepristone
203935|NCT02099825|d-cycloserine|d-cycloserine
203936|NCT02099799|Physical Activity|physical activity
203937|NCT02099799|COPD Self-Management|copd self-management
203938|NCT02099799|Internet|internet
203939|NCT02099799|6-Minute Walk Test|6-minute walk test
203940|NCT02099799|COPD Exacerbation|copd exacerbation
203941|NCT02099799|Health-related Quality of Life|health-related quality of life
203942|NCT02099786|hearing|hearing
203943|NCT02099786|cisplatin|cisplatin
203944|NCT02099786|Ototoxicity|ototoxicity
203945|NCT02099786|Veterans|veterans
203947|NCT02099773|support worker|support worker
203948|NCT02099773|direct care staff|direct care staff
203949|NCT02099773|intellectual disability|intellectual disability
203950|NCT02099773|learning disability|learning disability
203951|NCT02099773|communication|communication
203952|NCT02099773|adults|adults
203953|NCT02099760|gonorrhea|gonorrhea
203954|NCT02099760|chlamydia|chlamydia
203955|NCT02099760|trichomonas|trichomonas
203956|NCT02099747|Aplastic Anaemia|aplastic anaemia
203957|NCT02099747|Eltrombopag|eltrombopag
203958|NCT02099747|HATG|hatg
203959|NCT02099747|ATGAM|atgam
203960|NCT02099734|14-016|14-016
203971|NCT02099708|Pharmacological therapy|pharmacological therapy
203972|NCT02099695|Hyperhidrosis|hyperhidrosis
203973|NCT02099695|Oxybutynin|oxybutynin
203974|NCT02099682|Pharmacological therapy|pharmacological therapy
203975|NCT02099604|Hepatitis C - Genotype 4|hepatitis c - genotype 4
203976|NCT02099604|SVR (Sustained Virological Response)|svr (sustained virological response)
203977|NCT02099604|Vitamin D|vitamin d
203978|NCT02099604|Treatment Naïve|treatment naïve
203979|NCT02099591|Constipation|constipation
203980|NCT02099591|Colonic Inertia|colonic inertia
203981|NCT02099591|Dyschezia|dyschezia
203982|NCT02099591|Pharmacokinetics|pharmacokinetics
203983|NCT02099591|Naloxegol|naloxegol
203984|NCT02099591|Paediatric|paediatric
203985|NCT02099591|Opioids|opioids
203986|NCT02099591|Opioid induced constipation|opioid induced constipation
203987|NCT02099591|OIC|oic
203988|NCT02099591|Phase 1|phase 1
203989|NCT02099578|Blood pressure|blood pressure
203990|NCT02099578|Arterial stiffness|arterial stiffness
203991|NCT02099578|Pulse wave velocity|pulse wave velocity
203992|NCT02099578|Strawberries|strawberries
203993|NCT02099578|Endothelial function|endothelial function
203994|NCT02099578|Oxidative stress|oxidative stress
203995|NCT02099578|Postmenopausal women|postmenopausal women
203996|NCT02099565|Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)|major adverse cardiovascular and cerebrovascular events (macce)
203997|NCT02099565|Statins|statins
203998|NCT02099565|LDL-cholesterol|ldl-cholesterol
203999|NCT02099565|Inflammatory markers|inflammatory markers
204000|NCT02099565|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
204001|NCT02099552|X-Linked hypohidrotic ectodermal dysplasia|x-linked hypohidrotic ectodermal dysplasia
204002|NCT02099552|XLHED|xlhed
204003|NCT02099552|Hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
204004|NCT02099552|HED|hed
204005|NCT02099552|Christ-Siemens-Touraine syndrome|christ-siemens-touraine syndrome
204413|NCT02097823|aprepitant|aprepitant
204006|NCT02099539|absolute lymphocyte count|absolute lymphocyte count
204007|NCT02099539|antitumor|antitumor
204009|NCT02099539|immunotherapy|immunotherapy
204010|NCT02099539|immunochemotherapy|immunochemotherapy
204011|NCT02099539|interleukin-15|interleukin-15
204012|NCT02099539|multiple myeloma|multiple myeloma
204013|NCT02099539|NK cell|nk cell
204014|NCT02099539|refractory|refractory
204015|NCT02099539|relapsed|relapsed
204016|NCT02099539|T cell|t cell
204017|NCT02099539|white blood cell count|white blood cell count
204018|NCT02099526|cancer|cancer
204019|NCT02099526|caregiver|caregiver
204020|NCT02099526|caregiving|caregiving
204021|NCT02099526|care give|care give
204022|NCT02099526|elderly|elderly
204023|NCT02099526|older adults|older adults
204024|NCT02099526|unmet needs|unmet needs
204025|NCT02099526|post-discharge|post-discharge
204026|NCT02099526|cancer symptoms|cancer symptoms
204027|NCT02099513|Mobile Technology|mobile technology
204028|NCT02099513|Chronic illness|chronic illness
204029|NCT02099513|Wireless blood pressure device|wireless blood pressure device
204030|NCT02099513|Wireless scale|wireless scale
204031|NCT02099513|Pedometer|pedometer
204032|NCT02099500|Critical Limb Ischemia|critical limb ischemia
204033|NCT02099500|Peripheral Vascular Disease|peripheral vascular disease
204034|NCT02099500|Lower Limb Ulcer|lower limb ulcer
204035|NCT02099500|Gangrene|gangrene
204036|NCT02099500|Amputation|amputation
204037|NCT02099500|Lower Limb Wound|lower limb wound
204038|NCT02099487|HGG|hgg
204039|NCT02099474|HIV-1|hiv-1
204040|NCT02099474|HIV mother to child prevention|hiv mother to child prevention
204041|NCT02099474|Raltegravir|raltegravir
204042|NCT02099474|Pharmacokinetic|pharmacokinetic
204043|NCT02099435|Gastriointestinal|gastriointestinal
204044|NCT02099435|Lower gastriointestinal|lower gastriointestinal
204045|NCT02099435|Digestive|digestive
204046|NCT02099435|Hemostasis|hemostasis
204047|NCT02099435|Recurrent bleeding|recurrent bleeding
204048|NCT02099435|Hemospray|hemospray
204049|NCT02099409|Type 1 diabetes mellitus|type 1 diabetes mellitus
204050|NCT02099409|children|children
204051|NCT02099409|closed loop|closed loop
204052|NCT02099409|cross over|cross over
204053|NCT02099409|overnight|overnight
204054|NCT02099409|FLORENCED2|florenced2
204055|NCT02099409|DANA Diabecare R pump|dana diabecare r pump
204056|NCT02099409|FreeStyle Navigator II|freestyle navigator ii
204057|NCT02099409|Dexcom G4|dexcom g4
204008|NCT02099539|cancer|cancer
204058|NCT02099396|PFS,efficacy and safety,lobaplatin and gemcitabine in combination, second-line treatments on advanced osteosarcoma|pfs,efficacy and safety,lobaplatin and gemcitabine in combination, second-line treatments on advanced osteosarcoma
204060|NCT02099383|Dehydration|dehydration
204061|NCT02099383|Fluid Therapy|fluid therapy
204062|NCT02099370|Multiple Sclerosis|multiple sclerosis
204063|NCT02099370|Tecfidera(R)|tecfidera(r)
204064|NCT02099370|Oral medication|oral medication
204065|NCT02099370|Adherence|adherence
204066|NCT02099331|Atrial Fibrillation|atrial fibrillation
204067|NCT02099331|Reactive Oxygen Species|reactive oxygen species
204068|NCT02099331|Cardiac Surgery|cardiac surgery
204069|NCT02099318|Rehearsal Platform|rehearsal platform
204070|NCT02099305|Adolescent; Depression|adolescent; depression
204071|NCT02099305|Early intervention (education)|early intervention (education)
204072|NCT02099305|Randomized Controlled Trial|randomized controlled trial
204073|NCT02099305|Primary Prevention|primary prevention
204074|NCT02099305|schools|schools
204075|NCT02099305|Health Literacy|health literacy
204076|NCT02099305|Discrimination (Psychology)|discrimination (psychology)
204077|NCT02099305|Mental Health Services|mental health services
204078|NCT02099292|lymphoma|lymphoma
204079|NCT02099292|high dose therapy|high dose therapy
204080|NCT02099292|DexaBEAM|dexabeam
204081|NCT02099292|Rituximab|rituximab
204082|NCT02099292|role of alternative salvage treatment - dexaBEAM|role of alternative salvage treatment - dexabeam
204083|NCT02099266|Umbilical Cord Blood (UCB) Stem Cell Transplant|umbilical cord blood (ucb) stem cell transplant
204084|NCT02099266|Hyperbaric oxygen|hyperbaric oxygen
204085|NCT02099266|Leukemia|leukemia
204086|NCT02099266|Lymphoma|lymphoma
204087|NCT02099266|MDS|mds
204088|NCT02099253|Age|age
204089|NCT02099253|Pharmacodynamics|pharmacodynamics
204090|NCT02099253|dexmedetomidine|dexmedetomidine
204091|NCT02099240|Osteomyelitis|osteomyelitis
204092|NCT02099240|IV Antibiotics|iv antibiotics
204093|NCT02099240|Oral Antibiotics|oral antibiotics
204094|NCT02099227|pediatric|pediatric
676419|NCT00880399|safety|safety
204095|NCT02099227|soft tissue infections|soft tissue infections
204096|NCT02099227|ultrasonography|ultrasonography
204097|NCT02099227|effectiveness|effectiveness
204098|NCT02099214|myocardial iron overload|myocardial iron overload
204099|NCT02099214|HFE-Associated Hereditary Hemochromatosis|hfe-associated hereditary hemochromatosis
204100|NCT02099214|3 Tesla MRI|3 tesla mri
204101|NCT02099214|cardiological strategy in haemochromatosis|cardiological strategy in haemochromatosis
204102|NCT02099214|congestive heart failure|congestive heart failure
204103|NCT02099201|ACT-389949|act-389949
204104|NCT02099162|OCT|oct
204105|NCT02099162|Coronary|coronary
204107|NCT02099149|Group B Streptococcus|group b streptococcus
204108|NCT02099149|early onset disease|early onset disease
204109|NCT02099149|late onset disease|late onset disease
204110|NCT02099149|anticapsular antibodies|anticapsular antibodies
204111|NCT02099149|serotype specific|serotype specific
204112|NCT02099123|Survival|survival
204113|NCT02099123|Functional Disability|functional disability
204114|NCT02099123|Cardiovascular Disease|cardiovascular disease
204115|NCT02099123|Diabetes|diabetes
204116|NCT02099123|Dementia|dementia
204117|NCT02099123|Cancer|cancer
204118|NCT02099097|3D Coping Skills Game|3d coping skills game
204119|NCT02099097|Quit smoking|quit smoking
204120|NCT02099097|14-062|14-062
204121|NCT02099071|ACT-389949|act-389949
204122|NCT02099058|Advanced Solid Tumor|advanced solid tumor
204123|NCT02099058|Neoplasm|neoplasm
204124|NCT02099058|Cancer|cancer
204125|NCT02099032|nutrition|nutrition
204126|NCT02099032|milk|milk
204127|NCT02099032|polar lipids|polar lipids
204128|NCT02099032|cardiometabolic risk|cardiometabolic risk
204129|NCT02099019|Coronary CT angiography; Revascularization; Decision-making|coronary ct angiography; revascularization; decision-making
204130|NCT02098993|Sickle cell disease|sickle cell disease
204131|NCT02098993|Acute chest syndrome|acute chest syndrome
204132|NCT02098993|Hemoglobinopathy|hemoglobinopathy
204133|NCT02098993|Hemolytic anemia|hemolytic anemia
204134|NCT02098993|Heparin|heparin
204135|NCT02098993|Anticoagulant|anticoagulant
204137|NCT02098954|resistance|resistance
204138|NCT02098954|erlotinib|erlotinib
204139|NCT02098954|combined chemotherapy|combined chemotherapy
204140|NCT02098941|topiramate|topiramate
204141|NCT02098941|oxcarbazepine|oxcarbazepine
204142|NCT02098941|levetiracetam|levetiracetam
204143|NCT02098941|retention rate|retention rate
204144|NCT02098928|Acupuncture|acupuncture
204145|NCT02098928|Electro acupuncture|electro acupuncture
204146|NCT02098928|Menopause|menopause
204147|NCT02098915|gastroschisis|gastroschisis
204148|NCT02098915|intestinal motility|intestinal motility
204149|NCT02098915|prokinetic agents|prokinetic agents
204150|NCT02098915|intravenous metoclopramide|intravenous metoclopramide
204151|NCT02098915|time to full enteral feeding|time to full enteral feeding
204152|NCT02098902|Overweight|overweight
204153|NCT02098902|Obesity|obesity
204154|NCT02098902|Overnutrition|overnutrition
204155|NCT02098902|Weight Loss|weight loss
204156|NCT02098902|Body Weight|body weight
204160|NCT02098876|angulated coronary vessels|angulated coronary vessels
204161|NCT02098876|wall shear stress|wall shear stress
204162|NCT02098876|zotarolimus eluting stent|zotarolimus eluting stent
204163|NCT02098876|everolimus eluting stent|everolimus eluting stent
204164|NCT02098863|Sickle Cell Anemia|sickle cell anemia
204165|NCT02098863|Sickle Cell Disease|sickle cell disease
204167|NCT02098863|Mortality|mortality
204168|NCT02098863|End-Order Dysfunction|end-order dysfunction
204169|NCT02098850|Staphylococcus aureus|staphylococcus aureus
204170|NCT02098850|bloodstream infection|bloodstream infection
204171|NCT02098850|bacteremia|bacteremia
204172|NCT02098837|HIV|hiv
204173|NCT02098824|vascular cognitive impairment|vascular cognitive impairment
204174|NCT02098824|treatment|treatment
204175|NCT02098824|cerebrovascular lesions|cerebrovascular lesions
204176|NCT02098824|memory impairment|memory impairment
204177|NCT02098824|executive dysfunction|executive dysfunction
204178|NCT02098824|neuronal networks|neuronal networks
204179|NCT02098824|white matter tracts|white matter tracts
204180|NCT02098824|monoaminergic systems|monoaminergic systems
204181|NCT02098824|cholinergic systems|cholinergic systems
204182|NCT02098824|DTI|dti
204183|NCT02098824|rs-fMRI|rs-fmri
204184|NCT02098798|Dysplasia, Inflammatory Bowel Disease|dysplasia, inflammatory bowel disease
204185|NCT02098785|VAP|vap
204186|NCT02098785|liver|liver
204187|NCT02098785|hepatology|hepatology
204188|NCT02098785|caffeine|caffeine
204189|NCT02098772|aortic valve disease|aortic valve disease
204190|NCT02098772|coronary bypass surgery|coronary bypass surgery
204191|NCT02098772|cardioplegic solutions|cardioplegic solutions
204192|NCT02098759|TSC|tsc
204193|NCT02098759|tuberous sclerosis complex|tuberous sclerosis complex
204194|NCT02098759|epilepsy|epilepsy
204195|NCT02098746|Pharmacological therapy|pharmacological therapy
204196|NCT02098733|Pharmacological therapy|pharmacological therapy
204197|NCT02098707|Stabilometric Platform|stabilometric platform
204198|NCT02098707|Rehabilitation|rehabilitation
204199|NCT02098707|Balance Disorders|balance disorders
204200|NCT02098707|Falls|falls
204201|NCT02098694|Physiotherapy|physiotherapy
204202|NCT02098694|Outpatient clinic|outpatient clinic
204203|NCT02098681|Pectus Excavatum|pectus excavatum
204204|NCT02098668|menstrual cycle dynamics|menstrual cycle dynamics
204205|NCT02098668|PCOS|pcos
204206|NCT02098668|hyperprolactinemia|hyperprolactinemia
204212|NCT02098642|Metatarsophalangeal joint|metatarsophalangeal joint
204213|NCT02098629|Myocardial infarction|myocardial infarction
204214|NCT02098629|myocardial ischemia|myocardial ischemia
204215|NCT02098629|reperfusion injury|reperfusion injury
204216|NCT02098616|Hepatitis|hepatitis
204217|NCT02098616|Hepatitis, Chronic|hepatitis, chronic
204218|NCT02098616|Hepatitis C|hepatitis c
204219|NCT02098616|Hepatitis C, Chronic|hepatitis c, chronic
204220|NCT02098616|Liver Diseases|liver diseases
204221|NCT02098616|Digestive System Diseases|digestive system diseases
204222|NCT02098616|Hepatitis, Viral, Human|hepatitis, viral, human
204223|NCT02098616|RNA Virus Infections|rna virus infections
204224|NCT02098616|Antiviral Agents|antiviral agents
204225|NCT02098616|Drug Resistance, Viral|drug resistance, viral
204226|NCT02098590|Malaria|malaria
204227|NCT02098590|Plasmodium falciparum|plasmodium falciparum
204228|NCT02098577|Balance|balance
204229|NCT02098564|hand therapy|hand therapy
204230|NCT02098564|activity-based training|activity-based training
204231|NCT02098564|hand related injuries|hand related injuries
204232|NCT02098564|sense of coherence|sense of coherence
204233|NCT02098551|atopic dermatitis|atopic dermatitis
204234|NCT02098551|bet v 1|bet v 1
204235|NCT02098551|bet v 1 fragments|bet v 1 fragments
204236|NCT02098551|allergy|allergy
204237|NCT02098538|Regorafenib|regorafenib
204238|NCT02098538|13-244|13-244
204239|NCT02098525|Cryptococcal meningitis|cryptococcal meningitis
204240|NCT02098525|HIV/AIDS|hiv/aids
204241|NCT02098525|Antiretroviral therapy|antiretroviral therapy
204242|NCT02098525|Prognosis|prognosis
204243|NCT02098525|Thailand|thailand
204244|NCT02098512|Brentuximab Vedotin|brentuximab vedotin
204245|NCT02098512|Immunotherapy|immunotherapy
204246|NCT02098512|Relapsed Hodgkin Lymphoma|relapsed hodgkin lymphoma
204247|NCT02098512|Refractory Hodgkin Lymphoma|refractory hodgkin lymphoma
204248|NCT02098512|Reduced Intensity Conditioning|reduced intensity conditioning
204249|NCT02098512|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
204250|NCT02098486|Bile duct obstruction|bile duct obstruction
204251|NCT02098486|Cholangitis|cholangitis
204252|NCT02098486|Moxifloxacin|moxifloxacin
204253|NCT02098486|Ceftriaxone|ceftriaxone
204254|NCT02098486|Sepsis|sepsis
204255|NCT02098460|the Achilles tendon|the achilles tendon
204256|NCT02098460|intima-media thickness|intima-media thickness
204257|NCT02098447|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion
204258|NCT02098421|Induction of Labor|induction of labor
204259|NCT02098421|Pitocin|pitocin
204260|NCT02098421|Oxytocin|oxytocin
204261|NCT02098421|Foley bulb|foley bulb
204262|NCT02098408|Ultra-high risk psychosis|ultra-high risk psychosis
204263|NCT02098408|Schizophrenia prodrome|schizophrenia prodrome
204264|NCT02098408|Cognitive remediation|cognitive remediation
204265|NCT02098382|Cervical ripening|cervical ripening
204266|NCT02098369|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
204267|NCT02098369|Supplemental oxygen|supplemental oxygen
204268|NCT02098369|Adherence|adherence
204269|NCT02098369|Telephonic education|telephonic education
204270|NCT02098369|Peer coaching|peer coaching
204271|NCT02098356|hemodialysis|hemodialysis
204272|NCT02098356|dialysis|dialysis
204273|NCT02098356|acidosis|acidosis
204274|NCT02098356|bicarbonate|bicarbonate
204280|NCT02098330|Vestibular neuritis|vestibular neuritis
204281|NCT02098330|Vertigo|vertigo
204282|NCT02098330|Head impulse test|head impulse test
204283|NCT02098330|Steroid|steroid
204284|NCT02098317|NAFLD|nafld
204285|NCT02098317|NASH|nash
204286|NCT02098317|DHA|dha
204287|NCT02098317|VITAMIN D|vitamin d
204288|NCT02098317|OBESITY|obesity
204289|NCT02098317|CHILDREN|children
204290|NCT02098304|Caries|caries
204291|NCT02098304|ICDAS|icdas
204292|NCT02098304|Lesion activity|lesion activity
204293|NCT02098304|Demineralisation|demineralisation
204294|NCT02098304|Imaging|imaging
204295|NCT02098265|aneurysm|aneurysm
204296|NCT02098265|transient ischemic attack|transient ischemic attack
204297|NCT02098252|brain arteriovenous malformation|brain arteriovenous malformation
204298|NCT02098252|Arteriovenous Malformations|arteriovenous malformations
204299|NCT02098252|AVM|avm
204300|NCT02098252|BAVM|bavm
204301|NCT02098252|Stroke|stroke
204302|NCT02098252|Intracranial Hemorrhage|intracranial hemorrhage
676420|NCT00880412|safety|safety
204303|NCT02098252|Congenital Abnormalities|congenital abnormalities
204304|NCT02098252|Aneurysm|aneurysm
204305|NCT02098252|Vascular Malformations|vascular malformations
204414|NCT02097823|pediatrics|pediatrics
204306|NCT02098252|Cardiovascular Abnormalities|cardiovascular abnormalities
204307|NCT02098252|Cardiovascular Diseases|cardiovascular diseases
204308|NCT02098252|Vascular Diseases|vascular diseases
204309|NCT02098213|plaque psoriasis|plaque psoriasis
204310|NCT02098213|DLQI|dlqi
204311|NCT02098213|VQ Dermato|vq dermato
204312|NCT02098213|PASI|pasi
204313|NCT02098213|PASI change|pasi change
204314|NCT02098213|phototherapy|phototherapy
204315|NCT02098213|balneotherapy|balneotherapy
204316|NCT02098213|hydrotherapy|hydrotherapy
204317|NCT02098213|Euroquol EQ 5d scale|euroquol eq 5d scale
204318|NCT02098213|Visual analogic scale|visual analogic scale
204319|NCT02098213|SPA treatment Scale|spa treatment scale
204320|NCT02098213|PSS|pss
204321|NCT02098200|tricuspid|tricuspid
204322|NCT02098200|regurgitation|regurgitation
204323|NCT02098200|repair|repair
204324|NCT02098200|outcomes|outcomes
204325|NCT02098187|Glomerular Filtration Rate|glomerular filtration rate
204326|NCT02098187|Acute Kidney Injury|acute kidney injury
204327|NCT02098174|Glomerular Filtration Rate|glomerular filtration rate
204328|NCT02098174|Acute kidney injury|acute kidney injury
204329|NCT02098161|Leukemia|leukemia
204330|NCT02098161|Primary Myelofibrosis|primary myelofibrosis
204331|NCT02098161|PMF|pmf
204332|NCT02098161|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
204333|NCT02098161|Post-PV MF|post-pv mf
204334|NCT02098161|Post-Essential Thrombocytosis Myelofibrosis|post-essential thrombocytosis myelofibrosis
204335|NCT02098161|Post-ET MF|post-et mf
204336|NCT02098161|LCL-161|lcl-161
250097|NCT01888744|PGD|pgd
204337|NCT02098161|Questionnaire|questionnaire
204338|NCT02098161|Survey|survey
204339|NCT02098161|Phone Call|phone call
204340|NCT02098096|knee|knee
204341|NCT02098096|arthritis|arthritis
204342|NCT02098096|Veterans|veterans
204343|NCT02098096|strength|strength
204344|NCT02098096|exercise|exercise
204345|NCT02098096|muscle|muscle
204346|NCT02098083|acute|acute
204347|NCT02098083|stroke|stroke
204348|NCT02098083|gait|gait
204349|NCT02098070|Knee Pain|knee pain
204350|NCT02098070|Community Study|community study
204351|NCT02098070|Knee Osteoarthritis|knee osteoarthritis
204352|NCT02098070|Risk Factors|risk factors
204353|NCT02098057|IBS-diarrhea|ibs-diarrhea
204354|NCT02098044|knee osteoarthritis|knee osteoarthritis
204355|NCT02098044|epidemiology|epidemiology
204356|NCT02098044|risk factors|risk factors
204357|NCT02098044|prevalence|prevalence
204358|NCT02098044|professional football|professional football
204359|NCT02098031|Child Nutrition Sciences|child nutrition sciences
204360|NCT02098031|Growth and Development|growth and development
204361|NCT02098031|Developing Countries|developing countries
204362|NCT02097992|COPD|copd
204363|NCT02097992|airway blood flow|airway blood flow
204364|NCT02097979|glaucoma|glaucoma
204365|NCT02097979|adherence|adherence
204366|NCT02097979|medication possession ratio|medication possession ratio
204367|NCT02097979|intervention|intervention
204368|NCT02097953|Daptomycin|daptomycin
204369|NCT02097953|Rifampin|rifampin
204370|NCT02097953|P-glycoprotein|p-glycoprotein
204371|NCT02097953|Pharmacokinetic|pharmacokinetic
204372|NCT02097940|Postural balance|postural balance
204373|NCT02097940|Athletes|athletes
204374|NCT02097940|Sports|sports
204375|NCT02097940|Soccer|soccer
204376|NCT02097940|Physiotherapy|physiotherapy
204377|NCT02097927|Appetite|appetite
204378|NCT02097927|Satiety|satiety
204379|NCT02097927|Energy intake|energy intake
204380|NCT02097927|Saliva|saliva
204381|NCT02097927|Biomarkers|biomarkers
204382|NCT02097914|Secondhand smoke exposure|secondhand smoke exposure
204383|NCT02097914|Secondhand smoke|secondhand smoke
204384|NCT02097914|Environmental Tobacco Smoke|environmental tobacco smoke
204385|NCT02097914|Smoke-free homes|smoke-free homes
204386|NCT02097914|Smoke-free homes ban|smoke-free homes ban
204387|NCT02097901|Rotator Cuff|rotator cuff
204388|NCT02097901|Injury|injury
204389|NCT02097901|Repair|repair
204390|NCT02097901|Microfracture|microfracture
204391|NCT02097901|Healing|healing
204392|NCT02097875|Skin cancer|skin cancer
204393|NCT02097875|Basal cell carcinoma|basal cell carcinoma
204394|NCT02097875|Squamous cell carcinoma|squamous cell carcinoma
204395|NCT02097875|Melanoma|melanoma
204496|NCT02097381|CD4+|cd4+
204396|NCT02097862|Degenerative Disc Disease|degenerative disc disease
204397|NCT02097862|Disc Disease|disc disease
204398|NCT02097862|Back pain|back pain
204399|NCT02097862|stem cells|stem cells
204400|NCT02097862|adipose stem cells|adipose stem cells
204401|NCT02097862|ADSCs|adscs
204402|NCT02097849|vaccine|vaccine
204403|NCT02097849|pneumococcal|pneumococcal
204404|NCT02097849|meningococcal|meningococcal
204405|NCT02097849|tetanus diphtheria|tetanus diphtheria
204406|NCT02097849|immune response|immune response
204407|NCT02097836|postural control|postural control
204408|NCT02097836|Targeted Training|targeted training
204409|NCT02097836|cerebral palsy|cerebral palsy
204410|NCT02097836|trunk segments|trunk segments
204411|NCT02097823|olanzapine|olanzapine
204412|NCT02097823|Nausea and vomiting|nausea and vomiting
204415|NCT02097797|Inflammatory bowel disease|inflammatory bowel disease
204416|NCT02097797|Crohn's disease|crohn's disease
204417|NCT02097797|microbiota|microbiota
204418|NCT02097797|fecal transplantation|fecal transplantation
204419|NCT02097784|cirrhosis|cirrhosis
204420|NCT02097784|hepatorenal syndrome|hepatorenal syndrome
204421|NCT02097784|acute kidney injury|acute kidney injury
204422|NCT02097784|diastolic function|diastolic function
204423|NCT02097771|laryngeal mask airway ventilation|laryngeal mask airway ventilation
204424|NCT02097732|Metastatic melanoma|metastatic melanoma
204425|NCT02097732|Brain metastases|brain metastases
204426|NCT02097732|Radiation therapy|radiation therapy
204427|NCT02097732|Immune therapy|immune therapy
204428|NCT02097706|Boderline Personality Disorder|boderline personality disorder
204429|NCT02097706|Mental Illness|mental illness
204430|NCT02097706|Cognition|cognition
204431|NCT02097693|DBS|dbs
204432|NCT02097693|quality of life|quality of life
204433|NCT02097693|dystonia|dystonia
204434|NCT02097693|dyskinetic cerebral palsy|dyskinetic cerebral palsy
204435|NCT02097680|with disturbed glucose metabolism|with disturbed glucose metabolism
204436|NCT02097680|without disturbed glucose metabolism|without disturbed glucose metabolism
204437|NCT02097667|Severe early onset Fetal Growth Restrictions|severe early onset fetal growth restrictions
204438|NCT02097654|Hospital acquired|hospital acquired
204439|NCT02097654|Elderly|elderly
204440|NCT02097641|Allogeneic Bone Marrow-derived Human Mesenchymal Stem Cells|allogeneic bone marrow-derived human mesenchymal stem cells
204441|NCT02097641|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
204442|NCT02097628|volume controlled ventilation|volume controlled ventilation
204443|NCT02097628|pressure controlled ventilation|pressure controlled ventilation
204444|NCT02097615|soft|soft
204445|NCT02097615|tissue|tissue
204446|NCT02097615|infections|infections
204447|NCT02097602|Reticulated platelets|reticulated platelets
204448|NCT02097602|noncardiac surgery|noncardiac surgery
204449|NCT02097602|MACCEs|macces
204450|NCT02097602|major adverse cardiac and cerebrovascular events|major adverse cardiac and cerebrovascular events
204451|NCT02097602|outcome|outcome
204452|NCT02097602|High-risk or intermediate-risk noncardiac surgery|high-risk or intermediate-risk noncardiac surgery
204453|NCT02097589|Health Controls|health controls
204454|NCT02097576|Chronic Rhinosinusitis|chronic rhinosinusitis
204455|NCT02097563|Mood Disorders|mood disorders
204456|NCT02097563|Psychosis|psychosis
204457|NCT02097563|Subthreshold|subthreshold
204458|NCT02097563|Bipolar Disorder|bipolar disorder
204459|NCT02097550|Renal Insufficiency, Chronic|renal insufficiency, chronic
204460|NCT02097550|Kidney Failure, Chronic|kidney failure, chronic
204461|NCT02097550|Self Care|self care
204462|NCT02097550|Consumer Participation|consumer participation
204463|NCT02097550|Patient Participation|patient participation
204464|NCT02097550|Marketing|marketing
204465|NCT02097550|Consumer Health Information|consumer health information
204466|NCT02097511|Drug-drug interaction|drug-drug interaction
204467|NCT02097511|Pharmacokinetics|pharmacokinetics
204468|NCT02097511|Pharmacodynamics|pharmacodynamics
204469|NCT02097498|Simulation|simulation
204470|NCT02097498|Enhance|enhance
204471|NCT02097498|Safety|safety
204472|NCT02097498|Proficiency|proficiency
204473|NCT02097498|Paramedics.|paramedics.
204474|NCT02097498|Airway Management|airway management
204475|NCT02097498|Intubation|intubation
204476|NCT02097459|Breast cancer|breast cancer
204477|NCT02097459|Endocrine therapy|endocrine therapy
204478|NCT02097459|Perimenopausal and recently postmenopausal patients|perimenopausal and recently postmenopausal patients
204479|NCT02097459|Early-stage hormone receptor-positive|early-stage hormone receptor-positive
204480|NCT02097446|cystectomy|cystectomy
204481|NCT02097433|Dacomitinib|dacomitinib
204482|NCT02097433|PF299804|pf299804
204483|NCT02097433|pharmacokinetics|pharmacokinetics
204484|NCT02097433|healthy|healthy
204485|NCT02097433|Chinese|chinese
204486|NCT02097420|Mitral valve|mitral valve
204487|NCT02097381|HIV infection|hiv infection
204488|NCT02097381|GUT|gut
204489|NCT02097381|microbial translocation|microbial translocation
204490|NCT02097381|chronic inflammation|chronic inflammation
204491|NCT02097381|antiretroviral therapy|antiretroviral therapy
204492|NCT02097381|cART|cart
204493|NCT02097381|HAART|haart
204494|NCT02097381|Th17|th17
204495|NCT02097381|Th1|th1
204497|NCT02097368|Tongue strength|tongue strength
204498|NCT02097368|neuromuscular|neuromuscular
204499|NCT02097368|swallowing|swallowing
204500|NCT02097355|chronic disease|chronic disease
204501|NCT02097355|patient portal|patient portal
204502|NCT02097355|health information technology|health information technology
204503|NCT02097355|patient provider communication|patient provider communication
204504|NCT02097355|quality improvement|quality improvement
204505|NCT02097342|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
204506|NCT02097342|Insulin sensitivity- hyperinsulinemic euglycemic clamp|insulin sensitivity- hyperinsulinemic euglycemic clamp
204507|NCT02097342|Pancreatic beta cell function|pancreatic beta cell function
204508|NCT02097342|Linagliptin|linagliptin
204509|NCT02097342|Voglibose|voglibose
204510|NCT02097342|Mixed meal test|mixed meal test
204511|NCT02097342|GLP-1 response|glp-1 response
204512|NCT02097329|bioavailability|bioavailability
204513|NCT02097329|antacid|antacid
204514|NCT02097329|rabeprazole|rabeprazole
204515|NCT02097329|famotidine|famotidine
204516|NCT02097329|palbociclib|palbociclib
204517|NCT02097316|Glycemic control|glycemic control
204518|NCT02097316|JewelPump accuracy|jewelpump accuracy
204519|NCT02097303|Prostate Cancer|prostate cancer
204520|NCT02097303|Bone Metastasis|bone metastasis
204521|NCT02097303|Symptomatic|symptomatic
204522|NCT02097303|Androgen Independent|androgen independent
204523|NCT02097303|Hormone Refractory|hormone refractory
204524|NCT02097303|Castrate Resistant|castrate resistant
204525|NCT02097303|AIPC|aipc
204526|NCT02097303|pre-chemotherapy|pre-chemotherapy
204527|NCT02097303|Post-chemotherapy|post-chemotherapy
204528|NCT02097290|Threshold algorithms|threshold algorithms
204529|NCT02097290|CRT-D|crt-d
204530|NCT02097251|Mucopolysaccharidosis Type 7|mucopolysaccharidosis type 7
204531|NCT02097251|Sly syndrome|sly syndrome
204532|NCT02097251|UX003|ux003
204533|NCT02097251|Enzyme Replacement Therapy|enzyme replacement therapy
204534|NCT02097251|rare disease|rare disease
204535|NCT02097251|Lysosomal Storage Disease|lysosomal storage disease
204536|NCT02097251|metabolic disorder|metabolic disorder
204537|NCT02097212|Tracheobronchomalacia|tracheobronchomalacia
204538|NCT02097212|TBM|tbm
204539|NCT02097212|HyperDynamic Airway Collapse|hyperdynamic airway collapse
204540|NCT02097212|HDAC|hdac
204541|NCT02097212|Obstructive Sleep Apnea|obstructive sleep apnea
204542|NCT02097212|OSA|osa
204543|NCT02097199|activity, osteoprotegerin, endocan, atherosclerosis, biomarker|activity, osteoprotegerin, endocan, atherosclerosis, biomarker
204544|NCT02097186|Vascular disease|vascular disease
204545|NCT02097186|Open aortic aneurysm repair|open aortic aneurysm repair
204546|NCT02097186|Endovascular aneurysm repair|endovascular aneurysm repair
204547|NCT02097186|Carotid endartrectomy|carotid endartrectomy
204548|NCT02097186|Lower limb surgical revascularisation|lower limb surgical revascularisation
204549|NCT02097186|Major lower limb amputation|major lower limb amputation
204550|NCT02097160|childhood|childhood
204551|NCT02097160|healthy|healthy
204552|NCT02097160|vitamin D|vitamin d
204553|NCT02097160|bone|bone
204554|NCT02097160|dairy products|dairy products
204555|NCT02097147|Viibryd|viibryd
204556|NCT02097108|HIV infection|hiv infection
204557|NCT02097108|Raltegravir|raltegravir
204558|NCT02097108|Switch|switch
204559|NCT02097108|Hyperlipidemia|hyperlipidemia
204560|NCT02097108|Women|women
204561|NCT02097095|Correlates of risk|correlates of risk
204562|NCT02097095|TB|tb
204563|NCT02097095|Tuberculosis|tuberculosis
204564|NCT02097095|Sub-study|sub-study
204565|NCT02097095|TB-018|tb-018
204566|NCT02097082|Peripheral Arterial Disease|peripheral arterial disease
204567|NCT02097082|Intermittent Claudication|intermittent claudication
204568|NCT02097082|Vascular Diseases|vascular diseases
204569|NCT02097082|Cardiovascular Diseases|cardiovascular diseases
204570|NCT02097082|Superficial Femoral Artery|superficial femoral artery
204571|NCT02097069|Gestational diabetes mellitus|gestational diabetes mellitus
204572|NCT02097069|Myo-inositol|myo-inositol
204573|NCT02097069|D-chiro-inositol|d-chiro-inositol
204574|NCT02097069|Insulin resistance|insulin resistance
204575|NCT02097056|Alzheimer's disease|alzheimer's disease
204576|NCT02097017|lidocaine|lidocaine
204577|NCT02097017|laminaria|laminaria
204578|NCT02097017|dilatation and evacuation|dilatation and evacuation
204579|NCT02097017|pain|pain
204580|NCT02097004|chronic hepatitis B|chronic hepatitis b
204581|NCT02097004|Pegasys|pegasys
204582|NCT02097004|Euvax B|euvax b
204583|NCT02097004|Baracrude|baracrude
204584|NCT02096978|Implant|implant
204585|NCT02096978|Stability|stability
204586|NCT02096978|placement|placement
204587|NCT02096978|Osteotome|osteotome
204588|NCT02096965|Calcium oxalate|calcium oxalate
204589|NCT02096965|Calcium phosphate|calcium phosphate
204590|NCT02096965|Kidney stone|kidney stone
204591|NCT02096952|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
204592|NCT02096952|ADHD|adhd
204593|NCT02096952|Autism spectrum disorder|autism spectrum disorder
204595|NCT02096952|High-functioning ASD|high-functioning asd
204596|NCT02096952|Asperger's disorder|asperger's disorder
204597|NCT02096952|Asperger's|asperger's
204598|NCT02096926|Third Molar Extraction|third molar extraction
204599|NCT02096913|Rho-Inhibition|rho-inhibition
204600|NCT02096913|Plasticity|plasticity
204601|NCT02096913|Neurological Function|neurological function
204602|NCT02096913|RhoA|rhoa
204603|NCT02096913|Ibuprofen|ibuprofen
204604|NCT02096913|NSAIDs|nsaids
204605|NCT02096900|Pre-medication|pre-medication
676421|NCT00880412|efficacy|efficacy
204606|NCT02096900|Pre-operative anxiety|pre-operative anxiety
204607|NCT02096887|education|education
204608|NCT02096887|compliance|compliance
204609|NCT02096887|risk factors|risk factors
204610|NCT02096874|Peripheral retinal ischemia|peripheral retinal ischemia
204611|NCT02096874|ultra wide field fluorescein angiography|ultra wide field fluorescein angiography
204612|NCT02096874|Bevacizumab|bevacizumab
204613|NCT02096848|otitis media|otitis media
204614|NCT02096848|microbiology|microbiology
204615|NCT02096848|vaccines|vaccines
204616|NCT02096835|Postoperative nausea and vomiting|postoperative nausea and vomiting
204617|NCT02096835|Transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
204618|NCT02096835|Gynecological laparoscopic surgery|gynecological laparoscopic surgery
204619|NCT02096835|Tropisetron|tropisetron
204620|NCT02096835|Dexamethasone|dexamethasone
204621|NCT02096822|Facilitated tucking|facilitated tucking
204622|NCT02096822|Non nutritive sucking|non nutritive sucking
204623|NCT02096822|Preterm|preterm
204624|NCT02096822|Pain relief|pain relief
204625|NCT02096809|Bone Conduction|bone conduction
204626|NCT02096809|Hearing loss - conductive|hearing loss - conductive
204627|NCT02096809|Osseointegration|osseointegration
204628|NCT02096809|Prostheses and Implants|prostheses and implants
204629|NCT02096757|Claudication|claudication
204630|NCT02096757|Critical Limb Ischemia|critical limb ischemia
204631|NCT02096757|Endovascular procedure|endovascular procedure
204632|NCT02096757|Atherosclerosis|atherosclerosis
204633|NCT02096679|Phase I, healthy, pharmacokinetics, Mass balance|phase i, healthy, pharmacokinetics, mass balance
204634|NCT02096666|MET Amplified Gastric/ Gastroesophageal Junction/ Esophageal Adenocarcinomas, or other solid tumors|met amplified gastric/ gastroesophageal junction/ esophageal adenocarcinomas, or other solid tumors
204635|NCT02096653|sacroiliac joint|sacroiliac joint
204636|NCT02096653|low back pain|low back pain
204637|NCT02096653|steroid injection|steroid injection
204638|NCT02096627|Cataract, femtosecond laser, FLACS|cataract, femtosecond laser, flacs
204639|NCT02096614|Adoptive cell transfer|adoptive cell transfer
204640|NCT02096614|Cell therapy|cell therapy
204641|NCT02096614|Immunotherapy|immunotherapy
204642|NCT02096614|MAGE-A4|mage-a4
204643|NCT02096614|Esophageal cancer|esophageal cancer
204644|NCT02096614|Melanoma|melanoma
204645|NCT02096614|Head and neck cancer|head and neck cancer
204646|NCT02096614|Ovarian cancer|ovarian cancer
204647|NCT02096614|TCR gene therapy|tcr gene therapy
204648|NCT02096601|Motor fluctuations|motor fluctuations
204649|NCT02096601|levodopa pharmacokinetics|levodopa pharmacokinetics
204650|NCT02096601|levodopa and carbidopa solution|levodopa and carbidopa solution
204651|NCT02096601|continuous subcutaneous delivery|continuous subcutaneous delivery
204652|NCT02096588|Breast cancer|breast cancer
204653|NCT02096588|Adriamycin|adriamycin
204654|NCT02096588|Simvastatin|simvastatin
204655|NCT02096588|Statin|statin
204656|NCT02096588|Echocardiogram|echocardiogram
204657|NCT02096575|nitrous oxide|nitrous oxide
204658|NCT02096575|pain|pain
204659|NCT02096562|knee welling outpatient compression stockings|knee welling outpatient compression stockings
204660|NCT02096549|cerebral palsy|cerebral palsy
204661|NCT02096549|Botulinum toxin|botulinum toxin
204662|NCT02096549|Propofol|propofol
204663|NCT02096549|Deep sedation|deep sedation
204664|NCT02096549|Bispectral index monitor|bispectral index monitor
204665|NCT02096536|Neonate|neonate
204666|NCT02096536|Vancomycin|vancomycin
204667|NCT02096536|LC/MS-MS|lc/ms-ms
204668|NCT02096536|protein binding|protein binding
204669|NCT02096523|inherited platelet disorders|inherited platelet disorders
204670|NCT02096523|proteome|proteome
204671|NCT02096510|Addison Disease|addison disease
204672|NCT02096510|Adrenal Hyperplasia Congenital|adrenal hyperplasia congenital
204673|NCT02096484|Metacognitive therapy|metacognitive therapy
204674|NCT02096484|mindfulness meditation therapy|mindfulness meditation therapy
204675|NCT02096484|group therapy|group therapy
204676|NCT02096484|generalized anxiety disorder|generalized anxiety disorder
204677|NCT02096484|Group Based Metacognitive Therapy|group based metacognitive therapy
204678|NCT02096484|Group Based Mindfulness Meditation Therapy|group based mindfulness meditation therapy
204679|NCT02096471|Neurofibromatosis Type 1 (Neurofibromas)|neurofibromatosis type 1 (neurofibromas)
204680|NCT02096471|PD-0325901|pd-0325901
204681|NCT02096471|Radiographic Response|radiographic response
204682|NCT02096471|Inoperable Plexiform Neurofibromas|inoperable plexiform neurofibromas
204683|NCT02096458|Drug therapy|drug therapy
204684|NCT02096445|stroke|stroke
204685|NCT02096445|acute|acute
204686|NCT02096445|rehabilitation|rehabilitation
204687|NCT02096445|robot therapy|robot therapy
204688|NCT02096445|hand function|hand function
204689|NCT02096445|fine motor skills|fine motor skills
204690|NCT02096445|neurocognitive|neurocognitive
204691|NCT02096445|sensory|sensory
204692|NCT02096445|Perfetti|perfetti
204693|NCT02096445|haptics|haptics
204694|NCT02096419|clopidogrel|clopidogrel
204695|NCT02096419|platelet reactivity|platelet reactivity
204696|NCT02096419|acute coronary syndrome|acute coronary syndrome
204697|NCT02096419|tailoring therapy|tailoring therapy
204701|NCT02096406|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
204703|NCT02096406|Surgical valve repair|surgical valve repair
204704|NCT02096406|Valve Replacement|valve replacement
204705|NCT02096380|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
204706|NCT02096380|cycle|cycle
204707|NCT02096380|induction chemotherapy|induction chemotherapy
204708|NCT02096380|docetaxel|docetaxel
204709|NCT02096367|vibrations|vibrations
204710|NCT02096367|stroke|stroke
204711|NCT02096367|posture|posture
204712|NCT02096367|gait|gait
204713|NCT02096367|readaptation|readaptation
204714|NCT02096328|Ventilator Associated Pneumonia (VAP)|ventilator associated pneumonia (vap)
204715|NCT02096328|Lower respiratory infection|lower respiratory infection
204716|NCT02096328|POL7080|pol7080
204717|NCT02096328|Pseudomonas aeruginosa|pseudomonas aeruginosa
204718|NCT02096328|Nosocomial pneumonia|nosocomial pneumonia
204719|NCT02096315|POL7080|pol7080
204720|NCT02096315|Pseudomonas aeruginosa|pseudomonas aeruginosa
204721|NCT02096315|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
204722|NCT02096315|Exacerbation|exacerbation
204723|NCT02096302|Probiotics|probiotics
204724|NCT02096302|Infant Formula|infant formula
204725|NCT02096302|Microbiota|microbiota
204726|NCT02096302|Bifidobacterium longum biovar infantis CECT7210|bifidobacterium longum biovar infantis cect7210
204727|NCT02096302|Growth|growth
204728|NCT02096289|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
204729|NCT02096289|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
204730|NCT02096289|Thioridazine|thioridazine
204731|NCT02096289|Phase I|phase i
204732|NCT02096289|Clinical Trial|clinical trial
204733|NCT02096276|Pregnancy Registry|pregnancy registry
204734|NCT02096276|Boostrix|boostrix
204735|NCT02096276|Women|women
204736|NCT02096276|Cohort|cohort
204737|NCT02096276|Prospective|prospective
204738|NCT02096276|Pregnancy outcome|pregnancy outcome
204739|NCT02096276|Exploratory|exploratory
204745|NCT02096237|asthma, bronchial|asthma, bronchial
204746|NCT02096237|immunoadsorbents|immunoadsorbents
204747|NCT02096237|apheresis|apheresis
204748|NCT02096237|immunoglobulin E|immunoglobulin e
204749|NCT02096211|Total hip replacement|total hip replacement
204750|NCT02096211|Total hip arthroplasty|total hip arthroplasty
204751|NCT02096211|Hip joint replacement|hip joint replacement
204752|NCT02096211|Hip prosthesis replacement|hip prosthesis replacement
204753|NCT02096198|Total Hip Replacement|total hip replacement
204754|NCT02096198|Total Hip Arthroplasty|total hip arthroplasty
204755|NCT02096198|Hip Joint Replacement|hip joint replacement
204756|NCT02096198|Hip Prosthesis Replacement|hip prosthesis replacement
204757|NCT02096185|Breast cancer|breast cancer
204758|NCT02096185|Surgery|surgery
204759|NCT02096185|Specimen imaging|specimen imaging
204760|NCT02096159|Hypospadias|hypospadias
204761|NCT02096159|Anti-Bacterial Agents|anti-bacterial agents
204762|NCT02096146|Plate|plate
204763|NCT02096146|Hallux valgus|hallux valgus
204764|NCT02096146|Foot deformity|foot deformity
204765|NCT02096146|Screw|screw
204766|NCT02096146|Tarsometatarsal angle|tarsometatarsal angle
204767|NCT02096146|Cost effectiveness|cost effectiveness
204768|NCT02096133|Multiple sclerosis, vitamin D, HPA-axis, cortisol|multiple sclerosis, vitamin d, hpa-axis, cortisol
204769|NCT02096120|Periodontitis|periodontitis
204770|NCT02096107|Everolimus|everolimus
204771|NCT02096107|Graft dysfunction|graft dysfunction
204772|NCT02096107|Interstitial fibrosis|interstitial fibrosis
204773|NCT02096094|Antiseptics|antiseptics
204774|NCT02096094|Administration cutaneously|administration cutaneously
204775|NCT02096094|Chlorine compounds|chlorine compounds
204776|NCT02096094|Infection control|infection control
204777|NCT02096094|Anti-infecting agents, local|anti-infecting agents, local
204778|NCT02096081|Glabellar Frown Lines|glabellar frown lines
204779|NCT02096081|Frown Lines|frown lines
204780|NCT02096081|Facial Wrinkles|facial wrinkles
204781|NCT02096068|Neuroprotection|neuroprotection
204782|NCT02096055|Leukemia|leukemia
204783|NCT02096055|Acute Myeloid Leukemia|acute myeloid leukemia
204785|NCT02096055|Elderly|elderly
204786|NCT02096055|SGI-110|sgi-110
204787|NCT02096055|Idarubicin|idarubicin
204788|NCT02096055|Idamycin|idamycin
204789|NCT02096055|Leustatin|leustatin
204790|NCT02096055|2-CdA|2-cda
204791|NCT02096042|Leukemia|leukemia
204792|NCT02096042|Acute Myeloid Leukemia|acute myeloid leukemia
204793|NCT02096042|AML|aml
204794|NCT02096042|CD30-Positive|cd30-positive
204795|NCT02096042|Relapsed|relapsed
204796|NCT02096042|Refractory|refractory
204797|NCT02096042|Brentuximab Vedotin|brentuximab vedotin
204798|NCT02096042|SGN-35|sgn-35
204799|NCT02096042|Adcetris|adcetris
204800|NCT02096042|5-Azacytidine|5-azacytidine
204801|NCT02096042|Azacytidine|azacytidine
204802|NCT02096042|Azacitidine|azacitidine
204803|NCT02096042|5-aza|5-aza
204804|NCT02096042|Vidaza|vidaza
204805|NCT02096042|5-AZC|5-azc
204806|NCT02096042|AZA-CR|aza-cr
204807|NCT02096042|Ladakamycin|ladakamycin
204808|NCT02096042|NSC-102816|nsc-102816
204809|NCT02096029|smoking|smoking
204810|NCT02096029|smoking cessation|smoking cessation
204811|NCT02096029|nicotine replacement therapy|nicotine replacement therapy
204812|NCT02096029|primary care|primary care
204813|NCT02096029|comparative effectiveness|comparative effectiveness
204814|NCT02096016|Surveillance|surveillance
204815|NCT02096016|Follow up|follow up
204816|NCT02096003|Intrathecal hydromorphone|intrathecal hydromorphone
204817|NCT02096003|Intrathecal morphine|intrathecal morphine
204818|NCT02096003|Primary cesarean section|primary cesarean section
204819|NCT02096003|Analgesia|analgesia
204820|NCT02095990|Facial Melasma|facial melasma
204821|NCT02095977|St. Jude Riata lead failure|st. jude riata lead failure
204822|NCT02095977|implantable cardioverter-defibrillator (ICD)|implantable cardioverter-defibrillator (icd)
204823|NCT02095977|externalized conductors|externalized conductors
204824|NCT02095977|ventricular tachyarrythmia|ventricular tachyarrythmia
204825|NCT02095977|electrophysiology|electrophysiology
204826|NCT02095964|cardiac syndrome X|cardiac syndrome x
204827|NCT02095964|inflammation|inflammation
204828|NCT02095964|dyslipidemia|dyslipidemia
204829|NCT02095938|schizophrenia|schizophrenia
204830|NCT02095938|brain structure|brain structure
204831|NCT02095938|treatment response|treatment response
204832|NCT02095938|solian|solian
204833|NCT02095938|gene|gene
204834|NCT02095938|mri|mri
204835|NCT02095912|Squamous Cell Carcinoma|squamous cell carcinoma
204836|NCT02095899|Thoracic Surgical Procedures|thoracic surgical procedures
204837|NCT02095873|Oral glucose tolerance test|oral glucose tolerance test
204838|NCT02095873|Flow mediated dilatation|flow mediated dilatation
250713|NCT01885702|CRC|crc
195618|NCT02135913|Children|children
195619|NCT02135913|Vitamin D deficiency|vitamin d deficiency
195620|NCT02135913|Low HDL|low hdl
195621|NCT02135900|Heliox|heliox
195622|NCT02135900|Obstructive Sleep Apnea|obstructive sleep apnea
195624|NCT02135887|Grade 4 Neutropenia|grade 4 neutropenia
204839|NCT02095873|Aortal pulse wave velocity|aortal pulse wave velocity
204840|NCT02095873|Finger-fold capillary density by capillaroscopy|finger-fold capillary density by capillaroscopy
204841|NCT02095847|Uterine Cancer|uterine cancer
204842|NCT02095847|Endometrial cancer|endometrial cancer
204843|NCT02095847|Hysterectomy|hysterectomy
204844|NCT02095847|Hysteroscopy|hysteroscopy
204845|NCT02095847|High-resolution microendoscopy|high-resolution microendoscopy
204846|NCT02095847|HRME|hrme
204847|NCT02095847|Hysteroscopic-guided resection|hysteroscopic-guided resection
204848|NCT02095847|Proflavine|proflavine
204849|NCT02095834|Myeloma|myeloma
204850|NCT02095834|Multiple Myeloma|multiple myeloma
204851|NCT02095834|Relapsed|relapsed
204852|NCT02095834|Refractory|refractory
204853|NCT02095834|Carfilzomib|carfilzomib
204854|NCT02095834|Bendamustine|bendamustine
204855|NCT02095834|Bendamustine Hydrochloride|bendamustine hydrochloride
204856|NCT02095834|Bendamustine HCL|bendamustine hcl
204857|NCT02095834|CEP-18083|cep-18083
204858|NCT02095834|SDX-105|sdx-105
204859|NCT02095834|Treanda|treanda
204860|NCT02095834|Dexamethasone|dexamethasone
204861|NCT02095834|Decadron|decadron
204862|NCT02095795|Exercise Therapy|exercise therapy
204863|NCT02095782|non-small cell lung cancer|non-small cell lung cancer
204864|NCT02095782|erlotinib|erlotinib
204865|NCT02095782|chemotherapy|chemotherapy
204866|NCT02095769|Pharmacogenomics|pharmacogenomics
204867|NCT02095769|Adverse Drug Reactions|adverse drug reactions
204868|NCT02095743|Early breast cancer|early breast cancer
204869|NCT02095743|Chemotherapy|chemotherapy
204870|NCT02095743|PICC line|picc line
204871|NCT02095743|Implanted port|implanted port
204872|NCT02095730|crosslinking|crosslinking
204873|NCT02095730|cornea|cornea
204874|NCT02095730|keratoconus|keratoconus
204875|NCT02095730|ectasia|ectasia
204876|NCT02095730|irradiance|irradiance
204877|NCT02095730|riboflavin|riboflavin
204878|NCT02095691|Renal Sympathetic Denervation|renal sympathetic denervation
204879|NCT02095678|Hepatocellular Carcinoma|hepatocellular carcinoma
204880|NCT02095678|Hepatoma|hepatoma
204881|NCT02095678|Liver Cancer, Adult|liver cancer, adult
204882|NCT02095678|Liver Cell Carcinoma|liver cell carcinoma
204883|NCT02095678|Liver Cell Carcinoma, Adult|liver cell carcinoma, adult
204884|NCT02095678|HCC|hcc
204885|NCT02095665|ureteric stents|ureteric stents
204886|NCT02095665|LUTS|luts
204887|NCT02095665|lower urinary tract symptoms|lower urinary tract symptoms
204888|NCT02095587|Phase 1|phase 1
204889|NCT02095587|hepatic impairment|hepatic impairment
204890|NCT02095574|GDC-0199|gdc-0199
204891|NCT02095574|ADME|adme
204892|NCT02095574|Relapsed|relapsed
204893|NCT02095574|Refractory|refractory
204894|NCT02095574|ABT-199|abt-199
204895|NCT02095574|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
204896|NCT02095561|HPV self testing|hpv self testing
204897|NCT02095561|screening uptake|screening uptake
204898|NCT02095561|cervical cáncer|cervical cáncer
204899|NCT02095561|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
204900|NCT02095535|obstetric patients|obstetric patients
204901|NCT02095535|chloraprep|chloraprep
204902|NCT02095535|chlorhexidine|chlorhexidine
204903|NCT02095535|drying time|drying time
204904|NCT02095522|colchicine NSTEMI endothelial function inflammation|colchicine nstemi endothelial function inflammation
204906|NCT02095496|intensive care|intensive care
204907|NCT02095496|mechanical ventilation|mechanical ventilation
204908|NCT02095470|Laryngoscopy|laryngoscopy
204909|NCT02095470|Equipment|equipment
204910|NCT02095470|Video Laryngoscope|video laryngoscope
204911|NCT02095457|Routine Outcome Monitoring|routine outcome monitoring
204912|NCT02095457|Psychotherapy|psychotherapy
204913|NCT02095457|Alliance|alliance
204914|NCT02095457|Feedback Informed Treatment|feedback informed treatment
204915|NCT02095457|Mental Health Outpatients|mental health outpatients
204916|NCT02095431|patients undergoing the liver transplantation|patients undergoing the liver transplantation
204917|NCT02095431|acute kidney injury|acute kidney injury
204918|NCT02095418|New-onset diabetes after transplantation (NODAT)|new-onset diabetes after transplantation (nodat)
204919|NCT02095418|Liver transplantation|liver transplantation
204920|NCT02095405|Supraventricular Tachycardia|supraventricular tachycardia
204921|NCT02095405|Atrial Fibrillation|atrial fibrillation
204922|NCT02095405|Electrophysiology Study|electrophysiology study
204923|NCT02095405|Programmed Electrical Stimulation|programmed electrical stimulation
204924|NCT02095392|soluble phosphate|soluble phosphate
204925|NCT02095392|phosphorus metabolism|phosphorus metabolism
204926|NCT02095392|calcium metabolism|calcium metabolism
204927|NCT02095392|bone metabolism|bone metabolism
204928|NCT02095392|human study|human study
204929|NCT02095379|oligosecretary multiple myeloma|oligosecretary multiple myeloma
204930|NCT02095366|Acute Pain|acute pain
204931|NCT02095366|Traumatic Pain|traumatic pain
204932|NCT02095366|Emergency setting|emergency setting
204933|NCT02095366|Prehospital setting|prehospital setting
204934|NCT02095366|Analgesia|analgesia
204935|NCT02095366|Intranasal device|intranasal device
204936|NCT02095366|Intra veinous injection|intra veinous injection
204937|NCT02095366|Sufentanil citrate|sufentanil citrate
204938|NCT02095366|Morphine Sulfate|morphine sulfate
204939|NCT02095353|Brain tumor|brain tumor
204940|NCT02095353|extraaxial|extraaxial
204941|NCT02095353|metastasis|metastasis
204942|NCT02095353|glioma|glioma
204943|NCT02095353|primary brain tumor|primary brain tumor
204944|NCT02095353|secondary brain tumor|secondary brain tumor
204945|NCT02095353|MRI|mri
204946|NCT02095353|perfusion|perfusion
204947|NCT02095353|dynamic contrast enhancement|dynamic contrast enhancement
204948|NCT02095353|CBV|cbv
204949|NCT02095353|CBF|cbf
204950|NCT02095353|ktrans|ktrans
204951|NCT02095314|DTP-HB-Hib|dtp-hb-hib
204952|NCT02095314|Pentavalen|pentavalen
204953|NCT02095314|Pentabio|pentabio
204954|NCT02095314|Booster|booster
204955|NCT02095288|lipidomics|lipidomics
204956|NCT02095288|in vitro human whole blood assay|in vitro human whole blood assay
204957|NCT02095288|anti-inflammatory drugs|anti-inflammatory drugs
204958|NCT02095288|Lipidomics screening of anti-inflammatory drugs|lipidomics screening of anti-inflammatory drugs
204959|NCT02095275|BNP, acute kidney injury, fluid status|bnp, acute kidney injury, fluid status
204960|NCT02095249|prostate cancer|prostate cancer
204961|NCT02095249|radical prostatectomy|radical prostatectomy
204962|NCT02095223|Knee injury|knee injury
204963|NCT02095223|Meniscus injury|meniscus injury
204964|NCT02095223|Anterior cruciate ligament injury|anterior cruciate ligament injury
204965|NCT02095223|Knee ligament injury|knee ligament injury
204966|NCT02095210|PET scan|pet scan
204967|NCT02095210|HER2|her2
204968|NCT02095210|breast cancer|breast cancer
204969|NCT02095184|Breast Cancer|breast cancer
204971|NCT02095184|Hormone-Receptor Positive|hormone-receptor positive
204972|NCT02095119|Uterine cervical cancer|uterine cervical cancer
204973|NCT02095119|Palliative|palliative
204974|NCT02095119|Treatment|treatment
204975|NCT02095119|Monoclonal antibody|monoclonal antibody
204976|NCT02095119|Nimotuzumab|nimotuzumab
204977|NCT02095106|forearm fractures|forearm fractures
204978|NCT02095106|pediatric fractures|pediatric fractures
204979|NCT02095106|distal radius|distal radius
204980|NCT02095093|Total Hip Arthroplasty|total hip arthroplasty
204981|NCT02095093|Navigation|navigation
204982|NCT02095093|Imageless|imageless
204983|NCT02095093|THA|tha
204984|NCT02095093|Computer navigated|computer navigated
204985|NCT02095080|Leucine|leucine
204986|NCT02095080|Upper Intake Level (UL)|upper intake level (ul)
204987|NCT02095080|Elderly|elderly
204988|NCT02095080|Amino acids|amino acids
204989|NCT02095080|Protein|protein
204990|NCT02095067|Telemedicine|telemedicine
204991|NCT02095067|Emergency medical dispatch|emergency medical dispatch
204992|NCT02095067|Prehospital care|prehospital care
204993|NCT02095067|Video conference|video conference
204994|NCT02095054|Advanced Cancers|advanced cancers
204995|NCT02095054|Advanced malignancy|advanced malignancy
204996|NCT02095054|Metastatic cancer|metastatic cancer
204997|NCT02095054|Advanced solid tumor|advanced solid tumor
204998|NCT02095054|Regorafenib|regorafenib
204999|NCT02095054|Stivarga|stivarga
205000|NCT02095054|Cetuximab|cetuximab
205001|NCT02095054|C225|c225
205002|NCT02095054|Erbitux|erbitux
205003|NCT02095054|IMC-C225|imc-c225
205004|NCT02095054|MOAB C225|moab c225
205005|NCT02095054|Questionnaire|questionnaire
205006|NCT02095054|Survey|survey
205007|NCT02095041|Oxygen saturation.|oxygen saturation.
205008|NCT02095041|Term infants.|term infants.
205009|NCT02095041|Saturation trend.|saturation trend.
205010|NCT02095041|Histogram.|histogram.
205108|NCT02094625|Cisplatin|cisplatin
205011|NCT02095041|Public health nurse.|public health nurse.
205012|NCT02095041|congenital heart disease screening.|congenital heart disease screening.
205013|NCT02095015|MPS|mps
205014|NCT02095015|Mucopolysaccharidosis|mucopolysaccharidosis
205015|NCT02095015|MPS I|mps i
205016|NCT02095015|Mucopolysaccharidosis I|mucopolysaccharidosis i
205017|NCT02095015|Hurler, Hurler-Scheie, or Scheie syndrome|hurler, hurler-scheie, or scheie syndrome
205018|NCT02095015|MPS II|mps ii
205019|NCT02095015|Mucopolysaccharidosis II|mucopolysaccharidosis ii
205020|NCT02095015|Hunter syndrome|hunter syndrome
205021|NCT02095015|MPS VI|mps vi
205022|NCT02095015|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
205023|NCT02095015|Maroteaux-Lamy syndrome|maroteaux-lamy syndrome
205024|NCT02095015|iduronate-2-sulfatase|iduronate-2-sulfatase
205025|NCT02095015|ENT|ent
205026|NCT02095015|ear, nose and throat|ear, nose and throat
205027|NCT02095002|modified valsalva maneuver, internal jugular vein|modified valsalva maneuver, internal jugular vein
205028|NCT02094989|electrocardiogram|electrocardiogram
205029|NCT02094989|vectorcardiogram|vectorcardiogram
205030|NCT02094989|telecardiology|telecardiology
205031|NCT02094989|linear regression|linear regression
205032|NCT02094989|individual transformation matrix|individual transformation matrix
205033|NCT02094989|posture|posture
205034|NCT02094976|Prone position|prone position
205035|NCT02094976|Intra-abdominal pressure|intra-abdominal pressure
205036|NCT02094976|Respiratory system compliance|respiratory system compliance
205037|NCT02094976|Jackson table|jackson table
205038|NCT02094976|Wilson frame|wilson frame
205039|NCT02094976|Chest roll|chest roll
205040|NCT02094963|acute coronary syndrome|acute coronary syndrome
205041|NCT02094963|coronary disease|coronary disease
205042|NCT02094963|coronary artery disease|coronary artery disease
205043|NCT02094950|concurrent chemotherapy|concurrent chemotherapy
205044|NCT02094950|concurrent radiation|concurrent radiation
205045|NCT02094937|fluticasone propionate|fluticasone propionate
205046|NCT02094937|step-down regimen|step-down regimen
205047|NCT02094937|well-controlled subjects|well-controlled subjects
205048|NCT02094937|adults|adults
205049|NCT02094937|switching regimen|switching regimen
205050|NCT02094937|asthma|asthma
205051|NCT02094937|fluticasone furoate|fluticasone furoate
205052|NCT02094937|fluticasone furoate/Vilanterol|fluticasone furoate/vilanterol
205053|NCT02094924|Candesartan cilexetil|candesartan cilexetil
205054|NCT02094924|Hypertension|hypertension
205055|NCT02094924|Hydrochlorothiazide|hydrochlorothiazide
205056|NCT02094924|Healthy adult human subjects|healthy adult human subjects
205057|NCT02094924|Bioequivalence|bioequivalence
205058|NCT02094911|Prevention|prevention
205059|NCT02094911|Combined lifestyle intervention|combined lifestyle intervention
205060|NCT02094911|Primary health care|primary health care
205061|NCT02094898|Depression|depression
205062|NCT02094898|Unipolar|unipolar
205063|NCT02094898|Bipolar|bipolar
205064|NCT02094898|Suicidal|suicidal
205065|NCT02094859|Glucose Monitoring|glucose monitoring
205066|NCT02094846|Cellular phones|cellular phones
205067|NCT02094846|Type 2 diabetes|type 2 diabetes
205068|NCT02094846|Glycated hemoglobin|glycated hemoglobin
205069|NCT02094846|glycemic control|glycemic control
205070|NCT02094833|Diphtheria|diphtheria
205071|NCT02094833|Tetanus|tetanus
205072|NCT02094833|Pertussis|pertussis
205073|NCT02094833|Haemophilus influenzae type b infection|haemophilus influenzae type b infection
205074|NCT02094833|Hepatitis B|hepatitis b
205075|NCT02094833|DTaP-IPV-Hep - PRP-T vaccine|dtap-ipv-hep - prp-t vaccine
205076|NCT02094807|prospective study|prospective study
205077|NCT02094807|surgical management|surgical management
205078|NCT02094807|rib fractures|rib fractures
205079|NCT02094807|trauma|trauma
205080|NCT02094755|critical limb ischemia, High on-treatment platelet reactivity, HPR, aspirin, clopidogrel|critical limb ischemia, high on-treatment platelet reactivity, hpr, aspirin, clopidogrel
205081|NCT02094742|screening program|screening program
205082|NCT02094742|metastatic breast cancer|metastatic breast cancer
205083|NCT02094742|molecular profile|molecular profile
205084|NCT02094742|gene sequencing|gene sequencing
205085|NCT02094729|mild cognitive impairment|mild cognitive impairment
205086|NCT02094729|Alzheimer's disease|alzheimer's disease
205087|NCT02094716|Sarcoptes|sarcoptes
205088|NCT02094716|Scabiei|scabiei
205089|NCT02094716|Scabies|scabies
205090|NCT02094716|ectoparasite|ectoparasite
205091|NCT02094716|parasite|parasite
205092|NCT02094716|infestation|infestation
205093|NCT02094716|Renaissance|renaissance
205095|NCT02094703|age 18-65 years|age 18-65 years
205096|NCT02094703|storage symptoms|storage symptoms
205201|NCT02094157|Hemorrhage|hemorrhage
205097|NCT02094703|clinical urinary tract infection|clinical urinary tract infection
205098|NCT02094703|non complicated|non complicated
205099|NCT02094690|head and neck neoplasms|head and neck neoplasms
205100|NCT02094690|radiotherapy|radiotherapy
205101|NCT02094690|physical therapy|physical therapy
205102|NCT02094690|trismus|trismus
205103|NCT02094664|Heat|heat
205104|NCT02094664|Humidification|humidification
205105|NCT02094664|Oxygen|oxygen
205106|NCT02094651|Abnormal EEGs|abnormal eegs
205107|NCT02094638|Traditional Chinese Medicine Injection|traditional chinese medicine injection
205109|NCT02094625|N-acetylcysteine|n-acetylcysteine
205110|NCT02094625|Hearing Loss|hearing loss
205111|NCT02094625|Otoprotection|otoprotection
205112|NCT02094612|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
205113|NCT02094612|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
205114|NCT02094612|Pediatrics|pediatrics
205115|NCT02094612|Patient Outcome Assessment|patient outcome assessment
205116|NCT02094573|Drug Therapy|drug therapy
205117|NCT02094560|therapy refractory|therapy refractory
205118|NCT02094560|endstage|endstage
205119|NCT02094560|solid tumours|solid tumours
205120|NCT02094547|Infant Formula|infant formula
205121|NCT02094547|Cognition|cognition
205122|NCT02094547|Neurodevelopment|neurodevelopment
205123|NCT02094547|Immunity|immunity
205124|NCT02094547|Microbiota|microbiota
205125|NCT02094534|Diabetes type 1|diabetes type 1
205126|NCT02094534|Oral Insulin|oral insulin
205127|NCT02094534|Safety|safety
205128|NCT02094534|Tolerability|tolerability
205129|NCT02094534|Phase 2a|phase 2a
205130|NCT02094534|Randomized|randomized
205131|NCT02094534|Blinded|blinded
205132|NCT02094534|Parallel|parallel
205133|NCT02094508|Parasitemia|parasitemia
205134|NCT02094508|HIV-Exposed|hiv-exposed
205135|NCT02094508|HIV-Unexposed|hiv-unexposed
205136|NCT02094508|Liver Stage|liver stage
205137|NCT02094508|Randomized|randomized
205138|NCT02094495|Tamoxifen|tamoxifen
205139|NCT02094495|Breast cancer|breast cancer
205140|NCT02094495|Knowkedge|knowkedge
205141|NCT02094469|Treatment for vasospastic angina|treatment for vasospastic angina
205142|NCT02094456|diverticular disease|diverticular disease
205143|NCT02094456|diverticular bleeding|diverticular bleeding
205144|NCT02094456|endoscopic clipping|endoscopic clipping
205145|NCT02094456|endoscopy|endoscopy
205146|NCT02094456|lower gastrointestinal bleeding|lower gastrointestinal bleeding
205147|NCT02094443|Chronic hepatitis C genotype 2|chronic hepatitis c genotype 2
205148|NCT02094443|Chronic hepatitis C genotype 3|chronic hepatitis c genotype 3
205149|NCT02094443|Cyclophilin inhibitor|cyclophilin inhibitor
205150|NCT02094443|Interferon intolerant|interferon intolerant
205151|NCT02094417|Anemia, Aplastic|anemia, aplastic
205152|NCT02094417|Thrombopoietin|thrombopoietin
205153|NCT02094417|Thrombocytopenia|thrombocytopenia
205154|NCT02094404|Emergency Department|emergency department
205155|NCT02094404|Pediatric Early Warning Score|pediatric early warning score
205156|NCT02094404|Manchester Triage System|manchester triage system
205157|NCT02094378|Healthy|healthy
205158|NCT02094378|Esketamine|esketamine
205159|NCT02094378|Cognitive functioning|cognitive functioning
205160|NCT02094352|Complex Regional Pain Syndrome|complex regional pain syndrome
205161|NCT02094352|Pain management|pain management
205162|NCT02094352|Ketamine infusion|ketamine infusion
205163|NCT02094339|Local analgesia system|local analgesia system
205164|NCT02094339|Ropivacaine|ropivacaine
205165|NCT02094339|Analgesic efficacy after operation|analgesic efficacy after operation
205166|NCT02094339|Postoperative|postoperative
205167|NCT02094313|Atorvastatin|atorvastatin
205168|NCT02094313|Human Spermatozoa|human spermatozoa
205176|NCT02094300|Aortic dissection|aortic dissection
205177|NCT02094300|Rupture|rupture
205178|NCT02094300|Type B|type b
205179|NCT02094300|DeBakey type III|debakey type iii
205180|NCT02094300|Endovascular|endovascular
205181|NCT02094261|Phase II, open label study; safety and efficacy of AZD9291; diagnosis of Epidermal Growth Factor Receptor mutation positive and T790M mutation positive NSCLC|phase ii, open label study; safety and efficacy of azd9291; diagnosis of epidermal growth factor receptor mutation positive and t790m mutation positive nsclc
205182|NCT02094235|Dermatitis|dermatitis
205183|NCT02094235|Atopic|atopic
205184|NCT02094235|Pediatric|pediatric
205185|NCT02094235|Adolescent|adolescent
205186|NCT02094235|Child|child
205187|NCT02094209|External Fixation|external fixation
205188|NCT02094209|Tibial fracture|tibial fracture
205189|NCT02094209|Fracture healing|fracture healing
205190|NCT02094196|Reward- based learning|reward- based learning
205191|NCT02094196|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
205192|NCT02094196|Relapse Risk|relapse risk
205193|NCT02094196|Positron emission tomography (PET)|positron emission tomography (pet)
205194|NCT02094196|Magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
205195|NCT02094196|Dopamine receptor availability|dopamine receptor availability
205196|NCT02094196|Glutamate|glutamate
205197|NCT02094157|Atrial fibrillation|atrial fibrillation
205198|NCT02094157|Mechanical heart valve|mechanical heart valve
205200|NCT02094157|Venous thromboembolism|venous thromboembolism
205202|NCT02094144|Sedentary|sedentary
205203|NCT02094144|Physical activity|physical activity
205204|NCT02094144|Brisk walking|brisk walking
205211|NCT02094144|Biological effects|biological effects
205212|NCT02094131|incentive spirometry|incentive spirometry
205213|NCT02094131|flow-oriented spirometer|flow-oriented spirometer
205214|NCT02094131|volume-oriented spirometer|volume-oriented spirometer
205215|NCT02094131|physical therapy|physical therapy
205216|NCT02094131|respiratory muscle training|respiratory muscle training
205223|NCT02094105|esophageal cancer|esophageal cancer
205225|NCT02094105|endoscopy|endoscopy
205226|NCT02094105|prevention|prevention
205227|NCT02094092|L.reuteri ProTectis DSM 17938|l.reuteri protectis dsm 17938
205228|NCT02094092|Infantile colic|infantile colic
205229|NCT02094092|Maternal mental health.|maternal mental health.
205230|NCT02094092|Infant crying/fussing|infant crying/fussing
205231|NCT02094092|Edinburgh Postnatal Depression Scale (EPDS)|edinburgh postnatal depression scale (epds)
205232|NCT02094079|hypothyroidism|hypothyroidism
205233|NCT02094079|pregnancy|pregnancy
205234|NCT02094066|tranexamic acid|tranexamic acid
205235|NCT02094066|total hip arthroplasty|total hip arthroplasty
205236|NCT02094053|Down syndrome|down syndrome
196028|NCT02134106|RCT|rct
205237|NCT02094053|regression symptoms|regression symptoms
205238|NCT02094053|disabled activities of daily living|disabled activities of daily living
205239|NCT02094040|frailty|frailty
205240|NCT02094040|readmission|readmission
205241|NCT02094040|transition|transition
205242|NCT02094040|discharge|discharge
205243|NCT02094040|primary care|primary care
205244|NCT02094027|Obesity|obesity
205245|NCT02094027|Bariatric surgery|bariatric surgery
205246|NCT02094027|Binge eating|binge eating
205247|NCT02094027|Self help|self help
205248|NCT02094014|Perceptual masking|perceptual masking
205249|NCT02094014|Auditory stimulation|auditory stimulation
205250|NCT02094014|Speech|speech
205251|NCT02094014|Language|language
205252|NCT02094014|Verbal Fluency Disorders|verbal fluency disorders
205253|NCT02093962|TH-302|th-302
205254|NCT02093962|TH-CR-415|th-cr-415
205255|NCT02093962|Pemetrexed|pemetrexed
205256|NCT02093962|Non-small cell lung cancer|non-small cell lung cancer
205257|NCT02093962|Lung cancer|lung cancer
205258|NCT02093962|Evofosfamide|evofosfamide
205259|NCT02093936|airway inflammation|airway inflammation
205260|NCT02093936|induced sputum|induced sputum
205261|NCT02093936|normal values|normal values
205262|NCT02093936|lymphocyte|lymphocyte
205263|NCT02093936|eosinophil|eosinophil
205264|NCT02093936|neutrophil|neutrophil
205266|NCT02093910|multiple myeloma|multiple myeloma
205267|NCT02093910|peripheral neuropathy|peripheral neuropathy
205268|NCT02093910|prophylaxis|prophylaxis
205269|NCT02093884|Pregnancy|pregnancy
205270|NCT02093884|Pregnancy, unplanned|pregnancy, unplanned
205271|NCT02093884|Reproductive behavior|reproductive behavior
205272|NCT02093884|Pregnancy in Adolescence|pregnancy in adolescence
205207|NCT02094144|Balance|balance
205273|NCT02093884|Text messaging|text messaging
205274|NCT02093871|Ovarian cancer|ovarian cancer
205275|NCT02093871|Therapeutic hyperthermia|therapeutic hyperthermia
205277|NCT02093871|whole body hyperthermia|whole body hyperthermia
205278|NCT02093871|hyperthermia|hyperthermia
205279|NCT02093871|PISH|pish
205280|NCT02093871|Verthermia|verthermia
205281|NCT02093871|Phase 1 clinical trial|phase 1 clinical trial
205282|NCT02093871|stage 3 ovarian cancer|stage 3 ovarian cancer
205283|NCT02093871|stage 4 ovarian cancer|stage 4 ovarian cancer
205284|NCT02093871|stage III ovarian cancer|stage iii ovarian cancer
205285|NCT02093871|stage IV ovarian cancer|stage iv ovarian cancer
205286|NCT02093871|late stage ovarian cancer|late stage ovarian cancer
205287|NCT02093871|Core HFC|core hfc
205288|NCT02093871|Lilja|lilja
205289|NCT02093871|Vertrees|vertrees
205290|NCT02093871|Bastidas|bastidas
205291|NCT02093871|total body hyperthermia|total body hyperthermia
205292|NCT02093858|Metabolic Syndrome|metabolic syndrome
205293|NCT02093845|Percutaneous coronary intervention|percutaneous coronary intervention
205294|NCT02093845|DES|des
205295|NCT02093845|Angina pectoris|angina pectoris
205296|NCT02093845|Stent|stent
205297|NCT02093832|femoral head size|femoral head size
205298|NCT02093832|cup size|cup size
205299|NCT02093832|Total hip arthroplasty|total hip arthroplasty
205300|NCT02093767|prebiotics|prebiotics
205301|NCT02093767|Synergy1|synergy1
205302|NCT02093728|Phase I, healthy, pharmacokinetics|phase i, healthy, pharmacokinetics
205303|NCT02093715|Bronchiolitis|bronchiolitis
205304|NCT02093715|FeNO|feno
205305|NCT02093715|Asthma|asthma
205306|NCT02093715|wheezing, RSV|wheezing, rsv
205307|NCT02093676|diabetes|diabetes
205308|NCT02093676|type 1|type 1
205309|NCT02093676|adolescents|adolescents
205310|NCT02093676|parents counselling|parents counselling
205311|NCT02093663|Mild|mild
205312|NCT02093663|Moderate|moderate
205313|NCT02093650|Menopausal symptoms|menopausal symptoms
205314|NCT02093650|menopause related quality of life|menopause related quality of life
205315|NCT02093650|black cohosh|black cohosh
205316|NCT02093650|cimicifuga racemosa|cimicifuga racemosa
205317|NCT02093650|MENQOL|menqol
205318|NCT02093650|Kupperman index|kupperman index
205319|NCT02093650|KI|ki
205320|NCT02093650|liver function tests|liver function tests
205321|NCT02093598|pharmacokinetic|pharmacokinetic
205322|NCT02093598|pharmacodynamic|pharmacodynamic
205323|NCT02093598|Carcinoma, Endometrioid|carcinoma, endometrioid
205324|NCT02093598|mTOR protein|mtor protein
205325|NCT02093598|temsirolimus|temsirolimus
205326|NCT02093598|torisel|torisel
205327|NCT02093598|biological marker|biological marker
205328|NCT02093598|phase II|phase ii
205329|NCT02093585|HIV-1|hiv-1
205330|NCT02093585|Abacavir|abacavir
205331|NCT02093585|Platelet activation|platelet activation
205332|NCT02093585|Thromboelastography|thromboelastography
205333|NCT02093585|Coagulation|coagulation
205334|NCT02093572|Clock genes|clock genes
205335|NCT02093572|Metabolism|metabolism
205336|NCT02093572|Insulin sensitivity|insulin sensitivity
205337|NCT02093559|Clinical Trial|clinical trial
205338|NCT02093559|Naloxone|naloxone
205339|NCT02093559|Motivational Interviewing|motivational interviewing
205340|NCT02093546|Endometrial cancer|endometrial cancer
205341|NCT02093546|Endometrioid adenocarcinoma|endometrioid adenocarcinoma
205342|NCT02093546|Serous adenocarcinoma|serous adenocarcinoma
205343|NCT02093546|Undifferentiated carcinoma|undifferentiated carcinoma
205344|NCT02093546|Mixed epithelial carcinoma|mixed epithelial carcinoma
205345|NCT02093546|Adenocarcinoma not otherwise specified|adenocarcinoma not otherwise specified
205346|NCT02093546|NOS|nos
205347|NCT02093546|Companion Protocol to GOG229O|companion protocol to gog229o
205348|NCT02093546|Biomarkers|biomarkers
205349|NCT02093546|Circulating tumor cells|circulating tumor cells
205350|NCT02093546|CTCs|ctcs
205351|NCT02093546|Blood draw|blood draw
205352|NCT02093546|Biopsy|biopsy
205353|NCT02093533|Membranoproliferative glomerulonephritis|membranoproliferative glomerulonephritis
205354|NCT02093533|Nephrotic syndrome|nephrotic syndrome
205355|NCT02093533|Proteinuria|proteinuria
205356|NCT02093533|Alternative complement pathway|alternative complement pathway
205357|NCT02093533|Complement inhibition|complement inhibition
205358|NCT02093533|Eculizumab|eculizumab
205359|NCT02093520|Lumbar Spinal Stenosis|lumbar spinal stenosis
205360|NCT02093520|Spinal Stenosis|spinal stenosis
205361|NCT02093520|Neurogenic Claudication|neurogenic claudication
205362|NCT02093507|newborn|newborn
205363|NCT02093507|foot deformity congenital|foot deformity congenital
205364|NCT02093494|Septicemia|septicemia
205365|NCT02093494|Blood culture|blood culture
205366|NCT02093494|Contamination|contamination
205367|NCT02093468|Acute limb ischemia|acute limb ischemia
205368|NCT02093468|ALI|ali
205369|NCT02093468|Acute lower extremity arterial occlusion|acute lower extremity arterial occlusion
205370|NCT02093455|Endothelial function|endothelial function
205371|NCT02093416|Obesity|obesity
205372|NCT02093416|Leptin|leptin
205373|NCT02093403|AML|aml
205374|NCT02093403|Acute Myeloid Leukemia|acute myeloid leukemia
205375|NCT02093403|Adult Acute Myeloid Leukemia with T(8;21)(Q22;Q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
205376|NCT02093403|adult Acute Myeloid Leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
205377|NCT02093403|adult Acute Myeloid Leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
205378|NCT02093403|adult Acute Myeloid Leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
205379|NCT02093377|acute myocardial infarction|acute myocardial infarction
205380|NCT02093377|sleep apnea|sleep apnea
205381|NCT02093377|adaptive servo-ventilation|adaptive servo-ventilation
205382|NCT02093351|oncology, cancer, tumour, neoplasm, anticancer drug, pharmacokinetics, olaparib, anastrozole, tamoxifen, letrozole,|oncology, cancer, tumour, neoplasm, anticancer drug, pharmacokinetics, olaparib, anastrozole, tamoxifen, letrozole,
205383|NCT02093338|breast pain|breast pain
205384|NCT02093338|probiotic|probiotic
205385|NCT02093338|mastitis|mastitis
205386|NCT02093338|lactobacillus fermentun|lactobacillus fermentun
205387|NCT02093338|Staphylococcus|staphylococcus
205388|NCT02093325|eltrombopag , thrombocytopenia, gynecologic cancer|eltrombopag , thrombocytopenia, gynecologic cancer
205389|NCT02093312|Cancer|cancer
205390|NCT02093312|Food-delivery|food-delivery
205391|NCT02093312|Nutritional Intervention|nutritional intervention
205392|NCT02093312|Quality of life|quality of life
205393|NCT02093312|Outpatients|outpatients
205394|NCT02093286|Pentabio Vaccine|pentabio vaccine
205395|NCT02093286|Safety|safety
205396|NCT02093286|Infants|infants
205397|NCT02093286|Booster Dose|booster dose
205398|NCT02093286|DTwP/HepB/Hib|dtwp/hepb/hib
205399|NCT02093273|tOPV|topv
205400|NCT02093273|Antibody response|antibody response
205401|NCT02093273|Safety|safety
205697|NCT02091934|Astigmatism|astigmatism
205402|NCT02093260|Flubio Vaccine (Influenza HA)|flubio vaccine (influenza ha)
205403|NCT02093260|Infants|infants
205404|NCT02093260|Children|children
205405|NCT02093260|Safety|safety
205406|NCT02093260|Immunogenicity|immunogenicity
205407|NCT02093234|self care of diabetes type 2 patients|self care of diabetes type 2 patients
205408|NCT02093234|mobile health cell phone application impact on health|mobile health cell phone application impact on health
205409|NCT02093234|community health workers impact on health|community health workers impact on health
205912|NCT02090959|PTC124|ptc124
205410|NCT02093221|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
205411|NCT02093221|Alpha1-Proteinase Inhibitor|alpha1-proteinase inhibitor
205412|NCT02093221|Beta Cell|beta cell
205413|NCT02093221|Alpha1-Antitrypsin|alpha1-antitrypsin
205414|NCT02093195|Treatment, COPD, bosentan|treatment, copd, bosentan
205415|NCT02093156|bowel preparation|bowel preparation
205416|NCT02093156|Ottawa Score|ottawa score
205417|NCT02093143|Diagnostic panendoscopy of the upper airway|diagnostic panendoscopy of the upper airway
205418|NCT02093143|Total intravenous general anesthesia|total intravenous general anesthesia
205419|NCT02093143|Remifentanil|remifentanil
205420|NCT02093143|Propofol|propofol
205421|NCT02093143|Target controlled infusion|target controlled infusion
205422|NCT02093143|Direct laryngoscopy|direct laryngoscopy
205423|NCT02093143|Tracheoscopy|tracheoscopy
205424|NCT02093143|Oesophagoscopy|oesophagoscopy
205425|NCT02093143|Ear Nose and Throat (ENT) tumor|ear nose and throat (ent) tumor
205426|NCT02093143|Ear Nose and Throat (ENT) cancer|ear nose and throat (ent) cancer
205427|NCT02093130|Double-blind Trial|double-blind trial
196269|NCT02133092|RSV|rsv
205428|NCT02093130|Placebo-controlled|placebo-controlled
205429|NCT02093130|Pomegranate|pomegranate
205430|NCT02093130|Memory|memory
205431|NCT02093130|Memory Impairment|memory impairment
205432|NCT02093130|Cognition|cognition
205433|NCT02093130|Ages 50-75|ages 50-75
205434|NCT02093117|Supratentorial neurosurgery|supratentorial neurosurgery
205435|NCT02093117|Recruitment maneuver|recruitment maneuver
205436|NCT02093117|Subdural pressure|subdural pressure
205437|NCT02093117|Brain relaxation|brain relaxation
205438|NCT02093117|Cerebral perfusion pressure|cerebral perfusion pressure
205439|NCT02093104|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
205440|NCT02093104|(undergoing chemoembolization and radioembolization)|(undergoing chemoembolization and radioembolization)
205441|NCT02093091|nano-filled resin modified glass ionomer|nano-filled resin modified glass ionomer
205442|NCT02093091|clinical performance|clinical performance
205443|NCT02093091|class I|class i
205444|NCT02093091|primary teeth|primary teeth
205445|NCT02093091|dentin bond strength|dentin bond strength
205446|NCT02093091|Filling of class I|filling of class i
205447|NCT02093065|severe hemophilia A|severe hemophilia a
205448|NCT02093065|coated platelets|coated platelets
205449|NCT02093065|bleeding|bleeding
205450|NCT02093052|Parenting|parenting
205451|NCT02093052|Parent child relations|parent child relations
205452|NCT02093052|Middle childhood outcomes|middle childhood outcomes
205453|NCT02093039|breast cancer screening|breast cancer screening
205454|NCT02093039|patient decision aids|patient decision aids
205455|NCT02093039|informed decision|informed decision
205456|NCT02093039|empowerment|empowerment
205457|NCT02093039|randomized control trial|randomized control trial
205458|NCT02093039|From 50 to 74 years old|from 50 to 74 years old
205459|NCT02093039|invited to national breast cancer screening|invited to national breast cancer screening
205460|NCT02093013|asthma|asthma
205461|NCT02093013|intervention|intervention
205462|NCT02093013|medication adherence|medication adherence
205463|NCT02093013|inhaled corticosteroids|inhaled corticosteroids
205464|NCT02093013|asthma control|asthma control
205465|NCT02093013|integrated care|integrated care
205466|NCT02092987|Hispanic|hispanic
205467|NCT02092987|Dementia|dementia
205468|NCT02092987|Caregivers|caregivers
205469|NCT02092987|Depressive symptoms|depressive symptoms
205471|NCT02092987|Pragmatic randomized trial|pragmatic randomized trial
205472|NCT02092974|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
205473|NCT02092974|selective serotonin reuptake inhibitor (SSRI)|selective serotonin reuptake inhibitor (ssri)
205474|NCT02092974|young|young
205475|NCT02092974|older adults|older adults
205476|NCT02092961|Rheumatoid Arthritis|rheumatoid arthritis
205477|NCT02092961|OSKIRA|oskira
205478|NCT02092961|fostamatinib|fostamatinib
205479|NCT02092961|CE-MRI|ce-mri
205480|NCT02092961|DCE-MRI|dce-mri
205481|NCT02092948|metastatic|metastatic
205482|NCT02092948|PSCA|psca
205483|NCT02092948|minibody|minibody
205484|NCT02092948|PET/CT|pet/ct
205485|NCT02092935|CDAD|cdad
677963|NCT00887627|Vaprisol|vaprisol
205486|NCT02092935|Clostridium Difficile|clostridium difficile
205487|NCT02092896|Diabetes Mellitus|diabetes mellitus
205488|NCT02092896|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
205489|NCT02092896|Glucose Metabolism Disorders|glucose metabolism disorders
205490|NCT02092896|Metabolic Diseases|metabolic diseases
205491|NCT02092896|Cognitive performance|cognitive performance
205492|NCT02092896|Hypoglycemia|hypoglycemia
205493|NCT02092896|Insulin|insulin
205494|NCT02092896|Glucagon-Like Peptide 1|glucagon-like peptide 1
206475|NCT02088086|Overweight|overweight
205495|NCT02092896|Hypoglycemic Agents|hypoglycemic agents
205496|NCT02092896|Physiological Effects of Drugs|physiological effects of drugs
205497|NCT02092896|Pharmacologic Actions|pharmacologic actions
205498|NCT02092896|Incretins|incretins
205499|NCT02092896|Hormones|hormones
205500|NCT02092883|Infantile Spasms|infantile spasms
205501|NCT02092883|Neuroinflammation|neuroinflammation
205502|NCT02092883|PK11195|pk11195
205504|NCT02092883|ACTH|acth
205505|NCT02092870|Chronic Wounds|chronic wounds
205506|NCT02092870|Diabetes|diabetes
205507|NCT02092870|Adipose Derived Stem Cells|adipose derived stem cells
205508|NCT02092870|Diabetic Foot|diabetic foot
205509|NCT02092857|nutrient|nutrient
205510|NCT02092857|nutrition|nutrition
205511|NCT02092857|arachidonic acid|arachidonic acid
205512|NCT02092857|essential fatty acids|essential fatty acids
205513|NCT02092844|Menopause|menopause
205514|NCT02092844|Insomnia|insomnia
205515|NCT02092844|Hot Flashes|hot flashes
205516|NCT02092805|VAS|vas
205517|NCT02092805|VDS|vds
205518|NCT02092805|HAM-D|ham-d
205519|NCT02092805|Visceral pain|visceral pain
205520|NCT02092805|Malignancy|malignancy
205521|NCT02092805|rTMS|rtms
205522|NCT02092805|Motor cortex|motor cortex
205523|NCT02092805|Analgesia|analgesia
205524|NCT02092805|Dynorphin|dynorphin
205525|NCT02092766|malaria|malaria
205526|NCT02092766|anaemia|anaemia
205527|NCT02092766|artesunate|artesunate
205528|NCT02092753|Ketogenic diet, logi diet, breast cancer, rehabilitation|ketogenic diet, logi diet, breast cancer, rehabilitation
205529|NCT02092740|Testicular cancer|testicular cancer
205530|NCT02092727|Dialysis facilities|dialysis facilities
205531|NCT02092727|African Americans|african americans
205532|NCT02092727|Racial disparity|racial disparity
205533|NCT02092727|Kidney Transplantation|kidney transplantation
205534|NCT02092727|Community-based Participatory Research|community-based participatory research
205535|NCT02092727|Coalition|coalition
205536|NCT02092727|Georgia|georgia
205537|NCT02092688|time to delivery|time to delivery
205538|NCT02092688|PROM|prom
205539|NCT02092688|PTL|ptl
205540|NCT02092688|positive predictive value|positive predictive value
205541|NCT02092675|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
205542|NCT02092675|frequent exacerbator|frequent exacerbator
205543|NCT02092675|endothelial dysfunction|endothelial dysfunction
205544|NCT02092675|Flow mediated dilatation|flow mediated dilatation
205545|NCT02092675|Systemic inflammation|systemic inflammation
205546|NCT02092649|Omega-3|omega-3
205547|NCT02092649|Resting metabolic rate|resting metabolic rate
205548|NCT02092649|Eicosapentaenoic acid|eicosapentaenoic acid
205549|NCT02092649|Docosahexaenoic acid|docosahexaenoic acid
205550|NCT02092636|Hybrid NIR/US imaging technique|hybrid nir/us imaging technique
205551|NCT02092636|NIR/US imaging|nir/us imaging
205552|NCT02092636|US imaging|us imaging
205553|NCT02092636|US imaging technique|us imaging technique
205554|NCT02092623|Female|female
205555|NCT02092623|Prolapse surgery with transvaginal mesh|prolapse surgery with transvaginal mesh
205556|NCT02092623|Subjective outcome|subjective outcome
205557|NCT02092584|atherosclerotic|atherosclerotic
205558|NCT02092584|IGF-1|igf-1
205559|NCT02092584|IGFBP-3|igfbp-3
205560|NCT02092558|metaplasia, dysfunction, urinary bladder, children|metaplasia, dysfunction, urinary bladder, children
205561|NCT02092545|Obesity|obesity
205562|NCT02092519|EUSFNA|eusfna
205563|NCT02092519|endoscopic ultrasound|endoscopic ultrasound
205564|NCT02092519|pancreatic masses|pancreatic masses
205565|NCT02092506|H pylori|h pylori
205566|NCT02092506|therapy|therapy
205567|NCT02092493|ScopeGuide|scopeguide
205568|NCT02092493|Colonoscopy|colonoscopy
205569|NCT02092493|Mental workload|mental workload
205570|NCT02092480|Feasibility Trial|feasibility trial
205571|NCT02092480|Educational Intervention|educational intervention
205572|NCT02092480|Teenage Pregnancy|teenage pregnancy
205573|NCT02092480|Boys|boys
205574|NCT02092480|Gender sensitive interventions|gender sensitive interventions
205575|NCT02092480|Unintended pregnancy|unintended pregnancy
205576|NCT02092480|Parents|parents
205577|NCT02092480|Process evaluation|process evaluation
205578|NCT02092480|Economic costing|economic costing
205579|NCT02092467|Post-marketing|post-marketing
205580|NCT02092467|Phase 4|phase 4
205581|NCT02092467|Open-label|open-label
205582|NCT02092467|Safety Surveillance|safety surveillance
205583|NCT02092467|CP690550|cp690550
205584|NCT02092467|Xeljanz|xeljanz
205585|NCT02092467|oral treatment|oral treatment
205586|NCT02092441|Nausea|nausea
205587|NCT02092441|Vomiting|vomiting
205588|NCT02092441|Antiemetic|antiemetic
205589|NCT02092428|Coronary Magnetic Resonance Imaging|coronary magnetic resonance imaging
205591|NCT02092428|Coronary Magnetic Resonance Angiography|coronary magnetic resonance angiography
205592|NCT02092428|MRA|mra
205593|NCT02092428|3 Tesla MRI|3 tesla mri
205594|NCT02092415|Tourniquet|tourniquet
205595|NCT02092415|Muscle perfusion|muscle perfusion
205596|NCT02092415|Contrast ultrasound|contrast ultrasound
205597|NCT02092402|Fecal transplantation|fecal transplantation
205598|NCT02092402|microbiota transplantation|microbiota transplantation
205599|NCT02092402|irritable bowel syndrome|irritable bowel syndrome
205600|NCT02092402|IBS|ibs
205601|NCT02092389|Ulcerative Colitis|ulcerative colitis
205602|NCT02092389|Inflammatory Bowel Syndrome|inflammatory bowel syndrome
205603|NCT02092389|Adalimumab|adalimumab
205604|NCT02092389|Tumor necrosis factor (TNF) alpha Antibody|tumor necrosis factor (tnf) alpha antibody
205605|NCT02092389|Calprotectin|calprotectin
205606|NCT02092376|Bariatric surgery|bariatric surgery
205607|NCT02092376|vitamin D|vitamin d
205608|NCT02092376|supplementation|supplementation
205609|NCT02092363|Platinum-Sensitive Ovarian Cancer|platinum-sensitive ovarian cancer
205610|NCT02092337|CAST, Hearing aids, Speech recognition, Cochlear implants|cast, hearing aids, speech recognition, cochlear implants
205611|NCT02092311|varicocele|varicocele
205612|NCT02092311|varicocelectomy|varicocelectomy
205613|NCT02092311|complications of varicocelectomy|complications of varicocelectomy
205614|NCT02092311|Recurrence of varicocele|recurrence of varicocele
205615|NCT02092311|Post-varicocelectomy testicular atrophy|post-varicocelectomy testicular atrophy
205616|NCT02092311|Post-varicocelectomy hydrocele|post-varicocelectomy hydrocele
205617|NCT02092298|Gastrointestinal cancer|gastrointestinal cancer
205618|NCT02092298|Hyperthermic Intraperitoneal Chemoperfusion|hyperthermic intraperitoneal chemoperfusion
205619|NCT02092298|HIPEC|hipec
205620|NCT02092298|Gastric carcinomatosis|gastric carcinomatosis
196418|NCT02132299|Malaria|malaria
205621|NCT02092298|Gastroesophageal cancer|gastroesophageal cancer
205622|NCT02092298|Mitomycin C|mitomycin c
205623|NCT02092298|Mitomycin|mitomycin
205624|NCT02092298|Cisplatin|cisplatin
205625|NCT02092298|Platinol-AQ|platinol-aq
205626|NCT02092298|Platinol|platinol
205627|NCT02092298|CDDP|cddp
205628|NCT02092298|Sodium Thiosulfate|sodium thiosulfate
205629|NCT02092298|Tinver|tinver
205630|NCT02092233|ARIES HSV 1&2|aries hsv 1&2
205631|NCT02092220|Bionic Pancreas|bionic pancreas
205632|NCT02092220|Insulin|insulin
205633|NCT02092220|Glucagon|glucagon
205634|NCT02092220|Continuous Glucose Monitor|continuous glucose monitor
205635|NCT02092194|beta 2-Microglobulin|beta 2-microglobulin
205636|NCT02092194|Hemodiafiltration|hemodiafiltration
205637|NCT02092194|convective volume|convective volume
205638|NCT02092168|Opicapone|opicapone
205639|NCT02092168|BIAL|bial
205640|NCT02092142|Q fever|q fever
205641|NCT02092142|Coxiella burnetii|coxiella burnetii
205642|NCT02092129|Acromegaly, surgery, histopathology, hyperprolactinaemia,|acromegaly, surgery, histopathology, hyperprolactinaemia,
205643|NCT02092103|Premature Birth|premature birth
205644|NCT02092103|Umbilical Cord Clamping|umbilical cord clamping
205645|NCT02092090|salt substitute|salt substitute
205646|NCT02092090|sodium reduction|sodium reduction
205647|NCT02092090|stroke|stroke
205648|NCT02092090|cluster randomized trial|cluster randomized trial
205649|NCT02092090|China|china
205650|NCT02092077|Growth Hormone-Deficient|growth hormone-deficient
205651|NCT02092077|recombinant human growth hormone|recombinant human growth hormone
205652|NCT02092064|basal proteinuria|basal proteinuria
205653|NCT02092064|FMF|fmf
205654|NCT02092064|pregnancy|pregnancy
205655|NCT02092051|Continuous glucose monitoring|continuous glucose monitoring
205656|NCT02092051|Type 1 diabetes|type 1 diabetes
205657|NCT02092051|Insulin injections|insulin injections
205658|NCT02092051|Cross-over|cross-over
205659|NCT02092038|glioblastoma|glioblastoma
205660|NCT02092038|temozolomide|temozolomide
205661|NCT02092038|radiation therapy|radiation therapy
205666|NCT02092025|Pharmacological therapy|pharmacological therapy
205667|NCT02092012|postoperative pain|postoperative pain
205668|NCT02092012|dexketoprofen trometamol|dexketoprofen trometamol
205669|NCT02092012|dexmedetomidine|dexmedetomidine
205670|NCT02091999|Metastatic Urothelial Cancer|metastatic urothelial cancer
205671|NCT02091999|Safety|safety
205672|NCT02091999|AGS-22C3E|ags-22c3e
205673|NCT02091999|Nectin 4 protein, humans|nectin 4 protein, humans
205674|NCT02091999|Clinical Trial, Phase 1|clinical trial, phase 1
205675|NCT02091999|ASG-22CE|asg-22ce
205676|NCT02091999|ASG-22ME|asg-22me
205677|NCT02091999|Pharmacokinetics of ASG-22CE|pharmacokinetics of asg-22ce
205678|NCT02091986|asthma, children, budesonide pMDI|asthma, children, budesonide pmdi
205679|NCT02091973|everolimus|everolimus
205680|NCT02091973|tacrolimus|tacrolimus
205681|NCT02091973|kidney transplantation|kidney transplantation
205694|NCT02091934|Wavefront-guided|wavefront-guided
205695|NCT02091934|Wavefront-optimized|wavefront-optimized
205701|NCT02091908|aH5N1|ah5n1
205702|NCT02091908|H5N1 vaccine|h5n1 vaccine
205703|NCT02091908|Pandemic Influenza vaccine|pandemic influenza vaccine
205704|NCT02091908|MF59, Adjuvant, Avian flu|mf59, adjuvant, avian flu
205705|NCT02091908|Underlying medical conditions|underlying medical conditions
205706|NCT02091908|Underlying cardiovascular medical condition|underlying cardiovascular medical condition
205707|NCT02091908|Pandemic vaccine|pandemic vaccine
205708|NCT02091908|Charlson Comorbidity Index (CCI)|charlson comorbidity index (cci)
205709|NCT02091908|Adjuvanted vaccine|adjuvanted vaccine
205710|NCT02091895|probe-based confocal laser endomicroscopy, lower gastrointestinal disorders|probe-based confocal laser endomicroscopy, lower gastrointestinal disorders
205711|NCT02091882|OPC-14597 Digital|opc-14597 digital
205712|NCT02091882|Aripiprazole|aripiprazole
205713|NCT02091882|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
205714|NCT02091882|Ingestible Event Marker|ingestible event marker
205715|NCT02091869|Adolescents|adolescents
205716|NCT02091869|Asthma|asthma
205717|NCT02091869|Asthma Symptoms|asthma symptoms
205718|NCT02091817|oxytocin|oxytocin
205719|NCT02091817|face|face
205720|NCT02091817|memory|memory
205721|NCT02091804|Attachment theory|attachment theory
205913|NCT02090959|Ataluren|ataluren
205722|NCT02091804|Parent- child relationship|parent- child relationship
205723|NCT02091804|Child mental health|child mental health
205724|NCT02091804|Behavioral health|behavioral health
205725|NCT02091791|acute lumbar sciatica, lumbar traction, traction force, radicular pain, lumbar functional parameters, disc herniation|acute lumbar sciatica, lumbar traction, traction force, radicular pain, lumbar functional parameters, disc herniation
205726|NCT02091765|Sexual dysfunction.|sexual dysfunction.
205727|NCT02091765|Intimacy problems.|intimacy problems.
205728|NCT02091765|Breast cancer survivors.|breast cancer survivors.
205729|NCT02091765|Internet-based.|internet-based.
205730|NCT02091765|Cognitive behavioral therapy.|cognitive behavioral therapy.
205731|NCT02091752|Primary Myelofibrosis|primary myelofibrosis
205732|NCT02091752|Hematologic Diseases|hematologic diseases
205733|NCT02091752|Myeloproliferative Disorders|myeloproliferative disorders
205734|NCT02091752|INC424|inc424
205735|NCT02091752|Ruxolitinib|ruxolitinib
205736|NCT02091726|Circumcision|circumcision
205737|NCT02091726|HIV prevention|hiv prevention
205738|NCT02091726|Surgical device|surgical device
205739|NCT02091726|Cyanoacrylate|cyanoacrylate
205740|NCT02091726|Tissue Adhesive|tissue adhesive
205741|NCT02091726|voluntary|voluntary
205742|NCT02091713|FMS|fms
205743|NCT02091713|functional movement screen|functional movement screen
205744|NCT02091700|Normal|normal
205745|NCT02091700|Healthy|healthy
205746|NCT02091700|Normal healthy patient|normal healthy patient
205747|NCT02091674|ankle sprain|ankle sprain
205748|NCT02091674|hyaluronic acid|hyaluronic acid
205749|NCT02091661|Clinically localized prostate cancer|clinically localized prostate cancer
205750|NCT02091661|Radical retropubic prostatectomy|radical retropubic prostatectomy
205751|NCT02091661|External beam radiotherapy|external beam radiotherapy
205752|NCT02091661|Efficacy|efficacy
205753|NCT02091661|Quality of life|quality of life
205754|NCT02091661|adverse events|adverse events
205755|NCT02091648|Asthma|asthma
205756|NCT02091648|Stress|stress
205757|NCT02091648|Children|children
205758|NCT02091648|Psychosocial Factors|psychosocial factors
205759|NCT02091648|Relaxation|relaxation
205760|NCT02091648|Stress management|stress management
205761|NCT02091635|accommodation, emptying, motilitone|accommodation, emptying, motilitone
205762|NCT02091609|plaque removal around dental implants|plaque removal around dental implants
205763|NCT02091596|Wound|wound
205764|NCT02091596|Ulcer|ulcer
205765|NCT02091596|Infected|infected
205766|NCT02091596|Infection|infection
205767|NCT02091583|Metabolic syndrome|metabolic syndrome
205768|NCT02091583|Cardiovascular disease|cardiovascular disease
205699|NCT02091908|Influenza|influenza
205769|NCT02091583|High Oleic Canola Oil|high oleic canola oil
205770|NCT02091583|DHA|dha
205771|NCT02091583|β-glucan|β-glucan
205772|NCT02091583|Barley|barley
205773|NCT02091583|Cholesterol|cholesterol
205774|NCT02091583|Lipoproteins|lipoproteins
205775|NCT02091583|Lipids|lipids
205776|NCT02091583|Inflammation|inflammation
205777|NCT02091583|Glucose|glucose
205778|NCT02091583|Insulin|insulin
205779|NCT02091583|Satiety|satiety
205780|NCT02091583|Body composition|body composition
205781|NCT02091583|Blood pressure|blood pressure
205782|NCT02091570|Hunger|hunger
205783|NCT02091570|Fullness|fullness
205784|NCT02091570|Satiety|satiety
205785|NCT02091570|Nutrition bar|nutrition bar
205786|NCT02091570|Crossover|crossover
205787|NCT02091557|GnRH-a|gnrh-a
205788|NCT02091557|endometriosis|endometriosis
205789|NCT02091557|chronic pelvic pain|chronic pelvic pain
205790|NCT02091557|VAS score|vas score
205791|NCT02091557|diagnostic accuracy|diagnostic accuracy
205796|NCT02091531|mTOR Inhibitor MLN0128|mtor inhibitor mln0128
205798|NCT02091531|13-143|13-143
205799|NCT02091518|MRI|mri
205800|NCT02091518|13-239|13-239
205801|NCT02091518|volunteers|volunteers
205802|NCT02091518|patients|patients
205803|NCT02091492|Proximal humerus fracture, teriparatide|proximal humerus fracture, teriparatide
205804|NCT02091479|hæmorrhage, thrombosis|hæmorrhage, thrombosis
205805|NCT02091466|Hypothermia|hypothermia
205806|NCT02091466|Perioperative Care|perioperative care
205807|NCT02091466|Anesthesia|anesthesia
205808|NCT02091466|Spinal|spinal
205809|NCT02091466|Rewarming|rewarming
205810|NCT02091453|Brain injury|brain injury
205811|NCT02091453|stroke|stroke
205812|NCT02091453|cognitive rehabilitation|cognitive rehabilitation
205813|NCT02091440|Medical Device|medical device
205814|NCT02091440|Thoracic Surgical Procedure|thoracic surgical procedure
205815|NCT02091440|Pumps Heart Assist|pumps heart assist
205816|NCT02091440|Ventricular Assist Device|ventricular assist device
205817|NCT02091401|magnesium sulfate|magnesium sulfate
205818|NCT02091375|cannabidiol|cannabidiol
205819|NCT02091336|gestational diabetes|gestational diabetes
205820|NCT02091336|metformin|metformin
205821|NCT02091336|glyburide|glyburide
205822|NCT02091336|fetal growth|fetal growth
205823|NCT02091336|capillar glucose|capillar glucose
205824|NCT02091323|T2DM, gastric bypass surgery, BMI<35, obesity|t2dm, gastric bypass surgery, bmi<35, obesity
205825|NCT02091310|GFT505|gft505
205826|NCT02091310|TQT|tqt
205827|NCT02091310|QT/QTc|qt/qtc
205828|NCT02091310|Pharmacokinetic|pharmacokinetic
205829|NCT02091310|Healthy subjects|healthy subjects
205830|NCT02091310|Moxifloxacin|moxifloxacin
205831|NCT02091297|Buprenorphine|buprenorphine
205832|NCT02091297|Suboxone|suboxone
205833|NCT02091297|Subutex|subutex
205834|NCT02091297|Buprenex|buprenex
205835|NCT02091297|Caesarean Delivery|caesarean delivery
205836|NCT02091284|alcoholism|alcoholism
205837|NCT02091284|tDCS|tdcs
205838|NCT02091284|dlPFC|dlpfc
205839|NCT02091284|craving|craving
205840|NCT02091284|cognition|cognition
205841|NCT02091271|Evaluation|evaluation
205842|NCT02091271|Research|research
205843|NCT02091271|Healthy Volunteers|healthy volunteers
251971|NCT01880476|Aged|aged
196618|NCT02131428|BNP|bnp
205844|NCT02091245|Relapsed acute lymphoblastic leukemia (ALL)|relapsed acute lymphoblastic leukemia (all)
205845|NCT02091245|Refractory acute lymphoblastic leukemia (ALL)|refractory acute lymphoblastic leukemia (all)
205846|NCT02091245|Relapsed acute myelogenous leukemia (AML)|relapsed acute myelogenous leukemia (aml)
205847|NCT02091245|Refractory acute myelogenous leukemia (AML)|refractory acute myelogenous leukemia (aml)
205848|NCT02091245|Relapsed childhood leukemia|relapsed childhood leukemia
205849|NCT02091245|Relapsed mixed lineage leukemia|relapsed mixed lineage leukemia
205850|NCT02091245|Refractory mixed lineage leukemia|refractory mixed lineage leukemia
205851|NCT02091245|Relapsed biphenotypic leukemia|relapsed biphenotypic leukemia
205852|NCT02091245|Refractory biphenotypic leukemia|refractory biphenotypic leukemia
205853|NCT02091245|Chronic myelogenous leukemia (CML) in blast crisis|chronic myelogenous leukemia (cml) in blast crisis
205854|NCT02091219|Hypovitaminosis D|hypovitaminosis d
205855|NCT02091219|Free 25-hydroxyvitamin D|free 25-hydroxyvitamin d
205856|NCT02091219|Total 25-hydroxyvitamin D|total 25-hydroxyvitamin d
205857|NCT02091206|Cannabidiol|cannabidiol
205858|NCT02091193|Krill Oil|krill oil
205859|NCT02091193|Endothelial Function|endothelial function
205860|NCT02091193|Type II Diabetes Mellitus|type ii diabetes mellitus
205861|NCT02091180|Anesthesia|anesthesia
205862|NCT02091180|Recovery|recovery
205863|NCT02091180|laparoscopy|laparoscopy
205864|NCT02091180|cholecystectomy|cholecystectomy
205865|NCT02091167|crack-cocaine addiction|crack-cocaine addiction
205866|NCT02091167|tDCS|tdcs
205867|NCT02091167|dlPFC|dlpfc
205868|NCT02091167|craving|craving
205869|NCT02091167|cognition|cognition
205870|NCT02091154|Food Intake Regulation|food intake regulation
205871|NCT02091154|Fruit|fruit
205872|NCT02091154|Vegetable|vegetable
205873|NCT02091115|Constipation|constipation
205874|NCT02091115|ROMA III criteria|roma iii criteria
205875|NCT02091115|Scale Bristol|scale bristol
5761|NCT03254433|Neuroimaging|neuroimaging
205876|NCT02091076|Silk fibroin with bioactive coating layer dressing|silk fibroin with bioactive coating layer dressing
205877|NCT02091076|Wound healing|wound healing
205878|NCT02091076|Skin graft donor|skin graft donor
205879|NCT02091063|hematologic malignancies|hematologic malignancies
205880|NCT02091063|hodgkin|hodgkin
205881|NCT02091063|hodgkins|hodgkins
205882|NCT02091063|non-hodgkin|non-hodgkin
205883|NCT02091063|non-hodgkins|non-hodgkins
205884|NCT02091063|mantle cell lymphoma|mantle cell lymphoma
205885|NCT02091063|follicular|follicular
205886|NCT02091063|lymphoma|lymphoma
205887|NCT02091063|lymphoid malignancies|lymphoid malignancies
205888|NCT02091050|3D Brachytherapy|3d brachytherapy
205889|NCT02091050|cervical cancer|cervical cancer
205890|NCT02091050|endometrial cancer|endometrial cancer
205891|NCT02091050|vaginal vault brachytherapy|vaginal vault brachytherapy
205892|NCT02091037|Atopic dermatitis|atopic dermatitis
205893|NCT02091037|Bacterial colonization|bacterial colonization
205977|NCT02090517|Nasal telangiectasis|nasal telangiectasis
205894|NCT02091011|This study is designed to efficiently provide device and battery longevity data on market released|this study is designed to efficiently provide device and battery longevity data on market released
205895|NCT02091011|Boston Scientific ICD and CRT-D (Cardiac Resynchronization Therapy Defibrillator) devices. In addition, the data collected will allow for|boston scientific icd and crt-d (cardiac resynchronization therapy defibrillator) devices. in addition, the data collected will allow for
205896|NCT02091011|comparisons of device survival probability estimated in the Product Performance Report versus|comparisons of device survival probability estimated in the product performance report versus
205897|NCT02091011|those collected in the study. The data collected will also provide a better understanding on the|those collected in the study. the data collected will also provide a better understanding on the
205898|NCT02091011|potential predictors of pulse generator battery longevity.|potential predictors of pulse generator battery longevity.
205899|NCT02090998|Migraine Headache|migraine headache
205900|NCT02090998|Menstrual Migraine|menstrual migraine
205901|NCT02090998|Vascular Headache|vascular headache
205902|NCT02090998|Temporal Lobe Seizure|temporal lobe seizure
205903|NCT02090985|Stoma|stoma
205904|NCT02090985|Peri-stomal|peri-stomal
205905|NCT02090985|Lipomodelling|lipomodelling
205906|NCT02090959|Duchenne muscular dystrophy|duchenne muscular dystrophy
205907|NCT02090959|Dystrophinopathy|dystrophinopathy
205908|NCT02090959|Nonsense mutation|nonsense mutation
205909|NCT02090959|Premature stop codon|premature stop codon
205910|NCT02090959|Becker muscular dystrophy|becker muscular dystrophy
205911|NCT02090959|DMD/BMD|dmd/bmd
205914|NCT02090946|children with physical disabilities|children with physical disabilities
205915|NCT02090946|home activity programs|home activity programs
205916|NCT02090946|home programmes|home programmes
205917|NCT02090946|learning|learning
205918|NCT02090946|therapeutic relationship|therapeutic relationship
205919|NCT02090946|phenomenology|phenomenology
205920|NCT02090946|physiotherapy|physiotherapy
205921|NCT02090946|clinicians who teach|clinicians who teach
205922|NCT02090946|parent perspective|parent perspective
206049|NCT02090192|Blood flow;|blood flow;
205923|NCT02090946|parent-professional relationships|parent-professional relationships
205924|NCT02090946|Parents/carers|parents/carers
205925|NCT02090946|long term physiotherapy needs|long term physiotherapy needs
205926|NCT02090907|Subclinical hypothyroidism|subclinical hypothyroidism
205927|NCT02090907|Atherosclerosis|atherosclerosis
205928|NCT02090907|Cardiovascular disease|cardiovascular disease
205929|NCT02090907|Endothelial function|endothelial function
205930|NCT02090907|Prevention|prevention
205931|NCT02090868|Non-Invasive Ventilation|non-invasive ventilation
205932|NCT02090868|Bi-Level Positive Airway Pressure|bi-level positive airway pressure
205933|NCT02090868|Continuous Positive Airway Pressure|continuous positive airway pressure
205934|NCT02090868|Critical Care|critical care
205935|NCT02090868|Nutrition|nutrition
205936|NCT02090868|Malnutrition|malnutrition
205937|NCT02090868|Staff attitudes, knowledge and beliefs|staff attitudes, knowledge and beliefs
205938|NCT02090842|Milk proteins|milk proteins
205939|NCT02090842|Blood pressure|blood pressure
205940|NCT02090842|Vascular function|vascular function
205941|NCT02090829|Autism|autism
205942|NCT02090829|Oxytocin|oxytocin
205943|NCT02090829|Syntocinon|syntocinon
205944|NCT02090790|dexamethasone|dexamethasone
205945|NCT02090790|femoral block|femoral block
205946|NCT02090790|total knee arthroplasty|total knee arthroplasty
205947|NCT02090751|Retinal Rod Photoreceptor Cells|retinal rod photoreceptor cells
205948|NCT02090751|Dark Adaptation|dark adaptation
205949|NCT02090725|fluctuating muscle weakness|fluctuating muscle weakness
205950|NCT02090725|hyporeflexia|hyporeflexia
205951|NCT02090725|autonomic Dysfunction|autonomic dysfunction
205952|NCT02090712|myocardial infarction|myocardial infarction
205953|NCT02090712|acute coronary syndrome|acute coronary syndrome
205954|NCT02090712|coronary disease|coronary disease
205955|NCT02090699|thalassemia major|thalassemia major
205956|NCT02090699|chronic blood transfusion related iron overload|chronic blood transfusion related iron overload
205957|NCT02090699|magnetic resonance imaging|magnetic resonance imaging
205958|NCT02090699|myocardium|myocardium
205959|NCT02090699|fibrosis|fibrosis
205962|NCT02090634|Bipolar Disorder|bipolar disorder
205963|NCT02090634|Medication Adherence|medication adherence
205965|NCT02090621|transplantation|transplantation
205966|NCT02090621|Immunosuppression|immunosuppression
205967|NCT02090621|photopheresis|photopheresis
205968|NCT02090621|extracorporeal|extracorporeal
205969|NCT02090595|bipolar disorder|bipolar disorder
205970|NCT02090595|anxiety|anxiety
205971|NCT02090595|mindfulness|mindfulness
205972|NCT02090595|high risk|high risk
205973|NCT02090595|cognitive behavioral|cognitive behavioral
205974|NCT02090569|Functional micro-Doppler Sonography, fmDS, dysplasia, epilepsy, neurosurgery, cerebral blood volume, echography, hemodynamics|functional micro-doppler sonography, fmds, dysplasia, epilepsy, neurosurgery, cerebral blood volume, echography, hemodynamics
205975|NCT02090530|Cancer Genomics|cancer genomics
205976|NCT02090530|Tumor Sequencing|tumor sequencing
206375|NCT02088619|depression|depression
205981|NCT02090504|oxazepam|oxazepam
205982|NCT02090491|autism|autism
205983|NCT02090465|Actinic Keratosis|actinic keratosis
205984|NCT02090452|Telemedicine|telemedicine
205985|NCT02090452|Mobile|mobile
205986|NCT02090452|Vital signs|vital signs
205987|NCT02090452|Prehospital care|prehospital care
205988|NCT02090452|Emergency medicine|emergency medicine
205989|NCT02090413|multiple sclerosis|multiple sclerosis
205990|NCT02090413|flushing|flushing
205991|NCT02090413|aspirin|aspirin
205992|NCT02090400|Women|women
205993|NCT02090400|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
205994|NCT02090400|Bazedoxifene|bazedoxifene
205995|NCT02090400|BMD|bmd
205996|NCT02090374|Allergy|allergy
205997|NCT02090374|Asthma|asthma
205998|NCT02090374|Biomarkers|biomarkers
205999|NCT02090374|Chemokines|chemokines
206000|NCT02090374|Cytokines|cytokines
206001|NCT02090374|Eosinophil|eosinophil
206002|NCT02090374|Gene Expression|gene expression
206003|NCT02090374|Grass pollen|grass pollen
206004|NCT02090374|Hay Fever|hay fever
206005|NCT02090374|Human Challenge Study|human challenge study
206006|NCT02090374|Inflammation|inflammation
206007|NCT02090374|Innate Immune Response|innate immune response
206008|NCT02090374|Lipopolysaccharide|lipopolysaccharide
206009|NCT02090374|Mucosal Lining Fluid|mucosal lining fluid
206010|NCT02090374|Nasal|nasal
206011|NCT02090374|Nasorption|nasorption
206012|NCT02090374|Respiratory|respiratory
206013|NCT02090374|Respiratory Tract Infection|respiratory tract infection
206014|NCT02090374|T cells|t cells
206015|NCT02090374|Tuberculosis|tuberculosis
206016|NCT02090374|Virus|virus
206020|NCT02090335|community mental health|community mental health
206021|NCT02090335|health coach|health coach
206022|NCT02090335|weight loss|weight loss
206023|NCT02090335|fitness|fitness
206024|NCT02090335|serious mental illness|serious mental illness
206025|NCT02090335|health promotion|health promotion
206026|NCT02090322|ROP|rop
206027|NCT02090322|Bevacizumab|bevacizumab
206028|NCT02090322|No inferiority|no inferiority
206029|NCT02090283|Epidermolysis Bullosa|epidermolysis bullosa
206030|NCT02090283|Simplex|simplex
206031|NCT02090283|Recessive Dystrophic|recessive dystrophic
206032|NCT02090283|Junctional non-Herlitz|junctional non-herlitz
206033|NCT02090270|hair cortisol|hair cortisol
206034|NCT02090270|stroke|stroke
206035|NCT02090257|Heart transplant recipients who are entering into adult care.|heart transplant recipients who are entering into adult care.
206036|NCT02090244|PTH|pth
206037|NCT02090244|Spinal stenosis|spinal stenosis
206038|NCT02090244|Teriparatide|teriparatide
206039|NCT02090231|stroke|stroke
206040|NCT02090231|dysphagia|dysphagia
206041|NCT02090231|rTMS|rtms
206042|NCT02090205|cardio-pulmonary bypass|cardio-pulmonary bypass
206043|NCT02090205|cardiac surgery|cardiac surgery
206044|NCT02090205|lung injury prevention|lung injury prevention
206045|NCT02090205|mechanical ventilation|mechanical ventilation
206046|NCT02090205|pulmonary insufficiency|pulmonary insufficiency
206047|NCT02090192|Whole-body vibration;|whole-body vibration;
206048|NCT02090192|Frail Elderly;|frail elderly;
206050|NCT02090192|Bone density|bone density
206051|NCT02090192|Mobility;|mobility;
206052|NCT02090192|Balance;|balance;
206053|NCT02090192|Muscle strength;|muscle strength;
206054|NCT02090192|Lower Extremity;|lower extremity;
206055|NCT02090192|Musculoskeletal System;|musculoskeletal system;
206056|NCT02090192|Health Status;|health status;
206057|NCT02090192|Exercise;|exercise;
206058|NCT02090192|Mechanical Oscillation|mechanical oscillation
206059|NCT02090179|MPS IIIB|mps iiib
206060|NCT02090179|Mucopolysaccharidosis|mucopolysaccharidosis
206061|NCT02090179|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
206062|NCT02090179|Sanfilippo Syndrome|sanfilippo syndrome
206063|NCT02090179|Metabolism, Inborn Errors|metabolism, inborn errors
206064|NCT02090179|Metabolic Diseases|metabolic diseases
205979|NCT02090504|treatment|treatment
206065|NCT02090179|Genetic Diseases, Inborn|genetic diseases, inborn
206066|NCT02090153|Advance Gastric Cancer,|advance gastric cancer,
206067|NCT02090153|S-1 plus leucovorin,|s-1 plus leucovorin,
206068|NCT02090153|ORR,|orr,
206069|NCT02090153|OS,|os,
206070|NCT02090153|TTP,|ttp,
206071|NCT02090153|TTF,|ttf,
206072|NCT02090153|Adverse events,|adverse events,
206073|NCT02090153|Pharmacokinetics|pharmacokinetics
206074|NCT02090140|cartilage/transplantation|cartilage/transplantation
206075|NCT02090140|cartilage, articular/injuries|cartilage, articular/injuries
401992|NCT01233596|monocanalicular intubation|monocanalicular intubation
206076|NCT02090140|cartilage, articular/surgery|cartilage, articular/surgery
206077|NCT02090140|chondrocytes/cytology|chondrocytes/cytology
206078|NCT02090140|knee injuries/surgery|knee injuries/surgery
206079|NCT02090140|knee joint/surgery|knee joint/surgery
206080|NCT02090140|orthopedic procedures/methods|orthopedic procedures/methods
206081|NCT02090140|tissue engineering|tissue engineering
206082|NCT02090140|tissue scaffolds|tissue scaffolds
206083|NCT02090140|arthroscopy/methods|arthroscopy/methods
206084|NCT02090140|chondrocytes/transplantation|chondrocytes/transplantation
206085|NCT02090140|adipose tissue/cytology|adipose tissue/cytology
206086|NCT02090140|cartilage, articular/cytology|cartilage, articular/cytology
206087|NCT02090140|chondrogenesis/physiology|chondrogenesis/physiology
206088|NCT02090140|osteogenesis/physiology|osteogenesis/physiology
206089|NCT02090140|stem cell transplantation/methods|stem cell transplantation/methods
206090|NCT02090140|stem cells|stem cells
206091|NCT02090140|tissue engineering/methods|tissue engineering/methods
206092|NCT02090140|cartilage, articular/pathology|cartilage, articular/pathology
206093|NCT02090140|chondrocytes/pathology|chondrocytes/pathology
206094|NCT02090140|knee joint/pathology|knee joint/pathology
206095|NCT02090140|platelet-rich plasma|platelet-rich plasma
206096|NCT02090114|Bipolar Androgen Therapy|bipolar androgen therapy
206097|NCT02090114|Testosterone|testosterone
206098|NCT02090114|Enzalutamide|enzalutamide
206099|NCT02090114|Abiraterone|abiraterone
206100|NCT02090114|Androgen Ablative Therapies|androgen ablative therapies
206101|NCT02090075|cardiac Computed tomography|cardiac computed tomography
206102|NCT02090075|coronary calcification|coronary calcification
206103|NCT02090075|intervention|intervention
206104|NCT02090075|warfarin|warfarin
206105|NCT02090075|apixaban|apixaban
206106|NCT02090062|endoscopic resection|endoscopic resection
206107|NCT02090062|H. pylori infection|h. pylori infection
206108|NCT02090049|Appetite|appetite
206109|NCT02090049|Satiety|satiety
206110|NCT02090049|Bread|bread
206111|NCT02090049|Dietary fiber|dietary fiber
206112|NCT02090049|Gastrointestinal hormones|gastrointestinal hormones
206113|NCT02090049|Glycemia|glycemia
206114|NCT02090049|Insulinemia|insulinemia
206115|NCT02090036|Efficacy|efficacy
206116|NCT02090036|Safety|safety
206117|NCT02090036|Primaquine|primaquine
206118|NCT02090036|Artemether-lumefantrine|artemether-lumefantrine
206119|NCT02090036|Gametocytes|gametocytes
206120|NCT02090023|Obstructive sleep apnea|obstructive sleep apnea
206121|NCT02090023|National Health Insurance Research Database in Taiwan|national health insurance research database in taiwan
206122|NCT02090023|Survival Analysis|survival analysis
206123|NCT02090023|Validation Studies|validation studies
206124|NCT02090023|Cohort Studies|cohort studies
206125|NCT02089997|Pharmacological therapy|pharmacological therapy
206126|NCT02089984|Cognitive Behavior Therapy|cognitive behavior therapy
206127|NCT02089984|On-line training|on-line training
206128|NCT02089958|Lapraoscopy, incisional hernia repair, mesh|lapraoscopy, incisional hernia repair, mesh
206129|NCT02089945|transcatheter aortic valve implantation|transcatheter aortic valve implantation
206130|NCT02089945|severe aortic stenosis|severe aortic stenosis
206131|NCT02089945|cognition|cognition
206132|NCT02089945|functional capacity|functional capacity
206133|NCT02089945|quality of life|quality of life
206134|NCT02089932|femoral nerve block|femoral nerve block
206135|NCT02089932|peri-neural dexmedetomidine|peri-neural dexmedetomidine
206136|NCT02089867|Ezetimibe|ezetimibe
206137|NCT02089867|Plant sterol|plant sterol
206138|NCT02089867|Hydroxymethylglutaryl coenzyme A Reductase Inhibitors|hydroxymethylglutaryl coenzyme a reductase inhibitors
206139|NCT02089867|Coronary artery disease|coronary artery disease
206140|NCT02089867|LDL-cholesterol|ldl-cholesterol
206141|NCT02089854|triple negative breast cancer|triple negative breast cancer
206142|NCT02089854|estrogen receptor-beta|estrogen receptor-beta
206143|NCT02089854|endocrine therapy|endocrine therapy
206144|NCT02089841|Efficacy|efficacy
206145|NCT02089841|Artemether/lumefantrine|artemether/lumefantrine
206146|NCT02089841|Malaria|malaria
206147|NCT02089841|Children|children
206148|NCT02089802|RCC|rcc
206149|NCT02089789|Natural History|natural history
206150|NCT02089789|Glycosylation|glycosylation
206151|NCT02089789|Genetic Disorders|genetic disorders
206152|NCT02089776|Stroke|stroke
206153|NCT02089776|fMRI|fmri
206154|NCT02089776|Real Time fMRI Feedback|real time fmri feedback
206155|NCT02089763|Hepatocellular carcinoma|hepatocellular carcinoma
206156|NCT02089763|HCC|hcc
206157|NCT02089763|Pegylated recombinant human arginase|pegylated recombinant human arginase
206158|NCT02089763|PEG-BCT-100|peg-bct-100
206159|NCT02089763|ASS|ass
206160|NCT02089763|OTC|otc
206161|NCT02089750|Low Back Pain|low back pain
206162|NCT02089750|Chiropractic|chiropractic
206163|NCT02089750|Shoe Orthotics|shoe orthotics
206164|NCT02089711|Normal subjects|normal subjects
206165|NCT02089698|Kelman tip|kelman tip
206166|NCT02089698|Mini-flared|mini-flared
206167|NCT02089698|phacoemulsification|phacoemulsification
206168|NCT02089698|cataract|cataract
206169|NCT02089633|hepatocellular carcinoma|hepatocellular carcinoma
206170|NCT02089633|HCC|hcc
206171|NCT02089633|pegylated recombinant human arginase|pegylated recombinant human arginase
206172|NCT02089633|PEG-BCT-100|peg-bct-100
206173|NCT02089633|oxaliplatin|oxaliplatin
206174|NCT02089633|capecitabine|capecitabine
206175|NCT02089620|Premenstrual syndrome|premenstrual syndrome
206176|NCT02089620|Oral contraceptive pills|oral contraceptive pills
206177|NCT02089620|Calcium Supplements|calcium supplements
206178|NCT02089594|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
206179|NCT02089594|Mild Traumatic Brain Injury|mild traumatic brain injury
206180|NCT02089594|Persistent Post-Concussion Syndrome|persistent post-concussion syndrome
206181|NCT02089581|Healthy Volunteer|healthy volunteer
206182|NCT02089581|Pharmacokinetics|pharmacokinetics
206183|NCT02089581|Bioequivalence|bioequivalence
206184|NCT02089568|Living donation|living donation
206185|NCT02089568|Antibiotics|antibiotics
206186|NCT02089568|Laparoscopic surgery|laparoscopic surgery
206187|NCT02089542|thyroidectomy|thyroidectomy
206188|NCT02089542|parathyroid surgery|parathyroid surgery
206189|NCT02089542|parathyroid identification|parathyroid identification
206190|NCT02089542|methylene blue|methylene blue
206191|NCT02089542|near infrared fluorescence|near infrared fluorescence
206192|NCT02089542|intraoperative imaging|intraoperative imaging
206193|NCT02089529|Axial Spondyloarthritis|axial spondyloarthritis
206194|NCT02089529|Pain|pain
206195|NCT02089529|NSAIDs|nsaids
206196|NCT02089529|Placebo|placebo
206197|NCT02089529|Placebo intervention|placebo intervention
206198|NCT02089529|Stress|stress
206199|NCT02089529|Conditioning|conditioning
206200|NCT02089516|Frailty|frailty
206201|NCT02089516|Accelerometry|accelerometry
206202|NCT02089516|Physical activity|physical activity
206203|NCT02089516|validity|validity
206204|NCT02089477|Type 2 diabetes, InterWalk, Individual Support, Motivation|type 2 diabetes, interwalk, individual support, motivation
206205|NCT02089412|Healthy Subjects|healthy subjects
206206|NCT02089412|Absorption|absorption
206207|NCT02089412|High-Fat Meal|high-fat meal
206208|NCT02089360|Advanced glycation end product|advanced glycation end product
206209|NCT02089360|coronary|coronary
206210|NCT02089360|atherosclerosis|atherosclerosis
206211|NCT02089360|inflammation|inflammation
206212|NCT02089360|outcome|outcome
206213|NCT02089347|Tetanus|tetanus
206214|NCT02089347|Diphtheria|diphtheria
206215|NCT02089347|Pertussis|pertussis
206216|NCT02089347|TdaP vaccine|tdap vaccine
206217|NCT02089347|DT vaccine|dt vaccine
206218|NCT02089334|renal cell carcinoma|renal cell carcinoma
206219|NCT02089334|clear cell|clear cell
197007|NCT02129842|PAT|pat
206220|NCT02089334|renal cancer|renal cancer
206221|NCT02089334|metastatic renal cancer|metastatic renal cancer
206222|NCT02089334|Carcinoma, Renal Cell*/therapy|carcinoma, renal cell*/therapy
206223|NCT02089334|Humans|humans
206224|NCT02089334|Kidney Neoplasms*/therapy|kidney neoplasms*/therapy
206225|NCT02089321|low back pain|low back pain
206226|NCT02089321|lumbopelvic assessment|lumbopelvic assessment
206227|NCT02089321|active straight leg raise|active straight leg raise
206228|NCT02089321|active hip abduction|active hip abduction
206229|NCT02089308|Smoking cessation|smoking cessation
206230|NCT02089308|Nicotine|nicotine
206231|NCT02089308|Tobacco Use Disorder|tobacco use disorder
206232|NCT02089308|Central Nervous System Agents|central nervous system agents
206233|NCT02089295|dose proportionality|dose proportionality
206234|NCT02089295|oxycodone|oxycodone
206235|NCT02089269|pancreatic neoplasms|pancreatic neoplasms
206236|NCT02089269|neoplasms|neoplasms
206237|NCT02089269|registry|registry
206238|NCT02089269|advanced pancreatic cancer|advanced pancreatic cancer
206239|NCT02089269|health services research|health services research
206240|NCT02089269|epidemiology|epidemiology
206241|NCT02089269|Germany|germany
206242|NCT02089269|palliative treatment|palliative treatment
206243|NCT02089269|palliative care|palliative care
206244|NCT02089243|Epilepsy,Temporal Lobe|epilepsy,temporal lobe
206245|NCT02089243|Brain Diseases|brain diseases
206246|NCT02089230|Leukemia|leukemia
206247|NCT02089230|Acute Myeloid Leukemia|acute myeloid leukemia
206248|NCT02089230|AML|aml
206249|NCT02089230|Advanced leukemias|advanced leukemias
206250|NCT02089230|Myelodysplastic syndrome|myelodysplastic syndrome
206251|NCT02089230|MDS|mds
206252|NCT02089230|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
206253|NCT02089230|ALL|all
206254|NCT02089230|Relapsed|relapsed
206255|NCT02089230|Refractory|refractory
206256|NCT02089230|MEK 162|mek 162
206257|NCT02089217|asymptomatic|asymptomatic
206258|NCT02089217|carotid|carotid
206259|NCT02089217|stent|stent
206260|NCT02089217|endarterectomy|endarterectomy
206261|NCT02089217|embolic protection|embolic protection
206262|NCT02089217|medical management|medical management
206263|NCT02089217|hypertension|hypertension
206264|NCT02089217|hyperlipidemia|hyperlipidemia
206266|NCT02089217|risk factor control|risk factor control
206267|NCT02089204|Hypoxia Imaging -Guided Radiotherapy|hypoxia imaging -guided radiotherapy
206268|NCT02089204|PET/CT|pet/ct
206269|NCT02089204|simultaneous modulated accelerated radiation therapy (SMART)|simultaneous modulated accelerated radiation therapy (smart)
206270|NCT02089191|DACP|dacp
206271|NCT02089191|DAILIES® AquaComfort Plus|dailies® aquacomfort plus
206272|NCT02089191|Tear film stability|tear film stability
206273|NCT02089191|NIK-BUT|nik-but
206274|NCT02089178|total intravenous anesthesia, inhalation anesthesia, cancer cell cytotoxicity, breast tumor|total intravenous anesthesia, inhalation anesthesia, cancer cell cytotoxicity, breast tumor
206275|NCT02089152|Diabetes|diabetes
206276|NCT02089152|Melioidosis|melioidosis
206277|NCT02089152|stepped wedge trial|stepped wedge trial
206278|NCT02089152|behaviour change|behaviour change
206279|NCT02089152|Education program|education program
206280|NCT02089139|Back pain|back pain
206281|NCT02089139|Discogel|discogel
206282|NCT02089087|Rheumatoid arthritis, RA, first-in-human, single ascending dose, safety, tolerability|rheumatoid arthritis, ra, first-in-human, single ascending dose, safety, tolerability
206283|NCT02089074|Secondary Prevention|secondary prevention
206284|NCT02089074|Pharmacists|pharmacists
206285|NCT02089074|Directive Counseling|directive counseling
206286|NCT02089074|Medication Adherence|medication adherence
206287|NCT02089074|Patient Compliance|patient compliance
206288|NCT02089048|Amebiasis|amebiasis
206289|NCT02089048|auranofin|auranofin
206290|NCT02089048|pharmacodynamics|pharmacodynamics
206291|NCT02089048|pharmokinetics|pharmokinetics
206292|NCT02089035|Milk fatty acids|milk fatty acids
206293|NCT02089035|Total cholesterol|total cholesterol
206294|NCT02089035|Vascular function|vascular function
206295|NCT02089035|Blood pressure|blood pressure
206297|NCT02089022|Heat|heat
206298|NCT02089022|Ground reaction forces|ground reaction forces
206299|NCT02089022|Electromyography|electromyography
206300|NCT02089022|Lower Limb|lower limb
206301|NCT02089022|Center of pressure|center of pressure
206302|NCT02088970|Infectious keratitis|infectious keratitis
206303|NCT02088970|Corneal cross linking|corneal cross linking
206304|NCT02088970|Topical antibiotics|topical antibiotics
206305|NCT02088957|Brivaracetam|brivaracetam
206306|NCT02088957|Phenytoin|phenytoin
206307|NCT02088957|Nonconvulsive electrographic seizures|nonconvulsive electrographic seizures
206308|NCT02088931|Tregs|tregs
206309|NCT02088931|Kidney transplantation|kidney transplantation
206310|NCT02088905|PCIT, autism, parent training, noncompliance|pcit, autism, parent training, noncompliance
206311|NCT02088892|BCG challenge study|bcg challenge study
206312|NCT02088866|Tinnitus|tinnitus
206313|NCT02088866|Otolaryngology|otolaryngology
206314|NCT02088853|intestinal|intestinal
206315|NCT02088853|metabolic control|metabolic control
206316|NCT02088853|mucosa|mucosa
206317|NCT02088853|human|human
206318|NCT02088853|diet|diet
206319|NCT02088840|SIGNB|signb
206320|NCT02088840|severe infections gram negative bacteria|severe infections gram negative bacteria
206321|NCT02088840|stem cell transplant|stem cell transplant
206322|NCT02088827|Exercise|exercise
206323|NCT02088827|Sedentary Behaviour|sedentary behaviour
206324|NCT02088827|Type 2 Diabetes|type 2 diabetes
206325|NCT02088827|Older Adults|older adults
206326|NCT02088814|posttraumatic stress|posttraumatic stress
206327|NCT02088814|burns|burns
206328|NCT02088814|injuries|injuries
206329|NCT02088814|children|children
206330|NCT02088801|Intubation; Difficult|intubation; difficult
206331|NCT02088788|radiation|radiation
206332|NCT02088788|radiation injury|radiation injury
206333|NCT02088788|occupational risk|occupational risk
206334|NCT02088762|margin of safety|margin of safety
206335|NCT02088749|obesity|obesity
206336|NCT02088749|weight loss|weight loss
206337|NCT02088749|treatment|treatment
206338|NCT02088749|lifestyle|lifestyle
206339|NCT02088723|Sleep Apnea, Obstructive|sleep apnea, obstructive
206340|NCT02088723|Sleep Apnea Syndromes|sleep apnea syndromes
206341|NCT02088723|Polysomnography|polysomnography
206342|NCT02088723|Sleep|sleep
206343|NCT02088723|Patient Positioning|patient positioning
206344|NCT02088710|Patients´ Expectations|patients´ expectations
206345|NCT02088710|Breast Cancer|breast cancer
206346|NCT02088710|Adjuvant Endocrine Treatment|adjuvant endocrine treatment
206347|NCT02088710|Nocebo|nocebo
206348|NCT02088710|Psycho-oncology|psycho-oncology
206349|NCT02088710|Satisfaction with information|satisfaction with information
206350|NCT02088684|Hormone receptor positive, HER2 negative|hormone receptor positive, her2 negative
206351|NCT02088671|NeuroSENSE|neurosense
206352|NCT02088671|Anesthesia|anesthesia
206353|NCT02088671|Hypnosis|hypnosis
206354|NCT02088671|Desflurane|desflurane
206355|NCT02088671|Propofol|propofol
206356|NCT02088658|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
206357|NCT02088658|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
206358|NCT02088658|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
206359|NCT02088658|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
206360|NCT02088658|Diabetes Mellitus, Type II|diabetes mellitus, type ii
206361|NCT02088658|African Americans|african americans
206362|NCT02088658|Blacks|blacks
206363|NCT02088658|non-Hispanic Blacks|non-hispanic blacks
206364|NCT02088658|Randomized Control Trial|randomized control trial
206365|NCT02088658|Controlled Clinical Trial|controlled clinical trial
206366|NCT02088658|Behavioral Research|behavioral research
206367|NCT02088658|Behavioral Medicine|behavioral medicine
206368|NCT02088645|Calcitonin|calcitonin
206369|NCT02088645|Medullary thyroid carcinoma|medullary thyroid carcinoma
206370|NCT02088645|Peptide receptor radionuclide therapy|peptide receptor radionuclide therapy
206371|NCT02088645|Gastrin|gastrin
206372|NCT02088645|Cholecystokinin-2 receptor|cholecystokinin-2 receptor
206373|NCT02088619|psychological wellbeing|psychological wellbeing
206374|NCT02088619|anxiety|anxiety
206376|NCT02088619|autonomic functioning|autonomic functioning
206377|NCT02088606|Atrial fibrillation|atrial fibrillation
206378|NCT02088593|Medical Students|medical students
206379|NCT02088541|Relapsed/Refractory Acute Myeloid Leukemia|relapsed/refractory acute myeloid leukemia
206380|NCT02088541|Acute Myeloid Leukemia|acute myeloid leukemia
206381|NCT02088541|AML|aml
206382|NCT02088541|Karyopharm|karyopharm
206383|NCT02088541|Selinexor|selinexor
206384|NCT02088541|KPT-330|kpt-330
206385|NCT02088515|Nedaplatin|nedaplatin
206386|NCT02088515|lung squamous cell carcinoma|lung squamous cell carcinoma
206387|NCT02088502|Coronary Angiography|coronary angiography
206388|NCT02088502|Side Effects|side effects
206389|NCT02088502|Contrast-Induced Nephropathy|contrast-induced nephropathy
206390|NCT02088502|Prevention|prevention
206391|NCT02088489|Atrial flutter|atrial flutter
206392|NCT02088489|Thermocool catheter|thermocool catheter
206393|NCT02088489|Thermocool SF catheter|thermocool sf catheter
206394|NCT02088476|candidemia|candidemia
206395|NCT02088476|children|children
206396|NCT02088476|mortality|mortality
206397|NCT02088476|risk factors|risk factors
206398|NCT02088463|Mechanical LBP|mechanical lbp
206399|NCT02088463|Mobilization|mobilization
206400|NCT02088463|Postpartum|postpartum
206401|NCT02088450|Cardiovascular complications|cardiovascular complications
206402|NCT02088450|Clinical trial|clinical trial
206403|NCT02088450|Elderly|elderly
206404|NCT02088450|Isolated systolic hypertension|isolated systolic hypertension
206405|NCT02088450|Stroke|stroke
206406|NCT02088398|relative bioavailability|relative bioavailability
206407|NCT02088398|food-effect|food-effect
206408|NCT02088359|cycled light, near darkness, growth|cycled light, near darkness, growth
206409|NCT02088346|Stroke|stroke
206410|NCT02088346|Thrombolysis|thrombolysis
206411|NCT02088346|Tissue plasminogen activator|tissue plasminogen activator
206412|NCT02088346|Urokinase|urokinase
206413|NCT02088346|Telemedicine|telemedicine
206414|NCT02088333|colorectal cancer screening|colorectal cancer screening
206415|NCT02088333|computer-assisted instruction|computer-assisted instruction
206416|NCT02088333|mHealth|mhealth
206417|NCT02088333|text message|text message
206418|NCT02088307|cardiovascular supplement|cardiovascular supplement
206419|NCT02088307|cardiovascular disease|cardiovascular disease
206420|NCT02088307|coronary artery disease|coronary artery disease
206421|NCT02088294|obesity|obesity
206422|NCT02088294|stress|stress
206423|NCT02088294|intuitive eating|intuitive eating
206424|NCT02088294|guided imagery|guided imagery
206425|NCT02088294|adolescents|adolescents
206426|NCT02088294|insulin resistance|insulin resistance
206427|NCT02088294|latinos|latinos
206428|NCT02088294|minorities|minorities
206429|NCT02088281|Indigo naturalis, indirubin, Th1 cells, Th17 cells|indigo naturalis, indirubin, th1 cells, th17 cells
206430|NCT02088255|Rehabilitation|rehabilitation
206431|NCT02088255|Gait|gait
206432|NCT02088255|Stroke|stroke
206433|NCT02088255|Biomechanics|biomechanics
206434|NCT02088229|Diabetic Macular Edema|diabetic macular edema
206435|NCT02088216|N-acetylcysteine；|n-acetylcysteine；
206436|NCT02088216|Bronchiectasis；|bronchiectasis；
206437|NCT02088216|Acute exacerbations；|acute exacerbations；
206438|NCT02088216|Antioxidant；|antioxidant；
206439|NCT02088216|Anti-inflammatory|anti-inflammatory
206440|NCT02088177|Cannabis|cannabis
206441|NCT02088177|Cannabis Dependence|cannabis dependence
206442|NCT02088177|Cannabis Use Disorder|cannabis use disorder
206443|NCT02088177|Marijuana|marijuana
206444|NCT02088177|Naltrexone|naltrexone
206445|NCT02088177|Long Acting Injectable Naltrexone|long acting injectable naltrexone
206446|NCT02088177|Treatment|treatment
206447|NCT02088164|PSA,|psa,
206448|NCT02088164|asian men,|asian men,
206449|NCT02088164|survival|survival
206450|NCT02088151|selective laser therapy|selective laser therapy
206451|NCT02088151|retinal pigment epithelium|retinal pigment epithelium
206452|NCT02088151|macular edema|macular edema
206453|NCT02088151|diabetic retinopathy|diabetic retinopathy
206454|NCT02088151|central serous chorioretinopathy|central serous chorioretinopathy
206455|NCT02088151|age-related macular degeneration|age-related macular degeneration
206457|NCT02088138|Thoracic Surgery|thoracic surgery
206458|NCT02088138|Electrical Stimulation|electrical stimulation
206459|NCT02088138|Rehabilitation|rehabilitation
206460|NCT02088138|Quality of Life|quality of life
206461|NCT02088125|Stroke|stroke
206462|NCT02088125|Incentive Spirometry|incentive spirometry
206463|NCT02088125|Breath Stacking|breath stacking
206464|NCT02088125|Optoelectronic Plethysmography|optoelectronic plethysmography
206465|NCT02088112|NSCLC|nsclc
206466|NCT02088099|Traumatic brain injury|traumatic brain injury
206467|NCT02088099|Telehealth|telehealth
206468|NCT02088099|ehealth|ehealth
206469|NCT02088099|Mobile Health|mobile health
206470|NCT02088099|social participation|social participation
206471|NCT02088099|patient participation|patient participation
206472|NCT02088099|consumer participation|consumer participation
206473|NCT02088099|Patient Outcome Assessment|patient outcome assessment
206474|NCT02088086|Pediatric obesity|pediatric obesity
206476|NCT02088086|Body mass index|body mass index
206477|NCT02088086|Primary schools|primary schools
206478|NCT02088086|Secondary schools|secondary schools
206479|NCT02088047|Autism|autism
206480|NCT02088047|Self-Stimulating behaviors|self-stimulating behaviors
206481|NCT02088047|Autism Spectrum Disorders|autism spectrum disorders
206482|NCT02087995|Diabetes Mellitus|diabetes mellitus
206483|NCT02087956|Women|women
206484|NCT02087956|Depression|depression
206485|NCT02087956|Socioeconomically Disadvantaged|socioeconomically disadvantaged
206486|NCT02087956|Navigation|navigation
206487|NCT02087943|Atopic Dermatitis|atopic dermatitis
206488|NCT02087943|Atopic Eczema|atopic eczema
206489|NCT02087917|hypercholesterolemia|hypercholesterolemia
206490|NCT02087917|cholesterol absorption inhibitor|cholesterol absorption inhibitor
206491|NCT02087917|placebo-controlled trial|placebo-controlled trial
206492|NCT02087904|Pain|pain
206493|NCT02087904|Osteoarthritis|osteoarthritis
206494|NCT02087904|Synovitis|synovitis
206495|NCT02087904|Knee|knee
206496|NCT02087878|Hepatosplenic T-Cell Lymphoma|hepatosplenic t-cell lymphoma
206497|NCT02087852|Questionnaire|questionnaire
206498|NCT02087852|DNA|dna
206499|NCT02087852|saliva|saliva
206500|NCT02087852|kidney cancer|kidney cancer
206501|NCT02087852|13-218|13-218
206502|NCT02087839|Non-Small Cell Lung Cancer|non-small cell lung cancer
206503|NCT02087839|Lung Cancer|lung cancer
206504|NCT02087839|NSCLC|nsclc
206505|NCT02087839|ZD6474|zd6474
206506|NCT02087839|ZACTIMA|zactima
206507|NCT02087839|Vandetanib|vandetanib
206508|NCT02087839|Inoperable NSCLC|inoperable nsclc
206509|NCT02087839|Unresectable NSCLC|unresectable nsclc
206510|NCT02087839|Radiation Therapy|radiation therapy
206511|NCT02087839|Palliative radiation therapy|palliative radiation therapy
206512|NCT02087839|Angiogenesis|angiogenesis
206513|NCT02087813|neuromyelitis optica|neuromyelitis optica
252851|NCT01876875|obesity|obesity
206514|NCT02087813|optic neuritis|optic neuritis
206515|NCT02087813|longitudinally extensive transverse myelitis|longitudinally extensive transverse myelitis
206516|NCT02087800|smoking cessation|smoking cessation
206517|NCT02087800|smoking abstinence|smoking abstinence
206518|NCT02087800|allopregnanolone|allopregnanolone
206519|NCT02087787|bone marrow transplant|bone marrow transplant
206520|NCT02087787|hematologic malignancies|hematologic malignancies
206521|NCT02087761|ARIES Flu|aries flu
206522|NCT02087748|DOMS|doms
206523|NCT02087735|Cranberry|cranberry
206524|NCT02087735|Proanthocyanidins|proanthocyanidins
206525|NCT02087735|Urinary catabolites|urinary catabolites
206526|NCT02087722|Primary Insomnia|primary insomnia
206527|NCT02087696|Arthritis, Rheumatoid|arthritis, rheumatoid
206528|NCT02087696|methotrexate|methotrexate
206529|NCT02087696|intolerance|intolerance
206530|NCT02087696|poor compliance|poor compliance
206531|NCT02087696|contraindication|contraindication
206532|NCT02087696|Tocilizumab|tocilizumab
206533|NCT02087696|monotherapy|monotherapy
206534|NCT02087683|heart failure|heart failure
206535|NCT02087683|vitamin D deficiency|vitamin d deficiency
206536|NCT02087683|ventricular function|ventricular function
206537|NCT02087683|cytokines|cytokines
206538|NCT02087670|chronic heart failure|chronic heart failure
206539|NCT02087670|cardiac rehabilitation|cardiac rehabilitation
206540|NCT02087670|exercise|exercise
206541|NCT02087670|Natriuretic Brain Pro-peptid|natriuretic brain pro-peptid
206542|NCT02087657|Peripheral Blood Stem Cell (PBSC) Transplant|peripheral blood stem cell (pbsc) transplant
206543|NCT02087657|Hyperbaric oxygen|hyperbaric oxygen
206544|NCT02087657|Lymphoma|lymphoma
206545|NCT02087657|Myeloma|myeloma
206546|NCT02087631|multiple sclerosis|multiple sclerosis
206547|NCT02087631|quetiapine|quetiapine
206548|NCT02087631|remyelination|remyelination
206549|NCT02087618|MCI|mci
206550|NCT02087618|Alzheimer's|alzheimer's
206551|NCT02087618|Dementia|dementia
206552|NCT02087618|Tablet|tablet
206553|NCT02087618|Non-Pharmacological Intervention|non-pharmacological intervention
206554|NCT02087618|Cognition|cognition
206555|NCT02087605|Vascular stiffness, retinal vessels, target organ damage|vascular stiffness, retinal vessels, target organ damage
206556|NCT02087592|hereditary breast and ovarian cancer (HBOC)|hereditary breast and ovarian cancer (hboc)
206557|NCT02087592|BRCA1/2 mutation carriers|brca1/2 mutation carriers
206558|NCT02087592|Mediterranean diet|mediterranean diet
206559|NCT02087592|Structured exercise training|structured exercise training
206561|NCT02087579|Psychotic Disorders|psychotic disorders
206562|NCT02087579|Schizophrenia|schizophrenia
206563|NCT02087579|Bipolar Disorder|bipolar disorder
206564|NCT02087579|Depressive Disorder|depressive disorder
206565|NCT02087579|Antipsychotics|antipsychotics
206566|NCT02087579|Aripiprazole|aripiprazole
206567|NCT02087579|Olanzapine|olanzapine
206568|NCT02087579|Paliperidone|paliperidone
206569|NCT02087579|Quetiapine|quetiapine
206570|NCT02087579|Risperidone|risperidone
206571|NCT02087579|Capillary Concentration|capillary concentration
206572|NCT02087566|Linezolid|linezolid
206573|NCT02087566|Pharmacokinetics|pharmacokinetics
206574|NCT02087566|Haemodialysis|haemodialysis
206575|NCT02087566|Dosing adjustment|dosing adjustment
206576|NCT02087566|Eligible subjects were classified into three groups depending on their 24-h urinary creatinine clearance (CLcr) values or HD status.|eligible subjects were classified into three groups depending on their 24-h urinary creatinine clearance (clcr) values or hd status.
206577|NCT02087566|Group 1, included 6 healthy subjects with normal renal function (CLcr ˃80 ml/min);|group 1, included 6 healthy subjects with normal renal function (clcr ˃80 ml/min);
206578|NCT02087566|Group 2, included 6 patients with acute renal failure (RF) (30˂CLcr˂80 ml/mine);|group 2, included 6 patients with acute renal failure (rf) (30˂clcr˂80 ml/mine);
206579|NCT02087566|Group 3, included 6 patients on long term haemodialysis (minimum period of dialysis was 40 month while maximum period were 130 month)|group 3, included 6 patients on long term haemodialysis (minimum period of dialysis was 40 month while maximum period were 130 month)
206580|NCT02087553|Blood Transfusion|blood transfusion
206582|NCT02087553|Packed Red Blood Cells|packed red blood cells
206584|NCT02087553|NTBI|ntbi
206585|NCT02087527|Cellulitis|cellulitis
206586|NCT02087527|Soft Tissue Infections|soft tissue infections
206587|NCT02087527|Skin Diseases, Infectious|skin diseases, infectious
206588|NCT02087527|Corticosteroids|corticosteroids
206589|NCT02087527|Glucocorticoids|glucocorticoids
206590|NCT02087527|Dexamethasone|dexamethasone
206591|NCT02087514|Blood Transfusion|blood transfusion
206592|NCT02087514|Iron|iron
206593|NCT02087514|Red Blood Cells|red blood cells
206594|NCT02087501|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
206595|NCT02087501|AAA|aaa
206596|NCT02087501|Abdominal Aortoiliac Aneurysm|abdominal aortoiliac aneurysm
206597|NCT02087501|Endovascular Aortic Repair|endovascular aortic repair
206598|NCT02087501|EVAR|evar
206599|NCT02087488|primary insomnia|primary insomnia
206600|NCT02087488|auricular acupuncture|auricular acupuncture
206601|NCT02087462|Sciatica|sciatica
206602|NCT02087462|Electroacupuncture|electroacupuncture
197394|NCT02128256|Ceramic|ceramic
206603|NCT02087462|Intervertebral disc displacement|intervertebral disc displacement
206604|NCT02087423|Locally advanced, metastatic, Non-Small Cell Lung Cancer, MEDI4736, PD-L1|locally advanced, metastatic, non-small cell lung cancer, medi4736, pd-l1
206605|NCT02087397|Stem Cell|stem cell
206606|NCT02087397|Erectile Dysfunction|erectile dysfunction
206607|NCT02087384|Anal intraepithelial neoplasia|anal intraepithelial neoplasia
206608|NCT02087384|HIV|hiv
206609|NCT02087384|HPV|hpv
206610|NCT02087384|Vaccination|vaccination
206611|NCT02087384|Gardasil|gardasil
206612|NCT02087384|Prophylactic|prophylactic
206613|NCT02087358|alcohol dependence|alcohol dependence
206614|NCT02087358|Stress- correlation|stress- correlation
206615|NCT02087358|genetic|genetic
206616|NCT02087358|CRHR1|crhr1
206617|NCT02087332|Kidney damage hypertension cardiovascular diseases, congestive heart failure renal function natriuresis natriuresis monitoring|kidney damage hypertension cardiovascular diseases, congestive heart failure renal function natriuresis natriuresis monitoring
206618|NCT02087306|Adenovirus Infection|adenovirus infection
206619|NCT02087241|Stage IV Lung Cancer|stage iv lung cancer
206620|NCT02087228|Endometrial ablation, menorrhagia|endometrial ablation, menorrhagia
206621|NCT02087215|diabetes mellitus|diabetes mellitus
206622|NCT02087215|foot ulcer|foot ulcer
206623|NCT02087215|boron|boron
206624|NCT02087215|wound care|wound care
206625|NCT02087202|pain|pain
206626|NCT02087189|ICD, CRT-D, lead|icd, crt-d, lead
206627|NCT02087176|NSCLC|nsclc
206628|NCT02087137|aging|aging
206629|NCT02087137|memory|memory
206630|NCT02087137|memory training|memory training
206631|NCT02087124|Whey protein|whey protein
206632|NCT02087124|Postprandial lipaemia|postprandial lipaemia
206633|NCT02087124|Pre-meal|pre-meal
206634|NCT02087124|Metabolic syndrome|metabolic syndrome
206635|NCT02087111|Telaprevir|telaprevir
206636|NCT02087111|Genotype 3 HCV|genotype 3 hcv
206637|NCT02087098|overactive bladder|overactive bladder
206638|NCT02087098|solifenacin|solifenacin
206639|NCT02087098|quality of life|quality of life
206640|NCT02087072|home visits|home visits
206641|NCT02087072|transitions of care|transitions of care
206642|NCT02087072|pharmacist|pharmacist
206643|NCT02087059|Post-Polycythemia Vera (PV) MF|post-polycythemia vera (pv) mf
206644|NCT02087059|Post-Essential Thrombocythemia (ET) MF|post-essential thrombocythemia (et) mf
206581|NCT02087553|Iron|iron
206645|NCT02087033|supraventricular ectopic beats|supraventricular ectopic beats
206646|NCT02087020|Joint Prosthesis|joint prosthesis
206647|NCT02087020|Prosthesis-Related Infections|prosthesis-related infections
206648|NCT02087020|Joint Diseases|joint diseases
206649|NCT02087020|Therapeutic Irrigation|therapeutic irrigation
206650|NCT02087020|Prostheses and Implants|prostheses and implants
206651|NCT02087020|Arthroplasty Replacement|arthroplasty replacement
206652|NCT02087007|Treatment for vasospastic angina|treatment for vasospastic angina
206653|NCT02086994|carbetocin, misoprostol, pre-eclampsia, pph|carbetocin, misoprostol, pre-eclampsia, pph
206655|NCT02086955|Nursing counseling|nursing counseling
206656|NCT02086955|Foot ulceration|foot ulceration
206657|NCT02086955|Outpatient|outpatient
206658|NCT02086955|Advanced Practice Nurse|advanced practice nurse
206659|NCT02086929|Trazodone|trazodone
206660|NCT02086929|Venlafaxine|venlafaxine
206661|NCT02086929|Major depressive disorder|major depressive disorder
206662|NCT02086916|Clostridium difficile|clostridium difficile
206663|NCT02086916|Prediction|prediction
206664|NCT02086916|Treatment|treatment
206666|NCT02086903|Ticagrelor|ticagrelor
206667|NCT02086903|Clopidogrel|clopidogrel
206668|NCT02086903|Platelet function test|platelet function test
206669|NCT02086890|retinitis pigmentosa|retinitis pigmentosa
206670|NCT02086890|acupuncture|acupuncture
206671|NCT02086890|electroacupuncture|electroacupuncture
206672|NCT02086890|transcorneal electrical stimulation|transcorneal electrical stimulation
206673|NCT02086890|microcurrent|microcurrent
206674|NCT02086864|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
206675|NCT02086864|ADHD|adhd
206676|NCT02086864|Homeopathy|homeopathy
206677|NCT02086851|pediatric obesity|pediatric obesity
206678|NCT02086851|motivational interviewing|motivational interviewing
206679|NCT02086851|lifestyle intervention|lifestyle intervention
206680|NCT02086838|Iron deficiency anemia|iron deficiency anemia
206681|NCT02086838|Pregnancy|pregnancy
206682|NCT02086838|Iron therapy|iron therapy
206683|NCT02086799|asthma|asthma
206684|NCT02086799|thyroid hormones|thyroid hormones
206685|NCT02086799|treatment|treatment
206686|NCT02086799|asthma exacerbation|asthma exacerbation
206687|NCT02086773|Acute Leukemia|acute leukemia
206688|NCT02086773|Red Cell Transfusion|red cell transfusion
206689|NCT02086760|hydronephrosis|hydronephrosis
206690|NCT02086747|Abdominal Hysterectomy, Acetaminophen, chronic pain|abdominal hysterectomy, acetaminophen, chronic pain
206691|NCT02086734|Perfusion-CT|perfusion-ct
206692|NCT02086734|mRCC|mrcc
206693|NCT02086734|antiangiogenic therapy|antiangiogenic therapy
206694|NCT02086734|response assessment|response assessment
206695|NCT02086708|Sonoelastography,|sonoelastography,
206696|NCT02086708|Diffuse liver disease,|diffuse liver disease,
206697|NCT02086708|chronic liver disease,|chronic liver disease,
206698|NCT02086708|NASH,|nash,
206699|NCT02086708|NAFLD,|nafld,
206700|NCT02086708|Elevated Transaminases,|elevated transaminases,
206701|NCT02086708|Liver Biopsy,|liver biopsy,
206702|NCT02086708|Fibrosis,|fibrosis,
206703|NCT02086708|METAVIR|metavir
206704|NCT02086695|Chemotherapy|chemotherapy
206705|NCT02086695|Cardiotoxicity|cardiotoxicity
206706|NCT02086682|hemodialysis|hemodialysis
206707|NCT02086682|dialysis|dialysis
206708|NCT02086682|renal dialysis|renal dialysis
206709|NCT02086682|clotting|clotting
206710|NCT02086682|coagulation|coagulation
206711|NCT02086682|blood lines|blood lines
206712|NCT02086656|liver metastases|liver metastases
206713|NCT02086656|colorectal cancer|colorectal cancer
206714|NCT02086656|perioperative treatment|perioperative treatment
206715|NCT02086643|Infraclavicular block|infraclavicular block
206716|NCT02086643|Brachial Plexus|brachial plexus
206717|NCT02086643|Retroclavicular Approach|retroclavicular approach
206718|NCT02086643|Complications of retroclavicular approach|complications of retroclavicular approach
206719|NCT02086643|Success of retroclavicular approach|success of retroclavicular approach
206720|NCT02086643|Obese Patients|obese patients
206721|NCT02086643|Obesity and Anesthesia|obesity and anesthesia
206722|NCT02086630|disparities|disparities
206723|NCT02086630|antiretroviral|antiretroviral
206724|NCT02086630|HIV|hiv
206725|NCT02086630|barriers|barriers
206726|NCT02086630|access|access
206727|NCT02086630|delay|delay
206728|NCT02086630|decline|decline
206729|NCT02086630|discontinue|discontinue
206730|NCT02086630|African American|african american
206731|NCT02086630|Black|black
206732|NCT02086630|Latino|latino
206733|NCT02086630|Hispanic|hispanic
206734|NCT02086630|care continuum|care continuum
206735|NCT02086630|Heart to Heart Behavioral intervention|heart to heart behavioral intervention
206736|NCT02086630|Treatment as Usual|treatment as usual
206737|NCT02086591|Non Hodgkin Lymphoma|non hodgkin lymphoma
206738|NCT02086591|Doxycycline|doxycycline
206739|NCT02086578|multi-beam Intensity-Modulated Radiation Therapy (IMRT)|multi-beam intensity-modulated radiation therapy (imrt)
206740|NCT02086578|14-028|14-028
206741|NCT02086565|asthma,|asthma,
206742|NCT02086565|asthma control,|asthma control,
206743|NCT02086565|asthma-related quality of life|asthma-related quality of life
206744|NCT02086565|electronic health record,|electronic health record,
206745|NCT02086565|portal,|portal,
206746|NCT02086565|health literacy|health literacy
206747|NCT02086513|Graft versus Host Disease|graft versus host disease
206748|NCT02086513|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
206749|NCT02086500|Tranexamic acid|tranexamic acid
206750|NCT02086500|randomized|randomized
206751|NCT02086500|hemorrhage|hemorrhage
206752|NCT02086500|blinded|blinded
206753|NCT02086487|NIlotinib , Suboptimal Response , Imatinib|nilotinib , suboptimal response , imatinib
206754|NCT02086435|Myomectomy|myomectomy
206755|NCT02086435|Laparoscopic myomectomy|laparoscopic myomectomy
206756|NCT02086435|Morcellation|morcellation
206757|NCT02086435|Risk of dissemination|risk of dissemination
206758|NCT02086435|Uterine Sarcoma|uterine sarcoma
206759|NCT02086435|Parasitic myoma|parasitic myoma
206760|NCT02086396|obesity|obesity
206761|NCT02086396|cardiovascular risk factors|cardiovascular risk factors
206762|NCT02086396|pumpkin seed|pumpkin seed
206763|NCT02086396|diet quality|diet quality
206764|NCT02086383|Pulmonary Rehabilitation|pulmonary rehabilitation
206765|NCT02086383|Self-Efficacy|self-efficacy
206766|NCT02086383|Physical Activity|physical activity
206767|NCT02086370|PBS|pbs
206768|NCT02086370|Prophylactic bilateral salpingectomy|prophylactic bilateral salpingectomy
206769|NCT02086370|Ovarian cancer prevention|ovarian cancer prevention
206770|NCT02086370|Ovarian reserve|ovarian reserve
206771|NCT02086370|Permanent contraception|permanent contraception
206772|NCT02086370|Surgical sterilization|surgical sterilization
206773|NCT02086344|Total Laparoscopic Hysterectomy|total laparoscopic hysterectomy
206774|NCT02086344|TLH|tlh
206775|NCT02086344|Ovarian reserve|ovarian reserve
206776|NCT02086344|Prophylactic bilateral salpingectomy|prophylactic bilateral salpingectomy
206777|NCT02086344|Ovarian cancer prevention|ovarian cancer prevention
206778|NCT02086344|Ovarian cancer|ovarian cancer
206779|NCT02086344|Fallopian Tubes|fallopian tubes
206780|NCT02086318|Ovarian reserve|ovarian reserve
206781|NCT02086318|Ovarian age|ovarian age
206782|NCT02086318|Fertility|fertility
206783|NCT02086318|Reproductive prognosis|reproductive prognosis
206784|NCT02086318|Distance to menopause|distance to menopause
206785|NCT02086305|Transitional care|transitional care
206786|NCT02086305|Supportive and palliative care|supportive and palliative care
206787|NCT02086292|Injections|injections
206788|NCT02086292|Lidocaine|lidocaine
206789|NCT02086292|Pain|pain
206790|NCT02086292|Healthy volunteers|healthy volunteers
206791|NCT02086279|AMH levels|amh levels
206792|NCT02086279|Ovarian reserve|ovarian reserve
206793|NCT02086279|GnRH analogue|gnrh analogue
206794|NCT02086279|Ovarian reserve after GnRH analogue|ovarian reserve after gnrh analogue
206795|NCT02086279|Ovarian reserve modification|ovarian reserve modification
206796|NCT02086279|Antral follicle count|antral follicle count
206797|NCT02086279|Antral follicle count after GnRH analogue|antral follicle count after gnrh analogue
206798|NCT02086266|Prostatectomy|prostatectomy
206799|NCT02086266|Urinary Continence|urinary continence
206800|NCT02086266|Physical Therapy Modalities|physical therapy modalities
206801|NCT02086266|Pelvic Floor|pelvic floor
206802|NCT02086266|Randomized Trial.|randomized trial.
206803|NCT02086253|Endothelin, endothelium, flow-mediated dilatation|endothelin, endothelium, flow-mediated dilatation
206804|NCT02086227|Bioequivalence|bioequivalence
206805|NCT02086214|Upper limb|upper limb
206806|NCT02086214|Proprioceptive pressure therapy|proprioceptive pressure therapy
206807|NCT02086214|Children|children
206808|NCT02086214|Assisting Hand Assessment performance|assisting hand assessment performance
206809|NCT02086201|major depression|major depression
206810|NCT02086201|depression|depression
206811|NCT02086201|depressive disorder|depressive disorder
206812|NCT02086201|mental health|mental health
206813|NCT02086201|mental disorder|mental disorder
206814|NCT02086188|Multiple Sclerosis|multiple sclerosis
206815|NCT02086188|Overactive Bladder|overactive bladder
206816|NCT02086188|Incontinence|incontinence
206817|NCT02086188|Voiding|voiding
206818|NCT02086188|Bladder Urgency|bladder urgency
206819|NCT02086188|Pelvic Floor Exercises|pelvic floor exercises
206820|NCT02086175|relapsed/refractory indolent B cell non-Hodgkin lymphomas|relapsed/refractory indolent b cell non-hodgkin lymphomas
206821|NCT02086162|Schizophrenia|schizophrenia
206822|NCT02086162|Smoking|smoking
206823|NCT02086162|Tobacco|tobacco
206824|NCT02086162|Motivation|motivation
206825|NCT02086162|Cessation Treatment|cessation treatment
206826|NCT02086149|Quit smoking|quit smoking
206827|NCT02086149|Exercise|exercise
206828|NCT02086149|Tobacco|tobacco
206829|NCT02086149|Smoking|smoking
206830|NCT02086136|aortic dissection|aortic dissection
206831|NCT02086136|diagnosis|diagnosis
206832|NCT02086136|emergency medicine|emergency medicine
206833|NCT02086136|d-dimer|d-dimer
206834|NCT02086123|Analgesia|analgesia
206835|NCT02086123|Epidural Analgesia|epidural analgesia
206836|NCT02086123|Narcotic Analgesia|narcotic analgesia
206837|NCT02086123|Patient Controlled Analgesia|patient controlled analgesia
206838|NCT02086123|Anesthesia and Analgesia|anesthesia and analgesia
206839|NCT02086123|Anti inflammatory Analgesics|anti inflammatory analgesics
206840|NCT02086123|NSAIDS|nsaids
206842|NCT02086110|prebiotic|prebiotic
206843|NCT02086110|autism|autism
206844|NCT02086110|oligosaccharides|oligosaccharides
206845|NCT02086110|Bifidobacterium infantis|bifidobacterium infantis
206846|NCT02086097|pain|pain
206847|NCT02086097|symptomatic irreversible pulpitis|symptomatic irreversible pulpitis
206848|NCT02086097|postoperative dental pain|postoperative dental pain
206849|NCT02086084|Acute Exacerbation Chronic Obstructive Pulmonary Disease|acute exacerbation chronic obstructive pulmonary disease
206850|NCT02086084|AECOPD|aecopd
206851|NCT02086084|Non invasive ventilation|non invasive ventilation
206852|NCT02086084|NIV|niv
206853|NCT02086084|Extracorporeal carbon dioxide removal|extracorporeal carbon dioxide removal
206854|NCT02086084|ECCO2R|ecco2r
206855|NCT02086071|REBIOP re-biopsies advanced or metastatic NSCLC|rebiop re-biopsies advanced or metastatic nsclc
206856|NCT02086058|overactive bladder|overactive bladder
206857|NCT02086058|daytime urinary incontinence|daytime urinary incontinence
206858|NCT02086058|children|children
206859|NCT02086058|gene expression|gene expression
206860|NCT02086045|Coronary artery disease|coronary artery disease
206861|NCT02086032|Sleeping quality|sleeping quality
206862|NCT02086032|menopause|menopause
206863|NCT02086032|climacteric|climacteric
206864|NCT02086032|progestin|progestin
206865|NCT02086032|dydrogesterone|dydrogesterone
206866|NCT02086032|micronized progesterone|micronized progesterone
206867|NCT02086019|Revascularisation, octogenarian,acute coronary syndromes|revascularisation, octogenarian,acute coronary syndromes
206868|NCT02086006|Coronary artery disease|coronary artery disease
206869|NCT02085993|romiplostim,|romiplostim,
206870|NCT02085993|Nplate,|nplate,
206871|NCT02085993|immune thrombocytopenic purpura|immune thrombocytopenic purpura
206872|NCT02085967|Healthy|healthy
206873|NCT02085967|Metabolism|metabolism
206874|NCT02085967|Drug-Drug Interactions|drug-drug interactions
206875|NCT02085941|Head and Neck Neoplasms|head and neck neoplasms
206876|NCT02085941|Malignant Neoplasm of Vertebral Column|malignant neoplasm of vertebral column
206877|NCT02085928|Tennis elbow|tennis elbow
206878|NCT02085928|Lateral epicondylitis|lateral epicondylitis
206879|NCT02085928|Intratissue percutaneous electrolysis|intratissue percutaneous electrolysis
206880|NCT02085928|Eccentric exercise|eccentric exercise
206881|NCT02085928|Ultrasonography|ultrasonography
206882|NCT02085876|patients|patients
206883|NCT02085876|present|present
206884|NCT02085876|undergo bariatric surgery|undergo bariatric surgery
206885|NCT02085811|Kyphoplasty|kyphoplasty
206886|NCT02085811|at a single level|at a single level
206887|NCT02085811|(between T11 and L5)|(between t11 and l5)
197675|NCT02126982|clopidogrel hydrogen sulfate|clopidogrel hydrogen sulfate
197676|NCT02126982|Generic clopidogrel|generic clopidogrel
197677|NCT02126982|Coronary Artery Disease|coronary artery disease
197678|NCT02126969|Cancer|cancer
197679|NCT02126969|Low dose radiation|low dose radiation
197680|NCT02126956|ACT-128800|act-128800
197681|NCT02126943|PAH|pah
197684|NCT02126930|observance|observance
206888|NCT02085811|associated surgery|associated surgery
206983|NCT02085356|Couples|couples
206984|NCT02085356|Male involvement|male involvement
207479|NCT02083250|Myleran|myleran
206889|NCT02085798|Leukemia, Myelomonocytic, Chronic, myelodysplastic syndrome, Prospective, Treatment strategy, epidemiologic data|leukemia, myelomonocytic, chronic, myelodysplastic syndrome, prospective, treatment strategy, epidemiologic data
206890|NCT02085785|weight loss|weight loss
206891|NCT02085785|exercise|exercise
206892|NCT02085785|home-based|home-based
206893|NCT02085785|lower extremity amputation|lower extremity amputation
206894|NCT02085785|pilot study|pilot study
206895|NCT02085759|Healthy|healthy
206896|NCT02085733|Arthritis, Septic|arthritis, septic
206897|NCT02085681|Diabetic Retinopathy|diabetic retinopathy
206898|NCT02085681|Screening|screening
206899|NCT02085681|Tele-medicine|tele-medicine
206900|NCT02085681|Retinal Imaging|retinal imaging
206901|NCT02085681|Remote diagnosis|remote diagnosis
206902|NCT02085668|Chronic Heart Failure|chronic heart failure
206903|NCT02085668|Cardio-Renal Syndrome|cardio-renal syndrome
206904|NCT02085668|Renal Denervation|renal denervation
206905|NCT02085668|Symplicity|symplicity
206906|NCT02085668|Sympathetic activation|sympathetic activation
206907|NCT02085655|Extranodal NK/T-cell lymphoma|extranodal nk/t-cell lymphoma
206908|NCT02085655|PA-Gemox regimen|pa-gemox regimen
206909|NCT02085655|thalidomide|thalidomide
206910|NCT02085642|Stroke|stroke
206911|NCT02085642|Acupuncture|acupuncture
206912|NCT02085642|Gait|gait
206913|NCT02085642|Spasticity|spasticity
206914|NCT02085629|renal failure, end stage|renal failure, end stage
206915|NCT02085629|renal transplantation|renal transplantation
206916|NCT02085629|cell therapy|cell therapy
206917|NCT02085629|macrophages, monocyte derived|macrophages, monocyte derived
206918|NCT02085629|immune tolerance|immune tolerance
206919|NCT02085629|ONE Study|one study
206920|NCT02085629|immunotherapy|immunotherapy
206921|NCT02085616|Smoking cessation|smoking cessation
206922|NCT02085616|Tobacco cessation|tobacco cessation
206923|NCT02085616|Quitline|quitline
206924|NCT02085616|Telephone counselling|telephone counselling
206925|NCT02085616|Intensity|intensity
206926|NCT02085603|advanced solid malignancies|advanced solid malignancies
206927|NCT02085590|BCG vaccine|bcg vaccine
206928|NCT02085590|Sepsis|sepsis
206929|NCT02085590|Immunity|immunity
206930|NCT02085577|Morphine consumption|morphine consumption
206931|NCT02085577|Postoperative pain|postoperative pain
206932|NCT02085577|Ketamine|ketamine
206933|NCT02085577|Side effects|side effects
206934|NCT02085577|Spine surgery|spine surgery
206935|NCT02085577|Chronic pain|chronic pain
206936|NCT02085564|Gastroesophageal-junction cancer|gastroesophageal-junction cancer
206937|NCT02085564|neoadjuvant chemotherapy|neoadjuvant chemotherapy
206938|NCT02085551|peripheral arterial occlusion|peripheral arterial occlusion
206939|NCT02085551|visceral emboli|visceral emboli
206940|NCT02085551|limb ischemia|limb ischemia
206941|NCT02085551|adverse events|adverse events
206942|NCT02085551|Indigo System|indigo system
206943|NCT02085551|aspiration|aspiration
206944|NCT02085551|mechanical thrombectomy|mechanical thrombectomy
206945|NCT02085538|renal impairment|renal impairment
206946|NCT02085538|AUC|auc
206947|NCT02085538|Cmax|cmax
206948|NCT02085538|palbociclib|palbociclib
206949|NCT02085538|normal matched subjects|normal matched subjects
206950|NCT02085512|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
206951|NCT02085512|Major Depression|major depression
206952|NCT02085512|Secondary Prevention|secondary prevention
206953|NCT02085512|Neurocognitive Retraining|neurocognitive retraining
207155|NCT02084602|artesunate|artesunate
206954|NCT02085512|Randomized Controlled Trial|randomized controlled trial
206955|NCT02085499|nasal ventilation|nasal ventilation
206956|NCT02085499|premature infants|premature infants
206957|NCT02085499|synchronized ventilation|synchronized ventilation
206958|NCT02085486|dialysis|dialysis
206959|NCT02085486|av shunt|av shunt
206960|NCT02085486|cannulation|cannulation
206961|NCT02085486|ultrasound|ultrasound
206962|NCT02085486|outcome|outcome
206963|NCT02085447|Homelessness|homelessness
206964|NCT02085447|Antipsychotic Drugs|antipsychotic drugs
206965|NCT02085447|Antipsychotics|antipsychotics
206966|NCT02085447|Injectables|injectables
206967|NCT02085447|Long Acting Injectable Antipsychotic|long acting injectable antipsychotic
206968|NCT02085447|Psychotic Disorders|psychotic disorders
253474|NCT01873794|Fatigue|fatigue
206969|NCT02085447|Schizophrenia|schizophrenia
206970|NCT02085447|Schizoaffective Disorder|schizoaffective disorder
206971|NCT02085447|Medication Adherence|medication adherence
206972|NCT02085447|Medication Non-Adherence|medication non-adherence
206973|NCT02085447|Community Mental Health Centers|community mental health centers
206974|NCT02085421|tdcs, neuromodulation, CRT, psychosis, schizophrenia|tdcs, neuromodulation, crt, psychosis, schizophrenia
206975|NCT02085395|Actinic Keratosis, AK, Bowen's Disease, Bowen|actinic keratosis, ak, bowen's disease, bowen
206976|NCT02085382|Kangaroo Mother Care(KMC), Low-birth weight, neonates|kangaroo mother care(kmc), low-birth weight, neonates
206977|NCT02085369|bariatric surgery|bariatric surgery
206978|NCT02085369|cognitive function|cognitive function
206979|NCT02085369|gene expression|gene expression
206980|NCT02085356|HIV|hiv
206981|NCT02085356|PMTCT|pmtct
206982|NCT02085356|South Africa|south africa
206985|NCT02085343|Exposure therapy|exposure therapy
206986|NCT02085343|Specific phobia|specific phobia
206987|NCT02085343|Fear of heights|fear of heights
206988|NCT02085343|Acrophobia|acrophobia
206989|NCT02085343|Safety behavior fading|safety behavior fading
206990|NCT02085343|Anti-phobic Actions|anti-phobic actions
206991|NCT02085317|Microcirculation|microcirculation
206992|NCT02085317|Leprosy|leprosy
206993|NCT02085317|Nervous system|nervous system
206994|NCT02085317|Orthogonal polarization spectral (OPS) imaging|orthogonal polarization spectral (ops) imaging
206995|NCT02085317|Laser Doppler flowmetry|laser doppler flowmetry
206996|NCT02085317|Iontophoresis.|iontophoresis.
206997|NCT02085304|Glioblastoma|glioblastoma
206998|NCT02085304|GBM|gbm
206999|NCT02085304|Radiation|radiation
207000|NCT02085304|GammaKnife(R)|gammaknife(r)
207001|NCT02085304|Radiosurgery|radiosurgery
207002|NCT02085304|Gliadel(R)|gliadel(r)
207003|NCT02085304|Temozolomide|temozolomide
207004|NCT02085304|Temodar(R)|temodar(r)
207005|NCT02085291|septic shock, microcirculation, fluid|septic shock, microcirculation, fluid
207006|NCT02085278|arteriovenous malformation|arteriovenous malformation
207007|NCT02085278|Brain|brain
207008|NCT02085278|AVM|avm
207009|NCT02085278|Onyx|onyx
207010|NCT02085278|Micro catheter|micro catheter
207011|NCT02085278|catheter entrapment,|catheter entrapment,
207012|NCT02085278|Embolization|embolization
207013|NCT02085278|Vein Of Galen|vein of galen
207014|NCT02085265|Alzheimer's Disease|alzheimer's disease
207015|NCT02085265|Hypertension|hypertension
207016|NCT02085265|Perindopril|perindopril
207017|NCT02085265|Telmisartan|telmisartan
207018|NCT02085265|Brain atrophy|brain atrophy
207019|NCT02085252|Drug Therapy|drug therapy
207020|NCT02085239|Breast Biopsy|breast biopsy
207021|NCT02085239|Ultrasound|ultrasound
207022|NCT02085239|Lidocaine|lidocaine
207023|NCT02085239|Ropivacaine|ropivacaine
207024|NCT02085239|Breast Lesion|breast lesion
207025|NCT02085226|Stroke|stroke
207026|NCT02085226|Rehabilitation|rehabilitation
207027|NCT02085226|Creative Engagement|creative engagement
207028|NCT02085226|Psychosocial|psychosocial
207029|NCT02085226|Art|art
207030|NCT02085213|Retained placenta|retained placenta
207031|NCT02085213|Manual Removal of Placenta|manual removal of placenta
207032|NCT02085213|Glyceryl Trinitrate|glyceryl trinitrate
207033|NCT02085200|glenohumeral internal rotation deficit|glenohumeral internal rotation deficit
207034|NCT02085200|overhead athlete|overhead athlete
207035|NCT02085200|shoulder exercise|shoulder exercise
207036|NCT02085200|posterior glenohumeral capsule|posterior glenohumeral capsule
207037|NCT02085200|posteroinferior glenohumeral ligament|posteroinferior glenohumeral ligament
207038|NCT02085200|posterior rotator cuff|posterior rotator cuff
207039|NCT02085187|Pulmonary rehabilitation|pulmonary rehabilitation
207040|NCT02085187|Training|training
207041|NCT02085187|Counselling|counselling
207042|NCT02085187|Telemedicine|telemedicine
207043|NCT02085187|Videoconference|videoconference
207045|NCT02085187|Chronic disease|chronic disease
207046|NCT02085187|Internet.|internet.
207047|NCT02085148|Pediatric cancer|pediatric cancer
207048|NCT02085148|Rhabdomyosarcoma,|rhabdomyosarcoma,
207049|NCT02085148|Ewing sarcoma|ewing sarcoma
207050|NCT02085148|Hepatoblastoma|hepatoblastoma
207051|NCT02085148|Neuroblastoma|neuroblastoma
207052|NCT02085148|Wilm's tumor|wilm's tumor
207053|NCT02085135|depression|depression
207054|NCT02085135|major depressive disorder|major depressive disorder
207055|NCT02085135|Alkermes|alkermes
207056|NCT02085135|ALKS 5461|alks 5461
207057|NCT02085135|samidorphan|samidorphan
207058|NCT02085135|buprenorphine|buprenorphine
207059|NCT02085109|Cardiovascular Diseases|cardiovascular diseases
207060|NCT02085109|HDL metabolism|hdl metabolism
207061|NCT02085109|ApoA-I|apoa-i
207062|NCT02085109|High fat|high fat
207063|NCT02085109|Theobromine|theobromine
207064|NCT02085096|Caregivers|caregivers
207065|NCT02085096|Coping Skills|coping skills
207066|NCT02085083|Inflammatory Bowel Disease|inflammatory bowel disease
207067|NCT02085083|Transition|transition
207068|NCT02085083|Adolescent|adolescent
207069|NCT02085083|Chronic Disease|chronic disease
207070|NCT02085083|Colitis, Ulcerative|colitis, ulcerative
207071|NCT02085044|malnutrition|malnutrition
207072|NCT02085044|children's health|children's health
207073|NCT02085044|prevention|prevention
207074|NCT02085044|ready-to-use supplementary food|ready-to-use supplementary food
207075|NCT02085044|lipid based nutrient supplement|lipid based nutrient supplement
207076|NCT02085044|chad|chad
207077|NCT02085044|children|children
207078|NCT02085031|Roux-en-Y Anastomosis|roux-en-y anastomosis
207079|NCT02085031|laparoscopic surgery|laparoscopic surgery
207080|NCT02085031|minilaparotomy|minilaparotomy
207081|NCT02085031|stomach neoplasms|stomach neoplasms
207082|NCT02085018|omeprazole, idiopathic pulmonary fibrosis|omeprazole, idiopathic pulmonary fibrosis
207083|NCT02084992|Congestive Heart Failure|congestive heart failure
207084|NCT02084992|Disease management|disease management
207085|NCT02084992|Hospitalization|hospitalization
207086|NCT02084979|Primary care mental health consultation|primary care mental health consultation
207087|NCT02084979|Telepsychiatry|telepsychiatry
207088|NCT02084979|Asynchronous telepsychiatry|asynchronous telepsychiatry
207089|NCT02084966|Kidney|kidney
207090|NCT02084966|Transplantation|transplantation
207091|NCT02084966|Imaging|imaging
207092|NCT02084966|Renal function|renal function
207093|NCT02084966|Optical Coherence Tomography|optical coherence tomography
207094|NCT02084940|PCOS|pcos
207095|NCT02084940|OHSS|ohss
207096|NCT02084940|GnRH antagonist|gnrh antagonist
207099|NCT02084914|endometrial scratching|endometrial scratching
207100|NCT02084914|pipelle|pipelle
207101|NCT02084914|pregnancy rate|pregnancy rate
207102|NCT02084914|unexplained infertility|unexplained infertility
207103|NCT02084901|Biodegradable stents|biodegradable stents
207104|NCT02084901|converage|converage
207105|NCT02084901|OCT|oct
207106|NCT02084875|Food effect|food effect
207107|NCT02084875|pharmacokinetic|pharmacokinetic
207108|NCT02084875|healthy volunteer|healthy volunteer
207109|NCT02084862|Tracheostomy|tracheostomy
207110|NCT02084862|Ultrasound|ultrasound
207111|NCT02084836|fMRI obesity adolescents|fmri obesity adolescents
207112|NCT02084797|arginine vasopressin|arginine vasopressin
207113|NCT02084797|sweat sodium|sweat sodium
207114|NCT02084797|V2 antagonist|v2 antagonist
207115|NCT02084797|running|running
207116|NCT02084784|Near-infrared fluorescence|near-infrared fluorescence
207117|NCT02084784|Image guided surgery|image guided surgery
207118|NCT02084784|Breast cancer;|breast cancer;
207119|NCT02084784|Sentinel lymph node biopsy|sentinel lymph node biopsy
207120|NCT02084784|Indocyanine green|indocyanine green
207121|NCT02084784|Methylene blue|methylene blue
207122|NCT02084771|contrast nephropathy|contrast nephropathy
207123|NCT02084771|contrast induced acute kidney injury|contrast induced acute kidney injury
207124|NCT02084771|acute kidney injury|acute kidney injury
207125|NCT02084771|prophylaxis|prophylaxis
207126|NCT02084771|randomized trial|randomized trial
207127|NCT02084758|COPD|copd
207128|NCT02084758|nitrate supplementation|nitrate supplementation
207129|NCT02084758|metabolic efficiency|metabolic efficiency
207130|NCT02084745|Boston keratoprosthesis|boston keratoprosthesis
207131|NCT02084745|Glaucoma drainage device|glaucoma drainage device
207132|NCT02084745|Ahmed tube shunt|ahmed tube shunt
207133|NCT02084732|Sorafenib, thyroid neoplasms, salicylic acid|sorafenib, thyroid neoplasms, salicylic acid
207134|NCT02084680|Prenatal|prenatal
207135|NCT02084680|Newborn care|newborn care
207136|NCT02084680|mobile phones|mobile phones
207138|NCT02084654|exenatide|exenatide
207139|NCT02084654|weight loss|weight loss
207140|NCT02084654|insulin resistance|insulin resistance
207141|NCT02084654|acute insulin response|acute insulin response
207142|NCT02084654|insulin secretion|insulin secretion
207143|NCT02084641|ectopic fat|ectopic fat
207144|NCT02084641|obesity|obesity
207145|NCT02084641|triglyceride storage|triglyceride storage
207146|NCT02084641|adipocyte|adipocyte
207147|NCT02084641|overfeeding|overfeeding
207148|NCT02084641|intrahepatic fat|intrahepatic fat
207149|NCT02084641|adipocyte proliferation|adipocyte proliferation
207150|NCT02084641|inflammation|inflammation
207151|NCT02084641|macrophage|macrophage
207152|NCT02084615|Aspirin|aspirin
207153|NCT02084615|Postoperative hemorrhage|postoperative hemorrhage
207154|NCT02084615|Inguinal hernia|inguinal hernia
207156|NCT02084602|mefloquine|mefloquine
207157|NCT02084602|falciparum|falciparum
207158|NCT02084602|peruvian amazon|peruvian amazon
207159|NCT02084589|PCEA, labor analgesia, background infusion, ropivacaine|pcea, labor analgesia, background infusion, ropivacaine
207160|NCT02084576|Cystoid macular edema|cystoid macular edema
207161|NCT02084576|nonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drug
207162|NCT02084576|OCT|oct
207163|NCT02084576|phacoemulsification.|phacoemulsification.
207164|NCT02084563|Acute Myeloid Leukemia|acute myeloid leukemia
207165|NCT02084563|Myeloproliferative Neoplasms|myeloproliferative neoplasms
207166|NCT02084563|Myelodysplastic Syndromes|myelodysplastic syndromes
207167|NCT02084563|Myeloproliferative/Myelodysplastic Neoplasm|myeloproliferative/myelodysplastic neoplasm
207168|NCT02084563|Leukemia|leukemia
207169|NCT02084563|MDS|mds
207170|NCT02084563|MPN|mpn
207171|NCT02084563|AML|aml
207172|NCT02084563|Chronic myelomonocytic leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
207173|NCT02084563|Polycythemia Vera (PV)|polycythemia vera (pv)
207174|NCT02084563|Essential Thrombocythemia (ET)|essential thrombocythemia (et)
207175|NCT02084563|Myelofibrosis (MF)|myelofibrosis (mf)
207176|NCT02084537|symptomatic|symptomatic
207177|NCT02084537|infected|infected
207178|NCT02084537|necrotic collection|necrotic collection
207179|NCT02084524|vulnerable|vulnerable
207180|NCT02084524|nutrition|nutrition
207181|NCT02084524|cancer|cancer
207182|NCT02084524|colorectal|colorectal
207183|NCT02084524|tumor|tumor
207184|NCT02084498|Automated bolus calculator (ABC)|automated bolus calculator (abc)
207185|NCT02084498|Advanced carbohydrate counting (ACC)|advanced carbohydrate counting (acc)
207186|NCT02084498|Patient empowerment|patient empowerment
207187|NCT02084485|COPD|copd
207188|NCT02084485|LPS|lps
207189|NCT02084472|atopic eczema|atopic eczema
207190|NCT02084472|moisturisers|moisturisers
207191|NCT02084472|alternatives|alternatives
207192|NCT02084472|affordable|affordable
207193|NCT02084459|Chronic pain|chronic pain
207194|NCT02084459|Supportive care|supportive care
207195|NCT02084459|Psychosocial Circumstances|psychosocial circumstances
207196|NCT02084459|Autonomy support|autonomy support
207197|NCT02084459|Nursing intervention|nursing intervention
207198|NCT02084446|Everolimus|everolimus
207199|NCT02084446|Tacrolimus|tacrolimus
207200|NCT02084446|Sodium Mycophenolate|sodium mycophenolate
207201|NCT02084446|CMV|cmv
207202|NCT02084446|Graft function|graft function
207203|NCT02084446|Acute rejection|acute rejection
207204|NCT02084433|MIH of the first permanent molar|mih of the first permanent molar
207205|NCT02084407|DM1|dm1
207206|NCT02084407|Cardiopathy|cardiopathy
207207|NCT02084407|Adult|adult
207208|NCT02084394|CBF autoregulation, rSO2,doppler, TCD, delirium,|cbf autoregulation, rso2,doppler, tcd, delirium,
207209|NCT02084381|CKD5, dialysis, high porous membranes|ckd5, dialysis, high porous membranes
207210|NCT02084368|combined lumbar plexus and sciatic nerve block，|combined lumbar plexus and sciatic nerve block，
207211|NCT02084368|combined spinal and epidural anesthesia|combined spinal and epidural anesthesia
207212|NCT02084355|Significant cancer pain|significant cancer pain
207213|NCT02084355|at least numeric rating scale 4|at least numeric rating scale 4
207214|NCT02084342|desmopressin|desmopressin
207215|NCT02084342|tranexamic acid|tranexamic acid
207216|NCT02084342|blood loss|blood loss
207217|NCT02084342|transfusion need|transfusion need
207218|NCT02084342|posterior scoliosis orthopedics|posterior scoliosis orthopedics
207219|NCT02084329|Physiotherapy|physiotherapy
207220|NCT02084329|Physical therapy|physical therapy
207221|NCT02084329|neurotrauma rehabilitation|neurotrauma rehabilitation
207222|NCT02084329|Rehabilitation|rehabilitation
207223|NCT02084329|Balance|balance
207224|NCT02084329|Balance Confidence|balance confidence
207225|NCT02084329|concussion|concussion
207226|NCT02084329|Post-Concussion|post-concussion
207227|NCT02084329|Mild Traumatic Brain Injury|mild traumatic brain injury
207228|NCT02084316|China CDC|china cdc
207229|NCT02084316|One4All testing algorithm|one4all testing algorithm
207230|NCT02084316|Guangxi Autonomous Region|guangxi autonomous region
207231|NCT02084316|Testing and Linkage to HIV Care in China|testing and linkage to hiv care in china
207232|NCT02084290|Crohn's disease|crohn's disease
207233|NCT02084290|Shared Decision Making|shared decision making
207234|NCT02084290|Decision Aid|decision aid
207235|NCT02084277|Oral health-related quality of life (OHRQoL)|oral health-related quality of life (ohrqol)
207236|NCT02084277|Self-ligating brackets (SLB)|self-ligating brackets (slb)
207237|NCT02084277|Conventional brackets (CB)|conventional brackets (cb)
207238|NCT02084277|Oral Health Impact Profile-14 (OHIP-14)|oral health impact profile-14 (ohip-14)
207239|NCT02084277|Short Form-36 (SF-36)|short form-36 (sf-36)
207240|NCT02084264|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
207241|NCT02084264|Pediatric Scoliosis|pediatric scoliosis
207242|NCT02084251|safety,|safety,
207243|NCT02084251|pharmacokinetics,|pharmacokinetics,
207244|NCT02084251|Long acting GLP-1 analogue|long acting glp-1 analogue
207245|NCT02084238|SLE, IL-2|sle, il-2
207246|NCT02084225|low resource|low resource
207247|NCT02084225|conflict setting|conflict setting
207248|NCT02084225|ultrasound guided regional anesthesia|ultrasound guided regional anesthesia
207249|NCT02084225|acute injuries|acute injuries
207250|NCT02084225|pain management|pain management
207251|NCT02084225|education|education
207252|NCT02084225|ultrasound|ultrasound
207253|NCT02084225|trauma|trauma
207254|NCT02084225|emergency department|emergency department
207255|NCT02084173|alcohol|alcohol
207256|NCT02084173|60+ years|60+ years
207257|NCT02084173|treatment|treatment
207258|NCT02084173|met|met
207259|NCT02084173|cra|cra
207260|NCT02084173|multi site|multi site
207261|NCT02084173|multi country|multi country
207262|NCT02084173|questionnaire|questionnaire
198057|NCT02125045|oxidative stress|oxidative stress
198058|NCT02125019|Breast Cancer|breast cancer
198059|NCT02125019|Taxane|taxane
198060|NCT02125019|Gait|gait
198061|NCT02125019|Men|men
198062|NCT02125019|Women|women
198063|NCT02125006|Mindfulness|mindfulness
198064|NCT02125006|Breast Cancer|breast cancer
207263|NCT02084173|random|random
207264|NCT02084134|pituitary adenoma|pituitary adenoma
207265|NCT02084134|Pituitary Tumor|pituitary tumor
207266|NCT02084134|transsphenoidal resection|transsphenoidal resection
207267|NCT02084134|pituitary cyst|pituitary cyst
207268|NCT02084121|metachromatic leukodystrophy|metachromatic leukodystrophy
207269|NCT02084108|Frail and dependent older adults|frail and dependent older adults
207270|NCT02084108|Integrated care|integrated care
207271|NCT02084108|Home care|home care
207272|NCT02084108|Multidimensional geriatric assessment|multidimensional geriatric assessment
207273|NCT02084108|RAI-HC (resident assessment instrument- Home care)|rai-hc (resident assessment instrument- home care)
207274|NCT02084108|Palliative care.|palliative care.
207275|NCT02084043|aerosol delivery|aerosol delivery
207276|NCT02084043|vibrating mesh nebulizer|vibrating mesh nebulizer
207277|NCT02084043|breath-actuated nebulizer|breath-actuated nebulizer
207478|NCT02083250|Busulfex|busulfex
207278|NCT02084043|non invasive ventilation|non invasive ventilation
207279|NCT02084043|bilevel ventilator|bilevel ventilator
207280|NCT02084043|single limb circuit ventilator|single limb circuit ventilator
207281|NCT02084043|Amikacin|amikacin
207282|NCT02084030|cardiac surgery|cardiac surgery
207283|NCT02084030|POCD|pocd
207284|NCT02084030|GWAS|gwas
207285|NCT02084030|Susceptibility gene|susceptibility gene
207286|NCT02084017|Surgical Site Infection|surgical site infection
207287|NCT02084017|Vascular Surgery|vascular surgery
207288|NCT02084017|Negative Pressure Wound Therapy|negative pressure wound therapy
207289|NCT02084004|Type 2 diabetes mellitus|type 2 diabetes mellitus
207290|NCT02084004|Berberine Hydrochloride|berberine hydrochloride
207291|NCT02084004|Bifidobacterium|bifidobacterium
207292|NCT02083991|NODAT|nodat
207293|NCT02083991|Renal transplantation|renal transplantation
207294|NCT02083991|Corticosteroids avoidance|corticosteroids avoidance
207295|NCT02083991|CNI minimization|cni minimization
207296|NCT02083978|Bipolar Disorder|bipolar disorder
207297|NCT02083978|Magnetic Resonance Imaging (MRI) scanning|magnetic resonance imaging (mri) scanning
207298|NCT02083939|Inguinal hernia|inguinal hernia
207299|NCT02083939|Mesh repair|mesh repair
207300|NCT02083939|Prophylactic Antibiotics|prophylactic antibiotics
207301|NCT02083939|Herniorrhaphy|herniorrhaphy
207302|NCT02083939|Laparoscopic Inguinal Hernia Repair|laparoscopic inguinal hernia repair
207303|NCT02083926|Social Anxiety Disorder|social anxiety disorder
207304|NCT02083926|SAD|sad
207305|NCT02083926|Ketamine|ketamine
207306|NCT02083913|Severely obese|severely obese
207307|NCT02083913|Bariatric surgery|bariatric surgery
207308|NCT02083913|Physical activity|physical activity
207309|NCT02083913|Physical fitness|physical fitness
207310|NCT02083913|Telehealth|telehealth
207311|NCT02083913|Quality of life|quality of life
207312|NCT02083887|Immune response|immune response
207313|NCT02083887|Vaccine|vaccine
207314|NCT02083887|Malaria|malaria
207315|NCT02083874|cannabidiol|cannabidiol
207316|NCT02083874|CBD|cbd
207317|NCT02083874|marijuana|marijuana
207318|NCT02083874|withdrawal|withdrawal
207319|NCT02083874|treatment|treatment
207320|NCT02083861|osteoarthritis|osteoarthritis
207321|NCT02083861|arthritis|arthritis
207322|NCT02083861|musculoskeletal|musculoskeletal
678062|NCT00888043|Phase I|phase i
207323|NCT02083861|connective tissue disease|connective tissue disease
207324|NCT02083861|ultrasound|ultrasound
207325|NCT02083861|pain|pain
207326|NCT02083861|mobility|mobility
207327|NCT02083861|heat|heat
207328|NCT02083861|strength|strength
207329|NCT02083861|ZetrOZ|zetroz
207330|NCT02083861|LITUS|litus
207331|NCT02083861|Sam|sam
207332|NCT02083861|grade 1|grade 1
207333|NCT02083861|grade 2|grade 2
207334|NCT02083848|Locoregional invasion|locoregional invasion
207335|NCT02083848|Stage IB1, IB2, IIA or IIB|stage ib1, ib2, iia or iib
207336|NCT02083835|post-operative pain|post-operative pain
207337|NCT02083822|premature baby|premature baby
207338|NCT02083822|MRI : conventional and advanced images|mri : conventional and advanced images
207339|NCT02083822|Executive function testing at 5 years of age|executive function testing at 5 years of age
207340|NCT02083796|manual therapy|manual therapy
207341|NCT02083796|rehabilitation|rehabilitation
207342|NCT02083796|shoulder|shoulder
207343|NCT02083796|spine|spine
207344|NCT02083770|Hispanics|hispanics
207345|NCT02083770|Patient Participation|patient participation
207346|NCT02083770|Refusal to Participate|refusal to participate
207347|NCT02083770|Education|education
207348|NCT02083770|Clinical Trials|clinical trials
207349|NCT02083757|Fluid responsiveness; Passive leg raising|fluid responsiveness; passive leg raising
207350|NCT02083744|Congestive Heart Failure|congestive heart failure
207351|NCT02083744|Self-care|self-care
207352|NCT02083744|Spanish|spanish
207353|NCT02083731|CMV infection|cmv infection
207354|NCT02083731|Mesenchymal Stem Cells|mesenchymal stem cells
207355|NCT02083731|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
207356|NCT02083718|Poor Graft Function|poor graft function
207357|NCT02083718|Peripheral Blood Stem Cell|peripheral blood stem cell
207358|NCT02083718|Mesenchymal Stem Cells|mesenchymal stem cells
207359|NCT02083718|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
207360|NCT02083705|Chest compression, Delivery Room, NICU,|chest compression, delivery room, nicu,
207361|NCT02083679|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
207362|NCT02083679|Sym004|sym004
207363|NCT02083666|Phase I|phase i
207364|NCT02083666|Dose cohorts|dose cohorts
207365|NCT02083666|Escalating dose|escalating dose
207366|NCT02083666|Single dose|single dose
207367|NCT02083666|Multiple dose|multiple dose
207368|NCT02083666|Safety|safety
207369|NCT02083666|Tolerability|tolerability
207370|NCT02083666|Pharmacokinetics|pharmacokinetics
207371|NCT02083666|Pharmacodynamics|pharmacodynamics
207372|NCT02083666|volunteers|volunteers
207373|NCT02083653|Metastatic Colorectal Cancer|metastatic colorectal cancer
207374|NCT02083653|Sym004|sym004
207375|NCT02083653|Best Supportive Care|best supportive care
207376|NCT02083653|Capecitabine|capecitabine
207377|NCT02083653|Fluorouracil (5-FU)|fluorouracil (5-fu)
207378|NCT02083640|healthy volunteer|healthy volunteer
207379|NCT02083640|bioavailability|bioavailability
207380|NCT02083640|palbociclib|palbociclib
207381|NCT02083640|formulation|formulation
207382|NCT02083627|Pharmacokinetics|pharmacokinetics
207383|NCT02083627|Drug-Drug Interaction|drug-drug interaction
207384|NCT02083627|Intestinal Absorption|intestinal absorption
207385|NCT02083627|Fidaxomicin|fidaxomicin
207386|NCT02083627|Rosuvastatin|rosuvastatin
207387|NCT02083627|Multiple Doses|multiple doses
207388|NCT02083627|Single Doses|single doses
207389|NCT02083601|Caregivers|caregivers
207390|NCT02083601|Spinal Cord Injuries|spinal cord injuries
207391|NCT02083601|Psychology, Educational|psychology, educational
207392|NCT02083601|Counseling|counseling
207393|NCT02083601|Outcome Assessment (Health Care)|outcome assessment (health care)
207394|NCT02083588|Fibromyalgia|fibromyalgia
207395|NCT02083588|dTMS|dtms
207396|NCT02083588|pain|pain
207398|NCT02083588|Subjects with Fibromyalgia|subjects with fibromyalgia
207399|NCT02083575|vitamin c|vitamin c
207400|NCT02083575|thalassemia major|thalassemia major
207401|NCT02083575|iron chelation|iron chelation
207402|NCT02083562|Bronchopulmonary dysplasia, preterm infant|bronchopulmonary dysplasia, preterm infant
207403|NCT02083549|Massive Transfusion Protocol|massive transfusion protocol
207404|NCT02083536|Low Dose Fractionated Whole Abdominal Radiation Therapy|low dose fractionated whole abdominal radiation therapy
207405|NCT02083536|LDFWART|ldfwart
207406|NCT02083536|Docetaxel|docetaxel
207407|NCT02083536|Ovarian Cancer|ovarian cancer
207408|NCT02083536|Ovarian Carcinoma|ovarian carcinoma
207409|NCT02083536|Platinum-Resistant|platinum-resistant
207410|NCT02083523|Motivational Interview, normative feedback, adolescents|motivational interview, normative feedback, adolescents
207411|NCT02083510|Colchicine|colchicine
207412|NCT02083510|Hypertriglyceridemia|hypertriglyceridemia
207413|NCT02083510|Apolipoprotein CIII|apolipoprotein ciii
207414|NCT02083497|kick|kick
207415|NCT02083497|taping|taping
207416|NCT02083497|dynamic equilibrium|dynamic equilibrium
207417|NCT02083458|critical care|critical care
207418|NCT02083458|catheterization|catheterization
207419|NCT02083458|axillary vein|axillary vein
207420|NCT02083445|Traumatic brain injury|traumatic brain injury
207421|NCT02083445|Exercise|exercise
207422|NCT02083445|Psychology|psychology
207423|NCT02083445|Physiology|physiology
207424|NCT02083445|Progenitor cells|progenitor cells
207425|NCT02083445|Hypoxia|hypoxia
207426|NCT02083432|intra-oral injections|intra-oral injections
207427|NCT02083432|CBT|cbt
207428|NCT02083432|Blood-Injury-Injection-phobia|blood-injury-injection-phobia
207429|NCT02083432|DSM-IV. 300.29|dsm-iv. 300.29
207430|NCT02083419|Left Ventricular Assist Devices (LVAD)|left ventricular assist devices (lvad)
207431|NCT02083419|Cardiac Resynchronization Devices (CRT)|cardiac resynchronization devices (crt)
207432|NCT02083406|Malaria|malaria
207433|NCT02083406|Bio-availability|bio-availability
207434|NCT02083393|dendritic cell|dendritic cell
207435|NCT02083380|Plasmodium falciparum malaria|plasmodium falciparum malaria
207436|NCT02083380|malaria|malaria
207437|NCT02083380|OZ439|oz439
207438|NCT02083380|piperaquine|piperaquine
207440|NCT02083354|melanoma|melanoma
207441|NCT02083354|dabrafenib|dabrafenib
207442|NCT02083354|trametinib|trametinib
207443|NCT02083328|heart rate variability|heart rate variability
207444|NCT02083328|exercise performance|exercise performance
207445|NCT02083315|acute pain, analgesia, respiratory drive, ventilator response to hypercapnia, pupillometry|acute pain, analgesia, respiratory drive, ventilator response to hypercapnia, pupillometry
207446|NCT02083302|campus sexual assault|campus sexual assault
207447|NCT02083302|bystander intervention|bystander intervention
207448|NCT02083289|ONO-9054|ono-9054
207449|NCT02083289|ocular hypertension (OHT)|ocular hypertension (oht)
207450|NCT02083289|Open angle-glaucoma (OAG)|open angle-glaucoma (oag)
207451|NCT02083289|Glaucoma|glaucoma
207452|NCT02083289|Eye Diseases|eye diseases
207453|NCT02083289|Mild to moderate|mild to moderate
207454|NCT02083276|Chlamydia trachomatis|chlamydia trachomatis
207455|NCT02083276|Urethritis|urethritis
207456|NCT02083276|Genital Diseases, Male|genital diseases, male
207457|NCT02083263|Lung function|lung function
207458|NCT02083250|Leukemia|leukemia
207459|NCT02083250|Blood And Marrow Transplantation|blood and marrow transplantation
207460|NCT02083250|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
207461|NCT02083250|ALL|all
207462|NCT02083250|Acute myeloid leukemia|acute myeloid leukemia
207463|NCT02083250|AML|aml
207464|NCT02083250|Myelodysplastic syndrome|myelodysplastic syndrome
207465|NCT02083250|MDS|mds
207466|NCT02083250|Allogeneic stem cell transplant|allogeneic stem cell transplant
207467|NCT02083250|SCT|sct
207468|NCT02083250|Thymoglobulin|thymoglobulin
207469|NCT02083250|ATG|atg
207470|NCT02083250|Antithymocyte Globulin|antithymocyte globulin
207471|NCT02083250|Fludarabine|fludarabine
207472|NCT02083250|Fludarabine Phosphate|fludarabine phosphate
207473|NCT02083250|Fludara|fludara
207474|NCT02083250|Clofarabine|clofarabine
207475|NCT02083250|Clofarex|clofarex
207476|NCT02083250|Clolar|clolar
207477|NCT02083250|Busulfan|busulfan
207480|NCT02083250|SAHA|saha
207481|NCT02083250|Vorinostat|vorinostat
207482|NCT02083250|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
207483|NCT02083250|MSK-390|msk-390
207484|NCT02083250|Zolinza|zolinza
207485|NCT02083237|mild cognitive impairment|mild cognitive impairment
207486|NCT02083237|memory training|memory training
207487|NCT02083237|healthy lifestyle|healthy lifestyle
207488|NCT02083237|psychosocial support|psychosocial support
207489|NCT02083211|Cervical cancer|cervical cancer
207490|NCT02083211|Recurrent or persistent tumor|recurrent or persistent tumor
207491|NCT02083211|Monoclonal antibody|monoclonal antibody
207492|NCT02083198|hyperchloremic acidosis|hyperchloremic acidosis
207493|NCT02083198|balanced fluids|balanced fluids
207494|NCT02083198|plasmalyte|plasmalyte
207495|NCT02083172|USCOM (UltraSound Cardiac Output Monitor)|uscom (ultrasound cardiac output monitor)
207496|NCT02083172|2D echocardiography|2d echocardiography
207497|NCT02083172|agreement|agreement
207498|NCT02083172|pediatrics|pediatrics
207499|NCT02083133|Diabetes|diabetes
207500|NCT02083133|Renal Failure|renal failure
207501|NCT02083133|Dialysis|dialysis
207502|NCT02083133|End Stage Renal Disease|end stage renal disease
207503|NCT02083133|Hypoglycemia|hypoglycemia
207504|NCT02083120|high flow|high flow
207505|NCT02083120|COPD|copd
207506|NCT02083120|AIRVO|airvo
207507|NCT02083107|Postpartum hemorrhage|postpartum hemorrhage
207508|NCT02083107|Intrapartum blood loss|intrapartum blood loss
207509|NCT02083107|Misoprostol|misoprostol
207510|NCT02083081|tobacco|tobacco
207511|NCT02083081|smoking|smoking
207512|NCT02083068|Malaria, vaccine, P. vivax|malaria, vaccine, p. vivax
207513|NCT02083055|dexmedetomidine|dexmedetomidine
207514|NCT02083055|controlled hypotensive anesthesia|controlled hypotensive anesthesia
207515|NCT02083042|CMV|cmv
207516|NCT02083042|T-Track CMV|t-track cmv
207517|NCT02083042|kidney transplantation|kidney transplantation
207518|NCT02083029|Asthma|asthma
207519|NCT02083029|Death|death
207520|NCT02083029|Mechanism|mechanism
207522|NCT02083029|Dive reflex|dive reflex
207523|NCT02083003|Pain|pain
207524|NCT02083003|Polyamine|polyamine
207525|NCT02083003|Cholecystectomy|cholecystectomy
207526|NCT02082990|Alcohol-related disorders|alcohol-related disorders
207527|NCT02082990|Alcohol Drinking|alcohol drinking
207528|NCT02082990|e-health|e-health
207529|NCT02082990|Alcohol Use Disorder Test|alcohol use disorder test
207530|NCT02082990|Quality of Life|quality of life
207531|NCT02082977|Refractory|refractory
207532|NCT02082977|Phase I study, dose escalation study|phase i study, dose escalation study
207533|NCT02082977|diffuse large B cell lymphoma|diffuse large b cell lymphoma
207534|NCT02082977|Relapsed|relapsed
207535|NCT02082977|Solid tumors|solid tumors
207536|NCT02082977|transformed follicular lymphoma|transformed follicular lymphoma
207537|NCT02082977|Multiple myeloma|multiple myeloma
207538|NCT02082977|GSK2816126|gsk2816126
207539|NCT02082977|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
207540|NCT02082938|stroke,|stroke,
207541|NCT02082938|rehabilitation,|rehabilitation,
207542|NCT02082938|hemiparesis,|hemiparesis,
207543|NCT02082938|gait training|gait training
207544|NCT02082925|Exercise training|exercise training
207545|NCT02082925|Dyspnea threshold|dyspnea threshold
207546|NCT02082925|6MWT|6mwt
207547|NCT02082899|Allergic Conjunctivitis|allergic conjunctivitis
207548|NCT02082899|Interleukin 1 Receptor Inhibitor|interleukin 1 receptor inhibitor
207549|NCT02082899|Environmental Exposure Chamber|environmental exposure chamber
207550|NCT02082899|Conjunctival Allergen Provocation Test|conjunctival allergen provocation test
207551|NCT02082886|Metastasis|metastasis
207552|NCT02082886|Carcinomatosis|carcinomatosis
207553|NCT02082886|Carcinosis|carcinosis
207554|NCT02082886|Sarcomatosis|sarcomatosis
207556|NCT02082886|Cytoreductive surgery|cytoreductive surgery
207557|NCT02082886|HIPEC|hipec
207558|NCT02082886|Heated Intraperitoneal Chemotherapy|heated intraperitoneal chemotherapy
207559|NCT02082886|Intra-abdominal|intra-abdominal
207560|NCT02082886|Sugarbaker technique|sugarbaker technique
207561|NCT02082886|Mitomycin C|mitomycin c
207562|NCT02082886|Cisplatin|cisplatin
207563|NCT02082886|Doxorubicin|doxorubicin
207564|NCT02082886|Oxaliplatin|oxaliplatin
207565|NCT02082886|Melphalan|melphalan
207566|NCT02082873|Quantitative EEG|quantitative eeg
207567|NCT02082873|Nonconvulsive seizures|nonconvulsive seizures
207568|NCT02082873|ICU EEG monitoring|icu eeg monitoring
207569|NCT02082860|Porphyria|porphyria
207570|NCT02082860|Gene therapy|gene therapy
207572|NCT02082860|Liver gene transfer|liver gene transfer
207573|NCT02082834|Endovascular aneurysm repair EVAR|endovascular aneurysm repair evar
207574|NCT02082834|Endoleak/diagnosis|endoleak/diagnosis
207575|NCT02082834|VEOTM|veotm
207576|NCT02082834|Model-based iterative reconstruction (MBIR)|model-based iterative reconstruction (mbir)
207577|NCT02082834|Adaptive statistical iterative reconstruction (ASIR)|adaptive statistical iterative reconstruction (asir)
207578|NCT02082834|Aortic Aneurysm|aortic aneurysm
207579|NCT02082834|Low dose|low dose
207580|NCT02082834|Prospective|prospective
207581|NCT02082834|CTA|cta
207582|NCT02082808|Dolutegravir|dolutegravir
208097|NCT02080520|Soy|soy
207583|NCT02082808|healthy volunteer|healthy volunteer
207584|NCT02082808|pharmacokinetics|pharmacokinetics
207585|NCT02082808|daclatasvir|daclatasvir
207586|NCT02082808|drug interaction|drug interaction
207587|NCT02082795|Breech presentation|breech presentation
207588|NCT02082795|External cephalic version|external cephalic version
207589|NCT02082795|Anaesthesia|anaesthesia
207590|NCT02082795|Qualitative|qualitative
207591|NCT02082795|Pregnancy|pregnancy
207592|NCT02082782|Colorectal liver metastases (CRLM)|colorectal liver metastases (crlm)
207593|NCT02082782|Tumor ablation|tumor ablation
207594|NCT02082782|Irreversible electroporation (IRE)|irreversible electroporation (ire)
207595|NCT02082782|Interventional oncology|interventional oncology
207596|NCT02082782|NanoKnife|nanoknife
207597|NCT02082782|Colorectal liver metastasis, unresectable and not-thermally ablative due to location near vulnerable structures like vessels or bile ducts|colorectal liver metastasis, unresectable and not-thermally ablative due to location near vulnerable structures like vessels or bile ducts
207598|NCT02082769|Gout|gout
207599|NCT02082769|Uric Acid|uric acid
207600|NCT02082769|Xanthine oxidase|xanthine oxidase
207601|NCT02082769|Febuxostat|febuxostat
207602|NCT02082756|Prediabetes|prediabetes
207603|NCT02082756|Berberine Hydrochloride|berberine hydrochloride
207604|NCT02082756|Bifidobacterium|bifidobacterium
207605|NCT02082743|Myopia|myopia
207606|NCT02082743|Outdoor activity|outdoor activity
207607|NCT02082743|Recess outside classroom|recess outside classroom
207608|NCT02082730|CFS/ME, Chronic fatigue syndrome, Pediatric, remote mobile technology|cfs/me, chronic fatigue syndrome, pediatric, remote mobile technology
207609|NCT02082704|Diabetes|diabetes
207610|NCT02082704|Education, Patient|education, patient
207611|NCT02082704|Educational Technology|educational technology
207612|NCT02082691|G-202|g-202
207613|NCT02082691|Hepatocellular|hepatocellular
207614|NCT02082678|Bipolar Disorder|bipolar disorder
207615|NCT02082678|BPD|bpd
207616|NCT02082678|Alcohol Use Disorder|alcohol use disorder
207617|NCT02082678|Alcohol Abuse|alcohol abuse
207618|NCT02082678|Alcohol Dependence|alcohol dependence
207619|NCT02082678|Ondansetron|ondansetron
207620|NCT02082678|Cognition|cognition
207621|NCT02082678|Mood|mood
207622|NCT02082665|rosuvastatin|rosuvastatin
207623|NCT02082665|BRAF V600|braf v600
207624|NCT02082665|Melanoma|melanoma
207625|NCT02082665|dabrafenib|dabrafenib
207626|NCT02082665|midazolam|midazolam
207627|NCT02082652|Etonogestrel|etonogestrel
207628|NCT02082652|Efavirenz|efavirenz
207629|NCT02082652|Nevirapine|nevirapine
207630|NCT02082652|Pharmacokinetics|pharmacokinetics
207631|NCT02082639|Adolescents|adolescents
207632|NCT02082639|Havrix|havrix
207633|NCT02082639|Immunogenicity|immunogenicity
207634|NCT02082639|Cervarix|cervarix
207635|NCT02082639|Safety|safety
207636|NCT02082626|Phase I|phase i
207637|NCT02082626|Pediatric|pediatric
207638|NCT02082626|Cancer|cancer
207639|NCT02082626|Lymphoma|lymphoma
207640|NCT02082626|Eribulin|eribulin
207641|NCT02082613|Testicular hydrocele|testicular hydrocele
207642|NCT02082613|Hydrocele|hydrocele
207643|NCT02082613|Sclerotherapy|sclerotherapy
207644|NCT02082613|Surgery|surgery
207645|NCT02082613|Complications|complications
207646|NCT02082587|brain metastases|brain metastases
207647|NCT02082587|brain mets|brain mets
207648|NCT02082587|WBRT|wbrt
207649|NCT02082561|transdiagnostic treatment|transdiagnostic treatment
207650|NCT02082561|cognitive behavior therapy|cognitive behavior therapy
207651|NCT02082561|anxiety|anxiety
207652|NCT02082561|panic disorder|panic disorder
207653|NCT02082561|generalized anxiety disorder|generalized anxiety disorder
207654|NCT02082561|social anxiety disorder|social anxiety disorder
207655|NCT02082548|atrial fibrillation|atrial fibrillation
207656|NCT02082548|anticoagulation|anticoagulation
207657|NCT02082548|education|education
207658|NCT02082548|educational intervention|educational intervention
207659|NCT02082535|Premature Birth|premature birth
207660|NCT02082535|Brain Injuries|brain injuries
207661|NCT02082535|Leukomalacia Periventricular|leukomalacia periventricular
207662|NCT02082535|S100B protein human|s100b protein human
207663|NCT02082535|Glial Fibrillary Acidic Protein|glial fibrillary acidic protein
207664|NCT02082535|Magnetic Resonance Imaging|magnetic resonance imaging
207665|NCT02082535|Developmental Disabilities|developmental disabilities
207666|NCT02082522|Cholangiocarcinoma|cholangiocarcinoma
207667|NCT02082522|Unresectable perihilar cholangiocarcinoma|unresectable perihilar cholangiocarcinoma
207668|NCT02082522|Klatskin tumor|klatskin tumor
207669|NCT02082522|Photodynamic therapy|photodynamic therapy
207670|NCT02082522|Porfimer sodium|porfimer sodium
207671|NCT02082522|Photofrin|photofrin
207672|NCT02082522|Gemcitabine|gemcitabine
207673|NCT02082522|Cisplatin|cisplatin
207674|NCT02082522|Stents|stents
207675|NCT02082522|CCA|cca
207676|NCT02082522|PDT|pdt
207677|NCT02082522|Bile duct cancer|bile duct cancer
207678|NCT02082522|Bile duct tumor|bile duct tumor
207679|NCT02082522|Bile duct adenocarcinoma|bile duct adenocarcinoma
207680|NCT02082522|Chemotherapy|chemotherapy
207681|NCT02082509|Traumatic Brain Injury|traumatic brain injury
208407|NCT02079090|Propofol|propofol
207682|NCT02082509|Post-Concussive Symptoms|post-concussive symptoms
207683|NCT02082509|Brain Imaging|brain imaging
207684|NCT02082509|Cognition|cognition
207685|NCT02082496|Obesity|obesity
207686|NCT02082496|Obesity Genetics|obesity genetics
207687|NCT02082496|GLP-1|glp-1
207688|NCT02082496|GLP-1 Receptor Agonists|glp-1 receptor agonists
207689|NCT02082483|Kidney Transplant|kidney transplant
207690|NCT02082483|Screening|screening
207691|NCT02082457|Irritable Bowel Syndrome|irritable bowel syndrome
207692|NCT02082457|Constipation|constipation
207693|NCT02082457|C-IBS|c-ibs
207694|NCT02082431|Sensorineural hearing loss|sensorineural hearing loss
207695|NCT02082431|Long QT Syndrome|long qt syndrome
207696|NCT02082418|Mild cognitive impairment|mild cognitive impairment
207697|NCT02082418|Protein digestion|protein digestion
207698|NCT02082418|Tryptophan digestion|tryptophan digestion
207699|NCT02082418|Cognitive function|cognitive function
207700|NCT02082418|Mood|mood
207701|NCT02082418|Muscle function|muscle function
207702|NCT02082418|Alpha-lactalbumin|alpha-lactalbumin
207703|NCT02082379|Interface, aerosol, child, acceptance|interface, aerosol, child, acceptance
207704|NCT02082366|Atrial fibrillation|atrial fibrillation
207705|NCT02082366|CPVI|cpvi
207706|NCT02082366|TCD|tcd
207707|NCT02082366|nMARQ|nmarq
207708|NCT02082366|MES|mes
207709|NCT02082366|microembolic signals|microembolic signals
207710|NCT02082353|Granulomatous Disease, Chronic|granulomatous disease, chronic
207711|NCT02082353|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
207712|NCT02082340|Tuberculosis|tuberculosis
207713|NCT02082340|Armenia|armenia
207714|NCT02082340|Clinical trial|clinical trial
207715|NCT02082340|Directly Observed Therapy (DOT)|directly observed therapy (dot)
207716|NCT02082340|Self-administered drug intake|self-administered drug intake
207717|NCT02082327|Fabry Disease|fabry disease
207718|NCT02082327|Fabry|fabry
207719|NCT02082327|Lysosomal storage disorders|lysosomal storage disorders
207720|NCT02082327|LSD|lsd
207721|NCT02082327|Amicus|amicus
207722|NCT02082327|migalastat HCl|migalastat hcl
207723|NCT02082327|migalastat|migalastat
207724|NCT02082327|AT1001|at1001
207725|NCT02082314|radiofrequency ablation|radiofrequency ablation
207726|NCT02082314|bone metastases|bone metastases
207727|NCT02082288|ICSI outcome|icsi outcome
207728|NCT02082275|Prenatal Care|prenatal care
207729|NCT02082275|Obstetrics|obstetrics
207730|NCT02082249|carbidopa|carbidopa
207731|NCT02082249|Tolerability|tolerability
207736|NCT02082249|Safety|safety
207737|NCT02082236|Plasma concentrations|plasma concentrations
207738|NCT02082223|Quality of life|quality of life
207739|NCT02082223|Deficits|deficits
207740|NCT02082223|Complex gastrointestinal surgery|complex gastrointestinal surgery
207741|NCT02082197|low testosterone|low testosterone
207742|NCT02082184|Sensing Technology|sensing technology
207743|NCT02082184|Type 2 Diabetes,|type 2 diabetes,
207744|NCT02082171|older adults|older adults
207745|NCT02082171|physical disability|physical disability
207746|NCT02082171|multidomain intervention|multidomain intervention
207747|NCT02082171|prevention|prevention
207748|NCT02082171|pilot study|pilot study
198616|NCT02122471|CIC|cic
207749|NCT02082171|frailty|frailty
207750|NCT02082171|mobility|mobility
207751|NCT02082171|comprehensive geriatric assessment|comprehensive geriatric assessment
207757|NCT02082106|metabolic equivalent|metabolic equivalent
207758|NCT02082093|Chronic Kidney Disease|chronic kidney disease
207759|NCT02082093|telemedicine|telemedicine
207760|NCT02082054|rhinitis|rhinitis
207761|NCT02082054|seasonal|seasonal
207762|NCT02082054|allergic|allergic
207763|NCT02082015|Neuronal plasticity|neuronal plasticity
207764|NCT02082015|Transcranial magnetic stimulation|transcranial magnetic stimulation
207765|NCT02082015|Stroke|stroke
207766|NCT02082015|Upper extremity|upper extremity
207767|NCT02082015|Function|function
207768|NCT02082015|Recovery|recovery
207769|NCT02082002|Multiple scerlosis|multiple scerlosis
207770|NCT02082002|Fatigue|fatigue
207771|NCT02082002|Sleep|sleep
207772|NCT02082002|Somnolence|somnolence
207773|NCT02082002|Depression|depression
207774|NCT02082002|Cognitive disorders|cognitive disorders
207775|NCT02081989|Diabetes|diabetes
207776|NCT02081989|Renal denervation|renal denervation
207777|NCT02081963|Nebulized amikacin;|nebulized amikacin;
207778|NCT02081963|Non-Cystic Fibrosis Bronchiectasis;|non-cystic fibrosis bronchiectasis;
207779|NCT02081963|Bacterial clearance rate of sputum；|bacterial clearance rate of sputum；
207780|NCT02081963|Acute exacerbation.|acute exacerbation.
207781|NCT02081937|chimeric antigen receptor|chimeric antigen receptor
207782|NCT02081937|immunotherapy|immunotherapy
207783|NCT02081937|T lymphocyte|t lymphocyte
207784|NCT02081937|mantle cell lymphoma|mantle cell lymphoma
207785|NCT02081924|Infertility|infertility
207786|NCT02081924|Kisspeptin|kisspeptin
207787|NCT02081924|Reproductive hormones|reproductive hormones
207788|NCT02081911|adductor canal|adductor canal
207789|NCT02081911|femoral|femoral
207790|NCT02081911|quadriceps|quadriceps
207791|NCT02081898|low calorie diet|low calorie diet
207792|NCT02081898|BMI|bmi
207793|NCT02081898|sphingomyelin|sphingomyelin
207794|NCT02081898|L-leucine|l-leucine
207795|NCT02081898|L-phenylalanine|l-phenylalanine
207796|NCT02081885|Tricalcium phosphate|tricalcium phosphate
207797|NCT02081885|Chitosan|chitosan
207798|NCT02081885|Grafting, Bone|grafting, bone
207799|NCT02081885|Mandibular Fractures|mandibular fractures
207800|NCT02081872|Pharmacogenomics|pharmacogenomics
207801|NCT02081872|Target Drug Related Adverse Events (TDAE)|target drug related adverse events (tdae)
207807|NCT02081833|acute respiratory infections|acute respiratory infections
207808|NCT02081833|acute gastrointestinal infections|acute gastrointestinal infections
207809|NCT02081833|children|children
207810|NCT02081833|child|child
207811|NCT02081833|symptom diary|symptom diary
207812|NCT02081833|nasal swabs|nasal swabs
207813|NCT02081833|stool samples|stool samples
207814|NCT02081820|hyperglycemia|hyperglycemia
207815|NCT02081820|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
207816|NCT02081820|glycated hemoglobin|glycated hemoglobin
207817|NCT02081820|outcome|outcome
207818|NCT02081820|DCI|dci
207819|NCT02081768|Rathke's cleft cyst|rathke's cleft cyst
207820|NCT02081768|cystic craniopharyngiomas|cystic craniopharyngiomas
207821|NCT02081755|Immunosuppressive Agents|immunosuppressive agents
207822|NCT02081755|Liver Transplantation|liver transplantation
207823|NCT02081742|Colonoscopy, CT colonography, Colon capsule|colonoscopy, ct colonography, colon capsule
207824|NCT02081703|Postsurgical pain|postsurgical pain
207825|NCT02081703|Total knee arthroplasty|total knee arthroplasty
207826|NCT02081703|Total knee replacement|total knee replacement
207827|NCT02081690|PAH-SYMPACT|pah-sympact
207828|NCT02081690|psychometric instrument|psychometric instrument
207829|NCT02081664|Amalgam attributed health complaints|amalgam attributed health complaints
207830|NCT02081664|feasibility pilot study|feasibility pilot study
207831|NCT02081664|integrated medical care program|integrated medical care program
207832|NCT02081664|lifestyle|lifestyle
207833|NCT02081638|Immune Activation|immune activation
207834|NCT02081625|Duchenne muscular dystrophy|duchenne muscular dystrophy
207835|NCT02081625|NS-065/NCNP-01|ns-065/ncnp-01
207836|NCT02081625|exon 53 skipping|exon 53 skipping
207837|NCT02081625|morpholino|morpholino
207838|NCT02081599|insulin resistance|insulin resistance
207839|NCT02081586|CBT|cbt
207840|NCT02081586|Type 2 Diabetes|type 2 diabetes
207841|NCT02081586|Diabetes Distress|diabetes distress
207842|NCT02081586|Adherence|adherence
207843|NCT02081586|Smartphone App|smartphone app
207844|NCT02081586|Self-management|self-management
207845|NCT02081573|Brief CBT|brief cbt
207846|NCT02081573|smartphone app|smartphone app
207847|NCT02081573|mHealth|mhealth
207848|NCT02081573|diabetes distress|diabetes distress
207849|NCT02081573|adherence|adherence
207850|NCT02081560|pharmacokinetics|pharmacokinetics
207851|NCT02081560|antibiotic|antibiotic
207852|NCT02081560|Gram negative|gram negative
207853|NCT02081560|continuous renal replacement therapy|continuous renal replacement therapy
207854|NCT02081547|rectal carcinoma|rectal carcinoma
207855|NCT02081547|recurrence|recurrence
198678|NCT02122159|MMD|mmd
207856|NCT02081547|pathology|pathology
207857|NCT02081547|cytology|cytology
207858|NCT02081547|free cancer cells|free cancer cells
207859|NCT02081547|survival|survival
207860|NCT02081534|S-phosphate, hyperphosphatemia, hemodialysis, ESRD|s-phosphate, hyperphosphatemia, hemodialysis, esrd
207861|NCT02081521|behaviour change|behaviour change
207862|NCT02081521|diarrhoeal disease|diarrhoeal disease
207863|NCT02081521|handwashing|handwashing
207864|NCT02081521|breastfeeding|breastfeeding
207865|NCT02081521|diarrhoea management|diarrhoea management
207866|NCT02081508|Memory|memory
207867|NCT02081495|Neoplasms|neoplasms
207868|NCT02081495|Neoplasms, Ovarian|neoplasms, ovarian
207869|NCT02081495|Ovarian Cancer|ovarian cancer
207870|NCT02081495|Advanced or Refractory Solid Malignancies|advanced or refractory solid malignancies
207871|NCT02081495|Doxorubicin|doxorubicin
207872|NCT02081495|DOXIL|doxil
207873|NCT02081495|CAELYX|caelyx
207874|NCT02081469|Chronic hepatitis B|chronic hepatitis b
207875|NCT02081469|HBV|hbv
207876|NCT02081469|Chemotherapy|chemotherapy
207877|NCT02081469|Reactivation|reactivation
207878|NCT02081469|Prophylaxis|prophylaxis
207879|NCT02081443|coronary artery disease|coronary artery disease
207880|NCT02081443|platelet function|platelet function
207881|NCT02081443|ticagrelor|ticagrelor
207882|NCT02081443|cangrelor|cangrelor
207883|NCT02081417|Trauma|trauma
207884|NCT02081417|Post traumatic stress disorder|post traumatic stress disorder
207885|NCT02081417|substance use disorders|substance use disorders
207886|NCT02081417|peer-delivered trauma treatment|peer-delivered trauma treatment
207887|NCT02081404|Non-erosive Reflux Disease|non-erosive reflux disease
207888|NCT02081391|Acute Pain|acute pain
207889|NCT02081391|Post-operative|post-operative
207890|NCT02081391|Tapentadol|tapentadol
207891|NCT02081391|Opioid Treatment|opioid treatment
207892|NCT02081391|Pediatric Participants|pediatric participants
207893|NCT02081378|CML|cml
207894|NCT02081378|Ph+ ALL|ph+ all
207895|NCT02081352|Dermis|dermis
207896|NCT02081352|Diabetic foot ulcers|diabetic foot ulcers
207897|NCT02081352|Skin substitutes|skin substitutes
207898|NCT02081352|Decellularized|decellularized
207899|NCT02081326|Diabetes Mellitus, Type One|diabetes mellitus, type one
207900|NCT02081326|Diabetes Mellitus, Type I|diabetes mellitus, type i
207901|NCT02081326|Autoimmune Diabetes|autoimmune diabetes
207902|NCT02081326|Insulin Dependent Diabetes Mellitus 1|insulin dependent diabetes mellitus 1
207903|NCT02081326|IDDM|iddm
207904|NCT02081313|Netherton syndrome|netherton syndrome
207905|NCT02081313|Immune system|immune system
207906|NCT02081313|Skin barrier|skin barrier
207907|NCT02081300|Testosterone|testosterone
207908|NCT02081300|Male hypogonadism|male hypogonadism
207909|NCT02081300|Low testosterone|low testosterone
207910|NCT02081300|LPCN 1021|lpcn 1021
207911|NCT02081300|Androgel|androgel
207912|NCT02081300|Testim|testim
207913|NCT02081300|Testopel|testopel
207914|NCT02081300|Fortesta|fortesta
207915|NCT02081300|Axiron.|axiron.
207916|NCT02081300|Hypogonadism|hypogonadism
207917|NCT02081300|Eunuchism|eunuchism
207918|NCT02081300|Gonadal Disorders|gonadal disorders
207919|NCT02081300|Endocrine System Diseases|endocrine system diseases
207920|NCT02081300|Testosterone enanthate|testosterone enanthate
207921|NCT02081300|Testosterone undecanoate|testosterone undecanoate
207922|NCT02081300|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
207923|NCT02081300|Methyltestosterone|methyltestosterone
207924|NCT02081300|Androgens|androgens
207925|NCT02081300|Hormones|hormones
401993|NCT01233596|bicanalicular intubation|bicanalicular intubation
207926|NCT02081300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
207927|NCT02081300|Physiological Effects of Drugs|physiological effects of drugs
207928|NCT02081300|Pharmacologic Actions|pharmacologic actions
207929|NCT02081300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
207930|NCT02081300|Antineoplastic Agents|antineoplastic agents
207931|NCT02081300|Anabolic Agents|anabolic agents
207932|NCT02081287|Bipolar Disorder|bipolar disorder
207933|NCT02081287|Depression|depression
207934|NCT02081287|Inositol|inositol
207935|NCT02081287|Inositol Hexaphosphate|inositol hexaphosphate
207936|NCT02081287|Phytic Acid|phytic acid
207938|NCT02081287|Lithium|lithium
207939|NCT02081287|Lamotrigine|lamotrigine
207940|NCT02081274|tidal volume|tidal volume
207941|NCT02081274|congenital heart disease|congenital heart disease
207942|NCT02081274|mortality|mortality
207943|NCT02081261|coronary artery bypass surgery|coronary artery bypass surgery
207944|NCT02081261|acute kidney injury|acute kidney injury
207945|NCT02081261|creatinine|creatinine
207946|NCT02081261|mortality|mortality
207947|NCT02081235|congenital heart disease|congenital heart disease
207948|NCT02081235|acute kidney injury|acute kidney injury
207949|NCT02081235|risk factor|risk factor
207950|NCT02081235|anesthesia|anesthesia
207951|NCT02081222|congenital heart disease|congenital heart disease
207952|NCT02081222|rotational thromboelastometry|rotational thromboelastometry
207953|NCT02081222|blood loss|blood loss
207954|NCT02081222|transfusion requirements|transfusion requirements
207955|NCT02081209|Lipolysis|lipolysis
207956|NCT02081209|Cryolipolysis|cryolipolysis
207957|NCT02081209|Fat Reduction|fat reduction
207958|NCT02081196|Lipolysis|lipolysis
207959|NCT02081196|Cryolipolysis|cryolipolysis
207960|NCT02081196|Fat Reduction|fat reduction
207961|NCT02081144|Standard Care Condition|standard care condition
207962|NCT02081144|Texting + NRT Condition|texting + nrt condition
207963|NCT02081131|periampullary cancer|periampullary cancer
207964|NCT02081131|pancreatic cancer|pancreatic cancer
207965|NCT02081131|randomized controlled trial|randomized controlled trial
207966|NCT02081131|Whipple's operation|whipple's operation
207967|NCT02081131|laparoscopy|laparoscopy
207968|NCT02081105|ARDS,|ards,
207969|NCT02081105|PEEP,|peep,
207970|NCT02081105|lung recruitment,|lung recruitment,
207971|NCT02081105|lung recruitability,|lung recruitability,
207972|NCT02081105|Chest-X-Ray,|chest-x-ray,
207973|NCT02081105|lung imaging,|lung imaging,
207974|NCT02081105|Pressure/Volume (PV) curve,|pressure/volume (pv) curve,
207975|NCT02081105|compliance,|compliance,
207976|NCT02081105|respiratory mechanics|respiratory mechanics
207978|NCT02081092|Pulmonary Alveolar Proteinosis|pulmonary alveolar proteinosis
207979|NCT02081092|Pulmonary|pulmonary
207980|NCT02081092|Patients|patients
207981|NCT02081079|HCV GT 4|hcv gt 4
207982|NCT02081079|HCV GT 5|hcv gt 5
207983|NCT02081053|metastatic lesions|metastatic lesions
207984|NCT02081053|vertebral body|vertebral body
207985|NCT02081053|ablation|ablation
207986|NCT02081053|targeted radio-frequency ablation|targeted radio-frequency ablation
207987|NCT02081053|radio-frequency targeted vertebral augmentation|radio-frequency targeted vertebral augmentation
207988|NCT02081053|radiofrequency kyphoplasty|radiofrequency kyphoplasty
207989|NCT02081053|spine|spine
207990|NCT02081053|vertebral augmentation|vertebral augmentation
207991|NCT02081053|kyphoplasty|kyphoplasty
207992|NCT02081053|spinal ablation|spinal ablation
207993|NCT02081053|pain|pain
207994|NCT02081053|quality of life|quality of life
207995|NCT02081040|brainstem|brainstem
207996|NCT02081040|diaphragm|diaphragm
207997|NCT02081040|deglutition disorder|deglutition disorder
207998|NCT02081040|sonography|sonography
207999|NCT02081014|Hypoglycemia|hypoglycemia
208000|NCT02081014|Glucagon|glucagon
208001|NCT02081014|Diabetes|diabetes
208002|NCT02081001|Hypoglycemia|hypoglycemia
208003|NCT02081001|Glucagon|glucagon
208004|NCT02081001|Artificial Pancreas|artificial pancreas
208005|NCT02080988|stroke|stroke
208006|NCT02080988|deglutition disorders|deglutition disorders
208007|NCT02080988|cough|cough
208008|NCT02080988|aspiration pneumonia|aspiration pneumonia
208009|NCT02080988|diaphragm|diaphragm
208010|NCT02080988|respiratory function|respiratory function
208011|NCT02080962|non-melanoma skin cancer, radiotherapy, orthovoltage|non-melanoma skin cancer, radiotherapy, orthovoltage
208012|NCT02080949|brain metastases, hypofractionated stereotactic radiotherapy|brain metastases, hypofractionated stereotactic radiotherapy
208013|NCT02080936|Experimental approaches|experimental approaches
208014|NCT02080936|Peripheral muscle Keyword|peripheral muscle keyword
208015|NCT02080936|Rehabilitation|rehabilitation
208016|NCT02080923|Adolescent|adolescent
208017|NCT02080923|Adolescent Behavior|adolescent behavior
208018|NCT02080923|Age Factors|age factors
208019|NCT02080923|Courtship|courtship
208020|NCT02080923|Randomized Control Trial|randomized control trial
208021|NCT02080923|Female|female
208022|NCT02080923|Male|male
208023|NCT02080923|Minority Groups/statistics & numerical data|minority groups/statistics & numerical data
208024|NCT02080923|Risk-Taking|risk-taking
208025|NCT02080923|Sex Factors|sex factors
208026|NCT02080923|Sexual Behavior/statistics & numerical data|sexual behavior/statistics & numerical data
208027|NCT02080923|Substance-Related Disorders/epidemiology|substance-related disorders/epidemiology
208028|NCT02080923|Urban Population/statistics & numerical data|urban population/statistics & numerical data
208029|NCT02080923|Violence/statistics & numerical data|violence/statistics & numerical data
208030|NCT02080923|Dating Violence|dating violence
208031|NCT02080923|Dating Aggression|dating aggression
208032|NCT02080923|Perpetration|perpetration
208034|NCT02080910|stroke|stroke
208035|NCT02080910|psychoeducation|psychoeducation
208036|NCT02080910|problem-solving|problem-solving
208037|NCT02080897|non-surgical|non-surgical
208038|NCT02080897|palliative surgery|palliative surgery
208039|NCT02080871|PAD|pad
208040|NCT02080871|Stent|stent
208041|NCT02080871|Claudication|claudication
208042|NCT02080871|Viabahn|viabahn
208043|NCT02080871|Gore|gore
208044|NCT02080871|Endoprosthesis|endoprosthesis
208045|NCT02080871|Vascular Diseases|vascular diseases
208046|NCT02080871|Cardiovascular Diseases|cardiovascular diseases
208047|NCT02080871|Iliac Occlusive Disease|iliac occlusive disease
208048|NCT02080871|Balloon Expandable|balloon expandable
208049|NCT02080871|Stent-graft|stent-graft
208050|NCT02080871|VBX|vbx
208051|NCT02080858|Apixaban|apixaban
208052|NCT02080858|Ticagrelor|ticagrelor
198836|NCT02121548|Haitian|haitian
208053|NCT02080858|ASA|asa
208054|NCT02080858|shed blood|shed blood
208055|NCT02080858|perfusion chamber|perfusion chamber
208056|NCT02080845|Caffeine|caffeine
208057|NCT02080845|MRI|mri
208058|NCT02080845|Brain blood flow|brain blood flow
208059|NCT02080845|Cognition|cognition
208060|NCT02080845|Perfusion|perfusion
208061|NCT02080845|Resting functional magnetic resonance imaging (fMRI)|resting functional magnetic resonance imaging (fmri)
208062|NCT02080832|substance abuse|substance abuse
208063|NCT02080832|cocaine|cocaine
208064|NCT02080832|impulsivity|impulsivity
208065|NCT02080832|serotonin|serotonin
208066|NCT02080832|MRI|mri
208067|NCT02080819|drug abuse|drug abuse
208068|NCT02080819|cocaine|cocaine
208069|NCT02080819|impulsivity|impulsivity
208070|NCT02080819|dopamine|dopamine
208071|NCT02080806|stroke, dysphagia, cough, mechanical insufflation exsufflation|stroke, dysphagia, cough, mechanical insufflation exsufflation
208072|NCT02080754|Crush induction|crush induction
208073|NCT02080754|Cricoid pressure|cricoid pressure
208074|NCT02080754|Sellick maneuver|sellick maneuver
208075|NCT02080754|Lung aspiration|lung aspiration
208076|NCT02080754|Aspiration pneumonia|aspiration pneumonia
208077|NCT02080715|Sleep-wake|sleep-wake
208078|NCT02080715|regulation|regulation
208079|NCT02080715|volunteers|volunteers
208080|NCT02080702|GIT, Monosyn, anastomoses leakage|git, monosyn, anastomoses leakage
208081|NCT02080676|Cannabis|cannabis
208082|NCT02080676|Intra ocular pressure|intra ocular pressure
208083|NCT02080676|Ocular perfusion|ocular perfusion
208084|NCT02080676|Blood pressure|blood pressure
208085|NCT02080663|carpectomy, proximal row, long-term, wrist, arthritis|carpectomy, proximal row, long-term, wrist, arthritis
208086|NCT02080637|Single ventricle|single ventricle
208087|NCT02080585|Inactivity|inactivity
208088|NCT02080546|Vaginal cuff dehiscence|vaginal cuff dehiscence
208089|NCT02080546|Thermal Injury|thermal injury
208090|NCT02080546|Total laparoscopic hysterectomy|total laparoscopic hysterectomy
208091|NCT02080533|pulmonary arterial hypertension|pulmonary arterial hypertension
208092|NCT02080533|symptoms|symptoms
208093|NCT02080533|dyspnea|dyspnea
208094|NCT02080533|fatigue|fatigue
208095|NCT02080533|sleep|sleep
208096|NCT02080520|Prevention|prevention
208098|NCT02080520|Fermented soy|fermented soy
208099|NCT02080520|Nattokinase|nattokinase
208100|NCT02080520|Randomized controlled trial|randomized controlled trial
208101|NCT02080520|Carotid artery|carotid artery
208102|NCT02080520|Cognition|cognition
208103|NCT02080520|Atherothrombosis|atherothrombosis
208104|NCT02080507|rTMS|rtms
208105|NCT02080507|depression|depression
208106|NCT02080507|ECT|ect
208107|NCT02080494|tranexamic acid|tranexamic acid
208108|NCT02080494|orthopaedic trauma|orthopaedic trauma
208109|NCT02080494|pelvic fracture|pelvic fracture
208110|NCT02080494|hip fracture|hip fracture
208111|NCT02080494|femur fracture|femur fracture
208112|NCT02080494|blood loss|blood loss
208113|NCT02080468|Effect|effect
208114|NCT02080468|Ethinyl Estradiol/Norgestimate|ethinyl estradiol/norgestimate
208115|NCT02080468|Pharmacokinetics|pharmacokinetics
208116|NCT02080468|Lomitapide.|lomitapide.
208117|NCT02080442|COPD|copd
208118|NCT02080442|Balance|balance
208119|NCT02080442|Pulmonary Rehabilitation|pulmonary rehabilitation
208120|NCT02080416|EBV|ebv
208121|NCT02080416|KSHV|kshv
208122|NCT02080416|malignancy|malignancy
208123|NCT02080416|lymphoma|lymphoma
208124|NCT02080416|sarcoma|sarcoma
208125|NCT02080416|virus-associated|virus-associated
208126|NCT02080403|Peri-Implantitis|peri-implantitis
208127|NCT02080403|Periodontal Diseases|periodontal diseases
208128|NCT02080403|Chlorhexidine gluconate|chlorhexidine gluconate
208129|NCT02080403|PerioChip|periochip
208130|NCT02080403|Anti-Infective Agents|anti-infective agents
208131|NCT02080403|Mouth Diseases|mouth diseases
208132|NCT02080403|Antiseptics|antiseptics
208133|NCT02080390|Her 2 Positive Breast Cancer|her 2 positive breast cancer
208134|NCT02080390|Trastuzumab|trastuzumab
208135|NCT02080390|Herceptin|herceptin
208136|NCT02080390|Heart Failure|heart failure
208137|NCT02080390|Echocardiography|echocardiography
208138|NCT02080377|Pregnancy|pregnancy
208139|NCT02080377|Gestational diabetes|gestational diabetes
208140|NCT02080377|Glycaemic control|glycaemic control
208141|NCT02080377|Metformin|metformin
208142|NCT02080364|Alzheimer's disease|alzheimer's disease
208144|NCT02080364|ADAS-cog|adas-cog
208145|NCT02080364|CDR-sb|cdr-sb
208146|NCT02080338|Orthodontic, Bracket slot, Effective, Randomized, Duration|orthodontic, bracket slot, effective, randomized, duration
208147|NCT02080325|weight loss|weight loss
208148|NCT02080325|high protein diet|high protein diet
208149|NCT02080325|plant protein|plant protein
208150|NCT02080325|satiety|satiety
208151|NCT02080325|soy|soy
208152|NCT02080312|Meniere's disease|meniere's disease
208153|NCT02080312|endolymphatic hydrops|endolymphatic hydrops
208154|NCT02080286|spatial neglect|spatial neglect
208155|NCT02080286|rehabilitation|rehabilitation
208156|NCT02080286|brain stimulation|brain stimulation
208158|NCT02080286|prism adaptation|prism adaptation
208159|NCT02080234|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
208160|NCT02080234|asparaginase|asparaginase
208161|NCT02080234|GELOX|gelox
208162|NCT02080234|concurrent chemoradiotherapy|concurrent chemoradiotherapy
208163|NCT02080234|sIL-2R|sil-2r
208164|NCT02080221|metastatic pancreatic cancer|metastatic pancreatic cancer
208165|NCT02080221|pancreatic cancer|pancreatic cancer
208166|NCT02080221|metastatic|metastatic
208167|NCT02080208|hypoxemia|hypoxemia
208168|NCT02080208|high flow oxygen therapy|high flow oxygen therapy
208169|NCT02080208|respiratory failure|respiratory failure
208170|NCT02080182|Acute Pyelonephritis|acute pyelonephritis
208171|NCT02080182|Acetylcysteine|acetylcysteine
208172|NCT02080182|Pediatric|pediatric
208173|NCT02080169|Intensive care unit|intensive care unit
208174|NCT02080169|Mechanical ventilation|mechanical ventilation
208175|NCT02080169|Combined sedation|combined sedation
208176|NCT02080156|Obstructive Sleep Apnea|obstructive sleep apnea
208177|NCT02080156|Percutaneous Coronary Intervention|percutaneous coronary intervention
208178|NCT02080156|Coronary Artery Bypass Graft|coronary artery bypass graft
208179|NCT02080156|Mortality|mortality
208180|NCT02080156|Questionnaire|questionnaire
208181|NCT02080156|Biomarker|biomarker
208182|NCT02080143|Skin temperature measurements|skin temperature measurements
208183|NCT02080143|Heat patch adhesion|heat patch adhesion
208184|NCT02080143|Dermal irritation|dermal irritation
208185|NCT02080130|Gastroenteritis|gastroenteritis
208186|NCT02080130|diarrhea|diarrhea
208187|NCT02080117|kidney transplantation|kidney transplantation
208188|NCT02080117|delayed graft function|delayed graft function
208189|NCT02080117|creatinine|creatinine
208190|NCT02080117|graft survival|graft survival
208191|NCT02080104|postpartum hemorrhage|postpartum hemorrhage
208192|NCT02080104|oxytocin|oxytocin
208193|NCT02080104|vaginal delivery|vaginal delivery
208194|NCT02080104|prophylactic|prophylactic
208195|NCT02080078|Erlotinib|erlotinib
208196|NCT02080078|Theophylline|theophylline
208197|NCT02080078|Diarrhea|diarrhea
208198|NCT02080065|risk factor|risk factor
208199|NCT02080065|acute kidney injury|acute kidney injury
208200|NCT02080065|liver transplantation|liver transplantation
208201|NCT02080065|postoperative renal function|postoperative renal function
208202|NCT02080039|Spinal Cord Injury|spinal cord injury
208203|NCT02080039|Denervation|denervation
208204|NCT02080039|Electrical Stimulation|electrical stimulation
208205|NCT02080026|malaria|malaria
208206|NCT02080026|Plasmodium falciparum|plasmodium falciparum
208207|NCT02080000|Heart Failure|heart failure
208208|NCT02080000|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
208209|NCT02080000|Biventricular Pacemaker|biventricular pacemaker
208210|NCT02080000|Optimisation|optimisation
208211|NCT02079987|Health Literacy|health literacy
208212|NCT02079987|Care Transition Intervention|care transition intervention
208213|NCT02079987|Emergency Department Population|emergency department population
208214|NCT02079987|Access to Care|access to care
208215|NCT02079974|endometriosis|endometriosis
208216|NCT02079974|pain|pain
208217|NCT02079974|fertility|fertility
208218|NCT02079961|anemia|anemia
208219|NCT02079961|children|children
208220|NCT02079961|iron-fortified product|iron-fortified product
208221|NCT02079961|value chain|value chain
208222|NCT02079948|Aging|aging
208223|NCT02079948|Cognitive Function|cognitive function
208224|NCT02079948|Physical Function|physical function
678246|NCT00882089|Accelerated|accelerated
208225|NCT02079948|Systematic Inflammation|systematic inflammation
208226|NCT02079948|Methotrexate|methotrexate
208227|NCT02079948|Pain Symptoms|pain symptoms
208228|NCT02079935|BN|bn
208229|NCT02079935|Binge|binge
208230|NCT02079935|overconsumption of food|overconsumption of food
208231|NCT02079935|purging|purging
208232|NCT02079935|purge|purge
208233|NCT02079922|Multiple Ascending Dose|multiple ascending dose
208234|NCT02079922|healthy subjects|healthy subjects
208235|NCT02079922|Hypercholesterolemia|hypercholesterolemia
208236|NCT02079922|Hyperlipidemias|hyperlipidemias
208237|NCT02079922|Dyslipidemias|dyslipidemias
208238|NCT02079922|Lipid Metabolism Disorders|lipid metabolism disorders
208239|NCT02079922|Metabolic Diseases|metabolic diseases
208240|NCT02079909|Alzheimer's Disease|alzheimer's disease
208241|NCT02079909|Alzheimer's|alzheimer's
208242|NCT02079896|Dialysis|dialysis
208243|NCT02079844|Drug therapy|drug therapy
208244|NCT02079831|Adolescent obesity|adolescent obesity
208245|NCT02079831|childhood obesity|childhood obesity
208246|NCT02079831|anthropometry|anthropometry
208247|NCT02079831|body weights and measures|body weights and measures
208248|NCT02079818|visceral artery aneurysms|visceral artery aneurysms
208249|NCT02079818|arteriovenous malformations|arteriovenous malformations
208250|NCT02079818|Penumbra Ruby Coil System|penumbra ruby coil system
208251|NCT02079792|Budesonide|budesonide
208252|NCT02079792|Mucosal Atomization Device|mucosal atomization device
208253|NCT02079792|Head Position|head position
199111|NCT02120352|RPV|rpv
208254|NCT02079779|Robotic-assisted therapy|robotic-assisted therapy
208255|NCT02079779|Acute Stroke|acute stroke
208256|NCT02079779|International Classification of Functioning, Disability and Health|international classification of functioning, disability and health
208257|NCT02079753|COPD, portable concentrator, oxygen sources|copd, portable concentrator, oxygen sources
208258|NCT02079727|Condrosulf|condrosulf
208259|NCT02079727|Chondroitin sulfate|chondroitin sulfate
208260|NCT02079727|Celebrex|celebrex
208261|NCT02079727|Knee OA|knee oa
208262|NCT02079727|Knee osteoarthritis|knee osteoarthritis
208263|NCT02079714|Orthopaedic Trauma|orthopaedic trauma
208264|NCT02079714|Injury|injury
208265|NCT02079701|pneumonia|pneumonia
208266|NCT02079701|pneumococcus|pneumococcus
208267|NCT02079701|vaccine|vaccine
208268|NCT02079701|23-valent pneumococcal vaccine|23-valent pneumococcal vaccine
208269|NCT02079701|military recruits|military recruits
208270|NCT02079688|Antisense oligonucleotide|antisense oligonucleotide
208271|NCT02079688|atopic eczema|atopic eczema
208272|NCT02079688|atopic dermatitis|atopic dermatitis
208273|NCT02079688|Phase II|phase ii
208274|NCT02079688|Transcription factor GATA-3|transcription factor gata-3
208275|NCT02079688|dermal application|dermal application
208276|NCT02079688|Proof-of-Concept|proof-of-concept
208277|NCT02079662|Breast Cancer|breast cancer
208278|NCT02079662|Radiation Therapy|radiation therapy
208279|NCT02079662|Radiotherapy|radiotherapy
208280|NCT02079662|XRT|xrt
208281|NCT02079662|Aerobic Activity|aerobic activity
208282|NCT02079662|Dietician Counseling|dietician counseling
208283|NCT02079662|Dietary Assessment|dietary assessment
208284|NCT02079662|Yoga|yoga
208285|NCT02079662|Cognitive Behavior Therapy|cognitive behavior therapy
208286|NCT02079662|Smoking Cessation Counseling|smoking cessation counseling
208287|NCT02079662|Questionnaires|questionnaires
208288|NCT02079662|Surveys|surveys
208289|NCT02079662|Saliva Samples|saliva samples
208290|NCT02079662|Blood Samples|blood samples
208291|NCT02079649|Allergic conjunctivitis|allergic conjunctivitis
208292|NCT02079649|Red eyes|red eyes
208293|NCT02079649|Eyelid swelling|eyelid swelling
208294|NCT02079649|Ragweed|ragweed
208295|NCT02079649|Allergies|allergies
208296|NCT02079649|Itchy eyes|itchy eyes
208297|NCT02079649|Ocular redness|ocular redness
208298|NCT02079649|Chemosis|chemosis
208299|NCT02079649|Tearing|tearing
208300|NCT02079649|Watery eyes|watery eyes
208301|NCT02079623|Pancreatic cancer|pancreatic cancer
208302|NCT02079623|Electroporation|electroporation
208303|NCT02079623|Nano knife treatment|nano knife treatment
208304|NCT02079610|Depression|depression
208305|NCT02079610|Neurofeedback|neurofeedback
208306|NCT02079610|Amygdala|amygdala
208307|NCT02079597|SIRS|sirs
208308|NCT02079597|Ninj1|ninj1
208309|NCT02079597|Sepsis|sepsis
208310|NCT02079597|Healthy|healthy
208311|NCT02079584|Patient Compliance|patient compliance
208312|NCT02079584|Target Specific Anticoagulant|target specific anticoagulant
208313|NCT02079584|Quality of Life|quality of life
208314|NCT02079558|prevention|prevention
208315|NCT02079558|cesarean section|cesarean section
208316|NCT02079545|Healthy|healthy
208317|NCT02079545|Bioavailability|bioavailability
208318|NCT02079545|Pharmacokinetics|pharmacokinetics
208319|NCT02079545|Sirukumab|sirukumab
208320|NCT02079545|Subcutaneous|subcutaneous
208321|NCT02079545|Male|male
208322|NCT02079493|osteoarthritis|osteoarthritis
208323|NCT02079493|knee replacement|knee replacement
208324|NCT02079493|functional testing|functional testing
208325|NCT02079467|Arthroplasty, Hip|arthroplasty, hip
208326|NCT02079467|Replacement, Hip|replacement, hip
208327|NCT02079467|Postoperative Care|postoperative care
208328|NCT02079467|Rehabilitation|rehabilitation
208329|NCT02079441|Anti- TNF|anti- tnf
208330|NCT02079441|inflammatory bowel disease|inflammatory bowel disease
208331|NCT02079441|pregnancy|pregnancy
208332|NCT02079441|infant|infant
208333|NCT02079441|immunity|immunity
208334|NCT02079441|Immune function|immune function
208335|NCT02079428|Heart Failure|heart failure
208336|NCT02079428|Registry|registry
208337|NCT02079428|China|china
208338|NCT02079415|NICU|nicu
208339|NCT02079402|sepsis|sepsis
208340|NCT02079402|septic|septic
208341|NCT02079402|shock|shock
208343|NCT02079402|intensive|intensive
208344|NCT02079402|critical|critical
208345|NCT02079402|resuscitation|resuscitation
208346|NCT02079402|fluid|fluid
208347|NCT02079402|IV|iv
208348|NCT02079402|crystalloid|crystalloid
208349|NCT02079402|balance|balance
208350|NCT02079389|colon cancer|colon cancer
208351|NCT02079389|rectum cancer|rectum cancer
208352|NCT02079389|laparoscopic ultrasound|laparoscopic ultrasound
208353|NCT02079389|LUS|lus
208354|NCT02079389|Contrast enhanced ultrasound|contrast enhanced ultrasound
208355|NCT02079389|CEUS|ceus
208356|NCT02079389|Peroperative TNM staging|peroperative tnm staging
208357|NCT02079389|screening for liver metastases|screening for liver metastases
208358|NCT02079376|diabetes|diabetes
208359|NCT02079363|Pancreatic Diseases|pancreatic diseases
208360|NCT02079363|Pancreatic Neoplasms|pancreatic neoplasms
208361|NCT02079363|Pancreatitis|pancreatitis
208362|NCT02079363|DNA promoter hypermethylation|dna promoter hypermethylation
208363|NCT02079363|DNA methylation|dna methylation
208364|NCT02079363|Cell-free DNA|cell-free dna
208365|NCT02079363|Plasma|plasma
208366|NCT02079324|head and neck cancer|head and neck cancer
208367|NCT02079324|gene therapy|gene therapy
208368|NCT02079324|stem cell therapy|stem cell therapy
208369|NCT02079324|immunotherappy|immunotherappy
208370|NCT02079311|Patient warming|patient warming
208371|NCT02079311|Active warming|active warming
208372|NCT02079311|Forced Air Warming|forced air warming
208373|NCT02079311|Warming blanket|warming blanket
208374|NCT02079272|Tomotherapy|tomotherapy
208375|NCT02079272|Breast Cancer|breast cancer
208376|NCT02079272|Heart|heart
208377|NCT02079272|Subclinical cardiac lesions|subclinical cardiac lesions
208378|NCT02079272|Myocardial lesions|myocardial lesions
208379|NCT02079272|Coronary lesions|coronary lesions
208380|NCT02079272|Circulating biomarkers|circulating biomarkers
208381|NCT02079272|Ionizing radiation|ionizing radiation
208382|NCT02079272|Heart absorbed doses|heart absorbed doses
208383|NCT02079233|Basic Science|basic science
208384|NCT02079233|Safety|safety
208385|NCT02079233|Tolerability|tolerability
208386|NCT02079233|Efficacy of CLP|efficacy of clp
208387|NCT02079220|Colorectal Cancer|colorectal cancer
208388|NCT02079220|Metastatic Colorectal Cancer|metastatic colorectal cancer
208389|NCT02079194|Drug-eluting stents|drug-eluting stents
208390|NCT02079194|aspirin|aspirin
208391|NCT02079194|P2Y12 antagonist monotherapy|p2y12 antagonist monotherapy
208392|NCT02079168|Keloid|keloid
208393|NCT02079168|Cicatrix|cicatrix
208394|NCT02079168|Keloid prevention|keloid prevention
208395|NCT02079168|Keloid revision/excision|keloid revision/excision
208396|NCT02079168|Keloidectomy|keloidectomy
208397|NCT02079129|agreement between cMRI PVL grading and TTE PVL grading|agreement between cmri pvl grading and tte pvl grading
208398|NCT02079129|Edwards Sapien TAVR|edwards sapien tavr
208399|NCT02079116|Obesity|obesity
208400|NCT02079116|Lipids|lipids
208401|NCT02079116|Single Photon Emission Computed Tomography|single photon emission computed tomography
208402|NCT02079116|Functional Neuroimaging|functional neuroimaging
208403|NCT02079103|Virtual reality|virtual reality
208404|NCT02079103|Stroke|stroke
208405|NCT02079103|Arm motor function|arm motor function
208406|NCT02079103|Neurorehabilitation|neurorehabilitation
208408|NCT02079090|Ketamine|ketamine
208409|NCT02079090|Fentanyl|fentanyl
208410|NCT02079090|Procedural sedation|procedural sedation
208411|NCT02079090|children|children
208412|NCT02079090|Emergency Department|emergency department
208413|NCT02079077|HIV, Immune quiescence, ASA, Hydroxychloroquin|hiv, immune quiescence, asa, hydroxychloroquin
208414|NCT02079064|Splenectomy|splenectomy
208415|NCT02079064|Desflurane|desflurane
208416|NCT02079064|Propofol|propofol
208417|NCT02079064|TCI|tci
208418|NCT02079064|ROTEM|rotem
208419|NCT02079051|Obesity Physical Performance Weight loss Optifast|obesity physical performance weight loss optifast
208420|NCT02079025|Prostate Biopsy|prostate biopsy
208421|NCT02079025|Ultrasound guided biopsy of the prostate|ultrasound guided biopsy of the prostate
208422|NCT02079025|High-resolution ultrasound|high-resolution ultrasound
208423|NCT02079012|Walking Program|walking program
208424|NCT02079012|Mental Disorders|mental disorders
208425|NCT02079012|Physical Activity|physical activity
208426|NCT02079012|Physical Fitness|physical fitness
208427|NCT02079012|Anxiety|anxiety
208428|NCT02079012|Depression|depression
208429|NCT02079012|Self Determination|self determination
208430|NCT02078999|Mechanical ventilation, procalcitonin, c-reactive protein|mechanical ventilation, procalcitonin, c-reactive protein
208431|NCT02078986|Whole-Body-Electromyostimulation|whole-body-electromyostimulation
208432|NCT02078986|High Intensity Resistance Exercise Training (HIT)|high intensity resistance exercise training (hit)
208433|NCT02078986|Lean Body Mass|lean body mass
208434|NCT02078986|Muscle Strength|muscle strength
208435|NCT02078973|Tolvaptan|tolvaptan
208436|NCT02078973|L-NMMA|l-nmma
208437|NCT02078973|Healthy subjects|healthy subjects
208438|NCT02078973|Nephrology|nephrology
208439|NCT02078960|Chronic Phase|chronic phase
208440|NCT02078960|Accelerated Phase|accelerated phase
208441|NCT02078960|CML|cml
208442|NCT02078960|Chronic Myeloid Leukemia|chronic myeloid leukemia
208443|NCT02078947|Diastolic heart failure, Heart failure with preserved ejection fraction, exercise|diastolic heart failure, heart failure with preserved ejection fraction, exercise
208445|NCT02078934|Morbid Obesity|morbid obesity
208446|NCT02078934|Weight Loss|weight loss
208447|NCT02078934|Bariatrics|bariatrics
208448|NCT02078934|Complex incisional hernia with mesh|complex incisional hernia with mesh
208449|NCT02078908|Central blood pressure|central blood pressure
208450|NCT02078908|Peripheral (brachial) blood pressure|peripheral (brachial) blood pressure
208451|NCT02078908|Renal variables|renal variables
208452|NCT02078908|Vasoactive hormones|vasoactive hormones
208453|NCT02078908|Pharmacology|pharmacology
208454|NCT02078908|Pharmacokinetics|pharmacokinetics
208455|NCT02078895|Lower Urinary tract discomfort , ureteral stent pain|lower urinary tract discomfort , ureteral stent pain
208557|NCT02078466|readmission|readmission
208456|NCT02078882|Primary Biliary Cirrhosis|primary biliary cirrhosis
208457|NCT02078882|Ursodeoxycholic acid|ursodeoxycholic acid
208458|NCT02078882|Abatacept|abatacept
208459|NCT02078882|Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4)|cytotoxic t-lymphocyte antigen 4 (ctla-4)
208461|NCT02078843|Gallium-68-DOTATATE|gallium-68-dotatate
208462|NCT02078843|PET/CT|pet/ct
208463|NCT02078843|Indium-111-pentetreotide scintigraphy|indium-111-pentetreotide scintigraphy
208464|NCT02078843|octreoscan|octreoscan
208465|NCT02078843|GEP-NET|gep-net
208466|NCT02078843|gastroenteropancreatic neuroendocrine tumors|gastroenteropancreatic neuroendocrine tumors
208467|NCT02078830|Wound Contamination|wound contamination
208468|NCT02078817|Treatment-resistant|treatment-resistant
208469|NCT02078804|Colorectal cancer|colorectal cancer
208470|NCT02078804|Mortality|mortality
208471|NCT02078804|Incidence|incidence
208472|NCT02078804|Screening|screening
208473|NCT02078804|Health-economy|health-economy
208474|NCT02078791|Fibromyalgia|fibromyalgia
208475|NCT02078791|Group Problem Solving Technique|group problem solving technique
208476|NCT02078791|infiltration|infiltration
208477|NCT02078778|Continuous airway pressure|continuous airway pressure
208478|NCT02078778|Hypertension|hypertension
208479|NCT02078778|Obstructive sleep apnea|obstructive sleep apnea
208480|NCT02078765|hypertension|hypertension
208481|NCT02078765|chronic kidneys disease|chronic kidneys disease
208482|NCT02078765|obstructive sleep apnea|obstructive sleep apnea
208483|NCT02078765|24-h blood pressure|24-h blood pressure
208484|NCT02078765|central blood pressure|central blood pressure
208485|NCT02078765|peripheral blood pressure|peripheral blood pressure
208486|NCT02078752|ADC|adc
208487|NCT02078752|PF-06647263|pf-06647263
208488|NCT02078752|solid tumors|solid tumors
208489|NCT02078752|tumors|tumors
208490|NCT02078752|neoplasm metastasis|neoplasm metastasis
208491|NCT02078752|TNBC|tnbc
208492|NCT02078752|Triple negative breast cancer|triple negative breast cancer
208493|NCT02078739|Yoga|yoga
208494|NCT02078739|COPD|copd
208495|NCT02078739|Congestive Heart Failure|congestive heart failure
208496|NCT02078726|glucagon, screening colonoscopy|glucagon, screening colonoscopy
208497|NCT02078713|contraception|contraception
208498|NCT02078713|patient decision support|patient decision support
208499|NCT02078713|patient decision aid|patient decision aid
208500|NCT02078713|shared decision making|shared decision making
208501|NCT02078713|Decision Making, Shared|decision making, shared
208502|NCT02078713|Patient-Centered Outcomes Research|patient-centered outcomes research
208503|NCT02078700|cancer|cancer
208504|NCT02078700|early palliative care|early palliative care
208505|NCT02078700|feasibility|feasibility
208506|NCT02078687|very preterm|very preterm
208507|NCT02078687|nutrition|nutrition
208508|NCT02078687|6 year follow-up|6 year follow-up
208509|NCT02078687|growth|growth
208510|NCT02078687|metabolic syndrome|metabolic syndrome
208511|NCT02078687|allergy|allergy
208512|NCT02078687|dexa|dexa
208513|NCT02078674|H7N9|h7n9
208514|NCT02078661|Keratoconjunctivitis sicca|keratoconjunctivitis sicca
208515|NCT02078661|Dry eye|dry eye
208516|NCT02078648|Glioma Associated Antigen|glioma associated antigen
208517|NCT02078648|Vaccine|vaccine
208518|NCT02078648|Adult|adult
208519|NCT02078648|Recurrent Glioblastoma|recurrent glioblastoma
208520|NCT02078648|Immunotherapy|immunotherapy
208521|NCT02078635|Arterial plaque|arterial plaque
208522|NCT02078635|portfolio diet|portfolio diet
208523|NCT02078635|dietary modification|dietary modification
208524|NCT02078635|dietary trials|dietary trials
208525|NCT02078635|Canadian Network|canadian network
208526|NCT02078635|knowledge synthesis and translation|knowledge synthesis and translation
208527|NCT02078635|Magnetic resonance imaging|magnetic resonance imaging
208528|NCT02078622|COPD|copd
208529|NCT02078622|Respiratory Therapist|respiratory therapist
208530|NCT02078622|Case Management|case management
208531|NCT02078622|Education|education
208532|NCT02078609|AML,|aml,
208533|NCT02078609|MDS,|mds,
208534|NCT02078609|PIM,|pim,
208535|NCT02078609|LGH447,|lgh447,
208536|NCT02078609|acute myelod leukemia,|acute myelod leukemia,
208537|NCT02078609|myelodysplastic syndrome,|myelodysplastic syndrome,
208538|NCT02078609|midostaurin,|midostaurin,
208539|NCT02078609|PKC412|pkc412
208540|NCT02078596|temper outbursts|temper outbursts
208541|NCT02078596|pediatric aggression|pediatric aggression
208542|NCT02078596|irritability|irritability
208543|NCT02078544|Cancer in Gynaecologic Oncology|cancer in gynaecologic oncology
208544|NCT02078505|Change in gut microbial population|change in gut microbial population
208545|NCT02078505|polycystic ovary syndrome|polycystic ovary syndrome
208546|NCT02078505|gut microbiome|gut microbiome
208547|NCT02078505|diet|diet
208548|NCT02078479|Malignancy|malignancy
208550|NCT02078479|LANSS|lanss
208551|NCT02078479|VDS|vds
208552|NCT02078479|Neuropathic pain|neuropathic pain
199420|NCT02119156|PGA|pga
208553|NCT02078479|rTMS|rtms
208554|NCT02078479|motor cortex|motor cortex
208555|NCT02078479|analgesia|analgesia
208556|NCT02078466|Functional assessment|functional assessment
208558|NCT02078466|acute care|acute care
208559|NCT02078466|older medical patients|older medical patients
208560|NCT02078453|Dental caries|dental caries
208561|NCT02078453|Diagnosis|diagnosis
208562|NCT02078453|Visual inspection|visual inspection
208563|NCT02078453|Radiographic examination|radiographic examination
208564|NCT02078440|Type 2 Diabetes|type 2 diabetes
208565|NCT02078440|Children|children
208566|NCT02078440|Adolescents|adolescents
208567|NCT02078440|Bioavailability|bioavailability
208568|NCT02078440|Cycloset|cycloset
208569|NCT02078440|Bromocriptine Mesylate|bromocriptine mesylate
208570|NCT02078401|Optic pathway glioma|optic pathway glioma
208571|NCT02078401|Ophthalmological screening|ophthalmological screening
208572|NCT02078375|Rheumatoid Arthritis|rheumatoid arthritis
208573|NCT02078323|Irritable Bowel Syndrome with Constipation (IBS-C)|irritable bowel syndrome with constipation (ibs-c)
208574|NCT02078323|Linaclotide|linaclotide
208575|NCT02078310|Dementia,|dementia,
208576|NCT02078310|Healthy|healthy
208577|NCT02078310|geriatric|geriatric
208578|NCT02078310|volunteers|volunteers
208579|NCT02078310|patients|patients
208580|NCT02078297|IL-23|il-23
208581|NCT02078297|IL-17A|il-17a
208582|NCT02078297|Skin biopsies|skin biopsies
208583|NCT02078284|platelet transfusion|platelet transfusion
208584|NCT02078258|depression，adolescent，attention bias，modification|depression，adolescent，attention bias，modification
208585|NCT02078245|Familial pancreatic cancer|familial pancreatic cancer
208586|NCT02078245|Surveillance|surveillance
208587|NCT02078245|Screening|screening
208588|NCT02078232|fine needle aspiration under ultrasound endoscopy|fine needle aspiration under ultrasound endoscopy
208589|NCT02078232|solid pancreatic tumors|solid pancreatic tumors
208590|NCT02078232|head of pancreas|head of pancreas
208591|NCT02078232|19G Flex needle|19g flex needle
208592|NCT02078232|22G standard needle|22g standard needle
208593|NCT02078206|Critical illness|critical illness
208594|NCT02078206|Neurocognition|neurocognition
208595|NCT02078206|Neurocognitive stimulation|neurocognitive stimulation
208596|NCT02078206|Delirium|delirium
208597|NCT02078206|Virtual Reality|virtual reality
208598|NCT02078206|cognitive|cognitive
208599|NCT02078206|rehabilitation|rehabilitation
208600|NCT02078206|ICU|icu
208601|NCT02078167|ipercholesterolemia not familiarity|ipercholesterolemia not familiarity
208602|NCT02078154|D-Dimer|d-dimer
208603|NCT02078154|DVT|dvt
208604|NCT02078154|Wells score|wells score
208705|NCT02077673|surgery|surgery
208605|NCT02078141|18F-deoxyglucose (FDG) PET, idiopathic Dilated Cardiomyopathy|18f-deoxyglucose (fdg) pet, idiopathic dilated cardiomyopathy
208606|NCT02078128|burn, wound healing, skin graft|burn, wound healing, skin graft
208607|NCT02078089|Refractory cancer pain|refractory cancer pain
208608|NCT02078076|MRI|mri
208609|NCT02078076|free-breathing acquisitions|free-breathing acquisitions
208610|NCT02078076|myopathy|myopathy
208611|NCT02078076|fibrosis assessment|fibrosis assessment
208612|NCT02078076|function|function
208613|NCT02078037|Intracerebral hemorrhage|intracerebral hemorrhage
208614|NCT02078037|Perihematomal edema|perihematomal edema
208615|NCT02078037|hemorrhage|hemorrhage
208616|NCT02078037|normothermia|normothermia
208617|NCT02078024|Onchocerciasis|onchocerciasis
208618|NCT02077985|autism|autism
208619|NCT02077985|electrodermal activity|electrodermal activity
208620|NCT02077985|cooperation|cooperation
208622|NCT02077985|distress|distress
208623|NCT02077985|stress|stress
208624|NCT02077985|oral care|oral care
208625|NCT02077985|sensory processing|sensory processing
208626|NCT02077985|behavior|behavior
208627|NCT02077985|occupational therapy|occupational therapy
208628|NCT02077972|PTSD|ptsd
208629|NCT02077972|Military service|military service
208630|NCT02077972|depression|depression
208631|NCT02077972|Whole Body Hyperthermia (WBH)|whole body hyperthermia (wbh)
208632|NCT02077959|Relapsed Multiple Myeloma|relapsed multiple myeloma
208633|NCT02077959|Refractory Multiple Myeloma|refractory multiple myeloma
208634|NCT02077933|Solid tumors|solid tumors
208635|NCT02077933|renal cell carcinoma|renal cell carcinoma
208636|NCT02077933|pancreatic neuroendocrine tumors|pancreatic neuroendocrine tumors
208637|NCT02077933|breast cancer|breast cancer
208638|NCT02077933|PI3K inhibitor|pi3k inhibitor
208639|NCT02077933|BYL719|byl719
208640|NCT02077933|alpelisib|alpelisib
208641|NCT02077933|everolimus|everolimus
208642|NCT02077933|exemestane|exemestane
208643|NCT02077920|Ventilator-associated pneumonia VAP|ventilator-associated pneumonia vap
208644|NCT02077920|Chlorhexidine|chlorhexidine
208645|NCT02077920|Oropharyngeal decontamination|oropharyngeal decontamination
208646|NCT02077920|Subglottic secretion drainage|subglottic secretion drainage
208647|NCT02077894|Whole Genome Sequencing|whole genome sequencing
208648|NCT02077894|Genetic Eye Disease|genetic eye disease
208649|NCT02077881|metastatic|metastatic
208650|NCT02077881|metastasis|metastasis
208651|NCT02077881|Pancreatic|pancreatic
199473|NCT02118896|MR4|mr4
208652|NCT02077881|Pancreas|pancreas
208653|NCT02077881|Cancer|cancer
208654|NCT02077881|adenocarcinoma|adenocarcinoma
208655|NCT02077868|CRC|crc
208656|NCT02077868|mCRC|mcrc
208657|NCT02077868|maintenance treatment|maintenance treatment
208658|NCT02077868|immune modulation|immune modulation
208659|NCT02077868|colorectal cancer|colorectal cancer
208660|NCT02077868|immunotherapy|immunotherapy
208661|NCT02077868|metastatic|metastatic
208662|NCT02077855|Sensitivity and Sensitivity|sensitivity and sensitivity
208663|NCT02077829|Implementation process|implementation process
208664|NCT02077829|implementation strategy|implementation strategy
208665|NCT02077829|Implementation research|implementation research
208666|NCT02077829|evidence based practice|evidence based practice
208667|NCT02077829|recovery|recovery
208668|NCT02077829|Illness management and recovery|illness management and recovery
208669|NCT02077816|body temperature|body temperature
208670|NCT02077816|Thermometry|thermometry
208671|NCT02077816|Infrared Rays|infrared rays
208672|NCT02077816|catheter related infection|catheter related infection
208673|NCT02077803|Healthy|healthy
208674|NCT02077803|Canagliflozin|canagliflozin
208675|NCT02077803|Metformin|metformin
208676|NCT02077803|Type 2 diabetes mellitus|type 2 diabetes mellitus
208677|NCT02077803|Bioequivalence|bioequivalence
208678|NCT02077803|GLUMETZA®|glumetza®
208679|NCT02077777|mesalazine|mesalazine
208680|NCT02077777|colon|colon
208681|NCT02077777|cancer|cancer
208682|NCT02077764|heart transplantation,|heart transplantation,
208683|NCT02077764|rejection|rejection
208684|NCT02077764|cardiac vasculopathy|cardiac vasculopathy
208685|NCT02077764|optical coherence tomography|optical coherence tomography
208686|NCT02077764|speckle tracking|speckle tracking
208687|NCT02077764|Positron Emission Tomography .|positron emission tomography .
208688|NCT02077764|exercise capacity|exercise capacity
208689|NCT02077738|effectiveness|effectiveness
208690|NCT02077738|elderly|elderly
208691|NCT02077738|high frequency chest wall oscillation|high frequency chest wall oscillation
208692|NCT02077738|mechanical ventilation|mechanical ventilation
208693|NCT02077738|pneumonia|pneumonia
208694|NCT02077738|randomized controlled trial|randomized controlled trial
208695|NCT02077725|drug related problems|drug related problems
208696|NCT02077725|comprehensive medication review|comprehensive medication review
208697|NCT02077725|quality of life|quality of life
208698|NCT02077699|Lactobacillus casei DG|lactobacillus casei dg
208699|NCT02077699|Irritable Bowel Syndrome|irritable bowel syndrome
208700|NCT02077686|diabetes|diabetes
208701|NCT02077686|education|education
208702|NCT02077686|randomized|randomized
208703|NCT02077686|prospective|prospective
208704|NCT02077673|GEJ-cancer|gej-cancer
208706|NCT02077673|gastroesophageal resection|gastroesophageal resection
208707|NCT02077673|gastroesophageal anastomosis|gastroesophageal anastomosis
208708|NCT02077673|anastomotic leakage|anastomotic leakage
208709|NCT02077660|Green tea, aging, oxidation, anthropometrics.|green tea, aging, oxidation, anthropometrics.
208710|NCT02077647|Knee osteoarthritis|knee osteoarthritis
208711|NCT02077647|knee osteonecrosis|knee osteonecrosis
208712|NCT02077647|osteotomy|osteotomy
208713|NCT02077621|cancer-related fatigue|cancer-related fatigue
208714|NCT02077621|Palliative Abdominal Surgery|palliative abdominal surgery
208715|NCT02077621|HRQL|hrql
208716|NCT02077608|In vitro fertilization|in vitro fertilization
208717|NCT02077608|Embryotransfer|embryotransfer
208718|NCT02077608|Hyaluronan|hyaluronan
208719|NCT02077608|Pregnancy rate|pregnancy rate
208720|NCT02077608|Implantation rate|implantation rate
208721|NCT02077595|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
208722|NCT02077595|transcranial magnetic stimulation|transcranial magnetic stimulation
208723|NCT02077582|acute ischemic stroke|acute ischemic stroke
208724|NCT02077569|AKT inhibitor|akt inhibitor
208725|NCT02077569|AZD5363|azd5363
208726|NCT02077569|Anti-tumour activity|anti-tumour activity
208727|NCT02077569|Breast cancer|breast cancer
208728|NCT02077569|ER positive|er positive
208729|NCT02077569|Oestrogen positive|oestrogen positive
208730|NCT02077569|post menopausal|post menopausal
208731|NCT02077569|chemotherapy required|chemotherapy required
208732|NCT02077569|no prior cancer treatment|no prior cancer treatment
208733|NCT02077556|tacrolimus, everolimus, pharmacokinetics, drug interaction|tacrolimus, everolimus, pharmacokinetics, drug interaction
208734|NCT02077530|Patients with metabolic syndrome age between 30 to 64: Central obesity (Men ≥ 90 cm Women ≥ 85 cm), Plasma triglycerides ≥ 150 mg/dL|patients with metabolic syndrome age between 30 to 64: central obesity (men ≥ 90 cm women ≥ 85 cm), plasma triglycerides ≥ 150 mg/dl
208735|NCT02077530|HDL cholesterol Men < 40 mg/dL, Women < 50 mg/dL, Blood pressure ≥130/85 mm Hg (or treatment for hypertension),|hdl cholesterol men < 40 mg/dl, women < 50 mg/dl, blood pressure ≥130/85 mm hg (or treatment for hypertension),
208736|NCT02077530|Fasting plasma glucose ≥ 100 mg/dL|fasting plasma glucose ≥ 100 mg/dl
208737|NCT02077517|Roux en Y Gastric Bypass|roux en y gastric bypass
208738|NCT02077517|Postoperative complications|postoperative complications
208739|NCT02077517|Hand sewn anastomosis|hand sewn anastomosis
199544|NCT02118545|vWF|vwf
208740|NCT02077517|Stapled anastomosis|stapled anastomosis
208741|NCT02077491|Aged|aged
208742|NCT02077491|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
208743|NCT02077491|Body Composition|body composition
208744|NCT02077491|Dietary Protein|dietary protein
208745|NCT02077465|COPD, chronic obstructive pulmonary disease; Phase 1b, Safety, Pharmacokinetics|copd, chronic obstructive pulmonary disease; phase 1b, safety, pharmacokinetics
208746|NCT02077452|Glucokinase activator|glucokinase activator
208747|NCT02077452|Phase I|phase i
208748|NCT02077452|Type 2 diabetes mellitus|type 2 diabetes mellitus
208749|NCT02077439|Stroke|stroke
208750|NCT02077439|Hand|hand
208751|NCT02077439|Upper Extremity|upper extremity
208752|NCT02077439|Robotics|robotics
208753|NCT02077426|Functional Capacity|functional capacity
208754|NCT02077426|Exercise Independence|exercise independence
208755|NCT02077426|Peripheral|peripheral
208756|NCT02077426|Strength|strength
208757|NCT02077413|muscle|muscle
208758|NCT02077413|eccentric exercise|eccentric exercise
208759|NCT02077413|T2 MRI|t2 mri
208760|NCT02077387|Inhibitory control|inhibitory control
208761|NCT02077387|executive functioning|executive functioning
208762|NCT02077387|childhood obesity|childhood obesity
208763|NCT02077387|preschool|preschool
208764|NCT02077387|snack foods|snack foods
208765|NCT02077387|caloric intake|caloric intake
208766|NCT02077374|NAFLD|nafld
208767|NCT02077374|NASH|nash
208768|NCT02077361|choroideremia|choroideremia
208769|NCT02077361|gene therapy|gene therapy
208770|NCT02077361|gene transfer|gene transfer
208771|NCT02077348|Diabetes Mellitus type I|diabetes mellitus type i
208772|NCT02077348|Ketoacidosis|ketoacidosis
208773|NCT02077348|Insulin withdrawal|insulin withdrawal
208774|NCT02077348|Growth hormone injection|growth hormone injection
208775|NCT02077348|Lipolysis and ATGL|lipolysis and atgl
208776|NCT02077335|Brachytherapy|brachytherapy
208777|NCT02077335|Monotherapy|monotherapy
208778|NCT02077335|HDR|hdr
208779|NCT02077322|Merocel Middle Meatus Spacers|merocel middle meatus spacers
208780|NCT02077322|Silastic Middle Meatus Spacers|silastic middle meatus spacers
208781|NCT02077322|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
208782|NCT02077309|T2DM,|t2dm,
208783|NCT02077309|vascular inflammation,|vascular inflammation,
208784|NCT02077309|18-FDG-PET,|18-fdg-pet,
208785|NCT02077309|plaque morphology,|plaque morphology,
208786|NCT02077309|MRI,|mri,
208787|NCT02077309|DPP-4 Inhibition|dpp-4 inhibition
208788|NCT02077296|cytokines|cytokines
208789|NCT02077296|predictive value|predictive value
208790|NCT02077296|preoperative chemoradiotherapy|preoperative chemoradiotherapy
208791|NCT02077296|rectal cancer|rectal cancer
208792|NCT02077283|NAFLD (non-alcoholic fatty liver disease, NAFLD)|nafld (non-alcoholic fatty liver disease, nafld)
208793|NCT02077283|urinary metabonomics|urinary metabonomics
208794|NCT02077283|TCM pattern|tcm pattern
208795|NCT02077283|"liver depression and spleen deficiency pattern,"|"liver depression and spleen deficiency pattern,"
208796|NCT02077283|"damp-heat in the interior pattern"|"damp-heat in the interior pattern"
208797|NCT02077270|colonoscopy|colonoscopy
208798|NCT02077270|acupuncture|acupuncture
208799|NCT02077270|pain|pain
208800|NCT02077244|patient|patient
208801|NCT02077244|intensive care|intensive care
208802|NCT02077244|follow up|follow up
208803|NCT02077244|post traumatic stress symptoms|post traumatic stress symptoms
208804|NCT02077244|randomized controlled trial|randomized controlled trial
208805|NCT02077205|Diagnostic and Statistical Manual of Mental Disorders-IV/-5: Anxiety Disorders in children|diagnostic and statistical manual of mental disorders-iv/-5: anxiety disorders in children
208806|NCT02077179|Postpartum|postpartum
208807|NCT02077179|Preeclampsia|preeclampsia
208808|NCT02077179|Gestational Hypertension|gestational hypertension
208809|NCT02077179|Gestational Diabetes|gestational diabetes
208810|NCT02077179|Exercise Intervention|exercise intervention
208811|NCT02077179|Dietary Intervention|dietary intervention
208812|NCT02077179|Behavioral Intervention|behavioral intervention
208813|NCT02077179|Mobile Website|mobile website
208814|NCT02077179|Mobile Application|mobile application
208815|NCT02077166|DLBCL|dlbcl
208816|NCT02077101|HIV|hiv
208817|NCT02077101|Therapeutic vaccine|therapeutic vaccine
208818|NCT02077101|acceptability|acceptability
208819|NCT02077101|representations|representations
208820|NCT02077088|interventional|interventional
208821|NCT02077088|doubleblind|doubleblind
208822|NCT02077088|randomised|randomised
208823|NCT02077088|pediatric|pediatric
208824|NCT02077088|prebiotic|prebiotic
208825|NCT02077088|atopic|atopic
208826|NCT02077088|dermatitis|dermatitis
208827|NCT02077088|infant|infant
208828|NCT02077075|weight loss|weight loss
208829|NCT02077075|healthy weight|healthy weight
208830|NCT02077075|overweight|overweight
208831|NCT02077075|body mass index greater that 25 kg/m2|body mass index greater that 25 kg/m2
208832|NCT02077062|hepatectomy,|hepatectomy,
208833|NCT02077062|liver regeneration|liver regeneration
208834|NCT02077062|mediators|mediators
208835|NCT02077049|elderly|elderly
208836|NCT02077049|exercise program|exercise program
208837|NCT02077049|self-training|self-training
208838|NCT02077049|mobility|mobility
208839|NCT02077049|computer-based learning games|computer-based learning games
208840|NCT02077049|serious game|serious game
208841|NCT02077049|balance|balance
208842|NCT02077049|training adherence|training adherence
208843|NCT02077049|training compliance|training compliance
208844|NCT02077049|Kinect ®|kinect ®
208845|NCT02077049|Fit Bit ®|fit bit ®
208846|NCT02077023|Stroke|stroke
208847|NCT02077023|Heart Attack|heart attack
208848|NCT02077023|Asymptomatic Carotid Artery Disease|asymptomatic carotid artery disease
208849|NCT02077023|Atrial Fibrillation|atrial fibrillation
208850|NCT02077010|milrinone|milrinone
208851|NCT02077010|heart failure|heart failure
208852|NCT02077010|cardiomyopathy|cardiomyopathy
208854|NCT02076997|Cancer|cancer
208855|NCT02076997|High Dose Methotrexate|high dose methotrexate
208856|NCT02076984|Ventral hernia|ventral hernia
208857|NCT02076984|Incisional hernia|incisional hernia
208858|NCT02076984|Patient affected by ventral or incisional hernias|patient affected by ventral or incisional hernias
208859|NCT02076971|Lung transplant|lung transplant
208860|NCT02076971|Quantiferon|quantiferon
208861|NCT02076971|Immuknow|immuknow
208862|NCT02076958|Implementation|implementation
208863|NCT02076958|Cancer|cancer
208864|NCT02076958|Early detection|early detection
208865|NCT02076958|Faith-based|faith-based
208866|NCT02076958|Community health advisor|community health advisor
208867|NCT02076945|Regional anesthesia|regional anesthesia
208868|NCT02076945|Diabetic neuropathy|diabetic neuropathy
208869|NCT02076945|Ultrasound|ultrasound
208870|NCT02076919|LHA510|lha510
208871|NCT02076919|First in human|first in human
208872|NCT02076919|Safety|safety
208873|NCT02076919|Tolerability|tolerability
208874|NCT02076919|Pharmacokinetics|pharmacokinetics
208875|NCT02076919|Elderly|elderly
208876|NCT02076919|Age-Related Macular Degeneration|age-related macular degeneration
208878|NCT02076919|Ocular|ocular
208879|NCT02076919|Eye drop|eye drop
208880|NCT02076906|relapsed pediatric solid tumors|relapsed pediatric solid tumors
208881|NCT02076906|refractory pediatric solid tumors|refractory pediatric solid tumors
208882|NCT02076906|high intensity focused ultrasound|high intensity focused ultrasound
208883|NCT02076906|rhabdomyosarcoma|rhabdomyosarcoma
208884|NCT02076906|Ewing's sarcoma|ewing's sarcoma
208885|NCT02076906|osteosarcoma|osteosarcoma
208886|NCT02076906|neuroblastoma|neuroblastoma
208887|NCT02076906|Wilms' tumor|wilms' tumor
208888|NCT02076906|hepatic tumors|hepatic tumors
208889|NCT02076906|germ cell tumors|germ cell tumors
208890|NCT02076906|desmoid tumor|desmoid tumor
208891|NCT02076893|Tonsillectomy|tonsillectomy
208892|NCT02076893|Pain management|pain management
208893|NCT02076893|Pediatrics|pediatrics
208894|NCT02076880|Type 2 diabetes|type 2 diabetes
208895|NCT02076880|Obesity|obesity
208896|NCT02076880|Sleeve gastrectomy|sleeve gastrectomy
208897|NCT02076880|Insulin|insulin
208898|NCT02076880|GLP-1|glp-1
208899|NCT02076867|somatic symptoms and related disorders|somatic symptoms and related disorders
208900|NCT02076867|somatic symptoms|somatic symptoms
208901|NCT02076867|psychodynamic psychotherapy|psychodynamic psychotherapy
208902|NCT02076854|eating disorders|eating disorders
208903|NCT02076854|anorexia nervosa|anorexia nervosa
208904|NCT02076854|treatment|treatment
208905|NCT02076854|technology|technology
208906|NCT02076828|anemia|anemia
208907|NCT02076828|iron polymaltose complexes|iron polymaltose complexes
208908|NCT02076828|iron zinc|iron zinc
208909|NCT02076815|myeloproliferative neoplasm|myeloproliferative neoplasm
208910|NCT02076815|essential thrombocythemia|essential thrombocythemia
208911|NCT02076815|high risk patients|high risk patients
208912|NCT02076815|anagrelide|anagrelide
208913|NCT02076802|prehypertension|prehypertension
208914|NCT02076802|coronary atherosclerosis|coronary atherosclerosis
208915|NCT02076802|cardiovascular disease|cardiovascular disease
208916|NCT02076789|Device Replacement|device replacement
208917|NCT02076789|Device Upgrade|device upgrade
208918|NCT02076789|Long-term Postoperative Complications|long-term postoperative complications
208919|NCT02076789|Resource consumption and associated costs after device replacement/upgrade|resource consumption and associated costs after device replacement/upgrade
208920|NCT02076776|Stroke|stroke
208921|NCT02076776|Exercise|exercise
208922|NCT02076776|Rehabilitation|rehabilitation
208923|NCT02076776|Neuroplasticity|neuroplasticity
208924|NCT02076776|Task Practice|task practice
208925|NCT02076763|Observational|observational
208926|NCT02076763|Porphyria|porphyria
208927|NCT02076750|Inflammatory Bowel Diseases|inflammatory bowel diseases
208928|NCT02076750|Vitamin D|vitamin d
208929|NCT02076750|Cholecalciferol|cholecalciferol
208930|NCT02076750|Skin Pigmentation|skin pigmentation
208931|NCT02076737|Model-based iterative reconstruction MB-IR|model-based iterative reconstruction mb-ir
208932|NCT02076737|VEOTM|veotm
208933|NCT02076737|Ultra low-dose|ultra low-dose
208934|NCT02076737|Abdominal CT|abdominal ct
208935|NCT02076737|Dose reduction|dose reduction
208936|NCT02076737|Adaptative statistical iterative reconstruction ASIR|adaptative statistical iterative reconstruction asir
208937|NCT02076737|Acute renal colic|acute renal colic
208938|NCT02076724|Abdominal donor-site|abdominal donor-site
208939|NCT02076724|Breast reconstruction|breast reconstruction
208940|NCT02076724|Synthetic mesh|synthetic mesh
208941|NCT02076724|Biological mesh|biological mesh
208942|NCT02076711|Aortic Stenosis|aortic stenosis
208943|NCT02076711|Myocardial efficiency|myocardial efficiency
208944|NCT02076698|Deep Brain Stimulation|deep brain stimulation
208945|NCT02076698|Anterior Nucleus of thalamus|anterior nucleus of thalamus
208946|NCT02076698|Treatment refractory|treatment refractory
208947|NCT02076698|Pharmacoresistant partial epilepsy|pharmacoresistant partial epilepsy
208948|NCT02076698|vagus nerve stimulation therapy|vagus nerve stimulation therapy
208949|NCT02076685|pharmacogenetics|pharmacogenetics
208950|NCT02076685|anti-tuberculosis drug|anti-tuberculosis drug
208951|NCT02076685|genetic polymorphism|genetic polymorphism
208952|NCT02076685|isoniazid|isoniazid
208953|NCT02076672|prevention|prevention
208954|NCT02076672|non-malignant asbestos-related disease|non-malignant asbestos-related disease
208955|NCT02076672|benign pleural disease|benign pleural disease
208956|NCT02076672|asbestosis|asbestosis
208957|NCT02076659|F8|f8
208958|NCT02076659|IL10|il10
208959|NCT02076659|Interleukin|interleukin
208960|NCT02076659|monoclonal|monoclonal
208961|NCT02076659|antibody|antibody
208962|NCT02076659|Rheumatoid Arthritis|rheumatoid arthritis
208963|NCT02076646|Interleukin|interleukin
208964|NCT02076646|IL2|il2
208965|NCT02076646|monoclonal|monoclonal
208966|NCT02076646|antibody|antibody
208967|NCT02076646|cytokine|cytokine
208968|NCT02076646|Dacarbazine|dacarbazine
208969|NCT02076646|metastatic|metastatic
208970|NCT02076646|melanoma|melanoma
208971|NCT02076646|tumor targeting|tumor targeting
208972|NCT02076646|Dose definition|dose definition
208973|NCT02076646|L19|l19
208974|NCT02076633|L19|l19
208975|NCT02076633|monoclonal|monoclonal
208976|NCT02076633|antibody|antibody
208977|NCT02076633|IL-2|il-2
208978|NCT02076633|TNFα|tnfα
208979|NCT02076633|Interleukin|interleukin
208980|NCT02076633|Phase II|phase ii
208981|NCT02076633|metastatic melanoma|metastatic melanoma
208982|NCT02076633|clinical stage III|clinical stage iii
208983|NCT02076633|Clinical stage IV M1a|clinical stage iv m1a
208984|NCT02076620|L19|l19
208985|NCT02076620|monoclonal|monoclonal
208986|NCT02076620|antibody|antibody
208987|NCT02076620|doxorubicin|doxorubicin
208988|NCT02076620|TNFα|tnfα
208989|NCT02076620|solid tumour|solid tumour
208990|NCT02076620|sarcoma, breast cancer, lung carcinomas, gynecological cancer|sarcoma, breast cancer, lung carcinomas, gynecological cancer
208991|NCT02076620|anthracycline|anthracycline
208992|NCT02076607|vertebra|vertebra
208993|NCT02076607|column|column
208994|NCT02076607|lumbar|lumbar
208995|NCT02076607|toracica|toracica
208996|NCT02076607|fracture|fracture
208997|NCT02076607|burst|burst
208998|NCT02076568|diabetes|diabetes
208999|NCT02076568|education|education
209000|NCT02076568|randomized|randomized
209001|NCT02076568|prospective|prospective
209002|NCT02076555|diabetes|diabetes
209003|NCT02076555|education|education
209004|NCT02076555|randomized|randomized
209005|NCT02076555|prospective|prospective
209006|NCT02076542|diabetes|diabetes
209007|NCT02076542|education|education
209008|NCT02076542|randomized|randomized
209009|NCT02076542|prospective|prospective
209010|NCT02076529|chemotherapy induced nausea vomiting|chemotherapy induced nausea vomiting
209011|NCT02076516|Drug-eluting Stent,Coronary Artery Disease|drug-eluting stent,coronary artery disease
209012|NCT02076503|Neoplasm Staging|neoplasm staging
209013|NCT02076503|Positron-Emission Tomography|positron-emission tomography
209014|NCT02076503|Magnetic Resonance Imaging|magnetic resonance imaging
209015|NCT02076503|1-amino-3-fluorocyclobutane-1-carboxylic acid|1-amino-3-fluorocyclobutane-1-carboxylic acid
209016|NCT02076490|Telerehabilitation, mirror therapy, phantom limb pain|telerehabilitation, mirror therapy, phantom limb pain
209017|NCT02076477|intervention time|intervention time
209018|NCT02076477|radiotherapy|radiotherapy
209019|NCT02076477|oligometastatic|oligometastatic
209020|NCT02076477|non-small cell lung cancer|non-small cell lung cancer
209021|NCT02076438|antibiotics|antibiotics
209022|NCT02076438|diarrhea|diarrhea
209023|NCT02076438|c diff|c diff
209024|NCT02076438|Hospitalized patients|hospitalized patients
209025|NCT02076425|Depressive Disorder, Major|depressive disorder, major
209026|NCT02076425|Child Psychiatry|child psychiatry
209027|NCT02076425|Parent-Child Relationship|parent-child relationship
209028|NCT02076425|Therapy|therapy
209029|NCT02076399|Persistent Immune Thrombocytopenic Purpura|persistent immune thrombocytopenic purpura
209030|NCT02076399|Chronic Immune Thrombocytopenic Purpura|chronic immune thrombocytopenic purpura
209034|NCT02076360|Sacrocolpopexy|sacrocolpopexy
209035|NCT02076347|Metformin|metformin
209036|NCT02076347|Vitamin B12 Deficiency|vitamin b12 deficiency
209037|NCT02076347|Population Management|population management
209038|NCT02076347|Pharmacist|pharmacist
209039|NCT02076334|compression, isokinetic, far-infrared|compression, isokinetic, far-infrared
209040|NCT02076308|Acupuncture, ultrasound|acupuncture, ultrasound
209041|NCT02076295|Cognition|cognition
209042|NCT02076295|Cholinergic nicotinic receptors|cholinergic nicotinic receptors
209043|NCT02076295|Positron Emission Tomography|positron emission tomography
209044|NCT02076282|Stage III non-small cell lung cancer|stage iii non-small cell lung cancer
209049|NCT02076269|Dry Powder Inhaler|dry powder inhaler
209050|NCT02076269|COPD|copd
209051|NCT02076269|Pharyngometry|pharyngometry
209052|NCT02076269|Inhalation Profiles|inhalation profiles
209053|NCT02076256|helping relationships, healthy lifestyle, quality of life|helping relationships, healthy lifestyle, quality of life
209054|NCT02076243|cutaneous squamous cell carcinoma|cutaneous squamous cell carcinoma
209055|NCT02076243|SCC|scc
209056|NCT02076243|abraxane|abraxane
209057|NCT02076243|nab-paclitaxel|nab-paclitaxel
209058|NCT02076243|unresectable|unresectable
209059|NCT02076243|metastatic|metastatic
209060|NCT02076230|14C-TH-302|14c-th-302
209061|NCT02076230|Advanced or Metastatic Solid Tumors|advanced or metastatic solid tumors
209062|NCT02076230|Evofosfamide|evofosfamide
209063|NCT02076217|Highly Effective Contraception|highly effective contraception
209064|NCT02076217|Emergency Contraception|emergency contraception
209065|NCT02076217|Birth Control|birth control
209066|NCT02076217|LARC (Long Acting Reversible Contraception)|larc (long acting reversible contraception)
209067|NCT02076217|HERC (Highly Effective Contraception)|herc (highly effective contraception)
209071|NCT02076191|Ruxolitinib|ruxolitinib
209072|NCT02076191|Decitabine|decitabine
209073|NCT02076191|Myeloproliferative Neoplasms|myeloproliferative neoplasms
209074|NCT02076191|Combination Therapy|combination therapy
209075|NCT02076178|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
209076|NCT02076178|HIV integrase|hiv integrase
209077|NCT02076178|Intramuscular Injection|intramuscular injection
209078|NCT02076178|GSK1265744|gsk1265744
209079|NCT02076165|insomnia|insomnia
209080|NCT02076165|women|women
209081|NCT02076152|Recurrent Glioblastoma|recurrent glioblastoma
209082|NCT02076139|tuberculosis|tuberculosis
209083|NCT02076139|treg|treg
209084|NCT02076139|tolerance|tolerance
209085|NCT02076139|probiotic|probiotic
209086|NCT02076139|mycobacteria|mycobacteria
209087|NCT02076126|Lung maturity|lung maturity
209088|NCT02076126|RDS|rds
209089|NCT02076126|Prematurity|prematurity
209090|NCT02076126|Lecithin-sphingomyelin ratio|lecithin-sphingomyelin ratio
209091|NCT02076126|Spectroscopy|spectroscopy
209092|NCT02076126|Chemometrics|chemometrics
209093|NCT02076113|cervical spondylotic myelopathy|cervical spondylotic myelopathy
209094|NCT02076113|degenerative cervical spondylosis|degenerative cervical spondylosis
209095|NCT02076113|spinal fusion|spinal fusion
209096|NCT02076087|Subcutaneous adipose tissue|subcutaneous adipose tissue
209097|NCT02076087|Lipectomy|lipectomy
209098|NCT02076061|COPD|copd
209099|NCT02076061|Primary Care|primary care
209100|NCT02076061|Smoking|smoking
209101|NCT02076061|Smokers|smokers
209102|NCT02076061|ex-Smokers|ex-smokers
209103|NCT02076061|Lung Cancer|lung cancer
209104|NCT02076061|Cardiovascular Disease|cardiovascular disease
209105|NCT02076061|Proteomics|proteomics
209106|NCT02076061|Biomarkers|biomarkers
209107|NCT02076061|Biobank|biobank
209108|NCT02076061|Disease Staging|disease staging
209109|NCT02076061|Gold Stage|gold stage
209110|NCT02076048|LCPUFA supplementation|lcpufa supplementation
209111|NCT02076048|Brain Imaging|brain imaging
209112|NCT02076048|MRI|mri
209113|NCT02076048|MEG|meg
209114|NCT02076035|low back pain|low back pain
209115|NCT02076035|periduroscopy|periduroscopy
209116|NCT02076035|genetic|genetic
209117|NCT02076035|genomic|genomic
209118|NCT02076035|inflammation|inflammation
209119|NCT02076022|Fat Grafting|fat grafting
209120|NCT02076022|Pain at amputation site|pain at amputation site
209121|NCT02076022|prosthetic|prosthetic
209122|NCT02076009|Multiple Myeloma|multiple myeloma
209123|NCT02076009|Relapsed Multiple Myeloma|relapsed multiple myeloma
209124|NCT02076009|Refractory Multiple Myeloma|refractory multiple myeloma
209125|NCT02076009|Daratumumab|daratumumab
209126|NCT02076009|Lenalidomide|lenalidomide
209127|NCT02076009|Dexamethasone|dexamethasone
209128|NCT02075996|pomalidomide, Imnovid, dexamethasone, Poseidon, multiple myeloma, daily routine, secondary malignancies, Germany, non-interventional study, safety,|pomalidomide, imnovid, dexamethasone, poseidon, multiple myeloma, daily routine, secondary malignancies, germany, non-interventional study, safety,
209129|NCT02075983|HIV|hiv
209130|NCT02075983|Vaccine|vaccine
209131|NCT02075983|Immunisation|immunisation
209142|NCT02075970|Transfusion|transfusion
209143|NCT02075970|Erythropoetin|erythropoetin
209144|NCT02075970|Epoetin Alpha|epoetin alpha
209145|NCT02075970|Red Blood Cell|red blood cell
209153|NCT02075944|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
209154|NCT02075905|Barrett's Esophagus|barrett's esophagus
209155|NCT02075905|Esophageal Adenocarcinoma|esophageal adenocarcinoma
209156|NCT02075892|cordyceps, aerobic capacity, exercise performance, fatigue|cordyceps, aerobic capacity, exercise performance, fatigue
199995|NCT02116543|HCV|hcv
209160|NCT02075827|Appetite, metabolism, sedentary behaviour, stress response|appetite, metabolism, sedentary behaviour, stress response
209161|NCT02075801|Sealant, Margins Defect, Amalgam|sealant, margins defect, amalgam
209162|NCT02075775|instability|instability
209163|NCT02075749|irradiation|irradiation
209164|NCT02075749|mucositis|mucositis
209165|NCT02075749|triamcinolone acetonide|triamcinolone acetonide
209166|NCT02075749|licorice|licorice
209167|NCT02075749|mucoadhesive film|mucoadhesive film
209168|NCT02075710|Diet|diet
209169|NCT02075710|Sugar|sugar
209170|NCT02075710|Cardiovascular|cardiovascular
209171|NCT02075710|Lipid|lipid
209172|NCT02075697|psoriasis|psoriasis
209173|NCT02075697|biologic therapy|biologic therapy
209174|NCT02075697|infliximab|infliximab
209175|NCT02075697|etanercept|etanercept
209176|NCT02075697|efalizumab|efalizumab
209177|NCT02075697|adalimumab|adalimumab
209178|NCT02075697|ustekinumab|ustekinumab
209179|NCT02075697|methotrexate|methotrexate
209180|NCT02075697|cyclosporine|cyclosporine
209181|NCT02075697|acitretin|acitretin
209182|NCT02075671|Rosacea|rosacea
209183|NCT02075671|Photodynamic Therapy|photodynamic therapy
209184|NCT02075671|Aminolevulinic Acid|aminolevulinic acid
209185|NCT02075671|Papulopustular Rosacea|papulopustular rosacea
209186|NCT02075671|Blue Light|blue light
209187|NCT02075658|renal cell carcinoma|renal cell carcinoma
209188|NCT02075658|minimally invasive procedures|minimally invasive procedures
209189|NCT02075658|robotic nephrectomy|robotic nephrectomy
209190|NCT02075658|laparoscopic nephrectomy|laparoscopic nephrectomy
209191|NCT02075658|pneumoperitoneum|pneumoperitoneum
209192|NCT02075658|trocars|trocars
209193|NCT02075658|AirSeal® IFS|airseal® ifs
209194|NCT02075632|Alclometasone dipropionate|alclometasone dipropionate
209195|NCT02075632|Eczema|eczema
209196|NCT02075632|Psoriasis|psoriasis
209197|NCT02075632|Itch|itch
209198|NCT02075619|Amlodipine|amlodipine
209199|NCT02075619|Healthy volunteers|healthy volunteers
209200|NCT02075619|Rosuvastatin|rosuvastatin
209201|NCT02075619|Dyslipidaemia|dyslipidaemia
209202|NCT02075619|Pharmacokinetics|pharmacokinetics
209203|NCT02075619|Hypertension|hypertension
209205|NCT02075606|Symptomatic response|symptomatic response
209206|NCT02075606|Functioning NeuroEndocrine Tumours|functioning neuroendocrine tumours
209207|NCT02075606|midgut region|midgut region
209208|NCT02075593|dolutegravir/abacavir/lamivudine fixed dose combination|dolutegravir/abacavir/lamivudine fixed dose combination
209209|NCT02075593|pregnant women|pregnant women
209210|NCT02075593|once daily|once daily
209211|NCT02075593|antiretroviral therapy-naive|antiretroviral therapy-naive
209212|NCT02075593|HIV-1 Infection|hiv-1 infection
209213|NCT02075593|integrase inhibitor|integrase inhibitor
401994|NCT01233596|complications|complications
209214|NCT02075580|cancer, quality of life, body-image, subcutaneous-implant|cancer, quality of life, body-image, subcutaneous-implant
209215|NCT02075567|Diabetes Mellitus Type 1|diabetes mellitus type 1
209216|NCT02075567|Exercise|exercise
209217|NCT02075567|Insulin Reduction|insulin reduction
209218|NCT02075567|Glucose|glucose
209219|NCT02075567|Hypoglycemia|hypoglycemia
209421|NCT02074839|IDH1|idh1
209220|NCT02075567|Continuous Glucose Monitoring System|continuous glucose monitoring system
209221|NCT02075541|Immunogenicity|immunogenicity
209222|NCT02075541|Observer-blind|observer-blind
209223|NCT02075541|Reactogenicity|reactogenicity
209224|NCT02075541|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
209225|NCT02075541|Safety|safety
209226|NCT02075528|Paliperidone|paliperidone
209227|NCT02075528|Treatment response|treatment response
209228|NCT02075528|Schizophrenia|schizophrenia
209229|NCT02075528|Early prediction|early prediction
209230|NCT02075528|Pharmacokinetics|pharmacokinetics
209231|NCT02075515|Safety|safety
209233|NCT02075515|Immunogenicity|immunogenicity
209234|NCT02075515|Adults|adults
209235|NCT02075515|Consistency|consistency
209241|NCT02075489|Acupressure|acupressure
209242|NCT02075489|Reiki|reiki
209244|NCT02075489|EMG|emg
209245|NCT02075489|fatigue relief|fatigue relief
209246|NCT02075489|veterans|veterans
209247|NCT02075476|Fracture-luxation|fracture-luxation
209248|NCT02075476|humeral proximal extremity|humeral proximal extremity
209249|NCT02075476|Hemiarthroplasty|hemiarthroplasty
209250|NCT02075476|reverse Arthroplasty|reverse arthroplasty
209251|NCT02075463|recombinant human erythropoietin|recombinant human erythropoietin
209252|NCT02075463|GSK1278863|gsk1278863
209253|NCT02075463|hemodialysis|hemodialysis
209254|NCT02075463|anemia|anemia
209255|NCT02075463|Hemoglobin|hemoglobin
209256|NCT02075463|chronic rhEPO hyporesponsiveness|chronic rhepo hyporesponsiveness
209257|NCT02075463|chronic kidney disease|chronic kidney disease
209258|NCT02075463|erythropoiesis stimulating agents|erythropoiesis stimulating agents
209259|NCT02075463|pharmacokinetics|pharmacokinetics
209260|NCT02075450|Cardiac|cardiac
209261|NCT02075450|Arrest|arrest
209262|NCT02075450|Simulation|simulation
209263|NCT02075450|Feedback|feedback
200092|NCT02116049|HIV|hiv
209264|NCT02075437|Functional Abdominal Pain, Children|functional abdominal pain, children
209265|NCT02075437|Finding a treatment or intervention for children|finding a treatment or intervention for children
209266|NCT02075424|stress|stress
209267|NCT02075424|cortisol|cortisol
209268|NCT02075424|emergency call center|emergency call center
209269|NCT02075424|hospital staff|hospital staff
209270|NCT02075411|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
209271|NCT02075411|transplantation allografts|transplantation allografts
209272|NCT02075411|adolescent|adolescent
209273|NCT02075411|nerve block|nerve block
209274|NCT02075411|pain|pain
209275|NCT02075398|Portable pulse oximeter|portable pulse oximeter
209276|NCT02075385|Dysphagia|dysphagia
209277|NCT02075385|speech language therapy|speech language therapy
209278|NCT02075385|quality of life|quality of life
209279|NCT02075385|induction chemotherapy|induction chemotherapy
209280|NCT02075385|concurrent chemoradiotherapy|concurrent chemoradiotherapy
209281|NCT02075372|Chronic Total Occlusion of Coronary Artery|chronic total occlusion of coronary artery
209282|NCT02075372|Percutaneous Coronary Intervention|percutaneous coronary intervention
209283|NCT02075372|Hybrid|hybrid
209284|NCT02075372|Angioplasty|angioplasty
209285|NCT02075359|Total Energy Expenditure|total energy expenditure
209286|NCT02075359|Physical Activity Levels|physical activity levels
209287|NCT02075359|Body Mass Index|body mass index
209288|NCT02075359|Children|children
209289|NCT02075346|Patient safety monitors|patient safety monitors
209290|NCT02075320|CT|ct
209291|NCT02075320|Chest|chest
209292|NCT02075320|Lung|lung
209293|NCT02075307|insulin|insulin
209294|NCT02075307|diabetes|diabetes
209295|NCT02075307|obesity|obesity
209296|NCT02075307|DNA damage|dna damage
209297|NCT02075307|metabolic syndrome|metabolic syndrome
209298|NCT02075294|Aged|aged
209299|NCT02075294|Hepatitis B, Chronic|hepatitis b, chronic
209300|NCT02075294|Antiviral Agents|antiviral agents
209301|NCT02075268|Korean|korean
209302|NCT02075268|Healthy|healthy
209303|NCT02075268|Male|male
209304|NCT02075255|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases, OCS, Oral Corticosteroids|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases, ocs, oral corticosteroids
209305|NCT02075242|HBV|hbv
209306|NCT02075229|Cochlear Implant|cochlear implant
209307|NCT02075229|Post-lingual onset hearing loss|post-lingual onset hearing loss
209308|NCT02075229|Profound hearing loss|profound hearing loss
209309|NCT02075229|Low Frequency hearing loss|low frequency hearing loss
209310|NCT02075229|Profound sensorineural hearing loss|profound sensorineural hearing loss
209311|NCT02075229|High frequency hearing loss|high frequency hearing loss
209312|NCT02075229|CMS-eligible patients|cms-eligible patients
209313|NCT02075216|Urinary Incontinence|urinary incontinence
209314|NCT02075216|Children|children
209315|NCT02075216|Bladder Exstrophy|bladder exstrophy
209316|NCT02075216|Extrophy -Epispadias complex,|extrophy -epispadias complex,
209317|NCT02075216|Modern staged repair,|modern staged repair,
209318|NCT02075216|Bladder neck reconstruction|bladder neck reconstruction
209319|NCT02075203|BCG Vaccinated|bcg vaccinated
209320|NCT02075177|neuroblastoma|neuroblastoma
209321|NCT02075164|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
209713|NCT02073474|Registry|registry
209322|NCT02075164|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
209323|NCT02075164|NAFLD|nafld
209324|NCT02075164|NASH|nash
209325|NCT02075151|Bronchial Thermoplasty|bronchial thermoplasty
209326|NCT02075125|Korea|korea
209327|NCT02075125|Platelet inhibition|platelet inhibition
209328|NCT02075125|Prasugrel|prasugrel
209329|NCT02075125|Ticagrelor|ticagrelor
209330|NCT02075125|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
209331|NCT02075112|Soy|soy
209332|NCT02075112|Isoflavone|isoflavone
209333|NCT02075112|Radiation Therapy|radiation therapy
209334|NCT02075112|Cisplatin|cisplatin
209335|NCT02075099|whole blood donation|whole blood donation
209336|NCT02075099|donation water drink|donation water drink
209337|NCT02075099|isotonic drink|isotonic drink
209338|NCT02075099|presyncopal and syncopal reactions|presyncopal and syncopal reactions
209438|NCT02074761|SI joint|si joint
209339|NCT02075086|angiogenic switch|angiogenic switch
209340|NCT02075086|plasma cytokines|plasma cytokines
209341|NCT02075086|Colon cancer|colon cancer
209342|NCT02075073|Pharmacokinetics|pharmacokinetics
209343|NCT02075060|low-grade|low-grade
209344|NCT02075060|NMIBC|nmibc
209345|NCT02075047|Bipolar I Disorder (current or most recent episode manic). Children and adolescents aged 10 to 17 years.|bipolar i disorder (current or most recent episode manic). children and adolescents aged 10 to 17 years.
209346|NCT02075034|Myelodysplastic syndrome|myelodysplastic syndrome
209347|NCT02075034|MDS|mds
209348|NCT02075034|Low risk|low risk
209349|NCT02075034|Intermediate-1 risk|intermediate-1 risk
209350|NCT02075034|Intermediate-2 risk|intermediate-2 risk
209351|NCT02075034|International Prognostic Scoring System|international prognostic scoring system
209352|NCT02075034|IPSS|ipss
209353|NCT02075021|relapsed|relapsed
209354|NCT02075021|refractory|refractory
209355|NCT02075021|multiple myeloma|multiple myeloma
209356|NCT02075021|revlimid|revlimid
209357|NCT02075021|lenalidomide|lenalidomide
209358|NCT02075021|abraxane|abraxane
209359|NCT02075021|n-paclitaxel|n-paclitaxel
209360|NCT02075008|asthma|asthma
209361|NCT02075008|allergic asthma|allergic asthma
209362|NCT02075008|QGE031|qge031
209363|NCT02075008|open-label|open-label
209364|NCT02075008|IgE|ige
209365|NCT02075008|long-term safety|long-term safety
209366|NCT02074995|Burn, Severe burn, Lean body mass, Cachexia, Hypermetabolism, Catabolism, Wound healing|burn, severe burn, lean body mass, cachexia, hypermetabolism, catabolism, wound healing
209367|NCT02074982|chronic plaque type psoriasis, secukinumab, ustekinumab, inflammatory skin disease, scaling|chronic plaque type psoriasis, secukinumab, ustekinumab, inflammatory skin disease, scaling
209368|NCT02074969|re-operation rate|re-operation rate
209369|NCT02074969|pertrochanteric fractures|pertrochanteric fractures
209370|NCT02074969|GammaNail|gammanail
209371|NCT02074969|PFNA|pfna
209372|NCT02074969|Tip-Apex-Distance|tip-apex-distance
209373|NCT02074969|Parkers-Ratio|parkers-ratio
209374|NCT02074956|BCG Vaccinated|bcg vaccinated
209375|NCT02074956|HIV Negative|hiv negative
209376|NCT02074943|Androgenetic Alopecia|androgenetic alopecia
209377|NCT02074917|anterior cruciate ligament|anterior cruciate ligament
209378|NCT02074917|ACL|acl
209379|NCT02074917|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
209380|NCT02074917|outcome assessment|outcome assessment
209381|NCT02074917|outcome assessment, patient|outcome assessment, patient
209382|NCT02074917|treatment outcome|treatment outcome
209383|NCT02074917|exercise test|exercise test
209384|NCT02074917|anatomic|anatomic
209385|NCT02074917|anatomical|anatomical
209386|NCT02074917|single-bundle|single-bundle
209387|NCT02074917|force platform|force platform
209388|NCT02074917|postural balance|postural balance
209389|NCT02074917|biomechanics|biomechanics
209390|NCT02074917|CT scan|ct scan
209391|NCT02074917|X-ray computed tomography|x-ray computed tomography
209392|NCT02074917|tomography|tomography
209393|NCT02074917|diagnostic imaging|diagnostic imaging
209394|NCT02074917|knee|knee
209395|NCT02074917|knee injuries|knee injuries
209396|NCT02074917|joint instability|joint instability
209397|NCT02074917|reconstructive surgical procedures|reconstructive surgical procedures
209398|NCT02074917|knee surgery|knee surgery
209399|NCT02074917|arthroscopy|arthroscopy
209400|NCT02074917|athletes|athletes
209401|NCT02074917|sports medicine|sports medicine
209402|NCT02074917|humans|humans
209403|NCT02074917|prospective studies|prospective studies
209404|NCT02074917|Randomized Controlled Trial|randomized controlled trial
209405|NCT02074891|preexposure prophylaxis|preexposure prophylaxis
209406|NCT02074891|PrEP|prep
209407|NCT02074891|HIV|hiv
209408|NCT02074878|Breast Cancer|breast cancer
209409|NCT02074878|Metastatic|metastatic
209410|NCT02074878|Crizotinib|crizotinib
209411|NCT02074878|Sunitinib|sunitinib
209412|NCT02074878|Xalcori|xalcori
209413|NCT02074878|Sutent|sutent
209414|NCT02074839|acute myeloid leukemia|acute myeloid leukemia
209415|NCT02074839|AML|aml
209416|NCT02074839|myelodysplastic syndrome|myelodysplastic syndrome
209417|NCT02074839|MDS|mds
209418|NCT02074839|hematologic malignancies|hematologic malignancies
209420|NCT02074839|Untreated AML|untreated aml
209422|NCT02074839|relapsed AML|relapsed aml
209423|NCT02074839|refractory AML|refractory aml
209424|NCT02074813|Inspiratory muscle training|inspiratory muscle training
209425|NCT02074813|COPD|copd
209426|NCT02074813|dyspnea|dyspnea
209427|NCT02074813|Multidimensional Dyspnea Profile questionnaire (MDP).|multidimensional dyspnea profile questionnaire (mdp).
209428|NCT02074813|pulmonary rehabilitation|pulmonary rehabilitation
209429|NCT02074800|Healthy|healthy
209430|NCT02074800|CNTO 328|cnto 328
209431|NCT02074800|Sp2/0-derived CNTO 328|sp2/0-derived cnto 328
209432|NCT02074800|CHO-derived CNTO 328|cho-derived cnto 328
209434|NCT02074800|Pharmacokinetics|pharmacokinetics
209435|NCT02074774|nasal cannula, high flow oxygen therapy, pulse oximetry|nasal cannula, high flow oxygen therapy, pulse oximetry
209436|NCT02074761|sacroiliac joint fusion|sacroiliac joint fusion
209437|NCT02074761|SIJ fusion|sij fusion
209439|NCT02074761|SIJ|sij
209440|NCT02074748|Bunion|bunion
209441|NCT02074748|Foot Arch|foot arch
209442|NCT02074748|Instability|instability
209443|NCT02074735|alcohol dependence|alcohol dependence
209444|NCT02074735|alcohol abuse|alcohol abuse
209445|NCT02074709|Pain, Liposomal bupivacaine, Wound infiltration|pain, liposomal bupivacaine, wound infiltration
209446|NCT02074696|brain derived neurotrophic factor|brain derived neurotrophic factor
209447|NCT02074657|Immunotherapy|immunotherapy
209448|NCT02074657|NKAEs|nkaes
209449|NCT02074657|Expanded haploidentical natural killer cells|expanded haploidentical natural killer cells
209450|NCT02074657|Activated natural killer cells|activated natural killer cells
209451|NCT02074644|Prostatism|prostatism
209452|NCT02074644|Randomized Controlled Trial|randomized controlled trial
209453|NCT02074644|Embolization, Therapeutic|embolization, therapeutic
209454|NCT02074644|Hyperplasia|hyperplasia
209455|NCT02074644|Prostatic Diseases|prostatic diseases
209456|NCT02074644|Genital Diseases, Male|genital diseases, male
209457|NCT02074631|bone mineral content|bone mineral content
209458|NCT02074631|bone mineral density|bone mineral density
209459|NCT02074631|bone formation|bone formation
209460|NCT02074631|bone resorption|bone resorption
209461|NCT02074631|pamidronate|pamidronate
209462|NCT02074631|children|children
209463|NCT02074631|DXA|dxa
209464|NCT02074631|bone marrow transplant|bone marrow transplant
209465|NCT02074618|Physical Therapy.|physical therapy.
209466|NCT02074618|Exercise.|exercise.
209467|NCT02074618|Rehabilitation.|rehabilitation.
209468|NCT02074618|Renal Insufficiency.|renal insufficiency.
209469|NCT02074618|Quality of life.|quality of life.
209470|NCT02074605|Melanoma|melanoma
209471|NCT02074605|Interferon|interferon
209472|NCT02074605|Cognition|cognition
209473|NCT02074592|Self assessment|self assessment
209474|NCT02074592|Audit|audit
209475|NCT02074592|Feedback|feedback
209476|NCT02074592|Quality|quality
209477|NCT02074592|Ultrasound|ultrasound
209478|NCT02074592|Fetal|fetal
209479|NCT02074592|Biometry|biometry
209480|NCT02074579|Irritable Bowel Syndrome|irritable bowel syndrome
209481|NCT02074579|Rome III criteria|rome iii criteria
209482|NCT02074579|abdominal bloating|abdominal bloating
209483|NCT02074579|natural|natural
209484|NCT02074579|herbal|herbal
209485|NCT02074579|Kampo|kampo
209486|NCT02074579|Adult ages 18 to 65|adult ages 18 to 65
209487|NCT02074579|Female subjects|female subjects
209488|NCT02074566|Pulmonary Vein Isolation|pulmonary vein isolation
209489|NCT02074566|Atrial fibrillation|atrial fibrillation
209490|NCT02074566|Cryoballoon therapy|cryoballoon therapy
209491|NCT02074566|Duration|duration
209492|NCT02074527|congenital heart disease|congenital heart disease
209493|NCT02074527|cardiac catheterization|cardiac catheterization
209494|NCT02074527|brazilian electronic registration|brazilian electronic registration
209495|NCT02074501|stroke|stroke
209496|NCT02074501|elderly|elderly
209497|NCT02074501|caregivers|caregivers
209498|NCT02074501|empowerment|empowerment
209499|NCT02074501|self-care|self-care
209500|NCT02074501|pilot study|pilot study
209501|NCT02074488|balance|balance
209502|NCT02074488|gait|gait
209503|NCT02074462|Voriconazole|voriconazole
209504|NCT02074462|CRP|crp
209505|NCT02074462|Inflammation|inflammation
209506|NCT02074462|Pharmacokinetics|pharmacokinetics
209507|NCT02074449|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
209508|NCT02074449|Right Ventricular Performance|right ventricular performance
209509|NCT02074449|Treprostinil|treprostinil
209510|NCT02074449|Remodulin|remodulin
678247|NCT00882089|Partial|partial
209511|NCT02074436|hematological malignancies|hematological malignancies
209512|NCT02074436|thrombocytopenia|thrombocytopenia
209513|NCT02074436|aminocaproic acid|aminocaproic acid
209514|NCT02074423|Cinnamon extract|cinnamon extract
209515|NCT02074423|Postprandial glycemia|postprandial glycemia
209516|NCT02074423|Glycemic index|glycemic index
209517|NCT02074423|Pre-diabetes|pre-diabetes
209518|NCT02074423|Metabolic syndrome|metabolic syndrome
209519|NCT02074371|coronary artery bypass surgery|coronary artery bypass surgery
209520|NCT02074371|cardiopulmonary bypass|cardiopulmonary bypass
209521|NCT02074371|ICU|icu
209522|NCT02074371|postoperative respiratory depression|postoperative respiratory depression
209523|NCT02074345|Drug therapy|drug therapy
209524|NCT02074345|Safety and immunogenicity of Hib vaccine|safety and immunogenicity of hib vaccine
209525|NCT02074332|Obesity|obesity
209526|NCT02074332|Physical activity|physical activity
209527|NCT02074332|Schoolchildren|schoolchildren
209528|NCT02074332|Intervention Studies|intervention studies
209529|NCT02074319|Schizophrenia|schizophrenia
209530|NCT02074319|Anti-Inflammatory|anti-inflammatory
209531|NCT02074319|Methotrexate|methotrexate
209532|NCT02074319|Psychosis Not Otherwise Specified|psychosis not otherwise specified
209533|NCT02074306|endotracheal intubation|endotracheal intubation
209534|NCT02074306|low energy ultrasound|low energy ultrasound
209535|NCT02074306|sputum culture|sputum culture
209536|NCT02074293|Subdermal bloodless space|subdermal bloodless space
209537|NCT02074293|Subdermal injection|subdermal injection
209538|NCT02074293|injectable EMG needle|injectable emg needle
209539|NCT02074293|electrical stimulation|electrical stimulation
209540|NCT02074293|MRI with Gadolinium|mri with gadolinium
209541|NCT02074293|Cervical Dystonia|cervical dystonia
209542|NCT02074293|intramuscular injection|intramuscular injection
209543|NCT02074293|cervical dystonia,|cervical dystonia,
209544|NCT02074280|rifaximin|rifaximin
209545|NCT02074280|endotoxemia|endotoxemia
209546|NCT02074280|cirrhosis|cirrhosis
209547|NCT02074280|advanced cirrhosis|advanced cirrhosis
209548|NCT02074228|Attention-deficit/hyperactivity disorder,|attention-deficit/hyperactivity disorder,
209549|NCT02074228|symptomatology,|symptomatology,
209550|NCT02074228|neurocognitive endophenotype,|neurocognitive endophenotype,
209551|NCT02074228|medication response|medication response
209552|NCT02074215|Mild Cognitive Impairment|mild cognitive impairment
209553|NCT02074215|Alzheimer's disease|alzheimer's disease
209554|NCT02074215|Aerobic exercise|aerobic exercise
209555|NCT02074202|18F fluorocholine|18f fluorocholine
209556|NCT02074202|18F fluorodeoxyglucose|18f fluorodeoxyglucose
209557|NCT02074202|hepatocellular carcinoma|hepatocellular carcinoma
209558|NCT02074202|PET CT scan|pet ct scan
209559|NCT02074176|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
209560|NCT02074176|orexin A|orexin a
209561|NCT02074176|mRNA|mrna
209562|NCT02074163|Subdermal bloodless space|subdermal bloodless space
209563|NCT02074163|Subdermal injection|subdermal injection
209564|NCT02074163|injectable EMG needle|injectable emg needle
209565|NCT02074163|electrical stimulation|electrical stimulation
209566|NCT02074163|MRI with Gadolinium|mri with gadolinium
209567|NCT02074163|Chronic Migraine|chronic migraine
209568|NCT02074163|intramuscular injection|intramuscular injection
209569|NCT02074150|Subdermal bloodless space|subdermal bloodless space
209570|NCT02074150|Subdermal injection|subdermal injection
209571|NCT02074150|injectable EMG needle|injectable emg needle
209572|NCT02074150|electrical stimulation|electrical stimulation
209573|NCT02074150|MRI with Gadolinium|mri with gadolinium
209574|NCT02074150|Upper Limb Spasticity|upper limb spasticity
209575|NCT02074150|intramuscular injection|intramuscular injection
209576|NCT02074111|Moyamoya disease|moyamoya disease
209577|NCT02074111|Intracranial atherosclerotic stroke|intracranial atherosclerotic stroke
209578|NCT02074111|Intracranial steno-occlusive disease|intracranial steno-occlusive disease
209579|NCT02074111|ring finger 213 (RNF213) gene mutation|ring finger 213 (rnf213) gene mutation
209580|NCT02074111|high-resolution MRI|high-resolution mri
209581|NCT02074098|intubation|intubation
209582|NCT02074098|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
209583|NCT02074098|Manikin study|manikin study
209584|NCT02074072|Endotracheal intubation|endotracheal intubation
209585|NCT02074072|Left lateral tilt wedge|left lateral tilt wedge
209586|NCT02074072|Maternal Cardiopulmonary Resuscitation|maternal cardiopulmonary resuscitation
209587|NCT02074072|Manikin Study|manikin study
209588|NCT02074020|SLE|sle
209589|NCT02074020|Lupus|lupus
209590|NCT02074020|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
209591|NCT02074020|Autoimmune Diseases|autoimmune diseases
209592|NCT02074020|A-623|a-623
209593|NCT02074020|Blisibimod|blisibimod
209594|NCT02074020|Nephritis|nephritis
209595|NCT02074007|Acute Otitis Media|acute otitis media
209596|NCT02074007|Pain|pain
209597|NCT02074007|Ear Pain|ear pain
209598|NCT02074007|Ear Ache|ear ache
209599|NCT02074007|Ear infection|ear infection
209600|NCT02074007|middle ear infection|middle ear infection
209601|NCT02073994|chondrosarcoma|chondrosarcoma
209602|NCT02073994|cholangiocarcinoma|cholangiocarcinoma
209603|NCT02073994|glioma|glioma
209604|NCT02073994|advanced solid tumors|advanced solid tumors
209605|NCT02073994|IDH1|idh1
209606|NCT02073994|AG-120|ag-120
209607|NCT02073981|Parkinson Disease|parkinson disease
209608|NCT02073955|Stroke|stroke
209609|NCT02073955|Validation|validation
209610|NCT02073955|Community Health workers|community health workers
209611|NCT02073955|stroke symptom questionnaire|stroke symptom questionnaire
209612|NCT02073916|Breast Cancer|breast cancer
209613|NCT02073916|HER2 positive Breast Cancer|her2 positive breast cancer
209614|NCT02073903|dual handset interpreter phones|dual handset interpreter phones
209615|NCT02073903|communication|communication
209616|NCT02073903|14-042|14-042
209714|NCT02073474|Safety|safety
209715|NCT02073474|MS|ms
209617|NCT02073890|traumatic Subarachnoid Haemorrhage|traumatic subarachnoid haemorrhage
209618|NCT02073890|Head Trauma|head trauma
209619|NCT02073890|Computed Tomography|computed tomography
209620|NCT02073877|Peri-implant dermatitis|peri-implant dermatitis
209621|NCT02073864|Aortic valve stenosis, stenosis, intervention|aortic valve stenosis, stenosis, intervention
209622|NCT02073851|TAVR|tavr
209623|NCT02073825|Computer-assisted interventions|computer-assisted interventions
209624|NCT02073825|Alcohol use disorders|alcohol use disorders
209625|NCT02073825|At-risk drinking|at-risk drinking
209626|NCT02073825|Spouses|spouses
209627|NCT02073825|Military|military
209628|NCT02073825|Brief Intervention|brief intervention
209629|NCT02073773|stroke, virtual reality based therapy|stroke, virtual reality based therapy
209630|NCT02073760|Healthcare acquired infections|healthcare acquired infections
209631|NCT02073760|Cardiac Surgery|cardiac surgery
209632|NCT02073760|Sternal Superficial Wound Infection|sternal superficial wound infection
209633|NCT02073760|Deep Sternal Infection|deep sternal infection
209634|NCT02073760|Mediastinitis|mediastinitis
209635|NCT02073760|Thoracotomy|thoracotomy
209636|NCT02073760|Conduit harvest or cannulation site|conduit harvest or cannulation site
209637|NCT02073760|Sepsis|sepsis
209638|NCT02073760|Pneumonia|pneumonia
209639|NCT02073747|Albuterol|albuterol
209640|NCT02073747|Serum Lactate|serum lactate
209641|NCT02073747|Lactic Acidosis|lactic acidosis
209642|NCT02073747|Asthma|asthma
209643|NCT02073734|pelvic organ prolapse surgery|pelvic organ prolapse surgery
209644|NCT02073734|dexamethasone|dexamethasone
256855|NCT01858324|Anxiety|anxiety
209645|NCT02073734|postoperative nausea and vomiting|postoperative nausea and vomiting
209646|NCT02073734|peroperative administration|peroperative administration
209647|NCT02073695|Proximal humeral fracture|proximal humeral fracture
209648|NCT02073695|Shoulder|shoulder
209649|NCT02073695|Orthopaedics|orthopaedics
209650|NCT02073695|Neutral rotation brace|neutral rotation brace
209651|NCT02073695|Polysling|polysling
209652|NCT02073669|latent tuberculosis|latent tuberculosis
209653|NCT02073669|tuberculin skin test|tuberculin skin test
209654|NCT02073669|Interferon gamma release assay|interferon gamma release assay
209655|NCT02073669|immigration|immigration
209656|NCT02073656|genotype 1|genotype 1
209657|NCT02073656|genotype 4|genotype 4
209658|NCT02073656|HIV|hiv
209659|NCT02073630|magnetoencephalography|magnetoencephalography
209660|NCT02073630|non invasive brain stimulation|non invasive brain stimulation
209661|NCT02073630|cerebellum|cerebellum
209662|NCT02073630|gamma rhythms|gamma rhythms
209663|NCT02073617|DynaCT|dynact
209664|NCT02073617|Aortic valve and root measurements|aortic valve and root measurements
209665|NCT02073617|TAVR|tavr
209666|NCT02073604|Congenital mirror movements|congenital mirror movements
209667|NCT02073604|SMA|sma
209668|NCT02073604|Movement preparation|movement preparation
209669|NCT02073604|Movement lateralization|movement lateralization
209670|NCT02073604|MRI|mri
209671|NCT02073604|Transcranial magnetic stimulation|transcranial magnetic stimulation
209672|NCT02073591|Children|children
209673|NCT02073591|Atopic Dermatitis|atopic dermatitis
209674|NCT02073591|Ceradan|ceradan
209675|NCT02073591|PEST|pest
209676|NCT02073591|SCORAD|scorad
209677|NCT02073578|achalasia|achalasia
209678|NCT02073578|POEM|poem
209679|NCT02073578|peroral endoscopic myotomy|peroral endoscopic myotomy
209680|NCT02073578|myotomy|myotomy
209681|NCT02073578|Heller myotomy|heller myotomy
209682|NCT02073565|intracoronary stent|intracoronary stent
209683|NCT02073565|drug eluting stent|drug eluting stent
209684|NCT02073565|sirolimus|sirolimus
209685|NCT02073565|endothelial progenitor cells|endothelial progenitor cells
209686|NCT02073552|colon cleansing, bowel preparations; polyethyleneglycol|colon cleansing, bowel preparations; polyethyleneglycol
209687|NCT02073539|Chest compression|chest compression
209688|NCT02073539|One accelerometer|one accelerometer
209689|NCT02073539|Manikin Study|manikin study
209690|NCT02073526|Antibodies, Monoclonal|antibodies, monoclonal
209691|NCT02073526|Anti-TNF|anti-tnf
209692|NCT02073526|TNF-alpha|tnf-alpha
209693|NCT02073526|Trough level|trough level
209694|NCT02073526|Drug concentration|drug concentration
209695|NCT02073526|ELISA|elisa
209696|NCT02073513|Spasticity, Hand Function, Cerebral Palsy, Kinesiotape|spasticity, hand function, cerebral palsy, kinesiotape
209697|NCT02073500|Peritoneal carcinomatosis|peritoneal carcinomatosis
209698|NCT02073500|Peritoneal surface malignancy|peritoneal surface malignancy
209699|NCT02073500|Cytoreductive surgery|cytoreductive surgery
209700|NCT02073500|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
209701|NCT02073500|CRS|crs
209702|NCT02073500|HIPEC|hipec
209703|NCT02073500|Prognostic biomarker|prognostic biomarker
209704|NCT02073500|Predictive biomarker|predictive biomarker
209705|NCT02073487|Neoadjuvant Breast Cancer|neoadjuvant breast cancer
209706|NCT02073487|HER2 positive Breast Cancer|her2 positive breast cancer
209707|NCT02073474|cannabinoids|cannabinoids
209708|NCT02073474|Sativex|sativex
209709|NCT02073474|THC|thc
209710|NCT02073474|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
209711|NCT02073474|cannabidiol|cannabidiol
209712|NCT02073474|CBD|cbd
209716|NCT02073461|Acne Vulgaris|acne vulgaris
209717|NCT02073448|Acne Vulgaris|acne vulgaris
209718|NCT02073435|liver transplantation|liver transplantation
209719|NCT02073435|living donor|living donor
209720|NCT02073435|Safety|safety
209721|NCT02073422|Magnetic resonance imaging|magnetic resonance imaging
209722|NCT02073422|Myocardial stress perfusion magnetic resonance imaging|myocardial stress perfusion magnetic resonance imaging
209723|NCT02073422|Fractional flow reserve|fractional flow reserve
209724|NCT02073422|Relaxometry|relaxometry
209725|NCT02073422|Coronary artery disease|coronary artery disease
209726|NCT02073409|Nontuberculous Mycobacteria|nontuberculous mycobacteria
209727|NCT02073383|Axillary brachial plexus block|axillary brachial plexus block
209729|NCT02073383|Bupivacaine|bupivacaine
209730|NCT02073344|obstructive sleep apnea|obstructive sleep apnea
209731|NCT02073344|overhydration|overhydration
209732|NCT02073344|end stage renal disease|end stage renal disease
209733|NCT02073344|renal transplantation|renal transplantation
209734|NCT02073344|polysomnography|polysomnography
209735|NCT02073344|bioimpedance|bioimpedance
209736|NCT02073344|leg fluid shift|leg fluid shift
209737|NCT02073344|neck circumference|neck circumference
209738|NCT02073331|Open heart surgery, cardiac repair|open heart surgery, cardiac repair
209739|NCT02073305|obstructive sleep apnea|obstructive sleep apnea
209740|NCT02073305|end stage renal disease|end stage renal disease
209741|NCT02073305|cardiovascular events|cardiovascular events
209742|NCT02073240|Tuberculosis|tuberculosis
209743|NCT02073240|Infection Control|infection control
209744|NCT02073227|Healthy Volunteers|healthy volunteers
209745|NCT02073227|Canagliflozin|canagliflozin
209746|NCT02073227|Metformin|metformin
209747|NCT02073227|Type 2 diabetes mellitus|type 2 diabetes mellitus
209748|NCT02073175|Postpartum|postpartum
209749|NCT02073175|Dietary Supplements|dietary supplements
209750|NCT02073175|Mood Symptoms|mood symptoms
209751|NCT02073149|Iron|iron
209752|NCT02073149|Anemia|anemia
209753|NCT02073149|Sodium Fe(III)-ethylenediaminetetraacetic acid (NaFeEDTA)|sodium fe(iii)-ethylenediaminetetraacetic acid (nafeedta)
209754|NCT02073149|Ferrous compounds|ferrous compounds
209755|NCT02073149|Child, preschool|child, preschool
209756|NCT02073149|Kenya|kenya
209757|NCT02073123|Metastatic melanoma|metastatic melanoma
209758|NCT02073123|Stage III melanoma|stage iii melanoma
209759|NCT02073123|Stage IV melanoma|stage iv melanoma
209760|NCT02073123|unresectable|unresectable
209761|NCT02073110|Kidney cancer|kidney cancer
209762|NCT02073110|Renal mass|renal mass
209763|NCT02073110|Small renal mass|small renal mass
209764|NCT02073110|Optical Coherence Tomography|optical coherence tomography
209765|NCT02073110|OCT|oct
209766|NCT02073110|Diffuse Reflectance Spectroscopy|diffuse reflectance spectroscopy
209767|NCT02073110|DRS|drs
209768|NCT02073110|Optical Biopsy|optical biopsy
209769|NCT02073110|OB|ob
209770|NCT02073058|Subjects with Type 1 or Type 2 Diabetes Requiring Multiple daily Insulin Injection (MDI) or Continuous Subcutaneous Insulin Infusion (CSII)|subjects with type 1 or type 2 diabetes requiring multiple daily insulin injection (mdi) or continuous subcutaneous insulin infusion (csii)
209771|NCT02073032|Refeeding syndrome, risk factors, head and neck cancer|refeeding syndrome, risk factors, head and neck cancer
209772|NCT02073006|Chronic|chronic
209773|NCT02073006|Functional|functional
209774|NCT02073006|Constipation|constipation
209775|NCT02073006|less than 3 bowel movements per week|less than 3 bowel movements per week
209776|NCT02072993|Phase I, healthy, pharmacokinetics|phase i, healthy, pharmacokinetics
209777|NCT02072980|DT1|dt1
209778|NCT02072980|DAILIES TOTAL1®|dailies total1®
209779|NCT02072980|Lubricity|lubricity
209780|NCT02072967|Relapsed|relapsed
209781|NCT02072967|Refractory|refractory
209782|NCT02072967|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
209783|NCT02072967|Bendamustine|bendamustine
209784|NCT02072941|Advance care planning|advance care planning
209785|NCT02072941|Latino Health|latino health
209786|NCT02072941|Medical decision making|medical decision making
209787|NCT02072941|Health Literacy|health literacy
209788|NCT02072941|Limited English proficiency|limited english proficiency
209790|NCT02072902|Cohort|cohort
209791|NCT02072902|Historical|historical
209792|NCT02072902|Prospective|prospective
209793|NCT02072902|Medications|medications
678248|NCT00882089|Breast|breast
209794|NCT02072902|Observational|observational
209795|NCT02072902|Glucose|glucose
209796|NCT02072902|Control|control
209797|NCT02072889|Cardiac Surgery|cardiac surgery
209798|NCT02072889|Internal Jugular Cannulation|internal jugular cannulation
209799|NCT02072889|Optimal Neck Angle|optimal neck angle
209800|NCT02072876|Stroke|stroke
209801|NCT02072876|Asymptomatic Intracranial Atherosclerotic Disease|asymptomatic intracranial atherosclerotic disease
209802|NCT02072876|Lifestyle and socio-economic risk factors|lifestyle and socio-economic risk factors
209803|NCT02072876|Clinical predictors|clinical predictors
209804|NCT02072850|Myocardial infarction|myocardial infarction
209805|NCT02072850|Primary percutaneous coronary intervention (PCI)|primary percutaneous coronary intervention (pci)
209806|NCT02072850|Thrombolysis|thrombolysis
209807|NCT02072850|Rescue PCI|rescue pci
209808|NCT02072850|Electrocardiogram|electrocardiogram
209809|NCT02072850|Magnetic resonance imaging|magnetic resonance imaging
209810|NCT02072850|Area-at-risk|area-at-risk
209811|NCT02072850|Myocardial salvage|myocardial salvage
209812|NCT02072850|Infarct size|infarct size
209813|NCT02072850|Pressure wire|pressure wire
209814|NCT02072850|Coronary thermodilution|coronary thermodilution
209815|NCT02072850|Coronary microvascular function|coronary microvascular function
209816|NCT02072850|Index of microvascular resistance|index of microvascular resistance
209817|NCT02072850|Heart failure|heart failure
209818|NCT02072850|Prognosis|prognosis
209819|NCT02072837|hemodialysis, dyslipidemia, cardiovascular disease|hemodialysis, dyslipidemia, cardiovascular disease
209820|NCT02072824|Partial Onset Seizures|partial onset seizures
209821|NCT02072824|Epilepsy|epilepsy
209823|NCT02072824|Efficacy|efficacy
209824|NCT02072824|Tolerability|tolerability
209825|NCT02072824|Pregabalin|pregabalin
209826|NCT02072824|Lyrica|lyrica
209827|NCT02072824|Adjunctive treatment|adjunctive treatment
209828|NCT02072824|Placebo controlled|placebo controlled
209829|NCT02072824|blinded|blinded
209830|NCT02072824|Eligibility Criteria|eligibility criteria
209831|NCT02072811|AML|aml
209832|NCT02072798|Randomized Controlled Trial|randomized controlled trial
209833|NCT02072798|Caesarean Section|caesarean section
209834|NCT02072798|Surgical Site Infections|surgical site infections
209835|NCT02072798|Wound Infections|wound infections
209836|NCT02072798|Infectious Morbidity|infectious morbidity
209837|NCT02072785|Adult Acute Lymphoblastic Leukemia|adult acute lymphoblastic leukemia
209838|NCT02072785|Vincristine Sulfate Liposome|vincristine sulfate liposome
209839|NCT02072785|Vincristine Sulfate|vincristine sulfate
209840|NCT02072759|Insulin sensitivity|insulin sensitivity
209841|NCT02072759|Metabolic flexibility|metabolic flexibility
209842|NCT02072746|cirrhosis|cirrhosis
209843|NCT02072746|alcohol|alcohol
209844|NCT02072733|frailty|frailty
209845|NCT02072733|oncogeriatrics|oncogeriatrics
209846|NCT02072733|Multidisciplinary intervention|multidisciplinary intervention
209847|NCT02072733|multimorbidity|multimorbidity
209848|NCT02072733|Comprehensive geriatric assessment|comprehensive geriatric assessment
209849|NCT02072733|patients|patients
209850|NCT02072720|Radiotherapy|radiotherapy
209851|NCT02072720|VEGF|vegf
209852|NCT02072720|esophagus carcinoma|esophagus carcinoma
209853|NCT02072720|bevacizumab|bevacizumab
209854|NCT02072707|Ventricular Tachycardia|ventricular tachycardia
209855|NCT02072707|RF ablation|rf ablation
209856|NCT02072707|Epicardial Access|epicardial access
209857|NCT02072707|Contact Sensor Irrigated tip catheter|contact sensor irrigated tip catheter
209858|NCT02072694|Obesity|obesity
209859|NCT02072694|Single Photon Emission Computed Tomography|single photon emission computed tomography
209860|NCT02072694|Functional Neuroimaging|functional neuroimaging
209861|NCT02072668|sickle cell anemia|sickle cell anemia
209862|NCT02072668|sickle cell disease|sickle cell disease
209863|NCT02072668|rivaroxaban|rivaroxaban
209864|NCT02072668|direct Xa inhibition|direct xa inhibition
209865|NCT02072668|coagulation|coagulation
209866|NCT02072668|anticoagulation|anticoagulation
209867|NCT02072629|Antimalarials|antimalarials
209868|NCT02072629|Antibiotics|antibiotics
209869|NCT02072629|ORS Zn|ors zn
209870|NCT02072629|Village Health Volunteers|village health volunteers
209871|NCT02072629|Integrated Community Case Management|integrated community case management
209872|NCT02072616|Circulating Tumor Cells|circulating tumor cells
209873|NCT02072616|pancreatic adenocarcinoma|pancreatic adenocarcinoma
209874|NCT02072616|circulating tumor DNA (KRAS)|circulating tumor dna (kras)
209875|NCT02072616|CA 19.9|ca 19.9
209876|NCT02072603|Infant HIV|infant hiv
209877|NCT02072603|Kenya|kenya
209878|NCT02072603|HITSystem|hitsystem
209879|NCT02072603|EID care|eid care
209880|NCT02072603|Early Infant Diagnosis|early infant diagnosis
209881|NCT02072590|Celiac disease|celiac disease
209882|NCT02072590|Eosinophilic esophagitis|eosinophilic esophagitis
209883|NCT02072590|Endomysial antibodies|endomysial antibodies
209884|NCT02072590|Transglutaminase antibodies|transglutaminase antibodies
209885|NCT02072590|Small-bowel|small-bowel
209886|NCT02072577|Nursing care, oral health, educational video, oral hygiene.|nursing care, oral health, educational video, oral hygiene.
209887|NCT02072538|Stress testing|stress testing
209888|NCT02072538|Troponin T|troponin t
209889|NCT02072538|GRACE score|grace score
209890|NCT02072538|Outcome|outcome
209891|NCT02072525|Pertussis|pertussis
209892|NCT02072525|Healthy adults|healthy adults
209893|NCT02072525|Tetanus|tetanus
209894|NCT02072525|Human serum samples|human serum samples
209895|NCT02072525|Streptococcus|streptococcus
209896|NCT02072525|Diphtheria|diphtheria
209897|NCT02072525|Plasma|plasma
209898|NCT02072525|Meningococcus|meningococcus
209899|NCT02072512|pre- and perimenopausal HR+ advanced breast cancer|pre- and perimenopausal hr+ advanced breast cancer
209900|NCT02072473|Re-entrant Atrioventricular Node Tachycardia|re-entrant atrioventricular node tachycardia
209901|NCT02072473|Unsuccessful right-sided slow pathway ablation|unsuccessful right-sided slow pathway ablation
209902|NCT02072473|Coronary sinus / left-sided slow pathway ablation|coronary sinus / left-sided slow pathway ablation
209903|NCT02072447|absolute bioavailability,|absolute bioavailability,
209904|NCT02072447|microdose,|microdose,
209905|NCT02072447|AMS|ams
210212|NCT02070939|PD|pd
209906|NCT02072434|Atrial fibrillation|atrial fibrillation
209907|NCT02072434|anti-coagulant|anti-coagulant
209908|NCT02072434|warfarin|warfarin
209909|NCT02072434|edoxaban|edoxaban
209910|NCT02072434|electrical cardioversion|electrical cardioversion
209911|NCT02072395|morbid obesity|morbid obesity
209912|NCT02072395|bariatric surgery|bariatric surgery
209913|NCT02072395|gastric banding|gastric banding
209914|NCT02072395|gastric plication|gastric plication
209915|NCT02072382|Hypertension|hypertension
209916|NCT02072382|Metformin|metformin
209917|NCT02072382|Ambulatory blood pressure monitor|ambulatory blood pressure monitor
209919|NCT02072369|hand|hand
209920|NCT02072369|fingers|fingers
209921|NCT02072369|rehabilitation|rehabilitation
209922|NCT02072369|training|training
209923|NCT02072356|Humanitarian Device|humanitarian device
209924|NCT02072356|Carcinoma|carcinoma
209925|NCT02072356|Hepatocellular Carcinoma|hepatocellular carcinoma
209926|NCT02072356|TheraSphere®|therasphere®
209928|NCT02072343|Capnography|capnography
209929|NCT02072343|Catheters|catheters
209930|NCT02072343|Intubation|intubation
200757|NCT02113540|CIN|cin
209931|NCT02072330|Hypertension, Drug therapy|hypertension, drug therapy
209932|NCT02072317|PFS|pfs
209933|NCT02072304|mood disorder|mood disorder
209934|NCT02072304|depressive disorder|depressive disorder
209935|NCT02072304|mental disorders|mental disorders
209936|NCT02072304|program acceptability|program acceptability
209937|NCT02072304|behavioral symptoms|behavioral symptoms
209938|NCT02072304|suicidal ideation|suicidal ideation
209939|NCT02072304|patient adherence|patient adherence
209940|NCT02072265|infrared thermal image|infrared thermal image
209941|NCT02072265|wound healing|wound healing
209942|NCT02072265|wound infection|wound infection
209943|NCT02072252|Depression|depression
209944|NCT02072252|Anxiety|anxiety
209945|NCT02072252|Mobile Phone|mobile phone
209946|NCT02072252|Cellular Phone|cellular phone
209947|NCT02072252|Mobile Application|mobile application
209948|NCT02072252|Mobile Intervention|mobile intervention
209949|NCT02072252|App|app
209950|NCT02072252|mHealth|mhealth
209951|NCT02072252|eHealth|ehealth
209952|NCT02072252|Technology Assisted|technology assisted
209953|NCT02072252|Internet|internet
209954|NCT02072252|Cognitive Behavioral Therapy|cognitive behavioral therapy
209955|NCT02072252|LGBT|lgbt
209956|NCT02072252|Sexual Minorities|sexual minorities
209957|NCT02072252|Gay|gay
209958|NCT02072252|Bisexual|bisexual
209959|NCT02072252|Same Sex Attraction|same sex attraction
209960|NCT02072252|Males|males
209961|NCT02072252|Men|men
209962|NCT02072252|Youth|youth
209963|NCT02072252|Adolescents|adolescents
209964|NCT02072252|Young Adults|young adults
209965|NCT02072239|CABG|cabg
209966|NCT02072239|Intimal Hyperplasia|intimal hyperplasia
209967|NCT02072239|Atherosclerosis|atherosclerosis
209968|NCT02072239|Myocardial Infarction|myocardial infarction
209969|NCT02072213|Tamsulosin,controlled release formulation|tamsulosin,controlled release formulation
209970|NCT02072200|RA, MS, Safety, Efficacy, MR prednisone|ra, ms, safety, efficacy, mr prednisone
209971|NCT02072187|Depression|depression
209972|NCT02072187|Vitamin D|vitamin d
209973|NCT02072187|Complementary and Alternative Medicine|complementary and alternative medicine
209974|NCT02072187|Supplements|supplements
209975|NCT02072187|Non Remitted Depression|non remitted depression
209976|NCT02072161|Statin|statin
209977|NCT02072161|LDL|ldl
209978|NCT02072161|Cholesterol|cholesterol
209979|NCT02072148|Human Papilloma Virus|human papilloma virus
209980|NCT02072148|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
209981|NCT02072148|Transoral Robotic Surgery|transoral robotic surgery
209982|NCT02072122|dry eye|dry eye
209983|NCT02072122|fertility treatment|fertility treatment
209984|NCT02072122|Meibomian gland dysfunction|meibomian gland dysfunction
209985|NCT02072122|supra physiologic estrogen level|supra physiologic estrogen level
209986|NCT02072109|Near infrared spectroscopy|near infrared spectroscopy
209987|NCT02072109|Bolus nutrition|bolus nutrition
209988|NCT02072109|Continuous nutrition|continuous nutrition
209989|NCT02072109|Mesenteric circulation|mesenteric circulation
209990|NCT02072083|dexmedetomidine|dexmedetomidine
209991|NCT02072083|intranasal|intranasal
209992|NCT02072083|strabismus surgery|strabismus surgery
209993|NCT02072083|premedication|premedication
209994|NCT02072083|oculocardiac reflex|oculocardiac reflex
209995|NCT02072070|chondrocyte cells, Osteoarthritis, gene therapy|chondrocyte cells, osteoarthritis, gene therapy
209996|NCT02072044|Renal Cell Carcinoma（RCC）|renal cell carcinoma（rcc）
209997|NCT02072044|Anlotinib|anlotinib
209998|NCT02072031|Anlotinib|anlotinib
209999|NCT02072031|Sunitinib|sunitinib
210000|NCT02072031|Renal Cell Carcinoma（RCC）|renal cell carcinoma（rcc）
210001|NCT02072018|Peyronie's|peyronie's
210002|NCT02072018|Peyronie's disease|peyronie's disease
210003|NCT02072018|Treatment|treatment
210004|NCT02072018|Clinical Study|clinical study
210005|NCT02071979|Chronic|chronic
210006|NCT02071979|Non-healing|non-healing
210007|NCT02071979|Wounds|wounds
210008|NCT02071966|Micro-RNA, Microparticles, Ticagrelor, NSTE-ACS|micro-rna, microparticles, ticagrelor, nste-acs
210009|NCT02071940|Acral Melanoma subtypes|acral melanoma subtypes
210010|NCT02071940|Mucosal Melanoma subtypes|mucosal melanoma subtypes
210011|NCT02071927|leukemia|leukemia
210012|NCT02071927|glutaminase|glutaminase
210013|NCT02071927|glutamine|glutamine
210014|NCT02071888|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
210015|NCT02071888|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
210016|NCT02071888|Multiple myeloma|multiple myeloma
210017|NCT02071888|glutaminase|glutaminase
210018|NCT02071888|glutamine|glutamine
210019|NCT02071875|Vasospasm|vasospasm
210020|NCT02071875|Aneurysm|aneurysm
210021|NCT02071875|SAH|sah
210022|NCT02071875|Nautilus NeuroWave|nautilus neurowave
210023|NCT02071862|Tumor metabolism|tumor metabolism
210024|NCT02071862|Glutaminase|glutaminase
210025|NCT02071862|Glutamine|glutamine
210026|NCT02071862|Tricarboxylic acid (TCA) cycle|tricarboxylic acid (tca) cycle
210027|NCT02071849|Aortic Insufficiency|aortic insufficiency
210028|NCT02071849|Aortic Regurgitation|aortic regurgitation
200840|NCT02113254|AMD|amd
210029|NCT02071836|web application|web application
210030|NCT02071836|DWI intervention|dwi intervention
210031|NCT02071836|DUI intervention|dui intervention
210032|NCT02071836|Experimental group: Right Turns + treatment as usual|experimental group: right turns + treatment as usual
210033|NCT02071836|Control group: Treatment as usual|control group: treatment as usual
210034|NCT02071823|Opicapone,|opicapone,
210035|NCT02071823|Parkinson,|parkinson,
210036|NCT02071823|Bial,|bial,
210037|NCT02071823|BIA 9-1067|bia 9-1067
210038|NCT02071810|Parkinson's disease (PD)|parkinson's disease (pd)
210039|NCT02071810|Opicapone|opicapone
210040|NCT02071810|Bial|bial
210041|NCT02071810|BIA 9-1067|bia 9-1067
210042|NCT02071797|Therapeutic Hypothermia|therapeutic hypothermia
210043|NCT02071797|Cardiac Arrest|cardiac arrest
210044|NCT02071797|Randomised Controlled trial|randomised controlled trial
210045|NCT02071797|Pilot study|pilot study
210046|NCT02071771|DACP Toric|dacp toric
210047|NCT02071771|DAILIES® AquaComfort Plus®|dailies® aquacomfort plus®
210048|NCT02071771|Astigmatism|astigmatism
210049|NCT02071771|Toric|toric
210050|NCT02071758|Leishmaniasis|leishmaniasis
210051|NCT02071758|Visceral leishmaniasis|visceral leishmaniasis
210052|NCT02071758|Vaccine|vaccine
210053|NCT02071758|Adjuvant|adjuvant
210054|NCT02071758|GLA|gla
210055|NCT02071758|SLA|sla
210056|NCT02071693|subthalamic nucleus|subthalamic nucleus
210057|NCT02071693|deep brain stimulation|deep brain stimulation
210058|NCT02071693|cognition|cognition
210059|NCT02071693|white matter hyperintensities|white matter hyperintensities
210060|NCT02071680|atrial fibrillation|atrial fibrillation
210061|NCT02071680|atrial cardiac innervation|atrial cardiac innervation
210062|NCT02071680|catheter ablation of atrial fibrillation|catheter ablation of atrial fibrillation
210063|NCT02071680|High Frequency Stimulation|high frequency stimulation
210064|NCT02071680|ganglionated plexuses|ganglionated plexuses
210065|NCT02071680|123I-mIBG|123i-mibg
210066|NCT02071680|nuclear imaging|nuclear imaging
210067|NCT02071667|Chronic sinusitis|chronic sinusitis
210068|NCT02071667|Nasal Polyps|nasal polyps
210069|NCT02071654|Venus P-valve|venus p-valve
210070|NCT02071615|Brain Activity|brain activity
210071|NCT02071602|Heart attack|heart attack
210072|NCT02071602|Myocardial Infarction|myocardial infarction
210073|NCT02071602|STEMI|stemi
210074|NCT02071576|Myopia|myopia
210075|NCT02071576|Hyperopia|hyperopia
210076|NCT02071576|Proscan|proscan
210077|NCT02071576|LASIK|lasik
210078|NCT02071576|TENEO|teneo
210079|NCT02071576|Excimer|excimer
210080|NCT02071550|laparoscopic cholecystectomy, near infrared spectroscopy, positive end expiratory pressure|laparoscopic cholecystectomy, near infrared spectroscopy, positive end expiratory pressure
210081|NCT02071498|Pillbox|pillbox
210082|NCT02071498|Non-adherence|non-adherence
210083|NCT02071498|Applications|applications
210084|NCT02071498|Patient safety|patient safety
210085|NCT02071498|Elderly|elderly
210086|NCT02071459|L-threo DOPS (DroxiDopa)|l-threo dops (droxidopa)
210087|NCT02071459|Orthostatic Hypotension|orthostatic hypotension
210088|NCT02071459|Multiple system atrophy|multiple system atrophy
210089|NCT02071446|Deep Brain Stimulation|deep brain stimulation
210090|NCT02071446|Local Field Potential|local field potential
210091|NCT02071446|Subthalamic Nucleus|subthalamic nucleus
210092|NCT02071433|Saphenous nerve block|saphenous nerve block
210093|NCT02071433|Adductor canal block|adductor canal block
210094|NCT02071433|Anterior cruciate ligament|anterior cruciate ligament
210095|NCT02071433|Pain management|pain management
210096|NCT02071433|Day care|day care
210097|NCT02071407|traumatic brain injury|traumatic brain injury
210098|NCT02071407|sedation|sedation
210099|NCT02071407|midazolam|midazolam
210100|NCT02071394|Xenon|xenon
210101|NCT02071394|Hypothermia|hypothermia
210102|NCT02071394|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
210103|NCT02071394|Newborn|newborn
210104|NCT02071394|Neonate|neonate
210105|NCT02071394|Term|term
210106|NCT02071394|Neuroprotection|neuroprotection
210107|NCT02071394|Cooling|cooling
210108|NCT02071394|HIE|hie
210109|NCT02071368|Healthy|healthy
210110|NCT02071368|Canagliflozin|canagliflozin
210111|NCT02071368|Metformin|metformin
210112|NCT02071368|JNJ-28431754|jnj-28431754
210113|NCT02071368|GLUMETZA®|glumetza®
210114|NCT02071368|Bioequivalence|bioequivalence
210115|NCT02071368|Fixed Dose Combination|fixed dose combination
210116|NCT02071355|Healthy|healthy
210117|NCT02071355|Chinese participants|chinese participants
210118|NCT02071355|TMC435|tmc435
210119|NCT02071355|Multiple oral doses|multiple oral doses
210120|NCT02071355|Pharmacokinetics|pharmacokinetics
210121|NCT02071355|Safety|safety
210122|NCT02071355|Tolerability|tolerability
210123|NCT02071342|acute myocardial infarction|acute myocardial infarction
210124|NCT02071342|bioresorbable vascular scaffold|bioresorbable vascular scaffold
210125|NCT02071342|percutaneous coronary intervention|percutaneous coronary intervention
210126|NCT02071329|FP-01.1|fp-01.1
210127|NCT02071329|Influenza A|influenza a
210128|NCT02071329|Flu|flu
210129|NCT02071329|Vaccine|vaccine
210130|NCT02071329|Virus|virus
210131|NCT02071329|H1N1|h1n1
210132|NCT02071329|Challenge|challenge
210133|NCT02071316|upper gastrointestinal bleeding|upper gastrointestinal bleeding
210134|NCT02071316|Hexacapron|hexacapron
210135|NCT02071316|hemostasis|hemostasis
210136|NCT02071303|Pain|pain
210137|NCT02071303|Hysteroscopy|hysteroscopy
210138|NCT02071303|Tramadol|tramadol
210139|NCT02071303|Celecoxib|celecoxib
210140|NCT02071290|Hemorrhagic Shock|hemorrhagic shock
210141|NCT02071290|Remote Ischemic Conditioning|remote ischemic conditioning
210142|NCT02071277|Mechanical ventilation|mechanical ventilation
210143|NCT02071277|Airway pressure release ventilation|airway pressure release ventilation
210144|NCT02071277|Biphasic intermittent positive airway pressure|biphasic intermittent positive airway pressure
210145|NCT02071277|Pressure-controlled ventilation|pressure-controlled ventilation
210146|NCT02071277|Lung protective ventilation|lung protective ventilation
210147|NCT02071277|Spontaneous breathing|spontaneous breathing
210148|NCT02071264|HIV/AIDS|hiv/aids
210149|NCT02071264|sex work|sex work
210150|NCT02071264|reproductive health|reproductive health
210151|NCT02071264|human rights|human rights
210152|NCT02071264|ethics|ethics
210153|NCT02071251|Wound complications|wound complications
210154|NCT02071251|Wound infection|wound infection
210155|NCT02071251|Wound separation|wound separation
210156|NCT02071238|Carpal tunnel|carpal tunnel
210157|NCT02071238|Carpal tunnel release|carpal tunnel release
210158|NCT02071238|Risk Recall|risk recall
210159|NCT02071238|Patient satisfaction|patient satisfaction
210160|NCT02071238|Pamphlet|pamphlet
210161|NCT02071238|Brochure|brochure
210162|NCT02071199|Gingivitis|gingivitis
210163|NCT02071199|Periodontitis|periodontitis
210164|NCT02071199|ACCS|accs
210166|NCT02071160|hypothermia|hypothermia
210167|NCT02071160|encephalopathy|encephalopathy
210168|NCT02071160|anti oxidants|anti oxidants
210169|NCT02071160|MRI|mri
210170|NCT02071147|Follow-up|follow-up
210171|NCT02071147|No follow-up|no follow-up
210172|NCT02071147|removal|removal
210173|NCT02071147|Randomised Controlled Trial|randomised controlled trial
210174|NCT02071147|6 Weeks|6 weeks
210175|NCT02071134|Deep brain stimulation|deep brain stimulation
210176|NCT02071134|Parkinson's disease|parkinson's disease
210177|NCT02071134|Vercise|vercise
210178|NCT02071121|BIIB061|biib061
210179|NCT02071121|Healthy|healthy
210180|NCT02071095|Human immunodeficiency virus 1|human immunodeficiency virus 1
210181|NCT02071095|Combined Antiretroviral Therapy|combined antiretroviral therapy
210182|NCT02071095|Poly-ICLC|poly-iclc
210183|NCT02071095|Adjuvant|adjuvant
210184|NCT02071082|HIV|hiv
210185|NCT02071082|HBV|hbv
210186|NCT02071082|Coinfection|coinfection
210187|NCT02071069|Incurable colorectal cancer|incurable colorectal cancer
210188|NCT02071069|maintenance therapy|maintenance therapy
210189|NCT02071069|Cetuximab|cetuximab
210190|NCT02071043|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
678249|NCT00882089|Irradiation|irradiation
210191|NCT02071043|advanced gastric cancer patients|advanced gastric cancer patients
210192|NCT02071043|para-aortic lymph node metastasis|para-aortic lymph node metastasis
210193|NCT02071030|CBCT|cbct
210194|NCT02071030|Third molar removal|third molar removal
210195|NCT02071030|Inferior alveolar nerve injury|inferior alveolar nerve injury
210196|NCT02071004|acute ischemic stroke|acute ischemic stroke
210197|NCT02070991|pre- and post-capillary pulmonary hypertension|pre- and post-capillary pulmonary hypertension
210198|NCT02070991|CpcPH|cpcph
210199|NCT02070978|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
210200|NCT02070978|Atacicept 75 and 150 mg|atacicept 75 and 150 mg
210201|NCT02070978|LTE|lte
210202|NCT02070952|CyberKnife|cyberknife
210203|NCT02070952|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
210204|NCT02070952|Low and Intermediate Risk Prostate Cancer|low and intermediate risk prostate cancer
210205|NCT02070939|Phase 1|phase 1
210206|NCT02070939|Randomized|randomized
210207|NCT02070939|Double Blind|double blind
210208|NCT02070939|Placebo-Controlled|placebo-controlled
210209|NCT02070939|Single and Multiple Dose Escalation|single and multiple dose escalation
210210|NCT02070939|Safety Tolerability|safety tolerability
210211|NCT02070939|PK|pk
210213|NCT02070939|PF-06460414|pf-06460414
210214|NCT02070913|Hypothermia|hypothermia
210215|NCT02070913|Acute Myocardial Infarction|acute myocardial infarction
210216|NCT02070913|Percutaneous Coronary Intervention|percutaneous coronary intervention
210217|NCT02070913|AMI|ami
210218|NCT02070913|PCI|pci
210219|NCT02070913|Therapeutic Hypothermia|therapeutic hypothermia
210220|NCT02070900|Prevention of Mother to Child Transmission|prevention of mother to child transmission
210222|NCT02070900|Option B+|option b+
210223|NCT02070900|ART|art
210224|NCT02070900|Retention|retention
210225|NCT02070900|Loss to Follow Up|loss to follow up
210226|NCT02070900|Time to initiation|time to initiation
210227|NCT02070900|POC CD4|poc cd4
210228|NCT02070900|Clinical mentoring|clinical mentoring
210229|NCT02070900|Costing|costing
210230|NCT02070900|HIV|hiv
210231|NCT02070900|AIDS|aids
210232|NCT02070900|Zimbabwe|zimbabwe
210233|NCT02070874|pain and symptom management|pain and symptom management
210234|NCT02070861|Cardiac output|cardiac output
210235|NCT02070861|Endtidal CO2|endtidal co2
210236|NCT02070861|Nexfin|nexfin
210237|NCT02070861|Esophageal Doppler|esophageal doppler
210238|NCT02070848|red blood cell|red blood cell
210239|NCT02070848|knee extension exercise|knee extension exercise
210240|NCT02070835|Diabetic Foot Ulcer|diabetic foot ulcer
210241|NCT02070835|ReCell|recell
210242|NCT02070822|Hepatocellular carcinoma|hepatocellular carcinoma
210243|NCT02070822|Transarterial chemoembolization|transarterial chemoembolization
210244|NCT02070822|Magnetic resonance imaging|magnetic resonance imaging
210245|NCT02070809|wound|wound
210246|NCT02070809|tissue-engineered skin|tissue-engineered skin
210247|NCT02070796|Rotigotine|rotigotine
210248|NCT02070796|Transdermal Patch|transdermal patch
210249|NCT02070796|Bioequivalence|bioequivalence
210250|NCT02070783|depression|depression
210251|NCT02070783|cognition|cognition
210252|NCT02070783|emotion perception|emotion perception
210253|NCT02070783|information processing|information processing
210254|NCT02070757|Ventilator-associated bacterial pneumonia|ventilator-associated bacterial pneumonia
210255|NCT02070757|Hospital-acquired bacterial pneumonia|hospital-acquired bacterial pneumonia
210256|NCT02070757|Pneumonia|pneumonia
210257|NCT02070757|Lung Diseases|lung diseases
210258|NCT02070757|Respiratory Tract Diseases|respiratory tract diseases
210259|NCT02070757|Respiratory Tract Infections|respiratory tract infections
210260|NCT02070757|Infection|infection
210261|NCT02070757|Ventilator-Induced Lung Injury|ventilator-induced lung injury
210262|NCT02070757|Lung Injury|lung injury
210263|NCT02070744|CF|cf
210264|NCT02070731|TAVR|tavr
210265|NCT02070731|TAVI|tavi
210266|NCT02070731|Aortic Valve Stenosis|aortic valve stenosis
210267|NCT02070718|hot flashes|hot flashes
210268|NCT02070718|menopause|menopause
210269|NCT02070718|kappa agonist|kappa agonist
210270|NCT02070692|Contraceptive implant|contraceptive implant
210271|NCT02070692|Irregular vaginal bleeding|irregular vaginal bleeding
210272|NCT02070692|Etonogestrel implant|etonogestrel implant
210273|NCT02070679|Alpha-tocopherol|alpha-tocopherol
210274|NCT02070679|Vitamin E|vitamin e
210275|NCT02070679|Contrast-Induced Acute Kidney Injury|contrast-induced acute kidney injury
210276|NCT02070679|Coronary angiography|coronary angiography
210277|NCT02070666|ARDS|ards
210278|NCT02070666|Prevention|prevention
210279|NCT02070666|Protective mechanical ventilation|protective mechanical ventilation
210280|NCT02070666|low tidal volumes|low tidal volumes
210281|NCT02070653|Aorta|aorta
210282|NCT02070653|Aneurysm|aneurysm
210283|NCT02070653|Antiplatelet|antiplatelet
210284|NCT02070640|cholecystectomy|cholecystectomy
210285|NCT02070640|cholecystitis|cholecystitis
210286|NCT02070627|acute cholecystitis|acute cholecystitis
210287|NCT02070627|acute cholangitis|acute cholangitis
210288|NCT02070627|cholecystectomy|cholecystectomy
210289|NCT02070614|sufentanil|sufentanil
210290|NCT02070614|metabolism|metabolism
210291|NCT02070614|cytochrome P450 3A4|cytochrome p450 3a4
210292|NCT02070614|gene polymorphism|gene polymorphism
210294|NCT02070588|mTBI|mtbi
210295|NCT02070588|MR|mr
210296|NCT02070588|MRI|mri
210297|NCT02070588|Pulse Sequences|pulse sequences
210298|NCT02070588|NFL|nfl
210299|NCT02070575|PSA|psa
210300|NCT02070575|Human Kallikrein 2|human kallikrein 2
210301|NCT02070575|locally resected prostate cancer|locally resected prostate cancer
210302|NCT02070575|biochemical recurrence|biochemical recurrence
210303|NCT02070575|14-041|14-041
210304|NCT02070562|breast milk, dietary survey|breast milk, dietary survey
210305|NCT02070536|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
210306|NCT02070536|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
210307|NCT02070536|Soluble RAGE (sRAGE)|soluble rage (srage)
210308|NCT02070536|Gene polymorphisms|gene polymorphisms
210309|NCT02070536|Biomarker|biomarker
210310|NCT02070484|NuCel|nucel
210311|NCT02070484|Lumbar Spine|lumbar spine
210312|NCT02070484|Degenerative Disease|degenerative disease
210313|NCT02070484|Efficacy|efficacy
210314|NCT02070484|Fusion|fusion
210315|NCT02070445|CABG|cabg
210316|NCT02070445|pilot|pilot
210317|NCT02070445|ultrasound|ultrasound
210318|NCT02070445|perioperative|perioperative
210319|NCT02070445|low tidal volume ventilation|low tidal volume ventilation
210320|NCT02070432|LUZ11|luz11
210321|NCT02070432|head and neck cancer|head and neck cancer
210322|NCT02070432|photodynamic therapy|photodynamic therapy
210323|NCT02070432|Redaporfin|redaporfin
210324|NCT02070393|Hodgkins Disease in Young Females|hodgkins disease in young females
210325|NCT02070393|Breast Sparing Radiation Treatments|breast sparing radiation treatments
210327|NCT02070380|highly suspected brain disease|highly suspected brain disease
210328|NCT02070367|allodynia|allodynia
210329|NCT02070367|complex regional pain syndrome|complex regional pain syndrome
210330|NCT02070367|peripheral nerve injuries|peripheral nerve injuries
210331|NCT02070367|clinical measurement properties|clinical measurement properties
210332|NCT02070354|Obesity|obesity
210333|NCT02070354|Bariatric surgery|bariatric surgery
210334|NCT02070354|Physical Activity|physical activity
210335|NCT02070354|Nutrition|nutrition
210336|NCT02070354|Weight Loss|weight loss
210337|NCT02070341|patient tolerability|patient tolerability
210338|NCT02070341|quality|quality
210339|NCT02070328|Proton Therapy|proton therapy
210340|NCT02070328|Registry|registry
210341|NCT02070315|heart failure|heart failure
210342|NCT02070315|liver failure|liver failure
210343|NCT02070315|post liver transplant|post liver transplant
210344|NCT02070289|Multiple dose|multiple dose
210345|NCT02070289|safety|safety
210346|NCT02070289|tolerability|tolerability
210347|NCT02070289|PK|pk
210348|NCT02070276|Spinal anesthesia|spinal anesthesia
210349|NCT02070276|Systemic hypotension|systemic hypotension
210350|NCT02070276|Total fluid amount|total fluid amount
210351|NCT02070276|Non-invasive fluid responsiveness|non-invasive fluid responsiveness
210352|NCT02070276|Passive Leg Raising Test|passive leg raising test
210353|NCT02070263|Food allergy|food allergy
210354|NCT02070263|Tree nuts|tree nuts
210355|NCT02070250|Stress management|stress management
210356|NCT02070250|Coping skills|coping skills
210357|NCT02070250|Recently diagnosed cancer patients|recently diagnosed cancer patients
210358|NCT02070250|Intervention, Psychological|intervention, psychological
210359|NCT02070237|Obesity|obesity
210360|NCT02070237|Obesity, Morbid|obesity, morbid
210361|NCT02070237|Pregnancy|pregnancy
210362|NCT02070237|Cesarean|cesarean
210363|NCT02070237|Venous thromboembolism|venous thromboembolism
210364|NCT02070237|Deep venous thrombosis|deep venous thrombosis
210365|NCT02070237|Pulmonary embolism|pulmonary embolism
210366|NCT02070211|Psychotic Disorder|psychotic disorder
210367|NCT02070211|22q11 Deletion Syndrome|22q11 deletion syndrome
210368|NCT02070211|Fatty Acids, Omega-3|fatty acids, omega-3
210369|NCT02070198|Poor responders, IVF, GnRH agonist, GnRH antagonist, recombinant FSH|poor responders, ivf, gnrh agonist, gnrh antagonist, recombinant fsh
210370|NCT02070185|caloric adjustment,liking, flavour nutrient learning, children|caloric adjustment,liking, flavour nutrient learning, children
210371|NCT02070172|headache diagnosis|headache diagnosis
210372|NCT02070172|flexion rotation test|flexion rotation test
210373|NCT02070172|range of motion|range of motion
210374|NCT02070172|upper cervical|upper cervical
210375|NCT02070159|coronary artery disease|coronary artery disease
210376|NCT02070159|prasugrel|prasugrel
210377|NCT02070159|platelet function tests|platelet function tests
210378|NCT02070133|Chronic Bronchitis|chronic bronchitis
210379|NCT02070133|Statins|statins
210380|NCT02070133|Endothelial dysfunction|endothelial dysfunction
210381|NCT02070133|Systemic inflammation|systemic inflammation
210382|NCT02070133|BODE index|bode index
210383|NCT02070133|Uric acid|uric acid
210384|NCT02070133|Vascular growth factors|vascular growth factors
210385|NCT02070120|Nonmuscle invasive bladder cancer (NMIBC)|nonmuscle invasive bladder cancer (nmibc)
210386|NCT02070120|Mitomycin C|mitomycin c
210387|NCT02070120|Chemoresection|chemoresection
210388|NCT02070081|Obesity|obesity
210389|NCT02070081|Bariatric surgery|bariatric surgery
210390|NCT02070055|Maximal Rate of Fat Oxidation|maximal rate of fat oxidation
210391|NCT02070055|Substrate Oxidation|substrate oxidation
210392|NCT02070055|Fat oxidation|fat oxidation
210393|NCT02070055|Respiratory Exchange Ratio (RER)|respiratory exchange ratio (rer)
210394|NCT02070055|Exercise|exercise
210395|NCT02070055|indirect calorimetry|indirect calorimetry
210396|NCT02070055|substrate crossover|substrate crossover
210397|NCT02070042|Overactive Bladder|overactive bladder
210398|NCT02070042|Oxybutynin|oxybutynin
210399|NCT02070042|Omega -3 Fatty Acid|omega -3 fatty acid
210400|NCT02070029|Female Sexual Dysfunction (FSD)|female sexual dysfunction (fsd)
210401|NCT02070029|Hypoactive Sexual Desire Disorder (HSDD)|hypoactive sexual desire disorder (hsdd)
210402|NCT02070029|Low libido|low libido
210403|NCT02070029|Acupuncture|acupuncture
210404|NCT02069977|Autism|autism
210405|NCT02069977|Aripiprazole|aripiprazole
210406|NCT02069977|Abilify|abilify
210407|NCT02069951|Laparoscopy|laparoscopy
210408|NCT02069951|Training|training
210409|NCT02069951|Simulator|simulator
210410|NCT02069938|Subjects|subjects
210411|NCT02069912|Major Depression|major depression
210412|NCT02069912|Heart Disease|heart disease
210413|NCT02069912|Hispanics|hispanics
210414|NCT02069912|Collaborative Depression Care Management|collaborative depression care management
210415|NCT02069899|Hemophagocytic lymphohistiocytosis (HLH) previously treated with NI-0501|hemophagocytic lymphohistiocytosis (hlh) previously treated with ni-0501
210416|NCT02069886|Endocrine complications|endocrine complications
210420|NCT02069873|Treatment|treatment
210421|NCT02069873|Cognitive, Exposure, Skills|cognitive, exposure, skills
210422|NCT02069873|Women|women
210423|NCT02069873|Veterans|veterans
210424|NCT02069860|bona anchored|bona anchored
210425|NCT02069860|haemodialysis|haemodialysis
210426|NCT02069860|Mastoid bone|mastoid bone
210429|NCT02069860|permanent central venous access devices.|permanent central venous access devices.
201225|NCT02111720|HIV|hiv
210430|NCT02069847|Esophageal stricture formation|esophageal stricture formation
210431|NCT02069847|Endoscopic mucosal resection|endoscopic mucosal resection
210432|NCT02069847|Endoscopic submucosal dissection|endoscopic submucosal dissection
210434|NCT02069847|Radical endoscopic mucosal resection|radical endoscopic mucosal resection
210435|NCT02069847|EMR|emr
210436|NCT02069847|ESD|esd
210437|NCT02069834|Dolutegravir|dolutegravir
210438|NCT02069834|Rilpivirine|rilpivirine
210439|NCT02069834|PI- and NRTI- sparing ART regimen|pi- and nrti- sparing art regimen
210440|NCT02069834|switch study|switch study
210441|NCT02069795|concussion, athlete, speech analysis|concussion, athlete, speech analysis
210445|NCT02069769|Hospice Care|hospice care
210446|NCT02069769|Head and Neck cancer|head and neck cancer
210447|NCT02069769|Gynecological Oncology|gynecological oncology
210448|NCT02069769|Sarcoma|sarcoma
210449|NCT02069769|Melanoma|melanoma
210450|NCT02069756|Duchenne|duchenne
210451|NCT02069756|Becker|becker
210452|NCT02069756|Muscular Dystrophy|muscular dystrophy
210453|NCT02069743|cancer pain|cancer pain
210454|NCT02069730|molecular profiling|molecular profiling
210455|NCT02069730|selinexor|selinexor
210456|NCT02069730|tumor tissue|tumor tissue
210457|NCT02069704|colorectal cancer|colorectal cancer
210458|NCT02069704|metastatic|metastatic
210459|NCT02069704|first-line treatment|first-line treatment
210460|NCT02069704|comparability|comparability
210461|NCT02069691|stroke,|stroke,
210462|NCT02069691|rehabilitation,|rehabilitation,
210463|NCT02069691|leg cycling,|leg cycling,
210464|NCT02069691|feedback,|feedback,
210465|NCT02069691|virtual reality|virtual reality
210466|NCT02069665|pneumonia|pneumonia
210467|NCT02069665|pediatrics|pediatrics
210468|NCT02069665|viral|viral
210469|NCT02069613|Mild traumatic injury to extremity (for controls)|mild traumatic injury to extremity (for controls)
210470|NCT02069613|mTBI|mtbi
210471|NCT02069613|concussion|concussion
210472|NCT02069613|MEG|meg
210473|NCT02069613|EEG|eeg
210474|NCT02069613|Blood|blood
210475|NCT02069613|MRI|mri
210476|NCT02069613|DTI|dti
210477|NCT02069613|biomarkers|biomarkers
210478|NCT02069600|Elderly|elderly
210479|NCT02069600|CPAP|cpap
210480|NCT02069600|clinical trial|clinical trial
210481|NCT02069600|obstructive sleep apnea|obstructive sleep apnea
210482|NCT02069587|PPROM|pprom
210483|NCT02069587|PREGNANCY|pregnancy
210484|NCT02069587|POMEGRANATE|pomegranate
210485|NCT02069587|OXIDATIVE STRESS|oxidative stress
210486|NCT02069535|Cupressus arizonica|cupressus arizonica
210487|NCT02069509|Friedreich's Ataxia|friedreich's ataxia
210488|NCT02069509|EFACTS|efacts
210489|NCT02069509|FRDA|frda
210490|NCT02069483|smoking|smoking
210491|NCT02069483|smoker|smoker
210492|NCT02069483|text|text
210493|NCT02069483|smartphone|smartphone
210494|NCT02069483|motivation|motivation
210495|NCT02069483|quitting|quitting
210496|NCT02069483|cessation|cessation
210497|NCT02069483|feedback|feedback
210498|NCT02069483|messages|messages
210499|NCT02069470|Stepped wedged design|stepped wedged design
210500|NCT02069470|Early cancer diagnosis|early cancer diagnosis
210501|NCT02069470|Continuing medical education|continuing medical education
210502|NCT02069431|inflammation|inflammation
210503|NCT02069431|physical function|physical function
210504|NCT02069431|cognitive function|cognitive function
210505|NCT02069392|schizophrenia|schizophrenia
210506|NCT02069392|cognition|cognition
210507|NCT02069392|cognitive remediation|cognitive remediation
210508|NCT02069392|nicotine|nicotine
210509|NCT02069379|Metabolic syndrome|metabolic syndrome
210510|NCT02069379|Insulin resistance|insulin resistance
210511|NCT02069379|Mu-opioid system|mu-opioid system
210512|NCT02069379|Depression|depression
210513|NCT02069379|Emotion regulation|emotion regulation
210514|NCT02069366|Post-Traumatic Stress Disorders|post-traumatic stress disorders
210515|NCT02069366|Dronabinol|dronabinol
210516|NCT02069366|Extinction|extinction
210517|NCT02069366|fMRI|fmri
210518|NCT02069353|Cardiac arrest|cardiac arrest
210519|NCT02069353|Neurological injury|neurological injury
210520|NCT02069353|Seizures|seizures
210521|NCT02069353|Spreading depolarizations|spreading depolarizations
210522|NCT02069353|Cerebral hypoperfusion|cerebral hypoperfusion
210523|NCT02069353|Brain tissue hypoxia|brain tissue hypoxia
210524|NCT02069327|Femur|femur
210525|NCT02069327|Fat|fat
210526|NCT02069327|Emboli|emboli
210527|NCT02069327|Bone|bone
210528|NCT02069327|Marrow|marrow
210529|NCT02069327|proteomic|proteomic
210530|NCT02069327|proteomics|proteomics
210531|NCT02069327|metabolomics|metabolomics
210532|NCT02069327|metabolomic|metabolomic
210829|NCT02068027|Pain|pain
210533|NCT02069327|inflammatory|inflammatory
210534|NCT02069327|cytokine|cytokine
210535|NCT02069327|chemokine|chemokine
210536|NCT02069327|anaphlylatoxin|anaphlylatoxin
210537|NCT02069327|Thromboelastography|thromboelastography
210538|NCT02069327|Medical Center of the Rockies|medical center of the rockies
210539|NCT02069327|Fat Embolism Syndrome|fat embolism syndrome
210540|NCT02069327|Injury|injury
210541|NCT02069327|Fracture|fracture
210542|NCT02069327|Metabolite|metabolite
210543|NCT02069327|MCR|mcr
210544|NCT02069327|TEG|teg
210545|NCT02069327|FES|fes
210546|NCT02069301|Behavior Activation|behavior activation
210547|NCT02069301|Problem solving therapy|problem solving therapy
210548|NCT02069301|Depression Treatment|depression treatment
210549|NCT02069301|depression care integration|depression care integration
210550|NCT02069301|microfinance|microfinance
210551|NCT02069301|livelihood|livelihood
210552|NCT02069288|fludrocortisone|fludrocortisone
210553|NCT02069288|pharmacology|pharmacology
210554|NCT02069288|septic shock|septic shock
210555|NCT02069275|Immediate mobilization|immediate mobilization
210556|NCT02069275|Bedrest|bedrest
210557|NCT02069275|Coronary angiography|coronary angiography
210558|NCT02069275|Coronary percutaneous intervention|coronary percutaneous intervention
210559|NCT02069275|Vascular access complications|vascular access complications
210560|NCT02069275|Patients comfort|patients comfort
210561|NCT02069262|obscure gastrointestinal bleeding|obscure gastrointestinal bleeding
210562|NCT02069262|laparoscopy|laparoscopy
210563|NCT02069262|angiography|angiography
210564|NCT02069249|Preschool children|preschool children
210565|NCT02069249|Sleep problems|sleep problems
210566|NCT02069249|Nutrition problems|nutrition problems
210567|NCT02069249|Online intervention|online intervention
210568|NCT02069249|Psychological functioning|psychological functioning
210569|NCT02069236|Glucose-6 phosphate dehydrogenase deficiency|glucose-6 phosphate dehydrogenase deficiency
210570|NCT02069236|capillary|capillary
210571|NCT02069236|venous|venous
210572|NCT02069236|genotype phenotype correlation|genotype phenotype correlation
210573|NCT02069223|Biliopancreatic Diversion with Duodenal Switch|biliopancreatic diversion with duodenal switch
210574|NCT02069223|Gastrectomy|gastrectomy
210575|NCT02069197|ketogenic diet|ketogenic diet
210576|NCT02069197|obesity|obesity
210577|NCT02069197|diabetes|diabetes
210578|NCT02069197|obstructive sleep apnea|obstructive sleep apnea
210579|NCT02069184|opioid usage requirements|opioid usage requirements
210580|NCT02069184|pain|pain
210581|NCT02069184|IV acetaminophen|iv acetaminophen
210582|NCT02069184|opioid usage|opioid usage
210583|NCT02069184|c-section|c-section
210584|NCT02069171|Lower extremity edema|lower extremity edema
210585|NCT02069171|Lower leg lymphedema|lower leg lymphedema
210586|NCT02069171|Lower leg edema|lower leg edema
210587|NCT02069171|Lymphedema|lymphedema
210588|NCT02069171|Pelvic lymph node dissection|pelvic lymph node dissection
210589|NCT02069171|Gynecologic Cancer Lymphedema Questionnaire|gynecologic cancer lymphedema questionnaire
210590|NCT02069158|Advanced solid tumor|advanced solid tumor
210591|NCT02069145|Hepatocellular Cancer|hepatocellular cancer
210592|NCT02069145|Liver Cancer|liver cancer
210593|NCT02069132|Warfarin|warfarin
210594|NCT02069132|International Warfarin Pharmacogenetics Consortium algorithm|international warfarin pharmacogenetics consortium algorithm
210595|NCT02069132|Atrial Fibrillation|atrial fibrillation
210596|NCT02069132|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
210597|NCT02069132|elderly|elderly
210598|NCT02069132|comorbidity|comorbidity
210599|NCT02069106|low density lipoprotein cholesterol|low density lipoprotein cholesterol
210600|NCT02069106|triglycerides|triglycerides
210601|NCT02069106|mixed hyperlipoproteinemia|mixed hyperlipoproteinemia
210602|NCT02069106|Dehydroascorbic Acid|dehydroascorbic acid
210603|NCT02069106|Eicosapentaenoic Acid|eicosapentaenoic acid
210604|NCT02069106|Fish oil|fish oil
210605|NCT02069080|Positron Emission Tomograhy|positron emission tomograhy
210606|NCT02069080|Metastasis|metastasis
210607|NCT02069067|breakthrough cancer pain|breakthrough cancer pain
210608|NCT02069067|pain|pain
210609|NCT02069067|neuropathic pain|neuropathic pain
210610|NCT02069067|intractable pain|intractable pain
210611|NCT02069067|cancer|cancer
210612|NCT02069054|asthma|asthma
210613|NCT02069054|COPD|copd
210614|NCT02069054|airway inflammation|airway inflammation
210615|NCT02069054|remodeling|remodeling
210616|NCT02069054|cytokines|cytokines
210617|NCT02069054|airway wall thickness|airway wall thickness
210618|NCT02069028|surviving sepsis campaign|surviving sepsis campaign
210619|NCT02069028|sepsis|sepsis
210620|NCT02069028|septic|septic
210621|NCT02069028|septicemia|septicemia
210622|NCT02069028|mortality|mortality
210623|NCT02069028|compliance|compliance
210624|NCT02069015|Patient education|patient education
210625|NCT02069015|Hypertension|hypertension
210626|NCT02069015|Patient activation|patient activation
210627|NCT02069002|Indoor Air|indoor air
210628|NCT02069002|Medically unexplained symptoms|medically unexplained symptoms
210629|NCT02069002|Randomized controlled trial|randomized controlled trial
210630|NCT02069002|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
210631|NCT02069002|Applied relaxation|applied relaxation
210632|NCT02068950|Head and neck cancer|head and neck cancer
210633|NCT02068950|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
210634|NCT02068950|Progressive resistance training|progressive resistance training
210635|NCT02068950|Exercise|exercise
210636|NCT02068950|Feasibility|feasibility
210637|NCT02068950|Weight loss|weight loss
210638|NCT02068950|LBM|lbm
210639|NCT02068950|Body composition|body composition
210640|NCT02068937|Heart Failure|heart failure
210641|NCT02068937|Therapy|therapy
210642|NCT02068937|Diuretics|diuretics
210643|NCT02068937|Algorithms|algorithms
210644|NCT02068924|Slow freezing|slow freezing
210645|NCT02068924|Vitrification|vitrification
210646|NCT02068924|Single embryo transfer|single embryo transfer
210647|NCT02068911|Neuromuscular disease|neuromuscular disease
210648|NCT02068911|Home ventilation|home ventilation
210649|NCT02068911|End tidal CO2|end tidal co2
210650|NCT02068911|Transcutaneous CO2|transcutaneous co2
210651|NCT02068911|Monitoring|monitoring
210652|NCT02068885|Low carbohydrate diet|low carbohydrate diet
210653|NCT02068885|Low fat diet|low fat diet
210654|NCT02068885|Glycemic index|glycemic index
210655|NCT02068885|Weight loss maintenance|weight loss maintenance
210656|NCT02068872|Obesity|obesity
210657|NCT02068872|Transplant|transplant
210658|NCT02068872|Sleeve Gastrectomy|sleeve gastrectomy
210659|NCT02068872|Liver Transplantation|liver transplantation
210660|NCT02068872|Weight Loss|weight loss
210661|NCT02068846|HIV|hiv
210662|NCT02068846|Salivary Gland Disease|salivary gland disease
210663|NCT02068846|Benign Lymphoepithelial Lesion|benign lymphoepithelial lesion
210664|NCT02068846|BK Polyomavirus|bk polyomavirus
210665|NCT02068833|Microalbuminuria|microalbuminuria
210666|NCT02068833|Gastrectomy|gastrectomy
210667|NCT02068833|Biliopancreatic Diversion With Duodenal Switch|biliopancreatic diversion with duodenal switch
210668|NCT02068820|Sentinel lymph nodes|sentinel lymph nodes
210669|NCT02068820|da Vinci|da vinci
210670|NCT02068820|Firefly|firefly
210671|NCT02068820|Sentinel lymph node mapping|sentinel lymph node mapping
210672|NCT02068820|Fluorescence Imaging|fluorescence imaging
210673|NCT02068820|SLN|sln
210674|NCT02068820|SLN mapping|sln mapping
210675|NCT02068768|fusion|fusion
210676|NCT02068768|lateral interbody fusion system|lateral interbody fusion system
210677|NCT02068768|lumbar spine|lumbar spine
210678|NCT02068768|degenerative disc disease|degenerative disc disease
210679|NCT02068755|anemia|anemia
210680|NCT02068755|renal impairment|renal impairment
210681|NCT02068755|thrombocytopenia|thrombocytopenia
210682|NCT02068755|anticoagulation|anticoagulation
210683|NCT02068755|Coronary bypass|coronary bypass
210684|NCT02068755|Aortic valve surgery|aortic valve surgery
210685|NCT02068755|Mitral valve surgery|mitral valve surgery
210686|NCT02068755|red blood cell|red blood cell
210687|NCT02068755|platelet|platelet
678352|NCT00882570|Antibiotic|antibiotic
210688|NCT02068755|fresh frozen plasma|fresh frozen plasma
210689|NCT02068755|octaplas|octaplas
210690|NCT02068742|post-operative cognitive dysfunction|post-operative cognitive dysfunction
210691|NCT02068742|elderly|elderly
210692|NCT02068742|Mini Mental State Examination|mini mental state examination
210693|NCT02068742|Geriatric Index of Comorbidity|geriatric index of comorbidity
210694|NCT02068742|Geriatric Depression Scale|geriatric depression scale
210695|NCT02068742|Trail Making Test B-A|trail making test b-a
210696|NCT02068742|Digit Span|digit span
210697|NCT02068742|Digit Symbol Substitution Test|digit symbol substitution test
210698|NCT02068729|degenerative disc disease|degenerative disc disease
210699|NCT02068729|DDD|ddd
210700|NCT02068729|Grade 1 spondylolisthesis|grade 1 spondylolisthesis
210701|NCT02068729|spondylolisthesis|spondylolisthesis
210702|NCT02068729|L2-S1|l2-s1
210703|NCT02068716|Healthcare acquired infections|healthcare acquired infections
210704|NCT02068716|Cardiovascular Surgery|cardiovascular surgery
210705|NCT02068716|Mediastinitis|mediastinitis
210706|NCT02068716|Thoracotomy|thoracotomy
210707|NCT02068716|Conduit harvest or cannulation site|conduit harvest or cannulation site
210708|NCT02068703|survey|survey
210709|NCT02068664|spatial neglect|spatial neglect
210710|NCT02068664|aphasia|aphasia
210711|NCT02068651|End-of-life care|end-of-life care
210712|NCT02068651|Treatment decision making|treatment decision making
210713|NCT02068651|Advance care planning|advance care planning
210714|NCT02068638|exercise|exercise
210715|NCT02068638|isotope labeling, stable|isotope labeling, stable
210716|NCT02068638|spectroscopy, magnetic resonance|spectroscopy, magnetic resonance
210717|NCT02068638|monitoring, home blood glucose|monitoring, home blood glucose
210718|NCT02068638|hormones|hormones
210719|NCT02068625|retinal detachment|retinal detachment
210720|NCT02068625|rasagiline|rasagiline
210721|NCT02068625|optical coherence tomography|optical coherence tomography
210722|NCT02068625|visual acuity|visual acuity
210723|NCT02068625|neuroprotection|neuroprotection
210724|NCT02068625|azilect|azilect
210725|NCT02068612|Executive function,|executive function,
210726|NCT02068612|cardiovascular fitness,|cardiovascular fitness,
210727|NCT02068612|cognitive function|cognitive function
210728|NCT02068599|Osteoarthritis|osteoarthritis
210729|NCT02068599|OA|oa
210730|NCT02068599|Arthritis pain|arthritis pain
210731|NCT02068573|Childhood Asthma|childhood asthma
210732|NCT02068573|Allergy|allergy
210733|NCT02068573|House dust mites|house dust mites
210734|NCT02068573|Indoor air quality|indoor air quality
210735|NCT02068547|posterior cervical fusion|posterior cervical fusion
210736|NCT02068547|posterior cervical decompression|posterior cervical decompression
210737|NCT02068534|in-depth individual interview|in-depth individual interview
210738|NCT02068534|charcoal-burning suicide|charcoal-burning suicide
210739|NCT02068521|Growth Hormone Deficiency|growth hormone deficiency
210740|NCT02068521|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
210741|NCT02068521|GHD|ghd
210742|NCT02068521|PGHD|pghd
210743|NCT02068521|VRS-317|vrs-317
210744|NCT02068521|Versartis|versartis
210745|NCT02068521|Growth disorder|growth disorder
210746|NCT02068521|Long acting growth hormone|long acting growth hormone
210747|NCT02068521|Growth hormone|growth hormone
210748|NCT02068521|Weekly growth hormone dosing|weekly growth hormone dosing
210749|NCT02068521|Semi-monthly growth hormone dosing|semi-monthly growth hormone dosing
210750|NCT02068521|Monthly growth hormone dosing|monthly growth hormone dosing
210751|NCT02068521|IGF-I|igf-i
210752|NCT02068521|Short stature|short stature
210753|NCT02068521|Height velocity|height velocity
210754|NCT02068521|Annual height velocity|annual height velocity
210755|NCT02068521|Growth rate|growth rate
210756|NCT02068521|Somavaratan|somavaratan
210757|NCT02068508|Drug therapy|drug therapy
210758|NCT02068495|Drug therapy|drug therapy
210759|NCT02068482|Uncomplicated|uncomplicated
210760|NCT02068482|Symptomatic|symptomatic
210761|NCT02068456|Drug therapy|drug therapy
210762|NCT02068443|Drug therapy|drug therapy
210763|NCT02068430|Corneal Ulcers|corneal ulcers
210764|NCT02068430|cross-linking|cross-linking
210765|NCT02068430|UVA|uva
210766|NCT02068430|Riboflavin|riboflavin
210767|NCT02068417|IIEF score|iief score
210768|NCT02068417|ED|ed
210769|NCT02068404|Tocolysis|tocolysis
210770|NCT02068404|Preterm labor|preterm labor
210771|NCT02068404|Nifedipine|nifedipine
210772|NCT02068404|Pharmacokinetics|pharmacokinetics
210773|NCT02068391|covert stroke|covert stroke
210774|NCT02068391|cerebral blood flow|cerebral blood flow
210775|NCT02068391|grey matter|grey matter
210776|NCT02068391|attention|attention
210777|NCT02068391|executive function|executive function
210778|NCT02068391|aerobic exercise|aerobic exercise
210779|NCT02068352|Atopic Dermatitis, Eczema|atopic dermatitis, eczema
210780|NCT02068326|Mentalization-based Treatment|mentalization-based treatment
210781|NCT02068326|Adolescence|adolescence
210782|NCT02068326|Borderline Personality Disorder|borderline personality disorder
586128|NCT00523575|hip fracture|hip fracture
210783|NCT02068300|1,5-anhydro-D-glucitol, hypoglycemia, surrogate marker|1,5-anhydro-d-glucitol, hypoglycemia, surrogate marker
210784|NCT02068287|Septic Shock|septic shock
210785|NCT02068287|Hemodynamic|hemodynamic
210786|NCT02068287|Inflammatory status|inflammatory status
210787|NCT02068287|Beta adrenergic modulation|beta adrenergic modulation
210788|NCT02068287|Esmolol|esmolol
210789|NCT02068235|Ponesimod|ponesimod
210790|NCT02068235|Bioavailability|bioavailability
210791|NCT02068235|Pharmacokinetics|pharmacokinetics
210792|NCT02068235|Safety|safety
210793|NCT02068222|Hepatitis C|hepatitis c
210794|NCT02068222|HCV|hcv
210795|NCT02068222|Interferon Free|interferon free
210796|NCT02068222|Chronic Hepatitis C|chronic hepatitis c
210797|NCT02068222|Hepatitis C virus|hepatitis c virus
210798|NCT02068222|Hepatitis C Genotype 3|hepatitis c genotype 3
210799|NCT02068209|Outpatient hysteroscopy|outpatient hysteroscopy
210800|NCT02068209|Tramadol|tramadol
210801|NCT02068196|Cancer|cancer
210802|NCT02068196|Malignant Melanoma|malignant melanoma
210803|NCT02068196|Ipilimumab|ipilimumab
210804|NCT02068183|World Trade Center exposure|world trade center exposure
210805|NCT02068183|cardiovascular risk|cardiovascular risk
210806|NCT02068183|insulin resistance|insulin resistance
210807|NCT02068183|post-traumatic stress|post-traumatic stress
210808|NCT02068183|pulmonary disease|pulmonary disease
210809|NCT02068170|QT-prolongation|qt-prolongation
210810|NCT02068170|Torsade de Pointes|torsade de pointes
210811|NCT02068170|QT-prolonging drugs|qt-prolonging drugs
210812|NCT02068144|Cranberry Extract|cranberry extract
210813|NCT02068131|Metastatic Colorectal Cancer|metastatic colorectal cancer
210814|NCT02068131|Novaferon|novaferon
210815|NCT02068131|Recombinant anti-tumor and anti-virus protein for injection|recombinant anti-tumor and anti-virus protein for injection
210816|NCT02068131|xeloda|xeloda
210817|NCT02068118|E health|e health
210818|NCT02068118|Telecardiology program|telecardiology program
210819|NCT02068118|Heart failure|heart failure
210821|NCT02068105|samidorphan|samidorphan
211229|NCT02066077|Cognition|cognition
210822|NCT02068066|Physical work requirements|physical work requirements
210823|NCT02068066|Energy expenditure|energy expenditure
210824|NCT02068066|Physical activity|physical activity
210825|NCT02068066|Different occupational categories|different occupational categories
210826|NCT02068066|Aerobic capacity|aerobic capacity
210827|NCT02068040|with preserved ejection fraction of >55%|with preserved ejection fraction of >55%
210828|NCT02068027|Diabetes Mellitus|diabetes mellitus
210830|NCT02068027|Foot pain|foot pain
210831|NCT02068027|Neuropathy|neuropathy
210832|NCT02068014|stapplers- obesity- stomach|stapplers- obesity- stomach
210833|NCT02067988|Radioembolization|radioembolization
210834|NCT02067988|Somatostatin receptor treatment|somatostatin receptor treatment
210835|NCT02067988|Neuroendocrine tumors|neuroendocrine tumors
210836|NCT02067988|Liver metastases|liver metastases
210837|NCT02067975|tryptophan|tryptophan
210838|NCT02067975|kynurenic acid|kynurenic acid
210839|NCT02067975|schizophrenia|schizophrenia
210840|NCT02067962|Juvenile idiopathic arhtritis|juvenile idiopathic arhtritis
210842|NCT02067962|Gene identification|gene identification
210843|NCT02067962|Whole exome sequencing|whole exome sequencing
210844|NCT02067962|Next generation sequencing|next generation sequencing
210845|NCT02067962|Identification of molecular basis|identification of molecular basis
210846|NCT02067962|Acceptation of both parents to participate to the study|acceptation of both parents to participate to the study
210847|NCT02067923|T1D|t1d
210848|NCT02067923|type 1 diabetes|type 1 diabetes
210849|NCT02067923|type 1 diabetes mellitus|type 1 diabetes mellitus
210850|NCT02067923|juvenile diabetes|juvenile diabetes
210851|NCT02067923|autoimmune diabetes|autoimmune diabetes
210852|NCT02067923|autoimmune|autoimmune
210853|NCT02067923|anti-CD3 mAb|anti-cd3 mab
210854|NCT02067923|mAb hOKT3g1(Ala-Ala)|mab hokt3g1(ala-ala)
210855|NCT02067923|teplizumab|teplizumab
210856|NCT02067910|Abatacept|abatacept
210857|NCT02067910|Subcutaneous|subcutaneous
210858|NCT02067910|Sjögren's syndrome|sjögren's syndrome
210859|NCT02067910|Treatment|treatment
210860|NCT02067910|Safety|safety
210861|NCT02067910|Efficacy|efficacy
210862|NCT02067897|Nails, Ingrown|nails, ingrown
210863|NCT02067897|Children|children
210864|NCT02067897|Ambulatory Surgical Procedures|ambulatory surgical procedures
210865|NCT02067871|neuromuscular electrical stimulation|neuromuscular electrical stimulation
210866|NCT02067871|low-level laser therapy|low-level laser therapy
210867|NCT02067871|knee osteoarthritis|knee osteoarthritis
210868|NCT02067871|muscle architecture|muscle architecture
210869|NCT02067871|functionality|functionality
210870|NCT02067871|neuromuscular parameters|neuromuscular parameters
210871|NCT02067845|Lesbian, queer, bisexual women|lesbian, queer, bisexual women
210872|NCT02067845|HIV and STI prevention|hiv and sti prevention
210873|NCT02067845|Resilient coping|resilient coping
210874|NCT02067845|Sexual stigma|sexual stigma
210875|NCT02067845|Depression|depression
210876|NCT02067845|Safer-sex practices|safer-sex practices
210877|NCT02067845|Safer sex self-efficacy|safer sex self-efficacy
210878|NCT02067845|HIV/STI knowledge and testing|hiv/sti knowledge and testing
210879|NCT02067845|Pilot-testing|pilot-testing
210880|NCT02067819|Tourette's|tourette's
210881|NCT02067819|Tic Disorder|tic disorder
210882|NCT02067819|Dental Appliance|dental appliance
210883|NCT02067819|Oral Orthotic|oral orthotic
210884|NCT02067819|Mouthguard|mouthguard
210885|NCT02067806|PASS|pass
210886|NCT02067806|TNS|tns
210887|NCT02067806|CES|ces
210888|NCT02067806|CHLOROPROCAINE|chloroprocaine
210889|NCT02067793|NRX-1074|nrx-1074
210890|NCT02067793|NMDA Receptor Modulator|nmda receptor modulator
210891|NCT02067793|Major Depressive Disorder|major depressive disorder
210892|NCT02067793|Glycine site modulator|glycine site modulator
210893|NCT02067767|HIV-1 infection|hiv-1 infection
210894|NCT02067767|Nevirapine|nevirapine
210895|NCT02067767|Dolutegravir|dolutegravir
210896|NCT02067767|Anti-retroviral agents|anti-retroviral agents
210897|NCT02067754|The mutation profiling of circulating free DNA|the mutation profiling of circulating free dna
210898|NCT02067741|Post-menopausal women|post-menopausal women
210899|NCT02067741|topical application CR1447|topical application cr1447
210900|NCT02067741|endocrine responsive-HER2neg breast cancer|endocrine responsive-her2neg breast cancer
210901|NCT02067741|triple negative-androgen receptor positive breast cancer|triple negative-androgen receptor positive breast cancer
210902|NCT02067728|obesity prevention|obesity prevention
210903|NCT02067715|Tooth Discoloration|tooth discoloration
210904|NCT02067715|Bleaching Agents|bleaching agents
210905|NCT02067715|Tooth Bleaching|tooth bleaching
210906|NCT02067689|Normal cognition in healthy adults|normal cognition in healthy adults
210907|NCT02067689|Cognitive function|cognitive function
210908|NCT02067689|Transcranial direct current stimulation|transcranial direct current stimulation
210909|NCT02067689|Structural Magnetic Resonance Imaging|structural magnetic resonance imaging
210910|NCT02067689|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
210911|NCT02067676|Campylobacter jejuni|campylobacter jejuni
210912|NCT02067663|Postplacental IUD placement|postplacental iud placement
210913|NCT02067663|LNG-IUS|lng-ius
211038|NCT02066922|Contact lenses|contact lenses
210914|NCT02067637|cancer therapy, cancer treatment|cancer therapy, cancer treatment
210915|NCT02067611|Phase 2, Efficacy, Safety, Osteoarthritis|phase 2, efficacy, safety, osteoarthritis
210916|NCT02067598|Scapular exercises|scapular exercises
210917|NCT02067572|oral health|oral health
210918|NCT02067572|mouthwash|mouthwash
210919|NCT02067572|salvia|salvia
210920|NCT02067572|hospice|hospice
210921|NCT02067572|xerostomia|xerostomia
210922|NCT02067572|mouth sores|mouth sores
210923|NCT02067559|Post Traumatic Stress Disorder|post traumatic stress disorder
210924|NCT02067559|PTSD|ptsd
210925|NCT02067559|Intensive Care Unit|intensive care unit
210926|NCT02067559|ICU|icu
210927|NCT02067546|constipation|constipation
210928|NCT02067520|Post C/S pain relief|post c/s pain relief
210929|NCT02067507|Human Papillomavirus|human papillomavirus
210930|NCT02067507|Immunization|immunization
210931|NCT02067507|Oncogenic viruses|oncogenic viruses
210932|NCT02067507|Cervical Cancer|cervical cancer
210933|NCT02067507|Health Disparities|health disparities
210934|NCT02067494|Low Back Pain|low back pain
210935|NCT02067494|Chronic Pain|chronic pain
210936|NCT02067494|Manual Therapy|manual therapy
210937|NCT02067494|Randomized Clinical Trial|randomized clinical trial
210938|NCT02067494|Bandages|bandages
210939|NCT02067481|Breast cancer|breast cancer
210940|NCT02067481|Survivors|survivors
210941|NCT02067481|Weight loss|weight loss
210942|NCT02067481|Diet|diet
210943|NCT02067481|Physical activity|physical activity
210944|NCT02067468|Human Papillomavirus|human papillomavirus
210945|NCT02067468|cervical cancer|cervical cancer
210946|NCT02067468|health services research|health services research
210947|NCT02067468|Colombia|colombia
210948|NCT02067468|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
210949|NCT02067455|Right ventricular function|right ventricular function
210950|NCT02067455|echocardiography|echocardiography
210951|NCT02067455|left ventricular assist device|left ventricular assist device
210952|NCT02067455|exercise|exercise
210953|NCT02067442|acetaminophen intravenous oral pain scores opioids|acetaminophen intravenous oral pain scores opioids
210954|NCT02067416|neoadjuvant|neoadjuvant
210955|NCT02067416|mammostrat|mammostrat
210956|NCT02067416|TLE3|tle3
210957|NCT02067416|DDR|ddr
210958|NCT02067416|breast cancer|breast cancer
210959|NCT02067403|Pressure-support|pressure-support
210960|NCT02067403|Asynchrony|asynchrony
210961|NCT02067377|GOLD, COPD, cachexia, BMI|gold, copd, cachexia, bmi
210962|NCT02067364|hydrocephalus|hydrocephalus
210963|NCT02067364|CSF shunt|csf shunt
210964|NCT02067299|Depressive Disorder, Major|depressive disorder, major
210965|NCT02067299|Major Depressive Disorder|major depressive disorder
210966|NCT02067299|Insomnia|insomnia
210967|NCT02067299|JNJ-42847922|jnj-42847922
210968|NCT02067299|Placebo|placebo
210969|NCT02067221|percutaneous nephrolithotomy|percutaneous nephrolithotomy
210970|NCT02067221|renal calculi|renal calculi
210971|NCT02067221|ureteroscopy|ureteroscopy
210980|NCT02067195|acute myocardial infarction,contrast,coronary intervention|acute myocardial infarction,contrast,coronary intervention
210982|NCT02067169|CMV infection|cmv infection
210983|NCT02067169|antiviral resistance|antiviral resistance
210984|NCT02067156|glioblastoma|glioblastoma
210991|NCT02067130|Beta Thalassemia Major|beta thalassemia major
210992|NCT02067117|influenza|influenza
210993|NCT02067091|STEMI|stemi
210994|NCT02067091|Coronary|coronary
210995|NCT02067091|Bioresorbable scaffold|bioresorbable scaffold
210996|NCT02067091|Drug eluting stent|drug eluting stent
210997|NCT02067091|Optical coherence tomography|optical coherence tomography
210998|NCT02067091|Multislice computed tomography|multislice computed tomography
210999|NCT02067078|nerve block|nerve block
211000|NCT02067078|total knee arthroplasty|total knee arthroplasty
211001|NCT02067078|saphenous nerve block|saphenous nerve block
211002|NCT02067078|obturator nerve block|obturator nerve block
211003|NCT02067078|pain|pain
211004|NCT02067078|opioid consumption|opioid consumption
211005|NCT02067065|Colonoscopy|colonoscopy
211006|NCT02067065|Sedation|sedation
211007|NCT02067065|Propofol|propofol
211008|NCT02067065|Non-anesthesiologist propofol administration|non-anesthesiologist propofol administration
211009|NCT02067052|Vulvar neoplasm|vulvar neoplasm
211010|NCT02067052|sentinel nodes|sentinel nodes
211011|NCT02067052|chemotherapy|chemotherapy
211012|NCT02067052|radiotherapy|radiotherapy
211013|NCT02067039|HIV testing|hiv testing
211014|NCT02067039|Rapid HIV test|rapid hiv test
211015|NCT02067039|HIV self-testing|hiv self-testing
211016|NCT02067039|Men who have sex with men (MSM)|men who have sex with men (msm)
211017|NCT02067039|HIV diagnosis|hiv diagnosis
211018|NCT02067039|Sexual behavior|sexual behavior
211019|NCT02067026|overweight|overweight
211121|NCT02066571|Freezing of gait|freezing of gait
211020|NCT02067013|Tractional retinal detachment|tractional retinal detachment
211021|NCT02067013|Exudative retinal detachment|exudative retinal detachment
211022|NCT02067013|Macular hole|macular hole
211023|NCT02067013|Neovascular glaucoma|neovascular glaucoma
211024|NCT02066987|Action planning, Implementation intention|action planning, implementation intention
211025|NCT02066974|hepatocellular carcinoma|hepatocellular carcinoma
211026|NCT02066974|genomic expression|genomic expression
211027|NCT02066974|radiotherapy|radiotherapy
211028|NCT02066961|metastatic prostate cancer|metastatic prostate cancer
211029|NCT02066961|castration-resistant prostate cancer|castration-resistant prostate cancer
211030|NCT02066961|prostate cancer|prostate cancer
211032|NCT02066948|MRI|mri
211033|NCT02066948|Fitness assessment|fitness assessment
211034|NCT02066948|Meal tolerance test|meal tolerance test
211035|NCT02066935|immunosuppression|immunosuppression
211036|NCT02066935|medication nonadherence|medication nonadherence
211037|NCT02066935|kidney transplantation|kidney transplantation
211039|NCT02066922|Nearsightedness|nearsightedness
211040|NCT02066922|Corneal curvature|corneal curvature
211041|NCT02066922|K-reading|k-reading
211042|NCT02066922|High minus|high minus
211043|NCT02066922|Spectacle refraction|spectacle refraction
211044|NCT02066909|pharmacokinetics|pharmacokinetics
211045|NCT02066909|safety|safety
211046|NCT02066909|tolerability|tolerability
211047|NCT02066909|healthy volunteers|healthy volunteers
211048|NCT02066909|steady state|steady state
211049|NCT02066909|multiple doses|multiple doses
211050|NCT02066909|Japanese subjects|japanese subjects
211051|NCT02066896|Sjogrens Syndrome|sjogrens syndrome
211052|NCT02066896|Syndrome, Sjogren's|syndrome, sjogren's
211053|NCT02066896|Sjogren Syndrome|sjogren syndrome
211054|NCT02066896|Sicca Syndrome|sicca syndrome
211055|NCT02066896|Syndrome, Sicca|syndrome, sicca
211056|NCT02066870|Icotinib|icotinib
211057|NCT02066870|Arsenic Trioxide|arsenic trioxide
211058|NCT02066870|Resistance|resistance
211059|NCT02066870|Non-small cell lung cancer|non-small cell lung cancer
211060|NCT02066857|Wrist fracture|wrist fracture
211061|NCT02066857|Radius fracture|radius fracture
211062|NCT02066857|Elderly|elderly
211063|NCT02066857|Splint|splint
211064|NCT02066857|Cast|cast
211065|NCT02066844|Hip Pain|hip pain
211066|NCT02066844|Hip Injection|hip injection
211067|NCT02066844|Hip Fracture|hip fracture
211068|NCT02066844|Hip Bursitis|hip bursitis
211069|NCT02066844|Hip Arthritis|hip arthritis
211070|NCT02066844|Hip Sciatica|hip sciatica
211071|NCT02066818|local anesthetic|local anesthetic
211072|NCT02066818|incision and drainage|incision and drainage
211073|NCT02066818|pain|pain
211074|NCT02066818|cutaneous abscess|cutaneous abscess
211075|NCT02066792|Social Phobia|social phobia
211076|NCT02066753|Cardiac arrest|cardiac arrest
211077|NCT02066753|Therapeutic Hypothermia|therapeutic hypothermia
211078|NCT02066753|Cardioprotectiveness|cardioprotectiveness
211079|NCT02066753|Hemodynamics|hemodynamics
211080|NCT02066740|Superficial Femoral Artery|superficial femoral artery
211081|NCT02066740|Proximal Popliteal Artery|proximal popliteal artery
211082|NCT02066740|Everflex|everflex
211083|NCT02066740|Entrust|entrust
211084|NCT02066740|stent|stent
211085|NCT02066727|Dexmedetomidine|dexmedetomidine
211086|NCT02066727|obturator nerve block|obturator nerve block
211087|NCT02066727|lidocaine|lidocaine
211088|NCT02066727|EC50|ec50
211089|NCT02066714|Enterovirus Infections|enterovirus infections
211090|NCT02066714|Hand, Foot and Mouth Disease|hand, foot and mouth disease
211091|NCT02066714|Coxsackievirus Infections|coxsackievirus infections
211092|NCT02066714|Herpangina|herpangina
211093|NCT02066714|Cognition|cognition
211094|NCT02066714|Neurocognitive|neurocognitive
211095|NCT02066714|Sequelae|sequelae
211096|NCT02066714|Outcomes|outcomes
211097|NCT02066701|Barrett's esophagus|barrett's esophagus
211098|NCT02066675|Metastatic|metastatic
211099|NCT02066675|Locally advanced|locally advanced
211100|NCT02066675|Soft tissue tumors|soft tissue tumors
211101|NCT02066662|Coronary or Valvular Calcification|coronary or valvular calcification
211102|NCT02066662|Agatston Score|agatston score
211103|NCT02066662|Rivaroxaban|rivaroxaban
211104|NCT02066662|Coumarin|coumarin
211105|NCT02066662|Oral Anticoagulation Therapy (OAT)|oral anticoagulation therapy (oat)
211106|NCT02066662|Atrial Fibrillation|atrial fibrillation
211107|NCT02066662|Pulmonary Embolism|pulmonary embolism
211108|NCT02066649|portal hypertension|portal hypertension
211109|NCT02066649|esophageal varices|esophageal varices
211110|NCT02066649|variceal bleed|variceal bleed
211111|NCT02066649|carvedilol|carvedilol
211112|NCT02066649|variceal band ligation|variceal band ligation
211113|NCT02066623|coronary artery stenosis, vascular scaffold, ABSORB|coronary artery stenosis, vascular scaffold, absorb
211114|NCT02066597|Deep vein thrombosis|deep vein thrombosis
211115|NCT02066597|thrombectomy|thrombectomy
211116|NCT02066597|percutaneuos|percutaneuos
211117|NCT02066584|sibling oocytes|sibling oocytes
211118|NCT02066584|glucose|glucose
211119|NCT02066584|culture media|culture media
211120|NCT02066571|Parkinson's disease|parkinson's disease
211122|NCT02066571|Gait|gait
211123|NCT02066558|Carbon monoxide|carbon monoxide
211124|NCT02066558|Headache|headache
211125|NCT02066558|Migraine|migraine
211126|NCT02066532|Breast Neoplasms|breast neoplasms
211127|NCT02066532|Breast Cancer|breast cancer
211128|NCT02066532|Breast Carcinoma|breast carcinoma
211129|NCT02066532|Breast tumors|breast tumors
211130|NCT02066532|Cancer of the Breast|cancer of the breast
211230|NCT02066077|Memory|memory
211131|NCT02066532|Malignant tumor of the breast|malignant tumor of the breast
211133|NCT02066532|erythroblastosis virus oncogene B-2 (erbB-2)|erythroblastosis virus oncogene b-2 (erbb-2)
211134|NCT02066532|Metastatic Breast Cancer|metastatic breast cancer
211135|NCT02066532|Secondary Breast Cancer|secondary breast cancer
211136|NCT02066519|Myasthenia gravis|myasthenia gravis
211137|NCT02066519|physical exercise|physical exercise
211138|NCT02066519|quality of life|quality of life
211139|NCT02066519|muscular performance|muscular performance
211140|NCT02066519|fatigability|fatigability
211141|NCT02066506|systemic right ventricle|systemic right ventricle
211142|NCT02066506|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
211143|NCT02066506|congenital heart disease|congenital heart disease
211144|NCT02066493|giant intracranial aneurysm, cerebrovascular bypass, flow diverter|giant intracranial aneurysm, cerebrovascular bypass, flow diverter
211145|NCT02066467|Phrenic Nerve Stimulation|phrenic nerve stimulation
211146|NCT02066467|Heartfailure treatment|heartfailure treatment
211147|NCT02066467|CRT-D therapy|crt-d therapy
211148|NCT02066467|Quadripolar lead|quadripolar lead
211149|NCT02066467|Lead related complication free rate|lead related complication free rate
211150|NCT02066454|myeloma|myeloma
211151|NCT02066454|antiXa anticoagulant|antixa anticoagulant
211152|NCT02066454|venous thromboembolic disease|venous thromboembolic disease
211153|NCT02066454|iMiDs|imids
211154|NCT02066441|Vitamin D|vitamin d
211155|NCT02066441|bone formation|bone formation
211156|NCT02066441|resorption|resorption
211157|NCT02066441|mineral density|mineral density
211158|NCT02066441|inflammation|inflammation
211159|NCT02066441|flexibility|flexibility
211160|NCT02066441|balance|balance
211161|NCT02066441|elderly|elderly
211162|NCT02066428|BCG Vaccinated|bcg vaccinated
211163|NCT02066428|HIV Negative|hiv negative
211164|NCT02066415|Chronic Migraine|chronic migraine
211165|NCT02066389|anti-inflammatory agents|anti-inflammatory agents
211166|NCT02066389|Joint Diseases|joint diseases
211167|NCT02066389|Arthritis|arthritis
211168|NCT02066389|Musculoskeletal Disease|musculoskeletal disease
211169|NCT02066389|antirheumatic agents|antirheumatic agents
211170|NCT02066363|Bioelectrical impedance|bioelectrical impedance
211171|NCT02066363|Parenteral nutrition|parenteral nutrition
211172|NCT02066363|Malnutrition|malnutrition
211173|NCT02066363|Quality of life.|quality of life.
211174|NCT02066363|Cancer cachexia|cancer cachexia
211175|NCT02066363|Body composition|body composition
211176|NCT02066350|Diabetes type 1|diabetes type 1
211177|NCT02066350|Endothelial dysfunction|endothelial dysfunction
211178|NCT02066350|Pancreas transplantation|pancreas transplantation
211179|NCT02066337|Ozone gel|ozone gel
211180|NCT02066337|Antioxidants|antioxidants
211181|NCT02066337|Chronic periodontitis|chronic periodontitis
211182|NCT02066337|Superoxide dismutase|superoxide dismutase
211183|NCT02066311|lupus|lupus
211185|NCT02066298|Asthma|asthma
211186|NCT02066298|Mometasone|mometasone
211187|NCT02066298|Tiotropium|tiotropium
211188|NCT02066285|Solitary fibrous tumor|solitary fibrous tumor
211189|NCT02066285|Extraskeletal myxoid chondrosarcoma|extraskeletal myxoid chondrosarcoma
211190|NCT02066285|Unresectable|unresectable
211191|NCT02066285|Locally advanced|locally advanced
211192|NCT02066285|Metastatic disease|metastatic disease
211193|NCT02066272|IBD|ibd
211194|NCT02066272|anti-TNF|anti-tnf
211195|NCT02066272|biosimilars|biosimilars
211196|NCT02066272|safety|safety
211197|NCT02066259|colon cancer|colon cancer
211198|NCT02066259|cancer associated auto antibodies|cancer associated auto antibodies
211199|NCT02066259|colon cancer blood test|colon cancer blood test
211200|NCT02066246|laparoscopic robot-assisted surgery|laparoscopic robot-assisted surgery
211201|NCT02066246|in steep trendelenburg position|in steep trendelenburg position
211202|NCT02066233|Barrett's|barrett's
211203|NCT02066233|esophagus|esophagus
211204|NCT02066233|reflux|reflux
211205|NCT02066233|heartburn|heartburn
211206|NCT02066233|screening|screening
211207|NCT02066220|pediatric brain tumor|pediatric brain tumor
211208|NCT02066220|medulloblastoma|medulloblastoma
211209|NCT02066220|event-free survival (EFS)|event-free survival (efs)
211210|NCT02066220|progression-free survival (PFS)|progression-free survival (pfs)
211211|NCT02066220|overall survival (OS)|overall survival (os)
211212|NCT02066220|PNET|pnet
211213|NCT02066220|posterior fossa|posterior fossa
211214|NCT02066220|chemotherapy|chemotherapy
211215|NCT02066220|radiotherapy|radiotherapy
211216|NCT02066220|biological profile|biological profile
211217|NCT02066220|ß-catenin|ß-catenin
211218|NCT02066155|diabetes self-management support|diabetes self-management support
211725|NCT02063945|ODD|odd
211219|NCT02066155|diabetes-related distress|diabetes-related distress
211220|NCT02066155|parish nurses|parish nurses
211221|NCT02066155|peer support|peer support
211222|NCT02066129|Asthma|asthma
211223|NCT02066129|Fluticasone|fluticasone
211224|NCT02066090|acupuncture|acupuncture
211225|NCT02066090|obesity|obesity
211226|NCT02066090|metabolomics|metabolomics
211227|NCT02066077|Major Depressive Disorder|major depressive disorder
211228|NCT02066077|Modified Electroconvulsive Therapy|modified electroconvulsive therapy
211231|NCT02066064|Colorectal Cancer|colorectal cancer
211232|NCT02066064|Adenoma|adenoma
211233|NCT02066064|Standard Colonoscopy|standard colonoscopy
211234|NCT02066064|G-EYE(TM) Colonoscopy|g-eye(tm) colonoscopy
211235|NCT02066038|chemotherapy|chemotherapy
211236|NCT02066038|maintenance therapy|maintenance therapy
211237|NCT02066038|erlotinib|erlotinib
211238|NCT02066025|breast cancer|breast cancer
211239|NCT02066025|cancer associated auto antibodies|cancer associated auto antibodies
211240|NCT02066025|breast cancer blood test|breast cancer blood test
211241|NCT02066012|Dysmetabolic Iron Overload Syndrome|dysmetabolic iron overload syndrome
211242|NCT02066012|Metabolic Syndrome X|metabolic syndrome x
211243|NCT02066012|Iron|iron
211244|NCT02066012|Monocyte|monocyte
211245|NCT02066012|Macrophage|macrophage
211246|NCT02066012|Polarization|polarization
211247|NCT02065999|Hepatitis C, chronic|hepatitis c, chronic
211249|NCT02065986|Prevention|prevention
211250|NCT02065986|Truvada|truvada
211251|NCT02065960|Feasibility study|feasibility study
211252|NCT02065960|Early breast cancer|early breast cancer
211253|NCT02065960|Stereotactic body radiotherapy|stereotactic body radiotherapy
211254|NCT02065960|Cyberknife|cyberknife
211255|NCT02065960|Pre-operative radiotherapy|pre-operative radiotherapy
211256|NCT02065947|paravertebral block, mastectomy, efficiency|paravertebral block, mastectomy, efficiency
211257|NCT02065934|in hospital cardiac arrest|in hospital cardiac arrest
211258|NCT02065934|in situ simulation|in situ simulation
211259|NCT02065934|clinical audit|clinical audit
211260|NCT02065934|education|education
211261|NCT02065921|COPD cohort|copd cohort
211262|NCT02065921|COPD management|copd management
211263|NCT02065921|exacerbation|exacerbation
211264|NCT02065908|breast cancer|breast cancer
211265|NCT02065908|anthracyclines|anthracyclines
211266|NCT02065908|cardiotoxicity|cardiotoxicity
211267|NCT02065908|circulating microRNA|circulating microrna
211268|NCT02065908|biomarker|biomarker
211269|NCT02065908|serum|serum
211270|NCT02065908|anthracyclines based chemotherapy|anthracyclines based chemotherapy
211271|NCT02065895|Physiologic Insulin Delivery (PID)|physiologic insulin delivery (pid)
211272|NCT02065895|Closed Loop|closed loop
211273|NCT02065895|Sensor|sensor
211274|NCT02065895|Insulin sensitivity|insulin sensitivity
211275|NCT02065882|fibrinogen, bleeding,|fibrinogen, bleeding,
211276|NCT02065869|ALL|all
211277|NCT02065869|AML|aml
211278|NCT02065869|hematologic neoplasms|hematologic neoplasms
211279|NCT02065869|hematologic malignancies|hematologic malignancies
211280|NCT02065869|primary immune deficiences|primary immune deficiences
211281|NCT02065843|Anxiety|anxiety
211282|NCT02065843|Third molar surgery|third molar surgery
211283|NCT02065843|Blood pressure|blood pressure
211284|NCT02065843|Heart rate|heart rate
211285|NCT02065843|Oxygen saturation|oxygen saturation
211286|NCT02065830|Robot|robot
211287|NCT02065830|Spinal Cord Injury|spinal cord injury
211288|NCT02065830|Gait|gait
211289|NCT02065830|Quality of life|quality of life
211290|NCT02065830|Rehabilitation|rehabilitation
211291|NCT02065830|Lower Limb|lower limb
211292|NCT02065817|Lipid|lipid
211293|NCT02065817|Apolipoproteins|apolipoproteins
211294|NCT02065817|Cardiovascular disease risks|cardiovascular disease risks
211295|NCT02065804|Herniorrhaphy|herniorrhaphy
211296|NCT02065804|Surgical Equipment|surgical equipment
211297|NCT02065804|Chronic Pain|chronic pain
211298|NCT02065804|Inguinal Herniorrhaphy|inguinal herniorrhaphy
211299|NCT02065804|Laparoscopy|laparoscopy
211300|NCT02065804|Surgical Outcome|surgical outcome
211301|NCT02065791|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
211302|NCT02065791|Diabetic Nephropathies|diabetic nephropathies
211303|NCT02065791|Canagliflozin|canagliflozin
211304|NCT02065791|JNJ-28431754|jnj-28431754
211305|NCT02065791|End-Stage Kidney Disease|end-stage kidney disease
211306|NCT02065791|Chronic Kidney Disease|chronic kidney disease
211307|NCT02065791|Macroalbuminuria|macroalbuminuria
211308|NCT02065752|Healthy Volunteers|healthy volunteers
211309|NCT02065752|Canagliflozin|canagliflozin
211310|NCT02065752|Metformin|metformin
211311|NCT02065752|Type 2 diabetes mellitus|type 2 diabetes mellitus
211312|NCT02065739|Healthy|healthy
211313|NCT02065739|JNJ-42165279|jnj-42165279
211314|NCT02065739|Itraconazole|itraconazole
211315|NCT02065739|Pharmacokinetics|pharmacokinetics
211316|NCT02065713|Psoriatic arthritis, dactylitis, enthesitis|psoriatic arthritis, dactylitis, enthesitis
211317|NCT02065700|Methotrexate|methotrexate
211318|NCT02065700|insufficient responders|insufficient responders
212327|NCT02061215|CYTOF|cytof
211319|NCT02065674|type II Diabetes mellitus|type ii diabetes mellitus
211320|NCT02065674|FBS|fbs
211321|NCT02065674|PPBS|ppbs
211322|NCT02065674|HbA1c%|hba1c%
211323|NCT02065648|MRA|mra
211324|NCT02065648|Syngo Native|syngo native
211325|NCT02065648|Gadolinium|gadolinium
211326|NCT02065648|Non contrast|non contrast
211328|NCT02065609|Trastuzumab|trastuzumab
211329|NCT02065596|Sickle Cell Disease|sickle cell disease
211330|NCT02065596|Sickle Cell Anemia|sickle cell anemia
211331|NCT02065596|GvHD|gvhd
211332|NCT02065596|fludarabine|fludarabine
211333|NCT02065583|Ileus|ileus
211334|NCT02065583|Equipment and Supplies|equipment and supplies
211335|NCT02065583|Technology|technology
211336|NCT02065583|Acoustics|acoustics
211337|NCT02065570|Crohn's Disease|crohn's disease
211338|NCT02065557|Ulcerative Colitis|ulcerative colitis
211339|NCT02065557|adalimumab|adalimumab
211340|NCT02065544|Type 2 diabetes mellitus|type 2 diabetes mellitus
211341|NCT02065544|behavioral weight loss|behavioral weight loss
211342|NCT02065544|exercise training|exercise training
211343|NCT02065544|hemoglobin A1c|hemoglobin a1c
211344|NCT02065531|Low Back Pain|low back pain
211345|NCT02065531|Chronic Pain|chronic pain
211346|NCT02065531|Manipulation|manipulation
211347|NCT02065531|Manual Therapy|manual therapy
211348|NCT02065531|Randomized Controlled Trial|randomized controlled trial
211349|NCT02065518|Muscle strength|muscle strength
211350|NCT02065518|Electrical muscle stimulation|electrical muscle stimulation
211351|NCT02065518|Strength training|strength training
211352|NCT02065505|Spastic hemiparesis|spastic hemiparesis
211353|NCT02065505|Posture|posture
211354|NCT02065505|Pilates|pilates
211355|NCT02065505|Respiratory Capacity|respiratory capacity
211356|NCT02065492|Thalassemia|thalassemia
211357|NCT02065492|Amlodipine|amlodipine
211358|NCT02065492|Chelation|chelation
211359|NCT02065492|T2*|t2*
211360|NCT02065492|MRI|mri
211361|NCT02065492|Myocardial Iron|myocardial iron
211362|NCT02065479|Coronary Artery Disease|coronary artery disease
211363|NCT02065479|Percutaneous Coronary Intervention|percutaneous coronary intervention
211364|NCT02065479|Genetic Polymorphism|genetic polymorphism
211365|NCT02065479|Pharmacodynamic|pharmacodynamic
211366|NCT02065453|lap hysterectomy|lap hysterectomy
211367|NCT02065453|Women in need of a lap hysterectomy for benign disease.|women in need of a lap hysterectomy for benign disease.
211368|NCT02065440|Ebastine/Pseudoephedrine|ebastine/pseudoephedrine
211369|NCT02065440|subacute cough|subacute cough
211370|NCT02065440|upper airway cough syndrome|upper airway cough syndrome
211371|NCT02065427|Caregiver|caregiver
211372|NCT02065427|Burden|burden
211373|NCT02065427|Social support|social support
211374|NCT02065427|Primary health Care|primary health care
211375|NCT02065427|Home Care|home care
211376|NCT02065427|Intervention|intervention
211377|NCT02065414|Gums|gums
211378|NCT02065414|Gingiva|gingiva
211379|NCT02065414|Gingival Inflammation|gingival inflammation
211380|NCT02065414|Gingival Bleeding|gingival bleeding
211381|NCT02065375|RTA 408|rta 408
211382|NCT02065375|Ocular surgery|ocular surgery
211383|NCT02065375|Cataract surgery|cataract surgery
211384|NCT02065375|Ocular inflammation|ocular inflammation
211385|NCT02065375|Ocular pain|ocular pain
211386|NCT02065375|Eye inflammation|eye inflammation
211387|NCT02065362|EBV positive|ebv positive
211388|NCT02065362|TGFbeta|tgfbeta
211389|NCT02065362|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
211390|NCT02065362|cytotoxic T lymphocytes|cytotoxic t lymphocytes
211391|NCT02065349|peripheral neuropathy|peripheral neuropathy
211392|NCT02065349|PDPN|pdpn
211393|NCT02065349|PHN|phn
211394|NCT02065349|pain|pain
211395|NCT02065336|HBV|hbv
211396|NCT02065336|Hepatitis|hepatitis
211397|NCT02065323|Prostate Cancer|prostate cancer
211398|NCT02065323|Metastatic|metastatic
211399|NCT02065323|Hormone-sensitive|hormone-sensitive
211400|NCT02065323|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
211401|NCT02065323|Castration-Resistant Prostate Cancer (CRPC)|castration-resistant prostate cancer (crpc)
211402|NCT02065323|Dovitinib|dovitinib
211403|NCT02065323|TKI258|tki258
211404|NCT02065323|Circulating Tumor Cells|circulating tumor cells
211405|NCT02065310|AGE|age
211406|NCT02065310|Diabetes Biomarkers|diabetes biomarkers
211407|NCT02065310|CEdG|cedg
211408|NCT02065284|MS|ms
211409|NCT02065284|Ambulation|ambulation
211410|NCT02065258|Asthma, Clinical control, Exercise|asthma, clinical control, exercise
211411|NCT02065245|Aging Frailty, Frailty, Cardiovascular, stem cells|aging frailty, frailty, cardiovascular, stem cells
211412|NCT02065219|Chronic Pain|chronic pain
211413|NCT02065219|Inguinal Hernia|inguinal hernia
211414|NCT02065219|Outcome|outcome
211415|NCT02065219|Surgical Procedure, Operative|surgical procedure, operative
211416|NCT02065206|Focus groups|focus groups
211417|NCT02065206|Underrepresented Minorities|underrepresented minorities
211418|NCT02065206|Social Media|social media
211549|NCT02064738|Omega-6 fatty acids|omega-6 fatty acids
211419|NCT02065206|Clinical Research Careers|clinical research careers
211420|NCT02065167|avascular necrosis of femoral head|avascular necrosis of femoral head
211421|NCT02065167|cell therapy|cell therapy
211422|NCT02065167|Mesenchymal stem cells|mesenchymal stem cells
211423|NCT02065154|acute myeloid leukemia|acute myeloid leukemia
211424|NCT02065154|AML|aml
211425|NCT02065154|acute lymphoblastic leukemia|acute lymphoblastic leukemia
211426|NCT02065154|ALL|all
211427|NCT02065154|chronic myeloid leukemia|chronic myeloid leukemia
211428|NCT02065154|CML|cml
211429|NCT02065154|chronic lymphocytic leukemia|chronic lymphocytic leukemia
211430|NCT02065154|CLL|cll
211431|NCT02065154|non-Hodgkin lymphoma|non-hodgkin lymphoma
211432|NCT02065154|NHL|nhl
211433|NCT02065154|Hodgkin lymphoma|hodgkin lymphoma
211434|NCT02065154|HL|hl
211435|NCT02065154|myelodysplastic syndrome|myelodysplastic syndrome
211436|NCT02065154|MDS|mds
211437|NCT02065154|myelofibrosis|myelofibrosis
211438|NCT02065154|severe aplastic anemia|severe aplastic anemia
211439|NCT02065141|digestion|digestion
211440|NCT02065141|absorption|absorption
211441|NCT02065141|protein|protein
211442|NCT02065141|amino acids|amino acids
211443|NCT02065141|heart failure|heart failure
211444|NCT02065141|COPD|copd
211445|NCT02065115|ice|ice
211446|NCT02065115|cryotherapy|cryotherapy
211447|NCT02065115|puncture|puncture
211448|NCT02065115|pain|pain
211449|NCT02065102|Rotational atherectomy|rotational atherectomy
211450|NCT02065102|Angina|angina
211451|NCT02065102|Optical coherence tomography|optical coherence tomography
211452|NCT02065102|Intravascular ultrasound|intravascular ultrasound
211453|NCT02065102|Coronary stent|coronary stent
211454|NCT02065076|Sodium Polystyrene Sulfonate|sodium polystyrene sulfonate
211455|NCT02065076|Kayexalate|kayexalate
211456|NCT02065076|Pre-dialysis|pre-dialysis
211457|NCT02065076|Outpatients|outpatients
211458|NCT02065076|Hyperkalemia|hyperkalemia
211459|NCT02065076|Chronic kidney failure|chronic kidney failure
211460|NCT02065076|Potassium|potassium
211461|NCT02065063|MEK inhibitor|mek inhibitor
211462|NCT02065063|PD-0332991|pd-0332991
211463|NCT02065063|CDK4/6 inhibitor|cdk4/6 inhibitor
211464|NCT02065063|palbociclib|palbociclib
211465|NCT02065063|NRAS wild type|nras wild type
211466|NCT02065063|cutaneous melanoma|cutaneous melanoma
211467|NCT02065063|GSK1120212|gsk1120212
211468|NCT02065063|trametinib|trametinib
211469|NCT02065063|NRAS mutant|nras mutant
211470|NCT02065063|BRAFV600 wild type|brafv600 wild type
211471|NCT02065050|Diabetes mellitus|diabetes mellitus
211472|NCT02065050|Team approach|team approach
211473|NCT02065037|Insufflation|insufflation
211474|NCT02065037|Carbon Dioxide|carbon dioxide
211475|NCT02065037|Colonic Polyps|colonic polyps
211476|NCT02065037|Colonoscopy|colonoscopy
211477|NCT02065037|Randomized Controlled Trial|randomized controlled trial
211478|NCT02065024|b-cryptoxanthin|b-cryptoxanthin
211479|NCT02065024|plant sterols|plant sterols
211480|NCT02065024|serum Cholesterol|serum cholesterol
211481|NCT02065024|bone turnover markers|bone turnover markers
211482|NCT02064998|Randomized Controlled Trial|randomized controlled trial
211483|NCT02064998|Alcohol|alcohol
211484|NCT02064998|Internet|internet
211485|NCT02064998|Mobile phone|mobile phone
211486|NCT02064998|Screening|screening
211487|NCT02064998|Brief intervention|brief intervention
211488|NCT02064972|Graft vs Host Disease|graft vs host disease
211489|NCT02064972|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
211490|NCT02064972|Biological Marker|biological marker
211491|NCT02064972|Circulating Endothelial Cells|circulating endothelial cells
211492|NCT02064972|Endothelial Dysfunction|endothelial dysfunction
211493|NCT02064959|Subdural Hematoma|subdural hematoma
211494|NCT02064959|Traumatic Brain Injury|traumatic brain injury
211495|NCT02064959|Hypothermia|hypothermia
211496|NCT02064946|prostate cancer|prostate cancer
211497|NCT02064946|bone density|bone density
211498|NCT02064946|vitamin D|vitamin d
211499|NCT02064946|micronutrients|micronutrients
211500|NCT02064946|pharmacologic actions|pharmacologic actions
211501|NCT02064933|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
211502|NCT02064933|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
211503|NCT02064933|Genetic Therapy|genetic therapy
211504|NCT02064907|Drug therapy|drug therapy
211505|NCT02064894|children|children
211506|NCT02064894|analgesia|analgesia
211507|NCT02064894|musculoskeletal injury|musculoskeletal injury
211508|NCT02064894|emergency|emergency
211509|NCT02064894|opioids|opioids
211510|NCT02064881|Postprandial lipemia|postprandial lipemia
211511|NCT02064881|Diabetes|diabetes
211512|NCT02064881|Metformin glycinate|metformin glycinate
211513|NCT02064881|oxidized LDL|oxidized ldl
211514|NCT02064868|AHF,|ahf,
211515|NCT02064868|RLX030,|rlx030,
211516|NCT02064868|SOC,|soc,
211517|NCT02064868|WHF,|whf,
211518|NCT02064868|RELAX-AHF-EU|relax-ahf-eu
211519|NCT02064868|Renal Impairment|renal impairment
211520|NCT02064855|Spinal stenosis|spinal stenosis
211521|NCT02064855|Spondylolisthesis|spondylolisthesis
211522|NCT02064855|Degenerative disc disease|degenerative disc disease
211523|NCT02064855|Spinal fusion|spinal fusion
211524|NCT02064855|Allograft|allograft
212328|NCT02061215|CMV|cmv
211525|NCT02064855|Interbody fusion|interbody fusion
211526|NCT02064842|Healthy|healthy
211527|NCT02064842|TMC647055|tmc647055
211528|NCT02064842|TMC435|tmc435
211529|NCT02064842|Simeprevir|simeprevir
211530|NCT02064842|Sovriad|sovriad
211531|NCT02064842|Ritonavir (RTV)|ritonavir (rtv)
211532|NCT02064829|Metastatic breast cancer|metastatic breast cancer
211533|NCT02064829|Locally recurrent breast cancer|locally recurrent breast cancer
211534|NCT02064829|Bioequivalence|bioequivalence
211535|NCT02064829|IG-001|ig-001
211536|NCT02064829|nab-paclitaxel|nab-paclitaxel
211537|NCT02064829|Paclitaxel|paclitaxel
211538|NCT02064829|Pharmacokinetics|pharmacokinetics
211539|NCT02064816|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
211540|NCT02064816|Interferon beta 1a|interferon beta 1a
211541|NCT02064816|Rebif®|rebif®
211542|NCT02064790|Gabapentin|gabapentin
211543|NCT02064790|Pregabalin|pregabalin
211544|NCT02064790|Lyrica|lyrica
211545|NCT02064790|Neurontin|neurontin
211546|NCT02064790|lumbar|lumbar
211547|NCT02064790|cervical|cervical
211548|NCT02064738|Omega-3 fatty acids|omega-3 fatty acids
211550|NCT02064738|aspirin exacerbated respiratory disease|aspirin exacerbated respiratory disease
211551|NCT02064738|AERD|aerd
211552|NCT02064738|Samter's Triad|samter's triad
211553|NCT02064738|nasal polyp|nasal polyp
211554|NCT02064738|aspirin|aspirin
211555|NCT02064738|diet|diet
211556|NCT02064738|leukotriene|leukotriene
211557|NCT02064725|Endometrial cancer|endometrial cancer
211558|NCT02064725|Recurrent or persistent endometrial carcinoma|recurrent or persistent endometrial carcinoma
211559|NCT02064725|Progesterone Receptor Negative|progesterone receptor negative
211560|NCT02064725|Sodium cridanimod|sodium cridanimod
211561|NCT02064725|Virexxa|virexxa
211562|NCT02064712|Continuous Positive Airway Pressure|continuous positive airway pressure
211563|NCT02064699|Renal transplant|renal transplant
211567|NCT02064673|radical prostatectomy|radical prostatectomy
211568|NCT02064660|Myopia|myopia
211569|NCT02064660|Children|children
211570|NCT02064660|Acupressure|acupressure
211571|NCT02064660|Refractive error|refractive error
211572|NCT02064660|Axial length|axial length
211573|NCT02064660|Korean medicine|korean medicine
211574|NCT02064647|Insulin Infusion Systems|insulin infusion systems
211575|NCT02064647|Blood Glucose|blood glucose
211576|NCT02064634|Shinbaro Capsule|shinbaro capsule
211577|NCT02064634|Celecoxib|celecoxib
211578|NCT02064634|Osteoarthritis|osteoarthritis
211579|NCT02064634|GCSB-5|gcsb-5
211580|NCT02064634|Discontinuation rate|discontinuation rate
211581|NCT02064634|Gastrointestinal adverse event|gastrointestinal adverse event
211582|NCT02064634|NSAIDs|nsaids
211583|NCT02064634|OASIS|oasis
211584|NCT02064608|Prostate|prostate
211585|NCT02064608|Cancer|cancer
211586|NCT02064608|Prostate Cancer|prostate cancer
211587|NCT02064608|High Risk|high risk
211588|NCT02064608|Intermediate Risk|intermediate risk
211589|NCT02064608|Early disease|early disease
211590|NCT02064608|Neoadjuvant treatment|neoadjuvant treatment
211591|NCT02064608|Radical Prostatectomy|radical prostatectomy
211592|NCT02064595|Tibial fractures.|tibial fractures.
211593|NCT02064595|Fracture fixation.|fracture fixation.
211594|NCT02064595|External fixators.|external fixators.
211595|NCT02064595|Intramedullary.|intramedullary.
211596|NCT02064595|Quality of life.|quality of life.
211597|NCT02064582|prostate cancer, enzalutamide, radiation, hormone therapy|prostate cancer, enzalutamide, radiation, hormone therapy
211598|NCT02064543|Parkinson's disease|parkinson's disease
211599|NCT02064543|gait|gait
211600|NCT02064530|TAP block|tap block
211601|NCT02064530|dexmedetomidine|dexmedetomidine
211602|NCT02064530|bupivacaine|bupivacaine
211603|NCT02064530|postoperative analgesia|postoperative analgesia
211604|NCT02064517|Necrosed Immature monoradicular Teeth , Revascularisation pulpar, MTA apical barrier, Clinical and radiographic success|necrosed immature monoradicular teeth , revascularisation pulpar, mta apical barrier, clinical and radiographic success
211605|NCT02064504|Respiratory|respiratory
211606|NCT02064504|GSK961081 (MABA)|gsk961081 (maba)
211607|NCT02064504|healthy subjects|healthy subjects
211608|NCT02064504|pharmacokinetics|pharmacokinetics
211609|NCT02064504|GW685698 (fluticasone furoate)|gw685698 (fluticasone furoate)
211610|NCT02064491|Non-small cell lung cancer|non-small cell lung cancer
211611|NCT02064491|EGFR mutant|egfr mutant
211612|NCT02064491|Erlotinib|erlotinib
211613|NCT02064491|Treatment Beyond Progression|treatment beyond progression
211616|NCT02064452|behavior problems|behavior problems
211617|NCT02064452|children|children
211618|NCT02064452|prevention|prevention
211619|NCT02064452|parenting|parenting
211620|NCT02064452|online|online
211621|NCT02064452|pediatric|pediatric
211622|NCT02064439|deep vein thrombosis|deep vein thrombosis
211623|NCT02064439|pulmonary embolism|pulmonary embolism
211624|NCT02064439|long-term prevention of recurrent symptomatic VTE|long-term prevention of recurrent symptomatic vte
211625|NCT02064426|Anemia of CKD on dialysis|anemia of ckd on dialysis
211626|NCT02064413|Birth control|birth control
211627|NCT02064400|Rheumatoid arthritis|rheumatoid arthritis
211628|NCT02064400|Ultrasound|ultrasound
211629|NCT02064400|Remission|remission
211630|NCT02064400|Qualitative|qualitative
211631|NCT02064387|Multiple Myeloma|multiple myeloma
211632|NCT02064387|BCMA expressing Lymphomas|bcma expressing lymphomas
211633|NCT02064374|Dolutegravir|dolutegravir
202424|NCT02106663|PAF|paf
211634|NCT02064374|drug interaction|drug interaction
211635|NCT02064374|metformin|metformin
211636|NCT02064374|pharmacokinetics|pharmacokinetics
211637|NCT02064374|healthy volunteers|healthy volunteers
211638|NCT02064361|SCUBA diving|scuba diving
211639|NCT02064361|exercise,|exercise,
211640|NCT02064361|microparticles|microparticles
211641|NCT02064361|neutrophil activation,|neutrophil activation,
211944|NCT02062879|trauma|trauma
211642|NCT02064361|high intensity exercise|high intensity exercise
211643|NCT02064335|physical activity coach, diabetic persons, health, behaviour|physical activity coach, diabetic persons, health, behaviour
211644|NCT02064322|sacroiliac joint fusion|sacroiliac joint fusion
211645|NCT02064322|SIJ fusion|sij fusion
211646|NCT02064322|SI joint|si joint
211647|NCT02064296|Fibromyalgia Chronic Pain|fibromyalgia chronic pain
211648|NCT02064270|incision care|incision care
211649|NCT02064270|Total Hip Arthroplasty|total hip arthroplasty
211650|NCT02064270|Total Knee Arthroplasty|total knee arthroplasty
211651|NCT02064270|Knee surgery|knee surgery
211652|NCT02064270|Hip surgery|hip surgery
211653|NCT02064257|autonomic nervous system|autonomic nervous system
211654|NCT02064257|auditory processing disorder|auditory processing disorder
211655|NCT02064257|social behavior|social behavior
211656|NCT02064244|renal|renal
211657|NCT02064244|kidney|kidney
211658|NCT02064244|creatinine|creatinine
211659|NCT02064244|Inferior Vena Cava (IVC)|inferior vena cava (ivc)
211660|NCT02064244|Acute Renal Failure (ARF)|acute renal failure (arf)
211661|NCT02064244|Acute Kidney Injury (AKI)|acute kidney injury (aki)
211662|NCT02064205|pre-load|pre-load
211663|NCT02064205|satiety|satiety
211664|NCT02064205|energy intake|energy intake
211665|NCT02064205|appetite|appetite
211666|NCT02064192|defibrillator, implantable cardioverter|defibrillator, implantable cardioverter
211667|NCT02064192|sudden cardiac death|sudden cardiac death
211668|NCT02064192|primary prophylaxis|primary prophylaxis
211669|NCT02064192|risk stratification|risk stratification
211670|NCT02064179|Congenital heart disease|congenital heart disease
211671|NCT02064179|Antiplatelet therapy|antiplatelet therapy
211672|NCT02064179|Aspirin|aspirin
211673|NCT02064166|Parkinson disease|parkinson disease
211674|NCT02064166|Multiple system atrophy|multiple system atrophy
211675|NCT02064166|Intranasal|intranasal
211676|NCT02064166|Insulin|insulin
211677|NCT02064153|Dialysate temperature|dialysate temperature
211678|NCT02064153|Spent dialysate|spent dialysate
211679|NCT02064153|Toxin removal|toxin removal
211680|NCT02064153|Intra-dialytic hypotension|intra-dialytic hypotension
211681|NCT02064153|Inter-compartmental resistance|inter-compartmental resistance
211682|NCT02064140|ARDS|ards
211683|NCT02064140|Mechanical Ventilation|mechanical ventilation
211684|NCT02064140|Tidal volume|tidal volume
211685|NCT02064140|NMBA|nmba
211686|NCT02064114|BMI >40|bmi >40
211687|NCT02064101|Scoliosis|scoliosis
211689|NCT02064101|Pedicle screw|pedicle screw
211690|NCT02064101|Neuromonitoring|neuromonitoring
211691|NCT02064088|Regional anesthesia|regional anesthesia
211692|NCT02064088|TAP block|tap block
211693|NCT02064088|Pediatric anesthesia|pediatric anesthesia
211694|NCT02064088|analgesic effects|analgesic effects
211695|NCT02064088|pharmacokinetics|pharmacokinetics
211696|NCT02064075|Subarachnoid hemorrhage|subarachnoid hemorrhage
211697|NCT02064075|vasospasm|vasospasm
211698|NCT02064075|Lactated Ringer's solution|lactated ringer's solution
211699|NCT02064075|Hydroxyethyl starch solution|hydroxyethyl starch solution
211700|NCT02064062|Achilles Tendinopathy|achilles tendinopathy
211701|NCT02064062|Autologous Stem Cells|autologous stem cells
211702|NCT02064062|Musculoskeletal|musculoskeletal
211703|NCT02064049|Hepatitis C virus|hepatitis c virus
211704|NCT02064049|People who inject drugs|people who inject drugs
211705|NCT02064049|Drug users|drug users
211706|NCT02064049|Direct acting antiviral (DAA)|direct acting antiviral (daa)
211707|NCT02064049|Infectious diseases|infectious diseases
211708|NCT02064049|Prisoners|prisoners
211709|NCT02064036|Prostate Cancer|prostate cancer
211710|NCT02064036|Radiotherapy|radiotherapy
211711|NCT02064036|Androgen Deprivation|androgen deprivation
211712|NCT02064023|insulin pump|insulin pump
211713|NCT02064023|CSII|csii
211714|NCT02064023|multiple daily injections|multiple daily injections
211715|NCT02064023|MDI|mdi
211716|NCT02064023|type 1 diabetes|type 1 diabetes
211717|NCT02064023|type 2 diabetes|type 2 diabetes
211718|NCT02064023|pregnancy|pregnancy
211719|NCT02063971|Skin aging|skin aging
211720|NCT02063971|Soothing activity|soothing activity
211721|NCT02063971|Hyaluronic acid injections|hyaluronic acid injections
211722|NCT02063958|Neuroendocrine tumor|neuroendocrine tumor
211723|NCT02063958|Hsp90|hsp90
211724|NCT02063945|ADHA|adha
211726|NCT02063945|Conduct disorder|conduct disorder
211727|NCT02063945|Aggression|aggression
211728|NCT02063945|Treatment|treatment
211729|NCT02063945|Methylphenidate|methylphenidate
211730|NCT02063945|Risperidone|risperidone
211731|NCT02063932|mucosal microbiome|mucosal microbiome
211732|NCT02063932|H.pylori|h.pylori
259543|NCT01847287|MRI|mri
202517|NCT02106286|surgery|surgery
211733|NCT02063932|intestinal metaplasia|intestinal metaplasia
211734|NCT02063932|gastric neoplasia|gastric neoplasia
211735|NCT02063932|endomicroscopy|endomicroscopy
211736|NCT02063880|HIV-1|hiv-1
211737|NCT02063880|IRIS|iris
211738|NCT02063867|HAI|hai
211739|NCT02063867|MRSA|mrsa
211740|NCT02063867|VRE|vre
211741|NCT02063854|Drug Therapy|drug therapy
211742|NCT02063802|pediatric obesity|pediatric obesity
212550|NCT02060279|Obesity|obesity
211743|NCT02063802|conjugated linoleic acid|conjugated linoleic acid
211744|NCT02063802|CLA|cla
211745|NCT02063802|metformin|metformin
211746|NCT02063789|Immune Thrombocytopenia|immune thrombocytopenia
211747|NCT02063789|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
211748|NCT02063789|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
211749|NCT02063789|Human Immunoglobulin|human immunoglobulin
211750|NCT02063789|ITP|itp
211751|NCT02063789|IVIg|ivig
211752|NCT02063789|IgIV|igiv
211753|NCT02063789|IV-Globulin SN Inj.|iv-globulin sn inj.
211754|NCT02063776|Haemodiafiltration (HDF)|haemodiafiltration (hdf)
211755|NCT02063776|Haemodialysis (HD)|haemodialysis (hd)
211756|NCT02063776|Children|children
211757|NCT02063776|Carotid intima media thickness|carotid intima media thickness
211758|NCT02063776|Pulse wave velocity|pulse wave velocity
211759|NCT02063776|Height standard deviation score|height standard deviation score
211760|NCT02063763|Adult patients|adult patients
678353|NCT00882583|HNSCC|hnscc
211761|NCT02063763|Immune primary thrombocytopenia|immune primary thrombocytopenia
211762|NCT02063763|Splenectomy|splenectomy
211763|NCT02063763|TPO-mimetics|tpo-mimetics
211764|NCT02063763|Eltrombopag|eltrombopag
211765|NCT02063763|Romiplostim|romiplostim
211766|NCT02063750|Fibromyalgia|fibromyalgia
211767|NCT02063750|Muscle strength exercises|muscle strength exercises
211768|NCT02063750|Pain|pain
211769|NCT02063750|Quality of life|quality of life
211770|NCT02063737|Shift work|shift work
211771|NCT02063737|Fatigue|fatigue
211772|NCT02063737|Sleepiness|sleepiness
211773|NCT02063737|Injury|injury
211774|NCT02063724|Invasive Breast Cancer|invasive breast cancer
211775|NCT02063724|Breast Cancer|breast cancer
211776|NCT02063724|Immunotherapy|immunotherapy
211777|NCT02063724|Vaccine|vaccine
211778|NCT02063724|Dendritic Cell|dendritic cell
211779|NCT02063711|Prenatal Yoga|prenatal yoga
211780|NCT02063711|Yoga, Pregnancy|yoga, pregnancy
211781|NCT02063711|Yoga, Fetal Response|yoga, fetal response
211782|NCT02063646|polyphenols|polyphenols
211783|NCT02063646|memory|memory
211784|NCT02063646|elderly|elderly
211785|NCT02063633|Thoracic malignancy, irradiation, respiratory gating system PET|thoracic malignancy, irradiation, respiratory gating system pet
211786|NCT02063620|IVRA, ketamine, lidocaine, ECG|ivra, ketamine, lidocaine, ecg
211787|NCT02063607|Hepatitis C naive|hepatitis c naive
211788|NCT02063594|Iodixanol|iodixanol
211789|NCT02063594|Iodinated Contrast|iodinated contrast
211790|NCT02063594|Liposome|liposome
211791|NCT02063594|Computed Tomography|computed tomography
211792|NCT02063594|X-ray Imaging|x-ray imaging
211793|NCT02063594|Blood pool agent|blood pool agent
211794|NCT02063594|Biomarker|biomarker
211795|NCT02063555|Tuberculosis|tuberculosis
211796|NCT02063555|BCG|bcg
211797|NCT02063555|HIV|hiv
211798|NCT02063555|TB Vaccines|tb vaccines
211799|NCT02063542|Postoperative cognitive changes|postoperative cognitive changes
211800|NCT02063542|Acetylcholine in CSF|acetylcholine in csf
211801|NCT02063542|Surgery|surgery
211802|NCT02063529|Colorectal cancer|colorectal cancer
211803|NCT02063529|Metastatic colorectal cancer|metastatic colorectal cancer
211804|NCT02063529|Liver metastases|liver metastases
211805|NCT02063529|Liver resection|liver resection
211806|NCT02063529|Liver ablation|liver ablation
211807|NCT02063529|Conversion therapy|conversion therapy
211808|NCT02063529|FOLFOXIRI|folfoxiri
211809|NCT02063529|Cetuximab|cetuximab
211810|NCT02063529|Oxaliplatin|oxaliplatin
211811|NCT02063529|Irinotecan|irinotecan
211812|NCT02063529|Leucovorin|leucovorin
211813|NCT02063516|Airway Cuff|airway cuff
211814|NCT02063516|Guardian|guardian
211815|NCT02063516|Proseal|proseal
211816|NCT02063516|Cuff Pressure|cuff pressure
211817|NCT02063516|laryngeal Mask Airway|laryngeal mask airway
211818|NCT02063503|clinical prediction rule|clinical prediction rule
211819|NCT02063503|nonspecific|nonspecific
211820|NCT02063503|chronic|chronic
211821|NCT02063503|low back pain|low back pain
211822|NCT02063503|Non specific chronic low back pain|non specific chronic low back pain
211823|NCT02063490|Adherence|adherence
211824|NCT02063490|dialysis|dialysis
211825|NCT02063490|intervention|intervention
211826|NCT02063490|nurse-led|nurse-led
211827|NCT02063490|phosphate binders|phosphate binders
211828|NCT02063490|trial|trial
211829|NCT02063464|Tumorcidal|tumorcidal
211830|NCT02063464|Monocytes|monocytes
212329|NCT02061215|PCR|pcr
211831|NCT02063464|Interferons Alpha and Gamma|interferons alpha and gamma
211832|NCT02063451|Obesity [C18.654.726.500]|obesity [c18.654.726.500]
211833|NCT02063451|Receptor, Opioid, mu [D12.776.543.750.100.620.550]|receptor, opioid, mu [d12.776.543.750.100.620.550]
211834|NCT02063451|Brain [A08.186.211]|brain [a08.186.211]
211835|NCT02063451|Affect [F01.470.047]|affect [f01.470.047]
211836|NCT02063438|Thoracotomy|thoracotomy
211837|NCT02063438|Pain|pain
211838|NCT02063438|Intracostal Suture|intracostal suture
211839|NCT02063438|Pericostal Suture|pericostal suture
211841|NCT02063425|Fluoxetine|fluoxetine
211842|NCT02063425|Transcranial magnetic stimulation|transcranial magnetic stimulation
211843|NCT02063425|stroke|stroke
211844|NCT02063399|NPC|npc
211845|NCT02063399|Cancer screening|cancer screening
211846|NCT02063399|Plasma EBV DNA|plasma ebv dna
211847|NCT02063347|innate collateral supply|innate collateral supply
211848|NCT02063347|collateral|collateral
211849|NCT02063347|coronary collateral|coronary collateral
211850|NCT02063347|renal collateral|renal collateral
211851|NCT02063347|peripheral collateral|peripheral collateral
211852|NCT02063347|coronary artery disease|coronary artery disease
211853|NCT02063334|vitamin D3|vitamin d3
211854|NCT02063334|cholecalciferol|cholecalciferol
211855|NCT02063334|calcidiol|calcidiol
211856|NCT02063334|25-hydroxyvitamin D|25-hydroxyvitamin d
211857|NCT02063334|gene expression|gene expression
211858|NCT02063334|vitamin D receptor|vitamin d receptor
211859|NCT02063334|randomized controlled trial|randomized controlled trial
211860|NCT02063334|men|men
211861|NCT02063334|adults|adults
586129|NCT00523575|malnutrition|malnutrition
211862|NCT02063321|DME, diabetic retinopathy, diabetes mellitus, epidemiology|dme, diabetic retinopathy, diabetes mellitus, epidemiology
211863|NCT02063308|Oxaloacetate|oxaloacetate
211865|NCT02063308|AD|ad
211866|NCT02063308|Alzheimer's Disease|alzheimer's disease
211867|NCT02063295|Beloranib|beloranib
211868|NCT02063295|ZGN-440|zgn-440
211869|NCT02063295|ZGN-440 for injectable suspension|zgn-440 for injectable suspension
211870|NCT02063295|ZGN-433|zgn-433
211871|NCT02063282|Asymptomatic|asymptomatic
211872|NCT02063282|Carriage|carriage
211873|NCT02063282|Colonization|colonization
211874|NCT02063282|Clostridium difficile|clostridium difficile
211875|NCT02063282|Colitis|colitis
211876|NCT02063282|Rectal swab|rectal swab
211877|NCT02063269|rivastigmine, butyrylcholinesterase, MRI, PET|rivastigmine, butyrylcholinesterase, mri, pet
211878|NCT02063256|sperm count|sperm count
211879|NCT02063256|sperm concentration|sperm concentration
211880|NCT02063256|mobility|mobility
211881|NCT02063256|diet|diet
211882|NCT02063256|PUFA (polyunsaturated fatty acids)|pufa (polyunsaturated fatty acids)
211883|NCT02063243|Keloid, hypertrophic scar|keloid, hypertrophic scar
211884|NCT02063230|Phase I, healthy, pharmacokinetic, hepatic impairment|phase i, healthy, pharmacokinetic, hepatic impairment
211885|NCT02063204|Phase I, healthy, pharmacokinetics, renal impairment|phase i, healthy, pharmacokinetics, renal impairment
211886|NCT02063191|Atrial Fibrillation|atrial fibrillation
211887|NCT02063191|Bundle Branch Block|bundle branch block
211888|NCT02063165|Safflower Oil|safflower oil
211889|NCT02063165|Linoleic Acid|linoleic acid
211890|NCT02063165|Dyslipidemia|dyslipidemia
211891|NCT02063165|Hypertension|hypertension
211892|NCT02063139|Knemometry|knemometry
211893|NCT02063126|Coenzyme Q10 plus NADH|coenzyme q10 plus nadh
211894|NCT02063126|maximum Heart Rate|maximum heart rate
211895|NCT02063126|Fatigue|fatigue
211896|NCT02063126|Pain|pain
211897|NCT02063126|Sleep|sleep
211898|NCT02063113|Multiple myeloma,|multiple myeloma,
211899|NCT02063113|Older patient,|older patient,
211900|NCT02063113|Treatment,|treatment,
211901|NCT02063113|Geriatric assessment|geriatric assessment
211902|NCT02063100|Glomerulonephritis|glomerulonephritis
211903|NCT02063100|proteinuria|proteinuria
211904|NCT02063100|shenyankangfu tablets|shenyankangfu tablets
211905|NCT02063100|Losartan Potassium|losartan potassium
211906|NCT02063100|efficacy|efficacy
211907|NCT02063100|safety|safety
211908|NCT02063087|Head CT|head ct
211909|NCT02063087|Head Injury|head injury
211910|NCT02063087|Pediatric|pediatric
211911|NCT02063087|Emergency Department|emergency department
211912|NCT02063087|Decision Aids|decision aids
211913|NCT02063087|Shared Decision Making|shared decision making
211914|NCT02063061|extracorporeal shock wave therapy ESWT|extracorporeal shock wave therapy eswt
211915|NCT02063061|erectile dysfunction|erectile dysfunction
211916|NCT02063048|weight loss|weight loss
211917|NCT02063048|Text Messaging|text messaging
211918|NCT02063048|Short Message Service|short message service
211919|NCT02063048|Text Messages|text messages
211920|NCT02063035|lumbar spine surgery|lumbar spine surgery
211921|NCT02063035|thoracic spine surgery|thoracic spine surgery
211922|NCT02063022|Non metastatic Ewing's Sarcoma|non metastatic ewing's sarcoma
211923|NCT02062944|Liver Transplant|liver transplant
211924|NCT02062944|Sirolimus|sirolimus
211925|NCT02062944|Rapamune|rapamune
211926|NCT02062944|Immunosuppressant Therapy|immunosuppressant therapy
211927|NCT02062944|Withdrawal|withdrawal
211928|NCT02062931|Primary Infertility|primary infertility
211929|NCT02062931|Primary Amenorrhea|primary amenorrhea
202716|NCT02105545|DNA|dna
211930|NCT02062931|Sex Steroid Deficiency|sex steroid deficiency
211931|NCT02062931|Premature Ovarian Failure (POF)|premature ovarian failure (pof)
211932|NCT02062918|Abdominal belt|abdominal belt
211933|NCT02062918|Chronic low back pain|chronic low back pain
211934|NCT02062918|Pain|pain
211935|NCT02062918|Functional capacity|functional capacity
211936|NCT02062892|everolimus|everolimus
211937|NCT02062892|sirolimus|sirolimus
211938|NCT02062892|tacrolimus|tacrolimus
211939|NCT02062892|vascular endothelial function|vascular endothelial function
211940|NCT02062892|kidney|kidney
211941|NCT02062892|Transplantation|transplantation
211942|NCT02062892|biomarkers|biomarkers
211943|NCT02062879|pain|pain
211945|NCT02062840|Whole Body Hyperthermia|whole body hyperthermia
211946|NCT02062840|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
211947|NCT02062840|EEG|eeg
211948|NCT02062827|Glioma|glioma
211949|NCT02062801|Combined spinal epidural analgesia, labor, fetal bradycardia|combined spinal epidural analgesia, labor, fetal bradycardia
211950|NCT02062788|Early Recovery After Surgery|early recovery after surgery
211951|NCT02062788|Oral rehydration solution|oral rehydration solution
211952|NCT02062788|Insulin resistance|insulin resistance
211953|NCT02062788|Postoperative complication|postoperative complication
211954|NCT02062749|Colorectal cancer|colorectal cancer
211955|NCT02062749|Colon Cancer|colon cancer
211956|NCT02062749|Pediatric|pediatric
211957|NCT02062749|Adolescent|adolescent
211958|NCT02062749|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
211959|NCT02062749|HIPEC|hipec
211960|NCT02062749|Oxaliplatin|oxaliplatin
211961|NCT02062749|Eloxatin|eloxatin
211962|NCT02062736|methadone|methadone
211963|NCT02062736|heroin addiction|heroin addiction
211964|NCT02062736|methadone maintenance treatment|methadone maintenance treatment
211965|NCT02062736|adequate dosage of methadone|adequate dosage of methadone
211966|NCT02062723|methadone|methadone
211967|NCT02062723|heroin addiction|heroin addiction
211968|NCT02062723|methadone maintenance treatment|methadone maintenance treatment
211969|NCT02062723|adequate dosage of methadone|adequate dosage of methadone
211970|NCT02062710|cough|cough
211971|NCT02062710|cough reflex|cough reflex
211972|NCT02062710|capsaicin|capsaicin
211973|NCT02062710|diphenhydramine|diphenhydramine
211974|NCT02062710|phenylephrine|phenylephrine
211975|NCT02062710|dextromethorphan|dextromethorphan
211976|NCT02062710|placebo|placebo
211977|NCT02062697|Neoplasms|neoplasms
211978|NCT02062697|Glandular and Epithelial|glandular and epithelial
211979|NCT02062697|Ovarian Neoplasms|ovarian neoplasms
211980|NCT02062697|Ovarian cancer|ovarian cancer
211981|NCT02062684|IgAN|igan
211982|NCT02062684|IgA Nephropathy|iga nephropathy
211983|NCT02062684|A-623|a-623
211984|NCT02062684|Blisibimod|blisibimod
211985|NCT02062684|Kidney Disease|kidney disease
211986|NCT02062684|Persistent proteinuria|persistent proteinuria
211987|NCT02062671|ADPKD|adpkd
211988|NCT02062671|denervation|denervation
211989|NCT02062671|renal denervation|renal denervation
211990|NCT02062658|OCD|ocd
211991|NCT02062645|essential hypertension|essential hypertension
211992|NCT02062619|Stroke|stroke
211993|NCT02062619|Aphasia|aphasia
211994|NCT02062619|Acquired reading disorders|acquired reading disorders
211995|NCT02062619|Central alexia|central alexia
211996|NCT02062619|Computer based rehabilitation|computer based rehabilitation
211997|NCT02062619|Transcranial direct current stimulation|transcranial direct current stimulation
211998|NCT02062619|tDCS|tdcs
211999|NCT02062619|Magnetoencephalography|magnetoencephalography
212000|NCT02062619|MEG|meg
212001|NCT02062619|Magnetic Resonance Imaging|magnetic resonance imaging
212002|NCT02062619|MRI|mri
212003|NCT02062606|Scoliosis|scoliosis
212004|NCT02062606|Spinal Curvatures|spinal curvatures
212005|NCT02062606|Spinal Diseases|spinal diseases
212006|NCT02062606|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
212007|NCT02062606|Spinal Deformity|spinal deformity
212008|NCT02062593|Stable angina|stable angina
212009|NCT02062593|Percutaneous coronary intervention|percutaneous coronary intervention
212010|NCT02062593|Optimal medical therapy|optimal medical therapy
212011|NCT02062593|Sham-control|sham-control
212012|NCT02062580|Vaccine immunogenicity|vaccine immunogenicity
212013|NCT02062580|Immune activation|immune activation
212014|NCT02062554|Myocardial infarction|myocardial infarction
212015|NCT02062554|Clinical outcome|clinical outcome
212016|NCT02062554|Flow-mediated dilation|flow-mediated dilation
212017|NCT02062554|Inflammation|inflammation
212018|NCT02062541|functional assessment|functional assessment
212019|NCT02062541|rehabilitation|rehabilitation
212020|NCT02062541|cross-sectorial cooperation|cross-sectorial cooperation
212021|NCT02062528|EPA|epa
212022|NCT02062489|breast cancer,|breast cancer,
212023|NCT02062489|tamoxifen,|tamoxifen,
212024|NCT02062489|ER/PR negative, ER-beta positive|er/pr negative, er-beta positive
212025|NCT02062463|Asthma|asthma
212026|NCT02062450|Arthroplasty|arthroplasty
212027|NCT02062450|Hip Replacement|hip replacement
212028|NCT02062450|Acetabular cup|acetabular cup
212029|NCT02062450|Dual mobility|dual mobility
212030|NCT02062450|Hip revision surgery|hip revision surgery
212031|NCT02062437|Arthroplasty|arthroplasty
212032|NCT02062437|Hip Replacement|hip replacement
212033|NCT02062437|Ceramic|ceramic
212034|NCT02062437|Acetabular cup|acetabular cup
212035|NCT02062437|Femoral stem|femoral stem
212036|NCT02062424|ischemic heart disease, dietary guidelines|ischemic heart disease, dietary guidelines
212037|NCT02062411|attention deficit disorder (ADHD)|attention deficit disorder (adhd)
212038|NCT02062411|cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
212040|NCT02062398|PNP|pnp
212041|NCT02062398|Stimulation|stimulation
212042|NCT02062398|Peripheral neurostimulation|peripheral neurostimulation
212043|NCT02062372|7 T MRI|7 t mri
212742|NCT02059369|Recurrence|recurrence
212044|NCT02062372|Radiotherapy|radiotherapy
212045|NCT02062372|Glioblastoma|glioblastoma
212046|NCT02062372|Biopsy|biopsy
212047|NCT02062359|Malignant Melanoma|malignant melanoma
212048|NCT02062359|Metastatic Cancer|metastatic cancer
212049|NCT02062359|Gene Therapy|gene therapy
212050|NCT02062359|Immunotherapy|immunotherapy
212051|NCT02062359|Tumor Regression|tumor regression
212052|NCT02062346|endothelin;|endothelin;
212053|NCT02062346|blood pressure;|blood pressure;
212054|NCT02062346|vasculitis|vasculitis
212055|NCT02062333|dexmedetomidine|dexmedetomidine
212056|NCT02062333|esmolol|esmolol
212057|NCT02062333|stapes reflex|stapes reflex
212058|NCT02062320|Acute Pain Service|acute pain service
212059|NCT02062320|postoperative analgesia|postoperative analgesia
212060|NCT02062320|Caesarean Section|caesarean section
212061|NCT02062320|non-opioid analgesia|non-opioid analgesia
212062|NCT02062320|opioid analgesia|opioid analgesia
212063|NCT02062320|epidural analgesia|epidural analgesia
212064|NCT02062307|Hypogonadism|hypogonadism
212065|NCT02062307|Asymmetric Dimethyl Arginine|asymmetric dimethyl arginine
212066|NCT02062307|Osteoprotegerin|osteoprotegerin
212067|NCT02062307|Fibroblast Growth Factor|fibroblast growth factor
212068|NCT02062307|Vitamin D|vitamin d
212069|NCT02062281|Safety|safety
212070|NCT02062281|Immunogenicity|immunogenicity
212071|NCT02062281|vaccine|vaccine
212072|NCT02062281|pneumococcal|pneumococcal
212073|NCT02062281|influenza|influenza
212074|NCT02062268|KAP|kap
212075|NCT02062268|drink driving|drink driving
212076|NCT02062268|public|public
212077|NCT02062268|Jiangsu province|jiangsu province
212078|NCT02062268|China|china
212079|NCT02062255|Asprin|asprin
212080|NCT02062255|Omega-3 Free Fatty Acids|omega-3 free fatty acids
212081|NCT02062255|Obesity|obesity
212082|NCT02062255|COX-2 inhibitor|cox-2 inhibitor
212083|NCT02062242|Pelvic Floor|pelvic floor
212084|NCT02062242|Physical Therapy Specialty|physical therapy specialty
212085|NCT02062242|Awareness|awareness
212086|NCT02062242|Electric Stimulation|electric stimulation
212087|NCT02062242|Palpation|palpation
212088|NCT02062229|oxidative stress|oxidative stress
212089|NCT02062229|oxysterols|oxysterols
212090|NCT02062229|fatty acids|fatty acids
212091|NCT02062229|seminal fluid|seminal fluid
212092|NCT02062216|Coronary artery disease|coronary artery disease
212093|NCT02062216|Percutaneous coronary intervention|percutaneous coronary intervention
212094|NCT02062216|Inflammatory receptors|inflammatory receptors
212095|NCT02062203|Akebia|akebia
212096|NCT02062203|QT interval|qt interval
212097|NCT02062203|TQT|tqt
212098|NCT02062203|pharmacokinetic|pharmacokinetic
212099|NCT02062203|anemia|anemia
212100|NCT02062203|chronic kidney disease|chronic kidney disease
212101|NCT02062203|CKD|ckd
212102|NCT02062203|chronic renal insufficiency|chronic renal insufficiency
212103|NCT02062203|renal impairment|renal impairment
212104|NCT02062203|safety|safety
212105|NCT02062164|psychosocial, healthcare, co-morbidities, extremely obese adolescents|psychosocial, healthcare, co-morbidities, extremely obese adolescents
212106|NCT02062138|rehabilitation|rehabilitation
212107|NCT02062138|total knee arthroplasty|total knee arthroplasty
212108|NCT02062138|range of motion|range of motion
212109|NCT02062138|continuous passive motion|continuous passive motion
212110|NCT02062138|controlled active motion|controlled active motion
212111|NCT02062138|postoperative physical therapy|postoperative physical therapy
212112|NCT02062125|scleroderma|scleroderma
212113|NCT02062125|calcinosis|calcinosis
212114|NCT02062112|Bowel preparation solutions|bowel preparation solutions
212115|NCT02062112|Colonoscopy|colonoscopy
212116|NCT02062112|Polyethylene glycol|polyethylene glycol
212117|NCT02062086|Sarcopenia|sarcopenia
212118|NCT02062086|Mass muscle|mass muscle
212119|NCT02062086|Quality of life|quality of life
212120|NCT02062073|head lice|head lice
212121|NCT02062073|Hatchtech|hatchtech
212122|NCT02062060|Head Lice|head lice
212123|NCT02062060|Hatchtech|hatchtech
212124|NCT02062047|Diabetes Mellitus|diabetes mellitus
212125|NCT02062047|Chronic Periodontitis|chronic periodontitis
212126|NCT02062047|Root Planing|root planing
212127|NCT02062047|Cytokines|cytokines
212128|NCT02062047|microbiology|microbiology
212129|NCT02062047|Glycated hemoglobin|glycated hemoglobin
212130|NCT02062047|diabetic subjects|diabetic subjects
212131|NCT02062034|Oxidative stress|oxidative stress
212330|NCT02061215|HLA|hla
212132|NCT02062034|Mitochondrial dysfunction|mitochondrial dysfunction
212133|NCT02062034|Ubiquinone|ubiquinone
212134|NCT02062034|Antioxidant combined therapy|antioxidant combined therapy
212135|NCT02062034|Diabetic retinopathy|diabetic retinopathy
212136|NCT02062008|Positron Emission Tomography-Magnetic Resonance Imaging|positron emission tomography-magnetic resonance imaging
212137|NCT02062008|Cardiac Disease|cardiac disease
212138|NCT02061995|Bone Diseases|bone diseases
212139|NCT02061995|Metabolic Bone Diseases|metabolic bone diseases
212140|NCT02061995|Osteoporosis|osteoporosis
212141|NCT02061995|Bone Fractures|bone fractures
212142|NCT02061995|Osteoporotic Fractures|osteoporotic fractures
212143|NCT02061995|Musculoskeletal Diseases|musculoskeletal diseases
212743|NCT02059369|CFAE|cfae
212144|NCT02061982|Do It Yourself (DIY)|do it yourself (diy)
212145|NCT02061982|Caffeine|caffeine
212146|NCT02061982|Cognition|cognition
212147|NCT02061969|nursing home facility|nursing home facility
212148|NCT02061969|long-term care facility|long-term care facility
212149|NCT02061969|older patients|older patients
212150|NCT02061969|elderly patients|elderly patients
212151|NCT02061969|hyperglycemia|hyperglycemia
212152|NCT02061969|type 2 diabetes|type 2 diabetes
212153|NCT02061943|Spasmodic dysphonia|spasmodic dysphonia
678354|NCT00882583|Dasatinib|dasatinib
212154|NCT02061943|Laryngeal dystonia|laryngeal dystonia
212155|NCT02061943|Dystonia|dystonia
212156|NCT02061943|Severity|severity
212157|NCT02061930|single tooth|single tooth
212158|NCT02061930|dental implant|dental implant
212159|NCT02061930|aesthetics outcome|aesthetics outcome
212160|NCT02061930|long term|long term
212161|NCT02061930|soft tissue recession|soft tissue recession
212162|NCT02061930|pink esthetic score|pink esthetic score
212163|NCT02061930|white esthetic score|white esthetic score
212164|NCT02061917|Biomarkers|biomarkers
212165|NCT02061917|Tobacco|tobacco
212166|NCT02061917|Tobacco-heating|tobacco-heating
212167|NCT02061917|Smokeless Tobacco|smokeless tobacco
212168|NCT02061917|Snus|snus
212169|NCT02061917|Smoking|smoking
212170|NCT02061917|Exposure|exposure
212171|NCT02061917|Quality of Life|quality of life
212172|NCT02061891|Coronary Stenosis|coronary stenosis
212173|NCT02061891|Coronary Artery Disease|coronary artery disease
212174|NCT02061891|Acute coronary syndrome|acute coronary syndrome
212175|NCT02061891|Percutaneous Coronary Intervention|percutaneous coronary intervention
212176|NCT02061891|Multidetector Computed Tomography|multidetector computed tomography
212177|NCT02061878|ApoE|apoe
212178|NCT02061878|beta-amyloid|beta-amyloid
212179|NCT02061813|Hatchtech|hatchtech
212180|NCT02061800|Unrelated donor transplant|unrelated donor transplant
212303|NCT02061306|coeliac disease|coeliac disease
212181|NCT02061800|Allogenic Stem Cell Transplant|allogenic stem cell transplant
212182|NCT02061800|Adult Bone Marrow Transplant|adult bone marrow transplant
212183|NCT02061800|Pediatric Bone Marrow Transplant|pediatric bone marrow transplant
212184|NCT02061800|Related donor transplant|related donor transplant
212185|NCT02061800|Haploidentical donor transplant|haploidentical donor transplant
212186|NCT02061800|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
212187|NCT02061800|Non-malignant disease|non-malignant disease
212188|NCT02061800|Malignant disease|malignant disease
212189|NCT02061800|Bone marrow failure syndrome|bone marrow failure syndrome
212190|NCT02061800|Severe Aplastic Anemia|severe aplastic anemia
212191|NCT02061800|Severe Congenital Neutropenia|severe congenital neutropenia
212192|NCT02061800|Amegakaryocytic Thrombocytopenia|amegakaryocytic thrombocytopenia
212193|NCT02061800|Diamond-Blackfan Anemia|diamond-blackfan anemia
212194|NCT02061800|Schwachman Diamond Syndrome|schwachman diamond syndrome
212195|NCT02061800|Primary Immunodeficiency Syndrome|primary immunodeficiency syndrome
212196|NCT02061800|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
212197|NCT02061800|Histiocytic Syndrome|histiocytic syndrome
212198|NCT02061800|Familial Hemophagocytic Lymphocytosis|familial hemophagocytic lymphocytosis
212199|NCT02061800|Lymphohistiocytosis|lymphohistiocytosis
212200|NCT02061800|Macrophage Activation Syndrome|macrophage activation syndrome
212201|NCT02061800|Langerhans Cell Histiocytosis (LCH)|langerhans cell histiocytosis (lch)
212202|NCT02061800|Hemoglobinopathies|hemoglobinopathies
212203|NCT02061800|Reduced-Intensity Conditioning|reduced-intensity conditioning
212204|NCT02061800|Sickle Cell Disease|sickle cell disease
212205|NCT02061800|Sickle Cell-beta-thalassemia|sickle cell-beta-thalassemia
212206|NCT02061774|acetaminophen in transforaminal lumbar interbody fusion|acetaminophen in transforaminal lumbar interbody fusion
212207|NCT02061735|skin imaging|skin imaging
212208|NCT02061735|image analysis|image analysis
212209|NCT02061735|infrared thermography|infrared thermography
212210|NCT02061735|infantile hemangioma|infantile hemangioma
212211|NCT02061735|three dimensional imaging|three dimensional imaging
212212|NCT02061735|color imaging and analysis|color imaging and analysis
212213|NCT02061735|propranolol|propranolol
212214|NCT02061735|timolol|timolol
212215|NCT02061735|ontogeny|ontogeny
212216|NCT02061709|Rhinoconjunctivitis|rhinoconjunctivitis
212217|NCT02061709|Rhinitis|rhinitis
212218|NCT02061709|Seasonal|seasonal
212219|NCT02061709|Ragweed|ragweed
212220|NCT02061709|Allergy|allergy
212221|NCT02061696|Coronary Artery Disease|coronary artery disease
212222|NCT02061696|Coronary Disease|coronary disease
212223|NCT02061696|Heart disease|heart disease
212224|NCT02061696|Cardiovascular Diseases|cardiovascular diseases
212225|NCT02061696|Arteriosclerosis|arteriosclerosis
212226|NCT02061696|Atherosclerosis|atherosclerosis
212227|NCT02061696|Manual Compression|manual compression
212228|NCT02061670|Ragweed|ragweed
212229|NCT02061670|Allergy|allergy
212230|NCT02061670|rhinoconjunctivitis|rhinoconjunctivitis
212231|NCT02061670|rhinitis|rhinitis
212232|NCT02061670|asthma|asthma
212233|NCT02061618|South Asian|south asian
212234|NCT02061605|Laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
212235|NCT02061605|Surgical hemostasis|surgical hemostasis
212236|NCT02061605|Laser tissue welding|laser tissue welding
212237|NCT02061605|Tissue sealant|tissue sealant
212238|NCT02061579|Physical Activity|physical activity
212239|NCT02061566|Acute kidney injury|acute kidney injury
212240|NCT02061553|traumatic brain injury|traumatic brain injury
212241|NCT02061553|TBI|tbi
212242|NCT02061553|head injury|head injury
212243|NCT02061553|brain injury|brain injury
212244|NCT02061553|depression|depression
212245|NCT02061553|anxiety|anxiety
212246|NCT02061527|ADM|adm
212247|NCT02061527|Strattice|strattice
212248|NCT02061527|Breast reconstruction|breast reconstruction
212249|NCT02061527|Immediate breast reconstruction|immediate breast reconstruction
212250|NCT02061527|IBR|ibr
212251|NCT02061527|Acellular dermal matrix|acellular dermal matrix
212252|NCT02061527|Biological mesh|biological mesh
212253|NCT02061527|Randomized controlled trial|randomized controlled trial
212254|NCT02061527|RCT|rct
212255|NCT02061527|Breast cancer|breast cancer
212256|NCT02061527|Implants|implants
212257|NCT02061527|Mastectomy|mastectomy
212258|NCT02061527|Direct-to-implant|direct-to-implant
212259|NCT02061501|visual cognitive deficits|visual cognitive deficits
212260|NCT02061488|Artificial pancreas, closed loop glucose control, model predictive control|artificial pancreas, closed loop glucose control, model predictive control
212261|NCT02061475|Lidocaine patches|lidocaine patches
212262|NCT02061475|Pain|pain
212263|NCT02061475|Intravenous cannulation|intravenous cannulation
212264|NCT02061449|Toll-like receptor agonist|toll-like receptor agonist
212265|NCT02061449|immunostimulation|immunostimulation
212266|NCT02061436|chronic total occlusion, percutaneous coronary intervention|chronic total occlusion, percutaneous coronary intervention
212267|NCT02061423|Invasive Breast Cancer|invasive breast cancer
212268|NCT02061423|Breast Cancer|breast cancer
212269|NCT02061423|Immunotherapy|immunotherapy
212270|NCT02061423|Vaccine|vaccine
212271|NCT02061423|Dendritic Cell|dendritic cell
212272|NCT02061423|Neoadjuvant|neoadjuvant
212273|NCT02061410|Elderly|elderly
212274|NCT02061397|lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
212275|NCT02061397|tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
212276|NCT02061397|simvastatin|simvastatin
212277|NCT02061397|sirolimus|sirolimus
212278|NCT02061397|everolimus|everolimus
212279|NCT02061384|Infertility|infertility
212280|NCT02061371|stroke|stroke
212281|NCT02061371|spasticity|spasticity
212282|NCT02061371|physiotherapy|physiotherapy
212283|NCT02061371|virtual reality|virtual reality
212284|NCT02061358|Dengue|dengue
212285|NCT02061358|Arbovirus Infections|arbovirus infections
212286|NCT02061358|Flaviviridae Infections|flaviviridae infections
212287|NCT02061358|Flavivirus Infections|flavivirus infections
212288|NCT02061358|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
212289|NCT02061358|RNA Virus Infections|rna virus infections
212290|NCT02061358|Virus Diseases|virus diseases
212291|NCT02061358|Pharmaceutical Solutions|pharmaceutical solutions
212292|NCT02061358|Pharmacologic Actions|pharmacologic actions
212293|NCT02061358|Therapeutic Uses|therapeutic uses
212294|NCT02061345|Prostate cancer|prostate cancer
212295|NCT02061345|Androgen Deprivation Therapy|androgen deprivation therapy
212296|NCT02061345|Mild Cognitive Impairment|mild cognitive impairment
212297|NCT02061332|Breast Cancer|breast cancer
212298|NCT02061332|DCIS|dcis
212299|NCT02061332|Immunotherapy|immunotherapy
212300|NCT02061332|Vaccine|vaccine
212301|NCT02061332|Dendritic Cell|dendritic cell
212302|NCT02061306|Celiac disease|celiac disease
212304|NCT02061306|microbiome|microbiome
212305|NCT02061306|gluten|gluten
212306|NCT02061306|infants|infants
212307|NCT02061306|pregnancy|pregnancy
212308|NCT02061306|genetic|genetic
212309|NCT02061280|Asthma|asthma
212310|NCT02061280|Clinical Trial Design|clinical trial design
212311|NCT02061280|Electronic Data Entry|electronic data entry
212312|NCT02061280|Mobile Devices|mobile devices
212313|NCT02061280|Home Spirometry|home spirometry
212314|NCT02061267|Metabolic Syndrome|metabolic syndrome
212315|NCT02061267|Olive Oil|olive oil
212316|NCT02061267|Niacin|niacin
212317|NCT02061254|Venous insufficiency|venous insufficiency
212318|NCT02061254|Lymphedema|lymphedema
212319|NCT02061254|Elastograph|elastograph
212320|NCT02061254|Ultrasonography|ultrasonography
212321|NCT02061254|Fibrosis|fibrosis
212322|NCT02061254|Dermis|dermis
212323|NCT02061254|Hypodermis|hypodermis
212324|NCT02061254|Skin|skin
212325|NCT02061241|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
212326|NCT02061241|Pacing|pacing
212331|NCT02061202|Sickle Cell Disease|sickle cell disease
212332|NCT02061202|Pain Crisis|pain crisis
212333|NCT02061202|Painful Crisis|painful crisis
212334|NCT02061202|Sickle Pain|sickle pain
212335|NCT02061189|neuromuscular disease, Spinal Muscular Atrophy, Infantile,|neuromuscular disease, spinal muscular atrophy, infantile,
212336|NCT02061189|motor function measure, Hammersmith scale,|motor function measure, hammersmith scale,
212337|NCT02061189|rehabilitation program, physical exercise|rehabilitation program, physical exercise
212338|NCT02061176|Hemorrhoids|hemorrhoids
212339|NCT02061176|Haemorrhoids|haemorrhoids
212340|NCT02061176|Transanal Haemorrhoidal Dearterialization|transanal haemorrhoidal dearterialization
212341|NCT02061176|Transanal Hemorrhoidal Dearterialisation|transanal hemorrhoidal dearterialisation
212342|NCT02061176|Open Haemorrhoidectomy|open haemorrhoidectomy
212343|NCT02061176|Open Hemorrhoidectomy|open hemorrhoidectomy
212344|NCT02061150|Early onset GBS sepsis|early onset gbs sepsis
212345|NCT02061150|Prevention|prevention
212346|NCT02061150|Maternal risk factors|maternal risk factors
678355|NCT00882583|Cetuximab|cetuximab
212347|NCT02061137|Rett Syndrome (Mecp2 positive)|rett syndrome (mecp2 positive)
212348|NCT02061137|Fingolimod (FTY 720)|fingolimod (fty 720)
212349|NCT02061137|BDNF|bdnf
212350|NCT02061137|Brain Atrophy|brain atrophy
212351|NCT02061111|Mitochondria Function|mitochondria function
212352|NCT02061111|TPO-antibodies|tpo-antibodies
212353|NCT02061111|Subclinical Thyroid Disease|subclinical thyroid disease
212354|NCT02061111|Thyroid Disease In Pregnancy|thyroid disease in pregnancy
212355|NCT02061111|Children´s Development|children´s development
212356|NCT02061098|Pomegranate|pomegranate
212357|NCT02061098|Cardiovascular|cardiovascular
212358|NCT02061098|Urolithins|urolithins
212359|NCT02061098|Microbiota|microbiota
212360|NCT02061098|Polyphenols|polyphenols
212361|NCT02061098|Nutraceutical|nutraceutical
212362|NCT02061098|Dietary supplement|dietary supplement
212363|NCT02061085|Breast Neoplasm Metastasis|breast neoplasm metastasis
212364|NCT02061085|Receptor,HER-2|receptor,her-2
212365|NCT02061085|Eribulin|eribulin
212366|NCT02061085|Furans, quetones|furans, quetones
212367|NCT02061085|Antimitotic agent|antimitotic agent
212368|NCT02061072|pharmacokinetics|pharmacokinetics
212369|NCT02061072|population pharmacokinetics|population pharmacokinetics
212370|NCT02061072|hemophilia|hemophilia
212371|NCT02061072|factor VIII|factor viii
212372|NCT02061072|factor IX|factor ix
212373|NCT02061046|Gait|gait
212374|NCT02061046|Dual task|dual task
212375|NCT02061033|Hemophilia A|hemophilia a
212376|NCT02061033|Hemophilia B|hemophilia b
212377|NCT02061033|Von Willebrand's Disease|von willebrand's disease
212378|NCT02061033|Endogen thrombin potential|endogen thrombin potential
212379|NCT02061033|Overall hemostatic potential|overall hemostatic potential
212380|NCT02061033|Microparticles|microparticles
212381|NCT02061033|Fibrin clot|fibrin clot
212382|NCT02061020|delta-9-tetrahydrocannabinol, volunteers, cannabis users|delta-9-tetrahydrocannabinol, volunteers, cannabis users
212383|NCT02061007|skin cancer|skin cancer
212384|NCT02060981|Randomized controlled trial|randomized controlled trial
212385|NCT02060981|Primary medication adherence|primary medication adherence
212386|NCT02060981|Decision-support tool|decision-support tool
212387|NCT02060981|Patient-centered outcomes research|patient-centered outcomes research
212388|NCT02060981|Antihypertensive medications|antihypertensive medications
212389|NCT02060981|One-on-one patient interviews|one-on-one patient interviews
212390|NCT02060968|Promus PREMIER|promus premier
212391|NCT02060968|Routine Clinical Practice|routine clinical practice
212392|NCT02060955|Glioblastoma multiforme|glioblastoma multiforme
212393|NCT02060955|Immunotherapy|immunotherapy
212394|NCT02060955|Bevacizumab/Irinotecan|bevacizumab/irinotecan
212395|NCT02060955|ALECSAT|alecsat
212396|NCT02060955|recurrent|recurrent
212397|NCT02060942|Volume responsiveness mean systemic filling pressure|volume responsiveness mean systemic filling pressure
212398|NCT02060929|Healthy|healthy
212399|NCT02060929|Esketamine|esketamine
212400|NCT02060929|Intranasal|intranasal
212401|NCT02060929|Nasal Guide|nasal guide
212402|NCT02060929|Pharmacokinetics|pharmacokinetics
212403|NCT02060903|Head Lice|head lice
212404|NCT02060903|Hatchtech|hatchtech
212405|NCT02060890|Glioblastoma|glioblastoma
212406|NCT02060877|suspected lung cancer|suspected lung cancer
212407|NCT02060877|diagnostic work-up|diagnostic work-up
212408|NCT02060864|enzyme|enzyme
212409|NCT02060864|gluten|gluten
212410|NCT02060864|food intolerance|food intolerance
212411|NCT02060851|EPO|epo
212412|NCT02060851|Intravenous iron|intravenous iron
212413|NCT02060851|iron storage|iron storage
212414|NCT02060851|preterm anemia|preterm anemia
260427|NCT01842997|Flu|flu
212415|NCT02060812|ultrasound guided axillary nerve block|ultrasound guided axillary nerve block
212416|NCT02060812|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
212417|NCT02060812|ultrasound guided suprascapular nerve block|ultrasound guided suprascapular nerve block
212418|NCT02060812|rebound phenomenon of pain|rebound phenomenon of pain
212419|NCT02060799|Dyspnea|dyspnea
212420|NCT02060799|Emergency Service, Hospital|emergency service, hospital
212421|NCT02060799|prognosis|prognosis
212422|NCT02060799|Fatal Outcome|fatal outcome
212423|NCT02060799|Epidemiology|epidemiology
213606|NCT02055508|Exercise|exercise
212428|NCT02060773|Hepatic perfusion|hepatic perfusion
212429|NCT02060773|Indocyanine Green|indocyanine green
212435|NCT02060734|Whiplash,|whiplash,
212436|NCT02060734|injection,|injection,
212437|NCT02060734|lidocaine,|lidocaine,
212438|NCT02060734|sham needling|sham needling
5762|NCT03254433|Smoking Cessation|smoking cessation
212443|NCT02060682|Catheter|catheter
212444|NCT02060656|Relapsed or refractory Diffuse Large B-Cell Lymphoma after R-CHOP chemotherapy|relapsed or refractory diffuse large b-cell lymphoma after r-chop chemotherapy
212445|NCT02060630|Surgical revascularization|surgical revascularization
212446|NCT02060630|Endovascular revascularization|endovascular revascularization
212447|NCT02060630|Amputation|amputation
212448|NCT02060630|Peripheral artery disease|peripheral artery disease
212449|NCT02060630|Critical limb ischemia|critical limb ischemia
212450|NCT02060630|claudication|claudication
212451|NCT02060630|leg pain|leg pain
212452|NCT02060630|leg ulcer|leg ulcer
212453|NCT02060630|gangrene|gangrene
212454|NCT02060617|low back pain|low back pain
212455|NCT02060617|physical therapy|physical therapy
212456|NCT02060617|manual therapy|manual therapy
212457|NCT02060617|manipulation|manipulation
212458|NCT02060617|exercise|exercise
212459|NCT02060617|motor control|motor control
212460|NCT02060617|regional interdependence|regional interdependence
212461|NCT02060604|ketorolac|ketorolac
212462|NCT02060604|NSAIDs|nsaids
212463|NCT02060604|wet macular degeneration|wet macular degeneration
212464|NCT02060604|choroidal neovascularization|choroidal neovascularization
212465|NCT02060578|Cancer palliative care|cancer palliative care
212466|NCT02060578|Dead child|dead child
212467|NCT02060565|diagnosis|diagnosis
212468|NCT02060565|survival|survival
212469|NCT02060565|non-invasive method|non-invasive method
212470|NCT02060565|cirrhosis|cirrhosis
212471|NCT02060565|FibroScan|fibroscan
212472|NCT02060526|sulfoglucosamine sulfohydrolase (SGSH)|sulfoglucosamine sulfohydrolase (sgsh)
212473|NCT02060526|recombinant human heparan N-sulfatase (rhHNS)|recombinant human heparan n-sulfatase (rhhns)
212474|NCT02060526|Hunter's Syndrome|hunter's syndrome
212475|NCT02060526|Shire HGT|shire hgt
212476|NCT02060526|Lysosomal Storage Disease (LSD)|lysosomal storage disease (lsd)
212477|NCT02060526|Sanfilippo Syndrome Type A (Sanfilippo A)|sanfilippo syndrome type a (sanfilippo a)
212478|NCT02060526|enzyme replacement therapy (ERT)|enzyme replacement therapy (ert)
212479|NCT02060513|Wounded warriors|wounded warriors
212480|NCT02060513|Battlefield infection|battlefield infection
212481|NCT02060513|Acinetobacter|acinetobacter
212482|NCT02060513|ESBL|esbl
212483|NCT02060513|MRSA|mrsa
212485|NCT02060500|GERD|gerd
212486|NCT02060500|fundoplication|fundoplication
212487|NCT02060500|cardiaplication|cardiaplication
212488|NCT02060500|reflux|reflux
212489|NCT02060487|pulmonary arterial hypertension|pulmonary arterial hypertension
212490|NCT02060487|pulmonary hypertension|pulmonary hypertension
212492|NCT02060487|sildenafil|sildenafil
212493|NCT02060487|revatio|revatio
212494|NCT02060474|Allan-Herndon-Dudley Syndrome|allan-herndon-dudley syndrome
212495|NCT02060474|MCT8|mct8
212496|NCT02060474|Triac|triac
212497|NCT02060474|Therapeutic Trial|therapeutic trial
212498|NCT02060448|Non-suicidal self-injury|non-suicidal self-injury
212499|NCT02060448|Self-injurious behavior|self-injurious behavior
212500|NCT02060448|NSSI|nssi
212501|NCT02060448|Anxiety|anxiety
212502|NCT02060448|Depression|depression
212503|NCT02060448|Transdiagnostic|transdiagnostic
212505|NCT02060448|Unified Protocol|unified protocol
212506|NCT02060435|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
212507|NCT02060435|Ebstein-Barr Virus|ebstein-barr virus
212508|NCT02060422|Epilepsy|epilepsy
212509|NCT02060422|Drug-resistant epilepsy|drug-resistant epilepsy
212510|NCT02060422|Seizure|seizure
212511|NCT02060422|Mindfulness|mindfulness
212512|NCT02060422|Stress|stress
212513|NCT02060422|Psychotherapy|psychotherapy
212514|NCT02060409|myelodysplastic syndrome|myelodysplastic syndrome
212515|NCT02060409|decitabine|decitabine
212516|NCT02060409|spliceosome mutation|spliceosome mutation
212517|NCT02060383|Cushing's disease|cushing's disease
212518|NCT02060383|acromegaly|acromegaly
212519|NCT02060383|pasireotide|pasireotide
212520|NCT02060383|hyperglycemia|hyperglycemia
213609|NCT02055508|Lung Cancer|lung cancer
212521|NCT02060370|Genitourinary Cancer|genitourinary cancer
212522|NCT02060370|Kidney Cancer|kidney cancer
212523|NCT02060370|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
212524|NCT02060370|mRCC|mrcc
212525|NCT02060370|Sunitinib|sunitinib
212526|NCT02060370|Sunitinib malate|sunitinib malate
212527|NCT02060370|SUO11248|suo11248
212528|NCT02060370|Sutent|sutent
212529|NCT02060370|Questionnaire|questionnaire
212530|NCT02060370|Survey|survey
212531|NCT02060357|Diabetes Mellitus|diabetes mellitus
212532|NCT02060357|PCI|pci
5763|NCT03254433|Weight Loss|weight loss
212533|NCT02060357|Drug eluting stent|drug eluting stent
212534|NCT02060357|OCT|oct
212535|NCT02060344|Cardiovascular Disease|cardiovascular disease
212536|NCT02060344|Hispanic|hispanic
212537|NCT02060344|Latinos|latinos
212538|NCT02060331|Nocturia|nocturia
212539|NCT02060331|Pelvic Organ Prolapse|pelvic organ prolapse
212540|NCT02060331|Nocturnal Polyuria|nocturnal polyuria
212541|NCT02060331|Post-obstructive Diuresis|post-obstructive diuresis
212542|NCT02060318|Crohn Disease|crohn disease
212543|NCT02060318|Regulatory T-cells|regulatory t-cells
212544|NCT02060318|Infliximab|infliximab
212545|NCT02060292|COPD|copd
212546|NCT02060292|Cognitive Function|cognitive function
212547|NCT02060292|MRI Brain|mri brain
212548|NCT02060292|Aortic Stiffness|aortic stiffness
212549|NCT02060292|Cerebrovascular disease|cerebrovascular disease
212551|NCT02060279|Diabetes Mellitus|diabetes mellitus
212552|NCT02060279|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
212553|NCT02060279|Prevention|prevention
212554|NCT02060279|Behavioral research|behavioral research
212555|NCT02060279|Metabolic Syndrome|metabolic syndrome
212556|NCT02060279|Metabolic Disease|metabolic disease
212557|NCT02060279|Overnutrition|overnutrition
212558|NCT02060279|Nutrition Disorders|nutrition disorders
212559|NCT02060279|Overweight|overweight
212560|NCT02060279|Body weight|body weight
212561|NCT02060279|Insulin resistance|insulin resistance
212562|NCT02060279|Carotenoids|carotenoids
212563|NCT02060279|Dietary Supplement|dietary supplement
212564|NCT02060279|Physical fitness|physical fitness
212565|NCT02060279|Sedentary lifestyle|sedentary lifestyle
212566|NCT02060240|Obesity|obesity
212567|NCT02060240|Prediabetic State|prediabetic state
212568|NCT02060240|Sedentary Lifestyle|sedentary lifestyle
212569|NCT02060240|Insulin Resistance|insulin resistance
212570|NCT02060240|Endothelium|endothelium
212571|NCT02060240|Eicosanoids|eicosanoids
212572|NCT02060240|Nitric Oxide|nitric oxide
212573|NCT02060240|Regional Blood Flow|regional blood flow
212574|NCT02060175|Optical coherence tomography, Drug-eluting stent, Strut coverage|optical coherence tomography, drug-eluting stent, strut coverage
212575|NCT02060162|antiretroviral therapy|antiretroviral therapy
212576|NCT02060162|Hepatitis C virus|hepatitis c virus
212577|NCT02060149|Extensively Drug Resistant A. Baumannii|extensively drug resistant a. baumannii
212578|NCT02060136|Electronic micturition chart, validation|electronic micturition chart, validation
212579|NCT02060123|Qigong|qigong
212580|NCT02060123|Telomerase|telomerase
212581|NCT02060123|Perceived stress|perceived stress
212583|NCT02060123|Chinese|chinese
212584|NCT02060123|Abused women|abused women
212585|NCT02060123|intervention|intervention
212586|NCT02060123|Depression|depression
212587|NCT02060110|CRT|crt
212588|NCT02060110|HEART FAILURE|heart failure
212589|NCT02060097|Anti-aging|anti-aging
212590|NCT02060097|High-flavanol cocoa|high-flavanol cocoa
212591|NCT02060084|preterm;|preterm;
212592|NCT02060084|Intestinal flora;|intestinal flora;
212593|NCT02060084|early Micro-feeding|early micro-feeding
212594|NCT02060084|Feeding intolerance|feeding intolerance
212595|NCT02060071|aortic stenosis|aortic stenosis
212596|NCT02060058|hepatitis C virus|hepatitis c virus
212597|NCT02060058|hepatitis B virus|hepatitis b virus
212598|NCT02060058|boceprevir|boceprevir
212599|NCT02060058|null responder|null responder
212600|NCT02060058|partial responder|partial responder
212601|NCT02060058|relapser|relapser
212602|NCT02060045|bundle|bundle
212603|NCT02060045|prevention|prevention
212604|NCT02060045|Disturbance; Heart, Functional, Postoperative, Cardiac Surgery|disturbance; heart, functional, postoperative, cardiac surgery
212605|NCT02060032|Chronic periodontitis, Local drug delivery,|chronic periodontitis, local drug delivery,
212606|NCT02060019|Pharmacokinetics|pharmacokinetics
212607|NCT02060019|Pharmacodynamics|pharmacodynamics
212608|NCT02060019|Safety|safety
212609|NCT02060019|Tolerability|tolerability
212610|NCT02060006|TB|tb
212611|NCT02060006|IRIS|iris
212612|NCT02059993|continuous positive airway pressure|continuous positive airway pressure
212613|NCT02059993|hypertension|hypertension
212614|NCT02059993|coronary heart disease|coronary heart disease
212615|NCT02059993|metabolic disorder|metabolic disorder
212616|NCT02059993|obstructive sleep apnea|obstructive sleep apnea
212617|NCT02059980|OCD|ocd
212618|NCT02059980|Trichotillomania|trichotillomania
212619|NCT02059980|Response inhibition|response inhibition
212620|NCT02059980|Cognitive training|cognitive training
212621|NCT02059967|Lung|lung
212622|NCT02059954|Hysterectomy|hysterectomy
212623|NCT02059941|Severe traumatic brain injury, ICP, Latin America, outcomes|severe traumatic brain injury, icp, latin america, outcomes
212624|NCT02059928|fluid resuscitation|fluid resuscitation
212625|NCT02059928|invasive pressure monitoring|invasive pressure monitoring
212626|NCT02059915|pharmacokinetics|pharmacokinetics
212627|NCT02059915|bioequivalence|bioequivalence
212628|NCT02059915|bioavailability|bioavailability
212629|NCT02059915|oxycodone|oxycodone
212630|NCT02059902|Pain management|pain management
212631|NCT02059902|Narcotic consumption|narcotic consumption
212632|NCT02059902|Skin graft|skin graft
212633|NCT02059889|Lung|lung
212634|NCT02059876|breast cancer|breast cancer
212635|NCT02059876|dose dense|dose dense
212636|NCT02059876|neoadjuvant treatment|neoadjuvant treatment
212637|NCT02059876|pathologic complete response|pathologic complete response
212638|NCT02059863|cluster randomised trial|cluster randomised trial
212639|NCT02059863|low and middle income countries|low and middle income countries
212640|NCT02059863|community based intervention|community based intervention
212641|NCT02059863|complex intervention|complex intervention
212642|NCT02059824|Eyelid sensation, aesthesiometer|eyelid sensation, aesthesiometer
212643|NCT02059811|Kidney Diseases|kidney diseases
212644|NCT02059811|Renal Insufficiency, Chronic|renal insufficiency, chronic
212645|NCT02059811|Diet|diet
212646|NCT02059811|DASH diet|dash diet
212647|NCT02059811|Hypertension|hypertension
212648|NCT02059811|Vascular diseases|vascular diseases
212844|NCT02058849|Beetroot|beetroot
212649|NCT02059811|Cardiovascular Diseases|cardiovascular diseases
212650|NCT02059811|Blood pressure|blood pressure
212651|NCT02059798|Myelopathy|myelopathy
212652|NCT02059785|Pinocembrin for Injection|pinocembrin for injection
212653|NCT02059785|Placebo|placebo
212655|NCT02059759|low-dose interleukin 2|low-dose interleukin 2
212656|NCT02059746|cesarean section|cesarean section
212657|NCT02059746|vaginal birth|vaginal birth
212658|NCT02059746|twins|twins
212659|NCT02059746|urinary incontinence|urinary incontinence
212660|NCT02059746|sexuality|sexuality
212661|NCT02059746|quality of life|quality of life
212662|NCT02059733|18F-DTBZ|18f-dtbz
212663|NCT02059720|acute myeloid leukemia|acute myeloid leukemia
212664|NCT02059720|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
212665|NCT02059720|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
212666|NCT02059720|maintenance treatment|maintenance treatment
212667|NCT02059720|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
212668|NCT02059694|Eyelid surgery|eyelid surgery
212669|NCT02059694|local block/anesthesia|local block/anesthesia
212670|NCT02059694|hyaluronidase|hyaluronidase
212671|NCT02059694|Bilateral upper eyelid surgery|bilateral upper eyelid surgery
212672|NCT02059694|Duke Eye Centre|duke eye centre
212673|NCT02059694|Duke Aesthetic Center|duke aesthetic center
212674|NCT02059668|locally advanced head and neck cancer|locally advanced head and neck cancer
212675|NCT02059668|biomarkers|biomarkers
212676|NCT02059668|definitive treatment|definitive treatment
212677|NCT02059668|adjuvant treatment|adjuvant treatment
212678|NCT02059668|radiochemotherapy|radiochemotherapy
212679|NCT02059655|Graves' disease|graves' disease
212680|NCT02059629|Heart failure|heart failure
212681|NCT02059629|Eluna pacemaker family|eluna pacemaker family
212682|NCT02059629|Sentus OTW BP L left ventricular lead|sentus otw bp l left ventricular lead
212683|NCT02059629|Bradycardia|bradycardia
212684|NCT02059629|SADE-free rate|sade-free rate
212685|NCT02059603|Electroacupuncture|electroacupuncture
212686|NCT02059603|Fast track program|fast track program
212687|NCT02059603|Postoperative ileus|postoperative ileus
212688|NCT02059603|Laparoscopic surgery|laparoscopic surgery
212689|NCT02059603|Colorectal surgery|colorectal surgery
212690|NCT02059603|Randomized controlled trial|randomized controlled trial
212691|NCT02059603|Hospital stay|hospital stay
212692|NCT02059590|14C-labeled isavuconazonium sulfate|14c-labeled isavuconazonium sulfate
212693|NCT02059590|Pyridinylmethyl-14C-labeled isavuconazonium sulfate|pyridinylmethyl-14c-labeled isavuconazonium sulfate
212694|NCT02059590|Healthy Subjects|healthy subjects
212695|NCT02059590|BAL8728|bal8728
212696|NCT02059590|BAL4815|bal4815
212697|NCT02059577|vitamins|vitamins
212698|NCT02059577|minerals|minerals
212699|NCT02059577|essential fatty acids|essential fatty acids
212700|NCT02059577|Epsom salts|epsom salts
212701|NCT02059577|carnitine|carnitine
212702|NCT02059577|digestive enzymes|digestive enzymes
212703|NCT02059577|gluten-free casein-free diet|gluten-free casein-free diet
212704|NCT02059564|Diabetes Mellitus|diabetes mellitus
212705|NCT02059564|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
212706|NCT02059564|Glucose Metabolism Disorders|glucose metabolism disorders
212707|NCT02059564|Metabolic Diseases|metabolic diseases
212708|NCT02059564|Endocrine System Diseases|endocrine system diseases
212709|NCT02059564|Exendin-4|exendin-4
212710|NCT02059551|pulmonary embolism|pulmonary embolism
212711|NCT02059551|magnetic resonance imaging|magnetic resonance imaging
212712|NCT02059551|venous ultrasonography of the legs|venous ultrasonography of the legs
212713|NCT02059551|diagnostic performances|diagnostic performances
212714|NCT02059538|Obesity|obesity
260772|NCT01841216|TFL|tfl
212715|NCT02059538|Type 2 diabetes|type 2 diabetes
212716|NCT02059538|Coronary artery diseases|coronary artery diseases
212717|NCT02059538|Microbiota|microbiota
212718|NCT02059538|Omics (ie transcriptomics, metabolomics, metagenomics, lipidomics)|omics (ie transcriptomics, metabolomics, metagenomics, lipidomics)
212719|NCT02059525|observational|observational
212720|NCT02059525|Belgium|belgium
212721|NCT02059512|ischemic heart disease,|ischemic heart disease,
212722|NCT02059512|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
212723|NCT02059512|coronary artery bypass grafting|coronary artery bypass grafting
212724|NCT02059460|Terlipressin|terlipressin
212725|NCT02059460|Acute kidney injury|acute kidney injury
212726|NCT02059460|Liver transplantation|liver transplantation
212727|NCT02059460|NGAL|ngal
212728|NCT02059447|Controlled trial|controlled trial
212729|NCT02059447|Active control|active control
212730|NCT02059447|Waiting, non treatment, period|waiting, non treatment, period
212731|NCT02059447|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
212732|NCT02059447|Relaxation Therapy|relaxation therapy
212733|NCT02059421|Johrei therapy|johrei therapy
212734|NCT02059421|Sleep|sleep
212735|NCT02059421|CBT-I|cbt-i
212736|NCT02059421|Critical illness|critical illness
212737|NCT02059382|daily physical activity|daily physical activity
212738|NCT02059382|exercise|exercise
212739|NCT02059382|social support|social support
212740|NCT02059382|online social network|online social network
212741|NCT02059369|Atrial fibrillation|atrial fibrillation
212744|NCT02059369|linear ablation|linear ablation
212745|NCT02059356|Dementia|dementia
212746|NCT02059356|Alzheimer's|alzheimer's
212747|NCT02059356|Alzheimers|alzheimers
212748|NCT02059356|Cognitive decline|cognitive decline
212749|NCT02059356|Cognitive impairment|cognitive impairment
212750|NCT02059356|Memory loss|memory loss
212751|NCT02059356|Memory disorder|memory disorder
212752|NCT02059356|Forgetfulness|forgetfulness
212753|NCT02059356|Confusion|confusion
212754|NCT02059356|Senile|senile
212755|NCT02059356|Demented|demented
212756|NCT02059356|Developmental delay|developmental delay
212757|NCT02059356|Portal systemic shunting|portal systemic shunting
212758|NCT02059356|High ammonia level|high ammonia level
212759|NCT02059356|Elevated ammonia level|elevated ammonia level
212760|NCT02059343|pharmacokinetics|pharmacokinetics
212761|NCT02059343|pharmacodynamics|pharmacodynamics
212762|NCT02059343|safety|safety
212763|NCT02059343|dexmedetomidine|dexmedetomidine
212764|NCT02059343|cardiopulmonary bypass|cardiopulmonary bypass
212765|NCT02059343|children|children
212766|NCT02059330|Japanese PK-Bridging Study|japanese pk-bridging study
212767|NCT02059330|dose-proportionality study|dose-proportionality study
212768|NCT02059330|Palbociclib|palbociclib
212769|NCT02059330|PD-0332991|pd-0332991
212770|NCT02059330|healthy volunteers|healthy volunteers
212771|NCT02059304|cervical length|cervical length
212772|NCT02059304|prediction of preterm delivery|prediction of preterm delivery
212773|NCT02059291|Canakinumab, interleukin-1, Hereditary Periodic Fevers, auto-inflammatory diseases|canakinumab, interleukin-1, hereditary periodic fevers, auto-inflammatory diseases
212774|NCT02059278|Primary open angle glaucoma|primary open angle glaucoma
212775|NCT02059278|Ocular hypertension|ocular hypertension
212776|NCT02059239|NHL|nhl
212777|NCT02059239|HL|hl
212778|NCT02059239|Lymphoma|lymphoma
212779|NCT02059200|Randomised controlled trial|randomised controlled trial
212780|NCT02059200|Recurrent depression|recurrent depression
212781|NCT02059200|Mindfulness training|mindfulness training
212782|NCT02059200|Compassion training (MBCL)|compassion training (mbcl)
212783|NCT02059200|Fear of Compassion|fear of compassion
212784|NCT02059200|Added value Compassion|added value compassion
212785|NCT02059135|Preeclampsia|preeclampsia
212786|NCT02059135|Preterm preeclampsia|preterm preeclampsia
212787|NCT02059135|Pregnancy|pregnancy
212788|NCT02059109|Belmont|belmont
212789|NCT02059109|Rapid|rapid
212790|NCT02059109|Infuser|infuser
212791|NCT02059109|proficiency|proficiency
212792|NCT02059109|proficient|proficient
212793|NCT02059109|training|training
212794|NCT02059096|Multiple Sclerosis|multiple sclerosis
212795|NCT02059096|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
212796|NCT02059096|Chronic neuropathic pain|chronic neuropathic pain
212797|NCT02059096|Cortical excitability|cortical excitability
212798|NCT02059083|adolescent|adolescent
212799|NCT02059083|cannabis|cannabis
212800|NCT02059083|biofeedback|biofeedback
212801|NCT02059070|Nerve Block/adverse effects|nerve block/adverse effects
212802|NCT02059070|Phrenic Nerve|phrenic nerve
212803|NCT02059070|Respiratory function|respiratory function
212804|NCT02059070|Pain measurement|pain measurement
212805|NCT02059044|patient safety|patient safety
212806|NCT02059044|pharmacoepidemiology|pharmacoepidemiology
212807|NCT02059044|health services research|health services research
212808|NCT02059044|adherence|adherence
203599|NCT02101489|TVT|tvt
212809|NCT02059044|information technology|information technology
212810|NCT02059031|integrase inhibitor|integrase inhibitor
212811|NCT02059031|pharmacokinetics|pharmacokinetics
212812|NCT02059031|HIV|hiv
213610|NCT02055508|NSCLC|nsclc
212813|NCT02059031|relative bioavailability|relative bioavailability
212814|NCT02059031|food|food
212815|NCT02059031|GSK1265744|gsk1265744
212816|NCT02059005|Addiction|addiction
212817|NCT02059005|Substance Use Disorder|substance use disorder
212818|NCT02059005|Rehospitalization|rehospitalization
212819|NCT02059005|Community Disease Management|community disease management
212820|NCT02059005|Behavioral Health|behavioral health
212821|NCT02059005|Community Health Worker|community health worker
212822|NCT02058992|Drug therapy|drug therapy
212823|NCT02058966|Entacapone|entacapone
212824|NCT02058966|COMT val158met|comt val158met
212825|NCT02058966|Methamphetamine|methamphetamine
212826|NCT02058953|Melanoma|melanoma
212827|NCT02058953|skin cancer|skin cancer
212828|NCT02058953|brain metastases|brain metastases
212829|NCT02058953|craniotomy|craniotomy
212830|NCT02058927|HIV|hiv
212831|NCT02058927|ART|art
212832|NCT02058927|children|children
212833|NCT02058914|Sugar sweetened beverages|sugar sweetened beverages
212834|NCT02058914|metabolism|metabolism
212835|NCT02058914|endocrine|endocrine
212836|NCT02058914|lipids|lipids
212837|NCT02058914|blood glucose|blood glucose
212838|NCT02058901|sunitinib|sunitinib
212839|NCT02058901|solid tumors|solid tumors
212840|NCT02058888|metagenomics|metagenomics
212841|NCT02058888|antimicrobial resistance|antimicrobial resistance
212842|NCT02058888|multidrug resistance|multidrug resistance
212843|NCT02058849|Mucositis|mucositis
212845|NCT02058849|Head and neck cancer|head and neck cancer
212846|NCT02058836|Chronic testicular pain|chronic testicular pain
212847|NCT02058836|Orchialgia|orchialgia
212848|NCT02058836|Botulinum toxin|botulinum toxin
212849|NCT02058836|Botox|botox
212850|NCT02058836|Urology|urology
212851|NCT02058823|Hypoxia|hypoxia
212852|NCT02058823|Sleep apnea|sleep apnea
212853|NCT02058823|Valsartan|valsartan
212854|NCT02058823|Amlodipine|amlodipine
212855|NCT02058823|Healthy subjects|healthy subjects
212856|NCT02058823|Randomized|randomized
212857|NCT02058823|Cross-over|cross-over
212858|NCT02058823|International|international
212859|NCT02058823|Sympathetic nervous system|sympathetic nervous system
212860|NCT02058810|nasal high flow oxygen|nasal high flow oxygen
212861|NCT02058810|cardio-renal syndrom|cardio-renal syndrom
212862|NCT02058810|heartfailure|heartfailure
212863|NCT02058797|Procrastination|procrastination
212864|NCT02058797|Coherence Therapy|coherence therapy
212865|NCT02058797|Cognitive Behavioral Therapy|cognitive behavioral therapy
212866|NCT02058797|Repertory Grid Technique|repertory grid technique
212867|NCT02058797|Cognitive Conflicts|cognitive conflicts
212868|NCT02058797|Personal Dilemmas|personal dilemmas
212869|NCT02058771|Action potential duration restitution|action potential duration restitution
212870|NCT02058771|Ventricular arrhythmia|ventricular arrhythmia
212871|NCT02058771|Sudden cardiac death|sudden cardiac death
212872|NCT02058771|Body-surface potential mapping|body-surface potential mapping
212873|NCT02058771|Electrocardiogram|electrocardiogram
212874|NCT02058758|Breast cancer|breast cancer
212875|NCT02058758|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
212876|NCT02058758|Diffusion weighted imaging|diffusion weighted imaging
212877|NCT02058745|Neuro-oncology|neuro-oncology
212878|NCT02058745|Caregivers|caregivers
212879|NCT02058745|Intervention Research|intervention research
212880|NCT02058745|Representational Approach|representational approach
212881|NCT02058745|Cognitive Behavioral Therapy|cognitive behavioral therapy
212882|NCT02058745|Family|family
212883|NCT02058745|Internet|internet
212884|NCT02058680|prostate specific antigen (PSA)|prostate specific antigen (psa)
212885|NCT02058667|Breast Cancer|breast cancer
212886|NCT02058667|Paclitaxel|paclitaxel
212887|NCT02058667|Helical Tomotherapy|helical tomotherapy
212888|NCT02058667|Chest wall|chest wall
212889|NCT02058654|Creatine|creatine
212890|NCT02058654|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
212891|NCT02058654|Phosphorus-31 magnetic resonance spectroscopy (31P-MRS)|phosphorus-31 magnetic resonance spectroscopy (31p-mrs)
212892|NCT02058641|cellular accumulation|cellular accumulation
212893|NCT02058641|macrophage phenotype|macrophage phenotype
212894|NCT02058641|cantharidin blister|cantharidin blister
212895|NCT02058641|M1/M2|m1/m2
212896|NCT02058641|inflammatory mediators|inflammatory mediators
212897|NCT02058641|Type 2 diabetes mellitus|type 2 diabetes mellitus
212898|NCT02058641|darapladib|darapladib
212899|NCT02058641|cytokines|cytokines
212900|NCT02058628|azelaic acid|azelaic acid
212901|NCT02058628|Clindamycin|clindamycin
212902|NCT02058628|Benzoyl peroxide|benzoyl peroxide
212903|NCT02058628|Acne vulgaris|acne vulgaris
212904|NCT02058615|Male caregivers|male caregivers
212905|NCT02058615|Breast cancer|breast cancer
212906|NCT02058615|Intervention|intervention
212907|NCT02058615|Online toolkit|online toolkit
212908|NCT02058602|HRCT|hrct
212909|NCT02058602|Airway morphometry|airway morphometry
212910|NCT02058602|Resistivity|resistivity
212911|NCT02058602|Inhalation Profiles|inhalation profiles
212912|NCT02058602|Inhaler|inhaler
212913|NCT02058602|Pharyngometry|pharyngometry
212914|NCT02058602|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
212915|NCT02058589|Immunocompromised|immunocompromised
212916|NCT02058589|Safety|safety
212917|NCT02058589|≥ 18 years of age|≥ 18 years of age
212918|NCT02058589|Renal transplant|renal transplant
212919|NCT02058589|Adults|adults
212920|NCT02058589|Immunosuppressed|immunosuppressed
212921|NCT02058589|Immunogenicity|immunogenicity
212922|NCT02058589|Herpes zoster|herpes zoster
212923|NCT02058576|combination of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg|combination of dutasteride 0.5 mg and tamsulosin hcl 0.4 mg
212924|NCT02058576|Tamsulosin|tamsulosin
212925|NCT02058576|healthy subject|healthy subject
212926|NCT02058576|bioequivalence|bioequivalence
212927|NCT02058576|GI198745|gi198745
212928|NCT02058576|dutasteride|dutasteride
212929|NCT02058576|tamsulosin hydrochloride|tamsulosin hydrochloride
212930|NCT02058563|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
212932|NCT02058563|Immunogenicity|immunogenicity
212933|NCT02058524|Ulcerative Colitis|ulcerative colitis
212934|NCT02058524|Fecal Microbiota Transplantation|fecal microbiota transplantation
212935|NCT02058498|Liver transplant|liver transplant
212936|NCT02058498|Physical Activity|physical activity
212937|NCT02058498|Quality of Life|quality of life
212938|NCT02058485|hypertension|hypertension
212939|NCT02058485|dexmedetomidine|dexmedetomidine
212940|NCT02058485|midazolam|midazolam
212941|NCT02058485|premedication|premedication
213034|NCT02057952|Multiple Chronic Conditions|multiple chronic conditions
213427|NCT02056379|budesonide|budesonide
212942|NCT02058459|Chronic obstructive pulmonary disease, targeted lung denervation, intervention, device, safety, lung function, Holaira|chronic obstructive pulmonary disease, targeted lung denervation, intervention, device, safety, lung function, holaira
212943|NCT02058433|Chemotherapy|chemotherapy
212944|NCT02058433|Individual Paclitaxel dose|individual paclitaxel dose
212945|NCT02058433|pharmacokinetics|pharmacokinetics
212946|NCT02058420|bone health|bone health
212947|NCT02058407|food effect|food effect
212948|NCT02058407|pharmacokinetics|pharmacokinetics
212949|NCT02058407|GSK2793660|gsk2793660
212950|NCT02058407|FTIH|ftih
212951|NCT02058407|pharmacodynamics|pharmacodynamics
212952|NCT02058407|safety|safety
212953|NCT02058394|Retained nuclear lens fragments|retained nuclear lens fragments
212954|NCT02058394|Phacoemulsification|phacoemulsification
212955|NCT02058394|Cataract Surgery|cataract surgery
212956|NCT02058368|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
212957|NCT02058368|Quality of Life|quality of life
212958|NCT02058342|Prader Willi syndrome|prader willi syndrome
212959|NCT02058342|Obesity|obesity
212960|NCT02058342|Childhood|childhood
212961|NCT02058342|Family|family
212962|NCT02058342|Interactive games|interactive games
212963|NCT02058342|Playground games|playground games
212964|NCT02058342|Exercise routine|exercise routine
212965|NCT02058329|Hip fracture|hip fracture
212966|NCT02058329|postoperative complications|postoperative complications
212967|NCT02058329|Depression|depression
212968|NCT02058329|Environmental Hazards|environmental hazards
212969|NCT02058329|FIM scores|fim scores
212970|NCT02058329|Falls|falls
212971|NCT02058303|hand surgery|hand surgery
212972|NCT02058303|wrist surgery|wrist surgery
212973|NCT02058303|finger surgery|finger surgery
212974|NCT02058303|anesthesia|anesthesia
212975|NCT02058303|regional anesthesia|regional anesthesia
212976|NCT02058303|postoperative pain|postoperative pain
212977|NCT02058290|laparoscopic colectomy|laparoscopic colectomy
212978|NCT02058277|bosutinib|bosutinib
212979|NCT02058277|aprepitant|aprepitant
212980|NCT02058277|drug interaction|drug interaction
212981|NCT02058277|healthy volunteers|healthy volunteers
212982|NCT02058277|pharmacokinetics|pharmacokinetics
212983|NCT02058277|chronic myelogenous leukemia|chronic myelogenous leukemia
212984|NCT02058251|Alcohol|alcohol
212985|NCT02058251|Oxytocin|oxytocin
212986|NCT02058251|Stress reactivity|stress reactivity
212987|NCT02058238|Robotic-guided spinal fusions|robotic-guided spinal fusions
212988|NCT02058238|Scoliosis|scoliosis
212989|NCT02058238|Kyphoscoliosis|kyphoscoliosis
212990|NCT02058238|Spinal deformity|spinal deformity
212991|NCT02058238|Spondylosis|spondylosis
212992|NCT02058225|Infant Nutrition|infant nutrition
212993|NCT02058225|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
212994|NCT02058225|Infant Brain Development|infant brain development
212995|NCT02058225|Diffusion weighted Imaging|diffusion weighted imaging
212996|NCT02058225|Diffusion tensor tractography|diffusion tensor tractography
212997|NCT02058212|ICSI|icsi
212998|NCT02058212|antioxidants|antioxidants
212999|NCT02058212|ROS|ros
213000|NCT02058212|endometriosis|endometriosis
213001|NCT02058199|gastric bypass|gastric bypass
213002|NCT02058199|rivaroxaban|rivaroxaban
213003|NCT02058199|pharmacodynamics|pharmacodynamics
203794|NCT02100488|Closed-loop insulin infusion|closed-loop insulin infusion
213004|NCT02058186|Atopic dermatitis, vitamin D supplementation, cathelicidin, Staphylococcus aureus colonization, SCORAD score|atopic dermatitis, vitamin d supplementation, cathelicidin, staphylococcus aureus colonization, scorad score
213005|NCT02058121|Eating disorders|eating disorders
213006|NCT02058121|Acceptance and Commitment Therapy|acceptance and commitment therapy
213007|NCT02058121|Body image|body image
213008|NCT02058108|Chronic hepatitis B, pediatrics, antiviral treatment, telbivudine|chronic hepatitis b, pediatrics, antiviral treatment, telbivudine
213009|NCT02058082|Failure to Conceive Due to Infertility of Male Partner|failure to conceive due to infertility of male partner
213010|NCT02058082|DNA Damage|dna damage
213011|NCT02058056|Early prophylactic|early prophylactic
213012|NCT02058056|cranial irradiation|cranial irradiation
213013|NCT02058056|hippocampal avoidance|hippocampal avoidance
213014|NCT02058056|limited disease small-cell lung cancer|limited disease small-cell lung cancer
213015|NCT02058030|ProSeal laryngeal mask airway|proseal laryngeal mask airway
213016|NCT02058030|Insertion success|insertion success
213017|NCT02058030|complication|complication
213018|NCT02058004|Microaspiration|microaspiration
213019|NCT02058004|ARDS|ards
213020|NCT02058004|Hospital acquired pneumonia|hospital acquired pneumonia
213021|NCT02058004|Cricoid pressure|cricoid pressure
213022|NCT02057978|Late Lumen Loss|late lumen loss
213023|NCT02057978|MACE|mace
213024|NCT02057978|Death|death
213025|NCT02057978|TLF|tlf
213026|NCT02057978|Thrombosis(definite or probable )|thrombosis(definite or probable )
213027|NCT02057965|Mesenchymal Stromal Cells|mesenchymal stromal cells
213028|NCT02057965|Allograft rejection|allograft rejection
213029|NCT02057965|Fibrosis|fibrosis
213030|NCT02057952|Weight Management|weight management
213031|NCT02057952|Diabetes|diabetes
213032|NCT02057952|Exercise|exercise
213033|NCT02057952|Portion Control|portion control
213321|NCT02056756|CBD|cbd
213035|NCT02057939|Prostate cancer|prostate cancer
213036|NCT02057939|enzalutamide|enzalutamide
213037|NCT02057939|ADT|adt
213038|NCT02057939|radiation|radiation
213039|NCT02057926|Membrane degradation|membrane degradation
213040|NCT02057926|Collagen membrane bio-durability|collagen membrane bio-durability
213041|NCT02057913|Penile neoplasms|penile neoplasms
213042|NCT02057913|Chemotherapy|chemotherapy
213043|NCT02057913|Vinflunine|vinflunine
213044|NCT02057913|Phase II|phase ii
213045|NCT02057900|Postinfarction heart failure|postinfarction heart failure
213046|NCT02057900|Transplantation of human embryonic stem cell-derived cardiac progenitors|transplantation of human embryonic stem cell-derived cardiac progenitors
213047|NCT02057900|Tissue-engineered cellular graft|tissue-engineered cellular graft
213048|NCT02057900|Fibrin hydrogel|fibrin hydrogel
213049|NCT02057861|diabetes mellitus|diabetes mellitus
213050|NCT02057861|neuromuscular blockade|neuromuscular blockade
213051|NCT02057861|sugammadex|sugammadex
213052|NCT02057848|carbohydrate, hypoglycemia|carbohydrate, hypoglycemia
213053|NCT02057822|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
213054|NCT02057822|Cytokines|cytokines
213055|NCT02057822|Mediators|mediators
213056|NCT02057822|Tears|tears
213057|NCT02057809|Developmental Disabilities|developmental disabilities
213058|NCT02057809|Family-centered services|family-centered services
213059|NCT02057809|Pediatric rehabilitation|pediatric rehabilitation
213060|NCT02057796|HIV-1|hiv-1
213061|NCT02057796|Tuberculosis|tuberculosis
213062|NCT02057796|Systematic empiric TB treatment|systematic empiric tb treatment
213063|NCT02057796|ART|art
213064|NCT02057796|TB diagnosis|tb diagnosis
213065|NCT02057796|Xpert MTB/RIF®|xpert mtb/rif®
213066|NCT02057796|Urine LAM|urine lam
213067|NCT02057744|Robotic-guided surgery|robotic-guided surgery
213068|NCT02057744|Minimally invasive spinal surgery|minimally invasive spinal surgery
213069|NCT02057744|Spinal fusion|spinal fusion
213070|NCT02057744|Pedicle screws|pedicle screws
213071|NCT02057705|MTM|mtm
213072|NCT02057705|myotubular myopathy|myotubular myopathy
213073|NCT02057705|X-linked centronuclear myopathy|x-linked centronuclear myopathy
213074|NCT02057705|inherited myopathies|inherited myopathies
213075|NCT02057705|neuromuscular diseases|neuromuscular diseases
213076|NCT02057705|hypotonia|hypotonia
213077|NCT02057705|genetic mutation|genetic mutation
213078|NCT02057679|Acute cholecystitis.|acute cholecystitis.
213079|NCT02057679|Amoxicillin clavulanic|amoxicillin clavulanic
213080|NCT02057653|Goal-directed fluid management|goal-directed fluid management
213081|NCT02057601|Local anaesthetic infiltration|local anaesthetic infiltration
213082|NCT02057601|Fractured neck of femur|fractured neck of femur
213083|NCT02057601|Postoperative pain|postoperative pain
213084|NCT02057588|ablation|ablation
213085|NCT02057575|Open Angle Glaucoma|open angle glaucoma
213086|NCT02057575|Ocular Hypertension|ocular hypertension
213087|NCT02057575|Intraocular Pressure|intraocular pressure
213088|NCT02057575|AR13324|ar13324
213089|NCT02057575|PG324|pg324
213090|NCT02057562|Adenoma|adenoma
213091|NCT02057562|Diverticular disease|diverticular disease
203897|NCT02099942|Balloon Aortic Valvuloplasty|balloon aortic valvuloplasty
203898|NCT02099942|Valvuloplasty|valvuloplasty
203899|NCT02099942|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
203900|NCT02099942|Surgical Aortic Valve Replacement|surgical aortic valve replacement
203901|NCT02099929|Coffee|coffee
203902|NCT02099929|Glucose|glucose
203903|NCT02099929|Insulin|insulin
203904|NCT02099929|Diabetes|diabetes
203917|NCT02099890|Depression|depression
213092|NCT02057562|Diverticulosis|diverticulosis
213093|NCT02057562|Colorectal carcinoma|colorectal carcinoma
213094|NCT02057562|Polyp|polyp
213095|NCT02057536|estrogen receptor positive, aromatase inhibitors, exercise,|estrogen receptor positive, aromatase inhibitors, exercise,
213096|NCT02057510|Head and Neck Cancer|head and neck cancer
213097|NCT02057510|Radiation Therapy|radiation therapy
213098|NCT02057484|long-term follow-up|long-term follow-up
213099|NCT02057484|liver transplant|liver transplant
213100|NCT02057484|kidney transplant|kidney transplant
213101|NCT02057484|Advagraf|advagraf
213102|NCT02057471|Adenocarcinoma|adenocarcinoma
213103|NCT02057471|Anemia|anemia
213104|NCT02057471|Blood Transfusion|blood transfusion
213105|NCT02057471|Colorectal surgery|colorectal surgery
213106|NCT02057471|Preoperative care|preoperative care
213107|NCT02057471|Perioperative care|perioperative care
213108|NCT02057471|Postoperative care|postoperative care
213110|NCT02057471|Hematinics|hematinics
213111|NCT02057471|Hepcidin|hepcidin
213112|NCT02057471|Quality of life|quality of life
213113|NCT02057471|Postoperative complications|postoperative complications
213114|NCT02057458|arterial stiffness|arterial stiffness
213115|NCT02057458|flow-mediated dilation|flow-mediated dilation
213116|NCT02057458|endothelial function|endothelial function
213118|NCT02057458|inflammation|inflammation
213119|NCT02057458|oxidative stress|oxidative stress
678356|NCT00882583|Cisplatin|cisplatin
213120|NCT02057458|pulmonary function test|pulmonary function test
213121|NCT02057458|Cystic Fibrosis|cystic fibrosis
213122|NCT02057458|Lung Disease|lung disease
213123|NCT02057458|Nitric Oxide|nitric oxide
213124|NCT02057458|Exercise Capacity|exercise capacity
213125|NCT02057458|CF|cf
213126|NCT02057458|Muscle Function|muscle function
213127|NCT02057458|Sildenafil|sildenafil
213128|NCT02057458|Viagra|viagra
213129|NCT02057458|Revatio|revatio
213130|NCT02057445|cellular therapy|cellular therapy
213131|NCT02057445|lymphoma|lymphoma
213132|NCT02057445|lymphoproliferative disorder|lymphoproliferative disorder
213133|NCT02057432|I-II Breast Cancer|i-ii breast cancer
213134|NCT02057419|contraception|contraception
213135|NCT02057419|contraceptive methods|contraceptive methods
213136|NCT02057419|sexual lubricant|sexual lubricant
213137|NCT02057419|user experience|user experience
213138|NCT02057419|adherence|adherence
213139|NCT02057419|User experience: impact on use of contraceptive methods|user experience: impact on use of contraceptive methods
213140|NCT02057419|User experience: impact on use of sexual lubricants|user experience: impact on use of sexual lubricants
213141|NCT02057393|Melanoma|melanoma
213142|NCT02057393|Sentinel node biopsy|sentinel node biopsy
213143|NCT02057393|Indocyanine green|indocyanine green
213144|NCT02057393|Real time lymphangiography|real time lymphangiography
213145|NCT02057380|Paclitaxel|paclitaxel
213146|NCT02057380|Linsitinib|linsitinib
213147|NCT02057380|OSI-774|osi-774
213148|NCT02057380|Advanced Solid Tumor|advanced solid tumor
213149|NCT02057380|Tarceva|tarceva
213150|NCT02057380|Erlotinib|erlotinib
213151|NCT02057380|OSI-906|osi-906
213152|NCT02057367|supratentorial brain tumour|supratentorial brain tumour
213153|NCT02057367|craniotomy|craniotomy
213154|NCT02057354|Brain|brain
213155|NCT02057354|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
213156|NCT02057354|Brain Mapping|brain mapping
213157|NCT02057354|Cognition|cognition
213158|NCT02057354|Exercise|exercise
213159|NCT02057354|Hippocampus|hippocampus
213160|NCT02057354|Hydrocortisone|hydrocortisone
213161|NCT02057354|Learning|learning
213162|NCT02057354|Memory|memory
213163|NCT02057354|Magnetic Resonance Imaging|magnetic resonance imaging
213164|NCT02057354|Nerve Growth Factors|nerve growth factors
213165|NCT02057354|Neuroimaging|neuroimaging
213166|NCT02057354|Physical Endurance|physical endurance
213167|NCT02057354|Physical Fitness|physical fitness
213168|NCT02057354|Resistance Training|resistance training
213169|NCT02057354|Walking|walking
213170|NCT02057341|laminopathy|laminopathy
213171|NCT02057315|Migraine headache|migraine headache
213172|NCT02057315|Photophobia|photophobia
213173|NCT02057315|Phonophobia|phonophobia
213174|NCT02057315|Aura|aura
213175|NCT02057315|Topical treatment|topical treatment
213176|NCT02057302|Xuezhikang Dyslipidemia chinese medicine RCT|xuezhikang dyslipidemia chinese medicine rct
213177|NCT02057289|pediatric|pediatric
213178|NCT02057289|antifungal|antifungal
213179|NCT02057289|bone marrow|bone marrow
213180|NCT02057289|AML or relapsed ALL|aml or relapsed all
213181|NCT02057263|Vaccine|vaccine
213182|NCT02057263|Adjuvant|adjuvant
213183|NCT02057263|Bisphosphonates|bisphosphonates
213184|NCT02057263|Alendronate|alendronate
213185|NCT02057263|Hepatitis B vaccine|hepatitis b vaccine
213186|NCT02057224|Renal denervation|renal denervation
213187|NCT02057224|Hypertension|hypertension
213188|NCT02057224|Insulin resistance|insulin resistance
213189|NCT02057224|Adipose tissue function|adipose tissue function
213190|NCT02057185|Chronic Hematological Diseases|chronic hematological diseases
213191|NCT02057185|work|work
213192|NCT02057185|job|job
213193|NCT02057172|glycaemic control|glycaemic control
213194|NCT02057172|HM11260C|hm11260c
213195|NCT02057172|placebo|placebo
213196|NCT02057172|safety|safety
213197|NCT02057172|tolerability|tolerability
213198|NCT02057172|type 2 diabetes mellitus|type 2 diabetes mellitus
213199|NCT02057172|efficacy|efficacy
213200|NCT02057172|T2DM|t2dm
213201|NCT02057172|glycated haemoglobin (HbA1c)|glycated haemoglobin (hba1c)
213202|NCT02057172|glycosylated haemoglobin (HbA1c)|glycosylated haemoglobin (hba1c)
213203|NCT02057172|Glucagon-Like Peptide-1 (GLP-1) agonists|glucagon-like peptide-1 (glp-1) agonists
213204|NCT02057172|blood sugar levels|blood sugar levels
213205|NCT02057172|fasting plasma glucose (FPG)|fasting plasma glucose (fpg)
213206|NCT02057159|Secondary Progress Multiple Sclerosis|secondary progress multiple sclerosis
213207|NCT02057159|SPMS|spms
213208|NCT02057159|Multiple Sclerosis|multiple sclerosis
213209|NCT02057159|NeuroVax|neurovax
213211|NCT02057146|mother-baby endoscopy|mother-baby endoscopy
213212|NCT02057146|ERCP|ercp
213213|NCT02057146|IPMN|ipmn
213214|NCT02057120|Kinesio Taping, Soccer, Hop Test, Electromyography, Athletic Performance, Muscle Strength Dynamometer|kinesio taping, soccer, hop test, electromyography, athletic performance, muscle strength dynamometer
213109|NCT02057471|Iron|iron
213215|NCT02057081|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
213216|NCT02057081|Mild Traumatic Brain Injury|mild traumatic brain injury
213217|NCT02057081|Veterans Health|veterans health
213218|NCT02057081|Veterans|veterans
213219|NCT02057081|Spouses|spouses
213220|NCT02057081|Couples|couples
213221|NCT02057081|Psychotherapy, Group|psychotherapy, group
213222|NCT02057081|Depression|depression
213223|NCT02057081|Couples Therapy|couples therapy
213224|NCT02057081|Family Therapy|family therapy
213225|NCT02057081|PTSD|ptsd
213226|NCT02057081|posttraumatic stress disorder|posttraumatic stress disorder
213227|NCT02057068|Caregivers|caregivers
213228|NCT02057068|Telemedicine|telemedicine
213229|NCT02057068|Sleep Disorders|sleep disorders
213230|NCT02057068|Meditation|meditation
213231|NCT02057068|Dementia|dementia
213232|NCT02057068|Cognitive Behavioral Therapy|cognitive behavioral therapy
213233|NCT02057068|Exercise|exercise
213234|NCT02057068|Technology|technology
213235|NCT02057055|Antibacterial soaps|antibacterial soaps
213236|NCT02057055|Microbiome|microbiome
213237|NCT02057055|Commensal bacteria|commensal bacteria
213238|NCT02057055|Pyrosequencing|pyrosequencing
213239|NCT02057055|Innate immunity|innate immunity
213240|NCT02057042|Peer Support|peer support
213241|NCT02057042|cCBT|ccbt
213242|NCT02057042|primary care|primary care
213243|NCT02057029|Estrogen Receptor (ER) Positive|estrogen receptor (er) positive
213244|NCT02057029|Early Stage Breast Cancer|early stage breast cancer
213245|NCT02057029|Breast Cancer Index|breast cancer index
213246|NCT02057003|HIV|hiv
213247|NCT02057003|hepatitis C virus|hepatitis c virus
213248|NCT02057003|sustained virologic response|sustained virologic response
213249|NCT02057003|telaprevir|telaprevir
213250|NCT02057003|boceprevir|boceprevir
213251|NCT02057003|simeprevir|simeprevir
213252|NCT02057003|sofosbuvir|sofosbuvir
213253|NCT02057003|daclatasvir|daclatasvir
213254|NCT02057003|paritaprevir|paritaprevir
213255|NCT02057003|pegylated interferon|pegylated interferon
213256|NCT02057003|ribavirin|ribavirin
213257|NCT02057003|direct-acting antivirals|direct-acting antivirals
213258|NCT02057003|dasabuvir|dasabuvir
213259|NCT02057003|ombitasvir|ombitasvir
213260|NCT02057003|ledipasvir|ledipasvir
213261|NCT02057003|velpatasvir|velpatasvir
213262|NCT02057003|grazoprevir|grazoprevir
213263|NCT02057003|elbasvir|elbasvir
213264|NCT02056990|Athletes|athletes
213265|NCT02056977|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
213266|NCT02056977|Cardiac Surgical Procedure|cardiac surgical procedure
213267|NCT02056977|Mechanical Ventilation|mechanical ventilation
213268|NCT02056977|Postoperative Complications|postoperative complications
213269|NCT02056977|Positive End-Expiratory Pressure|positive end-expiratory pressure
213270|NCT02056977|Lung Collapse|lung collapse
213271|NCT02056977|Respiratory Failure|respiratory failure
213272|NCT02056977|Electrical Impedance Tomography|electrical impedance tomography
213273|NCT02056964|Acute Coronary Syndrome|acute coronary syndrome
213274|NCT02056964|Chest Pain|chest pain
213275|NCT02056964|Risk Stratification|risk stratification
213276|NCT02056964|Clinical Decision Aid|clinical decision aid
213277|NCT02056964|Emergency Department|emergency department
213278|NCT02056964|Low Risk Chest Pain|low risk chest pain
213279|NCT02056964|Non Cardiac Chest Pain|non cardiac chest pain
213280|NCT02056951|Rehabilitation|rehabilitation
213281|NCT02056951|Treatment Outcome|treatment outcome
213282|NCT02056951|Interprofessional Relations|interprofessional relations
213283|NCT02056951|Interdisciplinary Communication|interdisciplinary communication
213284|NCT02056951|Behavioural Exercise Therapy|behavioural exercise therapy
213285|NCT02056951|Cognitive Therapy|cognitive therapy
213286|NCT02056951|Health Education|health education
213287|NCT02056951|Workplace related information|workplace related information
213288|NCT02056951|Multicenter Study|multicenter study
213289|NCT02056938|Transplantation|transplantation
213290|NCT02056938|kidney|kidney
213291|NCT02056938|delayed graft function|delayed graft function
213292|NCT02056938|induction therapy|induction therapy
213293|NCT02056938|personalized medicine|personalized medicine
213294|NCT02056938|First kidney transplantation|first kidney transplantation
213295|NCT02056938|No anti HLA immunization prior transplantation|no anti hla immunization prior transplantation
213296|NCT02056938|Risk of DGF higher than 40% calculated byt he score DGFS|risk of dgf higher than 40% calculated byt he score dgfs
213297|NCT02056912|lipodystrophy|lipodystrophy
213298|NCT02056912|gene|gene
213299|NCT02056912|inborn error of metabolism|inborn error of metabolism
213300|NCT02056899|Preterm labor, premature birth, gabapentin|preterm labor, premature birth, gabapentin
213301|NCT02056886|breast cancer, sentinel lymph node, extemporaneous, OSNA|breast cancer, sentinel lymph node, extemporaneous, osna
213302|NCT02056873|deep brain stimulation|deep brain stimulation
213303|NCT02056873|DBS|dbs
213304|NCT02056873|tourette|tourette
213305|NCT02056873|tourette's|tourette's
213306|NCT02056873|tourette syndrome|tourette syndrome
213307|NCT02056873|TS|ts
213308|NCT02056860|cystic fibrosis|cystic fibrosis
213309|NCT02056847|Livalo, pitavastatin, hyperlipidemia, IFG|livalo, pitavastatin, hyperlipidemia, ifg
213310|NCT02056821|stroke|stroke
213311|NCT02056821|transcranial doppler|transcranial doppler
213312|NCT02056821|cerebral blood flow|cerebral blood flow
213313|NCT02056821|cardiac output|cardiac output
213314|NCT02056821|non-invasive hemodynamic monitoring|non-invasive hemodynamic monitoring
213315|NCT02056782|Acute Myeloid Leukemia|acute myeloid leukemia
213317|NCT02056782|ODSH|odsh
213318|NCT02056782|ODSH-AML|odsh-aml
213319|NCT02056782|Cantex|cantex
213320|NCT02056756|REFRACTORY OR RELAPSED|refractory or relapsed
213322|NCT02056730|chronic hemodialysis patients|chronic hemodialysis patients
213323|NCT02056730|Hyperparathyroidism|hyperparathyroidism
213324|NCT02056730|Regpara|regpara
213325|NCT02056730|FGF 23|fgf 23
213326|NCT02056704|Dialysis Fistula|dialysis fistula
213327|NCT02056704|Dialysis Graft|dialysis graft
213328|NCT02056704|Stenosis|stenosis
213329|NCT02056704|Intravascular Ultrasound|intravascular ultrasound
213330|NCT02056704|Angiography|angiography
213331|NCT02056691|Resectable|resectable
213332|NCT02056691|non-metastatic|non-metastatic
213333|NCT02056691|colorectal|colorectal
213334|NCT02056691|carcinoma|carcinoma
213335|NCT02056691|cancer|cancer
213336|NCT02056691|neoplasm|neoplasm
213337|NCT02056691|exercise|exercise
213338|NCT02056691|effects|effects
213339|NCT02056691|program|program
213340|NCT02056691|pre-operative|pre-operative
213341|NCT02056691|proliferation|proliferation
213342|NCT02056691|diagnosed|diagnosed
213343|NCT02056691|surgery|surgery
213344|NCT02056691|biopsy|biopsy
213345|NCT02056691|muscle|muscle
213346|NCT02056691|signalling|signalling
213347|NCT02056691|IGF1|igf1
213348|NCT02056691|ki67|ki67
213349|NCT02056691|p53|p53
213350|NCT02056691|response|response
213351|NCT02056691|training|training
213352|NCT02056691|biochemical|biochemical
213353|NCT02056691|pathways|pathways
213354|NCT02056691|glucose|glucose
213355|NCT02056678|cholecystitis|cholecystitis
213356|NCT02056678|cholelithiasis|cholelithiasis
213357|NCT02056678|obstructive sleep apnea|obstructive sleep apnea
213358|NCT02056678|acetaminophen|acetaminophen
213359|NCT02056665|Angelman Syndrome|angelman syndrome
213360|NCT02056665|EFFICACY|efficacy
213361|NCT02056665|SAFETY|safety
213362|NCT02056665|MINOCYCLINE|minocycline
213363|NCT02056665|Pediatrics population|pediatrics population
213364|NCT02056665|Rare diseases|rare diseases
213365|NCT02056652|Preterm birth|preterm birth
213366|NCT02056652|Preterm delivery|preterm delivery
213367|NCT02056652|short cervix|short cervix
213368|NCT02056652|pessary|pessary
213369|NCT02056639|Premature birth|premature birth
213370|NCT02056639|Premature delivery|premature delivery
213371|NCT02056639|Short cervix|short cervix
213372|NCT02056639|Pessary|pessary
213373|NCT02056626|hypertension|hypertension
213374|NCT02056613|Blood Donation|blood donation
213375|NCT02056613|Tissue Procurement|tissue procurement
213376|NCT02056613|Cellular Therapies|cellular therapies
213377|NCT02056587|renal cell carcinoma|renal cell carcinoma
213378|NCT02056587|kidney cancer|kidney cancer
213379|NCT02056587|bevacizumab failure|bevacizumab failure
213380|NCT02056587|everolimus|everolimus
213381|NCT02056574|Endovascular repair|endovascular repair
213382|NCT02056574|Subarachnoid hemorrhage|subarachnoid hemorrhage
213383|NCT02056574|Ruptured intracranial aneurysm|ruptured intracranial aneurysm
213384|NCT02056574|Stroke|stroke
213385|NCT02056574|Coiling|coiling
213386|NCT02056574|NA-1|na-1
213387|NCT02056561|Anesthesia|anesthesia
213388|NCT02056561|Oxidants|oxidants
213389|NCT02056561|Antioxidants|antioxidants
213390|NCT02056548|preemptive antiviral treatment|preemptive antiviral treatment
213391|NCT02056548|lymphoma|lymphoma
213392|NCT02056548|chronic hepatitis B|chronic hepatitis b
213393|NCT02056535|Alcohol|alcohol
213394|NCT02056535|SBIRT (Screening, Brief Intervention, Referral to Treatment)|sbirt (screening, brief intervention, referral to treatment)
213395|NCT02056522|Melanoma|melanoma
213396|NCT02056522|Skin Cancer|skin cancer
213397|NCT02056509|cardiopulmonary resuscitation,Ventilation|cardiopulmonary resuscitation,ventilation
213398|NCT02056496|Pomegranate|pomegranate
213399|NCT02056496|Ellagic acid|ellagic acid
213400|NCT02056496|Pharmacokinetics|pharmacokinetics
213401|NCT02056496|Urolithins|urolithins
213402|NCT02056496|Bioavailability|bioavailability
213403|NCT02056483|neoplasms|neoplasms
213404|NCT02056483|rehabilitation|rehabilitation
213405|NCT02056483|anxiety|anxiety
213406|NCT02056483|depression|depression
213407|NCT02056483|adverse effects|adverse effects
213408|NCT02056483|health behavior|health behavior
213409|NCT02056457|Responsible fatherhood|responsible fatherhood
213410|NCT02056457|Healthy marriage|healthy marriage
213411|NCT02056457|Healthy relationships|healthy relationships
213412|NCT02056457|Parenting|parenting
213413|NCT02056457|Economic self-sufficiency|economic self-sufficiency
213414|NCT02056444|Blood conservation|blood conservation
213415|NCT02056444|Tranexamic acid|tranexamic acid
213416|NCT02056444|Total hip arthroplasty|total hip arthroplasty
213417|NCT02056431|Diabetes|diabetes
213418|NCT02056431|Neuropathy|neuropathy
213419|NCT02056431|Patient-Reported Outcomes|patient-reported outcomes
213420|NCT02056405|Postoperative Ileus|postoperative ileus
213421|NCT02056405|Mosapride|mosapride
213546|NCT02055781|Spleen volume|spleen volume
213422|NCT02056405|Colorectal laparoscopic surgery|colorectal laparoscopic surgery
213423|NCT02056405|Prolonged postoperative ileus|prolonged postoperative ileus
213424|NCT02056392|Phase I, healthy, pharmacokinetics|phase i, healthy, pharmacokinetics
213425|NCT02056379|stridor|stridor
213426|NCT02056379|laryngitis|laryngitis
213428|NCT02056379|dexamethasone|dexamethasone
213429|NCT02056379|children|children
213430|NCT02056366|Cardiac Autonomic Neuropathy|cardiac autonomic neuropathy
213431|NCT02056353|Software|software
213432|NCT02056353|Algorithm|algorithm
213433|NCT02056353|Cardiac surgery|cardiac surgery
213434|NCT02056327|Oral Appliance|oral appliance
213435|NCT02056262|Bacteria|bacteria
213436|NCT02056262|microbial community|microbial community
213437|NCT02056262|hygiene|hygiene
213438|NCT02056249|hypoglycemia|hypoglycemia
213439|NCT02056249|Positron Emission Tomography|positron emission tomography
213440|NCT02056249|norepinephrine transporter|norepinephrine transporter
213441|NCT02056236|Cardiac arrest|cardiac arrest
213442|NCT02056236|Postanoxic encephalopathy|postanoxic encephalopathy
213443|NCT02056236|Electroencephalographic status epilepticus|electroencephalographic status epilepticus
213444|NCT02056236|EEG monitoring|eeg monitoring
213445|NCT02056236|Anti-epileptic drugs|anti-epileptic drugs
213446|NCT02056223|Patent ductus arteriosus|patent ductus arteriosus
213447|NCT02056223|Preterm infant|preterm infant
213448|NCT02056223|Paracetamol|paracetamol
213449|NCT02056223|Ibuprofen|ibuprofen
213450|NCT02056210|Stem cells|stem cells
213451|NCT02056210|Bone marrow|bone marrow
213452|NCT02056171|delirium|delirium
213453|NCT02056171|pediatrics|pediatrics
213454|NCT02056171|critical care|critical care
213455|NCT02056171|quetiapine|quetiapine
213456|NCT02056158|HIV|hiv
213457|NCT02056158|COPD|copd
213458|NCT02056158|Emphysema|emphysema
213459|NCT02056158|Smoking|smoking
213460|NCT02056119|Ventilators, mechanical|ventilators, mechanical
213461|NCT02056119|Aerosol Drug Therapy|aerosol drug therapy
213462|NCT02056119|Nebulizers|nebulizers
213463|NCT02056119|Equipment Contamination|equipment contamination
213464|NCT02056119|vibrating mesh nebulizer|vibrating mesh nebulizer
213465|NCT02056119|jet nebulizer|jet nebulizer
213466|NCT02056119|mechanical ventilation|mechanical ventilation
213467|NCT02056119|ventilator associated event|ventilator associated event
213468|NCT02056119|ventilator associated tracheobronchitis|ventilator associated tracheobronchitis
213469|NCT02056106|depression, Uganda, HIV, task-shifting, condom use, adherence|depression, uganda, hiv, task-shifting, condom use, adherence
213470|NCT02056093|NAVA - PAV- Breathing Variability - Asynchrony|nava - pav- breathing variability - asynchrony
213471|NCT02056080|Breast Neoplasm|breast neoplasm
213472|NCT02056080|Receptor,HER2|receptor,her2
213473|NCT02056080|Antineoplastic agent|antineoplastic agent
213474|NCT02056080|Antibodies, monoclonal|antibodies, monoclonal
213475|NCT02056080|Trastuzumab, Lapatinib|trastuzumab, lapatinib
213476|NCT02056080|Protein kinase inhibitors|protein kinase inhibitors
213477|NCT02056080|quinazolines|quinazolines
213478|NCT02056054|Autoimmune hepatitis|autoimmune hepatitis
213479|NCT02056054|Liver transplantation|liver transplantation
213480|NCT02056054|Hepatitis C|hepatitis c
213481|NCT02056002|Peer-driven intervention|peer-driven intervention
213482|NCT02056002|Interactive voice response system|interactive voice response system
213483|NCT02056002|Continuous Positive Airway Pressure therapy and adherence|continuous positive airway pressure therapy and adherence
213484|NCT02055976|PF-04950615|pf-04950615
213485|NCT02055976|Japan|japan
213486|NCT02055963|Head And Neck Cancer|head and neck cancer
213487|NCT02055963|Postsurgical symptom reduction|postsurgical symptom reduction
213488|NCT02055963|Minocycline|minocycline
213489|NCT02055963|Dynacin|dynacin
213490|NCT02055963|Minocin|minocin
213491|NCT02055963|Minocin PAC|minocin pac
213492|NCT02055963|Myrac|myrac
213493|NCT02055963|Solodyn|solodyn
213494|NCT02055963|Placebo|placebo
213495|NCT02055963|Sugar pill|sugar pill
213496|NCT02055963|Questionnaires|questionnaires
213497|NCT02055963|Surveys|surveys
213498|NCT02055950|Kidney transplant|kidney transplant
213499|NCT02055950|Marginal donors|marginal donors
213500|NCT02055950|Pulse perfusion|pulse perfusion
213501|NCT02055950|Graft function|graft function
213502|NCT02055937|mastectomy, reconstruction|mastectomy, reconstruction
213607|NCT02055508|Physical Activity|physical activity
213608|NCT02055508|Palliative Care|palliative care
213503|NCT02055924|Bruton's tyrosine kinase (BTK) Inhibition in B-cell Lymphomas|bruton's tyrosine kinase (btk) inhibition in b-cell lymphomas
213504|NCT02055911|diabetic macular edema|diabetic macular edema
213505|NCT02055911|intravitreal ranibizumab|intravitreal ranibizumab
213506|NCT02055911|f retinal ganglion cell|f retinal ganglion cell
213507|NCT02055872|Edema|edema
213508|NCT02055872|Hypoproteinemia|hypoproteinemia
213509|NCT02055872|Albumin|albumin
213510|NCT02055872|Diuresis|diuresis
213511|NCT02055872|Critical illness|critical illness
213512|NCT02055859|acoustic neuromas|acoustic neuromas
213513|NCT02055859|radiosurgery|radiosurgery
213514|NCT02055859|hearing preservation|hearing preservation
213515|NCT02055846|Androgen-independent prostate cancer|androgen-independent prostate cancer
213516|NCT02055807|Atelectasis|atelectasis
213517|NCT02055807|Ultrasound|ultrasound
213518|NCT02055807|Recruitment maneuver|recruitment maneuver
213519|NCT02055807|Positive end-expiratory pressure|positive end-expiratory pressure
213520|NCT02055794|perineal wound|perineal wound
213521|NCT02055794|perineal tear|perineal tear
213522|NCT02055794|perineum|perineum
213523|NCT02055794|pain|pain
213524|NCT02055794|childbirth|childbirth
213525|NCT02055781|Myelofibrosis|myelofibrosis
213526|NCT02055781|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
213527|NCT02055781|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
213528|NCT02055781|Primary Myelofibrosis|primary myelofibrosis
213529|NCT02055781|Polycythemia|polycythemia
213530|NCT02055781|Polycythemia Vera|polycythemia vera
213531|NCT02055781|Thrombocythemia, Essential|thrombocythemia, essential
213532|NCT02055781|Thrombocythemia|thrombocythemia
213533|NCT02055781|Myeloproliferative Disorders|myeloproliferative disorders
213534|NCT02055781|Bone Marrow Disease|bone marrow disease
213535|NCT02055781|Hematologic Diseases|hematologic diseases
213536|NCT02055781|Blood Platelet Disorders|blood platelet disorders
213537|NCT02055781|Hemorrhagic Disorders|hemorrhagic disorders
213538|NCT02055781|Splenomegaly|splenomegaly
213539|NCT02055781|Pacritinib|pacritinib
213540|NCT02055781|MPN-SAF|mpn-saf
213541|NCT02055781|MPN-SAF TSS|mpn-saf tss
213542|NCT02055781|Anemia|anemia
213543|NCT02055781|Myeloproliferative|myeloproliferative
213544|NCT02055781|Myeloproliferative Neoplasm|myeloproliferative neoplasm
213545|NCT02055781|Spleen|spleen
213547|NCT02055781|Thrombocytopenia|thrombocytopenia
213548|NCT02055781|SB1518|sb1518
213549|NCT02055755|Diabetes|diabetes
213550|NCT02055755|Wounds|wounds
213551|NCT02055755|Wound Healing|wound healing
213552|NCT02055755|Diabetic Foot Ulcer|diabetic foot ulcer
213553|NCT02055755|DFU|dfu
213554|NCT02055755|Clinical Decision Support|clinical decision support
213555|NCT02055729|bedsore|bedsore
213556|NCT02055729|bacteria|bacteria
213557|NCT02055729|colonization|colonization
213558|NCT02055729|ecology|ecology
213559|NCT02055703|Healthy Subjects|healthy subjects
213560|NCT02055690|Advanced Recurrent Ovarian Cancer|advanced recurrent ovarian cancer
213561|NCT02055690|Pazopanib|pazopanib
213562|NCT02055690|Votrient|votrient
213563|NCT02055690|Fosbretabulin|fosbretabulin
213564|NCT02055677|personality profiles|personality profiles
213565|NCT02055677|values|values
213566|NCT02055677|empathy|empathy
213567|NCT02055677|quality of life|quality of life
213568|NCT02055677|vegetarians|vegetarians
213569|NCT02055677|vegans|vegans
213570|NCT02055651|Worksite|worksite
213571|NCT02055651|Cardiovascular|cardiovascular
213572|NCT02055651|Epidemiology|epidemiology
213573|NCT02055651|Risk factors|risk factors
213574|NCT02055638|Intermittent Explosive Disorder|intermittent explosive disorder
213575|NCT02055638|IED|ied
213576|NCT02055638|Aggression|aggression
213577|NCT02055638|SRX246|srx246
213578|NCT02055638|Vasopressin 1a Receptor Antagonist|vasopressin 1a receptor antagonist
213579|NCT02055638|V1a|v1a
213580|NCT02055625|Graft-versus-host-disease|graft-versus-host-disease
213581|NCT02055625|Immune system diseases|immune system diseases
213582|NCT02055625|Oral|oral
213583|NCT02055612|wet AMD|wet amd
213584|NCT02055612|epidemiology|epidemiology
213585|NCT02055599|Wound|wound
213586|NCT02055599|Wound Healing|wound healing
213587|NCT02055599|Pressure Ulcers|pressure ulcers
213588|NCT02055599|Chronic Wounds|chronic wounds
213589|NCT02055599|Clinical Decision Support|clinical decision support
213590|NCT02055573|Abusive Head Trauma|abusive head trauma
213591|NCT02055573|Early Literacy|early literacy
213592|NCT02055573|Parental Education|parental education
213593|NCT02055573|Low Income|low income
213594|NCT02055560|colorectal|colorectal
213595|NCT02055560|OnDose|ondose
213596|NCT02055560|MyCare|mycare
213597|NCT02055560|5-FU|5-fu
213598|NCT02055560|pharmacokinetics|pharmacokinetics
213599|NCT02055560|exposure|exposure
213600|NCT02055560|optimization|optimization
213601|NCT02055560|dose adjustment|dose adjustment
213602|NCT02055521|Composite tissue allograft|composite tissue allograft
213603|NCT02055521|operational tolerance|operational tolerance
213604|NCT02055521|skin rejection|skin rejection
213605|NCT02055521|Hand and Face allotransplantation|hand and face allotransplantation
213611|NCT02055495|Painful flatfeet|painful flatfeet
213612|NCT02055495|Planovagus feet|planovagus feet
213613|NCT02055495|Subtalar arthroeresis|subtalar arthroeresis
213614|NCT02055495|Lateral column lengthening|lateral column lengthening
213615|NCT02055495|Kinematic motion analysis|kinematic motion analysis
213616|NCT02055482|Anemia on CKD|anemia on ckd
213617|NCT02055469|Achalasia|achalasia
213618|NCT02055456|Hormones|hormones
213619|NCT02055456|Androgens|androgens
213620|NCT02055456|Aplastic Anemia|aplastic anemia
751894|NCT01171105|AZD5213 Phase 1|azd5213 phase 1
213621|NCT02055456|Bone Marrow Failure Syndromes|bone marrow failure syndromes
213622|NCT02055456|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
213623|NCT02055456|Telomere|telomere
213624|NCT02055456|Telomere Shortening|telomere shortening
213625|NCT02055443|nuclear cardiology|nuclear cardiology
213626|NCT02055443|chest pain|chest pain
213627|NCT02055443|cardiac ischemia|cardiac ischemia
213628|NCT02055443|shortness of breath|shortness of breath
213629|NCT02055443|ECG|ecg
213630|NCT02055443|EKG|ekg
213631|NCT02055443|electrocardiogram|electrocardiogram
213632|NCT02055430|anuria|anuria
213633|NCT02055430|children|children
213634|NCT02055430|nephrostomy|nephrostomy
213635|NCT02055430|stents|stents
213636|NCT02055430|urinary calculi|urinary calculi
213637|NCT02055404|astigmatism|astigmatism
213638|NCT02055404|toric|toric
213639|NCT02055404|contact lenses|contact lenses
213640|NCT02055404|daily disposable contact lenses|daily disposable contact lenses
213641|NCT02055404|molded mark|molded mark
213642|NCT02055404|rotation mark|rotation mark
213643|NCT02055378|myopia|myopia
213644|NCT02055378|atropine|atropine
213645|NCT02055378|anterior chamber depth|anterior chamber depth
213646|NCT02055378|auricular acupoint|auricular acupoint
213647|NCT02055378|axial length|axial length
213648|NCT02055365|Hepatitis B vaccine|hepatitis b vaccine
213649|NCT02055326|Smoking|smoking
213650|NCT02055326|yoga|yoga
213651|NCT02055326|men|men
213652|NCT02055326|intervention|intervention
213653|NCT02055313|Exceptional patient|exceptional patient
213654|NCT02055313|Cancer care|cancer care
213655|NCT02055313|Lung cancer|lung cancer
213656|NCT02055313|Pancreatic cancer|pancreatic cancer
213657|NCT02055313|Stomach cancer|stomach cancer
213658|NCT02055313|Unexplained survival|unexplained survival
213659|NCT02055313|still alive from 2001-2008|still alive from 2001-2008
213660|NCT02055287|schizophrenia|schizophrenia
213661|NCT02055287|schizoaffective disorder|schizoaffective disorder
213662|NCT02055274|Parkinsons|parkinsons
213663|NCT02055248|Genetic Counseling|genetic counseling
213664|NCT02055248|Mobius Syndrome|mobius syndrome
213665|NCT02055248|Birth Defects|birth defects
213666|NCT02055248|Congenital Malformations|congenital malformations
213667|NCT02055248|Gene Identification|gene identification
213668|NCT02055235|Brain|brain
213669|NCT02055235|Pain|pain
213670|NCT02055235|Yoga|yoga
213671|NCT02055222|COPD|copd
213672|NCT02055222|Smoking|smoking
213673|NCT02055222|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
213674|NCT02055209|Coronary Artery Calcification|coronary artery calcification
213675|NCT02055209|African American|african american
213676|NCT02055209|African-American Families|african-american families
213677|NCT02055183|Registry|registry
213678|NCT02055183|Botulinum toxin|botulinum toxin
213679|NCT02055183|Botulism Antitoxin Heptavalent- (Equine)|botulism antitoxin heptavalent- (equine)
213680|NCT02055183|BAT®|bat®
213681|NCT02055157|Achondroplasia|achondroplasia
213682|NCT02055157|Dwarfism|dwarfism
213683|NCT02055157|Bone Diseases, Developmental|bone diseases, developmental
213684|NCT02055157|Bone Diseases|bone diseases
213685|NCT02055144|NSCLC|nsclc
213686|NCT02055144|VeriStrat|veristrat
213687|NCT02055144|chemotherapy|chemotherapy
213688|NCT02055144|circulating tumor cells|circulating tumor cells
213689|NCT02055131|vascular access|vascular access
213690|NCT02055131|hemodialysis|hemodialysis
213691|NCT02055131|aspirin resistance|aspirin resistance
213692|NCT02055131|PFA-100|pfa-100
213693|NCT02055118|hunters disease|hunters disease
213694|NCT02055118|MPS II|mps ii
213695|NCT02055118|lysosomal storage disorder|lysosomal storage disorder
213696|NCT02055118|hunters syndrome|hunters syndrome
213697|NCT02055118|ert treatment|ert treatment
213698|NCT02055118|hunter's disease|hunter's disease
213699|NCT02055118|iduronate sulfatase|iduronate sulfatase
213700|NCT02055118|MPS society|mps society
213701|NCT02055118|mps 2|mps 2
213702|NCT02055118|enlarged adenoids|enlarged adenoids
213703|NCT02055118|hunter's syndrome|hunter's syndrome
213704|NCT02055118|iduronate 2 sulfatase|iduronate 2 sulfatase
213705|NCT02055118|chronic ear infection|chronic ear infection
213706|NCT02055118|mucopolysaccharides|mucopolysaccharides
213707|NCT02055118|hunter syndrome therapy|hunter syndrome therapy
213708|NCT02055118|hunter's syndrome treatment|hunter's syndrome treatment
213709|NCT02055118|enzyme replacement therapy|enzyme replacement therapy
213710|NCT02055118|hunter syndrome treatment|hunter syndrome treatment
213711|NCT02055118|elaprase|elaprase
213712|NCT02055118|MPSII|mpsii
213713|NCT02055118|lysosomal storage disease|lysosomal storage disease
213714|NCT02055118|mps diagnosis|mps diagnosis
213715|NCT02055118|mps symptoms|mps symptoms
213716|NCT02055118|idursulfase|idursulfase
213717|NCT02055118|hunter disease|hunter disease
213718|NCT02055118|hunter's disease treatment|hunter's disease treatment
213720|NCT02055105|Pediatric Sepsis|pediatric sepsis
213721|NCT02055092|Young onset dementia|young onset dementia
213722|NCT02055092|Quality of life|quality of life
213723|NCT02055092|Specific needs|specific needs
213724|NCT02055092|Healthcare resources in dementia|healthcare resources in dementia
213726|NCT02055092|Alzheimer's disease|alzheimer's disease
213727|NCT02055092|Healthcare services|healthcare services
213728|NCT02055079|ADPKD|adpkd
213729|NCT02055079|PKD|pkd
213730|NCT02055079|Polycystic kidney disease|polycystic kidney disease
213731|NCT02055079|Mammalian target of rapamycin|mammalian target of rapamycin
213732|NCT02055079|mTOR-I|mtor-i
213733|NCT02055079|Sirolimus|sirolimus
213734|NCT02055066|cancer|cancer
213735|NCT02055066|c-MET|c-met
213736|NCT02055053|Post Operative Pain|post operative pain
213836|NCT02054611|ARDS|ards
213737|NCT02055053|hernia repair|hernia repair
213738|NCT02055027|Sleep Apnea, Obstructive|sleep apnea, obstructive
213739|NCT02055027|Continuous Positive Airway Pressure|continuous positive airway pressure
213740|NCT02055027|Perioperative Period|perioperative period
213741|NCT02055014|Endobarrier|endobarrier
213742|NCT02055014|Duodenal-jejunal bypass liner|duodenal-jejunal bypass liner
213743|NCT02055014|Glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
213744|NCT02055014|Liraglutide|liraglutide
213745|NCT02055014|Diabesity|diabesity
213746|NCT02055014|Type 2 diabetes|type 2 diabetes
213747|NCT02055014|Obesity|obesity
213748|NCT02055001|gender medicine|gender medicine
213749|NCT02055001|platelet function|platelet function
213750|NCT02055001|sex hormones|sex hormones
213751|NCT02055001|antiplatelet drugs|antiplatelet drugs
213752|NCT02055001|haemostasis|haemostasis
213753|NCT02054975|asthma, children, vitamin D deficiency, clinical trial|asthma, children, vitamin d deficiency, clinical trial
213754|NCT02054962|Pain|pain
213755|NCT02054949|N-acetyl cysteine|n-acetyl cysteine
213756|NCT02054949|Refractory Seizures|refractory seizures
213757|NCT02054923|colonoscopy|colonoscopy
213758|NCT02054923|videorecording|videorecording
213759|NCT02054923|quality indicators|quality indicators
213760|NCT02054923|screening|screening
213761|NCT02054923|colorectal cancer|colorectal cancer
213762|NCT02054884|Interleukin, IL2, F16, monoclonal, antibody, cytokine Paclitaxel, Merkel cell carcinoma|interleukin, il2, f16, monoclonal, antibody, cytokine paclitaxel, merkel cell carcinoma
213763|NCT02054871|Peripheral Angioplasty|peripheral angioplasty
213764|NCT02054871|Remote Ischaemic Preconditioning|remote ischaemic preconditioning
213765|NCT02054871|Contrast Induced Nephropathy|contrast induced nephropathy
213766|NCT02054858|Computerized Tomography|computerized tomography
213767|NCT02054858|Contrast enhanced|contrast enhanced
213768|NCT02054858|Acute Kidney Injury|acute kidney injury
213769|NCT02054858|Remote ischaemic preconditioning|remote ischaemic preconditioning
213770|NCT02054858|RIPC|ripc
213771|NCT02054845|Body awareness therapy|body awareness therapy
213772|NCT02054845|Physical therapy|physical therapy
213773|NCT02054819|lung cancer|lung cancer
213774|NCT02054819|NSCLC|nsclc
213775|NCT02054806|PD1|pd1
213776|NCT02054806|PD-1|pd-1
213777|NCT02054806|PDL1|pdl1
213778|NCT02054806|PD-L1|pd-l1
213779|NCT02054793|metastatic disease|metastatic disease
213780|NCT02054793|non-metastatic disease|non-metastatic disease
213781|NCT02054793|prostate cancer|prostate cancer
213782|NCT02054793|castration-resistant prostate cancer|castration-resistant prostate cancer
213783|NCT02054767|articaine|articaine
213784|NCT02054767|lidocaine|lidocaine
213785|NCT02054767|mepivacaine|mepivacaine
213786|NCT02054767|inferior alveolar nerve block|inferior alveolar nerve block
213787|NCT02054767|irreversible pulpitis|irreversible pulpitis
213788|NCT02054754|Dexanabinol|dexanabinol
213789|NCT02054754|Oral|oral
213790|NCT02054754|Safety|safety
213791|NCT02054754|Tolerability|tolerability
213792|NCT02054754|Pharmacokinetics|pharmacokinetics
213793|NCT02054728|right-heart catheterization|right-heart catheterization
213794|NCT02054728|respiratory muscle training|respiratory muscle training
213795|NCT02054728|inspiratory resistance|inspiratory resistance
213796|NCT02054728|hemodynamics|hemodynamics
213797|NCT02054702|Schizophrenia|schizophrenia
213798|NCT02054702|Mental Disorders|mental disorders
213799|NCT02054702|Psychotic Disorders|psychotic disorders
213800|NCT02054702|Antipsychotic|antipsychotic
213801|NCT02054702|Cognitive testing|cognitive testing
213802|NCT02054676|mandible|mandible
213803|NCT02054676|alveolar nerve inferior|alveolar nerve inferior
213804|NCT02054676|anatomy|anatomy
213805|NCT02054676|cross-sectional|cross-sectional
213806|NCT02054676|dental implants|dental implants
213807|NCT02054676|classification|classification
213808|NCT02054676|reliability|reliability
213809|NCT02054676|validity|validity
213810|NCT02054663|Acute coronary syndrome|acute coronary syndrome
213811|NCT02054663|Coronary artery disease|coronary artery disease
213812|NCT02054663|Antiplatelet therapy|antiplatelet therapy
213813|NCT02054663|Ticagrelor|ticagrelor
213814|NCT02054663|Clopidogrel|clopidogrel
213815|NCT02054650|Chronic low back pain|chronic low back pain
680134|NCT00895713|Recurrence|recurrence
213816|NCT02054650|Type 2 diabetes mellitus|type 2 diabetes mellitus
213817|NCT02054650|Back pain|back pain
213818|NCT02054650|Diabetes|diabetes
213819|NCT02054650|Osteopathic manual treatment|osteopathic manual treatment
213820|NCT02054650|Osteopathic manipulative treatment|osteopathic manipulative treatment
213822|NCT02054650|Biomarkers|biomarkers
213823|NCT02054650|Glycemic control|glycemic control
213824|NCT02054650|Kidney function|kidney function
213825|NCT02054637|Bile reflux|bile reflux
213826|NCT02054637|Reflux esophagitis|reflux esophagitis
213827|NCT02054637|Lanreotide autogel|lanreotide autogel
213828|NCT02054637|Somatuline|somatuline
213829|NCT02054637|Endoscopy|endoscopy
213830|NCT02054637|Impedancemetry|impedancemetry
213831|NCT02054624|Obesity|obesity
213832|NCT02054624|Rural Health|rural health
213833|NCT02054624|Exercise|exercise
213834|NCT02054624|Weight loss|weight loss
213835|NCT02054624|Behavior change|behavior change
213837|NCT02054611|Chest radiographs|chest radiographs
213838|NCT02054611|Vignettes|vignettes
213839|NCT02054611|Online educational video|online educational video
213840|NCT02054585|dehydration|dehydration
213841|NCT02054585|pediatric|pediatric
213842|NCT02054585|glucose|glucose
213843|NCT02054585|IV fluid|iv fluid
213844|NCT02054572|AMG 416, ESRD, hemodialysis|amg 416, esrd, hemodialysis
213845|NCT02054559|localized|localized
213846|NCT02054559|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
213847|NCT02054559|R-CHOP chemotherapy|r-chop chemotherapy
213848|NCT02054559|radiotherapy|radiotherapy
213849|NCT02054533|Crohn's disease|crohn's disease
213850|NCT02054533|Ulcerative colitis|ulcerative colitis
213851|NCT02054533|Inflammatory bowel disease|inflammatory bowel disease
213852|NCT02054533|Surgery|surgery
213853|NCT02054533|Anti-Tumor Necrosis Factor|anti-tumor necrosis factor
213854|NCT02054533|Infection|infection
213855|NCT02054520|Stage IV|stage iv
213856|NCT02054520|metastatic melanoma|metastatic melanoma
213857|NCT02054507|Children|children
213858|NCT02054507|Cognitive outcome|cognitive outcome
213859|NCT02054507|Prematurity|prematurity
213860|NCT02054507|Care Network|care network
213861|NCT02054507|Outpatient follow-up of cognitive development|outpatient follow-up of cognitive development
213862|NCT02054507|Care resources|care resources
213863|NCT02054468|Muscle relaxant, Rocuronium, TIVA, Propofol|muscle relaxant, rocuronium, tiva, propofol
213864|NCT02054455|PPI|ppi
213865|NCT02054455|SIBO|sibo
213866|NCT02054455|LP-F19|lp-f19
213867|NCT02054442|cetuximab|cetuximab
213868|NCT02054442|methotrexate|methotrexate
213869|NCT02054442|squamous cell carcinoma head neck|squamous cell carcinoma head neck
213870|NCT02054442|palliative chemotherapy|palliative chemotherapy
213871|NCT02054416|non-traumatic lower limb amputation|non-traumatic lower limb amputation
213872|NCT02054416|AKA|aka
213873|NCT02054416|BKA|bka
213874|NCT02054390|Angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
213875|NCT02054390|inflammation|inflammation
204698|NCT02096419|outcome|outcome
204699|NCT02096406|Coronary artery disease|coronary artery disease
204700|NCT02096406|Coronary artery bypass grafting|coronary artery bypass grafting
204702|NCT02096406|angiotensin receptor blocker|angiotensin receptor blocker
213876|NCT02054390|metabolic syndrome|metabolic syndrome
213877|NCT02054390|myonecrosis|myonecrosis
213878|NCT02054390|percutaneous coronary intervention|percutaneous coronary intervention
213879|NCT02054390|periprocedural myocardial injury|periprocedural myocardial injury
213880|NCT02054377|cystic fibrosis|cystic fibrosis
213881|NCT02054377|tai chi|tai chi
213882|NCT02054364|Eating Disorder|eating disorder
213883|NCT02054364|Anorexia Nervosa|anorexia nervosa
213884|NCT02054364|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
213885|NCT02054364|Maudsley|maudsley
213886|NCT02054364|Family-Based Therapy|family-based therapy
213887|NCT02054364|FBT|fbt
213888|NCT02054364|Family Therapy|family therapy
213889|NCT02054364|Cognitive Remediation Therapy|cognitive remediation therapy
213890|NCT02054364|CRT|crt
213891|NCT02054351|Advanced ovarian cancer|advanced ovarian cancer
213892|NCT02054351|CLDN6 positive|cldn6 positive
213893|NCT02054325|Sclerotherapy|sclerotherapy
213894|NCT02054325|varicose veins|varicose veins
213895|NCT02054325|veins|veins
213896|NCT02054273|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
213897|NCT02054247|Carpal tunnel syndrome,ultrasound,pulsed ultrasound|carpal tunnel syndrome,ultrasound,pulsed ultrasound
213898|NCT02054234|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
213899|NCT02054221|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
213900|NCT02054221|mitral valve|mitral valve
213901|NCT02054208|human umbilical cord blood derived mesenchymal stem cells|human umbilical cord blood derived mesenchymal stem cells
213902|NCT02054208|stem cells|stem cells
213903|NCT02054208|alzheimer's disease|alzheimer's disease
213904|NCT02054208|cognitive ability|cognitive ability
213905|NCT02054208|mesenchymal stem cells|mesenchymal stem cells
213906|NCT02054208|cord blood|cord blood
213907|NCT02054182|vitamin D supplementation, pneumonia, bronchiolitis|vitamin d supplementation, pneumonia, bronchiolitis
213908|NCT02054156|Cystic fibrosis (CF)|cystic fibrosis (cf)
213909|NCT02054156|Azithromycin|azithromycin
213910|NCT02054156|Tobramycin solution for inhalation (TIS)|tobramycin solution for inhalation (tis)
213911|NCT02054156|Pseudomonas aeruginosa (Pa)|pseudomonas aeruginosa (pa)
213912|NCT02054156|Early Pseudomonas aeruginosa infection|early pseudomonas aeruginosa infection
213913|NCT02054156|Pulmonary exacerbation|pulmonary exacerbation
213914|NCT02054156|Standardized anti-pseudomonal therapy|standardized anti-pseudomonal therapy
213915|NCT02054143|sevoflurane|sevoflurane
213916|NCT02054143|cerebral vasoreactivity|cerebral vasoreactivity
213917|NCT02054143|arterial stiffness|arterial stiffness
213918|NCT02054143|Transcranial Doppler|transcranial doppler
213919|NCT02054143|SphygmoCor|sphygmocor
213920|NCT02054130|Asthma|asthma
213921|NCT02054117|Hemorrhage|hemorrhage
213922|NCT02054117|Intracerebral hemorrhage (ICH)|intracerebral hemorrhage (ich)
213923|NCT02054104|Lung Cancer|lung cancer
213924|NCT02054104|Cancer Vaccine|cancer vaccine
213925|NCT02054104|Immunotherapy|immunotherapy
213926|NCT02054104|Adjuvant Therapy|adjuvant therapy
213927|NCT02054104|Surgical Intervention|surgical intervention
213928|NCT02054091|Preterm infants|preterm infants
213929|NCT02054091|Bovine colostrum|bovine colostrum
213930|NCT02054091|Feeding intolerance|feeding intolerance
213931|NCT02054091|Postnatal growth|postnatal growth
213932|NCT02054091|Intestinal maturation|intestinal maturation
213933|NCT02054091|Necrotizing enterocolitis|necrotizing enterocolitis
213934|NCT02054065|Urinary Catheter|urinary catheter
213935|NCT02054065|urinary tract infection|urinary tract infection
213936|NCT02054052|non-small cell lung cancer|non-small cell lung cancer
213937|NCT02054052|malignant pleural effusion|malignant pleural effusion
213938|NCT02054052|bevacizumab|bevacizumab
213939|NCT02054052|intrapleural injection|intrapleural injection
213940|NCT02054052|pericardial effusion|pericardial effusion
213941|NCT02054039|Cardiac surgery|cardiac surgery
213942|NCT02054039|Spirometry|spirometry
213943|NCT02054039|Physical Therapy Modalities|physical therapy modalities
213944|NCT02054039|Postoperative Complications|postoperative complications
213945|NCT02054000|No-reflow phenomenon, tirofiban, intracoronary|no-reflow phenomenon, tirofiban, intracoronary
213946|NCT02053974|Anthracycline|anthracycline
213947|NCT02053974|spironolactone|spironolactone
213948|NCT02053974|cardiotoxicity|cardiotoxicity
213949|NCT02053948|Reversal|reversal
213950|NCT02053948|Surgical technique|surgical technique
213951|NCT02053948|Pursestring Wound Closure|pursestring wound closure
213952|NCT02053948|Gunsight Skin Incision and Closure Technique|gunsight skin incision and closure technique
213953|NCT02053935|Dopamine|dopamine
213954|NCT02053935|hyperglycemic clamp|hyperglycemic clamp
213955|NCT02053935|sepsis|sepsis
213956|NCT02053935|hyperglycemia|hyperglycemia
213957|NCT02053935|insulin secretion|insulin secretion
213958|NCT02053922|caesarean section, ecbolics, postpartum hemorrhage|caesarean section, ecbolics, postpartum hemorrhage
213959|NCT02053909|Saphenous vein graft disease|saphenous vein graft disease
213960|NCT02053909|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
213961|NCT02053909|Antiplatelet therapy|antiplatelet therapy
213962|NCT02053909|Coronary artery disease|coronary artery disease
213963|NCT02053909|Secondary prevention|secondary prevention
213964|NCT02053909|Graft patency|graft patency
213965|NCT02053896|Type I Gaucher|type i gaucher
213966|NCT02053896|ISU302|isu302
213967|NCT02053896|Imiglucerase|imiglucerase
213969|NCT02053883|spinal cord injury|spinal cord injury
213970|NCT02053883|biologic drug|biologic drug
213971|NCT02053883|rho|rho
213972|NCT02053883|paralysis|paralysis
213973|NCT02053883|paraplegia|paraplegia
213974|NCT02053883|tetraplegia|tetraplegia
213975|NCT02053883|quadriplegia|quadriplegia
213976|NCT02053883|trauma|trauma
213977|NCT02053883|central nervous system|central nervous system
213978|NCT02053883|fibrin sealant|fibrin sealant
213979|NCT02053883|neurosurgery|neurosurgery
213980|NCT02053883|cervical|cervical
213981|NCT02053883|regeneration|regeneration
213982|NCT02053883|neurotrauma|neurotrauma
213983|NCT02053870|Adventitious lung sounds|adventitious lung sounds
213984|NCT02053870|Crackles|crackles
213985|NCT02053870|Wheezes|wheezes
213986|NCT02053870|Sputum location|sputum location
213987|NCT02053857|severe acute malnutrition|severe acute malnutrition
213988|NCT02053857|polyunsaturated fatty acids|polyunsaturated fatty acids
213989|NCT02053857|ready-to-use therapeutic food|ready-to-use therapeutic food
213990|NCT02053844|health care costs|health care costs
213991|NCT02053844|quality of health care|quality of health care
213992|NCT02053831|plastic surgery|plastic surgery
213993|NCT02053818|Cognitive dysfunction|cognitive dysfunction
213994|NCT02053818|Cardioprotection|cardioprotection
213995|NCT02053818|Recovery|recovery
213996|NCT02053818|Renal function|renal function
213997|NCT02053818|ICU discharge|icu discharge
213998|NCT02053805|prostate cancer|prostate cancer
213999|NCT02053805|BRCA1 Syndrome|brca1 syndrome
214000|NCT02053805|BRCA germ-line mutation|brca germ-line mutation
214001|NCT02053805|Lynch syndrome|lynch syndrome
214002|NCT02053805|BRCA2 Syndrome|brca2 syndrome
214003|NCT02053779|GnRH agonist|gnrh agonist
214004|NCT02053779|GnRH antagonist|gnrh antagonist
214005|NCT02053779|Luteal phase|luteal phase
214006|NCT02053766|Mitochondrial Diseases|mitochondrial diseases
214007|NCT02053766|Sevoflurane|sevoflurane
214008|NCT02053766|Dexmedetomidine (Precedex®)|dexmedetomidine (precedex®)
214009|NCT02053766|Propofol|propofol
214010|NCT02053753|denosumab, bioequivalence|denosumab, bioequivalence
214011|NCT02053727|Rheumatoid Arthritis|rheumatoid arthritis
214012|NCT02053727|Hepatitis B|hepatitis b
214013|NCT02053727|Abatacept|abatacept
214014|NCT02053727|Orencia|orencia
214015|NCT02053727|entecavir|entecavir
214016|NCT02053701|magnetic resonance spectroscopy|magnetic resonance spectroscopy
214017|NCT02053701|quantification precision|quantification precision
214018|NCT02053701|brain|brain
214019|NCT02053701|brain metabolites|brain metabolites
214020|NCT02053675|septic shock|septic shock
214021|NCT02053675|vasopressin|vasopressin
214022|NCT02053675|microcirculation|microcirculation
214023|NCT02053675|tissue oxygenation|tissue oxygenation
214024|NCT02053675|vasopressors|vasopressors
214025|NCT02053675|hemodynamics|hemodynamics
214026|NCT02053662|Bladder Cancer|bladder cancer
214027|NCT02053649|depression|depression
214028|NCT02053649|major depressive disorder|major depressive disorder
214029|NCT02053649|postpartum depression|postpartum depression
214030|NCT02053649|antenatal depression|antenatal depression
214031|NCT02053649|sleep|sleep
214032|NCT02053649|circadian|circadian
214033|NCT02053649|bright light|bright light
214034|NCT02053597|Primary breast cancer|primary breast cancer
214035|NCT02053597|Young women|young women
214036|NCT02053597|Ovarian function|ovarian function
214037|NCT02053597|Sexual function|sexual function
214038|NCT02053597|Eligible for adjuvant or neoadjuvant chemotherapy|eligible for adjuvant or neoadjuvant chemotherapy
214039|NCT02053597|Negative hormone-receptor status|negative hormone-receptor status
214040|NCT02053558|Anesthesiology|anesthesiology
214041|NCT02053558|Pain|pain
214042|NCT02053558|TAP block|tap block
214043|NCT02053558|Gynecology|gynecology
214044|NCT02053558|Postoperative|postoperative
214045|NCT02053558|Analgesia|analgesia
214046|NCT02053532|Trauma|trauma
214047|NCT02053532|Post-traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
214048|NCT02053532|Imaging|imaging
214049|NCT02053532|Neuroimaging|neuroimaging
214050|NCT02053532|F-18-fluorodeoxyglucose (FDG)|f-18-fluorodeoxyglucose (fdg)
214051|NCT02053493|Heart Failure|heart failure
214052|NCT02053493|Preserved Ejection Fraction|preserved ejection fraction
214053|NCT02053480|pyruvate kinase deficiency|pyruvate kinase deficiency
214054|NCT02053480|hemolytic anemia|hemolytic anemia
204905|NCT02095496|sleep|sleep
214055|NCT02053480|anemia|anemia
214056|NCT02053480|enzymopathy|enzymopathy
214057|NCT02053480|jaundice|jaundice
214058|NCT02053480|splenectomy|splenectomy
214059|NCT02053480|health-related quality of life|health-related quality of life
214060|NCT02053480|Hematologic diseases|hematologic diseases
214061|NCT02053467|eConsultation|econsultation
214062|NCT02053467|Specialist care|specialist care
214063|NCT02053467|Primary health care|primary health care
214064|NCT02053467|Reducing wait times for specialist care|reducing wait times for specialist care
214065|NCT02053467|Reducing referral rates|reducing referral rates
214066|NCT02053454|RNAi therapeutic|rnai therapeutic
214067|NCT02053441|Muscle Protein Synthesis|muscle protein synthesis
214068|NCT02053441|Muscle Protein Breakdown|muscle protein breakdown
214069|NCT02053428|Head and neck cancer|head and neck cancer
214070|NCT02053428|Percutaneous image-guided gastrostomy|percutaneous image-guided gastrostomy
214071|NCT02053428|Pain|pain
214072|NCT02053428|Quality of life|quality of life
214073|NCT02053428|Complication|complication
214074|NCT02053415|krill oil|krill oil
214075|NCT02053415|omega-3 index|omega-3 index
214076|NCT02053415|plasma lipid profile|plasma lipid profile
214077|NCT02053415|tolerance|tolerance
214078|NCT02053415|young adults|young adults
214079|NCT02053402|vitamin D supplementation, persistent asthma, control|vitamin d supplementation, persistent asthma, control
214080|NCT02053389|Patient-Physician communication|patient-physician communication
214081|NCT02053389|Decision Support Techniques|decision support techniques
214082|NCT02053389|Health Communication|health communication
214083|NCT02053389|Physician-Patient Relationship|physician-patient relationship
214084|NCT02053389|Decision Making|decision making
214085|NCT02053376|gallbladder cancer, biliary cancer, bile duct cancer, hepatobiliary cancer, Biliary Tract Carcinoma|gallbladder cancer, biliary cancer, bile duct cancer, hepatobiliary cancer, biliary tract carcinoma
214086|NCT02053376|Cholangiocarcinoma|cholangiocarcinoma
214087|NCT02053363|tranexamic acid, reconstructive spine surgery|tranexamic acid, reconstructive spine surgery
214088|NCT02053350|Clostridium difficile|clostridium difficile
214089|NCT02053350|glutamine|glutamine
214090|NCT02053350|diarrhea|diarrhea
214091|NCT02053350|alanyl-glutamine|alanyl-glutamine
214092|NCT02053324|AvidinOX|avidinox
214093|NCT02053311|adenocarcinoma of the prostate|adenocarcinoma of the prostate
214094|NCT02053311|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
214095|NCT02053311|maintenance therapy|maintenance therapy
214096|NCT02053311|orteronel|orteronel
214097|NCT02053311|TAK-700|tak-700
214098|NCT02053298|Glaucoma|glaucoma
214099|NCT02053272|Diabetes|diabetes
214100|NCT02053272|Glycaemic control|glycaemic control
214101|NCT02053272|Delta-9-tetrahydrocannabivarin|delta-9-tetrahydrocannabivarin
214102|NCT02053272|Cannabinoids|cannabinoids
214103|NCT02053233|stroke|stroke
214104|NCT02053233|robot-assisted therapy|robot-assisted therapy
214105|NCT02053233|conventional therapy|conventional therapy
214106|NCT02053233|motor function|motor function
214107|NCT02053207|Cognitive training|cognitive training
214108|NCT02053207|Brain training|brain training
214109|NCT02053207|Plasticity-based training|plasticity-based training
214110|NCT02053207|Cardiac surgery|cardiac surgery
214111|NCT02053207|Preoperative|preoperative
214112|NCT02053207|Cognitive function|cognitive function
214113|NCT02053194|Inappropriate prescribing|inappropriate prescribing
214114|NCT02053194|Health Education|health education
214115|NCT02053194|Community Pharmacy Services|community pharmacy services
214116|NCT02053194|Medication Therapy Management|medication therapy management
214117|NCT02053194|Preventive Health Services|preventive health services
214118|NCT02053194|Polypharmacy|polypharmacy
214119|NCT02053194|Inappropriate prescriptions|inappropriate prescriptions
214120|NCT02053194|Aged|aged
214121|NCT02053181|Cadazolid|cadazolid
214122|NCT02053181|ACT-179811|act-179811
214123|NCT02053181|Pharmacokinetics|pharmacokinetics
214124|NCT02053181|Safety|safety
214125|NCT02053181|Tolerability|tolerability
214126|NCT02053155|Smoking cessation|smoking cessation
214127|NCT02053155|perioperative complication|perioperative complication
214128|NCT02053155|Smokerlyzer|smokerlyzer
214129|NCT02053155|smokers help line|smokers help line
214130|NCT02053142|Pharmacokinetics|pharmacokinetics
214131|NCT02053142|Herpes simplex virus|herpes simplex virus
214132|NCT02053142|Genital herpes ulcers|genital herpes ulcers
214133|NCT02053129|tuberculosis|tuberculosis
214135|NCT02053129|pregnancy|pregnancy
214136|NCT02053090|Fibromyalgia|fibromyalgia
214137|NCT02053090|Group Acupuncture|group acupuncture
214138|NCT02053090|Group Education with Stretching|group education with stretching
214139|NCT02053090|Nociceptive Reflex Testing|nociceptive reflex testing
214140|NCT02053090|Pain|pain
214141|NCT02053090|Sleep|sleep
214142|NCT02053090|Fatigue|fatigue
214143|NCT02053064|Neurodegenerative diseases|neurodegenerative diseases
214144|NCT02053064|Nervous systems diseases|nervous systems diseases
214145|NCT02053064|Genetic diseases, Inborn|genetic diseases, inborn
214146|NCT02053064|Metabolic diseases|metabolic diseases
214147|NCT02053064|Gene therapy|gene therapy
214148|NCT02053064|Adeno Associated Virus (AAV)|adeno associated virus (aav)
214149|NCT02053025|appetite|appetite
214150|NCT02053025|overweight|overweight
214151|NCT02053025|energy intake|energy intake
214152|NCT02053025|obesity|obesity
214153|NCT02053025|gut hormones|gut hormones
214154|NCT02052986|Fatty Acids, Omega-3|fatty acids, omega-3
214155|NCT02052986|Omega-3 fatty acids|omega-3 fatty acids
214156|NCT02052986|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
214157|NCT02052986|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
214158|NCT02052986|Docosapentaenoic acid (DPA)|docosapentaenoic acid (dpa)
214159|NCT02052986|Omega Index|omega index
214160|NCT02052986|Omega Score|omega score
214161|NCT02052986|Cardiac Rehab|cardiac rehab
214162|NCT02052973|Streptococcus mutans|streptococcus mutans
214163|NCT02052973|Natural products|natural products
214164|NCT02052947|Alzheimer's disease|alzheimer's disease
214165|NCT02052947|cerebrovascular disease|cerebrovascular disease
214166|NCT02052947|Lewy body disease|lewy body disease
214167|NCT02052947|MRI|mri
214168|NCT02052947|SPECT|spect
214169|NCT02052947|CSF|csf
214170|NCT02052947|biomarkers|biomarkers
214171|NCT02052947|disability|disability
214172|NCT02052947|Multicenter and prospective cohort study|multicenter and prospective cohort study
214173|NCT02052934|Escherichia coli Infections|escherichia coli infections
214174|NCT02052934|ETEC Candidate Vaccine|etec candidate vaccine
214175|NCT02052934|Immunogenicity|immunogenicity
214176|NCT02052921|Observation|observation
214177|NCT02052921|Rectal Resection|rectal resection
214178|NCT02052921|complete clinical response|complete clinical response
214179|NCT02052921|neoadjuvant chemoradiotherapy.|neoadjuvant chemoradiotherapy.
214180|NCT02052895|Presepsin|presepsin
214181|NCT02052895|Sepsis|sepsis
214182|NCT02052895|SIRS|sirs
214183|NCT02052882|Romiplostim|romiplostim
214184|NCT02052882|Thrombocytopenia|thrombocytopenia
214185|NCT02052882|13-132|13-132
214186|NCT02052869|endotracheal intubation|endotracheal intubation
214187|NCT02052869|esophageal intubation|esophageal intubation
214188|NCT02052856|Tunnel Widening|tunnel widening
214189|NCT02052856|All-Inside Suspensory Method|all-inside suspensory method
214190|NCT02052856|Biointerference Screw Fixation|biointerference screw fixation
214191|NCT02052791|Spinal Muscular Atrophy|spinal muscular atrophy
214192|NCT02052791|SMA|sma
214193|NCT02052791|SMN|smn
214194|NCT02052791|SMNRx|smnrx
214195|NCT02052791|ISIS-SMNRx|isis-smnrx
214196|NCT02052791|ISIS 396443|isis 396443
214197|NCT02052791|IONIS-SMNRx|ionis-smnrx
214198|NCT02052791|IONIS-SMN Rx|ionis-smn rx
214199|NCT02052791|Spinraza|spinraza
214200|NCT02052778|Breast Cancer|breast cancer
214201|NCT02052778|Non Small Cell Lung Cancer|non small cell lung cancer
214202|NCT02052778|Gastric Cancer|gastric cancer
214203|NCT02052778|Multiple Myeloma|multiple myeloma
214204|NCT02052778|FGF|fgf
214205|NCT02052778|FGFR|fgfr
214206|NCT02052778|FGFR abnormality|fgfr abnormality
214207|NCT02052778|TAS-120|tas-120
214208|NCT02052778|Dose Escalation|dose escalation
214209|NCT02052739|Status Epilepticus|status epilepticus
214210|NCT02052739|Refractory status epilepticus|refractory status epilepticus
214211|NCT02052739|Super-refractory status epilepticus|super-refractory status epilepticus
214212|NCT02052739|SAGE-547|sage-547
214213|NCT02052739|SAGE|sage
214214|NCT02052739|Sage Therapeutics|sage therapeutics
214215|NCT02052713|dutasteride|dutasteride
214216|NCT02052713|tamsulosin|tamsulosin
214217|NCT02052713|healthy subject|healthy subject
214218|NCT02052713|dutasteride and tamsulosin combination|dutasteride and tamsulosin combination
214514|NCT02051478|spine|spine
214219|NCT02052713|combination capsule of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg|combination capsule of dutasteride 0.5 mg and tamsulosin hcl 0.4 mg
214220|NCT02052687|Healthy volunteer|healthy volunteer
214221|NCT02052674|Precursor to CAUTI|precursor to cauti
214222|NCT02052661|Infanrix™ hexa|infanrix™ hexa
214223|NCT02052661|Hepatitis B antibodies|hepatitis b antibodies
214224|NCT02052661|Immunogenicity|immunogenicity
214225|NCT02052661|Hepatitis B|hepatitis b
214226|NCT02052661|Adolescents|adolescents
214227|NCT02052661|Infancy|infancy
214228|NCT02052661|Engerix™-B Kinder|engerix™-b kinder
214229|NCT02052661|Safety|safety
214230|NCT02052648|glioblastoma multiforme|glioblastoma multiforme
214231|NCT02052648|glioma|glioma
214232|NCT02052648|gliosarcoma|gliosarcoma
214233|NCT02052648|malignant brain tumor|malignant brain tumor
214234|NCT02052635|Percutaneous Coronary Intervention|percutaneous coronary intervention
214235|NCT02052622|submental fat reduction|submental fat reduction
214236|NCT02052596|Boostrix|boostrix
214237|NCT02052596|Herpes zoster|herpes zoster
214238|NCT02052596|Immunogenicity|immunogenicity
214239|NCT02052596|Co-administration|co-administration
214240|NCT02052596|Adults|adults
214241|NCT02052596|Safety|safety
214242|NCT02052583|Cardiac arrest|cardiac arrest
214243|NCT02052583|Oxymetry|oxymetry
214244|NCT02052583|Hypothermia|hypothermia
214245|NCT02052570|School Reentry after pediatric HSCT|school reentry after pediatric hsct
205094|NCT02094703|female|female
214246|NCT02052557|Exparel|exparel
214247|NCT02052557|liposomal bupivicaine|liposomal bupivicaine
214248|NCT02052557|post operative pain control|post operative pain control
214249|NCT02052557|local anesthetic after surgery|local anesthetic after surgery
214250|NCT02052557|colorectal surgery|colorectal surgery
214251|NCT02052557|marcaine|marcaine
214252|NCT02052557|long acting local anesthetic|long acting local anesthetic
214253|NCT02052557|pain medication use after surgery|pain medication use after surgery
214254|NCT02052544|determination of heparin levels|determination of heparin levels
214255|NCT02052544|Patients|patients
214256|NCT02052544|requiring|requiring
214257|NCT02052544|unfractionated|unfractionated
214258|NCT02052518|Childhood obesity|childhood obesity
214259|NCT02052518|Breastfeeding|breastfeeding
214260|NCT02052518|Introduction of solids|introduction of solids
214261|NCT02052518|Introduction of juice|introduction of juice
214262|NCT02052505|inappropriate prescribing|inappropriate prescribing
214263|NCT02052505|psychiatry|psychiatry
214264|NCT02052505|medication quality|medication quality
214265|NCT02052505|patient safety|patient safety
214266|NCT02052505|medication errors|medication errors
214267|NCT02052479|Polycystic Ovary Syndrome|polycystic ovary syndrome
214268|NCT02052479|PCOS|pcos
214269|NCT02052479|Secondary Amenorrhea|secondary amenorrhea
214270|NCT02052479|Hirsutism|hirsutism
214271|NCT02052479|Hyperandrogenism|hyperandrogenism
214272|NCT02052479|Insulin Resistance|insulin resistance
214273|NCT02052466|Shoulder Joint|shoulder joint
214274|NCT02052466|Computed tomography|computed tomography
214275|NCT02052453|Pacemaker|pacemaker
214276|NCT02052453|ICD|icd
214277|NCT02052453|Surgery|surgery
214278|NCT02052453|Electrocautery|electrocautery
214279|NCT02052453|Electromagnetic interference|electromagnetic interference
214280|NCT02052427|Ischemic heart disease|ischemic heart disease
214281|NCT02052427|Coronary artery disease|coronary artery disease
214282|NCT02052427|Chronic Heart Failure|chronic heart failure
214283|NCT02052427|Cardiovascular disease|cardiovascular disease
214284|NCT02052427|adult stem cells|adult stem cells
214285|NCT02052427|adipose derived regenerative cells|adipose derived regenerative cells
214286|NCT02052414|side effects|side effects
214287|NCT02052414|safety|safety
214288|NCT02052414|efficacy|efficacy
214289|NCT02052414|Gralise|gralise
214290|NCT02052414|Fibromyalgia|fibromyalgia
214291|NCT02052414|gabapentin|gabapentin
214292|NCT02052401|OLD AGE|old age
214293|NCT02052401|Elderly|elderly
214294|NCT02052401|Domiciliary Intervention|domiciliary intervention
214295|NCT02052401|Occupational Therapy|occupational therapy
214296|NCT02052401|Rehospitalization|rehospitalization
214297|NCT02052388|Skin Infection|skin infection
214298|NCT02052388|Staph aureus|staph aureus
214299|NCT02052388|MRSA|mrsa
214300|NCT02052388|MSSA|mssa
214301|NCT02052388|Cellulitis/Erysipelas|cellulitis/erysipelas
214302|NCT02052388|Wound Infection|wound infection
214303|NCT02052388|Abscess|abscess
214304|NCT02052375|Rheumatoid Arthritis|rheumatoid arthritis
214305|NCT02052375|ASP2408|asp2408
214306|NCT02052375|methotrexate|methotrexate
214307|NCT02052362|absolute bioavailability|absolute bioavailability
214308|NCT02052362|healthy volunteers|healthy volunteers
214309|NCT02052349|relative bioavailability|relative bioavailability
751895|NCT01171105|Safety|safety
214311|NCT02052336|Drug-Drug interaction|drug-drug interaction
214312|NCT02052336|Pharmacokinetics|pharmacokinetics
214313|NCT02052323|P.f Malaria, Artemisinin resistance, ACT treatment failure|p.f malaria, artemisinin resistance, act treatment failure
214314|NCT02052310|Anemia|anemia
214315|NCT02052310|Chronic Kidney Disease|chronic kidney disease
214316|NCT02052310|Hemoglobin|hemoglobin
214711|NCT02050542|ultrasound|ultrasound
214317|NCT02052310|End-Stage Renal Disease|end-stage renal disease
214318|NCT02052310|Incident-Dialysis|incident-dialysis
214319|NCT02052310|Erythropoieitin|erythropoieitin
214320|NCT02052310|Erythropoieisis stimulating-agent|erythropoieisis stimulating-agent
214321|NCT02052310|Roxadustat|roxadustat
214322|NCT02052310|AZD9941|azd9941
214323|NCT02052310|ASP1517|asp1517
214324|NCT02052297|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
214325|NCT02052297|dosimetry|dosimetry
214326|NCT02052297|Positron Emission Tomograph (PET)|positron emission tomograph (pet)
214327|NCT02052284|ELBW|elbw
214328|NCT02052284|premature|premature
214329|NCT02052284|neonate|neonate
214330|NCT02052284|skin|skin
214331|NCT02052284|water loss|water loss
214332|NCT02052271|essential tremor|essential tremor
214333|NCT02052271|cerebellum|cerebellum
214334|NCT02052271|transcranial direct current stimulation|transcranial direct current stimulation
214335|NCT02052271|electrophysiology|electrophysiology
214336|NCT02052258|oxytocin|oxytocin
214337|NCT02052219|Blisibimod|blisibimod
214338|NCT02052219|IgA nephropathy|iga nephropathy
214339|NCT02052219|BAFF|baff
214340|NCT02052219|BLyS|blys
214341|NCT02052206|osteoarthritis|osteoarthritis
214342|NCT02052206|complexe proximal humeral fracture|complexe proximal humeral fracture
205199|NCT02094157|Stroke|stroke
214343|NCT02052206|shoulder|shoulder
214344|NCT02052206|shoulder replacement|shoulder replacement
214345|NCT02052206|accuracy|accuracy
214346|NCT02052206|computer-assisted|computer-assisted
214348|NCT02052180|Carpalmetacarpal arthroplasty|carpalmetacarpal arthroplasty
214349|NCT02052180|Proximal row carpectomy|proximal row carpectomy
214350|NCT02052180|Post-operative pain control|post-operative pain control
214351|NCT02052180|Exparel|exparel
214352|NCT02052180|Marcaine|marcaine
214353|NCT02052154|Pneumococcal infection|pneumococcal infection
214354|NCT02052154|Splenectomized|splenectomized
214355|NCT02052154|vaccination|vaccination
214356|NCT02052141|Pediatric|pediatric
214357|NCT02052141|C1 inhibitor|c1 inhibitor
214358|NCT02052141|HAE|hae
214359|NCT02052141|Cinryze|cinryze
214360|NCT02052141|C1 INH|c1 inh
214361|NCT02052141|Prevention|prevention
214362|NCT02052128|endometrial cancer|endometrial cancer
214363|NCT02052128|ovarian cancer|ovarian cancer
214364|NCT02052128|breast cancer|breast cancer
214365|NCT02052128|uterine sarcoma|uterine sarcoma
214366|NCT02052128|uterine endometrioid adenocarcinoma|uterine endometrioid adenocarcinoma
214367|NCT02052115|breast cancer|breast cancer
214368|NCT02052115|exercise|exercise
214369|NCT02052115|weight loss|weight loss
214370|NCT02052115|executive function|executive function
214371|NCT02052115|breast cancer survivor|breast cancer survivor
214372|NCT02052102|Deep inspiration breath hold|deep inspiration breath hold
214373|NCT02052102|radiation therapy|radiation therapy
214374|NCT02052102|Cardiac toxicity|cardiac toxicity
214375|NCT02052102|Left-sided breast cancer|left-sided breast cancer
214376|NCT02052089|Tennis Elbow|tennis elbow
214377|NCT02052089|lateral epicondylosis|lateral epicondylosis
214378|NCT02052089|lateral epicondylitis|lateral epicondylitis
214379|NCT02052089|Platelet-Rich Plasma|platelet-rich plasma
214380|NCT02052089|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
214381|NCT02052089|Prolotherapy|prolotherapy
214382|NCT02052089|Physiotherapy|physiotherapy
214383|NCT02052076|Energy balance|energy balance
214384|NCT02052076|meal pattern|meal pattern
214385|NCT02052076|metabolic syndrome|metabolic syndrome
214386|NCT02052063|rectocele|rectocele
214387|NCT02052063|intussusception|intussusception
214388|NCT02052063|surgery|surgery
214389|NCT02052050|colorectal-neoplasms,deep-muscles of the back,rehabilitation|colorectal-neoplasms,deep-muscles of the back,rehabilitation
214390|NCT02052037|Type 2 Diabetes|type 2 diabetes
214391|NCT02052037|Egg|egg
214392|NCT02052037|Glycemic Control|glycemic control
681207|NCT00891631|weapons|weapons
214393|NCT02052037|Insulin sensitivity|insulin sensitivity
214394|NCT02052037|Diet quality|diet quality
214395|NCT02052024|Spasticity|spasticity
214396|NCT02052024|Modified Ashworth Scale|modified ashworth scale
214397|NCT02052024|MYOBLOC|myobloc
214398|NCT02052024|Botox|botox
214399|NCT02052024|Muscle Atrophy|muscle atrophy
214400|NCT02052011|Chest Pain|chest pain
214795|NCT02050230|transfusion|transfusion
214401|NCT02052011|Microvascular Angina|microvascular angina
214402|NCT02052011|Ranolazine|ranolazine
214403|NCT02052011|Emergency department|emergency department
214404|NCT02052011|PET|pet
214405|NCT02051998|Geographic atrophy|geographic atrophy
214406|NCT02051998|Age-related macular degeneration|age-related macular degeneration
214407|NCT02051998|Retina|retina
214408|NCT02051998|Retinal pigment epithelium|retinal pigment epithelium
214409|NCT02051998|Optical coherence tomography|optical coherence tomography
214410|NCT02051998|Scanning laser ophthalmoscopy|scanning laser ophthalmoscopy
214411|NCT02051985|Chronic heart failure|chronic heart failure
214412|NCT02051985|Heart decompensation|heart decompensation
214413|NCT02051985|Aerobic exercise training|aerobic exercise training
214414|NCT02051985|Functional capacity|functional capacity
214415|NCT02051985|Dyspnea|dyspnea
214416|NCT02051985|Beta-adrenergic receptor signaling|beta-adrenergic receptor signaling
214417|NCT02051959|Phantom Limb Pain|phantom limb pain
214418|NCT02051959|Transcranial Direct Current Stimulation|transcranial direct current stimulation
214419|NCT02051959|Amputation|amputation
214420|NCT02051959|Diabetes Mellitus|diabetes mellitus
214421|NCT02051946|novel drug delivery technique for glaucoma patients|novel drug delivery technique for glaucoma patients
214422|NCT02051933|pilon|pilon
214423|NCT02051933|tibial plafond|tibial plafond
214424|NCT02051933|botox|botox
214425|NCT02051933|ankle dorsiflexion|ankle dorsiflexion
214426|NCT02051933|ankle functionality|ankle functionality
214427|NCT02051933|ankle range of motion|ankle range of motion
214428|NCT02051920|Elastography|elastography
214429|NCT02051894|Neonates|neonates
214430|NCT02051894|Dobutamine|dobutamine
214431|NCT02051894|Superior Vena Cana Flow|superior vena cana flow
214432|NCT02051894|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
214433|NCT02051894|Pleth Variability Index|pleth variability index
214434|NCT02051868|Squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
214435|NCT02051868|Anal cancer|anal cancer
214436|NCT02051868|Cancer of the anus|cancer of the anus
214437|NCT02051868|SCCA|scca
214438|NCT02051868|Cisplatin-5FU|cisplatin-5fu
214439|NCT02051868|Carboplatin-Paclitaxel|carboplatin-paclitaxel
214440|NCT02051868|inoperable|inoperable
214441|NCT02051868|locally recurrent|locally recurrent
214442|NCT02051868|metastatic|metastatic
214443|NCT02051855|Neonates|neonates
214444|NCT02051855|Superior Vena Cava Flow|superior vena cava flow
214445|NCT02051855|Pleth Variability Index|pleth variability index
214446|NCT02051855|Dobutamine|dobutamine
214447|NCT02051855|Intensive Care|intensive care
214448|NCT02051842|NAFLD|nafld
214449|NCT02051842|oxidative stress|oxidative stress
214450|NCT02051842|malondialdehyde|malondialdehyde
214451|NCT02051816|Endotracheal Intubation|endotracheal intubation
214452|NCT02051816|Apneic Oxygenation|apneic oxygenation
214453|NCT02051816|Respiratory failure|respiratory failure
214454|NCT02051803|smoking cessation|smoking cessation
214455|NCT02051803|women|women
214456|NCT02051751|Solid tumors, Head and neck non squamous cell carcinoma, breast cancer, PI3K inhibitor, BYL719, paclitaxel|solid tumors, head and neck non squamous cell carcinoma, breast cancer, pi3k inhibitor, byl719, paclitaxel
214457|NCT02051738|Healthy|healthy
214458|NCT02051738|Mebendazole|mebendazole
214459|NCT02051738|Fast-Disintegrating Chewable Formulation|fast-disintegrating chewable formulation
214460|NCT02051738|Bioavailability|bioavailability
214461|NCT02051712|chronic heart failure|chronic heart failure
214462|NCT02051712|exercise training|exercise training
214463|NCT02051712|preferred training|preferred training
214464|NCT02051712|prevention|prevention
214465|NCT02051699|Osteoarthritis of the knee|osteoarthritis of the knee
214466|NCT02051699|Weight bearing radiograph|weight bearing radiograph
214467|NCT02051699|Kellgren-Lawrence classification|kellgren-lawrence classification
214468|NCT02051699|Joint space width|joint space width
214469|NCT02051699|One-leg standing view|one-leg standing view
214470|NCT02051686|Acetabulum Fractures|acetabulum fractures
214471|NCT02051686|Pelvic Ring Injuries|pelvic ring injuries
214472|NCT02051686|Tranexamic Acid|tranexamic acid
214473|NCT02051673|Kidney Transplantation|kidney transplantation
214474|NCT02051647|medical students|medical students
214475|NCT02051647|Basel University|basel university
214476|NCT02051634|Aging|aging
214477|NCT02051634|Papaya|papaya
214478|NCT02051634|Fermented Papaya|fermented papaya
214479|NCT02051634|Inflammation|inflammation
214480|NCT02051634|Phytochemicals|phytochemicals
214481|NCT02051634|Physical function|physical function
214482|NCT02051634|Quality of life|quality of life
214483|NCT02051634|Fatigue|fatigue
214484|NCT02051634|Health|health
214485|NCT02051621|pulmonary vein isolation|pulmonary vein isolation
214486|NCT02051621|isthmus ablation|isthmus ablation
214487|NCT02051621|recurrence|recurrence
214488|NCT02051595|heart lung machine|heart lung machine
214489|NCT02051595|blood pump|blood pump
214490|NCT02051595|cardiac surgery|cardiac surgery
214491|NCT02051595|cardiopulmonary bypass|cardiopulmonary bypass
214492|NCT02051595|circulation|circulation
214493|NCT02051556|Parkinson's disease|parkinson's disease
214494|NCT02051556|Freezing of gait|freezing of gait
214495|NCT02051556|Asymmetry|asymmetry
214496|NCT02051556|Rehabilitation|rehabilitation
214497|NCT02051556|Physical therapy|physical therapy
214498|NCT02051530|mood|mood
214499|NCT02051530|empathy|empathy
214500|NCT02051530|mimicry|mimicry
214501|NCT02051530|emotional reactivity|emotional reactivity
214502|NCT02051530|prosody|prosody
214503|NCT02051517|Virectomy|virectomy
214504|NCT02051504|Type 1 diabetes|type 1 diabetes
214505|NCT02051504|Glycated hemoglobin|glycated hemoglobin
214506|NCT02051504|Muscle Oxygenation|muscle oxygenation
214507|NCT02051504|Exercise|exercise
214508|NCT02051504|Maximal Oxygen uptake|maximal oxygen uptake
214509|NCT02051504|Mitochondrial respiration|mitochondrial respiration
214510|NCT02051504|Endocannabinoid system|endocannabinoid system
214511|NCT02051504|Oxidative stress|oxidative stress
214512|NCT02051478|manipulation|manipulation
214513|NCT02051478|mobilization|mobilization
214515|NCT02051478|pressure pain|pressure pain
214516|NCT02051439|Varicose Veins|varicose veins
214517|NCT02051439|Venous Insufficiency|venous insufficiency
214518|NCT02051439|Doppler|doppler
214519|NCT02051439|Duplex|duplex
214520|NCT02051439|Valsava|valsava
214521|NCT02051426|neuropsychiatric effects|neuropsychiatric effects
214522|NCT02051413|Major depression|major depression
214523|NCT02051413|Antidepressant drug|antidepressant drug
214524|NCT02051413|Beta-arrestin|beta-arrestin
214525|NCT02051413|Biomarker|biomarker
214526|NCT02051413|Predictive factor|predictive factor
214527|NCT02051400|Intubation|intubation
214528|NCT02051400|Laryngoscopes|laryngoscopes
214529|NCT02051361|DAT = Dual Antiplatelet Treatment|dat = dual antiplatelet treatment
214530|NCT02051361|Major Cardiac Adverse Events|major cardiac adverse events
214531|NCT02051348|Helicobacter pylori|helicobacter pylori
214532|NCT02051348|Mild Indigestion|mild indigestion
214533|NCT02051335|Drug therapy|drug therapy
214534|NCT02051309|Smokers|smokers
214535|NCT02051309|Quit Smoking|quit smoking
263159|NCT01830439|PK|pk
214536|NCT02051309|Treatment|treatment
214537|NCT02051309|Guanfacine|guanfacine
214538|NCT02051283|Hepatocellular carcinoma|hepatocellular carcinoma
214539|NCT02051283|RFA|rfa
214540|NCT02051283|MRI|mri
214541|NCT02051270|Elderly|elderly
214542|NCT02051270|Nursing homes|nursing homes
214543|NCT02051270|Mild cognitive impairment|mild cognitive impairment
214544|NCT02051244|Alzheimer's Disease|alzheimer's disease
214545|NCT02051244|Retinal Nerve Fiber Layer|retinal nerve fiber layer
214546|NCT02051244|Ocular Computerized Tomography|ocular computerized tomography
214547|NCT02051244|Minimal Cognitive Impairment|minimal cognitive impairment
214548|NCT02051244|Subjective Memory Loss|subjective memory loss
214549|NCT02051244|Asymptomatic Preclinical Alzheimer's Disease|asymptomatic preclinical alzheimer's disease
214550|NCT02051231|Uterine contraction|uterine contraction
214551|NCT02051231|Oxytocin receptors|oxytocin receptors
214552|NCT02051231|Oxytocin desensitization|oxytocin desensitization
214553|NCT02051218|metastatic breast cancer|metastatic breast cancer
214554|NCT02051218|castration resistant metastatic prostate cancer|castration resistant metastatic prostate cancer
214555|NCT02051218|bone metastases|bone metastases
214556|NCT02051218|Denosumab|denosumab
214557|NCT02051218|XGEVA|xgeva
214558|NCT02051218|de-escalation|de-escalation
214559|NCT02051205|Parkinson's disease, risk factors, epidemiology|parkinson's disease, risk factors, epidemiology
214560|NCT02051192|obsessive-compulsive disorder|obsessive-compulsive disorder
214561|NCT02051192|Social phobia|social phobia
214562|NCT02051192|Generalized anxiety disorder|generalized anxiety disorder
214563|NCT02051192|Specific phobia|specific phobia
214564|NCT02051192|Separation anxiety disorder|separation anxiety disorder
214565|NCT02051192|Selective Mutism|selective mutism
214566|NCT02051192|Anxiety Disorder, Not Otherwise Specified|anxiety disorder, not otherwise specified
214567|NCT02051192|Counseling|counseling
214568|NCT02051192|Behavioral therapy|behavioral therapy
214569|NCT02051192|Psychotherapy|psychotherapy
214570|NCT02051192|Exposure|exposure
214571|NCT02051192|Young Children|young children
214572|NCT02051179|Repair|repair
214573|NCT02051179|Replacement|replacement
214574|NCT02051179|Dental Amalgam|dental amalgam
214575|NCT02051153|Modafinil|modafinil
214576|NCT02051153|Cognitive|cognitive
214577|NCT02051153|Performance|performance
214578|NCT02051140|Postural Balance|postural balance
214579|NCT02051140|Walking|walking
214580|NCT02051140|Giat|giat
214581|NCT02051140|Cognition|cognition
214582|NCT02051140|Learning|learning
214583|NCT02051140|Memory|memory
214584|NCT02051140|Antioxidants|antioxidants
214585|NCT02051140|Anti-Inflammatory Agents|anti-inflammatory agents
214586|NCT02051140|Brain|brain
214587|NCT02051140|Strawberry|strawberry
214588|NCT02051127|Exercise|exercise
214589|NCT02051127|Physical Fitness|physical fitness
214590|NCT02051127|Stress, Psychological|stress, psychological
214591|NCT02051127|Cognition|cognition
214592|NCT02051127|Psychophysiology|psychophysiology
214593|NCT02051127|Ergometry|ergometry
214594|NCT02051127|Exercise Test|exercise test
214595|NCT02051127|Sedentary Lifestyle|sedentary lifestyle
214596|NCT02051114|Rheumatoid arthritis|rheumatoid arthritis
214597|NCT02051088|Critical limb ischemia|critical limb ischemia
214598|NCT02051088|Intermittent claudication|intermittent claudication
214599|NCT02051088|endovascular treatment|endovascular treatment
214600|NCT02051088|drug-elution|drug-elution
214602|NCT02051075|ICSI|icsi
214603|NCT02051075|Asthenospermia|asthenospermia
214604|NCT02051075|pentoxyphylline|pentoxyphylline
214605|NCT02051075|Spermatozoa|spermatozoa
214606|NCT02051062|Pharmacokinetics|pharmacokinetics
214609|NCT02051049|CN|cn
214610|NCT02051049|UCD|ucd
214611|NCT02051036|moxibustion|moxibustion
214612|NCT02051023|keratoconjunctivitis sicca|keratoconjunctivitis sicca
214613|NCT02051023|dry eye|dry eye
214614|NCT02051023|dry eye syndrome|dry eye syndrome
214615|NCT02051023|dry eye disease|dry eye disease
214616|NCT02051023|steroids|steroids
214617|NCT02050984|Obesity|obesity
214618|NCT02050984|Hypertension|hypertension
214619|NCT02050984|Bariatric Surgery|bariatric surgery
214620|NCT02050984|Diabetes|diabetes
214621|NCT02050971|Umbilical Cord Blood|umbilical cord blood
214622|NCT02050971|Autologous Umbilical Cord Blood Transfusion|autologous umbilical cord blood transfusion
214623|NCT02050971|Prematurity Complications|prematurity complications
214624|NCT02050971|Infant, Premature, Diseases|infant, premature, diseases
214625|NCT02050971|Infant, Newborn, Diseases|infant, newborn, diseases
214626|NCT02050971|Hematologic Diseases|hematologic diseases
214627|NCT02050971|Lung Diseases|lung diseases
214628|NCT02050971|Central Nervous System Diseases|central nervous system diseases
214629|NCT02050971|Gastrointestinal Tract Diseases|gastrointestinal tract diseases
214630|NCT02050971|Vascular Diseases|vascular diseases
214631|NCT02050971|Retinopathies, Neonates|retinopathies, neonates
214632|NCT02050971|Prevention,Treatment|prevention,treatment
214633|NCT02050932|hepcidin|hepcidin
214634|NCT02050932|iron bioavailability|iron bioavailability
214635|NCT02050932|iron supplementation|iron supplementation
214636|NCT02050906|IDEA-P|idea-p
214637|NCT02050906|Androgen Deprivation Therapy|androgen deprivation therapy
214638|NCT02050893|septic shock|septic shock
214639|NCT02050893|sepsis|sepsis
214640|NCT02050893|fluid responsiveness|fluid responsiveness
214641|NCT02050893|Midazolam|midazolam
214642|NCT02050893|Propofol|propofol
214643|NCT02050893|haemodynamics|haemodynamics
214644|NCT02050880|Normal Eyes|normal eyes
214645|NCT02050880|Eye; Disorder with Glaucoma|eye; disorder with glaucoma
214646|NCT02050880|Eye; Disorder with Retinal Disease|eye; disorder with retinal disease
214647|NCT02050880|Eye; Disorder Corneal Disease incl kerato-refractive group|eye; disorder corneal disease incl kerato-refractive group
214648|NCT02050867|Youth Suicide|youth suicide
214649|NCT02050867|Suicide|suicide
214650|NCT02050854|Aripiprazole|aripiprazole
214651|NCT02050854|Treatment Adherence|treatment adherence
214652|NCT02050841|Pediatric|pediatric
214653|NCT02050841|patients|patients
214654|NCT02050841|replacement|replacement
214655|NCT02050841|coagulation factors|coagulation factors
214656|NCT02050841|plasma|plasma
214657|NCT02050841|s/d plasma|s/d plasma
214658|NCT02050841|Octaplas|octaplas
214659|NCT02050841|plasma replacement|plasma replacement
214660|NCT02050815|MEK162|mek162
214661|NCT02050815|Hepatic impairment|hepatic impairment
214662|NCT02050815|Healthy subjects|healthy subjects
214663|NCT02050802|Macitentan|macitentan
214664|NCT02050802|Pharmacokinetics|pharmacokinetics
214665|NCT02050802|Pharmacodynamics|pharmacodynamics
214666|NCT02050763|HIV|hiv
214667|NCT02050763|Intimate partner violence|intimate partner violence
214668|NCT02050763|Community based prevention intervention|community based prevention intervention
214669|NCT02050763|Uganda|uganda
214670|NCT02050763|Cluster randomized trial|cluster randomized trial
214671|NCT02050750|Must have registered with the ICORG 06-31 TAILORx trial|must have registered with the icorg 06-31 tailorx trial
214672|NCT02050737|Curative resection|curative resection
214673|NCT02050737|Adjuvant chemotherapy|adjuvant chemotherapy
214674|NCT02050724|Solitary Pulmonary Nodule|solitary pulmonary nodule
214675|NCT02050724|Thoracoscopy|thoracoscopy
214676|NCT02050724|Thoracic Surgery|thoracic surgery
214677|NCT02050724|Video-Assisted|video-assisted
214678|NCT02050724|Radioactive Tracers|radioactive tracers
214679|NCT02050724|Radioguided surgery|radioguided surgery
214680|NCT02050724|Handheld-SPECT|handheld-spect
214681|NCT02050711|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
214682|NCT02050711|Pulmonary rehabilitation|pulmonary rehabilitation
214683|NCT02050711|Computerized respiratory sounds|computerized respiratory sounds
214684|NCT02050698|fift metatarsal avulsion fracture|fift metatarsal avulsion fracture
214685|NCT02050698|hard-soled shoe|hard-soled shoe
214686|NCT02050698|short leg walking cast|short leg walking cast
214687|NCT02050698|protected weightbearing|protected weightbearing
214688|NCT02050672|Myoinositol|myoinositol
214689|NCT02050672|ART|art
214690|NCT02050672|EMBRYO QUALITY|embryo quality
214691|NCT02050646|Autoimmune hepatitis|autoimmune hepatitis
214692|NCT02050646|Liver dysfunction|liver dysfunction
214693|NCT02050646|Elevated serum auto antibodies|elevated serum auto antibodies
214694|NCT02050633|Craniocerebral Trauma|craniocerebral trauma
214695|NCT02050633|Long term outcome|long term outcome
214696|NCT02050633|Activities of Daily Living|activities of daily living
214697|NCT02050633|Cognitive Deficiency|cognitive deficiency
214698|NCT02050633|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
214699|NCT02050633|Burden of care|burden of care
214700|NCT02050620|Breast cancer, exercise and quality of life|breast cancer, exercise and quality of life
214601|NCT02051075|IVF|ivf
214701|NCT02050581|Platelets are a part of the blood hat helps with clotting|platelets are a part of the blood hat helps with clotting
214702|NCT02050581|ITP idiopathic thrombocytopenia purpura low platelet count|itp idiopathic thrombocytopenia purpura low platelet count
214704|NCT02050568|Genital prolapse surgery|genital prolapse surgery
214705|NCT02050568|Stress urinary incontinence|stress urinary incontinence
214706|NCT02050568|Urethral Pressure Reflectometry|urethral pressure reflectometry
214707|NCT02050542|cancer|cancer
214708|NCT02050542|prostate|prostate
214710|NCT02050542|biopsies|biopsies
214712|NCT02050542|MRI|mri
214713|NCT02050542|fusion of images|fusion of images
214714|NCT02050529|Hypertension, Pregnancy induced|hypertension, pregnancy induced
214715|NCT02050529|Pre-eclampsia|pre-eclampsia
214716|NCT02050529|Eclampsia|eclampsia
214717|NCT02050529|Labetalol|labetalol
214718|NCT02050529|Hydralazine|hydralazine
214719|NCT02050516|Blastocyst, micro-well group culture dish|blastocyst, micro-well group culture dish
214720|NCT02050503|Mucositis|mucositis
214721|NCT02050503|Breakthrough pain|breakthrough pain
214722|NCT02050503|Head Nad neck cancer|head nad neck cancer
214723|NCT02050503|Intranasal transmucosal fentanyl in pectin|intranasal transmucosal fentanyl in pectin
214724|NCT02050477|Obesity|obesity
214725|NCT02050477|Bariatric|bariatric
214726|NCT02050477|Surgery|surgery
214727|NCT02050477|Sleeve|sleeve
205590|NCT02092428|CAD|cad
214728|NCT02050477|Gastroplasty|gastroplasty
214729|NCT02050477|Laparoscopy|laparoscopy
214730|NCT02050464|Alzheimer Disease|alzheimer disease
214731|NCT02050464|Frontotemporal Dementia|frontotemporal dementia
214732|NCT02050464|Dementia, Vascular|dementia, vascular
214733|NCT02050464|Mild Cognitive Impairment|mild cognitive impairment
214734|NCT02050464|Diagnosis|diagnosis
214735|NCT02050464|Risk factors|risk factors
214736|NCT02050464|Biomarkers|biomarkers
214737|NCT02050464|AD|ad
214738|NCT02050464|FTD|ftd
214739|NCT02050464|VAD|vad
214740|NCT02050464|MCI|mci
214741|NCT02050451|radical cystectomy|radical cystectomy
214742|NCT02050451|urinary diversion|urinary diversion
214743|NCT02050451|nutrition|nutrition
214744|NCT02050451|oral supplementation|oral supplementation
214745|NCT02050451|enteral nutrition|enteral nutrition
214746|NCT02050438|Osteoarthritis Knee|osteoarthritis knee
214747|NCT02050438|Total Knee Arthroplasty|total knee arthroplasty
214748|NCT02050438|Quality of Life|quality of life
214749|NCT02050425|OSA|osa
214750|NCT02050425|CPAP|cpap
214751|NCT02050425|exhaled breath|exhaled breath
214752|NCT02050399|Isometric Exercise|isometric exercise
214753|NCT02050399|Arterial Pressure|arterial pressure
214754|NCT02050399|Autonomic Nervous System|autonomic nervous system
214755|NCT02050399|Cardiovascular system|cardiovascular system
214756|NCT02050399|Posture|posture
214757|NCT02050386|Brain arousal systems|brain arousal systems
214758|NCT02050386|Aging|aging
214759|NCT02050386|MRI|mri
214760|NCT02050386|fMRI|fmri
214761|NCT02050386|Cognition|cognition
214762|NCT02050373|Mucositis|mucositis
214763|NCT02050373|Stomatitis|stomatitis
214764|NCT02050373|Chemotherapy|chemotherapy
214765|NCT02050373|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
214766|NCT02050373|Laser therapy|laser therapy
214767|NCT02050373|Inflammatory cytokines|inflammatory cytokines
214768|NCT02050360|Raynaud's phenomenon|raynaud's phenomenon
214769|NCT02050360|Sildenafil|sildenafil
214770|NCT02050360|Systemic Sclerosis|systemic sclerosis
214771|NCT02050360|Local cooling|local cooling
214772|NCT02050360|Microcirculation|microcirculation
214773|NCT02050347|CD19.CAR-CD28zeta|cd19.car-cd28zeta
214774|NCT02050347|chimeric antigen receptor|chimeric antigen receptor
214775|NCT02050347|hematopoietic stem cell transplant|hematopoietic stem cell transplant
214776|NCT02050334|Phase 1|phase 1
214777|NCT02050334|Healthy Volunteer|healthy volunteer
214778|NCT02050334|Safety|safety
214779|NCT02050334|Healthy Volunteer Safety Study|healthy volunteer safety study
214780|NCT02050282|Dyspnea|dyspnea
214781|NCT02050282|Prehospital|prehospital
214782|NCT02050282|Biomarker|biomarker
214783|NCT02050282|Heart failure|heart failure
214784|NCT02050282|Triage|triage
214785|NCT02050282|Randomized, controlled study|randomized, controlled study
214786|NCT02050256|Palliative care|palliative care
214787|NCT02050256|Continuing medical education|continuing medical education
214788|NCT02050256|General practitioner|general practitioner
214789|NCT02050256|Electronic decision support|electronic decision support
214790|NCT02050243|pediatrics|pediatrics
214791|NCT02050243|brain tumor|brain tumor
214792|NCT02050243|CNS|cns
214793|NCT02050243|fluorescence|fluorescence
214794|NCT02050243|5ALA|5ala
214799|NCT02050217|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
214800|NCT02050217|Children|children
214801|NCT02050217|Respiratory Failure|respiratory failure
214802|NCT02050204|work to family conflict|work to family conflict
214803|NCT02050204|supervisor support|supervisor support
214804|NCT02050204|long work hours|long work hours
214805|NCT02050204|cardiometabolic risk|cardiometabolic risk
214809|NCT02050178|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
214810|NCT02050165|obesity|obesity
214811|NCT02050165|snacks|snacks
214812|NCT02050165|satiety|satiety
214813|NCT02050165|hunger|hunger
214814|NCT02050152|Amnesia|amnesia
214815|NCT02050152|Memory|memory
214816|NCT02050152|Implicit|implicit
214817|NCT02050152|Explicit|explicit
214818|NCT02050152|Nitrous Oxide|nitrous oxide
214819|NCT02050139|L-Cysteine|l-cysteine
214820|NCT02050139|Peritoneal dialysis|peritoneal dialysis
214821|NCT02050139|Diuresis|diuresis
214822|NCT02050139|Glomerular filtration rate|glomerular filtration rate
214823|NCT02050139|Peritoneal function|peritoneal function
214824|NCT02050139|Inflammation|inflammation
214825|NCT02050113|Complex Aortic Aneurysms|complex aortic aneurysms
214826|NCT02050113|Thoracoabdominal Aneurysms|thoracoabdominal aneurysms
214827|NCT02050113|Pararenal Aortic Aneurysms|pararenal aortic aneurysms
214828|NCT02050113|Juxtarenal Renal Aneurysms|juxtarenal renal aneurysms
214829|NCT02050113|Endovascular Branch Graft|endovascular branch graft
214830|NCT02050113|Fenestrated Stent Graft|fenestrated stent graft
214831|NCT02050113|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
214832|NCT02050113|Endovascular|endovascular
214833|NCT02050100|primary lung adenocarcinoma Stages I, II, IIIA, IIIB|primary lung adenocarcinoma stages i, ii, iiia, iiib
205682|NCT02091973|microRNA|microrna
205689|NCT02091947|FMS|fms
205690|NCT02091947|Urine incontinence|urine incontinence
205691|NCT02091934|Alcon|alcon
205692|NCT02091934|Wavelight|wavelight
205693|NCT02091934|PRK|prk
205696|NCT02091934|Myopia|myopia
214834|NCT02050100|squamous cell carcinoma Stages I, II, IIIA, IIIB|squamous cell carcinoma stages i, ii, iiia, iiib
214835|NCT02050100|benign non-calcified pulmonary nodules|benign non-calcified pulmonary nodules
214836|NCT02050100|early detection|early detection
214837|NCT02050087|Rotator cuff|rotator cuff
214838|NCT02050087|Rehabilitation|rehabilitation
214839|NCT02050048|Pancreatitis|pancreatitis
214840|NCT02050048|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
214841|NCT02050048|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
214842|NCT02050048|ERCP|ercp
214843|NCT02050048|High Volume|high volume
214844|NCT02050048|Lactated Ringer|lactated ringer
214845|NCT02050048|Intravenous Administration|intravenous administration
214846|NCT02050048|Sphincterotomy, Endoscopic|sphincterotomy, endoscopic
214847|NCT02050048|Pancreas|pancreas
214851|NCT02050022|Biomarkers|biomarkers
214852|NCT02050022|Genomics|genomics
214853|NCT02050022|Proteomics|proteomics
214854|NCT02050022|Diagnostics|diagnostics
214855|NCT02050022|Prognostics|prognostics
214856|NCT02049996|Quality of life|quality of life
214857|NCT02049996|Robotic surgery|robotic surgery
214858|NCT02049996|Vaginal surgery|vaginal surgery
214859|NCT02049996|Prolapse repair|prolapse repair
214860|NCT02049996|Vaginal hysterectomy|vaginal hysterectomy
214861|NCT02049970|Supraclavicular block|supraclavicular block
214862|NCT02049957|MLN0128|mln0128
214863|NCT02049944|Antibiotic Prophylaxis|antibiotic prophylaxis
214864|NCT02049944|Obesity|obesity
214865|NCT02049944|Obesity, Morbid|obesity, morbid
214866|NCT02049944|Pregnancy|pregnancy
214867|NCT02049944|Infection; Cesarean Section|infection; cesarean section
214868|NCT02049931|osteoporosis, compression fracture, brace|osteoporosis, compression fracture, brace
214869|NCT02049918|Respiratory viruses|respiratory viruses
214870|NCT02049905|soft tissue sarcoma|soft tissue sarcoma
214871|NCT02049905|unresectable|unresectable
214872|NCT02049905|metastatic|metastatic
214873|NCT02049905|locally advanced|locally advanced
214874|NCT02049905|sarcoma|sarcoma
214875|NCT02049892|Total Hip Replacement|total hip replacement
214876|NCT02049892|Metal Ion|metal ion
214877|NCT02049892|2-5 years after surgery|2-5 years after surgery
214878|NCT02049892|Asymptomatic|asymptomatic
214879|NCT02049866|osteoporosis|osteoporosis
214880|NCT02049866|premenopausal|premenopausal
214881|NCT02049866|denosumab|denosumab
214882|NCT02049866|idiopathic|idiopathic
214883|NCT02049866|Idiopathic Osteoporosis in Premenopausal Women|idiopathic osteoporosis in premenopausal women
214884|NCT02049853|acute dyspnea|acute dyspnea
682789|NCT00900744|Tamoxifen|tamoxifen
214885|NCT02049853|heart failure|heart failure
214886|NCT02049853|diagnostics|diagnostics
214887|NCT02049853|POCT analysis|poct analysis
214888|NCT02049853|preclinical area|preclinical area
214889|NCT02049840|Female sling|female sling
214890|NCT02049840|Stress Urinary Incontinence|stress urinary incontinence
214891|NCT02049840|Urination Disorders|urination disorders
214892|NCT02049840|Urologic Diseases|urologic diseases
214897|NCT02049762|platelet reactivity|platelet reactivity
214898|NCT02049762|acute coronary syndrome|acute coronary syndrome
214899|NCT02049749|Child Behavior Problems|child behavior problems
214900|NCT02049749|Parent Training Program|parent training program
214901|NCT02049723|Gastroesophageal reflux disease|gastroesophageal reflux disease
214902|NCT02049723|Knowledge|knowledge
214903|NCT02049697|Healthy|healthy
214904|NCT02049697|Healthy male participants|healthy male participants
214905|NCT02049697|14C-JNJ -39823277|14c-jnj -39823277
214798|NCT02050217|Helmet|helmet
214911|NCT02049697|Pharmacokinetics|pharmacokinetics
214912|NCT02049658|tumor|tumor
214913|NCT02049658|cancer|cancer
214914|NCT02049645|lung cancer|lung cancer
214915|NCT02049645|breast cancer|breast cancer
214920|NCT02049619|Pharyngeal pack|pharyngeal pack
214921|NCT02049619|Nausea|nausea
214922|NCT02049619|Vomiting|vomiting
214923|NCT02049619|orthognathic surgery|orthognathic surgery
214924|NCT02049619|maxillary osteotomy|maxillary osteotomy
214925|NCT02049606|LAYLA|layla
214926|NCT02049606|Non-inferiority|non-inferiority
214927|NCT02049606|100mm pain VAS|100mm pain vas
214928|NCT02049593|protocol specific|protocol specific
214929|NCT02049580|lymphoma|lymphoma
214930|NCT02049567|cataract, presbyopia|cataract, presbyopia
214931|NCT02049554|preconception care|preconception care
214932|NCT02049554|women's health|women's health
214933|NCT02049541|BKM120|bkm120
214934|NCT02049541|B-Cell Lymphoma|b-cell lymphoma
214935|NCT02049541|PI3K inhibitor|pi3k inhibitor
205797|NCT02091531|PSA|psa
214936|NCT02049528|Food Effect|food effect
214937|NCT02049528|Pharmacokinetic|pharmacokinetic
214938|NCT02049528|Healthy|healthy
214939|NCT02049528|Male|male
214940|NCT02049515|Phase 3|phase 3
214941|NCT02049515|CLL/SLL|cll/sll
214942|NCT02049515|PI3K|pi3k
214943|NCT02049502|ulcerative colitis|ulcerative colitis
214944|NCT02049502|fecal microbiota transplantation|fecal microbiota transplantation
214945|NCT02049489|ICT-121|ict-121
214946|NCT02049489|glioblastoma|glioblastoma
214947|NCT02049489|immunotherapy|immunotherapy
214948|NCT02049489|dendritic cell vaccine|dendritic cell vaccine
214949|NCT02049489|CD133|cd133
214950|NCT02049476|Uveitis, Intermediate|uveitis, intermediate
214951|NCT02049476|Uveitis, Posterior|uveitis, posterior
214952|NCT02049476|Dexamethasone|dexamethasone
214953|NCT02049476|Immunosuppressive Agents|immunosuppressive agents
214954|NCT02049476|Eye Abnormalities|eye abnormalities
214955|NCT02049476|Eye Diseases|eye diseases
214956|NCT02049476|Ophthalmology|ophthalmology
214957|NCT02049476|Ophthalmologic Surgical Procedures|ophthalmologic surgical procedures
214958|NCT02049476|Vision Disorders|vision disorders
214959|NCT02049476|Inflammation|inflammation
214960|NCT02049463|carotid artery|carotid artery
214961|NCT02049463|sound|sound
214962|NCT02049463|stenosis|stenosis
214963|NCT02049463|wall|wall
214964|NCT02049463|stroke|stroke
214965|NCT02049450|thalassemia|thalassemia
214966|NCT02049450|thalassemia major|thalassemia major
214967|NCT02049450|spleen enlargement|spleen enlargement
214968|NCT02049450|INC424|inc424
214969|NCT02049450|ruxolitinib|ruxolitinib
214970|NCT02049437|HIV|hiv
214971|NCT02049437|Immune failure|immune failure
214972|NCT02049437|Tocilizumab|tocilizumab
214973|NCT02049437|ACTEMRA|actemra
214974|NCT02049437|Antiretroviral therapy|antiretroviral therapy
214975|NCT02049437|HAART|haart
214976|NCT02049411|Ketamine|ketamine
214977|NCT02049411|acute cognitive dysfunction|acute cognitive dysfunction
214978|NCT02049411|geriatric patients|geriatric patients
214979|NCT02049398|Microbiome|microbiome
214980|NCT02049398|Saliva|saliva
214981|NCT02049398|Reliability|reliability
214982|NCT02049398|Oral Cavity|oral cavity
214983|NCT02049385|Glutamate|glutamate
214984|NCT02049385|Pathophysiology|pathophysiology
214985|NCT02049385|Depression|depression
214986|NCT02049385|Treatment|treatment
214987|NCT02049372|complications|complications
214988|NCT02049372|tonsillectomy|tonsillectomy
214989|NCT02049372|tonsillotomy|tonsillotomy
214990|NCT02049359|Diabetes|diabetes
214991|NCT02049346|Anemia|anemia
214992|NCT02049346|Hemodialysis|hemodialysis
214993|NCT02049346|Erythropoetin Stimulating Agents|erythropoetin stimulating agents
214994|NCT02049346|Comparison|comparison
214995|NCT02049294|Prednisone|prednisone
214996|NCT02049294|Eosinophils|eosinophils
214997|NCT02049294|Immunoglobin E (IgE)|immunoglobin e (ige)
214998|NCT02049294|Asthma|asthma
214999|NCT02049294|Bronchitis|bronchitis
215000|NCT02049294|Inflammation|inflammation
215002|NCT02049268|alcohol|alcohol
215003|NCT02049268|nicotine|nicotine
215004|NCT02049268|addiction|addiction
215005|NCT02049268|functional MRI|functional mri
215006|NCT02049268|functional connectivity|functional connectivity
215007|NCT02049268|brain circuits|brain circuits
215008|NCT02049255|All|all
215009|NCT02049242|Hemorrhage|hemorrhage
215010|NCT02049242|Leiomyoma|leiomyoma
215011|NCT02049242|Myofibroma|myofibroma
215012|NCT02049242|Uterine Myomectomy|uterine myomectomy
215013|NCT02049242|Tourniquet|tourniquet
215014|NCT02049229|Stent|stent
215015|NCT02049229|Titanium|titanium
215016|NCT02049229|drug eluting stent|drug eluting stent
215018|NCT02049229|stent thrombosis|stent thrombosis
215019|NCT02049216|knee|knee
215020|NCT02049216|osteoarthritis|osteoarthritis
215021|NCT02049216|tape|tape
215022|NCT02049216|exercise|exercise
215023|NCT02049216|rocktape|rocktape
215024|NCT02049190|Advanced Prostate Cancer|advanced prostate cancer
215025|NCT02049190|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
215026|NCT02049190|Prostatic Neoplasms|prostatic neoplasms
215027|NCT02049190|Genital Neoplasms, Male|genital neoplasms, male
215028|NCT02049190|Urogenital Neoplasms|urogenital neoplasms
215029|NCT02049190|Neoplasms by Site|neoplasms by site
215030|NCT02049190|Neoplasms|neoplasms
215031|NCT02049190|Genital Diseases, Male|genital diseases, male
215032|NCT02049190|Prostatic Diseases|prostatic diseases
215033|NCT02049190|onapristone|onapristone
215034|NCT02049177|Cancer|cancer
215035|NCT02049177|Epidemiology|epidemiology
215036|NCT02049177|Head and Neck|head and neck
215037|NCT02049177|HPV|hpv
215038|NCT02049164|AR08, Vasomotor Symptoms|ar08, vasomotor symptoms
215039|NCT02049151|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
215040|NCT02049151|Tecemotide|tecemotide
215041|NCT02049151|Placebo|placebo
215042|NCT02049151|NSCLC|nsclc
215043|NCT02049151|L-BLP25|l-blp25
215044|NCT02049138|Joint Diseases|joint diseases
215045|NCT02049138|Musculoskeletal Disease|musculoskeletal disease
215046|NCT02049138|Anti-inflammatory Agents|anti-inflammatory agents
215047|NCT02049138|Antirheumatic agents|antirheumatic agents
215048|NCT02049138|Arthritis|arthritis
215049|NCT02049125|NGAL|ngal
215050|NCT02049125|Acute kidney injury|acute kidney injury
215051|NCT02049125|Cirrhosis|cirrhosis
215052|NCT02049125|Hepatorenal syndrome|hepatorenal syndrome
215053|NCT02049112|Cross-over|cross-over
215054|NCT02049112|Salivary equivalent|salivary equivalent
215055|NCT02049112|Dry mouth|dry mouth
215056|NCT02049112|Medical device|medical device
215057|NCT02049086|SBIRT|sbirt
215058|NCT02049086|Screening|screening
215059|NCT02049086|Brief Intervention|brief intervention
215060|NCT02049086|Referral to Treatment|referral to treatment
215061|NCT02049086|Pain-Management|pain-management
215062|NCT02049086|Veterans|veterans
215063|NCT02049073|hearing loss|hearing loss
215064|NCT02049073|noise induced hearing loss|noise induced hearing loss
215065|NCT02049073|zonisamide|zonisamide
215066|NCT02049060|MPM|mpm
215067|NCT02049060|NSCLC|nsclc
215068|NCT02049047|thymoma thymic carcinoma|thymoma thymic carcinoma
215069|NCT02049034|GLP-1 agonist|glp-1 agonist
215070|NCT02049034|Lixisenatide|lixisenatide
215071|NCT02049034|Postprandial glucose metabolism|postprandial glucose metabolism
215072|NCT02049034|Postprandial lipid metabolism|postprandial lipid metabolism
215073|NCT02049034|Gastric emptying|gastric emptying
215074|NCT02049034|Lipoprotein lipase activity|lipoprotein lipase activity
215075|NCT02049021|schizophrenia|schizophrenia
215076|NCT02049021|electroconvulsive therapy|electroconvulsive therapy
215077|NCT02049021|refractory Schizophrenia|refractory schizophrenia
215078|NCT02049021|super refractory schizophrenia|super refractory schizophrenia
215079|NCT02049021|clozapine|clozapine
215080|NCT02048995|Bipolar Disorder|bipolar disorder
215081|NCT02048995|Depression|depression
215082|NCT02048995|Light Therapy|light therapy
215083|NCT02048995|Contrast Sensitivity|contrast sensitivity
215084|NCT02048995|Visual Evoked Potential|visual evoked potential
215085|NCT02048995|Visual or Neural Responses|visual or neural responses
215086|NCT02048995|Biomarker|biomarker
215087|NCT02048982|physician prescribing|physician prescribing
215088|NCT02048982|behavioral economics|behavioral economics
215089|NCT02048982|primary care practice|primary care practice
215090|NCT02048969|hepatic encephalopathy|hepatic encephalopathy
215091|NCT02048969|flumazenil|flumazenil
215092|NCT02048969|liver cirrhosis|liver cirrhosis
215093|NCT02048956|knee osteoarthritis|knee osteoarthritis
215094|NCT02048956|hydrotherapy|hydrotherapy
215095|NCT02048930|GPRD|gprd
215096|NCT02048930|effectiveness|effectiveness
215097|NCT02048930|cost-effectiveness|cost-effectiveness
215098|NCT02048930|Easyhaler|easyhaler
215099|NCT02048930|Primary care|primary care
215100|NCT02048930|DPI|dpi
215101|NCT02048917|Smoking|smoking
215102|NCT02048917|Cessation|cessation
215103|NCT02048917|Bupropion|bupropion
215104|NCT02048917|Varenicline|varenicline
215105|NCT02048917|Nicotine|nicotine
215106|NCT02048917|Counseling|counseling
215107|NCT02048917|Tobacco|tobacco
215108|NCT02048904|microalbuminuria|microalbuminuria
215109|NCT02048904|type 2 diabetes|type 2 diabetes
215110|NCT02048878|Insomnia|insomnia
215111|NCT02048865|VTE Cancer|vte cancer
215112|NCT02048852|menthol|menthol
215113|NCT02048852|nicotine|nicotine
215114|NCT02048826|stroke|stroke
215115|NCT02048800|Treosulfan pharmacokinetics|treosulfan pharmacokinetics
215116|NCT02048800|Children|children
215117|NCT02048800|Any condition that requires an allogeneic HSCT|any condition that requires an allogeneic hsct
215118|NCT02048787|Renal impairment|renal impairment
215119|NCT02048787|Healthy volunteers|healthy volunteers
215120|NCT02048787|Clinical pharmacology study|clinical pharmacology study
215121|NCT02048748|Home Care Services|home care services
215122|NCT02048748|Telemedicine|telemedicine
215123|NCT02048696|Exercise training|exercise training
215124|NCT02048696|High intensity interval training|high intensity interval training
215125|NCT02048696|left ventricular systolic function|left ventricular systolic function
215126|NCT02048696|G-protein related kinase 2|g-protein related kinase 2
215127|NCT02048696|heart failure|heart failure
215128|NCT02048696|myocardial infarction|myocardial infarction
215129|NCT02048696|coronary artery disease|coronary artery disease
215130|NCT02048696|beta adrenergic receptor|beta adrenergic receptor
215131|NCT02048683|Pharmacokinetics|pharmacokinetics
215132|NCT02048683|Sevoflurane|sevoflurane
215133|NCT02048683|Burn|burn
215134|NCT02048683|Sedation|sedation
215135|NCT02048670|Pilot study|pilot study
215136|NCT02048670|Assessment of sway phase|assessment of sway phase
215137|NCT02048670|Therapy trial phase|therapy trial phase
215138|NCT02048657|LMA, Foley Airway Stylet Tool (FAST), introducer-tool (I-Tool)|lma, foley airway stylet tool (fast), introducer-tool (i-tool)
215139|NCT02048644|Platelets adhesion|platelets adhesion
215140|NCT02048631|oral cancer,Quality of life,Sensory|oral cancer,quality of life,sensory
215141|NCT02048618|Active Crohn's Disease|active crohn's disease
215142|NCT02048618|GLPG0634|glpg0634
215143|NCT02048592|cystic fibrosis, immunonutrition, oxidative stress|cystic fibrosis, immunonutrition, oxidative stress
215144|NCT02048566|Echocardiography, Transesophageal|echocardiography, transesophageal
215145|NCT02048566|Monitoring, Physiologic|monitoring, physiologic
215146|NCT02048566|Shock|shock
215147|NCT02048553|ventriculostomy; complications in neurosurgery;catheter accuracy;|ventriculostomy; complications in neurosurgery;catheter accuracy;
215148|NCT02048514|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
215149|NCT02048514|Endovascular Procedures|endovascular procedures
215150|NCT02048501|Weight regain|weight regain
215151|NCT02048501|Sustain weight loss|sustain weight loss
215152|NCT02048501|Weight loss|weight loss
215153|NCT02048501|Gut hormones|gut hormones
215154|NCT02048488|non small cell lung cancer|non small cell lung cancer
215155|NCT02048488|NSCLC|nsclc
215156|NCT02048488|Anaplastic lymphoma kinase|anaplastic lymphoma kinase
215157|NCT02048488|ALK tyrosine kinase receptor|alk tyrosine kinase receptor
215158|NCT02048488|ALK+|alk+
215159|NCT02048488|TRK+|trk+
215160|NCT02048488|ALK inhibitor|alk inhibitor
215161|NCT02048488|TRK inhibitor|trk inhibitor
215162|NCT02048488|tropomyosin receptor kinase|tropomyosin receptor kinase
215163|NCT02048488|TRKA|trka
215164|NCT02048488|TRKB|trkb
215165|NCT02048488|TRKC|trkc
215166|NCT02048488|advanced malignancy|advanced malignancy
215167|NCT02048475|desflurane|desflurane
215168|NCT02048475|electroencephalogram|electroencephalogram
215169|NCT02048449|Reflux finding score, interrater reliability|reflux finding score, interrater reliability
215170|NCT02048436|Respiratory Rate|respiratory rate
215171|NCT02048423|suicidal|suicidal
215172|NCT02048397|Bronchiectasis.|bronchiectasis.
215173|NCT02048384|rapamycin|rapamycin
215174|NCT02048384|metformin|metformin
215175|NCT02048384|pancreatic cancer|pancreatic cancer
215176|NCT02048384|adenocarcinoma|adenocarcinoma
215177|NCT02048384|metastatic|metastatic
215178|NCT02048358|Healthy volunteers|healthy volunteers
215179|NCT02048358|first in human|first in human
215180|NCT02048358|2B3-201|2b3-201
215181|NCT02048358|methylprednisolone|methylprednisolone
215182|NCT02048358|CNS-targeting|cns-targeting
215183|NCT02048358|liposomal|liposomal
215184|NCT02048358|crossover|crossover
215185|NCT02048358|placebo controlled|placebo controlled
215186|NCT02048358|active controlled|active controlled
215187|NCT02048358|multiple sclerosis|multiple sclerosis
215188|NCT02048358|multiple sclerosis relapse|multiple sclerosis relapse
215189|NCT02048345|ten mL suspension of posaconazol (Noxafil) together with 240mL water will be taken by the volunteer in a fasted state|ten ml suspension of posaconazol (noxafil) together with 240ml water will be taken by the volunteer in a fasted state
215190|NCT02048345|ten mL suspension of posaconazol (Noxafil) together with 240mL water will be taken by the volunteer in a fed state|ten ml suspension of posaconazol (noxafil) together with 240ml water will be taken by the volunteer in a fed state
215191|NCT02048345|two point six mL of suspension that is dissolved in 247mL water will be administered to the volunteer by the stomach catheter in a fasted state|two point six ml of suspension that is dissolved in 247ml water will be administered to the volunteer by the stomach catheter in a fasted state
215290|NCT02048059|ANG1005|ang1005
215291|NCT02048059|GRN1005|grn1005
215192|NCT02048345|two point six mL of suspension that is dissolved in 247mL water will be administered to the volunteer by the stomach catheter in a fed state|two point six ml of suspension that is dissolved in 247ml water will be administered to the volunteer by the stomach catheter in a fed state
215193|NCT02048332|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
215194|NCT02048332|Adenovirus (ADV)|adenovirus (adv)
215195|NCT02048332|t-cells|t-cells
215196|NCT02048332|donor|donor
215197|NCT02048332|transplant|transplant
215198|NCT02048332|children|children
215199|NCT02048332|cytomegalovirus (CMV)|cytomegalovirus (cmv)
215200|NCT02048319|Liver cyst|liver cyst
215201|NCT02048319|Hepatic cyst|hepatic cyst
215202|NCT02048319|Symptomatic|symptomatic
215203|NCT02048319|Aspiration sclerotherapy|aspiration sclerotherapy
215204|NCT02048306|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
215205|NCT02048306|Pulmonary rehabilitation|pulmonary rehabilitation
215206|NCT02048306|Family|family
215207|NCT02048306|Integrated care|integrated care
215208|NCT02048306|Mixed methods|mixed methods
215209|NCT02048293|remifentanil|remifentanil
215210|NCT02048293|propofol|propofol
215211|NCT02048293|pharmacodynamic|pharmacodynamic
215212|NCT02048293|total intravenous anesthesia|total intravenous anesthesia
215213|NCT02048293|orotracheal intubation|orotracheal intubation
215214|NCT02048293|heart rate|heart rate
215215|NCT02048293|mean arterial pressure|mean arterial pressure
215216|NCT02048293|Cooper intubation condition score|cooper intubation condition score
215217|NCT02048267|Alcoholic|alcoholic
215218|NCT02048267|Non alcoholic|non alcoholic
215219|NCT02048267|Idiopathic|idiopathic
215220|NCT02048267|Tropical|tropical
215221|NCT02048267|Exocrine dysfunction|exocrine dysfunction
215222|NCT02048267|Endocrine dysfunction|endocrine dysfunction
215223|NCT02048267|Pain control|pain control
215423|NCT02047552|trauma|trauma
215224|NCT02048267|Frey's procedure|frey's procedure
215225|NCT02048267|Duodenum preserving pancreatic head resection|duodenum preserving pancreatic head resection
215226|NCT02048254|inoperable salivary gland cancer|inoperable salivary gland cancer
215227|NCT02048254|brachytherapy|brachytherapy
215228|NCT02048254|intensity-modulated radiation therapy|intensity-modulated radiation therapy
215229|NCT02048241|childhood|childhood
215230|NCT02048241|temper|temper
215231|NCT02048241|explosive|explosive
215232|NCT02048241|aggression|aggression
215233|NCT02048241|tantrums|tantrums
215234|NCT02048241|oppositional|oppositional
215235|NCT02048241|defiant|defiant
215236|NCT02048241|conduct|conduct
215237|NCT02048241|disruptive|disruptive
215238|NCT02048241|emotional dysregulation|emotional dysregulation
215239|NCT02048241|special education|special education
215240|NCT02048228|Clopidogrel,|clopidogrel,
215241|NCT02048228|Pharmacogenetics,|pharmacogenetics,
215242|NCT02048228|Platelet reactivity,|platelet reactivity,
215243|NCT02048228|CYP2C19,|cyp2c19,
215244|NCT02048228|point-of-care|point-of-care
215245|NCT02048215|thermogenesis|thermogenesis
215246|NCT02048215|low-calorie diet|low-calorie diet
215247|NCT02048215|uncoupling-protein 3|uncoupling-protein 3
215248|NCT02048215|beta-3 adrenoceptors|beta-3 adrenoceptors
215249|NCT02048215|thermogenic drugs|thermogenic drugs
215250|NCT02048202|clown|clown
215251|NCT02048202|neonate|neonate
215252|NCT02048202|premature|premature
215253|NCT02048176|Mutism|mutism
215254|NCT02048163|Meropenem|meropenem
215255|NCT02048163|Nausea|nausea
215256|NCT02048163|Pharmacokinetics|pharmacokinetics
215257|NCT02048124|25d ProCor needle|25d procor needle
215258|NCT02048124|22 gauge|22 gauge
215259|NCT02048124|endoscopic ultrasonography|endoscopic ultrasonography
215260|NCT02048124|fine needle biopsies|fine needle biopsies
215261|NCT02048124|Patients|patients
215262|NCT02048124|presenting|presenting
215263|NCT02048111|Hemophilia B|hemophilia b
215264|NCT02048111|Hemophilia A|hemophilia a
215265|NCT02048111|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
215266|NCT02048111|Blood Coagulation Disorders|blood coagulation disorders
215267|NCT02048111|Hematologic Diseases|hematologic diseases
215268|NCT02048111|Coagulation Protein Disorders|coagulation protein disorders
215269|NCT02048111|Hemorrhagic Disorders|hemorrhagic disorders
215270|NCT02048111|Genetic Diseases, Inborn|genetic diseases, inborn
215271|NCT02048111|Genetic Diseases, X-Linked|genetic diseases, x-linked
215272|NCT02048098|misoprostol|misoprostol
215273|NCT02048098|Labor, Induced|labor, induced
215274|NCT02048098|Pregnancy Trimester, Second|pregnancy trimester, second
215275|NCT02048098|Abortion, Induced|abortion, induced
215276|NCT02048085|ACS|acs
215277|NCT02048085|STEMI|stemi
215278|NCT02048085|Fibrinolysis|fibrinolysis
215279|NCT02048085|Pharmacodynamics|pharmacodynamics
215280|NCT02048085|Pharmacokinetics|pharmacokinetics
215281|NCT02048085|Plavix|plavix
215282|NCT02048085|Brilinta|brilinta
215283|NCT02048085|Ticagrelor|ticagrelor
215284|NCT02048085|Clopidogrel|clopidogrel
215285|NCT02048072|relapsing remitting|relapsing remitting
215286|NCT02048072|multiple sclerosis|multiple sclerosis
215287|NCT02048072|fingolimod|fingolimod
215288|NCT02048072|Gilenya|gilenya
215289|NCT02048072|autonomic nervous system|autonomic nervous system
215292|NCT02048059|LRP-1|lrp-1
215293|NCT02048059|Targeted therapy|targeted therapy
215294|NCT02048059|Breast cancer|breast cancer
215295|NCT02048059|Brain metastases|brain metastases
215296|NCT02048059|Brain tumor|brain tumor
215297|NCT02048059|Blood-brain barrier|blood-brain barrier
215298|NCT02048059|Trastuzumab|trastuzumab
215299|NCT02048059|Herceptin|herceptin
215300|NCT02048059|Paclitaxel|paclitaxel
215301|NCT02048059|Taxol|taxol
215302|NCT02048059|Breast cancer with brain metastases|breast cancer with brain metastases
215303|NCT02048059|Triple Negative|triple negative
215304|NCT02048059|TNBC|tnbc
215305|NCT02048059|HER2-positive|her2-positive
215306|NCT02048059|HER2-negative|her2-negative
215307|NCT02048059|Metastatic brain tumors|metastatic brain tumors
215308|NCT02048046|ECMO|ecmo
215309|NCT02048046|Nutrition therapy|nutrition therapy
215310|NCT02048033|Obesity|obesity
215311|NCT02048033|Endogastric suturing|endogastric suturing
215312|NCT02048033|Jujenal anastomosis|jujenal anastomosis
215313|NCT02048033|weight regain|weight regain
215314|NCT02048007|Childhood mortality|childhood mortality
215315|NCT02048007|Azithromycin|azithromycin
215316|NCT02048007|Mass treatment|mass treatment
215317|NCT02048007|Infection|infection
215318|NCT02048007|Bacterial infections|bacterial infections
215319|NCT02048007|Trachoma|trachoma
215320|NCT02048007|Chlamydia infections|chlamydia infections
215321|NCT02048007|Malaria|malaria
215322|NCT02048007|Diarrhea|diarrhea
215323|NCT02048007|Respiratory Infections|respiratory infections
215324|NCT02048007|Antibiotic resistance|antibiotic resistance
215325|NCT02048007|Verbal Autopsy|verbal autopsy
215326|NCT02048007|Microbiome|microbiome
215327|NCT02047994|Gastric cancer|gastric cancer
215328|NCT02047994|Gastric cancer mortality|gastric cancer mortality
215329|NCT02047994|Helicobacter pylori treatment|helicobacter pylori treatment
264166|NCT01825863|Adult|adult
215330|NCT02047994|Pepsinogen testing|pepsinogen testing
215331|NCT02047994|Endoscopy|endoscopy
215332|NCT02047994|Volatile marker|volatile marker
215333|NCT02047981|Childhood mortality|childhood mortality
215334|NCT02047981|Azithromycin|azithromycin
215335|NCT02047981|Mass treatment|mass treatment
215336|NCT02047981|Infection|infection
215337|NCT02047981|Verbal Autopsy|verbal autopsy
215338|NCT02047968|Wake therapy|wake therapy
215339|NCT02047968|Sleep deprivation|sleep deprivation
215340|NCT02047968|Light therapy|light therapy
215341|NCT02047968|Bipolar depression|bipolar depression
215342|NCT02047968|Sleep-wake cycle|sleep-wake cycle
215343|NCT02047968|Major depression|major depression
215344|NCT02047968|Depression|depression
215345|NCT02047968|Depressive Disorder|depressive disorder
215346|NCT02047968|Major Behavioural Symptoms|major behavioural symptoms
215347|NCT02047968|Mood Disorders|mood disorders
215348|NCT02047968|Mental Disorders|mental disorders
215349|NCT02047968|Dyssomnias|dyssomnias
215350|NCT02047968|Sleep Disorders|sleep disorders
215351|NCT02047968|Affective Disorders|affective disorders
215352|NCT02047929|Asthma|asthma
215353|NCT02047929|Shared decision making|shared decision making
215354|NCT02047929|Participatory methods|participatory methods
215355|NCT02047929|Practice facilitator|practice facilitator
215356|NCT02047929|Health coach|health coach
215357|NCT02047916|Neonates|neonates
215358|NCT02047916|Superior Vena Cava Flow|superior vena cava flow
215359|NCT02047916|Pleth variabilty index|pleth variabilty index
215360|NCT02047890|CDK inhibitor|cdk inhibitor
215361|NCT02047890|BAY1000394|bay1000394
215362|NCT02047890|Advanced malignancies|advanced malignancies
215363|NCT02047890|Japanese|japanese
215364|NCT02047877|Respiratory Secretions|respiratory secretions
215365|NCT02047877|Tracheal Secretions|tracheal secretions
215366|NCT02047877|Bronchial Secretions|bronchial secretions
215367|NCT02047877|NonBronchoscopic BAL|nonbronchoscopic bal
215368|NCT02047877|Interleukin 10|interleukin 10
215369|NCT02047877|Interleukin 12p70|interleukin 12p70
215370|NCT02047864|Osteoporosis|osteoporosis
215371|NCT02047864|Sarcopenia|sarcopenia
215372|NCT02047864|Strength|strength
215373|NCT02047864|Bone|bone
215374|NCT02047864|Muscle|muscle
215375|NCT02047864|Creatine|creatine
215376|NCT02047825|Multiple sclerosis|multiple sclerosis
215377|NCT02047825|Dexterity|dexterity
215378|NCT02047825|Upper limbs|upper limbs
215379|NCT02047812|Laparotomy|laparotomy
215380|NCT02047812|General Surgery|general surgery
215381|NCT02047812|Hospitals,General|hospitals,general
215382|NCT02047812|Hospitals,High-Volume|hospitals,high-volume
215383|NCT02047812|Hospitals,Low-Volume|hospitals,low-volume
215384|NCT02047812|Outcome Assessment (Health Care)|outcome assessment (health care)
401995|NCT01233583|Regulatory T-cells, psoriasis, IL-10.|regulatory t-cells, psoriasis, il-10.
215385|NCT02047799|elderly people, blood pressure, hypertension, vitamin D.|elderly people, blood pressure, hypertension, vitamin d.
215386|NCT02047786|Outcome Assessment (Health Care)|outcome assessment (health care)
215387|NCT02047786|Appendectomy|appendectomy
215388|NCT02047786|Child|child
215389|NCT02047786|Hospitals, Pediatric|hospitals, pediatric
215390|NCT02047786|Hospitals, General|hospitals, general
215391|NCT02047773|bronchiectasis|bronchiectasis
215392|NCT02047773|intravenous antibiotics|intravenous antibiotics
215490|NCT02047227|ESPART|espart
215393|NCT02047773|duration of antibiotic course|duration of antibiotic course
215394|NCT02047773|side effects|side effects
215395|NCT02047773|bacterial load|bacterial load
215396|NCT02047747|Brain|brain
215397|NCT02047747|Metastasis|metastasis
215398|NCT02047747|human epidermal receptor (HER)|human epidermal receptor (her)
215399|NCT02047695|migraine with aura|migraine with aura
215400|NCT02047695|migraine|migraine
215401|NCT02047695|case-control study|case-control study
215402|NCT02047695|magnetic resonance imaging|magnetic resonance imaging
215403|NCT02047695|brain diseases|brain diseases
215404|NCT02047656|Healthy volunteers, hypertension|healthy volunteers, hypertension
215405|NCT02047643|Type 1 diabetes|type 1 diabetes
215406|NCT02047643|Hypoglycemia|hypoglycemia
215407|NCT02047643|Accelerometer|accelerometer
215408|NCT02047630|Primary open angle glaucoma|primary open angle glaucoma
215409|NCT02047630|Ocular hypertension|ocular hypertension
215410|NCT02047630|latanoprost|latanoprost
215411|NCT02047630|generic|generic
215412|NCT02047630|intraocular pressure|intraocular pressure
215413|NCT02047617|Muscle Weakness|muscle weakness
215414|NCT02047617|Exercise therapy|exercise therapy
215415|NCT02047617|Physiotherapy|physiotherapy
215416|NCT02047617|Critical illness|critical illness
215417|NCT02047617|Intensive care|intensive care
215418|NCT02047617|Mechanical ventilation|mechanical ventilation
215419|NCT02047617|Rehabilitation|rehabilitation
215420|NCT02047604|Phase 2a multiple ascending dose, Anti-Very Late Antigen-1|phase 2a multiple ascending dose, anti-very late antigen-1
215421|NCT02047578|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
215422|NCT02047565|punch biopsy|punch biopsy
206296|NCT02089022|Ice|ice
215424|NCT02047552|iron|iron
215425|NCT02047552|anemia|anemia
215426|NCT02047552|red blood cell transfusion|red blood cell transfusion
215427|NCT02047526|Heart Failure|heart failure
215428|NCT02047526|Cardiovascular disease|cardiovascular disease
215429|NCT02047526|Congestive Heart Failure|congestive heart failure
215430|NCT02047500|TH-302|th-302
215431|NCT02047500|Nab-paclitaxel|nab-paclitaxel
215432|NCT02047500|Gemcitabine|gemcitabine
215433|NCT02047500|Evofosfamide|evofosfamide
215434|NCT02047461|Molybdenum cofactor deficiency (MoCD)|molybdenum cofactor deficiency (mocd)
215435|NCT02047461|molybdenum cofactor (MoCo) biosynthesis|molybdenum cofactor (moco) biosynthesis
215436|NCT02047461|sulfite oxidase (SO)|sulfite oxidase (so)
215437|NCT02047461|xanthine dehydrogenase|xanthine dehydrogenase
215438|NCT02047461|aldehyde oxidase|aldehyde oxidase
215439|NCT02047461|S sulfocysteine (SSC)|s sulfocysteine (ssc)
215440|NCT02047448|transition of care|transition of care
215441|NCT02047448|care transitions|care transitions
215442|NCT02047448|readmission|readmission
215443|NCT02047448|medication|medication
215444|NCT02047448|adherence|adherence
215445|NCT02047448|medication management|medication management
215446|NCT02047448|medication reconciliation|medication reconciliation
215447|NCT02047448|patient counseling|patient counseling
215448|NCT02047448|pharmacist|pharmacist
215449|NCT02047435|Social participation|social participation
215450|NCT02047435|Loneliness|loneliness
215451|NCT02047435|General practice|general practice
215452|NCT02047435|Cultural institutions|cultural institutions
215453|NCT02047422|Heart failure, diuretics, kidney, glomerular filtration rate|heart failure, diuretics, kidney, glomerular filtration rate
215454|NCT02047383|respiratory infection|respiratory infection
215455|NCT02047383|physical variables|physical variables
215456|NCT02047370|stretching, diaphragm, asthma, manual therapy|stretching, diaphragm, asthma, manual therapy
215457|NCT02047357|Maternal depression|maternal depression
215458|NCT02047357|Mother|mother
215459|NCT02047357|Child|child
215461|NCT02047357|Learning Through Play|learning through play
215462|NCT02047357|Healthy thinking|healthy thinking
215463|NCT02047344|NSCLC|nsclc
215464|NCT02047331|periarticular drug injection|periarticular drug injection
215465|NCT02047331|fascia iliaca block|fascia iliaca block
215466|NCT02047331|knee arthroplasty|knee arthroplasty
215467|NCT02047305|ESCN|escn
215468|NCT02047305|RFA|rfa
215469|NCT02047292|Gait analysis|gait analysis
215470|NCT02047292|3D videofluoroscopy|3d videofluoroscopy
215471|NCT02047292|Femoroacetabular impingement|femoroacetabular impingement
215472|NCT02047292|Neck-cup impingement|neck-cup impingement
215473|NCT02047292|Head-neck ratio|head-neck ratio
215474|NCT02047292|Hip scores|hip scores
215475|NCT02047292|Functional assessment|functional assessment
215476|NCT02047292|Cup size|cup size
215477|NCT02047292|Range of motion|range of motion
215478|NCT02047292|Unilateral Primary|unilateral primary
215479|NCT02047292|Secondary|secondary
215480|NCT02047279|Atrial fibrillation|atrial fibrillation
215481|NCT02047279|Mitral valve|mitral valve
215482|NCT02047266|MICS CABG OPCABG ONCABG CAD|mics cabg opcabg oncabg cad
215483|NCT02047253|carfilzomib|carfilzomib
215484|NCT02047253|prostate cancer|prostate cancer
215485|NCT02047253|PSA (prostate-specific antigen)|psa (prostate-specific antigen)
215486|NCT02047253|CRPC (castration-resistant prostate cancer)|crpc (castration-resistant prostate cancer)
215487|NCT02047240|liver cirrhosis|liver cirrhosis
215488|NCT02047240|glomerular filtration|glomerular filtration
215489|NCT02047240|cystatin C|cystatin c
215491|NCT02047227|Reproductive Techniques, Assisted|reproductive techniques, assisted
215492|NCT02047227|Infertility|infertility
215493|NCT02047227|Pergoveris®|pergoveris®
215494|NCT02047227|GONAL-f®|gonal-f®
215495|NCT02047214|Glioblastoma multiforme|glioblastoma multiforme
215496|NCT02047214|Glioblastoma|glioblastoma
215497|NCT02047214|Radiotherapy|radiotherapy
215498|NCT02047214|Temozolomide|temozolomide
215499|NCT02047214|TPI 287|tpi 287
215500|NCT02047214|Taxoid|taxoid
215501|NCT02047214|Avastin|avastin
215502|NCT02047214|Bevacizumab|bevacizumab
215503|NCT02047201|Head and neck cancer|head and neck cancer
215505|NCT02047201|induction chemotherapy|induction chemotherapy
215506|NCT02047201|IMRT|imrt
215507|NCT02047188|narrow band imaging,microvessels,matrix metalloproteinase-7|narrow band imaging,microvessels,matrix metalloproteinase-7
215508|NCT02047162|diarrhea|diarrhea
215509|NCT02047162|gastroenteritis|gastroenteritis
215510|NCT02047162|antimicrobial drug resistance|antimicrobial drug resistance
215511|NCT02047162|antimicrobial agents|antimicrobial agents
215512|NCT02047162|Pakistan|pakistan
215513|NCT02047162|ambulatory care|ambulatory care
215514|NCT02047162|bismuth|bismuth
215515|NCT02047149|Myelogenous Leukemia|myelogenous leukemia
215516|NCT02047123|commercial flaxseed|commercial flaxseed
215517|NCT02047123|cholesterol|cholesterol
215518|NCT02047123|lipidic profile|lipidic profile
215519|NCT02047123|yoghurt|yoghurt
215520|NCT02047123|consumption|consumption
215521|NCT02047110|ABBV-066|abbv-066
215522|NCT02047110|BI 655066|bi 655066
215523|NCT02047110|risankizumab|risankizumab
215524|NCT02047071|Obstructive sleep apnea|obstructive sleep apnea
215525|NCT02047071|Female gender|female gender
215526|NCT02047071|Continuous Positive Airway Pressure|continuous positive airway pressure
215527|NCT02047058|biomarker|biomarker
215528|NCT02047058|Q cell|q cell
215529|NCT02047058|Overall survival|overall survival
215530|NCT02047058|Progression-free survival|progression-free survival
215531|NCT02047045|severe chronic constipation|severe chronic constipation
215532|NCT02047045|randomized controlled|randomized controlled
215533|NCT02047045|electro-acupuncture|electro-acupuncture
215534|NCT02047045|prucalopride|prucalopride
215535|NCT02047032|electroacupuncture|electroacupuncture
215536|NCT02047032|urinary incontinence|urinary incontinence
215537|NCT02047032|PFMT|pfmt
215538|NCT02047032|Solifenacin|solifenacin
215539|NCT02047019|Drug combination|drug combination
215540|NCT02047019|Nifedipine GITS|nifedipine gits
215541|NCT02047019|Candesartan Cilexetil|candesartan cilexetil
215542|NCT02047019|Hypertension|hypertension
215543|NCT02047019|Combination therapy|combination therapy
215544|NCT02047006|Hemodialysis|hemodialysis
215545|NCT02047006|Rivaroxaban|rivaroxaban
215546|NCT02047006|AUC|auc
215547|NCT02046993|Hypertension|hypertension
215548|NCT02046993|self blood pressure monitoring|self blood pressure monitoring
215549|NCT02046993|smartphone based telemonitoring|smartphone based telemonitoring
215550|NCT02046993|primary care|primary care
215551|NCT02046967|endovenous laser ablation|endovenous laser ablation
215552|NCT02046967|endovenous steam ablation|endovenous steam ablation
215553|NCT02046967|great saphenous veins|great saphenous veins
215554|NCT02046967|quality of life|quality of life
215555|NCT02046954|transesophageal echocardiography|transesophageal echocardiography
215556|NCT02046954|tee|tee
215557|NCT02046954|toe|toe
215558|NCT02046954|cardiac surgery|cardiac surgery
215559|NCT02046941|aphasia|aphasia
215560|NCT02046941|stroke|stroke
215561|NCT02046941|Magnetic Resonance Imaging|magnetic resonance imaging
215562|NCT02046941|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
215563|NCT02046928|Leukemia|leukemia
215564|NCT02046928|Lymphoma|lymphoma
215565|NCT02046902|coronary artery disease|coronary artery disease
215566|NCT02046902|cardiac stent|cardiac stent
215567|NCT02046902|PCI procedure|pci procedure
215568|NCT02046902|Patient preference|patient preference
215569|NCT02046876|neck pain|neck pain
215570|NCT02046876|physiotherapy|physiotherapy
215571|NCT02046876|adapted swimming|adapted swimming
215572|NCT02046876|therapeutic exercises|therapeutic exercises
215573|NCT02046876|health education|health education
215574|NCT02046863|Parkinson's disease|parkinson's disease
215575|NCT02046863|Tremor|tremor
215576|NCT02046863|Bradykinesia|bradykinesia
215577|NCT02046863|Deep brain stimulation|deep brain stimulation
215578|NCT02046863|Kinesia|kinesia
215579|NCT02046850|Phase I, healthy, pharmacokinetics,|phase i, healthy, pharmacokinetics,
215580|NCT02046837|Prostate cancer|prostate cancer
215581|NCT02046837|Exercise|exercise
215582|NCT02046837|Elderly|elderly
215583|NCT02046837|Quality of life|quality of life
215584|NCT02046837|Fatigue|fatigue
215585|NCT02046837|Physical fitness|physical fitness
215586|NCT02046837|Adherence|adherence
215587|NCT02046837|Cost-effectiveness|cost-effectiveness
215588|NCT02046811|Skin neoplasms|skin neoplasms
215589|NCT02046811|Radiation|radiation
215590|NCT02046811|Screening|screening
215591|NCT02046811|Self-examination|self-examination
215592|NCT02046811|Comparative effectiveness research|comparative effectiveness research
215593|NCT02046811|Dermoscopy|dermoscopy
215594|NCT02046798|Pharmacokinetics|pharmacokinetics
215595|NCT02046798|ASP3652|asp3652
215596|NCT02046798|14C radio-labeled|14c radio-labeled
215597|NCT02046798|Phase 1|phase 1
215598|NCT02046785|Fluid administration|fluid administration
215599|NCT02046785|Cardiac output|cardiac output
215600|NCT02046785|Right atrial pressure|right atrial pressure
215601|NCT02046785|Resuscitation|resuscitation
215602|NCT02046772|hemorrhoidectomy|hemorrhoidectomy
215603|NCT02046772|analgesia|analgesia
215604|NCT02046772|anaesthetic|anaesthetic
215605|NCT02046772|bupivacaine|bupivacaine
215606|NCT02046772|morphine chloride|morphine chloride
215608|NCT02046733|CTLA-4|ctla-4
215609|NCT02046694|acute lymphoblastic leukemia|acute lymphoblastic leukemia
215610|NCT02046694|ALL|all
215611|NCT02046694|pediatric|pediatric
215612|NCT02046694|maintenance|maintenance
215613|NCT02046694|allopurinol|allopurinol
215614|NCT02046694|6-MP|6-mp
215615|NCT02046694|6-mercaptopurine|6-mercaptopurine
215616|NCT02046681|Medication Adherence|medication adherence
215617|NCT02046681|Medication Compliance|medication compliance
215618|NCT02046681|Medication Therapy Management|medication therapy management
215619|NCT02046681|Side effects|side effects
215620|NCT02046681|Analgesics|analgesics
215621|NCT02046681|Emergency Medicine|emergency medicine
215622|NCT02046681|Home care|home care
215623|NCT02046681|Aged|aged
215624|NCT02046681|Acetaminophen|acetaminophen
215625|NCT02046681|codeine|codeine
215626|NCT02046681|ibuprofen|ibuprofen
215627|NCT02046681|Oxycodone|oxycodone
215628|NCT02046668|Osteoarthritis of knee|osteoarthritis of knee
215629|NCT02046642|Amniotic fluid index;|amniotic fluid index;
215630|NCT02046642|amniotic fluid volume;|amniotic fluid volume;
215631|NCT02046642|intervention studies;|intervention studies;
215632|NCT02046642|maternal care patterns;|maternal care patterns;
215633|NCT02046642|mother-fetus relationships;|mother-fetus relationships;
215634|NCT02046642|rest;|rest;
215635|NCT02046642|sonography;|sonography;
215636|NCT02046642|transplacental exposure|transplacental exposure
215637|NCT02046590|Propofol|propofol
215638|NCT02046590|remifentanil|remifentanil
215639|NCT02046590|safety|safety
215640|NCT02046590|gastro-intestinal|gastro-intestinal
215641|NCT02046590|ERCP|ercp
215642|NCT02046590|minimally invasive|minimally invasive
215643|NCT02046590|intubation|intubation
215644|NCT02046590|ventilation|ventilation
215645|NCT02046577|Acute respiratory tract infections|acute respiratory tract infections
215646|NCT02046577|vitamin D|vitamin d
215647|NCT02046577|cholecalciferol|cholecalciferol
215648|NCT02046577|children|children
215649|NCT02046577|bronchiolitis|bronchiolitis
215650|NCT02046577|pneumonia|pneumonia
215651|NCT02046577|prevention|prevention
215652|NCT02046551|nicotine|nicotine
215653|NCT02046551|smoking|smoking
215654|NCT02046551|atomoxetine|atomoxetine
215655|NCT02046551|stress|stress
215656|NCT02046525|Fecal microbiota therapy|fecal microbiota therapy
215657|NCT02046512|Probiotics|probiotics
215658|NCT02046499|Prevention, post partum haemorrhage|prevention, post partum haemorrhage
215659|NCT02046486|ticagrelor|ticagrelor
215660|NCT02046486|ST elevation myocardial infarction|st elevation myocardial infarction
215661|NCT02046486|liquid formulation|liquid formulation
215662|NCT02046447|dystonia|dystonia
215663|NCT02046447|cervical dystonia|cervical dystonia
215664|NCT02046447|DYT1|dyt1
215665|NCT02046447|DYT 1|dyt 1
215666|NCT02046447|DYT-1|dyt-1
215667|NCT02046447|Dystonia 1|dystonia 1
215668|NCT02046447|fMRI|fmri
215669|NCT02046447|healthy|healthy
215670|NCT02046447|trihexyphenidyl|trihexyphenidyl
215671|NCT02046447|Artane|artane
215672|NCT02046447|Apo-Trihex|apo-trihex
215673|NCT02046447|Parkin|parkin
215674|NCT02046447|Pacitane|pacitane
215675|NCT02046447|Benzhexol|benzhexol
215676|NCT02046447|Trihex|trihex
215677|NCT02046408|Smoking|smoking
215678|NCT02046408|5A's for smoking cessation|5a's for smoking cessation
215679|NCT02046408|tailored health messages|tailored health messages
215680|NCT02046408|Patient-facing information technology|patient-facing information technology
215681|NCT02046408|Mobile health|mobile health
215682|NCT02046408|behavioral health|behavioral health
215683|NCT02046395|Type 2 Diabetes|type 2 diabetes
215684|NCT02046395|Hypertension|hypertension
215685|NCT02046382|IV Acetaminophen|iv acetaminophen
215686|NCT02046382|Cesarean Section|cesarean section
215687|NCT02046382|Pain, Postoperative|pain, postoperative
215688|NCT02046369|Lurasidone, Latuda, Bipolar Depression|lurasidone, latuda, bipolar depression
215689|NCT02046356|hepatocellular carcinoma|hepatocellular carcinoma
215690|NCT02046356|radiofrequency ablation|radiofrequency ablation
215691|NCT02046356|Milan Criteria|milan criteria
215692|NCT02046356|recurrence|recurrence
215693|NCT02046356|risk factor|risk factor
215694|NCT02046343|physical activity|physical activity
215695|NCT02046343|prevention|prevention
215696|NCT02046343|health disparities|health disparities
215697|NCT02046343|behavior|behavior
215804|NCT02045953|VENTOLIN Mini-Spacer|ventolin mini-spacer
215698|NCT02046343|community based intervention|community based intervention
215699|NCT02046330|Deep Brain Stimulation|deep brain stimulation
215700|NCT02046330|Treatment Resistant Depression|treatment resistant depression
215701|NCT02046330|Major Depressive Disorder|major depressive disorder
215702|NCT02046330|Depression|depression
215703|NCT02046330|ECT|ect
215704|NCT02046330|TNS|tns
215705|NCT02046304|Sarcoma|sarcoma
215706|NCT02046304|Soft Tissue Sarcomas|soft tissue sarcomas
215707|NCT02046304|STS|sts
215708|NCT02046304|Extremity and Trunk|extremity and trunk
215709|NCT02046304|Gemcitabine|gemcitabine
215710|NCT02046304|Gemcitabine Hydrochloride|gemcitabine hydrochloride
215711|NCT02046304|Gemzar|gemzar
215712|NCT02046304|External beam radiation therapy|external beam radiation therapy
215713|NCT02046304|EBRT|ebrt
215714|NCT02046304|Radiotherapy|radiotherapy
215715|NCT02046304|XRT|xrt
215716|NCT02046291|umbilical cord transplant|umbilical cord transplant
215717|NCT02046291|acute leukemia|acute leukemia
215718|NCT02046291|UCBT|ucbt
215719|NCT02046291|Hodgkin's Lymphoma|hodgkin's lymphoma
215720|NCT02046291|Lymphoid Leukemia|lymphoid leukemia
215721|NCT02046291|Multiple Myeloma|multiple myeloma
215722|NCT02046291|Myeloid and Monocytic Leukemia|myeloid and monocytic leukemia
215723|NCT02046291|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
215724|NCT02046291|Hematopoietic malignancies|hematopoietic malignancies
206583|NCT02087553|PRBC|prbc
215725|NCT02046265|Cervical cancer prevention|cervical cancer prevention
215726|NCT02046226|Critical Limb Ischemia|critical limb ischemia
215727|NCT02046226|Non Healing Wounds|non healing wounds
215728|NCT02046226|Diabetic Wounds|diabetic wounds
215729|NCT02046226|Foot Ulcers|foot ulcers
215730|NCT02046213|Metabolism and Excretion|metabolism and excretion
215731|NCT02046200|ivermectin, alcoholism, alcohol use disorder, treatment|ivermectin, alcoholism, alcohol use disorder, treatment
215732|NCT02046187|Ketogenic Diet|ketogenic diet
215733|NCT02046187|Brain tumor|brain tumor
215734|NCT02046187|Glioma|glioma
215735|NCT02046187|Glioblastoma|glioblastoma
215736|NCT02046187|Radiation|radiation
215737|NCT02046187|Chemotherapy|chemotherapy
215738|NCT02046187|temozolomide|temozolomide
215739|NCT02046174|colon|colon
215740|NCT02046174|colorectal|colorectal
215741|NCT02046174|rectal|rectal
215742|NCT02046174|cancer|cancer
215743|NCT02046174|macrobead|macrobead
215744|NCT02046174|stage IV|stage iv
215745|NCT02046174|metastatic|metastatic
215746|NCT02046174|biological|biological
215747|NCT02046174|mouse cells|mouse cells
215748|NCT02046174|new york|new york
215749|NCT02046174|new jersey|new jersey
215750|NCT02046174|clinical research|clinical research
215751|NCT02046161|colon preparation|colon preparation
215752|NCT02046148|Maternal vaccine|maternal vaccine
215753|NCT02046148|IgG|igg
215754|NCT02046148|IgA|iga
215755|NCT02046148|GBS|gbs
215756|NCT02046148|pregnant women|pregnant women
215757|NCT02046135|Pediatric|pediatric
215758|NCT02046135|Sodium bicarbonate|sodium bicarbonate
215759|NCT02046135|Acute kidney injury|acute kidney injury
215760|NCT02046135|Cardiac surgery|cardiac surgery
215761|NCT02046109|Repair|repair
215762|NCT02046109|Replace|replace
215763|NCT02046109|Composite|composite
215764|NCT02046109|restoration|restoration
215765|NCT02046109|failing dental restoration|failing dental restoration
215766|NCT02046109|filling|filling
215767|NCT02046109|dental|dental
215768|NCT02046109|dentistry|dentistry
215769|NCT02046096|Venous thrombosis|venous thrombosis
215770|NCT02046096|pulmonary embolism|pulmonary embolism
215771|NCT02046096|vena cava, inferior|vena cava, inferior
215772|NCT02046096|vena cava filters|vena cava filters
215773|NCT02046096|venous thromboembolism|venous thromboembolism
215774|NCT02046083|Teenager|teenager
215775|NCT02046083|Peanut|peanut
215776|NCT02046083|OIT (Oral Induction Tolerance)|oit (oral induction tolerance)
215777|NCT02046070|MLN9708|mln9708
215778|NCT02046070|Newly diagnosed|newly diagnosed
215779|NCT02046070|NDMM|ndmm
215780|NCT02046070|IXAZOMIB|ixazomib
215781|NCT02046070|RRMM|rrmm
215782|NCT02046057|Sentinel Lymph Node|sentinel lymph node
215783|NCT02046057|Ultrasound Guided Needle Core Biopsy|ultrasound guided needle core biopsy
215784|NCT02046044|Heart failure|heart failure
215785|NCT02046044|Digoxin|digoxin
215786|NCT02046044|Ivabradine|ivabradine
215787|NCT02046031|Ischemic stroke|ischemic stroke
215788|NCT02046031|safety|safety
215789|NCT02046031|Pharmacokinetics|pharmacokinetics
215790|NCT02046031|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
215791|NCT02046018|Maternal and Child Health|maternal and child health
215792|NCT02046018|Rural Uganda|rural uganda
215793|NCT02046005|Family History|family history
215794|NCT02046005|RA|ra
215795|NCT02046005|Rheumatoid Arthritis|rheumatoid arthritis
215796|NCT02046005|Genetics|genetics
215797|NCT02046005|Rheumatoid Factor|rheumatoid factor
215798|NCT02046005|Shared Epitope|shared epitope
215799|NCT02046005|Anti-CCP|anti-ccp
215800|NCT02045953|Healthy Subjects|healthy subjects
215801|NCT02045953|SERETIDE|seretide
215802|NCT02045953|Pharmocokinetics|pharmocokinetics
215803|NCT02045953|FLIXOTIDE|flixotide
215805|NCT02045940|FTIH|ftih
215806|NCT02045940|pharmacokinetics|pharmacokinetics
215807|NCT02045940|SARM|sarm
215808|NCT02045940|safety|safety
215809|NCT02045927|sedation|sedation
215810|NCT02045927|BIS|bis
215811|NCT02045927|monitoring|monitoring
215812|NCT02045914|calcium ionophore|calcium ionophore
215813|NCT02045914|fertilization rate|fertilization rate
215814|NCT02045914|poor ovarian reserve|poor ovarian reserve
215815|NCT02045901|Nausea|nausea
215816|NCT02045901|Vomiting|vomiting
215817|NCT02045901|Pregnancy|pregnancy
215818|NCT02045901|Adolescent|adolescent
215819|NCT02045901|Diclegis|diclegis
215820|NCT02045901|Morning|morning
215821|NCT02045901|Sickness|sickness
215822|NCT02045888|Hamstring|hamstring
215823|NCT02045888|Tear|tear
215824|NCT02045888|Muscle|muscle
215825|NCT02045888|Grade|grade
215826|NCT02045888|adipose|adipose
215827|NCT02045888|cells|cells
215828|NCT02045888|regenerative|regenerative
215829|NCT02045888|Celution|celution
215830|NCT02045888|stem|stem
215831|NCT02045888|cell|cell
215832|NCT02045888|liposuction|liposuction
215833|NCT02045888|fat|fat
215834|NCT02045875|Adherence monitoring|adherence monitoring
215835|NCT02045875|Motivational Interviewing Adherence strategies|motivational interviewing adherence strategies
215836|NCT02045862|Solifenacin Succinate|solifenacin succinate
215837|NCT02045862|Mirabegron|mirabegron
215838|NCT02045862|Urinary Incontinence|urinary incontinence
215839|NCT02045862|Combination Therapy|combination therapy
215840|NCT02045862|Urgency|urgency
215841|NCT02045862|Nocturia|nocturia
215842|NCT02045862|Overactive Bladder|overactive bladder
215843|NCT02045849|pharmacokinetics|pharmacokinetics
215844|NCT02045849|GSK2140944|gsk2140944
215845|NCT02045849|tolerability|tolerability
215846|NCT02045849|drug interaction|drug interaction
215847|NCT02045849|safety|safety
215848|NCT02045849|itraconazole|itraconazole
215849|NCT02045849|elderly healthy subjects|elderly healthy subjects
215850|NCT02045849|food effect|food effect
215851|NCT02045849|relative bioavailability|relative bioavailability
215852|NCT02045836|Pneumovax 23|pneumovax 23
215853|NCT02045836|Co-administration|co-administration
215854|NCT02045836|Herpes zoster|herpes zoster
215855|NCT02045836|Immunogenicity|immunogenicity
215856|NCT02045836|Safety|safety
215857|NCT02045836|Adults|adults
215858|NCT02045810|Measurement|measurement
215859|NCT02045810|nosiseption|nosiseption
215860|NCT02045797|Dose ranging|dose ranging
215861|NCT02045797|Intravenous|intravenous
215862|NCT02045797|Adaptive design|adaptive design
215863|NCT02045797|suspected or confirmed gram-positive acute bacterial skin and skin structure infection|suspected or confirmed gram-positive acute bacterial skin and skin structure infection
215864|NCT02045797|Subjects|subjects
215865|NCT02045797|infection|infection
215866|NCT02045797|Oral|oral
215867|NCT02045797|GSK2140944|gsk2140944
215868|NCT02045771|Depression|depression
215869|NCT02045771|Behavioral Activation|behavioral activation
215870|NCT02045745|Postoperative air leaks in risk patients.|postoperative air leaks in risk patients.
215871|NCT02045732|Multiple Sclerosis|multiple sclerosis
215872|NCT02045732|MRI|mri
215873|NCT02045719|cat´s claw|cat´s claw
215874|NCT02045719|uncaria tomentosa|uncaria tomentosa
215875|NCT02045719|quality of life|quality of life
215876|NCT02045719|no further therapeutic options|no further therapeutic options
215877|NCT02045706|Community Health Workers|community health workers
215878|NCT02045706|Service|service
215879|NCT02045706|Volunteerism|volunteerism
215880|NCT02045706|Health Behaviors|health behaviors
215881|NCT02045680|colorectal cancer|colorectal cancer
215882|NCT02045680|laparoscopy|laparoscopy
215883|NCT02045680|neuromuscular block|neuromuscular block
215884|NCT02045680|oxygen delivery|oxygen delivery
215885|NCT02045667|Becker's myotonia congenita (BMC)|becker's myotonia congenita (bmc)
215886|NCT02045667|Thomson's myotonia congenita (TMC)|thomson's myotonia congenita (tmc)
215887|NCT02045667|Paramyotonia Congenita (PMC)|paramyotonia congenita (pmc)
215888|NCT02045667|Sodium Channel Myotonia (SCM)|sodium channel myotonia (scm)
215889|NCT02045641|cardiac surgery|cardiac surgery
215890|NCT02045641|postoperative treatment|postoperative treatment
215891|NCT02045641|pleural effusion|pleural effusion
215892|NCT02045641|physical performance|physical performance
215893|NCT02045628|Bariatric Surgery|bariatric surgery
215894|NCT02045628|Health Psychology|health psychology
215895|NCT02045602|Cancer|cancer
215896|NCT02045602|Solid Tumors|solid tumors
215897|NCT02045602|Gemcitabine|gemcitabine
215898|NCT02045602|Oncolytic virus|oncolytic virus
215899|NCT02045602|Metastatic|metastatic
215900|NCT02045602|Pancreatic cancer|pancreatic cancer
215901|NCT02045589|Cancer|cancer
215902|NCT02045589|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
215903|NCT02045589|Locally advanced|locally advanced
215904|NCT02045589|Metastatic|metastatic
215905|NCT02045589|Gemcitabine|gemcitabine
215906|NCT02045589|Oncolytic virus|oncolytic virus
215907|NCT02045589|Abraxane®|abraxane®
215908|NCT02045576|Obstructive Sleep Apnea|obstructive sleep apnea
216303|NCT02043691|Fenestrated|fenestrated
215909|NCT02045576|sleep position trainer|sleep position trainer
215910|NCT02045576|oral appliance therapy|oral appliance therapy
215911|NCT02045576|mandibular advancement device or splint|mandibular advancement device or splint
215913|NCT02045498|cpr|cpr
215914|NCT02045498|feedback|feedback
215915|NCT02045498|capnography|capnography
215916|NCT02045498|outcome|outcome
215917|NCT02045498|quality|quality
215918|NCT02045498|resuscitation|resuscitation
215919|NCT02045472|Influenza|influenza
215921|NCT02045459|Microvascular Disease|microvascular disease
215922|NCT02045459|Exercise|exercise
215923|NCT02045459|Angina|angina
215924|NCT02045459|Chest pain|chest pain
215925|NCT02045420|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
215926|NCT02045420|Magnetic Resonance Imaging|magnetic resonance imaging
215927|NCT02045420|MR Venography|mr venography
215928|NCT02045420|Flow Quantification|flow quantification
215929|NCT02045420|Susceptibility Weighted Imaging|susceptibility weighted imaging
215930|NCT02045407|Brain Death|brain death
215931|NCT02045407|Neurological Death|neurological death
215932|NCT02045407|Cerebral circulatory arrest|cerebral circulatory arrest
215933|NCT02045407|Computed Tomography Angiography|computed tomography angiography
215934|NCT02045394|haemoptysis|haemoptysis
215935|NCT02045394|hemoptysis|hemoptysis
215936|NCT02045394|airway bleeding|airway bleeding
215937|NCT02045381|Cancer|cancer
215938|NCT02045381|MRI|mri
215939|NCT02045368|refractory|refractory
215940|NCT02045368|intolerant|intolerant
215941|NCT02045368|solid tumors|solid tumors
215942|NCT02045329|Staphylococcus aureus, mupirocin, decolonization|staphylococcus aureus, mupirocin, decolonization
215943|NCT02045316|Preeclampsia|preeclampsia
215944|NCT02045316|Aquaporins|aquaporins
215945|NCT02045316|Placenta|placenta
215946|NCT02045303|Sub-acute wound|sub-acute wound
215947|NCT02045303|Chronic wound|chronic wound
215948|NCT02045303|wound|wound
215949|NCT02045303|MIST|mist
215950|NCT02045303|Soring|soring
215951|NCT02045303|Contact Ultrasound|contact ultrasound
215952|NCT02045303|Noncontact ultrasound|noncontact ultrasound
215953|NCT02045303|Wound Care|wound care
215954|NCT02045303|VIP Ultrasound Protocol|vip ultrasound protocol
215955|NCT02045303|Ultrasound|ultrasound
215956|NCT02045264|Firazyr|firazyr
215957|NCT02045264|Angioedema|angioedema
215958|NCT02045264|Angioedemas, Hereditary|angioedemas, hereditary
215959|NCT02045264|Vascular Diseases|vascular diseases
215960|NCT02045264|Cardiovascular Diseases|cardiovascular diseases
215961|NCT02045264|Urticaria|urticaria
215962|NCT02045264|Skin Diseases, Vascular|skin diseases, vascular
215963|NCT02045264|Skin Diseases|skin diseases
215964|NCT02045264|Hypersensitivity, Immediate|hypersensitivity, immediate
215965|NCT02045264|Hypersensitivity|hypersensitivity
215966|NCT02045264|Immune System Diseases|immune system diseases
215967|NCT02045264|Genetic Diseases, Inborn|genetic diseases, inborn
215968|NCT02045264|Icatibant|icatibant
215969|NCT02045264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
215970|NCT02045264|Analgesics, Non-Narcotic|analgesics, non-narcotic
215971|NCT02045264|Analgesics|analgesics
215972|NCT02045264|Sensory System Agents|sensory system agents
215973|NCT02045264|Peripheral Nervous System Agents|peripheral nervous system agents
215974|NCT02045264|Physiological Effects of Drugs|physiological effects of drugs
215975|NCT02045264|Pharmacologic Actions|pharmacologic actions
215976|NCT02045264|Anti-Inflammatory Agents|anti-inflammatory agents
215977|NCT02045264|Therapeutic Uses|therapeutic uses
215978|NCT02045264|Antirheumatic Agents|antirheumatic agents
215979|NCT02045264|Adrenergic beta-Antagonists|adrenergic beta-antagonists
215980|NCT02045264|Adrenergic Antagonists|adrenergic antagonists
215981|NCT02045264|Adrenergic Agents|adrenergic agents
215982|NCT02045264|Neurotransmitter Agents|neurotransmitter agents
215983|NCT02045264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
215984|NCT02045264|Central Nervous System Agents|central nervous system agents
215985|NCT02045251|Helicobacter pylori|helicobacter pylori
215986|NCT02045251|H. pylori|h. pylori
215987|NCT02045251|Pylera|pylera
215993|NCT02045212|Traumatic Neuropathy|traumatic neuropathy
215994|NCT02045212|Non Arteritic Ischemic Neuropathy (NAION)|non arteritic ischemic neuropathy (naion)
215995|NCT02045199|Diabetic Neuropathies|diabetic neuropathies
215996|NCT02045199|Diabetes Mellitus|diabetes mellitus
215997|NCT02045199|Diabetic Foot|diabetic foot
215998|NCT02045199|Diabetes Complications|diabetes complications
215999|NCT02045186|Human Papilloma Virus|human papilloma virus
216000|NCT02045186|Oropharynx|oropharynx
216001|NCT02045186|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
216002|NCT02045186|Squamous Cell Carcinoma|squamous cell carcinoma
216003|NCT02045186|Radiation Therapy|radiation therapy
216004|NCT02045186|Chemotherapy|chemotherapy
216005|NCT02045173|Sleep apnea, Arrhythmias, Heart Failure, ICD, CRT-D, Apneascan|sleep apnea, arrhythmias, heart failure, icd, crt-d, apneascan
216006|NCT02045147|Home Bound Care Transitions|home bound care transitions
216007|NCT02045134|Post Operative Atrial Fibrillation after a cardiac surgery|post operative atrial fibrillation after a cardiac surgery
216008|NCT02045082|Flocked swab|flocked swab
216009|NCT02045082|Traditional fiber swab|traditional fiber swab
216010|NCT02045082|Herpes simplex epithelial keratitis|herpes simplex epithelial keratitis
216011|NCT02045082|Quantitative PCR|quantitative pcr
216012|NCT02045056|Alzheimer disease|alzheimer disease
216013|NCT02045056|mild cognitive impairment|mild cognitive impairment
216014|NCT02045056|normal cognition|normal cognition
216015|NCT02045043|Sudden Cardiac Death|sudden cardiac death
216016|NCT02045043|Arrhythmias|arrhythmias
216017|NCT02045043|Congestive Heart Failure|congestive heart failure
216018|NCT02045043|Cardiomyopathy|cardiomyopathy
216019|NCT02045043|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
216020|NCT02045043|Genomics|genomics
216021|NCT02045030|metastatic|metastatic
216022|NCT02045030|colorectal|colorectal
216024|NCT02045030|aflibercept|aflibercept
216025|NCT02045030|FOLFIRI|folfiri
216032|NCT02045004|Anesthesia|anesthesia
216033|NCT02045004|Surgery|surgery
216034|NCT02045004|Geriatrics|geriatrics
216035|NCT02045004|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
216036|NCT02045004|Postoperative delirium|postoperative delirium
216037|NCT02045004|Dementia|dementia
216038|NCT02045004|Postoperative complications|postoperative complications
216039|NCT02045004|Neurological complications|neurological complications
216040|NCT02045004|Psychological complications|psychological complications
216041|NCT02044991|Sciatica|sciatica
216042|NCT02044991|Pelvic girdle pain|pelvic girdle pain
216043|NCT02044965|urinary tract infection|urinary tract infection
216044|NCT02044965|antibiotic prophylaxis|antibiotic prophylaxis
216045|NCT02044965|probiotics|probiotics
216046|NCT02044965|neurogenic bladder|neurogenic bladder
216047|NCT02044965|clean intermittent catheterization|clean intermittent catheterization
216048|NCT02044952|Crohn's Disease|crohn's disease
216049|NCT02044952|mesalazine|mesalazine
216050|NCT02044952|Tripterygium Glycosides|tripterygium glycosides
216051|NCT02044952|induction remission|induction remission
216052|NCT02044939|Sarcoidosis, pulmonary rehabilitation|sarcoidosis, pulmonary rehabilitation
216053|NCT02044900|obstructive sleep apnea|obstructive sleep apnea
216054|NCT02044900|polysomnography|polysomnography
216055|NCT02044900|heart rate variability|heart rate variability
216056|NCT02044900|mathematical biomarker|mathematical biomarker
216057|NCT02044887|Physical activity|physical activity
216058|NCT02044887|dementia|dementia
216059|NCT02044887|relative caregivers|relative caregivers
216060|NCT02044887|podometer|podometer
216061|NCT02044887|cardiovascular risk|cardiovascular risk
216062|NCT02044848|type 1 diabetes mellitus|type 1 diabetes mellitus
216063|NCT02044835|atherosclerotic renal artery stenosis, herbal medicine|atherosclerotic renal artery stenosis, herbal medicine
216064|NCT02044822|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
216066|NCT02044783|Adults|adults
216067|NCT02044783|Elderly|elderly
216068|NCT02044770|laparoscopic|laparoscopic
216069|NCT02044770|colectomy|colectomy
216070|NCT02044770|ENSEAL|enseal
216071|NCT02044757|Caffeine|caffeine
216072|NCT02044757|Addiction|addiction
216073|NCT02044757|Withdrawal symptoms|withdrawal symptoms
216074|NCT02044757|Pediatric|pediatric
216075|NCT02044757|Adolescent|adolescent
216076|NCT02044757|Overweight|overweight
216077|NCT02044744|Obesity|obesity
216078|NCT02044744|Pediatric Obesity|pediatric obesity
216079|NCT02044744|Physical Activity|physical activity
216080|NCT02044744|Physical Fitness|physical fitness
216081|NCT02044744|Primary Health Care|primary health care
216082|NCT02044744|Referral and Consultation|referral and consultation
216083|NCT02044731|Schools|schools
216084|NCT02044731|Pediatrics|pediatrics
216085|NCT02044731|Obesity|obesity
216086|NCT02044731|Overweight|overweight
216087|NCT02044731|Intervention Studies|intervention studies
216088|NCT02044731|African Americans|african americans
216089|NCT02044731|Family|family
216090|NCT02044731|Body mass index|body mass index
216091|NCT02044718|adverse events|adverse events
216092|NCT02044718|unplanned admission intensive care|unplanned admission intensive care
216093|NCT02044718|chart review|chart review
216094|NCT02044705|Primary Health Care|primary health care
216095|NCT02044705|Pediatrics|pediatrics
216096|NCT02044705|Obesity|obesity
216097|NCT02044705|Overweight|overweight
216098|NCT02044705|Clinical trial|clinical trial
216099|NCT02044705|Hispanic Americans|hispanic americans
216100|NCT02044705|Family|family
216101|NCT02044705|Body mass index|body mass index
216102|NCT02044692|Hunter syndrome|hunter syndrome
216107|NCT02044653|Phase 2|phase 2
216108|NCT02044614|Hemodialysis/Peritoneal Dialysis|hemodialysis/peritoneal dialysis
216109|NCT02044614|functionally anuric|functionally anuric
216110|NCT02044614|Icodextrin|icodextrin
216111|NCT02044614|Kidney Disease Quality of Life|kidney disease quality of life
216112|NCT02044601|Lung Cancer|lung cancer
216113|NCT02044601|Non-small cell lung cancer|non-small cell lung cancer
216114|NCT02044601|NSCLC|nsclc
216115|NCT02044601|Squamous cell carcinoma of the lung|squamous cell carcinoma of the lung
216116|NCT02044601|Adenocarcinoma of the lung|adenocarcinoma of the lung
216117|NCT02044601|Radiation therapy|radiation therapy
216118|NCT02044601|Proton therapy|proton therapy
216119|NCT02044601|XRT|xrt
216120|NCT02044601|Carboplatin|carboplatin
216121|NCT02044601|Paraplatin|paraplatin
216122|NCT02044601|Paclitaxel|paclitaxel
216123|NCT02044601|Taxol|taxol
216124|NCT02044601|Onartuzumab|onartuzumab
216125|NCT02044601|Erlotinib|erlotinib
216126|NCT02044601|Erlotinib hydrochloride|erlotinib hydrochloride
216127|NCT02044601|OSI-774|osi-774
216128|NCT02044601|CP358774|cp358774
216129|NCT02044601|Tarceva|tarceva
216134|NCT02044575|Clock genes, circadian regulation|clock genes, circadian regulation
216135|NCT02044562|dietary nitrate|dietary nitrate
216136|NCT02044562|radiotherapy|radiotherapy
216137|NCT02044562|nasopharyngeal carcinoma|nasopharyngeal carcinoma
216138|NCT02044549|Carbetocin|carbetocin
216139|NCT02044549|syntometrine|syntometrine
216140|NCT02044549|postpartum hemorrhage|postpartum hemorrhage
216141|NCT02044549|cesarean section|cesarean section
216142|NCT02044536|biopsy; endoscopy; neoplasms|biopsy; endoscopy; neoplasms
216143|NCT02044523|Chronic liver disease|chronic liver disease
216144|NCT02044523|Fibrosis|fibrosis
216145|NCT02044523|Elastography|elastography
216146|NCT02044523|Ultrasound|ultrasound
216147|NCT02044523|Magnetic resonance elastography|magnetic resonance elastography
216148|NCT02044523|Diagnostic performance|diagnostic performance
216149|NCT02044523|Sensitivity and specificity|sensitivity and specificity
216150|NCT02044510|Multiple Sclerosis|multiple sclerosis
216151|NCT02044510|Spinal Cord Injuries|spinal cord injuries
216152|NCT02044510|mirabegron|mirabegron
216153|NCT02044510|Urodynamics|urodynamics
216154|NCT02044497|pharmacokinetics|pharmacokinetics
216155|NCT02044497|pharmacogenomics|pharmacogenomics
216156|NCT02044497|oral oxycodone|oral oxycodone
216157|NCT02044497|pediatric surgical patients|pediatric surgical patients
216158|NCT02044484|HIV|hiv
216159|NCT02044484|AIDS|aids
216160|NCT02044484|Viral load|viral load
216161|NCT02044484|Primary care|primary care
216162|NCT02044471|left ventricular assist device|left ventricular assist device
216163|NCT02044471|continuous flow|continuous flow
216164|NCT02044471|remote ischemic conditioning|remote ischemic conditioning
216165|NCT02044471|hypertension|hypertension
216166|NCT02044471|sympathetic tone|sympathetic tone
216167|NCT02044471|endothelial dysfunction|endothelial dysfunction
216168|NCT02044458|Foley Catheterization|foley catheterization
216169|NCT02044458|Induction of Labor|induction of labor
216170|NCT02044458|5 French Stylette|5 french stylette
216171|NCT02044445|IVF, hCG, oocyte retrieval, time interval|ivf, hcg, oocyte retrieval, time interval
216172|NCT02044419|Comparative|comparative
216173|NCT02044419|Bioavailability|bioavailability
216174|NCT02044419|lomitapide|lomitapide
216175|NCT02044341|Acute Otitis Media|acute otitis media
216176|NCT02044341|Pain|pain
216177|NCT02044341|Ear Pain|ear pain
216178|NCT02044341|Ear Ache|ear ache
216179|NCT02044341|Ear infection|ear infection
216180|NCT02044341|middle ear infection|middle ear infection
216181|NCT02044302|pain|pain
216182|NCT02044302|breast cancer|breast cancer
216183|NCT02044302|breast implant|breast implant
216184|NCT02044302|breast reconstruction|breast reconstruction
216185|NCT02044289|depression|depression
216186|NCT02044289|electroconvulsive therapy (ECT)|electroconvulsive therapy (ect)
216187|NCT02044289|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
216192|NCT02044263|Cognitive therapy|cognitive therapy
216193|NCT02044263|Behavior therapy|behavior therapy
216194|NCT02044263|Waiting lists|waiting lists
216195|NCT02044263|Therapy, computer-assisted|therapy, computer-assisted
216196|NCT02044263|Internet|internet
216197|NCT02044250|Aspirin|aspirin
216198|NCT02044250|Clopidogrel|clopidogrel
216199|NCT02044250|Antiplatelet monotherapy|antiplatelet monotherapy
216200|NCT02044250|Drug-eluting stent|drug-eluting stent
216201|NCT02044237|trichotillomania|trichotillomania
216202|NCT02044237|online therapy|online therapy
216203|NCT02044211|Heart Failure, Systolic|heart failure, systolic
216204|NCT02044211|Depressive Disorder|depressive disorder
216205|NCT02044211|Depressive Disorder, Major|depressive disorder, major
216206|NCT02044211|Mood Disorder|mood disorder
216207|NCT02044198|Plasmodium Falciparum|plasmodium falciparum
216209|NCT02044198|Vaccine|vaccine
216210|NCT02044198|Plasmodium|plasmodium
216211|NCT02044198|Falciparum|falciparum
216212|NCT02044185|HMGB1 Protein|hmgb1 protein
216213|NCT02044185|Graft versus Host Disease|graft versus host disease
216214|NCT02044185|Immunosuppressive Agents|immunosuppressive agents
216215|NCT02044185|oral mucositis|oral mucositis
216216|NCT02044172|Prostate cancer|prostate cancer
216217|NCT02044172|Treatment|treatment
216218|NCT02044172|Screening|screening
216219|NCT02044172|Surgery|surgery
216220|NCT02044172|Radiotherapy|radiotherapy
216221|NCT02044172|Active monitoring|active monitoring
216222|NCT02044159|Hydrocortisone|hydrocortisone
216223|NCT02044159|Pediatrics|pediatrics
216224|NCT02044159|Adrenal Insufficiency|adrenal insufficiency
216225|NCT02044107|Diarrhea,|diarrhea,
216226|NCT02044107|Pneumonia,|pneumonia,
216227|NCT02044107|Zinc treatment,|zinc treatment,
216228|NCT02044107|Patient Compliance.|patient compliance.
216229|NCT02044094|Opioid dependent|opioid dependent
216230|NCT02044094|Buprenorphine|buprenorphine
216231|NCT02044094|Suboxone Film|suboxone film
216232|NCT02044094|Opioid blockade|opioid blockade
216233|NCT02044094|Hydromorphone challenge|hydromorphone challenge
216234|NCT02044016|Achilles tendon rupture, lengthening, validity, goniometer.|achilles tendon rupture, lengthening, validity, goniometer.
216235|NCT02044003|angioplasty|angioplasty
216236|NCT02044003|dissections|dissections
216237|NCT02043990|NAVA|nava
216238|NCT02043990|noninvasive ventilation|noninvasive ventilation
216239|NCT02043990|infants|infants
216240|NCT02043977|Propofol|propofol
216241|NCT02043977|Insomnia|insomnia
216242|NCT02043977|Sleep disorder|sleep disorder
216243|NCT02043977|Sleep deprivation|sleep deprivation
216244|NCT02043977|Chronic insomnia|chronic insomnia
216245|NCT02043977|Refractory insomnia|refractory insomnia
216246|NCT02043977|Primary insomnia|primary insomnia
216247|NCT02043964|Multiple Sclerosis|multiple sclerosis
216248|NCT02043964|Clinically Isolated Syndrome|clinically isolated syndrome
216249|NCT02043964|Tears|tears
216250|NCT02043964|Isoelectric focusing|isoelectric focusing
207044|NCT02085187|COPD|copd
216251|NCT02043964|Oligoclonal profile|oligoclonal profile
216252|NCT02043925|QT-prolongation|qt-prolongation
216253|NCT02043925|Torsade de Pointes|torsade de pointes
216254|NCT02043925|drug interactions|drug interactions
216255|NCT02043925|psychiatry|psychiatry
216256|NCT02043912|QT-prolongation|qt-prolongation
216257|NCT02043912|Torsade de Pointes|torsade de pointes
216258|NCT02043912|Haloperidol|haloperidol
216259|NCT02043912|Drug interactions|drug interactions
216260|NCT02043899|Neuroblastoma|neuroblastoma
216261|NCT02043899|Positron emission tomography|positron emission tomography
216262|NCT02043899|124-iodine|124-iodine
216263|NCT02043899|Meta-Iodobenzylguanidine|meta-iodobenzylguanidine
216264|NCT02043886|Type 2 Diabetes, Postprandial Hypotension, Acarbose|type 2 diabetes, postprandial hypotension, acarbose
216265|NCT02043873|Clinical Trial|clinical trial
216266|NCT02043873|Composite Restorations|composite restorations
216267|NCT02043873|Restorations Repair|restorations repair
216268|NCT02043873|Replacement Restorations|replacement restorations
216269|NCT02043873|Operative Dentistry.|operative dentistry.
216270|NCT02043860|Multiple Myeloma|multiple myeloma
216271|NCT02043860|High Risk|high risk
216272|NCT02043860|Intermediate Risk|intermediate risk
216273|NCT02043860|Symptomatic|symptomatic
216274|NCT02043847|Multiple Myeloma|multiple myeloma
216275|NCT02043847|Relapsed|relapsed
216276|NCT02043847|Refractory|refractory
216277|NCT02043847|Progressive Disease|progressive disease
216278|NCT02043847|Symptomatic|symptomatic
216279|NCT02043795|Bioresorbable Vascular Scaffold System|bioresorbable vascular scaffold system
216280|NCT02043795|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
216281|NCT02043795|Stent|stent
216282|NCT02043769|South Africa|south africa
216283|NCT02043769|Eastern Cape|eastern cape
216284|NCT02043769|Child ARV|child arv
216285|NCT02043769|CLWHIV|clwhiv
216286|NCT02043756|Mitoxantrone Hydrochloride Liposome Injection|mitoxantrone hydrochloride liposome injection
216287|NCT02043730|pancreatic cancer|pancreatic cancer
216288|NCT02043730|locally advanced|locally advanced
216289|NCT02043730|unresectable cancer|unresectable cancer
216290|NCT02043717|Cystic Fibrosis|cystic fibrosis
216291|NCT02043717|Vitamin D|vitamin d
216292|NCT02043717|Lung function|lung function
216293|NCT02043704|IV Acetaminophen|iv acetaminophen
216294|NCT02043704|Vaginal Reconstruction|vaginal reconstruction
216295|NCT02043704|Pain, Postoperative|pain, postoperative
216296|NCT02043691|Endovascular|endovascular
216297|NCT02043691|Aortic|aortic
216298|NCT02043691|Aneurysm|aneurysm
216299|NCT02043691|Thoracoabdominal|thoracoabdominal
216300|NCT02043691|Juxtarenal|juxtarenal
216301|NCT02043691|Suprarenal|suprarenal
216302|NCT02043691|Endograft|endograft
216304|NCT02043691|Branched|branched
216305|NCT02043691|Complex|complex
216306|NCT02043691|Abdominal|abdominal
216307|NCT02043691|Thoracic|thoracic
216308|NCT02043691|Stent|stent
216309|NCT02043691|Stentgraft|stentgraft
216310|NCT02043678|Phase III|phase iii
216311|NCT02043678|Radium-223 dichloride|radium-223 dichloride
216312|NCT02043678|Abiraterone acetate|abiraterone acetate
216313|NCT02043678|Combination therapy|combination therapy
216314|NCT02043678|Chemotherapy-naive|chemotherapy-naive
216315|NCT02043678|Bone metastasis|bone metastasis
216316|NCT02043678|Castration-resistant prostate cancer (CRPC)|castration-resistant prostate cancer (crpc)
216317|NCT02043665|CAVATAK|cavatak
216318|NCT02043665|KEYNOTE-200|keynote-200
216319|NCT02043665|pembrolizumab|pembrolizumab
216320|NCT02043665|lung cancer|lung cancer
216321|NCT02043665|bladder cancer|bladder cancer
216322|NCT02043639|rotation|rotation
216323|NCT02043639|shoulder|shoulder
216324|NCT02043639|joint|joint
216326|NCT02043639|abduction,|abduction,
216327|NCT02043639|internal rotation,|internal rotation,
216328|NCT02043639|external rotation,|external rotation,
216329|NCT02043639|flexion|flexion
216330|NCT02043639|normal|normal
216331|NCT02043639|joint movement|joint movement
216208|NCT02044198|Malaria|malaria
216332|NCT02043639|physical examination|physical examination
216333|NCT02043626|childhood nutrition|childhood nutrition
216334|NCT02043626|physical activity|physical activity
216335|NCT02043626|school wellness|school wellness
216336|NCT02043626|school health|school health
216337|NCT02043626|nutritional policies|nutritional policies
216338|NCT02043626|childhood obesity|childhood obesity
216339|NCT02043613|Joint pain|joint pain
216340|NCT02043613|Context effects|context effects
216341|NCT02043613|Placebo effect|placebo effect
216342|NCT02043613|Exercise treatment|exercise treatment
216343|NCT02043600|Colitis, ulcerative|colitis, ulcerative
216344|NCT02043600|Yoga|yoga
216345|NCT02043587|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
216346|NCT02043587|Lymphoblastic leukemia|lymphoblastic leukemia
216347|NCT02043587|Lymphoblastic lymphoma|lymphoblastic lymphoma
216348|NCT02043574|Aerobic Exercise|aerobic exercise
216349|NCT02043574|Treadmill Test|treadmill test
216350|NCT02043574|Sedentary Lifestyle|sedentary lifestyle
216351|NCT02043548|dermatomyositis|dermatomyositis
216352|NCT02043548|polymyositis|polymyositis
216353|NCT02043548|tocilizumab|tocilizumab
216354|NCT02043548|Actemra|actemra
216355|NCT02043535|myocardial perfusion imaging|myocardial perfusion imaging
216356|NCT02043535|myocardial blood flow|myocardial blood flow
216357|NCT02043535|pharmacologic stress agents|pharmacologic stress agents
216358|NCT02043535|carbon dioxide|carbon dioxide
216359|NCT02043535|rubidium 82 radioisotope|rubidium 82 radioisotope
216360|NCT02043535|positron emission tomography|positron emission tomography
216361|NCT02043522|123I-mIBG|123i-mibg
216362|NCT02043522|SPECT Imaging|spect imaging
216363|NCT02043522|Phantom imaging|phantom imaging
216364|NCT02043522|Heart failure|heart failure
216365|NCT02043522|Coronary artery disease|coronary artery disease
216762|NCT02042053|imaging|imaging
216366|NCT02043522|Heart to mediastinum ratios|heart to mediastinum ratios
216367|NCT02043522|heart to calibration ratios|heart to calibration ratios
216368|NCT02043522|Myocardial blood flow|myocardial blood flow
216369|NCT02043522|Myocardial blood flow researve|myocardial blood flow researve
216370|NCT02043509|smoking cessation|smoking cessation
216371|NCT02043509|pregnancy|pregnancy
216372|NCT02043509|cessation support|cessation support
216373|NCT02043509|tailored text messages|tailored text messages
216374|NCT02043509|self-help|self-help
216375|NCT02043509|MiQuit|miquit
216376|NCT02043496|Binge Eating Disorder|binge eating disorder
216377|NCT02043496|Binge Eating|binge eating
216378|NCT02043496|Eating Disorders|eating disorders
216379|NCT02043496|Obesity|obesity
216380|NCT02043496|Psychotherapy|psychotherapy
216381|NCT02043496|Cognitive Behavioral Therapy|cognitive behavioral therapy
216382|NCT02043483|CPAP|cpap
216383|NCT02043483|OSAS|osas
216384|NCT02043483|CEDOC (Centro de Estudos de Doenças Crónicas)|cedoc (centro de estudos de doenças crónicas)
216385|NCT02043483|FCM (Faculdade de Ciências Médicas)|fcm (faculdade de ciências médicas)
216386|NCT02043483|UNL (Universidade Nova de Lisboa|unl (universidade nova de lisboa
216387|NCT02043483|NOVA MEDICAL SCHOOL|nova medical school
401996|NCT01233570|Cutaneous Crohns Disease|cutaneous crohns disease
216388|NCT02043483|FCT (Fundação para a Ciência e Tecnologia)|fct (fundação para a ciência e tecnologia)
216389|NCT02043470|Sinus/nasal cancer|sinus/nasal cancer
216390|NCT02043431|Heart failure|heart failure
216391|NCT02043431|Electronic medical records|electronic medical records
216392|NCT02043431|Genomics|genomics
216393|NCT02043431|Biobank|biobank
216395|NCT02043418|ARV|arv
216396|NCT02043418|Pediatric|pediatric
216397|NCT02043418|Cameroon|cameroon
216398|NCT02043392|intestinal anastomosis|intestinal anastomosis
216399|NCT02043392|non-emergent|non-emergent
216400|NCT02043392|intestinal revision|intestinal revision
216401|NCT02043392|magnetic compression|magnetic compression
216402|NCT02043392|anastomotic leak|anastomotic leak
216403|NCT02043379|congenital heart disease|congenital heart disease
216598|NCT02042729|volunteer|volunteer
216404|NCT02043379|Cardiopulmonary Bypass|cardiopulmonary bypass
216405|NCT02043379|Hypogammaglobulinemia|hypogammaglobulinemia
216406|NCT02043366|Remifentanil|remifentanil
216407|NCT02043366|Opioid-induced hyperalgesia|opioid-induced hyperalgesia
216408|NCT02043366|Postoperative pain|postoperative pain
216409|NCT02043366|Pain Intensity|pain intensity
216410|NCT02043340|Periodontitis|periodontitis
216411|NCT02043340|Bacterial viability|bacterial viability
216412|NCT02043340|Lactate dehydrogenase levels|lactate dehydrogenase levels
216413|NCT02043340|Indocyanine green|indocyanine green
216414|NCT02043340|Scaling and root planing|scaling and root planing
216415|NCT02043340|Antimicrobial photodynamic therapy.|antimicrobial photodynamic therapy.
216416|NCT02043327|Colonoscopy|colonoscopy
216417|NCT02043327|assessment|assessment
216418|NCT02043327|certification,|certification,
216419|NCT02043327|simulation,|simulation,
216420|NCT02043327|standard setting|standard setting
216421|NCT02043301|pharmacokinetics|pharmacokinetics
216422|NCT02043301|bioavailability|bioavailability
216423|NCT02043301|PF-04950615|pf-04950615
216424|NCT02043288|Pancreatic cancer|pancreatic cancer
216425|NCT02043288|Platinum|platinum
216426|NCT02043288|Micelle|micelle
216427|NCT02043275|resistance training|resistance training
216428|NCT02043262|Elderly|elderly
216429|NCT02043262|Home-based rehabilitation|home-based rehabilitation
216430|NCT02043262|Activities of daily living|activities of daily living
216431|NCT02043262|Restorative care|restorative care
216432|NCT02043262|Reablement|reablement
216433|NCT02043262|Everyday rehabilitation|everyday rehabilitation
216434|NCT02043249|DELAYED CORD CLAMPING|delayed cord clamping
216435|NCT02043249|MILKING OF CORD|milking of cord
216436|NCT02043249|PREMATURE INFANTS|premature infants
216437|NCT02043249|LEVEL OF IgG IN NEONATES|level of igg in neonates
216438|NCT02043236|Prostate cancer|prostate cancer
216439|NCT02043236|Androgen deprivation therapy|androgen deprivation therapy
216440|NCT02043236|Bone health|bone health
216441|NCT02043236|Bone mineral density|bone mineral density
216442|NCT02043223|Vitamin A|vitamin a
216443|NCT02043223|Breast milk|breast milk
216444|NCT02043223|Postpartum vitamin A supplementation|postpartum vitamin a supplementation
216445|NCT02043223|Infant vaccine response|infant vaccine response
216446|NCT02043210|substance use, Spanish speaking, CBT4CBT|substance use, spanish speaking, cbt4cbt
216447|NCT02043197|Depression,|depression,
216448|NCT02043197|depressive symptoms,|depressive symptoms,
216449|NCT02043197|major depressive disorder,|major depressive disorder,
216450|NCT02043197|Fevarine,|fevarine,
216451|NCT02043197|fluvoxamine,|fluvoxamine,
216452|NCT02043197|cognitive function,|cognitive function,
216453|NCT02043197|neurological disorders,|neurological disorders,
216454|NCT02043197|sleep state|sleep state
216455|NCT02043184|Neoplasms|neoplasms
216456|NCT02043184|Medication Adherence|medication adherence
216457|NCT02043184|Administration, Oral|administration, oral
216458|NCT02043184|Symptom Assessment|symptom assessment
216459|NCT02043184|Neurobehavioral Manifestations|neurobehavioral manifestations
216460|NCT02043184|Depression|depression
216461|NCT02043184|Behavioral Symptoms|behavioral symptoms
216462|NCT02043184|Utilization|utilization
216463|NCT02043158|Ovarian Cancer|ovarian cancer
216464|NCT02043158|Short term survivors|short term survivors
216465|NCT02043158|Long term survivors|long term survivors
216466|NCT02043158|Biobehavioral characteristics|biobehavioral characteristics
216467|NCT02043158|Sociodemographic characteristics|sociodemographic characteristics
216468|NCT02043158|Questionnaire|questionnaire
216469|NCT02043158|Survey|survey
216470|NCT02043158|Interview|interview
216471|NCT02043132|reverse shoulder arthroplasty|reverse shoulder arthroplasty
216472|NCT02043132|Rotator cuff|rotator cuff
216473|NCT02043132|Orthopedic joint surgery|orthopedic joint surgery
216474|NCT02043132|Total shoulder|total shoulder
216475|NCT02043132|Perioperative bleeding|perioperative bleeding
216476|NCT02043132|Tranexamic acid|tranexamic acid
216477|NCT02043132|Orthopedic complications|orthopedic complications
216478|NCT02043132|Hemorrhage|hemorrhage
216479|NCT02043132|Postoperative Hemorrhage|postoperative hemorrhage
216480|NCT02043132|Pathologic Processes|pathologic processes
216481|NCT02043132|Arthritis|arthritis
216482|NCT02043132|Joint Diseases|joint diseases
216483|NCT02043132|Musculoskeletal Diseases|musculoskeletal diseases
216484|NCT02043132|Postoperative Complications|postoperative complications
216485|NCT02043132|Antifibrinolytic Agents|antifibrinolytic agents
216486|NCT02043132|Fibrin Modulating Agents|fibrin modulating agents
216487|NCT02043132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
216488|NCT02043132|Pharmacologic Actions|pharmacologic actions
216489|NCT02043132|Hemostatics|hemostatics
216490|NCT02043132|Coagulants|coagulants
216491|NCT02043132|Hematologic Agents|hematologic agents
216492|NCT02043132|Therapeutic Uses|therapeutic uses
216493|NCT02043093|Adolescent suicide prevention|adolescent suicide prevention
216494|NCT02043093|Peer Leader prevention model|peer leader prevention model
216495|NCT02043093|Universal school-based prevention|universal school-based prevention
216496|NCT02043080|Tuberculosis|tuberculosis
216498|NCT02043080|Xpert MTB/RIF|xpert mtb/rif
218099|NCT02035748|Ocriplasmin|ocriplasmin
216499|NCT02043080|Determine TB-LAM|determine tb-lam
216501|NCT02043080|Zambia|zambia
216502|NCT02043080|Cost Effectiveness Analysis Curve|cost effectiveness analysis curve
216503|NCT02043080|Centre for Infectious Disease Research in Zambia|centre for infectious disease research in zambia
216505|NCT02043067|HIV|hiv
216506|NCT02043067|Extensively resistant TB|extensively resistant tb
216507|NCT02043067|Extra pulmonary TB|extra pulmonary tb
216508|NCT02043054|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
216509|NCT02043054|Young Adults|young adults
216510|NCT02043054|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
216511|NCT02043054|GLP1 Analogue|glp1 analogue
216512|NCT02043054|DPP IV Inhibitor|dpp iv inhibitor
216513|NCT02043054|Obesity|obesity
216514|NCT02043054|Cardiometabolic Effects|cardiometabolic effects
216515|NCT02043054|Cardiac MRI|cardiac mri
216516|NCT02043028|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
216517|NCT02043028|Chest compression|chest compression
216518|NCT02043028|Advanced cardiac life support|advanced cardiac life support
216519|NCT02043028|Posture|posture
216520|NCT02043015|voluntary counseling and testing (VCT)|voluntary counseling and testing (vct)
216521|NCT02043015|couples voluntary counseling and testing (CVCT)|couples voluntary counseling and testing (cvct)
216522|NCT02043015|pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
216523|NCT02043015|homosexuality|homosexuality
216525|NCT02043015|South Africa|south africa
216526|NCT02042989|Advanced Cancers|advanced cancers
216527|NCT02042989|Advanced solid tumor|advanced solid tumor
216528|NCT02042989|Advanced p53 Mutant Malignancies|advanced p53 mutant malignancies
216529|NCT02042989|MLN9708|mln9708
216530|NCT02042989|Vorinostat|vorinostat
216531|NCT02042989|SAHA|saha
216532|NCT02042989|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
216533|NCT02042989|MSK-390|msk-390
216534|NCT02042989|Zolinza|zolinza
216535|NCT02042976|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
216536|NCT02042976|Mindfulness-based cognitive therapy (MBCT)|mindfulness-based cognitive therapy (mbct)
216537|NCT02042976|Behavioural intervention|behavioural intervention
216538|NCT02042976|Quality-of-life|quality-of-life
216539|NCT02042976|Anxiety|anxiety
216540|NCT02042976|Depression|depression
216541|NCT02042976|Physical health status|physical health status
216542|NCT02042963|The cohort of Asian kidney transplant recipients|the cohort of asian kidney transplant recipients
216543|NCT02042963|The cohort of metabolic complication after kidney transplant|the cohort of metabolic complication after kidney transplant
216544|NCT02042963|The biorepository of Asian kidney transplant recipients|the biorepository of asian kidney transplant recipients
216545|NCT02042950|Lymphoma|lymphoma
216546|NCT02042950|Mantle Cell Lymphoma|mantle cell lymphoma
216547|NCT02042950|MCL|mcl
216548|NCT02042950|Relapsed|relapsed
216549|NCT02042950|Refractory|refractory
216550|NCT02042950|Carfilzomib|carfilzomib
216551|NCT02042937|Knee|knee
216552|NCT02042937|Hip|hip
216553|NCT02042937|Muscle Strength|muscle strength
216554|NCT02042937|Electromyography|electromyography
216763|NCT02042053|diagnostic|diagnostic
216555|NCT02042937|Biomechanical Phenomena|biomechanical phenomena
216556|NCT02042924|Leukemia|leukemia
216557|NCT02042924|Lymphoma|lymphoma
216558|NCT02042924|Myeloma|myeloma
216559|NCT02042924|Myelodysplastic Syndrome|myelodysplastic syndrome
216560|NCT02042898|Cardiac Surgery|cardiac surgery
216561|NCT02042898|Transfusion|transfusion
216562|NCT02042885|Prostate cancer|prostate cancer
216563|NCT02042872|Spinal Cord Injury|spinal cord injury
216564|NCT02042872|Disuse Osteoporosis|disuse osteoporosis
216565|NCT02042872|Zoledronic acid|zoledronic acid
216566|NCT02042872|Bisphosphonates|bisphosphonates
216567|NCT02042872|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
216568|NCT02042859|EndoHPB|endohpb
216569|NCT02042820|Dry Eye|dry eye
216570|NCT02042781|PG545|pg545
216571|NCT02042781|Phase I|phase i
216572|NCT02042781|Progen|progen
216573|NCT02042781|antimetastatic|antimetastatic
216574|NCT02042781|antiangiogenic|antiangiogenic
216575|NCT02042781|advanced cancer patients|advanced cancer patients
216576|NCT02042781|solid tumors|solid tumors
216577|NCT02042781|solid tumours|solid tumours
216578|NCT02042781|tumor microenvironment|tumor microenvironment
216579|NCT02042768|Glucose|glucose
216580|NCT02042768|Dialysate|dialysate
216581|NCT02042768|Peritoneal Dialysis|peritoneal dialysis
216582|NCT02042768|patients|patients
216583|NCT02042768|non-diabetic|non-diabetic
216584|NCT02042755|cataract|cataract
216585|NCT02042755|IOL|iol
216586|NCT02042755|trifocal|trifocal
216587|NCT02042755|FineVision|finevision
216588|NCT02042742|Cross-over studies|cross-over studies
216589|NCT02042742|Antioxidants|antioxidants
216590|NCT02042742|Hydroxytyrosol|hydroxytyrosol
216591|NCT02042742|Punicalagin|punicalagin
216592|NCT02042742|Treatment outcome|treatment outcome
216593|NCT02042742|Inflammatory markers|inflammatory markers
216594|NCT02042742|Endothelial function|endothelial function
216595|NCT02042742|Humans|humans
216596|NCT02042742|Adults|adults
216597|NCT02042742|volunteers|volunteers
216599|NCT02042716|preterm and term newborns|preterm and term newborns
216600|NCT02042716|diagnosis of cerebral white matter damage|diagnosis of cerebral white matter damage
216601|NCT02042716|quantitative brain elasticity|quantitative brain elasticity
216602|NCT02042716|Transfontanel ultrafast doppler|transfontanel ultrafast doppler
216603|NCT02042690|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
216604|NCT02042690|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
216605|NCT02042690|chemotherapy|chemotherapy
216606|NCT02042677|ileostomy|ileostomy
216607|NCT02042677|1-piece|1-piece
216608|NCT02042677|assessment|assessment
216609|NCT02042677|Nova|nova
216610|NCT02042677|NovaLife|novalife
216611|NCT02042677|Dansac|dansac
216612|NCT02042651|ESWT|eswt
216613|NCT02042651|Chronic pelvic pain|chronic pelvic pain
216614|NCT02042651|randomized|randomized
216615|NCT02042651|sham controlled|sham controlled
216616|NCT02042612|Pharmacokinetics|pharmacokinetics
216617|NCT02042612|Sevoflurane|sevoflurane
216618|NCT02042612|Obesity|obesity
216619|NCT02042612|Sedation|sedation
216620|NCT02042612|ICU patients|icu patients
216621|NCT02042599|Pharmacokinetics|pharmacokinetics
216622|NCT02042599|Sevoflurane|sevoflurane
216623|NCT02042599|Acute kidney injury|acute kidney injury
216624|NCT02042599|Sedation|sedation
216625|NCT02042599|ICU patients|icu patients
216626|NCT02042534|stroke|stroke
216627|NCT02042534|TIA|tia
216628|NCT02042521|Cigarette|cigarette
216629|NCT02042521|Withdrawal|withdrawal
216630|NCT02042521|Nicotine|nicotine
216631|NCT02042482|Ultra coenzyme Q10|ultra coenzyme q10
216632|NCT02042482|L-carnitine|l-carnitine
216633|NCT02042469|awareness, clinical research, Saudi arabia|awareness, clinical research, saudi arabia
216634|NCT02042456|breast cancer|breast cancer
216635|NCT02042456|dense breasts|dense breasts
216636|NCT02042456|mammography screening|mammography screening
216637|NCT02042456|Screening techniques|screening techniques
216638|NCT02042456|women|women
216639|NCT02042404|Hearing impairment|hearing impairment
216640|NCT02042404|Hearing loss|hearing loss
216641|NCT02042391|PTLD|ptld
216642|NCT02042391|CD20-positive|cd20-positive
216643|NCT02042391|solid organ transplantation|solid organ transplantation
216644|NCT02042378|BRCA|brca
216645|NCT02042378|BRCA mutation|brca mutation
216646|NCT02042378|germline BRCA|germline brca
216647|NCT02042378|somatic BRCA|somatic brca
216648|NCT02042378|PARP inhibitor|parp inhibitor
216649|NCT02042378|rucaparib|rucaparib
216650|NCT02042378|CO-338|co-338
216651|NCT02042378|PF 01367338|pf 01367338
216652|NCT02042378|AG 14699|ag 14699
216653|NCT02042378|Clovis|clovis
216654|NCT02042378|Clovis Oncology|clovis oncology
216655|NCT02042378|RucaPanc|rucapanc
216656|NCT02042365|Enhanced recovery,|enhanced recovery,
216657|NCT02042365|sleeve gastrectomy,|sleeve gastrectomy,
216658|NCT02042339|Hyperbaric Oxygen|hyperbaric oxygen
216659|NCT02042339|Diabetic ulcer|diabetic ulcer
216660|NCT02042339|Wound healing|wound healing
216661|NCT02042339|3-D life-viz- system|3-d life-viz- system
217163|NCT02039999|TRPA1|trpa1
216662|NCT02042339|Indocyanine green video angiography|indocyanine green video angiography
216663|NCT02042339|Transcutaneous oxygen pressure|transcutaneous oxygen pressure
216664|NCT02042339|Endothelial progenitor cells|endothelial progenitor cells
216665|NCT02042326|Arteriovenous Malformations|arteriovenous malformations
216666|NCT02042326|Sirolimus|sirolimus
216667|NCT02042326|Maxillofacial Surgery|maxillofacial surgery
216668|NCT02042300|XIENCE Xpedition|xience xpedition
216669|NCT02042300|Routine Clinical Practice|routine clinical practice
216670|NCT02042300|Alpine|alpine
216671|NCT02042287|Bacterial Infections and Mycoses|bacterial infections and mycoses
216672|NCT02042287|Pharmaceutical Preparations|pharmaceutical preparations
216673|NCT02042287|Health Occupations|health occupations
216674|NCT02042274|Fish oil|fish oil
216675|NCT02042274|EPA|epa
216676|NCT02042274|DHA|dha
216677|NCT02042274|fatty acids|fatty acids
216678|NCT02042274|genetic variation|genetic variation
216679|NCT02042274|gene expression|gene expression
216680|NCT02042248|HIV|hiv
216681|NCT02042248|Acute HIV Infection|acute hiv infection
216682|NCT02042248|Chronic HIV Infection|chronic hiv infection
216683|NCT02042248|AGS-004|ags-004
216684|NCT02042248|Phase 1|phase 1
216685|NCT02042248|Antiretroviral Therapy|antiretroviral therapy
216686|NCT02042248|ART|art
216687|NCT02042248|UNC|unc
216688|NCT02042248|Argos Therapeutics|argos therapeutics
216689|NCT02042248|The CARE Collaboratory of AIDS|the care collaboratory of aids
216690|NCT02042248|Immunization|immunization
216691|NCT02042248|vaccination|vaccination
216692|NCT02042235|prematurity|prematurity
216693|NCT02042235|language|language
216694|NCT02042235|parent-implemented intervention|parent-implemented intervention
216695|NCT02042235|speech therapy|speech therapy
216696|NCT02042235|neurodevelopment|neurodevelopment
216697|NCT02042222|Sickle cell|sickle cell
216698|NCT02042222|Hydroxyurea|hydroxyurea
216699|NCT02042222|Dose prediction|dose prediction
216700|NCT02042222|Maximum tolerated dose|maximum tolerated dose
216701|NCT02042209|acute coronary syndrome|acute coronary syndrome
218100|NCT02035748|JETREA|jetrea
216702|NCT02042209|thoracic pain|thoracic pain
216703|NCT02042209|prehospital|prehospital
216704|NCT02042209|diagnostic score|diagnostic score
216705|NCT02042196|endothelial function|endothelial function
216706|NCT02042196|women|women
216707|NCT02042196|estrogen deficiency|estrogen deficiency
216708|NCT02042196|sex hormones|sex hormones
216709|NCT02042196|adiposity|adiposity
216710|NCT02042196|oxidative stress|oxidative stress
216711|NCT02042196|antioxidants|antioxidants
216712|NCT02042157|Quality of Life|quality of life
216713|NCT02042157|Caregivers|caregivers
216714|NCT02042157|Caregiver burden|caregiver burden
216715|NCT02042157|Urinary Tract Infections|urinary tract infections
216716|NCT02042157|Bidet|bidet
216717|NCT02042157|Women's health|women's health
216718|NCT02042157|Toileting|toileting
216719|NCT02042157|Hygiene|hygiene
216720|NCT02042157|Activities of Daily Living|activities of daily living
216721|NCT02042157|Functional impairment|functional impairment
216722|NCT02042157|Geriatrics|geriatrics
216723|NCT02042144|Neoplasms, Colorectal|neoplasms, colorectal
216724|NCT02042131|suicide|suicide
216725|NCT02042131|suicidal ideation|suicidal ideation
216726|NCT02042131|ambivalence|ambivalence
216727|NCT02042131|suicide ambivalence|suicide ambivalence
216728|NCT02042131|reasons for living|reasons for living
216729|NCT02042131|reasons for dying|reasons for dying
216730|NCT02042131|military|military
216731|NCT02042131|veteran|veteran
216732|NCT02042131|clinical trial|clinical trial
216733|NCT02042131|cognitive behavioral therapy|cognitive behavioral therapy
216734|NCT02042131|psychotherapy|psychotherapy
216735|NCT02042131|crisis|crisis
216736|NCT02042131|Treatment As Usual (TAU)|treatment as usual (tau)
216737|NCT02042131|Crisis Response Plan (CRP)|crisis response plan (crp)
216738|NCT02042131|Enhanced Crisis Response Plan (E-CRP)|enhanced crisis response plan (e-crp)
216739|NCT02042118|Neonatal resuscitation|neonatal resuscitation
216740|NCT02042118|Laryngeal Mask Airway (LMA)|laryngeal mask airway (lma)
216741|NCT02042118|Face mask ventilation (FMV)|face mask ventilation (fmv)
216742|NCT02042118|Uganda|uganda
207521|NCT02083029|Syncope|syncope
216743|NCT02042118|Africa|africa
216744|NCT02042105|non-small-cell lung cancer|non-small-cell lung cancer
216745|NCT02042105|anaplastic lymphoma kinase|anaplastic lymphoma kinase
216746|NCT02042105|immunohistochemistry|immunohistochemistry
216747|NCT02042092|Ultrasound|ultrasound
216748|NCT02042092|MRA|mra
216749|NCT02042092|Large Vessel Vasculitis|large vessel vasculitis
216750|NCT02042092|Giant Cell Arteritis|giant cell arteritis
216751|NCT02042092|Takayasu Arteritis|takayasu arteritis
216752|NCT02042092|Immunological abnormalities|immunological abnormalities
216753|NCT02042079|Endoscopic full-thickness resection|endoscopic full-thickness resection
216754|NCT02042079|gastric subepithelial tumor|gastric subepithelial tumor
216755|NCT02042079|hybrid-NOTES|hybrid-notes
216756|NCT02042066|Resistant Hypertension|resistant hypertension
216757|NCT02042066|RH|rh
216758|NCT02042066|RHT|rht
216759|NCT02042066|Blood Pressure|blood pressure
216760|NCT02042066|Kidney|kidney
216761|NCT02042066|Shockwave|shockwave
216764|NCT02042053|castration resistant|castration resistant
216765|NCT02042053|metastatic prostate cancer|metastatic prostate cancer
216766|NCT02042053|immunotherapy|immunotherapy
216767|NCT02042027|corneal neovascularization|corneal neovascularization
216768|NCT02042027|Gamunex-C|gamunex-c
216769|NCT02042027|IVI-g|ivi-g
216770|NCT02042027|anterior segment inflammation|anterior segment inflammation
216771|NCT02042014|Pulmonary arterial hypertension, QTI571, open label study|pulmonary arterial hypertension, qti571, open label study
216772|NCT02041988|premedication|premedication
216773|NCT02041988|oral morphine|oral morphine
216774|NCT02041988|preemptive analgesia|preemptive analgesia
216775|NCT02041975|Prebiotics|prebiotics
216776|NCT02041975|Gut health|gut health
216777|NCT02041975|Satisfaction|satisfaction
216778|NCT02041962|Care Management|care management
216779|NCT02041962|Chronic Care Model|chronic care model
216780|NCT02041962|Mood Disorders|mood disorders
216781|NCT02041936|irreversible electroporation|irreversible electroporation
216782|NCT02041936|Nanoknife|nanoknife
216783|NCT02041936|pancreatic cancer|pancreatic cancer
216784|NCT02041923|preterm infant|preterm infant
216785|NCT02041923|stable infant|stable infant
216786|NCT02041923|mother-infant interaction|mother-infant interaction
216787|NCT02041923|health care cost|health care cost
216788|NCT02041923|H-HOPE intervention|h-hope intervention
216789|NCT02041923|mother outcomes|mother outcomes
216790|NCT02041923|infant behavioral organization|infant behavioral organization
216791|NCT02041923|infant growth|infant growth
216792|NCT02041897|EUS-FNA|eus-fna
216793|NCT02041897|Pancreatic cystic lesion|pancreatic cystic lesion
216794|NCT02041897|Diagnosis|diagnosis
216795|NCT02041884|Cognitive Behavioral Therapy|cognitive behavioral therapy
216796|NCT02041884|Dialectical Behavioral Therapy|dialectical behavioral therapy
216797|NCT02041884|Applied Relaxation|applied relaxation
216798|NCT02041884|Stress-reduction|stress-reduction
216799|NCT02041884|Smartphone application|smartphone application
216800|NCT02041884|ADHD|adhd
216801|NCT02041884|Randomized controlled trial|randomized controlled trial
216802|NCT02041884|Psychological treatment|psychological treatment
216803|NCT02041884|Efficacy|efficacy
216804|NCT02041871|Liver Surgery|liver surgery
216805|NCT02041871|Hepatectomy|hepatectomy
216806|NCT02041871|Immunonutrition|immunonutrition
216807|NCT02041871|Cancer|cancer
216808|NCT02041871|Morbidity|morbidity
216809|NCT02041871|Postoperative complication|postoperative complication
216810|NCT02041858|Alarms|alarms
216811|NCT02041858|Physiologic Monitoring|physiologic monitoring
216812|NCT02041858|Critical Care|critical care
216813|NCT02041858|Alarm fatigue|alarm fatigue
216814|NCT02041858|Adverse Events|adverse events
216815|NCT02041845|Radiotherapy|radiotherapy
216816|NCT02041845|Radiotherapy dosage|radiotherapy dosage
216817|NCT02041845|Dose fractionation|dose fractionation
216818|NCT02041845|Radiotherapy, image-guided|radiotherapy, image-guided
216819|NCT02041845|Thorax|thorax
216820|NCT02041819|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
216821|NCT02041819|Nimotuzumab|nimotuzumab
216822|NCT02041819|Nab-Paclitaxel|nab-paclitaxel
216823|NCT02041819|Carcinoma of Esophagus|carcinoma of esophagus
216824|NCT02041793|Acute pancreatitis|acute pancreatitis
216825|NCT02041793|Pseudocyst|pseudocyst
216826|NCT02041780|Diagnostic|diagnostic
216827|NCT02041780|Liver fibrosis|liver fibrosis
216828|NCT02041780|Ishak score|ishak score
216829|NCT02041780|Fibrotest|fibrotest
216830|NCT02041780|ShearWave elastography|shearwave elastography
216831|NCT02041780|Liver biopsies|liver biopsies
216832|NCT02041767|Ertapenem; prostatic diffusion; antibioprophylaxy; pharmacokinetics; benign prostatic hyperplasia|ertapenem; prostatic diffusion; antibioprophylaxy; pharmacokinetics; benign prostatic hyperplasia
216833|NCT02041741|happiness|happiness
216834|NCT02041741|well-being|well-being
216835|NCT02041741|distress|distress
216836|NCT02041741|positive psychology|positive psychology
216837|NCT02041715|Virus Diseases|virus diseases
216838|NCT02041715|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
216839|NCT02041715|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
216840|NCT02041715|RNA Virus Infections|rna virus infections
216841|NCT02041715|Filoviridae Infections|filoviridae infections
216842|NCT02041715|Mononegavirales Infections|mononegavirales infections
216843|NCT02041702|Bradycardia|bradycardia
216844|NCT02041702|Pacemaker|pacemaker
216845|NCT02041702|Magnetic|magnetic
216846|NCT02041702|Conditional|conditional
216847|NCT02041702|St Jude|st jude
216848|NCT02041702|Accent|accent
216849|NCT02041702|Tendril|tendril
216850|NCT02041689|Children|children
216851|NCT02041689|Cancer|cancer
216852|NCT02041689|Learning|learning
216853|NCT02041689|Education|education
216854|NCT02041689|Qualitative|qualitative
216855|NCT02041676|Chest|chest
216856|NCT02041676|Physiotherapy|physiotherapy
216857|NCT02041676|Increased Inspiratory Flow Technique|increased inspiratory flow technique
216858|NCT02041676|Prematurity|prematurity
216859|NCT02041676|Non Invasive Ventilation|non invasive ventilation
216860|NCT02041663|brain natriuretic peptide|brain natriuretic peptide
216861|NCT02041663|cardiac function|cardiac function
217486|NCT02038608|non motor|non motor
216862|NCT02041663|meningococcal infections|meningococcal infections
216863|NCT02041663|septic shock|septic shock
216864|NCT02041663|severe sepsis|severe sepsis
216865|NCT02041637|liver failure|liver failure
216866|NCT02041637|etiology|etiology
216867|NCT02041637|liver transplantation|liver transplantation
216868|NCT02041624|allergic|allergic
216869|NCT02041624|rhinitis|rhinitis
216870|NCT02041624|conjunctivitis|conjunctivitis
216871|NCT02041624|grass pollen|grass pollen
216872|NCT02041624|Allergen ImmunoTherapy (AIT)|allergen immunotherapy (ait)
216873|NCT02041624|grass mix|grass mix
216874|NCT02041611|WHO grade III and IV|who grade iii and iv
216875|NCT02041585|Hospital Readmission|hospital readmission
216876|NCT02041585|Social Isolation and Hospital Readmission|social isolation and hospital readmission
216877|NCT02041585|Age and Hospital Readmission|age and hospital readmission
216878|NCT02041585|Functional Status and Hospital Readmission|functional status and hospital readmission
216879|NCT02041585|Charlson Score and Hospital Readmission|charlson score and hospital readmission
216880|NCT02041585|Length of Stay and Hospital Readmission|length of stay and hospital readmission
216881|NCT02041546|Lung lavage,|lung lavage,
216882|NCT02041546|Surfactant,|surfactant,
216883|NCT02041546|Duration of mechanical|duration of mechanical
216884|NCT02041546|ventilation|ventilation
216885|NCT02041520|Seropositive HIV|seropositive hiv
216886|NCT02041520|Omega 3 fatty acids|omega 3 fatty acids
216887|NCT02041520|Oxidative stress|oxidative stress
216888|NCT02041507|Water-aided colonoscopy|water-aided colonoscopy
216889|NCT02041507|Water Immersion|water immersion
216890|NCT02041507|Water Exchange|water exchange
216891|NCT02041507|On-demand sedation|on-demand sedation
216892|NCT02041507|Unsedated colonoscopy|unsedated colonoscopy
216893|NCT02041507|Adenoma detection rate|adenoma detection rate
216894|NCT02041507|Mean adenomas per procedure|mean adenomas per procedure
216895|NCT02041494|Hernia|hernia
216896|NCT02041494|Ventral|ventral
216897|NCT02041494|Incisional|incisional
216898|NCT02041494|Abdominal|abdominal
218101|NCT02035735|NBI,|nbi,
216900|NCT02041494|Recurrence|recurrence
216901|NCT02041494|Infection|infection
216902|NCT02041494|Mesh|mesh
216903|NCT02041494|Biologic|biologic
216904|NCT02041494|Synthetic|synthetic
216906|NCT02041455|Fibromyalgia|fibromyalgia
216907|NCT02041455|Melatonin|melatonin
216908|NCT02041455|Amitriptylin|amitriptylin
216909|NCT02041455|Imune-pineal axis|imune-pineal axis
216910|NCT02041442|overactive bladder|overactive bladder
216911|NCT02041442|cystoscopy|cystoscopy
216912|NCT02041429|Recurrent Breast Cancer|recurrent breast cancer
216913|NCT02041429|Advanced Breast Cancer|advanced breast cancer
216914|NCT02041429|Metastatic Breast Cancer|metastatic breast cancer
216915|NCT02041416|Geriatric assessment|geriatric assessment
216916|NCT02041416|REDCap|redcap
216917|NCT02041416|touchscreen|touchscreen
216918|NCT02041416|age 65|age 65
216919|NCT02041364|Fatigue|fatigue
216920|NCT02041364|Biomarkers|biomarkers
216921|NCT02041364|Breast Cancer|breast cancer
216922|NCT02041351|metastatic breast cancer|metastatic breast cancer
216923|NCT02041351|taxanes|taxanes
216924|NCT02041351|heavily pretreated|heavily pretreated
216925|NCT02041312|Cholesterol|cholesterol
216926|NCT02041312|Gastric cancer|gastric cancer
216927|NCT02041312|Stage|stage
216929|NCT02041299|Iron overload|iron overload
216930|NCT02041299|Deferiprone|deferiprone
216931|NCT02041299|Ferriprox|ferriprox
216932|NCT02041299|deferoxamine|deferoxamine
216933|NCT02041299|Chelation|chelation
216934|NCT02041273|bioavailability|bioavailability
216935|NCT02041273|bioequivalence|bioequivalence
216937|NCT02041273|Cmax|cmax
216938|NCT02041260|Adult|adult
216939|NCT02041260|differentiated thyroid cancer (DTC),|differentiated thyroid cancer (dtc),
216940|NCT02041260|poorly differentiated thyroid cancer|poorly differentiated thyroid cancer
216941|NCT02041260|not anaplastic thyroid cancer|not anaplastic thyroid cancer
216942|NCT02041234|Diabetes|diabetes
216943|NCT02041234|surgical treatment|surgical treatment
216944|NCT02041234|medical treatment|medical treatment
216945|NCT02041221|pharmacokinetics, pharmacodynamics, asthma|pharmacokinetics, pharmacodynamics, asthma
216946|NCT02041208|Chronic renal anemia|chronic renal anemia
216947|NCT02041208|Hemoglobin|hemoglobin
216948|NCT02041208|Kidney transplant|kidney transplant
216949|NCT02041195|Overweight|overweight
216950|NCT02041182|youth violence|youth violence
216951|NCT02041182|doctor-patient communication|doctor-patient communication
216952|NCT02041182|health risk behaviors|health risk behaviors
216953|NCT02041182|pre-visit questionnaires|pre-visit questionnaires
216954|NCT02041130|Heart Failure|heart failure
216955|NCT02041130|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
216956|NCT02041104|Metabolic syndrome|metabolic syndrome
216957|NCT02041104|Two month intervention|two month intervention
216958|NCT02041104|Randomised placebo controlled parallel study|randomised placebo controlled parallel study
216959|NCT02041104|Beta-glucans|beta-glucans
216960|NCT02041104|Abdominal fat|abdominal fat
216961|NCT02041104|Dyslipidemia|dyslipidemia
216962|NCT02041104|Insulin resistance|insulin resistance
216963|NCT02041104|Hypertension|hypertension
216964|NCT02041104|Gut Microbiota Composition|gut microbiota composition
216965|NCT02041104|Oral Glucose Tolerance Test|oral glucose tolerance test
216966|NCT02041104|Lipid Profile|lipid profile
216967|NCT02041104|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
216968|NCT02041104|Denaturating Gradient Gel Electrophoresis|denaturating gradient gel electrophoresis
216969|NCT02041078|Liver surgery|liver surgery
216970|NCT02041078|Blood loss|blood loss
216971|NCT02041078|CUSA|cusa
216972|NCT02041078|Hepatic transection|hepatic transection
216973|NCT02041065|Liver transection|liver transection
216974|NCT02041065|Bloodloss|bloodloss
216976|NCT02041065|Safety|safety
216977|NCT02041065|feasibility|feasibility
216978|NCT02041026|probiotic|probiotic
216979|NCT02041026|Yoghurt|yoghurt
216980|NCT02041026|NN20|nn20
216981|NCT02041013|Asthma|asthma
216982|NCT02041013|Health Literacy|health literacy
216983|NCT02041000|COPD|copd
216984|NCT02041000|pulmonary|pulmonary
216985|NCT02041000|stem cells|stem cells
216986|NCT02041000|emphysema|emphysema
216987|NCT02041000|lungs|lungs
216988|NCT02040987|Thorough QT study|thorough qt study
216989|NCT02040974|immunotherapy, house dust mites, pollens, allergic rhinitis|immunotherapy, house dust mites, pollens, allergic rhinitis
216990|NCT02040961|Patients|patients
216991|NCT02040961|Undergoing|undergoing
216992|NCT02040961|Elective|elective
216993|NCT02040961|Thoracic|thoracic
216994|NCT02040961|Surgery|surgery
216995|NCT02040922|Antibiotics|antibiotics
216996|NCT02040922|Campylobacter|campylobacter
216997|NCT02040922|Diarrhoea|diarrhoea
216998|NCT02040922|Enteritis|enteritis
216999|NCT02040922|Microbiota|microbiota
217000|NCT02040922|Calprotectin|calprotectin
217001|NCT02040909|sedation|sedation
217002|NCT02040909|quality of intubation|quality of intubation
217003|NCT02040909|hypotension|hypotension
217004|NCT02040909|pharmacodynamics|pharmacodynamics
217005|NCT02040909|pharmacokinetics|pharmacokinetics
217006|NCT02040896|computed tomography|computed tomography
217007|NCT02040896|emergency|emergency
217008|NCT02040896|CT scan|ct scan
217009|NCT02040896|ordering behavior|ordering behavior
217010|NCT02040896|diagnosis|diagnosis
217011|NCT02040896|radiation|radiation
217012|NCT02040883|Schizophrenia|schizophrenia
217013|NCT02040883|Tandospirone|tandospirone
217014|NCT02040883|Cognitive Therapy|cognitive therapy
217015|NCT02040870|Non-Small Cell lung Cancer, NSCLC, ALK, LDK378|non-small cell lung cancer, nsclc, alk, ldk378
217016|NCT02040857|Breast Cancer|breast cancer
217017|NCT02040805|compulsive hoarding|compulsive hoarding
217018|NCT02040805|clutter|clutter
217019|NCT02040805|hoarding disorder|hoarding disorder
217020|NCT02040792|COPD|copd
217021|NCT02040792|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
217022|NCT02040779|asthma|asthma
217023|NCT02040779|breath-actuated inhaler|breath-actuated inhaler
217024|NCT02040779|beclomethasone|beclomethasone
217025|NCT02040766|asthma|asthma
217026|NCT02040766|breath-actuated inhaler|breath-actuated inhaler
217027|NCT02040766|metered dose inhaler|metered dose inhaler
217028|NCT02040753|Lifestyle intervention|lifestyle intervention
217029|NCT02040753|Change of body composition|change of body composition
217030|NCT02040753|Physical activity|physical activity
217031|NCT02040753|Weight loss maintenance|weight loss maintenance
217032|NCT02040727|Myokines|myokines
217033|NCT02040727|Osteokines|osteokines
217034|NCT02040727|Glucose homeostasis|glucose homeostasis
217036|NCT02040714|femur head necrosis|femur head necrosis
217037|NCT02040714|hip|hip
217038|NCT02040714|pediatric orthopedics|pediatric orthopedics
217039|NCT02040714|MRI|mri
217040|NCT02040714|Osteonecrosis|osteonecrosis
217041|NCT02040714|Bone diseases|bone diseases
217042|NCT02040714|Legg Calve Perthes Syndrome|legg calve perthes syndrome
217043|NCT02040662|paravertebral block|paravertebral block
217044|NCT02040662|thoracic epidural analgesia|thoracic epidural analgesia
217045|NCT02040662|videothoracoscopic surgery|videothoracoscopic surgery
217046|NCT02040662|lung lobectomy|lung lobectomy
217047|NCT02040649|Critical care|critical care
217048|NCT02040649|Respiration, artificial|respiration, artificial
217049|NCT02040636|Pertussis|pertussis
217050|NCT02040636|Tetanus|tetanus
217051|NCT02040636|Diphtheria|diphtheria
217052|NCT02040636|Poliomyelitis|poliomyelitis
217053|NCT02040636|Hepatitis B|hepatitis b
217054|NCT02040636|Acellular Pertussis Vaccines|acellular pertussis vaccines
217055|NCT02040623|Chronic Graft versus Host Disease|chronic graft versus host disease
217056|NCT02040623|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
217057|NCT02040610|Low Risk Prostate Cancer|low risk prostate cancer
217058|NCT02040610|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
217059|NCT02040610|Hypofractionated|hypofractionated
217060|NCT02040610|Image Guided Proton Therapy|image guided proton therapy
217061|NCT02040584|De Novo Liver Transplant Recipients, Tacrolimus Minimisation, Everolimus, Renal Function|de novo liver transplant recipients, tacrolimus minimisation, everolimus, renal function
217062|NCT02040545|Infertility|infertility
217063|NCT02040545|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
217487|NCT02038608|progression|progression
217064|NCT02040545|Venopuncture-free treatment|venopuncture-free treatment
217065|NCT02040545|Needle-free treatment|needle-free treatment
217066|NCT02040519|Overactive bladder|overactive bladder
217067|NCT02040519|Non obstructive urinary retention|non obstructive urinary retention
217068|NCT02040519|Sacral neuromodulation|sacral neuromodulation
217069|NCT02040506|Acute Myelogenous Leukemia|acute myelogenous leukemia
217070|NCT02040506|Acute Myeloid Leukemia|acute myeloid leukemia
217071|NCT02040506|Drug therapy|drug therapy
217072|NCT02040506|CD98|cd98
217073|NCT02040506|Relapsed|relapsed
217074|NCT02040506|Refractory|refractory
217075|NCT02040506|Monoclonal antibody|monoclonal antibody
217076|NCT02040493|breast cancer|breast cancer
217077|NCT02040493|IORT|iort
217078|NCT02040493|brachytherapy|brachytherapy
217079|NCT02040480|bioavailability|bioavailability
217080|NCT02040480|food effect|food effect
217081|NCT02040480|formulation|formulation
217082|NCT02040480|GSK2110183|gsk2110183
217083|NCT02040480|afuresertib|afuresertib
217084|NCT02040480|AKT inhibitor|akt inhibitor
217085|NCT02040441|Proteomics|proteomics
217086|NCT02040441|Diabetes|diabetes
217087|NCT02040441|Chronic kidney disease|chronic kidney disease
217088|NCT02040441|Diabetic nephropathy|diabetic nephropathy
217089|NCT02040441|Diabetic retinopathy|diabetic retinopathy
217090|NCT02040441|Mineralocorticoid receptor antagonists|mineralocorticoid receptor antagonists
217091|NCT02040441|Spironolactone|spironolactone
217092|NCT02040441|Microalbuminuria|microalbuminuria
217093|NCT02040428|Cardiovascular Diseases|cardiovascular diseases
217094|NCT02040428|Fibrin Sealant|fibrin sealant
217095|NCT02040428|Hemostatics|hemostatics
217096|NCT02040428|Coagulants|coagulants
217301|NCT02039414|Lipid Oxidation|lipid oxidation
217097|NCT02040402|Comparison of pneumococcal conjugated vaccine regimes|comparison of pneumococcal conjugated vaccine regimes
217098|NCT02040389|children|children
217099|NCT02040389|penile|penile
217100|NCT02040389|inguinal|inguinal
217101|NCT02040389|kidney parents|kidney parents
217102|NCT02040389|anxiety|anxiety
217103|NCT02040376|Paediatrics|paediatrics
217104|NCT02040376|Medulloblastoma|medulloblastoma
217105|NCT02040376|Metformin|metformin
217106|NCT02040363|COPD|copd
217107|NCT02040363|skeletal muscle|skeletal muscle
217108|NCT02040363|angiogenesis|angiogenesis
217109|NCT02040363|exercise training|exercise training
217110|NCT02040363|intensity|intensity
217111|NCT02040350|Pralidoxime, atropine, organophosphorous poisoning.|pralidoxime, atropine, organophosphorous poisoning.
217112|NCT02040285|CT colonography|ct colonography
217113|NCT02040259|ischemic stroke|ischemic stroke
217114|NCT02040259|mechanical thrombectomy device|mechanical thrombectomy device
217115|NCT02040259|Retriever|retriever
217116|NCT02040220|CRVO, Macular edema, Aflibercept, anti-VEGF|crvo, macular edema, aflibercept, anti-vegf
217117|NCT02040181|renal function, creatinine clearance|renal function, creatinine clearance
217118|NCT02040168|Ventilation|ventilation
217119|NCT02040168|PTSD|ptsd
217120|NCT02040168|sedation|sedation
217121|NCT02040142|Hyperthermic Intraperitoneal Mitomycin c|hyperthermic intraperitoneal mitomycin c
217122|NCT02040142|HIPEC|hipec
217123|NCT02040142|Cytoreduction|cytoreduction
217124|NCT02040116|Rapid Infusion Rituximab|rapid infusion rituximab
217125|NCT02040103|Deep Vein Thrombosis|deep vein thrombosis
217126|NCT02040103|Pulmonary Embolism|pulmonary embolism
217127|NCT02040103|Intermittent Pneumatic Compression|intermittent pneumatic compression
217128|NCT02040103|Pharmacologic DVT|pharmacologic dvt
217129|NCT02040103|Prophylaxis|prophylaxis
217130|NCT02040103|Critically Ill Patients.|critically ill patients.
217131|NCT02040077|opioid|opioid
217132|NCT02040077|overdose|overdose
217133|NCT02040077|OD|od
217134|NCT02040077|opiate|opiate
266435|NCT01815333|MRI|mri
217135|NCT02040077|prescription opioids|prescription opioids
217136|NCT02040077|prescription pain medication|prescription pain medication
217137|NCT02040077|heroin|heroin
217138|NCT02040077|detoxification|detoxification
217139|NCT02040077|prevention|prevention
217140|NCT02040051|intensive care units|intensive care units
217141|NCT02040051|mechanical ventilation|mechanical ventilation
217142|NCT02040051|music therapy|music therapy
217143|NCT02040038|Diabetes|diabetes
217144|NCT02040038|Virtual Environment|virtual environment
217145|NCT02040038|Self-Management|self-management
217146|NCT02040025|hypertension|hypertension
217147|NCT02040025|diabetes mellitus|diabetes mellitus
217148|NCT02040025|hemoglobin A1C|hemoglobin a1c
217149|NCT02040025|peripheral vascular resistance|peripheral vascular resistance
217150|NCT02040025|EECP|eecp
217151|NCT02040025|Blood pressure|blood pressure
217152|NCT02040025|angiogenesis|angiogenesis
217153|NCT02040025|Coronary Artery Disease|coronary artery disease
217154|NCT02040025|Coronary Disease|coronary disease
217155|NCT02040025|Heart Diseases|heart diseases
217156|NCT02040025|Cardiovascular Diseases|cardiovascular diseases
217157|NCT02040012|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
217158|NCT02039999|chronic|chronic
217159|NCT02039999|cough|cough
217160|NCT02039999|challenge|challenge
217161|NCT02039999|ATP|atp
217162|NCT02039999|hypersensitivity|hypersensitivity
217164|NCT02039986|cystic fibrosis|cystic fibrosis
217165|NCT02039986|CF|cf
217166|NCT02039986|cystic fibrosis related diabetes|cystic fibrosis related diabetes
217167|NCT02039986|CFRD|cfrd
217168|NCT02039986|kalydeco|kalydeco
217169|NCT02039986|ivacaftor|ivacaftor
217170|NCT02039973|HIV|hiv
217171|NCT02039973|AIDS|aids
217172|NCT02039973|Tanzania|tanzania
217179|NCT02039960|Drug Abuse Warning Network (DAWN)|drug abuse warning network (dawn)
217181|NCT02039960|abuse|abuse
217189|NCT02039934|type 2 diabetes|type 2 diabetes
217190|NCT02039934|exercise intervention|exercise intervention
217191|NCT02039934|high intensity interval training|high intensity interval training
217192|NCT02039908|Tolerance to stimulant medication|tolerance to stimulant medication
217193|NCT02039895|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
217194|NCT02039895|Helical irradiation of the total skin|helical irradiation of the total skin
217195|NCT02039895|Refractory|refractory
217196|NCT02039895|Total skin electron beam therapy|total skin electron beam therapy
217197|NCT02039882|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
217198|NCT02039882|Percutaneous Coronary Intervention PCI|percutaneous coronary intervention pci
217199|NCT02039882|Normals|normals
217200|NCT02039882|Myocardial Infarction MI|myocardial infarction mi
217201|NCT02039882|Point of Care POC|point of care poc
217202|NCT02039882|Hypoxanthine|hypoxanthine
217203|NCT02039882|Inosine|inosine
217204|NCT02039882|HPLC High Pressure Liquid Chromatography|hplc high pressure liquid chromatography
217205|NCT02039869|NERD|nerd
217206|NCT02039869|Non erosive reflux disease|non erosive reflux disease
217207|NCT02039869|functional dyspepsia|functional dyspepsia
217208|NCT02039869|erosive esophagitis|erosive esophagitis
217209|NCT02039869|confocal endomicroscopy|confocal endomicroscopy
217210|NCT02039869|cell visio|cell visio
217211|NCT02039869|proton pump inhibitor|proton pump inhibitor
217212|NCT02039869|sucralfate|sucralfate
217213|NCT02039856|Patient-centered medical homes|patient-centered medical homes
217214|NCT02039856|Primary care|primary care
217215|NCT02039856|Women's health|women's health
217216|NCT02039856|Veterans|veterans
217217|NCT02039830|female|female
217218|NCT02039830|aging|aging
217219|NCT02039830|physiotherapy|physiotherapy
217220|NCT02039830|pelvic floor|pelvic floor
217221|NCT02039830|rehabilitation|rehabilitation
217222|NCT02039817|pharmacokinetics|pharmacokinetics
217223|NCT02039817|pharmacodynamics|pharmacodynamics
217224|NCT02039817|renal impairment|renal impairment
217225|NCT02039778|Glioblastoma|glioblastoma
217226|NCT02039778|High-grade Glioma|high-grade glioma
217227|NCT02039778|Brain Tums|brain tums
217228|NCT02039778|Temozolomide|temozolomide
217229|NCT02039778|Stem cell radiation therapy|stem cell radiation therapy
217230|NCT02039778|IMRT|imrt
217231|NCT02039778|Proton beam radiotherapy|proton beam radiotherapy
217232|NCT02039778|Conventional external beam radiotherapy|conventional external beam radiotherapy
217233|NCT02039778|Quality of Life|quality of life
217234|NCT02039778|Neurocognition|neurocognition
217235|NCT02039765|Ocular Redness|ocular redness
217236|NCT02039752|Multivessel|multivessel
217238|NCT02039739|Drug Eluting Stent|drug eluting stent
217239|NCT02039739|Routine Clinical Practice|routine clinical practice
217240|NCT02039739|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
217241|NCT02039739|Coronary Artery Disease|coronary artery disease
217242|NCT02039726|Acute Myeloid Leukemia|acute myeloid leukemia
217244|NCT02039726|FMS-like tyrosine kinase 3|fms-like tyrosine kinase 3
217245|NCT02039726|FLT3-ITD|flt3-itd
217246|NCT02039726|Quizartinib|quizartinib
217247|NCT02039726|Leukemia|leukemia
217248|NCT02039726|Tablets|tablets
217249|NCT02039713|DeSyne|desyne
217250|NCT02039713|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
217251|NCT02039713|Coronary Artery Disease|coronary artery disease
217252|NCT02039687|neuropathy|neuropathy
217253|NCT02039687|sarcoidosis|sarcoidosis
217254|NCT02039674|PD-1|pd-1
217255|NCT02039674|PD1|pd1
217256|NCT02039674|Programmed Cell Death-1|programmed cell death-1
217257|NCT02039674|Programmed Cell Death 1|programmed cell death 1
217258|NCT02039661|Curettage;|curettage;
217259|NCT02039661|Pain Score|pain score
217260|NCT02039648|Periodontitis|periodontitis
217261|NCT02039648|Porphyromonas gingivalis|porphyromonas gingivalis
217262|NCT02039648|Rumex acetosa L.|rumex acetosa l.
217263|NCT02039648|Proanthocyanidins|proanthocyanidins
217264|NCT02039635|cancer|cancer
217265|NCT02039635|cancer related fatigue|cancer related fatigue
217266|NCT02039635|Korean red ginseng|korean red ginseng
217267|NCT02039635|chemotherapy|chemotherapy
217268|NCT02039583|live birth|live birth
217269|NCT02039583|infant|infant
217270|NCT02039583|infant, newborn|infant, newborn
217271|NCT02039583|second-hand smoke|second-hand smoke
217272|NCT02039583|tobacco smoke pollution|tobacco smoke pollution
217273|NCT02039583|smoke-free|smoke-free
217274|NCT02039583|smoke-free policy|smoke-free policy
217275|NCT02039570|haemorrhoids|haemorrhoids
217276|NCT02039570|pelvic reflux|pelvic reflux
217277|NCT02039531|Knee|knee
217278|NCT02039531|osteoarthritis|osteoarthritis
217279|NCT02039531|plasma rich in growth factors|plasma rich in growth factors
217280|NCT02039531|platelet rich plasma|platelet rich plasma
217281|NCT02039531|hyaluronic acid|hyaluronic acid
217282|NCT02039518|Progression free Survival|progression free survival
217283|NCT02039505|Drug therapy|drug therapy
217284|NCT02039479|anti-suicide|anti-suicide
217285|NCT02039479|Lithium|lithium
217286|NCT02039479|Depression|depression
217287|NCT02039479|suicidal Ideation/behavior|suicidal ideation/behavior
217288|NCT02039453|Colonoscopy|colonoscopy
217289|NCT02039453|sedation|sedation
217290|NCT02039453|propofol|propofol
217291|NCT02039453|fentanyl|fentanyl
217292|NCT02039453|pethidine|pethidine
217293|NCT02039427|Sore throat|sore throat
217294|NCT02039427|Hoarseness|hoarseness
217295|NCT02039427|Intubation|intubation
217296|NCT02039427|Thyroidectomy|thyroidectomy
217297|NCT02039427|Ketorolac|ketorolac
217298|NCT02039427|Dexamethasone|dexamethasone
217299|NCT02039414|Obesity|obesity
217300|NCT02039414|Physical Inactivity|physical inactivity
217302|NCT02039414|Oxidative stress|oxidative stress
217303|NCT02039414|pregnancy|pregnancy
217304|NCT02039414|neonatal adiposity|neonatal adiposity
217305|NCT02039414|neonatal insulin sensitivity|neonatal insulin sensitivity
217306|NCT02039401|ALS|als
217307|NCT02039401|Lou Gehrig's disease|lou gehrig's disease
217308|NCT02039401|neurodegenerative disease|neurodegenerative disease
217309|NCT02039388|Ovarian Epithelial Cancer|ovarian epithelial cancer
217310|NCT02039388|Serous Intraepithelial Carcinoma (STIC)|serous intraepithelial carcinoma (stic)
217311|NCT02039388|BRCA1 gene|brca1 gene
217312|NCT02039388|BRCA2 gene|brca2 gene
217313|NCT02039388|Mutation|mutation
217314|NCT02039388|Neoplasms|neoplasms
217315|NCT02039388|Glandular and Epithelial|glandular and epithelial
217316|NCT02039388|Ovarian Neoplasms|ovarian neoplasms
217317|NCT02039388|Ovarian cancer|ovarian cancer
217318|NCT02039388|Carcinoma in situ|carcinoma in situ
217319|NCT02039388|family history breast cancer|family history breast cancer
217320|NCT02039388|family history ovarian cancer|family history ovarian cancer
217321|NCT02039375|IV tPA|iv tpa
217322|NCT02039375|Thrombolysis|thrombolysis
217323|NCT02039375|Stroke|stroke
217324|NCT02039375|Ischemic|ischemic
217325|NCT02039375|Monitoring|monitoring
217326|NCT02039349|Alcoholism|alcoholism
217327|NCT02039349|Ghrelin|ghrelin
217328|NCT02039349|Ghrelin Antagonism|ghrelin antagonism
217329|NCT02039323|Tenofovir|tenofovir
217330|NCT02039323|Tenofovir disoproxil|tenofovir disoproxil
217331|NCT02039323|Maraviroc|maraviroc
217332|NCT02039323|Pharmacologic Actions|pharmacologic actions
217333|NCT02039323|Anti-HIV agents|anti-hiv agents
217334|NCT02039323|Pharmacodynamics|pharmacodynamics
217335|NCT02039297|AWARE, Checklist, ICU, Outcome, Adults|aware, checklist, icu, outcome, adults
217336|NCT02039284|Cerebral palsy|cerebral palsy
217337|NCT02039284|novel intervention|novel intervention
217338|NCT02039284|sensory electrical stimulation|sensory electrical stimulation
217339|NCT02039284|virtual reality|virtual reality
217340|NCT02039284|cycling training|cycling training
217341|NCT02039284|constraint-induced therapy|constraint-induced therapy
217342|NCT02039284|biomechanical|biomechanical
217343|NCT02039284|physiology|physiology
217344|NCT02039284|outcome|outcome
217345|NCT02039271|music|music
217346|NCT02039271|total knee replacement|total knee replacement
217347|NCT02039271|Pain management|pain management
217348|NCT02039258|Healthy Volunteers|healthy volunteers
217349|NCT02039258|Canagliflozin|canagliflozin
217350|NCT02039258|Metformin|metformin
217351|NCT02039258|INVOKANA®|invokana®
217352|NCT02039258|Type 2 diabetes mellitus|type 2 diabetes mellitus
217353|NCT02039245|Healthy Volunteers|healthy volunteers
217354|NCT02039245|Canagliflozin|canagliflozin
217355|NCT02039245|Metformin|metformin
217356|NCT02039245|INVOKANA®|invokana®
217357|NCT02039245|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
217358|NCT02039206|Machado Joseph disease|machado joseph disease
217359|NCT02039206|Deep TMS|deep tms
217360|NCT02039206|TMS|tms
217361|NCT02039206|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
217362|NCT02039206|SCA3|sca3
217363|NCT02039206|Magnetic Stimulation|magnetic stimulation
217364|NCT02039206|Brainsway|brainsway
217365|NCT02039193|Generalized anxiety disorder|generalized anxiety disorder
217366|NCT02039193|cognitive behavior therapy|cognitive behavior therapy
217367|NCT02039193|adherence|adherence
217368|NCT02039180|phase I|phase i
217369|NCT02039180|healthy volunteers|healthy volunteers
217370|NCT02039180|AZD3293|azd3293
217371|NCT02039180|bioavailability|bioavailability
217372|NCT02039180|Pharmacokinetics|pharmacokinetics
217373|NCT02039154|Exercise|exercise
682982|NCT00901394|vitamin B12|vitamin b12
217374|NCT02039154|Exercise tolerance|exercise tolerance
217375|NCT02039154|Aging|aging
217376|NCT02039154|Physical activity|physical activity
217377|NCT02039141|diabetes prevention program|diabetes prevention program
217378|NCT02039141|community based interventions|community based interventions
217379|NCT02039141|childhood obesity|childhood obesity
217380|NCT02039141|insulin resistance|insulin resistance
217381|NCT02039141|glucose tolerance|glucose tolerance
217382|NCT02039141|quality of life|quality of life
217383|NCT02039141|Latino youth|latino youth
217384|NCT02039141|physical activity|physical activity
217385|NCT02039141|nutrition|nutrition
217386|NCT02039102|hormonal contraceptives|hormonal contraceptives
217387|NCT02039102|combined pills|combined pills
217388|NCT02039102|progesterone-only contraceptives|progesterone-only contraceptives
217389|NCT02039102|body mass index|body mass index
217390|NCT02039102|asthma|asthma
217391|NCT02039102|Scotland|scotland
217392|NCT02039102|women|women
217393|NCT02039076|Healthy|healthy
217394|NCT02039063|Crohn's Disease|crohn's disease
217395|NCT02039050|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
217396|NCT02039050|Long-acting muscarinic antagonists|long-acting muscarinic antagonists
217397|NCT02039050|Impulse oscillometry|impulse oscillometry
217398|NCT02039024|18F-DTBZ|18f-dtbz
217399|NCT02039011|Asthma|asthma
217400|NCT02039011|Long acting beta-agonists|long acting beta-agonists
217401|NCT02039011|Long acting muscarinic antagonists|long acting muscarinic antagonists
217402|NCT02039011|Mannitol challenge|mannitol challenge
217403|NCT02038998|stroke|stroke
217404|NCT02038998|periodic acceleration|periodic acceleration
217405|NCT02038998|endothelium release|endothelium release
217406|NCT02038998|ischemic penumbra|ischemic penumbra
217407|NCT02038998|shear stress|shear stress
217408|NCT02038998|adrenomedullin|adrenomedullin
217409|NCT02038985|Endometriosis|endometriosis
217410|NCT02038985|Robotic Surgery|robotic surgery
217411|NCT02038985|Diagnostic Imaging|diagnostic imaging
217412|NCT02038959|Parkinson disease|parkinson disease
217413|NCT02038959|Parkinson's|parkinson's
217414|NCT02038959|Parkinson's disease|parkinson's disease
217415|NCT02038959|telemedicine|telemedicine
217416|NCT02038959|virtual visits|virtual visits
217417|NCT02038959|video calls|video calls
217418|NCT02038959|video conferencing|video conferencing
217419|NCT02038959|virtual house calls|virtual house calls
217420|NCT02038920|Drug Therapy|drug therapy
217421|NCT02038907|Norovirus, vaccination|norovirus, vaccination
217422|NCT02038894|Anesthetic|anesthetic
217423|NCT02038894|Pediatric|pediatric
217424|NCT02038894|Esophagogastroduodenoscopies|esophagogastroduodenoscopies
217425|NCT02038894|Eosinophilic esophagitis|eosinophilic esophagitis
217426|NCT02038894|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
217427|NCT02038894|Abdominal Pain|abdominal pain
217428|NCT02038894|Vomiting|vomiting
217429|NCT02038894|Sevofluorane|sevofluorane
217430|NCT02038894|Propofol|propofol
217431|NCT02038894|Nasal cannula|nasal cannula
217432|NCT02038894|Intubation|intubation
217433|NCT02038894|Endotracheal tube|endotracheal tube
217434|NCT02038868|BPH|bph
217435|NCT02038868|ASP4901|asp4901
217436|NCT02038855|Dual-diagnosis|dual-diagnosis
217437|NCT02038855|Latino|latino
217438|NCT02038855|Mental health|mental health
217439|NCT02038855|Substance use|substance use
217440|NCT02038855|HIV risk|hiv risk
217442|NCT02038803|Cystic Fibrosis Medication Adherence|cystic fibrosis medication adherence
217443|NCT02038790|opioid dependence|opioid dependence
217444|NCT02038790|buprenorphine/naloxone|buprenorphine/naloxone
217445|NCT02038790|Opioid-Related Disorders|opioid-related disorders
217446|NCT02038777|Hematologic Malignancies|hematologic malignancies
217447|NCT02038764|Phase 1|phase 1
217448|NCT02038764|RN168|rn168
217449|NCT02038764|Adults|adults
217450|NCT02038764|Type 1 Diabetes|type 1 diabetes
217452|NCT02038751|Genotyping|genotyping
217453|NCT02038751|Phenotyping|phenotyping
217454|NCT02038751|Sleep Apnea|sleep apnea
217455|NCT02038751|Genetic Association Studies|genetic association studies
217456|NCT02038751|Phenotype|phenotype
217457|NCT02038738|gallium|gallium
217458|NCT02038738|Ga|ga
217459|NCT02038738|PET Scan|pet scan
217460|NCT02038725|Risks|risks
217461|NCT02038725|Risk Factors|risk factors
217462|NCT02038725|ABCD2 score|abcd2 score
217463|NCT02038725|Predictive Value of Tests|predictive value of tests
217464|NCT02038725|Risk Assessment|risk assessment
217465|NCT02038725|Severity of Illness Index|severity of illness index
217466|NCT02038725|Decision Support Techniques|decision support techniques
217467|NCT02038712|Obesity|obesity
217468|NCT02038712|Binge eating disorder|binge eating disorder
217469|NCT02038712|fMRI|fmri
217470|NCT02038712|gut hormones|gut hormones
217471|NCT02038686|Hip fracture|hip fracture
217472|NCT02038686|Unstable (31A2 and 31A3)|unstable (31a2 and 31a3)
217473|NCT02038686|Proximal femoral nail|proximal femoral nail
217474|NCT02038673|ASP5878|asp5878
217475|NCT02038673|FGFR 1,2,3 and 4 inhibitor|fgfr 1,2,3 and 4 inhibitor
217476|NCT02038660|Coronary Artery Disease|coronary artery disease
217477|NCT02038660|Angioplasty, Balloon|angioplasty, balloon
217478|NCT02038647|Drug therapy|drug therapy
217479|NCT02038634|wrist|wrist
217480|NCT02038634|tendonitis|tendonitis
217481|NCT02038634|dequervain's|dequervain's
217482|NCT02038634|tenosynovitis|tenosynovitis
217483|NCT02038608|Parkinson|parkinson
217484|NCT02038608|serotonin|serotonin
217485|NCT02038608|dopamine|dopamine
217488|NCT02038608|PET|pet
217489|NCT02038595|brown adipose tissue|brown adipose tissue
217490|NCT02038582|HIV|hiv
217491|NCT02038582|HIV Counseling and Testing|hiv counseling and testing
217492|NCT02038582|Linkages to Care|linkages to care
217493|NCT02038582|Point of Care CD4|point of care cd4
217494|NCT02038582|Point of Care Viral Load|point of care viral load
217495|NCT02038543|Hyperoxaluria|hyperoxaluria
217496|NCT02038543|Oxalate|oxalate
217497|NCT02038543|Primary Hyperoxaluria|primary hyperoxaluria
217498|NCT02038530|Deep Vein Thrombosis|deep vein thrombosis
217499|NCT02038517|Insulin secretion|insulin secretion
217500|NCT02038517|Insulin sensitivity|insulin sensitivity
217501|NCT02038517|Orthotopic liver transplantation|orthotopic liver transplantation
217502|NCT02038517|Type 2 diabetes|type 2 diabetes
217503|NCT02038517|Metabolic syndrome|metabolic syndrome
217504|NCT02038517|Cardiovascular disease|cardiovascular disease
217505|NCT02038504|gastrointestinal fistula|gastrointestinal fistula
217813|NCT02037113|PAD|pad
217506|NCT02038504|enteral nutrition|enteral nutrition
217507|NCT02038504|thyroid function|thyroid function
217508|NCT02038491|Epidural anesthesia|epidural anesthesia
217509|NCT02038491|Spinal anesthesia|spinal anesthesia
217510|NCT02038491|nerve blocks|nerve blocks
217511|NCT02038491|complications|complications
217512|NCT02038478|Sickle Cell Disease|sickle cell disease
217513|NCT02038478|Thalassemia|thalassemia
217514|NCT02038452|hand|hand
217515|NCT02038452|wrist|wrist
217516|NCT02038452|carpal|carpal
217517|NCT02038452|tunnel|tunnel
217518|NCT02038452|syndrome|syndrome
217519|NCT02038452|pragmatic|pragmatic
217520|NCT02038452|randomised|randomised
217521|NCT02038452|steroid|steroid
217522|NCT02038452|splint|splint
217523|NCT02038439|Evidence-Based Medicine|evidence-based medicine
217524|NCT02038439|Evidence Retrieval|evidence retrieval
217525|NCT02038439|Knowledge Translation|knowledge translation
217526|NCT02038439|Medical Education|medical education
217527|NCT02038413|NSCLC|nsclc
217528|NCT02038413|cT1/cT2aN0M0|ct1/ct2an0m0
217529|NCT02038413|Stereotactic lung treatment|stereotactic lung treatment
217530|NCT02038413|MAASTRO|maastro
217531|NCT02038413|age >18 years|age >18 years
217532|NCT02038335|immune cells|immune cells
217533|NCT02038335|contraception|contraception
217534|NCT02038335|intrauterine device|intrauterine device
217535|NCT02038335|IUD|iud
217536|NCT02038335|copper|copper
217537|NCT02038335|microbiota|microbiota
217538|NCT02038335|DMPA|dmpa
217539|NCT02038335|etonogestrel|etonogestrel
217540|NCT02038335|subdermal implant|subdermal implant
217541|NCT02038335|NET-EN|net-en
217542|NCT02038335|Jadelle|jadelle
217543|NCT02038335|Implanon|implanon
217544|NCT02038335|Cyclofem|cyclofem
217545|NCT02038322|OTC Home Use Conception Aid Cervical Cap Insemination|otc home use conception aid cervical cap insemination
217546|NCT02038309|Acute coronary syndrome|acute coronary syndrome
217547|NCT02038309|persistent platelet reactivity|persistent platelet reactivity
217548|NCT02038296|Hepatocellular carcinoma|hepatocellular carcinoma
217549|NCT02038296|Transarterial chemoembolization|transarterial chemoembolization
217550|NCT02038296|Gemcitabine|gemcitabine
217551|NCT02038283|Colorectal Neoplasms|colorectal neoplasms
217552|NCT02038283|Early Detection of Cancer|early detection of cancer
217553|NCT02038283|Quality of Life|quality of life
217554|NCT02038283|Quality-Adjusted Life Years|quality-adjusted life years
217555|NCT02038283|Direct Service Costs|direct service costs
217556|NCT02038283|Cost-Benefit Analysis|cost-benefit analysis
217557|NCT02038231|Adolescence|adolescence
217558|NCT02038231|Substance abuse|substance abuse
217559|NCT02038231|Mindfulness|mindfulness
217560|NCT02038218|DM-CHOC-PEN|dm-choc-pen
217561|NCT02038218|CNS|cns
217562|NCT02038218|brain|brain
217563|NCT02038218|melanoma|melanoma
217564|NCT02038218|lung cancer|lung cancer
217565|NCT02038218|breast cancer|breast cancer
217566|NCT02038218|glioblastoma multiforme|glioblastoma multiforme
217567|NCT02038218|primary brain tumors|primary brain tumors
217568|NCT02038192|Caregiver|caregiver
217569|NCT02038192|Dementia|dementia
217570|NCT02038192|Long Term Care|long term care
217571|NCT02038192|Hope|hope
217572|NCT02038192|Quality of Life|quality of life
217573|NCT02038192|Intervention|intervention
217574|NCT02038179|Pre-hypertension|pre-hypertension
217575|NCT02038179|JNC 7 stage I hypertension|jnc 7 stage i hypertension
217576|NCT02038140|Primary Ankle Replacement|primary ankle replacement
217577|NCT02038140|Total Ankle Arthroplasty|total ankle arthroplasty
217578|NCT02038140|Total Ankle Replacement|total ankle replacement
217579|NCT02038140|Trabecular Metal Total Ankle|trabecular metal total ankle
217580|NCT02038114|Odette Cancer Centre at Sunnybrook Health Sciences Centre|odette cancer centre at sunnybrook health sciences centre
217581|NCT02038114|Toronto|toronto
217582|NCT02038114|Ontario|ontario
217583|NCT02038088|Need general anesthesia|need general anesthesia
217584|NCT02038075|suicide|suicide
217585|NCT02038075|suicidal ideation|suicidal ideation
217586|NCT02038075|military|military
217587|NCT02038075|veteran|veteran
217588|NCT02038075|cognitive behavioral therapy|cognitive behavioral therapy
217589|NCT02038075|behavioral therapy|behavioral therapy
217590|NCT02038075|psychotherapy|psychotherapy
217591|NCT02038075|Brief Cognitive Behavioral Therapy (BCBT)|brief cognitive behavioral therapy (bcbt)
217592|NCT02038075|Treatement As Usual (TAU)|treatement as usual (tau)
217593|NCT02038049|Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis, Magnetic Resonance Imaging, VAY736, monoclonal antibody, gadolinium [Gd]-enhancing lesions, B-Cell|multiple sclerosis, relapsing-remitting multiple sclerosis, magnetic resonance imaging, vay736, monoclonal antibody, gadolinium [gd]-enhancing lesions, b-cell
217594|NCT02038036|Polycythemia Vera|polycythemia vera
217595|NCT02038036|Hematologic Diseases|hematologic diseases
217596|NCT02038036|Myeloproliferative Disorders|myeloproliferative disorders
217597|NCT02038036|Bone Marrow Diseases|bone marrow diseases
217598|NCT02038036|Hydroxyurea|hydroxyurea
217599|NCT02038036|INC424|inc424
217600|NCT02038036|Ruxolitinib|ruxolitinib
217601|NCT02038023|Iv iron in pregnant women|iv iron in pregnant women
217602|NCT02038023|second and third trimester|second and third trimester
217603|NCT02037997|PFS|pfs
217604|NCT02037971|Systemic Lupus Erythematosus|systemic lupus erythematosus
217605|NCT02037971|Lupus|lupus
217606|NCT02037971|Sleep disorders|sleep disorders
217607|NCT02037971|Sleep disturbed|sleep disturbed
217608|NCT02037971|Physical exercise|physical exercise
217609|NCT02037971|Aerobic exercise|aerobic exercise
217610|NCT02037945|18F-Fluorocholine (18F-FCho)|18f-fluorocholine (18f-fcho)
217611|NCT02037945|Pet Scan|pet scan
217612|NCT02037945|MRI|mri
217613|NCT02037945|13-199|13-199
217614|NCT02037932|Aneurysm|aneurysm
217615|NCT02037932|Brain Aneurysm|brain aneurysm
217616|NCT02037906|Renal stones|renal stones
217617|NCT02037906|SWL|swl
217618|NCT02037880|Mucopolysaccharidosis|mucopolysaccharidosis
217619|NCT02037880|MPS|mps
217620|NCT02037880|Sanfilippo|sanfilippo
217621|NCT02037867|alcohol|alcohol
217622|NCT02037867|type 2 diabetes|type 2 diabetes
217623|NCT02037867|ALT|alt
217624|NCT02037867|abnormal liver enzymes|abnormal liver enzymes
217625|NCT02037867|hepatic fibrosis|hepatic fibrosis
217626|NCT02037867|cirrhosis|cirrhosis
217627|NCT02037841|Asthma|asthma
217628|NCT02037841|Nursing|nursing
217629|NCT02037841|Protocol|protocol
217630|NCT02037841|PRAM|pram
217631|NCT02037841|Length of Stay|length of stay
217632|NCT02037841|Weaning|weaning
217633|NCT02037841|Clinical pathway|clinical pathway
217634|NCT02037841|Asthma exacerbation|asthma exacerbation
217635|NCT02037828|COPD|copd
217636|NCT02037828|biomarker|biomarker
217637|NCT02037828|EBC|ebc
217638|NCT02037828|FEV1|fev1
217639|NCT02037815|hyperosmolar drugs|hyperosmolar drugs
217640|NCT02037815|mannitol|mannitol
217641|NCT02037815|hypertonic saline|hypertonic saline
217642|NCT02037815|serum osmolality|serum osmolality
217643|NCT02037815|correlation|correlation
217644|NCT02037802|caudal|caudal
217645|NCT02037802|epidural|epidural
217646|NCT02037802|pediatric|pediatric
217647|NCT02037802|renal|renal
217648|NCT02037802|transplant|transplant
217649|NCT02037802|hemodynamics|hemodynamics
217650|NCT02037789|pain|pain
217651|NCT02037789|low back pain|low back pain
217652|NCT02037789|GWAS|gwas
217653|NCT02037789|glycomics|glycomics
217654|NCT02037789|activomics|activomics
217655|NCT02037776|Rikkunshito|rikkunshito
217656|NCT02037776|Double blind|double blind
217657|NCT02037776|Functional dyspepsia (FD)|functional dyspepsia (fd)
217658|NCT02037763|Low back pain|low back pain
217659|NCT02037763|GWAS|gwas
217660|NCT02037763|Glycomics|glycomics
217661|NCT02037763|Activomics|activomics
217662|NCT02037763|Epigenetics|epigenetics
217663|NCT02037750|foster care|foster care
217664|NCT02037750|school adjustment|school adjustment
217665|NCT02037711|Laparoscopic|laparoscopic
217666|NCT02037711|Levobupivacaine|levobupivacaine
217667|NCT02037711|Pediatric|pediatric
217668|NCT02037711|Anesthesia|anesthesia
217669|NCT02037711|Instillation|instillation
217670|NCT02037711|surgeries|surgeries
217671|NCT02037698|CTO|cto
217672|NCT02037698|CT|ct
217673|NCT02037698|Revascularization|revascularization
217674|NCT02037685|Statins|statins
217675|NCT02037685|Cholesterol lowering medications|cholesterol lowering medications
217676|NCT02037685|Adherence|adherence
217677|NCT02037685|Motivational interviewing|motivational interviewing
217678|NCT02037685|Minority populations|minority populations
217679|NCT02037672|PCOS|pcos
217680|NCT02037672|PDE-4 inhibitor|pde-4 inhibitor
217681|NCT02037672|roflumilast|roflumilast
217682|NCT02037672|metformin|metformin
217683|NCT02037672|obesity|obesity
217684|NCT02037646|Colorectal cancer|colorectal cancer
217685|NCT02037646|Screening|screening
217686|NCT02037646|Fecal occult blood|fecal occult blood
217687|NCT02037646|Fecal immunochemical test|fecal immunochemical test
217688|NCT02037646|Qualitative|qualitative
217689|NCT02037646|Quantitative|quantitative
217690|NCT02037620|Epidural Stimulation|epidural stimulation
217691|NCT02037607|Deep vein thrombosis|deep vein thrombosis
217692|NCT02037607|Children|children
217693|NCT02037607|Pediatric|pediatric
217694|NCT02037607|Anti-coagulant|anti-coagulant
217695|NCT02037607|Neurosurgical procedures|neurosurgical procedures
217696|NCT02037607|Blood Clot|blood clot
217697|NCT02037594|HIV|hiv
217698|NCT02037594|Pre-exposure prophylaxis|pre-exposure prophylaxis
217699|NCT02037594|PrEP|prep
217700|NCT02037594|MSM|msm
217701|NCT02037594|Demonstration Project|demonstration project
217702|NCT02037581|integrated care|integrated care
217703|NCT02037581|hometreatment|hometreatment
217704|NCT02037581|assertive community treatment (ACT)|assertive community treatment (act)
217705|NCT02037581|psychosis|psychosis
217706|NCT02037581|schizophrenia|schizophrenia
217707|NCT02037581|bipolar disorder|bipolar disorder
217708|NCT02037581|first episode|first episode
217709|NCT02037568|depression|depression
217710|NCT02037568|stress|stress
217711|NCT02037568|caregiving|caregiving
217712|NCT02037568|anxiety|anxiety
217713|NCT02037568|psychoeducation intervention|psychoeducation intervention
217714|NCT02037568|psycho-oncology|psycho-oncology
217715|NCT02037568|allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
217716|NCT02037555|Antithrombin|antithrombin
217717|NCT02037555|Cardiopulmonary bypass|cardiopulmonary bypass
217718|NCT02037542|BMI, Lipid profile|bmi, lipid profile
217719|NCT02037529|Breast Cancer|breast cancer
217720|NCT02037529|Metastatic|metastatic
217721|NCT02037529|Locally Recurrent|locally recurrent
217722|NCT02037516|residual muscle weakness, respiratory events|residual muscle weakness, respiratory events
217723|NCT02037490|Infants|infants
217724|NCT02037490|Mothers|mothers
217725|NCT02037490|Social media|social media
217726|NCT02037490|Obesity prevention|obesity prevention
217727|NCT02037464|Prostate Cancer|prostate cancer
217728|NCT02037464|Active Surveillance|active surveillance
217729|NCT02037464|Radical Prostatectomy|radical prostatectomy
217730|NCT02037451|Parkinson's disease|parkinson's disease
217731|NCT02037451|Auditory Cueing|auditory cueing
217732|NCT02037438|Clinical sleep medicine|clinical sleep medicine
217733|NCT02037438|New methodology for healthcare delivery|new methodology for healthcare delivery
217734|NCT02037438|Diagnosis and treatment of sleep disorders|diagnosis and treatment of sleep disorders
217735|NCT02037438|Electronic health records|electronic health records
217736|NCT02037438|Clinical informatics|clinical informatics
217737|NCT02037438|Evidence-based comparative effectiveness research|evidence-based comparative effectiveness research
217738|NCT02037438|Sleep specialists|sleep specialists
217739|NCT02037438|Primary care providers|primary care providers
217740|NCT02037438|Allied health professionals|allied health professionals
217741|NCT02037438|Patient-centered care|patient-centered care
217742|NCT02037425|Chronic Migraine|chronic migraine
217743|NCT02037425|onabotulinumtoxinA|onabotulinumtoxina
217744|NCT02037425|Headache|headache
217745|NCT02037425|Migraine|migraine
217746|NCT02037425|Neuronal regrowth|neuronal regrowth
217747|NCT02037425|Botox|botox
217749|NCT02037412|strut coverage|strut coverage
217750|NCT02037412|DES|des
217751|NCT02037412|ACS|acs
217752|NCT02037412|OCT|oct
217753|NCT02037399|Endoscopic submucosal dissection|endoscopic submucosal dissection
217754|NCT02037399|early gastric cancer|early gastric cancer
217755|NCT02037399|pain relief|pain relief
267185|NCT01811745|Aged|aged
217756|NCT02037399|intravenous dexamethasone|intravenous dexamethasone
217757|NCT02037399|present pain intensity|present pain intensity
217758|NCT02037386|Side branch stent|side branch stent
217759|NCT02037386|Coronary bifurcation lesion|coronary bifurcation lesion
217760|NCT02037373|intra and post-op coagulopathy in patients undergoing OLT|intra and post-op coagulopathy in patients undergoing olt
217761|NCT02037360|Smoking|smoking
217762|NCT02037360|Cessation|cessation
217763|NCT02037334|Preterm delivery|preterm delivery
217764|NCT02037334|Diagnostics|diagnostics
217765|NCT02037334|Biomechanics|biomechanics
217766|NCT02037321|Systematic review and meta-analysis|systematic review and meta-analysis
217767|NCT02037308|Glu298Asp polymorphism|glu298asp polymorphism
217768|NCT02037308|Blood pressure|blood pressure
217769|NCT02037308|Plasma NOx|plasma nox
217770|NCT02037308|Beetroot|beetroot
217771|NCT02037295|Gut Microbiota|gut microbiota
217772|NCT02037295|Obesity|obesity
217773|NCT02037295|Absorption|absorption
217774|NCT02037295|Overfeeding|overfeeding
217775|NCT02037282|HAI Titer|hai titer
217776|NCT02037282|Hemagglutination Inhibition Assays|hemagglutination inhibition assays
217777|NCT02037282|Immunogenicity|immunogenicity
217778|NCT02037282|Serum Antibody Response|serum antibody response
217779|NCT02037269|Cerenkov Luminescence Imaging, CLI, margin status|cerenkov luminescence imaging, cli, margin status
217780|NCT02037243|behavior change|behavior change
217781|NCT02037243|handwashing|handwashing
217782|NCT02037243|water treatment|water treatment
217783|NCT02037243|disgust|disgust
217784|NCT02037243|shame|shame
217785|NCT02037243|neighbour|neighbour
217786|NCT02037243|willingness to pay|willingness to pay
217787|NCT02037204|IMPACT|impact
217788|NCT02037204|Chondrons|chondrons
217789|NCT02037204|Mesenchymal stem cells|mesenchymal stem cells
217790|NCT02037204|Allogeneic MSCs|allogeneic mscs
217791|NCT02037204|single-stage|single-stage
218180|NCT02035358|Cancer|cancer
217792|NCT02037204|Cartilage repair|cartilage repair
217793|NCT02037204|Safety|safety
217794|NCT02037204|Efficacy|efficacy
217795|NCT02037191|ALOPECIA AREATA|alopecia areata
217796|NCT02037191|TREATMENT METHOTREXATE|treatment methotrexate
217797|NCT02037178|Peripheral Obliterative Arteriopathy of the legs|peripheral obliterative arteriopathy of the legs
217798|NCT02037178|Screening by generalists|screening by generalists
217799|NCT02037178|Ultrasound|ultrasound
217800|NCT02037152|Chronic pain|chronic pain
217801|NCT02037152|Mobile applications|mobile applications
217802|NCT02037152|Mindfulness|mindfulness
217803|NCT02037152|Meditation|meditation
217804|NCT02037152|Telemedicine|telemedicine
217805|NCT02037152|Cellular phone|cellular phone
217806|NCT02037152|Pain Management|pain management
217807|NCT02037152|Therapy, computer-assisted|therapy, computer-assisted
217808|NCT02037139|Hearing loss|hearing loss
217809|NCT02037139|Tinnitus|tinnitus
217810|NCT02037139|Screening|screening
217811|NCT02037139|Primary Care|primary care
217812|NCT02037113|IVUS|ivus
217814|NCT02037113|Femoro-popliteal disease|femoro-popliteal disease
217815|NCT02037113|Intravascular ultrasound|intravascular ultrasound
217816|NCT02037087|Short Message Service|short message service
217817|NCT02037087|newborn health|newborn health
217818|NCT02037087|maternal behavior|maternal behavior
217819|NCT02037087|good household pregnancy practice|good household pregnancy practice
217820|NCT02037087|care seeking|care seeking
217944|NCT02036541|Trabeculectomy|trabeculectomy
217821|NCT02037074|Phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
217822|NCT02037022|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
217823|NCT02037022|Autism|autism
217824|NCT02036983|Ultrasound guided|ultrasound guided
217825|NCT02036983|Bilateral Transversus abdominis Plane Block|bilateral transversus abdominis plane block
217826|NCT02036983|Dexamethasone|dexamethasone
217827|NCT02036983|Preperitoneal Instillation|preperitoneal instillation
217828|NCT02036983|Local Analgesic|local analgesic
217829|NCT02036983|Efficacy|efficacy
217830|NCT02036983|Total Extraperitoneal Bilateral Inguinal hernia repair|total extraperitoneal bilateral inguinal hernia repair
217831|NCT02036970|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
217832|NCT02036970|PAH|pah
217833|NCT02036970|Bardoxolone methyl|bardoxolone methyl
217834|NCT02036970|6-minute walk distance|6-minute walk distance
217835|NCT02036970|CDDO-me|cddo-me
217836|NCT02036970|RTA 402|rta 402
217837|NCT02036970|Pulmonary Hypertension|pulmonary hypertension
217838|NCT02036970|Interstitial Lung Disease|interstitial lung disease
217839|NCT02036970|Idiopathic Interstitial Pneumonia|idiopathic interstitial pneumonia
217840|NCT02036970|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
217841|NCT02036970|Sarcoidosis|sarcoidosis
217842|NCT02036970|Respiratory Bronchiolitis Associated ILD|respiratory bronchiolitis associated ild
217843|NCT02036970|Desquamative Interstitial Pneumonia|desquamative interstitial pneumonia
217844|NCT02036970|Cryptogenic Organizing Pneumonia|cryptogenic organizing pneumonia
217845|NCT02036970|Acute Interstitial Pneumonitis|acute interstitial pneumonitis
217846|NCT02036970|Idiopathic Lymphoid Interstitial Pneumonia|idiopathic lymphoid interstitial pneumonia
267294|NCT01811355|ALS|als
208621|NCT02077985|anxiety|anxiety
217847|NCT02036970|Idiopathic Pleuroparenchymal Fibroelastosis|idiopathic pleuroparenchymal fibroelastosis
217848|NCT02036957|capecitabine|capecitabine
217849|NCT02036957|dermatologic toxicity|dermatologic toxicity
217850|NCT02036944|Celiac Disease|celiac disease
217851|NCT02036944|Celiac Sprue|celiac sprue
217852|NCT02036944|Iron-Deficiency Anemia|iron-deficiency anemia
217853|NCT02036931|Joint|joint
217854|NCT02036931|Osteoarthritis|osteoarthritis
217855|NCT02036931|Avascular Necrosis|avascular necrosis
217856|NCT02036918|castrate resistant prostate cancer|castrate resistant prostate cancer
217857|NCT02036918|metastatic|metastatic
217858|NCT02036918|sipuleucel-T|sipuleucel-t
217859|NCT02036918|lymphadenectomy|lymphadenectomy
217860|NCT02036918|Excisional lymph node biopsy|excisional lymph node biopsy
217861|NCT02036905|neck pain, orthopedic manual therapy|neck pain, orthopedic manual therapy
217862|NCT02036892|Diabetes|diabetes
217863|NCT02036879|Cystic Fibrosis|cystic fibrosis
217864|NCT02036879|Loestrin|loestrin
217865|NCT02036879|Hormone|hormone
217866|NCT02036866|knee osteoarthritis|knee osteoarthritis
217867|NCT02036866|grade I and II knee osteoarthritis|grade i and ii knee osteoarthritis
217868|NCT02036866|arthritis|arthritis
217869|NCT02036853|Triheptanoin|triheptanoin
217870|NCT02036853|Glut1 DS|glut1 ds
217871|NCT02036853|Epilepsy|epilepsy
217872|NCT02036853|Seizures|seizures
217873|NCT02036827|Pain, Postoperative|pain, postoperative
217874|NCT02036827|Neuromuscular Blocking Agents|neuromuscular blocking agents
217875|NCT02036827|Laparoscopy|laparoscopy
217876|NCT02036814|Hypertension|hypertension
217877|NCT02036814|Nursing|nursing
217878|NCT02036814|Therapeutic compliance|therapeutic compliance
217879|NCT02036814|Quality of life|quality of life
217880|NCT02036814|Health education|health education
217881|NCT02036801|ARDS|ards
217882|NCT02036801|Lung|lung
217883|NCT02036801|Specific Elastance|specific elastance
217884|NCT02036801|Pediatric patients|pediatric patients
218275|NCT02034851|Children|children
217885|NCT02036788|Esophageal pressure, Mechanical ventilation|esophageal pressure, mechanical ventilation
217886|NCT02036762|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
217887|NCT02036762|Thoracoabdominal Mechanics|thoracoabdominal mechanics
217888|NCT02036762|Functional capacity|functional capacity
217889|NCT02036762|Quality of life|quality of life
217890|NCT02036736|Orthopedic Surgery|orthopedic surgery
217891|NCT02036736|Total hip prosthesis|total hip prosthesis
217892|NCT02036736|Total knee replacement|total knee replacement
217893|NCT02036736|Intraoperative anesthetic strategy|intraoperative anesthetic strategy
217894|NCT02036736|Propofol|propofol
217895|NCT02036736|Desflurane|desflurane
217896|NCT02036723|Macular Degeneration|macular degeneration
217897|NCT02036723|Eye Diseases|eye diseases
217898|NCT02036723|Neovascular Macular Degeneration|neovascular macular degeneration
217899|NCT02036723|Choroidal Neovascularization|choroidal neovascularization
217900|NCT02036723|Geographic Atrophy|geographic atrophy
217901|NCT02036710|GLP-1|glp-1
217902|NCT02036710|PYY|pyy
217903|NCT02036710|Leptin|leptin
217904|NCT02036710|Duodenal Switch|duodenal switch
217905|NCT02036697|Cesarean section|cesarean section
217906|NCT02036697|spinal anesthesia|spinal anesthesia
217907|NCT02036697|low dose spinal|low dose spinal
217908|NCT02036697|bupivacaine|bupivacaine
217909|NCT02036697|hemodynamics|hemodynamics
217910|NCT02036697|blood pressure|blood pressure
217911|NCT02036697|cardiac output|cardiac output
217912|NCT02036684|Prostate cancer|prostate cancer
217913|NCT02036684|Radical prostatectomy|radical prostatectomy
217914|NCT02036684|Prehabilitation|prehabilitation
217915|NCT02036684|Pelvic floor muscle exercises|pelvic floor muscle exercises
217916|NCT02036671|Arteriovenous fistula|arteriovenous fistula
217917|NCT02036671|Fistula|fistula
217918|NCT02036671|Chronic kidney disease|chronic kidney disease
217919|NCT02036671|Percutaneous|percutaneous
217920|NCT02036671|Kidney Disease|kidney disease
217921|NCT02036671|Kidney Failure, Chronic|kidney failure, chronic
217922|NCT02036671|Urologic Diseases|urologic diseases
217923|NCT02036671|Renal Insufficiency, Chronic|renal insufficiency, chronic
217924|NCT02036671|Renal Insufficiency|renal insufficiency
217926|NCT02036671|hemodialysis|hemodialysis
217927|NCT02036658|social anxiety|social anxiety
217928|NCT02036658|treatment|treatment
217929|NCT02036619|gestational diabetes|gestational diabetes
217930|NCT02036619|pregestational diabetes|pregestational diabetes
217931|NCT02036619|screening|screening
217932|NCT02036619|diagnostic criteria|diagnostic criteria
217933|NCT02036619|IADPSG|iadpsg
217934|NCT02036593|Cardiovascular Risk Factors|cardiovascular risk factors
217935|NCT02036580|Japan|japan
217936|NCT02036580|Phase2|phase2
217937|NCT02036580|Safety|safety
217938|NCT02036580|Tolerability|tolerability
217939|NCT02036580|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
217940|NCT02036580|IPF|ipf
217941|NCT02036580|CAT-354|cat-354
217942|NCT02036580|Tralokinumab|tralokinumab
267422|NCT01810718|MTD|mtd
217943|NCT02036541|Glaucoma Implant|glaucoma implant
217946|NCT02036541|Primary Open Angle Glaucoma|primary open angle glaucoma
217947|NCT02036541|Pseudoexfoliation Glaucoma|pseudoexfoliation glaucoma
217948|NCT02036541|Pigmentary Glaucoma|pigmentary glaucoma
217949|NCT02036528|Foot Ulcer|foot ulcer
217950|NCT02036528|Diabetic Foot|diabetic foot
217951|NCT02036528|Gentamicins|gentamicins
217952|NCT02036528|infection|infection
217953|NCT02036502|PD1|pd1
217954|NCT02036502|PD-1|pd-1
217955|NCT02036502|PDL1|pdl1
217956|NCT02036502|PD-L1|pd-l1
217957|NCT02036476|Merkel Cell Carcinoma|merkel cell carcinoma
217958|NCT02036476|Skin Cancer|skin cancer
217959|NCT02036463|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
217960|NCT02036463|Corticosteroids|corticosteroids
217961|NCT02036450|atrial fibrillation|atrial fibrillation
217962|NCT02036450|cardiac arrhythmia|cardiac arrhythmia
217963|NCT02036450|stroke|stroke
217964|NCT02036450|implantable loop recorder|implantable loop recorder
217965|NCT02036450|bleeding|bleeding
217966|NCT02036450|anticoagulation|anticoagulation
217967|NCT02036450|hypertension|hypertension
217968|NCT02036450|diabetes|diabetes
217969|NCT02036450|heart failure|heart failure
217970|NCT02036450|mortality|mortality
217971|NCT02036437|Induction of Labor|induction of labor
217972|NCT02036437|Misoprostol|misoprostol
217973|NCT02036411|clomiphene citrate|clomiphene citrate
217974|NCT02036411|amh|amh
217975|NCT02036411|inhibin b|inhibin b
217976|NCT02036398|Percutaneous Nephrolithotomy (PCNL)|percutaneous nephrolithotomy (pcnl)
217977|NCT02036398|Nephrostomy|nephrostomy
217978|NCT02036398|Double J stent|double j stent
217979|NCT02036398|PleuraL Effusion|pleural effusion
217980|NCT02036398|Pain|pain
217981|NCT02036372|glucose|glucose
217982|NCT02036372|diabetes mellitus|diabetes mellitus
217983|NCT02036372|perioperative|perioperative
217984|NCT02036359|Non-small Cell Lung Cancer(NSCLC)|non-small cell lung cancer(nsclc)
217985|NCT02036346|ileostomy|ileostomy
217986|NCT02036346|colorectal resection|colorectal resection
217987|NCT02036346|dehydration|dehydration
217988|NCT02036346|nutritional status|nutritional status
217989|NCT02036333|near infrared spectroscopy|near infrared spectroscopy
217990|NCT02036333|pediatrics|pediatrics
217991|NCT02036307|Fish oils|fish oils
217992|NCT02036307|Triglycerides|triglycerides
217993|NCT02036307|Blood pressure|blood pressure
217994|NCT02036294|Patient self-care behaviors|patient self-care behaviors
217995|NCT02036294|Patient activation|patient activation
217996|NCT02036294|Family caregiver support|family caregiver support
217997|NCT02036294|Patient-centered care|patient-centered care
217998|NCT02036281|Terminally ill , histologically-confirmed advanced cancer|terminally ill , histologically-confirmed advanced cancer
217999|NCT02036281|Pain unrelieved by opioids|pain unrelieved by opioids
218000|NCT02036268|Ostomy education|ostomy education
218001|NCT02036268|Education|education
218002|NCT02036268|care of ostomy site|care of ostomy site
218003|NCT02036255|Prevention, Thrombosis, Hemodialysis, Vascular access device|prevention, thrombosis, hemodialysis, vascular access device
218004|NCT02036242|Opioid|opioid
218005|NCT02036242|Local anesthetic|local anesthetic
218006|NCT02036242|Labor delivery|labor delivery
218007|NCT02036242|Safety|safety
218008|NCT02036229|demodex|demodex
218009|NCT02036229|demodicidosis|demodicidosis
218010|NCT02036229|rosacea|rosacea
218011|NCT02036229|ivermectin|ivermectin
218012|NCT02036216|Hepatocellular Carcinoma；cell free tumor DNA; Mutation;|hepatocellular carcinoma；cell free tumor dna; mutation;
218013|NCT02036190|COPD, chronic obstructive pulmonary disease, emphysema|copd, chronic obstructive pulmonary disease, emphysema
218014|NCT02036164|Locally advanced cervical cancer|locally advanced cervical cancer
218015|NCT02036164|Concurrent chemoradiation|concurrent chemoradiation
218016|NCT02036164|Adjuvant chemotherapy|adjuvant chemotherapy
218017|NCT02036151|Xylitol|xylitol
218018|NCT02036151|prevention|prevention
218019|NCT02036151|Mutans streptococci|mutans streptococci
218020|NCT02036151|caries|caries
218021|NCT02036151|plaque|plaque
218022|NCT02036151|children|children
218023|NCT02036125|Corticosteroid|corticosteroid
218024|NCT02036125|Ultrasound|ultrasound
218025|NCT02036125|Guided injection|guided injection
218026|NCT02036112|Advanced Lower rectal cancer|advanced lower rectal cancer
218027|NCT02036112|Extralevator abdominoperineal excision|extralevator abdominoperineal excision
218028|NCT02036112|Circumferential resection margin|circumferential resection margin
218029|NCT02036112|Morbidity|morbidity
218030|NCT02036112|Survival|survival
218031|NCT02036099|Dementia|dementia
218032|NCT02036099|Automobile driving|automobile driving
218033|NCT02036099|Accidents, traffic|accidents, traffic
218034|NCT02036086|Melanoma stage IIIB or C with BRAF mutation|melanoma stage iiib or c with braf mutation
218035|NCT02036086|Recurrent regional lymphadenopathy not suitable for surgery|recurrent regional lymphadenopathy not suitable for surgery
218036|NCT02036086|Eligible for neoadjuvant vemurafenib and cobimetinib|eligible for neoadjuvant vemurafenib and cobimetinib
218037|NCT02036073|erythropoietin|erythropoietin
267596|NCT01809899|MRI|mri
218038|NCT02036073|preterm|preterm
218039|NCT02036073|brain injury|brain injury
218040|NCT02036073|cerebral palsy|cerebral palsy
218041|NCT02036073|PVL|pvl
218042|NCT02036060|Metastatic prostate cancer|metastatic prostate cancer
218043|NCT02036060|Abiraterone acetate|abiraterone acetate
218044|NCT02036021|pediatric anesthesia|pediatric anesthesia
218045|NCT02036021|perioperative respiratory events|perioperative respiratory events
218046|NCT02036021|days of hospitalization|days of hospitalization
218047|NCT02036021|cost of hospitalization|cost of hospitalization
218048|NCT02036008|Liver metastases|liver metastases
218049|NCT02036008|MRI|mri
218050|NCT02036008|Contrast Agents|contrast agents
218051|NCT02035995|gestational diabetes mellitus; optical coherence tomography; pregnancy; retinal nerve fiber layer.|gestational diabetes mellitus; optical coherence tomography; pregnancy; retinal nerve fiber layer.
218052|NCT02035956|IVAC MUTANOME|ivac mutanome
218053|NCT02035956|IVAC|ivac
218054|NCT02035956|personalized therapy|personalized therapy
218055|NCT02035956|personalized immuno therapy|personalized immuno therapy
218056|NCT02035956|RB_0004-01|rb_0004-01
218057|NCT02035956|Ribological|ribological
218058|NCT02035956|Melanoma|melanoma
218059|NCT02035956|cancer vaccine|cancer vaccine
218060|NCT02035930|Bispectral Index Monitor, Menstrual Cycle, Dexmedetomidine|bispectral index monitor, menstrual cycle, dexmedetomidine
218061|NCT02035891|colchicine|colchicine
401997|NCT01233570|Topical Tacrolimus|topical tacrolimus
218062|NCT02035891|urinary albumin-to-creatinine ratio|urinary albumin-to-creatinine ratio
218063|NCT02035891|carotid Intima-Media Thickness|carotid intima-media thickness
218064|NCT02035891|overt nephropathy|overt nephropathy
218065|NCT02035891|Type 2 diabetes|type 2 diabetes
218066|NCT02035878|anxiety|anxiety
218067|NCT02035878|depression|depression
218068|NCT02035878|probiotics|probiotics
218069|NCT02035878|adult|adult
218070|NCT02035878|human|human
218071|NCT02035878|depression anxiety stress scale|depression anxiety stress scale
218072|NCT02035878|anxiety sensitivity index|anxiety sensitivity index
218073|NCT02035865|Psychiatric morbidity|psychiatric morbidity
218074|NCT02035865|Cognitive function|cognitive function
218075|NCT02035865|Heart transplantation|heart transplantation
218076|NCT02035865|Mortality|mortality
218077|NCT02035865|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
218078|NCT02035839|Target Temperature Management|target temperature management
218079|NCT02035839|Cooling comatose survivors from OHCA|cooling comatose survivors from ohca
218080|NCT02035839|Good neurological outcome at modified Rankin Score (mRS) ≤ 3|good neurological outcome at modified rankin score (mrs) ≤ 3
218081|NCT02035813|metastatic breast cancer|metastatic breast cancer
218082|NCT02035813|circulating tumor cells|circulating tumor cells
218083|NCT02035813|everolimus|everolimus
218084|NCT02035813|eribulin|eribulin
218085|NCT02035800|Rheumatoid Arthritis|rheumatoid arthritis
218086|NCT02035800|Adalimumab|adalimumab
218087|NCT02035800|Humira|humira
218088|NCT02035787|metformin|metformin
218089|NCT02035787|endometrial cancer|endometrial cancer
218090|NCT02035787|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
218091|NCT02035787|complex atypical hyperplasia|complex atypical hyperplasia
218092|NCT02035774|Brachial plexus block|brachial plexus block
218093|NCT02035774|Suprascapular nerve block|suprascapular nerve block
218094|NCT02035761|MSA|msa
218095|NCT02035761|Shy-Dragers Syndrome|shy-dragers syndrome
218096|NCT02035761|Possible or Probable|possible or probable
218097|NCT02035748|Vitreomacular traction|vitreomacular traction
218098|NCT02035748|Symptomatic vitreomacular adhesion|symptomatic vitreomacular adhesion
218102|NCT02035735|squamous cell carcinoma,|squamous cell carcinoma,
218103|NCT02035735|pharynx, larynx, surgical margins.|pharynx, larynx, surgical margins.
218104|NCT02035709|Therapy|therapy
218105|NCT02035696|influenza|influenza
218106|NCT02035696|children|children
218107|NCT02035696|safety|safety
218108|NCT02035696|tolerability|tolerability
218109|NCT02035696|immunogenicity|immunogenicity
218110|NCT02035683|metabolic response|metabolic response
218111|NCT02035683|chemotherapy|chemotherapy
218112|NCT02035670|diagnostic strategy|diagnostic strategy
218113|NCT02035670|effectiveness|effectiveness
218114|NCT02035670|fever of unknown origin|fever of unknown origin
218115|NCT02035657|Merkel cell carcinoma|merkel cell carcinoma
218116|NCT02035657|MCC|mcc
218117|NCT02035631|Breast Neoplasms|breast neoplasms
218118|NCT02035631|Recurrence|recurrence
218119|NCT02035631|Motor Activity|motor activity
218120|NCT02035631|Diet|diet
218121|NCT02035631|Quality of Life|quality of life
218122|NCT02035579|concussion|concussion
218123|NCT02035579|mild traumatic brain injury|mild traumatic brain injury
218124|NCT02035579|post-concussion syndrome|post-concussion syndrome
218125|NCT02035579|adolescents|adolescents
218126|NCT02035579|sports injury|sports injury
218127|NCT02035579|aerobic training|aerobic training
218128|NCT02035579|stretching training|stretching training
218129|NCT02035566|Minority Health|minority health
218130|NCT02035566|Health Status Disparities|health status disparities
218131|NCT02035566|Health Care Disparities|health care disparities
218132|NCT02035566|Rural Health|rural health
218133|NCT02035566|Telemedicine|telemedicine
218134|NCT02035566|Health Services Research|health services research
218135|NCT02035566|Social Determinants of Health|social determinants of health
218136|NCT02035566|Ecological Theory of Health|ecological theory of health
218137|NCT02035527|squamous cell carcinoma|squamous cell carcinoma
218139|NCT02035514|multiple sclerosis|multiple sclerosis
218140|NCT02035514|mesenchymal stem cells|mesenchymal stem cells
218141|NCT02035514|autologous transplantation|autologous transplantation
218142|NCT02035514|MRI efficacy|mri efficacy
218143|NCT02035514|clinical safety|clinical safety
218144|NCT02035488|Dry powder inhalation|dry powder inhalation
218145|NCT02035488|Bronchiectasis|bronchiectasis
218146|NCT02035488|Tobramycin|tobramycin
218147|NCT02035475|Prevention|prevention
218148|NCT02035475|Pelvic Lymph Node Dissection|pelvic lymph node dissection
218149|NCT02035475|Lymphoceles|lymphoceles
218150|NCT02035475|Prostate Malignancies|prostate malignancies
218151|NCT02035475|daVinci|davinci
218152|NCT02035475|Vessel Sealer|vessel sealer
218153|NCT02035475|EndoWrist One|endowrist one
218154|NCT02035449|Video laryngoscope|video laryngoscope
218155|NCT02035449|Pre-hospital|pre-hospital
218156|NCT02035449|Endotracheal intubation|endotracheal intubation
218157|NCT02035449|Difficult endotracheal intubation|difficult endotracheal intubation
218158|NCT02035449|Pre hospital Critical care|pre hospital critical care
218159|NCT02035449|McGrath MAC|mcgrath mac
218160|NCT02035449|Airway device|airway device
218161|NCT02035436|Respiration, artificial|respiration, artificial
218162|NCT02035436|Critcal care|critcal care
218163|NCT02035423|Vitamin D Deficiency|vitamin d deficiency
218164|NCT02035423|Compliance|compliance
218165|NCT02035423|Milk|milk
218166|NCT02035410|cardiac devices|cardiac devices
218167|NCT02035410|prevention|prevention
218168|NCT02035410|infection|infection
218169|NCT02035397|botulinum toxin|botulinum toxin
218170|NCT02035397|Endoscopy|endoscopy
218171|NCT02035397|Satiation|satiation
218172|NCT02035397|Diet|diet
218173|NCT02035397|Weight Loss|weight loss
218174|NCT02035358|Metastatic|metastatic
218175|NCT02035358|Recurrent|recurrent
218176|NCT02035358|Refractory|refractory
218177|NCT02035358|Renal Cell Carcinoma|renal cell carcinoma
218178|NCT02035358|Kidney|kidney
218179|NCT02035358|clear-cell renal cancer|clear-cell renal cancer
218181|NCT02035345|Recurrent Ovarian Cancer|recurrent ovarian cancer
218182|NCT02035345|Platinum Sensitive Ovarian Cancer|platinum sensitive ovarian cancer
218183|NCT02035332|Excessive Uterine Bleeding|excessive uterine bleeding
218184|NCT02035332|Menorrhagia|menorrhagia
218185|NCT02035332|Endometrial Ablation|endometrial ablation
218186|NCT02035293|COPD Exacerbation|copd exacerbation
218187|NCT02035293|Pulmonary embolism|pulmonary embolism
218188|NCT02035293|Standardized and consensus diagnostic strategy|standardized and consensus diagnostic strategy
218189|NCT02035280|Spine|spine
218190|NCT02035280|Deformity|deformity
218191|NCT02035280|Fusion|fusion
218192|NCT02035280|Elderly|elderly
218193|NCT02035280|SRS-22r|srs-22r
218194|NCT02035241|Spices|spices
218195|NCT02035241|Herbs|herbs
218196|NCT02035241|Functional food|functional food
218197|NCT02035241|Cardiometabolic risk|cardiometabolic risk
218198|NCT02035241|Metabolic syndrome|metabolic syndrome
218199|NCT02035241|Inflammation|inflammation
218200|NCT02035241|Appetite|appetite
218201|NCT02035241|Gut hormone|gut hormone
218202|NCT02035228|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
218688|NCT02033083|abortion|abortion
218203|NCT02035228|Lung Hyperinflation|lung hyperinflation
218204|NCT02035228|Abdominal Muscle|abdominal muscle
218205|NCT02035228|Functional Electrical Stimulation|functional electrical stimulation
218206|NCT02035215|Hyperlipidemia, Familial Combined|hyperlipidemia, familial combined
218207|NCT02035215|Omega 3 acids ethylesters 90|omega 3 acids ethylesters 90
218208|NCT02035215|Atorvastatin|atorvastatin
218209|NCT02035176|autism|autism
218210|NCT02035176|ADHD|adhd
218211|NCT02035176|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
218212|NCT02035176|behavioral assessment|behavioral assessment
218213|NCT02035176|behavior|behavior
218214|NCT02035163|Atrial fibrillation|atrial fibrillation
218215|NCT02035163|coronary artery bypass graft|coronary artery bypass graft
218216|NCT02035163|cryoablation|cryoablation
218217|NCT02035163|ganglionic plexi|ganglionic plexi
218218|NCT02035150|breakfast|breakfast
218219|NCT02035150|oatmeal|oatmeal
218220|NCT02035150|appetite|appetite
218221|NCT02035150|cholesterol|cholesterol
218222|NCT02035124|Prostate|prostate
218223|NCT02035124|Metastatic|metastatic
218224|NCT02035124|Refractory|refractory
218225|NCT02035124|mCRPC|mcrpc
218226|NCT02035111|Migraine|migraine
218227|NCT02035111|Tianshu capsule|tianshu capsule
218228|NCT02035098|cancer, pain, cluster trial, quality improvement|cancer, pain, cluster trial, quality improvement
218229|NCT02035085|19F MRI|19f mri
218230|NCT02035059|Oral Glucose Tolerance Test|oral glucose tolerance test
218231|NCT02035059|Fibronectin|fibronectin
218232|NCT02035059|Adiponectin|adiponectin
218233|NCT02035059|Copeptin|copeptin
218234|NCT02035059|Cortisol|cortisol
218235|NCT02035046|Gitelman|gitelman
218236|NCT02035046|Heterozygous SLC12A3 mutation|heterozygous slc12a3 mutation
218237|NCT02035046|Blood pressure|blood pressure
218238|NCT02035046|Hypokalemia|hypokalemia
218239|NCT02035020|frataxin, gamma interferon, Friedreich ataxia|frataxin, gamma interferon, friedreich ataxia
218240|NCT02034994|school-based intervention|school-based intervention
218241|NCT02034994|after school physical activity|after school physical activity
218242|NCT02034994|sugar sweetened beverages|sugar sweetened beverages
218243|NCT02034994|sedentary behavior|sedentary behavior
218244|NCT02034994|schoolchildren|schoolchildren
218245|NCT02034981|metastatic or unresectable locally advanced malignancies.|metastatic or unresectable locally advanced malignancies.
218246|NCT02034981|genomic alterations.|genomic alterations.
218247|NCT02034981|biological crizotinib targets (ALK, MET, ROS1, RON, AXL).|biological crizotinib targets (alk, met, ros1, ron, axl).
218248|NCT02034968|Nimotuzumab|nimotuzumab
218249|NCT02034968|Nab-Paclitaxel|nab-paclitaxel
218250|NCT02034968|Carcinoma of Esophagus|carcinoma of esophagus
218251|NCT02034955|Prostate Cancer|prostate cancer
218252|NCT02034955|Adaptive Radiotherapy|adaptive radiotherapy
218253|NCT02034955|Prostatectomy|prostatectomy
218254|NCT02034955|Patients who had a prostatectomy|patients who had a prostatectomy
218255|NCT02034942|non-sedation|non-sedation
218256|NCT02034929|colon cancer|colon cancer
218257|NCT02034929|adenoma|adenoma
218258|NCT02034929|colon polyps|colon polyps
218259|NCT02034916|Breast cancer|breast cancer
218260|NCT02034916|BRCA mutation|brca mutation
218261|NCT02034916|PARP inhibitor|parp inhibitor
218262|NCT02034916|BRCA 1|brca 1
218263|NCT02034916|BRCA 2|brca 2
218264|NCT02034903|Enteral Feeding|enteral feeding
218265|NCT02034903|Infant, Premature|infant, premature
218266|NCT02034890|orthotopic neobladder|orthotopic neobladder
218267|NCT02034890|urinary tract infection|urinary tract infection
218268|NCT02034890|intravesical instillation|intravesical instillation
218269|NCT02034890|hyaluronic acid|hyaluronic acid
218270|NCT02034877|13-valent pneunococcal conjugate vaccine|13-valent pneunococcal conjugate vaccine
218271|NCT02034877|pneumococcal disease prevention; safety and immunogenicity study|pneumococcal disease prevention; safety and immunogenicity study
218272|NCT02034851|Acute pyelonephritis|acute pyelonephritis
218273|NCT02034851|Renal scarring|renal scarring
218274|NCT02034851|Dexamethasone|dexamethasone
218276|NCT02034851|Corticoids|corticoids
218277|NCT02034851|Complementary treatment|complementary treatment
218278|NCT02034851|Prevention strategy|prevention strategy
218280|NCT02034838|pharmacokinetic|pharmacokinetic
218281|NCT02034838|HIV-infected|hiv-infected
218282|NCT02034838|atazanavir|atazanavir
218283|NCT02034838|ritonavir|ritonavir
218284|NCT02034786|Mesenchymal stem cell|mesenchymal stem cell
218285|NCT02034786|Hyaluronic acid|hyaluronic acid
218286|NCT02034786|Adipose Tissue|adipose tissue
218287|NCT02034786|Filler Agent|filler agent
218288|NCT02034773|Safety, Pharmacokinetics, Pharmacodynamics, Healthy Subjects|safety, pharmacokinetics, pharmacodynamics, healthy subjects
218289|NCT02034760|Frailty|frailty
218290|NCT02034760|Ageing|ageing
218291|NCT02034760|Protein supplementation|protein supplementation
218292|NCT02034760|Protein quality|protein quality
218293|NCT02034760|Gut microbiota|gut microbiota
218294|NCT02034760|Metabolome|metabolome
218295|NCT02034760|Exercise training|exercise training
218296|NCT02034760|Sarcopenia|sarcopenia
218297|NCT02034747|Advagraf|advagraf
218298|NCT02034747|kidney transplant|kidney transplant
218299|NCT02034747|Corticosteroid|corticosteroid
218300|NCT02034747|Immunosuppressive regimen|immunosuppressive regimen
218301|NCT02034734|Phase 1|phase 1
218302|NCT02034734|ASP3652|asp3652
218303|NCT02034734|Cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
218304|NCT02034734|Multiple doses|multiple doses
218305|NCT02034721|Muscle damage|muscle damage
218306|NCT02034721|Muscle soreness|muscle soreness
218307|NCT02034721|Muscle function|muscle function
218308|NCT02034721|Innate immune function|innate immune function
218309|NCT02034721|Inflammation|inflammation
218310|NCT02034708|Primary brain tumor|primary brain tumor
218311|NCT02034695|Diabetes mellitus|diabetes mellitus
218312|NCT02034669|Acute Spinal cord Injury, Adipose derived stem cells|acute spinal cord injury, adipose derived stem cells
218313|NCT02034656|imatinib resistance|imatinib resistance
218314|NCT02034656|mutation|mutation
218315|NCT02034630|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
218316|NCT02034617|Cognition|cognition
218317|NCT02034617|Family nursing|family nursing
218318|NCT02034617|Infant, premature|infant, premature
218319|NCT02034617|Object attachment|object attachment
218320|NCT02034617|Stress, physiological|stress, physiological
218321|NCT02034617|Stress, psychological|stress, psychological
218322|NCT02034604|Naftopidil|naftopidil
218323|NCT02034604|safety|safety
218324|NCT02034539|peripheral artery disease|peripheral artery disease
218325|NCT02034539|critical limb ischemia|critical limb ischemia
218326|NCT02034539|VADOplex|vadoplex
218327|NCT02034539|intermittent foot compression|intermittent foot compression
218328|NCT02034526|Sinus node disease|sinus node disease
218329|NCT02034526|Atrial fibrillation|atrial fibrillation
218330|NCT02034526|Pacing|pacing
218331|NCT02034500|prevention|prevention
218332|NCT02034500|Shigella sonnei|shigella sonnei
218333|NCT02034487|Delayed Puberty|delayed puberty
218335|NCT02034487|Hormones|hormones
218336|NCT02034487|Polymorphism, Genetic|polymorphism, genetic
218337|NCT02034461|Micro-Electrodes|micro-electrodes
218338|NCT02034461|Peripheral Nerve Injury|peripheral nerve injury
218339|NCT02034461|Amputation|amputation
218340|NCT02034461|Spinal Cord Injury|spinal cord injury
218341|NCT02034448|CRRT|crrt
218342|NCT02034448|Renal|renal
218343|NCT02034448|Kidney|kidney
218344|NCT02034448|adults|adults
218345|NCT02034448|registry|registry
218347|NCT02034422|Exercise|exercise
218348|NCT02034409|Knee Osteoarthritis|knee osteoarthritis
218349|NCT02034409|Pulsed Low Intensity Ultrasound|pulsed low intensity ultrasound
218350|NCT02034396|Ulcers, venous, unna's boot|ulcers, venous, unna's boot
218351|NCT02034370|Interscalene nerve block|interscalene nerve block
218352|NCT02034370|Shoulder surgery|shoulder surgery
218353|NCT02034370|Obstructive Sleep Apnea|obstructive sleep apnea
218358|NCT02034357|Polysomnography|polysomnography
218359|NCT02034357|CPAP (continuous positive airway pressure) titration|cpap (continuous positive airway pressure) titration
218360|NCT02034357|CPAP (continuous positive airway pressure) treatment|cpap (continuous positive airway pressure) treatment
218361|NCT02034344|Lupus Erythematosus, Cutaneous|lupus erythematosus, cutaneous
218362|NCT02034344|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
218363|NCT02034344|Lupus Erythematosus, Discoid|lupus erythematosus, discoid
218364|NCT02034344|Healthy|healthy
218365|NCT02034344|Active Cutaneous Lupus Erythematosus|active cutaneous lupus erythematosus
218366|NCT02034344|Longitudinal Study|longitudinal study
218367|NCT02034344|Biomarkers|biomarkers
218368|NCT02034344|Subacute Cutaneous Lupus Erythematosus|subacute cutaneous lupus erythematosus
218369|NCT02034344|Skin Biopsy|skin biopsy
218370|NCT02034331|Insulin Sensitivity|insulin sensitivity
218371|NCT02034331|Microvascular permeability|microvascular permeability
218372|NCT02034331|Sympathetic nervous system|sympathetic nervous system
218373|NCT02034318|Fatigue|fatigue
218374|NCT02034318|Cardiac Sympathetic Denervation|cardiac sympathetic denervation
218375|NCT02034318|Parkinson Disease|parkinson disease
218376|NCT02034305|Airway Clearance|airway clearance
218377|NCT02034305|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
218378|NCT02034305|Peak Cough Flow|peak cough flow
218379|NCT02034279|cirrhosis|cirrhosis
218380|NCT02034266|Type one diabetes|type one diabetes
218381|NCT02034266|nerve damage|nerve damage
218382|NCT02034266|neuropathy|neuropathy
218383|NCT02034266|omega-3 fatty acid|omega-3 fatty acid
218384|NCT02034266|supplementation|supplementation
218385|NCT02034266|nutrition|nutrition
218386|NCT02034253|duration of untreated psychosis|duration of untreated psychosis
218387|NCT02034253|glutamate|glutamate
218388|NCT02034253|functional connectivity|functional connectivity
218389|NCT02034253|structural connectivity|structural connectivity
218390|NCT02034253|schizophrenia|schizophrenia
218391|NCT02034253|psychosis|psychosis
218392|NCT02034227|leukemia|leukemia
218394|NCT02034214|adolescents|adolescents
218395|NCT02034188|multiple sclerosis|multiple sclerosis
218396|NCT02034188|umbilical cord|umbilical cord
218397|NCT02034188|mesenchymal|mesenchymal
218398|NCT02034188|stem cells|stem cells
218399|NCT02034175|apnea|apnea
218400|NCT02034175|hypopnea|hypopnea
218401|NCT02034175|polysomnography|polysomnography
218402|NCT02034175|respiratory|respiratory
218403|NCT02034175|cheyne|cheyne
218404|NCT02034162|Helminth infections|helminth infections
218405|NCT02034162|Helminths|helminths
218406|NCT02034162|Pediatric|pediatric
218407|NCT02034162|Preschool aged|preschool aged
218408|NCT02034162|School aged|school aged
218409|NCT02034162|Mebendazole|mebendazole
218410|NCT02034162|Vermox|vermox
218411|NCT02034162|Placebo|placebo
218412|NCT02034149|chronic kidney disease|chronic kidney disease
218413|NCT02034149|high risk|high risk
218414|NCT02034149|intervention|intervention
218415|NCT02034149|hypertension|hypertension
218416|NCT02034149|hyperglycemia|hyperglycemia
218417|NCT02034149|hyperlipidemia|hyperlipidemia
218418|NCT02034123|First time in humans|first time in humans
218419|NCT02034123|Small cell lung carcinoma|small cell lung carcinoma
218420|NCT02034123|Oncology|oncology
218421|NCT02034123|GSK2879552|gsk2879552
218422|NCT02034123|LSD1 inhibitor|lsd1 inhibitor
218429|NCT02034097|ROS1|ros1
218430|NCT02034097|erlotinib|erlotinib
218431|NCT02034097|EGFR|egfr
218432|NCT02034097|non-small cell lung cancer|non-small cell lung cancer
218433|NCT02034097|foretinib|foretinib
218434|NCT02034084|Transradial approach,|transradial approach,
218435|NCT02034084|Coronary angiography|coronary angiography
218436|NCT02034071|Prader-Willi syndrome|prader-willi syndrome
209243|NCT02075489|EEG|eeg
218437|NCT02034058|Wingspan Stent System|wingspan stent system
218438|NCT02034058|Wingspan Stent|wingspan stent
218439|NCT02034058|Intracranial Stent|intracranial stent
218440|NCT02034058|Ischemic Stroke|ischemic stroke
218441|NCT02034058|Intracranial Atherosclerotic Disease|intracranial atherosclerotic disease
218393|NCT02034214|HIV|hiv
218442|NCT02034058|Intracranial Stenosis|intracranial stenosis
218443|NCT02034032|Osteoarthritis|osteoarthritis
218444|NCT02034032|Knee|knee
218445|NCT02034032|Arthritis|arthritis
218446|NCT02034032|TKA|tka
218447|NCT02034032|Total Knee Arthroplasty|total knee arthroplasty
218448|NCT02034006|pathological myopia|pathological myopia
218449|NCT02034006|choroidal neovascularization|choroidal neovascularization
218450|NCT02034006|ranibizumab|ranibizumab
218451|NCT02034006|mono-bilateral|mono-bilateral
218452|NCT02034006|poor visual acuity|poor visual acuity
401998|NCT01233570|Protopic|protopic
218453|NCT02034006|retinal disease|retinal disease
218454|NCT02034006|eye disease|eye disease
218455|NCT02034006|Angiogenesis Inhibitors|angiogenesis inhibitors
218456|NCT02034006|Angiogenesis Modulating Agents|angiogenesis modulating agents
218457|NCT02033980|narrow band imaging(NBI)|narrow band imaging(nbi)
218458|NCT02033980|NICE classification|nice classification
218459|NCT02033980|colorectal lesions|colorectal lesions
218460|NCT02033980|predicting histology|predicting histology
218461|NCT02033967|liver donor|liver donor
218462|NCT02033967|hepatectomy|hepatectomy
218463|NCT02033967|vasodilator|vasodilator
218464|NCT02033967|central venous pressure|central venous pressure
218465|NCT02033967|stroke volume variation|stroke volume variation
218466|NCT02033954|Embolization|embolization
218467|NCT02033954|Hemorrhage|hemorrhage
218468|NCT02033954|TIPS|tips
218469|NCT02033954|GI Bleeding|gi bleeding
218470|NCT02033954|AV Fistula|av fistula
218471|NCT02033954|AV Malformation|av malformation
218472|NCT02033954|Traumatic Vascular Injury|traumatic vascular injury
218473|NCT02033941|Alzheimer's Disease|alzheimer's disease
218474|NCT02033941|Grapeseed Extract|grapeseed extract
218475|NCT02033941|Clinical Trial|clinical trial
218476|NCT02033941|Meganatural-AZ|meganatural-az
218477|NCT02033941|anti-oligomerization|anti-oligomerization
218478|NCT02033941|Phase 2|phase 2
218479|NCT02033941|Dietary Supplement|dietary supplement
218480|NCT02033941|Nutraceutical|nutraceutical
218481|NCT02033928|Myeloma|myeloma
218482|NCT02033928|MGUS (monoclonal gammopathy of undetermined significance)|mgus (monoclonal gammopathy of undetermined significance)
218483|NCT02033928|amyloidosis|amyloidosis
218484|NCT02033928|stem cell transplant|stem cell transplant
218485|NCT02033915|Suicide risk assessment|suicide risk assessment
218486|NCT02033915|interactive discussion group|interactive discussion group
218487|NCT02033915|suicide attempt|suicide attempt
218488|NCT02033915|self-harm|self-harm
218489|NCT02033915|randomized control study|randomized control study
218490|NCT02033915|identifying high risk group for suicide|identifying high risk group for suicide
218491|NCT02033902|Epilepsy|epilepsy
218492|NCT02033863|Varicocele|varicocele
218493|NCT02033863|Pelvic Congestion Syndrome|pelvic congestion syndrome
218494|NCT02033863|Pelvic Venous Incompetence|pelvic venous incompetence
218495|NCT02033863|Ovarian Varices|ovarian varices
218496|NCT02033850|small vessel disease|small vessel disease
218497|NCT02033850|cognition|cognition
218498|NCT02033850|treatment|treatment
218499|NCT02033850|rehabilitation|rehabilitation
218500|NCT02033850|attention|attention
218501|NCT02033850|fMRI|fmri
218502|NCT02033850|vascular dementia|vascular dementia
218503|NCT02033837|Coronary artery disease|coronary artery disease
218504|NCT02033837|Cardiac CT|cardiac ct
218505|NCT02033837|Appropriate Use Criteria (AUC)|appropriate use criteria (auc)
218506|NCT02033811|mitral regurgitation|mitral regurgitation
218507|NCT02033811|MitraClip system|mitraclip system
218508|NCT02033811|percutaneous mitral valve repair|percutaneous mitral valve repair
218509|NCT02033798|Urodynamics|urodynamics
218510|NCT02033798|Glomerular Filtration Rate|glomerular filtration rate
218511|NCT02033785|Prostatic hyperplasia|prostatic hyperplasia
218512|NCT02033759|Lymphedema|lymphedema
218513|NCT02033733|Post cardiac arrest|post cardiac arrest
218514|NCT02033733|Postcardiac arrest therapeutic hypothermia|postcardiac arrest therapeutic hypothermia
218515|NCT02033733|Therapeutic hypothermia protocol|therapeutic hypothermia protocol
218516|NCT02033733|Neuromuscular blocking agents|neuromuscular blocking agents
218517|NCT02033733|Muscle relaxants|muscle relaxants
218518|NCT02033733|Hypothermia-induced increased muscle tone|hypothermia-induced increased muscle tone
218519|NCT02033733|Microshivering|microshivering
218520|NCT02033720|postcardiac arrest|postcardiac arrest
218521|NCT02033720|post cardiac arrest syndrome|post cardiac arrest syndrome
218522|NCT02033720|post cardiac arrest hypothermia|post cardiac arrest hypothermia
218523|NCT02033720|pulseless electrical activity|pulseless electrical activity
218524|NCT02033720|asystole|asystole
218525|NCT02033720|therapeutic hypothermia|therapeutic hypothermia
218526|NCT02033720|therapeutic hypothermia after cardiac arrest|therapeutic hypothermia after cardiac arrest
218527|NCT02033720|therapeutic hypothermia neurologic outcome|therapeutic hypothermia neurologic outcome
218528|NCT02033707|Hallucinogen|hallucinogen
218529|NCT02033707|Cognitive effects|cognitive effects
218530|NCT02033707|Subjective effects|subjective effects
218531|NCT02033694|Lipid|lipid
218532|NCT02033694|Vulnerable Plaque|vulnerable plaque
218533|NCT02033694|Plaque|plaque
218534|NCT02033694|Cholesterol|cholesterol
218535|NCT02033694|Near Infrared Spectroscopy|near infrared spectroscopy
218536|NCT02033694|NIRS-IVUS|nirs-ivus
218537|NCT02033694|Intravascular Ultrasound|intravascular ultrasound
218538|NCT02033694|Angiography|angiography
218539|NCT02033694|Coronary Imaging|coronary imaging
218540|NCT02033681|epinephrine|epinephrine
218541|NCT02033681|hand|hand
218542|NCT02033681|ischemia|ischemia
218543|NCT02033681|lidocaine|lidocaine
218544|NCT02033681|upper extremity|upper extremity
218545|NCT02033668|bioavailability|bioavailability
218546|NCT02033668|Pharmacokinetics|pharmacokinetics
218547|NCT02033668|intravenous|intravenous
218548|NCT02033668|subcutaneous and intramuscular administration|subcutaneous and intramuscular administration
218549|NCT02033668|amyloid beta|amyloid beta
218550|NCT02033668|monoclonal antibody|monoclonal antibody
218551|NCT02033655|weight loss|weight loss
218552|NCT02033655|older adults|older adults
218553|NCT02033655|obesity|obesity
218554|NCT02033629|Anesthesia|anesthesia
218555|NCT02033629|remifentanil|remifentanil
218556|NCT02033629|propofol|propofol
218557|NCT02033629|target-controlled infusion|target-controlled infusion
218558|NCT02033629|cardiac surgery|cardiac surgery
218559|NCT02033603|Total knee arthroplasty|total knee arthroplasty
218560|NCT02033603|Total knee replacement|total knee replacement
218561|NCT02033603|Femoral Nerve Block|femoral nerve block
218562|NCT02033603|Adductor Canal Block|adductor canal block
218563|NCT02033564|Sore Throat|sore throat
218564|NCT02033564|Intubation|intubation
218565|NCT02033564|Laryngoscopy|laryngoscopy
218566|NCT02033564|Anesthesiology|anesthesiology
218567|NCT02033564|Perioperative|perioperative
218568|NCT02033564|Airway Management|airway management
218569|NCT02033551|Gastric Cancer|gastric cancer
218570|NCT02033551|Lung Cancer|lung cancer
218571|NCT02033551|PARP Inhibitor|parp inhibitor
218572|NCT02033551|Ovarian Cancer|ovarian cancer
218573|NCT02033551|Solid Tumors|solid tumors
218574|NCT02033551|Breast Cancer|breast cancer
218575|NCT02033551|Colon Cancer|colon cancer
218576|NCT02033538|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
218577|NCT02033538|Nab-Paclitaxel|nab-paclitaxel
218578|NCT02033538|Carcinoma of Esophagus|carcinoma of esophagus
218579|NCT02033525|Chronic Meniscal Injury|chronic meniscal injury
218580|NCT02033525|Degenerative meniscus|degenerative meniscus
218581|NCT02033525|Meniscus injury|meniscus injury
218582|NCT02033525|Meniscal injury|meniscal injury
218866|NCT02032056|infant|infant
218583|NCT02033525|Mesenchymal stromal cells|mesenchymal stromal cells
218584|NCT02033525|Mesenchymal stem cells|mesenchymal stem cells
218585|NCT02033525|Advanced Therapy|advanced therapy
218586|NCT02033525|Bone marrow|bone marrow
218587|NCT02033512|Post-menopause|post-menopause
218588|NCT02033512|Hormone Replacement Therapy|hormone replacement therapy
218589|NCT02033512|Nanotechnology|nanotechnology
218590|NCT02033512|Biolipid B2|biolipid b2
218591|NCT02033499|Blood Glucose Self-Monitoring|blood glucose self-monitoring
218592|NCT02033499|Self-Monitoring, Blood Glucose|self-monitoring, blood glucose
218593|NCT02033499|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
218594|NCT02033499|Quality of Life|quality of life
218595|NCT02033486|diffuse optical tomography|diffuse optical tomography
218596|NCT02033486|digital breast tomosynthesis|digital breast tomosynthesis
218597|NCT02033486|breast cancer|breast cancer
218598|NCT02033486|solid benign lesions|solid benign lesions
218599|NCT02033486|cysts|cysts
218600|NCT02033486|malignant lesions|malignant lesions
218601|NCT02033473|Apelin|apelin
218602|NCT02033473|insulin|insulin
218603|NCT02033473|volunteers|volunteers
218604|NCT02033460|Manual therapy|manual therapy
218605|NCT02033460|Exercise|exercise
218606|NCT02033460|Education|education
218607|NCT02033447|Prostate Cancer|prostate cancer
218608|NCT02033434|intranasal|intranasal
218609|NCT02033434|ketamine|ketamine
218610|NCT02033434|analgesia|analgesia
218611|NCT02033434|mountain medicine|mountain medicine
218612|NCT02033434|pre-hospital care|pre-hospital care
218613|NCT02033434|patient transport|patient transport
218614|NCT02033434|pilot study|pilot study
218615|NCT02033434|mountain environment|mountain environment
218616|NCT02033421|Infective endocarditis|infective endocarditis
218617|NCT02033421|Therapeutic drug monitoring|therapeutic drug monitoring
218618|NCT02033408|IBD: Inflammatory Bowel Diseases|ibd: inflammatory bowel diseases
218619|NCT02033408|CD: Crohn's Disease|cd: crohn's disease
218620|NCT02033408|UC: Ulcerative Colitis|uc: ulcerative colitis
218621|NCT02033408|ASC: Acute Severe Colitis|asc: acute severe colitis
218622|NCT02033408|FMT: Fecal Microbiota Transplantation|fmt: fecal microbiota transplantation
218623|NCT02033408|PUCAI: Pediatric Ulcerative Colitis Activity Index|pucai: pediatric ulcerative colitis activity index
218624|NCT02033408|Ciprofloxacin, Doxycycline, Gentamycin, amoxicillin, vancomycin, metronidazole,ciprofloxacin|ciprofloxacin, doxycycline, gentamycin, amoxicillin, vancomycin, metronidazole,ciprofloxacin
218625|NCT02033369|Major depressive disorder|major depressive disorder
218626|NCT02033369|MDD|mdd
218627|NCT02033369|depression|depression
218628|NCT02033369|pramipexole|pramipexole
218629|NCT02033356|adductor canal block|adductor canal block
218630|NCT02033356|volunteers|volunteers
218631|NCT02033356|US-guided peripheral nerve block|us-guided peripheral nerve block
218632|NCT02033356|lower limb|lower limb
218633|NCT02033356|MRI|mri
218634|NCT02033343|Prostate Cancer|prostate cancer
218635|NCT02033343|Real-time tracking|real-time tracking
218636|NCT02033343|Radiotherapy|radiotherapy
218637|NCT02033343|Dynamic Multileaf Collimator|dynamic multileaf collimator
218638|NCT02033330|phenolics|phenolics
218639|NCT02033330|orange peel|orange peel
218640|NCT02033330|bioavailability|bioavailability
218641|NCT02033304|Cesarean section|cesarean section
218643|NCT02033304|Wound hyperalgesia|wound hyperalgesia
218644|NCT02033291|Cerebral Small Vessel Disease|cerebral small vessel disease
218645|NCT02033291|Blood-Brain Barrier permeability|blood-brain barrier permeability
218646|NCT02033291|Dynamic contrast enhanced Magnetic Resonance Imaging|dynamic contrast enhanced magnetic resonance imaging
218647|NCT02033291|Pharmacokinetic modeling|pharmacokinetic modeling
218648|NCT02033291|Reproducibility|reproducibility
218649|NCT02033265|Ultrasound-guided Axillary Brachial Plexus Block|ultrasound-guided axillary brachial plexus block
218650|NCT02033265|Obesity|obesity
218651|NCT02033265|Performance time|performance time
218652|NCT02033265|Failure rate|failure rate
218653|NCT02033265|Acute complications|acute complications
218654|NCT02033226|Periodontitis|periodontitis
218655|NCT02033226|Periodontal Regeneration|periodontal regeneration
218656|NCT02033226|Amniotic membrane|amniotic membrane
218657|NCT02033226|Guided tissue regeneration|guided tissue regeneration
218658|NCT02033226|Anti-inflammatory|anti-inflammatory
218659|NCT02033226|Periodontal Therapy.|periodontal therapy.
218660|NCT02033213|intraoperative|intraoperative
218661|NCT02033213|fluid management|fluid management
218662|NCT02033213|esophageal carcinoma|esophageal carcinoma
218663|NCT02033213|surgery|surgery
218664|NCT02033213|gas exchange|gas exchange
218665|NCT02033213|tissue perfusion|tissue perfusion
218666|NCT02033200|vision|vision
218667|NCT02033200|Stendra|stendra
218668|NCT02033200|avanafil|avanafil
218669|NCT02033200|PDE5 inhibitor|pde5 inhibitor
218670|NCT02033200|visual acuity|visual acuity
218671|NCT02033200|intraocular pressure|intraocular pressure
218672|NCT02033200|pupillometry|pupillometry
218673|NCT02033200|color vision discrimination|color vision discrimination
218674|NCT02033200|healthy males|healthy males
218675|NCT02033174|alcohol, inflammation, oxidation.|alcohol, inflammation, oxidation.
218676|NCT02033161|Functional gastrointestinal disorders|functional gastrointestinal disorders
218677|NCT02033161|FGID|fgid
218678|NCT02033161|Recurrent abdominal pain|recurrent abdominal pain
218679|NCT02033161|Abdominal pain|abdominal pain
218680|NCT02033161|pain-related functional gastrointestinal disorders|pain-related functional gastrointestinal disorders
218681|NCT02033135|Atherosclerosis|atherosclerosis
218682|NCT02033135|Intermittent claudication|intermittent claudication
218683|NCT02033135|Angioplasty|angioplasty
218684|NCT02033122|exercise, bronchial hyperresponsiveness, inflammation|exercise, bronchial hyperresponsiveness, inflammation
218685|NCT02033096|stannsoporfin|stannsoporfin
218686|NCT02033096|hyperbilirubinemia|hyperbilirubinemia
218687|NCT02033096|heme oxygenase|heme oxygenase
218689|NCT02033083|cervical dilation|cervical dilation
218691|NCT02033057|Muscular electrostimulation, mechanically ventilated, critically ill patients, muscular weakness.|muscular electrostimulation, mechanically ventilated, critically ill patients, muscular weakness.
218692|NCT02033044|borderline personality disorder|borderline personality disorder
218693|NCT02033044|cognitive rehabilitation|cognitive rehabilitation
218694|NCT02033044|psychoeducation|psychoeducation
218695|NCT02033044|psychosocial functioning|psychosocial functioning
218696|NCT02033031|branch retinal vein occlusion|branch retinal vein occlusion
218697|NCT02033031|central retinal thickness|central retinal thickness
218698|NCT02033031|visual acuity|visual acuity
218699|NCT02033031|central reintal sensitivity|central reintal sensitivity
218700|NCT02033018|Aflibercept|aflibercept
218701|NCT02033018|Myopia|myopia
218702|NCT02033018|Complications|complications
218703|NCT02033018|Neovascularization|neovascularization
218704|NCT02033018|OCT|oct
218705|NCT02033005|Body Composition|body composition
218706|NCT02033005|Adipose Tissue|adipose tissue
218707|NCT02033005|Intrahepatocellular Lipid|intrahepatocellular lipid
218708|NCT02033005|Infant|infant
218709|NCT02033005|Magnetic Resonance Imaging|magnetic resonance imaging
218710|NCT02033005|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
218711|NCT02032966|outcomes|outcomes
218712|NCT02032966|surgical|surgical
218713|NCT02032966|non-surgical|non-surgical
218714|NCT02032966|ankle|ankle
218715|NCT02032966|malleolus|malleolus
218716|NCT02032966|fracture|fracture
218717|NCT02032966|tibia|tibia
218718|NCT02032966|fibula|fibula
218719|NCT02032966|bimalleolar|bimalleolar
218720|NCT02032966|trimalleolar|trimalleolar
218721|NCT02032953|colorectal cancer|colorectal cancer
218722|NCT02032953|protein recovery|protein recovery
218723|NCT02032953|perioperative nutrition|perioperative nutrition
218724|NCT02032953|hyperinsulinemia|hyperinsulinemia
218725|NCT02032953|normoglycemia|normoglycemia
218726|NCT02032953|hyperinsulinemic-normoglycemic clamp|hyperinsulinemic-normoglycemic clamp
218727|NCT02032953|anabolism|anabolism
218728|NCT02032940|MRI, Angiography, Pulse Sequence|mri, angiography, pulse sequence
218729|NCT02032927|osteoarthritis|osteoarthritis
218730|NCT02032927|pain|pain
218731|NCT02032927|opioids|opioids
218732|NCT02032914|pyogenic liver abscess|pyogenic liver abscess
218733|NCT02032914|colon cancer|colon cancer
218734|NCT02032862|menopause, hot flushes, hot flashes, salvia, sage, sweating|menopause, hot flushes, hot flashes, salvia, sage, sweating
682983|NCT00901394|folate|folate
218735|NCT02032849|ventilator associated pneumonia|ventilator associated pneumonia
218736|NCT02032849|subglottic secretion drainage|subglottic secretion drainage
218737|NCT02032849|manual air-impingement operation|manual air-impingement operation
218738|NCT02032849|prolonged intubation|prolonged intubation
218739|NCT02032823|Breast Cancer|breast cancer
218740|NCT02032823|Adjuvant|adjuvant
218741|NCT02032823|Olaparib|olaparib
218742|NCT02032823|BRCA 1/2|brca 1/2
218743|NCT02032823|HER2|her2
218744|NCT02032810|Stage III Melanoma|stage iii melanoma
218745|NCT02032810|Stage IV Melanoma|stage iv melanoma
218746|NCT02032810|HDAC Inhibitor|hdac inhibitor
218747|NCT02032758|Occupational; Cramp(s)|occupational; cramp(s)
218748|NCT02032719|Hypertension, Systolic, Uncontrolled|hypertension, systolic, uncontrolled
218749|NCT02032706|obstructive sleep apnea|obstructive sleep apnea
218750|NCT02032706|position therapy|position therapy
218751|NCT02032706|snoring|snoring
218752|NCT02032706|positional|positional
218753|NCT02032693|Everycell|everycell
218754|NCT02032693|DNA damage|dna damage
218755|NCT02032693|DNA inflammation|dna inflammation
218756|NCT02032693|DNA stress|dna stress
218757|NCT02032667|physical activity|physical activity
218758|NCT02032667|exergames|exergames
218759|NCT02032654|antibiotics|antibiotics
218760|NCT02032654|flucloxacillin|flucloxacillin
218761|NCT02032654|therapy duration|therapy duration
218762|NCT02032654|cellulitis|cellulitis
218763|NCT02032654|erysipelas|erysipelas
218764|NCT02032654|skin infections|skin infections
218765|NCT02032654|hospital|hospital
218766|NCT02032641|Non-ablative laser|non-ablative laser
218767|NCT02032641|Scar revision|scar revision
218768|NCT02032641|direct brow lift|direct brow lift
218769|NCT02032628|epigenetics|epigenetics
218770|NCT02032628|cancer|cancer
218771|NCT02032628|exercise|exercise
218772|NCT02032628|intensity|intensity
218773|NCT02032628|duration|duration
218774|NCT02032615|anemia|anemia
218775|NCT02032602|Myofascial Pain Syndromes|myofascial pain syndromes
218776|NCT02032602|Trigger Point|trigger point
218777|NCT02032602|Shoulder Pain|shoulder pain
218778|NCT02032602|Aged|aged
218779|NCT02032576|major depressive episode, electroconvulsive therapy|major depressive episode, electroconvulsive therapy
218780|NCT02032563|neoadjuvant therapy|neoadjuvant therapy
218781|NCT02032550|Localized prostate cancer|localized prostate cancer
218782|NCT02032550|Patient preference|patient preference
218783|NCT02032550|Treatment choice|treatment choice
218784|NCT02032550|Decision making|decision making
218785|NCT02032550|Patient centered outcomes|patient centered outcomes
218786|NCT02032537|callmax cream|callmax cream
218787|NCT02032537|uremic pruritus|uremic pruritus
218788|NCT02032498|sentinel lymph nodes|sentinel lymph nodes
218789|NCT02032498|radiocolloids|radiocolloids
218790|NCT02032498|Indocyanine Green|indocyanine green
218791|NCT02032498|complementarity|complementarity
218792|NCT02032498|axillary lymph node dissection|axillary lymph node dissection
218793|NCT02032485|colorectal cancer|colorectal cancer
218794|NCT02032485|Indocyanine Green|indocyanine green
218795|NCT02032485|visualization of peritoneal metastases|visualization of peritoneal metastases
218796|NCT02032472|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
218797|NCT02032472|Arterial Pressure|arterial pressure
218798|NCT02032472|Hypertension Controlled|hypertension controlled
218799|NCT02032472|Pharmacies|pharmacies
218800|NCT02032459|Pregnancy|pregnancy
218801|NCT02032459|Minority Women|minority women
218802|NCT02032459|Preterm delivery|preterm delivery
218803|NCT02032459|Fetal growth restriction|fetal growth restriction
218804|NCT02032459|Preeclampsia|preeclampsia
218805|NCT02032459|Gestational Diabetes|gestational diabetes
218806|NCT02032459|Vitamin D|vitamin d
218807|NCT02032433|extended-release naltrexone (Vivitrol)|extended-release naltrexone (vivitrol)
218808|NCT02032433|buprenorphine-naloxone (Suboxone)|buprenorphine-naloxone (suboxone)
218809|NCT02032433|comparative effective|comparative effective
218810|NCT02032433|relapse prevention|relapse prevention
218811|NCT02032394|Chlorhexidine|chlorhexidine
218812|NCT02032394|Povidone-iodine|povidone-iodine
218813|NCT02032394|bacteriuria|bacteriuria
218814|NCT02032394|Urinary Catheterization|urinary catheterization
218815|NCT02032394|Urinary tract infection|urinary tract infection
218816|NCT02032381|non infectious pulmonary complications after hematopoietic cell transplant|non infectious pulmonary complications after hematopoietic cell transplant
218817|NCT02032381|functional respiratory test and exercise test|functional respiratory test and exercise test
218818|NCT02032381|thoracic tomodensitometry|thoracic tomodensitometry
218819|NCT02032368|circulating tumour cell;|circulating tumour cell;
218820|NCT02032368|transarterial chemoembolization;|transarterial chemoembolization;
218821|NCT02032368|hepatocellular carcinoma;|hepatocellular carcinoma;
218822|NCT02032368|recurrence|recurrence
218823|NCT02032329|Functional Electrical Stimulation (FES)|functional electrical stimulation (fes)
218825|NCT02032316|Ureteroscopy|ureteroscopy
218826|NCT02032316|Ureteral Stent|ureteral stent
218827|NCT02032316|post-uncomplicated ureteroscopy|post-uncomplicated ureteroscopy
218829|NCT02032277|Oncology|oncology
218830|NCT02032277|United States Oncology - 12152|united states oncology - 12152
218831|NCT02032277|Alliance - AFT-04|alliance - aft-04
218832|NCT02032277|Triple negative breast cancer|triple negative breast cancer
218833|NCT02032277|National Surgical Adjuvant Breast and Bowel Project - B-56-I|national surgical adjuvant breast and bowel project - b-56-i
218834|NCT02032277|Grupo Español de Investigación en Cáncer de Mama - GEICAM/2014-02|grupo español de investigación en cáncer de mama - geicam/2014-02
218835|NCT02032277|German Breast Group - GBG 81|german breast group - gbg 81
218836|NCT02032264|Next generation sequencing|next generation sequencing
218837|NCT02032264|Embryonic aneuploidy|embryonic aneuploidy
218838|NCT02032251|Sperm DNA damage ejaculated spermatozoa Ginger Herbal Drug Herbal medicine|sperm dna damage ejaculated spermatozoa ginger herbal drug herbal medicine
218839|NCT02032199|Gastric bypass|gastric bypass
218840|NCT02032199|Health-related quality of life|health-related quality of life
218842|NCT02032199|Questionnaire|questionnaire
218843|NCT02032199|Treatment guidelines|treatment guidelines
218844|NCT02032186|magnesium|magnesium
218845|NCT02032186|prematurity|prematurity
218846|NCT02032173|Ranibizumab|ranibizumab
218847|NCT02032173|Diabetic Macular Edema|diabetic macular edema
218848|NCT02032160|ADITEC|aditec
218849|NCT02032160|Immunology|immunology
218850|NCT02032160|Vaccines|vaccines
218851|NCT02032160|Hepatitis B|hepatitis b
218852|NCT02032160|Investigational study|investigational study
218853|NCT02032160|innate and adaptive immune responses|innate and adaptive immune responses
218854|NCT02032160|Hepatitis B vaccinations|hepatitis b vaccinations
218855|NCT02032134|Cryopreserved platelets, thrombocytopenia, DMSO|cryopreserved platelets, thrombocytopenia, dmso
218856|NCT02032121|Cancer survivors|cancer survivors
218857|NCT02032121|Long-term cancer survivor|long-term cancer survivor
218858|NCT02032108|Diabetes lifestyle intervention Rwanda|diabetes lifestyle intervention rwanda
218859|NCT02032095|IVIG|ivig
218860|NCT02032095|Renal transplantation|renal transplantation
218861|NCT02032095|desensitization|desensitization
218862|NCT02032056|Infections|infections
218863|NCT02032056|Allergy|allergy
218864|NCT02032056|Immune function|immune function
218865|NCT02032056|Microbiota|microbiota
218867|NCT02032043|Filariasis|filariasis
218868|NCT02032043|Onchocerciasis|onchocerciasis
218869|NCT02032043|Albendazole|albendazole
218870|NCT02032043|Ivermectin|ivermectin
218871|NCT02032043|STH Soil Transmitted Helminth infections|sth soil transmitted helminth infections
218872|NCT02032043|MDA Mass Drug Administration|mda mass drug administration
218873|NCT02032030|quality of Life|quality of life
218874|NCT02032030|pain|pain
218875|NCT02032030|nausea|nausea
218876|NCT02032030|falls|falls
218877|NCT02032030|intraoperative awareness|intraoperative awareness
218878|NCT02032030|anesthesia awareness|anesthesia awareness
218879|NCT02032030|cognition|cognition
218880|NCT02032030|activities of daily living|activities of daily living
218881|NCT02032030|major morbidity|major morbidity
218882|NCT02032030|all-cause mortality|all-cause mortality
218883|NCT02032017|Total Hip Arthroplasty|total hip arthroplasty
218884|NCT02032017|Gluteus medius|gluteus medius
218885|NCT02032017|Approach|approach
218886|NCT02032017|Rehabilitation|rehabilitation
218887|NCT02032017|Functional outcome|functional outcome
218888|NCT02032004|Chronic Heart Failure|chronic heart failure
218889|NCT02032004|CHF|chf
218890|NCT02032004|Left Ventricular Systolic Dysfunction|left ventricular systolic dysfunction
218891|NCT02032004|Ischemic Heart Failure|ischemic heart failure
218892|NCT02032004|Nonischemic Heart Failure|nonischemic heart failure
218893|NCT02032004|Stem Cells|stem cells
218894|NCT02032004|Allogeneic Mesenchymal Precursor Cells|allogeneic mesenchymal precursor cells
218895|NCT02031991|Bioequivalence|bioequivalence
218896|NCT02031991|Biosimilarity|biosimilarity
218897|NCT02031991|Similarity|similarity
218898|NCT02031991|PK|pk
218899|NCT02031991|Phase 1|phase 1
218900|NCT02031991|Bevacizumab|bevacizumab
218901|NCT02031991|Healthy Volunteers|healthy volunteers
218902|NCT02031991|Single-Dose|single-dose
218903|NCT02031991|Oncology|oncology
218904|NCT02031978|Breast Feeding|breast feeding
218905|NCT02031978|Infant Nutrition|infant nutrition
218906|NCT02031978|Childhood Obesity|childhood obesity
218907|NCT02031978|Infant feeding patterns|infant feeding patterns
218908|NCT02031978|WIC|wic
218909|NCT02031952|hepatocellular carcinoma|hepatocellular carcinoma
218910|NCT02031952|hepatectomy|hepatectomy
218911|NCT02031952|lymphadenectomy|lymphadenectomy
218912|NCT02031952|complication|complication
218913|NCT02031952|prognosis|prognosis
218914|NCT02031939|Rectal cancer|rectal cancer
218915|NCT02031939|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
218916|NCT02031939|optimization|optimization
218917|NCT02031913|Chronic hepatitis B|chronic hepatitis b
218918|NCT02031913|Hepatic fibrosis|hepatic fibrosis
218919|NCT02031913|Steatosis|steatosis
218920|NCT02031887|starter formula|starter formula
218921|NCT02031887|stool microbiota|stool microbiota
218922|NCT02031887|infants|infants
218923|NCT02031887|caesarean section delivery|caesarean section delivery
218924|NCT02031874|H1N1|h1n1
218926|NCT02031874|Immunogenecity|immunogenecity
218927|NCT02031848|weight loss|weight loss
218928|NCT02031848|diet|diet
218929|NCT02031822|Primary Headache|primary headache
218930|NCT02031822|Greater Occipital Nerve|greater occipital nerve
218931|NCT02031822|Ultrasound|ultrasound
218932|NCT02031822|Chronic Pain|chronic pain
218933|NCT02031822|Cervicogenic|cervicogenic
218934|NCT02031822|Occipital Neuralgia|occipital neuralgia
218935|NCT02031822|Migraine|migraine
218936|NCT02031822|Tension type headache|tension type headache
218937|NCT02031822|Cluster headache|cluster headache
218938|NCT02031809|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
218939|NCT02031770|vascular endothelial cells|vascular endothelial cells
218940|NCT02031757|Balance control|balance control
218941|NCT02031757|Aging|aging
218942|NCT02031757|Balance reactions|balance reactions
218943|NCT02031757|Perturbation|perturbation
218944|NCT02031705|Fibrillation|fibrillation
218945|NCT02031705|Catheter ablation|catheter ablation
218946|NCT02031692|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
218947|NCT02031692|Vitamin D|vitamin d
218948|NCT02031692|Calcium|calcium
218949|NCT02031692|Prevention|prevention
218950|NCT02031679|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
218951|NCT02031666|Healthy|healthy
218952|NCT02031666|JNJ-56021927|jnj-56021927
218953|NCT02031666|ARN-509|arn-509
218954|NCT02031666|Bioavailability|bioavailability
218955|NCT02031653|Penile Cuff Test|penile cuff test
218956|NCT02031640|asthma|asthma
218957|NCT02031640|breath-actuated inhaler|breath-actuated inhaler
218958|NCT02031640|metered-dose inhaler|metered-dose inhaler
218959|NCT02031627|lymphedema|lymphedema
218960|NCT02031627|lymphoedema|lymphoedema
218961|NCT02031627|leg lymphoedema|leg lymphoedema
218962|NCT02031627|lower extremity lymphoedema|lower extremity lymphoedema
218963|NCT02031627|pneumatic compression device|pneumatic compression device
218964|NCT02031614|anemia|anemia
218965|NCT02031614|blood withdrawal|blood withdrawal
218966|NCT02031614|phlebotomy|phlebotomy
218967|NCT02031614|innate immunity|innate immunity
218968|NCT02031614|Immune reponse|immune reponse
218969|NCT02031588|Study of commensal flora|study of commensal flora
218970|NCT02031588|Fluoroquinolones|fluoroquinolones
218971|NCT02031575|Reproductive Health|reproductive health
218972|NCT02031575|Contraception|contraception
218973|NCT02031575|Public Health|public health
218974|NCT02031575|Sexual Health|sexual health
218975|NCT02031575|Adolescents|adolescents
218976|NCT02031575|Mobile Health|mobile health
218977|NCT02031562|Balance|balance
218978|NCT02031562|Falls|falls
218979|NCT02031562|Low back pain|low back pain
218980|NCT02031562|Geriatric|geriatric
218981|NCT02031523|endometriosis|endometriosis
218982|NCT02031523|dysmenorrhea|dysmenorrhea
218983|NCT02031523|Sanjie analgesic capsule|sanjie analgesic capsule
218984|NCT02031523|effect/safety|effect/safety
218985|NCT02031497|Sweetener, insulin, body mass index, physical activity|sweetener, insulin, body mass index, physical activity
218986|NCT02031432|cancer-related pain|cancer-related pain
218987|NCT02031432|cebranopadol|cebranopadol
218988|NCT02031419|CC-122|cc-122
218989|NCT02031419|CC-223|cc-223
218990|NCT02031419|CC-292|cc-292
218991|NCT02031419|Rituximab|rituximab
218992|NCT02031419|Lymphoma|lymphoma
218993|NCT02031419|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
218994|NCT02031380|Glaucoma|glaucoma
218995|NCT02031380|Open angle glaucoma|open angle glaucoma
218996|NCT02031380|ocular hypertension|ocular hypertension
218997|NCT02031380|compliance|compliance
218998|NCT02031354|Lysine Chloride|lysine chloride
218999|NCT02031328|prostate|prostate
219000|NCT02031328|radiation|radiation
219001|NCT02031328|stereotactic body radiation|stereotactic body radiation
219002|NCT02031315|sudden death|sudden death
219003|NCT02031315|sudden cardiac arrest|sudden cardiac arrest
219004|NCT02031302|Lotus|lotus
219005|NCT02031302|Valve|valve
219006|NCT02031302|Real world|real world
219007|NCT02031302|Aortic stenosis|aortic stenosis
219008|NCT02031302|High risk|high risk
219009|NCT02031289|Anemia|anemia
219010|NCT02031289|Iron deficiency|iron deficiency
219011|NCT02031289|Cardiac surgery|cardiac surgery
219012|NCT02031289|Perioperative Care|perioperative care
219013|NCT02031276|ABBV-066|abbv-066
219014|NCT02031276|BI 655066|bi 655066
219015|NCT02031276|risankizumab|risankizumab
219016|NCT02031224|Chronic Kidney Disease|chronic kidney disease
219017|NCT02031224|Restricted protein diets|restricted protein diets
219018|NCT02031224|Nutritional status|nutritional status
219019|NCT02031198|Alzheimer's disease|alzheimer's disease
219020|NCT02031198|tau|tau
219021|NCT02031198|dementia|dementia
219022|NCT02031198|elderly|elderly
219023|NCT02031198|cognitive|cognitive
219024|NCT02031198|disease modifying|disease modifying
219025|NCT02031198|treatment|treatment
219026|NCT02031198|immunization|immunization
219028|NCT02031172|Dry Eye Disease|dry eye disease
219029|NCT02031172|Sjogren's Syndrome|sjogren's syndrome
219030|NCT02031172|Tear Film|tear film
219031|NCT02031172|Ocular Surface|ocular surface
219032|NCT02031172|Aqueous Tear Deficiency|aqueous tear deficiency
219033|NCT02031159|perioperative hypothermia|perioperative hypothermia
219034|NCT02031159|zero heat flux|zero heat flux
219035|NCT02031159|non-invasive measurement of body core temperature|non-invasive measurement of body core temperature
219036|NCT02031133|Antisense|antisense
219037|NCT02031133|miR-122 antagonist|mir-122 antagonist
219038|NCT02031133|host factor|host factor
219039|NCT02031133|Chronic hepatitis C|chronic hepatitis c
219040|NCT02031133|Hepatitis C|hepatitis c
219041|NCT02031107|stroke|stroke
219042|NCT02031107|brain stimulation|brain stimulation
219043|NCT02031107|electroencephalography|electroencephalography
219044|NCT02031107|functional magnetic resonance imaging|functional magnetic resonance imaging
219045|NCT02031107|functional connectivity|functional connectivity
219046|NCT02031068|active rehabilitation|active rehabilitation
219047|NCT02031068|exercise|exercise
219048|NCT02031068|concussion|concussion
219049|NCT02031055|Advanced solid tumors|advanced solid tumors
219050|NCT02031042|neoadjuvant chemotherapy|neoadjuvant chemotherapy
219051|NCT02031042|breast cancer|breast cancer
219052|NCT02031042|sentinel lymph node biopsy|sentinel lymph node biopsy
219053|NCT02031042|false negative rate|false negative rate
219054|NCT02031042|identification rate|identification rate
219055|NCT02031029|personality scores|personality scores
219056|NCT02031016|Chronic thoracic pain|chronic thoracic pain
219057|NCT02031016|Remifentanil|remifentanil
219058|NCT02031016|Fentanyl|fentanyl
219059|NCT02031016|sternotomy|sternotomy
219060|NCT02030990|photorefractive keratectomy|photorefractive keratectomy
219061|NCT02030990|corneal haze|corneal haze
219062|NCT02030990|mitomycin-C|mitomycin-c
219063|NCT02030990|postoperative steroids|postoperative steroids
219064|NCT02030951|preterm infant behavior|preterm infant behavior
219065|NCT02030951|tube feeding|tube feeding
219066|NCT02030951|feeding efficiency|feeding efficiency
219067|NCT02030938|breast implant|breast implant
219068|NCT02030938|revision augmentation|revision augmentation
219069|NCT02030938|stretch deformity|stretch deformity
219070|NCT02030938|fold malposition|fold malposition
219071|NCT02030938|bottoming out|bottoming out
219170|NCT02030496|Unstable fracture|unstable fracture
219072|NCT02030912|The impact of a number of different types of antibiotics|the impact of a number of different types of antibiotics
219073|NCT02030912|The emergence and persistence of antibiotic resistance|the emergence and persistence of antibiotic resistance
219074|NCT02030899|Cervical vertebrae|cervical vertebrae
219075|NCT02030899|single|single
219076|NCT02030899|degenerative disease|degenerative disease
219077|NCT02030899|Fusion|fusion
219078|NCT02030899|Sagittal angle|sagittal angle
219079|NCT02030873|virtual simulation|virtual simulation
219080|NCT02030873|temporal bone|temporal bone
219081|NCT02030873|surgical training|surgical training
219082|NCT02030873|medical education|medical education
219083|NCT02030873|self-directed learning|self-directed learning
219084|NCT02030873|final product assessment|final product assessment
219085|NCT02030873|cognitive load|cognitive load
219086|NCT02030873|reaction time|reaction time
219087|NCT02030873|skills training|skills training
219088|NCT02030873|simulator metrics|simulator metrics
219089|NCT02030808|Thoracic surgery|thoracic surgery
219090|NCT02030808|non-muscle relaxant|non-muscle relaxant
219091|NCT02030808|target-controlled infusion|target-controlled infusion
219092|NCT02030808|remifentanil|remifentanil
219093|NCT02030808|surgical conditions|surgical conditions
219094|NCT02030795|Thoracic surgery|thoracic surgery
219095|NCT02030795|Arndt® blocker|arndt® blocker
219096|NCT02030795|lung deflation|lung deflation
219097|NCT02030795|Disconnection technique|disconnection technique
219098|NCT02030795|Continuous suction|continuous suction
219099|NCT02030795|Elective video-assisted thoracoscopic|elective video-assisted thoracoscopic
219100|NCT02030782|depression|depression
219101|NCT02030782|quality improvement|quality improvement
219102|NCT02030782|treatment|treatment
219103|NCT02030782|adolescents|adolescents
219104|NCT02030769|Esophageal Neoplasms|esophageal neoplasms
219105|NCT02030769|Lugol's solution|lugol's solution
219106|NCT02030769|Pronase|pronase
219107|NCT02030769|Endoscopy, Digestive System|endoscopy, digestive system
219108|NCT02030769|Pretreatment method|pretreatment method
219109|NCT02030756|constipation|constipation
219110|NCT02030743|Falls|falls
219111|NCT02030743|Older adults|older adults
219112|NCT02030743|Balance|balance
219113|NCT02030743|Mobility|mobility
219114|NCT02030743|Visual attention|visual attention
219115|NCT02030730|Brief Parenting Training|brief parenting training
219116|NCT02030730|Early Intervention|early intervention
219117|NCT02030730|Child Behavior|child behavior
219118|NCT02030730|Greece|greece
219119|NCT02030717|Spinal anesthesia|spinal anesthesia
219120|NCT02030717|Epidural anesthesia|epidural anesthesia
219122|NCT02030717|renal cell carcinoma|renal cell carcinoma
219123|NCT02030691|Neonatal respiratory distress|neonatal respiratory distress
219124|NCT02030691|nHFPV|nhfpv
219125|NCT02030691|nCPAP|ncpap
219126|NCT02030691|cerebral tissue oxygenation|cerebral tissue oxygenation
219127|NCT02030691|NIRS|nirs
219128|NCT02030665|Marijuana Dependence|marijuana dependence
219129|NCT02030665|Individualized treatment|individualized treatment
219130|NCT02030665|Motivational Enhancement Treatment|motivational enhancement treatment
219131|NCT02030665|Cognitive-Behavioral Treatment|cognitive-behavioral treatment
219132|NCT02030665|Contingency Management|contingency management
219133|NCT02030652|premature newborn|premature newborn
219134|NCT02030652|nasal ventilation|nasal ventilation
219135|NCT02030652|noninvasive ventilation|noninvasive ventilation
219136|NCT02030652|continuous positive airway pressure|continuous positive airway pressure
219137|NCT02030626|Neuropathic pain|neuropathic pain
219138|NCT02030626|lumbar radiculopathy|lumbar radiculopathy
219139|NCT02030626|rTMS|rtms
219140|NCT02030626|tDCS|tdcs
219141|NCT02030626|placebo controlled study|placebo controlled study
219142|NCT02030613|juvenile idiopathic arthritis|juvenile idiopathic arthritis
219143|NCT02030613|etanercept|etanercept
219144|NCT02030587|Hyperaldosteronism|hyperaldosteronism
219145|NCT02030587|Adrenocortical adenoma|adrenocortical adenoma
219146|NCT02030587|Adrenalectomy|adrenalectomy
219147|NCT02030587|Catheter ablation|catheter ablation
219148|NCT02030561|NK cells|nk cells
219149|NCT02030561|trastuzumab|trastuzumab
219150|NCT02030561|immunotherapy|immunotherapy
219151|NCT02030548|CABG|cabg
219152|NCT02030548|dual antiplatelet therapy|dual antiplatelet therapy
219153|NCT02030548|aspirin|aspirin
219154|NCT02030548|clopidogrel|clopidogrel
219155|NCT02030548|prasugrel|prasugrel
219156|NCT02030548|ticagrelor|ticagrelor
219157|NCT02030522|Post-traumatic stress disorder|post-traumatic stress disorder
219158|NCT02030522|PTSD|ptsd
219159|NCT02030522|Accelerated Resolution Therapy|accelerated resolution therapy
219160|NCT02030522|Military|military
219161|NCT02030522|Veterans|veterans
219162|NCT02030522|Exposure therapy|exposure therapy
219163|NCT02030522|Eye movements|eye movements
219164|NCT02030509|cancer diagnosis|cancer diagnosis
219165|NCT02030496|distal radius fractures|distal radius fractures
219166|NCT02030496|Closed reduction|closed reduction
219167|NCT02030496|Open reduction internal fixation|open reduction internal fixation
219168|NCT02030496|Volar plate|volar plate
219169|NCT02030496|Redislocation|redislocation
219171|NCT02030496|Extra-articular fracture|extra-articular fracture
219172|NCT02030496|Colles fracture|colles fracture
219173|NCT02030496|Barton fracture|barton fracture
219174|NCT02030470|Periodontitis, treatment, photodynamic, mid-term, bacteria|periodontitis, treatment, photodynamic, mid-term, bacteria
219175|NCT02030444|Neoplasms Staging|neoplasms staging
219176|NCT02030444|Bronchoscopy|bronchoscopy
219177|NCT02030444|Nuclear Medicine|nuclear medicine
219178|NCT02030444|Radiology|radiology
219179|NCT02030392|Functional abdominal pain|functional abdominal pain
219180|NCT02030392|psychological intervention|psychological intervention
219181|NCT02030392|quality of life|quality of life
219182|NCT02030392|Randomized controlled trial|randomized controlled trial
219183|NCT02030392|children|children
219184|NCT02030379|Cancer|cancer
219185|NCT02030353|Lifestyle intervention|lifestyle intervention
219186|NCT02030353|Internet intervention|internet intervention
219187|NCT02030353|Breast neoplasms|breast neoplasms
219188|NCT02030353|Body weight|body weight
219189|NCT02030353|Body weight changes|body weight changes
219190|NCT02030340|urodynamic investigation|urodynamic investigation
219191|NCT02030340|lower urinary tract dysfunction|lower urinary tract dysfunction
219192|NCT02030340|catheter|catheter
219193|NCT02030340|air-charged|air-charged
219194|NCT02030340|water filled|water filled
219195|NCT02030327|proteomics|proteomics
219196|NCT02030327|multiple trauma|multiple trauma
219197|NCT02030327|organ dysfunction|organ dysfunction
219198|NCT02030314|Chlorthalidone|chlorthalidone
219199|NCT02030314|Resistant Hypertension|resistant hypertension
219200|NCT02030314|Kidney Transplant Patients|kidney transplant patients
219201|NCT02030301|Herpes Simplex Virus, Type 2|herpes simplex virus, type 2
219202|NCT02030301|Herpes|herpes
219203|NCT02030301|HSV-2|hsv-2
219204|NCT02030288|alcohol|alcohol
219205|NCT02030288|substance use|substance use
219206|NCT02030288|eHealth|ehealth
219207|NCT02030275|Hypertrophic scar|hypertrophic scar
219208|NCT02030275|Cicatrix|cicatrix
219209|NCT02030275|Scar prevention|scar prevention
219210|NCT02030275|Scar revision|scar revision
219211|NCT02030249|Pre-diabetes|pre-diabetes
219212|NCT02030249|Obesity|obesity
219213|NCT02030249|Low calorie diet|low calorie diet
219214|NCT02030249|Diet - reducing|diet - reducing
219215|NCT02030249|Appetite|appetite
219216|NCT02030249|Visual analogue scale|visual analogue scale
219217|NCT02030249|Ghrelin|ghrelin
219218|NCT02030249|Peptide YY|peptide yy
219219|NCT02030249|Bone mass|bone mass
219220|NCT02030249|Bone turnover|bone turnover
219221|NCT02030249|Muscle strength|muscle strength
219222|NCT02030236|hypothermia, induced|hypothermia, induced
219223|NCT02030236|rewarming|rewarming
219224|NCT02030236|therapeutic|therapeutic
219225|NCT02030236|heart arrest|heart arrest
219226|NCT02030236|asystole|asystole
219227|NCT02030236|frostbite|frostbite
219228|NCT02030223|transversus abdominis plane block|transversus abdominis plane block
219229|NCT02030223|inguinal hernia repair|inguinal hernia repair
219230|NCT02030223|acute postoperative pain|acute postoperative pain
219231|NCT02030223|neuropathic pain|neuropathic pain
219232|NCT02030210|Quality improvement|quality improvement
219233|NCT02030210|STEMI|stemi
219234|NCT02030210|Belgium|belgium
219235|NCT02030184|Lung cancer|lung cancer
219236|NCT02030184|Small cell lung cancer|small cell lung cancer
219237|NCT02030184|Neuroendocrine tumor|neuroendocrine tumor
219238|NCT02030184|Rhenium|rhenium
219239|NCT02030184|Re 188-P2045|re 188-p2045
219240|NCT02030171|Chronic low back pain|chronic low back pain
219241|NCT02030158|Severe sepsis|severe sepsis
219242|NCT02030158|Septic shock|septic shock
219243|NCT02030158|Early goal directed therapy|early goal directed therapy
219244|NCT02030158|Individual patient data meta-analysis|individual patient data meta-analysis
219245|NCT02030145|COPD|copd
219246|NCT02030145|Pulmonary|pulmonary
219247|NCT02030132|Physical activity|physical activity
219248|NCT02030132|Sedentary lifestyle|sedentary lifestyle
219249|NCT02030132|Pedometers|pedometers
219250|NCT02030132|Walking|walking
219251|NCT02030132|Financial Incentives|financial incentives
219252|NCT02030132|Behavioral Economics|behavioral economics
219253|NCT02030119|Sedentary lifestyle|sedentary lifestyle
219254|NCT02030119|Pedometers|pedometers
219255|NCT02030119|Obesity|obesity
219256|NCT02030119|Physical Activity|physical activity
219257|NCT02030119|Financial Incentives|financial incentives
219258|NCT02030119|Behavioral Economics|behavioral economics
219259|NCT02030106|Cervicovaginal microbiome|cervicovaginal microbiome
219260|NCT02030106|Microbiome|microbiome
219261|NCT02030106|Preterm Birth|preterm birth
219262|NCT02030106|Cervical Remodeling|cervical remodeling
219263|NCT02030106|Preterm delivery|preterm delivery
219264|NCT02030106|Microbiota|microbiota
219265|NCT02030093|Alcohol dependence|alcohol dependence
219266|NCT02030093|Telephone-based continuing care|telephone-based continuing care
219267|NCT02030093|Outcome monitoring|outcome monitoring
219268|NCT02030080|Pedometers|pedometers
219269|NCT02030080|Walking|walking
219270|NCT02030080|Financial incentives|financial incentives
219271|NCT02030080|Sedentary lifestyle|sedentary lifestyle
219272|NCT02030080|Behavioral economics|behavioral economics
219273|NCT02030067|oncology|oncology
219274|NCT02030067|tumor|tumor
219275|NCT02030067|metastatic|metastatic
219276|NCT02030041|simvastatin|simvastatin
219277|NCT02030041|cardiorespiratory fitness|cardiorespiratory fitness
219278|NCT02030041|vitamin D|vitamin d
219279|NCT02030041|exercise|exercise
219280|NCT02030041|mitochondria|mitochondria
219283|NCT02030015|infantile Tay-Sachs disease|infantile tay-sachs disease
219284|NCT02030015|juvenile Tay-Sachs disease|juvenile tay-sachs disease
219285|NCT02030015|infantile GM1 gangliosidosis|infantile gm1 gangliosidosis
219286|NCT02030015|juvenile GM1 gangliosidosis|juvenile gm1 gangliosidosis
219287|NCT02030015|infantile GM2 gangliosidosis|infantile gm2 gangliosidosis
219288|NCT02030015|juvenile GM2 gangliosidosis|juvenile gm2 gangliosidosis
219290|NCT02030015|gangliosidoses|gangliosidoses
219291|NCT02030015|miglustat|miglustat
219292|NCT02030015|ketogenic diet|ketogenic diet
219293|NCT02030015|SYNER-G regimen|syner-g regimen
219294|NCT02030015|Syner-G|syner-g
219295|NCT02030015|Zavesca|zavesca
219296|NCT02030015|Tay-Sachs disease|tay-sachs disease
219297|NCT02030015|Tay Sachs disease|tay sachs disease
219298|NCT02029989|Metabolic Syndrome|metabolic syndrome
219299|NCT02029989|Antipsychotics|antipsychotics
219300|NCT02029989|Schizophrenia|schizophrenia
219301|NCT02029989|Bipolar Disorder|bipolar disorder
219302|NCT02029989|Diabetes|diabetes
219303|NCT02029989|Dyslipidemia|dyslipidemia
219304|NCT02029989|Hyperlipidemia|hyperlipidemia
219305|NCT02029989|Hypertension|hypertension
219306|NCT02029989|Obesity|obesity
219307|NCT02029989|Medication Therapy Management|medication therapy management
219308|NCT02029989|MTM|mtm
219309|NCT02029989|Pharmacist|pharmacist
219310|NCT02029989|Comprehensive Medication Management|comprehensive medication management
219312|NCT02029989|Health Disparity|health disparity
219313|NCT02029989|Monitoring|monitoring
219314|NCT02029989|Point of Care Testing|point of care testing
219315|NCT02029989|Chronic Persistent Mental Illness|chronic persistent mental illness
219316|NCT02029937|Squamous cell neoplasia|squamous cell neoplasia
219317|NCT02029937|Proflavine|proflavine
219318|NCT02029937|Lugol's chromoendoscopy|lugol's chromoendoscopy
219319|NCT02029911|Menorrhagia|menorrhagia
219320|NCT02029911|Excessive uterine bleeding|excessive uterine bleeding
219321|NCT02029911|Endometrial Ablation|endometrial ablation
219325|NCT02029885|Hypertension|hypertension
219326|NCT02029885|Renal Denervation|renal denervation
219330|NCT02029859|pregnancy (after 30 weeks of amenorhea)|pregnancy (after 30 weeks of amenorhea)
219331|NCT02029859|obesity (BMI>35)|obesity (bmi>35)
219332|NCT02029859|sleep apnea syndrom|sleep apnea syndrom
219333|NCT02029859|preeclampsy|preeclampsy
219334|NCT02029859|intrauterine growth restriction|intrauterine growth restriction
219335|NCT02029820|Contrast Nephropathy|contrast nephropathy
219336|NCT02029820|Prevention|prevention
219337|NCT02029820|Renalguard|renalguard
219338|NCT02029794|Cervical Cancer|cervical cancer
219339|NCT02029794|Cervical Cancer Screening|cervical cancer screening
219340|NCT02029794|Low Resource setting|low resource setting
219341|NCT02029794|HPV|hpv
219342|NCT02029794|Self-Collection|self-collection
219343|NCT02029794|VIA|via
219344|NCT02029781|Appendicitis|appendicitis
219345|NCT02029781|Laparoscopy|laparoscopy
219346|NCT02029781|Appendectomy|appendectomy
219347|NCT02029781|Negative appendectomy|negative appendectomy
219348|NCT02029781|Morbidity|morbidity
219349|NCT02029768|outcome|outcome
219350|NCT02029755|transversus abdominis plane block|transversus abdominis plane block
219351|NCT02029755|local infiltration|local infiltration
219352|NCT02029755|ropivacaine|ropivacaine
219353|NCT02029755|heart rate variability|heart rate variability
219354|NCT02029755|postoperative analgesia|postoperative analgesia
219355|NCT02029742|Sickle cell disease|sickle cell disease
219356|NCT02029742|Medication adherence|medication adherence
219357|NCT02029742|Hydroxyurea|hydroxyurea
219358|NCT02029742|Community health worker intervention|community health worker intervention
219359|NCT02029742|Sickle Cell Treatment|sickle cell treatment
219360|NCT02029729|RTA 408|rta 408
219361|NCT02029729|RTA 408 Capsules|rta 408 capsules
219362|NCT02029729|Non-small cell lung cancer|non-small cell lung cancer
219363|NCT02029729|Metastatic non-small cell lung cancer|metastatic non-small cell lung cancer
219364|NCT02029729|Incurable non-small cell lung cancer|incurable non-small cell lung cancer
219365|NCT02029729|Refractory melanoma|refractory melanoma
219366|NCT02029729|Relapsed melanoma|relapsed melanoma
219367|NCT02029716|RTA 408|rta 408
219368|NCT02029716|RTA 408 Lotion|rta 408 lotion
219369|NCT02029716|Oxidative stress|oxidative stress
219370|NCT02029716|Inflammation|inflammation
219371|NCT02029716|Volunteers|volunteers
219372|NCT02029703|Knee Osteoarthritis|knee osteoarthritis
219373|NCT02029703|Knee Pain|knee pain
219374|NCT02029703|Synvisc-One|synvisc-one
219375|NCT02029690|argininosuccinate synthetase|argininosuccinate synthetase
219376|NCT02029690|arginine|arginine
219377|NCT02029690|arginine deiminase|arginine deiminase
219378|NCT02029651|Stroke|stroke
219379|NCT02029651|Hand|hand
219380|NCT02029651|Rehabilitation|rehabilitation
219381|NCT02029651|Game|game
219382|NCT02029638|Kidney Transplantation|kidney transplantation
219383|NCT02029638|Renal Transplantation|renal transplantation
219384|NCT02029612|Tobacco Use Cessation|tobacco use cessation
219385|NCT02029612|Cancer Prevention|cancer prevention
219386|NCT02029612|HIV/AIDS|hiv/aids
219387|NCT02029612|Questionnaires|questionnaires
219388|NCT02029612|Surveys|surveys
219389|NCT02029612|Nicotine patch|nicotine patch
219390|NCT02029612|Breath test|breath test
219391|NCT02029612|Cell Phone Calls for Smoking Cessation Counseling|cell phone calls for smoking cessation counseling
219392|NCT02029612|Text Message Smoking Cessation Support|text message smoking cessation support
219393|NCT02029573|Phase II|phase ii
219394|NCT02029573|Atorvastatin|atorvastatin
219395|NCT02029573|Temozolomide|temozolomide
219396|NCT02029573|Radiotherapy|radiotherapy
219397|NCT02029573|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
219398|NCT02029534|post-operative atrial fibrillation|post-operative atrial fibrillation
219399|NCT02029534|POAF|poaf
219400|NCT02029534|A-Fib|a-fib
219401|NCT02029521|cystic fibrosis|cystic fibrosis
219402|NCT02029521|growth Failure|growth failure
219403|NCT02029521|glutathione|glutathione
219404|NCT02029508|PSCC(Posterior semicircular canal)|pscc(posterior semicircular canal)
219405|NCT02029508|BPPV(Bening paroxysmal positional vertigo)|bppv(bening paroxysmal positional vertigo)
219406|NCT02029508|Vertigo|vertigo
219407|NCT02029508|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
219408|NCT02029495|Psoriatic Arthritis|psoriatic arthritis
219409|NCT02029495|Brodalumab|brodalumab
219410|NCT02029495|AMG 827|amg 827
219411|NCT02029482|ACT-128800|act-128800
219412|NCT02029469|Humeral Resurfacing|humeral resurfacing
219413|NCT02029469|Humeral Resurfacing Arthroplasty|humeral resurfacing arthroplasty
219414|NCT02029456|Massive Pulmonary embolism|massive pulmonary embolism
219415|NCT02029456|thrombolytic therapy|thrombolytic therapy
219416|NCT02029456|high risk|high risk
219417|NCT02029456|elderly|elderly
219418|NCT02029443|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
219419|NCT02029430|HIV +|hiv +
219420|NCT02029430|HIV positive|hiv positive
219421|NCT02029430|AIDS|aids
219282|NCT02030028|ACTH gel|acth gel
219422|NCT02029430|Kaposi's sarcoma|kaposi's sarcoma
219423|NCT02029430|Sarcoma|sarcoma
219424|NCT02029430|tumor|tumor
219425|NCT02029430|cancer|cancer
219426|NCT02029391|Myofascial pain syndrome|myofascial pain syndrome
219427|NCT02029391|taping|taping
219428|NCT02029391|manual therapies|manual therapies
219429|NCT02029365|Infertility|infertility
219430|NCT02029365|desire for children|desire for children
219431|NCT02029365|eating disorder|eating disorder
219432|NCT02029365|anorexia nervosa|anorexia nervosa
219433|NCT02029365|bulimia nervosa|bulimia nervosa
219434|NCT02029365|eating disorders not otherwise specified|eating disorders not otherwise specified
219435|NCT02029352|Treatment|treatment
219436|NCT02029352|Sinecatechins|sinecatechins
219437|NCT02029339|Negative pressure wound therapy|negative pressure wound therapy
219438|NCT02029339|Acute wound infection|acute wound infection
219439|NCT02029339|complicated abdominal infection|complicated abdominal infection
219440|NCT02029339|Cytokines|cytokines
219441|NCT02029339|Matrix metalloproteinase|matrix metalloproteinase
219442|NCT02029326|colorectal cancer, cetuximab, biomarker, prometheus|colorectal cancer, cetuximab, biomarker, prometheus
219443|NCT02029300|pediatrics|pediatrics
219444|NCT02029300|fiberoptic intubation|fiberoptic intubation
219445|NCT02029300|oral intubation|oral intubation
219446|NCT02029300|nasal intubation|nasal intubation
219447|NCT02029300|children under the age of 2|children under the age of 2
219448|NCT02029287|Chronic heart failure|chronic heart failure
219449|NCT02029287|telemedicine|telemedicine
219450|NCT02029287|health service platform|health service platform
219451|NCT02029274|Dermatomyositis|dermatomyositis
219452|NCT02029261|Burn|burn
219453|NCT02029248|Anorectal malformation|anorectal malformation
219454|NCT02029248|fecal incontinence|fecal incontinence
219455|NCT02029248|quality of life|quality of life
219456|NCT02029248|child|child
219457|NCT02029235|Adult|adult
219458|NCT02029235|soft-tissue hand surgery|soft-tissue hand surgery
219459|NCT02029183|stroke, SAHS, BiPAP|stroke, sahs, bipap
219460|NCT02029170|ankle fracture|ankle fracture
219461|NCT02029170|weightbearing|weightbearing
219462|NCT02029170|cast|cast
219463|NCT02029118|Acupoint Application,Stable Angina Pectoris,herbal medicine|acupoint application,stable angina pectoris,herbal medicine
219464|NCT02029105|Mesothelioma,|mesothelioma,
219465|NCT02029105|Pleural diseases,|pleural diseases,
219466|NCT02029105|Mesothelin,|mesothelin,
219467|NCT02029105|Osteopontin,|osteopontin,
219468|NCT02029105|Hyaluronan,|hyaluronan,
219469|NCT02029105|Syndecan-1|syndecan-1
219470|NCT02029092|International|international
219471|NCT02029092|Multicenter|multicenter
219472|NCT02029092|Observational registry|observational registry
219473|NCT02029092|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
219474|NCT02029092|Stenting|stenting
219475|NCT02029092|Treatment of coronary artery disease|treatment of coronary artery disease
219476|NCT02029092|Coronary revascularization|coronary revascularization
219578|NCT02028624|Mediterranean diet|mediterranean diet
219477|NCT02029092|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
219478|NCT02029092|STEMI|stemi
219479|NCT02029092|NSTEMI|nstemi
219480|NCT02029092|Ischemia|ischemia
219481|NCT02029092|Angina|angina
219482|NCT02029092|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
219483|NCT02029092|Small Vessels|small vessels
219484|NCT02029092|Chronical Total Occlusion (CTO)|chronical total occlusion (cto)
219485|NCT02029079|Malnutrition|malnutrition
219486|NCT02029066|actinic keratosis|actinic keratosis
219487|NCT02029066|SR-T100|sr-t100
219488|NCT02029066|pharmacokinetics|pharmacokinetics
219489|NCT02029053|Vaginal dryness|vaginal dryness
219490|NCT02029053|Vaginal lubrication|vaginal lubrication
219491|NCT02029053|Post-menopausal symptoms|post-menopausal symptoms
219492|NCT02029053|Peri-menopausal symptoms|peri-menopausal symptoms
219493|NCT02029053|Urogenital atrophy|urogenital atrophy
219494|NCT02029053|Dyspareunia|dyspareunia
219495|NCT02029053|Painful intercourse|painful intercourse
219496|NCT02029040|Bronchiolitis|bronchiolitis
219497|NCT02029040|Hypertonic saline|hypertonic saline
219498|NCT02029040|Emergency Department|emergency department
219499|NCT02029027|Urinary Stress Incontinence|urinary stress incontinence
219500|NCT02029027|Urinary Mixed Incontinence|urinary mixed incontinence
219501|NCT02029014|LAmbre|lambre
219502|NCT02029001|Solid tumor|solid tumor
219503|NCT02029001|Recurrent/metastatic|recurrent/metastatic
219504|NCT02029001|Personalized medicine|personalized medicine
219505|NCT02029001|Genomic alteration|genomic alteration
210293|NCT02070588|TBI|tbi
219506|NCT02029001|Targeted therapy|targeted therapy
219507|NCT02029001|Nilotinib|nilotinib
219508|NCT02029001|Everolimus|everolimus
219509|NCT02029001|Sorafenib|sorafenib
219510|NCT02029001|Lapatinib|lapatinib
219511|NCT02029001|Pazopanib|pazopanib
219512|NCT02028988|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
219513|NCT02028962|Smoking cessation|smoking cessation
219514|NCT02028962|Romanian adults|romanian adults
219515|NCT02028923|topical morphine|topical morphine
219516|NCT02028910|gastroenteritis|gastroenteritis
219517|NCT02028910|pediatrics|pediatrics
219518|NCT02028910|vomiting|vomiting
219519|NCT02028897|In vitro fertilization|in vitro fertilization
219521|NCT02028897|Embryo culture|embryo culture
219522|NCT02028897|Blastocyst transfer|blastocyst transfer
219523|NCT02028832|pain|pain
219524|NCT02028832|nausea/vomiting|nausea/vomiting
219525|NCT02028832|anxiety|anxiety
219526|NCT02028832|complementary and alternative medicine|complementary and alternative medicine
219527|NCT02028832|pediatric|pediatric
219528|NCT02028832|oncology|oncology
219529|NCT02028832|cost-effectiveness|cost-effectiveness
219530|NCT02028793|Pharmaceutical Care, Taiwan, pharmacist, Workload, pressure|pharmaceutical care, taiwan, pharmacist, workload, pressure
219531|NCT02028741|neck pain|neck pain
219532|NCT02028741|transverse vertebral pressures|transverse vertebral pressures
219533|NCT02028741|thoracic mobilization|thoracic mobilization
219534|NCT02028728|International|international
219535|NCT02028728|Multicenter|multicenter
219536|NCT02028728|Observational registry|observational registry
219537|NCT02028728|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
219538|NCT02028728|Stenting|stenting
219539|NCT02028728|Treatment of coronary artery disease|treatment of coronary artery disease
219540|NCT02028728|Coronary revascularization|coronary revascularization
219541|NCT02028728|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
219542|NCT02028728|STEMI|stemi
219543|NCT02028728|NSTEMI|nstemi
219544|NCT02028728|Ischemia|ischemia
219545|NCT02028728|Angina|angina
219546|NCT02028728|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
219547|NCT02028728|Small Vessels|small vessels
219548|NCT02028728|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
219549|NCT02028715|IV Acetaminophen|iv acetaminophen
219550|NCT02028715|Ofirmev|ofirmev
219551|NCT02028715|Post-operative pain|post-operative pain
219552|NCT02028702|red clover|red clover
219553|NCT02028702|menopause|menopause
219554|NCT02028702|bioactive compounds|bioactive compounds
219555|NCT02028702|isoflavones|isoflavones
219556|NCT02028702|phytoestrogen|phytoestrogen
219557|NCT02028676|HIV|hiv
219558|NCT02028676|Africa|africa
219559|NCT02028676|children|children
219560|NCT02028676|antiretroviral therapy|antiretroviral therapy
219561|NCT02028676|laboratory monitoring|laboratory monitoring
219562|NCT02028676|toxicity|toxicity
219563|NCT02028676|CD4|cd4
219564|NCT02028676|induction maintenance|induction maintenance
219565|NCT02028676|cotrimoxazole|cotrimoxazole
219566|NCT02028676|prophylaxis|prophylaxis
219567|NCT02028676|abacavir|abacavir
219568|NCT02028676|lamivudine|lamivudine
219569|NCT02028676|once daily|once daily
219570|NCT02028663|P-CAB|p-cab
219571|NCT02028663|APA(Acid Pump Antagonist)|apa(acid pump antagonist)
219572|NCT02028650|relapse leukemia|relapse leukemia
219573|NCT02028650|DSI|dsi
219574|NCT02028637|asthma|asthma
219575|NCT02028637|toll like receptor|toll like receptor
219576|NCT02028637|innate immunity|innate immunity
219577|NCT02028624|Rheumatoid arthritis|rheumatoid arthritis
219579|NCT02028624|Lifestyle intervention|lifestyle intervention
219580|NCT02028624|Adiponectin|adiponectin
219581|NCT02028624|Telephone counseling|telephone counseling
219582|NCT02028611|Rib fracture|rib fracture
219583|NCT02028611|Inverted grayscale|inverted grayscale
219584|NCT02028598|Clomipramine|clomipramine
219585|NCT02028598|Premature ejaculation|premature ejaculation
219586|NCT02028585|low-fat milk|low-fat milk
219587|NCT02028585|metabolic syndrome|metabolic syndrome
219588|NCT02028585|lipid profile|lipid profile
219589|NCT02028585|inflammation|inflammation
219590|NCT02028585|oxidative stress|oxidative stress
219591|NCT02028585|endothelial function|endothelial function
219592|NCT02028572|Structure function correlation|structure function correlation
219593|NCT02028572|Optical coherence tomography|optical coherence tomography
219594|NCT02028572|Retinal Nerve fibre layer thickness|retinal nerve fibre layer thickness
219595|NCT02028572|Visual fields|visual fields
219596|NCT02028572|Primary open angle glaucoma|primary open angle glaucoma
219597|NCT02028559|stones|stones
219598|NCT02028559|kidney|kidney
219599|NCT02028559|stone fragments|stone fragments
219600|NCT02028559|lithotripsy|lithotripsy
219601|NCT02028546|atopic dermatitis, skin cleansing, cleanser, moisturizer, skin hydration|atopic dermatitis, skin cleansing, cleanser, moisturizer, skin hydration
219602|NCT02028533|addiction|addiction
219603|NCT02028533|oxytocin|oxytocin
219604|NCT02028533|tolerability|tolerability
219605|NCT02028507|Palbociclib|palbociclib
219606|NCT02028507|Capecitabine|capecitabine
219607|NCT02028507|Hormonal Receptor positive|hormonal receptor positive
219608|NCT02028507|HER2 negative|her2 negative
219609|NCT02028507|Metastatic Breast Cancer|metastatic breast cancer
219610|NCT02028507|Resistance to non-steroidal Aromatase inhibitors|resistance to non-steroidal aromatase inhibitors
219611|NCT02028507|Fulvestrant|fulvestrant
219612|NCT02028507|Exemestane|exemestane
219613|NCT02028481|Macular hole|macular hole
219614|NCT02028481|Vitreoretinal surgery|vitreoretinal surgery
219615|NCT02028481|Macular surgery|macular surgery
219616|NCT02028481|Air tamponade|air tamponade
219617|NCT02028468|Femoral Neck Fracture|femoral neck fracture
219618|NCT02028468|Anterolateral approach|anterolateral approach
219619|NCT02028468|Trans-gluteal approach|trans-gluteal approach
219620|NCT02028468|Watson Jones approach|watson jones approach
219621|NCT02028468|Hardinge approach|hardinge approach
219622|NCT02028455|pediatric|pediatric
219623|NCT02028455|young adult|young adult
219624|NCT02028455|acute lymphoblastic leukemia|acute lymphoblastic leukemia
219625|NCT02028455|CD19|cd19
219626|NCT02028455|leukemia|leukemia
219627|NCT02028455|Chimeric Antigen Receptor|chimeric antigen receptor
219628|NCT02028455|T cell|t cell
219629|NCT02028429|Minimal Hepatic Encephalopathy (MHE)|minimal hepatic encephalopathy (mhe)
219630|NCT02028429|Psychometric Hepatic Encephalopathy Score (PHES)|psychometric hepatic encephalopathy score (phes)
219631|NCT02028429|Sickness Impact Profile (SIP)|sickness impact profile (sip)
219632|NCT02028429|Model for End-stage Liver Disease (MELD)|model for end-stage liver disease (meld)
219633|NCT02028429|Child-Turcotte-Pugh score (CTP)|child-turcotte-pugh score (ctp)
219634|NCT02028416|pancytopenia|pancytopenia
219635|NCT02028416|aplastic anemia|aplastic anemia
219636|NCT02028416|ATG|atg
219637|NCT02028416|Cyclosporin|cyclosporin
219638|NCT02028390|wounds|wounds
219639|NCT02028390|thermal|thermal
219640|NCT02028390|temperature|temperature
219641|NCT02028390|periwound|periwound
219642|NCT02028390|camera|camera
219643|NCT02028390|imaging|imaging
219644|NCT02028377|Adenocarcinoma|adenocarcinoma
219645|NCT02028377|imaging|imaging
219646|NCT02028377|PET|pet
219647|NCT02028377|MRI|mri
219648|NCT02028364|Locally advanced breast cancer|locally advanced breast cancer
219649|NCT02028364|HER2 negative|her2 negative
219650|NCT02028364|NSAI refractory|nsai refractory
219651|NCT02028364|Metastatic breast cancer|metastatic breast cancer
219652|NCT02028364|Estrogen-receptor positive (ER+)|estrogen-receptor positive (er+)
219653|NCT02028351|visual acuity|visual acuity
219654|NCT02028351|contrast sensitivity|contrast sensitivity
219655|NCT02028351|cataract|cataract
219656|NCT02028351|maculopathy|maculopathy
219657|NCT02028312|Dry Eye|dry eye
219658|NCT02028299|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
219659|NCT02028299|Pulmonary Vascular Resistance|pulmonary vascular resistance
219660|NCT02028299|Right Heart Catheterization|right heart catheterization
219661|NCT02028286|Rosacea|rosacea
219662|NCT02028273|Neurogenesis|neurogenesis
219663|NCT02028273|Addiction|addiction
219664|NCT02028273|Cocaine|cocaine
219665|NCT02028273|MRI|mri
219666|NCT02028273|MRS|mrs
219667|NCT02028247|Autism spectrum disorders|autism spectrum disorders
219668|NCT02028247|Autism|autism
219669|NCT02028247|Asperger's syndrome|asperger's syndrome
219670|NCT02028247|Pervasive developmental disability - not otherwise specified|pervasive developmental disability - not otherwise specified
219671|NCT02028247|obsessive-compulsive disorder|obsessive-compulsive disorder
219672|NCT02028247|Social phobia|social phobia
219673|NCT02028247|Generalized anxiety disorder|generalized anxiety disorder
219674|NCT02028247|Specific phobia|specific phobia
219876|NCT02027493|Ribavirin|ribavirin
219675|NCT02028247|Separation anxiety disorder|separation anxiety disorder
219676|NCT02028247|Counseling|counseling
219677|NCT02028247|Cognitive-behavioral therapy|cognitive-behavioral therapy
219678|NCT02028247|Psychotherapy|psychotherapy
219679|NCT02028221|Breast cancer prevention|breast cancer prevention
219680|NCT02028221|metformin|metformin
219681|NCT02028221|Breast cancer risk reduction|breast cancer risk reduction
219682|NCT02028208|Patch Test|patch test
219683|NCT02028208|Allergy Testing|allergy testing
219684|NCT02028208|Contact Dermatitis|contact dermatitis
219685|NCT02028208|Mercury, Aluminum or Palladium skin allergy|mercury, aluminum or palladium skin allergy
219686|NCT02028195|Health check|health check
219687|NCT02028195|Health promotion|health promotion
219688|NCT02028195|prevention diabetes|prevention diabetes
219689|NCT02028195|prevention cardiovascular disease|prevention cardiovascular disease
219690|NCT02028195|mental health|mental health
219691|NCT02028182|Patch Test|patch test
219692|NCT02028182|Allergy Testing|allergy testing
219693|NCT02028182|Contact dermatitis|contact dermatitis
219694|NCT02028182|Lyral allergen|lyral allergen
219695|NCT02028182|Fragrance Mix allergen|fragrance mix allergen
219696|NCT02028169|Work Productivity|work productivity
219697|NCT02028169|Anti-TNFs|anti-tnfs
219698|NCT02028169|Psoriatic Arthritis|psoriatic arthritis
219699|NCT02028143|Atrial Fibrillation|atrial fibrillation
269692|NCT01800721|HIV|hiv
219700|NCT02028130|Atrial fibrillation|atrial fibrillation
219701|NCT02028130|Ablation|ablation
219702|NCT02028130|Left atrial appendage occlusion|left atrial appendage occlusion
219703|NCT02028130|Stroke prevention|stroke prevention
219704|NCT02028091|Pulse walve arrival time differences|pulse walve arrival time differences
219705|NCT02028078|Endogenous glucose production|endogenous glucose production
219706|NCT02028078|Type 1 diabetes mellitus|type 1 diabetes mellitus
219707|NCT02028078|hypoglycaemic clamp|hypoglycaemic clamp
219708|NCT02028078|tracer to technique|tracer to technique
219709|NCT02028078|pharmacodynamics|pharmacodynamics
219710|NCT02028078|pharmacokinetics|pharmacokinetics
219711|NCT02028065|reversal of neuromuscular blockade|reversal of neuromuscular blockade
219712|NCT02028052|enlarged mediastinal nodes|enlarged mediastinal nodes
219713|NCT02028052|enlarged hilar lymph nodes|enlarged hilar lymph nodes
219714|NCT02028039|Leukemia|leukemia
219715|NCT02028039|Refractory Acute Lymphoblastic Leukemia|refractory acute lymphoblastic leukemia
219716|NCT02028039|ALL|all
219717|NCT02028039|Burkitt's lymphoma|burkitt's lymphoma
219718|NCT02028039|Lymphoblastic lymphoma|lymphoblastic lymphoma
219719|NCT02028039|IPI-145|ipi-145
219720|NCT02028026|Depressive Disorder|depressive disorder
219721|NCT02028026|Anxiety|anxiety
219722|NCT02028026|Comorbidity|comorbidity
219723|NCT02028026|Magnetic Resonance Imaging|magnetic resonance imaging
219724|NCT02028026|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
219725|NCT02028026|Citalopram|citalopram
219726|NCT02028026|Vilazodone|vilazodone
219727|NCT02028026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
219728|NCT02028026|Receptor, Serotonin, 5-HT1A|receptor, serotonin, 5-ht1a
219729|NCT02028013|Erectile dysfunction, sexual dysfunction, bioresonance|erectile dysfunction, sexual dysfunction, bioresonance
219730|NCT02028000|Pregnancy|pregnancy
219731|NCT02028000|Pregnant|pregnant
219732|NCT02028000|Cesarean Section Delivery|cesarean section delivery
219733|NCT02027987|valproate acid|valproate acid
219734|NCT02027987|traumatic brain injury|traumatic brain injury
219735|NCT02027987|brain protection|brain protection
219736|NCT02027987|epilepsy|epilepsy
219737|NCT02027974|Hip|hip
219738|NCT02027974|Arthroplasty|arthroplasty
219739|NCT02027974|Arthroplasties|arthroplasties
219740|NCT02027974|Prosthesis|prosthesis
219741|NCT02027974|Iconacy|iconacy
219742|NCT02027974|Osteoarthritis|osteoarthritis
219743|NCT02027974|Arthritis|arthritis
219744|NCT02027974|THA|tha
219745|NCT02027974|THR|thr
219746|NCT02027974|DJD|djd
219747|NCT02027961|Metastatic or Unresectable Melanoma, MEDI4736, dafrafenib, trametinib, BRAF-mutation positive, wild-type BRAF, PD-L1, PD-1|metastatic or unresectable melanoma, medi4736, dafrafenib, trametinib, braf-mutation positive, wild-type braf, pd-l1, pd-1
219748|NCT02027948|nutritional management algorithm|nutritional management algorithm
219749|NCT02027948|nutritional and functional assessments|nutritional and functional assessments
219750|NCT02027948|13-264|13-264
219751|NCT02027935|Melanoma|melanoma
219752|NCT02027935|Metastatic|metastatic
219753|NCT02027935|CD8+ T cells|cd8+ t cells
219754|NCT02027935|White blood cell|white blood cell
219755|NCT02027935|Leukapheresis|leukapheresis
219756|NCT02027935|Cyclophosphamide|cyclophosphamide
219757|NCT02027935|Cytoxan|cytoxan
219758|NCT02027935|Neosar|neosar
219759|NCT02027935|Interleukin-2|interleukin-2
219760|NCT02027935|Aldesleukin|aldesleukin
219761|NCT02027935|IL-2|il-2
219762|NCT02027935|Proleukin|proleukin
219763|NCT02027935|Ipilimumab|ipilimumab
219764|NCT02027935|Yervoy|yervoy
219765|NCT02027935|BMS-734016|bms-734016
219766|NCT02027935|MDX010|mdx010
219767|NCT02027922|white spot lesion|white spot lesion
219768|NCT02027922|caries|caries
219769|NCT02027909|Sinus Node Dysfunction|sinus node dysfunction
219976|NCT02027116|DNA Vaccine|dna vaccine
219770|NCT02027896|Perioperative outcomes|perioperative outcomes
219771|NCT02027883|Defibrillators|defibrillators
219772|NCT02027883|Ventricular Fibrillation Induction Testing|ventricular fibrillation induction testing
219773|NCT02027870|DES|des
219774|NCT02027870|CAD|cad
219775|NCT02027870|EXCEL-II|excel-ii
219776|NCT02027870|JWMS|jwms
219777|NCT02027870|PCI|pci
219778|NCT02027857|brain electrical impedance;|brain electrical impedance;
219779|NCT02027857|traumatic brain injury;|traumatic brain injury;
219780|NCT02027857|brain edema;|brain edema;
219781|NCT02027857|intracranial pressure|intracranial pressure
219782|NCT02027831|lymph nodes|lymph nodes
219783|NCT02027818|margins|margins
219784|NCT02027818|tumorectomy|tumorectomy
219785|NCT02027805|Steroid-resistant|steroid-resistant
219786|NCT02027805|Graft vs Host Disease|graft vs host disease
219787|NCT02027805|Refractory acute Graft vs Host Disease|refractory acute graft vs host disease
219788|NCT02027805|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
219789|NCT02027805|Stem Cell Transplantation|stem cell transplantation
219790|NCT02027805|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
219791|NCT02027805|Immune System Diseases|immune system diseases
219792|NCT02027805|Antibodies, monoclonal|antibodies, monoclonal
219793|NCT02027805|Immunotoxins|immunotoxins
219794|NCT02027805|Immunosuppressive agents|immunosuppressive agents
219795|NCT02027779|GreenGene™ F, Previously Treated Patients|greengene™ f, previously treated patients
219796|NCT02027727|inflammatory bowel disease|inflammatory bowel disease
219797|NCT02027727|infliximab|infliximab
219798|NCT02027727|trough level|trough level
219799|NCT02027727|crohn's disease|crohn's disease
219800|NCT02027727|ulcerative colitis|ulcerative colitis
219801|NCT02027714|Discordant|discordant
219802|NCT02027714|Lesotho|lesotho
219803|NCT02027714|Couples|couples
401999|NCT01233570|Metastatic Crohns Disease|metastatic crohns disease
219804|NCT02027714|Enhanced Prevention Package (EPP)|enhanced prevention package (epp)
219806|NCT02027714|Counseling|counseling
219807|NCT02027714|Male Circumcision|male circumcision
219808|NCT02027688|Oral feeding|oral feeding
219809|NCT02027688|Premature|premature
219810|NCT02027688|Infants|infants
219811|NCT02027688|Neonatal Intensive Care Unit|neonatal intensive care unit
219813|NCT02027675|immune function|immune function
219814|NCT02027675|inflammation|inflammation
219815|NCT02027675|immunity|immunity
219816|NCT02027675|diet|diet
219817|NCT02027675|obesity|obesity
219818|NCT02027675|asthma|asthma
219819|NCT02027649|Bladder cancer|bladder cancer
219820|NCT02027649|Keratin 14|keratin 14
219821|NCT02027649|Pronostic marker|pronostic marker
219822|NCT02027649|Diagnostic marker|diagnostic marker
219823|NCT02027649|Noninvasive technique|noninvasive technique
219824|NCT02027636|Depression|depression
219825|NCT02027636|Latinos|latinos
219826|NCT02027636|Mental Health|mental health
219827|NCT02027636|Disparities|disparities
219828|NCT02027623|Mechanical low back pain|mechanical low back pain
219829|NCT02027623|Non-specific low back pain|non-specific low back pain
219830|NCT02027623|Exercise|exercise
219831|NCT02027623|Motor skill training|motor skill training
219832|NCT02027610|Infant|infant
219833|NCT02027610|Bangladesh|bangladesh
219834|NCT02027610|vitamin A|vitamin a
219835|NCT02027610|microbiota|microbiota
219836|NCT02027610|vaccine|vaccine
219837|NCT02027610|immunity|immunity
219838|NCT02027597|video games|video games
219839|NCT02027597|oral health|oral health
219840|NCT02027597|social cognitive theory|social cognitive theory
219841|NCT02027597|behavior change|behavior change
219842|NCT02027597|randomized trial|randomized trial
219843|NCT02027597|growth modeling|growth modeling
219844|NCT02027597|minority|minority
219845|NCT02027597|gender|gender
219846|NCT02027584|infant, premature|infant, premature
219847|NCT02027584|infant, newborn|infant, newborn
219848|NCT02027584|choline|choline
219849|NCT02027571|Diabetes|diabetes
219850|NCT02027571|Race/Ethnicity|race/ethnicity
219851|NCT02027571|Offspring Cohort|offspring cohort
219852|NCT02027571|African Americans|african americans
219853|NCT02027571|Prediabetes Reversal|prediabetes reversal
219854|NCT02027571|Lifestyle Intervention|lifestyle intervention
219855|NCT02027571|Insulin Sensitivity|insulin sensitivity
219856|NCT02027571|Beta-cell Function|beta-cell function
219857|NCT02027571|Diabetes Prevention|diabetes prevention
219858|NCT02027558|cognitive behavioral therapy|cognitive behavioral therapy
219859|NCT02027558|insomnia|insomnia
219860|NCT02027558|apnea|apnea
219861|NCT02027545|cancer screening|cancer screening
219862|NCT02027545|decision making|decision making
219863|NCT02027519|Self-testing|self-testing
219864|NCT02027519|Home-based testing|home-based testing
219865|NCT02027519|Lesotho|lesotho
219866|NCT02027519|Discordant|discordant
219867|NCT02027506|ECG|ecg
219868|NCT02027506|aVL|avl
219869|NCT02027506|CHRONIC STABLE ANGINA|chronic stable angina
219870|NCT02027506|T WAVE|t wave
219871|NCT02027493|Children|children
219872|NCT02027493|Chronic hepatitis C|chronic hepatitis c
219873|NCT02027493|Hansenula polymorpha|hansenula polymorpha
219874|NCT02027493|Pegylated interferon|pegylated interferon
219875|NCT02027493|Response rate|response rate
219877|NCT02027493|Treatment|treatment
219878|NCT02027480|Antiretroviral Therapy (ART)|antiretroviral therapy (art)
219879|NCT02027480|Biomarkers|biomarkers
219880|NCT02027480|Nyanza Province|nyanza province
219881|NCT02027480|Kenya|kenya
219882|NCT02027467|Hematopoietic stem cells|hematopoietic stem cells
219883|NCT02027467|Herbal|herbal
219884|NCT02027467|Dietary|dietary
219885|NCT02027467|CD cells|cd cells
219886|NCT02027467|Basic research|basic research
219887|NCT02027454|GSK1265744|gsk1265744
219888|NCT02027454|HIV|hiv
219889|NCT02027454|placebo|placebo
219890|NCT02027454|cardiac repolarization|cardiac repolarization
219891|NCT02027454|12-lead ECG|12-lead ecg
219892|NCT02027454|moxifloxacin|moxifloxacin
219893|NCT02027454|QTc|qtc
219894|NCT02027441|Serodiscordant|serodiscordant
219895|NCT02027441|Lesotho|lesotho
219896|NCT02027441|Home-based testing|home-based testing
219897|NCT02027428|Nab-paclitaxel|nab-paclitaxel
219898|NCT02027428|Albumin bound paclitaxel|albumin bound paclitaxel
219899|NCT02027428|Taxanes|taxanes
219900|NCT02027428|Maintenance trials|maintenance trials
219901|NCT02027428|Celgene|celgene
269937|NCT01799551|CBT|cbt
219902|NCT02027428|Abraxane|abraxane
219903|NCT02027428|ABI-007|abi-007
219904|NCT02027428|NSCLC|nsclc
219905|NCT02027428|Non-Small Cell Lung Cancer|non-small cell lung cancer
219906|NCT02027428|Cancer of the Lung|cancer of the lung
219907|NCT02027428|Carcinoma, Squamous Cell|carcinoma, squamous cell
219908|NCT02027428|Lung Neoplasms|lung neoplasms
219909|NCT02027428|Abound.sqm|abound.sqm
219910|NCT02027415|air pollution|air pollution
219911|NCT02027415|food|food
219912|NCT02027415|nitrites|nitrites
219913|NCT02027415|nitrates|nitrates
219914|NCT02027415|breath tests/methods|breath tests/methods
219915|NCT02027389|MSSA, MRSA|mssa, mrsa
219916|NCT02027376|Advanced Breast Cancer|advanced breast cancer
219917|NCT02027376|LDE225|lde225
219918|NCT02027376|Triple Negative|triple negative
219919|NCT02027376|Hormonal Receptor negative|hormonal receptor negative
219920|NCT02027376|Her2 negative|her2 negative
219921|NCT02027363|Metastasis colorectal cancer|metastasis colorectal cancer
219922|NCT02027363|Maintenance|maintenance
219923|NCT02027363|First-line treatment|first-line treatment
219924|NCT02027363|Capecitabine|capecitabine
219925|NCT02027337|combined oral contraceptives|combined oral contraceptives
219926|NCT02027337|drospirenone|drospirenone
219927|NCT02027337|cyproterone|cyproterone
219928|NCT02027337|hemostasis|hemostasis
219929|NCT02027337|antioxidants|antioxidants
219930|NCT02027324|Surgical site infection|surgical site infection
219931|NCT02027324|Cesarean delivery|cesarean delivery
219932|NCT02027324|Antisepsis|antisepsis
219933|NCT02027324|Povidone iodine|povidone iodine
219934|NCT02027324|Chlorhexidine alcohol|chlorhexidine alcohol
219935|NCT02027324|Endometritis|endometritis
220190|NCT02025894|PCVC|pcvc
219936|NCT02027311|Endoscopic Retrograde Cholangiopancreatography (ERCP)|endoscopic retrograde cholangiopancreatography (ercp)
219937|NCT02027311|Conscious Sedation|conscious sedation
219938|NCT02027311|etomidate|etomidate
219939|NCT02027311|midazolam|midazolam
219940|NCT02027298|Abatacept|abatacept
219941|NCT02027298|Sjogren's Syndrome|sjogren's syndrome
219942|NCT02027298|Rheumatoid Arthritis|rheumatoid arthritis
219943|NCT02027285|fortified milk, aging, health status|fortified milk, aging, health status
219944|NCT02027272|Eclampsia|eclampsia
219945|NCT02027259|Diabetes|diabetes
219946|NCT02027259|Depression|depression
219947|NCT02027259|Group|group
219948|NCT02027246|spinal cord injury|spinal cord injury
219949|NCT02027246|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
219950|NCT02027246|stem cell therapy|stem cell therapy
219951|NCT02027233|Prevention|prevention
219952|NCT02027233|Influenza|influenza
219953|NCT02027233|Adults hospitalized|adults hospitalized
219954|NCT02027233|Vaccines|vaccines
219955|NCT02027233|Effectiveness|effectiveness
219956|NCT02027207|Cholera|cholera
219957|NCT02027207|Oral cholera vaccine|oral cholera vaccine
219958|NCT02027207|Shanchol|shanchol
219959|NCT02027207|Protective efficacy|protective efficacy
219960|NCT02027207|Bangladesh|bangladesh
219961|NCT02027194|Allergic Rhinitis|allergic rhinitis
219962|NCT02027194|Chinese herbal medicine|chinese herbal medicine
219963|NCT02027194|Adolescents|adolescents
219964|NCT02027194|Double-blinded|double-blinded
219965|NCT02027194|Randomized controlled trial|randomized controlled trial
219966|NCT02027168|infertility|infertility
219967|NCT02027168|elevated FSH|elevated fsh
219968|NCT02027168|alternative treatment|alternative treatment
219969|NCT02027168|Clear Passage Approach|clear passage approach
219970|NCT02027168|Clear Passage Physical Therapy|clear passage physical therapy
219971|NCT02027155|healthy volunteers|healthy volunteers
219972|NCT02027129|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
219973|NCT02027129|Cor Pulmonale|cor pulmonale
219974|NCT02027129|High Frequency Ventilaiton|high frequency ventilaiton
219975|NCT02027116|chronic hepatitis C|chronic hepatitis c
219977|NCT02027116|Electroporation|electroporation
220074|NCT02026388|APRT deficiency|aprt deficiency
219978|NCT02027116|Intramuscular (IM) Injection|intramuscular (im) injection
219979|NCT02027103|Fetuin-A|fetuin-a
219980|NCT02027103|OPG|opg
219981|NCT02027103|Metformin|metformin
219982|NCT02027103|Pioglitazone|pioglitazone
219983|NCT02027077|physical activity|physical activity
219984|NCT02027077|diet|diet
219985|NCT02027077|small change|small change
219986|NCT02027077|behavior change|behavior change
219987|NCT02027051|population genetics|population genetics
219988|NCT02027025|Spasticity, Multiple sclerosis|spasticity, multiple sclerosis
219989|NCT02026934|Graft-Versus-Host Disease(GVHD)|graft-versus-host disease(gvhd)
219990|NCT02026934|Hematopoietic Stem Cell Transplantation.|hematopoietic stem cell transplantation.
219991|NCT02026934|Graft failure|graft failure
219992|NCT02026934|Graft exhaustion|graft exhaustion
219993|NCT02026921|Phase II study,|phase ii study,
219994|NCT02026921|Recurrent platinum-sensitive ovarian cancer|recurrent platinum-sensitive ovarian cancer
219995|NCT02026921|docetaxel|docetaxel
219996|NCT02026921|Carboplatin|carboplatin
219997|NCT02026921|Toxicity|toxicity
219998|NCT02026908|Prostate Artery Embolization|prostate artery embolization
219999|NCT02026908|PAE|pae
220000|NCT02026908|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
220001|NCT02026908|BPH|bph
220002|NCT02026908|Lower Urinary Tract Symptoms|lower urinary tract symptoms
220003|NCT02026908|LUTS|luts
220004|NCT02026882|Airway, Caesarean|airway, caesarean
220005|NCT02026869|Vaginal administration, PCOS, Metformin|vaginal administration, pcos, metformin
402000|NCT01233570|Pyoderma Gangrenosum|pyoderma gangrenosum
220006|NCT02026856|oxidative stress, sepsis, selenium|oxidative stress, sepsis, selenium
220007|NCT02026830|Diabetic foot infections|diabetic foot infections
220008|NCT02026830|microorganisms|microorganisms
220009|NCT02026791|Supraglottic airway device|supraglottic airway device
220011|NCT02026791|SupremeLMA|supremelma
220012|NCT02026791|Elderly patient|elderly patient
220013|NCT02026739|minimally invasive esophagectomy; pulmonary function|minimally invasive esophagectomy; pulmonary function
220014|NCT02026674|urineflow|urineflow
220016|NCT02026674|urine flow|urine flow
220017|NCT02026674|uroflometry|uroflometry
220018|NCT02026674|bph|bph
220019|NCT02026635|heart failure|heart failure
220020|NCT02026635|Optivol® cardiac device|optivol® cardiac device
220021|NCT02026635|Medtronic CareLink|medtronic carelink
220022|NCT02026622|major depressive disorder|major depressive disorder
220023|NCT02026622|cerebrovascular reactivity|cerebrovascular reactivity
220024|NCT02026622|emotional reactivity|emotional reactivity
220025|NCT02026609|TIPS|tips
220026|NCT02026609|Hepatic encephalopathy|hepatic encephalopathy
220027|NCT02026609|Oral glutamine challenge|oral glutamine challenge
220028|NCT02026609|Psychometric tests|psychometric tests
220029|NCT02026609|Portal hypertension|portal hypertension
220030|NCT02026609|Cirrhosis|cirrhosis
220031|NCT02026596|subrachnoid hemorrhage|subrachnoid hemorrhage
220032|NCT02026596|secondary brain injury|secondary brain injury
220033|NCT02026570|Prosthesis|prosthesis
220034|NCT02026570|Falls|falls
220035|NCT02026570|Training|training
220036|NCT02026544|low frequency ultrasound|low frequency ultrasound
220037|NCT02026544|glomerular filtration rate|glomerular filtration rate
220038|NCT02026492|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
220039|NCT02026492|exercise-induced asthma|exercise-induced asthma
220040|NCT02026492|cold chamber|cold chamber
220041|NCT02026492|exercise challenge|exercise challenge
220042|NCT02026492|cold air challenge|cold air challenge
220043|NCT02026492|combined exercise- and cold-air challenge|combined exercise- and cold-air challenge
220044|NCT02026492|methacholine challenge|methacholine challenge
220045|NCT02026479|full-frequency sudden hearing loss|full-frequency sudden hearing loss
220046|NCT02026479|post auricular injection|post auricular injection
220047|NCT02026479|glucocorticoid|glucocorticoid
220048|NCT02026479|multi-center|multi-center
220049|NCT02026466|Coronary Artery Disease|coronary artery disease
220050|NCT02026466|Chronic Total Occlusion|chronic total occlusion
220051|NCT02026453|Adverse drug events|adverse drug events
220052|NCT02026440|oral fluid collection device cotinine detection|oral fluid collection device cotinine detection
220053|NCT02026414|PrimaVie|primavie
220054|NCT02026414|Herbal Supplement|herbal supplement
220055|NCT02026414|Muscle biopsy|muscle biopsy
220056|NCT02026414|Energy|energy
220057|NCT02026414|Exercise|exercise
220058|NCT02026414|Human skeletal muscle adaptation|human skeletal muscle adaptation
220059|NCT02026414|Muscle function|muscle function
220060|NCT02026388|PH|ph
220061|NCT02026388|primary hyperoxaluria|primary hyperoxaluria
220062|NCT02026388|hyperoxaluria|hyperoxaluria
220063|NCT02026388|primary oxalosis|primary oxalosis
220064|NCT02026388|Primary Hyperoxaluria Type 1|primary hyperoxaluria type 1
220065|NCT02026388|Primary Hyperoxaluria Type 2|primary hyperoxaluria type 2
220066|NCT02026388|Primary Hyperoxaluria Type 3|primary hyperoxaluria type 3
220067|NCT02026388|Dent|dent
220068|NCT02026388|Dents|dents
220069|NCT02026388|Dent Disease|dent disease
220070|NCT02026388|Dent 1|dent 1
220071|NCT02026388|Dent 2|dent 2
220072|NCT02026388|Cystinuria|cystinuria
220073|NCT02026388|APRT|aprt
220075|NCT02026388|Biobank|biobank
220076|NCT02026362|HCC|hcc
220077|NCT02026362|DC|dc
220078|NCT02026362|CTL|ctl
220079|NCT02026349|influenza|influenza
220080|NCT02026349|flu|flu
220081|NCT02026349|fever|fever
220082|NCT02026349|cough|cough
220083|NCT02026349|body aches|body aches
220084|NCT02026349|headache|headache
220085|NCT02026349|nasal congestion|nasal congestion
220086|NCT02026349|body pains|body pains
220087|NCT02026349|sore throat|sore throat
220088|NCT02026349|fatigue|fatigue
220089|NCT02026349|T-705|t-705
220090|NCT02026349|favipiravir|favipiravir
220091|NCT02026349|favor|favor
220092|NCT02026349|flu symptoms|flu symptoms
220093|NCT02026336|asthma; inflammation; electronic nose|asthma; inflammation; electronic nose
220094|NCT02026310|glimepiride|glimepiride
220095|NCT02026310|metformin|metformin
220096|NCT02026310|basal insulin|basal insulin
270192|NCT01798420|COPD|copd
220097|NCT02026310|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
220098|NCT02026310|glucose fluctuation|glucose fluctuation
220099|NCT02026310|hypoglycemia|hypoglycemia
220100|NCT02026297|postpartum hemorrhage|postpartum hemorrhage
220101|NCT02026297|estimated blood loss|estimated blood loss
220102|NCT02026297|coagulation|coagulation
220103|NCT02026297|thromboelastography|thromboelastography
220104|NCT02026297|tranexamic acid|tranexamic acid
220105|NCT02026284|Caesarean section|caesarean section
220106|NCT02026284|Anaesthesia|anaesthesia
220107|NCT02026284|Questionnaires|questionnaires
220108|NCT02026245|Arthritis|arthritis
220109|NCT02026245|rheumatoid|rheumatoid
220110|NCT02026245|joints|joints
220111|NCT02026245|swelling|swelling
220112|NCT02026245|measurement|measurement
220113|NCT02026245|movement|movement
220114|NCT02026245|electronic|electronic
220115|NCT02026245|data|data
220116|NCT02026245|glove|glove
220117|NCT02026245|goniometry|goniometry
220118|NCT02026245|outcome|outcome
220119|NCT02026245|stiffness|stiffness
220120|NCT02026232|Type 2 Diabetes|type 2 diabetes
220122|NCT02026206|Primary Dysmenorrhea|primary dysmenorrhea
220123|NCT02026206|Pain|pain
220124|NCT02026167|Chronic Pain|chronic pain
220125|NCT02026167|Mood|mood
220126|NCT02026167|Physical Activity|physical activity
220127|NCT02026154|hypertension, biomarkers, echocardiography, heart failure|hypertension, biomarkers, echocardiography, heart failure
220128|NCT02026128|Uveitis|uveitis
220129|NCT02026128|Inflammation|inflammation
220130|NCT02026128|OCT|oct
220131|NCT02026128|Grading|grading
220132|NCT02026115|cancer|cancer
220133|NCT02026115|hospice|hospice
220134|NCT02026115|pain|pain
220135|NCT02026102|decision aid|decision aid
220136|NCT02026102|patient decision making|patient decision making
220137|NCT02026102|heart failure|heart failure
220138|NCT02026102|ejection fraction|ejection fraction
220139|NCT02026102|primary prevention|primary prevention
220140|NCT02026102|implantable cardioverter defibrillator|implantable cardioverter defibrillator
220141|NCT02026102|ICD|icd
220142|NCT02026102|pilot trial|pilot trial
220143|NCT02026102|patient centered health care|patient centered health care
220144|NCT02026076|low back pain|low back pain
220145|NCT02026076|traction|traction
220146|NCT02026076|unloading|unloading
220147|NCT02026050|dexamethasone|dexamethasone
220148|NCT02026050|intraarticular injection|intraarticular injection
220149|NCT02026050|interscalene brachial plexus block|interscalene brachial plexus block
220150|NCT02026037|Stress Disorders|stress disorders
220151|NCT02026037|Post-Traumatic|post-traumatic
220152|NCT02026037|Burns|burns
220153|NCT02026037|Brief Psychotherapy|brief psychotherapy
220154|NCT02026037|Cognitive Behavior Therapy|cognitive behavior therapy
220155|NCT02026011|alcohol use disorder|alcohol use disorder
220156|NCT02026011|naltrexone|naltrexone
220157|NCT02026011|Asian American|asian american
220158|NCT02026011|pharmacogenetics|pharmacogenetics
220159|NCT02026011|OPRM1 gene|oprm1 gene
220160|NCT02025998|ibudilast, alcoholism|ibudilast, alcoholism
220161|NCT02025985|Karyopharm|karyopharm
220162|NCT02025985|KPT-330|kpt-330
220163|NCT02025985|Selinexor|selinexor
220164|NCT02025985|SIGN|sign
220165|NCT02025985|ovarian cancer|ovarian cancer
220166|NCT02025985|endometrial cancer|endometrial cancer
220167|NCT02025985|cervical cancer|cervical cancer
220168|NCT02025985|SINE™|sine™
220169|NCT02025985|breast cancer|breast cancer
220170|NCT02025985|HER2 negative|her2 negative
220171|NCT02025972|Cerebral palsy|cerebral palsy
220172|NCT02025972|Umbilical cord blood|umbilical cord blood
220173|NCT02025972|Rehabilitation|rehabilitation
220174|NCT02025972|Cytokine|cytokine
220175|NCT02025972|Outcome|outcome
220176|NCT02025959|staff empowerment|staff empowerment
220177|NCT02025959|Sleep Apnea|sleep apnea
220178|NCT02025959|educational intervention|educational intervention
220179|NCT02025933|Children|children
220180|NCT02025933|Age 9-12 years|age 9-12 years
220181|NCT02025933|Overweight (iso-BMI > 25)|overweight (iso-bmi > 25)
220182|NCT02025907|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
220183|NCT02025907|Canagliflozin|canagliflozin
220184|NCT02025907|Hemoglobin A1c|hemoglobin a1c
220185|NCT02025907|Metformin|metformin
220186|NCT02025907|Sitagliptin|sitagliptin
220187|NCT02025907|T2DM|t2dm
220188|NCT02025907|JNJ-28431754|jnj-28431754
220189|NCT02025894|neoplastic solid tumour|neoplastic solid tumour
220191|NCT02025894|thromboembolic complications|thromboembolic complications
220192|NCT02025894|infectious complications|infectious complications
220193|NCT02025894|risk factors|risk factors
220194|NCT02025868|Africa|africa
220195|NCT02025868|Antiretroviral Treatment|antiretroviral treatment
220196|NCT02025868|Adherence reinforcement|adherence reinforcement
220197|NCT02025868|Third line ART|third line art
220198|NCT02025868|Second line ART|second line art
220199|NCT02025868|Virologic failure|virologic failure
220200|NCT02025868|Adults|adults
270310|NCT01797887|CAM|cam
210972|NCT02067208|Osteoarthritis|osteoarthritis
210973|NCT02067208|Cartilage|cartilage
210974|NCT02067208|Musculoskeletal|musculoskeletal
210975|NCT02067208|Biomechanics|biomechanics
210976|NCT02067208|Subtype|subtype
210977|NCT02067208|Footwear|footwear
210978|NCT02067208|Orthotics|orthotics
210979|NCT02067208|Joint Loading|joint loading
210981|NCT02067169|Transplantation|transplantation
211031|NCT02066948|DXA|dxa
220201|NCT02025855|Iatrogenic opioid abstinence syndrome|iatrogenic opioid abstinence syndrome
220202|NCT02025855|Methadone|methadone
220203|NCT02025855|Mechanical ventilation|mechanical ventilation
220204|NCT02025855|ICU delirium|icu delirium
220205|NCT02025855|Continuous sedation|continuous sedation
220206|NCT02025842|Hepatocellular carcinoma|hepatocellular carcinoma
220207|NCT02025842|Hepatitis B|hepatitis b
220208|NCT02025829|cystic fibrosis|cystic fibrosis
220209|NCT02025829|IL-17 neutrophils|il-17 neutrophils
220210|NCT02025803|Advanced solid tumors|advanced solid tumors
220211|NCT02025790|Achalasia|achalasia
220212|NCT02025790|POEM|poem
220213|NCT02025790|Pneumatic dilatation|pneumatic dilatation
220214|NCT02025790|Eckardt score|eckardt score
220215|NCT02025777|Ulcerative Colitis|ulcerative colitis
220216|NCT02025777|PillCam|pillcam
220217|NCT02025777|IBD|ibd
220218|NCT02025751|Diabetes|diabetes
220219|NCT02025751|Gastroparesis|gastroparesis
220220|NCT02025751|Delayed gastric emptying|delayed gastric emptying
220221|NCT02025751|Nausea|nausea
220222|NCT02025751|Vomiting|vomiting
220223|NCT02025751|Bloating|bloating
220224|NCT02025751|Abdominal pain|abdominal pain
220225|NCT02025751|Early Satiety|early satiety
220226|NCT02025751|Gastric stasis|gastric stasis
220227|NCT02025751|Gastropathy|gastropathy
220228|NCT02025725|Gastroparesis|gastroparesis
220229|NCT02025725|Diabetic|diabetic
220230|NCT02025725|Delayed gastric emptying|delayed gastric emptying
220231|NCT02025725|Gastric stasis|gastric stasis
220232|NCT02025725|Nausea|nausea
220233|NCT02025725|Vomiting|vomiting
220234|NCT02025725|Bloating|bloating
220235|NCT02025725|Abdominal pain|abdominal pain
220236|NCT02025725|Early satiety|early satiety
220237|NCT02025725|Gastropathy|gastropathy
220238|NCT02025686|Pain|pain
220239|NCT02025686|Inflammation|inflammation
220240|NCT02025686|Hyperalgesia|hyperalgesia
220241|NCT02025686|burn injury|burn injury
220242|NCT02025686|Hyperbaric Oxygen|hyperbaric oxygen
220243|NCT02025660|Mw|mw
220244|NCT02025660|Mycobacterium indicum prannii|mycobacterium indicum prannii
220245|NCT02025660|Mycobacterium w|mycobacterium w
220246|NCT02025660|Severe sepsis|severe sepsis
220247|NCT02025660|Septic shock|septic shock
220248|NCT02025647|Mood disorders|mood disorders
220249|NCT02025647|Anxiety disorders|anxiety disorders
220250|NCT02025647|Eating concerns|eating concerns
220251|NCT02025647|Pain concerns|pain concerns
220252|NCT02025647|Alcohol abuse|alcohol abuse
220253|NCT02025647|Self harm|self harm
220254|NCT02025647|Mental health|mental health
220255|NCT02025647|Clinical Decision Support|clinical decision support
220256|NCT02025634|Pain, Postoperative|pain, postoperative
220257|NCT02025634|Ofirmev|ofirmev
220258|NCT02025634|Acetaminophen|acetaminophen
220259|NCT02025634|Analgesics, Non-Narcotic|analgesics, non-narcotic
220260|NCT02025634|Arthroscopy|arthroscopy
220261|NCT02025621|coronary artery bypass grafting|coronary artery bypass grafting
220262|NCT02025621|CABG|cabg
220263|NCT02025621|mitral valve|mitral valve
220264|NCT02025621|LCOS|lcos
220265|NCT02025621|low cardiac output syndrome|low cardiac output syndrome
220266|NCT02025621|levosimendan|levosimendan
220267|NCT02025608|Restless legs syndrome|restless legs syndrome
220268|NCT02025595|Brain|brain
220269|NCT02025595|Genes|genes
220270|NCT02025595|Environment|environment
220271|NCT02025595|Etiology|etiology
220272|NCT02025595|Reward|reward
220273|NCT02025595|Satiety Response|satiety response
220274|NCT02025595|Central Nervous System|central nervous system
220275|NCT02025595|Magnetic Resonance Imaging|magnetic resonance imaging
220276|NCT02025595|Twins, Monozygotic|twins, monozygotic
220277|NCT02025595|Overweight|overweight
220278|NCT02025595|Obesity|obesity
220279|NCT02025582|idiopathic toe walking|idiopathic toe walking
220280|NCT02025582|gait disorder|gait disorder
220281|NCT02025582|gait analysis|gait analysis
220282|NCT02025582|kinesio taping|kinesio taping
220283|NCT02025582|ultrasound elastography|ultrasound elastography
220284|NCT02025582|pediatric|pediatric
220285|NCT02025582|children|children
270453|NCT01797224|TNF|tnf
220286|NCT02025582|muscle stiffness|muscle stiffness
220287|NCT02025582|muscle elasticity|muscle elasticity
220288|NCT02025569|chronic ankle instability|chronic ankle instability
220289|NCT02025569|lateral ankle sprain|lateral ankle sprain
220290|NCT02025569|manual therapy|manual therapy
220291|NCT02025569|star excursion balance test|star excursion balance test
220292|NCT02025569|strain and counterstrain|strain and counterstrain
220293|NCT02025556|High Frequency Episodic Migraine Headache|high frequency episodic migraine headache
220294|NCT02025556|Episodic Migraine Headache|episodic migraine headache
220295|NCT02025556|Migraine Headache|migraine headache
220296|NCT02025543|MRI|mri
220297|NCT02025543|Iron overload|iron overload
220298|NCT02025530|Stillbirth|stillbirth
220299|NCT02025530|Modifiable risk factors|modifiable risk factors
220300|NCT02025517|Parkinson's disease|parkinson's disease
220301|NCT02025517|rehabilitation|rehabilitation
220302|NCT02025517|kinematics|kinematics
220303|NCT02025517|cognition|cognition
220304|NCT02025504|Colonoscopy, Looping, Sigmoid Looping, ColoWrap, Binder, Patient Satisfaction|colonoscopy, looping, sigmoid looping, colowrap, binder, patient satisfaction
220305|NCT02025491|Disseminated leishmaniasis|disseminated leishmaniasis
220306|NCT02025491|Liposomal Amphotericin B|liposomal amphotericin b
220307|NCT02025491|Leishmania braziliensis|leishmania braziliensis
220308|NCT02025478|children|children
220309|NCT02025478|bone marrow transplant|bone marrow transplant
220310|NCT02025478|autologous|autologous
220311|NCT02025478|allogeneic|allogeneic
220312|NCT02025478|breastmilk|breastmilk
220313|NCT02025478|hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
220314|NCT02025465|Atrial Fibrillation|atrial fibrillation
220315|NCT02025465|Atrial Flutter|atrial flutter
220316|NCT02025465|Metoprolol|metoprolol
220317|NCT02025465|Diltiazem|diltiazem
220318|NCT02025452|diarrhoea|diarrhoea
220319|NCT02025452|gastroenteritis|gastroenteritis
220320|NCT02025452|rapid diagnostics|rapid diagnostics
220321|NCT02025452|probiotics|probiotics
220322|NCT02025452|sub-Saharan Africa|sub-saharan africa
220323|NCT02025439|Traumatic Brain Injury|traumatic brain injury
220324|NCT02025439|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
220325|NCT02025439|Amantadine|amantadine
220326|NCT02025439|Vegetative State|vegetative state
220327|NCT02025439|Minimally Conscious State|minimally conscious state
220328|NCT02025426|Cesarean delivery|cesarean delivery
220329|NCT02025426|Spinal Anesthesia|spinal anesthesia
220330|NCT02025400|Rehabilitation|rehabilitation
220332|NCT02025400|Physical Therapy|physical therapy
220333|NCT02025400|e-Health|e-health
220334|NCT02025400|Telemedicine|telemedicine
220335|NCT02025400|Telerehabilitation|telerehabilitation
220336|NCT02025400|Patient-Centered|patient-centered
220337|NCT02025374|spinal anesthesia|spinal anesthesia
220338|NCT02025374|cesarean section|cesarean section
220339|NCT02025374|hyperbaric levobupivacaine|hyperbaric levobupivacaine
220340|NCT02025361|prostate biopsy, local anesthesia, cancer detection rate.|prostate biopsy, local anesthesia, cancer detection rate.
220341|NCT02025322|HIV/AIDS|hiv/aids
220342|NCT02025322|Peer Mentoring|peer mentoring
220343|NCT02025322|Medication Adherence|medication adherence
220344|NCT02025322|Medication Non-adherent|medication non-adherent
220345|NCT02025322|Newly diagnosed|newly diagnosed
220346|NCT02025322|HIV-positive individuals|hiv-positive individuals
220347|NCT02025322|HIV viral load|hiv viral load
220348|NCT02025322|CD4 lymphocyte cell counts|cd4 lymphocyte cell counts
220349|NCT02025322|Treatment adherence|treatment adherence
220350|NCT02025322|Health literacy|health literacy
220351|NCT02025322|Self-efficacy|self-efficacy
220352|NCT02025309|train of four|train of four
220353|NCT02025309|neuromuscular recovery|neuromuscular recovery
220354|NCT02025309|sugammadex|sugammadex
220355|NCT02025296|Telemedicine|telemedicine
220356|NCT02025296|Clinical decision support system|clinical decision support system
220357|NCT02025296|Ubiquitous healthcare|ubiquitous healthcare
220358|NCT02025296|Diabetes Care|diabetes care
220359|NCT02025296|Multifactorial Intervention|multifactorial intervention
220360|NCT02025283|Intervertebral disc disease|intervertebral disc disease
220361|NCT02025283|Radiculopathy|radiculopathy
220362|NCT02025283|Chronic pain|chronic pain
220363|NCT02025283|Thermocoagulation|thermocoagulation
220364|NCT02025270|Azoospermia, Spermatogonial Arrest, Maturation Arrest.|azoospermia, spermatogonial arrest, maturation arrest.
220365|NCT02025257|coronary artery disease|coronary artery disease
220366|NCT02025257|elderly|elderly
220367|NCT02025257|exercise|exercise
220368|NCT02025257|exercise-based cardiac rehabilitation|exercise-based cardiac rehabilitation
220369|NCT02025244|Key hole biopsy|key hole biopsy
220370|NCT02025244|Upper Gastrointestinal Submucosal Tumors|upper gastrointestinal submucosal tumors
220371|NCT02025244|EUS-FNA|eus-fna
220372|NCT02025244|Mitototic Activity|mitototic activity
220373|NCT02025244|GIST|gist
220374|NCT02025231|reirradiation|reirradiation
220375|NCT02025231|recurrent glioma|recurrent glioma
220376|NCT02025231|positron emission tomography|positron emission tomography
270568|NCT01796743|MRI|mri
211184|NCT02066311|SLE|sle
220377|NCT02025231|amino acid tracer|amino acid tracer
220378|NCT02025218|NSCLC|nsclc
220379|NCT02025218|EGFR|egfr
220380|NCT02025218|TKI|tki
220381|NCT02025218|Re-challenge|re-challenge
220382|NCT02025218|Lung Cancer|lung cancer
220383|NCT02025218|Resistance|resistance
220384|NCT02025192|ONT-380|ont-380
220484|NCT02024763|Children|children
220385|NCT02025192|Capecitabine|capecitabine
220386|NCT02025192|Trastuzumab|trastuzumab
220387|NCT02025192|Xeloda|xeloda
220388|NCT02025192|Herceptin|herceptin
220389|NCT02025192|HER2 positive breast cancer|her2 positive breast cancer
220390|NCT02025192|Breast cancer|breast cancer
220391|NCT02025192|ARRY-380|arry-380
220392|NCT02025192|Tucatinib|tucatinib
220393|NCT02025179|Teriparatide|teriparatide
220394|NCT02025179|Osteoporosis|osteoporosis
220395|NCT02025179|Spinal Cord Injury|spinal cord injury
220396|NCT02025179|Bone Diseases|bone diseases
220397|NCT02025179|Metabolic Bone Diseases|metabolic bone diseases
220398|NCT02025179|Musculoskeletal Diseases|musculoskeletal diseases
220399|NCT02025179|Spinal Cord Diseases|spinal cord diseases
220400|NCT02025179|Central Nervous System Diseases|central nervous system diseases
220401|NCT02025179|Nervous System Diseases|nervous system diseases
220402|NCT02025179|Nervous System|nervous system
220403|NCT02025179|Wounds and Injuries|wounds and injuries
220404|NCT02025179|Bone Density Conservation Agents|bone density conservation agents
220405|NCT02025179|Physiological Effects of Drugs|physiological effects of drugs
220406|NCT02025179|Pharmacologic Actions|pharmacologic actions
220407|NCT02025179|Vibration|vibration
220408|NCT02025166|Pain|pain
220409|NCT02025166|abortion|abortion
220410|NCT02025166|paracetamol|paracetamol
220411|NCT02025166|lornoxicam|lornoxicam
220412|NCT02025140|Computer controlled anesthesia (CCLAD)|computer controlled anesthesia (cclad)
220413|NCT02025140|pain perception|pain perception
220414|NCT02025140|Effectiveness|effectiveness
220415|NCT02025140|primary molars|primary molars
220416|NCT02025140|Behavior|behavior
220417|NCT02025127|septic shock|septic shock
220418|NCT02025127|mechanical ventilation|mechanical ventilation
220419|NCT02025127|enteral nutrition|enteral nutrition
220420|NCT02025127|trophic feeding|trophic feeding
220421|NCT02025114|NSCLC, EGFR mutation|nsclc, egfr mutation
220422|NCT02025101|Slow Coronary Flow|slow coronary flow
220423|NCT02025075|Tomography|tomography
220424|NCT02025075|Oximetry|oximetry
220425|NCT02025075|Echocardiography|echocardiography
220426|NCT02025062|head and neck squamous cell carcinomas (HNSCCs)|head and neck squamous cell carcinomas (hnsccs)
220427|NCT02025062|elderly|elderly
220428|NCT02025062|cancer|cancer
220429|NCT02025062|comprehensive geriatric assessment|comprehensive geriatric assessment
220430|NCT02025062|functional status|functional status
220431|NCT02025062|malnutrition|malnutrition
220432|NCT02025062|survival|survival
220433|NCT02025049|pancreatitis|pancreatitis
220434|NCT02025036|Chemoradiotherapy， Esophageal Squamous Cancer|chemoradiotherapy， esophageal squamous cancer
220435|NCT02025023|Size|size
220436|NCT02025023|Pain|pain
220437|NCT02025023|Resolution|resolution
220438|NCT02025023|Complications|complications
220439|NCT02025023|Swelling|swelling
220440|NCT02025010|castration-resistant prostate cancer|castration-resistant prostate cancer
220441|NCT02024997|Pancreatic malignancy|pancreatic malignancy
220442|NCT02024997|Radiation Therapy|radiation therapy
220443|NCT02024984|LPFPCCPCOS|lpfpccpcos
220444|NCT02024971|Drug therapy|drug therapy
220445|NCT02024958|Adult ICU patients|adult icu patients
220446|NCT02024958|spontaneous breathing|spontaneous breathing
220447|NCT02024958|invasive ventilation|invasive ventilation
220448|NCT02024958|non-invasive ventilation|non-invasive ventilation
220449|NCT02024945|Drug therapy|drug therapy
220450|NCT02024906|isoflavone|isoflavone
220451|NCT02024906|CVD|cvd
220452|NCT02024906|soy intake|soy intake
220453|NCT02024906|subclinical hypothyroid|subclinical hypothyroid
220454|NCT02024893|Humeral retroversion|humeral retroversion
220455|NCT02024893|dynamic control ratio|dynamic control ratio
220456|NCT02024893|GIRD|gird
220457|NCT02024880|in vitro fertilization|in vitro fertilization
220458|NCT02024880|embryo transfer|embryo transfer
220459|NCT02024880|transfer catheter|transfer catheter
220460|NCT02024867|Methicillin resistent Staphylococcus aureus|methicillin resistent staphylococcus aureus
220461|NCT02024867|Staphylococcus aureus|staphylococcus aureus
220462|NCT02024854|Kangaroo-Mother Care Method|kangaroo-mother care method
220463|NCT02024854|Stress, Physiological|stress, physiological
220464|NCT02024841|Gastric cancer|gastric cancer
220465|NCT02024841|Peritoneal carcinomatosis|peritoneal carcinomatosis
220466|NCT02024841|Intraperitoneal docetaxel|intraperitoneal docetaxel
220467|NCT02024841|Cisplatin|cisplatin
220468|NCT02024841|TS-ONE|ts-one
220469|NCT02024828|Infant feeding|infant feeding
220470|NCT02024802|Pain|pain
220471|NCT02024802|Pain Cream|pain cream
220472|NCT02024802|Nociceptive pain|nociceptive pain
220473|NCT02024802|neurologic pain|neurologic pain
220474|NCT02024802|transdermal|transdermal
220475|NCT02024802|compounding|compounding
220476|NCT02024802|compound|compound
220477|NCT02024776|Training|training
220478|NCT02024776|Wellness|wellness
220479|NCT02024776|Aerobic capacity|aerobic capacity
220480|NCT02024776|Information and communication technology, surgical risk|information and communication technology, surgical risk
220481|NCT02024776|Abdominal surgery|abdominal surgery
220482|NCT02024763|Energy Expenditure|energy expenditure
220483|NCT02024763|Physical Education|physical education
220485|NCT02024763|Randomized Controlled Trial|randomized controlled trial
220486|NCT02024750|Family centered care|family centered care
220487|NCT02024750|Patient centered care|patient centered care
220488|NCT02024750|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
220489|NCT02024750|Problem Recognition in Illness Self-Management (PRISM)|problem recognition in illness self-management (prism)
220490|NCT02024711|Cataract|cataract
220491|NCT02024711|Intraocular Lens|intraocular lens
220492|NCT02024711|IOL|iol
220493|NCT02024711|Aphakia|aphakia
220494|NCT02024685|Prostate|prostate
220495|NCT02024685|Localized Prostate Cancer|localized prostate cancer
220496|NCT02024685|Decision making|decision making
220497|NCT02024672|Intrauterine devices|intrauterine devices
220498|NCT02024672|IUDs|iuds
220499|NCT02024672|postpartum|postpartum
220500|NCT02024672|contraception|contraception
220501|NCT02024659|nasal polyps|nasal polyps
220502|NCT02024659|remodeling|remodeling
220503|NCT02024659|inflammatory cells|inflammatory cells
220504|NCT02024659|budesonide|budesonide
220505|NCT02024646|Psoriatic Arthritis|psoriatic arthritis
220506|NCT02024646|Brodalumab|brodalumab
220507|NCT02024646|AMG 827|amg 827
220508|NCT02024620|depression|depression
220509|NCT02024620|technology|technology
220510|NCT02024620|psychotherapy|psychotherapy
220511|NCT02024620|behavioral activation|behavioral activation
220512|NCT02024594|Nitrous Oxide-Oxygen conscious sedation|nitrous oxide-oxygen conscious sedation
220513|NCT02024594|Cognitive Behavioral Therapy|cognitive behavioral therapy
220514|NCT02024594|Children, Preschool|children, preschool
220515|NCT02024594|dental anxiety|dental anxiety
220516|NCT02024594|Patient Cooperation|patient cooperation
220517|NCT02024581|pediatric|pediatric
220518|NCT02024581|dermatology|dermatology
220519|NCT02024581|East Indian sandalwood oil|east indian sandalwood oil
220520|NCT02024581|pox virus|pox virus
220521|NCT02024568|Pregabalin|pregabalin
220522|NCT02024568|Arthralgia Myalgia Syndrome|arthralgia myalgia syndrome
220523|NCT02024568|Paclitaxel|paclitaxel
220524|NCT02024568|Pain management|pain management
220525|NCT02024568|Breast cancer|breast cancer
220526|NCT02024542|Bariatric Surgery|bariatric surgery
220527|NCT02024542|Obesity|obesity
220528|NCT02024542|Metabolic syndrome|metabolic syndrome
220529|NCT02024542|Diabetes|diabetes
220530|NCT02024516|Type 2 diabetes|type 2 diabetes
220531|NCT02024516|Pomegranate|pomegranate
220532|NCT02024516|Inflammation|inflammation
220533|NCT02024516|lipid profiles|lipid profiles
220534|NCT02024503|stroke|stroke
220535|NCT02024503|fMRI|fmri
220536|NCT02024503|DTI|dti
220537|NCT02024490|vitamin D, prematurity, RDS, BPD, maternal, neonatal|vitamin d, prematurity, rds, bpd, maternal, neonatal
220538|NCT02024477|endothelial cells|endothelial cells
220539|NCT02024477|cellular biomarker|cellular biomarker
220540|NCT02024477|endothelial dysfunction|endothelial dysfunction
220541|NCT02024464|Primary open angle glaucoma|primary open angle glaucoma
220542|NCT02024464|POAG|poag
220543|NCT02024464|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
220544|NCT02024464|PXG|pxg
220545|NCT02024464|Pigmentary dispersion glaucoma|pigmentary dispersion glaucoma
220546|NCT02024464|PDG|pdg
220547|NCT02024464|Hydrus|hydrus
220548|NCT02024451|Radial shock wave|radial shock wave
220549|NCT02024451|Acupuncture|acupuncture
220550|NCT02024438|metastatic gastric cancer|metastatic gastric cancer
220551|NCT02024438|neurotoxicity|neurotoxicity
220552|NCT02024438|mFOLFOX6|mfolfox6
220553|NCT02024438|monosialotetrahexosylganglioside Sodium Injection|monosialotetrahexosylganglioside sodium injection
220554|NCT02024425|Clinical trials|clinical trials
220555|NCT02024425|Adult|adult
220556|NCT02024425|Women|women
220557|NCT02024425|Functional food|functional food
220558|NCT02024425|Dietary Supplements|dietary supplements
220559|NCT02024425|Overweight|overweight
220560|NCT02024425|Obese|obese
220561|NCT02024425|Absorptiometry, Dual X-Ray|absorptiometry, dual x-ray
220562|NCT02024425|Rosmarinus|rosmarinus
220563|NCT02024425|Oligosaccharides|oligosaccharides
220564|NCT02024425|Lactulose|lactulose
220565|NCT02024425|Bioactive peptide|bioactive peptide
220566|NCT02024412|metastatic colorectal cancer|metastatic colorectal cancer
220567|NCT02024412|neurotoxicity|neurotoxicity
220568|NCT02024412|mFOLFOX6|mfolfox6
220569|NCT02024412|monosialotetrahexosylganglioside Sodium Injection|monosialotetrahexosylganglioside sodium injection
220570|NCT02024399|Pediatric Overweight/Obesity, DEXA, Fitness|pediatric overweight/obesity, dexa, fitness
220571|NCT02024386|Guanylate Cyclase|guanylate cyclase
220572|NCT02024386|Pulmonary Edema of Mountaineers|pulmonary edema of mountaineers
220573|NCT02024386|Mountaineering|mountaineering
220574|NCT02024386|Performance-Enhancing Substances|performance-enhancing substances
220575|NCT02024386|Athletic Performance|athletic performance
220576|NCT02024373|chronic subdural hematoma|chronic subdural hematoma
220577|NCT02024373|Atorvastatin|atorvastatin
220578|NCT02024373|oral administration therapy|oral administration therapy
220579|NCT02024360|obesity|obesity
220580|NCT02024360|overweight|overweight
220581|NCT02024360|children|children
220582|NCT02024360|prevention|prevention
220583|NCT02024334|JIA|jia
220584|NCT02024334|LEFLUNOMIDE|leflunomide
220585|NCT02024334|EFFICACY|efficacy
220586|NCT02024321|abdominal surgery|abdominal surgery
220587|NCT02024321|TPN|tpn
220588|NCT02024321|blood glucose|blood glucose
220589|NCT02024308|acute myeloid leukemia,|acute myeloid leukemia,
220590|NCT02024308|AML1-ETO fusion protein,|aml1-eto fusion protein,
220591|NCT02024308|Fludarabine,|fludarabine,
220592|NCT02024308|recurrence|recurrence
220593|NCT02024269|macular degeneration|macular degeneration
220594|NCT02024269|stem cells|stem cells
220595|NCT02024269|adipose stem cells|adipose stem cells
220596|NCT02024256|Vaginal delivery|vaginal delivery
220597|NCT02024256|Perineal swelling|perineal swelling
220598|NCT02024256|Perineal pain|perineal pain
220599|NCT02024256|MgSo4|mgso4
220600|NCT02024256|Magnesium sulfate|magnesium sulfate
220601|NCT02024256|Cold water|cold water
220602|NCT02024243|Micro RNA|micro rna
220603|NCT02024243|Wound|wound
220604|NCT02024243|Chronic Venous Leg Ulcer|chronic venous leg ulcer
220605|NCT02024243|VLU|vlu
220606|NCT02024243|miR210|mir210
220607|NCT02024243|OSU Comprehensive Wound Center|osu comprehensive wound center
220608|NCT02024204|World Trade Center Disaster|world trade center disaster
220609|NCT02024204|Environmental Exposure|environmental exposure
220610|NCT02024204|Respiratory Physiology|respiratory physiology
220611|NCT02024204|Inflammation|inflammation
220612|NCT02024204|Gastrointestinal Diseases|gastrointestinal diseases
220613|NCT02024204|Sinus Symptoms|sinus symptoms
220614|NCT02024204|PTSD|ptsd
220615|NCT02024204|Anxiety|anxiety
220616|NCT02024204|Depression|depression
220617|NCT02024204|Hypersensitivity|hypersensitivity
220618|NCT02024204|Spirometry|spirometry
220619|NCT02024204|Oscillometry|oscillometry
220620|NCT02024191|glutamine|glutamine
220621|NCT02024191|oxaliplatin|oxaliplatin
220622|NCT02024191|peripheral neuropathy|peripheral neuropathy
220623|NCT02024178|Prostate Cancer|prostate cancer
220624|NCT02024178|Radical Prostatectomy|radical prostatectomy
220625|NCT02024178|Ultrasound Imaging|ultrasound imaging
220626|NCT02024165|Ultrasound|ultrasound
220627|NCT02024165|FSE|fse
220628|NCT02024165|IUPC|iupc
220629|NCT02024139|Orthodontic pain|orthodontic pain
220630|NCT02024139|Chewing gum|chewing gum
220631|NCT02024126|Knee osteoarthritis|knee osteoarthritis
220632|NCT02024126|Exercise therapy|exercise therapy
220633|NCT02024126|RCT|rct
220634|NCT02024126|Intervention|intervention
220635|NCT02024126|Knee pain|knee pain
220636|NCT02024126|Muticenter|muticenter
220637|NCT02024126|Knee function|knee function
220638|NCT02024113|validation|validation
220639|NCT02024113|model|model
220640|NCT02024113|metabolic profile|metabolic profile
220641|NCT02024113|positron emission tomography|positron emission tomography
220642|NCT02024061|Adolescents|adolescents
220643|NCT02024061|Obesity|obesity
220644|NCT02024061|Physical activity|physical activity
220645|NCT02024061|Sedentary behavior|sedentary behavior
220646|NCT02024061|Psychosocial health|psychosocial health
220647|NCT02024048|Pregnancy|pregnancy
220648|NCT02024048|OCT|oct
220649|NCT02024048|Enhanced depth imaging|enhanced depth imaging
220650|NCT02024048|Choroid|choroid
220651|NCT02024035|Tomotherapy|tomotherapy
220652|NCT02024035|Head and neck squamous celle carcinoma|head and neck squamous celle carcinoma
220653|NCT02024035|Health economic evaluation|health economic evaluation
220654|NCT02024022|colonoscopy|colonoscopy
220655|NCT02024022|bowel cleansing|bowel cleansing
220656|NCT02024022|polyethylene glycol|polyethylene glycol
220657|NCT02024022|sodium picosulphate / magnesium citrate|sodium picosulphate / magnesium citrate
220658|NCT02024009|chemoradiotherapy|chemoradiotherapy
220659|NCT02024009|nelfinavir|nelfinavir
220660|NCT02024009|abraxane|abraxane
220661|NCT02024009|gemcitabine|gemcitabine
220662|NCT02024009|radiotherapy|radiotherapy
220663|NCT02024009|capecitabine|capecitabine
220664|NCT02023996|HER2 positive|her2 positive
220665|NCT02023996|PET Imaging|pet imaging
220666|NCT02023996|89Zr-DFO-trastuzumab|89zr-dfo-trastuzumab
220667|NCT02023996|13-165|13-165
220668|NCT02023983|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
220669|NCT02023983|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
220670|NCT02023983|Low risk|low risk
220671|NCT02023983|Early discharge|early discharge
402954|NCT01228903|uric acid kidney disease endothelial dysfunction|uric acid kidney disease endothelial dysfunction
221569|NCT02019615|stroke|stroke
220672|NCT02023970|Bioprosthetic heart valves, immune response, structural valve deterioration, valvular disease.|bioprosthetic heart valves, immune response, structural valve deterioration, valvular disease.
220673|NCT02023957|Interactive Health-risk assessment|interactive health-risk assessment
220674|NCT02023957|Primary Care|primary care
220675|NCT02023957|Randomized|randomized
220676|NCT02023957|Open Label|open label
220677|NCT02023957|Efficacy Study|efficacy study
220678|NCT02023944|Memory|memory
220679|NCT02023944|Aging|aging
220680|NCT02023944|Healthy People|healthy people
220681|NCT02023944|Intervention|intervention
220682|NCT02023931|Oral mucosa|oral mucosa
220683|NCT02023931|Nrf2 pathway|nrf2 pathway
220684|NCT02023931|Broccoli Sprout Extract|broccoli sprout extract
220685|NCT02023931|Head and Neck Cancer|head and neck cancer
220686|NCT02023918|Growth hormone antagonism|growth hormone antagonism
220687|NCT02023866|Leigh Syndrome|leigh syndrome
220688|NCT02023866|Leber's hereditary optic neuropathy|leber's hereditary optic neuropathy
220689|NCT02023866|myoclonic epilepsy|myoclonic epilepsy
220690|NCT02023866|mitochondrial encephalomyopathy|mitochondrial encephalomyopathy
220691|NCT02023866|Kearn-Sayre syndrome|kearn-sayre syndrome
220692|NCT02023866|POLG-related disorders|polg-related disorders
220693|NCT02023866|Neurogastrointestinal encephalopathy|neurogastrointestinal encephalopathy
220694|NCT02023840|periodontitis|periodontitis
220695|NCT02023840|pockets|pockets
220696|NCT02023827|Transtheoretical Model|transtheoretical model
220697|NCT02023827|Stages of change|stages of change
220698|NCT02023827|Computer-tailored intervention|computer-tailored intervention
220699|NCT02023827|Delinquency|delinquency
220700|NCT02023827|Substance abuse|substance abuse
220701|NCT02023827|Juvenile offender|juvenile offender
220702|NCT02023827|Juvenile justice|juvenile justice
220703|NCT02023827|Rise Above Your Situation (RAYS) program|rise above your situation (rays) program
220704|NCT02023801|Menorrhagia|menorrhagia
220705|NCT02023801|Dysfunctional Uterine Bleeding|dysfunctional uterine bleeding
220706|NCT02023801|Endometrial Ablation|endometrial ablation
220707|NCT02023788|human umbilical cord blood-derived mesenchymal stem cells|human umbilical cord blood-derived mesenchymal stem cells
220708|NCT02023788|bronchopulmonary dysplasia|bronchopulmonary dysplasia
220709|NCT02023788|respiratory tract infection|respiratory tract infection
220710|NCT02023788|Premature infants|premature infants
220711|NCT02023762|mitral regurgitation|mitral regurgitation
220712|NCT02023762|local anaesthesia|local anaesthesia
220713|NCT02023762|percutaneous repair|percutaneous repair
220714|NCT02023749|nuts|nuts
220715|NCT02023749|metabolic syndrome|metabolic syndrome
220716|NCT02023749|lipid profile|lipid profile
220717|NCT02023749|inflammation|inflammation
220718|NCT02023749|oxidative stress|oxidative stress
220719|NCT02023749|endothelial function|endothelial function
220720|NCT02023723|Energy Drink|energy drink
220721|NCT02023723|Electrocardiograph|electrocardiograph
220722|NCT02023723|Hemodynamic|hemodynamic
220723|NCT02023710|mucosal melanoma|mucosal melanoma
220724|NCT02023710|Bevacizumab|bevacizumab
220725|NCT02023710|Carboplatin|carboplatin
220726|NCT02023710|Paclitaxel|paclitaxel
220727|NCT02023684|Sleeve Gastrectomy|sleeve gastrectomy
220728|NCT02023684|Lidocaine|lidocaine
220729|NCT02023684|ropivacaine|ropivacaine
220730|NCT02023658|HIV|hiv
220731|NCT02023658|pMTCT|pmtct
220732|NCT02023645|lutein|lutein
220733|NCT02023645|cognition|cognition
220734|NCT02023645|neural efficiency|neural efficiency
220735|NCT02023645|aging|aging
220736|NCT02023632|older adults|older adults
220737|NCT02023632|physical activity|physical activity
220738|NCT02023632|self-categorization|self-categorization
220739|NCT02023632|group dynamics|group dynamics
220740|NCT02023632|self-identity|self-identity
220741|NCT02023619|Keratoconus|keratoconus
220742|NCT02023619|Astigmatism|astigmatism
220743|NCT02023619|Cornea|cornea
220744|NCT02023619|SD-OCT|sd-oct
220745|NCT02023606|Impulsive Aggression|impulsive aggression
220746|NCT02023606|ADHD|adhd
220747|NCT02023580|Viral suppression|viral suppression
220748|NCT02023580|Sexual risk|sexual risk
220749|NCT02023554|azithromycin|azithromycin
220750|NCT02023554|theophylline|theophylline
220751|NCT02023554|CYP3A4|cyp3a4
220752|NCT02023515|weight loss|weight loss
220753|NCT02023515|metabolic syndrome|metabolic syndrome
220754|NCT02023515|stress|stress
220755|NCT02023515|obesity|obesity
220756|NCT02023502|female stress urinary incontinence|female stress urinary incontinence
220757|NCT02023502|proteomics|proteomics
220758|NCT02023502|biomarker|biomarker
220759|NCT02023424|BDNF|bdnf
220760|NCT02023424|GLATIRAMER ACETATE|glatiramer acetate
220761|NCT02023424|RETT SYNDROME|rett syndrome
220762|NCT02023424|COPAXONE|copaxone
220763|NCT02023424|Bruria Ben-Zeev|bruria ben-zeev
220764|NCT02023411|Teriparatide|teriparatide
220765|NCT02023411|Inactive Charcot's neuroarthropathy|inactive charcot's neuroarthropathy
220766|NCT02023398|High Frequency|high frequency
220767|NCT02023398|Waist circumferential reduction|waist circumferential reduction
220768|NCT02023385|Low Level Laser Therapy|low level laser therapy
211564|NCT02064699|CMV|cmv
211565|NCT02064699|Test QuantiFERON-CMV|test quantiferon-cmv
211566|NCT02064673|prostate cancer|prostate cancer
220769|NCT02023385|LLLT|lllt
220770|NCT02023385|Waist circumferential reduction|waist circumferential reduction
220771|NCT02023372|NuCel|nucel
220772|NCT02023372|Lumbar Spine|lumbar spine
220773|NCT02023372|Degenerative Disease|degenerative disease
220774|NCT02023372|Efficacy|efficacy
220775|NCT02023372|Fusion|fusion
220776|NCT02023359|Advanced breast cancer|advanced breast cancer
220777|NCT02023359|Everolimus|everolimus
220778|NCT02023346|Patient-Physician Communication|patient-physician communication
220779|NCT02023346|Brain cancer|brain cancer
220780|NCT02023346|13-253|13-253
220781|NCT02023333|Regorafenib|regorafenib
220782|NCT02023333|Performance Status|performance status
220783|NCT02023333|13-211|13-211
220784|NCT02023281|Depression|depression
220785|NCT02023281|Exercise|exercise
220786|NCT02023281|Neurotransmitters|neurotransmitters
220787|NCT02023281|Catecholimines|catecholimines
220788|NCT02023281|EEG|eeg
220789|NCT02023255|Healthy|healthy
220790|NCT02023255|JNJ-39393406|jnj-39393406
220791|NCT02023255|Safety|safety
220792|NCT02023255|Tolerability|tolerability
220793|NCT02023255|Pharmacokinetics|pharmacokinetics
220794|NCT02023242|Primary open angle glaucoma|primary open angle glaucoma
220795|NCT02023242|POAG|poag
220796|NCT02023242|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
220797|NCT02023242|PXG|pxg
220798|NCT02023242|Pigmentary glaucoma|pigmentary glaucoma
220799|NCT02023242|PG|pg
220800|NCT02023242|Hydrus|hydrus
220801|NCT02023229|Branched chain aminoacids|branched chain aminoacids
220802|NCT02023229|Nutritional status|nutritional status
220803|NCT02023229|Hepatic encephalopathy|hepatic encephalopathy
220804|NCT02023216|Preterm infants|preterm infants
220805|NCT02023216|Non-nutritive sucking|non-nutritive sucking
220806|NCT02023216|Pacifier|pacifier
220807|NCT02023216|Gastro-esophageal reflux|gastro-esophageal reflux
220808|NCT02023216|pH-multiple intraluminal impedance|ph-multiple intraluminal impedance
220809|NCT02023216|Apneas|apneas
220810|NCT02023216|Bradycardias|bradycardias
220811|NCT02023216|Hypoxic episodes|hypoxic episodes
220812|NCT02023216|Polysomnographic monitoring|polysomnographic monitoring
220813|NCT02023190|liver cirrhosis|liver cirrhosis
220814|NCT02023190|liver transplant|liver transplant
220815|NCT02023190|nutritional status|nutritional status
220816|NCT02023190|bioelectrical impedance vector analysis|bioelectrical impedance vector analysis
220817|NCT02023177|phase angle|phase angle
220818|NCT02023177|liver cirrhosis|liver cirrhosis
220819|NCT02023177|mortality|mortality
220820|NCT02023177|malnutrition|malnutrition
220821|NCT02023138|Clinical practice guideline|clinical practice guideline
220822|NCT02023138|Brain injury|brain injury
220823|NCT02023138|Acceptability|acceptability
220824|NCT02023138|Feasibility|feasibility
220825|NCT02023138|Effectiveness|effectiveness
220826|NCT02023112|Japanese|japanese
220827|NCT02023112|Hepatitis C|hepatitis c
220828|NCT02023112|Treatment naive|treatment naive
220829|NCT02023112|Treatment experienced|treatment experienced
220830|NCT02023112|Genotype 2|genotype 2
220831|NCT02023112|Ombitasvir|ombitasvir
220832|NCT02023112|Paritaprevir|paritaprevir
220833|NCT02023112|Ritonavir|ritonavir
220834|NCT02023112|Ribavirin|ribavirin
220835|NCT02023112|VIEKIRAX Combination Tablets|viekirax combination tablets
220836|NCT02023099|Hepatitis C|hepatitis c
220837|NCT02023099|Genotype 1b|genotype 1b
220838|NCT02023099|Cirrhotic|cirrhotic
220839|NCT02023099|Treatment Experienced|treatment experienced
220840|NCT02023099|Treatment Naive|treatment naive
220841|NCT02023099|Japanese|japanese
220842|NCT02023099|ombitasvir|ombitasvir
220843|NCT02023099|paritaprevir|paritaprevir
220844|NCT02023099|ritonavir|ritonavir
220845|NCT02023099|VIEKIRAX Combination Tablets|viekirax combination tablets
220846|NCT02023086|Visual field defect|visual field defect
220847|NCT02023086|Blood oxygenation|blood oxygenation
220848|NCT02023086|Optic nerve Head|optic nerve head
220849|NCT02023047|Anal Fissure|anal fissure
220850|NCT02023047|Nifedipine|nifedipine
220851|NCT02023034|Parkinson's disease, Physical Therapy, Fatigue, Quality of Life|parkinson's disease, physical therapy, fatigue, quality of life
220852|NCT02023021|Pancreatic Cancer; Pancreatic Adenocarcinoma; Nab-paclitaxel; Gemcitabine; Adjuvant Therapy|pancreatic cancer; pancreatic adenocarcinoma; nab-paclitaxel; gemcitabine; adjuvant therapy
220853|NCT02022995|EGFR|egfr
220854|NCT02022995|cetuximab|cetuximab
220855|NCT02022995|colon cancer|colon cancer
220856|NCT02022982|KRAS mutant Non-Small Cell Lung Cancer|kras mutant non-small cell lung cancer
220857|NCT02022982|Solid Tumors|solid tumors
220858|NCT02022969|atelectasis|atelectasis
220859|NCT02022969|SPO2 - oscillations|spo2 - oscillations
220860|NCT02022943|Alzheimer's|alzheimer's
220861|NCT02022943|prevention|prevention
220862|NCT02022930|Osteoarthritis|osteoarthritis
220863|NCT02022930|Knee|knee
220864|NCT02022917|ovarian cancer.|ovarian cancer.
220865|NCT02022917|tubal cancer|tubal cancer
220866|NCT02022917|peritoneal cancer|peritoneal cancer
220867|NCT02022904|prostate cancer|prostate cancer
220868|NCT02022904|metastatic|metastatic
220869|NCT02022904|castrate resistant|castrate resistant
220870|NCT02022891|Sickle cell disease|sickle cell disease
220871|NCT02022891|psychological support|psychological support
220872|NCT02022891|quality of life|quality of life
220873|NCT02022878|Chronic total occlusion|chronic total occlusion
220874|NCT02022878|Percutaneous coronary intervention|percutaneous coronary intervention
220875|NCT02022878|Coronary computed tomography angiography|coronary computed tomography angiography
220876|NCT02022878|Coronary angiography|coronary angiography
220877|NCT02022865|periodontitis|periodontitis
220878|NCT02022865|cytokines|cytokines
220879|NCT02022865|adverse pregnancy outcome|adverse pregnancy outcome
220880|NCT02022852|Rectal Cancer|rectal cancer
220881|NCT02022852|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
220882|NCT02022852|Sequential Therapy|sequential therapy
220883|NCT02022839|mechanical ventilation, weaning|mechanical ventilation, weaning
220884|NCT02022839|ultrasonography|ultrasonography
220885|NCT02022826|Gastroparesis|gastroparesis
220886|NCT02022826|SmartPill Monitoring System (SPM)|smartpill monitoring system (spm)
220887|NCT02022826|Gastric Emptying Scintigraphy (GES)|gastric emptying scintigraphy (ges)
220888|NCT02022813|Energy requirements, Glucose turnover, Protein turnover|energy requirements, glucose turnover, protein turnover
220889|NCT02022787|RCC|rcc
220890|NCT02022787|Chemokines|chemokines
220891|NCT02022787|nephrectomy|nephrectomy
220892|NCT02022787|partial nephrectomy|partial nephrectomy
220893|NCT02022761|Mild or moderate asthmatics|mild or moderate asthmatics
220894|NCT02022761|Adults|adults
220895|NCT02022761|Laninamivir|laninamivir
220896|NCT02022735|Deep Brain Stimulation|deep brain stimulation
220897|NCT02022722|Pelvic Floor Myalgia|pelvic floor myalgia
220898|NCT02022722|Trigger Point Injections|trigger point injections
220899|NCT02022722|Pelvic Rehabilitation|pelvic rehabilitation
220900|NCT02022722|Dyspareunia|dyspareunia
220901|NCT02022709|Cognitive Behavior Therapy|cognitive behavior therapy
220902|NCT02022709|Exposure and Response/Ritual Prevention|exposure and response/ritual prevention
220903|NCT02022709|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
220904|NCT02022709|Psychotherapy|psychotherapy
220905|NCT02022709|Pharmacotherapy|pharmacotherapy
220906|NCT02022709|Citalopram|citalopram
220907|NCT02022709|Fluoxetine|fluoxetine
220908|NCT02022709|Paroxetine|paroxetine
220909|NCT02022709|Sertraline|sertraline
220910|NCT02022709|Fluvoxamine|fluvoxamine
220911|NCT02022709|fMRI|fmri
220912|NCT02022709|Stop Signal Task|stop signal task
220913|NCT02022696|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
220914|NCT02022696|Gene Therapy|gene therapy
220915|NCT02022696|Lentiviral Vectors|lentiviral vectors
220916|NCT02022683|Endoscopic lung volume reduction|endoscopic lung volume reduction
220917|NCT02022683|Endobronchial valves|endobronchial valves
220918|NCT02022670|endothelial function|endothelial function
220919|NCT02022670|arterial stiffness|arterial stiffness
220920|NCT02022670|flow-mediated dilation|flow-mediated dilation
220921|NCT02022670|pulse wave velocity|pulse wave velocity
220922|NCT02022670|sodium nitrite|sodium nitrite
220923|NCT02022670|aging|aging
220924|NCT02022670|vascular diseases|vascular diseases
220925|NCT02022657|Pre exposure prophylaxis|pre exposure prophylaxis
220926|NCT02022657|Dried blood spots|dried blood spots
220927|NCT02022618|Hypertension|hypertension
220928|NCT02022618|Target organ damage|target organ damage
220929|NCT02022618|polymorphism|polymorphism
220930|NCT02022618|Hypertensive patients|hypertensive patients
220931|NCT02022605|ERCP, trainning, trainees, EMS|ercp, trainning, trainees, ems
220932|NCT02022579|Breast Cancer|breast cancer
220933|NCT02022579|Diagnosis|diagnosis
220934|NCT02022579|Malignant|malignant
220935|NCT02022579|Benign|benign
220936|NCT02022579|Biopsy|biopsy
220937|NCT02022566|Osteoarthritis knee|osteoarthritis knee
220938|NCT02022566|Osteoarthritis hip|osteoarthritis hip
220939|NCT02022566|Physical activity|physical activity
220940|NCT02022566|accelerometer|accelerometer
220941|NCT02022553|rectal cancer|rectal cancer
220942|NCT02022553|RACHEL|rachel
220943|NCT02022553|oil chemoembolization|oil chemoembolization
220944|NCT02022540|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
220945|NCT02022540|AMD|amd
220946|NCT02022540|Macular Degeneration|macular degeneration
220947|NCT02022540|Age-Related Macular Degeneration|age-related macular degeneration
220948|NCT02022540|wet AMD|wet amd
220949|NCT02022540|neovascular AMD|neovascular amd
220950|NCT02022540|exudative AMD|exudative amd
220951|NCT02022527|Cost-Effectiveness,|cost-effectiveness,
220952|NCT02022527|Heart valve prosthesis|heart valve prosthesis
220953|NCT02022527|Warfarin,|warfarin,
220954|NCT02022527|Aspirin,|aspirin,
220955|NCT02022527|Egypt|egypt
220956|NCT02022501|Macular Degeneration|macular degeneration
220957|NCT02022488|Child|child
220958|NCT02022488|Sevoflurane|sevoflurane
220959|NCT02022488|Emergence delirium|emergence delirium
220960|NCT02022488|General anesthesia|general anesthesia
220961|NCT02022488|Premedication.|premedication.
220962|NCT02022475|vitamin D|vitamin d
220963|NCT02022475|fatigue|fatigue
220964|NCT02022462|Serious mental illnesses|serious mental illnesses
220965|NCT02022462|peer navigator|peer navigator
222080|NCT02017145|chloraprep|chloraprep
220966|NCT02022462|integrated health care|integrated health care
220967|NCT02022449|Maternal depression|maternal depression
220968|NCT02022449|Maternal psychosocial stress and distress|maternal psychosocial stress and distress
220969|NCT02022449|Maternal health outcomes|maternal health outcomes
220970|NCT02022449|Social support|social support
220971|NCT02022449|Pediatric cancer|pediatric cancer
220972|NCT02022410|CAS|cas
220973|NCT02022410|Length of stay|length of stay
220974|NCT02022410|Rehabilitation localisation|rehabilitation localisation
220975|NCT02022410|TKA|tka
220976|NCT02022397|tracheal intubation|tracheal intubation
220977|NCT02022397|predicting difficult intubation|predicting difficult intubation
220978|NCT02022397|general anesthesia|general anesthesia
220979|NCT02022397|difficult ventilation|difficult ventilation
220980|NCT02022384|Malignant glioma|malignant glioma
220981|NCT02022384|Anaplastic astrocytoma|anaplastic astrocytoma
220982|NCT02022384|Glioblastoma multiforme|glioblastoma multiforme
220983|NCT02022384|Immune|immune
220984|NCT02022384|Immunophenotyping|immunophenotyping
220985|NCT02022384|Immune cells|immune cells
220986|NCT02022384|activation state|activation state
220987|NCT02022384|Quality of live|quality of live
220988|NCT02022384|translational research|translational research
220989|NCT02022358|Osteosarcoma|osteosarcoma
220990|NCT02022358|Methotrexate|methotrexate
220991|NCT02022358|Glucarpidase|glucarpidase
220992|NCT02022358|Mucositis|mucositis
220993|NCT02022345|Percutaneous Coronary Intervention|percutaneous coronary intervention
220994|NCT02022345|Coronary Artery Disease|coronary artery disease
220995|NCT02022345|Angioplasty|angioplasty
220996|NCT02022345|Offsite cardiac surgery|offsite cardiac surgery
220997|NCT02022345|Heart disease|heart disease
220998|NCT02022345|Ischemic Heart Disease|ischemic heart disease
220999|NCT02022306|Hepatitis C|hepatitis c
221000|NCT02022293|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
221001|NCT02022293|Radiotherapy|radiotherapy
221002|NCT02022293|Carotid Stenosis|carotid stenosis
221003|NCT02022293|Atorvastatin|atorvastatin
221004|NCT02022267|clubfoot|clubfoot
221005|NCT02022267|gait analysis|gait analysis
221006|NCT02022267|outcome questionaire|outcome questionaire
221007|NCT02022267|Ponseti method|ponseti method
221008|NCT02022241|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
221009|NCT02022241|Luteinizing Hormone|luteinizing hormone
221010|NCT02022241|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
221011|NCT02022241|Ovarian Yield|ovarian yield
221012|NCT02022241|Ovarian Maturity|ovarian maturity
221013|NCT02022228|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
221014|NCT02022228|Luteinizing Hormone|luteinizing hormone
221015|NCT02022228|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
221016|NCT02022228|Ovarian Yield|ovarian yield
221017|NCT02022228|Ovarian Maturity|ovarian maturity
221018|NCT02022228|Gonadotropin Releasing Hormone Agonist|gonadotropin releasing hormone agonist
221019|NCT02022228|Human Chorionic Gonadotropin|human chorionic gonadotropin
221020|NCT02022189|Dent|dent
221021|NCT02022189|Dents|dents
221022|NCT02022189|Dent Disease|dent disease
221023|NCT02022189|Renal Biopsy|renal biopsy
221024|NCT02022189|Kidney Biopsy|kidney biopsy
221025|NCT02022189|Clinical Biopsy|clinical biopsy
221026|NCT02022176|Nitrate|nitrate
221027|NCT02022176|Nitrite|nitrite
221028|NCT02022176|Nitric oxide|nitric oxide
221029|NCT02022176|Resting metabolic rate|resting metabolic rate
221030|NCT02022176|Glucose uptake|glucose uptake
221031|NCT02022176|Insulin sensitivity|insulin sensitivity
221032|NCT02022176|Reactive oxygen species production|reactive oxygen species production
221033|NCT02022176|inorganic nitrate|inorganic nitrate
221034|NCT02022176|Sodium nitrite infusion|sodium nitrite infusion
221035|NCT02022163|Influenza, Human|influenza, human
221036|NCT02022163|RNA Virus Infections|rna virus infections
221037|NCT02022163|Respiratory Tract Diseases|respiratory tract diseases
221038|NCT02022163|Respiratory Tract Infections|respiratory tract infections
221039|NCT02022163|Aluminum Hydroxide|aluminum hydroxide
221040|NCT02022163|Adjuvants, Immunologic|adjuvants, immunologic
221041|NCT02022163|Immunogenic Factors|immunogenic factors
221042|NCT02022163|Physiological Effects of Drugs|physiological effects of drugs
221043|NCT02022163|Virus Diseases|virus diseases
221044|NCT02022163|Orthomyxoviridae Infections|orthomyxoviridae infections
221045|NCT02022163|Infection|infection
221046|NCT02022150|Paracentesis|paracentesis
221047|NCT02022150|Liver Cirrhosis|liver cirrhosis
221048|NCT02022150|ascites|ascites
221049|NCT02022150|body composition|body composition
221050|NCT02022137|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
221051|NCT02022137|Hepatic encephalopathy|hepatic encephalopathy
221052|NCT02022124|chronic low back pain|chronic low back pain
271461|NCT01792817|VNS|vns
211864|NCT02063308|OAA|oaa
221053|NCT02022124|open-label placebo|open-label placebo
221054|NCT02022046|chronic kidney disease|chronic kidney disease
221055|NCT02022046|cardiovascular disease|cardiovascular disease
221056|NCT02022046|nitric oxide|nitric oxide
221057|NCT02022046|homocysteine|homocysteine
221058|NCT02022046|asymmetric dimethylarginine|asymmetric dimethylarginine
221059|NCT02022046|methylation|methylation
222412|NCT02015663|CF|cf
221060|NCT02022033|Pancreatic Cancer|pancreatic cancer
221061|NCT02022033|Adjuvant|adjuvant
221062|NCT02022033|Pancreas|pancreas
221063|NCT02022033|Resected|resected
221064|NCT02022033|Invasive adenocarcinoma|invasive adenocarcinoma
221065|NCT02022033|adenosquamous cancer|adenosquamous cancer
221066|NCT02022033|Intraductal papillary mucinous neoplasm|intraductal papillary mucinous neoplasm
221067|NCT02022007|PCOS|pcos
221068|NCT02022007|IGT|igt
221069|NCT02022007|DPP-4 inhibitor|dpp-4 inhibitor
221070|NCT02021981|Quality Improvement|quality improvement
221071|NCT02021981|Primary Care|primary care
221072|NCT02021981|Blood Pressure, High|blood pressure, high
221073|NCT02021981|Feedback|feedback
221074|NCT02021981|Knowledge|knowledge
221075|NCT02021955|randomized controlled trial|randomized controlled trial
221076|NCT02021955|quality of life|quality of life
221077|NCT02021955|patient readmission|patient readmission
221078|NCT02021955|mortality|mortality
221079|NCT02021955|patient satisfaction|patient satisfaction
221080|NCT02021955|intervention studies|intervention studies
221081|NCT02021955|multicenter study|multicenter study
221082|NCT02021942|primary inoperable thymoma|primary inoperable thymoma
221083|NCT02021942|local recurrent thymoma|local recurrent thymoma
221084|NCT02021942|reduction of tumor size|reduction of tumor size
221085|NCT02021942|SOM230 LAR|som230 lar
221086|NCT02021929|Randomized Controlled Trial|randomized controlled trial
221087|NCT02021929|Clinical Trial|clinical trial
221088|NCT02021929|sorafenib|sorafenib
221089|NCT02021929|Hepatopulmonary Syndrome|hepatopulmonary syndrome
221090|NCT02021903|arterial hypotension|arterial hypotension
221091|NCT02021903|postprandial sleepiness|postprandial sleepiness
221092|NCT02021903|orthostatic hypotension|orthostatic hypotension
221093|NCT02021903|synucleinopathies|synucleinopathies
221094|NCT02021903|hyperglycemia|hyperglycemia
221098|NCT02021890|Weight loss|weight loss
221099|NCT02021877|Brain trauma|brain trauma
221100|NCT02021877|ICP measurement|icp measurement
221101|NCT02021877|cranial CT / MRI|cranial ct / mri
221102|NCT02021877|Glasgow Coma Score|glasgow coma score
221103|NCT02021877|acute TBI|acute tbi
221104|NCT02021877|EEG|eeg
221105|NCT02021877|metabolic, proteomic, and genetic biomarkers of TBIs|metabolic, proteomic, and genetic biomarkers of tbis
221106|NCT02021877|injury mechanism|injury mechanism
221107|NCT02021864|hypocalcemia, pregnancy, vitamin D|hypocalcemia, pregnancy, vitamin d
221108|NCT02021851|Dexamethasone,|dexamethasone,
221109|NCT02021851|Ondansetron|ondansetron
221110|NCT02021851|Aprepitant|aprepitant
221111|NCT02021851|PONV|ponv
221112|NCT02021851|Laparoscopic surgery|laparoscopic surgery
221113|NCT02021838|domestic violence homicide prevention|domestic violence homicide prevention
221114|NCT02021825|mitoxantrone|mitoxantrone
221115|NCT02021825|neuromyelitis optica|neuromyelitis optica
221116|NCT02021825|relapse|relapse
221117|NCT02021799|Gut microbiome|gut microbiome
221118|NCT02021799|Vaginal microbiome|vaginal microbiome
221119|NCT02021799|Oral microbiome|oral microbiome
221120|NCT02021799|Human milk microbiome|human milk microbiome
221121|NCT02021799|Nutritional Status|nutritional status
221122|NCT02021773|Headache|headache
221123|NCT02021773|Migraine|migraine
221124|NCT02021773|Chronic Migraine|chronic migraine
221125|NCT02021682|Aβ|aβ
221126|NCT02021682|ABeta|abeta
221127|NCT02021682|ABeta kinetics|abeta kinetics
221128|NCT02021682|Alzheimer's Disease|alzheimer's disease
221129|NCT02021682|Alzheimer's|alzheimer's
221130|NCT02021682|amyloid beta|amyloid beta
221131|NCT02021682|biomarker|biomarker
221132|NCT02021682|dementia|dementia
221133|NCT02021682|PET/PIB|pet/pib
221134|NCT02021669|Antidepressive agents|antidepressive agents
221135|NCT02021669|Coronary disease|coronary disease
221136|NCT02021669|Depression|depression
221137|NCT02021669|Depressive disorder|depressive disorder
221138|NCT02021669|Fatty Acids, Omega-3|fatty acids, omega-3
221139|NCT02021630|Obesity|obesity
221140|NCT02021630|Bariatric Surgery|bariatric surgery
221141|NCT02021630|Weight Loss|weight loss
221142|NCT02021630|Physical Activity|physical activity
221143|NCT02021630|Body Composition|body composition
221144|NCT02021617|Intraosseous Access|intraosseous access
221145|NCT02021617|EZ-IO|ez-io
221149|NCT02021591|Diabetes|diabetes
221150|NCT02021591|Chronic disease|chronic disease
221151|NCT02021591|problem solving|problem solving
221152|NCT02021591|self management|self management
221153|NCT02021578|Depression|depression
221154|NCT02021578|Mood disorder|mood disorder
221155|NCT02021565|Caregivers|caregivers
221156|NCT02021565|Activities of Daily Living|activities of daily living
271590|NCT01792206|CKD|ckd
221157|NCT02021565|Dementia|dementia
221158|NCT02021565|Veterans|veterans
221159|NCT02021565|Self-Help Devices|self-help devices
221160|NCT02021565|Telemedicine|telemedicine
221161|NCT02021552|Trauma|trauma
221162|NCT02021552|Sepsis|sepsis
221163|NCT02021539|Elastography of the cervix|elastography of the cervix
221164|NCT02021539|Cervical elastography|cervical elastography
221165|NCT02021539|Predicting delivery|predicting delivery
221166|NCT02021526|G1D|g1d
221167|NCT02021526|Glut1 Deficiency|glut1 deficiency
221168|NCT02021526|Glucose Transporter Type 1 Deficiency|glucose transporter type 1 deficiency
221169|NCT02021526|Glucose Transporter Type I Deficiency|glucose transporter type i deficiency
221170|NCT02021513|SLE|sle
221171|NCT02021513|Fish Oil|fish oil
221172|NCT02021513|Omega-3|omega-3
221173|NCT02021448|OHS|ohs
221174|NCT02021422|metastatic pancreatic ductal adenocarcinoma (PDAC)|metastatic pancreatic ductal adenocarcinoma (pdac)
221175|NCT02021422|pancreatic cancer|pancreatic cancer
221176|NCT02021422|pancreas cancer|pancreas cancer
221177|NCT02021422|pancreatic adenocarcinoma|pancreatic adenocarcinoma
221178|NCT02021422|metastatic pancreas cancer|metastatic pancreas cancer
221179|NCT02021422|metastatic pancreatic cancer|metastatic pancreatic cancer
221180|NCT02021409|Anemia on CKD|anemia on ckd
221181|NCT02021396|Rescue splenic trauma patients at high risk of splenectomy|rescue splenic trauma patients at high risk of splenectomy
221182|NCT02021383|Weight loss|weight loss
221183|NCT02021383|Weight maintenance|weight maintenance
221184|NCT02021383|Contingency Management|contingency management
221185|NCT02021383|College students|college students
221186|NCT02021383|Financial incentives|financial incentives
221187|NCT02021370|Anemia of CKD|anemia of ckd
221188|NCT02021357|Facial Pain|facial pain
221189|NCT02021357|Physical Therapy Modalities|physical therapy modalities
221190|NCT02021357|Temporomandibular Joint Disorders|temporomandibular joint disorders
221191|NCT02021357|Exercise Therapy|exercise therapy
221192|NCT02021331|jaw, edentulous, partially|jaw, edentulous, partially
221193|NCT02021318|Non-dialysis|non-dialysis
221194|NCT02021318|Roxadustat|roxadustat
221195|NCT02021318|ASP1517|asp1517
221196|NCT02021318|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
221197|NCT02021318|Anemia|anemia
221198|NCT02021318|Hemoglobin|hemoglobin
221199|NCT02021305|Toll like Receptors|toll like receptors
221200|NCT02021305|TLR 4|tlr 4
221201|NCT02021305|Urinary track infections in children|urinary track infections in children
221202|NCT02021305|TLR 4 polymorphisms|tlr 4 polymorphisms
221203|NCT02021305|Innate immunity|innate immunity
221204|NCT02021305|Defence mechanisms|defence mechanisms
221205|NCT02021305|Immune responses|immune responses
221206|NCT02021292|Chronic thromboembolic pulmonary hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
221207|NCT02021279|pelvic organ prolapse|pelvic organ prolapse
221208|NCT02021279|MatriStem|matristem
221209|NCT02021279|pelvic floor matrix|pelvic floor matrix
221210|NCT02021279|ACell|acell
221211|NCT02021279|native tissue repair|native tissue repair
221212|NCT02021253|Endotoxemia|endotoxemia
221213|NCT02021253|Probiotic|probiotic
221214|NCT02021253|Leaky gut|leaky gut
221215|NCT02021253|Gut permeability|gut permeability
221216|NCT02021253|Liver cirrhosis|liver cirrhosis
221217|NCT02021253|Liver fibrosis|liver fibrosis
221218|NCT02021253|Hepatocellular carcinoma|hepatocellular carcinoma
221219|NCT02021227|Acute respiratory failure|acute respiratory failure
221220|NCT02021227|Mechanical ventilation|mechanical ventilation
221221|NCT02021227|Rehabilitation|rehabilitation
221222|NCT02021227|Exercise chair sitting|exercise chair sitting
221223|NCT02021227|Weaning|weaning
221224|NCT02021227|Chronic respiratory failure|chronic respiratory failure
221225|NCT02021214|Methylphenidate|methylphenidate
221226|NCT02021214|Fear extinction|fear extinction
221227|NCT02021214|fMRI|fmri
221228|NCT02021214|mPFC|mpfc
221229|NCT02021188|Vascular inflammation|vascular inflammation
221230|NCT02021188|Atherosclerosis|atherosclerosis
221231|NCT02021188|Positron Emission Tomography|positron emission tomography
221232|NCT02021188|Molecular Imaging|molecular imaging
221233|NCT02021188|68Ga-DOTATATE|68ga-dotatate
221234|NCT02021175|Smoking Cessation|smoking cessation
221235|NCT02021175|Korean|korean
221236|NCT02021175|Youth|youth
221237|NCT02021175|Adolescent|adolescent
221238|NCT02021175|Dependence|dependence
221239|NCT02021175|Teen Smoking|teen smoking
221240|NCT02021175|Smoking and Youth|smoking and youth
221241|NCT02021175|Youth and Tobacco|youth and tobacco
221242|NCT02021175|Cognitive-Behavioral Motivational Enhancement|cognitive-behavioral motivational enhancement
221243|NCT02021175|Technology|technology
221244|NCT02021175|Nicotine Dependence|nicotine dependence
221245|NCT02021175|Cell Phone|cell phone
221246|NCT02021175|Smart Phone|smart phone
221247|NCT02021175|Internet|internet
221248|NCT02021175|Web|web
221249|NCT02021162|Multiple sclerosis|multiple sclerosis
221250|NCT02021162|Gilenya|gilenya
221251|NCT02021162|Healthy controls|healthy controls
221252|NCT02021162|Thalamic atrophy|thalamic atrophy
221253|NCT02021162|MRI|mri
221254|NCT02021149|Major Depressive Disorder|major depressive disorder
221255|NCT02021149|Whole Body Hyperthermia|whole body hyperthermia
221256|NCT02021149|Psychotherapy|psychotherapy
221257|NCT02021149|Therapist and patient alliance|therapist and patient alliance
221258|NCT02021123|Anidulafungin|anidulafungin
221259|NCT02021123|Gastric bypass|gastric bypass
221260|NCT02021123|Morbidly obese|morbidly obese
221261|NCT02021123|Pharmacokinetics|pharmacokinetics
221262|NCT02021123|Prophylaxis|prophylaxis
221263|NCT02021123|Yeast infection|yeast infection
221264|NCT02021097|Levonorgestrel；|levonorgestrel；
221265|NCT02021097|Ethinyl Estradiol；|ethinyl estradiol；
221266|NCT02021097|Oral Contraceptive|oral contraceptive
221267|NCT02021084|Familial Mediterranean Fever (FMF), probiotics|familial mediterranean fever (fmf), probiotics
221268|NCT02021032|BPH|bph
221269|NCT02021006|antibiotic prophylaxis|antibiotic prophylaxis
221270|NCT02021006|vesicoureteral reflux|vesicoureteral reflux
221271|NCT02021006|congenital abnormalities of kidney|congenital abnormalities of kidney
221272|NCT02021006|renal hypodysplasia|renal hypodysplasia
221273|NCT02021006|chronic kidney disease|chronic kidney disease
221274|NCT02020993|Nt-proBNP, newborn, preterm|nt-probnp, newborn, preterm
221275|NCT02020928|Oral Mucositis|oral mucositis
221276|NCT02020928|chemotherapy|chemotherapy
221277|NCT02020928|Bone Marrow Transplantation|bone marrow transplantation
221278|NCT02020889|eosinophils|eosinophils
221279|NCT02020889|SB 240563|sb 240563
221280|NCT02020889|Churg-Strauss Syndrome|churg-strauss syndrome
221281|NCT02020889|quality of life|quality of life
221282|NCT02020889|mepolizumab|mepolizumab
221283|NCT02020889|safety|safety
221284|NCT02020889|biomarkers|biomarkers
221285|NCT02020889|efficacy|efficacy
221286|NCT02020889|corticosteroids|corticosteroids
221287|NCT02020889|Eosinophilic granulomatosis with polyangiitis|eosinophilic granulomatosis with polyangiitis
221288|NCT02020850|Toe-Brachial Index|toe-brachial index
221289|NCT02020850|Ankle-Brachial Index|ankle-brachial index
221290|NCT02020850|Systolic blood pressure|systolic blood pressure
221291|NCT02020824|Acrophobia|acrophobia
221292|NCT02020785|proteinuria|proteinuria
221293|NCT02020772|primary health care|primary health care
221294|NCT02020772|Physical Therapy Specialty|physical therapy specialty
221295|NCT02020772|General Practitioners|general practitioners
221296|NCT02020772|General Practice|general practice
221297|NCT02020733|Hysterosalpingography|hysterosalpingography
221298|NCT02020733|balloon catheter|balloon catheter
221299|NCT02020733|metal cannula|metal cannula
221300|NCT02020733|pain assessment|pain assessment
221301|NCT02020694|Obesity|obesity
221302|NCT02020694|Insulin resistance|insulin resistance
221303|NCT02020694|Vitamin D|vitamin d
221304|NCT02020694|Cardiovascular risk factors|cardiovascular risk factors
221305|NCT02020681|Dental caries|dental caries
221306|NCT02020681|Curodont Repair|curodont repair
221307|NCT02020681|P11-4|p11-4
221308|NCT02020668|Pain|pain
221309|NCT02020668|Functional capacity|functional capacity
221310|NCT02020668|Quality of Life|quality of life
221311|NCT02020655|IL-1 alpha, Sebutape, shear- force|il-1 alpha, sebutape, shear- force
221312|NCT02020642|polysomnography|polysomnography
221313|NCT02020642|bioimpedance|bioimpedance
221314|NCT02020642|leg fluid shift|leg fluid shift
221315|NCT02020642|neck circumference|neck circumference
221316|NCT02020642|Sleep Apnea Syndromes|sleep apnea syndromes
221317|NCT02020642|Sleep Apnea, Obstructive|sleep apnea, obstructive
221318|NCT02020642|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
221319|NCT02020642|Sleep Disorders|sleep disorders
221320|NCT02020642|Apnea|apnea
221321|NCT02020642|Kidney Diseases|kidney diseases
221322|NCT02020642|Kidney Failure, Chronic|kidney failure, chronic
221323|NCT02020642|Renal Insufficiency, Chronic|renal insufficiency, chronic
221324|NCT02020642|Renal Insufficiency|renal insufficiency
221325|NCT02020642|Dyssomnias|dyssomnias
221326|NCT02020629|Glucagon|glucagon
221327|NCT02020629|Hypoglycemia|hypoglycemia
221328|NCT02020629|Counterregulation|counterregulation
221329|NCT02020603|peptic ulcer bleeding|peptic ulcer bleeding
221330|NCT02020603|hemostatic forceps|hemostatic forceps
221331|NCT02020603|soft coagulation|soft coagulation
221332|NCT02020603|argon plasma coagulation|argon plasma coagulation
221333|NCT02020590|Delayed-Union Fractures|delayed-union fractures
221334|NCT02020590|Impaired Healing|impaired healing
221335|NCT02020590|Fractures|fractures
221336|NCT02020590|Orthopedics|orthopedics
221337|NCT02020590|Bone|bone
221338|NCT02020590|Musculoskeletal Disorders|musculoskeletal disorders
221339|NCT02020564|Processing Speed|processing speed
221340|NCT02020564|Cognition|cognition
221341|NCT02020564|Intervention|intervention
221342|NCT02020564|Traumatic Brain Injury|traumatic brain injury
221343|NCT02020564|Mild Cognitive Impairment|mild cognitive impairment
221344|NCT02020551|Scores During IUD insertion.|scores during iud insertion.
221345|NCT02020538|Thoracic surgery|thoracic surgery
221346|NCT02020538|cardiac surgery|cardiac surgery
221347|NCT02020538|acute kidney injury|acute kidney injury
221348|NCT02020538|hyperchloremia|hyperchloremia
221349|NCT02020538|intravenous fluid|intravenous fluid
221350|NCT02020486|Healthy|healthy
221351|NCT02020473|Informed consents|informed consents
221352|NCT02020473|Withholding/withdrawing life support (WLS)|withholding/withdrawing life support (wls)
221353|NCT02020473|Intensive care unit (ICU)|intensive care unit (icu)
221354|NCT02020460|post-laminectomy pain syndrome,|post-laminectomy pain syndrome,
221355|NCT02020460|refractory,|refractory,
221356|NCT02020460|refractory chronic neuropathic pain,|refractory chronic neuropathic pain,
221357|NCT02020460|failed back surgery syndrome.|failed back surgery syndrome.
221358|NCT02019407|atrial fibrillation|atrial fibrillation
221359|NCT02019407|atrial flutter|atrial flutter
221360|NCT02019407|catheter ablation|catheter ablation
221361|NCT02019407|cavo-tricuspid isthmus block|cavo-tricuspid isthmus block
221362|NCT02019342|blood pressure|blood pressure
221363|NCT02019342|mean arterial pressure|mean arterial pressure
221365|NCT02019342|intraoperative|intraoperative
221366|NCT02019342|postoperative|postoperative
221367|NCT02019342|anesthesia|anesthesia
221368|NCT02019316|Supplementation|supplementation
221369|NCT02019316|Performance|performance
221370|NCT02019316|Cognitive Function|cognitive function
221371|NCT02019316|Muscular Endurance|muscular endurance
221372|NCT02019316|BioSteel|biosteel
221373|NCT02019316|BCAA|bcaa
221374|NCT02019316|Branched Chain Amino Acids|branched chain amino acids
221375|NCT02019316|Sprint Interval Exercise|sprint interval exercise
221376|NCT02019264|Diabetes|diabetes
221377|NCT02019264|Cardiovascular Disease|cardiovascular disease
221378|NCT02019264|Multiple Cardiovascular Risk Factors|multiple cardiovascular risk factors
221379|NCT02019264|Obesity|obesity
221380|NCT02019264|Overweight|overweight
221381|NCT02019264|MACE|mace
221382|NCT02019264|Conversion to Diabetes|conversion to diabetes
221383|NCT02019225|dialysis|dialysis
221384|NCT02019225|hemodialysis|hemodialysis
221385|NCT02019225|pragmatic trial|pragmatic trial
221386|NCT02019225|end stage renal disease|end stage renal disease
221387|NCT02019225|randomized clinical trial|randomized clinical trial
221388|NCT02020421|ischemic stroke|ischemic stroke
221389|NCT02020421|rehabilitation|rehabilitation
221390|NCT02020421|aphasia|aphasia
221391|NCT02020421|non-invasive brain stimulation|non-invasive brain stimulation
221392|NCT02020382|microRNAs|micrornas
221393|NCT02020382|IBD|ibd
221394|NCT02020382|Crohn's disease|crohn's disease
221395|NCT02020382|Ulcerative colitis|ulcerative colitis
221396|NCT02020382|colonic polyps screening|colonic polyps screening
221397|NCT02020382|controls|controls
221398|NCT02020356|Alzheimer's disease|alzheimer's disease
221399|NCT02020356|Neuroleptics|neuroleptics
221400|NCT02020356|Music therapy|music therapy
221401|NCT02020330|falciparum, malaria|falciparum, malaria
221402|NCT02020317|drug interactions|drug interactions
221403|NCT02020317|Drug Monitoring|drug monitoring
221404|NCT02020317|Potassium|potassium
221405|NCT02020317|Hyperkalemia|hyperkalemia
221406|NCT02020304|Combined spinal epidural duration|combined spinal epidural duration
221407|NCT02020304|labor pain|labor pain
221408|NCT02020291|Foxy-5|foxy-5
221409|NCT02020291|Wnt-5A|wnt-5a
221410|NCT02020278|Hyponatremia|hyponatremia
221411|NCT02020278|Euvolemic|euvolemic
221412|NCT02020278|Hypervolemic|hypervolemic
221413|NCT02020278|Serum sodium|serum sodium
221414|NCT02020278|Dilutional hyponatremia|dilutional hyponatremia
221415|NCT02020278|Electrolyte abnormality|electrolyte abnormality
221416|NCT02020278|Electrolyte imbalance|electrolyte imbalance
221417|NCT02020278|Metabolic disease|metabolic disease
221418|NCT02020278|Water-Electrolyte Imbalance|water-electrolyte imbalance
221419|NCT02020265|stress and depression related symptoms|stress and depression related symptoms
221420|NCT02020239|physical activity|physical activity
221421|NCT02020239|females|females
221422|NCT02020239|body composition|body composition
221423|NCT02020226|TH-302|th-302
221424|NCT02020226|Solid Tumors|solid tumors
221425|NCT02020226|QTc|qtc
221426|NCT02020226|Cardiac|cardiac
221427|NCT02020226|Evofosfamide|evofosfamide
221428|NCT02020213|successful percentage|successful percentage
221429|NCT02020200|Bipolar Disorder|bipolar disorder
221430|NCT02020200|Methylphenidate|methylphenidate
221431|NCT02020200|Cognitive Function|cognitive function
221432|NCT02020187|Congenital myopathy|congenital myopathy
221433|NCT02020187|Exercise|exercise
221434|NCT02020174|Preeclampsia|preeclampsia
221435|NCT02020174|Eclampsia|eclampsia
221436|NCT02020174|HELLP|hellp
221437|NCT02020174|HELLP Syndrome|hellp syndrome
221438|NCT02020174|Toxemia|toxemia
221439|NCT02020174|Hypertensive Disorder of Pregnancy|hypertensive disorder of pregnancy
221440|NCT02020174|Registry|registry
221441|NCT02020174|Pregnancy Complication|pregnancy complication
221442|NCT02020174|Pregnancy|pregnancy
221443|NCT02020174|Maternal Death|maternal death
221444|NCT02020174|Premature|premature
221445|NCT02020174|High Blood Pressure|high blood pressure
221446|NCT02020174|Hypertension|hypertension
221447|NCT02020148|pregnancy|pregnancy
221448|NCT02020148|oxytocin|oxytocin
221449|NCT02020148|postpartum depression|postpartum depression
221450|NCT02020148|depression|depression
221451|NCT02020148|pregnant women|pregnant women
221452|NCT02020148|mood|mood
221453|NCT02020148|anxiety|anxiety
221454|NCT02020148|hormones|hormones
221455|NCT02020148|women's health|women's health
221456|NCT02020148|mental health|mental health
221457|NCT02020148|baby blues|baby blues
221458|NCT02020148|mood disorders|mood disorders
221459|NCT02020122|endogenous pain modulation|endogenous pain modulation
221460|NCT02020122|coronary artery bypass grafting|coronary artery bypass grafting
221461|NCT02020122|quantitative sensory testings|quantitative sensory testings
221462|NCT02020122|duloxetine|duloxetine
221463|NCT02020122|pregabalin|pregabalin
221464|NCT02020122|preemptive treatment|preemptive treatment
221465|NCT02020096|Lumbar plexus block|lumbar plexus block
222619|NCT02014896|tPA|tpa
221466|NCT02020096|Ultrasound guidance|ultrasound guidance
221467|NCT02020096|Nerve stimulator|nerve stimulator
221468|NCT02020083|VIH ; Placental transfer ; Tenofovir ; Emtricitabine ; Membrane transporter|vih ; placental transfer ; tenofovir ; emtricitabine ; membrane transporter
221469|NCT02020070|Ipilimumab|ipilimumab
221470|NCT02020070|Degarelix|degarelix
221471|NCT02020070|Radical Prostatectomy|radical prostatectomy
221472|NCT02020070|13-134|13-134
221473|NCT02020031|Revision knee joint|revision knee joint
221474|NCT02020005|menthol cigarettes|menthol cigarettes
221475|NCT02020005|smoking cessation|smoking cessation
221476|NCT02019992|sepsis|sepsis
221477|NCT02019992|mitochondrial DNA|mitochondrial dna
221478|NCT02019992|systemic inflammation|systemic inflammation
221479|NCT02019992|outcome|outcome
221480|NCT02019979|non squamous|non squamous
221481|NCT02019979|non small cell|non small cell
221482|NCT02019979|lung cancer|lung cancer
221483|NCT02019979|metformin|metformin
221485|NCT02019927|Decreased vision|decreased vision
221486|NCT02019927|Eye trauma|eye trauma
221487|NCT02019927|TES|tes
221488|NCT02019927|Electrical stimulation|electrical stimulation
221489|NCT02019927|Multiple Sclerosis|multiple sclerosis
221490|NCT02019927|Optic Neuritis|optic neuritis
221491|NCT02019914|PTSD|ptsd
221492|NCT02019914|CPAP|cpap
221493|NCT02019914|OSA|osa
221494|NCT02019901|Rheumatoid arthritis|rheumatoid arthritis
221495|NCT02019901|Person-centered care|person-centered care
221496|NCT02019901|Tight control|tight control
221497|NCT02019888|Ear, Middle|ear, middle
221498|NCT02019888|Ear, Inner|ear, inner
221499|NCT02019888|Audiometry|audiometry
221500|NCT02019888|Acoustic impedance tests|acoustic impedance tests
221501|NCT02019875|Vitamin D|vitamin d
221502|NCT02019875|CYP3A4|cyp3a4
221503|NCT02019875|Calcium|calcium
221504|NCT02019862|Total hip arthroplasty|total hip arthroplasty
221505|NCT02019862|TRJ|trj
221506|NCT02019862|PMCF|pmcf
221507|NCT02019862|Hip stem|hip stem
221508|NCT02019849|THA, Plasmafit®|tha, plasmafit®
221509|NCT02019836|vit D; sepsis; newborn; maternal; neonatal|vit d; sepsis; newborn; maternal; neonatal
221510|NCT02019823|SMS-text|sms-text
221511|NCT02019823|mobile health|mobile health
221512|NCT02019823|mHealth|mhealth
221513|NCT02019823|treatment|treatment
221514|NCT02019823|adherence|adherence
221515|NCT02019797|aortic valve replacement|aortic valve replacement
221516|NCT02019784|Cirrhosis|cirrhosis
221517|NCT02019784|Hepatic encephalopathy|hepatic encephalopathy
221518|NCT02019771|HIV Infection|hiv infection
221519|NCT02019771|Men who have sex with men|men who have sex with men
221520|NCT02019771|Chlamydia|chlamydia
221521|NCT02019771|Gonorrhea|gonorrhea
221522|NCT02019745|Live attenuated influenza virus (LAIV)|live attenuated influenza virus (laiv)
221523|NCT02019745|Flu vaccine|flu vaccine
221524|NCT02019745|FluMist|flumist
221525|NCT02019745|Smokers|smokers
221526|NCT02019745|New and emerging tobacco products|new and emerging tobacco products
221527|NCT02019732|Mild outcomes|mild outcomes
221528|NCT02019732|Database|database
221529|NCT02019732|Influenza-attributable|influenza-attributable
221530|NCT02019732|Retrospective|retrospective
221532|NCT02019732|United States of America (USA)|united states of america (usa)
221533|NCT02019719|Hemodialysis|hemodialysis
221534|NCT02019719|GSK1278863|gsk1278863
221535|NCT02019719|Pharmacokinetics|pharmacokinetics
221536|NCT02019719|Erythropoiesis Stimulating Agents|erythropoiesis stimulating agents
221537|NCT02019719|Chronic Kidney Disease|chronic kidney disease
221538|NCT02019719|Hemoglobin|hemoglobin
221539|NCT02019719|Recombinant Erythropoietin|recombinant erythropoietin
221540|NCT02019719|Prolyl Hydroxylase Inhibitor|prolyl hydroxylase inhibitor
221541|NCT02019719|Anemia|anemia
221542|NCT02019706|Cushing Syndrome|cushing syndrome
221543|NCT02019706|Ectopic ACTH Secretion|ectopic acth secretion
221544|NCT02019706|Imaging|imaging
221545|NCT02019693|MET Inhibitor|met inhibitor
221546|NCT02019693|Sporadic|sporadic
221547|NCT02019693|Hereditary|hereditary
221548|NCT02019693|Multifocal|multifocal
221549|NCT02019693|HGF/MET Pathway|hgf/met pathway
221550|NCT02019680|Endothelial Function|endothelial function
221551|NCT02019680|Biomarkers|biomarkers
221552|NCT02019680|Atherosclerosis|atherosclerosis
221553|NCT02019680|Blood Flow|blood flow
221554|NCT02019680|Blood Pressure|blood pressure
221555|NCT02019667|GABA|gaba
221556|NCT02019667|Seizures|seizures
221557|NCT02019667|Neurotransmitters|neurotransmitters
221558|NCT02019654|Post -Traumatic Stress Disorder (PTSD)|post -traumatic stress disorder (ptsd)
221559|NCT02019654|Traumatic Brain Injury|traumatic brain injury
221560|NCT02019654|Neuroendocrine|neuroendocrine
221561|NCT02019654|Epigenetics|epigenetics
221562|NCT02019641|Exercise|exercise
221563|NCT02019641|Interstitial Lung Disease|interstitial lung disease
221564|NCT02019641|Pulmonary Rehabilitation|pulmonary rehabilitation
221565|NCT02019628|NK cells cytotoxicity, dietary supplementation|nk cells cytotoxicity, dietary supplementation
221566|NCT02019615|disorders of consciousness|disorders of consciousness
221567|NCT02019615|minimally conscious state|minimally conscious state
221568|NCT02019615|traumatic brain injury|traumatic brain injury
221570|NCT02019615|transcranial direct current stimulation|transcranial direct current stimulation
221571|NCT02019602|Cimzia®|cimzia®
221572|NCT02019602|CZP|czp
221573|NCT02019602|Placental transfer|placental transfer
221574|NCT02019602|Autoimmune diseases and pregnancy|autoimmune diseases and pregnancy
221575|NCT02019589|Secondary Amenorrhea|secondary amenorrhea
221576|NCT02019589|SPRY Trial|spry trial
221577|NCT02019576|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
221578|NCT02019576|mRCC|mrcc
221579|NCT02019576|Clear cell|clear cell
221580|NCT02019563|pediatrics|pediatrics
221581|NCT02019563|dental caries|dental caries
221582|NCT02019563|dental pulp exposure|dental pulp exposure
221583|NCT02019563|incisor|incisor
221586|NCT02019550|Rebiject II®|rebiject ii®
221587|NCT02019524|Stage I breast cancer|stage i breast cancer
221588|NCT02019524|Stage II breast cancer|stage ii breast cancer
221589|NCT02019524|Stage IIIA, IIIB, and IIIC breast cancer|stage iiia, iiib, and iiic breast cancer
221590|NCT02019524|Male breast cancer|male breast cancer
221591|NCT02019524|Ovarian cancer|ovarian cancer
221592|NCT02019511|Orthopedic surgery|orthopedic surgery
221593|NCT02019511|Infections|infections
221601|NCT02019485|Tapentadol|tapentadol
221602|NCT02019485|Tapentadol extended-release tamper-resistant formulation|tapentadol extended-release tamper-resistant formulation
221603|NCT02019485|Tapentadol extended-release prolonged-release formulation|tapentadol extended-release prolonged-release formulation
221604|NCT02019485|Bioequivalence|bioequivalence
221605|NCT02019485|Fasted Conditions|fasted conditions
221606|NCT02019472|Rheumatoid arthritis|rheumatoid arthritis
221607|NCT02019472|CNTO 136|cnto 136
221608|NCT02019472|Sirukumab|sirukumab
221609|NCT02019472|Adalimumab|adalimumab
221610|NCT02019472|HUMIRA®|humira®
221611|NCT02019446|type 2 diabetes mellitus|type 2 diabetes mellitus
221612|NCT02019446|onychomycosis|onychomycosis
221613|NCT02019446|laser treatment|laser treatment
221614|NCT02019446|antifungal|antifungal
221615|NCT02019433|THA, augment, revision, pelvis|tha, augment, revision, pelvis
221619|NCT02019212|99mTc-tetrofosmin|99mtc-tetrofosmin
221620|NCT02019212|myocardial perfusion imaging|myocardial perfusion imaging
221621|NCT02019212|SPECT|spect
221622|NCT02019212|radiation|radiation
221623|NCT02019186|type 1 diabetes|type 1 diabetes
221624|NCT02019186|endothelial function|endothelial function
221625|NCT02019186|adolescents|adolescents
221626|NCT02019186|vitamin C|vitamin c
221627|NCT02019186|vitamin E|vitamin e
221628|NCT02019173|exercise therapy|exercise therapy
221629|NCT02019173|brain injury|brain injury
221630|NCT02019173|postural balance|postural balance
221631|NCT02019160|silver nitrate|silver nitrate
221632|NCT02019160|sodium fluoride|sodium fluoride
221633|NCT02019160|silver diamine fluoride|silver diamine fluoride
221634|NCT02019160|caries|caries
221635|NCT02019160|non-inferiority trial|non-inferiority trial
221636|NCT02019147|HIE|hie
221637|NCT02019147|Biomarker|biomarker
221638|NCT02019134|chronic neck pain|chronic neck pain
221639|NCT02019134|relaxation technique|relaxation technique
221642|NCT02019108|knee|knee
221643|NCT02019108|walking|walking
221644|NCT02019108|toeout|toeout
221645|NCT02019108|gait modification|gait modification
221646|NCT02019095|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
221647|NCT02019095|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
221648|NCT02019095|Pulmonary Surfactant-Associated Proteins|pulmonary surfactant-associated proteins
221649|NCT02019095|activin A|activin a
221650|NCT02019030|benign prostatic hyperplasia|benign prostatic hyperplasia
221651|NCT02019030|Transurethral vaporization of prostate|transurethral vaporization of prostate
221652|NCT02019017|Cluster Headache|cluster headache
221653|NCT02019017|Botulinum Toxin Type A|botulinum toxin type a
221654|NCT02019017|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
221655|NCT02019017|Autonomic Nerve Block|autonomic nerve block
221656|NCT02018978|HIV prevention|hiv prevention
221657|NCT02018978|Behavioral intervention|behavioral intervention
221658|NCT02018978|Community-randomized trial|community-randomized trial
221659|NCT02018965|HIV|hiv
221660|NCT02018965|Extended-release Niacin|extended-release niacin
212491|NCT02060487|PAH|pah
221661|NCT02018965|Immune activation|immune activation
221662|NCT02018952|Septic arthritis|septic arthritis
221663|NCT02018952|Ultrasonography|ultrasonography
221664|NCT02018952|Prognosis parameters|prognosis parameters
221665|NCT02018939|pharmacokinetics, doripenem, renal replacement therapy, MARS, organ replacement therapy|pharmacokinetics, doripenem, renal replacement therapy, mars, organ replacement therapy
221673|NCT02018900|Synbiotics|synbiotics
221674|NCT02018900|Intestinal permeability|intestinal permeability
221675|NCT02018900|Microbiota|microbiota
221676|NCT02018900|Immune response|immune response
221677|NCT02018848|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
221678|NCT02018848|Attention Training|attention training
221679|NCT02018848|Attention Bias Modification|attention bias modification
221680|NCT02018848|Dot-Probe Task|dot-probe task
221681|NCT02018848|Randomized Controlled Trial|randomized controlled trial
221682|NCT02018848|Online Treatment|online treatment
221683|NCT02018848|Washing|washing
221684|NCT02018848|Checking|checking
221685|NCT02018822|restorative material|restorative material
221686|NCT02018809|Medication Adherence|medication adherence
221687|NCT02018809|High Blood Pressure|high blood pressure
221688|NCT02018809|Diabetes|diabetes
221689|NCT02018809|Statins|statins
221690|NCT02018770|Temporomandibular Disorders, Electromyogram,|temporomandibular disorders, electromyogram,
221691|NCT02018770|Modalities of physiotherapy,|modalities of physiotherapy,
221692|NCT02018770|Temporomandibular dysfunction syndrome,|temporomandibular dysfunction syndrome,
221693|NCT02018770|Lasers.|lasers.
221694|NCT02018757|Carcinoma, Hepatocellular|carcinoma, hepatocellular
221695|NCT02018757|primary liver cancer|primary liver cancer
221696|NCT02018757|primary hepatocellular carcinoma|primary hepatocellular carcinoma
221697|NCT02018757|transarterial chemoembolization|transarterial chemoembolization
221698|NCT02018757|Chemoembolization, Therapeutic|chemoembolization, therapeutic
221699|NCT02018757|arsenic trioxide|arsenic trioxide
221700|NCT02018757|arsenous anhydride|arsenous anhydride
221701|NCT02018757|diarsenic trioxide|diarsenic trioxide
221702|NCT02018757|randomized controlled trial|randomized controlled trial
221703|NCT02018757|multicenter study|multicenter study
221704|NCT02018757|HCC|hcc
221705|NCT02018757|TACE|tace
221706|NCT02018731|Becker's Muscular dystrophy|becker's muscular dystrophy
221707|NCT02018731|BMD|bmd
221708|NCT02018731|Metformin|metformin
221709|NCT02018731|L-citrulline|l-citrulline
221710|NCT02018718|Skeletal muscle|skeletal muscle
221711|NCT02018718|Marathon|marathon
221712|NCT02018718|MRI|mri
221713|NCT02018705|POEM|poem
221714|NCT02018705|LHM|lhm
221715|NCT02018705|Achalasia treatment|achalasia treatment
221716|NCT02018705|LES sphincter myotomy|les sphincter myotomy
221717|NCT02018679|Nodular basal cell carcinoma|nodular basal cell carcinoma
221718|NCT02018679|Er:YAG|er:yag
221719|NCT02018679|AFL-assisted|afl-assisted
221720|NCT02018679|MAL-PDT|mal-pdt
221721|NCT02018653|Cancer|cancer
221722|NCT02018653|Diarrhea|diarrhea
221723|NCT02018653|Calcium Alumina-Silicate|calcium alumina-silicate
221724|NCT02018653|CASAD|casad
221725|NCT02018653|Calcium Aluminosilicate anti-diarrheal|calcium aluminosilicate anti-diarrheal
221726|NCT02018653|Placebo|placebo
221727|NCT02018653|Sugar pill|sugar pill
221728|NCT02018653|Questionnaire|questionnaire
221729|NCT02018653|Survey|survey
221730|NCT02018640|cancer|cancer
221731|NCT02018640|tobacco use|tobacco use
221732|NCT02018640|pregnancy|pregnancy
221733|NCT02018627|bionic pancreas|bionic pancreas
221734|NCT02018627|artificial pancreas|artificial pancreas
221735|NCT02018627|insulin|insulin
221736|NCT02018627|glucagon|glucagon
221737|NCT02018627|clamp|clamp
221738|NCT02018614|Pain|pain
221739|NCT02018614|elderly|elderly
221740|NCT02018614|aged 65 or above 65|aged 65 or above 65
221585|NCT02019550|Rebif®Rebidose®|rebif®rebidose®
221741|NCT02018614|communication disorders|communication disorders
221742|NCT02018614|Algoplus® scale|algoplus® scale
221743|NCT02018588|requirements|requirements
221744|NCT02018588|amino acid|amino acid
221745|NCT02018588|tryptophan|tryptophan
221746|NCT02018575|lysine|lysine
221747|NCT02018575|bioavailability|bioavailability
221748|NCT02018575|amino acids|amino acids
221749|NCT02018575|corn|corn
221750|NCT02018562|Quality of Life|quality of life
221751|NCT02018562|Talking Tracheostomy Tube|talking tracheostomy tube
221752|NCT02018562|Speech|speech
221753|NCT02018562|Mechanically ventilated patients|mechanically ventilated patients
221754|NCT02018549|COPD|copd
221755|NCT02018549|placebo|placebo
221756|NCT02018549|inhalatory profile|inhalatory profile
221757|NCT02018536|Healthy|healthy
221758|NCT02018536|TMC435|tmc435
221759|NCT02018536|GSK2336805|gsk2336805
221760|NCT02018536|Pharmacokinetic|pharmacokinetic
221761|NCT02018536|Safety|safety
221762|NCT02018536|Tolerability|tolerability
221763|NCT02018523|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
221764|NCT02018523|Stage 3B/4|stage 3b/4
221765|NCT02018523|Maintenance Therapy|maintenance therapy
212582|NCT02060123|RCT|rct
221766|NCT02018523|Lenalidomide|lenalidomide
221767|NCT02018510|Healthy Volunteers|healthy volunteers
221768|NCT02018510|HIV|hiv
221769|NCT02018497|Essential arterial hypotension|essential arterial hypotension
221770|NCT02018497|Arterial hypotension|arterial hypotension
221771|NCT02018497|Low blood pressure|low blood pressure
221772|NCT02018497|Hypotension|hypotension
221773|NCT02018497|Essential arterial hypertension|essential arterial hypertension
221774|NCT02018497|Syncope|syncope
221775|NCT02018497|Dysautonomia|dysautonomia
221776|NCT02018497|Stress|stress
221777|NCT02018497|Adaptability|adaptability
221778|NCT02018497|Reactivity|reactivity
221779|NCT02018497|Homeostasis|homeostasis
221780|NCT02018497|Allostasis|allostasis
221781|NCT02018497|Allostatic load|allostatic load
221782|NCT02018497|Distress|distress
221783|NCT02018497|Epigenetic|epigenetic
221784|NCT02018497|Plasticity|plasticity
221877|NCT02017977|Laparotomy|laparotomy
221785|NCT02018484|Surgery / Knee / Replacement / MRI / Specific cutting guides|surgery / knee / replacement / mri / specific cutting guides
221786|NCT02018471|anxiety|anxiety
221787|NCT02018471|psychoeducational training|psychoeducational training
221788|NCT02018471|coping|coping
221789|NCT02018471|relaxation|relaxation
221790|NCT02018458|Dendritic cell vaccine|dendritic cell vaccine
221791|NCT02018458|Breast Cancer|breast cancer
221792|NCT02018458|Doxorubicin|doxorubicin
221793|NCT02018458|Paclitaxel|paclitaxel
221794|NCT02018458|Cyclophosphamide|cyclophosphamide
221795|NCT02018458|Carboplatin|carboplatin
221796|NCT02018406|Hematopoietic Growth Factors (EPO, G-CSF),|hematopoietic growth factors (epo, g-csf),
221797|NCT02018406|Neurological Diseases,|neurological diseases,
221798|NCT02018406|Neurorehabilitation,|neurorehabilitation,
221799|NCT02018406|Neurotrophic and Neuroprotective Effects|neurotrophic and neuroprotective effects
221800|NCT02018393|FEIBA®|feiba®
221801|NCT02018367|Barrett's esophagus|barrett's esophagus
221802|NCT02018367|proflavine|proflavine
221803|NCT02018367|Microscopic imaging|microscopic imaging
221804|NCT02018354|Orthopaedics|orthopaedics
221805|NCT02018354|Anterior cruciate ligament (ACL) reconstruction|anterior cruciate ligament (acl) reconstruction
221806|NCT02018354|Anterolateral ligament|anterolateral ligament
221807|NCT02018354|Lateral Extra-articular Tenodesis (LET)|lateral extra-articular tenodesis (let)
221808|NCT02018341|Assessment of biologic activity of a homeopathic remedy|assessment of biologic activity of a homeopathic remedy
221809|NCT02018315|G1D|g1d
221810|NCT02018315|Glut1 Disorder|glut1 disorder
221811|NCT02018315|Glucose Transporter Type 1 Disorder|glucose transporter type 1 disorder
221812|NCT02018315|Glucose Transporter Type I Disorder|glucose transporter type i disorder
221813|NCT02018302|G1D|g1d
221814|NCT02018302|Glut1 Deficiency|glut1 deficiency
221815|NCT02018302|Glucose Transporter Type 1 Deficiency|glucose transporter type 1 deficiency
221816|NCT02018302|Glucose Transporter Type I Deficiency|glucose transporter type i deficiency
221817|NCT02018289|Triclosan coated suture|triclosan coated suture
221818|NCT02018289|Surgical site infection|surgical site infection
221819|NCT02018289|Fecal peritonitis|fecal peritonitis
221820|NCT02018289|Superficial|superficial
221821|NCT02018289|incisional|incisional
221822|NCT02018276|Lidocaine|lidocaine
221823|NCT02018276|Magnesium|magnesium
221824|NCT02018276|Functional recovery|functional recovery
221825|NCT02018237|Obesity|obesity
221826|NCT02018237|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
221827|NCT02018237|High fructose corn syrup|high fructose corn syrup
221828|NCT02018224|Achilles tendon rupture, operative treatment, elongation, long-term follow up.|achilles tendon rupture, operative treatment, elongation, long-term follow up.
221829|NCT02018211|delayed onset muscle soreness|delayed onset muscle soreness
221830|NCT02018211|muscle damage|muscle damage
221831|NCT02018211|muscle function|muscle function
221832|NCT02018211|inflammation|inflammation
221833|NCT02018146|Laryngeal Masks|laryngeal masks
221834|NCT02018146|Airway Management|airway management
221835|NCT02018133|CKD|ckd
221836|NCT02018133|chronic|chronic
221837|NCT02018133|kidney|kidney
221838|NCT02018133|vitamin D|vitamin d
221839|NCT02018120|multiple gingival recession|multiple gingival recession
221840|NCT02018120|platelet rich fibrin|platelet rich fibrin
221841|NCT02018120|connective tissue graft|connective tissue graft
221842|NCT02018120|microsurgery|microsurgery
221843|NCT02018120|periodontal diseases|periodontal diseases
221844|NCT02018120|gingival recession|gingival recession
221845|NCT02018107|Liver Tumor Ablation|liver tumor ablation
221846|NCT02018107|Liver Neoplasms|liver neoplasms
221847|NCT02018107|Positron Emission Tomography|positron emission tomography
221848|NCT02018107|Computed Tomography|computed tomography
221849|NCT02018094|Amputation|amputation
221850|NCT02018094|Infection|infection
221851|NCT02018094|Skin Preparation|skin preparation
221852|NCT02018094|SSI|ssi
221853|NCT02018094|Stump|stump
221854|NCT02018094|Wound|wound
221855|NCT02018081|pharmacokinetic study : open, prospective, monocentric|pharmacokinetic study : open, prospective, monocentric
221856|NCT02018068|Patient-controlled Perineural analgesia|patient-controlled perineural analgesia
272458|NCT01787916|insulin|insulin
212654|NCT02059785|mRS|mrs
221857|NCT02018068|Postoperative|postoperative
221858|NCT02018068|Orthopedic surgery|orthopedic surgery
221859|NCT02018068|"Remote Control versus at bedside care"|"remote control versus at bedside care"
221860|NCT02018068|Comparative medico-economic evaluation|comparative medico-economic evaluation
221861|NCT02018042|Alopecia Areata|alopecia areata
221862|NCT02018042|AA|aa
221863|NCT02018029|Heart failure|heart failure
221864|NCT02018029|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
221865|NCT02018029|collagen peptides|collagen peptides
221866|NCT02018029|MIBG scintigraphy|mibg scintigraphy
221867|NCT02018016|Appendectomy|appendectomy
221868|NCT02018016|Hospitals,General|hospitals,general
221869|NCT02018016|Hospitals,High-Volume|hospitals,high-volume
221870|NCT02018016|Hospitals,Low-Volume|hospitals,low-volume
221871|NCT02018016|Outcome Assessment (Health Care)|outcome assessment (health care)
221872|NCT02017990|Renal transplantation|renal transplantation
221873|NCT02017990|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
221874|NCT02017990|Mortality|mortality
221875|NCT02017990|Graft loss|graft loss
221876|NCT02017990|Rejection|rejection
221878|NCT02017977|General Surgery|general surgery
221879|NCT02017977|Hospitals,General|hospitals,general
221880|NCT02017977|Hospitals,Rural|hospitals,rural
221881|NCT02017977|Hospitals,Urban|hospitals,urban
221882|NCT02017977|Rural Health Services|rural health services
221883|NCT02017977|Geography, Medical|geography, medical
221884|NCT02017977|Outcome Assessment (Health Care)|outcome assessment (health care)
221885|NCT02017951|Appendectomy|appendectomy
221886|NCT02017951|Hospitals,General|hospitals,general
221887|NCT02017951|Hospitals,Rural|hospitals,rural
221888|NCT02017951|Hospitals,Urban|hospitals,urban
221889|NCT02017951|Rural Health Services|rural health services
221890|NCT02017951|Geography, Medical|geography, medical
221891|NCT02017951|Outcome Assessment (Health Care)|outcome assessment (health care)
221892|NCT02017938|Fatigue|fatigue
221893|NCT02017938|electromyography (EMG)|electromyography (emg)
221894|NCT02017938|central fatigue|central fatigue
221895|NCT02017938|cycling training|cycling training
221896|NCT02017925|Pulmonary Rehabilitation|pulmonary rehabilitation
221897|NCT02017925|Non-Small Cell Lung Cancer|non-small cell lung cancer
221898|NCT02017925|NSCLC|nsclc
221899|NCT02017912|Mesenchymal Stromal cells|mesenchymal stromal cells
221900|NCT02017912|MSC-NTF|msc-ntf
221901|NCT02017912|Cell therapy|cell therapy
221903|NCT02017899|prevention|prevention
221904|NCT02017899|Shigella sonnei|shigella sonnei
221905|NCT02017886|Probiotics|probiotics
221906|NCT02017886|Oral health|oral health
221907|NCT02017886|Innate immunity|innate immunity
221908|NCT02017873|bleaching|bleaching
221909|NCT02017873|smokers|smokers
221910|NCT02017873|effectiveness|effectiveness
221911|NCT02017873|pain|pain
221912|NCT02017860|RAD001, everolimus, roll-over|rad001, everolimus, roll-over
221913|NCT02017847|oxygen consumption|oxygen consumption
221914|NCT02017847|activity monitors|activity monitors
221915|NCT02017847|METs|mets
221916|NCT02017847|intensity|intensity
221917|NCT02017834|oral cavity squamous cell carcinoma|oral cavity squamous cell carcinoma
221918|NCT02017834|head and neck cancer|head and neck cancer
221919|NCT02017834|oral cancer|oral cancer
221920|NCT02017821|Exercise|exercise
221921|NCT02017821|Oxygen Consumption|oxygen consumption
221922|NCT02017821|mental health|mental health
221923|NCT02017808|OCT|oct
221924|NCT02017808|Copaxone|copaxone
221925|NCT02017808|Multiple sclerosis|multiple sclerosis
221926|NCT02017808|relapsing-remitting|relapsing-remitting
221927|NCT02017795|asthma, mixed asthma, telehealth, action plan, exacerbation|asthma, mixed asthma, telehealth, action plan, exacerbation
221928|NCT02017782|Dust|dust
221929|NCT02017782|Ozone|ozone
221930|NCT02017782|Indoor air quality|indoor air quality
221931|NCT02017782|Indoor environment|indoor environment
221932|NCT02017782|Indoor climate|indoor climate
221933|NCT02017782|Cardiovascular diseases|cardiovascular diseases
221934|NCT02017782|Full body exposure|full body exposure
221935|NCT02017782|Exposure experiment with dust and ozone|exposure experiment with dust and ozone
751896|NCT01171105|tolerability|tolerability
221936|NCT02017782|Acute exposure to ozone and dust|acute exposure to ozone and dust
221937|NCT02017782|Respiratory outcomes|respiratory outcomes
221938|NCT02017782|Cardiovascular outcomes|cardiovascular outcomes
221939|NCT02017782|Acoustic rhinometry|acoustic rhinometry
221940|NCT02017782|Body inflammatory markers|body inflammatory markers
221941|NCT02017782|Cytokines|cytokines
221942|NCT02017782|Exhaled FeNO|exhaled feno
221943|NCT02017782|Nasal Lavage|nasal lavage
221944|NCT02017782|Heart rate variability|heart rate variability
221945|NCT02017782|Blood biomarkers|blood biomarkers
221946|NCT02017782|Subjective discomfort|subjective discomfort
221947|NCT02017782|General mucosal irritation|general mucosal irritation
221948|NCT02017769|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
221949|NCT02017769|Magnetic resonance imaging|magnetic resonance imaging
221950|NCT02017756|Carotid artery|carotid artery
221951|NCT02017756|Atherosclerosis|atherosclerosis
221952|NCT02017756|Vulnerable plaque|vulnerable plaque
221953|NCT02017756|Magnetic resonance imaging|magnetic resonance imaging
221954|NCT02017756|Arterial wall|arterial wall
221955|NCT02017704|Endorectal Brachytherapy Radiation Therapy|endorectal brachytherapy radiation therapy
221956|NCT02017704|Intensity Modulated Radiation Therapy and Capecitabine|intensity modulated radiation therapy and capecitabine
221957|NCT02017678|JX-594|jx-594
221958|NCT02017678|Ovarian cancer|ovarian cancer
221959|NCT02017678|Peritoneal|peritoneal
221960|NCT02017678|Carcinomatosis|carcinomatosis
221961|NCT02017678|Vaccinia virus|vaccinia virus
221962|NCT02017678|Oncolytic virus|oncolytic virus
221963|NCT02017665|encephalitis|encephalitis
221964|NCT02017665|viral infections|viral infections
221965|NCT02017665|central nervous system|central nervous system
221966|NCT02017652|bowel motility|bowel motility
221967|NCT02017652|cerebral perfusion|cerebral perfusion
221968|NCT02017652|intestinal perfusion|intestinal perfusion
221969|NCT02017626|Fish allergy|fish allergy
221970|NCT02017626|immunotherapy|immunotherapy
221971|NCT02017626|hypoallergen|hypoallergen
221972|NCT02017613|CLL, SLL, NHL, SLL, PTCL, CTCL, MM, AML|cll, sll, nhl, sll, ptcl, ctcl, mm, aml
221973|NCT02017574|Stroke|stroke
221974|NCT02017574|Cerebral Infarction|cerebral infarction
221975|NCT02017561|Diastolic dysfunction|diastolic dysfunction
221976|NCT02017561|Metabolic syndrome|metabolic syndrome
221977|NCT02017561|Metformin|metformin
221978|NCT02017548|advance directives, advance care planning|advance directives, advance care planning
221980|NCT02017522|Cardiac sarcoidosis|cardiac sarcoidosis
221981|NCT02017522|FDG|fdg
221982|NCT02017522|Cardiac MRI|cardiac mri
221983|NCT02017509|Immunophenotype|immunophenotype
221984|NCT02017509|Immunoscore|immunoscore
221985|NCT02017509|MRI|mri
221986|NCT02017509|RNA Later|rna later
221987|NCT02017496|Breast cancer|breast cancer
221988|NCT02017496|locally advanced|locally advanced
221989|NCT02017496|neoadjuvant treatment|neoadjuvant treatment
221990|NCT02017496|breast conserving surgery|breast conserving surgery
221991|NCT02017483|ADHD,|adhd,
221992|NCT02017483|emotion recognition|emotion recognition
221993|NCT02017483|attention|attention
221994|NCT02017470|Women Heart Health|women heart health
221995|NCT02017470|Cardiovascular Disease|cardiovascular disease
221996|NCT02017470|focus group|focus group
221997|NCT02017470|advisory board|advisory board
221998|NCT02017470|one-on-one interview|one-on-one interview
221999|NCT02017457|Hematology|hematology
222000|NCT02017457|Acute Myelogenous Leukemia|acute myelogenous leukemia
222001|NCT02017457|Myelodysplasic syndrome|myelodysplasic syndrome
222002|NCT02017457|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
222003|NCT02017457|Donor lymphocyte infusion|donor lymphocyte infusion
222004|NCT02017457|DLI|dli
222005|NCT02017457|Azacytidine|azacytidine
222006|NCT02017457|Vidaza|vidaza
222007|NCT02017457|Overall response rate|overall response rate
222008|NCT02017457|Relapse|relapse
222009|NCT02017444|Pseudotumor Cerebri|pseudotumor cerebri
222010|NCT02017444|Benign Intracranial Hypertension|benign intracranial hypertension
222011|NCT02017444|Headaches|headaches
222012|NCT02017444|Tinnitus|tinnitus
222013|NCT02017444|Papilledema|papilledema
222014|NCT02017444|Blindness|blindness
222015|NCT02017444|Optic Disk|optic disk
222016|NCT02017444|Intracranial Hypertension|intracranial hypertension
222017|NCT02017444|Clinical Trial, Phase 2|clinical trial, phase 2
222018|NCT02017444|11beta-Hydroxysteroid Dehydrogenase Type 1|11beta-hydroxysteroid dehydrogenase type 1
222019|NCT02017444|Obesity|obesity
222020|NCT02017431|Diesel exhaust|diesel exhaust
222021|NCT02017431|Particle depleted diesel exhaust|particle depleted diesel exhaust
222022|NCT02017431|Air pollution|air pollution
222023|NCT02017431|Airway responsiveness|airway responsiveness
222024|NCT02017431|Allergies|allergies
222025|NCT02017418|zeaxanthin|zeaxanthin
222026|NCT02017418|visual function|visual function
222027|NCT02017418|reaction time|reaction time
222028|NCT02017418|processing speed|processing speed
222029|NCT02017405|Digestibility|digestibility
222030|NCT02017405|Healthy volunteers|healthy volunteers
222031|NCT02017405|serum-derived bovine immunoglobulin protein isolate|serum-derived bovine immunoglobulin protein isolate
221902|NCT02017912|ALS|als
222032|NCT02017405|bovine IgG|bovine igg
222033|NCT02017405|adults|adults
222034|NCT02017392|postoperative agitation|postoperative agitation
222035|NCT02017392|endotracheal intubation|endotracheal intubation
222036|NCT02017392|general anesthesia|general anesthesia
222037|NCT02017379|upper gastrointestinal bleeding|upper gastrointestinal bleeding
222038|NCT02017379|melena|melena
222039|NCT02017379|hematemesis|hematemesis
222040|NCT02017366|Surgery|surgery
222041|NCT02017366|Malnutrition|malnutrition
222042|NCT02017366|Nutrition, Enteral|nutrition, enteral
222043|NCT02017340|Alzheimer's Disease|alzheimer's disease
222044|NCT02017340|Investigator-driven clinical trial|investigator-driven clinical trial
222045|NCT02017340|Nilvadipine|nilvadipine
222046|NCT02017340|Calcium Channel blocker|calcium channel blocker
222047|NCT02017340|Elderly|elderly
272699|NCT01787071|cvp|cvp
222048|NCT02017340|Therapeutic Intervention|therapeutic intervention
222049|NCT02017314|morbid obesity|morbid obesity
222050|NCT02017314|postoperative pain|postoperative pain
222051|NCT02017301|Liver Cirrhosis,Infection, Impedance, Body Composition|liver cirrhosis,infection, impedance, body composition
222052|NCT02017288|Head and Neck Cancers|head and neck cancers
222053|NCT02017288|Larynx|larynx
222054|NCT02017288|Oropharynx|oropharynx
222055|NCT02017288|Oral Cavity|oral cavity
222056|NCT02017262|Self-care|self-care
222057|NCT02017262|Patient education|patient education
222058|NCT02017236|Food Effect|food effect
222059|NCT02017236|Health subjects|health subjects
222060|NCT02017223|Physical activity|physical activity
222061|NCT02017197|Therapeutic Equivalency|therapeutic equivalency
222062|NCT02017197|Warfarin|warfarin
222063|NCT02017197|Drugs, Generic|drugs, generic
222064|NCT02017197|Anticoagulants|anticoagulants
222065|NCT02017197|Anticoagulants [Pharmacological Action]|anticoagulants [pharmacological action]
222066|NCT02017197|Coumarins|coumarins
222067|NCT02017184|Body Temperature Regulation Sensor Noninvasive|body temperature regulation sensor noninvasive
222068|NCT02017171|Kidney Diseases|kidney diseases
222069|NCT02017171|Diabetic Nephropathies|diabetic nephropathies
222070|NCT02017171|Diabetes Mellitus|diabetes mellitus
222071|NCT02017171|Diabetes Complications|diabetes complications
222072|NCT02017171|Uric acid|uric acid
222073|NCT02017171|Allopurinol|allopurinol
222079|NCT02017145|infection|infection
222081|NCT02017145|chlorhexidine|chlorhexidine
222082|NCT02017145|lower extremity surgery|lower extremity surgery
222083|NCT02017145|antiseptic|antiseptic
222084|NCT02017145|bacterial colonization|bacterial colonization
222085|NCT02017132|Pomegranate|pomegranate
222086|NCT02017132|Blood pressure|blood pressure
222087|NCT02017132|Body composition|body composition
222088|NCT02017132|Weight-loss|weight-loss
222089|NCT02017132|Fat mass|fat mass
222090|NCT02017132|Polyphenols|polyphenols
222091|NCT02017132|Quality of Life|quality of life
222092|NCT02017106|Varicose Veins|varicose veins
222093|NCT02017093|CVA, rehabilitation|cva, rehabilitation
222094|NCT02017080|fetal thyroid ultrasound|fetal thyroid ultrasound
222095|NCT02017080|fetal fT4|fetal ft4
222096|NCT02017080|antithyroid antibodies|antithyroid antibodies
222097|NCT02017080|pregnancy|pregnancy
222098|NCT02017080|autoimmune thyroid disease|autoimmune thyroid disease
222099|NCT02017067|Resistance training|resistance training
222100|NCT02017067|musculoskeletal conditions|musculoskeletal conditions
222102|NCT02017041|opioid dependence, buprenorphine, smartphone, suboxone|opioid dependence, buprenorphine, smartphone, suboxone
222103|NCT02017015|Pancreatic cancer|pancreatic cancer
222104|NCT02017015|Metastatic pancreatic cancer|metastatic pancreatic cancer
222105|NCT02017015|treatment for pancreatic cancer|treatment for pancreatic cancer
222106|NCT02017015|Abraxane clinical research trials|abraxane clinical research trials
222107|NCT02017015|Celgene clinical research trials|celgene clinical research trials
222108|NCT02017002|Esophageal cancer|esophageal cancer
222109|NCT02017002|minimally invasive|minimally invasive
222110|NCT02017002|Surgical Procedures|surgical procedures
222111|NCT02017002|Esophagectomy|esophagectomy
222112|NCT02016989|Bacterial keratitis|bacterial keratitis
222113|NCT02016989|OTR4120|otr4120
222114|NCT02016989|Matrix therapy|matrix therapy
222115|NCT02016963|Monoclonal Antibody|monoclonal antibody
222116|NCT02016963|Safety|safety
222117|NCT02016963|Raxibacumab|raxibacumab
222118|NCT02016963|HGS1021|hgs1021
222119|NCT02016963|Immunogenicity|immunogenicity
222120|NCT02016937|Anesthesia , lactation, birth|anesthesia , lactation, birth
222126|NCT02016898|Primary open angle glaucoma|primary open angle glaucoma
222127|NCT02016898|trabeculectomy|trabeculectomy
222128|NCT02016898|mitomycin-C|mitomycin-c
222129|NCT02016898|express mini-shunt|express mini-shunt
222130|NCT02016872|PET/CT|pet/ct
222131|NCT02016872|18F-FMISO|18f-fmiso
222132|NCT02016872|tumor hypoxia|tumor hypoxia
222133|NCT02016872|13-186|13-186
222134|NCT02016859|IPF Immature platelet fraction|ipf immature platelet fraction
222135|NCT02016859|ICU neutropenic fever|icu neutropenic fever
222136|NCT02016859|hip fracture|hip fracture
222137|NCT02016859|critically ill|critically ill
222138|NCT02016833|Ovarian Cancer|ovarian cancer
222139|NCT02016833|Cervical Cancer|cervical cancer
222140|NCT02016833|Leukemia|leukemia
222141|NCT02016833|Immunity|immunity
222148|NCT02016820|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
222149|NCT02016807|Mucositis|mucositis
222150|NCT02016807|Sucralfate|sucralfate
222151|NCT02016807|Prothelial|prothelial
222152|NCT02016807|High potency sucralfate|high potency sucralfate
222153|NCT02016807|Ulcerations|ulcerations
222154|NCT02016807|Chemotherapy induced diarrhea|chemotherapy induced diarrhea
222155|NCT02016807|Radiation induced mucositis|radiation induced mucositis
222156|NCT02016807|Chemotherapy colitis|chemotherapy colitis
222157|NCT02016807|Radiation colitis|radiation colitis
222158|NCT02016807|Mucosal erosions|mucosal erosions
222159|NCT02016794|cervical|cervical
222160|NCT02016794|interbody|interbody
222161|NCT02016794|spacer|spacer
222162|NCT02016794|degenerative|degenerative
222163|NCT02016794|pain|pain
222164|NCT02016794|neck|neck
222165|NCT02016794|decompression|decompression
222166|NCT02016794|fusion|fusion
222167|NCT02016794|implant|implant
222169|NCT02016755|Peripheral Arterial Disease|peripheral arterial disease
222170|NCT02016755|Vascular Disease|vascular disease
222171|NCT02016755|CLI|cli
222172|NCT02016755|Critical Limb Ischemia|critical limb ischemia
222173|NCT02016755|PAD|pad
222174|NCT02016755|AnGes|anges
222175|NCT02016755|HGF Plasmid|hgf plasmid
222176|NCT02016755|HGF|hgf
222177|NCT02016755|Hepatocyte Growth Factor Plasmid|hepatocyte growth factor plasmid
222178|NCT02016755|gene therapy|gene therapy
222179|NCT02016742|Pharmacokinetics|pharmacokinetics
222180|NCT02016729|AML|aml
222181|NCT02016716|Postmenopausal Osteoporosis|postmenopausal osteoporosis
222182|NCT02016703|erythritol|erythritol
222183|NCT02016703|polyol|polyol
222184|NCT02016703|laxation|laxation
222185|NCT02016703|gastrointestinal|gastrointestinal
222186|NCT02016703|tolerance|tolerance
222187|NCT02016703|soft drinks|soft drinks
222188|NCT02016703|child|child
222189|NCT02016703|diarrhoea|diarrhoea
222190|NCT02016690|Prevention of severe RSV infection|prevention of severe rsv infection
222191|NCT02016690|Respiratory syncytial virus (RSV) infection|respiratory syncytial virus (rsv) infection
222192|NCT02016690|Down Syndrome|down syndrome
222193|NCT02016690|Immunocompromised|immunocompromised
222197|NCT02016677|Sagging|sagging
222198|NCT02016664|Chronic Pain, Ketamine, Safety|chronic pain, ketamine, safety
222199|NCT02016638|Obstructive Sleep Apnea in pregnancy|obstructive sleep apnea in pregnancy
222200|NCT02016638|Pregnancy induced hypertension|pregnancy induced hypertension
222201|NCT02016638|Restless leg syndrome|restless leg syndrome
222202|NCT02016638|Sleep|sleep
222203|NCT02016612|Recurrent|recurrent
222204|NCT02016612|Ptosis|ptosis
222205|NCT02016612|Reduction|reduction
222206|NCT02016612|Mammoplasty|mammoplasty
222207|NCT02016612|Mastopexy|mastopexy
222208|NCT02016599|Hypotension|hypotension
222209|NCT02016599|Low blood pressure|low blood pressure
222210|NCT02016599|Neonate|neonate
222211|NCT02016599|Extremely Low Birth Weight Infant|extremely low birth weight infant
222212|NCT02016573|renal denervation|renal denervation
222213|NCT02016573|blood pressure|blood pressure
222214|NCT02016573|cardiovascular risk|cardiovascular risk
222215|NCT02016573|target organ damage|target organ damage
222216|NCT02016573|sympathetic activity|sympathetic activity
222217|NCT02016547|Stroke|stroke
222218|NCT02016547|Middle Cerebral Artery|middle cerebral artery
222219|NCT02016547|Thrombectomy|thrombectomy
222220|NCT02016547|Mechanical Thrombolysis|mechanical thrombolysis
222221|NCT02016547|Abciximab|abciximab
222222|NCT02016534|MET Amplified Gastric / Gastroesophageal Junction / Esophageal Adenocarcinoma, or other solid tumors.|met amplified gastric / gastroesophageal junction / esophageal adenocarcinoma, or other solid tumors.
222223|NCT02016521|Exercise|exercise
222224|NCT02016521|Clothing|clothing
222225|NCT02016521|Core body temperature|core body temperature
222226|NCT02016521|Skin Temperature|skin temperature
222227|NCT02016521|Performance|performance
222228|NCT02016508|Adult bone marrow stem cells|adult bone marrow stem cells
222229|NCT02016508|AMD|amd
222230|NCT02016482|Nail Psoriasis|nail psoriasis
222231|NCT02016482|Plaque Psoriasis|plaque psoriasis
222235|NCT02016443|inguinal hernia|inguinal hernia
222236|NCT02016430|TMAO|tmao
222237|NCT02016430|Gut Flora|gut flora
222238|NCT02016430|Dietary Intervention|dietary intervention
222239|NCT02016430|Choline|choline
222240|NCT02016430|Carnitine|carnitine
222241|NCT02016417|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
222242|NCT02016417|Induction chemotherapy|induction chemotherapy
222243|NCT02016417|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
222244|NCT02016417|Gemcitabine|gemcitabine
222245|NCT02016417|Docetaxel|docetaxel
222246|NCT02016404|blood pressure|blood pressure
222247|NCT02016404|sodium|sodium
222248|NCT02016404|salt|salt
222249|NCT02016404|low sodium high potassium salt|low sodium high potassium salt
222250|NCT02016404|potassium|potassium
222251|NCT02016404|Vietnam|vietnam
222252|NCT02016404|randomized controlled trial|randomized controlled trial
222253|NCT02016365|Transthyretin amyloidosis|transthyretin amyloidosis
222254|NCT02016365|Cardiomyopathy|cardiomyopathy
222255|NCT02016365|ATTR|attr
222256|NCT02016365|neuropathy|neuropathy
222257|NCT02016352|hydrocephalus|hydrocephalus
222258|NCT02016352|proteomic|proteomic
222259|NCT02016352|cerebrospinal fluid|cerebrospinal fluid
222260|NCT02016326|Colonoscopy|colonoscopy
222261|NCT02016326|High Definition White Light|high definition white light
222262|NCT02016326|I-Scan|i-scan
222263|NCT02016326|Adenomas|adenomas
222264|NCT02016300|cartilage|cartilage
222265|NCT02016300|microfracture|microfracture
222266|NCT02016300|knee|knee
222267|NCT02016300|bracing|bracing
222268|NCT02016261|Cognitive function|cognitive function
222269|NCT02016248|CyberKnife|cyberknife
222270|NCT02016248|Prostate Cancer|prostate cancer
222271|NCT02016248|Stereotactic Body Radiation|stereotactic body radiation
222272|NCT02016248|SBRT|sbrt
222273|NCT02016248|Radiosurgery|radiosurgery
222274|NCT02016248|SABR|sabr
222275|NCT02016248|Stereotactic Ablative Body Radiotherapy|stereotactic ablative body radiotherapy
222276|NCT02016248|Boost|boost
222277|NCT02016235|Dent|dent
222279|NCT02016235|Dent Disease|dent disease
222280|NCT02016235|Phosphorus Supplements|phosphorus supplements
222281|NCT02016235|FGF 23|fgf 23
222282|NCT02016222|primary progressive multiple sclerosis|primary progressive multiple sclerosis
222283|NCT02016222|diagnosis|diagnosis
222284|NCT02016222|tears|tears
222285|NCT02016222|isoelectric focusing|isoelectric focusing
222286|NCT02016222|oligoclonal bands|oligoclonal bands
222287|NCT02016196|TIPS|tips
222288|NCT02016196|portal pressure|portal pressure
222289|NCT02016196|rifaximin|rifaximin
222290|NCT02016196|overt hepatic encephalopathy|overt hepatic encephalopathy
222291|NCT02016196|microbiota|microbiota
222292|NCT02016183|Drug Therapy|drug therapy
222293|NCT02016170|platelet reactivity|platelet reactivity
222294|NCT02016170|ticagrelor|ticagrelor
222295|NCT02016170|prasugrel|prasugrel
222296|NCT02016157|Moxifloxacin|moxifloxacin
222297|NCT02016157|Chlorhexidine|chlorhexidine
222298|NCT02016157|In situ gel|in situ gel
222299|NCT02016157|Chronic periodontitis|chronic periodontitis
222300|NCT02016144|Airway management; Fiber optic technology; Intubation|airway management; fiber optic technology; intubation
222301|NCT02016131|endoleak|endoleak
222302|NCT02016131|EVAR|evar
222304|NCT02016131|CQDSA|cqdsa
222305|NCT02016118|RUTI|ruti
222306|NCT02016105|plaque type psoriasis|plaque type psoriasis
222307|NCT02016105|equivalent efficacy|equivalent efficacy
222308|NCT02016105|safety and immunogenicity|safety and immunogenicity
222309|NCT02016105|GP2017|gp2017
222310|NCT02016105|Humira®|humira®
222311|NCT02016092|Parkinson's disease|parkinson's disease
222312|NCT02016092|biomarkers|biomarkers
222313|NCT02016092|blood|blood
222314|NCT02016092|urine,|urine,
222315|NCT02016092|proteomics|proteomics
222316|NCT02016092|lipidomics|lipidomics
222317|NCT02016092|metabolomics|metabolomics
222318|NCT02016079|randomized controlled trial|randomized controlled trial
222319|NCT02016079|omega-3|omega-3
222320|NCT02016079|nutrition|nutrition
222321|NCT02016079|behavior problems|behavior problems
222322|NCT02016079|externalizing|externalizing
222323|NCT02016079|internalizing|internalizing
222324|NCT02016079|antisocial|antisocial
222325|NCT02016079|aggressive|aggressive
222326|NCT02016066|Healthy|healthy
222327|NCT02016066|CR6261|cr6261
222328|NCT02016066|Japanese|japanese
222329|NCT02016066|Safety|safety
222330|NCT02016066|Pharmacokinetics|pharmacokinetics
222331|NCT02016066|Immunogenicity|immunogenicity
222332|NCT02016040|Prostate cancer|prostate cancer
222333|NCT02016040|HIFU Hemi-ablation|hifu hemi-ablation
222334|NCT02016040|Prostate biopsies|prostate biopsies
222335|NCT02016014|Physical activity|physical activity
222336|NCT02016014|Alimentation|alimentation
222337|NCT02016014|Information and communication Technology|information and communication technology
222338|NCT02016014|Arterial aging|arterial aging
222339|NCT02016001|fluoride|fluoride
222340|NCT02016001|dental caries|dental caries
222341|NCT02016001|prevention|prevention
222342|NCT02015988|Acute coronary syndrome|acute coronary syndrome
222343|NCT02015988|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
222344|NCT02015988|Hypertriglyceridemia|hypertriglyceridemia
222345|NCT02015988|Simvastatin|simvastatin
222346|NCT02015988|Fenofibrate|fenofibrate
222347|NCT02015975|patellar fracture|patellar fracture
222348|NCT02015975|fracture of patella|fracture of patella
222349|NCT02015975|patella|patella
222350|NCT02015975|locking plate osteosynthesis|locking plate osteosynthesis
222351|NCT02015975|osteosynthesis|osteosynthesis
222353|NCT02015975|arrow-plate|arrow-plate
222354|NCT02015962|Hypokalemia|hypokalemia
222355|NCT02015962|Intravenous|intravenous
222356|NCT02015962|Enteral|enteral
222357|NCT02015962|post-cardiac surgery|post-cardiac surgery
222358|NCT02015936|stage III cancer|stage iii cancer
222359|NCT02015936|stage IV cancer|stage iv cancer
222360|NCT02015936|cancer|cancer
222361|NCT02015936|advanced stage cancer|advanced stage cancer
222362|NCT02015936|Nintendo Wii training|nintendo wii training
222363|NCT02015936|exercise|exercise
222364|NCT02015936|physical training|physical training
222365|NCT02015936|physical function|physical function
222366|NCT02015936|physical fitness test|physical fitness test
222367|NCT02015923|Colonic cancer|colonic cancer
222368|NCT02015923|Metastasis|metastasis
222369|NCT02015884|Incivility|incivility
222370|NCT02015884|Rudeness|rudeness
222371|NCT02015884|Aggression|aggression
222372|NCT02015884|Violent act|violent act
222373|NCT02015884|Healthcare workers|healthcare workers
222374|NCT02015884|Emergency unit|emergency unit
222375|NCT02015832|SYNTAX II Score|syntax ii score
222376|NCT02015832|Pressure wires|pressure wires
222377|NCT02015832|instantaneous wave-free ratio|instantaneous wave-free ratio
222378|NCT02015832|fractional flow reserve|fractional flow reserve
222379|NCT02015832|intravascular ultrasound|intravascular ultrasound
222380|NCT02015832|Drug eluting stents|drug eluting stents
222381|NCT02015832|Stents|stents
222382|NCT02015832|Angioplasty|angioplasty
222383|NCT02015832|multi slice computed tomography|multi slice computed tomography
222384|NCT02015806|Quality improvement|quality improvement
222385|NCT02015806|Randomized controlled trial|randomized controlled trial
222386|NCT02015806|Medication adherence|medication adherence
222387|NCT02015806|RxTimer Cap|rxtimer cap
222388|NCT02015806|PillMinder|pillminder
222389|NCT02015806|Take-N-Slide|take-n-slide
222390|NCT02015806|Low-touch devices|low-touch devices
222391|NCT02015806|Medication management|medication management
222392|NCT02015793|Crohn's Disease|crohn's disease
222393|NCT02015793|Pharmacokinetics|pharmacokinetics
222394|NCT02015780|Drug therapy|drug therapy
222395|NCT02015767|Drug therapy|drug therapy
222396|NCT02015728|Refractory|refractory
222397|NCT02015728|Recurrent|recurrent
222398|NCT02015728|Brain|brain
222399|NCT02015728|Tumor|tumor
222400|NCT02015728|Pediatric|pediatric
222401|NCT02015728|Biologically Targeted Therapy|biologically targeted therapy
222402|NCT02015728|Sorafenib|sorafenib
222403|NCT02015728|Everolimus|everolimus
222404|NCT02015728|Erlotinib|erlotinib
222405|NCT02015728|Dasatinib|dasatinib
222406|NCT02015728|Temozolomide|temozolomide
222407|NCT02015728|Etoposide|etoposide
222408|NCT02015702|Physicians|physicians
222409|NCT02015702|Electronic Health Record|electronic health record
222410|NCT02015702|Education|education
222411|NCT02015663|Cystic Fibrosis|cystic fibrosis
222413|NCT02015650|Locally advanced squamous cell carcinomas of head and neck|locally advanced squamous cell carcinomas of head and neck
222414|NCT02015637|Gonorrhea|gonorrhea
222415|NCT02015637|N. gonorrhoeae|n. gonorrhoeae
222416|NCT02015637|bacterial infection|bacterial infection
222417|NCT02015637|Anti-Infective Agents|anti-infective agents
222418|NCT02015637|Anti-Bacterial Agents|anti-bacterial agents
222419|NCT02015624|Acute coronary syndromes|acute coronary syndromes
222420|NCT02015624|Intensive Care Unit|intensive care unit
222421|NCT02015611|Vitamin D|vitamin d
222422|NCT02015611|Muscle power|muscle power
222423|NCT02015611|Muscle fiber|muscle fiber
222424|NCT02015611|Falls|falls
222425|NCT02015611|Aging|aging
222426|NCT02015598|Obstructive sleep apnoea|obstructive sleep apnoea
222427|NCT02015598|Antioxidant|antioxidant
222428|NCT02015598|drug treatment|drug treatment
222429|NCT02015598|oxidative stress|oxidative stress
222430|NCT02015598|Continuous Positive Airway Pressure|continuous positive airway pressure
222431|NCT02015572|Low back pain|low back pain
222432|NCT02015572|Return to work|return to work
222433|NCT02015572|Sickness absence|sickness absence
222434|NCT02015572|Rehabilitation|rehabilitation
222435|NCT02015572|Occupational intervention|occupational intervention
222436|NCT02015546|Major Depressive Disorder|major depressive disorder
222437|NCT02015546|Vilazodone|vilazodone
222438|NCT02015533|Healthy|healthy
222439|NCT02015533|CR8020|cr8020
222440|NCT02015533|Japanese|japanese
222441|NCT02015533|Safety|safety
222442|NCT02015533|Pharmacokinetics|pharmacokinetics
222443|NCT02015533|Immunogenicity|immunogenicity
222444|NCT02015494|Safety|safety
222445|NCT02015494|Immunogenicity|immunogenicity
222446|NCT02015481|Case control, safety, tolerability, efficacy.|case control, safety, tolerability, efficacy.
222447|NCT02015468|Distal radius fracture|distal radius fracture
222448|NCT02015468|Wrist fracture|wrist fracture
222449|NCT02015468|Physiotherapy|physiotherapy
222450|NCT02015468|Immobilization|immobilization
222451|NCT02015468|Volar locking plates|volar locking plates
222452|NCT02015468|Mobilization|mobilization
222453|NCT02015455|pragmatic trial|pragmatic trial
222454|NCT02015455|stepped-wedge design|stepped-wedge design
222455|NCT02015455|cluster-randomized trial|cluster-randomized trial
222456|NCT02015442|Sucrose in diet|sucrose in diet
222457|NCT02015429|Food intake|food intake
222458|NCT02015429|satiety|satiety
222459|NCT02015429|glycemia|glycemia
222460|NCT02015429|appetite|appetite
222461|NCT02015429|blood glucose|blood glucose
222462|NCT02015429|yellow peas|yellow peas
222463|NCT02015429|fibre|fibre
222464|NCT02015429|protein|protein
222465|NCT02015429|mixed meal|mixed meal
222466|NCT02015416|Melanoma|melanoma
222467|NCT02015416|Ovarian cancer|ovarian cancer
222468|NCT02015416|Sarcoma|sarcoma
222469|NCT02015416|Non-small cell lung cancer|non-small cell lung cancer
222470|NCT02015416|NSCLC|nsclc
222471|NCT02015416|Breast cancer|breast cancer
222472|NCT02015390|bone defects|bone defects
222473|NCT02015390|iatrogenic resection|iatrogenic resection
222474|NCT02015390|titanium mesh cage|titanium mesh cage
222475|NCT02015390|biomembrane|biomembrane
222476|NCT02015390|Masquelet technique|masquelet technique
222477|NCT02015364|Achilles tendon|achilles tendon
222478|NCT02015364|Rupture|rupture
273192|NCT01784913|cancer|cancer
222479|NCT02015364|Rehabilitation|rehabilitation
222480|NCT02015364|Dynamic rehabilitation|dynamic rehabilitation
222481|NCT02015351|Choroidal neovascularization|choroidal neovascularization
222482|NCT02015351|Vogt Koyanagi Harada Disease|vogt koyanagi harada disease
222483|NCT02015351|Inflammatory choroidal neovascularization|inflammatory choroidal neovascularization
222484|NCT02015351|Anti-VEGF|anti-vegf
222485|NCT02015338|Hemiparesis|hemiparesis
222486|NCT02015338|Cerebral Palsy|cerebral palsy
222487|NCT02015338|Congenital Stroke|congenital stroke
222488|NCT02015338|Congenital Infarct|congenital infarct
222489|NCT02015325|Water|water
222490|NCT02015325|Sanitation|sanitation
222491|NCT02015325|Hygiene|hygiene
222492|NCT02015325|Education|education
222493|NCT02015325|Evaluation|evaluation
222494|NCT02015312|Amyloidosis|amyloidosis
222495|NCT02015299|Diabetes|diabetes
222496|NCT02015299|Pulse Wave Velocity|pulse wave velocity
222497|NCT02015299|Dipeptidyl peptidase (DPP)-4 inhibitors|dipeptidyl peptidase (dpp)-4 inhibitors
222498|NCT02015299|Linagliptin|linagliptin
222499|NCT02015299|Arterial Stiffness|arterial stiffness
222500|NCT02015299|Subclinical arterial inflammation|subclinical arterial inflammation
222501|NCT02015286|Growth disorders|growth disorders
222502|NCT02015286|Saizen|saizen
222503|NCT02015286|Easypod|easypod
222504|NCT02015286|Growth hormone|growth hormone
222505|NCT02015286|Pediatric subject|pediatric subject
222506|NCT02015273|easypod™|easypod™
222507|NCT02015273|SAIZEN®|saizen®
222508|NCT02015260|human papilloma virus infection|human papilloma virus infection
222509|NCT02015260|Anogenital warts|anogenital warts
222510|NCT02015260|condylomata acuminata|condylomata acuminata
222511|NCT02015234|TNX-102 SL|tnx-102 sl
222512|NCT02015234|bedtime|bedtime
222513|NCT02015234|sublingual|sublingual
222514|NCT02015234|12-month|12-month
222515|NCT02015234|long term safety|long term safety
222516|NCT02015234|long term efficacy|long term efficacy
222517|NCT02015234|Fibromyalgia|fibromyalgia
222518|NCT02015221|chronic venous insufficiency|chronic venous insufficiency
222519|NCT02015221|venous leg ulcers|venous leg ulcers
222520|NCT02015221|pneumatic compression|pneumatic compression
222521|NCT02015208|CLL|cll
222522|NCT02015208|cytokine signaling|cytokine signaling
222523|NCT02015208|signal transduction inhibitors|signal transduction inhibitors
222524|NCT02015208|elderly|elderly
222525|NCT02015208|p53|p53
222526|NCT02015195|Jellyfish stings|jellyfish stings
222527|NCT02015195|Treatment|treatment
222528|NCT02015195|Humans|humans
222529|NCT02015195|Topical Treatments|topical treatments
222530|NCT02015195|Pain|pain
222531|NCT02015195|Erythema|erythema
222532|NCT02015182|Bupivacaine|bupivacaine
222533|NCT02015182|Sensorcaine|sensorcaine
222534|NCT02015182|Population pharmacokinetics|population pharmacokinetics
222535|NCT02015182|Children|children
222536|NCT02015182|Pediatrics|pediatrics
222537|NCT02015182|Transversus abdominis plane (TAP) block|transversus abdominis plane (tap) block
222538|NCT02015182|Regional Anesthesia|regional anesthesia
222539|NCT02015169|gastric cancer|gastric cancer
222540|NCT02015169|neoadjuvant chemotherapy|neoadjuvant chemotherapy
222541|NCT02015169|capecitabine|capecitabine
222542|NCT02015169|oxaliplatin|oxaliplatin
222543|NCT02015169|lapatinib|lapatinib
222544|NCT02015156|Trastuzumab|trastuzumab
222545|NCT02015156|Healthy Male Volunteers|healthy male volunteers
222546|NCT02015156|Single-Dose|single-dose
222547|NCT02015156|Phase 1|phase 1
222548|NCT02015156|Biosimilarity|biosimilarity
222549|NCT02015130|Type 2 diabetes|type 2 diabetes
222550|NCT02015130|hypertension|hypertension
222551|NCT02015130|individual|individual
222552|NCT02015104|Urothelial Cancinoma|urothelial cancinoma
222553|NCT02015104|Vaccines|vaccines
222554|NCT02015104|Immunotherapy|immunotherapy
222555|NCT02015104|TICE BCG|tice bcg
222556|NCT02015104|Intravesical Treatment|intravesical treatment
222557|NCT02015091|Healthy Subjects|healthy subjects
222558|NCT02015091|Vaccine-Mediated Protection|vaccine-mediated protection
222559|NCT02015091|Immunogenicity|immunogenicity
222560|NCT02015091|Sporozoites|sporozoites
222561|NCT02015091|Parasitemia|parasitemia
222562|NCT02015078|Eating Behavior|eating behavior
222563|NCT02015078|Cancer|cancer
222564|NCT02015078|Chronic Diseases|chronic diseases
222565|NCT02015078|Obesity|obesity
222566|NCT02015065|GIST|gist
222567|NCT02015065|Toxicity|toxicity
222568|NCT02015065|Mesenchymal Tumor|mesenchymal tumor
222569|NCT02015065|Clinical Activity|clinical activity
222570|NCT02015065|Survival|survival
222571|NCT02015039|Occupational Therapy|occupational therapy
222572|NCT02015039|Botulinum Toxin|botulinum toxin
222573|NCT02015039|Writer's Cramp|writer's cramp
222574|NCT02015026|Biospecimen Repository|biospecimen repository
222575|NCT02015026|Disease Progression Pattern|disease progression pattern
222576|NCT02015026|Specimen Analysis|specimen analysis
222577|NCT02015026|Genetic Analysis|genetic analysis
222578|NCT02015013|Leukapheresis|leukapheresis
222579|NCT02015013|Progenitor Cells|progenitor cells
273369|NCT01784055|MR|mr
213316|NCT02056782|AML|aml
222580|NCT02015000|Pterygium|pterygium
222581|NCT02015000|Recurrence|recurrence
222582|NCT02014987|Running related injury|running related injury
222583|NCT02014987|Overuse injury|overuse injury
222584|NCT02014987|Running pattern|running pattern
222585|NCT02014974|Fractures|fractures
222586|NCT02014974|burden of fractures|burden of fractures
222587|NCT02014974|orthopaedic fractures|orthopaedic fractures
222588|NCT02014974|orthopaedic injuries|orthopaedic injuries
222589|NCT02014974|orthopaedic trauma|orthopaedic trauma
222590|NCT02014974|fractures India|fractures india
222591|NCT02014974|observational study|observational study
222592|NCT02014974|outcomes of fracture care|outcomes of fracture care
222593|NCT02014974|wait times India|wait times india
222594|NCT02014974|epidemiology|epidemiology
222595|NCT02014948|Low Back Pain|low back pain
222596|NCT02014948|Physiotherapy|physiotherapy
222597|NCT02014935|Low-intensity Laser|low-intensity laser
222598|NCT02014935|Spasticity|spasticity
222600|NCT02014935|Fatigue|fatigue
222601|NCT02014909|KTN3379|ktn3379
222602|NCT02014909|Advanced cancer|advanced cancer
222603|NCT02014909|Phase 1|phase 1
222604|NCT02014909|Monoclonal antibody|monoclonal antibody
222605|NCT02014909|Safety and pharmacokinetics|safety and pharmacokinetics
222606|NCT02014909|CDX3379|cdx3379
222607|NCT02014896|Ischemic Stroke|ischemic stroke
222608|NCT02014896|Transient Ischemic Attack|transient ischemic attack
222609|NCT02014896|Transient Neurological Event|transient neurological event
222610|NCT02014896|Atrial Fibrillation|atrial fibrillation
222611|NCT02014896|Cryptogenic Stroke|cryptogenic stroke
222612|NCT02014896|Gene Expression|gene expression
222613|NCT02014896|RNA|rna
222614|NCT02014896|Anticoagulant|anticoagulant
222615|NCT02014896|NOAC|noac
222616|NCT02014896|Antiplatelet|antiplatelet
222617|NCT02014896|Cardiac monitoring|cardiac monitoring
222618|NCT02014896|Point of Care|point of care
222620|NCT02014896|Atheroembolic|atheroembolic
222621|NCT02014870|Influenza|influenza
222622|NCT02014870|Vaccine|vaccine
222623|NCT02014870|Virus|virus
222624|NCT02014870|H1N1|h1n1
222625|NCT02014870|Challenge|challenge
222626|NCT02014870|Vismederi|vismederi
222627|NCT02014857|Smoking, gingival crevicular fluid, matrix metalloproteinases, intercellular signaling peptides and proteins, healthy volunteers|smoking, gingival crevicular fluid, matrix metalloproteinases, intercellular signaling peptides and proteins, healthy volunteers
222628|NCT02014844|glioblastoma|glioblastoma
222629|NCT02014844|aldoxorubicin|aldoxorubicin
222630|NCT02014844|temozolomide|temozolomide
222631|NCT02014844|brain cancer|brain cancer
222632|NCT02014844|brain tumor|brain tumor
222633|NCT02014831|Squamous Cell Carcinoma of the penis|squamous cell carcinoma of the penis
222634|NCT02014831|Stage N3|stage n3
222635|NCT02014831|Metastasis|metastasis
222636|NCT02014831|TIP|tip
222637|NCT02014831|Cetuximab|cetuximab
222638|NCT02014831|Objective Response Rate|objective response rate
222639|NCT02014831|Safety profile|safety profile
222640|NCT02014831|Overall Survival|overall survival
222641|NCT02014831|Progression Free Survival|progression free survival
222642|NCT02014831|Quality of Life|quality of life
222643|NCT02014805|postoperative|postoperative
222644|NCT02014805|conformal|conformal
222645|NCT02014805|radiotherapy|radiotherapy
222646|NCT02014805|thymoma|thymoma
222647|NCT02014792|Haemodialysis|haemodialysis
222648|NCT02014792|Heart rate variability|heart rate variability
222649|NCT02014792|n-3 PUFA|n-3 pufa
222650|NCT02014779|Randomized Controlled Trial|randomized controlled trial
222651|NCT02014779|Alcohol|alcohol
222652|NCT02014779|Internet|internet
222653|NCT02014779|Internet based therapy|internet based therapy
222654|NCT02014779|Cognitive behavioral therapy|cognitive behavioral therapy
222655|NCT02014753|AMI|ami
222656|NCT02014753|STEMI|stemi
222657|NCT02014753|ACS|acs
222658|NCT02014740|Epicardial fat|epicardial fat
222659|NCT02014740|Type 2 diabetes|type 2 diabetes
222660|NCT02014740|Obesity|obesity
222661|NCT02014740|GLP-1 analogs|glp-1 analogs
222662|NCT02014727|Malaria vaccine|malaria vaccine
222663|NCT02014727|phase 1,|phase 1,
222664|NCT02014727|AMA1-DiCO|ama1-dico
222665|NCT02014701|echocardiogram|echocardiogram
222666|NCT02014701|regional wall motion abnormalities|regional wall motion abnormalities
222667|NCT02014701|myocardial contrast|myocardial contrast
222668|NCT02014688|Normal subjects|normal subjects
222669|NCT02014675|ICD|icd
222670|NCT02014675|CRT-D|crt-d
222671|NCT02014675|Lead|lead
222672|NCT02014662|Muscle function, Muscle damage and recovery, Eccentric exercise, Muscle soreness, Protein synthesis|muscle function, muscle damage and recovery, eccentric exercise, muscle soreness, protein synthesis
222673|NCT02014649|Influenza treatment|influenza treatment
222674|NCT02014649|pediatric|pediatric
222675|NCT02014649|laninamivir|laninamivir
222676|NCT02014636|Pazopanib (GW786034)|pazopanib (gw786034)
222677|NCT02014636|MK 3475|mk 3475
222678|NCT02014636|Renal cell carcinoma|renal cell carcinoma
222679|NCT02014623|Allergic rhinitis|allergic rhinitis
222680|NCT02014623|Asthma|asthma
222681|NCT02014623|Regulatory T cells|regulatory t cells
222682|NCT02014623|IgE|ige
222683|NCT02014623|IgG4|igg4
222684|NCT02014610|Neutrophil|neutrophil
222685|NCT02014610|Lymphocyte|lymphocyte
222686|NCT02014610|Eosinophil|eosinophil
222687|NCT02014610|Leukocyte count|leukocyte count
222688|NCT02014610|Cardiovascular disease|cardiovascular disease
222689|NCT02014610|Atherosclerosis|atherosclerosis
222690|NCT02014610|Monocyte|monocyte
222691|NCT02014610|Basophil|basophil
222692|NCT02014597|Glaucoma|glaucoma
222693|NCT02014584|quality of life|quality of life
222694|NCT02014584|safety|safety
222695|NCT02014584|sexual function|sexual function
222696|NCT02014584|male pattern hair loss (MPHL)|male pattern hair loss (mphl)
222697|NCT02014584|Androgenic alopecia (AGA)|androgenic alopecia (aga)
222698|NCT02014584|dutasteride|dutasteride
222699|NCT02014584|satisfaction with hair growth|satisfaction with hair growth
222700|NCT02014571|NS5B|ns5b
222701|NCT02014571|chronic hepatitis C (CHC)|chronic hepatitis c (chc)
222702|NCT02014571|antiviral activity|antiviral activity
222703|NCT02014571|pharmacokinetics (PK)|pharmacokinetics (pk)
222704|NCT02014571|Safety|safety
222705|NCT02014571|hepatitis C virus (HCV)|hepatitis c virus (hcv)
222706|NCT02014571|GSK2878175|gsk2878175
683387|NCT00902837|OXN PR|oxn pr
222707|NCT02014558|Acute Myeloid Leukemia|acute myeloid leukemia
222708|NCT02014558|ASP2215|asp2215
222709|NCT02014545|brain metastases|brain metastases
222710|NCT02014545|non-small cell lung cancer|non-small cell lung cancer
222711|NCT02014545|whole brain radiation therapy|whole brain radiation therapy
222712|NCT02014545|lucanthone|lucanthone
222713|NCT02014532|Leukotriene receptor antagonist|leukotriene receptor antagonist
222714|NCT02014532|Chronic periodontitis|chronic periodontitis
222715|NCT02014532|Scaling and root planing|scaling and root planing
222716|NCT02014532|C- reactive protein|c- reactive protein
222718|NCT02014519|Hungary|hungary
222719|NCT02014519|Bordetella pertussis|bordetella pertussis
222720|NCT02014519|Seroprevalence|seroprevalence
222721|NCT02014519|Pertussis antibodies|pertussis antibodies
222722|NCT02014506|Children and adolescents|children and adolescents
222723|NCT02014506|Malignant disease|malignant disease
222724|NCT02014506|Non-malignant disease|non-malignant disease
222725|NCT02014506|TCRαβ depletion|tcrαβ depletion
222726|NCT02014506|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
222727|NCT02014493|Respiration|respiration
222728|NCT02014493|Noninvasive Ventilation|noninvasive ventilation
222729|NCT02014493|Work of breathing|work of breathing
222730|NCT02014493|Infant, premature|infant, premature
222731|NCT02014493|Electromyography|electromyography
222732|NCT02014493|Diaphragm|diaphragm
222733|NCT02014480|Long-acting beta-agonist|long-acting beta-agonist
222734|NCT02014480|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
222735|NCT02014480|Umeclidinium|umeclidinium
222736|NCT02014480|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
222737|NCT02014480|Vilanterol|vilanterol
222738|NCT02014454|Retinopathy of prematurity|retinopathy of prematurity
222739|NCT02014454|Propranolol|propranolol
222740|NCT02014454|Eye drops|eye drops
222741|NCT02014454|Newborns|newborns
222742|NCT02014454|Retinal angiogenesis|retinal angiogenesis
222743|NCT02014454|Retinal neovascularization|retinal neovascularization
222744|NCT02014415|Alpha-1|alpha-1
222745|NCT02014415|AAT Deficiency|aat deficiency
222746|NCT02014415|AATD|aatd
222747|NCT02014415|Liver|liver
222748|NCT02014415|Fibrosis|fibrosis
222749|NCT02014415|Liver Transplant|liver transplant
222750|NCT02014415|Cirrhosis|cirrhosis
222751|NCT02014402|Vascular surgery|vascular surgery
222752|NCT02014402|Hepatic surgery|hepatic surgery
222753|NCT02014402|Soft tissue surgery|soft tissue surgery
222754|NCT02014402|Spinal surgery|spinal surgery
222755|NCT02014389|Retinal Dystrophies|retinal dystrophies
222756|NCT02014389|Retinitis Pigmentosa|retinitis pigmentosa
222757|NCT02014389|Glaucoma|glaucoma
222758|NCT02014389|Visual Field|visual field
222759|NCT02014376|Epidermolysis Bullosa|epidermolysis bullosa
222760|NCT02014376|Simplex|simplex
222761|NCT02014376|Recessive Dystrophic|recessive dystrophic
751897|NCT01171118|Breathing|breathing
222762|NCT02014376|Junctional non-Herlitz|junctional non-herlitz
222763|NCT02013336|pediatric|pediatric
222764|NCT02013336|MM-398|mm-398
222765|NCT02013336|cyclophosphamide|cyclophosphamide
222766|NCT02013336|irinotecan|irinotecan
222767|NCT02013323|Septiline, chronic periodontitis, Immunomodulator, microbiology|septiline, chronic periodontitis, immunomodulator, microbiology
222768|NCT02013297|Pediatrics|pediatrics
222769|NCT02013297|SBRT|sbrt
222770|NCT02013297|Brain metastasis|brain metastasis
222771|NCT02013297|Pulmonary metastasis|pulmonary metastasis
222772|NCT02013297|Spinal metastasis|spinal metastasis
222773|NCT02013297|Pulmonary primary tumor|pulmonary primary tumor
222774|NCT02013297|Spinal primary tumor|spinal primary tumor
222775|NCT02013297|Relapsed ependymoma|relapsed ependymoma
222776|NCT02013297|Relapsed irradiated tumors|relapsed irradiated tumors
222777|NCT02013297|Local control rate|local control rate
222778|NCT02013297|Safety|safety
222779|NCT02013297|Overall survival|overall survival
222780|NCT02013297|Progression Free Survival|progression free survival
222781|NCT02013258|Prader Willi syndrome|prader willi syndrome
222782|NCT02013258|Oxytocin|oxytocin
222783|NCT02013232|Risperidone;|risperidone;
222784|NCT02013232|Aripiprazole;|aripiprazole;
222785|NCT02013232|Hyperprolactinemia;|hyperprolactinemia;
222786|NCT02013232|dose effects|dose effects
222787|NCT02013193|drug-coated balloon|drug-coated balloon
222788|NCT02013193|drug-eluting balloon|drug-eluting balloon
222789|NCT02013193|peripheral artery disease|peripheral artery disease
222790|NCT02013193|claudication|claudication
222791|NCT02013180|Prostate cancer, PSA, zinc, zinc/PSA|prostate cancer, psa, zinc, zinc/psa
222792|NCT02014337|Mifepristone|mifepristone
222793|NCT02014337|Eribulin Mesylate|eribulin mesylate
222794|NCT02014337|Breast Cancer|breast cancer
222795|NCT02014337|Ovarian Cancer|ovarian cancer
222796|NCT02014337|Sarcoma|sarcoma
222797|NCT02014337|Non-small cell lung cancer|non-small cell lung cancer
222798|NCT02014337|Carcinoma, transitional cell|carcinoma, transitional cell
222799|NCT02014337|Prostate cancer|prostate cancer
222800|NCT02014337|Prostatic neoplasms|prostatic neoplasms
222801|NCT02014311|Multidetector Computed Tomography|multidetector computed tomography
222802|NCT02014311|Myocardial Perfusion Imaging|myocardial perfusion imaging
222803|NCT02014311|Coronary Stenosis|coronary stenosis
222804|NCT02014311|Coronary Artery Disease|coronary artery disease
222805|NCT02014311|Angina Pectoris|angina pectoris
222806|NCT02014298|Burns|burns
222807|NCT02014298|Non-ablative fractional laser|non-ablative fractional laser
222808|NCT02014298|scar texture|scar texture
222809|NCT02014298|histology|histology
222810|NCT02014298|laser treatment|laser treatment
222811|NCT02014298|erbium:glass laser|erbium:glass laser
222812|NCT02014298|meshed skin-grafts|meshed skin-grafts
222813|NCT02014298|photothermolysis|photothermolysis
222814|NCT02014298|skin|skin
222815|NCT02014285|Acute Respiratory Failure|acute respiratory failure
223009|NCT02013063|CT scan|ct scan
222816|NCT02014285|Critical Illness|critical illness
222817|NCT02014285|Mechanical Ventilation|mechanical ventilation
222818|NCT02014285|Muscle Architecture|muscle architecture
222819|NCT02014285|Muscle Ultrasound|muscle ultrasound
222820|NCT02014272|Bioequivalence|bioequivalence
222821|NCT02014272|RIN 150|rin 150
222822|NCT02014272|Healthy volunteers|healthy volunteers
222823|NCT02014246|Movement Disorders|movement disorders
222824|NCT02014246|Polymorphisms|polymorphisms
222826|NCT02014246|Lymphoblast Cell Lines|lymphoblast cell lines
222827|NCT02014233|Randomized clinical trial|randomized clinical trial
222828|NCT02014233|Humans|humans
222829|NCT02014233|Omega-3 fatty acids|omega-3 fatty acids
222830|NCT02014233|Essential fatty acid|essential fatty acid
222831|NCT02014233|Neuromuscular function|neuromuscular function
222832|NCT02014233|Wingate|wingate
222833|NCT02014233|Maximum voluntary contraction|maximum voluntary contraction
222834|NCT02014233|Electromyography|electromyography
222835|NCT02014233|Seal oil|seal oil
222836|NCT02014233|Cycling time trial|cycling time trial
222837|NCT02014233|Placebo controlled|placebo controlled
222838|NCT02014194|Attentional Bias|attentional bias
222839|NCT02014194|Attentional Bias modification treatment|attentional bias modification treatment
222840|NCT02014181|cystic fibrosis|cystic fibrosis
222841|NCT02014181|isoprostanes|isoprostanes
222842|NCT02014181|8-oxo-dGuo|8-oxo-dguo
222843|NCT02014181|oxidative stress|oxidative stress
222844|NCT02014181|inflammation|inflammation
222845|NCT02014181|flaxseed|flaxseed
222846|NCT02014181|enterodiol|enterodiol
222847|NCT02014181|enterolactone|enterolactone
222848|NCT02014155|Chronic Obstructive Pulmonary Disease,|chronic obstructive pulmonary disease,
222849|NCT02014103|bioequivalence|bioequivalence
222850|NCT02014103|tacrolimus|tacrolimus
222851|NCT02014103|transplant|transplant
222852|NCT02014103|CYP3A5 expressors/non expressors|cyp3a5 expressors/non expressors
222853|NCT02014090|ECP|ecp
222854|NCT02014090|Endurance exercise|endurance exercise
222855|NCT02014090|myocardial perfusion|myocardial perfusion
222856|NCT02014077|VATS( Video-Assisted Thoracoscopy )|vats( video-assisted thoracoscopy )
222857|NCT02014077|Thoracostomy Tube|thoracostomy tube
222858|NCT02014077|Empyema|empyema
222859|NCT02014077|Thoracotomy|thoracotomy
222860|NCT02014064|Methamphetamine, Atomoxetine, Clinical Pharmacology|methamphetamine, atomoxetine, clinical pharmacology
222862|NCT02014038|ultramarathon runners|ultramarathon runners
222863|NCT02014038|ULTRA|ultra
222864|NCT02014038|Physical activity|physical activity
222865|NCT02014038|Health Risks|health risks
222866|NCT02014038|sedentary|sedentary
222867|NCT02014038|moderately active|moderately active
222868|NCT02014025|Laparoscope hepatectomy|laparoscope hepatectomy
222869|NCT02014025|Open hepatectomy|open hepatectomy
222870|NCT02014025|large PHC|large phc
222871|NCT02014025|safety and sensibility|safety and sensibility
222872|NCT02013986|salivary cortisol|salivary cortisol
273721|NCT01782391|MCI|mci
222873|NCT02013986|circadian rhythm|circadian rhythm
222874|NCT02013986|children|children
222875|NCT02013986|etomidate|etomidate
222876|NCT02013973|Anti mullerian hormone|anti mullerian hormone
222877|NCT02013973|In vitro fertilization|in vitro fertilization
222878|NCT02013973|Optimal treatment|optimal treatment
222879|NCT02013973|Randomized controlled trial|randomized controlled trial
222880|NCT02013947|Exercise, moderate altitude, hypoxia, metabolic syndrome|exercise, moderate altitude, hypoxia, metabolic syndrome
222881|NCT02013921|Physical activity|physical activity
222882|NCT02013921|Cancer|cancer
222883|NCT02013908|acupuncture|acupuncture
222884|NCT02013908|emergency department|emergency department
222885|NCT02013908|acute pain|acute pain
222886|NCT02013908|ankle sprain|ankle sprain
222887|NCT02013908|neck pain|neck pain
222888|NCT02013908|primary headache|primary headache
222889|NCT02013895|liver|liver
222890|NCT02013895|surgery|surgery
222891|NCT02013895|liver function|liver function
222892|NCT02013895|GSA|gsa
222893|NCT02013895|ICG|icg
222894|NCT02013882|low flow anesthesia|low flow anesthesia
222895|NCT02013882|wash-in|wash-in
222896|NCT02013882|desflurane|desflurane
222897|NCT02013869|fresh gas flow|fresh gas flow
222898|NCT02013869|quality of anaesthesia|quality of anaesthesia
683388|NCT00902837|OxyPR|oxypr
222899|NCT02013869|minimal alveolar concentration|minimal alveolar concentration
222900|NCT02013856|Blood pressure|blood pressure
222901|NCT02013856|Flavanols|flavanols
222902|NCT02013856|Cardiovascular disease|cardiovascular disease
222903|NCT02013843|Pediatric obesity|pediatric obesity
222904|NCT02013843|Community-based treatment|community-based treatment
222905|NCT02013843|dyslipidemia|dyslipidemia
222906|NCT02013843|hypertension|hypertension
222907|NCT02013843|diabetes|diabetes
222908|NCT02013778|outside of transplant criteria|outside of transplant criteria
222909|NCT02013752|Delivery tears|delivery tears
222910|NCT02013752|Birth injuries|birth injuries
222911|NCT02013752|Perineal protection device|perineal protection device
222912|NCT02013713|Cardiology|cardiology
222913|NCT02013713|Family Hypercholesterolemia|family hypercholesterolemia
222914|NCT02013700|IPF|ipf
222915|NCT02013700|Pulmonary fibrosis|pulmonary fibrosis
222916|NCT02013674|Cardiovascular, Chronic Ischemic Left Ventricular Dysfunction|cardiovascular, chronic ischemic left ventricular dysfunction
222917|NCT02013661|periodontal debridement|periodontal debridement
222918|NCT02013661|sutures|sutures
222919|NCT02013661|tissue reaction|tissue reaction
222920|NCT02013648|AML|aml
222921|NCT02013648|Dasatinib|dasatinib
222922|NCT02013648|Core Binding Factor (CBF)|core binding factor (cbf)
222923|NCT02013635|cerebral venous thrombosis|cerebral venous thrombosis
222924|NCT02013635|thrombin generation|thrombin generation
222925|NCT02013635|d-dimers|d-dimers
222926|NCT02013635|clinical evolution|clinical evolution
222927|NCT02013622|schizophrenia|schizophrenia
222928|NCT02013622|Mental Disorders|mental disorders
222929|NCT02013622|Psychotic Disorders|psychotic disorders
222930|NCT02013622|social avoidance|social avoidance
222931|NCT02013622|emotional withdrawal|emotional withdrawal
222932|NCT02013622|passive/apathetic|passive/apathetic
222933|NCT02013622|social withdrawal|social withdrawal
222934|NCT02013622|antipsychotic|antipsychotic
222935|NCT02013609|schizophrenia|schizophrenia
222936|NCT02013609|Major depressive disorder|major depressive disorder
222937|NCT02013609|Anxiety Symptoms|anxiety symptoms
222938|NCT02013609|School, Work environment|school, work environment
222939|NCT02013609|Mental Disorders|mental disorders
222940|NCT02013609|Psychotic Disorders|psychotic disorders
222941|NCT02013609|antipsychotic|antipsychotic
222942|NCT02013596|hepatic dysfunction|hepatic dysfunction
222943|NCT02013596|renal dysfunction|renal dysfunction
222944|NCT02013596|pneumoperitoneum|pneumoperitoneum
222945|NCT02013596|Transcutaneous electric stimulation|transcutaneous electric stimulation
222946|NCT02013583|Glucose Transporter Type I Deficiency|glucose transporter type i deficiency
222947|NCT02013583|Glucose Transporter Type 1 Deficiency|glucose transporter type 1 deficiency
222948|NCT02013583|G1D|g1d
222949|NCT02013583|Glut1 Deficiency|glut1 deficiency
222950|NCT02013570|postoperative pain; dexmedetomidine; adenotonsillectomy|postoperative pain; dexmedetomidine; adenotonsillectomy
222951|NCT02013557|Gestational Diabetes|gestational diabetes
222952|NCT02013557|Postpartum screening|postpartum screening
222953|NCT02013557|Text-messages|text-messages
222825|NCT02014246|DNA|dna
222954|NCT02013557|75-g oral glucose tolerance test|75-g oral glucose tolerance test
222955|NCT02013544|Vulvovaginal atrophy (VVA)|vulvovaginal atrophy (vva)
222956|NCT02013544|Vaginal atrophy|vaginal atrophy
222957|NCT02013544|Atrophic vaginitis|atrophic vaginitis
222958|NCT02013544|prasterone|prasterone
222959|NCT02013544|DHEA|dhea
222960|NCT02013544|Intrarosa|intrarosa
222961|NCT02013531|schizophrenia|schizophrenia
222962|NCT02013531|Major depressive disorder|major depressive disorder
222963|NCT02013531|Anxiety Symptoms|anxiety symptoms
222964|NCT02013531|Mental Disorders|mental disorders
222965|NCT02013531|Psychotic Disorders|psychotic disorders
222966|NCT02013531|emotional withdrawal|emotional withdrawal
222967|NCT02013531|antipsychotic|antipsychotic
222968|NCT02013518|Alzheimers' disease|alzheimers' disease
222969|NCT02013518|Cognitive behavioral therapy|cognitive behavioral therapy
222970|NCT02013518|Depression|depression
222971|NCT02013518|Self-efficacy|self-efficacy
222972|NCT02013518|Quality of Life|quality of life
222973|NCT02013505|Colonoscopy|colonoscopy
222974|NCT02013492|Beta-Blocker|beta-blocker
222975|NCT02013492|metastatic melanoma|metastatic melanoma
222976|NCT02013492|hepatocellular carcinoma|hepatocellular carcinoma
222977|NCT02013466|Bioavailability|bioavailability
222978|NCT02013466|Amino Acids|amino acids
222979|NCT02013466|Elderly|elderly
222980|NCT02013466|Supplement|supplement
222981|NCT02013427|chronic|chronic
222982|NCT02013427|back|back
222983|NCT02013427|pain|pain
222984|NCT02013427|brain|brain
222986|NCT02013401|mother-infant dyadic regulation|mother-infant dyadic regulation
222987|NCT02013401|stress|stress
222988|NCT02013401|psychophysiology|psychophysiology
223376|NCT02011321|clevidipine|clevidipine
222989|NCT02013401|emotion regulation|emotion regulation
222990|NCT02013388|N91115|n91115
222991|NCT02013388|GSNORi|gsnori
222993|NCT02013388|Cavosonstat|cavosonstat
402001|NCT01233570|Granulomatous chelitis|granulomatous chelitis
683487|NCT00903188|everolimus|everolimus
222994|NCT02013167|Relapsed; Refractory; B-precursor; Acute Lymphoblastic Leukemia; Philadelphia Negative; ALL; Blinatumomab; Leukemia; Standard of Care; SOC|relapsed; refractory; b-precursor; acute lymphoblastic leukemia; philadelphia negative; all; blinatumomab; leukemia; standard of care; soc
222995|NCT02013141|Gram positive bacteria|gram positive bacteria
222996|NCT02013141|Telavancin|telavancin
222997|NCT02013141|VIBATIV|vibativ
222998|NCT02013141|Pediatric|pediatric
222999|NCT02013141|Pharmacokinetics|pharmacokinetics
223000|NCT02013115|infant|infant
223001|NCT02013115|respiratory distress syndrome|respiratory distress syndrome
223002|NCT02013089|genomic sequencing, Integrated genomic network analysis|genomic sequencing, integrated genomic network analysis
223003|NCT02013076|Asthma; Children; Cohort study; Corticosteroids|asthma; children; cohort study; corticosteroids
223004|NCT02013063|Single Pulmonary Nodule|single pulmonary nodule
223005|NCT02013063|SPN|spn
223006|NCT02013063|Lung cancer|lung cancer
223007|NCT02013063|Diagnostic|diagnostic
223008|NCT02013063|Computed Tomography|computed tomography
223010|NCT02013063|FDG-PET scan|fdg-pet scan
223011|NCT02013063|Dynamic CT scan|dynamic ct scan
223012|NCT02013063|DCE-CT scan|dce-ct scan
223013|NCT02013063|Dynamic contrast enhanced CT scan|dynamic contrast enhanced ct scan
223014|NCT02013063|soft tissue solitary dominant|soft tissue solitary dominant
223015|NCT02013063|≥ 8mm and ≤30mm|≥ 8mm and ≤30mm
223016|NCT02013037|cardiac transplantation|cardiac transplantation
223017|NCT02013037|immunosuppression|immunosuppression
223018|NCT02013037|acute cellular rejection|acute cellular rejection
223019|NCT02013037|antibody mediated rejection|antibody mediated rejection
223020|NCT02013037|sensitization|sensitization
223021|NCT02013037|antibody production in cardiac patients|antibody production in cardiac patients
223022|NCT02013037|panel reactive antibodies|panel reactive antibodies
223023|NCT02013037|desensitization strategies in heart transplant patients|desensitization strategies in heart transplant patients
223024|NCT02013037|complement activation|complement activation
223025|NCT02013037|complement c3d and c4d deposition|complement c3d and c4d deposition
223026|NCT02013037|terminal complement inhibition|terminal complement inhibition
223027|NCT02013037|complement C5 binding|complement c5 binding
223028|NCT02013037|Eculizumab|eculizumab
223029|NCT02013037|monoclonal antibody|monoclonal antibody
223030|NCT02013037|donor specific antibodies|donor specific antibodies
223031|NCT02012985|hyperoxaluria|hyperoxaluria
223032|NCT02012985|oxalate|oxalate
223033|NCT02012985|PH|ph
223034|NCT02012972|Antiretroviral therapy|antiretroviral therapy
223035|NCT02012972|HIV/AIDS|hiv/aids
223036|NCT02012972|Non-communicable diseases|non-communicable diseases
223037|NCT02012972|South Africa|south africa
223038|NCT02012959|Hyponatremia|hyponatremia
223039|NCT02012959|Euvolemic|euvolemic
223040|NCT02012959|Hypervolemic|hypervolemic
223041|NCT02012959|Serum sodium|serum sodium
223042|NCT02012959|Dilutional hyponatremia|dilutional hyponatremia
223043|NCT02012959|Electrolyte abnormality|electrolyte abnormality
223044|NCT02012959|Electrolyte imbalance|electrolyte imbalance
223045|NCT02012959|Metabolic disease|metabolic disease
223046|NCT02012933|3,4DAP, LEMS, CM|3,4dap, lems, cm
223047|NCT02012920|castration-resistant prostate cancer|castration-resistant prostate cancer
223049|NCT02012920|P450c17a|p450c17a
223050|NCT02012920|lyase|lyase
223051|NCT02012920|Prostate Cancer|prostate cancer
223052|NCT02012894|Obesity|obesity
223053|NCT02012894|Gastroesophageal reflux|gastroesophageal reflux
223054|NCT02012894|sleeve gastrectomy|sleeve gastrectomy
223055|NCT02012894|pH-monitoring|ph-monitoring
223056|NCT02012894|manometry|manometry
223057|NCT02012868|obstructive sleep apnoea|obstructive sleep apnoea
223058|NCT02012868|weight loss|weight loss
223059|NCT02012868|bariatric surgery|bariatric surgery
223060|NCT02012842|Metabolic Syndrome|metabolic syndrome
223061|NCT02012842|Periodontal Disease|periodontal disease
223062|NCT02012842|Periodontal therapy|periodontal therapy
223063|NCT02012842|inflammatory markers|inflammatory markers
223064|NCT02012842|C reactive protein|c reactive protein
223065|NCT02012842|serum fibrinogen|serum fibrinogen
223066|NCT02012842|glycated hemoglobin|glycated hemoglobin
223067|NCT02012829|cancer, CRC screening, communication|cancer, crc screening, communication
223068|NCT02012816|Uncircumcised men|uncircumcised men
223069|NCT02012816|Voluntary Medical Male circumcision|voluntary medical male circumcision
223070|NCT02012816|Peer-referral incentive|peer-referral incentive
223071|NCT02012803|Achilles tendon rupture|achilles tendon rupture
223072|NCT02012803|treatment, elongation|treatment, elongation
223073|NCT02012803|operative treatment of achilles tendon rupture|operative treatment of achilles tendon rupture
223074|NCT02012803|conservative treatment of achilles tendon rupture|conservative treatment of achilles tendon rupture
223075|NCT02012790|Migraine disorders|migraine disorders
223076|NCT02012777|sickle cell disease|sickle cell disease
223077|NCT02012777|propanolol|propanolol
223078|NCT02012777|red blood cell adhesion|red blood cell adhesion
223079|NCT02012764|Anti-CCP antibody|anti-ccp antibody
223080|NCT02012764|Inflammatory arthritis|inflammatory arthritis
223081|NCT02012764|Rheumatoid arthritis|rheumatoid arthritis
223082|NCT02012764|Musculoskeletal symptom|musculoskeletal symptom
223083|NCT02012751|Computer-assisted diagnosis|computer-assisted diagnosis
223084|NCT02012751|General practice|general practice
223085|NCT02012751|Dermatoscopy|dermatoscopy
223087|NCT02012751|Nevus|nevus
223088|NCT02012725|Healthy|healthy
223089|NCT02012725|Myocardial fibrosis|myocardial fibrosis
223090|NCT02012725|Chronic kidney disease|chronic kidney disease
223091|NCT02012712|Personal health record|personal health record
223092|NCT02012712|medication management|medication management
223093|NCT02012712|patient safety|patient safety
223094|NCT02012699|Pancreatic Cancer|pancreatic cancer
223095|NCT02012699|Thyroid Cancer|thyroid cancer
223096|NCT02012699|Esophageal cancer|esophageal cancer
223097|NCT02012699|Thymus cancer|thymus cancer
223098|NCT02012699|Pancreatic tumor|pancreatic tumor
223099|NCT02012699|Esophageal tumor|esophageal tumor
223100|NCT02012699|Thymus tumor|thymus tumor
223101|NCT02012699|Thyroid Tumor|thyroid tumor
223102|NCT02012699|Thyroid Nodule|thyroid nodule
223103|NCT02012699|Lung Tumor|lung tumor
223104|NCT02012686|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
223105|NCT02012686|thyroidectomy|thyroidectomy
223106|NCT02012686|neck pain|neck pain
223107|NCT02012686|pain management|pain management
223108|NCT02012673|COPD|copd
223109|NCT02012673|Emphysema|emphysema
223110|NCT02012673|Bronchoscopy|bronchoscopy
223111|NCT02012673|Lung Volume Reduction|lung volume reduction
223112|NCT02012647|parkinson|parkinson
223114|NCT02012647|parkinson disease|parkinson disease
223115|NCT02012647|parkinson's|parkinson's
223116|NCT02012647|parkinson's disease|parkinson's disease
223117|NCT02012647|parkinsons|parkinsons
223118|NCT02012647|parkinsons disease|parkinsons disease
223119|NCT02012647|TMS|tms
223120|NCT02012647|DBS|dbs
223121|NCT02012647|transcranial magnetic stimulation|transcranial magnetic stimulation
223122|NCT02012647|deep brain stimulation|deep brain stimulation
223123|NCT02012634|Breast Cancer|breast cancer
223124|NCT02012634|Capecitabine|capecitabine
223125|NCT02012634|Triple Negative Breast CancerTNBC（TNBC）|triple negative breast cancertnbc（tnbc）
223126|NCT02012621|HIV/AIDS|hiv/aids
223127|NCT02012621|Adherence|adherence
223128|NCT02012621|Tenofovir|tenofovir
223129|NCT02012621|Dried Blood Spots|dried blood spots
223131|NCT02012569|skin grafting|skin grafting
223132|NCT02012569|elective treatment|elective treatment
223133|NCT02012543|constipation, agar|constipation, agar
223134|NCT02012530|Articular cartilage|articular cartilage
223135|NCT02012530|Hyaluronic Acid (HA)|hyaluronic acid (ha)
223136|NCT02012530|Platelet rich plasma (PRP)|platelet rich plasma (prp)
223137|NCT02012517|surgical site infection|surgical site infection
223138|NCT02012517|breast reconstruction|breast reconstruction
223139|NCT02012517|drains|drains
223140|NCT02012517|prophylaxis|prophylaxis
223141|NCT02012491|Spontaneous abortion|spontaneous abortion
223142|NCT02012491|Early Pregnancy Failure|early pregnancy failure
223143|NCT02012491|Mifepristone|mifepristone
223144|NCT02012491|Misoprostol|misoprostol
223145|NCT02012465|Steroid induced hyperglycemia|steroid induced hyperglycemia
222992|NCT02013388|SNO|sno
223146|NCT02012465|Glucocorticoid induced hyperglycemia|glucocorticoid induced hyperglycemia
223148|NCT02012452|tobacco dependence|tobacco dependence
223149|NCT02012452|cognitive behavioral therapy|cognitive behavioral therapy
223150|NCT02012439|multiple sclerosis|multiple sclerosis
223151|NCT02012439|chronic pain|chronic pain
223152|NCT02012439|treatment|treatment
223153|NCT02012439|nonpharmacological|nonpharmacological
223154|NCT02012439|mindfulness|mindfulness
223155|NCT02012439|cognitive therapy|cognitive therapy
223156|NCT02012413|knee|knee
223157|NCT02012413|chondromalacia|chondromalacia
223158|NCT02012413|patella|patella
223159|NCT02012413|pulsed signal therapy|pulsed signal therapy
223160|NCT02012413|PST|pst
223161|NCT02012400|Asthma|asthma
223162|NCT02012400|Exercise|exercise
223163|NCT02012400|Asthma control|asthma control
223164|NCT02012400|Physical fitness|physical fitness
223165|NCT02012400|Quality of life|quality of life
223166|NCT02012387|Cholinergic urticaria|cholinergic urticaria
223167|NCT02012387|Omalizumab|omalizumab
223168|NCT02012374|aphasia|aphasia
223169|NCT02012374|anomia|anomia
223170|NCT02012374|speech therapy|speech therapy
223171|NCT02012374|rehabilitation|rehabilitation
223172|NCT02012374|neuroplasticity|neuroplasticity
223173|NCT02012374|fMRI|fmri
223174|NCT02012374|quality of life|quality of life
223175|NCT02012361|Ischemic preconditioning|ischemic preconditioning
223176|NCT02012361|Human limb ischemia|human limb ischemia
223177|NCT02012361|Total knee arthroplasty|total knee arthroplasty
223178|NCT02012361|Supplemental inspired helium|supplemental inspired helium
223179|NCT02012348|bacteria survival, surfactants|bacteria survival, surfactants
223180|NCT02012322|Aging|aging
223378|NCT02011295|OLT|olt
223196|NCT02012283|spices and vegetables|spices and vegetables
223197|NCT02012270|Aortic Aneurysm|aortic aneurysm
223199|NCT02012270|Abdominal Wound Closure Techniques|abdominal wound closure techniques
223200|NCT02012257|anterior middle superior alveolar nerve|anterior middle superior alveolar nerve
223201|NCT02012257|electric pulp tester|electric pulp tester
223202|NCT02012257|local anesthesia|local anesthesia
223325|NCT02011542|IBS|ibs
223203|NCT02012244|analgesia; colorectal surgery; immunity; local anesthetics; opioids|analgesia; colorectal surgery; immunity; local anesthetics; opioids
223204|NCT02012231|melanoma|melanoma
223205|NCT02012231|anaplastic thyroid cancer|anaplastic thyroid cancer
223206|NCT02012231|advanced papillary thyroid cancer|advanced papillary thyroid cancer
223207|NCT02012231|colorectal cancer|colorectal cancer
223208|NCT02012231|non-small cell lung cancer|non-small cell lung cancer
223209|NCT02012231|cholangiocarcinoma|cholangiocarcinoma
223210|NCT02012231|histiocytosis|histiocytosis
223211|NCT02012231|hairy cell leukemia|hairy cell leukemia
223212|NCT02012218|Major Depressive Disorder, Depression|major depressive disorder, depression
223213|NCT02012205|wet cupping - back pain - NSLBP - Saudi|wet cupping - back pain - nslbp - saudi
223214|NCT02012192|High-grade serous|high-grade serous
223215|NCT02012192|high-grade endometrioid|high-grade endometrioid
223216|NCT02012192|undifferentiated|undifferentiated
223217|NCT02012179|Diet|diet
223218|NCT02012179|Dietary sodium reduction|dietary sodium reduction
223219|NCT02012179|Salt restriction|salt restriction
223220|NCT02012179|Nutrition|nutrition
223221|NCT02012166|Diabetes Mellitus|diabetes mellitus
223222|NCT02012166|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
223223|NCT02012166|Glucose Metabolism Disorders|glucose metabolism disorders
223224|NCT02012166|Metabolic Diseases|metabolic diseases
223225|NCT02012166|Endocrine System Diseases|endocrine system diseases
223226|NCT02012166|Therapeutic Uses|therapeutic uses
223227|NCT02012166|Pharmacologic Actions|pharmacologic actions
223228|NCT02012166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
223229|NCT02012166|Physiological Effects of Drugs|physiological effects of drugs
223230|NCT02012153|Mesenchymal stromal cells|mesenchymal stromal cells
223231|NCT02012153|Kidney transplantation|kidney transplantation
223232|NCT02012153|Tolerance|tolerance
223233|NCT02012114|Cystinosis, compliance, cysteamine, neurological assessments|cystinosis, compliance, cysteamine, neurological assessments
223234|NCT02012101|COPD|copd
223235|NCT02012101|dyspnea|dyspnea
223236|NCT02012101|exercise|exercise
223237|NCT02012101|Noninvasive Ventilation|noninvasive ventilation
223238|NCT02012088|Follicular lymphoma, large B-cell lymphoma|follicular lymphoma, large b-cell lymphoma
223239|NCT02012062|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
223240|NCT02012062|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
223241|NCT02012062|Concurrent chemotherapy|concurrent chemotherapy
223242|NCT02012062|Nimotuzumab|nimotuzumab
223243|NCT02012049|Healthy|healthy
223244|NCT02012049|Risperdal OD|risperdal od
223245|NCT02012049|Risperdal Quicklet|risperdal quicklet
223246|NCT02012049|Korea|korea
223247|NCT02012023|Low anterior resection|low anterior resection
223248|NCT02012023|Anastomotic leakage|anastomotic leakage
223249|NCT02012023|Defunctioning stoma|defunctioning stoma
223250|NCT02012023|Controllable tube ileostomy|controllable tube ileostomy
223251|NCT02012023|Loop ileostomy|loop ileostomy
223259|NCT02011958|Randomised|randomised
223260|NCT02011958|Liposomal amphotericin B|liposomal amphotericin b
223261|NCT02011958|Ambisome|ambisome
223262|NCT02011958|Miltefosine|miltefosine
223263|NCT02011958|Pentamidine|pentamidine
223264|NCT02011958|Efficacy|efficacy
223265|NCT02011958|Safety|safety
223266|NCT02011906|antioxidant enzymes|antioxidant enzymes
223267|NCT02011906|omega 3|omega 3
223268|NCT02011906|vitamin E|vitamin e
223269|NCT02011906|CAD|cad
223270|NCT02011906|Sirtuins|sirtuins
223271|NCT02011906|FOXOs|foxos
223272|NCT02011880|breast cancer|breast cancer
274245|NCT01779765|IBS|ibs
223273|NCT02011880|bone metastasis|bone metastasis
223377|NCT02011321|transcranial dopplers|transcranial dopplers
223274|NCT02011880|traditional Chinese medicine(TCM)|traditional chinese medicine(tcm)
223275|NCT02011867|Inner Ear Malformations|inner ear malformations
223276|NCT02011867|Gusher|gusher
223277|NCT02011867|Cochlear Implantation|cochlear implantation
223278|NCT02011854|acupuncture，rehabilitation,Shoulder-hand Syndrome|acupuncture，rehabilitation,shoulder-hand syndrome
223279|NCT02011841|liver cirrhosis|liver cirrhosis
223280|NCT02011841|ascites|ascites
223281|NCT02011841|spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
223282|NCT02011841|recurrence|recurrence
223283|NCT02011828|Hemodialysis, paricalcitol|hemodialysis, paricalcitol
223284|NCT02011815|Breast neoplasms|breast neoplasms
223285|NCT02011815|Circadian rhythm|circadian rhythm
223286|NCT02011815|sleep|sleep
223287|NCT02011815|survival|survival
223288|NCT02011815|distress|distress
223289|NCT02011815|anxiety|anxiety
223290|NCT02011815|depression|depression
223291|NCT02011815|quality of life|quality of life
223292|NCT02011815|actigraph|actigraph
223293|NCT02011815|fatigue|fatigue
223294|NCT02011802|Sorbact TM|sorbact tm
223295|NCT02011802|Alginates|alginates
223296|NCT02011802|Dressing|dressing
223297|NCT02011802|Wound healing|wound healing
223298|NCT02011789|hypercholesterolemia|hypercholesterolemia
223299|NCT02011789|inflammation|inflammation
223300|NCT02011789|citrus limonoids|citrus limonoids
223301|NCT02011776|Corticosteroids Dry Eye Sjögren syndrome inflammation treatment|corticosteroids dry eye sjögren syndrome inflammation treatment
223302|NCT02011763|Hepatitis A|hepatitis a
223303|NCT02011763|hepatitis A virus|hepatitis a virus
223304|NCT02011763|Avaxim® 80U Pediatric|avaxim® 80u pediatric
223305|NCT02011750|schizophrenia|schizophrenia
223306|NCT02011750|toxoplasmosis|toxoplasmosis
223307|NCT02011737|Medical Expulsive therapy|medical expulsive therapy
223308|NCT02011698|Groin hernia|groin hernia
223309|NCT02011698|lichtenstein herniorrhaphy|lichtenstein herniorrhaphy
223310|NCT02011672|dairy|dairy
223311|NCT02011672|glucose|glucose
223312|NCT02011672|inflammation|inflammation
223313|NCT02011659|Ramosetron, postoperative nausea and vomiting, laparoscopy|ramosetron, postoperative nausea and vomiting, laparoscopy
223314|NCT02011646|diet|diet
223315|NCT02011646|body weight|body weight
223316|NCT02011646|eating|eating
223317|NCT02011646|eating disorder|eating disorder
223318|NCT02011646|exercise|exercise
223319|NCT02011581|Overweight|overweight
223320|NCT02011568|Therapeutic Hypothermia|therapeutic hypothermia
223321|NCT02011568|Out of hospital cardiac arrest|out of hospital cardiac arrest
223322|NCT02011568|Mild hypothermia|mild hypothermia
223323|NCT02011568|Moderate hypothermia|moderate hypothermia
223324|NCT02011542|GWI|gwi
223326|NCT02011542|Irritable Bowel Syndrome|irritable bowel syndrome
223327|NCT02011542|Gulf War Illness|gulf war illness
223328|NCT02011516|Marijuana|marijuana
223329|NCT02011516|Addiction|addiction
223330|NCT02011516|fMRI|fmri
223331|NCT02011516|Baclofen|baclofen
223332|NCT02011516|Treatment|treatment
223333|NCT02011477|Neural mobilization|neural mobilization
223334|NCT02011477|Physical therapy|physical therapy
223335|NCT02011477|Asymptomatic subjects|asymptomatic subjects
223336|NCT02011451|Multiple Sclerosis|multiple sclerosis
223337|NCT02011451|Green Tea|green tea
223338|NCT02011451|ECGC|ecgc
223339|NCT02011451|Theaphenon|theaphenon
223340|NCT02011451|Randomized placebo controlled trial|randomized placebo controlled trial
223341|NCT02011451|NAA|naa
223342|NCT02011451|Spectroscopy|spectroscopy
223343|NCT02011451|Brain Atrophy|brain atrophy
223344|NCT02011451|SIENA|siena
223345|NCT02011438|Social Anxiety|social anxiety
223346|NCT02011438|Prevention|prevention
223347|NCT02011438|Peer Relations|peer relations
223348|NCT02011438|Depression|depression
223349|NCT02011438|Adolescent|adolescent
223350|NCT02011438|High School|high school
223351|NCT02011438|Interpersonal|interpersonal
223352|NCT02011438|Peer Victimization|peer victimization
223353|NCT02011425|obstructive sleep apnea|obstructive sleep apnea
223354|NCT02011425|oral appliance|oral appliance
223355|NCT02011425|therapy|therapy
223356|NCT02011425|masseter muscle activity|masseter muscle activity
223357|NCT02011425|randomized controlled trial|randomized controlled trial
223358|NCT02011425|mandibular advancement device|mandibular advancement device
223359|NCT02011425|mandibular advancement appliance|mandibular advancement appliance
223360|NCT02011425|arousals|arousals
223361|NCT02011412|Trauma|trauma
223362|NCT02011412|Scoring Systems|scoring systems
223363|NCT02011412|Intermountain Risk Score|intermountain risk score
223364|NCT02011399|brain|brain
223365|NCT02011399|computer|computer
223366|NCT02011399|interfaces|interfaces
223367|NCT02011399|mobility impairments|mobility impairments
223368|NCT02011373|prolapse, laparoscopic sacrocolpopexy, IFABONDTM glue|prolapse, laparoscopic sacrocolpopexy, ifabondtm glue
223369|NCT02011360|Prader Willi syndrome|prader willi syndrome
214134|NCT02053129|HIV|hiv
223370|NCT02011360|childhood obesity|childhood obesity
223371|NCT02011360|ghrelin|ghrelin
223372|NCT02011360|appetite regulation|appetite regulation
223373|NCT02011321|subarachnoid hemorrhage|subarachnoid hemorrhage
223374|NCT02011321|aneurysm|aneurysm
223375|NCT02011321|vasospasm|vasospasm
223379|NCT02011295|Surgical Intervention|surgical intervention
223380|NCT02011295|BMAC|bmac
223381|NCT02011282|ICU,|icu,
223382|NCT02011282|MYOPATHY,|myopathy,
223383|NCT02011282|NEUROPATHY,|neuropathy,
223384|NCT02011282|PNEUMONIA|pneumonia
223385|NCT02011269|TSO|tso
223386|NCT02011269|Ova|ova
223387|NCT02011269|Psoriasis|psoriasis
223388|NCT02011269|plaque psoriasis|plaque psoriasis
223389|NCT02011269|plaque-type|plaque-type
223390|NCT02011269|Coronado|coronado
223391|NCT02011269|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
223392|NCT02011256|Transient Ischemic Attack|transient ischemic attack
223393|NCT02011256|Atrial Fibrillation|atrial fibrillation
223394|NCT02011256|NOTICE|notice
223395|NCT02011256|Implantable loop-recorder|implantable loop-recorder
223396|NCT02011256|Holter-monitoring|holter-monitoring
223397|NCT02011243|deficit|deficit
223398|NCT02011243|internal rotation|internal rotation
223399|NCT02011243|gleno humeral articulation|gleno humeral articulation
223400|NCT02011243|hand ball|hand ball
223401|NCT02011230|Dehydration|dehydration
223402|NCT02011230|Hoist|hoist
223403|NCT02011230|pain control|pain control
223404|NCT02011230|The intervention is to provide a commercially available isotonic hydration solution (Hoist®) to the patients.|the intervention is to provide a commercially available isotonic hydration solution (hoist®) to the patients.
223405|NCT02011230|Patients will drink this solution post procedure as needed.|patients will drink this solution post procedure as needed.
223406|NCT02011230|Patients in the control group will use their discretion to drink any solution they feel suitable|patients in the control group will use their discretion to drink any solution they feel suitable
223407|NCT02011217|Rye|rye
223408|NCT02011217|Dietary Fibre|dietary fibre
223409|NCT02011217|Bread|bread
223410|NCT02011217|Crisp bread|crisp bread
223411|NCT02011217|Appetite|appetite
223412|NCT02011217|Satiety|satiety
223413|NCT02011217|Hunger|hunger
223414|NCT02011217|Desire to eat|desire to eat
223415|NCT02011217|Metabolism|metabolism
223416|NCT02011217|Glucose|glucose
223417|NCT02011217|Insulin|insulin
223418|NCT02011217|Gut hormones|gut hormones
223419|NCT02011217|Gastric emptying rate|gastric emptying rate
223420|NCT02011191|Biotin|biotin
223421|NCT02011191|Restless|restless
223422|NCT02011191|Kidney|kidney
223423|NCT02011191|Dialysis|dialysis
223424|NCT02011191|Renal|renal
223425|NCT02011165|Macular hole|macular hole
223426|NCT02011165|Vitrectomy|vitrectomy
223427|NCT02011165|Gas tamponade|gas tamponade
223428|NCT02011165|Vitreomacular traction in danger of macular hole formation|vitreomacular traction in danger of macular hole formation
223429|NCT02011165|Epiretinal membrane in danger of macular hole formation|epiretinal membrane in danger of macular hole formation
223430|NCT02011113|Pomalidomide,|pomalidomide,
223431|NCT02011113|CC-4047,|cc-4047,
223432|NCT02011113|Dexamethasone,|dexamethasone,
223433|NCT02011113|Relapsed and refractory multiple myeloma,|relapsed and refractory multiple myeloma,
223434|NCT02011113|phase 2|phase 2
223435|NCT02011061|Multidetector Computed Tomography|multidetector computed tomography
223436|NCT02011061|Coronary Stenosis|coronary stenosis
223437|NCT02011061|Coronary Artery Disease|coronary artery disease
223438|NCT02011061|Angina Pectoris|angina pectoris
223439|NCT02011035|Oral health|oral health
223440|NCT02011035|Mouth health|mouth health
223441|NCT02011035|Halitosis|halitosis
223442|NCT02011035|Oral bacteria|oral bacteria
223443|NCT02011035|Sore throat|sore throat
223444|NCT02011035|Colds|colds
223445|NCT02011022|Methotrexate,|methotrexate,
223446|NCT02011022|Pharmacokinetic|pharmacokinetic
223447|NCT02011022|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
223448|NCT02011022|Model|model
223449|NCT02010970|phase I|phase i
223450|NCT02010970|healthy volunteers|healthy volunteers
223451|NCT02010970|AZD3293|azd3293
223452|NCT02010970|itraconazole|itraconazole
223453|NCT02010970|diltiazem|diltiazem
223454|NCT02010970|medazolam|medazolam
223455|NCT02010970|drug interactions|drug interactions
223456|NCT02010970|Pharmacokinetics|pharmacokinetics
223457|NCT02010957|123I Iodometomidate imaging|123i iodometomidate imaging
223458|NCT02010957|18F FDG positron emission tomography|18f fdg positron emission tomography
223459|NCT02010957|Adrenal tumour|adrenal tumour
223460|NCT02010944|Solifenacin|solifenacin
223461|NCT02010944|Mirabegron|mirabegron
223462|NCT02010944|Fixed-dose combination (FDC)|fixed-dose combination (fdc)
223463|NCT02010944|Single Entity Tablet (SET)|single entity tablet (set)
223464|NCT02010944|Pharmacokinetics|pharmacokinetics
223465|NCT02010944|Bioavailability|bioavailability
223466|NCT02010918|Knee Osteoarthritis;|knee osteoarthritis;
223467|NCT02010918|Glucosamine;|glucosamine;
223468|NCT02010918|Chondroitin.|chondroitin.
223469|NCT02010905|Losartan|losartan
274447|NCT01778998|OCT|oct
223470|NCT02010879|patent ductus arterioses|patent ductus arterioses
223471|NCT02010879|ductal closure|ductal closure
223472|NCT02010879|thrombocyte|thrombocyte
223473|NCT02010866|internship and residency|internship and residency
223474|NCT02010866|physicians|physicians
223475|NCT02010866|prevention|prevention
223476|NCT02010866|counseling|counseling
223477|NCT02010866|suicide|suicide
223478|NCT02010866|depression|depression
223479|NCT02010866|burnout|burnout
223480|NCT02010853|Transient Global amnesia|transient global amnesia
223481|NCT02010853|fMRI|fmri
223482|NCT02010853|resting state|resting state
223483|NCT02010840|Depressive symptoms, marital relationship, quality of life|depressive symptoms, marital relationship, quality of life
223484|NCT02010827|Diabetes mellitus|diabetes mellitus
223485|NCT02010827|Glucagon|glucagon
223486|NCT02010827|Endogenous glucose production|endogenous glucose production
683940|NCT00904813|Prognosis|prognosis
223487|NCT02010827|Incretin hormones|incretin hormones
223488|NCT02010814|PCOS|pcos
223489|NCT02010814|Inflammation|inflammation
223490|NCT02010814|Body Composition|body composition
223491|NCT02010801|hepatocellular carcinoma|hepatocellular carcinoma
223492|NCT02010801|irreversible electroporation|irreversible electroporation
223493|NCT02010801|liver cancer|liver cancer
223494|NCT02010762|Crohn's disease|crohn's disease
223495|NCT02010762|Vitamin D|vitamin d
223496|NCT02010762|Postoperative|postoperative
223497|NCT02010762|Recurrence|recurrence
223498|NCT02010762|Inflammatory bowel disease|inflammatory bowel disease
223499|NCT02010762|Gastroenteritis|gastroenteritis
223500|NCT02010762|Gastrointestinal Diseases|gastrointestinal diseases
223501|NCT02010762|Digestive System Diseases|digestive system diseases
223502|NCT02010762|Colonic Diseases|colonic diseases
223503|NCT02010762|Intestinal Diseases|intestinal diseases
223504|NCT02010762|Pathologic Processes|pathologic processes
223505|NCT02010736|Cerebral palsy|cerebral palsy
223506|NCT02010736|Gait|gait
223507|NCT02010736|Weight Bearing|weight bearing
223508|NCT02010736|Rehabilitation|rehabilitation
223509|NCT02010723|varicosis|varicosis
223510|NCT02010723|foam sclerotherapy|foam sclerotherapy
223511|NCT02010723|surgery|surgery
223512|NCT02010710|continuous electronic fetal monitoring|continuous electronic fetal monitoring
223513|NCT02010710|labour|labour
223514|NCT02010710|pregnancy|pregnancy
223515|NCT02010710|fetal distress|fetal distress
223516|NCT02010697|smoking cessation|smoking cessation
223517|NCT02010697|nonsmokers|nonsmokers
223518|NCT02010697|proxy|proxy
223519|NCT02010697|mail intervention|mail intervention
223520|NCT02010697|self-help|self-help
223521|NCT02010697|behavioral intervention|behavioral intervention
223522|NCT02010684|Diabetes|diabetes
223523|NCT02010684|Depression|depression
223524|NCT02010684|Self care|self care
223525|NCT02010684|Empowerment|empowerment
223526|NCT02010684|Behavioral intervention|behavioral intervention
223527|NCT02010684|Cognitive behavioral therapy|cognitive behavioral therapy
223528|NCT02010684|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
223529|NCT02010671|Pregnancy|pregnancy
223530|NCT02010671|Cesarean Section|cesarean section
223531|NCT02010671|Survey|survey
223532|NCT02010671|Delivery|delivery
223533|NCT02010645|Leukemia|leukemia
223534|NCT02010645|Advanced Myelodysplastic Syndrome|advanced myelodysplastic syndrome
223535|NCT02010645|MDS|mds
223536|NCT02010645|Intermediate-2 Myelodysplastic Syndrome|intermediate-2 myelodysplastic syndrome
223537|NCT02010645|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
223538|NCT02010645|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
223539|NCT02010645|CMML|cmml
223540|NCT02010645|Eltrombopag|eltrombopag
223541|NCT02010645|Promacta|promacta
223542|NCT02010645|Decitabine|decitabine
223543|NCT02010645|Dacogen|dacogen
223544|NCT02010632|Clopidogrel|clopidogrel
223545|NCT02010632|Platelet inhibition|platelet inhibition
223546|NCT02010632|Platelet aggregation|platelet aggregation
223547|NCT02010606|Newly diagnosed glioblastoma|newly diagnosed glioblastoma
223548|NCT02010606|Recurrent glioblastoma|recurrent glioblastoma
223549|NCT02010606|Dendritic cell vaccine|dendritic cell vaccine
223550|NCT02010606|Immunotherapy|immunotherapy
223551|NCT02010606|Cancer stem cells|cancer stem cells
223552|NCT02010606|Glioma stem cells|glioma stem cells
223553|NCT02010606|Glioma stem-like cells|glioma stem-like cells
223554|NCT02010606|Cancer stem-like cells|cancer stem-like cells
223555|NCT02010606|Neurosphere|neurosphere
223556|NCT02010606|Therapeutic Uses|therapeutic uses
223557|NCT02010606|Antineoplastic Agents|antineoplastic agents
223558|NCT02010606|Neoplasms|neoplasms
223559|NCT02010606|Immunologic Factors|immunologic factors
223560|NCT02010606|Interferon Inducers|interferon inducers
223561|NCT02010606|Physiological Effects of Drugs|physiological effects of drugs
223562|NCT02010606|Pharmacologic Actions|pharmacologic actions
223563|NCT02010567|rectal cancer|rectal cancer
223564|NCT02010567|colorectal cancer|colorectal cancer
223565|NCT02010567|locally advanced rectal cancer|locally advanced rectal cancer
223566|NCT02010567|locally advanced rectal cancer (resectable)|locally advanced rectal cancer (resectable)
223567|NCT02010567|locally advanced rectal cancer (non-resectable)|locally advanced rectal cancer (non-resectable)
223568|NCT02010567|chemoradiotherapy|chemoradiotherapy
223569|NCT02010567|nanopharmaceuticle|nanopharmaceuticle
223570|NCT02010567|CLX101|clx101
223571|NCT02010567|camptothecin|camptothecin
223572|NCT02010567|capecitabine|capecitabine
223573|NCT02010554|Multiple Sclerosis|multiple sclerosis
223574|NCT02010554|Disease modifying medication|disease modifying medication
223575|NCT02010554|Relapsing-Remitting MS|relapsing-remitting ms
223576|NCT02010554|Motivational Interviewing|motivational interviewing
223577|NCT02010554|Telephone Counseling|telephone counseling
223578|NCT02010541|type 1 diabetes among young children, sensor, insulin pump, education, psychological support|type 1 diabetes among young children, sensor, insulin pump, education, psychological support
223579|NCT02010528|Diabetes related distress, children, T1D, family hardiness, psychological well-being|diabetes related distress, children, t1d, family hardiness, psychological well-being
223580|NCT02010515|sudden cardiac death|sudden cardiac death
223581|NCT02010515|risk stratification|risk stratification
223582|NCT02010515|t-wave alternans|t-wave alternans
223583|NCT02010515|Holter electrocardiography|holter electrocardiography
223584|NCT02010515|heart rate turbulence|heart rate turbulence
223585|NCT02010502|Beet root|beet root
223586|NCT02010502|exercise performance|exercise performance
223587|NCT02010502|cyclists|cyclists
223588|NCT02010489|Bariatric Surgery|bariatric surgery
223589|NCT02010489|Exercise|exercise
223590|NCT02010489|Physical Fitness|physical fitness
223591|NCT02010476|Alzheimer's disease, CSF biomarkers, Insulin resistance|alzheimer's disease, csf biomarkers, insulin resistance
223592|NCT02010463|reward processing|reward processing
223593|NCT02010463|impulse control|impulse control
223594|NCT02010463|obese|obese
223595|NCT02010463|clinically obese|clinically obese
223596|NCT02010450|Sudden Infant Death Syndrome|sudden infant death syndrome
223597|NCT02010450|SIDS|sids
223598|NCT02010450|safe sleep|safe sleep
223599|NCT02010450|safe sleep message|safe sleep message
223600|NCT02010437|Superficial Venous Insufficiency|superficial venous insufficiency
223601|NCT02010424|reduced fertility|reduced fertility
223602|NCT02010398|Resistance training/methods|resistance training/methods
223603|NCT02010398|contralateral strength training|contralateral strength training
223604|NCT02010398|ipsilateral strength training|ipsilateral strength training
223605|NCT02010398|Isokinetic contraction|isokinetic contraction
223606|NCT02010398|Adaptation, Physiological/physiology|adaptation, physiological/physiology
223607|NCT02010398|Electromyography/methods|electromyography/methods
223608|NCT02010398|Transcranial Magnetic Stimulation/methods|transcranial magnetic stimulation/methods
223609|NCT02010398|Evoked Potentials, Motor|evoked potentials, motor
223610|NCT02010385|RYGB|rygb
223611|NCT02010385|Bariatric surgery|bariatric surgery
223612|NCT02010385|Taste|taste
223613|NCT02010385|Reward|reward
223614|NCT02010385|Food behaviour|food behaviour
223615|NCT02010385|Gut hormones|gut hormones
223616|NCT02010372|Immunization Registry|immunization registry
223617|NCT02010372|Human Papillomavirus|human papillomavirus
223618|NCT02010346|Early orthodontic treatment|early orthodontic treatment
223619|NCT02010346|Class II treatment|class ii treatment
223620|NCT02010346|Orthodontic treatment outcome|orthodontic treatment outcome
223621|NCT02010320|population model|population model
223622|NCT02010320|pharmacokinetic|pharmacokinetic
223623|NCT02010320|tacrolimus|tacrolimus
223624|NCT02010320|therapeutic drug monitoring|therapeutic drug monitoring
223625|NCT02010320|individualized dosing|individualized dosing
223626|NCT02010294|Invasive GAS infection|invasive gas infection
223627|NCT02010294|emm genotypes|emm genotypes
223628|NCT02010294|Bacterial virulence factors|bacterial virulence factors
223629|NCT02010294|Mendelian susceptibility to infections|mendelian susceptibility to infections
223630|NCT02010281|rTMS|rtms
223631|NCT02010281|peripheral neuropathic pain|peripheral neuropathic pain
223632|NCT02010281|randomized controlled trial|randomized controlled trial
223633|NCT02010268|Faecal calprotectin|faecal calprotectin
223634|NCT02010268|Feces|feces
223635|NCT02010268|Preterm neonates|preterm neonates
223636|NCT02010268|Enterocolitis|enterocolitis
223637|NCT02010268|Enteropathy|enteropathy
223638|NCT02010268|Necrotizing|necrotizing
223639|NCT02010242|Type 2 diabetes|type 2 diabetes
223640|NCT02010242|Proteinuria|proteinuria
223641|NCT02010242|Albuminuria|albuminuria
223642|NCT02010229|Placenta accreta|placenta accreta
223643|NCT02010229|previous caesarean|previous caesarean
223644|NCT02010229|placenta praevia|placenta praevia
223645|NCT02010229|severe obstetric haemorrhage|severe obstetric haemorrhage
223646|NCT02010229|population-based study|population-based study
223647|NCT02010203|TURBT|turbt
223648|NCT02010203|Bladder|bladder
223649|NCT02010203|Cancer|cancer
223650|NCT02010203|GP96|gp96
223651|NCT02010203|Vaccine|vaccine
223652|NCT02010203|Immunotherapy|immunotherapy
223653|NCT02010203|Heat Biologics|heat biologics
223654|NCT02010203|BCG|bcg
223655|NCT02010203|Bacillus Calmette-Guerin|bacillus calmette-guerin
223656|NCT02010203|Bacillus Calmette-Guérin|bacillus calmette-guérin
223657|NCT02010190|Pediatric malignancies|pediatric malignancies
223658|NCT02010190|Cancer survivors|cancer survivors
223659|NCT02010190|Coronary artery risk|coronary artery risk
223660|NCT02010190|Vascular function|vascular function
223661|NCT02010190|Cardiovascular risk in survivors of pediatric cancer|cardiovascular risk in survivors of pediatric cancer
223662|NCT02010164|Reproductive aging|reproductive aging
223663|NCT02010164|Mitochondria|mitochondria
223664|NCT02010151|Out of Hospital Cardiac Arrest|out of hospital cardiac arrest
223665|NCT02010151|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
223666|NCT02010151|dispatch|dispatch
223667|NCT02010151|emergency medicine|emergency medicine
223668|NCT02010138|Internal Limiting Membrane|internal limiting membrane
223669|NCT02010138|Metamorphopsia|metamorphopsia
223670|NCT02010125|Anterior Cruciate Ligament (ACL)|anterior cruciate ligament (acl)
223671|NCT02010125|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
223672|NCT02010125|Osteoarthritis (OA)|osteoarthritis (oa)
223673|NCT02010125|Bio-specimens|bio-specimens
223674|NCT02010125|Acute ACL Injury|acute acl injury
223675|NCT02010125|Arthritis Foundation (AF)|arthritis foundation (af)
223676|NCT02010112|H.Pylori|h.pylori
223677|NCT02010086|Intervention|intervention
223678|NCT02010086|Autism|autism
223679|NCT02010086|Treatment sensitivity|treatment sensitivity
223680|NCT02010086|School aged|school aged
223681|NCT02010086|Cognitive behavioral therapy|cognitive behavioral therapy
223682|NCT02010086|Social Skills Intervention|social skills intervention
223683|NCT02010073|Lung|lung
223684|NCT02010073|ARDS|ards
223685|NCT02010073|acute|acute
223686|NCT02010073|respiratory|respiratory
223687|NCT02010073|syndrome|syndrome
223688|NCT02010073|prognosis|prognosis
223689|NCT02010073|outcome research|outcome research
223690|NCT02010073|respiratory infection|respiratory infection
223691|NCT02010073|sepsis|sepsis
223692|NCT02010073|organ failure|organ failure
223693|NCT02010073|hypoxaemia|hypoxaemia
223694|NCT02010060|Exercise training|exercise training
223695|NCT02010060|Non-exercise physical activity|non-exercise physical activity
223696|NCT02010060|pedometers|pedometers
223697|NCT02010047|Anaplastic lymphoma kinase gene|anaplastic lymphoma kinase gene
223698|NCT02010047|Polymerase chain reaction|polymerase chain reaction
223699|NCT02010047|Immunohistochemistry|immunohistochemistry
223700|NCT02010047|Fluorescence in situ hybridization|fluorescence in situ hybridization
223701|NCT02010034|TPN|tpn
223702|NCT02010034|Liver Function|liver function
223703|NCT02010034|parenteral nutritional fat emulsions|parenteral nutritional fat emulsions
223704|NCT02010021|breast cancer|breast cancer
223705|NCT02010021|postmenopausal|postmenopausal
223706|NCT02010021|letrozole|letrozole
223707|NCT02010021|RAD001|rad001
223708|NCT02010021|Everolimus|everolimus
223709|NCT02010008|breast cancer|breast cancer
223710|NCT02010008|cancer disparities|cancer disparities
223711|NCT02010008|Latino women|latino women
223712|NCT02010008|Hispanic women|hispanic women
223713|NCT02010008|mammography|mammography
223714|NCT02010008|multi-level intervention|multi-level intervention
223715|NCT02009995|Diabetes Mellitus|diabetes mellitus
223716|NCT02009995|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
223717|NCT02009995|Resistance Training|resistance training
223718|NCT02009995|Resistance Exercise|resistance exercise
223719|NCT02009995|Resistance Band|resistance band
223720|NCT02009995|Thera-band|thera-band
223721|NCT02009995|elastic band|elastic band
223722|NCT02009995|exercise band|exercise band
223723|NCT02009982|Fainting|fainting
223724|NCT02009982|Ablation|ablation
223725|NCT02009982|Cardiology|cardiology
223726|NCT02009982|Cardiac Electrophysiology|cardiac electrophysiology
223727|NCT02009969|Psychosis|psychosis
223728|NCT02009969|Adverse effects|adverse effects
223729|NCT02009969|Symptom Severity|symptom severity
223730|NCT02009969|Magnetic Resonance Imaging|magnetic resonance imaging
223731|NCT02009943|critical illness|critical illness
223732|NCT02009943|iron supplementation|iron supplementation
223733|NCT02009943|functional iron deficiency|functional iron deficiency
223734|NCT02009943|ICU anemia|icu anemia
751898|NCT01171118|Sedation|sedation
223735|NCT02009943|red blood cell transfusion|red blood cell transfusion
223736|NCT02009930|Enlisted military members|enlisted military members
223737|NCT02009930|CAC|cac
223738|NCT02009930|Coronary Artery Calcium|coronary artery calcium
223739|NCT02009930|Cardiovascular|cardiovascular
223740|NCT02009917|Indicator Amino Acid Oxidation|indicator amino acid oxidation
223741|NCT02009917|Non essential Amino acids|non essential amino acids
223742|NCT02009917|Protein|protein
223743|NCT02009917|Amino acid|amino acid
223744|NCT02009904|PKU|pku
223745|NCT02009904|Phenylketonuria|phenylketonuria
223746|NCT02009904|Phenylalanine|phenylalanine
223747|NCT02009904|Children|children
223748|NCT02009904|Stable isotopes|stable isotopes
223749|NCT02009904|Sapropterin dihydrochloride responsiveness|sapropterin dihydrochloride responsiveness
223750|NCT02009891|predictive model|predictive model
223751|NCT02009891|in vitro fertilization|in vitro fertilization
223752|NCT02009891|elective single embryo transfer|elective single embryo transfer
223753|NCT02009878|SIADH|siadh
223754|NCT02009865|Hypertriglyceridemia|hypertriglyceridemia
223755|NCT02009865|Dyslipidemia|dyslipidemia
223756|NCT02009865|Eicosapentaenoic acid|eicosapentaenoic acid
223757|NCT02009865|EPA|epa
223758|NCT02009865|Docosahexaenoic acid|docosahexaenoic acid
223759|NCT02009865|DHA|dha
223760|NCT02009852|microRNA-29b|microrna-29b
223761|NCT02009852|Oral squamous cell carcinoma|oral squamous cell carcinoma
223762|NCT02009852|migration|migration
223763|NCT02009852|prognosis|prognosis
223764|NCT02009839|anxiety|anxiety
223765|NCT02009839|frequency of speech|frequency of speech
223766|NCT02009839|selective mutism|selective mutism
223774|NCT02009787|hypercholesterolemia; vitamin D; adjuvant therapy|hypercholesterolemia; vitamin d; adjuvant therapy
223776|NCT02009774|Adenoma detection rate|adenoma detection rate
223777|NCT02009774|Narrow band imaging|narrow band imaging
223778|NCT02009774|Optical biopsy|optical biopsy
223779|NCT02009774|Accuracy|accuracy
223780|NCT02009735|Enterovirus 71 and Influenza Virus|enterovirus 71 and influenza virus
223781|NCT02009722|Cesarean Delivery|cesarean delivery
223782|NCT02009722|Intrathecal Morphine|intrathecal morphine
223783|NCT02009722|Intrathecal Hydromorphone|intrathecal hydromorphone
223784|NCT02009722|Obstetrical Analgesia|obstetrical analgesia
223785|NCT02009722|Spinal Anesthesia|spinal anesthesia
223786|NCT02009709|keratoconus|keratoconus
223787|NCT02009709|collagen crosslinking|collagen crosslinking
223788|NCT02009709|crosslinking|crosslinking
223789|NCT02009709|ectasia|ectasia
223790|NCT02009644|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
223791|NCT02009644|AAA|aaa
223792|NCT02009644|Aneurysm|aneurysm
223793|NCT02009631|Solid Tumors|solid tumors
223794|NCT02009631|Ovarian Cancer|ovarian cancer
223795|NCT02009631|Colon Cancer|colon cancer
223796|NCT02009631|Lung Cancer|lung cancer
223797|NCT02009631|Breast Cancer|breast cancer
223798|NCT02009631|Gastric Cancer|gastric cancer
223799|NCT02009618|IBS|ibs
223800|NCT02009618|Rifaximin|rifaximin
223801|NCT02009605|icotinib, SCC|icotinib, scc
223802|NCT02009592|Hepatosteatosis|hepatosteatosis
223803|NCT02009592|Steatohepatitis|steatohepatitis
223804|NCT02009592|Rifaximin|rifaximin
223805|NCT02009592|Inflammatory cytokines|inflammatory cytokines
223806|NCT02009579|Uterine Cervical Cancer|uterine cervical cancer
223807|NCT02009579|Paclitaxel|paclitaxel
223808|NCT02009579|Carboplatin|carboplatin
223809|NCT02009579|Nintedanib|nintedanib
223810|NCT02009553|Anxiety|anxiety
223811|NCT02009553|Urodynamics|urodynamics
223812|NCT02009514|Hemodialysis|hemodialysis
223813|NCT02009514|Continuous glucose monitoring|continuous glucose monitoring
223814|NCT02009514|Hypoglycemia|hypoglycemia
223815|NCT02009514|Hyperglycemia|hyperglycemia
223816|NCT02009501|Infected wounds|infected wounds
223817|NCT02009501|NPWTi|npwti
223818|NCT02009501|VAC Instill|vac instill
223819|NCT02009501|Biofilm|biofilm
223820|NCT02009488|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
223821|NCT02009488|Metformin|metformin
223822|NCT02009488|Canagliflozin|canagliflozin
223823|NCT02009488|INVOKANA®|invokana®
223824|NCT02009488|Insulin sensitivity|insulin sensitivity
223825|NCT02009488|DPP-4 inhibitor|dpp-4 inhibitor
223826|NCT02009488|dipeptidyl peptidase-4|dipeptidyl peptidase-4
223827|NCT02009475|Rehabilitation|rehabilitation
223828|NCT02009475|Exercise Training|exercise training
223829|NCT02009475|Interval training|interval training
223830|NCT02009462|HIV|hiv
223831|NCT02009462|Facial lipoatrophy|facial lipoatrophy
223832|NCT02009449|Phase 1/Phase 1b|phase 1/phase 1b
223833|NCT02009449|Oncology|oncology
223834|NCT02009449|Cancer|cancer
223835|NCT02009449|Solid Tumors|solid tumors
223836|NCT02009423|Gastro-Intestinal Stromal Tumour, GIST, localized primary tumor, complete surgery, adjuvant therapy.|gastro-intestinal stromal tumour, gist, localized primary tumor, complete surgery, adjuvant therapy.
223837|NCT02009410|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
223838|NCT02009358|mental health promotion|mental health promotion
223839|NCT02009358|depression|depression
223840|NCT02009358|migrant workers|migrant workers
223841|NCT02009358|China|china
223842|NCT02009345|Familial hypercholesterolemia,|familial hypercholesterolemia,
223846|NCT02009319|endobronchial ultrasound|endobronchial ultrasound
223847|NCT02009319|EBUS - TBNA|ebus - tbna
223848|NCT02009319|elastography|elastography
223849|NCT02009319|strain ratio|strain ratio
223850|NCT02009319|lung cancer staging|lung cancer staging
223851|NCT02009306|Palliative|palliative
223852|NCT02009306|Symptom control|symptom control
223854|NCT02009306|Opioid|opioid
223855|NCT02009306|Benzodiazepine|benzodiazepine
223856|NCT02009293|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
223857|NCT02009293|cough|cough
223858|NCT02009293|quality of life|quality of life
223859|NCT02009280|Propofol|propofol
223860|NCT02009280|Lung transplantation|lung transplantation
223861|NCT02009280|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
214607|NCT02051062|BAT|bat
223862|NCT02009280|Acute kidney injury|acute kidney injury
223863|NCT02009241|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
223864|NCT02009241|Rehabilitation|rehabilitation
223865|NCT02009241|Exercise|exercise
223866|NCT02009228|Single-port laparoscopy|single-port laparoscopy
223867|NCT02009228|Abdominal pain|abdominal pain
223868|NCT02009228|Ovarian spillage|ovarian spillage
223869|NCT02009228|Endobag rupture|endobag rupture
223870|NCT02009228|Ovarian reserve|ovarian reserve
223871|NCT02009215|Uganda|uganda
223872|NCT02009215|intermittent preventive treatment|intermittent preventive treatment
223873|NCT02009215|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
223874|NCT02009215|schoolchildren|schoolchildren
223875|NCT02009215|malaria|malaria
223876|NCT02009202|Colon preparation|colon preparation
223877|NCT02009202|Child|child
223878|NCT02009189|home parenteral nutrition|home parenteral nutrition
223879|NCT02009189|central venous catheter|central venous catheter
223880|NCT02009176|Hepatocellular Carcinoma|hepatocellular carcinoma
223881|NCT02009176|Laparoscopic|laparoscopic
223882|NCT02009176|Aon-anatomical hepatectomy|aon-anatomical hepatectomy
223883|NCT02009176|Anatomical hepatectomy|anatomical hepatectomy
223884|NCT02009176|Micrometastases|micrometastases
223885|NCT02009137|small breast|small breast
223886|NCT02009137|augmentation|augmentation
223887|NCT02009137|breast volume|breast volume
223888|NCT02009137|External Soft Tissue Expansion System(ESTES)|external soft tissue expansion system(estes)
223889|NCT02009124|spinal cord injury|spinal cord injury
223890|NCT02009124|stem cell therapy|stem cell therapy
223891|NCT02009124|bone marrow|bone marrow
223892|NCT02009124|mononuclear cells|mononuclear cells
223893|NCT02009124|autologous|autologous
223894|NCT02009111|Transition to parenthood|transition to parenthood
223895|NCT02009111|Relationship intervention|relationship intervention
223896|NCT02009098|Randomized Controlled Trial|randomized controlled trial
223897|NCT02009098|Caesarean Section|caesarean section
223898|NCT02009098|preoperative|preoperative
223899|NCT02009098|intraoperative|intraoperative
223900|NCT02009098|prophylactic antibiotics|prophylactic antibiotics
223901|NCT02009098|antibiotics|antibiotics
223902|NCT02009098|timing|timing
223903|NCT02009098|surgical site infections|surgical site infections
223904|NCT02009098|endometritis|endometritis
223905|NCT02009098|wound infections|wound infections
223906|NCT02009098|urinary tract infections|urinary tract infections
223907|NCT02009098|infectious morbidity|infectious morbidity
223908|NCT02009098|neonatal antibiotics exposure|neonatal antibiotics exposure
223909|NCT02009098|Antibiotic Prophylaxis|antibiotic prophylaxis
223910|NCT02009072|Pterygium surgery|pterygium surgery
223911|NCT02009072|Sutureless glue free conjunctival autograft|sutureless glue free conjunctival autograft
223912|NCT02009072|Amniotic membrane graft.|amniotic membrane graft.
223913|NCT02009059|hypothermia|hypothermia
223914|NCT02009059|Temperature|temperature
223915|NCT02009059|epitympanic|epitympanic
223916|NCT02009059|pre-hospital|pre-hospital
223917|NCT02009046|Adolescent|adolescent
223918|NCT02009046|Sex education|sex education
223919|NCT02009046|Sexuality education|sexuality education
223920|NCT02009046|Sexually transmitted diseases|sexually transmitted diseases
223921|NCT02009046|Pregnancy|pregnancy
223922|NCT02009046|Sexual behavior|sexual behavior
223923|NCT02009046|Sexuality|sexuality
223924|NCT02009046|Relationship rights|relationship rights
223925|NCT02009046|Gender norms|gender norms
223926|NCT02009046|Human rights|human rights
223927|NCT02009046|Intervention studies|intervention studies
223928|NCT02009046|Parent intervention|parent intervention
223929|NCT02009046|Peer intervention|peer intervention
223930|NCT02009007|cerebral oximeter|cerebral oximeter
223931|NCT02009007|one lung ventilation|one lung ventilation
223932|NCT02009007|dopamine|dopamine
223933|NCT02009007|phenylephrine|phenylephrine
223934|NCT02008994|metastatic breast cancer|metastatic breast cancer
223935|NCT02008994|breast cancer|breast cancer
223936|NCT02008994|genomics|genomics
223937|NCT02008994|personalized medicine|personalized medicine
223938|NCT02008994|precision oncology|precision oncology
223939|NCT02008994|breast cancer treatment|breast cancer treatment
223940|NCT02008994|metastatic breast cancer treatment|metastatic breast cancer treatment
223941|NCT02008994|genetic testing and breast cancer treatment|genetic testing and breast cancer treatment
223942|NCT02008994|breast cancer trial|breast cancer trial
223943|NCT02008994|metastatic breast cancer trial|metastatic breast cancer trial
223944|NCT02008955|lysine, indicator amino acid oxidation, elderly females|lysine, indicator amino acid oxidation, elderly females
223945|NCT02008929|NKCELL|nkcell
223946|NCT02008916|AIN457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection|ain457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection
223947|NCT02008890|palmoplantar, pustular, psoriasis|palmoplantar, pustular, psoriasis
223948|NCT02008877|Malignant Peripheral Nerve Sheath Tumors|malignant peripheral nerve sheath tumors
223949|NCT02008877|MPNST|mpnst
223950|NCT02008877|Sarcoma|sarcoma
223951|NCT02008877|Ganetespib|ganetespib
223952|NCT02008877|Sirolimus|sirolimus
223953|NCT02008877|mTOR inhibitor|mtor inhibitor
223954|NCT02008877|Heat shock protein|heat shock protein
223955|NCT02008877|Hsp90|hsp90
223956|NCT02008864|End stage renal diseases|end stage renal diseases
223957|NCT02008864|Hemodialysis|hemodialysis
223958|NCT02008864|Uremic pruritus|uremic pruritus
223959|NCT02008864|Iranian traditional medicine|iranian traditional medicine
224958|NCT02004457|Disclosure|disclosure
223960|NCT02008864|Cassia angustifolia|cassia angustifolia
223961|NCT02008851|Chronic kidney disease|chronic kidney disease
223962|NCT02008851|Type 2 Diabetes|type 2 diabetes
223963|NCT02008851|Neo-kidney augment|neo-kidney augment
223964|NCT02008851|Regenerative medicine|regenerative medicine
223965|NCT02008825|ViSiGi|visigi
223966|NCT02008825|Calibration tube|calibration tube
223967|NCT02008825|Sleeve gastrectomy|sleeve gastrectomy
223968|NCT02008812|Adenovirus|adenovirus
223969|NCT02008799|Stem cell, infertility, Azoospermia|stem cell, infertility, azoospermia
223970|NCT02008786|Coronary Artery Dissection, Spontaneous|coronary artery dissection, spontaneous
223971|NCT02008786|Angina|angina
223972|NCT02008773|schizophrenia|schizophrenia
223973|NCT02008773|schizoaffective|schizoaffective
223974|NCT02008773|schizophreniform|schizophreniform
223975|NCT02008773|inflammatory markers|inflammatory markers
223976|NCT02008773|HSV1|hsv1
223977|NCT02008773|cognition|cognition
223978|NCT02008773|early psychosis|early psychosis
223979|NCT02008773|valacyclovir|valacyclovir
223980|NCT02008760|pain|pain
223981|NCT02008760|quality of life|quality of life
223983|NCT02008760|DOLO test|dolo test
223984|NCT02008760|compliance|compliance
223985|NCT02008760|D3|d3
223986|NCT02008747|Atrial fibrillation|atrial fibrillation
223987|NCT02008747|Neuropathic pain|neuropathic pain
223988|NCT02008747|Posterolateral thoracotomy|posterolateral thoracotomy
223989|NCT02008747|Lung resection|lung resection
223990|NCT02008721|Multiple System Atrophy|multiple system atrophy
223991|NCT02008721|epigallocatechin gallate|epigallocatechin gallate
223992|NCT02008708|Health|health
223993|NCT02008708|Microfinance|microfinance
223994|NCT02008695|Health|health
223995|NCT02008695|Youth|youth
223996|NCT02008695|Microfinance|microfinance
223997|NCT02008669|Multiple Sclerosis, Fatigue, Nutritional Status, Disability.|multiple sclerosis, fatigue, nutritional status, disability.
223998|NCT02008656|CAPECITABINE (ORAL)|capecitabine (oral)
223999|NCT02008656|FLUOROURACIL|fluorouracil
224000|NCT02008656|LEUCOVORIN|leucovorin
224001|NCT02008656|OXALIPLATIN|oxaliplatin
224002|NCT02008656|Total mesorectal excision|total mesorectal excision
224003|NCT02008656|Chemoradiation therapy|chemoradiation therapy
224004|NCT02008656|Total neoadjuvant therapy|total neoadjuvant therapy
224005|NCT02008656|13-213|13-213
224006|NCT02008643|Health related quality of life, food allergy, children, chronic diseases|health related quality of life, food allergy, children, chronic diseases
224007|NCT02008617|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
224008|NCT02008604|ischemia|ischemia
224009|NCT02008604|stroke|stroke
224010|NCT02008604|transient ischemic attack (TIA)|transient ischemic attack (tia)
224011|NCT02008604|microbiome|microbiome
224012|NCT02008604|microbiota|microbiota
224013|NCT02008604|gut|gut
224014|NCT02008591|Neuraxial Technique|neuraxial technique
224015|NCT02008591|Epidural Technique|epidural technique
224016|NCT02008591|Dural Puncture Epidural Technique|dural puncture epidural technique
224017|NCT02008591|Combined Spinal Epidural Technique|combined spinal epidural technique
224018|NCT02008591|Labor Analgesia|labor analgesia
224019|NCT02008591|Obstetric|obstetric
224020|NCT02008578|Antiviral|antiviral
224021|NCT02008578|Adjunctive Therapy|adjunctive therapy
224022|NCT02008578|Antibody|antibody
224023|NCT02008565|Fecal incontinence|fecal incontinence
224024|NCT02008565|Loperamide|loperamide
224025|NCT02008565|anal exercises|anal exercises
224026|NCT02008565|biofeedback|biofeedback
224027|NCT02008552|Genetic factor|genetic factor
224028|NCT02008552|Valvulopathy|valvulopathy
224029|NCT02008552|Mediator|mediator
224030|NCT02008526|Text Messaging|text messaging
224031|NCT02008526|mHealth|mhealth
224032|NCT02008526|Methamphetamine|methamphetamine
224033|NCT02008526|HIV|hiv
224034|NCT02008526|AIDS|aids
224035|NCT02008513|AFFITOPE® AD02|affitope® ad02
224036|NCT02008513|Alzheimer Disease|alzheimer disease
224037|NCT02008513|Dementia|dementia
224038|NCT02008513|Brain Disease|brain disease
224039|NCT02008513|Nervous System Diseases|nervous system diseases
224040|NCT02008513|Tauopathies|tauopathies
224041|NCT02008513|Neurodegenerative Diseases|neurodegenerative diseases
224042|NCT02008513|Mental Disorders|mental disorders
224043|NCT02008500|Dentinal Hypersensitivity|dentinal hypersensitivity
224044|NCT02008500|Gingival Recession|gingival recession
224045|NCT02008500|Visual Analogue Score|visual analogue score
224046|NCT02008487|wound|wound
224047|NCT02008487|palliative care|palliative care
224048|NCT02008487|hospice|hospice
224049|NCT02008487|pressure ulcers|pressure ulcers
224050|NCT02008435|Group-delivered Diabetes Prevention Program|group-delivered diabetes prevention program
224051|NCT02008435|Obesity|obesity
224052|NCT02008435|Overweight|overweight
224053|NCT02008435|Lifestyle change|lifestyle change
224054|NCT02008435|Healthy eating|healthy eating
224055|NCT02008435|Weight loss|weight loss
224056|NCT02008435|Exercise|exercise
224057|NCT02008435|Cognitive-behavioral intervention|cognitive-behavioral intervention
224058|NCT02008435|Implementation intentions|implementation intentions
224059|NCT02008435|Mental imagery|mental imagery
224959|NCT02004457|Stigma|stigma
224060|NCT02008435|Mental practice|mental practice
224061|NCT02008435|If-then plans|if-then plans
224062|NCT02008409|Minimally Invasive Surgery|minimally invasive surgery
224063|NCT02008409|EndoLift Liver Retractor|endolift liver retractor
224065|NCT02008396|autism|autism
224066|NCT02008396|social anxiety|social anxiety
224067|NCT02008383|Colorectal cancer|colorectal cancer
224068|NCT02008383|Panitumumab|panitumumab
224069|NCT02008383|Cabozantinib|cabozantinib
224070|NCT02008370|minimally invasive cardiac surgery|minimally invasive cardiac surgery
224071|NCT02008370|Exparel|exparel
224072|NCT02008357|Cognition|cognition
224073|NCT02008357|Prevention|prevention
224074|NCT02008344|influenza|influenza
224075|NCT02008344|flu|flu
224076|NCT02008344|fever|fever
224077|NCT02008344|cough|cough
224078|NCT02008344|body aches|body aches
224079|NCT02008344|headache|headache
224080|NCT02008344|nasal congestion|nasal congestion
224081|NCT02008344|body pains|body pains
224082|NCT02008344|sore throat|sore throat
224083|NCT02008344|fatigue|fatigue
224084|NCT02008344|T-705|t-705
224085|NCT02008344|favipiravir|favipiravir
224086|NCT02008344|favor|favor
224087|NCT02008344|flu symptoms|flu symptoms
224088|NCT02008331|chronic kidney disease|chronic kidney disease
224089|NCT02008331|p-cresol|p-cresol
224090|NCT02008331|synbiotic|synbiotic
224091|NCT02008292|smoking|smoking
224092|NCT02008292|schizophrenia|schizophrenia
224093|NCT02008292|acetylcholine|acetylcholine
224094|NCT02008279|Healthy|healthy
224095|NCT02008279|CNTO 3157|cnto 3157
224096|NCT02008279|Pharmacokinetics|pharmacokinetics
224097|NCT02008253|INTRASTROMAL CORNEAL RING|intrastromal corneal ring
224098|NCT02008253|ASTIGMATISM|astigmatism
224099|NCT02008240|Infertility|infertility
224100|NCT02008240|Hydrosalpinx|hydrosalpinx
224101|NCT02008240|IVF-ET|ivf-et
224102|NCT02008240|Salpingectomy|salpingectomy
224103|NCT02008214|Pentoxifylline|pentoxifylline
224104|NCT02008214|Sustained virologic response|sustained virologic response
224105|NCT02008214|Hepatic fibrosis|hepatic fibrosis
224106|NCT02008201|dose-response study|dose-response study
224107|NCT02008188|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
224108|NCT02008188|Artificial Pancreas|artificial pancreas
224109|NCT02008188|Closed Loop Control|closed loop control
224110|NCT02008188|Diabetes Assistant (DiAs)|diabetes assistant (dias)
224111|NCT02008188|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
224112|NCT02008188|Insulin Pump|insulin pump
224113|NCT02008188|Metabolic Diseases|metabolic diseases
224114|NCT02008188|Endocrine System Diseases|endocrine system diseases
224115|NCT02008188|Autoimmune Diseases|autoimmune diseases
224116|NCT02008175|paediatric, keratoconus, collagen cross linking|paediatric, keratoconus, collagen cross linking
224216|NCT02007850|quadriceps muscle strength|quadriceps muscle strength
224316|NCT02007486|Exercise|exercise
224117|NCT02008162|Emphysema, COPD, bronchoreversibility, ventilatory obstruction, lung volume reduction surgery, LVRS|emphysema, copd, bronchoreversibility, ventilatory obstruction, lung volume reduction surgery, lvrs
224118|NCT02008149|Osteoporosis|osteoporosis
224119|NCT02008136|myofascial pain|myofascial pain
224120|NCT02008136|muscle spasm|muscle spasm
224121|NCT02008136|botulinum toxin|botulinum toxin
224122|NCT02008136|cervicalgia|cervicalgia
224123|NCT02008136|lumbago|lumbago
224124|NCT02008136|low back pain|low back pain
224125|NCT02008123|Clopidogrel|clopidogrel
224126|NCT02008123|Clopidogrel Resistance|clopidogrel resistance
224127|NCT02008123|Primidone|primidone
224128|NCT02008123|Secondary Stroke Prevention|secondary stroke prevention
224129|NCT02008110|Heart failure|heart failure
224130|NCT02008110|Biomarker guided-therapy|biomarker guided-therapy
224131|NCT02008110|Carbohydrate antigen 125|carbohydrate antigen 125
224132|NCT02008110|Clinical outcomes.|clinical outcomes.
224133|NCT02008097|Ultrasound|ultrasound
224135|NCT02008097|Liver transplantation|liver transplantation
224136|NCT02008097|Arterial Occlusive Diseases|arterial occlusive diseases
224137|NCT02008097|Hypertension|hypertension
224138|NCT02008097|Pregnancy, High Risk|pregnancy, high risk
224139|NCT02008097|Pregnancy|pregnancy
224140|NCT02008084|hypertriglyceridemia|hypertriglyceridemia
224141|NCT02008084|mixed hyperlipidemia|mixed hyperlipidemia
224142|NCT02008058|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
224143|NCT02008058|LCCC 1231|lccc 1231
224144|NCT02008058|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
224145|NCT02008058|UNC Lineberger|unc lineberger
224146|NCT02008058|Prostate Cancer|prostate cancer
224147|NCT02008058|Pain|pain
224148|NCT02008045|MRI|mri
224149|NCT02008045|Imaging|imaging
275327|NCT01775150|infant|infant
224150|NCT02008045|Neurocognitive|neurocognitive
224151|NCT02008045|White matter injury|white matter injury
224152|NCT02008032|Mammography|mammography
224153|NCT02008032|Breast|breast
224154|NCT02008032|Implants|implants
224155|NCT02008019|Chondrosarcoma|chondrosarcoma
224156|NCT02008019|Neoadjuvant therapy|neoadjuvant therapy
224157|NCT02008019|Phase II|phase ii
224158|NCT02008019|Everolimus|everolimus
224159|NCT02008019|Success Rate|success rate
224160|NCT02008019|Progression Free Survival|progression free survival
224161|NCT02008019|Overall Survival|overall survival
224162|NCT02008019|Safety|safety
224163|NCT02008019|Quality of Life|quality of life
402002|NCT01233570|Oral crohns disease|oral crohns disease
224164|NCT02008019|Molecular study (ancillary study)|molecular study (ancillary study)
224165|NCT02008006|Follicular Lymphoma|follicular lymphoma
224166|NCT02008006|Chemosensitive relapse|chemosensitive relapse
224167|NCT02008006|High Dose Chemotherapy|high dose chemotherapy
224168|NCT02008006|Bendamustine|bendamustine
224169|NCT02008006|BeEAM|beeam
224170|NCT02008006|Autologous Stem Cell Transplantation|autologous stem cell transplantation
224171|NCT02008006|Safety|safety
224172|NCT02008006|Event Free Survival|event free survival
224173|NCT02008006|Overall Response Rate|overall response rate
224174|NCT02008006|Progression Free Survival|progression free survival
224175|NCT02008006|Overall Survival|overall survival
224176|NCT02008006|Phase II|phase ii
224177|NCT02008006|World Health Organization (WHO) 1 grade|world health organization (who) 1 grade
224178|NCT02008006|WHO 2 grade|who 2 grade
224179|NCT02008006|WHO 3a grade|who 3a grade
224180|NCT02007993|Halitosis,|halitosis,
224181|NCT02007993|Photodynamic Therapy,|photodynamic therapy,
224182|NCT02007993|Adolescent|adolescent
224183|NCT02007980|urological problems|urological problems
224184|NCT02007980|indwelling urologic stent|indwelling urologic stent
224185|NCT02007980|kidney stone disease|kidney stone disease
224186|NCT02007980|urinary system obstruction|urinary system obstruction
224187|NCT02007980|hydronephrosis|hydronephrosis
224188|NCT02007980|ureteral damage|ureteral damage
224189|NCT02007954|HCC|hcc
224190|NCT02007915|Adolescent|adolescent
224191|NCT02007915|Avascular Necrosis|avascular necrosis
224192|NCT02007915|Bisphosphonates|bisphosphonates
224193|NCT02007915|Pamidronate|pamidronate
224194|NCT02007902|Preterm baby|preterm baby
224195|NCT02007902|Total plasma protein|total plasma protein
224196|NCT02007902|Albumin|albumin
224197|NCT02007902|Hemodynamic disturbances|hemodynamic disturbances
224198|NCT02007902|Perfusion|perfusion
224199|NCT02007902|Near Infra Red Spectroscopy (NIRS)|near infra red spectroscopy (nirs)
224200|NCT02007902|Ultrasound|ultrasound
224201|NCT02007876|Mobility|mobility
224202|NCT02007876|Activity|activity
224203|NCT02007876|Training|training
224204|NCT02007876|Abdominal|abdominal
224205|NCT02007876|Surgery|surgery
224206|NCT02007876|Adult|adult
224207|NCT02007863|Leukemia|leukemia
224208|NCT02007863|Myelodysplasia|myelodysplasia
224209|NCT02007863|Acute lymphocytic leukemia|acute lymphocytic leukemia
224210|NCT02007863|ALL|all
224211|NCT02007863|Acute myelogenous leukemia|acute myelogenous leukemia
224212|NCT02007863|AML|aml
224213|NCT02007863|Pediatric|pediatric
224214|NCT02007850|continuous femoral nerve block|continuous femoral nerve block
224215|NCT02007850|knee arthroplasty|knee arthroplasty
224217|NCT02007837|pregnancy induced hypertension|pregnancy induced hypertension
224218|NCT02007837|gestational hypertension|gestational hypertension
224219|NCT02007837|pre-eclampsia|pre-eclampsia
224220|NCT02007837|preeclampsia|preeclampsia
224221|NCT02007837|hypertensive disorders in pregnancy|hypertensive disorders in pregnancy
224222|NCT02007824|pressure ulcer|pressure ulcer
224223|NCT02007824|chronic wound|chronic wound
224224|NCT02007824|tissue necrosis|tissue necrosis
224225|NCT02007824|slough|slough
224226|NCT02007824|ultra sound|ultra sound
224227|NCT02007798|dexmedetomidine|dexmedetomidine
224228|NCT02007798|supratentorial tumors|supratentorial tumors
224229|NCT02007785|Cognitive Orientation to daily Occupational Performance|cognitive orientation to daily occupational performance
224230|NCT02007785|CO-OP|co-op
224231|NCT02007772|COPD, nHF, BiPAP|copd, nhf, bipap
224232|NCT02007759|Dysphagia|dysphagia
224233|NCT02007759|neuromuscular electrical stimulation|neuromuscular electrical stimulation
224234|NCT02007759|NMES|nmes
224235|NCT02007759|Neonates|neonates
224236|NCT02007759|Vitalstim|vitalstim
224237|NCT02007746|sickle cell disease|sickle cell disease
224238|NCT02007746|hemochromatosis|hemochromatosis
224239|NCT02007746|liver fibrosis|liver fibrosis
224240|NCT02007746|liver cirrhosis|liver cirrhosis
224241|NCT02007746|FibroScan|fibroscan
224242|NCT02007746|Ferriscan|ferriscan
224243|NCT02007746|liver iron|liver iron
224244|NCT02007733|Diarrhea|diarrhea
224245|NCT02007733|Dehydration|dehydration
224246|NCT02007733|Children|children
224247|NCT02007733|Resuscitation|resuscitation
224248|NCT02007733|Clinical Prediction Rule|clinical prediction rule
224249|NCT02007733|Low Income Country|low income country
224250|NCT02007733|Bangladesh|bangladesh
224251|NCT02007720|Serelaxin,|serelaxin,
224252|NCT02007720|WHF,|whf,
224253|NCT02007720|Likert Scale,|likert scale,
224254|NCT02007720|RELAX-AHF-ASIA,|relax-ahf-asia,
224255|NCT02007720|RLX030,|rlx030,
224256|NCT02007720|AHF,|ahf,
224257|NCT02007720|acute heart failure|acute heart failure
224258|NCT02007707|Asian American|asian american
224259|NCT02007707|Vietnamese American|vietnamese american
224260|NCT02007707|Smoking cessation|smoking cessation
224261|NCT02007707|Community Health Worker|community health worker
224262|NCT02007707|Lay Health Worker Outreach|lay health worker outreach
224263|NCT02007707|Family Intervention|family intervention
224264|NCT02007694|Phobic Disorders (Fear of Flying and acrophobia)|phobic disorders (fear of flying and acrophobia)
224265|NCT02007694|Virtual Reality Exposure Therapy|virtual reality exposure therapy
224266|NCT02007694|Fear extinction|fear extinction
224267|NCT02007694|propranolol|propranolol
224268|NCT02007694|Yohimbine|yohimbine
224269|NCT02007681|Sedentary Behavior; Breaks; Workplace; Energy Expenditure; Physical activity; doubly labeled water|sedentary behavior; breaks; workplace; energy expenditure; physical activity; doubly labeled water
224270|NCT02007668|low back pain|low back pain
224271|NCT02007668|kinesio taping|kinesio taping
224272|NCT02007655|Cardiovascular|cardiovascular
224273|NCT02007616|Cognitive aging|cognitive aging
224274|NCT02007616|Video games training|video games training
224275|NCT02007616|Attention|attention
224276|NCT02007616|Memory|memory
224277|NCT02007616|Wellbeing|wellbeing
224278|NCT02007616|Speed of processing|speed of processing
224279|NCT02007616|Executive functions|executive functions
224280|NCT02007603|chronic hemodialysis|chronic hemodialysis
224281|NCT02007603|ampicillin|ampicillin
224282|NCT02007603|sulbactam|sulbactam
224283|NCT02007603|amoxicillin|amoxicillin
224284|NCT02007603|clavulanic acid|clavulanic acid
224285|NCT02007603|pharmacokinetics|pharmacokinetics
224286|NCT02007577|insulin resistant|insulin resistant
224287|NCT02007564|Palliative care dyads|palliative care dyads
224288|NCT02007564|Volunteers|volunteers
224289|NCT02007564|Community-based|community-based
224290|NCT02007564|Mixed methods|mixed methods
224291|NCT02007551|Social Isolation|social isolation
224292|NCT02007551|Nutrition Assessments|nutrition assessments
224293|NCT02007551|Food Habits|food habits
224294|NCT02007551|Meals|meals
224295|NCT02007551|Self Efficacy|self efficacy
224296|NCT02007551|Quality of Life|quality of life
224297|NCT02007551|Peer Group|peer group
224298|NCT02007538|Lung Cancer|lung cancer
224299|NCT02007538|Bronchoscopy|bronchoscopy
224300|NCT02007538|Fine Need Aspiration|fine need aspiration
224301|NCT02007538|Cytochemical Assays|cytochemical assays
224302|NCT02007512|advanced breast cancer|advanced breast cancer
224303|NCT02007512|enzalutamide|enzalutamide
224304|NCT02007512|MDV3100|mdv3100
224305|NCT02007512|Estrogen receptor positive (ER +)|estrogen receptor positive (er +)
224306|NCT02007512|Progesterone receptor positive (PgR +)|progesterone receptor positive (pgr +)
224307|NCT02007512|HER-2 normal|her-2 normal
224308|NCT02007499|Prehospital emergency care|prehospital emergency care
224309|NCT02007499|Out of hospital cardiac arrest|out of hospital cardiac arrest
224310|NCT02007499|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
224311|NCT02007499|CPR|cpr
224312|NCT02007499|Heart arrest|heart arrest
224313|NCT02007499|Outcome|outcome
224314|NCT02007499|Bystander|bystander
224315|NCT02007486|Heart Failure|heart failure
224317|NCT02007486|Dyspnea|dyspnea
224318|NCT02007486|Diaphragm electromyogram|diaphragm electromyogram
224319|NCT02007486|Respiratory mechanics|respiratory mechanics
224320|NCT02007473|Haemovigilance|haemovigilance
224321|NCT02007473|Plasma|plasma
224322|NCT02007473|Pathogen reduction|pathogen reduction
224323|NCT02007473|Methylene Blue|methylene blue
224324|NCT02007447|autism, oxytocin, autism spectrum disorder, social skills.|autism, oxytocin, autism spectrum disorder, social skills.
224325|NCT02007421|Human Papillomavirus,|human papillomavirus,
224326|NCT02007421|Anal High Grade Squamous intraepithelial lesions,|anal high grade squamous intraepithelial lesions,
224327|NCT02007421|Homosexual Men|homosexual men
224328|NCT02007421|High resolution anoscopy,|high resolution anoscopy,
224329|NCT02007421|Cancer Screening|cancer screening
224330|NCT02007421|HIV|hiv
224331|NCT02007408|abortion|abortion
224332|NCT02007408|analgesia|analgesia
224333|NCT02007408|paracervical block|paracervical block
224334|NCT02007408|lidocaine spray|lidocaine spray
224335|NCT02007343|Enterobacteriaceae|enterobacteriaceae
224336|NCT02007343|Pseudomonas|pseudomonas
224337|NCT02007343|Acinetobacter|acinetobacter
224338|NCT02007343|Stenotrophomonas|stenotrophomonas
224339|NCT02007343|Mortality|mortality
224340|NCT02007343|Morbidity|morbidity
224341|NCT02007343|Cost of Illness|cost of illness
224342|NCT02007343|Causality|causality
224343|NCT02007343|Multicenter Study|multicenter study
224344|NCT02007343|Cohort Studies|cohort studies
275590|NCT01773993|Lyrica|lyrica
224345|NCT02007343|Case-Control Studies|case-control studies
224346|NCT02007343|Prospective Studies|prospective studies
224347|NCT02007343|Follow-up Studies|follow-up studies
224348|NCT02007330|systemic lidocaine|systemic lidocaine
224349|NCT02007330|postoperative pain|postoperative pain
224350|NCT02007330|recovery, pediatric|recovery, pediatric
224351|NCT02007330|inguinal hernia|inguinal hernia
224352|NCT02007330|laparoscopy|laparoscopy
224353|NCT02007317|BCC|bcc
224354|NCT02007291|Alzheimer, MMSE, response, colinesterase inhibitors (ChEI)|alzheimer, mmse, response, colinesterase inhibitors (chei)
224355|NCT02007278|diabetes|diabetes
224356|NCT02007278|hypoglycemia|hypoglycemia
224357|NCT02007278|glycemic variability|glycemic variability
224358|NCT02007278|vildagliptin|vildagliptin
224359|NCT02007278|glimepiride|glimepiride
224363|NCT02007252|Abdominal ultrasound|abdominal ultrasound
224365|NCT02007239|hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
224366|NCT02007239|cytokine|cytokine
224367|NCT02007239|cytokine release syndrome|cytokine release syndrome
224372|NCT02007213|Neuromuscular Disease|neuromuscular disease
224373|NCT02007213|Motor Function|motor function
224374|NCT02007213|Proxy Reported Outcome|proxy reported outcome
224375|NCT02007213|Young Children|young children
224376|NCT02007187|Unstable Angina Pectoris|unstable angina pectoris
224377|NCT02007187|Randomized Controlled Trial|randomized controlled trial
224378|NCT02007187|Traditional Chinese Medicine|traditional chinese medicine
224379|NCT02007174|recurrent pterygium|recurrent pterygium
224380|NCT02007174|bevacizumab|bevacizumab
224381|NCT02007174|triple dose|triple dose
224382|NCT02007148|gastric adenocarcinoma,|gastric adenocarcinoma,
224383|NCT02007148|capecitabine,|capecitabine,
224384|NCT02007148|second line treatment,|second line treatment,
224385|NCT02007148|recurrent or metastatic disease,|recurrent or metastatic disease,
224386|NCT02007148|overall survival,|overall survival,
224387|NCT02007148|tumor response,|tumor response,
224388|NCT02007148|quality of life|quality of life
224389|NCT02007122|HD|hd
224390|NCT02007122|CVVH|cvvh
224391|NCT02007122|renal replacement therapy|renal replacement therapy
224392|NCT02007122|ceftaroline|ceftaroline
224393|NCT02007122|pharmacokinetics|pharmacokinetics
224394|NCT02007096|Transabdominal plane block|transabdominal plane block
224395|NCT02007096|ventral hernia|ventral hernia
224396|NCT02007096|umbilical hernia|umbilical hernia
224397|NCT02007096|incisional hernia|incisional hernia
224398|NCT02007096|hernia repair|hernia repair
224399|NCT02007083|Lumbar Spinal stenosis|lumbar spinal stenosis
224400|NCT02007083|Surgical treatment of LSS.|surgical treatment of lss.
224401|NCT02007070|PD1|pd1
224402|NCT02007070|PD-1|pd-1
224403|NCT02007070|PDL1|pdl1
224404|NCT02007070|PD-L1|pd-l1
224405|NCT02007057|Suprascapular nerve block|suprascapular nerve block
224406|NCT02007057|Interscalene nerve block|interscalene nerve block
224407|NCT02007044|Leukemia|leukemia
224408|NCT02007044|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
224409|NCT02007044|CLL|cll
224410|NCT02007044|Relapsed|relapsed
224411|NCT02007044|Ibrutinib|ibrutinib
224412|NCT02007044|PCI-32765|pci-32765
224413|NCT02007044|Rituximab|rituximab
224414|NCT02007044|Rituxan|rituxan
224415|NCT02007031|Hypertension|hypertension
224416|NCT02007031|Cold temperature|cold temperature
224417|NCT02007031|Blood pressure|blood pressure
224418|NCT02007031|Electrocardiography|electrocardiography
224419|NCT02007018|Surgical Site Infections|surgical site infections
224420|NCT02007018|Colorectal Resection|colorectal resection
224421|NCT02007018|Negative Pressure Wound Therapy|negative pressure wound therapy
224524|NCT02006537|Entero-Test|entero-test
224422|NCT02007005|superficial bladder cancer|superficial bladder cancer
224423|NCT02007005|mistletoe extract|mistletoe extract
224424|NCT02007005|maximum tolerated dose|maximum tolerated dose
224425|NCT02007005|marker tumor|marker tumor
224426|NCT02007005|remission|remission
224427|NCT02007005|recurrence rate|recurrence rate
224428|NCT02006979|cardiotoxicity|cardiotoxicity
224429|NCT02006979|Chemotherapy, Adjuvant|chemotherapy, adjuvant
224430|NCT02006979|Breast Neoplasms|breast neoplasms
224431|NCT02006979|Exercise|exercise
224432|NCT02006979|Cardiotoxins|cardiotoxins
224433|NCT02006979|Echocardiography|echocardiography
224434|NCT02006979|Speckle tracking|speckle tracking
224435|NCT02006979|Biological Markers|biological markers
224436|NCT02006979|Electrocardiography|electrocardiography
224437|NCT02006966|Systemic lidocaine|systemic lidocaine
224438|NCT02006966|postoperative pain|postoperative pain
224439|NCT02006966|Video-assisted thoracic surgery|video-assisted thoracic surgery
224440|NCT02006966|VATS|vats
224441|NCT02006953|gastrostomy|gastrostomy
224442|NCT02006953|enteral|enteral
224443|NCT02006940|alveoflex|alveoflex
224444|NCT02006940|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
224445|NCT02006940|pCLE|pcle
224446|NCT02006940|alveoscopy|alveoscopy
224447|NCT02006940|morphology|morphology
224448|NCT02006940|high resolution computed tomography|high resolution computed tomography
224449|NCT02006927|Prostate Cancer|prostate cancer
224450|NCT02006914|Insulin resistance|insulin resistance
224451|NCT02006914|HIV disease|hiv disease
224452|NCT02006914|chromium picolinate|chromium picolinate
224453|NCT02006901|surgical procedures, operative|surgical procedures, operative
224454|NCT02006901|lumbar vertebrae|lumbar vertebrae
224455|NCT02006901|decompression, surgical|decompression, surgical
224456|NCT02006901|microdecompression|microdecompression
224457|NCT02006901|laminectomy|laminectomy
224458|NCT02006901|registries|registries
224459|NCT02006888|Inflammation|inflammation
224460|NCT02006888|cataract surgery|cataract surgery
224461|NCT02006875|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
224462|NCT02006875|postural|postural
224464|NCT02006875|mobility|mobility
224465|NCT02006875|leg|leg
224466|NCT02006875|stroke|stroke
224467|NCT02006862|olanzapine|olanzapine
224468|NCT02006862|olanzapine treatment efficacy|olanzapine treatment efficacy
224469|NCT02006849|AfricanAmericans|africanamericans
224470|NCT02006849|Hypertension|hypertension
224471|NCT02006849|Proteinuria|proteinuria
224472|NCT02006849|ApoL1 gene|apol1 gene
224473|NCT02006836|glycemic index|glycemic index
224474|NCT02006836|glycemic response|glycemic response
224475|NCT02006836|diabetes|diabetes
224476|NCT02006836|pomelo|pomelo
224477|NCT02006823|Chronic Hepatitis C|chronic hepatitis c
224478|NCT02006810|Endothelium biomarkers|endothelium biomarkers
224479|NCT02006810|Atherosclerotic disease|atherosclerotic disease
224480|NCT02006810|Endothelial function|endothelial function
224481|NCT02006810|Nutritional stimuli|nutritional stimuli
224482|NCT02006797|reconciliation|reconciliation
224483|NCT02006797|discharge|discharge
224484|NCT02006797|pharmacist|pharmacist
224485|NCT02006797|drug related problems|drug related problems
224486|NCT02006771|Meal|meal
224487|NCT02006771|Postprandial oxidative stress|postprandial oxidative stress
224488|NCT02006719|Adhesive Capsulitis|adhesive capsulitis
224489|NCT02006719|Frozen Shoulder|frozen shoulder
224490|NCT02006719|Shoulder Range of Motion limitation|shoulder range of motion limitation
224491|NCT02006719|Shoulder Pain|shoulder pain
224492|NCT02006693|XEN|xen
224493|NCT02006693|Primary Open Angle Glaucoma|primary open angle glaucoma
224494|NCT02006693|Filtration Device|filtration device
224495|NCT02006693|Ab interno|ab interno
224496|NCT02006680|Central Precocious Puberty|central precocious puberty
224497|NCT02006680|Suppression|suppression
224498|NCT02006680|Alpha Subunit|alpha subunit
224499|NCT02006680|Leuprolide Stimulation Test|leuprolide stimulation test
224500|NCT02006628|GWP42003|gwp42003
224501|NCT02006628|Cannabinoids|cannabinoids
224502|NCT02006628|Schizophrenia|schizophrenia
224503|NCT02006602|Candesartan cilexetil|candesartan cilexetil
224504|NCT02006602|Healthy adult human subjects|healthy adult human subjects
224505|NCT02006602|Bioequivalence|bioequivalence
224506|NCT02006589|Bioequivalence|bioequivalence
224507|NCT02006589|Candesartan cilexetil|candesartan cilexetil
224508|NCT02006589|Healthy adult human subjects|healthy adult human subjects
224509|NCT02006576|Emphysema|emphysema
224510|NCT02006576|Prostaglandin E|prostaglandin e
224511|NCT02006576|Bronchoalveolar lavage|bronchoalveolar lavage
224512|NCT02006563|Brain Tumor|brain tumor
224513|NCT02006563|Glioblastoma multiforme|glioblastoma multiforme
224514|NCT02006563|GBM|gbm
224515|NCT02006563|Metabolic Tumor Volume|metabolic tumor volume
224516|NCT02006563|MTV|mtv
224517|NCT02006563|Clinical Tumor Volume|clinical tumor volume
224518|NCT02006563|CTV|ctv
224519|NCT02006550|Wnt|wnt
224520|NCT02006550|Notch|notch
224521|NCT02006550|Hedgehog|hedgehog
224522|NCT02006550|Tumor Sample|tumor sample
224523|NCT02006537|soluble epoxide hydrolase inhibitor|soluble epoxide hydrolase inhibitor
224525|NCT02006537|pharmacokinetics|pharmacokinetics
224526|NCT02006537|COPD|copd
224527|NCT02006537|safety|safety
224528|NCT02006524|Silent atrial fibrillation|silent atrial fibrillation
224529|NCT02006524|primary care|primary care
224530|NCT02006524|screening|screening
224531|NCT02006524|influenza vaccination|influenza vaccination
224532|NCT02006511|incisional negative pressure wound therapy|incisional negative pressure wound therapy
224533|NCT02006511|groin incision|groin incision
224534|NCT02006511|incisional VAC|incisional vac
224535|NCT02006511|Prevena|prevena
224536|NCT02006511|groin wound|groin wound
224537|NCT02006498|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
224538|NCT02006498|sillymarin|sillymarin
224539|NCT02006498|randomised trial|randomised trial
224540|NCT02006498|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
224541|NCT02006472|Huntington's Disease|huntington's disease
224542|NCT02006472|Pridopidine|pridopidine
224543|NCT02006472|Pride-HD|pride-hd
224544|NCT02006459|Gastrointestinal-mediated glucose disposal|gastrointestinal-mediated glucose disposal
224545|NCT02006459|Total pancreatectomy|total pancreatectomy
224546|NCT02006459|Incretin hormones|incretin hormones
224547|NCT02006459|Glucagon|glucagon
224548|NCT02006446|Male infertility|male infertility
224549|NCT02006446|sperm head vacuoles|sperm head vacuoles
224550|NCT02006446|sperm morphology|sperm morphology
224551|NCT02006446|aneuploidy|aneuploidy
224552|NCT02006446|DNA fragmentation|dna fragmentation
224553|NCT02006446|abnormal chromatin condensation|abnormal chromatin condensation
224554|NCT02006446|telomere abnormalities|telomere abnormalities
224555|NCT02006394|Inflammation|inflammation
224556|NCT02006394|Monocytes|monocytes
224557|NCT02006381|healthy boys|healthy boys
224558|NCT02006381|plasma oxytocin|plasma oxytocin
224559|NCT02006381|pediatric|pediatric
224560|NCT02006368|Volunteers|volunteers
224561|NCT02006368|Blood Platelets|blood platelets
224562|NCT02006368|Platelet Transfusion|platelet transfusion
224563|NCT02006342|Diabetes Mellitus|diabetes mellitus
224564|NCT02006342|Diabetic Ketoacidosis|diabetic ketoacidosis
224565|NCT02006342|Insulin Glargine|insulin glargine
224566|NCT02006342|Anion gap|anion gap
224567|NCT02006342|Metabolic acidosis|metabolic acidosis
224568|NCT02006303|Benign Prostate Hyperplasia|benign prostate hyperplasia
224569|NCT02006303|Green light|green light
224570|NCT02006303|Photoselective vaporization of the prostate|photoselective vaporization of the prostate
224571|NCT02006303|Prostatic artery embolization|prostatic artery embolization
224572|NCT02006303|Outcome|outcome
224573|NCT02006277|healthy volunteers|healthy volunteers
224574|NCT02006277|taste|taste
224575|NCT02006277|bioavailability|bioavailability
224576|NCT02006238|Hot flash|hot flash
224577|NCT02006238|Farabloc|farabloc
224578|NCT02006238|menopausal women|menopausal women
224579|NCT02006225|autologous|autologous
224580|NCT02006225|stem cell|stem cell
224581|NCT02006225|transplantation|transplantation
224582|NCT02006199|obsessive-compulsive disorder|obsessive-compulsive disorder
224583|NCT02006199|mindfulness|mindfulness
224584|NCT02006199|meditation|meditation
224585|NCT02006186|Bicycling|bicycling
224586|NCT02006173|Hya-Dermis mixed with lidocaine on reducing pain|hya-dermis mixed with lidocaine on reducing pain
224587|NCT02006134|Vasculitis|vasculitis
224588|NCT02006134|Primary CNS Vasculitis|primary cns vasculitis
224589|NCT02006134|Systemic vasculitis|systemic vasculitis
224590|NCT02006134|Churg-Strauss Syndrome|churg-strauss syndrome
224591|NCT02006134|Polyarteritis Nodosa|polyarteritis nodosa
224592|NCT02006134|Wegener Granulomatosis|wegener granulomatosis
224593|NCT02006134|Pediatric vasculitis|pediatric vasculitis
224594|NCT02006134|Childhood vasculitis|childhood vasculitis
224595|NCT02006134|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
224596|NCT02006134|Microscopic Polyangiitis|microscopic polyangiitis
224597|NCT02006134|Takayasu Arteritis|takayasu arteritis
224598|NCT02006134|Autoimmune|autoimmune
224599|NCT02006134|ANCA-associated vasculitis|anca-associated vasculitis
224600|NCT02006121|Parkinson's disease|parkinson's disease
224601|NCT02006121|motor fluctuations|motor fluctuations
224602|NCT02006121|not well controlled|not well controlled
224603|NCT02006121|medical treatment|medical treatment
224604|NCT02006108|kidney|kidney
224605|NCT02006108|transplant|transplant
224606|NCT02006108|rejection|rejection
224607|NCT02006108|Feraheme|feraheme
224608|NCT02006108|ferumoxytol|ferumoxytol
224609|NCT02006095|carotid artery stenting|carotid artery stenting
224610|NCT02006095|carotid endarterectomy|carotid endarterectomy
224611|NCT02006095|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
224612|NCT02006095|neuropsychological testing|neuropsychological testing
224613|NCT02006095|microemboli|microemboli
224614|NCT02006082|Telemedicine video-consultation (TVC)|telemedicine video-consultation (tvc)
224615|NCT02006082|Re-admission to hospital|re-admission to hospital
224616|NCT02006082|Time to re-admission|time to re-admission
224617|NCT02006082|Length if hospital stay|length if hospital stay
224618|NCT02006082|Patient satisfaction|patient satisfaction
224619|NCT02006082|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
216504|NCT02043067|TB|tb
224620|NCT02006069|CRT, non responders, MultiPoint Pacing (MPP)|crt, non responders, multipoint pacing (mpp)
224621|NCT02006030|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
224622|NCT02006030|Liver Cancer|liver cancer
224624|NCT02006030|ADI-PEG 20|adi-peg 20
224625|NCT02006004|AML|aml
224626|NCT02005991|PF-05212377|pf-05212377
224627|NCT02005991|phase 1|phase 1
224628|NCT02005991|open-label|open-label
224629|NCT02005991|5-HT2a receptor occupancy|5-ht2a receptor occupancy
224630|NCT02005991|positron emission tomography|positron emission tomography
224631|NCT02005991|healthy subjects|healthy subjects
224632|NCT02005991|brain|brain
224633|NCT02005991|cortex|cortex
224634|NCT02005991|alzheimers disease|alzheimers disease
224635|NCT02005965|Rectal Cancer|rectal cancer
224636|NCT02005965|Low Rectal Cancer|low rectal cancer
224637|NCT02005965|MERCURY|mercury
224639|NCT02005965|CRM|crm
224640|NCT02005965|Circumferential Margin|circumferential margin
224641|NCT02005965|Quality of Life|quality of life
224642|NCT02005965|MRI|mri
224643|NCT02005965|Radiology|radiology
224644|NCT02005965|Abdominoperineal Excision|abdominoperineal excision
224645|NCT02005965|Anterior Resection|anterior resection
224646|NCT02005965|Surgery|surgery
224647|NCT02005965|Pathology|pathology
224648|NCT02005939|Pomegranate|pomegranate
224649|NCT02005939|Blood pressure|blood pressure
224650|NCT02005939|Insulin sensitivity|insulin sensitivity
224651|NCT02005939|Cortisol|cortisol
224652|NCT02005939|Quality of life|quality of life
224653|NCT02005939|Body composition|body composition
224654|NCT02005926|Breast cancer|breast cancer
224655|NCT02005926|Sentinel lymph node biopsy|sentinel lymph node biopsy
224656|NCT02005926|Ultrasonography|ultrasonography
224657|NCT02005926|Fine needle aspiration|fine needle aspiration
224658|NCT02005900|DHA|dha
224659|NCT02005900|Omega 3|omega 3
224660|NCT02005900|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
224661|NCT02005900|Dyslipidemia induced by HAART|dyslipidemia induced by haart
224662|NCT02005900|Lipid metabolic alterations|lipid metabolic alterations
224663|NCT02005900|HIV|hiv
224664|NCT02005887|Premenopausal patients|premenopausal patients
224665|NCT02005887|ER-positive|er-positive
224666|NCT02005887|PgR+ (>50%)|pgr+ (>50%)
224667|NCT02005887|HER2-negative or not amplified|her2-negative or not amplified
224668|NCT02005861|osteochondral lesion|osteochondral lesion
224669|NCT02005861|talus|talus
224670|NCT02005861|ankle|ankle
224671|NCT02005861|cartilage repair|cartilage repair
224672|NCT02005848|Type-1 Diabetes|type-1 diabetes
224673|NCT02005848|T1D|t1d
224674|NCT02005848|Diabetes Mellitus|diabetes mellitus
224675|NCT02005835|HIV|hiv
224676|NCT02005835|Option B+|option b+
224677|NCT02005835|Prevention of Mother to Child Transmission|prevention of mother to child transmission
224678|NCT02005822|Cytomegalovirus|cytomegalovirus
224679|NCT02005822|Congenital infection|congenital infection
224680|NCT02005822|Sensorineural hearing loss|sensorineural hearing loss
224681|NCT02005822|Valganciclovir|valganciclovir
224682|NCT02005809|Endoscopic submucosal dissection|endoscopic submucosal dissection
224683|NCT02005809|gastric neoplasm|gastric neoplasm
224684|NCT02005809|second look endoscopy|second look endoscopy
224685|NCT02005783|incidence of grade 3/4 neutropenia|incidence of grade 3/4 neutropenia
224686|NCT02005783|incidence of febrile neutropenia|incidence of febrile neutropenia
224687|NCT02005783|time to neutropenia recovery|time to neutropenia recovery
224688|NCT02005783|safety|safety
224689|NCT02005757|rheumatoid arthritis|rheumatoid arthritis
224690|NCT02005757|RA|ra
224691|NCT02005757|Mizoribine|mizoribine
224692|NCT02005757|DAS28|das28
224693|NCT02005757|European League Against Rheumatism|european league against rheumatism
224694|NCT02005744|CKD-501|ckd-501
224695|NCT02005731|Low Intensity Shockwave|low intensity shockwave
224696|NCT02005731|Extracorporeal shockwave therapy|extracorporeal shockwave therapy
224697|NCT02005731|Erectile dysfunction|erectile dysfunction
224698|NCT02005692|pressure ulcers|pressure ulcers
224699|NCT02005692|bed sores|bed sores
224700|NCT02005692|patient turn protocol|patient turn protocol
224701|NCT02005692|patient movement|patient movement
224702|NCT02005692|patient monitoring|patient monitoring
224703|NCT02005679|Prelingual Deafness|prelingual deafness
224704|NCT02005679|Retention Disorders, Cognitive|retention disorders, cognitive
224705|NCT02005679|Sign language|sign language
224706|NCT02005679|Mini-Mental State|mini-mental state
224707|NCT02005666|Acne Vulgaris|acne vulgaris
224708|NCT02005666|DUAC|duac
224709|NCT02005666|CADILA|cadila
224710|NCT02005666|CLIANTHA|cliantha
224711|NCT02005653|Lymphatic filariasis|lymphatic filariasis
224712|NCT02005653|W. bancrofti|w. bancrofti
224713|NCT02005653|DEC|dec
224714|NCT02005653|Albendazole|albendazole
224715|NCT02005653|Doxycycline|doxycycline
224716|NCT02005627|grass pollen allergy|grass pollen allergy
224717|NCT02005627|hayfever|hayfever
224718|NCT02005627|atopy|atopy
224719|NCT02005627|allergic rhinitis|allergic rhinitis
224720|NCT02005627|sublingual immunotherapy tablets|sublingual immunotherapy tablets
224721|NCT02005614|Rational dose selection|rational dose selection
224722|NCT02005614|gamma knife radiosurgery|gamma knife radiosurgery
224723|NCT02005588|amino acid chelated iron|amino acid chelated iron
224724|NCT02005588|iron salt|iron salt
224725|NCT02005588|iron deficiency anemia|iron deficiency anemia
224726|NCT02005536|Poliomyelitis|poliomyelitis
224727|NCT02005536|Poliovirus|poliovirus
224728|NCT02005536|Polio|polio
224729|NCT02005536|IMOVAX POLIO®|imovax polio®
224730|NCT02005536|Inactivated polio vaccine|inactivated polio vaccine
224731|NCT02005510|cervical cancer|cervical cancer
224732|NCT02005510|screening|screening
224733|NCT02005510|human papillomavirus|human papillomavirus
224734|NCT02005510|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
224735|NCT02005497|Cancer prevention and control|cancer prevention and control
224736|NCT02005497|Health promotion|health promotion
224737|NCT02005497|Workplace|workplace
224738|NCT02005497|Dissemination|dissemination
224739|NCT02005497|Implementation|implementation
224740|NCT02005458|Neutropenia|neutropenia
224741|NCT02005458|Febrile neutropenia|febrile neutropenia
224742|NCT02005458|PEG-rhG-CSF|peg-rhg-csf
224743|NCT02005458|Myelosuppressive chemotherapy|myelosuppressive chemotherapy
224744|NCT02005445|Obstructive sleep apnea|obstructive sleep apnea
276153|NCT01771653|HCV|hcv
224745|NCT02005445|Coronary heart disease|coronary heart disease
224746|NCT02005445|Cardiac rehabilitation|cardiac rehabilitation
224747|NCT02005445|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
224748|NCT02005432|Diabetis|diabetis
224749|NCT02005432|Retinal Neovascularization|retinal neovascularization
224750|NCT02005432|laser treatment|laser treatment
224751|NCT02005419|Pancreatic Cancer|pancreatic cancer
224752|NCT02005419|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
224753|NCT02005419|Metformin|metformin
224754|NCT02005419|Gemcitabine|gemcitabine
224755|NCT02005419|Adjuvant Therapy|adjuvant therapy
224756|NCT02005406|Wei JET|wei jet
224757|NCT02005393|FICE|fice
224758|NCT02005393|NBI|nbi
224961|NCT02004444|Natalizumab|natalizumab
224759|NCT02005380|Alzheimer's Disease Rehabilitation|alzheimer's disease rehabilitation
224760|NCT02005367|substance use treatment|substance use treatment
224761|NCT02005367|person-centered treatment|person-centered treatment
224762|NCT02005367|residential treatment outcomes|residential treatment outcomes
224763|NCT02005367|dual diagnosis|dual diagnosis
224764|NCT02005367|recovery model|recovery model
224765|NCT02005367|psychosocial treatment|psychosocial treatment
224766|NCT02005354|Pain|pain
224767|NCT02005354|Bone marrow aspiration|bone marrow aspiration
224768|NCT02005354|trephine biopsy|trephine biopsy
224769|NCT02005341|Lumbar|lumbar
224770|NCT02005341|fusion|fusion
224771|NCT02005328|Xerostomia|xerostomia
224772|NCT02005328|hyposialia|hyposialia
224773|NCT02005328|hyposalivation|hyposalivation
224774|NCT02005328|saliva substitute|saliva substitute
224775|NCT02005328|Salivary Gland|salivary gland
224776|NCT02005328|Mouth Diseases|mouth diseases
224777|NCT02005328|Dry mouth|dry mouth
224778|NCT02005315|Pancreatic Cancer|pancreatic cancer
224779|NCT02005315|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
224780|NCT02005302|chronic kidney disease|chronic kidney disease
224781|NCT02005302|mineral and bone disease|mineral and bone disease
224782|NCT02005302|Malnutrition|malnutrition
224783|NCT02005302|Vitamin D|vitamin d
224784|NCT02005302|low protein diet|low protein diet
224785|NCT02005289|CLL|cll
224786|NCT02005289|SLL|sll
224787|NCT02005289|PLL|pll
224788|NCT02005289|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
224789|NCT02005289|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
224790|NCT02005289|Prolymphocytic Leukemia|prolymphocytic leukemia
224791|NCT02005289|MOR00208|mor00208
224792|NCT02005289|MOR208|mor208
224793|NCT02005276|Sedentary|sedentary
224794|NCT02005276|Behavioral Economic Intervention|behavioral economic intervention
224795|NCT02005276|Team Studies|team studies
224796|NCT02005276|Financial Incentives|financial incentives
224797|NCT02005276|Workplace Wellness|workplace wellness
224798|NCT02005276|Team Incentives|team incentives
224799|NCT02005263|Hysteroscopy|hysteroscopy
224800|NCT02005250|osteoporosis|osteoporosis
224801|NCT02005250|hyperthyroidism|hyperthyroidism
224802|NCT02005250|hypothyroidism|hypothyroidism
224803|NCT02005237|Exercise|exercise
224804|NCT02005237|Cognition|cognition
224805|NCT02005237|Neuroimaging|neuroimaging
224806|NCT02005237|Rehabilitation|rehabilitation
224807|NCT02005237|Connectivity|connectivity
224808|NCT02005224|Insulin sensitivity|insulin sensitivity
224809|NCT02005224|Lipid profile|lipid profile
224810|NCT02005224|Body composition|body composition
224811|NCT02005224|Weight|weight
224812|NCT02005211|AZD3293|azd3293
224813|NCT02005211|Healthy volunteers|healthy volunteers
224814|NCT02005211|Young volunteers|young volunteers
224815|NCT02005211|Elderly volunteers|elderly volunteers
224816|NCT02005211|Japanese volunteers|japanese volunteers
224817|NCT02005211|Phase 1|phase 1
224818|NCT02005211|Single and multiple ascending dose study|single and multiple ascending dose study
224819|NCT02005172|arrhythmia, palpitations, lightheadedness|arrhythmia, palpitations, lightheadedness
224820|NCT02005159|Enterobacteria|enterobacteria
224821|NCT02005159|Bacteremia|bacteremia
224822|NCT02005159|Minimum inhibitory concentration|minimum inhibitory concentration
224823|NCT02005159|Susceptible|susceptible
224824|NCT02005159|Prognosis|prognosis
224825|NCT02005146|Hepatitis B|hepatitis b
224826|NCT02005146|Nucleoside/nucleotide|nucleoside/nucleotide
224827|NCT02005146|HBsAg loss|hbsag loss
224828|NCT02005133|Wet age-related macular degeneration|wet age-related macular degeneration
224829|NCT02005068|Osteoarticular infections|osteoarticular infections
224830|NCT02005068|Osteomyelitis|osteomyelitis
224831|NCT02005068|Joint infections|joint infections
224832|NCT02005068|MRSA (Methicillin- Resistant Staphylococcus Aureus)|mrsa (methicillin- resistant staphylococcus aureus)
224833|NCT02005068|MSSA (Methicillin- Susceptible Staphylococcus Aureus)|mssa (methicillin- susceptible staphylococcus aureus)
224834|NCT02005055|Brachytherapy|brachytherapy
224835|NCT02005055|Radiotherapy|radiotherapy
224836|NCT02005055|Scar treatment|scar treatment
224837|NCT02005042|Physical activity|physical activity
224838|NCT02005042|Ecological Momentary Assessment|ecological momentary assessment
224839|NCT02005042|Ecological Momentary Intervention|ecological momentary intervention
224840|NCT02005042|Accelerometer|accelerometer
224841|NCT02005042|Smartphone|smartphone
224842|NCT02005029|Parkinson's Disease|parkinson's disease
224843|NCT02005029|Levodopa|levodopa
224844|NCT02005029|motor fluctuations|motor fluctuations
224845|NCT02005029|gastroparesis|gastroparesis
224846|NCT02005016|Aphasia|aphasia
224847|NCT02005016|Language Therapy|language therapy
224848|NCT02005016|Acquired Language Disorders|acquired language disorders
224849|NCT02005016|Semantics|semantics
224851|NCT02004990|Children, Plaque|children, plaque
224852|NCT02004951|Superficial femoral artery|superficial femoral artery
224853|NCT02004951|paclitaxel|paclitaxel
224854|NCT02004951|stent|stent
224855|NCT02004951|self expandable|self expandable
224856|NCT02004951|restenosis|restenosis
224857|NCT02004951|endovascular|endovascular
224858|NCT02004951|above-the-knee intermediate length|above-the-knee intermediate length
224859|NCT02004938|measurements|measurements
224860|NCT02004938|jugular|jugular
224861|NCT02004938|ultrasound|ultrasound
224862|NCT02004938|pediatric|pediatric
224863|NCT02004938|respiratory|respiratory
224864|NCT02004938|diameter|diameter
224865|NCT02004925|pneumoperitoneum|pneumoperitoneum
224866|NCT02004925|free peritoneal air|free peritoneal air
224867|NCT02004925|ultrasonography|ultrasonography
224868|NCT02004912|maternal|maternal
224869|NCT02004912|neonatal|neonatal
224870|NCT02004912|child|child
224871|NCT02004912|health services|health services
224872|NCT02004912|health care|health care
224873|NCT02004912|Karnataka|karnataka
224874|NCT02004912|India|india
224875|NCT02004899|Labor epidural analgesia|labor epidural analgesia
224876|NCT02004899|Fentanyl|fentanyl
224877|NCT02004899|Bupivacaine|bupivacaine
224878|NCT02004899|Onset|onset
224879|NCT02004886|Diabetes Mellitus|diabetes mellitus
224880|NCT02004886|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
224881|NCT02004886|Glucose Metabolism Disorders|glucose metabolism disorders
224882|NCT02004886|Metabolic Diseases|metabolic diseases
224883|NCT02004886|Endocrine System Diseases|endocrine system diseases
224884|NCT02004886|Therapeutic Uses|therapeutic uses
224885|NCT02004886|Pharmacologic Actions|pharmacologic actions
224886|NCT02004886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
224887|NCT02004886|Physiological Effects of Drugs|physiological effects of drugs
224888|NCT02004886|Metformin|metformin
224889|NCT02004873|pacemaker|pacemaker
224890|NCT02004873|leadless|leadless
224891|NCT02004873|single chamber|single chamber
224892|NCT02004860|local immunosuppressive|local immunosuppressive
224893|NCT02004860|Maintenance therapy|maintenance therapy
224894|NCT02004795|Boron Neutron Capture Therapy|boron neutron capture therapy
224895|NCT02004795|Image-guided intensity modulation radiotherapy|image-guided intensity modulation radiotherapy
224896|NCT02004769|Metastatic gastric or gastro-esophageal junction cancer|metastatic gastric or gastro-esophageal junction cancer
224897|NCT02004769|Trastuzumab|trastuzumab
224898|NCT02004769|HER2-positive|her2-positive
224899|NCT02004769|Capecitabine|capecitabine
224900|NCT02004769|Docetaxel|docetaxel
224901|NCT02004769|First-line therapy|first-line therapy
224902|NCT02004756|pediatric|pediatric
224903|NCT02004756|fontan|fontan
224904|NCT02004756|congenital heart disease|congenital heart disease
224905|NCT02004756|cardiac and musculoskeletal funion|cardiac and musculoskeletal funion
224906|NCT02004756|cardiac and/or musculoskeletal metabolism|cardiac and/or musculoskeletal metabolism
224907|NCT02004756|exercise training intervention|exercise training intervention
224908|NCT02004743|Early Intervention|early intervention
224909|NCT02004743|Prevention|prevention
224910|NCT02004743|Risk Factors|risk factors
224911|NCT02004743|Exposure Therapy|exposure therapy
224912|NCT02004743|Psychoeducation|psychoeducation
224913|NCT02004717|advanced solid tumor|advanced solid tumor
224914|NCT02004717|Phase 1|phase 1
224915|NCT02004717|Oncology|oncology
224916|NCT02004652|Prucalopride|prucalopride
224917|NCT02004652|Gastrointestinal Diseases|gastrointestinal diseases
224918|NCT02004652|Postoperative ileus|postoperative ileus
224919|NCT02004652|Randomised trial|randomised trial
224920|NCT02004639|IMRT or HT with chemotherapy|imrt or ht with chemotherapy
224921|NCT02004626|Collagenase|collagenase
224922|NCT02004626|Phase III|phase iii
224923|NCT02004626|National|national
224924|NCT02004626|Noninferiority|noninferiority
224925|NCT02004626|Double-blind|double-blind
224926|NCT02004626|Multicenter|multicenter
224927|NCT02004626|Prospective.|prospective.
224928|NCT02004587|Hepatic impairment|hepatic impairment
224929|NCT02004587|Pharmacokinetics|pharmacokinetics
224930|NCT02004587|Pharmacodynamics|pharmacodynamics
224931|NCT02004587|Gemigliptin|gemigliptin
224932|NCT02004561|bariatric_surgery|bariatric_surgery
224933|NCT02004561|pediatric obesity|pediatric obesity
224934|NCT02004561|diabetes|diabetes
224935|NCT02004535|Hearing loss|hearing loss
224936|NCT02004535|Asymmetric hearing loss|asymmetric hearing loss
224937|NCT02004535|Cochlear implantation|cochlear implantation
224938|NCT02004522|Phase 3|phase 3
224939|NCT02004522|CLL/SLL|cll/sll
276356|NCT01770652|L1|l1
224940|NCT02004522|Pi3K|pi3k
224941|NCT02004509|atrial fibrillation|atrial fibrillation
224942|NCT02004509|stroke|stroke
224943|NCT02004509|pacemaker|pacemaker
224944|NCT02004509|anticoagulant|anticoagulant
224945|NCT02004483|percutaneous coronary intervention|percutaneous coronary intervention
224946|NCT02004483|ischemia|ischemia
224947|NCT02004483|strain|strain
224948|NCT02004483|coronary stenosis|coronary stenosis
224949|NCT02004470|post laparoscopic shoulder pain|post laparoscopic shoulder pain
224950|NCT02004470|active suction|active suction
224951|NCT02004470|lavage and suction|lavage and suction
224952|NCT02004470|right shoulder pain|right shoulder pain
224953|NCT02004470|post operative shoulder pain|post operative shoulder pain
224954|NCT02004457|HIV|hiv
224955|NCT02004457|Primary care|primary care
224956|NCT02004457|Engagement|engagement
224957|NCT02004457|Acceptance|acceptance
224962|NCT02004431|Chronic post surgical pain|chronic post surgical pain
224963|NCT02004431|Orthopaedic|orthopaedic
224964|NCT02004431|Anxiety|anxiety
224965|NCT02004431|depression|depression
224966|NCT02004418|C-Choline PET scans|c-choline pet scans
224967|NCT02004418|external beam radiotherapy|external beam radiotherapy
224968|NCT02004405|autonomic nervous system|autonomic nervous system
224969|NCT02004405|fibromyalgia|fibromyalgia
224970|NCT02004405|autonomic dysfunction|autonomic dysfunction
224971|NCT02004405|strengthening|strengthening
224972|NCT02004405|flexibility|flexibility
224973|NCT02004405|exercise|exercise
224974|NCT02004405|heart rate variability|heart rate variability
224975|NCT02004392|Alzheimer's disease|alzheimer's disease
224976|NCT02004392|Cognition|cognition
224977|NCT02004392|Alpha-7 nAChR|alpha-7 nachr
224978|NCT02004379|HCV|hcv
224979|NCT02004379|Hepatitis C|hepatitis c
224980|NCT02004379|telaprevir|telaprevir
224981|NCT02004379|boceprevir|boceprevir
224982|NCT02004379|clinical practice|clinical practice
224983|NCT02004366|Diabetes|diabetes
224984|NCT02004366|Linagliptin|linagliptin
224985|NCT02004366|hospital hyperglycemia|hospital hyperglycemia
224986|NCT02004366|inpatient diabetes|inpatient diabetes
224987|NCT02004353|Cochlear® Hearing Implants|cochlear® hearing implants
224988|NCT02004340|pediatric epilepsy|pediatric epilepsy
224989|NCT02004340|transcutaneous vagus nerve stimulation|transcutaneous vagus nerve stimulation
224990|NCT02004314|Chloroquine|chloroquine
224991|NCT02004314|T cell immune activation|t cell immune activation
224992|NCT02004314|CD4 recovery|cd4 recovery
224993|NCT02004314|HIV|hiv
224994|NCT02004301|Formulation behaviour|formulation behaviour
224995|NCT02004301|Drug absorption profile|drug absorption profile
224996|NCT02004288|Probiotics|probiotics
224997|NCT02004288|Anorexia nervosa|anorexia nervosa
224998|NCT02004288|Constipation|constipation
224999|NCT02004288|Body weight|body weight
225000|NCT02004262|cancer|cancer
225001|NCT02004262|cancer vaccine|cancer vaccine
225002|NCT02004262|Listeria monocytogenes|listeria monocytogenes
225003|NCT02004262|Listeria-based vaccine|listeria-based vaccine
225004|NCT02004262|GVAX|gvax
225005|NCT02004262|cyclophosphamide|cyclophosphamide
225006|NCT02004262|Cytoxan|cytoxan
225007|NCT02004262|immunotherapy|immunotherapy
225008|NCT02004262|mesothelin|mesothelin
225009|NCT02004236|tRNS|trns
225010|NCT02004236|QEEG|qeeg
225011|NCT02004236|ERP|erp
225012|NCT02004236|ASD|asd
225013|NCT02004236|Autism|autism
225014|NCT02004236|verbal fluency|verbal fluency
225015|NCT02004236|empathy|empathy
225016|NCT02004236|noninvasive brain stimulation|noninvasive brain stimulation
225017|NCT02004236|tDCS|tdcs
225018|NCT02004223|Prostate Cancer|prostate cancer
225019|NCT02004223|Dose escalation|dose escalation
225020|NCT02004223|Stereotactic|stereotactic
225021|NCT02004223|SBRT|sbrt
225022|NCT02004223|Hypofractionation|hypofractionation
225023|NCT02004210|transarterial chemoembolization|transarterial chemoembolization
225024|NCT02004210|transarterial radioembolization|transarterial radioembolization
225025|NCT02004210|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
225026|NCT02004184|Pemetrexed|pemetrexed
225027|NCT02004184|drug therapy|drug therapy
225028|NCT02004171|electronic cigarette|electronic cigarette
225029|NCT02004171|nicotine inhaler|nicotine inhaler
225030|NCT02004171|smoking cessation|smoking cessation
225031|NCT02004158|Acute coronary syndrome|acute coronary syndrome
225032|NCT02004158|Health behavior|health behavior
225033|NCT02004158|Mental health|mental health
225034|NCT02004145|MDD|mdd
225035|NCT02004145|Positive Psychology|positive psychology
225036|NCT02004145|Suicidality|suicidality
225037|NCT02004080|TBI|tbi
225038|NCT02004080|ICU|icu
225039|NCT02004080|Comparative Effectiveness Research|comparative effectiveness research
225040|NCT02004067|Evaporative|evaporative
225041|NCT02004067|Aqueous deficient|aqueous deficient
225042|NCT02004067|Dry eye disease|dry eye disease
225043|NCT02004054|multiple sclerosis|multiple sclerosis
225044|NCT02004054|diameter pupil|diameter pupil
225045|NCT02004041|pruritus|pruritus
225046|NCT02004041|atopic dermatitis|atopic dermatitis
225047|NCT02004041|VLY-686|vly-686
225048|NCT02004028|Mesothelioma|mesothelioma
225049|NCT02004028|adenoma|adenoma
225050|NCT02004028|Neoplasms, Mesothelial|neoplasms, mesothelial
225051|NCT02004028|Focal Adhesion Kinase Inhibitor|focal adhesion kinase inhibitor
225052|NCT02004015|Analytical|analytical
225053|NCT02004015|Diagnostic|diagnostic
225054|NCT02004015|Anesthesia|anesthesia
225055|NCT02004015|Analgesia|analgesia
225056|NCT02003976|knee osteoarthritis|knee osteoarthritis
225057|NCT02003976|high tibial osteotomy|high tibial osteotomy
225058|NCT02003976|gait analysis|gait analysis
225059|NCT02003976|muscular strength|muscular strength
225060|NCT02003976|body composition|body composition
225061|NCT02003976|magnetic resonance imaging|magnetic resonance imaging
225062|NCT02003976|biological markers|biological markers
225063|NCT02003963|Physical Activity|physical activity
225064|NCT02003963|Sedentary Behavior|sedentary behavior
225065|NCT02003963|Video Games|video games
225066|NCT02003963|Exergames|exergames
225067|NCT02003911|Asthma|asthma
225068|NCT02003911|Acute asthma exacerbation|acute asthma exacerbation
225069|NCT02003911|Pediatric|pediatric
225070|NCT02003911|Azithromycin|azithromycin
225071|NCT02003911|Macrolide|macrolide
225072|NCT02003911|Length of Stay|length of stay
225073|NCT02003911|Hospital Medicine|hospital medicine
225074|NCT02003898|Diabetes|diabetes
225075|NCT02003898|Insulin pump|insulin pump
225076|NCT02003898|Threshold Suspend|threshold suspend
225077|NCT02003885|Desflurane, mitral annular velocity, tissue Doppler imaging|desflurane, mitral annular velocity, tissue doppler imaging
225079|NCT02003859|Pediatrics|pediatrics
225080|NCT02003859|pCLE|pcle
225081|NCT02003833|Poly-L-lactic acid|poly-l-lactic acid
225082|NCT02003833|Sculptra Aesthetic|sculptra aesthetic
225083|NCT02003833|Skin Quality|skin quality
225084|NCT02003833|Wrinkles|wrinkles
225085|NCT02003833|Filler|filler
225086|NCT02003820|Autism|autism
225087|NCT02003820|Dental Caries|dental caries
225088|NCT02003820|Prevention|prevention
225089|NCT02003820|Oral Hygiene|oral hygiene
225090|NCT02003794|acute ischemic stroke|acute ischemic stroke
225091|NCT02003794|intravenous fluid|intravenous fluid
225092|NCT02003794|้hydration|้hydration
225093|NCT02003781|cardiovascular disease|cardiovascular disease
225094|NCT02003781|metabolic disease|metabolic disease
225095|NCT02003781|high risk|high risk
225096|NCT02003781|prospective cohort|prospective cohort
225097|NCT02003768|pneumoperitoneum|pneumoperitoneum
225098|NCT02003768|optic nerve sheath diameter|optic nerve sheath diameter
225099|NCT02003768|laparoscopy|laparoscopy
225100|NCT02003768|Patients|patients
225101|NCT02003768|general anesthesia|general anesthesia
225102|NCT02003768|diameter|diameter
225103|NCT02003755|Cerebral palsy|cerebral palsy
225104|NCT02003755|Continuous passive motion|continuous passive motion
225105|NCT02003755|Hypertonia|hypertonia
225106|NCT02003742|LUTS|luts
225107|NCT02003742|BPH|bph
225108|NCT02003729|obstructive sleep apnea|obstructive sleep apnea
225109|NCT02003729|Portable Monitor|portable monitor
225110|NCT02003729|AHI|ahi
225111|NCT02003729|ESS|ess
225112|NCT02003729|Cost effectiveness|cost effectiveness
225113|NCT02003703|Vaccine|vaccine
225114|NCT02003703|Primary Prevention|primary prevention
225115|NCT02003703|Immunogenicity|immunogenicity
225116|NCT02003690|Bipolar disorder|bipolar disorder
225117|NCT02003690|Adolescent suicidal behavior|adolescent suicidal behavior
225118|NCT02003690|Psychotherapy|psychotherapy
225119|NCT02003664|Cocaine|cocaine
225120|NCT02003664|Treatment|treatment
225121|NCT02003664|fMRI|fmri
225122|NCT02003664|Outcomes|outcomes
225123|NCT02003651|Common cold|common cold
225124|NCT02003625|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
225125|NCT02003625|Hodgkin's lymphoma|hodgkin's lymphoma
225126|NCT02003625|Multiple myeloma|multiple myeloma
225127|NCT02003625|Hematopoietic stem cells|hematopoietic stem cells
225128|NCT02003599|Radiodermatitis|radiodermatitis
225129|NCT02003599|Breast neoplasms|breast neoplasms
225130|NCT02003599|Laser Therapy, Low- Level|laser therapy, low- level
225131|NCT02003586|subjects|subjects
226126|NCT01999010|software|software
225132|NCT02003560|breast cancer|breast cancer
225133|NCT02003560|breast conserving therapy|breast conserving therapy
225134|NCT02003560|accelerated partial breast irradiation|accelerated partial breast irradiation
225135|NCT02003560|3D conformal radiotherapy|3d conformal radiotherapy
225136|NCT02003560|intensity modulated radiotherapy|intensity modulated radiotherapy
225137|NCT02003521|Lung Flute|lung flute
225138|NCT02003508|Prevalence|prevalence
225139|NCT02003508|HPV|hpv
225140|NCT02003508|Human papillomavirus|human papillomavirus
225141|NCT02003508|Vaccination|vaccination
225142|NCT02003495|Immunogenicity, Safety, Meningococcal Conjugate Vaccine|immunogenicity, safety, meningococcal conjugate vaccine
225143|NCT02003482|Head and Neck Cancer|head and neck cancer
225144|NCT02003482|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
225145|NCT02003482|Intensity modulated radiation therapy|intensity modulated radiation therapy
225146|NCT02003482|IMRT|imrt
225147|NCT02003482|Anatomic Changes|anatomic changes
225148|NCT02003482|Postoperative|postoperative
225149|NCT02003482|Unresectable|unresectable
225150|NCT02003469|hypertension|hypertension
225151|NCT02003469|kidney disease|kidney disease
225152|NCT02003469|cardiovascular disease|cardiovascular disease
225153|NCT02003456|positron emission tomography|positron emission tomography
225154|NCT02003456|rubidium|rubidium
225155|NCT02003456|myocardial perfusion imaging|myocardial perfusion imaging
225156|NCT02003456|viability|viability
225157|NCT02003456|FDG|fdg
225158|NCT02003443|Acupressure|acupressure
225159|NCT02003443|Older Adults|older adults
225160|NCT02003443|Knee pain|knee pain
225161|NCT02003443|Pain Treatment|pain treatment
225162|NCT02003430|gynecologic malignancy|gynecologic malignancy
225163|NCT02003430|non-ovarian gynecological cancer|non-ovarian gynecological cancer
225164|NCT02003430|cervical cancer|cervical cancer
225165|NCT02003430|vaginal cancer|vaginal cancer
225166|NCT02003430|vulvar cancer|vulvar cancer
225167|NCT02003430|endometrial cancer|endometrial cancer
225168|NCT02003417|Prostate cancer|prostate cancer
225169|NCT02003417|External beam radiation treatment|external beam radiation treatment
225170|NCT02003417|Androgen deprivation therapy|androgen deprivation therapy
225171|NCT02003417|Definitive treatment|definitive treatment
225172|NCT02003417|Cardiovascular risk factors|cardiovascular risk factors
225173|NCT02003417|Quality of life|quality of life
225174|NCT02003404|ostomy appliance|ostomy appliance
225175|NCT02003391|Open Angle Glaucoma|open angle glaucoma
225176|NCT02003391|Ocular Hypertension|ocular hypertension
225177|NCT02003391|Intraocular Pressure|intraocular pressure
225178|NCT02003378|Chronotropic incompetence|chronotropic incompetence
225179|NCT02003365|osteoarthritis|osteoarthritis
225180|NCT02003365|knee|knee
225181|NCT02003365|steroids|steroids
225182|NCT02003365|FX006|fx006
225183|NCT02003365|triamcinolone acetonide|triamcinolone acetonide
225184|NCT02003365|synovial fluid|synovial fluid
225185|NCT02003352|TBI|tbi
225186|NCT02003352|PTSD|ptsd
225187|NCT02003352|Functional Neurology|functional neurology
225188|NCT02003352|Vestibular Rehabilitation|vestibular rehabilitation
225189|NCT02003352|Dynamic Computerized Posturography|dynamic computerized posturography
225190|NCT02003352|Saccadometry|saccadometry
225191|NCT02003313|safety, immunogenicity, Meningococcal Polysaccharide Vaccine|safety, immunogenicity, meningococcal polysaccharide vaccine
225192|NCT02003300|Oxygen uptake|oxygen uptake
225193|NCT02003300|Anesthetic gas uptake|anesthetic gas uptake
225194|NCT02003287|Deglutition Disorders|deglutition disorders
225195|NCT02003287|Intensive Care Units, Neonatal|intensive care units, neonatal
225196|NCT02003274|Mixed Meal Test|mixed meal test
225197|NCT02003274|Insulin Pump|insulin pump
225326|NCT02002598|treanda|treanda
225198|NCT02003274|Continuous Glucose Monitoring|continuous glucose monitoring
225199|NCT02003274|Metabolic Control Analysis|metabolic control analysis
225200|NCT02003274|Closed Loop Control|closed loop control
225201|NCT02003274|Artificial Pancreas|artificial pancreas
225202|NCT02003248|Parkinson's disease|parkinson's disease
225203|NCT02003248|ultrasound|ultrasound
225204|NCT02003248|dyskinesia|dyskinesia
225205|NCT02003248|magnetic resonance|magnetic resonance
225206|NCT02003235|Amblyopia|amblyopia
225207|NCT02003196|Brain injury|brain injury
225208|NCT02003196|virus|virus
225209|NCT02003196|immunosuppression|immunosuppression
225210|NCT02003196|mechanical ventilation|mechanical ventilation
225211|NCT02003183|CTE|cte
225212|NCT02003183|TBI|tbi
225213|NCT02003183|Cognitive Impairment|cognitive impairment
225214|NCT02003183|Brain Imaging|brain imaging
225215|NCT02003183|PET|pet
225216|NCT02003170|Autism|autism
225217|NCT02003170|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
225218|NCT02003170|Pervasive Developmental Disorder (PDD)|pervasive developmental disorder (pdd)
225219|NCT02003170|Developmental delays|developmental delays
225220|NCT02003170|Genetic disorder|genetic disorder
225221|NCT02003170|Mitochondrial disorder|mitochondrial disorder
225222|NCT02003157|hypnosis embryo transfer IVF ICSI|hypnosis embryo transfer ivf icsi
225223|NCT02003144|Long-term safety study|long-term safety study
225224|NCT02003144|Extension trial|extension trial
225225|NCT02003144|Eculizumab|eculizumab
226317|NCT01998165|Ultiva|ultiva
225226|NCT02003144|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
225227|NCT02003144|Devic's disease|devic's disease
225228|NCT02003144|Transverse Myelitis|transverse myelitis
225229|NCT02003144|Optic Neuritis|optic neuritis
225230|NCT02003144|Relapse|relapse
225231|NCT02003144|NMO-IgG|nmo-igg
225232|NCT02003144|CNS Autoimmune Disorders|cns autoimmune disorders
225233|NCT02003144|Demyelinating Disorders|demyelinating disorders
225234|NCT02003131|osteoarthritis|osteoarthritis
225235|NCT02003131|umbilical cord|umbilical cord
225236|NCT02003131|mesenchymal|mesenchymal
225237|NCT02003131|stem cells|stem cells
225238|NCT02003131|trophic factors|trophic factors
225239|NCT02003092|solid tumor|solid tumor
225240|NCT02003092|Rexahn|rexahn
225241|NCT02003092|Phase 1|phase 1
225242|NCT02003066|Fluid Therapy|fluid therapy
215988|NCT02045238|Bronchiolitis|bronchiolitis
215989|NCT02045238|Therapeutics|therapeutics
215990|NCT02045238|Saline Solution, Hypertonic|saline solution, hypertonic
215991|NCT02045225|social anxiety in sexual situations|social anxiety in sexual situations
215992|NCT02045212|Ischemic Optic Neuropathy|ischemic optic neuropathy
216065|NCT02044822|CLL|cll
225243|NCT02003066|Head and Neck Neoplasms|head and neck neoplasms
225244|NCT02003066|Surgical Flaps|surgical flaps
225245|NCT02003053|Critically ill|critically ill
225246|NCT02003053|intubated|intubated
225247|NCT02003053|safety|safety
225248|NCT02003053|feasibility|feasibility
225249|NCT02003053|inspiratory muscle training|inspiratory muscle training
225250|NCT02003014|Drug Therapy|drug therapy
225251|NCT02002975|Drug Therapy|drug therapy
225252|NCT02002949|Hemodialysis|hemodialysis
225253|NCT02002910|iFR|ifr
225254|NCT02002910|FFR|ffr
225255|NCT02002910|Medical Economy|medical economy
225256|NCT02002910|physiological assessment|physiological assessment
225257|NCT02002910|SYNTAX score|syntax score
225258|NCT02002897|Localized scleroderma UVA1 fractional carbon dioxide laser|localized scleroderma uva1 fractional carbon dioxide laser
225259|NCT02002884|Upper limb spasticity|upper limb spasticity
225260|NCT02002884|lower limb spasticity|lower limb spasticity
225261|NCT02002884|combined upper and lower limb spasticity|combined upper and lower limb spasticity
225262|NCT02002858|smoking|smoking
225263|NCT02002858|cessation|cessation
225264|NCT02002858|anxiety|anxiety
225265|NCT02002858|anxious|anxious
225266|NCT02002858|depression|depression
225267|NCT02002858|depressed|depressed
225268|NCT02002858|smoker|smoker
225269|NCT02002858|stress|stress
225270|NCT02002845|Tongue base resection, partial glossectomy|tongue base resection, partial glossectomy
225271|NCT02002819|Alzheimer's disease|alzheimer's disease
225273|NCT02002819|Early-onset AD|early-onset ad
225274|NCT02002819|EOAD|eoad
225275|NCT02002819|Early-onset Alzheimer's|early-onset alzheimer's
225276|NCT02002819|Early-onset Alzheimer's disease|early-onset alzheimer's disease
225277|NCT02002806|Pancreatic cancer|pancreatic cancer
225278|NCT02002806|Pain|pain
225279|NCT02002793|pancreatitis|pancreatitis
225280|NCT02002793|early stage|early stage
225281|NCT02002793|mini-invasive abdominal drainage|mini-invasive abdominal drainage
225282|NCT02002780|pediatrics|pediatrics
225283|NCT02002780|stress|stress
225284|NCT02002780|cardiac surgery|cardiac surgery
225285|NCT02002754|eosinophilic bronchitis|eosinophilic bronchitis
225286|NCT02002754|cough variant asthma|cough variant asthma
225287|NCT02002754|bronchodilator|bronchodilator
225288|NCT02002741|patent ductus arteriosus|patent ductus arteriosus
225289|NCT02002741|PDA|pda
225290|NCT02002741|Preterm|preterm
225291|NCT02002741|Infant|infant
225292|NCT02002741|Electrocardiography|electrocardiography
225293|NCT02002741|Paracetamol|paracetamol
225294|NCT02002741|Acamol|acamol
225295|NCT02002741|ibuprofen|ibuprofen
225296|NCT02002741|Placebo|placebo
225297|NCT02002715|eosinophilic bronchitis|eosinophilic bronchitis
225298|NCT02002715|inhaled corticosteroids|inhaled corticosteroids
225299|NCT02002715|therapeutic effect|therapeutic effect
225300|NCT02002702|Acute heart failure (AHF),|acute heart failure (ahf),
225301|NCT02002702|Japanese,|japanese,
225302|NCT02002702|Safety and tolerability, Pharmacokinetics,|safety and tolerability, pharmacokinetics,
225303|NCT02002702|Renal Impairment|renal impairment
225304|NCT02002689|Solid tumor malignancy,|solid tumor malignancy,
225305|NCT02002689|hematologic malignancy,|hematologic malignancy,
225306|NCT02002689|mutation, translocations,|mutation, translocations,
225307|NCT02002689|signature,|signature,
225308|NCT02002689|PTCH1,|ptch1,
225309|NCT02002689|SMO,|smo,
225310|NCT02002689|LDE225,|lde225,
225311|NCT02002689|endometrial cancer,|endometrial cancer,
225312|NCT02002689|colon cancer,|colon cancer,
225313|NCT02002689|bladder,|bladder,
225314|NCT02002689|NSCLC|nsclc
225315|NCT02002676|rest energy expenditure,critical ill, outcome|rest energy expenditure,critical ill, outcome
225316|NCT02002650|Indomethacin, pancreatitis, ERCP|indomethacin, pancreatitis, ercp
225317|NCT02002611|Lobeglitazone|lobeglitazone
225318|NCT02002611|Warfarin|warfarin
225319|NCT02002611|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
225320|NCT02002611|Drug-Drug interaction|drug-drug interaction
225321|NCT02002611|Phase 1|phase 1
225322|NCT02002598|Newly diagnosed|newly diagnosed
225323|NCT02002598|multiple myeloma|multiple myeloma
225324|NCT02002598|myeloma|myeloma
225325|NCT02002598|bendamustine|bendamustine
225327|NCT02002598|carfilzomib|carfilzomib
225328|NCT02002598|dexamethasone|dexamethasone
225329|NCT02002598|phase I|phase i
225330|NCT02002598|phase II|phase ii
225331|NCT02002598|dose escalation|dose escalation
225332|NCT02002598|transplant|transplant
225333|NCT02002598|non-transplant, plasma cells|non-transplant, plasma cells
225334|NCT02002585|Renal protection|renal protection
225335|NCT02002585|Renal sympathetic denervation|renal sympathetic denervation
225336|NCT02002572|Facial Mimic Muscle|facial mimic muscle
225337|NCT02002572|MRI|mri
225338|NCT02002572|Segmentation|segmentation
225339|NCT02002572|Three dimensional assessment|three dimensional assessment
225340|NCT02002572|Motion capture|motion capture
225341|NCT02002572|Movement analysis|movement analysis
225342|NCT02002572|Digital Image Correlation|digital image correlation
225343|NCT02002546|Heart Attack|heart attack
225344|NCT02002546|Myocardial Infarction|myocardial infarction
225345|NCT02002546|Angina|angina
225346|NCT02002546|Chest Pain|chest pain
225347|NCT02002520|Acute pain|acute pain
225348|NCT02002520|Epigenetic|epigenetic
225349|NCT02002520|Dental pain|dental pain
225350|NCT02002468|Risk Communication|risk communication
225351|NCT02002468|Follow-up|follow-up
225352|NCT02002468|Organisation of screening|organisation of screening
225354|NCT02002455|PET/CT|pet/ct
225355|NCT02002455|PET/MRI|pet/mri
225356|NCT02002455|Radical prostatectomy|radical prostatectomy
225357|NCT02002455|Radiotherapy|radiotherapy
225358|NCT02002442|Mouthwash|mouthwash
225359|NCT02002442|Chlorhexidine|chlorhexidine
225360|NCT02002442|cetylpyridinium chloride|cetylpyridinium chloride
225361|NCT02002442|Saline|saline
225362|NCT02002442|Implants|implants
225363|NCT02002442|Saliva Collection|saliva collection
225364|NCT02002429|Facet joint|facet joint
225365|NCT02002429|Medial branch block|medial branch block
225366|NCT02002429|Radiofrequency denervation|radiofrequency denervation
225367|NCT02002429|Zygapophysial joint|zygapophysial joint
225368|NCT02002429|Low back pain|low back pain
225461|NCT02002000|Vitamin D deficiency|vitamin d deficiency
225369|NCT02002416|C-met expression, gastric cancer, overall survival|c-met expression, gastric cancer, overall survival
225370|NCT02002403|Edema|edema
225371|NCT02002403|Macular Edema|macular edema
225372|NCT02002403|Retinal Diseases|retinal diseases
225373|NCT02002403|Eye Diseases|eye diseases
225374|NCT02002403|Danazol|danazol
225375|NCT02002403|Estrogen Antagonists|estrogen antagonists
225376|NCT02002403|Estrogen Receptor Modulators|estrogen receptor modulators
225377|NCT02002403|Hormone Antagonists|hormone antagonists
225378|NCT02002403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
225379|NCT02002403|Physiological Effects of Drugs|physiological effects of drugs
225380|NCT02002403|Pharmacologic Actions|pharmacologic actions
225381|NCT02002390|Stroke,Fingolimod(FTY 720), treatment|stroke,fingolimod(fty 720), treatment
225382|NCT02002377|Age Related Macular Degeneration, wet|age related macular degeneration, wet
225383|NCT02002377|aflibercept|aflibercept
225384|NCT02002364|tracheal intubation|tracheal intubation
225385|NCT02002338|pterygium surgery|pterygium surgery
225386|NCT02002338|refractive changes|refractive changes
225387|NCT02002338|surgical technique|surgical technique
225388|NCT02002312|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
225389|NCT02002312|Clear Cell Renal Cell Carcinoma (ccRCC)|clear cell renal cell carcinoma (ccrcc)
225390|NCT02002312|Lutetium-177|lutetium-177
225391|NCT02002312|Lu-177|lu-177
225392|NCT02002312|girentuximab|girentuximab
225393|NCT02002312|cG250|cg250
225394|NCT02002312|Monoclonal Antibody|monoclonal antibody
225395|NCT02002299|colorectal cancer|colorectal cancer
225396|NCT02002299|surface|surface
225397|NCT02002299|invasive front|invasive front
225398|NCT02002299|tumor budding|tumor budding
225399|NCT02002286|HIV-infected immunological non-responders|hiv-infected immunological non-responders
225400|NCT02002286|Tripterygium Wilfordii Hook F|tripterygium wilfordii hook f
225401|NCT02002286|Immune activation|immune activation
225402|NCT02002247|antioxidants|antioxidants
225403|NCT02002247|selenium|selenium
225404|NCT02002247|heart disease|heart disease
225405|NCT02002247|cardiac surgery|cardiac surgery
225406|NCT02002247|perioperative|perioperative
225407|NCT02002234|Hemicraniectomy, stroke, decompressive surgery, HeMMI|hemicraniectomy, stroke, decompressive surgery, hemmi
225408|NCT02002221|Diabetes Mellitus (DM) ,|diabetes mellitus (dm) ,
225409|NCT02002221|diabetes,|diabetes,
225410|NCT02002221|noninsulin-dependent diabetes mellitus (NIDDM),|noninsulin-dependent diabetes mellitus (niddm),
225411|NCT02002221|adult-onset diabetes,|adult-onset diabetes,
225412|NCT02002221|high blood sugar,|high blood sugar,
225413|NCT02002221|T2DM|t2dm
225414|NCT02002195|metastatic gastric cancer,|metastatic gastric cancer,
225415|NCT02002195|elderly,|elderly,
225416|NCT02002195|folinic acid,|folinic acid,
225417|NCT02002195|fluorouracil,|fluorouracil,
225418|NCT02002195|oxaliplatin,|oxaliplatin,
225419|NCT02002195|capecitabine,|capecitabine,
225420|NCT02002195|overall survival,|overall survival,
225421|NCT02002195|progression free survival|progression free survival
225422|NCT02002182|HPV|hpv
225423|NCT02002182|0ropharynx|0ropharynx
225424|NCT02002182|squamous cell carcinoma|squamous cell carcinoma
225425|NCT02002182|head and neck cancer|head and neck cancer
225426|NCT02002182|transoral robotic surgery|transoral robotic surgery
225427|NCT02002169|Catheter Related Bacteremia|catheter related bacteremia
225428|NCT02002143|Diabetes|diabetes
225429|NCT02002143|Older People|older people
225430|NCT02002143|Seniors|seniors
225431|NCT02002143|Group Appointments|group appointments
225432|NCT02002143|Group Medical Visits|group medical visits
225433|NCT02002143|Shared Appointments|shared appointments
225434|NCT02002143|Quality of Life|quality of life
225435|NCT02002143|Physical Activity|physical activity
225436|NCT02002143|Health care Utilization|health care utilization
225437|NCT02002143|Depression|depression
225438|NCT02002143|Anxiety|anxiety
225439|NCT02002130|Diabetes|diabetes
225440|NCT02002104|Expanded polytetrafluoroethylene( ePTFE)|expanded polytetrafluoroethylene( eptfe)
225441|NCT02002091|Type2 diabetes mellitus|type2 diabetes mellitus
225442|NCT02002091|Microangiopathy|microangiopathy
225443|NCT02002091|Chronic Kidney disease|chronic kidney disease
225444|NCT02002091|Cardiovascular disease|cardiovascular disease
225445|NCT02002078|caustic|caustic
225446|NCT02002078|corticosteroid therapy|corticosteroid therapy
225447|NCT02002078|stricture|stricture
225448|NCT02002078|children|children
225449|NCT02002065|hepatitis A|hepatitis a
225450|NCT02002065|inactivated hepatitis A vaccine|inactivated hepatitis a vaccine
225451|NCT02002065|attenuated alive hepatitis A vaccine|attenuated alive hepatitis a vaccine
225452|NCT02002065|immune persistence|immune persistence
225453|NCT02002052|non-small cell lung cancer, radiotherapy, chemotherapy, pneumonitis, functional lung avoidance|non-small cell lung cancer, radiotherapy, chemotherapy, pneumonitis, functional lung avoidance
225454|NCT02002039|Perinatal asphyxia|perinatal asphyxia
225455|NCT02002039|erythropoietin|erythropoietin
225456|NCT02002026|placenta previa, uterine artery ligation|placenta previa, uterine artery ligation
225457|NCT02002013|Adult|adult
225458|NCT02002013|ICU patient|icu patient
225459|NCT02002013|Fluid resuscitation|fluid resuscitation
225460|NCT02002013|observational study|observational study
225462|NCT02002000|Musculoskeletal pain|musculoskeletal pain
225463|NCT02002000|Vitamin D supplementation|vitamin d supplementation
225464|NCT02001974|HER 2 negative|her 2 negative
225465|NCT02001974|metastatic breast cancer|metastatic breast cancer
225466|NCT02001974|Cancer Stem Cells|cancer stem cells
225467|NCT02001961|Fibrosis|fibrosis
225468|NCT02001961|collagen metabolism|collagen metabolism
225469|NCT02001961|paediatric, dilated cardiomyopathy|paediatric, dilated cardiomyopathy
225470|NCT02001961|biomarkers|biomarkers
225471|NCT02001961|T1 mapping|t1 mapping
225473|NCT02001948|Spinal anaesthesia|spinal anaesthesia
225474|NCT02001948|morphine|morphine
225475|NCT02001948|postoperative analgesia|postoperative analgesia
225476|NCT02001948|vomiting|vomiting
225477|NCT02001935|COPD|copd
225478|NCT02001935|theophylline|theophylline
225479|NCT02001935|CYP1A2|cyp1a2
225480|NCT02001935|CYP2E1|cyp2e1
225481|NCT02001922|COPD|copd
225482|NCT02001922|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
225483|NCT02001922|Integrated care|integrated care
225484|NCT02001922|Outcome and process assessment|outcome and process assessment
225485|NCT02001922|Quality indicators, Health care|quality indicators, health care
225486|NCT02001922|Self-management,|self-management,
225487|NCT02001922|Patient empowerment|patient empowerment
225488|NCT02001922|Quantitative and qualitative methods|quantitative and qualitative methods
225489|NCT02001909|Regorafenib|regorafenib
225490|NCT02001909|Neomycin|neomycin
225491|NCT02001909|Cancer|cancer
225492|NCT02001909|Pharmacokinetics|pharmacokinetics
225493|NCT02001909|Safety|safety
225494|NCT02001896|NSCLC|nsclc
225495|NCT02001896|EGFR-TKI|egfr-tki
225496|NCT02001883|Coronary artery disease, nutraceuticals, statins|coronary artery disease, nutraceuticals, statins
225497|NCT02001870|Infertility|infertility
225498|NCT02001870|female age|female age
225499|NCT02001870|intra-uterine insemination|intra-uterine insemination
225500|NCT02001870|in vitro fecundation|in vitro fecundation
225501|NCT02001870|assisted reproductive technology center|assisted reproductive technology center
225502|NCT02001857|patients,|patients,
225503|NCT02001857|undergoing|undergoing
225504|NCT02001857|pelvic|pelvic
225505|NCT02001857|lymph|lymph
225506|NCT02001857|node|node
225507|NCT02001857|dissection.|dissection.
225508|NCT02001831|Sarcopenia|sarcopenia
225509|NCT02001831|Frailty|frailty
225510|NCT02001831|Aging|aging
225511|NCT02001831|Skeletal muscle|skeletal muscle
225512|NCT02001831|Nutrition|nutrition
225513|NCT02001792|sedation|sedation
225514|NCT02001792|endoscopy|endoscopy
225515|NCT02001792|patient positioning|patient positioning
225516|NCT02001792|hypoxemia|hypoxemia
225517|NCT02001779|Malignant biliary obstruction|malignant biliary obstruction
225518|NCT02001779|Obstruction/stricture|obstruction/stricture
225519|NCT02001779|Stent|stent
225520|NCT02001779|Brachytherapy|brachytherapy
225521|NCT02001779|Bile duct|bile duct
225522|NCT02001766|High intensity exercise|high intensity exercise
225523|NCT02001766|Glycemic control|glycemic control
225524|NCT02001766|Exercise|exercise
225525|NCT02001740|shoulder|shoulder
225526|NCT02001701|vitreomacular adhesion|vitreomacular adhesion
225527|NCT02001701|vitreomacular traction|vitreomacular traction
225528|NCT02001701|macular hole|macular hole
225529|NCT02001701|epiretinal membrane|epiretinal membrane
225530|NCT02001701|intravitreal gas|intravitreal gas
225531|NCT02001701|sulfahexafluoride gas|sulfahexafluoride gas
225532|NCT02001701|perfluoropropane gas|perfluoropropane gas
225533|NCT02001701|ocriplasmin|ocriplasmin
225534|NCT02001701|vitrectomy|vitrectomy
225535|NCT02001675|Neuromuscular electrical stimulation (NMES)|neuromuscular electrical stimulation (nmes)
225536|NCT02001662|Minor arthroscopic knee surgery including ACL-reconstruction (hamstrins graft)|minor arthroscopic knee surgery including acl-reconstruction (hamstrins graft)
225537|NCT02001662|High pain responders|high pain responders
225538|NCT02001662|Adductore Canal Block|adductore canal block
225539|NCT02001662|Analgesics|analgesics
751899|NCT01171131|TBI|tbi
225540|NCT02001662|Ultrasound guided nerve block|ultrasound guided nerve block
225541|NCT02001649|suicide|suicide
225542|NCT02001649|adolescent|adolescent
225543|NCT02001649|genetic|genetic
225545|NCT02001636|Bariatric surgery|bariatric surgery
225546|NCT02001636|Protein malnutrition|protein malnutrition
225547|NCT02001636|Protein supplementation|protein supplementation
225548|NCT02001636|Body composition|body composition
225549|NCT02001636|Body fat mass|body fat mass
225550|NCT02001636|Protein intake|protein intake
225551|NCT02001623|ovary cancer|ovary cancer
225552|NCT02001623|cervix cancer|cervix cancer
225553|NCT02001623|endometrium cancer|endometrium cancer
225554|NCT02001623|bladder cancer|bladder cancer
225555|NCT02001623|prostate cancer (CRPC)|prostate cancer (crpc)
225556|NCT02001623|esophagus cancer|esophagus cancer
225557|NCT02001623|lung cancer(NSCLC)|lung cancer(nsclc)
225558|NCT02001623|Squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
225559|NCT02001610|microbiota|microbiota
225560|NCT02001610|probiotics|probiotics
225561|NCT02001610|fecal markers|fecal markers
225563|NCT02001597|robotic|robotic
225564|NCT02001597|ultrasound|ultrasound
225565|NCT02001597|guidance|guidance
225566|NCT02001597|endorectal|endorectal
225567|NCT02001571|Prostate Cancer|prostate cancer
225568|NCT02001571|Abiraterone acetate|abiraterone acetate
225569|NCT02001571|Pharmacokinetics|pharmacokinetics
225570|NCT02001558|Spinal cord injuries|spinal cord injuries
225571|NCT02001558|Pressure ulcer|pressure ulcer
225572|NCT02001545|acute coronary syndrome, antithrombotic management patterns,quality of life, acute clinical management strategies|acute coronary syndrome, antithrombotic management patterns,quality of life, acute clinical management strategies
225573|NCT02001532|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
225574|NCT02001532|Diabetes Complications|diabetes complications
225575|NCT02001532|Diabetic Angiopathies|diabetic angiopathies
225576|NCT02001532|Diabetic Nephropathies|diabetic nephropathies
225577|NCT02001532|Myocardial Infarction|myocardial infarction
225578|NCT02001532|Stroke|stroke
225579|NCT02001532|Vascular Stiffness|vascular stiffness
225580|NCT02001532|Pulse Wave Analysis|pulse wave analysis
225581|NCT02001506|breast cancer|breast cancer
225582|NCT02001506|neoadjuvant|neoadjuvant
225583|NCT02001506|different number of chemotherapy cycles|different number of chemotherapy cycles
225584|NCT02001441|Physical Activity, Aging, Memory, Cognitive Impairment, MRI, Neuroscience|physical activity, aging, memory, cognitive impairment, mri, neuroscience
225585|NCT02001428|malaria|malaria
225586|NCT02001428|vivax|vivax
225587|NCT02001428|falciparum|falciparum
225588|NCT02001428|infants|infants
225589|NCT02001415|Progressive Myopia|progressive myopia
225590|NCT02001415|Contact Lenses|contact lenses
225591|NCT02001415|Spectacles|spectacles
225592|NCT02001402|climacteric symptoms ; nurse ;|climacteric symptoms ; nurse ;
225593|NCT02001402|intervention;follow-up|intervention;follow-up
225594|NCT02001389|Enzyme occupancy|enzyme occupancy
225595|NCT02001389|Positron emission tomography (PET)|positron emission tomography (pet)
225596|NCT02001389|Phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
225597|NCT02001363|Reperfusion injury|reperfusion injury
225598|NCT02001363|Liraglutide|liraglutide
225599|NCT02001337|pancreatic cancer|pancreatic cancer
225600|NCT02001337|new-onset diabetic|new-onset diabetic
225601|NCT02001337|diabetes|diabetes
225602|NCT02001324|quality of life, heavy menstrual bleeding, electronic data collection|quality of life, heavy menstrual bleeding, electronic data collection
225603|NCT02001311|chlorhexidine gel|chlorhexidine gel
225604|NCT02001311|orthodontic brackets|orthodontic brackets
225605|NCT02001311|orthodontic patients|orthodontic patients
225606|NCT02001311|bacterial count|bacterial count
225607|NCT02001311|friction|friction
225608|NCT02001298|remifentanil|remifentanil
225609|NCT02001298|nitroprusside|nitroprusside
225610|NCT02001298|hypotension|hypotension
225611|NCT02001285|remifentanil|remifentanil
225612|NCT02001272|Elderly|elderly
225613|NCT02001272|Vulnerable|vulnerable
225614|NCT02001272|Ovarian cancer|ovarian cancer
225615|NCT02001272|Chemotherapy|chemotherapy
226659|NCT01996813|beach chair|beach chair
225616|NCT02001259|post-operative pain control|post-operative pain control
225617|NCT02001259|total knee arthroplasty|total knee arthroplasty
277241|NCT01766895|HBV|hbv
216394|NCT02043418|HIV|hiv
225618|NCT02001259|epidural steroid injection|epidural steroid injection
225619|NCT02001246|mindfulness|mindfulness
225620|NCT02001246|cognitive behavior therapy|cognitive behavior therapy
225621|NCT02001246|awareness|awareness
225622|NCT02001246|anger|anger
225623|NCT02001246|aggression|aggression
225624|NCT02001233|EV71 vaccine|ev71 vaccine
225625|NCT02001233|EV71-associated HFMD|ev71-associated hfmd
225626|NCT02001233|efficacy|efficacy
225627|NCT02001233|safety|safety
225628|NCT02001233|immune persistence|immune persistence
225629|NCT02001220|screening|screening
225630|NCT02001220|invasive ventilation|invasive ventilation
225631|NCT02001220|mechanical ventilation|mechanical ventilation
225632|NCT02001220|weaning|weaning
225633|NCT02001220|spontaneous breathing trials|spontaneous breathing trials
225634|NCT02001194|Sedentary|sedentary
225635|NCT02001194|Behavioral Economic Intervention|behavioral economic intervention
225637|NCT02001194|Financial Incentives|financial incentives
225638|NCT02001194|Workplace Wellness|workplace wellness
225639|NCT02001194|Team Incentives|team incentives
225640|NCT02001181|Atopic Dermatitis|atopic dermatitis
225641|NCT02001181|Atopic Eczema|atopic eczema
225642|NCT02001181|Eczema|eczema
225643|NCT02001181|topical treatment|topical treatment
225644|NCT02001181|skin diseases|skin diseases
225645|NCT02001181|tofacitinib|tofacitinib
225646|NCT02001181|CP-690|cp-690
225647|NCT02001181|550|550
225648|NCT02001181|Janus Kinase inhibitor|janus kinase inhibitor
225649|NCT02001155|Water drinking test|water drinking test
225650|NCT02001155|trabeculectomy|trabeculectomy
225651|NCT02001155|tube shunt|tube shunt
225652|NCT02001142|Insulin Sensitivity|insulin sensitivity
225653|NCT02001142|Exercise|exercise
225654|NCT02001142|Metabolism|metabolism
225655|NCT02001129|Eye care adherence|eye care adherence
225656|NCT02001129|health care utilization|health care utilization
225657|NCT02001116|Quality of care|quality of care
225658|NCT02001116|Hospital|hospital
225659|NCT02001116|Children|children
225660|NCT02001116|WHO guideline|who guideline
225661|NCT02001103|adjuvant therapy|adjuvant therapy
225662|NCT02001103|cognitive deficits|cognitive deficits
225663|NCT02001103|first episode schizophrenia|first episode schizophrenia
225664|NCT02001103|glutamate hypothesis|glutamate hypothesis
225665|NCT02001103|memantine|memantine
225666|NCT02001103|negative symptoms|negative symptoms
225667|NCT02001090|Cardiac Surgical Procedures|cardiac surgical procedures
225668|NCT02001090|Heart-Lung Machine|heart-lung machine
225669|NCT02001090|Coronary Artery Bypass|coronary artery bypass
225670|NCT02001090|Brachial Artery|brachial artery
225671|NCT02001090|Vasodilation|vasodilation
225672|NCT02001090|Regional Blood Flow|regional blood flow
225673|NCT02001090|Ultrasonography|ultrasonography
225674|NCT02001064|interventions|interventions
225675|NCT02001064|technology|technology
225676|NCT02001064|adherence|adherence
225677|NCT02001064|ARV|arv
225678|NCT02001051|Diabetes, Hypertension, Hypercholesterolemia, Obesity, and Osteoporosis.|diabetes, hypertension, hypercholesterolemia, obesity, and osteoporosis.
225679|NCT02001051|Nonoperative and Operative Management|nonoperative and operative management
225680|NCT02001051|Adrenal Incidentalomas|adrenal incidentalomas
225681|NCT02001051|Excess of Cortisol|excess of cortisol
225682|NCT02001025|coronary vessels|coronary vessels
225683|NCT02001025|coronary stenosis|coronary stenosis
225684|NCT02001025|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
225685|NCT02001025|stents|stents
225686|NCT02001025|drug-eluting stents|drug-eluting stents
225687|NCT02001025|bioresorbable scaffolds|bioresorbable scaffolds
225688|NCT02001025|optical coherence tomography|optical coherence tomography
225689|NCT02001012|uncomplicated|uncomplicated
225690|NCT02001012|plasmodium|plasmodium
225691|NCT02001012|knowlesi|knowlesi
225692|NCT02001012|malaria|malaria
225693|NCT02001012|infection|infection
225694|NCT02000999|Bile duct stricture|bile duct stricture
225695|NCT02000999|Cholangiocarcinoma|cholangiocarcinoma
225696|NCT02000999|Pancreatic cancer|pancreatic cancer
225697|NCT02000999|Chronic pancreatitis|chronic pancreatitis
225698|NCT02000986|Hodgkin's Lymphoma|hodgkin's lymphoma
225699|NCT02000986|Brain and Nervous System|brain and nervous system
225700|NCT02000986|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
225701|NCT02000986|Leukemia, not otherwise specified|leukemia, not otherwise specified
225702|NCT02000960|Glut1 DS|glut1 ds
225703|NCT02000947|anti-CTLA-4|anti-ctla-4
225704|NCT02000947|anti-PD-L1|anti-pd-l1
225705|NCT02000947|immunotherapy|immunotherapy
225707|NCT02000934|TAK-659|tak-659
225708|NCT02000934|Solid Tumors|solid tumors
225709|NCT02000934|CLL|cll
225710|NCT02000934|DLBCL|dlbcl
225711|NCT02000921|Cigarette Smoking|cigarette smoking
225712|NCT02000921|Very Low Nicotine Content cigarettes (VLNC)|very low nicotine content cigarettes (vlnc)
225713|NCT02000921|Dual Tobacco Use|dual tobacco use
225714|NCT02000908|gynecological cancer|gynecological cancer
225715|NCT02000908|ovarian cancer|ovarian cancer
225716|NCT02000908|primary peritoneal cancer|primary peritoneal cancer
225717|NCT02000908|cervical caner|cervical caner
225718|NCT02000908|peripheral neuropathy|peripheral neuropathy
225719|NCT02000882|Breast Cancer|breast cancer
225720|NCT02000882|Triple Negative Breast Cancer|triple negative breast cancer
225721|NCT02000882|Brain Metastases|brain metastases
225722|NCT02000882|Capecitabine|capecitabine
225723|NCT02000882|Metastatic Breast Cancer|metastatic breast cancer
225724|NCT02000843|perforation|perforation
225725|NCT02000843|tympanoplasty|tympanoplasty
225726|NCT02000843|conchal cavum approach|conchal cavum approach
225727|NCT02000843|perichondrium/ cartilage|perichondrium/ cartilage
225728|NCT02000843|scar|scar
225729|NCT02000830|stannsoporfin|stannsoporfin
225730|NCT02000817|Beta Cell|beta cell
225731|NCT02000817|Monoclonal Antibody|monoclonal antibody
225732|NCT02000817|Otelixizumab|otelixizumab
225733|NCT02000817|Cytokine Release Syndrome|cytokine release syndrome
225734|NCT02000817|Epstein-Barr Virus|epstein-barr virus
225735|NCT02000817|Diabetes Mellitus|diabetes mellitus
402003|NCT01233570|Perianal crohns disease|perianal crohns disease
225736|NCT02000804|Darapladib, Safety, Pharmacokinetics, Pharmacodynamics, Healthy Chinese Subjects|darapladib, safety, pharmacokinetics, pharmacodynamics, healthy chinese subjects
225737|NCT02000791|cLMA|clma
225738|NCT02000791|laryngoscopy|laryngoscopy
225739|NCT02000791|fiberoptic|fiberoptic
225740|NCT02000778|Occult Ovarian Carcinoma|occult ovarian carcinoma
225741|NCT02000765|oral|oral
225742|NCT02000765|ADME|adme
225743|NCT02000765|IV|iv
225744|NCT02000765|antibiotic|antibiotic
225745|NCT02000765|healthy volunteer|healthy volunteer
225746|NCT02000765|[14C]-GSK2140944|[14c]-gsk2140944
225747|NCT02000765|mass balance|mass balance
225748|NCT02000765|radiolabel|radiolabel
225749|NCT02000752|Labor|labor
225750|NCT02000752|Acupuncture|acupuncture
225751|NCT02000752|Placental expulsion time|placental expulsion time
225752|NCT02000752|Postpartum hemorrhage|postpartum hemorrhage
225753|NCT02000739|Breast cancer|breast cancer
225754|NCT02000739|melanoma|melanoma
225755|NCT02000739|GI cancer|gi cancer
225756|NCT02000739|ovarian cancer|ovarian cancer
225757|NCT02000739|lung cancer|lung cancer
225758|NCT02000739|metastatic cancer|metastatic cancer
225759|NCT02000739|brain cancer|brain cancer
225760|NCT02000739|head and neck cancer|head and neck cancer
225761|NCT02000700|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
225762|NCT02000700|Canagliflozin|canagliflozin
225763|NCT02000700|JNJ-28431754|jnj-28431754
225764|NCT02000700|Pharmacokinetics|pharmacokinetics
225765|NCT02000700|Pharmacodynamics|pharmacodynamics
225766|NCT02000700|Children|children
225767|NCT02000700|Adolescents|adolescents
225768|NCT02000674|tracheal intubation|tracheal intubation
225769|NCT02000674|pre hospital emergency|pre hospital emergency
225770|NCT02000661|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
225771|NCT02000661|FFR guided coronary interventions|ffr guided coronary interventions
225772|NCT02000661|Percutaneous Coronary Intervention|percutaneous coronary intervention
225773|NCT02000648|Allergic Rhinitis|allergic rhinitis
225774|NCT02000648|Non-allergic Rhinitis|non-allergic rhinitis
225775|NCT02000648|Chronic urticaria|chronic urticaria
225776|NCT02000622|Breast Cancer|breast cancer
225777|NCT02000622|Metastatic|metastatic
225778|NCT02000622|Olaparib|olaparib
225779|NCT02000622|BRCA|brca
225780|NCT02000622|PARP inhibitor|parp inhibitor
225781|NCT02000622|HER2|her2
225782|NCT02000622|chemotherapy|chemotherapy
225783|NCT02000609|pharmacodynamics COPD|pharmacodynamics copd
225784|NCT02000596|HER2 overexpressed|her2 overexpressed
225785|NCT02000596|Metastatic Breast Cancer|metastatic breast cancer
225786|NCT02000596|Elderly|elderly
225787|NCT02000583|Alzheimer's Disease|alzheimer's disease
225788|NCT02000583|AD|ad
225789|NCT02000583|Aerobic Exercise|aerobic exercise
225790|NCT02000583|Exercise|exercise
225791|NCT02000570|sitting position|sitting position
225792|NCT02000570|PPV|ppv
225793|NCT02000570|SVV|svv
225794|NCT02000570|PVI|pvi
225795|NCT02000570|fluid challenge|fluid challenge
225796|NCT02000570|preload indicators|preload indicators
225797|NCT02000557|Photographic analysis|photographic analysis
225798|NCT02000557|Cephalometric analysis|cephalometric analysis
225799|NCT02000557|Standardized photographs|standardized photographs
225800|NCT02000557|Angular measurements|angular measurements
225801|NCT02000557|Linear measurements|linear measurements
225802|NCT02000557|Malocclusion|malocclusion
225803|NCT02000557|Facial Profile|facial profile
225804|NCT02000544|Extracorporeal Circulation|extracorporeal circulation
225805|NCT02000544|Cardiopulmonary Bypass|cardiopulmonary bypass
225806|NCT02000544|Cardiac surgery|cardiac surgery
225807|NCT02000531|Non-small-cell lung cancer (NSCLC)|non-small-cell lung cancer (nsclc)
225808|NCT02000518|emergency radiotherapy|emergency radiotherapy
225809|NCT02000518|MSCC|mscc
225810|NCT02000518|spine|spine
225811|NCT02000518|neurological outcome|neurological outcome
225812|NCT02000466|Women|women
225813|NCT02000466|Pregnancy exposure|pregnancy exposure
225814|NCT02000466|FluLaval Quadrivalent|flulaval quadrivalent
225815|NCT02000466|Pregnancy outcome|pregnancy outcome
225816|NCT02000466|Pregnancy Registry|pregnancy registry
225817|NCT02000453|Quality of Life|quality of life
225818|NCT02000453|Infection|infection
225819|NCT02000453|GSK2586184|gsk2586184
225820|NCT02000453|ulcerative colitis|ulcerative colitis
225821|NCT02000440|GW856553|gw856553
225822|NCT02000440|Focal segmental glomerulosclerosis (FSGS)|focal segmental glomerulosclerosis (fsgs)
225823|NCT02000440|p38 mitogen-activated protein kinase (MAPK) inhibitor|p38 mitogen-activated protein kinase (mapk) inhibitor
225824|NCT02000440|losmapimod|losmapimod
225825|NCT02000440|nephrotic syndrome|nephrotic syndrome
225826|NCT02000427|Relapsed; Refractory; Philadelphia Positive; B-precursor; Acute Lymphoblastic Leukemia; ALL; Blinatumomab; Leukemia;|relapsed; refractory; philadelphia positive; b-precursor; acute lymphoblastic leukemia; all; blinatumomab; leukemia;
225827|NCT02000414|intraperitoneal|intraperitoneal
225828|NCT02000414|peritoneal dialysis|peritoneal dialysis
225829|NCT02000414|daptomycin|daptomycin
225830|NCT02000414|pharmacokinetics|pharmacokinetics
225831|NCT02000414|peritonitis|peritonitis
225832|NCT02000375|metastatic breastcancer|metastatic breastcancer
225833|NCT02000375|ER/PgR-negative/AR-positive|er/pgr-negative/ar-positive
225834|NCT02000375|ER and/or PgR-positive/AR-positive|er and/or pgr-positive/ar-positive
225835|NCT02000375|Androgen Receptor positve|androgen receptor positve
225836|NCT02000362|Crohn's Disease|crohn's disease
225837|NCT02000362|Stem cell|stem cell
225838|NCT02000362|Cell therapy|cell therapy
225839|NCT02000362|Auto-immune disease|auto-immune disease
225840|NCT02000362|furestem|furestem
225842|NCT02000362|inflammatory bowel disease|inflammatory bowel disease
225843|NCT02000362|MSCs|mscs
225844|NCT02000362|Mesenchymal Stem Cells|mesenchymal stem cells
225845|NCT02000362|hUCB-MSC|hucb-msc
225846|NCT02000362|UCB-MSC|ucb-msc
225847|NCT02000362|Umbilical cord Blood|umbilical cord blood
225848|NCT02000349|infertility|infertility
225849|NCT02000349|next generation sequencing|next generation sequencing
225850|NCT02000336|radiographic damage|radiographic damage
225851|NCT02000336|rheumatoid arthritis|rheumatoid arthritis
225852|NCT02000323|pancreatitis|pancreatitis
225853|NCT02000323|enteral nutrition|enteral nutrition
225854|NCT02000310|Gaucher disease|gaucher disease
225951|NCT01999972|Carcinoma|carcinoma
225855|NCT02000310|Fabry disease|fabry disease
225856|NCT02000310|Pompe disease|pompe disease
225857|NCT02000310|Niemann-Pick disease|niemann-pick disease
225858|NCT02000297|Osteoarthritis|osteoarthritis
225860|NCT02000297|High tibial osteotomy|high tibial osteotomy
225861|NCT02000297|Calcium phosphate|calcium phosphate
225862|NCT02000297|Calcium sulfate|calcium sulfate
225863|NCT02000284|Autism Spectrum Disorder|autism spectrum disorder
225864|NCT02000284|ASD|asd
225865|NCT02000284|Autism|autism
225866|NCT02000284|Pervasive developmental disorder - Not Otherwise Specified|pervasive developmental disorder - not otherwise specified
225867|NCT02000284|PDD-NOS|pdd-nos
225868|NCT02000284|Asperger's Syndrome|asperger's syndrome
225869|NCT02000284|Mitochondrial Disease|mitochondrial disease
225870|NCT02000284|Developmental Delay|developmental delay
225871|NCT02000284|Typical Development|typical development
225872|NCT02000258|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
225873|NCT02000258|Double-bundle|double-bundle
225874|NCT02000258|MRI|mri
225875|NCT02000258|Graft location|graft location
225876|NCT02000245|bronchoscopy|bronchoscopy
225877|NCT02000245|anxiety|anxiety
225878|NCT02000245|touch|touch
225879|NCT02000245|sympathy|sympathy
225880|NCT02000232|gout|gout
225881|NCT02000232|colchicine|colchicine
225882|NCT02000219|hyperoxaluria|hyperoxaluria
225883|NCT02000219|oxalate|oxalate
225884|NCT02000219|PH|ph
225885|NCT02000219|dialysis|dialysis
225886|NCT02000206|Ketamine|ketamine
225887|NCT02000206|Alfentanil|alfentanil
225888|NCT02000206|Propofol|propofol
225889|NCT02000206|Oxygen saturation|oxygen saturation
225890|NCT02000206|Percutaneous carbon dioxide|percutaneous carbon dioxide
225891|NCT02000206|Bronchoscopy|bronchoscopy
225892|NCT02000167|Electron Transport Chain|electron transport chain
225893|NCT02000167|Mitochondrial Disease|mitochondrial disease
225894|NCT02000167|Chromosomal Deletion|chromosomal deletion
225895|NCT02000128|Peritoneal Dialysis|peritoneal dialysis
225896|NCT02000128|fluid overload|fluid overload
225897|NCT02000128|bioimpedance analysis|bioimpedance analysis
225898|NCT02000128|Randomized Controlled Trial|randomized controlled trial
225899|NCT02000089|familial pancreas cancer|familial pancreas cancer
225900|NCT02000089|(Peutz-Jeghers Syndrome) PJS|(peutz-jeghers syndrome) pjs
225901|NCT02000089|Breast cancer (BRCA) 2|breast cancer (brca) 2
225902|NCT02000089|Partner and Locator of BRCA2 (PALB2)|partner and locator of brca2 (palb2)
225903|NCT02000089|Familial Atypical Multiple Mole- Melanoma (FAMMM)|familial atypical multiple mole- melanoma (fammm)
225904|NCT02000089|p16|p16
225905|NCT02000089|Breast Cancer (BRCA)1|breast cancer (brca)1
402955|NCT01228851|Parkinson's Disease|parkinson's disease
225906|NCT02000089|(hereditary non-polyposis colorectal cancer or Lynch syndrome) HNPCC|(hereditary non-polyposis colorectal cancer or lynch syndrome) hnpcc
225907|NCT02000089|Lynch Syndrome|lynch syndrome
225908|NCT02000089|hereditary pancreatitis|hereditary pancreatitis
225909|NCT02000089|Protease Serine (PRSS)|protease serine (prss)
225910|NCT02000089|Chymotrypsin C (CTRC)|chymotrypsin c (ctrc)
225911|NCT02000089|Ataxia Telangiectasia Mutated(ATM)|ataxia telangiectasia mutated(atm)
225912|NCT02000076|Sleep|sleep
225913|NCT02000076|resting state|resting state
225914|NCT02000076|functional connectivity|functional connectivity
225915|NCT02000076|emotional contagion|emotional contagion
225916|NCT02000076|empathy|empathy
225917|NCT02000076|emotional regulation|emotional regulation
225918|NCT02000063|Hepatitis C|hepatitis c
225919|NCT02000063|acute|acute
225920|NCT02000063|early chronic|early chronic
225921|NCT02000050|resectable rectal cancer|resectable rectal cancer
225922|NCT02000050|up-front chemotherapy|up-front chemotherapy
225923|NCT02000050|neo-adjuvant short course radiotherapy|neo-adjuvant short course radiotherapy
225924|NCT02000050|short course radiotherapy|short course radiotherapy
225925|NCT02000011|patients|patients
225926|NCT02000011|aged 70 years old|aged 70 years old
225927|NCT02000011|thoracic,|thoracic,
225929|NCT02000011|urological|urological
225930|NCT02000011|resectable|resectable
225931|NCT01999985|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
225932|NCT01999985|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
225933|NCT01999985|Neoplasms|neoplasms
225934|NCT01999985|Lung Diseases|lung diseases
225935|NCT01999985|Respiratory Tract Diseases|respiratory tract diseases
225936|NCT01999985|Pleural Diseases|pleural diseases
225937|NCT01999985|Pleural Neoplasms|pleural neoplasms
225938|NCT01999985|Lung Neoplasms|lung neoplasms
225939|NCT01999985|Pleural Effusion|pleural effusion
225940|NCT01999985|Pleural Effusion, Malignant|pleural effusion, malignant
225941|NCT01999985|Respiratory Tract Neoplasms|respiratory tract neoplasms
225942|NCT01999985|Thoracic Neoplasms|thoracic neoplasms
225943|NCT01999985|Neoplasms by Site|neoplasms by site
225944|NCT01999985|EGFR mutation|egfr mutation
225945|NCT01999985|Afatinib|afatinib
225946|NCT01999985|Dasatinib|dasatinib
225947|NCT01999985|Carcinoma, Bronchogenic|carcinoma, bronchogenic
225948|NCT01999985|Gene Mutation|gene mutation
225949|NCT01999985|T790M mutation.|t790m mutation.
225950|NCT01999985|Non-small cell lung cancer|non-small cell lung cancer
225954|NCT01999946|Heroin Dependence|heroin dependence
225955|NCT01999946|Opioid-Related Disorders|opioid-related disorders
225956|NCT01999933|Cervical cancer|cervical cancer
225957|NCT01999933|postoperative risk factor|postoperative risk factor
225958|NCT01999933|treatment|treatment
225959|NCT01999920|Adult separation anxiety disorder|adult separation anxiety disorder
225960|NCT01999920|ASAD|asad
225961|NCT01999907|asthma|asthma
225962|NCT01999907|virus diseases|virus diseases
225963|NCT01999907|pediatric|pediatric
225964|NCT01999907|RCT|rct
225965|NCT01999907|steroid|steroid
225966|NCT01999894|Namenda|namenda
225967|NCT01999894|Autism|autism
225968|NCT01999894|Memantine|memantine
225969|NCT01999894|Pediatric|pediatric
225970|NCT01999894|Forest Laboratories|forest laboratories
225971|NCT01999868|psoriasis vulgaris|psoriasis vulgaris
225972|NCT01999868|ustekinumab|ustekinumab
225973|NCT01999868|abatacept|abatacept
225974|NCT01999842|H7N9|h7n9
225975|NCT01999842|Influenza|influenza
225976|NCT01999842|Safety|safety
225977|NCT01999842|Adults|adults
225978|NCT01999842|Adjuvant|adjuvant
225979|NCT01999842|Immunogenicity|immunogenicity
225980|NCT01999816|pressure ulcer|pressure ulcer
225981|NCT01999816|lifestyle redesign|lifestyle redesign
225982|NCT01999816|spinal cord injury|spinal cord injury
225983|NCT01999790|upper lid|upper lid
225984|NCT01999790|exophthalmos|exophthalmos
225985|NCT01999790|grave's orbitopathy|grave's orbitopathy
225986|NCT01999777|Epilepsy|epilepsy
225987|NCT01999777|seizure clusters|seizure clusters
225988|NCT01999777|acute repetitive seizures|acute repetitive seizures
225989|NCT01999777|rescue treatment|rescue treatment
225993|NCT01999725|Normal Volunteers, Safety, Pharmacokinetics|normal volunteers, safety, pharmacokinetics
225994|NCT01999712|heart failure|heart failure
225995|NCT01999712|left ventricular assist device|left ventricular assist device
225996|NCT01999712|right ventricular failure|right ventricular failure
225997|NCT01999699|Heplisav|heplisav
225998|NCT01999686|Polycystic ovarium syndrome|polycystic ovarium syndrome
225999|NCT01999686|DLBS3233|dlbs3233
226000|NCT01999686|metformin|metformin
226001|NCT01999686|insulin resistance|insulin resistance
226002|NCT01999686|Female|female
226003|NCT01999673|SUNRISE|sunrise
226004|NCT01999673|PPHM 1202|pphm 1202
226005|NCT01999673|Bavituximab|bavituximab
226006|NCT01999673|Peregrine|peregrine
226007|NCT01999660|Prostatic Neoplasms|prostatic neoplasms
226008|NCT01999660|Radiotherapy|radiotherapy
226009|NCT01999660|rectal toxicity|rectal toxicity
226010|NCT01999647|Lower Extremity|lower extremity
226011|NCT01999647|Sciatic Nerve|sciatic nerve
226012|NCT01999647|Anesthetics, Local|anesthetics, local
226013|NCT01999647|Ropivacaine|ropivacaine
226014|NCT01999647|Ultrasonography|ultrasonography
226015|NCT01999634|rectum|rectum
226016|NCT01999634|microdialysis|microdialysis
226017|NCT01999634|anastomotic leaks|anastomotic leaks
226018|NCT01999621|organ failure|organ failure
226019|NCT01999621|intensive care|intensive care
226020|NCT01999621|palliative care|palliative care
226021|NCT01999621|patient's wishes|patient's wishes
226022|NCT01999608|Infertility|infertility
226023|NCT01999595|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
226024|NCT01999595|pad size|pad size
226025|NCT01999595|pulse frequency|pulse frequency
226026|NCT01999595|blunt pressure pain|blunt pressure pain
226027|NCT01999595|healthy humans.|healthy humans.
226028|NCT01999582|Anemia|anemia
226029|NCT01999582|End Stage Kidney Disease|end stage kidney disease
226030|NCT01999582|Chronic Kidney Disease|chronic kidney disease
226031|NCT01999582|Dialysis|dialysis
226032|NCT01999582|Erythrpoietin Stimulating Agent (ESA)|erythrpoietin stimulating agent (esa)
226033|NCT01999543|Blood glucose|blood glucose
226034|NCT01999530|prazosin|prazosin
226035|NCT01999530|dopamine|dopamine
226040|NCT01999530|effect|effect
226041|NCT01999504|Glucagon-like peptide-1|glucagon-like peptide-1
226042|NCT01999504|Glucose-dependent Insulinotropic Peptide|glucose-dependent insulinotropic peptide
226043|NCT01999504|Peptide YY|peptide yy
226044|NCT01999504|Glucagon|glucagon
226045|NCT01999504|Satiety|satiety
226046|NCT01999504|Meal|meal
226047|NCT01999504|palaeolithic|palaeolithic
226048|NCT01999465|Brachial plexus injury|brachial plexus injury
226049|NCT01999465|Brachial plexus palsy|brachial plexus palsy
226050|NCT01999465|Neonate|neonate
226051|NCT01999452|Paleolithic diet|paleolithic diet
226052|NCT01999426|Physical Therapy Modalities|physical therapy modalities
226053|NCT01999426|Pediatrics|pediatrics
226054|NCT01999426|Critical Care|critical care
226055|NCT01999426|Respiration, Artificial|respiration, artificial
226057|NCT01999413|high-risk cytogenetics|high-risk cytogenetics
226058|NCT01999413|younger patients|younger patients
226059|NCT01999413|Induction treatment|induction treatment
226060|NCT01999413|OMEGAVEN|omegaven
226061|NCT01999387|food|food
226062|NCT01999387|consumption|consumption
226063|NCT01999309|Schizophrenia spectrum disorders|schizophrenia spectrum disorders
226064|NCT01999283|Cervical pain|cervical pain
226065|NCT01999283|yoga|yoga
226066|NCT01999283|pilates|pilates
226067|NCT01999283|exercise|exercise
226068|NCT01999257|Genetic Counseling|genetic counseling
226069|NCT01999257|Technology|technology
226070|NCT01999257|Ashkenazi Jewish|ashkenazi jewish
226071|NCT01999257|Carrier screening|carrier screening
226072|NCT01999244|Overweight|overweight
226073|NCT01999244|Obesity|obesity
226074|NCT01999244|Weight Loss|weight loss
226075|NCT01999244|Self-monitoring|self-monitoring
226076|NCT01999244|Food Records|food records
226077|NCT01999244|Self-weighing|self-weighing
226078|NCT01999244|Technology|technology
226079|NCT01999231|Safety|safety
226080|NCT01999231|Tolerability|tolerability
226081|NCT01999231|ESAT6|esat6
226082|NCT01999231|CFP10|cfp10
226083|NCT01999231|skin test|skin test
226084|NCT01999231|diagnostic test|diagnostic test
226085|NCT01999205|workplace|workplace
226086|NCT01999205|intervention|intervention
226087|NCT01999205|physical activity|physical activity
226088|NCT01999205|sedentary behavior|sedentary behavior
226089|NCT01999205|evaluation|evaluation
226090|NCT01999192|inadequate response to MTX|inadequate response to mtx
226091|NCT01999192|Methotrexate|methotrexate
226092|NCT01999192|rheumatoid Arthritis|rheumatoid arthritis
226093|NCT01999192|Phase 2b|phase 2b
226094|NCT01999179|catheter related thrombosis|catheter related thrombosis
226095|NCT01999179|upper extremity deep venous thrombosis|upper extremity deep venous thrombosis
226096|NCT01999179|central venous catheters|central venous catheters
226097|NCT01999179|cancer|cancer
226098|NCT01999179|Catheters|catheters
226099|NCT01999153|skin graft|skin graft
226100|NCT01999153|donor site|donor site
226101|NCT01999114|Healthy subjects|healthy subjects
226102|NCT01999114|Opioid|opioid
226103|NCT01999114|Transdermal|transdermal
226105|NCT01999088|Fatty Acids, Omega-3|fatty acids, omega-3
226106|NCT01999088|Rosemary extract|rosemary extract
226107|NCT01999088|Functional meat|functional meat
226108|NCT01999088|Cardiovascular disease|cardiovascular disease
226109|NCT01999075|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
226110|NCT01999075|Pulmonary complications|pulmonary complications
226111|NCT01999075|Lung volume recruitment,|lung volume recruitment,
226112|NCT01999075|Breath-stacking,|breath-stacking,
226113|NCT01999075|Cough efficacy,|cough efficacy,
226114|NCT01999075|Maximal insufflation capacity|maximal insufflation capacity
226115|NCT01999062|Breast RT|breast rt
226116|NCT01999062|Breast radiation therapy|breast radiation therapy
226117|NCT01999036|cardiac arrest, CPR, resuscitation|cardiac arrest, cpr, resuscitation
226118|NCT01999010|psychiatry|psychiatry
226119|NCT01999010|mental health|mental health
226120|NCT01999010|major depressive disorder|major depressive disorder
226121|NCT01999010|self-management|self-management
226122|NCT01999010|data visualization|data visualization
226123|NCT01999010|mood diaries|mood diaries
226124|NCT01999010|electronic diaries|electronic diaries
226125|NCT01999010|cell phones|cell phones
226127|NCT01999010|mental health telemetry|mental health telemetry
226128|NCT01999010|ecological momentary assessment|ecological momentary assessment
226129|NCT01998997|Delirium|delirium
226130|NCT01998997|Hospitalized elderly|hospitalized elderly
226131|NCT01998971|Multiple myeloma|multiple myeloma
226132|NCT01998971|Daratumumab|daratumumab
226133|NCT01998971|JNJ-54767414|jnj-54767414
226134|NCT01998971|Velcade-dexamethasone|velcade-dexamethasone
225952|NCT01999972|Renal Cell|renal cell
226135|NCT01998971|Velcade-melphalan-prednisone|velcade-melphalan-prednisone
226136|NCT01998971|Velcade-thalidomide-dexamethasone|velcade-thalidomide-dexamethasone
226137|NCT01998971|Pomalidomide-dexamethasone|pomalidomide-dexamethasone
226138|NCT01998971|Carfilzomib-dexamethasone|carfilzomib-dexamethasone
226139|NCT01998971|Carfilzomib-lenalidomide-dexamethasone|carfilzomib-lenalidomide-dexamethasone
226140|NCT01998971|Anti-CD38 Monoclonal Antibody|anti-cd38 monoclonal antibody
226141|NCT01998971|Immunomodulatory drug|immunomodulatory drug
226142|NCT01998971|IMiD|imid
226143|NCT01998958|Treatment resistant depressive disorder|treatment resistant depressive disorder
226144|NCT01998958|Intranasal esketamine|intranasal esketamine
226145|NCT01998958|Efficacy|efficacy
226146|NCT01998958|SYNAPSE|synapse
226147|NCT01998958|JNJ-54135419|jnj-54135419
226148|NCT01998945|Exposure therapy|exposure therapy
226149|NCT01998945|Cognitive behavioral therapy|cognitive behavioral therapy
226150|NCT01998945|Relaxation Training|relaxation training
226151|NCT01998945|Older Adults|older adults
226152|NCT01998945|Fall Injury|fall injury
226153|NCT01998945|Anxiety|anxiety
226154|NCT01998945|Posttraumatic Stress|posttraumatic stress
226155|NCT01998932|Venous Ulcer|venous ulcer
226156|NCT01998932|Leg Ulcer|leg ulcer
226157|NCT01998932|Metabonomics|metabonomics
226158|NCT01998932|Ulcer Fluid|ulcer fluid
226159|NCT01998854|Menorrhagia|menorrhagia
226160|NCT01998854|Leiomyoma|leiomyoma
226161|NCT01998854|Uterine Fibroids|uterine fibroids
226162|NCT01998828|Polycythemia|polycythemia
226163|NCT01998828|Polycythemia Vera|polycythemia vera
226164|NCT01998828|Essential Thrombocythemia|essential thrombocythemia
226165|NCT01998828|Thrombocytosis|thrombocytosis
226166|NCT01998828|Myeloproliferative Disorders|myeloproliferative disorders
226167|NCT01998828|Bone Marrow Diseases|bone marrow diseases
226168|NCT01998828|Hematologic Diseases|hematologic diseases
226169|NCT01998828|Blood Coagulation Disorders|blood coagulation disorders
226170|NCT01998828|Blood Platelet Disorders|blood platelet disorders
226171|NCT01998828|Hemorrhagic Disorders|hemorrhagic disorders
226172|NCT01998789|Liver Transplantation|liver transplantation
226173|NCT01998789|Everolimus|everolimus
226174|NCT01998789|Immunosuppression|immunosuppression
226175|NCT01998776|ulcer|ulcer
226176|NCT01998763|Vitamin D3 supplementation|vitamin d3 supplementation
226177|NCT01998763|metabolite profile|metabolite profile
226178|NCT01998763|SNPs|snps
226179|NCT01998763|bone-turnover marker|bone-turnover marker
226180|NCT01998750|obesity|obesity
226181|NCT01998750|genetics|genetics
226182|NCT01998750|early-onset|early-onset
226183|NCT01998750|childhood|childhood
226184|NCT01998737|Osteoporosis, diagnostics, ultrasound|osteoporosis, diagnostics, ultrasound
226185|NCT01998724|Chronic bronchitis|chronic bronchitis
226186|NCT01998724|Emphysema|emphysema
226187|NCT01998724|Pulmonary|pulmonary
226188|NCT01998724|COPD|copd
226189|NCT01998711|Alzheimer's disease|alzheimer's disease
226190|NCT01998711|Mild cognitive impairment|mild cognitive impairment
226191|NCT01998711|Memory intervention|memory intervention
226192|NCT01998711|Strategy use|strategy use
226193|NCT01998711|Memory group|memory group
226194|NCT01998698|cataract|cataract
226195|NCT01998698|phacoemulsification|phacoemulsification
226196|NCT01998698|monovision|monovision
226197|NCT01998698|multifocal lens|multifocal lens
226198|NCT01998685|Prostatectomy|prostatectomy
226199|NCT01998685|Coagulation Factor|coagulation factor
226200|NCT01998685|Balanced Anesthesia|balanced anesthesia
226201|NCT01998685|Intravenous Anesthesia,|intravenous anesthesia,
226202|NCT01998646|ASP4058|asp4058
226203|NCT01998646|healthy subjects|healthy subjects
226204|NCT01998633|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
226205|NCT01998633|Chronic Active EBV|chronic active ebv
226206|NCT01998633|Chronic Granulomatous Disease|chronic granulomatous disease
226207|NCT01998633|Hyperimmunoglobulin M Syndrome (Hyper IGM)|hyperimmunoglobulin m syndrome (hyper igm)
226208|NCT01998633|Leukocyte Adhesion Deficiency|leukocyte adhesion deficiency
226209|NCT01998633|IPEX|ipex
226210|NCT01998633|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
226211|NCT01998633|Non-Myeloablative Transplant (NST)|non-myeloablative transplant (nst)
402956|NCT01228851|Rehabilitation|rehabilitation
216975|NCT02041065|Operation time|operation time
226212|NCT01998633|Reduced-Intensity Conditioning (RIC)|reduced-intensity conditioning (ric)
226213|NCT01998620|Hepatitis B|hepatitis b
226214|NCT01998620|Cholestasis|cholestasis
226215|NCT01998607|Solid tumours|solid tumours
226216|NCT01998607|Bone Metastasis|bone metastasis
226217|NCT01998594|Thumb arthritis|thumb arthritis
226218|NCT01998594|CMC arthritis|cmc arthritis
226219|NCT01998594|Arthroplasty|arthroplasty
226220|NCT01998568|Intraocular pressure|intraocular pressure
226221|NCT01998568|Corneal edema|corneal edema
226222|NCT01998568|Tonometer|tonometer
226223|NCT01998568|Dynamic contour tonometer|dynamic contour tonometer
226224|NCT01998568|Tonopen|tonopen
226225|NCT01998568|iCare|icare
226226|NCT01998568|Goldmann applanation|goldmann applanation
226227|NCT01998542|Head and neck cancers|head and neck cancers
226228|NCT01998542|tumor vaccine|tumor vaccine
226229|NCT01998542|immunotherapy|immunotherapy
226230|NCT01998542|personalized anti-cancer vaccine|personalized anti-cancer vaccine
226231|NCT01998529|Lung Cancer|lung cancer
226232|NCT01998529|Unilateral Pleural Malignancy|unilateral pleural malignancy
226233|NCT01998529|Metastatic active pleural malignancy|metastatic active pleural malignancy
226234|NCT01998529|Lung tumors|lung tumors
226235|NCT01998529|Sarcomas|sarcomas
226236|NCT01998529|Cytoreductive Surgery|cytoreductive surgery
226237|NCT01998529|Hyperthermic Intrathoracic Pleural Chemotherapy|hyperthermic intrathoracic pleural chemotherapy
226238|NCT01998529|HITC|hitc
226239|NCT01998529|Cisplatin|cisplatin
226240|NCT01998529|Platinol-AQ|platinol-aq
226241|NCT01998529|Platinol|platinol
226242|NCT01998529|CDDP|cddp
226243|NCT01998529|Amifostine|amifostine
226244|NCT01998529|Ethyol|ethyol
226245|NCT01998529|Ethiofos|ethiofos
226246|NCT01998529|Gammaphos|gammaphos
226247|NCT01998516|Emotional Intelligence|emotional intelligence
226248|NCT01998503|AL amyloidosis|al amyloidosis
226249|NCT01998503|bortezomib|bortezomib
226250|NCT01998503|autologous stem cell transplantation|autologous stem cell transplantation
226251|NCT01998477|Influenza|influenza
226252|NCT01998477|Vaccine|vaccine
226254|NCT01998477|Children|children
226255|NCT01998477|Adolescents|adolescents
226256|NCT01998464|Retinal Vasculitis|retinal vasculitis
226257|NCT01998464|Optical coherence tomography|optical coherence tomography
226258|NCT01998464|OCT|oct
226259|NCT01998464|Imaging|imaging
226260|NCT01998451|double sphincter in gallbladder|double sphincter in gallbladder
226261|NCT01998451|recurrence rate of gallstones|recurrence rate of gallstones
226262|NCT01998438|tranexamic acid|tranexamic acid
226263|NCT01998438|cardiac surgery|cardiac surgery
226264|NCT01998438|cardiopulmonary bypass|cardiopulmonary bypass
226265|NCT01998425|circulating fibrocytes|circulating fibrocytes
226266|NCT01998425|fibrocyte|fibrocyte
226267|NCT01998425|NSCLC|nsclc
226268|NCT01998425|treatment response|treatment response
226269|NCT01998425|survival|survival
226270|NCT01998425|stage|stage
226271|NCT01998399|CAP|cap
226272|NCT01998399|Pneumonia|pneumonia
226273|NCT01998399|Intensive Care Unit|intensive care unit
226274|NCT01998399|Mechanical Ventilation|mechanical ventilation
226275|NCT01998386|Tooth Whitening|tooth whitening
226276|NCT01998386|Adolescent|adolescent
226277|NCT01998386|Clinical Trial|clinical trial
226278|NCT01998373|Patient training|patient training
226279|NCT01998373|Rheumatoid arthritis|rheumatoid arthritis
226280|NCT01998373|Quality of life|quality of life
226281|NCT01998360|Circumcision|circumcision
226282|NCT01998360|Voluntary medical male circumcision|voluntary medical male circumcision
226283|NCT01998360|Minimally-invasive|minimally-invasive
226284|NCT01998360|HIV prevention|hiv prevention
226285|NCT01998334|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
226286|NCT01998334|Continuous Blood Purification|continuous blood purification
226287|NCT01998321|PSI: Patient Specific Instrument|psi: patient specific instrument
226288|NCT01998321|TKA: Total Knee Arthroplasty|tka: total knee arthroplasty
226289|NCT01998321|Articular Deformity|articular deformity
226290|NCT01998321|Varus|varus
226291|NCT01998295|Clearance time|clearance time
226292|NCT01998295|Recurrence time|recurrence time
226293|NCT01998295|Artemether/lumefantrine|artemether/lumefantrine
226294|NCT01998295|P. falciparum|p. falciparum
226295|NCT01998295|Uncomplicated malaria|uncomplicated malaria
226296|NCT01998295|Children|children
226297|NCT01998282|Focus of study is to assess filter/stove use and efficacy in reducing exposure to waterborne and airborne pathogens.|focus of study is to assess filter/stove use and efficacy in reducing exposure to waterborne and airborne pathogens.
226298|NCT01998256|AV optimization|av optimization
226299|NCT01998256|Interatrial conduction delay|interatrial conduction delay
226300|NCT01998243|morbid obesity|morbid obesity
226301|NCT01998243|bioenterics intragastric balloon|bioenterics intragastric balloon
226302|NCT01998243|bariatric surgery|bariatric surgery
226303|NCT01998230|esophageal cancer|esophageal cancer
226304|NCT01998230|esophagectomy|esophagectomy
226305|NCT01998230|oral feeding|oral feeding
402957|NCT01228851|Balance|balance
226306|NCT01998217|extracorporeal shock wave lithotripsy|extracorporeal shock wave lithotripsy
226307|NCT01998217|remifentanil|remifentanil
226308|NCT01998217|flurbiprofen|flurbiprofen
226309|NCT01998217|pancreatic stone|pancreatic stone
226310|NCT01998204|Parkinson's disease|parkinson's disease
226311|NCT01998204|propofol|propofol
226312|NCT01998204|deep brain stimulator|deep brain stimulator
226313|NCT01998191|mortality|mortality
226314|NCT01998191|adverse events|adverse events
226315|NCT01998165|Anesthesia|anesthesia
226316|NCT01998165|Remifentanil|remifentanil
226318|NCT01998113|gestational diabetes mellitus|gestational diabetes mellitus
226319|NCT01998113|glyburide|glyburide
226320|NCT01998113|metformin|metformin
226321|NCT01998113|oral agents|oral agents
226322|NCT01998113|insulin|insulin
226323|NCT01998113|outcomes|outcomes
226324|NCT01998100|PTSD|ptsd
226325|NCT01998100|Anxiety|anxiety
226326|NCT01998100|Behavior Therapy|behavior therapy
226327|NCT01998100|Prolonged Exposure|prolonged exposure
226328|NCT01998100|Exercise|exercise
226329|NCT01998100|Wellness|wellness
226330|NCT01998100|Post-traumatic|post-traumatic
226332|NCT01998087|Exclusive breastfeeding|exclusive breastfeeding
226333|NCT01998087|Breastfeeding|breastfeeding
226334|NCT01998087|Proactive breastfeeding support|proactive breastfeeding support
226335|NCT01998087|Telephone breastfeeding support|telephone breastfeeding support
226336|NCT01998087|Infant feeding attitudes|infant feeding attitudes
226337|NCT01998087|Breastfeeding self-efficacy|breastfeeding self-efficacy
226338|NCT01998087|Breastfeeding difficulties|breastfeeding difficulties
226339|NCT01998074|Cow's Milk protein Allergy|cow's milk protein allergy
226340|NCT01998048|surgical treatment|surgical treatment
226342|NCT01998048|Latarjet|latarjet
226343|NCT01998048|redislocation|redislocation
226344|NCT01998035|Lymphoid Malignancies|lymphoid malignancies
226345|NCT01998035|Lymphoma|lymphoma
226346|NCT01998035|Hodgkin Lymphoma|hodgkin lymphoma
226347|NCT01998035|Non-hodgkin Lymphoma|non-hodgkin lymphoma
226348|NCT01998035|Follicular Lymphoma|follicular lymphoma
226349|NCT01998035|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
226452|NCT01997762|gestational diabetes,|gestational diabetes,
226350|NCT01998035|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
226351|NCT01998035|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
226352|NCT01998035|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
226353|NCT01998035|Mantle Cell Lymphoma|mantle cell lymphoma
226354|NCT01998035|Marginal Zone Lymphoma|marginal zone lymphoma
226355|NCT01998035|Burkitt Lymphoma|burkitt lymphoma
226356|NCT01998035|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
226357|NCT01998035|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
226358|NCT01998035|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
226359|NCT01998022|hypertension|hypertension
226360|NCT01998022|knowledge|knowledge
226361|NCT01998022|blood pressure control|blood pressure control
226362|NCT01998009|colorectal cancer|colorectal cancer
226363|NCT01998009|mass screening|mass screening
226364|NCT01998009|fecal occult blood|fecal occult blood
226365|NCT01997996|Pelvic Organ Prolapse|pelvic organ prolapse
226366|NCT01997996|PROLIFT+M|prolift+m
226367|NCT01997996|Vita sexualis|vita sexualis
226368|NCT01997983|interstitial cystitis|interstitial cystitis
226369|NCT01997983|PBS/IC|pbs/ic
226370|NCT01997983|IC|ic
226371|NCT01997983|Botox|botox
226372|NCT01997983|Botulinum toxin|botulinum toxin
226373|NCT01997983|TC-3 Gel|tc-3 gel
226374|NCT01997983|TCGel|tcgel
226375|NCT01997983|TheraCoat|theracoat
226376|NCT01997970|NEAT|neat
226377|NCT01997970|Treadmill desk|treadmill desk
226378|NCT01997957|Hepatocellular Carcinoma|hepatocellular carcinoma
226379|NCT01997957|Transarterial Chemoembolization|transarterial chemoembolization
226380|NCT01997957|Hepatic Arterial Infusion Chemotherapy|hepatic arterial infusion chemotherapy
226381|NCT01997957|Efficacy|efficacy
226382|NCT01997931|bispectral index|bispectral index
226383|NCT01997931|sedation|sedation
226384|NCT01997931|intensive care|intensive care
226385|NCT01997931|mechanical ventilation|mechanical ventilation
226386|NCT01997918|Secondary allogeneic HSCT|secondary allogeneic hsct
226387|NCT01997918|Haploidentical HSCT|haploidentical hsct
226388|NCT01997905|Left Atrial Appendage|left atrial appendage
226389|NCT01997905|LAA|laa
226390|NCT01997905|Atrial Fibrillation|atrial fibrillation
226391|NCT01997905|AFib|afib
226392|NCT01997905|AF|af
226393|NCT01997905|IRB approved|irb approved
226394|NCT01997905|clinical|clinical
226395|NCT01997905|Stroke|stroke
226396|NCT01997905|TIA|tia
226397|NCT01997905|contraindication to oral anticoagulation therapy|contraindication to oral anticoagulation therapy
226398|NCT01997905|Arrhythmias, Cardiac|arrhythmias, cardiac
226399|NCT01997905|OAC|oac
226400|NCT01997905|trial|trial
226401|NCT01997905|study|study
226402|NCT01997905|LAA occlusion|laa occlusion
226403|NCT01997905|occluded|occluded
226404|NCT01997905|prevent|prevent
226405|NCT01997892|CKD|ckd
226406|NCT01997892|Darbepoetin Alfa|darbepoetin alfa
217173|NCT02039973|depression|depression
217174|NCT02039973|perinatal|perinatal
217175|NCT02039973|psychotherapy|psychotherapy
217176|NCT02039973|task-sharing|task-sharing
217177|NCT02039973|problem-solving|problem-solving
217178|NCT02039960|Epidemiology|epidemiology
217180|NCT02039960|bupropion|bupropion
226407|NCT01997892|Dialysis|dialysis
226408|NCT01997892|Hemodialysis|hemodialysis
226409|NCT01997892|Anemia|anemia
226410|NCT01997892|Peg epoetin beta|peg epoetin beta
226411|NCT01997866|Obstructive Sleep Apnea|obstructive sleep apnea
226412|NCT01997866|Sleep Apnea|sleep apnea
226413|NCT01997866|Congestive Heart Failure|congestive heart failure
226414|NCT01997866|Heart Failure|heart failure
226415|NCT01997853|Omega 3 fatty acids|omega 3 fatty acids
226416|NCT01997853|C Reactive Protein|c reactive protein
226417|NCT01997853|Host Modulation|host modulation
226418|NCT01997853|Chronic Periodontitis|chronic periodontitis
226419|NCT01997840|Multiple Myeloma|multiple myeloma
226420|NCT01997840|Neoplasms, Plasma Cell|neoplasms, plasma cell
226421|NCT01997840|Neoplasms by Histologic Type|neoplasms by histologic type
226422|NCT01997840|Neoplasms|neoplasms
226423|NCT01997840|Blood Protein Disorders|blood protein disorders
226424|NCT01997840|Hematologic Diseases|hematologic diseases
226425|NCT01997840|Dexamethasone|dexamethasone
226426|NCT01997840|Dexamethasone acetate|dexamethasone acetate
226427|NCT01997840|Pomalidomide|pomalidomide
226428|NCT01997814|Herbal medicine,|herbal medicine,
226429|NCT01997814|Host modulation therapy,|host modulation therapy,
226430|NCT01997814|Periodontitis,|periodontitis,
226431|NCT01997814|Meta-analysis,|meta-analysis,
226432|NCT01997814|Scaling and root planing.|scaling and root planing.
226433|NCT01997801|Thyroidectomy|thyroidectomy
226434|NCT01997801|Endoscopy|endoscopy
226435|NCT01997801|Ketamine|ketamine
226436|NCT01997801|Acute Pain|acute pain
226437|NCT01997801|Chronic Pain|chronic pain
226438|NCT01997801|Postoperative period|postoperative period
226439|NCT01997788|Injection, Spinal|injection, spinal
226440|NCT01997788|Morphine|morphine
226441|NCT01997788|Analgesia|analgesia
226442|NCT01997788|Patient-Controlled|patient-controlled
226443|NCT01997788|Pain|pain
226444|NCT01997788|Postoperative|postoperative
226445|NCT01997788|Combined Modality Therapy|combined modality therapy
226446|NCT01997788|Nephrectomy|nephrectomy
226447|NCT01997775|IL-6|il-6
226448|NCT01997775|Metformin|metformin
226449|NCT01997775|Non-small cell lung cancer|non-small cell lung cancer
226450|NCT01997775|Lung adenocarcinoma|lung adenocarcinoma
226451|NCT01997762|resveratrol,|resveratrol,
226466|NCT01997671|Primary prevention|primary prevention
226467|NCT01997671|Cardiovascular diseases|cardiovascular diseases
226468|NCT01997671|Electronic Medical records|electronic medical records
226469|NCT01997671|Clinical Practice Guideline|clinical practice guideline
226470|NCT01997658|Glucocorticoids|glucocorticoids
226471|NCT01997658|Total complication rate|total complication rate
226472|NCT01997658|Hepatectomy.|hepatectomy.
226473|NCT01997645|Anal fistula|anal fistula
226474|NCT01997645|Rectal fistula|rectal fistula
226475|NCT01997645|Intersphincteric fistula|intersphincteric fistula
226476|NCT01997645|Perianal fistula|perianal fistula
226477|NCT01997632|Poliomyelitis|poliomyelitis
226478|NCT01997632|Vaccine|vaccine
226479|NCT01997619|biological mesh|biological mesh
226480|NCT01997619|contaminated hernia|contaminated hernia
226481|NCT01997619|abdominal wall reconstruction|abdominal wall reconstruction
226482|NCT01997593|analgesia|analgesia
226483|NCT01997593|pediatric|pediatric
226484|NCT01997593|pain|pain
226485|NCT01997593|laparoscopy|laparoscopy
226486|NCT01997593|ropivacaine|ropivacaine
226487|NCT01997580|depression|depression
226488|NCT01997580|treatment|treatment
226489|NCT01997580|electrophysiology|electrophysiology
226490|NCT01997580|biomarker|biomarker
226491|NCT01997567|Hip Arthroscopy|hip arthroscopy
226492|NCT01997567|Regional Anesthesia|regional anesthesia
226493|NCT01997567|Peripheral Nerve block|peripheral nerve block
226494|NCT01997554|TSH Testing|tsh testing
226495|NCT01997554|sub-clinical hypothyroidism|sub-clinical hypothyroidism
226496|NCT01997515|QOR-40|qor-40
226497|NCT01997515|Pain|pain
226498|NCT01997515|Hypoxia|hypoxia
226499|NCT01997515|Gastric Surgery|gastric surgery
226500|NCT01997515|Obesity|obesity
226501|NCT01997515|Ketamine|ketamine
226502|NCT01997502|Hemoglobin|hemoglobin
226503|NCT01997502|Non-invasive|non-invasive
226505|NCT01997489|Fabry|fabry
226506|NCT01997489|vessels|vessels
226507|NCT01997476|Combined Endoscopic Ultrasound Morphologic Evaluation.|combined endoscopic ultrasound morphologic evaluation.
402958|NCT01228851|Exercise|exercise
402959|NCT01228851|Parkinson's disease with balance deficits|parkinson's disease with balance deficits
226508|NCT01997450|Q/LAIV/FluMist® Quadrivalent Vaccine, Inactivated Influenza Vaccine (IIV), Effectiveness, Influenza|q/laiv/flumist® quadrivalent vaccine, inactivated influenza vaccine (iiv), effectiveness, influenza
226509|NCT01997437|Tissue-engineered tracheal transplantation|tissue-engineered tracheal transplantation
226510|NCT01997411|Diabetes Mellitus|diabetes mellitus
226511|NCT01997411|Glucagon|glucagon
226512|NCT01997398|Deep brain stimulation surgery under general anesthesia|deep brain stimulation surgery under general anesthesia
226513|NCT01997398|Deep brain stimulation target accuracy|deep brain stimulation target accuracy
226514|NCT01997398|Deep brain stimulation for Parkinsons's disease|deep brain stimulation for parkinsons's disease
226515|NCT01997398|Deep brain stimulation functional outcomes|deep brain stimulation functional outcomes
226516|NCT01997398|Deep brain stimulation quality of life outcomes|deep brain stimulation quality of life outcomes
226517|NCT01997385|adapted APD|adapted apd
226518|NCT01997385|dwell time|dwell time
226519|NCT01997385|fill volume|fill volume
226520|NCT01997372|ATG|atg
226521|NCT01997372|SAA|saa
226522|NCT01997372|immunosuppressive treatment|immunosuppressive treatment
226523|NCT01997372|cyclosporine|cyclosporine
226524|NCT01997359|ART initiation|art initiation
226525|NCT01997359|HIV|hiv
226526|NCT01997359|AIDS|aids
226527|NCT01997359|Ethiopia|ethiopia
226528|NCT01997346|ART initiation|art initiation
226529|NCT01997346|Ethiopia|ethiopia
226530|NCT01997346|Clinic observation|clinic observation
226531|NCT01997346|VCT observation|vct observation
226548|NCT01997320|Sarcopenia|sarcopenia
226549|NCT01997320|Frailty|frailty
226550|NCT01997320|Strength|strength
226551|NCT01997320|Protein supplementation|protein supplementation
226552|NCT01997320|Ageing|ageing
402004|NCT01233544|Colorectal carcinoma|colorectal carcinoma
226553|NCT01997307|acute coronary syndrome, coronary arteriography, menopause|acute coronary syndrome, coronary arteriography, menopause
226554|NCT01997294|sequential therapy|sequential therapy
226555|NCT01997294|atorvastatin|atorvastatin
226572|NCT01997242|NON CARDIAC SURGEY|non cardiac surgey
226573|NCT01997229|Myasthenia Gravis|myasthenia gravis
226575|NCT01997229|safety|safety
226576|NCT01997229|efficacy|efficacy
226577|NCT01997216|contact lenses|contact lenses
226578|NCT01997216|multifocal|multifocal
226579|NCT01997203|hepatitis C infection|hepatitis c infection
226580|NCT01997203|vitamin D|vitamin d
226581|NCT01997190|Immunotherapy|immunotherapy
226582|NCT01997190|Gene therapy|gene therapy
226583|NCT01997190|Tumor vaccine|tumor vaccine
226584|NCT01997177|simulation|simulation
226585|NCT01997177|training|training
226586|NCT01997177|colonoscopy|colonoscopy
226587|NCT01997177|standard setting|standard setting
226588|NCT01997138|pain, inflammation, surgery|pain, inflammation, surgery
226589|NCT01997112|Blood pressure|blood pressure
226590|NCT01997112|Hypertension|hypertension
226591|NCT01997112|Paracetamol|paracetamol
226592|NCT01997112|Acetaminophen|acetaminophen
226593|NCT01997099|Drug Library|drug library
226594|NCT01997099|Ambulatory Infusion Pump|ambulatory infusion pump
226595|NCT01997099|Medication Safety Software|medication safety software
226596|NCT01997099|CADD®-Solis VIP|cadd®-solis vip
226597|NCT01997099|Pump Programming|pump programming
226598|NCT01997099|Home Infusion Workflow|home infusion workflow
226599|NCT01997073|Respiratory enthalpy|respiratory enthalpy
226600|NCT01997073|One Lung Ventilation|one lung ventilation
226601|NCT01997060|Lifestyle intervention|lifestyle intervention
226602|NCT01997060|Body weight|body weight
226603|NCT01997060|Body composition|body composition
226604|NCT01997060|Weight loss maintenance|weight loss maintenance
226605|NCT01997060|Physical activity|physical activity
226606|NCT01997047|Pneumonia|pneumonia
226607|NCT01997047|bronchiolitis|bronchiolitis
226608|NCT01997047|asthma|asthma
226609|NCT01997047|children|children
226610|NCT01997047|tachypnea|tachypnea
226611|NCT01997047|developing countries|developing countries
226612|NCT01997047|diagnostic criteria|diagnostic criteria
226613|NCT01997034|Weight loss maintenance|weight loss maintenance
226614|NCT01997034|Body composition|body composition
226615|NCT01997034|Physical activity|physical activity
226616|NCT01997034|Lifestyle intervention|lifestyle intervention
226617|NCT01997021|Sedentary behavior|sedentary behavior
226618|NCT01997021|physical activity|physical activity
226619|NCT01997021|older adults|older adults
226620|NCT01996982|Induced therapeutic hypothermia|induced therapeutic hypothermia
226621|NCT01996969|metastatic colorectal cancer|metastatic colorectal cancer
226622|NCT01996969|refractory|refractory
226623|NCT01996969|regorafenib|regorafenib
226624|NCT01996969|biomarker|biomarker
226625|NCT01996969|gene sequencing|gene sequencing
226626|NCT01996956|stroke volume variation,|stroke volume variation,
226627|NCT01996956|cardiac output,|cardiac output,
226628|NCT01996956|fluid responsiveness,|fluid responsiveness,
226629|NCT01996956|noninvasive cardiac output monitor|noninvasive cardiac output monitor
226630|NCT01996943|Atrial Fibrillation|atrial fibrillation
226631|NCT01996943|Alcohol|alcohol
226632|NCT01996943|Electrophysiologic properties of the atria|electrophysiologic properties of the atria
226633|NCT01996943|Randomized Clinical Study|randomized clinical study
226634|NCT01996917|wound closure|wound closure
226635|NCT01996917|prineo|prineo
226636|NCT01996917|scar|scar
226637|NCT01996904|subscapularis tear|subscapularis tear
226638|NCT01996904|arthroscopic tendon repair|arthroscopic tendon repair
226639|NCT01996904|arthroscopic tendon debridement|arthroscopic tendon debridement
226641|NCT01996891|Asthma|asthma
226642|NCT01996891|Nutrition|nutrition
226643|NCT01996891|Anti-inflammatory diet|anti-inflammatory diet
226644|NCT01996878|Parkinson's disease|parkinson's disease
226645|NCT01996878|Genetic Polymorphism|genetic polymorphism
226837|NCT01996150|staphylococcus aureus|staphylococcus aureus
226838|NCT01996137|Stroke|stroke
226651|NCT01996826|Corneal Neovascularization|corneal neovascularization
226652|NCT01996826|Cornea Blood Vessels|cornea blood vessels
226653|NCT01996826|Corneal Graft Failure|corneal graft failure
226654|NCT01996826|High-Risk Penetrating Keratoplasty|high-risk penetrating keratoplasty
226655|NCT01996826|Corneal Transplant|corneal transplant
226656|NCT01996813|arthroscopy|arthroscopy
226657|NCT01996813|shoulder|shoulder
226658|NCT01996813|obesity|obesity
226660|NCT01996813|compression hose|compression hose
226661|NCT01996787|visibility tinted silicone hydrogel contact lenses for daily wear|visibility tinted silicone hydrogel contact lenses for daily wear
226662|NCT01996735|Endothelial function|endothelial function
226663|NCT01996735|Adenosine receptor stimulation|adenosine receptor stimulation
226664|NCT01996709|Silicone hydrogel contact lenses|silicone hydrogel contact lenses
226665|NCT01996709|Multi-purpose solution|multi-purpose solution
226666|NCT01996709|Lid Papillae|lid papillae
226667|NCT01996709|Palpebral Roughness|palpebral roughness
226668|NCT01996696|metformin|metformin
226669|NCT01996696|metabolic syndrome|metabolic syndrome
226670|NCT01996696|weight gain|weight gain
226671|NCT01996683|B-thalassemia|b-thalassemia
226672|NCT01996683|ferritin|ferritin
226673|NCT01996657|mechanical valves replacement|mechanical valves replacement
226674|NCT01996657|INR|inr
226675|NCT01996657|D-dimer|d-dimer
226676|NCT01996657|thromboembolic events|thromboembolic events
226677|NCT01996644|Anorexia, Bulimia, Eating disorder, Anxiety, Exposure Therapy|anorexia, bulimia, eating disorder, anxiety, exposure therapy
226678|NCT01996618|Premature Ventricular Beats|premature ventricular beats
226679|NCT01996618|Premature Heart Beats|premature heart beats
226680|NCT01996618|Ranolazine|ranolazine
226681|NCT01996592|chronic pain|chronic pain
226682|NCT01996592|cesarean section pain|cesarean section pain
226683|NCT01996579|Critically Ill|critically ill
226684|NCT01996579|Intensive care|intensive care
226685|NCT01996579|Nasogastric tube|nasogastric tube
226686|NCT01996579|Orogastric tube|orogastric tube
226687|NCT01996579|mechanically ventilated|mechanically ventilated
226688|NCT01996579|nosocomially acquired infections|nosocomially acquired infections
226689|NCT01996579|length of stay|length of stay
226690|NCT01996579|lactoferrin|lactoferrin
226691|NCT01996579|placebo controlled|placebo controlled
226692|NCT01996579|antibiotic free days|antibiotic free days
226693|NCT01996566|taste|taste
226694|NCT01996566|non-esterified fatty acids|non-esterified fatty acids
226695|NCT01996566|threshold|threshold
226696|NCT01996566|sensitivity|sensitivity
226697|NCT01996566|human|human
226698|NCT01996553|blood flow, regional|blood flow, regional
226699|NCT01996553|complications|complications
226700|NCT01996553|disease, arterial obstructive|disease, arterial obstructive
226701|NCT01996553|cardiac catheterization|cardiac catheterization
226702|NCT01996553|radial artery|radial artery
226703|NCT01996540|gastric neoplasm|gastric neoplasm
226704|NCT01996540|pancreatic neoplasm|pancreatic neoplasm
226705|NCT01996540|advanced|advanced
226706|NCT01996540|palliative care|palliative care
226707|NCT01996514|Children|children
226708|NCT01996514|Food advertisement|food advertisement
226709|NCT01996514|Obesity|obesity
226710|NCT01996514|Television viewing|television viewing
226711|NCT01996514|Food intake|food intake
226712|NCT01996449|Hypertension|hypertension
226713|NCT01996449|blood pressure|blood pressure
226714|NCT01996449|Aldosterone|aldosterone
226715|NCT01996449|Eplerenone|eplerenone
226716|NCT01996449|Amlodipine|amlodipine
226717|NCT01996449|Primary aldosteronism|primary aldosteronism
226718|NCT01996449|Exercise pressor reflex|exercise pressor reflex
226719|NCT01996449|handgrip exercise|handgrip exercise
226720|NCT01996449|passive arm cycling|passive arm cycling
226721|NCT01996449|active arm cycling|active arm cycling
226722|NCT01996436|cerebral vasospasm|cerebral vasospasm
226723|NCT01996436|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
226724|NCT01996436|intra arterial drug treatment for cerebral vasospasm|intra arterial drug treatment for cerebral vasospasm
226725|NCT01996436|nicardipine milrinone nitroglycerin verapamil|nicardipine milrinone nitroglycerin verapamil
226726|NCT01996423|Atopic dermatitis|atopic dermatitis
226727|NCT01996423|vitamin D|vitamin d
226728|NCT01996410|Breast Cancer|breast cancer
226729|NCT01996410|Acupuncture|acupuncture
226730|NCT01996410|Taxol|taxol
226731|NCT01996410|Cytoxan|cytoxan
226732|NCT01996410|Adriamycin|adriamycin
226733|NCT01996410|Taxotere|taxotere
226734|NCT01996410|Carboplatin|carboplatin
226735|NCT01996410|Perjeta|perjeta
226736|NCT01996410|Chemotherapy|chemotherapy
226737|NCT01996410|Chemotherapy-induced nausea, vomiting|chemotherapy-induced nausea, vomiting
226739|NCT01996410|Adriamycin (60 mg/m2), Cytoxan (600 mg/m2), Taxol (175 mg/m2)|adriamycin (60 mg/m2), cytoxan (600 mg/m2), taxol (175 mg/m2)
226740|NCT01996410|Adriamycin (60 mg/m2), Cytoxan (600 mg/m2), Taxol (80 g/m2)|adriamycin (60 mg/m2), cytoxan (600 mg/m2), taxol (80 g/m2)
402005|NCT01233544|Liver metastases|liver metastases
226742|NCT01996410|Taxotere (75 mg/m2), Carboplatin (AUC 6), Perjeta (840 mg loading fixed dose)|taxotere (75 mg/m2), carboplatin (auc 6), perjeta (840 mg loading fixed dose)
226743|NCT01996397|Heart failure|heart failure
226744|NCT01996397|Bundle branch block|bundle branch block
226745|NCT01996397|CRT response|crt response
226746|NCT01996384|Vulvodynia|vulvodynia
226747|NCT01996384|Provoked, localized vulvodynia|provoked, localized vulvodynia
226748|NCT01996384|vulvar vestibulitis|vulvar vestibulitis
226749|NCT01996384|provoked vestibulodynia|provoked vestibulodynia
226750|NCT01996384|vulvovaginal pain|vulvovaginal pain
226751|NCT01996384|vulvar pain|vulvar pain
226752|NCT01996384|vaginal pain|vaginal pain
226753|NCT01996384|chronic pain|chronic pain
226754|NCT01996384|lidocaine|lidocaine
226755|NCT01996384|numbing agent|numbing agent
226756|NCT01996384|anesthetic cream|anesthetic cream
226757|NCT01996384|acupuncture|acupuncture
226758|NCT01996384|electroacupuncture|electroacupuncture
226759|NCT01996384|electrical stimulated acupuncture|electrical stimulated acupuncture
226760|NCT01996384|manual acupuncture|manual acupuncture
226761|NCT01996384|classical acupuncture|classical acupuncture
226762|NCT01996384|non-classical acupuncture|non-classical acupuncture
226763|NCT01996384|Traditional Chinese Medicine|traditional chinese medicine
226765|NCT01996384|Chinese medicine|chinese medicine
226766|NCT01996384|Acupuncture and Oriental Medicine|acupuncture and oriental medicine
226767|NCT01996384|AOM|aom
226768|NCT01996384|treatment|treatment
226769|NCT01996384|feasibility|feasibility
226770|NCT01996384|pilot study|pilot study
226771|NCT01996384|Patient Reported Outcomes Measure Information System|patient reported outcomes measure information system
226772|NCT01996384|Tampon Test|tampon test
226773|NCT01996384|cotton swab test|cotton swab test
226774|NCT01996384|pain diary|pain diary
226775|NCT01996384|Research Electronic Data Capture|research electronic data capture
226776|NCT01996384|REDCap|redcap
226777|NCT01996358|Succinylcholine|succinylcholine
226778|NCT01996358|Rocuronium|rocuronium
226779|NCT01996358|Rigid Bronchoscopy|rigid bronchoscopy
226780|NCT01996345|Placenta Previa|placenta previa
226781|NCT01996345|Vaginal Pessary|vaginal pessary
226782|NCT01996345|Premature Birth|premature birth
226783|NCT01996319|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
226784|NCT01996319|COPD|copd
226785|NCT01996306|AXEPT|axept
226786|NCT01996306|Fluorouracil|fluorouracil
226787|NCT01996306|CPT-11|cpt-11
226788|NCT01996306|XELIRI|xeliri
226789|NCT01996306|Bevacizumab|bevacizumab
226790|NCT01996306|FOLFIRI|folfiri
226791|NCT01996306|Capecitabine|capecitabine
226792|NCT01996306|2nd-line metastatic colorectal cancer|2nd-line metastatic colorectal cancer
226793|NCT01996293|pregnant|pregnant
226794|NCT01996293|bipolar|bipolar
226795|NCT01996293|lamotrigine|lamotrigine
226796|NCT01996293|lamictal|lamictal
226797|NCT01996293|women|women
226798|NCT01996293|female|female
226799|NCT01996267|neoadjuvant|neoadjuvant
226800|NCT01996267|breast cancer|breast cancer
226801|NCT01996267|HER2 positive|her2 positive
226802|NCT01996254|electrical stimulation|electrical stimulation
226803|NCT01996254|neurostimulation|neurostimulation
226804|NCT01996254|neuromodulation|neuromodulation
226805|NCT01996254|post-amputation pain|post-amputation pain
226806|NCT01996254|phantom limb pain|phantom limb pain
226807|NCT01996254|residual limb pain|residual limb pain
226808|NCT01996254|neuropathic pain|neuropathic pain
226809|NCT01996254|amputee pain|amputee pain
226810|NCT01996241|adolescent girls|adolescent girls
226811|NCT01996241|female sex work|female sex work
226812|NCT01996241|age at marriage|age at marriage
226813|NCT01996241|retention in school|retention in school
226814|NCT01996241|sexual debut|sexual debut
226815|NCT01996241|India|india
226816|NCT01996241|Karnataka|karnataka
226817|NCT01996228|Type 1 diabetes|type 1 diabetes
226818|NCT01996228|autoimmune|autoimmune
226819|NCT01996228|cord blood stem cell|cord blood stem cell
226820|NCT01996228|stem cell educator|stem cell educator
226821|NCT01996228|immune modulation|immune modulation
226822|NCT01996228|children|children
226823|NCT01996228|Control autoimmunity|control autoimmunity
226824|NCT01996228|stimulate the regeneration of islet beta cells|stimulate the regeneration of islet beta cells
226825|NCT01996202|Melanoma|melanoma
226826|NCT01996176|Sedentary Lifestyle|sedentary lifestyle
226827|NCT01996176|Sedentary work|sedentary work
226828|NCT01996176|Office workers|office workers
226829|NCT01996176|Work|work
226830|NCT01996176|Workplace intervention|workplace intervention
278780|NCT01759615|SGA|sga
226831|NCT01996176|Sitting time|sitting time
226832|NCT01996150|atopic dermatitis|atopic dermatitis
226833|NCT01996150|eczema|eczema
226834|NCT01996150|bleach bath|bleach bath
226835|NCT01996150|itch|itch
226836|NCT01996150|skin barrier|skin barrier
226840|NCT01996137|Gait Speed|gait speed
226841|NCT01996124|COPD|copd
226842|NCT01996124|Pulmonary Hyperinflation|pulmonary hyperinflation
226843|NCT01996124|Ultra Long Acting Beta 2 Agonists|ultra long acting beta 2 agonists
226844|NCT01996124|Cor Pulmonale|cor pulmonale
226845|NCT01996124|Cardiac performance|cardiac performance
226846|NCT01996111|plantar fasciitis|plantar fasciitis
226847|NCT01996085|arterial hypertension|arterial hypertension
226848|NCT01996085|hemodynamics|hemodynamics
226849|NCT01996085|impedance cardiography|impedance cardiography
226850|NCT01996085|hypotensive therapy|hypotensive therapy
226851|NCT01996072|Primary hyperparathyroidism|primary hyperparathyroidism
226852|NCT01996072|Parathyroid|parathyroid
226853|NCT01996059|nutritional status|nutritional status
226854|NCT01996059|functional jejunal interposition|functional jejunal interposition
226855|NCT01996059|Roux-en-Y|roux-en-y
226856|NCT01996059|gastrectomy|gastrectomy
226857|NCT01996033|uncontrolled hypertension|uncontrolled hypertension
226858|NCT01996033|Renal Denervation|renal denervation
226859|NCT01996007|Pneumococcus|pneumococcus
226860|NCT01996007|Carriage|carriage
226861|NCT01996007|Children|children
226862|NCT01996007|Parents|parents
226863|NCT01996007|Immunogenicity|immunogenicity
226864|NCT01996007|PCV13|pcv13
226865|NCT01995981|Sarcoma, Soft Tissue|sarcoma, soft tissue
226866|NCT01995981|Pazopanib|pazopanib
226867|NCT01995981|Positron-Emission Tomography|positron-emission tomography
226868|NCT01995981|Pharmacokinetics|pharmacokinetics
226869|NCT01995981|Biomarker|biomarker
226870|NCT01995968|Stillbirth|stillbirth
226871|NCT01995968|Fetal growth restriction|fetal growth restriction
226872|NCT01995968|Small for gestational age|small for gestational age
226873|NCT01995968|Antenatal detection|antenatal detection
226874|NCT01995968|Prenatal Care|prenatal care
226875|NCT01995968|Mass Screening|mass screening
226876|NCT01995955|Coronary Microvascular Dysfunction|coronary microvascular dysfunction
226877|NCT01995955|coronary artery disease|coronary artery disease
226878|NCT01995955|index of myocardial resistance|index of myocardial resistance
226879|NCT01995942|Rectal Cancer|rectal cancer
226880|NCT01995942|EMVI|emvi
226881|NCT01995942|Extramural Venous Invasion|extramural venous invasion
226882|NCT01995942|Microarray|microarray
226883|NCT01995942|Biomarker|biomarker
226884|NCT01995942|mrEMVI|mremvi
226885|NCT01995942|Tumour Regression Grade|tumour regression grade
226886|NCT01995942|Cancer|cancer
226887|NCT01995942|Circumferential Resection Margin|circumferential resection margin
226889|NCT01995942|MRI|mri
226890|NCT01995942|Radiology|radiology
226891|NCT01995942|Surgery|surgery
226892|NCT01995942|Pathology|pathology
226893|NCT01995929|neurogenic dysphagia|neurogenic dysphagia
226894|NCT01995929|transnasal endoscopy|transnasal endoscopy
226895|NCT01995929|functional endoscopy|functional endoscopy
226896|NCT01995890|nepafenac eye drops|nepafenac eye drops
226897|NCT01995890|intraocular pressure|intraocular pressure
226898|NCT01995864|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
226899|NCT01995864|Community Psychiatry|community psychiatry
226900|NCT01995851|Influenza|influenza
226901|NCT01995851|Vaccine|vaccine
226902|NCT01995838|Chronic Insomnia|chronic insomnia
226903|NCT01995838|Adults|adults
226904|NCT01995838|Elderly|elderly
226905|NCT01995825|bioequivalence|bioequivalence
226906|NCT01995825|lamotrigine|lamotrigine
226907|NCT01995825|epilepsy|epilepsy
226908|NCT01995799|Myocardial Infarction (and related inflammation)|myocardial infarction (and related inflammation)
226909|NCT01995786|Fluid Therapy|fluid therapy
226910|NCT01995786|Cost-Benefit Analysis|cost-benefit analysis
226911|NCT01995786|Hemodynamics|hemodynamics
226912|NCT01995786|Cost Control|cost control
226913|NCT01995773|Healthy women|healthy women
226914|NCT01995773|Quality of life|quality of life
226915|NCT01995773|Glucose metabolism|glucose metabolism
226916|NCT01995773|Adrenal reactivity|adrenal reactivity
226917|NCT01995773|Physical activity|physical activity
226918|NCT01995773|Body Composition|body composition
226919|NCT01995760|vancomycin|vancomycin
226920|NCT01995760|therapeutic response monitoring|therapeutic response monitoring
226921|NCT01995760|AUC/MIC|auc/mic
226922|NCT01995747|IgE|ige
226923|NCT01995747|Atopic Dermatitis|atopic dermatitis
226924|NCT01995747|antibody|antibody
226925|NCT01995747|allergy|allergy
226926|NCT01995734|Acromegaly, Pituitary diseases|acromegaly, pituitary diseases
226927|NCT01995721|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
226928|NCT01995721|human papillomavirus|human papillomavirus
226929|NCT01995721|vaccine|vaccine
226930|NCT01995721|treatment|treatment
226931|NCT01995721|immunology|immunology
226932|NCT01995721|relapse|relapse
226933|NCT01995708|CT7|ct7
226934|NCT01995708|MAGE-A3|mage-a3
226935|NCT01995708|WT1 mRNA-electroporated Autologous Langerhans|wt1 mrna-electroporated autologous langerhans
226936|NCT01995708|vaccine|vaccine
226937|NCT01995708|Autologous Stem Cell Transplantation|autologous stem cell transplantation
226938|NCT01995708|13-009|13-009
226939|NCT01995682|Independent living|independent living
226940|NCT01995682|walk with or without walking aids|walk with or without walking aids
226941|NCT01995669|Lymphoma|lymphoma
226942|NCT01995669|Relapsed Indolent Non-Hodgkin's Lymphoma|relapsed indolent non-hodgkin's lymphoma
226943|NCT01995669|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
226945|NCT01995669|Relapsed/refractory indolent lymphoma|relapsed/refractory indolent lymphoma
226946|NCT01995669|Small lymphocytic lymphoma|small lymphocytic lymphoma
226947|NCT01995669|SLL|sll
226948|NCT01995669|Follicular lymphoma|follicular lymphoma
226949|NCT01995669|Marginal zone lymphoma|marginal zone lymphoma
226950|NCT01995669|Lenalidomide|lenalidomide
226951|NCT01995669|CC-5013|cc-5013
226952|NCT01995669|Revlimid|revlimid
226953|NCT01995669|Obinutuzumab|obinutuzumab
226954|NCT01995669|GA101|ga101
226955|NCT01995643|Grape seed extract|grape seed extract
226956|NCT01995643|Polyphenols|polyphenols
226957|NCT01995643|Insulin|insulin
226958|NCT01995643|Oxidative stress Marker|oxidative stress marker
226959|NCT01995643|Inflammatory marker|inflammatory marker
226960|NCT01995643|Healthy human|healthy human
226961|NCT01995617|vaccine|vaccine
226962|NCT01995617|Streptococcus pneumoniae|streptococcus pneumoniae
226963|NCT01995617|Strep pneumo|strep pneumo
226964|NCT01995591|colon cancer|colon cancer
226965|NCT01995591|sentinel lymph node|sentinel lymph node
226966|NCT01995591|Indocyanine Green|indocyanine green
226967|NCT01995578|5'-Azacitidine|5'-azacitidine
226968|NCT01995578|Stem cell transplant|stem cell transplant
226969|NCT01995578|13-192|13-192
226970|NCT01995552|Post myocardial infarction patients with low EF.|post myocardial infarction patients with low ef.
226971|NCT01995539|Type 2|type 2
226972|NCT01995500|CAD|cad
226973|NCT01995500|PCI|pci
226974|NCT01995500|ACS|acs
226975|NCT01995500|non ACS|non acs
226976|NCT01995500|BioNIR|bionir
226977|NCT01995500|DES|des
226978|NCT01995487|more comers|more comers
226979|NCT01995487|DES|des
226980|NCT01995487|BioNIR|bionir
226981|NCT01995487|ACS|acs
226982|NCT01995487|non ACS|non acs
226983|NCT01995487|complex lesions|complex lesions
226984|NCT01995474|EUS|eus
226985|NCT01995474|pancreatic cancer|pancreatic cancer
226986|NCT01995474|cytology|cytology
226987|NCT01995474|fine needle aspiration|fine needle aspiration
226988|NCT01995448|The acute phase of Sepsis|the acute phase of sepsis
226989|NCT01995448|multiparameter 8-color flow cytometry|multiparameter 8-color flow cytometry
226990|NCT01995422|Major depressive disorder|major depressive disorder
226991|NCT01995422|Follow-up study|follow-up study
226992|NCT01995422|Ecological momentary assessment|ecological momentary assessment
226993|NCT01995422|Physical activity|physical activity
226994|NCT01995422|Depression|depression
226995|NCT01995422|Self-esteem|self-esteem
226996|NCT01995422|Anxiety|anxiety
226997|NCT01995422|Rumination|rumination
226998|NCT01995422|Quality of life|quality of life
226999|NCT01995396|rectal cancer,|rectal cancer,
227000|NCT01995396|fecal incontinence,|fecal incontinence,
227001|NCT01995396|severe co-morbidity,|severe co-morbidity,
227002|NCT01995396|Hartmann´s procedure,|hartmann´s procedure,
227003|NCT01995396|abdominoperineal excision with intersphincteric dissection,|abdominoperineal excision with intersphincteric dissection,
227004|NCT01995396|postoperative complications,|postoperative complications,
227005|NCT01995396|pelvic abscess,|pelvic abscess,
227006|NCT01995396|perineal infections|perineal infections
227007|NCT01995370|Noncardioembolic cerebral infarction|noncardioembolic cerebral infarction
227008|NCT01995370|Dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
227009|NCT01995370|Cilostazol|cilostazol
227010|NCT01995370|Aspirin|aspirin
227011|NCT01995370|Clopidogrel|clopidogrel
227012|NCT01995331|aplastic anemia;|aplastic anemia;
227013|NCT01995331|cyclophosphamide;|cyclophosphamide;
227014|NCT01995331|immunosuppressive therapy;|immunosuppressive therapy;
227015|NCT01995331|cyclosporine A|cyclosporine a
227016|NCT01995318|Kinesiotaping|kinesiotaping
227017|NCT01995305|fanconi anemia|fanconi anemia
227018|NCT01995305|hematopoiesis maintainance|hematopoiesis maintainance
227019|NCT01995292|awake fiberoptic intubation|awake fiberoptic intubation
227020|NCT01995292|spray as you go technique|spray as you go technique
227021|NCT01995292|anesthesia|anesthesia
227022|NCT01995292|Enk Fiberoptic Atomizer Set|enk fiberoptic atomizer set
227023|NCT01995279|low back pain|low back pain
227024|NCT01995279|French Auriculotherapy|french auriculotherapy
227025|NCT01995279|postural control|postural control
227026|NCT01995279|balance|balance
227027|NCT01995279|posture|posture
227028|NCT01995240|pancreatic cancer|pancreatic cancer
227029|NCT01995240|MRI|mri
227030|NCT01995240|reproducibility|reproducibility
227031|NCT01995240|optimalization|optimalization
227032|NCT01995227|liver cancer|liver cancer
227033|NCT01995227|HCC|hcc
227034|NCT01995227|tumor vaccine|tumor vaccine
227035|NCT01995227|immunotherapy|immunotherapy
227036|NCT01995227|personalized anti-cancer vaccine|personalized anti-cancer vaccine
227037|NCT01995214|Postoperative delirium|postoperative delirium
227039|NCT01995214|General anesthesia|general anesthesia
227040|NCT01995214|Propofol|propofol
227041|NCT01995214|Sevoflurane|sevoflurane
227042|NCT01995175|Asthma|asthma
227043|NCT01995175|Respiratory Syncytial virus|respiratory syncytial virus
227044|NCT01995175|Cohort study|cohort study
227045|NCT01995175|Quarterly phone contacts|quarterly phone contacts
227046|NCT01995175|Wheeze|wheeze
227047|NCT01995175|New born|new born
227048|NCT01995175|Lower Respiratory Tract Infection|lower respiratory tract infection
227049|NCT01995149|Familial Hypercholesterolemia|familial hypercholesterolemia
227050|NCT01995149|Familial Combined Hypercholesterolemia|familial combined hypercholesterolemia
227051|NCT01995149|Weight loss; Lipids; Phytosterols|weight loss; lipids; phytosterols
227052|NCT01995149|Obesity|obesity
227053|NCT01995149|Overweight.|overweight.
227054|NCT01995149|Lipids|lipids
227055|NCT01995136|Glaucoma|glaucoma
227056|NCT01995136|Ocular hypertension|ocular hypertension
227057|NCT01995123|Tobacco dependence|tobacco dependence
227058|NCT01995123|PTSD|ptsd
227059|NCT01995123|Behavioral Activation Therapy|behavioral activation therapy
227060|NCT01995097|smoking cessation|smoking cessation
227061|NCT01995097|smoking reduction|smoking reduction
228560|NCT01987856|live birth|live birth
227062|NCT01995097|scheduled gradual reduction|scheduled gradual reduction
227063|NCT01995097|pregnancy|pregnancy
227064|NCT01995097|text message intervention|text message intervention
227065|NCT01995084|hypoxia|hypoxia
227066|NCT01995084|HX4|hx4
227067|NCT01995084|PET|pet
227068|NCT01995084|cancer|cancer
227069|NCT01995071|Chronic Hepatitis C|chronic hepatitis c
227070|NCT01995071|Cirrhosis|cirrhosis
227071|NCT01995071|Child Pugh A|child pugh a
227072|NCT01995071|Hepatitis C virus|hepatitis c virus
227073|NCT01995071|Compensated Cirrhosis|compensated cirrhosis
227074|NCT01995071|Hepatitis C Genotype 1|hepatitis c genotype 1
227075|NCT01995071|Hepatitis C|hepatitis c
227076|NCT01995071|Interferon-Free|interferon-free
227077|NCT01995071|Cirrhotic|cirrhotic
227078|NCT01995058|CRPC|crpc
227079|NCT01995058|castration resistant prostate cancer|castration resistant prostate cancer
227080|NCT01995058|prostate cancer|prostate cancer
227081|NCT01995045|Retina|retina
227082|NCT01995045|Vitreoretinal|vitreoretinal
227083|NCT01995045|Surgery|surgery
227084|NCT01995032|Duchenne's muscular dystrophy|duchenne's muscular dystrophy
227085|NCT01995032|DMD|dmd
227086|NCT01995019|Arthralgia|arthralgia
227087|NCT01995019|Temporomandibular joint|temporomandibular joint
227088|NCT01995019|corticosteroids|corticosteroids
227089|NCT01995019|injection|injection
227090|NCT01995019|intra-articular|intra-articular
227091|NCT01995006|Effect|effect
227092|NCT01995006|metamizole|metamizole
227093|NCT01995006|salt-depleted|salt-depleted
227094|NCT01995006|subjects|subjects
227095|NCT01994993|Antibiotics|antibiotics
227096|NCT01994993|ampicillin|ampicillin
227097|NCT01994993|metronidazole|metronidazole
227098|NCT01994993|clindamycin|clindamycin
227099|NCT01994993|piperacillin-tazobactam|piperacillin-tazobactam
227100|NCT01994993|Safety|safety
227101|NCT01994993|Infants|infants
227102|NCT01994993|Intra abdominal infections|intra abdominal infections
227103|NCT01994967|Phase III|phase iii
227104|NCT01994967|Noninferiority|noninferiority
227105|NCT01994967|Controlled|controlled
227106|NCT01994967|Double-blind|double-blind
227107|NCT01994967|Randomized|randomized
227108|NCT01994967|Spinal|spinal
227109|NCT01994967|Anesthetic|anesthetic
227110|NCT01994967|Lower limb|lower limb
227111|NCT01994954|newborn intensive care unit|newborn intensive care unit
227112|NCT01994954|NICU|nicu
227113|NCT01994954|supplemental oxygen|supplemental oxygen
227114|NCT01994941|Acute Coronary Syndrome|acute coronary syndrome
227115|NCT01994941|Platelet Reactivity|platelet reactivity
227116|NCT01994941|P2Y12 Receptor Blocker|p2y12 receptor blocker
227117|NCT01994941|CYP2C19 Genotyping|cyp2c19 genotyping
227118|NCT01994915|exacerbation|exacerbation
227119|NCT01994915|functionality|functionality
227120|NCT01994915|occupational therapy|occupational therapy
227121|NCT01994915|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
227122|NCT01994889|amyloidosis|amyloidosis
227123|NCT01994889|amyloid|amyloid
227124|NCT01994889|transthyretin|transthyretin
227125|NCT01994889|TTR|ttr
227126|NCT01994837|AML|aml
227127|NCT01994837|Acute Myelogenous Leukemia|acute myelogenous leukemia
227128|NCT01994837|Acute Myeloid Leukemia|acute myeloid leukemia
227129|NCT01994837|GDC-0199|gdc-0199
227130|NCT01994837|ABT-199|abt-199
227131|NCT01994837|Myeloid Leukemia|myeloid leukemia
227132|NCT01994811|cancer|cancer
227133|NCT01994811|cardiovascular disease|cardiovascular disease
227134|NCT01994811|diabetes|diabetes
227135|NCT01994785|Sedation|sedation
227136|NCT01994785|Endoscopy|endoscopy
227137|NCT01994785|Capnography|capnography
227138|NCT01994772|Therapeutic hypothermia|therapeutic hypothermia
279113|NCT01758042|CKD|ckd
227139|NCT01994772|Targeted controlled temperature|targeted controlled temperature
227140|NCT01994772|Cardiac arrest|cardiac arrest
227141|NCT01994772|Non shockable rhythm|non shockable rhythm
227142|NCT01994772|successful resuscitation|successful resuscitation
227143|NCT01994759|Plantar fasciitis|plantar fasciitis
227144|NCT01994759|Treatment|treatment
227145|NCT01994759|Training|training
227736|NCT01991704|Craving|craving
227146|NCT01994759|Glucocorticosteroid injection|glucocorticosteroid injection
227147|NCT01994746|Diabetes Mellitus|diabetes mellitus
227148|NCT01994746|Hypoglycemia|hypoglycemia
227149|NCT01994746|Glucagon|glucagon
227150|NCT01994733|end-stage renal disease|end-stage renal disease
227151|NCT01994733|hemodialysis|hemodialysis
227152|NCT01994733|mineral metabolism|mineral metabolism
227153|NCT01994733|serum phosphate|serum phosphate
227154|NCT01994733|phosphate binders|phosphate binders
227155|NCT01994720|Acute ischaemic stroke.|acute ischaemic stroke.
227156|NCT01994720|Transient ischaemic attack.|transient ischaemic attack.
227157|NCT01994707|Remote ischemic preconditioning|remote ischemic preconditioning
227158|NCT01994707|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
227159|NCT01994707|Troponin T|troponin t
227160|NCT01994707|Apoptosis|apoptosis
227161|NCT01994707|Experimental|experimental
227162|NCT01994707|Cardioprotection|cardioprotection
227163|NCT01994668|lorazepam|lorazepam
227164|NCT01994668|intravenous|intravenous
227165|NCT01994668|pharmacolinetics|pharmacolinetics
227167|NCT01994668|Japanese|japanese
227168|NCT01994655|climacteric symptoms|climacteric symptoms
227169|NCT01994655|menopause|menopause
227170|NCT01994655|nurses|nurses
227171|NCT01994629|meningococcal disease|meningococcal disease
227172|NCT01994629|children|children
227173|NCT01994629|vaccination|vaccination
227174|NCT01994616|Keloid, hypertrophic scar|keloid, hypertrophic scar
227175|NCT01994603|Prevention|prevention
227176|NCT01994603|HIV|hiv
227177|NCT01994603|AIDS|aids
227178|NCT01994603|Fetal Alcohol Syndrome (FAS)|fetal alcohol syndrome (fas)
227179|NCT01994603|Alcohol Related Neurodevelopmental Disorder (ARND)|alcohol related neurodevelopmental disorder (arnd)
227180|NCT01994590|Prostate Cancer|prostate cancer
227181|NCT01994590|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
227182|NCT01994590|mCRPC|mcrpc
227183|NCT01994590|Dovitinib|dovitinib
227184|NCT01994590|TKI258|tki258
227185|NCT01994590|Abiraterone Acetate|abiraterone acetate
227186|NCT01994590|Zytiga|zytiga
227187|NCT01994590|Prednisone|prednisone
227188|NCT01994577|Emergency Department|emergency department
227189|NCT01994577|Cardiac troponin|cardiac troponin
227190|NCT01994577|Myocardial infarction|myocardial infarction
227191|NCT01994564|OAG|oag
227192|NCT01994538|Urinary Tract Infections|urinary tract infections
227193|NCT01994538|Urinary antiinfective agents|urinary antiinfective agents
227194|NCT01994512|Spinal stenosis|spinal stenosis
227195|NCT01994512|Decompression|decompression
227196|NCT01994512|Fusion|fusion
227197|NCT01994512|Olisthesis|olisthesis
227198|NCT01994486|HCV Genotype 1|hcv genotype 1
227199|NCT01994486|Hepatitis C Virus Genotype 1|hepatitis c virus genotype 1
227200|NCT01994486|HCV|hcv
227201|NCT01994486|TVR|tvr
227202|NCT01994473|Schizophrenia|schizophrenia
227203|NCT01994460|Tuberculosis|tuberculosis
227204|NCT01994447|Informed Consent|informed consent
227205|NCT01994447|Instructional Films and Video|instructional films and video
227206|NCT01994447|Consent Comprehension|consent comprehension
227207|NCT01994447|Multimedia Consent|multimedia consent
227208|NCT01994447|Parent|parent
227209|NCT01994434|Deep branch of the ulnar nerve|deep branch of the ulnar nerve
227210|NCT01994434|Distal ulnar nerve compression|distal ulnar nerve compression
227211|NCT01994421|Facilitating kinesiotape|facilitating kinesiotape
227212|NCT01994421|Inhibiting kinesiotape|inhibiting kinesiotape
227213|NCT01994421|Classical tape|classical tape
227214|NCT01994421|No tape|no tape
227215|NCT01994408|physician inertia|physician inertia
227216|NCT01994408|hypertension|hypertension
227217|NCT01994408|telemedicine|telemedicine
227218|NCT01994408|mobile technology|mobile technology
227219|NCT01994395|Stroke|stroke
227220|NCT01994395|Gait|gait
227221|NCT01994395|Stride Management Assist|stride management assist
227222|NCT01994395|Mild-moderate Stroke, post 30 days or longer|mild-moderate stroke, post 30 days or longer
227223|NCT01994382|Leukemia|leukemia
227224|NCT01994382|Lymphocytic|lymphocytic
227225|NCT01994382|Chronic|chronic
227226|NCT01994382|B Cell|b cell
227227|NCT01994369|Breast Cancer|breast cancer
227228|NCT01994356|Contraceptive counseling|contraceptive counseling
227229|NCT01994356|Physician self disclosure|physician self disclosure
227230|NCT01994356|Satisfaction|satisfaction
227231|NCT01994356|Intrauterine contraceptive use|intrauterine contraceptive use
227232|NCT01994343|Chronic pelvic pain, women, pain, posture.|chronic pelvic pain, women, pain, posture.
227233|NCT01994330|acquired von Willebrand disease|acquired von willebrand disease
227234|NCT01994330|severe aortic stenosis|severe aortic stenosis
227235|NCT01994330|Heye´s syndrome|heye´s syndrome
227236|NCT01994330|desmopressin|desmopressin
227237|NCT01994330|von Willebrand multimers|von willebrand multimers
227238|NCT01994304|Safe Childbirth Checklist|safe childbirth checklist
227239|NCT01994304|Intrapartum mortality, Quality of Institutional delivery care|intrapartum mortality, quality of institutional delivery care
227240|NCT01994304|Maternal & newborn care practices|maternal & newborn care practices
227241|NCT01994291|Chemokine Antagonist|chemokine antagonist
227242|NCT01994291|Diabetic Macular Edema|diabetic macular edema
227244|NCT01994291|Diabetes Mellitus|diabetes mellitus
227245|NCT01994291|Macular Edema|macular edema
227246|NCT01994291|Diabetic Retinopathy|diabetic retinopathy
227247|NCT01994291|Anti-VEGF|anti-vegf
227248|NCT01994265|Atrial fibrillation|atrial fibrillation
227249|NCT01994265|Cognition|cognition
227250|NCT01994265|Cognitive impairment|cognitive impairment
227251|NCT01994265|Anticoagulation|anticoagulation
227252|NCT01994265|Dabigatran|dabigatran
227253|NCT01994265|Warfarin|warfarin
227254|NCT01994265|Efficacy|efficacy
227255|NCT01994252|defibrillator|defibrillator
227256|NCT01994252|cardiac resynchronization|cardiac resynchronization
227257|NCT01994239|Prostate-Specific Antigen|prostate-specific antigen
227258|NCT01994239|LHRH antagonist|lhrh antagonist
227259|NCT01994239|Radiotherapy|radiotherapy
227260|NCT01994213|Famitinib|famitinib
227261|NCT01994213|Gastroenteropancreatic Neuroendocrine Tumor|gastroenteropancreatic neuroendocrine tumor
227262|NCT01994213|GEPNET|gepnet
227263|NCT01994200|Thyroid cancer|thyroid cancer
227264|NCT01994200|New diagnosis|new diagnosis
227265|NCT01994200|Dedicated Nurse|dedicated nurse
227266|NCT01994200|Interdisciplinary team|interdisciplinary team
227267|NCT01994200|Randomized Controlled Trial|randomized controlled trial
227268|NCT01994200|Intervention|intervention
227269|NCT01994200|Supportive care|supportive care
227270|NCT01994187|Carotid stenosis|carotid stenosis
227271|NCT01994187|Angioplasty|angioplasty
227272|NCT01994187|Carotid endarterectomy|carotid endarterectomy
227273|NCT01994187|Stroke|stroke
227274|NCT01994174|vascular|vascular
227275|NCT01994174|retina|retina
227276|NCT01994174|Anti-VEGF|anti-vegf
227277|NCT01994174|Aqueous humor dynamics|aqueous humor dynamics
227278|NCT01994161|ischemic stroke|ischemic stroke
227279|NCT01994161|intracranial stenting|intracranial stenting
227280|NCT01994161|vascular risk factor management|vascular risk factor management
227281|NCT01994148|Trauma|trauma
227282|NCT01994148|Gastrointestinal injury|gastrointestinal injury
227283|NCT01994148|Laparoscopy|laparoscopy
227284|NCT01994109|Sialorrhea|sialorrhea
227285|NCT01994109|Parkinson's disease|parkinson's disease
227286|NCT01994109|Amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
227287|NCT01994109|stroke|stroke
227288|NCT01994109|neuroleptics|neuroleptics
227289|NCT01994057|Non-small cell lung cancer (NSCLC);|non-small cell lung cancer (nsclc);
227290|NCT01994057|EGFR-TKI;|egfr-tki;
227291|NCT01994057|Pharmacogenetics;|pharmacogenetics;
227292|NCT01994057|Precision medicine|precision medicine
227293|NCT01994057|somatic mutations ,germline mutations;|somatic mutations ,germline mutations;
227294|NCT01994044|Whiplash, surgery, multimodal rehabilitation, independent examiners|whiplash, surgery, multimodal rehabilitation, independent examiners
227295|NCT01994031|paclitaxel liposome injection|paclitaxel liposome injection
227296|NCT01994031|paclitaxel|paclitaxel
227297|NCT01994018|Vitamin D|vitamin d
227298|NCT01994018|Interferon Beta|interferon beta
227299|NCT01994018|Glatiramer Acetate|glatiramer acetate
227300|NCT01994018|Relapse rates|relapse rates
227301|NCT01993992|Anesthesia|anesthesia
227302|NCT01993979|Adjuvant chemotherapy|adjuvant chemotherapy
227303|NCT01993979|Surveillance|surveillance
227304|NCT01993979|Nephro-ureterectomy|nephro-ureterectomy
227305|NCT01993966|Urothelial carcinoma (UC),|urothelial carcinoma (uc),
227306|NCT01993966|(-)-epigallocatechin-3-gallate(EGCG),|(-)-epigallocatechin-3-gallate(egcg),
227307|NCT01993966|chemotherapy,|chemotherapy,
227308|NCT01993966|cytotoxicity,|cytotoxicity,
227309|NCT01993966|drug resistance,|drug resistance,
227310|NCT01993966|xenograft.|xenograft.
227311|NCT01993953|Muscle strength|muscle strength
227312|NCT01993953|Body composition|body composition
227313|NCT01993953|Body weight|body weight
227314|NCT01993953|Resistance training|resistance training
227315|NCT01993953|Personal training|personal training
227316|NCT01993953|BodyPump|bodypump
227317|NCT01993940|Opioid-induced Constipation|opioid-induced constipation
227318|NCT01993927|Drug Therapy|drug therapy
227319|NCT01993901|lung SBRT, ESAS, anxiety|lung sbrt, esas, anxiety
227320|NCT01993888|Hepatobiliary Surgery|hepatobiliary surgery
227321|NCT01993849|Anxiety|anxiety
227322|NCT01993849|Impulse control|impulse control
227323|NCT01993849|Depression|depression
227324|NCT01993849|ADHD|adhd
227325|NCT01993849|Fingernail Biting|fingernail biting
227326|NCT01993849|N-Acetylcysteine|n-acetylcysteine
227327|NCT01993849|NAC|nac
227328|NCT01993836|isoflurane|isoflurane
227329|NCT01993836|propofol|propofol
227330|NCT01993836|total intravenous anesthesia|total intravenous anesthesia
227331|NCT01993836|inhaled anesthetic|inhaled anesthetic
227332|NCT01993836|volatile anesthetic|volatile anesthetic
227333|NCT01993836|anesthesia|anesthesia
227334|NCT01993836|delirium|delirium
227335|NCT01993836|Post Operative Cognitive Dysfunction|post operative cognitive dysfunction
227336|NCT01993836|Alzheimer's Disease|alzheimer's disease
227337|NCT01993836|Mild Cognitive Impairment|mild cognitive impairment
227338|NCT01993810|Non small cell lung cancer|non small cell lung cancer
227339|NCT01993810|NSCLC|nsclc
227340|NCT01993810|proton radiotherapy|proton radiotherapy
227341|NCT01993797|Bronchiolitis|bronchiolitis
227342|NCT01993758|tourniquet pressure|tourniquet pressure
227343|NCT01993758|total knee arthroplasty|total knee arthroplasty
227344|NCT01993745|ECMO|ecmo
227345|NCT01993745|APACH II score|apach ii score
227346|NCT01993732|Cancer|cancer
227347|NCT01993732|Cryopreservation|cryopreservation
227348|NCT01993732|Ovarian Function|ovarian function
227349|NCT01993732|In Vitro|in vitro
227350|NCT01993719|Metastatic|metastatic
227351|NCT01993719|Melanoma|melanoma
227352|NCT01993719|Adoptive Cell Therapy|adoptive cell therapy
227353|NCT01993706|Broadly HIV-1 Neutralizing Activity|broadly hiv-1 neutralizing activity
227354|NCT01993706|Healthy Adults|healthy adults
227355|NCT01993706|Placebo|placebo
227356|NCT01993706|HIV Prevention|hiv prevention
227357|NCT01993706|Monoclonal Antibodies|monoclonal antibodies
227358|NCT01993706|Antibodies|antibodies
227359|NCT01993693|knee|knee
227360|NCT01993693|pain|pain
227361|NCT01993693|osteoarthritis|osteoarthritis
227362|NCT01993693|ultrasound|ultrasound
227363|NCT01993654|Pigmented Lesions|pigmented lesions
227365|NCT01993654|Ocular lesion|ocular lesion
227366|NCT01993641|Myelodysplastic Syndrome|myelodysplastic syndrome
227367|NCT01993641|MDS|mds
227368|NCT01993641|pracinostat|pracinostat
227369|NCT01993641|Hypomethylating Agent|hypomethylating agent
227370|NCT01993641|HMA|hma
227371|NCT01993641|azacitadine|azacitadine
227372|NCT01993641|Vidaza|vidaza
227373|NCT01993641|decitabine|decitabine
227374|NCT01993641|dacogen|dacogen
227375|NCT01993615|FAI|fai
227376|NCT01993615|femoroacetabular impingement|femoroacetabular impingement
227377|NCT01993615|hip pain|hip pain
227378|NCT01993615|hip arthroscopy|hip arthroscopy
227379|NCT01993615|physical therapy|physical therapy
227380|NCT01993602|general surgery|general surgery
227381|NCT01993602|postoperative care|postoperative care
227382|NCT01993602|breathing exercises|breathing exercises
227383|NCT01993602|respiratory muscle|respiratory muscle
227384|NCT01993602|postoperative complications|postoperative complications
227385|NCT01993602|lung volume measurements|lung volume measurements
227386|NCT01993602|pulmonary ventilations|pulmonary ventilations
227387|NCT01993602|thoracic wall|thoracic wall
227388|NCT01993589|Curettage; analgesia; paracetamol; lidocaine; Dexketoprofen trometamol; pethidine; diclofenac.|curettage; analgesia; paracetamol; lidocaine; dexketoprofen trometamol; pethidine; diclofenac.
227389|NCT01993563|Stroke|stroke
227390|NCT01993563|Rehabilitation|rehabilitation
227391|NCT01993563|Motor Imagery|motor imagery
227392|NCT01993563|Upper Extremity|upper extremity
227393|NCT01993563|Mirror Therapy|mirror therapy
227394|NCT01993550|lung cancer|lung cancer
227395|NCT01993550|family caregiving|family caregiving
227396|NCT01993550|behavioral intervention|behavioral intervention
227397|NCT01993550|counseling|counseling
227398|NCT01993550|symptom management|symptom management
227399|NCT01993498|cancer toxicities|cancer toxicities
227400|NCT01993498|cohort|cohort
227401|NCT01993498|breast cancer|breast cancer
227402|NCT01993485|transaortic valve replacement (TAVI)|transaortic valve replacement (tavi)
227403|NCT01993485|endothelial function|endothelial function
227404|NCT01993485|circulating microparticles|circulating microparticles
227405|NCT01993459|Quality of Recovery|quality of recovery
227406|NCT01993394|human centrifuge, oxygen, imaging, stroke volume, lung|human centrifuge, oxygen, imaging, stroke volume, lung
227407|NCT01993381|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
227408|NCT01993368|wisdom teeth extraction|wisdom teeth extraction
227409|NCT01993355|non-specific chronic low back pain,|non-specific chronic low back pain,
227410|NCT01993355|health-related quality of life,|health-related quality of life,
227411|NCT01993355|physioterapy,|physioterapy,
227412|NCT01993355|sophrology,|sophrology,
227413|NCT01993355|cognitive-behavioral therapy,|cognitive-behavioral therapy,
227414|NCT01993355|motivational interviewing|motivational interviewing
227415|NCT01993342|adipocytokines|adipocytokines
227416|NCT01993342|osteoarthritis|osteoarthritis
227417|NCT01993342|inflammation|inflammation
227418|NCT01993342|ultrasonography|ultrasonography
227419|NCT01993316|neurofeedback|neurofeedback
227420|NCT01993316|EEG|eeg
227421|NCT01993316|transcranial magnetic stimulation|transcranial magnetic stimulation
227422|NCT01993303|Myocardial Perfusion Imaging|myocardial perfusion imaging
227423|NCT01993303|PET|pet
227424|NCT01993303|Rb-82|rb-82
227425|NCT01993264|Heart disease|heart disease
227426|NCT01993264|Echocardiogram|echocardiogram
227427|NCT01993264|Ultrasound|ultrasound
227428|NCT01993264|Heart defect|heart defect
227429|NCT01993264|Heart Dysfunction|heart dysfunction
227430|NCT01993264|Pediatric Cardiologists|pediatric cardiologists
227431|NCT01993264|Prenatal|prenatal
227432|NCT01993251|sleep,melatonin,autism,children|sleep,melatonin,autism,children
227433|NCT01993225|Low Testosterone|low testosterone
227434|NCT01993212|Low Testosterone|low testosterone
227435|NCT01993186|Glucose Transporter Type 1 Deficiency Syndrome Glut1|glucose transporter type 1 deficiency syndrome glut1
227436|NCT01993173|Diphtheria|diphtheria
227437|NCT01993173|Tetanus|tetanus
227438|NCT01993173|Pertussis|pertussis
227439|NCT01993173|ADACEL®|adacel®
227440|NCT01993173|Tdap vaccine|tdap vaccine
227441|NCT01993160|Fluorocholine (FCH)|fluorocholine (fch)
227442|NCT01993160|Positron emission tomography (PET)|positron emission tomography (pet)
227443|NCT01993160|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
227444|NCT01993147|Methylphenidate|methylphenidate
227445|NCT01993147|Placebo|placebo
227571|NCT01992523|antiplatelet|antiplatelet
227446|NCT01993147|functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
227447|NCT01993147|Attention Control|attention control
227448|NCT01993134|Postoperative infection|postoperative infection
227449|NCT01993134|Antibiotic prophylaxis|antibiotic prophylaxis
227450|NCT01993134|Cefazolin|cefazolin
227451|NCT01993121|diabetes|diabetes
227452|NCT01993121|exercise|exercise
227453|NCT01993121|heart|heart
227454|NCT01993121|cardiovascular|cardiovascular
227455|NCT01993108|Methylphenidate|methylphenidate
227456|NCT01993108|Naltrexone|naltrexone
227457|NCT01993108|Placebo|placebo
227458|NCT01993108|Neuroimaging|neuroimaging
227459|NCT01993108|Prefrontal Control Circuits|prefrontal control circuits
228561|NCT01987843|Psoriasis|psoriasis
227460|NCT01993108|Attention Control|attention control
227461|NCT01993108|Motor Control|motor control
227462|NCT01993108|Appetitive Control|appetitive control
227463|NCT01993095|Multiple Sclerosis|multiple sclerosis
227464|NCT01993095|Quality of Life|quality of life
227465|NCT01993095|Functional Fitness|functional fitness
227466|NCT01993082|Caregivers|caregivers
227467|NCT01993082|Telomerase|telomerase
227468|NCT01993082|Telomere Length|telomere length
227469|NCT01993082|Psychological Stress|psychological stress
227470|NCT01993082|Cardiovascular Risk|cardiovascular risk
227471|NCT01993082|Exercise|exercise
227472|NCT01993056|injury incidence, male veteran soccer, 11+, Functional Movement Screen, FMS, warm-up|injury incidence, male veteran soccer, 11+, functional movement screen, fms, warm-up
227474|NCT01993043|Bevacizumab|bevacizumab
227475|NCT01993043|Laser|laser
227476|NCT01993043|Development|development
227477|NCT01993017|Acute Coronary Syndrome|acute coronary syndrome
227478|NCT01993017|Depressive Symptoms|depressive symptoms
227479|NCT01992991|transcranial stimulation|transcranial stimulation
227480|NCT01992991|Intracranial hemorrhage|intracranial hemorrhage
227481|NCT01992991|Home training|home training
227482|NCT01992991|Occupational Therapy|occupational therapy
227483|NCT01992991|Jebsen Taylor Hand Function Test|jebsen taylor hand function test
227484|NCT01992978|radiofrequency-assisted（RF）|radiofrequency-assisted（rf）
227485|NCT01992978|hepatectomy|hepatectomy
227486|NCT01992978|postoperative liver injury|postoperative liver injury
227487|NCT01992965|continuous glucose monitoring；|continuous glucose monitoring；
227488|NCT01992965|critically ill;|critically ill;
227489|NCT01992939|pulse|pulse
227490|NCT01992939|heat|heat
227491|NCT01992939|blood circulation|blood circulation
227492|NCT01992926|health literacy|health literacy
227493|NCT01992926|health numeracy|health numeracy
227494|NCT01992913|Schizophrenia|schizophrenia
227495|NCT01992913|Cognitive Behavioral Therapy|cognitive behavioral therapy
227496|NCT01992913|Cognition|cognition
227497|NCT01992913|Vocational Rehabilitation|vocational rehabilitation
227498|NCT01992913|Supported Employment|supported employment
227499|NCT01992913|Schizoaffective Disorder|schizoaffective disorder
227500|NCT01992900|Plasmodium falciparum Malaria|plasmodium falciparum malaria
227501|NCT01992900|Eurartesim|eurartesim
227502|NCT01992900|ACT|act
227503|NCT01992887|HIV/AIDS|hiv/aids
227504|NCT01992887|Retention|retention
227505|NCT01992887|ART (anti-retroviral therapy) ineligible|art (anti-retroviral therapy) ineligible
227506|NCT01992874|Neoplasms|neoplasms
227507|NCT01992874|Pimasertib|pimasertib
227508|NCT01992874|Cancer|cancer
227509|NCT01992822|rTMS|rtms
227510|NCT01992822|fibromyalgia|fibromyalgia
227511|NCT01992822|experimental pain|experimental pain
227512|NCT01992809|Nonalcoholic fatty liver|nonalcoholic fatty liver
227513|NCT01992809|omega 3|omega 3
227514|NCT01992796|irbesartan, angiotensin, sepsis|irbesartan, angiotensin, sepsis
227515|NCT01992783|Resistant Starch|resistant starch
227516|NCT01992783|Antioxidant Status|antioxidant status
227517|NCT01992783|Insulin Resistance|insulin resistance
227518|NCT01992783|Overweight|overweight
227519|NCT01992783|Obesity|obesity
227520|NCT01992770|behavioural medicine|behavioural medicine
227521|NCT01992770|pain|pain
227522|NCT01992770|physical therapy|physical therapy
227523|NCT01992770|physical exercise|physical exercise
227524|NCT01992770|primary care|primary care
218279|NCT02034838|PK|pk
227525|NCT01992757|functional fibrinogen assay|functional fibrinogen assay
227526|NCT01992757|cardiac surgery|cardiac surgery
227527|NCT01992744|pregnancy|pregnancy
227528|NCT01992744|brain-derived neurotrophic factor|brain-derived neurotrophic factor
227529|NCT01992744|birth outcomes|birth outcomes
686384|NCT00906997|Prevention|prevention
227530|NCT01992731|Age (38-42 years)|age (38-42 years)
227531|NCT01992731|pregnancy rates|pregnancy rates
227532|NCT01992731|3 IUI cycles|3 iui cycles
227533|NCT01992731|1 IVF/ICSI cycle|1 ivf/icsi cycle
227534|NCT01992705|pancreatic cancer|pancreatic cancer
227535|NCT01992692|Parkinson's disease|parkinson's disease
227536|NCT01992692|remifentanil|remifentanil
227537|NCT01992692|deep brain stimulator|deep brain stimulator
227538|NCT01992692|cardiovascular response|cardiovascular response
227539|NCT01992666|Systemic lupus erythematosus|systemic lupus erythematosus
227540|NCT01992666|genetic|genetic
227541|NCT01992666|immunological|immunological
227542|NCT01992666|pediatric|pediatric
227543|NCT01992666|mutation|mutation
227544|NCT01992666|lupus|lupus
227545|NCT01992627|High Intensity Laser Therapy|high intensity laser therapy
227546|NCT01992627|elbow epicondylosis|elbow epicondylosis
227547|NCT01992614|Single Ascending Dose|single ascending dose
227548|NCT01992614|healthy subjects|healthy subjects
227549|NCT01992614|Hypercholesterolemia|hypercholesterolemia
227550|NCT01992614|Hyperlipidemias|hyperlipidemias
227551|NCT01992614|Dyslipidemias|dyslipidemias
227552|NCT01992614|Lipid Metabolism Disorders|lipid metabolism disorders
227553|NCT01992614|Metabolic Diseases|metabolic diseases
227554|NCT01992601|Drug interaction|drug interaction
227555|NCT01992601|Rosuvastatin|rosuvastatin
227556|NCT01992601|Telmisartan|telmisartan
227557|NCT01992601|Pharmacokinetic|pharmacokinetic
227558|NCT01992601|(Pharmacokinetics and Drug Interaction)|(pharmacokinetics and drug interaction)
227559|NCT01992575|Retinal vein occlusion|retinal vein occlusion
227560|NCT01992575|OCT|oct
227561|NCT01992575|Optical coherence tomography|optical coherence tomography
227562|NCT01992575|Imaging|imaging
227563|NCT01992536|Meningococcal|meningococcal
227564|NCT01992536|Booster|booster
227565|NCT01992536|MenABCWY|menabcwy
227566|NCT01992536|Menveo|menveo
227567|NCT01992536|Vaccine Adolescents|vaccine adolescents
227568|NCT01992536|Immune Response|immune response
227569|NCT01992536|N. Meningitidis|n. meningitidis
227570|NCT01992523|Ticagrelor|ticagrelor
227572|NCT01992523|Acute Coronary Syndrome|acute coronary syndrome
227573|NCT01992497|Cesarean section, probiotic, formula fed, gut microbiota|cesarean section, probiotic, formula fed, gut microbiota
227574|NCT01992484|platelets, Acute coronary Syndrome (ACS), prasugrel, ticagrelor, aspirin|platelets, acute coronary syndrome (acs), prasugrel, ticagrelor, aspirin
227575|NCT01992471|BRCA1 testing|brca1 testing
227576|NCT01992471|BRCA2 testing|brca2 testing
227577|NCT01992471|13-215|13-215
227578|NCT01992458|implantable cardioverter defibrillator|implantable cardioverter defibrillator
227579|NCT01992458|death|death
227580|NCT01992458|shock|shock
227581|NCT01992458|mortality|mortality
227582|NCT01992458|complication|complication
227583|NCT01992458|sudden death|sudden death
227584|NCT01992445|suicide|suicide
227585|NCT01992445|suicidal intent|suicidal intent
227586|NCT01992445|thought markers|thought markers
227587|NCT01992432|Brain magnetic resonance imaging|brain magnetic resonance imaging
227588|NCT01992432|chemotherapy toxicity|chemotherapy toxicity
227589|NCT01992432|older woman|older woman
227590|NCT01992432|breast cancer|breast cancer
227591|NCT01992419|Out-of-hospital Cardiac arrest|out-of-hospital cardiac arrest
227592|NCT01992419|telephone dispatch assisted resuscitation|telephone dispatch assisted resuscitation
227593|NCT01992419|cardiac arrest phone detection|cardiac arrest phone detection
227594|NCT01992393|Epilepsy|epilepsy
227595|NCT01992393|Schizophrenia|schizophrenia
227596|NCT01992393|Schizoaffective Disorder|schizoaffective disorder
227597|NCT01992393|Bipolar Disorder|bipolar disorder
227598|NCT01992393|Depression|depression
227599|NCT01992393|Intervention|intervention
227600|NCT01992393|Treatment|treatment
227601|NCT01992393|Adherence|adherence
227602|NCT01992341|sarcomas|sarcomas
227603|NCT01992341|carcinomas|carcinomas
227604|NCT01992328|Immunoglobulin G Deficiency|immunoglobulin g deficiency
227605|NCT01992315|Scar|scar
227606|NCT01992315|Soft tissue defect|soft tissue defect
227607|NCT01992302|Rapid cycling|rapid cycling
227608|NCT01992289|XLHED|xlhed
227609|NCT01992289|HED|hed
227610|NCT01992289|Hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
227611|NCT01992289|Christ-Siemens-Touraine Syndrome|christ-siemens-touraine syndrome
227612|NCT01992276|Influenza|influenza
227613|NCT01992276|Virus|virus
227614|NCT01992276|Monoclonal Antibody|monoclonal antibody
227615|NCT01992276|Immunization|immunization
227616|NCT01992276|Treatment|treatment
227617|NCT01992263|tuberculosis|tuberculosis
227618|NCT01992263|vitamin D|vitamin d
227619|NCT01992263|immunity|immunity
227620|NCT01992250|Cryoablation|cryoablation
218354|NCT02034370|Sleep Disordered Breathing|sleep disordered breathing
218355|NCT02034357|Parkinson Disease|parkinson disease
218356|NCT02034357|Sleep Disordered Breathing|sleep disordered breathing
218357|NCT02034357|Sleep Obstructive Apnea|sleep obstructive apnea
227621|NCT01992237|ALI,|ali,
227622|NCT01992237|ARDS,|ards,
227623|NCT01992237|ECMO,|ecmo,
227624|NCT01992237|energy expenditure,|energy expenditure,
227625|NCT01992237|mechanical ventilation,|mechanical ventilation,
227626|NCT01992237|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
227627|NCT01992237|Nutrition Assessment|nutrition assessment
227628|NCT01992237|Pulmonary Ventilation|pulmonary ventilation
227629|NCT01992224|severe acute pancreatitis|severe acute pancreatitis
227630|NCT01992224|mechanical ventilation|mechanical ventilation
227631|NCT01992198|antibiothearpy strategy|antibiothearpy strategy
227632|NCT01992198|cefoperazone|cefoperazone
227633|NCT01992198|metronidazole|metronidazole
227634|NCT01992198|meropenem|meropenem
227635|NCT01992159|Osteoporosis, Osteoporosis-Postmenopausal, Bone Diseases-Metabolic, Bone Diseases, Musculoskeletal Diseases|osteoporosis, osteoporosis-postmenopausal, bone diseases-metabolic, bone diseases, musculoskeletal diseases
227636|NCT01992146|central sensitization|central sensitization
227637|NCT01992146|endogenous opioids|endogenous opioids
227638|NCT01992146|humans|humans
227639|NCT01992146|latent sensitization|latent sensitization
227640|NCT01992146|naloxone|naloxone
227641|NCT01992146|open groin hernia repair|open groin hernia repair
227642|NCT01992146|pain|pain
227643|NCT01992146|randomized controlled trial|randomized controlled trial
227644|NCT01992146|secondary hyperalgesia|secondary hyperalgesia
227645|NCT01992146|target-controlled infusion|target-controlled infusion
227646|NCT01992133|Former gestational Diabetes|former gestational diabetes
227647|NCT01992133|Vitamin D deficiency|vitamin d deficiency
227648|NCT01992133|insulin resistance|insulin resistance
228862|NCT01986348|brain tumor|brain tumor
227649|NCT01992133|beta cell function|beta cell function
227650|NCT01992120|Simulation|simulation
227651|NCT01992120|Sepsis|sepsis
227652|NCT01992120|High-fidelity|high-fidelity
227653|NCT01992120|Severe Sepsis|severe sepsis
227654|NCT01992120|Septic Shock|septic shock
227655|NCT01992120|Education|education
227656|NCT01992107|Influenza|influenza
227657|NCT01992107|Influenza vaccine|influenza vaccine
227658|NCT01992107|Novartis|novartis
227659|NCT01992107|children|children
227660|NCT01992094|Influenza|influenza
227661|NCT01992094|Influenza vaccine|influenza vaccine
227662|NCT01992094|Novartis|novartis
227663|NCT01992094|Adults|adults
227664|NCT01992081|COPD, Physical Activity, Telecoaching, PROactive|copd, physical activity, telecoaching, proactive
227665|NCT01992068|lung cancer|lung cancer
227666|NCT01992055|Executive dysfunction|executive dysfunction
227667|NCT01992055|Neuropsychological rehabilitation|neuropsychological rehabilitation
227668|NCT01992055|Goal Management Training|goal management training
227670|NCT01992029|miRNA|mirna
227671|NCT01992029|biomarker|biomarker
227672|NCT01992029|monocentric observational study|monocentric observational study
227673|NCT01992016|Prostate cancer|prostate cancer
227674|NCT01992016|F18 FDG-PET|f18 fdg-pet
227675|NCT01992016|Imaging|imaging
227676|NCT01992016|Ranolazine|ranolazine
227677|NCT01992016|Bone metastases|bone metastases
227678|NCT01992016|Soft tissue metastases|soft tissue metastases
227679|NCT01991964|stridor|stridor
227680|NCT01991964|laryngomalacia|laryngomalacia
227681|NCT01991964|ultrasound|ultrasound
227682|NCT01991938|PI3K Inhibitor|pi3k inhibitor
227683|NCT01991938|mTOR Inhibitor|mtor inhibitor
227684|NCT01991938|Dual PI3K/mTOR Inhibitor|dual pi3k/mtor inhibitor
227685|NCT01991938|CSC|csc
227686|NCT01991938|Cancer Stem Cells|cancer stem cells
227687|NCT01991912|irrigation endoscopic decompression|irrigation endoscopic decompression
227688|NCT01991912|minimally invasive surgery|minimally invasive surgery
227689|NCT01991912|spinal stenosis|spinal stenosis
227690|NCT01991899|Measles, mumps and rubella vaccine|measles, mumps and rubella vaccine
227691|NCT01991899|Tetraviral vaccine|tetraviral vaccine
227692|NCT01991899|Immunogenicity, Reactogenicity and Safety|immunogenicity, reactogenicity and safety
227693|NCT01991899|Consistency of production|consistency of production
227694|NCT01991886|nasal High Flow|nasal high flow
227695|NCT01991886|premature baby|premature baby
227696|NCT01991886|CPAP (Continuous positive airways pressure)|cpap (continuous positive airways pressure)
227697|NCT01991873|metastatic colorectal cancer|metastatic colorectal cancer
227698|NCT01991873|maintenance therapy|maintenance therapy
227699|NCT01991873|Panitumumab|panitumumab
227700|NCT01991873|Vectibix®|vectibix®
227701|NCT01991847|colon|colon
227702|NCT01991847|cancer|cancer
227703|NCT01991847|prevention|prevention
227704|NCT01991847|exercise|exercise
227705|NCT01991847|physical|physical
227706|NCT01991847|activity|activity
227707|NCT01991834|laparoscopy|laparoscopy
227708|NCT01991834|surgical wound infection|surgical wound infection
227709|NCT01991834|antibiotic prophylaxis|antibiotic prophylaxis
227710|NCT01991834|gynecologic surgical procedures|gynecologic surgical procedures
227711|NCT01991795|Diabetes|diabetes
227712|NCT01991795|Coronary artery disease|coronary artery disease
227713|NCT01991795|Outcome|outcome
227714|NCT01991795|Prevention|prevention
227715|NCT01991795|Antiplatelet|antiplatelet
227716|NCT01991782|Telemedicine|telemedicine
227717|NCT01991782|Fracture|fracture
227718|NCT01991782|Orthopaedics|orthopaedics
227719|NCT01991769|exercise|exercise
227720|NCT01991769|endothelium|endothelium
227721|NCT01991769|postprandial period|postprandial period
227722|NCT01991756|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
227723|NCT01991756|AAA|aaa
227724|NCT01991743|Version|version
227725|NCT01991743|Pregnancy|pregnancy
227726|NCT01991743|Vaginal Delivery|vaginal delivery
227727|NCT01991743|Pain Control|pain control
227728|NCT01991743|Combined Spinal Epidural|combined spinal epidural
227729|NCT01991717|Victus|victus
227730|NCT01991717|lensfragmentation|lensfragmentation
227731|NCT01991717|femtosecond laser assisted|femtosecond laser assisted
227732|NCT01991717|capsulotomy,|capsulotomy,
227733|NCT01991717|manual, continuous curvilinear capsulorhexis (CCC)|manual, continuous curvilinear capsulorhexis (ccc)
227734|NCT01991717|effective phaco time, phaco|effective phaco time, phaco
227737|NCT01991704|alcohol dependence|alcohol dependence
227738|NCT01991691|Antineoplastic Agents|antineoplastic agents
227739|NCT01991665|Intrapartum Ultrasound|intrapartum ultrasound
227740|NCT01991665|Vacuum|vacuum
227741|NCT01991665|Occiput position|occiput position
227742|NCT01991652|Wilms tumour|wilms tumour
227743|NCT01991652|Childhood cancer|childhood cancer
227744|NCT01991652|Africa|africa
227745|NCT01991639|frailty|frailty
227746|NCT01991639|community-dwelling|community-dwelling
227747|NCT01991639|malnutrition|malnutrition
227748|NCT01991639|physical activity|physical activity
227749|NCT01991639|nutritional intervention|nutritional intervention
227750|NCT01991600|iron absorption|iron absorption
227751|NCT01991600|bioavailability|bioavailability
227752|NCT01991600|anaemia|anaemia
227753|NCT01991600|iron deficiency|iron deficiency
227754|NCT01991600|ferrous sulphate|ferrous sulphate
227755|NCT01991587|Influenza|influenza
227756|NCT01991587|Human|human
227757|NCT01991587|RNA Virus Infections|rna virus infections
227758|NCT01991587|Immunologic|immunologic
227759|NCT01991587|Immunogenic Factors|immunogenic factors
227760|NCT01991587|Physiological Effects of Drugs|physiological effects of drugs
227761|NCT01991587|Virus diseases|virus diseases
227762|NCT01991587|Orthomyxoviridae Infections|orthomyxoviridae infections
227763|NCT01991587|Infection|infection
227764|NCT01991574|urinary phosphate|urinary phosphate
227765|NCT01991574|iron hydroxide|iron hydroxide
227766|NCT01991574|hypophosphatemia|hypophosphatemia
227767|NCT01991574|phosphate binder|phosphate binder
227768|NCT01991574|ferric hydroxide adipate|ferric hydroxide adipate
227769|NCT01991561|Influenza, Human|influenza, human
227770|NCT01991561|RNA Virus Infections|rna virus infections
227771|NCT01991561|Respiratory Tract Diseases|respiratory tract diseases
227772|NCT01991561|Respiratory Tract Infections|respiratory tract infections
227773|NCT01991561|Aluminum Hydroxide|aluminum hydroxide
227774|NCT01991561|Adjuvants, Immunologic|adjuvants, immunologic
227775|NCT01991561|Immunogenic Factors|immunogenic factors
227776|NCT01991561|GLA-SE|gla-se
227777|NCT01991561|Physiological Effects of Drugs|physiological effects of drugs
227778|NCT01991561|Virus Diseases|virus diseases
227779|NCT01991561|Orthomyxoviridae Infections|orthomyxoviridae infections
227780|NCT01991561|Infection|infection
227781|NCT01991548|Insulin pump|insulin pump
227782|NCT01991470|Insulin requiring diabetes|insulin requiring diabetes
227783|NCT01991470|Children|children
227784|NCT01991470|Sensor|sensor
227785|NCT01991470|Accuracy|accuracy
227786|NCT01991457|ALL|all
227787|NCT01991418|non-small cell lung cancer|non-small cell lung cancer
227788|NCT01991418|thioredoxin reductase|thioredoxin reductase
227789|NCT01991418|carcina embryonic antigen|carcina embryonic antigen
227790|NCT01991405|Mild Cognitive Impairment|mild cognitive impairment
227791|NCT01991405|Working Memory Training|working memory training
227792|NCT01991405|Neuropsychological function in MCI|neuropsychological function in mci
227793|NCT01991392|Pancreaticoduodenectomy|pancreaticoduodenectomy
227794|NCT01991392|nasogastric tube|nasogastric tube
227795|NCT01991379|MEK162|mek162
227796|NCT01991379|Imatinib|imatinib
227797|NCT01991379|13-162|13-162
227798|NCT01991366|Major adverse microvascular integrity|major adverse microvascular integrity
227799|NCT01991366|all cause mortality|all cause mortality
227800|NCT01991366|Q Wave MI|q wave mi
227801|NCT01991353|Knee|knee
227802|NCT01991353|meniscus|meniscus
227803|NCT01991353|platelet rich plasma|platelet rich plasma
227804|NCT01991301|graft-versus-host disease|graft-versus-host disease
227805|NCT01991301|stem cell transplantation|stem cell transplantation
227806|NCT01991301|matched unrelated donors|matched unrelated donors
227807|NCT01991301|proteosmoe inhibitor|proteosmoe inhibitor
227808|NCT01991301|carfilzumib|carfilzumib
227809|NCT01991288|Total Knee Replacement|total knee replacement
227810|NCT01991288|Bupivacaine|bupivacaine
227811|NCT01991288|Levobupivacaine|levobupivacaine
227812|NCT01991288|Saphenous Nerve Block|saphenous nerve block
227813|NCT01991288|Local Infiltration Analgesia|local infiltration analgesia
227814|NCT01991275|Prostatic Neoplasms|prostatic neoplasms
227815|NCT01991275|Laparoscopy|laparoscopy
227816|NCT01991275|Injections, Spinal|injections, spinal
227817|NCT01991275|Morphine|morphine
227818|NCT01991249|pediatric acute leukemia|pediatric acute leukemia
227819|NCT01991249|Targeted high throughput sequencing|targeted high throughput sequencing
227820|NCT01991249|messenger RNA|messenger rna
227821|NCT01991197|Psoriasis|psoriasis
227822|NCT01991197|Type 2 Diabetes|type 2 diabetes
227823|NCT01991197|Dipeptidyl peptidase-4 inhibition|dipeptidyl peptidase-4 inhibition
227824|NCT01991197|Sitagliptin|sitagliptin
227825|NCT01991197|Gliclazide|gliclazide
227826|NCT01991197|Psoriasis area and severity index|psoriasis area and severity index
227828|NCT01991171|Muscle activation|muscle activation
227829|NCT01991171|Muscle inhibition|muscle inhibition
227830|NCT01991158|GAD-M regimen|gad-m regimen
227831|NCT01991158|first line chemotherapy|first line chemotherapy
227832|NCT01991158|NK/T-cell Lymphoma|nk/t-cell lymphoma
227833|NCT01991145|Cerebral Palsy|cerebral palsy
227834|NCT01991145|Umbilical Cord Blood|umbilical cord blood
227835|NCT01991145|Erythropoietin|erythropoietin
227836|NCT01991145|Rehabilitation|rehabilitation
227837|NCT01991132|Dry Eyes|dry eyes
227838|NCT01991132|Meibomian glands|meibomian glands
227839|NCT01991132|Algorithm|algorithm
227840|NCT01991132|MediView software|mediview software
227841|NCT01991119|Atrial fibrillation|atrial fibrillation
227842|NCT01991119|Propafenone|propafenone
227843|NCT01991119|Dronedarone|dronedarone
227844|NCT01991106|Exercise|exercise
227845|NCT01991106|Myocardial function|myocardial function
227846|NCT01991106|Vascular function|vascular function
227847|NCT01991106|Cardiovascular disease/prevention & control|cardiovascular disease/prevention & control
227848|NCT01991106|Paediatric obesity|paediatric obesity
227849|NCT01991106|Visceral adipose tissue|visceral adipose tissue
227948|NCT01990625|Gestational Age Dating|gestational age dating
227850|NCT01991093|light transmittance aggregometry (LTA),multiple electrode aggregometry, clopidogrel-resistance|light transmittance aggregometry (lta),multiple electrode aggregometry, clopidogrel-resistance
227851|NCT01991080|biofeedback|biofeedback
227852|NCT01991080|relaxation|relaxation
227853|NCT01991080|Wheat germ juice|wheat germ juice
227854|NCT01991067|Marrow transplant recipients|marrow transplant recipients
227855|NCT01991054|Diabetes mellitus|diabetes mellitus
227857|NCT01991054|25(OH) vitamin D|25(oh) vitamin d
227858|NCT01991054|HgA1C levels above 7.5%|hga1c levels above 7.5%
227859|NCT01991041|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
227860|NCT01991002|14/21 diet|14/21 diet
227862|NCT01991002|biochemical blood markers|biochemical blood markers
227863|NCT01991002|quality of life|quality of life
227864|NCT01990989|clopidogrel|clopidogrel
227865|NCT01990989|pharmacogenomics|pharmacogenomics
227866|NCT01990989|CYP2C19|cyp2c19
227867|NCT01990989|platelet aggregation|platelet aggregation
227868|NCT01990989|score system|score system
227869|NCT01990989|ischemic cardiovascular outcomes|ischemic cardiovascular outcomes
227870|NCT01990989|hemorrhage complications|hemorrhage complications
227871|NCT01990976|Muscular Dystrophy|muscular dystrophy
227872|NCT01990976|Facioscapulohumeral|facioscapulohumeral
227873|NCT01990976|Physical training|physical training
227874|NCT01990976|Magnetic Resonance Imaging|magnetic resonance imaging
227875|NCT01990976|Muscle Biopsy|muscle biopsy
227876|NCT01990963|Brain trauma;|brain trauma;
227877|NCT01990963|MALUNA;|maluna;
227878|NCT01990963|densitometric data|densitometric data
227879|NCT01990963|CT|ct
227880|NCT01990950|Aneurysm|aneurysm
227881|NCT01990950|Aortic Aneurysm|aortic aneurysm
227882|NCT01990950|Iliac Aneurysm|iliac aneurysm
227883|NCT01990950|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
227884|NCT01990950|Vascular Diseases|vascular diseases
227885|NCT01990950|Cardiovascular Diseases|cardiovascular diseases
227886|NCT01990950|Aortic Diseases|aortic diseases
227887|NCT01990937|oral midazolam|oral midazolam
227888|NCT01990937|sedation|sedation
227889|NCT01990937|premedication|premedication
227890|NCT01990937|upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
227891|NCT01990937|EGD|egd
227892|NCT01990924|fluoroscopy|fluoroscopy
227893|NCT01990924|radiation|radiation
227894|NCT01990924|transradial|transradial
227895|NCT01990924|diagnostic|diagnostic
227896|NCT01990924|angiography|angiography
227897|NCT01990924|cardiac|cardiac
227898|NCT01990924|coronary|coronary
227899|NCT01990924|angioplasty|angioplasty
227900|NCT01990911|hypertension|hypertension
227901|NCT01990911|hypertensive heart disease|hypertensive heart disease
227902|NCT01990911|atrial fibrillation|atrial fibrillation
227903|NCT01990911|autonomic imbalance|autonomic imbalance
227904|NCT01990872|Vitamin D status|vitamin d status
227905|NCT01990872|25-hydroxyvitamin D|25-hydroxyvitamin d
227906|NCT01990872|Vitamin D3|vitamin d3
227907|NCT01990872|RCT|rct
227908|NCT01990872|Calcium intake|calcium intake
227909|NCT01990872|Dietary requirement|dietary requirement
227910|NCT01990846|antiviral, influenza|antiviral, influenza
227911|NCT01990820|Pediatric Chronic Rhinosinusitis|pediatric chronic rhinosinusitis
227912|NCT01990807|high risk|high risk
227913|NCT01990807|Philadelphia Chromosome absent|philadelphia chromosome absent
227914|NCT01990807|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
227915|NCT01990794|Cobalt|cobalt
227916|NCT01990794|Dietary Supplements|dietary supplements
227917|NCT01990794|Hematological|hematological
227918|NCT01990794|Thyroid|thyroid
227919|NCT01990781|Lidocaine, Dexamethasone, Postoperative sore throat|lidocaine, dexamethasone, postoperative sore throat
227920|NCT01990768|tranexamic acid|tranexamic acid
227921|NCT01990768|traumatic brain injury|traumatic brain injury
227922|NCT01990768|intracranial hemorrhage|intracranial hemorrhage
227923|NCT01990768|prehospital|prehospital
227924|NCT01990768|neurologic outcome|neurologic outcome
227925|NCT01990768|glasgow outcome scale extended|glasgow outcome scale extended
227926|NCT01990768|disability rating scale|disability rating scale
227928|NCT01990716|Colonoscopy|colonoscopy
227929|NCT01990703|Contraception|contraception
227930|NCT01990703|Birth Control|birth control
227931|NCT01990703|Levonorgestrel IUD|levonorgestrel iud
227932|NCT01990703|Mirena IUD|mirena iud
228026|NCT01990313|Subthalamic Nucleus|subthalamic nucleus
228027|NCT01990300|Drug Therapy|drug therapy
227933|NCT01990690|oligohydramnios,antioxidant,oxidative stress and pregnancy outcomes|oligohydramnios,antioxidant,oxidative stress and pregnancy outcomes
227934|NCT01990677|Central Serous Chorioretinopathy|central serous chorioretinopathy
227935|NCT01990677|csr|csr
227936|NCT01990677|cscr|cscr
227937|NCT01990677|eplerenone|eplerenone
227938|NCT01990677|vision|vision
227939|NCT01990677|choroid|choroid
227940|NCT01990677|retina|retina
227941|NCT01990677|acute|acute
227942|NCT01990677|chronic|chronic
227943|NCT01990638|coronary artery bypass graft|coronary artery bypass graft
227944|NCT01990638|Diabetes mellitus, type 2|diabetes mellitus, type 2
227945|NCT01990625|Maternal Near Miss Morbidity|maternal near miss morbidity
227946|NCT01990625|Maternal Mortality|maternal mortality
227947|NCT01990625|Neonatal Mortality|neonatal mortality
228454|NCT01988233|Aging|aging
227949|NCT01990625|Pregnancy Complications|pregnancy complications
227950|NCT01990625|Ultrasound|ultrasound
227951|NCT01990625|Stillbirth|stillbirth
227952|NCT01990612|Induction of labor|induction of labor
227953|NCT01990612|Expectant management of labor|expectant management of labor
227954|NCT01990612|39 weeks gestation|39 weeks gestation
227955|NCT01990599|nasopharyngeal tube|nasopharyngeal tube
227956|NCT01990599|airway management|airway management
227957|NCT01990599|thermal coagulation of the Gasserian ganglion|thermal coagulation of the gasserian ganglion
227958|NCT01990573|spinal surgery|spinal surgery
227959|NCT01990573|Methadone|methadone
227960|NCT01990560|mild hypercortisolism|mild hypercortisolism
227961|NCT01990560|Subclinical Cushing's Syndrome|subclinical cushing's syndrome
227962|NCT01990560|Preclinical Cushing's Syndrome|preclinical cushing's syndrome
227963|NCT01990547|Virtual Reality Exposure Therapy|virtual reality exposure therapy
227964|NCT01990547|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
227965|NCT01990547|Traumatic Event|traumatic event
227966|NCT01990547|Trauma Survivor|trauma survivor
227967|NCT01990547|Combat-related PTSD|combat-related ptsd
227968|NCT01990547|mTBI|mtbi
227969|NCT01990547|mild TBI|mild tbi
227970|NCT01990547|PTSD|ptsd
227971|NCT01990547|Veteran|veteran
227972|NCT01990534|Lymphoma|lymphoma
227973|NCT01990534|Hodgkin|hodgkin
227974|NCT01990534|Relapsed|relapsed
227975|NCT01990534|Refractory|refractory
227976|NCT01990534|Antigens, CD30|antigens, cd30
227977|NCT01990534|Antibody-Drug Conjugate|antibody-drug conjugate
227978|NCT01990534|Antibodies, Monoclonal|antibodies, monoclonal
227979|NCT01990534|Monomethyl auristatin E|monomethyl auristatin e
227980|NCT01990534|Drug Therapy|drug therapy
227981|NCT01990534|Immunotherapy|immunotherapy
227982|NCT01990534|Hematologic Diseases|hematologic diseases
227983|NCT01990534|Additional Relevant MeSH terms:|additional relevant mesh terms:
227984|NCT01990534|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
227985|NCT01990534|Lymphoma, Hodgkin|lymphoma, hodgkin
227986|NCT01990534|Neoplasms by Histologic Type|neoplasms by histologic type
227987|NCT01990534|Neoplasms|neoplasms
227988|NCT01990534|Lymphoproliferative Disorders|lymphoproliferative disorders
227989|NCT01990534|Lymphatic Diseases|lymphatic diseases
227990|NCT01990534|Immunoproliferative Disorders|immunoproliferative disorders
227991|NCT01990534|Immune System Diseases|immune system diseases
227992|NCT01990534|Lymphoma, B-Cell|lymphoma, b-cell
227993|NCT01990534|Lymphoma, T-Cell|lymphoma, t-cell
227994|NCT01990534|Immunologic Factors|immunologic factors
227995|NCT01990534|Physiological Effects of Drugs|physiological effects of drugs
227996|NCT01990534|Pharmacologic Actions|pharmacologic actions
227997|NCT01990508|sugar-sweetened beverages|sugar-sweetened beverages
227998|NCT01990508|traffic-light labels|traffic-light labels
227999|NCT01990508|financial incentives|financial incentives
228000|NCT01990508|low-income community|low-income community
228001|NCT01990508|obesity prevention|obesity prevention
228002|NCT01990495|Renal failure|renal failure
228003|NCT01990495|Exercise testing|exercise testing
228004|NCT01990495|Exercise training|exercise training
228005|NCT01990495|Protein signaling|protein signaling
228006|NCT01990495|Skeletal muscle|skeletal muscle
228007|NCT01990469|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
228008|NCT01990456|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
228009|NCT01990456|Ventilator-Induced Lung Injury|ventilator-induced lung injury
228010|NCT01990456|Ventilators, Mechanical|ventilators, mechanical
228011|NCT01990456|Pulmonary Heart Disease|pulmonary heart disease
228012|NCT01990456|Ultrasonography|ultrasonography
228013|NCT01990443|Reslizumab|reslizumab
228014|NCT01990443|monoclonal antibody|monoclonal antibody
228015|NCT01990417|Muscle Stretching Exercises|muscle stretching exercises
228016|NCT01990417|Joint range of motion|joint range of motion
228017|NCT01990417|Resistance Training|resistance training
228018|NCT01990417|Physical Therapy|physical therapy
228019|NCT01990404|Premixed nitrous oxide and oxygen|premixed nitrous oxide and oxygen
228020|NCT01990404|Severe acute pain|severe acute pain
228021|NCT01990404|Prehospital setting|prehospital setting
228022|NCT01990365|Vertebral fracture, low back pain, gips, mobility|vertebral fracture, low back pain, gips, mobility
228023|NCT01990313|Parkinson's Disease|parkinson's disease
228024|NCT01990313|DBS|dbs
228025|NCT01990313|Deep Brain Stimulation|deep brain stimulation
228028|NCT01990287|Low Back Pain|low back pain
228029|NCT01990287|Failed Back surgery Syndrome|failed back surgery syndrome
228030|NCT01990287|Post-Laminectomy Syndrome|post-laminectomy syndrome
228031|NCT01990287|Spinal Cord Stimulation|spinal cord stimulation
228032|NCT01990287|Peripheral Nerve field Stimulation|peripheral nerve field stimulation
228033|NCT01990287|Pain|pain
228034|NCT01990274|Tuberculosis|tuberculosis
228035|NCT01990274|Diagnosis|diagnosis
228036|NCT01990274|GeneXpert MTB/RIF|genexpert mtb/rif
228037|NCT01990274|Point-of-treatment|point-of-treatment
228038|NCT01990274|Mobile unit|mobile unit
228039|NCT01990235|Advance care planning|advance care planning
228040|NCT01990235|Aging|aging
228041|NCT01990235|Health communication|health communication
228042|NCT01990235|Health literacy|health literacy
228043|NCT01990235|Medical decision making|medical decision making
228044|NCT01990235|primary care|primary care
228045|NCT01990235|vulnerable population|vulnerable population
228046|NCT01990235|chronic illness|chronic illness
228047|NCT01990222|ADHD|adhd
228048|NCT01990209|triple-negative breast cancer|triple-negative breast cancer
228049|NCT01990209|orteronel|orteronel
228050|NCT01990209|TAK-700|tak-700
228051|NCT01990209|metastatic breast cancer|metastatic breast cancer
228052|NCT01990196|prostate cancer|prostate cancer
228053|NCT01990196|hormone therapy|hormone therapy
228054|NCT01990196|radical prostatectomy|radical prostatectomy
228055|NCT01990183|preterm infants|preterm infants
228056|NCT01990183|early intervention|early intervention
228057|NCT01990183|enrichment|enrichment
228058|NCT01990183|cognitive, motor, visual development|cognitive, motor, visual development
228059|NCT01990183|tele-rehabilitation|tele-rehabilitation
228060|NCT01990131|computerized intervention|computerized intervention
228061|NCT01990131|cognitive bias modification|cognitive bias modification
228062|NCT01990131|anxiety|anxiety
228063|NCT01990131|suicide|suicide
228064|NCT01990118|Renal transplant|renal transplant
228065|NCT01990118|Renal allograft rejection|renal allograft rejection
228066|NCT01990118|Cyclosporine|cyclosporine
228067|NCT01990118|Gengraf|gengraf
228068|NCT01990105|atrial fibrillation|atrial fibrillation
228069|NCT01990105|anticoagulation|anticoagulation
228070|NCT01990105|antiarrhythmic medication|antiarrhythmic medication
228071|NCT01990105|CHA2DS2VASc score|cha2ds2vasc score
228072|NCT01990105|HAS-BLED score|has-bled score
228073|NCT01990105|CHADS2 score|chads2 score
228074|NCT01990092|Metanx|metanx
228075|NCT01990092|B vitamins|b vitamins
228076|NCT01990092|neuropathy|neuropathy
228077|NCT01990092|nutrition|nutrition
228078|NCT01990079|PTSD|ptsd
228079|NCT01990079|smoking|smoking
228080|NCT01990066|Quality of Life|quality of life
228081|NCT01990066|Physical Function|physical function
228082|NCT01990040|Short Bowel Syndrome|short bowel syndrome
228083|NCT01990040|SBS|sbs
228084|NCT01990040|teduglutide|teduglutide
228085|NCT01990040|Gattex|gattex
228086|NCT01990027|kidney stone|kidney stone
228087|NCT01990001|contraception, adherence, medication reminder|contraception, adherence, medication reminder
228088|NCT01989988|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
228089|NCT01989988|Obesity|obesity
228090|NCT01989988|Laparoscopic gastric bypass|laparoscopic gastric bypass
228091|NCT01989988|Duodenum exclusion|duodenum exclusion
228092|NCT01989975|Sensor-Augmented Pump Therapy|sensor-augmented pump therapy
228093|NCT01989975|Connected Care|connected care
228094|NCT01989962|Aboriginal Health|aboriginal health
228095|NCT01989962|Diabetes Mellitus Type 2|diabetes mellitus type 2
218841|NCT02032199|SF-36|sf-36
228096|NCT01989962|Cultural Competency|cultural competency
228097|NCT01989962|Continuing Medical Education|continuing medical education
228098|NCT01989923|Smoking cessation|smoking cessation
228099|NCT01989923|Traditional nicotine replacement therapy|traditional nicotine replacement therapy
228100|NCT01989923|Electronic nicotine delivery devices|electronic nicotine delivery devices
228101|NCT01989923|electronic cigarettes|electronic cigarettes
228102|NCT01989923|cervical dysplasia|cervical dysplasia
228103|NCT01989910|Efavirenz|efavirenz
228104|NCT01989910|Raltegravir|raltegravir
228105|NCT01989910|Combination antiretroviral therapy|combination antiretroviral therapy
228106|NCT01989897|diluent|diluent
228107|NCT01989897|rhinitis|rhinitis
228108|NCT01989897|allergic|allergic
228109|NCT01989871|preterm|preterm
228110|NCT01989871|oral feeding|oral feeding
228111|NCT01989871|outcome|outcome
228112|NCT01989858|localized gastric adenocarcinoma, operable considered.|localized gastric adenocarcinoma, operable considered.
228113|NCT01989832|cohort|cohort
228114|NCT01989832|pharmaco-economic|pharmaco-economic
228115|NCT01989832|kidney|kidney
228116|NCT01989832|transplantation|transplantation
228117|NCT01989832|quality of life|quality of life
228118|NCT01989806|Spinal cord injury|spinal cord injury
228120|NCT01989806|locomotion|locomotion
228121|NCT01989793|sarcopenia|sarcopenia
228122|NCT01989793|frailty|frailty
228123|NCT01989793|losartan|losartan
228124|NCT01989767|sickness absence|sickness absence
228125|NCT01989767|rehabilitation|rehabilitation
228126|NCT01989767|mental disorders|mental disorders
228127|NCT01989767|screening|screening
228128|NCT01989754|Albuminuria|albuminuria
228129|NCT01989754|Canagliflozin|canagliflozin
228130|NCT01989754|Cardiovascular outcomes|cardiovascular outcomes
228131|NCT01989754|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
228132|NCT01989754|T2DM|t2dm
228133|NCT01989754|JNJ-28431754|jnj-28431754
228134|NCT01989754|Antihyperglycemic Agent|antihyperglycemic agent
228135|NCT01989741|sleep restriction, decision making, wakefullness|sleep restriction, decision making, wakefullness
228136|NCT01989728|sickness absence, return to work, psychiatric examination, feedback, psychological distress, quality of life, attrition analysis, multiple imputation|sickness absence, return to work, psychiatric examination, feedback, psychological distress, quality of life, attrition analysis, multiple imputation
228137|NCT01989689|PSORIASIS|psoriasis
228138|NCT01989676|Phase 3|phase 3
228139|NCT01989676|trastuzumab|trastuzumab
228140|NCT01989676|Breast Neoplasms|breast neoplasms
228141|NCT01989663|Healthy Women|healthy women
228142|NCT01989624|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
228143|NCT01989624|diagnosis|diagnosis
228144|NCT01989624|treatment|treatment
228145|NCT01989572|locally advanced or stage IV melanoma|locally advanced or stage iv melanoma
228146|NCT01989572|GM-CSF|gm-csf
228147|NCT01989572|peptide vaccine|peptide vaccine
228148|NCT01989546|DNA Damage|dna damage
228149|NCT01989546|Advanced Solid Tumors|advanced solid tumors
228150|NCT01989546|BRCA Mutations|brca mutations
228151|NCT01989546|PARP Inhibitor|parp inhibitor
228152|NCT01989546|Pharmacodynamics|pharmacodynamics
228153|NCT01989533|HIV Vaccine|hiv vaccine
228154|NCT01989533|Adenovirus|adenovirus
228155|NCT01989520|Relative bioavailability, Healthy volunteers, Neutrophils|relative bioavailability, healthy volunteers, neutrophils
228156|NCT01989507|tobacco smoking|tobacco smoking
228157|NCT01989507|smoking cessation|smoking cessation
228158|NCT01989507|nicotine dependence|nicotine dependence
228159|NCT01989507|tobacco use disorder|tobacco use disorder
228160|NCT01989494|anesthesiologists|anesthesiologists
228161|NCT01989494|physical activity|physical activity
228162|NCT01989494|pedometer|pedometer
228163|NCT01989494|wellness|wellness
228164|NCT01989494|exercise|exercise
228165|NCT01989468|Psoriatic arthritis|psoriatic arthritis
228166|NCT01989468|AIN457|ain457
228168|NCT01989468|ACR|acr
228169|NCT01989468|CASPAR|caspar
228170|NCT01989468|PASDAS|pasdas
228171|NCT01989468|secukinumab|secukinumab
228172|NCT01989468|autoinjector|autoinjector
228173|NCT01989455|Healthy|healthy
228174|NCT01989455|Deferiprone|deferiprone
228175|NCT01989455|DFP|dfp
228176|NCT01989455|L1|l1
228177|NCT01989442|cpap failure|cpap failure
228178|NCT01989442|bronchopulmonary dysplasia|bronchopulmonary dysplasia
228179|NCT01989442|nasal trauma|nasal trauma
228180|NCT01989442|ventilation duration|ventilation duration
228181|NCT01989442|non-invasive ventilation|non-invasive ventilation
228182|NCT01989429|psoriasis|psoriasis
228183|NCT01989429|Vitamin D3|vitamin d3
228184|NCT01989429|topical|topical
228185|NCT01989429|ointments|ointments
228186|NCT01989416|colonization|colonization
228187|NCT01989338|hallux valgus|hallux valgus
228188|NCT01989338|pain|pain
228189|NCT01989338|functional status|functional status
228190|NCT01989338|quality of life|quality of life
228191|NCT01989312|ultrasound|ultrasound
228192|NCT01989312|peripheral nerves|peripheral nerves
228193|NCT01989312|anesthetics|anesthetics
228195|NCT01989299|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
228196|NCT01989299|ILR|ilr
228197|NCT01989299|ventricular tachyarrhythmias|ventricular tachyarrhythmias
228198|NCT01989299|Safety|safety
228199|NCT01989286|Plagiocephaly|plagiocephaly
228200|NCT01989286|Posture|posture
228201|NCT01989286|Spine|spine
228202|NCT01989260|Endometriosis|endometriosis
228203|NCT01989247|Depression|depression
228204|NCT01989247|Anxiety|anxiety
228205|NCT01989247|Randomized Controlled Trial|randomized controlled trial
228206|NCT01989247|Self Care|self care
228207|NCT01989247|Intervention Studies|intervention studies
228208|NCT01989247|Health Education|health education
228209|NCT01989208|Heart Failure|heart failure
228210|NCT01989208|Congestive Heart Failure|congestive heart failure
228211|NCT01989208|Oxidative Stress|oxidative stress
228212|NCT01989208|Hydrogen Sulfide|hydrogen sulfide
228213|NCT01989195|ISCHEMIC OR CORONARY HEART DISEASE|ischemic or coronary heart disease
228214|NCT01989195|MYOCARDIAL INFARCTION|myocardial infarction
228215|NCT01989195|MAGNETIC RESONANCE IMAGING|magnetic resonance imaging
228216|NCT01989195|DELAYED GADOLINIUM ENHANCEMENT MRI|delayed gadolinium enhancement mri
228217|NCT01989195|MANGANESE-ENHANCED MRI|manganese-enhanced mri
228218|NCT01989195|INFARCT VOLUME/SIZE|infarct volume/size
228219|NCT01989195|ALL CAUSE MORTALITY|all cause mortality
228220|NCT01989195|VENTRICULAR ARRHYTHMIAS|ventricular arrhythmias
228221|NCT01989182|Endobronchial Valves|endobronchial valves
228222|NCT01989182|Intrabronchial Valves|intrabronchial valves
228223|NCT01989182|Bronchial Valve|bronchial valve
228224|NCT01989182|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
228324|NCT01988857|Vietnam|vietnam
228226|NCT01989182|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
228227|NCT01989182|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
228228|NCT01989182|BLVR|blvr
228229|NCT01989182|TLVR|tlvr
228230|NCT01989182|Emphysema|emphysema
228231|NCT01989182|Pulmonary Emphysema|pulmonary emphysema
228232|NCT01989182|Pathologic Process|pathologic process
228233|NCT01989182|Lung Diseases|lung diseases
228234|NCT01989182|Respiratory Tract Disease|respiratory tract disease
228235|NCT01989182|China|china
228236|NCT01989156|Smoking|smoking
228237|NCT01989156|Candidate modified risk tobacco product|candidate modified risk tobacco product
228238|NCT01989156|Menthol conventional cigarettes|menthol conventional cigarettes
228239|NCT01989156|Reduced exposure|reduced exposure
228240|NCT01989156|HPHCs|hphcs
228241|NCT01989156|Ambulatory|ambulatory
228242|NCT01989143|Phase 1|phase 1
228243|NCT01989143|Randomized|randomized
228244|NCT01989143|Double-blind|double-blind
228245|NCT01989143|Placebo-controlled|placebo-controlled
228246|NCT01989143|Dose escalating|dose escalating
228247|NCT01989143|Single and Multiple doses|single and multiple doses
228248|NCT01989143|Safety|safety
228249|NCT01989143|Tolerability|tolerability
228250|NCT01989143|PK/PD|pk/pd
228251|NCT01989143|PF-06480605|pf-06480605
228252|NCT01989130|antimicrobial stewardship|antimicrobial stewardship
228253|NCT01989130|Cepheid Xpert CT/NG|cepheid xpert ct/ng
228254|NCT01989130|chlamydia|chlamydia
228255|NCT01989130|gonorrhea|gonorrhea
228256|NCT01989130|emergency department|emergency department
228257|NCT01989130|Diagnostic Techniques, Obstetrical and Gynecological|diagnostic techniques, obstetrical and gynecological
228258|NCT01989130|Diagnostic Techniques, Urological|diagnostic techniques, urological
228259|NCT01989104|Indirect calorimetry|indirect calorimetry
228260|NCT01989091|kidney dialysis|kidney dialysis
228261|NCT01989091|hemodialysis|hemodialysis
228262|NCT01989091|locking solution|locking solution
228263|NCT01989091|antimicrobial|antimicrobial
228264|NCT01989091|thrombolytic|thrombolytic
228265|NCT01989078|Kidney disorder|kidney disorder
228266|NCT01989078|Blood disorder|blood disorder
228267|NCT01989078|Pediatrics|pediatrics
228268|NCT01989065|Child obesity|child obesity
228269|NCT01989065|childhood obesity|childhood obesity
228270|NCT01989065|obesity treatment|obesity treatment
228271|NCT01989065|text messaging|text messaging
228272|NCT01989065|Lifestyle|lifestyle
228273|NCT01989052|Carboxyamidotriazole Orotate|carboxyamidotriazole orotate
228275|NCT01989052|Lomustine|lomustine
228276|NCT01989052|N-(2-chloroethyl)-N'-cyclo-hexyl-N-nitrosourea (CCNU)|n-(2-chloroethyl)-n'-cyclo-hexyl-n-nitrosourea (ccnu)
228277|NCT01989052|CeeNU|ceenu
228278|NCT01989052|Malignant Glioma|malignant glioma
228279|NCT01989052|Pro00047969|pro00047969
228280|NCT01989052|Desjardins|desjardins
228281|NCT01989052|Duke|duke
228282|NCT01989052|The Preston Robert Tisch Brain Tumor Center|the preston robert tisch brain tumor center
228283|NCT01989026|BCG|bcg
228284|NCT01989026|non-specific effects|non-specific effects
228285|NCT01989026|neonatal mortality|neonatal mortality
228286|NCT01989026|vaccines|vaccines
228287|NCT01989013|Parkinson's disease|parkinson's disease
228288|NCT01989013|Craniosacral therapy|craniosacral therapy
228289|NCT01989013|cranial osteopathy|cranial osteopathy
228290|NCT01989000|Pancreatic cancer|pancreatic cancer
228291|NCT01989000|Hypoxia|hypoxia
228292|NCT01989000|Vasculature|vasculature
228293|NCT01989000|Stroma|stroma
228294|NCT01988987|Gestational diabetes|gestational diabetes
228295|NCT01988987|Postpartum glucose testing|postpartum glucose testing
228296|NCT01988987|Impaired glucose metabolism|impaired glucose metabolism
228297|NCT01988987|Diabetes mellitus|diabetes mellitus
228298|NCT01988961|Colitis, Ulcerative|colitis, ulcerative
228299|NCT01988961|Golimumab|golimumab
228300|NCT01988961|CNTO148|cnto148
228301|NCT01988961|SIMPONI|simponi
228302|NCT01988961|Length-109 Probe Set Panel|length-109 probe set panel
228303|NCT01988948|Human papilloma virus|human papilloma virus
228304|NCT01988948|Young women|young women
228305|NCT01988948|I-Share|i-share
228306|NCT01988922|ketamine polymorphisms|ketamine polymorphisms
686485|NCT00907361|pacemaker|pacemaker
228307|NCT01988909|Cutaneous leishmaniasis|cutaneous leishmaniasis
228308|NCT01988909|Paromomycin + Gentamicin Topical Cream|paromomycin + gentamicin topical cream
228309|NCT01988909|Safety|safety
228310|NCT01988909|Efficacy|efficacy
228311|NCT01988883|Postural Tachycardia Syndrome|postural tachycardia syndrome
228312|NCT01988883|Tachycardia|tachycardia
228313|NCT01988883|Orthostatic Intolerance|orthostatic intolerance
228314|NCT01988883|Autonomic Nervous System Diseases|autonomic nervous system diseases
228315|NCT01988883|Primary Dysautonomias|primary dysautonomias
228316|NCT01988883|Nervous System Diseases|nervous system diseases
228317|NCT01988883|Cardiovascular Diseases|cardiovascular diseases
228318|NCT01988883|Modafinil|modafinil
228319|NCT01988883|Propranolol|propranolol
228320|NCT01988883|Neurobehavioral Manifestations|neurobehavioral manifestations
228321|NCT01988883|Neurologic Manifestations|neurologic manifestations
228322|NCT01988883|Cognitive Symptoms|cognitive symptoms
228323|NCT01988883|Neuropsychological Tests|neuropsychological tests
228329|NCT01988857|dTpa|dtpa
228330|NCT01988857|Booster|booster
228331|NCT01988857|Healthy|healthy
228332|NCT01988844|functionality|functionality
228333|NCT01988844|Cerebral palsy|cerebral palsy
228334|NCT01988844|Handwriting|handwriting
228335|NCT01988831|Malignant melanoma|malignant melanoma
228336|NCT01988831|betablocker|betablocker
228337|NCT01988831|propranolol|propranolol
228338|NCT01988831|interventional|interventional
228339|NCT01988831|prospective|prospective
228340|NCT01988831|adjuvant|adjuvant
228341|NCT01988831|recurrence|recurrence
228342|NCT01988818|wound dressing|wound dressing
228343|NCT01988818|silicone|silicone
228344|NCT01988818|standard wound dressing|standard wound dressing
228345|NCT01988766|Thrombosis|thrombosis
228346|NCT01988766|Central Venosis Catheter|central venosis catheter
228347|NCT01988766|Renal Disease|renal disease
228348|NCT01988766|Vascular Access|vascular access
228349|NCT01988753|Serum Biomarkers|serum biomarkers
228350|NCT01988753|Sheer-wave Elastography|sheer-wave elastography
228351|NCT01988753|Ultrasound imaging|ultrasound imaging
228352|NCT01988753|Viral hepatitis|viral hepatitis
228353|NCT01988753|Liver Fibrosis|liver fibrosis
228354|NCT01988753|Liver disease|liver disease
228355|NCT01988753|Hepatitis B|hepatitis b
228356|NCT01988753|Hepatitis C|hepatitis c
228357|NCT01988740|Ischemia-modified albumin|ischemia-modified albumin
228358|NCT01988740|Recurrent pregnancy loss|recurrent pregnancy loss
228359|NCT01988740|Abnormal placenta|abnormal placenta
228360|NCT01988714|Targeted cognitive training (TCT) plus evidence-based SE|targeted cognitive training (tct) plus evidence-based se
228361|NCT01988714|Computer games (CG) plus evidence-based SE|computer games (cg) plus evidence-based se
228362|NCT01988701|GVHD|gvhd
228363|NCT01988701|chronic Graft versus Host Disease|chronic graft versus host disease
228364|NCT01988688|deep brain stimulation|deep brain stimulation
228365|NCT01988662|nAMD, VEGF, VEGF agent, BCVA, CRT, Ranibizumab, Lucentis, Aflibercept, Eylea|namd, vegf, vegf agent, bcva, crt, ranibizumab, lucentis, aflibercept, eylea
228366|NCT01988649|Pain|pain
228367|NCT01988649|Oxytocin|oxytocin
228368|NCT01988636|Randomized|randomized
228369|NCT01988636|Double Blinded|double blinded
228370|NCT01988636|Mali|mali
228371|NCT01988636|Malaria|malaria
228372|NCT01988636|Transmission|transmission
228373|NCT01988623|Intellectual Disabilities|intellectual disabilities
228374|NCT01988623|Speech Delay|speech delay
228375|NCT01988623|Language Disorder|language disorder
228376|NCT01988610|cognition|cognition
228377|NCT01988610|prediabetes|prediabetes
228378|NCT01988610|mood|mood
228379|NCT01988597|Dry Eyes|dry eyes
228380|NCT01988597|Quality of life|quality of life
228381|NCT01988597|Utility assessment|utility assessment
228382|NCT01988584|Cerebral Palsy|cerebral palsy
228383|NCT01988584|Brain Injury|brain injury
228384|NCT01988584|Stem Cells|stem cells
228385|NCT01988584|Mononuclear Cells|mononuclear cells
228386|NCT01988584|Bone Morrow|bone morrow
228387|NCT01988584|Umbilical Cord Blood|umbilical cord blood
228388|NCT01988571|Stage I breast cancer|stage i breast cancer
228389|NCT01988571|Stage II breast cancer|stage ii breast cancer
228390|NCT01988571|Stage III breast cancer|stage iii breast cancer
228391|NCT01988558|Recurrent Tonsillitis|recurrent tonsillitis
228392|NCT01988558|Streptococcus A|streptococcus a
228393|NCT01988545|GLP-1|glp-1
228394|NCT01988545|blood flow|blood flow
228395|NCT01988545|cardiac out put|cardiac out put
228396|NCT01988545|stroke volume|stroke volume
228397|NCT01988545|beat to beat|beat to beat
228398|NCT01988545|effect of GLP-1 on cardiac parameters and blood flow|effect of glp-1 on cardiac parameters and blood flow
228399|NCT01988506|IL2,|il2,
228400|NCT01988506|Interleukin 2,|interleukin 2,
228401|NCT01988506|IL-2,|il-2,
228402|NCT01988506|Proleukin®, RhIL-2|proleukin®, rhil-2
228403|NCT01988506|Auto-immune disease|auto-immune disease
228404|NCT01988506|Inflammatory disease|inflammatory disease
228405|NCT01988506|Inflammation|inflammation
228406|NCT01988506|Regulatory T cells,|regulatory t cells,
228407|NCT01988506|Treg|treg
228408|NCT01988506|Immunoregulation|immunoregulation
228409|NCT01988506|Immune tolerance|immune tolerance
228414|NCT01988480|Guided surgery|guided surgery
228415|NCT01988480|Sinus graft|sinus graft
228416|NCT01988467|nasal breathing, oral breathing, secondhand smoking,|nasal breathing, oral breathing, secondhand smoking,
228417|NCT01988441|autophagy|autophagy
228418|NCT01988441|children|children
228419|NCT01988441|polymorphism|polymorphism
228420|NCT01988428|sepsis|sepsis
228421|NCT01988428|severe sepsis|severe sepsis
228422|NCT01988428|septic shock|septic shock
228423|NCT01988402|gout|gout
228424|NCT01988402|allopurinol|allopurinol
228427|NCT01988363|cervicogenic headache|cervicogenic headache
228428|NCT01988350|pancreatic insufficiency|pancreatic insufficiency
228429|NCT01988350|pancreatic elastase|pancreatic elastase
228430|NCT01988350|fecal elastase|fecal elastase
228432|NCT01988350|tobacco|tobacco
228433|NCT01988311|Psilocybin|psilocybin
228434|NCT01988311|Hallucinogens|hallucinogens
228435|NCT01988311|Pharmacologic Actions|pharmacologic actions
228436|NCT01988311|Central Nervous System Agents|central nervous system agents
228437|NCT01988311|Therapeutic Uses|therapeutic uses
228438|NCT01988311|Psychotropic Drugs|psychotropic drugs
228439|NCT01988285|Esophagitis|esophagitis
228440|NCT01988285|Eosinophilic Esophagitis|eosinophilic esophagitis
228441|NCT01988285|Esophageal Diseases|esophageal diseases
228442|NCT01988285|Gastrointestinal Diseases|gastrointestinal diseases
228443|NCT01988285|Digestive System Diseases|digestive system diseases
228444|NCT01988272|SPECT/CT|spect/ct
228445|NCT01988272|Dosimetry|dosimetry
228446|NCT01988272|Radiation absorbed dose|radiation absorbed dose
228447|NCT01988272|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
228448|NCT01988272|I-131 tositumomab radioimmunotherapy|i-131 tositumomab radioimmunotherapy
228449|NCT01988246|Diabetes|diabetes
228450|NCT01988246|Diabetic Retinopathy|diabetic retinopathy
228451|NCT01988233|Physical activity|physical activity
228452|NCT01988233|Dance|dance
228453|NCT01988233|Latinos|latinos
228455|NCT01988233|Older adults|older adults
228456|NCT01988233|Health disparities|health disparities
228457|NCT01988220|stroke|stroke
228458|NCT01988220|sensory deficit|sensory deficit
228459|NCT01988220|sensory retraining|sensory retraining
228460|NCT01988220|perceptual learning|perceptual learning
228461|NCT01988220|lower extremity|lower extremity
228462|NCT01988207|Muscle Tension Dysphonia|muscle tension dysphonia
228463|NCT01988207|Voice|voice
228464|NCT01988207|Hyperfunction|hyperfunction
228465|NCT01988194|acupuncture|acupuncture
228466|NCT01988194|postoperative pain|postoperative pain
228467|NCT01988194|nausea|nausea
228468|NCT01988194|vomiting|vomiting
228469|NCT01988194|anxiety|anxiety
228470|NCT01988194|depression|depression
228471|NCT01988194|hospitalization|hospitalization
228472|NCT01988194|inpatient|inpatient
228473|NCT01988181|Intradialytic Hypotension|intradialytic hypotension
228474|NCT01988181|Renal Dialysis|renal dialysis
228475|NCT01988181|Blood Volume Determination|blood volume determination
228476|NCT01988181|Clinical Trials, Randomized|clinical trials, randomized
228477|NCT01988181|Crossover Studies|crossover studies
228478|NCT01988168|Suture Techniques|suture techniques
228479|NCT01988168|Sutures|sutures
228480|NCT01988168|Surgical Staplers|surgical staplers
228481|NCT01988142|Spinal Cord Injury|spinal cord injury
228482|NCT01988142|Passive motion|passive motion
228483|NCT01988142|Fatigue index|fatigue index
228484|NCT01988142|Hypertonia|hypertonia
228485|NCT01988129|sleep|sleep
228486|NCT01988129|firefighter|firefighter
228487|NCT01988129|fire|fire
228488|NCT01988129|apnea|apnea
228489|NCT01988129|insomnia|insomnia
228490|NCT01988129|shift|shift
228491|NCT01988129|narcolepsy|narcolepsy
228492|NCT01988129|restless leg|restless leg
228493|NCT01988129|rls|rls
228494|NCT01988129|fatigue|fatigue
228495|NCT01988129|actigraph|actigraph
228496|NCT01988129|actigraphy|actigraphy
228497|NCT01988129|actiwatch|actiwatch
228498|NCT01988129|safety|safety
228499|NCT01988129|sleepiness|sleepiness
228500|NCT01988129|sleepy|sleepy
228501|NCT01988129|work|work
228502|NCT01988129|hours|hours
228503|NCT01988129|Federal Emergency Management Agency|federal emergency management agency
228504|NCT01988129|drowsy|drowsy
228505|NCT01988116|Chronic kidney disease|chronic kidney disease
228506|NCT01988116|Anemia of chronic disease|anemia of chronic disease
228507|NCT01988116|Iron Metabolism|iron metabolism
228508|NCT01988116|Iron Homeostasis|iron homeostasis
228509|NCT01988116|Vitamin D|vitamin d
228510|NCT01988116|Calcitriol|calcitriol
228511|NCT01988116|hemojuvelin|hemojuvelin
228512|NCT01988116|hepcidin|hepcidin
228513|NCT01988116|anemia|anemia
228514|NCT01988116|ferroportin|ferroportin
228515|NCT01988103|Psoriasis; Psoriatic Arthritis|psoriasis; psoriatic arthritis
228516|NCT01988090|Breast Cancer|breast cancer
228517|NCT01988090|Hormone Receptor Positive|hormone receptor positive
228518|NCT01988090|Vitamin D|vitamin d
228519|NCT01988064|pulse rate|pulse rate
228520|NCT01988064|patient education|patient education
228521|NCT01988064|training|training
228522|NCT01988038|Polycystic Kidney Disease|polycystic kidney disease
228523|NCT01988038|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
228524|NCT01988038|Disease Progression|disease progression
228525|NCT01987986|cellulite|cellulite
228526|NCT01987986|dimple|dimple
228527|NCT01987986|orange peel|orange peel
228528|NCT01987986|cottage cheese|cottage cheese
228529|NCT01987986|mattress texture|mattress texture
228530|NCT01987947|MEMP1972A|memp1972a
228832|NCT01986465|steroid|steroid
228531|NCT01987934|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
228532|NCT01987934|Methyl Green Pyronin Staining|methyl green pyronin staining
228533|NCT01987934|AgNORs|agnors
228534|NCT01987934|Morphometry|morphometry
228535|NCT01987921|Acute kidney injury|acute kidney injury
228536|NCT01987921|Pediatrics|pediatrics
228537|NCT01987921|Critical Care|critical care
228538|NCT01987908|Pain|pain
228539|NCT01987908|Biomarkers|biomarkers
228540|NCT01987908|6 minute walk test|6 minute walk test
228541|NCT01987908|5-HMF|5-hmf
228542|NCT01987908|Pharmacokinetics|pharmacokinetics
228543|NCT01987908|Analgesic use|analgesic use
228544|NCT01987908|Sickle cell disease|sickle cell disease
228545|NCT01987908|Aes-103|aes-103
228546|NCT01987908|SpO2|spo2
228547|NCT01987908|Anemia|anemia
228548|NCT01987908|Hemoglobin|hemoglobin
228549|NCT01987895|Post-antibiotic diarrhea|post-antibiotic diarrhea
228550|NCT01987895|Clostridium difficile infection|clostridium difficile infection
228551|NCT01987882|Outcomes research, treatment effectiveness, quality of life|outcomes research, treatment effectiveness, quality of life
228552|NCT01987869|hiperemesis gravidarum,vomiting,serotonin levels,ketonuria|hiperemesis gravidarum,vomiting,serotonin levels,ketonuria
228553|NCT01987856|aCGH|acgh
228554|NCT01987856|chromosome|chromosome
228555|NCT01987856|blastocyst|blastocyst
228556|NCT01987856|trophectoderm|trophectoderm
228557|NCT01987856|vitrification|vitrification
228558|NCT01987856|natural cycle|natural cycle
228559|NCT01987856|pregnancy|pregnancy
228562|NCT01987843|Plaque Psoriasis|plaque psoriasis
228563|NCT01987830|Recurrent glioblastoma|recurrent glioblastoma
228564|NCT01987817|Characterized Peanut Allergen|characterized peanut allergen
228565|NCT01987817|Peanut|peanut
228566|NCT01987817|OIT|oit
228567|NCT01987817|Oral Desensitization|oral desensitization
228568|NCT01987817|Peanut Allergen|peanut allergen
228569|NCT01987817|Allergy|allergy
228570|NCT01987817|Peanut Allergy|peanut allergy
228571|NCT01987817|Peanut-Allergic Children|peanut-allergic children
228572|NCT01987817|Children|children
228573|NCT01987817|Peanut-Allergic Adults|peanut-allergic adults
228574|NCT01987778|Hot flashes|hot flashes
228575|NCT01987778|Menopause|menopause
228576|NCT01987778|HRQoL|hrqol
228577|NCT01987778|Resistance training|resistance training
228578|NCT01987778|Physical activity|physical activity
228579|NCT01987778|Adipose tissue|adipose tissue
228580|NCT01987739|Almorexant|almorexant
228581|NCT01987739|Zolpidem|zolpidem
228582|NCT01987726|Solid Tumor Malignancies|solid tumor malignancies
228583|NCT01987700|Abdominal Hernia Repair|abdominal hernia repair
228584|NCT01987700|Dermal Allograft|dermal allograft
228585|NCT01987700|Mesh|mesh
228586|NCT01987700|Component Separation|component separation
228587|NCT01987661|COPD|copd
228588|NCT01987661|NIV|niv
228589|NCT01987661|Airtrapping|airtrapping
228590|NCT01987661|Ventimotion2|ventimotion2
228591|NCT01987648|Craniotomy|craniotomy
228592|NCT01987648|Postoperative complications|postoperative complications
228593|NCT01987648|Perioperative care|perioperative care
228594|NCT01987648|Postoperative intracerebral hemorrhage|postoperative intracerebral hemorrhage
228595|NCT01987648|Postoperative seizure|postoperative seizure
228596|NCT01987635|Mitral valve disease|mitral valve disease
228597|NCT01987635|primarily regurgitation|primarily regurgitation
228598|NCT01987635|necessitating surgical repair|necessitating surgical repair
228599|NCT01987622|lumbar spinal stenosis|lumbar spinal stenosis
228600|NCT01987622|claudication|claudication
228601|NCT01987622|low back pain|low back pain
228602|NCT01987622|radiculopathy|radiculopathy
228603|NCT01987622|acupuncture|acupuncture
280978|NCT01749007|HIV|hiv
228604|NCT01987622|Korean medicine|korean medicine
228605|NCT01987622|randomized controlled trial|randomized controlled trial
228606|NCT01987609|Psoriasis|psoriasis
228607|NCT01987609|Dendritic cells|dendritic cells
228608|NCT01987609|Hyaluronidase|hyaluronidase
228609|NCT01987609|Hylenex|hylenex
228610|NCT01987570|Xanthine oxidase|xanthine oxidase
228611|NCT01987570|Magnetic resonance|magnetic resonance
228612|NCT01987570|Oxidative stress|oxidative stress
686486|NCT00907361|ICD|icd
228613|NCT01987570|Inflammation|inflammation
228614|NCT01987557|treadmill|treadmill
228615|NCT01987557|parkinson's|parkinson's
228616|NCT01987557|proprioception|proprioception
228617|NCT01987557|cadence|cadence
228618|NCT01987557|step length|step length
228619|NCT01987557|intrinsic feedback|intrinsic feedback
228620|NCT01987544|COPD|copd
228621|NCT01987544|telemonitoring|telemonitoring
228622|NCT01987544|training|training
228623|NCT01987544|ergometer|ergometer
228624|NCT01987544|telemedicine|telemedicine
228625|NCT01987531|after open cardiac chamber cardiac surgery|after open cardiac chamber cardiac surgery
228626|NCT01987466|Neutrophil Gelatinase-associated Lipocalin(NGAL)|neutrophil gelatinase-associated lipocalin(ngal)
228627|NCT01987466|Acute renal failure|acute renal failure
228628|NCT01987466|Cardiac arrest|cardiac arrest
228629|NCT01987466|Hypothermia|hypothermia
228630|NCT01987453|genotype 1|genotype 1
228631|NCT01987427|Overweight|overweight
228633|NCT01987427|Weight Management|weight management
228634|NCT01987414|Stroke|stroke
228635|NCT01987414|Cardiovascular Accident|cardiovascular accident
228636|NCT01987414|Task-oriented approach|task-oriented approach
228637|NCT01987414|Orthosis|orthosis
228638|NCT01987414|occupational therapy|occupational therapy
228639|NCT01987401|pulmonary|pulmonary
228640|NCT01987401|lung|lung
228641|NCT01987401|military and environmental exposures|military and environmental exposures
228642|NCT01987401|epidemiologic|epidemiologic
228643|NCT01987401|observational|observational
228644|NCT01987401|interview or questionnaire|interview or questionnaire
228645|NCT01987401|deployment related|deployment related
228646|NCT01987401|Enduring Freedom|enduring freedom
228647|NCT01987401|Iraqi Freedom|iraqi freedom
228648|NCT01987375|HNSCC|hnscc
228649|NCT01987375|Imaging|imaging
228650|NCT01987349|Influenza vaccines|influenza vaccines
228651|NCT01987349|healthy participants|healthy participants
228652|NCT01987349|immunity to influenza|immunity to influenza
228653|NCT01987349|identical twins|identical twins
228654|NCT01987349|fraternal twins|fraternal twins
228655|NCT01987349|non-twins|non-twins
228656|NCT01987336|Standard Foley Catheter|standard foley catheter
228657|NCT01987323|glaucoma|glaucoma
228658|NCT01987323|raised intraocular pressure|raised intraocular pressure
228659|NCT01987310|non alcoholic fatty liver disease|non alcoholic fatty liver disease
228660|NCT01987310|endothelial function|endothelial function
228661|NCT01987310|liver steatosis|liver steatosis
228662|NCT01987310|liver fibrosis|liver fibrosis
228663|NCT01987310|statin treatment|statin treatment
228664|NCT01987297|arsenic|arsenic
228665|NCT01987297|acute promyelocytic leukemia|acute promyelocytic leukemia
228666|NCT01987297|outcome|outcome
228667|NCT01987271|exercise tolerance|exercise tolerance
228668|NCT01987271|exercise test|exercise test
228669|NCT01987271|noninvasive ventilation|noninvasive ventilation
228670|NCT01987258|Glycemic control|glycemic control
228671|NCT01987258|excess post-exercise oxygen consumption|excess post-exercise oxygen consumption
228672|NCT01987219|familial dysautonomia|familial dysautonomia
228673|NCT01987206|artificial pancreas|artificial pancreas
228674|NCT01987193|Proton radiation|proton radiation
228675|NCT01987193|tumor blood flow|tumor blood flow
228676|NCT01987180|self-efficacy|self-efficacy
228677|NCT01987167|acute optic neuritis|acute optic neuritis
228678|NCT01987115|Trigger Finger|trigger finger
228679|NCT01987115|Physiotherapy|physiotherapy
228680|NCT01987115|Fascial Manipulation|fascial manipulation
228681|NCT01987102|Methotrexate|methotrexate
228682|NCT01987102|rescue treatment|rescue treatment
228683|NCT01987089|Insomnia|insomnia
228684|NCT01987089|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
228685|NCT01987089|Alcoholism|alcoholism
228686|NCT01987089|Cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
228687|NCT01987076|DRESS|dress
228688|NCT01987076|Systemic steroid|systemic steroid
228689|NCT01987076|Topical steroid|topical steroid
228690|NCT01987076|Treatment|treatment
228691|NCT01987063|Twin delivery|twin delivery
228692|NCT01987063|Planned vaginal delivery|planned vaginal delivery
228693|NCT01987063|Planned cesarean delivery|planned cesarean delivery
228694|NCT01987063|Total breech extraction|total breech extraction
228695|NCT01987063|Internal cephalic version|internal cephalic version
228696|NCT01987063|External cephalic version|external cephalic version
228697|NCT01987037|autism spectrum disorder|autism spectrum disorder
228698|NCT01987037|neuropsychomotor assessment|neuropsychomotor assessment
228699|NCT01987037|NP-MOT|np-mot
281109|NCT01748305|GDM|gdm
228700|NCT01987037|motor skills|motor skills
228701|NCT01987037|gross motor|gross motor
228702|NCT01987011|Avian influenza|avian influenza
228703|NCT01986998|Multiple sclerosis relapse|multiple sclerosis relapse
228704|NCT01986998|oral methylprednisolone|oral methylprednisolone
228705|NCT01986998|EDSS|edss
228706|NCT01986998|gadolinium|gadolinium
228707|NCT01986972|Toothbrushing|toothbrushing
228708|NCT01986972|Dental plaque|dental plaque
228709|NCT01986972|Dentifrice|dentifrice
686864|NCT00919282|combination|combination
228710|NCT01986972|Oral hygiene|oral hygiene
228711|NCT01986959|Periodontal Dressings|periodontal dressings
228712|NCT01986959|Surgical crown lengthening|surgical crown lengthening
228713|NCT01986959|Periodontal surgery|periodontal surgery
228714|NCT01986920|SK|sk
228715|NCT01986907|wet AMD|wet amd
228716|NCT01986907|macular degeneration|macular degeneration
228717|NCT01986907|ranibizumab|ranibizumab
228718|NCT01986907|mono-bilateral|mono-bilateral
228719|NCT01986907|poor visual acuity|poor visual acuity
228720|NCT01986907|retinal disease|retinal disease
228721|NCT01986907|eye disease|eye disease
228722|NCT01986907|Angiogenesis Inhibitors|angiogenesis inhibitors
228723|NCT01986907|Angiogenesis Modulating Agents|angiogenesis modulating agents
228724|NCT01986894|TQT|tqt
228725|NCT01986894|Pharmacokinetic|pharmacokinetic
228726|NCT01986894|Healthy|healthy
228727|NCT01986868|Coronary Magnetic Resonance Angiography|coronary magnetic resonance angiography
228728|NCT01986868|CMRA|cmra
228729|NCT01986868|MRI with contrast|mri with contrast
228730|NCT01986868|MultiHance|multihance
228731|NCT01986868|Optimark|optimark
228732|NCT01986868|Gadolinium-based contrast|gadolinium-based contrast
228733|NCT01986868|MRA|mra
228734|NCT01986868|MR angiography|mr angiography
228735|NCT01986842|Muscle protein synthesis|muscle protein synthesis
228736|NCT01986842|Digestion and absorption kinetics|digestion and absorption kinetics
228737|NCT01986842|Leucine|leucine
228738|NCT01986842|Whey protein|whey protein
228739|NCT01986816|Obesity|obesity
228740|NCT01986816|Bariatric surgery|bariatric surgery
228741|NCT01986816|Laparoscopic gastric bypass|laparoscopic gastric bypass
228742|NCT01986816|Quality of life|quality of life
228743|NCT01986816|QALY|qaly
228744|NCT01986803|ST-elevation Myocardial Infarction (STEMI)|st-elevation myocardial infarction (stemi)
228745|NCT01986803|Primary Percutaneous Coronary Intervention within 24 hrs|primary percutaneous coronary intervention within 24 hrs
228746|NCT01986803|Healing score|healing score
228747|NCT01986803|OFDI|ofdi
228748|NCT01986790|Health insurance|health insurance
228749|NCT01986790|Health services accessibility|health services accessibility
228750|NCT01986790|Decision making|decision making
228751|NCT01986790|Health literacy|health literacy
228752|NCT01986777|cognitive complains|cognitive complains
228753|NCT01986777|RRSO|rrso
228754|NCT01986777|oophorectomy|oophorectomy
228755|NCT01986777|memory|memory
228756|NCT01986777|cognition|cognition
228757|NCT01986777|early menopause|early menopause
228758|NCT01986764|oophorectomy|oophorectomy
228759|NCT01986764|RRSO|rrso
228760|NCT01986764|menopause|menopause
228761|NCT01986764|early menopause|early menopause
228762|NCT01986764|cognition|cognition
228763|NCT01986764|memory|memory
228764|NCT01986764|brain-imaging|brain-imaging
228765|NCT01986751|nerve|nerve
228766|NCT01986751|block|block
228767|NCT01986751|motor blockade|motor blockade
228768|NCT01986751|lower extremity pain|lower extremity pain
228769|NCT01986751|nerve block|nerve block
228770|NCT01986725|vulvar neoplasia|vulvar neoplasia
228771|NCT01986725|vulvar cancer|vulvar cancer
228772|NCT01986725|vulvar intraepithelial neoplasia|vulvar intraepithelial neoplasia
228773|NCT01986725|self management|self management
228774|NCT01986725|symptom management|symptom management
228775|NCT01986712|Melanoma, Stage III, adjuvant, Quality of Life|melanoma, stage iii, adjuvant, quality of life
228776|NCT01986699|polypectomy|polypectomy
228777|NCT01986699|laparoscopic|laparoscopic
228778|NCT01986673|Pharmacokinetic Characterization|pharmacokinetic characterization
228779|NCT01986660|Pharmacokinetic Study|pharmacokinetic study
228780|NCT01986647|exercise|exercise
228781|NCT01986647|older adults|older adults
228782|NCT01986647|mobility disability|mobility disability
228783|NCT01986634|Laser Resurfacing|laser resurfacing
228784|NCT01986634|Rhytids|rhytids
228785|NCT01986634|Perioral|perioral
228786|NCT01986608|Lacosamide|lacosamide
228787|NCT01986608|Vimpat|vimpat
228788|NCT01986608|Bioequivalence|bioequivalence
228789|NCT01986608|Bioavailability|bioavailability
228790|NCT01986608|Japanese|japanese
228791|NCT01986595|Neuroblastoma|neuroblastoma
228792|NCT01986595|anaplastic lymphoma kinase|anaplastic lymphoma kinase
228793|NCT01986595|cancer genetics|cancer genetics
228794|NCT01986595|target therapy|target therapy
228795|NCT01986595|RNA and genomic DNA extraction|rna and genomic dna extraction
228796|NCT01986595|complementary DNA(cDNA) preparation|complementary dna(cdna) preparation
228797|NCT01986595|Array-comparative genomic hybridization|array-comparative genomic hybridization
281208|NCT01747915|Safety|safety
228798|NCT01986595|Multiplex ligation-dependent probe amplification (MLPA)|multiplex ligation-dependent probe amplification (mlpa)
228799|NCT01986595|Sequencing of cDNA prepared from NB|sequencing of cdna prepared from nb
228800|NCT01986595|Pyrosequencing|pyrosequencing
228801|NCT01986595|Quantitative real-time polymerase chain reaction(RT-PCR)|quantitative real-time polymerase chain reaction(rt-pcr)
228802|NCT01986595|Immunohistochemistry|immunohistochemistry
228803|NCT01986582|Allergic Rhinitis|allergic rhinitis
228804|NCT01986582|Congestion|congestion
687137|NCT00920257|lymphoma|lymphoma
228805|NCT01986582|Mucoadhesive Treatment|mucoadhesive treatment
228806|NCT01986582|Nasal Decongestant|nasal decongestant
228807|NCT01986569|Fluoroestradiol (FES)|fluoroestradiol (fes)
228808|NCT01986569|PET/CT scan|pet/ct scan
228809|NCT01986569|Estrogen Receptor|estrogen receptor
228810|NCT01986569|Recurrent breast cancer|recurrent breast cancer
228811|NCT01986569|Stage IV breast cancer|stage iv breast cancer
228812|NCT01986543|Pharmacokinetic|pharmacokinetic
228813|NCT01986530|irisin|irisin
228814|NCT01986530|adiponectin|adiponectin
228815|NCT01986530|leptin|leptin
228816|NCT01986530|lean body mass|lean body mass
228817|NCT01986530|fat mass|fat mass
228818|NCT01986517|Feedback|feedback
228819|NCT01986517|Therapeutic competencies|therapeutic competencies
228820|NCT01986517|Training|training
228821|NCT01986504|Infection|infection
228822|NCT01986504|Cohort|cohort
228823|NCT01986504|Prospective|prospective
228824|NCT01986504|Epidemiology|epidemiology
228825|NCT01986504|Outcome|outcome
228826|NCT01986491|Healthy|healthy
228827|NCT01986491|JNJ-39393406|jnj-39393406
228828|NCT01986491|Relative Bioavailability|relative bioavailability
228829|NCT01986491|Solid Formulation|solid formulation
228830|NCT01986465|lateral epicondylitis|lateral epicondylitis
228833|NCT01986465|immobilization|immobilization
228834|NCT01986452|OSA|osa
228835|NCT01986452|Apoplexy|apoplexy
228836|NCT01986452|CPAP|cpap
228837|NCT01986452|adherence|adherence
228838|NCT01986452|telemonitoring|telemonitoring
228839|NCT01986426|Transdermal accessible tumours|transdermal accessible tumours
228840|NCT01986413|COPD|copd
228841|NCT01986413|chronic hypercapnic respiratory failure|chronic hypercapnic respiratory failure
228842|NCT01986413|NIV|niv
228843|NCT01986413|respiratory events|respiratory events
228844|NCT01986413|IVAPS|ivaps
228845|NCT01986400|Adolescent|adolescent
228846|NCT01986400|Skype|skype
228847|NCT01986400|Peer Mentorship|peer mentorship
228848|NCT01986400|Internet Self-Management|internet self-management
228849|NCT01986387|adolescent|adolescent
228850|NCT01986387|Skype|skype
228851|NCT01986387|peer mentorship|peer mentorship
228852|NCT01986387|internet self-management|internet self-management
228853|NCT01986374|IVF , embryo implantation, HCG|ivf , embryo implantation, hcg
228854|NCT01986361|Pharyngitis|pharyngitis
228855|NCT01986361|Sore Throat|sore throat
228856|NCT01986361|acute upper respiratory tract infection (URTI)|acute upper respiratory tract infection (urti)
228857|NCT01986348|GBM|gbm
228858|NCT01986348|Glioblastoma|glioblastoma
228859|NCT01986348|selinexor|selinexor
228860|NCT01986348|KPT-330|kpt-330
228861|NCT01986348|Karyopharm|karyopharm
228863|NCT01986348|brain cancer|brain cancer
228864|NCT01986348|Glioma|glioma
228865|NCT01986348|Astrocytoma|astrocytoma
228866|NCT01986348|Oligodendrogliomas|oligodendrogliomas
228867|NCT01986348|Oligo-astrocytomas|oligo-astrocytomas
228868|NCT01986335|Combined pentavalent DTP/HB/Hib vaccine|combined pentavalent dtp/hb/hib vaccine
228869|NCT01986335|Infants|infants
228870|NCT01986335|Primary vaccination|primary vaccination
228871|NCT01986322|DTP/HB/Hib vaccine|dtp/hb/hib vaccine
228872|NCT01986322|Immunogenicity|immunogenicity
228873|NCT01986322|Infants|infants
228874|NCT01986322|Safety|safety
228875|NCT01986309|Postoperative|postoperative
228876|NCT01986309|Nausea|nausea
228877|NCT01986309|Vomiting|vomiting
228878|NCT01986309|Pain|pain
228879|NCT01986309|Surgery|surgery
228880|NCT01986283|Abuse potential|abuse potential
228881|NCT01986283|PF-00345439|pf-00345439
228882|NCT01986283|drug abuse|drug abuse
228883|NCT01986244|Osteoarthritis|osteoarthritis
228884|NCT01986244|Arthritis|arthritis
228885|NCT01986244|Joint Diseases|joint diseases
228886|NCT01986231|diabetes|diabetes
228887|NCT01986231|insulin|insulin
228888|NCT01986231|glucagon|glucagon
228889|NCT01986231|glycogen|glycogen
228890|NCT01986231|MRS|mrs
228891|NCT01986205|Concussion, mild|concussion, mild
228892|NCT01986205|Traumatic brain injury|traumatic brain injury
228893|NCT01986205|Hyperbaric oxygenation|hyperbaric oxygenation
228894|NCT01986205|Post-concussion symptoms|post-concussion symptoms
228895|NCT01986205|Headache|headache
228896|NCT01986192|anticoagulation|anticoagulation
228897|NCT01986192|pharmacomechanical thrombolysis|pharmacomechanical thrombolysis
228898|NCT01986192|aspiration thrombectomy|aspiration thrombectomy
228899|NCT01986153|Fatty acid, essential|fatty acid, essential
228900|NCT01986153|Immune system|immune system
228901|NCT01986153|Home parenteral nutrition|home parenteral nutrition
228902|NCT01986140|Breast Cancer|breast cancer
228903|NCT01986140|Alopecia|alopecia
228904|NCT01986140|Scalp|scalp
228905|NCT01986140|Cooling|cooling
228906|NCT01986127|Crohn disease|crohn disease
228907|NCT01986075|Cocaine Dependence Treatment|cocaine dependence treatment
228908|NCT01986075|Computer-assisted therapy|computer-assisted therapy
228909|NCT01986075|Pharmacotherapy|pharmacotherapy
228910|NCT01986062|ADHD|adhd
228911|NCT01986062|AR11|ar11
228912|NCT01986062|classroom design|classroom design
228913|NCT01986062|amphetamine sulfate|amphetamine sulfate
228914|NCT01986023|Stroke|stroke
228915|NCT01986023|Medication Adherence|medication adherence
228916|NCT01986023|SMS|sms
228917|NCT01986023|Randomised|randomised
228918|NCT01985997|FluMist, Quadrivalent, Vaccine|flumist, quadrivalent, vaccine
228919|NCT01985984|Head and neck cancer|head and neck cancer
228920|NCT01985906|Aorta|aorta
228921|NCT01985906|Aneurysm|aneurysm
228922|NCT01985906|Stents|stents
228923|NCT01985906|Collateral Circulation|collateral circulation
228924|NCT01985893|Metastatic|metastatic
228925|NCT01985893|breast|breast
228926|NCT01985893|cancer|cancer
228927|NCT01985880|Biomarkers|biomarkers
228928|NCT01985854|Desflurane|desflurane
228929|NCT01985854|Propofol|propofol
228930|NCT01985854|Total intravenous anesthesia|total intravenous anesthesia
228931|NCT01985854|Neurosurgery|neurosurgery
228932|NCT01985841|Early breast cancer|early breast cancer
228933|NCT01985841|Primary operable breast cancer|primary operable breast cancer
228934|NCT01985841|HER2- negative|her2- negative
228935|NCT01985841|bevacizumab|bevacizumab
228936|NCT01985828|Prostate neoplasm|prostate neoplasm
228937|NCT01985828|Prostate Cancer|prostate cancer
228938|NCT01985815|obsessive-compulsive disorder|obsessive-compulsive disorder
229040|NCT01985477|Decadron|decadron
228939|NCT01985815|Deep Brain Stimulation|deep brain stimulation
228940|NCT01985815|Psychosurgery|psychosurgery
228941|NCT01985789|airway hyperresponsiveness|airway hyperresponsiveness
228942|NCT01985776|Exercise|exercise
228943|NCT01985776|Electric Stimulation|electric stimulation
228944|NCT01985763|Genistein|genistein
228945|NCT01985763|soy supplements|soy supplements
228946|NCT01985763|phytoestrogens|phytoestrogens
228947|NCT01985763|colon cancer|colon cancer
228948|NCT01985763|rectal cancer|rectal cancer
228949|NCT01985763|colorectal cancer|colorectal cancer
228950|NCT01985763|metastatic|metastatic
228951|NCT01985763|stage IV|stage iv
228952|NCT01985763|FOLFOX|folfox
228953|NCT01985763|FOLFOX-Avastin|folfox-avastin
228954|NCT01985763|Chemotherapy|chemotherapy
228955|NCT01985750|dyspnea|dyspnea
228956|NCT01985750|fmri|fmri
228957|NCT01985750|d-cycloserine|d-cycloserine
228958|NCT01985737|Neonatal Intensive Care Units (NICUs)|neonatal intensive care units (nicus)
228959|NCT01985737|NICUs|nicus
228960|NCT01985737|Neonates|neonates
228961|NCT01985737|CLABSI|clabsi
228962|NCT01985737|Microbiome|microbiome
228963|NCT01985737|DNA signature|dna signature
228964|NCT01985737|Catheter infections|catheter infections
228965|NCT01985724|Early breast cancer|early breast cancer
228966|NCT01985724|Axillary node positive|axillary node positive
228967|NCT01985724|HER-2 negative|her-2 negative
228968|NCT01985724|Adjuvant chemotherapy|adjuvant chemotherapy
228969|NCT01985724|Dose dense|dose dense
228970|NCT01985724|Docetaxel|docetaxel
228971|NCT01985724|FEC|fec
228972|NCT01985711|Motivational Interviewing|motivational interviewing
228973|NCT01985711|Cognitive Behavioral Therapy|cognitive behavioral therapy
228974|NCT01985711|Transtheoretical Model of behavior change|transtheoretical model of behavior change
228975|NCT01985711|Questionnaires|questionnaires
228976|NCT01985711|Telemedicine/*methods|telemedicine/*methods
228977|NCT01985711|Comorbidity|comorbidity
228978|NCT01985711|Diabetes|diabetes
228979|NCT01985711|Glucose/metabolism|glucose/metabolism
228980|NCT01985711|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
228981|NCT01985711|Blood Pressure|blood pressure
228982|NCT01985711|Cholesterol, LDL/blood|cholesterol, ldl/blood
228983|NCT01985711|Quality of life|quality of life
228984|NCT01985711|Depressive Disorder/psychology/*therapy|depressive disorder/psychology/*therapy
228985|NCT01985711|Randomized Controlled Trials|randomized controlled trials
228986|NCT01985698|Low rectal cancer|low rectal cancer
228987|NCT01985698|Robotic|robotic
228988|NCT01985698|Laparoscopic|laparoscopic
228989|NCT01985698|Abdominoperineal resection|abdominoperineal resection
228990|NCT01985685|VO2, critically ill, oxygen consumption|vo2, critically ill, oxygen consumption
228991|NCT01985672|Infertility|infertility
228992|NCT01985659|Lymph Node Excision|lymph node excision
228993|NCT01985659|Thoracic Surgical Procedures|thoracic surgical procedures
228994|NCT01985659|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
228995|NCT01985659|Thoracotomy|thoracotomy
228996|NCT01985646|Hirschsprung disease|hirschsprung disease
228997|NCT01985646|conservative treatment|conservative treatment
228998|NCT01985646|surgery treatment|surgery treatment
228999|NCT01985646|infants|infants
229000|NCT01985633|Osteoarthritis|osteoarthritis
229001|NCT01985633|stem cells|stem cells
229002|NCT01985633|Platelet gel|platelet gel
229003|NCT01985633|Functional outcome|functional outcome
229004|NCT01985620|Vaccination|vaccination
229005|NCT01985620|RSV|rsv
229006|NCT01985620|Influenza|influenza
229007|NCT01985620|Prematurity|prematurity
229008|NCT01985594|preterm labor|preterm labor
229009|NCT01985581|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
229010|NCT01985581|Intuniv extended release|intuniv extended release
229011|NCT01985581|Executive Function|executive function
229012|NCT01985581|Quality of Life|quality of life
229013|NCT01985568|Obesity|obesity
229014|NCT01985568|weight-loss|weight-loss
229015|NCT01985568|Physical activity|physical activity
229016|NCT01985555|Phase I|phase i
229017|NCT01985555|Safety|safety
229018|NCT01985555|Pharmacokinetics|pharmacokinetics
229019|NCT01985516|Pain|pain
229020|NCT01985516|Urethra|urethra
229021|NCT01985516|Catheter|catheter
229022|NCT01985503|positron emission tomography|positron emission tomography
229023|NCT01985503|magnetic resonance imaging|magnetic resonance imaging
229024|NCT01985503|brown adipose tissue|brown adipose tissue
229025|NCT01985503|obesity|obesity
229026|NCT01985503|cardiovascular disease|cardiovascular disease
229027|NCT01985503|subclinical atherosclerosis|subclinical atherosclerosis
229028|NCT01985490|epiretinal membrane|epiretinal membrane
229029|NCT01985490|foveal avascular zone|foveal avascular zone
229030|NCT01985490|internal limiting membrane|internal limiting membrane
229031|NCT01985477|Myeloma|myeloma
229032|NCT01985477|Multiple myeloma|multiple myeloma
229033|NCT01985477|MM|mm
229034|NCT01985477|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
229035|NCT01985477|RR MM|rr mm
229036|NCT01985477|Lenalidomide|lenalidomide
229037|NCT01985477|CC-5013|cc-5013
229038|NCT01985477|Revlimid|revlimid
229039|NCT01985477|Dexamethasone|dexamethasone
229041|NCT01985477|All-Trans Retinoic Acid|all-trans retinoic acid
229042|NCT01985477|ATRA|atra
229043|NCT01985477|Tretinoin (Oral)|tretinoin (oral)
229044|NCT01985477|Vesanoid|vesanoid
229045|NCT01985464|rheumatoid arthritis|rheumatoid arthritis
229046|NCT01985464|umbilical cord|umbilical cord
229047|NCT01985464|mesenchymal|mesenchymal
229048|NCT01985464|stem cells|stem cells
229049|NCT01985451|Lymphoma|lymphoma
229050|NCT01985438|Head and Neck Neoplasms|head and neck neoplasms
229051|NCT01985438|Nutritional Support|nutritional support
229052|NCT01985438|Randomized Controlled Trial|randomized controlled trial
229053|NCT01985438|Percutaneous Endoscopic Gastrostomy tube|percutaneous endoscopic gastrostomy tube
229054|NCT01985438|Nasogastric tube|nasogastric tube
229055|NCT01985438|Radiation Effects|radiation effects
229056|NCT01985438|Pakistan|pakistan
229057|NCT01985412|Rejection|rejection
229058|NCT01985412|Transplant|transplant
229059|NCT01985412|Cardiac|cardiac
229060|NCT01985412|Pulmonary|pulmonary
229061|NCT01985412|Heart|heart
229062|NCT01985412|Lung|lung
229063|NCT01985412|Cell-Free DNA|cell-free dna
229064|NCT01985412|cfDNA|cfdna
229065|NCT01985412|Cell|cell
229066|NCT01985412|Free|free
229067|NCT01985412|DNA|dna
229068|NCT01985412|Biopsy|biopsy
229069|NCT01985412|Non-Invasive|non-invasive
229070|NCT01985399|HIV|hiv
229071|NCT01985399|AIDS|aids
229072|NCT01985399|Aging|aging
229073|NCT01985386|Iron absorption|iron absorption
229074|NCT01985386|Slow release iron|slow release iron
229075|NCT01985386|Gastric delivery system|gastric delivery system
229076|NCT01985386|Iron deficiency|iron deficiency
229077|NCT01985373|intravenous immunoglobulin|intravenous immunoglobulin
229078|NCT01985373|pharmacokinetics|pharmacokinetics
229079|NCT01985373|10% IVIG|10% ivig
229080|NCT01985334|Moderate COPD, glycopyrronium bromide, indacaterol maleate and glycopyrronium bromide FDC, NVA237, QVA149|moderate copd, glycopyrronium bromide, indacaterol maleate and glycopyrronium bromide fdc, nva237, qva149
229081|NCT01985321|herpes labialis|herpes labialis
229082|NCT01985321|cold sore|cold sore
229083|NCT01985269|High risk|high risk
229084|NCT01985269|ART naive|art naive
229085|NCT01985243|Dietary diversity|dietary diversity
229086|NCT01985243|Infant and young child|infant and young child
229087|NCT01985243|Adolescents|adolescents
229088|NCT01985243|Anemia|anemia
229089|NCT01985243|Rural health|rural health
229090|NCT01985204|iodine|iodine
229091|NCT01985204|thyroid hormones|thyroid hormones
229092|NCT01985204|obesity|obesity
229093|NCT01985204|TSH|tsh
229094|NCT01985204|dyslipidemia|dyslipidemia
229095|NCT01985204|insulin resistance|insulin resistance
229096|NCT01985139|Obesity, food pleasure, behavioral tasks, endocannabinoids|obesity, food pleasure, behavioral tasks, endocannabinoids
229097|NCT01985126|Multiple myeloma|multiple myeloma
229098|NCT01985126|Daratumumab|daratumumab
229099|NCT01985126|Proteasome inhibitor|proteasome inhibitor
229100|NCT01985126|Immunomodulatory drug|immunomodulatory drug
229101|NCT01985126|IMiD|imid
229102|NCT01985113|thioredoxin reductase|thioredoxin reductase
219805|NCT02027714|ART|art
229103|NCT01985113|non-small cell lung cancer|non-small cell lung cancer
229104|NCT01985074|case management, disease management, emergency|case management, disease management, emergency
229105|NCT01985074|department|department
229106|NCT01985061|Myelodysplasic syndrome|myelodysplasic syndrome
229107|NCT01985061|Acute Myeloid leukemia|acute myeloid leukemia
229108|NCT01985035|Obstructive sleep apnea|obstructive sleep apnea
229109|NCT01985035|obesity|obesity
229110|NCT01985035|diet|diet
229111|NCT01985035|energy expenditure|energy expenditure
229112|NCT01985022|autism|autism
229113|NCT01985022|autism spectrum disorders|autism spectrum disorders
687232|NCT00920621|Asthma|asthma
229114|NCT01985022|pervasive developmental disorders|pervasive developmental disorders
229115|NCT01985022|toddlers|toddlers
229116|NCT01985022|intervention|intervention
229117|NCT01984983|Venezuelan equine encephalitis virus|venezuelan equine encephalitis virus
229118|NCT01984983|DNA vaccine|dna vaccine
229119|NCT01984983|electroporation|electroporation
229120|NCT01984983|intradermal|intradermal
229121|NCT01984983|intramuscular|intramuscular
229122|NCT01984970|McGrath Videolaryngoscope|mcgrath videolaryngoscope
229123|NCT01984970|double-lumen tube intubation|double-lumen tube intubation
229124|NCT01984970|Thoracic surgery|thoracic surgery
229125|NCT01984957|ALS|als
229126|NCT01984957|Motor neuron diseases|motor neuron diseases
229127|NCT01984957|Transcriptome|transcriptome
229128|NCT01984944|circadian rhythm|circadian rhythm
229129|NCT01984931|post operative nausea and vomiting|post operative nausea and vomiting
229130|NCT01984931|Trimebutine Maleate|trimebutine maleate
229131|NCT01984905|18 FDG PET-scan|18 fdg pet-scan
229132|NCT01984905|angioscan|angioscan
229133|NCT01984905|aortic dissection|aortic dissection
229134|NCT01984892|Autologous Vaccination|autologous vaccination
229135|NCT01984892|Intratumoral Injections|intratumoral injections
229136|NCT01984892|Intramuscular Injections|intramuscular injections
229137|NCT01984892|Advanced Accessible Solid Tumors|advanced accessible solid tumors
229138|NCT01984892|Poly-ICLC|poly-iclc
229139|NCT01984892|Phase II Clinical Trial|phase ii clinical trial
229140|NCT01984892|Safety|safety
229142|NCT01984892|Autovaccination|autovaccination
229143|NCT01984892|In Situ|in situ
229144|NCT01984892|Host Targeted Strategy|host targeted strategy
229145|NCT01984892|Overall Survival|overall survival
229146|NCT01984892|Immunotherapy|immunotherapy
229147|NCT01984892|Adjuvant|adjuvant
229148|NCT01984866|CPR: Complete Pathological Response|cpr: complete pathological response
229149|NCT01984853|ACS|acs
229150|NCT01984853|repository|repository
229151|NCT01984853|Observational|observational
229152|NCT01984827|Hyperglycaemia|hyperglycaemia
229153|NCT01984827|Moxifloxacin|moxifloxacin
229154|NCT01984827|QTc prolongation|qtc prolongation
229155|NCT01984827|C-peptide|c-peptide
229156|NCT01984827|Dead in bed syndrome|dead in bed syndrome
229157|NCT01984801|SCD1|scd1
229158|NCT01984801|Gel|gel
229159|NCT01984801|Topical Administration|topical administration
229160|NCT01984801|Acne|acne
229161|NCT01984788|Oral Prophylaxis|oral prophylaxis
229162|NCT01984775|safety|safety
229163|NCT01984775|dermal|dermal
229164|NCT01984775|GSK2894512|gsk2894512
229165|NCT01984775|Cumulative irritation|cumulative irritation
229166|NCT01984736|Pharmacokinetic|pharmacokinetic
229167|NCT01984736|Safety|safety
229168|NCT01984723|Pharmacokinetic|pharmacokinetic
229169|NCT01984723|Safety|safety
229170|NCT01984710|Treatment Resistant Depression|treatment resistant depression
229171|NCT01984710|Deep Brain Stimulation|deep brain stimulation
229172|NCT01984710|Psychiatry|psychiatry
229173|NCT01984710|Neuro Surgery|neuro surgery
229174|NCT01984684|Bacterial skin infection|bacterial skin infection
229175|NCT01984684|infection|infection
229176|NCT01984684|skin|skin
229177|NCT01984684|delafloxacin|delafloxacin
229178|NCT01984684|vancomycin|vancomycin
229179|NCT01984684|aztreonam|aztreonam
229180|NCT01984684|MRSA bacteria|mrsa bacteria
229181|NCT01984684|bacterial infection|bacterial infection
229182|NCT01984684|Anti-Infective Agents|anti-infective agents
229184|NCT01984645|Emergency Visit|emergency visit
229185|NCT01984645|Secure Health messaging|secure health messaging
229186|NCT01984645|Inpatient|inpatient
229187|NCT01984593|Yoga|yoga
229188|NCT01984593|Hypertension|hypertension
229189|NCT01984593|Quality of Life|quality of life
229190|NCT01984593|Primary Health Care|primary health care
229191|NCT01984593|Stress|stress
229192|NCT01984593|Anxiety|anxiety
229193|NCT01984593|Depression|depression
229194|NCT01984580|Barrett's esophagus|barrett's esophagus
229195|NCT01984580|Esophagus|esophagus
229196|NCT01984580|Adenocarcinoma|adenocarcinoma
229197|NCT01984567|Oxyphytosterols|oxyphytosterols
229198|NCT01984567|Oxidative stress|oxidative stress
229199|NCT01984567|Vitamin E|vitamin e
229200|NCT01984567|Lipoic acid|lipoic acid
229201|NCT01984541|Pollen|pollen
229202|NCT01984528|Immunotherapy|immunotherapy
229203|NCT01984528|Skin prick test|skin prick test
229204|NCT01984528|Standardization|standardization
229205|NCT01984528|Alternaria alternata|alternaria alternata
229206|NCT01984515|Post-traumatic Stress Disorder|post-traumatic stress disorder
229207|NCT01984515|Evidence-Based Psychotherapy|evidence-based psychotherapy
229208|NCT01984515|Treatment Engagement|treatment engagement
229209|NCT01984515|Cognitive Behavioral Therapy|cognitive behavioral therapy
229210|NCT01984515|Implementation Science|implementation science
229211|NCT01984502|Larynx Cancer|larynx cancer
229212|NCT01984489|SHR117887, Metformin,combination,PhaseII|shr117887, metformin,combination,phaseii
229213|NCT01984476|spinal cord injury|spinal cord injury
229214|NCT01984476|autonomic dysreflexia|autonomic dysreflexia
229215|NCT01984476|baroreceptor integrity|baroreceptor integrity
229216|NCT01984476|sympathetic integrity|sympathetic integrity
229217|NCT01984476|vagal integrity|vagal integrity
229218|NCT01984476|autonomic integrity|autonomic integrity
229219|NCT01984476|arterial stiffness|arterial stiffness
229220|NCT01984476|cognitive function|cognitive function
229221|NCT01984476|traumatic brain injury|traumatic brain injury
229222|NCT01984476|cerebral blood flow|cerebral blood flow
229223|NCT01984476|white matter hyperintensities|white matter hyperintensities
229224|NCT01984476|cerebral vascular resistance index|cerebral vascular resistance index
229225|NCT01984463|Postoperative pain|postoperative pain
229226|NCT01984463|Shoulder pain|shoulder pain
229227|NCT01984463|Thoracotomy|thoracotomy
229228|NCT01984450|Articular cartilage|articular cartilage
229229|NCT01984450|Autologous collagen|autologous collagen
229231|NCT01984437|Vascular disease|vascular disease
229232|NCT01984437|Minimally invasive treatment|minimally invasive treatment
229233|NCT01984437|Endovascular treatment|endovascular treatment
229234|NCT01984437|Magellan|magellan
229236|NCT01984424|High Cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
229237|NCT01984346|Atrial Fibrillation|atrial fibrillation
229238|NCT01984346|Convergent Procedure|convergent procedure
229239|NCT01984346|Combined Epicardial/ Endocardial Ablation|combined epicardial/ endocardial ablation
229240|NCT01984346|Hybrid Procedure|hybrid procedure
229241|NCT01984346|Radiofrequency Ablation|radiofrequency ablation
229242|NCT01984346|Arrhythmia|arrhythmia
229243|NCT01984346|RF Ablation|rf ablation
229244|NCT01984333|trichotillomania|trichotillomania
229245|NCT01984333|response inhibition|response inhibition
229246|NCT01984333|cognitive retraining|cognitive retraining
229247|NCT01984320|OHSS|ohss
229248|NCT01984320|ICSI|icsi
229249|NCT01984320|Coasting|coasting
229250|NCT01984320|Cabergoline|cabergoline
229251|NCT01984307|Acute coronary syndrome|acute coronary syndrome
229252|NCT01984307|Myocardial infarction|myocardial infarction
229253|NCT01984307|retrospective|retrospective
229254|NCT01984307|cohort study|cohort study
229255|NCT01984307|Healthcare resources utilization|healthcare resources utilization
229256|NCT01984294|HCV genotype 1|hcv genotype 1
229258|NCT01984294|Sustained Virologic Response|sustained virologic response
229259|NCT01984294|Direct-Acting Antiviral|direct-acting antiviral
229260|NCT01984294|Combination Therapy|combination therapy
229261|NCT01984294|GS-7977|gs-7977
229262|NCT01984294|GS-5885|gs-5885
229263|NCT01984294|Ribavirin|ribavirin
229264|NCT01984294|Open Label|open label
229265|NCT01984294|Sofosbuvir|sofosbuvir
229266|NCT01984294|Treatment-Naive|treatment-naive
229267|NCT01984294|Protease Inhibitors|protease inhibitors
229269|NCT01984294|Treatment experienced|treatment experienced
229270|NCT01984294|Cirrhotic|cirrhotic
229374|NCT01983969|Gemcitabine|gemcitabine
229271|NCT01984281|Physical Activity|physical activity
229272|NCT01984281|Pedometers|pedometers
229273|NCT01984281|Quality of Life|quality of life
229274|NCT01984268|Rheumatoid arthritis|rheumatoid arthritis
229275|NCT01984268|ACTHAR|acthar
229276|NCT01984268|Methotrexate|methotrexate
229277|NCT01984268|Inadequate response|inadequate response
229278|NCT01984203|Shoulder|shoulder
229279|NCT01984203|Impingement|impingement
229280|NCT01984203|Rotator Cuff Syndrome|rotator cuff syndrome
229281|NCT01984203|Subacromial Impingement Syndrome|subacromial impingement syndrome
229282|NCT01984203|Exercise|exercise
229283|NCT01984203|Physiotherapy|physiotherapy
229284|NCT01984190|venous thromboembolism|venous thromboembolism
229285|NCT01984190|deep vein thrombosis|deep vein thrombosis
229286|NCT01984190|pulmonary emboli|pulmonary emboli
229287|NCT01984190|hip arthroplasty|hip arthroplasty
229288|NCT01984190|knee arthroplasty|knee arthroplasty
229289|NCT01984190|efficacy|efficacy
229290|NCT01984190|mobile compression device|mobile compression device
229291|NCT01984190|mechanical device|mechanical device
229292|NCT01984190|prophylaxis.|prophylaxis.
229293|NCT01984177|Cocaine|cocaine
229294|NCT01984177|Substance-Related Disorders|substance-related disorders
229295|NCT01984177|Drug Addiction|drug addiction
229296|NCT01984177|Substance Addiction|substance addiction
229297|NCT01984177|Dopamine|dopamine
229298|NCT01984177|Receptors, Dopamine D2|receptors, dopamine d2
229299|NCT01984177|Receptors, Dopamine D3|receptors, dopamine d3
220010|NCT02026791|I-gel|i-gel
229300|NCT01984177|Stress, Psychological|stress, psychological
229301|NCT01984177|Corticorelin|corticorelin
229302|NCT01984177|Neuroendocrine System|neuroendocrine system
229303|NCT01984177|Cortisol|cortisol
229304|NCT01984177|Adrenocorticotropic Hormone|adrenocorticotropic hormone
229305|NCT01984177|Positron-Emission Tomography|positron-emission tomography
229306|NCT01984177|11C-PHNO|11c-phno
229307|NCT01984164|cerebrovascular function|cerebrovascular function
229308|NCT01984138|estrogen receptor positive breast cancer|estrogen receptor positive breast cancer
229309|NCT01984138|breast cancer|breast cancer
229310|NCT01984125|Adolescent Immunization Rates|adolescent immunization rates
229311|NCT01984125|Provider prompts|provider prompts
229312|NCT01984112|Humerus|humerus
229313|NCT01984112|fracture|fracture
229314|NCT01984112|nail|nail
229315|NCT01984112|plate|plate
229316|NCT01984112|tuberosity|tuberosity
229317|NCT01984099|Postmolar Gestational Trophoblastic Disease, Hydatidiform Mole|postmolar gestational trophoblastic disease, hydatidiform mole
229318|NCT01984086|COPD|copd
229319|NCT01984086|Asthma|asthma
229320|NCT01984086|Respiratory|respiratory
229321|NCT01984073|Atherogenic dyslipidemia phenotype|atherogenic dyslipidemia phenotype
229322|NCT01984060|Aging|aging
229323|NCT01984060|Physical Activity|physical activity
229324|NCT01984060|Physical Function|physical function
229325|NCT01984060|HIV|hiv
229326|NCT01984060|Frailty|frailty
229327|NCT01984060|Autonomous Motivation|autonomous motivation
229328|NCT01984060|Depression|depression
229329|NCT01984047|safety|safety
229330|NCT01984047|GSK3050002|gsk3050002
229331|NCT01984047|CCR6 receptor|ccr6 receptor
229332|NCT01984047|single dose escalation|single dose escalation
229333|NCT01984047|Phase 1|phase 1
229334|NCT01984047|CCL20|ccl20
229335|NCT01984034|Educational outreach|educational outreach
229336|NCT01984034|Academic detailing|academic detailing
229337|NCT01984034|Guideline adherence|guideline adherence
229338|NCT01984034|Family Practice|family practice
229339|NCT01984034|Drug utilization|drug utilization
229340|NCT01984034|Program evaluation|program evaluation
229341|NCT01984034|Cost effectiveness|cost effectiveness
229342|NCT01984021|Physical Therapy Modalities|physical therapy modalities
229343|NCT01984021|Neck pain|neck pain
229344|NCT01984021|Acupuncture|acupuncture
229345|NCT01983995|Breast Cancer|breast cancer
229346|NCT01983995|Aromatase Inhibitors|aromatase inhibitors
229347|NCT01983995|Actigraphy|actigraphy
229348|NCT01983995|Pain|pain
229349|NCT01983995|Fatigue|fatigue
229350|NCT01983995|Sleep quality|sleep quality
229351|NCT01983982|Breast Cancer|breast cancer
229352|NCT01983982|Chemotherapy|chemotherapy
229353|NCT01983982|Chronic Pain|chronic pain
229354|NCT01983982|Survivorship|survivorship
229355|NCT01983969|Advanced Cancers|advanced cancers
229356|NCT01983969|Lymphoma|lymphoma
229357|NCT01983969|Recurrent Hodgkin's|recurrent hodgkin's
229358|NCT01983969|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
229359|NCT01983969|Stem cell transplant|stem cell transplant
229360|NCT01983969|Azacitidine|azacitidine
229361|NCT01983969|5-azacytidine|5-azacytidine
229362|NCT01983969|5-aza|5-aza
229363|NCT01983969|Vidaza|vidaza
229364|NCT01983969|5-AZC|5-azc
229365|NCT01983969|AZA-CR|aza-cr
229366|NCT01983969|Ladakamycin|ladakamycin
229367|NCT01983969|NSC-102816|nsc-102816
229368|NCT01983969|Azacytidine|azacytidine
229369|NCT01983969|Vorinostat|vorinostat
229370|NCT01983969|SAHA|saha
229371|NCT01983969|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
229372|NCT01983969|MSK-390|msk-390
229373|NCT01983969|Zolinza|zolinza
229375|NCT01983969|Gemcitabine Hydrochloride|gemcitabine hydrochloride
229376|NCT01983969|Gemzar|gemzar
229377|NCT01983969|Busulfan|busulfan
229378|NCT01983969|Busulfex|busulfex
229379|NCT01983969|Myleran|myleran
229380|NCT01983969|Melphalan|melphalan
229381|NCT01983969|Alkeran|alkeran
229382|NCT01983969|Dexamethasone|dexamethasone
229383|NCT01983969|Decadron|decadron
229384|NCT01983969|Caphosol|caphosol
229385|NCT01983969|Glutamine|glutamine
229386|NCT01983969|Enterex|enterex
229387|NCT01983969|Glutapak-10|glutapak-10
229388|NCT01983969|NutreStore|nutrestore
229389|NCT01983969|Resource|resource
229390|NCT01983969|GlutaSolve|glutasolve
229391|NCT01983969|Sympt-X G.I.|sympt-x g.i.
229392|NCT01983969|Sympt-X|sympt-x
229393|NCT01983969|Pyridoxine|pyridoxine
229394|NCT01983969|Rituximab|rituximab
229395|NCT01983969|Rituxan|rituxan
229396|NCT01983956|early palliative care|early palliative care
229397|NCT01983956|patient empowerment|patient empowerment
229398|NCT01983956|cancer|cancer
229399|NCT01983956|assessment|assessment
229400|NCT01983956|end of life|end of life
229401|NCT01983930|Memory impairment|memory impairment
229402|NCT01983930|Meditation|meditation
229403|NCT01983930|Yoga|yoga
229404|NCT01983930|memory training|memory training
229405|NCT01983930|Mild cognitive impairment|mild cognitive impairment
229406|NCT01983930|MCI|mci
229407|NCT01983930|geriatric|geriatric
229408|NCT01983930|fMRI|fmri
229409|NCT01983917|diabetes|diabetes
229410|NCT01983917|mobile application|mobile application
229411|NCT01983917|diabetic retinopathy|diabetic retinopathy
229412|NCT01983904|Major depressive disorder (MDD)|major depressive disorder (mdd)
229413|NCT01983904|Bi-polar disorder (BP)|bi-polar disorder (bp)
229414|NCT01983891|food shelf|food shelf
229415|NCT01983891|nutrition education|nutrition education
229416|NCT01983891|cooking course|cooking course
229417|NCT01983852|End of Life Care|end of life care
229418|NCT01983852|Paediatric|paediatric
229419|NCT01983852|Experiences|experiences
229420|NCT01983852|Needs|needs
229421|NCT01983852|Current Practices|current practices
229422|NCT01983839|Moxifloxacin|moxifloxacin
229423|NCT01983839|Pneumonia|pneumonia
229424|NCT01983839|Pharmacokinetics|pharmacokinetics
229425|NCT01983826|nitrates|nitrates
229426|NCT01983826|blood flow|blood flow
229427|NCT01983826|vascular function|vascular function
229428|NCT01983826|exercise|exercise
229429|NCT01983813|Diabetes|diabetes
229430|NCT01983813|High Blood Pressure|high blood pressure
229431|NCT01983813|High Cholesterol|high cholesterol
229432|NCT01983813|Heart Irregularity|heart irregularity
229433|NCT01983813|Stroke|stroke
229434|NCT01983800|Mechanical Ventilation|mechanical ventilation
229435|NCT01983800|Volatile Sedation|volatile sedation
229436|NCT01983800|Intravenous Sedation|intravenous sedation
229437|NCT01983800|Delirium|delirium
229438|NCT01983787|Cystic Fibrosis|cystic fibrosis
229439|NCT01983787|Continuous infusion|continuous infusion
229440|NCT01983787|Pharmacokinetics|pharmacokinetics
229441|NCT01983774|CF|cf
229442|NCT01983748|Uveal Melanoma, Monosomy 3|uveal melanoma, monosomy 3
229443|NCT01983735|TELMINUVO Tab.|telminuvo tab.
229445|NCT01983735|Hypertension|hypertension
229446|NCT01983735|Stage 2 Hypertension|stage 2 hypertension
229447|NCT01983735|S-Amlodipine|s-amlodipine
229448|NCT01983735|Telmisartan|telmisartan
229449|NCT01982760|Rhinoplasty|rhinoplasty
229450|NCT01982760|Ecchymosis|ecchymosis
229451|NCT01982760|Edema|edema
229452|NCT01982747|Cardiac Safety|cardiac safety
229453|NCT01982747|General Safety|general safety
229454|NCT01982747|Pharmacokinetics|pharmacokinetics
229455|NCT01982734|bioavailability|bioavailability
229456|NCT01982734|curcumin|curcumin
229457|NCT01982734|pharmacokinetic|pharmacokinetic
229458|NCT01982734|curcuma longa|curcuma longa
229459|NCT01982734|age differences|age differences
229460|NCT01982734|sex differences|sex differences
229461|NCT01982708|Evaluation|evaluation
229462|NCT01982695|Duchenne muscular Dystrophy (DMD)|duchenne muscular dystrophy (dmd)
229463|NCT01982695|Cardiomyopathy|cardiomyopathy
229464|NCT01982695|Losartan|losartan
229465|NCT01982695|Lisinopril|lisinopril
229466|NCT01982669|Salty taste|salty taste
229467|NCT01982669|Urinary sodium excretion|urinary sodium excretion
229468|NCT01982669|Spicy hedonic|spicy hedonic
229469|NCT01982669|Blood pressure|blood pressure
229470|NCT01982617|Transtheoretical Model|transtheoretical model
229471|NCT01982617|Stages of Change|stages of change
229472|NCT01982617|Nicotine Dependence|nicotine dependence
229473|NCT01982617|Severe Mental Illness|severe mental illness
229474|NCT01983696|low oxygen tension|low oxygen tension
229475|NCT01983696|embryo quality|embryo quality
229476|NCT01983683|Clostridium difficile infection|clostridium difficile infection
229477|NCT01983683|Post-antibiotic diarrhea|post-antibiotic diarrhea
229478|NCT01983670|Pre-movement facilitation|pre-movement facilitation
229479|NCT01983670|Fast goal directed movement|fast goal directed movement
229480|NCT01983670|Triphasic EMG pattern|triphasic emg pattern
229481|NCT01983670|Temporal electrical stimulation,|temporal electrical stimulation,
229482|NCT01983670|Spinocerebellar Ataxia|spinocerebellar ataxia
229483|NCT01983657|Pulmonary|pulmonary
229484|NCT01983657|Pulmonary Alveolar Proteinosis|pulmonary alveolar proteinosis
229485|NCT01983657|PAP|pap
229486|NCT01983644|acute ischemic stroke,endovascular recanalization|acute ischemic stroke,endovascular recanalization
229487|NCT01983644|mechanical thrombectomy|mechanical thrombectomy
229488|NCT01983631|Whole body vibration|whole body vibration
229489|NCT01983631|Reciprocal inhibition|reciprocal inhibition
229490|NCT01983631|Spinocerebellar ataxia|spinocerebellar ataxia
229491|NCT01983631|voluntary activation level|voluntary activation level
229492|NCT01983618|Cerebral ischemia|cerebral ischemia
229493|NCT01983618|Beachchair position|beachchair position
229494|NCT01983618|Interscalene nerve block|interscalene nerve block
229495|NCT01983592|Homeopathy|homeopathy
229496|NCT01983592|Fatigue|fatigue
229497|NCT01983592|Chemotherapy|chemotherapy
229498|NCT01983592|Cancer|cancer
229499|NCT01983553|Dengue Virus|dengue virus
229500|NCT01983553|Dengue Fever|dengue fever
229501|NCT01983553|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
229502|NCT01983553|CYD Dengue Vaccine|cyd dengue vaccine
229503|NCT01983540|Diphtheria|diphtheria
229504|NCT01983540|Tetanus|tetanus
229505|NCT01983540|Whooping Cough|whooping cough
229506|NCT01983540|Hepatitis B|hepatitis b
229507|NCT01983540|Poliomyelitis|poliomyelitis
229508|NCT01983540|Pediatric combined vaccine|pediatric combined vaccine
229509|NCT01983527|Arthrographic distention|arthrographic distention
229510|NCT01983527|Hydrodilatation|hydrodilatation
229511|NCT01983527|Intra-articular corticosteroid injection|intra-articular corticosteroid injection
229512|NCT01983514|oxytocin|oxytocin
229513|NCT01983514|fMRI|fmri
229514|NCT01983514|social cognition|social cognition
229515|NCT01983514|heart rate variability|heart rate variability
229516|NCT01983514|pupillometry|pupillometry
229517|NCT01983514|eye tracking|eye tracking
229518|NCT01983501|ONT-380|ont-380
229519|NCT01983501|T-DM1|t-dm1
229520|NCT01983501|Kadcyla|kadcyla
229521|NCT01983501|HER2 positive breast cancer|her2 positive breast cancer
229522|NCT01983501|Breast cancer|breast cancer
229523|NCT01983501|ARRY-380|arry-380
229524|NCT01983501|Tucatinib|tucatinib
229525|NCT01983501|Tucatinib (ONT-380)|tucatinib (ont-380)
229526|NCT01983488|Uveitis|uveitis
229527|NCT01983488|Vision Loss|vision loss
229528|NCT01983475|Spinal Cord Injury|spinal cord injury
229529|NCT01983475|Denosumab|denosumab
229530|NCT01983475|Osteoporosis|osteoporosis
229531|NCT01983475|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
229532|NCT01983462|Prehypertension|prehypertension
229533|NCT01983462|Hypertension|hypertension
229534|NCT01983462|Obese|obese
229535|NCT01983462|Sympathetic Nervous System|sympathetic nervous system
229536|NCT01983462|renin-angiotensin system|renin-angiotensin system
229537|NCT01983462|Endothelial function|endothelial function
229538|NCT01983449|Adventitia|adventitia
229539|NCT01983449|Peripheral Artery Disease|peripheral artery disease
229540|NCT01983449|Restenosis|restenosis
229541|NCT01983449|Inflammation|inflammation
229542|NCT01983449|Anti-Inflammatory|anti-inflammatory
229543|NCT01983449|Dexamethasone|dexamethasone
229544|NCT01983436|Maxillofacial Orthognathic Surgery|maxillofacial orthognathic surgery
229545|NCT01983436|Manual lymphatic drainage|manual lymphatic drainage
229546|NCT01983423|Endometrial Biopsy|endometrial biopsy
229547|NCT01983423|Endometrial Sampling|endometrial sampling
229548|NCT01983423|In Vitro Fertilization|in vitro fertilization
229549|NCT01983423|Pregnancy|pregnancy
229550|NCT01983423|Implantation|implantation
229551|NCT01983410|BRCA Mutation Carriers|brca mutation carriers
229552|NCT01983410|PDAC carriers|pdac carriers
229553|NCT01983410|BRCAmut carriers|brcamut carriers
229554|NCT01983410|Registry|registry
229555|NCT01983410|13-217|13-217
229556|NCT01983397|aged, 80 and over|aged, 80 and over
229557|NCT01983397|Exercise|exercise
229558|NCT01983397|Cognition|cognition
229559|NCT01983397|Balance|balance
229560|NCT01983397|Randomized controlled trial|randomized controlled trial
229561|NCT01983384|Delirium|delirium
229562|NCT01983384|Cognition|cognition
229563|NCT01983384|Surgery|surgery
229564|NCT01983384|Anesthesia|anesthesia
229565|NCT01983384|Aging|aging
229566|NCT01983358|PARP-1 inhibitor|parp-1 inhibitor
229567|NCT01983345|Myelomeningocele|myelomeningocele
229568|NCT01983345|Arnold Chiari malformation|arnold chiari malformation
229569|NCT01983345|Spina bifida|spina bifida
229570|NCT01983332|MDACC|mdacc
229571|NCT01983332|MOHO|moho
229572|NCT01983306|Constipation|constipation
229573|NCT01983306|Opioid|opioid
229574|NCT01983306|GC C Agonist|gc c agonist
229575|NCT01983306|Pain|pain
229576|NCT01983293|Non-left bundle branch block|non-left bundle branch block
229578|NCT01983293|LV lead pacing location|lv lead pacing location
229579|NCT01983293|CRT-D|crt-d
229580|NCT01983280|polysomnography|polysomnography
229581|NCT01983280|sleep|sleep
229582|NCT01983280|healing touch|healing touch
229583|NCT01983280|pediatric burn|pediatric burn
229584|NCT01983254|coping|coping
229684|NCT01982864|Necessity|necessity
229585|NCT01983254|acute respiratory failure|acute respiratory failure
229586|NCT01983254|critical illness|critical illness
229587|NCT01983254|depression|depression
229588|NCT01983254|anxiety|anxiety
229589|NCT01983254|post-traumatic stress|post-traumatic stress
229590|NCT01983254|intensive care unit|intensive care unit
229591|NCT01983241|Pulmonary Emphysema|pulmonary emphysema
229592|NCT01983241|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
229593|NCT01983241|AATD|aatd
229594|NCT01983241|Alpha-1 PI Deficiency|alpha-1 pi deficiency
229595|NCT01983241|Alpha-1 Protienase Inhibitor|alpha-1 protienase inhibitor
229596|NCT01983228|Musculoskeletal Pain|musculoskeletal pain
229597|NCT01983228|Walking|walking
229598|NCT01983228|African American|african american
229599|NCT01983228|Telephone Coaching|telephone coaching
229600|NCT01983228|Pedometer|pedometer
229601|NCT01983215|groin incisions|groin incisions
229602|NCT01983202|PCOS|pcos
229603|NCT01983202|Pregnancy|pregnancy
229604|NCT01983202|Obstetric|obstetric
229605|NCT01983189|TMS|tms
229606|NCT01983189|transcranial magnetic stimulation|transcranial magnetic stimulation
229607|NCT01983189|rTMS|rtms
229608|NCT01983189|recurrent transcranial magnetic stimulation|recurrent transcranial magnetic stimulation
220331|NCT02025400|eRehab|erehab
229609|NCT01983189|fMRI|fmri
229610|NCT01983189|functional magnetic resonance imaging.|functional magnetic resonance imaging.
229611|NCT01983176|Parotid tumor|parotid tumor
229612|NCT01983176|Partial superficial parotidectomy|partial superficial parotidectomy
229613|NCT01983176|Facial palsy|facial palsy
229614|NCT01983150|Population Health|population health
229615|NCT01983150|Smoking cessation|smoking cessation
229616|NCT01983150|Young adults|young adults
229617|NCT01983150|Cancer prevention|cancer prevention
229618|NCT01983150|Tobacco control strategies|tobacco control strategies
229619|NCT01983150|Behaviour modification|behaviour modification
229620|NCT01983150|Social Media|social media
229621|NCT01983150|Smartphone technology|smartphone technology
229622|NCT01983137|Chronic pain|chronic pain
229623|NCT01983137|Severe pain|severe pain
229624|NCT01983137|oxycodon|oxycodon
229625|NCT01983137|naloxon|naloxon
229626|NCT01983137|opioid-induced constipation|opioid-induced constipation
229627|NCT01983137|opioid|opioid
229628|NCT01983137|quality of life|quality of life
229629|NCT01983137|laxative|laxative
229630|NCT01983137|analgesic rescue medication|analgesic rescue medication
229631|NCT01983124|Advanced Melanoma|advanced melanoma
229632|NCT01983098|Colorectal cancer|colorectal cancer
229633|NCT01983098|Metastatic|metastatic
229634|NCT01983098|Circulating tumor DNA|circulating tumor dna
229635|NCT01983098|Biomaker|biomaker
229636|NCT01983085|Nitric Oxide Dressing|nitric oxide dressing
229637|NCT01983085|Nitric oxide|nitric oxide
229638|NCT01983085|Superficial partial thickness wound|superficial partial thickness wound
229639|NCT01983085|Burns|burns
229640|NCT01983085|Skin graft donor sites|skin graft donor sites
229641|NCT01983085|Improved healing|improved healing
229642|NCT01983085|Vasodilation|vasodilation
229643|NCT01983085|Angiogenesis|angiogenesis
229644|NCT01983085|Anti-microbial|anti-microbial
229645|NCT01983072|colonization of the gastrointestinal tract with bacteria|colonization of the gastrointestinal tract with bacteria
229646|NCT01983007|Diabetes Mellitus.|diabetes mellitus.
229647|NCT01982994|Physical Activity Education|physical activity education
229648|NCT01982994|Caregivers|caregivers
229649|NCT01982981|perception|perception
229650|NCT01982981|wellbeing|wellbeing
229651|NCT01982981|plain water|plain water
229652|NCT01982968|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
229653|NCT01982968|IPF|ipf
230159|NCT01980628|MZL|mzl
229654|NCT01982968|Gastroesophageal reflux|gastroesophageal reflux
229656|NCT01982968|GERD|gerd
229657|NCT01982955|MSC2156119J|msc2156119j
229658|NCT01982955|Gefitinib|gefitinib
229659|NCT01982955|Pemetrexed|pemetrexed
229660|NCT01982955|Cisplatin|cisplatin
229661|NCT01982955|MET positive|met positive
229662|NCT01982955|Tepotinib|tepotinib
229663|NCT01982955|Carboplatin|carboplatin
229664|NCT01982955|INSIGHT|insight
229665|NCT01982916|Allergic Rhinitis|allergic rhinitis
229666|NCT01982916|Perennial Allergic Rhinitis|perennial allergic rhinitis
229667|NCT01982916|Non-seasonal Allergic Rhinitis|non-seasonal allergic rhinitis
229668|NCT01982916|PAR|par
229669|NCT01982903|kidney transplantation|kidney transplantation
229670|NCT01982903|connective tissue growth factor|connective tissue growth factor
229671|NCT01982903|fibrosis|fibrosis
229672|NCT01982890|Telomere length|telomere length
229673|NCT01982890|Longitudinal observation|longitudinal observation
229674|NCT01982877|decision making|decision making
229675|NCT01982877|values elicitation|values elicitation
229676|NCT01982877|patient centered care|patient centered care
229677|NCT01982877|Four Supports|four supports
229678|NCT01982877|Family Support|family support
229679|NCT01982864|Aminoglycosides|aminoglycosides
229680|NCT01982864|hemodialysis|hemodialysis
229681|NCT01982864|clinical pharmacokinetics|clinical pharmacokinetics
229682|NCT01982864|pharmacokinetic modelling|pharmacokinetic modelling
229683|NCT01982864|Bayesian estimation|bayesian estimation
229685|NCT01982864|of the treatment|of the treatment
229686|NCT01982864|gentamicin|gentamicin
229687|NCT01982851|pain|pain
229688|NCT01982851|epidural|epidural
229689|NCT01982851|combined spinal epidural|combined spinal epidural
229690|NCT01982838|pain|pain
229691|NCT01982838|epidural|epidural
229692|NCT01982838|combined spinal epidural|combined spinal epidural
229693|NCT01982825|Tobacco use cessation|tobacco use cessation
229694|NCT01982825|Cigarette smoking|cigarette smoking
229695|NCT01982799|Endodontic treatment, analgesics, anesthesia, post-operative pain|endodontic treatment, analgesics, anesthesia, post-operative pain
229696|NCT01982773|Virtual Hope Box|virtual hope box
229697|NCT01982578|Treatment|treatment
229698|NCT01982578|Genistein|genistein
229699|NCT01982578|Alzheimer's disease|alzheimer's disease
229700|NCT01982578|Cerebrospinal fluid|cerebrospinal fluid
229701|NCT01982578|Amyloid beta|amyloid beta
229702|NCT01982565|Nitric oxide|nitric oxide
229703|NCT01982565|Nitric oxide dressing|nitric oxide dressing
229704|NCT01982565|NOx|nox
229705|NCT01982565|NOx dressing|nox dressing
229706|NCT01982565|Diabetic|diabetic
229707|NCT01982565|Foot|foot
229708|NCT01982565|Ulcers|ulcers
229709|NCT01982565|Chronic|chronic
229710|NCT01982552|Plaque psoriasis|plaque psoriasis
229711|NCT01982552|calcipotriene|calcipotriene
229712|NCT01982552|betamethasone dipropionate|betamethasone dipropionate
229713|NCT01982552|topical|topical
229714|NCT01982539|pain|pain
229715|NCT01982539|NSAID|nsaid
229716|NCT01982539|moderate pain|moderate pain
229717|NCT01982539|mild pain|mild pain
229718|NCT01982539|acute pain|acute pain
229719|NCT01982539|mild acute pain|mild acute pain
229720|NCT01982539|moderate acute pain|moderate acute pain
687233|NCT00920621|Vitamin D|vitamin d
229721|NCT01982539|mild or moderate acute pain|mild or moderate acute pain
229722|NCT01982526|Ovarian reserve|ovarian reserve
229723|NCT01982526|Antimullerian hormone|antimullerian hormone
229724|NCT01982513|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
229725|NCT01982513|Pregnancy|pregnancy
229726|NCT01982513|Ultrasound|ultrasound
229727|NCT01982513|Inferior Vena Cava|inferior vena cava
229728|NCT01982500|Ovarian Cancer|ovarian cancer
229729|NCT01982500|Chemotherapy|chemotherapy
229730|NCT01982500|Anti-angiogenic agent|anti-angiogenic agent
229731|NCT01982500|Bevacizumab|bevacizumab
229732|NCT01982500|Front Line|front line
229733|NCT01982474|allergic rhinitis|allergic rhinitis
229734|NCT01982448|TRIPLE NEGATIVE BREAST CANCER WITHOUT GERMLINE BRCA MUTATIONS|triple negative breast cancer without germline brca mutations
229735|NCT01982448|CISPLATIN|cisplatin
229736|NCT01982448|PACLITAXEL|paclitaxel
229737|NCT01982435|Diabetes|diabetes
229738|NCT01982435|Macular Edema|macular edema
229739|NCT01982422|Attention Deficit and Hyperactivity Disorder|attention deficit and hyperactivity disorder
229740|NCT01982422|Nutrition|nutrition
229741|NCT01982422|Diet|diet
229742|NCT01982422|Developmental Origins of Disease|developmental origins of disease
229744|NCT01982396|paediatric|paediatric
229745|NCT01982396|Abacavir|abacavir
229746|NCT01982396|lamivudine|lamivudine
229748|NCT01982383|Edema|edema
229749|NCT01982383|Retinopathy|retinopathy
229750|NCT01982344|mini-exchange-room|mini-exchange-room
229751|NCT01982344|physical activity|physical activity
229752|NCT01982344|quality of life|quality of life
229753|NCT01982344|peritoneal dialysis|peritoneal dialysis
229754|NCT01982331|H2N2|h2n2
229755|NCT01982331|vaccine|vaccine
229756|NCT01982318|Venous Leg Ulcer|venous leg ulcer
229757|NCT01982318|Leg Ulcer|leg ulcer
229758|NCT01982318|Venous Hypertension|venous hypertension
229759|NCT01982318|Venous Reflux|venous reflux
229760|NCT01982318|Deep Venous System|deep venous system
229761|NCT01982318|Chronic leg ulceration|chronic leg ulceration
229762|NCT01982318|Calf perforator|calf perforator
229763|NCT01982292|Chronic Heart Failure, CHF, Heart Failure, HF, Immunogenicity, Anti-bodies, Hypersensitivity, Serelaxin, RELAX-REPEAT|chronic heart failure, chf, heart failure, hf, immunogenicity, anti-bodies, hypersensitivity, serelaxin, relax-repeat
229764|NCT01982279|Caloric compensation|caloric compensation
229765|NCT01982279|Eating in the absence of hunger|eating in the absence of hunger
229766|NCT01982279|Preschool children|preschool children
229767|NCT01982279|Maternal feeding practices|maternal feeding practices
229768|NCT01982279|Maternal eating behavior|maternal eating behavior
229769|NCT01982279|one year|one year
229770|NCT01982279|children|children
229771|NCT01982253|Drug therapy|drug therapy
229772|NCT01982240|CIC|cic
229773|NCT01982240|Constipation|constipation
229774|NCT01982240|Chronic Constipation|chronic constipation
229775|NCT01982240|Synergy|synergy
229776|NCT01982240|Plecanatide|plecanatide
229777|NCT01982227|colorectal cancer metastatic|colorectal cancer metastatic
229778|NCT01982227|indocyanine green|indocyanine green
229779|NCT01982214|osteopenia|osteopenia
229780|NCT01982214|whole body vibration|whole body vibration
229781|NCT01982214|women|women
229782|NCT01982214|bone microarchitecture|bone microarchitecture
229783|NCT01982214|bone density|bone density
229784|NCT01982188|single incision sling|single incision sling
230193|NCT01980394|cancer|cancer
229785|NCT01982188|cough stress test|cough stress test
229786|NCT01982188|MiniArc|miniarc
229787|NCT01982188|UDI-6|udi-6
229788|NCT01982188|UIQ-7|uiq-7
229789|NCT01982188|Sandvick Severity Index (SSI)|sandvick severity index (ssi)
229790|NCT01982175|Alemtuzumab|alemtuzumab
229791|NCT01982175|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
229792|NCT01982175|CD52|cd52
229793|NCT01982162|Sputum|sputum
229794|NCT01982162|Clinical cohorts|clinical cohorts
229795|NCT01982162|Smokers|smokers
229796|NCT01982162|Asthma|asthma
229797|NCT01982162|Biopsies|biopsies
229798|NCT01982162|Severe asthma|severe asthma
229799|NCT01982162|Collaborative research|collaborative research
229800|NCT01982162|Phenotyping|phenotyping
229801|NCT01982162|Lipidomics|lipidomics
229802|NCT01982162|Transcriptomics|transcriptomics
229803|NCT01982162|Proteomics|proteomics
229804|NCT01982162|Paediatric cohort|paediatric cohort
229805|NCT01982162|Systems Biology|systems biology
229806|NCT01982149|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
229807|NCT01982149|COPD|copd
229808|NCT01982149|Smokers|smokers
229809|NCT01982149|Nonsmokers|nonsmokers
229810|NCT01982110|smoking cessation|smoking cessation
229811|NCT01982110|mindfulness|mindfulness
229812|NCT01982110|behavioral intervention|behavioral intervention
229813|NCT01982097|Non-interventional|non-interventional
229814|NCT01982097|Nexavar|nexavar
229815|NCT01982097|Sorafenib|sorafenib
229816|NCT01982097|Carcinoma, renal cell|carcinoma, renal cell
229817|NCT01982097|Neoadjuvant|neoadjuvant
229818|NCT01982097|Nephrectomy|nephrectomy
229819|NCT01982097|Russian Federation|russian federation
229820|NCT01982084|Group B streptococcus|group b streptococcus
229821|NCT01982084|Immunisation|immunisation
229822|NCT01982084|Pregnancy|pregnancy
229823|NCT01982084|Attitudes|attitudes
229824|NCT01982071|Micafungin|micafungin
229825|NCT01982071|candidiasis|candidiasis
229826|NCT01982071|candidemia|candidemia
229827|NCT01982071|Open-label design|open-label design
229828|NCT01982045|Bone graft|bone graft
229829|NCT01982045|Ceramic|ceramic
229830|NCT01982045|Spinal fusion|spinal fusion
229831|NCT01982045|RCT|rct
229832|NCT01982045|Thoracolumbar region|thoracolumbar region
229833|NCT01982032|Periprosthetic aortic valve regurgitation|periprosthetic aortic valve regurgitation
229834|NCT01982032|3D transesophageal echocardiography|3d transesophageal echocardiography
229835|NCT01982032|Cardiac MRI|cardiac mri
229836|NCT01982019|26RFa|26rfa
229837|NCT01982019|sleeve gastrectomy|sleeve gastrectomy
229838|NCT01982019|diabetes|diabetes
229839|NCT01982019|obesity|obesity
229840|NCT01982006|cataract surgery|cataract surgery
229841|NCT01982006|femtosecond laser cataract surgery|femtosecond laser cataract surgery
229842|NCT01982006|phacoemulsification|phacoemulsification
229843|NCT01982006|Cost-Benefit Analysis|cost-benefit analysis
229844|NCT01982006|Cost Effectiveness|cost effectiveness
229845|NCT01982006|Hospital Costs|hospital costs
229846|NCT01981980|Carbon dioxide|carbon dioxide
229847|NCT01981980|Carboxytherapy|carboxytherapy
229848|NCT01981980|Radiofrequency|radiofrequency
229849|NCT01981967|Japanese encephalitis|japanese encephalitis
229850|NCT01981967|IMOJEV®|imojev®
229851|NCT01981967|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
229852|NCT01981954|Solifenacin succinate suspension|solifenacin succinate suspension
229853|NCT01981954|Efficacy|efficacy
229854|NCT01981954|Safety|safety
229855|NCT01981941|Gabapentin|gabapentin
229856|NCT01981941|Restless legs syndrome (RLS)|restless legs syndrome (rls)
229857|NCT01981928|Phase 1|phase 1
229858|NCT01981928|Healthy Subjects|healthy subjects
229859|NCT01981928|Safety|safety
229860|NCT01981928|Tolerability|tolerability
229861|NCT01981928|Pharmacokinetics|pharmacokinetics
229862|NCT01981928|Single Ascending Oral Dose|single ascending oral dose
229863|NCT01981928|Food Effect|food effect
229864|NCT01981915|Cough augmentation|cough augmentation
229865|NCT01981915|Peak cough flow|peak cough flow
229866|NCT01981915|hyperinsufflation|hyperinsufflation
229867|NCT01981902|Dehydration|dehydration
229868|NCT01981889|steroid, inflammatory bowel diseases|steroid, inflammatory bowel diseases
229869|NCT01981876|Dysplasia|dysplasia
229870|NCT01981876|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
229871|NCT01981863|cardiac surgery|cardiac surgery
229872|NCT01981863|cardiopulmonary bypass|cardiopulmonary bypass
229873|NCT01981863|fibrinolysis|fibrinolysis
229874|NCT01981863|thromboelastography|thromboelastography
229875|NCT01981863|D-Dimers|d-dimers
229876|NCT01981863|antifibrinolytic agents|antifibrinolytic agents
229877|NCT01981850|fibrosis|fibrosis
229878|NCT01981837|RNAi therapeutic|rnai therapeutic
229879|NCT01981824|prediction IUGR FL/MTC|prediction iugr fl/mtc
229880|NCT01981811|OPC-14597 Digital|opc-14597 digital
229881|NCT01981811|Aripiprazole|aripiprazole
229882|NCT01981811|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
229883|NCT01981811|Treatment Adherence|treatment adherence
229884|NCT01981811|Ingestible Event Marker|ingestible event marker
229885|NCT01981798|outpatient intervention program|outpatient intervention program
229886|NCT01981798|behavioral therapy approach|behavioral therapy approach
229887|NCT01981798|unspecific back pain|unspecific back pain
229888|NCT01981798|unspecific neck pain|unspecific neck pain
229889|NCT01981798|chronic pain|chronic pain
229890|NCT01981798|physiotherapy|physiotherapy
229891|NCT01981798|occupational therapy|occupational therapy
229892|NCT01981798|psychosocial aspects|psychosocial aspects
229893|NCT01981798|fear avoidance beliefs|fear avoidance beliefs
229894|NCT01981798|health-related quality of life|health-related quality of life
229895|NCT01981785|Primary immune deficiencies|primary immune deficiencies
229896|NCT01981785|Autoimmune diseases|autoimmune diseases
229897|NCT01981785|Inflammatory diseases|inflammatory diseases
229898|NCT01981785|Common variable immune deficiencies|common variable immune deficiencies
229899|NCT01981785|Primary Immunodeficiencies|primary immunodeficiencies
229900|NCT01981785|Immunoglobulin|immunoglobulin
229901|NCT01981785|IgG|igg
229902|NCT01981785|IVIG|ivig
229903|NCT01981785|Recurrent Infections|recurrent infections
229904|NCT01981759|Schizophrenia|schizophrenia
229905|NCT01981759|Delusions|delusions
229906|NCT01981759|D-Cycloserine|d-cycloserine
229907|NCT01981759|CBT|cbt
229908|NCT01981746|adductor canal block|adductor canal block
229909|NCT01981746|healthy volunteers|healthy volunteers
229910|NCT01981746|US-guided peripheral nerve block|us-guided peripheral nerve block
229911|NCT01981746|lower limb|lower limb
229912|NCT01981733|Deep Vein Thrombosis|deep vein thrombosis
229913|NCT01981707|castration-resistant prostate cancer|castration-resistant prostate cancer
229914|NCT01981707|abiraterone acetate|abiraterone acetate
229915|NCT01981707|enzalutamide|enzalutamide
229916|NCT01981707|choline pet|choline pet
229917|NCT01981694|Phase 1|phase 1
229918|NCT01981694|Randomized|randomized
229919|NCT01981694|Double Blind|double blind
229920|NCT01981694|Placebo-Controlled|placebo-controlled
229921|NCT01981694|Single-Dose Escalation|single-dose escalation
229922|NCT01981694|Safety|safety
229923|NCT01981694|Tolerability|tolerability
229924|NCT01981694|PK|pk
229925|NCT01981694|PD|pd
229926|NCT01981694|PF-06649751|pf-06649751
229927|NCT01981681|Phase 1|phase 1
229928|NCT01981681|Randomized|randomized
229929|NCT01981681|Placebo-Controlled|placebo-controlled
229930|NCT01981681|Multiple Dose Escalation|multiple dose escalation
229931|NCT01981681|Tolerability|tolerability
229932|NCT01981681|Safety|safety
229933|NCT01981681|PK|pk
229934|NCT01981681|Topical|topical
229935|NCT01981681|Healthy|healthy
229936|NCT01981681|PF-06263276|pf-06263276
229937|NCT01981655|Sodium Lactate|sodium lactate
229938|NCT01981655|Acute|acute
229939|NCT01981655|Heart|heart
229940|NCT01981655|Failure|failure
229941|NCT01981655|Perfusion|perfusion
229942|NCT01981629|Shock|shock
229943|NCT01981629|USCOM|uscom
229944|NCT01981629|Cardiac Ultrasound|cardiac ultrasound
229945|NCT01981629|Emergency Department|emergency department
229946|NCT01981616|Drug therapy|drug therapy
229947|NCT01981603|Navigators|navigators
229948|NCT01981603|Kidney Transplant|kidney transplant
229949|NCT01981603|Hemodialysis|hemodialysis
229950|NCT01981590|breathing, heart failure, sleep apnea|breathing, heart failure, sleep apnea
229951|NCT01981577|Parkinson Disease|parkinson disease
229952|NCT01981577|Subthalamic Nucleus|subthalamic nucleus
229953|NCT01981577|Ultrahigh field Magnetic Resonance imaging|ultrahigh field magnetic resonance imaging
229954|NCT01981577|Functional connectivity|functional connectivity
229955|NCT01981577|Structural connectivity|structural connectivity
229956|NCT01981564|Pediatric|pediatric
229957|NCT01981564|Emergency department visit|emergency department visit
229958|NCT01981551|Desmoid Tumor|desmoid tumor
229959|NCT01981551|Aggressive Fibromatosis|aggressive fibromatosis
229960|NCT01981551|Gamma-secretase Inhibitor|gamma-secretase inhibitor
229961|NCT01981551|Notch Pathway|notch pathway
229962|NCT01981538|Web-Based Survey|web-based survey
229963|NCT01981538|Cancer Caregivers|cancer caregivers
229964|NCT01981525|TP53 Mutation|tp53 mutation
229965|NCT01981525|Autosomal Dominant Hereditary Disorder|autosomal dominant hereditary disorder
229966|NCT01981525|Chemoprevention|chemoprevention
229967|NCT01981499|PF-05180999|pf-05180999
229969|NCT01981499|tolerability|tolerability
229970|NCT01981499|pharmacokinetics|pharmacokinetics
229971|NCT01981499|histamine|histamine
229973|NCT01981499|flare|flare
229974|NCT01981499|migraine|migraine
229975|NCT01981499|PDE2|pde2
229976|NCT01981486|PF-05180999|pf-05180999
229977|NCT01981486|safety|safety
229978|NCT01981486|tolerability|tolerability
229979|NCT01981486|pharmacokinetics|pharmacokinetics
229980|NCT01981486|migraine|migraine
229981|NCT01981486|PDE2|pde2
229982|NCT01981486|cAMP|camp
229983|NCT01981486|cGMP|cgmp
229984|NCT01981486|cantharidin|cantharidin
229985|NCT01981486|blister|blister
229986|NCT01981486|CYP3A induction|cyp3a induction
229987|NCT01981473|rheumatoid arthritis|rheumatoid arthritis
229988|NCT01981473|etanercept|etanercept
229989|NCT01981473|adalimumab|adalimumab
229990|NCT01981473|infliximab|infliximab
229991|NCT01981473|anti-drug antibody|anti-drug antibody
229992|NCT01981473|immunogenicity|immunogenicity
229993|NCT01981473|drug concentration|drug concentration
229994|NCT01981447|epilepsy|epilepsy
229995|NCT01981421|Liver fibrosis|liver fibrosis
229996|NCT01981421|Elastography|elastography
229997|NCT01981421|MR Elastography|mr elastography
229998|NCT01981421|Quantitative imaging|quantitative imaging
229999|NCT01981395|fenobam|fenobam
230000|NCT01981395|heat|heat
230001|NCT01981395|capsaicin|capsaicin
230002|NCT01981395|hyperalgesia|hyperalgesia
230003|NCT01981395|allodynia|allodynia
230004|NCT01981395|mood|mood
230005|NCT01981395|cognitive function|cognitive function
230006|NCT01981382|low back pain|low back pain
230007|NCT01981382|pain sensitivity|pain sensitivity
230008|NCT01981382|genes|genes
230009|NCT01981382|gene expression,|gene expression,
230010|NCT01981382|quantitative sensory testing|quantitative sensory testing
230011|NCT01981369|Dexmedetomidine sedation|dexmedetomidine sedation
230012|NCT01981369|Regional Anesthesia|regional anesthesia
230013|NCT01981369|Infraclavicular block|infraclavicular block
230014|NCT01981356|Psychotic Disorders|psychotic disorders
230015|NCT01981356|Acceptance and Commitment Therapy|acceptance and commitment therapy
230016|NCT01981356|Inpatient psychiatry|inpatient psychiatry
230017|NCT01981356|Schizophrenia|schizophrenia
230018|NCT01981356|Acute psychiatric disorder|acute psychiatric disorder
230019|NCT01981343|Gallbladder motility|gallbladder motility
230020|NCT01981343|A-F Betafood|a-f betafood
230021|NCT01981343|Betaine|betaine
230022|NCT01981343|Ejection fraction|ejection fraction
230023|NCT01981343|Ejection rate|ejection rate
230024|NCT01981343|Ultrasound|ultrasound
230025|NCT01981330|vocal fold scarring|vocal fold scarring
230026|NCT01981330|mesenchymal stem cells|mesenchymal stem cells
230027|NCT01981317|Obsessive Compulsive Disorder|obsessive compulsive disorder
230028|NCT01981317|Cognitive Behavioral Therapy|cognitive behavioral therapy
230029|NCT01981317|Stepped Care CBT|stepped care cbt
230030|NCT01981317|Exposure and Response Prevention|exposure and response prevention
230031|NCT01981317|Psychotherapy|psychotherapy
230032|NCT01981317|Counseling|counseling
230033|NCT01981304|Coronary artery disease|coronary artery disease
230034|NCT01981304|Percutaneous coronary intervention|percutaneous coronary intervention
230035|NCT01981291|Lower Extremity|lower extremity
230036|NCT01981291|Sciatic Nerve|sciatic nerve
230037|NCT01981291|Anesthesia, Regional|anesthesia, regional
230038|NCT01981291|Anesthetics, Local|anesthetics, local
230039|NCT01981291|Mepivacaine|mepivacaine
230040|NCT01981291|Ultrasonography|ultrasonography
230041|NCT01981278|Healthy|healthy
230042|NCT01981278|Tapentadol|tapentadol
230043|NCT01981278|Bioequivalence|bioequivalence
230044|NCT01981278|Fasted|fasted
230045|NCT01981252|Ulthera® System|ulthera® system
230046|NCT01981252|Ultherapy™ Treatment|ultherapy™ treatment
230047|NCT01981252|Ulthera, Inc.|ulthera, inc.
230048|NCT01981252|Micro-focused Ultrasound with Visualization (MFU-V)|micro-focused ultrasound with visualization (mfu-v)
230049|NCT01981239|voice analysis aspiration prediction|voice analysis aspiration prediction
230050|NCT01981213|Acetaminophen|acetaminophen
230052|NCT01981213|Attempts|attempts
230053|NCT01981213|Early Predictors of Hepatic Injury|early predictors of hepatic injury
230054|NCT01981213|Childhood Suicidal Behaviour|childhood suicidal behaviour
230055|NCT01981200|COPD acute exacerbation|copd acute exacerbation
230056|NCT01981200|Physiotherapy|physiotherapy
230057|NCT01981200|Resistance training|resistance training
230058|NCT01981200|Muscle strength|muscle strength
230059|NCT01981200|Handheld dynamometer|handheld dynamometer
230060|NCT01981161|progressive multifocal leucoencephalopathy|progressive multifocal leucoencephalopathy
230061|NCT01981161|JC virus|jc virus
230062|NCT01981161|Zoster infection|zoster infection
230063|NCT01981135|Controlled Human exposure study|controlled human exposure study
230064|NCT01981135|Air Pollution|air pollution
230065|NCT01981135|Temperature|temperature
230066|NCT01981135|Lung Function|lung function
230067|NCT01981135|Cardiovascular|cardiovascular
230068|NCT01981096|juvenile fibromyalgia|juvenile fibromyalgia
230069|NCT01981096|pain in children|pain in children
230070|NCT01981096|musculoskeletal pain|musculoskeletal pain
230071|NCT01981096|cognitive behavioral therapy|cognitive behavioral therapy
230072|NCT01981096|coping skills training|coping skills training
230073|NCT01981083|Protein-Energy Malnutrition|protein-energy malnutrition
230074|NCT01981083|Chronic Kidney Disease|chronic kidney disease
230075|NCT01981083|Malnutrition-Inflammation Score|malnutrition-inflammation score
230076|NCT01981083|Subjective Global Assessment|subjective global assessment
230077|NCT01981083|Hemodialysis|hemodialysis
230078|NCT01981083|Egg albumin|egg albumin
230079|NCT01981070|parent support|parent support
230080|NCT01981070|mindfulness|mindfulness
230081|NCT01981070|intellectual disability|intellectual disability
230082|NCT01981070|developmental disability|developmental disability
230083|NCT01981070|empowerment|empowerment
230084|NCT01981070|psychological acceptance|psychological acceptance
230085|NCT01981070|parental stress|parental stress
230086|NCT01981070|parental depression|parental depression
230087|NCT01981057|parenteral nutrition|parenteral nutrition
230088|NCT01981057|Numeta|numeta
230089|NCT01981057|prescription software Cato Pan|prescription software cato pan
230090|NCT01981018|Mental imagery, CBT, anxiety, mood instability|mental imagery, cbt, anxiety, mood instability
230091|NCT01980992|Food Allergy|food allergy
230092|NCT01980992|Wheat Allergy|wheat allergy
230093|NCT01980992|Oral Immunotherapy|oral immunotherapy
230094|NCT01980979|congenital heart disease,pulmonary hypertension,prostacyclin|congenital heart disease,pulmonary hypertension,prostacyclin
230095|NCT01980927|Migraine|migraine
230096|NCT01980927|National Upper Cervical Chiropractic Association atlas correction|national upper cervical chiropractic association atlas correction
230097|NCT01980914|hypoglycemia|hypoglycemia
230098|NCT01980914|type 2 diabetes|type 2 diabetes
230099|NCT01980914|insulin glargine|insulin glargine
230100|NCT01980914|cardiac function|cardiac function
230101|NCT01980914|myocardial ischemia|myocardial ischemia
230102|NCT01980914|cardiac rhythm|cardiac rhythm
230103|NCT01980914|autonomic cardiovascular function|autonomic cardiovascular function
230104|NCT01980901|AAA|aaa
230105|NCT01980849|Nadroparin|nadroparin
230106|NCT01980849|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
230107|NCT01980836|Rheumatoid arthritis|rheumatoid arthritis
230108|NCT01980836|Tocilizumab|tocilizumab
230109|NCT01980836|Seasonal influenza vaccine|seasonal influenza vaccine
230110|NCT01980823|Breast Cancer|breast cancer
230111|NCT01980823|Metformin|metformin
230112|NCT01980823|Atorvastatin|atorvastatin
230113|NCT01980823|Ki-67|ki-67
230114|NCT01980797|Bicuspid aortic valve disease|bicuspid aortic valve disease
230115|NCT01980797|Thoracic aortic disease|thoracic aortic disease
230116|NCT01980797|Genetics|genetics
230117|NCT01980797|Echocardiography|echocardiography
230118|NCT01980797|Cardiac CT|cardiac ct
230119|NCT01980797|Cardiac MRI|cardiac mri
230120|NCT01980784|Spinal Cord Injury|spinal cord injury
230121|NCT01980771|HIV|hiv
230122|NCT01980771|prevention|prevention
230123|NCT01980771|men|men
230124|NCT01980771|African American|african american
230125|NCT01980758|obesity, pediatric obesity, bariatric, bariatric surgery|obesity, pediatric obesity, bariatric, bariatric surgery
230126|NCT01980745|autoimmune hepatitis|autoimmune hepatitis
230127|NCT01980745|recurrence|recurrence
230128|NCT01980745|treatment withdrawal|treatment withdrawal
230129|NCT01980745|chloroquine|chloroquine
230130|NCT01980745|maintenance of remission|maintenance of remission
230131|NCT01980706|Baclofen|baclofen
230132|NCT01980706|Alcohol Dependence|alcohol dependence
230133|NCT01980667|lurbinectedin|lurbinectedin
230134|NCT01980667|PM01183|pm01183
230135|NCT01980667|tumors|tumors
230136|NCT01980667|cancer|cancer
230137|NCT01980667|Pharma Mar|pharma mar
230138|NCT01980654|Pharmacyclics|pharmacyclics
230139|NCT01980654|PCYC|pcyc
230140|NCT01980654|Lymphoma|lymphoma
230141|NCT01980654|Follicular Lymphoma|follicular lymphoma
230142|NCT01980654|FL|fl
230143|NCT01980654|Rituximab|rituximab
230144|NCT01980654|Ibrutinib|ibrutinib
230146|NCT01980654|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
230147|NCT01980654|NHL|nhl
230148|NCT01980654|B-cell Lymphoma|b-cell lymphoma
230149|NCT01980641|Stroke|stroke
230150|NCT01980641|ADL|adl
230151|NCT01980641|mHealth|mhealth
230152|NCT01980641|App|app
230153|NCT01980641|Adherence|adherence
230154|NCT01980641|Home|home
230155|NCT01980641|Environment|environment
230156|NCT01980641|Tool|tool
230157|NCT01980641|Advice|advice
230158|NCT01980641|Smartphone|smartphone
230160|NCT01980628|NHL|nhl
230161|NCT01980628|SMZL|smzl
230162|NCT01980628|NMZL|nmzl
230163|NCT01980628|MALT|malt
230164|NCT01980602|Intermittent claudication|intermittent claudication
230165|NCT01980602|endothelial function|endothelial function
230166|NCT01980602|cardiopulmonary testing|cardiopulmonary testing
230167|NCT01980602|inflammation|inflammation
230168|NCT01980602|muscle architecture|muscle architecture
230169|NCT01980589|multiple myeloma|multiple myeloma
230170|NCT01980576|Pain|pain
230171|NCT01980576|Sensitization|sensitization
230172|NCT01980576|Spondylitis|spondylitis
230173|NCT01980485|smoker|smoker
230174|NCT01980459|Hypomagnesemia, Cellular Mg, Inflammation, Diabetes Mellitus|hypomagnesemia, cellular mg, inflammation, diabetes mellitus
230175|NCT01980446|Coma|coma
230176|NCT01980446|Cardiac arrest|cardiac arrest
230177|NCT01980446|Neurophysiology|neurophysiology
230178|NCT01980446|Auditory evoked potential|auditory evoked potential
230179|NCT01980433|Wilson disease|wilson disease
230180|NCT01980433|Dystonia|dystonia
230181|NCT01980433|Movement Disorders|movement disorders
230182|NCT01980433|Handwriting|handwriting
230183|NCT01980433|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
230184|NCT01980420|Sleeve gastrectomy|sleeve gastrectomy
230185|NCT01980420|Oesogastric junction - GEJ|oesogastric junction - gej
230186|NCT01980420|Dynamic MRI Imaging|dynamic mri imaging
230187|NCT01980407|S-1|s-1
230188|NCT01980407|Oxaliplatin|oxaliplatin
230189|NCT01980407|Leucovorin|leucovorin
230190|NCT01980407|Gastric Cancer|gastric cancer
230191|NCT01980394|esophagus|esophagus
230192|NCT01980394|gastro-esophegeal junction|gastro-esophegeal junction
230194|NCT01980394|tumor seeding|tumor seeding
230195|NCT01980394|free viable tumor cells|free viable tumor cells
230196|NCT01980394|surgery|surgery
230197|NCT01980394|intraluminal tumor cells|intraluminal tumor cells
230198|NCT01980394|stump washout|stump washout
230199|NCT01980355|cancer|cancer
230200|NCT01980355|surgery|surgery
230201|NCT01980355|oncology|oncology
230202|NCT01980355|major|major
230203|NCT01980355|surgical oncology|surgical oncology
230204|NCT01980355|tranexamic acid|tranexamic acid
230205|NCT01980342|Long acting reversible contraception|long acting reversible contraception
230206|NCT01980342|HIV|hiv
230207|NCT01980329|CYP3A5|cyp3a5
230208|NCT01980329|maraviroc|maraviroc
230209|NCT01980329|polymorphism|polymorphism
230210|NCT01980316|Argatroban|argatroban
230211|NCT01980316|Extracranial vertebral Artery Stenting|extracranial vertebral artery stenting
230212|NCT01980316|restenosis|restenosis
230213|NCT01980303|Healthy|healthy
230214|NCT01980303|Japanese|japanese
230215|NCT01980303|Caucasian|caucasian
230216|NCT01980303|Anesthetics|anesthetics
230217|NCT01980303|Intranasal|intranasal
230218|NCT01980303|Esketamine|esketamine
687319|NCT00910572|Radiation|radiation
230219|NCT01980303|Pharmacokinetics|pharmacokinetics
230220|NCT01980290|HCV genotype 1|hcv genotype 1
230221|NCT01980290|Liver Fibrosis|liver fibrosis
230222|NCT01980290|ex-People who INject Drugs (ex-PWIDs)|ex-people who inject drugs (ex-pwids)
230223|NCT01980264|BD, AK|bd, ak
230224|NCT01980251|Delirium, electroencephalography, CSD|delirium, electroencephalography, csd
230225|NCT01980238|LAR|lar
230226|NCT01980238|anastomotic leakage|anastomotic leakage
230227|NCT01980238|Cannula ileostomy|cannula ileostomy
230228|NCT01980238|loop ileostomy|loop ileostomy
230229|NCT01980225|vitrification, blastocyst, artificial shrinkage, collapse|vitrification, blastocyst, artificial shrinkage, collapse
230230|NCT01980212|non-small cell lung cancer|non-small cell lung cancer
230231|NCT01980212|thioredoxin reductase|thioredoxin reductase
230232|NCT01980199|visceral leishmaniasis|visceral leishmaniasis
230233|NCT01980199|fexinidazole|fexinidazole
230234|NCT01980199|adults|adults
230235|NCT01980199|proof of concept|proof of concept
230236|NCT01980199|efficacy|efficacy
230237|NCT01980199|safety|safety
230238|NCT01980199|pharmacokinetic|pharmacokinetic
230239|NCT01980199|pharmacodynamic|pharmacodynamic
230240|NCT01980186|transcranial ultrasound|transcranial ultrasound
230241|NCT01980186|autism|autism
230242|NCT01980186|cortical dysplasia|cortical dysplasia
230243|NCT01980186|extra-axial fluid|extra-axial fluid
230244|NCT01980173|Bakri balloon|bakri balloon
230245|NCT01980147|Severe Mental Illness|severe mental illness
230246|NCT01980134|adenomatous colorectal lesions|adenomatous colorectal lesions
230247|NCT01980134|colorectal polyps|colorectal polyps
230248|NCT01980134|polyps|polyps
230249|NCT01980121|Respiratory Aspiration|respiratory aspiration
230250|NCT01980121|Pregnancy|pregnancy
230251|NCT01980121|Ultrasound|ultrasound
230252|NCT01980121|Gastric Contents|gastric contents
230253|NCT01980108|Pregnancy|pregnancy
230254|NCT01980108|Respiratory Aspiration|respiratory aspiration
230255|NCT01980108|Gastric Contents|gastric contents
230256|NCT01980108|Ultrasound|ultrasound
230257|NCT01980095|Helicobacter pylori|helicobacter pylori
230258|NCT01980095|H. pylori|h. pylori
230259|NCT01980095|Dyspepsia|dyspepsia
230260|NCT01980082|head and neck surgery|head and neck surgery
230261|NCT01980082|surgical wound infection|surgical wound infection
230262|NCT01980082|antibiotic prophylaxis|antibiotic prophylaxis
230263|NCT01980069|Sugammadex|sugammadex
230264|NCT01980069|Neostigmine|neostigmine
230266|NCT01980056|INT-2 or high-risk MDS|int-2 or high-risk mds
230267|NCT01980017|Diabetes Type 2 Mellitus|diabetes type 2 mellitus
230268|NCT01980017|Ottawa Model for Smoking Cessation|ottawa model for smoking cessation
230269|NCT01980017|Diabetes Education Programs|diabetes education programs
230270|NCT01979965|Mitral Regurgitation|mitral regurgitation
230271|NCT01979965|cardiac resynchronization therapy|cardiac resynchronization therapy
230272|NCT01979965|ranolazine|ranolazine
230273|NCT01979965|maximal medical therapy|maximal medical therapy
230274|NCT01979965|ischemic cardiomyopathy|ischemic cardiomyopathy
230275|NCT01979913|Primary Open Angle Glaucoma|primary open angle glaucoma
230276|NCT01979913|Ocular Hypertension|ocular hypertension
230277|NCT01979913|Tafluprost|tafluprost
230278|NCT01979913|Saflutan|saflutan
230279|NCT01979913|Intraocular pressure|intraocular pressure
230280|NCT01979913|Preservative free|preservative free
230281|NCT01979913|Single dose unit|single dose unit
230282|NCT01979900|TB Infection|tb infection
230283|NCT01979900|Lesion Degree|lesion degree
230284|NCT01979900|Bacteriology Indicators|bacteriology indicators
230285|NCT01979900|Cavity|cavity
230286|NCT01979900|Humoral Immunity|humoral immunity
230287|NCT01979900|Cellular Immunologic Response|cellular immunologic response
230288|NCT01979861|Endometrial ablation with vapor|endometrial ablation with vapor
230289|NCT01979848|continence outcomes|continence outcomes
230290|NCT01979848|sexual function|sexual function
230291|NCT01979848|Robotic Assisted Radical Prostatectomy|robotic assisted radical prostatectomy
230292|NCT01979848|thermal imaging|thermal imaging
230293|NCT01979848|localized hypothermia|localized hypothermia
230294|NCT01979835|intrauterine device, contraception|intrauterine device, contraception
230295|NCT01979822|medication pump, complications, safety observation|medication pump, complications, safety observation
230296|NCT01979809|Dietary change|dietary change
230297|NCT01979809|Young adult|young adult
230298|NCT01979809|Prevention|prevention
230299|NCT01979809|Web-based intervention|web-based intervention
230300|NCT01979809|eCoaching|ecoaching
230301|NCT01979796|Addiction, Schizophrenia, Electronic cigarettes|addiction, schizophrenia, electronic cigarettes
230302|NCT01979770|Adolescent|adolescent
230303|NCT01979770|Nutritional status|nutritional status
230304|NCT01979770|Body composition|body composition
230305|NCT01979770|Biochemical status|biochemical status
230306|NCT01979744|Intravenous ultrasound,|intravenous ultrasound,
230307|NCT01979744|third generation drug-eluting stent|third generation drug-eluting stent
230308|NCT01979731|Occupational health|occupational health
230309|NCT01979731|Ergonomics|ergonomics
230310|NCT01979731|Environments|environments
230311|NCT01979731|Prevention and Control|prevention and control
230313|NCT01979692|The study will|the study will
230314|NCT01979692|focus on using|focus on using
230315|NCT01979692|CLM to|clm to
230316|NCT01979692|distinguish between|distinguish between
230317|NCT01979692|viable and|viable and
230318|NCT01979692|necrotic tissue|necrotic tissue
230319|NCT01979692|at TTNB in real time|at ttnb in real time
230320|NCT01979666|Knee AVN, Nitrates|knee avn, nitrates
230321|NCT01979640|bronchial cuff|bronchial cuff
230322|NCT01979640|double lumen tube|double lumen tube
230323|NCT01979640|blood tight seal|blood tight seal
230324|NCT01979627|transulnar approach|transulnar approach
230325|NCT01979627|transradial approach|transradial approach
230326|NCT01979627|angiography|angiography
230327|NCT01979627|angioplasty|angioplasty
230328|NCT01979614|coronary artery disease|coronary artery disease
230329|NCT01979601|hypercholesterolemia,|hypercholesterolemia,
230330|NCT01979601|LGT209,|lgt209,
230331|NCT01979601|PCSK9,|pcsk9,
230332|NCT01979601|LDL-C|ldl-c
230333|NCT01979575|Nexfin|nexfin
230334|NCT01979575|Flotrac|flotrac
230335|NCT01979575|Esophageal|esophageal
230336|NCT01979575|Cardiac output|cardiac output
230337|NCT01979562|Overuse injury|overuse injury
230338|NCT01979562|Femur|femur
230339|NCT01979562|Tibia|tibia
230340|NCT01979562|Running|running
230341|NCT01979562|Prevention|prevention
230342|NCT01979549|Adverse events|adverse events
230343|NCT01979549|Upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
230344|NCT01979549|Sedation|sedation
230345|NCT01979484|bioavailability|bioavailability
230346|NCT01979471|Cardiovascular risk reduction|cardiovascular risk reduction
230347|NCT01979471|Diabetes|diabetes
230348|NCT01979471|Chronic Kidney Disease|chronic kidney disease
230349|NCT01979471|Atherosclerotic vascular disease|atherosclerotic vascular disease
230350|NCT01979471|Community Pharmacist|community pharmacist
230351|NCT01979471|Randomized controlled trial|randomized controlled trial
230352|NCT01979471|[eGFR <60 ml/min/1.73m2 and/or (ACR >= 30 mg/mmol or two consecutive ACR tests which are >= 3 mg/mmol)]|[egfr <60 ml/min/1.73m2 and/or (acr >= 30 mg/mmol or two consecutive acr tests which are >= 3 mg/mmol)]
230353|NCT01979458|Colonoscopy|colonoscopy
230354|NCT01979445|CAD|cad
230355|NCT01979432|Alzheimer, cognitive diseases, Ankle-to-brachial index|alzheimer, cognitive diseases, ankle-to-brachial index
230356|NCT01979419|mild cognitive impairment|mild cognitive impairment
230357|NCT01979419|Alzheimer's disease|alzheimer's disease
230358|NCT01979419|subcortical Vascular Dementia|subcortical vascular dementia
230359|NCT01979419|amyloid|amyloid
230360|NCT01979419|plaques|plaques
230361|NCT01979419|neuroimaging|neuroimaging
230362|NCT01979419|biomarkers|biomarkers
230363|NCT01979419|cognition disorder|cognition disorder
230364|NCT01979419|early detection|early detection
230365|NCT01979419|pre-dementia|pre-dementia
230366|NCT01979419|dementia|dementia
230367|NCT01979419|vascular MCI|vascular mci
230368|NCT01979406|Anthrax vaccine|anthrax vaccine
230369|NCT01979393|Locally advanced|locally advanced
230370|NCT01979393|stage III|stage iii
230371|NCT01979393|stage IV|stage iv
230372|NCT01979393|residual disease after primary surgery|residual disease after primary surgery
230373|NCT01979393|newly diagnosed HGUS|newly diagnosed hgus
230374|NCT01979393|Metastatic|metastatic
230375|NCT01979380|KD101|kd101
230376|NCT01979380|Anti-obesity Agents|anti-obesity agents
230377|NCT01979354|spinal morphine|spinal morphine
230378|NCT01979354|VATs lobectomy|vats lobectomy
230379|NCT01979341|dual trigger|dual trigger
230380|NCT01979341|hCG|hcg
230381|NCT01979341|GnRH agonist|gnrh agonist
230382|NCT01979341|ICSI|icsi
230383|NCT01979341|pregnancy|pregnancy
230384|NCT01979341|OHSS|ohss
230385|NCT01979328|Deep Vein Thrombosis|deep vein thrombosis
230386|NCT01979302|Geriatric Depression|geriatric depression
230387|NCT01979302|Depression Care Management|depression care management
230388|NCT01979302|home healthcare|home healthcare
230389|NCT01979302|nurse training intervention|nurse training intervention
230390|NCT01979289|Executive Dysfunction|executive dysfunction
230391|NCT01979289|Cognitive Remediation|cognitive remediation
230392|NCT01979289|Geriatric|geriatric
230393|NCT01979289|Depression|depression
230394|NCT01979250|endothelial keratoplasty|endothelial keratoplasty
230395|NCT01979250|Descemet's stripping automated endothelial keratoplasty|descemet's stripping automated endothelial keratoplasty
230396|NCT01979250|lamellar keratoplasty|lamellar keratoplasty
230397|NCT01979224|educational intervention, Asthma control, asthma knowledge|educational intervention, asthma control, asthma knowledge
230398|NCT01979211|head and neck cancer|head and neck cancer
230399|NCT01979198|burst fracture, kyphotic angle, surgical outcome|burst fracture, kyphotic angle, surgical outcome
230400|NCT01979172|LASIK|lasik
230401|NCT01979172|Intraocular lens|intraocular lens
230402|NCT01979172|Biometry|biometry
221095|NCT02021890|Dance|dance
221096|NCT02021890|Physical activity|physical activity
221097|NCT02021890|Physical fitness|physical fitness
230403|NCT01979172|IOL master|iol master
230404|NCT01979159|aphasia|aphasia
230405|NCT01979159|apraxia of speech|apraxia of speech
230406|NCT01979159|outcomes|outcomes
230407|NCT01979146|Cancer|cancer
230408|NCT01979120|Sleep-disordered breathing|sleep-disordered breathing
230409|NCT01979120|Chronic heart failure|chronic heart failure
230410|NCT01979120|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
230411|NCT01979120|Apnea-Hypopnea-Index|apnea-hypopnea-index
230412|NCT01979120|Portable Polygraphy Monitoring|portable polygraphy monitoring
230413|NCT01979120|Polysomnography|polysomnography
230414|NCT01979107|Health behavior|health behavior
230415|NCT01979107|Chronic disease|chronic disease
230416|NCT01979107|Proactive action|proactive action
230417|NCT01979107|General practitioner|general practitioner
230418|NCT01979107|Preventive health check|preventive health check
230419|NCT01979107|Social inequality in health|social inequality in health
230420|NCT01979107|Randomised controlled trial|randomised controlled trial
230421|NCT01979055|asthma|asthma
230422|NCT01979055|older adults|older adults
230423|NCT01979055|elderly|elderly
230424|NCT01979055|behavior|behavior
230425|NCT01979042|renal colic|renal colic
230426|NCT01979042|acute renal failure|acute renal failure
230427|NCT01979042|Neutrophil gelatinase associated lipocalin|neutrophil gelatinase associated lipocalin
230428|NCT01978977|mBC|mbc
230429|NCT01978977|HER2 negative|her2 negative
230430|NCT01978977|Chemotherapy|chemotherapy
230431|NCT01978977|Anti-angiogenic agent|anti-angiogenic agent
230432|NCT01978977|Bevacizumab|bevacizumab
230433|NCT01978977|1st Line|1st line
230434|NCT01978964|ONT-10|ont-10
230435|NCT01978964|MUC1|muc1
230436|NCT01978964|Vaccine|vaccine
230437|NCT01978964|Phase 1b|phase 1b
230438|NCT01978964|Solid tumors|solid tumors
230439|NCT01978964|Maintenance therapy|maintenance therapy
230440|NCT01978951|Chronic Kidney Disease|chronic kidney disease
230441|NCT01978951|Integrated Chronic Kidney Disease Care|integrated chronic kidney disease care
230442|NCT01978951|Village Health Volunteers|village health volunteers
230443|NCT01978925|Pharmaceutical care|pharmaceutical care
230444|NCT01978925|Medication Adherence|medication adherence
230445|NCT01978925|Blood Pressure|blood pressure
230446|NCT01978925|Diabetes|diabetes
230447|NCT01978925|Emergency|emergency
230448|NCT01978886|Diabetes Mellitus|diabetes mellitus
230449|NCT01978886|frozen shoulder|frozen shoulder
230450|NCT01978886|adhesive capsulitis|adhesive capsulitis
230451|NCT01978860|CABG Coronary artery bypass grafting|cabg coronary artery bypass grafting
230452|NCT01978860|CTO Chronic Total Occlusion|cto chronic total occlusion
230453|NCT01978860|PCI Percutaneous coronary intervention|pci percutaneous coronary intervention
230454|NCT01978860|MACE Major adverse cardiovascular event(s)|mace major adverse cardiovascular event(s)
230455|NCT01978860|MI Myocardial infarction|mi myocardial infarction
230456|NCT01978834|Osteoporosis, diagnosis, ultrasound|osteoporosis, diagnosis, ultrasound
230457|NCT01978821|Cerebral Palsy|cerebral palsy
230458|NCT01978821|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
230459|NCT01978821|stem cell therapy|stem cell therapy
230460|NCT01978795|concussion|concussion
230461|NCT01978795|high school|high school
230462|NCT01978795|web-based training|web-based training
230463|NCT01978795|school-based health care|school-based health care
230464|NCT01978782|raltegravir|raltegravir
230465|NCT01978782|citalopram|citalopram
230466|NCT01978782|pharmacokinetics|pharmacokinetics
230467|NCT01978782|drug-drug interaction|drug-drug interaction
230468|NCT01978756|Outpatient clinic|outpatient clinic
230469|NCT01978756|Breast cancer|breast cancer
230470|NCT01978756|Late toxicity|late toxicity
230471|NCT01978743|HIV|hiv
230472|NCT01978743|HIV-associated neurocognitive disorder|hiv-associated neurocognitive disorder
230473|NCT01978743|neurotoxicity|neurotoxicity
230474|NCT01978730|vascular dementia|vascular dementia
230475|NCT01978730|cognition|cognition
230476|NCT01978730|stroke|stroke
230477|NCT01978717|Anesthesia|anesthesia
230478|NCT01978717|T-helper|t-helper
230479|NCT01978717|MDSCs|mdscs
230480|NCT01978717|Colorectal cancer|colorectal cancer
230481|NCT01978717|Fast track|fast track
230482|NCT01978691|Obesity|obesity
230483|NCT01978691|Blood glucose|blood glucose
230484|NCT01978691|Waist circumference|waist circumference
230485|NCT01978691|Lipid metabolism|lipid metabolism
230486|NCT01978691|Probiotics|probiotics
230487|NCT01978691|Prebiotics|prebiotics
230488|NCT01978691|Dietary supplements|dietary supplements
230489|NCT01978691|Endotoxemia|endotoxemia
230490|NCT01978665|COPD exercise inflammation prednisone|copd exercise inflammation prednisone
230491|NCT01978626|Insomnia|insomnia
230492|NCT01978626|Comorbid insomnia|comorbid insomnia
230493|NCT01978626|Cognitive Behavioral Therapy|cognitive behavioral therapy
230494|NCT01978600|Open-Angle Glaucoma|open-angle glaucoma
230495|NCT01978600|Ocular Hypertension|ocular hypertension
230496|NCT01978600|Simbrinza™|simbrinza™
230497|NCT01978600|Intraocular Pressure|intraocular pressure
230498|NCT01978587|End-stage Renal Disease|end-stage renal disease
230499|NCT01978587|Hemodialysis|hemodialysis
230500|NCT01978587|Pharmacokinetics|pharmacokinetics
230501|NCT01978574|Cognitive reserve|cognitive reserve
230502|NCT01978574|intellectual enrichment|intellectual enrichment
230503|NCT01978548|Alzheimer Disease|alzheimer disease
230504|NCT01978548|Prodromal Alzheimer Disease|prodromal alzheimer disease
230505|NCT01978548|Safety|safety
230506|NCT01978548|Tolerability|tolerability
230507|NCT01978548|Pharmacokinetic|pharmacokinetic
230508|NCT01978548|Proof of Mechanism|proof of mechanism
230509|NCT01978548|JNJ-54861911|jnj-54861911
230510|NCT01978535|POTS|pots
230511|NCT01978522|Randomised trial|randomised trial
230512|NCT01978522|postal questionnaires|postal questionnaires
230513|NCT01978522|return rates|return rates
230514|NCT01978509|Colonoscopy|colonoscopy
230515|NCT01978483|Humans|humans
230516|NCT01978483|Adult|adult
230517|NCT01978483|skin|skin
230518|NCT01978483|metabolism|metabolism
230519|NCT01978483|radiation effects|radiation effects
230520|NCT01978483|Ultraviolet Rays|ultraviolet rays
230521|NCT01978483|RANKL|rankl
230522|NCT01978483|RANK Ligand|rank ligand
230523|NCT01978483|denosumab|denosumab
230524|NCT01978483|diphenylcyclopropenone|diphenylcyclopropenone
230525|NCT01978483|diphencyprone|diphencyprone
230526|NCT01978483|immunology|immunology
230527|NCT01978483|immunosuppression|immunosuppression
230528|NCT01978483|Antibodies, Monoclonal|antibodies, monoclonal
230529|NCT01978483|Dermatitis, Allergic Contact|dermatitis, allergic contact
230530|NCT01978483|Hypersensitivity, Delayed|hypersensitivity, delayed
230531|NCT01978470|epilepsy|epilepsy
230532|NCT01978470|drug resistent epilepsy|drug resistent epilepsy
230533|NCT01978470|partial onset seizures|partial onset seizures
230534|NCT01978470|trigeminal nerve stimulation|trigeminal nerve stimulation
230535|NCT01978470|neuromodulation|neuromodulation
230536|NCT01978444|D2 lymphadenectomy|d2 lymphadenectomy
230537|NCT01978444|Complete Mesogastrium Excision|complete mesogastrium excision
230538|NCT01978418|Lung fluid|lung fluid
230539|NCT01978418|Postnatal adaptation|postnatal adaptation
230540|NCT01978418|Salbutamol|salbutamol
230541|NCT01978418|Albuterol|albuterol
230542|NCT01978418|Epithelial Sodium Channel|epithelial sodium channel
230543|NCT01978405|Type 2 diabetes|type 2 diabetes
230544|NCT01978405|Nephropathy|nephropathy
230545|NCT01978405|Contrast medium|contrast medium
230546|NCT01978405|Alpha lipoic acid|alpha lipoic acid
230547|NCT01978392|disability|disability
230548|NCT01978392|self-management|self-management
230549|NCT01978392|chronic illness|chronic illness
230550|NCT01978392|chronic pain|chronic pain
230551|NCT01978392|occupation|occupation
230552|NCT01978392|> 6 months|> 6 months
230553|NCT01978379|General Anesthesia|general anesthesia
230554|NCT01978379|Nociception Level|nociception level
230555|NCT01978366|Duchenne muscular dystrophy|duchenne muscular dystrophy
230556|NCT01978366|halofuginone hydrobromide|halofuginone hydrobromide
230557|NCT01978366|anti-fibrotic|anti-fibrotic
230558|NCT01978366|anti-inflammatory|anti-inflammatory
230559|NCT01978366|muscle regeneration|muscle regeneration
230560|NCT01978366|protein synthesis inhibitor|protein synthesis inhibitor
230561|NCT01978353|Mild cognitive impairment|mild cognitive impairment
230562|NCT01978353|Dementia|dementia
230563|NCT01978353|Alzheimer's disease|alzheimer's disease
230564|NCT01978353|Memory Training|memory training
230565|NCT01978353|Cognitive Training|cognitive training
230566|NCT01978353|Cognitive Rehabilitation|cognitive rehabilitation
230567|NCT01978353|Neuropsychological Rehabilitation|neuropsychological rehabilitation
230568|NCT01978327|Alzheimer's disease|alzheimer's disease
230569|NCT01978327|GSK2647544|gsk2647544
230570|NCT01978327|drug-drug interaction|drug-drug interaction
230571|NCT01978327|healthy subjects|healthy subjects
230572|NCT01978327|Lp-PLA2|lp-pla2
230573|NCT01978327|simvastatin|simvastatin
230574|NCT01978314|Chronic Kidney Disease|chronic kidney disease
230575|NCT01978314|Acute Kidney Injury|acute kidney injury
230577|NCT01978314|CKD|ckd
230578|NCT01978314|Plasma Volume|plasma volume
230579|NCT01978314|GFR|gfr
230580|NCT01978314|Glomerular Filtration Rate|glomerular filtration rate
230581|NCT01978314|Blood volume|blood volume
230582|NCT01978314|mGFR|mgfr
230583|NCT01978314|measured GFR|measured gfr
230584|NCT01978314|kidney biomarker|kidney biomarker
230585|NCT01978314|renal disease|renal disease
230586|NCT01978314|renal biomarker|renal biomarker
230587|NCT01978314|Renal function|renal function
230588|NCT01978314|kidney function|kidney function
230589|NCT01978314|organ function|organ function
230590|NCT01978314|kidney monitor|kidney monitor
230591|NCT01978314|kidney device|kidney device
230592|NCT01978301|triamcinolone acetonide (TAC)|triamcinolone acetonide (tac)
230593|NCT01978301|heavy water|heavy water
230594|NCT01978301|fibrosis|fibrosis
230595|NCT01978301|deuterium|deuterium
230596|NCT01978301|collagen degradation|collagen degradation
230597|NCT01978301|collagen synthesis|collagen synthesis
230598|NCT01978301|Keloid|keloid
230599|NCT01978301|patient|patient
230600|NCT01978275|total knee arthroplasty|total knee arthroplasty
230601|NCT01978275|lumbar plexus block|lumbar plexus block
230602|NCT01978275|stimulating catheters|stimulating catheters
230603|NCT01978275|peripheral nerve blocks|peripheral nerve blocks
230604|NCT01978262|influenza vaccine|influenza vaccine
230605|NCT01978262|cytokines|cytokines
230606|NCT01978262|hormones|hormones
230607|NCT01978262|progesterone|progesterone
230608|NCT01978249|Colorectal cancer|colorectal cancer
230609|NCT01978249|Primary tumor resection|primary tumor resection
230610|NCT01978249|Chemotherapy|chemotherapy
230611|NCT01978249|Overall survival|overall survival
230612|NCT01978249|Quality of life|quality of life
230613|NCT01978236|BRAF V600E mutation|braf v600e mutation
230614|NCT01978236|brain metastases|brain metastases
230615|NCT01978236|BRAF V600K mutation|braf v600k mutation
230616|NCT01978236|Metastatic melanoma|metastatic melanoma
230617|NCT01978236|BRAF inhibitor|braf inhibitor
230618|NCT01978236|brain neoplasms|brain neoplasms
230619|NCT01978236|GSK2118436|gsk2118436
230620|NCT01978223|Rotarix™|rotarix™
230621|NCT01978223|Case-control|case-control
230622|NCT01978223|Venezuela|venezuela
230623|NCT01978223|Vaccine effectiveness|vaccine effectiveness
230624|NCT01978223|Rotavirus Severe Gastroenteritis|rotavirus severe gastroenteritis
230625|NCT01978223|Children|children
230626|NCT01978223|Hospitalised|hospitalised
230627|NCT01978210|autism|autism
230628|NCT01978210|enuresis|enuresis
230629|NCT01978210|toilet-training|toilet-training
230630|NCT01978184|Pancreatic Cancer, resectable adenocarcinoma of the pancreas|pancreatic cancer, resectable adenocarcinoma of the pancreas
230631|NCT01978171|breast neoplasms|breast neoplasms
230632|NCT01978171|everolimus|everolimus
230633|NCT01978171|interstitial lung disease|interstitial lung disease
230634|NCT01978171|pneumonitis|pneumonitis
230635|NCT01978158|Oxygen|oxygen
230636|NCT01978158|Hypoxia|hypoxia
230637|NCT01978158|Hyperoxia|hyperoxia
230638|NCT01978158|Inflammation|inflammation
230639|NCT01978158|Innate immunity|innate immunity
230640|NCT01978145|efficacy|efficacy
230641|NCT01978145|tolerability|tolerability
230642|NCT01978145|capsule-based inhaler|capsule-based inhaler
230643|NCT01978145|quality of life|quality of life
230644|NCT01978145|safety|safety
230645|NCT01978145|multi-dose inhaler|multi-dose inhaler
230646|NCT01978145|fluticasone propionate/salmeterol (FSC) 250/50 mcg|fluticasone propionate/salmeterol (fsc) 250/50 mcg
230647|NCT01978145|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
230648|NCT01978132|primary hyperaldosteronism|primary hyperaldosteronism
230649|NCT01978132|primary hypertension|primary hypertension
230650|NCT01978132|forearm ischemia-reperfusion|forearm ischemia-reperfusion
230651|NCT01978132|(reduction) in brachial artery FMD|(reduction) in brachial artery fmd
230652|NCT01978132|endothelial ischemia-reperfusion injury|endothelial ischemia-reperfusion injury
230653|NCT01978119|Multi-Dose Inhaler|multi-dose inhaler
230654|NCT01978119|safety|safety
230655|NCT01978119|Asthma|asthma
230656|NCT01978119|efficacy|efficacy
230657|NCT01978119|pharmacodynamics|pharmacodynamics
230658|NCT01978119|fluticasone propionate/salmeterol (FSC) 250/50 mcg|fluticasone propionate/salmeterol (fsc) 250/50 mcg
230659|NCT01978119|tolerability|tolerability
230660|NCT01978119|Capsule-Based Inhaler|capsule-based inhaler
230661|NCT01978106|toric calculator|toric calculator
230662|NCT01978106|toric intraocular lens power|toric intraocular lens power
230663|NCT01978106|Acrysof|acrysof
230664|NCT01978106|Tecnis|tecnis
230665|NCT01978106|iTrace|itrace
230666|NCT01978093|Conjugate|conjugate
230667|NCT01978093|Immunogenicity|immunogenicity
230668|NCT01978093|Hib-MenCY-TT vaccine|hib-mency-tt vaccine
230669|NCT01978093|Haemophilus type b|haemophilus type b
230670|NCT01978093|Safety|safety
230671|NCT01978093|Reactogenicity|reactogenicity
230672|NCT01978067|Uterine Scar From Previous Cesarean Delivery|uterine scar from previous cesarean delivery
230673|NCT01978067|previous caesarean scar deficiency|previous caesarean scar deficiency
230674|NCT01978067|transvaginal resection|transvaginal resection
230675|NCT01978067|quality of life|quality of life
230676|NCT01978067|sexual activity|sexual activity
230677|NCT01978054|Information Dissemination|information dissemination
230678|NCT01978054|Information Sharing|information sharing
230679|NCT01978054|Innovation Diffusion|innovation diffusion
230680|NCT01978054|Public Health Practice|public health practice
230681|NCT01978054|Evidence-Based Public Health|evidence-based public health
230682|NCT01978054|Chronic Disease Prevention|chronic disease prevention
230683|NCT01978054|Cancer Prevention and Control|cancer prevention and control
230684|NCT01978041|pharmacokinetics, saliva, plasma, fluoride, dental fluorosis, dental caries|pharmacokinetics, saliva, plasma, fluoride, dental fluorosis, dental caries
230685|NCT01978028|heart failure|heart failure
230686|NCT01978015|primary open angle glaucoma|primary open angle glaucoma
230687|NCT01978015|timolol|timolol
230688|NCT01978015|prostaglandin analogues|prostaglandin analogues
230689|NCT01977976|Endometrial injury|endometrial injury
230690|NCT01977976|Pipelle|pipelle
230691|NCT01977976|Implantation|implantation
230692|NCT01977976|Ongoing pregnancy rate|ongoing pregnancy rate
230693|NCT01977976|IVF|ivf
230694|NCT01977950|Undernutrition, Nutritional risk, NRS2002, nutritional care practices, hospital, elderly patients, nursing students|undernutrition, nutritional risk, nrs2002, nutritional care practices, hospital, elderly patients, nursing students
230695|NCT01977937|gabapentin|gabapentin
230696|NCT01977937|Analgesic Drugs|analgesic drugs
230697|NCT01977937|Analgesics, Nonopioid|analgesics, nonopioid
230698|NCT01977924|sleep apnea|sleep apnea
230699|NCT01977924|polyphenols|polyphenols
230700|NCT01977924|endothelial function|endothelial function
230701|NCT01977911|Airway reconstruction|airway reconstruction
230702|NCT01977911|Regenerative medicine|regenerative medicine
230703|NCT01977898|Postdural puncture headache|postdural puncture headache
230704|NCT01977898|Intrathecal morphine|intrathecal morphine
230705|NCT01977898|Intrathecal catheter|intrathecal catheter
230706|NCT01977898|Headache|headache
230707|NCT01977898|Labor and delivery|labor and delivery
230708|NCT01977898|Unintentional dural puncture|unintentional dural puncture
230709|NCT01977885|epigenetics|epigenetics
230710|NCT01977885|obesity|obesity
230711|NCT01977885|overweight|overweight
230712|NCT01977885|high protein diet|high protein diet
230713|NCT01977885|exercise|exercise
230714|NCT01977885|post menopausal women|post menopausal women
230715|NCT01977872|Arthritis|arthritis
230716|NCT01977872|Physical Activity|physical activity
230717|NCT01977872|Diet|diet
230718|NCT01977859|B-type Natriuretic Peptide|b-type natriuretic peptide
230719|NCT01977859|Metabolism|metabolism
230720|NCT01977859|Insulin infusion|insulin infusion
230721|NCT01977846|genetic testing|genetic testing
230722|NCT01977846|ABCA4|abca4
230723|NCT01977846|Stargardt|stargardt
230724|NCT01977846|retina|retina
230725|NCT01977846|retinal degeneration|retinal degeneration
230726|NCT01977833|BTdiet|btdiet
230727|NCT01977833|Dtdiet|dtdiet
230728|NCT01977833|High Calorie Breakfast diet (BTdiet)|high calorie breakfast diet (btdiet)
230729|NCT01977833|High Calorie Dinner diet (DTdiet)|high calorie dinner diet (dtdiet)
230730|NCT01977820|Phenylketonuria|phenylketonuria
230731|NCT01977820|Sapropterin|sapropterin
230732|NCT01977820|Placebo|placebo
230733|NCT01977820|Cognitive Abilities|cognitive abilities
230734|NCT01977820|Kuvan®|kuvan®
230735|NCT01977807|Myopia|myopia
230736|NCT01977807|Hyperopia|hyperopia
230738|NCT01977807|Supracor|supracor
230739|NCT01977807|Zyoptix|zyoptix
230740|NCT01977807|Proscan|proscan
230741|NCT01977807|LASIK|lasik
230742|NCT01977794|Bisoprolol|bisoprolol
230743|NCT01977794|Amlodipine|amlodipine
230744|NCT01977794|Fixed dose combination (FDC)|fixed dose combination (fdc)
230745|NCT01977794|Systolic Blood Pressure (SBP)|systolic blood pressure (sbp)
230746|NCT01977794|Diastolic Blood Pressure (DBP)|diastolic blood pressure (dbp)
230747|NCT01977781|GVHD|gvhd
230748|NCT01977781|Ocular GVHD|ocular gvhd
230749|NCT01977781|Tacrolimus|tacrolimus
230750|NCT01977781|Methylprednisolone|methylprednisolone
230751|NCT01977768|M. vaccae|m. vaccae
230752|NCT01977768|TB|tb
230753|NCT01977768|MDR-TB|mdr-tb
230754|NCT01977768|V7-immunitor|v7-immunitor
230755|NCT01977729|anxiety|anxiety
230756|NCT01977716|Peritonitis|peritonitis
230757|NCT01977716|loss of residual renal function|loss of residual renal function
230758|NCT01977716|technique survival|technique survival
230759|NCT01977703|Heart Failure|heart failure
230760|NCT01977703|Advanced Heart Failure|advanced heart failure
230761|NCT01977703|LVAD|lvad
230762|NCT01977703|Left Ventricular Assist Device|left ventricular assist device
230763|NCT01977703|Heart-Assist Devices|heart-assist devices
230764|NCT01977664|oocyte maturation failure|oocyte maturation failure
230765|NCT01977664|Maturation induction in vitro|maturation induction in vitro
230766|NCT01977651|enzalutamide|enzalutamide
230767|NCT01977651|Xtandi|xtandi
230768|NCT01977651|seizure|seizure
230769|NCT01977651|Central Nervous System|central nervous system
230770|NCT01977651|MDV3100|mdv3100
230771|NCT01977651|metastatic castration-resistant prostate cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
230772|NCT01977638|Advanced solid tumours|advanced solid tumours
230773|NCT01977638|Lymphoma|lymphoma
230774|NCT01977638|Myeloma|myeloma
230775|NCT01977625|Menopause|menopause
230776|NCT01977625|fMRI|fmri
230777|NCT01977625|Vyvanse|vyvanse
230778|NCT01977612|Wound infection|wound infection
230779|NCT01977612|Wound separation|wound separation
230780|NCT01977612|Skin staples|skin staples
230781|NCT01977612|Subcuticular suture|subcuticular suture
230782|NCT01977599|Text message reminders|text message reminders
230783|NCT01977599|Short Message Service (SMS) Reminders|short message service (sms) reminders
231075|NCT01976585|SLL|sll
230784|NCT01977599|Social Health Inequalities|social health inequalities
230785|NCT01977599|Breast Screening|breast screening
230786|NCT01977599|Screening|screening
230787|NCT01977599|Public Health Intervention|public health intervention
230788|NCT01977599|Missed Appointments|missed appointments
230789|NCT01977599|Non-attendance|non-attendance
230790|NCT01977586|Clear cell renal cell carcinoma|clear cell renal cell carcinoma
230791|NCT01977586|Stage IV renal cell carcinoma|stage iv renal cell carcinoma
230792|NCT01977586|Anti-angiogenic therapy|anti-angiogenic therapy
230793|NCT01977586|Response assessment|response assessment
230794|NCT01977586|Magnetic resonance imaging|magnetic resonance imaging
230795|NCT01977573|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
230796|NCT01977573|pharmacokinetics|pharmacokinetics
230797|NCT01977573|GSK1278863|gsk1278863
230798|NCT01977573|Anemia|anemia
230799|NCT01977573|hemoglobin|hemoglobin
230800|NCT01977573|erythropoiesis stimulating agents|erythropoiesis stimulating agents
230801|NCT01977573|Chronic kidney disease|chronic kidney disease
230802|NCT01977560|Type 2 diabetes|type 2 diabetes
230803|NCT01977560|Exercise|exercise
230804|NCT01977560|High protein|high protein
230805|NCT01977547|Red blood cell transfusions|red blood cell transfusions
230806|NCT01977547|Red blood cell storage age|red blood cell storage age
230807|NCT01977547|Pediatrics|pediatrics
230808|NCT01977547|Critical Care|critical care
230809|NCT01977534|Bioabsorbable|bioabsorbable
230810|NCT01977534|Coronary Stent|coronary stent
230811|NCT01977534|Everolimus|everolimus
230812|NCT01977534|drug eluting stents|drug eluting stents
230813|NCT01977534|stents|stents
230814|NCT01977534|angioplasty|angioplasty
230815|NCT01977534|coronary artery disease|coronary artery disease
230816|NCT01977534|total coronary occlusion|total coronary occlusion
230817|NCT01977534|coronary artery restenosis|coronary artery restenosis
230818|NCT01977534|stent thrombosis|stent thrombosis
230819|NCT01977534|vascular disease|vascular disease
230820|NCT01977534|myocardial ischemia|myocardial ischemia
230821|NCT01977534|coronary artery stenosis|coronary artery stenosis
230822|NCT01977534|CAD|cad
230823|NCT01977534|CAOD|caod
230824|NCT01977508|Vascular access grafts|vascular access grafts
230825|NCT01977508|Haemodialysis|haemodialysis
230826|NCT01977495|Diabetes|diabetes
230827|NCT01977495|Enrollment methods|enrollment methods
230828|NCT01977495|Behavioral Economic Intervention|behavioral economic intervention
230829|NCT01977495|Opt-in Enrollment|opt-in enrollment
230830|NCT01977495|Opt-out Enrollment|opt-out enrollment
230831|NCT01977495|lottery|lottery
230832|NCT01977495|financial incentives|financial incentives
230833|NCT01977482|hemoglobin|hemoglobin
230834|NCT01977482|recombinant human erythropoietin|recombinant human erythropoietin
230835|NCT01977482|Chronic kidney disease|chronic kidney disease
230836|NCT01977482|hemodialysis|hemodialysis
230837|NCT01977482|pharmacokinetics|pharmacokinetics
230838|NCT01977482|erythropoiesis stimulating agents|erythropoiesis stimulating agents
230839|NCT01977482|Anemia|anemia
230840|NCT01977482|GSK1278863|gsk1278863
230841|NCT01977469|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
230842|NCT01977469|Activities of Daily Living|activities of daily living
230843|NCT01977469|Mortality|mortality
230844|NCT01977469|Strength Training|strength training
230845|NCT01977456|acute ischemic stroke|acute ischemic stroke
230846|NCT01977456|stroke|stroke
230847|NCT01977456|rt-PA, thrombolytic|rt-pa, thrombolytic
230848|NCT01977456|t-PA|t-pa
230849|NCT01977456|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
230850|NCT01977456|Activase|activase
230851|NCT01977456|eptifibatide|eptifibatide
230852|NCT01977456|Integrilin|integrilin
230853|NCT01977456|fibrinolytic agents|fibrinolytic agents
230854|NCT01977456|clot dissolving|clot dissolving
230855|NCT01977456|blood clot|blood clot
230856|NCT01977430|Residual renal function|residual renal function
230857|NCT01977430|Combined thiazide-furosemide therapy|combined thiazide-furosemide therapy
230858|NCT01977430|Haemodialysis|haemodialysis
230859|NCT01977417|Endothelial Function|endothelial function
230860|NCT01977417|Arterial Stiffness|arterial stiffness
230861|NCT01977417|Inflammation|inflammation
230862|NCT01977417|Muscle Sympathetic Nervous System|muscle sympathetic nervous system
230863|NCT01977417|Prediabetes|prediabetes
230864|NCT01977417|Autonomic function|autonomic function
230865|NCT01977404|Congestive heart failure|congestive heart failure
230866|NCT01977404|Energy expenditure|energy expenditure
230867|NCT01977404|Body composition|body composition
230868|NCT01977404|Caloric intake|caloric intake
230869|NCT01977365|Cluster Randomized Trial,|cluster randomized trial,
230870|NCT01977365|Nutrition counseling,|nutrition counseling,
230871|NCT01977365|Caretaker's knowledge|caretaker's knowledge
230872|NCT01977365|Child growth,|child growth,
230873|NCT01977365|Prevention,|prevention,
230874|NCT01977365|Acute malnutrition|acute malnutrition
230875|NCT01977352|Exparel|exparel
230876|NCT01977352|Liposomal Bupivacaine|liposomal bupivacaine
230877|NCT01977352|Arthroscopic Shoulder Surgery|arthroscopic shoulder surgery
230878|NCT01977339|Femoral Nerve Block|femoral nerve block
230879|NCT01977339|Liposomal Bupivacaine|liposomal bupivacaine
230880|NCT01977326|task sharing|task sharing
230881|NCT01977326|task shifting|task shifting
230882|NCT01977326|prenatal depression|prenatal depression
221594|NCT02019511|Steroid|steroid
221595|NCT02019511|Fast-track|fast-track
221596|NCT02019511|Total knee arthroplasty|total knee arthroplasty
221597|NCT02019511|Safety|safety
221598|NCT02019498|low back pain|low back pain
221599|NCT02019498|relaxation|relaxation
221600|NCT02019485|Healthy|healthy
230883|NCT01977326|counselling|counselling
230884|NCT01977326|lay health workers|lay health workers
230885|NCT01977287|Multiple Sclerosis|multiple sclerosis
230886|NCT01977287|Functional Electrical Stimulation|functional electrical stimulation
230887|NCT01977287|Ankle Foot Orthosis|ankle foot orthosis
230888|NCT01977287|Walking performance|walking performance
230889|NCT01977287|gait analysis|gait analysis
230890|NCT01977287|fatigue|fatigue
230891|NCT01977287|activity monitoring|activity monitoring
230892|NCT01977274|ovarian, endometrium, cervix cancer|ovarian, endometrium, cervix cancer
687915|NCT00912964|Mirabegron|mirabegron
230893|NCT01977235|Irinotecan; Cisplatin; Small-cell lung cancer; UGT1A1|irinotecan; cisplatin; small-cell lung cancer; ugt1a1
230894|NCT01977209|NSCLC; Gossypol; APE1; Chemotherapy|nsclc; gossypol; ape1; chemotherapy
230895|NCT01977196|DTB/HB/Hib vaccine|dtb/hb/hib vaccine
230896|NCT01977196|Infants|infants
230897|NCT01977196|Phase I|phase i
230898|NCT01977183|gastrointestinal|gastrointestinal
230899|NCT01977183|microbiome|microbiome
230900|NCT01977183|prebiotic|prebiotic
230901|NCT01977183|starch|starch
230902|NCT01977170|Adults|adults
230903|NCT01977170|Hib vaccines|hib vaccines
230904|NCT01977170|Immunogenicity|immunogenicity
230905|NCT01977170|Safety|safety
230906|NCT01977157|Impedance cardiography|impedance cardiography
230907|NCT01977157|bioimpedance|bioimpedance
230908|NCT01977157|spectroscopy|spectroscopy
230909|NCT01977157|extracellular resistance|extracellular resistance
230910|NCT01977157|body composition|body composition
230911|NCT01977157|hemodynamics|hemodynamics
230912|NCT01977157|alcohol|alcohol
230913|NCT01977144|Single Embryo Transfer|single embryo transfer
230914|NCT01977144|Double Embryo Transfer|double embryo transfer
230915|NCT01977144|CCS (Comprehensive Chromosome Screening)|ccs (comprehensive chromosome screening)
230916|NCT01977144|Aneuploidy|aneuploidy
230917|NCT01977144|Low Responders|low responders
230918|NCT01977118|Streptokinase|streptokinase
230919|NCT01977118|Percutaneous catheter drainage|percutaneous catheter drainage
230920|NCT01977118|Pancreatic necrosis|pancreatic necrosis
230921|NCT01977118|peripancreatic necrosis|peripancreatic necrosis
230922|NCT01977105|Infants|infants
230923|NCT01977105|Mothers|mothers
230924|NCT01977105|Social media|social media
230925|NCT01977105|Obesity prevention|obesity prevention
230926|NCT01977092|sober living houses|sober living houses
230927|NCT01977092|HIV|hiv
230928|NCT01977092|alcohol and drugs|alcohol and drugs
230929|NCT01977079|pregnancy|pregnancy
230930|NCT01977079|premature birth|premature birth
230931|NCT01977079|procalcitonin|procalcitonin
230932|NCT01977066|pancreatic cancer|pancreatic cancer
230933|NCT01977066|exercise training|exercise training
230934|NCT01977066|quality of life|quality of life
230935|NCT01977066|physical functioning|physical functioning
230936|NCT01977053|breast cancer|breast cancer
230937|NCT01977053|colon cancer|colon cancer
230938|NCT01977053|rectal cancer|rectal cancer
230939|NCT01977053|adjuvant chemotherapy|adjuvant chemotherapy
230940|NCT01977053|phone calls|phone calls
230941|NCT01977053|emotional states|emotional states
230942|NCT01977053|quality of life|quality of life
230943|NCT01977040|Vasa Previa|vasa previa
230944|NCT01977027|Rehabilitation|rehabilitation
230945|NCT01977027|Fingers|fingers
230946|NCT01977027|Grasp|grasp
230947|NCT01977027|Strength|strength
230948|NCT01977027|Hand Function|hand function
230949|NCT01977027|Motor Function|motor function
230950|NCT01977027|Post Stroke|post stroke
230951|NCT01977027|Brain Infraction|brain infraction
230952|NCT01977027|Biomechanis|biomechanis
230953|NCT01977027|Neuronal Plasticity|neuronal plasticity
230954|NCT01977027|Weight-Bearing|weight-bearing
230955|NCT01977001|Primary headache|primary headache
230956|NCT01977001|Headache|headache
230957|NCT01977001|MigraineBox|migrainebox
230958|NCT01976975|Depression|depression
230959|NCT01976975|Major Depressive Disorder|major depressive disorder
230960|NCT01976975|Bipolar Disorder|bipolar disorder
230961|NCT01976975|Mania|mania
230962|NCT01976975|Hypomania|hypomania
230963|NCT01976975|EEG|eeg
230964|NCT01976975|MRI|mri
230965|NCT01976975|Reward|reward
230966|NCT01976962|Prostatic neoplasms|prostatic neoplasms
230967|NCT01976962|Radiotherapy|radiotherapy
230968|NCT01976962|Dose fractionation|dose fractionation
230969|NCT01976962|Magnetic resonance imaging|magnetic resonance imaging
402970|NCT01228825|Antibiotic prophylaxis|antibiotic prophylaxis
402971|NCT01228825|Cefuroxime|cefuroxime
230970|NCT01976949|Cancer, social-networking intervention, cancer-related distress, internet health services, intervention delivery|cancer, social-networking intervention, cancer-related distress, internet health services, intervention delivery
230971|NCT01976936|Stroke|stroke
230972|NCT01976936|Rhabdomyolysis|rhabdomyolysis
230973|NCT01976936|Jaundice|jaundice
230974|NCT01976923|Intravitreal Bevacizumab|intravitreal bevacizumab
230975|NCT01976923|Tractional Retinal Detachment|tractional retinal detachment
230976|NCT01976923|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
230977|NCT01976923|Small gauge pars plana vitrectomy|small gauge pars plana vitrectomy
230978|NCT01976923|Intraoperative bleeding|intraoperative bleeding
230979|NCT01976923|Post-operative vitreous hemorrhage|post-operative vitreous hemorrhage
230980|NCT01976923|Visual acuity|visual acuity
230981|NCT01976910|Glioblastoma multiforme|glioblastoma multiforme
230982|NCT01976910|Advanced cancers|advanced cancers
230983|NCT01976910|Brain Neoplasms, Malignant, Primary|brain neoplasms, malignant, primary
230984|NCT01976910|Brain Tumor, Recurrent|brain tumor, recurrent
230985|NCT01976910|Advanced cancer|advanced cancer
230986|NCT01976897|heel - mattress pressure interface|heel - mattress pressure interface
230987|NCT01976897|flexion|flexion
230988|NCT01976897|knee angular position|knee angular position
230989|NCT01976884|sepsis|sepsis
687916|NCT00912964|YM178|ym178
230990|NCT01976884|immunosuppression|immunosuppression
230991|NCT01976884|PD-L1|pd-l1
230992|NCT01976871|Restless Legs Syndrome|restless legs syndrome
230993|NCT01976871|Ekbom Syndrome|ekbom syndrome
230994|NCT01976871|Willis-Ekbom Disease|willis-ekbom disease
230995|NCT01976871|Rotigotine|rotigotine
230996|NCT01976871|Neupro|neupro
230997|NCT01976871|Dopamine Agonist|dopamine agonist
230998|NCT01976858|PEX168, diabetes, phase I|pex168, diabetes, phase i
230999|NCT01976845|propofol|propofol
231000|NCT01976845|midazolam|midazolam
231001|NCT01976845|sedative|sedative
231002|NCT01976845|anxiolytic|anxiolytic
231003|NCT01976845|amnesic|amnesic
231004|NCT01976845|recall|recall
231005|NCT01976845|Memory|memory
231006|NCT01976845|Perioperative outcomes|perioperative outcomes
231007|NCT01976819|Tracheotomy|tracheotomy
231008|NCT01976819|Tracheostomy|tracheostomy
231009|NCT01976819|Speaking valve|speaking valve
231010|NCT01976819|HME|hme
231011|NCT01976819|patients|patients
231012|NCT01976806|Docosahexaenoic acid|docosahexaenoic acid
231013|NCT01976806|DHA|dha
231014|NCT01976806|Periodontitis|periodontitis
231015|NCT01976806|Gingivitis|gingivitis
231016|NCT01976806|Omega-3 fatty acid|omega-3 fatty acid
231017|NCT01976806|Fish oil|fish oil
231018|NCT01976793|Recurrent depressive disorder|recurrent depressive disorder
231019|NCT01976793|Depression|depression
231020|NCT01976793|Depressive episode|depressive episode
231021|NCT01976793|Atypical antipsychotics|atypical antipsychotics
231022|NCT01976780|Malaria|malaria
231023|NCT01976780|P. falciparum mono infection|p. falciparum mono infection
231024|NCT01976780|Early Treatment Failure|early treatment failure
231025|NCT01976780|Late Treatment Failure|late treatment failure
231026|NCT01976767|Sputum|sputum
231027|NCT01976767|Clinical cohorts|clinical cohorts
231028|NCT01976767|Smokers|smokers
231029|NCT01976767|Asthma|asthma
231030|NCT01976767|Biopsies|biopsies
231031|NCT01976767|Severe asthma|severe asthma
231032|NCT01976767|Collaborative research|collaborative research
231033|NCT01976767|Phenotyping|phenotyping
231034|NCT01976767|Lipidomics|lipidomics
231035|NCT01976767|Transcriptomics|transcriptomics
231036|NCT01976767|Proteomics|proteomics
231037|NCT01976767|Paediatric cohort|paediatric cohort
231038|NCT01976767|Systems Biology|systems biology
231039|NCT01976741|Phase I|phase i
231040|NCT01976741|Dose escalation|dose escalation
231041|NCT01976741|refractory, locally advanced or metastatic solid tumor|refractory, locally advanced or metastatic solid tumor
231042|NCT01976741|Bladder cancer|bladder cancer
231043|NCT01976741|squamous non-small cell lung cancer|squamous non-small cell lung cancer
231044|NCT01976741|pan-FGFR inhibitor|pan-fgfr inhibitor
231045|NCT01976741|lung adenocarcinoma|lung adenocarcinoma
231046|NCT01976741|head and neck cancer|head and neck cancer
231047|NCT01976715|HIV|hiv
231048|NCT01976715|Treatment Failure|treatment failure
231049|NCT01976715|Drug Resistance|drug resistance
231050|NCT01976702|HIV risk behaviors|hiv risk behaviors
231051|NCT01976702|Pregnant drug abusers|pregnant drug abusers
231052|NCT01976689|Glucose Regulation|glucose regulation
231053|NCT01976689|Left Ventricular Hypertrophy|left ventricular hypertrophy
231054|NCT01976689|New-onset Diabetes|new-onset diabetes
231055|NCT01976689|Renal Transplantation|renal transplantation
231056|NCT01976598|chronic|chronic
231057|NCT01976598|back|back
231059|NCT01976598|pain|pain
231060|NCT01976598|sub-sensory|sub-sensory
231061|NCT01976598|stimulation|stimulation
231062|NCT01976598|Neuromodulation|neuromodulation
231063|NCT01976598|Yearwood|yearwood
231064|NCT01976585|Intratumoral injections|intratumoral injections
231065|NCT01976585|rhuFlt3L|rhuflt3l
231066|NCT01976585|Flt3L|flt3l
231067|NCT01976585|CDX-301|cdx-301
231068|NCT01976585|Vaccine|vaccine
231069|NCT01976585|Poly-ICLC|poly-iclc
231070|NCT01976585|iNHL|inhl
231071|NCT01976585|TLR3|tlr3
231072|NCT01976585|Low-Grade B-cell Lymphoma|low-grade b-cell lymphoma
231073|NCT01976585|Follicular|follicular
231074|NCT01976585|Marginal Zone|marginal zone
231076|NCT01976585|Small lymphocytic|small lymphocytic
231077|NCT01976572|CKD Stage V|ckd stage v
231078|NCT01976572|dialysis|dialysis
231079|NCT01976559|ICP|icp
231080|NCT01976559|Intracranial pressure|intracranial pressure
231081|NCT01976559|Hydrocephalus|hydrocephalus
231082|NCT01976559|Idiopathic normal pressure hydrocephalus|idiopathic normal pressure hydrocephalus
231083|NCT01976559|CSF|csf
231084|NCT01976559|Cerebrospinal fluid|cerebrospinal fluid
231085|NCT01976559|Noninvasive ICP|noninvasive icp
231086|NCT01976520|Cancer vaccine|cancer vaccine
231087|NCT01976520|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
231088|NCT01976520|CLL|cll
231089|NCT01976520|Autologous vaccine|autologous vaccine
231090|NCT01976520|B cell leukemia|b cell leukemia
231091|NCT01976494|Patient controlled analgesia equipment|patient controlled analgesia equipment
231092|NCT01976494|efficacy|efficacy
231093|NCT01976494|safety|safety
231094|NCT01976494|Accufuser Omnibus®|accufuser omnibus®
231095|NCT01976494|Upper abdominal surgery|upper abdominal surgery
231096|NCT01976494|laparotomy|laparotomy
231097|NCT01976455|obesity|obesity
231098|NCT01976455|carbon13|carbon13
231099|NCT01976455|over-eating|over-eating
231100|NCT01976455|metabolic chamber|metabolic chamber
231101|NCT01976455|room calorimeter|room calorimeter
231102|NCT01976442|Leukemia|leukemia
231103|NCT01976442|Transfusion|transfusion
231104|NCT01976429|barotrauma|barotrauma
231105|NCT01976429|barotitis|barotitis
231106|NCT01976429|middle ear|middle ear
231107|NCT01976429|flying|flying
231108|NCT01976429|diving|diving
231109|NCT01976429|Eustachian tube|eustachian tube
231110|NCT01976416|Hydroxyurea|hydroxyurea
231111|NCT01976390|Kidney|kidney
231112|NCT01976390|Kidney transplant|kidney transplant
231113|NCT01976390|Renal failure|renal failure
231114|NCT01976390|End Stage Renal Disease|end stage renal disease
231115|NCT01976390|kidney transplant recipient|kidney transplant recipient
231116|NCT01976364|Tofacitinib|tofacitinib
231117|NCT01976364|Psoriatic Arthritis|psoriatic arthritis
231118|NCT01976364|Xeljanz|xeljanz
231119|NCT01976364|CP-690550|cp-690550
231120|NCT01976364|Jak-inhibitor|jak-inhibitor
231121|NCT01976364|oral treatment|oral treatment
231122|NCT01976364|psoriasis|psoriasis
231123|NCT01976364|OPAL BALANCE|opal balance
231124|NCT01976364|methotrexate|methotrexate
231125|NCT01976364|pruritus|pruritus
231126|NCT01976364|itch|itch
231127|NCT01976364|DLQI|dlqi
231128|NCT01976351|Barrett's esophagus|barrett's esophagus
231129|NCT01976351|image-enhanced endoscopy|image-enhanced endoscopy
231130|NCT01976338|BRVO|brvo
231131|NCT01976338|macular edema|macular edema
231132|NCT01976338|vision impairment|vision impairment
231133|NCT01976338|retinal vein occlusion|retinal vein occlusion
231134|NCT01976338|ranibizumab|ranibizumab
231135|NCT01976338|branch retinal vein occlusion|branch retinal vein occlusion
231136|NCT01976338|anti-VEGF therapy|anti-vegf therapy
231137|NCT01976338|RFB002|rfb002
231138|NCT01976325|decision aid|decision aid
231139|NCT01976325|imported malaria|imported malaria
231140|NCT01976325|malaria prevention and control|malaria prevention and control
231141|NCT01976325|malaria chemoprophylaxis|malaria chemoprophylaxis
231143|NCT01976325|lariam|lariam
231144|NCT01976325|atovaquone-proguanil|atovaquone-proguanil
231145|NCT01976325|malarone|malarone
231146|NCT01976325|doxycycline|doxycycline
231147|NCT01976325|vibramycin|vibramycin
231148|NCT01976312|CRVO, macular edema, vision impairment, retinal vein occlusion, ranibizumab|crvo, macular edema, vision impairment, retinal vein occlusion, ranibizumab
231149|NCT01976221|Comprehensive referrals|comprehensive referrals
231150|NCT01976221|Appropriate referring|appropriate referring
231151|NCT01976221|Priority setting|priority setting
231152|NCT01976221|Waiting time in hospital|waiting time in hospital
231153|NCT01976208|Omalizumab|omalizumab
231154|NCT01976208|IgE|ige
231155|NCT01976208|Asthma|asthma
231156|NCT01976195|Thalidomide|thalidomide
231157|NCT01976195|Dexamethasone|dexamethasone
231158|NCT01976195|ITP|itp
231159|NCT01976182|large granular lymphocytes leukemia|large granular lymphocytes leukemia
231160|NCT01976182|immunosuppressive drugs|immunosuppressive drugs
231161|NCT01976182|methotrexate|methotrexate
231162|NCT01976182|cyclophosphamide|cyclophosphamide
231163|NCT01976182|efficiency|efficiency
231164|NCT01976182|phase II randomized controlled trial|phase ii randomized controlled trial
231165|NCT01976169|Breast Cancer|breast cancer
231166|NCT01976169|Advanced Breast Cancer|advanced breast cancer
231167|NCT01976104|Thrombocytopenia|thrombocytopenia
231168|NCT01976104|Chronic Liver Disease|chronic liver disease
231169|NCT01976091|limb girdle muscular dystrophy|limb girdle muscular dystrophy
231170|NCT01976091|LGMD2D|lgmd2d
231171|NCT01976091|alpha-sarcoglycan|alpha-sarcoglycan
231172|NCT01976091|gene transfer|gene transfer
231173|NCT01976091|adeno-associated virus|adeno-associated virus
231174|NCT01976078|Voriconazole|voriconazole
231175|NCT01976078|Pharmacokinetics|pharmacokinetics
231176|NCT01976078|Ontogeny|ontogeny
231177|NCT01976078|Modeling|modeling
231178|NCT01976078|Bayesian|bayesian
231179|NCT01976065|Necrotic tooth pulp|necrotic tooth pulp
231180|NCT01976065|Immature permanent teeth|immature permanent teeth
231181|NCT01976065|Regeneration|regeneration
231182|NCT01976052|Biomarkers|biomarkers
231183|NCT01976052|Genomics|genomics
231184|NCT01976039|motorcyclist|motorcyclist
231185|NCT01976039|nasal mucociliary clearance|nasal mucociliary clearance
231186|NCT01976039|physical therapy|physical therapy
231187|NCT01976026|Flow Diversion|flow diversion
231188|NCT01976026|Aneurysm|aneurysm
231189|NCT01976026|Intracranial|intracranial
231190|NCT01976026|Cerebral|cerebral
231191|NCT01976026|Vertebral|vertebral
231192|NCT01976026|blood blister-like|blood blister-like
231193|NCT01976026|ruptured aneurysm|ruptured aneurysm
231194|NCT01976026|Pipeline Flow Diversion|pipeline flow diversion
231195|NCT01976026|Pipeline Flow Diverter|pipeline flow diverter
688014|NCT00921102|Antiemetics|antiemetics
231196|NCT01976026|Best-Standard Treatment|best-standard treatment
231197|NCT01976013|PT|pt
231198|NCT01976013|INR|inr
231199|NCT01976013|intraventricular haemorrhage|intraventricular haemorrhage
231200|NCT01976013|pulmonary haemorrhage|pulmonary haemorrhage
231201|NCT01976013|ELBW infants|elbw infants
231202|NCT01975987|Intubation|intubation
231203|NCT01975987|Bonfils fiberscope|bonfils fiberscope
231204|NCT01975974|vascular|vascular
231205|NCT01975974|access|access
231206|NCT01975974|ultrasound|ultrasound
231207|NCT01975948|Mental Health|mental health
231208|NCT01975948|Education and Practice Support Program|education and practice support program
231209|NCT01975948|Depression|depression
231210|NCT01975948|Primary Care|primary care
231211|NCT01975948|Skill-based training|skill-based training
231212|NCT01975948|Patient centered outcomes|patient centered outcomes
231213|NCT01975935|diabetes mellitus type 2|diabetes mellitus type 2
231214|NCT01975935|non-alcoholic fatt liver disease|non-alcoholic fatt liver disease
231215|NCT01975935|obesity|obesity
231216|NCT01975922|language impairment|language impairment
231217|NCT01975922|language disorder|language disorder
231218|NCT01975922|language delay|language delay
231219|NCT01975922|late talkers|late talkers
231220|NCT01975922|late talking|late talking
231221|NCT01975909|Spinocerebellar Ataxia|spinocerebellar ataxia
231222|NCT01975909|SCA|sca
231223|NCT01975909|Ataxia|ataxia
231224|NCT01975909|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
231225|NCT01975909|TMS|tms
231226|NCT01975883|Blood Glucose|blood glucose
231227|NCT01975883|Postoperative Complications|postoperative complications
231228|NCT01975883|Spine|spine
231229|NCT01975883|Orthopedic surgery|orthopedic surgery
231230|NCT01975870|Sedentary behavior, smartphone, application|sedentary behavior, smartphone, application
231231|NCT01975857|mild traumatic brain injury|mild traumatic brain injury
231232|NCT01975857|sleep|sleep
231233|NCT01975857|mind body intervention|mind body intervention
231234|NCT01975857|mind body bridging|mind body bridging
231235|NCT01975844|Anemia|anemia
231236|NCT01975844|End Stage Renal Disease|end stage renal disease
231237|NCT01975831|Non Triple Negative Breast Cancer|non triple negative breast cancer
231238|NCT01975818|Anemia of CKD on dialysis|anemia of ckd on dialysis
231239|NCT01975805|cesarean delivery|cesarean delivery
231240|NCT01975805|chlorhexidine|chlorhexidine
231241|NCT01975805|iodine|iodine
231242|NCT01975805|skin disinfectant|skin disinfectant
231243|NCT01975792|PPROM|pprom
231244|NCT01975792|Pregnant|pregnant
231245|NCT01975792|Preterm|preterm
231246|NCT01975792|Premature, labor|premature, labor
231247|NCT01975766|Carcinoma, squamous cell of head and neck|carcinoma, squamous cell of head and neck
231248|NCT01975766|Head and neck cancer|head and neck cancer
231249|NCT01975766|ketogenic diet|ketogenic diet
231250|NCT01975766|radiotherapy|radiotherapy
231251|NCT01975766|cisplatin|cisplatin
231252|NCT01975753|pain|pain
231253|NCT01975727|PONV|ponv
231254|NCT01975727|Dexamethasone|dexamethasone
231255|NCT01975727|Treatment|treatment
231256|NCT01975714|Glaucoma|glaucoma
232154|NCT01971515|Tamoxifen|tamoxifen
231257|NCT01975714|Ocular hypertension|ocular hypertension
231258|NCT01975714|Preservative-free prostaglandins|preservative-free prostaglandins
231259|NCT01975701|BGJ398,|bgj398,
231260|NCT01975701|recurrent glioblastoma'|recurrent glioblastoma'
231261|NCT01975701|recurrent GBM,|recurrent gbm,
231262|NCT01975701|FGFR,|fgfr,
231263|NCT01975662|MRSA|mrsa
231264|NCT01975662|bacteremia|bacteremia
231265|NCT01975662|vancomycin|vancomycin
231266|NCT01975662|daptomycin|daptomycin
231267|NCT01975649|postmenopausal|postmenopausal
231268|NCT01975649|hypoactive|hypoactive
231269|NCT01975649|sexual disorder|sexual disorder
231270|NCT01975649|androgen|androgen
231271|NCT01975636|Metabolism and Elimination|metabolism and elimination
231272|NCT01975623|Video assisted thoracoscopic surgery (VATS)|video assisted thoracoscopic surgery (vats)
231273|NCT01975610|Arthritis, Rheumatoid, Autoimmune, Inflammatory, Synovial, Bruton's tyrosine kinase (Btk), CC-292, Joint Disease|arthritis, rheumatoid, autoimmune, inflammatory, synovial, bruton's tyrosine kinase (btk), cc-292, joint disease
231274|NCT01975571|residual hearing|residual hearing
231275|NCT01975571|hybrid|hybrid
231276|NCT01975571|hearing preservation|hearing preservation
231277|NCT01975545|Down syndrome|down syndrome
231278|NCT01975545|Caries|caries
231279|NCT01975545|Dental varnish|dental varnish
231280|NCT01975519|TRC105|trc105
231281|NCT01975519|CD105|cd105
231282|NCT01975519|Endoglin|endoglin
231283|NCT01975519|Angiogenesis Inhibitor|angiogenesis inhibitor
231284|NCT01975519|STS|sts
231285|NCT01975519|Soft Tissue Sarcoma|soft tissue sarcoma
231286|NCT01975519|TKI|tki
231287|NCT01975519|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
231288|NCT01975519|Pazopanib|pazopanib
231289|NCT01975519|Votrient|votrient
231290|NCT01975519|Advanced Soft Tissue Sarcoma|advanced soft tissue sarcoma
231291|NCT01975519|Angiosarcoma|angiosarcoma
231292|NCT01975506|Head Start|head start
231293|NCT01975506|Occupational Therapy|occupational therapy
231294|NCT01975493|Infectious Diseases|infectious diseases
231295|NCT01975493|Paediatrics|paediatrics
231296|NCT01975493|Neonatology|neonatology
231297|NCT01975493|Pharmacokinetics|pharmacokinetics
231298|NCT01975493|Antimicrobials|antimicrobials
231299|NCT01975467|midshaft clavicle fracture|midshaft clavicle fracture
231300|NCT01975467|intramedullary nail|intramedullary nail
231301|NCT01975467|sling|sling
231302|NCT01975454|Metastatic colorectal cancer|metastatic colorectal cancer
231303|NCT01975454|Chemotherapy|chemotherapy
231304|NCT01975454|Traditional Chinese Medicine (TCM)|traditional chinese medicine (tcm)
231305|NCT01975454|Teng-Long-Bu-Zhong-Tang|teng-long-bu-zhong-tang
231306|NCT01975441|Diethycarbamazine|diethycarbamazine
231307|NCT01975441|Albendazole|albendazole
231308|NCT01975441|Ivermectin|ivermectin
231309|NCT01975441|Lymphatic filariasis|lymphatic filariasis
231310|NCT01975415|Meditation|meditation
231311|NCT01975415|Sensors|sensors
231312|NCT01975415|Digital medicine|digital medicine
231313|NCT01975402|Congestive Heart Failure|congestive heart failure
231314|NCT01975389|myocardial infarction|myocardial infarction
231315|NCT01975389|stroke|stroke
231316|NCT01975389|hyperlipidemia|hyperlipidemia
231317|NCT01975376|myocardial infarction|myocardial infarction
231318|NCT01975376|stroke|stroke
231319|NCT01975376|hyperlipidemia|hyperlipidemia
231320|NCT01975363|Breast Cancer|breast cancer
231321|NCT01975350|Colistimethate sodium inhalation|colistimethate sodium inhalation
231322|NCT01975324|Ampyra|ampyra
231323|NCT01975324|NAION|naion
231324|NCT01975324|Dalfampridine|dalfampridine
231325|NCT01975298|RRMS|rrms
231326|NCT01975285|Pain management|pain management
231327|NCT01975285|Postoperative opioid requirements|postoperative opioid requirements
231328|NCT01975285|Perioperative outcomes|perioperative outcomes
231329|NCT01975285|Dexamethasone|dexamethasone
231330|NCT01975285|Anesthetic adjuvant|anesthetic adjuvant
231331|NCT01975285|Analgesic adjuvant|analgesic adjuvant
231332|NCT01975272|postoperative|postoperative
231333|NCT01975272|anemia|anemia
231334|NCT01975272|gynaecologic|gynaecologic
231335|NCT01975272|surgery|surgery
231336|NCT01975233|Endovascular|endovascular
231337|NCT01975233|Brain Aneurysm|brain aneurysm
751900|NCT01171131|Brain Injury|brain injury
231338|NCT01975181|cardiovascular disease risk factors|cardiovascular disease risk factors
231339|NCT01975181|cardiovascular disease prevention|cardiovascular disease prevention
231340|NCT01975168|laser acupuncture|laser acupuncture
231341|NCT01975168|obesity|obesity
231342|NCT01975155|Celiac disease|celiac disease
231343|NCT01975155|Gluten free diet nutrient content|gluten free diet nutrient content
231344|NCT01975155|mycotoxins|mycotoxins
231345|NCT01975155|Gluten free diet|gluten free diet
231346|NCT01975142|Metastatic breast cancer|metastatic breast cancer
231347|NCT01975142|Primary tumor HER2 negative|primary tumor her2 negative
231348|NCT01975142|CTC HER2 positive|ctc her2 positive
231349|NCT01975077|patients with mCRC who failed 2nd therapy or more|patients with mcrc who failed 2nd therapy or more
231350|NCT01975064|Breast neoplasms|breast neoplasms
231351|NCT01975064|Colonic neoplasms|colonic neoplasms
231352|NCT01975064|Rectal neoplasms|rectal neoplasms
231353|NCT01975051|Kala- azar|kala- azar
231354|NCT01975051|PKDL|pkdl
231355|NCT01975051|Treatment|treatment
231361|NCT01975038|Skin Diseases|skin diseases
231362|NCT01975025|Renal Dialysis|renal dialysis
231364|NCT01974999|Transplant|transplant
231365|NCT01974999|Rejection|rejection
231366|NCT01974986|dehydration|dehydration
231367|NCT01974986|exercise|exercise
231368|NCT01974986|rehydration|rehydration
231369|NCT01974986|sodium|sodium
231370|NCT01974986|water|water
231371|NCT01974986|carbohydrate|carbohydrate
231372|NCT01974973|autism spectrum disorders|autism spectrum disorders
231373|NCT01974973|stem cells|stem cells
222144|NCT02016833|HPV|hpv
231374|NCT01974947|Metabolic syndrome|metabolic syndrome
231375|NCT01974947|Epigenetic|epigenetic
231376|NCT01974947|Male infertility|male infertility
231377|NCT01974947|Sperm parameters|sperm parameters
231378|NCT01974947|Biomarkers|biomarkers
231379|NCT01974921|Asthma|asthma
231380|NCT01974921|Bronchial Thermoplasty|bronchial thermoplasty
231381|NCT01974921|Bronchial smooth muscle|bronchial smooth muscle
231382|NCT01974908|Ventricular Tachycardia|ventricular tachycardia
231383|NCT01974895|Children|children
231384|NCT01974895|Immunogenicity|immunogenicity
231385|NCT01974895|Fluzone®|fluzone®
231386|NCT01974895|6 to 35 months of age|6 to 35 months of age
231387|NCT01974895|Seasonal influenza|seasonal influenza
231388|NCT01974895|Safety|safety
231389|NCT01974882|abdominal surgery|abdominal surgery
231390|NCT01974882|cryotherapy|cryotherapy
231391|NCT01974882|pain score|pain score
231392|NCT01974882|narcotic utilization|narcotic utilization
231393|NCT01974869|Surgery,Crohn's disease,Ulcerative colitis|surgery,crohn's disease,ulcerative colitis
231394|NCT01974830|alpha-1|alpha-1
231395|NCT01974830|anti-trypsin|anti-trypsin
231396|NCT01974830|pulmonary function|pulmonary function
231397|NCT01974830|augmentation therayp|augmentation therayp
231398|NCT01974830|home care|home care
231399|NCT01974817|pneumococcal vaccine|pneumococcal vaccine
231405|NCT01974765|Enzalutamide|enzalutamide
231406|NCT01974765|Androgen Receptor Positive (AR+)|androgen receptor positive (ar+)
231407|NCT01974765|13-119|13-119
231408|NCT01974752|uveal melanoma|uveal melanoma
231409|NCT01974739|intensive care|intensive care
231410|NCT01974739|diuretics|diuretics
231411|NCT01974726|ear|ear
231412|NCT01974726|middle ear|middle ear
231413|NCT01974726|Eustachian tube|eustachian tube
231414|NCT01974726|Eustachian tube dysfunction|eustachian tube dysfunction
231415|NCT01974726|Eustachian tube function|eustachian tube function
231420|NCT01974687|Hepatitis C virus|hepatitis c virus
231421|NCT01974687|HCV|hcv
231422|NCT01974674|diabetes|diabetes
231423|NCT01974674|transplantation|transplantation
231424|NCT01974648|Laryngeal Mask Airway Supreme|laryngeal mask airway supreme
231425|NCT01974648|propofol|propofol
231426|NCT01974648|remifentanil|remifentanil
231427|NCT01974648|effective dose of intravenous propofol|effective dose of intravenous propofol
231428|NCT01974648|ED50|ed50
231429|NCT01974635|Spinal Cord Injury|spinal cord injury
231430|NCT01974635|Robotic therapy|robotic therapy
231431|NCT01974635|Rehabilitation|rehabilitation
231432|NCT01974635|Sensation|sensation
231433|NCT01974635|Movement|movement
231434|NCT01974635|Proprioception|proprioception
231435|NCT01974635|Stroke|stroke
231436|NCT01974635|Acquired Brain Injury|acquired brain injury
231442|NCT01974596|Dental implants|dental implants
231443|NCT01974596|Probiotics|probiotics
231444|NCT01974596|Lactobacillus reuteri|lactobacillus reuteri
231445|NCT01974596|Periimplant mucositis|periimplant mucositis
231446|NCT01974596|Cytokines|cytokines
231447|NCT01974596|Bacterial load|bacterial load
231448|NCT01974583|the split-thickness skin graft （STSG） donor site|the split-thickness skin graft （stsg） donor site
231449|NCT01974583|regraft|regraft
231450|NCT01974583|wound healing|wound healing
231451|NCT01974570|Prehypertension|prehypertension
231452|NCT01974570|Hypertension|hypertension
231453|NCT01974570|Shrimp protein hydrolysate|shrimp protein hydrolysate
231454|NCT01974570|Marine protein hydrolysate|marine protein hydrolysate
231455|NCT01974570|Ambulatory blood pressure|ambulatory blood pressure
231456|NCT01974570|Blood pressure|blood pressure
231457|NCT01974557|Cardiac physiology|cardiac physiology
231458|NCT01974557|ageing|ageing
231465|NCT01974518|Pemphigus|pemphigus
231466|NCT01974518|Rituximab|rituximab
231467|NCT01974518|Rituximab and IV cyclophosphamide combination|rituximab and iv cyclophosphamide combination
231468|NCT01974518|B cell re-population characteristics following Rituximab|b cell re-population characteristics following rituximab
231469|NCT01974492|saphenous vein graft|saphenous vein graft
231470|NCT01974492|composite graft|composite graft
231471|NCT01974492|coronary artery bypass grafting|coronary artery bypass grafting
231472|NCT01974492|graft remodeling|graft remodeling
231473|NCT01974479|Redirected Natural Killer Cells|redirected natural killer cells
231474|NCT01974479|Haploidentical Cell Therapy|haploidentical cell therapy
231475|NCT01974466|pancreatitis|pancreatitis
231476|NCT01974466|resuscitation goal|resuscitation goal
231477|NCT01974453|Radiation dose, transradial approach, percutaneous coronary interventions, coronary angiography|radiation dose, transradial approach, percutaneous coronary interventions, coronary angiography
231478|NCT01974440|Lymphoma|lymphoma
231479|NCT01974440|Follicular lymphoma|follicular lymphoma
231480|NCT01974440|Marginal zone lymphoma|marginal zone lymphoma
231481|NCT01974440|Indolent Non-Hodgkin lymphoma|indolent non-hodgkin lymphoma
231482|NCT01974440|PCI-32765|pci-32765
231483|NCT01974440|Ibrutinib|ibrutinib
231484|NCT01974440|Bendamustine|bendamustine
231485|NCT01974440|Rituximab|rituximab
231486|NCT01974440|Cyclophosphamide|cyclophosphamide
231487|NCT01974440|Doxorubicin|doxorubicin
222194|NCT02016690|Effectiveness of palivizumab|effectiveness of palivizumab
222195|NCT02016677|Breast reduction|breast reduction
222196|NCT02016677|Mastopexy|mastopexy
231488|NCT01974440|Vincristine|vincristine
231489|NCT01974440|Prednisone|prednisone
231490|NCT01974440|R-CHOP|r-chop
231491|NCT01974427|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
231492|NCT01974427|Functional Imaging|functional imaging
231493|NCT01974427|BOLD Effect|bold effect
231494|NCT01974427|EEG|eeg
231495|NCT01974427|MEG|meg
231496|NCT01974414|oral lichen planus|oral lichen planus
231497|NCT01974414|cedar honey|cedar honey
231498|NCT01974414|atrophic|atrophic
231499|NCT01974414|erosive|erosive
231500|NCT01974414|pain|pain
231501|NCT01974414|treatment|treatment
231502|NCT01974414|clinical trial|clinical trial
231503|NCT01974401|oral irrigator|oral irrigator
231504|NCT01974401|leukemia|leukemia
231505|NCT01974401|blood dyscrasia|blood dyscrasia
231506|NCT01974401|Oral Health Index Simplified (OHI-S)|oral health index simplified (ohi-s)
231507|NCT01974401|supra gingival irrigator|supra gingival irrigator
231508|NCT01974388|Bariatric surgery, sleeve gastrectomy, gastric leak|bariatric surgery, sleeve gastrectomy, gastric leak
231509|NCT01974375|Living donor|living donor
231510|NCT01974375|Liver transplant|liver transplant
231511|NCT01974375|antifungal prevention|antifungal prevention
231512|NCT01974362|Monolithic Zirconia|monolithic zirconia
231513|NCT01974362|Zirconia-Feldspathic zirconia|zirconia-feldspathic zirconia
231514|NCT01974362|Dental Implants|dental implants
231515|NCT01974362|Fracture|fracture
231516|NCT01974362|Chipping|chipping
231517|NCT01974349|Phase I, healthy, pharmacokinetics, food effect.|phase i, healthy, pharmacokinetics, food effect.
231518|NCT01974310|Macular Holes|macular holes
231519|NCT01974310|Non face down positioning|non face down positioning
231520|NCT01974310|Face down positioning|face down positioning
231521|NCT01974297|Hyperlipidemia|hyperlipidemia
231522|NCT01974297|Atorvastatin|atorvastatin
231523|NCT01974297|Fenofibric acid|fenofibric acid
231524|NCT01974297|combination|combination
231525|NCT01974297|monotherapy|monotherapy
231526|NCT01974245|Cholecalciferol|cholecalciferol
231527|NCT01974245|Kidney diseases|kidney diseases
231528|NCT01974232|Immune Thrombocytopenia (ITP), Thrombopoietin (TPO) agents, children, romiplostim and eltrombopag|immune thrombocytopenia (itp), thrombopoietin (tpo) agents, children, romiplostim and eltrombopag
231529|NCT01974219|HIV|hiv
231530|NCT01974219|COPD|copd
231531|NCT01974219|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
231532|NCT01974219|Smoking|smoking
231533|NCT01974206|ASP0113|asp0113
231534|NCT01974206|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
231535|NCT01974206|Kidney Transplantation|kidney transplantation
231536|NCT01974180|Smoking|smoking
231537|NCT01974180|COPD|copd
231538|NCT01974180|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
231539|NCT01974180|Healthy Smoker|healthy smoker
231540|NCT01974180|Non-smoker|non-smoker
231541|NCT01974167|glucocorticoid-induced osteoporosis|glucocorticoid-induced osteoporosis
231542|NCT01974154|COPD|copd
231543|NCT01974154|Smoking|smoking
231544|NCT01974154|Non-smoker|non-smoker
231545|NCT01974128|MI|mi
231546|NCT01974115|Cellulite|cellulite
231547|NCT01974115|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
231548|NCT01974115|ESWT|eswt
231549|NCT01974115|Radial shock wave therapy|radial shock wave therapy
231550|NCT01974115|RSWT|rswt
231551|NCT01974089|Dysphagia|dysphagia
231552|NCT01974089|Modified diet|modified diet
231553|NCT01974089|Community acquired pneumonia|community acquired pneumonia
231554|NCT01974089|Mortality|mortality
231555|NCT01974089|Rehospitalization|rehospitalization
231556|NCT01974063|Smoking|smoking
231557|NCT01974063|Smoking Cessation|smoking cessation
231558|NCT01974063|Healthy Smoker|healthy smoker
231559|NCT01974063|Shisha Smoker|shisha smoker
231560|NCT01974063|Non-smoker|non-smoker
231561|NCT01974050|Influenza vaccination|influenza vaccination
231562|NCT01974024|Dexamethasone|dexamethasone
231563|NCT01974024|Hiccup|hiccup
231564|NCT01974024|Chemotherapy|chemotherapy
231565|NCT01974024|Methylprednisolone|methylprednisolone
231566|NCT01973998|COPD|copd
231567|NCT01973998|Emphysema|emphysema
231568|NCT01973998|Roflumilast|roflumilast
231569|NCT01973998|readmission|readmission
231570|NCT01973985|Pleural Effusion|pleural effusion
231571|NCT01973972|Diabetes|diabetes
231572|NCT01973972|Obesity|obesity
231573|NCT01973972|Complex Care|complex care
231574|NCT01973972|Primary Care|primary care
231575|NCT01973972|Chronic Disease|chronic disease
231576|NCT01973946|Cancer|cancer
231577|NCT01973933|Metformin|metformin
231578|NCT01973933|Pyrimethamine|pyrimethamine
231579|NCT01973933|Drug interaction|drug interaction
231580|NCT01973920|Diabetes Mellitus|diabetes mellitus
231581|NCT01973920|Oral Insulin|oral insulin
231582|NCT01973907|Sepsis|sepsis
231583|NCT01973907|Septic Shock|septic shock
231584|NCT01973907|Fluid Therapy|fluid therapy
231585|NCT01973907|Pediatrics|pediatrics
231586|NCT01973907|Resuscitation|resuscitation
231587|NCT01973907|Emergency Medicine|emergency medicine
231588|NCT01973907|Critical Care|critical care
231589|NCT01973894|PBPK|pbpk
231590|NCT01973894|Midazolam|midazolam
231591|NCT01973894|Pharmacokinetics|pharmacokinetics
231592|NCT01973894|Critically ill patients|critically ill patients
231593|NCT01973868|Regorafenib|regorafenib
231594|NCT01973868|Cetuximab|cetuximab
231595|NCT01973868|Solid tumors|solid tumors
231596|NCT01973868|Cancer|cancer
231597|NCT01973868|Safety|safety
231598|NCT01973868|Tolerability|tolerability
231599|NCT01973868|Pharmacokinetics|pharmacokinetics
231600|NCT01973842|GnRH agonist|gnrh agonist
231601|NCT01973842|OHSS|ohss
231602|NCT01973842|Triggering final oocyte maturation|triggering final oocyte maturation
688122|NCT00923247|Cancer|cancer
231603|NCT01973829|CERTAIN, Checklist, ICU, Outcome, Adults|certain, checklist, icu, outcome, adults
231604|NCT01973816|deep endometriosis;|deep endometriosis;
231605|NCT01973816|rectal endometriosis;|rectal endometriosis;
231606|NCT01973816|rectal shaving;|rectal shaving;
231607|NCT01973816|colorectal resection;|colorectal resection;
231608|NCT01973816|bowel endometriosis|bowel endometriosis
231609|NCT01973803|Carpometacarpal joint|carpometacarpal joint
231610|NCT01973803|Osteoarthritis of CMC-1 joint|osteoarthritis of cmc-1 joint
231611|NCT01973790|Z-338|z-338
231612|NCT01973790|Functional Dyspepsia|functional dyspepsia
231613|NCT01973790|Postprandial Distress Syndrome|postprandial distress syndrome
231614|NCT01973777|intrauterine device, contraception|intrauterine device, contraception
231615|NCT01973764|Intraoperative ultrasound|intraoperative ultrasound
231616|NCT01973764|Ventricular System|ventricular system
231617|NCT01973764|Puncture|puncture
231618|NCT01973764|Ventricular catheter|ventricular catheter
231619|NCT01973764|Ventriculostomy|ventriculostomy
231620|NCT01973764|Hydrocephalus|hydrocephalus
231621|NCT01973764|Excessive accumulation of cerebrospinal fluids within the cranium. Often associated with dilatation of cerebral ventricles|excessive accumulation of cerebrospinal fluids within the cranium. often associated with dilatation of cerebral ventricles
231622|NCT01973764|Intracranial Hypertension|intracranial hypertension
231623|NCT01973764|increased pressure within the cranial vault. This may result from several conditions, including hydrocephalus, brain edema.|increased pressure within the cranial vault. this may result from several conditions, including hydrocephalus, brain edema.
231624|NCT01973738|raloxifene|raloxifene
231625|NCT01973738|bazedoxifene|bazedoxifene
231626|NCT01973738|bone mineral density|bone mineral density
231627|NCT01973738|bone turnover markers|bone turnover markers
231628|NCT01973738|bone quality|bone quality
231629|NCT01973699|shoulder arthroscopy, epinephrine, visualization|shoulder arthroscopy, epinephrine, visualization
231630|NCT01973673|prostate cancer|prostate cancer
231631|NCT01973673|ADT|adt
231632|NCT01973673|bone health|bone health
231633|NCT01973660|Human Epidermal Growth Factor Receptor 2|human epidermal growth factor receptor 2
231634|NCT01973660|HER2|her2
231635|NCT01973660|HER2 positive|her2 positive
231636|NCT01973660|PAM50|pam50
231637|NCT01973660|lapatinib|lapatinib
231638|NCT01973660|trastuzumab|trastuzumab
231639|NCT01973660|dual HER2 blockade|dual her2 blockade
231640|NCT01973660|neoadjuvant|neoadjuvant
231641|NCT01973647|insomnia|insomnia
231642|NCT01973647|cognitive behavioral therapy|cognitive behavioral therapy
231643|NCT01973647|COPD|copd
231644|NCT01973647|fatigue|fatigue
231645|NCT01973634|Radiotherapy|radiotherapy
231646|NCT01973608|Melanoma|melanoma
231647|NCT01973608|MSB0010445|msb0010445
231648|NCT01973608|Dose limiting toxicity|dose limiting toxicity
231649|NCT01973608|Stereotactic body radiation therapy|stereotactic body radiation therapy
231650|NCT01973595|almonds|almonds
231651|NCT01973595|inflammation|inflammation
231652|NCT01973595|immunity|immunity
231653|NCT01973595|gut microbiota|gut microbiota
231654|NCT01973595|stress|stress
231655|NCT01973595|diet quality|diet quality
231656|NCT01973582|Hepatitis B|hepatitis b
231657|NCT01973582|epidemiology|epidemiology
231658|NCT01973582|youth|youth
231659|NCT01973582|vaccine|vaccine
231660|NCT01973569|Rheumatoid Arthritis|rheumatoid arthritis
231661|NCT01973569|Denosumab|denosumab
231662|NCT01973569|RANKL|rankl
231663|NCT01973569|RANK|rank
231664|NCT01973569|AMG 162|amg 162
231665|NCT01973569|joint damage|joint damage
231666|NCT01973569|Developmental Phase III|developmental phase iii
231668|NCT01973543|Parkinson's disease|parkinson's disease
231669|NCT01973543|Aromatic Amino Acid Decarboxylase|aromatic amino acid decarboxylase
231670|NCT01973543|AADC|aadc
231671|NCT01973543|AAV2-AADC|aav2-aadc
231672|NCT01973543|AAV2|aav2
231673|NCT01973543|Viral Vector|viral vector
231674|NCT01973543|Gene Therapy|gene therapy
231675|NCT01973543|Gene Transfer|gene transfer
231676|NCT01973543|MRI|mri
231677|NCT01973543|PET|pet
231678|NCT01973543|VY-AADC01|vy-aadc01
231679|NCT01973530|femoral nerve block|femoral nerve block
231680|NCT01973530|adductor canal block|adductor canal block
231681|NCT01973530|steroid|steroid
231682|NCT01973530|total knee replacement|total knee replacement
231683|NCT01973517|Multiple sclerosis|multiple sclerosis
231684|NCT01973517|MRI|mri
231685|NCT01973517|USPIO|uspio
231686|NCT01973517|Ferumoxytol|ferumoxytol
231687|NCT01973517|Feraheme|feraheme
231688|NCT01973504|Trauma|trauma
231689|NCT01973504|Hemorrhagic shock|hemorrhagic shock
231690|NCT01973504|Hemorrhage|hemorrhage
231691|NCT01973504|Lactic acidosis|lactic acidosis
231692|NCT01973504|Oxygen therapeutics|oxygen therapeutics
231693|NCT01973504|Oxygen carriers|oxygen carriers
231694|NCT01973504|Ischemic rescue therapy|ischemic rescue therapy
231695|NCT01973504|Hemoglobin solutions|hemoglobin solutions
231696|NCT01973504|PEGylated hemoglobin|pegylated hemoglobin
231697|NCT01973491|ATX-MS-1467 (MSC2358825A)|atx-ms-1467 (msc2358825a)
231698|NCT01973491|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
231699|NCT01973491|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
231700|NCT01973491|M2736|m2736
231701|NCT01973478|Major depressive disorder|major depressive disorder
231702|NCT01973478|Recurrent depressive disorder|recurrent depressive disorder
231703|NCT01973478|Bipolar disorder|bipolar disorder
231704|NCT01973478|Deep brain stimulation|deep brain stimulation
231705|NCT01973478|Accumbens|accumbens
231706|NCT01973465|C-Diff|c-diff
231707|NCT01973465|Diarrhea|diarrhea
231708|NCT01973452|Dexmedetomidine|dexmedetomidine
231709|NCT01973452|Opioid|opioid
231710|NCT01973452|Thoracic Surgery|thoracic surgery
231711|NCT01973439|HIV|hiv
231712|NCT01973439|Abacavir|abacavir
231713|NCT01973439|Lamivudine|lamivudine
231714|NCT01973439|Pharmacokinetics|pharmacokinetics
231715|NCT01973426|Robot|robot
231716|NCT01973426|Thumb|thumb
231717|NCT01973426|Orthosis|orthosis
231718|NCT01973426|Hemiplegia|hemiplegia
231719|NCT01973426|Hemiplegic Stroke|hemiplegic stroke
231720|NCT01973426|Hemiplegic Cerebral Palsy|hemiplegic cerebral palsy
231721|NCT01973426|Stroke|stroke
231722|NCT01973426|Cerebral Palsy|cerebral palsy
231723|NCT01973426|Grasp assistance|grasp assistance
231724|NCT01973413|Artificial Pancreas Project|artificial pancreas project
231725|NCT01973413|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
231726|NCT01973413|Insulin pump therapy|insulin pump therapy
231727|NCT01973413|Continuous Glucose Monitors (CGM)|continuous glucose monitors (cgm)
231728|NCT01973413|Juvenile-Onset Diabetes|juvenile-onset diabetes
231729|NCT01973413|Autoimmune Diabetes|autoimmune diabetes
231730|NCT01973413|Closed-to-Range|closed-to-range
231731|NCT01973413|Diabetes Assistant (DiAs)|diabetes assistant (dias)
231732|NCT01973387|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
231733|NCT01973387|Small lymphocytic lymphoma|small lymphocytic lymphoma
231734|NCT01973387|Relapsed or refractory chronic lymphocytic leukemia|relapsed or refractory chronic lymphocytic leukemia
231735|NCT01973387|Relapsed or refractory small lymphocytic lymphoma|relapsed or refractory small lymphocytic lymphoma
231736|NCT01973387|Ibrutinib|ibrutinib
231737|NCT01973387|PCI-32765|pci-32765
231738|NCT01973387|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
231739|NCT01973387|Rituximab|rituximab
231740|NCT01973387|Asia Pacific region participants|asia pacific region participants
231741|NCT01973361|Wounds|wounds
231742|NCT01973361|Lower extremity|lower extremity
231743|NCT01973361|Diabetes|diabetes
231744|NCT01973361|Arterial Insufficiency|arterial insufficiency
231745|NCT01973361|Debridement|debridement
231746|NCT01973361|Low frequency ultrasound|low frequency ultrasound
231747|NCT01973361|Contact ultrasound|contact ultrasound
231748|NCT01973361|Wound clinic|wound clinic
231749|NCT01973361|Wound bed preparation|wound bed preparation
231750|NCT01973361|Wound infection|wound infection
231751|NCT01973361|Chronic wound inflammation|chronic wound inflammation
231752|NCT01973348|amblyopia|amblyopia
231753|NCT01973335|acetazolamide|acetazolamide
231754|NCT01973335|bumetanide|bumetanide
231755|NCT01973335|cardio-renal syndrome|cardio-renal syndrome
231756|NCT01973335|diuretics|diuretics
231757|NCT01973335|heart failure|heart failure
231758|NCT01973335|natriuresis|natriuresis
231759|NCT01973335|spironolactone|spironolactone
231760|NCT01973322|Malignant melanoma stage III or IV|malignant melanoma stage iii or iv
231761|NCT01973322|pretreated melanoma|pretreated melanoma
231762|NCT01973322|vaccination|vaccination
231763|NCT01973322|autologous dendritic cells|autologous dendritic cells
231764|NCT01973322|autologous tumor lysate or homogenate|autologous tumor lysate or homogenate
231765|NCT01973322|immunomodulating radiotherapy|immunomodulating radiotherapy
231766|NCT01973309|Locally Recurrent|locally recurrent
231767|NCT01973309|Metastatic Breast Cancer|metastatic breast cancer
231768|NCT01973296|Health Literacy|health literacy
231769|NCT01973296|Care Transition Intervention|care transition intervention
231770|NCT01973296|Emergency Department Population|emergency department population
231771|NCT01973296|Access to Care|access to care
231772|NCT01973218|Meningitis, adolescents, Meningococcal B|meningitis, adolescents, meningococcal b
231773|NCT01973205|Migraine|migraine
231774|NCT01973205|acetaminophen|acetaminophen
231775|NCT01973205|aspirin|aspirin
231776|NCT01973166|Tattoo Removal|tattoo removal
231777|NCT01973166|Q-switched laser|q-switched laser
231778|NCT01973166|Nd:YAG laser|nd:yag laser
231779|NCT01973166|Nanosecond laser|nanosecond laser
231780|NCT01973166|Picosecond laser|picosecond laser
231781|NCT01973166|Laser therapy|laser therapy
231782|NCT01973166|Tattoo|tattoo
231783|NCT01973166|pulsed-laser|pulsed-laser
231784|NCT01973166|laser treatment|laser treatment
231785|NCT01973166|remove tattoo|remove tattoo
231786|NCT01973166|tattoo clearing|tattoo clearing
231787|NCT01973166|tattoo lightening|tattoo lightening
231788|NCT01973166|tattoo lighten|tattoo lighten
231789|NCT01973153|Obesity prevention|obesity prevention
231790|NCT01973153|Weight management|weight management
231791|NCT01973153|Motivational Interviewing|motivational interviewing
231792|NCT01973140|Tolvaptan|tolvaptan
231793|NCT01973140|Aquaretic Efficacy|aquaretic efficacy
231794|NCT01973127|alcohol|alcohol
231795|NCT01973127|addiction|addiction
231797|NCT01973127|craving|craving
231799|NCT01973127|rTMS|rtms
231800|NCT01973127|EEG|eeg
231801|NCT01973127|LPP|lpp
231802|NCT01973127|p300|p300
231803|NCT01973127|ERN|ern
231804|NCT01973127|SST|sst
231805|NCT01973127|CCT|cct
231806|NCT01973127|AAAT|aaat
231807|NCT01973114|Menière's disease|menière's disease
231808|NCT01973114|Vertigo|vertigo
231809|NCT01973114|Hearing loss|hearing loss
231810|NCT01973114|Tinnitus|tinnitus
231811|NCT01973101|Advanced carcinomas of uterine cervix|advanced carcinomas of uterine cervix
231812|NCT01973101|Chemoradiation|chemoradiation
231813|NCT01973101|Chemo-induction|chemo-induction
231814|NCT01973101|Cisplatin|cisplatin
231815|NCT01973101|Gemcitabine|gemcitabine
231816|NCT01973075|Premature Ovarian Insufficiency (POI)|premature ovarian insufficiency (poi)
231817|NCT01973036|foley catheter|foley catheter
231818|NCT01973036|foley bulb|foley bulb
231819|NCT01973036|oxytocin|oxytocin
231820|NCT01973023|botulinum toxin injection|botulinum toxin injection
231821|NCT01973023|stroke|stroke
231822|NCT01973023|3D motion analysis|3d motion analysis
231823|NCT01973023|gait pattern|gait pattern
231824|NCT01973010|massage|massage
231825|NCT01973010|low back pain|low back pain
231826|NCT01972984|Estrogen receptor positive|estrogen receptor positive
231827|NCT01972971|warfarin|warfarin
231828|NCT01972971|pharmacist|pharmacist
231829|NCT01972971|anticoagulation|anticoagulation
231830|NCT01972945|vaginoscopy|vaginoscopy
231831|NCT01972945|hysteroscopy|hysteroscopy
231832|NCT01972945|office hysteroscopy|office hysteroscopy
231833|NCT01972945|outpatient hysteroscopy|outpatient hysteroscopy
231834|NCT01972932|Bio-K+®|bio-k+®
231835|NCT01972932|Placebo|placebo
231836|NCT01972932|AAD|aad
231837|NCT01972932|CDI|cdi
231838|NCT01972932|hospitalized subjects|hospitalized subjects
231839|NCT01972906|moxibustion|moxibustion
231840|NCT01972906|primary dysmenorrhea|primary dysmenorrhea
231841|NCT01972893|Selective GLP-1 agonist|selective glp-1 agonist
231842|NCT01972880|Open-label design|open-label design
231843|NCT01972880|Bioequivalence|bioequivalence
231844|NCT01972880|ASP1941|asp1941
231845|NCT01972867|Focal|focal
231846|NCT01972867|Prostate|prostate
231847|NCT01972867|Cancer|cancer
231848|NCT01972867|Irreversible|irreversible
231849|NCT01972867|Electroporation|electroporation
231850|NCT01972867|NanoKnife|nanoknife
231851|NCT01972854|keratoconus|keratoconus
231852|NCT01972854|cross-linking|cross-linking
231853|NCT01972854|KXL|kxl
231854|NCT01972841|Combination Therapy|combination therapy
231855|NCT01972841|Mirabegron|mirabegron
231856|NCT01972841|Overactive Bladder|overactive bladder
231857|NCT01972841|Urgency|urgency
231858|NCT01972841|Urinary Incontinence|urinary incontinence
231859|NCT01972841|Nocturia|nocturia
231860|NCT01972841|Solifenacin Succinate|solifenacin succinate
231861|NCT01972828|Septic shock|septic shock
231862|NCT01972828|Randomized controlled trial|randomized controlled trial
231863|NCT01972828|Preload dependence|preload dependence
231864|NCT01972828|Pulmonary thermodilution|pulmonary thermodilution
231865|NCT01972802|HEAD AND NECK|head and neck
231866|NCT01972789|Subfoveal choroidal neovascularization (CNV)|subfoveal choroidal neovascularization (cnv)
231867|NCT01972789|wet age-related macular degeneration(AMD)|wet age-related macular degeneration(amd)
231868|NCT01972789|inject and extend|inject and extend
231869|NCT01972789|retinal fluid|retinal fluid
231870|NCT01972776|COPD, inflammation, small airways, LCI, PFTs, lung heterogeneity|copd, inflammation, small airways, lci, pfts, lung heterogeneity
231871|NCT01972750|glioblastoma|glioblastoma
231872|NCT01972750|recurrence|recurrence
231874|NCT01972737|Colon cancer|colon cancer
231875|NCT01972737|safety|safety
231876|NCT01972737|tolerability|tolerability
231877|NCT01972737|antibody responses|antibody responses
231878|NCT01972737|T cell responses|t cell responses
231879|NCT01972724|Drug therapy|drug therapy
231880|NCT01972711|Schizophrenia|schizophrenia
231881|NCT01972698|Focused Cardiac Ultrasound|focused cardiac ultrasound
231882|NCT01972698|Lung Ultrasound|lung ultrasound
231883|NCT01972698|Simulation|simulation
231884|NCT01972698|Education|education
231885|NCT01972698|Web-based learning|web-based learning
231886|NCT01972685|ILD, transbronchial, cryoprobe, VATS|ild, transbronchial, cryoprobe, vats
231887|NCT01972659|sugammadex|sugammadex
231888|NCT01972659|rocuronium|rocuronium
231889|NCT01972659|magnesium|magnesium
231890|NCT01972659|female|female
231891|NCT01972646|Cellulitis, treatment failure, skin and soft tissue infections, risk factors.|cellulitis, treatment failure, skin and soft tissue infections, risk factors.
231892|NCT01972633|endovenous treatment|endovenous treatment
231893|NCT01972633|Laser, Vnus Closure Fast|laser, vnus closure fast
231894|NCT01972633|Varicosis|varicosis
231895|NCT01972633|great saphenous vein|great saphenous vein
231896|NCT01972633|small saphenous vein|small saphenous vein
231897|NCT01972633|Venous Insufficiency|venous insufficiency
231898|NCT01972620|gallstones|gallstones
231899|NCT01972620|cholelithiasis|cholelithiasis
231900|NCT01972620|cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
231901|NCT01972620|pain|pain
231902|NCT01972607|Migraine, aerobic exercise, prevention|migraine, aerobic exercise, prevention
231903|NCT01972581|neurocognitive visual reaction training|neurocognitive visual reaction training
231904|NCT01972581|baseball|baseball
231905|NCT01972568|Atacicept 75 and 150 mg|atacicept 75 and 150 mg
231906|NCT01972568|Placebo|placebo
231907|NCT01972542|Postprandial period|postprandial period
231908|NCT01972542|triglyceride|triglyceride
231909|NCT01972542|Diabetes mellitus, type 2|diabetes mellitus, type 2
231910|NCT01972542|Prediabetic state|prediabetic state
231911|NCT01972529|Thrombocytopenia|thrombocytopenia
231912|NCT01972529|Chronic Liver Disease|chronic liver disease
231913|NCT01972516|Platinum-Sensitive|platinum-sensitive
231914|NCT01972516|Ovarian Cancer|ovarian cancer
231915|NCT01972516|Fallopian Tube Cancer|fallopian tube cancer
231916|NCT01972516|Primary Peritoneal Cancer|primary peritoneal cancer
231917|NCT01972516|High-grade Serous|high-grade serous
231918|NCT01972503|Colorectal Neoplasms|colorectal neoplasms
231919|NCT01972503|Liver|liver
231920|NCT01972503|Neoplasm Metastasis|neoplasm metastasis
231921|NCT01972503|Tegafur|tegafur
231922|NCT01972503|oxaliplatin|oxaliplatin
231923|NCT01972490|colorectal neoplasms|colorectal neoplasms
231924|NCT01972490|liver metastasis|liver metastasis
231925|NCT01972490|chemotherapy|chemotherapy
231926|NCT01972490|avastin|avastin
231927|NCT01972477|DLBS1449|dlbs1449
231928|NCT01972477|diabetes mellitus|diabetes mellitus
231929|NCT01972477|HDL-cholesterol|hdl-cholesterol
231930|NCT01972464|Progesterone|progesterone
231931|NCT01972464|Placebo|placebo
231932|NCT01972464|Postpartum|postpartum
231933|NCT01972464|Tobacco|tobacco
231934|NCT01972464|Pregnancy|pregnancy
231935|NCT01972438|Graft Versus Host Disease|graft versus host disease
231936|NCT01972438|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
231937|NCT01972412|nursing care|nursing care
231938|NCT01972412|diabetes mellitus|diabetes mellitus
231939|NCT01972412|phone support|phone support
231940|NCT01972412|chronic care model|chronic care model
231941|NCT01972373|VEGF|vegf
231942|NCT01972373|Fluorescence|fluorescence
231943|NCT01972373|Endoscopy|endoscopy
231944|NCT01972373|Rectal cancer|rectal cancer
231945|NCT01972360|SPECT|spect
231946|NCT01972360|CMR|cmr
231947|NCT01972360|High risk for ischemic cardiovascular events|high risk for ischemic cardiovascular events
231948|NCT01972347|Melanoma|melanoma
231949|NCT01972347|Cutaneous melanoma|cutaneous melanoma
231950|NCT01972347|Malignant melanoma|malignant melanoma
231951|NCT01972347|Stage III B / C melanoma|stage iii b / c melanoma
231952|NCT01972347|Neoadjuvant treatment|neoadjuvant treatment
231954|NCT01972347|Biomarkers|biomarkers
231955|NCT01972347|Dabrafenib|dabrafenib
231956|NCT01972347|Trametinib|trametinib
231957|NCT01972334|clostridium difficile|clostridium difficile
231958|NCT01972334|children|children
231959|NCT01972334|fecal transplant|fecal transplant
231960|NCT01972321|Community health worker|community health worker
231961|NCT01972321|Motivation|motivation
231962|NCT01972321|Performance|performance
231963|NCT01972321|Quality of care|quality of care
231964|NCT01972321|Africa|africa
231965|NCT01972308|asthma|asthma
231966|NCT01972308|patient advocate|patient advocate
231967|NCT01972308|health disparity|health disparity
231968|NCT01972308|patient-provider communication|patient-provider communication
231969|NCT01972282|Atrial fibrillation|atrial fibrillation
231970|NCT01972282|Stroke|stroke
231971|NCT01972282|Thrombus|thrombus
231972|NCT01972282|Thromboembolism|thromboembolism
231973|NCT01972282|Left atrial appendage|left atrial appendage
231974|NCT01972269|Epidural|epidural
231975|NCT01972269|Labor Analgesia|labor analgesia
231976|NCT01972269|Bupivacaine|bupivacaine
231977|NCT01972269|Minimum effective volume|minimum effective volume
231978|NCT01972243|risk of recurrent|risk of recurrent
231979|NCT01972217|Olaparib|olaparib
231980|NCT01972217|castration-resistant, metastatic prostate cancer|castration-resistant, metastatic prostate cancer
285218|NCT01730209|RAD001|rad001
231981|NCT01972217|Prior Docetaxel Chemotherapy|prior docetaxel chemotherapy
231982|NCT01972191|Toric marking, Corneal horizontal marking|toric marking, corneal horizontal marking
231983|NCT01972165|Carpal tunnel syndrome|carpal tunnel syndrome
231984|NCT01972152|Hypoglycemia|hypoglycemia
231985|NCT01972152|Glucagon|glucagon
231986|NCT01972139|Uncontrolled hypertension|uncontrolled hypertension
231987|NCT01972139|blood pressure|blood pressure
231988|NCT01972139|renal denervation|renal denervation
231989|NCT01972139|HTN-4|htn-4
231990|NCT01972139|SYMPLICITY|symplicity
231991|NCT01972113|Vitamin K|vitamin k
231992|NCT01972113|Vitamin K2|vitamin k2
231993|NCT01972113|Menaquinone-7|menaquinone-7
231994|NCT01972113|Osteocalcin|osteocalcin
231995|NCT01972113|Children|children
231996|NCT01972113|Obesity|obesity
231997|NCT01972113|Insulin resistance|insulin resistance
231998|NCT01972113|Insulin sensitivity|insulin sensitivity
231999|NCT01972113|Beta-cell function|beta-cell function
232000|NCT01972113|Prediabetes|prediabetes
232001|NCT01972113|Matrix Gla protein|matrix gla protein
232002|NCT01972113|Arterial stiffness|arterial stiffness
232003|NCT01972113|Endothelial function|endothelial function
232004|NCT01972100|Low-level laser therapy|low-level laser therapy
232005|NCT01972100|Muscle fatigue resistance|muscle fatigue resistance
232006|NCT01972074|Autism spectrum disorder|autism spectrum disorder
232007|NCT01972074|Treatment|treatment
232008|NCT01972074|Adolescents|adolescents
232009|NCT01972074|Memantine|memantine
232010|NCT01972074|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
232011|NCT01972074|MRS|mrs
232012|NCT01972074|Neuroimaging|neuroimaging
232013|NCT01972048|breast cancer|breast cancer
232014|NCT01972048|breast cancer screening|breast cancer screening
232015|NCT01972048|mammogram|mammogram
232016|NCT01972035|EBV|ebv
232017|NCT01972035|CMV|cmv
232018|NCT01972035|Kidney transplant|kidney transplant
232019|NCT01972035|valganciclovir|valganciclovir
232020|NCT01972035|valacyclovir|valacyclovir
232021|NCT01972022|Drug Eluting Stents|drug eluting stents
232022|NCT01972022|Bioabsorbale Polymer Coating|bioabsorbale polymer coating
232023|NCT01972022|Neoatherosclerosis|neoatherosclerosis
232024|NCT01972022|Stent Coverage|stent coverage
232025|NCT01972022|Stent Failure|stent failure
232026|NCT01971996|Near infrared Spectroscopy|near infrared spectroscopy
232027|NCT01971983|Low back pain|low back pain
232028|NCT01971983|Spinal manipulation|spinal manipulation
232029|NCT01971983|Osteopathy|osteopathy
232030|NCT01971983|Muscle energy technique|muscle energy technique
232031|NCT01971983|Muscle thickness|muscle thickness
232032|NCT01971970|Inflammatory bowel disease|inflammatory bowel disease
232033|NCT01971970|Pediatric|pediatric
232034|NCT01971970|Adult|adult
232035|NCT01971970|Biomarker|biomarker
232036|NCT01971970|Anti-TNF response|anti-tnf response
232037|NCT01971970|Infliximab|infliximab
232038|NCT01971970|Adalimumab|adalimumab
232039|NCT01971957|ichthyosis|ichthyosis
232040|NCT01971957|spasticity|spasticity
232041|NCT01971957|spastic diplegia|spastic diplegia
232042|NCT01971957|intellectual disability|intellectual disability
232043|NCT01971944|Beta Blocker|beta blocker
232044|NCT01971944|Inotrope|inotrope
232045|NCT01971918|spondyloarthritis|spondyloarthritis
232046|NCT01971918|monoclonal antibodies anti-TNF|monoclonal antibodies anti-tnf
232047|NCT01971918|secondary treatment failure|secondary treatment failure
232048|NCT01971892|Abdominal surgery;|abdominal surgery;
232049|NCT01971892|Postoperative complication;|postoperative complication;
232050|NCT01971892|Acute respiratory failure;|acute respiratory failure;
232051|NCT01971892|Hypoxemia;|hypoxemia;
232052|NCT01971892|Intubation;|intubation;
232053|NCT01971892|Non-invasive ventilation|non-invasive ventilation
232054|NCT01971879|Remote ischemic preconditioning|remote ischemic preconditioning
232055|NCT01971879|Obliterating Arteriopathy of the Lower Limbs|obliterating arteriopathy of the lower limbs
232056|NCT01971866|Proton radiation|proton radiation
232057|NCT01971866|AlignRT|alignrt
232058|NCT01971853|Analgesia|analgesia
232059|NCT01971840|Physical activity|physical activity
232060|NCT01971840|Physical fitness|physical fitness
232061|NCT01971840|Obesity|obesity
232062|NCT01971840|Adiposity|adiposity
232063|NCT01971840|Adiposity rebound period|adiposity rebound period
232064|NCT01971840|Children|children
232065|NCT01971840|Blood pressure|blood pressure
232066|NCT01971840|Randomized controlled trials|randomized controlled trials
232067|NCT01971840|Barriers and facilitators of the environment|barriers and facilitators of the environment
232068|NCT01971827|Physical activity|physical activity
232069|NCT01971827|Obesity|obesity
232070|NCT01971827|Adiposity rebound period|adiposity rebound period
232071|NCT01971827|Children with ADHD|children with adhd
232072|NCT01971827|Children without ADHD|children without adhd
232073|NCT01971827|Academic performance|academic performance
232074|NCT01971827|Motor skills|motor skills
232075|NCT01971827|Health related-quality of life|health related-quality of life
232076|NCT01971827|Sleep|sleep
232077|NCT01971801|urinary incontinence|urinary incontinence
232078|NCT01971801|bowel incontinence|bowel incontinence
232079|NCT01971801|vitamin D|vitamin d
232080|NCT01971801|overactive bladder|overactive bladder
232081|NCT01971801|lower urinary tract symptoms|lower urinary tract symptoms
232082|NCT01971801|quality of life|quality of life
232083|NCT01971775|Ultrasonically Activated Shear|ultrasonically activated shear
232084|NCT01971775|Conventional Monopolar Electrocautery|conventional monopolar electrocautery
232085|NCT01971775|Gastric Cancer|gastric cancer
232086|NCT01971762|multiresistant bacteremia|multiresistant bacteremia
232087|NCT01971762|bacteremia management|bacteremia management
232088|NCT01971762|blood culture|blood culture
232089|NCT01971749|Coronary stent procedure (CSP|coronary stent procedure (csp
232090|NCT01971749|Coronary-artery bypass grafting (CABG)|coronary-artery bypass grafting (cabg)
232091|NCT01971736|1064nm YAG laser|1064nm yag laser
232092|NCT01971736|laxity|laxity
232093|NCT01971736|rhytides|rhytides
232094|NCT01971736|asian|asian
232095|NCT01971723|Testosterone|testosterone
232096|NCT01971723|Estrogen|estrogen
232097|NCT01971723|Insulin|insulin
232098|NCT01971723|Blood Lipid|blood lipid
232099|NCT01971723|Glucose|glucose
232100|NCT01971723|Creatine Kinase|creatine kinase
232101|NCT01971723|Strength|strength
232102|NCT01971723|Power Athlete|power athlete
232103|NCT01971710|HIV|hiv
232104|NCT01971710|AIDS|aids
232105|NCT01971710|PMTCT|pmtct
232106|NCT01971684|ITP|itp
232107|NCT01971684|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
232108|NCT01971684|bleeding score|bleeding score
232109|NCT01971684|platelet count|platelet count
232110|NCT01971684|health-related quality of life|health-related quality of life
232111|NCT01971684|HRQL|hrql
232112|NCT01971684|Purpura|purpura
232113|NCT01971684|Purpura, Thrombocytopenic|purpura, thrombocytopenic
232114|NCT01971684|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
232115|NCT01971684|Blood Coagulation Disorders|blood coagulation disorders
232116|NCT01971684|Hematologic Diseases|hematologic diseases
232117|NCT01971684|Hemorrhage|hemorrhage
232118|NCT01971684|Skin Manifestations|skin manifestations
232119|NCT01971684|Thrombocytopenia|thrombocytopenia
232120|NCT01971684|Blood Platelet Disorders|blood platelet disorders
232121|NCT01971684|Immune System Diseases|immune system diseases
232122|NCT01971684|Hemorrhagic Disorders|hemorrhagic disorders
232123|NCT01971684|Autoimmune Diseases|autoimmune diseases
232124|NCT01971684|Therapeutic Uses|therapeutic uses
232125|NCT01971658|Multiple myeloma|multiple myeloma
232126|NCT01971658|Newly Diagnosed|newly diagnosed
232127|NCT01971645|Dexamethasone|dexamethasone
232128|NCT01971645|Ropivacaine|ropivacaine
232129|NCT01971645|Knee arthroscopy|knee arthroscopy
232130|NCT01971645|Femoral nerve blocks|femoral nerve blocks
232131|NCT01971645|Peripheral nerve blocks|peripheral nerve blocks
232132|NCT01971645|Adjuvant|adjuvant
232133|NCT01971645|Pediatrics|pediatrics
232134|NCT01971606|Statin, coronary artery bypass grafting, off-pump surgery, acute coronary syndrome|statin, coronary artery bypass grafting, off-pump surgery, acute coronary syndrome
232135|NCT01971567|Insomnia|insomnia
232136|NCT01971567|Electroencephalic|electroencephalic
232137|NCT01971567|Biofeedback|biofeedback
232138|NCT01971567|Neural oscillations|neural oscillations
232139|NCT01971567|Auto calibration|auto calibration
232140|NCT01971567|Relaxation|relaxation
232141|NCT01971541|mindfulness|mindfulness
232142|NCT01971541|behavior therapies, cognitive|behavior therapies, cognitive
232143|NCT01971541|posttraumatic stress disorder|posttraumatic stress disorder
232144|NCT01971541|group therapy|group therapy
232145|NCT01971528|Muscle strength, fatigue, electromyography (EMG), central fatigue, strength straining|muscle strength, fatigue, electromyography (emg), central fatigue, strength straining
232146|NCT01971515|MSC2363318A|msc2363318a
232147|NCT01971515|Maximum tolerated dose|maximum tolerated dose
232148|NCT01971515|Dose limiting toxicities|dose limiting toxicities
232149|NCT01971515|Recommended phase 2 dose|recommended phase 2 dose
232150|NCT01971515|M2698|m2698
232151|NCT01971515|Metastatic Breast Cancer|metastatic breast cancer
232152|NCT01971515|HER2+ Metastatic Breast Cancer|her2+ metastatic breast cancer
232153|NCT01971515|Hormone refractory ER/PR+ breast cancer|hormone refractory er/pr+ breast cancer
232155|NCT01971515|PAM Pathway Alteration(s)|pam pathway alteration(s)
232156|NCT01971515|PAM Pathway|pam pathway
232157|NCT01971515|Targeted Therapy|targeted therapy
232158|NCT01971515|P70S6K|p70s6k
232159|NCT01971515|AKT Inhibition|akt inhibition
232160|NCT01971515|PI3K Pathway|pi3k pathway
232161|NCT01971515|HER2+ Trastuzumab Resistance|her2+ trastuzumab resistance
232162|NCT01971450|Non-interventional|non-interventional
232163|NCT01971450|Ventavis|ventavis
232164|NCT01971450|Iloprost|iloprost
232165|NCT01971450|Pulmonary hypertension|pulmonary hypertension
232166|NCT01971450|Compliance|compliance
232167|NCT01971450|Russian Federation|russian federation
232168|NCT01971437|Overactive Bladder|overactive bladder
232169|NCT01971437|OAB|oab
232170|NCT01971437|Cystoscopy|cystoscopy
232171|NCT01971437|Cystodistension|cystodistension
232172|NCT01971437|UTI|uti
232173|NCT01971437|Cytokines|cytokines
232174|NCT01971424|magnesium|magnesium
232175|NCT01971424|SPPB|sppb
232176|NCT01971424|strength|strength
232177|NCT01971424|physical performance|physical performance
232178|NCT01971424|24 hour magnesuria|24 hour magnesuria
232179|NCT01971411|Hyperparathyroidism|hyperparathyroidism
232180|NCT01971411|Hypoparathyroidism|hypoparathyroidism
232181|NCT01971411|Calcium|calcium
232182|NCT01971411|Vitamin D|vitamin d
232183|NCT01971411|Bone mineral density|bone mineral density
232184|NCT01971411|African American|african american
232185|NCT01971411|Female|female
232186|NCT01971411|Elderly|elderly
232187|NCT01971398|Fetal Alcohol Spectrum Disorders (FASD)|fetal alcohol spectrum disorders (fasd)
232188|NCT01971398|Prevention|prevention
232189|NCT01971398|Alcohol-Exposed Pregnancy|alcohol-exposed pregnancy
232190|NCT01971398|Knowledge|knowledge
232191|NCT01971398|Attitudes|attitudes
232192|NCT01971359|Stroke, Intracerebral Hemorrhage, ICH|stroke, intracerebral hemorrhage, ich
232193|NCT01971346|Psoriasis|psoriasis
232194|NCT01971346|ENBREL|enbrel
232195|NCT01971346|etanercept|etanercept
232196|NCT01971346|anti-TNF|anti-tnf
232197|NCT01971333|pulse pressure variation|pulse pressure variation
232198|NCT01971333|stroke volume variation|stroke volume variation
232302|NCT01970852|Inpatient|inpatient
232199|NCT01971333|plethysmographic variation index|plethysmographic variation index
232200|NCT01971333|fluid responsiveness|fluid responsiveness
232201|NCT01971294|Urinary symptoms|urinary symptoms
232202|NCT01971294|Systemic sclerosis|systemic sclerosis
232203|NCT01971294|Severity index|severity index
232204|NCT01971294|Urinary tract infection|urinary tract infection
232205|NCT01971294|mortality|mortality
232206|NCT01971294|Quality of life|quality of life
232207|NCT01971281|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
232208|NCT01971281|Pancreas tumor|pancreas tumor
232209|NCT01971281|Treatment|treatment
232210|NCT01971281|Minimal toxicity|minimal toxicity
232211|NCT01971281|TTFields|ttfields
232212|NCT01971281|Tumor Treating Fields|tumor treating fields
232213|NCT01971281|Novocure|novocure
232214|NCT01971268|T3 dental implants|t3 dental implants
232215|NCT01971268|Marginal bone loss|marginal bone loss
232216|NCT01971268|Survival rate|survival rate
232217|NCT01971255|Influenza A|influenza a
232218|NCT01971255|HAI|hai
232219|NCT01971255|H1N1|h1n1
232220|NCT01971255|Challenge Study|challenge study
232221|NCT01971255|Correlates of Protection|correlates of protection
232222|NCT01971242|Parkinson's|parkinson's
232223|NCT01971242|Parkinson's Disease|parkinson's disease
232224|NCT01971242|Exenatide|exenatide
232225|NCT01971242|Bydureon|bydureon
232226|NCT01971216|Breastfeeding, relaxation, anxiety, infant growth|breastfeeding, relaxation, anxiety, infant growth
232227|NCT01971203|seroquel XR|seroquel xr
232228|NCT01971203|quetiapine XR|quetiapine xr
232229|NCT01971203|major depression|major depression
232230|NCT01971203|generalized anxiety disorder|generalized anxiety disorder
232231|NCT01971203|CBT|cbt
232232|NCT01971203|co-morbid MDD|co-morbid mdd
232233|NCT01971164|anemia|anemia
232234|NCT01971164|chronic kidney disease|chronic kidney disease
232235|NCT01971164|hemodialysis|hemodialysis
232236|NCT01971151|Chronic|chronic
232237|NCT01971151|Back pain|back pain
232238|NCT01971151|Low back|low back
232239|NCT01971125|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
232240|NCT01971125|Heart Diseases|heart diseases
232241|NCT01971125|Left Ventricular Dysfunction|left ventricular dysfunction
232242|NCT01971112|Multi-vitamins|multi-vitamins
232243|NCT01971112|Minerals|minerals
232244|NCT01971112|Respiratory infections|respiratory infections
232245|NCT01971112|DTH|dth
232246|NCT01971112|CRP|crp
232247|NCT01971112|Cathelicidin|cathelicidin
232248|NCT01971099|sexual function|sexual function
232249|NCT01971099|hypoactive|hypoactive
232250|NCT01971099|desire|desire
232251|NCT01971099|androgens|androgens
232252|NCT01971073|schizophrenic patients|schizophrenic patients
232253|NCT01971073|tDCS|tdcs
232254|NCT01971073|Executive functions|executive functions
232255|NCT01971073|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
232256|NCT01971060|uterine fibroids|uterine fibroids
232257|NCT01971060|barbed suture|barbed suture
232258|NCT01971060|infertility|infertility
232259|NCT01971060|adhesions|adhesions
232260|NCT01971047|Diabetes|diabetes
232261|NCT01971047|Surgery|surgery
232262|NCT01971047|anesthesiology|anesthesiology
232263|NCT01971047|endocrinology|endocrinology
232264|NCT01970995|Candidate modified risk tobacco product|candidate modified risk tobacco product
232265|NCT01970995|Conventional cigarettes|conventional cigarettes
232266|NCT01970995|Reduced exposure|reduced exposure
232267|NCT01970995|HPHCs|hphcs
232268|NCT01970995|Ambulatory|ambulatory
232269|NCT01970982|Candidate modified risk tobacco product|candidate modified risk tobacco product
232270|NCT01970982|Conventional cigarette|conventional cigarette
232271|NCT01970982|Reduced exposure|reduced exposure
232272|NCT01970982|HPHCs|hphcs
232273|NCT01970982|Confinement|confinement
232274|NCT01970969|Atrial Fibrillation|atrial fibrillation
232275|NCT01970969|Cardiac monitoring|cardiac monitoring
232276|NCT01970969|Genomics|genomics
232277|NCT01970943|migraine, headache, episodic, chronic, pain|migraine, headache, episodic, chronic, pain
232278|NCT01970930|Tissue banking|tissue banking
232279|NCT01970917|tear film thickness|tear film thickness
232280|NCT01970917|optical coherence tomography|optical coherence tomography
232281|NCT01970917|topical lubricants|topical lubricants
232282|NCT01970917|tear film thickness in healthy subjects|tear film thickness in healthy subjects
232283|NCT01970904|Chronic hepatitis C|chronic hepatitis c
232284|NCT01970904|DEB025|deb025
232285|NCT01970904|Alisporivir|alisporivir
232286|NCT01970904|ribavirin therapy|ribavirin therapy
232287|NCT01970904|genotype 2/3 treatment naive patients|genotype 2/3 treatment naive patients
232288|NCT01970891|Freezing of Gait|freezing of gait
232289|NCT01970891|Gait|gait
232290|NCT01970891|Comfort|comfort
232291|NCT01970891|Pain tolerance|pain tolerance
232292|NCT01970891|Pain|pain
232293|NCT01970891|Sensory threshold|sensory threshold
232294|NCT01970891|Motor threshold|motor threshold
232295|NCT01970891|Pain threshold|pain threshold
232296|NCT01970865|Phase 1|phase 1
232297|NCT01970865|Phase 2|phase 2
232298|NCT01970865|safety|safety
232299|NCT01970865|pharmacokinetic|pharmacokinetic
232300|NCT01970865|pharmacodynamic|pharmacodynamic
232301|NCT01970865|efficacy|efficacy
232303|NCT01970852|PHR Portal|phr portal
232304|NCT01970852|Information Technology|information technology
232305|NCT01970839|Tourniquet|tourniquet
232306|NCT01970839|Endoneural|endoneural
232307|NCT01970839|Ischemia|ischemia
232308|NCT01970826|aseptic sterilized field|aseptic sterilized field
232309|NCT01970826|clean sterilized field|clean sterilized field
232310|NCT01970826|dental implants|dental implants
232311|NCT01970826|Surgery|surgery
232312|NCT01970813|Parkinson's disease|parkinson's disease
232313|NCT01970813|Idiopathic Parkinson's disease|idiopathic parkinson's disease
232314|NCT01970813|acupuncture|acupuncture
232315|NCT01970813|bee venom acupuncture|bee venom acupuncture
232316|NCT01970800|IGF-1|igf-1
232317|NCT01970800|Short Stature|short stature
232318|NCT01970800|GH|gh
232319|NCT01970748|Variceal bleeding|variceal bleeding
232320|NCT01970748|Portal hypertension|portal hypertension
232321|NCT01970748|Hepatocellular carcinoma|hepatocellular carcinoma
232322|NCT01970748|Endoscopic variceal ligation|endoscopic variceal ligation
232323|NCT01970748|Non-selective beta-blocker|non-selective beta-blocker
232324|NCT01970709|Adverse Drug Reactions|adverse drug reactions
232325|NCT01970709|Emergency Department Visits|emergency department visits
232326|NCT01970709|Hospitalizations|hospitalizations
232327|NCT01970709|Pharmacogenomic|pharmacogenomic
232328|NCT01970696|ovarian|ovarian
232329|NCT01970696|testicular|testicular
232330|NCT01970696|stromal|stromal
232331|NCT01970696|Sertoli|sertoli
232332|NCT01970696|Leydig|leydig
232333|NCT01970696|gynandroblastoma|gynandroblastoma
232334|NCT01970696|juvenile granulosa cell tumor|juvenile granulosa cell tumor
232335|NCT01970696|DICER1|dicer1
232336|NCT01970657|Venous Stasis Ulcer|venous stasis ulcer
232337|NCT01970657|VLU|vlu
232338|NCT01970644|Neoplasm metastasis|neoplasm metastasis
232339|NCT01970644|Brain neoplasms|brain neoplasms
232340|NCT01970644|Radiosurgery|radiosurgery
232341|NCT01970644|Cognition disorders|cognition disorders
232342|NCT01970644|Cranial irradiation|cranial irradiation
232343|NCT01970631|Osteoarthritis|osteoarthritis
232344|NCT01970631|Total Knee Replacement|total knee replacement
232345|NCT01970631|total Knee Arthroplasty|total knee arthroplasty
232346|NCT01970631|Post-operative recovery TKR|post-operative recovery tkr
232347|NCT01970631|Physical Activity|physical activity
232348|NCT01970631|Motivational Interviewing|motivational interviewing
232349|NCT01970631|Financial Incentives|financial incentives
232350|NCT01970592|exercise|exercise
232351|NCT01970592|rehabilitation|rehabilitation
232352|NCT01970592|walking|walking
232353|NCT01970566|Intense Exercise/Moderate Calorie Restriction|intense exercise/moderate calorie restriction
232354|NCT01970566|Topiramate-Phentermine|topiramate-phentermine
232356|NCT01970553|PM01183|pm01183
232357|NCT01970553|tumors|tumors
232358|NCT01970553|cancer|cancer
232359|NCT01970553|Pharma Mar|pharma mar
232360|NCT01970540|lurbinectedin|lurbinectedin
232361|NCT01970540|PM01183|pm01183
232362|NCT01970540|tumors|tumors
232363|NCT01970540|cancer|cancer
232364|NCT01970540|Pharma Mar|pharma mar
232365|NCT01970501|atrial fibrillation|atrial fibrillation
232366|NCT01970501|atrial flutter|atrial flutter
232367|NCT01970501|heart failure|heart failure
232368|NCT01970501|reduced left ventricle ejection fraction|reduced left ventricle ejection fraction
232369|NCT01970501|electrical cardioversion|electrical cardioversion
232370|NCT01970501|GENETIC-AF|genetic-af
232371|NCT01970501|Medtronic|medtronic
232372|NCT01970501|bucindolol|bucindolol
232373|NCT01970501|pharmacogenetic|pharmacogenetic
232374|NCT01970501|ARCA|arca
232375|NCT01970501|Toprol|toprol
232376|NCT01970501|Toprol-XL|toprol-xl
223113|NCT02012647|PD|pd
232377|NCT01970501|Metoprolol|metoprolol
232378|NCT01970501|Metoprolol succinate|metoprolol succinate
232379|NCT01970488|Plaque Psoriasis|plaque psoriasis
232380|NCT01970475|Arthritis|arthritis
232381|NCT01970475|Rheumatoid|rheumatoid
232382|NCT01970436|Prenatal care|prenatal care
232383|NCT01970436|Pregnancy|pregnancy
232384|NCT01970436|Obstetrics|obstetrics
232385|NCT01970436|Telemedicine|telemedicine
232386|NCT01970423|Patients with pacemaker or ICD therapy|patients with pacemaker or icd therapy
232387|NCT01970410|teriflunomide|teriflunomide
232388|NCT01970410|natalizumab|natalizumab
232389|NCT01970410|relapsing multiple sclerosis|relapsing multiple sclerosis
232390|NCT01970384|transcranial direct current stimulation|transcranial direct current stimulation
232391|NCT01970384|stroke-related dysphagia|stroke-related dysphagia
232392|NCT01970384|cortical plasticity|cortical plasticity
232393|NCT01970371|Gram-negative|gram-negative
232394|NCT01970371|bacterial infection|bacterial infection
232395|NCT01970371|antibacterial|antibacterial
232396|NCT01970371|antimicrobial|antimicrobial
232397|NCT01970371|CRE|cre
232398|NCT01970371|CPE|cpe
232399|NCT01970371|BSI|bsi
232400|NCT01970371|pneumonia|pneumonia
232401|NCT01970371|HABP|habp
232402|NCT01970371|VABP|vabp
232403|NCT01970371|AP|ap
232404|NCT01970371|cUTI|cuti
232405|NCT01970371|UTI|uti
232406|NCT01970358|melanoma|melanoma
232407|NCT01970358|melanoma vaccine|melanoma vaccine
232408|NCT01970358|adjuvant therapy|adjuvant therapy
232409|NCT01970345|Autism Spectrum Disorder|autism spectrum disorder
232410|NCT01970345|IGF-1|igf-1
232411|NCT01970332|Peripheral Arterial Disease|peripheral arterial disease
232412|NCT01970332|Peripheral Vascular Disease|peripheral vascular disease
232413|NCT01970332|Claudication|claudication
232414|NCT01970332|Myopathy|myopathy
232415|NCT01970332|Oxidative stress|oxidative stress
232416|NCT01970332|Mitochondrial dysfunction|mitochondrial dysfunction
232417|NCT01970332|Biomechanics|biomechanics
232418|NCT01970332|Inflammation|inflammation
232419|NCT01970306|Esophageal Reinforcement|esophageal reinforcement
232420|NCT01970306|ACell MatriStem|acell matristem
232421|NCT01970306|13-178|13-178
232422|NCT01970293|Alcohol use|alcohol use
232423|NCT01970293|STI|sti
232424|NCT01970293|Incarcerated women|incarcerated women
232425|NCT01970293|AA|aa
232426|NCT01970254|hepatitis B virus infection|hepatitis b virus infection
232427|NCT01970254|HBV|hbv
232428|NCT01970254|Cancer Patients|cancer patients
232429|NCT01970254|chemotherapy|chemotherapy
232430|NCT01970254|HBV screening strategy|hbv screening strategy
232431|NCT01970254|HBV care|hbv care
232432|NCT01970254|chronic HBV|chronic hbv
232433|NCT01970254|concomitant HBV infection|concomitant hbv infection
232434|NCT01970254|viral infections|viral infections
232435|NCT01970241|corticosteroid|corticosteroid
232436|NCT01970241|diabetes|diabetes
232437|NCT01970241|insulin|insulin
232438|NCT01970202|obesity|obesity
232439|NCT01970202|overweight|overweight
232440|NCT01970202|sleeve gastrectomy|sleeve gastrectomy
232441|NCT01970189|Immune Thrombocytopenia|immune thrombocytopenia
232442|NCT01970189|Primary Immune Thrombocytopenia|primary immune thrombocytopenia
232443|NCT01970189|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
232444|NCT01970189|Autoimmune Thrombocytopenia|autoimmune thrombocytopenia
232445|NCT01970189|Thrombocytopenia|thrombocytopenia
232446|NCT01970163|Diabetic foot ulcer|diabetic foot ulcer
232447|NCT01970163|Venous stasis ulcer|venous stasis ulcer
232448|NCT01970163|Wound of the lower extremity|wound of the lower extremity
232449|NCT01970163|Skin substitute|skin substitute
232450|NCT01970163|Acellular Dermal Matrix|acellular dermal matrix
232451|NCT01970150|rTMS|rtms
232452|NCT01970150|Alzheimer Disease|alzheimer disease
232453|NCT01970150|Memory|memory
232454|NCT01970150|attention|attention
232455|NCT01970150|EEG|eeg
232456|NCT01970137|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
232457|NCT01970137|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
232458|NCT01970137|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
232459|NCT01970124|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
232460|NCT01970124|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
232461|NCT01970124|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
232462|NCT01970111|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
232463|NCT01970111|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
232464|NCT01970111|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
232465|NCT01970111|Cortical Cerebellar Atrophy (CCA)|cortical cerebellar atrophy (cca)
232466|NCT01970098|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
232467|NCT01970098|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
232468|NCT01970098|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
232469|NCT01970098|Cortical Cerebellar Atrophy (CCA)|cortical cerebellar atrophy (cca)
232470|NCT01970072|Remimazolam Tosylate|remimazolam tosylate
232471|NCT01970072|Phase Ⅰ study|phase ⅰ study
223198|NCT02012270|Hernia|hernia
232473|NCT01970059|Hypertension|hypertension
232475|NCT01970046|Phase III|phase iii
232476|NCT01970046|combination therapy|combination therapy
232477|NCT01970033|SP2086|sp2086
232478|NCT01970033|Phase III|phase iii
232479|NCT01970033|Monotherapy|monotherapy
232480|NCT01970020|Healthy|healthy
232481|NCT01970020|JNJ-38518168|jnj-38518168
232482|NCT01970020|14C-JNJ-38518168|14c-jnj-38518168
232483|NCT01970020|Absorption|absorption
232484|NCT01970020|Metabolism|metabolism
232485|NCT01970020|Excretion|excretion
232486|NCT01970007|venous|venous
232487|NCT01970007|outflow obstruction|outflow obstruction
232488|NCT01970007|iliofemoral vein|iliofemoral vein
232489|NCT01969994|Epicatechin|epicatechin
232490|NCT01969994|Flavanols|flavanols
232491|NCT01969994|Procyanidins|procyanidins
232492|NCT01969994|Polyphenols|polyphenols
232493|NCT01969994|Phytonutrients|phytonutrients
232494|NCT01969994|AMDE|amde
232495|NCT01969994|Antioxidants|antioxidants
232496|NCT01969981|Peripheral Inserted Central Catheter|peripheral inserted central catheter
232497|NCT01969955|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
232498|NCT01969955|Squamous Cell Carcinoma of Lung|squamous cell carcinoma of lung
232499|NCT01969942|Ewings sarcoma|ewings sarcoma
232500|NCT01969916|Cardiac CT imaging|cardiac ct imaging
232501|NCT01969916|Myocardial ischemia|myocardial ischemia
232502|NCT01969916|Myocardial perfusion|myocardial perfusion
232503|NCT01969916|Vasodilator stress testing|vasodilator stress testing
232504|NCT01969916|Regadenoson|regadenoson
232505|NCT01969903|brachial plexus block|brachial plexus block
232506|NCT01969903|lidocaine|lidocaine
232507|NCT01969903|dexmedetomidine|dexmedetomidine
232508|NCT01969903|bradycardia|bradycardia
232509|NCT01969903|hypotension|hypotension
232510|NCT01969877|Head and neck cancer|head and neck cancer
232511|NCT01969877|Cetuximab|cetuximab
232512|NCT01969877|Cisplatin|cisplatin
232513|NCT01969877|Radiotherapy|radiotherapy
232514|NCT01969877|Quality of life|quality of life
232515|NCT01969877|Human papilloma virus|human papilloma virus
232516|NCT01969877|Health economy|health economy
232517|NCT01969877|Biomarker investigations|biomarker investigations
232518|NCT01969864|Randomized Controlled Trial|randomized controlled trial
232519|NCT01969864|Healthcare Disparities|healthcare disparities
232520|NCT01969851|Lacosamide|lacosamide
232521|NCT01969851|Vimpat|vimpat
232522|NCT01969851|Epilepsy|epilepsy
232523|NCT01969851|Children|children
232524|NCT01969825|Infertility|infertility
232525|NCT01969825|Intrauterine insemination|intrauterine insemination
232526|NCT01969825|Male factor infertility|male factor infertility
232527|NCT01969825|Massage|massage
232528|NCT01969825|Total motile sperm count|total motile sperm count
232529|NCT01969812|Infertility|infertility
232530|NCT01969812|Intrauterine Insemination|intrauterine insemination
232531|NCT01969812|Slow-release Insemination|slow-release insemination
232532|NCT01969812|Evie|evie
232533|NCT01969799|Gram-negative pneumonia|gram-negative pneumonia
232534|NCT01969799|Aerosol antibiotics|aerosol antibiotics
232535|NCT01969799|Mechanical ventilation|mechanical ventilation
232536|NCT01969799|Amikacin|amikacin
232537|NCT01969799|Fosfomycin|fosfomycin
232538|NCT01969799|Pneumonia, Bacterial|pneumonia, bacterial
232539|NCT01969799|Pneumonia|pneumonia
232540|NCT01969799|Bacterial Infections|bacterial infections
232541|NCT01969799|Lung Diseases|lung diseases
232542|NCT01969799|Respiratory Tract Diseases|respiratory tract diseases
232543|NCT01969799|Respiratory Tract Infections|respiratory tract infections
232544|NCT01969799|Anti-Bacterial Agents|anti-bacterial agents
232545|NCT01969799|Anti-Infective Agents|anti-infective agents
232546|NCT01969799|Therapeutic Uses|therapeutic uses
232547|NCT01969799|Pharmacologic Actions|pharmacologic actions
232548|NCT01969773|Botulinum Toxin A (BoNT-A)|botulinum toxin a (bont-a)
232549|NCT01969773|Interstitial Cystitis|interstitial cystitis
232550|NCT01969734|Emphysema|emphysema
232551|NCT01969734|Moderate COPD|moderate copd
232552|NCT01969734|Hyperinflation|hyperinflation
232553|NCT01969734|Endobronchial valves|endobronchial valves
232554|NCT01969695|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
232556|NCT01969695|Safety|safety
232557|NCT01969695|Refractory|refractory
232558|NCT01969695|GDC-0199|gdc-0199
232559|NCT01969695|Relapsed|relapsed
232560|NCT01969695|Cancer|cancer
232561|NCT01969682|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
232562|NCT01969682|GDC-0199|gdc-0199
232563|NCT01969682|Safety|safety
232564|NCT01969682|Relapsed|relapsed
232565|NCT01969682|Refractory|refractory
232566|NCT01969682|ABT-199|abt-199
232567|NCT01969682|Pharmacokinetics|pharmacokinetics
232568|NCT01969682|Cancer|cancer
232569|NCT01969669|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
232570|NCT01969669|GDC-0199|gdc-0199
232571|NCT01969669|Safety|safety
232572|NCT01969669|Relapsed|relapsed
232573|NCT01969669|Refractory|refractory
232574|NCT01969669|ABT-199|abt-199
232575|NCT01969669|Pharmacokinetics|pharmacokinetics
286011|NCT01726712|HIV|hiv
232576|NCT01969669|Cancer|cancer
232577|NCT01969656|vitamin D analog|vitamin d analog
232578|NCT01969643|Breast cancer|breast cancer
232579|NCT01969643|Monomethyl auristatin E|monomethyl auristatin e
232580|NCT01969643|Antibody-drug conjugate|antibody-drug conjugate
232581|NCT01969643|Drug therapy|drug therapy
232582|NCT01969643|Metastatic|metastatic
232583|NCT01969643|LIV-1 protein, human|liv-1 protein, human
232584|NCT01969643|Trastuzumab|trastuzumab
232585|NCT01969630|femoropopliteal lesions|femoropopliteal lesions
232586|NCT01969604|Rheumatoid Arthritis|rheumatoid arthritis
232587|NCT01969604|Sedentary Behaviour|sedentary behaviour
232588|NCT01969604|Motivational Counselling|motivational counselling
232589|NCT01969604|Short Text Message Service|short text message service
232590|NCT01969604|Fatigue|fatigue
232591|NCT01969604|Pain|pain
232592|NCT01969604|Self-efficacy|self-efficacy
232593|NCT01969604|ActivPAL|activpal
232594|NCT01969591|Fast track surgery, Laparoscopic surgery, colorectal cancer|fast track surgery, laparoscopic surgery, colorectal cancer
232595|NCT01969578|salivary duct cancer|salivary duct cancer
232596|NCT01969578|adenocarcinoma, NOS|adenocarcinoma, nos
232597|NCT01969578|androgen deprivation|androgen deprivation
232598|NCT01969578|androgen receptor|androgen receptor
232599|NCT01969552|TSH, thyroid hormones, thyroid tresting, levothyroxine|tsh, thyroid hormones, thyroid tresting, levothyroxine
232600|NCT01969526|Frail elderly|frail elderly
232601|NCT01969513|Vestibular Diseases|vestibular diseases
232602|NCT01969513|Vertigo|vertigo
232603|NCT01969513|Primary care|primary care
232604|NCT01969513|Epley maneuver|epley maneuver
232605|NCT01969500|Schizophrenia|schizophrenia
232606|NCT01969500|Schizoaffective Disorder|schizoaffective disorder
232607|NCT01969500|Self Management of Schizophrenia|self management of schizophrenia
232608|NCT01969500|SOS|sos
232609|NCT01969500|SMI|smi
232610|NCT01969500|Psychosis|psychosis
232611|NCT01969500|Social Dysfunction|social dysfunction
232612|NCT01969500|Medication Adherence|medication adherence
232613|NCT01969500|Mobile Application|mobile application
232614|NCT01969500|EHealth|ehealth
232615|NCT01969500|E-Health|e-health
232616|NCT01969500|Health Technology|health technology
232617|NCT01969500|mHealth|mhealth
232618|NCT01969500|m-Health|m-health
232619|NCT01969474|Tinnitus Cannabis|tinnitus cannabis
232620|NCT01969461|HIV positive|hiv positive
232621|NCT01969461|Adolescents|adolescents
232622|NCT01969461|Adolescent Trials Network|adolescent trials network
232623|NCT01969461|Comparative Effectiveness Trial|comparative effectiveness trial
232624|NCT01969461|Implementation|implementation
232625|NCT01969461|Adherence Intervention|adherence intervention
232626|NCT01969461|Alcohol Intervention|alcohol intervention
232627|NCT01969448|Nipple-areola skin sparing mastectomy|nipple-areola skin sparing mastectomy
232628|NCT01969448|Immediate reconstruction|immediate reconstruction
232629|NCT01969448|Prophylactic Mastectomy|prophylactic mastectomy
232630|NCT01969448|Breast-Q|breast-q
232631|NCT01969448|Breast Cancer|breast cancer
232632|NCT01969448|Ductal Carcinoma in Situ - Category|ductal carcinoma in situ - category
232633|NCT01969409|Lung|lung
232634|NCT01969409|Fibrosis|fibrosis
232635|NCT01969396|Biopsy|biopsy
232636|NCT01969396|Endometrial biopsy|endometrial biopsy
232637|NCT01969396|Endometrial sampling|endometrial sampling
232638|NCT01969396|sonohysterography|sonohysterography
232639|NCT01969383|healthy|healthy
232640|NCT01969370|Cancer|cancer
232641|NCT01969370|Cardiovascular disease|cardiovascular disease
232642|NCT01969370|Neurodegenerative disease|neurodegenerative disease
232643|NCT01969370|Neurodevelopmental disease|neurodevelopmental disease
232644|NCT01969370|Dysmorphology|dysmorphology
232645|NCT01969370|Hearing loss|hearing loss
232646|NCT01969370|Other conditions, including ophthalmic conditions|other conditions, including ophthalmic conditions
232647|NCT01969357|Sp2086|sp2086
232648|NCT01969357|Phase II|phase ii
232649|NCT01969357|monotherapy|monotherapy
232650|NCT01969331|Gastritis|gastritis
232651|NCT01969331|Helicobacter pylori|helicobacter pylori
232652|NCT01969318|SP2086|sp2086
232653|NCT01969318|Phase II|phase ii
232654|NCT01969318|combination therapy|combination therapy
232655|NCT01969305|Kazakhstan|kazakhstan
232656|NCT01969305|Central Asia|central asia
232657|NCT01969305|HIV prevention|hiv prevention
232658|NCT01969305|Adolescents|adolescents
232659|NCT01969305|Sexual risk behaviors|sexual risk behaviors
232660|NCT01969305|Drug abuse prevention|drug abuse prevention
232661|NCT01969305|Multi-media intervention|multi-media intervention
232662|NCT01969305|Drug use|drug use
232663|NCT01969292|colonoscopy|colonoscopy
232664|NCT01969292|quality assurance|quality assurance
232665|NCT01969279|Osteoporosis|osteoporosis
232666|NCT01969279|Bisphosphonate|bisphosphonate
232667|NCT01969279|Atypical femoral fracture|atypical femoral fracture
232668|NCT01969279|Side effect|side effect
232669|NCT01969266|Healthy volunteer|healthy volunteer
232670|NCT01969266|PCI-32765|pci-32765
232671|NCT01969266|PCI 45227|pci 45227
232672|NCT01969266|JNJ-54179060|jnj-54179060
232673|NCT01969266|Pharmacokinetic|pharmacokinetic
232674|NCT01969253|Breast Cancer, Axillary Lymph Node Dissection, Lymphedema|breast cancer, axillary lymph node dissection, lymphedema
232675|NCT01969240|Chest Pain|chest pain
232676|NCT01969240|Decision Aid|decision aid
232677|NCT01969240|Acute Coronary Syndrome|acute coronary syndrome
232679|NCT01969240|Emergency Department|emergency department
232680|NCT01969240|Cardiac Testing|cardiac testing
232681|NCT01969240|Healthcare Utilization|healthcare utilization
232682|NCT01969240|Patient Centered Outcomes|patient centered outcomes
232683|NCT01969240|Shared Decision Making|shared decision making
232684|NCT01969240|Unnecessary hospital admissions|unnecessary hospital admissions
232685|NCT01969201|In vitro fertilization (IVF)|in vitro fertilization (ivf)
232686|NCT01969201|Assisted reproduction technologies (ART)|assisted reproduction technologies (art)
232687|NCT01969201|GnRH-antagonist|gnrh-antagonist
586130|NCT00523575|nutritional support|nutritional support
232688|NCT01969201|Follicle stimulating hormone (FSH)|follicle stimulating hormone (fsh)
232689|NCT01969188|spondyloarthritis|spondyloarthritis
232690|NCT01969188|ankylosing spondylitis|ankylosing spondylitis
232691|NCT01969188|psoriatic arthritis|psoriatic arthritis
232692|NCT01969149|Stress Hyperglycemia|stress hyperglycemia
232693|NCT01969149|Perioperative glycemic control|perioperative glycemic control
232694|NCT01969149|Cardiac surgery|cardiac surgery
232695|NCT01969149|Coronary artery bypass surgery|coronary artery bypass surgery
232696|NCT01969136|Alzheimer's disease|alzheimer's disease
232697|NCT01969136|Cognition|cognition
232698|NCT01969136|Alpha-7 nAChR|alpha-7 nachr
232699|NCT01969123|Alzheimer's disease|alzheimer's disease
232700|NCT01969123|Cognition|cognition
232701|NCT01969123|Alpha-7 nAChR|alpha-7 nachr
232702|NCT01969110|Immunonutrition|immunonutrition
232704|NCT01969097|Hemiparesis|hemiparesis
232705|NCT01969097|tDCS|tdcs
232706|NCT01969097|Motor cortex|motor cortex
232707|NCT01969084|Type II Diabetes Mellitus|type ii diabetes mellitus
232708|NCT01969084|Diabetes|diabetes
232709|NCT01969084|Metabolism|metabolism
232710|NCT01969084|Linagliptin|linagliptin
232711|NCT01969084|Tradjenta|tradjenta
232712|NCT01969084|Glucose|glucose
232713|NCT01969071|levosimendan|levosimendan
232714|NCT01969071|mitral valve surgery|mitral valve surgery
232715|NCT01969071|cardiopulmonary bypass|cardiopulmonary bypass
232716|NCT01969071|serum creatinine|serum creatinine
232717|NCT01969071|estimated glomerular filtration rate|estimated glomerular filtration rate
232718|NCT01969071|ejection fraction|ejection fraction
232719|NCT01969045|felxible bronchoscopy|felxible bronchoscopy
232720|NCT01969045|anaesthetics|anaesthetics
232721|NCT01969045|transcutaneous pCO2|transcutaneous pco2
232722|NCT01969045|capillary pCO2|capillary pco2
232723|NCT01969006|inguinal hernia, postoperative pain, localanesthesia, nerve blockage|inguinal hernia, postoperative pain, localanesthesia, nerve blockage
232724|NCT01968993|Degenerative Disc Disease|degenerative disc disease
232725|NCT01968980|High Risk of cardiovascular events|high risk of cardiovascular events
232726|NCT01968980|Heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
232727|NCT01968967|mixed dyslipidemia|mixed dyslipidemia
232728|NCT01968967|high risk of cardiovascular events|high risk of cardiovascular events
232729|NCT01968967|multiple cardiovascular disease risk factors|multiple cardiovascular disease risk factors
232730|NCT01968954|mixed dyslipidemia|mixed dyslipidemia
232731|NCT01968954|high risk of cardiovascular events|high risk of cardiovascular events
232732|NCT01968941|stereotactic body radiotherapy|stereotactic body radiotherapy
232733|NCT01968941|conventional radiotherapy|conventional radiotherapy
232734|NCT01968941|inoperable patients|inoperable patients
232735|NCT01968941|local control|local control
232736|NCT01968941|cancer recurrence|cancer recurrence
232737|NCT01968941|toxicity|toxicity
232738|NCT01968941|survival|survival
232739|NCT01968928|Bladder urothelial carcinoma (UC)|bladder urothelial carcinoma (uc)
232740|NCT01968928|pyruvate kinase|pyruvate kinase
232741|NCT01968928|drug resistance|drug resistance
232742|NCT01968928|shikonin|shikonin
232743|NCT01968915|LCL161, Paclitaxel, Japanese patient, Neoplasms|lcl161, paclitaxel, japanese patient, neoplasms
232744|NCT01968902|spasticity|spasticity
232745|NCT01968902|lower limb|lower limb
232746|NCT01968902|multiple sclerosis|multiple sclerosis
232748|NCT01968889|Critical illness neuromyopathy|critical illness neuromyopathy
232749|NCT01968889|Diaphragm dysfunction|diaphragm dysfunction
232750|NCT01968889|Mechanical ventilation|mechanical ventilation
232751|NCT01968889|Weaning|weaning
232752|NCT01968889|Ultrasound|ultrasound
232753|NCT01968850|osteoporosis|osteoporosis
232754|NCT01968850|HIV|hiv
232755|NCT01968850|bone Mineral Density|bone mineral density
232756|NCT01968850|alendronate|alendronate
232757|NCT01968850|vitamin D|vitamin d
232758|NCT01968824|pain|pain
232759|NCT01968798|ACES|aces
232760|NCT01968798|ASPREE Cancer Endpoints Study|aspree cancer endpoints study
232761|NCT01968798|Cancer|cancer
232762|NCT01968798|Aspirin|aspirin
232763|NCT01968798|Tumor|tumor
232764|NCT01968772|Fibromyalgia|fibromyalgia
232765|NCT01968772|Fibromyalgia Syndrome|fibromyalgia syndrome
232766|NCT01968772|Magnesium Chloride|magnesium chloride
232767|NCT01968772|Transdermal Magnesium Chloride|transdermal magnesium chloride
232768|NCT01968759|Chronic kidney disease|chronic kidney disease
232769|NCT01968759|Sevelamer carbonate|sevelamer carbonate
232770|NCT01968759|Proteinuria|proteinuria
232771|NCT01968759|Phosphate binders|phosphate binders
232772|NCT01968746|Sepsis|sepsis
232773|NCT01968746|Shock|shock
232774|NCT01968733|Pneumonia|pneumonia
232775|NCT01968733|CABP|cabp
232776|NCT01968733|CAP|cap
232777|NCT01968733|Macrolide|macrolide
232778|NCT01968707|surgical prep|surgical prep
232779|NCT01968707|CHG|chg
232780|NCT01968707|IPA|ipa
232781|NCT01968694|endometriosis|endometriosis
232782|NCT01968694|chronic pain|chronic pain
232783|NCT01968694|intravenous lidocaine|intravenous lidocaine
232784|NCT01968668|BAY94-8862|bay94-8862
232785|NCT01968668|MR antagonist|mr antagonist
232786|NCT01968668|Diabetic nephropathy|diabetic nephropathy
232787|NCT01968668|Japanese patients|japanese patients
232788|NCT01968655|Factor VIII Inhibitory Auto-antibodies|factor viii inhibitory auto-antibodies
232789|NCT01968642|Transthoracic echocardiograms|transthoracic echocardiograms
232790|NCT01968642|Appropriate Use Criteria|appropriate use criteria
232791|NCT01968642|Medical Education|medical education
232792|NCT01968629|Hepatocellular Carcinoma|hepatocellular carcinoma
232793|NCT01968590|Vitamin D|vitamin d
232794|NCT01968590|Cholecalciferol|cholecalciferol
232795|NCT01968590|Bone density|bone density
232796|NCT01968577|Coronary angioplasty|coronary angioplasty
232797|NCT01968577|Myocardial infarction|myocardial infarction
232798|NCT01968551|HIV-1|hiv-1
232799|NCT01968551|HIV|hiv
232800|NCT01968551|Treatment-Experienced|treatment-experienced
232801|NCT01968525|anemia|anemia
232802|NCT01968525|non-hypoxic apnoea|non-hypoxic apnoea
232803|NCT01968525|tracheal intubation|tracheal intubation
232804|NCT01968525|anesthesia|anesthesia
232805|NCT01968512|Attention Deficit Hyperactivity Disorder (ADHD);|attention deficit hyperactivity disorder (adhd);
232806|NCT01968512|Transcranial Direct Current Stimulation (tDCS);|transcranial direct current stimulation (tdcs);
232807|NCT01968512|Control Inhibitory;|control inhibitory;
232808|NCT01968512|Quantitative electroencephalography;|quantitative electroencephalography;
232809|NCT01968512|Functional Brain Network;|functional brain network;
232810|NCT01968512|Go/No Go test.|go/no go test.
232811|NCT01968499|coronary stent implantation; clopidogrel low response|coronary stent implantation; clopidogrel low response
232812|NCT01968473|Parkinson's disease|parkinson's disease
232813|NCT01968473|Freezing of Gait|freezing of gait
232814|NCT01968473|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
232815|NCT01968473|Comfort|comfort
232816|NCT01968473|Pain tolerance|pain tolerance
232817|NCT01968473|Pain|pain
232818|NCT01968473|Sensory threshold|sensory threshold
232819|NCT01968473|Motor threshold|motor threshold
232820|NCT01968473|Pain threshold|pain threshold
232821|NCT01968460|Parkinson's Disease, Rasagiline, Pramipexole|parkinson's disease, rasagiline, pramipexole
232822|NCT01968434|cough|cough
232823|NCT01968434|common cold|common cold
232824|NCT01968434|antitussive agents|antitussive agents
232825|NCT01968434|mucosal protection|mucosal protection
232826|NCT01968434|medical device|medical device
232827|NCT01968421|OM-85, bronchiectasis, placebo, acute exacerbation|om-85, bronchiectasis, placebo, acute exacerbation
232828|NCT01968408|nosocomial diarrhea|nosocomial diarrhea
232829|NCT01968408|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
232830|NCT01968408|rotavirus diarrhea|rotavirus diarrhea
232831|NCT01968408|probiotics|probiotics
232832|NCT01968382|IMM 124-E|imm 124-e
232833|NCT01968382|Bovine Colostrum|bovine colostrum
232834|NCT01968382|Alcoholic|alcoholic
232835|NCT01968382|Hepatitis|hepatitis
232836|NCT01968382|LPS|lps
232837|NCT01968382|Hyper-immune|hyper-immune
232838|NCT01968369|flow mediated vasodilatation|flow mediated vasodilatation
232839|NCT01968369|tomato|tomato
232840|NCT01968369|arterial stiffness|arterial stiffness
232841|NCT01968369|lycopene|lycopene
232842|NCT01968356|surgical skin prep|surgical skin prep
232843|NCT01968356|CHG|chg
232844|NCT01968356|IPA|ipa
232678|NCT01969240|Cardiac|cardiac
232845|NCT01968317|Endometrial Atypical Hyperplasia|endometrial atypical hyperplasia
232846|NCT01968317|Endometrial Adenocarcinoma|endometrial adenocarcinoma
232847|NCT01968317|Conservative Medication|conservative medication
232848|NCT01968304|Iron Status, Cancer|iron status, cancer
232849|NCT01968291|Health Literacy|health literacy
232850|NCT01968291|Teach-back|teach-back
232851|NCT01968291|Emergency|emergency
232852|NCT01968265|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
232853|NCT01968265|T2DM|t2dm
232854|NCT01968252|Speckle-tracking echocardiography|speckle-tracking echocardiography
232855|NCT01968252|Transthoracic echocardiography|transthoracic echocardiography
232856|NCT01968252|Transesophageal echocardiography|transesophageal echocardiography
232857|NCT01968239|BRVO|brvo
232858|NCT01968239|Macular edema|macular edema
232859|NCT01968239|Ranibizumab|ranibizumab
232860|NCT01968239|re-treatment|re-treatment
232861|NCT01968226|carotid artery disease|carotid artery disease
232862|NCT01968226|carotid stenosis|carotid stenosis
232863|NCT01968226|carotid endarterectomy|carotid endarterectomy
232864|NCT01968226|RDG-K5|rdg-k5
232865|NCT01968226|PET imaging|pet imaging
232866|NCT01968213|ARIEL3|ariel3
232867|NCT01968213|ARIEL 3|ariel 3
232868|NCT01968213|platinum sensitive|platinum sensitive
232869|NCT01968213|PARP Inhibitor|parp inhibitor
232870|NCT01968213|rucaparib|rucaparib
232871|NCT01968213|homologous recombination|homologous recombination
232872|NCT01968213|homologous recombination deficiency|homologous recombination deficiency
232873|NCT01968213|CO-338|co-338
232874|NCT01968213|PF 01367338|pf 01367338
232875|NCT01968213|AG 14699|ag 14699
232876|NCT01968213|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
232877|NCT01968213|platinum sensitive fallopian tube cancer|platinum sensitive fallopian tube cancer
586234|NCT00523939|Lymphomatous Meningitis|lymphomatous meningitis
232878|NCT01968213|platinum sensitive primary peritoneal cancer|platinum sensitive primary peritoneal cancer
232879|NCT01968213|platinum sensitive peritoneal cancer|platinum sensitive peritoneal cancer
232880|NCT01968213|gynecological cancer|gynecological cancer
232881|NCT01968213|Clovis|clovis
232882|NCT01968213|Clovis Oncology|clovis oncology
232883|NCT01968200|cancer|cancer
232884|NCT01968200|chemotherapy|chemotherapy
232885|NCT01968200|anthracyclines|anthracyclines
232886|NCT01968174|astigmatism|astigmatism
232887|NCT01968174|lid surgery|lid surgery
232888|NCT01968174|older than 40 years|older than 40 years
232889|NCT01968174|can sign an acceptance form|can sign an acceptance form
232890|NCT01968174|uper lid surgery|uper lid surgery
232891|NCT01968148|glucose|glucose
232892|NCT01968148|cardiac arrest|cardiac arrest
232893|NCT01968148|resuscitation|resuscitation
232894|NCT01968148|insulin|insulin
232895|NCT01968148|GLP-1|glp-1
232896|NCT01968122|symptomatic Intracranial artery stenosis|symptomatic intracranial artery stenosis
232897|NCT01968122|conventional treatment|conventional treatment
232898|NCT01968122|stenting|stenting
232899|NCT01968122|stroke prevention|stroke prevention
232900|NCT01968122|medical treatment|medical treatment
232901|NCT01968122|endovascular treatment|endovascular treatment
232902|NCT01968096|Reflex|reflex
232903|NCT01968096|Post activation|post activation
232904|NCT01968096|Spinal cord injury|spinal cord injury
232905|NCT01968096|Pre-synaptic inhibition|pre-synaptic inhibition
232906|NCT01968096|Machine driven passive strech|machine driven passive strech
232907|NCT01968044|renal impairment|renal impairment
232908|NCT01968031|Parkinson's disease|parkinson's disease
232909|NCT01968031|Moderate to Severe Parkinson's Disease|moderate to severe parkinson's disease
232910|NCT01968018|Cancer|cancer
232911|NCT01968018|Chronic Cancer Pain|chronic cancer pain
232912|NCT01968018|Tramadol HCI|tramadol hci
232913|NCT01968018|Acetaminophen|acetaminophen
232914|NCT01968018|Analgesics|analgesics
232915|NCT01968018|Pain assessment|pain assessment
232916|NCT01967992|diabetes|diabetes
232917|NCT01967992|obesity|obesity
232918|NCT01967992|mindful eating|mindful eating
232919|NCT01967992|positive affect|positive affect
232920|NCT01967992|low carbohydrate|low carbohydrate
232921|NCT01967992|ketogenic|ketogenic
232922|NCT01967992|diet|diet
232923|NCT01967940|HIV-1|hiv-1
232925|NCT01967940|Treatment-Experienced|treatment-experienced
232926|NCT01967927|carcinoma|carcinoma
232927|NCT01967927|cancer|cancer
232928|NCT01967927|head|head
232929|NCT01967927|neck|neck
232930|NCT01967927|otolaryngology|otolaryngology
232931|NCT01967901|Diabetic nephropathies|diabetic nephropathies
232932|NCT01967901|Nursing|nursing
232933|NCT01967901|Multidisciplinary|multidisciplinary
232934|NCT01967901|Self-care|self-care
232935|NCT01967901|Quality of Life|quality of life
232936|NCT01967888|Pancreatic islet auto-transplantation|pancreatic islet auto-transplantation
232937|NCT01967875|Gastric Cancer|gastric cancer
232938|NCT01967875|ERCC1|ercc1
232939|NCT01967875|Platinum|platinum
232940|NCT01967875|Chemotherapy|chemotherapy
232941|NCT01967849|obesity|obesity
232942|NCT01967849|type 2 diabetes|type 2 diabetes
232943|NCT01967836|Invasive Line|invasive line
232944|NCT01967836|IV Dressing protection|iv dressing protection
232945|NCT01967836|Hygiene|hygiene
232946|NCT01967836|Oncology|oncology
232947|NCT01967836|Ambulatory Care|ambulatory care
232948|NCT01967823|Metastatic Cancer|metastatic cancer
232949|NCT01967823|Gene Therapy|gene therapy
232950|NCT01967823|Immunotherapy|immunotherapy
232951|NCT01967823|Tumor Regression|tumor regression
232952|NCT01967810|glioma|glioma
232953|NCT01967810|glioblastoma|glioblastoma
232954|NCT01967810|brain cancer|brain cancer
232955|NCT01967810|brain tumor|brain tumor
232956|NCT01967810|recurrent|recurrent
232957|NCT01967797|Obesity|obesity
232958|NCT01967784|Influenza|influenza
232959|NCT01967784|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
232960|NCT01967771|healthy volunteers|healthy volunteers
232961|NCT01967771|drug interaction|drug interaction
232962|NCT01967771|carbamazepine|carbamazepine
232963|NCT01967771|Dolutegravir|dolutegravir
232964|NCT01967771|pharmacokinetics|pharmacokinetics
232965|NCT01967758|Astrocytic Tumors|astrocytic tumors
232966|NCT01967758|Glioblastoma Multiforme|glioblastoma multiforme
232967|NCT01967758|Anaplastic Astrocytoma|anaplastic astrocytoma
232968|NCT01967758|Brain Tumor|brain tumor
232969|NCT01967758|Brain Cancer|brain cancer
232970|NCT01967758|Immunotherapy|immunotherapy
232971|NCT01967745|open appendectomy|open appendectomy
232972|NCT01967745|laparoscopic appendectomy|laparoscopic appendectomy
232973|NCT01967745|appendicitis|appendicitis
232974|NCT01967732|Smoking|smoking
232975|NCT01967732|Nicotine absorption|nicotine absorption
232976|NCT01967732|Modified risk tobacco product|modified risk tobacco product
232977|NCT01967732|Conventional cigarette|conventional cigarette
232978|NCT01967732|Nicotine replacement therapy|nicotine replacement therapy
232979|NCT01967732|Nicotine nasal spray|nicotine nasal spray
232980|NCT01967719|Smoking|smoking
232981|NCT01967719|Nicotine absorption|nicotine absorption
232982|NCT01967719|Candidate modified risk tobacco product|candidate modified risk tobacco product
232983|NCT01967719|Conventional cigarette|conventional cigarette
232984|NCT01967719|Nicotine replacement therapy: nasal spray|nicotine replacement therapy: nasal spray
232985|NCT01967706|Smoking|smoking
232986|NCT01967706|Nicotine absorption|nicotine absorption
232987|NCT01967706|Modified risk tobacco product|modified risk tobacco product
232988|NCT01967706|Conventional cigarette|conventional cigarette
232989|NCT01967706|Nicotine replacement therapy|nicotine replacement therapy
232990|NCT01967706|Nicotine gum|nicotine gum
232991|NCT01967693|Laryngeal contact granuloma|laryngeal contact granuloma
232992|NCT01967693|Treatment type|treatment type
232993|NCT01967693|Outcome|outcome
232994|NCT01967641|opioid dependence|opioid dependence
232995|NCT01967641|opioid abuse|opioid abuse
232996|NCT01967641|suboxone|suboxone
232997|NCT01967641|prescription pain medications|prescription pain medications
232998|NCT01967628|Vitamin D|vitamin d
232999|NCT01967628|Respiratory infection|respiratory infection
233000|NCT01967628|Innate immunity|innate immunity
233001|NCT01967615|PCI,|pci,
233002|NCT01967615|CTO,|cto,
233003|NCT01967615|bifurcation,|bifurcation,
233004|NCT01967615|clopidogrel,|clopidogrel,
233005|NCT01967615|prasugrel,|prasugrel,
233006|NCT01967615|ticagrelor|ticagrelor
233007|NCT01967602|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
233008|NCT01967602|Extracorporeal membrane oxygenation (ECMO)|extracorporeal membrane oxygenation (ecmo)
233009|NCT01967602|biomarker|biomarker
233010|NCT01967576|Mutation in SDHB gene|mutation in sdhb gene
233011|NCT01967576|Mutation in SDHV gene|mutation in sdhv gene
233012|NCT01967576|Mutation in VHL gene|mutation in vhl gene
233013|NCT01967576|Pharmacogenomics analyses|pharmacogenomics analyses
233014|NCT01967576|Germline DNA examination|germline dna examination
233015|NCT01967563|Energy Expenditure|energy expenditure
233016|NCT01967563|Obesity|obesity
233017|NCT01967563|Carbohydrate|carbohydrate
233019|NCT01967563|Ketones|ketones
233020|NCT01967550|Symptomatic knee OA Kellgren-Lawrence grade 1-3|symptomatic knee oa kellgren-lawrence grade 1-3
233021|NCT01967537|NET|net
233022|NCT01967537|MEN1|men1
233023|NCT01967537|Von Hippel Lindau (VHL)|von hippel lindau (vhl)
233024|NCT01967537|Surgical Resection|surgical resection
233025|NCT01967537|Somatostatin Receptor Status|somatostatin receptor status
233026|NCT01967524|Myofascial pain|myofascial pain
233027|NCT01967524|Perineal pain|perineal pain
233028|NCT01967524|Chronic pelvic pain|chronic pelvic pain
233029|NCT01967524|Botulinum toxin type A|botulinum toxin type a
233030|NCT01967524|Ropivacaïne|ropivacaïne
233031|NCT01967511|Cross-sectional study|cross-sectional study
233032|NCT01967511|Fibromuscular dysplasia|fibromuscular dysplasia
233033|NCT01967511|Fibroblast|fibroblast
233034|NCT01967511|Spontaneous Coronary Artery Dissection|spontaneous coronary artery dissection
233035|NCT01967511|Cervical Artery Dissection|cervical artery dissection
233036|NCT01967498|chronic otitis media with effusion|chronic otitis media with effusion
233037|NCT01967498|conductive hearing loss|conductive hearing loss
233038|NCT01967485|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
233039|NCT01967485|Medication adherence|medication adherence
233040|NCT01967485|Disease management|disease management
233041|NCT01967485|Text message|text message
233042|NCT01967485|ADHD|adhd
233043|NCT01967485|Children|children
233044|NCT01967485|Reminder systems|reminder systems
233045|NCT01967485|Text Messaging|text messaging
233046|NCT01967485|Telemedicine|telemedicine
233047|NCT01967433|Fentanyl|fentanyl
233048|NCT01967433|Midazolam|midazolam
233049|NCT01967433|Sedation|sedation
233050|NCT01967433|Patient tolerance|patient tolerance
233051|NCT01967433|Duration of colonoscopy|duration of colonoscopy
233052|NCT01967420|Cognitive remediation|cognitive remediation
233053|NCT01967420|Social cognition training|social cognition training
233054|NCT01967420|First episode psychosis|first episode psychosis
233055|NCT01967420|Schizophrenia|schizophrenia
233056|NCT01967407|kidney tumor|kidney tumor
233057|NCT01967407|renal cell cancer|renal cell cancer
233058|NCT01967407|RCC|rcc
286631|NCT01723865|ICD|icd
233059|NCT01967407|irreversible electroporation|irreversible electroporation
233060|NCT01967407|IRE|ire
233061|NCT01967407|partial kidney resection|partial kidney resection
233062|NCT01967407|percutaneous|percutaneous
233063|NCT01967407|ablation|ablation
233064|NCT01967407|IRENE|irene
233065|NCT01967394|Health Care Quality|health care quality
233066|NCT01967394|Access|access
233067|NCT01967394|Evaluation|evaluation
233068|NCT01967368|Influenza vaccine|influenza vaccine
233069|NCT01967368|intradermal|intradermal
233070|NCT01967368|intramuscular|intramuscular
233071|NCT01967368|efficacy|efficacy
233072|NCT01967368|safety|safety
233073|NCT01967355|preeclampsia|preeclampsia
233074|NCT01967355|lipid apheresis|lipid apheresis
233075|NCT01967355|apheresis|apheresis
233076|NCT01967342|chronic pain|chronic pain
233077|NCT01967342|pain|pain
233078|NCT01967342|chronic pain syndrome|chronic pain syndrome
233079|NCT01967342|widespread chronic pain|widespread chronic pain
233080|NCT01967342|back pain|back pain
233081|NCT01967342|literacy|literacy
233082|NCT01967342|health literacy|health literacy
233083|NCT01967342|group therapy|group therapy
233084|NCT01967342|psychosocial treatment|psychosocial treatment
233085|NCT01967342|cognitive-behavioral therapy|cognitive-behavioral therapy
233086|NCT01967342|pain education|pain education
233087|NCT01967342|health disparities|health disparities
233088|NCT01967342|patient-centered outcomes|patient-centered outcomes
233089|NCT01967303|Restless legs syndrome|restless legs syndrome
233090|NCT01967303|Stroke|stroke
233091|NCT01967303|Transient ischemic attack|transient ischemic attack
233092|NCT01967303|Cerebrovascular risk factors|cerebrovascular risk factors
233093|NCT01967290|stroke|stroke
233094|NCT01967290|motor deficits|motor deficits
233095|NCT01967290|motor rehabilitation|motor rehabilitation
233096|NCT01967290|neurorehabilitation|neurorehabilitation
233097|NCT01967290|medical devices|medical devices
233098|NCT01967290|wearable devices|wearable devices
233099|NCT01967290|e-health systems|e-health systems
233100|NCT01967264|Drug therapy|drug therapy
233101|NCT01967251|Prostatic Hyperplasia|prostatic hyperplasia
233102|NCT01967251|Phosphodiesterase 5 inhibitors|phosphodiesterase 5 inhibitors
233103|NCT01967251|Erectile DysfunctionDrug Therapy|erectile dysfunctiondrug therapy
233104|NCT01967238|immune response|immune response
233105|NCT01967225|Methicillin Resistant Staphylococcus Aureus,|methicillin resistant staphylococcus aureus,
233106|NCT01967225|Skin and soft tissue infection,|skin and soft tissue infection,
233107|NCT01967225|Bacteremia,|bacteremia,
233108|NCT01967225|Tedizolid|tedizolid
233109|NCT01967212|stroke|stroke
233110|NCT01967212|swallowing training|swallowing training
233111|NCT01967212|game-based|game-based
233112|NCT01967212|biofeedback|biofeedback
233113|NCT01967199|drug-eluting stent|drug-eluting stent
233114|NCT01967199|drug-coated Balloon|drug-coated balloon
233115|NCT01967199|recurrent In-Stent restenosis|recurrent in-stent restenosis
233116|NCT01967186|Type 1 diabetes|type 1 diabetes
233117|NCT01967186|islets|islets
233118|NCT01967186|transplantation|transplantation
233119|NCT01967186|nephropathy|nephropathy
233120|NCT01967186|intramuscular|intramuscular
233121|NCT01967173|Asthma|asthma
233122|NCT01967173|Fluticasone|fluticasone
233123|NCT01967173|Salmeterol|salmeterol
233124|NCT01967147|Dry eye|dry eye
233125|NCT01967147|Lipid deficiency|lipid deficiency
233126|NCT01967147|Tear film break-up time|tear film break-up time
233127|NCT01967134|HIV Negative|hiv negative
233128|NCT01967121|Compex, ice|compex, ice
233129|NCT01967095|Erlotinib|erlotinib
233130|NCT01967095|12-278|12-278
233131|NCT01967095|CNS involvement|cns involvement
233132|NCT01967082|Cancer Prevention|cancer prevention
233133|NCT01967082|Tobacco Control Program for Youth|tobacco control program for youth
233134|NCT01967082|Smoking cessation|smoking cessation
233135|NCT01967082|Smoking prevention|smoking prevention
233136|NCT01967082|Smokers|smokers
233137|NCT01967082|Non smokers|non smokers
233138|NCT01967082|Students|students
233139|NCT01967082|University of Houston|university of houston
233140|NCT01967082|Survey|survey
233141|NCT01967082|Questionnaire|questionnaire
233142|NCT01967082|Telephone survey|telephone survey
233143|NCT01967082|Smart phone application|smart phone application
233144|NCT01967056|Muscle strength|muscle strength
233145|NCT01967056|respiratory failure|respiratory failure
233146|NCT01967056|extubation failure|extubation failure
233147|NCT01967056|intensive care unit|intensive care unit
233148|NCT01967056|outcome prediction|outcome prediction
233149|NCT01967030|gestational diabetes mellitus|gestational diabetes mellitus
233150|NCT01967030|breastfeeding|breastfeeding
233152|NCT01967030|diabetes|diabetes
233153|NCT01967030|lactation|lactation
233154|NCT01967017|Intrauterine device|intrauterine device
233155|NCT01967017|Paracervical block|paracervical block
233156|NCT01966991|Down syndrome|down syndrome
233157|NCT01966991|prenatal screening|prenatal screening
233158|NCT01966991|trisomy 21|trisomy 21
233159|NCT01966991|patient satisfaction|patient satisfaction
233160|NCT01966978|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
233161|NCT01966978|Insulin|insulin
233162|NCT01966978|Insulin, Long-Acting|insulin, long-acting
233163|NCT01966978|Insulin, Short Acting|insulin, short acting
233164|NCT01966978|Detemir|detemir
233165|NCT01966978|Liraglutide|liraglutide
233166|NCT01966978|GLP-1|glp-1
233167|NCT01966978|Glucagon Like Peptide|glucagon like peptide
233168|NCT01966978|Metformin|metformin
233169|NCT01966978|Uncontrolled Diabetes|uncontrolled diabetes
233170|NCT01966978|Elevated A1c|elevated a1c
233171|NCT01966978|Incretins|incretins
233172|NCT01966965|PIOLIN®, PEDICULOSIS, EFFICACY, SAFETY, PHYTOMEDICINE,|piolin®, pediculosis, efficacy, safety, phytomedicine,
233173|NCT01966965|ARRUDA, RUTA|arruda, ruta
233174|NCT01966952|Hypertension|hypertension
233175|NCT01966939|craniotomy|craniotomy
233176|NCT01966939|craniectomy|craniectomy
233177|NCT01966939|temporalis|temporalis
233178|NCT01966939|TMJ|tmj
233179|NCT01966939|mastication|mastication
233180|NCT01966939|QoL|qol
233181|NCT01966926|self monitoring|self monitoring
233182|NCT01966926|self weighing|self weighing
233183|NCT01966926|weight tracking|weight tracking
233184|NCT01966926|psychosocial outcomes|psychosocial outcomes
233185|NCT01966926|feasibility|feasibility
233186|NCT01966913|Germ Cell Tumors|germ cell tumors
233187|NCT01966913|Bevacizumab|bevacizumab
233188|NCT01966913|salvage therapy|salvage therapy
233189|NCT01966900|Human immunodeficiency disease|human immunodeficiency disease
233190|NCT01966900|HIV|hiv
233191|NCT01966900|Vaccine|vaccine
233192|NCT01966900|CN54gp140|cn54gp140
233193|NCT01966900|Glucopyranosyl lipid adjuvant|glucopyranosyl lipid adjuvant
233194|NCT01966900|GLA|gla
233195|NCT01966900|GLA-AF|gla-af
233196|NCT01966887|Heart failure|heart failure
233197|NCT01966887|Gene therapy|gene therapy
233198|NCT01966887|Serca2a|serca2a
233199|NCT01966887|Cardiomyopathy|cardiomyopathy
233200|NCT01966874|Medical abortion|medical abortion
233201|NCT01966874|Mifepristone|mifepristone
233202|NCT01966874|Misoprostol|misoprostol
233203|NCT01966874|Zacafemyl|zacafemyl
233204|NCT01966874|Mexico|mexico
233205|NCT01966861|mechanical ventilation|mechanical ventilation
233206|NCT01966861|weaning|weaning
233207|NCT01966861|acute respiratory failure|acute respiratory failure
233208|NCT01966861|weaning failure|weaning failure
233209|NCT01966861|lung ultrasound|lung ultrasound
233210|NCT01966848|Knee|knee
233211|NCT01966848|osteoarthritis|osteoarthritis
233212|NCT01966848|arthroplasty|arthroplasty
233213|NCT01966848|tka|tka
233214|NCT01966848|rsa|rsa
233215|NCT01966835|sleep quality|sleep quality
233216|NCT01966835|sleep disturbances|sleep disturbances
233217|NCT01966835|high intensity aerobic interval training|high intensity aerobic interval training
233218|NCT01966835|rheumatoid arthritis|rheumatoid arthritis
233219|NCT01966835|fatigue|fatigue
233220|NCT01966835|pain|pain
233221|NCT01966835|polysomnography|polysomnography
233222|NCT01966835|watt max|watt max
233223|NCT01966822|Osteoporosis|osteoporosis
233224|NCT01966822|Bone mineral density|bone mineral density
233225|NCT01966822|Dual-energy X-ray absorptiometry|dual-energy x-ray absorptiometry
233226|NCT01966822|HIV infection|hiv infection
233227|NCT01966822|Dolutegravir|dolutegravir
233228|NCT01966822|Integrase inhibitor|integrase inhibitor
233229|NCT01966809|Brain Tumor|brain tumor
233230|NCT01966809|Photodynamic Therapy|photodynamic therapy
233231|NCT01966809|Photochemotherapy|photochemotherapy
233232|NCT01966809|Astrocytoma|astrocytoma
233233|NCT01966809|Pilocytic Astrocytoma|pilocytic astrocytoma
233234|NCT01966809|Low grade Astrocytoma|low grade astrocytoma
233235|NCT01966809|Anaplastic Astrocytoma|anaplastic astrocytoma
233236|NCT01966809|Glioblastoma|glioblastoma
233237|NCT01966809|GBM|gbm
233238|NCT01966809|Chordoma|chordoma
233239|NCT01966809|Germinoma|germinoma
233240|NCT01966809|Germ Cell Tumor|germ cell tumor
233241|NCT01966809|Non-germinoma|non-germinoma
233242|NCT01966809|CNS Lymphoma|cns lymphoma
233243|NCT01966809|Craniopharyngioma|craniopharyngioma
233244|NCT01966809|Mixed Glioma|mixed glioma
233245|NCT01966809|Optic Nerve Glioma|optic nerve glioma
233246|NCT01966809|Meningioma|meningioma
233247|NCT01966809|Oligodendroglioma|oligodendroglioma
233248|NCT01966809|Pituitary Tumors|pituitary tumors
233249|NCT01966809|Desmoplastic Neuroepithelial Tumor|desmoplastic neuroepithelial tumor
233251|NCT01966809|glioblastoma multiforme|glioblastoma multiforme
233252|NCT01966809|glioma|glioma
233253|NCT01966809|glioblastoma survivors|glioblastoma survivors
233254|NCT01966809|what is glioblastoma|what is glioblastoma
233255|NCT01966809|gbm cancer|gbm cancer
233256|NCT01966809|oligoastrocytoma|oligoastrocytoma
233257|NCT01966809|gbm tumor|gbm tumor
233258|NCT01966809|anaplastic oligodendroglioma|anaplastic oligodendroglioma
233259|NCT01966809|High-Grade Glioma|high-grade glioma
233260|NCT01966809|high grade glioma|high grade glioma
233261|NCT01966809|glioblastomas|glioblastomas
233262|NCT01966809|glioblastoma cancer|glioblastoma cancer
223982|NCT02008760|ADL|adl
233263|NCT01966809|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
233264|NCT01966809|astrocytoma glioma|astrocytoma glioma
233265|NCT01966809|glioblastoma clinical trials|glioblastoma clinical trials
233266|NCT01966809|photodynamic therapy for cancer|photodynamic therapy for cancer
233267|NCT01966809|glioblastoma multiforme clinical trials|glioblastoma multiforme clinical trials
233268|NCT01966809|astrocytoma glioblastoma|astrocytoma glioblastoma
233269|NCT01966809|gbm grade 4|gbm grade 4
233270|NCT01966809|clinical trials for glioblastoma|clinical trials for glioblastoma
233271|NCT01966809|photodynamic therapy cancer|photodynamic therapy cancer
233272|NCT01966809|clinical trials glioblastoma|clinical trials glioblastoma
233273|NCT01966809|glioblastoma clinical trials 2015|glioblastoma clinical trials 2015
233274|NCT01966809|glioblastoma clinical trials 2014 not open in 2014|glioblastoma clinical trials 2014 not open in 2014
233275|NCT01966809|glioblastoma trials|glioblastoma trials
233276|NCT01966809|gbm clinical trials|gbm clinical trials
233277|NCT01966809|glioblastoma immunotherapy|glioblastoma immunotherapy
233278|NCT01966809|malignant gliomas|malignant gliomas
233279|NCT01966809|anaplastic astrocytomas|anaplastic astrocytomas
233280|NCT01966809|immunotherapy for glioblastoma|immunotherapy for glioblastoma
233281|NCT01966809|immunotherapy glioblastoma|immunotherapy glioblastoma
233282|NCT01966809|High Grade Glioblastoma Multiforme|high grade glioblastoma multiforme
233283|NCT01966809|clinical trial glioblastoma|clinical trial glioblastoma
233284|NCT01966809|glioblastoma clinical trial|glioblastoma clinical trial
233285|NCT01966809|glioblastoma trial|glioblastoma trial
233286|NCT01966809|brain tumors|brain tumors
233287|NCT01966809|recurrent brain tumors|recurrent brain tumors
233288|NCT01966809|glioma grade 3|glioma grade 3
233289|NCT01966809|grade 3 brain tumor|grade 3 brain tumor
233290|NCT01966809|grade 4 brain tumor|grade 4 brain tumor
233291|NCT01966796|healthcare associated pneumonia|healthcare associated pneumonia
233292|NCT01966796|drug-resistant bacteria|drug-resistant bacteria
233293|NCT01966796|pneumonia severity index|pneumonia severity index
233294|NCT01966757|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
233295|NCT01966757|NCL|ncl
233296|NCT01966757|Batten's Disease|batten's disease
233297|NCT01966757|Children's Sleep Habits Questionnaire|children's sleep habits questionnaire
233298|NCT01966757|Restless Leg Syndrome|restless leg syndrome
233299|NCT01966731|Africa|africa
233300|NCT01966718|Rheumatoid arthritis|rheumatoid arthritis
233301|NCT01966718|Joint pain|joint pain
233302|NCT01966718|Repository corticotropin injection|repository corticotropin injection
233303|NCT01966705|severe health anxiety|severe health anxiety
233304|NCT01966705|somatic symptom disorder|somatic symptom disorder
233305|NCT01966705|illness anxiety disorder|illness anxiety disorder
233306|NCT01966705|cognitive behavior therapy|cognitive behavior therapy
233307|NCT01966705|bibliotherapy|bibliotherapy
233308|NCT01966705|internet|internet
233309|NCT01966705|exposure|exposure
233310|NCT01966692|Bioequivalence|bioequivalence
233311|NCT01966692|Fluticasone Propionate|fluticasone propionate
233312|NCT01966666|Alzheimer's disease|alzheimer's disease
233313|NCT01966666|mild to moderate|mild to moderate
233314|NCT01966653|nitrofurantoin|nitrofurantoin
233315|NCT01966653|fosfomycin|fosfomycin
233316|NCT01966653|urinary tract infection|urinary tract infection
233317|NCT01966653|clinical efficacy|clinical efficacy
233318|NCT01966653|bacteriologic response|bacteriologic response
233319|NCT01966640|diagnosis of allergy|diagnosis of allergy
233320|NCT01966640|Basophil Activation Test|basophil activation test
233321|NCT01966627|non alcoholic fatty liver|non alcoholic fatty liver
233322|NCT01966627|childhood obesity|childhood obesity
233323|NCT01966627|genetic variants|genetic variants
233324|NCT01966614|Benign prostatic hyperplasia|benign prostatic hyperplasia
233325|NCT01966614|BPH|bph
233326|NCT01966614|Enlarged prostate|enlarged prostate
233327|NCT01966614|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
233328|NCT01966588|Antipsychotic agents|antipsychotic agents
233329|NCT01966588|Adverse effects|adverse effects
233330|NCT01966588|Genomics|genomics
233331|NCT01966588|Transcriptome|transcriptome
233332|NCT01966575|Polycystic ovary syndrome|polycystic ovary syndrome
233333|NCT01966575|Progestin|progestin
233334|NCT01966575|Endometrial shedding|endometrial shedding
233335|NCT01966575|Ovulation induction cycles|ovulation induction cycles
233336|NCT01966575|Clomiphene citrate|clomiphene citrate
233337|NCT01966575|Clinical pregnancy rate|clinical pregnancy rate
233338|NCT01966549|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
233339|NCT01966549|Moderate to Severe Chronic Obstructive Pulmonary Disease|moderate to severe chronic obstructive pulmonary disease
233340|NCT01966549|CNTO 6785|cnto 6785
233341|NCT01966549|Placebo|placebo
233342|NCT01966510|cord blood transplant|cord blood transplant
233343|NCT01966510|advanced lymphoid malignancies|advanced lymphoid malignancies
233344|NCT01966497|AML|aml
233345|NCT01966484|Succinylcholine|succinylcholine
233346|NCT01966484|Mivacurium|mivacurium
233347|NCT01966484|Rigid Bronchoscopy|rigid bronchoscopy
233348|NCT01966484|Intubating conditions|intubating conditions
287001|NCT01721967|dyspnea|dyspnea
233349|NCT01966484|Short Procedure|short procedure
233350|NCT01966445|GSK2849330|gsk2849330
233351|NCT01966445|Oncology|oncology
233352|NCT01966445|First Time in Human|first time in human
233353|NCT01966445|HER3|her3
233354|NCT01966432|Substance abuse|substance abuse
233355|NCT01966432|Alcohol use|alcohol use
233356|NCT01966432|Tobacco use|tobacco use
233357|NCT01966432|Brief intervention|brief intervention
233358|NCT01966432|Referral to treatment|referral to treatment
233359|NCT01966419|hepatic encephalopathy|hepatic encephalopathy
233360|NCT01966419|hyperammonemia|hyperammonemia
233361|NCT01966419|cirrhosis|cirrhosis
233362|NCT01966419|ornithine phenylacetate|ornithine phenylacetate
233363|NCT01966419|OCR-002|ocr-002
233364|NCT01966406|Pancreaticoduodenectomy|pancreaticoduodenectomy
233365|NCT01966406|nasogastric tube|nasogastric tube
233366|NCT01966393|Type 1 diabetes|type 1 diabetes
233367|NCT01966393|Hypoglycemia|hypoglycemia
233368|NCT01966393|Insulin|insulin
233369|NCT01966393|Glucagon|glucagon
233370|NCT01966393|Closed-loop strategy|closed-loop strategy
233371|NCT01966393|Artificial pancreas|artificial pancreas
233372|NCT01966367|Unrelated donor transplant|unrelated donor transplant
233373|NCT01966367|Haploidentical donor transplant|haploidentical donor transplant
233374|NCT01966367|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
233375|NCT01966367|CD34+ selection|cd34+ selection
233376|NCT01966367|Non-malignant disease|non-malignant disease
233377|NCT01966367|Bone marrow failure syndrome|bone marrow failure syndrome
233378|NCT01966367|Severe Aplastic Anemia|severe aplastic anemia
233379|NCT01966367|Severe Congenital Neutropenia|severe congenital neutropenia
233380|NCT01966367|Amegakaryocytic Thrombocytopenia|amegakaryocytic thrombocytopenia
233381|NCT01966367|Diamond-Blackfan Anemia|diamond-blackfan anemia
233382|NCT01966367|Schwachman Diamond Syndrome|schwachman diamond syndrome
233383|NCT01966367|Primary Immunodeficiency Syndrome|primary immunodeficiency syndrome
233384|NCT01966367|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
233385|NCT01966367|Histiocytic Syndrome|histiocytic syndrome
233386|NCT01966367|Familial Hemophagocytic Lymphocytosis|familial hemophagocytic lymphocytosis
233387|NCT01966367|Lymphohistiocytosis|lymphohistiocytosis
233388|NCT01966367|Macrophage Activation Syndrome|macrophage activation syndrome
233389|NCT01966367|Langerhans Cell Histiocytosis (LCH)|langerhans cell histiocytosis (lch)
233390|NCT01966367|Hemoglobinopathies|hemoglobinopathies
233391|NCT01966367|Sickle Cell Disease|sickle cell disease
233392|NCT01966367|Sickle Cell-beta-thalassemia|sickle cell-beta-thalassemia
233393|NCT01966354|adult|adult
233394|NCT01966354|catheterization, central venous|catheterization, central venous
233395|NCT01966354|ultrasonography, interventional|ultrasonography, interventional
233396|NCT01966354|evidence-based medicine|evidence-based medicine
233397|NCT01966354|cost-benefit analysis|cost-benefit analysis
233398|NCT01966302|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
233399|NCT01966302|prostacyclin|prostacyclin
233400|NCT01966302|oral|oral
233401|NCT01966289|Colorectal Neoplasms|colorectal neoplasms
233402|NCT01966289|Intestinal Neoplasms|intestinal neoplasms
233403|NCT01966289|Gastrointestinal Neoplasms|gastrointestinal neoplasms
233404|NCT01966289|Digestive System Neoplasms|digestive system neoplasms
233405|NCT01966289|Neoplasms by Site|neoplasms by site
233406|NCT01966289|Neoplasms|neoplasms
233407|NCT01966289|Digestive System Diseases|digestive system diseases
233408|NCT01966289|Gastrointestinal Diseases|gastrointestinal diseases
233409|NCT01966289|Colonic Diseases|colonic diseases
233410|NCT01966289|Intestinal Diseases|intestinal diseases
233411|NCT01966289|Rectal Diseases|rectal diseases
233412|NCT01966276|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
233413|NCT01966276|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
233414|NCT01966276|central nervous system (CNS)|central nervous system (cns)
233415|NCT01966276|fatigue|fatigue
233416|NCT01966276|alertness|alertness
233417|NCT01966276|brain fog|brain fog
233418|NCT01966276|mitochondria|mitochondria
233419|NCT01966276|methylphenidate|methylphenidate
233420|NCT01966276|Ritalin|ritalin
233421|NCT01966276|stimulant|stimulant
233422|NCT01966276|multivitamin|multivitamin
233423|NCT01966276|multimineral|multimineral
233424|NCT01966276|micronutrients|micronutrients
233425|NCT01966276|supplements|supplements
233426|NCT01966263|total knee arthroplasty|total knee arthroplasty
233427|NCT01966263|femoral nerve block|femoral nerve block
233428|NCT01966263|local infiltration analgesia|local infiltration analgesia
233429|NCT01966263|fast track|fast track
751901|NCT01171157|vaccine effectiveness|vaccine effectiveness
233430|NCT01966198|pulse plethysmography, autonomic nervous system, heart rate variability, baro-reflex|pulse plethysmography, autonomic nervous system, heart rate variability, baro-reflex
233431|NCT01966185|virtual simulation|virtual simulation
233432|NCT01966185|temporal bone|temporal bone
233433|NCT01966185|surgical training|surgical training
233434|NCT01966185|medical education|medical education
233435|NCT01966185|self-directed learning|self-directed learning
233436|NCT01966185|final product assessment|final product assessment
233437|NCT01966185|cognitive load|cognitive load
233438|NCT01966185|reaction time|reaction time
233439|NCT01966185|skills training|skills training
233440|NCT01966185|simulator metrics|simulator metrics
233441|NCT01966172|NSAID, gabapentin, multimodal, morphine, dexamethasone, cardiac surgery, postoperative pain, analgesia.|nsaid, gabapentin, multimodal, morphine, dexamethasone, cardiac surgery, postoperative pain, analgesia.
233442|NCT01966133|HCC|hcc
233443|NCT01966133|Randomised controlled trial|randomised controlled trial
233444|NCT01966133|TACE|tace
233445|NCT01966133|Resection|resection
233446|NCT01966120|Photodynamic Therapy|photodynamic therapy
233447|NCT01966120|Field-directed Treatment|field-directed treatment
233448|NCT01966068|Asthma|asthma
233449|NCT01966068|Pediatrics|pediatrics
233450|NCT01966068|Health Technology|health technology
233451|NCT01966068|Meaningful Use Stage-3|meaningful use stage-3
233452|NCT01966068|Web Portal|web portal
233453|NCT01966042|Refractory angina|refractory angina
233454|NCT01966042|Cell Therapy|cell therapy
233455|NCT01966042|Bone Marrow|bone marrow
233456|NCT01966042|Mononuclear Cells|mononuclear cells
233457|NCT01966016|LV- Left Ventricular|lv- left ventricular
233458|NCT01966016|CRT- Cardiac resynchronization therapy|crt- cardiac resynchronization therapy
233459|NCT01966016|MSCRT- Multisite Cardiac resynchronization therapy (P-pacemaker; D-defibrillator)|mscrt- multisite cardiac resynchronization therapy (p-pacemaker; d-defibrillator)
233460|NCT01966016|BBB -bundle branch block|bbb -bundle branch block
233461|NCT01965990|Enteral nutrition|enteral nutrition
233462|NCT01965990|very low-calorie diet|very low-calorie diet
233463|NCT01965990|severe obesity|severe obesity
233464|NCT01965990|weight loss|weight loss
233465|NCT01965990|ketosis|ketosis
233466|NCT01965964|Dysphagia, Swallowing functions, Questionnaire in German|dysphagia, swallowing functions, questionnaire in german
233467|NCT01965925|Cognition|cognition
233468|NCT01965925|Sleep problems|sleep problems
233469|NCT01965925|Bipolar Disorder|bipolar disorder
233470|NCT01965912|Phenylketonuria|phenylketonuria
233471|NCT01965912|Kuvan|kuvan
233472|NCT01965912|Sapropterin dihydrochloride|sapropterin dihydrochloride
233473|NCT01965886|osteoarthritis|osteoarthritis
233474|NCT01965886|knee|knee
233475|NCT01965886|arthroplasty|arthroplasty
233476|NCT01965886|replacement|replacement
233477|NCT01965873|Pancreatitis, Acute necrotizing|pancreatitis, acute necrotizing
233478|NCT01965873|Enteral nutrition|enteral nutrition
233479|NCT01965873|Fasting|fasting
233480|NCT01965873|Complications|complications
233481|NCT01965873|Mortality|mortality
233909|NCT01963962|Copper IUD|copper iud
233482|NCT01965834|Multiple Myeloma|multiple myeloma
233483|NCT01965834|Fenofibrate|fenofibrate
233484|NCT01965821|tracheal cuff pressure|tracheal cuff pressure
233485|NCT01965821|continuous control|continuous control
233486|NCT01965821|microaspiration|microaspiration
233487|NCT01965795|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
233488|NCT01965795|Cognitive function|cognitive function
233489|NCT01965795|Dietary supplement|dietary supplement
233490|NCT01965795|Coffee plant extract|coffee plant extract
233491|NCT01965769|Very low birth weight infants|very low birth weight infants
233492|NCT01965769|premature|premature
233493|NCT01965769|nutrition|nutrition
233494|NCT01965769|gastric residual|gastric residual
233495|NCT01965756|Alzheimer's Disease|alzheimer's disease
233496|NCT01965756|Vascular Dementia|vascular dementia
233497|NCT01965756|Dementia|dementia
233498|NCT01965756|Memory Impairment|memory impairment
233499|NCT01965743|intrauterine contraception (IUC)|intrauterine contraception (iuc)
233500|NCT01965743|social networks|social networks
233501|NCT01965743|social influence|social influence
233502|NCT01965743|diffusion of innovation|diffusion of innovation
233503|NCT01965743|intrauterine device (IUD)|intrauterine device (iud)
233504|NCT01965743|LARC|larc
233505|NCT01965730|dilated ascending aorta|dilated ascending aorta
233506|NCT01965717|endoleak|endoleak
233507|NCT01965717|MMP- 9|mmp- 9
233508|NCT01965717|biomarker|biomarker
233509|NCT01965704|Narcotic addiction during pregnancy|narcotic addiction during pregnancy
233510|NCT01965704|Neonatal abstinence syndrome|neonatal abstinence syndrome
233511|NCT01965704|NAS|nas
233512|NCT01965691|Phenylketonuria|phenylketonuria
233513|NCT01965691|PKU|pku
233514|NCT01965691|Phenylalanine metabolism|phenylalanine metabolism
233515|NCT01965691|Protein requirements|protein requirements
233516|NCT01965691|Indicator Amino acid Oxidation|indicator amino acid oxidation
233517|NCT01965691|Stable isotopes|stable isotopes
233518|NCT01965678|Osteopathic manipulative treatment|osteopathic manipulative treatment
233519|NCT01965678|muscle-skeletal disorder|muscle-skeletal disorder
233520|NCT01965678|quality of life|quality of life
233521|NCT01965665|Diabetes|diabetes
233522|NCT01965665|Surgical Intervention|surgical intervention
233524|NCT01965652|Opioid Induced Constipation|opioid induced constipation
233525|NCT01965639|Diabetes Mellitus Type 2|diabetes mellitus type 2
233526|NCT01965639|Standard of care|standard of care
233527|NCT01965639|Quality of life|quality of life
233528|NCT01965639|Disease management|disease management
233529|NCT01965626|Oseltamivir|oseltamivir
233530|NCT01965626|Dexamethasone|dexamethasone
233531|NCT01965626|ITP|itp
233532|NCT01965613|Pyoderma Gangrenosum|pyoderma gangrenosum
233533|NCT01965600|Endotoxin challenge|endotoxin challenge
233534|NCT01965587|novasure|novasure
233535|NCT01965587|Mirena IUS|mirena ius
233536|NCT01965587|menorrhagia|menorrhagia
233537|NCT01965587|pelvic pain|pelvic pain
233538|NCT01965587|ashermanns|ashermanns
233642|NCT01965106|Acute angle closure|acute angle closure
233539|NCT01965574|ARDS - FLUID LOADING - PRELOAD DEPENDENCE|ards - fluid loading - preload dependence
233540|NCT01965548|spleen|spleen
233541|NCT01965548|injury|injury
233542|NCT01965548|patient transfer|patient transfer
233543|NCT01965548|splenectomy|splenectomy
233544|NCT01965548|embolization, theurapeutic|embolization, theurapeutic
233545|NCT01965535|Hepatitis C|hepatitis c
233547|NCT01965535|Cirrhosis|cirrhosis
233548|NCT01965522|Breast cancer|breast cancer
233549|NCT01965522|melatonin|melatonin
233550|NCT01965522|vitamin d|vitamin d
233551|NCT01965522|ki67|ki67
233552|NCT01965509|PEX168|pex168
233553|NCT01965509|Phase I/II|phase i/ii
233554|NCT01965509|add on to metformin|add on to metformin
233555|NCT01965496|PEX168|pex168
233556|NCT01965496|Phase I|phase i
233557|NCT01965496|titration|titration
233558|NCT01965483|radiotherapy|radiotherapy
233559|NCT01965483|adjuvant|adjuvant
233560|NCT01965483|weekly hypofractionation|weekly hypofractionation
233561|NCT01965457|obstructive sleep apnea|obstructive sleep apnea
233562|NCT01965457|pediatric|pediatric
233563|NCT01965457|adenoid hypertrophy|adenoid hypertrophy
233564|NCT01965444|Sub-epidermal moisture|sub-epidermal moisture
233565|NCT01965444|Pressure Ulcers|pressure ulcers
233566|NCT01965405|HIV|hiv
233567|NCT01965405|AIDS|aids
233568|NCT01965405|Nicotine Dependence|nicotine dependence
233569|NCT01965405|Smoking|smoking
233570|NCT01965405|Smoking cessation|smoking cessation
233571|NCT01965405|Contingency Management|contingency management
233572|NCT01965379|Dialysis|dialysis
233573|NCT01965379|Phosphorus|phosphorus
233574|NCT01965379|Diet|diet
233575|NCT01965366|Dexamethasone|dexamethasone
233576|NCT01965366|Virtual Reality|virtual reality
233577|NCT01965366|Military|military
233578|NCT01965366|PTSD|ptsd
233579|NCT01965353|Relapsed Multiple Myeloma|relapsed multiple myeloma
233580|NCT01965353|Relapse-Refractory Multiple Myeloma|relapse-refractory multiple myeloma
233581|NCT01965340|patients|patients
233582|NCT01965327|Friedreich ataxia|friedreich ataxia
233583|NCT01965327|Interferon gamma-1b|interferon gamma-1b
233584|NCT01965327|FRDA|frda
233585|NCT01965314|ultrasound guided regional anaesthesia|ultrasound guided regional anaesthesia
233586|NCT01965314|upper limb surgery|upper limb surgery
233587|NCT01965314|ultrasound guided axillary brachial plexus blockade|ultrasound guided axillary brachial plexus blockade
233588|NCT01965275|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
233589|NCT01965275|High-dose|high-dose
233590|NCT01965275|Pulsatile|pulsatile
233591|NCT01965275|EGFR-TKIs|egfr-tkis
233592|NCT01965249|Laparotomy|laparotomy
233593|NCT01965249|short stitch|short stitch
233594|NCT01965249|long stitch|long stitch
233595|NCT01965249|MonoMax|monomax
233596|NCT01965236|hypertension, sodium intake, left ventricular function|hypertension, sodium intake, left ventricular function
233597|NCT01965223|Oligometastatic|oligometastatic
233598|NCT01965223|Neoplasia|neoplasia
233599|NCT01965223|Radiosurgery|radiosurgery
233600|NCT01965223|Stereotactic Ablative Body Radiotherapy|stereotactic ablative body radiotherapy
233601|NCT01965223|SABR|sabr
233602|NCT01965223|Metastases to the Lung|metastases to the lung
233603|NCT01965223|Non Haematological|non haematological
233604|NCT01965210|Rye|rye
233605|NCT01965210|Fermentable dietary fibre|fermentable dietary fibre
233606|NCT01965210|Inulin|inulin
233607|NCT01965210|Plant protein|plant protein
233608|NCT01965210|Gluten|gluten
233609|NCT01965210|Porridge|porridge
233610|NCT01965210|Bread|bread
233611|NCT01965210|Appetite|appetite
233612|NCT01965210|Satiety|satiety
233613|NCT01965210|Hunger|hunger
233614|NCT01965210|Desire to eat|desire to eat
233615|NCT01965210|Metabolism|metabolism
233616|NCT01965210|Glucose|glucose
233617|NCT01965210|Insulin|insulin
233618|NCT01965210|Gut hormones|gut hormones
233619|NCT01965210|Metabolomics|metabolomics
233620|NCT01965210|Gastric emptying rate|gastric emptying rate
233621|NCT01965210|Breath hydrogen and methane excretion|breath hydrogen and methane excretion
233622|NCT01965184|child|child
233623|NCT01965184|cognitive behavioral therapy|cognitive behavioral therapy
233624|NCT01965184|CBT|cbt
233625|NCT01965184|aggression|aggression
233626|NCT01965184|disruptive behavior|disruptive behavior
233627|NCT01965184|treatment|treatment
233628|NCT01965184|frustrative non-reward|frustrative non-reward
233629|NCT01965171|hematologic malignancy|hematologic malignancy
233630|NCT01965171|iron overload|iron overload
233631|NCT01965171|magnetic resonance imaging|magnetic resonance imaging
233632|NCT01965171|childhood cancer survivors|childhood cancer survivors
233633|NCT01965158|Opioid-induced Constipation|opioid-induced constipation
224960|NCT02004444|JC Virus|jc virus
224360|NCT02007252|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
224361|NCT02007252|AAA|aaa
224362|NCT02007252|IL-1b|il-1b
224364|NCT02007239|tocilizumab|tocilizumab
233634|NCT01965132|Rheumatiod Arhthritis|rheumatiod arhthritis
233635|NCT01965132|Ankylosing spondylitis|ankylosing spondylitis
233636|NCT01965132|Psoriatic arthritis|psoriatic arthritis
233637|NCT01965132|Biologic agents|biologic agents
233638|NCT01965132|Cohort studies|cohort studies
233639|NCT01965106|Glaucoma, Angle-Closure|glaucoma, angle-closure
233640|NCT01965106|Glaucoma, Closed-Angle|glaucoma, closed-angle
233641|NCT01965106|Primary angle closure|primary angle closure
233643|NCT01965106|Acute angle-closure glaucoma|acute angle-closure glaucoma
233644|NCT01965093|perioperative|perioperative
233645|NCT01965093|desaturation|desaturation
233646|NCT01965093|growth development|growth development
233647|NCT01965093|intelligence outcome|intelligence outcome
233648|NCT01965080|Endometrial cancer|endometrial cancer
233649|NCT01965054|Intrahepatic cholestasis of pregnancy|intrahepatic cholestasis of pregnancy
233650|NCT01965054|fish oil|fish oil
233651|NCT01965054|omega-3|omega-3
233652|NCT01965054|Docosahexaenoic acid,|docosahexaenoic acid,
233653|NCT01965054|eicosapentaenoic acid|eicosapentaenoic acid
233654|NCT01965041|AVA Study|ava study
233655|NCT01965028|tinnitus|tinnitus
233656|NCT01965028|transcranial random noise stimulation|transcranial random noise stimulation
233657|NCT01965028|tRNS|trns
233658|NCT01965028|auditory cortex|auditory cortex
233659|NCT01965028|non-invasive brain stimulation|non-invasive brain stimulation
233660|NCT01965015|Heart Failure (HF)|heart failure (hf)
233661|NCT01965015|Left Atrial Pressure|left atrial pressure
233662|NCT01964989|Influenza|influenza
233663|NCT01964989|children|children
233664|NCT01964950|drug therapy|drug therapy
233665|NCT01964911|Martorell ulcer|martorell ulcer
233666|NCT01964911|Hypertensive leg ulcer|hypertensive leg ulcer
233667|NCT01964911|Pain|pain
233668|NCT01964911|Continuous nerve block|continuous nerve block
233669|NCT01964911|Ropivacaïne|ropivacaïne
233670|NCT01964911|Local anesthesic|local anesthesic
233671|NCT01964898|Smoking|smoking
233672|NCT01964898|Mood Management|mood management
233673|NCT01964898|Depression|depression
233674|NCT01964898|Behavioral Activation|behavioral activation
233675|NCT01964898|Acute Coronary Syndrome|acute coronary syndrome
233676|NCT01964898|Myocardial Infarction|myocardial infarction
233677|NCT01964872|Healthy volunteers|healthy volunteers
233678|NCT01964872|JNJ-38877618|jnj-38877618
233679|NCT01964872|Pharmacokinetic|pharmacokinetic
233680|NCT01964872|Safety|safety
233681|NCT01964872|Single-ascending dose|single-ascending dose
233682|NCT01964872|Multiple-ascending dose|multiple-ascending dose
233683|NCT01964859|healthy skin|healthy skin
233684|NCT01964859|wounds and injuries|wounds and injuries
233685|NCT01964859|prosthetics|prosthetics
233686|NCT01964859|amputations|amputations
233687|NCT01964859|dermal fibroblasts|dermal fibroblasts
233688|NCT01964846|inflammation|inflammation
233689|NCT01964846|high fat meal|high fat meal
233690|NCT01964846|resveratrol|resveratrol
233691|NCT01964846|curcumin|curcumin
233692|NCT01964846|gene expression|gene expression
233693|NCT01964833|clinical trial|clinical trial
233694|NCT01964833|DMT2|dmt2
233695|NCT01964833|periodontitis|periodontitis
233697|NCT01964807|Cardiovascular|cardiovascular
233698|NCT01964807|tobacco|tobacco
233699|NCT01964807|cigarettes|cigarettes
233700|NCT01964807|secondhand cigarette smoke|secondhand cigarette smoke
233702|NCT01964807|smokeless tobacco|smokeless tobacco
233703|NCT01964807|chewing tobacco|chewing tobacco
233704|NCT01964807|snus|snus
233705|NCT01964807|electronic cigarettes|electronic cigarettes
233706|NCT01964807|vapor|vapor
233707|NCT01964807|particles|particles
233708|NCT01964807|oxidative stress|oxidative stress
233709|NCT01964807|flow-mediated dilation|flow-mediated dilation
233710|NCT01964807|FMD|fmd
233711|NCT01964794|Warfarin|warfarin
233712|NCT01964781|Administration, topical|administration, topical
233713|NCT01964781|tranexamic acid|tranexamic acid
233714|NCT01964781|adrenaline|adrenaline
233715|NCT01964781|bupivacaine|bupivacaine
233716|NCT01964781|surgery|surgery
233717|NCT01964755|EBV+|ebv+
233718|NCT01964755|NHL|nhl
233719|NCT01964755|HL|hl
233720|NCT01964755|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
233721|NCT01964755|Hodgkin's Lymphoma|hodgkin's lymphoma
233722|NCT01964755|Epstein Barr Virus|epstein barr virus
233723|NCT01964755|Epstein Barr Virus Associated Non Hodgkin's Lymphoma|epstein barr virus associated non hodgkin's lymphoma
233724|NCT01964755|Epstein Barr Virus Associated Hodgkin's Lymphoma|epstein barr virus associated hodgkin's lymphoma
233725|NCT01964755|Post-Transplant Lymphoproliferative Disease|post-transplant lymphoproliferative disease
233726|NCT01964729|rTMS|rtms
233727|NCT01964729|Pain threshold|pain threshold
233728|NCT01964729|Neuromodulation|neuromodulation
233729|NCT01964729|Myofascial|myofascial
233730|NCT01964716|Prevenar 13|prevenar 13
233731|NCT01964716|13vPnC|13vpnc
233732|NCT01964716|Healthy Subjects|healthy subjects
233733|NCT01964690|Lactate|lactate
233734|NCT01964690|Sepsis|sepsis
233735|NCT01964690|Capillary lactate|capillary lactate
233736|NCT01964690|Venous lactate|venous lactate
233737|NCT01964690|Quick test|quick test
233738|NCT01964677|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
233739|NCT01964677|High Intensity Focused Ultrasound (HIFU)|high intensity focused ultrasound (hifu)
233740|NCT01964664|Mindfulness|mindfulness
233741|NCT01964664|Meditation|meditation
233742|NCT01964664|acute lateral sclerosis|acute lateral sclerosis
233743|NCT01964664|Cerebral Palsy|cerebral palsy
233744|NCT01964664|Cerebral Ataxia|cerebral ataxia
233745|NCT01964664|Locked-in Syndrome|locked-in syndrome
233746|NCT01964651|Healthy|healthy
233747|NCT01964651|JNJ-42165279|jnj-42165279
233748|NCT01964651|Pharmacokinetics|pharmacokinetics
233749|NCT01964651|Elderly|elderly
233750|NCT01964651|Young|young
233751|NCT01964638|Prostate Cancer|prostate cancer
233752|NCT01964638|Prostate Biopsy|prostate biopsy
233763|NCT01964560|Vimpat|vimpat
233765|NCT01964560|Epilepsy|epilepsy
233766|NCT01964560|Partial Onset Seizures|partial onset seizures
233767|NCT01964560|Pediatric|pediatric
233768|NCT01964547|Cognition|cognition
233769|NCT01964547|Mood|mood
233770|NCT01964534|Metastatic|metastatic
233771|NCT01964534|Pancreatic|pancreatic
233772|NCT01964534|Cancer|cancer
233773|NCT01964534|Pancreas|pancreas
233774|NCT01964534|GERCOR|gercor
233775|NCT01964534|Gemcitabine|gemcitabine
233776|NCT01964534|LV5FU2|lv5fu2
233777|NCT01964534|ABI-007|abi-007
233778|NCT01964534|PACLITAXEL ALBUMIN-BOUND PARTICLES|paclitaxel albumin-bound particles
233779|NCT01964482|Hospitalization|hospitalization
233780|NCT01964482|Older|older
233781|NCT01964482|Medical patient|medical patient
233782|NCT01964482|Strength training|strength training
233783|NCT01964456|Bodily self-consciousness|bodily self-consciousness
233784|NCT01964456|intersubjective body|intersubjective body
233785|NCT01964456|Anorexia Nervosa|anorexia nervosa
233786|NCT01964456|Joint perception task|joint perception task
233787|NCT01964456|Interoceptive awareness|interoceptive awareness
233788|NCT01964443|Plaque Psoriasis|plaque psoriasis
233789|NCT01964443|Alexithymia|alexithymia
233790|NCT01964443|Quality of life|quality of life
233803|NCT01964417|BOWEL PREPARATION|bowel preparation
233804|NCT01964417|PEG|peg
233805|NCT01964417|Low-volume PEG Plus Ascorbic Acid|low-volume peg plus ascorbic acid
233806|NCT01964404|Dronabinol|dronabinol
233807|NCT01964404|Schizophrenia|schizophrenia
233808|NCT01964404|Dual Diagnosis|dual diagnosis
233809|NCT01964404|Substance Abuse|substance abuse
233810|NCT01964404|Cannabis Use Disorder|cannabis use disorder
233811|NCT01964378|cancer-related pain|cancer-related pain
233812|NCT01964378|neuropathic related cancer pain|neuropathic related cancer pain
233813|NCT01964378|morphine|morphine
233814|NCT01964378|cebranopadol (GRT6005)|cebranopadol (grt6005)
233815|NCT01964378|Numerical Rating Scale|numerical rating scale
233816|NCT01964326|atorvastatin|atorvastatin
233817|NCT01964326|Hypercholesterolemia|hypercholesterolemia
233818|NCT01964313|Acute coronary syndrome|acute coronary syndrome
233819|NCT01964313|treatment strategy|treatment strategy
233820|NCT01964313|genetics|genetics
233821|NCT01964274|Nursing Delirium Screening Scale,|nursing delirium screening scale,
233822|NCT01964274|Acetylcholinesterase Activity|acetylcholinesterase activity
233823|NCT01964261|Neural|neural
233824|NCT01964261|Prosthetic|prosthetic
233825|NCT01964261|Brain machine interface|brain machine interface
233826|NCT01964261|brain computer interface|brain computer interface
233827|NCT01964261|brain control|brain control
233828|NCT01964261|paralysis|paralysis
233829|NCT01964261|tetraplegia|tetraplegia
233830|NCT01964261|quadriplegia|quadriplegia
233831|NCT01964261|spinal cord injury|spinal cord injury
233832|NCT01964261|stimulation|stimulation
233833|NCT01964261|sensory feedback|sensory feedback
233834|NCT01964248|Blood gas analysis|blood gas analysis
233835|NCT01964248|Arterial puncture|arterial puncture
233836|NCT01964248|Local anesthesia|local anesthesia
233837|NCT01964248|Eutectic mixture|eutectic mixture
233838|NCT01964248|Lidocaïne/prilocaïne cream (5%)|lidocaïne/prilocaïne cream (5%)
233839|NCT01964248|Placebo|placebo
233840|NCT01964248|Pain Intensity Scale|pain intensity scale
233841|NCT01964248|Numerical Rating Scale|numerical rating scale
233842|NCT01964235|INC280, advanced hepatocellular carcinoma, c-MET pathway dysregulation.|inc280, advanced hepatocellular carcinoma, c-met pathway dysregulation.
233843|NCT01964222|Cancer|cancer
233844|NCT01964222|Clinical trials|clinical trials
233845|NCT01964222|Informed consent|informed consent
233846|NCT01964222|Health literacy|health literacy
233847|NCT01964209|ADHD|adhd
233848|NCT01964209|Validation|validation
233849|NCT01964209|Quality Improvement|quality improvement
233850|NCT01964209|Vanderbilt|vanderbilt
233851|NCT01964209|Conners 3rd Edition|conners 3rd edition
233852|NCT01964209|ADHD Measures|adhd measures
233853|NCT01964209|ADHD Adolescent|adhd adolescent
233854|NCT01964209|ADHD Questionnaire|adhd questionnaire
233855|NCT01964209|ICISS|iciss
233856|NCT01964209|Integrated Clinical Information Sharing System|integrated clinical information sharing system
233857|NCT01964196|Renal anemia|renal anemia
233858|NCT01964196|Chronic Renal Failure|chronic renal failure
233859|NCT01964196|ASP1517|asp1517
233860|NCT01964183|Open-label design|open-label design
233861|NCT01964183|Pharmacokinetics|pharmacokinetics
233862|NCT01964183|Drug-Drug Interaction|drug-drug interaction
233863|NCT01964183|Mirabegron|mirabegron
233865|NCT01964170|Prostate cancer|prostate cancer
233866|NCT01964157|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
233867|NCT01964144|thyroid cancer, dovitinib|thyroid cancer, dovitinib
233868|NCT01964131|Bioequivalence|bioequivalence
233869|NCT01964131|pharmacodynamics|pharmacodynamics
233870|NCT01964131|pharmacokinetics|pharmacokinetics
233871|NCT01964131|safety|safety
233872|NCT01964131|tolerability|tolerability
233873|NCT01964131|D961H|d961h
233874|NCT01964131|Japanese|japanese
233875|NCT01964118|intermittent fasting|intermittent fasting
233876|NCT01964118|obesity|obesity
233877|NCT01964118|calorie restriction|calorie restriction
233878|NCT01964105|Hypomastia|hypomastia
233879|NCT01964105|Augmentation|augmentation
233880|NCT01964105|Breast|breast
233882|NCT01964105|Breast Q|breast q
233883|NCT01964092|Disability|disability
233884|NCT01964092|Individual placement and support|individual placement and support
233885|NCT01964092|Mental health|mental health
233886|NCT01964092|Quality of life|quality of life
233887|NCT01964092|Randomized controlled trial|randomized controlled trial
233888|NCT01964092|Rehabilitation|rehabilitation
233889|NCT01964092|Return to work|return to work
233890|NCT01964092|Supported employment|supported employment
233891|NCT01964066|therapeutic ERCP|therapeutic ercp
233892|NCT01964066|prevention of post-ERCP pancreatitis|prevention of post-ercp pancreatitis
233893|NCT01964066|thoracic epidural analgesia|thoracic epidural analgesia
233894|NCT01964053|Self-management adherence|self-management adherence
233895|NCT01964053|post acute care|post acute care
233896|NCT01964053|critical access hospitals|critical access hospitals
233897|NCT01964053|patient activation|patient activation
233898|NCT01964053|hospital readmission|hospital readmission
233899|NCT01964040|femoral nerve block|femoral nerve block
233900|NCT01964040|peri-neural dexmedetomidine|peri-neural dexmedetomidine
233901|NCT01964027|second line chemoregime|second line chemoregime
233902|NCT01964027|gastric cancer|gastric cancer
233903|NCT01964014|once|once
233904|NCT01963988|Bladder Pain Syndrome|bladder pain syndrome
233905|NCT01963988|Transurethral Resection of Ulcer|transurethral resection of ulcer
233906|NCT01963988|Transurethral Coagulation of Ulcer|transurethral coagulation of ulcer
233907|NCT01963962|Emergency contraception|emergency contraception
233908|NCT01963962|Levonorgestrel IUD|levonorgestrel iud
233910|NCT01963962|Oral Levonorgestrel|oral levonorgestrel
233911|NCT01963936|Infant newborn|infant newborn
233912|NCT01963936|Laryngeal mask airway|laryngeal mask airway
233913|NCT01963936|Positive pressure ventilation|positive pressure ventilation
233914|NCT01963936|Resuscitation|resuscitation
233915|NCT01963923|Pulmonary Rehabilitation|pulmonary rehabilitation
233916|NCT01963923|Lung Cancer Resection|lung cancer resection
233917|NCT01963923|Video-assisted thoracic surgery|video-assisted thoracic surgery
233918|NCT01963923|Exercise tolerance|exercise tolerance
233919|NCT01963923|Quality of life|quality of life
233920|NCT01963910|Mannitol|mannitol
233921|NCT01963910|TRPV1 receptor|trpv1 receptor
233922|NCT01963910|Pain|pain
233923|NCT01963910|Burning pain|burning pain
233924|NCT01963910|neuropathy|neuropathy
233925|NCT01963910|neuropathic pain|neuropathic pain
233926|NCT01963897|Genotype/phenotype correlations|genotype/phenotype correlations
233927|NCT01963897|Growth|growth
233928|NCT01963897|Bone health|bone health
233929|NCT01963897|Puberty|puberty
233930|NCT01963897|Quality of life|quality of life
233931|NCT01963884|Extraction Sockets|extraction sockets
233932|NCT01963884|Ridge dimensions|ridge dimensions
233933|NCT01963884|Dental Alveolar Anatomy|dental alveolar anatomy
233934|NCT01963884|Dental Implants|dental implants
233935|NCT01963884|Bone Physiology|bone physiology
233936|NCT01963871|chronic low back pain|chronic low back pain
233937|NCT01963871|low back pain|low back pain
233938|NCT01963871|yoga|yoga
233939|NCT01963832|stroke|stroke
233940|NCT01963832|Fluoxetine (FLX)|fluoxetine (flx)
233941|NCT01963832|eCIMT|ecimt
233942|NCT01963832|Central Nervous System|central nervous system
233943|NCT01963793|Pruritus|pruritus
233944|NCT01963780|lung transplantation|lung transplantation
233945|NCT01963780|lung preservation|lung preservation
233946|NCT01963780|breathing lung transplant|breathing lung transplant
233947|NCT01963767|memory|memory
233948|NCT01963767|cognition|cognition
233949|NCT01963767|dietary supplements|dietary supplements
233950|NCT01963754|Articaine 1:100.000|articaine 1:100.000
233951|NCT01963754|Dental Implants|dental implants
233952|NCT01963754|Posterior mandible|posterior mandible
233953|NCT01963754|Loco-regional Anesthesia|loco-regional anesthesia
233954|NCT01963754|Subperiosteal Anesthesia|subperiosteal anesthesia
233956|NCT01963741|allergic rhinitis|allergic rhinitis
233957|NCT01963741|nasal airway resistance|nasal airway resistance
233958|NCT01963741|nasal provocation test|nasal provocation test
233959|NCT01963741|nasal hyperreactivity|nasal hyperreactivity
233960|NCT01963741|airway inflammation|airway inflammation
233961|NCT01963741|asthma|asthma
233962|NCT01963728|post-transplant|post-transplant
233963|NCT01963728|diabetes mellitus|diabetes mellitus
233964|NCT01963728|renal transplant|renal transplant
233965|NCT01963728|kidney transplant|kidney transplant
233966|NCT01963728|lung transplant|lung transplant
233967|NCT01963728|heart transplant|heart transplant
233968|NCT01963728|insulin|insulin
233969|NCT01963715|IMGN289|imgn289
233970|NCT01963715|Antibody Drug Conjugate|antibody drug conjugate
233971|NCT01963715|antibody|antibody
233972|NCT01963715|EGFR|egfr
233973|NCT01963715|NSCLC|nsclc
233974|NCT01963715|SCCHN|scchn
233975|NCT01963715|Head and neck|head and neck
233976|NCT01963715|Squamous cell carcinoma|squamous cell carcinoma
233977|NCT01963715|Solid tumor|solid tumor
233978|NCT01963715|Immunogen|immunogen
233979|NCT01963715|Lung|lung
233980|NCT01963715|Phase 1|phase 1
233981|NCT01963702|predictive factor|predictive factor
233982|NCT01963702|response|response
233983|NCT01963702|gastric neoplasm|gastric neoplasm
233984|NCT01963702|oxaliplatin|oxaliplatin
233985|NCT01963702|docetaxol|docetaxol
233986|NCT01963702|capecitabine|capecitabine
233987|NCT01963689|Anxiety|anxiety
233988|NCT01963689|Self-Esteem|self-esteem
233989|NCT01963676|schizophrenia|schizophrenia
233990|NCT01963676|auditory hallucinations|auditory hallucinations
233991|NCT01963676|transcranial stimulation|transcranial stimulation
233992|NCT01963676|tDCS|tdcs
233993|NCT01963676|tACS|tacs
233994|NCT01963663|YKL-40|ykl-40
233995|NCT01963663|Chronic low grade inflammation|chronic low grade inflammation
233996|NCT01963663|type 2 diabetes mellitus|type 2 diabetes mellitus
233997|NCT01963663|metformin|metformin
233998|NCT01963663|pioglitazone|pioglitazone
233999|NCT01963637|obesity, sleeve gastrectomy, gastric bypass, gastric tomodensitometry, gastric pouch size, weight regain|obesity, sleeve gastrectomy, gastric bypass, gastric tomodensitometry, gastric pouch size, weight regain
234000|NCT01963624|Breast|breast
234001|NCT01963624|Screening|screening
234002|NCT01963624|Ultrasound|ultrasound
234003|NCT01963624|Elastography|elastography
234004|NCT01963624|Doppler ultrasonography|doppler ultrasonography
234005|NCT01963611|Multiple Sclerosis|multiple sclerosis
234006|NCT01963611|Relapsing Remitting|relapsing remitting
234007|NCT01963611|Plovamer acetate|plovamer acetate
234008|NCT01963611|Copaxone|copaxone
234009|NCT01963585|C reactive protein|c reactive protein
234010|NCT01963585|Airway hyperreactivity|airway hyperreactivity
234011|NCT01963585|Body mass index|body mass index
234012|NCT01963572|Breast cancer|breast cancer
234013|NCT01963572|Care model|care model
234014|NCT01963572|Physical Therapy|physical therapy
234015|NCT01963546|diabetic|diabetic
234016|NCT01963546|laparoscopic gastric bypass surgery|laparoscopic gastric bypass surgery
234017|NCT01963546|stress response|stress response
234018|NCT01963546|anesthesia|anesthesia
234019|NCT01963546|dexmedetomidine|dexmedetomidine
234020|NCT01963533|lung cancer|lung cancer
234021|NCT01963533|telomere length|telomere length
234022|NCT01963533|comorbidity|comorbidity
234023|NCT01963533|Eastern Cooperation Oncology Group (ECOG)|eastern cooperation oncology group (ecog)
234024|NCT01963533|chemotherapy|chemotherapy
234025|NCT01963520|Hip prosthesis infection|hip prosthesis infection
234026|NCT01963520|Reinfection|reinfection
234027|NCT01963520|Excision-synovectomy|excision-synovectomy
234028|NCT01963520|One stage/two stage revision|one stage/two stage revision
234029|NCT01963520|Antibiotherapy|antibiotherapy
234030|NCT01963494|Physical activity|physical activity
234031|NCT01963494|Health-behavior-change|health-behavior-change
234032|NCT01963494|Dyadic Planning|dyadic planning
234033|NCT01963494|Individual Planning|individual planning
234034|NCT01963481|hormonal therapy|hormonal therapy
234035|NCT01963481|immunotherapy|immunotherapy
234036|NCT01963468|Hearing Loss|hearing loss
234037|NCT01963468|Cochlear Implant|cochlear implant
234038|NCT01963468|Deaf|deaf
234039|NCT01963468|Hearing Impairment|hearing impairment
234040|NCT01963468|Hard of Hearing|hard of hearing
234041|NCT01963455|transplantation autologous stress urinary incontinence|transplantation autologous stress urinary incontinence
234042|NCT01963455|muscle derived cells|muscle derived cells
234043|NCT01963429|hepatocellular|hepatocellular
234044|NCT01963429|Proton|proton
234046|NCT01963403|etonogestrel implant|etonogestrel implant
234047|NCT01963403|birth control|birth control
234048|NCT01963403|irregular bleeding|irregular bleeding
234049|NCT01963403|heavy bleeding|heavy bleeding
234050|NCT01963390|Hypogonadism|hypogonadism
234051|NCT01963390|Testosterone Deficiency|testosterone deficiency
234052|NCT01963377|bronchoscopy|bronchoscopy
234053|NCT01963377|O2-supplementation|o2-supplementation
234054|NCT01963364|fructans|fructans
234055|NCT01963364|inulin|inulin
234056|NCT01963364|oligofructose|oligofructose
234057|NCT01963364|colonic fermentation|colonic fermentation
234059|NCT01963364|whoe gut transit|whoe gut transit
234060|NCT01963351|NSCLC|nsclc
234061|NCT01963351|Non-squamous|non-squamous
234062|NCT01963286|ICD|icd
234063|NCT01963286|CRT-D|crt-d
234064|NCT01963286|Sudden cardiac death|sudden cardiac death
234065|NCT01963286|Device settings|device settings
234066|NCT01963286|Optimized programming strategy|optimized programming strategy
234067|NCT01963221|elderly|elderly
234068|NCT01963221|aorta|aorta
234069|NCT01963221|inflammation|inflammation
234070|NCT01963221|arterial stiffness|arterial stiffness
234071|NCT01963221|PET/CT Imaging|pet/ct imaging
234072|NCT01963221|hypertension|hypertension
234073|NCT01963221|MRI|mri
234074|NCT01963208|partial onset seizures|partial onset seizures
234075|NCT01963208|complex partial seizures|complex partial seizures
234076|NCT01963208|simple partial seizures|simple partial seizures
234077|NCT01963208|anticonvulsant|anticonvulsant
234078|NCT01963208|ganaxolone|ganaxolone
234079|NCT01963208|neurosteroid|neurosteroid
234080|NCT01963208|Marinus|marinus
234081|NCT01963208|epilepsy|epilepsy
234082|NCT01963195|Adverse Reaction to Drug|adverse reaction to drug
234083|NCT01963195|Self Efficacy|self efficacy
234084|NCT01963169|Bone Health|bone health
234085|NCT01963169|Online intervention|online intervention
234086|NCT01963169|Dissemination|dissemination
234087|NCT01963169|Theory-based intervention|theory-based intervention
234088|NCT01963156|Prescription synchronization|prescription synchronization
234089|NCT01963156|Cardiovascular disease|cardiovascular disease
234090|NCT01963156|Medication adherence|medication adherence
234091|NCT01963156|Randomized controlled trial|randomized controlled trial
234092|NCT01963156|Chronic disease|chronic disease
234093|NCT01963156|Pharmacy benefit design|pharmacy benefit design
234094|NCT01963156|Quality improvement|quality improvement
234095|NCT01963130|Vildagliptin|vildagliptin
234096|NCT01963130|Portal Vein Pressure|portal vein pressure
234097|NCT01963130|Hepatosteatosis|hepatosteatosis
234098|NCT01963104|hearing test, audiology, healthcare utilization,|hearing test, audiology, healthcare utilization,
234099|NCT01963104|patient education, hearing screening|patient education, hearing screening
234100|NCT01963065|Children's environmental health|children's environmental health
234101|NCT01963065|preterm birth|preterm birth
234102|NCT01963065|newborns|newborns
234103|NCT01963065|bisphenol A|bisphenol a
234104|NCT01963065|BPA|bpa
234105|NCT01963065|phthalates|phthalates
234106|NCT01963065|metals exposure|metals exposure
234107|NCT01963065|very low birth weight|very low birth weight
234108|NCT01963065|NICU|nicu
234109|NCT01963052|Metastatic Urothelial Cancer|metastatic urothelial cancer
234110|NCT01963052|AGS15E|ags15e
234111|NCT01963052|AGS15E-13-1|ags15e-13-1
234112|NCT01963052|ASG-15ME|asg-15me
234113|NCT01963052|Pharmacokinetics of AGS15E|pharmacokinetics of ags15e
234411|NCT01962012|Orthodontic|orthodontic
234114|NCT01963026|spinal cord injury|spinal cord injury
234115|NCT01963026|upper extremity|upper extremity
234116|NCT01963026|skill performance|skill performance
234117|NCT01963026|motor learning|motor learning
234118|NCT01963013|Non-returning catheter valve|non-returning catheter valve
234119|NCT01963013|Catheter associated urinary tract infection|catheter associated urinary tract infection
234120|NCT01963013|Critically ill patients|critically ill patients
234121|NCT01963013|Prevention|prevention
234122|NCT01963000|Community Acquired Pneumonia|community acquired pneumonia
234123|NCT01963000|Emergency Department|emergency department
234124|NCT01963000|Standardized Care|standardized care
234125|NCT01963000|Reduced Mortality|reduced mortality
234126|NCT01963000|CRB-65 Risk Classes|crb-65 risk classes
234127|NCT01963000|Antibiotic Therapy|antibiotic therapy
234128|NCT01962974|Arthritis, Rheumatoid|arthritis, rheumatoid
234129|NCT01962961|HIV|hiv
234130|NCT01962961|Endothelial function|endothelial function
234131|NCT01962961|Oxidative stress|oxidative stress
234132|NCT01962961|Cardiovascular disease|cardiovascular disease
234133|NCT01962961|N-acetylcysteine|n-acetylcysteine
234134|NCT01962935|Healthy volunteer|healthy volunteer
234135|NCT01962935|Multiple ascending dose|multiple ascending dose
234136|NCT01962909|Pancreatic Resection|pancreatic resection
234137|NCT01962883|Post Concussion Syndrome|post concussion syndrome
234138|NCT01962883|Vestibular disturbance|vestibular disturbance
234139|NCT01962883|Balance|balance
234140|NCT01962883|Dizziness|dizziness
234141|NCT01962883|Dizziness handicap inventory|dizziness handicap inventory
234142|NCT01962883|Balance Error Scoring System|balance error scoring system
234143|NCT01962857|Physical activity|physical activity
234144|NCT01962857|Exercise|exercise
234145|NCT01962857|Insulin resistance|insulin resistance
234146|NCT01962857|High intensity interval training|high intensity interval training
234147|NCT01962857|Fat oxidation|fat oxidation
234148|NCT01962857|Fitness|fitness
224850|NCT02005016|Stroke|stroke
234149|NCT01962857|Lipids|lipids
234150|NCT01962857|Blood pressure|blood pressure
234151|NCT01962844|chronic coronary artery disease|chronic coronary artery disease
234152|NCT01962844|coconut oil extra virgin|coconut oil extra virgin
234153|NCT01962844|index of diet quality|index of diet quality
234154|NCT01962844|nutritional treatment|nutritional treatment
234155|NCT01962831|obesity|obesity
234156|NCT01962831|labor, induced|labor, induced
234157|NCT01962831|pregnancy|pregnancy
234158|NCT01962831|cervical ripening|cervical ripening
234159|NCT01962831|dinoprostone|dinoprostone
234160|NCT01962818|Respiratory Distress Syndrome In Premature Infants|respiratory distress syndrome in premature infants
234161|NCT01962818|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
234162|NCT01962818|Ventilator-Induced Lung Injury|ventilator-induced lung injury
234163|NCT01962818|Functional Residual Capacity|functional residual capacity
234164|NCT01962818|Electric impedance tomography|electric impedance tomography
234165|NCT01962792|PCI-32765|pci-32765
234166|NCT01962792|Multiple Myeloma|multiple myeloma
234167|NCT01962792|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
234168|NCT01962792|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
234169|NCT01962792|Carfilzomib|carfilzomib
234170|NCT01962792|Dexamethasone|dexamethasone
234171|NCT01962792|Ibrutinib|ibrutinib
234172|NCT01962779|Sleep Disordered Breathing|sleep disordered breathing
234173|NCT01962779|Cognitively normal elderly|cognitively normal elderly
234174|NCT01962779|Alzheimer's disease|alzheimer's disease
234175|NCT01962779|Prevention|prevention
234176|NCT01962779|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
234177|NCT01962753|Affective symptoms as prodromal stage of Alzheimer|affective symptoms as prodromal stage of alzheimer
234178|NCT01962727|scapular dyskinesis, kinematics, muscular activities|scapular dyskinesis, kinematics, muscular activities
234179|NCT01962714|Behavior therapies, cognitive|behavior therapies, cognitive
234180|NCT01962714|Mindfulness|mindfulness
234181|NCT01962714|Emotion|emotion
234182|NCT01962714|Group therapy|group therapy
234183|NCT01962701|C-section|c-section
234184|NCT01962688|Heart Failure|heart failure
234185|NCT01962688|Handheld ultrasound|handheld ultrasound
234186|NCT01962688|Inferior Vena Cava|inferior vena cava
234187|NCT01962675|tDCS|tdcs
234188|NCT01962675|motor training|motor training
234189|NCT01962675|SCI|sci
234190|NCT01962662|stroke|stroke
234191|NCT01962662|transcranial magnetic stimulation|transcranial magnetic stimulation
234192|NCT01962662|EMG biofeedback|emg biofeedback
234193|NCT01962662|motor function|motor function
234194|NCT01962662|neural plasticity|neural plasticity
234195|NCT01962662|force|force
234196|NCT01962636|Umbilical Cord Transplant|umbilical cord transplant
234197|NCT01962636|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
234198|NCT01962636|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
234199|NCT01962636|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
234200|NCT01962636|Plasma Cell Leukemia|plasma cell leukemia
234201|NCT01962636|Myelofibrosis|myelofibrosis
234202|NCT01962636|Myelodysplasia|myelodysplasia
234203|NCT01962636|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
234204|NCT01962636|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
234205|NCT01962636|Marginal Zone B-Cell Lymphoma|marginal zone b-cell lymphoma
234206|NCT01962636|Follicular Lymphoma|follicular lymphoma
234207|NCT01962636|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
234208|NCT01962636|Mantle-Cell Lymphoma|mantle-cell lymphoma
234209|NCT01962636|Prolymphocytic Leukemia|prolymphocytic leukemia
234210|NCT01962636|Large Cell Non-Hodgkin Lymphoma|large cell non-hodgkin lymphoma
234211|NCT01962636|Lymphoblastic Lymphoma|lymphoblastic lymphoma
234212|NCT01962636|Burkitt's Lymphoma|burkitt's lymphoma
234213|NCT01962636|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
234214|NCT01962636|Multiple Myeloma|multiple myeloma
234215|NCT01962623|Severe Mood Dysregulation|severe mood dysregulation
234216|NCT01962623|Mood Disorders|mood disorders
234217|NCT01962623|Irritability|irritability
234218|NCT01962623|Disruptive Mood Dysregulation Disorder|disruptive mood dysregulation disorder
234219|NCT01962623|Interpersonal Psychotherapy|interpersonal psychotherapy
234220|NCT01962610|Pain care|pain care
234221|NCT01962610|emergency|emergency
234222|NCT01962610|clinical decision support|clinical decision support
234223|NCT01962610|abdominal pain|abdominal pain
234224|NCT01962597|hemodialysis|hemodialysis
234225|NCT01962597|aerobic exercise|aerobic exercise
234226|NCT01962597|resistance training|resistance training
234227|NCT01962597|walking speed|walking speed
234228|NCT01962597|randomized controlled trial|randomized controlled trial
234229|NCT01962571|Optic neuritis|optic neuritis
234230|NCT01962571|Multiple Sclerosis|multiple sclerosis
234231|NCT01962571|Clinically isolated syndrome|clinically isolated syndrome
234232|NCT01962571|Erythropoietin|erythropoietin
234233|NCT01962558|Tinnitus|tinnitus
234234|NCT01962558|Medical Device|medical device
234235|NCT01962558|Randomized|randomized
234236|NCT01962558|Vagus Nerve Stimulation|vagus nerve stimulation
234237|NCT01962545|Atrial Fibrillation|atrial fibrillation
234238|NCT01962545|Percutaneous coronary intervention|percutaneous coronary intervention
234240|NCT01962545|Anticoagulant therapy|anticoagulant therapy
234241|NCT01962545|Antiplatelet therapy|antiplatelet therapy
234242|NCT01962545|Warfarin|warfarin
234243|NCT01962545|NOAC|noac
234244|NCT01962545|Aspirin|aspirin
234245|NCT01962545|Clopidogrel|clopidogrel
234247|NCT01962532|Lymphoma|lymphoma
234248|NCT01962532|Advanced or refractory solid tumors|advanced or refractory solid tumors
234249|NCT01962532|Advanced or refractory lymphoma|advanced or refractory lymphoma
234250|NCT01962532|Gastric adenocarcinoma|gastric adenocarcinoma
234251|NCT01962532|Gastroesophageal junctions|gastroesophageal junctions
234252|NCT01962532|JNJ-42756493|jnj-42756493
234253|NCT01962532|Pharmacokinetics|pharmacokinetics
234254|NCT01962532|Japanese|japanese
234255|NCT01962532|Asian|asian
234256|NCT01962532|Pharmacodynamics|pharmacodynamics
234257|NCT01962519|gastrectomy|gastrectomy
234258|NCT01962519|gastric cancer|gastric cancer
234259|NCT01962519|oral feeding|oral feeding
234260|NCT01962519|complications|complications
234261|NCT01962506|Chest pain|chest pain
234262|NCT01962506|Copeptin|copeptin
234263|NCT01962506|High-sensitivity cardiac troponin|high-sensitivity cardiac troponin
234264|NCT01962506|Non-ST-Elevation (NSTE) - ACS|non-st-elevation (nste) - acs
234265|NCT01962467|Allergic rhinitis|allergic rhinitis
234266|NCT01962467|healthy volunteers|healthy volunteers
234267|NCT01962467|fluticasone furoate|fluticasone furoate
234268|NCT01962467|levocabastine|levocabastine
234269|NCT01962467|fixed dose combination|fixed dose combination
234270|NCT01962467|pharmacokinetics|pharmacokinetics
234271|NCT01962454|muscle mass|muscle mass
234272|NCT01962454|dynamic proteomics|dynamic proteomics
234273|NCT01962454|Duke University|duke university
234274|NCT01962454|Microbiopsy|microbiopsy
234275|NCT01962454|D2O|d2o
234276|NCT01962454|testosterone|testosterone
234277|NCT01962454|skeletal muscle|skeletal muscle
234278|NCT01962441|7977|7977
234279|NCT01962441|GS-7977|gs-7977
234280|NCT01962441|PSI-7977|psi-7977
234281|NCT01962441|Sofosbuvir (SOF)|sofosbuvir (sof)
234282|NCT01962441|Pegylated Interferon (Peg-IFN)|pegylated interferon (peg-ifn)
234283|NCT01962441|Ribavirin (RBV)|ribavirin (rbv)
234284|NCT01962428|ticagrelor|ticagrelor
234285|NCT01962428|loading dose|loading dose
234286|NCT01962428|non-ST-segment elevation acute coronary syndromes|non-st-segment elevation acute coronary syndromes
234287|NCT01962428|percutaneous coronary intervention|percutaneous coronary intervention
234288|NCT01962428|the antiplatelet effects|the antiplatelet effects
234289|NCT01962428|bleeding events|bleeding events
234290|NCT01962428|major adverse cardiac events|major adverse cardiac events
234291|NCT01962415|Severe Combined Immune Deficiency (SCID)|severe combined immune deficiency (scid)
234292|NCT01962415|Omenn Syndrome|omenn syndrome
234293|NCT01962415|Bare Lymphocyte Syndrome (BLS)|bare lymphocyte syndrome (bls)
234294|NCT01962415|Combined Immune Deficiency (CID) syndromes|combined immune deficiency (cid) syndromes
234295|NCT01962415|Combined Variable Immune Deficiency (CVID) syndrome|combined variable immune deficiency (cvid) syndrome
234296|NCT01962415|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
234297|NCT01962415|Leukocyte adhesion deficiency|leukocyte adhesion deficiency
234298|NCT01962415|Chronic granulomatous disease (CGD)|chronic granulomatous disease (cgd)
234299|NCT01962415|X-linked Hyper IgM (XHIM) syndrome|x-linked hyper igm (xhim) syndrome
234300|NCT01962415|IPEX syndrome|ipex syndrome
234301|NCT01962415|Chediak - Higashi Syndrome|chediak - higashi syndrome
234302|NCT01962415|Autoimmune Lymphoproliferative Syndrome (ALPS)|autoimmune lymphoproliferative syndrome (alps)
234303|NCT01962415|Hemophagocytic Lymphohistiocytosis (HLH) syndromes|hemophagocytic lymphohistiocytosis (hlh) syndromes
234304|NCT01962415|Lymphocyte Signaling defects|lymphocyte signaling defects
234305|NCT01962415|Dyskeratosis Congenita (DC)|dyskeratosis congenita (dc)
234306|NCT01962415|Congenital Amegakaryocytic Thrombocytopenia (CAMT)|congenital amegakaryocytic thrombocytopenia (camt)
234307|NCT01962415|Osteopetrosis|osteopetrosis
234308|NCT01962415|Mucopolysaccharidoses|mucopolysaccharidoses
234309|NCT01962415|Hurler syndrome (MPS I)|hurler syndrome (mps i)
234310|NCT01962415|Hunter syndrome (MPS II)|hunter syndrome (mps ii)
234311|NCT01962415|Sanfilippo syndrome (MPS II)|sanfilippo syndrome (mps ii)
234312|NCT01962415|Leukodystrophies|leukodystrophies
234313|NCT01962415|Krabbe Disease|krabbe disease
234314|NCT01962415|Metachromatic leukodystrophy (MLD)|metachromatic leukodystrophy (mld)
234315|NCT01962415|X-linked adrenoleukodystrophy (ALD)|x-linked adrenoleukodystrophy (ald)
234316|NCT01962415|Alpha mannosidosis|alpha mannosidosis
234317|NCT01962415|Gaucher Disease|gaucher disease
234318|NCT01962415|Thalassemia major|thalassemia major
234319|NCT01962415|Sickle cell disease (SCD)|sickle cell disease (scd)
234320|NCT01962415|Diamond Blackfan Anemia (DBA)|diamond blackfan anemia (dba)
234321|NCT01962415|Crohn's Disease|crohn's disease
234322|NCT01962415|Inflammatory Bowel Disease|inflammatory bowel disease
234323|NCT01962415|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
234324|NCT01962415|Congenital transfusion dependent anemias|congenital transfusion dependent anemias
234325|NCT01962415|Globoid cell leukodystrophy|globoid cell leukodystrophy
225078|NCT02003859|IBD|ibd
234326|NCT01962389|ISR, Laser, SFA, PAD|isr, laser, sfa, pad
234327|NCT01962376|Capecitabine|capecitabine
234335|NCT01962350|Bipolar Depression;|bipolar depression;
234336|NCT01962350|Cognition.|cognition.
234337|NCT01962324|Quality of Life|quality of life
234338|NCT01962324|Radiotherapy|radiotherapy
234339|NCT01962324|Radiotherapy, dose-escalation|radiotherapy, dose-escalation
234340|NCT01962311|ALS|als
234342|NCT01962311|Urine|urine
234343|NCT01962311|SERUM|serum
234344|NCT01962311|Diagnosis|diagnosis
234345|NCT01962285|neuronal inertia|neuronal inertia
234346|NCT01962285|loss of consciousness|loss of consciousness
234347|NCT01962285|propofol pharmacodynamics|propofol pharmacodynamics
234348|NCT01962285|Bispectral index|bispectral index
234349|NCT01962285|anesthesia, general/pharmacology|anesthesia, general/pharmacology
234350|NCT01962272|cancer|cancer
234351|NCT01962272|radiotherapy|radiotherapy
234352|NCT01962272|chemotherapy|chemotherapy
234353|NCT01962272|nutrition|nutrition
234354|NCT01962272|dietary counseling|dietary counseling
234355|NCT01962272|quality of life|quality of life
234356|NCT01962246|Capecitabine|capecitabine
234357|NCT01962246|Oxaliplatin|oxaliplatin
234358|NCT01962246|Preoperative Concurrent Chemoradiotherapy|preoperative concurrent chemoradiotherapy
234359|NCT01962246|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
234360|NCT01962220|HIV/AIDS|hiv/aids
234361|NCT01962220|PMTCT|pmtct
234362|NCT01962220|Pregnant Women|pregnant women
234363|NCT01962220|Kenya|kenya
234364|NCT01962220|Maternal Health|maternal health
234365|NCT01962207|10 years Meningitec|10 years meningitec
234366|NCT01962207|Safety|safety
234367|NCT01962207|booster response|booster response
234368|NCT01962207|Adolescents|adolescents
234369|NCT01962207|Adults|adults
234370|NCT01962207|Immunogenicity|immunogenicity
234371|NCT01962207|Mencevax ACWY|mencevax acwy
234372|NCT01962181|EEG Attention Deficit / Hyperactivity Disorder (ADHD) Ritalin machine learning|eeg attention deficit / hyperactivity disorder (adhd) ritalin machine learning
234373|NCT01962168|Biliary Tract Neoplasms|biliary tract neoplasms
234374|NCT01962168|Neoplasms|neoplasms
234375|NCT01962168|Gastrointestinal Diseases|gastrointestinal diseases
234376|NCT01962168|Digestive System Diseases|digestive system diseases
234377|NCT01962168|Biliary Tract|biliary tract
234378|NCT01962168|Stents|stents
234379|NCT01962155|Fibrosis|fibrosis
234380|NCT01962155|Liver Cirrhosis|liver cirrhosis
234381|NCT01962155|non-invasive|non-invasive
234382|NCT01962155|biopsy|biopsy
234383|NCT01962155|hepatitis B virus|hepatitis b virus
234394|NCT01962090|Neck Pain|neck pain
234395|NCT01962090|Thoracic spine thrust manipulation|thoracic spine thrust manipulation
234396|NCT01962090|Osteopathic Manipulation|osteopathic manipulation
234397|NCT01962090|Dentistry|dentistry
234398|NCT01962090|Range of Motion|range of motion
234399|NCT01962077|pulpotomy|pulpotomy
234400|NCT01962077|MTA|mta
234401|NCT01962077|primary teeth|primary teeth
234402|NCT01962077|formocresol|formocresol
234403|NCT01962038|Mild Cognitive Impairment|mild cognitive impairment
234404|NCT01962038|Aging|aging
234405|NCT01962025|Renal failure|renal failure
234406|NCT01962025|Hemodialysis|hemodialysis
234407|NCT01962025|Canulation technique|canulation technique
234408|NCT01962025|Training time|training time
234409|NCT01962025|Cost|cost
234410|NCT01962025|Patient discomfort with cannulation technique|patient discomfort with cannulation technique
234412|NCT01962012|Orthodontic Treatment|orthodontic treatment
234413|NCT01962012|Accelerated Tooth Movement|accelerated tooth movement
234414|NCT01962012|Malocclusion|malocclusion
234415|NCT01962012|Device|device
234416|NCT01962012|AcceleDent Aura|acceledent aura
234417|NCT01962012|Clear Aligners|clear aligners
234418|NCT01961999|Acute kidney injury|acute kidney injury
234419|NCT01961999|Cardiac surgery|cardiac surgery
234420|NCT01961999|Renal replacement therapy|renal replacement therapy
234421|NCT01961986|Rotator Cuff|rotator cuff
234422|NCT01961986|Rotator Cuff Sparing|rotator cuff sparing
234423|NCT01961986|Shoulder Replacement|shoulder replacement
234424|NCT01961986|Total Shoulder Replacement|total shoulder replacement
234425|NCT01961986|Total Shoulder Arthroplasty|total shoulder arthroplasty
234426|NCT01961986|Arthritis|arthritis
234427|NCT01961973|Articular cartilage|articular cartilage
234428|NCT01961973|Chondrocytes|chondrocytes
234429|NCT01961973|BMAC|bmac
234430|NCT01961960|ASP7374|asp7374
234431|NCT01961960|Prevention of seasonal influenza|prevention of seasonal influenza
234432|NCT01961947|ASP7374|asp7374
234433|NCT01961947|Approved egg-derived vaccine|approved egg-derived vaccine
234434|NCT01961947|Prevention of seasonal influenza|prevention of seasonal influenza
234435|NCT01961934|glioblastoma|glioblastoma
234436|NCT01961934|high grade brain tumors|high grade brain tumors
234437|NCT01961934|recurrent|recurrent
234438|NCT01961934|pseudo-progression|pseudo-progression
234439|NCT01961934|radionecrosis|radionecrosis
234440|NCT01961934|carbon acetate|carbon acetate
234441|NCT01961934|C11 aceate|c11 aceate
234442|NCT01961934|PET|pet
234443|NCT01961934|positron emission tomography|positron emission tomography
234444|NCT01961921|RNAi therapeutic|rnai therapeutic
234445|NCT01961895|Continuous lumbar plexus (LP) block analgesia|continuous lumbar plexus (lp) block analgesia
234446|NCT01961882|OCV-501|ocv-501
234447|NCT01961882|Acute Myeloid Leukemia|acute myeloid leukemia
234239|NCT01962545|Stent|stent
234456|NCT01961817|Retromolar|retromolar
234457|NCT01961817|Difficult Intubation|difficult intubation
234458|NCT01961791|gastric cancer, staging system, prognosis|gastric cancer, staging system, prognosis
234459|NCT01961765|Relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
234460|NCT01961765|Refractory acute myeloid leukemia|refractory acute myeloid leukemia
234461|NCT01961752|bupivacaine,|bupivacaine,
234462|NCT01961752|triamcinolone acetonide,|triamcinolone acetonide,
234463|NCT01961752|endoscopic|endoscopic
234464|NCT01961752|submucosal|submucosal
234465|NCT01961752|dissection|dissection
234466|NCT01961752|Patients|patients
234467|NCT01961739|Hemorrhoids|hemorrhoids
234468|NCT01961739|Lidocaine|lidocaine
234469|NCT01961713|circulating tumor cells|circulating tumor cells
234470|NCT01961713|CTC-Chip|ctc-chip
234471|NCT01961661|intestinal inflammation|intestinal inflammation
234472|NCT01961661|intestinal microflora|intestinal microflora
234473|NCT01961661|children|children
234474|NCT01961648|Apnea|apnea
234475|NCT01961648|Sleep Apnea Disorder|sleep apnea disorder
234476|NCT01961648|Respiratory chemical drive|respiratory chemical drive
234477|NCT01961648|CO2|co2
234478|NCT01961635|Dental Implants|dental implants
234479|NCT01961635|Zirconia Abutments|zirconia abutments
234480|NCT01961635|Titanium abutments|titanium abutments
234481|NCT01961635|Acrylic abutments|acrylic abutments
234482|NCT01961635|Gingival Healing|gingival healing
234483|NCT01961635|Inflammation|inflammation
234484|NCT01961635|Bone loss|bone loss
234485|NCT01961622|Type 1 diabetes|type 1 diabetes
234486|NCT01961622|Closed loop insulin delivery|closed loop insulin delivery
234487|NCT01961622|Continuous subcutaneous glucose monitoring|continuous subcutaneous glucose monitoring
234488|NCT01961622|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
234489|NCT01961609|Chronic plaque psoriasis|chronic plaque psoriasis
234490|NCT01961596|Cooling ice spray|cooling ice spray
234491|NCT01961596|Time to stability|time to stability
234492|NCT01961596|Jump|jump
234493|NCT01961570|Early stage hand osteoarthritis|early stage hand osteoarthritis
234494|NCT01961570|Carpometacarpal osteoarthritis|carpometacarpal osteoarthritis
234495|NCT01961557|EEG|eeg
234496|NCT01961557|Cerebral Palsy|cerebral palsy
234497|NCT01961557|Knee|knee
234498|NCT01961544|Breast Cancer|breast cancer
234499|NCT01961544|Metastatic|metastatic
234500|NCT01961531|DCIS|dcis
234501|NCT01961531|IDC|idc
234502|NCT01961531|Invasive breast carcinoma|invasive breast carcinoma
234503|NCT01961479|Premenstrual syndrome (PMS)|premenstrual syndrome (pms)
234504|NCT01961479|Premenstrual Dysphoric Disorder (PMDD)|premenstrual dysphoric disorder (pmdd)
234505|NCT01961479|Internet-based Therapy|internet-based therapy
234506|NCT01961479|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
234507|NCT01961453|Hypertension|hypertension
234508|NCT01961453|Isosorbide Mononitrate|isosorbide mononitrate
234509|NCT01961453|Myocardial fibrosis|myocardial fibrosis
234510|NCT01961427|dietary nitrate|dietary nitrate
234511|NCT01961427|beetroot juice|beetroot juice
234512|NCT01961427|exercise performance|exercise performance
234513|NCT01961427|oxygen consumption|oxygen consumption
234514|NCT01961414|Exudative|exudative
234515|NCT01961414|AMD|amd
234516|NCT01961414|Macular|macular
234517|NCT01961414|Degeneration|degeneration
234518|NCT01961414|Aflibercept|aflibercept
234519|NCT01961414|Eylea|eylea
234520|NCT01961414|Intravitreal|intravitreal
234521|NCT01961401|exercise|exercise
234522|NCT01961401|exercise therapy|exercise therapy
234523|NCT01961401|insulin resistance|insulin resistance
234814|NCT01960023|NSABP|nsabp
234524|NCT01961388|Type 2 Diabetes|type 2 diabetes
234525|NCT01961362|Pulmonary fibrosis|pulmonary fibrosis
234526|NCT01961362|Interstitial lung disease|interstitial lung disease
234527|NCT01961362|Connective tissue disease|connective tissue disease
234528|NCT01961362|Chronic hypersensitivity pneumonitis|chronic hypersensitivity pneumonitis
234529|NCT01961362|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
234530|NCT01961362|Pulmonary fibrosis of any cause|pulmonary fibrosis of any cause
234531|NCT01961362|Primary supporters/caregivers|primary supporters/caregivers
234532|NCT01961349|sedation, propofol, gastrointestinal endoscopy|sedation, propofol, gastrointestinal endoscopy
688123|NCT00923247|Solid Tumor|solid tumor
234533|NCT01961336|IVF, poor responder, testosterone|ivf, poor responder, testosterone
234534|NCT01961323|Hypertension|hypertension
234535|NCT01961323|high blood pressure|high blood pressure
234536|NCT01961323|stress echocardiogram|stress echocardiogram
234537|NCT01961323|nebivolol|nebivolol
234538|NCT01961323|left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
234539|NCT01961310|bacterial translocation|bacterial translocation
234540|NCT01961310|intestinal microbiota|intestinal microbiota
234541|NCT01961297|dystonia|dystonia
234543|NCT01961297|treatment|treatment
234544|NCT01961297|sodium oxybate|sodium oxybate
234545|NCT01961297|brain activity|brain activity
234547|NCT01961271|buprenorphine|buprenorphine
234548|NCT01961271|transdermal|transdermal
234549|NCT01961271|patch|patch
234550|NCT01961271|chronic pain|chronic pain
234551|NCT01961271|non-malignant|non-malignant
234552|NCT01961271|osteoarthritis|osteoarthritis
234553|NCT01961271|rheumatoid arthritis|rheumatoid arthritis
234554|NCT01961271|lower back pain|lower back pain
234555|NCT01961271|joint pain|joint pain
234556|NCT01961271|muscle pain|muscle pain
234557|NCT01961271|opioid|opioid
234558|NCT01961271|analgesic|analgesic
234559|NCT01961271|painkiller|painkiller
234560|NCT01961271|Mundipharma|mundipharma
234561|NCT01961258|Severe Asthma, Community, comorbidities, patient compliance,PFT, anti-IgE therapy|severe asthma, community, comorbidities, patient compliance,pft, anti-ige therapy
234562|NCT01961232|Pulmonary Hypertension|pulmonary hypertension
234563|NCT01961232|biomarker|biomarker
234564|NCT01961232|cardiac|cardiac
234565|NCT01961232|circulation|circulation
234566|NCT01961232|heart disease|heart disease
234567|NCT01961232|lung disease|lung disease
234568|NCT01961193|critically ill patients|critically ill patients
234569|NCT01961193|punctal plug|punctal plug
234570|NCT01961193|corneal injuries|corneal injuries
234571|NCT01961180|Quality of Life|quality of life
234572|NCT01961180|Adrenal hyper activity|adrenal hyper activity
234573|NCT01961180|Glucose metabolism|glucose metabolism
234574|NCT01961154|Asthma|asthma
234575|NCT01961154|medication reduction|medication reduction
234576|NCT01961154|asthma exacerbation|asthma exacerbation
234577|NCT01961141|Ultrasound Doppler|ultrasound doppler
234578|NCT01961141|Pulmonary diseases|pulmonary diseases
234579|NCT01961141|Cardiopulmonary conditions|cardiopulmonary conditions
234580|NCT01961128|High risk|high risk
234581|NCT01961102|postmenopausal bleeding|postmenopausal bleeding
234582|NCT01961102|postmenopausal hyperplasia|postmenopausal hyperplasia
234583|NCT01961102|endometrial cancer|endometrial cancer
234584|NCT01961102|atypical hyperplasia|atypical hyperplasia
234585|NCT01961102|curettage|curettage
234586|NCT01961102|intraoperative rapid section|intraoperative rapid section
234587|NCT01961050|alcohol|alcohol
234588|NCT01961050|pregnancy|pregnancy
234589|NCT01961050|fetal exposure|fetal exposure
234590|NCT01961050|prevention|prevention
234591|NCT01961050|FAS|fas
234592|NCT01961050|Alcohol-Related Neurodevelopmental Disorder (ARND)|alcohol-related neurodevelopmental disorder (arnd)
234593|NCT01961037|Accidental Falls|accidental falls
234594|NCT01961037|Tai Chi|tai chi
234595|NCT01961037|Older Adults|older adults
234596|NCT01961037|Balance|balance
234597|NCT01961037|Moving for Better Balance|moving for better balance
234598|NCT01961037|Church|church
234599|NCT01961037|Congregational Intervention|congregational intervention
234600|NCT01961037|Rural|rural
234601|NCT01961037|West Virginia|west virginia
234602|NCT01961024|VLDL-TG kinetics|vldl-tg kinetics
234603|NCT01961024|Postprandial state|postprandial state
234604|NCT01961024|Obesity|obesity
234605|NCT01961011|nerve compression, carpal tunnel, clinical decision making|nerve compression, carpal tunnel, clinical decision making
234606|NCT01960998|radical prostatectomy|radical prostatectomy
234607|NCT01960998|urinary incontinence|urinary incontinence
234608|NCT01960998|prostate cancer|prostate cancer
234609|NCT01960998|telehealth|telehealth
234610|NCT01960998|pelvic floor muscle training|pelvic floor muscle training
234611|NCT01960985|Balance, Postural|balance, postural
234612|NCT01960985|Parkinson´s Disease|parkinson´s disease
234613|NCT01960985|H&Y 1-3|h&y 1-3
234614|NCT01960985|Exrecice|exrecice
234615|NCT01960985|Postural adjustments|postural adjustments
234616|NCT01960985|antecipatory postural|antecipatory postural
234617|NCT01960985|compensatory postural adjustments|compensatory postural adjustments
234618|NCT01960972|Blood pressure|blood pressure
234619|NCT01960972|Hypertension|hypertension
234620|NCT01960972|Stepped wedge trial design|stepped wedge trial design
234621|NCT01960946|Hypertension|hypertension
234622|NCT01960946|Galectin 3|galectin 3
234623|NCT01960946|Fibrosis|fibrosis
234624|NCT01960946|Vascular Stiffness|vascular stiffness
234625|NCT01960946|Echocardiography|echocardiography
234627|NCT01960933|MVD|mvd
234628|NCT01960933|Full revascularization|full revascularization
234629|NCT01960933|Culprit lesion revascularization only|culprit lesion revascularization only
234630|NCT01960933|Primary PCI|primary pci
234631|NCT01960920|Air Pollution|air pollution
234632|NCT01960920|Heart Failure|heart failure
234633|NCT01960920|Endothelium|endothelium
234634|NCT01960920|Autonomic Dysfunction|autonomic dysfunction
234635|NCT01960920|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
234637|NCT01960907|CHF|chf
234638|NCT01960907|SDB|sdb
234639|NCT01960881|Prostate cancer|prostate cancer
234640|NCT01960855|anti-inflammatory agents|anti-inflammatory agents
234641|NCT01960855|Joint Diseases|joint diseases
234642|NCT01960855|Arthritis|arthritis
234643|NCT01960855|Musculoskeletal Disease|musculoskeletal disease
234644|NCT01960855|antirheumatic agents|antirheumatic agents
234645|NCT01960842|levodopa|levodopa
234646|NCT01960842|Advanced Parkinson's Disease|advanced parkinson's disease
234647|NCT01960842|carbidopa|carbidopa
234648|NCT01960842|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
234649|NCT01960842|Safety and Efficacy|safety and efficacy
234650|NCT01960829|melanoma|melanoma
234651|NCT01960829|TOR Serine-Threonine Kinases|tor serine-threonine kinases
234652|NCT01960816|nasal obstruction|nasal obstruction
234653|NCT01960803|Stage I Breast Carcinoma|stage i breast carcinoma
234654|NCT01960790|Humira®|humira®
234655|NCT01960790|Behcet's Disease|behcet's disease
234656|NCT01960790|Adalimumab|adalimumab
234657|NCT01960777|Hernia, Inguinal|hernia, inguinal
234658|NCT01960777|Laparoscopy|laparoscopy
234659|NCT01960777|Onstep|onstep
234660|NCT01960764|Autologous microbiome transplant|autologous microbiome transplant
234661|NCT01960764|Bacteria transplant|bacteria transplant
234662|NCT01960764|Treatment for atopic dermatitis|treatment for atopic dermatitis
234663|NCT01960738|Diving|diving
234664|NCT01960738|Water|water
234665|NCT01960738|Recreation|recreation
234666|NCT01960738|Precursor|precursor
234667|NCT01960725|Gastroenteritis|gastroenteritis
234668|NCT01960725|Diarrhea|diarrhea
234669|NCT01960725|Rotavirus|rotavirus
234670|NCT01960725|Vaccine|vaccine
234671|NCT01960725|Dehydration|dehydration
234672|NCT01960699|Prognosis|prognosis
234673|NCT01960699|Neurological outcome|neurological outcome
234674|NCT01960699|Resuscitation|resuscitation
234675|NCT01960699|Biomarker|biomarker
234676|NCT01960673|supraglottic airway,igel-LMA, ambu-LMA, changing position, head and neck position, oropharyngeal leak pressure,degree of rotation|supraglottic airway,igel-lma, ambu-lma, changing position, head and neck position, oropharyngeal leak pressure,degree of rotation
234677|NCT01960660|Fish Oil|fish oil
234678|NCT01960660|EPA|epa
234679|NCT01960660|DHA|dha
234680|NCT01960660|Omega-Score|omega-score
234681|NCT01960660|Lipemic Index|lipemic index
234682|NCT01960660|ethyl esters|ethyl esters
234683|NCT01960660|triglycerides|triglycerides
234684|NCT01960660|phospholipids|phospholipids
234685|NCT01960595|PCA,Nerve block,Hullax Valgus|pca,nerve block,hullax valgus
234686|NCT01960582|Housing adaptation|housing adaptation
234687|NCT01960582|Independence|independence
234688|NCT01960582|Costs|costs
234689|NCT01960569|Thrombexx|thrombexx
234690|NCT01960569|Topical r-Hirudin|topical r-hirudin
234691|NCT01960569|Efficacy|efficacy
234692|NCT01960569|haematoma|haematoma
234693|NCT01960556|simulation|simulation
234694|NCT01960543|Intrathecal anesthesia|intrathecal anesthesia
234695|NCT01960543|Levobupivacaine|levobupivacaine
234696|NCT01960543|Bupivacaine|bupivacaine
234697|NCT01960543|Hip fracture|hip fracture
234698|NCT01960517|Urinary|urinary
234699|NCT01960517|Incontinence|incontinence
234700|NCT01960517|Catheter|catheter
234701|NCT01960504|DREAMS|dreams
234702|NCT01960504|Drug Eluting Absorbable Metal Scaffold|drug eluting absorbable metal scaffold
234703|NCT01960504|Scaffold|scaffold
234704|NCT01960504|Coronary Artery Disease|coronary artery disease
234705|NCT01960504|Myocardial Ischemia|myocardial ischemia
234706|NCT01960504|Atherosclerosis|atherosclerosis
234707|NCT01960465|CPAP treatment|cpap treatment
234708|NCT01960465|hypertension|hypertension
234709|NCT01960452|Insomnia|insomnia
234710|NCT01960452|Primary insomnia|primary insomnia
234711|NCT01960452|High density EEG|high density eeg
234712|NCT01960452|Polysomnography|polysomnography
234713|NCT01960452|Healthy sleeping controls|healthy sleeping controls
234714|NCT01960439|disease activity|disease activity
234715|NCT01960439|central reader|central reader
235411|NCT01956825|magnesium|magnesium
234716|NCT01960439|endoscopic indices|endoscopic indices
234717|NCT01960426|Harvey Bradshaw score|harvey bradshaw score
234718|NCT01960426|Partial Mayo Clinical Score|partial mayo clinical score
234719|NCT01960426|Infliximab|infliximab
234720|NCT01960426|Adalimumab|adalimumab
234724|NCT01960400|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
234725|NCT01960400|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
234727|NCT01960387|clofarabine|clofarabine
234728|NCT01960387|cytarabine|cytarabine
234729|NCT01960387|persistent AML|persistent aml
234730|NCT01960387|induction therapy|induction therapy
234731|NCT01960374|RAS or RAF oncogenes, Inhibition of MEK pathway, inhibition cancer cell proliferation promising anti-cancer therapeutic strategy.|ras or raf oncogenes, inhibition of mek pathway, inhibition cancer cell proliferation promising anti-cancer therapeutic strategy.
234732|NCT01960348|RNAi therapeutic|rnai therapeutic
234734|NCT01960348|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
234736|NCT01960348|Transthyretin|transthyretin
234737|NCT01960348|Amyloidosis|amyloidosis
234738|NCT01960335|whey protein intake|whey protein intake
234739|NCT01960335|obesity|obesity
234740|NCT01960335|visceral fat|visceral fat
234741|NCT01960335|resistance exercise training|resistance exercise training
234742|NCT01960335|sprint interval training|sprint interval training
225472|NCT02001961|MRI|mri
234743|NCT01960335|endurance exercise training|endurance exercise training
234744|NCT01960335|yoga training|yoga training
234745|NCT01960335|healthy eating|healthy eating
234746|NCT01960335|healthy lifestyle strategies|healthy lifestyle strategies
234747|NCT01960335|leptin|leptin
234748|NCT01960335|hunger|hunger
234749|NCT01960322|adherence|adherence
234750|NCT01960322|nonadherence|nonadherence
234751|NCT01960322|compliance|compliance
234752|NCT01960322|noncompliance|noncompliance
234753|NCT01960322|liver transplantation|liver transplantation
234754|NCT01960296|clopidogrel|clopidogrel
234755|NCT01960296|general surgery|general surgery
234756|NCT01960270|relapse after an initial clinical response|relapse after an initial clinical response
234762|NCT01960244|familial|familial
234763|NCT01960244|hypercholesterolemia|hypercholesterolemia
234764|NCT01960244|FH|fh
234765|NCT01960218|acute decompensated heart failure|acute decompensated heart failure
234766|NCT01960218|gas exchange|gas exchange
234767|NCT01960218|cardiopulmonary|cardiopulmonary
234768|NCT01960218|dyspnea|dyspnea
234769|NCT01960218|cardiopulmonary analyzer|cardiopulmonary analyzer
234770|NCT01960218|heart disease|heart disease
234771|NCT01960218|cardiovascular disease|cardiovascular disease
234772|NCT01960218|cardiopulmonary exercise|cardiopulmonary exercise
234773|NCT01960205|Saxagliptin, prediabetes, glucose intolerance,obesity|saxagliptin, prediabetes, glucose intolerance,obesity
234774|NCT01960192|primary CNS lymphoma;chemotherapy;|primary cns lymphoma;chemotherapy;
234775|NCT01960192|RR;PFS;OS|rr;pfs;os
234776|NCT01960153|Heart failure|heart failure
234777|NCT01960153|Pulmonary hypertension|pulmonary hypertension
234778|NCT01960153|tadalafil|tadalafil
234779|NCT01960153|Phosphodiesterase Type 5 Inhibition|phosphodiesterase type 5 inhibition
234780|NCT01960114|Acetaminophen|acetaminophen
234781|NCT01960114|Paracetamol Analgesics|paracetamol analgesics
234782|NCT01960114|Analgesics|analgesics
234783|NCT01960114|Non-Narcotic Pain|non-narcotic pain
234784|NCT01960114|Postoperative Pain|postoperative pain
234785|NCT01960114|Antipyretics Dental Surgery|antipyretics dental surgery
234786|NCT01960114|Third molar extraction|third molar extraction
234787|NCT01960101|xerostomia|xerostomia
234788|NCT01960101|Saliva|saliva
234789|NCT01960101|iatrogenic oral dryness|iatrogenic oral dryness
234790|NCT01960101|antidepressants|antidepressants
234791|NCT01960101|mouth dryness|mouth dryness
234792|NCT01960101|milk product|milk product
234793|NCT01960088|Adolescent vaccines|adolescent vaccines
234794|NCT01960088|HPV vaccine|hpv vaccine
234795|NCT01960088|Pharmacies|pharmacies
234796|NCT01960075|status epilepticus, refractory, benzodiazepine, fosphenytoin, levetiracetam, valproic acid|status epilepticus, refractory, benzodiazepine, fosphenytoin, levetiracetam, valproic acid
234797|NCT01960062|diabetes|diabetes
234798|NCT01960062|web-based|web-based
234799|NCT01960062|software|software
234800|NCT01960062|device|device
234801|NCT01960049|Postoperative pain|postoperative pain
234802|NCT01960049|Liver resection|liver resection
234803|NCT01960049|Medial Open Transversus Abdominis Plane catheter|medial open transversus abdominis plane catheter
234804|NCT01960036|Substance Use Disorders|substance use disorders
234805|NCT01960036|Complementary Therapies|complementary therapies
234806|NCT01960036|Women|women
234807|NCT01960036|Mind-Body Therapies|mind-body therapies
234808|NCT01960036|Behavior and Behavior Mechanisms|behavior and behavior mechanisms
234809|NCT01960023|Colorectal cancer|colorectal cancer
234810|NCT01960023|KRAS|kras
234811|NCT01960023|BRAF|braf
234812|NCT01960023|NRAS|nras
234813|NCT01960023|PIK3CA|pik3ca
234815|NCT01959958|Nocturnal enuresis|nocturnal enuresis
234816|NCT01959958|Barriers to treatment|barriers to treatment
234817|NCT01959945|Prevention|prevention
234818|NCT01959932|Smoking|smoking
234819|NCT01959932|Candidate Modified Risk Tobacco Product|candidate modified risk tobacco product
235412|NCT01956825|fat content|fat content
234820|NCT01959932|Conventional cigarettes|conventional cigarettes
234821|NCT01959932|Reduced exposure|reduced exposure
234822|NCT01959932|Confinement|confinement
234823|NCT01959906|Esophagectomy|esophagectomy
234824|NCT01959880|Breast Augmentation|breast augmentation
234825|NCT01959880|Breast Reconstruction|breast reconstruction
234826|NCT01959880|Breast Revision|breast revision
234827|NCT01959880|Silicone Gel|silicone gel
234828|NCT01959880|Contour Profile Gel|contour profile gel
234829|NCT01959880|Siltex|siltex
234830|NCT01959880|CPG Styles|cpg styles
234831|NCT01959867|mastectomy|mastectomy
234832|NCT01959867|breast reconstruction|breast reconstruction
234833|NCT01959867|bovine|bovine
234834|NCT01959867|ADM|adm
234835|NCT01959867|breast cancer|breast cancer
234836|NCT01959867|breast implants|breast implants
234837|NCT01959867|breast expanders|breast expanders
234838|NCT01959867|radiation therapy|radiation therapy
234844|NCT01959828|LVAD|lvad
234845|NCT01959802|Macular pseudohole|macular pseudohole
234846|NCT01959802|Cone outer segment tips line|cone outer segment tips line
234847|NCT01959789|Randomized Controlled Clinical Trial|randomized controlled clinical trial
234848|NCT01959789|Tooth Bleaching|tooth bleaching
234849|NCT01959776|cone outer segment tips line, foveal displacement|cone outer segment tips line, foveal displacement
234850|NCT01959763|Metabolic syndrome|metabolic syndrome
234851|NCT01959763|obesity|obesity
234852|NCT01959763|overweight|overweight
234853|NCT01959763|weight loss intervention|weight loss intervention
234854|NCT01959763|cognitive behavioral therapy|cognitive behavioral therapy
234855|NCT01959763|ICT intervention|ict intervention
234856|NCT01959763|cardiovascular disease|cardiovascular disease
234857|NCT01959763|persuasive systems design|persuasive systems design
234858|NCT01959737|reactivity of HPA axis|reactivity of hpa axis
234859|NCT01959724|Macular detachment|macular detachment
234860|NCT01959724|Macular retinoschisis|macular retinoschisis
234861|NCT01959724|Vitrectomy|vitrectomy
234862|NCT01959711|Lateral transperitoneal laparoscopic adrenalectomy|lateral transperitoneal laparoscopic adrenalectomy
234863|NCT01959711|Posterior retroperitoneoscopic adrenalectomy|posterior retroperitoneoscopic adrenalectomy
234864|NCT01959646|Immune Function|immune function
234865|NCT01959646|Aged Garlic Extract|aged garlic extract
234866|NCT01959646|Supplementation|supplementation
234867|NCT01959646|Inflammation|inflammation
234868|NCT01959620|PTSD|ptsd
234869|NCT01959607|Smoking|smoking
234870|NCT01959607|Nicotine absorption|nicotine absorption
234871|NCT01959607|Modified risk tobacco product|modified risk tobacco product
234872|NCT01959607|Conventional cigarettes|conventional cigarettes
234873|NCT01959607|Nicotine Replacement Therapy gum (NRT gum)|nicotine replacement therapy gum (nrt gum)
234874|NCT01959594|multiple doses|multiple doses
234875|NCT01959594|pharmacokinetics|pharmacokinetics
234876|NCT01959594|safety|safety
234877|NCT01959594|tolerability|tolerability
234878|NCT01959594|healthy volunteers|healthy volunteers
234879|NCT01959594|steady state|steady state
234880|NCT01959594|cognitive impairment associated with schizophrenia|cognitive impairment associated with schizophrenia
234881|NCT01959581|Wilmington Robotic Exoskeleton|wilmington robotic exoskeleton
234882|NCT01959581|Reaching|reaching
234883|NCT01959581|Upper extremity function|upper extremity function
234884|NCT01959581|Preterm Infants|preterm infants
234885|NCT01959581|Brain injury|brain injury
234886|NCT01959581|Pediatrics|pediatrics
234887|NCT01959581|Early Intervention|early intervention
234888|NCT01959581|Arthrogryposis|arthrogryposis
234889|NCT01959568|Retinal Detachment|retinal detachment
234890|NCT01959568|Double Tamponade|double tamponade
234891|NCT01959568|Perfluorocarbon liquids|perfluorocarbon liquids
234892|NCT01959568|Vitrectomy|vitrectomy
234893|NCT01959542|Prostate Cancer|prostate cancer
234894|NCT01959516|COPD, early morning symptoms|copd, early morning symptoms
234895|NCT01959503|Aorta|aorta
234896|NCT01959503|Aortic|aortic
234897|NCT01959503|Reconstruction|reconstruction
234898|NCT01959503|CABG|cabg
234899|NCT01959503|Bypass|bypass
234900|NCT01959464|Assisted reproductive technology|assisted reproductive technology
234901|NCT01959464|Infertility|infertility
234902|NCT01959464|Progesterone|progesterone
234903|NCT01959464|Vaginal gel|vaginal gel
234904|NCT01959464|Luteal-phase support|luteal-phase support
234905|NCT01959451|Prasugrel|prasugrel
234906|NCT01959451|Clopidogrel|clopidogrel
234907|NCT01959438|Phase I study for safety|phase i study for safety
234908|NCT01959438|Later Phase II study for responses|later phase ii study for responses
234909|NCT01959425|Anticoagulation|anticoagulation
234910|NCT01959425|Oral|oral
235002|NCT01958957|safety|safety
234911|NCT01959425|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
234912|NCT01959425|Patients post successful cardiac ablation|patients post successful cardiac ablation
234913|NCT01959425|Symptomatic high-burden paroxysmal AF|symptomatic high-burden paroxysmal af
234914|NCT01959425|3 months post procedure|3 months post procedure
234915|NCT01959425|Remain free from AF recurrence|remain free from af recurrence
234916|NCT01959412|wheezing, short of breath, laba, inhaler|wheezing, short of breath, laba, inhaler
234917|NCT01959399|ASP015K|asp015k
234918|NCT01959399|healthy subjects|healthy subjects
234919|NCT01959360|Arthroplasty, Total Hip Replacement, Hip|arthroplasty, total hip replacement, hip
234920|NCT01959360|Surgical Procedures, Operative|surgical procedures, operative
234921|NCT01959360|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
234922|NCT01959347|urinary incontinence|urinary incontinence
234923|NCT01959347|midurethral sling|midurethral sling
234726|NCT01960387|AML|aml
234924|NCT01959347|pelvic floor therapy|pelvic floor therapy
234925|NCT01959334|Diabetes Mellitus|diabetes mellitus
234926|NCT01959334|Hypoglycemia|hypoglycemia
234927|NCT01959334|Glucagon|glucagon
234928|NCT01959334|Anti-glucagon Antibody|anti-glucagon antibody
234929|NCT01959334|Immunogenicity|immunogenicity
234930|NCT01959308|Adherence|adherence
234931|NCT01959308|Compliance|compliance
234932|NCT01959308|Immunosuppressive Therapy|immunosuppressive therapy
234933|NCT01959308|Liver Transplant|liver transplant
234934|NCT01959308|Liver Recipients|liver recipients
234935|NCT01959308|Adult|adult
234936|NCT01959308|Adolescent|adolescent
234937|NCT01959282|Colitis, Ulcerative|colitis, ulcerative
234938|NCT01959282|JNJ-54781532|jnj-54781532
234939|NCT01959282|Moderate|moderate
234940|NCT01959282|Severe|severe
234941|NCT01959282|Active|active
234942|NCT01959256|Stroke|stroke
234943|NCT01959256|Visual Field Defect|visual field defect
234944|NCT01959256|Visual perceptual learning|visual perceptual learning
234945|NCT01959256|Brain connectivity|brain connectivity
234946|NCT01959243|Ocular redness|ocular redness
234947|NCT01959230|Ocular redness|ocular redness
234949|NCT01959217|Substance Abuse|substance abuse
234950|NCT01959217|Prospective Memory|prospective memory
234951|NCT01959204|pharmacokinetics|pharmacokinetics
234952|NCT01959204|safety|safety
234953|NCT01959191|Platelet activity, CABG, off-pump surgery|platelet activity, cabg, off-pump surgery
234954|NCT01959165|Ulcerative Colitis, Japanese, subcutaneously|ulcerative colitis, japanese, subcutaneously
234955|NCT01959152|Cochlear Implant|cochlear implant
234956|NCT01959152|HiRes™ 90K Advantage implant|hires™ 90k advantage implant
234957|NCT01959152|Cochlear Implantation|cochlear implantation
234958|NCT01959152|HiFocus™ Mid-Scala electrode|hifocus™ mid-scala electrode
234959|NCT01959152|Listening Benefits|listening benefits
234960|NCT01959152|Adults|adults
234961|NCT01959152|Cochlear Implant Benefit|cochlear implant benefit
234962|NCT01959152|HiRes Fidelity 120™|hires fidelity 120™
234963|NCT01959152|Electrical Stimulation|electrical stimulation
234964|NCT01959126|Telomerase|telomerase
234965|NCT01959126|Telomere length|telomere length
234966|NCT01959126|Psychological Sress|psychological sress
234967|NCT01959126|Mindfulness|mindfulness
234968|NCT01959113|Microbiome|microbiome
234969|NCT01959113|Bacteria transplant|bacteria transplant
234970|NCT01959113|Atopic dermatitis treatments|atopic dermatitis treatments
235096|NCT01958437|Imaging|imaging
234971|NCT01959100|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
234972|NCT01959100|pulmonary non-infectious complications|pulmonary non-infectious complications
234973|NCT01959100|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
234974|NCT01959087|Single port surgery|single port surgery
234975|NCT01959087|Colonic surgery|colonic surgery
234976|NCT01959087|Postoperative morbidity|postoperative morbidity
234977|NCT01959087|Postoperative outcomes|postoperative outcomes
234978|NCT01959061|Advanced colorectal cancer of liver metastatic|advanced colorectal cancer of liver metastatic
234979|NCT01959048|Clostridium difficile associated disease|clostridium difficile associated disease
234980|NCT01959048|fecal microbiota transplantation|fecal microbiota transplantation
234981|NCT01959022|Posttramatic Stress Disorder|posttramatic stress disorder
234982|NCT01959022|Post-traumatic Stress Disorder|post-traumatic stress disorder
234983|NCT01959022|PTSD|ptsd
234984|NCT01959022|Doxazosin|doxazosin
234985|NCT01959022|Nightmares|nightmares
234986|NCT01959022|Sleep Disturbance|sleep disturbance
234987|NCT01959009|newborn, lung disease, mechanical ventilation, lung recruitment, high frequency ventilation|newborn, lung disease, mechanical ventilation, lung recruitment, high frequency ventilation
234988|NCT01958983|dementia|dementia
234989|NCT01958983|drumming|drumming
234990|NCT01958983|emotion|emotion
234991|NCT01958983|cognition|cognition
234992|NCT01958983|functional MRI|functional mri
234993|NCT01958970|End Stage Renal Disease|end stage renal disease
234994|NCT01958970|ESRD|esrd
234995|NCT01958970|Maintenance Hemodialysis|maintenance hemodialysis
234996|NCT01958970|Hemodialysis|hemodialysis
234997|NCT01958970|Dialysis|dialysis
234998|NCT01958970|MHD|mhd
234999|NCT01958970|Protein Energy Wasting|protein energy wasting
235000|NCT01958970|PEW|pew
235001|NCT01958957|ischemic stroke|ischemic stroke
235003|NCT01958957|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
235004|NCT01958944|CF|cf
235005|NCT01958944|Cystic Fibrosis|cystic fibrosis
235006|NCT01958944|NO|no
235007|NCT01958944|nitric oxide|nitric oxide
235008|NCT01958944|inhalation|inhalation
235009|NCT01958918|neovascular AMD|neovascular amd
235010|NCT01958918|ranibizumab|ranibizumab
235011|NCT01958918|aflibercept|aflibercept
235012|NCT01958918|BCVA|bcva
235013|NCT01958918|SD OCT|sd oct
235014|NCT01958892|BPH|bph
235717|NCT01955200|Ticagrelor|ticagrelor
235015|NCT01958879|internal derangement,arthrocentesis,corticosteroid|internal derangement,arthrocentesis,corticosteroid
235016|NCT01958866|Fever|fever
235017|NCT01958866|Body temperature|body temperature
235018|NCT01958853|Pain|pain
235019|NCT01958840|Behavioral|behavioral
235020|NCT01958840|Activation|activation
235021|NCT01958840|Treatment|treatment
235022|NCT01958827|Dose Escalation|dose escalation
235023|NCT01958827|Crohn's Disease|crohn's disease
235024|NCT01958801|Supraclavicular brachial plexus block|supraclavicular brachial plexus block
235025|NCT01958801|Interscalene brachial plexus block|interscalene brachial plexus block
235026|NCT01958801|Arthroscopic shoulder surgery|arthroscopic shoulder surgery
235027|NCT01958788|Cognitive-behavioral treatment|cognitive-behavioral treatment
235028|NCT01958788|Generalized anxiety disorder|generalized anxiety disorder
235029|NCT01958788|Worry|worry
235030|NCT01958788|Behavioral experiments|behavioral experiments
235031|NCT01958788|Safety behaviors|safety behaviors
235032|NCT01958788|Anxiety|anxiety
235033|NCT01958775|Lipoproteins, apoB, GLP-2|lipoproteins, apob, glp-2
235034|NCT01958762|Screening|screening
235035|NCT01958762|Cancer|cancer
235036|NCT01958762|Tobacco|tobacco
235037|NCT01958762|General Practitioner|general practitioner
235038|NCT01958762|Precancerous Lesion|precancerous lesion
235039|NCT01958762|Dysplasia|dysplasia
235040|NCT01958762|Tobacco vendor|tobacco vendor
235041|NCT01958723|Problem Specific Template|problem specific template
235042|NCT01958723|Physician Documentation|physician documentation
235043|NCT01958723|Electronic Medical Record Documentation|electronic medical record documentation
235044|NCT01958710|Catheterization, Bronchial|catheterization, bronchial
235045|NCT01958710|Pneumonectomy|pneumonectomy
235046|NCT01958710|Lobectomy|lobectomy
235047|NCT01958710|Thoracoplasty|thoracoplasty
235048|NCT01958697|Nutritional Disorders|nutritional disorders
235049|NCT01958697|Feeding Behavior|feeding behavior
235050|NCT01958684|Bleeding pattern|bleeding pattern
235051|NCT01958684|LNG-IUS|lng-ius
235052|NCT01958684|Cu-IUD|cu-iud
235053|NCT01958684|postabortion|postabortion
235054|NCT01958645|Phase 1, healthy male subjects, safety and tolerability, pharmacodynamic, pharmacokinetic|phase 1, healthy male subjects, safety and tolerability, pharmacodynamic, pharmacokinetic
235055|NCT01958619|open label|open label
235056|NCT01958619|healthy volunteers|healthy volunteers
235057|NCT01958619|pharmacokinetic|pharmacokinetic
235058|NCT01958619|parallel group|parallel group
235059|NCT01958606|Stroke|stroke
235060|NCT01958606|Rehabilitation|rehabilitation
235061|NCT01958606|Exercise|exercise
235062|NCT01958606|Intensity|intensity
235063|NCT01958606|Gait|gait
235064|NCT01958593|PTSD|ptsd
235065|NCT01958593|Posttraumatic stress disorder|posttraumatic stress disorder
235066|NCT01958593|MDMA|mdma
235067|NCT01958593|psychotherapy|psychotherapy
235068|NCT01958567|Scleritis|scleritis
235069|NCT01958567|Episcleritis|episcleritis
235070|NCT01958567|Optical coherence Tomography|optical coherence tomography
235071|NCT01958541|Sleep|sleep
235072|NCT01958541|Insomnia|insomnia
235073|NCT01958541|Suicidal Symptoms|suicidal symptoms
235074|NCT01958541|Suicidal Ideation|suicidal ideation
235075|NCT01958541|Military Veteran|military veteran
235076|NCT01958541|Service Member|service member
235077|NCT01958541|Depression|depression
235078|NCT01958515|Radiation Therapy|radiation therapy
235079|NCT01958515|Chemotherapy|chemotherapy
235080|NCT01958515|Chemoradiation Therapy|chemoradiation therapy
235081|NCT01958502|nonunion|nonunion
235082|NCT01958502|mesenchymal stem cell|mesenchymal stem cell
235083|NCT01958502|scaffold|scaffold
235084|NCT01958502|BMP2|bmp2
235085|NCT01958502|long bone|long bone
235086|NCT01958476|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
235087|NCT01958476|Opioids|opioids
235088|NCT01958463|Clostridium Difficile Infection|clostridium difficile infection
235089|NCT01958463|Fecal Microbiota Transplantation|fecal microbiota transplantation
235090|NCT01958450|acne scar|acne scar
235091|NCT01958450|Laser therapy|laser therapy
235092|NCT01958450|wound healing|wound healing
235093|NCT01958437|Aging|aging
235094|NCT01958437|Alzheimer's Disease/Dementia|alzheimer's disease/dementia
235095|NCT01958437|Cognitive Disorders|cognitive disorders
235097|NCT01958437|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
235098|NCT01958437|Neurology|neurology
235099|NCT01958437|Physical Medicine & Rehabilitation|physical medicine & rehabilitation
235100|NCT01958437|transcranial direct current stimulation|transcranial direct current stimulation
235101|NCT01958424|metabolic syndrome|metabolic syndrome
235102|NCT01958424|in vitro fertilization|in vitro fertilization
235206|NCT01957865|mHealth|mhealth
235103|NCT01958424|c reactive protein|c reactive protein
235104|NCT01958424|over-weight women|over-weight women
235105|NCT01958424|ovarian stimulation|ovarian stimulation
235106|NCT01958398|Randomized Controlled Trial|randomized controlled trial
235107|NCT01958398|Alcohol|alcohol
235108|NCT01958398|Internet|internet
235109|NCT01958398|Mobile phone|mobile phone
235110|NCT01958398|Screening|screening
235111|NCT01958398|Brief intervention|brief intervention
235112|NCT01958385|Total Body Weight Loss|total body weight loss
235113|NCT01958359|Randomized Controlled Trial|randomized controlled trial
235114|NCT01958359|Alcohol|alcohol
235115|NCT01958359|Telephone|telephone
235116|NCT01958359|Mobile phone|mobile phone
235117|NCT01958359|Screening|screening
235118|NCT01958359|Brief intervention|brief intervention
751902|NCT01171157|Influenza-like illness|influenza-like illness
235119|NCT01958359|IVR-based conversation menu with exercises and vignettes|ivr-based conversation menu with exercises and vignettes
235120|NCT01958333|Health-Related Physical Fitness|health-related physical fitness
235121|NCT01958333|Aerobic Endurance|aerobic endurance
235122|NCT01958333|Muscular Endurance|muscular endurance
235123|NCT01958333|Flexibility|flexibility
235124|NCT01958320|patent ductus arteriosus|patent ductus arteriosus
235125|NCT01958320|patent ductus arteriosus ligation|patent ductus arteriosus ligation
235126|NCT01958320|necrotizing enterocolitis|necrotizing enterocolitis
235127|NCT01958320|spontaneous intestinal perforation|spontaneous intestinal perforation
235128|NCT01958255|tobacco quit rates|tobacco quit rates
235129|NCT01958242|Cardiopulmonary bypass|cardiopulmonary bypass
235130|NCT01958242|pediatric|pediatric
235131|NCT01958242|blood products|blood products
235132|NCT01958242|conservation|conservation
235133|NCT01958216|TICE-human-stable isotopes|tice-human-stable isotopes
235134|NCT01958190|Liver transplantation long term renal function|liver transplantation long term renal function
235135|NCT01958190|tacrolimus sirolimus|tacrolimus sirolimus
235136|NCT01958177|stem cell|stem cell
235137|NCT01958177|cerebellar ataxia|cerebellar ataxia
235139|NCT01958151|colonoscopy|colonoscopy
235140|NCT01958151|deep sedation|deep sedation
235141|NCT01958151|anxiety|anxiety
235142|NCT01958138|Laryngeal Mask Airway|laryngeal mask airway
235143|NCT01958138|Propofol|propofol
235144|NCT01958138|Isoflurane|isoflurane
235145|NCT01958138|Pediatric patients|pediatric patients
235146|NCT01958138|Emergence|emergence
235147|NCT01958125|vagus nerve stimulation|vagus nerve stimulation
235148|NCT01958125|vagal nerve stimulation|vagal nerve stimulation
235149|NCT01958125|nVNS|nvns
235150|NCT01958125|VNS|vns
235151|NCT01958125|cluster headache|cluster headache
235152|NCT01958125|non invasive|non invasive
235153|NCT01958125|gammacore|gammacore
235154|NCT01958112|Cervical Cancer|cervical cancer
235155|NCT01958112|Cervical|cervical
235156|NCT01958112|Cervix|cervix
235157|NCT01958099|Injury Prevention|injury prevention
235158|NCT01958086|Neural|neural
235159|NCT01958086|Prosthetic|prosthetic
235160|NCT01958086|brain machine interface|brain machine interface
235161|NCT01958086|brain computer interface|brain computer interface
235162|NCT01958086|brain control|brain control
235163|NCT01958086|paralysis|paralysis
235164|NCT01958086|tetraplegia|tetraplegia
235165|NCT01958086|quadriplegia|quadriplegia
235166|NCT01958086|spinal cord injury|spinal cord injury
235167|NCT01958073|Recurrent Urinary Tract Infection|recurrent urinary tract infection
235168|NCT01958073|Postmenopausal|postmenopausal
235169|NCT01958073|Vaginal Estrogen|vaginal estrogen
235170|NCT01958047|Phase I|phase i
235171|NCT01958047|ASP3652|asp3652
235172|NCT01958047|Single dose|single dose
235173|NCT01958047|Dietary intake|dietary intake
235174|NCT01958021|HR-positive|hr-positive
235175|NCT01958021|HER2-negative|her2-negative
235176|NCT01958021|Advanced breast cancer|advanced breast cancer
235177|NCT01958021|LEE011|lee011
235178|NCT01958021|Letrozole|letrozole
235179|NCT01958021|CDK|cdk
235180|NCT01958021|CDK4|cdk4
235181|NCT01958021|CDK6|cdk6
235182|NCT01958021|CDK4/6|cdk4/6
235183|NCT01958021|Phase III|phase iii
235184|NCT01958021|ER-positive|er-positive
235185|NCT01958021|PR-positive|pr-positive
235186|NCT01958021|Postmenopausal|postmenopausal
235187|NCT01957943|Omega 3 lipid emulsions|omega 3 lipid emulsions
235188|NCT01957943|Liver transplantation|liver transplantation
235189|NCT01957943|Ischemia reperfusion injury|ischemia reperfusion injury
235190|NCT01957943|graft function|graft function
235191|NCT01957930|HbA1c|hba1c
235192|NCT01957930|Iontophoresis|iontophoresis
235193|NCT01957930|Intensified insulin treatment|intensified insulin treatment
235194|NCT01957930|Ischemic foot ulcer|ischemic foot ulcer
235195|NCT01957930|Type 1 diabetes|type 1 diabetes
235196|NCT01957917|HIV|hiv
235197|NCT01957917|Food Insecurity|food insecurity
235198|NCT01957917|Antiretroviral Therapy|antiretroviral therapy
235199|NCT01957904|ArterX, surgical sealant|arterx, surgical sealant
235200|NCT01957891|Hypoxia|hypoxia
235201|NCT01957891|Multiple wavelengths|multiple wavelengths
235202|NCT01957865|HIV/AIDS|hiv/aids
235203|NCT01957865|adherence|adherence
235204|NCT01957865|real time monitoring|real time monitoring
235205|NCT01957865|SMS|sms
235207|NCT01957865|social support|social support
235208|NCT01957826|mesenchymal|mesenchymal
235209|NCT01957826|stem cells|stem cells
235210|NCT01957826|transendocardial injection|transendocardial injection
235211|NCT01957826|dilated idiopathic cardiomyopathy|dilated idiopathic cardiomyopathy
235212|NCT01957826|idiopathic cardiomyopathy|idiopathic cardiomyopathy
235213|NCT01957813|APHIA AIDS, Population and Health Integrated Assistance|aphia aids, population and health integrated assistance
235214|NCT01957813|DIC Drop-in center|dic drop-in center
235215|NCT01957813|DMPA depot medroxyprogesterone acetate|dmpa depot medroxyprogesterone acetate
235216|NCT01957813|DRH Division of Reproductive Health|drh division of reproductive health
235217|NCT01957813|FAIR Family AIDS Initiative Response|fair family aids initiative response
235218|NCT01957813|FHOK Family Health Options Kenya|fhok family health options kenya
751903|NCT01171157|elderly|elderly
235219|NCT01957813|FP Family planning|fp family planning
235220|NCT01957813|FGD Focus group discussion|fgd focus group discussion
235221|NCT01957813|FSW Female sex worker|fsw female sex worker
235222|NCT01957813|GSKenya Gold Star Kenya|gskenya gold star kenya
235223|NCT01957813|HTC HIV testing and counseling|htc hiv testing and counseling
235224|NCT01957813|HIV Human Immunodeficiency Virus|hiv human immunodeficiency virus
235225|NCT01957813|KNASP Kenya National AIDS Strategic Plan|knasp kenya national aids strategic plan
235226|NCT01957813|MARPS Most at-risk populations|marps most at-risk populations
235227|NCT01957813|MoPHS Ministry of Public Health and Sanitation|mophs ministry of public health and sanitation
235228|NCT01957813|MMS Ministry of Medical Services|mms ministry of medical services
235229|NCT01957813|NASCOP National AIDS and STI Control Program|nascop national aids and sti control program
235230|NCT01957813|RH Reproductive health|rh reproductive health
235231|NCT01957813|SRH Sexual and reproductive health|srh sexual and reproductive health
235232|NCT01957813|STI Sexually transmitted infection|sti sexually transmitted infection
235233|NCT01957813|USAID United States Agency for International Development|usaid united states agency for international development
235234|NCT01957800|weight loss|weight loss
235235|NCT01957800|healthy diet|healthy diet
235237|NCT01957800|action planning|action planning
235238|NCT01957800|phone|phone
235239|NCT01957800|social|social
235240|NCT01957787|Metastatic lung tumors|metastatic lung tumors
235241|NCT01957787|Pulmonary metastatic disease|pulmonary metastatic disease
235242|NCT01957748|Retention|retention
235243|NCT01957748|Care|care
235244|NCT01957748|Engagement|engagement
235245|NCT01957735|metastatic cancer|metastatic cancer
235246|NCT01957735|solid tumor|solid tumor
235247|NCT01957735|unresectable tumor|unresectable tumor
235248|NCT01957735|brain cancer|brain cancer
235249|NCT01957735|lymphoma|lymphoma
235250|NCT01957696|Diabetes mellitus|diabetes mellitus
235251|NCT01957696|Pancreas transplantation|pancreas transplantation
235252|NCT01957696|Rejection|rejection
235253|NCT01957696|Surgical complications|surgical complications
235254|NCT01957696|Allograft biopsies|allograft biopsies
235255|NCT01957696|Immunological analyses|immunological analyses
235256|NCT01957696|Pancreas graft survival|pancreas graft survival
235257|NCT01957683|intracranial aneurysm|intracranial aneurysm
235258|NCT01957683|bifurcation|bifurcation
235259|NCT01957683|wide-neck|wide-neck
235260|NCT01957683|saccular|saccular
235261|NCT01957683|endovascular treatment|endovascular treatment
235262|NCT01957683|coil embolization|coil embolization
235263|NCT01957683|stent|stent
235264|NCT01957683|bare platinum|bare platinum
235265|NCT01957670|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
235266|NCT01957670|Dry Eye Syndromes|dry eye syndromes
235267|NCT01957631|Plantar Fasciitis|plantar fasciitis
235268|NCT01957631|Steroid|steroid
235269|NCT01957631|Platelet rich plasma|platelet rich plasma
235270|NCT01957631|Injection|injection
235271|NCT01957631|Ultrasound|ultrasound
235272|NCT01957605|prone position|prone position
235273|NCT01957605|hemodynamic variation|hemodynamic variation
235274|NCT01957605|mean systemic pressure|mean systemic pressure
235275|NCT01957579|Phase I|phase i
235276|NCT01957579|advanced|advanced
235277|NCT01957579|B cell malignancies|b cell malignancies
235278|NCT01957579|dose escalation|dose escalation
235279|NCT01957579|CD19|cd19
235280|NCT01957579|Japanese|japanese
235281|NCT01957566|propofol sedation|propofol sedation
235282|NCT01957566|children|children
235283|NCT01957566|procedure sedation|procedure sedation
235284|NCT01957540|ticagrelor|ticagrelor
235285|NCT01957540|prasugrel|prasugrel
235286|NCT01957540|endothelial function|endothelial function
235287|NCT01957527|ticagrelor|ticagrelor
235288|NCT01957527|endothelial function|endothelial function
235289|NCT01957527|peripheral arterial tonometry|peripheral arterial tonometry
235290|NCT01957501|Major Depressive Disorder|major depressive disorder
235291|NCT01957501|Bipolar Disorder|bipolar disorder
235292|NCT01957501|Adolescents|adolescents
235293|NCT01957501|Biomarker|biomarker
235294|NCT01957436|prostate|prostate
235295|NCT01957436|cancer|cancer
235296|NCT01957436|metastatic hormone-naive|metastatic hormone-naive
235297|NCT01957436|radiotherapy|radiotherapy
235298|NCT01957436|abiraterone acetate|abiraterone acetate
235299|NCT01957423|Crohn's disease|crohn's disease
235300|NCT01957423|whey protein|whey protein
235301|NCT01957423|soy protein|soy protein
235302|NCT01957423|nutritional status|nutritional status
235303|NCT01957423|activity of disease|activity of disease
235304|NCT01957410|Major Depressive Disorder|major depressive disorder
235305|NCT01957410|Ketamine|ketamine
235306|NCT01957410|Evoked potentials|evoked potentials
235307|NCT01957410|Somatosensory evoked potentials|somatosensory evoked potentials
235308|NCT01957410|Motor evoked potentials|motor evoked potentials
235309|NCT01957410|Cortical plasticity|cortical plasticity
235312|NCT01957371|Complementary and Alternative Medicine (CAM)|complementary and alternative medicine (cam)
235314|NCT01957345|constitutional functional disorders of platelets|constitutional functional disorders of platelets
235315|NCT01957345|platelet signalling defects|platelet signalling defects
235316|NCT01957332|molecular imaging|molecular imaging
235318|NCT01957332|89Zr-trastuzumab|89zr-trastuzumab
235320|NCT01957332|metastatic breast cancer|metastatic breast cancer
235321|NCT01957332|clinical utility|clinical utility
235322|NCT01957306|hot flashes, night sweats|hot flashes, night sweats
235323|NCT01957280|HER3|her3
235324|NCT01957267|Glaucoma|glaucoma
235325|NCT01957267|Optical Coherence Tomography|optical coherence tomography
235326|NCT01957267|Intraocular pressure|intraocular pressure
289521|NCT01710943|PTSD|ptsd
235327|NCT01957267|Optic nervehead|optic nervehead
235328|NCT01957267|Nerve fiber layer|nerve fiber layer
235329|NCT01957202|levocabastine fixed dose combination, Rhinitis, Allergic, Perennial and Seasonal, Allergic Rhinitis, fluticasone furoate|levocabastine fixed dose combination, rhinitis, allergic, perennial and seasonal, allergic rhinitis, fluticasone furoate
235330|NCT01957189|pharmacokinetics, Chinese|pharmacokinetics, chinese
235331|NCT01957189|Avodart, Duodart, dutasteride, tamsulosin, drug-drug interaction,|avodart, duodart, dutasteride, tamsulosin, drug-drug interaction,
235332|NCT01957176|myelodysplastic syndromes|myelodysplastic syndromes
235333|NCT01957176|thrombocytopenia|thrombocytopenia
235334|NCT01957176|acute myeloid leukemia|acute myeloid leukemia
235335|NCT01957176|, idiopathic thrombocytopenic purpura|, idiopathic thrombocytopenic purpura
235336|NCT01957176|Eltrombopag|eltrombopag
235337|NCT01957176|pediatrics|pediatrics
235338|NCT01957163|dry powder inhaler|dry powder inhaler
235339|NCT01957163|fluticasone furoate/vilanterol|fluticasone furoate/vilanterol
235340|NCT01957163|umeclidinium bromide|umeclidinium bromide
235341|NCT01957163|safety|safety
235342|NCT01957163|long acting beta2- receptor agonist|long acting beta2- receptor agonist
235343|NCT01957163|long acting muscarininc receptor antagonist|long acting muscarininc receptor antagonist
235344|NCT01957163|efficacy|efficacy
235345|NCT01957163|COPD|copd
235346|NCT01957163|inhaled corticosteroid|inhaled corticosteroid
235347|NCT01957137|Urinary|urinary
235348|NCT01957137|Urge|urge
235349|NCT01957137|Incontinence|incontinence
235350|NCT01957098|L-arabinose|l-arabinose
235351|NCT01957098|D-xylose|d-xylose
235352|NCT01957098|sucrose|sucrose
235353|NCT01957098|glucose|glucose
235354|NCT01957098|insulin|insulin
235355|NCT01957098|C-peptide|c-peptide
235356|NCT01957098|GLP-1|glp-1
235357|NCT01957085|Hepatitis C|hepatitis c
235358|NCT01957072|Cystic fibrosis|cystic fibrosis
235359|NCT01957072|Nutrition|nutrition
235360|NCT01957072|Weight|weight
235362|NCT01957072|Behaviour change|behaviour change
235363|NCT01957059|DMD|dmd
235364|NCT01957059|Duchenne muscular dystrophy|duchenne muscular dystrophy
235365|NCT01957059|Duchenne|duchenne
235366|NCT01957059|BMN053|bmn053
235367|NCT01957059|BioMarin|biomarin
235368|NCT01957046|Opioid induced constipation|opioid induced constipation
235369|NCT01957046|Laxatives|laxatives
235370|NCT01957033|whiplash|whiplash
235371|NCT01957033|neck pain|neck pain
235372|NCT01957033|manual therapy|manual therapy
235373|NCT01957033|exercise|exercise
235374|NCT01957033|dosage|dosage
235375|NCT01957007|Phase 1|phase 1
235376|NCT01957007|dose escalation|dose escalation
235377|NCT01957007|histologically confirmed|histologically confirmed
235378|NCT01957007|malignancy metastatic|malignancy metastatic
235379|NCT01956994|Whey Protein|whey protein
235380|NCT01956994|Arterial Stiffness|arterial stiffness
235381|NCT01956994|Neurovascular Coupling|neurovascular coupling
235382|NCT01956994|Cerebrovascular Reactivity|cerebrovascular reactivity
235383|NCT01956994|Hemodynamics|hemodynamics
235384|NCT01956994|Blood Flow|blood flow
235385|NCT01956994|Pulsatility|pulsatility
235386|NCT01956981|controlled hypotension, dexmedetomidine, magnesium sulfate.|controlled hypotension, dexmedetomidine, magnesium sulfate.
235387|NCT01956968|Shoulder pain, Scapular dyskinesia, Physical examination|shoulder pain, scapular dyskinesia, physical examination
235388|NCT01956942|GLAUCOMA|glaucoma
235389|NCT01956942|MICROPULSE|micropulse
235390|NCT01956942|LASER|laser
235391|NCT01956942|TRABECULOPLASTY|trabeculoplasty
235392|NCT01956942|OPEN ANGLE|open angle
235393|NCT01956942|INTRAOCULAR PRESSURE|intraocular pressure
235397|NCT01956916|Pulmonary exacerbation|pulmonary exacerbation
235398|NCT01956916|Inflammation|inflammation
235399|NCT01956916|Intestinal microbiota|intestinal microbiota
235400|NCT01956903|mesenchymal stem cell transplantation|mesenchymal stem cell transplantation
235401|NCT01956890|Breast neoplasms|breast neoplasms
235402|NCT01956890|PET|pet
235403|NCT01956890|MRI|mri
235404|NCT01956864|Vitamin D|vitamin d
688323|NCT00923884|Genotype|genotype
235405|NCT01956851|insulin, kisspeptin, GLP 1|insulin, kisspeptin, glp 1
235406|NCT01956838|food intake|food intake
235407|NCT01956838|tastants|tastants
235408|NCT01956838|obesity|obesity
235409|NCT01956825|non alcoholic fatty liver disease|non alcoholic fatty liver disease
235410|NCT01956825|LCARNITINE amino acid|lcarnitine amino acid
235413|NCT01956812|clivatuzumab tetraxetan|clivatuzumab tetraxetan
235414|NCT01956812|90Y-clivatuzumab tetraxetan|90y-clivatuzumab tetraxetan
235415|NCT01956812|IMMU-107|immu-107
235416|NCT01956799|MDS|mds
235417|NCT01956799|PMF|pmf
235418|NCT01956799|CMML|cmml
235419|NCT01956799|AA|aa
235420|NCT01956786|Amlodipine|amlodipine
235421|NCT01956786|Folic Acid|folic acid
235422|NCT01956786|Homocysteine|homocysteine
235423|NCT01956786|Blood Pressure|blood pressure
235424|NCT01956773|family health history|family health history
235425|NCT01956773|prevention|prevention
235426|NCT01956773|genetic risk|genetic risk
235427|NCT01956773|clinical decision support|clinical decision support
235428|NCT01956760|Insomnia|insomnia
235429|NCT01956734|glioblastoma|glioblastoma
235430|NCT01956734|first recurrence|first recurrence
235431|NCT01956734|temozolomide|temozolomide
235432|NCT01956721|Heart Failure , Skeletal muscle,Calcium,Ryanodine Receptor, Mitochondria, Exercise training, Muscle biopsy, Healthy volunteers|heart failure , skeletal muscle,calcium,ryanodine receptor, mitochondria, exercise training, muscle biopsy, healthy volunteers
235433|NCT01956669|VEGF|vegf
235434|NCT01956669|Pazopanib|pazopanib
235435|NCT01956669|Sarcoma|sarcoma
235436|NCT01956669|GW786034|gw786034
235437|NCT01956669|Refractory Solid Tumors|refractory solid tumors
235438|NCT01956656|lotus leaf, mouthwash, gingivitis|lotus leaf, mouthwash, gingivitis
235439|NCT01956643|sham feeding|sham feeding
235440|NCT01956643|postoperative ileus|postoperative ileus
235441|NCT01956643|liver transplantation|liver transplantation
235442|NCT01956591|Treatment efficacy|treatment efficacy
235443|NCT01956591|Long-term effects|long-term effects
235444|NCT01956591|Tachyphylaxis|tachyphylaxis
235445|NCT01956591|Undesirable effects|undesirable effects
235446|NCT01956591|Side effects|side effects
235447|NCT01956591|Self-assessment|self-assessment
235448|NCT01956591|Hyperhidrosis|hyperhidrosis
235449|NCT01956591|Quality of life|quality of life
235450|NCT01956565|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
235451|NCT01956565|Rehabilitation|rehabilitation
235452|NCT01956565|Physiotherapy|physiotherapy
235453|NCT01956565|Patient Compliance|patient compliance
235454|NCT01956565|Inspiratory Muscle Training|inspiratory muscle training
235455|NCT01956565|Respiratory Muscle Training|respiratory muscle training
235456|NCT01956552|Metastatic breast cancer|metastatic breast cancer
235457|NCT01956552|Tumor biopsy|tumor biopsy
235458|NCT01956552|Phenotype and genotype characterization|phenotype and genotype characterization
235459|NCT01956526|Heart Failure with Preserved Ejection Fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
235460|NCT01956526|Diastolic Heart Failure (DHF)|diastolic heart failure (dhf)
235461|NCT01956526|Diastolic Dysfunction (DD)|diastolic dysfunction (dd)
235462|NCT01956513|ADC|adc
235463|NCT01956513|breast cancer|breast cancer
235464|NCT01956513|complete pathological response|complete pathological response
235465|NCT01956500|glucosamine|glucosamine
235466|NCT01956500|inflammation|inflammation
235467|NCT01956500|quality of life|quality of life
235468|NCT01956500|physical function|physical function
235469|NCT01956487|Bioequivalence|bioequivalence
235470|NCT01956487|RYTHMOL SR®|rythmol sr®
235471|NCT01956487|Atrial fibrillation|atrial fibrillation
235472|NCT01956487|Propafenone|propafenone
235473|NCT01956487|Pharmavokinetics|pharmavokinetics
235474|NCT01956474|keratoconus|keratoconus
235475|NCT01956474|cross-linking|cross-linking
235476|NCT01956474|Post-LASIK ectasia|post-lasik ectasia
235477|NCT01956474|Pellucid marginal degeneration|pellucid marginal degeneration
235478|NCT01956474|Forme fruste pellucid marginal degeneration|forme fruste pellucid marginal degeneration
235479|NCT01956474|FFKC|ffkc
235480|NCT01956474|Radial Keratotomy|radial keratotomy
235481|NCT01956474|Terrien's Marginal Degeneration|terrien's marginal degeneration
235482|NCT01956461|osteoporosis|osteoporosis
235483|NCT01956461|BMD|bmd
235484|NCT01956461|teriparatide|teriparatide
235485|NCT01956461|nursing home|nursing home
235486|NCT01956448|Percutaneous coronary intervention|percutaneous coronary intervention
235487|NCT01956448|DES|des
235488|NCT01956448|Angina pectoris|angina pectoris
235489|NCT01956448|Stent|stent
235490|NCT01956409|breast neoplasms|breast neoplasms
235491|NCT01956409|18F-FCH PET|18f-fch pet
235492|NCT01956409|MRI|mri
235493|NCT01956396|male circumcision|male circumcision
235494|NCT01956396|HIV|hiv
235495|NCT01956396|Zimbabwe|zimbabwe
235496|NCT01956383|male circumcision|male circumcision
235497|NCT01956383|HIV|hiv
235498|NCT01956383|Zimbabwe|zimbabwe
235499|NCT01956370|Male Circumcision|male circumcision
235500|NCT01956370|HIV Prevention|hiv prevention
235501|NCT01956370|Medical Device|medical device
235502|NCT01956357|aquatic exercises;|aquatic exercises;
235503|NCT01956357|deep water running;|deep water running;
235504|NCT01956357|diabetes;|diabetes;
235505|NCT01956357|blood glucose;|blood glucose;
235506|NCT01956357|inflammation.|inflammation.
235507|NCT01956344|Hoarding Disorder|hoarding disorder
235508|NCT01956344|Clutter|clutter
235509|NCT01956344|CBT|cbt
235510|NCT01956344|Cognitive behavior therapy|cognitive behavior therapy
235511|NCT01956344|fMRI|fmri
235718|NCT01955200|Cilostazol|cilostazol
235512|NCT01956344|Obsessive compulsive disorder (OCD)|obsessive compulsive disorder (ocd)
235513|NCT01956344|Healthy control|healthy control
235514|NCT01956331|NSC lung Cancer,Elderly patients,post operative,|nsc lung cancer,elderly patients,post operative,
751904|NCT01171157|Influenza|influenza
235515|NCT01956318|Chronic venous insufficiency|chronic venous insufficiency
235516|NCT01956318|Varicose vein|varicose vein
235517|NCT01956318|Crenobalneotherapy|crenobalneotherapy
235518|NCT01956318|Balneotherapy|balneotherapy
235519|NCT01956318|Spa therapy|spa therapy
235520|NCT01956279|Pregnenolone|pregnenolone
226253|NCT01998477|Flu|flu
235521|NCT01956279|Gulf War Veteran|gulf war veteran
235522|NCT01956279|Fatigue|fatigue
235523|NCT01956279|Musculoskeletal Pain|musculoskeletal pain
235524|NCT01956279|Cognitive Decline|cognitive decline
235525|NCT01956279|Placebo Control|placebo control
235526|NCT01956266|Prosody|prosody
235527|NCT01956266|Communication|communication
235528|NCT01956266|Dysarthria|dysarthria
235529|NCT01956253|Bladder Cancer|bladder cancer
235530|NCT01956253|Neratinib|neratinib
235531|NCT01956253|13-2526|13-2526
235532|NCT01956240|shoulder|shoulder
235533|NCT01956240|pectoralis minor|pectoralis minor
235534|NCT01956240|stretching|stretching
235535|NCT01956240|scapular kinematics|scapular kinematics
235536|NCT01956214|hemodialysis|hemodialysis
235537|NCT01956214|exercise|exercise
235538|NCT01956214|electrical stimulation|electrical stimulation
235539|NCT01956175|electrical pharyngeal stimulation|electrical pharyngeal stimulation
235540|NCT01956175|stroke-related dysphagia|stroke-related dysphagia
235541|NCT01956175|tracheostomy|tracheostomy
235542|NCT01956175|decannulation|decannulation
235543|NCT01956149|gastric cancer|gastric cancer
235544|NCT01956149|second-line treatment|second-line treatment
235545|NCT01956149|Cabazitaxel|cabazitaxel
235546|NCT01956149|response|response
235547|NCT01956045|Intensive Care Units|intensive care units
235548|NCT01956045|Judgment|judgment
235549|NCT01956045|Disability Evaluation|disability evaluation
235550|NCT01956045|Autonomy|autonomy
235551|NCT01956032|LCIG|lcig
235552|NCT01956032|Parkinson's disease|parkinson's disease
235553|NCT01956032|levodopa carbidopa intestinal gel|levodopa carbidopa intestinal gel
235554|NCT01956032|Telemedicine|telemedicine
235555|NCT01955993|Obesity, adolescence,pharmacokinetics,fentanyl|obesity, adolescence,pharmacokinetics,fentanyl
235556|NCT01955980|CRS|crs
235557|NCT01955980|without polyposis|without polyposis
235558|NCT01955967|Effect|effect
235559|NCT01955967|Lidocaine|lidocaine
235560|NCT01955954|carbon dioxide monitoring|carbon dioxide monitoring
235561|NCT01955954|panic disorder|panic disorder
235562|NCT01955954|biofeedback|biofeedback
235563|NCT01955954|breathing training|breathing training
235564|NCT01955954|Primary diagnosis|primary diagnosis
235565|NCT01955941|Uveal melanoma|uveal melanoma
235566|NCT01955941|brachytherapy|brachytherapy
235567|NCT01955941|radiation|radiation
235568|NCT01955941|ciliary body|ciliary body
235569|NCT01955941|choroid|choroid
235570|NCT01955941|I-125 plaque brachytherapy|i-125 plaque brachytherapy
235571|NCT01955915|choroid|choroid
235572|NCT01955915|tumor|tumor
235573|NCT01955915|OCT|oct
235574|NCT01955915|malignant melanoma|malignant melanoma
235575|NCT01955902|Opioid dependence|opioid dependence
235576|NCT01955902|Buprenorphine|buprenorphine
235577|NCT01955902|Adherence|adherence
235578|NCT01955902|Substance use|substance use
235579|NCT01955902|Suboxone|suboxone
235580|NCT01955889|Exercise|exercise
235581|NCT01955889|Rehabilitation|rehabilitation
235582|NCT01955889|Telemedicine|telemedicine
235583|NCT01955876|Fosrenol|fosrenol
235584|NCT01955876|hyperphosphatemia|hyperphosphatemia
235585|NCT01955876|chronic kidney disease not on dialysis|chronic kidney disease not on dialysis
235586|NCT01955863|Prostatic Neoplasms|prostatic neoplasms
235587|NCT01955863|Prostatectomy, Retropubic|prostatectomy, retropubic
235588|NCT01955863|Patient Discharge|patient discharge
235589|NCT01955824|bronchoscopy|bronchoscopy
235590|NCT01955824|lignocaine|lignocaine
235591|NCT01955824|cough|cough
235592|NCT01955811|platelet transfusion|platelet transfusion
235593|NCT01955811|Fibrinogen|fibrinogen
235594|NCT01955811|blood coagulation|blood coagulation
235595|NCT01955811|Thrombocytopenia|thrombocytopenia
235596|NCT01955811|in-vitro experiments|in-vitro experiments
235597|NCT01955811|FGTW|fgtw
235598|NCT01955811|Fit2012|fit2012
235599|NCT01955811|factor I|factor i
235600|NCT01955811|Fibrin|fibrin
235601|NCT01955798|Laparoscopy|laparoscopy
235602|NCT01955798|Gyneacological|gyneacological
235603|NCT01955798|Entry techniques|entry techniques
235608|NCT01955772|Haematopoietic stem cell transplantation|haematopoietic stem cell transplantation
235610|NCT01955772|Artificial nutrition|artificial nutrition
235611|NCT01955694|BAY94-8862|bay94-8862
235612|NCT01955694|MR antagonist|mr antagonist
235613|NCT01955694|Heart failure|heart failure
235614|NCT01955694|Japanese patients|japanese patients
235615|NCT01955681|Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor retrement.|epidermal growth factor receptor tyrosine kinase inhibitor retrement.
235719|NCT01955200|Clopidogrel|clopidogrel
235616|NCT01955668|11q-deleted relapsed/refractory chronic lymphocytic leukaemia|11q-deleted relapsed/refractory chronic lymphocytic leukaemia
235617|NCT01955668|Prolymphocytic leukaemia|prolymphocytic leukaemia
235618|NCT01955668|B cell lymphomas|b cell lymphomas
235619|NCT01955655|Baclofen|baclofen
235620|NCT01955655|cerebral palsy|cerebral palsy
235621|NCT01955655|colic|colic
235622|NCT01955655|crying infant|crying infant
235623|NCT01955655|recurrent crying spells|recurrent crying spells
235624|NCT01955655|spasticity|spasticity
226331|NCT01998100|Stress|stress
235625|NCT01955655|therapy|therapy
235626|NCT01955642|Clopidogrel|clopidogrel
235627|NCT01955642|Brain Ischemia|brain ischemia
235628|NCT01955642|Ischemic attack|ischemic attack
235629|NCT01955642|Biological response to clopidogrel|biological response to clopidogrel
235630|NCT01955616|Parkinson's disease, chronic constipation|parkinson's disease, chronic constipation
235631|NCT01955590|Metacognitive therapy|metacognitive therapy
235632|NCT01955590|Eye Movement Desensitization Reprocessing (EMDR)|eye movement desensitization reprocessing (emdr)
235633|NCT01955590|Cognitive therapy|cognitive therapy
235634|NCT01955577|Vitamin D deficiency|vitamin d deficiency
235635|NCT01955577|Ring fixator|ring fixator
235636|NCT01955577|Tibial fracture|tibial fracture
235637|NCT01955525|Acute coronary syndrome|acute coronary syndrome
235638|NCT01955525|health related quality of life|health related quality of life
235639|NCT01955525|mortality|mortality
235640|NCT01955486|flight simulation|flight simulation
235641|NCT01955486|middle ear|middle ear
235642|NCT01955486|Eustachian tube function|eustachian tube function
235643|NCT01955473|Solid tumors|solid tumors
235644|NCT01955473|Sym004|sym004
235645|NCT01955473|Phase 1|phase 1
235646|NCT01955460|Melanoma|melanoma
235647|NCT01955460|Metastatic|metastatic
235648|NCT01955460|T-cells|t-cells
235649|NCT01955460|Autologous tumor infiltrating lymphocytes|autologous tumor infiltrating lymphocytes
235650|NCT01955460|TIL|til
235651|NCT01955460|DNRII|dnrii
235652|NCT01955460|NGFR|ngfr
235653|NCT01955460|Cyclophosphamide|cyclophosphamide
235654|NCT01955460|Cytoxan|cytoxan
235655|NCT01955460|Neosar|neosar
235656|NCT01955460|Mesna|mesna
235657|NCT01955460|Mesnex|mesnex
235658|NCT01955460|Fludarabine|fludarabine
235659|NCT01955460|Fludarabine phosphate|fludarabine phosphate
235660|NCT01955460|Fludara|fludara
235661|NCT01955460|Interleukin-2|interleukin-2
235662|NCT01955460|IL-2|il-2
235663|NCT01955460|Aldesleukin|aldesleukin
235664|NCT01955460|Proleukin|proleukin
235665|NCT01955447|Blood glucose|blood glucose
235666|NCT01955421|NSCLC|nsclc
235667|NCT01955421|stage IIIB|stage iiib
235668|NCT01955421|stage IV)|stage iv)
235669|NCT01955421|confirmed by histology or cytology methods|confirmed by histology or cytology methods
235670|NCT01955421|Harboring a PCR-confirmed activating mutation of EGFR, including an exon 19 deletion or an exon 21 L858R point mutation|harboring a pcr-confirmed activating mutation of egfr, including an exon 19 deletion or an exon 21 l858r point mutation
235671|NCT01955408|overactive bladder|overactive bladder
235672|NCT01955408|bladder cancer|bladder cancer
235673|NCT01955408|Synergo|synergo
235674|NCT01955408|urodynamic study|urodynamic study
235675|NCT01955395|Relaxation Response Resiliency Program (3RP)|relaxation response resiliency program (3rp)
235676|NCT01955395|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
235677|NCT01955395|smoldering multiple myeloma|smoldering multiple myeloma
235678|NCT01955382|Parasite Clearance Rate|parasite clearance rate
235679|NCT01955382|Parasite Half Life|parasite half life
235680|NCT01955382|Actidose Aqua|actidose aqua
235681|NCT01955382|Severe Malaria|severe malaria
235682|NCT01955369|incidence|incidence
235683|NCT01955369|phenotype|phenotype
235684|NCT01955369|mortality|mortality
235685|NCT01955356|Scratching|scratching
235686|NCT01955356|Endometrial biopsy|endometrial biopsy
235687|NCT01955356|Ongoing embryo implantation|ongoing embryo implantation
235688|NCT01955356|Assisted reproductive techniques|assisted reproductive techniques
235689|NCT01955343|Immune response|immune response
235690|NCT01955343|Cancer|cancer
235691|NCT01955330|CABG, Hybrid, Robotic surgery|cabg, hybrid, robotic surgery
235698|NCT01955291|Virtual Reality, Motor Learning, Rehabilitation, Upper Limb|virtual reality, motor learning, rehabilitation, upper limb
235699|NCT01955278|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
235700|NCT01955278|Parastomal hernia|parastomal hernia
235701|NCT01955278|Prophylactic|prophylactic
235703|NCT01955265|Positive youth development|positive youth development
235704|NCT01955265|Sports / physical activity|sports / physical activity
235705|NCT01955252|Endemic treponematoses|endemic treponematoses
235706|NCT01955252|Azithromycin|azithromycin
235707|NCT01955252|Mass drug administration|mass drug administration
235708|NCT01955252|Eradication|eradication
235709|NCT01955239|Head and Neck Cancer|head and neck cancer
235710|NCT01955239|Radiotherapy|radiotherapy
235711|NCT01955239|IMRT|imrt
235712|NCT01955239|Stem cell|stem cell
235713|NCT01955239|Parotid gland|parotid gland
235714|NCT01955213|constipation, methylnaltrexone, opoid|constipation, methylnaltrexone, opoid
235715|NCT01955200|Stent implantation|stent implantation
235716|NCT01955200|Clopidogrel low response|clopidogrel low response
235720|NCT01955187|SEQUENTIAL THERAPY|sequential therapy
235721|NCT01955187|PRIMARY MEMBRANOUS NEPHROPATHY|primary membranous nephropathy
235722|NCT01955187|TACROLIMUS|tacrolimus
235723|NCT01955187|RITUXIMAB|rituximab
235724|NCT01955174|Botulinum toxin|botulinum toxin
235725|NCT01955174|Esophageal motility disorder|esophageal motility disorder
235726|NCT01955174|Distal esophageal spasm|distal esophageal spasm
235728|NCT01955148|sPTB|sptb
235729|NCT01955148|cervical cerclage|cervical cerclage
235730|NCT01955148|LEEP|leep
235731|NCT01955148|PROM|prom
235732|NCT01955148|short cervix|short cervix
235733|NCT01955135|Prematurity, Retinopathy, propofol, ketamine, sedation|prematurity, retinopathy, propofol, ketamine, sedation
235734|NCT01955122|polyp/adenoma miss rate|polyp/adenoma miss rate
235735|NCT01955122|colonoscopy add-on device|colonoscopy add-on device
235736|NCT01955122|enhanced screening|enhanced screening
235737|NCT01955109|Food allergy|food allergy
235738|NCT01955109|Immediate hypersensitivity|immediate hypersensitivity
235739|NCT01955109|Whole peanut extract|whole peanut extract
235740|NCT01955109|Allergenic product|allergenic product
235741|NCT01955109|Specific Immunotherapy|specific immunotherapy
235742|NCT01955109|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
235743|NCT01955096|fast-track surgery, laparoscopic gastrectomy|fast-track surgery, laparoscopic gastrectomy
235744|NCT01955083|Obstructive sleep apnea|obstructive sleep apnea
235745|NCT01955083|snoring|snoring
235746|NCT01955083|radiofrequency|radiofrequency
235747|NCT01955083|pillar implant|pillar implant
235748|NCT01955083|snore sound analysis|snore sound analysis
235749|NCT01955070|Informed consent|informed consent
235750|NCT01955070|Ethics|ethics
235751|NCT01955044|neonatal prematurity|neonatal prematurity
235752|NCT01955044|infant, extremely low birth weight|infant, extremely low birth weight
235753|NCT01955044|fatty acids, polyunsaturated|fatty acids, polyunsaturated
235754|NCT01955031|Telemedicine|telemedicine
235755|NCT01955031|Telemonitoring|telemonitoring
235756|NCT01955031|Education|education
235757|NCT01955031|Nutrition|nutrition
235758|NCT01955031|Food behaviour|food behaviour
235759|NCT01955031|Weight|weight
235760|NCT01955031|Physical activity|physical activity
235761|NCT01955031|Glycaemia|glycaemia
235762|NCT01955031|Self-monitoring blood glucose|self-monitoring blood glucose
235763|NCT01955018|computed tomography|computed tomography
235764|NCT01955018|radiation|radiation
235765|NCT01955018|screening|screening
235766|NCT01955018|asbestos|asbestos
235767|NCT01955018|workers|workers
235768|NCT01955018|cancer|cancer
235769|NCT01955005|Health Records, Personal|health records, personal
235770|NCT01955005|Delivery of healthcare|delivery of healthcare
235771|NCT01955005|Consumer Participation|consumer participation
235772|NCT01955005|Internet|internet
235773|NCT01954992|glufosfamide|glufosfamide
235774|NCT01954992|5-FU|5-fu
235775|NCT01954992|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
235776|NCT01954979|Graft versus Host Disease|graft versus host disease
235777|NCT01954979|ABATACEPT|abatacept
235778|NCT01954966|Nicotine|nicotine
235779|NCT01954966|Smoking|smoking
235780|NCT01954953|Retinitis Pigmentosa Syndromic|retinitis pigmentosa syndromic
235781|NCT01954953|Congenital Deafness|congenital deafness
235782|NCT01954953|Usher Syndrome Retinitis Pigmentosa and Deafness|usher syndrome retinitis pigmentosa and deafness
235783|NCT01954953|Progressive Hearing Loss|progressive hearing loss
235784|NCT01954953|Retinitis Pigmentosa|retinitis pigmentosa
235785|NCT01954940|Whole body vibration therapy, muscle strength testing, bone health, ambulatory, endurance.|whole body vibration therapy, muscle strength testing, bone health, ambulatory, endurance.
235786|NCT01954927|Pain control|pain control
235787|NCT01954914|Plerixafor|plerixafor
235788|NCT01954914|donor|donor
235789|NCT01954914|allogeneic peripheral stam cell donation|allogeneic peripheral stam cell donation
235790|NCT01954914|PBSC|pbsc
235791|NCT01954914|poor donors|poor donors
235792|NCT01954875|neurodegenerative diseases|neurodegenerative diseases
235793|NCT01954875|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
235794|NCT01954875|multiple sclerosis|multiple sclerosis
235795|NCT01954875|Parkinson's Disease|parkinson's disease
235796|NCT01954862|Water-aided colonoscopy|water-aided colonoscopy
235797|NCT01954862|Water Immersion colonoscopy|water immersion colonoscopy
235798|NCT01954862|Water Exchange colonoscopy|water exchange colonoscopy
235799|NCT01954862|Carbon-dioxide colonoscopy|carbon-dioxide colonoscopy
235800|NCT01954862|Painless unsedated colonoscopy|painless unsedated colonoscopy
235801|NCT01954862|Adenoma detection rate|adenoma detection rate
235802|NCT01954862|Mean Adenomas per Procedure|mean adenomas per procedure
235803|NCT01954849|gingivitis|gingivitis
235804|NCT01954849|inflammation|inflammation
235805|NCT01954849|plaque|plaque
235806|NCT01954849|orthodontics|orthodontics
235807|NCT01954836|short-term fasting|short-term fasting
235808|NCT01954836|adjuvant chemotherapy|adjuvant chemotherapy
235809|NCT01954836|toxicity|toxicity
235810|NCT01954836|side-effects|side-effects
235811|NCT01954836|ovarial carinoma|ovarial carinoma
235812|NCT01954836|breast cancer|breast cancer
235813|NCT01954823|Multiple sclerosis, Patient-reported outcomes, patient diary|multiple sclerosis, patient-reported outcomes, patient diary
235814|NCT01954810|JECV|jecv
235815|NCT01954810|IMOJEV|imojev
235816|NCT01954810|Booster response|booster response
235817|NCT01954810|Children|children
235818|NCT01954810|antibody response|antibody response
235820|NCT01954797|Physical fitness|physical fitness
235821|NCT01954797|relaxation|relaxation
235822|NCT01954797|stroke|stroke
235823|NCT01954797|cerebral ischemia|cerebral ischemia
235824|NCT01954797|cerebral perfusion|cerebral perfusion
235825|NCT01954797|biomarkers|biomarkers
235826|NCT01954797|MRI|mri
235827|NCT01954771|Diabetes mellitus|diabetes mellitus
235828|NCT01954771|Coronary artery disease|coronary artery disease
235829|NCT01954771|SMBG|smbg
235830|NCT01954771|Elderly|elderly
235831|NCT01954758|Window of implantation|window of implantation
235832|NCT01954758|Personalized embryo transfer|personalized embryo transfer
235833|NCT01954758|Fresh embryo transfer|fresh embryo transfer
235834|NCT01954758|Delayed embryo transfer|delayed embryo transfer
235835|NCT01954758|Elective deferred embryo transfer|elective deferred embryo transfer
235836|NCT01954758|Endometrial receptivity array|endometrial receptivity array
235837|NCT01954758|Endometrial receptivity analysis|endometrial receptivity analysis
235838|NCT01954758|Endometrial receptivity test|endometrial receptivity test
235839|NCT01954745|Bile Duct Cancer|bile duct cancer
235840|NCT01954745|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
235841|NCT01954745|extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
235842|NCT01954745|Cabozantinib|cabozantinib
235843|NCT01954719|Cervix Uteri, Cesarean Section, Infection, Dilatation|cervix uteri, cesarean section, infection, dilatation
235844|NCT01954693|Tuberous Sclerosis|tuberous sclerosis
235845|NCT01954693|Everolimus|everolimus
235846|NCT01954693|Neurocognitive functioning|neurocognitive functioning
235847|NCT01954680|bipolar disorder|bipolar disorder
235848|NCT01954680|child|child
235849|NCT01954680|adolescent|adolescent
235850|NCT01954667|Gastroesophageal Reflux Disease; Anthropometric Measures; Leptin|gastroesophageal reflux disease; anthropometric measures; leptin
235851|NCT01954641|breast cancer|breast cancer
235852|NCT01954641|lung cancer|lung cancer
235853|NCT01954641|cancer treatments|cancer treatments
235854|NCT01954641|racial inequity|racial inequity
235855|NCT01954641|health systems change|health systems change
235856|NCT01954641|transparency|transparency
235857|NCT01954641|accountability|accountability
235858|NCT01954628|Exacerbation of COPD|exacerbation of copd
235859|NCT01954628|Unstable COPD|unstable copd
235860|NCT01954615|ACT-281959|act-281959
235861|NCT01954615|ACT-246475|act-246475
235862|NCT01954602|Biliary cannulation|biliary cannulation
235863|NCT01954602|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
235864|NCT01954602|Touch guide-wire techniques|touch guide-wire techniques
235865|NCT01954602|No touch guide-wire techniques|no touch guide-wire techniques
235866|NCT01954589|ACT-462206|act-462206
235867|NCT01954589|Selective dual orexin receptor antagonist|selective dual orexin receptor antagonist
235868|NCT01954576|bevacizumab-naïve recurrent GBM|bevacizumab-naïve recurrent gbm
235869|NCT01954576|bevacizumab-refractory GBM|bevacizumab-refractory gbm
235870|NCT01954563|Tuberculosis|tuberculosis
235871|NCT01954563|Vaccine|vaccine
235872|NCT01954563|Immunogenicity|immunogenicity
235873|NCT01954550|Exercise|exercise
235874|NCT01954550|Dementia|dementia
235875|NCT01954550|Cognition|cognition
235876|NCT01954550|Brain Volume|brain volume
235877|NCT01954550|Aging|aging
235878|NCT01954537|Exertional heat illness|exertional heat illness
235879|NCT01954537|Hydration Status|hydration status
235880|NCT01954537|Preseason football|preseason football
235881|NCT01954537|heat stroke|heat stroke
235882|NCT01954511|Stomatognathic diseases;|stomatognathic diseases;
235883|NCT01954511|Temporomandibular Joint Dysfunction Syndrome|temporomandibular joint dysfunction syndrome
235884|NCT01954498|Randomized controlled trial|randomized controlled trial
235885|NCT01954498|Spermatozoa|spermatozoa
235887|NCT01954498|Male Infertility|male infertility
235888|NCT01954498|Walnuts|walnuts
235889|NCT01954498|Nutrition|nutrition
235890|NCT01954498|Male Reproduction|male reproduction
235891|NCT01954485|LaserLok, connective tissue, adhesion|laserlok, connective tissue, adhesion
235892|NCT01954472|Portfolio diet|portfolio diet
235893|NCT01954472|dietary modification|dietary modification
235894|NCT01954472|hypercholesterolemia|hypercholesterolemia
235895|NCT01954472|diabetes|diabetes
235896|NCT01954472|Exercise|exercise
235897|NCT01954472|CVD risk|cvd risk
235898|NCT01954472|glycemic index|glycemic index
235899|NCT01954472|inflammatory biomarkers|inflammatory biomarkers
235900|NCT01954472|monounsaturated fat|monounsaturated fat
235901|NCT01954472|saturated fat|saturated fat
235902|NCT01954472|nuts|nuts
235903|NCT01954472|plant sterols|plant sterols
235904|NCT01954472|vegetable protein|vegetable protein
235905|NCT01954472|viscous fiber|viscous fiber
235906|NCT01954472|soy|soy
235907|NCT01954459|Type 1 diabetes|type 1 diabetes
235908|NCT01954459|Continuous glucose sensor|continuous glucose sensor
235909|NCT01954459|Insupatch|insupatch
235910|NCT01954433|Cost-effectiveness analyses|cost-effectiveness analyses
235911|NCT01954433|Cost-utility analyses|cost-utility analyses
235912|NCT01954433|Upper extremity|upper extremity
235913|NCT01954433|Orthopedic|orthopedic
290287|NCT01707602|skin|skin
235914|NCT01954433|Shoulder arthroplasty|shoulder arthroplasty
235915|NCT01954433|Rotator cuff tear repair|rotator cuff tear repair
235916|NCT01954433|Resection interposition suspension arthroplasty|resection interposition suspension arthroplasty
235917|NCT01954420|Pain|pain
235918|NCT01954420|Fatigue|fatigue
235919|NCT01954420|Sleep|sleep
235920|NCT01954420|Cancer|cancer
235921|NCT01954420|Relaxation|relaxation
235922|NCT01954420|Distraction|distraction
235923|NCT01954420|Symptoms|symptoms
235924|NCT01954407|smoking-related messages|smoking-related messages
235925|NCT01954407|anti-smoking messages|anti-smoking messages
235926|NCT01954407|smoking-related beliefs|smoking-related beliefs
235927|NCT01954407|anti-smoking intentions|anti-smoking intentions
235928|NCT01954355|advanced solid tumor|advanced solid tumor
235929|NCT01954355|ovarian cancer|ovarian cancer
235930|NCT01954355|LDE225|lde225
235931|NCT01954355|Paclitaxel|paclitaxel
235932|NCT01954355|Hedgehog inhibitor|hedgehog inhibitor
235933|NCT01954342|Pregnancy|pregnancy
235934|NCT01954342|Postpartum|postpartum
235935|NCT01954329|Biomarkers|biomarkers
235936|NCT01954329|TIA|tia
235937|NCT01954329|Diagnosis|diagnosis
235938|NCT01954316|advanced cancer|advanced cancer
235939|NCT01954316|CFI-400945 fumarate|cfi-400945 fumarate
235940|NCT01954316|polo-like kinase 4|polo-like kinase 4
235941|NCT01954316|PLK4|plk4
235942|NCT01954316|tablet|tablet
235943|NCT01954316|dose escalation|dose escalation
235944|NCT01954316|genetic testing|genetic testing
235945|NCT01954290|Stroke|stroke
235946|NCT01954290|Brain Edema|brain edema
235947|NCT01954290|Brain Herniation|brain herniation
235948|NCT01954290|Conivaptan|conivaptan
235949|NCT01954277|Chronic Tension-Type Headache|chronic tension-type headache
235950|NCT01954277|Electroacupuncture|electroacupuncture
235951|NCT01954277|Headache Impact|headache impact
235952|NCT01954277|BDNF|bdnf
235953|NCT01954277|TNF|tnf
235954|NCT01954264|Saharan Western Africa|saharan western africa
235955|NCT01954264|Epidemiology|epidemiology
235956|NCT01954264|Post-Approval Programme study|post-approval programme study
235957|NCT01954264|Malaria|malaria
235958|NCT01954264|Burden of Disease Study|burden of disease study
235959|NCT01954251|FLU-D-QIV|flu-d-qiv
235960|NCT01954251|Adults|adults
235961|NCT01954251|Safety|safety
235962|NCT01954251|Immunogenicity|immunogenicity
235963|NCT01954251|co-administration|co-administration
235964|NCT01954251|Herpes zoster|herpes zoster
235965|NCT01954238|Anti-coagulant|anti-coagulant
235966|NCT01954238|Coagulation factor Xa inhibitor|coagulation factor xa inhibitor
235967|NCT01954225|Fistula in ano|fistula in ano
235968|NCT01954225|Bhagandara|bhagandara
235969|NCT01954225|Udumbara sutra|udumbara sutra
235970|NCT01954212|Oral health|oral health
235971|NCT01954199|Sciatica|sciatica
235972|NCT01954199|Nerve pain|nerve pain
235973|NCT01954199|Low back pain|low back pain
235974|NCT01954186|Oxytocin|oxytocin
235975|NCT01954186|Active Management of Third Stage of Labour|active management of third stage of labour
235976|NCT01954134|Tumor Suppressor Protein p53,|tumor suppressor protein p53,
235977|NCT01954134|Iodine Radioisotopes|iodine radioisotopes
235978|NCT01954121|Levetiracetam|levetiracetam
235979|NCT01954121|Keppra|keppra
235980|NCT01954121|Monotherapy|monotherapy
235981|NCT01954121|China|china
235982|NCT01954121|Epilepsy|epilepsy
235983|NCT01954121|Partial-onset Seizures|partial-onset seizures
235984|NCT01954108|tendinopathy|tendinopathy
235985|NCT01954108|hyaluronan|hyaluronan
235986|NCT01954108|tendon|tendon
235987|NCT01954108|hyaluronic acid|hyaluronic acid
235988|NCT01954108|extracorporeal shock wave|extracorporeal shock wave
235989|NCT01954095|17-OHPC, Prometrium, Cerclage, Pre-term birth, Short cervix|17-ohpc, prometrium, cerclage, pre-term birth, short cervix
235990|NCT01954082|Retinopathy|retinopathy
235991|NCT01954082|Prematurity|prematurity
235992|NCT01954082|Infant, Newborn, Diseases|infant, newborn, diseases
235993|NCT01954056|NICHD Neonatal Research Network|nichd neonatal research network
235994|NCT01954056|Mechanical ventilation|mechanical ventilation
235995|NCT01954056|Intubation|intubation
235996|NCT01954056|Neurodevelopmental impairment|neurodevelopmental impairment
235997|NCT01954043|melanoma|melanoma
235998|NCT01954043|dabrafenib|dabrafenib
235999|NCT01954043|BRAF V600|braf v600
236000|NCT01954043|rabeprazole|rabeprazole
236001|NCT01954043|rifampin|rifampin
236002|NCT01954030|Carboxyamidotriazole Orotate|carboxyamidotriazole orotate
236003|NCT01954030|CTO|cto
236004|NCT01954030|Bevacizumab|bevacizumab
236005|NCT01954030|Avastin|avastin
236006|NCT01954030|Malignant Glioma|malignant glioma
236007|NCT01954030|Pro00044274|pro00044274
236008|NCT01954030|Desjardins|desjardins
236009|NCT01954030|Duke|duke
236010|NCT01954030|The Preston Robert Tisch Brain Tumor Center|the preston robert tisch brain tumor center
236011|NCT01953978|Pain|pain
236012|NCT01953978|Analgesia|analgesia
236013|NCT01953978|Postoperative|postoperative
236014|NCT01953978|Dexamethasone|dexamethasone
236015|NCT01953978|Spine surgery|spine surgery
236016|NCT01953926|Neratinib|neratinib
236017|NCT01953926|Fulvestrant|fulvestrant
236018|NCT01953926|Breast|breast
236020|NCT01953926|Endometrial Ovarian Cancer|endometrial ovarian cancer
236021|NCT01953926|Biliary Tract|biliary tract
236022|NCT01953926|Solid tumors|solid tumors
236023|NCT01953926|HER2|her2
236024|NCT01953926|Paclitaxel|paclitaxel
236025|NCT01953926|Bladder/Urinary Tract|bladder/urinary tract
236026|NCT01953926|Nerlynx|nerlynx
236027|NCT01953900|Sarcoma|sarcoma
236028|NCT01953900|T-Cells|t-cells
236029|NCT01953900|varicella zoster virus (VZV)|varicella zoster virus (vzv)
236030|NCT01953900|GD2|gd2
236031|NCT01953887|Phase I|phase i
236032|NCT01953887|Final formulation EC905|final formulation ec905
236033|NCT01953887|Solifenacin succinate|solifenacin succinate
236034|NCT01953887|Tamsulosin HCl|tamsulosin hcl
236035|NCT01953887|Marketed drugs|marketed drugs
236036|NCT01953874|heart failure|heart failure
236037|NCT01953874|congestive heart failure|congestive heart failure
236038|NCT01953874|acute decompensated heart failure|acute decompensated heart failure
236039|NCT01953874|chronic heart failure|chronic heart failure
236040|NCT01953874|left-sided heart failure|left-sided heart failure
236041|NCT01953874|heart failure decompensation|heart failure decompensation
236042|NCT01953874|sleep apnea|sleep apnea
236043|NCT01953874|sleep disordered breathing|sleep disordered breathing
236044|NCT01953874|central sleep apnea|central sleep apnea
236045|NCT01953874|obstructive sleep apnea|obstructive sleep apnea
236046|NCT01953874|cheyne-stokes respiration|cheyne-stokes respiration
236047|NCT01953861|Phase I|phase i
236048|NCT01953861|Combination tablet EC905|combination tablet ec905
236049|NCT01953861|Omnic OCAS®|omnic ocas®
236050|NCT01953861|Vesicare®|vesicare®
236051|NCT01953861|Food effect|food effect
236052|NCT01953861|Vesomni|vesomni
236053|NCT01953861|VesiFlow|vesiflow
236054|NCT01953861|Urizia|urizia
236055|NCT01953848|Phase I|phase i
236056|NCT01953848|Combination tablet EC905|combination tablet ec905
236057|NCT01953848|Steady-state|steady-state
236058|NCT01953848|Vesomni|vesomni
236059|NCT01953848|VesiFlow|vesiflow
236060|NCT01953848|Urizia|urizia
236061|NCT01953835|Pharmacokinetics|pharmacokinetics
236062|NCT01953835|GSK2586184|gsk2586184
236063|NCT01953835|Simvastatin|simvastatin
236064|NCT01953835|Rosuvastatin|rosuvastatin
236065|NCT01953835|Poloxamer|poloxamer
236066|NCT01953822|Observational|observational
236067|NCT01953822|Cohort|cohort
236068|NCT01953822|Autoimmune disease|autoimmune disease
236069|NCT01953822|Cervarix®|cervarix®
236070|NCT01953822|Women aged 9 to 25 years|women aged 9 to 25 years
236071|NCT01953822|United Kingdom|united kingdom
236072|NCT01953809|oral|oral
236073|NCT01953809|oral contraceptive|oral contraceptive
236074|NCT01953809|pharmacokinetics|pharmacokinetics
236075|NCT01953809|drug interaction|drug interaction
236076|NCT01953809|pharmacodynamics|pharmacodynamics
236077|NCT01953809|GSK1322322|gsk1322322
236078|NCT01953809|antibiotic|antibiotic
236079|NCT01953809|safety|safety
236080|NCT01953796|Polycystic Ovarian Syndrome stair step traditional protocol|polycystic ovarian syndrome stair step traditional protocol
236081|NCT01953770|Acute lymphoblastic leukemia, children, adolescents, L-asparaginase, methotrexate|acute lymphoblastic leukemia, children, adolescents, l-asparaginase, methotrexate
236082|NCT01953757|diabetic neuropathy, diet, vegan, vegetarian|diabetic neuropathy, diet, vegan, vegetarian
236083|NCT01953744|Fluconazole; Meglumine antimoniate;L.Braziliensis;|fluconazole; meglumine antimoniate;l.braziliensis;
236084|NCT01953744|L.Guyanensis|l.guyanensis
236085|NCT01953731|palbociclib|palbociclib
236086|NCT01953731|PD-0332991|pd-0332991
236087|NCT01953731|rifampin|rifampin
236088|NCT01953731|drug-drug interaction study|drug-drug interaction study
236089|NCT01953705|omega 3 fatty acids|omega 3 fatty acids
236090|NCT01953705|cognitive decline|cognitive decline
236091|NCT01953705|MRI|mri
236092|NCT01953705|endothelial function|endothelial function
236093|NCT01953705|white matter|white matter
236094|NCT01953705|executive function|executive function
236095|NCT01953705|prevention|prevention
236096|NCT01953705|DTI|dti
236097|NCT01953705|ASL|asl
236098|NCT01953692|PD1|pd1
236099|NCT01953692|PD-1|pd-1
236100|NCT01953692|PDL1|pdl1
236101|NCT01953692|PD-L1|pd-l1
236102|NCT01953666|word prediction software, text input speed, copm, occupational therapist, rehabilitation, spinal cord injury|word prediction software, text input speed, copm, occupational therapist, rehabilitation, spinal cord injury
236103|NCT01953614|quantitative encephalography|quantitative encephalography
236104|NCT01953614|brain computer interface|brain computer interface
236105|NCT01953614|chiropractic|chiropractic
236106|NCT01953614|sacro-occipital technique|sacro-occipital technique
236107|NCT01953575|Mucosal Impedance|mucosal impedance
236108|NCT01953575|Eosinophilic Esophagitis|eosinophilic esophagitis
236109|NCT01953575|EoE|eoe
236110|NCT01953562|infants|infants
236111|NCT01953562|NICU|nicu
236112|NCT01953562|intubated|intubated
236113|NCT01953562|ventilator|ventilator
402972|NCT01228812|Rheumatoid arthritis, physical activity|rheumatoid arthritis, physical activity
236216|NCT01952951|rectal neoplasms|rectal neoplasms
236114|NCT01953549|physical activity, relaxation, activities of daily living, motor functions, cognitive functions|physical activity, relaxation, activities of daily living, motor functions, cognitive functions
236115|NCT01953523|erectile dysfunction|erectile dysfunction
236116|NCT01953523|peyronies|peyronies
236117|NCT01953523|interstitial cystitis|interstitial cystitis
236118|NCT01953523|cardiomyopathy|cardiomyopathy
236119|NCT01953523|emphysema|emphysema
236120|NCT01953523|copd|copd
236121|NCT01953523|arthritis|arthritis
236122|NCT01953523|multiple sclerosis|multiple sclerosis
236123|NCT01953523|parkinson's|parkinson's
236124|NCT01953510|Pneumococcal vaccines|pneumococcal vaccines
236125|NCT01953510|10-valent pneumococcal vaccine|10-valent pneumococcal vaccine
236126|NCT01953510|13-valent pneumococcal vaccine|13-valent pneumococcal vaccine
236127|NCT01953510|Immunization Schedule|immunization schedule
236128|NCT01953510|Public Health|public health
236129|NCT01953458|Hepatitis B and C|hepatitis b and c
236130|NCT01953458|ANRS HEPATHER French Cohort|anrs hepather french cohort
236131|NCT01953432|Cocaine-Related Disorders|cocaine-related disorders
236132|NCT01953432|Cocaine|cocaine
236133|NCT01953432|Doxazosin|doxazosin
236134|NCT01953432|Cardiovascular Agents|cardiovascular agents
236135|NCT01953432|Antihypertensive Agents|antihypertensive agents
236136|NCT01953432|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists
236137|NCT01953432|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
236138|NCT01953432|Adrenergic Antagonists|adrenergic antagonists
236139|NCT01953432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
236140|NCT01953432|Neurotransmitter Agents|neurotransmitter agents
236141|NCT01953432|Therapeutic Uses|therapeutic uses
236142|NCT01953432|Pharmacologic Actions|pharmacologic actions
236143|NCT01953432|Substance-Related Disorders|substance-related disorders
236144|NCT01953406|hepatocellular carcinoma|hepatocellular carcinoma
236145|NCT01953406|lung metastasis|lung metastasis
236146|NCT01953406|5-fluorouracil/mitomycin|5-fluorouracil/mitomycin
236147|NCT01953380|Intervention Studies|intervention studies
236148|NCT01953380|Eczema|eczema
236149|NCT01953380|Randomized Controlled Trial|randomized controlled trial
236150|NCT01953380|Knowledge|knowledge
236151|NCT01953380|Quality of Life|quality of life
236152|NCT01953367|Bioequivalence|bioequivalence
236153|NCT01953367|AUC|auc
236154|NCT01953367|Cmax|cmax
236155|NCT01953354|Ulcerative colitis (UC)|ulcerative colitis (uc)
236156|NCT01953354|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
236157|NCT01953354|Trichuris suis ova (TSO)|trichuris suis ova (tso)
236158|NCT01953341|Migraine|migraine
236159|NCT01953328|Japanese, high cholesterol, LDL-C, High Cardiovascular Risk|japanese, high cholesterol, ldl-c, high cardiovascular risk
236160|NCT01953315|urinary incontinence, muscle progenitor cells, MPCs|urinary incontinence, muscle progenitor cells, mpcs
236161|NCT01953302|ventral hernia|ventral hernia
236162|NCT01953302|infection|infection
236163|NCT01953302|hematoma|hematoma
236164|NCT01953302|seroma|seroma
236165|NCT01953302|recurrence|recurrence
236166|NCT01953302|mesh technique|mesh technique
236167|NCT01953289|Appendicitis|appendicitis
236168|NCT01953289|Free fluid|free fluid
236169|NCT01953276|Acute Coronary Syndrome|acute coronary syndrome
236170|NCT01953276|Chest pain|chest pain
236171|NCT01953276|Electrocardiograms|electrocardiograms
236172|NCT01953276|Risk Stratification|risk stratification
236173|NCT01953276|Emergency Department|emergency department
236174|NCT01953263|urinary incontinence, muscle fibers|urinary incontinence, muscle fibers
236175|NCT01953250|Deep infiltrating endometriosis|deep infiltrating endometriosis
688324|NCT00923884|SCLC|sclc
236176|NCT01953250|Laparoscopic sigmoid resection|laparoscopic sigmoid resection
236177|NCT01953250|laparoscopic rectum resection|laparoscopic rectum resection
236178|NCT01953250|Colorectal surgery|colorectal surgery
236179|NCT01953237|Schizophrenia|schizophrenia
236186|NCT01953224|Obesity|obesity
236187|NCT01953198|hypoxia hypobaric|hypoxia hypobaric
236188|NCT01953185|elderly|elderly
236189|NCT01953185|subjects|subjects
236190|NCT01953146|PCOS|pcos
236191|NCT01953107|Anemia|anemia
236192|NCT01953107|Ovarian cancer|ovarian cancer
236193|NCT01953107|Uterine cancer|uterine cancer
236194|NCT01953107|Cervical cancer|cervical cancer
236195|NCT01953107|Oral iron|oral iron
236196|NCT01953094|Cervical|cervical
236197|NCT01953081|Enteral feeding|enteral feeding
236198|NCT01953068|POCD|pocd
236199|NCT01953068|Executive Reaction Time Test|executive reaction time test
236200|NCT01953068|Aortic valve surgery|aortic valve surgery
236201|NCT01953068|Cognitive functions|cognitive functions
236202|NCT01953068|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
236203|NCT01953055|stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
236204|NCT01953055|androgen deprivation therapy|androgen deprivation therapy
236205|NCT01953042|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
236206|NCT01953042|Health Education|health education
236338|NCT01952366|Aged|aged
236212|NCT01952990|Pharmacokinetic|pharmacokinetic
236213|NCT01952964|exit site infection|exit site infection
236214|NCT01952964|skin allergy|skin allergy
226944|NCT01995669|NHL|nhl
236215|NCT01952964|physical damage|physical damage
236217|NCT01952951|radiotherapy|radiotherapy
236218|NCT01952951|Antineoplastic Agents|antineoplastic agents
236219|NCT01952938|knee revision surgery,|knee revision surgery,
236220|NCT01952938|rotating hinge prosthesis|rotating hinge prosthesis
236221|NCT01952899|Intensive Care Unit|intensive care unit
236222|NCT01952899|Delirium|delirium
236223|NCT01952899|Implementation|implementation
236224|NCT01952899|Guideline|guideline
236225|NCT01952886|malignant glioma|malignant glioma
236226|NCT01952886|antiemetic|antiemetic
236227|NCT01952886|ondansetron|ondansetron
236228|NCT01952886|granisetron|granisetron
236229|NCT01952886|Preston Robert Tisch Brain Tumor Center|preston robert tisch brain tumor center
236230|NCT01952886|Pro00041233|pro00041233
236231|NCT01952886|Duke|duke
236232|NCT01952873|stents|stents
236233|NCT01952873|angioplasty, balloon, coronary|angioplasty, balloon, coronary
236234|NCT01952873|coronary artery stenosis|coronary artery stenosis
236235|NCT01952873|optical coherence tomography|optical coherence tomography
236236|NCT01952860|Lung Cancer|lung cancer
236237|NCT01952860|Non-small cell lung cancer|non-small cell lung cancer
236238|NCT01952860|NSCLC|nsclc
236239|NCT01952860|Caregiving partner|caregiving partner
236240|NCT01952860|Hatha Yoga|hatha yoga
236241|NCT01952860|Radiation therapy|radiation therapy
236242|NCT01952860|XRT|xrt
236243|NCT01952860|Questionnaires|questionnaires
236244|NCT01952860|Surveys|surveys
236245|NCT01952847|Advanced Cancers|advanced cancers
236246|NCT01952847|Mucositis|mucositis
236247|NCT01952847|Esophagitis|esophagitis
236248|NCT01952847|mTOR Inhibitor-based Regimen|mtor inhibitor-based regimen
236249|NCT01952847|Radiation to the Esophagus|radiation to the esophagus
236250|NCT01952847|Thoracic malignancies|thoracic malignancies
236251|NCT01952847|Placebo|placebo
236252|NCT01952847|Glutamine|glutamine
236253|NCT01952847|Enterex|enterex
236254|NCT01952847|Glutapak-10|glutapak-10
236255|NCT01952847|NutreStore|nutrestore
236256|NCT01952847|Resource|resource
236257|NCT01952847|GlutaSolve|glutasolve
236258|NCT01952847|Sympt-X G.I.|sympt-x g.i.
236259|NCT01952847|Sympt-X|sympt-x
236260|NCT01952847|Questionnaires|questionnaires
236261|NCT01952847|Surveys|surveys
236262|NCT01952834|coronary artery disease|coronary artery disease
236263|NCT01952834|probiotic|probiotic
236264|NCT01952834|endothelial function|endothelial function
236265|NCT01952834|brachial artery|brachial artery
236266|NCT01952834|ntric oxide|ntric oxide
236267|NCT01952821|Head and Neck Cancer|head and neck cancer
236268|NCT01952821|Physical function|physical function
236269|NCT01952821|Cancer Related Fatigue|cancer related fatigue
236270|NCT01952821|Gait Speed|gait speed
236271|NCT01952821|6MWT|6mwt
236272|NCT01952821|10-Meter Walk Test|10-meter walk test
236273|NCT01952821|30-Second Chair Stand|30-second chair stand
236274|NCT01952821|Linear Analog Scale of Function|linear analog scale of function
236275|NCT01952821|Modified Brief Fatigue Inventory|modified brief fatigue inventory
236276|NCT01952769|anti PD1,diffuse pontine glioma|anti pd1,diffuse pontine glioma
236277|NCT01952756|cilostazol|cilostazol
236278|NCT01952756|endothelial progenitor cells|endothelial progenitor cells
236279|NCT01952756|vasculogenesis|vasculogenesis
236280|NCT01952756|angiogenesis|angiogenesis
236281|NCT01952756|peripheral arterial disease|peripheral arterial disease
236282|NCT01952756|biomarkers|biomarkers
236283|NCT01952743|Atrial Fibrillation|atrial fibrillation
236284|NCT01952743|Hypertension|hypertension
236285|NCT01952743|Renal Denervation|renal denervation
236286|NCT01952730|Stage IV|stage iv
236287|NCT01952730|Hepatic Lesions|hepatic lesions
236288|NCT01952691|hallux valgus|hallux valgus
236289|NCT01952691|pain|pain
236290|NCT01952691|conservative|conservative
236291|NCT01952691|treatment|treatment
236292|NCT01952678|DaTscan|datscan
236293|NCT01952678|Parkinson's Disease|parkinson's disease
236294|NCT01952652|Naproxen-codeine|naproxen-codeine
236295|NCT01952652|preemptive analgesia|preemptive analgesia
236296|NCT01952652|day case surgery|day case surgery
236297|NCT01952626|intrathecal|intrathecal
236298|NCT01952626|morphine|morphine
236299|NCT01952626|ondansetron|ondansetron
236300|NCT01952626|palonosetron|palonosetron
236301|NCT01952626|pruritus|pruritus
236302|NCT01952613|Foot drop|foot drop
236303|NCT01952613|Functional Electrical Stimulation|functional electrical stimulation
236304|NCT01952600|Chronic Kidney Disease|chronic kidney disease
236305|NCT01952600|Hemodialysis|hemodialysis
236306|NCT01952600|Peritoneal Dialysis|peritoneal dialysis
236307|NCT01952574|migraine, headache, prevention, prophylaxis|migraine, headache, prevention, prophylaxis
236308|NCT01952561|pharmacokinetics|pharmacokinetics
236309|NCT01952561|vaginal ring|vaginal ring
236310|NCT01952522|Resistance training|resistance training
236311|NCT01952522|Walking|walking
236312|NCT01952522|Weight bearing|weight bearing
236313|NCT01952496|Cerebral Palsy|cerebral palsy
236314|NCT01952496|Non ambulatory|non ambulatory
290784|NCT01705522|IBD|ibd
236315|NCT01952496|Neuromuscular disability|neuromuscular disability
236316|NCT01952496|Children|children
236317|NCT01952483|Multiple Sclerosis (MS)|multiple sclerosis (ms)
236318|NCT01952470|Lung transplantation|lung transplantation
236319|NCT01952470|Respiratory Tract Infections|respiratory tract infections
236320|NCT01952470|Respiratory Therapy|respiratory therapy
236326|NCT01952431|Total Lung Capacity|total lung capacity
236327|NCT01952392|Effectiveness study|effectiveness study
236328|NCT01952392|Acute coronary Syndrome|acute coronary syndrome
236329|NCT01952392|Real-life|real-life
236330|NCT01952392|France|france
236331|NCT01952379|Melasma|melasma
236332|NCT01952379|Lymphocytes|lymphocytes
236333|NCT01952379|Macrophages|macrophages
236334|NCT01952379|Mast cells|mast cells
236335|NCT01952379|Interleukin 17|interleukin 17
236336|NCT01952379|COX-2|cox-2
236337|NCT01952379|Inflammation|inflammation
236339|NCT01952366|Depression|depression
236340|NCT01952366|Cognition|cognition
236341|NCT01952366|Longitudinal study|longitudinal study
236342|NCT01952353|Hepatocellular Carcinoma; Transarterial Chemoembolization; Hepatic Resection; Portal Vein Tumor Thrombosis|hepatocellular carcinoma; transarterial chemoembolization; hepatic resection; portal vein tumor thrombosis
236343|NCT01952301|Autologous; Collagen Matrix; Keratinized Tissue|autologous; collagen matrix; keratinized tissue
236344|NCT01952262|ultrasound|ultrasound
236345|NCT01952262|diaphragm|diaphragm
236346|NCT01952262|intensive care|intensive care
236347|NCT01952262|critical care|critical care
236348|NCT01952249|Ovarian|ovarian
236349|NCT01952249|Primary Peritoneal|primary peritoneal
236350|NCT01952249|Fallopian Tube Cancer|fallopian tube cancer
236351|NCT01952236|Smoking|smoking
236352|NCT01952236|Quit|quit
236353|NCT01952236|Tobacco|tobacco
236354|NCT01952236|Abstinence|abstinence
236355|NCT01952236|Adult|adult
236356|NCT01952236|Text Messaging|text messaging
236357|NCT01952236|Web-based|web-based
236358|NCT01952236|Mobile phone|mobile phone
236359|NCT01952236|smartphone|smartphone
236360|NCT01952236|internet|internet
236362|NCT01952223|adenocarcinome|adenocarcinome
236363|NCT01952223|prostate|prostate
236364|NCT01952223|relapse|relapse
236365|NCT01952223|Radiotherapy|radiotherapy
236366|NCT01952223|Androgen Deprivation Therapy|androgen deprivation therapy
236367|NCT01952223|Cabazitaxel|cabazitaxel
236368|NCT01952197|Passive Leg Raise|passive leg raise
236369|NCT01952197|Cardiac arrest|cardiac arrest
236370|NCT01952197|Survival after CPR|survival after cpr
236371|NCT01952184|vitrification|vitrification
236372|NCT01952184|oocyte|oocyte
236373|NCT01952184|donor|donor
236374|NCT01952184|open|open
236375|NCT01952184|closed|closed
236376|NCT01952171|Genomics|genomics
236377|NCT01952171|Congenital Malformations|congenital malformations
236378|NCT01952171|Birth Defects|birth defects
236379|NCT01952171|Heart Disease|heart disease
236380|NCT01952158|Multidrug-Resistant Organisms|multidrug-resistant organisms
236381|NCT01952158|Hospital Infection|hospital infection
236382|NCT01952158|Colonization|colonization
236383|NCT01952158|Healthcare Personnel|healthcare personnel
236384|NCT01952132|Schizophrenia|schizophrenia
236385|NCT01952119|hypertension|hypertension
236386|NCT01952106|venepuncture|venepuncture
236387|NCT01952106|distraction|distraction
236388|NCT01952106|distress|distress
236389|NCT01952093|Early intervention|early intervention
236390|NCT01952093|Mother-child interaction|mother-child interaction
236391|NCT01952093|Neurodevelopment|neurodevelopment
236392|NCT01952093|Parenting|parenting
236393|NCT01952093|Prematurity|prematurity
236394|NCT01952093|School age|school age
236395|NCT01952080|Short Bowel Syndrome|short bowel syndrome
236396|NCT01952080|SBS|sbs
236397|NCT01952080|Pediatric SBS|pediatric sbs
236398|NCT01952067|Hip Prosthesis|hip prosthesis
236399|NCT01952067|surgery|surgery
236400|NCT01952067|cements|cements
236401|NCT01952067|Radiostereometric Analysis|radiostereometric analysis
236402|NCT01952054|Breast cancer|breast cancer
236403|NCT01952054|Breast carcinoma|breast carcinoma
236404|NCT01952054|Bone metastasis|bone metastasis
236405|NCT01952054|Cancer that has spread to the bone|cancer that has spread to the bone
236406|NCT01952054|Denosumab|denosumab
236407|NCT01952054|AMG 162|amg 162
236408|NCT01952054|Prolia|prolia
236409|NCT01952054|Hormonal agent|hormonal agent
236410|NCT01952041|Schizophrenia|schizophrenia
236411|NCT01952041|Schizoaffective Disorder|schizoaffective disorder
236412|NCT01952041|Mobile Application|mobile application
236413|NCT01952041|Relapse Signature|relapse signature
236414|NCT01952041|Relapse|relapse
236415|NCT01952041|SMI|smi
236416|NCT01952041|EHealth|ehealth
236417|NCT01952041|E-Health|e-health
236418|NCT01952041|Health Technology|health technology
236419|NCT01952041|mHealth|mhealth
236420|NCT01952041|m-Health|m-health
236421|NCT01952028|MDC1A|mdc1a
236422|NCT01952028|Congenital Muscular Dystrophy|congenital muscular dystrophy
236423|NCT01952028|Merosin Deficient|merosin deficient
290924|NCT01704781|CD4|cd4
236424|NCT01952028|LAMA2|lama2
236425|NCT01952028|brain white matter abnormalities|brain white matter abnormalities
236426|NCT01952028|Seizure|seizure
236427|NCT01952015|generalized pustular psoriasis|generalized pustular psoriasis
236428|NCT01952002|Blood Pressure|blood pressure
236429|NCT01952002|heart rate|heart rate
236430|NCT01952002|electrocardiogram|electrocardiogram
236431|NCT01952002|Cardiac arrhythmias|cardiac arrhythmias
236432|NCT01952002|respiratory exercise|respiratory exercise
236433|NCT01951989|Gaucher disease|gaucher disease
236434|NCT01951989|Imiglucerase|imiglucerase
236435|NCT01951989|Pharmacokinetics|pharmacokinetics
236436|NCT01951976|breast|breast
236437|NCT01951976|carcinoma|carcinoma
236438|NCT01951976|stage 0-III breast cancer|stage 0-iii breast cancer
236439|NCT01951976|post-menopausal|post-menopausal
236440|NCT01951976|aromatase inhibitor (AI)|aromatase inhibitor (ai)
236441|NCT01951976|joint pain|joint pain
236442|NCT01951976|AI-associated joint pain|ai-associated joint pain
236443|NCT01951963|pain management|pain management
236444|NCT01951963|ketamine|ketamine
236445|NCT01951963|morphine|morphine
236446|NCT01951963|pediatrics|pediatrics
236447|NCT01951963|emergency medicine|emergency medicine
236448|NCT01951937|Cognitive Test|cognitive test
236449|NCT01951937|Omega-3 Fatty acids|omega-3 fatty acids
236450|NCT01951924|Multifocal Motor Neuropathy|multifocal motor neuropathy
236451|NCT01951911|Pain Management|pain management
236452|NCT01951911|Ketamine|ketamine
236453|NCT01951911|Palliative care|palliative care
236454|NCT01951898|asthma|asthma
236455|NCT01951898|regulatory T cells|regulatory t cells
236456|NCT01951898|leukotriene antagonist|leukotriene antagonist
236457|NCT01951872|caffeine dependence|caffeine dependence
236458|NCT01951872|caffeine withdrawal|caffeine withdrawal
236459|NCT01951872|caffeine use disorder|caffeine use disorder
236460|NCT01951833|Lung clearance index (LCI)|lung clearance index (lci)
236461|NCT01951807|Psychosocial Effects of Cancer and Treatment|psychosocial effects of cancer and treatment
236462|NCT01951807|Coping|coping
236463|NCT01951794|HIV infected|hiv infected
236464|NCT01951794|HIV exposed|hiv exposed
236465|NCT01951794|HIV-free|hiv-free
236466|NCT01951781|marker CD64|marker cd64
236467|NCT01951781|blood sample|blood sample
236468|NCT01951781|nosocomial infection|nosocomial infection
236469|NCT01951781|preterm newborn|preterm newborn
236470|NCT01951755|Inoperable NSCLC|inoperable nsclc
236471|NCT01951755|TKIs|tkis
236472|NCT01951742|wrinkles|wrinkles
236473|NCT01951729|Blood sugar|blood sugar
236474|NCT01951729|GIP|gip
236475|NCT01951729|Xenin-25|xenin-25
236476|NCT01951729|Cholinergic Signaling|cholinergic signaling
236477|NCT01951729|Atropine|atropine
236478|NCT01951729|Insulin|insulin
236479|NCT01951729|Glucagon|glucagon
236480|NCT01951729|Pancreatic polypeptide|pancreatic polypeptide
236481|NCT01951716|Vagotomy|vagotomy
236482|NCT01951716|Vagus Nerve|vagus nerve
236483|NCT01951716|Xenin-25|xenin-25
236484|NCT01951716|GIP|gip
236485|NCT01951716|Insulin Secretion|insulin secretion
236486|NCT01951716|Glucagon Secretion|glucagon secretion
236487|NCT01951716|Gastric Emptying|gastric emptying
236488|NCT01951690|Focal Adhesion Kinase inhibitor|focal adhesion kinase inhibitor
236500|NCT01951625|Worsening Heart Failure|worsening heart failure
236501|NCT01951625|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
688325|NCT00923884|Lung Cancer|lung cancer
236502|NCT01951612|cognitive impairment|cognitive impairment
236503|NCT01951612|ischemic white matter disease|ischemic white matter disease
236504|NCT01951612|small vessel disease|small vessel disease
236505|NCT01951612|transient ischemic attack|transient ischemic attack
236506|NCT01951612|mild stroke|mild stroke
236507|NCT01951612|stroke risk|stroke risk
236508|NCT01951599|Phase I, healthy, bioavailability, pharmacokinetics, safety, tolerability.|phase i, healthy, bioavailability, pharmacokinetics, safety, tolerability.
236509|NCT01951573|contact lenses|contact lenses
236510|NCT01951573|multifocal|multifocal
236511|NCT01951573|daily disposable|daily disposable
236512|NCT01951573|silicone hydrogel|silicone hydrogel
236513|NCT01951573|presbyopia|presbyopia
236514|NCT01951547|HbA1c|hba1c
236515|NCT01951547|hs-CRP|hs-crp
236516|NCT01951547|non-surgical periodontal therapy|non-surgical periodontal therapy
236517|NCT01951547|oral health education|oral health education
236518|NCT01951547|probing pocket depth|probing pocket depth
236519|NCT01951547|plaque index|plaque index
236520|NCT01951547|gingival bleeding index.|gingival bleeding index.
236521|NCT01951534|breast reconstruction|breast reconstruction
236522|NCT01951521|Rectal cancer|rectal cancer
236523|NCT01951521|Locally advanced rectal cancer|locally advanced rectal cancer
236524|NCT01951521|Radiotherapy|radiotherapy
236525|NCT01951521|Boost|boost
236526|NCT01951521|Dose-escalation|dose-escalation
236527|NCT01951521|Pathological complete response|pathological complete response
236528|NCT01951521|Response|response
236529|NCT01951508|Methylphenidate|methylphenidate
236530|NCT01951508|Modafinil|modafinil
236531|NCT01951508|MDMA|mdma
236532|NCT01951508|fMRI|fmri
236533|NCT01951508|emotion-processing|emotion-processing
236534|NCT01951508|social cognition|social cognition
236535|NCT01951456|Smoking cessation|smoking cessation
236536|NCT01951456|resistance training|resistance training
236537|NCT01951443|ginseng|ginseng
236538|NCT01951443|clinical trial|clinical trial
236539|NCT01951443|vascular|vascular
236540|NCT01951443|ginsenosides|ginsenosides
236541|NCT01951443|blood pressure|blood pressure
236542|NCT01951430|Adult patients|adult patients
236543|NCT01951430|Infective events|infective events
236544|NCT01951430|Antibiotic|antibiotic
236545|NCT01951430|Antifungal|antifungal
236546|NCT01951430|Myelodysplastic syndrome|myelodysplastic syndrome
236547|NCT01951404|Left Ventricular Hypertrophy|left ventricular hypertrophy
236548|NCT01951404|Allopurinol|allopurinol
236549|NCT01951404|End Stage Renal Disease|end stage renal disease
236550|NCT01951404|Haemodialysis|haemodialysis
236551|NCT01951404|Renal Replacement Therapy|renal replacement therapy
236552|NCT01951404|MRI|mri
236553|NCT01951391|study|study
236554|NCT01951391|subjects|subjects
236555|NCT01951378|Asthma|asthma
236556|NCT01951378|Asthma exacerbation|asthma exacerbation
236557|NCT01951365|Schwannoma|schwannoma
236558|NCT01951365|Growth|growth
236559|NCT01951365|intradural|intradural
236560|NCT01951365|natural history|natural history
236561|NCT01951352|study|study
236562|NCT01951352|meant|meant
236563|NCT01951352|individuals|individuals
236577|NCT01951313|Meal tolerance test focusing on carotenoids absorption|meal tolerance test focusing on carotenoids absorption
236578|NCT01951261|Telemonitoring|telemonitoring
236579|NCT01951261|COPD|copd
236580|NCT01951261|Home care|home care
236581|NCT01951248|chronic kidney disease|chronic kidney disease
236582|NCT01951248|obstructive sleep apnea|obstructive sleep apnea
236583|NCT01951248|24-h blood pressure|24-h blood pressure
236584|NCT01951248|central blood pressure|central blood pressure
236585|NCT01951248|peripheral blood pressure|peripheral blood pressure
236586|NCT01951222|Asthma, COPD, broncodilator, airway, lung, inhalation, antimuscarinic|asthma, copd, broncodilator, airway, lung, inhalation, antimuscarinic
236587|NCT01951209|Human|human
236588|NCT01951209|Hepatitis C|hepatitis c
236589|NCT01951209|Cirrhosis|cirrhosis
236590|NCT01951209|B-cell|b-cell
236591|NCT01951209|Rifaximin|rifaximin
236592|NCT01951196|Chronic kidney disease|chronic kidney disease
236593|NCT01951196|24 hour blood pressure|24 hour blood pressure
236594|NCT01951196|central blood pressure|central blood pressure
236847|NCT01950104|Embryo biopsy|embryo biopsy
236595|NCT01951196|peripheral blood pressure|peripheral blood pressure
236596|NCT01951196|obstructive sleep apnea|obstructive sleep apnea
236597|NCT01951144|Phase 1|phase 1
236598|NCT01951144|Single Dose|single dose
236599|NCT01951144|Pharmacokinetics|pharmacokinetics
236600|NCT01951144|Safety|safety
236601|NCT01951144|Toleration|toleration
236602|NCT01951144|Pharmacodynamics|pharmacodynamics
236603|NCT01951118|Smell|smell
236604|NCT01951118|Olfaction Disorders|olfaction disorders
236605|NCT01951118|Atropine|atropine
236606|NCT01951118|Donepezil|donepezil
236607|NCT01951118|Cholinesterase Inhibitors|cholinesterase inhibitors
236608|NCT01951118|Cognition Disorders|cognition disorders
236609|NCT01951105|Subacute|subacute
236610|NCT01951105|Back|back
236611|NCT01951105|Pain|pain
236612|NCT01951105|Brain|brain
236613|NCT01951105|MRI|mri
236614|NCT01951092|HIV|hiv
236615|NCT01951092|adherence|adherence
236616|NCT01951092|retention|retention
236617|NCT01951092|texting|texting
236618|NCT01951079|Digoxin|digoxin
236619|NCT01951079|Intra-amniotic injection|intra-amniotic injection
236620|NCT01951079|feticide|feticide
236621|NCT01951079|second trimester abortion|second trimester abortion
236622|NCT01951053|Healthy|healthy
236623|NCT01951053|Safety|safety
236624|NCT01951053|Tolerability|tolerability
236625|NCT01951053|Pharmacokinetics|pharmacokinetics
236626|NCT01951053|Pharmacodynamics|pharmacodynamics
236627|NCT01951053|JNJ-40411813|jnj-40411813
236628|NCT01951053|Positive allosteric modulator|positive allosteric modulator
236629|NCT01951040|Oxytocin, breastfeeding|oxytocin, breastfeeding
236630|NCT01951027|Safety|safety
236631|NCT01951027|Pharmacokinetics|pharmacokinetics
236632|NCT01951027|Pharmacodynamics|pharmacodynamics
236633|NCT01951027|DLT|dlt
236634|NCT01951027|Immunogenecity|immunogenecity
236635|NCT01951014|Adolescence|adolescence
236636|NCT01951014|Pregnancy|pregnancy
236637|NCT01951014|Telemedicine|telemedicine
236638|NCT01951001|Acute Coronary Syndrome, Asians, platelet, prasugrel|acute coronary syndrome, asians, platelet, prasugrel
236639|NCT01950936|Infection|infection
236640|NCT01950936|Antibiotics|antibiotics
236641|NCT01950936|COLD|cold
236642|NCT01950910|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
236643|NCT01950910|motor neuron disease|motor neuron disease
236644|NCT01950910|biological markers|biological markers
236645|NCT01950910|biomarkers|biomarkers
236646|NCT01950897|muscular dystrophies|muscular dystrophies
227364|NCT01993654|PAM|pam
236647|NCT01950897|muscular dystrophy|muscular dystrophy
236655|NCT01950832|Macular Thickness|macular thickness
236656|NCT01950832|Retinal Nerve Fiber Layer|retinal nerve fiber layer
236657|NCT01950832|Choroidal Thickness|choroidal thickness
236659|NCT01950832|Optical Coherence Tomography|optical coherence tomography
236660|NCT01950819|kidney failure|kidney failure
236661|NCT01950819|dialysis|dialysis
236662|NCT01950819|renal failure|renal failure
236663|NCT01950819|transplantation|transplantation
236664|NCT01950793|Hyaluronic acid, trigger finger|hyaluronic acid, trigger finger
236665|NCT01950780|Alopecia Areata|alopecia areata
236666|NCT01950780|Ruxolitinib|ruxolitinib
236667|NCT01948739|Brain machine interface|brain machine interface
236668|NCT01948739|Rehabilitation robotics|rehabilitation robotics
236669|NCT01948739|Stroke|stroke
236670|NCT01948739|Hemiparesis|hemiparesis
236671|NCT01948726|Breast cancer|breast cancer
236672|NCT01948726|Hypofractionation|hypofractionation
236673|NCT01948726|Simultaneous integrated boost|simultaneous integrated boost
236674|NCT01948726|Toxicity|toxicity
236675|NCT01948700|Motivational Interviewing|motivational interviewing
236676|NCT01948700|Problem Drinking|problem drinking
236677|NCT01948700|Adolescents|adolescents
236678|NCT01948700|Minority Health|minority health
236679|NCT01948687|real time elastography|real time elastography
236680|NCT01948687|hepatitis|hepatitis
236681|NCT01948648|plant sterols|plant sterols
236682|NCT01948648|cholesterol|cholesterol
236683|NCT01948648|colesevelam|colesevelam
236684|NCT01948648|phytosterolemia|phytosterolemia
236685|NCT01948648|fish oil|fish oil
236686|NCT01948635|tracheal cuff shape|tracheal cuff shape
236687|NCT01948635|microaspiration|microaspiration
236688|NCT01948635|pepsin|pepsin
236689|NCT01948635|ventilator-associated pneumonia|ventilator-associated pneumonia
236691|NCT01948622|Third molar surgery|third molar surgery
236692|NCT01948622|Blood pressure|blood pressure
236693|NCT01948622|Heart rate|heart rate
236694|NCT01948622|Oxygen saturation|oxygen saturation
236695|NCT01948596|pregnant women|pregnant women
236696|NCT01948596|depression|depression
236697|NCT01948596|depressive symptoms|depressive symptoms
236698|NCT01948596|omega-3 fatty acids|omega-3 fatty acids
236699|NCT01948583|vaginal dryness|vaginal dryness
236700|NCT01948583|hyaluronic acid|hyaluronic acid
236701|NCT01948583|menopause|menopause
236702|NCT01950728|volunteers|volunteers
236703|NCT01950728|18 to 65 years|18 to 65 years
236704|NCT01950728|Females|females
236705|NCT01950715|Irritable Bowel Syndrome|irritable bowel syndrome
236706|NCT01950715|Sacral Nerve Stimulation|sacral nerve stimulation
236707|NCT01950715|Gastro-colic response|gastro-colic response
236708|NCT01950715|Multimodal Stimulation|multimodal stimulation
236709|NCT01950663|Diagnostic Equipment|diagnostic equipment
236710|NCT01950663|Validation Studies|validation studies
688529|NCT00924534|controlled|controlled
236713|NCT01950611|acute promyelocytic leukemia|acute promyelocytic leukemia
236714|NCT01950611|arsenic trioxide|arsenic trioxide
236715|NCT01950611|proteasome inhibition|proteasome inhibition
236716|NCT01950611|bortezomib|bortezomib
236717|NCT01950598|Boston Keratoprosthesis type I surgery, frozen corneal graft|boston keratoprosthesis type i surgery, frozen corneal graft
236718|NCT01950585|Hydroxyurea|hydroxyurea
236719|NCT01950585|Pulmonary Hypertension|pulmonary hypertension
236848|NCT01950104|Blastocyst stage|blastocyst stage
236720|NCT01950585|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
236721|NCT01950585|Familial Pulmonary Arterial Hypertension|familial pulmonary arterial hypertension
236722|NCT01950585|CD34 + Cells|cd34 + cells
236723|NCT01950572|Samples|samples
236724|NCT01950572|Biobank|biobank
236725|NCT01950572|Pleural Mesothelioma|pleural mesothelioma
236726|NCT01950572|Peritoneal Mesothelioma|peritoneal mesothelioma
236727|NCT01950559|soy allergy|soy allergy
236728|NCT01950559|food allergy|food allergy
236729|NCT01950559|pediatric|pediatric
236730|NCT01950559|adult|adult
236731|NCT01950546|silver nanoparticles|silver nanoparticles
236732|NCT01950546|antimicrobial activity|antimicrobial activity
236733|NCT01950546|toxicity|toxicity
236734|NCT01950546|biofilm|biofilm
236735|NCT01950546|cariostatic agents|cariostatic agents
236736|NCT01950533|Peanut allergy|peanut allergy
236737|NCT01950533|Milk allergy|milk allergy
236738|NCT01950533|Egg allergy|egg allergy
236739|NCT01950533|Pediatric|pediatric
236740|NCT01950533|Adult|adult
236741|NCT01950533|Food allergy|food allergy
236742|NCT01950520|Adipose Tissue|adipose tissue
236743|NCT01950520|Adult|adult
236744|NCT01950520|Body Composition|body composition
236745|NCT01950520|Brown Adipose Tissue|brown adipose tissue
236746|NCT01950520|Non-Shivering Thermogenesis|non-shivering thermogenesis
236747|NCT01950507|Fluconazole|fluconazole
236748|NCT01950507|Graft Versus Host Disease|graft versus host disease
236749|NCT01950507|Voriconazole|voriconazole
236750|NCT01950507|Azoles|azoles
236751|NCT01950494|hand dermatitis|hand dermatitis
236752|NCT01950494|health care workers|health care workers
236753|NCT01950494|hand sanitizer|hand sanitizer
236754|NCT01950481|LDK378|ldk378
236755|NCT01950481|pharmacokinetics|pharmacokinetics
236756|NCT01950481|hepatic impairment|hepatic impairment
236757|NCT01950468|Parkinson's Disease|parkinson's disease
236758|NCT01950455|Parkinson's Disease|parkinson's disease
236761|NCT01950429|Microbiome|microbiome
236762|NCT01950429|Sickle Cell Disease|sickle cell disease
236763|NCT01950429|Bone Marrow Transplant|bone marrow transplant
236764|NCT01950416|ST elevation myocardial infarction|st elevation myocardial infarction
236765|NCT01950416|Fibrinolysis|fibrinolysis
236766|NCT01950416|Ticagrelor|ticagrelor
236767|NCT01950416|Clopidogrel|clopidogrel
236768|NCT01950416|Platelet reactivity|platelet reactivity
236769|NCT01950377|Dopamine Transporter|dopamine transporter
236770|NCT01950377|D2 Dopamine Receptor Subtype|d2 dopamine receptor subtype
236771|NCT01950377|Dopamine|dopamine
236772|NCT01950377|Dopamine Genes|dopamine genes
236773|NCT01950377|Dopaminergic Mechanisms|dopaminergic mechanisms
236774|NCT01950364|Lymphoma|lymphoma
236775|NCT01950364|Hodgkin|hodgkin
236776|NCT01950364|Anaplastic Large-cell|anaplastic large-cell
236777|NCT01950364|Relapsed|relapsed
236778|NCT01950364|Refractory|refractory
236779|NCT01950364|Antigens, CD30|antigens, cd30
236780|NCT01950364|Antibody-Drug Conjugate|antibody-drug conjugate
236781|NCT01950364|Antibodies, Monoclonal|antibodies, monoclonal
236782|NCT01950364|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
236783|NCT01950364|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
236784|NCT01950364|Monomethyl auristatin E|monomethyl auristatin e
236785|NCT01950364|Drug Therapy|drug therapy
236786|NCT01950364|Immunotherapy|immunotherapy
236787|NCT01950364|Hematologic Diseases|hematologic diseases
236788|NCT01950351|Prostate Cancer|prostate cancer
236789|NCT01950351|Localized prostate cancer|localized prostate cancer
236790|NCT01950351|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
236791|NCT01950351|Proton therapy|proton therapy
236792|NCT01950351|Radiation therapy|radiation therapy
236794|NCT01950351|Gray|gray
236795|NCT01950351|Gy|gy
236796|NCT01950351|Questionnaire|questionnaire
236797|NCT01950351|Survey|survey
236798|NCT01950325|HIV-1 Viral Load|hiv-1 viral load
236799|NCT01950325|CD4 Count|cd4 count
236800|NCT01950325|Antiviral|antiviral
236801|NCT01950325|HIV-1 Infection|hiv-1 infection
236802|NCT01950325|Broadly Neutralizing Antibody|broadly neutralizing antibody
236803|NCT01950312|Autoimmune Inner Ear Disease|autoimmune inner ear disease
236804|NCT01950312|Inner Ear Disease|inner ear disease
236805|NCT01950312|Meniere's Disease|meniere's disease
236806|NCT01950312|Sudden Sensorineural Hearing Loss|sudden sensorineural hearing loss
586235|NCT00523952|dermatitis, atopic|dermatitis, atopic
236807|NCT01950286|T-cell Acute Lymphoblastic Leukemia|t-cell acute lymphoblastic leukemia
236808|NCT01950286|chemotherapy|chemotherapy
236809|NCT01950286|allogeneic stem cell transplantation|allogeneic stem cell transplantation
236810|NCT01950260|Graves' disease|graves' disease
236811|NCT01950260|Radioactive iodine|radioactive iodine
236812|NCT01950260|Hypothyroidism|hypothyroidism
236813|NCT01950221|Double-blind Trial|double-blind trial
236814|NCT01950221|Placebo-controlled|placebo-controlled
236815|NCT01950221|Pomegranate|pomegranate
236816|NCT01950221|Memory|memory
236817|NCT01950221|Memory Impairment|memory impairment
236818|NCT01950221|Cognition|cognition
236819|NCT01950221|Ages 50-75|ages 50-75
236820|NCT01950208|Assessment|assessment
236821|NCT01950195|Melanoma|melanoma
236822|NCT01950195|Metastases|metastases
236823|NCT01950195|Brain|brain
236824|NCT01950195|Spine|spine
236825|NCT01950195|SRS(Stereotactic Radiosurgery))|srs(stereotactic radiosurgery))
236826|NCT01950195|Ipilimumab|ipilimumab
236827|NCT01950182|Luminal B2 subtype|luminal b2 subtype
236828|NCT01950182|First line treatment|first line treatment
236829|NCT01950169|Hip fracture|hip fracture
236830|NCT01950169|Nutritional supplement|nutritional supplement
236831|NCT01950169|Bisphosphonates|bisphosphonates
236832|NCT01950169|Bone mineral density|bone mineral density
236833|NCT01950169|Body composition|body composition
236834|NCT01950143|prostate cancer prevention|prostate cancer prevention
236835|NCT01950143|diet|diet
236836|NCT01950143|global gene expression|global gene expression
236837|NCT01950143|metabolic changes|metabolic changes
236839|NCT01950130|IABC|iabc
236840|NCT01950130|coronary artery disease|coronary artery disease
236841|NCT01950130|prophylactic|prophylactic
236842|NCT01950130|cardiac assist|cardiac assist
236843|NCT01950117|nonpedunculated|nonpedunculated
236844|NCT01950117|neoplastic|neoplastic
236845|NCT01950117|colorectal|colorectal
236846|NCT01950117|polyps|polyps
236849|NCT01950104|Day 3|day 3
236850|NCT01950104|Preimplantation genetic screening|preimplantation genetic screening
236851|NCT01950091|low back pain|low back pain
236852|NCT01950091|internet|internet
236854|NCT01950091|prevention|prevention
236855|NCT01950091|treatment|treatment
236856|NCT01950078|gene polymorphism|gene polymorphism
236857|NCT01950078|pain perception|pain perception
236858|NCT01950078|postoperative pain|postoperative pain
236859|NCT01950052|VLCD|vlcd
236860|NCT01950052|Low calorie diet|low calorie diet
236861|NCT01950052|very low calorie diet|very low calorie diet
236862|NCT01950052|pre-operative diet|pre-operative diet
236863|NCT01950052|liver shrinking diet|liver shrinking diet
236864|NCT01950052|bariatric surgery|bariatric surgery
236865|NCT01950052|gastric bypass|gastric bypass
236866|NCT01950039|Obesity|obesity
236867|NCT01950039|Glucose Intolerance|glucose intolerance
236868|NCT01950026|skin temperature|skin temperature
236869|NCT01950026|ethnic groups|ethnic groups
236870|NCT01950026|cryotherapy|cryotherapy
236871|NCT01950013|Presbycusis|presbycusis
236872|NCT01950013|Aging|aging
236873|NCT01950013|hearing aids|hearing aids
236874|NCT01950013|hearing training|hearing training
236875|NCT01950000|Pain. Analgesia. Prevention|pain. analgesia. prevention
236876|NCT01949974|Palliative Chemotherapy|palliative chemotherapy
236877|NCT01949974|Integral Attention Program|integral attention program
236878|NCT01949974|Advanced cancer|advanced cancer
236879|NCT01949974|Randomized Clinical Trial|randomized clinical trial
236880|NCT01949961|intervention|intervention
236881|NCT01949961|sonothrombolysis|sonothrombolysis
236882|NCT01949961|Ultrasound treatment|ultrasound treatment
236883|NCT01949948|treatment, intervention, thrombolysis|treatment, intervention, thrombolysis
236884|NCT01949935|Mupirocin|mupirocin
236885|NCT01949935|Surgical Site Infections|surgical site infections
236886|NCT01949935|Coronary Artery Bypass Grafting|coronary artery bypass grafting
236887|NCT01949922|regenerative medicine|regenerative medicine
236888|NCT01949922|fecal incontinence|fecal incontinence
236889|NCT01949922|muscle fiber injection|muscle fiber injection
236890|NCT01949909|plasmodium falciparum|plasmodium falciparum
237385|NCT01947335|Contrast|contrast
236891|NCT01949909|long synthetic peptide|long synthetic peptide
236892|NCT01949909|antibody|antibody
236893|NCT01949909|T cell|t cell
236894|NCT01949909|cytokine|cytokine
236895|NCT01949909|vaccine|vaccine
236896|NCT01949909|safety|safety
236897|NCT01949909|phase 1|phase 1
236898|NCT01949896|Pro inflammatory cytokine|pro inflammatory cytokine
236899|NCT01949896|Necrotizing enterocolitis|necrotizing enterocolitis
236900|NCT01949896|Packed red blood cell transfusion|packed red blood cell transfusion
236901|NCT01949883|Phase 1|phase 1
236902|NCT01949883|Oncology|oncology
236903|NCT01949883|BET Inhibitor|bet inhibitor
236904|NCT01949857|Hepatitis A|hepatitis a
236905|NCT01949857|Vaccine|vaccine
236906|NCT01949857|Safety|safety
236907|NCT01949857|efficacy|efficacy
236909|NCT01949844|Magnetic Resonance Imaging|magnetic resonance imaging
236911|NCT01949844|myocardial perfusion imaging|myocardial perfusion imaging
236912|NCT01949844|Novel MRI Techniques|novel mri techniques
236913|NCT01949831|functional assessment|functional assessment
236914|NCT01949831|acute care|acute care
236915|NCT01949831|older medical patients|older medical patients
236917|NCT01948557|Breastfeeding|breastfeeding
236918|NCT01948557|Infants|infants
236919|NCT01948557|Mother to child transmission of HIV|mother to child transmission of hiv
236920|NCT01948557|Survival|survival
236921|NCT01948544|COPD|copd
236922|NCT01948544|LTOT|ltot
236923|NCT01948544|Long-Term Oxygen Therapy|long-term oxygen therapy
236924|NCT01948544|Portable Oxygen Concentrator|portable oxygen concentrator
236925|NCT01948544|Quality of Life|quality of life
236926|NCT01948544|Six Minute Walk Distance Test|six minute walk distance test
236927|NCT01949753|Obsessive-compulsive disorder (OCD)|obsessive-compulsive disorder (ocd)
236928|NCT01949753|Exposure therapy|exposure therapy
236929|NCT01949753|Extinction learning|extinction learning
236930|NCT01949753|Pregnenolone|pregnenolone
236931|NCT01949727|AECOPD|aecopd
236932|NCT01949727|COPD|copd
236933|NCT01949727|Emphysema|emphysema
236934|NCT01949727|Chronic bronchitis|chronic bronchitis
236935|NCT01949675|Cholera|cholera
236936|NCT01949675|Shanchol™|shanchol™
236937|NCT01949675|Cholera Vaccine|cholera vaccine
236938|NCT01949662|Advanced Cancers|advanced cancers
236939|NCT01949662|Locally advanced cancer|locally advanced cancer
236940|NCT01949662|Metastatic cancer|metastatic cancer
236941|NCT01949662|Recurrent cancer|recurrent cancer
236942|NCT01949662|Incurable cancer|incurable cancer
236943|NCT01949662|Delirium|delirium
236944|NCT01949662|Agitation|agitation
236945|NCT01949662|Lorazepam|lorazepam
236946|NCT01949662|Haloperidol|haloperidol
236948|NCT01949662|Questionnaires|questionnaires
236949|NCT01949662|Surveys|surveys
236950|NCT01949662|Acute palliative care unit|acute palliative care unit
236951|NCT01949649|body image|body image
236952|NCT01949649|body dissatisfaction|body dissatisfaction
236953|NCT01949623|RP|rp
236954|NCT01949610|Healthy Participants|healthy participants
236955|NCT01949610|JNJ26489112|jnj26489112
236956|NCT01949610|14C-JNJ26489112|14c-jnj26489112
236957|NCT01949610|Absorption|absorption
236958|NCT01949610|Metabolism|metabolism
236959|NCT01949610|Excretion|excretion
236960|NCT01949571|Mirtazapine.|mirtazapine.
236961|NCT01949571|Addiction.|addiction.
236962|NCT01949571|Cocaine.|cocaine.
236963|NCT01949571|Cocaine-craving.|cocaine-craving.
236964|NCT01949571|Cocaine-withdrawal|cocaine-withdrawal
236965|NCT01949558|diet|diet
236966|NCT01949558|lifestyle|lifestyle
236967|NCT01949519|prostate cancer|prostate cancer
236968|NCT01949519|lycopene|lycopene
236969|NCT01949519|docetaxel|docetaxel
236970|NCT01949519|metastatic|metastatic
236971|NCT01949519|castration resistant|castration resistant
236972|NCT01949506|Lung metastases|lung metastases
236973|NCT01949506|Radiation Therapy|radiation therapy
236974|NCT01949506|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
236975|NCT01949493|carpal tunnel syndrome|carpal tunnel syndrome
236976|NCT01949493|traction|traction
236977|NCT01949493|mechanical traction|mechanical traction
236978|NCT01949493|Phystrac|phystrac
236979|NCT01949480|Peripheral nerve block|peripheral nerve block
236980|NCT01949480|Ultrasound guidance|ultrasound guidance
236981|NCT01949480|Postoperative pain management post status thoracotomy|postoperative pain management post status thoracotomy
236982|NCT01949480|Postoperative pain management post status VATS|postoperative pain management post status vats
236983|NCT01949467|ferroportin disease|ferroportin disease
236984|NCT01949467|dysmetabolic hepatosiderosis|dysmetabolic hepatosiderosis
236985|NCT01949467|genetic hemochromatosis|genetic hemochromatosis
236986|NCT01949467|hyperferritinemia|hyperferritinemia
236987|NCT01949467|hepcidin|hepcidin
236988|NCT01949467|iron fumarate|iron fumarate
236989|NCT01949467|physiopathological study|physiopathological study
236990|NCT01949467|diagnosis|diagnosis
236991|NCT01949467|HFE gene|hfe gene
236992|NCT01949467|TRF2 gene|trf2 gene
236993|NCT01949467|iron parameters|iron parameters
236994|NCT01949467|divalent cations|divalent cations
236995|NCT01949454|trachoma|trachoma
236996|NCT01949454|trichiasis|trichiasis
236997|NCT01949454|trachomatous trichiasis|trachomatous trichiasis
236998|NCT01949454|bilamellar tarsal rotation|bilamellar tarsal rotation
236999|NCT01949454|fluorometholone|fluorometholone
237000|NCT01949454|placebo controlled|placebo controlled
237001|NCT01949441|HDM Allergy|hdm allergy
237002|NCT01949441|Rhinoconjunctivitis|rhinoconjunctivitis
237003|NCT01949441|Immunotherapy|immunotherapy
237004|NCT01949441|ToleroMune HDM|toleromune hdm
237005|NCT01949428|HDM Allergy|hdm allergy
237006|NCT01949428|Rhinoconjunctivitis|rhinoconjunctivitis
237007|NCT01949415|House Dust Mite|house dust mite
237008|NCT01949415|Rhinoconjunctivitis|rhinoconjunctivitis
237009|NCT01949415|ToleroMune|toleromune
237010|NCT01949376|breast cancer|breast cancer
237011|NCT01949376|invasive ductal carcinoma|invasive ductal carcinoma
237012|NCT01949376|cognitive impairment|cognitive impairment
237013|NCT01949376|adjuvant therapy|adjuvant therapy
237014|NCT01949376|hormone therapy|hormone therapy
237015|NCT01949376|hormonal therapy|hormonal therapy
237016|NCT01949376|chemotherapy|chemotherapy
237017|NCT01949376|chemo brain|chemo brain
237018|NCT01949376|MRI|mri
237019|NCT01949363|Gonococcal Infections, Cefixime, Neisseria gonorrhoeae, Azithromycin, antibiotic, cephalosporin|gonococcal infections, cefixime, neisseria gonorrhoeae, azithromycin, antibiotic, cephalosporin
237020|NCT01949324|MacTel|mactel
237021|NCT01949298|immediate loading of dental implant|immediate loading of dental implant
237022|NCT01949298|implant supported over denture|implant supported over denture
237023|NCT01949285|Spinal cord injury|spinal cord injury
237024|NCT01949285|Paralysis|paralysis
237025|NCT01949285|Rehabilitation|rehabilitation
237026|NCT01949285|Assessment|assessment
237027|NCT01949285|Theranostics|theranostics
237028|NCT01949272|ARDS|ards
237029|NCT01949259|Retrospective|retrospective
237030|NCT01949259|Lung cancer|lung cancer
237031|NCT01949246|Biomarkers|biomarkers
237032|NCT01949220|Inherited|inherited
237033|NCT01949220|Von Willebrand disease|von willebrand disease
237034|NCT01949220|Von Willebrand factor|von willebrand factor
237035|NCT01949220|Deficiency|deficiency
237036|NCT01949220|safety|safety
237037|NCT01949207|Incompetent perforating veins|incompetent perforating veins
237038|NCT01949207|EVLA|evla
237039|NCT01949207|Phlebectomies|phlebectomies
237040|NCT01949207|TRansluminal Occlusion of Perforators (TRLOP) closure of incompetent perforators.|transluminal occlusion of perforators (trlop) closure of incompetent perforators.
237041|NCT01949194|liver metastases|liver metastases
237043|NCT01949181|Metalloids|metalloids
237044|NCT01949181|Blood|blood
237045|NCT01949181|Hair|hair
237046|NCT01949181|Lung|lung
237047|NCT01949181|Lung cancer|lung cancer
237048|NCT01949181|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
237049|NCT01949155|otitis media|otitis media
237050|NCT01949155|otorrhea|otorrhea
237051|NCT01949155|middle ear effusion|middle ear effusion
237052|NCT01949155|tympanostomy tubes|tympanostomy tubes
237053|NCT01949142|otitis media|otitis media
237054|NCT01949142|otorrhea|otorrhea
237055|NCT01949142|middle ear effusion|middle ear effusion
237056|NCT01949142|tympanostomy tubes|tympanostomy tubes
237057|NCT01949129|stem cell transplantation|stem cell transplantation
237058|NCT01949129|children and adolescents|children and adolescents
237059|NCT01949129|high risk acute lymphoblastic leukaemia|high risk acute lymphoblastic leukaemia
237060|NCT01949103|Gram-positive|gram-positive
237061|NCT01949090|H7N1|h7n1
237062|NCT01949090|AS03 adjuvant|as03 adjuvant
237063|NCT01949090|Safety|safety
237064|NCT01949090|Immunogenicity|immunogenicity
237065|NCT01949090|Influenza|influenza
237066|NCT01949090|Adults|adults
237067|NCT01949090|Elderly adults|elderly adults
237068|NCT01949077|Hepatitis|hepatitis
237069|NCT01949077|Hepatitis C|hepatitis c
237070|NCT01949077|Observational study|observational study
237071|NCT01949077|Biomarkers of treatment response|biomarkers of treatment response
237072|NCT01949051|Allergic rhinitis|allergic rhinitis
237073|NCT01949051|levocabastine|levocabastine
237074|NCT01949051|allergen challenge|allergen challenge
237075|NCT01949038|Pain|pain
237076|NCT01949038|Discomfort|discomfort
237077|NCT01949038|Anxiety|anxiety
237078|NCT01949038|Satisfaction|satisfaction
237079|NCT01949038|Compliance|compliance
237080|NCT01949012|Midazolam|midazolam
237081|NCT01949012|Endtidal carbon dioxide|endtidal carbon dioxide
237082|NCT01949012|Desaturation|desaturation
237083|NCT01948999|electroconvulsive therapy|electroconvulsive therapy
237084|NCT01948999|treatment-refractory schizophrenia|treatment-refractory schizophrenia
237085|NCT01948973|Irritable Bowel Syndrome|irritable bowel syndrome
237086|NCT01948973|Sacral Nerve Stimulation|sacral nerve stimulation
237087|NCT01948973|Symptoms|symptoms
237088|NCT01948973|Quality of Life|quality of life
237089|NCT01948973|Bowel habits|bowel habits
237090|NCT01948960|Breast Neoplasms|breast neoplasms
237091|NCT01948960|everolimus|everolimus
237092|NCT01948960|pharmacokinetics|pharmacokinetics
237093|NCT01948960|elderly patients|elderly patients
237094|NCT01948960|obese patients|obese patients
237095|NCT01948934|Skin|skin
237096|NCT01948934|Injury|injury
237097|NCT01948934|Membrane amniotic|membrane amniotic
237098|NCT01948934|Wound|wound
237099|NCT01948921|EGD|egd
237100|NCT01948921|tolerance|tolerance
237101|NCT01948921|discomfort|discomfort
237102|NCT01948908|Sedation|sedation
237103|NCT01948908|Laceration repair|laceration repair
237104|NCT01948908|Children|children
237105|NCT01948908|Intranasal|intranasal
237106|NCT01948908|Midazolam|midazolam
237107|NCT01948895|Desvenlafaxine|desvenlafaxine
237108|NCT01948895|Open-label|open-label
237109|NCT01948895|Flexible-dose|flexible-dose
586236|NCT00523952|tacrolimus|tacrolimus
237110|NCT01948895|Dysthymic disorder|dysthymic disorder
237111|NCT01948895|Anxiety disorders|anxiety disorders
237112|NCT01948895|Generalized anxiety disorder|generalized anxiety disorder
237113|NCT01948895|Social anxiety disorder|social anxiety disorder
237114|NCT01948895|Post-traumatic stress disorder|post-traumatic stress disorder
237115|NCT01948882|Birth control|birth control
237116|NCT01948869|Phoenix|phoenix
237117|NCT01948869|Mild atopic dermatitis|mild atopic dermatitis
237118|NCT01948869|efficacy|efficacy
237119|NCT01948869|safety|safety
237120|NCT01948856|Recurrent common cold|recurrent common cold
237121|NCT01948856|laryngitis|laryngitis
237122|NCT01948856|pharyngitis/tonsillitis|pharyngitis/tonsillitis
237123|NCT01948856|acute rhinitis|acute rhinitis
237124|NCT01948856|acute rhinosinusitis|acute rhinosinusitis
237125|NCT01948856|acute otitis media|acute otitis media
237126|NCT01948843|HER2 Negative Metastatic Breast Cancer|her2 negative metastatic breast cancer
237127|NCT01948830|Ranibizumab, Lucentis, choroidal neovascularization, age-related macular degeneration, treat and extend regimen|ranibizumab, lucentis, choroidal neovascularization, age-related macular degeneration, treat and extend regimen
237128|NCT01948817|Thalassemia|thalassemia
237129|NCT01948791|Alzheimer's disease|alzheimer's disease
237130|NCT01948791|ENA713|ena713
237131|NCT01948791|Chinese patients|chinese patients
237132|NCT01948791|INSTINCT|instinct
237133|NCT01948765|xenon anesthesia|xenon anesthesia
237134|NCT01948765|Off-pump coronary artery bypass graft surgery|off-pump coronary artery bypass graft surgery
237135|NCT01948752|Nutrition policy|nutrition policy
237136|NCT01948752|food labelling|food labelling
237137|NCT01948752|diet|diet
237138|NCT01948752|obesity|obesity
237139|NCT01948752|health behavior|health behavior
237140|NCT01948531|Antiage|antiage
237141|NCT01948518|Pulmonary hypertension|pulmonary hypertension
237142|NCT01948518|Parenchymal Lung Disease|parenchymal lung disease
237143|NCT01948518|Diffusion Capacity|diffusion capacity
237144|NCT01948505|Craniotomy|craniotomy
237145|NCT01948466|Nutrition|nutrition
237146|NCT01948466|Commercials|commercials
237147|NCT01948466|Elementary|elementary
237148|NCT01948466|Lunchroom|lunchroom
237149|NCT01948466|Fruits|fruits
237150|NCT01948466|Vegetables|vegetables
237152|NCT01948453|CIMT|cimt
237153|NCT01948453|FMD|fmd
237154|NCT01948440|Substance abuse, early recovery, relapse prevention|substance abuse, early recovery, relapse prevention
237155|NCT01948427|UCD|ucd
237156|NCT01948427|BUPHENYL|buphenyl
237157|NCT01948427|RAVICTI|ravicti
237158|NCT01948427|Urea|urea
237159|NCT01948427|Urea cycle disorder|urea cycle disorder
227856|NCT01991054|HgA1C|hga1c
237160|NCT01948427|Glycerol phenylbutyrate|glycerol phenylbutyrate
237161|NCT01948427|Benzoate|benzoate
237162|NCT01948427|Sodium phenylbutyrate|sodium phenylbutyrate
237163|NCT01948427|Ornithine transcarbamylase (OTC)|ornithine transcarbamylase (otc)
237164|NCT01948427|Argininosuccinate synthetase (ASS)|argininosuccinate synthetase (ass)
237165|NCT01948427|Argininosuccinate lyase (ASL)|argininosuccinate lyase (asl)
237166|NCT01948427|Carbamyl phosphate synthetase (CPS)|carbamyl phosphate synthetase (cps)
237167|NCT01948427|Arginine|arginine
237168|NCT01948427|Citrulline|citrulline
237169|NCT01948427|Ammonia|ammonia
237170|NCT01948414|Obesity|obesity
237171|NCT01948414|Hyperalimentation|hyperalimentation
237172|NCT01948414|Event-Related Potential|event-related potential
237173|NCT01948414|P300|p300
237174|NCT01948388|Rheumatoid arthritis|rheumatoid arthritis
237175|NCT01948375|subject blinding|subject blinding
237176|NCT01948375|placebo needle|placebo needle
237177|NCT01948336|Contrast-induced nephropathy, Dexmedetomidine, Endothelin-1|contrast-induced nephropathy, dexmedetomidine, endothelin-1
237178|NCT01948323|Pregnancy|pregnancy
237179|NCT01948323|Maternal health|maternal health
237180|NCT01948323|Newborn health|newborn health
237181|NCT01948323|Information technology|information technology
237182|NCT01948323|Health education|health education
237183|NCT01948323|Cellphone|cellphone
237184|NCT01948323|Touch screen technology|touch screen technology
237185|NCT01948323|Pregnancy outcome|pregnancy outcome
237186|NCT01948323|Low-Middle income|low-middle income
237187|NCT01948323|Nurse-led|nurse-led
237188|NCT01948323|Nutrition|nutrition
237189|NCT01948323|Exercise|exercise
237190|NCT01948284|cecal intubation time|cecal intubation time
237191|NCT01948284|water exchange|water exchange
237192|NCT01948284|pain|pain
237193|NCT01948271|Psoriasis|psoriasis
237581|NCT01946542|fatigue|fatigue
237194|NCT01948271|Trichuris suis ova|trichuris suis ova
237195|NCT01948271|T-lymphocytes|t-lymphocytes
237196|NCT01948258|Pregnancy|pregnancy
237197|NCT01948245|Catheter Related Blood Stream Infection|catheter related blood stream infection
237198|NCT01948245|Long-term intestinal Failure|long-term intestinal failure
237199|NCT01948245|Taurolidine|taurolidine
237200|NCT01948245|Catheter lock solution|catheter lock solution
237201|NCT01948245|Antimicrobial agent|antimicrobial agent
237202|NCT01948245|Home Parenteral Nutrition|home parenteral nutrition
237203|NCT01948245|Anti-infective agents|anti-infective agents
237204|NCT01948206|Sudden Cardiac Death|sudden cardiac death
586237|NCT00523952|adult|adult
237205|NCT01948206|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
237206|NCT01948206|Cardiomyopathy|cardiomyopathy
237207|NCT01948206|Prolonged Paced QRS Duration|prolonged paced qrs duration
237208|NCT01948193|Diphtheria|diphtheria
237209|NCT01948193|Tetanus|tetanus
237210|NCT01948193|Whooping Cough|whooping cough
237211|NCT01948193|Hepatitis B|hepatitis b
237212|NCT01948193|Poliomyelitis|poliomyelitis
237213|NCT01948193|DTaP IPV-Hep B-PRP~T combined vaccine (Hexaxim™)|dtap ipv-hep b-prp~t combined vaccine (hexaxim™)
237214|NCT01948180|NKTCL|nktcl
237215|NCT01948180|T cell|t cell
237216|NCT01948180|CITADEL|citadel
237217|NCT01948180|Epstein-Barr Virus|epstein-barr virus
237218|NCT01948180|Natural Killer|natural killer
237219|NCT01948167|Depression|depression
237220|NCT01948167|Prevention|prevention
237221|NCT01948167|Adolescents|adolescents
237222|NCT01948154|Cerebral Palsy|cerebral palsy
237223|NCT01948154|Early Intervention|early intervention
237224|NCT01948154|Speech Function|speech function
237225|NCT01948154|Quality of Life|quality of life
237226|NCT01948128|Breast|breast
237227|NCT01948115|Breech presentation|breech presentation
237228|NCT01948115|equimolar mixture of oxygen and nitrous oxide|equimolar mixture of oxygen and nitrous oxide
237229|NCT01948115|external cephalic version|external cephalic version
237230|NCT01948102|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
237231|NCT01948102|motor neuron disease|motor neuron disease
237232|NCT01948102|biological markers|biological markers
237233|NCT01948102|biomarkers|biomarkers
237234|NCT01948089|Chronic Stroke|chronic stroke
237235|NCT01948089|near transfer|near transfer
237236|NCT01948089|far transfer|far transfer
237237|NCT01948089|working memory|working memory
237238|NCT01948089|fluid intelligence|fluid intelligence
237239|NCT01948089|cognitive training|cognitive training
237240|NCT01948089|dual n-back|dual n-back
237241|NCT01948076|splenomegaly|splenomegaly
237242|NCT01948076|pleural effusion|pleural effusion
237243|NCT01948037|hydrotherapy|hydrotherapy
237244|NCT01948037|randomized controlled trial|randomized controlled trial
237245|NCT01948037|lower extremity arterial disease|lower extremity arterial disease
237246|NCT01948037|diabetes|diabetes
237247|NCT01947998|Rivaroxaban,|rivaroxaban,
237248|NCT01947998|Pulmonary Embolism,|pulmonary embolism,
237249|NCT01947998|Venous Thrombosis,|venous thrombosis,
237250|NCT01947998|Venous Thromboembolism,|venous thromboembolism,
237251|NCT01947998|Acute Coronary Syndrome,|acute coronary syndrome,
237252|NCT01947998|Intracranial Hemorrhages,|intracranial hemorrhages,
237253|NCT01947998|Gastrointestinal Hemorrhage,|gastrointestinal hemorrhage,
237254|NCT01947998|Warfarin|warfarin
237255|NCT01947985|Rivaroxaban|rivaroxaban
237256|NCT01947985|Stroke Prevention in Atrial Fibrillation,|stroke prevention in atrial fibrillation,
237257|NCT01947985|Anticoagulants|anticoagulants
237258|NCT01947985|Hematologic Agents|hematologic agents
237259|NCT01947985|Therapeutic Uses|therapeutic uses
237260|NCT01947985|Observational|observational
237261|NCT01947985|Venous Thromboembolism|venous thromboembolism
237262|NCT01947985|Secondary Prevention of Acute Coronary Syndrome|secondary prevention of acute coronary syndrome
237263|NCT01947985|Intracranial Hemorrhages|intracranial hemorrhages
237264|NCT01947985|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
237265|NCT01947972|preterm neonate|preterm neonate
237266|NCT01947972|tailored fortification|tailored fortification
237267|NCT01947972|nutrition|nutrition
237268|NCT01947972|maternal breast milk composition|maternal breast milk composition
237269|NCT01947959|Rivaroxaban|rivaroxaban
237270|NCT01947959|Stroke Prevention in Atrial Fibrillation,|stroke prevention in atrial fibrillation,
237271|NCT01947959|Anticoagulants|anticoagulants
237272|NCT01947959|Hematologic Agents|hematologic agents
237273|NCT01947959|Therapeutic Uses|therapeutic uses
237274|NCT01947959|Observational|observational
237275|NCT01947959|Venous Thromboembolism|venous thromboembolism
237276|NCT01947959|Secondary Prevention of Acute Coronary Syndrome|secondary prevention of acute coronary syndrome
237277|NCT01947959|Intracranial Hemorrhages|intracranial hemorrhages
237278|NCT01947959|Gastrointestinal Hemorrhage,|gastrointestinal hemorrhage,
237279|NCT01947946|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
237280|NCT01947920|Healthy|healthy
237281|NCT01947920|Pain|pain
237282|NCT01947920|Tramadol hydrochloride|tramadol hydrochloride
237283|NCT01947920|Tramadol HCl|tramadol hcl
237284|NCT01947920|Analgesic|analgesic
237285|NCT01947920|QT prolongation|qt prolongation
237776|NCT01945619|Adenovirus|adenovirus
237286|NCT01947920|RWJ-26898-002|rwj-26898-002
237287|NCT01947907|Human Growth Hormone|human growth hormone
237289|NCT01947907|hGH|hgh
237290|NCT01947907|GHD|ghd
237291|NCT01947881|Diabetic Macular Edema|diabetic macular edema
237292|NCT01947881|anti-VEGF|anti-vegf
237293|NCT01947881|Treatment Response|treatment response
237294|NCT01947842|Smartphone|smartphone
237295|NCT01947842|adherence|adherence
237296|NCT01947842|contraceptives|contraceptives
237297|NCT01947842|college|college
237298|NCT01947842|females|females
237299|NCT01947829|hemodialysis|hemodialysis
237300|NCT01947829|dialysis dose|dialysis dose
237301|NCT01947816|Ulcerative Colitis|ulcerative colitis
237302|NCT01947803|Schizophrenia|schizophrenia
237303|NCT01947803|Paliperidone|paliperidone
237304|NCT01947803|Safety|safety
237305|NCT01947803|Effectiveness|effectiveness
237306|NCT01947803|Chinese|chinese
237307|NCT01947790|Type 2 diabetes|type 2 diabetes
237308|NCT01947790|left ventricular mass|left ventricular mass
237309|NCT01947790|pioglitazone|pioglitazone
237310|NCT01947777|Phase 1|phase 1
237311|NCT01947777|Healthy subjects|healthy subjects
237312|NCT01947777|DDI|ddi
237313|NCT01947777|CYP3A|cyp3a
237314|NCT01947764|HIV|hiv
237315|NCT01947764|Disclosure|disclosure
237316|NCT01947764|Pediatrics|pediatrics
237317|NCT01947751|Catheter related infection|catheter related infection
237318|NCT01947751|Central venous catheter|central venous catheter
237319|NCT01947751|CVC infection|cvc infection
237320|NCT01947738|Healthy|healthy
237321|NCT01947738|Subjects|subjects
237322|NCT01947738|Safety|safety
237323|NCT01947738|Tolerability|tolerability
237324|NCT01947738|VBY891|vby891
237325|NCT01947738|Maximum|maximum
237326|NCT01947738|Pharmacodynamic|pharmacodynamic
237327|NCT01947738|Pharmacokinetic|pharmacokinetic
237328|NCT01947725|Posttraumatic Stress Disorders|posttraumatic stress disorders
237329|NCT01947725|PTSD|ptsd
237330|NCT01947725|Smoking Cessation|smoking cessation
237331|NCT01947725|Smoking|smoking
237332|NCT01947725|Behavior Therapy|behavior therapy
237333|NCT01947712|Peripheral arterial disease|peripheral arterial disease
237334|NCT01947712|Oxidative stress|oxidative stress
237335|NCT01947712|Cocoa|cocoa
237336|NCT01947712|polyphenols|polyphenols
237337|NCT01947712|NADPH oxidase|nadph oxidase
237338|NCT01947686|osteoarthritis, patellofemoral|osteoarthritis, patellofemoral
237339|NCT01947647|behavior therapy|behavior therapy
237340|NCT01947647|Randomized Controlled Trials|randomized controlled trials
237341|NCT01947647|Depressive Disorder|depressive disorder
237342|NCT01947647|Anxiety Disorders|anxiety disorders
237343|NCT01947647|comorbidity|comorbidity
237344|NCT01947621|Broken heart syndrome, stress cardiomyopathy|broken heart syndrome, stress cardiomyopathy
237345|NCT01947595|diabetes mellitus type 2|diabetes mellitus type 2
237346|NCT01947595|impaired glucose tolerance|impaired glucose tolerance
237347|NCT01947595|lifestyle intervention|lifestyle intervention
237348|NCT01947595|body fat distribution|body fat distribution
237349|NCT01947595|prevention|prevention
237350|NCT01947582|multiple sclerosis|multiple sclerosis
237351|NCT01947582|gait|gait
237352|NCT01947582|ankle foot orthosis (AFO)|ankle foot orthosis (afo)
237353|NCT01947556|diabetes|diabetes
237354|NCT01947556|insulin administration|insulin administration
237355|NCT01947556|hyperglycaemia|hyperglycaemia
237356|NCT01947556|insulin aspart|insulin aspart
237357|NCT01947478|Drug-Eluting Angioplasty Balloon|drug-eluting angioplasty balloon
237358|NCT01947478|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
237359|NCT01947478|Peripheral Artery Disease|peripheral artery disease
237360|NCT01947478|Experimental|experimental
237361|NCT01947478|Percutaneous Transluminal Angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
237362|NCT01947452|Youth violence reduction|youth violence reduction
237363|NCT01947452|Youth crime reduction|youth crime reduction
237364|NCT01947452|School engagement|school engagement
237365|NCT01947452|Employment|employment
237366|NCT01947452|Social-emotional learning|social-emotional learning
237367|NCT01947439|multivessel stenting|multivessel stenting
237368|NCT01947426|DHA, term neonates, mother milk|dha, term neonates, mother milk
237369|NCT01947413|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
237370|NCT01947413|BoNTA|bonta
237371|NCT01947413|stroke|stroke
237372|NCT01947413|optimal treatment protocol|optimal treatment protocol
237373|NCT01947413|randomized controlled trial|randomized controlled trial
237374|NCT01947413|motor control|motor control
237375|NCT01947413|clinical predictors|clinical predictors
237376|NCT01947400|Physician and Patient Communication|physician and patient communication
237377|NCT01947400|Acknowledge Introduce Duration Explanation Thank|acknowledge introduce duration explanation thank
237378|NCT01947400|Hospital Consumer Assessment of Health Plans Survey|hospital consumer assessment of health plans survey
237379|NCT01947374|Cartilage|cartilage
237380|NCT01947374|Articular|articular
237381|NCT01947335|Coronary|coronary
237382|NCT01947335|Angioplasty|angioplasty
237383|NCT01947335|Percutaneous coronary intervention|percutaneous coronary intervention
237384|NCT01947335|Stent|stent
237386|NCT01947335|Acute Renal failure|acute renal failure
237387|NCT01947335|Intravascular ultrasound|intravascular ultrasound
237388|NCT01947335|Prevention|prevention
237389|NCT01947322|Natural killer cell|natural killer cell
237390|NCT01947322|Haploidentical|haploidentical
237391|NCT01947322|Acute myeloid leukemia|acute myeloid leukemia
237392|NCT01947322|Chemotherapy|chemotherapy
402006|NCT01233544|Stereotactic body radiation therapy|stereotactic body radiation therapy
237393|NCT01947309|Revlimid, lenalidomide, multiple myeloma, PFS, Response Rates|revlimid, lenalidomide, multiple myeloma, pfs, response rates
237394|NCT01947296|Oral antineoplastic agent|oral antineoplastic agent
237395|NCT01947296|Adverse Effects|adverse effects
237396|NCT01947296|Cancer Networks|cancer networks
237397|NCT01947296|Continuity of care|continuity of care
237398|NCT01947296|Coordination of patient's care|coordination of patient's care
237399|NCT01947283|Patient-Provider Relationship|patient-provider relationship
237400|NCT01947283|Shared Decision Making|shared decision making
237401|NCT01947283|Therapeutic Alliance|therapeutic alliance
237402|NCT01947283|Mental Health|mental health
237403|NCT01947283|Minority Health|minority health
237404|NCT01947283|Patient Activation|patient activation
237405|NCT01947283|Communication|communication
237406|NCT01947270|Potentially inappropriate medications|potentially inappropriate medications
237408|NCT01947270|Prevention|prevention
237409|NCT01947270|Multidisciplinary program|multidisciplinary program
237410|NCT01947270|Checklist|checklist
237411|NCT01947270|Stepped wedge design|stepped wedge design
237412|NCT01947270|AGED, 75 AND OVER|aged, 75 and over
237413|NCT01947244|Doulas|doulas
237414|NCT01947244|Parenting|parenting
237415|NCT01947244|Breast Feeding|breast feeding
237416|NCT01947244|Pregnancy in Adolescence|pregnancy in adolescence
237417|NCT01947244|Child Development|child development
237418|NCT01947231|neck pain|neck pain
237419|NCT01947231|chronic|chronic
237420|NCT01947231|Global Postural Re-education|global postural re-education
237421|NCT01947231|manual therapy|manual therapy
237422|NCT01947231|physical therapy|physical therapy
237423|NCT01947205|Curettage|curettage
237424|NCT01947205|analgesia|analgesia
237425|NCT01947205|paracervical block|paracervical block
237426|NCT01947205|paracetamol|paracetamol
237427|NCT01947205|lidocaine|lidocaine
237428|NCT01947205|Dexketoprofen trometamol|dexketoprofen trometamol
237429|NCT01947192|Chlorhexidine|chlorhexidine
237430|NCT01947192|Matrix metalloproteinases (MMP) inhibitor|matrix metalloproteinases (mmp) inhibitor
237431|NCT01947192|Adhesive system|adhesive system
237432|NCT01947192|Controlled clinical trial|controlled clinical trial
237433|NCT01947192|Dental restoration|dental restoration
237434|NCT01947192|Noncarious cervical lesions|noncarious cervical lesions
237435|NCT01947192|Dental restoration failure|dental restoration failure
237437|NCT01947140|Lymphoid Malignancies|lymphoid malignancies
237438|NCT01947140|Multiple Myeloma|multiple myeloma
237439|NCT01947140|Lymphoma|lymphoma
237440|NCT01947140|Hodgkin Lymphoma|hodgkin lymphoma
237441|NCT01947140|Non-hodgkin Lymphoma|non-hodgkin lymphoma
237442|NCT01947140|Follicular Lymphoma|follicular lymphoma
237443|NCT01947140|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
237444|NCT01947140|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
237445|NCT01947140|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
237446|NCT01947140|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
237447|NCT01947140|Mantle Cell Lymphoma|mantle cell lymphoma
237448|NCT01947140|Marginal Zone Lymphoma|marginal zone lymphoma
237449|NCT01947140|Burkitt Lymphoma|burkitt lymphoma
237450|NCT01947140|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
237451|NCT01947140|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
237452|NCT01947140|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
237453|NCT01947127|Lactate|lactate
237454|NCT01947127|Sepsis|sepsis
237455|NCT01947127|Septic shock|septic shock
237456|NCT01947127|Disease progression|disease progression
237457|NCT01947127|Prognosis|prognosis
237458|NCT01947114|General anesthesia,|general anesthesia,
237459|NCT01947114|Children,|children,
237460|NCT01947114|Rigid Bronchoscopy,|rigid bronchoscopy,
237461|NCT01947114|Remifentanil,|remifentanil,
237462|NCT01947114|Propofol,|propofol,
237463|NCT01947114|Ketamine.|ketamine.
237464|NCT01947101|Stool transplant|stool transplant
237465|NCT01947101|Ulcerative Colitis|ulcerative colitis
237466|NCT01947101|Fecal transplant|fecal transplant
237467|NCT01947101|Inflammatory Bowel Disease|inflammatory bowel disease
237468|NCT01947088|Epilepsy, seizure disorder|epilepsy, seizure disorder
237469|NCT01947075|Fever|fever
237470|NCT01947075|Tanzania|tanzania
237471|NCT01947075|Pneumonia|pneumonia
237472|NCT01947075|HIV|hiv
237473|NCT01947075|Diabetes|diabetes
237474|NCT01947075|Indoor Air Pollution|indoor air pollution
237475|NCT01947062|NSCLC|nsclc
237476|NCT01947062|Metronomic chemotherapy|metronomic chemotherapy
237477|NCT01947062|Metronomic cyclophosphamide|metronomic cyclophosphamide
237478|NCT01947049|Influenza|influenza
237479|NCT01947049|diagnostic testing|diagnostic testing
237480|NCT01947049|antiviral treatment|antiviral treatment
237481|NCT01947049|rapid influenza testing|rapid influenza testing
237484|NCT01947036|T and B cells immunophenotype|t and b cells immunophenotype
237486|NCT01947036|genetic risk variants|genetic risk variants
237487|NCT01947010|antibodies|antibodies
237488|NCT01946984|diclofenac, ERCP and pancreatitis|diclofenac, ercp and pancreatitis
237489|NCT01946958|Triple P|triple p
237490|NCT01946945|infertility|infertility
237491|NCT01946945|recurrent pregnancy loss|recurrent pregnancy loss
237492|NCT01946945|miscarriage|miscarriage
237493|NCT01946945|Next Generation Sequencing|next generation sequencing
237494|NCT01946932|Induced hypothermia|induced hypothermia
237495|NCT01946932|Mild induced hypothermia|mild induced hypothermia
237496|NCT01946932|Resuscitation|resuscitation
237497|NCT01946932|Therapeutic hypothermia|therapeutic hypothermia
237498|NCT01946932|Neurological function|neurological function
237499|NCT01946932|Cardiovascular diseases|cardiovascular diseases
237500|NCT01946932|Rehabilitation|rehabilitation
237501|NCT01946932|Quality of life|quality of life
237502|NCT01946932|Cognition|cognition
237503|NCT01946919|Cinepazide|cinepazide
237504|NCT01946919|Adverse Drug Reaction|adverse drug reaction
237505|NCT01946919|Safety|safety
237506|NCT01946919|Real World Study|real world study
237507|NCT01946893|meditation|meditation
237508|NCT01946893|education|education
237509|NCT01946893|stress, psychological|stress, psychological
237510|NCT01946893|aged|aged
237511|NCT01946880|Systemic Lupus Erythematosus|systemic lupus erythematosus
237512|NCT01946880|Mycophenolate Mofetil (MMF)|mycophenolate mofetil (mmf)
237513|NCT01946867|Oral cavity Cancer|oral cavity cancer
237514|NCT01946867|Oropharynx Cancer|oropharynx cancer
237515|NCT01946854|Gastrointestinal|gastrointestinal
237516|NCT01946854|Metastatic Well-differentiated Mucinous Appendiceal Adenocarcinomas with Pseudomyxoma Peritonea|metastatic well-differentiated mucinous appendiceal adenocarcinomas with pseudomyxoma peritonea
237517|NCT01946854|Appendiceal cancer|appendiceal cancer
237518|NCT01946854|Surgically unresectable|surgically unresectable
237519|NCT01946854|Chemotherapy|chemotherapy
237520|NCT01946854|Observation|observation
237521|NCT01946854|Questionnaires|questionnaires
237522|NCT01946841|Chronic kidney disease|chronic kidney disease
237523|NCT01946841|Hemodialysis|hemodialysis
237524|NCT01946841|Severe malnutrition|severe malnutrition
237525|NCT01946841|Enteral nutrition|enteral nutrition
237526|NCT01946828|Field Induced Mydriasis|field induced mydriasis
237527|NCT01946828|FIM|fim
237528|NCT01946828|ATI|ati
237288|NCT01947907|rhGH|rhgh
237530|NCT01946802|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
237531|NCT01946802|Hypothermia induced|hypothermia induced
237532|NCT01946802|Seizures|seizures
237533|NCT01946802|Electroencephalography|electroencephalography
237534|NCT01946789|cancer|cancer
237535|NCT01946789|IL-15|il-15
237536|NCT01946789|melanoma|melanoma
237537|NCT01946789|metastatic|metastatic
237538|NCT01946789|unresectable|unresectable
237539|NCT01946789|solid tumors|solid tumors
237540|NCT01946789|renal cell|renal cell
237541|NCT01946789|non-small cell lung|non-small cell lung
237542|NCT01946789|squamous cell head and neck|squamous cell head and neck
237543|NCT01946737|Coronary|coronary
237544|NCT01946737|Artery|artery
237545|NCT01946737|Disease|disease
237546|NCT01946737|Diagnostic|diagnostic
237547|NCT01946737|Performance|performance
237548|NCT01946737|Angiography|angiography
237549|NCT01946711|CRS|crs
237550|NCT01946711|polyposis|polyposis
237551|NCT01946672|gynaecological malignancy|gynaecological malignancy
237552|NCT01946672|pelvic lymphadenectomy|pelvic lymphadenectomy
237553|NCT01946672|lymphedema|lymphedema
237554|NCT01946672|sentinel node|sentinel node
237555|NCT01946672|reverse mapping|reverse mapping
237556|NCT01946659|Tailored Telephone Intervention|tailored telephone intervention
237560|NCT01946607|Neuroticism|neuroticism
237561|NCT01946607|Emotion processing|emotion processing
237562|NCT01946607|Eye gaze movements|eye gaze movements
237563|NCT01946607|Heart Rate Variability|heart rate variability
237564|NCT01946594|fever|fever
237565|NCT01946594|antipyretics|antipyretics
237566|NCT01946594|acetaminophen|acetaminophen
237567|NCT01946594|influenza vaccine|influenza vaccine
237568|NCT01946594|influenza, human|influenza, human
237569|NCT01946594|body temperature changes|body temperature changes
237570|NCT01946594|Orthomyxoviridae Infections|orthomyxoviridae infections
237571|NCT01946594|RNA virus infections|rna virus infections
237572|NCT01946594|Virus Diseases|virus diseases
237573|NCT01946594|Respiratory Tract Infections|respiratory tract infections
237574|NCT01946594|Respiratory Tract Diseases|respiratory tract diseases
237575|NCT01946555|Breakthrough cancer pain|breakthrough cancer pain
237576|NCT01946555|Neuropathic pain|neuropathic pain
237577|NCT01946555|Major opioid|major opioid
237578|NCT01946555|Analgesics|analgesics
237579|NCT01946542|exercise|exercise
237580|NCT01946542|heart failure|heart failure
237585|NCT01946503|Short Gut|short gut
237586|NCT01946503|Short Bowel Syndrome|short bowel syndrome
237587|NCT01946503|Intestinal Failure|intestinal failure
237588|NCT01946503|Home parenteral nutrition|home parenteral nutrition
237589|NCT01946503|Feeding Behavior|feeding behavior
237590|NCT01946503|Enteral Nutrition|enteral nutrition
237591|NCT01946503|Parent-Child Relations|parent-child relations
237592|NCT01946503|Parenteral Nutrition|parenteral nutrition
237593|NCT01946503|Digestive System Diseases|digestive system diseases
237595|NCT01946464|edentulous|edentulous
237596|NCT01946464|bearded|bearded
237597|NCT01946464|patients|patients
237598|NCT01946464|requiring|requiring
237599|NCT01946464|general anesthesia|general anesthesia
237600|NCT01946464|Mallampati Class II or IV|mallampati class ii or iv
237601|NCT01946451|idiopathic epiretinal membranes|idiopathic epiretinal membranes
237602|NCT01946451|secondary epiretinal membranes|secondary epiretinal membranes
237603|NCT01946438|Influenza|influenza
237604|NCT01946438|Fluzone® Quadrivalent, Influenza Virus Vaccine (2013-2014 formulation),|fluzone® quadrivalent, influenza virus vaccine (2013-2014 formulation),
237605|NCT01946438|Fluzone® Intradermal, Influenza Virus Vaccine (2013-2014 formulation),|fluzone® intradermal, influenza virus vaccine (2013-2014 formulation),
237606|NCT01946438|Fluzone® High-Dose, Influenza Virus Vaccine (2013-2014 formulation)|fluzone® high-dose, influenza virus vaccine (2013-2014 formulation)
237607|NCT01946425|Influenza|influenza
237608|NCT01946425|Influenza virus vaccine|influenza virus vaccine
237609|NCT01946425|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
237610|NCT01946412|Cystic Fibrosis|cystic fibrosis
237611|NCT01946373|Melanoma|melanoma
237612|NCT01946373|Dendritic cell vaccination|dendritic cell vaccination
237613|NCT01946373|Lymphodepletion|lymphodepletion
237614|NCT01946373|Adoptive cell transfer|adoptive cell transfer
237615|NCT01946373|T cells|t cells
237616|NCT01946373|Tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
237617|NCT01946373|Fludarabine|fludarabine
237618|NCT01946373|IL-2|il-2
237619|NCT01946373|Interleukin-2|interleukin-2
237620|NCT01946373|Cyclophosphamide|cyclophosphamide
237621|NCT01946373|Phase I study|phase i study
237622|NCT01946373|Monocytes|monocytes
237623|NCT01946373|Autologous|autologous
237624|NCT01946373|NY-ESO-1|ny-eso-1
237625|NCT01946347|Insulin Resistance|insulin resistance
237626|NCT01946347|Hyperglycemia|hyperglycemia
237627|NCT01946347|Endothelial function|endothelial function
237628|NCT01946347|Oxidative stress|oxidative stress
237629|NCT01946308|sleep|sleep
237630|NCT01946308|sleep efficiency|sleep efficiency
237631|NCT01946308|active sleep|active sleep
237632|NCT01946308|quiet sleep|quiet sleep
237636|NCT01946308|mattress|mattress
237637|NCT01946308|feeding difficulty|feeding difficulty
237638|NCT01946308|neonatal intensive care unit|neonatal intensive care unit
237639|NCT01946308|sleep state|sleep state
237640|NCT01946308|behavioral observation|behavioral observation
237641|NCT01946308|stress behavior|stress behavior
237642|NCT01946308|self-regulatory behavior|self-regulatory behavior
237643|NCT01946308|surgery|surgery
237644|NCT01946308|gastrointestinal|gastrointestinal
237645|NCT01946282|neoplasm|neoplasm
237646|NCT01946282|colorectal|colorectal
292417|NCT01698762|RA|ra
237647|NCT01946282|cancer|cancer
237648|NCT01946282|uninsured|uninsured
237649|NCT01946282|FIT|fit
237650|NCT01946282|Fecal Immunochemical Test|fecal immunochemical test
237651|NCT01946204|Prostate neoplasms|prostate neoplasms
237652|NCT01946204|Prostate cancer|prostate cancer
237653|NCT01946204|Castration-resistant prostate cancer|castration-resistant prostate cancer
237654|NCT01946204|Non-metastatic castration-resistant prostate cancer|non-metastatic castration-resistant prostate cancer
237655|NCT01946204|ARN-509|arn-509
237656|NCT01946204|Apalutamide|apalutamide
237657|NCT01946191|Weight maintenance|weight maintenance
237658|NCT01946191|Electronic health record|electronic health record
237659|NCT01946191|Primary care|primary care
237660|NCT01946178|Uterine Fibroids|uterine fibroids
237661|NCT01946178|Leiomyomas|leiomyomas
237662|NCT01946178|High-Intensity Focused Ultrasound Ablation|high-intensity focused ultrasound ablation
237663|NCT01946178|Ultrasonography|ultrasonography
237664|NCT01946165|Prostate Cancer|prostate cancer
237665|NCT01946165|High risk prostate cancer|high risk prostate cancer
237666|NCT01946165|Abiraterone acetate|abiraterone acetate
237667|NCT01946165|Zytiga|zytiga
237668|NCT01946165|Prednisone|prednisone
237669|NCT01946165|Enzalutamide|enzalutamide
237670|NCT01946165|MDV3100|mdv3100
237671|NCT01946165|XTANDI|xtandi
237672|NCT01946165|Androgen ablation|androgen ablation
237673|NCT01946165|LHRHa|lhrha
237674|NCT01946165|Hormonal therapy|hormonal therapy
237675|NCT01946152|Myeloma|myeloma
237676|NCT01946152|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
237677|NCT01946152|MM|mm
237678|NCT01946152|Pomalidomide|pomalidomide
237679|NCT01946152|CC-4047|cc-4047
237680|NCT01946152|Dexamethasone|dexamethasone
237681|NCT01946152|Decadron|decadron
237682|NCT01946152|C-CSF|c-csf
237683|NCT01946152|Filgrastim|filgrastim
237684|NCT01946152|Neupogen|neupogen
237685|NCT01946152|Granulocyte colony stimulating factor|granulocyte colony stimulating factor
237686|NCT01946100|multifocal|multifocal
237687|NCT01946100|genetic|genetic
237688|NCT01946100|bronchoalveolar carcinoma|bronchoalveolar carcinoma
237689|NCT01946100|adenocarcinoma in situ|adenocarcinoma in situ
237690|NCT01946100|ground glass opacity|ground glass opacity
237691|NCT01946100|next generation sequencing|next generation sequencing
237692|NCT01946087|Remote ischemic preconditioning|remote ischemic preconditioning
237693|NCT01946087|cardiac surgery|cardiac surgery
237694|NCT01946087|left ventricular hypertrophy|left ventricular hypertrophy
237695|NCT01946087|reperfusion injury salvage kinase|reperfusion injury salvage kinase
237696|NCT01946074|advanced solid tumor|advanced solid tumor
237697|NCT01946074|cancer|cancer
237698|NCT01946074|neoplasm|neoplasm
237699|NCT01946074|colorectal cancer|colorectal cancer
237700|NCT01946061|Oxaliplatin, S-1, Gastric cancer, Adjuvant chemotherapy|oxaliplatin, s-1, gastric cancer, adjuvant chemotherapy
237701|NCT01946022|infertility|infertility
237702|NCT01946022|ovulation induction|ovulation induction
237703|NCT01946022|luteal phase|luteal phase
237704|NCT01946022|granulosa cells function|granulosa cells function
237705|NCT01946022|GnRH agonist and antagonist|gnrh agonist and antagonist
237706|NCT01946022|HMG|hmg
237707|NCT01946022|FSHr|fshr
237708|NCT01945996|Hispanic Americans|hispanic americans
237709|NCT01945996|Cellular Phone|cellular phone
237710|NCT01945996|Behavior|behavior
237711|NCT01945983|Septic shock|septic shock
237712|NCT01945983|Severe sepsis|severe sepsis
237713|NCT01945983|Norepinephrine|norepinephrine
237714|NCT01945970|Vascular function|vascular function
237715|NCT01945970|Flow mediated dilation|flow mediated dilation
237716|NCT01945970|Tea|tea
237717|NCT01945957|autism|autism
237718|NCT01945957|brain|brain
237719|NCT01945957|functional magnetic resonance imaging|functional magnetic resonance imaging
237720|NCT01945957|oxytocin|oxytocin
237721|NCT01945944|pediatric|pediatric
237722|NCT01945944|mucolytic|mucolytic
237723|NCT01945944|respiratory failure|respiratory failure
237724|NCT01945944|atelectasis|atelectasis
237725|NCT01945944|hypertonic saline|hypertonic saline
237726|NCT01945931|Maternal health|maternal health
237727|NCT01945931|perinatal health|perinatal health
237728|NCT01945931|mHealth|mhealth
237729|NCT01945931|smartphone|smartphone
237730|NCT01945931|mobile phone|mobile phone
237734|NCT01945918|Primary Health Care|primary health care
237735|NCT01945918|Self care|self care
237736|NCT01945905|Tuberculosis|tuberculosis
237737|NCT01945905|Adherence, medication|adherence, medication
237738|NCT01945905|Patient compliance|patient compliance
237739|NCT01945892|macular edema, irvine gass syndrome, ozurdex|macular edema, irvine gass syndrome, ozurdex
237740|NCT01945879|pancreatic cancer|pancreatic cancer
237741|NCT01945879|heparin|heparin
237742|NCT01945879|thromboembolic events|thromboembolic events
237743|NCT01945879|bleedings|bleedings
237744|NCT01945866|Diabetic Macular Edema|diabetic macular edema
237745|NCT01945866|Anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
402973|NCT01228799|trabeculectomy,|trabeculectomy,
237746|NCT01945866|Dexamethasone Intravitreal implant|dexamethasone intravitreal implant
237747|NCT01945866|Ranibizumab intravitreal injection|ranibizumab intravitreal injection
237748|NCT01945801|Sleep apnea|sleep apnea
237749|NCT01945801|Treatment|treatment
237750|NCT01945801|Sodium-Restricted Diet|sodium-restricted diet
237751|NCT01945801|Diuretic|diuretic
237752|NCT01945801|Lasilactone|lasilactone
237753|NCT01945775|Breast cancer|breast cancer
237754|NCT01945775|BRCA mutation|brca mutation
237755|NCT01945775|PARP inhibitor|parp inhibitor
237756|NCT01945775|BRCA 1|brca 1
237757|NCT01945775|BRCA 2|brca 2
237758|NCT01945762|RET Mutation|ret mutation
237759|NCT01945762|DIagnostics|diagnostics
237760|NCT01945762|Medullary Thyroid Cancer|medullary thyroid cancer
237761|NCT01945762|MTC|mtc
237762|NCT01945736|Opiate withdrawal in children|opiate withdrawal in children
237763|NCT01945723|Endoscopy|endoscopy
237764|NCT01945723|Gastrointestinal tract|gastrointestinal tract
237765|NCT01945723|Bacterial markers|bacterial markers
237766|NCT01945723|volunteers|volunteers
237767|NCT01945710|Tumors|tumors
237768|NCT01945697|DNA methylation, biomarkers, oral cancer|dna methylation, biomarkers, oral cancer
237769|NCT01945645|Prevention|prevention
237770|NCT01945645|Screening|screening
237771|NCT01945645|Type 2 diabetes|type 2 diabetes
237772|NCT01945645|Action Competence|action competence
237773|NCT01945645|Family practice|family practice
237774|NCT01945645|Health Services Research|health services research
237775|NCT01945619|CMV|cmv
237777|NCT01945619|EBV|ebv
237778|NCT01945619|Stem cell transplant|stem cell transplant
237779|NCT01945619|cytotoxic T-lymphocytes|cytotoxic t-lymphocytes
237780|NCT01945580|POP|pop
237781|NCT01945580|Transvaginal|transvaginal
237782|NCT01945580|Native Tissue Repair|native tissue repair
237783|NCT01945580|Repair Augmented with Mesh|repair augmented with mesh
237784|NCT01945580|Biologic Graft|biologic graft
237785|NCT01945580|Pelvic Organ Prolapse|pelvic organ prolapse
237786|NCT01945567|Parkinson's disease|parkinson's disease
237787|NCT01945567|Essential tremor|essential tremor
237788|NCT01945567|Tremor|tremor
237789|NCT01945567|Deep brain stimulation|deep brain stimulation
237790|NCT01945567|Posterior subthalamic area|posterior subthalamic area
237791|NCT01945567|Zona incerta|zona incerta
237792|NCT01945554|infiltrative therapy|infiltrative therapy
237793|NCT01945554|cervical disc herniation|cervical disc herniation
237794|NCT01945554|lumbar disc herniation|lumbar disc herniation
237795|NCT01945541|Intraoperative Fluid Administration|intraoperative fluid administration
237796|NCT01945541|Body Composition Measurement|body composition measurement
237797|NCT01945528|Platelet Rich Plasma|platelet rich plasma
237798|NCT01945528|tendinopathy|tendinopathy
237799|NCT01945528|epicondylitis|epicondylitis
237800|NCT01945528|ultrasound|ultrasound
237801|NCT01945528|injection therapy|injection therapy
237802|NCT01945528|needle tenotomy|needle tenotomy
237803|NCT01945515|Stroke|stroke
237804|NCT01945515|transcranial direct current stimulation|transcranial direct current stimulation
237805|NCT01945515|robotic rehabilitation|robotic rehabilitation
237806|NCT01945515|gait|gait
237807|NCT01945476|midazolam|midazolam
237808|NCT01945476|premedication|premedication
237809|NCT01945476|functional recovery|functional recovery
237810|NCT01945476|breast cancer|breast cancer
237811|NCT01945424|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
237812|NCT01945424|Pregnancy Registry|pregnancy registry
237813|NCT01945424|Influenza|influenza
237814|NCT01945411|Airway Management|airway management
237815|NCT01945411|Ventilation|ventilation
237816|NCT01945398|Pulmonary Rehabilitation|pulmonary rehabilitation
237817|NCT01945398|Inspiratory Muscle Training|inspiratory muscle training
237818|NCT01945398|Inspiratory Muscle Strength|inspiratory muscle strength
237819|NCT01945398|Vascular Resistance|vascular resistance
237820|NCT01945398|Exercise|exercise
237821|NCT01945398|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
237822|NCT01945385|Abortion|abortion
237823|NCT01945385|LARC|larc
237824|NCT01945385|Contraception|contraception
237826|NCT01945385|Contraceptive implant|contraceptive implant
237827|NCT01945385|behavioral change|behavioral change
237829|NCT01945359|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
237830|NCT01945359|Dimethyl Fumarate|dimethyl fumarate
237831|NCT01945359|Natalizumab|natalizumab
237832|NCT01945346|PRX167700|prx167700
237833|NCT01945346|Osteoarthritis|osteoarthritis
237834|NCT01945333|Cognitive remediation|cognitive remediation
237835|NCT01945333|Schizophrenia|schizophrenia
237836|NCT01945333|Schizoaffective disorder|schizoaffective disorder
237837|NCT01945320|hemodialysis|hemodialysis
237838|NCT01945320|wasting and malnutrition|wasting and malnutrition
237839|NCT01945320|nutrition status|nutrition status
237840|NCT01945320|bioelectrical impedance analysis|bioelectrical impedance analysis
237841|NCT01945320|body composition|body composition
237842|NCT01945307|Complement|complement
237843|NCT01945307|Serum Bactericidal Assay|serum bactericidal assay
237844|NCT01945268|vascular, influenza, vaccine, heart failure|vascular, influenza, vaccine, heart failure
292670|NCT01697319|LSD|lsd
237845|NCT01945255|Calcification|calcification
237846|NCT01945255|aortic pulse wave velocity|aortic pulse wave velocity
237847|NCT01945255|peripheral artery occlusion disease|peripheral artery occlusion disease
237848|NCT01945255|hemodialysis|hemodialysis
237849|NCT01945255|metabolic syndrome|metabolic syndrome
237850|NCT01945242|Drug Therapy|drug therapy
237851|NCT01945216|Drug therapy|drug therapy
237852|NCT01945203|Calcification|calcification
237853|NCT01945203|aortic pulse wave velocity|aortic pulse wave velocity
237854|NCT01945203|peripheral artery occlusion disease|peripheral artery occlusion disease
237855|NCT01945203|peritoneal dialysis|peritoneal dialysis
237856|NCT01945203|metabolic syndrome|metabolic syndrome
237857|NCT01945177|endoscopy|endoscopy
237858|NCT01945177|gastric intestinal metaplasia|gastric intestinal metaplasia
237859|NCT01945177|gastric cancer|gastric cancer
237860|NCT01945164|XL999|xl999
237861|NCT01945164|Advanced Malignancy|advanced malignancy
237862|NCT01945151|spastic hemiparesis|spastic hemiparesis
237863|NCT01945138|Total Pancreatectomy|total pancreatectomy
237864|NCT01945138|Islet Auto-Transplantation|islet auto-transplantation
237865|NCT01945138|Closed Loop Insulin Pump|closed loop insulin pump
237866|NCT01945099|diabetes, insulin,post prandial, closed loop, artificial pancreas, hyperglycemia|diabetes, insulin,post prandial, closed loop, artificial pancreas, hyperglycemia
237867|NCT01945086|Dermatitis, Atopic|dermatitis, atopic
237868|NCT01945086|Eczema|eczema
237869|NCT01945086|Ustekinumab|ustekinumab
237870|NCT01945086|CNTO1275|cnto1275
237871|NCT01945086|STELARA|stelara
237872|NCT01945073|Educational intervention|educational intervention
237873|NCT01945073|Formal Counselling|formal counselling
237874|NCT01945073|Knowledge|knowledge
237875|NCT01945073|Illness Perception|illness perception
237876|NCT01945060|Artificial Pancreas Project|artificial pancreas project
237877|NCT01945060|Diabetes Assistant (DiAs) Medical Platform System|diabetes assistant (dias) medical platform system
237878|NCT01945060|Artificial Pancreas Platform|artificial pancreas platform
237879|NCT01945060|Insulin Pump|insulin pump
237880|NCT01945060|Continuous Glucose Monitor|continuous glucose monitor
237881|NCT01945060|Closed-Loop Control|closed-loop control
237882|NCT01945060|heart rate Control to Range System (hrCTR)|heart rate control to range system (hrctr)
237883|NCT01945047|depression|depression
237884|NCT01945047|treatment|treatment
237885|NCT01945047|ketamine|ketamine
237886|NCT01945047|ottawa|ottawa
237887|NCT01945047|treatment-resistant|treatment-resistant
237888|NCT01945047|infusion|infusion
237889|NCT01945034|topical ibuprofen|topical ibuprofen
237890|NCT01945034|ankle sprain|ankle sprain
237891|NCT01945021|Non small cell lung cancer|non small cell lung cancer
237892|NCT01945021|NSCLC|nsclc
237893|NCT01945021|ROS1|ros1
237894|NCT01945021|ROS1 positive|ros1 positive
237895|NCT01945021|ROS1 proto oncogene|ros1 proto oncogene
237896|NCT01945021|c ros tyrosine kinases|c ros tyrosine kinases
237897|NCT01945021|ROS1 positive NSCLC|ros1 positive nsclc
237898|NCT01945021|ROS1 lung cancer|ros1 lung cancer
237899|NCT01945021|ALK negative|alk negative
237900|NCT01945021|Lung Carcinoma|lung carcinoma
237901|NCT01945021|Neoplasm|neoplasm
237902|NCT01945021|Crizotinib|crizotinib
237903|NCT01945021|Xalkori|xalkori
237904|NCT01945021|Previously treated or untreated|previously treated or untreated
237905|NCT01945021|North East Asian|north east asian
237906|NCT01945008|HCV|hcv
237907|NCT01945008|observational study|observational study
237908|NCT01945008|HCV direct-acting antiviral agents|hcv direct-acting antiviral agents
237909|NCT01944982|Immunotherapy|immunotherapy
237910|NCT01944982|NKAEs|nkaes
237911|NCT01944982|Expanded haploidentical natural killer cells|expanded haploidentical natural killer cells
237912|NCT01944982|Activated natural killer cells|activated natural killer cells
237913|NCT01944956|Maturation|maturation
237914|NCT01944956|preterm infants|preterm infants
237915|NCT01944956|sucking and swallowing|sucking and swallowing
237916|NCT01944943|refractory/relapsed|refractory/relapsed
237917|NCT01944943|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
237918|NCT01944943|indolent non-hodgkin lymphoma|indolent non-hodgkin lymphoma
237919|NCT01944943|Primary central nervous system lymphoma|primary central nervous system lymphoma
237920|NCT01944943|chronic lymphocytic leukemia|chronic lymphocytic leukemia
237921|NCT01944917|Electromagnetic field|electromagnetic field
237922|NCT01944917|VAS score|vas score
237923|NCT01944917|Heart Rate Variability|heart rate variability
237924|NCT01944904|XOS|xos
237925|NCT01944904|pre-diabetic|pre-diabetic
237926|NCT01944904|abnormal glucose levels|abnormal glucose levels
237927|NCT01944891|Adolescent girls|adolescent girls
237928|NCT01944891|Mozambique|mozambique
237929|NCT01944891|Diet|diet
237930|NCT01944891|Anthropometrics|anthropometrics
237931|NCT01944891|Serum biomarkers|serum biomarkers
237932|NCT01944878|Peptic ulcer|peptic ulcer
237933|NCT01944878|Liver cirrhosis|liver cirrhosis
237934|NCT01944878|Portal hypertension|portal hypertension
237935|NCT01944865|Aerobic Interval Training|aerobic interval training
237936|NCT01944865|Supramaximal Training|supramaximal training
237937|NCT01944852|icodextrin|icodextrin
237938|NCT01944852|double dose|double dose
237939|NCT01944852|elderly incident CAPD patients|elderly incident capd patients
237940|NCT01944852|DIDo study|dido study
237941|NCT01944839|Wet AMD|wet amd
237942|NCT01944839|choroidal neovascularization|choroidal neovascularization
237943|NCT01944839|Fovista®|fovista®
237944|NCT01944839|E10030|e10030
237945|NCT01944839|Lucentis®|lucentis®
237946|NCT01944826|Dyspnea|dyspnea
237947|NCT01944826|Angina pectoris|angina pectoris
237948|NCT01944813|Advance Care planning|advance care planning
237949|NCT01944813|End-of-life Discussions|end-of-life discussions
237950|NCT01944813|Questionaires|questionaires
237951|NCT01944813|Palliative Care|palliative care
237952|NCT01944800|Ticagrelor|ticagrelor
237953|NCT01944800|Prasugrel|prasugrel
237954|NCT01944800|Acute coronary syndrome|acute coronary syndrome
237955|NCT01944800|Percutaneous coronary intervention|percutaneous coronary intervention
237956|NCT01944774|Moxifloxacin|moxifloxacin
237957|NCT01944761|pediatrics|pediatrics
237958|NCT01944761|Brain Tumor|brain tumor
237959|NCT01944761|Neuro-radiation|neuro-radiation
237960|NCT01944761|Exercise|exercise
237961|NCT01944709|melanoma|melanoma
237962|NCT01944709|dendritic cells|dendritic cells
237963|NCT01944709|peptide|peptide
237964|NCT01944709|Melan-A|melan-a
237965|NCT01944696|hyperbilirubinemia|hyperbilirubinemia
237966|NCT01944696|prematurity|prematurity
237967|NCT01944696|extremely low birth weight (ELBW)|extremely low birth weight (elbw)
237968|NCT01944696|phototherapy|phototherapy
239274|NCT01938807|parents|parents
237969|NCT01944696|cycled phototherapy|cycled phototherapy
237970|NCT01944696|intermittent phototherapy|intermittent phototherapy
237971|NCT01944657|Major Depressive Disorder Clinical Outcomes|major depressive disorder clinical outcomes
237972|NCT01944657|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
237973|NCT01944657|Standard Medication Monotherapy|standard medication monotherapy
237974|NCT01944657|Exploratory Field Study|exploratory field study
237975|NCT01944605|Endotoxin|endotoxin
237976|NCT01944605|Cytokine|cytokine
237977|NCT01944605|Metabolism|metabolism
237978|NCT01944592|Gynaecology Teaching Associate|gynaecology teaching associate
237979|NCT01944592|Pelvic examination|pelvic examination
237980|NCT01944592|Students|students
237981|NCT01944553|Spine|spine
237982|NCT01944553|Accurancy|accurancy
237983|NCT01944553|Robotic|robotic
237984|NCT01944553|Screw placement|screw placement
237985|NCT01944553|Degenerative|degenerative
237986|NCT01944514|Action potential duration restitution|action potential duration restitution
237987|NCT01944514|Ventricular arrhythmia|ventricular arrhythmia
237988|NCT01944514|Sudden cardiac death|sudden cardiac death
237989|NCT01944514|Peri-infarct zone|peri-infarct zone
237990|NCT01944514|Electrocardiogram|electrocardiogram
237991|NCT01944501|tinnitus|tinnitus
237992|NCT01944501|hearing loss|hearing loss
237993|NCT01944501|Transcranial magnetic stimulation|transcranial magnetic stimulation
237994|NCT01944501|Transcranial direct current stimulation|transcranial direct current stimulation
237995|NCT01944488|Precocious puberty|precocious puberty
237996|NCT01944488|GnRH-test|gnrh-test
237997|NCT01944475|Precocious puberty|precocious puberty
237998|NCT01944475|Premature thelarche|premature thelarche
237999|NCT01944475|Tanner-stage|tanner-stage
238000|NCT01944475|GnRH-test|gnrh-test
238001|NCT01944462|pneumococcal vaccine|pneumococcal vaccine
238002|NCT01944462|pharmacist vaccination|pharmacist vaccination
238003|NCT01944462|Pneumovax 23|pneumovax 23
238004|NCT01944462|pneumococcal vaccine polyvalent|pneumococcal vaccine polyvalent
238005|NCT01944449|Type 2 diabetes (T2D)|type 2 diabetes (t2d)
238006|NCT01944449|Whey Protein Concentrate (WPC)|whey protein concentrate (wpc)
238007|NCT01944436|Pharmacogenomics|pharmacogenomics
238008|NCT01944436|Dementia with Lewy bodies|dementia with lewy bodies
238009|NCT01944436|Adverse events|adverse events
238010|NCT01944436|Polymorphisms|polymorphisms
238011|NCT01944436|Acetylcholinesterase|acetylcholinesterase
238012|NCT01944436|Parkinson's Disease Dementia|parkinson's disease dementia
238013|NCT01944436|Cognitive enhancers|cognitive enhancers
238014|NCT01944436|Clinical efficacy|clinical efficacy
238015|NCT01944436|Cytochrome P450|cytochrome p450
238016|NCT01944436|Butyrylcholinesterase|butyrylcholinesterase
238018|NCT01944410|TBC|tbc
238019|NCT01944410|Treatment|treatment
238020|NCT01944397|Atrial fibrillation|atrial fibrillation
238021|NCT01944397|Heart failure|heart failure
238022|NCT01944397|Stroke|stroke
238023|NCT01944397|Myocardial infarction|myocardial infarction
238024|NCT01944371|Latent reservoir|latent reservoir
238025|NCT01944358|Syphilis; human immunodeficiency virus; penicillin|syphilis; human immunodeficiency virus; penicillin
238026|NCT01944332|gamete treatment|gamete treatment
238027|NCT01944332|ICSI|icsi
238028|NCT01944332|IVF|ivf
238029|NCT01944332|infertility|infertility
238030|NCT01944332|oocyte activation|oocyte activation
238031|NCT01944319|Infection; Meropenem; Pharmacokinetics; Pharmacodynamics|infection; meropenem; pharmacokinetics; pharmacodynamics
238032|NCT01944306|Pharmacokinetics|pharmacokinetics
238033|NCT01944306|Pharmacology, Clinical|pharmacology, clinical
292935|NCT01696084|AML|aml
238034|NCT01944306|Drug Efficacy|drug efficacy
238035|NCT01944306|Drug Failure|drug failure
238036|NCT01944306|Contraceptive Agents|contraceptive agents
238037|NCT01944293|Ketamine|ketamine
238038|NCT01944293|Midazolam|midazolam
238039|NCT01944293|Bipolar Disorder|bipolar disorder
238040|NCT01944293|Major Depressive Episode|major depressive episode
238041|NCT01944293|Suicidal Ideation|suicidal ideation
238042|NCT01944293|Suicide|suicide
238043|NCT01944293|Depression|depression
238044|NCT01944293|Treatment|treatment
238045|NCT01944293|Ketamine Treatment|ketamine treatment
238046|NCT01944254|Cardiac surgical procedures|cardiac surgical procedures
238047|NCT01944254|Pulmonary Artery Catheterizations|pulmonary artery catheterizations
238048|NCT01944254|Cardiac output|cardiac output
238049|NCT01944254|Swan Ganz Catheterization|swan ganz catheterization
238050|NCT01944241|cervical surgery|cervical surgery
238051|NCT01944241|LLETZ|lletz
238052|NCT01944241|LEEP|leep
238053|NCT01944241|Cone biopsy|cone biopsy
238054|NCT01944241|Fertility|fertility
238055|NCT01944228|inflammation|inflammation
238056|NCT01944228|vagus nerve stimulation|vagus nerve stimulation
238057|NCT01944228|chronic heart failure|chronic heart failure
238058|NCT01944228|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
238059|NCT01944228|sepsis|sepsis
238060|NCT01944228|auto-immune diseases|auto-immune diseases
238061|NCT01944215|Normal subjects|normal subjects
238062|NCT01944215|Female|female
238063|NCT01944215|Molecular Breast Imaging|molecular breast imaging
238064|NCT01944215|Fasting|fasting
238065|NCT01944215|Exercise|exercise
238066|NCT01944215|Tracer Uptake|tracer uptake
238067|NCT01944215|Tc-99m Sestamibi|tc-99m sestamibi
238068|NCT01944215|Prandial status|prandial status
238069|NCT01944215|metabolic status|metabolic status
238070|NCT01944215|negative mammogram|negative mammogram
238071|NCT01944215|Caffeine|caffeine
238072|NCT01944215|External Warming|external warming
238073|NCT01944202|Echocardiography|echocardiography
238074|NCT01944202|Appropriate Use Criteria|appropriate use criteria
238075|NCT01944202|Educational Intervention|educational intervention
238076|NCT01944189|lumefantrine pharmacokinetics & bioavailability|lumefantrine pharmacokinetics & bioavailability
238077|NCT01944176|COPD|copd
238078|NCT01944176|Statins|statins
238079|NCT01944176|Cytokines|cytokines
238080|NCT01944163|Low back pain|low back pain
238081|NCT01944163|Impact analysis|impact analysis
238082|NCT01944163|Cluster randomized trial|cluster randomized trial
238083|NCT01944163|Referral rule|referral rule
238084|NCT01944163|Axial spondyloarthritis|axial spondyloarthritis
238085|NCT01944150|Hypnosis|hypnosis
238086|NCT01944150|chronic pain|chronic pain
238087|NCT01944150|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
238088|NCT01944150|nociceptive pain|nociceptive pain
238089|NCT01944150|neuropathic pain|neuropathic pain
238090|NCT01944150|complementary therapies|complementary therapies
238091|NCT01944137|colonic neoplasms|colonic neoplasms
238092|NCT01944137|Lung neoplasms|lung neoplasms
238093|NCT01944137|patient-centered nursing|patient-centered nursing
238094|NCT01944137|breast neoplasms|breast neoplasms
238095|NCT01944124|Mobile health|mobile health
238096|NCT01944124|Metabolic syndrome|metabolic syndrome
238097|NCT01944124|Exercise prescription|exercise prescription
238098|NCT01944124|Exercise intervention|exercise intervention
238099|NCT01944124|Disease prevention|disease prevention
238100|NCT01944124|Rural health|rural health
238101|NCT01944111|Gastric plication|gastric plication
238102|NCT01944085|children|children
238103|NCT01944085|supracondylar fracture|supracondylar fracture
238104|NCT01944085|pin removal|pin removal
238105|NCT01944085|analgesia|analgesia
238106|NCT01944085|pain score|pain score
238107|NCT01944072|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
238108|NCT01944072|COPD|copd
238109|NCT01944072|Pulmonary rehabilitation|pulmonary rehabilitation
238110|NCT01944072|Aerobic exercise|aerobic exercise
238111|NCT01944072|CEDOC|cedoc
238112|NCT01944072|FCM|fcm
238113|NCT01944072|UNL|unl
238114|NCT01944072|NOVA MEDICAL SCHOOL|nova medical school
238115|NCT01944046|autism, ASD, autistic, Asperger's, PDD-NOS, oxytocin|autism, asd, autistic, asperger's, pdd-nos, oxytocin
238116|NCT01944033|β2-agonist|β2-agonist
238117|NCT01944033|Ipratropium Bromide|ipratropium bromide
238118|NCT01944033|Chronic Obstructive Pulmonary Disease Exacerbation|chronic obstructive pulmonary disease exacerbation
238119|NCT01944033|Emergency departement|emergency departement
238120|NCT01944020|Sleep Apnea, Obstructive|sleep apnea, obstructive
238121|NCT01944020|Energy Balance|energy balance
238122|NCT01944020|Food Intake|food intake
238123|NCT01944020|Energy Expenditure|energy expenditure
238124|NCT01944020|Sleep|sleep
238125|NCT01944020|Obesity|obesity
238126|NCT01944007|CLP|clp
238127|NCT01943994|Psilocybin|psilocybin
238128|NCT01943994|Smoking cessation|smoking cessation
238129|NCT01943955|dizziness|dizziness
238130|NCT01943955|vertigo|vertigo
238131|NCT01943955|unsteadiness|unsteadiness
238132|NCT01943955|unbalance|unbalance
238133|NCT01943955|falls|falls
238134|NCT01943942|Mexico|mexico
238135|NCT01943942|Montelukast|montelukast
238136|NCT01943942|Pharmacokinetics|pharmacokinetics
238137|NCT01943942|Bioequivalence|bioequivalence
238138|NCT01943929|Nasal septum|nasal septum
238139|NCT01943929|Headache|headache
238140|NCT01943929|Mucosa contact point headache|mucosa contact point headache
238141|NCT01943916|breast imaging diagnosis|breast imaging diagnosis
238142|NCT01943916|breast ultrasound|breast ultrasound
238143|NCT01943916|Imagio|imagio
238144|NCT01943916|Seno Medical Instruments, Inc.|seno medical instruments, inc.
238145|NCT01943916|Seno|seno
238146|NCT01943916|opto-acoustics|opto-acoustics
238147|NCT01943916|OA|oa
238148|NCT01943916|angiogenesis|angiogenesis
238149|NCT01943916|blood map|blood map
238150|NCT01943890|Hypertonic saline|hypertonic saline
238151|NCT01943890|Lung physiotherapy|lung physiotherapy
238152|NCT01943864|pharmacokinetics|pharmacokinetics
238153|NCT01943864|second line monotherapy|second line monotherapy
238154|NCT01943864|GSK1120212 (trametinib)|gsk1120212 (trametinib)
238155|NCT01943864|MEK inhibitor|mek inhibitor
238156|NCT01943864|locally advanced or metastatic biliary tract cancers|locally advanced or metastatic biliary tract cancers
238157|NCT01943851|leukemia|leukemia
238158|NCT01943851|Acute myeloid leukemia|acute myeloid leukemia
238159|NCT01943851|BET inhibitor|bet inhibitor
238160|NCT01943851|lymphoma|lymphoma
238161|NCT01943851|Myelodysplastic syndromes|myelodysplastic syndromes
238162|NCT01943851|Oncology|oncology
238163|NCT01943851|multiple myeloma|multiple myeloma
238164|NCT01943851|GSK525762|gsk525762
238165|NCT01943825|Dengue|dengue
238166|NCT01943825|Dengue fever|dengue fever
238167|NCT01943825|CYD dengue vaccine|cyd dengue vaccine
238170|NCT01943799|Hepatitis B (HBV)|hepatitis b (hbv)
238171|NCT01943799|Oral antiviral (OAV)|oral antiviral (oav)
238172|NCT01943799|GS-4774|gs-4774
238173|NCT01943786|Wild type KRAS|wild type kras
238174|NCT01943773|delirium|delirium
238175|NCT01943773|surgery|surgery
238176|NCT01943773|operation|operation
238177|NCT01943773|geriatric|geriatric
238178|NCT01943773|complication|complication
238179|NCT01943760|Tramadol|tramadol
238180|NCT01943760|Children|children
238181|NCT01943760|Hernioplasty|hernioplasty
238182|NCT01943760|Wound infiltration|wound infiltration
238183|NCT01943747|sepsis|sepsis
238184|NCT01943747|severe sepsis|severe sepsis
238185|NCT01943747|septic shock|septic shock
238186|NCT01943747|infection|infection
238187|NCT01943747|organ dysfunction|organ dysfunction
238188|NCT01943747|quality improvement|quality improvement
238189|NCT01943734|Information|information
238190|NCT01943734|Lifestyle|lifestyle
238191|NCT01943734|Occupational Health|occupational health
238192|NCT01943695|Breast Cancer|breast cancer
238193|NCT01943695|Exercise|exercise
238194|NCT01943695|Chemotherapy|chemotherapy
238195|NCT01943695|15-178|15-178
238196|NCT01943682|Relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
238197|NCT01943682|non-therapy related acute myeloid leukemia|non-therapy related acute myeloid leukemia
238198|NCT01943682|Refractory acute myeloid leukemia|refractory acute myeloid leukemia
238199|NCT01943682|Untreated acute myeloid leukemia|untreated acute myeloid leukemia
238200|NCT01943682|Lymphoma|lymphoma
238201|NCT01943682|Leukemia|leukemia
238202|NCT01943669|Spinal Cord Injury|spinal cord injury
238203|NCT01943656|Spinal Cord Injury|spinal cord injury
238204|NCT01943643|angiography, bifurcation, stenting, CT|angiography, bifurcation, stenting, ct
238205|NCT01943630|HPV condyloma acuminata|hpv condyloma acuminata
238206|NCT01943617|Liver Cirrhosis|liver cirrhosis
238207|NCT01943617|Hepatitis B|hepatitis b
238208|NCT01943617|Compensation|compensation
238209|NCT01943617|Efficacy|efficacy
238210|NCT01943604|Neuropsychology|neuropsychology
238211|NCT01943604|Breakfast eating patters|breakfast eating patters
238212|NCT01943604|Glucose|glucose
238213|NCT01943604|Child Psychology|child psychology
238214|NCT01943591|treatment trial|treatment trial
238215|NCT01943591|cerebral aneurysm|cerebral aneurysm
238216|NCT01943591|randomized|randomized
238217|NCT01943591|coils|coils
238218|NCT01943591|endovascular|endovascular
238219|NCT01943591|Aneurysm|aneurysm
238220|NCT01943591|Intracranial Aneurysm|intracranial aneurysm
238221|NCT01943591|Vascular Diseases|vascular diseases
238222|NCT01943591|Cardiovascular Diseases|cardiovascular diseases
238223|NCT01943591|Intracranial Arterial Diseases|intracranial arterial diseases
238224|NCT01943591|Cerebrovascular Disorders|cerebrovascular disorders
238225|NCT01943591|Brain Diseases|brain diseases
238226|NCT01943591|Central Nervous System Diseases|central nervous system diseases
238227|NCT01943591|Nervous System Diseases|nervous system diseases
238228|NCT01943565|Pregnancy|pregnancy
238229|NCT01943565|Healthy|healthy
238230|NCT01943565|Intrathecal|intrathecal
238231|NCT01943565|Opioids|opioids
238232|NCT01943565|Spinal|spinal
238233|NCT01943565|Anesthesia|anesthesia
238234|NCT01943565|Pain|pain
238235|NCT01943565|Cesarean|cesarean
238236|NCT01943565|Delivery|delivery
238237|NCT01943565|Human|human
238240|NCT01943513|Muscle Disuse Atrophy|muscle disuse atrophy
238241|NCT01943500|Breast cancer|breast cancer
238242|NCT01943500|Prostate cancer|prostate cancer
238243|NCT01943500|Colorectal cancer|colorectal cancer
238244|NCT01943500|Circulating tumor cell (CTC)|circulating tumor cell (ctc)
238245|NCT01943487|Phase I|phase i
238246|NCT01943487|Verapamil|verapamil
238247|NCT01943487|Tamsulosin OCAS|tamsulosin ocas
238248|NCT01943487|Solifenacin|solifenacin
238249|NCT01943487|Pharmacokinetics|pharmacokinetics
238250|NCT01943487|EC905|ec905
238251|NCT01943474|IV Catheter comparison|iv catheter comparison
238252|NCT01943474|AccuCath versus Conventional IV Catheters|accucath versus conventional iv catheters
238253|NCT01943474|IV Catheter Study|iv catheter study
238254|NCT01943474|IV Catheter User Preference Comparison|iv catheter user preference comparison
238255|NCT01943474|First Attempt Success Rate for IV Catheters|first attempt success rate for iv catheters
238256|NCT01943474|AccuCath Device Performance|accucath device performance
238257|NCT01943474|Complication Rates for IV Catheters|complication rates for iv catheters
238258|NCT01943474|Average Dwell Time for IV Catheters|average dwell time for iv catheters
238259|NCT01943474|Patient Satisfaction with IV Catheters|patient satisfaction with iv catheters
238260|NCT01943474|Clinician Satisfaction with AccuCath Device Performance|clinician satisfaction with accucath device performance
238261|NCT01943461|Solid Tumors|solid tumors
238262|NCT01943461|MSB0010718C|msb0010718c
238263|NCT01943461|anti PD-L1|anti pd-l1
238264|NCT01943461|avelumab|avelumab
238265|NCT01943461|Phase 1|phase 1
238266|NCT01943448|Macula Lutea Hemorrhage|macula lutea hemorrhage
238267|NCT01943448|High Myopia|high myopia
238268|NCT01943448|Optical Coherence Tomography|optical coherence tomography
238269|NCT01943435|Spinal Stenosis|spinal stenosis
238270|NCT01943435|Spinal manipulation|spinal manipulation
238271|NCT01943435|Exercise|exercise
238272|NCT01943435|Epidural injection|epidural injection
238273|NCT01943422|advanced|advanced
238274|NCT01943422|melanoma|melanoma
238275|NCT01943422|Vemurafenib|vemurafenib
238276|NCT01943422|High-dose Interferon alfa-2b|high-dose interferon alfa-2b
238277|NCT01943409|Parenteral nutrition|parenteral nutrition
238278|NCT01943409|lipid emulsion|lipid emulsion
238279|NCT01943409|Intralipid|intralipid
238280|NCT01943409|ClinOleic|clinoleic
238281|NCT01943409|Inflammation|inflammation
238282|NCT01943409|Infection|infection
238283|NCT01943409|Bloodstream Infection|bloodstream infection
238284|NCT01943409|length of stay|length of stay
238285|NCT01943409|mortality|mortality
238286|NCT01943396|age-related macular degeneration|age-related macular degeneration
238287|NCT01943396|AMD|amd
238288|NCT01943396|rheohemapheresis|rheohemapheresis
238289|NCT01943396|plasma filtration|plasma filtration
238290|NCT01943396|electroretinography|electroretinography
238291|NCT01943396|ERG|erg
238292|NCT01943396|multifocal ERG|multifocal erg
238293|NCT01943396|double plasma filtration|double plasma filtration
238294|NCT01943383|Hypertension|hypertension
238295|NCT01943370|endoscopic sinus surgery|endoscopic sinus surgery
238296|NCT01943370|post-operative irrigation|post-operative irrigation
238297|NCT01943370|pain|pain
238298|NCT01943370|debridement|debridement
238299|NCT01943357|diabetes|diabetes
238300|NCT01943357|patient education|patient education
238301|NCT01943357|self management|self management
238302|NCT01943357|health improvement|health improvement
238303|NCT01943344|vascular large hole closure|vascular large hole closure
238304|NCT01943344|arteriotomy closure|arteriotomy closure
238305|NCT01943344|Large hole vascular closure device|large hole vascular closure device
238306|NCT01943344|vascular closure device|vascular closure device
238307|NCT01943344|percutaneous vascular closure device|percutaneous vascular closure device
238308|NCT01943318|Liver Cirrhosis|liver cirrhosis
238309|NCT01943318|Hepatocellular carcinoma|hepatocellular carcinoma
238310|NCT01943305|Yellow Fever|yellow fever
238311|NCT01943305|vaccination|vaccination
238312|NCT01943305|Japanese encephalitis|japanese encephalitis
238313|NCT01943305|antibodies|antibodies
238314|NCT01943292|Focal Adhesion Kinase inhibitor|focal adhesion kinase inhibitor
238315|NCT01943292|FAK inhibitor|fak inhibitor
238316|NCT01943292|Cancer Stem Cells|cancer stem cells
238317|NCT01943292|CSC|csc
238318|NCT01943279|medical abortion|medical abortion
238319|NCT01943279|telephone follow-up|telephone follow-up
238320|NCT01943279|ultrasound|ultrasound
238321|NCT01943279|serum hCG|serum hcg
238322|NCT01943279|methotrexate|methotrexate
238325|NCT01943253|endoscopic submucosal dissection (ESD)|endoscopic submucosal dissection (esd)
238326|NCT01943253|water-jet assisted ESD|water-jet assisted esd
238327|NCT01943227|humidity|humidity
238328|NCT01943227|enthalpy|enthalpy
238329|NCT01943227|mechanical ventilation|mechanical ventilation
238330|NCT01943214|Diabetes Mellitus|diabetes mellitus
238331|NCT01943214|Body constitution|body constitution
238332|NCT01943175|schizophrenia|schizophrenia
238333|NCT01943175|stem cells|stem cells
238334|NCT01943175|neurons|neurons
238335|NCT01943175|genetic hish risk for schizophrenia|genetic hish risk for schizophrenia
238336|NCT01943136|impetigo|impetigo
238337|NCT01943136|papaya extract ointment|papaya extract ointment
238338|NCT01943123|probiotics,|probiotics,
238339|NCT01943123|streptococcus mutans,|streptococcus mutans,
238340|NCT01943123|lactobacilli,|lactobacilli,
238341|NCT01943123|plaque index,|plaque index,
238342|NCT01943123|gingival index|gingival index
238343|NCT01943110|Intradermal injections|intradermal injections
238344|NCT01943110|Vaccine delivery devices|vaccine delivery devices
238345|NCT01943071|dementia|dementia
238346|NCT01943071|day care centre programs|day care centre programs
238347|NCT01943071|patients|patients
238348|NCT01943071|family carers|family carers
238349|NCT01943071|cost-consequence analysis|cost-consequence analysis
238350|NCT01943006|Mucopolysaccaride polysulfate (MPS)|mucopolysaccaride polysulfate (mps)
238351|NCT01943006|MPS|mps
238352|NCT01943006|Heparinoide|heparinoide
238353|NCT01943006|Infusionphlebitis|infusionphlebitis
238354|NCT01943006|Prevention|prevention
238355|NCT01943006|Superficial thrombophlebitis|superficial thrombophlebitis
238356|NCT01943006|Treatment|treatment
238357|NCT01942993|melanoma|melanoma
238358|NCT01942993|unresectable|unresectable
238359|NCT01942993|mutation|mutation
238360|NCT01942993|BRAF protein|braf protein
238361|NCT01942980|Breast cancer|breast cancer
238362|NCT01942980|one brain metastasis|one brain metastasis
238363|NCT01942967|Neonate|neonate
238364|NCT01942967|Hemodynamic|hemodynamic
238365|NCT01942967|Tissue oxygenation|tissue oxygenation
238366|NCT01942967|Non invasive ventilation|non invasive ventilation
238367|NCT01942954|Alcohol Dependence|alcohol dependence
238368|NCT01942954|Cognitive Therapy|cognitive therapy
238369|NCT01942954|Executive Function|executive function
238370|NCT01942954|Mobile Health|mobile health
238371|NCT01942954|Recovery of Function|recovery of function
238372|NCT01942954|Rehabilitation|rehabilitation
238373|NCT01942889|COPD|copd
238374|NCT01942889|exercise training|exercise training
238375|NCT01942889|pulmonary rehabilitation|pulmonary rehabilitation
238376|NCT01942889|antioxidant|antioxidant
238377|NCT01942889|muscle|muscle
238378|NCT01942876|Drugs|drugs
238379|NCT01942876|at risk|at risk
238380|NCT01942876|community health center patients|community health center patients
238381|NCT01942837|Enzalutamid|enzalutamid
238382|NCT01942837|Prostate Cancer|prostate cancer
238383|NCT01942811|DRUG PREVENTION|drug prevention
238384|NCT01942811|BINATIONAL|binational
238385|NCT01942811|CASUAL USE OF ILLICIT DRUGS|casual use of illicit drugs
238386|NCT01942811|BRIEF INTERVENTION|brief intervention
238387|NCT01942811|SBIRT|sbirt
238388|NCT01942798|Rehabilitation|rehabilitation
238389|NCT01942798|Lower Limb Amputation|lower limb amputation
238390|NCT01942798|Prosthetic|prosthetic
238391|NCT01942798|Walking|walking
238392|NCT01942798|unilateral transtibial amputation|unilateral transtibial amputation
238393|NCT01942798|unilateral transfemoral amputation|unilateral transfemoral amputation
238394|NCT01942798|older adults|older adults
238395|NCT01942798|cognitive computer games|cognitive computer games
238396|NCT01942798|home-based training|home-based training
238397|NCT01942798|Nintendo Wii|nintendo wii
238398|NCT01942798|virtual reality|virtual reality
238399|NCT01942772|powered ankle-foot orthosis|powered ankle-foot orthosis
238400|NCT01942772|mechanical structure|mechanical structure
238401|NCT01942772|optimization|optimization
238402|NCT01942772|dorsiflexion|dorsiflexion
238403|NCT01942772|plantar flexion|plantar flexion
238404|NCT01942772|gait|gait
238405|NCT01942772|servomotor|servomotor
238406|NCT01942772|ankle rehabilitation|ankle rehabilitation
238407|NCT01942759|Breast Neoplasms|breast neoplasms
238408|NCT01942759|Positron-Emission Tomography|positron-emission tomography
238409|NCT01942759|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
238410|NCT01942746|blueberry|blueberry
238411|NCT01942746|anthocyanin|anthocyanin
238412|NCT01942746|dark vision|dark vision
238413|NCT01942746|photo bleaching|photo bleaching
238414|NCT01942746|Visual Perception|visual perception
238415|NCT01942746|Photic Stimulation|photic stimulation
238416|NCT01942707|Abdominoplasty,Seroma,Bariatric surgery|abdominoplasty,seroma,bariatric surgery
238417|NCT01942694|Prediabetes|prediabetes
238418|NCT01942694|Vitamin D|vitamin d
238419|NCT01942681|female|female
238420|NCT01942681|mixed urinary incontinence|mixed urinary incontinence
238421|NCT01942668|Vasomotor symptoms|vasomotor symptoms
238422|NCT01942668|Hot flashes|hot flashes
238423|NCT01942668|Endometrial protection|endometrial protection
238425|NCT01942655|Chronic inflammatory bowel disease|chronic inflammatory bowel disease
238426|NCT01942655|Reservoirs|reservoirs
238427|NCT01942655|IL-17|il-17
238428|NCT01942655|IL-23|il-23
238429|NCT01942655|Intestinal biopsies|intestinal biopsies
238430|NCT01942642|cataract surgery, meibomian gland dysfunction, meibum expressibility, meibography|cataract surgery, meibomian gland dysfunction, meibum expressibility, meibography
238431|NCT01942629|prognostic markers,Pancreatic ductal adenocarcinoma|prognostic markers,pancreatic ductal adenocarcinoma
238432|NCT01942616|IPV|ipv
238433|NCT01942603|Minimal (SN) tumor burden|minimal (sn) tumor burden
238434|NCT01942603|Stage III|stage iii
238435|NCT01942603|Patients|patients
238436|NCT01942603|Lymphnode Dissections|lymphnode dissections
238437|NCT01942590|Pompe disease|pompe disease
238438|NCT01942577|NoSting|nosting
238439|NCT01942577|Skin protectants|skin protectants
238440|NCT01942577|Emollients|emollients
238441|NCT01942577|Skin microbiome|skin microbiome
238442|NCT01942564|traumatic brain injury|traumatic brain injury
238443|NCT01942564|photophobia|photophobia
238444|NCT01942564|photosensitivity|photosensitivity
238445|NCT01942564|pupil|pupil
238446|NCT01942538|rTMS|rtms
238447|NCT01942538|fibromyalgia|fibromyalgia
238448|NCT01942538|sham|sham
238449|NCT01942538|maintenance session|maintenance session
238450|NCT01942538|pain|pain
238451|NCT01942525|IUGR|iugr
238452|NCT01942525|aEEG|aeeg
238453|NCT01942525|preterm infants|preterm infants
238454|NCT01942525|neurodevelopmental outcome|neurodevelopmental outcome
238455|NCT01942512|Intracranial Aneurysm - Endovascular treatment -|intracranial aneurysm - endovascular treatment -
238456|NCT01942512|Coiling - Stenting - Flow diversion - Flow disruption -|coiling - stenting - flow diversion - flow disruption -
238457|NCT01942512|Recanalization - Risk factors|recanalization - risk factors
238458|NCT01942499|COPD, exercise, community|copd, exercise, community
238459|NCT01942486|migraine|migraine
238460|NCT01942486|photophobia|photophobia
238461|NCT01942486|light sensitivity|light sensitivity
238462|NCT01942486|melanopsin cells|melanopsin cells
238463|NCT01942486|intrinsically photosensitive retinal ganglion cells|intrinsically photosensitive retinal ganglion cells
238464|NCT01942460|Iron|iron
238465|NCT01942460|Anemia|anemia
238466|NCT01942460|Chronic Kidney Disease|chronic kidney disease
238467|NCT01942460|Peritoneal Dialysis|peritoneal dialysis
238468|NCT01942460|Inflammation|inflammation
238469|NCT01942460|Oxidative stress|oxidative stress
238470|NCT01942447|Fecal microbiota transplantation|fecal microbiota transplantation
238471|NCT01942447|microbiota|microbiota
238472|NCT01942447|clostridium difficile|clostridium difficile
238473|NCT01942447|clostridium difficile infection|clostridium difficile infection
238474|NCT01942447|Efficacy of FMT|efficacy of fmt
238475|NCT01942434|Fatty acids|fatty acids
238476|NCT01942434|Breast milk nutrients|breast milk nutrients
238477|NCT01942434|Cognitive development|cognitive development
238478|NCT01942434|Electrophysiology|electrophysiology
238479|NCT01942434|Long-term assessment|long-term assessment
238480|NCT01942421|Limbal deficiency|limbal deficiency
238481|NCT01942421|Cultivated limbal transplantation|cultivated limbal transplantation
238482|NCT01942421|Ex vivo limbal transplantation|ex vivo limbal transplantation
238483|NCT01942421|Cultivated autologous mucosal epithelial transplantation|cultivated autologous mucosal epithelial transplantation
238484|NCT01942408|Atrial fibrillation|atrial fibrillation
238485|NCT01942408|Pulmonary vein isolation|pulmonary vein isolation
238486|NCT01942408|Pulmonary vein reconnection|pulmonary vein reconnection
238487|NCT01942395|Diet|diet
238488|NCT01942395|Sodium|sodium
238489|NCT01942395|Hypertension|hypertension
238490|NCT01942395|Potassium|potassium
238491|NCT01942395|Antioxidants|antioxidants
238492|NCT01942395|Congestive Heart Failure|congestive heart failure
238493|NCT01942395|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
238494|NCT01942395|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
238495|NCT01942382|Schizophrenia|schizophrenia
238496|NCT01942382|JNS010|jns010
238497|NCT01942382|Paliperidone Palmitate|paliperidone palmitate
238498|NCT01942382|Clinical Pharmacology|clinical pharmacology
238499|NCT01942369|Endometriosis|endometriosis
238500|NCT01942304|Sinus Floor Augmentation|sinus floor augmentation
238501|NCT01942304|Maxillary Sinus|maxillary sinus
238502|NCT01942304|Bone Substitutes|bone substitutes
238503|NCT01942304|Bone Regeneration|bone regeneration
238504|NCT01942291|Niacin|niacin
238505|NCT01942291|Endothelial function|endothelial function
238506|NCT01942291|Laropiprant|laropiprant
238507|NCT01942291|HDL|hdl
238508|NCT01942278|Healthcare|healthcare
238509|NCT01942278|Patients|patients
238510|NCT01942265|Influenza, Immunogenicity, Monovalent, A/H7N9, Vaccine, AS03, Adjuvant|influenza, immunogenicity, monovalent, a/h7n9, vaccine, as03, adjuvant
238511|NCT01942252|Secondhand smoking, pain, postoperative complications|secondhand smoking, pain, postoperative complications
238512|NCT01942239|hypoglycemia|hypoglycemia
238513|NCT01942239|very low birth weight neonate|very low birth weight neonate
238514|NCT01942239|continuous glucose monitoring|continuous glucose monitoring
238515|NCT01942226|Dry eye syndrome|dry eye syndrome
238517|NCT01942213|Degeneration|degeneration
238518|NCT01942213|Age related|age related
238519|NCT01942213|Neovascular|neovascular
238520|NCT01942200|carcinoma|carcinoma
238521|NCT01942200|colon cancer|colon cancer
238522|NCT01942200|colorectal cancer|colorectal cancer
238523|NCT01942200|ambulant chemotherapy|ambulant chemotherapy
238524|NCT01942200|treatment cycles|treatment cycles
238525|NCT01942200|Oxaliplatin|oxaliplatin
229257|NCT01984294|HCV|hcv
238526|NCT01942200|Oxaliplatin onkovis|oxaliplatin onkovis
238527|NCT01942200|Quantity of Oxaliplatin|quantity of oxaliplatin
238528|NCT01942200|Packaging Sizes|packaging sizes
238529|NCT01942174|Antipneumococcal vaccination|antipneumococcal vaccination
238530|NCT01942174|Methotrexate treatment|methotrexate treatment
238531|NCT01942161|Schyzophrenia, pediatric patients|schyzophrenia, pediatric patients
238532|NCT01942148|Schizophrenia, Pediatric patients|schizophrenia, pediatric patients
238533|NCT01942135|Palbociclib (PD-0332991)|palbociclib (pd-0332991)
238534|NCT01942135|Fulvestrant|fulvestrant
238535|NCT01942135|Goserelin|goserelin
238536|NCT01942135|Hormone receptor-+|hormone receptor-+
238537|NCT01942135|HER2-negative|her2-negative
238538|NCT01942135|Prior Endocrine treatment|prior endocrine treatment
238539|NCT01942135|any menopausal status|any menopausal status
238540|NCT01942135|PALOMA-3|paloma-3
238541|NCT01942122|DLBS1442|dlbs1442
238542|NCT01942122|Endometriosis|endometriosis
238543|NCT01942122|Pain|pain
238544|NCT01942122|Visual Analogue Scale|visual analogue scale
238545|NCT01942122|Endometriosis Health Profile (EHP-30TM)|endometriosis health profile (ehp-30tm)
238546|NCT01942109|heart failure|heart failure
238547|NCT01942109|diuretics|diuretics
238548|NCT01942109|furosemide|furosemide
238549|NCT01942109|torasemide|torasemide
238550|NCT01942070|Cardiovascular Disease|cardiovascular disease
238551|NCT01942070|Myocardial Infarction|myocardial infarction
238552|NCT01942070|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
238553|NCT01942070|Durable polymer everolimus-eluting stent|durable polymer everolimus-eluting stent
238554|NCT01942070|Primary angioplasty|primary angioplasty
238555|NCT01942070|Stent|stent
238556|NCT01942044|Shear stress|shear stress
238557|NCT01942044|Optical coherence tomography|optical coherence tomography
239253|NCT01938911|Oxytocin|oxytocin
238558|NCT01942044|Drug-eluting stents|drug-eluting stents
238559|NCT01942031|Ischemic stroke|ischemic stroke
238560|NCT01942031|Hemorrhagic stroke|hemorrhagic stroke
238561|NCT01942031|TIA|tia
238562|NCT01942031|Atrial fibrillation|atrial fibrillation
238563|NCT01942031|prevention|prevention
238564|NCT01942031|primary care|primary care
238565|NCT01942018|esophagogastric junction outflow obstruction|esophagogastric junction outflow obstruction
238566|NCT01942018|EGOO|egoo
238567|NCT01942018|Per oral endoscopic myotomy|per oral endoscopic myotomy
238568|NCT01942018|POEM|poem
238569|NCT01942018|Gastroesophageal reflux disease|gastroesophageal reflux disease
238570|NCT01942018|GERD|gerd
238571|NCT01941992|head and neck|head and neck
238572|NCT01941992|Squamous Cell Carcinoma|squamous cell carcinoma
238573|NCT01941992|oral mucositis|oral mucositis
238574|NCT01941992|Chemo-radiotherapy|chemo-radiotherapy
238575|NCT01941966|Anal canal cancer;capecitabine; mitomycin; radiotherapy.|anal canal cancer;capecitabine; mitomycin; radiotherapy.
238576|NCT01941953|Metformin|metformin
238577|NCT01941953|Metastatic Colorectal Cancer|metastatic colorectal cancer
238578|NCT01941953|Fluorouracil|fluorouracil
238579|NCT01941927|Melanoma|melanoma
238580|NCT01941927|Wild-type|wild-type
238581|NCT01941927|BRAF|braf
238582|NCT01941914|Calcium electroporation|calcium electroporation
238583|NCT01941914|calcium|calcium
238584|NCT01941914|electroporation|electroporation
238585|NCT01941914|electrotransfer|electrotransfer
238586|NCT01941914|keloid|keloid
238587|NCT01941901|Cutaneous metastases|cutaneous metastases
238588|NCT01941875|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
238589|NCT01941875|gonadotropins|gonadotropins
238590|NCT01941875|intrauterine insemination|intrauterine insemination
238591|NCT01941875|infertility|infertility
238592|NCT01941875|luteal progesterone|luteal progesterone
238593|NCT01941862|computerized intervention|computerized intervention
238594|NCT01941862|cognitive bias modification|cognitive bias modification
238595|NCT01941862|anxiety|anxiety
238596|NCT01941862|mood|mood
238597|NCT01941862|perceived burdensomeness|perceived burdensomeness
238598|NCT01941862|thwarted belongingness|thwarted belongingness
238599|NCT01941862|suicide|suicide
238600|NCT01941862|post-traumatic stress disorder|post-traumatic stress disorder
238601|NCT01941849|Phaeochromocytoma|phaeochromocytoma
238602|NCT01941849|Paraganglioma|paraganglioma
238603|NCT01941849|Neuroendocrine Tumour|neuroendocrine tumour
238604|NCT01941849|Vandetanib|vandetanib
238605|NCT01941849|131I-mIBG|131i-mibg
238606|NCT01941849|Radionucleotide Therapy|radionucleotide therapy
238607|NCT01941849|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
238608|NCT01941849|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
238610|NCT01941849|Tyrosine Kinase|tyrosine kinase
238611|NCT01941836|Statin intolerant|statin intolerant
238612|NCT01941836|Statin tolerant|statin tolerant
238613|NCT01941836|LDL|ldl
238614|NCT01941836|Cholesterol|cholesterol
238615|NCT01941823|acute renal failure|acute renal failure
238616|NCT01941823|CRRT|crrt
238617|NCT01941823|continuous dialysis|continuous dialysis
238618|NCT01941823|carnitine|carnitine
238619|NCT01941823|cardiac strain|cardiac strain
293681|NCT01692886|13vPnC|13vpnc
238620|NCT01941771|Breast cancer|breast cancer
238621|NCT01941771|Metronomic chemotherapy|metronomic chemotherapy
238622|NCT01941771|Vinorelbine|vinorelbine
238623|NCT01941771|Navelbine|navelbine
238624|NCT01941771|Capecitabine|capecitabine
238625|NCT01941771|Xeloda|xeloda
238626|NCT01941771|Antineoplastic Agents|antineoplastic agents
238627|NCT01941719|Diabetes Mellitus|diabetes mellitus
238628|NCT01941719|Diabetic Foot|diabetic foot
238629|NCT01941719|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
238630|NCT01941719|Diabetic Foot Education|diabetic foot education
238631|NCT01941706|Epilepsy|epilepsy
238632|NCT01941706|Seizure|seizure
238633|NCT01941706|Cognitive Behavioral Therapy|cognitive behavioral therapy
238634|NCT01941706|Mindfulness|mindfulness
238635|NCT01941706|Depression|depression
238636|NCT01941706|Depressive symptoms|depressive symptoms
238637|NCT01941706|prevention|prevention
238638|NCT01941706|Coping skills|coping skills
238639|NCT01941706|Quality of life|quality of life
238640|NCT01941706|Telehealth|telehealth
238641|NCT01941706|Phone intervention|phone intervention
238642|NCT01941706|Internet-based intervention|internet-based intervention
238643|NCT01941693|alcohol|alcohol
238644|NCT01941693|anxiety|anxiety
238645|NCT01941693|depression|depression
238646|NCT01941693|comorbidity|comorbidity
238647|NCT01941693|CBT|cbt
238648|NCT01941667|Congenital Heart Disease|congenital heart disease
238649|NCT01941667|Neonates and infants|neonates and infants
238650|NCT01941667|Telehealth|telehealth
238651|NCT01941667|Virtual Home Visits|virtual home visits
238652|NCT01941628|Cesarean section|cesarean section
238653|NCT01941628|General anesthesia|general anesthesia
238654|NCT01941628|neuromuscular blockade|neuromuscular blockade
238655|NCT01941628|Surgical conditions|surgical conditions
238656|NCT01941602|surgery|surgery
238657|NCT01941602|enoxaparin|enoxaparin
238658|NCT01941602|venous thromboembolism|venous thromboembolism
238659|NCT01941602|perioperative care|perioperative care
238660|NCT01941576|Heart defects, Congenital|heart defects, congenital
238661|NCT01941576|rhBNP|rhbnp
238662|NCT01941576|heart failure|heart failure
238663|NCT01941550|untreated, high risk prostate cancer|untreated, high risk prostate cancer
238664|NCT01941537|Atopic Dermatitis|atopic dermatitis
238665|NCT01941524|Brain oxygenation|brain oxygenation
238666|NCT01941524|NIRS|nirs
238667|NCT01941524|aEEG|aeeg
238668|NCT01941524|surfactant|surfactant
238669|NCT01941511|QTc|qtc
238670|NCT01941511|African-American|african-american
238671|NCT01941511|GMI-1070|gmi-1070
238672|NCT01941511|QT/QTc interval prolongation|qt/qtc interval prolongation
238673|NCT01941498|nearsighted|nearsighted
238674|NCT01941498|farsighted|farsighted
238675|NCT01941498|astigmatism|astigmatism
238676|NCT01941498|LASIK|lasik
238677|NCT01941498|refractive surgery|refractive surgery
238678|NCT01941498|WaveLight|wavelight
238679|NCT01941485|nearsighted|nearsighted
238680|NCT01941485|astigmatism|astigmatism
238681|NCT01941485|LASIK|lasik
238682|NCT01941485|refractive surgery|refractive surgery
238683|NCT01941485|WaveLight|wavelight
238684|NCT01941459|CK-MB|ck-mb
238685|NCT01941459|troponin-T|troponin-t
238686|NCT01941433|rheumatoid arthritis|rheumatoid arthritis
238687|NCT01941433|self-management|self-management
238688|NCT01941433|online|online
238689|NCT01941433|patient passport|patient passport
238690|NCT01941420|CK-MB|ck-mb
238691|NCT01941420|troponin-T|troponin-t
238692|NCT01941420|Cytokines under ischemia|cytokines under ischemia
238693|NCT01941394|GVHD|gvhd
238694|NCT01941394|Relapse|relapse
238695|NCT01941394|Overall Survival|overall survival
238696|NCT01941381|Otitis Media|otitis media
238697|NCT01941381|Tympanometry|tympanometry
238698|NCT01941368|Performance|performance
238699|NCT01941368|Aerobic Exercise|aerobic exercise
238700|NCT01941342|Obstructive Jaundice|obstructive jaundice
238701|NCT01941342|Preoperative Biliary Drainage|preoperative biliary drainage
238702|NCT01941342|Pancreatoduodenectomy|pancreatoduodenectomy
238703|NCT01941329|Diabetes|diabetes
238704|NCT01941329|Proliferative Retinopathy|proliferative retinopathy
238705|NCT01941329|Ranibizumab|ranibizumab
238706|NCT01941329|Panretinal Photocoagulation|panretinal photocoagulation
238707|NCT01941316|Carfilzomib|carfilzomib
238708|NCT01941316|Irinotecan|irinotecan
238709|NCT01941316|Small Cell Lung Cancer|small cell lung cancer
238710|NCT01941316|Non Small Cell Lung Cancer|non small cell lung cancer
238711|NCT01941316|Ovarian Cancer|ovarian cancer
238712|NCT01941316|Gastric Cancer|gastric cancer
238713|NCT01941316|Esophageal Cancer|esophageal cancer
238714|NCT01941316|Cervical Cancer|cervical cancer
238715|NCT01941303|Non-small cell lung cancer|non-small cell lung cancer
238716|NCT01941290|International|international
238717|NCT01941290|Multicenter|multicenter
238718|NCT01941290|Observational registry|observational registry
238719|NCT01941290|Orsiro Drug Eluting Stents (DES)|orsiro drug eluting stents (des)
238720|NCT01941290|Stenting|stenting
238721|NCT01941290|Treatment of Coronary Artery Disease|treatment of coronary artery disease
238722|NCT01941290|Coronary Revascularization|coronary revascularization
238723|NCT01941290|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
238724|NCT01941290|Diabetes Mellitus Type 1|diabetes mellitus type 1
238725|NCT01941290|Diabetes Mellitus Type 2|diabetes mellitus type 2
238726|NCT01941290|STEMI|stemi
238727|NCT01941290|NSTEMI|nstemi
238728|NCT01941290|Ischemia|ischemia
238729|NCT01941290|Angina|angina
238730|NCT01941290|Subgroups|subgroups
238731|NCT01941290|Acute Myocardial Infarction|acute myocardial infarction
238732|NCT01941290|Small Vessels|small vessels
238733|NCT01941290|Chronic Total Occlusion|chronic total occlusion
238734|NCT01941264|malaria|malaria
238735|NCT01941264|placenta|placenta
238736|NCT01941264|pregnancy|pregnancy
238737|NCT01941264|plasmodium falciparum|plasmodium falciparum
238738|NCT01941264|screening and treatment|screening and treatment
238739|NCT01941264|rapid diagnostic test|rapid diagnostic test
238740|NCT01941264|coartem|coartem
238741|NCT01941264|artemether-lumefantrine|artemether-lumefantrine
238742|NCT01941264|community health worker|community health worker
238743|NCT01941251|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
238744|NCT01941251|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
238745|NCT01941251|Schizophrenia|schizophrenia
238746|NCT01941251|Schizoaffective Disorder|schizoaffective disorder
238747|NCT01941251|Treatment|treatment
238748|NCT01941251|Negative Symptoms|negative symptoms
238749|NCT01941251|Positive Symptoms|positive symptoms
238750|NCT01941251|TMS|tms
238751|NCT01941251|rTMS|rtms
238752|NCT01941238|Ramadan|ramadan
238753|NCT01941238|Fasting|fasting
238754|NCT01941238|Diabetes|diabetes
238755|NCT01941238|Type1|type1
238756|NCT01941238|Insulin|insulin
238757|NCT01941238|Pump|pump
238758|NCT01941225|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
238759|NCT01941225|Pulmonary vasculature|pulmonary vasculature
238760|NCT01941225|Inhaled iloprost|inhaled iloprost
238761|NCT01941225|Inhaled prostacyclin|inhaled prostacyclin
586238|NCT00523965|Kala-azar|kala-azar
238762|NCT01941225|Dynamic hyperinflation|dynamic hyperinflation
238763|NCT01941225|Oxidative stress|oxidative stress
238764|NCT01941225|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
238765|NCT01941225|B-type natriuretic peptide|b-type natriuretic peptide
238766|NCT01941212|Music therapy|music therapy
238767|NCT01941212|pain|pain
238768|NCT01941212|gynecological surgeries|gynecological surgeries
238769|NCT01941186|Children|children
238770|NCT01941186|Developmental Delays|developmental delays
238771|NCT01941186|Early Intervention (EI)|early intervention (ei)
238772|NCT01941186|Patient Decision Aid (PDA)|patient decision aid (pda)
238773|NCT01941147|Acute Stroke|acute stroke
238774|NCT01941147|Brain Ischemia|brain ischemia
238775|NCT01941147|Extremely Low Frequency Magnetic Fields|extremely low frequency magnetic fields
238776|NCT01941121|HIV Screening|hiv screening
238777|NCT01941121|Linkage to PrEP|linkage to prep
238778|NCT01941121|Linkage to Care|linkage to care
238779|NCT01941121|CCTG|cctg
238781|NCT01941108|AIDS|aids
238782|NCT01941108|peer navigation|peer navigation
238783|NCT01941108|ecological momentary assessment|ecological momentary assessment
238784|NCT01941108|eMOCHA|emocha
238785|NCT01941108|Baltimore|baltimore
238786|NCT01941108|IDU|idu
238787|NCT01941030|Peripheral Artery Disease|peripheral artery disease
238788|NCT01941030|Critical Limb Ischemia|critical limb ischemia
238789|NCT01941030|Orbital Atherectomy|orbital atherectomy
238790|NCT01941030|Balloon Angioplasty|balloon angioplasty
238791|NCT01941030|Intravascular Ultrasound (IVUS)|intravascular ultrasound (ivus)
238792|NCT01941030|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
238793|NCT01941004|multiple sclerosis (MS)|multiple sclerosis (ms)
238794|NCT01941004|relapsing remitting multiple sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
238795|NCT01941004|fingolimod|fingolimod
238796|NCT01940978|Methamphetamine|methamphetamine
238797|NCT01940978|Methylphenidate|methylphenidate
238798|NCT01940978|ADHD|adhd
238799|NCT01940939|schizophrenia|schizophrenia
238800|NCT01940926|rheumatoid arthritis|rheumatoid arthritis
238801|NCT01940926|angiogenesis|angiogenesis
238802|NCT01940926|68Ga-PRGD2|68ga-prgd2
238803|NCT01940926|18F-FDG|18f-fdg
238804|NCT01940926|positron emission tomography/computed tomography|positron emission tomography/computed tomography
238805|NCT01940900|Wet AMD|wet amd
238806|NCT01940900|choroidal neovascularization|choroidal neovascularization
238807|NCT01940900|Fovista®|fovista®
238808|NCT01940900|E10030|e10030
238809|NCT01940900|Lucentis®|lucentis®
238810|NCT01940887|Wet AMD|wet amd
238811|NCT01940887|choroidal neovascularization|choroidal neovascularization
238812|NCT01940887|Fovista®|fovista®
238813|NCT01940887|E10030|e10030
238814|NCT01940887|Avastin®|avastin®
238815|NCT01940887|Eylea®|eylea®
238816|NCT01940874|Cerebral Oximetry.|cerebral oximetry.
238817|NCT01940874|Aortic valve stenosis.|aortic valve stenosis.
238818|NCT01940874|Aortic valve regurgitation.|aortic valve regurgitation.
238819|NCT01940874|Coronary artery disease.|coronary artery disease.
238820|NCT01940848|Iberogast|iberogast
238821|NCT01940848|efficacy|efficacy
238822|NCT01940848|safety|safety
238823|NCT01940796|Brentuximab Vedotin|brentuximab vedotin
238824|NCT01940796|GVHD|gvhd
238825|NCT01940796|Refractory Chronic Graft vs Host Disease|refractory chronic graft vs host disease
238826|NCT01940770|Diabetes Mellitus(DM)|diabetes mellitus(dm)
238827|NCT01940770|Bydureon|bydureon
238828|NCT01940770|Exenatide|exenatide
238829|NCT01940757|Necator americanus|necator americanus
238830|NCT01940757|Hookworm Infection|hookworm infection
238831|NCT01940757|Experimental challenge infection|experimental challenge infection
238832|NCT01940744|Low back pain|low back pain
238833|NCT01940744|Non-specific Low back pain|non-specific low back pain
238834|NCT01940718|Priapism|priapism
238835|NCT01940718|Sickle cell disease|sickle cell disease
238836|NCT01940718|Testosterone|testosterone
238837|NCT01940718|Androgen deficiency|androgen deficiency
238838|NCT01940705|hearing aids|hearing aids
238839|NCT01940705|counseling|counseling
238840|NCT01940705|outcomes assessment (health care)|outcomes assessment (health care)
238841|NCT01940705|rehabilitation|rehabilitation
238842|NCT01940666|Hyperandrogenism/|hyperandrogenism/
238843|NCT01940666|FAI/|fai/
238844|NCT01940666|Metabolic syndrome/|metabolic syndrome/
238845|NCT01940666|Adipocytokines/|adipocytokines/
238846|NCT01940666|Insulin resistance.|insulin resistance.
238847|NCT01940640|neonates, DHA|neonates, dha
238848|NCT01940627|Ubiquinol, exercise|ubiquinol, exercise
238849|NCT01940614|Copeptin|copeptin
238850|NCT01940614|differential diagnosis of polyuria polydipsia syndrome|differential diagnosis of polyuria polydipsia syndrome
238851|NCT01940614|diabetes insipidus|diabetes insipidus
238852|NCT01940614|compulsive water drinking|compulsive water drinking
238853|NCT01940614|water deprivation test|water deprivation test
238854|NCT01940601|solid tumors|solid tumors
238855|NCT01940601|balugrastim|balugrastim
238856|NCT01940575|Tissue restorative biomaterial|tissue restorative biomaterial
238857|NCT01940575|Hyaluronic acid|hyaluronic acid
238858|NCT01940575|Restylane®|restylane®
238859|NCT01940575|Wrinkle Severity Rating Scale (WSRS)|wrinkle severity rating scale (wsrs)
238860|NCT01940575|Global Aesthetic Improvement Scale (GAIS)|global aesthetic improvement scale (gais)
238861|NCT01940575|Nasolabial fold(NLF)|nasolabial fold(nlf)
238862|NCT01940562|cord blood transplantation|cord blood transplantation
238863|NCT01940562|platelets|platelets
238864|NCT01940562|eltrombopag|eltrombopag
238865|NCT01940549|PTSD|ptsd
238866|NCT01940549|tDCS|tdcs
238867|NCT01940549|Trauma|trauma
238868|NCT01940536|Hip Fracture|hip fracture
238869|NCT01940536|Blood Transfusion|blood transfusion
238870|NCT01940536|Blood Loss|blood loss
238871|NCT01940536|Tranexamic Acid|tranexamic acid
238872|NCT01940523|total knee arthroplasty|total knee arthroplasty
238873|NCT01940523|total knee replacement|total knee replacement
238874|NCT01940523|tranexamic acid|tranexamic acid
238875|NCT01940523|osteoarthritis|osteoarthritis
238876|NCT01940523|degenerative joint disease|degenerative joint disease
238877|NCT01940471|Hepatitis|hepatitis
238878|NCT01940471|Tenofovir|tenofovir
238879|NCT01940471|Viread|viread
238880|NCT01940432|simple stress urinary incontinence|simple stress urinary incontinence
238881|NCT01940419|Reduction of blood loss|reduction of blood loss
238882|NCT01940419|Surgical complication|surgical complication
238883|NCT01940419|Hysterectomy|hysterectomy
238884|NCT01940419|Antifibrinolytic Agents|antifibrinolytic agents
238885|NCT01940419|Randomized Controlled Trials|randomized controlled trials
238886|NCT01940406|Essential Tremor|essential tremor
238887|NCT01940406|Parkinson Disease|parkinson disease
238888|NCT01940406|Electrical Stimulation|electrical stimulation
238889|NCT01940406|Tremor|tremor
238890|NCT01940393|urticaria|urticaria
238891|NCT01940393|bilastine|bilastine
238892|NCT01940393|fexofenadine|fexofenadine
238893|NCT01940393|cetirizine|cetirizine
238894|NCT01940393|ebastine|ebastine
238895|NCT01940393|desloratadine|desloratadine
238896|NCT01940367|Overactive Bladder|overactive bladder
238897|NCT01940367|TENS|tens
238898|NCT01940367|PTNS|ptns
238899|NCT01940367|Electrical Nerve Stimulation|electrical nerve stimulation
238900|NCT01940367|Urge Urinary Incontinence|urge urinary incontinence
238901|NCT01940354|IV Catheter comparison|iv catheter comparison
238902|NCT01940354|AccuCath versus Conventional IV Catheters|accucath versus conventional iv catheters
238903|NCT01940354|IV Catheter Study|iv catheter study
238904|NCT01940354|IV Catheter User Preference Comparison|iv catheter user preference comparison
238905|NCT01940354|First Attempt Success Rate for IV Catheters|first attempt success rate for iv catheters
238906|NCT01940354|AccuCath Device Performance|accucath device performance
238907|NCT01940354|Patient Satisfaction with IV Catheters|patient satisfaction with iv catheters
238908|NCT01940354|Clinician Satisfaction with AccuCath Device Performance|clinician satisfaction with accucath device performance
238909|NCT01940341|Hepatitis|hepatitis
238910|NCT01940341|Tenofovir|tenofovir
238912|NCT01940328|Ultrasound Doppler|ultrasound doppler
238913|NCT01940328|Congestive heart failure|congestive heart failure
238914|NCT01940328|Pulmonary Edema|pulmonary edema
238915|NCT01940315|Defender Study|defender study
238916|NCT01940315|experimental vaccine|experimental vaccine
238917|NCT01940315|inhalational intoxication|inhalational intoxication
238918|NCT01940302|Malnutrition; Metabolic disorders|malnutrition; metabolic disorders
238919|NCT01940289|algometry|algometry
238920|NCT01940289|pain|pain
238922|NCT01940276|Prostate cancer|prostate cancer
238923|NCT01940276|metastatic|metastatic
238924|NCT01940276|castrate resistant|castrate resistant
238925|NCT01940276|abiraterone acetate|abiraterone acetate
238926|NCT01940276|prednisone|prednisone
238927|NCT01940276|metastatic prostate cancer|metastatic prostate cancer
238928|NCT01940263|oxidative stress|oxidative stress
238929|NCT01940263|dyslipidemia|dyslipidemia
238930|NCT01940263|inflammation|inflammation
238931|NCT01940263|apoptosis|apoptosis
238932|NCT01940250|Hand, foot and mouth disease|hand, foot and mouth disease
238933|NCT01940250|Autonomic nervous system dysregulation|autonomic nervous system dysregulation
238934|NCT01940250|Magnesium sulphate|magnesium sulphate
238935|NCT01940237|Depression|depression
238936|NCT01940237|Psychotherapy|psychotherapy
238937|NCT01940237|Cancer|cancer
238938|NCT01940237|Pancreatic Cancer|pancreatic cancer
238939|NCT01940237|Lung Cancer|lung cancer
238940|NCT01940237|Colon Cancer|colon cancer
238941|NCT01940237|Prostate Cancer|prostate cancer
238942|NCT01940224|Pregabalin|pregabalin
238943|NCT01940224|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
238944|NCT01940224|Postoperative pain|postoperative pain
238945|NCT01940224|Opioid consumption|opioid consumption
238946|NCT01940198|Atazanavir|atazanavir
238947|NCT01940198|long-term|long-term
238948|NCT01940198|primary care setting|primary care setting
238949|NCT01940198|sydney|sydney
238950|NCT01940159|Schizophrenia|schizophrenia
238951|NCT01940159|Schizoaffective disorders|schizoaffective disorders
238952|NCT01940120|Mitral Valve Insufficiency|mitral valve insufficiency
238953|NCT01940120|Mitral Valve Regurgitation|mitral valve regurgitation
586239|NCT00523965|miltefosine|miltefosine
238954|NCT01940120|Mitral Valve Incompetence|mitral valve incompetence
238955|NCT01940120|Mitral Regurgitation|mitral regurgitation
238956|NCT01940120|Mitral Insufficiency|mitral insufficiency
238957|NCT01940120|Mitral Valve|mitral valve
238959|NCT01940120|Mitral Valve Prolapse|mitral valve prolapse
238960|NCT01940120|Edge to Edge (E2E)|edge to edge (e2e)
238961|NCT01940120|Alfieri Technique|alfieri technique
238962|NCT01940120|MitraClip|mitraclip
238963|NCT01940120|Functional MR|functional mr
238964|NCT01940120|Degenerative MR|degenerative mr
238965|NCT01940120|Echocardiogram|echocardiogram
238966|NCT01940120|Coronary Artery Disease (CAD)|coronary artery disease (cad)
238967|NCT01940120|Heart Failure|heart failure
238968|NCT01940120|Heart Attack|heart attack
238969|NCT01940120|EVEREST|everest
238970|NCT01940120|EVEREST I|everest i
238971|NCT01940120|EVEREST II|everest ii
238972|NCT01940120|REALISM|realism
238973|NCT01940107|breast cancer,|breast cancer,
238974|NCT01940107|radiotherapy,|radiotherapy,
238975|NCT01940107|physical therapy,|physical therapy,
238976|NCT01940107|upper limb|upper limb
238977|NCT01940094|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
238978|NCT01940094|Wegener's granulomatosis|wegener's granulomatosis
238979|NCT01940094|WG|wg
238980|NCT01940094|GPA|gpa
238981|NCT01940094|ANCA-Associated Vasculitis|anca-associated vasculitis
238982|NCT01940094|AAV|aav
238983|NCT01940094|Vasculitis|vasculitis
238984|NCT01940094|Prednisone|prednisone
238985|NCT01940094|Glucocorticoid|glucocorticoid
238986|NCT01940094|Taper|taper
238987|NCT01940081|Cardiomyopathy, Dilated|cardiomyopathy, dilated
238988|NCT01940081|Tachycardia, Ventricular|tachycardia, ventricular
238989|NCT01940081|Ventricular Fibrillation|ventricular fibrillation
238990|NCT01940081|Arrhythmias, Cardiac/etiology|arrhythmias, cardiac/etiology
238991|NCT01940081|Arrhythmias, Cardiac/physiopathology|arrhythmias, cardiac/physiopathology
238992|NCT01940081|Magnetic Resonance Imaging|magnetic resonance imaging
238993|NCT01940081|3-Iodobenzylguanidine/diagnostic use|3-iodobenzylguanidine/diagnostic use
238994|NCT01940081|Sympathetic Nervous System/radionuclide imaging|sympathetic nervous system/radionuclide imaging
238995|NCT01940081|Electrophysiologic Techniques, Cardiac|electrophysiologic techniques, cardiac
238996|NCT01940081|Biopsy|biopsy
238997|NCT01940081|Genetic Testing|genetic testing
238998|NCT01940081|Echocardiography|echocardiography
238999|NCT01940081|Electrocardiography, Ambulatory|electrocardiography, ambulatory
239000|NCT01940081|Exercise Test|exercise test
239001|NCT01940068|Hypersensitivity|hypersensitivity
239002|NCT01940068|Milk Hypersensitivity|milk hypersensitivity
239003|NCT01940068|Immune System Diseases|immune system diseases
239004|NCT01940068|Food Hypersensitivity|food hypersensitivity
239006|NCT01940055|Gait|gait
239007|NCT01940055|Instrumented Treadmill|instrumented treadmill
239008|NCT01940055|Recumbent cycle|recumbent cycle
239009|NCT01940055|Cognitive games|cognitive games
239010|NCT01940029|vancomycin, neurosurgery, critical ill, pharmacokinetics|vancomycin, neurosurgery, critical ill, pharmacokinetics
239011|NCT01940016|Feasibility study|feasibility study
239012|NCT01940016|Interactive voice response system (IVR)|interactive voice response system (ivr)
239013|NCT01940016|health coach|health coach
239014|NCT01940016|no evidence of disease|no evidence of disease
239015|NCT01940003|Diabetes, Gestational|diabetes, gestational
239016|NCT01940003|Pregnancy Outcome|pregnancy outcome
239017|NCT01940003|Exercise|exercise
239018|NCT01940003|glycemic control|glycemic control
239019|NCT01939990|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
239020|NCT01939977|Hyperparathyroidism|hyperparathyroidism
239021|NCT01939977|Hyperparathyroidism Secondary|hyperparathyroidism secondary
239022|NCT01939977|Paricalcitol|paricalcitol
239023|NCT01939977|Calcifediol|calcifediol
239024|NCT01939977|Parathyroid hormone|parathyroid hormone
239025|NCT01939977|Renal transplantation|renal transplantation
239026|NCT01939964|Wrinkles|wrinkles
239027|NCT01939964|Activation Mist|activation mist
239028|NCT01939951|Asthma|asthma
239029|NCT01939951|Persistent|persistent
239030|NCT01939925|patient education|patient education
239031|NCT01939925|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
239032|NCT01939925|comprehension|comprehension
239033|NCT01939925|consumer health information|consumer health information
239034|NCT01939899|MLN9708|mln9708
239035|NCT01939899|Lymphoma|lymphoma
239036|NCT01939899|IXAZOMIB|ixazomib
239037|NCT01939886|Malaria treatment efficacy|malaria treatment efficacy
239038|NCT01939886|Malaria transmission|malaria transmission
239039|NCT01939873|Kristeller maneuver; Second stage of labor;|kristeller maneuver; second stage of labor;
239040|NCT01939873|Perineal laceration; Obstetrical outcome;|perineal laceration; obstetrical outcome;
239041|NCT01939873|Neonatal outcome|neonatal outcome
239042|NCT01939847|Metastatic breast cancer|metastatic breast cancer
239043|NCT01939847|Breast cancer|breast cancer
239044|NCT01939847|Molecular profiling|molecular profiling
239045|NCT01939847|Personalized medicine|personalized medicine
239046|NCT01939834|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
239047|NCT01939834|Artificial Pancreas|artificial pancreas
239048|NCT01939834|Diabetes Assistant (DiAs)|diabetes assistant (dias)
239053|NCT01939821|quality of care|quality of care
239054|NCT01939795|cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
239055|NCT01939782|Metabolic CLock Genes (MCG)|metabolic clock genes (mcg)
239056|NCT01939782|Type 2 Diabetes (T2D)|type 2 diabetes (t2d)
239062|NCT01939756|High risk non-muscle invasive urothelial bladder cancer|high risk non-muscle invasive urothelial bladder cancer
239063|NCT01939756|Intravesical BCG|intravesical bcg
239064|NCT01939756|Local toxicity|local toxicity
239065|NCT01939756|Natural baobab oil|natural baobab oil
239066|NCT01939730|Lymphoma|lymphoma
239067|NCT01939730|Follicular B-Cell Lymphoma|follicular b-cell lymphoma
239068|NCT01939730|Rituximab|rituximab
239069|NCT01939730|Rituxan|rituxan
239070|NCT01939730|GM-CSF|gm-csf
239071|NCT01939730|Sargramostim|sargramostim
239072|NCT01939730|Leukine|leukine
239073|NCT01939717|Parkinson's disease|parkinson's disease
239074|NCT01939717|Irish set dancing|irish set dancing
239075|NCT01939691|difluprednate|difluprednate
239076|NCT01939691|prednisolone acetate|prednisolone acetate
239077|NCT01939691|nepafenac|nepafenac
239078|NCT01939665|Locally advanced pancreatic carcinoma|locally advanced pancreatic carcinoma
239079|NCT01939665|LAPC|lapc
239080|NCT01939665|Irreversible electroporation|irreversible electroporation
239081|NCT01939665|NanoKnife|nanoknife
239082|NCT01939665|IRE|ire
239083|NCT01939665|Safety|safety
239084|NCT01939665|Efficacy|efficacy
239085|NCT01939665|Non-thermal ablation|non-thermal ablation
239086|NCT01939665|Percutaneous ablation|percutaneous ablation
239087|NCT01939665|Low Energy Direct Current|low energy direct current
239088|NCT01939652|minilaparotomy|minilaparotomy
239089|NCT01939652|AAA|aaa
239090|NCT01939652|fluid regime|fluid regime
239091|NCT01939639|Oxytocin|oxytocin
239092|NCT01939639|fMRI|fmri
239093|NCT01939626|embryo|embryo
239094|NCT01939626|culture|culture
239095|NCT01939613|fluid resuscitation|fluid resuscitation
239096|NCT01939613|burn|burn
239097|NCT01939613|colloid,|colloid,
239098|NCT01939613|multiple organ dysfunction|multiple organ dysfunction
239099|NCT01939613|intra-abdominal pressure|intra-abdominal pressure
239100|NCT01939600|Resistant starch|resistant starch
239101|NCT01939600|Ileostomy|ileostomy
239102|NCT01939600|In vivo|in vivo
239103|NCT01939600|Carbohydrate digestibility|carbohydrate digestibility
239104|NCT01939587|Adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
239105|NCT01939587|Asthma|asthma
239106|NCT01939587|adenosine receptor modulator|adenosine receptor modulator
239107|NCT01939587|COPD|copd
239108|NCT01939574|Glioblastoma|glioblastoma
239109|NCT01939574|Potential Image Biomarkers|potential image biomarkers
239111|NCT01939574|Bevacizumab|bevacizumab
239112|NCT01939574|Conventional Therapy|conventional therapy
239113|NCT01939561|Myotonia|myotonia
294326|NCT01690182|MRI|mri
239114|NCT01939561|Lamotrigine|lamotrigine
239115|NCT01939561|RCT|rct
239116|NCT01939561|treatment|treatment
239117|NCT01939548|PF-02545920|pf-02545920
239118|NCT01939548|schizophrenia|schizophrenia
239119|NCT01939548|outpatient|outpatient
239120|NCT01939548|safety|safety
239121|NCT01939548|efficacy|efficacy
239122|NCT01939548|suboptimal response|suboptimal response
239123|NCT01939535|Endometriosis|endometriosis
239124|NCT01939535|Magnetic resonance imaging|magnetic resonance imaging
239125|NCT01939522|diabetes|diabetes
239126|NCT01939522|pneumococcal|pneumococcal
239127|NCT01939496|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
239128|NCT01939496|Hypertension|hypertension
239129|NCT01939496|Canagliflozin|canagliflozin
239130|NCT01939496|JNJ 28431754|jnj 28431754
239131|NCT01939496|Sodium-Glucose Transporter 2|sodium-glucose transporter 2
239132|NCT01939496|Blood Glucose|blood glucose
239133|NCT01939496|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
239134|NCT01939483|Irinotecan hydrochloride|irinotecan hydrochloride
239135|NCT01939483|Irinotecan|irinotecan
239136|NCT01939483|CAMPTOSAR|camptosar
239137|NCT01939470|osteoporosis|osteoporosis
239138|NCT01939470|bone|bone
239139|NCT01939470|inflammation|inflammation
239140|NCT01939470|diabetes|diabetes
239141|NCT01939470|vitamin D|vitamin d
239142|NCT01939444|Antidotes|antidotes
239143|NCT01939444|naloxone|naloxone
239144|NCT01939444|administration, intravenous|administration, intravenous
239145|NCT01939444|administration, intranasal|administration, intranasal
239146|NCT01939444|pharmacology|pharmacology
239147|NCT01939431|Podoconiosis|podoconiosis
239148|NCT01939431|Gene Expression|gene expression
239149|NCT01939431|Genomics|genomics
239150|NCT01939431|Pathogenesis|pathogenesis
239151|NCT01939418|metastatic breast cancer|metastatic breast cancer
239254|NCT01938911|Hypertension|hypertension
239152|NCT01939418|triple negative breast cancer|triple negative breast cancer
239153|NCT01939418|gemcitabine|gemcitabine
239154|NCT01939418|RAD001|rad001
239155|NCT01939405|Obesity|obesity
239156|NCT01939405|Overweight|overweight
239157|NCT01939405|Physical Activity|physical activity
239158|NCT01939405|Built Environment|built environment
239159|NCT01939405|counseling|counseling
239160|NCT01939392|Resistant hypertension|resistant hypertension
239161|NCT01939392|Uncontrolled hypertension|uncontrolled hypertension
239162|NCT01939392|Renal artery ablation|renal artery ablation
239163|NCT01939379|Total knee arthroplasty|total knee arthroplasty
239164|NCT01939379|nerve block|nerve block
239165|NCT01939379|Pain control after surgery|pain control after surgery
239377|NCT01938391|PAD|pad
239166|NCT01939366|Painful Diabetic Peripheral Neuropathy|painful diabetic peripheral neuropathy
239167|NCT01939353|Adult ADHD|adult adhd
239168|NCT01939327|diffuse large B cell|diffuse large b cell
239169|NCT01939327|non-Hodgkin lymphoma|non-hodgkin lymphoma
239170|NCT01939314|Headache|headache
239171|NCT01939314|Migraine|migraine
239172|NCT01939301|Pulmonary embolism clot|pulmonary embolism clot
239173|NCT01939262|Arthritis|arthritis
239174|NCT01939262|Pain|pain
239175|NCT01939262|Function|function
239176|NCT01939262|Diet|diet
239177|NCT01939262|Vegan|vegan
239178|NCT01939262|Vegetarian|vegetarian
239179|NCT01939262|Restriction|restriction
239180|NCT01939236|chronic heart failure|chronic heart failure
239181|NCT01939236|traditional Chinese medicine|traditional chinese medicine
239182|NCT01939236|syndrome differentiation|syndrome differentiation
239183|NCT01939223|Stage IV colorectal cancer / Liver Metastasis|stage iv colorectal cancer / liver metastasis
239184|NCT01939197|Cirrhotic|cirrhotic
239185|NCT01939197|HCV Genotype 4|hcv genotype 4
239186|NCT01939197|Hepatitis C Genotype 1|hepatitis c genotype 1
239187|NCT01939197|HCV Genotype 1|hcv genotype 1
239188|NCT01939197|Compensated Cirrhosis|compensated cirrhosis
239189|NCT01939197|Hepatitis C Genotype 4|hepatitis c genotype 4
239190|NCT01939197|Interferon-Free|interferon-free
239191|NCT01939197|HIV-1|hiv-1
239192|NCT01939197|HCV / HIV coinfection|hcv / hiv coinfection
239193|NCT01939197|Hepatitis C|hepatitis c
239194|NCT01939171|Thymoglobulin|thymoglobulin
239195|NCT01939171|Cadaver donor|cadaver donor
239196|NCT01939171|Kidney injury brain death related|kidney injury brain death related
239197|NCT01939158|Co-administration|co-administration
239198|NCT01939158|Safety|safety
239199|NCT01939158|Persistence|persistence
239200|NCT01939158|Immunogenicity|immunogenicity
239201|NCT01939158|Prevenar 13|prevenar 13
239202|NCT01939158|Meningococcal vaccine|meningococcal vaccine
239203|NCT01939158|Toddlers|toddlers
239204|NCT01939158|5 years|5 years
239205|NCT01939145|hospital admission|hospital admission
239206|NCT01939132|Psoriatic Arthritis|psoriatic arthritis
239207|NCT01939132|ACTH|acth
239208|NCT01939132|Acthar|acthar
239209|NCT01939119|retinal vascular occlusion|retinal vascular occlusion
238958|NCT01940120|MR|mr
239215|NCT01939106|pouch|pouch
239216|NCT01939106|Drainable Pouch for collection of stool|drainable pouch for collection of stool
239217|NCT01939093|Quetiapine|quetiapine
239218|NCT01939093|Haloperidol|haloperidol
239219|NCT01939093|Methamphetamine|methamphetamine
239220|NCT01939093|Psychosis|psychosis
239221|NCT01939080|moderate risk|moderate risk
239222|NCT01939080|high risk|high risk
239223|NCT01939067|respiratory distress|respiratory distress
239224|NCT01939067|Heated Humidified High Flow Nasal Cannula (HHHFNC)|heated humidified high flow nasal cannula (hhhfnc)
239225|NCT01939067|HHHFNC|hhhfnc
239226|NCT01939067|noninvasive nasal continuous positive airway pressure (NCPAP)|noninvasive nasal continuous positive airway pressure (ncpap)
239227|NCT01939067|NCPAP|ncpap
239228|NCT01939041|Subacute Stroke|subacute stroke
239229|NCT01939041|Unilateral Robot-Assisted Training|unilateral robot-assisted training
239230|NCT01939041|Bilateral Robot-Assisted Training|bilateral robot-assisted training
239231|NCT01939041|Motor control|motor control
239232|NCT01939041|Physiological Response|physiological response
239233|NCT01939015|3D miniplate|3d miniplate
239234|NCT01939015|angle mandibular fracture|angle mandibular fracture
239235|NCT01939015|champy technique|champy technique
239236|NCT01939015|internal rigid fixation|internal rigid fixation
239237|NCT01939002|flu-like symptoms|flu-like symptoms
239238|NCT01938989|cataract|cataract
239239|NCT01938989|intraocular lens|intraocular lens
239240|NCT01938989|IOL|iol
239241|NCT01938989|blue light filter|blue light filter
239242|NCT01938976|Asthma|asthma
239243|NCT01938976|Tobacco|tobacco
239244|NCT01938976|Waterpipe|waterpipe
239245|NCT01938976|Cigarettes|cigarettes
239246|NCT01938976|Adolescents|adolescents
239247|NCT01938976|Peer education|peer education
239248|NCT01938976|Jordan|jordan
239249|NCT01938963|Depression|depression
239250|NCT01938963|Hypertension|hypertension
239251|NCT01938963|Older Adults|older adults
239252|NCT01938911|Trier social stress test|trier social stress test
239255|NCT01938898|Randomized trial|randomized trial
239256|NCT01938898|Invitation letter|invitation letter
239257|NCT01938898|Recruitment|recruitment
239258|NCT01938898|Retention|retention
239259|NCT01938872|critical limb ischemia|critical limb ischemia
239260|NCT01938872|drug-eluting balloon|drug-eluting balloon
239261|NCT01938872|restenosis|restenosis
239262|NCT01938859|bipolar disorder|bipolar disorder
239263|NCT01938859|lithium|lithium
239264|NCT01938859|quetiapine|quetiapine
239265|NCT01938859|Medicine, Chinese Traditional|medicine, chinese traditional
239266|NCT01938859|efficacy|efficacy
239267|NCT01938859|safety|safety
239268|NCT01938859|Recurrence|recurrence
239269|NCT01938820|Hepatitis B|hepatitis b
239270|NCT01938820|Liver Cirrhosis|liver cirrhosis
239271|NCT01938820|Regression|regression
239272|NCT01938820|Efficacy|efficacy
239273|NCT01938807|type 1 diabetes|type 1 diabetes
239275|NCT01938807|mobile application|mobile application
239276|NCT01938807|diabetes management|diabetes management
239277|NCT01938781|Hepatitis B|hepatitis b
239278|NCT01938781|Liver fibrosis|liver fibrosis
239279|NCT01938781|Regression|regression
239280|NCT01938781|Efficacy|efficacy
239281|NCT01938768|Multiple trauma|multiple trauma
239282|NCT01938768|Polytrauma|polytrauma
239283|NCT01938768|Hyperfibrinolysis|hyperfibrinolysis
239284|NCT01938768|Tranexamic acid|tranexamic acid
239285|NCT01938768|Thrombelastometry|thrombelastometry
239286|NCT01938742|A/H7N9,Adjuvant,Immunogenicity,Influenza,MF59,Monovalent,Vaccine|a/h7n9,adjuvant,immunogenicity,influenza,mf59,monovalent,vaccine
239287|NCT01938729|HEPATIC ARTERIAL INFUSION|hepatic arterial infusion
239288|NCT01938729|FLOXURIDINE|floxuridine
239289|NCT01938729|DEXAMETHASONE|dexamethasone
239290|NCT01938729|GEMCITABINE|gemcitabine
239291|NCT01938729|Pump|pump
239292|NCT01938729|13-148|13-148
239293|NCT01938716|Pancreatic Cancer|pancreatic cancer
239294|NCT01938716|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
239295|NCT01938716|Intratumoral gemcitabine levels|intratumoral gemcitabine levels
239296|NCT01938716|Pancreatic surgery|pancreatic surgery
239297|NCT01938716|Pharmacokinetic testing|pharmacokinetic testing
239298|NCT01938716|PK|pk
239299|NCT01938716|Gemcitabine|gemcitabine
239300|NCT01938716|Gemcitabine Hydrochloride|gemcitabine hydrochloride
239301|NCT01938716|Gemzar|gemzar
239302|NCT01938690|stroke, transcranial magnetic stimulation, rehabilitation|stroke, transcranial magnetic stimulation, rehabilitation
239303|NCT01938677|Vestibular schwannoma|vestibular schwannoma
239304|NCT01938677|Gamma knife radiosurgery|gamma knife radiosurgery
239305|NCT01938677|Hearing preservation|hearing preservation
239306|NCT01938664|cocaine|cocaine
239307|NCT01938664|dependence|dependence
239308|NCT01938664|pharmacotherapy|pharmacotherapy
239309|NCT01938638|Advanced malignancies|advanced malignancies
239310|NCT01938638|TNBC|tnbc
239311|NCT01938638|DLBCL|dlbcl
239312|NCT01938638|Gastric cancer|gastric cancer
239313|NCT01938625|Hepatitis C, Chronic|hepatitis c, chronic
239314|NCT01938625|Recurrent Chronic Hepatitis C|recurrent chronic hepatitis c
239315|NCT01938625|Pharmacokinetics|pharmacokinetics
239316|NCT01938625|Simeprevir|simeprevir
239317|NCT01938625|Daclatasvir|daclatasvir
239318|NCT01938625|Ribavirin|ribavirin
294563|NCT01688947|Pain|pain
239319|NCT01938625|Orthotopic Liver Transplantation|orthotopic liver transplantation
239320|NCT01938625|TMC435|tmc435
239321|NCT01938625|BMS-790052|bms-790052
239322|NCT01938625|RBV|rbv
239323|NCT01938612|MEDI4736|medi4736
239324|NCT01938612|Advanced solid tumors|advanced solid tumors
239325|NCT01938612|squamous cell carcinoma of the head and Neck|squamous cell carcinoma of the head and neck
239326|NCT01938612|biliary tract cancer|biliary tract cancer
239327|NCT01938612|squamous cell carcinoma of esophagus cancer|squamous cell carcinoma of esophagus cancer
239328|NCT01938612|B7-H1|b7-h1
239329|NCT01938612|PD-L1|pd-l1
239330|NCT01938599|Plaque Psoriasis|plaque psoriasis
239331|NCT01938586|Scar|scar
239332|NCT01938586|Appearance|appearance
239333|NCT01938547|perioperative|perioperative
239334|NCT01938547|blood pressure|blood pressure
239335|NCT01938547|pediatrics|pediatrics
239336|NCT01938547|pediatric surgery|pediatric surgery
239337|NCT01938521|Red Grape Cells powder (RGC)|red grape cells powder (rgc)
239338|NCT01938521|Placebo (PLA)|placebo (pla)
239339|NCT01938508|dermatitis|dermatitis
239340|NCT01938508|Minocycline|minocycline
239341|NCT01938508|bioavailability|bioavailability
239342|NCT01938495|ALS|als
239343|NCT01938495|DPS|dps
239344|NCT01938495|Diaphragm Pacing|diaphragm pacing
239345|NCT01938482|SCD1|scd1
239346|NCT01938482|Topical Administration|topical administration
239347|NCT01938482|Acne|acne
239348|NCT01938482|Gel|gel
239349|NCT01938469|Bariatric|bariatric
239350|NCT01938469|Gastric Bypass|gastric bypass
239351|NCT01938469|Gastric Banding,|gastric banding,
239352|NCT01938469|Incretins|incretins
239353|NCT01938469|glucagon-like peptide-1(GLP-1)|glucagon-like peptide-1(glp-1)
239354|NCT01938469|gastric inhibitory peptide (GIP)|gastric inhibitory peptide (gip)
239355|NCT01938456|Non-small cell lung cancer|non-small cell lung cancer
239356|NCT01938456|GSK1120212 (trametinib)|gsk1120212 (trametinib)
239358|NCT01938456|Phase Ib|phase ib
239359|NCT01938456|combination therapy|combination therapy
239360|NCT01938456|docetaxel|docetaxel
239361|NCT01938456|MEK inhibitor|mek inhibitor
239362|NCT01938443|pharmacodynamics|pharmacodynamics
239363|NCT01938443|MEK inhibitor|mek inhibitor
239364|NCT01938443|Focal adhesion kinase inhibitor|focal adhesion kinase inhibitor
239366|NCT01938443|pharmacokinetic|pharmacokinetic
239367|NCT01938443|mesothelioma|mesothelioma
239368|NCT01938443|Phase 1|phase 1
239369|NCT01938417|tobramycin|tobramycin
239370|NCT01938417|bone graft substitute|bone graft substitute
239371|NCT01938417|pharmacokinetics|pharmacokinetics
239372|NCT01938417|renal failure|renal failure
239373|NCT01938404|Plasma exchange|plasma exchange
239374|NCT01938404|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
239375|NCT01938404|TTP|ttp
239376|NCT01938391|Peripheral Artery Disease|peripheral artery disease
239378|NCT01938391|Claudication|claudication
239379|NCT01938391|Peripheral Vascular Disease|peripheral vascular disease
239380|NCT01938391|PVD|pvd
239381|NCT01938391|Orbital Atherectomy|orbital atherectomy
239382|NCT01938391|Balloon Angioplasty|balloon angioplasty
239383|NCT01938391|Intravascular Ultrasound (IVUS)|intravascular ultrasound (ivus)
239385|NCT01938352|Influenza|influenza
239386|NCT01938352|Virus|virus
239387|NCT01938352|Monoclonal Antibody|monoclonal antibody
239388|NCT01938352|Immunization|immunization
239389|NCT01938352|Treatment|treatment
239390|NCT01938339|prostate cancer|prostate cancer
239391|NCT01938339|MRI|mri
239392|NCT01938339|PET|pet
239393|NCT01938326|Stomach neoplasm|stomach neoplasm
239394|NCT01938326|TLDG|tldg
239395|NCT01938326|SIDG|sidg
239396|NCT01938326|single-port|single-port
239397|NCT01938326|inflammatory response|inflammatory response
239398|NCT01938313|gastric cancer|gastric cancer
239399|NCT01938313|ERAS (early recovery after surgery)|eras (early recovery after surgery)
239400|NCT01938313|fast track|fast track
239401|NCT01938313|laparoscopic gastrectomy|laparoscopic gastrectomy
239402|NCT01938274|Hip|hip
239403|NCT01938274|Knee|knee
239404|NCT01938274|Osteoarthritis|osteoarthritis
239405|NCT01938274|Arthroplasty|arthroplasty
239406|NCT01938274|Physical Activity|physical activity
239407|NCT01938274|Expectations|expectations
239408|NCT01938274|Leisure Activity|leisure activity
239409|NCT01938248|Pacemaker, Artificial|pacemaker, artificial
239410|NCT01938248|Defibrillators, Implantable|defibrillators, implantable
239411|NCT01938248|Atrial Fibrillation|atrial fibrillation
239412|NCT01938248|Stroke Risk|stroke risk
239413|NCT01938235|Myocardial infarction|myocardial infarction
751905|NCT01171170|non small cell lung cancer|non small cell lung cancer
239414|NCT01938235|Percutaneous coronary intervention|percutaneous coronary intervention
239415|NCT01938235|Reperfusion injury|reperfusion injury
239416|NCT01938235|Exenatide|exenatide
239417|NCT01938235|Magnetic resonance imaging|magnetic resonance imaging
239418|NCT01938222|abdominal wall closure|abdominal wall closure
239419|NCT01938222|short stitch technique|short stitch technique
239420|NCT01938196|Chronic Constipation|chronic constipation
239421|NCT01938196|Constipation|constipation
239422|NCT01938196|Functional gastrointestinal disorders|functional gastrointestinal disorders
239423|NCT01938183|chronic periodontitis|chronic periodontitis
239424|NCT01938183|metronidazole|metronidazole
239425|NCT01938157|High Risk of Breast Cancer|high risk of breast cancer
239426|NCT01938157|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
239427|NCT01938144|Common cold|common cold
239428|NCT01938144|efficacy|efficacy
239429|NCT01938144|symptoms|symptoms
239430|NCT01938144|Wisconsin Upper Respiratory Symptom Survey - 21|wisconsin upper respiratory symptom survey - 21
239431|NCT01938144|ibuprofen|ibuprofen
239432|NCT01938144|phenylephrine|phenylephrine
239433|NCT01938144|pseudoephedrine|pseudoephedrine
239434|NCT01938131|knee, osteoarthritis, muscle vibration|knee, osteoarthritis, muscle vibration
239435|NCT01938118|Infant diet|infant diet
239436|NCT01938118|Family diet|family diet
239437|NCT01938118|Responsive feeding|responsive feeding
239438|NCT01938118|Infant temperament|infant temperament
239439|NCT01938118|Physical activity|physical activity
239440|NCT01938118|Television|television
239441|NCT01938105|Cervical cancer|cervical cancer
239442|NCT01938105|Nimotuzumab|nimotuzumab
239443|NCT01938105|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
239444|NCT01938105|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
239445|NCT01938092|High-tone pelvic floor dysfunction|high-tone pelvic floor dysfunction
239446|NCT01938092|Spasm|spasm
239447|NCT01938092|Pelvic pain|pelvic pain
239448|NCT01938092|Diazepam|diazepam
239449|NCT01938092|Female|female
239450|NCT01938092|Randomized trial|randomized trial
239451|NCT01938079|ECMO|ecmo
239452|NCT01938079|Ketamine|ketamine
239453|NCT01938079|Opiates|opiates
239454|NCT01938079|Lung failure|lung failure
239455|NCT01938079|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
239456|NCT01938079|Mechanical ventilation|mechanical ventilation
239457|NCT01938079|Sedation|sedation
239458|NCT01938066|procellera|procellera
239459|NCT01938053|STI, STD|sti, std
239460|NCT01938040|laparoscopic cholecystectomy|laparoscopic cholecystectomy
239461|NCT01938027|Rectal Neoplasms|rectal neoplasms
239462|NCT01938027|Colorectal Neoplasms|colorectal neoplasms
239463|NCT01938027|transanal surgery|transanal surgery
239464|NCT01938014|MPS I|mps i
239465|NCT01938014|MPS II|mps ii
239466|NCT01938014|MPS III|mps iii
239467|NCT01938014|MPS VI|mps vi
239468|NCT01938014|Krabbe disease|krabbe disease
239469|NCT01938014|globoid cell leukodystrophy|globoid cell leukodystrophy
239470|NCT01938014|galactosylceramide lipidosis|galactosylceramide lipidosis
239471|NCT01938014|mucopolysaccharidoses|mucopolysaccharidoses
239472|NCT01938014|mucopolysaccharidosis|mucopolysaccharidosis
239473|NCT01938014|Rare Diseases Clinical Research Network|rare diseases clinical research network
239474|NCT01938014|Lysosomal Disease Network|lysosomal disease network
239475|NCT01938014|enzyme replacement therapy|enzyme replacement therapy
239573|NCT01937455|AAV|aav
239476|NCT01938014|hematopoietic stem cell transplant|hematopoietic stem cell transplant
239477|NCT01938014|telephone-based surveillance|telephone-based surveillance
239478|NCT01938014|Hurler syndrome|hurler syndrome
239479|NCT01938014|Hunter syndrome|hunter syndrome
239480|NCT01938014|Scheie syndrome|scheie syndrome
239481|NCT01938014|Hurler-Scheie syndrome|hurler-scheie syndrome
239482|NCT01938014|Sanfilippo syndrome|sanfilippo syndrome
239483|NCT01938014|Maroteaux-Lamy syndrome|maroteaux-lamy syndrome
239484|NCT01938001|Non-Hodgkins Follicular lymphoma, Non-Hodgkins Marginal zone lymphoma, treatment for follicular lymphoma, treatment for Marginal zone lymphoma|non-hodgkins follicular lymphoma, non-hodgkins marginal zone lymphoma, treatment for follicular lymphoma, treatment for marginal zone lymphoma
239485|NCT01937988|Doula|doula
239486|NCT01937988|Abortion|abortion
239487|NCT01937988|Pain|pain
239488|NCT01937988|support|support
239489|NCT01937949|Aortic aneurysm|aortic aneurysm
239490|NCT01937936|caregiver stress|caregiver stress
239491|NCT01937936|depression|depression
239492|NCT01937936|quality of life|quality of life
239493|NCT01937936|cognitive behavioral therapy|cognitive behavioral therapy
239494|NCT01937910|neuroplastic change|neuroplastic change
239495|NCT01937910|myelin|myelin
239496|NCT01937897|Unilateral Massage|unilateral massage
239497|NCT01937897|Depression|depression
239498|NCT01937858|HbA1c|hba1c
239499|NCT01937858|glycated hemoglobin|glycated hemoglobin
239500|NCT01937858|correlation|correlation
239501|NCT01937858|diabetes|diabetes
239502|NCT01937858|renal failure|renal failure
239503|NCT01937819|BOWEL PREPARATION|bowel preparation
239504|NCT01937819|SMARTPHONE APPLICATION|smartphone application
239505|NCT01937806|Chronic hepatitis B|chronic hepatitis b
239506|NCT01937793|radiation|radiation
239507|NCT01937793|speech-language pathology|speech-language pathology
239509|NCT01937754|Nitric Oxide|nitric oxide
239510|NCT01937754|Blood Pressure|blood pressure
239511|NCT01937754|Functional Capacity|functional capacity
239512|NCT01937754|Quality of Life|quality of life
239513|NCT01937728|Hepatitis C|hepatitis c
239514|NCT01937728|Genotype 1|genotype 1
239515|NCT01937728|Peg interferon|peg interferon
239516|NCT01937728|alfa 1a|alfa 1a
239517|NCT01937728|Ribavirin|ribavirin
239518|NCT01937689|Breast cancer|breast cancer
239519|NCT01937689|advanced|advanced
239520|NCT01937689|Pyrotinib|pyrotinib
239521|NCT01937689|Phase I|phase i
239522|NCT01937689|HER2 positive advanced breast cancer|her2 positive advanced breast cancer
239523|NCT01937663|Chronic Constipation|chronic constipation
239524|NCT01937663|Constipation|constipation
239525|NCT01937663|Functional gastrointestinal disorders|functional gastrointestinal disorders
239526|NCT01937650|Radiotherapy, metronidazole, cervical cancer, Mulago|radiotherapy, metronidazole, cervical cancer, mulago
239527|NCT01937637|Cognitive Behavioral Intervention for Breathlessness|cognitive behavioral intervention for breathlessness
239528|NCT01937624|Diagnostic ultrasound|diagnostic ultrasound
239529|NCT01937611|dexmedetomidine|dexmedetomidine
239530|NCT01937611|intramuscular premedication|intramuscular premedication
239531|NCT01937611|bradycardiac|bradycardiac
239532|NCT01937598|Incretin, DPP-4 inhibitor|incretin, dpp-4 inhibitor
239533|NCT01937585|prostate cancer|prostate cancer
239534|NCT01937585|partner|partner
239535|NCT01937585|communication messages|communication messages
239536|NCT01937585|monitoring style|monitoring style
239537|NCT01937585|AA men|aa men
239538|NCT01937572|Total knee arthroplasty (TKA)|total knee arthroplasty (tka)
239539|NCT01937572|Computer aided systems|computer aided systems
239540|NCT01937559|tranexaminic acid (TXA)|tranexaminic acid (txa)
239541|NCT01937546|Anal Canal/injuries|anal canal/injuries
239542|NCT01937546|Delivery, Obstetric/methods|delivery, obstetric/methods
239543|NCT01937546|Labour Stage, Second|labour stage, second
239544|NCT01937546|Lacerations/prevention & control|lacerations/prevention & control
239545|NCT01937546|Obstetric Labour Complications/prevention & control|obstetric labour complications/prevention & control
239546|NCT01937546|perineum/injuries|perineum/injuries
239547|NCT01937533|Magnetic Resonance Imaging|magnetic resonance imaging
239548|NCT01937520|acupuncture|acupuncture
239549|NCT01937520|inflammation|inflammation
239550|NCT01937520|thyroid|thyroid
239551|NCT01937520|parathyroid|parathyroid
239552|NCT01937494|asthma|asthma
239553|NCT01937494|bronchial hyperresponsiveness|bronchial hyperresponsiveness
239554|NCT01937494|histamine challenge test|histamine challenge test
239555|NCT01937494|spirometry|spirometry
239556|NCT01937481|Child, Preschool|child, preschool
239557|NCT01937481|Parents|parents
239558|NCT01937481|Family|family
239559|NCT01937481|Obesity|obesity
239560|NCT01937481|Overweight|overweight
239561|NCT01937481|Diet|diet
239562|NCT01937481|Overnutrition|overnutrition
239563|NCT01937481|Motor Activity|motor activity
239564|NCT01937481|Child Care|child care
239565|NCT01937481|Schools|schools
239566|NCT01937468|Chronic GVHD|chronic gvhd
239567|NCT01937468|Chronic graft versus host disease|chronic graft versus host disease
239568|NCT01937468|Allogeneic stem cell transplant|allogeneic stem cell transplant
239569|NCT01937455|HIV|hiv
239570|NCT01937455|AIDS|aids
239571|NCT01937455|HIV vaccine|hiv vaccine
239572|NCT01937455|HIV prevention|hiv prevention
239574|NCT01937455|PG9|pg9
239575|NCT01937442|Multiple myeloma|multiple myeloma
239576|NCT01937442|Pharmacokinetics|pharmacokinetics
239577|NCT01937442|Thalidomide|thalidomide
239578|NCT01937429|Colonoscopy - Chromoendoscopy - Indigo Carmin® - Adenoma detection - Tepid water|colonoscopy - chromoendoscopy - indigo carmin® - adenoma detection - tepid water
239579|NCT01937403|Physical Therapy|physical therapy
239580|NCT01937403|Return to sport|return to sport
239581|NCT01937351|Atherectomy|atherectomy
239582|NCT01937351|Optical Coherence Tomography|optical coherence tomography
239583|NCT01937351|Lumivascular|lumivascular
239584|NCT01937338|Healthy volunteers, Phase 1|healthy volunteers, phase 1
239585|NCT01937325|Eligible CF patients with G551D gene mutation|eligible cf patients with g551d gene mutation
239586|NCT01937312|glaucoma|glaucoma
239587|NCT01937312|prostaglandin analogue|prostaglandin analogue
239588|NCT01937312|brinzolamide|brinzolamide
239589|NCT01937312|brimonidine|brimonidine
239590|NCT01937299|glaucoma|glaucoma
239591|NCT01937299|prostaglandin analogue|prostaglandin analogue
239592|NCT01937299|brinzolamide|brinzolamide
239593|NCT01937299|brimonidine|brimonidine
239594|NCT01937286|LDLT,HCC, Microvascular invasion|ldlt,hcc, microvascular invasion
239595|NCT01937273|Nutritional status, malnutrition, chemo-radiotherapy|nutritional status, malnutrition, chemo-radiotherapy
239596|NCT01937247|Operative Time|operative time
239597|NCT01937247|Operating Rooms|operating rooms
239598|NCT01937247|Efficiency|efficiency
239599|NCT01937221|mild cognitive impairment|mild cognitive impairment
239600|NCT01937221|mild to moderate cognitive impairment|mild to moderate cognitive impairment
239601|NCT01937208|Esophageal Carcinoma|esophageal carcinoma
239602|NCT01937208|chemoradiation|chemoradiation
239603|NCT01937208|radiation dose|radiation dose
239604|NCT01937195|IV Catheter comparison|iv catheter comparison
239605|NCT01937195|AccuCath versus Conventional IV Catheters|accucath versus conventional iv catheters
239606|NCT01937195|IV Catheter Study|iv catheter study
239607|NCT01937195|IV Catheter User Preference Comparison|iv catheter user preference comparison
239608|NCT01937195|First Attempt Success Rate for IV Catheters|first attempt success rate for iv catheters
239609|NCT01937195|AccuCath Device Performance|accucath device performance
239610|NCT01937195|Complication Rates for IV Catheters|complication rates for iv catheters
239611|NCT01937195|Average Dwell Time for IV Catheters|average dwell time for iv catheters
239612|NCT01937195|Patient Satisfaction with IV Catheters|patient satisfaction with iv catheters
239613|NCT01937195|Clinician Satisfaction with AccuCath Device Performance|clinician satisfaction with accucath device performance
239614|NCT01937182|Stroke|stroke
239615|NCT01937182|SSRI (Selective Serotonin Reuptake Inhibitors)|ssri (selective serotonin reuptake inhibitors)
239616|NCT01937182|Serotonin|serotonin
239617|NCT01937182|5-HT (5-Hydroxytryptamine)|5-ht (5-hydroxytryptamine)
239618|NCT01937182|Neuroprotection|neuroprotection
239619|NCT01937182|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
239620|NCT01937182|Platelet|platelet
239621|NCT01937182|CT (computerized tomography)|ct (computerized tomography)
239622|NCT01937182|Post Stroke Depression|post stroke depression
239623|NCT01937143|parent education|parent education
239624|NCT01937143|immunization|immunization
239625|NCT01937143|vaccination|vaccination
239626|NCT01937143|infant|infant
239627|NCT01937143|pain management|pain management
239628|NCT01937130|Liver Failure|liver failure
239629|NCT01937130|Cirrhosis|cirrhosis
239630|NCT01937130|Alcoholic Hepatitis|alcoholic hepatitis
239631|NCT01937117|Breast cancer|breast cancer
239632|NCT01937117|Preoperative treatment|preoperative treatment
239633|NCT01937117|Neoadjuvant treatment|neoadjuvant treatment
239634|NCT01937104|Intracranial pressure|intracranial pressure
239635|NCT01937104|Laparoscopy|laparoscopy
239636|NCT01937104|Optic nerve sheath diameter|optic nerve sheath diameter
239637|NCT01937104|Position|position
239639|NCT01937091|clinical trials|clinical trials
239640|NCT01937013|Frontotemporal Dementia|frontotemporal dementia
239641|NCT01937013|emotion|emotion
239642|NCT01937013|oxytocin|oxytocin
239644|NCT01936961|Cancer|cancer
239645|NCT01936948|Large colon polyps|large colon polyps
239646|NCT01936948|Polyp resection|polyp resection
239647|NCT01936948|Colon cancer screening|colon cancer screening
239648|NCT01936948|Colonoscopy|colonoscopy
239649|NCT01936948|Endoscopic mucosal resection|endoscopic mucosal resection
239650|NCT01936935|Insulin sensitivity|insulin sensitivity
239651|NCT01936922|Fall accidents|fall accidents
239653|NCT01936922|Balance|balance
239654|NCT01936922|Fear of falling|fear of falling
239655|NCT01936922|Virtual reality|virtual reality
239656|NCT01936896|Acute myocardial infarction|acute myocardial infarction
239657|NCT01936896|Heart Failure|heart failure
239658|NCT01936896|Inflammation|inflammation
239659|NCT01936883|prostatic neoplasm|prostatic neoplasm
239660|NCT01936883|brachytherapy|brachytherapy
239661|NCT01936883|quality of life|quality of life
239662|NCT01936883|high dose rate|high dose rate
239663|NCT01936883|low dose rate|low dose rate
239664|NCT01936870|Toviaz|toviaz
239665|NCT01936870|Fesoterodine|fesoterodine
239666|NCT01936870|Post marketing surveillance|post marketing surveillance
239667|NCT01936870|Japanese|japanese
239668|NCT01936870|Overactive Bladder|overactive bladder
239669|NCT01936870|OAB|oab
239670|NCT01936870|Good post marketing practice|good post marketing practice
239671|NCT01936870|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
239672|NCT01936792|Concussion|concussion
239673|NCT01936792|Mild Traumatic Brain Injury|mild traumatic brain injury
239674|NCT01936792|Traumatic Brain Injury|traumatic brain injury
239675|NCT01936779|plasma triglycerides|plasma triglycerides
239676|NCT01936779|dietary fat|dietary fat
239677|NCT01936779|liver fat metabolism|liver fat metabolism
239678|NCT01936779|human|human
239679|NCT01936766|malaria, falciparum|malaria, falciparum
239680|NCT01936766|sepsis|sepsis
239681|NCT01936766|fluid therapy|fluid therapy
239682|NCT01936766|thermodilution|thermodilution
239683|NCT01936766|extravascular lung water|extravascular lung water
239684|NCT01936766|acute kidney injury|acute kidney injury
239685|NCT01936753|PMTCT|pmtct
239686|NCT01936753|HIV|hiv
239687|NCT01936753|Mentor Mothers|mentor mothers
239688|NCT01936753|Nigeria|nigeria
239689|NCT01936753|Retention|retention
239690|NCT01936753|Adherence|adherence
239691|NCT01936740|Efficacy and Safety|efficacy and safety
239692|NCT01936727|efficiency and safety|efficiency and safety
239693|NCT01936714|Efficacy and Safety|efficacy and safety
239694|NCT01936675|Coronary Artery Disease|coronary artery disease
239695|NCT01936675|Myocardial Infarction|myocardial infarction
239696|NCT01936675|Genomic Risk Communication|genomic risk communication
239697|NCT01936675|Risk Stratification|risk stratification
239698|NCT01936662|Airway management comparison|airway management comparison
239699|NCT01936649|Nuclear imaging|nuclear imaging
239700|NCT01936649|Radiopharmaceutical|radiopharmaceutical
239701|NCT01936649|Iobenguane|iobenguane
239702|NCT01936649|I-123|i-123
239703|NCT01936649|reproducibility|reproducibility
239704|NCT01936649|Quantitative measurements|quantitative measurements
239705|NCT01936649|myocardial uptake|myocardial uptake
239706|NCT01936649|SPECT imaging|spect imaging
239707|NCT01936649|planar imaging|planar imaging
239708|NCT01936649|AdreView™|adreview™
239709|NCT01936636|Breakthrough cancer pain|breakthrough cancer pain
239710|NCT01936636|diary|diary
239711|NCT01936636|quality of life|quality of life
239712|NCT01936636|Abstral|abstral
239713|NCT01936636|BTcP|btcp
239714|NCT01936623|brief intervention|brief intervention
239715|NCT01936623|computerized brief intervention|computerized brief intervention
239716|NCT01936610|Lecture|lecture
239717|NCT01936610|Role-playing|role-playing
239718|NCT01936610|Knowledge|knowledge
239719|NCT01936610|Attitude|attitude
239720|NCT01936610|Decision making|decision making
239721|NCT01936610|Type of delivery|type of delivery
239722|NCT01936597|external cardiac massage, medical hotline,|external cardiac massage, medical hotline,
239723|NCT01936545|Liver transplantation, reactive oxygen species, antioxidant|liver transplantation, reactive oxygen species, antioxidant
239724|NCT01936532|multiple myeloma|multiple myeloma
239725|NCT01936519|Everolimus|everolimus
239726|NCT01936519|Zortress|zortress
239727|NCT01936519|Renal Function|renal function
239728|NCT01936519|Tacrolimus|tacrolimus
239729|NCT01936519|Cyclosporine|cyclosporine
239730|NCT01936519|Myfortic|myfortic
239731|NCT01936519|Mycophenolic Acid|mycophenolic acid
239732|NCT01936519|Liver Transplantation|liver transplantation
239733|NCT01936506|Cognitive training|cognitive training
239734|NCT01936506|Depression|depression
239735|NCT01936493|Uterine leiomyomas (fibroids or myomas)|uterine leiomyomas (fibroids or myomas)
239736|NCT01936493|Uterine fibroids|uterine fibroids
239737|NCT01936493|Fibroids|fibroids
239738|NCT01936493|Uterine leiomyomas|uterine leiomyomas
239739|NCT01936467|Pancreatic solid lesions|pancreatic solid lesions
239740|NCT01936467|Pancreatic mass|pancreatic mass
239741|NCT01936467|Pancreatic cancer|pancreatic cancer
239742|NCT01936467|Endoscopic Ultrasound|endoscopic ultrasound
239744|NCT01936467|Fine needle aspiration|fine needle aspiration
239745|NCT01936467|FNA|fna
239746|NCT01936467|EUS-FNA|eus-fna
239747|NCT01936441|Menopause|menopause
239748|NCT01936441|Vasomotor|vasomotor
239749|NCT01936441|Symptoms|symptoms
239750|NCT01936441|Sleep|sleep
239751|NCT01936441|Cognitive Behavioral Therapy|cognitive behavioral therapy
239752|NCT01936415|Knee prosthesis|knee prosthesis
239753|NCT01936402|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
239754|NCT01936376|kidney safety|kidney safety
239755|NCT01936376|biomarkers|biomarkers
239756|NCT01936376|serum creatinine|serum creatinine
239757|NCT01936376|BUN|bun
239758|NCT01936376|cystic fibrosis|cystic fibrosis
239759|NCT01936376|head and neck cancer|head and neck cancer
239760|NCT01936376|renal injury|renal injury
239761|NCT01936376|drug induced acute kidney injury|drug induced acute kidney injury
239762|NCT01936376|aminoglycoside|aminoglycoside
239763|NCT01936376|cisplatin|cisplatin
239764|NCT01936376|nephrotoxicity|nephrotoxicity
239765|NCT01936376|biomarker qualification|biomarker qualification
239766|NCT01936363|Ovarian Cancer|ovarian cancer
239767|NCT01936363|Pimasertib|pimasertib
239768|NCT01936363|Placebo|placebo
239769|NCT01936363|SAR245409|sar245409
239770|NCT01936350|Heart failure|heart failure
239771|NCT01936324|acne vulgaris|acne vulgaris
239772|NCT01936311|Health Behavior|health behavior
239773|NCT01936311|Behavior change|behavior change
239774|NCT01936311|self-management goal|self-management goal
239775|NCT01936311|health goal|health goal
239776|NCT01936298|Hand Edema|hand edema
239777|NCT01936298|Exercise Therapy|exercise therapy
239778|NCT01936233|Hepatocellular Carcinoma|hepatocellular carcinoma
239779|NCT01936233|Aspirin|aspirin
239780|NCT01936233|antiviral treatment|antiviral treatment
239781|NCT01936233|recurrence free survival|recurrence free survival
239782|NCT01936233|radical therapy|radical therapy
239783|NCT01936220|Schizophrenia|schizophrenia
239784|NCT01936220|First-psychotic episode|first-psychotic episode
239785|NCT01936220|Initial phase|initial phase
239786|NCT01936220|Relapse prevention|relapse prevention
239787|NCT01936220|Specialized treatment|specialized treatment
239788|NCT01936220|Parent groups|parent groups
239789|NCT01936220|Social functioning|social functioning
239790|NCT01936207|acute|acute
239791|NCT01936207|respiratory|respiratory
239792|NCT01936207|syndrome|syndrome
239793|NCT01936207|prognosis|prognosis
239794|NCT01936207|outcome research|outcome research
239795|NCT01936207|respiratory infection|respiratory infection
239796|NCT01936207|sepsis|sepsis
239797|NCT01936207|organ failure|organ failure
239798|NCT01936181|Rheumatoid Arthritis|rheumatoid arthritis
239799|NCT01936181|Infliximab|infliximab
239800|NCT01936181|Biosimilar|biosimilar
239801|NCT01936168|GSV|gsv
239802|NCT01936168|Primary Varicose Veins|primary varicose veins
239803|NCT01936168|Great Saphenous Vein|great saphenous vein
239804|NCT01936168|Treatment|treatment
239805|NCT01936155|Joint Mobility|joint mobility
239806|NCT01936155|Skin Tissue Oxygenation|skin tissue oxygenation
239807|NCT01936155|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
239808|NCT01936155|Goniometry|goniometry
239809|NCT01936155|Transcutaneous Oxygen Measurements (tcpO2)|transcutaneous oxygen measurements (tcpo2)
239810|NCT01936155|Water Displacement|water displacement
239811|NCT01936142|Resynchroniztion therapy|resynchroniztion therapy
239813|NCT01936142|Contrast media|contrast media
239814|NCT01936142|Prevention|prevention
239815|NCT01936116|Sonohysterography|sonohysterography
239816|NCT01936116|catheter placement|catheter placement
239817|NCT01936116|pain magnitude|pain magnitude
239818|NCT01936116|vasovagal reaction|vasovagal reaction
239819|NCT01936103|Acute anterior myocardial infarction|acute anterior myocardial infarction
239820|NCT01936103|Percutaneous coronary stent implantation|percutaneous coronary stent implantation
239821|NCT01936103|Intensive statin therapy|intensive statin therapy
239822|NCT01936103|Left ventricular function|left ventricular function
239823|NCT01936077|Infertility, IVF, ovarian stimulation, rec LH, GnRH antagonist|infertility, ivf, ovarian stimulation, rec lh, gnrh antagonist
239824|NCT01936064|Breast Cancer|breast cancer
239825|NCT01936064|Jobelyn|jobelyn
239826|NCT01936064|Sorghum bicolor|sorghum bicolor
239827|NCT01936038|CPAP|cpap
239828|NCT01936038|Upper Airway Toning|upper airway toning
239829|NCT01936038|Obstructive Sleep Apnoea|obstructive sleep apnoea
239830|NCT01936025|Diabetes mellitus|diabetes mellitus
239831|NCT01936012|Lisinopril|lisinopril
239832|NCT01936012|Bioequivalence|bioequivalence
239833|NCT01936012|Bioavailability|bioavailability
239834|NCT01936012|Pharmacokinetic|pharmacokinetic
239835|NCT01936012|Angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
239836|NCT01935999|Colostomy|colostomy
239837|NCT01935999|peristomal skin|peristomal skin
239838|NCT01935999|stoma|stoma
239839|NCT01935999|pouch|pouch
688530|NCT00924534|PK|pk
239840|NCT01935908|Subarachnoid Hemorrhage|subarachnoid hemorrhage
239841|NCT01935908|Seizures|seizures
239842|NCT01935908|Prophylaxis|prophylaxis
239843|NCT01935908|Levetiracetam|levetiracetam
239844|NCT01935895|blood pressure reduction|blood pressure reduction
239845|NCT01935895|vascular reactivity|vascular reactivity
239846|NCT01935895|combined exercise session|combined exercise session
239847|NCT01935856|patients|patients
239848|NCT01935856|receiving|receiving
239849|NCT01935856|hemodialysis|hemodialysis
239850|NCT01935856|Secondary|secondary
239851|NCT01935843|CART-HER-2|cart-her-2
239852|NCT01935843|HER-2 positive|her-2 positive
239853|NCT01935843|Advanced|advanced
239854|NCT01935843|Refactory|refactory
239855|NCT01935843|Solid tumors|solid tumors
239856|NCT01935830|PET Imaging|pet imaging
239857|NCT01935830|Efavirenz|efavirenz
239858|NCT01935830|Ritonavior [11C] LAAM|ritonavior [11c] laam
239859|NCT01935830|Healthy volunteers|healthy volunteers
239860|NCT01935804|pioglitazone|pioglitazone
239861|NCT01935804|metformin|metformin
239862|NCT01935804|hyperglycemic agents|hyperglycemic agents
239863|NCT01935804|physiological effects of drugs|physiological effects of drugs
239864|NCT01935804|bone health|bone health
239865|NCT01935765|Type 1 diabetes, sleep apnea, polysomnography,|type 1 diabetes, sleep apnea, polysomnography,
239866|NCT01935765|autonomic neuropathy, intima media thickness|autonomic neuropathy, intima media thickness
239867|NCT01935752|fibromuscular|fibromuscular
239868|NCT01935752|dysplasia|dysplasia
239869|NCT01935752|endothelium|endothelium
239870|NCT01935752|microparticles|microparticles
239871|NCT01935752|microRNA|microrna
239872|NCT01935726|Pulmonary fibrosis|pulmonary fibrosis
239873|NCT01935726|Interstitial lung disease|interstitial lung disease
239874|NCT01935726|Connective tissue disease|connective tissue disease
239875|NCT01935726|Chronic hypersensitivity pneumonitis|chronic hypersensitivity pneumonitis
239876|NCT01935726|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
239877|NCT01935700|hepatocellular carcinoma|hepatocellular carcinoma
239878|NCT01935700|colchicine|colchicine
239879|NCT01935687|Instrumented Wheel|instrumented wheel
239880|NCT01935687|Manual Wheelchair|manual wheelchair
239881|NCT01935687|Spinal Cord Injury (SCI)|spinal cord injury (sci)
239882|NCT01935687|Manual wheelchair Users|manual wheelchair users
239883|NCT01935687|Aged between 18-70 years|aged between 18-70 years
239884|NCT01935674|Hypercholesterolaemia|hypercholesterolaemia
239886|NCT01935674|Rosuvastatin|rosuvastatin
239887|NCT01935674|Protease inhibitor switching|protease inhibitor switching
239888|NCT01935661|Blood transfusion|blood transfusion
239889|NCT01935661|Hemosiderosis|hemosiderosis
239890|NCT01935661|ERP|erp
239891|NCT01935648|Knee arthroplasty|knee arthroplasty
239892|NCT01935635|CHB|chb
239893|NCT01935635|Antiviral|antiviral
239894|NCT01935635|Dentritic cells|dentritic cells
239895|NCT01935635|Immune Therapy|immune therapy
239896|NCT01935622|heart failure|heart failure
239897|NCT01935622|non-ischemic cardiomyopathy|non-ischemic cardiomyopathy
239652|NCT01936922|Gait|gait
239898|NCT01935609|traumatic brain injury|traumatic brain injury
239899|NCT01935609|acquired brain injury|acquired brain injury
239900|NCT01935596|Anesthesia|anesthesia
239901|NCT01935596|Randomized study|randomized study
239902|NCT01935596|Lower limbs surgery|lower limbs surgery
239903|NCT01935583|traumatic brain injury|traumatic brain injury
239904|NCT01935570|Bioavailability of magnesium|bioavailability of magnesium
239905|NCT01935570|Digestive and general tolerance|digestive and general tolerance
239906|NCT01935557|Continuous heparin infusion|continuous heparin infusion
239907|NCT01935557|Intermittent heparin infusion|intermittent heparin infusion
239908|NCT01935557|during catheter ablation|during catheter ablation
239909|NCT01935544|Botulinum Toxin|botulinum toxin
239910|NCT01935544|Ultrasound-guidance|ultrasound-guidance
239911|NCT01935544|Stroke|stroke
239912|NCT01935544|Spasticity|spasticity
239913|NCT01935544|Ultrasonography|ultrasonography
239914|NCT01935544|Hemiplegia|hemiplegia
239915|NCT01935531|actinic keratoses|actinic keratoses
239916|NCT01935531|tumor metabolism|tumor metabolism
239917|NCT01935531|glycolysis|glycolysis
239918|NCT01935531|diclofenac|diclofenac
239919|NCT01935531|warburg effect|warburg effect
239920|NCT01935505|smoking cessation|smoking cessation
239921|NCT01935505|intervention model|intervention model
239922|NCT01935505|Chinese|chinese
239923|NCT01935505|quitting rate|quitting rate
239924|NCT01935492|metastatic breast cancer|metastatic breast cancer
239925|NCT01935492|HER2/neu negative|her2/neu negative
239926|NCT01935492|paclitaxel|paclitaxel
239927|NCT01935492|bevacizumab|bevacizumab
239928|NCT01935492|liposomal doxorubicine|liposomal doxorubicine
239929|NCT01935492|capecitabine|capecitabine
239930|NCT01935479|AK159, teriparatide acetate|ak159, teriparatide acetate
239931|NCT01935466|Pioglitazone|pioglitazone
239932|NCT01935466|Bladder cancer|bladder cancer
239933|NCT01935466|Type 2 Diabetes|type 2 diabetes
239934|NCT01935440|HIV, drug use|hiv, drug use
239935|NCT01935427|Pulse Oximeter|pulse oximeter
239936|NCT01935427|Stroke Volume|stroke volume
239937|NCT01935427|Hemorrhagic shock|hemorrhagic shock
239938|NCT01935427|Compensatory Reserve Index|compensatory reserve index
239939|NCT01935401|Bulimia Nervosa|bulimia nervosa
239940|NCT01935401|Bulimia|bulimia
239941|NCT01935401|Response Inhibition|response inhibition
239942|NCT01935401|fNIR|fnir
239943|NCT01935401|Neuroimaging|neuroimaging
239944|NCT01935388|Mechanical ventilation|mechanical ventilation
239945|NCT01935388|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
239946|NCT01935388|asthma|asthma
239947|NCT01935388|common canister|common canister
239948|NCT01935388|MDI|mdi
239949|NCT01935388|ventilator associated pneumonia|ventilator associated pneumonia
239950|NCT01935375|Postpartum Depression|postpartum depression
239951|NCT01935375|Nurse Midwife|nurse midwife
239952|NCT01935375|Interpersonal Psychotherapy|interpersonal psychotherapy
239953|NCT01935362|Flavanones|flavanones
239954|NCT01935362|Bioavailability|bioavailability
239955|NCT01935362|Blood vessel health|blood vessel health
239956|NCT01935362|Blood glucose|blood glucose
239957|NCT01935349|Diabetes mellitus (DM)|diabetes mellitus (dm)
239958|NCT01935349|hypertension (HT)|hypertension (ht)
239959|NCT01935349|Hong Kong|hong kong
239960|NCT01935336|Lung Cancer|lung cancer
239961|NCT01935336|Malignancy|malignancy
239962|NCT01935336|Predictive biomarkers|predictive biomarkers
239963|NCT01935323|high intensity interval training|high intensity interval training
239964|NCT01935323|aerobic exercise|aerobic exercise
239965|NCT01935323|insulin sensitivity|insulin sensitivity
239966|NCT01935323|obesity|obesity
239967|NCT01935323|cardiovascular fitness|cardiovascular fitness
239968|NCT01935310|Photoaging|photoaging
239969|NCT01935310|imiquimod|imiquimod
239970|NCT01935310|wrinkles|wrinkles
239971|NCT01935310|elastosis|elastosis
239972|NCT01935271|immunosenescence|immunosenescence
239973|NCT01935271|sarcopenia|sarcopenia
239974|NCT01935258|Medically unexplained symptoms|medically unexplained symptoms
239975|NCT01935258|Somatization|somatization
239976|NCT01935258|Psychosomatic therapy|psychosomatic therapy
239977|NCT01935245|Coronary artery bypass grafting|coronary artery bypass grafting
239978|NCT01935245|Extracorporeal circulation|extracorporeal circulation
239979|NCT01935245|Minimal extracorporeal circulation|minimal extracorporeal circulation
239980|NCT01935245|Coagulopathy|coagulopathy
239981|NCT01935245|Thrombocytopathy|thrombocytopathy
239982|NCT01935245|Platelet dysfunction|platelet dysfunction
239983|NCT01935232|Osteoporosis, diagnostics, ultrasound|osteoporosis, diagnostics, ultrasound
239984|NCT01935219|mild cognitive impairment|mild cognitive impairment
239985|NCT01935219|seniors|seniors
239986|NCT01935219|cognitive training|cognitive training
239987|NCT01935219|driving|driving
239988|NCT01935219|driving simulation|driving simulation
239989|NCT01935219|intervention|intervention
239990|NCT01935219|goal management training|goal management training
239991|NCT01935219|process speed training|process speed training
239992|NCT01935206|secondary hyperalgesia|secondary hyperalgesia
239993|NCT01935206|allodynia|allodynia
239994|NCT01935206|mechanical pain threshold|mechanical pain threshold
239995|NCT01935206|naloxone|naloxone
239996|NCT01935206|endogenous opioids|endogenous opioids
239997|NCT01935206|pain|pain
239998|NCT01935193|platelets aggregation|platelets aggregation
239999|NCT01935193|asa resistance|asa resistance
240000|NCT01935180|colon polyps|colon polyps
240001|NCT01935180|adenoma resection|adenoma resection
240002|NCT01935180|colon cancer screening|colon cancer screening
240003|NCT01935180|colonoscopy|colonoscopy
240004|NCT01935180|polyp detection|polyp detection
240005|NCT01935167|Microalbuminuria|microalbuminuria
240006|NCT01935154|NSCLC|nsclc
240007|NCT01935154|Vaccine|vaccine
240008|NCT01935141|Pulmonary Embolus|pulmonary embolus
240009|NCT01935141|Radio Contrast Material|radio contrast material
240010|NCT01935141|Computed Tomography|computed tomography
240011|NCT01935128|Renal Transplant|renal transplant
240012|NCT01935128|Immunosuppression|immunosuppression
240013|NCT01935128|Steroid Avoidance|steroid avoidance
240014|NCT01935128|Calcineurin Avoidance|calcineurin avoidance
240015|NCT01935128|Mammalian Target of Rapamycin (mTOR)|mammalian target of rapamycin (mtor)
240016|NCT01935128|Kidney|kidney
240017|NCT01935115|Depression|depression
240019|NCT01935115|Treatment Resistant Depression|treatment resistant depression
240020|NCT01935115|Electroconvulsive Therapy|electroconvulsive therapy
240021|NCT01935115|ECT|ect
240022|NCT01935115|Ketamine|ketamine
240023|NCT01935115|Propofol|propofol
240024|NCT01935115|NMDA|nmda
240025|NCT01935102|metastatic breast cancer|metastatic breast cancer
240026|NCT01935102|bevacizumab|bevacizumab
240027|NCT01935102|single nucleotide polymorphism|single nucleotide polymorphism
240028|NCT01935102|VEGF-A|vegf-a
240029|NCT01935102|VEGFR-2|vegfr-2
240030|NCT01935102|IL-8|il-8
240031|NCT01935089|HIV-1|hiv-1
240032|NCT01935089|Interferon alpha|interferon alpha
240033|NCT01935089|Integrated DNA|integrated dna
240034|NCT01935089|Latent reservoir|latent reservoir
240035|NCT01935076|Maternal obesity|maternal obesity
240036|NCT01935076|Macrosomic|macrosomic
240037|NCT01935076|miRNA|mirna
240038|NCT01935076|Fetal overgrowth|fetal overgrowth
240039|NCT01935063|Vulvodynia|vulvodynia
240040|NCT01935063|Provoked vestibulodynia|provoked vestibulodynia
240041|NCT01935063|Vulvar pain|vulvar pain
240042|NCT01935063|Dyspareunia|dyspareunia
240043|NCT01935063|Couples therapy|couples therapy
240044|NCT01935063|Lidocaine|lidocaine
240045|NCT01935063|Cognitive behavioral couple therapy|cognitive behavioral couple therapy
240046|NCT01935063|Cognitive behavioral therapy|cognitive behavioral therapy
240047|NCT01935063|Pain|pain
240048|NCT01935063|Pain during sexual intercourse|pain during sexual intercourse
240049|NCT01935050|Depression|depression
240050|NCT01935050|Parkinson's disease|parkinson's disease
240051|NCT01935050|Cognitive-Behavioral Treatment|cognitive-behavioral treatment
240052|NCT01935024|Alzheimer's disease|alzheimer's disease
240053|NCT01935024|dementia|dementia
240054|NCT01935024|aerobic exercise|aerobic exercise
240055|NCT01934998|SCA6, parkinsonism, Datscan|sca6, parkinsonism, datscan
240056|NCT01934985|Single-Photon Emission-Computed Tomography|single-photon emission-computed tomography
240057|NCT01934985|Myocardial Perfusion Imaging|myocardial perfusion imaging
240058|NCT01934985|Ischemia|ischemia
240059|NCT01934985|Stress test|stress test
240060|NCT01934985|Coronary Artery Disease (CAD)|coronary artery disease (cad)
240061|NCT01934985|Coronary Flow Reserve (CFR)|coronary flow reserve (cfr)
240062|NCT01934985|Coronary Angiography|coronary angiography
240063|NCT01934972|Bipolar disorder|bipolar disorder
240064|NCT01934946|hip fracture|hip fracture
240065|NCT01934933|ossification|ossification
240066|NCT01934933|etanercept|etanercept
240067|NCT01934894|HER2-positive breast cancer|her2-positive breast cancer
240068|NCT01934894|intracranial metastases|intracranial metastases
240069|NCT01934894|lapatinib|lapatinib
240070|NCT01934894|cabazitaxel|cabazitaxel
240071|NCT01934868|low back pain|low back pain
240072|NCT01934868|sciatica|sciatica
240073|NCT01934868|spinal stenosis|spinal stenosis
240074|NCT01934868|epidural injections|epidural injections
240075|NCT01934868|prolotherapy|prolotherapy
240076|NCT01934868|sacroiliac pain or dysfunction.|sacroiliac pain or dysfunction.
240078|NCT01934855|radiotherapy|radiotherapy
240079|NCT01934855|4D-MRI|4d-mri
240080|NCT01934855|4D-CT|4d-ct
240081|NCT01934855|MRI|mri
240082|NCT01934816|Incretins, KATP channels, intradermal injection|incretins, katp channels, intradermal injection
240083|NCT01934803|Alcohol Use|alcohol use
240084|NCT01934803|Microbial Translocation|microbial translocation
240085|NCT01934803|Inflammation|inflammation
240086|NCT01934803|Altered Coagulation|altered coagulation
240087|NCT01934803|Russia|russia
240088|NCT01934803|Zinc|zinc
240089|NCT01934803|AMI|ami
240090|NCT01934803|VACS index|vacs index
240091|NCT01934803|Reynolds risk score|reynolds risk score
240092|NCT01934777|NAFLD|nafld
240093|NCT01934777|NASH|nash
240094|NCT01934777|fibrosis|fibrosis
240095|NCT01934738|Multiple dose|multiple dose
240096|NCT01934738|safety|safety
240097|NCT01934738|tolerability|tolerability
240098|NCT01934738|PK|pk
240099|NCT01934725|Ischemic Stroke|ischemic stroke
240100|NCT01934725|Brain Infarction|brain infarction
240101|NCT01934725|Patent Foramen Ovale|patent foramen ovale
240102|NCT01934725|Stroke in the Young|stroke in the young
240103|NCT01934725|Myocardial Infarction|myocardial infarction
240104|NCT01934725|Cerebral Venous Thrombosis|cerebral venous thrombosis
240105|NCT01934725|Pulmonary Embolism|pulmonary embolism
240106|NCT01934725|Deep Vein Thrombosis|deep vein thrombosis
240107|NCT01934725|Subarachnoid Hemorrhage|subarachnoid hemorrhage
240108|NCT01934725|Prognosis|prognosis
240109|NCT01934725|Databases, Genetic|databases, genetic
240110|NCT01934699|Coronary stenosis|coronary stenosis
240111|NCT01934699|Angina pectoris|angina pectoris
240112|NCT01934699|Left ventricular wall motion abnormalities|left ventricular wall motion abnormalities
240113|NCT01934699|2D-Strain|2d-strain
240114|NCT01934660|Cardiovascular Disease|cardiovascular disease
240115|NCT01934660|Diabetes Mellitus|diabetes mellitus
240116|NCT01934660|Inflammation|inflammation
240117|NCT01934634|Pancreatic Cancer|pancreatic cancer
240118|NCT01934634|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
240119|NCT01934634|Stage IV metastatic pancreatic ductal adenocarcinoma|stage iv metastatic pancreatic ductal adenocarcinoma
240120|NCT01934621|Stroke|stroke
240121|NCT01934621|Rehabilitation|rehabilitation
240122|NCT01934621|Cognition|cognition
240123|NCT01934621|Disability|disability
240124|NCT01934595|Critically ill|critically ill
240125|NCT01934595|Protein|protein
240126|NCT01934595|Supplement|supplement
240128|NCT01934595|Protein synthesis|protein synthesis
240129|NCT01934530|implant complications|implant complications
240130|NCT01934530|esthetics|esthetics
240131|NCT01934530|soft tissue grafting|soft tissue grafting
240132|NCT01934504|clinical tolerance|clinical tolerance
240133|NCT01934504|biomarker(s) identification|biomarker(s) identification
240134|NCT01934491|Cognitive training|cognitive training
240135|NCT01934491|Depression|depression
240136|NCT01934478|Breast|breast
240137|NCT01934478|Cancer|cancer
240138|NCT01934478|Human Epidermal Growth Factor 2 (Her2)|human epidermal growth factor 2 (her2)
240139|NCT01934478|irradiation|irradiation
240140|NCT01934465|NSCLC|nsclc
240141|NCT01934465|Chemotherapy|chemotherapy
240142|NCT01934465|Anti-angiogenic agent|anti-angiogenic agent
240143|NCT01934465|Bevacizumab|bevacizumab
240144|NCT01934465|1st Line|1st line
240145|NCT01934452|complete remission|complete remission
240146|NCT01934439|Stroke|stroke
240147|NCT01934439|Rehabilitation|rehabilitation
240148|NCT01934439|Dyssynergia|dyssynergia
240149|NCT01934439|Robotics|robotics
240150|NCT01934439|AMES|ames
240151|NCT01934439|Cerebrovascular Accident|cerebrovascular accident
240152|NCT01934426|Admission High Risk Elderly|admission high risk elderly
240153|NCT01934413|Palliative Care|palliative care
240154|NCT01934413|Technology|technology
240155|NCT01934413|Rural|rural
240156|NCT01934413|Transitional Care|transitional care
240157|NCT01934400|Osteoporosis|osteoporosis
240158|NCT01934400|fall prevention|fall prevention
240159|NCT01934400|high risk population|high risk population
240160|NCT01934387|World Health Organization Fracture Risk Assessment Tool|world health organization fracture risk assessment tool
240161|NCT01934387|Osteoporosis|osteoporosis
240162|NCT01934387|Aged|aged
240163|NCT01934387|Prevention|prevention
240164|NCT01934387|Fracture|fracture
240165|NCT01934387|FRAX|frax
240166|NCT01934374|task-oriented training, long-term effects, plasticity|task-oriented training, long-term effects, plasticity
240167|NCT01934361|BKM120|bkm120
240168|NCT01934361|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
240169|NCT01934361|rGBM|rgbm
240170|NCT01934361|buparlisib|buparlisib
240171|NCT01934335|breast cancer, TKI, tyrosine kinase inhibitor, vandetanib, Ki-67|breast cancer, tki, tyrosine kinase inhibitor, vandetanib, ki-67
240172|NCT01934322|frequent users of the emergency department|frequent users of the emergency department
240173|NCT01934322|vulnerable populations|vulnerable populations
240174|NCT01934322|case management|case management
240175|NCT01934322|cost savings intervention|cost savings intervention
240176|NCT01934322|quality of life|quality of life
240177|NCT01934322|number of emergency department visits|number of emergency department visits
240178|NCT01934309|tuberculosis|tuberculosis
240179|NCT01934309|isoniazid preventative therapy|isoniazid preventative therapy
240180|NCT01934309|clinical decision support|clinical decision support
240181|NCT01934309|HIV|hiv
240182|NCT01934309|Kenya|kenya
240183|NCT01934309|eHealth|ehealth
240184|NCT01934296|deep brain stimulation|deep brain stimulation
240185|NCT01934296|cortical recording|cortical recording
240186|NCT01934296|neuroprosthesis|neuroprosthesis
240187|NCT01934231|Acute bacterial rhinosinusitis|acute bacterial rhinosinusitis
240188|NCT01934231|Amoxicilin|amoxicilin
240189|NCT01934231|Infection|infection
240190|NCT01934231|Potassium clavulanate|potassium clavulanate
240191|NCT01934218|Knee|knee
240192|NCT01934218|Osteoarthritis|osteoarthritis
240193|NCT01934218|Intra-articular injection|intra-articular injection
240194|NCT01934205|GSK2140944|gsk2140944
240195|NCT01934205|pharmacokinetics|pharmacokinetics
240196|NCT01934205|bronchoalveolar lavage|bronchoalveolar lavage
240197|NCT01934205|pulmonary|pulmonary
240198|NCT01934205|antimicrobial|antimicrobial
240199|NCT01934205|healthy volunteer|healthy volunteer
240200|NCT01934192|tolerability|tolerability
240201|NCT01934192|camicinal|camicinal
240202|NCT01934192|single dose|single dose
240203|NCT01934192|acetaminophen|acetaminophen
240204|NCT01934192|gastric emptying|gastric emptying
240205|NCT01934192|critically ill|critically ill
240206|NCT01934192|GSK962040|gsk962040
240207|NCT01934192|pharmacokinetics|pharmacokinetics
240208|NCT01934192|pharmacodynamics|pharmacodynamics
240209|NCT01934192|gut motility|gut motility
240210|NCT01934153|hyperhidrosis|hyperhidrosis
240212|NCT01934153|[14C] radiolabel|[14c] radiolabel
240213|NCT01934153|palm|palm
240214|NCT01934153|GSK573719|gsk573719
240215|NCT01934153|axilla|axilla
240216|NCT01934153|Umeclidinium|umeclidinium
240217|NCT01934140|Healthy|healthy
240218|NCT01934140|Adults|adults
240219|NCT01934140|Safety|safety
240220|NCT01934140|Neisseria meningitidis|neisseria meningitidis
240221|NCT01934140|Booster response|booster response
240222|NCT01934140|Immunogenicity|immunogenicity
240223|NCT01934140|Adolescents|adolescents
240224|NCT01934140|Serogroups A, C, W-135, and Y|serogroups a, c, w-135, and y
240225|NCT01934140|long-term antibody persistence|long-term antibody persistence
240226|NCT01934127|Immunogenicity|immunogenicity
240227|NCT01934127|H7N1|h7n1
240228|NCT01934127|Influenza|influenza
240229|NCT01934127|Safety|safety
240230|NCT01934127|AS03 adjuvant|as03 adjuvant
240231|NCT01934127|Adults|adults
240232|NCT01934088|Inflammatory Bowel disease|inflammatory bowel disease
240233|NCT01934088|IBD|ibd
240234|NCT01934088|Sedation|sedation
240235|NCT01934088|NAPS|naps
240236|NCT01934088|Propofol|propofol
240237|NCT01934088|Midazolam|midazolam
240238|NCT01934088|Satisfaction|satisfaction
240239|NCT01934088|Feasibility|feasibility
240240|NCT01934075|Obstetric fistula|obstetric fistula
240241|NCT01934075|Mental health|mental health
240242|NCT01934075|Tanzania|tanzania
240243|NCT01934036|Weight loss|weight loss
240244|NCT01934036|Nutritional supplement|nutritional supplement
240245|NCT01934036|Waist|waist
240246|NCT01934036|Body composition|body composition
240247|NCT01934036|Skinfolds|skinfolds
240248|NCT01934023|plasticity, schizophrenia, varenicline, non smokers,|plasticity, schizophrenia, varenicline, non smokers,
240249|NCT01933997|pharmacokinetics|pharmacokinetics
240250|NCT01933997|metadoxine|metadoxine
240251|NCT01933984|Bronchodilator agents,|bronchodilator agents,
240252|NCT01933984|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
240253|NCT01933984|endotracheal intubation,|endotracheal intubation,
240254|NCT01933984|mechanical ventilator|mechanical ventilator
240255|NCT01933958|Regorafenib|regorafenib
240256|NCT01933958|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
240257|NCT01933932|Mitogen-Activated Protein Kinase Kinase inhibitor; Non Small Cell Lung Cancer; metastatic; second line treatment for Non Small Cell Lung Cancer; KRAS mutation|mitogen-activated protein kinase kinase inhibitor; non small cell lung cancer; metastatic; second line treatment for non small cell lung cancer; kras mutation
240258|NCT01933919|Obsessive Compulsive Disorder|obsessive compulsive disorder
240259|NCT01933919|Adolescent Subjects|adolescent subjects
240260|NCT01933919|Pediatric Subjects|pediatric subjects
240262|NCT01933906|Chronic myeloid leukemia|chronic myeloid leukemia
240263|NCT01933906|Chronic myeloid leukaemia|chronic myeloid leukaemia
240264|NCT01933906|PEG-Proline-Interferon-alpha 2b|peg-proline-interferon-alpha 2b
240265|NCT01933906|Interferon|interferon
240266|NCT01933906|P1101|p1101
240267|NCT01933906|Imatinib|imatinib
240268|NCT01933893|Pipelle, luteal, follicular, implantation|pipelle, luteal, follicular, implantation
240269|NCT01933880|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
240270|NCT01933880|Methylphenidate Hydrochloride|methylphenidate hydrochloride
240271|NCT01933880|CONCERTA|concerta
240272|NCT01933867|water|water
240273|NCT01933867|colonoscopy|colonoscopy
240274|NCT01933867|Crohn´s disease|crohn´s disease
240275|NCT01933867|ulcerative colitis|ulcerative colitis
240276|NCT01933854|Urinary incontinence|urinary incontinence
240277|NCT01933854|riverside|riverside
240278|NCT01933854|women|women
240279|NCT01933854|Amapa|amapa
240280|NCT01933841|Post operative residual curarization|post operative residual curarization
240281|NCT01933841|Neuromuscular blocking drugs|neuromuscular blocking drugs
240282|NCT01933828|Lung cancer|lung cancer
240283|NCT01933828|surgery video-assisted|surgery video-assisted
240284|NCT01933828|robot|robot
240285|NCT01933828|surgical treatment|surgical treatment
240286|NCT01933815|Glioblastoma multiforme|glioblastoma multiforme
240287|NCT01933815|Glioblastoma|glioblastoma
240288|NCT01933815|Radiotherapy|radiotherapy
240289|NCT01933815|Temozolomide|temozolomide
240290|NCT01933815|TPI 287|tpi 287
240291|NCT01933815|Taxoid|taxoid
240292|NCT01933815|Avastin|avastin
240293|NCT01933815|Bevacizumab|bevacizumab
240294|NCT01933802|mesenchymal stem cells|mesenchymal stem cells
240295|NCT01933802|neural progenitors|neural progenitors
240296|NCT01933802|autologous|autologous
240297|NCT01933802|bone marrow|bone marrow
240298|NCT01933802|multiple sclerosis|multiple sclerosis
240299|NCT01933789|Palliative Care|palliative care
240300|NCT01933789|End-of-Life Issues|end-of-life issues
240301|NCT01933789|Patient/Clinician Communication|patient/clinician communication
240302|NCT01933789|Patient/Family Communication|patient/family communication
240303|NCT01933789|Concordance|concordance
240304|NCT01933789|Treatment Preferences|treatment preferences
240305|NCT01933789|Anxiety|anxiety
240306|NCT01933789|Depressive Symptoms|depressive symptoms
240307|NCT01933789|Talking with Your Doctor|talking with your doctor
240308|NCT01933789|Coping with Serious Illness|coping with serious illness
240309|NCT01933789|Outpatient Collaboration|outpatient collaboration
240310|NCT01933776|Diphtheria|diphtheria
240311|NCT01933776|Tetanus|tetanus
240312|NCT01933776|Pertussis|pertussis
240313|NCT01933776|ADACEL®|adacel®
240314|NCT01933776|Tdap vaccine|tdap vaccine
240315|NCT01933750|Presbyopia|presbyopia
240316|NCT01933750|Reading Glasses|reading glasses
240317|NCT01933750|Near Vision|near vision
240318|NCT01933737|postural balance;|postural balance;
240319|NCT01933737|elderly;|elderly;
240320|NCT01933737|proprioception;|proprioception;
240321|NCT01933737|prevention;|prevention;
240322|NCT01933737|fall|fall
240323|NCT01933724|granulomatosis with polyangiitis|granulomatosis with polyangiitis
240324|NCT01933724|GPA|gpa
240325|NCT01933724|Wegeners'|wegeners'
240326|NCT01933724|WG|wg
240327|NCT01933724|vasculitis|vasculitis
240328|NCT01933724|taper|taper
240329|NCT01933724|prednisone|prednisone
240330|NCT01933724|glucocorticoid|glucocorticoid
240331|NCT01933724|ANCA-associated vasculitis|anca-associated vasculitis
240332|NCT01933724|AAV|aav
240333|NCT01933724|Wegener Granulomatosis|wegener granulomatosis
240334|NCT01933724|Systemic Vasculitis|systemic vasculitis
240335|NCT01933724|Lung diseases, interstitial|lung diseases, interstitial
240336|NCT01933724|Lung diseases|lung diseases
240337|NCT01933724|Respiratory Tract Diseases|respiratory tract diseases
240338|NCT01933724|Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis|anti-neutrophil cytoplasmic antibody-associated vasculitis
240339|NCT01933724|Vascular Diseases|vascular diseases
240340|NCT01933724|Cardiovascular Diseases|cardiovascular diseases
240341|NCT01933724|Glucocorticoids|glucocorticoids
240342|NCT01933724|Hormones|hormones
240343|NCT01933724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
240344|NCT01933724|Physiological Effects of Drugs|physiological effects of drugs
240345|NCT01933724|Pharmacologic Actions|pharmacologic actions
240346|NCT01933724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
240347|NCT01933724|Antineoplastic Agents|antineoplastic agents
240348|NCT01933724|Therapeutic Uses|therapeutic uses
240349|NCT01933724|Anti-Inflammatory Agents|anti-inflammatory agents
240350|NCT01933711|CD20+ aggressive lymphoma|cd20+ aggressive lymphoma
240351|NCT01933711|mantle cell lymphoma|mantle cell lymphoma
240352|NCT01933711|rituximab|rituximab
240353|NCT01933711|maintenance|maintenance
240354|NCT01933698|Bioequivalence|bioequivalence
240355|NCT01933698|Amoxicillin|amoxicillin
240356|NCT01933698|Human|human
240357|NCT01933672|Phase 1b|phase 1b
240358|NCT01933672|type 2 diabetes|type 2 diabetes
240359|NCT01933672|metformin background|metformin background
240360|NCT01933672|PF-04937319|pf-04937319
240361|NCT01933659|Helicobacter pylori|helicobacter pylori
240362|NCT01933659|deep see water|deep see water
240363|NCT01933646|Group B streptococcus|group b streptococcus
240364|NCT01933646|Incidence|incidence
240365|NCT01933646|Case fatality rate|case fatality rate
240366|NCT01933646|Serotype distribution|serotype distribution
240367|NCT01933633|Pregnancy|pregnancy
240368|NCT01933633|Fertility|fertility
240369|NCT01933633|exercise|exercise
240370|NCT01933633|Fertilization in vitro|fertilization in vitro
240371|NCT01933620|Microbiome|microbiome
240372|NCT01933620|Nosocomial Infection|nosocomial infection
240373|NCT01933620|Multidrug Resistance|multidrug resistance
240374|NCT01933542|Chlorzoxazone|chlorzoxazone
240375|NCT01933542|Postoperative pain|postoperative pain
240376|NCT01933542|Spine surgery|spine surgery
240377|NCT01933542|Opioid consumption|opioid consumption
240378|NCT01933529|diabetes|diabetes
240379|NCT01933529|glucose tolerance|glucose tolerance
240380|NCT01933529|insulin secretion|insulin secretion
240381|NCT01933529|insulin sensitivity|insulin sensitivity
240382|NCT01933529|erythropoietin|erythropoietin
240383|NCT01933529|inflammation|inflammation
240384|NCT01933529|cytokines|cytokines
240385|NCT01933516|GP2013|gp2013
240386|NCT01933516|Japanese|japanese
240387|NCT01933516|indolent B-cell non-Hodgkin's lymphoma|indolent b-cell non-hodgkin's lymphoma
240388|NCT01933516|biosimilar|biosimilar
240389|NCT01933516|CD20|cd20
240390|NCT01933516|GP13-101|gp13-101
240392|NCT01933503|SAD|sad
240393|NCT01933503|Obeticholic Acid (OCA)|obeticholic acid (oca)
240394|NCT01933490|hyperinsulinemic hypoglycemia|hyperinsulinemic hypoglycemia
240395|NCT01933477|Maternal Health|maternal health
240396|NCT01933477|Child Health|child health
295949|NCT01682746|GBM|gbm
751906|NCT01171170|stage IV|stage iv
240398|NCT01933477|Antenatal care|antenatal care
240399|NCT01933477|Postpartum care|postpartum care
240400|NCT01933477|Prevention of mother to child transmission (PMTCT)|prevention of mother to child transmission (pmtct)
240401|NCT01933477|Breast feeding|breast feeding
240402|NCT01933477|Antiretrovirals|antiretrovirals
240403|NCT01933464|Rosacea|rosacea
240404|NCT01933464|Cromolyn sodium|cromolyn sodium
240405|NCT01933451|fluid therapy|fluid therapy
240406|NCT01933451|Intraoperative care|intraoperative care
240407|NCT01933451|Patient Outcome Assessment|patient outcome assessment
240408|NCT01933451|pulse pressure variation|pulse pressure variation
240409|NCT01933451|restrictive fluid therapy|restrictive fluid therapy
240410|NCT01933451|goal-directed fluid therapy|goal-directed fluid therapy
240411|NCT01933451|esophagectomy|esophagectomy
240412|NCT01933438|birth related brachial plexus injury|birth related brachial plexus injury
240413|NCT01933438|brachial plexus|brachial plexus
240414|NCT01933438|splint|splint
240415|NCT01933425|surgical conditions|surgical conditions
240416|NCT01933425|laparoscopy|laparoscopy
240417|NCT01933412|Dialysis|dialysis
240418|NCT01933412|Hepatitis B|hepatitis b
240419|NCT01933399|Low back pain|low back pain
240420|NCT01933399|Back brace|back brace
240421|NCT01933399|Lumbar orthoses|lumbar orthoses
240422|NCT01933399|Lumbosacral orthoses|lumbosacral orthoses
240423|NCT01933399|Low back pain treatment|low back pain treatment
240424|NCT01933386|Single Sided Deafness|single sided deafness
240425|NCT01933386|SSD|ssd
240426|NCT01933386|Unilateral hearing loss|unilateral hearing loss
240427|NCT01933373|Randomized|randomized
240428|NCT01933373|Toupet|toupet
240429|NCT01933373|Dor|dor
240430|NCT01933373|Achalasia|achalasia
240431|NCT01933360|Misoprostol|misoprostol
688531|NCT00924534|PD|pd
240432|NCT01933360|First trimester pregnancy|first trimester pregnancy
240433|NCT01933360|Surgical abortion|surgical abortion
240434|NCT01933360|Cervical priming|cervical priming
240435|NCT01933334|pirfenidone|pirfenidone
240436|NCT01933334|SSc-ILD|ssc-ild
240437|NCT01933334|scleroderma|scleroderma
240438|NCT01933334|systemic sclerosis|systemic sclerosis
240439|NCT01933334|interstitial lung disease|interstitial lung disease
240440|NCT01933321|ALS, stem cells|als, stem cells
240441|NCT01933308|Pulmonary Rehabilitation|pulmonary rehabilitation
240442|NCT01933308|Comparison of exercise training protocol|comparison of exercise training protocol
240443|NCT01933308|Exercise tolerance|exercise tolerance
240444|NCT01933308|Functional and quality of life status|functional and quality of life status
240445|NCT01933308|Cognitive and psychological status|cognitive and psychological status
240446|NCT01933308|Compliance to exercise recommendations|compliance to exercise recommendations
240447|NCT01933308|Long term adherence to exercise recommendations|long term adherence to exercise recommendations
240448|NCT01933295|treatment|treatment
240449|NCT01933282|MESA, chemotherapy,NK/T cell lymphoma|mesa, chemotherapy,nk/t cell lymphoma
240450|NCT01933256|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
240451|NCT01933256|HIP2B|hip2b
240452|NCT01933256|Placebo|placebo
240453|NCT01933256|islet β cell|islet β cell
240454|NCT01933243|Anxiety|anxiety
240455|NCT01933243|Anorexia nervosa|anorexia nervosa
240456|NCT01933243|Adolescents|adolescents
240457|NCT01933243|Fish oil|fish oil
240458|NCT01933217|TBI|tbi
240459|NCT01933217|traumatic brain injury|traumatic brain injury
240460|NCT01933217|ADHD|adhd
240461|NCT01933217|methylphenidate|methylphenidate
240462|NCT01933217|Concerta|concerta
240463|NCT01933217|attention problems|attention problems
240464|NCT01933204|perimenopause|perimenopause
240465|NCT01933204|hot flash|hot flash
240466|NCT01933204|palpitation|palpitation
240467|NCT01933191|Dental Anxiety, Physical Activity, Dental Phobia|dental anxiety, physical activity, dental phobia
240468|NCT01933191|Cortisol, Amylase|cortisol, amylase
240469|NCT01933178|Dry eyes|dry eyes
240470|NCT01933178|Cirrus AS-OCT|cirrus as-oct
240471|NCT01933178|Excess folds of the conjunctiva|excess folds of the conjunctiva
240472|NCT01933165|Dry Eyes|dry eyes
240473|NCT01933165|LipiView|lipiview
240474|NCT01933165|Lipid thickness|lipid thickness
240475|NCT01933152|wAMD|wamd
240476|NCT01933152|anti-VEGF|anti-vegf
240477|NCT01933139|Informed consent|informed consent
240478|NCT01933139|preoperative counseling|preoperative counseling
240479|NCT01933139|hysterectomy|hysterectomy
240480|NCT01933113|Obesity|obesity
240481|NCT01933113|Deep Brain Stimulation|deep brain stimulation
240482|NCT01933113|LHA|lha
240483|NCT01933100|Functional constipation|functional constipation
240484|NCT01933100|Brown rice based-meal|brown rice based-meal
240485|NCT01933100|Polished rice based-meal|polished rice based-meal
240486|NCT01933100|Wheat based-meal|wheat based-meal
240487|NCT01933087|Hand hygiene,|hand hygiene,
240488|NCT01933087|Randonmised Controlled Trials,|randonmised controlled trials,
240489|NCT01933087|Hospital|hospital
240490|NCT01933074|Urinary Urgency|urinary urgency
240491|NCT01933061|Skin cancer, Melanoma|skin cancer, melanoma
240492|NCT01933048|influenza|influenza
240493|NCT01933035|ITP|itp
240494|NCT01933035|Thrombocytopenia|thrombocytopenia
240495|NCT01933035|mean platelet mass|mean platelet mass
240496|NCT01933035|mean platelet component|mean platelet component
240497|NCT01933022|Exploratory|exploratory
240498|NCT01933022|Biomarkers|biomarkers
240500|NCT01933022|Metastatic prostate cancer|metastatic prostate cancer
240501|NCT01932996|Smoking Cessation|smoking cessation
240502|NCT01932996|Smoking Cessation Products|smoking cessation products
240503|NCT01932996|Tobacco Use Cessation Products|tobacco use cessation products
240504|NCT01932983|Neuromuscular blockade|neuromuscular blockade
240505|NCT01932983|TOF test|tof test
240506|NCT01932983|Quantitative TOF method|quantitative tof method
240507|NCT01932983|Visual interpretation of TOF|visual interpretation of tof
240508|NCT01932970|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
240509|NCT01932957|Laparoscopy|laparoscopy
240510|NCT01932957|Ruptured ectopic pregnancy|ruptured ectopic pregnancy
240511|NCT01932931|Vitamin D|vitamin d
240512|NCT01932931|Major depression|major depression
240513|NCT01932931|SSRIs|ssris
240514|NCT01932931|Osteoporosis|osteoporosis
240515|NCT01932918|reactive oxygen species|reactive oxygen species
240516|NCT01932918|ischemia reperfusion injury|ischemia reperfusion injury
240517|NCT01932905|deep repetitive transcranial magnetic stimulation|deep repetitive transcranial magnetic stimulation
240518|NCT01932905|chronic pain|chronic pain
240519|NCT01932905|assessment|assessment
240520|NCT01932905|neuropathic pain|neuropathic pain
240521|NCT01932905|central pain|central pain
240522|NCT01932905|treatment|treatment
240523|NCT01932892|transhumeral|transhumeral
240524|NCT01932866|pre-diabetes|pre-diabetes
240525|NCT01932866|diabetes risk score|diabetes risk score
240526|NCT01932866|motivation|motivation
240527|NCT01932866|Air Force|air force
240528|NCT01932866|Military|military
240529|NCT01932866|Lifestyle change|lifestyle change
240530|NCT01932840|attitudes and understanding of plant sterol claims|attitudes and understanding of plant sterol claims
240531|NCT01932840|general Canadian population|general canadian population
240532|NCT01932827|Attitudes and understanding of oat fibre claims|attitudes and understanding of oat fibre claims
240533|NCT01932827|Food labels|food labels
240534|NCT01932827|General Canadian population|general canadian population
240535|NCT01932814|Aminoglycosides|aminoglycosides
240536|NCT01932814|Acute kidney injury|acute kidney injury
240537|NCT01932814|Severe sepsis|severe sepsis
240538|NCT01932814|Critically ill patient|critically ill patient
240638|NCT01932281|SierraSil|sierrasil
240731|NCT01931956|EVEREST II|everest ii
240539|NCT01932801|harm reduction, naltrexone, alcohol dependence, homelessness|harm reduction, naltrexone, alcohol dependence, homelessness
240540|NCT01932788|pregnancy|pregnancy
240541|NCT01932788|Vitamin D status|vitamin d status
240542|NCT01932736|middle ear|middle ear
240543|NCT01932736|Eustachian tube|eustachian tube
240544|NCT01932736|fMRI|fmri
240545|NCT01932723|Stabilization exercises, Pain, Disability, Menstruation|stabilization exercises, pain, disability, menstruation
240546|NCT01932710|Leukemia|leukemia
240547|NCT01932710|Acute myelogenous leukemia|acute myelogenous leukemia
240548|NCT01932710|AML|aml
240549|NCT01932710|High-risk myelodysplastic leukemia|high-risk myelodysplastic leukemia
240550|NCT01932710|MDS|mds
240551|NCT01932710|Infection risk|infection risk
240552|NCT01932710|White Blood Cell transfusion|white blood cell transfusion
240553|NCT01932710|Prophylactic therapy|prophylactic therapy
240554|NCT01932671|Cardiovascular diseases|cardiovascular diseases
240555|NCT01932671|Atherosclerosis|atherosclerosis
240556|NCT01932671|Multidetector Computed Tomography|multidetector computed tomography
240557|NCT01932671|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
240558|NCT01932658|autologous|autologous
240559|NCT01932658|Lymphoablation|lymphoablation
240560|NCT01932658|hematopoietic|hematopoietic
240561|NCT01932658|immune system|immune system
240562|NCT01932645|prostatitis|prostatitis
240563|NCT01932645|pelvic pain|pelvic pain
240564|NCT01932645|urinary symptoms|urinary symptoms
240565|NCT01932645|sexual dysfunction|sexual dysfunction
240566|NCT01932632|Polypharmacy|polypharmacy
240567|NCT01932632|De-prescribing|de-prescribing
240568|NCT01932632|Frailty|frailty
240569|NCT01932593|multiple sclerosis|multiple sclerosis
240570|NCT01932593|bone marrow|bone marrow
240571|NCT01932593|stem cell therapy|stem cell therapy
240572|NCT01932580|gastric|gastric
240573|NCT01932580|esophageal|esophageal
240574|NCT01932580|adenocarcinoma|adenocarcinoma
240575|NCT01932554|Sickle Cell Pain Crisis|sickle cell pain crisis
240576|NCT01932554|Abciximab|abciximab
240577|NCT01932554|Integrins|integrins
240578|NCT01932554|Cell Adhesion Molecules|cell adhesion molecules
240579|NCT01932541|Bipolar Disorder|bipolar disorder
240580|NCT01932541|Mania|mania
240581|NCT01932541|Bipolar I|bipolar i
240582|NCT01932541|Bipolar II|bipolar ii
240583|NCT01932541|Bipolar Spectrum Disorder|bipolar spectrum disorder
240584|NCT01932541|Pediatric|pediatric
240585|NCT01932528|Absorption|absorption
240586|NCT01932528|Metabolism|metabolism
240587|NCT01932528|Excretion|excretion
240588|NCT01932502|epilepsy|epilepsy
240590|NCT01932502|clonazepam|clonazepam
240591|NCT01932463|Tremor|tremor
240592|NCT01932463|Essential Tremor|essential tremor
240593|NCT01932463|Medication-refractory Essential Tremor|medication-refractory essential tremor
240594|NCT01932450|hypertension|hypertension
240595|NCT01932450|radiofrequency ablation|radiofrequency ablation
240596|NCT01932450|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
240597|NCT01932424|Children|children
240598|NCT01932398|Alpha|alpha
240599|NCT01932398|Lateralization|lateralization
240600|NCT01932398|Attention|attention
240601|NCT01932398|ADHD|adhd
240602|NCT01932398|Oscillation|oscillation
240603|NCT01932385|Sorafenib|sorafenib
240604|NCT01932385|Hepatocellular carcinoma|hepatocellular carcinoma
240605|NCT01932385|Best supportive care|best supportive care
240606|NCT01932385|Survival|survival
240607|NCT01932372|Rheumatoid Arthritis|rheumatoid arthritis
240608|NCT01932372|Good Post Marketing Study Practice|good post marketing study practice
240609|NCT01932372|Tofacitinib|tofacitinib
240610|NCT01932372|Xeljanz|xeljanz
240611|NCT01932372|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
240612|NCT01932359|Scar outcome|scar outcome
240613|NCT01932359|Mohs surgery|mohs surgery
240614|NCT01932359|face|face
240615|NCT01932346|near infra-red spectroscopy, coronary artery bypass grafting|near infra-red spectroscopy, coronary artery bypass grafting
240616|NCT01932333|Healthy|healthy
240617|NCT01932333|Safety|safety
240618|NCT01932333|Tolerability|tolerability
240619|NCT01932333|Pharmacokinetics|pharmacokinetics
240620|NCT01932333|Pharmacodynamics|pharmacodynamics
240621|NCT01932333|JNJ-40411813|jnj-40411813
240622|NCT01932333|Positive allosteric modulator|positive allosteric modulator
240623|NCT01932320|Healthy|healthy
240624|NCT01932320|Relative Bioavailability|relative bioavailability
240625|NCT01932320|Food effect|food effect
240626|NCT01932320|JNJ-40411813|jnj-40411813
240627|NCT01932320|Positive allosteric modulator|positive allosteric modulator
240628|NCT01932320|Solid Dosage Formulation of JNJ-40411813|solid dosage formulation of jnj-40411813
240629|NCT01932320|Ketoconazole|ketoconazole
240630|NCT01932307|Surgeon neck health|surgeon neck health
240631|NCT01932294|Advanced Heart Failure|advanced heart failure
240632|NCT01932294|Refractory Heart Failure|refractory heart failure
240633|NCT01932294|Mechanical Circulatory Support Device|mechanical circulatory support device
240634|NCT01932294|Ventricular Assist Device|ventricular assist device
240635|NCT01932294|Medamacs|medamacs
240636|NCT01932281|muscle power|muscle power
240637|NCT01932281|muscle fatigue|muscle fatigue
240639|NCT01932255|microvascular decompression surgery|microvascular decompression surgery
240640|NCT01932255|cerebrospinal fluid leakage|cerebrospinal fluid leakage
240641|NCT01932255|postoperative complications|postoperative complications
240642|NCT01932229|Advanced NSCLC|advanced nsclc
240643|NCT01932229|EGFR mutation|egfr mutation
240644|NCT01932229|TKIs|tkis
240645|NCT01932229|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
240646|NCT01932216|robotic single-site cholecystectomy|robotic single-site cholecystectomy
240647|NCT01932216|laparoscopic cholecystectomy|laparoscopic cholecystectomy
240648|NCT01932216|cosmesis|cosmesis
240649|NCT01932216|quality of life|quality of life
240650|NCT01932203|Cerebral small vessel disease|cerebral small vessel disease
240651|NCT01932203|Leukoaraiosis|leukoaraiosis
240652|NCT01932203|Magnetic Resonance Imaging|magnetic resonance imaging
240653|NCT01932203|Diffusion Tensor Imaging|diffusion tensor imaging
240654|NCT01932190|Acute Kidney Injury|acute kidney injury
240655|NCT01932190|Critical Care|critical care
240656|NCT01932190|Renal Replacement Therapy|renal replacement therapy
240657|NCT01932190|Treatment Outcome|treatment outcome
240658|NCT01932177|Everolimus ; Sorafenib ; Phase 1 trial ; Solid tumor|everolimus ; sorafenib ; phase 1 trial ; solid tumor
240659|NCT01932164|Cleft lip and palate|cleft lip and palate
240942|NCT01930916|Aged|aged
240660|NCT01932164|Deciduous dental pulp stem cells|deciduous dental pulp stem cells
240661|NCT01932164|mesenchymal stem cells|mesenchymal stem cells
240662|NCT01932164|tissue engineering|tissue engineering
240663|NCT01932164|bone tissue engineering|bone tissue engineering
240664|NCT01932164|bioengineering|bioengineering
240665|NCT01932151|type-1 HRS|type-1 hrs
240666|NCT01932151|active bacterial infections|active bacterial infections
240667|NCT01932151|terlipressin and albumin|terlipressin and albumin
240668|NCT01932151|kidney function|kidney function
240669|NCT01932138|Community-based intervention|community-based intervention
240670|NCT01932138|Community health workers|community health workers
240671|NCT01932138|Antenatal care|antenatal care
240672|NCT01932138|HIV|hiv
240673|NCT01932138|PMTCT|pmtct
240674|NCT01932138|HIV vertical transmission|hiv vertical transmission
240675|NCT01932138|Public-sector health systems|public-sector health systems
240676|NCT01932112|Pulmonary Vein Isolation|pulmonary vein isolation
240677|NCT01932112|Adenosin effect|adenosin effect
402975|NCT01228799|glaucoma surgery|glaucoma surgery
231400|NCT01974817|end stage renal disease|end stage renal disease
231401|NCT01974817|dialysis|dialysis
231402|NCT01974804|MRI|mri
231403|NCT01974804|Brain metastases|brain metastases
231404|NCT01974804|13-094|13-094
240678|NCT01932112|Atrial fibrillation ablation|atrial fibrillation ablation
240679|NCT01932099|pathological constriction; restricted outflow, stenosis|pathological constriction; restricted outflow, stenosis
240680|NCT01932086|male|male
240681|NCT01932086|Glucose|glucose
240682|NCT01932086|Triglyceride|triglyceride
240683|NCT01932086|Glycemic index|glycemic index
240684|NCT01932086|White rice|white rice
240685|NCT01932086|Brown rice|brown rice
240686|NCT01932086|Black rice|black rice
240687|NCT01932086|Bread|bread
240688|NCT01932073|Radiation|radiation
240689|NCT01932073|dermatitis|dermatitis
240690|NCT01932073|radiodermatitis|radiodermatitis
240691|NCT01932073|radiotherapy induced|radiotherapy induced
240692|NCT01932073|skin reactions|skin reactions
240693|NCT01932073|low level laser therapy|low level laser therapy
240694|NCT01932073|breast cancer|breast cancer
240695|NCT01932060|Oxytocin|oxytocin
240696|NCT01932060|blood loss|blood loss
240697|NCT01932060|Cesarean delivery|cesarean delivery
240698|NCT01932034|Vancomycin|vancomycin
240699|NCT01932034|Pharmacokinetics|pharmacokinetics
240700|NCT01932034|Pharmacodynamics|pharmacodynamics
240701|NCT01932034|Decision support|decision support
240702|NCT01932021|necrotitis angiodermatitis|necrotitis angiodermatitis
240703|NCT01932021|autologous fat transplantation|autologous fat transplantation
240704|NCT01932021|mesenchymal stem cells|mesenchymal stem cells
240705|NCT01932008|Coronary artery bypass grafting|coronary artery bypass grafting
240706|NCT01932008|Chronic kidney disease|chronic kidney disease
240707|NCT01932008|Body composition|body composition
240708|NCT01932008|Physical activity|physical activity
240709|NCT01932008|Physical function|physical function
240710|NCT01931982|diabetes, GLP-1, Victoza, CFR, microvascular dysfunction|diabetes, glp-1, victoza, cfr, microvascular dysfunction
240711|NCT01931969|Vein catheterization; Ultrasound; Landmark; Complication|vein catheterization; ultrasound; landmark; complication
240712|NCT01931956|Mitral Valve Insufficiency|mitral valve insufficiency
240713|NCT01931956|Mitral Valve Regurgitation|mitral valve regurgitation
240714|NCT01931956|Mitral Valve Incompetence|mitral valve incompetence
240715|NCT01931956|Mitral Regurgitation|mitral regurgitation
240716|NCT01931956|Mitral Insufficiency|mitral insufficiency
240717|NCT01931956|Mitral Valve|mitral valve
240718|NCT01931956|Mitral Regurgitation (MR)|mitral regurgitation (mr)
240719|NCT01931956|Mitral Valve Prolapse|mitral valve prolapse
240720|NCT01931956|Edge to Edge (E2E)|edge to edge (e2e)
240721|NCT01931956|Alfieri Technique|alfieri technique
240722|NCT01931956|MitraClip|mitraclip
240723|NCT01931956|Functional MR|functional mr
240724|NCT01931956|Degenerative MR|degenerative mr
240725|NCT01931956|Echocardiogram|echocardiogram
240726|NCT01931956|Coronary Artery Disease (CAD)|coronary artery disease (cad)
240727|NCT01931956|Heart Failure|heart failure
240728|NCT01931956|Heart Attack|heart attack
240729|NCT01931956|EVEREST|everest
240730|NCT01931956|EVEREST I|everest i
240732|NCT01931956|REALISM|realism
240733|NCT01931930|Gastrointestinal discomfort|gastrointestinal discomfort
240734|NCT01931930|Perilla frutescens|perilla frutescens
240735|NCT01931930|bloating|bloating
240736|NCT01931930|abdominal discomfort|abdominal discomfort
240737|NCT01931930|human study|human study
240738|NCT01931930|healthy subjects|healthy subjects
240739|NCT01931917|Prevention|prevention
240740|NCT01931917|Parenting|parenting
240741|NCT01931917|Infants|infants
240742|NCT01931917|Family programs|family programs
240743|NCT01931917|Early intervention|early intervention
240744|NCT01931904|IOP|iop
240745|NCT01931904|Glaucoma|glaucoma
240746|NCT01931904|Trabeculectomy|trabeculectomy
240747|NCT01931891|preeclampsia, ADAMTS , wharton jelly, extracellüler matrix, placenta|preeclampsia, adamts , wharton jelly, extracellüler matrix, placenta
240748|NCT01931878|Restless Legs Syndrome|restless legs syndrome
240749|NCT01931878|Leg pain|leg pain
240750|NCT01931878|Sleep|sleep
240751|NCT01931878|Dysesthesias|dysesthesias
240752|NCT01931878|incobotulinumtoxin|incobotulinumtoxin
240753|NCT01931865|cancer pain, radiation therapy, surgery, incobotulinum toxin|cancer pain, radiation therapy, surgery, incobotulinum toxin
240754|NCT01931852|Acute Coronary Syndrome|acute coronary syndrome
240755|NCT01931852|Chest pain|chest pain
240756|NCT01931852|Cardiac MRI|cardiac mri
240757|NCT01931852|Risk Stratification|risk stratification
240758|NCT01931852|Emergency Department|emergency department
240759|NCT01931852|Elevated Troponin|elevated troponin
240760|NCT01931852|Troponin|troponin
240761|NCT01931852|Non-ST Elevation Myocardial Infarction|non-st elevation myocardial infarction
240762|NCT01931826|Schistosomiasis|schistosomiasis
240763|NCT01931826|Surgical treatment|surgical treatment
240764|NCT01931826|Endoscopic treatment|endoscopic treatment
240765|NCT01931774|acne vulgaris cognitive functions|acne vulgaris cognitive functions
240766|NCT01931761|Pharmacokinetics, mass balance, AZD6244|pharmacokinetics, mass balance, azd6244
240767|NCT01931735|menisci|menisci
240768|NCT01931735|tibial|tibial
240769|NCT01931722|branched chain amino acid requirement|branched chain amino acid requirement
240770|NCT01931722|older men|older men
240771|NCT01931722|strength training|strength training
240772|NCT01931722|sarcopenia|sarcopenia
240773|NCT01931696|Efficacy|efficacy
240774|NCT01931696|Acupuncture|acupuncture
240775|NCT01931696|Asthma|asthma
240776|NCT01931683|LMA removal|lma removal
240777|NCT01931683|remifentanil|remifentanil
240778|NCT01931683|propofol|propofol
240779|NCT01931670|Dysmenorrhea (DYS)|dysmenorrhea (dys)
240781|NCT01931670|Gonadotropin-Releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
240782|NCT01931670|Non-Menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
240783|NCT01931670|Endometriosis Associated Pain|endometriosis associated pain
240784|NCT01931657|LNG-IUS|lng-ius
240785|NCT01931657|Mirena|mirena
240786|NCT01931657|Contraception|contraception
240787|NCT01931657|Bleeding|bleeding
240788|NCT01931657|Hormonal effects in the breast|hormonal effects in the breast
240789|NCT01931644|Graft-versus-Host Disease (GVHD)|graft-versus-host disease (gvhd)
240790|NCT01931644|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
240791|NCT01931644|Cancer|cancer
240792|NCT01931644|Diabetes|diabetes
240793|NCT01931644|Melanoma|melanoma
240794|NCT01931644|Hepatitis B|hepatitis b
240795|NCT01931644|Lupus|lupus
240796|NCT01931644|Multiple Sclerosis|multiple sclerosis
240797|NCT01931644|Asthma|asthma
240798|NCT01931644|Crohn's Disease|crohn's disease
240799|NCT01931644|Ulcerative Colitis|ulcerative colitis
240800|NCT01931644|Kidney Disease|kidney disease
240801|NCT01931644|Alzheimer's Disease|alzheimer's disease
240802|NCT01931644|Parkinson's Disease|parkinson's disease
240803|NCT01931644|Huntington's Disease|huntington's disease
240804|NCT01931644|Rheumatoid Arthritis|rheumatoid arthritis
240805|NCT01931644|Sjogren's Syndrome|sjogren's syndrome
240806|NCT01931644|Leukemia|leukemia
240807|NCT01931644|Lymphoma|lymphoma
240808|NCT01931644|Myeloma|myeloma
240809|NCT01931644|CIDP|cidp
240810|NCT01931644|COPD|copd
240811|NCT01931644|Idiopathic Thrombocytopenia Purpura|idiopathic thrombocytopenia purpura
240812|NCT01931644|Cystic Fibrosis|cystic fibrosis
240813|NCT01931644|Primary Biliary Cirrhosis|primary biliary cirrhosis
240814|NCT01931631|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
240815|NCT01931631|Diet, Vegetarian|diet, vegetarian
240816|NCT01931631|Diet, Fat-Restricted|diet, fat-restricted
240817|NCT01931631|Glycemic Index|glycemic index
240818|NCT01931618|alcohol|alcohol
240819|NCT01931618|online intervention|online intervention
240820|NCT01931618|hazardous drinking|hazardous drinking
240821|NCT01931618|harmful drinking|harmful drinking
240822|NCT01931618|early intervention|early intervention
240823|NCT01931618|behavior change intervention|behavior change intervention
240824|NCT01931592|ESBL|esbl
240825|NCT01931592|neutropenia|neutropenia
240826|NCT01931592|eradication|eradication
240827|NCT01931592|bloodstream infection|bloodstream infection
240828|NCT01931592|immunosuppression|immunosuppression
240829|NCT01931579|confocal endo-microscopy, lung nodule, respiratory neoplasms|confocal endo-microscopy, lung nodule, respiratory neoplasms
240830|NCT01931566|Drug therapy|drug therapy
240831|NCT01931540|Obesity|obesity
240832|NCT01931540|Epigenesis, Genetic|epigenesis, genetic
240833|NCT01931540|Exercise Therapy|exercise therapy
240834|NCT01931527|Obesity|obesity
240835|NCT01931527|Metabolic syndrome|metabolic syndrome
240836|NCT01931527|Hyperuricemia|hyperuricemia
240837|NCT01931462|Cancer of the Kidney|cancer of the kidney
240838|NCT01931462|Renal Cancer|renal cancer
240839|NCT01931462|Renal Neoplasms|renal neoplasms
240840|NCT01931462|Neoplasms, Kidney|neoplasms, kidney
240841|NCT01931449|Pancreatoduodenectomy|pancreatoduodenectomy
240842|NCT01931449|Digestive Tract Reconstruction|digestive tract reconstruction
240843|NCT01931449|Pancreas|pancreas
240844|NCT01931436|Menopause, pharmacokinetic|menopause, pharmacokinetic
240845|NCT01931397|Dried blood spots|dried blood spots
240846|NCT01931397|kidney transplant|kidney transplant
240847|NCT01931397|Children|children
240848|NCT01931384|Luteal phase support|luteal phase support
240849|NCT01931384|Human chorionic gonadotrophin|human chorionic gonadotrophin
240850|NCT01931384|frozen-thawed embryo transfer cycle|frozen-thawed embryo transfer cycle
240851|NCT01931371|fistula in ano|fistula in ano
240852|NCT01931371|anal fistula|anal fistula
240853|NCT01931371|recurrence|recurrence
240854|NCT01931371|costs|costs
240855|NCT01931345|Rapid HIV testing|rapid hiv testing
240856|NCT01931345|MSM|msm
240857|NCT01931345|Motivational Interviewing|motivational interviewing
240858|NCT01931345|HIV prevention|hiv prevention
240859|NCT01931345|HIV/AIDS|hiv/aids
240860|NCT01931345|At-risk anal intercourse|at-risk anal intercourse
240861|NCT01931345|Randomized trial|randomized trial
240862|NCT01931332|Arthroplasty|arthroplasty
240863|NCT01931332|Analgesia|analgesia
240864|NCT01931319|baclofen withdrawal|baclofen withdrawal
240865|NCT01931319|interruption|interruption
240866|NCT01931319|spasticity|spasticity
240867|NCT01931319|pharmacokinetics|pharmacokinetics
240868|NCT01931319|tolerability|tolerability
240869|NCT01931319|intravenous|intravenous
240870|NCT01931293|atrophic glossitis, burning mouth syndrome, gastric parietal cell antibody, thyroglobulin antibody, thyroid microsomal antibody, HLA-DR, HLA-DQ|atrophic glossitis, burning mouth syndrome, gastric parietal cell antibody, thyroglobulin antibody, thyroid microsomal antibody, hla-dr, hla-dq
240871|NCT01931280|Gestational diabetes|gestational diabetes
240872|NCT01931241|atherosclerosis|atherosclerosis
240873|NCT01931241|atherosclerotic heart disease|atherosclerotic heart disease
240874|NCT01931241|hypercholesteremia|hypercholesteremia
240875|NCT01931241|atherosclerotic plaque|atherosclerotic plaque
240876|NCT01931241|hyperlipidemia|hyperlipidemia
240877|NCT01931228|Intensive care unit|intensive care unit
240878|NCT01931228|acute respiratory insufficiency|acute respiratory insufficiency
240879|NCT01931228|Respiratory failure|respiratory failure
240880|NCT01931228|Mechanical Insufflation-Exsufflation|mechanical insufflation-exsufflation
240881|NCT01931150|Topical Dapsone 5% Gel|topical dapsone 5% gel
240882|NCT01931150|Moisturizer|moisturizer
240883|NCT01931150|rash|rash
240884|NCT01931150|13-012|13-012
240885|NCT01931124|maximal oxygen uptake, activity levels, elderly|maximal oxygen uptake, activity levels, elderly
240886|NCT01931111|physical activity|physical activity
240887|NCT01931111|maximal oxygen uptake|maximal oxygen uptake
240888|NCT01931098|Brain Tumors|brain tumors
240889|NCT01931072|Exercise|exercise
240890|NCT01931072|High-intensity interval training|high-intensity interval training
240891|NCT01931072|Moderate training|moderate training
240892|NCT01931072|Healthy elderly|healthy elderly
240893|NCT01931072|Skeletal muscle|skeletal muscle
240894|NCT01931072|DNA-methylation|dna-methylation
240895|NCT01931072|Gene expression|gene expression
240896|NCT01931072|subjects|subjects
240897|NCT01931059|Imaging|imaging
240898|NCT01931059|Risperidone|risperidone
240899|NCT01931059|Placebo|placebo
240900|NCT01931059|antipsychotic|antipsychotic
240901|NCT01931046|prostate cancer|prostate cancer
240902|NCT01931046|adenocarcinoma of the prostate|adenocarcinoma of the prostate
240903|NCT01931033|Autism Spectrum Disorders|autism spectrum disorders
240904|NCT01931033|Pervasive Developmental Disorders|pervasive developmental disorders
240905|NCT01931033|ASD|asd
240906|NCT01931033|PDD|pdd
240907|NCT01931033|Oxytocin|oxytocin
240908|NCT01931033|Syntocinon|syntocinon
240909|NCT01931033|treatment|treatment
240910|NCT01931020|Pain|pain
240911|NCT01931020|Preterm|preterm
240912|NCT01931020|Neonates|neonates
240913|NCT01931020|24% Sucrose|24% sucrose
240914|NCT01931020|25% Dextrose|25% dextrose
240915|NCT01931007|osteoarthritis|osteoarthritis
240916|NCT01930994|LNG: Levonorgestrel|lng: levonorgestrel
240917|NCT01930994|MSI: Marie Stopes International|msi: marie stopes international
240918|NCT01930994|MSK: Marie Stopes Kenya|msk: marie stopes kenya
240919|NCT01930994|PK: Pharmacokinetic|pk: pharmacokinetic
240920|NCT01930981|quality of life|quality of life
240921|NCT01930981|toxicities|toxicities
240922|NCT01930981|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
240923|NCT01930968|Uveal melanoma, ocular melanoma|uveal melanoma, ocular melanoma
240924|NCT01930955|Non-antibiotic prescribing|non-antibiotic prescribing
240925|NCT01930955|acute upper respiratory tract infection|acute upper respiratory tract infection
240926|NCT01930955|white cell count|white cell count
240927|NCT01930955|vomiting|vomiting
240928|NCT01930942|rectal carcinoma|rectal carcinoma
240929|NCT01930942|preoperative concurrent chemoradiotherapy|preoperative concurrent chemoradiotherapy
240930|NCT01930929|Bariatric surgery|bariatric surgery
240931|NCT01930929|Complications|complications
240932|NCT01930929|Drugs|drugs
240933|NCT01930916|Prothrombin Time/instrumentation|prothrombin time/instrumentation
240934|NCT01930916|Prothrombin Time/utilization|prothrombin time/utilization
240935|NCT01930916|Blood Coagulation Disorders/blood|blood coagulation disorders/blood
240936|NCT01930916|Blood Coagulation Disorders/complications|blood coagulation disorders/complications
240937|NCT01930916|Blood Coagulation Disorders/diagnosis|blood coagulation disorders/diagnosis
240938|NCT01930916|Prospective Studies|prospective studies
240939|NCT01930916|Adult|adult
240940|NCT01930916|Reproducibility of Results|reproducibility of results
240941|NCT01930916|Point-of-Care Systems/utilization|point-of-care systems/utilization
240943|NCT01930916|Elderly|elderly
240944|NCT01930903|PRO-Kinetic Energy BMS + Pantera Lux DEB combination|pro-kinetic energy bms + pantera lux deb combination
240945|NCT01930877|quality of recovery|quality of recovery
240946|NCT01930877|spine surgery|spine surgery
240947|NCT01930877|intravenous lidocaine|intravenous lidocaine
240948|NCT01930864|metformin|metformin
240949|NCT01930864|colorectal cancer|colorectal cancer
240950|NCT01930864|chemotherapy|chemotherapy
240951|NCT01930851|Bariatric surgery|bariatric surgery
240952|NCT01930851|Quality of life|quality of life
240953|NCT01930851|Complications|complications
240954|NCT01930838|Bariatric surgery|bariatric surgery
240955|NCT01930838|Complications|complications
240956|NCT01930838|Osteoporosis|osteoporosis
240957|NCT01930838|Neuropathy|neuropathy
240958|NCT01930838|Vitamine deficiency|vitamine deficiency
240959|NCT01930812|18F-NaF PET/CT|18f-naf pet/ct
240960|NCT01930812|Bone imaging|bone imaging
240961|NCT01930773|clopidogrel|clopidogrel
240962|NCT01930773|prasugrel|prasugrel
240963|NCT01930773|platelet function testing|platelet function testing
240964|NCT01930773|genotyping|genotyping
240965|NCT01930773|peri-procedural MI|peri-procedural mi
240966|NCT01930760|pediatric|pediatric
240967|NCT01930760|Childhood Obesity|childhood obesity
240968|NCT01930760|motivational interviewing|motivational interviewing
240969|NCT01930760|pediatric primary care physicians|pediatric primary care physicians
240971|NCT01930747|laparoscopy|laparoscopy
240972|NCT01930734|Heart Failure|heart failure
240973|NCT01930734|Dobutamine|dobutamine
240974|NCT01930708|BG-12|bg-12
240975|NCT01930695|DX functionality|dx functionality
240976|NCT01930695|Atrial fibrillation|atrial fibrillation
240977|NCT01930695|CRT-D indication|crt-d indication
240978|NCT01930682|Myocardial Infarction|myocardial infarction
240979|NCT01930682|Catheterization|catheterization
240980|NCT01930682|Fibrinolysis|fibrinolysis
240981|NCT01930669|Heart Rate Variability|heart rate variability
240982|NCT01930669|Multiple Organ Dysfunction Syndrome|multiple organ dysfunction syndrome
240983|NCT01930669|Critically Ill|critically ill
240984|NCT01930656|osteoporisis|osteoporisis
240985|NCT01930656|fracture|fracture
240986|NCT01930656|risk|risk
240987|NCT01930656|cost effectiveness|cost effectiveness
240988|NCT01930656|FRAX|frax
240989|NCT01930656|mobile device|mobile device
240990|NCT01930643|Electric muscle stimulation|electric muscle stimulation
240991|NCT01930643|mechanical ventilation|mechanical ventilation
240992|NCT01930643|chronic respiratory failure|chronic respiratory failure
240993|NCT01930630|extraesophageal saline injection (ESI);|extraesophageal saline injection (esi);
240994|NCT01930630|esophageal squamous cell carcinoma (ESCC);|esophageal squamous cell carcinoma (escc);
240995|NCT01930630|esophageal cancer;|esophageal cancer;
240996|NCT01930630|endoscopic ultrasonography (EUS)|endoscopic ultrasonography (eus)
240997|NCT01930617|surgery|surgery
240998|NCT01930617|trephining|trephining
240999|NCT01930617|drainage|drainage
241000|NCT01930617|therapeutic irrigation|therapeutic irrigation
241001|NCT01930617|subdural space|subdural space
241002|NCT01930617|postoperative complications|postoperative complications
241003|NCT01930617|mortality|mortality
241004|NCT01930604|Palmar hyperhidrosis.|palmar hyperhidrosis.
241005|NCT01930604|Plantar hyperhidrosis.|plantar hyperhidrosis.
241006|NCT01930604|Inguinal (groins and buttocks) hyperhidrosis.|inguinal (groins and buttocks) hyperhidrosis.
241007|NCT01930604|Craniofacial hyperhidrosis.|craniofacial hyperhidrosis.
241008|NCT01930604|Truncal hyperhidrosis.|truncal hyperhidrosis.
241009|NCT01930591|fibrinolytic therapy|fibrinolytic therapy
241010|NCT01930591|stenting|stenting
241011|NCT01930591|platelet activity|platelet activity
241012|NCT01930578|bioimpedance analysis|bioimpedance analysis
241013|NCT01930578|spectroscopy|spectroscopy
241014|NCT01930578|electrolyte sodium bromide|electrolyte sodium bromide
241015|NCT01930578|extracellular water|extracellular water
241016|NCT01930565|acne|acne
241017|NCT01930565|therapeutics|therapeutics
241018|NCT01930565|clinical trial|clinical trial
241019|NCT01930565|natural compound|natural compound
241020|NCT01930565|Lactobacillus fermented Chamaecypris obtuse|lactobacillus fermented chamaecypris obtuse
241021|NCT01930565|tea tree oil|tea tree oil
241022|NCT01930526|COPD|copd
241023|NCT01930526|Exercise|exercise
241024|NCT01930526|Cycling|cycling
241025|NCT01930526|Single leg|single leg
241026|NCT01930526|Pulmonary Rehabilitation|pulmonary rehabilitation
241027|NCT01930513|Obesity|obesity
241028|NCT01930513|Obstructive Sleep Apnea|obstructive sleep apnea
241029|NCT01930513|Exercise|exercise
241030|NCT01930513|Walking tests|walking tests
241031|NCT01930513|Cardiopulmonary exercise tests|cardiopulmonary exercise tests
241032|NCT01930513|Physical activity|physical activity
241033|NCT01930487|Primary open angle glaucoma|primary open angle glaucoma
241034|NCT01930487|intraocular pressure|intraocular pressure
241035|NCT01930487|ocular perfusion pressure|ocular perfusion pressure
241036|NCT01930487|retrobulbar blood flow|retrobulbar blood flow
241037|NCT01930487|retinal capillary blood flow|retinal capillary blood flow
241038|NCT01930487|choroidal blood flow|choroidal blood flow
241039|NCT01930474|lung cancer, plasma DNA, free DNA, EGFR, ALK|lung cancer, plasma dna, free dna, egfr, alk
241040|NCT01930448|Bariatric|bariatric
241041|NCT01930448|Gastric Bypass|gastric bypass
241042|NCT01930448|Gastric Banding,|gastric banding,
241043|NCT01930448|Type 2 Diabetes|type 2 diabetes
241044|NCT01930448|Incretins|incretins
241045|NCT01930448|GLP-1|glp-1
241046|NCT01930448|GIP|gip
241047|NCT01930448|Insulin secretion|insulin secretion
241048|NCT01930448|insulin sensitivity|insulin sensitivity
241049|NCT01930435|Quality of Life|quality of life
231798|NCT01973127|use|use
241050|NCT01930422|Direct transcranial electrical stimulation (tDCS)|direct transcranial electrical stimulation (tdcs)
241051|NCT01930422|Sham procedure|sham procedure
241052|NCT01930422|Tobacco consumption|tobacco consumption
241053|NCT01930422|Craving|craving
241054|NCT01930409|Femoral Fractures|femoral fractures
241055|NCT01930409|Hip Fractures|hip fractures
241056|NCT01930409|Frail older adults|frail older adults
241057|NCT01930409|Quality of Life|quality of life
241058|NCT01930409|Feasibility Studies|feasibility studies
241059|NCT01930396|Hemodialysis|hemodialysis
241060|NCT01930396|Anticoagulation|anticoagulation
241061|NCT01930396|Tinzaparin|tinzaparin
241062|NCT01930396|Unfractionated Heparin|unfractionated heparin
241063|NCT01930396|Randomized Controlled Trial|randomized controlled trial
241064|NCT01930383|biomarkers|biomarkers
241065|NCT01930370|pediatrics|pediatrics
241066|NCT01930370|phosphate and postassium revmoval|phosphate and postassium revmoval
241067|NCT01930370|dialysate bicarbonate modeling|dialysate bicarbonate modeling
241068|NCT01930357|Rabies|rabies
241069|NCT01930357|Purified Vero Rabies Vaccine - Serum Free (VRVg)|purified vero rabies vaccine - serum free (vrvg)
241070|NCT01930357|Imovax® rabies|imovax® rabies
241071|NCT01930357|Human Diploid Cell Vaccine|human diploid cell vaccine
241072|NCT01930344|stereopsis|stereopsis
241073|NCT01930344|3D laparoscopy|3d laparoscopy
241074|NCT01930344|OCHRA|ochra
241075|NCT01930331|Uncomplicated Plasmodium falciparum Malaria|uncomplicated plasmodium falciparum malaria
241076|NCT01930305|Heating transfusion|heating transfusion
241077|NCT01930279|T cell markers|t cell markers
241078|NCT01930227|hypotension|hypotension
241079|NCT01930227|spinal anesthesia|spinal anesthesia
241080|NCT01930227|cesarean|cesarean
241081|NCT01930175|Pemphigus vulgaris|pemphigus vulgaris
241082|NCT01930175|pemphigus|pemphigus
241083|NCT01930175|blistering disease|blistering disease
241084|NCT01930162|HSC835|hsc835
241085|NCT01930162|single umbilical cord blood transplantation|single umbilical cord blood transplantation
241086|NCT01930162|non-myeloablative conditioning regimen|non-myeloablative conditioning regimen
241087|NCT01930162|Umbilical cord blood|umbilical cord blood
241088|NCT01930162|UCB transplantation|ucb transplantation
241089|NCT01930149|Cholesterol screening|cholesterol screening
241090|NCT01930149|High cholesterol|high cholesterol
241091|NCT01930149|Cardiovascular disease|cardiovascular disease
241092|NCT01930149|Statin treatment|statin treatment
241093|NCT01930136|Calorie restriction|calorie restriction
241094|NCT01930136|Type 2 diabetes|type 2 diabetes
241096|NCT01930136|Diabetic nephropathy prevention|diabetic nephropathy prevention
241097|NCT01930123|Fructose|fructose
241098|NCT01930123|NASH|nash
241099|NCT01930123|advanced fibrosis|advanced fibrosis
241100|NCT01930123|biomarker|biomarker
241101|NCT01930123|magnetic resonance|magnetic resonance
241102|NCT01930110|Type 1 diabetes|type 1 diabetes
241103|NCT01930110|Hypoglycemia|hypoglycemia
241104|NCT01930110|Insulin|insulin
241105|NCT01930110|Glucagon|glucagon
241106|NCT01930110|Closed-loop system|closed-loop system
241107|NCT01930110|Artificial pancreas|artificial pancreas
241108|NCT01930097|Type 1 diabetes|type 1 diabetes
241109|NCT01930097|Hypoglycemia|hypoglycemia
241110|NCT01930097|Insulin|insulin
241111|NCT01930097|Glucagon|glucagon
241112|NCT01930097|Closed-loop system|closed-loop system
241113|NCT01930097|Artificial pancreas|artificial pancreas
241114|NCT01930097|Carbohydrate counting|carbohydrate counting
241115|NCT01930084|HIV|hiv
241116|NCT01930084|linkage|linkage
241117|NCT01930084|retention|retention
242224|NCT01924949|Sofosbuvir|sofosbuvir
241118|NCT01930032|Clostridium difficile infection|clostridium difficile infection
241119|NCT01930019|etomidate,|etomidate,
241120|NCT01930019|thiopental,|thiopental,
241121|NCT01930019|serum cortisol concentration,|serum cortisol concentration,
241122|NCT01930006|c-Met|c-met
241123|NCT01930006|VEGFR|vegfr
241124|NCT01930006|Ron|ron
241125|NCT01930006|Cancer|cancer
241126|NCT01930006|Tumor|tumor
241127|NCT01930006|Safety|safety
241128|NCT01930006|Phase 1|phase 1
241129|NCT01929993|Conization|conization
241130|NCT01929993|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
241131|NCT01929993|Cervix Dysplasia|cervix dysplasia
241132|NCT01929993|Therapy|therapy
241133|NCT01929993|Electrosurgery|electrosurgery
241134|NCT01929980|HSCT|hsct
241135|NCT01929980|cytopenia|cytopenia
241136|NCT01929980|immune suppression|immune suppression
241137|NCT01929980|proteasome inhibitor|proteasome inhibitor
241138|NCT01929967|Heterotaxy syndrome|heterotaxy syndrome
241139|NCT01929967|Asplenia|asplenia
241140|NCT01929967|Polysplenia|polysplenia
241141|NCT01929889|schizophrenia|schizophrenia
241142|NCT01929889|schizoaffective disorder|schizoaffective disorder
241143|NCT01929889|iloperidone|iloperidone
241144|NCT01929889|Fanapt|fanapt
241145|NCT01929889|social cognition|social cognition
241146|NCT01929889|cognition|cognition
241147|NCT01929863|Metformin|metformin
241148|NCT01929863|Diabetes|diabetes
241149|NCT01929837|Tinnitus|tinnitus
241150|NCT01929837|Transcranial magnetic stimulation|transcranial magnetic stimulation
241151|NCT01929824|dysphagia, trouble swallowing, chest pain|dysphagia, trouble swallowing, chest pain
241152|NCT01929798|artificial pancreas|artificial pancreas
241153|NCT01929785|post tranplant heart allograft|post tranplant heart allograft
241154|NCT01929759|HIV|hiv
241155|NCT01929759|neurocognitive symptoms|neurocognitive symptoms
241156|NCT01929759|efavirenz|efavirenz
241157|NCT01929759|elvitegravir|elvitegravir
241158|NCT01929759|neurometabolites|neurometabolites
241159|NCT01929733|Patent Ductus Arteriosus|patent ductus arteriosus
241160|NCT01929720|cancer|cancer
241161|NCT01929720|cancer survivors|cancer survivors
241162|NCT01929720|worry|worry
241163|NCT01929720|insomnia|insomnia
241164|NCT01929720|symptoms|symptoms
241165|NCT01929720|fatigue|fatigue
241166|NCT01929720|depression|depression
241167|NCT01929720|anxiety|anxiety
751907|NCT01171170|nitroglycerin|nitroglycerin
241168|NCT01929681|Low Field Magnetic Stimulation|low field magnetic stimulation
241169|NCT01929681|bipolar|bipolar
241170|NCT01929681|depression|depression
241171|NCT01929681|alternative treatment|alternative treatment
241172|NCT01929668|ulcerative colitis|ulcerative colitis
241173|NCT01929668|bowel preparation|bowel preparation
241174|NCT01929655|Phase II|phase ii
241175|NCT01929655|symptomatic castration-resistant prostate cancer|symptomatic castration-resistant prostate cancer
241176|NCT01929655|bone metastases|bone metastases
241177|NCT01929642|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
241178|NCT01929642|self-injury|self-injury
241179|NCT01929642|Autism|autism
241180|NCT01929629|Phase 1|phase 1
241181|NCT01929629|Healthy Volunteers|healthy volunteers
241182|NCT01929629|First Time in Man|first time in man
241183|NCT01929629|Pharmacokinetics|pharmacokinetics
241184|NCT01929616|adenocarcinoma, colorectal,regorafenib|adenocarcinoma, colorectal,regorafenib
241185|NCT01929603|oncology, cancer, tumour, anticancer drug, pharmacokinetics, olaparib, rifampicin, neoplasm, CYP P450 inducer|oncology, cancer, tumour, anticancer drug, pharmacokinetics, olaparib, rifampicin, neoplasm, cyp p450 inducer
241186|NCT01929590|Colonoscopy|colonoscopy
241187|NCT01929590|Preparation|preparation
241188|NCT01929590|Polyp|polyp
241189|NCT01929590|Polyethylene glycol|polyethylene glycol
241190|NCT01929577|ASP015K|asp015k
241191|NCT01929577|healthy subjects|healthy subjects
241192|NCT01929564|cardiovascular disease|cardiovascular disease
241193|NCT01929564|risk factor|risk factor
241194|NCT01929564|broccoli|broccoli
241195|NCT01929564|GST|gst
241196|NCT01929564|blood pressure|blood pressure
241197|NCT01929564|Total cholesterol|total cholesterol
241198|NCT01929551|glycemic index|glycemic index
241199|NCT01929538|Chronic pancreatitis|chronic pancreatitis
241200|NCT01929538|Biliary stricture|biliary stricture
241201|NCT01929538|Endoscopic treatment|endoscopic treatment
241202|NCT01929538|cSEMS|csems
241203|NCT01929499|Colon cancer|colon cancer
241204|NCT01929499|Cytokine-induced killer cells|cytokine-induced killer cells
241205|NCT01929499|Adjuvant immunotherapy|adjuvant immunotherapy
241206|NCT01929499|Adjuvant chemotherapy|adjuvant chemotherapy
241207|NCT01929473|Pertussis infection|pertussis infection
241208|NCT01929473|Risk factors|risk factors
241209|NCT01929447|sleep disorders|sleep disorders
241210|NCT01929447|sleep apnea|sleep apnea
241211|NCT01929447|ambulatory device|ambulatory device
241212|NCT01929447|WatchPAT|watchpat
241213|NCT01929434|cerebral palsy|cerebral palsy
241214|NCT01929434|cell transplantation|cell transplantation
241215|NCT01929434|rehabilitation|rehabilitation
241216|NCT01929421|colorectal cancer|colorectal cancer
241217|NCT01929421|gemcitabine|gemcitabine
241218|NCT01929421|S-1|s-1
241219|NCT01929395|Breast Cancer|breast cancer
241220|NCT01929395|Breast Conserving Surgery|breast conserving surgery
241221|NCT01929395|Breast diagnostics|breast diagnostics
241222|NCT01929395|Breast imaging|breast imaging
241223|NCT01929382|dose titration|dose titration
241224|NCT01929382|FLS|fls
241225|NCT01929382|flu like symptoms|flu like symptoms
241226|NCT01929382|Actimmune|actimmune
241227|NCT01929369|ESRD|esrd
241228|NCT01929369|CKD|ckd
241229|NCT01929369|AV GRAFTS|av grafts
241230|NCT01929369|THROMBOSED AV GRAFTS|thrombosed av grafts
241231|NCT01929356|lung function tests|lung function tests
241232|NCT01929356|chest physiotherapy|chest physiotherapy
241233|NCT01929343|cocaine|cocaine
241234|NCT01929343|addiction|addiction
241235|NCT01929343|lidocaine|lidocaine
241236|NCT01929343|memory|memory
241237|NCT01929343|drug abuse|drug abuse
241238|NCT01929330|Bioequivalence|bioequivalence
241239|NCT01929330|Healthy Male Volunteers|healthy male volunteers
241240|NCT01929330|Androgenetic Alopecia|androgenetic alopecia
241241|NCT01929330|Dutasteride|dutasteride
241242|NCT01929330|Safety|safety
241243|NCT01929330|Tolerability|tolerability
241244|NCT01929317|Ropinirole|ropinirole
241245|NCT01929317|Parkinson's disease|parkinson's disease
241246|NCT01929291|Korea|korea
241247|NCT01929291|Post-marketing surveillance|post-marketing surveillance
241248|NCT01929291|Boostrix|boostrix
241249|NCT01929291|Prescribing information|prescribing information
241250|NCT01929291|Safety|safety
241251|NCT01929265|INFL|infl
241252|NCT01929265|Indolent non-follicular|indolent non-follicular
241253|NCT01929265|untreated INFL|untreated infl
241254|NCT01929252|dexmedetomidine|dexmedetomidine
241255|NCT01929252|wound infiltration|wound infiltration
241256|NCT01929252|postoperative analgesia|postoperative analgesia
241257|NCT01929187|Onychomycosis, BioEqual carrier system, amorolfine.|onychomycosis, bioequal carrier system, amorolfine.
241258|NCT01929174|Congenital heart disease|congenital heart disease
241259|NCT01929174|Myocardial fibrosis|myocardial fibrosis
241260|NCT01929174|Diastolic dysfunction|diastolic dysfunction
241261|NCT01929161|positive emotions|positive emotions
241262|NCT01929161|meditation|meditation
241263|NCT01929161|oxytocin|oxytocin
241264|NCT01929148|risk-reducing salpingectomy|risk-reducing salpingectomy
241265|NCT01929148|prophylactic bilateral salpingectomy|prophylactic bilateral salpingectomy
241266|NCT01929148|ovarian cancer prevention|ovarian cancer prevention
751908|NCT01171170|carboplatin|carboplatin
241267|NCT01929148|ovarian reserve|ovarian reserve
241268|NCT01929135|Periodontal Disease|periodontal disease
241269|NCT01929135|Chronic Periodontitis|chronic periodontitis
241270|NCT01929135|Atorvastatin|atorvastatin
241271|NCT01929135|Statins|statins
241272|NCT01929135|Hydroxymethylglutaryl-coenzyme A Reductase Inhibitors|hydroxymethylglutaryl-coenzyme a reductase inhibitors
241273|NCT01929135|Dentifrice|dentifrice
241274|NCT01929122|Prevention & control|prevention & control
241275|NCT01929122|Diet|diet
241276|NCT01929122|Functional food|functional food
241277|NCT01929122|Nutrition Assessment|nutrition assessment
241278|NCT01929122|Oryza sativa|oryza sativa
241279|NCT01929122|Rice Bran|rice bran
241280|NCT01929122|Phaseolus vulgaris L.|phaseolus vulgaris l.
241281|NCT01929122|Legumes|legumes
241282|NCT01929122|Microbiome|microbiome
241283|NCT01929122|Metabolomics|metabolomics
241284|NCT01929122|Prebiotics|prebiotics
241285|NCT01929083|Torsades de pointes|torsades de pointes
241286|NCT01929083|Progesterone|progesterone
241287|NCT01929083|Clinical trial|clinical trial
241288|NCT01929083|Risk reduction|risk reduction
241289|NCT01929083|Electrocardiography|electrocardiography
241291|NCT01929070|Rosuvastatin|rosuvastatin
241292|NCT01929070|Omega-3|omega-3
241293|NCT01929018|Amputation|amputation
241294|NCT01929018|Rehabilitation|rehabilitation
241295|NCT01929018|Exercise|exercise
241296|NCT01929018|Movement|movement
241297|NCT01929005|Comprehensive care|comprehensive care
241298|NCT01929005|Medicare|medicare
241299|NCT01929005|Cost-sharing|cost-sharing
241300|NCT01929005|Quality of care|quality of care
241301|NCT01928992|Mammography|mammography
241302|NCT01928992|3D|3d
241303|NCT01928992|Breast Cancer Detection|breast cancer detection
241304|NCT01928979|LA/LAA Thrombus|la/laa thrombus
241305|NCT01928979|Atrial Fibrillation|atrial fibrillation
241306|NCT01928979|Observation|observation
241307|NCT01928966|dietary fat|dietary fat
241308|NCT01928966|fat intake|fat intake
241309|NCT01928966|blood pressure|blood pressure
241310|NCT01928966|women|women
241311|NCT01928966|phytoestrogen|phytoestrogen
241312|NCT01928966|pumpkin seeds|pumpkin seeds
241313|NCT01928966|cardiovascular disease|cardiovascular disease
241314|NCT01928966|heart disease|heart disease
241315|NCT01928966|secoisolariciresinol|secoisolariciresinol
241316|NCT01928966|monounsaturated fat|monounsaturated fat
241317|NCT01928966|polyunsaturated fat|polyunsaturated fat
241318|NCT01928966|feeding study|feeding study
241319|NCT01928953|opioid induced constipation in patients without cancer and with cancer|opioid induced constipation in patients without cancer and with cancer
241320|NCT01928940|Advanced solid tumors|advanced solid tumors
241321|NCT01928940|BRAF|braf
241322|NCT01928940|Melanoma|melanoma
241323|NCT01928888|Acute heartburn episodes|acute heartburn episodes
241324|NCT01928849|Amputation|amputation
241325|NCT01928849|Post-amputation Pain|post-amputation pain
241326|NCT01928849|Neuropathic pain|neuropathic pain
241327|NCT01928849|Valproic Acid|valproic acid
241328|NCT01928849|Anesthesia, Conduction|anesthesia, conduction
241329|NCT01928849|Neuralgia, stump|neuralgia, stump
241330|NCT01928836|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
241331|NCT01928836|Small Cell Lung Carcinoma|small cell lung carcinoma
241332|NCT01928836|Biological Markers|biological markers
241333|NCT01928836|ROC Curve|roc curve
241334|NCT01928836|Delayed Diagnosis|delayed diagnosis
241335|NCT01928823|agoraphobia|agoraphobia
241336|NCT01928823|panic disorder|panic disorder
241337|NCT01928823|D-Cycloserine|d-cycloserine
241338|NCT01928823|DCS|dcs
241339|NCT01928823|exposure|exposure
241340|NCT01928823|cognitive behavioral therapy|cognitive behavioral therapy
241341|NCT01928823|CBT|cbt
241342|NCT01928823|augmentation|augmentation
241343|NCT01928810|Panic Disorder|panic disorder
241344|NCT01928810|Agoraphobia|agoraphobia
241345|NCT01928810|Physical Activity|physical activity
241346|NCT01928797|cardiac output pregnancy spinal anesthesia|cardiac output pregnancy spinal anesthesia
241347|NCT01928784|Low back pain|low back pain
297222|NCT01677273|Obesity|obesity
241348|NCT01928784|extracorporeal shock wave therapy|extracorporeal shock wave therapy
241349|NCT01928784|Trigger Points|trigger points
241350|NCT01928771|Asthma,|asthma,
241351|NCT01928771|Bronchial Diseases,|bronchial diseases,
241352|NCT01928771|Respiratory Tract Diseases,|respiratory tract diseases,
241353|NCT01928771|Lung Diseases,|lung diseases,
241354|NCT01928771|Obstructive Lung Diseases|obstructive lung diseases
241355|NCT01928758|Smoking|smoking
241356|NCT01928758|Nicotine|nicotine
241357|NCT01928745|Stewart approach|stewart approach
241358|NCT01928745|sepsis|sepsis
241359|NCT01928745|SIRS|sirs
241360|NCT01928745|cardiothoracic surgery|cardiothoracic surgery
241361|NCT01928745|CABG|cabg
241362|NCT01928719|Smoking|smoking
241363|NCT01928719|Nicotine|nicotine
241364|NCT01928706|edentulism|edentulism
241365|NCT01928706|denture liner|denture liner
241366|NCT01928706|prosthodontics|prosthodontics
241367|NCT01928706|OHIP EDENT|ohip edent
241368|NCT01928693|infectious corneal ulcers|infectious corneal ulcers
241369|NCT01928680|Triple Negative Breast Cancer, Cisplatin, Capecitabine|triple negative breast cancer, cisplatin, capecitabine
241370|NCT01928654|Edema|edema
241371|NCT01928654|Diabetic|diabetic
241372|NCT01928654|Laser|laser
241373|NCT01928654|Treatment|treatment
241374|NCT01928602|Crossover|crossover
241375|NCT01928602|Chronic stroke|chronic stroke
241376|NCT01928602|Stroke|stroke
241377|NCT01928602|Rehabilitation|rehabilitation
241378|NCT01928602|Language Therapy|language therapy
241379|NCT01928602|Aphasia|aphasia
241380|NCT01928602|Aphasia Therapy|aphasia therapy
241381|NCT01928602|Computerised Therapy|computerised therapy
241382|NCT01928602|Computerised Rehabilitation|computerised rehabilitation
241383|NCT01928602|Tablet|tablet
241384|NCT01928602|Apps|apps
241385|NCT01928602|Aphasia Rehabilitation|aphasia rehabilitation
241386|NCT01928602|Rehabilitation on Portable Tablets|rehabilitation on portable tablets
241387|NCT01928589|Cyclophosphamide|cyclophosphamide
241388|NCT01928589|Doxorubicin|doxorubicin
241389|NCT01928589|Docetaxel|docetaxel
241390|NCT01928589|Carboplatin|carboplatin
241391|NCT01928589|Herceptin|herceptin
241392|NCT01928589|Partial Breast Irradiation|partial breast irradiation
241393|NCT01928589|Concurrent Chemotherapy|concurrent chemotherapy
241394|NCT01928550|Diabetes|diabetes
241396|NCT01928550|PDR|pdr
241397|NCT01928537|International Working Group|international working group
241398|NCT01928537|azacitidine|azacitidine
241399|NCT01928537|decitabine|decitabine
241400|NCT01928524|Gastric cancer|gastric cancer
241401|NCT01928524|Cancer of the esophagus|cancer of the esophagus
241402|NCT01928524|Oxaliplatin|oxaliplatin
241403|NCT01928524|Docetaxel|docetaxel
241404|NCT01928524|S1|s1
241405|NCT01928511|Hepatitis B virus|hepatitis b virus
241406|NCT01928511|HBeAg positive|hbeag positive
241407|NCT01928511|HBeAg negative|hbeag negative
241408|NCT01928511|antiviral therapy|antiviral therapy
241409|NCT01928511|nucleoside analogues|nucleoside analogues
241410|NCT01928498|arteriovenous fistulae|arteriovenous fistulae
241411|NCT01928498|arteriovenous graft|arteriovenous graft
241412|NCT01928498|restenosis|restenosis
241413|NCT01928498|angioplasty|angioplasty
241414|NCT01928498|drug eluting balloon|drug eluting balloon
241415|NCT01928472|Influenza, H7N9, Vaccine|influenza, h7n9, vaccine
241416|NCT01928459|BGJ398|bgj398
241417|NCT01928459|BYL719|byl719
241418|NCT01928459|advanced solid tumor|advanced solid tumor
241419|NCT01928459|metastatic breast cancer|metastatic breast cancer
241420|NCT01928459|PK3CA|pk3ca
241421|NCT01928459|FGFR|fgfr
241422|NCT01928459|fibroblast growth factor receptor|fibroblast growth factor receptor
241423|NCT01928446|Lithium|lithium
241424|NCT01928446|Placebos|placebos
241425|NCT01928446|Double-blind methods|double-blind methods
242225|NCT01924949|Ledipasvir|ledipasvir
241426|NCT01928446|Clinical Trials, Randomized|clinical trials, randomized
241427|NCT01928446|Veterans|veterans
241428|NCT01928433|Urinary Tract Infection|urinary tract infection
241429|NCT01928433|Pyelonephritis|pyelonephritis
241430|NCT01928420|Alzheimer Disease|alzheimer disease
241431|NCT01928420|Alzheimer Type Senile Dementia|alzheimer type senile dementia
241432|NCT01928420|Alzheimer's Disease|alzheimer's disease
241433|NCT01928420|clinical trial|clinical trial
241434|NCT01928420|dementia|dementia
241435|NCT01928420|diabetes|diabetes
241436|NCT01928420|dietary supplements|dietary supplements
241437|NCT01928420|Senile Dementia, Alzheimer|senile dementia, alzheimer
241438|NCT01928420|Therapeutics|therapeutics
241439|NCT01928420|Brain Diseases|brain diseases
241440|NCT01928420|Central Nervous System Diseases|central nervous system diseases
241441|NCT01928420|Nervous System Diseases|nervous system diseases
241442|NCT01928420|Neurodegenerative Diseases|neurodegenerative diseases
241443|NCT01928420|Delirium, Dementia, Amnestic, Cognitive|delirium, dementia, amnestic, cognitive
241444|NCT01928420|Disorders|disorders
241445|NCT01928420|Mental Disorders|mental disorders
241446|NCT01928407|naives, CD4 < 200 cell/mm3, Atazanavir, Darunavir|naives, cd4 < 200 cell/mm3, atazanavir, darunavir
241447|NCT01928368|Mild asthma|mild asthma
241448|NCT01928368|Atopic asthma|atopic asthma
241449|NCT01928368|Healthy volunteers|healthy volunteers
241450|NCT01928368|First-in-human|first-in-human
241451|NCT01928316|Healthy|healthy
241452|NCT01928316|Bioequivalence|bioequivalence
241453|NCT01928316|Mizolastine|mizolastine
241454|NCT01928316|Domestic|domestic
241455|NCT01928316|Imported|imported
241456|NCT01928303|opioids|opioids
241457|NCT01928303|chronic pain|chronic pain
241458|NCT01928303|oxycodone|oxycodone
241459|NCT01928303|oxymorphone|oxymorphone
241460|NCT01928303|patients using opioid pain medication|patients using opioid pain medication
241461|NCT01928277|Symptom assessment agreement|symptom assessment agreement
241462|NCT01928277|Work of breathing|work of breathing
241463|NCT01928264|Mental disorders|mental disorders
241464|NCT01928264|Physical activity|physical activity
241465|NCT01928264|Disability pension|disability pension
241466|NCT01928264|Disability pension due to mental illness|disability pension due to mental illness
241467|NCT01928264|Ability to work|ability to work
241468|NCT01928264|Mental toughness|mental toughness
241469|NCT01928238|NIV|niv
241470|NCT01928238|NAVA|nava
241471|NCT01928238|noninvasive neurally adjusted ventilatory|noninvasive neurally adjusted ventilatory
241472|NCT01928238|noninvasive pressure support ventilation|noninvasive pressure support ventilation
241474|NCT01928225|CIN|cin
241475|NCT01928225|HPV|hpv
241476|NCT01928225|HPV vaccination|hpv vaccination
241477|NCT01928225|gardasil|gardasil
241478|NCT01928225|HIV|hiv
241479|NCT01928225|cervical dysplasia|cervical dysplasia
241480|NCT01928225|LEEP|leep
241481|NCT01928225|cervical cancer|cervical cancer
241482|NCT01928212|retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
241483|NCT01928212|optical coherence tomography|optical coherence tomography
241484|NCT01928212|Parkinson disease|parkinson disease
241485|NCT01928199|diabetes|diabetes
241486|NCT01928199|transplant|transplant
241487|NCT01928199|kidney|kidney
241488|NCT01928173|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
241489|NCT01928173|Cognitive Therapy|cognitive therapy
241490|NCT01928160|Non-small cell lung cancer, EGFR mutation, erlotinib acquired resistance|non-small cell lung cancer, egfr mutation, erlotinib acquired resistance
241491|NCT01928147|NS5B polymerase inhibitor|ns5b polymerase inhibitor
241492|NCT01928147|Phase 1|phase 1
241493|NCT01928147|Genotype 1|genotype 1
241494|NCT01928134|Vitamin K2|vitamin k2
241495|NCT01928134|Vitamin D3|vitamin d3
241496|NCT01928134|Bioavailability of calcium|bioavailability of calcium
241497|NCT01928134|volunteers|volunteers
241498|NCT01928134|Men|men
241499|NCT01928134|non-pregnant women|non-pregnant women
241500|NCT01928134|twenty years of age|twenty years of age
241501|NCT01928121|nurse|nurse
241502|NCT01928121|expert program|expert program
241503|NCT01928121|primary care|primary care
241504|NCT01928121|implementation|implementation
241505|NCT01928121|interdisciplinary|interdisciplinary
241506|NCT01928121|effectiveness|effectiveness
241507|NCT01928121|disease management system|disease management system
241508|NCT01928095|atherosclerosis|atherosclerosis
241509|NCT01928095|carotid endartherectomy|carotid endartherectomy
241510|NCT01928082|Hypercalciuria, Familial Idiopathic|hypercalciuria, familial idiopathic
241511|NCT01928082|Hypercalciuria|hypercalciuria
241512|NCT01928082|Osteopenia|osteopenia
241513|NCT01928082|Osteoporosis|osteoporosis
241514|NCT01928082|Postmenopausal women|postmenopausal women
241515|NCT01928004|edentulous|edentulous
241516|NCT01928004|complete denture|complete denture
241517|NCT01927991|tinnitus|tinnitus
241518|NCT01927991|cognitive behavioural therapy|cognitive behavioural therapy
241519|NCT01927991|internet treatment|internet treatment
241520|NCT01927978|Esophageal cancer|esophageal cancer
241521|NCT01927978|18F-FDG PET|18f-fdg pet
241522|NCT01927978|staging|staging
241523|NCT01927978|therapy planning|therapy planning
241524|NCT01927978|therapy response monitoring|therapy response monitoring
241525|NCT01927978|prognosis|prognosis
241526|NCT01927965|gastrointestinal tract|gastrointestinal tract
241527|NCT01927965|GI tract|gi tract
241528|NCT01927965|advanced gastrointestinal tumors|advanced gastrointestinal tumors
241529|NCT01927965|gastrointestinal tumors|gastrointestinal tumors
241530|NCT01927965|GI tumors|gi tumors
241531|NCT01927965|biliary|biliary
241532|NCT01927965|gallbladder,|gallbladder,
241533|NCT01927965|colorectal,|colorectal,
241534|NCT01927965|gastric,|gastric,
241535|NCT01927965|hepatocellular|hepatocellular
241536|NCT01927965|esophageal|esophageal
241537|NCT01927965|pancreatic|pancreatic
241538|NCT01927952|hammertoe|hammertoe
241539|NCT01927939|Breast cancer; bone metastases; 18F-FDG PET; 99mTc bone scintigraphy; therapy response monitoring; prognosis|breast cancer; bone metastases; 18f-fdg pet; 99mtc bone scintigraphy; therapy response monitoring; prognosis
241540|NCT01927926|Energy intake|energy intake
241541|NCT01927926|appetite|appetite
241542|NCT01927926|satiety|satiety
241543|NCT01927926|gut hormones|gut hormones
241544|NCT01927900|Human milk oligosaccharides|human milk oligosaccharides
241545|NCT01927900|Microbiota|microbiota
241546|NCT01927900|Prebiotics|prebiotics
241547|NCT01927887|Papillary Carcinoma of Thyroid|papillary carcinoma of thyroid
241548|NCT01927887|Follicular thyroid cancer lymph node metastasis|follicular thyroid cancer lymph node metastasis
241549|NCT01927887|Metastatic medullary thyroid cancer|metastatic medullary thyroid cancer
241550|NCT01927874|infiltration|infiltration
241551|NCT01927874|hemorrhoidectomy|hemorrhoidectomy
241552|NCT01927874|Postoperative pain|postoperative pain
241553|NCT01927822|termination of pregnancy, abortion|termination of pregnancy, abortion
241554|NCT01927809|Hereditary Diseases|hereditary diseases
241555|NCT01927809|Colon|colon
241556|NCT01927783|Cardiovascular Disease|cardiovascular disease
241557|NCT01927783|Obesity|obesity
241558|NCT01927770|Whole Genome Sequencing|whole genome sequencing
241559|NCT01927770|Informed Choice|informed choice
241560|NCT01927757|rheumatoid arthritis|rheumatoid arthritis
241561|NCT01927757|etanercept|etanercept
241562|NCT01927757|arthritis|arthritis
241563|NCT01927757|adalimumab failure to respond|adalimumab failure to respond
241564|NCT01927757|loss of response to adalimumab|loss of response to adalimumab
241565|NCT01927757|ACR20|acr20
241566|NCT01927757|methotrexate|methotrexate
241567|NCT01927757|Swollen joints|swollen joints
241568|NCT01927757|tender joints|tender joints
241569|NCT01927744|Head and Neck Cancer|head and neck cancer
241570|NCT01927744|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
241572|NCT01927744|Oral cavity squamous cell carcinomas|oral cavity squamous cell carcinomas
241573|NCT01927744|Docetaxel|docetaxel
241574|NCT01927744|Taxotere|taxotere
241575|NCT01927744|Erlotinib|erlotinib
241576|NCT01927744|Erlotinib Hydrochloride|erlotinib hydrochloride
241577|NCT01927744|OSI-774|osi-774
241578|NCT01927744|CP358774|cp358774
241579|NCT01927744|Tarceva|tarceva
241580|NCT01927744|Questionnaire|questionnaire
241581|NCT01927744|Survey|survey
241582|NCT01927744|Phone call|phone call
241583|NCT01927731|Blood And Marrow Transplantation|blood and marrow transplantation
241584|NCT01927731|Cord blood transplantation|cord blood transplantation
241586|NCT01927731|Platelet count|platelet count
241587|NCT01927731|Haploidentical donor stem cell transplant|haploidentical donor stem cell transplant
241588|NCT01927731|Eltrombopag|eltrombopag
241589|NCT01927731|Promacta|promacta
241590|NCT01927718|Blood And Marrow Transplantation|blood and marrow transplantation
241591|NCT01927718|Myeloma|myeloma
241592|NCT01927718|Multiple myeloma|multiple myeloma
241593|NCT01927718|MM|mm
241594|NCT01927718|Autologous stem cell transplantation|autologous stem cell transplantation
241595|NCT01927718|ASCT|asct
241596|NCT01927718|Thalidomide|thalidomide
241597|NCT01927718|Thalomid|thalomid
241598|NCT01927718|Lenalidomide|lenalidomide
241599|NCT01927718|CC-5013|cc-5013
241600|NCT01927718|Revlimid|revlimid
241601|NCT01927718|Questionnaires|questionnaires
241602|NCT01927718|Surveys|surveys
241603|NCT01927705|Atopic dermatitis|atopic dermatitis
241604|NCT01927705|Stem cell|stem cell
241605|NCT01927705|Cell therapy|cell therapy
241606|NCT01927705|skin disease|skin disease
241607|NCT01927705|furestem|furestem
241608|NCT01927705|AD|ad
241609|NCT01927705|hUCB-MSC|hucb-msc
241610|NCT01927705|UCB-MSC|ucb-msc
241611|NCT01927705|Umbilical cord Blood|umbilical cord blood
241612|NCT01927692|MG|mg
241613|NCT01927666|glucoraphanin|glucoraphanin
241614|NCT01927666|broccoli|broccoli
241615|NCT01927666|gut microbiota|gut microbiota
241616|NCT01927653|Amnestic mild cognitive impairment|amnestic mild cognitive impairment
241617|NCT01927653|Dysexecutive mild cognitive impairment|dysexecutive mild cognitive impairment
241618|NCT01927653|Diffusion MRI|diffusion mri
241619|NCT01927640|Cocaine|cocaine
241620|NCT01927640|Dexmedetomidine|dexmedetomidine
241621|NCT01927640|Myocardial Contrast Echocardiography|myocardial contrast echocardiography
241622|NCT01927627|Prostate cancer|prostate cancer
241623|NCT01927627|adenocarcinoma of the prostate|adenocarcinoma of the prostate
241624|NCT01927627|Enzalutamide|enzalutamide
241625|NCT01927614|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
241626|NCT01927614|Cardiac MRI|cardiac mri
241627|NCT01927614|Cardiac CT|cardiac ct
241628|NCT01927614|Observational study|observational study
241629|NCT01927601|TAVR|tavr
241630|NCT01927601|aortic disease|aortic disease
241631|NCT01927588|Certican|certican
241632|NCT01927588|Renal Transplant|renal transplant
241633|NCT01927588|Cytomegalovirus Infection|cytomegalovirus infection
241634|NCT01927575|TOMOSYNTHESIS|tomosynthesis
241635|NCT01927549|cardiogenic shock|cardiogenic shock
241636|NCT01927549|infarction|infarction
241637|NCT01927549|multivessel coronary artery disease|multivessel coronary artery disease
241638|NCT01927549|angioplasty|angioplasty
241639|NCT01927523|Youth violence|youth violence
241640|NCT01927523|Crime|crime
241641|NCT01927523|Educational achievement|educational achievement
241642|NCT01927510|Early mobilization, rehabilitation, intensive care|early mobilization, rehabilitation, intensive care
241643|NCT01927497|Rectal cancer|rectal cancer
402976|NCT01228799|non-penetrating surgery|non-penetrating surgery
241644|NCT01927497|Extralevator abdominoperineal resection|extralevator abdominoperineal resection
241645|NCT01927497|Biological Mesh|biological mesh
241646|NCT01927497|Primary closure|primary closure
241647|NCT01927484|methotrexate,|methotrexate,
241648|NCT01927484|osteoarthritis,|osteoarthritis,
241649|NCT01927484|pain,|pain,
241650|NCT01927484|function,|function,
241651|NCT01927484|synovitis|synovitis
241652|NCT01927471|Menstrual cycles|menstrual cycles
241653|NCT01927471|Ultrasound|ultrasound
241654|NCT01927471|Ovary|ovary
241655|NCT01927471|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
241656|NCT01927471|Physical activity|physical activity
241657|NCT01927471|Diet|diet
241658|NCT01927432|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
241659|NCT01927432|Nutrition|nutrition
241660|NCT01927432|Metabolism|metabolism
241661|NCT01927432|Antral follicle growth|antral follicle growth
241662|NCT01927432|Menstrual Cyclicity|menstrual cyclicity
241663|NCT01927406|Thyroid Eye Disease|thyroid eye disease
241664|NCT01927406|Graves' Disease|graves' disease
241665|NCT01927406|Prostaglandin Analogues|prostaglandin analogues
241666|NCT01927380|autonomic nervous system modulation|autonomic nervous system modulation
241667|NCT01927380|heart rate variability|heart rate variability
241669|NCT01927380|steep trendelenburg|steep trendelenburg
241670|NCT01927380|pneumoperitoneum|pneumoperitoneum
241671|NCT01927367|Clinical Decision Support System|clinical decision support system
241672|NCT01927367|Primary Health Care|primary health care
241673|NCT01927367|Clinical Practice Guidelines|clinical practice guidelines
241674|NCT01927354|Head-and-Neck squamous cell carcinoma (HNSCC)|head-and-neck squamous cell carcinoma (hnscc)
241675|NCT01927354|epithelial-mesenchymal transition (EMT)|epithelial-mesenchymal transition (emt)
241676|NCT01927354|microRNA29|microrna29
241677|NCT01927354|Twist1|twist1
241678|NCT01927341|MEK162,|mek162,
241679|NCT01927341|panitumumab,|panitumumab,
241680|NCT01927341|mutant RAS,|mutant ras,
241681|NCT01927341|wild-type RAS,|wild-type ras,
241682|NCT01927341|metastatic colorectal cancer,|metastatic colorectal cancer,
241683|NCT01927341|adult mCRC patient|adult mcrc patient
241684|NCT01927328|Adenocarcinoma|adenocarcinoma
241685|NCT01927328|Anemia|anemia
241686|NCT01927328|Palliative therapy|palliative therapy
241687|NCT01927328|Palliative care|palliative care
241688|NCT01927328|Palliative treatments|palliative treatments
241689|NCT01927328|Chemotherapy|chemotherapy
241690|NCT01927328|Esophageal Cancer|esophageal cancer
241691|NCT01927328|Gastric Cancer|gastric cancer
241692|NCT01927315|Stem cells|stem cells
241693|NCT01927315|Regeneration|regeneration
241694|NCT01927315|Angiogenesis|angiogenesis
241695|NCT01927315|Prevention|prevention
241696|NCT01927302|Aphasia|aphasia
241697|NCT01927302|Dysgraphia|dysgraphia
241698|NCT01927302|Anomia|anomia
241699|NCT01927302|Agrammatism|agrammatism
241700|NCT01927302|Stroke|stroke
241701|NCT01927302|Language Recovery|language recovery
241702|NCT01927302|Treatment|treatment
241703|NCT01927302|Biomarkers of Recovery|biomarkers of recovery
241704|NCT01927289|Ultrasound|ultrasound
241705|NCT01927289|supraclavicular block|supraclavicular block
241706|NCT01927289|distal forearm block|distal forearm block
241707|NCT01927289|Grip Strength|grip strength
241708|NCT01927289|Satisfaction|satisfaction
241709|NCT01927276|Schizophrenia|schizophrenia
241710|NCT01927276|Gluten|gluten
241711|NCT01927250|cohort study|cohort study
241712|NCT01927250|diet program|diet program
241713|NCT01927250|art therapy|art therapy
241714|NCT01927250|laying-on-of-hands|laying-on-of-hands
241715|NCT01927250|quality of life|quality of life
241716|NCT01927237|pulmonary artery pressure|pulmonary artery pressure
241717|NCT01927237|ARDS|ards
241718|NCT01927237|alveolar hypoventilation|alveolar hypoventilation
241719|NCT01927237|hypercapnic acidosis|hypercapnic acidosis
241720|NCT01927237|permissive hypercapnia|permissive hypercapnia
241721|NCT01927237|myocardial strain|myocardial strain
242226|NCT01924949|FDC|fdc
241722|NCT01927211|cesarean section incisions|cesarean section incisions
241723|NCT01927211|silver|silver
241724|NCT01927211|C-section|c-section
241725|NCT01927211|wound infection|wound infection
241726|NCT01927211|scar appearance|scar appearance
241727|NCT01927211|pain|pain
241728|NCT01927185|central venous access|central venous access
241729|NCT01927185|ultrasonography|ultrasonography
241730|NCT01927185|subclavian vein|subclavian vein
241731|NCT01927185|pneumothorax|pneumothorax
241732|NCT01927185|vessel view|vessel view
241733|NCT01927159|Tuberculosis|tuberculosis
241734|NCT01927159|TB|tb
241735|NCT01927159|Pulmonary|pulmonary
241736|NCT01927159|Vaccine|vaccine
241737|NCT01927159|Adjuvant|adjuvant
241738|NCT01927146|Lauren classification|lauren classification
241739|NCT01927146|HER2 status|her2 status
241740|NCT01927146|Resectable gastric cancer|resectable gastric cancer
241741|NCT01927133|Fibrosis, HBV, HCV, ALD, NAFLD|fibrosis, hbv, hcv, ald, nafld
241742|NCT01927120|GVHD|gvhd
241743|NCT01927120|Allogeneic|allogeneic
241744|NCT01927120|Hematopoietic Cell Transplant|hematopoietic cell transplant
297694|NCT01674998|RBD|rbd
241745|NCT01927107|probiotics|probiotics
241746|NCT01927107|obesity|obesity
241747|NCT01927107|oxidative stress|oxidative stress
241748|NCT01927094|probiotics, diarrhea|probiotics, diarrhea
241749|NCT01927055|NOH|noh
241750|NCT01927055|OH|oh
241751|NCT01927055|PD|pd
241752|NCT01927055|MSA|msa
241753|NCT01927055|PAF|paf
241754|NCT01927055|DBH|dbh
241755|NCT01927042|Eating Disorders|eating disorders
241756|NCT01927042|Carers|carers
241757|NCT01927029|twin pregnancy|twin pregnancy
241758|NCT01927029|progesterone|progesterone
241759|NCT01927029|preterm delivery|preterm delivery
241760|NCT01927029|>14 years|>14 years
241761|NCT01927029|Abscense of cerclage,|abscense of cerclage,
241762|NCT01927029|TTTS, hemorrage,|ttts, hemorrage,
241763|NCT01927029|history of thrombosis.|history of thrombosis.
241764|NCT01927029|cervix >15mm|cervix >15mm
241765|NCT01927016|Esophageal Neoplasm|esophageal neoplasm
241766|NCT01927016|Esophagus|esophagus
241767|NCT01927016|Surgery|surgery
241768|NCT01927016|Outcome assessment|outcome assessment
241769|NCT01927003|defect,|defect,
241770|NCT01927003|dorsal branch of the digital artery,|dorsal branch of the digital artery,
241585|NCT01927731|CBT|cbt
241771|NCT01927003|dorsal digital flap,|dorsal digital flap,
241772|NCT01927003|dorsal metacarpal artery flap.|dorsal metacarpal artery flap.
241773|NCT01926964|Adjuvant treatment recommendation|adjuvant treatment recommendation
241774|NCT01926964|Early breast cancer|early breast cancer
241775|NCT01926964|Oncotype DX|oncotype dx
241776|NCT01926964|Genetic profiling|genetic profiling
241777|NCT01926951|hypertension|hypertension
241778|NCT01926925|Type 2 diabetes, Endothelium, children/adolescents|type 2 diabetes, endothelium, children/adolescents
241779|NCT01926912|Schizophrenia|schizophrenia
241780|NCT01926912|Paliperidone Palmitate|paliperidone palmitate
241781|NCT01926912|Hospital setting|hospital setting
241782|NCT01926912|Schizophrenic Disorders|schizophrenic disorders
241783|NCT01926860|Prevenar13|prevenar13
241784|NCT01926860|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
241785|NCT01926860|Epaxal|epaxal
241786|NCT01926860|hepatitis A vaccine|hepatitis a vaccine
241787|NCT01926847|Digital ischemia|digital ischemia
241788|NCT01926847|Raynaud's phenomenon|raynaud's phenomenon
241789|NCT01926834|promoting angiogenesis in multiple targets|promoting angiogenesis in multiple targets
241790|NCT01926834|herbal medicine|herbal medicine
241791|NCT01926834|traditional chinese medicine|traditional chinese medicine
241792|NCT01926834|random clinical trial|random clinical trial
241793|NCT01926795|toddler's fracture|toddler's fracture
241794|NCT01926795|tibial fracture|tibial fracture
241795|NCT01926795|children|children
241796|NCT01926769|Colorectal cancer|colorectal cancer
241797|NCT01926769|Metformin|metformin
241798|NCT01926769|FOLFOX6|folfox6
241799|NCT01926769|FOFIRI|fofiri
241800|NCT01926769|5FU|5fu
241801|NCT01926769|irinotecan|irinotecan
241802|NCT01926769|oxaliplatin|oxaliplatin
241803|NCT01926756|bacteriuria|bacteriuria
241804|NCT01926756|straight catheterization|straight catheterization
241805|NCT01926756|urinary tract infections|urinary tract infections
241806|NCT01926756|iatrogenic|iatrogenic
241807|NCT01926743|near infrared|near infrared
241808|NCT01926743|fluorescence imaging|fluorescence imaging
241809|NCT01926743|indocyanine green|indocyanine green
241810|NCT01926743|gastrectomy|gastrectomy
241811|NCT01926717|Single Roux-y of Pancreaticojejunostomy-choledochojejunostomy|single roux-y of pancreaticojejunostomy-choledochojejunostomy
241812|NCT01926691|dementia|dementia
241813|NCT01926691|poststroke cognitive impairment|poststroke cognitive impairment
241814|NCT01926691|inflammation|inflammation
241815|NCT01926691|stress|stress
241816|NCT01926678|swedish massage|swedish massage
241817|NCT01926678|fatigue|fatigue
241818|NCT01926678|light touch|light touch
241819|NCT01926678|inflammation|inflammation
241820|NCT01926665|Blood And Marrow Transplantation|blood and marrow transplantation
241821|NCT01926665|Mantle cell lymphoma|mantle cell lymphoma
241822|NCT01926665|MCL|mcl
241823|NCT01926665|T-cell lymphoma|t-cell lymphoma
241824|NCT01926665|TCL|tcl
241825|NCT01926665|Diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
241826|NCT01926665|DLBCL|dlbcl
241827|NCT01926665|Autologous stem cell transplantation|autologous stem cell transplantation
241828|NCT01926665|ASCT|asct
241829|NCT01926665|Carfilzomib|carfilzomib
241830|NCT01926665|CFZ|cfz
241831|NCT01926665|Dexamethasone|dexamethasone
241832|NCT01926665|Decadron|decadron
241833|NCT01926639|Follicular lymphoma|follicular lymphoma
241834|NCT01926639|Rituximab|rituximab
241835|NCT01926639|Autologous dendritic cells|autologous dendritic cells
241836|NCT01926639|Cancer vaccine|cancer vaccine
241837|NCT01926626|Nicotine addiction|nicotine addiction
241838|NCT01926626|Smoking Cessation|smoking cessation
241839|NCT01926626|Quit Smoking|quit smoking
241840|NCT01926626|moclobemide|moclobemide
241841|NCT01926626|Nicotine Patch|nicotine patch
241842|NCT01926613|Schizophrenia|schizophrenia
241843|NCT01926613|Chronic Mental Disorder|chronic mental disorder
241844|NCT01926613|Employment|employment
241845|NCT01926613|Cognitive remediation|cognitive remediation
241846|NCT01926613|Vocational rehabilitation|vocational rehabilitation
241847|NCT01926600|gastric ulcer|gastric ulcer
241848|NCT01926600|duodenal ulcer|duodenal ulcer
241849|NCT01926600|re-bleeding rate|re-bleeding rate
241850|NCT01926600|intragastric pH|intragastric ph
241851|NCT01926600|proton pump inhibitor|proton pump inhibitor
241852|NCT01926587|rigosertib|rigosertib
241853|NCT01926587|ON 01910.Na|on 01910.na
241854|NCT01926587|azacitidine|azacitidine
241855|NCT01926587|Vidaza|vidaza
241856|NCT01926574|absenteeism|absenteeism
241857|NCT01926574|rehabilitation|rehabilitation
241858|NCT01926574|return to work|return to work
241859|NCT01926561|Hypotensive bradycardic event|hypotensive bradycardic event
241860|NCT01926561|Interscalene brachial plexus block|interscalene brachial plexus block
241861|NCT01926561|Sitting position|sitting position
241862|NCT01926561|Shoulder arthroscopic surgery|shoulder arthroscopic surgery
241863|NCT01926548|Pharmacokinetics|pharmacokinetics
241864|NCT01926548|Safety|safety
241865|NCT01926535|amniotic membrane|amniotic membrane
241866|NCT01926535|contact lens|contact lens
241867|NCT01926535|bullous keratopathy|bullous keratopathy
241868|NCT01926522|Exercise Therapy|exercise therapy
241869|NCT01926483|Stage IIIA-N2 NSCLC|stage iiia-n2 nsclc
241870|NCT01926470|epidural injections, intravascular injection|epidural injections, intravascular injection
241871|NCT01926457|First trimester treatment of prediabetes|first trimester treatment of prediabetes
241872|NCT01926457|First trimester treatment of gestational diabetes|first trimester treatment of gestational diabetes
241873|NCT01926457|Umbilical cord C-Peptide|umbilical cord c-peptide
241874|NCT01926457|Neonatal fat mass|neonatal fat mass
241875|NCT01926457|Gestational weight gain|gestational weight gain
241876|NCT01926457|Infant obesity|infant obesity
241877|NCT01926444|colonoscopy|colonoscopy
241878|NCT01926444|sedation-free|sedation-free
241879|NCT01926444|colorectal cancer|colorectal cancer
241880|NCT01926444|CRC screening|crc screening
241881|NCT01926444|prevention|prevention
241882|NCT01926444|analgesia|analgesia
241883|NCT01926444|colonic|colonic
241884|NCT01926444|kappa|kappa
241885|NCT01926444|opioid agonist|opioid agonist
241886|NCT01926444|pain management|pain management
241887|NCT01926444|oral|oral
241888|NCT01926444|hydrogen sulfide|hydrogen sulfide
241889|NCT01926444|peripheral|peripheral
241891|NCT01926418|Condoms|condoms
241892|NCT01926418|Men who have sex with men|men who have sex with men
241893|NCT01926418|implementation intentions|implementation intentions
241894|NCT01926418|executive function|executive function
241895|NCT01926405|hypersomnia|hypersomnia
241896|NCT01926405|narcolepsy|narcolepsy
241897|NCT01926405|amylase|amylase
241898|NCT01926405|salivary sampling|salivary sampling
241899|NCT01926379|Ethiopia|ethiopia
241900|NCT01926379|TB|tb
241901|NCT01926379|tuberculosis|tuberculosis
241902|NCT01926379|HIV|hiv
241903|NCT01926379|IPT|ipt
241904|NCT01926379|isoniazid|isoniazid
241905|NCT01926379|adherence|adherence
241906|NCT01926379|combination intervention package|combination intervention package
241907|NCT01926379|retention|retention
241908|NCT01926353|Vesicoureteral Reflux (VUR)|vesicoureteral reflux (vur)
241909|NCT01926353|Complicated Urinary Tract Infection|complicated urinary tract infection
241910|NCT01926353|Vantris|vantris
241911|NCT01926353|Polyacrylate Polyalcohol Copolymer|polyacrylate polyalcohol copolymer
241912|NCT01926327|PRP PRGF Osteoarthritis|prp prgf osteoarthritis
241913|NCT01926301|sepsis|sepsis
241914|NCT01926301|cerebrovascular autoregulation|cerebrovascular autoregulation
241915|NCT01926301|delirium|delirium
241916|NCT01926275|COPD|copd
241917|NCT01926275|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
241918|NCT01926275|Respiratory Muscle Training|respiratory muscle training
241919|NCT01926262|Pain, Neck, Exercise, Pilots, Crewmembers,|pain, neck, exercise, pilots, crewmembers,
241920|NCT01926249|Alzheimer's disease|alzheimer's disease
241921|NCT01926249|Mild Cognitive Impairment|mild cognitive impairment
241922|NCT01926210|Poor ovarian response|poor ovarian response
241923|NCT01926210|in vitro fertilization|in vitro fertilization
242531|NCT01923701|Psychosis|psychosis
241924|NCT01926210|mild ovarian stimulation|mild ovarian stimulation
241925|NCT01926210|controlled ovarian stimulation|controlled ovarian stimulation
241926|NCT01926184|HIV/AIDS|hiv/aids
241927|NCT01926184|Treatment as Prevention|treatment as prevention
241928|NCT01926184|Methamphetamine|methamphetamine
241929|NCT01926184|Cocaine|cocaine
241930|NCT01926184|HIV viral Load|hiv viral load
241931|NCT01926158|Denosumab|denosumab
241932|NCT01926158|Osteoporosis|osteoporosis
241933|NCT01926158|Hip replacement|hip replacement
241934|NCT01926158|Osteoarthritis|osteoarthritis
241935|NCT01926158|Radiostereometric analysis (RSA)|radiostereometric analysis (rsa)
241936|NCT01926158|Dual energy X-ray absorptiometry (DXA)|dual energy x-ray absorptiometry (dxa)
241937|NCT01926132|ascorbic acid|ascorbic acid
241938|NCT01926132|fatigue|fatigue
241939|NCT01926132|mitochondrial DNA|mitochondrial dna
241940|NCT01926132|patient for more than 6 months|patient for more than 6 months
241941|NCT01926106|Nasal Intermittent Positive-Pressure Ventilation|nasal intermittent positive-pressure ventilation
242140|NCT01925274|irinotecan|irinotecan
241942|NCT01926106|Nasal Continuous Positive Airway Pressure|nasal continuous positive airway pressure
241943|NCT01926106|twin|twin
241944|NCT01926106|respiratory distress syndrome|respiratory distress syndrome
241945|NCT01926093|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
241946|NCT01926080|Depression|depression
241947|NCT01926080|Spirituality|spirituality
241948|NCT01926080|Neonatal death|neonatal death
241949|NCT01926080|Bereavement|bereavement
241950|NCT01926080|Randomized controlled trial|randomized controlled trial
241951|NCT01926067|Accelerometer|accelerometer
241952|NCT01926067|Cardiopulmonary by pass|cardiopulmonary by pass
241953|NCT01926041|community|community
241954|NCT01926041|preventive medicine|preventive medicine
241955|NCT01926041|prediabetes|prediabetes
241956|NCT01926041|smoking cessation|smoking cessation
241957|NCT01926028|recurrent vulvovaginal candidiasis|recurrent vulvovaginal candidiasis
241958|NCT01926028|candida|candida
241959|NCT01926028|NDV3|ndv3
241960|NCT01926028|vaginal thrush|vaginal thrush
241961|NCT01926028|chronic yeast infection|chronic yeast infection
241962|NCT01925976|obesity|obesity
241963|NCT01925976|dietetic intervention|dietetic intervention
241964|NCT01925976|eating behaviors|eating behaviors
241965|NCT01925976|children|children
241966|NCT01925976|healthy eating|healthy eating
241967|NCT01925976|energy dense foods|energy dense foods
241968|NCT01925963|Normal|normal
241969|NCT01925963|Traumatic brain injury|traumatic brain injury
241970|NCT01925963|Neuroimaging|neuroimaging
241971|NCT01925963|Hyperbaric oxygen|hyperbaric oxygen
241972|NCT01925963|Neurobehavioral symptom inventory|neurobehavioral symptom inventory
241973|NCT01925950|BDP|bdp
241974|NCT01925950|orBec|orbec
241975|NCT01925950|GVHD|gvhd
241976|NCT01925950|beclomethasone dipropionate|beclomethasone dipropionate
241977|NCT01925950|bone marrow transplant|bone marrow transplant
241978|NCT01925950|hematopoietic cell transplant|hematopoietic cell transplant
241979|NCT01925950|HCT|hct
241980|NCT01925950|stem cell transplant|stem cell transplant
241981|NCT01925950|marrow transplant|marrow transplant
241982|NCT01925950|SCT|sct
241983|NCT01925950|beclomethasone 17,21-dipropionate|beclomethasone 17,21-dipropionate
241984|NCT01925937|Coenzyme Q10|coenzyme q10
241985|NCT01925937|Atorvastatin|atorvastatin
241986|NCT01925937|clinical trial|clinical trial
241987|NCT01925937|congestive heart failure|congestive heart failure
241988|NCT01925924|Dental cements|dental cements
241989|NCT01925924|Orthodontic adhesives|orthodontic adhesives
241990|NCT01925924|Glass ionomer cement|glass ionomer cement
241991|NCT01925924|Tooth demineralization|tooth demineralization
241992|NCT01925911|Phase 1|phase 1
241993|NCT01925911|Healthy subjects|healthy subjects
241994|NCT01925911|DDI|ddi
241995|NCT01925911|CYP3A|cyp3a
241996|NCT01925898|Laceration|laceration
241997|NCT01925898|Sedation|sedation
241998|NCT01925898|Pediatrics|pediatrics
241999|NCT01925885|Atrial Arrhythmia|atrial arrhythmia
242000|NCT01925872|ischemic cerebrovascular disease|ischemic cerebrovascular disease
242001|NCT01925872|Percutaneous transluminal angioplasty and stenting|percutaneous transluminal angioplasty and stenting
242002|NCT01925872|Clopidogrel resistance|clopidogrel resistance
242003|NCT01925859|Pharmacokinetic analysis|pharmacokinetic analysis
242004|NCT01925859|EryDex|erydex
242005|NCT01925846|Pseudomonas aeruginosa|pseudomonas aeruginosa
242006|NCT01925846|type three secretory system|type three secretory system
242007|NCT01925846|contact lens associated microbial keratitis|contact lens associated microbial keratitis
242008|NCT01925820|Hepatitis B,Entecavir,Pegylated IFN|hepatitis b,entecavir,pegylated ifn
242009|NCT01925807|Adolescent|adolescent
242010|NCT01925807|Suicidal Ideation|suicidal ideation
242011|NCT01925807|Emergency Department|emergency department
242012|NCT01925807|Crisis|crisis
242013|NCT01925807|Attachment|attachment
242014|NCT01925807|Coping|coping
242015|NCT01925794|Stent, Coronary Arteries for Early healing|stent, coronary arteries for early healing
242016|NCT01925781|Smoking Cessation|smoking cessation
242017|NCT01925781|Nicotine Addiction|nicotine addiction
242018|NCT01925781|e-Cigarette|e-cigarette
242019|NCT01925781|electronic nicotine delivery device|electronic nicotine delivery device
242020|NCT01925781|electronic cigarette|electronic cigarette
242021|NCT01925781|nicotine replacement therapy|nicotine replacement therapy
242022|NCT01925768|Apremilast, Psoriatic Arthritis, PDE4 inhibitor|apremilast, psoriatic arthritis, pde4 inhibitor
242023|NCT01925755|Non-interventional|non-interventional
242024|NCT01925755|Rivaroxaban|rivaroxaban
242025|NCT01925755|Prevention in prior stroke or TIA|prevention in prior stroke or tia
242026|NCT01925755|Russian Federation|russian federation
242027|NCT01925742|Fetal aneuploidy|fetal aneuploidy
242028|NCT01925729|middle ear|middle ear
242029|NCT01925729|allergy|allergy
242030|NCT01925729|nose|nose
242031|NCT01925716|cholesterol,LDL|cholesterol,ldl
242032|NCT01925716|vegetable oils|vegetable oils
242033|NCT01925716|heart diseases|heart diseases
242034|NCT01925690|Multiple Sclerosis|multiple sclerosis
242035|NCT01925690|Disease modifying medication|disease modifying medication
242036|NCT01925690|Relapsing-Remitting MS|relapsing-remitting ms
242037|NCT01925690|Motivational Interviewing|motivational interviewing
242038|NCT01925690|Telephone Counseling|telephone counseling
242039|NCT01925677|Transplant|transplant
242040|NCT01925677|donor|donor
242041|NCT01925677|nephrectomy|nephrectomy
242042|NCT01925677|robotic|robotic
242043|NCT01925677|laparoscopy|laparoscopy
242044|NCT01925677|single-port|single-port
242045|NCT01925664|Doulas|doulas
242046|NCT01925664|Parenting|parenting
242047|NCT01925664|Breastfeeding|breastfeeding
242048|NCT01925664|Pregnancy in Adolescence|pregnancy in adolescence
242049|NCT01925651|Post Mastectomy Radiotherapy|post mastectomy radiotherapy
242050|NCT01925651|Breast Cancer|breast cancer
242051|NCT01925651|Bolus|bolus
242052|NCT01925651|Radiodermatitis|radiodermatitis
242053|NCT01925638|Healthy Volunteers|healthy volunteers
242054|NCT01925638|Refametinib|refametinib
242055|NCT01925638|Ketoconazole|ketoconazole
242056|NCT01925638|Pharmacokinetics|pharmacokinetics
242057|NCT01925612|Antibodies, Monoclonal|antibodies, monoclonal
242058|NCT01925612|Antibody-Drug Conjugate|antibody-drug conjugate
242059|NCT01925612|Antigens, CD30|antigens, cd30
242060|NCT01925612|Drug Therapy|drug therapy
242061|NCT01925612|Hematologic Diseases|hematologic diseases
242062|NCT01925612|Lymphoma, B-cell|lymphoma, b-cell
751909|NCT01171170|paclitaxel|paclitaxel
242063|NCT01925612|Lymphoma, Large B-cell, Diffuse|lymphoma, large b-cell, diffuse
242064|NCT01925612|Monomethyl auristatin E|monomethyl auristatin e
242065|NCT01925599|Nevus|nevus
242066|NCT01925599|Choroidal Melanoma|choroidal melanoma
242067|NCT01925599|BAP1 mutation|bap1 mutation
242068|NCT01925573|RECURRENT GLIOBLASTOMA|recurrent glioblastoma
242069|NCT01925573|Brain Tumor|brain tumor
242070|NCT01925534|Optiflow|optiflow
242071|NCT01925534|Humidified high-flow oxygen therapy|humidified high-flow oxygen therapy
242072|NCT01925534|Noninvasive ventilation|noninvasive ventilation
242073|NCT01925534|Acute respiratory failure|acute respiratory failure
242074|NCT01925534|Standard oxygen therapy|standard oxygen therapy
242075|NCT01925521|Intestinal Infection|intestinal infection
242076|NCT01925495|otitis media|otitis media
242077|NCT01925495|middle ear|middle ear
242078|NCT01925495|feedback pathways|feedback pathways
242079|NCT01925495|middle-ear pressure|middle-ear pressure
242080|NCT01925482|middle ear|middle ear
242081|NCT01925482|otitis|otitis
242082|NCT01925482|gas exchange|gas exchange
242083|NCT01925469|Hysterosalpingogram|hysterosalpingogram
242084|NCT01925469|HSG|hsg
242085|NCT01925469|Pain relief|pain relief
242086|NCT01925469|Analgesia|analgesia
242087|NCT01925469|Benzocaine|benzocaine
242088|NCT01925456|urge urinary incontinence|urge urinary incontinence
242089|NCT01925443|diabetes mellitus non-insulin-dependent|diabetes mellitus non-insulin-dependent
242090|NCT01925443|low level laser therapy|low level laser therapy
242091|NCT01925430|Observational|observational
242092|NCT01925430|Sleep|sleep
242093|NCT01925430|Algorithm|algorithm
242094|NCT01925417|Clostridium difficile|clostridium difficile
242095|NCT01925417|C diff|c diff
242096|NCT01925417|Microbiota Restoration Therapy|microbiota restoration therapy
242098|NCT01925417|microbiota suspension|microbiota suspension
242099|NCT01925417|CDI|cdi
242100|NCT01925417|CDAD|cdad
242101|NCT01925417|Fecal transplant|fecal transplant
242102|NCT01925417|Fecal Microbiota Transplant|fecal microbiota transplant
242103|NCT01925417|FMT|fmt
242104|NCT01925417|Diarrhea|diarrhea
242105|NCT01925417|Fecal bacteriotherapy|fecal bacteriotherapy
242106|NCT01925404|Physical activity|physical activity
242107|NCT01925404|parks|parks
242108|NCT01925404|programming|programming
242109|NCT01925404|public health|public health
242110|NCT01925391|Pediatric glaucoma|pediatric glaucoma
242111|NCT01925391|Intraocular pressure|intraocular pressure
242112|NCT01925391|pediatric glaucoma diagnosis|pediatric glaucoma diagnosis
242113|NCT01925391|Volatiles and intraocular pressure|volatiles and intraocular pressure
242114|NCT01925391|nitrous oxide|nitrous oxide
242115|NCT01925391|Tetracaine|tetracaine
242116|NCT01925378|Cervical Dysplasia|cervical dysplasia
242117|NCT01925352|ischemic heart disease|ischemic heart disease
242118|NCT01925352|adenovirus|adenovirus
242119|NCT01925352|hepatocyte growth factor|hepatocyte growth factor
242120|NCT01925313|Safety|safety
242121|NCT01925313|Pharmacokinetics|pharmacokinetics
242122|NCT01925300|Pharmacokinetics|pharmacokinetics
242123|NCT01925300|Pharmacodynamics|pharmacodynamics
242124|NCT01925300|Safety|safety
242125|NCT01925300|Tolerability|tolerability
242126|NCT01925287|bioavailability|bioavailability
242127|NCT01925287|curcumin|curcumin
242128|NCT01925287|curcuma longa|curcuma longa
242129|NCT01925287|healthy humans|healthy humans
242130|NCT01925287|safety|safety
242131|NCT01925287|sex differences|sex differences
242132|NCT01925274|metastatic colorectal cancer|metastatic colorectal cancer
232924|NCT01967940|HIV|hiv
242133|NCT01925274|colorectal cancer|colorectal cancer
242134|NCT01925274|KRAS|kras
242135|NCT01925274|colon cancer|colon cancer
242136|NCT01925274|mCRC|mcrc
242137|NCT01925274|CRC|crc
242138|NCT01925274|PF-05212384|pf-05212384
242139|NCT01925274|KRAS wild type colorectal cancer|kras wild type colorectal cancer
242141|NCT01925274|cetuximab|cetuximab
242142|NCT01925274|NRAS|nras
242143|NCT01925261|knee osteoarthritis|knee osteoarthritis
242144|NCT01925261|bilateral|bilateral
242145|NCT01925261|osteoarthritis|osteoarthritis
242146|NCT01925248|Whey protein|whey protein
242147|NCT01925248|protein supplement|protein supplement
242148|NCT01925248|Diabetes|diabetes
242149|NCT01925248|Type 2 DM|type 2 dm
242150|NCT01925248|Hyperglycemia|hyperglycemia
242151|NCT01925248|Insulin secretagogue|insulin secretagogue
242152|NCT01925235|remote ischemic preconditioning|remote ischemic preconditioning
242153|NCT01925235|acute kidney injury|acute kidney injury
242154|NCT01925235|TAVI|tavi
242155|NCT01925235|RenPRO trial|renpro trial
242156|NCT01925235|parameters|parameters
242157|NCT01925209|sporadic inclusion body myositis,|sporadic inclusion body myositis,
242158|NCT01925209|myositis,|myositis,
242159|NCT01925209|muscle wasting,|muscle wasting,
242160|NCT01925209|controlled clinical trial,|controlled clinical trial,
242161|NCT01925209|randomized,|randomized,
242162|NCT01925209|body mass,|body mass,
242163|NCT01925209|muscle function,|muscle function,
242164|NCT01925209|strength,|strength,
242165|NCT01925209|performance,|performance,
242166|NCT01925209|physical function|physical function
242167|NCT01925196|Motor Neuron Disease|motor neuron disease
242168|NCT01925196|Frontotemporal Dementia|frontotemporal dementia
242169|NCT01925196|Cognitive Testing|cognitive testing
242170|NCT01925196|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
242171|NCT01925196|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
242172|NCT01925183|Boceprevir|boceprevir
242173|NCT01925183|HIV/HCV-coinfection|hiv/hcv-coinfection
242174|NCT01925183|HIV/HCV coinfection|hiv/hcv coinfection
242175|NCT01925183|HIV/HCV|hiv/hcv
242176|NCT01925183|Response-guided therapy|response-guided therapy
242177|NCT01925170|Dense breast tissue|dense breast tissue
688532|NCT00924534|safety|safety
242178|NCT01925170|Breast Cancer Screening|breast cancer screening
242179|NCT01925170|Molecular Breast Imaging|molecular breast imaging
242180|NCT01925170|Breast Cancer|breast cancer
242181|NCT01925170|Breast|breast
242182|NCT01925105|Polypharmacy|polypharmacy
242183|NCT01925092|Cushing's disease|cushing's disease
242184|NCT01925092|Mifepristone|mifepristone
242185|NCT01925092|Cushing's syndrome|cushing's syndrome
242186|NCT01925092|Pharmacokinetic-pharmacodynamic|pharmacokinetic-pharmacodynamic
242187|NCT01925092|Child/pediatric population|child/pediatric population
242188|NCT01925092|Safety-efficacy|safety-efficacy
242189|NCT01925079|acute coronary syndrome|acute coronary syndrome
242190|NCT01925079|statins|statins
242191|NCT01925079|LDL-C|ldl-c
242192|NCT01925079|intensive education|intensive education
242193|NCT01925027|Nano+ DES|nano+ des
242194|NCT01925027|OCT|oct
242195|NCT01925027|Neointimal hyperplasia|neointimal hyperplasia
242196|NCT01925027|DAPT|dapt
242197|NCT01925027|3 month|3 month
242198|NCT01925014|Appendectomy|appendectomy
242199|NCT01925014|Appendicitis|appendicitis
242200|NCT01925014|False Positive Reactions|false positive reactions
242201|NCT01925014|Humans|humans
242202|NCT01925014|Radiation Dosage|radiation dosage
242203|NCT01925014|Tomography, X-Ray Computed|tomography, x-ray computed
242204|NCT01925014|Young Adult|young adult
242205|NCT01925001|Sickle cell anemia|sickle cell anemia
242206|NCT01925001|Sickle cell disease|sickle cell disease
242207|NCT01925001|Sickling crisis|sickling crisis
242208|NCT01925001|Vaso-occlusive crisis|vaso-occlusive crisis
242209|NCT01925001|Carboxyhemoglobin|carboxyhemoglobin
242210|NCT01925001|Oxygen therapeutic|oxygen therapeutic
242211|NCT01925001|Ischemic rescue therapy|ischemic rescue therapy
242212|NCT01925001|Hemoglobin solution|hemoglobin solution
242213|NCT01925001|Pegylated hemoglobin|pegylated hemoglobin
242214|NCT01924988|BPH, benign prostatic hyperplasia|bph, benign prostatic hyperplasia
242215|NCT01924962|chronic occlusion of coronary artery|chronic occlusion of coronary artery
242216|NCT01924962|left ventricular function|left ventricular function
242217|NCT01924962|revascularisation|revascularisation
242218|NCT01924949|7977|7977
242219|NCT01924949|5885|5885
242220|NCT01924949|GS-7977|gs-7977
242221|NCT01924949|GS-5885|gs-5885
242222|NCT01924949|SOF|sof
242227|NCT01924923|uveal melanoma|uveal melanoma
242228|NCT01924923|biopsy|biopsy
242229|NCT01924923|enucleation|enucleation
242230|NCT01924923|ocular cancer|ocular cancer
242231|NCT01924910|Healthy, by self report|healthy, by self report
242232|NCT01924897|CPET test|cpet test
242233|NCT01924897|Exercise training|exercise training
242234|NCT01924897|Prehabilitation|prehabilitation
242235|NCT01924897|Exercise Test|exercise test
242236|NCT01924884|Vacuum-Assisted Closure|vacuum-assisted closure
242237|NCT01924884|Topical Negative-Pressure Therapy|topical negative-pressure therapy
242238|NCT01924884|Negative-Pressure Dressings|negative-pressure dressings
242239|NCT01924858|PET, healthy subjects|pet, healthy subjects
242240|NCT01924858|Lp-PLA2|lp-pla2
242241|NCT01924858|positron emission tomography|positron emission tomography
242242|NCT01924858|Alzheimer's disease|alzheimer's disease
242243|NCT01924858|brain exposure|brain exposure
242244|NCT01924858|GSK2647544|gsk2647544
242245|NCT01924819|Gastric cancer|gastric cancer
242246|NCT01924819|Stomach cancer|stomach cancer
242247|NCT01924819|Chemoradiotherapy|chemoradiotherapy
242248|NCT01924819|Surgery|surgery
242249|NCT01924819|Chemotherapy|chemotherapy
242250|NCT01924819|Neoadjuvant|neoadjuvant
242251|NCT01924806|debridement|debridement
242252|NCT01924806|post-debridement|post-debridement
242253|NCT01924806|infection|infection
242254|NCT01924806|prevention|prevention
242255|NCT01924806|wound|wound
242256|NCT01924806|wound tissue|wound tissue
242257|NCT01924806|wound management|wound management
242258|NCT01924806|WoundWand|woundwand
242259|NCT01924806|wound size reduction|wound size reduction
242260|NCT01924806|wound bed debridement|wound bed debridement
242261|NCT01924806|WoundWand Debridement Device|woundwand debridement device
242262|NCT01924806|chronic wound|chronic wound
242263|NCT01924806|delayed healing|delayed healing
242264|NCT01924806|cellular senescence|cellular senescence
242265|NCT01924806|acute wound|acute wound
242266|NCT01924806|diabetic foot ulcer|diabetic foot ulcer
242267|NCT01924806|venous leg ulcers|venous leg ulcers
242268|NCT01924806|radiofrequency debridement|radiofrequency debridement
242269|NCT01924806|necrotic tissue|necrotic tissue
242270|NCT01924806|wound healing|wound healing
242271|NCT01924806|skin|skin
242272|NCT01924780|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
242273|NCT01924754|HPV|hpv
242274|NCT01924754|Gardasil|gardasil
242275|NCT01924754|seroconversion|seroconversion
242276|NCT01924741|Liver neoplasms|liver neoplasms
242277|NCT01924741|Liver regeneration|liver regeneration
242278|NCT01924715|somatoform disorder|somatoform disorder
242279|NCT01924715|psychotherapy|psychotherapy
242280|NCT01924715|depression|depression
242281|NCT01924715|anxiety|anxiety
242282|NCT01924715|personality disorder|personality disorder
242283|NCT01924689|Phase 1|phase 1
242284|NCT01924689|Metastatic Disease|metastatic disease
242285|NCT01924689|Solid Tumor|solid tumor
242286|NCT01924689|Malignancy|malignancy
242287|NCT01924689|Metastases|metastases
242288|NCT01924689|Clinical Trial|clinical trial
242289|NCT01924689|Hypoxia|hypoxia
242290|NCT01924689|Necrosis|necrosis
242291|NCT01924689|Intratumoral|intratumoral
242292|NCT01924689|Locally advanced cancer|locally advanced cancer
242293|NCT01924689|Immunotherapy|immunotherapy
242294|NCT01924689|Sarcoma|sarcoma
242295|NCT01924689|Chordoma|chordoma
242296|NCT01924689|Bacteriolytic|bacteriolytic
242297|NCT01924676|food effect|food effect
242298|NCT01924676|pharmacokinetics|pharmacokinetics
242299|NCT01924676|bioavailability|bioavailability
242300|NCT01924676|oxycodone|oxycodone
242301|NCT01924676|management of moderate to severe pain|management of moderate to severe pain
242302|NCT01924663|Heart Failure|heart failure
242303|NCT01924663|Acute Kidney Injury|acute kidney injury
242304|NCT01924663|Myocardial Dysfunction|myocardial dysfunction
242305|NCT01924663|Pediatric Critical Care|pediatric critical care
242306|NCT01924663|Pediatric Intensive Care Units|pediatric intensive care units
242307|NCT01924663|Respiratory Virus|respiratory virus
242308|NCT01924611|Dental caries|dental caries
242309|NCT01924611|Atraumatic Restorative Technique|atraumatic restorative technique
242310|NCT01924598|Anorexia Nervosa|anorexia nervosa
242311|NCT01924598|Treatment Development|treatment development
242312|NCT01924598|Capacity|capacity
242313|NCT01924598|Neuroimaging|neuroimaging
242314|NCT01924598|Magnetoencephalography|magnetoencephalography
242315|NCT01924598|functional MRI|functional mri
242316|NCT01924598|Reward processing|reward processing
242317|NCT01924598|Habit formation|habit formation
242318|NCT01924585|Colorectal|colorectal
242319|NCT01924585|Surgery|surgery
242320|NCT01924585|Frailty|frailty
242321|NCT01924585|Elderly|elderly
242322|NCT01924585|Quality of Life|quality of life
242323|NCT01924572|umbilical cord clamping|umbilical cord clamping
242324|NCT01924572|Placental residual blood volume|placental residual blood volume
242325|NCT01924572|hematocrit|hematocrit
242326|NCT01924572|hemoglobin|hemoglobin
242327|NCT01924572|bilirubin|bilirubin
242328|NCT01924559|Airway|airway
242329|NCT01924546|cognition|cognition
242330|NCT01924546|hydration|hydration
242331|NCT01924546|schoolchildren|schoolchildren
242332|NCT01924520|Antipsychotic|antipsychotic
242333|NCT01924520|FK949E|fk949e
242334|NCT01924520|Quetiapine|quetiapine
242335|NCT01924507|Sleep medicine|sleep medicine
242336|NCT01924507|Sleep apnea|sleep apnea
242337|NCT01924507|Acute myocardial infarction|acute myocardial infarction
242338|NCT01924507|Heart failure|heart failure
242339|NCT01924507|CPAP|cpap
242340|NCT01924494|telemedicine, tele-endoscopy|telemedicine, tele-endoscopy
242341|NCT01924481|Caffeine|caffeine
242342|NCT01924481|Flavonoids|flavonoids
242343|NCT01924481|MRI|mri
242344|NCT01924481|Brain blood flow|brain blood flow
242345|NCT01924481|Cognition|cognition
242346|NCT01924481|Perfusion|perfusion
242347|NCT01924481|Resting functional magnetic resonance imaging (fMRI)|resting functional magnetic resonance imaging (fmri)
242348|NCT01924468|Cognitive Control|cognitive control
242349|NCT01924468|fMRI|fmri
242350|NCT01924468|Genetics|genetics
242351|NCT01924468|Dopamine|dopamine
242352|NCT01924455|HIV|hiv
242353|NCT01924455|HBV|hbv
242354|NCT01924442|Coronary Artery Disease|coronary artery disease
242355|NCT01924442|Off-Pump|off-pump
242356|NCT01924442|Myocardial Ischemia|myocardial ischemia
242357|NCT01924442|Heart Disease|heart disease
242358|NCT01924429|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
242359|NCT01924429|ADHD|adhd
242360|NCT01924429|fMRI|fmri
242361|NCT01924429|Imaging|imaging
242362|NCT01924429|Vyvanse|vyvanse
242363|NCT01924429|Stimulant Medication|stimulant medication
242364|NCT01924429|Treatment|treatment
242365|NCT01924429|Clinical Trial|clinical trial
242366|NCT01924429|Adult|adult
242367|NCT01924403|TKA|tka
242368|NCT01924403|Wound Closure|wound closure
242369|NCT01924403|Wound Perfusion|wound perfusion
242370|NCT01924390|Tooth extraction|tooth extraction
242371|NCT01924377|AF|af
242372|NCT01924364|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
242373|NCT01924364|Facial Trauma|facial trauma
242374|NCT01924364|Fat Grafts|fat grafts
242375|NCT01924364|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
242376|NCT01924364|Wounded warriors|wounded warriors
242377|NCT01924351|Breast Cancer with Brain Metastasis|breast cancer with brain metastasis
242378|NCT01924351|HER2-positive|her2-positive
242379|NCT01924351|HER-2 therapy|her-2 therapy
242380|NCT01924338|Patient|patient
242381|NCT01924338|localisation|localisation
242382|NCT01924338|in cranial|in cranial
242383|NCT01924338|radiation|radiation
242384|NCT01924338|therapy|therapy
242385|NCT01924338|thickness of|thickness of
242386|NCT01924325|apixaban|apixaban
242387|NCT01924325|clopidogrel|clopidogrel
242388|NCT01924325|aspirin|aspirin
242389|NCT01924325|new oral anticoagulant|new oral anticoagulant
242390|NCT01924325|TIA|tia
242391|NCT01924325|acute minor ischemic stroke|acute minor ischemic stroke
242392|NCT01924312|stroke, dementia, hypertension, diabetes, hyperlipidemia, smoking, obesity|stroke, dementia, hypertension, diabetes, hyperlipidemia, smoking, obesity
242393|NCT01924286|HIV|hiv
242394|NCT01924286|Tuberculosis|tuberculosis
242395|NCT01924286|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
242396|NCT01924286|Highly active antiretroviral therapy|highly active antiretroviral therapy
242397|NCT01924286|Glucocorticoids|glucocorticoids
242398|NCT01924286|Prednisone|prednisone
242399|NCT01924286|Preventive therapy|preventive therapy
242400|NCT01924273|Port Wine Stain Birthmarks|port wine stain birthmarks
242401|NCT01924234|Remifentanil|remifentanil
242402|NCT01924234|Pharyngeal dysfunction|pharyngeal dysfunction
242403|NCT01924234|Subjective swallowing difficulties|subjective swallowing difficulties
242404|NCT01924234|Pulmonary aspiration|pulmonary aspiration
242405|NCT01924208|Timothy|timothy
242406|NCT01924208|Influenza|influenza
242407|NCT01924208|Interferon|interferon
242408|NCT01924208|T cell|t cell
242409|NCT01924208|Tonsil|tonsil
242410|NCT01924195|lung|lung
242411|NCT01924195|Anlotinib|anlotinib
242412|NCT01924195|AL3818|al3818
242413|NCT01924195|NSCLC|nsclc
242414|NCT01924195|Cancer|cancer
242415|NCT01924182|chronic pain|chronic pain
242416|NCT01924182|inadequate pain relief|inadequate pain relief
242417|NCT01924182|intolerable side effects|intolerable side effects
242418|NCT01924169|Hematologic Disorder|hematologic disorder
242419|NCT01924169|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
242420|NCT01924169|CLL|cll
242421|NCT01924169|Hypogammaglobulinemia|hypogammaglobulinemia
242422|NCT01924169|Impaired Response to Vaccinations|impaired response to vaccinations
242423|NCT01924169|Immunoglobulins|immunoglobulins
242424|NCT01924169|Immune system's function|immune system's function
242425|NCT01924169|Lenalidomide|lenalidomide
242426|NCT01924169|CC-5013|cc-5013
242427|NCT01924169|Revlimid|revlimid
242428|NCT01924169|Flu vaccine|flu vaccine
242429|NCT01924169|TIV|tiv
242430|NCT01924169|Pneumonia vaccine|pneumonia vaccine
242431|NCT01924143|ADHD|adhd
242432|NCT01924143|Fibromyalgia|fibromyalgia
242433|NCT01924117|cervical intraepithelial neoplasia, HPV, Cancer|cervical intraepithelial neoplasia, hpv, cancer
242434|NCT01924104|IVF failure, implantation rate, heparin & aspirin|ivf failure, implantation rate, heparin & aspirin
242435|NCT01924078|breast cancer|breast cancer
242436|NCT01924078|metronomic chemotherapy|metronomic chemotherapy
242437|NCT01924078|aromatase inhibitors|aromatase inhibitors
298591|NCT01671319|female|female
242438|NCT01924065|Atrial fibrillation, conversion, stroke|atrial fibrillation, conversion, stroke
242439|NCT01924039|Psychosis|psychosis
242440|NCT01924039|Substance Use|substance use
242441|NCT01924039|Motivational Enhancement Therapy|motivational enhancement therapy
242442|NCT01924026|Phenylketonuria|phenylketonuria
242443|NCT01924026|Mild Hyperphenylalaninemia|mild hyperphenylalaninemia
242444|NCT01924026|PKU|pku
242445|NCT01924026|MHP|mhp
242446|NCT01924013|Pregnancy|pregnancy
242447|NCT01924013|Infant Growth|infant growth
242448|NCT01924013|Vitamin D|vitamin d
242449|NCT01924013|Bangladesh|bangladesh
242450|NCT01923987|Short course radiotherapy|short course radiotherapy
242451|NCT01923987|Modified FOLFOX6|modified folfox6
242452|NCT01923987|Delayed surgery|delayed surgery
242453|NCT01923987|Rectal cancer|rectal cancer
242454|NCT01923987|Synchronous metastasis|synchronous metastasis
242455|NCT01923987|Liver metastasis|liver metastasis
242456|NCT01923987|Lung metastasis|lung metastasis
242457|NCT01923961|Maintenance hemodialysis or hemodiafiltration|maintenance hemodialysis or hemodiafiltration
242458|NCT01923961|>18 years|>18 years
242459|NCT01923961|Stable condition|stable condition
242460|NCT01923948|Hepatocellular carcinoma|hepatocellular carcinoma
242461|NCT01923948|Hepatectomy|hepatectomy
242462|NCT01923948|randomized controlled trials(RCTs)|randomized controlled trials(rcts)
242463|NCT01923948|Postoperative Pain|postoperative pain
242464|NCT01923935|Multiple myeloma, busulfan, melphalan,transplantation|multiple myeloma, busulfan, melphalan,transplantation
242465|NCT01923922|glioblastoma multiforme|glioblastoma multiforme
242466|NCT01923922|CT Perfusion|ct perfusion
242467|NCT01923922|Survival|survival
242468|NCT01923909|Knee|knee
242469|NCT01923909|Osteoarthritis|osteoarthritis
242470|NCT01923909|Bahrain|bahrain
242471|NCT01923909|PRP|prp
242472|NCT01923909|Steroid|steroid
242473|NCT01923909|WOMAC|womac
242474|NCT01923909|Oxford Knee Score|oxford knee score
751910|NCT01171170|bevacizumab|bevacizumab
242475|NCT01923909|Platelet-rich plasma|platelet-rich plasma
242476|NCT01923896|food refusal|food refusal
242477|NCT01923896|behavioral intervention|behavioral intervention
242478|NCT01923896|D-cycloserine|d-cycloserine
242479|NCT01923844|Newborn|newborn
242480|NCT01923844|perfusion index|perfusion index
242481|NCT01923844|pulsatility index|pulsatility index
242482|NCT01923844|respiratory distress syndrome|respiratory distress syndrome
242483|NCT01923844|surfactant|surfactant
688819|NCT00925574|CNTO 1959|cnto 1959
242484|NCT01923844|transcutaneous carbon monoxide|transcutaneous carbon monoxide
242485|NCT01923831|Magnesium, Post operative sore throat, Prone position, Tracheal intubation|magnesium, post operative sore throat, prone position, tracheal intubation
242486|NCT01923818|rivaroxaban|rivaroxaban
242488|NCT01923818|new oral anticoagulant|new oral anticoagulant
242490|NCT01923818|acute minor ischemic stroke|acute minor ischemic stroke
242491|NCT01923792|House Dust Mite Allergy|house dust mite allergy
242492|NCT01923792|Rhinoconjunctivitis|rhinoconjunctivitis
242493|NCT01923792|Environmental Exposure Unit|environmental exposure unit
242494|NCT01923792|Immunotherapy|immunotherapy
242495|NCT01923792|ToleroMune HDM|toleromune hdm
242496|NCT01923779|Grass allergy|grass allergy
242497|NCT01923779|Rhinoconjunctivitis|rhinoconjunctivitis
242498|NCT01923779|Environmental Exposure Unit|environmental exposure unit
242499|NCT01923779|Immunotherapy|immunotherapy
242500|NCT01923779|ToleroMune Grass|toleromune grass
242501|NCT01923766|Transplantation|transplantation
242502|NCT01923753|Cystic Fibrosis|cystic fibrosis
242503|NCT01923753|Neural respiratory drive|neural respiratory drive
242504|NCT01923753|Airway clearance technique|airway clearance technique
242505|NCT01923753|Expectoration|expectoration
242506|NCT01923753|Positive expiratory pressure device|positive expiratory pressure device
242507|NCT01923740|Absorb™ BVS|absorb™ bvs
242508|NCT01923740|Angioplasty|angioplasty
242509|NCT01923740|Bioabsorbable|bioabsorbable
242510|NCT01923740|BVS|bvs
242511|NCT01923740|Bioresorbable|bioresorbable
242512|NCT01923740|Coronary Artery Disease|coronary artery disease
242513|NCT01923740|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
242514|NCT01923740|Coronary artery restenosis|coronary artery restenosis
242515|NCT01923740|Coronary artery stenosis|coronary artery stenosis
242516|NCT01923740|Coronary scaffold|coronary scaffold
242517|NCT01923740|Coronary Stent|coronary stent
242518|NCT01923740|Drug eluting stents|drug eluting stents
242519|NCT01923740|Everolimus|everolimus
242520|NCT01923740|Myocardial ischemia|myocardial ischemia
242521|NCT01923740|Stent thrombosis|stent thrombosis
242522|NCT01923740|Stents|stents
242523|NCT01923727|[89Zr]Df-IAB2M|[89zr]df-iab2m
242524|NCT01923727|Prostate|prostate
242525|NCT01923727|PET Scan|pet scan
242526|NCT01923714|Glaucoma|glaucoma
242527|NCT01923701|At Risk Mental State|at risk mental state
242528|NCT01923701|Attenuated Psychosis Syndrome|attenuated psychosis syndrome
242529|NCT01923701|Prodrom|prodrom
242530|NCT01923701|Paranoia|paranoia
242532|NCT01923701|Cognitive Behavioral Therapy|cognitive behavioral therapy
242533|NCT01923701|Group|group
242534|NCT01923701|Family|family
242535|NCT01923701|ARMS|arms
242536|NCT01923688|Prediction Prevention Severe Hypoglycemia RealTime Alert|prediction prevention severe hypoglycemia realtime alert
242537|NCT01923675|myopia|myopia
242538|NCT01923675|nearsightedness|nearsightedness
242539|NCT01923675|axial elongation of the eye|axial elongation of the eye
242540|NCT01923675|refractive error|refractive error
242541|NCT01923662|Paraplegia|paraplegia
242542|NCT01923662|Tetraplegia|tetraplegia
242543|NCT01923662|Spinal Cord Injury|spinal cord injury
242544|NCT01923662|FES|fes
242545|NCT01923649|postoperative dumping|postoperative dumping
242546|NCT01923649|somatostatin analogues|somatostatin analogues
242547|NCT01923649|somatulin|somatulin
242548|NCT01923649|lanreotide|lanreotide
243250|NCT01920230|Stress|stress
242549|NCT01923649|dumping syndrome|dumping syndrome
242550|NCT01923636|Cytomegalovirus, congenital, handicap|cytomegalovirus, congenital, handicap
242551|NCT01923610|Low risk HIV infection|low risk hiv infection
242552|NCT01923610|HIV Seronegativity|hiv seronegativity
242553|NCT01923610|HIV Preventive Vaccine|hiv preventive vaccine
242554|NCT01923597|Proteinuria|proteinuria
242555|NCT01923597|Oxidative stress|oxidative stress
242556|NCT01923597|Epigallocatechin gallate|epigallocatechin gallate
242557|NCT01923545|PEG-G-CSF|peg-g-csf
242558|NCT01923493|neck pain|neck pain
242559|NCT01923493|tuina|tuina
242560|NCT01923467|smoking|smoking
242561|NCT01923467|nicotine replacement|nicotine replacement
242562|NCT01923467|internet|internet
242563|NCT01923454|paracentesis|paracentesis
242564|NCT01923454|primary acute angle closure|primary acute angle closure
242565|NCT01923454|iridotomy|iridotomy
242566|NCT01923454|filtration|filtration
242567|NCT01923454|glaucoma|glaucoma
242568|NCT01923415|Lupus Erythematosus, Subacute, Cutaneous|lupus erythematosus, subacute, cutaneous
242569|NCT01923415|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
242570|NCT01923415|Lupus Erythematosus, Discoid|lupus erythematosus, discoid
242571|NCT01923415|Active Cutaneous Lupus Erythematosus|active cutaneous lupus erythematosus
242572|NCT01923415|Systemic Cutaneous Lupus Erythematosus|systemic cutaneous lupus erythematosus
242573|NCT01923415|Skin Biopsy|skin biopsy
242574|NCT01923415|Lesions|lesions
242575|NCT01923402|Biomarkers|biomarkers
242576|NCT01923402|Metabolic Profiling|metabolic profiling
242577|NCT01923402|Metabolomics|metabolomics
242578|NCT01923402|Tobacco|tobacco
242579|NCT01923402|Smokeless Tobacco|smokeless tobacco
242580|NCT01923402|Moist Snuff|moist snuff
242581|NCT01923389|T2DM|t2dm
242582|NCT01923389|obesity|obesity
242583|NCT01923389|safety|safety
242584|NCT01923389|multiple dose|multiple dose
242585|NCT01923389|intravenous|intravenous
242586|NCT01923376|hepatic encephalopathy|hepatic encephalopathy
242587|NCT01923376|hepatic coma|hepatic coma
242588|NCT01923376|HE|he
242589|NCT01923376|PSE|pse
242590|NCT01923376|lactulose|lactulose
242591|NCT01923376|golytely|golytely
242592|NCT01923376|cirrhosis|cirrhosis
242593|NCT01923376|Hepatic Insufficiency|hepatic insufficiency
242594|NCT01923376|Liver Cirrhosis|liver cirrhosis
242595|NCT01923376|Fibrosis|fibrosis
242596|NCT01923376|Brain Damage, Chronic|brain damage, chronic
242597|NCT01923376|Delirium|delirium
242598|NCT01923376|Encephalitis|encephalitis
242599|NCT01923376|Neurotoxicity Syndromes|neurotoxicity syndromes
242600|NCT01923376|Liver Failure|liver failure
242601|NCT01923376|Liver Diseases|liver diseases
242602|NCT01923376|Digestive System Diseases|digestive system diseases
242603|NCT01923376|Brain Diseases, Metabolic|brain diseases, metabolic
242604|NCT01923376|Brain Diseases|brain diseases
242605|NCT01923376|Central Nervous System Diseases|central nervous system diseases
242606|NCT01923376|Nervous System Diseases|nervous system diseases
242607|NCT01923376|Metabolic Diseases|metabolic diseases
242608|NCT01923376|Pathologic Processes|pathologic processes
242609|NCT01923376|Confusion|confusion
242610|NCT01923376|Neurobehavioral Manifestations|neurobehavioral manifestations
242611|NCT01923376|Neurologic Manifestations|neurologic manifestations
242612|NCT01923376|Signs and Symptoms|signs and symptoms
242613|NCT01923376|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
242614|NCT01923376|Mental Disorders|mental disorders
242615|NCT01923376|Central Nervous System Viral Diseases|central nervous system viral diseases
242616|NCT01923376|Virus Diseases|virus diseases
242617|NCT01923376|Central Nervous System Infections|central nervous system infections
242618|NCT01923376|Poisoning|poisoning
242619|NCT01923376|Substance-Related Disorders|substance-related disorders
242620|NCT01923376|Citric Acid|citric acid
242621|NCT01923363|pharmacokinetics|pharmacokinetics
242622|NCT01923363|obesity|obesity
242623|NCT01923363|piperacillin-tazobactam combination product|piperacillin-tazobactam combination product
242624|NCT01923363|pharmacodynamics|pharmacodynamics
242625|NCT01923363|piperacillin/tazobactam|piperacillin/tazobactam
242626|NCT01923350|Weight reduction|weight reduction
242627|NCT01923350|Behavioral intervention|behavioral intervention
242628|NCT01923350|Gestational diabetes mellitus|gestational diabetes mellitus
242735|NCT01922700|lacrimation|lacrimation
242629|NCT01923350|Type 2 diabetes|type 2 diabetes
242630|NCT01923350|Diabetes testing|diabetes testing
242631|NCT01923337|Colorectal cancer|colorectal cancer
242632|NCT01923311|Pediatrics|pediatrics
242633|NCT01923311|Adolescents|adolescents
242634|NCT01923311|HIV|hiv
242635|NCT01923311|HIV-1|hiv-1
242636|NCT01923311|Treatment-experienced|treatment-experienced
242637|NCT01923246|Alcohol consumption|alcohol consumption
242638|NCT01923246|Brief intervention|brief intervention
242639|NCT01923246|Automated techniques|automated techniques
242640|NCT01923233|liver cancer|liver cancer
242641|NCT01923233|HCC|hcc
242642|NCT01923233|tumor vaccine|tumor vaccine
242643|NCT01923233|immunotherapy|immunotherapy
242644|NCT01923220|Breast Cancer|breast cancer
242645|NCT01923220|Radiation Therapy|radiation therapy
243251|NCT01920230|Mindfulness|mindfulness
242646|NCT01923220|Radiation Dermatitis|radiation dermatitis
242647|NCT01923168|Breast Cancer, Pathological Complete Response, neoadjuvant, hormone receptor-positive|breast cancer, pathological complete response, neoadjuvant, hormone receptor-positive
242648|NCT01923142|Vitiligo|vitiligo
242649|NCT01923142|Outer-Root-Sheath|outer-root-sheath
242650|NCT01923142|Melanocytes|melanocytes
242651|NCT01923142|Hair Follicles|hair follicles
242652|NCT01923129|indwelling catheter|indwelling catheter
242653|NCT01923129|foley|foley
242654|NCT01923129|duration|duration
242655|NCT01923116|Anal intraepithelial neoplasia|anal intraepithelial neoplasia
242656|NCT01923116|HIV|hiv
242657|NCT01923116|HPV|hpv
242658|NCT01923116|Vaccination|vaccination
242659|NCT01923116|Treatment|treatment
242660|NCT01923077|acute myocardial infarction|acute myocardial infarction
242661|NCT01923077|Statin|statin
242662|NCT01923077|speckle tracking echocardiography|speckle tracking echocardiography
242663|NCT01923077|Strain|strain
242664|NCT01923077|MSCT|msct
242665|NCT01923077|plaque|plaque
242666|NCT01923077|vulnerable plaque|vulnerable plaque
242667|NCT01923051|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
242668|NCT01923051|COPD|copd
242669|NCT01923051|national database|national database
242670|NCT01923051|observational|observational
242671|NCT01923038|atelectasis|atelectasis
242672|NCT01923038|laparoscopic surgery|laparoscopic surgery
242673|NCT01923038|anesthesia|anesthesia
242674|NCT01923038|mechanical ventilation|mechanical ventilation
242676|NCT01923038|shape of the airway|shape of the airway
688910|NCT00916149|Epilepsy|epilepsy
242677|NCT01923038|pressure-time curve|pressure-time curve
242678|NCT01922986|stroke|stroke
242679|NCT01922986|rehabilitation|rehabilitation
242680|NCT01922986|hemiplegia|hemiplegia
242681|NCT01922986|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
242682|NCT01922973|ghrelin|ghrelin
242683|NCT01922973|growth hormone|growth hormone
242684|NCT01922973|aging|aging
242685|NCT01922973|normal volunteers|normal volunteers
242686|NCT01922960|trauma|trauma
242687|NCT01922960|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
242688|NCT01922908|Ischemic|ischemic
242689|NCT01922908|Stroke|stroke
242690|NCT01922908|Stem Cells|stem cells
242691|NCT01922908|MSC|msc
242692|NCT01922908|Allogeneic|allogeneic
242693|NCT01922908|Bone Marrow|bone marrow
242694|NCT01922895|Alcoholic Hepatitis|alcoholic hepatitis
242695|NCT01922895|MELD < 20|meld < 20
242696|NCT01922895|Probiotic|probiotic
242697|NCT01922895|Nutritional Supplement|nutritional supplement
242698|NCT01922895|Lactobacillus Rhamnosus GG|lactobacillus rhamnosus gg
242699|NCT01922882|HIV|hiv
242700|NCT01922882|Maternal disclosure|maternal disclosure
242701|NCT01922882|Health promotion|health promotion
242702|NCT01922882|Maternal mental health|maternal mental health
242703|NCT01922882|Child behavior|child behavior
242704|NCT01922869|Absorption|absorption
242705|NCT01922869|Metabolism|metabolism
242706|NCT01922869|Excretion|excretion
242707|NCT01922869|Flavonoids|flavonoids
242708|NCT01922869|Polyphenols|polyphenols
242709|NCT01922869|Genes|genes
242710|NCT01922869|Gut-microflora|gut-microflora
242711|NCT01922843|Hemodialysis|hemodialysis
242712|NCT01922830|Sleeve Gastrectomy|sleeve gastrectomy
242713|NCT01922830|NAFLD|nafld
242714|NCT01922830|gut microbiot|gut microbiot
242715|NCT01922830|Bariatric surgery|bariatric surgery
242716|NCT01922791|Nutrition|nutrition
242717|NCT01922791|Probiotics|probiotics
242718|NCT01922791|Fish oil|fish oil
242719|NCT01922765|Helicobacter|helicobacter
242720|NCT01922765|Eradication|eradication
242721|NCT01922752|CEP-37440|cep-37440
242722|NCT01922752|Advanced solid tumors|advanced solid tumors
242723|NCT01922752|Metastatic solid tumors|metastatic solid tumors
242724|NCT01922739|low back pain|low back pain
242725|NCT01922739|hydrocodone bitartrate|hydrocodone bitartrate
242726|NCT01922739|opioids|opioids
242727|NCT01922713|biofortification|biofortification
242728|NCT01922713|vitamin A|vitamin a
242729|NCT01922713|maize|maize
242730|NCT01922713|beta-carotene|beta-carotene
242731|NCT01922713|breastmilk|breastmilk
242732|NCT01922713|Zambia|zambia
242733|NCT01922700|Pepper spray|pepper spray
242734|NCT01922700|bronchospasm|bronchospasm
242736|NCT01922648|RSV|rsv
242737|NCT01922648|Immune response|immune response
242738|NCT01922648|Paediatric|paediatric
242739|NCT01922635|Primary lymphedema quality of life, genetic research|primary lymphedema quality of life, genetic research
242740|NCT01922622|minimum effective dose of local anaesthetic|minimum effective dose of local anaesthetic
242741|NCT01922622|spinal catheter|spinal catheter
242742|NCT01922622|fractured neck of femur|fractured neck of femur
242743|NCT01922622|a step up, step down methodology|a step up, step down methodology
242744|NCT01922609|Carotid stenting|carotid stenting
242745|NCT01922609|Proximal protection system|proximal protection system
242746|NCT01922609|Transcranial Doppler ultrasound|transcranial doppler ultrasound
242747|NCT01922609|Cerebrovascular reserve|cerebrovascular reserve
242748|NCT01922596|Total Knee Arthroplasty|total knee arthroplasty
244136|NCT01916538|genetics|genetics
242749|NCT01922596|Adductor Canal Blockade|adductor canal blockade
242750|NCT01922596|Us-guided nerve blockade|us-guided nerve blockade
242751|NCT01922583|NSCLC, EGFR mutation|nsclc, egfr mutation
242752|NCT01922570|Enteral nutrition|enteral nutrition
242753|NCT01922570|Supplemental parenteral nutrition|supplemental parenteral nutrition
242754|NCT01922570|Critical illness|critical illness
242755|NCT01922570|ICU patients|icu patients
242756|NCT01922570|diarrhea|diarrhea
242757|NCT01922544|heart failure|heart failure
242758|NCT01922544|cardiac resynchronization therapy|cardiac resynchronization therapy
242759|NCT01922544|coronary sinus lead|coronary sinus lead
242760|NCT01922531|mTBI|mtbi
242761|NCT01922531|Mild Traumatic Brain Injury|mild traumatic brain injury
242762|NCT01922531|Axonal Injury|axonal injury
242763|NCT01922518|atrioventricular block, cardiomyopathy|atrioventricular block, cardiomyopathy
242764|NCT01922492|autologous islet transplantation|autologous islet transplantation
242765|NCT01922492|partial pancreatectomy|partial pancreatectomy
242766|NCT01922492|pancreatogenic diabetes|pancreatogenic diabetes
242767|NCT01922479|Heart Failure|heart failure
242768|NCT01922479|Anemia|anemia
242769|NCT01922479|Iron Deficiency|iron deficiency
242770|NCT01922479|Ferric Carboxymaltose|ferric carboxymaltose
242771|NCT01922479|Asian|asian
242772|NCT01922466|chronic neck pain|chronic neck pain
242773|NCT01922466|combined treatment between conventional and complementary alternative medical treatment|combined treatment between conventional and complementary alternative medical treatment
242774|NCT01922466|bee venom acupuncture|bee venom acupuncture
242776|NCT01922453|breech presentation|breech presentation
242777|NCT01922453|vertex presentation|vertex presentation
242778|NCT01922440|Registry|registry
242779|NCT01922440|Chronic Hypoparathyroidism|chronic hypoparathyroidism
242780|NCT01922440|Observational study|observational study
242781|NCT01922440|Natural History|natural history
242782|NCT01922440|Chronic HPTH|chronic hpth
242783|NCT01922414|Staghorn stones|staghorn stones
242784|NCT01922414|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
242785|NCT01922414|Laser|laser
242786|NCT01922414|Randomized trial|randomized trial
242787|NCT01922414|Lithotripsy|lithotripsy
242788|NCT01922388|Parkinson disease|parkinson disease
242789|NCT01922388|deep brain stimulation|deep brain stimulation
242790|NCT01922388|subthalamic nucleus|subthalamic nucleus
242791|NCT01922388|motor complication|motor complication
242792|NCT01922388|quality of life|quality of life
242793|NCT01922362|STSG|stsg
242794|NCT01922362|wound healing|wound healing
242795|NCT01922336|Pharmacokinetics|pharmacokinetics
242796|NCT01922323|Living liver donor|living liver donor
242797|NCT01922297|Delinquency|delinquency
242798|NCT01922297|HIV Associated Risk Behavior|hiv associated risk behavior
242799|NCT01922297|Juveniles|juveniles
242800|NCT01922297|Family based treatment|family based treatment
242801|NCT01922297|Multidimensional Family Therapy|multidimensional family therapy
242802|NCT01922284|HIV|hiv
242803|NCT01922284|Vaccine|vaccine
242804|NCT01922284|Immunisation|immunisation
242805|NCT01922284|DNA|dna
242806|NCT01922284|Adverse events|adverse events
242807|NCT01922284|MVA-C|mva-c
242808|NCT01922284|GLA-AF|gla-af
242809|NCT01922284|Antibody|antibody
242810|NCT01922271|COPD|copd
242811|NCT01922258|OPC-34712|opc-34712
242812|NCT01922258|brexpiprazole|brexpiprazole
242813|NCT01922258|Dementia|dementia
242814|NCT01922258|Alzheimer's Disease|alzheimer's disease
242815|NCT01922258|Cognitive Disorders|cognitive disorders
242816|NCT01922258|Memory|memory
242817|NCT01922258|Agitation|agitation
242818|NCT01922245|aphasia|aphasia
242819|NCT01922245|therapy|therapy
242820|NCT01922245|stroke|stroke
242821|NCT01922245|language|language
242822|NCT01922245|naming|naming
242823|NCT01922245|quality of life|quality of life
242824|NCT01922245|tDCS|tdcs
242825|NCT01922245|treatment|treatment
242826|NCT01922219|depression|depression
242827|NCT01922219|cognitive therapy|cognitive therapy
242828|NCT01922219|cognitive behavioral therapy|cognitive behavioral therapy
242829|NCT01922219|CBT|cbt
242830|NCT01922219|psychotherapy|psychotherapy
242831|NCT01922219|MDD|mdd
299150|NCT01668693|ERA|era
242832|NCT01922219|major depressive disorder|major depressive disorder
242833|NCT01922219|MRI|mri
242834|NCT01922219|fMRI|fmri
242835|NCT01922206|HIV|hiv
242836|NCT01922206|Maternal Disclosure|maternal disclosure
242837|NCT01922180|Chest Computed Tomography|chest computed tomography
242838|NCT01922167|Aging|aging
242839|NCT01922167|Frailty|frailty
242840|NCT01922167|Leucine|leucine
242841|NCT01922167|Resistance Exercise|resistance exercise
242842|NCT01922154|Angiogenesis inhibitors|angiogenesis inhibitors
242843|NCT01922154|Neovascular|neovascular
242844|NCT01922154|Intraocular pressure|intraocular pressure
242845|NCT01922154|Retinal Vein Occlusion|retinal vein occlusion
242846|NCT01922154|Vascular Endothelial Growth Factor|vascular endothelial growth factor
243216|NCT01920360|SULPHUROUS WATERS|sulphurous waters
242847|NCT01922141|High blood pressure, stage 1 and 2 hypertension|high blood pressure, stage 1 and 2 hypertension
242848|NCT01922128|Non-exudative, dry AMD|non-exudative, dry amd
242849|NCT01922115|COGNITIVE FUNCTION|cognitive function
242850|NCT01922115|OVERACTIVE BLADDER|overactive bladder
242851|NCT01922115|[C23.888.942.343.780]|[c23.888.942.343.780]
242852|NCT01922102|Pathologic myopia (PM), choroidal neovascularization (CNV), ranibizumab, verteporfin PDT, Brilliance|pathologic myopia (pm), choroidal neovascularization (cnv), ranibizumab, verteporfin pdt, brilliance
242853|NCT01922089|Heart failure, reduced ejection fraction, LCZ696, titration, safety, tolerability|heart failure, reduced ejection fraction, lcz696, titration, safety, tolerability
242854|NCT01922063|disc herniation surgery|disc herniation surgery
242855|NCT01922063|physiotherapy, exercise therapy|physiotherapy, exercise therapy
242856|NCT01922063|randomized|randomized
242857|NCT01922063|long term|long term
242858|NCT01922063|follow up|follow up
242859|NCT01921972|AD, Dementia|ad, dementia
242860|NCT01921946|Fimasartan|fimasartan
242861|NCT01921933|End-stage renal disease|end-stage renal disease
242862|NCT01921933|ESRD|esrd
242863|NCT01921933|AVF|avf
242864|NCT01921933|Fistulas|fistulas
242865|NCT01921920|Omeprazole, Prilosec, Phase I, Healthy Subjects, Pharmacokinetics, Bioequivalence|omeprazole, prilosec, phase i, healthy subjects, pharmacokinetics, bioequivalence
242866|NCT01921907|Actinic keratosis|actinic keratosis
242867|NCT01921907|topical|topical
242868|NCT01921907|dermatology|dermatology
242869|NCT01921907|treatment|treatment
242870|NCT01921907|clinical study|clinical study
242871|NCT01921907|double blinded|double blinded
242872|NCT01921894|asthma|asthma
242873|NCT01921894|vitamin D|vitamin d
242874|NCT01921881|Glucose tolerance|glucose tolerance
242875|NCT01921829|Cardiorenal failure|cardiorenal failure
242876|NCT01921829|Cardiorenal syndrome|cardiorenal syndrome
242877|NCT01921829|Diuretic resistance|diuretic resistance
242878|NCT01921829|Volume overload|volume overload
242879|NCT01921829|Edema|edema
242880|NCT01921829|Health-related quality of life|health-related quality of life
242881|NCT01921829|Outcomes|outcomes
242882|NCT01921829|Treatment protocol|treatment protocol
242883|NCT01921790|Avastin+ GemAOD|avastin+ gemaod
242884|NCT01921790|first line chemotherapy|first line chemotherapy
242885|NCT01921790|NK/T-cell Lymphoma|nk/t-cell lymphoma
242886|NCT01921777|Muscle|muscle
242887|NCT01921777|exercise|exercise
242888|NCT01921777|soreness|soreness
242889|NCT01921777|Damage|damage
242890|NCT01921777|Traumeel|traumeel
242891|NCT01921777|homeopathy|homeopathy
242892|NCT01921751|SMAD4|smad4
242893|NCT01921751|IMRT|imrt
242894|NCT01921751|gemcitabine|gemcitabine
242895|NCT01921751|FOLFIRINOX|folfirinox
242896|NCT01921751|high-dose radiotherapy|high-dose radiotherapy
242897|NCT01921738|Chronic Periodontitis, Azithromycin, SRP|chronic periodontitis, azithromycin, srp
242898|NCT01921725|wound healing|wound healing
242899|NCT01921725|carbon|carbon
242900|NCT01921712|COPD|copd
242901|NCT01921712|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
242902|NCT01921699|macrophages|macrophages
242903|NCT01921699|adenocarcinoma|adenocarcinoma
242904|NCT01921699|chemoresistance|chemoresistance
242905|NCT01921686|Eosinophil|eosinophil
242906|NCT01921686|Reflux|reflux
242907|NCT01921686|Esophagus|esophagus
242908|NCT01921686|Food allergy|food allergy
242909|NCT01921686|Trouble Swallowing|trouble swallowing
242910|NCT01921686|Pediatrics|pediatrics
242911|NCT01921686|Healthy Volunteers|healthy volunteers
242912|NCT01921673|Gastric cancer|gastric cancer
242913|NCT01921673|Phase I/II|phase i/ii
242914|NCT01921673|Second-line chemotherapy|second-line chemotherapy
242915|NCT01921673|Dovitinib|dovitinib
242916|NCT01921673|Docetaxel|docetaxel
242917|NCT01921673|Refractory to first-line chemotherapy|refractory to first-line chemotherapy
242918|NCT01921647|safety/tolerability and pharmacokinetics/pharmacodynamics|safety/tolerability and pharmacokinetics/pharmacodynamics
242919|NCT01921621|proficiency based progression|proficiency based progression
242920|NCT01921621|surgical skill|surgical skill
242921|NCT01921621|metric validation|metric validation
242922|NCT01921621|formative feedback|formative feedback
242923|NCT01921621|simulator model|simulator model
242924|NCT01921608|Male Circumcision|male circumcision
233696|NCT01964833|PDT|pdt
242925|NCT01921608|HIV Prevention|hiv prevention
242926|NCT01921608|HIV Infections|hiv infections
242927|NCT01921595|balanced salt colloid, coagulation profiles, spinal cord tumor|balanced salt colloid, coagulation profiles, spinal cord tumor
242928|NCT01921543|Deep Brain Stimulation|deep brain stimulation
242929|NCT01921543|Major Depressive Disorder|major depressive disorder
242930|NCT01921543|Psychosurgery|psychosurgery
242931|NCT01921543|Electrical stimulation|electrical stimulation
242932|NCT01921530|Posterolateral Fusion|posterolateral fusion
242933|NCT01921530|Interbody Fusion|interbody fusion
242934|NCT01921530|Lumbar|lumbar
242935|NCT01921530|Spinal Stenosis|spinal stenosis
242936|NCT01921530|Degenerative Spondylolisthesis|degenerative spondylolisthesis
242937|NCT01921517|Biomechanics|biomechanics
242938|NCT01921517|Osteogenesis|osteogenesis
242939|NCT01921504|Functional Dyspepsia|functional dyspepsia
242940|NCT01921504|Acupuncture|acupuncture
242941|NCT01921504|Genotype|genotype
242942|NCT01921504|Ghrelin|ghrelin
242943|NCT01921465|outpatient care|outpatient care
242944|NCT01921465|videoconferencing|videoconferencing
242945|NCT01921465|elective cesarean section|elective cesarean section
242946|NCT01921452|Hypothyroidism|hypothyroidism
242947|NCT01921452|Third generation TSH kit|third generation tsh kit
242948|NCT01921452|Quantitative POC TSH kit|quantitative poc tsh kit
242949|NCT01921452|Qualitative POC TSH kit|qualitative poc tsh kit
242950|NCT01921439|smoking|smoking
242951|NCT01921439|quit smoking|quit smoking
242952|NCT01921439|smoking cessation|smoking cessation
242953|NCT01921439|smoking study|smoking study
242954|NCT01921439|secondhand smoke|secondhand smoke
242955|NCT01921439|smokers|smokers
242956|NCT01921426|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
242957|NCT01921426|Oral Cavity|oral cavity
242958|NCT01921426|Oropharynx|oropharynx
242959|NCT01921426|Radiation|radiation
242960|NCT01921426|Chemotherapy|chemotherapy
242961|NCT01921426|Cisplatin|cisplatin
242962|NCT01921426|Oral Mucositis|oral mucositis
242963|NCT01921426|Superoxide Dismutase|superoxide dismutase
242964|NCT01921413|Plasmodium falciparum|plasmodium falciparum
242965|NCT01921413|Clinical Malaria|clinical malaria
242966|NCT01921413|Fever|fever
242967|NCT01921413|Schistosoma hematobium|schistosoma hematobium
242968|NCT01921413|Rheumatoid arthritis|rheumatoid arthritis
242969|NCT01921400|Hepatitis C (HCV)|hepatitis c (hcv)
242970|NCT01921400|Infection Transmission, Maternal-Fetal|infection transmission, maternal-fetal
242971|NCT01921400|Placenta|placenta
242972|NCT01921400|Trophoblast|trophoblast
242973|NCT01921374|Duchenne;|duchenne;
242974|NCT01921374|mothers caregivers;|mothers caregivers;
242975|NCT01921374|sleep;|sleep;
242976|NCT01921374|hormonal profile;|hormonal profile;
242977|NCT01921374|cardiac profile;|cardiac profile;
242978|NCT01921374|biochemical profile;|biochemical profile;
242979|NCT01921374|inflammatory profile.|inflammatory profile.
242980|NCT01921361|Shivering|shivering
242981|NCT01921361|Dexmedetomidine|dexmedetomidine
242982|NCT01921361|Spinal anesthesia|spinal anesthesia
242983|NCT01921348|Hay Fever|hay fever
242984|NCT01921348|Hayfever|hayfever
242985|NCT01921348|Pollen Allergy|pollen allergy
242986|NCT01921348|Pollinosis|pollinosis
242987|NCT01921348|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
242988|NCT01921335|ARRY-380|arry-380
242989|NCT01921335|Trastuzumab|trastuzumab
242990|NCT01921335|Advanced HER2-positive breast cancer|advanced her2-positive breast cancer
242991|NCT01921309|osteoarthritis|osteoarthritis
242992|NCT01921309|avascular necrosis|avascular necrosis
242993|NCT01921309|rheumatoid arthritis|rheumatoid arthritis
242994|NCT01921309|correction of functional deformity|correction of functional deformity
242995|NCT01921309|dysplasia of the hip|dysplasia of the hip
242996|NCT01921296|Breast cancer|breast cancer
242997|NCT01921296|Aromatase inhibitor|aromatase inhibitor
242998|NCT01921283|propofol, endoscopy, bispectral index|propofol, endoscopy, bispectral index
242999|NCT01921270|Oromandibular Dystonia|oromandibular dystonia
243000|NCT01921270|Oral Dystonia|oral dystonia
243001|NCT01921270|Tardive Dystonia|tardive dystonia
243002|NCT01921270|botulinum toxin|botulinum toxin
243003|NCT01921270|abobotulinumtoxinA|abobotulinumtoxina
243004|NCT01921257|Cat Allergy|cat allergy
243005|NCT01921257|Rhinoconjunctivitis|rhinoconjunctivitis
243006|NCT01921244|Autistic Disorder|autistic disorder
243007|NCT01921244|Decision Making|decision making
243008|NCT01921244|Medication Therapy Management|medication therapy management
243009|NCT01921218|Kidney transplant|kidney transplant
243010|NCT01921205|Lacosamide|lacosamide
243011|NCT01921205|Vimpat|vimpat
243012|NCT01921205|UCB|ucb
243013|NCT01921205|Epilepsy|epilepsy
243014|NCT01921205|Partial Onset Seizures|partial onset seizures
243015|NCT01921205|Pediatric|pediatric
243016|NCT01921179|Post Traumatic Stress Disorder,|post traumatic stress disorder,
243017|NCT01921179|Mild Traumatic Brain Injury|mild traumatic brain injury
243018|NCT01921179|Concussion|concussion
243019|NCT01921179|Cognitive Rehabilitation|cognitive rehabilitation
233753|NCT01964638|Targeted Biopsy|targeted biopsy
233754|NCT01964625|Chronic GvHD|chronic gvhd
233755|NCT01964599|Fiber|fiber
233756|NCT01964599|Gastrointestinal|gastrointestinal
233757|NCT01964586|Septoplasty, Dexmedetomidine, Surgical Conditions|septoplasty, dexmedetomidine, surgical conditions
233758|NCT01964573|Parkinson's Disease|parkinson's disease
233759|NCT01964573|Rotigotine|rotigotine
233760|NCT01964573|Pharmacokinetics|pharmacokinetics
233761|NCT01964573|Healthy subjects|healthy subjects
233762|NCT01964560|Lacosamide|lacosamide
233764|NCT01964560|UCB|ucb
243020|NCT01921166|infertility|infertility
243021|NCT01921166|diminished ovarian reserve|diminished ovarian reserve
243022|NCT01921166|fertilization in vitro|fertilization in vitro
243023|NCT01921166|ovulation inducion|ovulation inducion
243024|NCT01921166|vitrification|vitrification
243025|NCT01921140|Oncology, cancer, tumour, neoplasm, anticancer drug, food, area under the curve, pharmacokinetics, olaparib, neoplasm, metabolites, QT interval effects|oncology, cancer, tumour, neoplasm, anticancer drug, food, area under the curve, pharmacokinetics, olaparib, neoplasm, metabolites, qt interval effects
243032|NCT01921088|Neurofeedback|neurofeedback
243033|NCT01921088|Blood pressure|blood pressure
243034|NCT01921088|Psychophysiology|psychophysiology
244137|NCT01916538|gene|gene
243035|NCT01921075|physiology, normal function|physiology, normal function
243036|NCT01921062|Distal radius fracture|distal radius fracture
243037|NCT01921062|Motor imagery|motor imagery
243038|NCT01921062|Immobilisation|immobilisation
243039|NCT01921062|Effectivity|effectivity
243040|NCT01921023|Blood Gas analysis|blood gas analysis
243041|NCT01920997|Healthy|healthy
243042|NCT01920997|normal menstrual cycles|normal menstrual cycles
243043|NCT01920971|chronic low back pain|chronic low back pain
243044|NCT01920971|infrared energy|infrared energy
243045|NCT01920971|effects|effects
243053|NCT01920906|Psoriasis|psoriasis
243054|NCT01920906|Korean|korean
243055|NCT01920906|Healthy Volunteers|healthy volunteers
243056|NCT01920880|Anterior cutaneous nerve entrapment syndrome|anterior cutaneous nerve entrapment syndrome
243057|NCT01920880|ACNES|acnes
243058|NCT01920880|chronic abdominal wall pain|chronic abdominal wall pain
243059|NCT01920880|CAWP|cawp
243060|NCT01920867|Stem Cells|stem cells
243061|NCT01920867|Bone Marrow Derived Stem Cells|bone marrow derived stem cells
243062|NCT01920867|BMSC|bmsc
243063|NCT01920867|BMC (Bone Marrow Cell)|bmc (bone marrow cell)
243064|NCT01920867|Mesenchymal Stem Cells|mesenchymal stem cells
243066|NCT01920867|Eye Disease|eye disease
243067|NCT01920867|Eye Stem Cells|eye stem cells
243068|NCT01920867|Ophthalmology|ophthalmology
243069|NCT01920867|Ophthalmic Disease|ophthalmic disease
243070|NCT01920867|Retina|retina
243071|NCT01920867|Retinal Disease|retinal disease
243072|NCT01920867|Macular Degeneration|macular degeneration
243073|NCT01920867|Age Related Macular Degeneration|age related macular degeneration
243074|NCT01920867|Myopic Macular Degeneration|myopic macular degeneration
243075|NCT01920867|Geographic Atrophy|geographic atrophy
243076|NCT01920867|Dry Macular Degeneration|dry macular degeneration
243077|NCT01920867|Wet Macular Degeneration|wet macular degeneration
243078|NCT01920867|Retinal Atrophy|retinal atrophy
243079|NCT01920867|Retinal Dystrophy|retinal dystrophy
688911|NCT00916149|Cognition|cognition
243080|NCT01920867|Hereditary Retinal Dystrophy|hereditary retinal dystrophy
243081|NCT01920867|Retinitis Pigmentosa|retinitis pigmentosa
243082|NCT01920867|Stargardt Disease|stargardt disease
243083|NCT01920867|Cone Dystrophy|cone dystrophy
243084|NCT01920867|Cone Rod Dystrophy|cone rod dystrophy
243085|NCT01920867|Maculopathy|maculopathy
243086|NCT01920867|Optic Nerve Disease|optic nerve disease
243087|NCT01920867|Optic Nerve Atrophy|optic nerve atrophy
243088|NCT01920867|Optic Atrophy|optic atrophy
243089|NCT01920867|Ischemic Optic Neuropathy|ischemic optic neuropathy
243090|NCT01920867|Optic Nerve Damage|optic nerve damage
243091|NCT01920867|Optic Nerve Compression|optic nerve compression
243092|NCT01920867|Compressive Optic Neuropathy|compressive optic neuropathy
243093|NCT01920867|Devics Syndrome|devics syndrome
243094|NCT01920854|Soluble Ferric Pyrophosphate, Pharmacokinetics, Iron, Hemodialysis|soluble ferric pyrophosphate, pharmacokinetics, iron, hemodialysis
243095|NCT01920841|lipolytic|lipolytic
243096|NCT01920841|herbal extracts|herbal extracts
243097|NCT01920841|thigh girth|thigh girth
243098|NCT01920841|thigh smoothness|thigh smoothness
243099|NCT01920789|Non-small call lung cancer|non-small call lung cancer
243100|NCT01920789|Medically inoperable|medically inoperable
243101|NCT01920789|Stage one|stage one
243102|NCT01920789|Radiotherapy|radiotherapy
243103|NCT01920789|SBRT|sbrt
299495|NCT01667250|VNS|vns
243104|NCT01920789|Hypofractionation|hypofractionation
243105|NCT01920789|Conventional fractionation|conventional fractionation
243106|NCT01920776|critical ultrasound|critical ultrasound
243107|NCT01920763|Intracerebral hemorrhage|intracerebral hemorrhage
243108|NCT01920763|Surgical evacuation|surgical evacuation
243109|NCT01920763|Minimally-invasive surgery|minimally-invasive surgery
243110|NCT01920750|Leprosy, skin test, MLSA-LAM, MLCwA, diagnosis, Protocol 98-202|leprosy, skin test, mlsa-lam, mlcwa, diagnosis, protocol 98-202
243112|NCT01920737|Bone Marrow|bone marrow
243113|NCT01920737|Ph Negative|ph negative
243114|NCT01920737|Daunorubicin|daunorubicin
243115|NCT01920737|Vincristine|vincristine
243116|NCT01920737|Prednisone|prednisone
243117|NCT01920737|PEG-Asparaginase|peg-asparaginase
243118|NCT01920737|Methotrexate|methotrexate
243119|NCT01920737|16-MP (6-Mercaptopurine)|16-mp (6-mercaptopurine)
243120|NCT01920737|Cyclophosphamide|cyclophosphamide
243121|NCT01920737|Cytarabine|cytarabine
243122|NCT01920737|Leucovorin|leucovorin
243123|NCT01920737|Dexamethasone|dexamethasone
243124|NCT01920737|12-266|12-266
243125|NCT01920724|Preschool children|preschool children
243126|NCT01920724|Body composition|body composition
243127|NCT01920711|Heart failure|heart failure
243128|NCT01920711|preserved ejection fraction|preserved ejection fraction
243129|NCT01920711|diastolic heart failure|diastolic heart failure
243130|NCT01920698|Heart Valve Diseases|heart valve diseases
243131|NCT01920698|Heart failure|heart failure
243132|NCT01920698|Heart diseases|heart diseases
243133|NCT01920698|Mitral valve insufficiency|mitral valve insufficiency
243134|NCT01920685|Paranoia|paranoia
243136|NCT01920685|Reasoning|reasoning
243137|NCT01920685|Anxiety|anxiety
243138|NCT01920659|High Intensity Training|high intensity training
243139|NCT01920659|Insulin sensitivity|insulin sensitivity
243140|NCT01920659|Fitness|fitness
243141|NCT01920620|obesity, inpatient, intervention, weight loss|obesity, inpatient, intervention, weight loss
243142|NCT01920607|Fecal Incontinence.|fecal incontinence.
243143|NCT01920607|Anal Incontinence.|anal incontinence.
243144|NCT01920607|Functional Bowel Disorders.|functional bowel disorders.
243145|NCT01920607|SNS.|sns.
243146|NCT01920607|Artificial Sphincters.|artificial sphincters.
243147|NCT01920607|Magnetic Anal Sphincter.|magnetic anal sphincter.
243148|NCT01920594|GSK1278863|gsk1278863
243149|NCT01920594|Thoracic Aortic Aneurysm Repair|thoracic aortic aneurysm repair
243150|NCT01920581|CEIP|ceip
243151|NCT01920581|pharmacodependance|pharmacodependance
243152|NCT01920581|addictovigilance|addictovigilance
243153|NCT01920581|benzodiazepines and benzodiazepines related drugs|benzodiazepines and benzodiazepines related drugs
243154|NCT01920581|elderly|elderly
243155|NCT01920568|GSK2371746|gsk2371746
243156|NCT01920568|Denosumab|denosumab
243157|NCT01920568|China|china
243158|NCT01920568|skeletal-related events|skeletal-related events
243159|NCT01920568|bone metastases|bone metastases
243160|NCT01920568|bridging study|bridging study
243161|NCT01920568|solid tumors|solid tumors
243162|NCT01920555|Depression|depression
243163|NCT01920555|Treatment Resistant Depression|treatment resistant depression
243164|NCT01920555|Ketamine|ketamine
243165|NCT01920555|Antidepressant|antidepressant
243166|NCT01920555|MDD|mdd
243167|NCT01920555|Major Depression|major depression
243168|NCT01920529|asthma, aerobic exercise, child, cytokines|asthma, aerobic exercise, child, cytokines
243169|NCT01920516|Isolated limb infusion|isolated limb infusion
243170|NCT01920516|Melphalan|melphalan
243171|NCT01920516|Limb Melanoma|limb melanoma
243172|NCT01920516|Tumor response|tumor response
243173|NCT01920503|cholangiocarcinoma|cholangiocarcinoma
243174|NCT01920503|transarterial chemoembolization|transarterial chemoembolization
243175|NCT01920503|doxorubicin|doxorubicin
243183|NCT01920477|Phase 3|phase 3
243184|NCT01920477|monoclonal antibody|monoclonal antibody
243185|NCT01920477|ofatumumab|ofatumumab
243186|NCT01920477|PV|pv
243187|NCT01920477|rare disease|rare disease
243188|NCT01920451|sleep|sleep
243189|NCT01920451|insomnia|insomnia
243190|NCT01920451|posttraumatic stress disorder|posttraumatic stress disorder
243191|NCT01920451|hypertension|hypertension
243192|NCT01920451|cardiovascular disease|cardiovascular disease
243193|NCT01920438|Percutaneous endoscopic gastrostomy,|percutaneous endoscopic gastrostomy,
243194|NCT01920438|Radiologically inserted gastrostomy,|radiologically inserted gastrostomy,
243195|NCT01920438|Complications|complications
243196|NCT01920425|Parkinson's disease|parkinson's disease
243197|NCT01920425|dyskinesia|dyskinesia
243198|NCT01920425|fluctuations|fluctuations
243199|NCT01920425|tremor|tremor
243200|NCT01920425|bradykinesia|bradykinesia
243201|NCT01920425|levodopa|levodopa
243202|NCT01920412|Atrial fibrillation|atrial fibrillation
243203|NCT01920412|Thrombosis|thrombosis
243204|NCT01920412|Ischemic stroke|ischemic stroke
243205|NCT01920412|Left atrial appendage occluder|left atrial appendage occluder
243206|NCT01920412|Intervention method|intervention method
243207|NCT01920399|CAZ-AVI China phase I PK study|caz-avi china phase i pk study
243208|NCT01920386|Acute Toothache|acute toothache
243209|NCT01920386|Wontran|wontran
243210|NCT01920386|Wontran SR Tab.|wontran sr tab.
243211|NCT01920386|Tramadol Hydrochloride/Acetaminophen|tramadol hydrochloride/acetaminophen
243212|NCT01920373|degenerative joint disease|degenerative joint disease
243213|NCT01920373|temporomandibular joint|temporomandibular joint
243214|NCT01920360|KNEE OSTEOARTHRITIS|knee osteoarthritis
243215|NCT01920360|BALNEOTHERAPY|balneotherapy
243217|NCT01920360|WOMAC|womac
243218|NCT01920360|LEQUESNE|lequesne
243219|NCT01920360|HEALTH ASSESSMENT QUESTIONNAIRE|health assessment questionnaire
243220|NCT01920360|SHORT FORM - 36|short form - 36
243222|NCT01920347|hypoxic encephalopathy|hypoxic encephalopathy
243223|NCT01920347|cardiac arrest|cardiac arrest
243224|NCT01920347|outcome|outcome
243225|NCT01920347|pupillary reflex|pupillary reflex
243226|NCT01920334|coronary disease|coronary disease
243227|NCT01920334|heart diseases|heart diseases
243228|NCT01920334|enzymes|enzymes
243229|NCT01920334|sleep|sleep
243230|NCT01920334|troponin|troponin
243231|NCT01920334|zolpidem|zolpidem
243232|NCT01920321|COPD|copd
243233|NCT01920321|Bronchoscopic LVR|bronchoscopic lvr
243234|NCT01920321|Emphysema|emphysema
243235|NCT01920321|Hot injury|hot injury
243236|NCT01920269|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
243237|NCT01920269|intravesical chemotherapy|intravesical chemotherapy
243238|NCT01920269|mitomycin|mitomycin
243239|NCT01920269|passive diffusion|passive diffusion
243240|NCT01920269|electromotive drug administration|electromotive drug administration
243241|NCT01920256|Insulin therapy|insulin therapy
243242|NCT01920256|Type 2 diabetes|type 2 diabetes
243243|NCT01920243|Telemedicine|telemedicine
243244|NCT01920243|self-management|self-management
243245|NCT01920243|Medical psychology|medical psychology
243246|NCT01920243|Health psychology|health psychology
243247|NCT01920243|Rehabilitation|rehabilitation
243248|NCT01920243|Education, Health|education, health
243249|NCT01920230|Burnout|burnout
243252|NCT01920230|Acceptance-commitment therapy (ACT)|acceptance-commitment therapy (act)
243253|NCT01920230|Intervention|intervention
243254|NCT01920230|Effectiveness|effectiveness
243255|NCT01920230|Working conditions|working conditions
243256|NCT01920230|Work engagement|work engagement
243257|NCT01920230|Psychological well-being|psychological well-being
243258|NCT01920230|Life situation|life situation
243259|NCT01920217|sepsis|sepsis
243260|NCT01920217|SNP|snp
243261|NCT01920217|mortality|mortality
243262|NCT01920204|Mastocytosis|mastocytosis
243263|NCT01920204|ISM|ism
243264|NCT01920204|SSM|ssm
243265|NCT01920191|Glioblastoma|glioblastoma
243266|NCT01920165|respiratory tract infections|respiratory tract infections
243267|NCT01920165|upper respiratory tract infections|upper respiratory tract infections
243268|NCT01920165|lower respiratory tract infections|lower respiratory tract infections
243269|NCT01920165|hospitalisation|hospitalisation
243270|NCT01920165|child|child
243271|NCT01920165|children|children
243272|NCT01920165|minors|minors
243273|NCT01920165|infants|infants
243274|NCT01920165|second-hand smoke|second-hand smoke
243275|NCT01920165|tobacco smoke pollution|tobacco smoke pollution
243276|NCT01920165|smoke-free|smoke-free
243277|NCT01920165|smoke-free policy|smoke-free policy
243278|NCT01920165|smoke-free legislation|smoke-free legislation
688912|NCT00916149|Lamictal|lamictal
243279|NCT01920165|public places|public places
243280|NCT01920152|Hip, Chondropenia, Osteoarthritis.|hip, chondropenia, osteoarthritis.
243281|NCT01920126|sodium bicarbonate, renal function, infective endocarditis, open heart surgery|sodium bicarbonate, renal function, infective endocarditis, open heart surgery
243282|NCT01920113|Endoscopic submucosal dissection|endoscopic submucosal dissection
243283|NCT01920113|propofol|propofol
243284|NCT01920113|remifentanil|remifentanil
243285|NCT01920113|dexmedetomidine|dexmedetomidine
243286|NCT01920113|efficacy|efficacy
243287|NCT01920113|safeness|safeness
243288|NCT01920100|Health Care Costs|health care costs
243289|NCT01920100|Genetic Polymorphism|genetic polymorphism
243290|NCT01920087|Atypical Facial Pain|atypical facial pain
243291|NCT01920087|Persistent Idiopathic Facial Pain|persistent idiopathic facial pain
243292|NCT01920087|Atypical Trigeminal Neuralgia|atypical trigeminal neuralgia
243293|NCT01920087|Orofacial Pain|orofacial pain
243294|NCT01920087|Orofacial neuropathic pain|orofacial neuropathic pain
243295|NCT01920087|Fothergill Disease|fothergill disease
243296|NCT01920087|Tic Douloureux|tic douloureux
243297|NCT01920087|Prosopalgia|prosopalgia
243298|NCT01920074|Anal Fissure|anal fissure
243299|NCT01920074|Nitroglycerin|nitroglycerin
243300|NCT01920074|Pediatrics|pediatrics
243301|NCT01920074|RECTIV®|rectiv®
243302|NCT01920074|Pediatric Research Equity Act|pediatric research equity act
243303|NCT01920061|Advanced cancer|advanced cancer
243304|NCT01920061|solid tumors|solid tumors
243305|NCT01920061|PI3K|pi3k
243306|NCT01920061|mTOR|mtor
243307|NCT01920061|PI3K/mTOR|pi3k/mtor
243308|NCT01920061|metastatic|metastatic
299751|NCT01666028|CGM|cgm
243309|NCT01920061|Triple Negative Breast Cancer (TNBC)|triple negative breast cancer (tnbc)
243310|NCT01920048|Heart Failure|heart failure
243311|NCT01920048|Ventricular Dysfunction|ventricular dysfunction
243312|NCT01920048|Ischemic Cardiomyopathy|ischemic cardiomyopathy
243313|NCT01920048|Ischemic Heart Disease|ischemic heart disease
243314|NCT01920048|Revascularization|revascularization
243315|NCT01920048|Percutaneous Coronary Intervention|percutaneous coronary intervention
243316|NCT01920048|Randomized Control Trial|randomized control trial
243317|NCT01920048|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
243318|NCT01920035|Incontinence post RARP|incontinence post rarp
243319|NCT01920035|Surgery induced incontinence|surgery induced incontinence
243320|NCT01920035|Incontinence after prostatectomy|incontinence after prostatectomy
243321|NCT01920035|Neuropathy-induced incontinence|neuropathy-induced incontinence
243322|NCT01920022|medical abortion|medical abortion
244310|NCT01915628|Efficacy|efficacy
243323|NCT01920022|postabortion contraception|postabortion contraception
243324|NCT01920022|LARC|larc
243325|NCT01920022|Nexplanon|nexplanon
243326|NCT01920022|subdermal contraceptive implant|subdermal contraceptive implant
243327|NCT01920009|pharmacy care|pharmacy care
243328|NCT01920009|adherence|adherence
243329|NCT01920009|coronary heart disease|coronary heart disease
243330|NCT01919996|Ocular safety|ocular safety
243331|NCT01919996|azithromycin|azithromycin
243332|NCT01919996|pharyngitis|pharyngitis
243333|NCT01919996|tonsillitis|tonsillitis
243334|NCT01919983|cardiac|cardiac
243335|NCT01919983|innervation|innervation
243336|NCT01919983|inflammation|inflammation
243337|NCT01919983|sudden|sudden
243338|NCT01919983|death|death
243339|NCT01919970|Autism|autism
243340|NCT01919970|Asperger's Syndrome|asperger's syndrome
243341|NCT01919970|Pervasive Developmental Disorder Not Otherwise Specified|pervasive developmental disorder not otherwise specified
243342|NCT01919970|Treatment|treatment
243343|NCT01919970|Cognitive-behavioral therapy|cognitive-behavioral therapy
243344|NCT01919970|Anxiety|anxiety
243345|NCT01919970|Children|children
243346|NCT01919970|Therapy|therapy
243347|NCT01919970|Generalized Anxiety Disorder|generalized anxiety disorder
243348|NCT01919970|Social Phobia|social phobia
243349|NCT01919970|Separation Anxiety Disorder|separation anxiety disorder
243350|NCT01919970|Obsessive-compulsive Disorder|obsessive-compulsive disorder
243351|NCT01919970|Specific Phobia|specific phobia
243352|NCT01919957|epilepsy|epilepsy
243353|NCT01919957|surgery|surgery
243354|NCT01919957|functional MRI|functional mri
243355|NCT01919957|memory outcome|memory outcome
243356|NCT01919944|itch|itch
243357|NCT01919931|Candida albicans|candida albicans
243358|NCT01919931|Candidiasis|candidiasis
243359|NCT01919931|Biofilm|biofilm
243360|NCT01919931|Flow cytometry|flow cytometry
243361|NCT01919931|Mannose Binding Lectin|mannose binding lectin
243362|NCT01919905|Mozzarella cheese fortification|mozzarella cheese fortification
243363|NCT01919905|Bioavailability of Vitamin D|bioavailability of vitamin d
243364|NCT01919892|predictors of response|predictors of response
243365|NCT01919892|bipolar disorder|bipolar disorder
243366|NCT01919892|depression|depression
243367|NCT01919892|lithium treatment|lithium treatment
243368|NCT01919892|biomarkers|biomarkers
243369|NCT01919879|Chemotherapy refractory|chemotherapy refractory
243370|NCT01919879|wtKRAS metastatic colorectal cancer|wtkras metastatic colorectal cancer
243371|NCT01919879|cross over|cross over
243372|NCT01919853|Cancer|cancer
243373|NCT01919853|Fatigue|fatigue
243374|NCT01919853|Mindfulness|mindfulness
243375|NCT01919853|Meditation|meditation
243376|NCT01919853|Neoplasms|neoplasms
243377|NCT01919853|Signs and symptoms|signs and symptoms
243378|NCT01919840|hemostatic disorders|hemostatic disorders
243379|NCT01919840|ardiac surgery|ardiac surgery
243380|NCT01919840|cardiopulmonary bypass|cardiopulmonary bypass
243381|NCT01919827|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
243382|NCT01919827|Stem cells|stem cells
243383|NCT01919827|Mesenchymal stem cells|mesenchymal stem cells
243384|NCT01919801|ACE-I|ace-i
243385|NCT01919801|Firazyr|firazyr
243386|NCT01919801|icatibant|icatibant
243387|NCT01919788|Diabetes Mellitus Type I|diabetes mellitus type i
243388|NCT01919788|Hypoglycemia|hypoglycemia
243389|NCT01919788|Counter-regulatory mechanisms|counter-regulatory mechanisms
243390|NCT01919762|Bacteremia|bacteremia
243391|NCT01919762|Sepsis|sepsis
243392|NCT01919762|Acinetobacter baumannii|acinetobacter baumannii
243393|NCT01919762|Staphylococcus aureus|staphylococcus aureus
243394|NCT01919762|Klebsiella pneumonia|klebsiella pneumonia
243395|NCT01919762|Pseudomonas aeruginosa|pseudomonas aeruginosa
243396|NCT01919762|Enterococcus faecalis|enterococcus faecalis
243397|NCT01919762|Magnetic Relaxation Detection|magnetic relaxation detection
243398|NCT01919762|Nuclear Magnetic Resonance Detection|nuclear magnetic resonance detection
243399|NCT01919762|Blood culture|blood culture
243400|NCT01919749|breast cancer metastatic|breast cancer metastatic
243401|NCT01919749|molecular profiling|molecular profiling
243402|NCT01919749|sequencing|sequencing
243403|NCT01919749|profiling|profiling
243404|NCT01919749|breast cancer|breast cancer
243405|NCT01919736|knee OA|knee oa
243407|NCT01919723|Ticagrelor|ticagrelor
243408|NCT01919723|Eptifibatide|eptifibatide
243409|NCT01919710|Neutropenia|neutropenia
243410|NCT01919710|chemotherapy|chemotherapy
243411|NCT01919710|rHSA/GCSF|rhsa/gcsf
243412|NCT01919697|Plecantaide|plecantaide
243413|NCT01919697|Chronic Idiopathic Constipation|chronic idiopathic constipation
243414|NCT01919697|Chronic|chronic
243415|NCT01919697|Idiopathic|idiopathic
243416|NCT01919697|Constipation|constipation
243417|NCT01919697|Synergy|synergy
243418|NCT01919697|CIC|cic
243419|NCT01919697|CIC study|cic study
243420|NCT01919697|CIC OLE|cic ole
243421|NCT01919697|CIC OLE study|cic ole study
243422|NCT01919697|OLE|ole
243423|NCT01919697|OLE CIC|ole cic
243424|NCT01919697|OLE CIC3|ole cic3
243425|NCT01919697|Open label|open label
243426|NCT01919697|Open label study|open label study
243427|NCT01919697|Long term|long term
243428|NCT01919697|Long term study|long term study
243429|NCT01919697|Extension|extension
243430|NCT01919697|Extension study|extension study
243431|NCT01919684|Glucagon receptor antagonist|glucagon receptor antagonist
243432|NCT01919671|Ischemic Stroke|ischemic stroke
243433|NCT01919671|Tongxinluo capsule|tongxinluo capsule
243434|NCT01919658|nerve blocks in Anterior cruciate ligament surgery|nerve blocks in anterior cruciate ligament surgery
243435|NCT01919645|Rheumatoid Arthritis|rheumatoid arthritis
243436|NCT01919645|Sleep Disorders|sleep disorders
243437|NCT01919645|Polysomnography|polysomnography
243438|NCT01919645|Sleep Stages|sleep stages
243439|NCT01919645|Physical Exercise|physical exercise
243440|NCT01919632|lifestyle|lifestyle
243441|NCT01919632|physical activity|physical activity
243442|NCT01919632|endothelial function|endothelial function
243443|NCT01919632|cardiovascular|cardiovascular
243444|NCT01919632|occupational|occupational
243445|NCT01919632|prevention|prevention
243446|NCT01919619|Blood And Marrow Transplantation|blood and marrow transplantation
243447|NCT01919619|Leukemia|leukemia
243448|NCT01919619|Lymphoma|lymphoma
243449|NCT01919619|Allogeneic stem cell transplant|allogeneic stem cell transplant
243450|NCT01919619|Autologous stem cell transplant|autologous stem cell transplant
243451|NCT01919619|SCT|sct
243452|NCT01919619|Lenalidomide CC-5013|lenalidomide cc-5013
243453|NCT01919619|Revlimid|revlimid
243454|NCT01919619|Ipilimumab|ipilimumab
243455|NCT01919619|Yervoy|yervoy
243456|NCT01919619|BMS-734016|bms-734016
243457|NCT01919619|MDX010|mdx010
243458|NCT01919606|hysterectomy|hysterectomy
243459|NCT01919606|analgesia|analgesia
243460|NCT01919593|Blood culture|blood culture
243461|NCT01919593|Contamination|contamination
243462|NCT01919593|Chlorhexidine gluconate|chlorhexidine gluconate
243463|NCT01919593|Povidone iodine|povidone iodine
243464|NCT01919580|Gα12|gα12
243465|NCT01919580|Oral cancer|oral cancer
243466|NCT01919567|SOX-9|sox-9
243467|NCT01919567|Oral cancer|oral cancer
243468|NCT01919567|arecoline|arecoline
243469|NCT01919554|House Dust Mite Allergic Rhinitis|house dust mite allergic rhinitis
243470|NCT01919554|Phase I|phase i
243471|NCT01919554|House Dust Mite Allergen Extract|house dust mite allergen extract
243472|NCT01919541|Colorectal Surgery|colorectal surgery
688913|NCT00916149|Lamotrigine|lamotrigine
243473|NCT01919528|ultrasonography|ultrasonography
243474|NCT01919528|catheterization|catheterization
243475|NCT01919528|central line|central line
243476|NCT01919528|mechanical ventilation|mechanical ventilation
243477|NCT01919528|intensive care|intensive care
243478|NCT01919528|axillary vein|axillary vein
243479|NCT01919515|pediatric|pediatric
243480|NCT01919515|primary molars|primary molars
243481|NCT01919515|stainless steel crowns|stainless steel crowns
243482|NCT01919489|Incretins|incretins
243483|NCT01919489|Liraglutide|liraglutide
243484|NCT01919489|Glargine|glargine
243485|NCT01919489|Randomized controlled trial|randomized controlled trial
243486|NCT01919489|basal insulin|basal insulin
243487|NCT01919489|hospital discharge|hospital discharge
243488|NCT01919489|inpatient diabetes|inpatient diabetes
243489|NCT01919476|Postprandial|postprandial
243490|NCT01919476|Insulin resistance|insulin resistance
243491|NCT01919476|Lipids|lipids
243492|NCT01919476|Satiety|satiety
243493|NCT01919476|Almonds|almonds
243494|NCT01919463|Colonoscopy|colonoscopy
243495|NCT01919463|Lower Gastrointestinal Tract|lower gastrointestinal tract
243496|NCT01919463|Magnetic Endoscopic Imaging|magnetic endoscopic imaging
243497|NCT01919463|Abdominal Compression|abdominal compression
243499|NCT01919450|Lexiscan|lexiscan
243500|NCT01919450|Regadenoson|regadenoson
243501|NCT01919450|Rubidium|rubidium
243502|NCT01919450|Blood Flow Reserve|blood flow reserve
243503|NCT01919450|Myocardial Perfusion|myocardial perfusion
243504|NCT01919450|Quantitated Myocardial Perfusion|quantitated myocardial perfusion
243505|NCT01919411|Chronic rhinosinusitis|chronic rhinosinusitis
243506|NCT01919411|Sinus surgery|sinus surgery
243507|NCT01919411|Antibiotics|antibiotics
243508|NCT01919385|Type 1 diabetes|type 1 diabetes
243509|NCT01919385|Insulin Pump|insulin pump
243510|NCT01919359|ablative laser|ablative laser
243511|NCT01919359|soft tissue filler|soft tissue filler
243512|NCT01919346|Kidney Transplantation|kidney transplantation
243513|NCT01919346|Delayed Graft Function|delayed graft function
243514|NCT01919320|SynCardia|syncardia
243515|NCT01919320|Total Artificial Heart|total artificial heart
243516|NCT01919320|TAH-t|tah-t
243517|NCT01919307|Seizures|seizures
243518|NCT01919307|Convulsions|convulsions
243519|NCT01919307|Anticonvulsants|anticonvulsants
243520|NCT01919307|Epilepsy|epilepsy
243521|NCT01919307|Neurologic|neurologic
243522|NCT01919294|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
243523|NCT01919294|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
243524|NCT01919294|hypogonadism|hypogonadism
243525|NCT01919294|testosterone replacement therapy|testosterone replacement therapy
243526|NCT01919281|exercise|exercise
243527|NCT01919281|resistance training|resistance training
243528|NCT01919281|insulin resistance|insulin resistance
243529|NCT01919281|high intensity interval training|high intensity interval training
243530|NCT01919268|Pilates-based exercises|pilates-based exercises
243531|NCT01919268|Electrotherapy|electrotherapy
243532|NCT01919268|Interferencial current|interferencial current
243533|NCT01919255|Colonoscopy|colonoscopy
243534|NCT01919255|Bowel preparation|bowel preparation
243535|NCT01919255|Picolight|picolight
243536|NCT01919255|Clicolon|clicolon
243537|NCT01919255|Coolprep|coolprep
243538|NCT01919229|HR-positive|hr-positive
243539|NCT01919229|HER2-negative|her2-negative
243540|NCT01919229|Breast cancer|breast cancer
243541|NCT01919229|LEE011|lee011
243542|NCT01919229|Letrozole|letrozole
243544|NCT01919229|CDK4|cdk4
243545|NCT01919229|CDK6|cdk6
243546|NCT01919229|CDK4/6|cdk4/6
243547|NCT01919229|Pharmacodynamics|pharmacodynamics
243548|NCT01919229|Pre-surgical|pre-surgical
243549|NCT01919229|Postmenopausal|postmenopausal
243550|NCT01919177|Heart Failure|heart failure
243551|NCT01919177|Arterial hemodynamics|arterial hemodynamics
243552|NCT01919177|Exercise capacity|exercise capacity
243553|NCT01919177|Mitochondrial oxidative capacity|mitochondrial oxidative capacity
244235|NCT01916070|syncope|syncope
243554|NCT01919164|Osteoarthritis of knee|osteoarthritis of knee
243555|NCT01919164|AS902330|as902330
243556|NCT01919164|Recombinant Human Fibroblast Growth Factor-18 (rhFGF-18)|recombinant human fibroblast growth factor-18 (rhfgf-18)
243557|NCT01919164|Sprifermin|sprifermin
243558|NCT01919164|Placebo|placebo
243559|NCT01919151|survival|survival
243560|NCT01919125|Chronic hepatitis C|chronic hepatitis c
243561|NCT01919125|Hepatitis C virus|hepatitis c virus
243562|NCT01919125|HCV|hcv
243563|NCT01919112|Brain stimulation|brain stimulation
243564|NCT01919099|Transplantation Costs|transplantation costs
243565|NCT01919099|Risk Factors|risk factors
243566|NCT01919099|Transplant Infections|transplant infections
243567|NCT01919086|Bortezomib|bortezomib
243568|NCT01919086|Dexamethasone|dexamethasone
243569|NCT01919086|Lenalidomide|lenalidomide
243570|NCT01919086|13-064|13-064
243571|NCT01919073|Attention Deficit, ADD, ADHD, ODD, Oppositional Behavior, Disruptive Behavior, Behavior Modification, Parent Management Training, Pre-School|attention deficit, add, adhd, odd, oppositional behavior, disruptive behavior, behavior modification, parent management training, pre-school
243572|NCT01919047|overactive bladder|overactive bladder
243573|NCT01919047|mirabegron|mirabegron
243574|NCT01919047|occurrence of adverse events|occurrence of adverse events
243575|NCT01919047|Overactive Bladder Symptom Score|overactive bladder symptom score
243576|NCT01919034|Interleukin-20, Thrombomodulin, Huntington disease, patient control analgesic|interleukin-20, thrombomodulin, huntington disease, patient control analgesic
243577|NCT01919008|FK949E|fk949e
243578|NCT01919008|Pharmacokinetics|pharmacokinetics
243579|NCT01919008|Major Depressive Disorder|major depressive disorder
243580|NCT01918995|CVT3146|cvt3146
243581|NCT01918995|Regadenoson|regadenoson
243582|NCT01918982|Aortic aneurysm|aortic aneurysm
243583|NCT01918982|circulating endothelial progenitor cells|circulating endothelial progenitor cells
243584|NCT01918969|Endothelial progenitor cells|endothelial progenitor cells
243585|NCT01918969|Healthy blood donors|healthy blood donors
243586|NCT01918956|immunotherapy|immunotherapy
243587|NCT01918956|birch pollen|birch pollen
243588|NCT01918956|seasonal allergy|seasonal allergy
243589|NCT01918956|up-dosing|up-dosing
243590|NCT01918943|Spine|spine
243591|NCT01918943|Aspen device|aspen device
243592|NCT01918943|PLIF|plif
243593|NCT01918943|Low back pain|low back pain
243594|NCT01918930|Melanoma|melanoma
243595|NCT01918930|Accessible tumors|accessible tumors
243596|NCT01918930|B7-H3 positive tumors|b7-h3 positive tumors
243597|NCT01918917|Arthroscopic knee surgery|arthroscopic knee surgery
243598|NCT01918917|Dexmedetomidine|dexmedetomidine
243599|NCT01918917|Analgesia|analgesia
243600|NCT01918904|calcinosis|calcinosis
243601|NCT01918904|sodium thiosulfate|sodium thiosulfate
243602|NCT01918904|topical treatment|topical treatment
243603|NCT01918904|connective tissue disease|connective tissue disease
243604|NCT01918891|stroke|stroke
243605|NCT01918891|transient ischemic attack|transient ischemic attack
243606|NCT01918891|High blood pressure|high blood pressure
243607|NCT01918891|Hypertension|hypertension
243608|NCT01918878|age-related macular degeneration|age-related macular degeneration
243609|NCT01918878|intravitreal injections|intravitreal injections
243610|NCT01918878|Aflibercept|aflibercept
243611|NCT01918878|EYLEA|eylea
243612|NCT01918865|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
243613|NCT01918865|T2DM|t2dm
243614|NCT01918852|Hand-foot syndrome|hand-foot syndrome
243615|NCT01918852|Toxicity|toxicity
243616|NCT01918852|Fluoropyrimidine|fluoropyrimidine
243617|NCT01918852|Capecitabine|capecitabine
243618|NCT01918852|Teysuno|teysuno
243619|NCT01918852|S1|s1
243620|NCT01918839|Investigational Device (VINCI Plus)|investigational device (vinci plus)
243621|NCT01918839|Correction of nasolabial fold|correction of nasolabial fold
243622|NCT01918839|Wrinkle improvement|wrinkle improvement
243623|NCT01918839|Wrinkle correction|wrinkle correction
243624|NCT01918800|fatigue|fatigue
243625|NCT01918800|quality of life|quality of life
243626|NCT01918800|rehabilitation|rehabilitation
244311|NCT01915628|On label|on label
243627|NCT01918800|self management|self management
243628|NCT01918800|energy effectiveness|energy effectiveness
243629|NCT01918774|Unemployment|unemployment
243630|NCT01918774|Cognitive Behavioral Therapy|cognitive behavioral therapy
243631|NCT01918774|Mental Disorders|mental disorders
243632|NCT01918761|NSCLC|nsclc
243633|NCT01918761|Stage IV|stage iv
243634|NCT01918761|Pemetrexed|pemetrexed
243635|NCT01918761|Dacomitinib|dacomitinib
243636|NCT01918735|Safety|safety
243637|NCT01918735|Tolerability|tolerability
243638|NCT01918735|Assessment of potential adverse events|assessment of potential adverse events
243639|NCT01918735|Assessment of potential laboratory abnormalities|assessment of potential laboratory abnormalities
243640|NCT01918722|Activating blood stagnation and expelling blood stasis|activating blood stagnation and expelling blood stasis
243641|NCT01918722|Hematoma enlargement|hematoma enlargement
243642|NCT01918722|herbal medicine|herbal medicine
243643|NCT01918722|traditional chinese medicine|traditional chinese medicine
243644|NCT01918722|random clinical trial|random clinical trial
243645|NCT01918696|suicide|suicide
243646|NCT01918696|anger|anger
243647|NCT01918696|interpretation modification|interpretation modification
243648|NCT01918696|computerized treatment|computerized treatment
243649|NCT01918670|atrial fibrillation; catheter ablation; relapse; stroke; death|atrial fibrillation; catheter ablation; relapse; stroke; death
243650|NCT01918657|Interventional|interventional
243651|NCT01918657|Randomized|randomized
243652|NCT01918657|Double blind|double blind
243653|NCT01918657|Placebo controlled|placebo controlled
243654|NCT01918657|Pediatric|pediatric
243655|NCT01918618|levosimendan|levosimendan
243656|NCT01918618|renal effects|renal effects
243657|NCT01918618|cardiac surgery|cardiac surgery
243658|NCT01918618|left heart insufficiency|left heart insufficiency
243659|NCT01918605|prostate cancer|prostate cancer
243660|NCT01918605|brachytherapy|brachytherapy
243661|NCT01918605|spacer|spacer
243662|NCT01918605|side effect|side effect
243663|NCT01918592|bladder cancer|bladder cancer
243664|NCT01918592|neoadjuvant chemotherapy|neoadjuvant chemotherapy
243665|NCT01918592|radical cystectomy|radical cystectomy
243666|NCT01918592|lymphadenectomy|lymphadenectomy
243667|NCT01918592|biomarker|biomarker
243668|NCT01918553|AMD|amd
243669|NCT01918553|epidemiology|epidemiology
243670|NCT01918553|risk factors|risk factors
243671|NCT01918553|cohort study|cohort study
243672|NCT01918540|Radiostereometry|radiostereometry
243673|NCT01918540|Total Hip Arthroplasty|total hip arthroplasty
243674|NCT01918540|Stem design|stem design
243675|NCT01918527|Locally advanced colon cancer|locally advanced colon cancer
243676|NCT01918527|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
243677|NCT01918514|Magnesium sulfate|magnesium sulfate
243678|NCT01918514|epidural|epidural
243679|NCT01918514|interscalene|interscalene
243680|NCT01918514|NMDA receptor|nmda receptor
243681|NCT01918501|multiple sclerosis|multiple sclerosis
243682|NCT01918501|Remyelination|remyelination
243683|NCT01918501|Mitochondria|mitochondria
243684|NCT01918501|fatty acids|fatty acids
243685|NCT01918488|Diabetic Nephropathies|diabetic nephropathies
243686|NCT01918488|Hypertension|hypertension
243687|NCT01918488|Proteinuria|proteinuria
243688|NCT01918488|Albuminuria|albuminuria
243689|NCT01918488|Epithelial Sodium Channels|epithelial sodium channels
243690|NCT01918488|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers
243691|NCT01918488|Amiloride|amiloride
243692|NCT01918475|randomized controlled trial|randomized controlled trial
243693|NCT01918475|placebo controlled trial|placebo controlled trial
243694|NCT01918475|cross over trial|cross over trial
243695|NCT01918462|Alcoholic hepatitis|alcoholic hepatitis
243696|NCT01918462|IL-22|il-22
243697|NCT01918462|Kupffer cells|kupffer cells
243698|NCT01918449|OSA|osa
243699|NCT01918449|CPAP treatment|cpap treatment
243700|NCT01918449|primary care|primary care
243701|NCT01918449|efficacy|efficacy
243702|NCT01918436|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
243703|NCT01918436|Neurocognitive training for preschool children with ADHD|neurocognitive training for preschool children with adhd
243704|NCT01918436|Play intervention for children with ADHD|play intervention for children with adhd
243705|NCT01918423|Childhood adiposity|childhood adiposity
243706|NCT01918423|Metabolic risk factors|metabolic risk factors
243707|NCT01918423|Bone mineralization|bone mineralization
243708|NCT01918410|contact lens|contact lens
243709|NCT01918410|alginic|alginic
243710|NCT01918410|dry eyes|dry eyes
243711|NCT01918384|Duchenne muscular dystrophy|duchenne muscular dystrophy
243712|NCT01918384|NPC-14|npc-14
243713|NCT01918384|Arbekacin|arbekacin
243714|NCT01918384|nonsense|nonsense
243715|NCT01918384|readthrough|readthrough
243716|NCT01918345|Diabetes|diabetes
243717|NCT01918345|Diabetes Mellitus|diabetes mellitus
243718|NCT01918345|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
243719|NCT01918345|Diabetes, gestational|diabetes, gestational
243720|NCT01918345|Prevention & control|prevention & control
243721|NCT01918345|Postpartum Period|postpartum period
243722|NCT01918345|Mothers|mothers
243723|NCT01918345|Diet|diet
244705|NCT01913899|amputees|amputees
243724|NCT01918345|Diabetic Diet|diabetic diet
243725|NCT01918345|Exercise|exercise
243726|NCT01918345|Life Style|life style
243727|NCT01918345|Motivation|motivation
243728|NCT01918345|Health Behavior|health behavior
243729|NCT01918345|Insulin-Secreting Cells|insulin-secreting cells
243730|NCT01918345|Randomized Controlled Trial|randomized controlled trial
243731|NCT01918345|Clinical Trial|clinical trial
243732|NCT01918345|Pilot Projects|pilot projects
243733|NCT01918345|Feasibility Studies|feasibility studies
243734|NCT01918306|Triple Negative Breast Cancer|triple negative breast cancer
243735|NCT01918306|Estrogen receptor negative breast cancer|estrogen receptor negative breast cancer
243736|NCT01918306|Metastatic breast cancer|metastatic breast cancer
243737|NCT01918306|Stage IV breast cancer|stage iv breast cancer
243738|NCT01918306|HER2 negative breast cancer|her2 negative breast cancer
243739|NCT01918293|ASTHMA|asthma
243740|NCT01918293|SMARTPHONE APPLICATION|smartphone application
243741|NCT01918280|Klinefelter Syndrome|klinefelter syndrome
243742|NCT01918280|Azoospermia|azoospermia
243743|NCT01918280|Seminal analyses|seminal analyses
243744|NCT01918280|Testicular biopsy|testicular biopsy
243745|NCT01918241|Pegylation|pegylation
243746|NCT01918241|G-CSF|g-csf
243747|NCT01918241|Efficacy|efficacy
243748|NCT01918241|Satety|satety
243749|NCT01918202|Enzyme occupancy|enzyme occupancy
243750|NCT01918202|PET|pet
243751|NCT01918202|Phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
243752|NCT01918189|back pain|back pain
243753|NCT01918189|low back pain|low back pain
243754|NCT01918189|chronic pain|chronic pain
243755|NCT01918189|cognitive behavior therapy|cognitive behavior therapy
243756|NCT01918189|behavior therapy|behavior therapy
243757|NCT01918176|Palbociclib|palbociclib
243758|NCT01918176|PD-0332991|pd-0332991
243759|NCT01918176|Proton Pump Inhibitor|proton pump inhibitor
243760|NCT01918176|DDI|ddi
243761|NCT01918176|Healthy Volunteers|healthy volunteers
243762|NCT01918176|Pharmacokinetics|pharmacokinetics
243763|NCT01918176|Rabeprazole|rabeprazole
402007|NCT01233544|Radiofrequency ablation|radiofrequency ablation
751911|NCT01171183|cocaine dependence|cocaine dependence
243764|NCT01918163|pomegranate pills, male infertility, pregnancy rate, semen analysis, ROS, oxidative stress|pomegranate pills, male infertility, pregnancy rate, semen analysis, ros, oxidative stress
243765|NCT01918124|disease free survival, overall survival|disease free survival, overall survival
243766|NCT01918111|Renal denervation, Exercise diastolic function, Atherosclerosis, New methods|renal denervation, exercise diastolic function, atherosclerosis, new methods
243768|NCT01918072|Hospitals, Veterans|hospitals, veterans
243769|NCT01918072|Education|education
243770|NCT01918072|Remote consultation|remote consultation
243771|NCT01918072|Videoconferencing|videoconferencing
243772|NCT01918059|Trauma|trauma
243773|NCT01918059|Eyelid|eyelid
243774|NCT01918059|Laceration|laceration
243775|NCT01918059|Tissue adhesive|tissue adhesive
243776|NCT01918059|suture|suture
243777|NCT01918059|cosmetic|cosmetic
243778|NCT01918059|octyl-2-cyanoacrylate|octyl-2-cyanoacrylate
243779|NCT01918046|biomarker|biomarker
243780|NCT01918046|MIOX|miox
243781|NCT01918033|Rhinitis|rhinitis
243782|NCT01918033|Allergic Rhinitis|allergic rhinitis
243783|NCT01918033|Nose Diseases|nose diseases
243784|NCT01918033|Respiratory Tract Diseases|respiratory tract diseases
243785|NCT01918033|Immune System Diseases|immune system diseases
243786|NCT01918033|Cholinergic Antagonists|cholinergic antagonists
243787|NCT01918033|Cholinergic Agents|cholinergic agents
243788|NCT01918033|Neurotransmitter Agents|neurotransmitter agents
243789|NCT01918033|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating
243790|NCT01918033|Histamine H1 Antagonists|histamine h1 antagonists
234546|NCT01961271|Norspan|norspan
243791|NCT01918033|Histamine Antagonists|histamine antagonists
243792|NCT01918033|Histamine Agents|histamine agents
243793|NCT01918020|Fruit|fruit
243794|NCT01918020|Vegetables|vegetables
243795|NCT01918020|Motor Activity|motor activity
243796|NCT01918007|Apnea|apnea
243797|NCT01918007|Sleep Apnea Syndromes|sleep apnea syndromes
243798|NCT01918007|Snoring|snoring
243799|NCT01918007|Sleep Apnea, Obstructive|sleep apnea, obstructive
243800|NCT01918007|Respiration Disorders|respiration disorders
243801|NCT01918007|Respiratory Tract Diseases|respiratory tract diseases
243802|NCT01918007|Signs and Symptoms, Respiratory Signs and Symptoms|signs and symptoms, respiratory signs and symptoms
243803|NCT01918007|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
243804|NCT01918007|Dyssomnias|dyssomnias
243805|NCT01918007|Sleep Disorders|sleep disorders
243806|NCT01918007|Respiratory Sounds|respiratory sounds
243807|NCT01917981|Intermittent cardiac monitoring|intermittent cardiac monitoring
243808|NCT01917981|Implantable device|implantable device
243809|NCT01917968|POP|pop
243810|NCT01917968|Transvaginal|transvaginal
243811|NCT01917968|Native Tissue Repair|native tissue repair
243812|NCT01917968|Repair Augmented with Mesh|repair augmented with mesh
243813|NCT01917968|Pelvic Organ Prolapse|pelvic organ prolapse
243814|NCT01917955|MRI|mri
243815|NCT01917942|Radiotherapy|radiotherapy
243816|NCT01917942|Humidification|humidification
243817|NCT01917942|Mucositis|mucositis
243818|NCT01917929|[E04.555.110.110.110]|[e04.555.110.110.110]
243819|NCT01917903|walking|walking
243820|NCT01917903|Parkinson's disease|parkinson's disease
243821|NCT01917903|traumatic brain injury|traumatic brain injury
243822|NCT01917903|multiple sclerosis|multiple sclerosis
243823|NCT01917903|physical therapy|physical therapy
243824|NCT01917903|falls|falls
243825|NCT01917903|memory|memory
243826|NCT01917903|attention|attention
243827|NCT01917903|multitasking|multitasking
243828|NCT01917903|exercise|exercise
243829|NCT01917890|curcumin|curcumin
243830|NCT01917890|radioprotective|radioprotective
243831|NCT01917890|radiosensitizer|radiosensitizer
243832|NCT01917877|Becacizumab|becacizumab
243833|NCT01917877|pulmonary fibrosis|pulmonary fibrosis
243834|NCT01917877|irradiation|irradiation
243835|NCT01917877|chemotherapy|chemotherapy
243836|NCT01917864|Autism|autism
243837|NCT01917864|Autism Spectrum Disorders|autism spectrum disorders
243838|NCT01917864|Prosody|prosody
243839|NCT01917864|Speech treatment|speech treatment
243840|NCT01917851|Accurate|accurate
243841|NCT01917851|Hb|hb
243842|NCT01917851|noninvasive measurement|noninvasive measurement
243843|NCT01917838|Mental Health Services|mental health services
243844|NCT01917825|radicular pain|radicular pain
243845|NCT01917812|physical activity|physical activity
243846|NCT01917812|exercise|exercise
243847|NCT01917812|mHealth|mhealth
243848|NCT01917812|smartphone|smartphone
243849|NCT01917812|activity tracker|activity tracker
243850|NCT01917812|pedometer|pedometer
243851|NCT01917812|text messaging|text messaging
243852|NCT01917812|SMS|sms
243853|NCT01917799|Aspirin|aspirin
243854|NCT01917799|Heparin|heparin
243855|NCT01917799|pregnancy|pregnancy
243856|NCT01917799|miscarriage|miscarriage
243857|NCT01917760|Gamma-aminobutyric acid|gamma-aminobutyric acid
243858|NCT01917760|Pharmacokinetics|pharmacokinetics
243859|NCT01917760|Pharmacodynamics|pharmacodynamics
243860|NCT01917760|Insulin|insulin
243861|NCT01917760|C-peptide|c-peptide
243862|NCT01917760|Glucagon|glucagon
688914|NCT00916149|Keppra|keppra
243863|NCT01917747|Infant hearing screening|infant hearing screening
243864|NCT01917747|Patient Navigator|patient navigator
243865|NCT01917734|severe acute malnutrition|severe acute malnutrition
243866|NCT01917734|severe wasting|severe wasting
243867|NCT01917734|facility-based care|facility-based care
243868|NCT01917734|community-based care|community-based care
243869|NCT01917734|Madhya Pradesh|madhya pradesh
243871|NCT01917721|Kawasaki disease|kawasaki disease
243872|NCT01917721|doxycycline|doxycycline
243873|NCT01917721|coronary artery aneurysm|coronary artery aneurysm
243874|NCT01917708|non malignant conditions|non malignant conditions
243875|NCT01917708|blood and marrow transplant|blood and marrow transplant
243876|NCT01917695|Bulky cervical cancers|bulky cervical cancers
243877|NCT01917695|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
243878|NCT01917695|Neoadjuvant Chemoradiotherapy|neoadjuvant chemoradiotherapy
243879|NCT01917682|robotic-assisted PCI|robotic-assisted pci
243880|NCT01917682|coronary intervention|coronary intervention
243881|NCT01917682|CorPath PRECISION Registry|corpath precision registry
243882|NCT01917682|PCI|pci
243883|NCT01917682|angioplasty|angioplasty
243884|NCT01917643|COPD, Comparative Effectiveness, Symbicort|copd, comparative effectiveness, symbicort
243885|NCT01917630|Celiac disease|celiac disease
243886|NCT01917630|Gluten-free diet|gluten-free diet
243887|NCT01917630|Coeliac disease|coeliac disease
243888|NCT01917630|Celiac sprue|celiac sprue
243889|NCT01917604|open versus closed surgical technique|open versus closed surgical technique
243890|NCT01917604|impacted maxillary canine|impacted maxillary canine
243891|NCT01917604|orthodontic disimpaction|orthodontic disimpaction
243892|NCT01917591|Bandages|bandages
243893|NCT01917591|Biological Dressings|biological dressings
243894|NCT01917591|Chronic Disease|chronic disease
243895|NCT01917591|Collagen|collagen
243896|NCT01917591|Epithelium|epithelium
243897|NCT01917591|Extracellular Matrix|extracellular matrix
243898|NCT01917591|Extra Cellular Matrix|extra cellular matrix
243899|NCT01917591|Fibroblasts|fibroblasts
243900|NCT01917591|Granulation Tissue|granulation tissue
243901|NCT01917591|Leg Ulcer|leg ulcer
243902|NCT01917591|Middle Aged|middle aged
243903|NCT01917591|Prospective Studies|prospective studies
243904|NCT01917591|Soft Tissue Injuries|soft tissue injuries
243905|NCT01917591|Treatment Outcome|treatment outcome
243906|NCT01917591|Varicose Ulcer|varicose ulcer
243907|NCT01917591|Wound Healing|wound healing
243908|NCT01917591|Wounds and Injuries|wounds and injuries
243909|NCT01917591|biopsy|biopsy
243910|NCT01917591|autoimmunity|autoimmunity
243911|NCT01917578|Breast Cancer|breast cancer
243912|NCT01917578|shrinkage modes|shrinkage modes
243913|NCT01917578|three-dimensional reconstruction|three-dimensional reconstruction
243914|NCT01917578|neoadjuvant chemotherapy|neoadjuvant chemotherapy
243915|NCT01917578|Magnetic Resonance Imaging|magnetic resonance imaging
243916|NCT01917565|airway management|airway management
243917|NCT01917565|laryngoscope|laryngoscope
243918|NCT01917565|Airtraq|airtraq
243919|NCT01917565|Macintosh laryngoscope|macintosh laryngoscope
243920|NCT01917565|fiberoptic bronchoscope|fiberoptic bronchoscope
243921|NCT01917565|intubation|intubation
245006|NCT01912209|obesity|obesity
243922|NCT01917552|Gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, adjuvant, capecitabine, gastric cancer, stage 1b|gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, adjuvant, capecitabine, gastric cancer, stage 1b
243923|NCT01917526|Oxygen|oxygen
243924|NCT01917526|PACU|pacu
243925|NCT01917526|Hypoxemia|hypoxemia
243926|NCT01917513|Adenoma|adenoma
243927|NCT01917513|Polyps|polyps
243928|NCT01917513|CRC|crc
243929|NCT01917513|Colonoscopy|colonoscopy
243930|NCT01917513|Detection Yield|detection yield
243931|NCT01917500|Continues non-invasive Blood pressure measurement|continues non-invasive blood pressure measurement
243932|NCT01917500|Continues non-invasive Cardiac Output measurement|continues non-invasive cardiac output measurement
243933|NCT01917474|low-lipid diet|low-lipid diet
243934|NCT01917474|normal lipid intake|normal lipid intake
243935|NCT01917474|saturated fats reduction|saturated fats reduction
243936|NCT01917474|headache attacks|headache attacks
243937|NCT01917448|postoperative pain|postoperative pain
243938|NCT01917448|spinal morphine|spinal morphine
243939|NCT01917448|video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
243940|NCT01917435|fiberoptic bronchoscopy,|fiberoptic bronchoscopy,
243941|NCT01917435|Video-stylet,|video-stylet,
243942|NCT01917435|Nasotracheal Intubation|nasotracheal intubation
243943|NCT01917409|Conventional Laryngoscopy ,|conventional laryngoscopy ,
243944|NCT01917409|Video-stylet ,|video-stylet ,
243945|NCT01917409|Nasotracheal Intubation|nasotracheal intubation
243946|NCT01917396|caesarean, bowel, gass|caesarean, bowel, gass
243947|NCT01917383|glaucoma|glaucoma
243948|NCT01917383|primary open angle glaucoma|primary open angle glaucoma
243949|NCT01917383|ocular hypertension|ocular hypertension
243950|NCT01917383|adenosine agonist|adenosine agonist
243951|NCT01917383|eye drop|eye drop
243952|NCT01917383|trabodenoson|trabodenoson
243953|NCT01917383|trabecular meshwork|trabecular meshwork
243954|NCT01917370|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
243955|NCT01917370|icc|icc
243956|NCT01917370|vegf signal pathway|vegf signal pathway
243957|NCT01917357|Vaccination|vaccination
243958|NCT01917357|Immunisation|immunisation
243959|NCT01917357|Virus|virus
243960|NCT01917357|Diphtheria|diphtheria
243961|NCT01917357|Pertussis|pertussis
243962|NCT01917357|Tetanus|tetanus
243963|NCT01917357|Hepatitis B|hepatitis b
243964|NCT01917357|Haemophilus Influenzae|haemophilus influenzae
243965|NCT01917357|Immunity|immunity
243966|NCT01917344|Phenylketonuria|phenylketonuria
243967|NCT01917344|MRI|mri
243968|NCT01917344|Neuropsychological functioning|neuropsychological functioning
243969|NCT01917344|Neurological functioning|neurological functioning
243970|NCT01917344|EEG|eeg
243971|NCT01917331|spirometry|spirometry
243972|NCT01917331|severe COPD|severe copd
243973|NCT01917331|lung disease|lung disease
243974|NCT01917331|fixed combination|fixed combination
243975|NCT01917318|Post traumatic stress disorder|post traumatic stress disorder
243976|NCT01917318|Treatment of post traumatic stress disorder|treatment of post traumatic stress disorder
243977|NCT01917318|Symptoms of arousal in post traumatic stress disorder|symptoms of arousal in post traumatic stress disorder
243978|NCT01917318|Iloperidone in post traumatic stress disorder|iloperidone in post traumatic stress disorder
243979|NCT01917305|Bacteria|bacteria
243980|NCT01917305|bone level|bone level
243981|NCT01917305|bone loss|bone loss
243982|NCT01917305|dental implants|dental implants
243983|NCT01917305|implant design|implant design
243984|NCT01917305|platform-shifting|platform-shifting
243985|NCT01917305|platform-matching|platform-matching
243986|NCT01917292|Periodontitis|periodontitis
243987|NCT01917292|Prehypertension|prehypertension
243988|NCT01917292|Periodontal Intervention|periodontal intervention
243989|NCT01917279|Metastatic Breast Cancer|metastatic breast cancer
243990|NCT01917279|Antineoplastic Agents|antineoplastic agents
243991|NCT01917279|Therapeutic Uses|therapeutic uses
243992|NCT01917279|Antimetabolites|antimetabolites
243993|NCT01917279|Tubulin Modulators|tubulin modulators
243994|NCT01917279|Maintenance chemotherapy|maintenance chemotherapy
243995|NCT01917279|Metronomic chemotherapy|metronomic chemotherapy
243996|NCT01917279|Capecitabine|capecitabine
243997|NCT01917279|Docetaxel|docetaxel
243998|NCT01917253|infiltration, phlebitis, occlusion, thrombosis|infiltration, phlebitis, occlusion, thrombosis
243999|NCT01917240|Monophasic|monophasic
244000|NCT01917240|Sequential|sequential
244001|NCT01917240|Media|media
244002|NCT01917201|Coronary Artery Disease|coronary artery disease
244003|NCT01917201|Drug Eluting Stents|drug eluting stents
244004|NCT01917201|Intravascular Ultrasound|intravascular ultrasound
244005|NCT01917201|Optical Coherence Tomography|optical coherence tomography
244006|NCT01917201|Intravascular Visualization|intravascular visualization
244007|NCT01917175|HIV|hiv
244008|NCT01917175|Cohort|cohort
244009|NCT01917175|Early HIV infection|early hiv infection
244010|NCT01917175|Côte d'Ivoire|côte d'ivoire
244011|NCT01917175|Disease progression|disease progression
244012|NCT01917162|contact lenses|contact lenses
244013|NCT01917162|daily disposable contact lenses|daily disposable contact lenses
244014|NCT01917162|silicone hydrogel|silicone hydrogel
244015|NCT01917162|contact lens comfort|contact lens comfort
244016|NCT01917162|near-sighted|near-sighted
244017|NCT01917149|Dilated cardiomyopathy|dilated cardiomyopathy
244018|NCT01917149|High dose ACEI/ARB|high dose acei/arb
244019|NCT01917136|pulmonary hypertension|pulmonary hypertension
244020|NCT01917136|right ventricular function|right ventricular function
244021|NCT01917136|11C acetate|11c acetate
244022|NCT01917136|FDG|fdg
244023|NCT01917136|ranolazine|ranolazine
244024|NCT01917123|L-Citrulline malate,Coronary Heart Disease, Brachial Index|l-citrulline malate,coronary heart disease, brachial index
244025|NCT01917084|Passive range of motion|passive range of motion
244026|NCT01917084|Single ventricle|single ventricle
244027|NCT01917084|Infants|infants
244028|NCT01917084|Congenital heart disease|congenital heart disease
244029|NCT01917058|Alopecia Areata|alopecia areata
244030|NCT01917058|Abatacept|abatacept
244031|NCT01917045|sufentanil|sufentanil
244032|NCT01917045|morphine|morphine
244033|NCT01917045|postoperative pain control|postoperative pain control
244034|NCT01917045|body fat percentage|body fat percentage
244035|NCT01917045|gynecology laparoscopic surgery|gynecology laparoscopic surgery
244036|NCT01917045|lipid solubility|lipid solubility
244037|NCT01917032|Trace Elements|trace elements
244038|NCT01917032|Preschool|preschool
244039|NCT01917032|Malnutrition|malnutrition
244040|NCT01917032|Fortified Food|fortified food
244041|NCT01917019|Japan|japan
244042|NCT01916980|Dermatitis|dermatitis
244043|NCT01916980|Dermatitis, Atopic|dermatitis, atopic
244044|NCT01916980|Skin Diseases|skin diseases
244045|NCT01916980|Skin Diseases, Genetic|skin diseases, genetic
244046|NCT01916980|Genetic Diseases, Inborn|genetic diseases, inborn
244047|NCT01916980|Skin Diseases, Eczematous|skin diseases, eczematous
244048|NCT01916980|Hypersensitivity, Immediate|hypersensitivity, immediate
244049|NCT01916980|Hypersensitivity|hypersensitivity
244050|NCT01916980|Immune System Diseases|immune system diseases
244051|NCT01916967|Urticaria|urticaria
244052|NCT01916967|Skin Diseases, Vascular|skin diseases, vascular
244053|NCT01916967|Skin Diseases|skin diseases
244054|NCT01916967|Hypersensitivity, Immediate|hypersensitivity, immediate
244056|NCT01916967|Immune System Diseases|immune system diseases
244057|NCT01916967|Cholinergic Antagonists|cholinergic antagonists
244058|NCT01916967|Cholinergic Agents|cholinergic agents
244059|NCT01916967|Neurotransmitter Agents|neurotransmitter agents
244060|NCT01916967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating
244061|NCT01916967|Histamine H1 Antagonists|histamine h1 antagonists
244062|NCT01916967|Histamine Antagonists|histamine antagonists
244063|NCT01916967|Histamine Agents|histamine agents
244064|NCT01916954|Malaria|malaria
244065|NCT01916954|Pregnancy|pregnancy
244066|NCT01916954|Plasmodium falciparum|plasmodium falciparum
244067|NCT01916928|Circulating cell free fetal DNA|circulating cell free fetal dna
244068|NCT01916928|Intrauterine fetal demise|intrauterine fetal demise
244069|NCT01916928|Miscarriage|miscarriage
244070|NCT01916902|Optical Coherence Tomography|optical coherence tomography
244071|NCT01916902|Ticagrelor|ticagrelor
244072|NCT01916889|Delirium|delirium
244073|NCT01916876|medical in-patients|medical in-patients
244074|NCT01916876|follow-up care|follow-up care
244075|NCT01916876|developing country|developing country
244076|NCT01916837|Breast cancer|breast cancer
244077|NCT01916837|Feasibility|feasibility
244078|NCT01916837|Genomic grade index|genomic grade index
244079|NCT01916824|depression|depression
244080|NCT01916824|melancholia|melancholia
244081|NCT01916824|treatment|treatment
244082|NCT01916811|Low Back Pain|low back pain
244083|NCT01916811|Load quantitative MRI|load quantitative mri
244084|NCT01916798|Infertility|infertility
244085|NCT01916798|intralipid|intralipid
244086|NCT01916798|invitro fertilization|invitro fertilization
244087|NCT01916798|repeated implantation failure|repeated implantation failure
244088|NCT01916798|repeated miscarriage|repeated miscarriage
244089|NCT01916772|cherubism|cherubism
244090|NCT01916772|bone tumors|bone tumors
244091|NCT01916759|immunization|immunization
244092|NCT01916746|Caesarean Scar Pregnancy|caesarean scar pregnancy
244093|NCT01916746|Transvaginal Resection|transvaginal resection
244094|NCT01916746|treatment|treatment
244095|NCT01916707|trauma|trauma
244096|NCT01916707|enoxaparin|enoxaparin
244097|NCT01916707|weight based|weight based
244098|NCT01916707|prophylaxis|prophylaxis
244099|NCT01916694|Gestational diabetes mellitus|gestational diabetes mellitus
244100|NCT01916694|m Health|m health
244101|NCT01916694|Smartphone|smartphone
244102|NCT01916694|Blood glucose monitoring|blood glucose monitoring
244103|NCT01916681|Induction|induction
244104|NCT01916681|Labor|labor
244105|NCT01916681|Cervical foley|cervical foley
244106|NCT01916681|Misoprostol|misoprostol
244107|NCT01916681|Pitocin|pitocin
244108|NCT01916681|Oxytocin|oxytocin
244109|NCT01916681|Cytotec|cytotec
244110|NCT01916681|Delivery|delivery
244111|NCT01916681|IOL|iol
244112|NCT01916655|Obstructive Sleep Apnea|obstructive sleep apnea
244113|NCT01916655|Adherence|adherence
244114|NCT01916655|Chronic Disease|chronic disease
244115|NCT01916655|Telemedicine|telemedicine
244116|NCT01916655|Continuous Positive Airway Pressure|continuous positive airway pressure
244117|NCT01916655|Mobile Health|mobile health
244118|NCT01916642|iv lidocaine|iv lidocaine
244119|NCT01916642|inducing dose|inducing dose
244120|NCT01916642|etomidate|etomidate
244121|NCT01916642|dose response|dose response
244122|NCT01916616|paradoxical vocal fold motion|paradoxical vocal fold motion
244123|NCT01916616|cognitive-behavioral therapy|cognitive-behavioral therapy
244124|NCT01916590|Post-operative pain|post-operative pain
244125|NCT01916590|Anterior Cruciate Ligament repair|anterior cruciate ligament repair
244126|NCT01916577|Stem Cell Mobilization|stem cell mobilization
244127|NCT01916577|Stem Cells|stem cells
244128|NCT01916577|Transplantation|transplantation
244129|NCT01916577|Autologous|autologous
244130|NCT01916564|Bowel preparation|bowel preparation
244131|NCT01916564|Morning colonoscopy|morning colonoscopy
244132|NCT01916564|Split-dose|split-dose
244133|NCT01916564|Same-morning whole-dose|same-morning whole-dose
244134|NCT01916564|Reduced-volume PEG-ELS|reduced-volume peg-els
244135|NCT01916538|anorexia nervosa|anorexia nervosa
244138|NCT01916538|eating disorder|eating disorder
244139|NCT01916525|Acute coronary syndrome|acute coronary syndrome
244140|NCT01916525|Cost-effectiveness|cost-effectiveness
244141|NCT01916525|Cardiac rehabilitation|cardiac rehabilitation
244142|NCT01916525|Exercise|exercise
244143|NCT01916525|Physical activity|physical activity
244144|NCT01916525|Home monitoring|home monitoring
244145|NCT01916512|CETP, HDL, LDL, apoB-100, apoB-48, remnants|cetp, hdl, ldl, apob-100, apob-48, remnants
244146|NCT01916499|Child, adolescent|child, adolescent
244147|NCT01916499|Coronary artery disease|coronary artery disease
689112|NCT00916916|Lanreotide|lanreotide
244148|NCT01916499|Magnetic resonance imaging|magnetic resonance imaging
244149|NCT01916473|Epidural analgesia|epidural analgesia
244150|NCT01916473|continuous wound infusion|continuous wound infusion
244151|NCT01916473|ropivacaine|ropivacaine
244152|NCT01916473|total abdominal hysterectomy|total abdominal hysterectomy
244153|NCT01916460|Gastroparesis|gastroparesis
244154|NCT01916460|Endoscopic ultrasound|endoscopic ultrasound
244155|NCT01916460|Interstitial cell of Cajal|interstitial cell of cajal
244156|NCT01916447|Angiogenesis Inhibitor|angiogenesis inhibitor
244157|NCT01916447|Monoclonal Antibody|monoclonal antibody
244158|NCT01916447|Vascular Endothelial Growth Factor A (VEGF-A)|vascular endothelial growth factor a (vegf-a)
244159|NCT01916434|Farmed fish|farmed fish
244160|NCT01916434|Dietary intervention|dietary intervention
244161|NCT01916434|Long-term intervention|long-term intervention
244162|NCT01916434|Omega-3 index|omega-3 index
244163|NCT01916434|Cardiovascular risk markers|cardiovascular risk markers
244164|NCT01916434|Coagulation and endothelial activation|coagulation and endothelial activation
244165|NCT01916434|Bleeding time|bleeding time
244166|NCT01916434|Inflammation|inflammation
244167|NCT01916434|Oxidative stress|oxidative stress
244168|NCT01916434|Gut health|gut health
244169|NCT01916434|Micronutrient availability|micronutrient availability
244170|NCT01916421|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
244171|NCT01916421|lymphadenopathy|lymphadenopathy
244172|NCT01916421|Endoscopic ultrasound|endoscopic ultrasound
244173|NCT01916408|Exercise|exercise
244174|NCT01916408|Inflammation|inflammation
244175|NCT01916408|Upper Respiratory Tract Illness|upper respiratory tract illness
300931|NCT01659697|BMI|bmi
244176|NCT01916408|Oral Proteolytic and Hydrolytic Enzymes|oral proteolytic and hydrolytic enzymes
244177|NCT01916408|Flavinoids|flavinoids
244178|NCT01916395|Migraine|migraine
244179|NCT01916382|Alkaptonuria, nitisinone,Ochronosis, Homogentisic acid|alkaptonuria, nitisinone,ochronosis, homogentisic acid
244180|NCT01916369|Peripheral Arterial Disease|peripheral arterial disease
244181|NCT01916369|Fontaine Stage II, III or IV|fontaine stage ii, iii or iv
244182|NCT01916369|Vascular disease|vascular disease
244183|NCT01916369|Cardiovascular diseases|cardiovascular diseases
244184|NCT01916369|Neural stem cell|neural stem cell
244185|NCT01916356|Infertility|infertility
244186|NCT01916356|Education|education
244187|NCT01916356|Risk Factors|risk factors
244188|NCT01916356|Fertility knowledge|fertility knowledge
244189|NCT01916356|Fertility myths|fertility myths
244190|NCT01916343|Laparoscopy|laparoscopy
244191|NCT01916343|Surgical skills|surgical skills
244192|NCT01916343|Team training|team training
244193|NCT01916343|Obstetrics and Gynecology|obstetrics and gynecology
244194|NCT01916343|Curriculum|curriculum
244195|NCT01916304|Drug Therapy|drug therapy
244196|NCT01916252|Multiple Myeloma|multiple myeloma
244197|NCT01916252|MEL200|mel200
244198|NCT01916252|BUMEL|bumel
244199|NCT01916239|Pomegranate|pomegranate
244200|NCT01916239|Urolithins|urolithins
244201|NCT01916239|Colorectal cancer|colorectal cancer
244202|NCT01916239|Colon cancer|colon cancer
244203|NCT01916239|Metabolite|metabolite
244204|NCT01916239|Gene expression|gene expression
244205|NCT01916239|microRNA|microrna
244206|NCT01916239|Nutraceutical|nutraceutical
244207|NCT01916239|Food supplement|food supplement
244208|NCT01916239|Polyphenol|polyphenol
244209|NCT01916239|Gut microbiota|gut microbiota
244210|NCT01916226|cetirizine|cetirizine
244211|NCT01916226|seasonal allergic rhinitis|seasonal allergic rhinitis
244212|NCT01916226|Quality of Life|quality of life
245106|NCT01911728|Xtandi|xtandi
244213|NCT01916226|fluticasone propionate nasal spray|fluticasone propionate nasal spray
244214|NCT01916161|Crohn's disease|crohn's disease
244215|NCT01916161|ulcerative colitis|ulcerative colitis
244217|NCT01916161|patient knowledge|patient knowledge
244218|NCT01916161|information sources|information sources
244219|NCT01916148|Hypoglycemia|hypoglycemia
244220|NCT01916148|Hyperinsulinism|hyperinsulinism
244221|NCT01916135|[18F]-SKI-249380|[18f]-ski-249380
244222|NCT01916135|PET Imaging|pet imaging
244223|NCT01916135|CT Imaging|ct imaging
244224|NCT01916135|12-182|12-182
244225|NCT01916122|Fluorestradiol (FES)|fluorestradiol (fes)
244226|NCT01916122|PET/CT scan|pet/ct scan
244227|NCT01916122|Estrogen Receptor|estrogen receptor
244228|NCT01916122|13-071|13-071
244229|NCT01916109|Gemcitabine|gemcitabine
244230|NCT01916109|Carboplatin|carboplatin
244231|NCT01916109|Panitumumab|panitumumab
244232|NCT01916109|(GCaP)|(gcap)
244233|NCT01916109|radical cystectomy|radical cystectomy
244234|NCT01916109|10-103|10-103
244236|NCT01916070|near syncope|near syncope
244237|NCT01916070|prognosis|prognosis
244238|NCT01916070|emergency department|emergency department
244239|NCT01916057|Positron-Emission Tomography Scan|positron-emission tomography scan
244240|NCT01916057|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
244241|NCT01916057|Magnetic Resonance Imaging|magnetic resonance imaging
244242|NCT01916057|Enzyme-Linked Immunospot Assay|enzyme-linked immunospot assay
244243|NCT01916057|Immune Reconstitution Inflammatory Syndrome|immune reconstitution inflammatory syndrome
689614|NCT00926627|bosentan|bosentan
244244|NCT01916057|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
244245|NCT01916057|beta-1,3-D-glucan|beta-1,3-d-glucan
244246|NCT01916057|Candida spp.|candida spp.
244247|NCT01916057|Genetic Susceptibility|genetic susceptibility
244248|NCT01916057|Genotype|genotype
244249|NCT01916044|caesarean,|caesarean,
244250|NCT01916044|trial of labor,|trial of labor,
244251|NCT01916044|ultrasound|ultrasound
244252|NCT01916018|Congenital hypothyroidism|congenital hypothyroidism
244253|NCT01916018|Thyroid dysgenesis|thyroid dysgenesis
244254|NCT01916018|Genetics|genetics
244255|NCT01916018|Associated malformations|associated malformations
244256|NCT01916018|Psychomotor delay|psychomotor delay
244257|NCT01916018|Mental retardation|mental retardation
244258|NCT01915979|plasma rich in growth factors, tendinopathy, traumatology|plasma rich in growth factors, tendinopathy, traumatology
244259|NCT01915979|,rotator cuff, effectiveness, plasma rich in platelets|,rotator cuff, effectiveness, plasma rich in platelets
244260|NCT01915953|Accurte Hb noninvasive measurement|accurte hb noninvasive measurement
244261|NCT01915940|Glaucoma|glaucoma
244262|NCT01915940|Primary Open-Angle Glaucoma|primary open-angle glaucoma
244263|NCT01915940|Ocular Hypertension|ocular hypertension
244264|NCT01915888|Clinical|clinical
244265|NCT01915888|Children|children
244266|NCT01915888|Rotavirus|rotavirus
244267|NCT01915888|Cost|cost
244268|NCT01915888|Rotarix vaccination|rotarix vaccination
244269|NCT01915875|Cystic fibrosis-pain-sophrology|cystic fibrosis-pain-sophrology
244270|NCT01915862|Acute ischemic stroke|acute ischemic stroke
244271|NCT01915862|Blood pressure variability|blood pressure variability
244272|NCT01915862|Ambulatory arterial stiffness index|ambulatory arterial stiffness index
244273|NCT01915862|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
244274|NCT01915862|Outcome|outcome
244275|NCT01915836|11-043|11-043
244276|NCT01915836|MSKCC Tobacco Cessation Program|mskcc tobacco cessation program
244277|NCT01915810|Tobacco Use Cessation|tobacco use cessation
244278|NCT01915810|Smoking Cessation with Physical Activity|smoking cessation with physical activity
244279|NCT01915810|SCwPA|scwpa
244280|NCT01915810|Cancer Prevention|cancer prevention
244281|NCT01915810|African American cigarette smoker|african american cigarette smoker
244282|NCT01915810|Questionnaires|questionnaires
244283|NCT01915810|Surveys|surveys
244284|NCT01915810|Phone Counseling|phone counseling
244285|NCT01915810|Breath Test|breath test
244286|NCT01915810|Walking Program|walking program
244287|NCT01915810|Nicotine Patch|nicotine patch
244288|NCT01915810|Audio Recorded Focus Group|audio recorded focus group
244289|NCT01915797|Pediatric patients, tumor, developmental abnormalities|pediatric patients, tumor, developmental abnormalities
244290|NCT01915745|Osteoporosis|osteoporosis
244291|NCT01915745|Bone densitometry|bone densitometry
244292|NCT01915745|Fracture|fracture
244293|NCT01915745|Anti-osteoporotic treatment|anti-osteoporotic treatment
244294|NCT01915745|Short message service|short message service
244295|NCT01915706|Glaucoma drainage device|glaucoma drainage device
244296|NCT01915706|Baerveldt 350|baerveldt 350
244297|NCT01915706|Ripcord|ripcord
244298|NCT01915706|Complications|complications
244299|NCT01915693|Radiotherapy|radiotherapy
244300|NCT01915693|stent|stent
244301|NCT01915693|quality of life|quality of life
244302|NCT01915654|Cardiac surgery|cardiac surgery
244303|NCT01915654|Transfusion|transfusion
244304|NCT01915641|walking capacity|walking capacity
244305|NCT01915641|COPD|copd
244307|NCT01915641|CPAP|cpap
244308|NCT01915628|MACE|mace
244309|NCT01915628|Safety|safety
244312|NCT01915628|Myocardial Infarction|myocardial infarction
244313|NCT01915628|Cardiac death|cardiac death
244314|NCT01915628|TVR|tvr
244315|NCT01915628|stent thrombosis|stent thrombosis
244316|NCT01915615|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
244317|NCT01915615|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
244318|NCT01915615|CMR|cmr
244319|NCT01915615|Genetics|genetics
244320|NCT01915615|Biomarkers|biomarkers
244321|NCT01915615|Late gadolinium enhancement|late gadolinium enhancement
244322|NCT01915615|T1 mapping|t1 mapping
244323|NCT01915602|Hepatocellular Carcinoma|hepatocellular carcinoma
244324|NCT01915602|Mitogen-activated Extracellular-signal-regulated kinase (MEK) inhibitor|mitogen-activated extracellular-signal-regulated kinase (mek) inhibitor
244325|NCT01915602|Sorafenib|sorafenib
244326|NCT01915602|Objective tumor response rate (ORR)|objective tumor response rate (orr)
244327|NCT01915602|modified RECIST criteria|modified recist criteria
244328|NCT01915589|Hepatocellular Carcinoma|hepatocellular carcinoma
244329|NCT01915589|Mitogen-activated Extracellular-signal-regulated kinase (MEK) inhibitor|mitogen-activated extracellular-signal-regulated kinase (mek) inhibitor
244330|NCT01915589|Objective tumor response rate (ORR)|objective tumor response rate (orr)
244331|NCT01915589|modified RECIST criteria|modified recist criteria
244332|NCT01915563|Mechanical ventilation|mechanical ventilation
244333|NCT01915563|Weaning|weaning
244334|NCT01915563|Extubation failure|extubation failure
244335|NCT01915550|Diabetes mellitus|diabetes mellitus
244336|NCT01915550|Pregnancy|pregnancy
244337|NCT01915550|Insulin|insulin
244338|NCT01915550|Metformin|metformin
244339|NCT01915537|poor prognosis|poor prognosis
244340|NCT01915537|severe RA|severe ra
244341|NCT01915537|infliximab|infliximab
244342|NCT01915511|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
244343|NCT01915511|Pulmonary fibrosis|pulmonary fibrosis
244344|NCT01915511|IPF|ipf
244346|NCT01915511|1199.174|1199.174
244347|NCT01915498|acute myeloid leukemia|acute myeloid leukemia
244348|NCT01915498|AML|aml
244349|NCT01915498|myelodysplastic syndrome|myelodysplastic syndrome
244350|NCT01915498|MDS|mds
244351|NCT01915498|hematologic malignancies|hematologic malignancies
244352|NCT01915498|IDH2|idh2
244353|NCT01915498|Phase I|phase i
244354|NCT01915498|Phase II|phase ii
244355|NCT01915498|AG-221|ag-221
244356|NCT01915498|relapse AML|relapse aml
244357|NCT01915498|refractory AML|refractory aml
244358|NCT01915472|Metastatic Colorectal Cancer|metastatic colorectal cancer
244359|NCT01915472|Colorectal Cancer|colorectal cancer
244360|NCT01915472|Rectal Cancer|rectal cancer
244361|NCT01915472|previously treated|previously treated
244362|NCT01915459|Stroke|stroke
244363|NCT01915459|Spasticity|spasticity
244364|NCT01915446|EVAR|evar
244365|NCT01915446|endovascular aortic repair|endovascular aortic repair
244366|NCT01915446|acute kidney failure|acute kidney failure
244367|NCT01915446|mesenteric ischemia|mesenteric ischemia
244368|NCT01915433|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
244369|NCT01915433|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
235138|NCT01958177|BMMNC|bmmnc
244370|NCT01915433|Relapsing progressive multiple sclerosis|relapsing progressive multiple sclerosis
244371|NCT01915433|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
244372|NCT01915433|Fatigue|fatigue
244373|NCT01915433|Quality of life|quality of life
244374|NCT01915433|Paleo|paleo
244375|NCT01915433|Nutrition|nutrition
244376|NCT01915433|Ketogenic|ketogenic
244377|NCT01915420|Drug eluting stent|drug eluting stent
244378|NCT01915420|Bioabsorbable|bioabsorbable
244379|NCT01915420|Bioresorbable|bioresorbable
244380|NCT01915420|Coronary Stent|coronary stent
244381|NCT01915420|Scaffold|scaffold
244382|NCT01915420|Stents|stents
244383|NCT01915420|Angioplasty|angioplasty
244384|NCT01915420|Coronary Artery Disease|coronary artery disease
244385|NCT01915420|Stentthrombosis|stentthrombosis
244386|NCT01915420|Rotational atherectomy|rotational atherectomy
244387|NCT01915394|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
244388|NCT01915394|Epidemics|epidemics
244389|NCT01915394|Neonatal Intensive Care Unit|neonatal intensive care unit
244390|NCT01915394|Newborn infants|newborn infants
244391|NCT01915381|Intellectual disability|intellectual disability
244392|NCT01915381|mHealth|mhealth
244393|NCT01915381|App|app
244394|NCT01915381|Physical activity|physical activity
244395|NCT01915381|Adherence|adherence
244396|NCT01915368|Exercise|exercise
244397|NCT01915368|Rehabilitation|rehabilitation
244398|NCT01915368|Dose|dose
244399|NCT01915368|Randomized controlled trial|randomized controlled trial
244400|NCT01915368|Stroke|stroke
244401|NCT01915355|onychomycosis|onychomycosis
244402|NCT01915355|nail|nail
244403|NCT01915355|fungus|fungus
244404|NCT01915342|Monosynaptic reflex|monosynaptic reflex
244405|NCT01915342|H-reflex|h-reflex
244406|NCT01915329|CRPS|crps
244407|NCT01915329|repetitive sensory stimulation|repetitive sensory stimulation
244408|NCT01915329|cortical reorganization|cortical reorganization
244409|NCT01915329|2-point-discrimination|2-point-discrimination
245408|NCT01910259|Ibudilast|ibudilast
244410|NCT01915303|Cushing's disease, pituitary tumors, pasireotide, cabergoline, combination treatment, UFC, hormone disorder, cortisol, adrenocorticotropic hormone|cushing's disease, pituitary tumors, pasireotide, cabergoline, combination treatment, ufc, hormone disorder, cortisol, adrenocorticotropic hormone
244413|NCT01915277|Pediatric corrective cardiac surgery|pediatric corrective cardiac surgery
244414|NCT01915264|Diabetes Mellitus|diabetes mellitus
244415|NCT01915264|Type 2 Diabetes|type 2 diabetes
244416|NCT01915264|Acarbose (25/50mg) and Metformin (500mg) in fixed dose combination|acarbose (25/50mg) and metformin (500mg) in fixed dose combination
244417|NCT01915251|Vulvovaginal Candidiasis|vulvovaginal candidiasis
244418|NCT01915251|Amoxicilin|amoxicilin
244419|NCT01915251|Microbiome|microbiome
244422|NCT01915225|Tissue Procurement|tissue procurement
244423|NCT01915225|Surgery|surgery
244424|NCT01915225|Metastasectomy|metastasectomy
244425|NCT01915212|Vaccination|vaccination
244426|NCT01915212|Replication-Defective|replication-defective
244427|NCT01915212|Genital Herpes|genital herpes
244428|NCT01915212|Safety|safety
244429|NCT01915212|Immune Responses|immune responses
244430|NCT01915186|DHEA|dhea
244431|NCT01915186|Poor ovarian reserve|poor ovarian reserve
244432|NCT01915186|Normal ovarian reserve|normal ovarian reserve
244433|NCT01915186|In vitro fertilization treatment|in vitro fertilization treatment
244434|NCT01915186|Ovarian response|ovarian response
244435|NCT01915186|Pregnancy outcomes|pregnancy outcomes
586240|NCT00523965|liposomal amphotericin B|liposomal amphotericin b
244436|NCT01915173|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
244437|NCT01915173|Heartburn|heartburn
244438|NCT01915173|Dyspepsia|dyspepsia
244439|NCT01915147|oxycodone naloxone combination|oxycodone naloxone combination
244440|NCT01915147|severe chronic pain|severe chronic pain
244441|NCT01915147|non-malignant pain|non-malignant pain
244216|NCT01916161|anxiety|anxiety
244442|NCT01915147|Non-malignant pain that requires around-the-clock opioid therapy|non-malignant pain that requires around-the-clock opioid therapy
244443|NCT01915134|nasopharyngeal carcinoma|nasopharyngeal carcinoma
244444|NCT01915134|Recombinant Human Endostatin|recombinant human endostatin
244445|NCT01915134|chemotherapy|chemotherapy
244446|NCT01915134|gemcitabine and cisplatin|gemcitabine and cisplatin
244447|NCT01915121|Bladder Cancer|bladder cancer
244448|NCT01915121|Intervention|intervention
244449|NCT01915121|Education|education
244450|NCT01915121|Randomized Controlled Trials|randomized controlled trials
244451|NCT01915095|spinal cord injury|spinal cord injury
244452|NCT01915095|neural control|neural control
244453|NCT01915095|motor function|motor function
244454|NCT01915095|hand movement|hand movement
244455|NCT01915082|Lung Function|lung function
244456|NCT01915082|Allograft Outcome|allograft outcome
244457|NCT01915069|contraception|contraception
244458|NCT01915069|Cilostazol|cilostazol
244459|NCT01915069|phosphodiesterase inhibitors|phosphodiesterase inhibitors
244460|NCT01915069|To assess the ability of Cilostazol to act as a contraceptive agent|to assess the ability of cilostazol to act as a contraceptive agent
301228|NCT01658826|AIC316|aic316
244461|NCT01915056|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
244462|NCT01915056|GA-driven interventions|ga-driven interventions
244463|NCT01915056|Toxicity|toxicity
244464|NCT01915056|Outcomes|outcomes
244465|NCT01915056|providing information|providing information
244466|NCT01915056|older cancer patients|older cancer patients
244467|NCT01915056|first-line chemotherapy|first-line chemotherapy
244468|NCT01915056|second-line chemotherapy|second-line chemotherapy
244469|NCT01915043|lymphedema, prevention, ehealth, cancer|lymphedema, prevention, ehealth, cancer
244470|NCT01915030|Muscle|muscle
244471|NCT01915030|Physical performance|physical performance
244472|NCT01915030|Protein|protein
244473|NCT01915030|Diet|diet
244474|NCT01915030|Caloric restriction|caloric restriction
244475|NCT01915017|Cognitive Adaptation Training|cognitive adaptation training
244476|NCT01915017|Cognitive Behavior Therapy for Psychosis|cognitive behavior therapy for psychosis
244477|NCT01915017|Schizophrenia|schizophrenia
244478|NCT01915004|Pediatric Urology|pediatric urology
244479|NCT01915004|Urotherapy|urotherapy
244480|NCT01915004|Nonneurogenic Lower Urinary Tract Dysfunction|nonneurogenic lower urinary tract dysfunction
244481|NCT01915004|Dysfunctional Elimination Syndrome|dysfunctional elimination syndrome
244482|NCT01915004|Randomized Controlled Trial|randomized controlled trial
244483|NCT01914991|proximal interphalangeal joint|proximal interphalangeal joint
244484|NCT01914991|Orthoses|orthoses
244485|NCT01914965|Huntington's disease|huntington's disease
244486|NCT01914965|Apathy|apathy
244487|NCT01914965|Bupropion|bupropion
244488|NCT01914952|CaHMB|cahmb
244489|NCT01914952|HMB free acid|hmb free acid
244490|NCT01914952|HMB|hmb
244491|NCT01914939|autism spectrum disorder|autism spectrum disorder
244492|NCT01914939|social skills deficits|social skills deficits
244493|NCT01914939|cognitive behavioral therapy|cognitive behavioral therapy
244494|NCT01914939|oxytocin|oxytocin
244495|NCT01914939|young adult|young adult
244496|NCT01914926|metoprolol|metoprolol
244497|NCT01914926|diltiazem|diltiazem
244498|NCT01914926|heart rate|heart rate
244499|NCT01914913|retinitis pigmentosa|retinitis pigmentosa
244500|NCT01914913|Bone marrow|bone marrow
244501|NCT01914913|stem cell|stem cell
244502|NCT01914913|BMMNC|bmmnc
244503|NCT01914900|oral cavity cancer|oral cavity cancer
244504|NCT01914900|induction chemotherapy|induction chemotherapy
244505|NCT01914900|TP53|tp53
244506|NCT01914900|beta tubulin II|beta tubulin ii
244507|NCT01914887|Ulcerative Colitis|ulcerative colitis
244508|NCT01914887|Inflammatory Bowel Disease|inflammatory bowel disease
244509|NCT01914887|Mesenchymal stem cells|mesenchymal stem cells
244510|NCT01914874|Community Sample|community sample
244511|NCT01914835|cocaine dependence|cocaine dependence
244512|NCT01914835|neuropsychological rehabilitation|neuropsychological rehabilitation
244513|NCT01914835|executive functions|executive functions
244514|NCT01914822|Ritalin|ritalin
244515|NCT01914822|methylphenidate hydrochloride|methylphenidate hydrochloride
244516|NCT01914822|experimental pain|experimental pain
244517|NCT01914796|Phase 1|phase 1
244518|NCT01914796|Randomized|randomized
244519|NCT01914796|Double Blind|double blind
244520|NCT01914796|Placebo-Controlled|placebo-controlled
244521|NCT01914796|Single-Dose Escalation|single-dose escalation
244522|NCT01914796|Safety|safety
244523|NCT01914796|Tolerability|tolerability
244524|NCT01914796|PK|pk
244525|NCT01914796|PD|pd
244526|NCT01914796|PF-06412562|pf-06412562
244527|NCT01914783|air pollution|air pollution
244528|NCT01914783|ozone|ozone
244529|NCT01914783|fine particle|fine particle
244530|NCT01914783|cytokine|cytokine
244531|NCT01914783|chemokine|chemokine
244532|NCT01914783|oxidative stress|oxidative stress
244533|NCT01914783|inflammation|inflammation
244534|NCT01914783|heart rate variability|heart rate variability
244535|NCT01914783|autonomic nervous system|autonomic nervous system
244536|NCT01914783|sympathetic nerve activity|sympathetic nerve activity
244537|NCT01914783|plasma catecholamine|plasma catecholamine
244542|NCT01914770|steroid use|steroid use
244543|NCT01914770|responder rate|responder rate
244544|NCT01914770|flares|flares
244545|NCT01914770|belimumab|belimumab
244546|NCT01914770|BILAG|bilag
244547|NCT01914757|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
244548|NCT01914744|NHL|nhl
244549|NCT01914744|HBV|hbv
244550|NCT01914744|entecavir|entecavir
244551|NCT01914744|lamivudine|lamivudine
244552|NCT01914731|Fecal Microbiota Transplant|fecal microbiota transplant
244553|NCT01914731|Clostridium difficile|clostridium difficile
244554|NCT01914731|Diarrhea|diarrhea
244555|NCT01914718|DLBCL|dlbcl
244556|NCT01914718|DA-EPOCH-R|da-epoch-r
244557|NCT01914705|Landmark|landmark
244558|NCT01914705|Ultrasound|ultrasound
244559|NCT01914705|central venous catheter|central venous catheter
244560|NCT01914679|Fibromyalgia|fibromyalgia
244561|NCT01914679|Pain|pain
235310|NCT01957371|PTSD|ptsd
235311|NCT01957371|Yoga|yoga
235313|NCT01957371|Chronic Pain|chronic pain
235319|NCT01957332|FES-PET|fes-pet
244562|NCT01914679|Brain|brain
244563|NCT01914679|Stimulation|stimulation
244564|NCT01914679|Device|device
244565|NCT01914679|Treatment|treatment
244566|NCT01914666|Chronic Low Back Pain|chronic low back pain
244567|NCT01914666|CLBP|clbp
244568|NCT01914640|Waist circumference, Metabolic Syndrome, Cardiovascular risk|waist circumference, metabolic syndrome, cardiovascular risk
244569|NCT01914627|Psoriasis capitis|psoriasis capitis
244570|NCT01914627|Scaling|scaling
244571|NCT01914627|Salicylic acid|salicylic acid
244572|NCT01914627|Dimethicone|dimethicone
244573|NCT01914627|Plaque removal|plaque removal
244574|NCT01914614|Breast Cancer|breast cancer
244575|NCT01914614|Working Women|working women
244576|NCT01914601|Laryngoscope|laryngoscope
244577|NCT01914601|Macintosh|macintosh
244578|NCT01914601|King Vision|king vision
244579|NCT01914601|tracheal intubation|tracheal intubation
244580|NCT01914601|cervical spines|cervical spines
244581|NCT01914536|POMPE|pompe
244582|NCT01914536|Glycogenosis type II|glycogenosis type ii
244583|NCT01914536|Acid maltase deficiency|acid maltase deficiency
244584|NCT01914523|Laryngoscope|laryngoscope
244585|NCT01914523|Macintosh|macintosh
244586|NCT01914523|Glidescope|glidescope
244587|NCT01914523|King Vision|king vision
244588|NCT01914523|AirTraq|airtraq
244589|NCT01914523|tracheal intubation|tracheal intubation
244590|NCT01914510|ovarian|ovarian
244591|NCT01914510|cancer|cancer
244592|NCT01914510|clear cell|clear cell
244593|NCT01914510|ENMD-2076|enmd-2076
244594|NCT01914510|oral|oral
244595|NCT01914510|capsule|capsule
244596|NCT01914484|tyrosine kinase inhibitor resistance|tyrosine kinase inhibitor resistance
244597|NCT01914484|chronic myeloid leukemia|chronic myeloid leukemia
244598|NCT01914484|acute lymphoblastic leukemia|acute lymphoblastic leukemia
244599|NCT01914484|nilotinib|nilotinib
244600|NCT01914484|ruxolitinib|ruxolitinib
244601|NCT01914458|Lung cancer|lung cancer
244602|NCT01914458|Low-dose computed tomography scan|low-dose computed tomography scan
245409|NCT01910259|Amiloride|amiloride
244603|NCT01914419|Postpartum hemorrhage|postpartum hemorrhage
244604|NCT01914419|Oxytocin|oxytocin
244605|NCT01914419|Prevention|prevention
244606|NCT01914419|Third stage of labor|third stage of labor
244607|NCT01914419|Hemoglobin|hemoglobin
244608|NCT01914419|Intravenous|intravenous
244609|NCT01914419|Intramuscular|intramuscular
244611|NCT01914406|Heart transplant recipients|heart transplant recipients
244612|NCT01914406|Exercise capacity|exercise capacity
244613|NCT01914406|endothelial function|endothelial function
244614|NCT01914406|Quality of life|quality of life
244615|NCT01914393|Schizophrenia|schizophrenia
244616|NCT01914393|Autism|autism
244617|NCT01914393|Lurasidone|lurasidone
244618|NCT01914393|Latuda|latuda
244619|NCT01914380|Wet age-related macular degeneration|wet age-related macular degeneration
244620|NCT01914380|Anti-VEGF-Therapy|anti-vegf-therapy
244621|NCT01914380|Observational study|observational study
244622|NCT01914354|T cells|t cells
244623|NCT01914354|Human Alloimmune Reactivity|human alloimmune reactivity
244624|NCT01914354|immunosuppression|immunosuppression
244625|NCT01914341|Infant|infant
244626|NCT01914341|Newborn|newborn
244627|NCT01914341|Music|music
244628|NCT01914328|Postoperative Pulmonary Complications|postoperative pulmonary complications
244629|NCT01914328|PORC|porc
244630|NCT01914328|Surgical Related Outcome|surgical related outcome
244631|NCT01914328|Surgical Related Mortality|surgical related mortality
244632|NCT01914328|Postoperative ICU length of stay|postoperative icu length of stay
244633|NCT01914315|Rehabilitation|rehabilitation
244634|NCT01914315|Heart failure|heart failure
244635|NCT01914315|HFPEF|hfpef
244636|NCT01914315|Exercise training|exercise training
244637|NCT01914289|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
244638|NCT01914289|Prognosis|prognosis
244639|NCT01914289|Resection|resection
244640|NCT01914289|Radiotherapy|radiotherapy
244641|NCT01914263|Cord blood-Derived cytokine induced killer cells,|cord blood-derived cytokine induced killer cells,
244642|NCT01914263|Radical resection|radical resection
244643|NCT01914250|Frenotomy|frenotomy
244644|NCT01914250|Pain|pain
244645|NCT01914237|Single-Branched Stent Graft System|single-branched stent graft system
244646|NCT01914237|Aortic Dissection|aortic dissection
244647|NCT01914237|Endovascular Repair|endovascular repair
244648|NCT01914224|Prehypertension|prehypertension
244649|NCT01914224|Hypertension|hypertension
244650|NCT01914224|Sodium|sodium
244651|NCT01914224|Potassium|potassium
244652|NCT01914224|renin|renin
244653|NCT01914224|aldosterone|aldosterone
244654|NCT01914198|sleep study|sleep study
244655|NCT01914198|NCH|nch
244656|NCT01914185|Childhood|childhood
244657|NCT01914185|Physical activity|physical activity
244658|NCT01914185|Nutrition|nutrition
244659|NCT01914185|Health Promotion|health promotion
244660|NCT01914172|rare disease|rare disease
244661|NCT01914172|community-based participatory research|community-based participatory research
244662|NCT01914172|health promotion|health promotion
244663|NCT01914172|quantitative research|quantitative research
244664|NCT01914172|qualitative research|qualitative research
244665|NCT01914172|focus group|focus group
244666|NCT01914146|Diabetes|diabetes
244667|NCT01914146|Insulin|insulin
244668|NCT01914146|Orthostatic Hypotension|orthostatic hypotension
244669|NCT01914146|Falls|falls
244670|NCT01914146|Syncope|syncope
244671|NCT01914133|Acarbose|acarbose
244672|NCT01914133|PPH (Post Prandial Hypotension)|pph (post prandial hypotension)
244673|NCT01914133|Falls|falls
244674|NCT01914133|Syncope|syncope
244675|NCT01914133|Elderly|elderly
244676|NCT01914120|lung cancer|lung cancer
244677|NCT01914120|quality of life|quality of life
244678|NCT01914120|FACT-L|fact-l
244679|NCT01914107|malignancy|malignancy
244680|NCT01914107|solid tumor|solid tumor
244681|NCT01914107|cancer pain|cancer pain
244682|NCT01914094|Preoperative care|preoperative care
244683|NCT01914094|Exercise therapy|exercise therapy
244684|NCT01914094|Cardiac surgery|cardiac surgery
244685|NCT01914081|Non-ischemic cardiomyopathy|non-ischemic cardiomyopathy
244686|NCT01914081|Resveratrol|resveratrol
244687|NCT01914068|Neoadjuvant chemoradiotherapy (NACRT)|neoadjuvant chemoradiotherapy (nacrt)
244688|NCT01914068|Rectal cancer|rectal cancer
244689|NCT01914068|Physical fitness|physical fitness
244690|NCT01914068|Exercise programme|exercise programme
244691|NCT01914068|Surgery|surgery
244692|NCT01914068|Stage III/IV|stage iii/iv
244693|NCT01914068|Locally advanced operable|locally advanced operable
244694|NCT01914068|patients|patients
244695|NCT01914042|Opioid induced hyperalgesia|opioid induced hyperalgesia
244696|NCT01914042|Neuropathic pain|neuropathic pain
244697|NCT01914042|Opioids|opioids
244698|NCT01914042|Sciatica|sciatica
244699|NCT01914042|Serotonin-norepinephrine reuptake inhibitor (SNRI)|serotonin-norepinephrine reuptake inhibitor (snri)
244700|NCT01913990|Nausea|nausea
244701|NCT01913990|Vomiting|vomiting
244702|NCT01913938|Hemophagocytosis, adults, rhG-CSF|hemophagocytosis, adults, rhg-csf
244703|NCT01913899|phantom limb pain|phantom limb pain
244704|NCT01913899|mirror therapy|mirror therapy
244706|NCT01913899|phantom limb|phantom limb
244707|NCT01913899|occupational therapy|occupational therapy
244708|NCT01913886|Cardiovascular Diseases|cardiovascular diseases
244709|NCT01913886|Myocardial Ischemia|myocardial ischemia
244710|NCT01913886|Coronary Artery Disease|coronary artery disease
244711|NCT01913886|Heart Diseases|heart diseases
244712|NCT01913886|Coronary Disease|coronary disease
244713|NCT01913886|Ventricular Dysfunction|ventricular dysfunction
244714|NCT01913886|Arteriosclerosis|arteriosclerosis
244715|NCT01913873|High-sensitivity Cardiac Troponin|high-sensitivity cardiac troponin
244716|NCT01913873|Creatinin Kinase MB|creatinin kinase mb
244717|NCT01913873|Cardiac Surgery|cardiac surgery
244718|NCT01913873|Myocardial injury|myocardial injury
244719|NCT01913873|Myocardial infarction|myocardial infarction
244720|NCT01913873|Concentration change|concentration change
244722|NCT01913860|antibiotics|antibiotics
244723|NCT01913860|prescribing|prescribing
244724|NCT01913860|primary care|primary care
244725|NCT01913834|Parathyroid hormone 1-34|parathyroid hormone 1-34
244726|NCT01913808|Postoperative anemia|postoperative anemia
244727|NCT01913808|Total knee arthroplasty|total knee arthroplasty
244728|NCT01913808|Iron therapy|iron therapy
244828|NCT01913223|safety|safety
244729|NCT01913782|Chronic low back pain, CLBC, fMRI|chronic low back pain, clbc, fmri
244730|NCT01913769|post-RT|post-rt
244731|NCT01913769|myocardial perfusion images|myocardial perfusion images
244732|NCT01913743|fMRI|fmri
244733|NCT01913743|cognitive strategies|cognitive strategies
244734|NCT01913743|obesity|obesity
244735|NCT01913743|weight loss|weight loss
244736|NCT01913743|mindsets|mindsets
244737|NCT01913730|Multiple Myeloma|multiple myeloma
244738|NCT01913730|Refractory|refractory
244739|NCT01913730|Relapsed|relapsed
244740|NCT01913717|Prostate cancer|prostate cancer
244741|NCT01913717|Radiotherapy|radiotherapy
244742|NCT01913717|hypofractionated radiotherapy|hypofractionated radiotherapy
244744|NCT01913704|mixed aetiology leg ulcers|mixed aetiology leg ulcers
244745|NCT01913691|Neuroendocrine Skin Cancer|neuroendocrine skin cancer
244746|NCT01913691|Merkel Cell Polyomavirus|merkel cell polyomavirus
244747|NCT01913691|Immunotherapy|immunotherapy
244748|NCT01913652|dedifferentiated liposarcoma|dedifferentiated liposarcoma
244749|NCT01913652|cabazitaxel|cabazitaxel
244750|NCT01913652|ifosfamide|ifosfamide
244751|NCT01913639|BAY 73-4506 (REGORAFENIB)|bay 73-4506 (regorafenib)
244752|NCT01913639|FLUOROURACIL|fluorouracil
244753|NCT01913639|LEUCOVORIN|leucovorin
244754|NCT01913639|OXALIPLATIN|oxaliplatin
244755|NCT01913626|subjective memory complains|subjective memory complains
244756|NCT01913600|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
244757|NCT01913600|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
244758|NCT01913600|Coronary Artery Disease|coronary artery disease
244759|NCT01913600|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
244760|NCT01913600|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
244761|NCT01913600|STENT THROMBOSIS|stent thrombosis
244762|NCT01913600|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
244763|NCT01913561|Electrocardiogram|electrocardiogram
244764|NCT01913561|gel electrodes|gel electrodes
244765|NCT01913561|textile electrodes|textile electrodes
244766|NCT01913535|Depression|depression
244767|NCT01913535|Treatment Resistant Depression|treatment resistant depression
244768|NCT01913535|Antidepressant|antidepressant
244769|NCT01913535|Major Depression|major depression
244770|NCT01913535|MDD|mdd
244771|NCT01913509|hemiplegic shoulder pain|hemiplegic shoulder pain
244772|NCT01913509|poststroke fatigue|poststroke fatigue
244773|NCT01913509|functional electrical stimulation|functional electrical stimulation
244774|NCT01913509|stroke rehabilitation|stroke rehabilitation
244775|NCT01913496|web application|web application
244776|NCT01913496|nutrition knowledge|nutrition knowledge
244777|NCT01913496|physical activity|physical activity
244778|NCT01913470|NAFLD|nafld
244779|NCT01913470|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
244780|NCT01913470|Obesity|obesity
244781|NCT01913470|Pediatrics|pediatrics
244782|NCT01913470|Children|children
244783|NCT01913470|Losartan|losartan
244784|NCT01913470|Cozaar|cozaar
244785|NCT01913457|Ultrasound Doppler|ultrasound doppler
244786|NCT01913457|Lungs|lungs
244787|NCT01913457|Pulmonary artery hypertension|pulmonary artery hypertension
244788|NCT01913444|Recombinant Antithrombin|recombinant antithrombin
244789|NCT01913444|ATryn|atryn
244790|NCT01913444|Pharmacokinetics|pharmacokinetics
244791|NCT01913444|ECMO|ecmo
244792|NCT01913444|Neonates|neonates
244793|NCT01913418|Traditional Chinese Medicine|traditional chinese medicine
244794|NCT01913418|Suan-Zao-Ren Tang|suan-zao-ren tang
244795|NCT01913418|Methadone|methadone
244796|NCT01913418|Opiate dependence|opiate dependence
244797|NCT01913418|Sleep|sleep
244798|NCT01913379|Phase 1|phase 1
244799|NCT01913379|MDV3100|mdv3100
244800|NCT01913379|Gemfibrozil|gemfibrozil
244801|NCT01913379|Itraconazole|itraconazole
244802|NCT01913379|Xtandi|xtandi
244803|NCT01913379|enzalutamide|enzalutamide
244804|NCT01913340|erythropoietin|erythropoietin
244805|NCT01913340|therapeutic hypothermia|therapeutic hypothermia
244806|NCT01913327|cognition|cognition
244807|NCT01913327|executive function|executive function
244808|NCT01913327|prefrontal cortex|prefrontal cortex
244809|NCT01913327|locus coeruleus|locus coeruleus
244810|NCT01913288|neonatal care, preterm, maternal sounds, auditory stimulation|neonatal care, preterm, maternal sounds, auditory stimulation
244811|NCT01913275|cholecystojejunostomy|cholecystojejunostomy
244812|NCT01913275|whipple's pancreaticoduodenectomy|whipple's pancreaticoduodenectomy
244813|NCT01913275|endoscopic stenting|endoscopic stenting
244814|NCT01913275|hyperbilirubinemia|hyperbilirubinemia
244815|NCT01913262|depression|depression
244816|NCT01913262|phq9|phq9
244817|NCT01913262|phq-9|phq-9
244818|NCT01913262|standard treatment|standard treatment
244819|NCT01913249|Anorectal fistula|anorectal fistula
244820|NCT01913249|LIFT|lift
244821|NCT01913249|Seton|seton
244822|NCT01913236|Tailored implementation interventions|tailored implementation interventions
244823|NCT01913236|Primary care|primary care
244824|NCT01913236|Depression in the elderly|depression in the elderly
244825|NCT01913223|Endoscopic submucosal dissection|endoscopic submucosal dissection
244826|NCT01913223|jet injector|jet injector
244827|NCT01913223|saline solution|saline solution
244829|NCT01913223|effectiveness|effectiveness
244831|NCT01913119|extranodal NKTcell lymphoma|extranodal nktcell lymphoma
244832|NCT01913093|Childhood leukemia survivors|childhood leukemia survivors
244833|NCT01913093|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
244835|NCT01913093|Late effects|late effects
244836|NCT01913093|Folate|folate
244837|NCT01913093|Blood folate|blood folate
244838|NCT01913093|Neurotoxicity|neurotoxicity
244839|NCT01913093|Methotrexate|methotrexate
244840|NCT01913093|Pharmacogenetics|pharmacogenetics
244841|NCT01913093|Cognitive|cognitive
244842|NCT01913093|Cognitive late effects|cognitive late effects
244843|NCT01913093|N-PhenoGENICS|n-phenogenics
244844|NCT01913080|health management|health management
244845|NCT01913067|brain metastasis|brain metastasis
244846|NCT01913067|breast cancer|breast cancer
244847|NCT01913067|HER2 negative|her2 negative
244848|NCT01913067|NSCLC|nsclc
244849|NCT01913054|Etomidate|etomidate
244850|NCT01913054|Propofol|propofol
244851|NCT01913054|Painless gastroscopy|painless gastroscopy
244852|NCT01913041|perioperative hypothermia|perioperative hypothermia
244853|NCT01913041|Epidemiology|epidemiology
244854|NCT01913041|Tympanic temperature|tympanic temperature
244855|NCT01913028|safety, tolerability, pharmacokinetics,immunogenicity, MEDI9929, Japanese|safety, tolerability, pharmacokinetics,immunogenicity, medi9929, japanese
235604|NCT01955785|Traumatic brain injury|traumatic brain injury
235605|NCT01955785|Intracranial pressure|intracranial pressure
235606|NCT01955785|Ventilation|ventilation
235607|NCT01955785|Respiratory therapy|respiratory therapy
235609|NCT01955772|Malignant hemopathy|malignant hemopathy
244856|NCT01912989|motivational interviewing|motivational interviewing
244857|NCT01912989|obesity|obesity
244858|NCT01912989|parent|parent
244859|NCT01912976|Bowen's disease|bowen's disease
244860|NCT01912976|Er:YAG|er:yag
244861|NCT01912976|AFL-assisted|afl-assisted
244862|NCT01912976|MAL-PDT|mal-pdt
244863|NCT01912963|HER-2 Positive Breast Cancer|her-2 positive breast cancer
244864|NCT01912950|intense pulsed light|intense pulsed light
244866|NCT01912950|healthy volunteer|healthy volunteer
244867|NCT01912950|light-based hair removal|light-based hair removal
244868|NCT01912950|hair removal|hair removal
244869|NCT01912950|epilation|epilation
244870|NCT01912950|laser hair removal|laser hair removal
244871|NCT01912950|permanent hair reduction|permanent hair reduction
244872|NCT01912937|Paclitaxel|paclitaxel
244873|NCT01912937|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
244874|NCT01912937|Balloon Catheter|balloon catheter
244875|NCT01912937|Pharmacokinetic|pharmacokinetic
244876|NCT01912937|Peripheral Artery Disease|peripheral artery disease
244878|NCT01912924|chronic pain from failed knee surgery|chronic pain from failed knee surgery
244879|NCT01912846|End-of-life care|end-of-life care
244880|NCT01912846|Preference of end-of-life care|preference of end-of-life care
244881|NCT01912846|RCT|rct
244882|NCT01912846|Terminally ill cancer patients|terminally ill cancer patients
244883|NCT01912833|postpartum depression|postpartum depression
244884|NCT01912807|Postoperative vomiting|postoperative vomiting
244885|NCT01912807|Children|children
244886|NCT01912794|Cerebrovascular Accident|cerebrovascular accident
244887|NCT01912794|Rehabilitation|rehabilitation
244888|NCT01912794|Sensory System|sensory system
244889|NCT01912781|contact lenses|contact lenses
244890|NCT01912781|contact lens solution|contact lens solution
244891|NCT01912781|gas permeable contact lenses|gas permeable contact lenses
244892|NCT01912768|contact lenses|contact lenses
244893|NCT01912768|contact lens solution|contact lens solution
244894|NCT01912768|soft contact lenses|soft contact lenses
244895|NCT01912755|Pulpitis|pulpitis
244896|NCT01912755|Hot tooth|hot tooth
244897|NCT01912755|Articaine|articaine
244898|NCT01912755|Lidocaine|lidocaine
244899|NCT01912755|Local anesthetics|local anesthetics
244900|NCT01912742|Weight loss|weight loss
245410|NCT01910259|Riluzole|riluzole
244901|NCT01912742|Speed of weight loss|speed of weight loss
244902|NCT01912742|Metabolic compensation|metabolic compensation
244903|NCT01912742|Diet therapy|diet therapy
244904|NCT01912729|Depression prevention|depression prevention
244905|NCT01912729|Technology Assisted|technology assisted
244906|NCT01912729|Adolescents|adolescents
244907|NCT01912729|Peer networked|peer networked
244908|NCT01912716|pancreatitis|pancreatitis
244909|NCT01912716|ERCP|ercp
244910|NCT01912677|hypertension in pregnancy|hypertension in pregnancy
244911|NCT01912677|preeclampsia|preeclampsia
244912|NCT01912677|anti-hypertension|anti-hypertension
244913|NCT01912677|labetalol|labetalol
244914|NCT01912677|nifedipine|nifedipine
244915|NCT01912677|methyldopa|methyldopa
244916|NCT01912651|facial skin wound|facial skin wound
244917|NCT01912651|facial wound|facial wound
244918|NCT01912651|skin wound|skin wound
244919|NCT01912651|facial defect|facial defect
244920|NCT01912651|reconstructive skin graft|reconstructive skin graft
244921|NCT01912638|Trabeculectomy|trabeculectomy
244922|NCT01912638|Glaucoma|glaucoma
244923|NCT01912638|Steroids|steroids
244924|NCT01912638|Ologen|ologen
244925|NCT01912638|Viscoelastic|viscoelastic
244928|NCT01912599|Glaucoma|glaucoma
244929|NCT01912599|Intraocular Pressure|intraocular pressure
244930|NCT01912599|Blood Pressure|blood pressure
244931|NCT01912586|erectile dysfunction|erectile dysfunction
244932|NCT01912586|laparoscopic surgery|laparoscopic surgery
244933|NCT01912586|rectal cancer|rectal cancer
244934|NCT01912586|sildenafil|sildenafil
244935|NCT01912586|vacuum erection device|vacuum erection device
244936|NCT01912573|heroin|heroin
244937|NCT01912573|prescription pain killers|prescription pain killers
244938|NCT01912573|narcotics|narcotics
244939|NCT01912534|Sarcomere Mutations|sarcomere mutations
244941|NCT01912521|Stigma|stigma
244942|NCT01912521|Social support|social support
244721|NCT01913860|UTI|uti
244943|NCT01912521|Social network|social network
244944|NCT01912521|Kenya|kenya
244945|NCT01912508|cervical length|cervical length
244946|NCT01912508|cervical curvature|cervical curvature
244947|NCT01912469|Muscle|muscle
244948|NCT01912469|exercise|exercise
235727|NCT01955148|PTB|ptb
244949|NCT01912469|soreness|soreness
244950|NCT01912469|Damage|damage
244951|NCT01912469|Traumeel|traumeel
244952|NCT01912456|Hereditary Angioedema|hereditary angioedema
244953|NCT01912430|Integrated Care Coaching|integrated care coaching
244954|NCT01912430|Chronic Care Coaching|chronic care coaching
244955|NCT01912430|Care Coaching|care coaching
244956|NCT01912417|HEMODIALYSIS|hemodialysis
244957|NCT01912417|Kidney Failure, Chronic|kidney failure, chronic
244958|NCT01912417|AEROBIC EXERCISE|aerobic exercise
244959|NCT01912404|alcoholic hepatitis|alcoholic hepatitis
244960|NCT01912391|Depression|depression
244961|NCT01912391|Anxiety|anxiety
244962|NCT01912391|Headaches|headaches
244963|NCT01912391|Migraines|migraines
244964|NCT01912391|Irritable Bowel Syndrome IBS|irritable bowel syndrome ibs
244965|NCT01912391|Neurodermatitis|neurodermatitis
244966|NCT01912391|Fibromyalgia|fibromyalgia
244967|NCT01912391|Premenstrual Syndrome PMS|premenstrual syndrome pms
244968|NCT01912391|Temporomandibular Joint Dysfunction TMJ|temporomandibular joint dysfunction tmj
244969|NCT01912365|Fracture|fracture
244970|NCT01912365|Supracondylar|supracondylar
244971|NCT01912365|Pediatric|pediatric
244972|NCT01912365|Orthopedic|orthopedic
244973|NCT01912352|ADHD|adhd
244974|NCT01912352|ADRA2A|adra2a
244975|NCT01912352|Methylphenidate|methylphenidate
244976|NCT01912352|Response|response
244977|NCT01912339|Hyperlasia|hyperlasia
244978|NCT01912339|Retention|retention
244979|NCT01912339|Prostate|prostate
244980|NCT01912326|pacemaker|pacemaker
244981|NCT01912326|atrial fibrillation|atrial fibrillation
244982|NCT01912313|IBS patients|ibs patients
244983|NCT01912313|healthy subjects|healthy subjects
244984|NCT01912287|Generalized Anxiety Disorder|generalized anxiety disorder
244985|NCT01912287|GAD|gad
244986|NCT01912287|Yoga|yoga
244987|NCT01912287|CBT|cbt
244988|NCT01912274|AML|aml
244989|NCT01912274|open label|open label
244990|NCT01912274|nonrandomized|nonrandomized
244991|NCT01912274|single arm|single arm
244992|NCT01912274|elderly patients|elderly patients
244993|NCT01912274|HMA|hma
244994|NCT01912274|newly diagnosed|newly diagnosed
244995|NCT01912261|Coronary artery bypass gafting|coronary artery bypass gafting
244996|NCT01912261|Anemia|anemia
244997|NCT01912261|Postoperative fatigue|postoperative fatigue
244998|NCT01912261|Functional Capacity|functional capacity
244999|NCT01912261|Iron|iron
245000|NCT01912261|Adherence|adherence
245001|NCT01912248|acute rise of systolic and diastolic bloodpressure|acute rise of systolic and diastolic bloodpressure
245002|NCT01912235|Arginine synthesis|arginine synthesis
245003|NCT01912235|15N2 arginine, 1-13C Glutamine, 2-15N Glutamine, 15N Proline|15n2 arginine, 1-13c glutamine, 2-15n glutamine, 15n proline
245004|NCT01912209|employees|employees
245005|NCT01912209|metabolic syndrome|metabolic syndrome
245007|NCT01912209|sub-clinical cardiovascular disease|sub-clinical cardiovascular disease
245008|NCT01912209|weight loss|weight loss
245009|NCT01912209|diet|diet
245010|NCT01912196|Depressive Disorder|depressive disorder
245011|NCT01912183|pediatric obesity|pediatric obesity
245012|NCT01912183|e-learning|e-learning
245013|NCT01912183|personal health record|personal health record
245014|NCT01912183|personal electronic device|personal electronic device
245015|NCT01912183|pilot|pilot
245016|NCT01912170|omega-3 fatty acid|omega-3 fatty acid
245017|NCT01912170|gestational diabetes|gestational diabetes
245018|NCT01912170|insulin sensitivity|insulin sensitivity
245019|NCT01912131|13-120|13-120
245020|NCT01912118|Nociception|nociception
245021|NCT01912118|General anesthesia|general anesthesia
245022|NCT01912105|endotracheal tube|endotracheal tube
245023|NCT01912105|ct scan|ct scan
245024|NCT01912105|cleaning device|cleaning device
245025|NCT01912105|biofilm|biofilm
245026|NCT01912105|mechanical ventilation|mechanical ventilation
245027|NCT01912053|Intra-hepatic Cholangiocarcinoma treatment|intra-hepatic cholangiocarcinoma treatment
245028|NCT01912040|Safety profile|safety profile
245029|NCT01912040|locally produced 123 Iodine MIBG|locally produced 123 iodine mibg
245030|NCT01912014|stroke|stroke
245031|NCT01912014|psychosocial|psychosocial
245032|NCT01912014|intervention|intervention
245033|NCT01912014|quality of life|quality of life
245034|NCT01912001|end stage renal disease|end stage renal disease
245035|NCT01912001|kidney failure|kidney failure
245036|NCT01912001|home dialysis|home dialysis
245037|NCT01912001|hemodialysis|hemodialysis
245038|NCT01912001|peritoneal dialysis|peritoneal dialysis
245039|NCT01912001|gaps in care|gaps in care
245040|NCT01912001|co-morbidity|co-morbidity
245041|NCT01912001|transitions of care settings|transitions of care settings
245042|NCT01911988|Peripheral immune cells|peripheral immune cells
245043|NCT01911988|Colorectal Cancers|colorectal cancers
245044|NCT01911988|Stage II/ Stage III|stage ii/ stage iii
245045|NCT01911988|Recurrence|recurrence
245046|NCT01911988|Metastasis|metastasis
245047|NCT01911975|Small Fiber Neuropathy|small fiber neuropathy
245048|NCT01911975|Painful Neuropathy|painful neuropathy
302089|NCT01655095|PEG|peg
245049|NCT01911975|NAV1.7 Voltage-Gated Sodium Channel|nav1.7 voltage-gated sodium channel
245050|NCT01911975|SCN9A|scn9a
245051|NCT01911949|femoral nerve block|femoral nerve block
245052|NCT01911949|ultrasound guided|ultrasound guided
245053|NCT01911949|total hip arthroplasty|total hip arthroplasty
245054|NCT01911936|CLJM716,|cljm716,
245055|NCT01911936|Japanese patients,|japanese patients,
245056|NCT01911936|Neoplasms|neoplasms
245057|NCT01911910|primary prevention|primary prevention
245058|NCT01911910|Cardiovascular disease|cardiovascular disease
245059|NCT01911910|Cardiovascular magnetic resonance (CMR)|cardiovascular magnetic resonance (cmr)
245060|NCT01911910|Electronic coaching (e-coaching)|electronic coaching (e-coaching)
245061|NCT01911897|Hypertension|hypertension
245062|NCT01911884|Rokitansky syndrome|rokitansky syndrome
245063|NCT01911884|surgical or vaginal dilatation of vaginal aplasia|surgical or vaginal dilatation of vaginal aplasia
245064|NCT01911884|quality of global and sexual life|quality of global and sexual life
245065|NCT01911871|Thalassemia|thalassemia
245066|NCT01911871|sickle cell disease|sickle cell disease
245067|NCT01911871|myelodysplasia|myelodysplasia
245068|NCT01911871|transfusion|transfusion
245069|NCT01911871|chelation|chelation
245070|NCT01911845|HCV Genotype 1|hcv genotype 1
245071|NCT01911845|Hepatitis Genotype 1|hepatitis genotype 1
245072|NCT01911845|Interferon Free|interferon free
245073|NCT01911845|methadone|methadone
245074|NCT01911845|HCV|hcv
245075|NCT01911845|Buprenorphine|buprenorphine
245076|NCT01911845|Hepatitis C|hepatitis c
245077|NCT01911845|Viekira Pak|viekira pak
245078|NCT01911845|paritaprevir|paritaprevir
245079|NCT01911845|Viekira|viekira
245080|NCT01911845|ombitasvir|ombitasvir
245081|NCT01911845|dasabuvir|dasabuvir
245082|NCT01911832|Cancer of the esophagogastric junction|cancer of the esophagogastric junction
245083|NCT01911832|Reconstruction of gastric tube|reconstruction of gastric tube
245084|NCT01911832|Quality of life|quality of life
245085|NCT01911832|Width|width
245086|NCT01911832|Regurgitation|regurgitation
245087|NCT01911819|Histomorphometric Analysis|histomorphometric analysis
245088|NCT01911819|New bone Formation|new bone formation
245089|NCT01911819|Sinus Augmentation|sinus augmentation
245090|NCT01911819|Bone Graft Materials|bone graft materials
245091|NCT01911806|Back care pillow|back care pillow
245092|NCT01911806|chronic non-specific low back pain|chronic non-specific low back pain
245093|NCT01911806|randomized controlled trial|randomized controlled trial
245094|NCT01911793|stoma|stoma
245095|NCT01911793|ileus|ileus
245096|NCT01911793|postoperative|postoperative
245097|NCT01911793|stoma tube|stoma tube
245098|NCT01911741|Phase I|phase i
245099|NCT01911741|Enzalutamide|enzalutamide
245100|NCT01911741|Relative bioavailability of MDV3100|relative bioavailability of mdv3100
245101|NCT01911741|Immediate release oral formulation|immediate release oral formulation
245102|NCT01911741|Xtandi|xtandi
245103|NCT01911728|Drug-Drug Interaction|drug-drug interaction
245104|NCT01911728|Phase 1|phase 1
245105|NCT01911728|MDV3100|mdv3100
245107|NCT01911728|Enzalutamide|enzalutamide
245108|NCT01911715|Phase 1|phase 1
245109|NCT01911715|Mass Balance|mass balance
245110|NCT01911715|MDV3100|mdv3100
245111|NCT01911715|Xtandi|xtandi
245112|NCT01911715|Enzalutamide|enzalutamide
245113|NCT01911715|Metabolism|metabolism
245114|NCT01911715|Excretion|excretion
245115|NCT01911689|pancreatitis|pancreatitis
245117|NCT01911689|APACHEⅡ|apacheⅱ
245118|NCT01911689|T2*|t2*
245119|NCT01911689|T2 star|t2 star
245120|NCT01911650|Achilles|achilles
245121|NCT01911650|tendinopathy|tendinopathy
245122|NCT01911637|Healthy|healthy
245123|NCT01911637|Subjects|subjects
245124|NCT01911637|Safety|safety
245125|NCT01911637|Tolerability|tolerability
245126|NCT01911637|VBY-036|vby-036
245127|NCT01911637|Maximum|maximum
245128|NCT01911637|Pharmacodynamic|pharmacodynamic
245129|NCT01911637|Pharmacokinetic|pharmacokinetic
245130|NCT01911585|Posttraumatic Stress Disorder|posttraumatic stress disorder
245131|NCT01911585|PTSD|ptsd
245132|NCT01911585|Prolonged Exposure Therapy|prolonged exposure therapy
245133|NCT01911585|Cognitive Behavioral Therapy|cognitive behavioral therapy
245134|NCT01911572|Streptococcus species|streptococcus species
245135|NCT01911572|Streptococcus pyogenes|streptococcus pyogenes
245136|NCT01911572|Streptococcus agalactiae|streptococcus agalactiae
245137|NCT01911572|Necrotising fasciitis|necrotising fasciitis
245138|NCT01911572|Sepsis|sepsis
245139|NCT01911559|Standing-frame|standing-frame
245140|NCT01911559|Chronic constipation|chronic constipation
245141|NCT01911559|Cerebral palsy|cerebral palsy
245142|NCT01911559|Quadriplegia|quadriplegia
245143|NCT01911559|Severe diplegia|severe diplegia
245144|NCT01911494|cluster randomized controlled trial|cluster randomized controlled trial
245145|NCT01911494|pre-eclampsia|pre-eclampsia
245146|NCT01911494|eclampsia|eclampsia
245147|NCT01911494|maternal mortality|maternal mortality
245148|NCT01911468|PCOS|pcos
245149|NCT01911468|obesity|obesity
245150|NCT01911468|GLP-1 receptor agonist|glp-1 receptor agonist
245151|NCT01911468|liraglutide|liraglutide
245152|NCT01911468|metformin|metformin
245153|NCT01911455|Fragile X Syndrome|fragile x syndrome
245154|NCT01911442|Autism, Lurasidone, Latuda|autism, lurasidone, latuda
245155|NCT01911429|schizophrenia|schizophrenia
245156|NCT01911429|Lurasidone|lurasidone
245158|NCT01911403|Femoral Artery puncture|femoral artery puncture
245159|NCT01911390|High cholesterol.|high cholesterol.
245160|NCT01911364|Frequent exacerbators|frequent exacerbators
245161|NCT01911351|nitrous oxide|nitrous oxide
245162|NCT01911351|pediatric pain and anxiety|pediatric pain and anxiety
245163|NCT01911338|Spinal Manipulation|spinal manipulation
245164|NCT01911338|Teaching|teaching
245165|NCT01911338|Thoracic Vertebrae|thoracic vertebrae
245166|NCT01911338|Feedback|feedback
245167|NCT01911325|Squamous non-small cell lung cancer|squamous non-small cell lung cancer
245168|NCT01911325|NSCLC|nsclc
245169|NCT01911325|Docetaxel|docetaxel
245170|NCT01911325|Buparlisib|buparlisib
245171|NCT01911325|BKM120|bkm120
245172|NCT01911325|Metastatic|metastatic
245173|NCT01911325|Stage IIIb|stage iiib
245174|NCT01911325|Stage IV|stage iv
245175|NCT01911325|PI3K inhibitor|pi3k inhibitor
245176|NCT01911299|Choline|choline
245177|NCT01911299|Glycerophosphocholine|glycerophosphocholine
245178|NCT01911299|Choline alphoscerate|choline alphoscerate
245179|NCT01911299|Fetal alcohol spectrum disorders|fetal alcohol spectrum disorders
245180|NCT01911299|Fetal alcohol syndrome|fetal alcohol syndrome
245181|NCT01911299|Partial fetal alcohol syndrome|partial fetal alcohol syndrome
245182|NCT01911299|Alcohol-related neurodevelopmental disorder|alcohol-related neurodevelopmental disorder
245183|NCT01911299|Prenatal alcohol exposure|prenatal alcohol exposure
245184|NCT01911299|Fetal Alcohol Effects|fetal alcohol effects
245185|NCT01911299|Pregnancy Complications|pregnancy complications
245186|NCT01911299|Alcohol-Induced Disorders|alcohol-induced disorders
245187|NCT01911299|Alcohol-Related Disorders|alcohol-related disorders
245188|NCT01911299|Central Nervous System Agents|central nervous system agents
245189|NCT01911299|Therapeutic Uses|therapeutic uses
245190|NCT01911273|Hepatocellular carcinoma|hepatocellular carcinoma
245191|NCT01911273|monoclonal antibody|monoclonal antibody
245192|NCT01911273|ALK-1|alk-1
245193|NCT01911273|best supportive care|best supportive care
245194|NCT01911260|Zinc|zinc
245195|NCT01911260|Growth|growth
245196|NCT01911260|Child|child
245197|NCT01911260|Dietary Supplements|dietary supplements
245198|NCT01911260|Randomized Controlled Trial|randomized controlled trial
245199|NCT01911221|Meningococcal disease,|meningococcal disease,
245200|NCT01911221|Adults|adults
245201|NCT01911208|Minority|minority
245202|NCT01911208|Recruitment|recruitment
245203|NCT01911195|General anesthesia|general anesthesia
245204|NCT01911195|cognition|cognition
245205|NCT01911195|consciousness|consciousness
245206|NCT01911182|apnea of prematurity|apnea of prematurity
245207|NCT01911182|control of breathing|control of breathing
245208|NCT01911182|newborn|newborn
245209|NCT01911182|CO2 inhalation|co2 inhalation
245210|NCT01911169|atherosclerosis|atherosclerosis
245211|NCT01911169|systemic lupus erythematosus|systemic lupus erythematosus
245212|NCT01911169|flow mediated dilation|flow mediated dilation
245213|NCT01911169|interferon gene signature|interferon gene signature
245214|NCT01911156|Chronic Hepatitis B|chronic hepatitis b
245215|NCT01911130|outcomes measures|outcomes measures
245216|NCT01911130|strength measurement|strength measurement
245217|NCT01911130|disease progression|disease progression
245218|NCT01911104|muscle|muscle
245219|NCT01911104|mitochondrial function|mitochondrial function
245220|NCT01911104|exercise resistance|exercise resistance
245221|NCT01911104|human|human
245222|NCT01911104|myotubes|myotubes
245223|NCT01911104|epigenetics|epigenetics
245224|NCT01911091|skeletal muscle|skeletal muscle
245225|NCT01911091|adipose tissue|adipose tissue
245226|NCT01911091|metabolism|metabolism
245227|NCT01911091|oxidation|oxidation
245228|NCT01911091|mitochondrial capacity|mitochondrial capacity
245229|NCT01911078|Metabolic syndrome|metabolic syndrome
245230|NCT01911078|Renal denervation|renal denervation
245231|NCT01911078|Renal artery|renal artery
245232|NCT01911078|Muscle sympathetic nerve activity|muscle sympathetic nerve activity
245233|NCT01911065|Herpes zoster|herpes zoster
245234|NCT01911065|immune response|immune response
245235|NCT01911065|Zostavax|zostavax
245236|NCT01911065|twins|twins
245237|NCT01911065|non-twins|non-twins
245238|NCT01911052|Bowel preparation|bowel preparation
245239|NCT01911039|GVHD|gvhd
245240|NCT01911039|cGVHD|cgvhd
245241|NCT01911026|Bowel preparation|bowel preparation
245242|NCT01911013|degenerative cervical disease|degenerative cervical disease
245243|NCT01911013|anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
245244|NCT01911013|plate and cage|plate and cage
245245|NCT01911013|cage alone|cage alone
245246|NCT01910987|Multiple Myeloma|multiple myeloma
245247|NCT01910987|bortezomib|bortezomib
245248|NCT01910987|Velcade|velcade
245249|NCT01910987|First or Second Relapse|first or second relapse
245250|NCT01910987|retreatment|retreatment
245251|NCT01910987|Prolonged therapy|prolonged therapy
245252|NCT01910974|oesophagus|oesophagus
245253|NCT01910974|stomach|stomach
245254|NCT01910974|intestine|intestine
245255|NCT01910974|rectum|rectum
245256|NCT01910948|omega-3 gastric cancer perioperation|omega-3 gastric cancer perioperation
245257|NCT01910935|Physical activity|physical activity
245258|NCT01910935|Hypertension|hypertension
245259|NCT01910935|Scheme reference|scheme reference
245260|NCT01910935|Primary care|primary care
245261|NCT01910922|vegetable acceptance|vegetable acceptance
245262|NCT01910922|vegetable intake|vegetable intake
245263|NCT01910922|vegetable liking|vegetable liking
245264|NCT01910922|learning mechanisms|learning mechanisms
245265|NCT01910922|repeated exposure to flavor|repeated exposure to flavor
245266|NCT01910922|flavor learning|flavor learning
245267|NCT01910922|replace salt with spice|replace salt with spice
245268|NCT01910909|Hepatocellular carcinoma|hepatocellular carcinoma
245269|NCT01910909|unresectable|unresectable
245270|NCT01910909|small size|small size
245271|NCT01910909|Stereotactic body radiotherapy|stereotactic body radiotherapy
245272|NCT01910883|Safety|safety
245273|NCT01910883|Tolerability|tolerability
245274|NCT01910883|Pharmacokinetic|pharmacokinetic
245275|NCT01910870|Early-relapse|early-relapse
245276|NCT01910844|triple negative breast cancer|triple negative breast cancer
245277|NCT01910844|late-relapse|late-relapse
245278|NCT01910831|bruising, reduction, older age, aging|bruising, reduction, older age, aging
245279|NCT01910818|radiation|radiation
245280|NCT01910818|dermatitis|dermatitis
245281|NCT01910818|laser|laser
245282|NCT01910818|fractional|fractional
245283|NCT01910818|CO2|co2
245284|NCT01910818|chronic|chronic
245285|NCT01910818|fibrosis|fibrosis
245286|NCT01910818|scar|scar
245287|NCT01910805|Gestational diabetes|gestational diabetes
245288|NCT01910805|Diabetes mellitus|diabetes mellitus
245289|NCT01910805|diabetes in pregnancy|diabetes in pregnancy
245290|NCT01910805|diabetes risk|diabetes risk
245291|NCT01910805|diabetes risk awareness|diabetes risk awareness
245292|NCT01910805|African-American|african-american
245293|NCT01910805|Women|women
245294|NCT01910779|Atrial Fibrillation|atrial fibrillation
245295|NCT01910779|Cardioversion|cardioversion
245296|NCT01910779|Biphasic Shock|biphasic shock
245297|NCT01910766|pcos|pcos
245298|NCT01910766|coenzymeQ10|coenzymeq10
245299|NCT01910766|clomiphene citrate|clomiphene citrate
245300|NCT01910753|Head and neck cancer,|head and neck cancer,
245301|NCT01910753|physical activity,|physical activity,
245302|NCT01910753|nutrition therapeutic education|nutrition therapeutic education
245303|NCT01910740|Randomized Controlled Trial|randomized controlled trial
245304|NCT01910740|Exercise Movement Techniques|exercise movement techniques
245305|NCT01910740|Frail Elderly|frail elderly
245306|NCT01910740|Gait|gait
245307|NCT01910727|American Indian|american indian
245308|NCT01910727|Diabetes|diabetes
245309|NCT01910727|Pre-diabetes|pre-diabetes
245310|NCT01910727|Family health Coach|family health coach
245311|NCT01910714|HIV/AIDS|hiv/aids
245312|NCT01910714|Prevention|prevention
245313|NCT01910714|American Indian|american indian
245314|NCT01910714|Substance use|substance use
245315|NCT01910714|CBPR|cbpr
245316|NCT01910701|Home visiting interventions|home visiting interventions
245317|NCT01910701|American Indian|american indian
245318|NCT01910701|Community based participatory research|community based participatory research
245319|NCT01910688|RGB Salvage, RFA|rgb salvage, rfa
245320|NCT01910662|Suction Skin Blister|suction skin blister
245321|NCT01910662|Induration|induration
245322|NCT01910662|Tuberculin Purified Protein Derivative|tuberculin purified protein derivative
245323|NCT01910662|Erythema|erythema
245324|NCT01910662|Biopsy|biopsy
245325|NCT01910662|Keyhole Limpet Hemocyanin|keyhole limpet hemocyanin
245326|NCT01910662|Delayed Type Hypersensitivity|delayed type hypersensitivity
245327|NCT01910649|drisapersen|drisapersen
245328|NCT01910636|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
245329|NCT01910623|Quality of life|quality of life
245330|NCT01910623|Health related quality of life outcomes|health related quality of life outcomes
245331|NCT01910623|Long-term|long-term
245332|NCT01910623|Aida 0493|aida 0493
245333|NCT01910623|AIDA 2000|aida 2000
245334|NCT01910610|wild-type RAS metastatic colorectal cancer|wild-type ras metastatic colorectal cancer
245335|NCT01910584|quality of life|quality of life
245336|NCT01910584|sexual activity|sexual activity
245337|NCT01910584|Novasure endometrial ablation|novasure endometrial ablation
245338|NCT01910584|menorrhagia|menorrhagia
245339|NCT01910558|Alpha-cyclodextrin|alpha-cyclodextrin
245340|NCT01910558|Dietary fiber|dietary fiber
245341|NCT01910558|Fecal fat|fecal fat
245342|NCT01910558|Saturated fat|saturated fat
245343|NCT01910519|influenza A (H5N1) virus|influenza a (h5n1) virus
245344|NCT01910519|H5N1 influenza|h5n1 influenza
245345|NCT01910519|influenza A/H5/N1|influenza a/h5/n1
245346|NCT01910519|monovalent H5N1 influenza vaccine|monovalent h5n1 influenza vaccine
245347|NCT01910519|systems biology|systems biology
245348|NCT01910519|AS03 adjuvant|as03 adjuvant
245349|NCT01910519|unadjuvanted|unadjuvanted
245350|NCT01910493|mhealth|mhealth
245351|NCT01910493|mobile health|mobile health
245353|NCT01910493|SMS reminders|sms reminders
245354|NCT01910493|ART retention in care|art retention in care
245356|NCT01910493|PMTCT cascade|pmtct cascade
245357|NCT01910493|retention in care|retention in care
245358|NCT01910454|Stroke|stroke
245359|NCT01910454|Occupational Therapy|occupational therapy
245360|NCT01910454|Cognition|cognition
245361|NCT01910441|Type 2 Diabetes Mellitus, Glycemic variability|type 2 diabetes mellitus, glycemic variability
245362|NCT01910428|L-asparaginase encapsulated in RBCs, leukemia, lymphoma|l-asparaginase encapsulated in rbcs, leukemia, lymphoma
245363|NCT01910402|antiretroviral therapy naïve|antiretroviral therapy naïve
245364|NCT01910402|women|women
245365|NCT01910402|once daily|once daily
245366|NCT01910402|HIV infection|hiv infection
245367|NCT01910402|atazanavir|atazanavir
245368|NCT01910402|tenofovir/emtricitabine|tenofovir/emtricitabine
245369|NCT01910402|dolutegravir/abacavir/lamivudine fixed dose combination|dolutegravir/abacavir/lamivudine fixed dose combination
245370|NCT01910402|integrase inhibitor|integrase inhibitor
245371|NCT01910402|ritonavir|ritonavir
245372|NCT01910389|Heart failure|heart failure
245373|NCT01910389|Pulmonary hypertension|pulmonary hypertension
245374|NCT01910389|tadalafil|tadalafil
245375|NCT01910389|Phosphodiesterase Type 5 Inhibition|phosphodiesterase type 5 inhibition
245376|NCT01910363|poststroke spasticity|poststroke spasticity
245377|NCT01910363|lower limb|lower limb
245378|NCT01910363|botulinum toxin|botulinum toxin
245379|NCT01910363|A2|a2
245380|NCT01910350|Breast & cervical cancer prevention & screening|breast & cervical cancer prevention & screening
245381|NCT01910337|ASA I patients|asa i patients
245382|NCT01910324|Juvenile Offenders|juvenile offenders
245383|NCT01910324|HIV/STD Prevention|hiv/std prevention
245384|NCT01910324|Adolescent Substance Abuse|adolescent substance abuse
245385|NCT01910324|Multidimensional Family Therapy|multidimensional family therapy
245386|NCT01910298|Breast reconstruction|breast reconstruction
245387|NCT01910298|Breast implant|breast implant
245388|NCT01910298|Breast cancer|breast cancer
245389|NCT01910298|Mastectomy|mastectomy
245390|NCT01910285|Anesthetic induction|anesthetic induction
245391|NCT01910285|Intubation conditions|intubation conditions
245392|NCT01910285|Tooth extraction|tooth extraction
245393|NCT01910285|Propofol|propofol
245394|NCT01910285|Sufentanil|sufentanil
245395|NCT01910285|Remifentanil|remifentanil
245396|NCT01910272|Radiation attenuation|radiation attenuation
245397|NCT01910272|Fluoroscopy|fluoroscopy
245398|NCT01910272|Invasive cardiac procedures|invasive cardiac procedures
245399|NCT01910272|Cardiac Catheterization|cardiac catheterization
245400|NCT01910259|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
245401|NCT01910259|Neuroprotective|neuroprotective
245402|NCT01910259|Repurposed drugs|repurposed drugs
245403|NCT01910259|Brain atrophy|brain atrophy
245404|NCT01910259|Percentage Brain Volume Change|percentage brain volume change
245405|NCT01910259|Magnetic Resonance Imaging|magnetic resonance imaging
245406|NCT01910259|Optical Coherence Tomography|optical coherence tomography
245407|NCT01910259|Cerebrospinal fluid|cerebrospinal fluid
245411|NCT01910259|Double blind|double blind
245412|NCT01910259|Placebo|placebo
245413|NCT01910246|Metformin|metformin
245414|NCT01910246|Insulin Resistance|insulin resistance
245415|NCT01910246|Cardiac Function|cardiac function
245416|NCT01910233|dyspnea|dyspnea
245417|NCT01910233|registry|registry
245418|NCT01910233|baseline characteristics|baseline characteristics
245419|NCT01910233|mortality|mortality
245420|NCT01910233|risk assessment|risk assessment
245421|NCT01910233|emergency department|emergency department
245422|NCT01910142|bone metabolism|bone metabolism
245423|NCT01910129|vagus nerve stimulation|vagus nerve stimulation
245424|NCT01910129|vagal nerve stimulation|vagal nerve stimulation
245425|NCT01910129|nVNS|nvns
245426|NCT01910129|VNS|vns
245427|NCT01910129|epilepsy|epilepsy
245428|NCT01910129|non invasive|non invasive
245429|NCT01910129|gammacore|gammacore
245430|NCT01910116|osteoarthritis|osteoarthritis
245431|NCT01910116|hand|hand
245432|NCT01910116|Shinbaro|shinbaro
245433|NCT01910116|GCSB-5|gcsb-5
245434|NCT01910103|Breast Neoplasms/radiography|breast neoplasms/radiography
245435|NCT01910103|Mammography/methods|mammography/methods
245436|NCT01910103|Mass Screening|mass screening
245437|NCT01910103|Tomography, X-Ray Computed/methods|tomography, x-ray computed/methods
245438|NCT01910103|Predictive Value of Tests|predictive value of tests
245439|NCT01910103|False Positive Reactions|false positive reactions
245440|NCT01910090|fasting condition|fasting condition
245441|NCT01910077|tacrolimus|tacrolimus
245442|NCT01910077|tacrobell capsule|tacrobell capsule
245443|NCT01910077|prograf capsule|prograf capsule
245444|NCT01910077|bioequivalence|bioequivalence
245445|NCT01910064|Acne Vulgaris|acne vulgaris
245446|NCT01910025|Argininosuccinate Synthetase|argininosuccinate synthetase
245447|NCT01910025|Arginine|arginine
245448|NCT01910025|Arginine deiminase|arginine deiminase
245449|NCT01910012|Argininosuccinate Synthetase|argininosuccinate synthetase
245450|NCT01910012|Arginine|arginine
245451|NCT01910012|Arginine deiminase|arginine deiminase
245452|NCT01909999|Dental Implants|dental implants
245453|NCT01909999|Osseointegration|osseointegration
245454|NCT01909999|Immediate Dental Implant Loading|immediate dental implant loading
245455|NCT01909999|Bone formation|bone formation
245456|NCT01909986|ONO-4053|ono-4053
245457|NCT01909986|Healthy adult male subjects|healthy adult male subjects
245458|NCT01909986|pharmacokinetics|pharmacokinetics
245459|NCT01909986|metabolism|metabolism
245460|NCT01909986|excretion|excretion
245461|NCT01909986|mass balance|mass balance
245462|NCT01909973|Depression|depression
245463|NCT01909973|Antidepressant Medication|antidepressant medication
245464|NCT01909973|Adherence|adherence
245465|NCT01909973|Mobile Smartphone Intervention|mobile smartphone intervention
245466|NCT01909973|Telemedicine|telemedicine
245467|NCT01909973|Primary Care|primary care
245468|NCT01909960|Normal pressure hydrocephalus|normal pressure hydrocephalus
245469|NCT01909960|Flow MRI|flow mri
245470|NCT01909960|Dementia|dementia
245471|NCT01909960|Cerebrospinal fluid|cerebrospinal fluid
245472|NCT01909960|Shunt|shunt
245473|NCT01909947|Respiratory rate variability|respiratory rate variability
245474|NCT01909947|Heart rate variability|heart rate variability
245475|NCT01909947|Extubation readiness|extubation readiness
245476|NCT01909947|Extubation failure|extubation failure
245477|NCT01909947|Clinical predictors|clinical predictors
245478|NCT01909934|Lymphoma|lymphoma
245479|NCT01909934|Anaplastic Large-cell|anaplastic large-cell
245480|NCT01909934|Relapsed|relapsed
245481|NCT01909934|Refractory|refractory
245482|NCT01909934|Antigens, CD30|antigens, cd30
245483|NCT01909934|Antibody-Drug Conjugate|antibody-drug conjugate
245484|NCT01909934|Antibodies, Monoclonal|antibodies, monoclonal
245485|NCT01909934|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
245486|NCT01909934|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
245487|NCT01909934|monomethyl auristatin E|monomethyl auristatin e
245488|NCT01909934|Drug Therapy|drug therapy
245489|NCT01909934|Immunotherapy|immunotherapy
245490|NCT01909934|Hematologic Diseases|hematologic diseases
245491|NCT01909908|Wounds and injuries|wounds and injuries
245492|NCT01909908|Ulcer|ulcer
245493|NCT01909908|Diabetic angiopathies|diabetic angiopathies
245494|NCT01909908|Diabetic foot|diabetic foot
245495|NCT01909908|Venous insufficiency|venous insufficiency
245496|NCT01909908|Extracellular matrix|extracellular matrix
245497|NCT01909882|Family member's massage therapy|family member's massage therapy
245498|NCT01909882|Vital signs|vital signs
245499|NCT01909882|Glasgow coma scale|glasgow coma scale
245500|NCT01909882|Intensive care unit|intensive care unit
245501|NCT01909882|Randomized controlled Clinical Trial|randomized controlled clinical trial
245502|NCT01909882|Iran|iran
245503|NCT01909869|MACE|mace
245504|NCT01909869|TVR|tvr
245505|NCT01909869|MI|mi
245506|NCT01909869|TLF|tlf
245507|NCT01909869|Death|death
245508|NCT01909830|Colorectal Cancer Metastatic|colorectal cancer metastatic
245509|NCT01909830|pretreated|pretreated
245510|NCT01909804|Hepatitis|hepatitis
245511|NCT01909804|Genotype 1|genotype 1
245512|NCT01909804|Genotype 3|genotype 3
245513|NCT01909804|Treatment experienced|treatment experienced
245514|NCT01909791|Diabetic Macular Edema|diabetic macular edema
245515|NCT01909791|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
245516|NCT01909765|Circumcision|circumcision
245517|NCT01909765|postoperative pain|postoperative pain
245518|NCT01909752|Lung cancer|lung cancer
245519|NCT01909752|DRibble Vaccine|dribble vaccine
245520|NCT01909752|Imiquimod|imiquimod
245521|NCT01909752|GM-CSF|gm-csf
245522|NCT01909752|HPV vaccine (Ceravix)|hpv vaccine (ceravix)
245523|NCT01909752|Cyclophosphamide|cyclophosphamide
245524|NCT01909739|AKI, atrovastatin, Valvular heart surgery|aki, atrovastatin, valvular heart surgery
245525|NCT01909726|Hospital Design|hospital design
245526|NCT01909726|Technology|technology
245527|NCT01909726|Anxiety|anxiety
245528|NCT01909713|acne, pediatric|acne, pediatric
245529|NCT01909700|Single Incision, Mesh, Complications|single incision, mesh, complications
245530|NCT01909687|blood glucose monitoring systems|blood glucose monitoring systems
245531|NCT01909687|ISO 15197|iso 15197
245532|NCT01909687|system accuracy|system accuracy
245534|NCT01909661|Cow's milk protein|cow's milk protein
245535|NCT01909661|Tolerance|tolerance
245536|NCT01909661|Efficacy|efficacy
245537|NCT01909661|Infants' growth|infants' growth
245538|NCT01909622|Vitamin D|vitamin d
245539|NCT01909622|Milk fortification|milk fortification
245540|NCT01909622|Children|children
245541|NCT01909622|Colombia|colombia
245542|NCT01909609|male|male
245543|NCT01909583|congenital|congenital
245544|NCT01909583|surgery|surgery
245545|NCT01909583|peri-operative|peri-operative
245546|NCT01909583|counselling|counselling
245547|NCT01909557|Acetyl-L-carnitine|acetyl-l-carnitine
245548|NCT01909557|Interferons|interferons
245549|NCT01909557|Ribavirin|ribavirin
245550|NCT01909557|Hepatitis C|hepatitis c
245551|NCT01909557|Fatigue|fatigue
245552|NCT01909544|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
245553|NCT01909544|Muscle fatigue|muscle fatigue
245554|NCT01909544|Energy metabolism|energy metabolism
245555|NCT01909544|Muscle oxygenation|muscle oxygenation
245556|NCT01909531|Deep Brain Stimulation|deep brain stimulation
245557|NCT01909531|Parkinsons Disease|parkinsons disease
245558|NCT01909531|Essential Tremor|essential tremor
245559|NCT01909531|Asleep DBS|asleep dbs
245560|NCT01909518|Esophageal Squamous Intraepithelial Neoplasia|esophageal squamous intraepithelial neoplasia
245561|NCT01909518|surface maturation scoring|surface maturation scoring
245562|NCT01909518|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
245563|NCT01909518|virtual chromoendoscopy|virtual chromoendoscopy
245564|NCT01909492|Multiple Sclerosis|multiple sclerosis
245566|NCT01909492|Relaxin|relaxin
245567|NCT01909466|OPC-14597|opc-14597
245568|NCT01909466|Aripiprazole|aripiprazole
245569|NCT01909466|Schizophrenia|schizophrenia
245570|NCT01909453|Melanoma|melanoma
245571|NCT01909453|Cutaneous melanoma|cutaneous melanoma
245572|NCT01909453|Skin disease|skin disease
245573|NCT01909453|Skin cancer|skin cancer
245574|NCT01909453|Skin Neoplasms|skin neoplasms
245575|NCT01909453|Neoplasm Metastasis|neoplasm metastasis
245576|NCT01909453|BRAF mutant|braf mutant
245577|NCT01909453|BRAF V600E|braf v600e
245578|NCT01909453|BRAF V600K|braf v600k
245579|NCT01909453|Cancer|cancer
245580|NCT01909453|LGX818|lgx818
245581|NCT01909453|MEK162|mek162
245582|NCT01909453|vemurafenib|vemurafenib
245583|NCT01909453|combination|combination
245584|NCT01909453|BRAF inhibitor|braf inhibitor
245585|NCT01909453|resistance|resistance
245586|NCT01909453|The combination of a selective BRAF- and a MEK1/2-inhibitor|the combination of a selective braf- and a mek1/2-inhibitor
245587|NCT01909453|Prior immunotherapy|prior immunotherapy
245588|NCT01909453|MEK inhibitor|mek inhibitor
245589|NCT01909453|Phase III|phase iii
245590|NCT01909453|Combo 300, Combo 450|combo 300, combo 450
245591|NCT01909427|Active rheumatoid arthritis despite methotrexate therapy|active rheumatoid arthritis despite methotrexate therapy
245592|NCT01909427|CNTO 6785|cnto 6785
245593|NCT01909427|Methotrexate|methotrexate
245594|NCT01909401|Liver Transplantation|liver transplantation
245595|NCT01909388|Cancer|cancer
245596|NCT01909388|Prostate Cancer|prostate cancer
245597|NCT01909388|Brachytherapy|brachytherapy
245598|NCT01909388|Dose escalation|dose escalation
245599|NCT01909388|High Dose Rate|high dose rate
245600|NCT01909388|MRI-TRUS fusion|mri-trus fusion
245601|NCT01909388|Detection of DILs by MRI|detection of dils by mri
245602|NCT01909362|advanced metastatic colorectal cancer|advanced metastatic colorectal cancer
245603|NCT01909362|mCRC|mcrc
245604|NCT01909362|Colorectal Cancer|colorectal cancer
245605|NCT01909362|Colorectal Carcinoma|colorectal carcinoma
245606|NCT01909362|Colorectal Tumors|colorectal tumors
245607|NCT01909362|Genetic mutation testing|genetic mutation testing
245608|NCT01909362|Tumor tissue sampling|tumor tissue sampling
245609|NCT01909349|medical rehabilitation|medical rehabilitation
245610|NCT01909349|aftercare|aftercare
245611|NCT01909349|multiple health behavior change|multiple health behavior change
245612|NCT01909349|diet|diet
245613|NCT01909349|physical activity|physical activity
245614|NCT01909349|computer|computer
245615|NCT01909349|international study|international study
245616|NCT01909349|ETHNOPSYCHOLOGY|ethnopsychology
245617|NCT01909349|HABIT|habit
245618|NCT01909349|HEALTH|health
245619|NCT01909349|eHealth|ehealth
245620|NCT01909349|eLearning|elearning
245621|NCT01909310|anesthesia, cardiac arrest, resuscitation, ventilation|anesthesia, cardiac arrest, resuscitation, ventilation
245622|NCT01909297|airway management|airway management
245623|NCT01909271|Stroke|stroke
245624|NCT01909271|Community Health Education|community health education
245625|NCT01909271|Minority Health|minority health
245626|NCT01909271|healthcare disparities|healthcare disparities
245627|NCT01909245|Islet cells|islet cells
245628|NCT01909245|hypoglycemia|hypoglycemia
245629|NCT01909245|hypoglycemia unawareness|hypoglycemia unawareness
245630|NCT01909245|islet after kidney transplantation|islet after kidney transplantation
245631|NCT01909245|islet transplant|islet transplant
245632|NCT01909245|insulin independence|insulin independence
245633|NCT01909245|insulin dependence|insulin dependence
245634|NCT01909232|Depression|depression
245635|NCT01909232|Depressive Disorder|depressive disorder
245636|NCT01909232|Major depression|major depression
245637|NCT01909232|Major depressive disorder|major depressive disorder
245638|NCT01909232|MDD|mdd
245639|NCT01909232|Treatment resistant depression|treatment resistant depression
245640|NCT01909232|Treatment intolerant depression|treatment intolerant depression
245641|NCT01909232|TRMD|trmd
245642|NCT01909232|TIMD|timd
245643|NCT01909232|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
245644|NCT01909232|TMS|tms
245645|NCT01909219|preparation, cleansing, colon|preparation, cleansing, colon
245646|NCT01909167|Pregnancy|pregnancy
245647|NCT01909167|symptoms of depression|symptoms of depression
245648|NCT01909167|anxiety|anxiety
245649|NCT01909167|online CBT therapy|online cbt therapy
245650|NCT01909167|treatment as usual|treatment as usual
245651|NCT01909167|maternal bonding|maternal bonding
245652|NCT01909167|postnatal period|postnatal period
245653|NCT01909154|neurophysiological parameters improvement|neurophysiological parameters improvement
245654|NCT01909154|spinal cord injury|spinal cord injury
245655|NCT01909154|biology therapy|biology therapy
245656|NCT01909141|letrozole|letrozole
245657|NCT01909141|clomiphene citrate|clomiphene citrate
245658|NCT01909141|pioglitazone|pioglitazone
245659|NCT01909141|metformin|metformin
245660|NCT01909141|ovulation induction|ovulation induction
245661|NCT01909141|PCOS|pcos
245662|NCT01909128|children, fermented milk fermented rice, gastrointestinal infections, respiratory infections|children, fermented milk fermented rice, gastrointestinal infections, respiratory infections
245663|NCT01909102|Acceptance and Commitment Therapy|acceptance and commitment therapy
245664|NCT01909102|Cardiac rehabilitation|cardiac rehabilitation
245665|NCT01909050|celiac disease|celiac disease
245666|NCT01909050|refractory celiac disease|refractory celiac disease
245667|NCT01909050|gluten sensitivity|gluten sensitivity
245668|NCT01909037|osteoarthritis|osteoarthritis
245669|NCT01909037|curcumin|curcumin
245670|NCT01909037|biomarker|biomarker
245671|NCT01909037|pain|pain
245672|NCT01909024|Randomised controlled trial|randomised controlled trial
245673|NCT01909024|Endovenous laser treatment|endovenous laser treatment
245674|NCT01909024|Transjugular coil embolisation|transjugular coil embolisation
245675|NCT01908998|Y-Balance test|y-balance test
245676|NCT01908985|glaucoma|glaucoma
245677|NCT01908985|high intensity focused ultrasound|high intensity focused ultrasound
245678|NCT01908985|aqueous humor|aqueous humor
245679|NCT01908985|fluorophotometry|fluorophotometry
245680|NCT01908972|Hemangioma|hemangioma
245681|NCT01908972|Propranolol|propranolol
245682|NCT01908972|prednisolone|prednisolone
245683|NCT01908972|steroid|steroid
245684|NCT01908959|Hispanic Women|hispanic women
245685|NCT01908959|Postpartum|postpartum
245686|NCT01908959|Overweight Hispanic Women|overweight hispanic women
245687|NCT01908959|Low-income|low-income
245688|NCT01908959|Physical Activity|physical activity
245689|NCT01908959|Walking|walking
245690|NCT01908946|Polio|polio
245691|NCT01908933|Advanced Emphysema|advanced emphysema
245692|NCT01908933|Heterogeneous Lower Lobe Predominant Emphysema|heterogeneous lower lobe predominant emphysema
245693|NCT01908933|Heterogeneous Upper and Lower Lobe Predominant|heterogeneous upper and lower lobe predominant
245694|NCT01908907|Premature Infants|premature infants
245695|NCT01908907|DHA(docosahexaenoic acid)|dha(docosahexaenoic acid)
245696|NCT01908907|DHA deficit|dha deficit
245697|NCT01908881|Child Development|child development
245698|NCT01908881|Mother-Child relations|mother-child relations
245699|NCT01908881|Primary Health Care|primary health care
245700|NCT01908881|Public Policy|public policy
245701|NCT01908855|somatoform symptoms|somatoform symptoms
245702|NCT01908855|somatic symptoms|somatic symptoms
245703|NCT01908855|somatoform disorder|somatoform disorder
245704|NCT01908855|somatic symptom disorder|somatic symptom disorder
245705|NCT01908855|cognitive-behavioral therapy|cognitive-behavioral therapy
245706|NCT01908855|emotion regulation training|emotion regulation training
245707|NCT01908842|Opioid|opioid
245708|NCT01908842|Dependence|dependence
245709|NCT01908842|agonist|agonist
245710|NCT01908842|buprenorphine|buprenorphine
245711|NCT01908842|naloxone|naloxone
245712|NCT01908842|BUP/NAL|bup/nal
245713|NCT01908829|Overactive Bladder (OAB)|overactive bladder (oab)
245714|NCT01908829|Urinary incontinence|urinary incontinence
245715|NCT01908829|Urgency incontinence|urgency incontinence
245716|NCT01908829|Frequency|frequency
245717|NCT01908829|Urgency|urgency
245718|NCT01908829|Micturition|micturition
245719|NCT01908829|YM178|ym178
245720|NCT01908829|Mirabegron|mirabegron
245721|NCT01908829|Solifenacin|solifenacin
245722|NCT01908829|Betmiga|betmiga
245723|NCT01908829|Myrbetriq|myrbetriq
245724|NCT01908829|Betanis|betanis
245725|NCT01908829|Vesicare|vesicare
245726|NCT01908829|Vesitrim|vesitrim
245727|NCT01908829|Vesikur|vesikur
245728|NCT01908829|YM905|ym905
245729|NCT01908803|AOMT|aomt
245730|NCT01908803|tympanostomy tubes|tympanostomy tubes
245731|NCT01908803|Otorrhea|otorrhea
245732|NCT01908803|anti-infective|anti-infective
245733|NCT01908790|venous oximeter|venous oximeter
245734|NCT01908790|non-invasive monitor|non-invasive monitor
245735|NCT01908790|heart failure (HF)|heart failure (hf)
245736|NCT01908764|ear tubes|ear tubes
245737|NCT01908764|tympanostomy tubes|tympanostomy tubes
245738|NCT01908764|Otitis Media at the time of Tympanostomy Tube surgery|otitis media at the time of tympanostomy tube surgery
245739|NCT01908764|OMTT|omtt
245740|NCT01908738|Endometrial biopsy|endometrial biopsy
245741|NCT01908738|paracervical block|paracervical block
245742|NCT01908738|Lidocaine spray|lidocaine spray
245743|NCT01908738|women|women
245744|NCT01908738|abnormal uterine bleeding|abnormal uterine bleeding
245745|NCT01908686|ASD|asd
245746|NCT01908673|heart rate variability biofeedback|heart rate variability biofeedback
245747|NCT01908673|automatic self transcedental meditation|automatic self transcedental meditation
245748|NCT01908660|HIV|hiv
245749|NCT01908660|hepatitis C virus|hepatitis c virus
245750|NCT01908660|hepatitis B virus|hepatitis b virus
245751|NCT01908660|antiretroviral drugs|antiretroviral drugs
245752|NCT01908660|nucleos(t)ide reverse transcriptase inhibitors|nucleos(t)ide reverse transcriptase inhibitors
245753|NCT01908660|non-nucleos(t)ide reverse transcriptase inhibitors|non-nucleos(t)ide reverse transcriptase inhibitors
245754|NCT01908660|protease inhibitors|protease inhibitors
245755|NCT01908660|integrase inhibitors|integrase inhibitors
245756|NCT01908660|entry inhibitors|entry inhibitors
245757|NCT01908660|transaminase elevations|transaminase elevations
245758|NCT01908660|alanine aminotransferase|alanine aminotransferase
245759|NCT01908660|aspartate aminotransferase|aspartate aminotransferase
245760|NCT01908660|bilirubin elevations|bilirubin elevations
245761|NCT01908660|hepatic fibrosis|hepatic fibrosis
245762|NCT01908647|mTBI|mtbi
245763|NCT01908647|PTSD|ptsd
245764|NCT01908634|Bioavailability|bioavailability
245765|NCT01908634|Strawberry polyphenols|strawberry polyphenols
245766|NCT01908634|Fruit Beverage Matrix|fruit beverage matrix
245767|NCT01908621|multiple myeloma|multiple myeloma
245768|NCT01908621|mobilization|mobilization
245769|NCT01908621|G-CSF|g-csf
245770|NCT01908621|filgrastim|filgrastim
245771|NCT01908621|cytosine arabinoside|cytosine arabinoside
245772|NCT01908621|autologous stem cell transplantation|autologous stem cell transplantation
245773|NCT01908569|MACS, time-lapse, embryo, spermatozoid, sperm|macs, time-lapse, embryo, spermatozoid, sperm
245774|NCT01908543|Iron deficiency|iron deficiency
245775|NCT01908543|Nosebleeds|nosebleeds
245776|NCT01908530|Diabetes,Continuous Glucose Monitoring,Microprobes|diabetes,continuous glucose monitoring,microprobes
245777|NCT01908517|HPV Vaccine Adherence|hpv vaccine adherence
245778|NCT01908517|Electronic Reminders|electronic reminders
245779|NCT01908491|patient controlled analgesia|patient controlled analgesia
245780|NCT01908491|wound catheter infusion|wound catheter infusion
245781|NCT01908491|postoperative pain control|postoperative pain control
245782|NCT01908491|pectus excavatum|pectus excavatum
245783|NCT01908491|pain score|pain score
245784|NCT01908478|locally advanced|locally advanced
245785|NCT01908478|unresectable|unresectable
245786|NCT01908478|pancreatic|pancreatic
245787|NCT01908478|pancreas|pancreas
245788|NCT01908478|pancreatic adenocarcinoma|pancreatic adenocarcinoma
245789|NCT01908452|Schizophrenia|schizophrenia
245790|NCT01908452|pyridoxal kinase activity|pyridoxal kinase activity
245791|NCT01908452|plasma pyridoxal level|plasma pyridoxal level
245792|NCT01908439|muscle electrical activity|muscle electrical activity
245793|NCT01908439|whole-body vibration|whole-body vibration
245794|NCT01908439|latency|latency
245795|NCT01908426|cabozantinib|cabozantinib
245796|NCT01908426|XL184|xl184
245797|NCT01908426|liver cancer|liver cancer
245798|NCT01908426|hepatocellular carcinoma|hepatocellular carcinoma
245799|NCT01908426|tyrosine kinase inhibitor|tyrosine kinase inhibitor
245801|NCT01908426|vascular endothelial growth factor receptor 2 (VEGFR2)|vascular endothelial growth factor receptor 2 (vegfr2)
245802|NCT01908413|Advanced Solid Tumors|advanced solid tumors
245803|NCT01908413|Lymphoma|lymphoma
245804|NCT01908413|Open-Label|open-label
245998|NCT01907321|cough|cough
245805|NCT01908413|Dose-Escalation|dose-escalation
245806|NCT01908413|IAP|iap
245807|NCT01908400|Mental retardation , stem cell,BMMNC|mental retardation , stem cell,bmmnc
245808|NCT01908387|Oral azacitidine|oral azacitidine
245809|NCT01908387|CC-486|cc-486
245810|NCT01908387|Hematological neoplasms|hematological neoplasms
245811|NCT01908387|Phase 1|phase 1
245812|NCT01908374|Active-placebo controlled double blind cross over|active-placebo controlled double blind cross over
245813|NCT01908361|comparative efficacy research|comparative efficacy research
245814|NCT01908361|combination therapy|combination therapy
690206|NCT00921492|HPA axis|hpa axis
245815|NCT01908361|neurorehabilitation|neurorehabilitation
245816|NCT01908361|robotic rehabilitation|robotic rehabilitation
245817|NCT01908361|restraint therapy|restraint therapy
245818|NCT01908335|interferon|interferon
245819|NCT01908335|ribavirin|ribavirin
245820|NCT01908335|virological response|virological response
245821|NCT01908322|Hepatocellular carcinoma|hepatocellular carcinoma
245822|NCT01908322|Intermediate stage|intermediate stage
245823|NCT01908322|Observational study|observational study
245824|NCT01908309|acute kidney injury|acute kidney injury
245825|NCT01908309|contrast media|contrast media
245826|NCT01908309|cystatin-C|cystatin-c
245827|NCT01908296|FK949E|fk949e
245828|NCT01908296|fluvoxamine|fluvoxamine
245829|NCT01908296|Antipsychotic|antipsychotic
245830|NCT01908296|Quetiapine|quetiapine
245831|NCT01908244|Preterm infants, music, Neonatal Intensive Care Unit (NICU)|preterm infants, music, neonatal intensive care unit (nicu)
245832|NCT01908231|Pulmonary embolism, plasma lactate, right ventricular dysfunction|pulmonary embolism, plasma lactate, right ventricular dysfunction
302997|NCT01650792|Stroke|stroke
245833|NCT01908218|ULBT, diffficult laryngoscopy, Predictive Value of Tests|ulbt, diffficult laryngoscopy, predictive value of tests
245834|NCT01908205|Autism|autism
245835|NCT01908205|Social|social
245836|NCT01908205|Functioning|functioning
245837|NCT01908205|Cognition|cognition
245838|NCT01908205|Repetitive Behaviors|repetitive behaviors
245839|NCT01908205|Anxiety|anxiety
245840|NCT01908205|Quality of Life|quality of life
245841|NCT01908192|Sodium Benzoate|sodium benzoate
245842|NCT01908192|Schizophrenia|schizophrenia
245843|NCT01908192|Adolescent|adolescent
245844|NCT01908192|Antipsychotic|antipsychotic
245845|NCT01908192|Anti-psychotic|anti-psychotic
245846|NCT01908192|NMDA|nmda
245847|NCT01908192|NaBen|naben
245848|NCT01908192|pediatric|pediatric
245849|NCT01908179|Sterotactic Radiosurgery|sterotactic radiosurgery
245850|NCT01908153|Picture food type|picture food type
245851|NCT01908153|Taste type|taste type
245852|NCT01908127|film modelling|film modelling
245853|NCT01908127|dental anxiety|dental anxiety
245854|NCT01908127|cooperative behaviour|cooperative behaviour
245855|NCT01908127|children|children
245856|NCT01908114|Polio disease|polio disease
245857|NCT01908114|Intervention Package|intervention package
245858|NCT01908114|Polio sero prevalence and sero conversion|polio sero prevalence and sero conversion
245859|NCT01908114|Polio high risk areas of Pakistan|polio high risk areas of pakistan
245860|NCT01908088|Epidermolysis Bullosa mitten hand deformity autologous cultured fibroblast|epidermolysis bullosa mitten hand deformity autologous cultured fibroblast
245861|NCT01908088|amniotic membrane|amniotic membrane
245862|NCT01908075|Primary care|primary care
245863|NCT01908075|Asthma management|asthma management
245864|NCT01908075|Real-world|real-world
245865|NCT01908075|Observational|observational
245866|NCT01908075|Fostair|fostair
245867|NCT01908075|Seretide|seretide
245868|NCT01908062|Substance related disorders|substance related disorders
245869|NCT01908062|HIV|hiv
245870|NCT01908062|naltrexone|naltrexone
245871|NCT01908049|Probiotic|probiotic
245872|NCT01908049|HIV|hiv
245873|NCT01908049|Microbial translocation|microbial translocation
245874|NCT01908049|inflammation|inflammation
245875|NCT01908049|microbiota composition|microbiota composition
245876|NCT01908036|Chronic fatigue syndrome|chronic fatigue syndrome
245877|NCT01908036|CFS|cfs
245878|NCT01908036|myalgic encephalomyelitis|myalgic encephalomyelitis
245879|NCT01908036|M.E.|m.e.
245880|NCT01908036|activity monitor|activity monitor
245881|NCT01908023|exercise therapy|exercise therapy
245882|NCT01908023|oxygen consumption|oxygen consumption
245883|NCT01908010|Alzheimer's disease|alzheimer's disease
245884|NCT01907997|Systemic lidocaine, Intravenous lidocaine infusion, postoperative pain, quality of recovery, Robot-assisted thyroidectomy, thyroid cancer|systemic lidocaine, intravenous lidocaine infusion, postoperative pain, quality of recovery, robot-assisted thyroidectomy, thyroid cancer
245885|NCT01907984|premedication|premedication
245886|NCT01907984|diclofenac|diclofenac
245887|NCT01907984|postoperative headache|postoperative headache
245888|NCT01907984|Visual Analog Scale|visual analog scale
245889|NCT01907958|Microalbuminuria|microalbuminuria
245890|NCT01907958|Hypertensive|hypertensive
245891|NCT01907958|Diabetics|diabetics
245892|NCT01907958|urine albumin|urine albumin
245893|NCT01907945|Household water treatment|household water treatment
245894|NCT01907945|Waterborne illness|waterborne illness
245895|NCT01907945|ceramic filters|ceramic filters
245896|NCT01907945|social network|social network
245897|NCT01907932|splenomegaly|splenomegaly
245898|NCT01907932|ultrasound|ultrasound
245899|NCT01907932|VScan|vscan
245900|NCT01907919|Pulp capping, Diode laser 808 nm, Tertiary dentin, RM-GIC|pulp capping, diode laser 808 nm, tertiary dentin, rm-gic
245901|NCT01907906|Pathogen reduction technology|pathogen reduction technology
245902|NCT01907880|breast|breast
245903|NCT01907880|bone|bone
245904|NCT01907880|pain|pain
245905|NCT01907841|Investigate IPC on EIMD|investigate ipc on eimd
245906|NCT01907789|Ovarian Carcinoma|ovarian carcinoma
245907|NCT01907789|Ovary|ovary
245908|NCT01907789|BRCA Mutation Carriers|brca mutation carriers
245909|NCT01907789|BRCA1 or BRCA2 mutation|brca1 or brca2 mutation
245910|NCT01907789|High risk for developing ovarian cancer|high risk for developing ovarian cancer
245911|NCT01907789|Ovarian cancer screening|ovarian cancer screening
245912|NCT01907789|Risk-reducing salpingo-oophorectomy|risk-reducing salpingo-oophorectomy
245913|NCT01907789|RRSO|rrso
245914|NCT01907789|Prophylactic salpingectomy with delayed oophorectomy|prophylactic salpingectomy with delayed oophorectomy
245915|NCT01907789|PSDO|psdo
245916|NCT01907789|Questionnaire|questionnaire
245917|NCT01907789|Quality of life|quality of life
245918|NCT01907789|QOL|qol
245919|NCT01907789|Survey|survey
245920|NCT01907789|Transvaginal ultrasound|transvaginal ultrasound
245921|NCT01907789|Phone call|phone call
245922|NCT01907763|asthma|asthma
245923|NCT01907763|SOTB07|sotb07
245924|NCT01907750|biliary fistula|biliary fistula
245925|NCT01907750|biliary stricture|biliary stricture
236711|NCT01950624|Patient Registry|patient registry
236712|NCT01950624|Down Syndrome|down syndrome
245926|NCT01907750|biliary drainage tube|biliary drainage tube
245927|NCT01907724|Chronic hepatitis C|chronic hepatitis c
245928|NCT01907724|Hepatitis C virus|hepatitis c virus
245929|NCT01907724|HCV|hcv
245930|NCT01907711|Acupuncture.|acupuncture.
245931|NCT01907711|Fatigue syndrome chronic.|fatigue syndrome chronic.
245932|NCT01907711|Sleep disturbances.|sleep disturbances.
245933|NCT01907711|Pain.|pain.
245934|NCT01907711|Cognitive impairment.|cognitive impairment.
245935|NCT01907698|vaginal intercourse|vaginal intercourse
245936|NCT01907698|labour|labour
245937|NCT01907698|term pregnancy|term pregnancy
245938|NCT01907672|Malaria|malaria
245939|NCT01907672|Rapid Diagnostic Tests for Malaria|rapid diagnostic tests for malaria
245940|NCT01907672|Chemical Shops|chemical shops
245941|NCT01907672|Drug Shops|drug shops
245942|NCT01907672|Diagnostics|diagnostics
245943|NCT01907672|Testing for Malaria|testing for malaria
245944|NCT01907659|Respiratory|respiratory
245945|NCT01907659|Viruses|viruses
245946|NCT01907659|Bacterial|bacterial
245947|NCT01907659|Antibiotics|antibiotics
245948|NCT01907659|Procalcitonin|procalcitonin
245949|NCT01907646|bladder training, radical hysterectomy,gynaecologic cancer|bladder training, radical hysterectomy,gynaecologic cancer
245950|NCT01907633|Death, Sudden, Cardiac|death, sudden, cardiac
245951|NCT01907633|Risk of Sudden Cardiac Death|risk of sudden cardiac death
245952|NCT01907633|Domperidone|domperidone
245953|NCT01907633|Proton Pump Inhibitors (PPI)|proton pump inhibitors (ppi)
245954|NCT01907633|Metoclopramide|metoclopramide
245955|NCT01907633|Observational Study|observational study
245956|NCT01907607|Advanced Gastrointestinal Stromal Tumor Refractory to Imatinib and Sunitinib|advanced gastrointestinal stromal tumor refractory to imatinib and sunitinib
245957|NCT01907607|PD-0332991|pd-0332991
245958|NCT01907607|Orally|orally
245959|NCT01907607|Efficacy and safety|efficacy and safety
245960|NCT01907607|Adult patients|adult patients
245961|NCT01907607|Refractory|refractory
245962|NCT01907607|Imatinib|imatinib
245963|NCT01907607|Sunitinib|sunitinib
245964|NCT01907490|Topical treatment of Head Lice Infestation|topical treatment of head lice infestation
245965|NCT01907464|Anorexia nervosa|anorexia nervosa
245966|NCT01907464|Bone mineral density|bone mineral density
245967|NCT01907464|Teenagers or young women|teenagers or young women
245968|NCT01907464|Bone remodelling markers|bone remodelling markers
245969|NCT01907438|BRCA|brca
245970|NCT01907438|estrogen|estrogen
245971|NCT01907438|epithelial breast cells|epithelial breast cells
245972|NCT01907438|genome profile|genome profile
245973|NCT01907412|First time parents|first time parents
245974|NCT01907412|Coparenting|coparenting
245975|NCT01907412|Family Foundations|family foundations
245976|NCT01907399|obese patients|obese patients
245977|NCT01907399|obese patients with type 2 diabetes|obese patients with type 2 diabetes
245978|NCT01907399|healthy volunteers|healthy volunteers
245979|NCT01907386|Endoleaks|endoleaks
245980|NCT01907386|Non-invasive vascular elastography|non-invasive vascular elastography
245981|NCT01907373|olmesartan|olmesartan
245982|NCT01907373|probenecid|probenecid
245983|NCT01907373|pharmacokinetics|pharmacokinetics
245984|NCT01907373|tolerability|tolerability
245985|NCT01907347|intensive care unit (ICU)|intensive care unit (icu)
245986|NCT01907347|body composition|body composition
245987|NCT01907347|phase angle|phase angle
245988|NCT01907347|mortality|mortality
245989|NCT01907347|nosocomial infection|nosocomial infection
245990|NCT01907347|bioimpedance analysis|bioimpedance analysis
245991|NCT01907347|nutrition|nutrition
245992|NCT01907334|oscillometry|oscillometry
245993|NCT01907334|asthma|asthma
245994|NCT01907334|methacholine|methacholine
245995|NCT01907321|stroke|stroke
245996|NCT01907321|dysphagia|dysphagia
245997|NCT01907321|dystussia|dystussia
245999|NCT01907321|maximum expiratory pressure|maximum expiratory pressure
246000|NCT01907308|Bladder cancer|bladder cancer
246001|NCT01907308|Urothelial cancer|urothelial cancer
246002|NCT01907308|Urothelial carcinoma|urothelial carcinoma
246003|NCT01907295|idiopathic|idiopathic
246004|NCT01907295|heritable|heritable
246005|NCT01907295|anorexigen|anorexigen
690207|NCT00921492|HPO axis|hpo axis
246006|NCT01907282|Schizophrenia|schizophrenia
246007|NCT01907282|psychosis|psychosis
246008|NCT01907230|Rheumatoid arthritis|rheumatoid arthritis
246009|NCT01907230|Inactive HBV carrier|inactive hbv carrier
246010|NCT01907230|Resolved Hepatitis B|resolved hepatitis b
246011|NCT01907230|HBV reactivation|hbv reactivation
246012|NCT01907230|Anti-tumor necrotic factor-alfa|anti-tumor necrotic factor-alfa
246013|NCT01907217|Electroconvulsive therapy|electroconvulsive therapy
246014|NCT01907217|ECT|ect
246015|NCT01907217|electrode placement|electrode placement
246016|NCT01907217|effectiveness|effectiveness
246017|NCT01907217|cognition|cognition
246018|NCT01907217|autobiographical memory|autobiographical memory
246019|NCT01907191|Hip Arthroscopy|hip arthroscopy
236853|NCT01950091|app|app
246231|NCT01906073|morphine|morphine
246020|NCT01907191|Liposomal Bupivacaine|liposomal bupivacaine
246021|NCT01907191|Bupivacaine|bupivacaine
246022|NCT01907178|total knee arthroplasty|total knee arthroplasty
246023|NCT01907152|malnutrition|malnutrition
246024|NCT01907152|undernourishment|undernourishment
246025|NCT01907152|loss of muscle mass|loss of muscle mass
246026|NCT01907139|comparative efficacy research|comparative efficacy research
246027|NCT01907139|combination therapy|combination therapy
246028|NCT01907139|neurorehabilitation|neurorehabilitation
246029|NCT01907139|robot-assisted therapy|robot-assisted therapy
246030|NCT01907139|constraint-induced therapy|constraint-induced therapy
246031|NCT01907126|HIV|hiv
246032|NCT01907126|Sexually transmitted infections|sexually transmitted infections
246033|NCT01907126|Sexual abuse|sexual abuse
246034|NCT01907126|Physical abuse|physical abuse
246035|NCT01907126|Women|women
246036|NCT01907126|Prison|prison
246037|NCT01907087|Late infantile Neuronal Ceroid Lipofuscinosis Type 2|late infantile neuronal ceroid lipofuscinosis type 2
246038|NCT01907087|LINCL|lincl
246039|NCT01907087|NCL2|ncl2
246040|NCT01907087|CLN2|cln2
246041|NCT01907087|Jansky-Bielschowsky disease|jansky-bielschowsky disease
246042|NCT01907074|liver function tests|liver function tests
246043|NCT01907074|end stage liver disease|end stage liver disease
246044|NCT01907074|cirrhosis|cirrhosis
246045|NCT01907074|living liver donor|living liver donor
246046|NCT01907061|acute renal failure|acute renal failure
246047|NCT01907061|post liver transplant|post liver transplant
246048|NCT01907048|Survey|survey
246049|NCT01907048|Effectiveness of risk minimization measures|effectiveness of risk minimization measures
246050|NCT01907048|Rivaroxaban|rivaroxaban
246051|NCT01907048|Anticoagulants|anticoagulants
246052|NCT01907022|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
246053|NCT01907022|chronic tinnitus|chronic tinnitus
246054|NCT01907022|relaxation|relaxation
246055|NCT01906944|trigger point injection|trigger point injection
246056|NCT01906944|transversus abdominis plane|transversus abdominis plane
246057|NCT01906944|abdominal wall pain|abdominal wall pain
246058|NCT01906931|Interstitial lung disease|interstitial lung disease
246059|NCT01906931|Oxygen therapy|oxygen therapy
246060|NCT01906931|Walk|walk
246061|NCT01906918|ischemia|ischemia
246062|NCT01906918|reperfusion|reperfusion
246063|NCT01906918|myocardial ischemia|myocardial ischemia
246064|NCT01906918|myocardial reperfusion|myocardial reperfusion
246065|NCT01906866|Sleep disturbance|sleep disturbance
246066|NCT01906866|Circadian|circadian
246067|NCT01906866|Prolong release melatonin|prolong release melatonin
246068|NCT01906866|Autism Spectrum Disorder|autism spectrum disorder
246069|NCT01906866|Smith-Magenis Syndrome|smith-magenis syndrome
246070|NCT01906866|Angelman Syndrome|angelman syndrome
246071|NCT01906866|tuberous sclerosis|tuberous sclerosis
246072|NCT01906853|BCG|bcg
246073|NCT01906853|Bacille Calmette Guérin|bacille calmette guérin
246074|NCT01906853|Allergy|allergy
246075|NCT01906853|Immunity|immunity
246076|NCT01906853|Immune response|immune response
246077|NCT01906853|Vaccine|vaccine
246078|NCT01906853|Infants|infants
246079|NCT01906853|Children|children
246080|NCT01906853|Infection|infection
246081|NCT01906840|Chronic renal failure|chronic renal failure
246082|NCT01906840|Hemodialysis|hemodialysis
246083|NCT01906840|Oxidative stress|oxidative stress
246084|NCT01906840|Turmeric|turmeric
246085|NCT01906827|cholestasis|cholestasis
246086|NCT01906827|pregnancy|pregnancy
246087|NCT01906827|p wave dispersion|p wave dispersion
246088|NCT01906827|arrhythmia|arrhythmia
246089|NCT01906801|Osteoarthritis|osteoarthritis
246090|NCT01906801|Glucosamine sulfate|glucosamine sulfate
246091|NCT01906801|Diacerein|diacerein
246092|NCT01906801|Randomized controlled trial|randomized controlled trial
246093|NCT01906775|ICD|icd
246094|NCT01906775|ventricular tachyarrhythmia|ventricular tachyarrhythmia
246095|NCT01906775|shock|shock
246096|NCT01906775|sub-threshold pacing|sub-threshold pacing
246097|NCT01906762|Morphine, Acetaminophen, Renal colic, Emergency treatment|morphine, acetaminophen, renal colic, emergency treatment
246098|NCT01906749|Acute coronary syndrome|acute coronary syndrome
246099|NCT01906749|Colchicine|colchicine
246100|NCT01906710|Adverse Drug Events|adverse drug events
246101|NCT01906710|Drug related problems|drug related problems
246102|NCT01906710|Medication Reconciliation|medication reconciliation
246103|NCT01906710|Medication review|medication review
246104|NCT01906710|discharge counseling|discharge counseling
246105|NCT01906710|Hospital Pharmacy based|hospital pharmacy based
246106|NCT01906710|integrated medicines management|integrated medicines management
246107|NCT01906710|patient safety|patient safety
246108|NCT01906684|Acthar Gel|acthar gel
246109|NCT01906684|MS relapse|ms relapse
246110|NCT01906684|7T MRI imaging|7t mri imaging
246111|NCT01906684|Quality of Life|quality of life
246112|NCT01906671|6-mercaptopurine|6-mercaptopurine
246113|NCT01906671|Drug formulation|drug formulation
246114|NCT01906658|H.P. Acthar Gel|h.p. acthar gel
246115|NCT01906658|Acthar|acthar
236910|NCT01949844|myocardial perfusion|myocardial perfusion
246116|NCT01906658|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
246118|NCT01906645|Patient Readmission|patient readmission
246119|NCT01906645|Continuity of Patient Care|continuity of patient care
246120|NCT01906619|Febrile Seizure|febrile seizure
246121|NCT01906619|Respiratory physiology|respiratory physiology
246122|NCT01906619|Respiratory drive|respiratory drive
246123|NCT01906619|Respiratory alkalosis|respiratory alkalosis
246124|NCT01906606|child nutritional status|child nutritional status
246125|NCT01906606|child development|child development
246126|NCT01906606|maternal depression|maternal depression
246127|NCT01906593|safety|safety
246128|NCT01906593|influenza vaccine|influenza vaccine
246129|NCT01906593|post-marketing|post-marketing
246130|NCT01906580|HBV|hbv
246131|NCT01906580|entecavir|entecavir
246132|NCT01906580|peginterferon|peginterferon
246133|NCT01906567|cadmium|cadmium
246134|NCT01906567|lead|lead
246135|NCT01906567|mercury|mercury
246136|NCT01906567|preeclampsia|preeclampsia
246137|NCT01906567|pregnancy|pregnancy
246138|NCT01906541|X-CGD|x-cgd
246139|NCT01906541|chronic granulomatous disease|chronic granulomatous disease
246140|NCT01906541|gene-therapy|gene-therapy
246141|NCT01906528|Nondepolarizing neuromuscular blocking drug|nondepolarizing neuromuscular blocking drug
246142|NCT01906528|Mivacurium|mivacurium
246143|NCT01906528|Sensitivity|sensitivity
246144|NCT01906528|Sex|sex
246145|NCT01906515|Anemia|anemia
246146|NCT01906515|Blood transfusion|blood transfusion
246147|NCT01906515|non invasive hemoglobin monitoring|non invasive hemoglobin monitoring
246148|NCT01906515|patient safety|patient safety
246149|NCT01906489|anemia|anemia
246150|NCT01906489|chronic kidney disease|chronic kidney disease
246151|NCT01906489|CKD|ckd
246152|NCT01906489|chronic renal insufficiency|chronic renal insufficiency
246153|NCT01906489|renal impairment|renal impairment
246154|NCT01906489|erythropoietin|erythropoietin
246155|NCT01906489|kidney|kidney
246156|NCT01906489|oral anemia treatment|oral anemia treatment
246157|NCT01906489|hemoglobin|hemoglobin
246158|NCT01906489|hypoxia-inducible factor|hypoxia-inducible factor
246159|NCT01906489|HIF|hif
246160|NCT01906489|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
246161|NCT01906489|HIF-PHI|hif-phi
246162|NCT01906489|efficacy|efficacy
246163|NCT01906489|safety|safety
246164|NCT01906489|pharmacokinetics|pharmacokinetics
246165|NCT01906476|Depression|depression
246166|NCT01906476|Telephone Cognitive Behavior Therapy|telephone cognitive behavior therapy
246167|NCT01906476|Internet Cognitive Behavioral Therapy|internet cognitive behavioral therapy
246168|NCT01906437|Cardiac fibrosis and Lymphoma|cardiac fibrosis and lymphoma
246169|NCT01906424|spinal cord injury|spinal cord injury
246170|NCT01906424|quadriplegia|quadriplegia
246171|NCT01906424|tetraplegia|tetraplegia
246172|NCT01906424|stimulation|stimulation
246173|NCT01906398|Refractory epilepsy|refractory epilepsy
246174|NCT01906398|ketogenic diet|ketogenic diet
246175|NCT01906398|efficacy|efficacy
246176|NCT01906385|Glioblastoma|glioblastoma
246177|NCT01906385|Astrocytoma|astrocytoma
246178|NCT01906385|Brain Tumor|brain tumor
246179|NCT01906385|Radiotherapy|radiotherapy
246180|NCT01906372|dermatomyositis|dermatomyositis
246181|NCT01906372|polymyositis|polymyositis
246182|NCT01906359|Interesterified fat|interesterified fat
246183|NCT01906359|Stereospecific number 2|stereospecific number 2
246184|NCT01906359|Gut hormones|gut hormones
246185|NCT01906359|GIP|gip
246186|NCT01906359|Insulin sensitivity|insulin sensitivity
246187|NCT01906359|Postprandial lipaemia|postprandial lipaemia
246188|NCT01906359|Haemostatic markers|haemostatic markers
246189|NCT01906333|Exercise|exercise
246190|NCT01906333|Ectopic fat accumulation|ectopic fat accumulation
246191|NCT01906320|anorexia nervosa|anorexia nervosa
246192|NCT01906320|restricting type|restricting type
246193|NCT01906320|muscle strength|muscle strength
246194|NCT01906320|exercise|exercise
246195|NCT01906320|body composition|body composition
246196|NCT01906320|physical activity|physical activity
246197|NCT01906307|hepatorenal syndrome|hepatorenal syndrome
246198|NCT01906294|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
246204|NCT01906268|Panic Disorder|panic disorder
246205|NCT01906268|Antidepressants Resistant|antidepressants resistant
246206|NCT01906268|Attentional Bias Modification Treatment (ABMT)|attentional bias modification treatment (abmt)
246207|NCT01906268|Attentional Retraining|attentional retraining
246208|NCT01906268|Adjuvant Therapy|adjuvant therapy
246216|NCT01906216|Hepatocellular carcinoma|hepatocellular carcinoma
246217|NCT01906216|sorafenib|sorafenib
246218|NCT01906216|transarterial chemoembolization|transarterial chemoembolization
246219|NCT01906203|Ultramarathon|ultramarathon
246220|NCT01906203|bioelectrical impedance|bioelectrical impedance
246221|NCT01906203|Phase-Angle|phase-angle
246222|NCT01906190|influenza vaccine|influenza vaccine
246223|NCT01906190|immune response|immune response
246224|NCT01906190|persistence|persistence
246225|NCT01906164|RSV|rsv
246226|NCT01906125|Bioequivalence|bioequivalence
246227|NCT01906125|Cmax|cmax
246228|NCT01906125|AUC|auc
246229|NCT01906073|fentanyl|fentanyl
246230|NCT01906073|administration, intranasal|administration, intranasal
246232|NCT01906073|patient satisfaction|patient satisfaction
246233|NCT01906073|patient preference|patient preference
246234|NCT01906047|Non-cystic fibrosis bronchiectasis|non-cystic fibrosis bronchiectasis
246235|NCT01906021|Thermomap|thermomap
246236|NCT01906021|Hepatic Lesions|hepatic lesions
246237|NCT01906021|Radiofrequency Ablation|radiofrequency ablation
246238|NCT01906021|Microwave|microwave
246239|NCT01906021|Non-Invasive Technique|non-invasive technique
246240|NCT01906008|Colorectal cancer|colorectal cancer
246241|NCT01906008|CRC|crc
246242|NCT01906008|Acute peripheral neuropathy|acute peripheral neuropathy
246243|NCT01906008|Numbness|numbness
246244|NCT01906008|Pain|pain
246245|NCT01906008|Loss of motor function|loss of motor function
246246|NCT01906008|Minocycline|minocycline
246247|NCT01906008|Dynacin|dynacin
246248|NCT01906008|Minocin|minocin
246249|NCT01906008|Minocin PAC|minocin pac
246250|NCT01906008|Myrac|myrac
246251|NCT01906008|Solodyn|solodyn
246252|NCT01906008|Placebo|placebo
246253|NCT01906008|Questionnaires|questionnaires
246254|NCT01906008|Surveys|surveys
246255|NCT01906008|Sensory tests|sensory tests
246256|NCT01905995|deep brain sitimulation|deep brain sitimulation
246257|NCT01905995|local field potentials|local field potentials
246258|NCT01905969|Gastric caner, adjuvant chemotherapy|gastric caner, adjuvant chemotherapy
246259|NCT01905917|Stroke|stroke
246260|NCT01905904|electroconvulsive therapy|electroconvulsive therapy
246261|NCT01905904|seizures|seizures
246262|NCT01905904|sevoflurane|sevoflurane
246263|NCT01905891|Non melanoma skin cancer|non melanoma skin cancer
246264|NCT01905891|Field of cancerization|field of cancerization
246265|NCT01905891|Skin carcinogenesis|skin carcinogenesis
246266|NCT01905865|Uncertainty|uncertainty
246267|NCT01905865|Undiagnosed Disease|undiagnosed disease
246268|NCT01905865|Coping|coping
246269|NCT01905852|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
246270|NCT01905852|Ejection Fraction|ejection fraction
246271|NCT01905852|Fractional Flow Reserve|fractional flow reserve
246272|NCT01905852|Myocardial Fibrosis|myocardial fibrosis
246273|NCT01905839|Rigidity|rigidity
246274|NCT01905839|Assessment|assessment
246275|NCT01905839|Parkinson's Disease|parkinson's disease
246276|NCT01905839|Physiological Measures|physiological measures
246277|NCT01905826|Hematopoiesis|hematopoiesis
246278|NCT01905826|Immunodeficiency|immunodeficiency
246279|NCT01905826|Myelodysplasia/Leukemia|myelodysplasia/leukemia
246280|NCT01905826|Lymphedema|lymphedema
246281|NCT01905826|Pulmonary Alveolar Proteinosis|pulmonary alveolar proteinosis
246282|NCT01905800|Vertigo and dizziness.|vertigo and dizziness.
246283|NCT01905800|semicircular canals|semicircular canals
246284|NCT01905774|Renal Function|renal function
246285|NCT01905761|obesity|obesity
246286|NCT01905748|Coagulation|coagulation
246287|NCT01905735|RA|ra
246288|NCT01905722|MRI|mri
246289|NCT01905722|metabolism|metabolism
246290|NCT01905722|healthy|healthy
246291|NCT01905722|7 Tesla|7 tesla
246292|NCT01905709|C diff|c diff
246293|NCT01905709|CDI|cdi
246294|NCT01905709|clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
246295|NCT01905670|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
246296|NCT01905670|cardiac pacing|cardiac pacing
246297|NCT01905670|electrical stimulation|electrical stimulation
246298|NCT01905670|bi-ventricular pacing|bi-ventricular pacing
246299|NCT01905657|PD1|pd1
246300|NCT01905657|PD-1|pd-1
246301|NCT01905657|PDL1|pdl1
246302|NCT01905657|PD-L1|pd-l1
246303|NCT01905644|Vaginal delivery|vaginal delivery
246304|NCT01905644|Perineal lesions|perineal lesions
246305|NCT01905644|Anal sphincter rupture|anal sphincter rupture
246306|NCT01905644|Ultrasound|ultrasound
246307|NCT01905618|Medical Education|medical education
246308|NCT01905618|Tobacco Dependence Treatment|tobacco dependence treatment
246309|NCT01905618|Physician Delivered Intervention|physician delivered intervention
246310|NCT01905592|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|human epidermal growth factor 2 negative carcinoma of breast
246311|NCT01905592|BRCA1 Gene Mutation|brca1 gene mutation
246312|NCT01905592|BRCA2 Gene Mutation|brca2 gene mutation
246313|NCT01905592|Parp Inhibitor|parp inhibitor
246314|NCT01905592|BRCA|brca
246315|NCT01905579|flaremetry|flaremetry
246316|NCT01905579|aqueous proteins|aqueous proteins
246317|NCT01905579|clinical grading|clinical grading
246318|NCT01905579|Compare flaremetry readings with the protein content of the aqueous|compare flaremetry readings with the protein content of the aqueous
246319|NCT01905579|Compare flaremetry readings with clinical grading of flare|compare flaremetry readings with clinical grading of flare
246320|NCT01905566|Plaque, Atherosclerotic|plaque, atherosclerotic
246321|NCT01905566|clopidogrel|clopidogrel
246322|NCT01905566|ticagrelor|ticagrelor
246323|NCT01905566|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
246324|NCT01905566|Positron-Emission Tomography and Computed Tomography|positron-emission tomography and computed tomography
246325|NCT01905527|Multiple Sclerosis|multiple sclerosis
246326|NCT01905527|Relapsing-Remitting|relapsing-remitting
246327|NCT01905527|Rebif|rebif
246328|NCT01905527|Quintiles Geographic Area Group|quintiles geographic area group
246329|NCT01905527|Standard Subgroup|standard subgroup
246330|NCT01905527|Custom Subgroup|custom subgroup
246331|NCT01905527|RxCrossroads Geographic Area Group|rxcrossroads geographic area group
246332|NCT01905501|Balanced anesthesia|balanced anesthesia
246333|NCT01905501|Inhalation anesthesia|inhalation anesthesia
246334|NCT01905501|Reperfusion injury|reperfusion injury
246335|NCT01905501|Microsurgical Free flap|microsurgical free flap
246336|NCT01905475|STEMI|stemi
246338|NCT01905475|repair|repair
246339|NCT01905462|Cervarix|cervarix
246340|NCT01905462|Spontaneous abortion|spontaneous abortion
246341|NCT01905462|Vaccine|vaccine
246342|NCT01905462|Human Papillomavirus|human papillomavirus
246343|NCT01905436|Filariasis|filariasis
246344|NCT01905436|Onchocerciasis|onchocerciasis
246345|NCT01905436|Albendazole|albendazole
246346|NCT01905436|Ivermectin|ivermectin
751912|NCT01171183|cocaine withdrawal|cocaine withdrawal
246352|NCT01905423|STH Soil Transmitted Helminths|sth soil transmitted helminths
246353|NCT01905423|MDA Mass Drug Administration|mda mass drug administration
246354|NCT01905384|pancreatic cancer|pancreatic cancer
246355|NCT01905384|cholangiocarcinoma|cholangiocarcinoma
246356|NCT01905384|metastatic malignancy|metastatic malignancy
246357|NCT01905384|jaundice|jaundice
246358|NCT01905371|amphetamine|amphetamine
246359|NCT01905371|stroke recovery|stroke recovery
246360|NCT01905319|juvenile idiopathic arthritis|juvenile idiopathic arthritis
246361|NCT01905319|incidence rate|incidence rate
246362|NCT01905306|dental implants|dental implants
246363|NCT01905306|immediate loading|immediate loading
246364|NCT01905306|full-arch|full-arch
246365|NCT01905306|computer guided implant surgery|computer guided implant surgery
246366|NCT01905280|allograft|allograft
246367|NCT01905280|acellular dermal matrix|acellular dermal matrix
246368|NCT01905280|alveolar ridge|alveolar ridge
246369|NCT01905267|mindfulness|mindfulness
246370|NCT01905267|relapse prevention|relapse prevention
246371|NCT01905267|recovery|recovery
246372|NCT01905267|depression|depression
246373|NCT01905267|adolescents|adolescents
246374|NCT01905254|Transient elastography|transient elastography
246375|NCT01905254|mini-laparoscopy|mini-laparoscopy
246376|NCT01905254|liver biopsy|liver biopsy
246377|NCT01905254|liver cirrhosis|liver cirrhosis
246378|NCT01905254|autoimmune hepatitis|autoimmune hepatitis
246379|NCT01905228|Metastatic Advance Solid Neoplasms|metastatic advance solid neoplasms
246380|NCT01905228|Unresectable Advance Solid Neoplasms|unresectable advance solid neoplasms
246381|NCT01905215|Immunogenicity|immunogenicity
246382|NCT01905215|Respiratory Syncytial Virus|respiratory syncytial virus
246383|NCT01905215|Reactogenicity|reactogenicity
246384|NCT01905215|Vaccination|vaccination
246385|NCT01905215|Safety|safety
246386|NCT01905202|Proton Pump Inhibitor|proton pump inhibitor
246387|NCT01905202|Safety|safety
246388|NCT01905202|Tolerability|tolerability
246389|NCT01905202|pH control|ph control
246390|NCT01905202|Bile Acid|bile acid
246391|NCT01905189|pulmonary arterial hypertension|pulmonary arterial hypertension
246392|NCT01905189|cardiac resynchronization therapy|cardiac resynchronization therapy
246393|NCT01905176|Heart Failure|heart failure
246394|NCT01905176|Randomized Control Trial|randomized control trial
246395|NCT01905176|Disease management|disease management
246396|NCT01905176|Self-care|self-care
246397|NCT01905176|Nursing|nursing
246398|NCT01905176|Patient education as topic|patient education as topic
246399|NCT01905163|Laparoscopy, interval debulking surgery|laparoscopy, interval debulking surgery
246400|NCT01905150|pancreatic Cancer|pancreatic cancer
246401|NCT01905150|G-FLIP, Gemcitabine 5FU Leucovorin Irinotecan Oxaliplatin|g-flip, gemcitabine 5fu leucovorin irinotecan oxaliplatin
246402|NCT01905150|G-FLIP-DM (G-FLIP + Low doses Docetaxel and Mitomycin C)|g-flip-dm (g-flip + low doses docetaxel and mitomycin c)
246403|NCT01905150|Vitamin C (ascorbic acid)|vitamin c (ascorbic acid)
246404|NCT01905137|Myofascial pelvic pain|myofascial pelvic pain
246405|NCT01905124|Uveitis|uveitis
246406|NCT01905124|Intermediate uveitis|intermediate uveitis
246407|NCT01905124|Posterior uveitis|posterior uveitis
246408|NCT01905098|Detoxification|detoxification
246409|NCT01905098|Sauna|sauna
246410|NCT01905098|Hyperthermia|hyperthermia
246411|NCT01905072|Obesity|obesity
246412|NCT01905072|Breastfeeding|breastfeeding
246413|NCT01905072|Educational Intervention|educational intervention
246414|NCT01905059|HIV infection|hiv infection
246415|NCT01905059|second line ART|second line art
246416|NCT01905059|maintenance strategies|maintenance strategies
246417|NCT01905059|Protease inhibitors|protease inhibitors
246418|NCT01905059|mono or bi-therapy|mono or bi-therapy
246419|NCT01905033|Sepsis|sepsis
246420|NCT01905033|Pneumonia|pneumonia
246421|NCT01905033|Peritonitis|peritonitis
246422|NCT01905033|Biomarkers|biomarkers
246423|NCT01905033|Transcriptomics|transcriptomics
303751|NCT01646749|Satiety|satiety
246424|NCT01905033|Pathogen detection|pathogen detection
246425|NCT01905020|Type 1 diabetes|type 1 diabetes
246426|NCT01905020|Hypoglycemia|hypoglycemia
246427|NCT01905020|Insulin|insulin
246428|NCT01905020|Glucagon|glucagon
246429|NCT01905020|Closed-loop system|closed-loop system
246430|NCT01905020|Artificial pancreas|artificial pancreas
246431|NCT01905007|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
246432|NCT01905007|Defibrillation threshold testing|defibrillation threshold testing
246433|NCT01904994|HIV (Human Immunodeficiency Virus)|hiv (human immunodeficiency virus)
246434|NCT01904994|ART (antiretroviral therapy)|art (antiretroviral therapy)
246435|NCT01904994|financial incentive|financial incentive
246437|NCT01904994|retention|retention
246438|NCT01904994|SMS (Short Message Service) appointment reminder|sms (short message service) appointment reminder
246439|NCT01904994|accelerated ART|accelerated art
246440|NCT01904994|CD4+ count|cd4+ count
246441|NCT01904903|Breast Cancer HER2 Positive|breast cancer her2 positive
246442|NCT01904903|Cardiac Safety|cardiac safety
246443|NCT01904890|Asian Americans|asian americans
246444|NCT01904890|colorectal cancer screening|colorectal cancer screening
246445|NCT01904890|cancer prevention|cancer prevention
246446|NCT01904890|Filipinos Americans|filipinos americans
246447|NCT01904890|Hmong Americans|hmong americans
246448|NCT01904890|Korean Americans|korean americans
246449|NCT01904890|Randomized Controlled Trials|randomized controlled trials
246450|NCT01904877|HIV testing|hiv testing
246451|NCT01904877|linkage|linkage
246452|NCT01904877|care|care
246453|NCT01904864|randomized controlled trial|randomized controlled trial
246454|NCT01904864|iron medication|iron medication
246455|NCT01904864|Anemia|anemia
246456|NCT01904864|Hematologic Disease|hematologic disease
246457|NCT01904864|Anemia, Iron deficiency|anemia, iron deficiency
246458|NCT01904864|anemia, nutritional|anemia, nutritional
246459|NCT01904864|ferrous sulfate|ferrous sulfate
246460|NCT01904864|NovaFerrum®|novaferrum®
246461|NCT01904851|Peripheral Arterial Disease|peripheral arterial disease
246462|NCT01904851|Stents|stents
246463|NCT01904851|Registry|registry
246464|NCT01904851|Angioplasty|angioplasty
246465|NCT01904851|Endovascular Procedures|endovascular procedures
246466|NCT01904786|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
246467|NCT01904786|Newborn|newborn
246468|NCT01904786|Outcomes|outcomes
246469|NCT01904786|Melatonin|melatonin
246470|NCT01904773|Combined Multiple Motor and Vocal Tic Disorder; Tourette Disorder; Gilles de la Tourette Syndrome; Tourette Disease|combined multiple motor and vocal tic disorder; tourette disorder; gilles de la tourette syndrome; tourette disease
246471|NCT01904760|agitation|agitation
246472|NCT01904760|delirium|delirium
246473|NCT01904760|dexmedetomidine|dexmedetomidine
246474|NCT01904760|head and neck surgery|head and neck surgery
246475|NCT01904760|microvascular free tissue transfer|microvascular free tissue transfer
246476|NCT01904760|flap|flap
246477|NCT01904747|Food|food
246478|NCT01904747|Bioavailability|bioavailability
246479|NCT01904747|Fasted|fasted
246480|NCT01904747|Fed|fed
246481|NCT01904734|testosterone|testosterone
246482|NCT01904734|hypogonadism|hypogonadism
246483|NCT01904734|pituitary|pituitary
246484|NCT01904708|Phenylketonuria|phenylketonuria
246485|NCT01904708|PKU|pku
246486|NCT01904708|Exercise|exercise
246487|NCT01904708|Muscle Protein Synthesis|muscle protein synthesis
246488|NCT01904708|Plasma Phenylalanine concentration|plasma phenylalanine concentration
246489|NCT01904695|resistant hypertension|resistant hypertension
246490|NCT01904695|causal inference|causal inference
246491|NCT01904695|a chorot study|a chorot study
246492|NCT01904695|recipe of removing both phlegm and blood stasis|recipe of removing both phlegm and blood stasis
246493|NCT01904682|Erythrocyte transfusion|erythrocyte transfusion
246494|NCT01904682|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
246495|NCT01904682|International Prognostic Scoring System|international prognostic scoring system
246496|NCT01904669|Fertility|fertility
246497|NCT01904669|Infertility|infertility
246498|NCT01904669|Pregnancy|pregnancy
246499|NCT01904669|Conception|conception
246500|NCT01904669|Behavioral|behavioral
246501|NCT01904669|Lifestyle|lifestyle
246502|NCT01904669|Preconception Care|preconception care
246503|NCT01904669|Women's Health|women's health
246504|NCT01904669|Abortion, Spontaneous|abortion, spontaneous
246505|NCT01904669|Cohort Studies|cohort studies
246506|NCT01904669|Epidemiology|epidemiology
246507|NCT01904669|Internet|internet
246508|NCT01904656|Colorectal Cancer Screening|colorectal cancer screening
246509|NCT01904656|Ohio Appalachia|ohio appalachia
246510|NCT01904630|gene sequencing|gene sequencing
246511|NCT01904630|familial|familial
246512|NCT01904630|risk factors|risk factors
246513|NCT01904617|Length of labor|length of labor
246514|NCT01904617|second stage of labor|second stage of labor
246515|NCT01904617|intravenous hydration of labor|intravenous hydration of labor
246516|NCT01904617|intravenous glucose|intravenous glucose
246517|NCT01904604|Peanut Allergy|peanut allergy
246518|NCT01904604|Food Allergy|food allergy
246519|NCT01904604|Viaskin peanut patch|viaskin peanut patch
246520|NCT01904604|Allergen Immunotherapy|allergen immunotherapy
246521|NCT01904604|Epicutaneous Immunotherapy|epicutaneous immunotherapy
246522|NCT01904604|Whole peanut extract|whole peanut extract
246523|NCT01904604|Allergenic product|allergenic product
246524|NCT01904604|Immediate hypersensitivity|immediate hypersensitivity
246525|NCT01904591|Spinal Cord Injury|spinal cord injury
246526|NCT01904591|Antioxidants|antioxidants
246527|NCT01904591|tractography|tractography
246528|NCT01904591|ASIA assessment|asia assessment
246529|NCT01904578|Menopause|menopause
246530|NCT01904578|Sleep quality|sleep quality
246531|NCT01904578|Acupressure|acupressure
246532|NCT01904565|Hyperthermia,|hyperthermia,
246337|NCT01905475|AMI|ami
246533|NCT01904565|Proton beam therapy|proton beam therapy
246534|NCT01904565|Soft Tissue Sarcoma|soft tissue sarcoma
246535|NCT01904565|Radiotherapy|radiotherapy
246536|NCT01904565|Phase I/II trial|phase i/ii trial
246537|NCT01904552|Apical periodontitis|apical periodontitis
246538|NCT01904552|Dentaport ZX|dentaport zx
246539|NCT01904552|electronic apex locators|electronic apex locators
246541|NCT01904552|Raypex 5|raypex 5
246542|NCT01904552|working length|working length
246543|NCT01904526|Guanfacine|guanfacine
246544|NCT01904526|PK/PD|pk/pd
246545|NCT01904526|Smokers|smokers
246546|NCT01904513|Metals|metals
246547|NCT01904513|Pesticides|pesticides
246548|NCT01904513|Toxicity|toxicity
246549|NCT01904500|Cesarean delivery|cesarean delivery
246550|NCT01904474|obesity|obesity
246551|NCT01904474|overweight|overweight
246552|NCT01904474|technology|technology
246553|NCT01904474|internet|internet
246554|NCT01904474|intervention|intervention
246555|NCT01904474|adolescents|adolescents
246556|NCT01904461|tonsillectomy|tonsillectomy
246557|NCT01904461|children|children
246558|NCT01904461|vacuum|vacuum
246559|NCT01904461|medical device|medical device
246560|NCT01904461|pain|pain
246561|NCT01904461|hemorrhage|hemorrhage
246562|NCT01904461|post-surgical complications|post-surgical complications
246563|NCT01904448|pediatric|pediatric
246564|NCT01904448|profound hearing loss|profound hearing loss
246565|NCT01904448|auditory brainstem implant|auditory brainstem implant
246566|NCT01904448|cochlear implant|cochlear implant
246567|NCT01904448|developmental or acquired cochlear nerve deficiency (CND)|developmental or acquired cochlear nerve deficiency (cnd)
246568|NCT01904448|cochlear aplasia (Michel)|cochlear aplasia (michel)
246569|NCT01904448|post-meningitis cochlear ossification|post-meningitis cochlear ossification
246570|NCT01904448|cochlear malformation|cochlear malformation
246571|NCT01904448|CND|cnd
246572|NCT01904422|Diabetes mellitus.|diabetes mellitus.
246573|NCT01904422|Periodontitis|periodontitis
246574|NCT01904422|Periodontal treatment.|periodontal treatment.
246575|NCT01904357|Cefazolin, Pediatric|cefazolin, pediatric
246576|NCT01904344|Sleep|sleep
246577|NCT01904344|Sleep- related breathing disorders|sleep- related breathing disorders
246578|NCT01904344|Respiratory pathology|respiratory pathology
246579|NCT01904331|Cardiotoxicity|cardiotoxicity
246580|NCT01904331|long-term effects|long-term effects
246581|NCT01904331|chemotherapy|chemotherapy
246582|NCT01904331|radiotherapy|radiotherapy
246583|NCT01904318|male|male
246584|NCT01904318|Phase I|phase i
246585|NCT01904318|A dose block-randomized|a dose block-randomized
246586|NCT01904318|Double-blinded|double-blinded
246587|NCT01904318|Placebo controlled|placebo controlled
246588|NCT01904318|Single Dose|single dose
246589|NCT01904318|dose Escalation|dose escalation
246590|NCT01904318|IDP-73152 mesylate|idp-73152 mesylate
246591|NCT01904318|Food Effect|food effect
246592|NCT01904318|Pharmacokinetics|pharmacokinetics
246593|NCT01904318|health male volunteer|health male volunteer
246597|NCT01904240|Parkinson's disease|parkinson's disease
246598|NCT01904240|GI tract|gi tract
246599|NCT01904240|Lipopolysaccharide binding protein|lipopolysaccharide binding protein
246600|NCT01904227|Borderline Personality Disorder|borderline personality disorder
246601|NCT01904227|Dialectical Behavior Therapy|dialectical behavior therapy
246602|NCT01904214|renal impairement|renal impairement
246603|NCT01904214|pharmacokinetics|pharmacokinetics
246604|NCT01904201|Immune function|immune function
246605|NCT01904201|Interferon-gamma release assays|interferon-gamma release assays
690208|NCT00921492|Ovulation|ovulation
246606|NCT01904201|Active HIV cell Reservoirs|active hiv cell reservoirs
246612|NCT01904175|Stem cell transplantation, non-myeloablative|stem cell transplantation, non-myeloablative
246613|NCT01904149|Moderate to severe acute pain|moderate to severe acute pain
246614|NCT01904149|Postoperative pain|postoperative pain
246615|NCT01904149|Abdominal hysterectomy|abdominal hysterectomy
246616|NCT01904149|Analgesics|analgesics
246617|NCT01904149|Dexketoprofen|dexketoprofen
246618|NCT01904149|Tramadol|tramadol
246619|NCT01904136|Leukemia|leukemia
246620|NCT01904136|Myeloproliferative Diseases|myeloproliferative diseases
246621|NCT01904136|Blood And Marrow Transplantation|blood and marrow transplantation
246622|NCT01904136|High Risk Myeloid Malignancies|high risk myeloid malignancies
246623|NCT01904136|Acute myeloid leukemia|acute myeloid leukemia
246625|NCT01904136|Myelodysplastic syndrome|myelodysplastic syndrome
246627|NCT01904136|Chronic myeloid leukemia|chronic myeloid leukemia
246628|NCT01904136|CML|cml
246629|NCT01904136|Haploidentical Stem-cell Transplantation|haploidentical stem-cell transplantation
246630|NCT01904136|HaploSCT|haplosct
246631|NCT01904136|Expanded natural killer cells|expanded natural killer cells
246632|NCT01904136|NK|nk
246633|NCT01904136|Melphalan|melphalan
246634|NCT01904136|Alkeran|alkeran
246635|NCT01904136|Mesna|mesna
246636|NCT01904136|Mesnex|mesnex
246825|NCT01903421|Dementia|dementia
246637|NCT01904136|Cyclophosphamide|cyclophosphamide
246638|NCT01904136|Cytoxan|cytoxan
246639|NCT01904136|Neosar|neosar
246640|NCT01904136|Tacrolimus|tacrolimus
246641|NCT01904136|Prograf|prograf
751913|NCT01171196|Sleep Apnea|sleep apnea
246642|NCT01904136|Mycophenolate mofetil|mycophenolate mofetil
246644|NCT01904136|CellCept|cellcept
246645|NCT01904136|G-CSF|g-csf
246646|NCT01904136|Filgrastim|filgrastim
246647|NCT01904136|Neupogen|neupogen
246648|NCT01904136|Fludarabine|fludarabine
246649|NCT01904136|Fludarabine phosphate|fludarabine phosphate
246650|NCT01904136|Fludara|fludara
246651|NCT01904123|Brain cancer|brain cancer
246652|NCT01904123|Central nervous system neoplasms|central nervous system neoplasms
246653|NCT01904123|CNS|cns
246654|NCT01904123|Melanoma|melanoma
246655|NCT01904123|Glioblastoma Multiforme|glioblastoma multiforme
246656|NCT01904123|GBM|gbm
246657|NCT01904123|Solid tumors|solid tumors
246658|NCT01904123|Metastatic to the brain|metastatic to the brain
246659|NCT01904123|WP1066|wp1066
246660|NCT01904123|Recurrent malignant glioma|recurrent malignant glioma
246661|NCT01904123|Glioblastoma|glioblastoma
246662|NCT01904123|Anaplastic glioma|anaplastic glioma
246663|NCT01904123|Advanced Brain Tumor Imaging|advanced brain tumor imaging
246664|NCT01904123|ABTI|abti
246665|NCT01904110|Risedronate,cholecalciferol,BMD,montly,weekly,compliance|risedronate,cholecalciferol,bmd,montly,weekly,compliance
246666|NCT01904097|Fibromyalgia|fibromyalgia
246667|NCT01904097|Transcranial Direct Current Stimulation|transcranial direct current stimulation
246668|NCT01904097|tDCS|tdcs
246669|NCT01904097|Pregabalin|pregabalin
246670|NCT01904097|Functional Neuroimaging|functional neuroimaging
246671|NCT01904097|Near Infrared Spectroscopy|near infrared spectroscopy
246672|NCT01904097|NIRS|nirs
246673|NCT01904097|Chronic Pain|chronic pain
246674|NCT01904097|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
246675|NCT01904097|TMS|tms
246676|NCT01904084|Distal radius fracture|distal radius fracture
246677|NCT01904071|Hip Fracture|hip fracture
246678|NCT01904071|Ultrasound|ultrasound
246679|NCT01904071|Nerve Block|nerve block
246680|NCT01904058|PBC|pbc
246681|NCT01904032|Vitamin D|vitamin d
246682|NCT01904032|Diabetes|diabetes
246683|NCT01904032|Self-Management|self-management
246684|NCT01904032|Depression|depression
246685|NCT01904032|Women|women
246686|NCT01904019|arthroplasty|arthroplasty
246687|NCT01904019|trapezio-metacarpial|trapezio-metacarpial
246688|NCT01904006|grouped embryo culture|grouped embryo culture
246689|NCT01904006|embryo density|embryo density
246690|NCT01904006|low oxygen|low oxygen
246691|NCT01904006|benchtop incubator|benchtop incubator
246692|NCT01904006|culture condition|culture condition
246693|NCT01903980|Epipericardial Fat Necrosis|epipericardial fat necrosis
246694|NCT01903980|Fat Necrosis|fat necrosis
246695|NCT01903980|Chest Pain|chest pain
246696|NCT01903980|Pericardial Necrosis|pericardial necrosis
246697|NCT01903980|Pleuritic pain|pleuritic pain
246698|NCT01903967|Pituitary|pituitary
246699|NCT01903967|CGH array|cgh array
246700|NCT01903967|Tumor|tumor
246701|NCT01903941|exercise|exercise
246702|NCT01903928|cytomegalovirus|cytomegalovirus
246703|NCT01903928|DNA vaccine|dna vaccine
246704|NCT01903928|transplantation|transplantation
246705|NCT01903928|HCT|hct
246706|NCT01903902|Coronary artery disease|coronary artery disease
246707|NCT01903902|Balloon angioplasty|balloon angioplasty
246708|NCT01903902|Drug-eluting balloon|drug-eluting balloon
246709|NCT01903889|AE adverse event|ae adverse event
246710|NCT01903889|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
246711|NCT01903889|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
246712|NCT01903889|ART antiretroviral therapy|art antiretroviral therapy
246713|NCT01903889|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
246714|NCT01903889|DCF data collection forms|dcf data collection forms
246715|NCT01903889|DMC Data Monitoring Committee|dmc data monitoring committee
246716|NCT01903889|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
246717|NCT01903889|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
246718|NCT01903889|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
246719|NCT01903889|ICH International Conference of Harmonization|ich international conference of harmonization
246720|NCT01903889|IND Investigational New Drug Application|ind investigational new drug application
246721|NCT01903889|IRB Institutional Review Board|irb institutional review board
246722|NCT01903889|IU International units|iu international units
246723|NCT01903889|mg milligram(s)|mg milligram(s)
246724|NCT01903889|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
246725|NCT01903889|PCR polymerase chain reaction|pcr polymerase chain reaction
246726|NCT01903889|SAE serious adverse event|sae serious adverse event
246727|NCT01903889|µg microgram|µg microgram
246728|NCT01903889|ULN upper limit of the normal range|uln upper limit of the normal range
246729|NCT01903889|WB Western Blot|wb western blot
246730|NCT01903889|ANC Antenatal care|anc antenatal care
246731|NCT01903889|ARV Antiretroviral|arv antiretroviral
246732|NCT01903889|C&T Care and treatment|c&t care and treatment
246826|NCT01903421|Elderly|elderly
246733|NCT01903889|CPR Contraceptive prevalence rate|cpr contraceptive prevalence rate
246734|NCT01903889|DHS Demographic and Health Survey|dhs demographic and health survey
5859|NCT03253861|Acute necrotizing pancreatitis|acute necrotizing pancreatitis
246739|NCT01903889|IUCD Intrauterine contraceptive device|iucd intrauterine contraceptive device
246740|NCT01903889|MCH Maternal/child health|mch maternal/child health
246741|NCT01903889|PDA Personal digital assistant|pda personal digital assistant
246742|NCT01903889|PEPFAR President's Emergency Plan for AIDS Relief|pepfar president's emergency plan for aids relief
246743|NCT01903889|PHSC Protection of Human Subjects Committee|phsc protection of human subjects committee
246744|NCT01903889|PMTCT Prevention of maternal to child transmission|pmtct prevention of maternal to child transmission
246745|NCT01903889|STAR-SW Strengthening TB and HIV/AIDS Response in the South Western Region of Uganda|star-sw strengthening tb and hiv/aids response in the south western region of uganda
246746|NCT01903889|STI Sexually transmitted infection|sti sexually transmitted infection
246747|NCT01903889|TM Technical monitor|tm technical monitor
246748|NCT01903889|USAID United States Agency for International Development|usaid united states agency for international development
246749|NCT01903889|WHO World Health Organization|who world health organization
246751|NCT01903863|fresh frozen plasma|fresh frozen plasma
246752|NCT01903863|ECMO|ecmo
246753|NCT01903863|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
246754|NCT01903863|anticoagulation|anticoagulation
246755|NCT01903863|transfusion|transfusion
246756|NCT01903850|Benign central airway obstruction|benign central airway obstruction
246757|NCT01903850|Malignant central airway obstruction|malignant central airway obstruction
246758|NCT01903850|Spray cryotherapy|spray cryotherapy
246759|NCT01903850|Endoluminal tumors|endoluminal tumors
246760|NCT01903850|Airway granulation tissue|airway granulation tissue
246761|NCT01903837|Schizophrenia|schizophrenia
246762|NCT01903837|Olanzapine|olanzapine
246763|NCT01903837|Samidorphan|samidorphan
246764|NCT01903837|Alkermes|alkermes
246765|NCT01903824|Irdabisant|irdabisant
246766|NCT01903824|cognitive impairment|cognitive impairment
246767|NCT01903811|carfilzomib|carfilzomib
246768|NCT01903811|relapsed|relapsed
246769|NCT01903811|refractory|refractory
246770|NCT01903811|multiple myeloma|multiple myeloma
246771|NCT01903785|exercise-induced bronchoconstriction (EIB)|exercise-induced bronchoconstriction (eib)
246772|NCT01903785|inhaled salbutamol|inhaled salbutamol
246773|NCT01903785|performance enhancing|performance enhancing
246774|NCT01903785|cycling|cycling
246775|NCT01903733|Subjects|subjects
246971|NCT01902771|Lysate|lysate
246776|NCT01903733|Chronic Myeloid Leukemia|chronic myeloid leukemia
246778|NCT01903733|Bosutinib|bosutinib
246779|NCT01903733|Extension|extension
246780|NCT01903707|Schizophrenia|schizophrenia
246781|NCT01903707|Psychosis|psychosis
246782|NCT01903707|Cognitive deficits|cognitive deficits
246783|NCT01903681|Sleep problems, autism spectrum disorder, prolonged-release melatonin, Circadin, endogenous saliva melatonin|sleep problems, autism spectrum disorder, prolonged-release melatonin, circadin, endogenous saliva melatonin
246784|NCT01903681|Smith-Magenis syndrome, Angelman syndrome, Tuberous Sclerosis|smith-magenis syndrome, angelman syndrome, tuberous sclerosis
246785|NCT01903603|cerebral palsy|cerebral palsy
246786|NCT01903603|multi-modal brain techniques|multi-modal brain techniques
246787|NCT01903603|MRI|mri
246788|NCT01903603|Kinematic|kinematic
246789|NCT01903603|motor control|motor control
246790|NCT01903590|TVT,TOT,Randomized|tvt,tot,randomized
246791|NCT01903577|Ergonomics|ergonomics
246792|NCT01903577|Robotic Surgery|robotic surgery
246793|NCT01903577|Laparoscopic Surgery|laparoscopic surgery
246794|NCT01903564|fetus|fetus
246795|NCT01903564|fetal arrhythmia|fetal arrhythmia
246796|NCT01903564|fetal heart rate|fetal heart rate
246797|NCT01903564|long QT syndrome|long qt syndrome
246798|NCT01903551|post-operative pain|post-operative pain
246799|NCT01903551|loco-regional analgesia|loco-regional analgesia
246800|NCT01903551|minimally invasive surgery|minimally invasive surgery
246801|NCT01903512|TMJ arthrocentesis|tmj arthrocentesis
246802|NCT01903512|internal derangement|internal derangement
246803|NCT01903512|conservative treatment|conservative treatment
246804|NCT01903486|Trouble swallowing|trouble swallowing
246805|NCT01903486|dysphagia|dysphagia
246806|NCT01903486|disorder of the esophagus|disorder of the esophagus
246807|NCT01903473|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
246808|NCT01903473|GVHD|gvhd
246809|NCT01903473|Regulatory T cells|regulatory t cells
304270|NCT01644409|OAB|oab
246810|NCT01903473|Steroid refractory|steroid refractory
246811|NCT01903473|Rapamycin|rapamycin
246812|NCT01903473|Immune recovery|immune recovery
246813|NCT01903473|Infusion|infusion
246814|NCT01903473|HLA-identical sibling|hla-identical sibling
246815|NCT01903473|HLA-matched unrelated donor|hla-matched unrelated donor
246816|NCT01903447|Internalizing psychopathologies|internalizing psychopathologies
246817|NCT01903447|Depression|depression
246818|NCT01903447|Anxiety|anxiety
246820|NCT01903447|medication treatment|medication treatment
246821|NCT01903447|psychotherapy|psychotherapy
246822|NCT01903447|brain function|brain function
246823|NCT01903421|Elderly surgical patients|elderly surgical patients
246824|NCT01903421|Alzheimer's disease|alzheimer's disease
246827|NCT01903421|Surgery|surgery
246828|NCT01903395|Colorectal Neoplasms/*drug therapy/*secondary|colorectal neoplasms/*drug therapy/*secondary
246829|NCT01903395|Health Services Accessibility|health services accessibility
246830|NCT01903395|Humans|humans
246831|NCT01903395|Supportive Care Needs|supportive care needs
246832|NCT01903395|Psychooncology|psychooncology
246833|NCT01903395|Primary Health Care/*methods|primary health care/*methods
246834|NCT01903395|Treatment Outcome|treatment outcome
246835|NCT01903395|Socioeconomic Factors|socioeconomic factors
246836|NCT01903395|Quality Assurance, Health Care|quality assurance, health care
246837|NCT01903395|Adult|adult
246838|NCT01903395|Aged|aged
246839|NCT01903395|Aged, 80 and over|aged, 80 and over
246840|NCT01903369|Shear wave|shear wave
246841|NCT01903369|Elastography|elastography
246842|NCT01903369|Repeatability and Reproducibility|repeatability and reproducibility
246843|NCT01903343|Shear wave|shear wave
246844|NCT01903343|Elastography|elastography
246845|NCT01903343|Repeatability and Reproducibility|repeatability and reproducibility
246846|NCT01903330|ERC1671|erc1671
246847|NCT01903330|GM-CSF|gm-csf
246848|NCT01903330|Cyclophosphamide|cyclophosphamide
246849|NCT01903330|Bevacizumab|bevacizumab
246850|NCT01903304|Olive oil|olive oil
246851|NCT01903304|DTH|dth
246852|NCT01903304|elderly|elderly
246853|NCT01903278|interferon|interferon
246854|NCT01903278|ribavirin|ribavirin
246855|NCT01903278|sustained virological response|sustained virological response
246856|NCT01903265|pain|pain
246857|NCT01903265|sleep|sleep
246858|NCT01903252|UC|uc
246859|NCT01903226|spinal cord injury|spinal cord injury
246860|NCT01903226|physical capacity|physical capacity
246861|NCT01903226|energy expenditure|energy expenditure
246862|NCT01903226|training|training
246863|NCT01903213|Peritoneal dialysis|peritoneal dialysis
246864|NCT01903213|Bixalomer|bixalomer
246865|NCT01903213|Chronic renal failure patients with Hyperphosphatemia|chronic renal failure patients with hyperphosphatemia
246866|NCT01903213|Kiklin®|kiklin®
246867|NCT01903200|Antipsychotic|antipsychotic
246868|NCT01903200|FK949E|fk949e
246869|NCT01903200|Quetiapine|quetiapine
246870|NCT01903200|Elderly|elderly
246871|NCT01903187|hypertension|hypertension
246872|NCT01903187|resistant hypertension|resistant hypertension
246873|NCT01903187|renal denervation|renal denervation
246874|NCT01903174|Breast Cancer|breast cancer
246875|NCT01903174|Breast Reconstruction|breast reconstruction
246876|NCT01903174|Breast Tissue Expansion|breast tissue expansion
246877|NCT01903174|Breast Tissue Expander|breast tissue expander
246878|NCT01903174|Two Stage Breast Reconstruction|two stage breast reconstruction
246879|NCT01903161|delayed remote ischemic preconditioning|delayed remote ischemic preconditioning
246880|NCT01903161|troponin|troponin
246881|NCT01903161|valve replacement surgery|valve replacement surgery
246882|NCT01903148|ANEMIA IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS|anemia in chronic kidney disease patients not on dialysis
246883|NCT01903135|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
246884|NCT01903135|Prevalence|prevalence
246885|NCT01903135|Bicarbonate|bicarbonate
246886|NCT01903096|Panic disorder|panic disorder
690516|NCT00922740|Nocturia|nocturia
246887|NCT01903096|Generalized anxiety disorder|generalized anxiety disorder
246888|NCT01903096|Social phobia|social phobia
246889|NCT01903096|Specific phobia|specific phobia
246890|NCT01903096|Major depressive disorder|major depressive disorder
246891|NCT01903096|Dysthymia|dysthymia
246892|NCT01903096|Somatizations disorder|somatizations disorder
246893|NCT01903096|Pain disorder|pain disorder
246894|NCT01903083|Pancreas|pancreas
246895|NCT01903083|Pancreatic cancer|pancreatic cancer
246896|NCT01903083|Immunotherapy|immunotherapy
246897|NCT01903083|Chemotherapy|chemotherapy
246898|NCT01903083|Radiation|radiation
246899|NCT01903083|Surgery|surgery
246900|NCT01903083|Pancreaticoduodenectomy|pancreaticoduodenectomy
246901|NCT01903057|Mass Drug Administration|mass drug administration
246902|NCT01903057|Neglected Tropical Diseases|neglected tropical diseases
246903|NCT01903057|Preventive Chemotherapy and Transmission Control|preventive chemotherapy and transmission control
246904|NCT01903057|Preventive Chemotherapy|preventive chemotherapy
246905|NCT01903044|Lowe extremity ischemia|lowe extremity ischemia
246906|NCT01903044|Bone marrow|bone marrow
246907|NCT01903044|Neoangiogenesis|neoangiogenesis
246908|NCT01903005|Opioid, Dependence, agonist, Buprenorphine, Naloxone|opioid, dependence, agonist, buprenorphine, naloxone
246909|NCT01902966|Cervical Cancer|cervical cancer
246910|NCT01902966|Propranolol|propranolol
246911|NCT01902966|Betachron|betachron
246912|NCT01902966|Inderal|inderal
246914|NCT01902966|Questionnaires|questionnaires
246915|NCT01902966|Surveys|surveys
246916|NCT01902966|Symptom inventory|symptom inventory
246917|NCT01902966|Anxiety and depression survey|anxiety and depression survey
246918|NCT01902966|Pain inventory|pain inventory
246919|NCT01902966|Quality of life survey|quality of life survey
246920|NCT01902966|Relaxation audio recording|relaxation audio recording
246921|NCT01902966|MP3 player|mp3 player
246922|NCT01902966|Diary|diary
246923|NCT01902953|Sentinel lymph nodes|sentinel lymph nodes
246924|NCT01902953|colon cancer|colon cancer
246925|NCT01902953|rectal cancer|rectal cancer
246926|NCT01902953|immunohistochemistry|immunohistochemistry
246927|NCT01902927|Exercise tolerance|exercise tolerance
246928|NCT01902927|Dyspnea|dyspnea
246929|NCT01902927|Affective distraction|affective distraction
246930|NCT01902914|hearing aids|hearing aids
246931|NCT01902914|hearing disability|hearing disability
246932|NCT01902914|community|community
246933|NCT01902914|hearing aids service|hearing aids service
246934|NCT01902901|Whole Genome Sequencing|whole genome sequencing
246935|NCT01902901|Carrier status|carrier status
246936|NCT01902901|Genetics|genetics
246937|NCT01902888|popliteal artery|popliteal artery
246938|NCT01902888|aneurysm|aneurysm
246939|NCT01902888|popliteal artery aneurysm|popliteal artery aneurysm
246940|NCT01902888|asymptomatic aneurysm|asymptomatic aneurysm
246941|NCT01902888|mural thrombus|mural thrombus
246942|NCT01902888|Viabahn|viabahn
246943|NCT01902888|Gore|gore
246944|NCT01902888|Endoprosthesis|endoprosthesis
246945|NCT01902862|Lymphoma, follicular|lymphoma, follicular
246946|NCT01902862|Bortezomib|bortezomib
246947|NCT01902862|Rituximab|rituximab
246948|NCT01902849|intravenous anesthesia|intravenous anesthesia
246949|NCT01902849|inhalational anesthesia|inhalational anesthesia
246950|NCT01902849|interleukins|interleukins
246951|NCT01902849|colorectal surgery|colorectal surgery
246952|NCT01902836|Dialyzable Leukocyte Extracts|dialyzable leukocyte extracts
246953|NCT01902836|Transferon|transferon
246954|NCT01902836|atopic dermatitis|atopic dermatitis
246955|NCT01902823|Nurse Navigator|nurse navigator
246956|NCT01902823|Satisfaction with Care|satisfaction with care
246957|NCT01902823|Quality of Life|quality of life
246958|NCT01902823|Symptom Distress|symptom distress
246959|NCT01902797|Refugee camps|refugee camps
246960|NCT01902797|Household residence|household residence
246961|NCT01902797|Treated bednets|treated bednets
246962|NCT01902797|PCR|pcr
246963|NCT01902784|Intensive Care Unit patients and families|intensive care unit patients and families
246964|NCT01902784|Surrogate decision making|surrogate decision making
246965|NCT01902784|Life Sustaining Treatments (LST)|life sustaining treatments (lst)
246966|NCT01902771|Dendritic Cell Vaccine|dendritic cell vaccine
246967|NCT01902771|DCV|dcv
246968|NCT01902771|Pediatric|pediatric
246969|NCT01902771|Brain Tumor|brain tumor
246970|NCT01902771|In Situ|in situ
246977|NCT01902771|High Grade Glioma|high grade glioma
246978|NCT01902771|HGG|hgg
246979|NCT01902758|exercise performance|exercise performance
246980|NCT01902693|HIV|hiv
246981|NCT01902693|Chemotherapy|chemotherapy
246982|NCT01902693|Cohort|cohort
246983|NCT01902693|Cancer|cancer
246984|NCT01902693|HAART|haart
246985|NCT01902693|Malignancy|malignancy
246986|NCT01902680|Prostate cancer, permanent implant brachytherapy, image fusion, focal therapy, active surveillance|prostate cancer, permanent implant brachytherapy, image fusion, focal therapy, active surveillance
246987|NCT01902667|Retroperitoneal Sarcoma|retroperitoneal sarcoma
246988|NCT01902667|Magnetic Resonance Imaging|magnetic resonance imaging
246989|NCT01902654|Osteoarthritis|osteoarthritis
246990|NCT01902654|cardiovascular disease|cardiovascular disease
246991|NCT01902641|succinylcholine|succinylcholine
246992|NCT01902641|rocuronium|rocuronium
246993|NCT01902641|sugammadex|sugammadex
246994|NCT01902641|Intubating Conditions|intubating conditions
246995|NCT01902641|short Procedures|short procedures
246996|NCT01902563|osteopathic manipulative treatment|osteopathic manipulative treatment
246997|NCT01902563|newborns|newborns
246998|NCT01902563|preterm infants|preterm infants
246999|NCT01902563|procedures|procedures
247000|NCT01902550|Healthy|healthy
247001|NCT01902550|JNJ-54452840|jnj-54452840
247002|NCT01902550|Metoprolol Tartrate Immediate-Release|metoprolol tartrate immediate-release
247003|NCT01902550|Placebo|placebo
247004|NCT01902550|Male|male
247005|NCT01902537|Constipation|constipation
247006|NCT01902537|Prucalopride|prucalopride
247007|NCT01902524|Chronic Pain|chronic pain
247008|NCT01902524|Fentanyl-TTS|fentanyl-tts
247009|NCT01902524|Fentanyl Patch|fentanyl patch
247010|NCT01902524|Transdermal|transdermal
247011|NCT01902524|Non-cancer Pain|non-cancer pain
247012|NCT01902498|aspirin|aspirin
237825|NCT01945385|IUD|iud
247013|NCT01902485|Contraception|contraception
247014|NCT01902485|Medical Abortion|medical abortion
247015|NCT01902485|Implant|implant
247016|NCT01902485|Injectable|injectable
247017|NCT01902485|Quickstart|quickstart
247024|NCT01902459|Hemostasis|hemostasis
247025|NCT01902446|Chlorhexidine|chlorhexidine
247026|NCT01902446|Randomized Controlled Trial|randomized controlled trial
247027|NCT01902446|Emergency Medical Services|emergency medical services
247028|NCT01902446|Intubation, Endotracheal|intubation, endotracheal
247029|NCT01902407|Pcrit|pcrit
247030|NCT01902407|Critical closing pressure|critical closing pressure
247031|NCT01902407|Down syndrome|down syndrome
247032|NCT01902407|Obstructive Sleep Apnea|obstructive sleep apnea
247033|NCT01902407|Sleep MRI|sleep mri
247034|NCT01902394|digestive health and natural defenses|digestive health and natural defenses
247035|NCT01902368|Gluten free diet|gluten free diet
247036|NCT01902355|Central Venous Catheterization|central venous catheterization
247037|NCT01902329|Acute Myeloid Leukemia|acute myeloid leukemia
247038|NCT01902329|Antibody-Drug Conjugate|antibody-drug conjugate
247039|NCT01902329|CD33 Antigen|cd33 antigen
247040|NCT01902329|Immunotherapy|immunotherapy
247041|NCT01902329|Drug Therapy|drug therapy
247042|NCT01902329|Acute Myelogenous Leukemia|acute myelogenous leukemia
247043|NCT01902329|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
247044|NCT01902329|APL|apl
247045|NCT01902316|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
247046|NCT01902316|peptide biomarker|peptide biomarker
247047|NCT01902316|early diagnosis|early diagnosis
247048|NCT01902316|label free|label free
247049|NCT01902303|Herpes Labialis|herpes labialis
247050|NCT01902303|Herpes Simplex|herpes simplex
247051|NCT01902303|Herpes|herpes
247052|NCT01902303|Ultra Violet (UV) Induced|ultra violet (uv) induced
247053|NCT01902290|Inadequately controlled asthma, brodalumab, AMG 827|inadequately controlled asthma, brodalumab, amg 827
247054|NCT01902277|Delirium|delirium
247055|NCT01902277|Intensive Care Unit|intensive care unit
247056|NCT01902277|Critical illness|critical illness
247057|NCT01902264|Levomefolate calcium|levomefolate calcium
247058|NCT01902264|Contraceptives, oral, combined|contraceptives, oral, combined
247059|NCT01902264|Neural tube defects|neural tube defects
247060|NCT01902251|Phase 1|phase 1
247061|NCT01902251|Prostate cancer|prostate cancer
247062|NCT01902251|Bioavailability|bioavailability
247063|NCT01902251|Food effect|food effect
247064|NCT01902251|Pharmacokinetics|pharmacokinetics
247065|NCT01902251|Xtandi|xtandi
247066|NCT01902251|Enzalutamide|enzalutamide
247067|NCT01902251|MDV3100|mdv3100
247068|NCT01902238|neuroendocrine tumor|neuroendocrine tumor
247069|NCT01902238|ethanol|ethanol
247070|NCT01902238|endoscopic ultrasonography|endoscopic ultrasonography
247071|NCT01902225|Lymphoma|lymphoma
247072|NCT01902225|T-Cell|t-cell
247073|NCT01902225|Cutaneous|cutaneous
247074|NCT01902225|Doxil|doxil
247075|NCT01902225|romidepsin|romidepsin
247076|NCT01902225|skin|skin
247077|NCT01902186|HIV|hiv
247078|NCT01902186|osteopenia|osteopenia
247079|NCT01902186|t-score|t-score
247080|NCT01902186|DEXA|dexa
247081|NCT01902186|tenofovir|tenofovir
247082|NCT01902186|raltegravir|raltegravir
247083|NCT01902147|abdominal|abdominal
247084|NCT01902147|thoracic|thoracic
247085|NCT01902147|arthroplasty|arthroplasty
247086|NCT01902134|Moderate to severe acute pain|moderate to severe acute pain
247087|NCT01902134|Postoperative pain|postoperative pain
247088|NCT01902134|Hip arthroplasty|hip arthroplasty
247089|NCT01902134|Analgesics|analgesics
247090|NCT01902134|Dexketoprofen|dexketoprofen
247091|NCT01902134|Tramadol|tramadol
247092|NCT01902108|clonidine|clonidine
247093|NCT01902108|bupivacaine|bupivacaine
247094|NCT01902108|post-operative pain|post-operative pain
247095|NCT01902108|arthrodesis|arthrodesis
247096|NCT01902108|discectomy|discectomy
247097|NCT01902108|local infiltration|local infiltration
247098|NCT01902095|tooth pastes|tooth pastes
247099|NCT01902095|tooth powders|tooth powders
247100|NCT01902095|Stain Index|stain index
247101|NCT01902082|ARDS|ards
247102|NCT01902082|mesenchymal stem cells|mesenchymal stem cells
247103|NCT01902082|Safety|safety
247104|NCT01902082|Cytokines|cytokines
247105|NCT01902069|sweet and fat preference|sweet and fat preference
247106|NCT01902056|allograft|allograft
247107|NCT01902056|acellular dermal matrix|acellular dermal matrix
247108|NCT01902056|Alloderm|alloderm
247109|NCT01902043|diabetes mellitus|diabetes mellitus
247110|NCT01902043|cohort study|cohort study
247111|NCT01902043|quality of care|quality of care
247112|NCT01902043|quality indicators, Health care|quality indicators, health care
247113|NCT01902043|quality of Health Care|quality of health care
247114|NCT01902043|outcome and process assessment|outcome and process assessment
247115|NCT01902043|health services research|health services research
247116|NCT01902043|chronic diseases prevention and management|chronic diseases prevention and management
247117|NCT01902017|Joint|joint
247118|NCT01902017|Contracture|contracture
247119|NCT01902017|Elbow|elbow
247120|NCT01902017|Fracture|fracture
247121|NCT01902017|Dislocation|dislocation
247122|NCT01902004|Major Depression|major depression
247123|NCT01902004|Geriatric Major Depression|geriatric major depression
247124|NCT01902004|Executive Cognitive Dysfunction|executive cognitive dysfunction
247125|NCT01902004|Mild Cognitive Impairment|mild cognitive impairment
247126|NCT01902004|Older Adults|older adults
247127|NCT01902004|Geriatric|geriatric
247132|NCT01902004|Medical Burden|medical burden
247134|NCT01902004|Candidate Genes|candidate genes
247135|NCT01901991|Nonpalpable breast lesions|nonpalpable breast lesions
247136|NCT01901991|Breast Cancer and carcinoma in situ|breast cancer and carcinoma in situ
247137|NCT01901991|Radioactive seed localization|radioactive seed localization
247138|NCT01901991|Wire-guided localization|wire-guided localization
247139|NCT01901991|Randomized study|randomized study
247140|NCT01901978|Obesity|obesity
247141|NCT01901978|Insulin Resistance|insulin resistance
247142|NCT01901978|Weight loss|weight loss
247143|NCT01901978|Women|women
247838|NCT01898624|glaucoma|glaucoma
247144|NCT01901952|Self management diabetes intervention|self management diabetes intervention
247145|NCT01901939|exercise|exercise
247146|NCT01901939|elderly|elderly
247147|NCT01901939|activities of daily living|activities of daily living
247148|NCT01901939|disability|disability
247149|NCT01901913|Type 1 Diabetes|type 1 diabetes
247150|NCT01901913|Artificial pancreas|artificial pancreas
247151|NCT01901913|Closed loop|closed loop
247152|NCT01901900|moderate to severe RA|moderate to severe ra
247153|NCT01901900|anti-TNF inadequate responders|anti-tnf inadequate responders
247154|NCT01901887|Adults|adults
247155|NCT01901887|Suicidality|suicidality
247156|NCT01901861|GLP-1, GIP, DPP-4 inhibition, iset function|glp-1, gip, dpp-4 inhibition, iset function
247157|NCT01901848|Smoking Cessation|smoking cessation
247158|NCT01901848|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
247159|NCT01901848|Psychotherapy|psychotherapy
247160|NCT01901822|acellular dermal matrix|acellular dermal matrix
247161|NCT01901809|Heart failure, diastolic|heart failure, diastolic
247162|NCT01901809|HFpEF|hfpef
247163|NCT01901809|Diuretics|diuretics
247164|NCT01901809|Dopamine|dopamine
247165|NCT01901796|Anxiety|anxiety
247166|NCT01901796|Depression|depression
247167|NCT01901796|CBT|cbt
247168|NCT01901783|allograft|allograft
247169|NCT01901783|regeneration|regeneration
247170|NCT01901783|alveolar ridge|alveolar ridge
247171|NCT01901770|HPV|hpv
247172|NCT01901770|Ohio Appalachia|ohio appalachia
247173|NCT01901770|HPV vaccine|hpv vaccine
247174|NCT01901770|No evidence of disease|no evidence of disease
247175|NCT01901744|Contrast Sensitivity , Pediatric Cataract Surgery,|contrast sensitivity , pediatric cataract surgery,
247672|NCT01899521|pulmonary|pulmonary
247176|NCT01901731|transjugular coil embolisation|transjugular coil embolisation
247177|NCT01901731|endovenous treatment of varicose veins|endovenous treatment of varicose veins
247178|NCT01901731|pelvic venous reflux|pelvic venous reflux
247179|NCT01901731|recurrent varicose veins|recurrent varicose veins
247180|NCT01901718|Breakthrough Pain|breakthrough pain
247181|NCT01901718|Subsys|subsys
247182|NCT01901718|Fentanyl|fentanyl
247183|NCT01901718|Opioid|opioid
247184|NCT01901718|Persistent Pain|persistent pain
247185|NCT01901705|Psoriasis|psoriasis
247186|NCT01901705|Indigo Naturalis|indigo naturalis
247187|NCT01901705|chinese medicine|chinese medicine
247188|NCT01901679|Obesity|obesity
247189|NCT01901679|Post-menopausal|post-menopausal
247190|NCT01901666|growth hormone, Chronic Myelogenous Leukemia, Imatinib,serum IGF-1|growth hormone, chronic myelogenous leukemia, imatinib,serum igf-1
247191|NCT01901653|Small cell lung cancer|small cell lung cancer
247192|NCT01901627|Spondylitis, Ankylosing|spondylitis, ankylosing
247193|NCT01901627|adalimumab|adalimumab
247194|NCT01901627|Prospective Studies|prospective studies
247195|NCT01901614|Keratoconus|keratoconus
247196|NCT01901614|Corneal Opacity|corneal opacity
247197|NCT01901614|Keratoplasty|keratoplasty
247198|NCT01901601|KERATOPLASTY|keratoplasty
247199|NCT01901601|STROMAL OPACITIES|stromal opacities
247200|NCT01901588|strabismus|strabismus
247201|NCT01901588|pediatric|pediatric
247202|NCT01901588|emergence delirium|emergence delirium
247203|NCT01901588|precedex/dexmedetomidine|precedex/dexmedetomidine
247204|NCT01901575|idiopathic ventricular tachycardia|idiopathic ventricular tachycardia
247205|NCT01901562|ductoscopy|ductoscopy
247206|NCT01901562|nipple discharge|nipple discharge
247207|NCT01901562|breast|breast
247208|NCT01901562|papilloma|papilloma
247209|NCT01901536|First time parents|first time parents
247210|NCT01901536|Coparenting|coparenting
247211|NCT01901536|Family Foundations|family foundations
247212|NCT01901523|Discrepancy|discrepancy
247213|NCT01901523|Committee on Publication Ethics|committee on publication ethics
247214|NCT01901523|Correction|correction
247215|NCT01901523|Erratum|erratum
247216|NCT01901523|Retraction|retraction
247217|NCT01901510|polyp|polyp
247218|NCT01901497|non invasive ventilation|non invasive ventilation
247219|NCT01901497|single limb circuit ventilator|single limb circuit ventilator
247220|NCT01901497|bilevel|bilevel
247221|NCT01901497|nebulization|nebulization
238017|NCT01944410|PRP|prp
247222|NCT01901497|nebulizer|nebulizer
247223|NCT01901497|vibrating mesh nebulizer|vibrating mesh nebulizer
247224|NCT01901497|amikacin|amikacin
247225|NCT01901484|Schistosoma mansoni|schistosoma mansoni
247226|NCT01901484|morbidity|morbidity
247227|NCT01901484|chemotherapy|chemotherapy
247228|NCT01901471|Cyclosporine, cardiogenic shock, SOFA score,|cyclosporine, cardiogenic shock, sofa score,
247229|NCT01901458|apheresis|apheresis
247230|NCT01901458|peripheral blood progenitor cells|peripheral blood progenitor cells
247231|NCT01901458|peripheral blood stem cells|peripheral blood stem cells
247232|NCT01901445|Quality of life|quality of life
247233|NCT01901445|Constipation|constipation
247234|NCT01901445|Focus groups|focus groups
247235|NCT01901445|Health education|health education
247236|NCT01901445|Problem-based learning|problem-based learning
247237|NCT01901432|chronic myeloproliferative neoplasms|chronic myeloproliferative neoplasms
247238|NCT01901432|Polycythemia Vera|polycythemia vera
247239|NCT01901432|Essential Thrombocythemia|essential thrombocythemia
247839|NCT01898611|Frailty|frailty
247240|NCT01901432|Primary Myelofibrosis|primary myelofibrosis
247241|NCT01901432|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
247242|NCT01901432|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
247243|NCT01901432|Givinostat|givinostat
247244|NCT01901419|nitroglycerin|nitroglycerin
247245|NCT01901419|cardiopulmonary bypass|cardiopulmonary bypass
247246|NCT01901419|cardiac surgery|cardiac surgery
247247|NCT01901406|epiretinal membrane, stereopsis, aniseikonia|epiretinal membrane, stereopsis, aniseikonia
247248|NCT01901393|Post Operative Pain,|post operative pain,
247249|NCT01901393|Pail relief|pail relief
247250|NCT01901367|Adiponectin, Glucose, Insulin, Leptin|adiponectin, glucose, insulin, leptin
247251|NCT01901354|Acute lung injury (ALI)|acute lung injury (ali)
247252|NCT01901354|Adult respiratory distress syndrome (ARDS)|adult respiratory distress syndrome (ards)
247253|NCT01901354|Low-tidal-volume strategy|low-tidal-volume strategy
247254|NCT01901354|ARDSNet|ardsnet
247255|NCT01901354|airway pressure release ventilation (APRV)|airway pressure release ventilation (aprv)
247256|NCT01901354|biomarkers of lung injury|biomarkers of lung injury
247257|NCT01901341|Opioid|opioid
247258|NCT01901341|Constipation|constipation
247259|NCT01901341|Chronic|chronic
247260|NCT01901341|Pain|pain
247261|NCT01901328|Opioid|opioid
247262|NCT01901328|Constipation|constipation
247263|NCT01901328|Chronic|chronic
247264|NCT01901328|Pain|pain
247265|NCT01901315|telepsychiatry|telepsychiatry
247266|NCT01901315|telemental health|telemental health
247267|NCT01901315|teleassistance|teleassistance
247268|NCT01901315|health care delivery|health care delivery
247269|NCT01901315|depression|depression
247270|NCT01901315|Telemedicine|telemedicine
247271|NCT01901315|Remote Consultation|remote consultation
247272|NCT01901315|Videoconferencing|videoconferencing
247273|NCT01901315|Community Mental Health Services|community mental health services
247274|NCT01901302|Opioid|opioid
247275|NCT01901302|Constipation|constipation
247276|NCT01901302|Chronic|chronic
247277|NCT01901302|Pain|pain
247278|NCT01901289|Peripheral Vascular Disease|peripheral vascular disease
247279|NCT01901289|Femoral Artery|femoral artery
247280|NCT01901289|Popliteal Artery|popliteal artery
247281|NCT01901289|Drug-Eluting Stent|drug-eluting stent
247282|NCT01901276|Proton Pump Inhibitors|proton pump inhibitors
247283|NCT01901276|Microbiome|microbiome
247284|NCT01901276|Clostridium difficile|clostridium difficile
247285|NCT01901263|Cognitive and behavioral units|cognitive and behavioral units
247286|NCT01901263|Alzheimer Disease|alzheimer disease
247287|NCT01901263|Dementia|dementia
247288|NCT01901250|Dental Caries|dental caries
247289|NCT01901250|Xylitol|xylitol
247290|NCT01901250|Prevention|prevention
247291|NCT01901237|Cancer|cancer
247292|NCT01901237|Adolescent and Young Adult|adolescent and young adult
247293|NCT01901237|Exercise|exercise
247294|NCT01901237|Physical Activity|physical activity
247295|NCT01901237|Quality of Life|quality of life
247296|NCT01901237|End-of-Life|end-of-life
247297|NCT01901237|Palliative|palliative
247298|NCT01901237|Terminal|terminal
247299|NCT01901237|Yoga|yoga
247300|NCT01901237|Alternative Therapies|alternative therapies
247301|NCT01901237|Fitness|fitness
247302|NCT01901237|Fatigue|fatigue
247303|NCT01901211|Cerebral palsy|cerebral palsy
247304|NCT01901211|Interactive computer play|interactive computer play
247305|NCT01901211|Multi-player gaming|multi-player gaming
247306|NCT01901211|Exercise|exercise
247307|NCT01901146|Human Epidermal Growth Factor Receptor 2 (HER2)|human epidermal growth factor receptor 2 (her2)
247308|NCT01901146|Positive Early Breast Cancer|positive early breast cancer
247309|NCT01901133|Phase 1|phase 1
247310|NCT01901133|MDV3100|mdv3100
247311|NCT01901133|Hepatic Impairment|hepatic impairment
247312|NCT01901133|Kidney Diseases|kidney diseases
247313|NCT01901133|Xtandi|xtandi
247314|NCT01901133|enzalutamide|enzalutamide
247315|NCT01901120|Betanis®|betanis®
247316|NCT01901120|mirabegron|mirabegron
247317|NCT01901120|Overactive Bladder|overactive bladder
247318|NCT01901107|Hemodialysis|hemodialysis
5860|NCT03253861|Acute pancreatitis|acute pancreatitis
247319|NCT01901107|CKD (chronic kidney disease)|ckd (chronic kidney disease)
247320|NCT01901107|ASP1585|asp1585
247321|NCT01901107|Hyperphosphatemia|hyperphosphatemia
247322|NCT01901081|Implantable Myoelectric Sensor|implantable myoelectric sensor
247323|NCT01901081|IMES|imes
247324|NCT01901081|transradial|transradial
247325|NCT01901081|amputation|amputation
247326|NCT01901081|myoelectric|myoelectric
247327|NCT01901081|prosthesis|prosthesis
247328|NCT01901081|prosthetic control|prosthetic control
247329|NCT01901068|Laparotomy|laparotomy
247330|NCT01901068|Surgical Procedures, Elective|surgical procedures, elective
247331|NCT01901068|Sutures|sutures
247332|NCT01901068|Abdominal Wound Closure Techniques|abdominal wound closure techniques
247333|NCT01901055|sleep apnea|sleep apnea
247334|NCT01901055|diabetes|diabetes
247335|NCT01901042|Quality of life|quality of life
247336|NCT01901042|Symbiotic|symbiotic
247337|NCT01901042|Proctitis/Radiotherapy|proctitis/radiotherapy
247338|NCT01901029|Male Reproductive Health|male reproductive health
247339|NCT01901029|Floating Population|floating population
247340|NCT01901029|Sexual Behavior|sexual behavior
247341|NCT01901029|Erectile Dysfunction|erectile dysfunction
247342|NCT01901029|Premature Ejaculation|premature ejaculation
247344|NCT01901016|depressive symptoms|depressive symptoms
247345|NCT01901016|quality of life|quality of life
247346|NCT01901016|relaxation|relaxation
247347|NCT01901016|viral load|viral load
247348|NCT01901016|CD4+ T cell count|cd4+ t cell count
247349|NCT01900990|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
247350|NCT01900990|Invasive Positive Pressure Ventilation|invasive positive pressure ventilation
247351|NCT01900990|tracheotomy|tracheotomy
247352|NCT01900977|Universal Test and Treat (UTT)|universal test and treat (utt)
247353|NCT01900977|Combination Prevention|combination prevention
247354|NCT01900964|Regeneration|regeneration
247355|NCT01900964|Bone regeneration|bone regeneration
247356|NCT01900964|Grafting, Bone|grafting, bone
247357|NCT01900964|Allograft|allograft
247358|NCT01900964|Xenograft|xenograft
247359|NCT01900951|Small cell lung cancer|small cell lung cancer
247360|NCT01900951|temozolomide|temozolomide
247361|NCT01900951|Maintenance chemotherapy|maintenance chemotherapy
247362|NCT01900938|Cholangiopancreatography|cholangiopancreatography
247363|NCT01900938|Endoscopic Retrograde|endoscopic retrograde
247364|NCT01900925|Low back pain, non-specific low back pain|low back pain, non-specific low back pain
247365|NCT01900912|sanitation|sanitation
247366|NCT01900912|diarrhea prevalence|diarrhea prevalence
247367|NCT01900912|health|health
247368|NCT01900912|social networks|social networks
247369|NCT01900912|cooperation|cooperation
247370|NCT01900899|Healthy|healthy
247371|NCT01900899|Immunogenicity|immunogenicity
247372|NCT01900899|Children|children
247373|NCT01900899|Neisseria meningitidis|neisseria meningitidis
247374|NCT01900899|Long-term antibody persistence|long-term antibody persistence
247375|NCT01900899|Safety|safety
247376|NCT01900899|Serogroups A, C, W-135, and Y|serogroups a, c, w-135, and y
247377|NCT01900886|prison, disorder, hepatitis c|prison, disorder, hepatitis c
247378|NCT01900873|Inspiratory Muscle Training|inspiratory muscle training
247379|NCT01900873|COPD|copd
247380|NCT01900873|Inspiratory Muscle Function|inspiratory muscle function
247381|NCT01900873|Dyspnea|dyspnea
247382|NCT01900860|Vitamin D|vitamin d
247383|NCT01900860|Bone quality|bone quality
247384|NCT01900860|Bone density|bone density
247385|NCT01900860|calcium metabolism|calcium metabolism
247386|NCT01900860|High resolution peripheral quantitative computed tomography|high resolution peripheral quantitative computed tomography
247387|NCT01900860|Dual X-ray absorptiometry|dual x-ray absorptiometry
247388|NCT01900860|Quality of life|quality of life
247389|NCT01900847|Ketamine|ketamine
247390|NCT01900847|Acute Pain|acute pain
247391|NCT01900795|Postsurgical pain|postsurgical pain
247392|NCT01900743|Sarcoma|sarcoma
247393|NCT01900743|Metastatic|metastatic
247394|NCT01900743|Regorafenib|regorafenib
247395|NCT01900730|Breast cancer|breast cancer
247396|NCT01900730|Metastatic|metastatic
247397|NCT01900730|Indwelling pleural catheter|indwelling pleural catheter
247398|NCT01900730|Valproic acid|valproic acid
247400|NCT01900730|Depakene|depakene
247401|NCT01900730|Placebo|placebo
247402|NCT01900730|Pill diary|pill diary
247403|NCT01900730|Drainage diary|drainage diary
247404|NCT01900730|Questionnaires|questionnaires
247405|NCT01900730|Surveys|surveys
247406|NCT01900691|Esophageal Fistula|esophageal fistula
247407|NCT01900691|Esophageal Neoplasms|esophageal neoplasms
247408|NCT01900691|Esophageal Perforation|esophageal perforation
247409|NCT01900691|Esophageal Stenosis|esophageal stenosis
247410|NCT01900691|Stents|stents
247411|NCT01900639|aspirin|aspirin
247412|NCT01900639|circadian rhythm|circadian rhythm
247413|NCT01900639|platelet reactivity|platelet reactivity
247414|NCT01900639|platelet activation|platelet activation
247415|NCT01900639|time dependent|time dependent
247416|NCT01900613|child obesity|child obesity
247417|NCT01900613|Mexican-American|mexican-american
247418|NCT01900613|Nutrition education|nutrition education
247419|NCT01900613|Intervention|intervention
247420|NCT01900587|Healthy|healthy
247421|NCT01900587|Bio-equivalence|bio-equivalence
247422|NCT01900587|Tapentadol extended release|tapentadol extended release
247423|NCT01900587|Tamper-resistant formulation|tamper-resistant formulation
247424|NCT01900574|Colitis, Ulcerative|colitis, ulcerative
247425|NCT01900574|Ulcerative Colitis|ulcerative colitis
247426|NCT01900574|Moderately to Severely Active Ulcerative Colitis|moderately to severely active ulcerative colitis
247427|NCT01900574|Golimumab|golimumab
247428|NCT01900574|Simponi|simponi
247429|NCT01900574|Human anti-TNFα Antibody|human anti-tnfα antibody
247430|NCT01900574|Pediatric participants|pediatric participants
247431|NCT01900574|Safety and Pharmacokinetics|safety and pharmacokinetics
247432|NCT01900561|prostate cancer|prostate cancer
247433|NCT01900561|survivorship|survivorship
247434|NCT01900561|intervention|intervention
247435|NCT01900561|telemedicine|telemedicine
247436|NCT01900548|Osteopenia|osteopenia
247437|NCT01900548|Sarcopenia|sarcopenia
247438|NCT01900548|Osteoporosis|osteoporosis
247439|NCT01900548|Physical function|physical function
247440|NCT01900548|Body composition|body composition
247441|NCT01900548|Muscle protein|muscle protein
247442|NCT01900548|Leucine|leucine
247443|NCT01900548|Ketogenic amino acids|ketogenic amino acids
247444|NCT01900548|Resistance Training|resistance training
247445|NCT01900548|Whey protein|whey protein
247446|NCT01900548|Soy protein|soy protein
247447|NCT01900548|Bone turnover|bone turnover
247448|NCT01900535|chlorhexidine|chlorhexidine
247449|NCT01900535|gingivitis|gingivitis
247450|NCT01900535|periodontitis|periodontitis
247451|NCT01900522|Drug therapy|drug therapy
247452|NCT01900509|Childhood leukemia|childhood leukemia
247453|NCT01900509|Childhood lymphoma|childhood lymphoma
247454|NCT01900509|Bendamustine|bendamustine
247455|NCT01900496|cHL|chl
247456|NCT01900496|Hodgkin lymphoma|hodgkin lymphoma
247457|NCT01900496|Lymphoma|lymphoma
247458|NCT01900496|relapsed Lymphoma|relapsed lymphoma
247459|NCT01900496|SGN-35|sgn-35
247460|NCT01900496|Brentuximab Vedotin|brentuximab vedotin
247461|NCT01900496|Rituxan|rituxan
247462|NCT01900496|Rituximab|rituximab
247463|NCT01900470|Multiple chronic conditions|multiple chronic conditions
247464|NCT01900444|Japanese encephalitis|japanese encephalitis
247465|NCT01900444|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
247466|NCT01900444|IMOJEV®|imojev®
247467|NCT01900418|breast cancer|breast cancer
247468|NCT01900418|aromatase inhibitors|aromatase inhibitors
247469|NCT01900418|physical activity|physical activity
247470|NCT01900418|joint pain|joint pain
247471|NCT01900405|Dexmedetomidine|dexmedetomidine
247472|NCT01900405|Administration, Intranasal|administration, intranasal
247473|NCT01900405|Children|children
247474|NCT01900405|Computerized Tomography|computerized tomography
247475|NCT01900379|Obstructive sleep apneas syndrome|obstructive sleep apneas syndrome
247476|NCT01900379|Continuous positive airway pressure treatment|continuous positive airway pressure treatment
247477|NCT01900379|Heart failure|heart failure
247478|NCT01900379|Coronary reperfusion surgery|coronary reperfusion surgery
247479|NCT01900366|Obesity|obesity
247480|NCT01900366|Healthy Volunteers|healthy volunteers
247481|NCT01900340|GLP-1|glp-1
247482|NCT01900340|satiation peptides|satiation peptides
247483|NCT01900340|food intake|food intake
247484|NCT01900327|pancreatic cancer|pancreatic cancer
247485|NCT01900327|surgery|surgery
247486|NCT01900327|chemoradiation|chemoradiation
247487|NCT01900327|neoadjuvant treatment|neoadjuvant treatment
247488|NCT01900327|overall survival|overall survival
690702|NCT00929578|Psoriasis|psoriasis
247489|NCT01900314|Major Depression|major depression
247490|NCT01900314|Major Depressive Disorder|major depressive disorder
247491|NCT01900314|TMS|tms
247492|NCT01900314|rTMS|rtms
247493|NCT01900301|exposure|exposure
247494|NCT01900301|scopolamine|scopolamine
247495|NCT01900301|extinction learning|extinction learning
247496|NCT01900301|social anxiety|social anxiety
247497|NCT01900288|short bowel disorder|short bowel disorder
247498|NCT01900288|short bowel syndrome|short bowel syndrome
247499|NCT01900288|home parenteral nutrition|home parenteral nutrition
247500|NCT01900288|HPN|hpn
247501|NCT01900288|total parenteral nutrition|total parenteral nutrition
247502|NCT01900288|TPN|tpn
247503|NCT01900288|telehealth|telehealth
247504|NCT01900288|telemedicine|telemedicine
247505|NCT01900275|Sepsis|sepsis
247506|NCT01900275|Trauma|trauma
247507|NCT01900275|Shock|shock
247508|NCT01900275|Acute kidney injury|acute kidney injury
247509|NCT01900275|Heparanase|heparanase
247510|NCT01900262|Biomechanics|biomechanics
247511|NCT01900262|Ankle Strength|ankle strength
247512|NCT01900262|Postural Control|postural control
247513|NCT01900262|Running Mechanics|running mechanics
247514|NCT01900236|Patients newly initiating outpatient HIV medical care|patients newly initiating outpatient hiv medical care
247515|NCT01900210|Criminal justice|criminal justice
247516|NCT01900210|substance abuse treatment|substance abuse treatment
247517|NCT01900210|HIV risk behaviors|hiv risk behaviors
247518|NCT01900158|Phase I, Phase II, Dose Escalation, Safety, Tolerability,|phase i, phase ii, dose escalation, safety, tolerability,
247519|NCT01900158|Efficacy, Amphinex induced Photochemical Internalisation, PCI, Amphinex, Gemcitabine, Cisplatin,|efficacy, amphinex induced photochemical internalisation, pci, amphinex, gemcitabine, cisplatin,
247520|NCT01900158|Inoperable Cholangiocarcinomas, CCA, Cholangiocarcinoma, bile duct cancer, photodynamic therapy|inoperable cholangiocarcinomas, cca, cholangiocarcinoma, bile duct cancer, photodynamic therapy
247522|NCT01900132|Neuromuscular Disease|neuromuscular disease
247523|NCT01900119|Oral Microbiome|oral microbiome
247524|NCT01900119|Next Generation Sequencing|next generation sequencing
247525|NCT01900106|late presenter|late presenter
247526|NCT01900106|naïve|naïve
247527|NCT01900106|advanced HIV disease|advanced hiv disease
247528|NCT01900080|HIV|hiv
247529|NCT01900080|AIDS|aids
247530|NCT01900080|Antiretroviral therapy|antiretroviral therapy
247531|NCT01900080|Retention in care|retention in care
247532|NCT01900080|Adherence|adherence
247533|NCT01900080|Cost-effectiveness|cost-effectiveness
247534|NCT01900054|TAU-284|tau-284
247535|NCT01900054|Bepotastine besilate|bepotastine besilate
247634|NCT01899664|upper extremity|upper extremity
247536|NCT01900054|Histamine H1 receptor antagonists|histamine h1 receptor antagonists
247537|NCT01900054|children|children
247538|NCT01900028|oncology,|oncology,
247539|NCT01900028|cancer,|cancer,
247540|NCT01900028|tumour,|tumour,
247541|NCT01900028|anticancer drug,|anticancer drug,
247542|NCT01900028|pharmacokinetics,|pharmacokinetics,
247543|NCT01900028|olaparib,itraconazole,|olaparib,itraconazole,
247544|NCT01900028|neoplasm,|neoplasm,
247545|NCT01900028|QT interval|qt interval
247546|NCT01900002|Liver Cancer|liver cancer
247547|NCT01900002|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
247548|NCT01900002|HCC|hcc
247549|NCT01900002|Sorafenib|sorafenib
247550|NCT01900002|Nexavar|nexavar
247551|NCT01900002|BAY 43-9006|bay 43-9006
247552|NCT01900002|Yttrium-90|yttrium-90
247553|NCT01900002|Microspheres|microspheres
247554|NCT01900002|Phone calls|phone calls
247555|NCT01899989|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
247556|NCT01899989|Chemotherapy|chemotherapy
247557|NCT01899989|13-113|13-113
247558|NCT01899976|covered biliary stent|covered biliary stent
247559|NCT01899976|X-Suit NIR Covered Biliary Stent|x-suit nir covered biliary stent
247560|NCT01899976|malignant strictures in biliary tree|malignant strictures in biliary tree
247561|NCT01899963|wet Age Related Macular Degeneration|wet age related macular degeneration
247562|NCT01899963|Diabetic Macular Edema|diabetic macular edema
247563|NCT01899963|Telemedicine|telemedicine
247564|NCT01899963|Teleophthalmology|teleophthalmology
247565|NCT01899963|Time to Treatment|time to treatment
247566|NCT01899950|Niemann-Pick disease type C|niemann-pick disease type c
247567|NCT01899950|Lysosomal disease|lysosomal disease
247568|NCT01899937|Endothelial dysfunction|endothelial dysfunction
247569|NCT01899937|Flow mediated dilation|flow mediated dilation
247570|NCT01899937|Brachial artery flow mediated dilation|brachial artery flow mediated dilation
247571|NCT01899937|FMD|fmd
247572|NCT01899898|Refractory epilepsy|refractory epilepsy
247573|NCT01899898|Dietary therapy|dietary therapy
247574|NCT01899898|Non-Pharmacological therapy|non-pharmacological therapy
247575|NCT01899898|Simplified Modified Atkins Diet|simplified modified atkins diet
247576|NCT01899885|Emergency laparotomy|emergency laparotomy
247577|NCT01899885|Emergency laparoscopy|emergency laparoscopy
247578|NCT01899872|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
247579|NCT01899872|Endothelial progenitor cell|endothelial progenitor cell
247580|NCT01899872|Endothelial function|endothelial function
247581|NCT01899872|Exercise|exercise
247582|NCT01899859|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
247584|NCT01899846|Pharmacokinetics|pharmacokinetics
247585|NCT01899846|Prior preterm delivery|prior preterm delivery
247586|NCT01899846|Hydroxyprogesterone Caproate|hydroxyprogesterone caproate
247587|NCT01899846|17P|17p
247588|NCT01899833|Coronary Artery Disease|coronary artery disease
247589|NCT01899833|CAD|cad
247590|NCT01899781|Lacerations|lacerations
247591|NCT01899781|Tendons|tendons
247592|NCT01899781|Antobiotic|antobiotic
247593|NCT01899768|efficacy|efficacy
247594|NCT01899768|hypertussive challenge|hypertussive challenge
247595|NCT01899768|voltage gated sodium channels (VGSC)|voltage gated sodium channels (vgsc)
247596|NCT01899768|anaesthesia|anaesthesia
247597|NCT01899768|Safety and tolerability|safety and tolerability
247598|NCT01899768|capsaicin challenge|capsaicin challenge
247599|NCT01899768|cough|cough
247600|NCT01899768|citric acid challenge|citric acid challenge
247601|NCT01899768|pharmacokinetics|pharmacokinetics
247602|NCT01899755|monoclonal antibody|monoclonal antibody
247603|NCT01899755|healthy volunteer|healthy volunteer
247604|NCT01899755|TNF alpha|tnf alpha
247605|NCT01899729|plaque psoriasis|plaque psoriasis
247606|NCT01899729|autoimmune disease|autoimmune disease
247607|NCT01899729|Toll like receptor|toll like receptor
247608|NCT01899716|Severe Depression|severe depression
247609|NCT01899716|Quality of life|quality of life
247610|NCT01899716|Exercise|exercise
247611|NCT01899716|BDNF|bdnf
247612|NCT01899716|TBARS|tbars
247399|NCT01900730|VPA|vpa
247613|NCT01899703|Intestinal bile acid transport inhibitor|intestinal bile acid transport inhibitor
247614|NCT01899703|Pruritus|pruritus
247615|NCT01899703|Primary biliary cirrhosis|primary biliary cirrhosis
247616|NCT01899703|Ursodeoxycholic acid|ursodeoxycholic acid
247617|NCT01899703|GSK2330672|gsk2330672
247618|NCT01899703|Pharmacokinetics|pharmacokinetics
247619|NCT01899690|breast reconstruction|breast reconstruction
247620|NCT01899690|cancer|cancer
247621|NCT01899690|expander|expander
247622|NCT01899690|antibiotics|antibiotics
247623|NCT01899690|infection|infection
247624|NCT01899690|surgical site infection|surgical site infection
247625|NCT01899690|surgery|surgery
247626|NCT01899690|oncology|oncology
247627|NCT01899690|plastic surgery|plastic surgery
247628|NCT01899677|Symbiotic,cytokines, necrotising enterocolitis|symbiotic,cytokines, necrotising enterocolitis
247629|NCT01899664|peripheral nerves|peripheral nerves
247630|NCT01899664|quadriplegia|quadriplegia
247631|NCT01899664|nerve transfer|nerve transfer
247632|NCT01899664|surgical procedures, operative|surgical procedures, operative
247633|NCT01899664|hand|hand
247635|NCT01899664|quality of life|quality of life
247636|NCT01899651|EEG|eeg
247637|NCT01899651|Brain|brain
247638|NCT01899651|Infants|infants
247639|NCT01899651|Preterm|preterm
247640|NCT01899651|Hemorrhage|hemorrhage
247641|NCT01899651|Bleeding|bleeding
247642|NCT01899625|Obesity|obesity
247643|NCT01899625|weight loss|weight loss
247644|NCT01899625|young adults|young adults
247645|NCT01899612|menopause|menopause
247646|NCT01899612|vaginal atrophy|vaginal atrophy
247647|NCT01899612|cytokine|cytokine
247648|NCT01899612|IL-1beta|il-1beta
247649|NCT01899612|IL-6|il-6
247650|NCT01899612|IL-8|il-8
247651|NCT01899612|TNF-alpha|tnf-alpha
247652|NCT01899586|Aging|aging
247653|NCT01899586|Functional Capacity|functional capacity
247654|NCT01899586|Exercise Independence|exercise independence
247655|NCT01899586|Peripheral Adaptations|peripheral adaptations
247656|NCT01899586|Vascular|vascular
247657|NCT01899573|Heart failure|heart failure
247658|NCT01899573|mitral regurgitation|mitral regurgitation
247659|NCT01899573|mitral valve|mitral valve
247660|NCT01899560|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
247661|NCT01899560|positive end expiratory pressure (PEEP)|positive end expiratory pressure (peep)
247662|NCT01899560|Staircase recruitment maneuver (SRM)|staircase recruitment maneuver (srm)
247663|NCT01899560|Lung elastance|lung elastance
247664|NCT01899560|chest wall elastance|chest wall elastance
247665|NCT01899534|Pregnancy|pregnancy
247666|NCT01899534|Mental Health|mental health
247667|NCT01899534|Screening|screening
247668|NCT01899534|Computer|computer
247669|NCT01899534|Feasibility|feasibility
247670|NCT01899521|alcoholism|alcoholism
247671|NCT01899521|lung health|lung health
247673|NCT01899521|macrophage|macrophage
247674|NCT01899521|zinc|zinc
247675|NCT01899521|SAMe|same
247676|NCT01899521|S-adenosylmethionine|s-adenosylmethionine
247677|NCT01899521|alveolar|alveolar
247678|NCT01899495|blood pressure|blood pressure
247679|NCT01899495|hypertension|hypertension
247680|NCT01899495|salt sensitivity|salt sensitivity
247681|NCT01899482|Venous Insufficiency|venous insufficiency
247682|NCT01899482|Physical Therapy Techniques|physical therapy techniques
247683|NCT01899482|Manual Lymphatic Drainage|manual lymphatic drainage
247684|NCT01899443|total hip replacement|total hip replacement
247685|NCT01899443|total knee replacement|total knee replacement
247686|NCT01899443|patient outcomes|patient outcomes
247687|NCT01899443|health services research|health services research
247688|NCT01899430|PCOS|pcos
247689|NCT01899430|obesity|obesity
247690|NCT01899430|GLP-1 receptor agonist|glp-1 receptor agonist
247691|NCT01899430|liraglutide|liraglutide
247692|NCT01899430|metformin|metformin
247693|NCT01899417|osteoarthritis|osteoarthritis
247694|NCT01899417|knee replacement|knee replacement
247695|NCT01899417|patient-specific|patient-specific
247696|NCT01899417|economics|economics
247697|NCT01899404|Cervical Cancer|cervical cancer
247698|NCT01899404|PET Scan for cervix|pet scan for cervix
247699|NCT01899404|MRI for cervix|mri for cervix
247700|NCT01899391|Prostate cancer|prostate cancer
247701|NCT01899378|probiotics|probiotics
247702|NCT01899365|anti-pneumococcal vaccination|anti-pneumococcal vaccination
247703|NCT01899365|information|information
247704|NCT01899365|emergency department|emergency department
247705|NCT01899339|submassive pulmonary embolism|submassive pulmonary embolism
247706|NCT01899339|Ultrasonic energy|ultrasonic energy
247707|NCT01899339|Ekosonic Endovascular Device|ekosonic endovascular device
247708|NCT01899339|RV:LV function after Pulmonary Embolism|rv:lv function after pulmonary embolism
305365|NCT01639768|Safety|safety
247709|NCT01899313|methamphetamine dependence|methamphetamine dependence
247710|NCT01899313|texting|texting
247711|NCT01899313|short message service|short message service
247712|NCT01899313|addiction|addiction
247713|NCT01899313|amphetamine|amphetamine
247714|NCT01899313|outpatient|outpatient
5861|NCT03253861|Sepsis/complications|sepsis/complications
247715|NCT01899300|Refractory Benign Esophageal Strictures caused by Caustic Ingestion|refractory benign esophageal strictures caused by caustic ingestion
247716|NCT01899287|workers education|workers education
247717|NCT01899287|occupational|occupational
247718|NCT01899209|Obstructed Defecation|obstructed defecation
247719|NCT01899209|Rectal rectocele|rectal rectocele
247720|NCT01899209|Intussusception|intussusception
247721|NCT01899209|STARR|starr
247722|NCT01899209|Ventral Rectopexy|ventral rectopexy
247723|NCT01899196|Cardiac surgery|cardiac surgery
247724|NCT01899183|Chronic cough|chronic cough
247725|NCT01899183|Esophagus|esophagus
247726|NCT01899183|Gastro-esophageal reflux disease|gastro-esophageal reflux disease
247727|NCT01899183|Esophageal surgery|esophageal surgery
247728|NCT01899183|Minimally invasive surgery|minimally invasive surgery
247729|NCT01899183|Extra-esophageal reflux symptoms.|extra-esophageal reflux symptoms.
247730|NCT01899170|deep brain stimulation|deep brain stimulation
247731|NCT01899170|multi-coil transcranial magnetic stimulation|multi-coil transcranial magnetic stimulation
247732|NCT01899170|PET-imaging|pet-imaging
247733|NCT01899170|personalized treatment|personalized treatment
247734|NCT01899157|Nutritional status|nutritional status
247735|NCT01899157|Nutritional situation|nutritional situation
247736|NCT01899144|Albuterol Spiromax|albuterol spiromax
247737|NCT01899144|ProAir HFA|proair hfa
247738|NCT01899144|albuterol sulfate|albuterol sulfate
247739|NCT01899131|dental implants|dental implants
247740|NCT01899131|crestal bone|crestal bone
247741|NCT01899131|gingival margin|gingival margin
247742|NCT01899118|locally advanced rectal cancer|locally advanced rectal cancer
247743|NCT01899118|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
247744|NCT01899118|Nimotuzumab|nimotuzumab
247745|NCT01899092|Genotype 1|genotype 1
247746|NCT01899092|Chronic Hepatitis C|chronic hepatitis c
247747|NCT01899092|CHC|chc
247748|NCT01899092|HCV|hcv
247749|NCT01899092|Hepatitis|hepatitis
247750|NCT01899092|RNAi|rnai
247751|NCT01899092|shRNA|shrna
247752|NCT01899092|ddRNAi|ddrnai
247753|NCT01899092|AAV8|aav8
247754|NCT01899092|AAV|aav
247755|NCT01899092|Adeno-associated virus|adeno-associated virus
247756|NCT01899092|Adeno-associated viral vectors|adeno-associated viral vectors
247757|NCT01899079|Breast Cancer|breast cancer
247758|NCT01899079|Prosigna|prosigna
247759|NCT01899079|FFPE|ffpe
247760|NCT01899079|node negative|node negative
247761|NCT01899079|estrogen receptor positive|estrogen receptor positive
247762|NCT01899079|HER2 negative|her2 negative
247763|NCT01899066|Efficacy|efficacy
247764|NCT01899053|Solid tumors|solid tumors
247765|NCT01899053|MLN0128|mln0128
247766|NCT01899053|MLN1117|mln1117
247767|NCT01899040|neuromodulation|neuromodulation
247768|NCT01899040|migraine headache|migraine headache
247769|NCT01899027|Arterial hypertension|arterial hypertension
247770|NCT01899027|Radiofrequency ablation|radiofrequency ablation
247771|NCT01899027|Renal function|renal function
247772|NCT01899014|Atherosclerosis|atherosclerosis
247773|NCT01899014|18F-choline|18f-choline
247774|NCT01899014|PET-CT|pet-ct
247775|NCT01899014|MRI|mri
247776|NCT01899014|Ultrasound|ultrasound
247777|NCT01899001|Polycystic Ovary Syndrome|polycystic ovary syndrome
247778|NCT01899001|PCOS|pcos
247779|NCT01899001|Depression|depression
247780|NCT01899001|Anxiety|anxiety
247781|NCT01899001|Weight loss|weight loss
247782|NCT01899001|Exercise|exercise
247783|NCT01899001|Nutrition|nutrition
247784|NCT01899001|Therapy|therapy
247785|NCT01899001|Mood symptoms|mood symptoms
247786|NCT01899001|Stress|stress
247787|NCT01898975|Neurosurgical patients|neurosurgical patients
247788|NCT01898975|Fluid loading|fluid loading
247789|NCT01898975|Fluid responsiveness|fluid responsiveness
247790|NCT01898975|NICOM|nicom
247791|NCT01898975|Stroke volume variation|stroke volume variation
247792|NCT01898975|Pulse pressure variation|pulse pressure variation
247793|NCT01898975|Total peripheral resistance|total peripheral resistance
247794|NCT01898975|Gray zone approach|gray zone approach
247795|NCT01898962|Oligometastases|oligometastases
247796|NCT01898962|Metastatic cancer|metastatic cancer
247797|NCT01898962|Stereotactic radiosurgery|stereotactic radiosurgery
247798|NCT01898949|Diet-induced thermogenesis|diet-induced thermogenesis
247799|NCT01898949|Cold-induced thermogenesis|cold-induced thermogenesis
247800|NCT01898949|Brown adipose tissue|brown adipose tissue
247801|NCT01898949|Brown fat|brown fat
247802|NCT01898923|WH-1,Diabetic Foot,Ulcer|wh-1,diabetic foot,ulcer
247803|NCT01898845|Neoplasms|neoplasms
247804|NCT01898832|Cholestasis, pregnant, interleukin 17|cholestasis, pregnant, interleukin 17
247805|NCT01898819|DEXMEDETOMIDINE|dexmedetomidine
305507|NCT01639001|ALK|alk
247806|NCT01898819|intraocular pressure|intraocular pressure
247807|NCT01898806|Alopecia Areata|alopecia areata
247808|NCT01898806|Kenalog|kenalog
247809|NCT01898806|Triamcinolone|triamcinolone
247810|NCT01898767|mild|mild
247811|NCT01898767|asthma|asthma
247812|NCT01898767|allergic|allergic
247813|NCT01898754|Transmitted Drug Resistance|transmitted drug resistance
247814|NCT01898741|Pancreatic cancer|pancreatic cancer
247815|NCT01898741|Radiotherapy|radiotherapy
247816|NCT01898741|SBRT|sbrt
247817|NCT01898715|Adrenocortical carcinoma|adrenocortical carcinoma
247818|NCT01898715|Adrenal cancer|adrenal cancer
247819|NCT01898715|ACC|acc
247820|NCT01898676|Extended-release divalproex sodium|extended-release divalproex sodium
247821|NCT01898676|Depakote ER|depakote er
247822|NCT01898650|craniosynostosis|craniosynostosis
247823|NCT01898650|sagittal synostosis|sagittal synostosis
247824|NCT01898650|metopic synostosis|metopic synostosis
247825|NCT01898650|coronal synostosis|coronal synostosis
247826|NCT01898650|lambdoid synostosis|lambdoid synostosis
247827|NCT01898637|pulmonary embolism|pulmonary embolism
247828|NCT01898637|pulse oximetry|pulse oximetry
247829|NCT01898637|change in oxygen saturation|change in oxygen saturation
247830|NCT01898637|hypoxemia|hypoxemia
247831|NCT01898637|emergency department|emergency department
247832|NCT01898637|deep inspiration|deep inspiration
247833|NCT01898637|vital capacity|vital capacity
247834|NCT01898637|clinical diagnosis|clinical diagnosis
247835|NCT01898624|mirabegron|mirabegron
247836|NCT01898624|Overactive Bladder|overactive bladder
247837|NCT01898624|Betanis®|betanis®
247840|NCT01898611|Sarcopenia|sarcopenia
247841|NCT01898611|Weight Loss|weight loss
247842|NCT01898611|Exercise|exercise
247843|NCT01898611|Aging|aging
247844|NCT01898611|Ghrelin|ghrelin
247845|NCT01898611|Elderly|elderly
247846|NCT01898572|Newly Diagnosed Type II Diabetes Mellitus|newly diagnosed type ii diabetes mellitus
247847|NCT01898572|Carotid Intimae-media Thickness|carotid intimae-media thickness
247848|NCT01898572|Carotid Plaque|carotid plaque
247849|NCT01898572|Cardiovascular Disease|cardiovascular disease
247850|NCT01898559|little cigars|little cigars
247851|NCT01898559|cigarettes|cigarettes
247852|NCT01898559|smoking|smoking
247853|NCT01898546|Ischemic postconditioning|ischemic postconditioning
247854|NCT01898546|Myocardial Infarction|myocardial infarction
247855|NCT01898546|Microvascular Obstruction|microvascular obstruction
247856|NCT01898520|Spasticity|spasticity
247857|NCT01898507|low nicotine|low nicotine
247858|NCT01898507|cigarettes|cigarettes
247859|NCT01898507|NMR|nmr
247860|NCT01898481|Health care decision making|health care decision making
247861|NCT01898468|Neuropathic pain symptoms|neuropathic pain symptoms
247862|NCT01898468|Intracostal Closure Technique|intracostal closure technique
247863|NCT01898468|Pericostal Suture Closure Technique|pericostal suture closure technique
247864|NCT01898468|Post surgical pain|post surgical pain
247865|NCT01898468|Post thoracotomy pain|post thoracotomy pain
247866|NCT01898455|Migraine|migraine
247867|NCT01898455|Cluster headache|cluster headache
247868|NCT01898455|headache|headache
247869|NCT01898442|platelet function|platelet function
247870|NCT01898442|ticagrelor|ticagrelor
247871|NCT01898442|STEMI|stemi
247872|NCT01898429|Treatment Resistant Depression|treatment resistant depression
247873|NCT01898429|Treatment Refractory Depression|treatment refractory depression
248070|NCT01897311|pain|pain
247874|NCT01898429|Treatment Resistant Bipolar Disorder|treatment resistant bipolar disorder
247875|NCT01898429|Treatment Refractory Bipolar Disorder|treatment refractory bipolar disorder
247876|NCT01898429|Deep brain stimulation|deep brain stimulation
247877|NCT01898429|DBS|dbs
247878|NCT01898390|Parkinson's Disease|parkinson's disease
247879|NCT01898390|Allo-Transplantation|allo-transplantation
247880|NCT01898390|Fetal Ventral Mesencephalic Tissue|fetal ventral mesencephalic tissue
247881|NCT01898377|Children|children
247882|NCT01898377|Chronic graft-versus-host disease|chronic graft-versus-host disease
247883|NCT01898351|Alternative sources of plant proteins|alternative sources of plant proteins
247884|NCT01898351|High protein diets|high protein diets
247885|NCT01898351|Satiety|satiety
247886|NCT01898351|Postprandial effects|postprandial effects
247887|NCT01898351|Bioactive phytochemicals|bioactive phytochemicals
247888|NCT01898351|Phytochemicals bioactivity and metabolism|phytochemicals bioactivity and metabolism
247889|NCT01898351|Macronutrients metabolism|macronutrients metabolism
247890|NCT01898351|Health effects of plant proteins vs. meat proteins|health effects of plant proteins vs. meat proteins
247891|NCT01898351|Partial meat proteins replacement with plant proteins|partial meat proteins replacement with plant proteins
247892|NCT01898351|Satiety of meals rich in plant proteins|satiety of meals rich in plant proteins
247893|NCT01898351|Postprandial effects of meals rich in plant proteins|postprandial effects of meals rich in plant proteins
247894|NCT01898351|Plant phytochemicals and macronutrients bioavailability and metabolism|plant phytochemicals and macronutrients bioavailability and metabolism
247895|NCT01898338|MRSA|mrsa
247896|NCT01898338|bacteremia|bacteremia
247897|NCT01898338|therapy|therapy
247898|NCT01898325|Fibrosis|fibrosis
247899|NCT01898325|Gaucher disease|gaucher disease
247900|NCT01898299|Schizophrenia|schizophrenia
247901|NCT01898286|C peptide|c peptide
247902|NCT01898286|beta cell function|beta cell function
247903|NCT01898286|immune modulation of type 1 diabetes|immune modulation of type 1 diabetes
247904|NCT01898286|immune intervention in type 1 diabetes|immune intervention in type 1 diabetes
247905|NCT01898273|Glioma|glioma
247906|NCT01898273|Glioblastoma Multiforme|glioblastoma multiforme
247907|NCT01898273|PET|pet
247908|NCT01898273|Imaging|imaging
247909|NCT01898273|Radiopharmaceutical|radiopharmaceutical
247910|NCT01898273|Diagnostic|diagnostic
247911|NCT01898260|contact lenses|contact lenses
247912|NCT01898260|daily disposable contact lenses|daily disposable contact lenses
247913|NCT01898260|silicone hydrogel|silicone hydrogel
247914|NCT01898260|contact lens comfort|contact lens comfort
247915|NCT01898260|near-sighted|near-sighted
247916|NCT01898247|Thoracentesis|thoracentesis
247917|NCT01898247|Simulation Based Mastery Learning|simulation based mastery learning
247918|NCT01898247|Medical Education|medical education
247919|NCT01898247|Length of Stay|length of stay
247920|NCT01898247|Cost of Care|cost of care
247921|NCT01898234|Hemodynamics|hemodynamics
247922|NCT01898234|intradialytic hypotension|intradialytic hypotension
247923|NCT01898234|subjective tolerance|subjective tolerance
247924|NCT01898234|dialysis membranes|dialysis membranes
247925|NCT01898234|high flux|high flux
247926|NCT01898234|low flux|low flux
247927|NCT01898234|hemodialysis|hemodialysis
247928|NCT01898208|Bacteremia|bacteremia
247929|NCT01898208|Fungemia|fungemia
247930|NCT01898208|Bloodstream infection|bloodstream infection
247931|NCT01898208|susceptibility|susceptibility
247932|NCT01898208|MRSA|mrsa
247933|NCT01898208|VRE|vre
247934|NCT01898143|Whole body vibration, cardiorespiratory response|whole body vibration, cardiorespiratory response
247935|NCT01898117|Triple negative|triple negative
247936|NCT01898117|Metastatic|metastatic
247937|NCT01898104|rectal|rectal
247938|NCT01898104|low risk|low risk
247939|NCT01898104|moderate risk|moderate risk
247940|NCT01898091|Oral|oral
247941|NCT01898091|Mucositis|mucositis
247942|NCT01898091|Stomatitis|stomatitis
247943|NCT01898091|Radiotherapy|radiotherapy
247944|NCT01898078|MLN8237|mln8237
247945|NCT01898078|alisertib|alisertib
247946|NCT01898078|food effects|food effects
247947|NCT01898065|Hypoxia|hypoxia
247948|NCT01898065|radiotherapy|radiotherapy
247949|NCT01898065|PET with 18-F-MISO|pet with 18-f-miso
247950|NCT01898065|MRI|mri
247951|NCT01898052|pain control|pain control
247952|NCT01898052|periarticular injection|periarticular injection
247953|NCT01898052|Total knee arthroplasty|total knee arthroplasty
247954|NCT01898052|levobupivacaine|levobupivacaine
247955|NCT01898052|multimodal drug injection|multimodal drug injection
247956|NCT01898039|malignant melanoma|malignant melanoma
247957|NCT01898039|vaccine|vaccine
247958|NCT01898039|cell line|cell line
247959|NCT01898039|high risk|high risk
247960|NCT01898039|residual disease|residual disease
247961|NCT01898026|PGX|pgx
247962|NCT01898026|fibre|fibre
247963|NCT01898026|postprandial glycemia|postprandial glycemia
247964|NCT01898013|pain|pain
247965|NCT01898013|pregnenolone|pregnenolone
247966|NCT01898013|Veterans|veterans
247967|NCT01898013|clinical trial|clinical trial
247968|NCT01898013|neurosteroid|neurosteroid
247969|NCT01898013|allopregnanolone|allopregnanolone
247970|NCT01898013|low back|low back
247971|NCT01898013|placebo controlled|placebo controlled
247972|NCT01898013|randomized|randomized
247973|NCT01898013|musculoskeletal|musculoskeletal
247974|NCT01898000|Gingivitis|gingivitis
247975|NCT01898000|Herbal medicine|herbal medicine
247976|NCT01898000|Plaque control|plaque control
247977|NCT01897987|Human Umbilical Cord Blood Derived Mesenchymal Stem Cells|human umbilical cord blood derived mesenchymal stem cells
247978|NCT01897987|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
247979|NCT01897987|Premature infants|premature infants
247980|NCT01897935|Uveitis|uveitis
247981|NCT01897896|Chorea|chorea
247982|NCT01897896|Huntington Disease|huntington disease
247983|NCT01897870|continuity of care|continuity of care
247984|NCT01897870|medicines management|medicines management
247985|NCT01897870|home visit|home visit
247986|NCT01897870|drug-related problems|drug-related problems
247987|NCT01897857|diabetes mellitus(DM)|diabetes mellitus(dm)
247988|NCT01897857|radial artery cannulation|radial artery cannulation
247989|NCT01897857|artery blood flow|artery blood flow
247990|NCT01897857|complication|complication
247991|NCT01897857|End stage renal disease undergoing kidney transplantation|end stage renal disease undergoing kidney transplantation
247992|NCT01897844|volunteers|volunteers
247993|NCT01897831|Piperacillin Sodium and sulbactam sodium|piperacillin sodium and sulbactam sodium
247994|NCT01897831|Phase IV clinical studies|phase iv clinical studies
247995|NCT01897831|Respiratory and urinary tract infections|respiratory and urinary tract infections
238780|NCT01941121|593|593
247996|NCT01897805|Coronary artery disease|coronary artery disease
247997|NCT01897766|Genotropin|genotropin
247998|NCT01897766|Somatropin|somatropin
247999|NCT01897766|Long Term Follow-Up|long term follow-up
248000|NCT01897766|Special Investigation|special investigation
248001|NCT01897766|Small for Gestational Age|small for gestational age
248002|NCT01897766|SGA|sga
248003|NCT01897753|SGA|sga
248004|NCT01897753|Growth hormone|growth hormone
248005|NCT01897740|sildenafil|sildenafil
248006|NCT01897740|pulmonary arterial hypertension|pulmonary arterial hypertension
248007|NCT01897740|PAH|pah
248008|NCT01897727|sleep apnea|sleep apnea
248009|NCT01897727|hypertension|hypertension
248010|NCT01897727|aldosterone|aldosterone
248011|NCT01897727|hyperaldosteronism|hyperaldosteronism
248012|NCT01897727|spironolactone|spironolactone
248013|NCT01897727|blood pressure|blood pressure
248014|NCT01897727|resistant|resistant
248015|NCT01897701|H7N9|h7n9
248016|NCT01897688|Diabetes|diabetes
248017|NCT01897688|Islet|islet
248018|NCT01897688|Pancreas|pancreas
248019|NCT01897688|Hypoglycemia|hypoglycemia
248020|NCT01897688|T1D|t1d
248021|NCT01897688|Transplant|transplant
248022|NCT01897675|Cutaneous Abscess|cutaneous abscess
248023|NCT01897675|Emergency Department|emergency department
248024|NCT01897662|overweight|overweight
248025|NCT01897662|satiety|satiety
248026|NCT01897662|functional food|functional food
248027|NCT01897662|food intake|food intake
248028|NCT01897662|digestive tolerance|digestive tolerance
248029|NCT01897649|functional food|functional food
248030|NCT01897649|digestive tolerance|digestive tolerance
248031|NCT01897649|microbiota|microbiota
248032|NCT01897649|bifidogenic effect|bifidogenic effect
248033|NCT01897636|endoscopic ultrasound-guided fine-needle injection|endoscopic ultrasound-guided fine-needle injection
248034|NCT01897636|dendritic cell|dendritic cell
248035|NCT01897636|vaccination|vaccination
248036|NCT01897610|Immuncell-LC, advanced hepatocellular carcinoma|immuncell-lc, advanced hepatocellular carcinoma
248037|NCT01897584|laparoscopy, Trendelenburg Position, ventilation|laparoscopy, trendelenburg position, ventilation
248038|NCT01897545|Arterial hypertension|arterial hypertension
248039|NCT01897545|Atrial Fibrillation|atrial fibrillation
248040|NCT01897545|Percutaneous renal denervation|percutaneous renal denervation
248041|NCT01897519|High risk surgery|high risk surgery
248042|NCT01897519|Acute Kidney Injury|acute kidney injury
248043|NCT01897506|Food insecurity|food insecurity
248044|NCT01897506|Health literacy|health literacy
248045|NCT01897506|Quality of life|quality of life
248046|NCT01897402|Central Nervous System Infections|central nervous system infections
248047|NCT01897402|Meningitis|meningitis
248048|NCT01897402|toxoid|toxoid
248049|NCT01897402|Meningococcal vaccine|meningococcal vaccine
248050|NCT01897402|conjugate vaccines|conjugate vaccines
248051|NCT01897389|Healthy volunteers|healthy volunteers
248052|NCT01897389|Bioavailability|bioavailability
248053|NCT01897389|Abiraterone acetate|abiraterone acetate
248054|NCT01897389|ZYTIGA|zytiga
248055|NCT01897376|wound|wound
248056|NCT01897376|infection|infection
248057|NCT01897376|cesarean delivery|cesarean delivery
248058|NCT01897376|obesity|obesity
248059|NCT01897363|Prader Willi Syndrome|prader willi syndrome
248060|NCT01897363|Hypoglycemia|hypoglycemia
248061|NCT01897363|Fasting study|fasting study
248062|NCT01897350|STEMI|stemi
248063|NCT01897350|Myocardial edema|myocardial edema
248064|NCT01897350|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
248065|NCT01897324|Poor Ovarian Response|poor ovarian response
248066|NCT01897324|Poor Responders|poor responders
248067|NCT01897324|IVF/ICSI|ivf/icsi
248068|NCT01897324|Growth Hormone|growth hormone
248069|NCT01897311|cesarean section|cesarean section
248071|NCT01897311|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
248072|NCT01897311|postpartum period|postpartum period
586241|NCT00523978|Atrial Fibrillation|atrial fibrillation
248073|NCT01897298|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
248074|NCT01897298|urban training|urban training
248075|NCT01897298|physical activity|physical activity
248076|NCT01897298|active aging|active aging
248077|NCT01897285|Performance and safety of the AQUACEL® foam adhesive dressing|performance and safety of the aquacel® foam adhesive dressing
248078|NCT01897272|carpal tunnel syndrome|carpal tunnel syndrome
248079|NCT01897272|splinting|splinting
248080|NCT01897272|nerve decompression|nerve decompression
248081|NCT01897259|tennis elbow|tennis elbow
248082|NCT01897259|lateral epicondylitis|lateral epicondylitis
248083|NCT01897246|distal radius malunion|distal radius malunion
248084|NCT01897246|extra-articular|extra-articular
248085|NCT01897220|Noncardiac surgery;|noncardiac surgery;
248086|NCT01897220|Perioperative ischemic complications;|perioperative ischemic complications;
248087|NCT01897220|Perioperative bleeding complications;|perioperative bleeding complications;
248088|NCT01897220|Antithrombotic therapy;|antithrombotic therapy;
248089|NCT01897220|Coronary artery disease;|coronary artery disease;
248090|NCT01897220|Stent thrombosis;|stent thrombosis;
248091|NCT01897220|Perioperative infarction.|perioperative infarction.
248092|NCT01897207|prostate cancer|prostate cancer
248093|NCT01897207|dendritic cells|dendritic cells
248094|NCT01897207|vaccination|vaccination
248095|NCT01897181|Central auditory processing|central auditory processing
248096|NCT01897181|Bilateral sensorineural hearing loss|bilateral sensorineural hearing loss
248097|NCT01897181|Hearing aids|hearing aids
248098|NCT01897155|analgesia, postoperative;|analgesia, postoperative;
248099|NCT01897155|analgesics opioid;|analgesics opioid;
248100|NCT01897155|hyperalgesia;|hyperalgesia;
248101|NCT01897155|remifentanil;|remifentanil;
248102|NCT01897155|hypertension.|hypertension.
248103|NCT01897103|Peripheral Artery Disease|peripheral artery disease
248104|NCT01897103|Endarterectomy (Carotid)|endarterectomy (carotid)
248105|NCT01897103|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
248106|NCT01897103|Aortic Aneurysm, Thoracic|aortic aneurysm, thoracic
248107|NCT01897103|Amputation|amputation
248108|NCT01897103|Platelet Activity|platelet activity
248109|NCT01897103|Thrombin|thrombin
248110|NCT01897103|Transcriptomics|transcriptomics
248111|NCT01897090|Elimination Diet|elimination diet
248112|NCT01897090|Crohn's disease|crohn's disease
248113|NCT01897077|Food Allergy|food allergy
248114|NCT01897077|Peanut|peanut
248115|NCT01897077|Sublingual Immunotherapy|sublingual immunotherapy
248116|NCT01897064|Schizophrenia|schizophrenia
248117|NCT01897064|Cognition|cognition
248118|NCT01897064|Aerobic Exercise|aerobic exercise
248119|NCT01897051|Liver cirrhosis|liver cirrhosis
248120|NCT01897051|Portal hypertension|portal hypertension
248121|NCT01897051|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
248122|NCT01897051|Rifaximin|rifaximin
248123|NCT01897025|Stroke|stroke
248124|NCT01897025|Noninvasive brain stimulation|noninvasive brain stimulation
248125|NCT01897025|Brain-computer interface|brain-computer interface
248126|NCT01897025|Motor imagery|motor imagery
248127|NCT01897025|Rehabilitation|rehabilitation
248919|NCT01893619|supplements|supplements
248128|NCT01896986|Special risk patients|special risk patients
248129|NCT01896986|Immunosuppressive biologic treatments|immunosuppressive biologic treatments
248130|NCT01896986|PRD (Paediatric Rheumatological Disease)|prd (paediatric rheumatological disease)
248131|NCT01896986|IBD (Inflammatory Bowel Disease)|ibd (inflammatory bowel disease)
248132|NCT01896973|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
248133|NCT01896973|BPH|bph
248134|NCT01896973|LUTS|luts
248135|NCT01896973|Vortx Rx|vortx rx
248136|NCT01896973|Histotripsy|histotripsy
248137|NCT01896960|Post spinal hypotension|post spinal hypotension
248138|NCT01896960|Cesarian Section|cesarian section
248139|NCT01896960|ET50|et50
248140|NCT01896960|Bupivacaine|bupivacaine
248141|NCT01896960|Fentanyl|fentanyl
248142|NCT01896934|Depression|depression
248143|NCT01896934|Antidepressants|antidepressants
248144|NCT01896934|Elderly|elderly
248145|NCT01896934|Geriatrics|geriatrics
248146|NCT01896921|HIV|hiv
248147|NCT01896908|diastolic dysfunction|diastolic dysfunction
248148|NCT01896908|Sodium restriction|sodium restriction
248149|NCT01896908|Randomized clinical trial|randomized clinical trial
248150|NCT01896882|Diet, Sodium-Restricted|diet, sodium-restricted
248151|NCT01896882|Food and Nutrition Education|food and nutrition education
248152|NCT01896882|Renal Dialyisis|renal dialyisis
248153|NCT01896869|Pancreatic Cancer|pancreatic cancer
248154|NCT01896869|Vaccine|vaccine
248155|NCT01896869|Immunotherapy|immunotherapy
248156|NCT01896869|Ipilimumab|ipilimumab
248157|NCT01896869|CTLA-4|ctla-4
248158|NCT01896869|antibody|antibody
248159|NCT01896869|FOLFIRINOX|folfirinox
248160|NCT01896856|SGI-110|sgi-110
248161|NCT01896856|irinotecan|irinotecan
248162|NCT01896856|regorafenib|regorafenib
248163|NCT01896856|methylation|methylation
248164|NCT01896856|colorectal|colorectal
248165|NCT01896856|metastatic|metastatic
248166|NCT01896856|TAS-102|tas-102
248167|NCT01896856|lonsurf|lonsurf
248168|NCT01896843|Positron Emission Tomography (PET)|positron emission tomography (pet)
248169|NCT01896843|Metabotropic Glutamate Receptors|metabotropic glutamate receptors
248170|NCT01896830|Clostridium difficile infection|clostridium difficile infection
248171|NCT01896830|Clostridium difficile Toxoid Vaccine|clostridium difficile toxoid vaccine
248172|NCT01896739|Healthy infants with over than 37 weeks gestation periods.|healthy infants with over than 37 weeks gestation periods.
248173|NCT01896739|over than 2.5Kg at at birth weight.|over than 2.5kg at at birth weight.
248174|NCT01896713|Prostate Cancer|prostate cancer
248175|NCT01896713|MRI|mri
248176|NCT01896713|TRUSBx|trusbx
248177|NCT01896700|Multiple sclerosis|multiple sclerosis
248178|NCT01896700|postural balance|postural balance
248179|NCT01896700|walking|walking
248180|NCT01896687|nonspecific low back pain|nonspecific low back pain
248181|NCT01896687|chronic low back pain|chronic low back pain
248182|NCT01896674|Computed tomography|computed tomography
248183|NCT01896661|Sleep apnea|sleep apnea
248184|NCT01896661|Hypertension|hypertension
248185|NCT01896661|Treatment|treatment
248186|NCT01896661|Diuretics|diuretics
248187|NCT01896661|Chlorthalidone|chlorthalidone
248188|NCT01896661|Amlodipine|amlodipine
248189|NCT01896635|Ulcerative Colitis|ulcerative colitis
248190|NCT01896635|Inflammatory Bowel Disease|inflammatory bowel disease
248191|NCT01896635|Fecal Transplantation|fecal transplantation
248192|NCT01896635|Fecal Microbiota Transplantation|fecal microbiota transplantation
248193|NCT01896622|Dabigatran Etexilate|dabigatran etexilate
248194|NCT01896622|Ritonavir|ritonavir
248195|NCT01896622|Cobicistat|cobicistat
248196|NCT01896622|P-Glycoprotein|p-glycoprotein
248197|NCT01896609|Chronic hepatitis c|chronic hepatitis c
248198|NCT01896609|Egyptian population|egyptian population
248199|NCT01896609|Reiferon Retard|reiferon retard
248200|NCT01896609|Ribavirin|ribavirin
248201|NCT01896609|Nitazoxanide|nitazoxanide
248202|NCT01896609|Bon one|bon one
248203|NCT01896596|vaccines|vaccines
248204|NCT01896596|immunogenicity|immunogenicity
248205|NCT01896596|adverse reactions|adverse reactions
5862|NCT03253861|Infection|infection
248206|NCT01896570|atrial fibrillation|atrial fibrillation
248207|NCT01896570|catheter ablation|catheter ablation
248208|NCT01896570|subsequent atrial tachycardia|subsequent atrial tachycardia
248209|NCT01896570|mechanisms|mechanisms
248210|NCT01896557|clopidogrel|clopidogrel
248211|NCT01896557|omeprazole|omeprazole
248212|NCT01896557|ranitidin|ranitidin
248213|NCT01896557|interaction|interaction
248214|NCT01896557|aggregability|aggregability
248215|NCT01896544|cholecalciferol|cholecalciferol
248216|NCT01896544|vitamin D|vitamin d
248217|NCT01896544|sepsis|sepsis
248218|NCT01896544|infection|infection
248219|NCT01896518|second hand smoke exposure; children|second hand smoke exposure; children
248220|NCT01896505|bone|bone
248221|NCT01896505|soft-tissue|soft-tissue
248222|NCT01896505|sarcoma|sarcoma
248223|NCT01896505|KPT-330|kpt-330
248224|NCT01896505|food|food
248225|NCT01896505|effects|effects
248226|NCT01896505|Selinexor|selinexor
248227|NCT01896492|PCOS,|pcos,
248228|NCT01896492|NAC,|nac,
248229|NCT01896492|OVULATION INDUCTION,|ovulation induction,
248230|NCT01896492|CLOMOPHEN CITRATE|clomophen citrate
248231|NCT01896479|thyroid cancer|thyroid cancer
248232|NCT01896479|medullary thyroid cancer|medullary thyroid cancer
248233|NCT01896466|Fall Risk|fall risk
248234|NCT01896466|Gait|gait
248235|NCT01896466|Dynamic Balance|dynamic balance
248236|NCT01896466|Static Balance|static balance
248237|NCT01896466|Neuromodulation|neuromodulation
248238|NCT01896440|Pediatric|pediatric
248239|NCT01896440|Ondansetron|ondansetron
248240|NCT01896440|Cardiac repolarization|cardiac repolarization
248241|NCT01896440|QTc interval|qtc interval
248242|NCT01896427|Third Molar|third molar
248243|NCT01896427|Edema|edema
248244|NCT01896427|pain|pain
248245|NCT01896427|trismus|trismus
248246|NCT01896414|Metabolic Syndrome|metabolic syndrome
248247|NCT01896414|Omega 3 Fish Oil|omega 3 fish oil
248248|NCT01896401|large bore endovascular catheterization procedures|large bore endovascular catheterization procedures
248249|NCT01896401|Vascular Closure Device|vascular closure device
248250|NCT01896388|PTSD/ifenprodil|ptsd/ifenprodil
248251|NCT01896375|Gutkha|gutkha
248252|NCT01896375|Pan masala ban|pan masala ban
248253|NCT01896375|Legislation|legislation
248254|NCT01896375|Smokeless tobacco|smokeless tobacco
248255|NCT01896349|Psychotherapy, Treatment Resistant Depression, depression|psychotherapy, treatment resistant depression, depression
248256|NCT01896271|kidney cancer|kidney cancer
248257|NCT01896271|metastatic cancer|metastatic cancer
248258|NCT01896245|hoarseness|hoarseness
248259|NCT01896245|sore throat|sore throat
248260|NCT01896245|intubating conditions|intubating conditions
248261|NCT01896245|vocal cord injuries|vocal cord injuries
248262|NCT01896245|sevoflurane|sevoflurane
248263|NCT01896232|Secondary Hyperparathyroidism, renal, kidney, kidneys, dialysis, hemodialysis, chronic kidney disease, CKD, SHPT|secondary hyperparathyroidism, renal, kidney, kidneys, dialysis, hemodialysis, chronic kidney disease, ckd, shpt
248264|NCT01896219|Medical device|medical device
248266|NCT01896219|Needle|needle
248267|NCT01896219|Navigation|navigation
248268|NCT01896219|IMACTIS-CT®|imactis-ct®
248269|NCT01896219|Thoraco-abdominal level|thoraco-abdominal level
248270|NCT01896219|anesthesia needles|anesthesia needles
248271|NCT01896180|POAG|poag
248272|NCT01896180|OHT|oht
248273|NCT01896180|OHTN|ohtn
248274|NCT01896180|IOP|iop
248275|NCT01896167|Headache|headache
248276|NCT01896167|Migraine|migraine
248277|NCT01896167|Aura|aura
248278|NCT01896167|Cerebral hemodynamics|cerebral hemodynamics
248279|NCT01896154|dietary fibers, influenza vaccination, HI titres|dietary fibers, influenza vaccination, hi titres
248280|NCT01896128|stroke|stroke
248281|NCT01896128|CVA|cva
248282|NCT01896128|cerebrovascular accident|cerebrovascular accident
248283|NCT01896128|hemiparesis|hemiparesis
248284|NCT01896128|impairment|impairment
248285|NCT01896128|motor recovery|motor recovery
248286|NCT01896128|neuroplasticity|neuroplasticity
248287|NCT01896128|nuvigil|nuvigil
248288|NCT01896128|armodafinil|armodafinil
402977|NCT01228786|VDR, CaSR, PTH, Cyclin D1, Ki67, PCNA|vdr, casr, pth, cyclin d1, ki67, pcna
248289|NCT01896115|Stimulation, implantable pulse generator, deep brain stimulation|stimulation, implantable pulse generator, deep brain stimulation
248290|NCT01896102|Adrenoleukodystrophy|adrenoleukodystrophy
248291|NCT01896102|X-linked adrenoleukodystrophy|x-linked adrenoleukodystrophy
248292|NCT01896102|Gene therapy|gene therapy
248293|NCT01896102|Hematopoietic stem cell|hematopoietic stem cell
248294|NCT01896076|caudal space|caudal space
248295|NCT01896076|children|children
248296|NCT01896076|ultrasound evaluation|ultrasound evaluation
248297|NCT01896063|Electroacupuncture, Sedation|electroacupuncture, sedation
248298|NCT01896050|Joint pain|joint pain
248299|NCT01896050|Grip strength|grip strength
248300|NCT01896050|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
248301|NCT01896037|Spinal cord injury|spinal cord injury
248302|NCT01896037|Tetraplegia|tetraplegia
248303|NCT01896037|Quadraplegia|quadraplegia
248304|NCT01896037|Cholesterol|cholesterol
248305|NCT01896037|HDL-c|hdl-c
248306|NCT01896037|LDL-c|ldl-c
248307|NCT01896037|Omega-3 fatty acids|omega-3 fatty acids
248308|NCT01895998|sickle cell disease|sickle cell disease
248309|NCT01895998|pulmonary hypertension|pulmonary hypertension
248310|NCT01895998|airway hyperreactivity|airway hyperreactivity
248311|NCT01895998|acute chest syndrome|acute chest syndrome
248312|NCT01895959|knee osteoarthritis (OA)|knee osteoarthritis (oa)
248313|NCT01895959|hyaluronic acid injection|hyaluronic acid injection
248314|NCT01895946|Advanced solid malignancy, AZD5363,|advanced solid malignancy, azd5363,
248315|NCT01895946|food effect,|food effect,
248316|NCT01895946|formulation comparison|formulation comparison
248317|NCT01895933|Investigational device (chitosan gel)|investigational device (chitosan gel)
248318|NCT01895933|Wound healing|wound healing
248319|NCT01895933|Endoscopic sinus surgery|endoscopic sinus surgery
248320|NCT01895933|SurgiShield|surgishield
248322|NCT01895920|Biofilm|biofilm
248323|NCT01895920|Transmission|transmission
248324|NCT01895907|Special Olympics|special olympics
248325|NCT01895907|occupational therapy|occupational therapy
248326|NCT01895907|SCOPE|scope
248327|NCT01895907|life participation improvement|life participation improvement
248328|NCT01895894|Mycophenolate mofetil|mycophenolate mofetil
248329|NCT01895894|Immunosuppressive Agents|immunosuppressive agents
248330|NCT01895894|Nephrosis|nephrosis
248331|NCT01895881|Intracranial Aneurysm|intracranial aneurysm
248332|NCT01895881|Estradiol|estradiol
248333|NCT01895868|Ultrasound training|ultrasound training
248334|NCT01895868|Ultrasound simulation|ultrasound simulation
248335|NCT01895868|Ultrasound assessment|ultrasound assessment
248336|NCT01895868|Technology-enhanced learning|technology-enhanced learning
248337|NCT01895868|virtual reality simulation|virtual reality simulation
248338|NCT01895842|Leukemia|leukemia
248339|NCT01895842|Myelodysplastic syndrome|myelodysplastic syndrome
248340|NCT01895842|MDS|mds
248341|NCT01895842|Low or intermediate-1 risk|low or intermediate-1 risk
248342|NCT01895842|Maximum tolerated dose|maximum tolerated dose
248343|NCT01895842|MTD|mtd
248344|NCT01895842|Ruxolitinib|ruxolitinib
248345|NCT01895842|Jakafi|jakafi
248346|NCT01895842|INCB018424|incb018424
248347|NCT01895842|INC424|inc424
248348|NCT01895829|Head and Neck Cancer|head and neck cancer
248349|NCT01895829|Squamous cell carcinomas of the head and neck|squamous cell carcinomas of the head and neck
248350|NCT01895829|HNSCC|hnscc
248351|NCT01895829|Magnetic resonance imaging|magnetic resonance imaging
248352|NCT01895829|MRI|mri
248353|NCT01895829|Ferumoxytol|ferumoxytol
248354|NCT01895829|Ultra-small superparamagnetic iron oxide nanoparticle|ultra-small superparamagnetic iron oxide nanoparticle
248355|NCT01895829|USPIO|uspio
248356|NCT01895829|Contrast agent|contrast agent
248357|NCT01895829|Dynamic contrast imaging|dynamic contrast imaging
248358|NCT01895829|DCI|dci
248359|NCT01895816|male infertility,oligo spermia|male infertility,oligo spermia
248360|NCT01895803|smoking woman|smoking woman
248361|NCT01895790|Pancreatic Cancer|pancreatic cancer
248362|NCT01895790|Pancreatic Duct|pancreatic duct
248363|NCT01895790|Stent|stent
248364|NCT01895790|Pancreatic Duct Stent|pancreatic duct stent
248365|NCT01895790|Cancer|cancer
248366|NCT01895790|Pain|pain
248367|NCT01895790|Obstructive Pain|obstructive pain
248368|NCT01895790|Palliative|palliative
248369|NCT01895764|ankylosing spondylitis|ankylosing spondylitis
248370|NCT01895751|Non-ST elevation myocardial infarction (NSTEMI)|non-st elevation myocardial infarction (nstemi)
248371|NCT01895751|Non-ST elevation acute coronary syndrome (NSTE-ACS)|non-st elevation acute coronary syndrome (nste-acs)
248372|NCT01895751|Unstable Angina|unstable angina
248373|NCT01895751|Medical therapy|medical therapy
248374|NCT01895751|Coronary angiogram|coronary angiogram
248375|NCT01895751|Percutaneous coronary intervention|percutaneous coronary intervention
248376|NCT01895751|Coronary artery bypass surgery|coronary artery bypass surgery
248377|NCT01895751|Coronary revascularization|coronary revascularization
248378|NCT01895751|Health economics|health economics
248379|NCT01895738|Trauma|trauma
248380|NCT01895738|Injuries|injuries
248381|NCT01895738|Violence|violence
248382|NCT01895738|Adolescent|adolescent
248383|NCT01895738|WrapAround care|wraparound care
248384|NCT01895712|International|international
248385|NCT01895712|Multicenter|multicenter
248386|NCT01895712|Observational registry|observational registry
248387|NCT01895712|Orsiro Drug Eluting Stents (DES)|orsiro drug eluting stents (des)
248388|NCT01895712|Stenting|stenting
248389|NCT01895712|Treatment of Coronary Artery Disease|treatment of coronary artery disease
248390|NCT01895712|Coronary revascularization|coronary revascularization
248391|NCT01895712|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
248392|NCT01895712|Diabetes Mellitus Type 1|diabetes mellitus type 1
248393|NCT01895712|Diabetes Mellitus Type 2|diabetes mellitus type 2
248394|NCT01895712|STEMI|stemi
248395|NCT01895712|NSTEMI|nstemi
248396|NCT01895712|Ischemia|ischemia
248397|NCT01895712|Angina|angina
248398|NCT01895712|Subgroups|subgroups
248399|NCT01895712|Acute Myocardial Infarction|acute myocardial infarction
248400|NCT01895712|Small vessels|small vessels
248401|NCT01895712|Chronic Total Occlusion|chronic total occlusion
248402|NCT01895699|Contrast agent|contrast agent
248403|NCT01895699|endothelium|endothelium
248404|NCT01895699|Free radical|free radical
248405|NCT01895699|Alpha lipoic acid|alpha lipoic acid
248406|NCT01895686|open angle glaucoma|open angle glaucoma
248407|NCT01895686|narrow angles|narrow angles
248408|NCT01895686|angle closure glaucoma|angle closure glaucoma
248409|NCT01895686|gonioscopy|gonioscopy
248410|NCT01895686|anterior segment OCT|anterior segment oct
248411|NCT01895673|FDG-PET|fdg-pet
248412|NCT01895673|Radiofrequency Ablation|radiofrequency ablation
248413|NCT01895673|Magnetic Resonance Imaging|magnetic resonance imaging
248414|NCT01895660|P-CIMT|p-cimt
248415|NCT01895660|Pediatric Constraint Induced Movement Therapy|pediatric constraint induced movement therapy
248416|NCT01895660|Hemiparesis|hemiparesis
248417|NCT01895660|Cerebral Palsy|cerebral palsy
248418|NCT01895660|Children|children
248419|NCT01895647|electric muscle stimulation|electric muscle stimulation
248420|NCT01895647|respiratory failure|respiratory failure
248421|NCT01895647|sepsis|sepsis
248422|NCT01895647|interleukin 6|interleukin 6
248423|NCT01895647|interleukin 15|interleukin 15
248424|NCT01895634|Ischemia|ischemia
248425|NCT01895634|Stroke|stroke
248426|NCT01895634|Ischemic Stroke|ischemic stroke
248427|NCT01895634|Thrombectomy|thrombectomy
248428|NCT01895634|Brain clot|brain clot
248429|NCT01895634|Cerebrovascular disease|cerebrovascular disease
248430|NCT01895634|Recanalization|recanalization
248431|NCT01895634|Revascularization|revascularization
248432|NCT01895634|Clot Retriever|clot retriever
248433|NCT01895634|Neurovascular Intervention|neurovascular intervention
248434|NCT01895634|Interventional Neuroradiology|interventional neuroradiology
248435|NCT01895634|neurovascular clinical trial|neurovascular clinical trial
248436|NCT01895608|aged or aged 80 and over|aged or aged 80 and over
248437|NCT01895608|gait disorder|gait disorder
248438|NCT01895608|attention|attention
248439|NCT01895595|obesity|obesity
248440|NCT01895595|stress|stress
248441|NCT01895595|intuitive eating|intuitive eating
248442|NCT01895595|guided imagery|guided imagery
248443|NCT01895595|latinos|latinos
248444|NCT01895595|adolescents|adolescents
248445|NCT01895595|insulin resistance|insulin resistance
248446|NCT01895582|Ageing|ageing
248447|NCT01895582|Tuberculosis|tuberculosis
248448|NCT01895582|Interferon gamma releasing tests|interferon gamma releasing tests
248449|NCT01895556|Malawi|malawi
248450|NCT01895556|Risk Compensation|risk compensation
248451|NCT01895556|Male Circumcision|male circumcision
248452|NCT01895556|Demand|demand
248453|NCT01895530|Probiotics|probiotics
248454|NCT01895530|colorectal cancer|colorectal cancer
248455|NCT01895530|postoperative infection|postoperative infection
248456|NCT01895530|immune function|immune function
248457|NCT01895530|bacterial translocation|bacterial translocation
248458|NCT01895530|gastrointestinal surgery|gastrointestinal surgery
248459|NCT01895504|Colonoscopy|colonoscopy
248460|NCT01895504|Colorectal cancer|colorectal cancer
248461|NCT01895504|Adenoma|adenoma
248462|NCT01895478|asthma|asthma
248463|NCT01895478|pediatrics|pediatrics
248464|NCT01895478|control|control
248465|NCT01895478|medication adherence|medication adherence
248466|NCT01895465|urine collection, contamination|urine collection, contamination
248467|NCT01895452|Schizophrenia|schizophrenia
248468|NCT01895439|Bone marrow derived Mesenchymal Stem Cells|bone marrow derived mesenchymal stem cells
248469|NCT01895439|Multiple Sclerosis|multiple sclerosis
248470|NCT01895439|Oligodendrocytes|oligodendrocytes
248471|NCT01895439|Neuroimmunology|neuroimmunology
248472|NCT01895439|Autoimmune disease|autoimmune disease
248473|NCT01895413|Cartilage injury|cartilage injury
248474|NCT01895413|Osteoarthritis|osteoarthritis
248475|NCT01895413|Mesenchymal stem cells|mesenchymal stem cells
248476|NCT01895400|Renexin for Recurrent Vestibulopathy|renexin for recurrent vestibulopathy
248477|NCT01895374|Laser therapy|laser therapy
248478|NCT01895374|Biological dressing|biological dressing
248479|NCT01895374|Amniotic membrane|amniotic membrane
248480|NCT01895374|Hydrocolloid bandages|hydrocolloid bandages
306341|NCT01635023|AUC|auc
248481|NCT01895374|wound healing|wound healing
248483|NCT01895361|P-selectin|p-selectin
248484|NCT01895361|monoclonal antibody|monoclonal antibody
248485|NCT01895361|sickle cell disease|sickle cell disease
248486|NCT01895361|sickle cell anemia|sickle cell anemia
248487|NCT01895361|sickle cell|sickle cell
248488|NCT01895361|pain crisis|pain crisis
248489|NCT01895361|pain crises|pain crises
248490|NCT01895361|vasoocclusion|vasoocclusion
248491|NCT01895361|vaso-occlusion|vaso-occlusion
248492|NCT01895361|priapism|priapism
248493|NCT01895361|hepatic sequestration|hepatic sequestration
248494|NCT01895361|splenic sequestration|splenic sequestration
248495|NCT01895361|chest syndrome|chest syndrome
248496|NCT01895322|Tolvaptan|tolvaptan
248497|NCT01895322|dialysis|dialysis
248498|NCT01895309|Rheumatoid Arthritis|rheumatoid arthritis
248499|NCT01895309|Etanercept|etanercept
248500|NCT01895309|Biosimilar|biosimilar
248501|NCT01895296|dumping syndrome|dumping syndrome
248502|NCT01895296|OGTT|ogtt
248503|NCT01895296|hypoglycemia|hypoglycemia
248504|NCT01895283|Aerobic training|aerobic training
248505|NCT01895283|VO2max|vo2max
248506|NCT01895283|Bethlem myopathy|bethlem myopathy
248507|NCT01895270|opioid dependence|opioid dependence
248508|NCT01895270|buprenorphine|buprenorphine
248509|NCT01895270|isradipine|isradipine
248510|NCT01895270|opioid withdrawal|opioid withdrawal
248511|NCT01895270|opioid detoxification|opioid detoxification
248512|NCT01895257|TTP1|ttp1
248513|NCT01895257|TTP2|ttp2
248515|NCT01895257|Safety|safety
248516|NCT01895257|R0 resection rate|r0 resection rate
248517|NCT01895257|Quality of life|quality of life
248518|NCT01895257|Overall Survival|overall survival
248519|NCT01895244|scleroderma|scleroderma
248520|NCT01895244|autologous stem cell transplantation|autologous stem cell transplantation
248521|NCT01895244|thiotepa|thiotepa
248522|NCT01895244|cluster of differentiation (CD) 34 selection|cluster of differentiation (cd) 34 selection
248523|NCT01895192|sperm morphology|sperm morphology
248524|NCT01895192|vacuoles|vacuoles
248525|NCT01895192|fertile|fertile
248526|NCT01895192|Motile Sperm Organellar Morphology Examination|motile sperm organellar morphology examination
248527|NCT01895192|high magnification|high magnification
248528|NCT01895192|reference values|reference values
248529|NCT01895179|Time-restricted feeding|time-restricted feeding
248530|NCT01895179|Intermittent fasting|intermittent fasting
248531|NCT01895179|Prediabetes|prediabetes
248532|NCT01895179|Insulin resistance|insulin resistance
248533|NCT01895179|Glucose tolerance|glucose tolerance
248534|NCT01895179|Insulin sensitivity|insulin sensitivity
248535|NCT01895179|Circadian rhythms|circadian rhythms
248536|NCT01895179|Diurnal|diurnal
248537|NCT01895166|Endobronchial ultrasonography with a guide sheath|endobronchial ultrasonography with a guide sheath
248538|NCT01895166|Peripheral pulmonary lesions|peripheral pulmonary lesions
248539|NCT01895166|Transbronchial biopsy|transbronchial biopsy
248540|NCT01895153|bladder pain syndrome|bladder pain syndrome
248541|NCT01895153|pentosan polysulfate|pentosan polysulfate
248542|NCT01895153|hydrodistension|hydrodistension
248543|NCT01895140|Treatment-resistant hypertension|treatment-resistant hypertension
248544|NCT01895140|Renal denervation|renal denervation
248545|NCT01895140|Ambulatory blood pressure|ambulatory blood pressure
248546|NCT01895127|Kidney Transplant|kidney transplant
248547|NCT01895127|Renal Transplant|renal transplant
248548|NCT01895127|Rejection|rejection
248549|NCT01895127|Antibody mediated|antibody mediated
248550|NCT01895127|Humoral|humoral
248551|NCT01895127|Eculizumab|eculizumab
248552|NCT01895114|Renal function|renal function
248553|NCT01895114|cirrhotic patients|cirrhotic patients
248554|NCT01895114|transplant evaluation|transplant evaluation
248555|NCT01895101|blood loss|blood loss
248556|NCT01895101|tranexamix acid|tranexamix acid
248557|NCT01895101|cardiac surgery|cardiac surgery
248558|NCT01895088|presbyopia|presbyopia
248559|NCT01895075|Budesonide|budesonide
248560|NCT01895075|Inhalation|inhalation
248561|NCT01895075|Premature infants|premature infants
248562|NCT01895062|colonoscopy|colonoscopy
248563|NCT01895062|oxygen desaturation|oxygen desaturation
248564|NCT01895049|Tacrolimus|tacrolimus
248565|NCT01895049|Everolimus|everolimus
248566|NCT01895049|Cytomegalovirus|cytomegalovirus
248567|NCT01895049|Thymoglobulin|thymoglobulin
248568|NCT01895049|Deceased donors|deceased donors
248569|NCT01895049|Expanded criteria|expanded criteria
248570|NCT01895036|maintained on 2 mg or less of buprenorphine, in which discontinuation of agonist treatment is clinically feasible but difficult|maintained on 2 mg or less of buprenorphine, in which discontinuation of agonist treatment is clinically feasible but difficult
248571|NCT01895010|prevention and treatment|prevention and treatment
248572|NCT01895010|improvement of the patient's appetite|improvement of the patient's appetite
248574|NCT01894997|Deep Vein Thrombosis|deep vein thrombosis
248575|NCT01894997|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
248576|NCT01894997|Intermittent Pneumatic Compression|intermittent pneumatic compression
248577|NCT01894997|Doppler Ultrasound|doppler ultrasound
239365|NCT01938443|cancer|cancer
248578|NCT01894984|Schizophrenia|schizophrenia
248579|NCT01894984|Risperidone|risperidone
248580|NCT01894984|Risperdal Consta|risperdal consta
248581|NCT01894984|Oral antipsychotic|oral antipsychotic
248582|NCT01894958|Fragile X disorder|fragile x disorder
248583|NCT01894958|Autism|autism
248584|NCT01894932|Psychotherapy, Group|psychotherapy, group
248585|NCT01894919|Meningococcal B disease,|meningococcal b disease,
248586|NCT01894919|Antibody persistence|antibody persistence
248587|NCT01894906|Soluble Ferric Pyrophosphate,|soluble ferric pyrophosphate,
248588|NCT01894906|Pharmacokinetics,|pharmacokinetics,
248589|NCT01894906|Iron, Mass Transfer,|iron, mass transfer,
248590|NCT01894906|Hemodialysis|hemodialysis
248591|NCT01894906|chronic therapy;|chronic therapy;
248592|NCT01894867|LIVER CIRRHOSIS|liver cirrhosis
248593|NCT01894867|MAGNESIUM|magnesium
248594|NCT01894867|MINIMAL ENCEPHALOPATHY|minimal encephalopathy
248595|NCT01894867|MUSCLE WEAKNESS|muscle weakness
248596|NCT01894854|Radiostereometry|radiostereometry
248597|NCT01894854|Total Hip Arthroplasty|total hip arthroplasty
248598|NCT01894854|Stem design|stem design
248599|NCT01894841|depression|depression
248600|NCT01894841|prevention|prevention
248601|NCT01894841|Veterans health|veterans health
248603|NCT01894828|Gastrointestinal cancer|gastrointestinal cancer
248604|NCT01894828|Malnutrition|malnutrition
248605|NCT01894815|major depressive disorder|major depressive disorder
248606|NCT01894815|major depression|major depression
248607|NCT01894815|depressive disorder|depressive disorder
248608|NCT01894815|major depressive episode|major depressive episode
248609|NCT01894802|Tetraplegia|tetraplegia
248610|NCT01894802|Quadriplegia|quadriplegia
248611|NCT01894802|Spinal cord injury|spinal cord injury
248612|NCT01894802|Brainstem or spinal stroke|brainstem or spinal stroke
248613|NCT01894802|Neuroprosthetic|neuroprosthetic
248614|NCT01894802|Brain-machine interface|brain-machine interface
248615|NCT01894802|Brain-computer interface|brain-computer interface
248616|NCT01894802|Neural activity|neural activity
248617|NCT01894802|Sensory stimulation|sensory stimulation
248618|NCT01894802|Microstimulation|microstimulation
248619|NCT01894789|myocardial blood flow|myocardial blood flow
248620|NCT01894789|myocardial perfusion imaging|myocardial perfusion imaging
248621|NCT01894789|myocardial blood flow reserve|myocardial blood flow reserve
248920|NCT01893606|diarrhea|diarrhea
248622|NCT01894789|positron emission tomography|positron emission tomography
248623|NCT01894789|adenosine|adenosine
248624|NCT01894789|ticagrelor|ticagrelor
248625|NCT01894789|clopidogrel|clopidogrel
248626|NCT01894776|healthy volunteers|healthy volunteers
248627|NCT01894763|esophagus|esophagus
248628|NCT01894763|cancer|cancer
248629|NCT01894750|Heart Failure|heart failure
248630|NCT01894750|Self-Care|self-care
248631|NCT01894685|Colorectal|colorectal
248632|NCT01894685|Adenoma|adenoma
248633|NCT01894685|Recurrence|recurrence
248634|NCT01894685|Mesalazine|mesalazine
248635|NCT01894685|Chemoprevention|chemoprevention
248636|NCT01894672|LGX818|lgx818
248637|NCT01894672|BRAF Inhibitor|braf inhibitor
248638|NCT01894672|Stage IV melanoma|stage iv melanoma
248639|NCT01894672|unresectable stage III melanoma|unresectable stage iii melanoma
248640|NCT01894672|BRAFV600 mutation|brafv600 mutation
248641|NCT01894672|13-053|13-053
248642|NCT01894633|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
248643|NCT01894633|Metastasis|metastasis
248644|NCT01894633|Cloroquine|cloroquine
248645|NCT01894620|Alzheimer's|alzheimer's
248646|NCT01894620|rTMS|rtms
248647|NCT01894620|sleep quality|sleep quality
248648|NCT01894620|dementia|dementia
248649|NCT01894620|memory|memory
248650|NCT01894607|Kidney Cancer|kidney cancer
248651|NCT01894607|Renal Mass|renal mass
248652|NCT01894607|Open partial nephrectomy|open partial nephrectomy
248653|NCT01894607|Ultrasound-guided surgery|ultrasound-guided surgery
248654|NCT01894607|DEFINITY|definity
248655|NCT01894607|Contrast agent|contrast agent
248656|NCT01894607|Phone call|phone call
248657|NCT01894594|Sickle cell disease|sickle cell disease
248658|NCT01894594|Chronic kidney disease|chronic kidney disease
248659|NCT01894594|Bicarbonate therapy|bicarbonate therapy
248660|NCT01894555|Platelet Transcriptome|platelet transcriptome
248661|NCT01894555|Coronary Artery Disease|coronary artery disease
248662|NCT01894555|Myocardial Ischemia|myocardial ischemia
248663|NCT01894555|Coronary Disease|coronary disease
248664|NCT01894555|Heart Diseases|heart diseases
248665|NCT01894555|Cardiovascular Diseases|cardiovascular diseases
248666|NCT01894555|Arteriosclerosis|arteriosclerosis
248667|NCT01894555|Arterial Occlusive Diseases|arterial occlusive diseases
248668|NCT01894555|Vascular Diseases|vascular diseases
248669|NCT01894555|Aspirin|aspirin
248670|NCT01894529|ischemic stroke|ischemic stroke
248671|NCT01894529|immune biomarkers|immune biomarkers
248672|NCT01894529|stroke-associated infection|stroke-associated infection
248673|NCT01894529|functional outcome|functional outcome
248674|NCT01894529|prediction|prediction
402978|NCT01228773|Cancer Survivors, Fatigue, web-based, tailored program|cancer survivors, fatigue, web-based, tailored program
306609|NCT01633476|CMV|cmv
248675|NCT01894490|Gastrointestinal surgery, complications, length of hospital stay, mortality|gastrointestinal surgery, complications, length of hospital stay, mortality
248676|NCT01894464|truancy|truancy
248677|NCT01894464|attendance|attendance
248678|NCT01894464|education|education
248679|NCT01894464|primary school|primary school
248680|NCT01894464|elementary school|elementary school
248681|NCT01894451|Inflammatory Breast Carcinoma|inflammatory breast carcinoma
248682|NCT01894451|89Zr-bevacizumab|89zr-bevacizumab
248683|NCT01894438|NAFLD|nafld
248684|NCT01894438|NASH|nash
248685|NCT01894438|Mediterranean diet|mediterranean diet
248686|NCT01894438|Mediterranean lifestyle|mediterranean lifestyle
248687|NCT01894425|Medically assisted procreation|medically assisted procreation
248688|NCT01894425|Assisted reproductive technology|assisted reproductive technology
248689|NCT01894425|Human papilloma virus|human papilloma virus
248690|NCT01894399|HM61713|hm61713
248691|NCT01894399|pharmacokinetics|pharmacokinetics
248692|NCT01894399|Phase I|phase i
248693|NCT01894399|healthy|healthy
248694|NCT01894399|olmutinib|olmutinib
248695|NCT01894386|GW642444 (Vilanterol)|gw642444 (vilanterol)
248696|NCT01894386|GSK573719 (Umeclidinium)|gsk573719 (umeclidinium)
248697|NCT01894386|GW685698 (Fluticasone Furoate)|gw685698 (fluticasone furoate)
248698|NCT01894386|pharmacokinetics|pharmacokinetics
248699|NCT01894386|Healthy subjects|healthy subjects
248700|NCT01894360|Pharmacokinetics|pharmacokinetics
248702|NCT01894360|Healthy Subjects|healthy subjects
248703|NCT01894360|Comparability|comparability
248704|NCT01894360|Belimumab|belimumab
248705|NCT01894347|Colistin, MDR, inhalative therapy|colistin, mdr, inhalative therapy
248706|NCT01894334|Aortic dissection|aortic dissection
248707|NCT01894334|acute lung injury|acute lung injury
248708|NCT01894334|injury mechanism|injury mechanism
248709|NCT01894334|early intervention|early intervention
248710|NCT01894321|Acute cholecystitis|acute cholecystitis
248711|NCT01894321|Elderly|elderly
248712|NCT01894321|Critically ill patients|critically ill patients
248713|NCT01894321|Surgical high risk|surgical high risk
248714|NCT01894321|Percutaneous cholecystostomy|percutaneous cholecystostomy
248715|NCT01894321|Cholecystectomy|cholecystectomy
248716|NCT01894308|Male Hormone Replacement|male hormone replacement
248717|NCT01894308|Multiple Dose|multiple dose
248718|NCT01894308|Single Period|single period
248719|NCT01894308|Phase II|phase ii
248720|NCT01894308|Dose Ranging|dose ranging
248721|NCT01894308|Adult Male Subjects|adult male subjects
248722|NCT01894308|Testosterone Replacement|testosterone replacement
248723|NCT01894295|Vitamin D analogues|vitamin d analogues
248724|NCT01894295|Resting Metabolic rate|resting metabolic rate
248725|NCT01894295|obesity|obesity
248726|NCT01894282|Chronic Lower Back Pain|chronic lower back pain
248727|NCT01894282|Manual Therapy|manual therapy
248728|NCT01894282|Cognitive Behavioral Therapy|cognitive behavioral therapy
248729|NCT01894256|oncology,|oncology,
248730|NCT01894256|cancer,|cancer,
248731|NCT01894256|neoplasm,|neoplasm,
248732|NCT01894256|anticancer drug,|anticancer drug,
248733|NCT01894256|pharmacokinetics,|pharmacokinetics,
248734|NCT01894256|area under curve,|area under curve,
248735|NCT01894256|olaparib,|olaparib,
248736|NCT01894256|solid tumour,|solid tumour,
248737|NCT01894256|mild renal impairment,|mild renal impairment,
248738|NCT01894256|moderate renal impairment|moderate renal impairment
248739|NCT01894243|oncology,|oncology,
248740|NCT01894243|cancer,|cancer,
248741|NCT01894243|neoplasm,|neoplasm,
248742|NCT01894243|anticancer drug,|anticancer drug,
248743|NCT01894243|pharmacokinetics,|pharmacokinetics,
248744|NCT01894243|area under curve,|area under curve,
248745|NCT01894243|olaparib,|olaparib,
248746|NCT01894243|solid tumour,|solid tumour,
248747|NCT01894243|mild hepatic impairment,|mild hepatic impairment,
248748|NCT01894243|moderate hepatic impairment|moderate hepatic impairment
248749|NCT01894230|high cholesterol|high cholesterol
248750|NCT01894230|genetic testing|genetic testing
248751|NCT01894230|medication adherence|medication adherence
248752|NCT01894230|statins|statins
248753|NCT01894230|Adverse Effects|adverse effects
248754|NCT01894230|pharmacogenetics|pharmacogenetics
691943|NCT00937716|risperidone|risperidone
248755|NCT01894217|high cholesterol|high cholesterol
248756|NCT01894217|genetic testing|genetic testing
248757|NCT01894217|medication adherence|medication adherence
248758|NCT01894217|statins|statins
248759|NCT01894217|Adverse Effects|adverse effects
248760|NCT01894217|Pharmacogenetic|pharmacogenetic
248761|NCT01894204|HTTPE|httpe
248762|NCT01894204|Idiopathic Pulmonary embolism|idiopathic pulmonary embolism
248763|NCT01894191|adenoma detection rate|adenoma detection rate
248764|NCT01894191|colonoscopy|colonoscopy
248765|NCT01894191|water exchange|water exchange
248766|NCT01894165|molybdenum cofactor deficiency (MoCD)|molybdenum cofactor deficiency (mocd)
248767|NCT01894165|deficiency of activity of molybdenum-dependent enzymes|deficiency of activity of molybdenum-dependent enzymes
248768|NCT01894152|XIENCE PRIME EECSS|xience prime eecss
248769|NCT01894152|XIENCE V EECSS|xience v eecss
248770|NCT01894152|XIENCE PRIME|xience prime
248771|NCT01894152|SPIRIT PRIME|spirit prime
248772|NCT01894152|XIENCE PRIME SV (Small Vessel)|xience prime sv (small vessel)
248773|NCT01894152|XIENCE PRIME LL (Long Lesion)|xience prime ll (long lesion)
248774|NCT01894152|Coronary Artery Disease|coronary artery disease
248775|NCT01894152|Coronary Heart Disease|coronary heart disease
248776|NCT01894152|Cardiovascular Disease|cardiovascular disease
248777|NCT01894152|Myocardial Infarction|myocardial infarction
248778|NCT01894152|Stent Thrombosis|stent thrombosis
248779|NCT01894139|Gestational weight gain|gestational weight gain
248780|NCT01894139|Obese women|obese women
248781|NCT01894139|Fetal programming|fetal programming
248782|NCT01894139|Metabolic disorders|metabolic disorders
248783|NCT01894139|Development of obesity|development of obesity
248784|NCT01894139|Development og overweight|development og overweight
248785|NCT01894139|Complications during pregnancy and birth|complications during pregnancy and birth
248786|NCT01894113|interstitial lung disease|interstitial lung disease
248787|NCT01894113|transbronchial biopsy|transbronchial biopsy
248788|NCT01894113|cryobiopsy|cryobiopsy
248789|NCT01894074|Subfertility|subfertility
248790|NCT01894074|Anovulatory|anovulatory
248791|NCT01894074|Obese|obese
248792|NCT01894074|Women|women
248793|NCT01894061|adult giant cell glioblastoma|adult giant cell glioblastoma
248794|NCT01894061|adult glioblastoma|adult glioblastoma
248573|NCT01895010|TACE|tace
248795|NCT01894061|adult gliosarcoma|adult gliosarcoma
248796|NCT01894061|recurrent adult brain tumor|recurrent adult brain tumor
248797|NCT01894061|Bevacizumab-naive|bevacizumab-naive
248798|NCT01894061|NovoTTF-100A|novottf-100a
248799|NCT01894048|asthma control|asthma control
248800|NCT01894048|small airways|small airways
248801|NCT01894048|extra-fine particle inhaled corticosteroids|extra-fine particle inhaled corticosteroids
248802|NCT01894035|Pulmonary Hypertension|pulmonary hypertension
248803|NCT01894035|Ventavis|ventavis
248804|NCT01894035|Patient compliance|patient compliance
248805|NCT01894022|Inoperable chronic thromboembolic pulmonary hypertension, endothelin receptor antagonist|inoperable chronic thromboembolic pulmonary hypertension, endothelin receptor antagonist
248806|NCT01894009|Osteopathic manipulation|osteopathic manipulation
248807|NCT01894009|Exercise therapy|exercise therapy
248808|NCT01894009|Pregnancy pelvic girdle pain|pregnancy pelvic girdle pain
248809|NCT01893996|rheumatoid|rheumatoid
248810|NCT01893996|arthritis|arthritis
248811|NCT01893996|cardiovascular|cardiovascular
248812|NCT01893996|adalimumab|adalimumab
248813|NCT01893996|tnf|tnf
248814|NCT01893996|biologic|biologic
248815|NCT01893983|Mental Health|mental health
248816|NCT01893983|Veterans Health|veterans health
248817|NCT01893983|Rural|rural
248818|NCT01893983|Motivational Interviewing|motivational interviewing
248819|NCT01893957|breast cancer|breast cancer
248820|NCT01893957|physical therapy|physical therapy
248821|NCT01893957|electrical stimulation|electrical stimulation
248822|NCT01893957|tactile sensitivity|tactile sensitivity
248823|NCT01893957|flow blood|flow blood
248824|NCT01893944|Breast cancer|breast cancer
248825|NCT01893944|vibratory therapy|vibratory therapy
248826|NCT01893944|virtual reality|virtual reality
248827|NCT01893931|Geriatrics|geriatrics
248828|NCT01893931|Emergency Medicine|emergency medicine
248829|NCT01893931|Care Transitions|care transitions
248830|NCT01893918|Smoking|smoking
248831|NCT01893918|Dyspnea|dyspnea
248832|NCT01893892|Basal Cell Carcinoma|basal cell carcinoma
248833|NCT01893892|Gorlin syndrome|gorlin syndrome
248834|NCT01893892|Erivedge|erivedge
248835|NCT01893892|Basal Cell Nevus Syndrome|basal cell nevus syndrome
248836|NCT01893853|dehydration|dehydration
248837|NCT01893853|fluid balance|fluid balance
248838|NCT01893853|exercise|exercise
248839|NCT01893853|heat|heat
248840|NCT01893853|body weight|body weight
248841|NCT01893853|performance|performance
248842|NCT01893827|Naltrexone|naltrexone
248843|NCT01893827|Extended-release naltrexone|extended-release naltrexone
248844|NCT01893827|Oral naltrexone|oral naltrexone
248845|NCT01893827|Vivitrol|vivitrol
248846|NCT01893827|XR-NTX|xr-ntx
248847|NCT01893827|alcohol dependence|alcohol dependence
248848|NCT01893827|primary care|primary care
248849|NCT01893827|Medical Management|medical management
692045|NCT00929071|aesthetic|aesthetic
248850|NCT01893801|pancreatic cancer|pancreatic cancer
248851|NCT01893801|pancreatic adenocarcinoma|pancreatic adenocarcinoma
248852|NCT01893801|Stage IV pancreatic cancer|stage iv pancreatic cancer
248853|NCT01893801|pancreas|pancreas
248854|NCT01893801|pancreatic|pancreatic
248855|NCT01893788|hypertension|hypertension
248856|NCT01893788|left ventricular hypertrophy|left ventricular hypertrophy
249651|NCT01890746|leukemia|leukemia
248857|NCT01893788|renin angiotensin system|renin angiotensin system
248858|NCT01893788|aldosterone|aldosterone
248859|NCT01893788|aliskiren|aliskiren
248860|NCT01893788|eplerenone|eplerenone
248861|NCT01893788|P3NP|p3np
248862|NCT01893775|Anti CD 122|anti cd 122
248863|NCT01893775|Monoclonal Antibody Therapy|monoclonal antibody therapy
306847|NCT01632397|HIV|hiv
239643|NCT01937013|fMRI|fmri
248864|NCT01893775|Autoimmune Inflammatory Enteropathy|autoimmune inflammatory enteropathy
248865|NCT01893762|neutrophil|neutrophil
248866|NCT01893762|exercise|exercise
248867|NCT01893762|URTI|urti
248868|NCT01893762|Innate|innate
248869|NCT01893762|Immune|immune
248870|NCT01893749|depression|depression
248871|NCT01893749|prevention|prevention
248872|NCT01893749|teen|teen
248873|NCT01893749|at risk|at risk
248874|NCT01893749|internet|internet
248875|NCT01893736|Breastfeeding|breastfeeding
248876|NCT01893736|professional support|professional support
248877|NCT01893736|postnatal|postnatal
248878|NCT01893736|interventions|interventions
248879|NCT01893736|exclusive breastfeeding|exclusive breastfeeding
248880|NCT01893736|randomized controlled trial|randomized controlled trial
248881|NCT01893723|autonomous nervous system monitoring|autonomous nervous system monitoring
248882|NCT01893723|analgesia nociception balance|analgesia nociception balance
248883|NCT01893723|remifentanil|remifentanil
248884|NCT01893723|analgesia nociception index|analgesia nociception index
248885|NCT01893723|hemodynamic reactivity|hemodynamic reactivity
248886|NCT01893710|peritoneal dialysis|peritoneal dialysis
248887|NCT01893710|parietal peritoneum|parietal peritoneum
248888|NCT01893710|omentum|omentum
248889|NCT01893710|children|children
248890|NCT01893684|protein|protein
248891|NCT01893684|physical function|physical function
248892|NCT01893684|muscle quality|muscle quality
248893|NCT01893684|fatigue|fatigue
248894|NCT01893684|weight loss|weight loss
248896|NCT01893671|corneal power|corneal power
248897|NCT01893671|astigmatism|astigmatism
248898|NCT01893671|HOA|hoa
248899|NCT01893671|Optical Coherence Tomography|optical coherence tomography
248900|NCT01893658|Interstitial Nephritis|interstitial nephritis
248901|NCT01893658|Nephritis|nephritis
248902|NCT01893658|Tubulointerstitial|tubulointerstitial
248903|NCT01893658|Renal disease|renal disease
248904|NCT01893658|Kidney|kidney
248905|NCT01893645|Pronto-7|pronto-7
248906|NCT01893645|SpHb|sphb
248907|NCT01893645|Obstetric patients|obstetric patients
248908|NCT01893632|Benzodiazepines|benzodiazepines
248909|NCT01893632|clonazepam|clonazepam
248910|NCT01893632|alprazolam|alprazolam
248911|NCT01893632|Klonopin|klonopin
248912|NCT01893632|Xanax|xanax
248913|NCT01893632|diazepam|diazepam
248914|NCT01893632|Valium|valium
248915|NCT01893632|lorazepam|lorazepam
248916|NCT01893632|Ativan|ativan
248917|NCT01893619|Chronic fatigue syndrome|chronic fatigue syndrome
248918|NCT01893619|Karnofsky score|karnofsky score
248921|NCT01893606|abdominal pain|abdominal pain
248922|NCT01893593|Cardiovascular risk|cardiovascular risk
248923|NCT01893593|lifestyle change|lifestyle change
248924|NCT01893593|blood pressure|blood pressure
248925|NCT01893593|body mass index|body mass index
248926|NCT01893593|tobacco|tobacco
248927|NCT01893580|Cancer|cancer
248928|NCT01893580|Rehabilitation|rehabilitation
248929|NCT01893580|Exercise|exercise
248930|NCT01893580|Lung cancer|lung cancer
248931|NCT01893580|NSCLC|nsclc
248932|NCT01893541|CIRRHOTIC|cirrhotic
248933|NCT01893541|VARICEAL BLEEDING|variceal bleeding
248934|NCT01893541|PRIMARY PROPHYLAXIS|primary prophylaxis
248935|NCT01893489|positron emission tomography|positron emission tomography
248936|NCT01893489|macrophage|macrophage
248937|NCT01893489|neomannosyl human serum albumin|neomannosyl human serum albumin
248938|NCT01893476|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
248939|NCT01893476|implementation|implementation
248940|NCT01893463|hemorrhage control|hemorrhage control
248941|NCT01893463|wound closure|wound closure
248942|NCT01893450|Graves ophthalmopathy|graves ophthalmopathy
248943|NCT01893450|Exophthalmos|exophthalmos
248944|NCT01893450|Proptosis|proptosis
248945|NCT01893450|Quality of life|quality of life
248946|NCT01893424|Biological Availability|biological availability
248947|NCT01893424|Pharmacokinetics|pharmacokinetics
248948|NCT01893385|vitamin D|vitamin d
248949|NCT01893385|supplementation|supplementation
248950|NCT01893385|immunocompetente cells, immune system|immunocompetente cells, immune system
248951|NCT01893385|influenza vaccine|influenza vaccine
248952|NCT01893385|elderly|elderly
248953|NCT01893372|Leukemia|leukemia
248954|NCT01893372|Myelodysplastic syndrome|myelodysplastic syndrome
248955|NCT01893372|MDS|mds
248956|NCT01893372|Overall response rate|overall response rate
248957|NCT01893372|ORR|orr
248958|NCT01893372|Eltrombopag|eltrombopag
248959|NCT01893372|Promacta|promacta
248960|NCT01893372|Hypomethylating Agent|hypomethylating agent
248961|NCT01893359|hyperopia|hyperopia
248962|NCT01893359|hyperopic astigmatism|hyperopic astigmatism
248963|NCT01893359|cross-linking|cross-linking
248964|NCT01893346|Ceftazidime, Avibactam, Anti-Infectives|ceftazidime, avibactam, anti-infectives
248965|NCT01893333|cervical cancer|cervical cancer
248966|NCT01893333|nerve sparing radical hysterectomy|nerve sparing radical hysterectomy
248967|NCT01893320|Leukemia|leukemia
248968|NCT01893320|Acute Myeloid Leukemia|acute myeloid leukemia
248970|NCT01893320|High-risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
248971|NCT01893320|MDS|mds
248972|NCT01893320|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
248973|NCT01893320|CMM|cmm
248974|NCT01893320|Maximum tolerated dose|maximum tolerated dose
248975|NCT01893320|MTD|mtd
248976|NCT01893320|Vosaroxin|vosaroxin
248977|NCT01893320|Decitabine|decitabine
248978|NCT01893320|Dacogen|dacogen
248979|NCT01893307|Head And Neck Cancer|head and neck cancer
248980|NCT01893307|Oropharyngeal Cancer|oropharyngeal cancer
248981|NCT01893307|Squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
248982|NCT01893307|Acute and late toxicity|acute and late toxicity
248983|NCT01893307|Intensity modulated photon therapy|intensity modulated photon therapy
248984|NCT01893307|IMRT|imrt
248985|NCT01893307|Intensity modulated proton therapy|intensity modulated proton therapy
248986|NCT01893307|IMPT|impt
248987|NCT01893307|Modified barium swallow|modified barium swallow
248988|NCT01893307|MBS|mbs
248989|NCT01893307|Questionnaires|questionnaires
248990|NCT01893307|Surveys|surveys
248991|NCT01893229|Bipolar disorder|bipolar disorder
248992|NCT01893229|Comparative Effectiveness Research|comparative effectiveness research
248993|NCT01893229|Therapeutics|therapeutics
248994|NCT01893229|Patient Dropouts|patient dropouts
248995|NCT01893216|anxiety|anxiety
248996|NCT01893216|depression|depression
248997|NCT01893216|sexual dysfunction|sexual dysfunction
248998|NCT01893216|infertility|infertility
248999|NCT01893190|Ruptured saccular aneurysm|ruptured saccular aneurysm
249000|NCT01893190|nimodipine|nimodipine
249002|NCT01893190|tolerability|tolerability
249003|NCT01893190|Subarachnoid hemorrhage|subarachnoid hemorrhage
249004|NCT01893177|Influenza|influenza
249005|NCT01893177|Virus|virus
249006|NCT01893177|Vaccination|vaccination
249007|NCT01893177|Inflexal V|inflexal v
249008|NCT01893164|cubital tunnel syndrome|cubital tunnel syndrome
249009|NCT01893164|simple decompression|simple decompression
249010|NCT01893164|anterior subcutaneous transposition of ulnar nerve|anterior subcutaneous transposition of ulnar nerve
249011|NCT01893164|anterior intramuscular transposition of ulnar nerve|anterior intramuscular transposition of ulnar nerve
249012|NCT01893164|severity scale|severity scale
249013|NCT01893151|Iguratimod|iguratimod
249014|NCT01893151|MRI|mri
249015|NCT01893151|Rheumatoid Arthritis|rheumatoid arthritis
249016|NCT01893138|Urinary Incontinence, Stress|urinary incontinence, stress
249017|NCT01893138|Tissue Therapy (Cell Therapy)|tissue therapy (cell therapy)
249018|NCT01893138|Transplantation, Autologous|transplantation, autologous
249019|NCT01893060|Prematurity|prematurity
249020|NCT01893060|Central line care|central line care
249021|NCT01893060|Umbilical line colonization|umbilical line colonization
249022|NCT01893060|Colonization|colonization
249023|NCT01893060|Newborn Intensive Care Unit|newborn intensive care unit
249024|NCT01893060|Neonatal Intensive Care Unit|neonatal intensive care unit
249025|NCT01893047|breast milk production|breast milk production
249026|NCT01893034|Femoroacetabular Impingement|femoroacetabular impingement
249027|NCT01893034|Arthroscopy|arthroscopy
249028|NCT01893034|Physiotherapy|physiotherapy
249029|NCT01893034|Randomised Controlled Trial|randomised controlled trial
249030|NCT01893008|Esophageal cancer|esophageal cancer
249031|NCT01893008|Surgery|surgery
249032|NCT01892995|suicide|suicide
249033|NCT01892995|ketamine|ketamine
249034|NCT01892995|low-dose ketamine|low-dose ketamine
249035|NCT01892995|suicidal ideations|suicidal ideations
249036|NCT01892995|emergency department|emergency department
249037|NCT01892982|Maternal Depression|maternal depression
249038|NCT01892982|Preterm Birth|preterm birth
249039|NCT01892982|Preterm Outcomes|preterm outcomes
249040|NCT01892982|Child Development|child development
249041|NCT01892917|International|international
249042|NCT01892917|Multicenter|multicenter
249043|NCT01892917|Observational registry|observational registry
249044|NCT01892917|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
249045|NCT01892917|Stenting|stenting
249046|NCT01892917|Treatment of Coronary Artery Disease|treatment of coronary artery disease
249047|NCT01892917|Coronary revascularization|coronary revascularization
692141|NCT00938171|surgery|surgery
249048|NCT01892917|Percutaneous Coronary Intervention|percutaneous coronary intervention
249049|NCT01892917|STEMI|stemi
249050|NCT01892917|NSTEMI|nstemi
249051|NCT01892917|Ischemia|ischemia
249052|NCT01892917|Subgroups|subgroups
249053|NCT01892917|Acute Myocardial Infarction|acute myocardial infarction
249054|NCT01892917|Diabetes|diabetes
249055|NCT01892917|Small Vessels|small vessels
249056|NCT01892917|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
249057|NCT01892904|YAZ|yaz
249058|NCT01892904|Flexible regimen|flexible regimen
249059|NCT01892904|Drospirenone|drospirenone
249060|NCT01892904|Ethinylestradiol Betadex|ethinylestradiol betadex
249061|NCT01892904|Dysmenorrhea|dysmenorrhea
249062|NCT01892904|Japanese patients|japanese patients
239885|NCT01935674|HIV|hiv
249063|NCT01892891|Healthy|healthy
249064|NCT01892891|Subjects|subjects
249065|NCT01892891|Safety|safety
249066|NCT01892891|Tolerability|tolerability
249067|NCT01892891|VBY036|vby036
249068|NCT01892891|maximum|maximum
249069|NCT01892891|pharmacodynamic|pharmacodynamic
249070|NCT01892891|pharmacokinetic|pharmacokinetic
249071|NCT01892865|Operating room utilization|operating room utilization
249072|NCT01892852|Acupuncture|acupuncture
249073|NCT01892852|Traditional Korean Medicine|traditional korean medicine
249074|NCT01892826|FET|fet
249075|NCT01892826|Blastocyst|blastocyst
249076|NCT01892826|natural cycle|natural cycle
249077|NCT01892826|hCG|hcg
249078|NCT01892826|Spontaneous LH pic|spontaneous lh pic
249079|NCT01892813|Nicotine dependence|nicotine dependence
249080|NCT01892813|Smoking cessation|smoking cessation
249081|NCT01892813|Telehealth|telehealth
249082|NCT01892813|Alcohol use|alcohol use
249083|NCT01892813|Depression|depression
249084|NCT01892813|Body weight|body weight
249085|NCT01892800|Lung Cancer|lung cancer
249086|NCT01892800|Ventricular function, Right|ventricular function, right
249087|NCT01892787|Asthma|asthma
249088|NCT01892787|Small airways|small airways
249089|NCT01892787|Extra fine particle long-acting beta agonists|extra fine particle long-acting beta agonists
249090|NCT01892774|LSPAF|lspaf
249091|NCT01892774|asymptomatic|asymptomatic
249092|NCT01892774|exercise tolerance|exercise tolerance
249093|NCT01892761|mycophenolate mofetil|mycophenolate mofetil
249094|NCT01892761|mycophenolic acid|mycophenolic acid
249095|NCT01892761|MPA|mpa
249096|NCT01892761|MMF|mmf
249097|NCT01892761|Pharmacokinetics|pharmacokinetics
249098|NCT01892761|renal transplantation|renal transplantation
249099|NCT01892748|Lupus|lupus
249100|NCT01892748|Juvenile|juvenile
249101|NCT01892748|Cholecalciferol|cholecalciferol
249102|NCT01892748|Disease activity|disease activity
249103|NCT01892748|Bone Mass|bone mass
249104|NCT01892748|Fatigue|fatigue
249105|NCT01892748|Safety|safety
249106|NCT01892722|pediatric|pediatric
249107|NCT01892722|multiple sclerosis|multiple sclerosis
249108|NCT01892709|acute|acute
249109|NCT01892709|pain|pain
249110|NCT01892709|emergency department|emergency department
249111|NCT01892709|hydromorphone|hydromorphone
249112|NCT01892709|in ER|in er
249113|NCT01892696|inspiratory flow pattern|inspiratory flow pattern
249114|NCT01892696|mechanical ventilation|mechanical ventilation
249115|NCT01892696|cardiac preload|cardiac preload
249116|NCT01892696|arterial pulse pressure variation|arterial pulse pressure variation
249117|NCT01892696|inferior vena cava collapsibility|inferior vena cava collapsibility
249118|NCT01892683|propofol|propofol
249119|NCT01892683|exhaled|exhaled
249120|NCT01892683|monitoring|monitoring
249121|NCT01892683|anesthesia|anesthesia
249122|NCT01892670|Blood|blood
249123|NCT01892670|Whole blood|whole blood
249323|NCT01891968|Bortezomib|bortezomib
249124|NCT01892670|Cold-storage|cold-storage
249125|NCT01892670|Filtration|filtration
249126|NCT01892670|Transfusion|transfusion
249127|NCT01892670|Platelet-function|platelet-function
249128|NCT01892657|Cetaphil Daily Facial Moisturizer with SPF 50+|cetaphil daily facial moisturizer with spf 50+
249129|NCT01892657|Hypoallergenicity|hypoallergenicity
249130|NCT01892657|Skin Irritation|skin irritation
249131|NCT01892644|Hemochromatosis|hemochromatosis
249132|NCT01892644|Myelodysplastic syndromes|myelodysplastic syndromes
249133|NCT01892644|Iron overload|iron overload
249134|NCT01892644|Deferasirox|deferasirox
249135|NCT01892644|Chelation therapy|chelation therapy
249136|NCT01892644|Venesection|venesection
249137|NCT01892644|Phlebotomy|phlebotomy
249138|NCT01892644|Ferritin|ferritin
249139|NCT01892644|Transfusional siderosis|transfusional siderosis
249140|NCT01892631|Text messaging|text messaging
249141|NCT01892605|Mozart K.448|mozart k.448
249142|NCT01892605|first unprovoked seizure|first unprovoked seizure
249143|NCT01892605|epileptiform discharges|epileptiform discharges
249144|NCT01892605|music therapy|music therapy
249145|NCT01892605|children|children
249146|NCT01892592|Hypertension|hypertension
249147|NCT01892592|African American|african american
249148|NCT01892592|Health Disparities|health disparities
249149|NCT01892592|Stroke|stroke
249150|NCT01892592|Cardiovascular Disease|cardiovascular disease
249151|NCT01892579|Agitation|agitation
249152|NCT01892579|Dementia|dementia
249153|NCT01892579|Alzheimer's Disease|alzheimer's disease
249154|NCT01892579|Neuropsychiatric Behaviors|neuropsychiatric behaviors
249155|NCT01892566|HIV|hiv
249156|NCT01892566|mobile health|mobile health
249157|NCT01892566|spirometry|spirometry
249158|NCT01892553|Dyspnea|dyspnea
249159|NCT01892553|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
249160|NCT01892553|Perception|perception
249161|NCT01892527|Colorectal Cancer Metastatic|colorectal cancer metastatic
249162|NCT01892527|wild type KRAS|wild type kras
249163|NCT01892527|C-met overexpression|c-met overexpression
249164|NCT01892527|Tivantinib|tivantinib
249165|NCT01892527|Cetuximab|cetuximab
249652|NCT01890746|sAML/MDS|saml/mds
249166|NCT01892514|osteonecrosis|osteonecrosis
249167|NCT01892514|bone marrow concentrate|bone marrow concentrate
249168|NCT01892514|demineralized bone matrix|demineralized bone matrix
249169|NCT01892514|homologous lyophilized bone chips|homologous lyophilized bone chips
249170|NCT01892514|autologous platelet rich fibrin|autologous platelet rich fibrin
249171|NCT01892514|mesenchymal stromal cells|mesenchymal stromal cells
249172|NCT01892501|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
249173|NCT01892501|PET CT to 18FDG|pet ct to 18fdg
249174|NCT01892501|EUS|eus
249175|NCT01892488|COPD|copd
249176|NCT01892488|AE-COPD|ae-copd
249177|NCT01892488|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
249178|NCT01892488|acute exacerbations of Chronic obstructive pulmonary disease|acute exacerbations of chronic obstructive pulmonary disease
249179|NCT01892475|Physical Activity|physical activity
249180|NCT01892475|Incentives|incentives
249181|NCT01892475|Mental Accounting|mental accounting
249182|NCT01892475|Older adults|older adults
249183|NCT01892436|Extension study, psoriatic arthritis, pre-filled syringe|extension study, psoriatic arthritis, pre-filled syringe
249184|NCT01892397|intracranial supratentorial meningioma|intracranial supratentorial meningioma
249185|NCT01892397|Atypical and Anaplastic Meningioma|atypical and anaplastic meningioma
249186|NCT01892397|Optune (NovoTTF-100A)|optune (novottf-100a)
249187|NCT01892397|13-067|13-067
249188|NCT01892371|Leukemia|leukemia
249189|NCT01892371|Acute Myeloid Leukemia|acute myeloid leukemia
249190|NCT01892371|AML|aml
249191|NCT01892371|Myelodysplastic Syndrome|myelodysplastic syndrome
249192|NCT01892371|MDS|mds
249193|NCT01892371|Quizartinib|quizartinib
249194|NCT01892371|AC220|ac220
249195|NCT01892371|ASP2689|asp2689
249196|NCT01892371|Cytarabine|cytarabine
249197|NCT01892371|Ara-C|ara-c
249198|NCT01892371|Cytosar|cytosar
249199|NCT01892371|DepoCyt|depocyt
249200|NCT01892371|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
249201|NCT01892371|AZA|aza
249202|NCT01892371|Vidaza|vidaza
249203|NCT01892371|Azacitidine|azacitidine
249204|NCT01892371|5-Azacytidine|5-azacytidine
249205|NCT01892371|5-AZA|5-aza
249206|NCT01892371|5-AZC|5-azc
249207|NCT01892371|AZA-CR|aza-cr
249208|NCT01892371|Ladakamycin|ladakamycin
249209|NCT01892371|NSC-102816|nsc-102816
249210|NCT01892371|Azacytidine|azacytidine
249211|NCT01892371|Maximum tolerated dose|maximum tolerated dose
249212|NCT01892371|MTD|mtd
249213|NCT01892371|Overall response|overall response
249214|NCT01892371|Complete remission|complete remission
249215|NCT01892371|CR|cr
249216|NCT01892371|Complete remission with incomplete blood count recovery|complete remission with incomplete blood count recovery
249217|NCT01892371|Cri|cri
249218|NCT01892371|Partial remission|partial remission
249219|NCT01892371|PR|pr
249220|NCT01892371|Hematologic improvement|hematologic improvement
249221|NCT01892371|HI|hi
249222|NCT01892358|injection drug use|injection drug use
249223|NCT01892345|Neuromyelitis Optica|neuromyelitis optica
249224|NCT01892345|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
249225|NCT01892345|Devic's disease, Transverse Myelitis|devic's disease, transverse myelitis
249226|NCT01892345|Optic Neuritis|optic neuritis
249227|NCT01892345|relapse|relapse
249228|NCT01892345|eculizumab|eculizumab
249229|NCT01892345|soliris|soliris
249230|NCT01892345|NMO-IgG|nmo-igg
249231|NCT01892345|CNS Autoimmune Disorders|cns autoimmune disorders
249232|NCT01892345|Demyelinating Disorders|demyelinating disorders
249233|NCT01892345|NMO|nmo
249234|NCT01892345|NMOSD|nmosd
249235|NCT01892293|Multiple Myeloma|multiple myeloma
249236|NCT01892293|Autologous stem cell transplantation|autologous stem cell transplantation
249237|NCT01892293|Received initial treatment previously|received initial treatment previously
249238|NCT01892267|PEGJ|pegj
249239|NCT01892267|PEG-J|peg-j
249240|NCT01892267|Percutaneous Endoscopic Gastrostomy|percutaneous endoscopic gastrostomy
249241|NCT01892267|Feeding tube|feeding tube
249242|NCT01892267|Gastroparesis|gastroparesis
249243|NCT01892267|Acute pancreatitis|acute pancreatitis
249244|NCT01892267|Stroke|stroke
249245|NCT01892267|Respiratory failure|respiratory failure
249246|NCT01892267|GERD|gerd
249247|NCT01892267|Balloon|balloon
249248|NCT01892267|Self-propelled|self-propelled
249249|NCT01892254|incretin effect|incretin effect
249250|NCT01892254|PCOS|pcos
692241|NCT00939029|snuff|snuff
249251|NCT01892254|insulin resistance|insulin resistance
249252|NCT01892254|OGTT|ogtt
249253|NCT01892254|IIGI|iigi
249254|NCT01892241|Chronic hepatitis B,Spontaneous Decline of HBV DNA,Peginterferon a-2a, entecavir|chronic hepatitis b,spontaneous decline of hbv dna,peginterferon a-2a, entecavir
249255|NCT01892228|antiretroviral therapy|antiretroviral therapy
249256|NCT01892228|education|education
249257|NCT01892228|mortality|mortality
249258|NCT01892215|Uterine incision.|uterine incision.
249259|NCT01892215|Blunt transversal expansion.|blunt transversal expansion.
249260|NCT01892215|Blunt cephalad-caudad expansion.|blunt cephalad-caudad expansion.
249261|NCT01892189|Drug therapy|drug therapy
249262|NCT01892176|coenzyme Q10, Parkinson disease, oxidative damage|coenzyme q10, parkinson disease, oxidative damage
249263|NCT01892163|Diabetic macular edema, Ozurdex|diabetic macular edema, ozurdex
249264|NCT01892137|Actinic Keratosis|actinic keratosis
249265|NCT01892137|Histopathology|histopathology
249266|NCT01892137|Reflectance Confocal Microscopy|reflectance confocal microscopy
249267|NCT01892137|Local Skin Reaction|local skin reaction
249268|NCT01892124|Motivational Interviewing|motivational interviewing
249269|NCT01892124|Cognitive Therapy|cognitive therapy
249270|NCT01892124|Community-Based Participatory Research|community-based participatory research
249271|NCT01892124|Indians, North American|indians, north american
249273|NCT01892111|infertility|infertility
249274|NCT01892111|IVF/ICSI|ivf/icsi
249275|NCT01892111|pregnancy|pregnancy
249276|NCT01892098|Zinc|zinc
249277|NCT01892098|Bone|bone
249278|NCT01892098|Adolescents|adolescents
249279|NCT01892098|Growth|growth
249280|NCT01892085|Breast milk|breast milk
249281|NCT01892085|lactogenesis stage two|lactogenesis stage two
249282|NCT01892085|premature infant|premature infant
249283|NCT01892085|insufficient milk supply|insufficient milk supply
249284|NCT01892085|breast milk expression|breast milk expression
249285|NCT01892072|hepatocellular carcinoma|hepatocellular carcinoma
249286|NCT01892072|HCC|hcc
249287|NCT01892072|VEGF signaling pathway|vegf signaling pathway
249288|NCT01892059|renal tumour|renal tumour
249289|NCT01892059|partial nephrectomy|partial nephrectomy
249290|NCT01892059|laparoscope|laparoscope
249291|NCT01892059|segmental renal artery clamping|segmental renal artery clamping
249292|NCT01892046|Small Cell Lung Cancer|small cell lung cancer
249293|NCT01892046|Non Small Cell Lung Cancer|non small cell lung cancer
249294|NCT01892046|Hsp90|hsp90
249295|NCT01892033|Posttraumatic Stress Disorder|posttraumatic stress disorder
249296|NCT01892033|PTSD|ptsd
249297|NCT01892033|Aerobic Exercise|aerobic exercise
249298|NCT01892033|Women|women
249299|NCT01892033|Veteran|veteran
249300|NCT01892007|Hearing loss|hearing loss
249301|NCT01892007|Hearing aid|hearing aid
249302|NCT01892007|Speech intelligibility|speech intelligibility
249303|NCT01892007|Speech perception|speech perception
249304|NCT01892007|Cognitive training|cognitive training
249305|NCT01892007|Working memory|working memory
249306|NCT01892007|Working memory training|working memory training
249307|NCT01891994|Cytokine|cytokine
249308|NCT01891994|Hematopoiesis|hematopoiesis
249309|NCT01891994|Autoimmunity|autoimmunity
249310|NCT01891994|Thrombocytopenia|thrombocytopenia
249311|NCT01891994|Neutropenia|neutropenia
249312|NCT01891981|Leukemia|leukemia
249313|NCT01891981|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
249314|NCT01891981|ALL|all
249315|NCT01891981|Relapsed and/or refractory|relapsed and/or refractory
249316|NCT01891981|Moxetumomab Pasudotox|moxetumomab pasudotox
249317|NCT01891981|Maximum tolerated dose|maximum tolerated dose
249318|NCT01891981|MTD|mtd
249319|NCT01891968|Leukemia|leukemia
249320|NCT01891968|Myelodysplastic syndrome|myelodysplastic syndrome
249321|NCT01891968|MDS|mds
249322|NCT01891968|Low or intermediate-1|low or intermediate-1
249324|NCT01891968|Velcade|velcade
249325|NCT01891968|LDP-341|ldp-341
249326|NCT01891968|MLN341|mln341
249327|NCT01891968|PS-341|ps-341
249328|NCT01891955|Diabetes mellitus type 2|diabetes mellitus type 2
249329|NCT01891955|Cereals|cereals
249330|NCT01891955|Dairy|dairy
249331|NCT01891955|Dietary carbohydrates|dietary carbohydrates
249332|NCT01891955|Dietary fiber|dietary fiber
249333|NCT01891955|Food|food
249334|NCT01891955|Metabolic syndrome|metabolic syndrome
249335|NCT01891955|Satiety|satiety
249336|NCT01891942|Normal|normal
249337|NCT01891942|subjects|subjects
249338|NCT01891929|Schizophrenia|schizophrenia
249339|NCT01891929|Cognitive Remediation|cognitive remediation
249340|NCT01891929|Working abilities and social functioning|working abilities and social functioning
249341|NCT01891877|Sickle Cell Trait|sickle cell trait
249342|NCT01891877|Football|football
249343|NCT01891877|Sickling|sickling
249344|NCT01891877|Heat Illness|heat illness
249345|NCT01891877|SCT|sct
249346|NCT01891851|Healthy|healthy
249347|NCT01891851|Hepatitis C|hepatitis c
249348|NCT01891851|TMC435350|tmc435350
249349|NCT01891851|Ritonavir|ritonavir
249350|NCT01891851|Pharmacokinetics|pharmacokinetics
249351|NCT01891838|surgery|surgery
249352|NCT01891838|transsphenoidal surgery|transsphenoidal surgery
249353|NCT01891838|pituitary adenoma|pituitary adenoma
249354|NCT01891838|mechanical ventilation|mechanical ventilation
249355|NCT01891838|bleeding|bleeding
249356|NCT01891825|Atrial fibrillation|atrial fibrillation
249357|NCT01891825|Persistent atrial fibrillation|persistent atrial fibrillation
249358|NCT01891825|Atrial fibrillation ablation|atrial fibrillation ablation
249359|NCT01891812|Sickle cell disease|sickle cell disease
249360|NCT01891812|Vaso-occlusive crisis|vaso-occlusive crisis
249361|NCT01891812|Nitrous oxide|nitrous oxide
249362|NCT01891812|Emergency department|emergency department
249363|NCT01891799|HIV/AIDS|hiv/aids
249364|NCT01891799|PMTCT|pmtct
249365|NCT01891799|Option B+|option b+
249366|NCT01891799|Swaziland|swaziland
249367|NCT01891773|Asthma|asthma
249368|NCT01891773|Inhaled Corticosteroids|inhaled corticosteroids
249369|NCT01891773|School Nurses|school nurses
249370|NCT01891747|gliomas|gliomas
249371|NCT01891734|Veterans|veterans
249372|NCT01891734|Health Services|health services
249373|NCT01891734|Mental Health|mental health
249374|NCT01891734|Technology|technology
249375|NCT01891734|Primary Health Care|primary health care
249376|NCT01891734|Psychotherapy|psychotherapy
249377|NCT01891721|cognitive training|cognitive training
249378|NCT01891721|schizophrenia|schizophrenia
249379|NCT01891721|mismatch negativity|mismatch negativity
249380|NCT01891721|cognition|cognition
249381|NCT01891721|functional capacity|functional capacity
249382|NCT01891721|EEG|eeg
249383|NCT01891682|Methionine Metabolism|methionine metabolism
249384|NCT01891682|Parenteral Nutrition|parenteral nutrition
249385|NCT01891682|Pediatric|pediatric
249386|NCT01891682|Pediatrics|pediatrics
249387|NCT01891682|Sepsis|sepsis
249388|NCT01891682|Observational Study|observational study
249389|NCT01891669|ADC 5T4|adc 5t4
249390|NCT01891669|PF-06263507|pf-06263507
249391|NCT01891669|solid tumors|solid tumors
249392|NCT01891669|lung cancer|lung cancer
249393|NCT01891669|breast cancer|breast cancer
249394|NCT01891669|ovarian cancer|ovarian cancer
249395|NCT01891669|cancer|cancer
249396|NCT01891669|tumors|tumors
249397|NCT01891669|neoplasm metastasis|neoplasm metastasis
249398|NCT01891656|Motivational Interviewing|motivational interviewing
249399|NCT01891656|Internet|internet
249400|NCT01891656|Treatment|treatment
249401|NCT01891656|Substance-Related Disorders|substance-related disorders
249402|NCT01891656|Criminal Justice|criminal justice
249403|NCT01891630|African American|african american
249405|NCT01891617|exercise|exercise
249406|NCT01891617|high carbohydrate and high fat diets|high carbohydrate and high fat diets
249407|NCT01891617|insulin|insulin
249408|NCT01891617|gut peptides|gut peptides
249409|NCT01891617|appetite|appetite
249410|NCT01891617|metabolism|metabolism
249411|NCT01891617|glucose|glucose
249412|NCT01891591|Obesity|obesity
249413|NCT01891591|Gastric bypass|gastric bypass
249414|NCT01891591|Energy balance|energy balance
249415|NCT01891591|Nutritional status|nutritional status
249416|NCT01891591|Protein balance|protein balance
249417|NCT01891552|Colon Cancer, Liver Metastasis, DEBIRI, cetuximab, efficacy|colon cancer, liver metastasis, debiri, cetuximab, efficacy
249418|NCT01891539|Hepatocellular carcinoma, doxorubicin, chemoembolization|hepatocellular carcinoma, doxorubicin, chemoembolization
249419|NCT01891526|Metabolisation of 9-cis-retinoic acid|metabolisation of 9-cis-retinoic acid
249420|NCT01891526|hepatic patients|hepatic patients
249421|NCT01891526|investigation of urine and blood samples|investigation of urine and blood samples
249422|NCT01891513|Physical activity|physical activity
249423|NCT01891513|Hypertension|hypertension
249424|NCT01891513|Physical function|physical function
249425|NCT01891513|Aging|aging
249426|NCT01891500|Persistent Fetal Circulation Syndrome|persistent fetal circulation syndrome
249427|NCT01891500|Infant, Newborn|infant, newborn
249428|NCT01891500|Nitric Oxide|nitric oxide
249429|NCT01891500|Oxidative Stress|oxidative stress
249430|NCT01891500|Endothelin 1|endothelin 1
249431|NCT01891500|Vascular Endothelial Growth Factor|vascular endothelial growth factor
249432|NCT01891487|Eyebrow|eyebrow
249433|NCT01891487|Hypotrichosis|hypotrichosis
249434|NCT01891487|Thinning|thinning
249435|NCT01891487|Bimatoprost|bimatoprost
249436|NCT01891461|total knee arthroplasty|total knee arthroplasty
249437|NCT01891461|post-operative bleeding|post-operative bleeding
249438|NCT01891461|floseal|floseal
249439|NCT01891435|antipyretics|antipyretics
249440|NCT01891435|oral paracetamol|oral paracetamol
249441|NCT01891435|intravenous paracetamol|intravenous paracetamol
249442|NCT01891435|intramuscular diclofenac|intramuscular diclofenac
249443|NCT01891435|emergency department|emergency department
249444|NCT01891422|Glycoprotein Storage Disease|glycoprotein storage disease
249445|NCT01891422|Lysosomal Storage Disease|lysosomal storage disease
249446|NCT01891422|mannosidase deficiency disorders|mannosidase deficiency disorders
402008|NCT01233518|CCTA Coronary Artery Disease CAD|ccta coronary artery disease cad
249447|NCT01891422|Neuraminidase deficiency with beta-galactosidase deficiency|neuraminidase deficiency with beta-galactosidase deficiency
249448|NCT01891422|mucolipidoses|mucolipidoses
249449|NCT01891422|Oligosaccharidoses|oligosaccharidoses
249450|NCT01891422|Lysosomal Disease|lysosomal disease
249451|NCT01891422|Metabolic Disease, Inborn|metabolic disease, inborn
249452|NCT01891422|aspartylglucosaminuria|aspartylglucosaminuria
249453|NCT01891422|fucosidosis|fucosidosis
249454|NCT01891422|galactosialidosis|galactosialidosis
249455|NCT01891422|alpha mannosidosis|alpha mannosidosis
249456|NCT01891422|beta mannosidosis|beta mannosidosis
249457|NCT01891422|mucolipidosis II|mucolipidosis ii
249458|NCT01891422|mucolipidosis III|mucolipidosis iii
249459|NCT01891422|Schindler disease|schindler disease
249460|NCT01891422|sialidosis|sialidosis
249461|NCT01891409|HIV prevention|hiv prevention
249462|NCT01891409|Male Circumcision|male circumcision
249463|NCT01891409|Children|children
249464|NCT01891409|Childhood|childhood
249465|NCT01891409|Shang Ring|shang ring
249846|NCT01889823|Hyperoxia|hyperoxia
249466|NCT01891396|Knee osteoarthritis|knee osteoarthritis
249467|NCT01891396|Hyaluronic acid|hyaluronic acid
249468|NCT01891396|HA Injection|ha injection
249469|NCT01891396|Steroid Injection|steroid injection
249470|NCT01891396|Knee injection|knee injection
249471|NCT01891383|Dementia|dementia
249472|NCT01891383|Traumatic brain injury (TBI)|traumatic brain injury (tbi)
249473|NCT01891383|Mild cognitive impairment (MCI)|mild cognitive impairment (mci)
249474|NCT01891383|Chronic traumatic encephalopathy (CTE)|chronic traumatic encephalopathy (cte)
249475|NCT01891383|Remote effects of TBI|remote effects of tbi
249476|NCT01891383|Post-traumatic stress disorder (PTSD_|post-traumatic stress disorder (ptsd_
249477|NCT01891357|Unilateral primary invasive carcinoma of the breast|unilateral primary invasive carcinoma of the breast
249478|NCT01891344|ovarian cancer|ovarian cancer
249479|NCT01891344|fallopian tube cancer|fallopian tube cancer
249480|NCT01891344|primary peritoneal cancer|primary peritoneal cancer
249481|NCT01891344|peritoneal cancer|peritoneal cancer
249482|NCT01891344|platinum sensitive|platinum sensitive
249483|NCT01891344|relapsed disease|relapsed disease
249484|NCT01891344|PARP Inhibitor|parp inhibitor
249485|NCT01891344|rucaparib|rucaparib
249486|NCT01891344|homologous recombination|homologous recombination
249487|NCT01891344|homologous recombination deficiency|homologous recombination deficiency
249488|NCT01891344|genomic scarring|genomic scarring
249489|NCT01891344|loss of heterozygosity|loss of heterozygosity
249491|NCT01891344|PF 01367338|pf 01367338
249492|NCT01891344|AG 14699|ag 14699
249493|NCT01891344|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
249494|NCT01891344|platinum sensitive fallopian tube cancer|platinum sensitive fallopian tube cancer
249495|NCT01891344|platinum sensitive primary peritoneal cancer|platinum sensitive primary peritoneal cancer
249496|NCT01891344|platinum sensitive peritoneal cancer|platinum sensitive peritoneal cancer
249497|NCT01891344|gynecological cancer|gynecological cancer
249498|NCT01891344|Clovis|clovis
249499|NCT01891344|Clovis Oncology|clovis oncology
249500|NCT01891344|ARIEL2|ariel2
249501|NCT01891344|ARIEL 2|ariel 2
249502|NCT01891344|ARIEL3|ariel3
249503|NCT01891344|ARIEL 3|ariel 3
249504|NCT01891279|short bowel syndrome|short bowel syndrome
249505|NCT01891279|Elemental formula|elemental formula
249506|NCT01891279|partially hydrolyzed formula|partially hydrolyzed formula
249507|NCT01891279|Enteral feeding|enteral feeding
249508|NCT01891279|TPN dependency|tpn dependency
249509|NCT01891279|Intestinal adaptation|intestinal adaptation
249510|NCT01891279|TPN cholestasis|tpn cholestasis
249511|NCT01891253|cardiac output|cardiac output
249512|NCT01891253|mechanical ventilation|mechanical ventilation
249513|NCT01891253|inert gas rebreathing|inert gas rebreathing
249514|NCT01891253|pulse contour analysis|pulse contour analysis
249515|NCT01891240|Diagnostic|diagnostic
249516|NCT01891240|Pre-eclampsia|pre-eclampsia
249517|NCT01891240|Pregnancy outcome|pregnancy outcome
249518|NCT01891240|Mass screening|mass screening
249519|NCT01891240|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
249520|NCT01891227|Bendamustine|bendamustine
249521|NCT01891227|Capecitabine|capecitabine
249522|NCT01891227|Pretreated|pretreated
249523|NCT01891227|Her2 negative|her2 negative
249524|NCT01891227|Advanced breast cancer|advanced breast cancer
249525|NCT01891227|Metastatic breast cancer|metastatic breast cancer
249526|NCT01891227|Anthracycline pretreatment|anthracycline pretreatment
249527|NCT01891227|Taxane pretreatment|taxane pretreatment
249528|NCT01891214|Inflammatory bowel diseases|inflammatory bowel diseases
249529|NCT01891214|Inflammatory Bowel Disease Questionnaire (IBDQ)|inflammatory bowel disease questionnaire (ibdq)
249530|NCT01891201|Bonding|bonding
249531|NCT01891201|Oxytocin|oxytocin
249532|NCT01891201|Breastfeeding|breastfeeding
249533|NCT01891201|Newborn|newborn
249534|NCT01891201|Delivery|delivery
249535|NCT01891188|hepatic blood,|hepatic blood,
249536|NCT01891188|cardiac cath,|cardiac cath,
249537|NCT01891188|hepatic oxygenation,|hepatic oxygenation,
249538|NCT01891188|pediatrics|pediatrics
249539|NCT01891175|Caesarean|caesarean
249540|NCT01891175|hypotension|hypotension
249541|NCT01891175|Spinal Anaesthesia|spinal anaesthesia
249542|NCT01891175|intermittent pneumatic compression|intermittent pneumatic compression
249543|NCT01891175|lower extremities|lower extremities
249544|NCT01891162|quality of life, incontinence urinary, socioeconomic|quality of life, incontinence urinary, socioeconomic
249545|NCT01891136|Peanut allergy|peanut allergy
249546|NCT01891123|Non-small Cell Lung Cancer|non-small cell lung cancer
249547|NCT01891123|Breast cancer|breast cancer
249548|NCT01891123|plasma drug concentration|plasma drug concentration
249549|NCT01891123|Nasopharygeal carcinoma|nasopharygeal carcinoma
249550|NCT01891110|electric stimulation|electric stimulation
249551|NCT01891110|tilt-table|tilt-table
249552|NCT01891097|Insomnia|insomnia
249553|NCT01891097|Acupuncture|acupuncture
249554|NCT01891097|Electroacupuncture|electroacupuncture
249555|NCT01891097|Aricular acupuncture|aricular acupuncture
249556|NCT01891097|Randomized Clinical Trial|randomized clinical trial
249557|NCT01891097|Traditional Chinese Medicine|traditional chinese medicine
249558|NCT01891084|Influenza|influenza
249559|NCT01891084|Antipyretics|antipyretics
249560|NCT01891084|Fever|fever
249561|NCT01891071|Multiple sclerosis|multiple sclerosis
249562|NCT01891071|Lung volume recruitment|lung volume recruitment
249563|NCT01891071|Pulmonary function impairment|pulmonary function impairment
249564|NCT01891071|Cough impairment|cough impairment
249565|NCT01891045|Psychotherapy|psychotherapy
249566|NCT01891045|Drug addiction|drug addiction
249567|NCT01891045|Drop-out|drop-out
249568|NCT01891045|OQ-45.2|oq-45.2
249569|NCT01891045|Clinical trial|clinical trial
249570|NCT01891045|Randomized Controlled Trail|randomized controlled trail
249571|NCT01891032|acute kidney injury, partial nephrectomy, biomarker|acute kidney injury, partial nephrectomy, biomarker
249572|NCT01891006|Randomized Controlled Trial|randomized controlled trial
249573|NCT01891006|Economical Evaluation|economical evaluation
249574|NCT01891006|Caesarean Section|caesarean section
249575|NCT01891006|Cesarean Section|cesarean section
249576|NCT01891006|Postoperative Wound Treatment|postoperative wound treatment
249577|NCT01891006|Surgical Site Infections|surgical site infections
249578|NCT01891006|Wound Infections|wound infections
249579|NCT01891006|Infectious Morbidity|infectious morbidity
249580|NCT01891006|Negative Pressure Wound Therapy|negative pressure wound therapy
249581|NCT01890980|WT-1-vaccine Montanide|wt-1-vaccine montanide
249582|NCT01890980|GM-CSF|gm-csf
249583|NCT01890980|Wilms Tumor-1 vaccine|wilms tumor-1 vaccine
249584|NCT01890980|immunotherapy|immunotherapy
249585|NCT01890980|Montanide|montanide
249586|NCT01890980|Sargramostim|sargramostim
249587|NCT01890980|Granulocyte Macrophage Colony Stimulating Factor|granulocyte macrophage colony stimulating factor
249588|NCT01890980|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
249590|NCT01890980|soluble mesothelin related protein|soluble mesothelin related protein
249591|NCT01890980|SMRP|smrp
249592|NCT01890967|low density lipoprotein, heterozygous familial hypercholesterolemia, polygenic hypercholesterolemia|low density lipoprotein, heterozygous familial hypercholesterolemia, polygenic hypercholesterolemia
249593|NCT01890954|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
249594|NCT01890954|Closed Loop Control (CLC)|closed loop control (clc)
249595|NCT01890954|Diabetes Assistant (DiAs)|diabetes assistant (dias)
249596|NCT01890954|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
249597|NCT01890941|Dry eye syndromes|dry eye syndromes
249598|NCT01890941|Corneal diseases|corneal diseases
249599|NCT01890941|Conjunctival diseases|conjunctival diseases
249600|NCT01890928|Gluconeogenesis|gluconeogenesis
249601|NCT01890928|Glycogenolysis|glycogenolysis
249602|NCT01890928|Pyruvate cycling|pyruvate cycling
249603|NCT01890928|Glucose production rates|glucose production rates
249604|NCT01890928|Mitochondria|mitochondria
249605|NCT01890928|Acylcarnitines|acylcarnitines
249606|NCT01890915|Spinal cord injury|spinal cord injury
249607|NCT01890915|Body temperature|body temperature
249608|NCT01890915|Executive function|executive function
249609|NCT01890915|Sweat|sweat
249610|NCT01890889|Total Cholesterol|total cholesterol
249611|NCT01890889|LDL|ldl
249707|NCT01890525|radiation|radiation
249612|NCT01890876|glucose tolerance, hypoxia, myokines, exercise|glucose tolerance, hypoxia, myokines, exercise
249613|NCT01890863|asthma|asthma
249614|NCT01890863|fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
249615|NCT01890863|PK equivalence|pk equivalence
249616|NCT01890863|COPD|copd
249617|NCT01890863|pharmacokinetics|pharmacokinetics
249618|NCT01890863|fluticasone propionate/salmeterol in a capsule-based inhaler|fluticasone propionate/salmeterol in a capsule-based inhaler
249619|NCT01890863|fluticasone propionate/salmeterol in a multi-dose dry powder inhaler|fluticasone propionate/salmeterol in a multi-dose dry powder inhaler
249620|NCT01890863|Respiratory|respiratory
249621|NCT01890850|Risk factors|risk factors
249622|NCT01890850|U.S. commercially insured population|u.s. commercially insured population
249623|NCT01890850|Pertussis/whooping cough infection|pertussis/whooping cough infection
249624|NCT01890850|Retrospective database study|retrospective database study
249625|NCT01890837|Rectal Compliance|rectal compliance
249626|NCT01890837|Rectal Sensation|rectal sensation
249627|NCT01890837|Rectal Tone|rectal tone
249628|NCT01890824|Breast Cancer|breast cancer
249629|NCT01890824|Fat metabolism|fat metabolism
249630|NCT01890824|Fat digestion|fat digestion
249631|NCT01890824|physical activity|physical activity
249632|NCT01890824|muscle function|muscle function
249633|NCT01890811|CKD|ckd
249634|NCT01890811|Hemodialysis|hemodialysis
249635|NCT01890811|Protein Digestion|protein digestion
249636|NCT01890811|Fat Digestion|fat digestion
249637|NCT01890811|Gut Function|gut function
249638|NCT01890811|Glucose Absorption|glucose absorption
249639|NCT01890811|Muscle Function|muscle function
249640|NCT01890798|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
249641|NCT01890798|GSK2402968|gsk2402968
249642|NCT01890798|drisapersen|drisapersen
249643|NCT01890772|Hepatitis C Genotype 1|hepatitis c genotype 1
249644|NCT01890772|Vitamin D|vitamin d
249645|NCT01890772|treatment-naive|treatment-naive
249646|NCT01890759|Meningitis|meningitis
249647|NCT01890759|Meningococcal Infection|meningococcal infection
249648|NCT01890759|Menactra®|menactra®
249649|NCT01890746|de novo AML|de novo aml
249650|NCT01890746|Eltrombopag|eltrombopag
249654|NCT01890746|secondary acute myeloid|secondary acute myeloid
249655|NCT01890746|thrombocytopenia|thrombocytopenia
249656|NCT01890733|Massive Rotator Cuff Tear, Sub-acromial spacer, Best repair of rotator cuff,|massive rotator cuff tear, sub-acromial spacer, best repair of rotator cuff,
249657|NCT01890720|Randomized Controlled Trial|randomized controlled trial
249658|NCT01890720|Economical Evaluation|economical evaluation
249659|NCT01890720|Caesarean Section|caesarean section
249660|NCT01890720|postoperative wound treatment|postoperative wound treatment
249661|NCT01890720|surgical site infections|surgical site infections
249662|NCT01890720|wound infections|wound infections
249663|NCT01890720|infectious morbidity|infectious morbidity
249664|NCT01890720|Negative Pressure Wound Therapy|negative pressure wound therapy
249665|NCT01890720|Incisional Negative Pressure Wound Therapy|incisional negative pressure wound therapy
249666|NCT01890720|Obesity|obesity
249667|NCT01890707|Gynecology|gynecology
249668|NCT01890707|Pain|pain
249669|NCT01890707|Anesthesia|anesthesia
249670|NCT01890707|Quality of Recovery 40|quality of recovery 40
249671|NCT01890694|Hyponatremia|hyponatremia
249672|NCT01890694|Dilutional Hyponatremia|dilutional hyponatremia
249673|NCT01890694|Euvolemic Hyponatremia|euvolemic hyponatremia
249674|NCT01890694|Hypervolemic Hyponatremia|hypervolemic hyponatremia
249675|NCT01890694|Fluid Restriction|fluid restriction
249676|NCT01890694|Tolvaptan|tolvaptan
249677|NCT01890681|childhood obesity|childhood obesity
249678|NCT01890681|child care|child care
249679|NCT01890681|infant|infant
249680|NCT01890681|toddler|toddler
249681|NCT01890668|Breastfeeding behaviour|breastfeeding behaviour
249682|NCT01890668|OMT (Osteopathic Manipulative Treatment)|omt (osteopathic manipulative treatment)
249683|NCT01890668|suboptimal infant breastfeeding behaviour|suboptimal infant breastfeeding behaviour
249684|NCT01890668|healthy newborns|healthy newborns
249685|NCT01890655|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
249686|NCT01890655|RRMS|rrms
249687|NCT01890642|Pain|pain
249688|NCT01890642|Children|children
249689|NCT01890642|Venipuncture|venipuncture
249690|NCT01890642|J tip|j tip
249691|NCT01890642|Lidocaine|lidocaine
249692|NCT01890642|video observation|video observation
249693|NCT01890629|diabetes mellitus|diabetes mellitus
249694|NCT01890603|Care coordination, primary care|care coordination, primary care
249695|NCT01890603|nurse care management|nurse care management
249696|NCT01890603|practice facilitation|practice facilitation
249697|NCT01890590|Renal Cell Carcinoma|renal cell carcinoma
249698|NCT01890590|Cyberknife|cyberknife
249699|NCT01890577|Chronic kidney disease|chronic kidney disease
249700|NCT01890577|Dialysis|dialysis
249701|NCT01890577|Erythropoiesis stimulating agent|erythropoiesis stimulating agent
249702|NCT01890577|South Africa|south africa
249703|NCT01890551|Adoloescent, patellofemoral, instability,biomechanics, magnetic resonance imaging|adoloescent, patellofemoral, instability,biomechanics, magnetic resonance imaging
249704|NCT01890538|vertigo|vertigo
249705|NCT01890538|dimenhydrinate|dimenhydrinate
249706|NCT01890538|piracetam|piracetam
249708|NCT01890499|tolerability|tolerability
249709|NCT01890499|diet after operation|diet after operation
249710|NCT01890447|Cocooning|cocooning
249711|NCT01890447|Web-based questionnaire|web-based questionnaire
249712|NCT01890447|Italy|italy
249713|NCT01890447|Pertussis|pertussis
249714|NCT01890447|Spain|spain
249715|NCT01890447|Survey|survey
249716|NCT01890434|Myocardial Perfusion Imaging|myocardial perfusion imaging
249718|NCT01890408|Laparotomy|laparotomy
249719|NCT01890408|Hepatic resection|hepatic resection
249720|NCT01890408|continuous wound catheter analgesia|continuous wound catheter analgesia
249721|NCT01890408|morphine|morphine
249722|NCT01890408|post operative recovery|post operative recovery
249723|NCT01890395|mitochondrial DAMPS|mitochondrial damps
249724|NCT01890382|resistance exercise|resistance exercise
249725|NCT01890382|protein|protein
249726|NCT01890382|creatine|creatine
249727|NCT01890382|leucine|leucine
249728|NCT01890382|aging|aging
249729|NCT01890369|Old Age|old age
249730|NCT01890369|Sarcopenia|sarcopenia
249731|NCT01890369|Amino Acid|amino acid
249732|NCT01890369|Muscle|muscle
249733|NCT01890356|Depression|depression
249734|NCT01890356|Treatment|treatment
249735|NCT01890356|Transcranial electrical stimulation|transcranial electrical stimulation
249736|NCT01890356|Maintenance|maintenance
249737|NCT01890330|Canola Oil|canola oil
249738|NCT01890330|Metabolic Syndrome|metabolic syndrome
249739|NCT01890330|Serum LDL cholesterol|serum ldl cholesterol
249740|NCT01890317|Cardiogenic shock|cardiogenic shock
249741|NCT01890317|acute myocardial infarction|acute myocardial infarction
249742|NCT01890317|mild hypothermia|mild hypothermia
307992|NCT01627080|RT|rt
249743|NCT01890304|Traumatic Brain Injury|traumatic brain injury
249744|NCT01890304|TBI|tbi
249745|NCT01890304|Concussion|concussion
249746|NCT01890304|Sports related injury|sports related injury
249747|NCT01890291|Immuncell-LC, Hepatocellular carcinoma|immuncell-lc, hepatocellular carcinoma
249748|NCT01890278|Brain Cancer|brain cancer
249749|NCT01890278|Metastatic Brain Cancer|metastatic brain cancer
249750|NCT01890278|IMRT|imrt
249751|NCT01890265|Idiopathic Pulmonary Fibrosis, IPF, Idiopathic Interstitial Pneumonia, Interstitial Lung Disease, Lung Fibrosis|idiopathic pulmonary fibrosis, ipf, idiopathic interstitial pneumonia, interstitial lung disease, lung fibrosis
249752|NCT01890213|alphavirus|alphavirus
249753|NCT01890213|colon cancer|colon cancer
249754|NCT01890213|immune response|immune response
249755|NCT01890213|CEA|cea
249756|NCT01890200|add-on treatment|add-on treatment
249757|NCT01890200|botanical drug|botanical drug
249758|NCT01890200|HCV genotype 1|hcv genotype 1
249759|NCT01890200|TCM-700C|tcm-700c
249760|NCT01890161|asthma|asthma
249761|NCT01890148|Asthma|asthma
249762|NCT01890135|randomized|randomized
249763|NCT01890135|double blind|double blind
249764|NCT01890135|blood flow|blood flow
249765|NCT01890135|muscle perfusion|muscle perfusion
249766|NCT01890135|safety|safety
249767|NCT01890122|Drug therapy|drug therapy
249768|NCT01890109|Vasomotor symptoms; Hot Flashes|vasomotor symptoms; hot flashes
249769|NCT01890096|HDR|hdr
249770|NCT01890096|monotherapy|monotherapy
249771|NCT01890096|low|low
249772|NCT01890096|intermediate|intermediate
249773|NCT01890096|prostate cancer|prostate cancer
249774|NCT01890083|Hepatitis C|hepatitis c
249775|NCT01890083|Interferon-alpha|interferon-alpha
249776|NCT01890083|Depression|depression
249777|NCT01890083|Major Depressive Disorder|major depressive disorder
249778|NCT01890083|Exercise|exercise
249779|NCT01890083|Physical Activity|physical activity
249780|NCT01890070|mediterranean diet, nutrigenomics, body composition, inflammation, oxidative stress|mediterranean diet, nutrigenomics, body composition, inflammation, oxidative stress
249781|NCT01890044|VTE|vte
249783|NCT01890044|Venous Thromboembolism|venous thromboembolism
249784|NCT01890044|Deep Vein Thrombosis|deep vein thrombosis
249785|NCT01890044|Pulmonary embolus|pulmonary embolus
249787|NCT01890031|cardiovascular disease|cardiovascular disease
249788|NCT01890031|cholesterol|cholesterol
249789|NCT01890018|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
249790|NCT01890018|taking a statin medication|taking a statin medication
249791|NCT01890018|also have a medication adherence ratio (MPR)|also have a medication adherence ratio (mpr)
249792|NCT01890005|Preeclampsia|preeclampsia
249793|NCT01890005|Low dose aspirin|low dose aspirin
249794|NCT01890005|Fetal growth restriction|fetal growth restriction
249795|NCT01890005|Neonatal death|neonatal death
249796|NCT01890005|Stillbirth|stillbirth
249797|NCT01890005|Abruptio placenta|abruptio placenta
249798|NCT01889992|Heart transplantation|heart transplantation
249799|NCT01889992|Cardiac allograft remodeling|cardiac allograft remodeling
249800|NCT01889992|Immunosuppression|immunosuppression
249801|NCT01889992|Cardiac MRI|cardiac mri
249802|NCT01889992|M-TOR inhibitor|m-tor inhibitor
249803|NCT01889979|Pain during labour|pain during labour
249804|NCT01889979|Duration of labour|duration of labour
249805|NCT01889979|Apgar score|apgar score
249806|NCT01889979|Umbilical cord pH|umbilical cord ph
249807|NCT01889966|vasoreactivity testing|vasoreactivity testing
249808|NCT01889966|Sildenafil|sildenafil
250023|NCT01889056|Cognition|cognition
249809|NCT01889966|precapillary pulmonary hypertension|precapillary pulmonary hypertension
249810|NCT01889966|connective tissue disease|connective tissue disease
249811|NCT01889966|mean pressure in the pulmonary artery 25 mmHg or more|mean pressure in the pulmonary artery 25 mmhg or more
249812|NCT01889966|mean pulmonary capillary wedge pressure below 16 mmHg|mean pulmonary capillary wedge pressure below 16 mmhg
249813|NCT01889953|EUS-Guided Biliary Drainage|eus-guided biliary drainage
249814|NCT01889953|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
249815|NCT01889953|Malignant Biliary Obstruction|malignant biliary obstruction
249816|NCT01889940|Acute Spinal Cord Injury|acute spinal cord injury
249817|NCT01889940|Patient Satisfaction|patient satisfaction
249819|NCT01889940|Rehabilitation|rehabilitation
249820|NCT01889940|Training Professionals|training professionals
249821|NCT01889940|Burnout|burnout
249822|NCT01889940|Job Content|job content
249823|NCT01889927|exercise|exercise
249824|NCT01889927|physiotherapy|physiotherapy
249825|NCT01889927|lung function|lung function
249826|NCT01889927|quality of life|quality of life
249827|NCT01889901|Physical Activity|physical activity
249828|NCT01889901|Epilepsy|epilepsy
249829|NCT01889901|Seizures|seizures
249830|NCT01889901|Quality of Life|quality of life
249831|NCT01889888|Male urethral stricture|male urethral stricture
249832|NCT01889888|ADRC|adrc
249833|NCT01889888|Adipose-derived regenerative cells|adipose-derived regenerative cells
249834|NCT01889888|Fat tissue|fat tissue
249835|NCT01889888|Stem cells|stem cells
249837|NCT01889862|PEG-PAL|peg-pal
249838|NCT01889862|Prism|prism
249839|NCT01889862|BioMarin|biomarin
249840|NCT01889862|rAvPAL-PEG|ravpal-peg
249841|NCT01889862|Pegvalaise|pegvalaise
249842|NCT01889836|meningococcal conjugate vaccine serogroup C|meningococcal conjugate vaccine serogroup c
249843|NCT01889836|Prevention|prevention
249844|NCT01889823|Oxygen|oxygen
249845|NCT01889823|Hypoxia|hypoxia
249850|NCT01889797|Untreated Non-Hodgkin's Lymphoma|untreated non-hodgkin's lymphoma
249851|NCT01889797|Low Tumor Burden Non-Hodgkin's Lymphoma|low tumor burden non-hodgkin's lymphoma
249852|NCT01889797|NHL|nhl
249853|NCT01889797|Indolent|indolent
249854|NCT01889797|Rituximab|rituximab
249855|NCT01889797|Rituxan|rituxan
249856|NCT01889797|GA101|ga101
249857|NCT01889797|Obinutuzumab|obinutuzumab
249858|NCT01889784|diabetes mellitus, type 2|diabetes mellitus, type 2
249859|NCT01889784|phototherapy|phototherapy
249860|NCT01889784|physical exercise|physical exercise
249861|NCT01889784|oxygen consumption|oxygen consumption
249862|NCT01889784|arterial blood pressure|arterial blood pressure
249863|NCT01889784|heart rate|heart rate
249864|NCT01889784|baroreflex sensitivity|baroreflex sensitivity
249865|NCT01889784|cardiovascular autonomic control|cardiovascular autonomic control
249866|NCT01889758|bioequivalence|bioequivalence
249867|NCT01889758|tacrolimus|tacrolimus
249868|NCT01889758|kidney|kidney
249869|NCT01889758|liver|liver
249870|NCT01889758|transplant|transplant
249871|NCT01889719|HIV Prevention|hiv prevention
249872|NCT01889706|Type 1 diabetes mellitus,|type 1 diabetes mellitus,
249873|NCT01889706|metformin,|metformin,
249874|NCT01889706|insulin resistance,|insulin resistance,
249875|NCT01889706|obesity|obesity
249876|NCT01889693|positron emission tomography|positron emission tomography
249877|NCT01889693|macrophage|macrophage
249878|NCT01889693|neomannosyl human serum albumin|neomannosyl human serum albumin
249879|NCT01889680|colorectal cancer|colorectal cancer
249880|NCT01889680|metastatic colorectal cancer|metastatic colorectal cancer
249881|NCT01889680|ziv-aflibercept|ziv-aflibercept
249882|NCT01889680|NSABP|nsabp
249883|NCT01889667|Oral Insulin|oral insulin
249884|NCT01889667|Diabetes Mellitus Type 2|diabetes mellitus type 2
249886|NCT01889667|Pharmacodynamics|pharmacodynamics
249887|NCT01889667|Pharmacokinetics|pharmacokinetics
249888|NCT01889628|Glycaemic response|glycaemic response
249889|NCT01889628|Glycaemic Index|glycaemic index
249890|NCT01889628|Nutritional formula|nutritional formula
249891|NCT01889628|Asia|asia
249892|NCT01889628|Ethnic differences|ethnic differences
249893|NCT01889628|Chinese|chinese
249894|NCT01889628|Malay|malay
249895|NCT01889628|Indian|indian
249896|NCT01889615|Ovarian cancer|ovarian cancer
249897|NCT01889615|PET/CT|pet/ct
249898|NCT01889615|glucose 6 phosphatase|glucose 6 phosphatase
249899|NCT01889602|Healthy volunteers|healthy volunteers
249900|NCT01889602|Topiramate|topiramate
249901|NCT01889602|Neurocognition|neurocognition
249902|NCT01889602|Drug-induced cognitive deficits|drug-induced cognitive deficits
249903|NCT01889576|glucose|glucose
249904|NCT01889563|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
249905|NCT01889563|heart rate variability|heart rate variability
249906|NCT01889563|physical training|physical training
249907|NCT01889550|Screening|screening
249908|NCT01889550|Downs syndrome|downs syndrome
249909|NCT01889550|Informed choice|informed choice
249910|NCT01889550|eHealth|ehealth
249912|NCT01889511|Text Messaging|text messaging
249913|NCT01889511|Medication Adherence|medication adherence
249914|NCT01889511|Oral Agents|oral agents
250024|NCT01889056|Exercise|exercise
250525|NCT01886638|Platelets|platelets
249915|NCT01889498|Acetazolamide, intracranial/cerebrospinal fluid pressure, paraplegia, thoracoabdominal aortic surgery|acetazolamide, intracranial/cerebrospinal fluid pressure, paraplegia, thoracoabdominal aortic surgery
249916|NCT01889485|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
249917|NCT01889485|Carotid Stenosis|carotid stenosis
249918|NCT01889485|Peripheral Arterial Disease|peripheral arterial disease
249919|NCT01889485|Health Services Accessibility|health services accessibility
249920|NCT01889472|CPAP compliance|cpap compliance
249921|NCT01889472|leaks|leaks
249922|NCT01889472|Respiratory disturbances index|respiratory disturbances index
249923|NCT01889472|quality of life|quality of life
249924|NCT01889446|Propionic acid|propionic acid
249925|NCT01889446|Food preservatives|food preservatives
249926|NCT01889433|Hepatitis C|hepatitis c
249927|NCT01889433|Cepeginterferon alfa|cepeginterferon alfa
249928|NCT01889433|Peginterferon|peginterferon
249929|NCT01889433|Treatment|treatment
249930|NCT01889420|myeloma|myeloma
249931|NCT01889420|relapse|relapse
249932|NCT01889420|refractory|refractory
249933|NCT01889420|relapsed|relapsed
249934|NCT01889420|pomalidomide|pomalidomide
249935|NCT01889420|pomalyst|pomalyst
249936|NCT01889420|everolimus|everolimus
249937|NCT01889420|afinitor|afinitor
249938|NCT01889420|dexamethasone|dexamethasone
249939|NCT01889407|Acute Myeloid Leukemia|acute myeloid leukemia
249944|NCT01889368|Insulin resistance|insulin resistance
249945|NCT01889368|Central adiposity|central adiposity
249946|NCT01889368|Elevated blood pressure|elevated blood pressure
249947|NCT01889368|Vascular reactivity|vascular reactivity
249948|NCT01889368|Elevated triglycerides|elevated triglycerides
249949|NCT01889368|Low high-density lipoprotein (HDL)|low high-density lipoprotein (hdl)
249950|NCT01889355|diabetes|diabetes
249951|NCT01889355|glucose|glucose
249952|NCT01889355|glucometer|glucometer
249953|NCT01889342|MCT|mct
249954|NCT01889342|Metacognitive therapy|metacognitive therapy
249955|NCT01889342|Anxiety disorders|anxiety disorders
249956|NCT01889342|Transdiagnostic|transdiagnostic
249957|NCT01889316|Fetal monitoring|fetal monitoring
249958|NCT01889316|ECG|ecg
249959|NCT01889303|concurrent chemoradiotherapy|concurrent chemoradiotherapy
249960|NCT01889303|FOLFOX6|folfox6
249961|NCT01889303|chemotherapy|chemotherapy
249962|NCT01889303|docetaxel|docetaxel
249963|NCT01889303|cisplatin|cisplatin
249964|NCT01889303|gastric cancer|gastric cancer
249965|NCT01889290|methylnaltrexone|methylnaltrexone
249966|NCT01889290|opioid-antagonist|opioid-antagonist
249967|NCT01889290|Obstipation|obstipation
249968|NCT01889290|pharmacokinetics|pharmacokinetics
249969|NCT01889277|Diabetic Nephropathy|diabetic nephropathy
249970|NCT01889264|Methionine Metabolism|methionine metabolism
249971|NCT01889264|Enteral Nutrition|enteral nutrition
249972|NCT01889264|Pediatric|pediatric
249973|NCT01889264|Pediatrics|pediatrics
249974|NCT01889264|Sepsis|sepsis
249975|NCT01889264|Observational Study|observational study
249976|NCT01889251|Vitreomacular Adhesion|vitreomacular adhesion
249977|NCT01889251|Vitreomacular Traction|vitreomacular traction
249978|NCT01889251|Vitreomacular Traction Syndrome|vitreomacular traction syndrome
249979|NCT01889251|Vitrectomy|vitrectomy
249980|NCT01889251|Central Visual Field Defect|central visual field defect
249981|NCT01889251|Blind Spot|blind spot
249982|NCT01889251|Intravitreal Injection|intravitreal injection
249983|NCT01889251|Macula|macula
249984|NCT01889251|Retina|retina
249985|NCT01889251|Decreased Visual Acuity|decreased visual acuity
249986|NCT01889251|Visual Complaint|visual complaint
249987|NCT01889251|SD-OCT|sd-oct
249988|NCT01889251|Macular Hole|macular hole
249989|NCT01889238|breast cancer|breast cancer
249993|NCT01889199|hirsutism|hirsutism
249994|NCT01889199|anovulation|anovulation
249995|NCT01889199|oligomenorrhea|oligomenorrhea
249996|NCT01889199|amenorrhea|amenorrhea
249997|NCT01889199|hyperandrogenism|hyperandrogenism
249998|NCT01889199|antiandrogen effect|antiandrogen effect
249999|NCT01889186|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
250000|NCT01889186|17 p Deletion|17 p deletion
250001|NCT01889160|Healthy volunteers, Phase 1|healthy volunteers, phase 1
250002|NCT01889147|Peak plasma concentration|peak plasma concentration
250003|NCT01889147|safety and efficacy|safety and efficacy
250004|NCT01889147|therapeutic agent|therapeutic agent
250005|NCT01889147|LPS-mediated diseases|lps-mediated diseases
250006|NCT01889147|Pharmacokinetics of administered hRESCAP|pharmacokinetics of administered hrescap
250007|NCT01889147|Determine half-time|determine half-time
250008|NCT01889134|primary hyperparathyroidism|primary hyperparathyroidism
250009|NCT01889134|RANKL|rankl
250010|NCT01889134|osteoprotegerin|osteoprotegerin
250011|NCT01889134|bone mineral density|bone mineral density
250012|NCT01889134|alendronate|alendronate
250013|NCT01889134|parathyroidectomy|parathyroidectomy
250014|NCT01889108|Premature|premature
250015|NCT01889108|Development|development
250016|NCT01889108|Motor|motor
250017|NCT01889108|Cognitive|cognitive
250018|NCT01889108|Parent|parent
250019|NCT01889082|Obesity|obesity
250020|NCT01889082|weight loss|weight loss
250021|NCT01889082|young adults|young adults
250022|NCT01889056|Erythropoietin|erythropoietin
250025|NCT01889043|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
250026|NCT01889043|Noninvasive Ventilation|noninvasive ventilation
250027|NCT01889043|Polysomnography|polysomnography
250028|NCT01889030|Cardiovascular primary prevention|cardiovascular primary prevention
250029|NCT01889030|Cardiovascular risk strtification|cardiovascular risk strtification
250030|NCT01889017|generic immunosuppressive|generic immunosuppressive
250031|NCT01889004|Cerebral blood flow|cerebral blood flow
250032|NCT01889004|Consciousness|consciousness
250033|NCT01889004|Dexmedetomidine|dexmedetomidine
250034|NCT01889004|EEG|eeg
250035|NCT01889004|Event related potentials|event related potentials
250036|NCT01889004|Functional magnetic resonance imaging|functional magnetic resonance imaging
250037|NCT01889004|General anesthesia|general anesthesia
250038|NCT01889004|Positron emission tomography|positron emission tomography
250039|NCT01889004|Propofol|propofol
250040|NCT01888991|Glucose|glucose
250041|NCT01888991|Exercise|exercise
250042|NCT01888991|Metabolic flexibility|metabolic flexibility
250043|NCT01888991|Substrate Oxidation|substrate oxidation
250044|NCT01888991|Food intake|food intake
250045|NCT01888978|Pancreas|pancreas
250046|NCT01888978|cancer|cancer
250047|NCT01888978|metastatic|metastatic
250048|NCT01888978|chemotherapy|chemotherapy
250049|NCT01888965|Maintenance therapy|maintenance therapy
250050|NCT01888965|Adjuvant Therapy|adjuvant therapy
250051|NCT01888939|Executive Function|executive function
250052|NCT01888939|Child|child
250053|NCT01888939|Obesity|obesity
250054|NCT01888939|Exercise|exercise
250055|NCT01888939|Insulin Sensitivity|insulin sensitivity
250056|NCT01888926|rPAS|rpas
250057|NCT01888926|Dystonia|dystonia
250058|NCT01888913|Body Weight|body weight
250059|NCT01888913|Virtual Reality Technology|virtual reality technology
250060|NCT01888900|Hepatitis C|hepatitis c
250061|NCT01888900|Non-Responders|non-responders
250062|NCT01888900|Direct Acting Antivirals|direct acting antivirals
250063|NCT01888900|Interferon Free|interferon free
250064|NCT01888900|Cirrhosis|cirrhosis
250065|NCT01888874|Methotrexate insufficient responders|methotrexate insufficient responders
250066|NCT01888861|length of stay in ICU|length of stay in icu
250067|NCT01888861|ventilator free days|ventilator free days
250068|NCT01888848|Postural Balance|postural balance
250069|NCT01888848|Walking|walking
250070|NCT01888848|Gait|gait
250071|NCT01888848|Cognition|cognition
250072|NCT01888848|Learning|learning
250073|NCT01888848|Memory|memory
250074|NCT01888848|Blueberry|blueberry
250075|NCT01888848|Antioxidants|antioxidants
250076|NCT01888848|Anti-Inflammatory Agents|anti-inflammatory agents
250077|NCT01888848|Brain|brain
250078|NCT01888835|HIV|hiv
250079|NCT01888835|sexual behavior|sexual behavior
250080|NCT01888822|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
250081|NCT01888822|Prophylactic antibiotics|prophylactic antibiotics
250082|NCT01888809|teen parents|teen parents
250083|NCT01888809|early childhood development|early childhood development
250084|NCT01888809|home visitation|home visitation
250085|NCT01888809|evidence-based treatment|evidence-based treatment
250086|NCT01888796|T2DM|t2dm
249847|NCT01889823|Inflammation|inflammation
250087|NCT01888796|diastolic dysfunction|diastolic dysfunction
250089|NCT01888783|tactile acuity|tactile acuity
250090|NCT01888783|2-point-discrimination|2-point-discrimination
250091|NCT01888783|Grating Orientation Task|grating orientation task
250092|NCT01888783|sensory signs|sensory signs
250093|NCT01888757|Bioequivalence|bioequivalence
250094|NCT01888757|Lamotrigine Extended Release|lamotrigine extended release
250095|NCT01888757|crossover|crossover
250096|NCT01888744|Intracytoplasmic sperm injection (ICSI)|intracytoplasmic sperm injection (icsi)
250098|NCT01888744|GnrH agonist|gnrh agonist
250099|NCT01888744|GnRH antagonist|gnrh antagonist
250100|NCT01888731|Bioequivalence|bioequivalence
250101|NCT01888731|Lamotrigine Extended Release|lamotrigine extended release
250102|NCT01888731|crossover|crossover
250103|NCT01888705|COPD|copd
250104|NCT01888705|Complexity|complexity
250105|NCT01888705|Entropy Sampling|entropy sampling
250106|NCT01888705|Variability|variability
250107|NCT01888705|Respiratory Mechanics|respiratory mechanics
250108|NCT01888705|FOT|fot
250109|NCT01888692|PET/CT|pet/ct
250110|NCT01888692|Radiotherapy|radiotherapy
250111|NCT01888692|Lung Cancer|lung cancer
250112|NCT01888679|Airway|airway
250113|NCT01888679|Endotracheal intubation|endotracheal intubation
250114|NCT01888679|selective intubation|selective intubation
250115|NCT01888653|PTSD|ptsd
250116|NCT01888653|Attention Bias to threat|attention bias to threat
250117|NCT01888653|Attention Bias Modification Treatment|attention bias modification treatment
250118|NCT01888640|TENS|tens
250119|NCT01888640|Fibromyalgia|fibromyalgia
250120|NCT01888640|Accelerometer|accelerometer
250121|NCT01888627|Schizophrenia|schizophrenia
250122|NCT01888627|Bipolar disorder|bipolar disorder
250123|NCT01888627|Assertive community treatment|assertive community treatment
250124|NCT01888627|Integrated care|integrated care
250125|NCT01888627|Severe and persistent mental disorder|severe and persistent mental disorder
250126|NCT01888614|carbon mono oxide|carbon mono oxide
250127|NCT01888614|sickle cell|sickle cell
250128|NCT01888614|hemolysis|hemolysis
250129|NCT01888588|Uncomplicated peptic ulcer|uncomplicated peptic ulcer
250130|NCT01888588|Low dose aspirin (ASA)|low dose aspirin (asa)
250131|NCT01888588|Acid-suppressing drugs|acid-suppressing drugs
250132|NCT01888588|Epidemiology|epidemiology
250133|NCT01888575|Discontinuation of low dose ASA,|discontinuation of low dose asa,
250134|NCT01888575|Secondary cardiovascular prevention,|secondary cardiovascular prevention,
250135|NCT01888575|Acid-suppressing drugs,|acid-suppressing drugs,
250136|NCT01888575|Gastrointestinal risk,|gastrointestinal risk,
250137|NCT01888575|Epidemiology|epidemiology
250138|NCT01888549|Chronic cough, proton pump inhibitor, GERD, nonacid reflux,|chronic cough, proton pump inhibitor, gerd, nonacid reflux,
250139|NCT01888497|Sleeplessness|sleeplessness
250141|NCT01888471|Streptococcal disease|streptococcal disease
250142|NCT01888471|Feasibility|feasibility
250143|NCT01888471|Infants|infants
250144|NCT01888458|Adult|adult
250145|NCT01888458|allo-Stem Cell Transplantation|allo-stem cell transplantation
250146|NCT01888458|Cord Blood|cord blood
250147|NCT01888445|Renal anemia|renal anemia
250148|NCT01888445|Chronic Renal Failure|chronic renal failure
250149|NCT01888445|ASP1517|asp1517
250150|NCT01888432|liver transplantation|liver transplantation
250151|NCT01888432|everolimus|everolimus
250152|NCT01888432|tacrolimus|tacrolimus
250153|NCT01888432|reduced calcineuron inhibitor|reduced calcineuron inhibitor
250154|NCT01888432|renal function|renal function
250155|NCT01888432|living donor|living donor
250156|NCT01888432|RAD001H2307|rad001h2307
250157|NCT01888432|RAD001H|rad001h
250158|NCT01888419|Post Breast Therapy Pain Syndrome|post breast therapy pain syndrome
250159|NCT01888419|Lipotransplantation|lipotransplantation
250160|NCT01888419|Breast Cancer|breast cancer
250161|NCT01888419|Pain|pain
250162|NCT01888406|Obesity|obesity
250163|NCT01888406|Weight gain prevention|weight gain prevention
250164|NCT01888406|Eating disorder|eating disorder
250165|NCT01888406|Binge eating|binge eating
250166|NCT01888393|pharmacokinetics, hepatic impairment|pharmacokinetics, hepatic impairment
250167|NCT01888380|Autopsy|autopsy
250168|NCT01888380|Minimally invasive|minimally invasive
250169|NCT01888380|Foetuses|foetuses
250170|NCT01888380|Newborns|newborns
250171|NCT01888380|Children|children
250172|NCT01888380|Adolescents|adolescents
250173|NCT01888354|MS|ms
250174|NCT01888354|Multiple Sclerosis|multiple sclerosis
250175|NCT01888315|Hypertension|hypertension
250176|NCT01888315|Heart Failure|heart failure
250177|NCT01888315|Sympathetic activity|sympathetic activity
250178|NCT01888276|Words generation, compulsive gamblers|words generation, compulsive gamblers
250179|NCT01888263|Bioequivalence|bioequivalence
250180|NCT01888263|Lamotrigine Extended Release|lamotrigine extended release
250181|NCT01888263|crossover|crossover
250182|NCT01888250|Bioequivalence|bioequivalence
250183|NCT01888250|Lamotrigine Extended Release|lamotrigine extended release
250184|NCT01888250|crossover|crossover
250185|NCT01888237|Dyspepsia|dyspepsia
250186|NCT01888237|Helicobacter pylori|helicobacter pylori
250187|NCT01888237|Clarithromycin resistance|clarithromycin resistance
250188|NCT01888237|Other Specified Disorders of Function of Stomach|other specified disorders of function of stomach
250189|NCT01888198|ablation|ablation
250190|NCT01888198|quality of Life (QOL)|quality of life (qol)
250191|NCT01888198|kidney|kidney
250192|NCT01888198|registry|registry
250193|NCT01888198|Ablation of Renal Masses Outcomes Registry (ARMOR)|ablation of renal masses outcomes registry (armor)
250194|NCT01888198|13-116|13-116
250195|NCT01888185|Parkinson's|parkinson's
250196|NCT01888185|PD|pd
250197|NCT01888185|nigrostriatal|nigrostriatal
250198|NCT01888185|substantia nigra|substantia nigra
250199|NCT01888185|MRI|mri
250200|NCT01888185|DTI|dti
250201|NCT01888185|FA|fa
250202|NCT01888185|R2*|r2*
250203|NCT01888185|Parkinson's Disease Biomarkers Program|parkinson's disease biomarkers program
250204|NCT01888185|PDBP|pdbp
250205|NCT01888185|ferritin|ferritin
250206|NCT01888185|transferrin|transferrin
250207|NCT01888185|Fe|fe
250208|NCT01888185|iron protein|iron protein
250209|NCT01888185|PSP|psp
250210|NCT01888185|MSA|msa
250211|NCT01888146|Pain management|pain management
250212|NCT01888146|Opioid use|opioid use
250213|NCT01888146|Pragmatic|pragmatic
250214|NCT01888146|Collaborative care|collaborative care
250215|NCT01888146|Primary care|primary care
250216|NCT01888107|Schizophrenia|schizophrenia
250217|NCT01888107|Schizoaffective Disorder|schizoaffective disorder
250218|NCT01888107|Antipsychotics|antipsychotics
250219|NCT01888107|Risperidone|risperidone
250220|NCT01888107|Long-acting injectable|long-acting injectable
250221|NCT01888094|Central venous catheter|central venous catheter
250222|NCT01888094|Complications|complications
250223|NCT01888094|Ultrasound|ultrasound
250224|NCT01888094|Subclavian vein cannulation|subclavian vein cannulation
250225|NCT01888094|Critical care|critical care
250226|NCT01888094|Echocardiography|echocardiography
250227|NCT01888094|Chest radiographyiography|chest radiographyiography
250228|NCT01888055|Healthy older adults Cortical Plasticity|healthy older adults cortical plasticity
250229|NCT01888055|Transcranial Direct Current Stimulation|transcranial direct current stimulation
250230|NCT01888029|mild cognitive impairment|mild cognitive impairment
250231|NCT01888029|Transcranial Direct Current Stimulation|transcranial direct current stimulation
250232|NCT01888029|Cortical Plasticity|cortical plasticity
250233|NCT01888003|anemia|anemia
250234|NCT01887977|Orthognathic surgery|orthognathic surgery
250235|NCT01887977|Speech production|speech production
250236|NCT01887977|MRI|mri
250237|NCT01887964|Diabetes|diabetes
250238|NCT01887964|Obesity|obesity
250239|NCT01887964|Cardiovascular disease|cardiovascular disease
250240|NCT01887964|Metabolic syndrome|metabolic syndrome
250241|NCT01887925|breast neoplasms|breast neoplasms
250242|NCT01887925|sleep|sleep
250243|NCT01887925|anxiety|anxiety
250244|NCT01887925|depression|depression
250245|NCT01887925|life quality|life quality
250246|NCT01887912|Clostridium difficile Toxoid Vaccine|clostridium difficile toxoid vaccine
250247|NCT01887912|Clostridium difficile infection|clostridium difficile infection
250248|NCT01887912|Cdiffense|cdiffense
250249|NCT01887899|cortical plasticity|cortical plasticity
250352|NCT01887418|Hypogonadism|hypogonadism
242223|NCT01924949|LDV|ldv
250250|NCT01887899|transcranial direct current stimulation|transcranial direct current stimulation
250251|NCT01887873|open angle glaucoma|open angle glaucoma
250252|NCT01887873|cataract|cataract
250253|NCT01887860|Cetaphil Daily Facial Moisturizer SPF 50|cetaphil daily facial moisturizer spf 50
250254|NCT01887847|nicotine|nicotine
250255|NCT01887847|pharmacokinetics|pharmacokinetics
250256|NCT01887834|bloating|bloating
250257|NCT01887834|constipation|constipation
250258|NCT01887834|diarrhea|diarrhea
250259|NCT01887834|gas|gas
250260|NCT01887834|mucous|mucous
250261|NCT01887834|cramping|cramping
250262|NCT01887808|Determine|determine
250263|NCT01887808|Hypoallergenicity|hypoallergenicity
250264|NCT01887808|Cetaphil DermaControl Oil Control Moisturizer SPF 30|cetaphil dermacontrol oil control moisturizer spf 30
250265|NCT01887795|Informed Consent;|informed consent;
250266|NCT01887795|Ethical Principles;|ethical principles;
250267|NCT01887795|Data collection|data collection
250268|NCT01887782|depression|depression
250269|NCT01887782|magnetic|magnetic
250270|NCT01887782|brain stimulation|brain stimulation
250271|NCT01887782|treatment-resistant|treatment-resistant
250272|NCT01887769|Lung cancer|lung cancer
250273|NCT01887769|Body composition analysis|body composition analysis
250274|NCT01887769|Ct-Scan|ct-scan
250275|NCT01887769|Muscle mass|muscle mass
250276|NCT01887769|Cachexia|cachexia
250277|NCT01887756|telerehabilitation stroke virtual reatlity|telerehabilitation stroke virtual reatlity
250278|NCT01887743|GERD|gerd
250279|NCT01887743|Obesity|obesity
250280|NCT01887743|Pediatric|pediatric
250281|NCT01887743|Pantoprazole|pantoprazole
250282|NCT01887743|CYP2C19|cyp2c19
250283|NCT01887743|Pharmacokinetic|pharmacokinetic
250284|NCT01887730|Hand Hygiene|hand hygiene
250285|NCT01887730|Communicable Diseases|communicable diseases
250286|NCT01887730|Prevention|prevention
250287|NCT01887717|hepatocellular carcinoma|hepatocellular carcinoma
250288|NCT01887717|portal vein thrombosis|portal vein thrombosis
250289|NCT01887691|Diabetes|diabetes
250290|NCT01887691|Prediabetic|prediabetic
250291|NCT01887691|Prediabetes|prediabetes
250292|NCT01887691|Glucose intolerance|glucose intolerance
250293|NCT01887691|Sleep quality|sleep quality
250294|NCT01887691|Continuous glucose monitoring|continuous glucose monitoring
250295|NCT01887691|Diabetes risk|diabetes risk
250296|NCT01887691|eszopiclone|eszopiclone
250297|NCT01887665|substance use disorders|substance use disorders
250298|NCT01887665|substance abuse|substance abuse
250299|NCT01887665|substance abuse treatment|substance abuse treatment
250300|NCT01887665|contingency management|contingency management
250301|NCT01887652|In Vitro Fertilization|in vitro fertilization
250302|NCT01887652|ovulation induction|ovulation induction
250303|NCT01887652|anti-mullerian hormone|anti-mullerian hormone
250304|NCT01887639|Non-psychotic unipolar major depression|non-psychotic unipolar major depression
250305|NCT01887639|Resistant depression|resistant depression
250306|NCT01887626|Phase 1, pharmacokinetic, safety, Ticagrelor|phase 1, pharmacokinetic, safety, ticagrelor
250307|NCT01887613|Gabapentin|gabapentin
250308|NCT01887600|anemia|anemia
250309|NCT01887600|chronic kidney disease (CKD)|chronic kidney disease (ckd)
250310|NCT01887600|Hemoglobin (Hb)|hemoglobin (hb)
250311|NCT01887600|non-dialysis|non-dialysis
250312|NCT01887548|Crohn's disease|crohn's disease
250313|NCT01887548|inflammatory bowel disease|inflammatory bowel disease
250314|NCT01887548|quality of life|quality of life
250315|NCT01887548|personality|personality
250316|NCT01887548|neuroticism|neuroticism
250317|NCT01887535|Healthy|healthy
250318|NCT01887535|Elderly|elderly
250319|NCT01887535|Safety|safety
250320|NCT01887535|Tolerability|tolerability
250321|NCT01887535|Pharmacokinetic|pharmacokinetic
250322|NCT01887535|Alzheimer's Disease|alzheimer's disease
250323|NCT01887535|JNJ-54861911|jnj-54861911
250324|NCT01887522|Children|children
250325|NCT01887522|Adolescents|adolescents
250326|NCT01887522|Young Adults|young adults
250327|NCT01887509|Rectal cancer|rectal cancer
250328|NCT01887509|Tumor margin|tumor margin
250329|NCT01887509|Confocal endomicroscopy|confocal endomicroscopy
250330|NCT01887509|Virtual biopsy|virtual biopsy
250331|NCT01887509|Fluorescein|fluorescein
250332|NCT01887496|Varicella|varicella
250333|NCT01887496|Turkey|turkey
250334|NCT01887496|hospitalization|hospitalization
250335|NCT01887496|varicella vaccine|varicella vaccine
250336|NCT01887483|IBS|ibs
250337|NCT01887483|bowel function|bowel function
250338|NCT01887483|probiotic|probiotic
250339|NCT01887470|Bowel Evacuation|bowel evacuation
250340|NCT01887470|Colonoscopy Preparation|colonoscopy preparation
250341|NCT01887457|voriconazole|voriconazole
250342|NCT01887457|VFEND|vfend
250343|NCT01887457|individualised|individualised
250344|NCT01887457|personalised|personalised
250345|NCT01887444|Pediatric Gastroenterology|pediatric gastroenterology
250346|NCT01887444|Probiotics|probiotics
250347|NCT01887444|Lactobacillus reuteri|lactobacillus reuteri
250348|NCT01887431|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
241095|NCT01930136|Obesity|obesity
250349|NCT01887431|Adult|adult
250350|NCT01887431|Insulin Infusion Systems|insulin infusion systems
250351|NCT01887431|Telecare|telecare
250353|NCT01887418|Testosterone enanthate|testosterone enanthate
250354|NCT01887405|Adrenaline|adrenaline
250355|NCT01887405|Auto-injector|auto-injector
250356|NCT01887405|Jext|jext
250357|NCT01887405|Epipen|epipen
250358|NCT01887392|Long-term Care|long-term care
250359|NCT01887392|Knowledge Translation|knowledge translation
250360|NCT01887379|Gastroretentive drug formulation|gastroretentive drug formulation
250361|NCT01887379|Furosemide|furosemide
250362|NCT01887379|Magnetic Marker Monitoring|magnetic marker monitoring
250363|NCT01887379|Magnetic marker|magnetic marker
250364|NCT01887379|Oedema|oedema
250365|NCT01887366|Cocaine addiction|cocaine addiction
250366|NCT01887366|TV-1380|tv-1380
250367|NCT01887366|Recombinant human serum albumin (HSA) mutated butyrylcholinesterase (AlbuBChE)|recombinant human serum albumin (hsa) mutated butyrylcholinesterase (albubche)
250368|NCT01887353|atrial fibrillation|atrial fibrillation
250369|NCT01887353|heart failure|heart failure
250370|NCT01887353|ranolazine|ranolazine
250371|NCT01887353|cardioversion|cardioversion
250372|NCT01887353|persistent AF|persistent af
250373|NCT01887353|paroxysmal AF|paroxysmal af
250374|NCT01887327|G6PD deficiency|g6pd deficiency
250375|NCT01887327|ABO incompatibility|abo incompatibility
250376|NCT01887327|Coombs positive ABO/RH incompatibility|coombs positive abo/rh incompatibility
250377|NCT01887327|intensive phototherapy in neonates|intensive phototherapy in neonates
250378|NCT01887327|Hyperbilirubinemia|hyperbilirubinemia
250379|NCT01887327|Neonatal Jaundice|neonatal jaundice
250380|NCT01887314|Cancer|cancer
250381|NCT01887314|Cisplatin|cisplatin
250382|NCT01887314|Nausea|nausea
250383|NCT01887314|Ginger|ginger
250384|NCT01887314|Zingiber officinale|zingiber officinale
250385|NCT01887314|5HT3|5ht3
250386|NCT01887314|Dexamethasone|dexamethasone
250387|NCT01887314|Neurokinin-1 (NK-1)|neurokinin-1 (nk-1)
250388|NCT01887314|Interleukin-6 (IL-6)|interleukin-6 (il-6)
5863|NCT03253861|Organ Dysfunction Scores|organ dysfunction scores
250389|NCT01887314|Tumor necrosis factor-alpha (TNF-alpha)|tumor necrosis factor-alpha (tnf-alpha)
250390|NCT01887314|Insulin like growth factor-1 (IGF-1)|insulin like growth factor-1 (igf-1)
250391|NCT01887314|Placebo|placebo
250392|NCT01887314|FLIE|flie
250393|NCT01887314|BFI|bfi
250394|NCT01887275|Chronic hepatitis B|chronic hepatitis b
250395|NCT01887275|Medical Ozone|medical ozone
250396|NCT01887275|Interferon-α|interferon-α
250397|NCT01887275|Efficacy|efficacy
250398|NCT01887262|fluid|fluid
250399|NCT01887262|edema|edema
250400|NCT01887223|Encapsulated blebs|encapsulated blebs
250401|NCT01887223|trabeculectomy failure|trabeculectomy failure
250402|NCT01887223|glaucoma|glaucoma
250403|NCT01887210|HIV|hiv
250404|NCT01887210|youth|youth
250405|NCT01887210|medical adherence|medical adherence
250406|NCT01887197|cystic fibrosis|cystic fibrosis
250407|NCT01887197|mucociliary clearance|mucociliary clearance
250408|NCT01887197|airway surface liquid|airway surface liquid
250409|NCT01887197|nuclear medicine|nuclear medicine
250410|NCT01887197|mannitol|mannitol
250411|NCT01887171|Liver transplantation|liver transplantation
250412|NCT01887171|Early allograft dysfunction|early allograft dysfunction
250413|NCT01887171|Ischemic reperfusion injury|ischemic reperfusion injury
250414|NCT01887171|Portal and arterial ex vivo HTK flush|portal and arterial ex vivo htk flush
250415|NCT01887145|Carpal tunnel syndrome|carpal tunnel syndrome
250416|NCT01887145|Surgery|surgery
250417|NCT01887145|Outcomes|outcomes
250418|NCT01887132|Sleep Architecture|sleep architecture
250419|NCT01887132|Autism|autism
250420|NCT01887132|Language Development|language development
250421|NCT01887093|coronary artery disease|coronary artery disease
250422|NCT01887093|walking|walking
250423|NCT01887093|lipids|lipids
250424|NCT01887093|inflammatory markers|inflammatory markers
250425|NCT01887093|time of day|time of day
692335|NCT00939432|shame|shame
250426|NCT01887080|Cardiovascular rehabilitation home-based|cardiovascular rehabilitation home-based
250427|NCT01887080|Acute myocardial infarction|acute myocardial infarction
250428|NCT01887080|Obesity|obesity
250429|NCT01887080|Microcurrent|microcurrent
250430|NCT01887067|Hypertension|hypertension
250431|NCT01887067|Diabetes Mellitus|diabetes mellitus
250432|NCT01887041|Advanced, metastasising pancreatic head carcinoma|advanced, metastasising pancreatic head carcinoma
250433|NCT01887041|Jaundice|jaundice
250434|NCT01887041|Biliodigestive anastomosis|biliodigestive anastomosis
250435|NCT01887041|Endoscopically inserted biliary tract drainage|endoscopically inserted biliary tract drainage
250436|NCT01887041|Quality of Life|quality of life
250437|NCT01887028|Carbon deoxide pneumoperitoneum|carbon deoxide pneumoperitoneum
250438|NCT01887028|Intraperitoneal pressure|intraperitoneal pressure
250439|NCT01887028|Peritoneum|peritoneum
250440|NCT01887028|Gene expression|gene expression
250441|NCT01887028|Post-operative recovery|post-operative recovery
250442|NCT01887028|Laparoscopic Humidification System|laparoscopic humidification system
250443|NCT01887015|Postoperative pulmonary complications|postoperative pulmonary complications
250444|NCT01887015|Oxygen therapy|oxygen therapy
250445|NCT01887015|Nasal high flow oxygen therapy|nasal high flow oxygen therapy
250446|NCT01887015|Nasal high flow cannula|nasal high flow cannula
250447|NCT01887002|Irritable Bowel Syndrome|irritable bowel syndrome
250448|NCT01887002|IBS|ibs
250449|NCT01887002|ONO-2952|ono-2952
250450|NCT01886989|diabetes|diabetes
250451|NCT01886989|cocoa polyphenols|cocoa polyphenols
250452|NCT01886989|postprandial glycemia|postprandial glycemia
250453|NCT01886989|postprandial lipemia|postprandial lipemia
250454|NCT01886976|multiple myeloma|multiple myeloma
250455|NCT01886950|CKD stage 5|ckd stage 5
250456|NCT01886950|Bone histomorphometry|bone histomorphometry
250457|NCT01886950|Renal transplantation|renal transplantation
250458|NCT01886924|Tobacco|tobacco
250459|NCT01886924|Nicotine|nicotine
250460|NCT01886924|Dependence|dependence
250461|NCT01886924|Quitline|quitline
250462|NCT01886911|prosocial behavior|prosocial behavior
250463|NCT01886911|prosocial|prosocial
250464|NCT01886911|attention training|attention training
250465|NCT01886911|attention|attention
250466|NCT01886911|empathy|empathy
250467|NCT01886911|emotion recognition|emotion recognition
250468|NCT01886885|Mindfulness|mindfulness
250469|NCT01886885|Meditation|meditation
250470|NCT01886885|Chronic Pain|chronic pain
250471|NCT01886833|Rotavirus|rotavirus
250472|NCT01886833|Diarrhoea|diarrhoea
250473|NCT01886833|Dmmunisation|dmmunisation
250474|NCT01886833|Seroconversion|seroconversion
250475|NCT01886833|Breastmilk|breastmilk
250477|NCT01886833|Zinc|zinc
250478|NCT01886833|Vitamin A|vitamin a
250479|NCT01886833|Failure|failure
250480|NCT01886820|Dementia|dementia
250481|NCT01886820|Alzheimer's Disease|alzheimer's disease
250482|NCT01886820|Terminally Ill|terminally ill
250483|NCT01886794|pelvic floor dysfunction|pelvic floor dysfunction
250484|NCT01886794|pelvic organ prolapse|pelvic organ prolapse
250485|NCT01886794|vaginal estrogen effects|vaginal estrogen effects
250486|NCT01886781|only constipation and diarrhea predominant|only constipation and diarrhea predominant
250487|NCT01886781|no mixed or alternating types|no mixed or alternating types
250488|NCT01886768|Nasal anesthesia|nasal anesthesia
250489|NCT01886768|endoscopes|endoscopes
250490|NCT01886768|transnasal endoscopy|transnasal endoscopy
250491|NCT01886755|Acute gastroenteritis|acute gastroenteritis
250492|NCT01886755|Probiotics|probiotics
250493|NCT01886755|Lactobacillus reuteri|lactobacillus reuteri
250494|NCT01886755|Zinc supplementation|zinc supplementation
250495|NCT01886755|Infants|infants
250496|NCT01886755|Age 6 months to 36 months|age 6 months to 36 months
250497|NCT01886742|Perioperative antibiotic prophylaxis|perioperative antibiotic prophylaxis
250498|NCT01886742|Morbidly Obese|morbidly obese
250499|NCT01886729|transcranial direct current stimulation|transcranial direct current stimulation
250500|NCT01886729|time shift|time shift
250501|NCT01886716|Alcohol Abuse|alcohol abuse
250502|NCT01886716|Alcohol Dependence|alcohol dependence
250503|NCT01886716|Alcohol Drinking|alcohol drinking
250504|NCT01886716|Social Anxiety|social anxiety
250505|NCT01886716|Social Phobia|social phobia
250506|NCT01886716|Anxiety Disorders|anxiety disorders
250507|NCT01886703|Physical activity|physical activity
250508|NCT01886703|Exercise|exercise
250509|NCT01886703|Quality of Life|quality of life
250510|NCT01886703|Radiation Therapy|radiation therapy
250511|NCT01886703|Breast Cancer|breast cancer
250512|NCT01886703|Head and Neck Cancer|head and neck cancer
250513|NCT01886677|prostate cancer|prostate cancer
250514|NCT01886677|intervention|intervention
250515|NCT01886677|diet|diet
250516|NCT01886677|physical activity|physical activity
250517|NCT01886677|exercise|exercise
250518|NCT01886677|weight loss|weight loss
250519|NCT01886677|biomarkers|biomarkers
250520|NCT01886677|cancer progression|cancer progression
250521|NCT01886651|acute lymphoblastic leukemia|acute lymphoblastic leukemia
250522|NCT01886651|child|child
250523|NCT01886651|6-mercaptopurine|6-mercaptopurine
250524|NCT01886651|methotrexate|methotrexate
250526|NCT01886638|HIV|hiv
250527|NCT01886638|Cardiovascular disease|cardiovascular disease
250528|NCT01886638|Acute myocardial infarction|acute myocardial infarction
250529|NCT01886638|Abacavir|abacavir
250530|NCT01886638|Antiretrovirals|antiretrovirals
250531|NCT01886612|Deep Vein Thrombosis|deep vein thrombosis
250532|NCT01886612|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
250533|NCT01886612|Intermittent Pneumatic Compression|intermittent pneumatic compression
250534|NCT01886612|Doppler Ultrasound|doppler ultrasound
250535|NCT01886586|Mild Cognitive Impairment|mild cognitive impairment
250536|NCT01886586|memory impairment|memory impairment
250537|NCT01886586|problem-solving therapy|problem-solving therapy
250538|NCT01886586|depression prevention|depression prevention
250539|NCT01886586|caregiver stress|caregiver stress
250540|NCT01886586|exercise|exercise
250541|NCT01886534|Heart failure|heart failure
241290|NCT01929070|HCP1007|hcp1007
250542|NCT01886534|Heart diseases|heart diseases
250543|NCT01886534|Cardiovascular diseases|cardiovascular diseases
250544|NCT01886534|Health information technology|health information technology
250545|NCT01886534|Disease management|disease management
250546|NCT01886534|Patient care management|patient care management
250547|NCT01886534|Self care|self care
250548|NCT01886534|Informal caregiver|informal caregiver
250549|NCT01886534|Care partner|care partner
250550|NCT01886534|Peer support|peer support
250551|NCT01886534|Transitional care|transitional care
250552|NCT01886534|Patient education|patient education
250553|NCT01886534|Teach-back|teach-back
250554|NCT01886534|Clinical decision aid|clinical decision aid
250555|NCT01886443|Liver|liver
250556|NCT01886443|Transplantation|transplantation
250557|NCT01886443|Ischemia-reperfusion|ischemia-reperfusion
250558|NCT01886443|Safety|safety
250559|NCT01886404|HIV|hiv
250560|NCT01886404|efavirenz|efavirenz
250561|NCT01886404|Sustiva|sustiva
250562|NCT01886404|pharmacokinetics|pharmacokinetics
250563|NCT01886404|Pharmacogenomics|pharmacogenomics
250564|NCT01886391|Heart Failure|heart failure
250565|NCT01886391|Dyspnea|dyspnea
250566|NCT01886391|Diaphragmatic breathing retraining|diaphragmatic breathing retraining
250567|NCT01886391|Fatigue|fatigue
250568|NCT01886391|Health-related Outcomes|health-related outcomes
250569|NCT01886378|FAOD|faod
250570|NCT01886378|VLCAD|vlcad
250571|NCT01886378|CPT II|cpt ii
250572|NCT01886378|CPT2|cpt2
250573|NCT01886378|CPT 2|cpt 2
250574|NCT01886378|LCHAD|lchad
250575|NCT01886378|UX007|ux007
250576|NCT01886378|Triheptanoin|triheptanoin
250577|NCT01886378|TFP|tfp
250578|NCT01886378|C7|c7
250579|NCT01886365|Computer based glycemic control, insulin, blood glucose|computer based glycemic control, insulin, blood glucose
250580|NCT01886352|laparoscopic|laparoscopic
250581|NCT01886352|pain|pain
250582|NCT01886326|Obesity|obesity
250583|NCT01886326|energy balance|energy balance
250584|NCT01886326|variety|variety
250585|NCT01886326|nut intake|nut intake
250586|NCT01886313|Herpes Zoster|herpes zoster
250587|NCT01886313|Postherpetic Neuralgia|postherpetic neuralgia
250588|NCT01886313|Shingles|shingles
250589|NCT01886313|Civamide|civamide
250590|NCT01886313|Zucapsaicin|zucapsaicin
250591|NCT01886313|Neuropeptides|neuropeptides
250592|NCT01886313|TRPV-1|trpv-1
250593|NCT01886287|endocrine system|endocrine system
250594|NCT01886287|neuroendocrine tumors|neuroendocrine tumors
250595|NCT01886287|neuroendocrine cancer|neuroendocrine cancer
250596|NCT01886287|metastatic|metastatic
250597|NCT01886287|neuroendocrine|neuroendocrine
250598|NCT01886287|gastrointestinal (GI)|gastrointestinal (gi)
250599|NCT01886287|high-dose octreotide|high-dose octreotide
250600|NCT01886287|flushing|flushing
250601|NCT01886287|diarrhea|diarrhea
250602|NCT01886287|quality of life in patients|quality of life in patients
250603|NCT01886287|disease-related symptoms|disease-related symptoms
250605|NCT01886274|migraine|migraine
250606|NCT01886274|pain|pain
250607|NCT01886274|phosphene|phosphene
250608|NCT01886274|tDCs|tdcs
250609|NCT01886274|TMS|tms
250610|NCT01886261|validation|validation
250611|NCT01886261|physical activity|physical activity
250612|NCT01886261|place-based interventions|place-based interventions
250613|NCT01886261|construct validity|construct validity
250614|NCT01886261|divergent validity|divergent validity
250615|NCT01886261|usability|usability
250616|NCT01886261|gps|gps
250617|NCT01886261|PALMS|palms
250618|NCT01886248|hepatic veno-occlusive disease after hematopoietic stem cell transplantation|hepatic veno-occlusive disease after hematopoietic stem cell transplantation
250619|NCT01886222|Traumatic brain injury|traumatic brain injury
250620|NCT01886196|elderly|elderly
250621|NCT01886196|women|women
250622|NCT01886196|exercise|exercise
250623|NCT01886196|pQCT|pqct
250624|NCT01886196|ibuprofen|ibuprofen
250625|NCT01886183|Postural Balance|postural balance
250626|NCT01886183|Virtual Reality Exposure Therapy|virtual reality exposure therapy
250627|NCT01886183|Gait|gait
250628|NCT01886183|Stroke|stroke
250718|NCT01885650|Chest physiotherapy|chest physiotherapy
250629|NCT01886170|Adults with self-reported diagnosis of diabetes recruited from waiting rooms at outpatient primary care sites at the University of Pennsylvania|adults with self-reported diagnosis of diabetes recruited from waiting rooms at outpatient primary care sites at the university of pennsylvania
250630|NCT01886157|trigger finger|trigger finger
250631|NCT01886157|orthotic intervention|orthotic intervention
250632|NCT01886144|OA|oa
250633|NCT01886144|arthritis|arthritis
250634|NCT01886144|knee OA|knee oa
250635|NCT01886131|REM behaviour disorder|rem behaviour disorder
250636|NCT01886131|Subthalamic nucleus|subthalamic nucleus
250637|NCT01886131|Local field potential|local field potential
250638|NCT01886131|Motor control|motor control
250639|NCT01886118|In vitro fertilization|in vitro fertilization
250640|NCT01886118|Autologous Endometrial Co-Culture|autologous endometrial co-culture
250641|NCT01886105|Osteosarcoma|osteosarcoma
250642|NCT01886105|Osteogenic Sarcoma|osteogenic sarcoma
250643|NCT01886105|Sarcoma|sarcoma
250644|NCT01886105|Bone Cancer|bone cancer
250645|NCT01886092|tinnitus|tinnitus
250646|NCT01886027|IBS|ibs
250647|NCT01886027|Relaxation|relaxation
250648|NCT01886027|Emotional exposure|emotional exposure
250649|NCT01886027|Emotional Processing|emotional processing
250650|NCT01886014|pain|pain
250651|NCT01886014|pain modulation|pain modulation
250652|NCT01886014|placebo analgesia|placebo analgesia
250653|NCT01886001|Newborn Intensive Care Unit|newborn intensive care unit
250654|NCT01886001|Neonatal Intensive Care Unit|neonatal intensive care unit
250655|NCT01886001|Colonization|colonization
250656|NCT01886001|Line Colonization|line colonization
250657|NCT01886001|Umbilical line|umbilical line
250658|NCT01886001|Umbilical Cord Care|umbilical cord care
250659|NCT01885988|Erectile dysfunction|erectile dysfunction
250660|NCT01885975|Apical Ballooning syndrome|apical ballooning syndrome
250661|NCT01885975|Personality|personality
250662|NCT01885962|pressure ulcer prevention|pressure ulcer prevention
250663|NCT01885962|spinal cord injury|spinal cord injury
250664|NCT01885962|internet delivered pressure ulcer intervention|internet delivered pressure ulcer intervention
250665|NCT01885949|Metastatic|metastatic
250666|NCT01885936|LOPD|lopd
250667|NCT01885936|Pompe Disease|pompe disease
250668|NCT01885923|schizophrenia; relapse prevention; information technology|schizophrenia; relapse prevention; information technology
250669|NCT01885897|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
250670|NCT01885897|Acute lymphoblastic leukemia (ALL)|acute lymphoblastic leukemia (all)
250671|NCT01885897|Myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
250672|NCT01885897|Lymphoma|lymphoma
250673|NCT01885897|Myeloma|myeloma
250674|NCT01885897|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
250675|NCT01885897|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
250676|NCT01885884|Supportive Care|supportive care
250677|NCT01885884|Palliative Care|palliative care
250678|NCT01885884|Pancreatic Cancer|pancreatic cancer
250679|NCT01885884|Embedded, coordinated model of supportive care within oncology care|embedded, coordinated model of supportive care within oncology care
250680|NCT01885884|Patient and Caregiver support|patient and caregiver support
250681|NCT01885871|Sun|sun
250682|NCT01885871|Age|age
250683|NCT01885871|Spot|spot
250684|NCT01885858|health services research|health services research
250476|NCT01886833|HIV|hiv
250685|NCT01885858|family planning|family planning
250686|NCT01885858|ethnicity|ethnicity
250687|NCT01885858|healthcare disparities|healthcare disparities
250688|NCT01885845|postpartum blood loss measurement|postpartum blood loss measurement
250689|NCT01885845|BRASSS-V drape|brasss-v drape
250690|NCT01885832|autologous adipose stem cells|autologous adipose stem cells
250691|NCT01885832|stromal vascular fraction|stromal vascular fraction
250692|NCT01885832|osteoarthritis|osteoarthritis
250693|NCT01885819|Adipose stromal vascular fraction|adipose stromal vascular fraction
250694|NCT01885819|Rheumatoid arthritis|rheumatoid arthritis
250695|NCT01885819|adult stem cells|adult stem cells
250696|NCT01885806|Apathy; Alzheimer's disease; Cognition; Burden of Care|apathy; alzheimer's disease; cognition; burden of care
250697|NCT01885780|Astigmatism, arcuate incisions, astigmatic keratotomy|astigmatism, arcuate incisions, astigmatic keratotomy
250698|NCT01885767|Neurofibromatosis|neurofibromatosis
250699|NCT01885767|NF|nf
250700|NCT01885767|Neurofibromatosis 1|neurofibromatosis 1
250701|NCT01885767|NF1|nf1
250702|NCT01885767|Neurofibromatosis 2|neurofibromatosis 2
250703|NCT01885767|NF2|nf2
250704|NCT01885767|Schwannomatosis|schwannomatosis
250705|NCT01885754|Biopsy|biopsy
250706|NCT01885754|Maximal incremental cardiopulmonary test|maximal incremental cardiopulmonary test
250707|NCT01885754|Muscle strength test|muscle strength test
250708|NCT01885754|magnetic stimulation|magnetic stimulation
250709|NCT01885702|Dendritic cell vaccination|dendritic cell vaccination
250710|NCT01885702|MSI-high colorectal cancer (CRC)|msi-high colorectal cancer (crc)
250711|NCT01885702|Vaccines|vaccines
250712|NCT01885702|Immunotherapy|immunotherapy
250714|NCT01885702|Germline MMR-gene mutation without disease criteria of CRC|germline mmr-gene mutation without disease criteria of crc
250715|NCT01885663|Umbilical cord blood|umbilical cord blood
250716|NCT01885663|Acquired brain injury|acquired brain injury
250717|NCT01885650|Non invasive ventilation|non invasive ventilation
250719|NCT01885650|Airway clearance|airway clearance
250720|NCT01885637|Palliative|palliative
250721|NCT01885637|Palliation|palliation
250722|NCT01885637|Cancer|cancer
250723|NCT01885637|Care|care
250725|NCT01885637|Caregivers|caregivers
250726|NCT01885637|Home Care Services, Hospital-Based|home care services, hospital-based
250727|NCT01885637|Psychological|psychological
250728|NCT01885637|From Oncological Treatment to Palliative Care at Home|from oncological treatment to palliative care at home
250729|NCT01885637|Place of death|place of death
250730|NCT01885624|TAB08|tab08
250731|NCT01885624|healthy volunteers|healthy volunteers
250732|NCT01885611|Leprosy|leprosy
250733|NCT01885572|breast reconstruction|breast reconstruction
250734|NCT01885572|mastectomy|mastectomy
250735|NCT01885572|mesh|mesh
250736|NCT01885572|breast cancer|breast cancer
250737|NCT01885559|polycystic kidney disease|polycystic kidney disease
250738|NCT01885559|polycystic|polycystic
250739|NCT01885559|kidney|kidney
250740|NCT01885559|disease|disease
250741|NCT01885559|adpkd|adpkd
250742|NCT01885559|halt|halt
250743|NCT01885559|pkd|pkd
250744|NCT01885559|blood pressure|blood pressure
250745|NCT01885559|bp|bp
250746|NCT01885559|hypertension|hypertension
250747|NCT01885559|renal|renal
250748|NCT01885559|renin-angiotensin-aldosterone-system|renin-angiotensin-aldosterone-system
250749|NCT01885559|RAAS|raas
250750|NCT01885546|diabetes|diabetes
250751|NCT01885546|glucose|glucose
250752|NCT01885546|glucometer|glucometer
250753|NCT01885533|Graves' disease|graves' disease
250754|NCT01885533|radioiodine|radioiodine
250755|NCT01885533|thyroid|thyroid
250756|NCT01885533|hypothyroidism|hypothyroidism
250757|NCT01885533|Graves' orbitopathy|graves' orbitopathy
250758|NCT01885520|low back pain|low back pain
250759|NCT01885481|dexamethasone|dexamethasone
250760|NCT01885481|betamethasone|betamethasone
250761|NCT01885481|epidural steroid injection|epidural steroid injection
250762|NCT01885481|comparative effectiveness research|comparative effectiveness research
250763|NCT01885468|Hydrocephalus shunt|hydrocephalus shunt
250764|NCT01885468|proGAV|progav
250765|NCT01885455|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
250766|NCT01885442|mechanical ventilation|mechanical ventilation
250767|NCT01885442|cycle ergometry|cycle ergometry
250768|NCT01885442|intensive care unit|intensive care unit
250769|NCT01885442|rehabilitation|rehabilitation
250770|NCT01885429|Protein Turnover|protein turnover
250771|NCT01885429|Resistance Exercise|resistance exercise
250772|NCT01885429|Whey Protein|whey protein
250773|NCT01885429|Leucine|leucine
250774|NCT01885403|Acute Cardiogenic Pulmonary Edema,|acute cardiogenic pulmonary edema,
250775|NCT01885403|Acute Decompensated Heart Failure,|acute decompensated heart failure,
250776|NCT01885403|BiLevel Positive Airway Pressure,|bilevel positive airway pressure,
250777|NCT01885403|Continuous Positive Airway Pressure|continuous positive airway pressure
250778|NCT01885390|Hypertension|hypertension
250779|NCT01885390|High blood pressure|high blood pressure
250780|NCT01885390|Resistant blood pressure|resistant blood pressure
250781|NCT01885390|Uncontrolled blood pressure|uncontrolled blood pressure
250782|NCT01885377|Subacromial pain|subacromial pain
250783|NCT01885377|Impingement|impingement
250784|NCT01885377|Exercises|exercises
250785|NCT01885377|Physical therapy|physical therapy
250786|NCT01885377|Primary care|primary care
250787|NCT01885364|esmolol|esmolol
250788|NCT01885364|pain|pain
250789|NCT01885364|propofol|propofol
250790|NCT01885364|remifentanil|remifentanil
250791|NCT01885351|Colorectal Cancer Screening|colorectal cancer screening
250792|NCT01885351|Ambulatory Care|ambulatory care
250793|NCT01885351|Patient-Centered Care|patient-centered care
250794|NCT01885351|Intervention Studies|intervention studies
250795|NCT01885351|Longitudinal Studies|longitudinal studies
250796|NCT01885338|Schizophrenia|schizophrenia
250797|NCT01885338|Cognition|cognition
250798|NCT01885338|Neurocognition|neurocognition
250799|NCT01885338|N-Acetylcysteine|n-acetylcysteine
250800|NCT01885338|NAC|nac
250801|NCT01885338|EEG|eeg
250802|NCT01885325|Physical Activity|physical activity
250803|NCT01885325|Sedentary Behavior|sedentary behavior
250804|NCT01885325|Preschool Children|preschool children
250805|NCT01885312|Drinking|drinking
250806|NCT01885312|Heavy Drinking|heavy drinking
250807|NCT01885312|Technology|technology
250808|NCT01885312|Mobile Phone|mobile phone
250809|NCT01885312|Text Message|text message
250810|NCT01885312|Problem Drinking|problem drinking
250811|NCT01885312|Alcohol Problems|alcohol problems
250812|NCT01885312|Alcoholism|alcoholism
250813|NCT01885312|Moderation-Oriented Treatment|moderation-oriented treatment
250814|NCT01885312|Controlled Drinking|controlled drinking
250815|NCT01885312|Reduced Drinking|reduced drinking
250816|NCT01885299|Radiosurgery|radiosurgery
250817|NCT01885299|CyberKnife|cyberknife
250818|NCT01885299|Benign tumors|benign tumors
250819|NCT01885299|Malignant tumors|malignant tumors
250820|NCT01885299|Cranial tumors|cranial tumors
250821|NCT01885299|Extracranial tumors|extracranial tumors
250822|NCT01885299|Lung|lung
250823|NCT01885299|Liver|liver
250824|NCT01885299|Pancreas|pancreas
250825|NCT01885299|Prostate|prostate
250826|NCT01885299|Stereotactic radiosurgery|stereotactic radiosurgery
250827|NCT01885299|Stereotactic body radiotherapy|stereotactic body radiotherapy
250828|NCT01885286|circumcision|circumcision
250829|NCT01885286|HIV prevention|hiv prevention
250830|NCT01885273|pressurized irrigation|pressurized irrigation
250831|NCT01885273|wound cleansing method|wound cleansing method
250832|NCT01885273|irrigation|irrigation
250833|NCT01885273|swabbing|swabbing
250834|NCT01885273|appropriate pressure for irrigation|appropriate pressure for irrigation
250835|NCT01885260|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
250836|NCT01885260|T2DM|t2dm
250837|NCT01885234|Glycated hemoglobin|glycated hemoglobin
250838|NCT01885234|HOMA|homa
250839|NCT01885234|Pregnancy|pregnancy
250840|NCT01885234|aerobic exercise|aerobic exercise
250841|NCT01885221|smokeless tobacco cessation|smokeless tobacco cessation
250842|NCT01885221|social support|social support
250843|NCT01885221|partner support|partner support
250844|NCT01885195|RAS, RAF, MEK, NF1, MEK162, signature, papillary thyroid, small intestine, bladder, esophagus, lung cancer, NSCLC, acute myelogenous leukemia, AML|ras, raf, mek, nf1, mek162, signature, papillary thyroid, small intestine, bladder, esophagus, lung cancer, nsclc, acute myelogenous leukemia, aml
250845|NCT01885169|Cystic fibrosis|cystic fibrosis
250846|NCT01885169|Influenza|influenza
250847|NCT01885169|Vaccine|vaccine
250848|NCT01885143|Mammography|mammography
250849|NCT01885117|Influenza,|influenza,
250850|NCT01885117|Adults,|adults,
250851|NCT01885117|Elderly,|elderly,
250852|NCT01885117|Immunology,|immunology,
250853|NCT01885117|Safety|safety
250854|NCT01885052|Smoking Cessation Clinical Trial|smoking cessation clinical trial
250855|NCT01885052|Text Messaging Program|text messaging program
250856|NCT01885052|Smoking Cessation Aid|smoking cessation aid
250857|NCT01885039|Cancer|cancer
250858|NCT01885039|Breast Cancer|breast cancer
250859|NCT01885039|Molecular Subtypes|molecular subtypes
250860|NCT01885039|Asian Breast Cancer|asian breast cancer
250861|NCT01885026|Randomized Controlled Trial|randomized controlled trial
250862|NCT01885026|Alcohol|alcohol
250863|NCT01885026|Drugs|drugs
250864|NCT01885026|Internet|internet
250865|NCT01885026|Screening|screening
250866|NCT01885026|Brief intervention|brief intervention
250867|NCT01885013|HER2 negative|her2 negative
250868|NCT01885013|metastatic breast cancer|metastatic breast cancer
250869|NCT01885013|non endocrine responsive disease|non endocrine responsive disease
250870|NCT01884974|Myeloproliferative disease|myeloproliferative disease
250871|NCT01884974|Pulmonary Hypertension|pulmonary hypertension
250872|NCT01884948|at least 1 segment|at least 1 segment
250873|NCT01884948|multiple wedge resections (≥3)|multiple wedge resections (≥3)
250874|NCT01884935|Pediatric|pediatric
250875|NCT01884922|Children|children
250876|NCT01884922|adolescents|adolescents
250877|NCT01884922|young adults|young adults
250878|NCT01884870|Asymptomatic|asymptomatic
250879|NCT01884870|ureteral|ureteral
250880|NCT01884870|calculi|calculi
250881|NCT01884870|renal function|renal function
250882|NCT01884870|treatment|treatment
5864|NCT03253861|Drainage|drainage
250883|NCT01884831|damage to the skin, the skin equivalent, cell therapy|damage to the skin, the skin equivalent, cell therapy
250884|NCT01884818|Thoracic spine, pain, manipulation|thoracic spine, pain, manipulation
250885|NCT01884805|Adaptive Optics Visual Simulator|adaptive optics visual simulator
250886|NCT01884805|Wavefront aberrometer|wavefront aberrometer
250887|NCT01884805|Optical Aberrations|optical aberrations
250888|NCT01884805|Hyperopia|hyperopia
250889|NCT01884792|prediabetes|prediabetes
250890|NCT01884792|physical inactivity|physical inactivity
250891|NCT01884792|sedentary|sedentary
250892|NCT01884792|standing|standing
250894|NCT01884779|Histoplasmosis|histoplasmosis
250895|NCT01884779|Histoplasma capsulatum var.capsulatum|histoplasma capsulatum var.capsulatum
250896|NCT01884779|ELISA test|elisa test
250897|NCT01884753|lower urinary tract symptoms|lower urinary tract symptoms
250898|NCT01884753|overactive bladder syndrome|overactive bladder syndrome
250899|NCT01884753|antimuscarinic drug|antimuscarinic drug
250900|NCT01884753|three-dimensional power Doppler ultrasound|three-dimensional power doppler ultrasound
250901|NCT01884753|sexual dysfunction|sexual dysfunction
250902|NCT01884740|GBM|gbm
250903|NCT01884740|AA|aa
250904|NCT01884740|FA|fa
250905|NCT01884740|PXA|pxa
250906|NCT01884740|AOA|aoa
250907|NCT01884740|High grade glioma|high grade glioma
250908|NCT01884727|Obesity|obesity
250909|NCT01884727|Overweight|overweight
250910|NCT01884727|Over nutrition|over nutrition
250911|NCT01884727|nutrition disorders|nutrition disorders
250912|NCT01884727|energy expenditure|energy expenditure
250913|NCT01884727|metabolic rate|metabolic rate
250914|NCT01884714|diabetes|diabetes
250915|NCT01884714|obesity|obesity
250916|NCT01884714|metabolism|metabolism
250917|NCT01884714|clinical study|clinical study
250918|NCT01884701|Chronic Total Occlusion CTO|chronic total occlusion cto
250919|NCT01884688|Asymptomatic Multiple Myeloma|asymptomatic multiple myeloma
250920|NCT01884688|Auto-ENK Cell Therapy|auto-enk cell therapy
250921|NCT01884688|Natural Killer Cells|natural killer cells
250922|NCT01884675|Endothelin Receptor Antagonist|endothelin receptor antagonist
250923|NCT01884675|Inoperable Chronic Thromboembolic Pulmonary Hypertension|inoperable chronic thromboembolic pulmonary hypertension
250924|NCT01884662|spinal cord injury|spinal cord injury
250925|NCT01884662|neuropathic pain|neuropathic pain
250926|NCT01884649|Acute phase reactant, fetuin A, Hashimoto thyroiditis|acute phase reactant, fetuin a, hashimoto thyroiditis
250927|NCT01884636|Isavuconazole|isavuconazole
250928|NCT01884636|Pharmacokinetics|pharmacokinetics
309480|NCT01620515|NX-1207|nx-1207
250929|NCT01884636|Healthy Subjects|healthy subjects
250930|NCT01884636|BAL8557|bal8557
250931|NCT01884636|BAL4815|bal4815
250932|NCT01884636|methotrexate|methotrexate
250933|NCT01884597|PEARL2|pearl2
250934|NCT01884597|PCV|pcv
250935|NCT01884597|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
250936|NCT01884571|Immunosuppression|immunosuppression
250937|NCT01884571|ALS|als
250938|NCT01884571|Neuromuscular Disorders|neuromuscular disorders
250939|NCT01884558|Isavuconazole|isavuconazole
250940|NCT01884558|Pharmacokinetics|pharmacokinetics
250941|NCT01884558|Healthy Subjects|healthy subjects
250942|NCT01884558|BAL8557|bal8557
250943|NCT01884558|BAL4815|bal4815
250944|NCT01884558|metformin|metformin
250945|NCT01884545|heart disease|heart disease
250946|NCT01884545|type 2 diabetes|type 2 diabetes
250947|NCT01884545|genetic testing|genetic testing
250948|NCT01884545|health coaching|health coaching
250949|NCT01884545|risk assessment|risk assessment
250950|NCT01884532|Adverse Local Tissue Reaction|adverse local tissue reaction
250951|NCT01884532|Metal Ions|metal ions
250952|NCT01884532|Serum|serum
250953|NCT01884532|Whole Blood|whole blood
250954|NCT01884532|Metal-on-Metal|metal-on-metal
250955|NCT01884532|Total Hip Arthroplasty|total hip arthroplasty
250956|NCT01884532|ASR-XL Metal-on-Metal|asr-xl metal-on-metal
250957|NCT01884532|Revised ASR-XL Metal-on-Metal|revised asr-xl metal-on-metal
250958|NCT01884519|Elderly|elderly
250959|NCT01884519|Influenza|influenza
250960|NCT01884519|Safety|safety
250961|NCT01884519|Adults|adults
250962|NCT01884519|Immunogenicity|immunogenicity
250963|NCT01884493|Parkinson's Disease|parkinson's disease
250964|NCT01884493|Freezing of Gait|freezing of gait
250965|NCT01884493|movement-related cortical potential|movement-related cortical potential
250966|NCT01884493|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
250967|NCT01884480|Advagraf, pharmacogenetics, Cyp3A5|advagraf, pharmacogenetics, cyp3a5
250968|NCT01884467|Urinary Tract Infections|urinary tract infections
250969|NCT01884467|Gentamicin|gentamicin
250970|NCT01884454|sleep|sleep
250971|NCT01884454|obstructive sleep apnea|obstructive sleep apnea
250972|NCT01884454|reproduction|reproduction
250973|NCT01884454|sperm|sperm
250974|NCT01884454|hormones|hormones
250975|NCT01884454|men|men
250976|NCT01884441|Hodgkin|hodgkin
250977|NCT01884441|Lymphoma|lymphoma
250978|NCT01884441|refractory|refractory
250979|NCT01884441|relapsed|relapsed
250980|NCT01884428|Hodgkin|hodgkin
250981|NCT01884428|Lymphoma|lymphoma
250982|NCT01884389|HIV|hiv
250983|NCT01884389|Chronic disease|chronic disease
5865|NCT03253861|Catheters|catheters
250984|NCT01884389|Early palliative care|early palliative care
250985|NCT01884389|Patient navigation|patient navigation
250986|NCT01884376|nerve biopsy|nerve biopsy
250987|NCT01884376|nerve regeneration|nerve regeneration
250988|NCT01884376|neuroma pain|neuroma pain
250989|NCT01884376|loss of sensation|loss of sensation
250990|NCT01884363|Endothelial function|endothelial function
250991|NCT01884363|walnuts|walnuts
250992|NCT01884363|clinical trial|clinical trial
250993|NCT01884363|Nutrition|nutrition
250994|NCT01884363|cardiovascular disease|cardiovascular disease
250995|NCT01884324|Gastroschisis|gastroschisis
250996|NCT01884324|Cesarean delivery|cesarean delivery
250997|NCT01884324|Neonatal outcomes|neonatal outcomes
250998|NCT01884311|Primary Immune Deficiency Disorders|primary immune deficiency disorders
250999|NCT01884311|Common Variable Immunodeficiency|common variable immunodeficiency
251000|NCT01884311|X-linked agammaglobulinaemia|x-linked agammaglobulinaemia
251001|NCT01884311|Hyper-IgM Syndrome|hyper-igm syndrome
251002|NCT01884311|Subcutaneous|subcutaneous
251003|NCT01884311|Immunoglobulins|immunoglobulins
251004|NCT01884298|remifentanil|remifentanil
251005|NCT01884298|isolated systolic hypertension|isolated systolic hypertension
251006|NCT01884298|morbidity|morbidity
251007|NCT01884298|epidural combined general anesthesia|epidural combined general anesthesia
251008|NCT01884285|Advanced Castrate-resistant Prostate Cancer(CRPC)|advanced castrate-resistant prostate cancer(crpc)
251009|NCT01884285|Squamous Non-Small Cell Lung Cancer(sqNSCLC)|squamous non-small cell lung cancer(sqnsclc)
251010|NCT01884285|Triple Negative Breast Cancer(TNBC)|triple negative breast cancer(tnbc)
251011|NCT01884285|PTEN-deficient/mutated Advanced Solid Malignancies|pten-deficient/mutated advanced solid malignancies
251012|NCT01884285|PIK3CB mutated/amplified advanced solid malignancies|pik3cb mutated/amplified advanced solid malignancies
251013|NCT01884259|local advanced squamous cell carcinoma|local advanced squamous cell carcinoma
251015|NCT01884259|Hypopharynx|hypopharynx
251016|NCT01884259|Oropharynx|oropharynx
251017|NCT01884259|Cavum oris|cavum oris
251018|NCT01884259|docetaxel|docetaxel
251019|NCT01884259|cisplatin|cisplatin
251020|NCT01884259|5-fluorouracil|5-fluorouracil
251021|NCT01884259|Cetuximab|cetuximab
251022|NCT01884246|lifestyle change|lifestyle change
251023|NCT01884246|behavior change|behavior change
251024|NCT01884246|obesity|obesity
251025|NCT01884246|hypertension|hypertension
251026|NCT01884246|hyperlipidemia|hyperlipidemia
251027|NCT01884246|physical inactivity|physical inactivity
251028|NCT01884246|depression|depression
251029|NCT01884233|HIV|hiv
251030|NCT01884233|Opioid Abuse|opioid abuse
251031|NCT01884233|Mobile technology|mobile technology
251032|NCT01884220|Wolman Disease|wolman disease
251033|NCT01884220|Cholesteryl Ester Storage Disease|cholesteryl ester storage disease
251034|NCT01884220|Enzyme deficiency|enzyme deficiency
251035|NCT01884220|Natural History|natural history
251036|NCT01884220|Medical Records Review|medical records review
251037|NCT01884194|retinoblastoma|retinoblastoma
251038|NCT01884194|pineoblastoma|pineoblastoma
251039|NCT01884181|Huntington Disease, diffusion MRI, diagnosis, fast imaging|huntington disease, diffusion mri, diagnosis, fast imaging
251040|NCT01884129|Circulating tumor cells|circulating tumor cells
251041|NCT01884129|Head and neck cancer|head and neck cancer
251042|NCT01884129|Squamous cell carcinoma|squamous cell carcinoma
251043|NCT01884129|Survival|survival
251044|NCT01884129|Prognosis|prognosis
251045|NCT01884116|Capsaicin|capsaicin
251046|NCT01884116|myofascial pain syndrome|myofascial pain syndrome
251047|NCT01884116|non-steroidal anti-inflammatory agents|non-steroidal anti-inflammatory agents
251048|NCT01884116|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
251049|NCT01884103|TBI|tbi
251050|NCT01884103|Trauma|trauma
251051|NCT01884103|Traumatic Brain Injury|traumatic brain injury
251052|NCT01884090|Empowerment|empowerment
251053|NCT01884090|Youth|youth
251054|NCT01884090|Violence|violence
251055|NCT01884090|Community|community
251056|NCT01884090|Prevention|prevention
251057|NCT01884077|patient outcomes two years after shoulder replacement|patient outcomes two years after shoulder replacement
251058|NCT01884077|seventy years of age and older|seventy years of age and older
251059|NCT01884064|focal hand dystonia|focal hand dystonia
251060|NCT01884064|rehabilitation|rehabilitation
251061|NCT01884064|rTMS|rtms
251062|NCT01884064|writer's cramp|writer's cramp
251063|NCT01884064|clinical|clinical
251064|NCT01884051|Pulmonary arterial hypertension|pulmonary arterial hypertension
251065|NCT01884038|Liver Transplant|liver transplant
251066|NCT01884038|Prostacyclin|prostacyclin
251067|NCT01884038|Treprostinil sodium|treprostinil sodium
251068|NCT01884038|Remodulin|remodulin
251069|NCT01884038|Reperfusion Injury|reperfusion injury
251070|NCT01884038|Primary Nonfunction|primary nonfunction
251071|NCT01884025|patient centered care|patient centered care
251072|NCT01884025|physical activity|physical activity
251073|NCT01884025|behavioral activation|behavioral activation
251074|NCT01884025|self efficacy|self efficacy
251075|NCT01884025|serious mental illness|serious mental illness
251076|NCT01883986|palliative care|palliative care
251077|NCT01883973|PD|pd
251078|NCT01883973|DBS|dbs
251079|NCT01883960|cerebral palsy|cerebral palsy
251080|NCT01883960|cerebral vascular accident|cerebral vascular accident
251081|NCT01883960|multi-modal brain techniques|multi-modal brain techniques
251082|NCT01883960|MRI|mri
251083|NCT01883960|motor control|motor control
251084|NCT01883947|Stroke|stroke
251085|NCT01883947|Massage|massage
251086|NCT01883947|General Health|general health
251087|NCT01883947|Independence|independence
251088|NCT01883934|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
251089|NCT01883934|Embryo donation|embryo donation
251090|NCT01883921|Primary Immunodeficiency|primary immunodeficiency
251091|NCT01883921|Immunodeficiencies|immunodeficiencies
251092|NCT01883921|Primary Immunodeficiency Diseases|primary immunodeficiency diseases
251093|NCT01883921|PIDD|pidd
251094|NCT01883921|CVID|cvid
251095|NCT01883921|PI|pi
251096|NCT01883921|Common Variable Immunodeficiency|common variable immunodeficiency
251097|NCT01883921|Hypogammaglobulinemia|hypogammaglobulinemia
251098|NCT01883921|Acquired Hypogammaglobulinemia|acquired hypogammaglobulinemia
251099|NCT01883921|Immunology|immunology
251100|NCT01883921|Autoimmune Deficiency|autoimmune deficiency
251101|NCT01883921|Intravenous Immunoglobulin|intravenous immunoglobulin
251102|NCT01883921|Subcutaneous Immunoglobulin|subcutaneous immunoglobulin
251103|NCT01883921|IVIg|ivig
251104|NCT01883921|SCIg|scig
251105|NCT01883921|Immune Globulin|immune globulin
251106|NCT01883921|Outcomes Research|outcomes research
251107|NCT01883921|Immunodeficiency|immunodeficiency
251108|NCT01883908|Acupuncture therapy|acupuncture therapy
251109|NCT01883908|Mucositis|mucositis
251110|NCT01883908|oropharyngeal cancer|oropharyngeal cancer
251111|NCT01883895|Pain|pain
251112|NCT01883895|exercise-induced hypoalgesia|exercise-induced hypoalgesia
251113|NCT01883882|chronic non-cancer pain|chronic non-cancer pain
251114|NCT01883882|opioid taper|opioid taper
251804|NCT01881152|Stroke|stroke
251115|NCT01883882|chronic pain self-management|chronic pain self-management
251116|NCT01883882|motivational interviewing|motivational interviewing
251117|NCT01883869|Platelet inhibition|platelet inhibition
251118|NCT01883869|Platelet-leukocyte aggregates|platelet-leukocyte aggregates
251119|NCT01883869|Platelet-neutrophil aggregates|platelet-neutrophil aggregates
251120|NCT01883869|CAP|cap
251121|NCT01883869|HAP|hap
251122|NCT01883869|ALI|ali
251123|NCT01883869|Blood Platelets|blood platelets
251124|NCT01883856|Refractory Glaucoma|refractory glaucoma
251125|NCT01883856|Intractable Glaucoma|intractable glaucoma
251126|NCT01883856|Primary Open Angle Glaucoma|primary open angle glaucoma
251127|NCT01883856|Neovascular Glaucoma|neovascular glaucoma
251128|NCT01883843|Chronic Stroke|chronic stroke
251129|NCT01883843|tDCS|tdcs
251130|NCT01883843|transcranial direct current stimulation|transcranial direct current stimulation
251131|NCT01883843|task oriented circuit training|task oriented circuit training
251132|NCT01883843|TOCT|toct
251133|NCT01883843|gait training|gait training
251134|NCT01883830|traumatic brain injury (TBI)|traumatic brain injury (tbi)
251135|NCT01883830|balance disorders|balance disorders
251136|NCT01883830|attention deficits|attention deficits
251137|NCT01883830|x-box|x-box
251138|NCT01883830|gaming|gaming
251139|NCT01883830|virtual reality|virtual reality
251140|NCT01883817|ADHD|adhd
251141|NCT01883804|Diabetes|diabetes
251142|NCT01883804|Diabetes Mellitus|diabetes mellitus
251143|NCT01883804|Type 1 Diabetes|type 1 diabetes
251144|NCT01883791|substance abuse prevention and treatment|substance abuse prevention and treatment
251145|NCT01883791|comorbidity|comorbidity
251146|NCT01883791|SBIRT|sbirt
251147|NCT01883778|Attitudes of health personnel|attitudes of health personnel
251148|NCT01883778|Attitudes of patients|attitudes of patients
251149|NCT01883778|Medical compliance|medical compliance
251150|NCT01883778|Cost awareness|cost awareness
251151|NCT01883778|Cost analysis|cost analysis
251152|NCT01883778|Patient knowledge|patient knowledge
251153|NCT01883778|Physician knowledge|physician knowledge
251154|NCT01883778|Medical economics|medical economics
251155|NCT01883778|Policy|policy
251156|NCT01883778|Questionnaires|questionnaires
251157|NCT01883778|Health literacy|health literacy
251158|NCT01883765|ADHD, Neurofeedback, CBT|adhd, neurofeedback, cbt
251159|NCT01883752|Goal-directed fluid therapy|goal-directed fluid therapy
251160|NCT01883739|Parental anxiety|parental anxiety
251161|NCT01883739|Children's safety|children's safety
251162|NCT01883739|Family Centered Care|family centered care
251163|NCT01883739|Bedside Transfer Rounds|bedside transfer rounds
251164|NCT01883739|Pediatric Cardiac Intensive Care|pediatric cardiac intensive care
251165|NCT01883726|Unilateral complete cleft lip, Nasoalveolar molding|unilateral complete cleft lip, nasoalveolar molding
251166|NCT01883713|anemia|anemia
251167|NCT01883713|CPB|cpb
251168|NCT01883713|methemoglobin|methemoglobin
251169|NCT01883713|hypoxia|hypoxia
251170|NCT01883700|Healthy|healthy
251171|NCT01883700|Glycemic Index|glycemic index
251172|NCT01883700|Glycemic Load|glycemic load
251173|NCT01883700|Blood Glucose|blood glucose
251174|NCT01883700|Arterial Stiffness|arterial stiffness
251175|NCT01883674|Sarcopenia|sarcopenia
251176|NCT01883674|Physical capacity|physical capacity
251177|NCT01883674|Muscle force|muscle force
251178|NCT01883674|Muscle quality|muscle quality
251179|NCT01883674|Milk proteins|milk proteins
251180|NCT01883674|Essential amino acids|essential amino acids
251181|NCT01883674|Proteins|proteins
251182|NCT01883674|Resistance training|resistance training
251183|NCT01883674|Exercise|exercise
251184|NCT01883661|stem cell|stem cell
251185|NCT01883661|Multiple Sclerosis|multiple sclerosis
251186|NCT01883661|BMMNC|bmmnc
251187|NCT01883648|Mild to Moderate Alzheimer's disease|mild to moderate alzheimer's disease
251188|NCT01883622|diabetes|diabetes
251189|NCT01883622|pregnancy|pregnancy
251190|NCT01883622|glucose variability|glucose variability
251191|NCT01883622|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
251192|NCT01883622|gestational diabetes mellitus (GDM)|gestational diabetes mellitus (gdm)
251193|NCT01883609|Plasmodium Falciparum|plasmodium falciparum
251194|NCT01883609|Malaria|malaria
251195|NCT01883609|Vaccine|vaccine
251196|NCT01883609|Plasmodium|plasmodium
251197|NCT01883609|Falciparum|falciparum
251198|NCT01883583|Ultrasound|ultrasound
251199|NCT01883583|Perfusion Imaging|perfusion imaging
251200|NCT01883583|Elasticity Imaging Techniques|elasticity imaging techniques
251201|NCT01883583|Kidney Transplantation|kidney transplantation
251202|NCT01883583|Graft Rejection|graft rejection
692715|NCT00940966|ADA diet|ada diet
251203|NCT01883583|Chronic allograft nephropathy|chronic allograft nephropathy
251204|NCT01883570|visual search strategy, training, chest x-ray|visual search strategy, training, chest x-ray
251205|NCT01883544|Safety|safety
251206|NCT01883544|Tolerability|tolerability
251207|NCT01883544|Pharmacokinetics|pharmacokinetics
251208|NCT01883544|Pharmacodynamics|pharmacodynamics
251209|NCT01883544|ALXN1007|alxn1007
251210|NCT01883544|Healthy Male and Female Subjects|healthy male and female subjects
251211|NCT01883531|improving lung function|improving lung function
251212|NCT01883531|paediatric and adolescent|paediatric and adolescent
251213|NCT01883531|FEV1|fev1
251214|NCT01883518|Fibrosarcoma|fibrosarcoma
251215|NCT01883518|Neurofibrosarcoma|neurofibrosarcoma
251216|NCT01883518|Histiocytoma|histiocytoma
251217|NCT01883518|Histiocytoma, Malignant Fibrous|histiocytoma, malignant fibrous
251218|NCT01883518|Chondrosarcoma|chondrosarcoma
251219|NCT01883518|Synovial Sarcoma|synovial sarcoma
251220|NCT01883518|Leiomyosarcoma|leiomyosarcoma
251221|NCT01883518|Liposarcoma|liposarcoma
251222|NCT01883518|Myosarcoma|myosarcoma
251223|NCT01883518|Rhabdomyosarcoma|rhabdomyosarcoma
251224|NCT01883518|Sarcoma, Alveolar Soft Part|sarcoma, alveolar soft part
251225|NCT01883518|NY-ESO-1|ny-eso-1
251226|NCT01883518|MAGE|mage
251227|NCT01883518|MAGE A3|mage a3
251228|NCT01883518|Vaccine|vaccine
251229|NCT01883518|Immunotherapy|immunotherapy
251230|NCT01883505|Motor fluctuations|motor fluctuations
251231|NCT01883505|levodopa pharmacokinetics|levodopa pharmacokinetics
251232|NCT01883505|levodopa and carbidopa solution|levodopa and carbidopa solution
251233|NCT01883505|continuous subcutaneous delivery|continuous subcutaneous delivery
251234|NCT01883505|Patch-pump|patch-pump
251235|NCT01883492|Only Female|only female
251236|NCT01883492|Age between 20 - 75 at the time of operation|age between 20 - 75 at the time of operation
251237|NCT01883466|Air Pollution|air pollution
251238|NCT01883466|Biodiesel exhaust|biodiesel exhaust
251239|NCT01883466|Diesel exhaust|diesel exhaust
251240|NCT01883466|Vascular function|vascular function
251241|NCT01883466|Fibrinolysis|fibrinolysis
251242|NCT01883466|Acute endothelial responses|acute endothelial responses
251243|NCT01883440|Duration|duration
251244|NCT01883427|Days with URTI symptoms|days with urti symptoms
251245|NCT01883414|Ulthera, Ultherapy, Surgical scar, scar,|ulthera, ultherapy, surgical scar, scar,
251246|NCT01883401|Strawberries|strawberries
251247|NCT01883401|Heart health|heart health
251248|NCT01883401|Anthocyanins|anthocyanins
251249|NCT01883388|Lung Cancer|lung cancer
251250|NCT01883388|blood sample|blood sample
251251|NCT01883375|Palliative Care|palliative care
251252|NCT01883375|Family|family
251253|NCT01883375|adaptation, psychological|adaptation, psychological
251254|NCT01883362|acute myeloid leukemia|acute myeloid leukemia
251255|NCT01883362|AML|aml
251256|NCT01883362|FLT3-ITD|flt3-itd
251257|NCT01883362|midostaurin|midostaurin
251258|NCT01883362|PKC412|pkc412
251259|NCT01883362|allogeneic hematopoeitic stem cell tranplant|allogeneic hematopoeitic stem cell tranplant
251260|NCT01883362|SCT|sct
251261|NCT01883362|HSCT|hsct
251262|NCT01883362|CR1|cr1
251263|NCT01883336|Incidental pancreatic cysts|incidental pancreatic cysts
251264|NCT01883323|Measurable|measurable
251265|NCT01883323|Unresectable|unresectable
251266|NCT01883323|Stage III|stage iii
251267|NCT01883323|Stage IV|stage iv
251268|NCT01883323|Metastatic|metastatic
251269|NCT01883323|Melanoma|melanoma
251270|NCT01883323|Tumor-Infiltrating Lymphocytes|tumor-infiltrating lymphocytes
251271|NCT01883323|Low-Dose Interleukin-2|low-dose interleukin-2
251272|NCT01883323|Cyclophosphamide|cyclophosphamide
251273|NCT01883323|Fludarabine|fludarabine
251274|NCT01883310|Multiple Sclerosis|multiple sclerosis
251275|NCT01883310|transcranial direct current stimulation|transcranial direct current stimulation
251276|NCT01883310|TOCT|toct
251277|NCT01883310|task-oriented circuit training|task-oriented circuit training
251278|NCT01883310|locomotor function|locomotor function
251279|NCT01883310|mobility|mobility
251280|NCT01883310|balance|balance
251281|NCT01883297|Measurable|measurable
251282|NCT01883297|Recurrent|recurrent
251283|NCT01883297|Platinum resistant|platinum resistant
251284|NCT01883297|Tumor-Infiltrating Lymphocytes|tumor-infiltrating lymphocytes
251285|NCT01883297|Low-Dose Interleukin-2|low-dose interleukin-2
251286|NCT01883297|Autologous dendritic cells|autologous dendritic cells
251287|NCT01883297|Anti-CD3 monoclonal antibody|anti-cd3 monoclonal antibody
251288|NCT01883297|High grade serous ovarian, fallopian tube, or primary peritoneal cancer|high grade serous ovarian, fallopian tube, or primary peritoneal cancer
251289|NCT01883297|Cyclophosphamide|cyclophosphamide
251290|NCT01883284|Cystic Fibrosis|cystic fibrosis
251291|NCT01883284|nasal epithelia|nasal epithelia
251292|NCT01883284|mucins|mucins
251293|NCT01883245|Orofacial chronic pain|orofacial chronic pain
251294|NCT01883245|tDCS|tdcs
251295|NCT01883245|Transcranial direct current stimulation|transcranial direct current stimulation
251296|NCT01883245|Brain stimulation|brain stimulation
251297|NCT01883219|Philadelphia chromosome|philadelphia chromosome
692803|NCT00933283|Telaprevir|telaprevir
251298|NCT01883219|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
251299|NCT01883219|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
251300|NCT01883219|Minimal residual disease|minimal residual disease
251301|NCT01883219|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
251302|NCT01883206|Cytomegalovirus|cytomegalovirus
251303|NCT01883193|preconception maternal nutrition|preconception maternal nutrition
251304|NCT01883193|LBW|lbw
251305|NCT01883193|Length-for-age|length-for-age
251306|NCT01883193|maternal nutrition supplement|maternal nutrition supplement
252012|NCT01880281|urine|urine
251307|NCT01883193|multi-micronutrient fortified lipid-based supplement|multi-micronutrient fortified lipid-based supplement
251308|NCT01883193|infant growth|infant growth
251309|NCT01883193|low-resource settings|low-resource settings
251310|NCT01883180|haploidentical hematopoietic Stem Cell Transplantation|haploidentical hematopoietic stem cell transplantation
251311|NCT01883180|Antithymocyte globulin|antithymocyte globulin
251312|NCT01883180|viral infection|viral infection
251313|NCT01883128|Biochemical Failure|biochemical failure
251314|NCT01883128|Radiotherapy|radiotherapy
251315|NCT01883128|Radiorecurrent Prostate Cancer|radiorecurrent prostate cancer
251316|NCT01883128|MRI Prostate|mri prostate
251317|NCT01883128|Whole Body MRI|whole body mri
251318|NCT01883128|Bone Scan|bone scan
251319|NCT01883128|Choline PET|choline pet
251320|NCT01883128|Focal Salvage Treatment|focal salvage treatment
251321|NCT01883128|HIFU|hifu
251322|NCT01883128|Cryotherapy|cryotherapy
251323|NCT01883115|Telescopic extraperitoneal dissection|telescopic extraperitoneal dissection
251324|NCT01883115|Single incision laparosocpic surgery|single incision laparosocpic surgery
251325|NCT01883115|Inguinal hernia|inguinal hernia
251326|NCT01883115|Triport system|triport system
251327|NCT01883076|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
251328|NCT01883076|HLHS|hlhs
251329|NCT01883076|Congenital Heart Disease|congenital heart disease
251330|NCT01883076|Umbilical cord blood|umbilical cord blood
251331|NCT01883076|UCB|ucb
251332|NCT01883076|Cord blood|cord blood
251333|NCT01883076|Stem cells|stem cells
251334|NCT01883076|Regenerative therapy|regenerative therapy
251335|NCT01883076|Stage II Glenn|stage ii glenn
251336|NCT01883076|Glenn Surgery|glenn surgery
251337|NCT01883050|Coronary artery disease|coronary artery disease
251338|NCT01883050|Percutaneous Intervention|percutaneous intervention
251339|NCT01883050|Stent|stent
251340|NCT01883050|Balloon angioplasty|balloon angioplasty
251341|NCT01883050|Angiogram|angiogram
251342|NCT01883050|Coronary angiogram|coronary angiogram
251343|NCT01883037|Cystic Fibrosis|cystic fibrosis
251344|NCT01883037|Cystic Fibrosis related diabetes|cystic fibrosis related diabetes
251345|NCT01883037|Oral glucose tolerance test|oral glucose tolerance test
251346|NCT01883024|Real time continuous glucose monitoring, decision support software, smartphone application.|real time continuous glucose monitoring, decision support software, smartphone application.
251347|NCT01883011|Piracetam|piracetam
251348|NCT01883011|Stroke|stroke
251349|NCT01883011|Aphasia|aphasia
251350|NCT01883011|Acute|acute
251351|NCT01883011|Cerebral|cerebral
251352|NCT01883011|Ischemic|ischemic
251353|NCT01883011|Nootropil|nootropil
251354|NCT01882998|HIV and pregnancy|hiv and pregnancy
251355|NCT01882998|HIV and breastfeeding|hiv and breastfeeding
251356|NCT01882998|Mother-to-child transmission of HIV|mother-to-child transmission of hiv
251357|NCT01882998|Africa|africa
251358|NCT01882998|Uganda|uganda
251359|NCT01882985|docetaxel|docetaxel
251360|NCT01882985|lycopene|lycopene
251361|NCT01882985|prostate cancer|prostate cancer
251362|NCT01882933|Gastric adenocarcinoma|gastric adenocarcinoma
251363|NCT01882933|HIPEC|hipec
251364|NCT01882933|Oxaliplatin|oxaliplatin
251365|NCT01882933|Signet ring cell|signet ring cell
251366|NCT01882920|Cytoreductive surgery|cytoreductive surgery
251367|NCT01882920|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
5866|NCT03253861|Antibiotics|antibiotics
251368|NCT01882920|Goal directed fluid therapy|goal directed fluid therapy
251369|NCT01882907|vildagliptin|vildagliptin
251370|NCT01882907|metformin|metformin
251371|NCT01882894|Plantar fasciitis, orthotic, functional outcome|plantar fasciitis, orthotic, functional outcome
251372|NCT01882842|Infertility|infertility
251373|NCT01882842|Endometrium|endometrium
251374|NCT01882842|Live birth|live birth
251375|NCT01882829|depression|depression
251376|NCT01882829|major depressive disorder|major depressive disorder
251377|NCT01882829|treatment resistant|treatment resistant
251378|NCT01882829|Nuedexta|nuedexta
251379|NCT01882829|dextromethorphan|dextromethorphan
251380|NCT01882829|antidepressant|antidepressant
251381|NCT01882829|glutamate|glutamate
251382|NCT01882829|NMDA receptor|nmda receptor
251383|NCT01882816|non-anaplastic|non-anaplastic
251384|NCT01882816|non-medullary|non-medullary
251385|NCT01882816|radiation|radiation
251387|NCT01882816|Doxorubicin|doxorubicin
251388|NCT01882816|13-070|13-070
251389|NCT01882803|PI3K Inhibitor|pi3k inhibitor
251390|NCT01882790|coronary artery spasm|coronary artery spasm
251391|NCT01882790|hypertension|hypertension
251392|NCT01882790|Pathophysiology|pathophysiology
251393|NCT01882790|atrioventricular block|atrioventricular block
251394|NCT01882790|blood pressure|blood pressure
251395|NCT01882790|autonomic nervous function|autonomic nervous function
251396|NCT01882751|kinematics|kinematics
251397|NCT01882751|knee joint|knee joint
251398|NCT01882738|Cervical length|cervical length
251399|NCT01882738|BMI|bmi
251400|NCT01882699|Insomnia|insomnia
251401|NCT01882686|Pain|pain
251402|NCT01882686|Back Pain|back pain
251403|NCT01882686|Low Back Pain|low back pain
251404|NCT01882686|Chronic Low Back Pain|chronic low back pain
252013|NCT01880281|pH|ph
251405|NCT01882686|Cognitive Functional Therapy|cognitive functional therapy
251406|NCT01882686|Intervention|intervention
251407|NCT01882686|Subclassification|subclassification
251408|NCT01882686|Multidimensional|multidimensional
251409|NCT01882673|Tobacco|tobacco
251410|NCT01882673|nicotine|nicotine
251411|NCT01882673|dependence|dependence
251412|NCT01882673|quitline|quitline
251413|NCT01882647|psoriasis|psoriasis
251414|NCT01882647|lotion|lotion
251415|NCT01882647|investigator's global assessment|investigator's global assessment
251416|NCT01882621|NSCLC|nsclc
251417|NCT01882621|Monosialoganglioside(GM1)|monosialoganglioside(gm1)
251418|NCT01882621|neurotoxicity|neurotoxicity
251419|NCT01882608|psychiatry|psychiatry
251420|NCT01882608|mental health|mental health
251421|NCT01882608|mood disorders|mood disorders
251422|NCT01882608|mood diaries|mood diaries
251423|NCT01882608|electronic diaries|electronic diaries
251424|NCT01882608|cell phones|cell phones
251425|NCT01882608|software|software
251426|NCT01882608|mental health telemetry|mental health telemetry
251427|NCT01882608|ecological momentary assessment|ecological momentary assessment
251428|NCT01882595|Nebulization aerosol nebulizer tracheostomy|nebulization aerosol nebulizer tracheostomy
251429|NCT01882556|Early treatment of spasticity.|early treatment of spasticity.
251430|NCT01882556|Post stroke spasticity.|post stroke spasticity.
251431|NCT01882543|Interstitial cystitis|interstitial cystitis
251432|NCT01882543|Bladder pain syndrome|bladder pain syndrome
251433|NCT01882543|IC/BPS|ic/bps
251434|NCT01882543|AQX-1125|aqx-1125
251435|NCT01882543|SHIP1|ship1
251436|NCT01882530|Post operative analgesia ;|post operative analgesia ;
251437|NCT01882530|Paracetamol ;|paracetamol ;
251438|NCT01882530|Ketoprofen ;|ketoprofen ;
251439|NCT01882530|Nefopam ;|nefopam ;
251440|NCT01882530|Morphine|morphine
251441|NCT01882504|Pyoderma Gangrenosum|pyoderma gangrenosum
251442|NCT01882504|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
251443|NCT01882504|Atypical Pyoderma Gangrenosum|atypical pyoderma gangrenosum
251444|NCT01882504|Peristomal Pyoderma Gangrenosum|peristomal pyoderma gangrenosum
251445|NCT01882491|Erosive Osteoarthritis|erosive osteoarthritis
251446|NCT01882491|Osteoarthritis|osteoarthritis
251447|NCT01882491|Osteoarthritis of the Hand|osteoarthritis of the hand
251448|NCT01882478|Barrett's esophagus|barrett's esophagus
251449|NCT01882478|Early esophageal adenocarcinoma|early esophageal adenocarcinoma
251450|NCT01882478|Radio Frequency Ablation|radio frequency ablation
251451|NCT01882478|Cryotherapy|cryotherapy
251452|NCT01882452|Memory specificity training|memory specificity training
251453|NCT01882452|Autobiographical memory|autobiographical memory
251454|NCT01882452|Major depressive disorder|major depressive disorder
251455|NCT01882439|psoriatic arthritis|psoriatic arthritis
251456|NCT01882439|tofacitinib|tofacitinib
251457|NCT01882439|ACR20|acr20
251458|NCT01882439|HAQ-DI|haq-di
251459|NCT01882439|TNF inhibitor failure|tnf inhibitor failure
251460|NCT01882426|CONSTRUCT|construct
251461|NCT01882426|Cluster randomization controlled trial|cluster randomization controlled trial
251462|NCT01882426|Gastroenterology practices in North America|gastroenterology practices in north america
251463|NCT01882400|Osteoporosis|osteoporosis
251464|NCT01882400|Severe muscular dystrophy|severe muscular dystrophy
251465|NCT01882400|Cystic fibrosis|cystic fibrosis
5867|NCT03253861|Multiresistant organism|multiresistant organism
251466|NCT01882387|Allogeneic Peripheral Blood Stem Cell Transplantation|allogeneic peripheral blood stem cell transplantation
251467|NCT01882387|Graft-vs-Host Disease|graft-vs-host disease
251468|NCT01882387|Neutrophil Engraftment|neutrophil engraftment
251469|NCT01882387|Platelet Engraftment|platelet engraftment
251470|NCT01882387|Immune Reconstitution|immune reconstitution
251471|NCT01882387|Mucositis|mucositis
251472|NCT01882374|Double Umbilical Cord Blood Transplantation|double umbilical cord blood transplantation
251473|NCT01882374|Acute Graft versus Host Disease|acute graft versus host disease
251474|NCT01882374|Neutrophil Engraftment|neutrophil engraftment
251475|NCT01882374|Platelet Recovery|platelet recovery
251476|NCT01882374|Immune Reconstitution|immune reconstitution
251477|NCT01882374|Mucositis|mucositis
251478|NCT01882361|opioid addiction|opioid addiction
251479|NCT01882361|opioid treatment|opioid treatment
251480|NCT01882361|naloxone|naloxone
251481|NCT01882348|tobacco control, tobacco treatment, pediatrics, parents|tobacco control, tobacco treatment, pediatrics, parents
251482|NCT01882335|Human capital formation|human capital formation
251483|NCT01882322|FK506|fk506
251484|NCT01882322|tacrolimus|tacrolimus
251485|NCT01882322|immunosuppressant|immunosuppressant
251486|NCT01882283|serum lipids|serum lipids
251487|NCT01882283|cholesterol|cholesterol
251488|NCT01882283|serum cholesterol|serum cholesterol
251489|NCT01882283|black tea|black tea
251490|NCT01882283|flavonoids|flavonoids
251491|NCT01882283|crossover trial|crossover trial
251492|NCT01882283|randomized control trial|randomized control trial
251493|NCT01882283|diet controlled|diet controlled
251494|NCT01882270|pericoronitis|pericoronitis
251495|NCT01882270|periodontal|periodontal
251496|NCT01882257|obstructive sleep apnea|obstructive sleep apnea
251497|NCT01882257|sleep-disordered breathing|sleep-disordered breathing
251498|NCT01882257|hypercapnia|hypercapnia
251499|NCT01882257|spinal cord injury|spinal cord injury
251500|NCT01882244|traumatic brain injury|traumatic brain injury
251501|NCT01882244|cognition|cognition
251502|NCT01882244|rehabilitation|rehabilitation
251503|NCT01882244|attentional regulation|attentional regulation
251504|NCT01882244|working memory|working memory
251505|NCT01882231|Osteosarcoma|osteosarcoma
251506|NCT01882231|Ewing sarcoma|ewing sarcoma
251507|NCT01882231|Paget's disease|paget's disease
251508|NCT01882231|bone cancer|bone cancer
251509|NCT01882231|childhood cancers|childhood cancers
251510|NCT01882231|DCE MRI|dce mri
251511|NCT01882231|DW MRI|dw mri
251512|NCT01882231|CEST MRI|cest mri
251513|NCT01882231|MT MRI|mt mri
251514|NCT01882218|Liver cancer|liver cancer
251515|NCT01882205|Ulcerative colitis|ulcerative colitis
251516|NCT01882205|DALM|dalm
251517|NCT01882205|chromoendoscopy|chromoendoscopy
251518|NCT01882205|dysplasia|dysplasia
251519|NCT01882205|virtual chromoendoscopy|virtual chromoendoscopy
251520|NCT01882205|FICE|fice
251521|NCT01882205|NBI|nbi
251522|NCT01882205|I-scan|i-scan
251523|NCT01882192|family|family
251524|NCT01882192|physical activity|physical activity
251525|NCT01882192|planning|planning
251526|NCT01882179|Reperfusion injury|reperfusion injury
251527|NCT01882179|myocardial infarct size|myocardial infarct size
251528|NCT01882179|MRI|mri
251529|NCT01882179|spironolactone|spironolactone
251530|NCT01882166|Fertilization in Vitro|fertilization in vitro
251531|NCT01882166|Sperm Injections, Intracytoplasmic|sperm injections, intracytoplasmic
251532|NCT01882166|Follicle Stimulating Hormone|follicle stimulating hormone
251533|NCT01882166|Embryonic Development|embryonic development
251534|NCT01882140|burns|burns
251737|NCT01881334|MDS|mds
251535|NCT01882140|wound healing|wound healing
251536|NCT01882140|magnetic field therapy|magnetic field therapy
251537|NCT01882127|Purpura|purpura
251538|NCT01882127|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
251539|NCT01882101|Fecal incontinence|fecal incontinence
251540|NCT01882101|posterior tibial nerve stimulation|posterior tibial nerve stimulation
251541|NCT01882101|biofeedback|biofeedback
251542|NCT01882101|quality of life|quality of life
251543|NCT01882075|Anesthesia|anesthesia
251544|NCT01882075|Fluid administration|fluid administration
251545|NCT01882075|Closed-loop|closed-loop
251546|NCT01882023|EDNOS|ednos
251547|NCT01882023|adolescents|adolescents
251548|NCT01882010|Parkinson's disease|parkinson's disease
251549|NCT01882010|motor function|motor function
251550|NCT01882010|immune activation|immune activation
251551|NCT01882010|T cells|t cells
251552|NCT01882010|CD4|cd4
251553|NCT01882010|GMCSF|gmcsf
251554|NCT01882010|leukine|leukine
251555|NCT01882010|sargramostim|sargramostim
251556|NCT01882010|magnetoencephalography|magnetoencephalography
251557|NCT01881997|Procedure|procedure
251558|NCT01881997|Abscess|abscess
251559|NCT01881997|Emergency Department|emergency department
251560|NCT01881997|Opioid|opioid
251561|NCT01881997|Fentanyl|fentanyl
251562|NCT01881984|Medium-chain acyl-CoA dehydrogenase deficiency|medium-chain acyl-coa dehydrogenase deficiency
251563|NCT01881984|MCAD deficiency|mcad deficiency
251564|NCT01881984|MCADD|mcadd
251565|NCT01881984|ACADM deficiency|acadm deficiency
251566|NCT01881984|MCADH deficiency|mcadh deficiency
251567|NCT01881984|985A>G mutation|985a>g mutation
251568|NCT01881984|K304E mutation|k304e mutation
251569|NCT01881984|Ravicti|ravicti
251570|NCT01881984|glycerol phenylbutyrate|glycerol phenylbutyrate
251572|NCT01881971|lung|lung
251573|NCT01881971|lipids|lipids
251574|NCT01881971|no lipid lowering medication|no lipid lowering medication
251575|NCT01881971|normal liver and kidney function|normal liver and kidney function
251576|NCT01881971|on stable ART regimen|on stable art regimen
251577|NCT01881971|not pregnant|not pregnant
251578|NCT01881945|Swallowing|swallowing
251579|NCT01881945|Hyperventilation|hyperventilation
251580|NCT01881932|acupuncture therapy|acupuncture therapy
251581|NCT01881932|sham acupuncture therapy|sham acupuncture therapy
251582|NCT01881932|chemotherapy-induced peripheral neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
251583|NCT01881919|Functional Food|functional food
251584|NCT01881906|aerobic exercise|aerobic exercise
251585|NCT01881906|Lung cancer|lung cancer
251586|NCT01881906|psyco-social|psyco-social
251587|NCT01881893|Quality of life|quality of life
251588|NCT01881893|Psychosocial Support Systems|psychosocial support systems
251589|NCT01881893|Randomized Controls as Topic|randomized controls as topic
251590|NCT01881893|Cognitive Therapy|cognitive therapy
251591|NCT01881893|Feasibility Studies|feasibility studies
251592|NCT01881880|Tomosynthesis|tomosynthesis
251593|NCT01881880|Mammography|mammography
251594|NCT01881880|Breast cancer|breast cancer
251595|NCT01881841|Alcohol abuse|alcohol abuse
251596|NCT01881841|Substance use|substance use
251597|NCT01881841|Tobacco use disorder|tobacco use disorder
251598|NCT01881841|Motivational Enhancement Therapy|motivational enhancement therapy
251599|NCT01881841|Adolescents|adolescents
251600|NCT01881815|Chronic wounds with different etiologies|chronic wounds with different etiologies
251601|NCT01881815|Diabetic foot ulcers|diabetic foot ulcers
251602|NCT01881815|venous leg ulcers|venous leg ulcers
251603|NCT01881815|pressure sores|pressure sores
251604|NCT01881815|acute wounds|acute wounds
251605|NCT01881802|Opioid drug Abuse|opioid drug abuse
251606|NCT01881802|Morphine|morphine
251607|NCT01881802|Immune Function|immune function
251608|NCT01881789|multiple myeloma|multiple myeloma
251609|NCT01881789|proteasome inhibitor|proteasome inhibitor
251610|NCT01881789|oprozomib|oprozomib
251611|NCT01881789|orpozomib tablets|orpozomib tablets
251612|NCT01881776|Single injection interscalene brachial plexus block|single injection interscalene brachial plexus block
251613|NCT01881776|Continuous interscalene brachial plexus block|continuous interscalene brachial plexus block
251614|NCT01881776|General anesthesia|general anesthesia
251615|NCT01881776|Postoperative pain|postoperative pain
251616|NCT01881776|Recovery profile|recovery profile
251617|NCT01881763|Electroconvulsive Therapy|electroconvulsive therapy
251618|NCT01881763|Ketamine|ketamine
251619|NCT01881763|anesthesia|anesthesia
251620|NCT01881763|depression|depression
251621|NCT01881763|unipolar|unipolar
251622|NCT01881763|bipolar|bipolar
251623|NCT01881750|Autism PRT|autism prt
251624|NCT01881737|autism|autism
251625|NCT01881711|hydrocephalus|hydrocephalus
251626|NCT01881711|CSF shunt|csf shunt
251627|NCT01881711|shunt malfunction|shunt malfunction
251628|NCT01881711|shunt obstruction|shunt obstruction
251629|NCT01881711|ShuntCheck|shuntcheck
251630|NCT01881711|ShuntCheck-Micro-Pumper|shuntcheck-micro-pumper
251631|NCT01881698|pregnancy|pregnancy
251632|NCT01881698|platelet function|platelet function
251633|NCT01881698|monitoring|monitoring
251634|NCT01881698|multiple electrode aggregometry|multiple electrode aggregometry
251635|NCT01881672|Aspiration pneumonia|aspiration pneumonia
251636|NCT01881672|Coma|coma
251637|NCT01881672|Mechanical ventilation|mechanical ventilation
251638|NCT01881659|cervical cancer|cervical cancer
251639|NCT01881659|cancer prevention|cancer prevention
251640|NCT01881659|cervical screening|cervical screening
251641|NCT01881659|HPV testing|hpv testing
251642|NCT01881659|triage techniques|triage techniques
251643|NCT01881646|Neuroinflammation|neuroinflammation
251644|NCT01881646|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
251645|NCT01881633|gaucher disease, imiglucerase, ISU302|gaucher disease, imiglucerase, isu302
251646|NCT01881620|PET scan|pet scan
251647|NCT01881620|CT scan|ct scan
251648|NCT01881620|Diagnostic performance|diagnostic performance
251649|NCT01881607|tobacco smoke pollution|tobacco smoke pollution
251650|NCT01881607|Tobacco use|tobacco use
251651|NCT01881594|ileostomy closure,postoperative ileus,stimulation ileostomy|ileostomy closure,postoperative ileus,stimulation ileostomy
251652|NCT01881581|Therapeutic|therapeutic
251653|NCT01881581|Vaccine|vaccine
251654|NCT01881581|HIV|hiv
251655|NCT01881581|MVA|mva
251656|NCT01881581|DNA|dna
251657|NCT01881568|Total Knee Arthroplasty, TKA, blood loss|total knee arthroplasty, tka, blood loss
251658|NCT01881555|fractional flow reserve|fractional flow reserve
251659|NCT01881555|multivessel coronary artery disease|multivessel coronary artery disease
251660|NCT01881555|angiography|angiography
251661|NCT01881542|preeclampsia|preeclampsia
251662|NCT01881542|proteinuria|proteinuria
251663|NCT01881542|urine collection|urine collection
251665|NCT01881529|diffuse scleroderma|diffuse scleroderma
251666|NCT01881529|Sclerosis|sclerosis
251667|NCT01881529|Progressive|progressive
251668|NCT01881529|Limited|limited
251669|NCT01881503|life-threatening anemia|life-threatening anemia
251670|NCT01881503|blood alternative|blood alternative
251671|NCT01881503|HBOC|hboc
251672|NCT01881490|Crohn's Disease|crohn's disease
251673|NCT01881490|MRE|mre
251674|NCT01881490|Pelvic MRI|pelvic mri
251675|NCT01881490|P-MRI|p-mri
251676|NCT01881490|colonoscopy|colonoscopy
251677|NCT01881490|gastroscopy|gastroscopy
251678|NCT01881477|immobilization|immobilization
251679|NCT01881477|physical therapy|physical therapy
251680|NCT01881477|intensive care|intensive care
251681|NCT01881477|bed rest|bed rest
251682|NCT01881477|movement|movement
251683|NCT01881451|Tumour hypoxia|tumour hypoxia
251684|NCT01881451|Clear Cell Ovarian Cancer|clear cell ovarian cancer
251685|NCT01881451|Recurrent|recurrent
251686|NCT01881451|Metastatic|metastatic
251687|NCT01881438|Retinal Detachment|retinal detachment
251688|NCT01881438|Fluoroquinolones|fluoroquinolones
251689|NCT01881438|Ciprofloxacin|ciprofloxacin
251690|NCT01881438|Levofloxacin|levofloxacin
251691|NCT01881438|Gatifloxacin|gatifloxacin
251692|NCT01881438|Gemifloxacin|gemifloxacin
251693|NCT01881438|Moxifloxacin|moxifloxacin
251694|NCT01881438|Norfloxacin|norfloxacin
251695|NCT01881438|Ofloxacin|ofloxacin
251696|NCT01881438|Beta-Lactam|beta-lactam
251698|NCT01881412|Asthma|asthma
251699|NCT01881412|Children|children
251700|NCT01881412|Inhaled Corticosteroids|inhaled corticosteroids
251701|NCT01881412|Emergency Department|emergency department
251702|NCT01881399|Cholelithiasis|cholelithiasis
251703|NCT01881399|Gallbladder polyps|gallbladder polyps
251704|NCT01881399|Fluorescence|fluorescence
251705|NCT01881399|Indocyanine green (ICG)|indocyanine green (icg)
242487|NCT01923818|aspirin|aspirin
251706|NCT01881399|Intraoperative cholangiography (IOC)|intraoperative cholangiography (ioc)
251707|NCT01881399|da Vinci surgical system|da vinci surgical system
251708|NCT01881386|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
251709|NCT01881386|Lactate|lactate
251710|NCT01881373|Obesity|obesity
251711|NCT01881373|Child|child
251712|NCT01881373|Food|food
251713|NCT01881373|Physical Activity|physical activity
251714|NCT01881373|Pacific|pacific
251715|NCT01881360|fibromyalgia|fibromyalgia
251716|NCT01881360|celiac-type symptoms|celiac-type symptoms
251717|NCT01881360|gluten-free diet|gluten-free diet
251718|NCT01881360|hypocaloric diet|hypocaloric diet
251719|NCT01881347|endothelium|endothelium
251720|NCT01881347|mitochondria|mitochondria
251721|NCT01881347|reactive oxygen species|reactive oxygen species
251722|NCT01881347|vascular biology|vascular biology
251723|NCT01881347|arterial stiffness|arterial stiffness
251724|NCT01881347|nitric oxide|nitric oxide
251725|NCT01881334|Haploidentical Donor|haploidentical donor
251726|NCT01881334|T-cell depleted Stem Cells|t-cell depleted stem cells
251727|NCT01881334|Allogeneic Transplant|allogeneic transplant
251728|NCT01881334|Umbilical Cord Blood Donor|umbilical cord blood donor
251729|NCT01881334|High Risk Malignancies|high risk malignancies
251730|NCT01881334|Metabolic Disorders|metabolic disorders
251731|NCT01881334|Immune Deficiency|immune deficiency
251732|NCT01881334|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
251733|NCT01881334|Acute Myelogenous Leukemia|acute myelogenous leukemia
251734|NCT01881334|Myelodysplastic Syndrome|myelodysplastic syndrome
251735|NCT01881334|ALL|all
251736|NCT01881334|AML|aml
251738|NCT01881334|CGD|cgd
251739|NCT01881334|SCID|scid
251740|NCT01881334|Adrenoleukodystrophy|adrenoleukodystrophy
251741|NCT01881334|Metachromaticleukodystrophy|metachromaticleukodystrophy
251742|NCT01881334|Krabbe|krabbe
251743|NCT01881334|PMD|pmd
251744|NCT01881334|Hunter's|hunter's
251745|NCT01881334|Hurler's|hurler's
251746|NCT01881334|Severe Aplastic Anemia|severe aplastic anemia
251747|NCT01881334|Lymphoma|lymphoma
251748|NCT01881334|Sickle Cell Disease|sickle cell disease
251749|NCT01881334|Thalassemia|thalassemia
251750|NCT01881321|Contraception|contraception
251751|NCT01881321|Counseling|counseling
251752|NCT01881295|Potassium|potassium
251753|NCT01881295|Potato|potato
251754|NCT01881295|French Fries|french fries
251755|NCT01881295|Bioavailability|bioavailability
251756|NCT01881295|Blood Pressure|blood pressure
251757|NCT01881282|Hemorrhoids|hemorrhoids
251758|NCT01881282|Carraghenates|carraghenates
251759|NCT01881282|Mayinglong Musk|mayinglong musk
251760|NCT01881282|Titanoreine|titanoreine
251761|NCT01881256|Preterm birth|preterm birth
251762|NCT01881256|Parenteral and enteral nutrition|parenteral and enteral nutrition
251763|NCT01881256|Body composition in preterm infants|body composition in preterm infants
251764|NCT01881243|Cardiac Arrest, Hyperoxia, Ischemia-reperfusion Injury, Reactive Oxygen Species, Oxidative Stress, Neuropsychological Tests|cardiac arrest, hyperoxia, ischemia-reperfusion injury, reactive oxygen species, oxidative stress, neuropsychological tests
251765|NCT01881230|Breast Cancer|breast cancer
251766|NCT01881230|Cancer of the Breast|cancer of the breast
251767|NCT01881230|Metastatic Breast Cancer|metastatic breast cancer
251768|NCT01881230|Metastatic Triple Negative Breast Cancer|metastatic triple negative breast cancer
251769|NCT01881230|Triple Negative Breast Cancer|triple negative breast cancer
251770|NCT01881230|Triple Negative Metastatic Breast Cancer|triple negative metastatic breast cancer
251771|NCT01881230|Basal-like breast cancer|basal-like breast cancer
251772|NCT01881230|Hormone receptor negative breast cancer|hormone receptor negative breast cancer
251773|NCT01881230|Estrogen receptor negative breast cancer|estrogen receptor negative breast cancer
251774|NCT01881230|Progesterone negative receptor breast cancer|progesterone negative receptor breast cancer
251775|NCT01881230|HER2 Negative Breast Cancer|her2 negative breast cancer
251776|NCT01881230|Abraxane|abraxane
251777|NCT01881230|nab-Paclitaxel|nab-paclitaxel
251778|NCT01881230|ABI-007|abi-007
251779|NCT01881230|gemcitabine|gemcitabine
251780|NCT01881230|Gemzar|gemzar
251781|NCT01881230|carboplatin|carboplatin
251782|NCT01881230|Paraplatin|paraplatin
251783|NCT01881230|Paraplatin AQ|paraplatin aq
251784|NCT01881230|Phase 2|phase 2
251785|NCT01881230|Phase 3|phase 3
251786|NCT01881217|Phase I|phase i
251787|NCT01881217|Dose escalation|dose escalation
251788|NCT01881217|Advanced, refractory solid tumors|advanced, refractory solid tumors
251789|NCT01881217|FGFR2|fgfr2
251790|NCT01881204|Hesperidin|hesperidin
251791|NCT01881204|Osteoporosis|osteoporosis
251792|NCT01881204|Bone Loss|bone loss
251793|NCT01881191|multiple sclerosis|multiple sclerosis
251794|NCT01881191|relapsing remitting|relapsing remitting
251796|NCT01881191|teriflunomide|teriflunomide
251797|NCT01881191|aubagio|aubagio
251798|NCT01881191|gray matter atrophy|gray matter atrophy
251799|NCT01881191|gray matter pathology|gray matter pathology
251800|NCT01881178|CRP|crp
251801|NCT01881178|Nopalea|nopalea
251802|NCT01881178|Fruit|fruit
251803|NCT01881178|Juice|juice
251805|NCT01881152|Community education|community education
251806|NCT01881152|Awareness|awareness
251807|NCT01881152|Prehospital delay|prehospital delay
251808|NCT01881139|Exercise|exercise
251809|NCT01881139|Lipid|lipid
251810|NCT01881139|Left ventricular|left ventricular
251811|NCT01881139|heart function|heart function
251812|NCT01881100|resin infiltration|resin infiltration
251813|NCT01881100|randomized clinical trial|randomized clinical trial
251814|NCT01881100|fluoride varnish|fluoride varnish
251815|NCT01881100|caries lesion|caries lesion
251816|NCT01881100|deciduous teeth|deciduous teeth
251817|NCT01881087|Knee Arthroscopy|knee arthroscopy
251818|NCT01881087|Levobupivacaine|levobupivacaine
251819|NCT01881087|Spinal Anesthesia|spinal anesthesia
251820|NCT01881087|Motor Block|motor block
251821|NCT01881074|Type II Diabetes|type ii diabetes
251822|NCT01881074|Periodontal Disease|periodontal disease
251823|NCT01881074|Periodontitis|periodontitis
251824|NCT01881074|Gum Disease|gum disease
251825|NCT01881074|Gingivitis|gingivitis
251826|NCT01881074|Triclosan|triclosan
251827|NCT01881074|Inflammatory Markers|inflammatory markers
251828|NCT01881074|Immune Response|immune response
251829|NCT01881061|Sonography|sonography
251830|NCT01881061|ICU|icu
251831|NCT01881061|PEEP|peep
251832|NCT01881048|Breast cancer|breast cancer
251833|NCT01881048|Omega-3 Fatty Acid|omega-3 fatty acid
251834|NCT01881048|Celecoxib|celecoxib
251835|NCT01881048|Celebrex|celebrex
251836|NCT01881048|Surgery|surgery
251837|NCT01881035|Hypertension|hypertension
251838|NCT01881035|End stage renal disease|end stage renal disease
251839|NCT01881022|Breast Cancer|breast cancer
251841|NCT01881022|Sexual Dysfunction|sexual dysfunction
251842|NCT01881022|Psychosexual Intervention|psychosexual intervention
251843|NCT01881022|Sex Therapy|sex therapy
251844|NCT01881022|Online Support|online support
251845|NCT01881022|e-health|e-health
251846|NCT01881009|Diabetes|diabetes
251847|NCT01881009|Insulin|insulin
251848|NCT01881009|Closed loop|closed loop
251849|NCT01881009|Nocturnal glucose control|nocturnal glucose control
251850|NCT01880996|Ovarian Cancer|ovarian cancer
251851|NCT01880996|Gynecological Malignancies|gynecological malignancies
251852|NCT01880996|Chemotherapy|chemotherapy
251853|NCT01880996|Tai-chi|tai-chi
251854|NCT01880996|Qigong|qigong
251855|NCT01880996|Fatigue|fatigue
251856|NCT01880996|Quality of life|quality of life
251857|NCT01880996|Sleep disturbance|sleep disturbance
251858|NCT01880983|EPP|epp
251859|NCT01880983|Bloomer|bloomer
251860|NCT01880983|Porphyria|porphyria
251861|NCT01880957|bipolar disorder|bipolar disorder
251862|NCT01880957|bipolar depression|bipolar depression
251863|NCT01880957|serotonin transporter|serotonin transporter
251864|NCT01880957|serotonin receptors|serotonin receptors
251865|NCT01880957|binding potential|binding potential
251866|NCT01880957|brain imaging|brain imaging
251867|NCT01880957|unipolar depression|unipolar depression
251868|NCT01880944|spine|spine
251869|NCT01880944|trauma|trauma
251870|NCT01880944|MRI|mri
251871|NCT01880944|contrast|contrast
251872|NCT01880918|Compression Anastomosis|compression anastomosis
251873|NCT01880905|the length of uterine ovarian ligament|the length of uterine ovarian ligament
251874|NCT01880879|coronary artery disease|coronary artery disease
251875|NCT01880879|PCI|pci
251876|NCT01880879|stent|stent
251877|NCT01880866|PAH|pah
251878|NCT01880853|breast cancer|breast cancer
251879|NCT01880853|screening|screening
251880|NCT01880853|mammography|mammography
251881|NCT01880853|ultrasound|ultrasound
251882|NCT01880827|GIP|gip
251883|NCT01880827|GLP-1|glp-1
251884|NCT01880827|type 2 diabetes|type 2 diabetes
251885|NCT01880827|obesity|obesity
251886|NCT01880827|splanchnic blood flow|splanchnic blood flow
251887|NCT01880827|incretin hormones|incretin hormones
251888|NCT01880814|Depression, child, cognitive behavioral treatment, parent training, personalized treatment|depression, child, cognitive behavioral treatment, parent training, personalized treatment
251889|NCT01880801|ITP|itp
251890|NCT01880788|Age Related Macular Degeneration|age related macular degeneration
251891|NCT01880788|Choroidal Neovascularization|choroidal neovascularization
251892|NCT01880788|Central Serous Chorioretinopathy|central serous chorioretinopathy
251893|NCT01880762|PET MR development and validation|pet mr development and validation
251894|NCT01880723|exhaled breath condensate|exhaled breath condensate
251895|NCT01880723|diffusion capacity of the lungs for carbon monoxide and nitric oxide|diffusion capacity of the lungs for carbon monoxide and nitric oxide
251896|NCT01880723|albuterol|albuterol
251897|NCT01880723|peripheral oxygen saturation|peripheral oxygen saturation
251898|NCT01880723|ion regulation|ion regulation
251899|NCT01880710|long term follow-up|long term follow-up
251900|NCT01880710|urinary incontinence|urinary incontinence
251901|NCT01880710|pelvic organ prolapse|pelvic organ prolapse
251902|NCT01880710|total versus subtotal hysterectomy|total versus subtotal hysterectomy
251903|NCT01880697|Influenza|influenza
251904|NCT01880697|adults|adults
251905|NCT01880697|elderly|elderly
251906|NCT01880697|immunology|immunology
251907|NCT01880697|safety|safety
252014|NCT01880281|acidosis|acidosis
251908|NCT01880684|Thermodilution|thermodilution
251909|NCT01880684|Blood Volume|blood volume
251910|NCT01880684|Cardiac Output|cardiac output
251911|NCT01880684|Leg|leg
251912|NCT01880684|Capnography|capnography
251913|NCT01880684|Blood Pressure|blood pressure
251914|NCT01880658|Maintenance therapy|maintenance therapy
251915|NCT01880658|Capecitabine|capecitabine
251916|NCT01880658|Adjuvant chemotherapy|adjuvant chemotherapy
251917|NCT01880658|Post-operation|post-operation
251918|NCT01880645|Breast Cancer|breast cancer
251919|NCT01880645|Invasive breast cancer|invasive breast cancer
251920|NCT01880645|Axillary lymph node metastases|axillary lymph node metastases
251921|NCT01880645|Ultrasound|ultrasound
251922|NCT01880645|Fine needle aspiration|fine needle aspiration
251923|NCT01880645|FNA|fna
251924|NCT01880645|Lymph node surgery|lymph node surgery
251925|NCT01880645|Partial mastectomy|partial mastectomy
251926|NCT01880645|Total mastectomy|total mastectomy
251927|NCT01880632|XELOX|xelox
251928|NCT01880632|perioperative treatment|perioperative treatment
251929|NCT01880632|locally advanced gastric adenocarcinoma|locally advanced gastric adenocarcinoma
251930|NCT01880632|D2 resection|d2 resection
251931|NCT01880619|Double J|double j
251932|NCT01880619|Ureteral stents|ureteral stents
251933|NCT01880619|Symptoms|symptoms
251934|NCT01880619|Alpha blockers|alpha blockers
251935|NCT01880619|Anticholinergic|anticholinergic
251936|NCT01880593|Ketamine|ketamine
251937|NCT01880593|glutamate|glutamate
251938|NCT01880593|N-methyl-D-aspartate|n-methyl-d-aspartate
251939|NCT01880593|depression|depression
251940|NCT01880593|major depressive disorder|major depressive disorder
251941|NCT01880593|treatment resistant|treatment resistant
251942|NCT01880593|antidepressant|antidepressant
251944|NCT01880567|Lymphoma|lymphoma
251945|NCT01880567|Relapsed/Refractory Mantle Cell Lymphoma|relapsed/refractory mantle cell lymphoma
251946|NCT01880567|R/R MCL|r/r mcl
251947|NCT01880567|Ibrutinib|ibrutinib
251948|NCT01880567|PCI-32765|pci-32765
251949|NCT01880567|Rituximab|rituximab
251950|NCT01880567|Rituxan|rituxan
251951|NCT01880567|Newly-Diagnosed Untreated Mantle Cell Lymphoma|newly-diagnosed untreated mantle cell lymphoma
251952|NCT01880567|MCL|mcl
251953|NCT01880554|Liver metastases|liver metastases
251954|NCT01880554|Colorectal primary cancer|colorectal primary cancer
251955|NCT01880554|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
251956|NCT01880554|Sonovue®|sonovue®
251957|NCT01880541|Patients with breast cancer and breast surgery requiring|patients with breast cancer and breast surgery requiring
251958|NCT01880515|Lung cancer|lung cancer
251959|NCT01880515|BIBW 2992|bibw 2992
251960|NCT01880515|Skin Rash|skin rash
251961|NCT01880515|Tetracycline|tetracycline
251962|NCT01880515|Afatinib|afatinib
251963|NCT01880502|Healthy, Volunteers|healthy, volunteers
251964|NCT01880489|transgender women|transgender women
251965|NCT01880489|sexual risk|sexual risk
251966|NCT01880489|substance use|substance use
251967|NCT01880489|HIV prevention|hiv prevention
251968|NCT01880489|behavioral intervention|behavioral intervention
251969|NCT01880476|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
251970|NCT01880476|Comorbidity|comorbidity
251972|NCT01880476|Health Services|health services
251974|NCT01880463|incidence|incidence
251975|NCT01880463|progression|progression
251976|NCT01880411|PEK fusion protein Healthbanks|pek fusion protein healthbanks
251977|NCT01880398|FIstula in ano; Bhagandar|fistula in ano; bhagandar
251978|NCT01880385|bevacizumab|bevacizumab
251979|NCT01880385|inflammatory breast cancer|inflammatory breast cancer
251980|NCT01880385|non metastatic|non metastatic
251981|NCT01880385|Avastin|avastin
251982|NCT01880372|Diabetes|diabetes
251983|NCT01880372|Diabetic Retinopathy|diabetic retinopathy
251984|NCT01880372|Retinopathy|retinopathy
251985|NCT01880372|Free radical|free radical
251986|NCT01880372|Retinal diseases|retinal diseases
251987|NCT01880372|Antioxidants|antioxidants
251988|NCT01880372|Protective agents|protective agents
251989|NCT01880372|Thioctic acid|thioctic acid
251990|NCT01880346|Cystic Fibrosis|cystic fibrosis
251991|NCT01880346|Vitamin D|vitamin d
251992|NCT01880346|absorption|absorption
251993|NCT01880346|vitamin Deficiency|vitamin deficiency
251994|NCT01880346|fat soluble|fat soluble
251995|NCT01880333|Refractory epilepsy|refractory epilepsy
251996|NCT01880333|dietary therapy|dietary therapy
251997|NCT01880333|non-pharmacological therapy|non-pharmacological therapy
251998|NCT01880333|Modified Atkin Diet|modified atkin diet
251999|NCT01880307|Crohn's disease|crohn's disease
252000|NCT01880307|pediatric|pediatric
252001|NCT01880307|infliximab|infliximab
252002|NCT01880307|top-down|top-down
252003|NCT01880307|ITSKids|itskids
252004|NCT01880294|Constipation|constipation
252005|NCT01880294|Chronic constipation|chronic constipation
252006|NCT01880294|Asia-Pacific|asia-pacific
252007|NCT01880294|Gastroentrology|gastroentrology
252008|NCT01880294|Asian participants|asian participants
252009|NCT01880281|G protein-coupled receptor 99 (GPR99)|g protein-coupled receptor 99 (gpr99)
252010|NCT01880281|2-oxoglutarate receptor 1 (OXGR1)|2-oxoglutarate receptor 1 (oxgr1)
252011|NCT01880281|alpha-ketoglutarate|alpha-ketoglutarate
252015|NCT01880281|alkalosis|alkalosis
252016|NCT01880281|Healthy volunteers|healthy volunteers
252017|NCT01880255|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
252018|NCT01880255|Schizophrenia|schizophrenia
252019|NCT01880255|Cognition|cognition
252020|NCT01880255|Working Memory|working memory
252021|NCT01880242|International|international
252022|NCT01880242|Multicenter|multicenter
252023|NCT01880242|Observational registry|observational registry
252024|NCT01880242|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
252025|NCT01880242|Stenting|stenting
252026|NCT01880242|Treatment of Coronary Artery Disease|treatment of coronary artery disease
252027|NCT01880242|Coronary revascularization|coronary revascularization
252028|NCT01880242|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
252029|NCT01880242|STEMI|stemi
252030|NCT01880242|NSTEMI|nstemi
252031|NCT01880242|Ischemia|ischemia
252032|NCT01880242|Angina|angina
252033|NCT01880242|Subgroups|subgroups
252034|NCT01880242|Acute Myocardial Infarction|acute myocardial infarction
252035|NCT01880242|Diabetes|diabetes
252036|NCT01880242|Small Vessels|small vessels
252037|NCT01880242|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
252038|NCT01880216|Deep vein thrombosis|deep vein thrombosis
252039|NCT01880216|DVT|dvt
252040|NCT01880216|Treatment|treatment
252041|NCT01880216|Low molecular weight heparin|low molecular weight heparin
252042|NCT01880216|Bemiparin|bemiparin
252043|NCT01880216|Enoxaparin|enoxaparin
252044|NCT01880203|thyroid|thyroid
252045|NCT01880203|elastography SWE|elastography swe
252046|NCT01880203|indeterminate cytology|indeterminate cytology
252047|NCT01880164|Scoliosis|scoliosis
252048|NCT01880164|Kyphosis|kyphosis
252049|NCT01880164|Sagittal plane deformity|sagittal plane deformity
252050|NCT01880151|Alzheimer's disease|alzheimer's disease
252051|NCT01880151|Dementia|dementia
252052|NCT01880151|Prodromal|prodromal
252053|NCT01880151|EEG|eeg
252054|NCT01880151|ERP|erp
252055|NCT01880151|Biomarkers|biomarkers
252056|NCT01880138|Animated cartoon, Emergence agitation|animated cartoon, emergence agitation
252057|NCT01880125|Tramadol|tramadol
252058|NCT01880125|Acetaminophen|acetaminophen
252059|NCT01880125|Pharmacokinetics|pharmacokinetics
252060|NCT01880125|Sustained release|sustained release
252061|NCT01880125|Immediate release|immediate release
252062|NCT01880112|Infection|infection
252063|NCT01880112|Cesarean delivery|cesarean delivery
252064|NCT01880112|Antibiotic prophylaxis|antibiotic prophylaxis
252065|NCT01880112|Cefazolin dosing|cefazolin dosing
252066|NCT01880099|addiction|addiction
252067|NCT01880099|smoking|smoking
252068|NCT01880099|tobacco|tobacco
252069|NCT01880099|cigarettes|cigarettes
252070|NCT01880086|Chronic pain|chronic pain
252071|NCT01880086|Low testosterone|low testosterone
252072|NCT01880086|Hypogonadism|hypogonadism
252073|NCT01880086|Opioid analgesics|opioid analgesics
252074|NCT01880086|Narcotics|narcotics
252075|NCT01880086|Opioid-induced androgen deficiency|opioid-induced androgen deficiency
252077|NCT01880086|Male infertility|male infertility
252078|NCT01880086|Clomiphene citrate|clomiphene citrate
252079|NCT01880086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
252080|NCT01880086|Testosterone replacement therapy|testosterone replacement therapy
252081|NCT01880060|Worksite|worksite
252082|NCT01880060|weight loss|weight loss
252083|NCT01880060|obesity|obesity
252084|NCT01880047|Immune Thrombocytopenia|immune thrombocytopenia
252085|NCT01880047|ITP|itp
252086|NCT01880047|Eltrombopag|eltrombopag
252087|NCT01880047|Promacta|promacta
252088|NCT01880008|positron emission tomography|positron emission tomography
692908|NCT00933647|Obesity|obesity
252089|NCT01880008|magnetic resonance imaging|magnetic resonance imaging
252090|NCT01880008|diffusion magnetic resonance imaging|diffusion magnetic resonance imaging
252091|NCT01880008|radionuclide imaging|radionuclide imaging
252092|NCT01880008|disease management|disease management
252093|NCT01880008|radiation therapy|radiation therapy
252094|NCT01879982|Bipolar disorder|bipolar disorder
252095|NCT01879982|subtypes|subtypes
252096|NCT01879969|computer-assisted orthognathic surgery; facial asymmetry|computer-assisted orthognathic surgery; facial asymmetry
252097|NCT01879956|Executive Functions|executive functions
252098|NCT01879956|Schizophrenia|schizophrenia
252099|NCT01879956|Occupational Therapy|occupational therapy
252100|NCT01879943|Colorectal cancer|colorectal cancer
252101|NCT01879943|Follow up|follow up
252102|NCT01879943|Colonoscopy|colonoscopy
252103|NCT01879943|Videocapsule|videocapsule
252104|NCT01879930|randomized|randomized
252105|NCT01879930|placebo-controlled|placebo-controlled
252106|NCT01879930|double-blind study|double-blind study
252107|NCT01879930|doxycycline|doxycycline
252108|NCT01879917|c-peptide|c-peptide
252109|NCT01879917|insulin|insulin
252110|NCT01879917|hypoglycemia|hypoglycemia
252111|NCT01879917|Newly onset|newly onset
252112|NCT01879917|Diabetes|diabetes
252113|NCT01879917|Type 1|type 1
252114|NCT01879917|Beta cell|beta cell
252115|NCT01879917|Autoimmune|autoimmune
252116|NCT01879917|Glucagon|glucagon
252117|NCT01879917|Meal test|meal test
252118|NCT01879904|Colorectal Neoplasms|colorectal neoplasms
252119|NCT01879891|Exercise Intensity|exercise intensity
252120|NCT01879891|Metabolism|metabolism
252121|NCT01879891|Insulin|insulin
252122|NCT01879878|pancreatic adenocarcinoma|pancreatic adenocarcinoma
252123|NCT01879878|broccoli sprouts|broccoli sprouts
252124|NCT01879878|sulforaphane|sulforaphane
252125|NCT01879878|palliative chemotherapy|palliative chemotherapy
252126|NCT01879878|cancer stem cells|cancer stem cells
252127|NCT01879865|PKPD|pkpd
252128|NCT01879865|Dexmedetomidine|dexmedetomidine
252129|NCT01879865|Auditory Stimulation|auditory stimulation
252130|NCT01879865|Cardiac Output|cardiac output
252131|NCT01879852|Quadriceps strength|quadriceps strength
252132|NCT01879852|Knee|knee
252133|NCT01879852|Rehabilitation|rehabilitation
252134|NCT01879826|Aculaser|aculaser
252135|NCT01879826|Microlight ML830|microlight ml830
252136|NCT01879826|Kidney biopsy|kidney biopsy
252137|NCT01879826|Pain|pain
252138|NCT01879826|Anxiety|anxiety
252139|NCT01879826|Sedation|sedation
252140|NCT01879813|Memory|memory
252141|NCT01879813|Attention|attention
252142|NCT01879787|Stroke|stroke
252143|NCT01879787|transcranial direct current stimulation|transcranial direct current stimulation
252144|NCT01879787|constraint-induced movement therapy|constraint-induced movement therapy
252145|NCT01879787|mental practice|mental practice
252146|NCT01879774|Hyponatremia|hyponatremia
252147|NCT01879761|Immunosuppressed|immunosuppressed
252148|NCT01879761|Sepsis|sepsis
252149|NCT01879761|Staphylococcus Aureus|staphylococcus aureus
252150|NCT01879761|Bacteremia|bacteremia
252151|NCT01879761|HLA-DR|hla-dr
252152|NCT01879748|Parkinson's disease|parkinson's disease
252153|NCT01879748|Azilect|azilect
252154|NCT01879748|rasagiline mesylate|rasagiline mesylate
252155|NCT01879722|Drug therapy|drug therapy
252156|NCT01879709|schizophrenia|schizophrenia
252157|NCT01879709|Cognition|cognition
252158|NCT01879709|Independent living skills|independent living skills
252159|NCT01879683|Hunner's lesion|hunner's lesion
252160|NCT01879644|ADHD|adhd
252161|NCT01879644|Neurofeedback|neurofeedback
252162|NCT01879644|Self-Management|self-management
252163|NCT01879644|Parental Psychoeducation|parental psychoeducation
252164|NCT01879644|Social Support|social support
252165|NCT01879631|radial keratotomy; keratoconus; optical rehabilitation|radial keratotomy; keratoconus; optical rehabilitation
252166|NCT01879618|Fragmin|fragmin
252167|NCT01879618|dalteparin|dalteparin
252168|NCT01879618|hemodialysis|hemodialysis
252169|NCT01879618|anticoagulation|anticoagulation
252170|NCT01879618|Renal Failure|renal failure
252171|NCT01879605|Spinal surgery|spinal surgery
252172|NCT01879605|Bowel preparation|bowel preparation
252173|NCT01879605|Ileus|ileus
252174|NCT01879605|Constipation|constipation
252175|NCT01879605|Well-being|well-being
252176|NCT01879592|Sickle cell disease|sickle cell disease
252178|NCT01879592|Metabolomics|metabolomics
252179|NCT01879592|Gene expression|gene expression
252180|NCT01879579|Insulin|insulin
252181|NCT01879579|Telemedicine|telemedicine
252182|NCT01879553|Influenza,|influenza,
252183|NCT01879553|Adults,|adults,
252184|NCT01879553|Elderly,|elderly,
252185|NCT01879553|Immunology,|immunology,
252186|NCT01879553|Safety|safety
252187|NCT01879540|Influenza,|influenza,
252188|NCT01879540|Elderly,|elderly,
252189|NCT01879540|Immunology,|immunology,
252190|NCT01879540|Safety|safety
252191|NCT01879514|IgA nephropathy|iga nephropathy
252192|NCT01879514|Therapy of Chinese medicine|therapy of chinese medicine
252193|NCT01879501|Low vision|low vision
252194|NCT01879501|Self management|self management
252195|NCT01879501|Randomized controlled trial|randomized controlled trial
252196|NCT01879501|Quality of life|quality of life
252197|NCT01879501|Self efficacy|self efficacy
252198|NCT01879501|Effectiveness|effectiveness
252199|NCT01879501|Chronic eye diseases management|chronic eye diseases management
252200|NCT01879488|Aerosol|aerosol
252201|NCT01879488|Lung deposition|lung deposition
252202|NCT01879488|Mechanical ventilation|mechanical ventilation
252203|NCT01879462|chronic hepatitis C (CHC)|chronic hepatitis c (chc)
252204|NCT01879462|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
252205|NCT01879462|NS5B|ns5b
252206|NCT01879462|pharmacokinetics|pharmacokinetics
252207|NCT01879462|GSK2878175|gsk2878175
252208|NCT01879462|safety|safety
252209|NCT01879462|FTIH|ftih
252210|NCT01879462|healthy subjects|healthy subjects
252211|NCT01879449|Spasticity|spasticity
252212|NCT01879449|Veterans|veterans
252213|NCT01879449|Prevalence|prevalence
252214|NCT01879436|Pregnancy, Placenta, Cancer|pregnancy, placenta, cancer
252215|NCT01879410|GSK573719|gsk573719
252216|NCT01879410|lung function|lung function
252217|NCT01879410|salmeterol (SAL)|salmeterol (sal)
252218|NCT01879410|umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
252219|NCT01879410|GW642444|gw642444
252220|NCT01879410|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
252221|NCT01879410|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
252222|NCT01879410|fluticasone propionate (FP)|fluticasone propionate (fp)
252223|NCT01879410|vilanterol (VI)|vilanterol (vi)
252224|NCT01879397|atherosclerosis|atherosclerosis
252225|NCT01879397|arteriosclerosis|arteriosclerosis
252226|NCT01879397|carotid stenosis|carotid stenosis
252227|NCT01879397|carotid endarterectomy|carotid endarterectomy
252228|NCT01879397|Stroke|stroke
252229|NCT01879384|microdialysis|microdialysis
252230|NCT01879384|bone free flap|bone free flap
252231|NCT01879384|head and neck|head and neck
252232|NCT01879384|monitoring free flap|monitoring free flap
252233|NCT01879384|reconstructive surgery|reconstructive surgery
252234|NCT01879358|Drug-eluting stent|drug-eluting stent
252235|NCT01879358|Safety|safety
252236|NCT01879358|Efficacy|efficacy
252237|NCT01879345|Anticonvulsant|anticonvulsant
252238|NCT01879332|Anticonvulsant|anticonvulsant
252239|NCT01879319|LDL-C, triglycerides, high cholesterol|ldl-c, triglycerides, high cholesterol
252240|NCT01879293|Metformin|metformin
252241|NCT01879293|Left ventricular mass|left ventricular mass
252242|NCT01879293|Endothelial dysfunction|endothelial dysfunction
252243|NCT01879293|cardiac magnetic resonance|cardiac magnetic resonance
252244|NCT01879293|aortic pulse wave|aortic pulse wave
252245|NCT01879280|pterional craniotomy|pterional craniotomy
252246|NCT01879280|osteoplastic craniotomy|osteoplastic craniotomy
252247|NCT01879280|temporalis|temporalis
252248|NCT01879280|minimally-invasive|minimally-invasive
252249|NCT01879254|obsessive compulsive disorder (OCD)|obsessive compulsive disorder (ocd)
252250|NCT01879254|deep brain stimulation (DBS)|deep brain stimulation (dbs)
252251|NCT01879254|psychosurgery|psychosurgery
252252|NCT01879254|long-term follow-up|long-term follow-up
252253|NCT01879241|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
252254|NCT01879241|survival time|survival time
252255|NCT01879241|ALS functioning Rating Scale|als functioning rating scale
252256|NCT01879241|quality of life|quality of life
252257|NCT01879241|survival|survival
252258|NCT01879228|Cystic Fibrosis|cystic fibrosis
252259|NCT01879228|Diabetes|diabetes
252260|NCT01879228|Pancreatic Insufficiency|pancreatic insufficiency
252261|NCT01879202|multiple sclerosis|multiple sclerosis
252263|NCT01879202|fatigue severity scale|fatigue severity scale
252264|NCT01879202|fatigue impact scale|fatigue impact scale
252265|NCT01879202|quality of life|quality of life
252266|NCT01879163|Vaccine|vaccine
252267|NCT01879163|Immunogenicity|immunogenicity
252268|NCT01879137|Copeptin|copeptin
252269|NCT01879137|Arginin stimulation test|arginin stimulation test
252270|NCT01879111|Depressive episode|depressive episode
252271|NCT01879111|Chronic ischaemic heart disease|chronic ischaemic heart disease
252272|NCT01879111|Hypertension|hypertension
252273|NCT01879098|probiotics|probiotics
252274|NCT01879098|inflammation|inflammation
252275|NCT01879098|bile|bile
252276|NCT01879098|hunger|hunger
252277|NCT01879098|satiety|satiety
252279|NCT01879085|metastatic|metastatic
252280|NCT01879085|unresectable|unresectable
252281|NCT01879085|soft|soft
252282|NCT01879085|tissue|tissue
252283|NCT01879085|sarcomas|sarcomas
252284|NCT01879072|Biomarkers|biomarkers
252285|NCT01879072|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
252286|NCT01879059|insulin resistance|insulin resistance
252287|NCT01879059|exercise|exercise
252288|NCT01879059|continuous glucose monitoring|continuous glucose monitoring
252289|NCT01879059|blood flow|blood flow
252290|NCT01879059|endothelial function|endothelial function
252291|NCT01879046|Mesenchymal stem cells|mesenchymal stem cells
692909|NCT00933660|Education|education
252292|NCT01879046|articular cartilage|articular cartilage
252293|NCT01879046|tissue engineering|tissue engineering
252294|NCT01879046|immunomodulation|immunomodulation
252295|NCT01879046|osteo-arthritis|osteo-arthritis
252296|NCT01879033|Obesity|obesity
252297|NCT01879033|endothelial function|endothelial function
252298|NCT01879033|Rh-PAT|rh-pat
252299|NCT01879033|adipocytokines|adipocytokines
252300|NCT01879020|MT-8995|mt-8995
252301|NCT01879020|Dyslipidemia|dyslipidemia
252302|NCT01879020|Cholesteryl ester transfer proteins|cholesteryl ester transfer proteins
252303|NCT01878994|Overweight|overweight
252304|NCT01878994|Obesity|obesity
252305|NCT01878994|Children|children
252306|NCT01878994|Behaviour|behaviour
252307|NCT01878994|Physical Activity|physical activity
252308|NCT01878994|Nutrition|nutrition
252309|NCT01878981|Catheter Ablation versus Drug Therapy in AF in China|catheter ablation versus drug therapy in af in china
252310|NCT01878955|Antimullarian hormone(AMH)|antimullarian hormone(amh)
252311|NCT01878955|Polycystic Ovary|polycystic ovary
243135|NCT01920685|CBT|cbt
252312|NCT01878955|Multicystic Ovary|multicystic ovary
252313|NCT01878942|LSD|lsd
252314|NCT01878942|Pharmacology|pharmacology
252315|NCT01878942|Pharmacokinetics|pharmacokinetics
252316|NCT01878942|Pharmacodynamics|pharmacodynamics
252317|NCT01878942|Mechanism of action|mechanism of action
252318|NCT01878942|Psychedelic|psychedelic
252319|NCT01878942|Serotonin|serotonin
252320|NCT01878942|Prepulse inhibition|prepulse inhibition
252321|NCT01878942|LSD-induced neuroendocrine effects|lsd-induced neuroendocrine effects
252322|NCT01878942|Long-term psychological effects|long-term psychological effects
252323|NCT01878929|pollen|pollen
252324|NCT01878929|allergen immunotherapy|allergen immunotherapy
252325|NCT01878929|subcutaneous allergen immunotherapy|subcutaneous allergen immunotherapy
252326|NCT01878929|SCIT|scit
252327|NCT01878916|the incidence of thrombosis,|the incidence of thrombosis,
252328|NCT01878916|the effect of Hcy on thrombosis formation,|the effect of hcy on thrombosis formation,
252329|NCT01878916|the relation between Hcy and plasma vitamin levels,|the relation between hcy and plasma vitamin levels,
252330|NCT01878916|to compare these results with the control group|to compare these results with the control group
252331|NCT01878890|Solid tumors (other than pancreas)|solid tumors (other than pancreas)
252332|NCT01878877|Chronic pain|chronic pain
252333|NCT01878877|neuropathic pain|neuropathic pain
252334|NCT01878864|Pain, Discomfort, Periodontitis, Scaling and Root Planning, Visual Analogue Scale, McGills Pain Questionnaire|pain, discomfort, periodontitis, scaling and root planning, visual analogue scale, mcgills pain questionnaire
252335|NCT01878825|Immunogenicity|immunogenicity
252336|NCT01878825|Trivalent|trivalent
252337|NCT01878825|Safety|safety
252338|NCT01878825|Adults|adults
252339|NCT01878825|Elderly|elderly
252340|NCT01878825|Influenza|influenza
252341|NCT01878812|Immunogenicity|immunogenicity
252342|NCT01878812|Influenza|influenza
252343|NCT01878812|Adults|adults
252344|NCT01878812|Safety|safety
252345|NCT01878812|Elderly|elderly
252348|NCT01878799|Interferon Sparing|interferon sparing
252349|NCT01878799|Ribavirin Sparing|ribavirin sparing
252350|NCT01878786|kidney failure|kidney failure
252351|NCT01878773|Prostate Cancer|prostate cancer
252352|NCT01878773|MRI scan|mri scan
252353|NCT01878773|External beam radiotherapy|external beam radiotherapy
252354|NCT01878760|APRICOT|apricot
252355|NCT01878760|Anaesthesia|anaesthesia
252356|NCT01878760|Children|children
252357|NCT01878760|kids|kids
252358|NCT01878760|Paediatric Anaesthesia|paediatric anaesthesia
252359|NCT01878760|Observational Trial|observational trial
252360|NCT01878760|epidemiology|epidemiology
252361|NCT01878760|severe critical events in|severe critical events in
252362|NCT01878760|European Society of Anaesthesiology|european society of anaesthesiology
252363|NCT01878760|Europe|europe
252364|NCT01878747|Pediatric|pediatric
252365|NCT01878747|Pain|pain
252366|NCT01878747|Postoperative|postoperative
252367|NCT01878747|General Anesthesia|general anesthesia
252368|NCT01878747|Anesthesia Recovery Period|anesthesia recovery period
252369|NCT01878747|Infant Behavior|infant behavior
252370|NCT01878747|Adolescent Behavior|adolescent behavior
252371|NCT01878747|Patient Satisfaction|patient satisfaction
252375|NCT01878708|T-Cell Lymphoma|t-cell lymphoma
252376|NCT01878708|Relapsed T-Cell Lymphoma|relapsed t-cell lymphoma
252377|NCT01878708|Refractory T-Cell Lymphoma|refractory t-cell lymphoma
252378|NCT01878708|Oncaspar®|oncaspar®
252379|NCT01878708|PEG-L-asparaginase and dexamethasone|peg-l-asparaginase and dexamethasone
252381|NCT01878695|Breast Cancer|breast cancer
252382|NCT01878695|Stage 0|stage 0
252383|NCT01878695|Stage 1|stage 1
252384|NCT01878669|n-acetyl cysteine|n-acetyl cysteine
252385|NCT01878669|percutaneous coronary intervention|percutaneous coronary intervention
252386|NCT01878643|aerosolized antibiotic|aerosolized antibiotic
252387|NCT01878643|ventilator-associated pneumonia|ventilator-associated pneumonia
252388|NCT01878643|bacterial resistance|bacterial resistance
252389|NCT01878643|ventilator -associated tracheobronchitis|ventilator -associated tracheobronchitis
692910|NCT00933660|Retention|retention
252390|NCT01878643|clinical pulmonary infection score|clinical pulmonary infection score
252391|NCT01878630|Chronic Heart Failure|chronic heart failure
252393|NCT01878617|SJMB12|sjmb12
252394|NCT01878617|Brain Cancer|brain cancer
252395|NCT01878617|Brain Tumors in Children|brain tumors in children
252396|NCT01878617|Cisplatin|cisplatin
252397|NCT01878617|Cyclophosphamide|cyclophosphamide
252398|NCT01878617|Embryonal Tumors of CNS|embryonal tumors of cns
252399|NCT01878617|GDC-0449|gdc-0449
252400|NCT01878617|Gemcitabine|gemcitabine
252401|NCT01878617|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
252402|NCT01878617|Infratentorial|infratentorial
252403|NCT01878617|Mass in Brain|mass in brain
252404|NCT01878617|Medulloblastoma|medulloblastoma
252405|NCT01878617|Medulloblastoma Brain Tumor|medulloblastoma brain tumor
252406|NCT01878617|Medulloblastoma Tumor|medulloblastoma tumor
252407|NCT01878617|Molecular|molecular
252408|NCT01878617|Neuroectodermal Tumor, Primitive|neuroectodermal tumor, primitive
252409|NCT01878617|Newly Diagnosed Childhood Medulloblastoma|newly diagnosed childhood medulloblastoma
252410|NCT01878617|Non-SHH Non-WNT|non-shh non-wnt
252411|NCT01878617|Pediatric Brain Tumor|pediatric brain tumor
252412|NCT01878617|Pemetrexed|pemetrexed
252413|NCT01878617|Posterior Fossa Tumor|posterior fossa tumor
252414|NCT01878617|Proton Beam Therapy|proton beam therapy
252415|NCT01878617|Radiation Therapy|radiation therapy
252416|NCT01878617|Rare Brain Tumor|rare brain tumor
252417|NCT01878617|Risk|risk
252418|NCT01878617|SHH|shh
252419|NCT01878617|Sonic Hedgehog Pathway|sonic hedgehog pathway
252420|NCT01878617|St Jude Medullo|st jude medullo
252421|NCT01878617|St. Jude Brain Tumor Studies|st. jude brain tumor studies
252422|NCT01878617|St. Jude Medullo|st. jude medullo
252423|NCT01878617|St. Jude Studies|st. jude studies
252424|NCT01878617|St. Jude Treatment|st. jude treatment
252425|NCT01878617|Treatment for Brain Tumors in Children|treatment for brain tumors in children
252426|NCT01878617|Untreated Childhood Medulloblastoma|untreated childhood medulloblastoma
252427|NCT01878617|Vincristine|vincristine
252428|NCT01878617|Vismodegib|vismodegib
252429|NCT01878617|WNT|wnt
252430|NCT01878591|labour|labour
252431|NCT01878591|dystocia|dystocia
252432|NCT01878591|operative delivery|operative delivery
252433|NCT01878591|vacuum|vacuum
252434|NCT01878591|ultrasound|ultrasound
252435|NCT01878578|Anticonvulsant, BIA 2-093|anticonvulsant, bia 2-093
252436|NCT01878565|HBIg|hbig
252437|NCT01878565|GM-CSF|gm-csf
252438|NCT01878565|HBV vaccine|hbv vaccine
252439|NCT01878565|immune regulatory therapy|immune regulatory therapy
252440|NCT01878526|gastroesophageal reflux disease|gastroesophageal reflux disease
252441|NCT01878526|heart burn|heart burn
252442|NCT01878526|regurgitation|regurgitation
252443|NCT01878526|systemic sclerosis|systemic sclerosis
252444|NCT01878526|scleroderma|scleroderma
252445|NCT01878526|proton pump inhibitor|proton pump inhibitor
252446|NCT01878526|alginic acid|alginic acid
252447|NCT01878526|omeprazole|omeprazole
252448|NCT01878526|prokinetic|prokinetic
252449|NCT01878500|Bladder exstrophy epispadias complex|bladder exstrophy epispadias complex
252450|NCT01878500|Pelvic floor musculature|pelvic floor musculature
252451|NCT01878500|Intraoperative stereotactic imaging|intraoperative stereotactic imaging
252452|NCT01878487|Acute MI|acute mi
252453|NCT01878487|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
252454|NCT01878487|thrombus aspiration, IVUS|thrombus aspiration, ivus
252455|NCT01878474|MT-8995|mt-8995
252456|NCT01878474|Dyslipidemia|dyslipidemia
252457|NCT01878474|Cholesteryl ester transfer proteins|cholesteryl ester transfer proteins
252458|NCT01878435|Short Message System|short message system
252459|NCT01878435|SMS reminder|sms reminder
252460|NCT01878435|mobile phone|mobile phone
252461|NCT01878435|cell phone|cell phone
252462|NCT01878435|vaccination|vaccination
252463|NCT01878435|immunization|immunization
252464|NCT01878435|mHealth|mhealth
252465|NCT01878409|Sexuality|sexuality
252466|NCT01878409|Parkinson Disease|parkinson disease
252467|NCT01878409|BISF|bisf
252468|NCT01878409|IIEF|iief
252469|NCT01878409|FSFI|fsfi
252470|NCT01878396|Circulating Melanoma cells in metastatic melanoma|circulating melanoma cells in metastatic melanoma
252471|NCT01878383|(HSV)|(hsv)
252472|NCT01878357|MST|mst
252473|NCT01878357|Malaria|malaria
252474|NCT01878357|Indonesia|indonesia
252475|NCT01878357|Transmission|transmission
252478|NCT01878305|electroencephalogram|electroencephalogram
252479|NCT01878305|transcranial Doppler ultrasonography|transcranial doppler ultrasonography
252480|NCT01878305|physiological monitoring|physiological monitoring
252482|NCT01878266|Diffuse Intrinsic Pontine Glioma (DIPG)|diffuse intrinsic pontine glioma (dipg)
252483|NCT01878266|Hypofractionated Radiotherapy|hypofractionated radiotherapy
252484|NCT01878266|Radiotherapy|radiotherapy
252485|NCT01878266|Median survival|median survival
252486|NCT01876628|Clindamycin|clindamycin
252487|NCT01876628|Cellulitis|cellulitis
252488|NCT01876628|Flucloxacillin|flucloxacillin
252489|NCT01876628|Group A streptococcus|group a streptococcus
252490|NCT01876628|Staphylococcus aureus|staphylococcus aureus
252491|NCT01876615|safety/tolerability and pharmacokinetics/pharmacodynamics|safety/tolerability and pharmacokinetics/pharmacodynamics
252492|NCT01876602|adolescents|adolescents
252493|NCT01876602|exercise|exercise
252495|NCT01876602|school-based|school-based
252496|NCT01876589|Coronary Artery Disease (CAD)|coronary artery disease (cad)
252497|NCT01876589|Invasive coronary angiography (ICA)|invasive coronary angiography (ica)
252498|NCT01876589|Positron Emission Tomography (PET)|positron emission tomography (pet)
252499|NCT01876576|colonoscopy|colonoscopy
252500|NCT01876563|thioredoxin|thioredoxin
252501|NCT01876563|TBP-2|tbp-2
252502|NCT01876563|thioredoxin reductase|thioredoxin reductase
252503|NCT01876563|vitamin D|vitamin d
252504|NCT01876563|DIABETES|diabetes
252505|NCT01876550|Mupirocin Calcium Cream 2%|mupirocin calcium cream 2%
252506|NCT01876550|Bactroban® Cream|bactroban® cream
252507|NCT01876550|Secondarily infected traumatic skin lesions|secondarily infected traumatic skin lesions
311527|NCT01611584|ALA|ala
252508|NCT01876524|Substance Use Disorder|substance use disorder
252509|NCT01876524|Attention Deficit Disorder With Hyperactivity|attention deficit disorder with hyperactivity
252510|NCT01876524|Schizophrenia|schizophrenia
252511|NCT01876524|Bipolar disorder|bipolar disorder
252512|NCT01876524|Personality disorder|personality disorder
252513|NCT01876511|MSI|msi
252514|NCT01876511|MSS|mss
252515|NCT01876511|MLH 1|mlh 1
252516|NCT01876511|MSH 2|msh 2
252517|NCT01876511|MSH 6|msh 6
252518|NCT01876511|PMS2|pms2
252519|NCT01876511|BRAF pV600E|braf pv600e
252520|NCT01876511|TGFBR2|tgfbr2
252521|NCT01876485|Diabetes Mellitus|diabetes mellitus
252522|NCT01876485|health literacy|health literacy
252523|NCT01876485|patient activation|patient activation
252524|NCT01876485|goals of care|goals of care
252525|NCT01878240|Vascular surgery|vascular surgery
252526|NCT01878240|Abdominal Aortic aneurysm|abdominal aortic aneurysm
252527|NCT01878240|endovascular|endovascular
252528|NCT01878214|Health communication|health communication
252529|NCT01878214|Smoking cessation|smoking cessation
252530|NCT01878214|Health behavior|health behavior
252531|NCT01878214|Construction industry|construction industry
252532|NCT01878214|Audience segmentation|audience segmentation
252533|NCT01878201|Fimasartan|fimasartan
252534|NCT01878201|24 hours ABP monitoring(ABPM)|24 hours abp monitoring(abpm)
252535|NCT01878201|antihypertension|antihypertension
252536|NCT01878175|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
252537|NCT01878175|Veterans|veterans
252538|NCT01878175|Exercise|exercise
252539|NCT01878162|Prevention|prevention
252540|NCT01878162|Wellness|wellness
252541|NCT01878162|Occupation|occupation
252542|NCT01878162|Work|work
252945|NCT01876121|NSAIDs|nsaids
252543|NCT01878162|Law Enforcement|law enforcement
252544|NCT01878162|Exercise|exercise
252545|NCT01878123|Arthritis|arthritis
252546|NCT01878123|Rheumatoid Arthritis|rheumatoid arthritis
252547|NCT01878123|Joint Diseases|joint diseases
252548|NCT01878123|Musculoskeletal Diseases|musculoskeletal diseases
252549|NCT01878123|Rheumatic Diseases|rheumatic diseases
252550|NCT01878123|Connective Tissue Diseases|connective tissue diseases
252551|NCT01878123|Autoimmune Diseases|autoimmune diseases
252552|NCT01878123|Immune System Diseases|immune system diseases
252553|NCT01878123|Antirheumatic agents|antirheumatic agents
252554|NCT01878110|Trichotillomania|trichotillomania
252555|NCT01878110|Hair pulling|hair pulling
252556|NCT01878110|Behavior therapy|behavior therapy
252557|NCT01878084|Tissue regeneration|tissue regeneration
252558|NCT01878084|sol gel bioglass|sol gel bioglass
252559|NCT01878084|alveolar ridge preservation|alveolar ridge preservation
252560|NCT01878084|children|children
252561|NCT01878084|Egyptian|egyptian
252562|NCT01878084|class II orthodontic cases|class ii orthodontic cases
252563|NCT01878058|Prostate cancer|prostate cancer
252564|NCT01878058|Brachytherapy|brachytherapy
252565|NCT01878058|Seed implant|seed implant
252566|NCT01878045|American Indians|american indians
252567|NCT01878045|Diabetic Nephropathy|diabetic nephropathy
252568|NCT01878045|Kidney Biopsy|kidney biopsy
252569|NCT01878045|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
252570|NCT01878045|Retinopathy|retinopathy
252571|NCT01878032|Retinal Disease|retinal disease
252572|NCT01878032|Inherited Retinal Degeneration|inherited retinal degeneration
252574|NCT01878019|Placebo|placebo
252575|NCT01878019|Opiate Antagonist|opiate antagonist
252576|NCT01878006|Opiate Receptor|opiate receptor
252577|NCT01878006|Genotype|genotype
252578|NCT01878006|PET Imaging|pet imaging
252579|NCT01877993|coronary artery spasm|coronary artery spasm
252580|NCT01877993|pathophysiology|pathophysiology
252581|NCT01877993|atrioventricular block|atrioventricular block
252582|NCT01877993|blood pressure|blood pressure
252583|NCT01877993|autonomic nervous function|autonomic nervous function
252584|NCT01877954|hydrofluoroalkane beclomethasone|hydrofluoroalkane beclomethasone
252585|NCT01877954|fluticasone|fluticasone
252586|NCT01877954|paediatrics|paediatrics
252587|NCT01877954|real-life|real-life
252588|NCT01877954|observational|observational
252589|NCT01877954|primary care|primary care
252590|NCT01877941|cardiac output|cardiac output
252591|NCT01877941|pulse oximetry|pulse oximetry
252592|NCT01877941|hemodynamics|hemodynamics
252593|NCT01877928|Obstructive sleep apnea, CPAP, Boussignac|obstructive sleep apnea, cpap, boussignac
252594|NCT01877915|Heart Failure|heart failure
252595|NCT01877915|Coronary Artery Disease|coronary artery disease
252596|NCT01877915|Stroke|stroke
252597|NCT01877915|Myocardial Infarction|myocardial infarction
252598|NCT01877915|Anticoagulation|anticoagulation
252599|NCT01877889|Healthy|healthy
252600|NCT01877889|Canagliflozin|canagliflozin
252601|NCT01877889|INVOKANA|invokana
252602|NCT01877889|Dapagliflozin|dapagliflozin
252603|NCT01877889|FORXIGA|forxiga
252604|NCT01877889|Pharmacodynamics|pharmacodynamics
252605|NCT01877863|intradialytic exercise|intradialytic exercise
252606|NCT01877863|hemodialysis|hemodialysis
311608|NCT01611233|ASR|asr
252607|NCT01877837|Stem cell transplant|stem cell transplant
252608|NCT01877837|Sickle cell|sickle cell
252609|NCT01877837|Stem cell transplantation|stem cell transplantation
252610|NCT01877837|Related|related
252611|NCT01877837|Unrelated|unrelated
252612|NCT01877824|Surgery|surgery
252613|NCT01877824|Training|training
252614|NCT01877811|Lung Cancer|lung cancer
252615|NCT01877811|RET Inhibitor|ret inhibitor
252616|NCT01877811|Solid Tumors|solid tumors
252617|NCT01877811|RET mutations or rearrangements|ret mutations or rearrangements
252618|NCT01877811|BRAF mutations or rearrangements|braf mutations or rearrangements
252619|NCT01877811|Squamous NSCLC|squamous nsclc
252620|NCT01877811|KRAS mutation|kras mutation
252621|NCT01877811|Other Lung adenocarcinomas|other lung adenocarcinomas
252622|NCT01877772|cuff repair|cuff repair
252623|NCT01877772|arthroscopic|arthroscopic
252624|NCT01877772|Trephination|trephination
252625|NCT01877772|Bone|bone
252626|NCT01877772|cuff tear|cuff tear
252627|NCT01877759|Stem cell ,liver cirrhosis|stem cell ,liver cirrhosis
252629|NCT01877746|myocarditis|myocarditis
252630|NCT01877746|cardiomyopathy|cardiomyopathy
252631|NCT01877746|endomyocardial biopsy|endomyocardial biopsy
252632|NCT01877746|immunosuppression|immunosuppression
252633|NCT01877733|Resistance training|resistance training
252634|NCT01877720|Preterm infant less than 32 weeks of gestation age|preterm infant less than 32 weeks of gestation age
252635|NCT01877720|intubated more than 48 hours after birth|intubated more than 48 hours after birth
252636|NCT01877720|postextubation|postextubation
252637|NCT01877694|pink eye|pink eye
252638|NCT01877668|psoriatic arthritis|psoriatic arthritis
252639|NCT01877668|radiographic changes|radiographic changes
252640|NCT01877668|active comparator|active comparator
252641|NCT01877668|tofacitinib|tofacitinib
252642|NCT01877655|ASP0113|asp0113
252643|NCT01877655|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
252644|NCT01877655|Hematopoietic Cell Transplant (HCT)|hematopoietic cell transplant (hct)
252645|NCT01877642|ADASUVE|adasuve
252646|NCT01877642|inhaled loxapine|inhaled loxapine
252647|NCT01877642|drug drug interaction|drug drug interaction
252648|NCT01877642|lorazepam|lorazepam
252649|NCT01877642|acute treatment of agitation|acute treatment of agitation
252650|NCT01877629|ACT-129968|act-129968
252651|NCT01877629|Pharmacokinetics|pharmacokinetics
252652|NCT01877629|Safety|safety
252653|NCT01877629|Tolerability|tolerability
252654|NCT01877616|sleep disorders|sleep disorders
252655|NCT01877616|insomnia|insomnia
252656|NCT01877616|hypersomnia|hypersomnia
252657|NCT01877616|sleep-disordered breathing|sleep-disordered breathing
252658|NCT01877616|cardiovascular health|cardiovascular health
252659|NCT01877616|stroke|stroke
252660|NCT01877616|ischemic heart disease|ischemic heart disease
252661|NCT01877616|Atahualpa|atahualpa
252662|NCT01877551|HIV|hiv
252663|NCT01877551|Protease inhibitor|protease inhibitor
252664|NCT01877551|insulin resistance|insulin resistance
252665|NCT01877551|Tauroursodeoxycholic acid|tauroursodeoxycholic acid
252666|NCT01877525|colorectal polyps|colorectal polyps
252667|NCT01877525|resect and discard|resect and discard
252668|NCT01877525|endoscopic prediction|endoscopic prediction
252669|NCT01877525|histological diagnosis|histological diagnosis
252670|NCT01877525|narrow band imaging|narrow band imaging
252671|NCT01877499|Hemodiafiltration|hemodiafiltration
252672|NCT01877499|Convection volume|convection volume
252673|NCT01877499|Filtration fraction|filtration fraction
252674|NCT01877499|Blood flow|blood flow
252675|NCT01877499|Treatment time|treatment time
252676|NCT01877486|atrial fibrillation|atrial fibrillation
252677|NCT01877486|cryoballoon ablation|cryoballoon ablation
252678|NCT01877486|persistent AF|persistent af
252679|NCT01877486|paroxysmal AF|paroxysmal af
252680|NCT01877486|dofetilide|dofetilide
252681|NCT01877473|atrial fibrillation|atrial fibrillation
252682|NCT01877473|persistent AF|persistent af
252683|NCT01877473|catheter ablation|catheter ablation
252684|NCT01877473|duration of 7 days to one year|duration of 7 days to one year
252685|NCT01877473|with symptoms and failure of at least one antiarrhythmic drug|with symptoms and failure of at least one antiarrhythmic drug
252686|NCT01877460|sodium alginate|sodium alginate
252687|NCT01877460|chocolate milk|chocolate milk
252688|NCT01877460|satiety|satiety
252689|NCT01877460|energy intake|energy intake
252690|NCT01877460|glycemia|glycemia
252691|NCT01877460|insulinemia|insulinemia
252692|NCT01877447|tDCS|tdcs
252693|NCT01877447|Brain stimulation|brain stimulation
252694|NCT01877447|depressive disorder|depressive disorder
252695|NCT01877434|Reversed shoulder arthroplasty|reversed shoulder arthroplasty
252696|NCT01877434|Treatment|treatment
252697|NCT01877434|TESS|tess
252698|NCT01877421|Reducing plaque|reducing plaque
252699|NCT01877421|Reducing gingivitis|reducing gingivitis
252700|NCT01877421|safety|safety
252701|NCT01877421|proof of concept|proof of concept
252702|NCT01877421|antiplaque chewing gum|antiplaque chewing gum
252703|NCT01877408|disposable circumcision device|disposable circumcision device
252704|NCT01877408|Tissue adhesive|tissue adhesive
252705|NCT01877408|Open surgical circumcision|open surgical circumcision
252706|NCT01877408|Minimally-invasive circumcision|minimally-invasive circumcision
252707|NCT01877395|Rabies|rabies
252708|NCT01877395|Purified Vero Rabies Vaccine - Serum Free|purified vero rabies vaccine - serum free
252709|NCT01877395|Human Diploid Cell Vaccine|human diploid cell vaccine
252710|NCT01877395|Imovax® Rabies|imovax® rabies
252711|NCT01876394|Healthy|healthy
252712|NCT01876394|Arterial Stiffness|arterial stiffness
252713|NCT01876394|Blood Pressure|blood pressure
252714|NCT01876394|Blood Glucose|blood glucose
252715|NCT01876394|Vascular Function|vascular function
252716|NCT01876368|hypertension,|hypertension,
252717|NCT01876368|LCZ696,|lcz696,
252718|NCT01876368|olmesartan|olmesartan
252719|NCT01876355|Delirium, clonidine, ICU, sedation|delirium, clonidine, icu, sedation
252720|NCT01876342|sports hernia|sports hernia
252721|NCT01876342|sportsman's hernia|sportsman's hernia
252722|NCT01876342|chronic groin pain|chronic groin pain
252723|NCT01876342|open minimal repair|open minimal repair
252724|NCT01876342|totally extraperitoneal endoscopic technique|totally extraperitoneal endoscopic technique
252725|NCT01876329|Rheumatoid Arthritis|rheumatoid arthritis
252726|NCT01876329|Vitamin B12 deficiency|vitamin b12 deficiency
252727|NCT01876329|Autoimmune Thyroid Disease|autoimmune thyroid disease
252728|NCT01876329|Autoantibodies|autoantibodies
252729|NCT01876316|Moxifloxacin|moxifloxacin
252730|NCT01876316|QT interval prolongation|qt interval prolongation
252731|NCT01876316|Korean|korean
252732|NCT01876316|Japanese|japanese
252733|NCT01876290|Anesthesiology|anesthesiology
252734|NCT01876290|Complications|complications
252735|NCT01876290|Closed-loop|closed-loop
252736|NCT01876277|Cancer|cancer
252737|NCT01876277|Body image|body image
252738|NCT01876277|Adolescent|adolescent
252739|NCT01877356|ambulatory surgery|ambulatory surgery
252740|NCT01877356|spinal anesthesia|spinal anesthesia
252741|NCT01877356|micturition|micturition
252742|NCT01877356|bladder retention|bladder retention
252743|NCT01877356|unilateral block|unilateral block
252744|NCT01877356|prilocaine hyperbaric|prilocaine hyperbaric
252745|NCT01877356|prilocaine plain|prilocaine plain
252746|NCT01877356|local anaesthetic dose|local anaesthetic dose
252747|NCT01877343|cardiac functional health classification|cardiac functional health classification
252748|NCT01877343|Congenital heart failure|congenital heart failure
252749|NCT01877343|chronic heart failure|chronic heart failure
252750|NCT01877330|shoulder arthroscopy|shoulder arthroscopy
252751|NCT01877330|ultrasound guided nerve block|ultrasound guided nerve block
252752|NCT01877330|interscalene nerve block|interscalene nerve block
252753|NCT01877317|Audiology|audiology
252754|NCT01877317|hearing loss|hearing loss
252755|NCT01877317|hearing healthcare|hearing healthcare
252756|NCT01877317|mobile app|mobile app
252757|NCT01877317|hearing aid fitting|hearing aid fitting
252758|NCT01877317|audiometry|audiometry
252759|NCT01877317|audiogram|audiogram
252760|NCT01877291|smoking, nasal lavage, exhaled breath condensate, mucociliary transport|smoking, nasal lavage, exhaled breath condensate, mucociliary transport
252761|NCT01877278|Osteoarthritis|osteoarthritis
252762|NCT01877278|Pulsed electromagnetic fields|pulsed electromagnetic fields
252763|NCT01877278|Device|device
252764|NCT01877278|Pain|pain
252765|NCT01877278|Pressure algometry|pressure algometry
252766|NCT01877252|critical limb ischemia|critical limb ischemia
252767|NCT01877252|endovascular treatment|endovascular treatment
252768|NCT01877252|open surgical repair|open surgical repair
252769|NCT01877252|diabetic foot|diabetic foot
252770|NCT01877226|Healthy|healthy
252771|NCT01877226|Tapentadol|tapentadol
252772|NCT01877213|coaching|coaching
252773|NCT01877213|therapeutic education|therapeutic education
252774|NCT01877213|hospital admission|hospital admission
252775|NCT01877213|quality improvement strategies|quality improvement strategies
252776|NCT01877213|management program|management program
692911|NCT00933660|Retrieval|retrieval
252777|NCT01877213|nurse follow up|nurse follow up
252778|NCT01877213|discharge planning|discharge planning
252779|NCT01877213|rehospitalization|rehospitalization
252780|NCT01877187|Primary liver cancer|primary liver cancer
252781|NCT01877187|Metastatic liver cancer|metastatic liver cancer
252782|NCT01877174|Internal Carotid Stenosis|internal carotid stenosis
252783|NCT01877174|Reverse Flow|reverse flow
252784|NCT01877174|Carotid stenting|carotid stenting
252785|NCT01877174|MICHI(TM) NPS+f|michi(tm) nps+f
252786|NCT01877148|Parkinson, rehabilitation, tDCS|parkinson, rehabilitation, tdcs
252787|NCT01877135|anal carcinoma|anal carcinoma
252788|NCT01877135|AIN3|ain3
252789|NCT01877135|cohort study|cohort study
252790|NCT01877109|Lymphoma|lymphoma
252791|NCT01877109|Prognosis|prognosis
252792|NCT01877109|Biomarker|biomarker
252793|NCT01877109|Quality of life|quality of life
252794|NCT01877096|Motivational Interviewing|motivational interviewing
252795|NCT01877096|Screening Colonoscopy|screening colonoscopy
252796|NCT01877096|Cancer Prevention|cancer prevention
252797|NCT01877083|KIF5B-RET-Positive Adenocarcinoma|kif5b-ret-positive adenocarcinoma
252798|NCT01877083|Lung Cancer|lung cancer
252799|NCT01877083|NSCLC|nsclc
252800|NCT01877083|Non-Small Cell Lung Cancer|non-small cell lung cancer
252801|NCT01877070|assessments|assessments
252802|NCT01877070|13-076|13-076
252803|NCT01877057|Pea protein|pea protein
252804|NCT01877057|Satiety hormone|satiety hormone
252805|NCT01877057|Ussing Chamber|ussing chamber
252806|NCT01877044|Prebiotics|prebiotics
252807|NCT01877044|Intestinal permeability|intestinal permeability
252808|NCT01877044|Gut barrier function|gut barrier function
252809|NCT01877044|Immunity|immunity
252810|NCT01877031|central line|central line
252811|NCT01877031|ultrasound guided central line insertion|ultrasound guided central line insertion
252812|NCT01877031|virtual reality|virtual reality
252813|NCT01877031|augmented reality|augmented reality
252814|NCT01877018|Comparative Effectiveness Research|comparative effectiveness research
252815|NCT01877018|Reminder Systems|reminder systems
252816|NCT01877018|Patient Participation|patient participation
252817|NCT01877018|Primary Health Care|primary health care
252924|NCT01876199|acute|acute
252818|NCT01877018|Early Detection of Cancer|early detection of cancer
252819|NCT01877018|Colorectal Neoplasms|colorectal neoplasms
252820|NCT01877005|Multicenter, single arm and opened label phase II study|multicenter, single arm and opened label phase ii study
252821|NCT01876992|diabetes|diabetes
252822|NCT01876992|pediatrics|pediatrics
252823|NCT01876992|obesity|obesity
252824|NCT01876992|healthy volunteers|healthy volunteers
252825|NCT01876992|metformin|metformin
252826|NCT01876992|nutrition|nutrition
252827|NCT01876992|healthy controls|healthy controls
252828|NCT01876992|bmi|bmi
252829|NCT01876966|HIV|hiv
252830|NCT01876966|pharmacokinetic interaction|pharmacokinetic interaction
252831|NCT01876966|healthy HIV-negative person|healthy hiv-negative person
252832|NCT01876940|supraglottic airway|supraglottic airway
252833|NCT01876940|children|children
252834|NCT01876940|tracheal intubation|tracheal intubation
252835|NCT01876940|fiberoptic bronchoscopy|fiberoptic bronchoscopy
252836|NCT01876927|Locally|locally
252837|NCT01876927|Advanced|advanced
252838|NCT01876927|Resectable|resectable
252839|NCT01876927|Gastric Cancer|gastric cancer
252840|NCT01876914|Diabetes|diabetes
252841|NCT01876914|Edema|edema
252842|NCT01876914|DME|dme
252843|NCT01876914|OCT|oct
252844|NCT01876901|Rectal cancer|rectal cancer
252845|NCT01876901|Coloanal anastomosis|coloanal anastomosis
252846|NCT01876901|Phase 2 clinical trial|phase 2 clinical trial
252847|NCT01876888|patient satisfaction|patient satisfaction
252848|NCT01876888|physical therapy|physical therapy
252849|NCT01876888|MedRisk instrument|medrisk instrument
252850|NCT01876875|psoriasis|psoriasis
252852|NCT01876862|HIV-1|hiv-1
252853|NCT01876862|chronic infection|chronic infection
252854|NCT01876862|cure|cure
252855|NCT01876862|remission|remission
252856|NCT01876849|diabetes|diabetes
252857|NCT01876849|exenatide|exenatide
252858|NCT01876849|Byetta|byetta
252859|NCT01876849|Amylin|amylin
252860|NCT01876849|Lilly|lilly
252861|NCT01876836|i-gel|i-gel
252862|NCT01876836|C-LMA|c-lma
252863|NCT01876836|gastroeosephageal reflux|gastroeosephageal reflux
252864|NCT01876836|sore troat|sore troat
252865|NCT01876823|Memory Decline|memory decline
252866|NCT01876823|Depression|depression
252867|NCT01876823|Elderly|elderly
252868|NCT01876823|Antidepressants|antidepressants
252869|NCT01876823|Treatment|treatment
252870|NCT01876823|memantine|memantine
252871|NCT01876810|Gemfibrozil|gemfibrozil
252872|NCT01876810|Nicotine Dependence|nicotine dependence
252873|NCT01876810|Smoking|smoking
252874|NCT01876810|Cigarettes|cigarettes
252875|NCT01876784|vandetanib, AZD 6474, Differentiated Thyroid Cancer|vandetanib, azd 6474, differentiated thyroid cancer
252876|NCT01876771|177lutetium-DOTA(O)Tyr3)octreotate|177lutetium-dota(o)tyr3)octreotate
252877|NCT01876758|ECT|ect
252878|NCT01876758|Memory Training|memory training
252879|NCT01876758|Cognitive Remediation|cognitive remediation
252880|NCT01876758|Electroconvulsive Therapy|electroconvulsive therapy
252881|NCT01876758|Treatment Resistant Depression|treatment resistant depression
252882|NCT01876758|Depression|depression
252883|NCT01876758|Geriatric Depression|geriatric depression
252884|NCT01876758|Memory Loss|memory loss
252885|NCT01876758|Cognitive Training|cognitive training
252886|NCT01876732|hemodialysis|hemodialysis
252887|NCT01876732|viatmin B12 deficiency|viatmin b12 deficiency
252888|NCT01876732|Epogen|epogen
252889|NCT01876719|ADHD|adhd
252890|NCT01876719|AR08|ar08
252891|NCT01876719|adrenergic receptor agonists|adrenergic receptor agonists
252892|NCT01876719|randomized, placebo-controlled clinical trial|randomized, placebo-controlled clinical trial
252893|NCT01876706|UroLift System|urolift system
252894|NCT01876680|chronic|chronic
252895|NCT01876680|neck|neck
252896|NCT01876680|shoulder|shoulder
252897|NCT01876680|exercise|exercise
252898|NCT01876654|Total Knee Replacement|total knee replacement
252899|NCT01876654|Patient specific instrumentation|patient specific instrumentation
252900|NCT01876641|Metastatic melanoma|metastatic melanoma
252901|NCT01876641|melanoma|melanoma
252902|NCT01876641|BRAF-mutated Metastatic Melanoma|braf-mutated metastatic melanoma
252903|NCT01876641|V600EBRAF-mutated metastatic melanoma|v600ebraf-mutated metastatic melanoma
252904|NCT01876641|Decitabine|decitabine
252905|NCT01876641|Vemurafenib|vemurafenib
252906|NCT01876264|Colorectal surgery|colorectal surgery
252907|NCT01876264|Colonoscopy|colonoscopy
252908|NCT01876264|Randomized controlled trial|randomized controlled trial
252909|NCT01876251|Breast cancer metastatic|breast cancer metastatic
252910|NCT01876251|docetaxel|docetaxel
252911|NCT01876251|PF-03084014|pf-03084014
252912|NCT01876238|Breast Cancer|breast cancer
252913|NCT01876238|Patient-Doctor Communication|patient-doctor communication
252914|NCT01876238|Supportive Care|supportive care
252915|NCT01876225|cervical biopsy|cervical biopsy
252916|NCT01876225|forced cough|forced cough
252917|NCT01876225|pain|pain
252918|NCT01876225|VAS scale|vas scale
252919|NCT01876212|melanoma|melanoma
252920|NCT01876212|metastatic|metastatic
252921|NCT01876212|vaccine|vaccine
252922|NCT01876212|BRAF|braf
252923|NCT01876199|HIV-1|hiv-1
252925|NCT01876199|diagnosis|diagnosis
252926|NCT01876199|pharmacies|pharmacies
252927|NCT01876199|healthcare facilities|healthcare facilities
252928|NCT01876186|antimuscarinic treatment|antimuscarinic treatment
252929|NCT01876186|urodynamic studies|urodynamic studies
252930|NCT01876186|nerve growth factor|nerve growth factor
252931|NCT01876173|Sudden cardiac death|sudden cardiac death
252932|NCT01876173|implantable cardioverter defibrillator|implantable cardioverter defibrillator
252933|NCT01876173|decision aid|decision aid
252934|NCT01876147|Low vision|low vision
252935|NCT01876147|Vision testing|vision testing
252936|NCT01876147|Retinitis Pigmentosa|retinitis pigmentosa
252937|NCT01876147|AMD|amd
252938|NCT01876147|Visual acuity|visual acuity
252939|NCT01876147|Poor vision|poor vision
252940|NCT01876147|Quantification|quantification
252941|NCT01876134|Cardiac surgery|cardiac surgery
252942|NCT01876134|Acute kidney injury|acute kidney injury
252943|NCT01876134|Cyr-61|cyr-61
252944|NCT01876134|Pulse wave analysis|pulse wave analysis
252946|NCT01876121|Acute pain|acute pain
252947|NCT01876108|Steatohepatitis|steatohepatitis
252948|NCT01876108|Helicobacter pylori|helicobacter pylori
252949|NCT01876108|Alanine aminotransferase|alanine aminotransferase
252950|NCT01876108|Aspartate aminotransferase|aspartate aminotransferase
252951|NCT01876108|Fatty Liver|fatty liver
252952|NCT01876108|Liver Diseases|liver diseases
252953|NCT01876108|Digestive System Diseases|digestive system diseases
252954|NCT01876082|Desmoids tumors|desmoids tumors
252955|NCT01876082|Pazopanib|pazopanib
252956|NCT01876082|Phase 2 clinical trial|phase 2 clinical trial
252957|NCT01876082|Cross over|cross over
252958|NCT01876056|Psychosis|psychosis
252959|NCT01876056|Culture|culture
252960|NCT01876056|CBT|cbt
252961|NCT01876030|Functional electrical stimulation (FES)|functional electrical stimulation (fes)
252962|NCT01876030|Sub acute stroke|sub acute stroke
252963|NCT01876030|Gait analysis|gait analysis
252964|NCT01876017|CRF|crf
252965|NCT01876017|STEM CELL|stem cell
252966|NCT01876017|CKD|ckd
252967|NCT01876004|ectopic pregnancy|ectopic pregnancy
252968|NCT01876004|methotrexate|methotrexate
252969|NCT01876004|human chorionic gonadotropin beta subunit|human chorionic gonadotropin beta subunit
252970|NCT01876004|expectant management|expectant management
252971|NCT01875978|Phytosterols|phytosterols
252972|NCT01875978|Endothelial progenitor cells|endothelial progenitor cells
5868|NCT03253861|Pancreatitis/complications|pancreatitis/complications
252973|NCT01875952|Latent tuberculosis infection|latent tuberculosis infection
252974|NCT01875952|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
252975|NCT01875952|Treatment|treatment
252976|NCT01875952|Isoniazid|isoniazid
252977|NCT01875939|healthy volunteers|healthy volunteers
252978|NCT01875913|Curiosity|curiosity
252979|NCT01875913|Intention|intention
252980|NCT01875913|Follow Through|follow through
252981|NCT01875900|neonatal resuscitation|neonatal resuscitation
252982|NCT01875900|video-assisted learning|video-assisted learning
252983|NCT01875900|self-directed training|self-directed training
252984|NCT01875900|simulation|simulation
252985|NCT01875900|simulation-based training|simulation-based training
252986|NCT01875900|simulation-based medical education|simulation-based medical education
252987|NCT01875900|objective structured clinical examination|objective structured clinical examination
252988|NCT01875874|liver failure|liver failure
252989|NCT01875874|acute liver failure|acute liver failure
252990|NCT01875874|fulminant hepatic failure|fulminant hepatic failure
252991|NCT01875874|primary graft non-function|primary graft non-function
252992|NCT01875874|surgically-induced liver failure|surgically-induced liver failure
252993|NCT01875874|ELAD|elad
252994|NCT01875874|ALF|alf
252995|NCT01875874|FHF|fhf
252996|NCT01875874|PNF|pnf
252997|NCT01875861|Antipsychotic Agents|antipsychotic agents
252998|NCT01875861|Metabolic Syndrome|metabolic syndrome
252999|NCT01875861|Quality Improvement|quality improvement
253000|NCT01875848|pain management|pain management
253001|NCT01875835|Acute myocardiac infarction|acute myocardiac infarction
253002|NCT01875835|Bare-metal stent|bare-metal stent
253003|NCT01875835|Everolimus-eluting stent|everolimus-eluting stent
253004|NCT01875835|Optical coherence tomography|optical coherence tomography
253005|NCT01875822|Curcumin|curcumin
253006|NCT01875822|Epigenetics|epigenetics
253007|NCT01875822|Schizophrenia|schizophrenia
253008|NCT01875822|Nitric Oxide synthetase|nitric oxide synthetase
253009|NCT01875822|cognition|cognition
253010|NCT01875822|negative symptoms|negative symptoms
253011|NCT01875809|RDN|rdn
253012|NCT01875809|renal denervation|renal denervation
253013|NCT01875809|catecholamine|catecholamine
253014|NCT01875809|spill-over|spill-over
253015|NCT01875809|blood pressure|blood pressure
253016|NCT01875809|electrophysiology|electrophysiology
253017|NCT01875809|ablation|ablation
253018|NCT01875796|cannabis|cannabis
253019|NCT01875796|marijuana|marijuana
253020|NCT01875796|anxiety|anxiety
253021|NCT01875796|transdiagnostic|transdiagnostic
253022|NCT01875796|dual diagnosis|dual diagnosis
253023|NCT01875796|cannabis abuse|cannabis abuse
253024|NCT01875796|cannabis dependence|cannabis dependence
253025|NCT01875796|cannabis use disorder|cannabis use disorder
253026|NCT01875783|diabetes|diabetes
253027|NCT01875783|diabetic macular edema|diabetic macular edema
253028|NCT01875783|diabetic retinopathy|diabetic retinopathy
253029|NCT01875783|optical coherence tomography|optical coherence tomography
253030|NCT01875770|Retinal Vein Occlusion|retinal vein occlusion
253031|NCT01875757|Vitamin D|vitamin d
253032|NCT01875757|Acute bronchitis|acute bronchitis
253033|NCT01875757|Upper respiratory tract infection|upper respiratory tract infection
253034|NCT01875757|Recurrent bronchitis|recurrent bronchitis
253035|NCT01875757|Acute bronchiolitis|acute bronchiolitis
253036|NCT01875757|Infants|infants
253037|NCT01875744|constipation|constipation
253038|NCT01875744|children|children
253039|NCT01875744|polyethylene glycol|polyethylene glycol
253040|NCT01875731|Pneumonia|pneumonia
253041|NCT01875731|Acute respiratory infection|acute respiratory infection
253042|NCT01875731|Decision-support techniques|decision-support techniques
253043|NCT01875692|Metagenomic|metagenomic
253044|NCT01875692|Ventilator-Associated Pneumonia (VAP)|ventilator-associated pneumonia (vap)
253045|NCT01875679|Surgical education|surgical education
253046|NCT01875679|Deliberate practice|deliberate practice
253047|NCT01875679|Debriefing|debriefing
253048|NCT01875679|Behaviour modelling|behaviour modelling
253049|NCT01875666|breast cancer|breast cancer
253050|NCT01875666|Kinome|kinome
253051|NCT01875666|HER two positive|her two positive
253052|NCT01875653|metastatic melanoma|metastatic melanoma
253053|NCT01875653|dendritic cells|dendritic cells
253054|NCT01875653|immunotherapy|immunotherapy
253055|NCT01875653|Granulocyte-Macrophage Colony Stimulating Factor|granulocyte-macrophage colony stimulating factor
253056|NCT01875653|overall survival|overall survival
253057|NCT01875653|autologous|autologous
253058|NCT01875653|peripheral blood mononuclear cells|peripheral blood mononuclear cells
253059|NCT01875653|treatment|treatment
253060|NCT01875653|phase 3|phase 3
253061|NCT01875653|tumor cells|tumor cells
253062|NCT01875640|disorder of sex development|disorder of sex development
253063|NCT01875640|intersex|intersex
253064|NCT01875640|46,XX congenital adrenal hyperplasia|46,xx congenital adrenal hyperplasia
253065|NCT01875640|hypospadias|hypospadias
253066|NCT01875640|decision support tool|decision support tool
253067|NCT01875601|NK Cells|nk cells
253068|NCT01875601|Cytokine|cytokine
253069|NCT01875601|Lymphodepleting Chemotherapy|lymphodepleting chemotherapy
253070|NCT01875601|Immunotherapy|immunotherapy
253071|NCT01875601|Pediatric|pediatric
253072|NCT01875588|Healthy Controls|healthy controls
253073|NCT01875588|HIV-positive|hiv-positive
693403|NCT00935402|Food intake|food intake
253074|NCT01875588|Neurophyschological Testing|neurophyschological testing
253075|NCT01875588|PET/CT Scan|pet/ct scan
253076|NCT01875588|Lumbar Drain/Puncture|lumbar drain/puncture
253077|NCT01875575|glucagon-like peptide-1|glucagon-like peptide-1
253078|NCT01875575|peptide tyrosine tyrosine|peptide tyrosine tyrosine
253079|NCT01875575|ghrelin|ghrelin
253080|NCT01875575|stomach|stomach
253081|NCT01875575|small intestine|small intestine
253082|NCT01875575|gastric emptying|gastric emptying
253083|NCT01875562|Neck pain|neck pain
253084|NCT01875562|Cervical radiculopathy|cervical radiculopathy
253085|NCT01875562|Qishe Pill|qishe pill
253086|NCT01875562|Traditional Chinese Medicine|traditional chinese medicine
253087|NCT01875536|transcranial magnetic stimulation|transcranial magnetic stimulation
253088|NCT01875536|spasticity|spasticity
253089|NCT01875536|physiotherapy|physiotherapy
253090|NCT01875536|Rehabilitation|rehabilitation
253091|NCT01875523|Renal disease|renal disease
253092|NCT01875523|renal impairment|renal impairment
253093|NCT01875523|End stage renal disease|end stage renal disease
253094|NCT01875523|Healthy volunteer|healthy volunteer
253095|NCT01875523|Pharmacokinetics|pharmacokinetics
253224|NCT01875120|Anxiety|anxiety
253096|NCT01875497|athletes, polyphenols, nutrition, oxidative stress|athletes, polyphenols, nutrition, oxidative stress
253097|NCT01875484|miR-126|mir-126
243870|NCT01917734|India|india
253098|NCT01875484|Left Ventricular Remodeling|left ventricular remodeling
253099|NCT01875484|Myocardial Infarction|myocardial infarction
253100|NCT01875484|primary percutaneous coronary intervention|primary percutaneous coronary intervention
253101|NCT01875484|left ventricular end diastolic volume|left ventricular end diastolic volume
253102|NCT01875484|left ventricular ejection fraction|left ventricular ejection fraction
253103|NCT01875484|major adverse cardiovascular events|major adverse cardiovascular events
253104|NCT01875458|Aclasta|aclasta
253105|NCT01875458|Actonel|actonel
253106|NCT01875458|alendronate|alendronate
253107|NCT01875458|alendronate/cholecalciferol|alendronate/cholecalciferol
253108|NCT01875458|Aredia|aredia
253109|NCT01875458|Atelvia|atelvia
253110|NCT01875458|Boniva|boniva
253111|NCT01875458|Didronel|didronel
253112|NCT01875458|etidronate|etidronate
253113|NCT01875458|Fosamax|fosamax
253114|NCT01875458|Fosamax Plus D|fosamax plus d
253115|NCT01875458|ibandronate|ibandronate
253116|NCT01875458|pamidronate|pamidronate
253117|NCT01875458|Reclast|reclast
253118|NCT01875458|risedronate|risedronate
253119|NCT01875458|Skelid|skelid
253120|NCT01875458|tiludronate|tiludronate
253121|NCT01875458|zoledronic acid|zoledronic acid
253122|NCT01875458|Zometa|zometa
253123|NCT01875458|Bisphosphonate|bisphosphonate
253124|NCT01875458|Atypical Femur Fracture (AFF)|atypical femur fracture (aff)
253125|NCT01875458|Osteoporosis|osteoporosis
253126|NCT01875458|Bisphosphonate Related Osteonecrosis of the Jaw (BRONJ)|bisphosphonate related osteonecrosis of the jaw (bronj)
253127|NCT01875445|Inositol|inositol
253128|NCT01875445|Trichotillomania|trichotillomania
253129|NCT01875445|Hair Pulling|hair pulling
253130|NCT01875445|Impulse Control Disorder|impulse control disorder
253131|NCT01875393|Prostatic Disease|prostatic disease
253132|NCT01875393|Genital Neoplasm,male|genital neoplasm,male
253133|NCT01875393|Urogenital neoplasm|urogenital neoplasm
253134|NCT01875393|Genital disease,male|genital disease,male
253135|NCT01875393|Male urogenital disease|male urogenital disease
253136|NCT01875393|Neoplasms|neoplasms
253137|NCT01875393|Neoplasms by site|neoplasms by site
253138|NCT01875393|Prostatic neoplasm|prostatic neoplasm
253139|NCT01875393|Carcinoma|carcinoma
253140|NCT01875380|metastatic colorectal cancer|metastatic colorectal cancer
253141|NCT01875380|frail and unfit patient|frail and unfit patient
253142|NCT01875380|regorafenib|regorafenib
253143|NCT01875367|Subcutaneous trastuzumab|subcutaneous trastuzumab
253144|NCT01875367|Intravenous trastuzumab|intravenous trastuzumab
253145|NCT01875367|HER2 positive|her2 positive
253146|NCT01875367|Advanced Breast Cancer|advanced breast cancer
253147|NCT01875341|type 2 diabetes|type 2 diabetes
253148|NCT01875341|diabetic nephropathy|diabetic nephropathy
253149|NCT01875341|hypertension|hypertension
253150|NCT01875341|sleep apnea|sleep apnea
253151|NCT01875341|sympathetic hyperactivity|sympathetic hyperactivity
253152|NCT01875328|stroke|stroke
253153|NCT01875328|blood pressure|blood pressure
253154|NCT01875328|telemedicine|telemedicine
253155|NCT01875302|COPD PRO Instraments equivalency|copd pro instraments equivalency
253156|NCT01875276|Rhinitis|rhinitis
253157|NCT01875276|Antihistamine|antihistamine
253158|NCT01875276|Nasal Steroid Therapy|nasal steroid therapy
253159|NCT01875263|catheter-related bacteremia, SAMS|catheter-related bacteremia, sams
253160|NCT01875263|catheter related bacteremia|catheter related bacteremia
253161|NCT01875263|susceptible|susceptible
253162|NCT01875263|aureus meticillin|aureus meticillin
253163|NCT01875250|Gene Transfer|gene transfer
253164|NCT01875250|Androgen Receptor Antagonist|androgen receptor antagonist
253166|NCT01875250|Immune Response|immune response
253167|NCT01875250|Immunotherapy|immunotherapy
253168|NCT01875237|Leukemia|leukemia
253169|NCT01875237|Myeloma|myeloma
253170|NCT01875237|Myeloproliferative Diseases|myeloproliferative diseases
253171|NCT01875237|Myelodysplastic syndrome|myelodysplastic syndrome
253172|NCT01875237|MDS|mds
253173|NCT01875237|Lymphoma|lymphoma
253174|NCT01875237|Hodgkin disease|hodgkin disease
253175|NCT01875237|Multiple myeloma|multiple myeloma
253176|NCT01875237|MM|mm
253177|NCT01875237|Transplant donor|transplant donor
253178|NCT01875237|T-cells|t-cells
253179|NCT01875237|G-versus-host disease|g-versus-host disease
253180|NCT01875237|GvHD|gvhd
253181|NCT01875237|G-CSF|g-csf
253182|NCT01875237|Filgrastim|filgrastim
253183|NCT01875237|Neupogen|neupogen
253184|NCT01875237|Fludarabine|fludarabine
253185|NCT01875237|Fludarabine phosphate|fludarabine phosphate
253186|NCT01875237|Fludara|fludara
253187|NCT01875237|Melphalan|melphalan
253188|NCT01875237|Alkeran|alkeran
253189|NCT01875237|Alemtuzumab|alemtuzumab
253190|NCT01875237|CAMPATH-1H|campath-1h
253191|NCT01875237|Campath|campath
253192|NCT01875237|Tacrolimus|tacrolimus
253193|NCT01875237|Prograf|prograf
253194|NCT01875237|Mini-methotrexate|mini-methotrexate
253195|NCT01875237|AP 1903|ap 1903
253196|NCT01875237|Methylprednisolone|methylprednisolone
253197|NCT01875237|Depo-Medrol|depo-medrol
253198|NCT01875237|Medrol|medrol
253199|NCT01875237|Solu-Medrol|solu-medrol
253200|NCT01875237|Stem cell infusion|stem cell infusion
253201|NCT01875237|Donor lymphocyte infusion|donor lymphocyte infusion
253202|NCT01875237|DLI|dli
253203|NCT01875237|Questionnaire|questionnaire
253204|NCT01875237|Survey|survey
253205|NCT01875224|kidney transplant|kidney transplant
253206|NCT01875224|diabetes after transplant|diabetes after transplant
253207|NCT01875224|belatacept|belatacept
253208|NCT01875198|Splenectomy;|splenectomy;
253209|NCT01875198|Spleen-preserving|spleen-preserving
253210|NCT01875185|acute coronary syndrome|acute coronary syndrome
253211|NCT01875185|clotting|clotting
253212|NCT01875185|hormones|hormones
253213|NCT01875185|women|women
253214|NCT01875172|bupropion SR|bupropion sr
253215|NCT01875172|randomized controlled trial|randomized controlled trial
253216|NCT01875172|pregnancy|pregnancy
253217|NCT01875159|Prematurity|prematurity
253218|NCT01875159|Apnea of prematurity|apnea of prematurity
253219|NCT01875159|Intermittent hypoxia|intermittent hypoxia
253220|NCT01875133|airway disease|airway disease
253221|NCT01875133|bronchitis|bronchitis
253222|NCT01875133|emphysema|emphysema
253223|NCT01875133|lung|lung
253225|NCT01875120|Somatoform Disorders|somatoform disorders
253226|NCT01875068|referrals|referrals
253227|NCT01875068|nurse practitioners|nurse practitioners
253228|NCT01875068|physician assistants|physician assistants
253229|NCT01875068|consultative general internal medicine|consultative general internal medicine
253230|NCT01875055|Cerebral|cerebral
253231|NCT01875055|desaturation|desaturation
253232|NCT01875029|Low back pain|low back pain
253233|NCT01875029|chronic pain|chronic pain
253234|NCT01875029|tDCS|tdcs
253235|NCT01875029|transcranial direct current stimulation|transcranial direct current stimulation
253236|NCT01875016|Cryo ablation|cryo ablation
253237|NCT01875016|Cardiomyopathy|cardiomyopathy
253238|NCT01874977|rheumatoid arthritis|rheumatoid arthritis
253239|NCT01874977|fatigue|fatigue
253240|NCT01874977|physical activity|physical activity
253241|NCT01874964|HIV Prevention|hiv prevention
253242|NCT01874964|Opioid-Related Disorders|opioid-related disorders
253243|NCT01874964|Medication Assisted Treatment|medication assisted treatment
253244|NCT01874964|Methadone|methadone
253245|NCT01874951|Depression|depression
253246|NCT01874951|Recurrence|recurrence
253247|NCT01874951|Relapse|relapse
253248|NCT01874951|Antidepressants|antidepressants
253249|NCT01874951|Naltrexone|naltrexone
253250|NCT01874951|Drug augmentation|drug augmentation
253251|NCT01874886|Magnetic resonance imaging|magnetic resonance imaging
253252|NCT01874886|Diffusion tensor imaging|diffusion tensor imaging
253253|NCT01874886|Hippocampus|hippocampus
253254|NCT01874886|Cannabis|cannabis
253255|NCT01874886|Geriatrics|geriatrics
253256|NCT01874886|Neuropsychology|neuropsychology
253257|NCT01874886|Apolipoprotein E|apolipoprotein e
253258|NCT01874847|melatonin|melatonin
253260|NCT01874847|post-concussion syndrome|post-concussion syndrome
253261|NCT01874847|mild traumatic brain injury|mild traumatic brain injury
253262|NCT01874847|concussion|concussion
253263|NCT01874847|treatment|treatment
253264|NCT01874847|outcome|outcome
253265|NCT01874847|children|children
253266|NCT01874847|functional magnetic resonance imaging|functional magnetic resonance imaging
253267|NCT01874847|transcranial magnetic stimulation|transcranial magnetic stimulation
253268|NCT01874847|sleep|sleep
253269|NCT01874834|ozone|ozone
253270|NCT01874834|diesel|diesel
253271|NCT01874834|lung function|lung function
253272|NCT01874834|cardiac electrophysiology|cardiac electrophysiology
253273|NCT01874834|mediators of inflammation and clotting|mediators of inflammation and clotting
253274|NCT01874821|Frozen Shoulder|frozen shoulder
253275|NCT01874821|Adhesive Capsulitis|adhesive capsulitis
253276|NCT01874821|ROM|rom
253277|NCT01874821|Dynasplint|dynasplint
253278|NCT01874808|movement preparation|movement preparation
253279|NCT01874808|gait|gait
253280|NCT01874808|gait initiation|gait initiation
253281|NCT01874808|postural control|postural control
253282|NCT01874808|neuroimaging|neuroimaging
253283|NCT01874795|Autonomic Nervous System|autonomic nervous system
253284|NCT01874795|Neuromodulation|neuromodulation
253285|NCT01874795|Exercise|exercise
253286|NCT01874795|Pulmonary oxygen kinetics|pulmonary oxygen kinetics
253287|NCT01874795|Oxygen uptake|oxygen uptake
253288|NCT01874782|spinal cord injury|spinal cord injury
253289|NCT01874782|cardiovascular|cardiovascular
253290|NCT01874782|orthostatic hypotension|orthostatic hypotension
253291|NCT01874782|transcranial electrical stimulation|transcranial electrical stimulation
253292|NCT01874782|electrotherapy|electrotherapy
253293|NCT01874769|RDEB|rdeb
253294|NCT01874769|COL7A1|col7a1
253295|NCT01874769|Collagen VII|collagen vii
253296|NCT01874756|schizophrenia|schizophrenia
253297|NCT01874756|Estrogen receptor agonist|estrogen receptor agonist
253298|NCT01874756|cognitive impairment|cognitive impairment
253299|NCT01874756|negative symptoms|negative symptoms
253300|NCT01874743|HIV,|hiv,
253301|NCT01874743|Rosuvastatine,|rosuvastatine,
253302|NCT01874743|Antiretroviral therapy|antiretroviral therapy
253303|NCT01874730|colorectal surgery|colorectal surgery
253304|NCT01874730|fluid therapy|fluid therapy
253305|NCT01874717|Conscious sedation|conscious sedation
253306|NCT01874717|Dental anxiety|dental anxiety
253307|NCT01874717|Oral midazolam|oral midazolam
253308|NCT01874717|Intravenous midazolam|intravenous midazolam
253309|NCT01874717|Behaviour|behaviour
253310|NCT01874704|Stress, occupation, biomarkers, emergency, physicians|stress, occupation, biomarkers, emergency, physicians
253311|NCT01874691|acute myocardial infarction|acute myocardial infarction
253312|NCT01874691|China|china
253313|NCT01874691|Registry|registry
253314|NCT01874665|Gastrointestinal Neoplasms|gastrointestinal neoplasms
253315|NCT01874665|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
253316|NCT01874665|mesenchymal tumor|mesenchymal tumor
253317|NCT01874639|Hepatectomy|hepatectomy
253318|NCT01874639|blood loss|blood loss
253319|NCT01874639|hemostasis|hemostasis
253320|NCT01874639|coagulation|coagulation
253321|NCT01874639|Liver surgery (benign or malign)|liver surgery (benign or malign)
253322|NCT01874639|Resection of 2 or more segments|resection of 2 or more segments
253323|NCT01874626|acute ankle sprain|acute ankle sprain
253324|NCT01874626|Grade I or Grade II|grade i or grade ii
253325|NCT01874613|Craniofacial bone reconstruction|craniofacial bone reconstruction
253326|NCT01874613|Fibre-reinforced composite|fibre-reinforced composite
253327|NCT01874613|Bioactive glass|bioactive glass
253328|NCT01874613|Craniotomy|craniotomy
253329|NCT01874613|Skull bone defect|skull bone defect
253330|NCT01874587|Adaptative radiotherapy|adaptative radiotherapy
253331|NCT01874587|oropharynx carcinoma|oropharynx carcinoma
253332|NCT01874587|xerostomia|xerostomia
253333|NCT01874574|Knee Osteoarthritis|knee osteoarthritis
253334|NCT01874574|Corticosteroid|corticosteroid
253335|NCT01874574|Hyaluronic acid|hyaluronic acid
253336|NCT01874574|Intra-articular injection|intra-articular injection
253337|NCT01874561|Custirsen sodium|custirsen sodium
253338|NCT01874561|TV1011|tv1011
253339|NCT01874561|OGX-011|ogx-011
253340|NCT01874561|Thorough QT study|thorough qt study
253341|NCT01874561|cancer|cancer
253342|NCT01874548|Autophagy|autophagy
253343|NCT01874548|Cancer metabolism|cancer metabolism
253344|NCT01874548|Cervical cancer|cervical cancer
253345|NCT01874548|Diffusion weighted imaging|diffusion weighted imaging
253346|NCT01874548|Human papillomavirus|human papillomavirus
253347|NCT01874548|Magnetic resonance spectroscopy.|magnetic resonance spectroscopy.
253348|NCT01874522|Advanced solid tumors (excluding breast cancer) for which no standard therapy exists|advanced solid tumors (excluding breast cancer) for which no standard therapy exists
253349|NCT01874405|Iron overload|iron overload
253350|NCT01874405|thalassaemia|thalassaemia
253351|NCT01874405|deferasirox|deferasirox
253352|NCT01874405|magnetic resonance|magnetic resonance
253353|NCT01874405|endocrine function|endocrine function
253354|NCT01874379|Joint Replacement|joint replacement
253355|NCT01874379|Hip Replacement|hip replacement
253356|NCT01874379|Knee Replacement|knee replacement
253357|NCT01874379|Complementary Medicine Intervention|complementary medicine intervention
253358|NCT01874353|BRCA|brca
253359|NCT01874353|Ovarian cancer|ovarian cancer
253360|NCT01874353|Chemotherapy|chemotherapy
253361|NCT01874353|PARP Inhibitor|parp inhibitor
253362|NCT01874353|Platinum sensitive|platinum sensitive
253363|NCT01874340|Multiple Sclerosis|multiple sclerosis
253364|NCT01874340|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
253365|NCT01874340|AIN457|ain457
253366|NCT01874340|Secukinumab|secukinumab
253367|NCT01874340|Magnetic Resonance Imaging|magnetic resonance imaging
253368|NCT01874340|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
253369|NCT01874340|Autoimmune Diseases|autoimmune diseases
253370|NCT01874340|Nervous System Diseases|nervous system diseases
253371|NCT01874340|Immune System Diseases|immune system diseases
253372|NCT01874340|Demyelinating Diseases|demyelinating diseases
253373|NCT01874314|tuberculosis, SQ109, QTc, moxifloxacin, crossover, placebo, pharmacokinetic, randomized, single-center|tuberculosis, sq109, qtc, moxifloxacin, crossover, placebo, pharmacokinetic, randomized, single-center
253375|NCT01874288|Immunocytokine|immunocytokine
253376|NCT01874288|Lymphoma|lymphoma
253377|NCT01874288|Non-Hodgkin|non-hodgkin
253378|NCT01874288|B-cell|b-cell
253379|NCT01874288|IL (interleukin)|il (interleukin)
253380|NCT01874249|Hepatic fibrosis|hepatic fibrosis
253381|NCT01874249|Steatosis|steatosis
253382|NCT01874249|Noninvasive markers.|noninvasive markers.
253383|NCT01874236|SI joint pain, SI joint dysfunction, degenerative sacroiliitis, sacroiliac joint disruption|si joint pain, si joint dysfunction, degenerative sacroiliitis, sacroiliac joint disruption
253384|NCT01874223|Interstitial Lung Disease (ILD)|interstitial lung disease (ild)
253385|NCT01874223|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
253386|NCT01874197|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
253387|NCT01874197|Branched vessels|branched vessels
253388|NCT01874158|Trichomonas vaginalis|trichomonas vaginalis
253389|NCT01874145|Multiple Sclerosis|multiple sclerosis
253390|NCT01874145|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
253391|NCT01874145|Glatiramer Acetate|glatiramer acetate
253392|NCT01874145|Glatiramer|glatiramer
253393|NCT01874132|Exercise|exercise
253394|NCT01874132|Blood pressure|blood pressure
253395|NCT01874132|Lipids|lipids
253396|NCT01874132|Body composition|body composition
253397|NCT01874132|Fitness|fitness
253398|NCT01874132|Bone density|bone density
253399|NCT01874132|Quality of life|quality of life
253400|NCT01874119|melanoma|melanoma
253401|NCT01874119|renal cell carcinoma|renal cell carcinoma
253402|NCT01874119|interleukin-2|interleukin-2
253403|NCT01874106|Hemodialysis|hemodialysis
253404|NCT01874106|Diet|diet
253405|NCT01874106|Inflammation|inflammation
253406|NCT01874106|Malnutrition|malnutrition
253407|NCT01874054|Antibody-Drug Conjugate|antibody-drug conjugate
253408|NCT01874054|Antibodies, Monoclonal|antibodies, monoclonal
253409|NCT01874054|Hodgkin Disease|hodgkin disease
253410|NCT01874054|Hematologic Diseases|hematologic diseases
253411|NCT01874054|Drug Therapy|drug therapy
253412|NCT01874054|Immunotherapy|immunotherapy
253413|NCT01874054|Antigens, CD30|antigens, cd30
253414|NCT01874054|Lymphoma|lymphoma
253415|NCT01874054|monomethylauristatin E|monomethylauristatin e
253416|NCT01874041|Physical Therapy Modalities|physical therapy modalities
253417|NCT01874041|Facial Pain|facial pain
253418|NCT01874041|Orthodontic Appliances|orthodontic appliances
253419|NCT01874028|Trientine|trientine
253523|NCT01873612|Propofol|propofol
253420|NCT01874028|Pharmacokinetics|pharmacokinetics
253421|NCT01874015|Crohn's disease|crohn's disease
253422|NCT01874015|mesenchymal stem cell|mesenchymal stem cell
253423|NCT01874015|fistula|fistula
253424|NCT01874002|Stents|stents
253425|NCT01874002|Stent|stent
253426|NCT01874002|Drug eluting|drug eluting
253427|NCT01874002|Drug eluting stent|drug eluting stent
253428|NCT01874002|Drug eluting stents|drug eluting stents
253429|NCT01874002|Endothelial progenitor cell|endothelial progenitor cell
253430|NCT01874002|Endothelial progenitor cell capturing|endothelial progenitor cell capturing
253431|NCT01874002|Sirolimus|sirolimus
253432|NCT01874002|Sirolimus eluting|sirolimus eluting
253433|NCT01874002|Percutaneous Coronary Intervention|percutaneous coronary intervention
253434|NCT01874002|PCI|pci
253435|NCT01874002|Registry|registry
253436|NCT01874002|Registries|registries
253437|NCT01874002|Multi center|multi center
253438|NCT01874002|Multi centre|multi centre
253439|NCT01873989|Chronic pain|chronic pain
253440|NCT01873989|Opioid addiction|opioid addiction
253441|NCT01873989|Symptomatic hypogonadism|symptomatic hypogonadism
253442|NCT01873989|Testosterone replacement|testosterone replacement
253443|NCT01873989|Opioid agonist maintenance|opioid agonist maintenance
253444|NCT01873989|Methadone|methadone
253445|NCT01873989|Buprenorphine|buprenorphine
253446|NCT01873937|Lasertherapy|lasertherapy
253447|NCT01873937|Ledtherapy|ledtherapy
253448|NCT01873937|TMJs|tmjs
253449|NCT01873937|pain relief|pain relief
253450|NCT01873937|oral aperture|oral aperture
253451|NCT01873924|Batten disease|batten disease
253452|NCT01873924|NCL|ncl
253453|NCT01873924|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
253454|NCT01873911|MPS IIIA|mps iiia
253455|NCT01873911|MPS IIIB|mps iiib
253456|NCT01873911|Sanfilippo syndrome type A|sanfilippo syndrome type a
253457|NCT01873911|Sanfilippo syndrome type B|sanfilippo syndrome type b
253458|NCT01873911|Hurler syndrome|hurler syndrome
253459|NCT01873911|cognitive decline|cognitive decline
253460|NCT01873911|MPS IH|mps ih
253461|NCT01873885|PB1046, VIP, Essential Hypertension, Vasomera|pb1046, vip, essential hypertension, vasomera
253462|NCT01873859|Lactic acidosis|lactic acidosis
253463|NCT01873859|Contrast media|contrast media
253464|NCT01873859|Angiography|angiography
253465|NCT01873859|Diabetic|diabetic
253466|NCT01873859|Metformin|metformin
253259|NCT01874847|placebo|placebo
253467|NCT01873820|Vitamin C|vitamin c
253468|NCT01873820|calcium ascorbate|calcium ascorbate
253469|NCT01873820|ascorbic acid|ascorbic acid
253470|NCT01873807|Idarubicin|idarubicin
253471|NCT01873807|Etoposide|etoposide
253472|NCT01873807|HSCT|hsct
253473|NCT01873807|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
253475|NCT01873794|Sleep|sleep
253476|NCT01873794|Quality of life|quality of life
253477|NCT01873794|Cancer|cancer
253478|NCT01873794|Light|light
253479|NCT01873768|Tranexamic acid|tranexamic acid
253480|NCT01873768|6-Aminocaproic Acid|6-aminocaproic acid
253481|NCT01873768|Arthroplasty|arthroplasty
253482|NCT01873768|Osteoarthritis|osteoarthritis
253483|NCT01873768|Arthritis|arthritis
253484|NCT01873768|Joint Diseases|joint diseases
253485|NCT01873768|Musculoskeletal Diseases|musculoskeletal diseases
253486|NCT01873768|Rheumatic Diseases|rheumatic diseases
253487|NCT01873768|Antifibrinolytic Agents|antifibrinolytic agents
253488|NCT01873768|Fibrin Modulating Agents|fibrin modulating agents
253489|NCT01873768|Pharmacologic Actions|pharmacologic actions
253490|NCT01873768|Coagulants|coagulants
253491|NCT01873768|Therapeutic Uses|therapeutic uses
253492|NCT01873755|asthma|asthma
253493|NCT01873755|children|children
253494|NCT01873755|physical activity|physical activity
253495|NCT01873755|school|school
253496|NCT01873742|Psychotherapy feedback|psychotherapy feedback
253497|NCT01873729|ADHD|adhd
253498|NCT01873729|Naltrexone|naltrexone
253499|NCT01873729|Adults|adults
253500|NCT01873716|Atherosclerosis|atherosclerosis
253501|NCT01873716|Molecular Imaging|molecular imaging
253502|NCT01873716|Vascular Biology|vascular biology
253503|NCT01873716|Inflammation|inflammation
253504|NCT01873716|Fluorescence|fluorescence
253505|NCT01873703|MDS|mds
253506|NCT01873703|High risk myelodysplastic syndrome|high risk myelodysplastic syndrome
253507|NCT01873703|Intermediate-2 Myelodysplastic syndrome|intermediate-2 myelodysplastic syndrome
253508|NCT01873703|Untreated|untreated
253509|NCT01873690|Antibiotics|antibiotics
253510|NCT01873690|Shock Wave Lithotripsy|shock wave lithotripsy
253511|NCT01873690|Urinary Tract Infection|urinary tract infection
253512|NCT01873664|fMRI|fmri
253513|NCT01873664|Jaw tapping|jaw tapping
253514|NCT01873664|Memory disorder|memory disorder
253515|NCT01873664|Mild cognitive impairment|mild cognitive impairment
253516|NCT01873664|MCI|mci
253517|NCT01873664|Working memory|working memory
253518|NCT01873638|5-year outcome after cholecystectomy|5-year outcome after cholecystectomy
253519|NCT01873625|mesenchymal stem cells|mesenchymal stem cells
253520|NCT01873625|osteoarthritis|osteoarthritis
253521|NCT01873625|arthritis rheumatoid|arthritis rheumatoid
253522|NCT01873612|Dexmedetomidine|dexmedetomidine
253524|NCT01873612|Hypoxic ventilatory response|hypoxic ventilatory response
253525|NCT01873612|Hypercapnic ventilatory response|hypercapnic ventilatory response
253526|NCT01873573|radiation-induced stricture|radiation-induced stricture
253527|NCT01873573|anastomotic stricture|anastomotic stricture
253528|NCT01873573|esophagogastroduodenoscopy (EGD)|esophagogastroduodenoscopy (egd)
253529|NCT01873573|dilation|dilation
253530|NCT01873573|steroid injection|steroid injection
253531|NCT01873573|triamcinolone|triamcinolone
253532|NCT01873573|difficulty swallowing|difficulty swallowing
253533|NCT01873560|fractional flow reserve|fractional flow reserve
253534|NCT01873560|drug eluting stent|drug eluting stent
253535|NCT01873560|coronary atherosclerosis|coronary atherosclerosis
253536|NCT01873547|spinal cord injury|spinal cord injury
253537|NCT01873547|cell transplantation|cell transplantation
253538|NCT01873547|rehabilitation|rehabilitation
253539|NCT01873534|Anemia|anemia
253540|NCT01873521|Positive Pressure Ventilation|positive pressure ventilation
253541|NCT01873521|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
253550|NCT01873430|Sunlight|sunlight
253551|NCT01873430|Ultraviolet rays|ultraviolet rays
253552|NCT01873391|Diagnostic hysteroscopy|diagnostic hysteroscopy
253553|NCT01873391|Pain|pain
253554|NCT01873391|VAS|vas
253555|NCT01873391|Multivariate analysis|multivariate analysis
253556|NCT01873391|Normal saline|normal saline
253557|NCT01873391|Carbon dioxide|carbon dioxide
253558|NCT01873378|Uterine myoma|uterine myoma
253559|NCT01873378|GnRHa|gnrha
253560|NCT01873378|Hysteroscopy|hysteroscopy
253561|NCT01873378|Cold loop|cold loop
253562|NCT01873365|Quality of life|quality of life
253563|NCT01873365|Herpes zoster|herpes zoster
253564|NCT01873365|Postherpetic neuralgia|postherpetic neuralgia
253565|NCT01873365|Japan|japan
253566|NCT01873365|Physician-practice|physician-practice
253567|NCT01873365|Adults|adults
253568|NCT01873365|Health economics|health economics
253569|NCT01873339|Drug interaction, healthy volunteer, SB-480848, Lp-PLA2, darapladib, atherosclerosis, midazolam|drug interaction, healthy volunteer, sb-480848, lp-pla2, darapladib, atherosclerosis, midazolam
253579|NCT01873300|Achalasia|achalasia
253580|NCT01873300|Dysphagia|dysphagia
253581|NCT01873300|Endoscopic|endoscopic
253582|NCT01873300|Myotomy|myotomy
253583|NCT01873300|Heller|heller
253584|NCT01873300|NOTES|notes
253585|NCT01873300|POEM|poem
253586|NCT01873287|Concussions|concussions
253587|NCT01873287|Persistent post-concussion symptoms|persistent post-concussion symptoms
253589|NCT01873287|Clinical Prediction Rule|clinical prediction rule
253590|NCT01873261|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
253591|NCT01873261|Pediatric Acute Respiratory Failure|pediatric acute respiratory failure
253592|NCT01873261|non-invasive ventilation|non-invasive ventilation
253593|NCT01873248|Neuroendocrine Carcinoma|neuroendocrine carcinoma
253594|NCT01873222|Coronary Artery Disease|coronary artery disease
253595|NCT01873222|Percutaneous Coronary Intervention|percutaneous coronary intervention
253596|NCT01873222|Optical Frequency Domain Imaging|optical frequency domain imaging
253597|NCT01873222|Intravascular Ultrasound|intravascular ultrasound
253598|NCT01873183|echocardiography|echocardiography
253599|NCT01873183|morbid obesity|morbid obesity
253600|NCT01873183|bariatric surgery|bariatric surgery
253601|NCT01873183|venous return|venous return
253602|NCT01873183|mean arterial blood pressure|mean arterial blood pressure
253603|NCT01873170|immune cells|immune cells
253604|NCT01873170|contraception|contraception
253605|NCT01873170|intrauterine device|intrauterine device
253606|NCT01873170|IUD|iud
253607|NCT01873170|copper|copper
253608|NCT01873170|microflora|microflora
253609|NCT01873170|DMPA|dmpa
253610|NCT01873170|etonogestrel|etonogestrel
253611|NCT01873170|subdermal implant|subdermal implant
253612|NCT01873157|Kidney transplantation|kidney transplantation
253613|NCT01873157|Antibody formation|antibody formation
253614|NCT01873157|Graft rejection|graft rejection
253615|NCT01873157|Proteasome inhibitors|proteasome inhibitors
253616|NCT01873157|Randomized controlled trial|randomized controlled trial
253617|NCT01873144|Bronchiolitis|bronchiolitis
253618|NCT01873144|Hypertonic saline solution|hypertonic saline solution
253619|NCT01873144|High-flow oxygen therapy|high-flow oxygen therapy
253620|NCT01873144|Respiratory distress|respiratory distress
253621|NCT01873144|Comfort|comfort
253622|NCT01873131|hemangioma|hemangioma
253623|NCT01873131|infantile hemangioma|infantile hemangioma
253624|NCT01873131|pulsed dye laser|pulsed dye laser
253625|NCT01873131|PDL|pdl
253626|NCT01873131|topical beta blocker|topical beta blocker
253627|NCT01873131|timolol maleate|timolol maleate
253628|NCT01873131|timolol|timolol
253629|NCT01873118|hospital discharge|hospital discharge
253630|NCT01873118|discharge readiness|discharge readiness
253631|NCT01873118|readmission|readmission
253632|NCT01873118|Emergency Department visits|emergency department visits
253633|NCT01873118|Nurse assessment|nurse assessment
253634|NCT01873092|Oximetry|oximetry
253635|NCT01873092|Physical Activity|physical activity
253636|NCT01873079|ERCP|ercp
253637|NCT01873079|sphincterotomy|sphincterotomy
254155|NCT01870570|Glycaemia|glycaemia
253638|NCT01873079|proton pump inhibitor|proton pump inhibitor
253639|NCT01873066|Type 1 diabetes|type 1 diabetes
253640|NCT01873066|Closed-loop glucose control|closed-loop glucose control
253641|NCT01873066|Artificial Pancreas|artificial pancreas
253934|NCT01871714|XLHED|xlhed
253642|NCT01873066|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
253643|NCT01873066|Continuous glucose monitoring|continuous glucose monitoring
253644|NCT01873053|Osteoarthritis, Knee|osteoarthritis, knee
253645|NCT01873053|WIN-34B|win-34b
253646|NCT01873040|Social Media|social media
253647|NCT01873040|Vaccine|vaccine
253648|NCT01873040|Immunization|immunization
253649|NCT01873027|Coronary Artery Disease|coronary artery disease
253650|NCT01873027|Percutaneous Coronary Intervention|percutaneous coronary intervention
253651|NCT01873027|Optical Frequency Domain Imaging|optical frequency domain imaging
253652|NCT01873027|Intravascular Ultrasound|intravascular ultrasound
253653|NCT01873001|Healthy volunteers|healthy volunteers
253654|NCT01873001|Drug-drug Interaction|drug-drug interaction
253655|NCT01873001|Pharmacokinetics|pharmacokinetics
253656|NCT01873001|Abiraterone|abiraterone
253657|NCT01873001|JNJ-589485|jnj-589485
253658|NCT01873001|Abiraterone acetate|abiraterone acetate
253659|NCT01873001|JNJ-212082|jnj-212082
253660|NCT01873001|Pioglitazone HCl|pioglitazone hcl
253661|NCT01872988|antiviral therapy|antiviral therapy
253662|NCT01872988|intermediate stage|intermediate stage
253663|NCT01872988|hepatitis B virus|hepatitis b virus
253664|NCT01872962|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
253665|NCT01872962|Induction chemotherapy|induction chemotherapy
253666|NCT01872962|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
253667|NCT01872962|Clinical trial|clinical trial
253668|NCT01872949|Heart Failure|heart failure
253669|NCT01872949|NYHA Class III|nyha class iii
253670|NCT01872949|NYHA Class IV|nyha class iv
253671|NCT01872923|Amphinex|amphinex
253672|NCT01872923|PCI|pci
253673|NCT01872923|Bleomycin|bleomycin
253674|NCT01872923|Cutaneous malignancies|cutaneous malignancies
253675|NCT01872923|Sub-cutaneous malignancies|sub-cutaneous malignancies
253676|NCT01872923|Safety|safety
253677|NCT01872923|Phase I|phase i
253678|NCT01872923|Photochemical Internalisation|photochemical internalisation
253679|NCT01872923|Squamous Cell Carcinoma|squamous cell carcinoma
253680|NCT01872923|Head and Neck cancer|head and neck cancer
253688|NCT01872897|GERD|gerd
253689|NCT01872897|Acid reflux|acid reflux
253690|NCT01872897|Compound Sodium Alginate Double Action Chewable Tablet|compound sodium alginate double action chewable tablet
253691|NCT01872897|Gaviscon Double Action Tablets|gaviscon double action tablets
253692|NCT01872884|Stroke|stroke
253693|NCT01872884|Ischemic stroke|ischemic stroke
253694|NCT01872884|Acute stroke|acute stroke
253695|NCT01872884|Embolectomy|embolectomy
253696|NCT01872884|Endovascular therapy|endovascular therapy
253697|NCT01872884|Intra-arterial therapy|intra-arterial therapy
253698|NCT01872884|Sedation|sedation
253699|NCT01872884|Anesthesia|anesthesia
253700|NCT01872845|Statin|statin
253701|NCT01872845|CIMT|cimt
253702|NCT01872845|BES|bes
253703|NCT01872793|bioelectrical impedance vector analysis|bioelectrical impedance vector analysis
253704|NCT01872793|nutritional assessment|nutritional assessment
253705|NCT01872793|nutritional status|nutritional status
253706|NCT01872793|mortality|mortality
253707|NCT01872793|complications|complications
253708|NCT01872780|CYP2C8|cyp2c8
253709|NCT01872780|genetic polymorphism|genetic polymorphism
253710|NCT01872780|rosiglitazone|rosiglitazone
253711|NCT01872780|Korean|korean
253712|NCT01872767|Acute on Chronic Liver Failure (ACLF),Cirrhosis,|acute on chronic liver failure (aclf),cirrhosis,
253713|NCT01872767|Institute of Liver & Biliary Sciences (ILBS)|institute of liver & biliary sciences (ilbs)
253714|NCT01872754|Bronchial fibroscopy|bronchial fibroscopy
253715|NCT01872754|Remifentanil|remifentanil
253716|NCT01872754|Propofol|propofol
253717|NCT01872754|Sedation|sedation
253718|NCT01872754|Target Controlled Infusion|target controlled infusion
253719|NCT01872741|craniotomy,|craniotomy,
253720|NCT01872741|intracerebral aneurysms,|intracerebral aneurysms,
253721|NCT01872741|atrophy,|atrophy,
253722|NCT01872741|temporal muscle,|temporal muscle,
253723|NCT01872741|outcome|outcome
253724|NCT01872728|facial block|facial block
253725|NCT01872728|levobupivacaine|levobupivacaine
253726|NCT01872728|regional anesthesia|regional anesthesia
253727|NCT01872728|rhinoplasty|rhinoplasty
253728|NCT01872728|outpatient|outpatient
253729|NCT01872715|Papulopustular Rosacea|papulopustular rosacea
253730|NCT01872715|Oracea|oracea
253731|NCT01872715|anti inflammatory doxycycline|anti inflammatory doxycycline
253732|NCT01872702|Malaria elimination|malaria elimination
253733|NCT01872702|Chemotherapy|chemotherapy
253734|NCT01872702|Epidemiology|epidemiology
253735|NCT01872702|South East Asia|south east asia
253736|NCT01872702|Artemisinin resistance|artemisinin resistance
253737|NCT01872702|Dihydroartemisinin piperaquine|dihydroartemisinin piperaquine
253738|NCT01872702|Primaquine|primaquine
253739|NCT01872676|Thermography|thermography
253740|NCT01872676|Skin Temperature|skin temperature
253741|NCT01872676|Manipulation, Spinal|manipulation, spinal
253742|NCT01872676|Physical Therapy Modalities|physical therapy modalities
253743|NCT01872663|Morbid obesity|morbid obesity
253744|NCT01872663|Bariatric surgery|bariatric surgery
253745|NCT01872663|Pulmonary atelectasis|pulmonary atelectasis
253746|NCT01872663|Spirometry|spirometry
253747|NCT01872663|Continuos Positive Airway Pressure|continuos positive airway pressure
253748|NCT01872663|Physical therapy speciality|physical therapy speciality
253749|NCT01872650|postoperative adhesions|postoperative adhesions
253750|NCT01872650|adhesion prevention|adhesion prevention
253751|NCT01872650|colorectal surgery|colorectal surgery
253752|NCT01872650|temporary ostomy|temporary ostomy
253753|NCT01872611|Diabetes Type I|diabetes type i
253754|NCT01872611|Diabetes Type II|diabetes type ii
253755|NCT01872611|Non-proliferative diabetic retinopathy|non-proliferative diabetic retinopathy
253756|NCT01872611|Macular edema|macular edema
253757|NCT01872611|Cataract|cataract
253758|NCT01872598|Alzheimer|alzheimer
253759|NCT01872598|dementia|dementia
253760|NCT01872598|cognitive disease|cognitive disease
253761|NCT01872598|memory loss|memory loss
253762|NCT01872598|cerebrovascular disease|cerebrovascular disease
253763|NCT01872585|Parenting|parenting
253764|NCT01872585|Mental Illness|mental illness
253765|NCT01872585|Maternal sensitivity|maternal sensitivity
253766|NCT01872585|Parent-child relationship|parent-child relationship
253767|NCT01872533|obesity|obesity
253768|NCT01872533|hypoxia|hypoxia
253769|NCT01872533|insulin sensitivity|insulin sensitivity
253770|NCT01872533|altitude|altitude
5869|NCT03253861|Pancreatitis/diagnosis|pancreatitis/diagnosis
253771|NCT01872520|the Injection of DanShenDuoFenSuanYan|the injection of danshenduofensuanyan
253772|NCT01872520|Magnesium Lithospermate B|magnesium lithospermate b
253774|NCT01872520|Real World Study|real world study
253775|NCT01872507|cerebral palsy|cerebral palsy
253776|NCT01872507|autonomic nerveus system|autonomic nerveus system
253777|NCT01872507|heart rate variability|heart rate variability
253778|NCT01872494|Local analgesia system|local analgesia system
253779|NCT01872494|Ropivacaine|ropivacaine
253780|NCT01872494|Analgesic efficacy after operation|analgesic efficacy after operation
253781|NCT01872494|Postoperative|postoperative
253782|NCT01872481|Phantom limb pain syndrome|phantom limb pain syndrome
253783|NCT01872481|Neuropathic pain|neuropathic pain
253784|NCT01872481|Antipersonnel landmines|antipersonnel landmines
253785|NCT01872481|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
253786|NCT01872468|Glomerular filtration Rate.|glomerular filtration rate.
253787|NCT01872468|Primary Health Care.|primary health care.
253788|NCT01872468|Cluster Clinical Trial.|cluster clinical trial.
253789|NCT01872429|subtotal parathyroidectomy|subtotal parathyroidectomy
253790|NCT01872429|calcium|calcium
253791|NCT01872429|phosphorus|phosphorus
253792|NCT01872429|parathyroid hormone|parathyroid hormone
253793|NCT01872429|hyperparathyroidism|hyperparathyroidism
253794|NCT01872416|Refractory and relapsed small cell lung cancer|refractory and relapsed small cell lung cancer
253795|NCT01872416|Liposomal Doxorubicin|liposomal doxorubicin
253796|NCT01872416|ifosfamide|ifosfamide
253797|NCT01872403|Squamous Cell Carcinoma of the lung|squamous cell carcinoma of the lung
253798|NCT01872390|Lesotho|lesotho
253799|NCT01872390|TB|tb
253800|NCT01872390|tuberculosis|tuberculosis
253801|NCT01872390|HIV|hiv
253802|NCT01872390|antiretroviral therapy|antiretroviral therapy
253803|NCT01872390|ART|art
253804|NCT01872390|adherence|adherence
244541|NCT01914770|SLE|sle
253805|NCT01872390|combination intervention package|combination intervention package
253806|NCT01872390|retention|retention
253807|NCT01872377|pancreas|pancreas
253808|NCT01872377|pancreatic|pancreatic
253809|NCT01872377|unresectable|unresectable
253810|NCT01872377|CyberKnife|cyberknife
253811|NCT01872377|SBRT|sbrt
253812|NCT01872364|Hernia repair|hernia repair
253813|NCT01872364|Hydrocelectomy|hydrocelectomy
253814|NCT01872364|Global Health|global health
253815|NCT01872364|Global Disease Burden|global disease burden
253816|NCT01872364|Surgical Mission|surgical mission
253817|NCT01872364|Dominican Republic|dominican republic
253818|NCT01872364|Cost-minimization|cost-minimization
253819|NCT01872364|Procedural cost|procedural cost
253820|NCT01872364|Material cost|material cost
253821|NCT01872364|Item utilization|item utilization
253822|NCT01872364|Excision of benign cutaneous mass|excision of benign cutaneous mass
253823|NCT01872364|Minor procedure|minor procedure
253824|NCT01872351|chronic fatigue syndrome|chronic fatigue syndrome
253825|NCT01872351|mitochondrial disorder|mitochondrial disorder
253826|NCT01872351|conditioning exercise|conditioning exercise
253827|NCT01872351|nutraceutical supplements|nutraceutical supplements
253828|NCT01872351|high protein diet|high protein diet
253829|NCT01872338|suicide prevention|suicide prevention
253830|NCT01872338|cognitive behavioral therapy|cognitive behavioral therapy
253831|NCT01872338|mindfulness meditation|mindfulness meditation
253832|NCT01872338|Veterans|veterans
253833|NCT01872338|safety planning|safety planning
253834|NCT01872325|cardiac arrest|cardiac arrest
253835|NCT01872325|bystander cardiopulmonary resuscitation CPR|bystander cardiopulmonary resuscitation cpr
253836|NCT01872325|dispatch-assisted CPR instructions|dispatch-assisted cpr instructions
253837|NCT01872325|agonal breathing|agonal breathing
253838|NCT01872312|BPF(Bronchopleural fistulae)|bpf(bronchopleural fistulae)
253839|NCT01872286|Capsule Endoscopy|capsule endoscopy
253840|NCT01872273|Metabolic Syndrome|metabolic syndrome
253841|NCT01872273|Obese|obese
253842|NCT01872273|Overweight|overweight
253843|NCT01872273|Hypertension|hypertension
253844|NCT01872273|Hyperlipidemia|hyperlipidemia
253845|NCT01872273|Glucose Intolerant|glucose intolerant
253846|NCT01872273|High blood sugar|high blood sugar
253847|NCT01872273|Exercise in obesity|exercise in obesity
253848|NCT01872273|Platelets|platelets
253849|NCT01872260|Hormone-receptor positive|hormone-receptor positive
253850|NCT01872234|Heart Failure|heart failure
253851|NCT01872234|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
253852|NCT01872234|Mild systolic dysfunction|mild systolic dysfunction
253853|NCT01872234|Left Bundle Branch Block|left bundle branch block
253854|NCT01872221|Glioblastoma|glioblastoma
253855|NCT01872221|Spectroscopy|spectroscopy
253856|NCT01872221|MRI|mri
253857|NCT01872221|Glioma stem cells|glioma stem cells
253858|NCT01872221|Surgery|surgery
253859|NCT01872221|Radioresistance|radioresistance
253860|NCT01872208|PAD|pad
253861|NCT01872208|Atherosclerosis|atherosclerosis
253862|NCT01872208|Peripheral circulation|peripheral circulation
253863|NCT01872208|Blood Vessel Prosthesis|blood vessel prosthesis
253864|NCT01872208|Tissue-Engineered Vascular Graft|tissue-engineered vascular graft
253865|NCT01872208|Vascular Prosthesis Implantation|vascular prosthesis implantation
253866|NCT01872208|Femoro-Popliteal Bypass|femoro-popliteal bypass
253867|NCT01872195|Checklist|checklist
253868|NCT01872195|In-Hospital Mortality|in-hospital mortality
253869|NCT01872195|In-Hospital Morbidity|in-hospital morbidity
253871|NCT01872156|Primary care|primary care
253872|NCT01872130|Moh's Surgery|moh's surgery
253873|NCT01872130|mosaicing algorithm|mosaicing algorithm
253874|NCT01872130|intraoperative imaging|intraoperative imaging
253875|NCT01872130|12-239|12-239
253876|NCT01872104|rectal cancer|rectal cancer
253877|NCT01872104|rectal adenocarcinoma|rectal adenocarcinoma
253878|NCT01872104|photodynamic therapy|photodynamic therapy
253879|NCT01872104|chemothrapy|chemothrapy
253880|NCT01872078|Pharmacokinetics, Pharmacodynamics, endocrinopathies, PCOS, female, hormone, LH|pharmacokinetics, pharmacodynamics, endocrinopathies, pcos, female, hormone, lh
253881|NCT01872039|Nicardipine|nicardipine
253882|NCT01872039|Hypertension|hypertension
253883|NCT01872039|Calcium blocker|calcium blocker
253884|NCT01872026|Plasma concentration|plasma concentration
253885|NCT01872026|Pharmacokinetics|pharmacokinetics
253886|NCT01872026|Pharmacodynamics|pharmacodynamics
253887|NCT01872026|ASP7991|asp7991
253888|NCT01872013|Plasma concentration|plasma concentration
253889|NCT01872013|Urinary concentration|urinary concentration
253890|NCT01872013|ASP7991|asp7991
253891|NCT01872000|Intraocular lens|intraocular lens
253892|NCT01872000|Phacoemulsification|phacoemulsification
253893|NCT01871987|FK949E|fk949e
253894|NCT01871987|Quetiapine|quetiapine
253895|NCT01871987|Antipsychotic|antipsychotic
253896|NCT01871974|FK949E|fk949e
253897|NCT01871974|Antipsychotic|antipsychotic
253898|NCT01871974|Quetiapine|quetiapine
253899|NCT01871909|Physical trauma|physical trauma
253900|NCT01871896|Surgical Endoscopy|surgical endoscopy
253901|NCT01871896|Morbid Obesity|morbid obesity
253902|NCT01871896|Weight Loss|weight loss
253903|NCT01871896|Bariatrics|bariatrics
253904|NCT01871896|Surgical Revision|surgical revision
253905|NCT01871883|Sensitive skin|sensitive skin
253906|NCT01871883|Transient potential receptor vanilloid 1|transient potential receptor vanilloid 1
253907|NCT01871883|TRPV1|trpv1
253908|NCT01871883|Transepidermal water loss|transepidermal water loss
253909|NCT01871883|Skin Phototype|skin phototype
253910|NCT01871883|Lactic acid test|lactic acid test
253911|NCT01871883|Skin irritancy tests|skin irritancy tests
253912|NCT01871818|Multiple sclerosis|multiple sclerosis
253913|NCT01871818|Rehabilitation|rehabilitation
253914|NCT01871818|Chronic evolutive disease|chronic evolutive disease
253915|NCT01871818|Physiotherapy|physiotherapy
253916|NCT01871818|Resistance training|resistance training
253917|NCT01871818|Endurance training|endurance training
253918|NCT01871792|Contrast-induced nephropathy|contrast-induced nephropathy
253919|NCT01871792|Prevention|prevention
253920|NCT01871792|Statin|statin
253921|NCT01871792|Pitavastatin|pitavastatin
253922|NCT01871766|Rhabdomyosarcoma|rhabdomyosarcoma
253923|NCT01871766|Radiation therapy|radiation therapy
253924|NCT01871766|Proton beam|proton beam
253925|NCT01871740|Folic acid|folic acid
253926|NCT01871740|Renal function decline|renal function decline
253927|NCT01871740|Hypertension|hypertension
253928|NCT01871740|Hyperhomocysteinemia|hyperhomocysteinemia
253929|NCT01871740|Chronic kidney disease|chronic kidney disease
253930|NCT01871740|MTHFR C677T genotype|mthfr c677t genotype
253931|NCT01871740|Randomized controlled trial|randomized controlled trial
253932|NCT01871727|Persistent or Recurrent Cutaneous T-Cell Lymphoma|persistent or recurrent cutaneous t-cell lymphoma
253933|NCT01871727|E7777|e7777
253935|NCT01871714|HED|hed
253936|NCT01871714|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
253937|NCT01871714|X Linked Hypohidrotic Ectodermal Dysplasia|x linked hypohidrotic ectodermal dysplasia
253938|NCT01871701|Corrected QT interval prolongation|corrected qt interval prolongation
253939|NCT01871701|Psychotropic drugs|psychotropic drugs
253940|NCT01871688|pelvic floor dysfunction|pelvic floor dysfunction
253941|NCT01871688|neuromodulation|neuromodulation
253942|NCT01871688|rehabilitation|rehabilitation
253943|NCT01871675|Lymphoma|lymphoma
253944|NCT01871675|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
253945|NCT01871675|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
253946|NCT01871675|T-cell Lymphoma|t-cell lymphoma
253947|NCT01871675|Rituxan|rituxan
253948|NCT01871675|Bendamustine|bendamustine
253949|NCT01871675|Hematologic Malignancy|hematologic malignancy
253950|NCT01871675|Relapsed|relapsed
253951|NCT01871675|Refractory|refractory
253952|NCT01871662|HCV|hcv
253953|NCT01871662|Hepatitis C|hepatitis c
253954|NCT01871649|psoriatic arthritis|psoriatic arthritis
253955|NCT01871649|golimumab|golimumab
253956|NCT01871649|methotrexate|methotrexate
253957|NCT01871649|minimal disease activity|minimal disease activity
253958|NCT01871649|safety|safety
253959|NCT01871649|withdrawal|withdrawal
253960|NCT01871636|endoscopy|endoscopy
253961|NCT01871636|WESD|wesd
253962|NCT01871636|EMR|emr
253963|NCT01871623|Cleft lip and palate|cleft lip and palate
253964|NCT01871623|Cone-Beam Computed Tomography|cone-beam computed tomography
253965|NCT01871623|Le Fort I Osteotomy|le fort i osteotomy
253966|NCT01871623|Segmental Osteotomy|segmental osteotomy
253968|NCT01871610|Traumatic brain injury|traumatic brain injury
253969|NCT01871610|mild TBI|mild tbi
253970|NCT01871610|Alzheimer's disease|alzheimer's disease
253971|NCT01871610|[18F]AV-45 PET amyloid binding imaging|[18f]av-45 pet amyloid binding imaging
253972|NCT01871597|Lung cancer|lung cancer
253973|NCT01871597|VATS procedure|vats procedure
253974|NCT01871597|Pulmonary Artery Sealing|pulmonary artery sealing
253975|NCT01871584|A colon hydrotherapy system|a colon hydrotherapy system
253976|NCT01871584|Hydrocolonic preparation|hydrocolonic preparation
253977|NCT01871584|Preparation for colonoscopy|preparation for colonoscopy
253978|NCT01871558|type 2 diabetes|type 2 diabetes
253979|NCT01871558|basal insulin|basal insulin
253980|NCT01871558|vildagliptin|vildagliptin
253981|NCT01871545|hepatocellular carcinoma|hepatocellular carcinoma
253982|NCT01871545|HCC|hcc
253983|NCT01871545|liver cancer|liver cancer
253984|NCT01871545|liver disease|liver disease
253985|NCT01871545|magnetic resonance imaging|magnetic resonance imaging
253986|NCT01871545|MRI|mri
253987|NCT01871532|Monofollicular Development|monofollicular development
253988|NCT01871532|Gonal-f®|gonal-f®
253989|NCT01871532|Recombinant Follicle Stimulating Hormone|recombinant follicle stimulating hormone
253990|NCT01871532|Ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
253991|NCT01871519|vertebral body compression fracture|vertebral body compression fracture
253992|NCT01871480|NSCLC|nsclc
253993|NCT01871480|CIK|cik
253994|NCT01871480|Gefitinib|gefitinib
253995|NCT01871480|Adenocarcinoma|adenocarcinoma
253996|NCT01871402|psoriasis|psoriasis
253997|NCT01871402|lotion|lotion
253998|NCT01871402|investigator's global assessment|investigator's global assessment
253999|NCT01871376|PCV|pcv
254000|NCT01871363|Preoperative Chemoradiotherapy|preoperative chemoradiotherapy
254001|NCT01871363|Bevacizumab|bevacizumab
254002|NCT01871363|Locally Advanced Rectal Cancer|locally advanced rectal cancer
254003|NCT01871350|Cancer|cancer
254004|NCT01871350|Chemotherapy|chemotherapy
254005|NCT01871350|Chemo related toxicity|chemo related toxicity
254006|NCT01871350|Protein digestion|protein digestion
254007|NCT01871350|Fat digestion|fat digestion
254008|NCT01871350|Gut function|gut function
254009|NCT01871350|Glucose absorption|glucose absorption
254010|NCT01871350|Muscle function|muscle function
254011|NCT01871337|Multiple Sclerosis|multiple sclerosis
254012|NCT01871337|urinary incontinence|urinary incontinence
254013|NCT01871311|metastatic Kras wildtype|metastatic kras wildtype
254014|NCT01871311|squamous cell carcinoma|squamous cell carcinoma
254015|NCT01871311|cetuximab|cetuximab
254016|NCT01871311|nilotinib|nilotinib
254017|NCT01871298|internet and mobile technology use|internet and mobile technology use
254018|NCT01871298|history of drug use|history of drug use
254019|NCT01871298|injection drug user (IDU) syringe customers|injection drug user (idu) syringe customers
254020|NCT01871285|ATC, Opioid, withdrawal, switch|atc, opioid, withdrawal, switch
254021|NCT01871259|Sedation, sleep apnea, propofol|sedation, sleep apnea, propofol
254022|NCT01871233|anti-epileptic drug|anti-epileptic drug
254023|NCT01871233|Extended Access Program|extended access program
254024|NCT01871233|partial onset seizures|partial onset seizures
254025|NCT01871233|Perampanel|perampanel
254026|NCT01871220|Implant Abutments|implant abutments
254027|NCT01871220|Oral Mucosa Changes|oral mucosa changes
254028|NCT01871220|Implant Esthetics|implant esthetics
254029|NCT01871207|Erythropoietin (EPO)|erythropoietin (epo)
254030|NCT01871207|Diabetes|diabetes
254031|NCT01871207|Diabetic Retinopathy|diabetic retinopathy
254032|NCT01871207|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
254033|NCT01871207|Erythropoiesis Stimulating Agents (ESA)|erythropoiesis stimulating agents (esa)
254034|NCT01871142|5 Hydroxymethyl 2 Furfural|5 hydroxymethyl 2 furfural
254035|NCT01871142|AES103|aes103
254036|NCT01871142|Exercise|exercise
254037|NCT01871129|Dexmedetomidine|dexmedetomidine
254038|NCT01871129|Postoperative Period|postoperative period
254039|NCT01871129|Airway extubation|airway extubation
254040|NCT01871129|Systolic Pressure|systolic pressure
254041|NCT01871116|breast cancer|breast cancer
254042|NCT01871116|early stage|early stage
254043|NCT01871116|weight loss|weight loss
254044|NCT01871103|Soft tissue defect|soft tissue defect
254045|NCT01871103|dorsal branch of the digital artery|dorsal branch of the digital artery
254046|NCT01871103|dorsal branch of the digital nerve|dorsal branch of the digital nerve
254047|NCT01871103|dorsal homodigital island flap|dorsal homodigital island flap
254048|NCT01871090|Remote Monitoring|remote monitoring
254049|NCT01871090|Remote Care|remote care
254050|NCT01871090|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
254051|NCT01871090|Pacemaker|pacemaker
254052|NCT01871090|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
254053|NCT01871064|Laparotomy|laparotomy
254054|NCT01871064|laparoscopic surgery|laparoscopic surgery
254055|NCT01871064|general anesthesia|general anesthesia
254056|NCT01871064|Neuromuscular Block|neuromuscular block
254057|NCT01871038|vaccine effectiveness|vaccine effectiveness
254058|NCT01871038|rotavirus|rotavirus
254059|NCT01871038|acute gastroenteritis|acute gastroenteritis
254060|NCT01871025|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
254062|NCT01871012|Intraoperative Care|intraoperative care
254063|NCT01871012|Postoperative Recovery and Complications|postoperative recovery and complications
254064|NCT01871012|Stress and Inflammation|stress and inflammation
254065|NCT01870986|Healthy Volunteers|healthy volunteers
254067|NCT01870986|PK|pk
254068|NCT01870986|adalimumab|adalimumab
254069|NCT01870986|Single-dose|single-dose
254070|NCT01870986|Immunology|immunology
254071|NCT01870986|Bioequivalence|bioequivalence
254072|NCT01870986|Biosimilarity|biosimilarity
254073|NCT01870986|Similarity.|similarity.
254074|NCT01870973|postoperative pain|postoperative pain
254075|NCT01870973|root canal treatment|root canal treatment
254076|NCT01870947|Stage I endometrial adenocarcinoma|stage i endometrial adenocarcinoma
254077|NCT01870947|Obesity|obesity
254078|NCT01870947|Exercise and Physical Fitness|exercise and physical fitness
254079|NCT01870947|Diet|diet
254080|NCT01870947|Cancer|cancer
254081|NCT01870934|Telemedicine|telemedicine
254082|NCT01870934|Diabetes|diabetes
254083|NCT01870934|Foot Ulcers|foot ulcers
254084|NCT01870895|YM060|ym060
254085|NCT01870895|Ramosetron|ramosetron
254086|NCT01870895|Diarrhea-predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
254087|NCT01870882|Opioid-Related Disorders|opioid-related disorders
254088|NCT01870882|Cocaine-Related Disorders|cocaine-related disorders
254089|NCT01870882|Substance-Related Disorders|substance-related disorders
254090|NCT01870882|Mental Disorders|mental disorders
254091|NCT01870882|Cocaine|cocaine
254092|NCT01870882|Methadone|methadone
244830|NCT01913197|Prostate Brachytherapy|prostate brachytherapy
244834|NCT01913093|Leukemia|leukemia
254093|NCT01870882|Therapeutic Uses|therapeutic uses
254094|NCT01870856|Ocular discomfort|ocular discomfort
254095|NCT01870856|Contact lenses|contact lenses
254096|NCT01870856|Myopia|myopia
254097|NCT01870843|Depressive Disorder, Major|depressive disorder, major
254098|NCT01870843|Depressive Disorder|depressive disorder
254099|NCT01870843|Depression|depression
254100|NCT01870843|Anxiety|anxiety
254101|NCT01870843|Escitalopram|escitalopram
254102|NCT01870843|Quality of life|quality of life
254103|NCT01870843|Social functionality|social functionality
254104|NCT01870817|Randomized|randomized
254105|NCT01870817|Jejunostomy|jejunostomy
254106|NCT01870817|Enteral|enteral
254107|NCT01870817|Nutrition|nutrition
254108|NCT01870817|Esophagectomy|esophagectomy
254109|NCT01870817|Gastrectomy|gastrectomy
254110|NCT01870804|Statins|statins
254111|NCT01870804|Contrast-Induced Acute Kidney Injury|contrast-induced acute kidney injury
254112|NCT01870804|Periprocedural Myocardial Damage|periprocedural myocardial damage
254113|NCT01870791|Esophageal adenocarcinoma|esophageal adenocarcinoma
254114|NCT01870791|Gastric adenocarcinoma|gastric adenocarcinoma
254115|NCT01870778|acute heart failure,|acute heart failure,
254116|NCT01870778|AHF,|ahf,
254117|NCT01870778|multi-center,|multi-center,
254118|NCT01870778|randomized,|randomized,
254119|NCT01870778|double-blind|double-blind
254120|NCT01870739|LCZ696,|lcz696,
254121|NCT01870739|Hypertension,|hypertension,
254122|NCT01870739|Aortic stiffness,|aortic stiffness,
254123|NCT01870739|Central blood pressure,|central blood pressure,
254124|NCT01870739|Cardiovascular MRI|cardiovascular mri
254125|NCT01870713|gastric bypass surgery|gastric bypass surgery
254126|NCT01870713|proteomics|proteomics
254127|NCT01870687|vitex agnus castus|vitex agnus castus
254128|NCT01870687|clinical trial|clinical trial
254129|NCT01870687|cyclic mastodynia|cyclic mastodynia
254151|NCT01870583|Cesarean delivery|cesarean delivery
254152|NCT01870583|Surgical site infection|surgical site infection
254154|NCT01870583|Postpartum|postpartum
254156|NCT01870570|Insulinemia|insulinemia
254157|NCT01870557|Diabetes Mellitus|diabetes mellitus
254158|NCT01870557|Bone|bone
254159|NCT01870557|Bone Status|bone status
254160|NCT01870557|Glycemic Markers|glycemic markers
254161|NCT01870557|Osteoporosis|osteoporosis
254162|NCT01870557|Osteopenia|osteopenia
254163|NCT01870544|gastric bypass|gastric bypass
254164|NCT01870544|microbiota|microbiota
254165|NCT01870544|probiotic|probiotic
254166|NCT01870531|Transient Ischemic Attack|transient ischemic attack
254167|NCT01870518|Parkinson's disease|parkinson's disease
254168|NCT01870518|Dementia|dementia
254169|NCT01870505|BYL719|byl719
254170|NCT01870505|Letrozole|letrozole
254171|NCT01870505|Exemestane|exemestane
254172|NCT01870505|13-027|13-027
254173|NCT01870492|IV-tPA|iv-tpa
254174|NCT01870492|Activase|activase
254175|NCT01870492|endovascular therapy|endovascular therapy
254176|NCT01870479|Malignant Lymphoma|malignant lymphoma
254177|NCT01870479|Chemotherapy|chemotherapy
254178|NCT01870479|Music therapy|music therapy
254179|NCT01870453|Alzheimer Disease|alzheimer disease
254180|NCT01870453|Dementia|dementia
254181|NCT01870453|Postoperative Care|postoperative care
254182|NCT01870453|Cognitive Reserve|cognitive reserve
254183|NCT01870440|Uveitis|uveitis
254184|NCT01870440|Macular Edema|macular edema
254185|NCT01870427|Macular Edema|macular edema
254186|NCT01870427|Central Retinal Vein Occlusion|central retinal vein occlusion
254187|NCT01870427|CRVO|crvo
254188|NCT01870427|Aflibercept|aflibercept
254189|NCT01870427|VEGF Trap-Eye|vegf trap-eye
254190|NCT01870427|Eylea|eylea
254191|NCT01870427|Ranibizumab|ranibizumab
254192|NCT01870427|Bevacizumab|bevacizumab
254215|NCT01870349|cytokines|cytokines
254216|NCT01870349|dental implants|dental implants
254217|NCT01870349|peri-implantitis|peri-implantitis
254218|NCT01870310|Heart failure|heart failure
254219|NCT01870310|Renal denervation|renal denervation
254220|NCT01870271|PTSD|ptsd
254221|NCT01870271|childhood sexual abuse|childhood sexual abuse
254222|NCT01870271|physical abuse|physical abuse
254223|NCT01870271|developmentally adapted cognitive processing therapy|developmentally adapted cognitive processing therapy
254224|NCT01870258|Myocardial infarction|myocardial infarction
254225|NCT01870258|artificial neural networks|artificial neural networks
254226|NCT01870258|Electrocardiography|electrocardiography
254227|NCT01870232|Greater palatine nerve Block|greater palatine nerve block
254228|NCT01870232|Inferior Alveolar nerve block|inferior alveolar nerve block
254229|NCT01870232|dental anesthesia|dental anesthesia
254230|NCT01870232|Ultrasonography|ultrasonography
254231|NCT01870219|sevoflurane|sevoflurane
254232|NCT01870219|ketamine|ketamine
254233|NCT01870219|QT interval|qt interval
254234|NCT01870206|Immunogenicity|immunogenicity
254235|NCT01870206|Safety|safety
244940|NCT01912521|HIV|hiv
254236|NCT01870206|Efficacy|efficacy
254237|NCT01870206|Poliomyelitis|poliomyelitis
254238|NCT01870206|Newborn|newborn
254239|NCT01870193|Glutathione deficiency in aging|glutathione deficiency in aging
254240|NCT01870193|Impaired mitochondrial fatty-acid oxidation in aging|impaired mitochondrial fatty-acid oxidation in aging
254241|NCT01870180|Meibomian Glad Dysfunction|meibomian glad dysfunction
254242|NCT01870180|EyeBag|eyebag
254243|NCT01870180|Hot Compress|hot compress
254244|NCT01870180|Dry Eyes|dry eyes
254245|NCT01870167|PEG|peg
254246|NCT01870167|Percutaneous Endoscopic Gastrostomy|percutaneous endoscopic gastrostomy
254247|NCT01870167|antibiotic prophylaxis|antibiotic prophylaxis
254248|NCT01870154|Burnout syndrome|burnout syndrome
254249|NCT01870154|Job stressors|job stressors
254250|NCT01870154|Primary Health Care|primary health care
254251|NCT01870154|Health professional|health professional
254252|NCT01870141|Glucose Control|glucose control
254253|NCT01870141|Depression|depression
254254|NCT01870141|Self-Efficacy|self-efficacy
254255|NCT01870128|Rheumatoid arthritis|rheumatoid arthritis
254256|NCT01870128|Steroid|steroid
254257|NCT01870115|Melatonin|melatonin
254258|NCT01870115|Strontium Citrate|strontium citrate
254259|NCT01870115|Osteoporosis|osteoporosis
254260|NCT01870115|Osteopenia|osteopenia
254261|NCT01870089|Non invasive ventilation|non invasive ventilation
254262|NCT01870089|Computer-driven system|computer-driven system
254263|NCT01870089|Acute respiratory failure|acute respiratory failure
254264|NCT01870063|5 minute bleeding test|5 minute bleeding test
254265|NCT01870063|swamb|swamb
254266|NCT01870063|fibtem|fibtem
254267|NCT01870063|extem|extem
254268|NCT01870050|lichen simplex chronicus|lichen simplex chronicus
254269|NCT01870050|prurigo|prurigo
254270|NCT01870037|OAB, gene therapy|oab, gene therapy
254271|NCT01870024|status epilepticus|status epilepticus
254272|NCT01870024|epilepsy|epilepsy
254273|NCT01870024|seizures|seizures
254274|NCT01870024|convulsive seizures|convulsive seizures
254275|NCT01870024|convulsions|convulsions
254276|NCT01870024|benzodiazepines|benzodiazepines
254277|NCT01870024|anticonvulsants|anticonvulsants
254278|NCT01870011|Propofol, renal protection, kidney transplantation|propofol, renal protection, kidney transplantation
254279|NCT01869998|Vortex|vortex
254280|NCT01869998|Thrombus|thrombus
254281|NCT01869998|Contrast echocardiography|contrast echocardiography
254282|NCT01869998|Prediction and prevention of apical thrombus formation in acute myocardial infarction patient by using Vortex parameters.|prediction and prevention of apical thrombus formation in acute myocardial infarction patient by using vortex parameters.
254283|NCT01869985|HCP1104|hcp1104
254284|NCT01869985|Eperisone Hydrochloride|eperisone hydrochloride
254285|NCT01869985|Aceclofenac|aceclofenac
254286|NCT01869972|PKU|pku
254287|NCT01869972|phenylketonuria|phenylketonuria
254288|NCT01869972|hyperphenylalaninemia|hyperphenylalaninemia
254289|NCT01869972|Kuvan|kuvan
254290|NCT01869972|sapropterin|sapropterin
254291|NCT01869946|Hip arthroplasty|hip arthroplasty
254292|NCT01869933|Proliferative, Diabetic, Retinopathy|proliferative, diabetic, retinopathy
254293|NCT01869920|breastfeeding|breastfeeding
254294|NCT01869920|education|education
254295|NCT01869920|intervention|intervention
254296|NCT01869894|Malignant biliary obstruction|malignant biliary obstruction
254297|NCT01869894|metal stent|metal stent
254298|NCT01869894|patency|patency
254299|NCT01869855|chronic subdural hematoma|chronic subdural hematoma
254300|NCT01869855|traumatic brain injury|traumatic brain injury
254301|NCT01869855|burr hole trepanation|burr hole trepanation
254302|NCT01869855|drainage after evacuation of chronic subdural hematoma|drainage after evacuation of chronic subdural hematoma
254303|NCT01869855|intracranial bleed|intracranial bleed
5870|NCT03253861|Pancreatitis/surgery|pancreatitis/surgery
254325|NCT01869673|extubation|extubation
254326|NCT01869673|nasal surgery|nasal surgery
254327|NCT01869660|First hospitalization|first hospitalization
254328|NCT01869647|kidney stones|kidney stones
254329|NCT01869634|HIV|hiv
254330|NCT01869634|cardiovascular risk|cardiovascular risk
254429|NCT01869218|Cancer|cancer
254331|NCT01869634|systemic immune activation|systemic immune activation
254332|NCT01869608|postpartum screening|postpartum screening
254333|NCT01869608|type 2 diabetes|type 2 diabetes
254334|NCT01869595|2000 MSM and TG sites in Bangkok,Lampang,Ubonratchathani|2000 msm and tg sites in bangkok,lampang,ubonratchathani
254335|NCT01869582|Fetal hypoxia|fetal hypoxia
254336|NCT01869582|Birth asphyxia|birth asphyxia
254337|NCT01869582|Neonatal resuscitation|neonatal resuscitation
254338|NCT01869569|Radiation|radiation
254339|NCT01869569|Neuropathic Pain|neuropathic pain
254340|NCT01869569|Pregabalin|pregabalin
254341|NCT01869556|pregnancy|pregnancy
254342|NCT01869556|postpartum hemorrhage|postpartum hemorrhage
254343|NCT01869556|Cesarean delivery|cesarean delivery
254344|NCT01869556|failure to progress in labor|failure to progress in labor
254345|NCT01869504|Ballooned intercostal drain|ballooned intercostal drain
254346|NCT01869504|Pleural effusion|pleural effusion
254347|NCT01869491|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
254348|NCT01869491|GERD|gerd
254349|NCT01869491|Dyspepsia|dyspepsia
254350|NCT01869491|Indigestion|indigestion
254351|NCT01869491|Heartburn|heartburn
254352|NCT01869491|Acid reflux|acid reflux
254353|NCT01869491|Compound Sodium Alginate Double Action Chewable Tablets|compound sodium alginate double action chewable tablets
254354|NCT01869491|Gaviscon Double Action Tablets|gaviscon double action tablets
254355|NCT01869452|education|education
254356|NCT01869452|risk factors|risk factors
254357|NCT01869452|quality of life|quality of life
254358|NCT01869452|coronary disease|coronary disease
254359|NCT01869452|telephone follow up|telephone follow up
254360|NCT01869452|dedicated nurse|dedicated nurse
254361|NCT01869439|Pressure Ulcers|pressure ulcers
254362|NCT01869439|Bed Sores|bed sores
254363|NCT01869439|Measuring|measuring
254364|NCT01869439|Visual Images|visual images
254365|NCT01869439|Thermal Images|thermal images
254366|NCT01869439|External Wounds|external wounds
254367|NCT01869439|Area|area
254368|NCT01869439|Length|length
254369|NCT01869439|Width|width
254370|NCT01869439|Gradiency|gradiency
254371|NCT01869426|colics|colics
254372|NCT01869413|urothelial cell carcinoma|urothelial cell carcinoma
254373|NCT01869413|transition cell carcinoma|transition cell carcinoma
254374|NCT01869413|bladder cancer|bladder cancer
254375|NCT01869413|radical cystectomy|radical cystectomy
254376|NCT01869413|cystectomy|cystectomy
254377|NCT01869413|bladder removal|bladder removal
254378|NCT01869413|tranexamic acid|tranexamic acid
254379|NCT01869413|cyklokapron|cyklokapron
254380|NCT01869374|Depression|depression
254130|NCT01870687|PMS|pms
254381|NCT01869374|Brain Stimulation|brain stimulation
254382|NCT01869374|Seizure therapy|seizure therapy
254383|NCT01869374|Convulsive Therapy|convulsive therapy
254384|NCT01869361|preterm labor|preterm labor
254386|NCT01869361|indomethacin|indomethacin
254387|NCT01869348|Physical activity|physical activity
254388|NCT01869348|Activity monitor|activity monitor
254389|NCT01869348|Technology|technology
254390|NCT01869348|Obesity|obesity
254391|NCT01869348|Aging muscle|aging muscle
254392|NCT01869335|breast cancer|breast cancer
254393|NCT01869335|MRI|mri
254394|NCT01869335|mammography|mammography
254395|NCT01869335|microcalcifications|microcalcifications
254396|NCT01869335|Local staging of breast microcalcifications|local staging of breast microcalcifications
402009|NCT01233492|adult glioblastoma|adult glioblastoma
254397|NCT01869335|Evaluation of ex vivo MRI for breast malignancies detected by MRI only|evaluation of ex vivo mri for breast malignancies detected by mri only
254398|NCT01869322|Humerus|humerus
254399|NCT01869322|Fracture|fracture
254400|NCT01869322|Sling|sling
254401|NCT01869322|Splint|splint
254402|NCT01869322|Coaptation|coaptation
254403|NCT01869309|Coronary artery disease|coronary artery disease
254404|NCT01869309|anti-platelet medications|anti-platelet medications
254405|NCT01869309|Platelet-aggregation Inhibitors|platelet-aggregation inhibitors
254406|NCT01869296|unsedated|unsedated
254407|NCT01869296|water immersion colonoscopy|water immersion colonoscopy
254408|NCT01869296|endoscope water pump flow rates|endoscope water pump flow rates
254409|NCT01869283|Physical Therapy Modalities|physical therapy modalities
254410|NCT01869283|Myofascial Pain Syndromes|myofascial pain syndromes
254411|NCT01869283|Skeletal Muscle|skeletal muscle
254412|NCT01869270|hexosaminidase deficiency|hexosaminidase deficiency
254413|NCT01869270|Tay-Sachs disease|tay-sachs disease
254414|NCT01869270|Sandhoff disease|sandhoff disease
254415|NCT01869270|late-onset Tay-Sachs disease|late-onset tay-sachs disease
254416|NCT01869270|adult-onset Tay-Sachs disease|adult-onset tay-sachs disease
254417|NCT01869270|late onset Tay Sachs disease|late onset tay sachs disease
254418|NCT01869270|adult onset Tay Sachs disease|adult onset tay sachs disease
254419|NCT01869270|retrospective|retrospective
254420|NCT01869270|hexosaminidase A activity|hexosaminidase a activity
254421|NCT01869270|GM2-ganglioside|gm2-ganglioside
254422|NCT01869270|gangliosidoses|gangliosidoses
254423|NCT01869270|natural history|natural history
254424|NCT01869270|hexosaminidase|hexosaminidase
254425|NCT01869257|triclosan|triclosan
254426|NCT01869257|colorectal|colorectal
254427|NCT01869257|surgery|surgery
254428|NCT01869257|surgical site infection|surgical site infection
254430|NCT01869218|Advanced|advanced
254431|NCT01869218|Solid|solid
254432|NCT01869218|Hematological|hematological
254433|NCT01869218|Malignancy|malignancy
254434|NCT01869218|Tissue|tissue
254435|NCT01869218|Bank|bank
254436|NCT01869205|COPD|copd
254437|NCT01869205|Emphysema|emphysema
254438|NCT01869205|Bronchoscopic lung volume reduction|bronchoscopic lung volume reduction
254439|NCT01869205|Endobronchial valve|endobronchial valve
254440|NCT01869192|Malignant|malignant
254441|NCT01869192|Neoplasm|neoplasm
254442|NCT01869192|Cancer|cancer
254443|NCT01869192|Female|female
254444|NCT01869192|Breast|breast
254445|NCT01869192|Stage II|stage ii
254446|NCT01869192|Stage III|stage iii
254447|NCT01869179|Well being|well being
254448|NCT01869179|Low income|low income
254449|NCT01869179|Choir singing|choir singing
254450|NCT01869179|Spanish speaking|spanish speaking
254451|NCT01869179|Community based|community based
254452|NCT01869179|Seniors|seniors
254453|NCT01869179|60+ aged adults|60+ aged adults
254454|NCT01869166|chemotherapy and/or EGFR-antibody/kinase inhibitor therapy refractory solid tumors|chemotherapy and/or egfr-antibody/kinase inhibitor therapy refractory solid tumors
254455|NCT01869153|Growth, weight|growth, weight
254456|NCT01869127|hookworm|hookworm
254457|NCT01869127|necator americanus|necator americanus
254458|NCT01869127|ancyclostoma duodenale|ancyclostoma duodenale
254459|NCT01869127|shoes|shoes
254460|NCT01869127|anaemia|anaemia
254461|NCT01869127|children|children
254462|NCT01869101|Prediabetes|prediabetes
254463|NCT01869101|Diabetes prevention|diabetes prevention
254464|NCT01869088|TACE|tace
254465|NCT01869088|Carcinoma,Hepatocellular|carcinoma,hepatocellular
254466|NCT01869088|Liver Neoplasms|liver neoplasms
254467|NCT01869088|overall survival|overall survival
254468|NCT01869088|Recombinant Human Adenovirus Type 5 Injection|recombinant human adenovirus type 5 injection
254469|NCT01869075|Quality Improvement|quality improvement
254470|NCT01869075|Patient Safety|patient safety
254471|NCT01869075|Knowledge Translation|knowledge translation
254472|NCT01869062|CRT|crt
254473|NCT01869049|Immune Thrombocytopenia|immune thrombocytopenia
254474|NCT01869049|macrophage|macrophage
254475|NCT01869049|spleen tissue|spleen tissue
254476|NCT01869036|Caudal|caudal
254477|NCT01869036|anesthesia|anesthesia
254478|NCT01869036|morphine|morphine
254479|NCT01869036|children|children
254480|NCT01869023|Advanced Malignant Pleural Mesothelioma|advanced malignant pleural mesothelioma
254481|NCT01869023|Gemcitabine and cisplatin|gemcitabine and cisplatin
254482|NCT01869023|Gemcitabine continuous infusion|gemcitabine continuous infusion
254483|NCT01869010|HIV infection|hiv infection
254484|NCT01869010|Antiretroviral treatment|antiretroviral treatment
254485|NCT01869010|Renal disease|renal disease
254486|NCT01869010|Renal tubular damage|renal tubular damage
254487|NCT01869010|Free-water clearance|free-water clearance
254488|NCT01868997|Thyroid Eye Disease, Graves Orbitopathy, Thyroid Associated|thyroid eye disease, graves orbitopathy, thyroid associated
254489|NCT01868997|Ophthalmopathy|ophthalmopathy
254490|NCT01868971|EndoRings|endorings
254491|NCT01868958|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
254492|NCT01868958|Diffusion tensor imaging|diffusion tensor imaging
254493|NCT01868958|Spine|spine
254494|NCT01868945|Vitamin D3|vitamin d3
254495|NCT01868945|Calcifediol 25|calcifediol 25
254496|NCT01868945|Frail|frail
254497|NCT01868945|Dose-response|dose-response
254498|NCT01868932|wheeze|wheeze
254499|NCT01868932|early childhood|early childhood
254500|NCT01868932|asthma|asthma
254501|NCT01868932|bronchiolitis|bronchiolitis
254502|NCT01868932|infection triggered|infection triggered
254503|NCT01868919|"Pilot Projects[Mesh]"|"pilot projects[mesh]"
254504|NCT01868919|"Parenting[Mesh]"|"parenting[mesh]"
254505|NCT01868919|"Child Behaviour[Mesh]"|"child behaviour[mesh]"
254506|NCT01868919|"Mental Health[Mesh]"|"mental health[mesh]"
254507|NCT01868919|"Family Practice[Mesh]"|"family practice[mesh]"
254508|NCT01868906|Anaplastic Astrocytoma|anaplastic astrocytoma
254509|NCT01868906|Brain Tumors|brain tumors
254510|NCT01868906|Cancer Imaging|cancer imaging
254511|NCT01868906|Fluoromisonidazole|fluoromisonidazole
254512|NCT01868906|FMISO PET|fmiso pet
254513|NCT01868906|Glioblastoma|glioblastoma
254514|NCT01868906|High Grade Glioma|high grade glioma
254515|NCT01868906|Hypoxia Modification|hypoxia modification
254516|NCT01868906|Positron Emission Tomography|positron emission tomography
254517|NCT01868906|Radiation-Sensitizing Agents|radiation-sensitizing agents
254518|NCT01868906|Spinal Cord Stimulation|spinal cord stimulation
254519|NCT01868906|Tumor Hypoxia Measurement|tumor hypoxia measurement
254520|NCT01868854|Tip catheter|tip catheter
254521|NCT01868854|Peritoneal Dialysis|peritoneal dialysis
254522|NCT01868854|Risk Factot|risk factot
254523|NCT01868854|Mecanical Function|mecanical function
254524|NCT01868841|123I-mIBG|123i-mibg
254525|NCT01868841|AdreView|adreview
254526|NCT01868841|SPECT|spect
254527|NCT01868841|Heart to Mediastinal Ratio|heart to mediastinal ratio
254528|NCT01868828|Multiple Myeloma|multiple myeloma
254529|NCT01868828|Combination Therapy|combination therapy
254530|NCT01868802|Ketamine|ketamine
254531|NCT01868802|Depression|depression
254532|NCT01868802|Depressive Disorder|depressive disorder
254533|NCT01868789|Adult-acquired flatfoot disorder (AAFD)|adult-acquired flatfoot disorder (aafd)
254534|NCT01868789|flexible flatfoot|flexible flatfoot
254535|NCT01868789|computed tomography (CT)|computed tomography (ct)
254536|NCT01868763|telemedicine|telemedicine
254537|NCT01868763|coaching|coaching
254538|NCT01868763|lifestyle change|lifestyle change
254539|NCT01868763|weight loss|weight loss
254540|NCT01868737|Human Immunodeficiency Virus|human immunodeficiency virus
254541|NCT01868737|Necrotizing Enterocolitis|necrotizing enterocolitis
254542|NCT01868737|Premature infant|premature infant
254543|NCT01868737|Probiotic|probiotic
254544|NCT01868737|Very Low Birth Weight|very low birth weight
254545|NCT01868724|Kidney Renal|kidney renal
254546|NCT01868711|Major Depressive Disorder|major depressive disorder
254547|NCT01868711|Cognitive Behavior Therapy|cognitive behavior therapy
254548|NCT01868711|Psychological Mindedness|psychological mindedness
254549|NCT01868698|Physical Therapy Modalities|physical therapy modalities
254550|NCT01868698|Electric Stimulation Therapy|electric stimulation therapy
254551|NCT01868698|Hyperthermia, Induced|hyperthermia, induced
254552|NCT01868698|Diabetes Mellitus|diabetes mellitus
254553|NCT01868685|Muscle, anabolism, cachexia, respiratory failure, diaphragm|muscle, anabolism, cachexia, respiratory failure, diaphragm
254554|NCT01868672|Secondhand smoke exposure|secondhand smoke exposure
254555|NCT01868672|Smoke-free homes|smoke-free homes
254556|NCT01868672|Smoke-free home bans|smoke-free home bans
254557|NCT01868646|Combined Treatment of Patients With Type II Diabetes Mellitus|combined treatment of patients with type ii diabetes mellitus
254558|NCT01868633|Cesarean delivery|cesarean delivery
254559|NCT01868633|Analgesia|analgesia
254560|NCT01868633|Pain|pain
254561|NCT01868633|Dexamethasone|dexamethasone
254562|NCT01868633|intrathecal morphine|intrathecal morphine
254563|NCT01868633|spinal anesthesia|spinal anesthesia
254564|NCT01868620|Progressive keratoconus|progressive keratoconus
254565|NCT01868620|standard CXL|standard cxl
254566|NCT01868620|iontophoretic CXL|iontophoretic cxl
254567|NCT01868620|keratometry|keratometry
254568|NCT01868607|Respiratory resistance|respiratory resistance
254569|NCT01868607|Respiratory reactance|respiratory reactance
254570|NCT01868607|Adult lung function|adult lung function
254571|NCT01868607|Forced oscillation technique|forced oscillation technique
254572|NCT01868607|subjects|subjects
5871|NCT03253861|Pancreatitis/therapy|pancreatitis/therapy
254573|NCT01868594|Combined treatment of patients with type I diabetes mellitus|combined treatment of patients with type i diabetes mellitus
254574|NCT01868490|Cholangiocarcinoma|cholangiocarcinoma
254575|NCT01868490|Cytokine induced killer cells|cytokine induced killer cells
254577|NCT01868490|Treg|treg
254578|NCT01868490|Th17|th17
254579|NCT01868477|myelodysplastic syndrome|myelodysplastic syndrome
254581|NCT01868477|myelodysplasia|myelodysplasia
254582|NCT01868477|blood disorder|blood disorder
254583|NCT01868477|cytopenias|cytopenias
254584|NCT01868477|low blood counts|low blood counts
254585|NCT01868477|progressive bone marrow failure|progressive bone marrow failure
254586|NCT01868464|challenge|challenge
254587|NCT01868464|Mycobacterium tuberculosis|mycobacterium tuberculosis
693501|NCT00941499|Eloxatin|eloxatin
254588|NCT01868464|parent protocol|parent protocol
254589|NCT01868464|TB|tb
254590|NCT01868464|Tice BCG|tice bcg
254591|NCT01868464|tuberculosis|tuberculosis
254592|NCT01868451|DACARBAZINE|dacarbazine
254593|NCT01868451|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
254594|NCT01868451|SGN-35 (BRENTUXIMAB VEDOTIN)|sgn-35 (brentuximab vedotin)
254595|NCT01868451|VINBLASTINE|vinblastine
254596|NCT01868451|Involved-site radiation therapy (ISRT)|involved-site radiation therapy (isrt)
254597|NCT01868451|Early stage|early stage
254598|NCT01868451|13-034|13-034
254599|NCT01868438|Pyronaridine artesunate tablet|pyronaridine artesunate tablet
254600|NCT01868438|Pyronaridine artesunate granules|pyronaridine artesunate granules
254601|NCT01868438|Pyramax tablet|pyramax tablet
254602|NCT01868438|Pyramax granules|pyramax granules
254603|NCT01868438|Bioavailability|bioavailability
254604|NCT01868412|Wound healing|wound healing
254605|NCT01868412|Wound infection|wound infection
254606|NCT01868412|Resin salve|resin salve
254607|NCT01868412|Medical honey|medical honey
254608|NCT01868399|dengue virus|dengue virus
254609|NCT01868386|Radiotherapy, hypofractionated|radiotherapy, hypofractionated
254610|NCT01868386|Salvage therapy|salvage therapy
254611|NCT01868386|Radiotherapy, adjuvant|radiotherapy, adjuvant
254612|NCT01868373|commensal microbiota bacteroides colitis pseudomembranous|commensal microbiota bacteroides colitis pseudomembranous
254613|NCT01868360|cornea|cornea
254614|NCT01868360|transplant|transplant
254615|NCT01868360|graft|graft
254616|NCT01868360|neovascularization|neovascularization
254617|NCT01868347|obese patients|obese patients
254618|NCT01868347|specific elastance|specific elastance
254619|NCT01868347|Trendelenburg Position|trendelenburg position
254620|NCT01868347|Pneumoperitoneum|pneumoperitoneum
254621|NCT01868347|robotic surgery|robotic surgery
254622|NCT01868347|Prostatectomy|prostatectomy
254623|NCT01868334|influenza vaccine|influenza vaccine
254624|NCT01868334|PPSV|ppsv
254625|NCT01868334|Tdap|tdap
254626|NCT01868334|vaccination|vaccination
254627|NCT01868334|adult|adult
254628|NCT01868321|Mechanical ventilation|mechanical ventilation
254629|NCT01868321|Acute respiratory failure|acute respiratory failure
254630|NCT01868321|Acute respiratory distress syndrome|acute respiratory distress syndrome
254631|NCT01868282|anterior cruciate ligament repair, Obturator nerve block, Hamstrings graft, Ropivacaine,|anterior cruciate ligament repair, obturator nerve block, hamstrings graft, ropivacaine,
254632|NCT01868282|Postoperative pain|postoperative pain
254633|NCT01868256|myocardial infarction|myocardial infarction
254634|NCT01868256|primary percutaneous intervention|primary percutaneous intervention
245352|NCT01910493|SMS|sms
254635|NCT01868256|prognosis|prognosis
254636|NCT01868256|early discharge|early discharge
254637|NCT01868243|Atrial Fibrillation|atrial fibrillation
254638|NCT01868243|Bioprosthesis|bioprosthesis
254639|NCT01868243|Stroke|stroke
254640|NCT01868243|Dabigatran|dabigatran
254641|NCT01868243|Warfarin|warfarin
254642|NCT01868204|Obesity|obesity
254643|NCT01868204|Binge eating disorder|binge eating disorder
254644|NCT01868204|Pharmacogenetic|pharmacogenetic
254645|NCT01868204|Food craving|food craving
254646|NCT01868204|Brain areas|brain areas
254647|NCT01868204|Topiramate|topiramate
254648|NCT01868191|Diabetes|diabetes
254649|NCT01868191|Neuropathy|neuropathy
254650|NCT01868178|awareness|awareness
254651|NCT01868165|Cognitive decline|cognitive decline
254652|NCT01868165|High blood pressure|high blood pressure
254653|NCT01868165|Hypertension|hypertension
254654|NCT01868165|Ageing|ageing
254655|NCT01868165|Dementia|dementia
254656|NCT01868165|Antihypertensives|antihypertensives
254657|NCT01868152|sufentanil|sufentanil
254658|NCT01868152|individual variation|individual variation
254659|NCT01868152|pain threshold|pain threshold
254660|NCT01868152|narcotrend index|narcotrend index
254661|NCT01868139|Cryotherapy|cryotherapy
254662|NCT01868139|Esophageal cancer|esophageal cancer
254663|NCT01868139|Esophageal carcinoma|esophageal carcinoma
254664|NCT01868139|Liquid nitrogen|liquid nitrogen
254665|NCT01868139|Esophageal adenocarcinoma|esophageal adenocarcinoma
254666|NCT01868139|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
254667|NCT01868139|Endoscopy|endoscopy
254668|NCT01868139|Ablation|ablation
254669|NCT01868126|Santen|santen
254670|NCT01868126|Eye|eye
254671|NCT01868126|Glaucoma|glaucoma
254673|NCT01868113|Children U-5|children u-5
254674|NCT01868113|ALRI|alri
254675|NCT01868113|Inhaled Corticosteroids|inhaled corticosteroids
254676|NCT01868100|Cancer|cancer
254677|NCT01868100|quality of life|quality of life
254678|NCT01868100|palliative care|palliative care
254679|NCT01868100|supportive care|supportive care
254680|NCT01868100|Financial distress|financial distress
254681|NCT01868087|nutritional supplement|nutritional supplement
254682|NCT01868087|immune system|immune system
254683|NCT01868087|RC surgery|rc surgery
254684|NCT01868074|pregnancy, arch height, collapsed arch|pregnancy, arch height, collapsed arch
254685|NCT01868048|Spasticity|spasticity
254686|NCT01868048|Multiple Sclerosis|multiple sclerosis
254687|NCT01868035|radioimmunotherapy|radioimmunotherapy
254688|NCT01868035|Iodine 131 Tositumomab|iodine 131 tositumomab
254689|NCT01868022|FGFR1|fgfr1
254690|NCT01868022|FP1039|fp1039
254691|NCT01868022|GSK3052230|gsk3052230
254692|NCT01868022|docetaxel|docetaxel
254693|NCT01868022|FGFR|fgfr
254694|NCT01868022|carboplatin|carboplatin
254695|NCT01868022|HGS1036|hgs1036
254696|NCT01868022|squamous non-small cell lung cancer|squamous non-small cell lung cancer
254697|NCT01868022|paclitaxel|paclitaxel
254698|NCT01868009|fluticasone furoate|fluticasone furoate
254699|NCT01868009|COPD|copd
254700|NCT01868009|ELLIPTA|ellipta
254701|NCT01868009|fluticasone propionate|fluticasone propionate
254702|NCT01868009|DISKUS|diskus
254703|NCT01868009|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
254704|NCT01868009|device preference|device preference
254705|NCT01868009|salmeterol|salmeterol
254706|NCT01868009|vilanterol|vilanterol
254707|NCT01867996|Retosiban, Efavirenz, Induction|retosiban, efavirenz, induction
254708|NCT01867983|Tobacco cessation|tobacco cessation
254709|NCT01867983|Weight gain prevention|weight gain prevention
254710|NCT01867970|remote sensing technology|remote sensing technology
254711|NCT01867970|physical activity|physical activity
254712|NCT01867970|self-management support|self-management support
254713|NCT01867970|primary care nursing|primary care nursing
254714|NCT01867957|anthrax|anthrax
254715|NCT01867957|vaccine|vaccine
254716|NCT01867957|bioterrorism|bioterrorism
254717|NCT01867957|efficacy|efficacy
254718|NCT01867957|safety|safety
254719|NCT01867944|Chronic constipation|chronic constipation
254720|NCT01867944|Hemorrhoids|hemorrhoids
254721|NCT01867944|Acupressure|acupressure
254722|NCT01867905|Severe sepsis|severe sepsis
254723|NCT01867905|Septic shock|septic shock
254724|NCT01867905|Bacteremia|bacteremia
254725|NCT01867905|Antibiotics|antibiotics
254726|NCT01867905|Blood culture positivity|blood culture positivity
254821|NCT01867437|Healthy Volunteers|healthy volunteers
254727|NCT01867892|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
254728|NCT01867879|Advanced solid tumors (excluding breast cancer) for which no standard therapy exists|advanced solid tumors (excluding breast cancer) for which no standard therapy exists
254729|NCT01867866|Advanced solid tumors (excluding breast cancer) for which no standard therapy exists|advanced solid tumors (excluding breast cancer) for which no standard therapy exists
254730|NCT01867801|PCI|pci
254731|NCT01867801|Coronary disease|coronary disease
254732|NCT01867801|Ischemia|ischemia
254733|NCT01867775|Alzheimer's disease|alzheimer's disease
254734|NCT01867775|Sleep disorders|sleep disorders
254735|NCT01867775|Mirtazapine|mirtazapine
254736|NCT01867775|Treatment|treatment
254737|NCT01867775|Intervention|intervention
254738|NCT01867775|insomnia|insomnia
254739|NCT01867762|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
254740|NCT01867762|JNJ 49095397|jnj 49095397
254741|NCT01867762|RV568|rv568
254742|NCT01867762|Forced expiratory volume in one second|forced expiratory volume in one second
254743|NCT01867762|FEV1|fev1
254744|NCT01867749|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
254745|NCT01867749|Miscarriage|miscarriage
254746|NCT01867749|Stillbirth|stillbirth
254747|NCT01867749|Neonatal death|neonatal death
254748|NCT01867749|Interpersonal psychotherapy|interpersonal psychotherapy
254749|NCT01867749|Group Therapy|group therapy
254750|NCT01867749|Coping with Depression (CWD)|coping with depression (cwd)
254751|NCT01867736|Stenosis|stenosis
254752|NCT01867736|Occlusions|occlusions
254753|NCT01867736|Infrapopliteal arteries|infrapopliteal arteries
254754|NCT01867736|Below the knee arteries|below the knee arteries
254755|NCT01867736|PTA|pta
254756|NCT01867736|POBA|poba
254757|NCT01867736|DRB|drb
254758|NCT01867723|Cancer internet support program|cancer internet support program
254759|NCT01867710|Mineralocorticoid Excess ; Chemotherapy-Naïve; Metastatic Castration-Resistant Prostate Cancer; Abiraterone Acetate; Zytiga; Prednisone; dexamethasone|mineralocorticoid excess ; chemotherapy-naïve; metastatic castration-resistant prostate cancer; abiraterone acetate; zytiga; prednisone; dexamethasone
254760|NCT01867684|Stroke|stroke
254761|NCT01867684|Acquired brain injury|acquired brain injury
254762|NCT01867671|Allergy, Peanut|allergy, peanut
254763|NCT01867671|Peanut allergy|peanut allergy
254764|NCT01867671|Hypersensitivity|hypersensitivity
254765|NCT01867671|Immunotherapy|immunotherapy
254576|NCT01868490|CIK|cik
254766|NCT01867671|Desensitization, Immunologic|desensitization, immunologic
254767|NCT01867658|Pleural Air Leak|pleural air leak
254768|NCT01867658|Pulmonary resection|pulmonary resection
254769|NCT01867658|Video Assisted|video assisted
254770|NCT01867658|Robotic Assisted|robotic assisted
254771|NCT01867645|Critical illness|critical illness
254772|NCT01867645|Critical illness polyneuropathy and/or myopathy|critical illness polyneuropathy and/or myopathy
254773|NCT01867645|Intravenous immunoglobulins|intravenous immunoglobulins
254774|NCT01867645|Multiple organ failure|multiple organ failure
254775|NCT01867645|SIRS|sirs
254776|NCT01867645|Sepsis|sepsis
254777|NCT01867632|Palatoplasty|palatoplasty
254778|NCT01867632|Acellular Dermal Matrix|acellular dermal matrix
254779|NCT01867619|Brain Neoplasms|brain neoplasms
254780|NCT01867619|Melanoma|melanoma
254781|NCT01867619|Metastatic Melanoma|metastatic melanoma
254782|NCT01867619|Brain Metastasis|brain metastasis
254783|NCT01867619|Temozolomide|temozolomide
254784|NCT01867619|Temodar|temodar
254785|NCT01867619|Thalidomide|thalidomide
254786|NCT01867619|Thalomid|thalomid
254787|NCT01867619|Lomustine|lomustine
254788|NCT01867619|CCNU|ccnu
254789|NCT01867619|CeeNU|ceenu
254790|NCT01867593|Newly diagnosed|newly diagnosed
254791|NCT01867567|cesarean|cesarean
254792|NCT01867567|bandage removal|bandage removal
254793|NCT01867567|infection|infection
254794|NCT01867567|disruption|disruption
254795|NCT01867567|satisfaction|satisfaction
254796|NCT01867567|patient satisfaction|patient satisfaction
254797|NCT01867554|Intellectual disability|intellectual disability
254798|NCT01867554|Autism spectrum disorders|autism spectrum disorders
254799|NCT01867554|gene|gene
254800|NCT01867554|Next generation sequencing|next generation sequencing
254801|NCT01867541|cataract surgery|cataract surgery
254802|NCT01867541|intraocular lens power calculation|intraocular lens power calculation
254803|NCT01867541|effective lens position|effective lens position
254804|NCT01867541|improving the refractive outcome after cataract surgery|improving the refractive outcome after cataract surgery
254805|NCT01867541|predicting the IOL position|predicting the iol position
254806|NCT01867515|Hearing|hearing
254807|NCT01867515|Hearing Loss, sensorineural|hearing loss, sensorineural
254808|NCT01867515|Speech Perception|speech perception
254809|NCT01867463|Antigen|antigen
254810|NCT01867463|Ookinetes|ookinetes
254811|NCT01867463|Mosquito|mosquito
254812|NCT01867463|Membrane|membrane
254813|NCT01867463|Assay|assay
254814|NCT01867450|Biomarkers|biomarkers
254815|NCT01867450|Deisel Exhaust|deisel exhaust
254816|NCT01867450|Occupational Exposure|occupational exposure
254817|NCT01867450|Cross-Sectional Study|cross-sectional study
254818|NCT01867437|24 Hour Energy Expenditure|24 hour energy expenditure
254819|NCT01867437|Resting Energy Expenditure|resting energy expenditure
254820|NCT01867437|Obesity|obesity
254822|NCT01867424|Testosterone Membrane Transporter|testosterone membrane transporter
254823|NCT01867424|OATP1B3|oatp1b3
254824|NCT01867424|Castration Resistant Prostate Cancer|castration resistant prostate cancer
254825|NCT01867424|Prostatectomy|prostatectomy
254826|NCT01867424|Gadolinium-Based Contrast Agent|gadolinium-based contrast agent
254827|NCT01867411|Smoking Cessation|smoking cessation
254828|NCT01867411|Biomarkers|biomarkers
254829|NCT01867411|fMRI|fmri
245533|NCT01909661|allergy|allergy
254830|NCT01867411|e-Cigarettes|e-cigarettes
254831|NCT01867398|Conduct Disorder|conduct disorder
254832|NCT01867398|Antipsychotic|antipsychotic
254833|NCT01867398|Treatment Study|treatment study
254834|NCT01867398|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
254835|NCT01867398|Adolescents|adolescents
254836|NCT01867385|Fatigue|fatigue
254837|NCT01867385|Chronic Hepatitis|chronic hepatitis
254838|NCT01867385|Chronic Hepatitis B|chronic hepatitis b
254839|NCT01867385|Chronic Hepatitis C|chronic hepatitis c
254840|NCT01867385|Hepatitis|hepatitis
254841|NCT01867372|Alzheimer's Disease|alzheimer's disease
254842|NCT01867359|Alzheimer Disease|alzheimer disease
254843|NCT01867359|Molecular|molecular
254844|NCT01867359|Molecular Genetics|molecular genetics
254846|NCT01867346|Cognition|cognition
254847|NCT01867346|Aging|aging
254848|NCT01867346|Cognitive Decline|cognitive decline
254849|NCT01867346|Dementia|dementia
254850|NCT01867346|Alzheimer's Disease|alzheimer's disease
254851|NCT01867333|Immunotherapy|immunotherapy
254852|NCT01867333|Gene Transfer|gene transfer
254853|NCT01867333|Androgen Receptor Antagonist|androgen receptor antagonist
254854|NCT01867333|PSA|psa
254855|NCT01867333|Immune Response|immune response
254856|NCT01867320|HTLV-1|htlv-1
254857|NCT01867320|HTLV-1 Associated Myelopathy|htlv-1 associated myelopathy
254858|NCT01867281|aspirin|aspirin
254859|NCT01867281|asthma|asthma
254860|NCT01867281|Aspirin desensitization|aspirin desensitization
254861|NCT01867281|Aspirin induced asthma|aspirin induced asthma
254862|NCT01867281|Immune System Diseases|immune system diseases
254863|NCT01867281|Respiratory Hypersensitivity|respiratory hypersensitivity
254864|NCT01867268|Acetazolamide administration|acetazolamide administration
254865|NCT01867268|prone positioning|prone positioning
254866|NCT01867268|Cerebrospinal fluid leakage|cerebrospinal fluid leakage
254867|NCT01867268|Cerebrospinal fluid collection|cerebrospinal fluid collection
254868|NCT01867268|wound dehiscence|wound dehiscence
254869|NCT01867255|venlafaxine|venlafaxine
254870|NCT01867255|Effexor|effexor
254871|NCT01867255|antidepressive agent|antidepressive agent
254872|NCT01867242|cigarette|cigarette
254873|NCT01867242|snus|snus
254874|NCT01867242|smoking|smoking
254875|NCT01867242|tobacco|tobacco
254876|NCT01867229|pre-menauposal|pre-menauposal
254877|NCT01867229|neo-adjuvant or adjuvant chemotherapy|neo-adjuvant or adjuvant chemotherapy
254878|NCT01867229|no metastases|no metastases
254879|NCT01867190|CLI|cli
254880|NCT01867177|HIV|hiv
254881|NCT01867177|health care utilization|health care utilization
254882|NCT01867177|HIV testing|hiv testing
254883|NCT01867177|access to care|access to care
254884|NCT01867164|Vaginitis|vaginitis
254885|NCT01867164|Infectious vaginosis|infectious vaginosis
254886|NCT01867164|Terconazole|terconazole
254887|NCT01867164|Clindamycin|clindamycin
254888|NCT01867164|Fluocinolone|fluocinolone
254889|NCT01867164|Metronidazole|metronidazole
254890|NCT01867164|Nystatin|nystatin
254891|NCT01867151|Burning Mouth Syndrome|burning mouth syndrome
254892|NCT01867151|Gluten|gluten
254893|NCT01867151|Gluten Free Diet|gluten free diet
254894|NCT01867138|Coagulase negative staphylococcus|coagulase negative staphylococcus
254895|NCT01867138|nosocomial neonatal sepsis|nosocomial neonatal sepsis
254896|NCT01867138|cefazolin|cefazolin
254897|NCT01867138|vancomycin|vancomycin
254898|NCT01867138|newborn|newborn
254899|NCT01867086|ovarian cancer|ovarian cancer
254900|NCT01867060|Cardiac monitoring|cardiac monitoring
254901|NCT01867060|Biomarkers|biomarkers
254902|NCT01867060|Transthoracic echocardiography|transthoracic echocardiography
254903|NCT01867034|non ST segment myocardial infarction|non st segment myocardial infarction
254904|NCT01867021|Trivalent inactivated subunit influenza vaccines|trivalent inactivated subunit influenza vaccines
254905|NCT01867021|50 years and above|50 years and above
254906|NCT01867021|healthy subjects|healthy subjects
254907|NCT01866995|Ginseng|ginseng
254908|NCT01866995|Prostatostasis|prostatostasis
254909|NCT01866995|Erectile Dysfunction|erectile dysfunction
254910|NCT01866982|umbilical cord milking|umbilical cord milking
254911|NCT01866982|delayed cord clamping|delayed cord clamping
254912|NCT01866943|Blood Loss|blood loss
254913|NCT01866943|Tranexamic Acid|tranexamic acid
254914|NCT01866943|Total Hip Arthroplasty|total hip arthroplasty
254915|NCT01866943|Post Op|post op
254916|NCT01866943|Post Operative|post operative
254917|NCT01866943|Prevent Post Operative Blood Loss|prevent post operative blood loss
254918|NCT01866917|Transversis Abdominis Plane Block|transversis abdominis plane block
254919|NCT01866917|obese|obese
254920|NCT01866917|robotic surgery|robotic surgery
254921|NCT01866917|laparoscopic surgery|laparoscopic surgery
254922|NCT01866904|Coronary artery disease, Myocardial infarction|coronary artery disease, myocardial infarction
254923|NCT01866891|hemodialysis|hemodialysis
254924|NCT01866891|microcirculation|microcirculation
254925|NCT01866891|physical perdialytic activity|physical perdialytic activity
254926|NCT01866891|cycling|cycling
254927|NCT01866878|transcutaneous electrical nerve stimulation, sensitivity, multiple sclerosis,Reeducation through labor tactile discrimination|transcutaneous electrical nerve stimulation, sensitivity, multiple sclerosis,reeducation through labor tactile discrimination
254928|NCT01866865|BRCA1|brca1
254929|NCT01866865|BRCA2|brca2
254930|NCT01866852|Longitudinal Study|longitudinal study
254931|NCT01866839|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
254932|NCT01866839|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
254933|NCT01866839|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
254934|NCT01866839|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
254935|NCT01866839|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
254936|NCT01866826|HIV|hiv
254937|NCT01866826|Eradication Strategies|eradication strategies
254938|NCT01866826|Immune Activation|immune activation
254939|NCT01866813|breast cancer|breast cancer
254940|NCT01866813|cancer survivors|cancer survivors
254941|NCT01866800|TAVI|tavi
254942|NCT01866800|TAVR|tavr
254943|NCT01866800|CIN|cin
254944|NCT01866800|AKI|aki
254945|NCT01866787|Postoperative orthostatic intolerance|postoperative orthostatic intolerance
254946|NCT01866787|Surgical inflammatory response|surgical inflammatory response
254947|NCT01866722|nicotine dependence|nicotine dependence
254948|NCT01866722|smoking cessation|smoking cessation
254949|NCT01866722|lapse|lapse
254950|NCT01866722|relapse|relapse
254951|NCT01866722|tobacco|tobacco
254952|NCT01866722|quit attempts|quit attempts
254953|NCT01866722|abstinence|abstinence
254954|NCT01866722|motivation|motivation
254955|NCT01866722|reduction|reduction
254956|NCT01866696|Computer assisted implant surgery,|computer assisted implant surgery,
254957|NCT01866696|Immediate loading,|immediate loading,
254958|NCT01866696|CAD/CAM|cad/cam
254959|NCT01866683|Yoga|yoga
254960|NCT01866683|Electroencephalography|electroencephalography
254961|NCT01866683|Heart rate variability|heart rate variability
254962|NCT01866683|Breathing Exercises|breathing exercises
254963|NCT01866683|Quality of life|quality of life
254964|NCT01866670|spiritual distress|spiritual distress
254965|NCT01866670|nursing|nursing
254966|NCT01866670|breast neoplasms|breast neoplasms
254967|NCT01866657|cerebral oximetry|cerebral oximetry
254968|NCT01866657|randomized controlled pilot study|randomized controlled pilot study
254969|NCT01866657|thoracic surgery|thoracic surgery
254970|NCT01866657|single lung ventilation|single lung ventilation
254971|NCT01866644|Liver transplantation, n-acetylcysteine|liver transplantation, n-acetylcysteine
254972|NCT01866618|Natural|natural
254973|NCT01866618|IVF Cycle|ivf cycle
254974|NCT01866605|anxiety|anxiety
254975|NCT01866605|midazolam|midazolam
254976|NCT01866605|forced-air warming|forced-air warming
254977|NCT01866592|Psoriasis|psoriasis
254978|NCT01866592|Cardiovascular Disease|cardiovascular disease
254979|NCT01866592|Vascular Inflammation|vascular inflammation
254980|NCT01866592|Lipid Biomarkers|lipid biomarkers
254981|NCT01866592|Metabolic biomarkers|metabolic biomarkers
254982|NCT01866592|FDG-PET/CT|fdg-pet/ct
254983|NCT01866579|Retinal Nerve Fiber Layer Thickness, Optical Coherence Tomography, Ethambutol optic neuropathy|retinal nerve fiber layer thickness, optical coherence tomography, ethambutol optic neuropathy
254984|NCT01866553|CML|cml
254985|NCT01866553|suboptimal molecular response|suboptimal molecular response
254986|NCT01866553|nilotinib|nilotinib
254987|NCT01866553|pegylated interferon α2b|pegylated interferon α2b
254988|NCT01866540|influenza, LAIV, immune response|influenza, laiv, immune response
254989|NCT01866527|Developmental dysplasia of the hip,|developmental dysplasia of the hip,
254990|NCT01866527|DDH,|ddh,
254991|NCT01866527|avascular necrosis,|avascular necrosis,
254992|NCT01866527|late detected cases|late detected cases
254993|NCT01866514|EZ-IO|ez-io
254994|NCT01866514|IO|io
254995|NCT01866514|Intraosseous Vascular Access|intraosseous vascular access
254996|NCT01866501|Intraosseous Vascular Access|intraosseous vascular access
254997|NCT01866501|IO Access|io access
254998|NCT01866501|IO Vascular Access|io vascular access
254999|NCT01866501|EZ-IO|ez-io
255000|NCT01866488|Labor induction|labor induction
255001|NCT01866488|Misoprostol|misoprostol
255002|NCT01866488|Cytotec|cytotec
255003|NCT01866488|Cook Obstetric Double Balloon Catheter|cook obstetric double balloon catheter
255004|NCT01866475|IO access|io access
255005|NCT01866475|Intraosseous vascular access|intraosseous vascular access
255006|NCT01866475|EZ-IO|ez-io
255007|NCT01866436|Cognitive skills|cognitive skills
255008|NCT01866436|Multimedia|multimedia
255009|NCT01866436|Education|education
255010|NCT01866436|Colorectal surgery|colorectal surgery
255011|NCT01866397|cidofovir|cidofovir
255012|NCT01866397|cvvh|cvvh
255013|NCT01866397|renal replacement therapy|renal replacement therapy
255014|NCT01866397|HCMV|hcmv
255015|NCT01866397|Pharmacokinetics of cidofovir during CVVH|pharmacokinetics of cidofovir during cvvh
255120|NCT01865903|cachexia|cachexia
255016|NCT01866397|continuous venovenous hemofiltration|continuous venovenous hemofiltration
255017|NCT01866371|Retina|retina
255018|NCT01866371|imaging|imaging
255019|NCT01866371|retinal degeneration|retinal degeneration
255020|NCT01866345|orthodontics|orthodontics
255021|NCT01866345|Tooth Movement|tooth movement
255022|NCT01866345|Bone Remodeling|bone remodeling
255023|NCT01866345|Mandible|mandible
255024|NCT01866345|Osteotomy|osteotomy
255025|NCT01866332|back pain|back pain
255026|NCT01866332|tape|tape
255027|NCT01866332|chronic|chronic
255028|NCT01866319|PD-1|pd-1
255029|NCT01866319|PD1|pd1
255030|NCT01866319|PD-L1|pd-l1
255031|NCT01866319|PDL1|pdl1
255032|NCT01866293|Cabozantinib (XL184)|cabozantinib (xl184)
255033|NCT01866293|12-240|12-240
255034|NCT01866280|Sleep|sleep
255035|NCT01866280|Sleep duration|sleep duration
255036|NCT01866280|Meals|meals
255037|NCT01866280|Food intake|food intake
255038|NCT01866280|Obesity|obesity
255039|NCT01866267|Human Immunodeficiency Virus|human immunodeficiency virus
255040|NCT01866267|AIDS|aids
255041|NCT01866254|Hydromorphone|hydromorphone
255042|NCT01866254|Morphine|morphine
255043|NCT01866254|cesarean delivery|cesarean delivery
255044|NCT01866254|pain management|pain management
255045|NCT01866254|respiratory depression|respiratory depression
255046|NCT01866228|Consultation Recording|consultation recording
255047|NCT01866228|Brain Tumor|brain tumor
255048|NCT01866228|Neuroendocrine Cancer|neuroendocrine cancer
255049|NCT01866228|Quality of Life|quality of life
255050|NCT01866228|Patient Satisfaction|patient satisfaction
255051|NCT01866215|gluconeogenesis|gluconeogenesis
255052|NCT01866215|de novo lipogenesis|de novo lipogenesis
255053|NCT01866215|intramyocellular lipids|intramyocellular lipids
255054|NCT01866215|muscle glycogen|muscle glycogen
255055|NCT01866215|fructose|fructose
255056|NCT01866189|ischemic stroke|ischemic stroke
255057|NCT01866189|hypoxic tissues|hypoxic tissues
255058|NCT01866189|F-MISO uptake|f-miso uptake
255059|NCT01866189|Magnetic Resonance Imaging|magnetic resonance imaging
255060|NCT01866189|F-MISO Positon Emission Tomography|f-miso positon emission tomography
255061|NCT01866137|Copeptin|copeptin
255062|NCT01866137|psychological stress|psychological stress
751914|NCT01171196|Questionnaire|questionnaire
255063|NCT01866137|The Trier Social Stress Test (TSST)|the trier social stress test (tsst)
255064|NCT01866124|acute malnutrition|acute malnutrition
255065|NCT01866124|multiannual and seasonal cash transfers|multiannual and seasonal cash transfers
255066|NCT01866124|safety nets|safety nets
255067|NCT01866124|Burkina Faso|burkina faso
255068|NCT01866098|antipsychotic|antipsychotic
255069|NCT01866098|severe mental illness|severe mental illness
255070|NCT01866098|weight loss|weight loss
255071|NCT01866085|stress urinary incontinence|stress urinary incontinence
255072|NCT01866085|post prostatectomy|post prostatectomy
255074|NCT01866072|AVH|avh
255075|NCT01866072|Fibroscan|fibroscan
255076|NCT01866072|Transient elastography|transient elastography
255077|NCT01866059|root caries|root caries
255078|NCT01866059|GIC|gic
255079|NCT01866059|RMGIC|rmgic
255080|NCT01866059|Biodentine|biodentine
255081|NCT01866059|Calcium silicate|calcium silicate
255082|NCT01866046|battered women|battered women
255083|NCT01866046|HIV risk|hiv risk
255084|NCT01866046|STI risk|sti risk
255085|NCT01866033|Healthy volunteer|healthy volunteer
255086|NCT01866033|PCI-32765|pci-32765
255087|NCT01866033|PCI 45227|pci 45227
255088|NCT01866033|13C6 PCI-32765|13c6 pci-32765
255089|NCT01866033|Pharmacokinetic|pharmacokinetic
255090|NCT01866033|Bioavailability|bioavailability
255091|NCT01866020|aspergillosis|aspergillosis
255092|NCT01866020|fungal infection|fungal infection
255093|NCT01866020|ICU|icu
255094|NCT01866007|Healthy|healthy
255095|NCT01866007|Guselkumab|guselkumab
255096|NCT01866007|CNTO1959|cnto1959
255097|NCT01866007|Pharmacokinetics|pharmacokinetics
255098|NCT01866007|UltraSafe Passive Delivery System (PFS-U)|ultrasafe passive delivery system (pfs-u)
255099|NCT01866007|Prefilled syringe facilitated injection device (PFS FID)|prefilled syringe facilitated injection device (pfs fid)
255100|NCT01865994|Cardiac Output|cardiac output
255101|NCT01865994|esCCO|escco
255102|NCT01865994|TEE|tee
255103|NCT01865994|Pediatric cardiac surgery|pediatric cardiac surgery
255104|NCT01865981|iPS cells|ips cells
255105|NCT01865981|cardiomyocytes|cardiomyocytes
255106|NCT01865981|Brugada|brugada
255107|NCT01865981|Ventricular Fibrillation|ventricular fibrillation
255108|NCT01865981|electrophysiology|electrophysiology
255109|NCT01865968|inactivated HAV vaccine; live attenuated HAV vaccine; immunogenicity; safety|inactivated hav vaccine; live attenuated hav vaccine; immunogenicity; safety
255110|NCT01865955|Ultrasound|ultrasound
255111|NCT01865955|Spinal anesthesia|spinal anesthesia
255112|NCT01865955|Cesarean section|cesarean section
255113|NCT01865942|spinal metastases|spinal metastases
255114|NCT01865942|spine surgery|spine surgery
255115|NCT01865942|metastatic spinal cord compression|metastatic spinal cord compression
255116|NCT01865942|EQ-5D|eq-5d
255117|NCT01865942|HRQOL|hrqol
255118|NCT01865903|NSCLC|nsclc
255119|NCT01865903|sarcopenia|sarcopenia
255121|NCT01865890|Plavix or clopidogrel resistance|plavix or clopidogrel resistance
255122|NCT01865877|Parkinson's disease|parkinson's disease
314730|NCT01598467|POP|pop
255123|NCT01865877|Motor|motor
255124|NCT01865877|Non-motor|non-motor
255125|NCT01865877|Progression|progression
255126|NCT01865877|Complications|complications
255127|NCT01865864|CPAP|cpap
255128|NCT01865864|diurnal blood pressure|diurnal blood pressure
255129|NCT01865864|obstructive sleep apnea|obstructive sleep apnea
255130|NCT01865864|24 hour blood pressure monitor|24 hour blood pressure monitor
255131|NCT01865851|Inspired oxygen|inspired oxygen
255132|NCT01865851|end-tidal oxygen|end-tidal oxygen
255133|NCT01865851|end-tidal carbon dioxide|end-tidal carbon dioxide
255134|NCT01865851|respiratory rate|respiratory rate
255135|NCT01865851|preoxygenation|preoxygenation
255136|NCT01865851|classic face mask|classic face mask
255137|NCT01865851|NuMask|numask
255138|NCT01865838|Total thyroidectomy|total thyroidectomy
255139|NCT01865838|Seprafilm|seprafilm
255140|NCT01865838|Swallowing difficulty post thyroidectomy|swallowing difficulty post thyroidectomy
255141|NCT01865825|Erosive Esophagitis|erosive esophagitis
255142|NCT01865825|Gastroesophageal reflux disease|gastroesophageal reflux disease
255143|NCT01865799|FTC/TDF|ftc/tdf
255144|NCT01865799|PrEP|prep
255145|NCT01865799|Truvada|truvada
255146|NCT01865799|Drug utilization|drug utilization
255147|NCT01865786|FTC/TDF|ftc/tdf
255148|NCT01865786|Truvada|truvada
255149|NCT01865786|PrEP|prep
255150|NCT01865786|Antiretroviral Pregnancy Registry|antiretroviral pregnancy registry
255151|NCT01865760|Glucagon like peptide 1|glucagon like peptide 1
255152|NCT01865760|Insulin secretion|insulin secretion
255153|NCT01865760|Hypoglycemia|hypoglycemia
255154|NCT01865747|renal cell cancer|renal cell cancer
255155|NCT01865747|kidney|kidney
255156|NCT01865747|vascular endothelial growth factor receptor 2 (VEGFR2)|vascular endothelial growth factor receptor 2 (vegfr2)
255157|NCT01865747|tyrosine kinase inhibitor|tyrosine kinase inhibitor
255158|NCT01865747|hepatocyte growth factor receptor protein (MET)|hepatocyte growth factor receptor protein (met)
255159|NCT01865747|von Hippel-Lindau gene|von hippel-lindau gene
255160|NCT01865734|Fasciitis, Plantar|fasciitis, plantar
255161|NCT01865734|Heel Pain|heel pain
255162|NCT01865734|Physical Therapy|physical therapy
255163|NCT01865734|Podiatry|podiatry
255164|NCT01865734|Musculoskeletal Manipulations|musculoskeletal manipulations
255165|NCT01865734|Exercise Therapy|exercise therapy
255166|NCT01865721|Bowel cancer screening|bowel cancer screening
255167|NCT01865721|Analgesia|analgesia
255169|NCT01865721|Pain|pain
255170|NCT01865721|Side effects|side effects
255171|NCT01865721|Colonoscopy|colonoscopy
255172|NCT01865708|Ethanol Lock|ethanol lock
255173|NCT01865708|Alcohol lock|alcohol lock
255174|NCT01865708|Urinary catheter|urinary catheter
255175|NCT01865708|Safety|safety
255176|NCT01865695|pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
255177|NCT01865695|faecal elastase|faecal elastase
255178|NCT01865695|diarrhoea|diarrhoea
255179|NCT01865695|coeliac|coeliac
255180|NCT01865695|creon|creon
255181|NCT01865695|gastrointestinal|gastrointestinal
255182|NCT01865682|Ankle|ankle
255183|NCT01865682|Knee|knee
255184|NCT01865682|Orthosis|orthosis
255185|NCT01865682|Kinematics|kinematics
255186|NCT01865682|Kinetics|kinetics
255187|NCT01865669|Uterine contraction|uterine contraction
255188|NCT01865669|Dose response|dose response
255189|NCT01865669|Oxytocin|oxytocin
255190|NCT01865656|provider skill and self-efficacy|provider skill and self-efficacy
255191|NCT01865656|Appropriate and timely referral for obstetric emergencies|appropriate and timely referral for obstetric emergencies
255192|NCT01865656|Intervention feasibility and acceptability|intervention feasibility and acceptability
255193|NCT01865643|Laryngoscopy|laryngoscopy
255194|NCT01865643|Intubation|intubation
255195|NCT01865643|Glidescope|glidescope
255196|NCT01865630|Prophylactic treatment with Etanercept in aSAH.|prophylactic treatment with etanercept in asah.
255197|NCT01865630|Safety of Etanercept in the prevention of DCI in aSAH.|safety of etanercept in the prevention of dci in asah.
255198|NCT01865591|hypertension|hypertension
255199|NCT01865591|uncontrolled hypertension|uncontrolled hypertension
255200|NCT01865591|resistant hypertension|resistant hypertension
255201|NCT01865565|gastrointestinal stromal tumor|gastrointestinal stromal tumor
255202|NCT01865565|GIST|gist
255203|NCT01865565|neoadjuvant|neoadjuvant
255204|NCT01865565|imatinib|imatinib
255205|NCT01865552|Pharmacokinetics|pharmacokinetics
255206|NCT01865539|Chronic lower back pain|chronic lower back pain
255207|NCT01865539|Custom foot orthotics|custom foot orthotics
255208|NCT01865539|Veterans|veterans
255209|NCT01865526|Chronic kidney disease|chronic kidney disease
255210|NCT01865526|Low protein diet|low protein diet
255211|NCT01865526|CKD stage 3b-5|ckd stage 3b-5
255212|NCT01865513|Anaesthesia|anaesthesia
255213|NCT01865513|Anaesthesiology|anaesthesiology
255214|NCT01865513|muscle Relaxants|muscle relaxants
255215|NCT01865513|POPULAR|popular
255216|NCT01865513|postoperative pulmonary complications|postoperative pulmonary complications
255217|NCT01865513|Respiratory failure|respiratory failure
255218|NCT01865513|Suspected pulmonary infection|suspected pulmonary infection
255219|NCT01865513|Pulmonary infiltrates|pulmonary infiltrates
255220|NCT01865513|Pleural effusion|pleural effusion
255221|NCT01865513|Atelectasis|atelectasis
255222|NCT01865513|Pneumothorax|pneumothorax
255223|NCT01865513|Bronchospasm|bronchospasm
255224|NCT01865513|Aspiration pneumonitis|aspiration pneumonitis
255225|NCT01865513|Cardiopulmonary oedema|cardiopulmonary oedema
255226|NCT01865513|European Society of Anaesthesiology|european society of anaesthesiology
255227|NCT01865513|neuromuscular blockade|neuromuscular blockade
255228|NCT01865513|europe|europe
255229|NCT01865500|COPD exacerbation|copd exacerbation
255230|NCT01865500|Nebulized budesonide|nebulized budesonide
255231|NCT01865500|Parenteral steroid|parenteral steroid
255232|NCT01865487|BCG Vaccinated|bcg vaccinated
255233|NCT01865487|HIV Negative|hiv negative
255234|NCT01865474|DLBS1033, Type 2 DM, fibrinolytic, hypercoagulation|dlbs1033, type 2 dm, fibrinolytic, hypercoagulation
255235|NCT01865461|Magnetic Resonance Imaging|magnetic resonance imaging
255236|NCT01865448|Docosahexaenoic Acids|docosahexaenoic acids
255237|NCT01865448|Fatty Acids, Omega-3|fatty acids, omega-3
255238|NCT01865448|Obesity|obesity
255239|NCT01865448|Inflammation|inflammation
255240|NCT01865409|Newborn|newborn
255241|NCT01865409|Prematures|prematures
255242|NCT01865409|Feeding difficulty|feeding difficulty
255243|NCT01865409|Kangaroo Care|kangaroo care
255244|NCT01865409|Heart rate variability|heart rate variability
255245|NCT01865266|ventilator-associated pneumonia|ventilator-associated pneumonia
255246|NCT01865266|mechanical ventilation|mechanical ventilation
255247|NCT01865266|ulinastatin for injection|ulinastatin for injection
255248|NCT01865266|bronchoalveolar lavage fluid|bronchoalveolar lavage fluid
255249|NCT01865266|inflammatory factors|inflammatory factors
255250|NCT01865253|renal denervation|renal denervation
255251|NCT01865253|blood pressure|blood pressure
255252|NCT01865253|cardiovascular risk|cardiovascular risk
255253|NCT01865253|target organ damage|target organ damage
255254|NCT01865253|sympathetic activity|sympathetic activity
255255|NCT01865253|chronic kidney disease|chronic kidney disease
255256|NCT01865253|non-compliance|non-compliance
255257|NCT01865240|renal denervation|renal denervation
255258|NCT01865240|blood pressure|blood pressure
255259|NCT01865240|cardiovascular risk|cardiovascular risk
255260|NCT01865240|target organ damage|target organ damage
255261|NCT01865240|sympathetic activity|sympathetic activity
255262|NCT01865227|Obesity|obesity
255263|NCT01865227|Bariatric surgery|bariatric surgery
255264|NCT01865227|Binge Eating Disorder|binge eating disorder
255265|NCT01865227|Psychological Health|psychological health
255266|NCT01865227|Counselling|counselling
255267|NCT01865201|Radiotherapy|radiotherapy
255268|NCT01865201|Radiation-induced brain necrosis|radiation-induced brain necrosis
255269|NCT01865201|Edaravone|edaravone
255270|NCT01865201|Effectiveness|effectiveness
255271|NCT01865201|Safety|safety
255272|NCT01865188|LCZ696,|lcz696,
255273|NCT01865188|amlodipine,|amlodipine,
255274|NCT01865188|hypertension,|hypertension,
255275|NCT01865188|ABPM|abpm
255276|NCT01865162|Glioblastoma multiforme, ketogenic diet, neoplasm|glioblastoma multiforme, ketogenic diet, neoplasm
255277|NCT01865149|Child|child
255682|NCT01863615|Mexico|mexico
255278|NCT01865149|Optic nerve sheath diameter|optic nerve sheath diameter
255279|NCT01865149|Hydrocephalus|hydrocephalus
255280|NCT01865149|Intracranial hypertension|intracranial hypertension
255281|NCT01865123|post-traumatic stress disorder|post-traumatic stress disorder
255282|NCT01865123|transcendental meditation|transcendental meditation
255283|NCT01865123|cognitive behavioral therapy|cognitive behavioral therapy
255284|NCT01865123|prolonged exposure|prolonged exposure
255285|NCT01865110|Mantle Cell Lymphoma|mantle cell lymphoma
255286|NCT01865110|RCHOP|rchop
255287|NCT01865110|RHAD|rhad
255288|NCT01865110|rituximab|rituximab
255289|NCT01865110|lenalidomide|lenalidomide
255290|NCT01865097|Imagery|imagery
255291|NCT01865097|Pain|pain
255292|NCT01865097|Depression|depression
255293|NCT01865097|Non-Motor|non-motor
255294|NCT01865071|ileostomy|ileostomy
255295|NCT01865071|rectal resection|rectal resection
255296|NCT01865071|proctectomy|proctectomy
255297|NCT01865071|stoma closure|stoma closure
255298|NCT01865071|rectal cancer|rectal cancer
255299|NCT01864993|non celiac gluten sensitivity|non celiac gluten sensitivity
255300|NCT01864993|gluten|gluten
255301|NCT01864993|irritable bowel syndrome|irritable bowel syndrome
255302|NCT01864993|functional disorders|functional disorders
255303|NCT01864967|carbon dioxide infusion|carbon dioxide infusion
255304|NCT01864967|dilatation of peripheral blood vessels|dilatation of peripheral blood vessels
255305|NCT01864967|capillaries|capillaries
255306|NCT01864967|macrophags|macrophags
255307|NCT01864967|fibroblasts|fibroblasts
255308|NCT01864967|Improvement granulation tissue in chronic wounds|improvement granulation tissue in chronic wounds
255309|NCT01864954|Smoking|smoking
255310|NCT01864954|Postpartum|postpartum
255311|NCT01864954|Pregnancy|pregnancy
255312|NCT01864954|Quit|quit
255313|NCT01864954|Tobacco|tobacco
255314|NCT01864954|Abstinence|abstinence
255315|NCT01864954|Relapse|relapse
255316|NCT01864954|Relapse prevention|relapse prevention
255317|NCT01864941|Multiple Sclerosis|multiple sclerosis
255319|NCT01864941|CCSVI|ccsvi
255320|NCT01864941|Zamboni|zamboni
255321|NCT01864941|catheter venography|catheter venography
255322|NCT01864941|balloon angioplasty|balloon angioplasty
255323|NCT01864928|Acute Ischemic stroke|acute ischemic stroke
255324|NCT01864928|ePRISM|eprism
255325|NCT01864915|colon capsule|colon capsule
255326|NCT01864915|bowel preparation|bowel preparation
255327|NCT01864915|booster|booster
255328|NCT01864915|prucalopride|prucalopride
255329|NCT01864915|picosalax|picosalax
255330|NCT01864902|CD33 positive acute myeloid leukemia (AML)|cd33 positive acute myeloid leukemia (aml)
255331|NCT01864850|HNSCC|hnscc
255332|NCT01864850|Elderly|elderly
255333|NCT01864850|Geriatry|geriatry
255334|NCT01864837|tongue coating thickness|tongue coating thickness
255335|NCT01864837|tongue diagnosis system|tongue diagnosis system
255336|NCT01864837|tongue coating percentage|tongue coating percentage
255337|NCT01864837|availability|availability
255338|NCT01864837|diagnostic device|diagnostic device
255339|NCT01864824|air pollution|air pollution
255340|NCT01864824|particulate matter 2.5 (PM2.5)|particulate matter 2.5 (pm2.5)
255341|NCT01864824|methyl donor|methyl donor
255342|NCT01864824|DNA methylation|dna methylation
255343|NCT01864824|mRNA|mrna
255344|NCT01864824|epigenetics|epigenetics
255345|NCT01864824|controlled human exposures|controlled human exposures
255346|NCT01864824|cardiovascular responses|cardiovascular responses
255347|NCT01864811|infants|infants
255348|NCT01864811|unilateral cerebral pares|unilateral cerebral pares
255349|NCT01864811|hand function|hand function
255350|NCT01864811|early intervention|early intervention
255351|NCT01864811|constraint induced movement therapy|constraint induced movement therapy
255352|NCT01864798|Young|young
255353|NCT01864798|Breast Neoplasms|breast neoplasms
255354|NCT01864798|Denosumab|denosumab
255355|NCT01864798|RANKL|rankl
255356|NCT01864785|Operative treatment|operative treatment
255357|NCT01864785|internal fixation|internal fixation
255358|NCT01864785|posterior spinal fusion|posterior spinal fusion
255359|NCT01864772|HNSCC|hnscc
255360|NCT01864772|Metastatic|metastatic
255361|NCT01864772|Recurrent|recurrent
255362|NCT01864772|Elderly|elderly
255363|NCT01864772|Geriatry|geriatry
255364|NCT01864759|melanoma|melanoma
255365|NCT01864759|oncolytic|oncolytic
255366|NCT01864759|adenovirus|adenovirus
255367|NCT01864759|virotherapy|virotherapy
693502|NCT00941499|Bevacizumab|bevacizumab
255368|NCT01864759|locally advanced|locally advanced
255369|NCT01864759|metastatic|metastatic
255370|NCT01864733|Chronic heart failure|chronic heart failure
255371|NCT01864733|Undernutrition|undernutrition
255372|NCT01864733|Rehabilitation|rehabilitation
255373|NCT01864733|Physical exercise|physical exercise
255374|NCT01864733|Nutrition|nutrition
255375|NCT01864733|n-3 fatty acids|n-3 fatty acids
255376|NCT01864733|Androgen|androgen
255377|NCT01864733|Testosterone|testosterone
255378|NCT01864720|stepped care model|stepped care model
255379|NCT01864720|insomnia|insomnia
255380|NCT01864720|cancer|cancer
255381|NCT01864720|cognitive-behavioural therapy|cognitive-behavioural therapy
255382|NCT01864720|self-help treatment|self-help treatment
255383|NCT01864720|Internet|internet
255384|NCT01864720|non-inferiority design|non-inferiority design
255385|NCT01864720|cost-effectiveness|cost-effectiveness
255386|NCT01864707|multiple sclerosis, fatigue|multiple sclerosis, fatigue
255387|NCT01864694|behavioral research|behavioral research
255388|NCT01864694|diet|diet
255389|NCT01864694|health information systems|health information systems
255390|NCT01864681|NSCLC|nsclc
255391|NCT01864681|TKIs|tkis
255392|NCT01864681|Metformin|metformin
255394|NCT01864681|overall survival|overall survival
255395|NCT01864681|IL-6|il-6
255396|NCT01864668|Acute respiratory distress syndrome|acute respiratory distress syndrome
255397|NCT01864668|lung strain|lung strain
255398|NCT01864668|small tidal volume|small tidal volume
255399|NCT01864616|Vitamin D|vitamin d
255400|NCT01864616|Crohn disease|crohn disease
255401|NCT01864616|Disease activity|disease activity
255402|NCT01864616|Inflammation|inflammation
255403|NCT01864616|prevention|prevention
255404|NCT01864603|HIV treatment and prevention|hiv treatment and prevention
255405|NCT01864603|Tuberculosis|tuberculosis
255406|NCT01864603|Community health campaign|community health campaign
255407|NCT01864603|PrEP|prep
255408|NCT01864590|Open Abdomen|open abdomen
255409|NCT01864590|Negative Pressure Wound Therapy|negative pressure wound therapy
255410|NCT01864590|Temporary Abdominal Closure|temporary abdominal closure
255411|NCT01864590|Mesh|mesh
255412|NCT01864590|Abdominal reconstruction|abdominal reconstruction
255413|NCT01864564|Gestational diabetes|gestational diabetes
255414|NCT01864564|Screening|screening
255415|NCT01864564|Obesity|obesity
255416|NCT01864564|Anhydroglucitol|anhydroglucitol
255417|NCT01864538|TH-302|th-302
246117|NCT01906658|ALS|als
255418|NCT01864538|Advanced Melanoma|advanced melanoma
255419|NCT01864538|Metastatic|metastatic
255420|NCT01864538|Biomarker|biomarker
255421|NCT01864538|Mucosal Melanoma|mucosal melanoma
255422|NCT01864538|Evofosfamide|evofosfamide
255423|NCT01864525|voice|voice
255424|NCT01864525|tremor|tremor
255425|NCT01864525|essential tremor|essential tremor
255426|NCT01864525|essential voice tremor|essential voice tremor
255427|NCT01864525|voice treatment|voice treatment
255428|NCT01864525|octanoic acid|octanoic acid
255429|NCT01864525|octanol|octanol
255430|NCT01864525|voice disorder|voice disorder
255431|NCT01864525|dysphonia|dysphonia
255432|NCT01864512|Immune Thrombocytopenia|immune thrombocytopenia
255433|NCT01864512|eltrombopag|eltrombopag
255434|NCT01864512|immune regulation|immune regulation
255435|NCT01864473|Fistula , Bhagandar|fistula , bhagandar
255436|NCT01864460|autonomic|autonomic
255437|NCT01864460|neuropathy|neuropathy
255438|NCT01864460|balance|balance
255439|NCT01864460|exercise|exercise
255440|NCT01864447|VTE|vte
255441|NCT01864447|Exercise|exercise
255442|NCT01864447|Diet|diet
255443|NCT01864447|Weight loss|weight loss
255444|NCT01864447|DVT|dvt
255445|NCT01864447|PE|pe
255446|NCT01864434|Knee Prosthesis|knee prosthesis
255447|NCT01864434|Total Knee Arthroplasty|total knee arthroplasty
255448|NCT01864434|Cruciate Retaining|cruciate retaining
255449|NCT01864434|Posterior Cruciate Retaining|posterior cruciate retaining
255450|NCT01864421|Infant, Newborn|infant, newborn
255451|NCT01864421|Delivery, Obstetric|delivery, obstetric
255452|NCT01864421|Umbilical Cord|umbilical cord
255453|NCT01864408|Patient counseling|patient counseling
255454|NCT01864408|Patient satisfaction|patient satisfaction
255455|NCT01864408|Pelvic organ prolapse|pelvic organ prolapse
255456|NCT01864395|cardiovascular surgery|cardiovascular surgery
255457|NCT01864395|cardiac surgery|cardiac surgery
255458|NCT01864395|cardiopulmonary bypass|cardiopulmonary bypass
255459|NCT01864395|IV fluids|iv fluids
255460|NCT01864395|blood pressure|blood pressure
255461|NCT01864395|heart-lung machine|heart-lung machine
255462|NCT01864395|hemofilter|hemofilter
255463|NCT01864395|online MUF|online muf
255464|NCT01864395|offline MUF|offline muf
255465|NCT01864395|modified ultrafiltration|modified ultrafiltration
255466|NCT01864395|multiple-pass hemofiltration|multiple-pass hemofiltration
751915|NCT01171209|MS|ms
255467|NCT01864395|centrifugation method|centrifugation method
255468|NCT01864395|blood transfusion|blood transfusion
255469|NCT01864395|plasma proteins|plasma proteins
255470|NCT01864395|post-cardiopulmonary bypass|post-cardiopulmonary bypass
255471|NCT01864395|hemoglobin|hemoglobin
255472|NCT01864395|clotting factors|clotting factors
255473|NCT01864395|systemic blood pressure|systemic blood pressure
255474|NCT01864395|cardiac index|cardiac index
255475|NCT01864395|cytokines|cytokines
255476|NCT01864395|post-operative bleeding|post-operative bleeding
255477|NCT01864395|protamine administration|protamine administration
255478|NCT01864395|patient size|patient size
255479|NCT01864395|allogeneic transfusion|allogeneic transfusion
255480|NCT01864395|total protein|total protein
255482|NCT01864395|vasoactive inotrope score|vasoactive inotrope score
255483|NCT01864395|fluid balance|fluid balance
255484|NCT01864395|chest tube loss|chest tube loss
255485|NCT01864395|length of stay|length of stay
255486|NCT01864395|ventilation time|ventilation time
255487|NCT01864395|markers of inflammation|markers of inflammation
255488|NCT01864382|Trunk performance|trunk performance
255489|NCT01864382|exercise,|exercise,
255490|NCT01864382|"core stability,"|"core stability,"
255491|NCT01864382|sitting balance|sitting balance
255492|NCT01864369|Heart Failure|heart failure
255493|NCT01864369|e-counseling|e-counseling
255494|NCT01864369|quality of life|quality of life
255495|NCT01864369|self-care|self-care
255496|NCT01864356|IVF failure|ivf failure
255497|NCT01864356|Repeated IVF failure|repeated ivf failure
255498|NCT01864356|Implantation failure|implantation failure
255499|NCT01864356|Repeated implantation failure|repeated implantation failure
255500|NCT01864356|IVF|ivf
255501|NCT01864356|NT100|nt100
255502|NCT01864343|Myocardial Infarction|myocardial infarction
255503|NCT01864343|Myocardial Reperfusion Injury|myocardial reperfusion injury
255504|NCT01864343|Reperfusion Injury|reperfusion injury
255505|NCT01864343|Anterior Wall Myocardial Infarction|anterior wall myocardial infarction
255506|NCT01864343|Inferior Wall Myocardial Infarction|inferior wall myocardial infarction
255507|NCT01864343|Myocardial Ischemia|myocardial ischemia
255508|NCT01864330|topical lubricants|topical lubricants
255509|NCT01864330|optical coherence tomography|optical coherence tomography
255510|NCT01864330|tear break up time|tear break up time
255511|NCT01864330|Schirmer I test|schirmer i test
255512|NCT01864317|7-Tesla Magnetic Resonance Imaging|7-tesla magnetic resonance imaging
255513|NCT01864317|Intraocular Pressure|intraocular pressure
255514|NCT01864317|Retinal Nerve Fiber Thickness|retinal nerve fiber thickness
255515|NCT01864317|Visual Field Test|visual field test
255516|NCT01864304|Williams Syndrome|williams syndrome
255517|NCT01864291|Auditory Brainstem Implant|auditory brainstem implant
255518|NCT01864291|ABI|abi
255519|NCT01864291|Nucleus 24|nucleus 24
255520|NCT01864291|Deafness|deafness
255524|NCT01864291|Pediatric|pediatric
255525|NCT01864291|ABI541|abi541
255526|NCT01864265|Rheumatoid arthritis|rheumatoid arthritis
255527|NCT01864265|functional MRI|functional mri
255528|NCT01864265|Prediction of Response|prediction of response
255529|NCT01864265|Certolizumab Pegol|certolizumab pegol
255530|NCT01864265|RF and/or ACPA positive|rf and/or acpa positive
255531|NCT01864239|Adherence|adherence
255532|NCT01864187|Pharmacokinetics|pharmacokinetics
255533|NCT01864187|Dexmedetomidine|dexmedetomidine
255534|NCT01864187|Obesity|obesity
255535|NCT01864122|nutrient biomarkers|nutrient biomarkers
255536|NCT01864122|food frequency questionnaire|food frequency questionnaire
255537|NCT01864122|predictors of CVD|predictors of cvd
255538|NCT01864122|fatty acids|fatty acids
255539|NCT01864122|phylloquinone|phylloquinone
255540|NCT01864122|dihydrophylloquinone|dihydrophylloquinone
255541|NCT01864109|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
255542|NCT01864109|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
255543|NCT01864109|ETOPOSIDE (VP-16)|etoposide (vp-16)
255544|NCT01864109|IFOSFAMIDE|ifosfamide
255545|NCT01864109|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
255546|NCT01864109|TEMOZOLOMIDE|temozolomide
255547|NCT01864109|VINCRISTINE|vincristine
255548|NCT01864109|13-068|13-068
255549|NCT01864096|localized|localized
255550|NCT01864096|prostate|prostate
255551|NCT01864096|cancer|cancer
255552|NCT01864096|metformin|metformin
255553|NCT01864096|active surveillance|active surveillance
255557|NCT01864070|Liver cancer|liver cancer
255558|NCT01864070|Neuroendocrine tumors|neuroendocrine tumors
255559|NCT01864070|NET|net
255560|NCT01864070|Liver dominant disease|liver dominant disease
255561|NCT01864070|TheraSphere|therasphere
255562|NCT01864070|Yttrium-90|yttrium-90
255563|NCT01864070|Y-90|y-90
255564|NCT01864070|Everolimus|everolimus
255565|NCT01864070|Afinitor|afinitor
255566|NCT01864070|Zortress|zortress
255567|NCT01864070|RAD001|rad001
255568|NCT01864070|Microspheres|microspheres
255569|NCT01864057|thiamine deficiency|thiamine deficiency
255570|NCT01864031|Alcohol|alcohol
255571|NCT01864031|Drinking|drinking
255572|NCT01864031|Abstainers|abstainers
255318|NCT01864941|MS|ms
255573|NCT01864031|Former drinkers|former drinkers
255574|NCT01864031|Ex-drinkers|ex-drinkers
255575|NCT01864031|Aetiology|aetiology
255576|NCT01864031|Initial presentation|initial presentation
693503|NCT00941499|Avastin|avastin
255577|NCT01864031|Chronic Stable Angina|chronic stable angina
255578|NCT01864031|Unstable Angina|unstable angina
255579|NCT01864031|Coronary Heart Disease Not Otherwise Specified|coronary heart disease not otherwise specified
255580|NCT01864031|Acute Myocardial Infarction|acute myocardial infarction
255581|NCT01864031|Heart Failure|heart failure
255582|NCT01864031|ST elevation Myocardial Infarction (STEMI)|st elevation myocardial infarction (stemi)
255583|NCT01864031|non-ST elevation Myocardial Infarction (nSTEMI)|non-st elevation myocardial infarction (nstemi)
255584|NCT01864031|Myocardial Infarction Not Otherwise Specified (MI NOS)|myocardial infarction not otherwise specified (mi nos)
255585|NCT01864031|Ventricular Arrhythmias|ventricular arrhythmias
255586|NCT01864031|Cardiac Arrest|cardiac arrest
255587|NCT01864031|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
255985|NCT01862185|mortality|mortality
255588|NCT01864031|Peripheral Arterial Disease|peripheral arterial disease
255589|NCT01864031|Ischaemic Stroke|ischaemic stroke
255590|NCT01864031|Subarachnoid Haemorrhagic Stroke|subarachnoid haemorrhagic stroke
255591|NCT01864031|Intracerebral haemorrhagic Stroke|intracerebral haemorrhagic stroke
255592|NCT01864031|Stroke Not Otherwise Specified|stroke not otherwise specified
255593|NCT01864031|Sudden Cardiac Death|sudden cardiac death
255594|NCT01864031|Unheralded Coronary Death|unheralded coronary death
255595|NCT01864031|Mortality|mortality
255596|NCT01864031|Coronary Heart Disease (CHD)|coronary heart disease (chd)
255597|NCT01864031|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
255598|NCT01864031|Fatal Cardiovascular Disease (fatal CVD)|fatal cardiovascular disease (fatal cvd)
255599|NCT01864005|Non-ST or ST Elevation Acute Coronary Syndromes, Ticagrelor, Clopidogrel, Antiplatelet Effect|non-st or st elevation acute coronary syndromes, ticagrelor, clopidogrel, antiplatelet effect
255600|NCT01863992|home ventilation|home ventilation
255601|NCT01863979|Atrial Fibrillation|atrial fibrillation
255602|NCT01863979|Thromboembolism|thromboembolism
255603|NCT01863966|Achalasia|achalasia
255604|NCT01863966|Hot water drinking therapy|hot water drinking therapy
255605|NCT01863966|Pneumatic dilation|pneumatic dilation
255606|NCT01863914|ESRD|esrd
255607|NCT01863914|Diabetes mellitus|diabetes mellitus
255608|NCT01863914|Endothelial progenitor cells|endothelial progenitor cells
255609|NCT01863914|Hemodialysis|hemodialysis
255610|NCT01863914|rosuvastatin|rosuvastatin
255611|NCT01863875|Cochlear Implant|cochlear implant
255612|NCT01863875|Hearing loss|hearing loss
255613|NCT01863875|Language Development|language development
255614|NCT01863875|Quality of life|quality of life
255615|NCT01863862|Rectal cancer|rectal cancer
255616|NCT01863862|Chemoradiation|chemoradiation
255617|NCT01863862|Complete pathological response|complete pathological response
255618|NCT01863849|uncontrolled,|uncontrolled,
255619|NCT01863849|open,|open,
255620|NCT01863849|multi-centre|multi-centre
255621|NCT01863849|immunogenicity and tolerability|immunogenicity and tolerability
255622|NCT01863849|two groups according to age (18-59 years and ≥60 years)|two groups according to age (18-59 years and ≥60 years)
255623|NCT01863836|Radial endobronchial ultrasound|radial endobronchial ultrasound
255624|NCT01863836|Peripheral lung lesion|peripheral lung lesion
255625|NCT01863836|Fluoroscopy|fluoroscopy
255626|NCT01863836|Lung cancer|lung cancer
255627|NCT01863823|Symptomatic patients|symptomatic patients
255628|NCT01863823|asymptomatic individuals|asymptomatic individuals
255629|NCT01863823|clinical trial|clinical trial
255630|NCT01863810|Diabetic Neuropathy|diabetic neuropathy
255631|NCT01863810|Neuropathic Pain|neuropathic pain
255632|NCT01863810|Pregabalin|pregabalin
255633|NCT01863784|Hepatic Impairment|hepatic impairment
255634|NCT01863784|Mild and moderate hepatic impairment|mild and moderate hepatic impairment
255635|NCT01863784|Normal hepatic function|normal hepatic function
255636|NCT01863784|Pharmacokinetics|pharmacokinetics
255637|NCT01863784|JNJ-38518168|jnj-38518168
255638|NCT01863771|Ulcerative Colitis|ulcerative colitis
255639|NCT01863771|Japanese|japanese
255640|NCT01863771|Subcutaneous|subcutaneous
255641|NCT01863771|Golimumab|golimumab
255642|NCT01863745|ggastrointestinal stromal tumors|ggastrointestinal stromal tumors
255643|NCT01863745|gastrointestinal,|gastrointestinal,
255644|NCT01863745|stromal,|stromal,
255645|NCT01863745|tumors,|tumors,
255646|NCT01863745|GIST,|gist,
255647|NCT01863745|AMN107,|amn107,
255648|NCT01863745|nilotinib|nilotinib
255649|NCT01863732|AIN457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, PFS, pre-filled syringe, secukinumab, self-injection|ain457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, pfs, pre-filled syringe, secukinumab, self-injection
255650|NCT01863719|Colistin|colistin
255651|NCT01863719|Multi Drug Resistant|multi drug resistant
255652|NCT01863719|Nosocomial Pneumonia|nosocomial pneumonia
255653|NCT01863719|Pneumococcal Infections|pneumococcal infections
255654|NCT01863706|Misoprostol|misoprostol
255655|NCT01863706|Oxytocin|oxytocin
255656|NCT01863706|Post Partum Hemorrhage (PPH)|post partum hemorrhage (pph)
255657|NCT01863706|Third stage of labour|third stage of labour
255658|NCT01863680|Infertility|infertility
255661|NCT01863680|Fertilization in Vitro|fertilization in vitro
255662|NCT01863680|Embryo Transfer|embryo transfer
255663|NCT01863654|Bioequivalence|bioequivalence
255664|NCT01863654|Mexico|mexico
255665|NCT01863654|Asthma|asthma
255666|NCT01863654|Montelukast|montelukast
255667|NCT01863654|Chewable|chewable
255668|NCT01863641|lupus nephritis|lupus nephritis
255669|NCT01863641|proteinuria|proteinuria
255670|NCT01863641|SLE|sle
255671|NCT01863641|calcitriol|calcitriol
255672|NCT01863628|Prodromal Symptoms|prodromal symptoms
255673|NCT01863628|bipolar disorder|bipolar disorder
255674|NCT01863628|Neuropsychological Tests|neuropsychological tests
255675|NCT01863628|Magnetic Resonance Imaging|magnetic resonance imaging
255676|NCT01863628|Treatment Outcome|treatment outcome
255677|NCT01863628|aerobic exercise|aerobic exercise
255678|NCT01863628|psychotherapy|psychotherapy
255679|NCT01863615|pharmacokinetics|pharmacokinetics
255680|NCT01863615|Isotretinoin|isotretinoin
255681|NCT01863615|bioequivalence|bioequivalence
255683|NCT01863576|Chagas disease|chagas disease
255684|NCT01863576|Chagas Cardiomyopathy|chagas cardiomyopathy
255685|NCT01863576|Trypanosoma cruzi|trypanosoma cruzi
255686|NCT01863576|Omega-3|omega-3
255687|NCT01863576|Cytokines|cytokines
255688|NCT01863576|Lipid profile|lipid profile
255689|NCT01863576|Nutritional assessment|nutritional assessment
255690|NCT01863563|tonsillectomy|tonsillectomy
255691|NCT01863563|adenoidectomy|adenoidectomy
255692|NCT01863563|obstructive sleep apnea|obstructive sleep apnea
255693|NCT01863524|Abdominal Aortic Aneurysm (AAA),|abdominal aortic aneurysm (aaa),
255694|NCT01863524|Echocardiography (TTE),|echocardiography (tte),
255695|NCT01863524|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
255696|NCT01863524|Patients over 65 years old|patients over 65 years old
255697|NCT01863511|Treatment options for acute decompensated heart failure|treatment options for acute decompensated heart failure
255698|NCT01863511|Ultrafiltration|ultrafiltration
255699|NCT01863511|tolvaptan|tolvaptan
255700|NCT01863498|pectus excavatum|pectus excavatum
255701|NCT01863498|pain control|pain control
255702|NCT01863485|advanced cancer|advanced cancer
255703|NCT01863459|ADHD|adhd
255704|NCT01863459|ADD|add
255705|NCT01863459|Anxiety|anxiety
255706|NCT01863459|Anxiety Disorders|anxiety disorders
255707|NCT01863459|Depression|depression
255708|NCT01863459|Attention|attention
255709|NCT01863459|Attention Deficit|attention deficit
255710|NCT01863446|Pregnancy|pregnancy
255711|NCT01863446|Melatonin|melatonin
255712|NCT01863446|Contractions|contractions
255713|NCT01863446|Light|light
256713|NCT01858922|vincristine|vincristine
255714|NCT01863420|gastric cancer|gastric cancer
255715|NCT01863420|rectal cancer|rectal cancer
255716|NCT01863420|bone marrow toxicity|bone marrow toxicity
255717|NCT01863420|IMRT|imrt
255718|NCT01863420|hematologic toxicity|hematologic toxicity
255719|NCT01863407|Ileus|ileus
255720|NCT01863407|Intestinal Obstruction|intestinal obstruction
255721|NCT01863407|Intestinal Diseases|intestinal diseases
255722|NCT01863407|Gastrointestinal Diseases|gastrointestinal diseases
255723|NCT01863407|Digestive System Diseases|digestive system diseases
255724|NCT01863394|Screening|screening
255725|NCT01863394|Malnutrition|malnutrition
255726|NCT01863394|Community Management of Acute Malnutrition|community management of acute malnutrition
255727|NCT01863381|Hydrocephalus|hydrocephalus
255728|NCT01863381|Idiopathic intracranial hypertension|idiopathic intracranial hypertension
255729|NCT01863381|Pseudotumor cerebri|pseudotumor cerebri
255730|NCT01863381|ICP|icp
255731|NCT01863381|Intracranial pressure|intracranial pressure
255732|NCT01863381|CSF pressure|csf pressure
255733|NCT01863381|VIIP|viip
255734|NCT01863368|Dry eye syndrome|dry eye syndrome
255735|NCT01863368|Systane Ultra|systane ultra
255736|NCT01863368|Optive|optive
255737|NCT01863368|Ocular Surface Staining|ocular surface staining
255738|NCT01863368|OSDI|osdi
255739|NCT01863368|Eye drops|eye drops
255740|NCT01863355|IntravenousPCA, fentanyl, postoperative pain, laparoscopic gastrectomy|intravenouspca, fentanyl, postoperative pain, laparoscopic gastrectomy
255741|NCT01863342|central sensitization; osteoarthritis; epidural analgesia|central sensitization; osteoarthritis; epidural analgesia
255742|NCT01863329|Optic nerve sheath diameter|optic nerve sheath diameter
255743|NCT01863329|Hydrocephalus|hydrocephalus
255744|NCT01863329|Intracranial hypertension|intracranial hypertension
255745|NCT01863316|LMA Supreme, i-gel, supraglottic airway|lma supreme, i-gel, supraglottic airway
255746|NCT01863303|colorectal cancer|colorectal cancer
255747|NCT01863303|epidemiology|epidemiology
255748|NCT01863303|industry|industry
255749|NCT01863303|genetic|genetic
255750|NCT01863290|prison|prison
255751|NCT01863290|reentry|reentry
255752|NCT01863290|health care utilization|health care utilization
255753|NCT01863264|dysphagia|dysphagia
255754|NCT01863264|swallowing|swallowing
255755|NCT01863264|infant|infant
255756|NCT01863264|premature|premature
255757|NCT01863264|neonate|neonate
255758|NCT01863264|thermal|thermal
255759|NCT01863264|cold|cold
255760|NCT01863264|bolus|bolus
255761|NCT01863264|temperature|temperature
255762|NCT01863264|deglutition|deglutition
255763|NCT01863264|NICU|nicu
255764|NCT01863264|bottle|bottle
255765|NCT01863264|nippling|nippling
255766|NCT01863251|Opiates|opiates
255767|NCT01863251|ATS|ats
255768|NCT01863251|HIV Risks|hiv risks
255769|NCT01863238|Cystic Fibrosis|cystic fibrosis
255770|NCT01863199|Wet AMD|wet amd
255771|NCT01863199|AMD|amd
255772|NCT01863199|Choroidal neovascularization|choroidal neovascularization
255773|NCT01863199|Neovascular membrane|neovascular membrane
255774|NCT01863186|lofexidine|lofexidine
255775|NCT01863186|opioid dependence|opioid dependence
255776|NCT01863186|acute withdrawal syndrome|acute withdrawal syndrome
255777|NCT01863186|opioid withdrawal|opioid withdrawal
255778|NCT01863173|Thalassemia cardiomyopathy|thalassemia cardiomyopathy
255779|NCT01863173|metoprolol succinate|metoprolol succinate
255780|NCT01863173|echocardiography|echocardiography
255781|NCT01863173|six minute walk test|six minute walk test
255782|NCT01863160|Safety|safety
255783|NCT01863160|Tolerability|tolerability
255784|NCT01863160|Pharmacokinetic profile|pharmacokinetic profile
255785|NCT01863160|ZEP-3 Cream (0.1% and 1.0%)|zep-3 cream (0.1% and 1.0%)
255786|NCT01863160|administered topically|administered topically
255787|NCT01863147|Type 2 diabetes|type 2 diabetes
255788|NCT01863147|left ventricular mass|left ventricular mass
255789|NCT01863147|inhibitor of dipeptidyl peptidase-4|inhibitor of dipeptidyl peptidase-4
255790|NCT01863121|cirrhosis|cirrhosis
255791|NCT01863121|CTPK|ctpk
255792|NCT01863121|CTP|ctp
255793|NCT01863121|MELD|meld
255794|NCT01863121|Severity Score|severity score
255795|NCT01863108|Melanoma|melanoma
255796|NCT01863108|Immunotherapy|immunotherapy
255797|NCT01863108|Dermatology|dermatology
255798|NCT01863108|cancer vaccine|cancer vaccine
255799|NCT01863108|Plasmacytoid dendritic cell line|plasmacytoid dendritic cell line
255800|NCT01863108|Advanced Medicinal Therapy Product|advanced medicinal therapy product
255801|NCT01863108|allogeneic|allogeneic
255802|NCT01863082|Resistant Hypertension|resistant hypertension
255803|NCT01863069|inhaled|inhaled
255804|NCT01863069|interferon beta-1a|interferon beta-1a
255805|NCT01863069|healthy subjects|healthy subjects
255806|NCT01863056|Sedentary time|sedentary time
255807|NCT01863056|Non Exercise Activity|non exercise activity
255808|NCT01863056|Sit Stand Workstation|sit stand workstation
255809|NCT01863043|Premature Infant|premature infant
255810|NCT01863043|Nutrition|nutrition
255811|NCT01863043|Enteral|enteral
255812|NCT01863030|Resorbable mesh|resorbable mesh
255813|NCT01863030|Phasix mesh|phasix mesh
255814|NCT01863017|Obesity|obesity
255815|NCT01863017|Over weight|over weight
255816|NCT01862991|Induced Abortion|induced abortion
255817|NCT01862991|Mifepristone|mifepristone
255818|NCT01862991|Dilation and Evacuation|dilation and evacuation
255819|NCT01862991|Cervical Preparation|cervical preparation
255820|NCT01862991|Osmotic Dilators|osmotic dilators
255821|NCT01862978|Stroke|stroke
255822|NCT01862978|Heparin|heparin
255823|NCT01862978|Nadroparin|nadroparin
255824|NCT01862965|firstline|firstline
255825|NCT01862965|treatment|treatment
255826|NCT01862965|prednisone|prednisone
255827|NCT01862965|everolimus|everolimus
255828|NCT01862939|type 2 diabetes mellitus|type 2 diabetes mellitus
255829|NCT01862926|connective tissue disease|connective tissue disease
255830|NCT01862926|interstitial lung disease|interstitial lung disease
255831|NCT01862926|pulmonary fibrosis|pulmonary fibrosis
255832|NCT01862926|rituximab|rituximab
255833|NCT01862926|scleroderma|scleroderma
255834|NCT01862926|polymyositis|polymyositis
255835|NCT01862926|dermatomyositis|dermatomyositis
255836|NCT01862913|depression|depression
255837|NCT01862913|adolescents|adolescents
255838|NCT01862900|Breast Cancer|breast cancer
255839|NCT01862900|Metastatic|metastatic
255840|NCT01862900|Lung metastases|lung metastases
255841|NCT01862900|Liver metastases|liver metastases
255842|NCT01862900|Stereotactic body radiation|stereotactic body radiation
255843|NCT01862900|anti-OX40 antibody|anti-ox40 antibody
255844|NCT01862900|MEDI6469|medi6469
255845|NCT01862900|Immunotherapy|immunotherapy
255846|NCT01862861|Bioidentical Hormone Replacement Therapy|bioidentical hormone replacement therapy
255847|NCT01862848|Topical Compounded Pain Creams and Pain Perception|topical compounded pain creams and pain perception
255848|NCT01862822|Paediatrics|paediatrics
255849|NCT01862822|Urinary tract infection|urinary tract infection
255850|NCT01862822|Urine collection|urine collection
255851|NCT01862809|Oral Microbiota|oral microbiota
255852|NCT01862809|Cigarette Smoking|cigarette smoking
255853|NCT01862809|Tobacco- Related Cancer|tobacco- related cancer
255854|NCT01862796|Food Intake|food intake
255855|NCT01862796|Weight Loss|weight loss
255856|NCT01862796|Compliance|compliance
255857|NCT01862783|Erythrocytes|erythrocytes
255858|NCT01862783|Parasites|parasites
751916|NCT01171222|soccer|soccer
255859|NCT01862783|Plasmodium Falciparum|plasmodium falciparum
255860|NCT01862783|Placenta|placenta
255861|NCT01862783|Resistant|resistant
255862|NCT01862770|Lung Cancer|lung cancer
255863|NCT01862770|Smokers|smokers
255864|NCT01862770|Genetic Risk Communication|genetic risk communication
255865|NCT01862770|Smoking Cessation|smoking cessation
255866|NCT01862757|Obesity|obesity
255867|NCT01862757|Insulin|insulin
255868|NCT01862757|Skeletal Muscle|skeletal muscle
255869|NCT01862757|Strength Testing|strength testing
255870|NCT01862744|Parkinson's Disease|parkinson's disease
255872|NCT01862744|Cognitive|cognitive
255873|NCT01862731|Muscle Force|muscle force
255874|NCT01862731|Knee|knee
255875|NCT01862731|Magnetic Resonance Imaging|magnetic resonance imaging
255876|NCT01862731|Quadriceps|quadriceps
255877|NCT01862731|Ultrasound|ultrasound
255878|NCT01862718|Fusion|fusion
255879|NCT01862718|Tracking|tracking
255880|NCT01862718|Ablation|ablation
255881|NCT01862718|Hepatic Neoplasms|hepatic neoplasms
255882|NCT01862666|Barrett's Esophagus|barrett's esophagus
255883|NCT01862666|Dysplasia|dysplasia
255884|NCT01862666|Intramucosal Adenocarcinoma|intramucosal adenocarcinoma
255886|NCT01862666|Endoscopy|endoscopy
255887|NCT01862653|Post Traumatic Stress Disorder|post traumatic stress disorder
256695|NCT01859000|Adolescents|adolescents
255888|NCT01862653|Sleep Disturbance|sleep disturbance
255889|NCT01862653|Acupuncture|acupuncture
255890|NCT01862640|OPC-34712|opc-34712
255891|NCT01862640|brexpiprazole|brexpiprazole
255892|NCT01862640|Dementia|dementia
255893|NCT01862640|Alzheimer's Disease|alzheimer's disease
255894|NCT01862640|Cognitive Disorders|cognitive disorders
255895|NCT01862640|Memory|memory
255896|NCT01862640|Agitation|agitation
255897|NCT01862627|Macular retinoschisis|macular retinoschisis
255898|NCT01862627|Macular detachment|macular detachment
255899|NCT01862627|vitrectomy|vitrectomy
255900|NCT01862614|Degree of pulpal anesthesia obtained.|degree of pulpal anesthesia obtained.
255901|NCT01862614|Primary infiltration in the lower first molar.|primary infiltration in the lower first molar.
255902|NCT01862614|Buffered local anesthetic.|buffered local anesthetic.
255903|NCT01862588|septic shock|septic shock
255904|NCT01862588|acute kidney injury|acute kidney injury
255905|NCT01862588|renal resistive index|renal resistive index
255906|NCT01862562|Laparoscopic surgery|laparoscopic surgery
255907|NCT01862562|Colorectal cancer|colorectal cancer
255908|NCT01862562|Elderly patient|elderly patient
255909|NCT01862562|Randomized control study|randomized control study
255910|NCT01862536|Randomized trial|randomized trial
255911|NCT01862536|COPD|copd
255912|NCT01862536|tadalafil|tadalafil
255913|NCT01862536|Phosphodiesterase inhibitor|phosphodiesterase inhibitor
246626|NCT01904136|MDS|mds
255914|NCT01862536|Pulmonary hypertension|pulmonary hypertension
255915|NCT01862510|Celiac Disease|celiac disease
255916|NCT01862510|Hypothyroidism|hypothyroidism
255917|NCT01862510|Celiac Sprue|celiac sprue
255918|NCT01862510|Malabsorption|malabsorption
255919|NCT01862497|Intradialytic Hypertension|intradialytic hypertension
255920|NCT01862497|Hemodialysis|hemodialysis
255921|NCT01862497|Hypertension|hypertension
255922|NCT01862497|Extracellular Volume|extracellular volume
255923|NCT01862497|Endothelial Cell Dysfunction|endothelial cell dysfunction
255924|NCT01862497|Endothelin 1|endothelin 1
255925|NCT01862497|Carvedilol|carvedilol
255926|NCT01862484|ADHD|adhd
255927|NCT01862484|Diet|diet
255928|NCT01862484|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
255929|NCT01862471|Deep Vein Thrombosis|deep vein thrombosis
255930|NCT01862471|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
255931|NCT01862471|Intermittent Pneumatic Compression|intermittent pneumatic compression
255932|NCT01862471|Doppler Ultrasound|doppler ultrasound
255933|NCT01862458|empyema|empyema
255934|NCT01862458|tPA|tpa
255935|NCT01862458|dornase|dornase
255936|NCT01862445|Chronic Lymphoid Leukemia, Chlorambucil, Rituximab|chronic lymphoid leukemia, chlorambucil, rituximab
255937|NCT01862393|electrical stimulation|electrical stimulation
255938|NCT01862393|torque|torque
255939|NCT01862380|Adrenocortical function|adrenocortical function
255940|NCT01862380|Adrenal hyperplasia, Congenital|adrenal hyperplasia, congenital
255941|NCT01862380|21-hydroxylase|21-hydroxylase
255942|NCT01862380|deficiency|deficiency
255943|NCT01862380|cortisol|cortisol
255944|NCT01862380|replacement therapy|replacement therapy
255945|NCT01862380|Woman|woman
255946|NCT01862380|Healthy people|healthy people
255947|NCT01862354|Postoperative analgesia|postoperative analgesia
255948|NCT01862354|Abdominoplasty|abdominoplasty
255949|NCT01862354|Continuous wound infusion|continuous wound infusion
255950|NCT01862354|Transverse abdominal plan block|transverse abdominal plan block
255951|NCT01862354|Local anesthetics : Ropivacaine|local anesthetics : ropivacaine
255952|NCT01862354|Regional anesthesia|regional anesthesia
255953|NCT01862341|Constipation|constipation
255954|NCT01862341|Bowel movement|bowel movement
255955|NCT01862341|Intestinal health|intestinal health
255956|NCT01862328|MLN4924|mln4924
255957|NCT01862328|Solid Tumors|solid tumors
255958|NCT01862315|Hepatic Arterial Infusion (HAI)|hepatic arterial infusion (hai)
255959|NCT01862315|Floxuridine (FUDR)|floxuridine (fudr)
255962|NCT01862315|Oxaliplatin|oxaliplatin
255963|NCT01862315|13-066|13-066
255964|NCT01862302|Prevention delirium|prevention delirium
255965|NCT01862302|Cardiac surgery|cardiac surgery
255966|NCT01862289|difficult asthma|difficult asthma
255967|NCT01862289|hyperventilation syndrome|hyperventilation syndrome
255968|NCT01862289|prevalence|prevalence
255969|NCT01862263|Diabetes,|diabetes,
255970|NCT01862263|Type 2 diabetes,|type 2 diabetes,
255971|NCT01862263|Diabetes mellitus,|diabetes mellitus,
255972|NCT01862263|insulin,|insulin,
255973|NCT01862237|Type II diabetes|type ii diabetes
255974|NCT01862237|aortic valve stenosis|aortic valve stenosis
255975|NCT01862237|left ventricular remodeling|left ventricular remodeling
255976|NCT01862237|aortic valve replacement surgery|aortic valve replacement surgery
255977|NCT01862224|Active rheumatoid arthritis despite methotrexate therapy|active rheumatoid arthritis despite methotrexate therapy
255978|NCT01862224|JNJ-38518168|jnj-38518168
255979|NCT01862224|Synovial|synovial
255980|NCT01862211|alpha antitrypsin, hepatic disease, genetic, polymorphism|alpha antitrypsin, hepatic disease, genetic, polymorphism
255981|NCT01862185|semiquantitative|semiquantitative
255982|NCT01862185|procalcitonin|procalcitonin
255983|NCT01862185|sepsis|sepsis
255984|NCT01862185|antibiotics|antibiotics
255986|NCT01862172|Cortical focal atrophy|cortical focal atrophy
255987|NCT01862172|Stroke|stroke
255988|NCT01862172|Internal capsule|internal capsule
255989|NCT01862172|Corticospinal tract|corticospinal tract
255990|NCT01862172|Wallerian degeneration|wallerian degeneration
255991|NCT01862172|Primary motor area.|primary motor area.
255992|NCT01862159|bariatric surgery|bariatric surgery
255993|NCT01862159|postoperative complications|postoperative complications
255994|NCT01862146|TCA|tca
255995|NCT01862146|FMD|fmd
255996|NCT01862146|IMT|imt
255997|NCT01862146|Smoking|smoking
255998|NCT01862133|Electronic Health Record|electronic health record
255999|NCT01862133|Health Information Technology|health information technology
256000|NCT01862133|Patient Privacy|patient privacy
256001|NCT01862133|Personal Health Information|personal health information
256002|NCT01862120|Recently diagnosed|recently diagnosed
256003|NCT01862120|Regulatory T Cells|regulatory t cells
256004|NCT01862120|Tolerance Induction|tolerance induction
256005|NCT01862120|Paediatrics|paediatrics
256006|NCT01862120|Low dose|low dose
256007|NCT01862120|IL-2|il-2
256008|NCT01862107|Biomarkers|biomarkers
256009|NCT01862107|Immune Responses|immune responses
256010|NCT01862107|Lumbar Puncture|lumbar puncture
256011|NCT01862107|Neurological Diseases|neurological diseases
256012|NCT01862107|Novel Pathogens|novel pathogens
256013|NCT01862068|Pronostic factors|pronostic factors
256014|NCT01862068|Neutrophils|neutrophils
256015|NCT01862068|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
256016|NCT01862068|Microscopic polyangiitis|microscopic polyangiitis
256017|NCT01862068|ANCA associated vasculitis|anca associated vasculitis
256018|NCT01862068|Proteomics|proteomics
256020|NCT01862055|Anxiety|anxiety
256021|NCT01862055|Cesarean Section|cesarean section
256022|NCT01862055|Spinal anesthesia|spinal anesthesia
256023|NCT01862055|Hypotension|hypotension
256024|NCT01862042|Spinal Muscular Atrophy (SMA) type 1|spinal muscular atrophy (sma) type 1
256025|NCT01862042|Supportive care|supportive care
256026|NCT01862042|Palliative care|palliative care
256027|NCT01862029|Mitochondria in Diabetes|mitochondria in diabetes
256028|NCT01862029|Obesity|obesity
256029|NCT01862029|Roflumilast|roflumilast
256030|NCT01862029|Phosphodiesterase-4|phosphodiesterase-4
256031|NCT01862029|Pre-Diabetes|pre-diabetes
256032|NCT01862016|Acute respiratory distress syndrome|acute respiratory distress syndrome
256033|NCT01862016|APRV ventilatory mode|aprv ventilatory mode
256034|NCT01862016|Spontaneous breathing|spontaneous breathing
256035|NCT01862016|Intensive Care Unit|intensive care unit
256036|NCT01862003|Colorectal cancer|colorectal cancer
256037|NCT01862003|Metastatic Colorectal cancer|metastatic colorectal cancer
256038|NCT01862003|Recurrent Colorectal cancer|recurrent colorectal cancer
256039|NCT01862003|FOLFIRI|folfiri
256040|NCT01862003|AZD8931|azd8931
256041|NCT01862003|Chemotherapy|chemotherapy
256042|NCT01862003|EGFR|egfr
256043|NCT01861990|Glioma|glioma
256044|NCT01861990|Glioblastoma|glioblastoma
256045|NCT01861990|Pediatric|pediatric
256046|NCT01861990|Child|child
256047|NCT01861990|Brain tumor|brain tumor
256048|NCT01861990|Astrocytoma|astrocytoma
256049|NCT01861990|Medulloblastoma|medulloblastoma
256050|NCT01861990|PNET|pnet
256051|NCT01861977|Cognitive Therapy|cognitive therapy
256052|NCT01861977|Health Education|health education
256053|NCT01861977|Secondary Prevention|secondary prevention
256054|NCT01861977|Cardiovascular Disease|cardiovascular disease
256055|NCT01861964|XOS|xos
256056|NCT01861964|Xylooligosarcharide|xylooligosarcharide
256057|NCT01861964|Prebiotic|prebiotic
256058|NCT01861951|soft tissue sarcoma|soft tissue sarcoma
256059|NCT01861951|firstline treatment|firstline treatment
256060|NCT01861951|eldery patients|eldery patients
256061|NCT01861938|melanoma|melanoma
256063|NCT01861938|Resectable AJCC stage IV|resectable ajcc stage iv
256064|NCT01861938|AJCC stages IIb-c, III|ajcc stages iib-c, iii
256065|NCT01861938|Patients with low-burden|patients with low-burden
256066|NCT01861938|failed|failed
256067|NCT01861938|respond|respond
256068|NCT01861938|one treatment line|one treatment line
256069|NCT01861912|Carcinoma, Hepatocellular|carcinoma, hepatocellular
256070|NCT01861912|Arsenic trioxide|arsenic trioxide
256071|NCT01861899|Sacro-iliac Joint|sacro-iliac joint
256072|NCT01861886|Birth control|birth control
256073|NCT01861886|Permanent Contraception|permanent contraception
256074|NCT01861873|liver function|liver function
256075|NCT01861873|galactose|galactose
256076|NCT01861873|18-F-deoxy-galactose|18-f-deoxy-galactose
256077|NCT01861860|stenting using IVUS in long lEsion|stenting using ivus in long lesion
256078|NCT01861834|Total parenteral nutrition|total parenteral nutrition
256079|NCT01861834|TPN|tpn
256080|NCT01861834|Intestinal Failure|intestinal failure
256081|NCT01861834|Short Bowel Syndrome|short bowel syndrome
256082|NCT01861834|Cholestasis|cholestasis
256083|NCT01861834|Intestinal failure associated liver disease|intestinal failure associated liver disease
256084|NCT01861834|Parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
256085|NCT01861821|Epidural catheter|epidural catheter
256086|NCT01861821|Epidural analgesia|epidural analgesia
256906|NCT01858090|fentanyl|fentanyl
256087|NCT01861821|Labor epidural analgesia|labor epidural analgesia
256088|NCT01861821|Analgesic efficacy|analgesic efficacy
256089|NCT01861821|Multiport epidural catheter|multiport epidural catheter
256090|NCT01861821|Uniport epidural catheter|uniport epidural catheter
256091|NCT01861821|Flexible epidural catheter|flexible epidural catheter
256092|NCT01861808|Spinal Cord Injuries|spinal cord injuries
256093|NCT01861808|Cerebrospinal Fluid|cerebrospinal fluid
256094|NCT01861795|Drug therapy|drug therapy
256095|NCT01861769|Cognitive Processing Therapy|cognitive processing therapy
256096|NCT01861769|Consultation|consultation
256097|NCT01861756|Shared Decision Making|shared decision making
256098|NCT01861756|Decision Aids|decision aids
256099|NCT01861743|Multi-modal Pain Management|multi-modal pain management
256100|NCT01861743|Lumbar fusion|lumbar fusion
256101|NCT01861743|misTLIF|mistlif
256102|NCT01861730|BCG Vaccinated|bcg vaccinated
256103|NCT01861730|HIV Negative|hiv negative
256104|NCT01861717|excess growth hormone|excess growth hormone
256105|NCT01861717|excess GH|excess gh
256106|NCT01861717|gigantism|gigantism
256107|NCT01861717|pituitary tumor|pituitary tumor
256108|NCT01861717|pituitary adenoma|pituitary adenoma
316008|NCT01593241|RT|rt
256109|NCT01861717|growth hormone tumor|growth hormone tumor
256110|NCT01861717|GH secreting adenoma|gh secreting adenoma
256111|NCT01861717|Somatuline|somatuline
256112|NCT01861717|lanreotide|lanreotide
256113|NCT01861704|Mild to moderate hearing loss|mild to moderate hearing loss
256114|NCT01861691|Transverse colon cancer|transverse colon cancer
256115|NCT01861691|Descending colon cancer|descending colon cancer
256116|NCT01861691|Laparoscopic surgery|laparoscopic surgery
256117|NCT01861691|Randomized controlled trial|randomized controlled trial
256118|NCT01861678|Rectal cancer|rectal cancer
256119|NCT01861678|Anterior resection|anterior resection
256120|NCT01861678|High tie of inferior mesenteric artery|high tie of inferior mesenteric artery
256121|NCT01861678|Low tie of inferior mesenteric artery|low tie of inferior mesenteric artery
256122|NCT01861678|Randomized controlled trial|randomized controlled trial
256123|NCT01861652|Restless legs syndrome, Ekbom syndrome, Restless legs|restless legs syndrome, ekbom syndrome, restless legs
256124|NCT01861600|Stool composition|stool composition
256125|NCT01861535|VIN|vin
256126|NCT01861535|Imiquimod|imiquimod
256127|NCT01861535|Surgery|surgery
256128|NCT01861535|HPV|hpv
256129|NCT01861535|Patient satisfaction|patient satisfaction
256130|NCT01861522|TAU-284|tau-284
256131|NCT01861522|Bepotastine besilate|bepotastine besilate
256132|NCT01861522|Histamine H1 receptor antagonists|histamine h1 receptor antagonists
256133|NCT01861522|children|children
256134|NCT01861509|BP-C1|bp-c1
256135|NCT01861509|CDBPA|cdbpa
256136|NCT01861509|Metronomic chemotherapy|metronomic chemotherapy
256137|NCT01861509|Platinum analogue|platinum analogue
256138|NCT01861509|Cis-coordinated complexes of platinum(II) with polymer of benzene polycarboxylic acids derived from lignin|cis-coordinated complexes of platinum(ii) with polymer of benzene polycarboxylic acids derived from lignin
256139|NCT01861509|Benzene polycarboxylic acids complex with cis-diammineplatinum(II)|benzene polycarboxylic acids complex with cis-diammineplatinum(ii)
256140|NCT01861509|Breast cancer|breast cancer
256141|NCT01861509|Cisplatin|cisplatin
256142|NCT01861509|Metastatic Breast Cancer|metastatic breast cancer
256143|NCT01861496|Cisplatin|cisplatin
256144|NCT01861496|Liposomal formulation|liposomal formulation
256145|NCT01861496|DRP (Dose Response Prediction)|drp (dose response prediction)
256146|NCT01861457|nasal sanitizer®|nasal sanitizer®
256147|NCT01861457|S. aureus|s. aureus
256151|NCT01861431|HIV, prevention, microfinance, sex work, Mongolia|hiv, prevention, microfinance, sex work, mongolia
256153|NCT01861418|low back pain|low back pain
256154|NCT01861418|lumbopelvic manipulation|lumbopelvic manipulation
256155|NCT01861418|Chicago manipulation|chicago manipulation
256157|NCT01861418|electromyography|electromyography
256158|NCT01861418|reliability|reliability
256159|NCT01861392|postural balance sensory motor trayning physical therapy modalities diabetes mellitus|postural balance sensory motor trayning physical therapy modalities diabetes mellitus
256160|NCT01861366|Implementation|implementation
256161|NCT01861366|Guidelines|guidelines
256162|NCT01861366|Nutrition|nutrition
256163|NCT01861366|Nursing home|nursing home
256164|NCT01861327|Carbon dioxide|carbon dioxide
256165|NCT01861327|aortic aneurysm|aortic aneurysm
256166|NCT01861327|angioplasty|angioplasty
256167|NCT01861327|Critical lower limb ischemia|critical lower limb ischemia
256168|NCT01861288|Inflammatory Bowel Disease|inflammatory bowel disease
256169|NCT01861288|Fecal Calprotectin|fecal calprotectin
256170|NCT01861288|Clinical IBD score (SCCAI, PUCAI, aPCDAI)|clinical ibd score (sccai, pucai, apcdai)
256171|NCT01861288|Endoscopic deep remission|endoscopic deep remission
256172|NCT01861288|Histopathologic deep remission|histopathologic deep remission
256173|NCT01861288|Immunological deep remission|immunological deep remission
256174|NCT01861288|Treatment algorithm|treatment algorithm
256175|NCT01861275|osa|osa
256176|NCT01861275|cerebral palsy|cerebral palsy
256177|NCT01861275|thrombolysis in cerebral palsy|thrombolysis in cerebral palsy
256178|NCT01861275|sleep registration|sleep registration
256179|NCT01861262|emergency|emergency
256180|NCT01861262|drug poisoning|drug poisoning
256181|NCT01861262|StO2 measurement|sto2 measurement
256182|NCT01861262|blood pressure|blood pressure
256183|NCT01861262|hemodynamic failure|hemodynamic failure
256184|NCT01861223|acquired resistance|acquired resistance
256185|NCT01861223|gefitinib|gefitinib
256186|NCT01861223|erlotinib|erlotinib
256187|NCT01861210|Homosexuality, Male|homosexuality, male
256188|NCT01861197|Efficacy|efficacy
256189|NCT01861197|Dovitinib|dovitinib
256190|NCT01861197|Squamous NSCLC|squamous nsclc
256191|NCT01861184|Lower respiratory tract infection|lower respiratory tract infection
256192|NCT01861184|LRTI|lrti
256193|NCT01861184|Pneumococcal carriage|pneumococcal carriage
256194|NCT01861158|Parenting|parenting
256195|NCT01861158|Adolescence|adolescence
256196|NCT01861158|Delinquency|delinquency
256197|NCT01861158|Online intervention|online intervention
256198|NCT01861158|Juvenile Justice|juvenile justice
256199|NCT01861145|Intranasal steroids|intranasal steroids
256200|NCT01861132|Pregnancy, cesarean delivery, blood pressure, cardiac output|pregnancy, cesarean delivery, blood pressure, cardiac output
316104|NCT01592994|HIV|hiv
256206|NCT01861093|Unrelated Hematopoietic Stem Cell Transplantation|unrelated hematopoietic stem cell transplantation
256207|NCT01861093|Cryopreserved Cord Blood Units|cryopreserved cord blood units
256208|NCT01861093|National Cord Blood Program|national cord blood program
256209|NCT01861080|target organ damage|target organ damage
256210|NCT01861080|incident hypertension|incident hypertension
256211|NCT01861080|cohort|cohort
256212|NCT01861054|Cancer Stem Cells|cancer stem cells
256213|NCT01861054|Novel targeted therapy|novel targeted therapy
256214|NCT01861054|CXCR1/2 Inhibitors|cxcr1/2 inhibitors
256215|NCT01861041|low dose|low dose
256216|NCT01861041|different baricity|different baricity
256217|NCT01861041|spinal anesthesia|spinal anesthesia
256218|NCT01861028|total knee replacement|total knee replacement
256219|NCT01861028|total knee arthroplasty|total knee arthroplasty
256220|NCT01861028|patient-specific|patient-specific
256221|NCT01861002|Relapse|relapse
256222|NCT01861002|Lymphoblastic|lymphoblastic
256223|NCT01861002|Leukemia|leukemia
256224|NCT01861002|Azacytidine|azacytidine
256225|NCT01861002|Refractory|refractory
256226|NCT01861002|Myelogenous|myelogenous
256227|NCT01861002|Acute|acute
256228|NCT01861002|Childhood|childhood
256229|NCT01861002|Pediatric|pediatric
256230|NCT01861002|ALL|all
256231|NCT01861002|AML|aml
256232|NCT01861002|Methylation|methylation
256233|NCT01861002|Epigenetic therapy|epigenetic therapy
256234|NCT01860989|parasitemia|parasitemia
256235|NCT01860963|ASIL|asil
256236|NCT01860963|Anal dysplasia|anal dysplasia
256237|NCT01860963|IBD|ibd
256238|NCT01860963|HPV DNA|hpv dna
256239|NCT01860950|Healthy Adults|healthy adults
256240|NCT01860950|Pain Perception|pain perception
256241|NCT01860937|T cell Immunotherapy|t cell immunotherapy
256242|NCT01860937|CD19 Targeted Therapy|cd19 targeted therapy
256243|NCT01860937|Chimeric Antigen Receptor (CAR) Modified T cells|chimeric antigen receptor (car) modified t cells
256244|NCT01860937|Conditioning Chemotherapy|conditioning chemotherapy
256246|NCT01860924|exercise|exercise
256247|NCT01860924|depression|depression
256248|NCT01860924|smoking|smoking
256249|NCT01860898|lung|lung
256250|NCT01860898|cancer|cancer
256251|NCT01860898|thoracic|thoracic
256252|NCT01860898|chest|chest
256253|NCT01860898|pulmonary|pulmonary
256254|NCT01860885|naloxone|naloxone
256255|NCT01860885|children|children
256256|NCT01860885|opioid|opioid
256257|NCT01860885|respiratory depression|respiratory depression
256258|NCT01860885|safety|safety
256259|NCT01860872|Cystic Fibrosis|cystic fibrosis
256260|NCT01860872|Pulmonary perfusion|pulmonary perfusion
256261|NCT01860872|Inflammatory markers|inflammatory markers
256262|NCT01860872|MRI|mri
256263|NCT01860872|CT of chest|ct of chest
256264|NCT01860872|Lung Clearance Index|lung clearance index
256265|NCT01860859|cesarean|cesarean
256266|NCT01860859|ultrasound|ultrasound
256267|NCT01860859|hysterotomy|hysterotomy
256268|NCT01860859|uterus|uterus
256269|NCT01860859|suture|suture
256270|NCT01860846|Crohn's Disease|crohn's disease
256271|NCT01860833|Knee Osteoarthritis|knee osteoarthritis
256272|NCT01860820|IPC/TEDS|ipc/teds
256273|NCT01860820|Geko device|geko device
256274|NCT01860807|methamphetamine|methamphetamine
256275|NCT01860807|ibudilast|ibudilast
256276|NCT01860807|HIV|hiv
256277|NCT01860781|Schizophrenia|schizophrenia
256278|NCT01860781|Injection|injection
256279|NCT01860781|Switch|switch
256280|NCT01860781|Paliperidone|paliperidone
256281|NCT01860781|refractory, chronic akathisia, poor complianc|refractory, chronic akathisia, poor complianc
256282|NCT01860768|Acute aortic dissection|acute aortic dissection
256283|NCT01860768|Serum biomarkers|serum biomarkers
256284|NCT01860768|Early diagnosis|early diagnosis
256285|NCT01860755|Sport-related concussion|sport-related concussion
256286|NCT01860755|Dizziness|dizziness
256287|NCT01860755|Neck pain|neck pain
256288|NCT01860755|Headaches|headaches
256289|NCT01860755|Physiotherapy|physiotherapy
256290|NCT01860755|Treatment|treatment
258230|NCT01852955|Breast|breast
256291|NCT01860742|Peptide Receptor Radionuclide Therapy (PRRT)|peptide receptor radionuclide therapy (prrt)
256292|NCT01860742|Neuroendocrine Tumors|neuroendocrine tumors
256293|NCT01860742|Interferon alpha|interferon alpha
256294|NCT01860716|Melatonin, liver transplant, oxidative stress|melatonin, liver transplant, oxidative stress
256295|NCT01860703|Ferriprox®|ferriprox®
256296|NCT01860703|LI|li
256297|NCT01860703|DFP|dfp
256298|NCT01860703|Deferiprone|deferiprone
256299|NCT01860703|Healthy Volunteers|healthy volunteers
256300|NCT01860690|MTX|mtx
256301|NCT01860690|Ectopic pregnancy|ectopic pregnancy
256302|NCT01860690|medical treatment|medical treatment
256303|NCT01860677|cranial stimulation|cranial stimulation
256304|NCT01860677|BOLD (Blood Oxygenation Level Dependent)|bold (blood oxygenation level dependent)
256305|NCT01860677|fMRI (Functional Magnetic Resonance Imaging)|fmri (functional magnetic resonance imaging)
256306|NCT01860677|spectroscopy|spectroscopy
256307|NCT01860664|allergy|allergy
256308|NCT01860664|allergic|allergic
256309|NCT01860664|conjunctivitis|conjunctivitis
256310|NCT01860664|corticosteroid|corticosteroid
256311|NCT01860664|hydrocortisone|hydrocortisone
256312|NCT01860664|ophthalmic|ophthalmic
256313|NCT01860664|ointment|ointment
256314|NCT01860651|Inflammatory Bowel Disease|inflammatory bowel disease
256315|NCT01860651|Ulcerative Colitis|ulcerative colitis
256316|NCT01860651|Crohn´s Disease|crohn´s disease
256317|NCT01860651|Children|children
256318|NCT01860651|Adolescence|adolescence
256319|NCT01860651|E-health web-monitoring|e-health web-monitoring
256320|NCT01860651|Adherence|adherence
256321|NCT01860651|Disease activity|disease activity
256322|NCT01860651|Fecal Calprotectin|fecal calprotectin
256323|NCT01860599|prediabetes|prediabetes
256324|NCT01860599|EPC's|epc's
256325|NCT01860599|vascular reactivity|vascular reactivity
256326|NCT01860586|pvr|pvr
256327|NCT01860586|rd|rd
256328|NCT01860586|Proliferative Vitreoretinopathy|proliferative vitreoretinopathy
256329|NCT01860586|retinal detachment|retinal detachment
256330|NCT01860586|detachment|detachment
256331|NCT01860573|Amino acids|amino acids
256332|NCT01860573|Protein|protein
256333|NCT01860560|OSA|osa
256334|NCT01860560|Obstructive Sleep Apnea|obstructive sleep apnea
256335|NCT01860560|High Flow Therapy|high flow therapy
256336|NCT01860560|CPAP|cpap
256337|NCT01860560|HFT|hft
256338|NCT01860560|Continuous Positive Airway Pressure|continuous positive airway pressure
256339|NCT01860560|Mild OSA|mild osa
256340|NCT01860560|Moderate OSA|moderate osa
256341|NCT01860534|pain|pain
256342|NCT01860534|mydriasis|mydriasis
256343|NCT01860534|light|light
256344|NCT01860521|Termination of pregnancy|termination of pregnancy
256345|NCT01860521|Second trimester|second trimester
256473|NCT01860079|PPCI|ppci
256346|NCT01860521|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
256347|NCT01860521|Continuous epidural infusion|continuous epidural infusion
256348|NCT01860521|Epidural analgesia|epidural analgesia
256349|NCT01860521|Legally Induced Abortion|legally induced abortion
256350|NCT01860508|Progression free Survival|progression free survival
256351|NCT01860495|growth factors|growth factors
256352|NCT01860495|periodontal pockets|periodontal pockets
256353|NCT01860482|Refractory Reflux Esophagitis|refractory reflux esophagitis
256354|NCT01860482|GERD|gerd
256355|NCT01860482|Phase 4|phase 4
256356|NCT01860456|Chronic myeloid leukemia|chronic myeloid leukemia
256357|NCT01860456|Imatinib|imatinib
256358|NCT01860456|Nilotinib|nilotinib
256359|NCT01860456|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
256360|NCT01860456|Pharmacokinetics|pharmacokinetics
256361|NCT01860456|ATP-Binding Cassette Transporters|atp-binding cassette transporters
256362|NCT01860456|SLC Transporters|slc transporters
256363|NCT01860456|Treatment outcome|treatment outcome
256364|NCT01860456|Toxicity|toxicity
256365|NCT01860443|depression|depression
256366|NCT01860443|adolescents|adolescents
256367|NCT01860430|Locally Advanced|locally advanced
256368|NCT01860430|Head and Neck Cancer|head and neck cancer
256369|NCT01860430|Ipilimumab (YERVOY®)|ipilimumab (yervoy®)
256370|NCT01860417|Degenerative Disc Disease,|degenerative disc disease,
256371|NCT01860417|Intervertebral Disc Disease|intervertebral disc disease
256372|NCT01860417|Low Back Pain|low back pain
256373|NCT01860417|Nucleus pulposus|nucleus pulposus
256374|NCT01860417|Stem cell|stem cell
256375|NCT01860417|Cellular therapy|cellular therapy
256376|NCT01860417|Regenerative therapy|regenerative therapy
256377|NCT01860417|Mesenchymal stem cells|mesenchymal stem cells
256378|NCT01860417|Bone marrow|bone marrow
256379|NCT01860417|Musculoskeletal Diseases|musculoskeletal diseases
256380|NCT01860417|Mesenchymal Stromal Cells (allogenic)|mesenchymal stromal cells (allogenic)
256381|NCT01860404|Concussion|concussion
256382|NCT01860404|Branched chain amino acids|branched chain amino acids
256384|NCT01860404|HIT HEADS|hit heads
256385|NCT01860391|Silver|silver
256386|NCT01860391|Fluoride|fluoride
256387|NCT01860391|Diammine Silver Fluoride|diammine silver fluoride
256388|NCT01860391|Saliva|saliva
256389|NCT01860378|Whooping Cough|whooping cough
256390|NCT01860378|Pertussis|pertussis
256391|NCT01860378|Tdap vaccination|tdap vaccination
256392|NCT01860378|Randomized placebo controlled factorial trial|randomized placebo controlled factorial trial
256393|NCT01860365|Quality of life|quality of life
256394|NCT01860365|Integrative medicine|integrative medicine
256395|NCT01860365|Supportive care|supportive care
256396|NCT01860365|Cancer|cancer
256397|NCT01860365|Chemotherapy|chemotherapy
256398|NCT01860352|Fish Oil|fish oil
256399|NCT01860352|colon health|colon health
256400|NCT01860352|fatty acid metabolism|fatty acid metabolism
256401|NCT01860339|Huntington's Disease|huntington's disease
256402|NCT01860339|HD|hd
256403|NCT01860339|Huntington Disease|huntington disease
256404|NCT01860339|Juvenile Huntington's Disease|juvenile huntington's disease
256405|NCT01860339|JHD|jhd
256406|NCT01860326|hepatic impairment|hepatic impairment
256407|NCT01860326|mild and moderate hepatic impairment|mild and moderate hepatic impairment
256408|NCT01860326|Alisporivir|alisporivir
256409|NCT01860313|effectiveness|effectiveness
256410|NCT01860313|distance learning|distance learning
256411|NCT01860313|mental health|mental health
256412|NCT01860300|Tic Disorders|tic disorders
256413|NCT01860300|Tourette Syndrome|tourette syndrome
256414|NCT01860287|opioid|opioid
256415|NCT01860287|subjective|subjective
256416|NCT01860287|stress|stress
256417|NCT01860287|buprenorphine|buprenorphine
256418|NCT01860274|Mesh|mesh
256419|NCT01860274|Graft|graft
256420|NCT01860274|Patency|patency
256422|NCT01860261|AIDS|aids
256423|NCT01860261|sedentary|sedentary
256424|NCT01860261|fitness|fitness
256425|NCT01860261|aging|aging
256426|NCT01860261|V02max|v02max
256427|NCT01860261|d-dimer|d-dimer
256428|NCT01860261|IL-6|il-6
256429|NCT01860261|CRP|crp
256430|NCT01860261|ChiWalking|chiwalking
256431|NCT01860261|ChiRunning|chirunning
256432|NCT01860261|aerobic exercise|aerobic exercise
256433|NCT01860261|strength training|strength training
256434|NCT01860248|vapocoolant effectiveness|vapocoolant effectiveness
256435|NCT01860248|arterial puncture|arterial puncture
256436|NCT01860235|Local anesthesia|local anesthesia
256437|NCT01860235|Pain measurement|pain measurement
256438|NCT01860235|Pain perception|pain perception
256439|NCT01860235|Dental anesthesia|dental anesthesia
256440|NCT01860235|Root planing|root planing
256441|NCT01860222|Hepatocellular carcinoma|hepatocellular carcinoma
256442|NCT01860222|CSPH|csph
256443|NCT01860222|Hepatectomy|hepatectomy
256444|NCT01860222|percutaneous local ablative|percutaneous local ablative
256445|NCT01860222|therapy (PLAT)|therapy (plat)
256446|NCT01860222|randomized controlled trials(RCTs)|randomized controlled trials(rcts)
256447|NCT01860209|obstructive sleep apnea|obstructive sleep apnea
693709|NCT00942019|adolescents|adolescents
256448|NCT01860209|overhydration|overhydration
256449|NCT01860209|end stage renal disease|end stage renal disease
256450|NCT01860209|intermittent ambulatory hemodialysis|intermittent ambulatory hemodialysis
256451|NCT01860209|polysomnography|polysomnography
256452|NCT01860209|bioimpedance|bioimpedance
256453|NCT01860209|leg fluid shift|leg fluid shift
256454|NCT01860209|neck circumference|neck circumference
256455|NCT01860183|kidney transplantation|kidney transplantation
256456|NCT01860183|chronic allograft dysfunction|chronic allograft dysfunction
256457|NCT01860183|mycophenolate mofetil|mycophenolate mofetil
256458|NCT01860183|Chronic|chronic
256459|NCT01860170|Blood and Marrow Transplant (BMT)|blood and marrow transplant (bmt)
256460|NCT01860170|MRD|mrd
256461|NCT01860170|MUD|mud
256462|NCT01860170|GVHD|gvhd
256463|NCT01860157|rTMS|rtms
256464|NCT01860157|depression|depression
256465|NCT01860157|magnetic|magnetic
256466|NCT01860144|bevacizumab|bevacizumab
256467|NCT01860144|overall survival|overall survival
256468|NCT01860144|adverse events|adverse events
256469|NCT01860144|tumor resection rate|tumor resection rate
256470|NCT01860131|bariatrics, lifestyle and behavioral modification programs|bariatrics, lifestyle and behavioral modification programs
256471|NCT01860079|Early discharge|early discharge
256472|NCT01860079|STEMI|stemi
256474|NCT01860066|COPD|copd
256475|NCT01860014|Pulmonary hemorrhage|pulmonary hemorrhage
256476|NCT01860014|Mortality|mortality
256477|NCT01860014|Newborn|newborn
256478|NCT01860001|cancer|cancer
256479|NCT01860001|metabolic acidosis|metabolic acidosis
256480|NCT01859988|Eczema|eczema
256481|NCT01859962|Liver diseases|liver diseases
256482|NCT01859962|Virus diseases|virus diseases
256483|NCT01859962|Ribavirin|ribavirin
256484|NCT01859962|protease inhibitor|protease inhibitor
256485|NCT01859962|NS5B polymerase inhibitor|ns5b polymerase inhibitor
256486|NCT01859962|NS5A inhibitor|ns5a inhibitor
256487|NCT01859949|Genotropin(somatropin)|genotropin(somatropin)
256488|NCT01859949|SGA|sga
256489|NCT01859949|Short Stature|short stature
256490|NCT01859949|Long-term|long-term
256491|NCT01859949|Safety|safety
256492|NCT01859923|Tuberculosis|tuberculosis
256493|NCT01859923|Tuberculosis, Multidrug-Resistant|tuberculosis, multidrug-resistant
256494|NCT01859923|Mycobacterium Infections|mycobacterium infections
256495|NCT01859923|Actinomycetales Infections|actinomycetales infections
256496|NCT01859923|Gram-Positive Infections|gram-positive infections
256497|NCT01859923|Bacterial Infections|bacterial infections
256498|NCT01859923|Pediatric|pediatric
256499|NCT01859884|Kidney transplantation|kidney transplantation
256500|NCT01859884|Increased risk donor kidneys|increased risk donor kidneys
256501|NCT01859884|Kidney donation|kidney donation
256502|NCT01859884|Organ donation|organ donation
256503|NCT01859884|Human Immunodeficiency Virus|human immunodeficiency virus
256504|NCT01859884|Hepatitis B|hepatitis b
256505|NCT01859884|Hepatitis C|hepatitis c
256506|NCT01859884|Infectious disease|infectious disease
256507|NCT01859884|Disease transmission|disease transmission
256508|NCT01859884|Centers for Disease Control (CDC)|centers for disease control (cdc)
256509|NCT01859884|Web-based intervention|web-based intervention
256510|NCT01859871|Living kidney donation|living kidney donation
256511|NCT01859871|End-stage renal disease|end-stage renal disease
256512|NCT01859871|Latinos|latinos
256513|NCT01859871|Undocumented Immigrants|undocumented immigrants
256514|NCT01859871|Bilingual|bilingual
256515|NCT01859871|Spanish|spanish
256516|NCT01859871|Website|website
256517|NCT01859871|Dialysis|dialysis
256518|NCT01859871|Hispanics|hispanics
256519|NCT01859871|Transplantation|transplantation
256520|NCT01859858|mCRC (metastatic colorectal cancer)|mcrc (metastatic colorectal cancer)
256521|NCT01859858|CRC (colorectal cancer)|crc (colorectal cancer)
256522|NCT01859858|Advanced colorectal cancer|advanced colorectal cancer
256523|NCT01859858|Metastatic colorectal cancer|metastatic colorectal cancer
256524|NCT01859858|Colon cancer|colon cancer
256525|NCT01859845|Melanoma|melanoma
256526|NCT01859845|Opportunistic surveillance|opportunistic surveillance
256527|NCT01859845|Melanoma simulation model|melanoma simulation model
256528|NCT01859845|Smartphone devices|smartphone devices
256529|NCT01859832|renal transplant|renal transplant
256530|NCT01859832|kidney transplantation|kidney transplantation
256531|NCT01859832|immune status|immune status
256532|NCT01859832|immunosuppressive medications|immunosuppressive medications
256533|NCT01859819|Pediatric|pediatric
256534|NCT01859819|Lymphoma (NOT primary mediastinal B-cell lymphoma)|lymphoma (not primary mediastinal b-cell lymphoma)
256535|NCT01859819|B-Cell---Burkitt's like|b-cell---burkitt's like
256536|NCT01859819|Rituximab|rituximab
256537|NCT01859819|Liposomal ARA-C|liposomal ara-c
256538|NCT01859806|periampullary tumour|periampullary tumour
256539|NCT01859806|isolated Roux loop PJ|isolated roux loop pj
256540|NCT01859806|PG|pg
256541|NCT01859793|dipeptidyl peptidase-4 inhibitor|dipeptidyl peptidase-4 inhibitor
256542|NCT01859793|endothelium, vascular|endothelium, vascular
256543|NCT01859793|diabetes type 2|diabetes type 2
256544|NCT01859793|nitric oxide|nitric oxide
256545|NCT01859793|inflammation|inflammation
256546|NCT01859780|Poison control|poison control
256547|NCT01859780|Child resistant packaging|child resistant packaging
256548|NCT01859780|prescription vials|prescription vials
256549|NCT01859780|prescription blisters|prescription blisters
256550|NCT01859780|drug packaging|drug packaging
256551|NCT01859767|Alzheimer's disease|alzheimer's disease
256552|NCT01859767|SPECT|spect
256553|NCT01859754|Primary Immune Deficiency Syndrome|primary immune deficiency syndrome
256554|NCT01859754|Primary immunodeficiency Disease (PIDD)|primary immunodeficiency disease (pidd)
256555|NCT01859754|PID|pid
256556|NCT01859741|Newly diagnosed Stage IV Small Cell Lung Cancer|newly diagnosed stage iv small cell lung cancer
256557|NCT01859728|biliary cancer|biliary cancer
256558|NCT01859728|irinotecan|irinotecan
256559|NCT01859728|cisplatin|cisplatin
256560|NCT01859728|gemcitabine|gemcitabine
256561|NCT01859715|Drug Interactions|drug interactions
256562|NCT01859715|CYP2D6|cyp2d6
256563|NCT01859715|opioid efficacy|opioid efficacy
256565|NCT01859715|nausea|nausea
256566|NCT01859702|Aqueous Humor|aqueous humor
256567|NCT01859702|Moxifloxacin|moxifloxacin
256568|NCT01859702|Vigadexa|vigadexa
256569|NCT01859663|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
256570|NCT01859663|Diet|diet
256571|NCT01859663|Exercise|exercise
256572|NCT01859663|Questionnaires|questionnaires
256573|NCT01859663|Health Beliefs|health beliefs
256574|NCT01859637|Filgrastim, immunogenicity, severe chronic neutropenia|filgrastim, immunogenicity, severe chronic neutropenia
256575|NCT01859624|LOPD|lopd
256576|NCT01859624|Pompe Disease|pompe disease
256577|NCT01859598|diabetes|diabetes
256578|NCT01859598|basal insulin|basal insulin
256579|NCT01859598|effectiveness and safety|effectiveness and safety
256580|NCT01859598|oral antidiabetic drugs|oral antidiabetic drugs
256581|NCT01859598|real world clinical practice|real world clinical practice
256582|NCT01859585|preemptive analgesia|preemptive analgesia
256583|NCT01859585|lumbar fusion|lumbar fusion
256584|NCT01859585|Parecoxib|parecoxib
256585|NCT01859585|Ketorolac|ketorolac
256586|NCT01859572|Stroke|stroke
256587|NCT01859572|Cerebral Infarction|cerebral infarction
256588|NCT01859572|Brain Disorders|brain disorders
256589|NCT01859572|Central Nervous System Diseases|central nervous system diseases
256590|NCT01859572|Nervous System Diseases|nervous system diseases
256591|NCT01859572|Vascular Diseases|vascular diseases
256592|NCT01859572|Cardiovascular Diseases|cardiovascular diseases
256593|NCT01859572|Brain Infarction|brain infarction
256594|NCT01859572|Brain Ischaemia|brain ischaemia
256595|NCT01859559|ultrasound|ultrasound
256596|NCT01859559|peripheral intravenous access|peripheral intravenous access
256597|NCT01859559|operator experience|operator experience
256598|NCT01859546|SMS|sms
256599|NCT01859520|Spermatozoa|spermatozoa
256600|NCT01859520|DNA fragmentation|dna fragmentation
256601|NCT01859520|Swim-up|swim-up
256602|NCT01859520|Density gradient|density gradient
256603|NCT01859507|Vaginismus|vaginismus
256604|NCT01859507|Botox|botox
256605|NCT01859507|Sex|sex
256606|NCT01859507|Clostridium|clostridium
256607|NCT01859507|Botulinum|botulinum
256608|NCT01859507|Neurotoxin|neurotoxin
256609|NCT01859507|Perineal|perineal
256610|NCT01859507|Muscles|muscles
256611|NCT01859455|Hypercholesterolemia,|hypercholesterolemia,
256612|NCT01859455|LDL cholesterol lowering,|ldl cholesterol lowering,
256613|NCT01859455|proprotein convertase subtilisin/kexin type 9 (PCSK9),|proprotein convertase subtilisin/kexin type 9 (pcsk9),
256614|NCT01859455|LGT209,|lgt209,
256615|NCT01859455|drug safety,|drug safety,
256616|NCT01859455|pharmacokinetics,|pharmacokinetics,
256617|NCT01859455|pharmacodynamics|pharmacodynamics
256618|NCT01859429|Cancer patients|cancer patients
256619|NCT01859429|Psycho-oncological Care Provision|psycho-oncological care provision
256620|NCT01859429|Structured Screening|structured screening
256621|NCT01859429|Stepped care|stepped care
256622|NCT01859403|veteran|veteran
256623|NCT01859403|obesity|obesity
256624|NCT01859403|personalized genomics|personalized genomics
256625|NCT01859390|Antioxidants|antioxidants
256626|NCT01859390|Vitamins|vitamins
256627|NCT01859390|Inflammation|inflammation
256628|NCT01859390|Oxidative stress|oxidative stress
256629|NCT01859364|Tobacco|tobacco
256630|NCT01859364|Smoking|smoking
256631|NCT01859364|Smoking Cessation|smoking cessation
256632|NCT01859364|Outcome|outcome
256633|NCT01859364|Nicotine Dependence|nicotine dependence
256634|NCT01859325|HIV-MAG pDNA Prime|hiv-mag pdna prime
256635|NCT01859325|HIV Therapy|hiv therapy
256636|NCT01859325|Therapeutic Vaccine|therapeutic vaccine
256637|NCT01859312|Glucocorticoids|glucocorticoids
256638|NCT01859312|Adrenal Insufficiency|adrenal insufficiency
256639|NCT01859312|Congenital Adrenal Hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
256640|NCT01859312|Adrenal|adrenal
256641|NCT01859299|Oral Tolerance|oral tolerance
256642|NCT01859299|Uveitis|uveitis
256643|NCT01859299|AMD|amd
256644|NCT01859273|renal failure|renal failure
256645|NCT01859273|medication adherence|medication adherence
256646|NCT01859273|hypertension|hypertension
256647|NCT01859260|chronic kidney disease, acute kidney injury, obstructive sleep apnea|chronic kidney disease, acute kidney injury, obstructive sleep apnea
256648|NCT01859247|cervical dystonia|cervical dystonia
256649|NCT01859247|torticollis|torticollis
256650|NCT01859247|rTMS|rtms
256651|NCT01859234|multiple myeloma|multiple myeloma
256652|NCT01859234|PET scan|pet scan
256653|NCT01859221|Prostate cancer|prostate cancer
256654|NCT01859221|Oligometastatic prostate cancer|oligometastatic prostate cancer
256655|NCT01859221|Proton radiation|proton radiation
256656|NCT01859195|HIV/STI|hiv/sti
256657|NCT01859195|Prevention|prevention
256658|NCT01859195|Microbicides, Topical|microbicides, topical
256659|NCT01859169|bili duct neoplasms|bili duct neoplasms
256660|NCT01859169|bile duct cancer|bile duct cancer
256661|NCT01859169|photodynamic therapy|photodynamic therapy
256662|NCT01859169|biliary drainage|biliary drainage
256663|NCT01859156|Carbon Monoxide|carbon monoxide
256664|NCT01859156|Carboxyhemoglobin|carboxyhemoglobin
256665|NCT01859156|End-tidal carbon dioxide|end-tidal carbon dioxide
256666|NCT01859156|Capnography|capnography
256667|NCT01859143|Trivalent|trivalent
256668|NCT01859143|Influenza|influenza
256669|NCT01859143|FluMist Quadrivalent|flumist quadrivalent
256670|NCT01859143|Vaccine|vaccine
256671|NCT01859143|Prevention|prevention
256672|NCT01859143|Healthy|healthy
256673|NCT01859117|Peripheral arterial disease|peripheral arterial disease
256674|NCT01859117|diabetic foot|diabetic foot
256675|NCT01859091|Lipolysis|lipolysis
256676|NCT01859091|Cryolipolysis|cryolipolysis
256677|NCT01859091|Fat Reduction|fat reduction
256678|NCT01859065|Non-urgent ED visits|non-urgent ed visits
256679|NCT01859065|Neonates|neonates
256680|NCT01859065|Newborn care|newborn care
256681|NCT01859052|migraine|migraine
256682|NCT01859052|obesity|obesity
256683|NCT01859052|low fat diet|low fat diet
256684|NCT01859052|low carbohydrate diet|low carbohydrate diet
256685|NCT01859039|Egg allergy|egg allergy
256686|NCT01859039|Anaphylaxis|anaphylaxis
256687|NCT01859039|Children|children
256688|NCT01859039|Influenza vaccine|influenza vaccine
256689|NCT01859026|Epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
256690|NCT01859026|EGFR mutation|egfr mutation
256691|NCT01859026|Kirsten rat sarcoma 2 viral oncogene homolog(KRAS)|kirsten rat sarcoma 2 viral oncogene homolog(kras)
256692|NCT01859026|KRAS mutation|kras mutation
256693|NCT01859026|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
256694|NCT01859026|Advanced-stage IV|advanced-stage iv
256696|NCT01859000|Hurricane Katrina|hurricane katrina
256697|NCT01859000|Family-based treatment|family-based treatment
256698|NCT01859000|Multidimensional Family Therapy|multidimensional family therapy
256699|NCT01859000|Group CBT|group cbt
256700|NCT01858974|multiplex PCR|multiplex pcr
256701|NCT01858974|MALDI-TOF|maldi-tof
256702|NCT01858974|pneumonia|pneumonia
256703|NCT01858974|microbiological investigation|microbiological investigation
256704|NCT01858974|intensive care|intensive care
256705|NCT01858948|Bipolar disorder|bipolar disorder
256706|NCT01858948|Second-generation antipsychotics|second-generation antipsychotics
256707|NCT01858948|Obesity|obesity
256708|NCT01858948|Cardiometabolic risk|cardiometabolic risk
316793|NCT01589978|DES|des
256709|NCT01858922|Hodgkin's Lymphoma|hodgkin's lymphoma
256710|NCT01858922|ABVE-PC|abve-pc
256711|NCT01858922|doxorubicin|doxorubicin
256712|NCT01858922|bleomycin|bleomycin
256714|NCT01858922|etoposide|etoposide
256715|NCT01858922|prednisone|prednisone
256716|NCT01858922|cyclophosphamide|cyclophosphamide
256717|NCT01858922|DECA|deca
256718|NCT01858922|decadron|decadron
256719|NCT01858922|cisplatin|cisplatin
256720|NCT01858922|cytarabine|cytarabine
256721|NCT01858922|Radiation|radiation
256722|NCT01858909|Sepsis|sepsis
256723|NCT01858896|hypoglycemia|hypoglycemia
256724|NCT01858896|GLP-1|glp-1
256725|NCT01858896|Type 2 diabetes|type 2 diabetes
256726|NCT01858896|endothelial function|endothelial function
256727|NCT01858870|Lacosamide|lacosamide
256728|NCT01858870|Partial Crisis|partial crisis
256729|NCT01858857|geriatric psychiatry|geriatric psychiatry
256730|NCT01858857|pharmacovigilance|pharmacovigilance
256731|NCT01858818|CAIS Computer Assisted Infusion System|cais computer assisted infusion system
256732|NCT01858818|real life drinking behavior|real life drinking behavior
256733|NCT01858818|family history of alcoholism|family history of alcoholism
256734|NCT01858818|conditioning|conditioning
256735|NCT01858818|instrumental learning|instrumental learning
256736|NCT01858818|habitization|habitization
256737|NCT01858805|esophagus carcinoma|esophagus carcinoma
256738|NCT01858805|surgery|surgery
256739|NCT01858805|circulating tumor cells|circulating tumor cells
256740|NCT01858779|stroke|stroke
256741|NCT01858779|atrial fibrillation|atrial fibrillation
256742|NCT01858779|secondary prevention of stroke|secondary prevention of stroke
256743|NCT01858779|peripheral pulse measurement|peripheral pulse measurement
256744|NCT01858766|Hepatitis|hepatitis
256745|NCT01858766|HCV Genotype 1|hcv genotype 1
256746|NCT01858766|HCV Genotype 2|hcv genotype 2
256747|NCT01858766|HCV Genotype 3|hcv genotype 3
256748|NCT01858766|HCV Genotype 4|hcv genotype 4
256749|NCT01858766|HCV Genotype 5|hcv genotype 5
256750|NCT01858766|HCV Genotype 6|hcv genotype 6
256751|NCT01858766|treatment naive|treatment naive
256752|NCT01858753|burn scars|burn scars
256753|NCT01858753|restrictive|restrictive
256754|NCT01858753|contractures|contractures
256755|NCT01858753|autologous fibroblasts|autologous fibroblasts
256756|NCT01858727|forced-air|forced-air
256757|NCT01858727|hypothermia|hypothermia
256758|NCT01858727|TUR-P surgery|tur-p surgery
256759|NCT01858727|core temperatures|core temperatures
256760|NCT01858727|prewarming|prewarming
256761|NCT01858727|general anaesthesia|general anaesthesia
256762|NCT01858714|obesity|obesity
256763|NCT01858714|overweight|overweight
256764|NCT01858714|weight loss|weight loss
256765|NCT01858701|myopia|myopia
256766|NCT01858701|hyperopia|hyperopia
256767|NCT01858701|astigmatism|astigmatism
256768|NCT01858701|contact lenses|contact lenses
751917|NCT01171222|prevention|prevention
256769|NCT01858688|Prostate Cancer|prostate cancer
256770|NCT01858688|MRI|mri
256771|NCT01858688|Active surveillance in prostate cancer|active surveillance in prostate cancer
256772|NCT01858675|ProADM|proadm
256773|NCT01858675|ProANP|proanp
256774|NCT01858675|proendothelin|proendothelin
256775|NCT01858675|proAVP|proavp
256776|NCT01858675|Cr 51|cr 51
256777|NCT01858675|Volemia|volemia
256778|NCT01858675|fluid management|fluid management
256779|NCT01858675|ICU patients|icu patients
256780|NCT01858675|poly trauma patients|poly trauma patients
256781|NCT01858662|metastatic colorectal cancer|metastatic colorectal cancer
256782|NCT01858662|Liver|liver
256783|NCT01858662|cetuximab|cetuximab
256784|NCT01858662|Pathological response|pathological response
256785|NCT01858649|metastatic|metastatic
256786|NCT01858649|colorectal|colorectal
256787|NCT01858649|cancer|cancer
256788|NCT01858649|liver|liver
256789|NCT01858649|Bevacizumab|bevacizumab
256790|NCT01858649|Pathological response|pathological response
256791|NCT01858623|Healthy Normotensive Participants|healthy normotensive participants
256792|NCT01858623|Fixed dose combination|fixed dose combination
256793|NCT01858623|Pharmacokinetics|pharmacokinetics
256794|NCT01858623|Losartan|losartan
256795|NCT01858623|Hydrochlorothiazide|hydrochlorothiazide
256796|NCT01858610|Fixed dose combination|fixed dose combination
256797|NCT01858610|Pharmacokinetics|pharmacokinetics
256798|NCT01858610|Irbesartan|irbesartan
256799|NCT01858610|Hydrochlorothiazide|hydrochlorothiazide
256800|NCT01858610|Pharmacodynamics|pharmacodynamics
256801|NCT01858610|Normotensive Participants|normotensive participants
256802|NCT01858597|GDM, FGF|gdm, fgf
256803|NCT01858584|GER|ger
256804|NCT01858584|Alginate|alginate
256805|NCT01858584|Regurgitation|regurgitation
256806|NCT01858584|questionnaire|questionnaire
256807|NCT01858571|Childhood Cancer|childhood cancer
256808|NCT01858532|Diabetes|diabetes
256809|NCT01858532|Nephropathy|nephropathy
256810|NCT01858519|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
256811|NCT01858519|antibodies|antibodies
256812|NCT01858519|porcine viruses|porcine viruses
256813|NCT01858519|epidemiology|epidemiology
256814|NCT01858519|prospective|prospective
256815|NCT01858506|Type 2 diabetes mellitus|type 2 diabetes mellitus
256816|NCT01858506|Lifestyle counselling|lifestyle counselling
256817|NCT01858506|Lifestyle assessment|lifestyle assessment
256818|NCT01858506|Randomized controlled trial|randomized controlled trial
256819|NCT01858506|Diabetes education|diabetes education
256820|NCT01858493|Urinary incontinence|urinary incontinence
256821|NCT01858493|Falls|falls
256822|NCT01858493|Quality of life|quality of life
256823|NCT01858493|Stigma|stigma
256824|NCT01858493|Community-dwelling older women|community-dwelling older women
256825|NCT01858493|Continence promotion|continence promotion
256826|NCT01858480|CHF|chf
256827|NCT01858467|Airway, Cesarean|airway, cesarean
256828|NCT01858402|Pediatric spinal anesthesia, paracetamol, dipyrone|pediatric spinal anesthesia, paracetamol, dipyrone
256829|NCT01858389|Non-small cell lung cancer|non-small cell lung cancer
256830|NCT01858389|T790M mutation. dacomitinib|t790m mutation. dacomitinib
256831|NCT01858376|LDL cholesterol|ldl cholesterol
256832|NCT01858376|anti-hyperlipidemic|anti-hyperlipidemic
256833|NCT01858376|hyperlipidemic|hyperlipidemic
256834|NCT01858376|Capros|capros
256835|NCT01858376|Natural Supplement|natural supplement
256836|NCT01858363|Peripheral arterial disease|peripheral arterial disease
256837|NCT01858363|claudication|claudication
256838|NCT01858363|drug-coated balloon|drug-coated balloon
256839|NCT01858363|drug-eluting balloon|drug-eluting balloon
256840|NCT01858350|CAM|cam
256841|NCT01858350|Sedation|sedation
256842|NCT01858350|MRI|mri
256843|NCT01858350|Music Therapy|music therapy
256844|NCT01858337|weaning|weaning
256845|NCT01858337|infants|infants
256846|NCT01858337|vegetables|vegetables
256847|NCT01858337|repeated-exposure|repeated-exposure
256848|NCT01858324|Preeclampsia|preeclampsia
256849|NCT01858324|Hypertensive disorders of pregnancy|hypertensive disorders of pregnancy
256854|NCT01858324|Knowledge|knowledge
256856|NCT01858324|Satisfaction|satisfaction
256857|NCT01858311|Stroke survivors|stroke survivors
256858|NCT01858311|TIA survivors|tia survivors
256859|NCT01858311|Vitamin E|vitamin e
256860|NCT01858311|Carotech|carotech
256861|NCT01858311|Tocotrienol|tocotrienol
256862|NCT01858298|Dental caries|dental caries
256863|NCT01858298|Quality of Life|quality of life
256864|NCT01858298|Pulpectomy|pulpectomy
256865|NCT01858298|Tooth extraction|tooth extraction
256866|NCT01858285|Epilepsy|epilepsy
256867|NCT01858285|Ohtahara|ohtahara
256869|NCT01858285|MMPEI|mmpei
256870|NCT01858285|EMEE|emee
256871|NCT01858285|EIEE|eiee
256872|NCT01858246|Hearing Loss, Conductive|hearing loss, conductive
256873|NCT01858246|Bone Conduction|bone conduction
256874|NCT01858246|bone conduction thresholds better than 45 dBHL|bone conduction thresholds better than 45 dbhl
256875|NCT01858233|Gestational diabetes|gestational diabetes
256876|NCT01858220|Gastroparesis|gastroparesis
256877|NCT01858220|Small bowel video capsule|small bowel video capsule
256878|NCT01858220|gastric retention|gastric retention
256879|NCT01858207|HCC|hcc
256880|NCT01858207|hepatocellular carcinoma|hepatocellular carcinoma
256881|NCT01858207|liver cancer|liver cancer
256882|NCT01858194|Tachycardia, Renal Sympathetic Denervation|tachycardia, renal sympathetic denervation
256883|NCT01858194|Catheter Ablation|catheter ablation
256884|NCT01858194|Cardioverter-Defibrillator|cardioverter-defibrillator
256885|NCT01858142|Pediatric anesthesia|pediatric anesthesia
256886|NCT01858142|Pre-operative anxiety|pre-operative anxiety
256887|NCT01858142|parental presence|parental presence
256888|NCT01858142|children|children
256889|NCT01858142|elective surgical procedures|elective surgical procedures
256890|NCT01858142|mask induction|mask induction
256891|NCT01858129|TTN|ttn
256892|NCT01858103|Mucopolysaccharidosis IVA Type A|mucopolysaccharidosis iva type a
256893|NCT01858103|MPS IVA Type A|mps iva type a
256894|NCT01858103|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
256895|NCT01858103|MPS IVA|mps iva
256896|NCT01858103|Morquio A Syndrome|morquio a syndrome
256897|NCT01858103|Lysosomal Storage Disorder|lysosomal storage disorder
256898|NCT01858103|LSD|lsd
256899|NCT01858103|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
256900|NCT01858103|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
256901|NCT01858090|spinal anesthesia|spinal anesthesia
256902|NCT01858090|caesarean section|caesarean section
256903|NCT01858090|local anesthetics|local anesthetics
256904|NCT01858090|levobupivacaine|levobupivacaine
256905|NCT01858090|sufentanil|sufentanil
256907|NCT01858090|above 18 years of age|above 18 years of age
256908|NCT01858090|pregnant women|pregnant women
256909|NCT01858090|multiparous|multiparous
256910|NCT01858090|nulliparous|nulliparous
256911|NCT01858064|ADHD|adhd
256912|NCT01858064|OROS-MPH|oros-mph
256913|NCT01858064|Adults|adults
256914|NCT01858064|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
256915|NCT01858051|Vitamin D|vitamin d
256916|NCT01858051|Perioperative immune regulation|perioperative immune regulation
247583|NCT01899846|Makena|makena
256917|NCT01858051|LL-37|ll-37
256918|NCT01858051|Hospital-acquired infection|hospital-acquired infection
256919|NCT01858051|Surgical site infections|surgical site infections
256920|NCT01858038|Scar|scar
256921|NCT01858012|insulin resistance|insulin resistance
256922|NCT01857999|Renin-aldosterone system|renin-aldosterone system
256923|NCT01857999|Hemodynamic|hemodynamic
256924|NCT01857999|Low cardiac output|low cardiac output
256925|NCT01857999|Vasodilation|vasodilation
256926|NCT01857999|Natriuretic peptide|natriuretic peptide
256927|NCT01857986|Endotracheal intubation|endotracheal intubation
256928|NCT01857986|Mechanical ventilation|mechanical ventilation
256929|NCT01857986|Critical care|critical care
256934|NCT01857960|Acne|acne
256935|NCT01857960|Treatment|treatment
256936|NCT01857960|Cost|cost
256937|NCT01857960|Behavior|behavior
256938|NCT01857947|AECOPD Mr ProADM Biomarkers ER Outcome|aecopd mr proadm biomarkers er outcome
256939|NCT01857934|Anti-GD2 monoclonal antibody|anti-gd2 monoclonal antibody
256940|NCT01857934|hu14.18K322A|hu14.18k322a
256941|NCT01857934|High-risk neuroblastoma|high-risk neuroblastoma
256942|NCT01857934|Phase II|phase ii
256943|NCT01857934|Allogeneic NK cells|allogeneic nk cells
256944|NCT01857908|Adenocarcinoma|adenocarcinoma
256945|NCT01857908|Abiraterone|abiraterone
256946|NCT01857908|Abiraterone Acetate|abiraterone acetate
256947|NCT01857908|Zytiga|zytiga
256948|NCT01857908|Correlative study|correlative study
256949|NCT01857908|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
256950|NCT01857908|Abiraterone Correlative study|abiraterone correlative study
256951|NCT01857895|Nausea|nausea
256952|NCT01857895|subcutaneous infusion|subcutaneous infusion
256953|NCT01857895|exenatide|exenatide
256954|NCT01857882|breast cancer|breast cancer
256955|NCT01857882|breast reconstruction|breast reconstruction
256956|NCT01857882|shared decision making|shared decision making
256957|NCT01857882|decision support intervention|decision support intervention
256958|NCT01857869|Efficacy|efficacy
256959|NCT01857869|Sporozoite challenge model|sporozoite challenge model
256960|NCT01857869|Malaria|malaria
256961|NCT01857869|Immunogenicity|immunogenicity
256962|NCT01857869|Malaria- naïve adults|malaria- naïve adults
256963|NCT01857869|Safety|safety
256964|NCT01857856|Phospholamban|phospholamban
256965|NCT01857856|cardiomyopathy|cardiomyopathy
256966|NCT01857856|Eplerenone|eplerenone
256967|NCT01857856|presymptomatic|presymptomatic
256968|NCT01857830|Telomerase|telomerase
256969|NCT01857830|Telomere Length|telomere length
256970|NCT01857830|Psychological Stress|psychological stress
256971|NCT01857830|Amyloid beta proteins|amyloid beta proteins
256972|NCT01857830|Meditation|meditation
256973|NCT01857804|peri-implantitis|peri-implantitis
256974|NCT01857804|surgical therapy|surgical therapy
256975|NCT01857804|systemic antibiotics|systemic antibiotics
256976|NCT01857804|local antiseptics|local antiseptics
256977|NCT01857778|Breastfeeding|breastfeeding
256978|NCT01857778|Breast tissue|breast tissue
256979|NCT01857778|Breast pump|breast pump
256980|NCT01857765|rehabilitation|rehabilitation
256981|NCT01857765|reconstructive surgery|reconstructive surgery
256982|NCT01857752|Retinoblastoma|retinoblastoma
256983|NCT01857726|hepatocellular carcinoma|hepatocellular carcinoma
256984|NCT01857726|portal vein invasion|portal vein invasion
256985|NCT01857726|transarterial chemoembolization|transarterial chemoembolization
256986|NCT01857726|transarterial chemoinfusion|transarterial chemoinfusion
256987|NCT01857674|Laryngeal edema|laryngeal edema
256988|NCT01857674|Post-extubation|post-extubation
256989|NCT01857674|Acute respiratory distress|acute respiratory distress
256990|NCT01857674|Ultrasonography|ultrasonography
256991|NCT01857674|Intensive care unit|intensive care unit
256992|NCT01857661|tinnitus|tinnitus
256993|NCT01857661|hearing loss|hearing loss
256994|NCT01857661|hearing devices|hearing devices
256995|NCT01857648|Physical Activity|physical activity
256996|NCT01857648|Health Promotion|health promotion
256997|NCT01857648|Primary Health Care|primary health care
256998|NCT01857648|Intervention Studies|intervention studies
256999|NCT01857648|Public health Practice|public health practice
257000|NCT01857635|Acute respiratory failure|acute respiratory failure
257001|NCT01857635|Hypercapnia|hypercapnia
257002|NCT01857635|Non invasive ventilation|non invasive ventilation
257003|NCT01857635|Transcutaneous CO2 measurement|transcutaneous co2 measurement
257004|NCT01857622|anticoagulant|anticoagulant
257005|NCT01857622|DU-176b|du-176b
257006|NCT01857622|edoxaban|edoxaban
257007|NCT01857622|factor Xa|factor xa
257008|NCT01857622|oral|oral
257009|NCT01857622|atrial fibrillation|atrial fibrillation
257010|NCT01857622|severe renal impairment|severe renal impairment
257011|NCT01857609|Metformin|metformin
257012|NCT01857609|Proton pump inhibitor|proton pump inhibitor
257013|NCT01857609|Drug interaction|drug interaction
257014|NCT01857596|Female Sexual Dysfunction|female sexual dysfunction
257015|NCT01857596|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
257016|NCT01857596|Sexual Interest/Arousal Disorder|sexual interest/arousal disorder
257017|NCT01857596|Lorexys|lorexys
257018|NCT01857596|Premenopausal female health|premenopausal female health
257019|NCT01857583|anticoagulant|anticoagulant
257020|NCT01857583|DU-176b|du-176b
257021|NCT01857583|edoxaban|edoxaban
257022|NCT01857583|factor Xa|factor xa
257023|NCT01857583|oral|oral
257024|NCT01857583|orthopedic surgery of lower limbs|orthopedic surgery of lower limbs
257025|NCT01857583|severe renal impairment|severe renal impairment
257026|NCT01857570|Radius fracture|radius fracture
257027|NCT01857570|Scaphoid fracture|scaphoid fracture
257028|NCT01857570|Tomography, x-ray computed|tomography, x-ray computed
257029|NCT01857557|Exercise|exercise
257030|NCT01857557|Fitness program|fitness program
257031|NCT01857544|Retinal Vein Occlusion|retinal vein occlusion
257032|NCT01857544|Central Retinal Vein Occlusion|central retinal vein occlusion
257033|NCT01857544|Macular Edema|macular edema
257034|NCT01857531|Smoking Cessation|smoking cessation
257035|NCT01857531|Quit Smoking|quit smoking
257036|NCT01857531|Ganaxolone|ganaxolone
257037|NCT01857531|Nicotine Patch|nicotine patch
257038|NCT01857505|Total Hip replacement|total hip replacement
257039|NCT01857505|Fracture table|fracture table
257040|NCT01857505|DePuySynthes|depuysynthes
257041|NCT01857505|Direct anterior approach hip replacement|direct anterior approach hip replacement
257042|NCT01857505|Posterior approach hip replacement|posterior approach hip replacement
257043|NCT01857492|abdominal pain|abdominal pain
257044|NCT01857492|pancreatitis|pancreatitis
257045|NCT01857492|chronic abdominal pain|chronic abdominal pain
257046|NCT01857492|visceral pain|visceral pain
257047|NCT01857492|meditation|meditation
257048|NCT01857492|tDCS|tdcs
257049|NCT01857492|noninvasive brain stimulation|noninvasive brain stimulation
257050|NCT01857492|EEG|eeg
257051|NCT01857492|Kirtan Kriya|kirtan kriya
257052|NCT01857479|ABPA|abpa
257053|NCT01857453|Adult Patients Medulloblatoma Standard risk group Chemotherapy Radiotherapy Quality of Life|adult patients medulloblatoma standard risk group chemotherapy radiotherapy quality of life
257054|NCT01857440|Glaucoma|glaucoma
257055|NCT01857440|Pupil|pupil
257056|NCT01857440|Melanopsin|melanopsin
257057|NCT01857414|ST-elevation myocardial infarction|st-elevation myocardial infarction
257058|NCT01857414|Remote Ischaemic Conditioning|remote ischaemic conditioning
257059|NCT01857414|Myocardial Reperfusion Injury|myocardial reperfusion injury
257060|NCT01857414|Cardiovascular mortality|cardiovascular mortality
257061|NCT01857388|school-based program, mental health, implementation|school-based program, mental health, implementation
257062|NCT01857375|Diabetes - insulin administration|diabetes - insulin administration
257063|NCT01857362|Orfadin|orfadin
257064|NCT01857362|Nitisinone|nitisinone
257065|NCT01857362|Bioequivalence|bioequivalence
257066|NCT01857349|Efficacy|efficacy
257067|NCT01857349|surgical scrubs|surgical scrubs
257068|NCT01857349|Total Knee Arthroplasty|total knee arthroplasty
257069|NCT01857323|asthma|asthma
257070|NCT01857323|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
257071|NCT01857323|COPD|copd
257072|NCT01857323|Albuterol Spiromax®|albuterol spiromax®
257073|NCT01857310|Folic Acid|folic acid
257074|NCT01857310|Zinc|zinc
257075|NCT01857310|Semen|semen
257076|NCT01857310|In vitro fertilization|in vitro fertilization
257077|NCT01857310|Assisted reproductive technology|assisted reproductive technology
257078|NCT01857310|Ovulation induction|ovulation induction
257079|NCT01857310|Intrauterine insemination|intrauterine insemination
257080|NCT01857310|Pregnancy|pregnancy
257081|NCT01857310|Live Birth|live birth
257082|NCT01857310|Abortion, spontaneous|abortion, spontaneous
257083|NCT01857284|Tauroursodeoxycholic Acid|tauroursodeoxycholic acid
257084|NCT01857284|Primary Biliary Cirrhosis|primary biliary cirrhosis
257085|NCT01857284|Safety|safety
257086|NCT01857284|Efficacy|efficacy
257087|NCT01857258|green tea|green tea
257088|NCT01857258|catechins|catechins
257089|NCT01857258|vascular endothelial function|vascular endothelial function
257090|NCT01857258|postprandial hyperglycemia|postprandial hyperglycemia
257091|NCT01857258|oxidative stress|oxidative stress
257092|NCT01857245|addiction|addiction
257093|NCT01857245|Adherence (attribute)|adherence (attribute)
257094|NCT01857245|Adverse effects|adverse effects
257095|NCT01857245|Agonist|agonist
257096|NCT01857245|Antiviral Agents|antiviral agents
257097|NCT01857245|arm|arm
257098|NCT01857245|base|base
257099|NCT01857245|care delivery|care delivery
257100|NCT01857245|Caring|caring
257101|NCT01857245|Chronic Hepatitis C|chronic hepatitis c
257102|NCT01857245|Clinic|clinic
257103|NCT01857245|Clinical Trials|clinical trials
257104|NCT01857245|Complex|complex
257105|NCT01857245|Computer Simulation|computer simulation
257106|NCT01857245|cost|cost
258231|NCT01852955|Pain|pain
257107|NCT01857245|cost effective|cost effective
257108|NCT01857245|cost effectiveness|cost effectiveness
257109|NCT01857245|Data|data
257110|NCT01857245|Development|development
257111|NCT01857245|Directly Observed Therapy|directly observed therapy
257112|NCT01857245|Disease|disease
257113|NCT01857245|Dose|dose
317219|NCT01587703|NMC|nmc
257114|NCT01857245|Drug resistance|drug resistance
257115|NCT01857245|drug resistant virus|drug resistant virus
257116|NCT01857245|Educational aspects|educational aspects
257117|NCT01857245|Epidemic|epidemic
257118|NCT01857245|experience|experience
257415|NCT01856127|Vilazodone|vilazodone
257119|NCT01857245|Frequencies (time pattern)|frequencies (time pattern)
257120|NCT01857245|Fright|fright
257121|NCT01857245|Genotype|genotype
257122|NCT01857245|Group Therapy|group therapy
257123|NCT01857245|Health Care Costs|health care costs
257124|NCT01857245|Health Personnel|health personnel
257125|NCT01857245|Healthcare Systems|healthcare systems
257126|NCT01857245|Hepatitis C|hepatitis c
257127|NCT01857245|Hepatitis C Prevalence|hepatitis c prevalence
257128|NCT01857245|Hepatitis C Transmission|hepatitis c transmission
257129|NCT01857245|Hepatitis C virus|hepatitis c virus
257130|NCT01857245|HIV|hiv
257131|NCT01857245|Homelessness|homelessness
257132|NCT01857245|improved|improved
257133|NCT01857245|Incidence|incidence
257134|NCT01857245|Infection|infection
257135|NCT01857245|Injecting drug user|injecting drug user
257136|NCT01857245|Injection of therapeutic agent|injection of therapeutic agent
257137|NCT01857245|Intensive Care|intensive care
257138|NCT01857245|Interferons|interferons
257139|NCT01857245|Intervention|intervention
257140|NCT01857245|Knowledge|knowledge
257141|NCT01857245|Life|life
257142|NCT01857245|Liver diseases|liver diseases
257143|NCT01857245|Liver Failure|liver failure
257144|NCT01857245|liver transplantation|liver transplantation
257145|NCT01857245|Living Costs|living costs
257146|NCT01857245|Mental disorders|mental disorders
257147|NCT01857245|Methadone|methadone
257148|NCT01857245|methadone clinic/center|methadone clinic/center
257149|NCT01857245|Modeling|modeling
257150|NCT01857245|Mortality Vital Statistics|mortality vital statistics
257151|NCT01857245|Motivation|motivation
257152|NCT01857245|multidisciplinary|multidisciplinary
257153|NCT01857245|Opiates|opiates
257154|NCT01857245|Oral|oral
257155|NCT01857245|Outcome|outcome
257156|NCT01857245|Patients|patients
257157|NCT01857245|Persons|persons
257158|NCT01857245|Pharmaceutical Preparations|pharmaceutical preparations
257159|NCT01857245|Physicians|physicians
257160|NCT01857245|pill (pharmacologic)|pill (pharmacologic)
257161|NCT01857245|Play|play
257162|NCT01857245|Poverty|poverty
257163|NCT01857245|Primary Health Care|primary health care
257164|NCT01857245|programs|programs
257165|NCT01857245|Psychiatric therapeutic procedure|psychiatric therapeutic procedure
257166|NCT01857245|psychosocial|psychosocial
257167|NCT01857245|Publishing|publishing
257168|NCT01857245|Quality-Adjusted Life Years|quality-adjusted life years
257169|NCT01857245|Randomized|randomized
257170|NCT01857245|Randomized Controlled Trials|randomized controlled trials
257171|NCT01857245|randomized trial|randomized trial
257172|NCT01857245|Recruitment Activity|recruitment activity
257173|NCT01857245|Regimen|regimen
257174|NCT01857245|Resistance|resistance
257175|NCT01857245|Resistance development|resistance development
257176|NCT01857245|response|response
257177|NCT01857245|Risk|risk
257178|NCT01857245|risk perception|risk perception
257179|NCT01857245|Role|role
257180|NCT01857245|Site|site
257181|NCT01857245|skills|skills
257182|NCT01857245|Social support|social support
257183|NCT01857245|standard care|standard care
257184|NCT01857245|substance abuse treatment|substance abuse treatment
257185|NCT01857245|success|success
257186|NCT01857245|Time|time
257187|NCT01857245|Treatment outcome|treatment outcome
257188|NCT01857245|Treatment Protocols|treatment protocols
257189|NCT01857245|treatment site|treatment site
257190|NCT01857245|Trust|trust
257191|NCT01857245|United States|united states
257192|NCT01857245|Viral|viral
257193|NCT01857245|Virus|virus
257194|NCT01857219|fMRI|fmri
257195|NCT01857206|Influenza|influenza
257196|NCT01857206|children and adolescents|children and adolescents
257197|NCT01857206|trivalent vaccine|trivalent vaccine
257198|NCT01857206|cell culture|cell culture
257199|NCT01857206|embryonated chicken eggs|embryonated chicken eggs
257200|NCT01857193|Open label; dose escalation; ER+; LEE011; CDK4/6; everolimus; advanced breast cancer; mTOR; HR positive; HER2 negative|open label; dose escalation; er+; lee011; cdk4/6; everolimus; advanced breast cancer; mtor; hr positive; her2 negative
257201|NCT01857167|omega-3 fatty acids|omega-3 fatty acids
257202|NCT01857167|randomized controlled trial|randomized controlled trial
257203|NCT01857154|Bone mineral density|bone mineral density
257204|NCT01857154|Bone mineral content|bone mineral content
257205|NCT01857154|Bone density|bone density
257206|NCT01857154|Bone health|bone health
257207|NCT01857154|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
258232|NCT01852942|Infection|infection
257208|NCT01857141|dexmedetomidine|dexmedetomidine
257209|NCT01857141|heart rate variability|heart rate variability
257210|NCT01857141|preemptive epidural|preemptive epidural
257211|NCT01857141|gastrectomy|gastrectomy
257212|NCT01857115|Multiple myeloma|multiple myeloma
257213|NCT01857115|Diagnosis|diagnosis
257214|NCT01857115|Weekly|weekly
257215|NCT01857115|CCyd|ccyd
257216|NCT01857089|Pressure Ulcer|pressure ulcer
257217|NCT01857089|prevention|prevention
257218|NCT01857076|Type 2 Diabetes mellitus|type 2 diabetes mellitus
257219|NCT01857076|Grade I obesity|grade i obesity
257220|NCT01857076|Inadequate glycemic control|inadequate glycemic control
257416|NCT01856127|Sertraline|sertraline
257226|NCT01856998|Therapeutic Equivalence|therapeutic equivalence
257227|NCT01856998|Propofol|propofol
257228|NCT01856985|Medical abortion|medical abortion
257229|NCT01856985|Misoprostol|misoprostol
257230|NCT01856985|Mifepristone|mifepristone
257231|NCT01856972|Limited Dorsiflexion Range of Motion|limited dorsiflexion range of motion
257232|NCT01856972|Gastrocnemius tightness|gastrocnemius tightness
257233|NCT01856972|Soleus tightness|soleus tightness
257234|NCT01856959|magnesium sulfate|magnesium sulfate
257235|NCT01856959|nebulized|nebulized
257236|NCT01856959|lung function|lung function
257237|NCT01856933|GBM|gbm
257238|NCT01856933|Glioblastoma Multiforme|glioblastoma multiforme
257239|NCT01856933|Gliosarcoma|gliosarcoma
257240|NCT01856920|Calcitonin|calcitonin
257241|NCT01856920|T-cells|t-cells
257242|NCT01856920|Immune Response|immune response
257243|NCT01856920|HLA Patients|hla patients
257244|NCT01856920|Vaccine|vaccine
257249|NCT01856894|polycystic ovary syndrome|polycystic ovary syndrome
257250|NCT01856894|Anti-Mullerian Hormone|anti-mullerian hormone
257251|NCT01856894|obesity|obesity
257252|NCT01856881|Type 2 diabetes|type 2 diabetes
257253|NCT01856868|BMD|bmd
257254|NCT01856868|Becker muscular dystrophy|becker muscular dystrophy
257255|NCT01856868|epicatechin|epicatechin
257256|NCT01856868|clinical trial|clinical trial
257257|NCT01856868|neuromuscular disease|neuromuscular disease
257258|NCT01856855|Prostate Cancer|prostate cancer
257259|NCT01856855|Prostate Adenocarcinoma|prostate adenocarcinoma
257260|NCT01856855|Radiation|radiation
257261|NCT01856855|SBRT|sbrt
257262|NCT01856855|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
257263|NCT01856842|Pulmonary Arteriovenous Malformations|pulmonary arteriovenous malformations
257264|NCT01856842|Hereditary Hemorrhagic Telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
257265|NCT01856842|Embolization|embolization
257266|NCT01856842|reperfusion rates|reperfusion rates
257267|NCT01856777|Medical Abortion|medical abortion
257268|NCT01856777|Pregnancy Test|pregnancy test
257269|NCT01856777|continuing pregnancy|continuing pregnancy
257270|NCT01856764|Atopic dermatitis|atopic dermatitis
257271|NCT01856751|Haemophilia|haemophilia
257272|NCT01856751|TGA|tga
257273|NCT01856751|TEM|tem
257274|NCT01856738|Parkinson's disease|parkinson's disease
257275|NCT01856738|Visual hallucinations|visual hallucinations
257276|NCT01856738|Rivastigmine|rivastigmine
257277|NCT01856738|Cholinesterase inhibitor|cholinesterase inhibitor
257278|NCT01856738|Randomized controlled trial|randomized controlled trial
257279|NCT01856738|Cost-effectiveness analysis|cost-effectiveness analysis
257280|NCT01856712|alcohol|alcohol
257281|NCT01856712|veterans|veterans
257282|NCT01856699|supratentorial superficial siderosis|supratentorial superficial siderosis
257283|NCT01856699|intracerebral hemorrhage|intracerebral hemorrhage
257284|NCT01856699|cerebral amyloid angiopathy|cerebral amyloid angiopathy
257285|NCT01856686|ADD|add
257286|NCT01856686|ADHD|adhd
257287|NCT01856686|Proteins|proteins
257289|NCT01856686|Nutrition|nutrition
257290|NCT01856686|QEEG|qeeg
257291|NCT01856686|ERP|erp
257292|NCT01856686|ICA|ica
257293|NCT01856673|Mental Health|mental health
257294|NCT01856673|Displacement|displacement
257295|NCT01856673|Torture|torture
257296|NCT01856673|Violence|violence
257297|NCT01856673|Post-Traumatic Stress Disorder|post-traumatic stress disorder
257298|NCT01856673|Depression|depression
257299|NCT01856673|Anxiety|anxiety
257300|NCT01856673|Community-based intervention|community-based intervention
257301|NCT01856673|Prevention trial|prevention trial
257302|NCT01856673|Disabled Persons|disabled persons
257303|NCT01856660|Obesity|obesity
257304|NCT01856660|Weight Loss|weight loss
257305|NCT01856660|Body Weight Change|body weight change
257306|NCT01856660|Taste|taste
257307|NCT01856660|Taste Phenotype|taste phenotype
257308|NCT01856660|Lifestyle Intervention|lifestyle intervention
257309|NCT01856647|Psoriasis|psoriasis
257310|NCT01856647|Obesity|obesity
257311|NCT01856634|Tuberculosis|tuberculosis
257312|NCT01856634|Tuberculosis, Multidrug-Resistant|tuberculosis, multidrug-resistant
257313|NCT01856634|Mycobacterium Infections|mycobacterium infections
257314|NCT01856634|Actinomycetales Infections|actinomycetales infections
257315|NCT01856634|Gram-Positive Infections|gram-positive infections
257316|NCT01856634|Bacterial Infections|bacterial infections
257317|NCT01856634|Pediatric|pediatric
257318|NCT01856582|Primary Immunodeficiency Disease(s)|primary immunodeficiency disease(s)
257319|NCT01856582|Mixed Donor Chimerism|mixed donor chimerism
257320|NCT01856582|bone marrow failure syndromes|bone marrow failure syndromes
257321|NCT01856582|allogeneic hematopoietic stem cell transplant (HSCT)|allogeneic hematopoietic stem cell transplant (hsct)
257322|NCT01856582|children|children
257323|NCT01856556|safety|safety
257324|NCT01856556|tolerability|tolerability
257325|NCT01856556|pharmacokinetics|pharmacokinetics
257326|NCT01856543|Breast cancer|breast cancer
257327|NCT01856543|Status post mastectomy|status post mastectomy
257328|NCT01856543|plan to receive PMRT|plan to receive pmrt
257329|NCT01856543|Topical|topical
257330|NCT01856543|steroid cream|steroid cream
257331|NCT01856543|emollient skin care|emollient skin care
257332|NCT01856543|Eucerin|eucerin
257333|NCT01856543|Mometasone Furoate 0.1%|mometasone furoate 0.1%
257334|NCT01856517|pressor response|pressor response
257335|NCT01856517|chronotropic response|chronotropic response
257336|NCT01856504|Heart Disease|heart disease
257337|NCT01856504|Coronary Artery Disease|coronary artery disease
257338|NCT01856504|Coronary Arteriosclerosis|coronary arteriosclerosis
257339|NCT01856491|RELIANCE 4-FRONT|reliance 4-front
257340|NCT01856491|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
257341|NCT01856491|Cardiac Resynchronization Therapy - Defibrillator (CRT-D)|cardiac resynchronization therapy - defibrillator (crt-d)
257342|NCT01856465|Bariatric surgery|bariatric surgery
257343|NCT01856465|NAFLD|nafld
257344|NCT01856465|Steatohepatitis|steatohepatitis
257345|NCT01856465|Simple Steatosis|simple steatosis
257346|NCT01856465|Intestinal Microbiota|intestinal microbiota
257347|NCT01856452|Sentinel lymph node|sentinel lymph node
257348|NCT01856452|multimodal|multimodal
257349|NCT01856452|breast cancer|breast cancer
257350|NCT01856439|ProSavin|prosavin
257351|NCT01856439|Gene therapy|gene therapy
257352|NCT01856426|Hepatitis C infected subjects|hepatitis c infected subjects
257353|NCT01856413|Prevention|prevention
257354|NCT01856413|Hepatitis B virus re-infection|hepatitis b virus re-infection
257355|NCT01856413|HBV-DNA negative|hbv-dna negative
257356|NCT01856413|Liver transplantation|liver transplantation
257357|NCT01856400|ventricular arrythmias|ventricular arrythmias
257358|NCT01856400|SERCA2a|serca2a
257359|NCT01856400|Chronic Kidney Disease|chronic kidney disease
257360|NCT01856400|microvolt T wave alternans|microvolt t wave alternans
257361|NCT01856387|preeclampsia|preeclampsia
257362|NCT01856387|eclampsia|eclampsia
257363|NCT01856387|prediction|prediction
257364|NCT01856387|neutrophil-to Lymphocyte ratio|neutrophil-to lymphocyte ratio
257365|NCT01856361|Male infertility|male infertility
257366|NCT01856361|Low sperm count|low sperm count
257367|NCT01856361|Poor sperm motility|poor sperm motility
257368|NCT01856361|Poor Sperm shape and morphology|poor sperm shape and morphology
257369|NCT01856335|Seizures|seizures
257370|NCT01856335|Epilepsy|epilepsy
257371|NCT01856322|Colorectal Cancer|colorectal cancer
257372|NCT01856322|Liver Metastasis|liver metastasis
257373|NCT01856322|Sulindac|sulindac
257374|NCT01856309|Rheumatoid Arthritis|rheumatoid arthritis
257375|NCT01856309|Sirukumab|sirukumab
257376|NCT01856309|CNTO 136|cnto 136
257377|NCT01856309|CNTO136ARA3002|cnto136ara3002
257378|NCT01856309|SIRROUND-D|sirround-d
257379|NCT01856309|CNTO136ARA3003|cnto136ara3003
257380|NCT01856309|SIRROUND-T|sirround-t
257381|NCT01856309|SIRROUND-LTE|sirround-lte
257382|NCT01856270|Traumatic brain injury|traumatic brain injury
257383|NCT01856270|Post-traumatic headache|post-traumatic headache
257384|NCT01856270|Drug therapy|drug therapy
257385|NCT01856257|Kidney Transplantation|kidney transplantation
257391|NCT01856244|treadmill training|treadmill training
257392|NCT01856244|gait|gait
257393|NCT01856244|balance|balance
257394|NCT01856244|mobility|mobility
257395|NCT01856231|COPD|copd
257396|NCT01856231|Physical activity|physical activity
257397|NCT01856218|Mucopolysaccharidosis type 7, MPS 7, Sly syndrome, enzyme replacement therapy, rare disease, lysosomal storage disease, metabolic disorder|mucopolysaccharidosis type 7, mps 7, sly syndrome, enzyme replacement therapy, rare disease, lysosomal storage disease, metabolic disorder
257398|NCT01856205|Japanese Encephalitis, Randomized Controlled Trial, intravenous immunoglobulin, safety, efficacy, Nepal|japanese encephalitis, randomized controlled trial, intravenous immunoglobulin, safety, efficacy, nepal
257399|NCT01856179|Conversion of ALA and SDA|conversion of ala and sda
257400|NCT01856179|Metabolism of n-3 fatty acids|metabolism of n-3 fatty acids
257401|NCT01856166|Nulliparous|nulliparous
257402|NCT01856166|Singleton|singleton
257403|NCT01856166|delivery|delivery
257404|NCT01856166|pregnancy|pregnancy
257405|NCT01856153|Bioavailability|bioavailability
257406|NCT01856153|Strawberry polyphenols|strawberry polyphenols
257407|NCT01856153|Time Influence|time influence
257408|NCT01856140|adipose derived mesenchymal stem cell|adipose derived mesenchymal stem cell
257409|NCT01856140|allogeneic stem cell|allogeneic stem cell
257410|NCT01856127|Sexual Dysfunction|sexual dysfunction
257411|NCT01856127|Antidepressant|antidepressant
257412|NCT01856127|Major Depressant|major depressant
257413|NCT01856127|SSRI|ssri
257414|NCT01856127|SNRI|snri
257417|NCT01856114|Advanced Cancers|advanced cancers
257523|NCT01855659|Lung diseases,|lung diseases,
257418|NCT01856114|Cancer with evidence of active disease|cancer with evidence of active disease
257419|NCT01856114|Exercise induced breakthrough dyspnea|exercise induced breakthrough dyspnea
257420|NCT01856114|Shortness of breath|shortness of breath
257421|NCT01856114|Fentanyl Buccal Tablets|fentanyl buccal tablets
257422|NCT01856114|FBT|fbt
257423|NCT01856114|Placebo|placebo
257424|NCT01856114|Walk tests|walk tests
257425|NCT01856114|Questionnaires|questionnaires
257426|NCT01856114|Surveys|surveys
257427|NCT01856101|TCC|tcc
257428|NCT01856101|Failure of platinum based chemotherapy|failure of platinum based chemotherapy
257429|NCT01856088|Coronary artery|coronary artery
257430|NCT01856088|Drug eluting stent|drug eluting stent
257431|NCT01856088|thrombosis|thrombosis
257432|NCT01856075|Atrial Fibrillation|atrial fibrillation
257433|NCT01856075|Dronedarone|dronedarone
257434|NCT01856075|Cohort|cohort
257435|NCT01856075|Effectiveness|effectiveness
257436|NCT01856062|ovulation induction|ovulation induction
257437|NCT01856062|dexamethasone|dexamethasone
257438|NCT01856049|HLHS|hlhs
257439|NCT01856049|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
257440|NCT01856049|UCB (umbilical cord blood)|ucb (umbilical cord blood)
257441|NCT01856049|Umbilical cord blood|umbilical cord blood
257442|NCT01856049|Cord blood|cord blood
257443|NCT01856049|Cardiac regeneration|cardiac regeneration
257444|NCT01856036|Ductal Histology|ductal histology
257445|NCT01856036|Unifocal|unifocal
257448|NCT01856023|melanoma|melanoma
257449|NCT01856023|metastatic|metastatic
257450|NCT01856023|skin cancer|skin cancer
257451|NCT01856023|Stage IV|stage iv
257452|NCT01856023|interleukin-2|interleukin-2
257453|NCT01856010|Dementia|dementia
257454|NCT01856010|Aggression|aggression
257455|NCT01856010|Agitation|agitation
257456|NCT01855984|ADHD|adhd
257457|NCT01855984|Children|children
257458|NCT01855984|Tocotrienol|tocotrienol
257459|NCT01855958|Osteoarthritis|osteoarthritis
257460|NCT01855958|Electro acupuncture|electro acupuncture
257461|NCT01855958|Deep intramuscular stimulation|deep intramuscular stimulation
257462|NCT01855958|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
257463|NCT01855958|Pain pressure threshold|pain pressure threshold
257464|NCT01855958|Conditioned pain modulation|conditioned pain modulation
257465|NCT01855958|Clinical trial|clinical trial
257466|NCT01855945|Influenza|influenza
257467|NCT01855919|Chronic Low Back Pain|chronic low back pain
257468|NCT01855919|CLBP|clbp
257469|NCT01855906|Total knee replacement|total knee replacement
257470|NCT01855906|Gap balanced|gap balanced
257471|NCT01855906|Measured resection|measured resection
257472|NCT01855893|Neck pain|neck pain
257473|NCT01855880|psoriasis|psoriasis
257474|NCT01855880|dermatology|dermatology
257475|NCT01855880|monoclonal antibody|monoclonal antibody
257476|NCT01855867|HIV|hiv
257477|NCT01855867|PEP|pep
257478|NCT01855867|nPEP|npep
257479|NCT01855867|Prophylaxis|prophylaxis
257480|NCT01855867|Post Exposure Prophylaxis|post exposure prophylaxis
257481|NCT01855867|exposure to HIV|exposure to hiv
257482|NCT01855867|HIV prevention|hiv prevention
257483|NCT01855841|ERCP|ercp
257484|NCT01855841|virgin papilla|virgin papilla
257485|NCT01855841|risk of post-ERCP acute pancreatitis|risk of post-ercp acute pancreatitis
257486|NCT01855802|Greece|greece
257487|NCT01855802|Ophthalmology|ophthalmology
257488|NCT01855802|Glaucoma|glaucoma
257489|NCT01855802|Generics|generics
257490|NCT01855802|Perception|perception
257491|NCT01855776|Physical Activity/Walking|physical activity/walking
257492|NCT01855776|Full-time employees|full-time employees
257493|NCT01855776|RCT|rct
257494|NCT01855776|Incentives|incentives
257495|NCT01855776|Wireless pedometer|wireless pedometer
257496|NCT01855763|gestational diabetes|gestational diabetes
257497|NCT01855763|type 2 diabetes|type 2 diabetes
257498|NCT01855763|pregnancy|pregnancy
257499|NCT01855763|metformin|metformin
257500|NCT01855763|insulin|insulin
257501|NCT01855750|Lymphoma|lymphoma
257502|NCT01855750|B-cell lymphoma|b-cell lymphoma
257503|NCT01855750|Non-germinal center B-cell subtype|non-germinal center b-cell subtype
257504|NCT01855750|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
257505|NCT01855750|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
257506|NCT01855750|PCI-32765|pci-32765
257507|NCT01855750|JNJ-54179060|jnj-54179060
257508|NCT01855750|Ibrutinib|ibrutinib
257509|NCT01855750|Rituximab|rituximab
257510|NCT01855750|Cyclophosphamide|cyclophosphamide
257511|NCT01855750|Doxorubicin|doxorubicin
257512|NCT01855750|Vincristine|vincristine
257513|NCT01855750|Prednisone|prednisone
257514|NCT01855737|gene guided|gene guided
257515|NCT01855737|warfarin dose|warfarin dose
257516|NCT01855737|Chinese|chinese
257517|NCT01855711|Alosetron hydrochloride|alosetron hydrochloride
257518|NCT01855711|Global Improvement Scale(GIS)|global improvement scale(gis)
257519|NCT01855711|Diarrhea-predominant IBS|diarrhea-predominant ibs
257716|NCT01854866|ascites|ascites
257521|NCT01855685|XCGD, lentivirus, cellular therapy|xcgd, lentivirus, cellular therapy
257522|NCT01855672|Migraine, occipital nerve, stimulation|migraine, occipital nerve, stimulation
257524|NCT01855659|Obstructive,|obstructive,
257525|NCT01855659|Peak Inspiratory Flow|peak inspiratory flow
257526|NCT01855659|[C08.381.495.389]|[c08.381.495.389]
257527|NCT01855620|Contraception|contraception
257528|NCT01855620|Implant|implant
257529|NCT01855620|Obesity|obesity
257530|NCT01855607|chemotherapy induced neuropathy|chemotherapy induced neuropathy
257531|NCT01855542|metabolic acidosis, plasmalyte solution, 0.9% normal saline|metabolic acidosis, plasmalyte solution, 0.9% normal saline
257532|NCT01855529|ropivacaine, pain, mastectomy|ropivacaine, pain, mastectomy
257533|NCT01855516|Antithrombotic prophylaxis|antithrombotic prophylaxis
257534|NCT01855503|Metastatic|metastatic
257535|NCT01855503|Breast Cancer|breast cancer
257536|NCT01855503|Metastatic Breast Cancer|metastatic breast cancer
257537|NCT01855503|Breast|breast
257538|NCT01855503|Biopsy|biopsy
257539|NCT01855503|Molecular|molecular
257540|NCT01855503|Genetic|genetic
257541|NCT01855464|pneumothorax|pneumothorax
257542|NCT01855464|primary pneumothorax|primary pneumothorax
257543|NCT01855464|lung collapse|lung collapse
693812|NCT00942435|Bleeding|bleeding
257544|NCT01855451|Human Papilloma Virus|human papilloma virus
257546|NCT01855451|Oropharyngeal|oropharyngeal
257547|NCT01855451|Squamous Cell|squamous cell
257548|NCT01855451|Carcinoma|carcinoma
257549|NCT01855438|Live donor kidney transplantation|live donor kidney transplantation
257550|NCT01855438|Living donation|living donation
257551|NCT01855438|Patient education|patient education
257552|NCT01855438|Kidney transplant candidates|kidney transplant candidates
257553|NCT01855412|PAD|pad
257554|NCT01855412|LIBERTY|liberty
257555|NCT01855412|Observational|observational
257556|NCT01855399|Peer Support|peer support
257557|NCT01855399|Self Management|self management
257558|NCT01855399|Health Disparities|health disparities
257559|NCT01855373|Blood Sugar|blood sugar
257560|NCT01855373|Endothelial Function|endothelial function
257561|NCT01855373|Blood Vessel Health|blood vessel health
257562|NCT01855360|amyloid|amyloid
257563|NCT01855360|amyloidosis|amyloidosis
257564|NCT01855360|cardiac amyloidosis|cardiac amyloidosis
257565|NCT01855360|senile amyloidosis|senile amyloidosis
257566|NCT01855360|familial amyloidosis|familial amyloidosis
257567|NCT01855360|transthyretin amyloidosis|transthyretin amyloidosis
257568|NCT01855347|Prematurity|prematurity
257569|NCT01855347|Hypoxia|hypoxia
257570|NCT01855347|Necrotizing Enterocolitis|necrotizing enterocolitis
257571|NCT01855347|Near Infrared Spectroscopy|near infrared spectroscopy
257572|NCT01855347|Abdominal tissue oxygenation|abdominal tissue oxygenation
257573|NCT01855347|NICU|nicu
257574|NCT01855334|Dialysis|dialysis
257575|NCT01855334|ESRD|esrd
257576|NCT01855334|Cardiovascular disease|cardiovascular disease
257577|NCT01855334|spironolactone|spironolactone
257578|NCT01855334|L-arginine|l-arginine
257579|NCT01855334|myocardial perfusion|myocardial perfusion
257580|NCT01855334|coronary flow reserve|coronary flow reserve
257581|NCT01855334|diastolic function|diastolic function
257582|NCT01855321|uncontrolled diabetes|uncontrolled diabetes
257583|NCT01855321|vitamin D deficiency|vitamin d deficiency
257584|NCT01855295|Dialysis|dialysis
257585|NCT01855295|End Stage Renal Disease|end stage renal disease
257586|NCT01855295|Protein supplementation|protein supplementation
257587|NCT01855295|Inflammation|inflammation
257588|NCT01855295|Quality of Life|quality of life
257589|NCT01855282|Diabetes Type II,|diabetes type ii,
257590|NCT01855282|Overweight,|overweight,
257591|NCT01855282|Obesity,|obesity,
257592|NCT01855282|Behavioral Intervention,|behavioral intervention,
257593|NCT01855282|Latino, farm worker|latino, farm worker
257594|NCT01855282|randomized controlled intervention|randomized controlled intervention
257595|NCT01855269|probiotic|probiotic
257596|NCT01855269|infantile colic|infantile colic
257597|NCT01855256|hyperhidrosis|hyperhidrosis
257598|NCT01855256|oxybutynin|oxybutynin
257599|NCT01855243|Type 2 D M|type 2 d m
257600|NCT01855243|sliding scale insulin|sliding scale insulin
257601|NCT01855243|70/30 insulin|70/30 insulin
257602|NCT01855243|basals insulin|basals insulin
257603|NCT01855243|supplemental insulin|supplemental insulin
257604|NCT01855217|morbid|morbid
257605|NCT01855217|obesity|obesity
257606|NCT01855217|sugammadex|sugammadex
257607|NCT01855217|pharmacodynamics|pharmacodynamics
257608|NCT01855204|Computed Tomography, Spiral|computed tomography, spiral
257609|NCT01855204|Urography|urography
257610|NCT01855204|Radiation dosage|radiation dosage
257611|NCT01855204|Contrast media|contrast media
257612|NCT01855178|nocturnal|nocturnal
257613|NCT01855178|epilepsy|epilepsy
257614|NCT01855165|chronic heart failure|chronic heart failure
257615|NCT01855165|drug-drug interactions|drug-drug interactions
257616|NCT01855165|pharmacist's intervention|pharmacist's intervention
257617|NCT01855152|Dementia|dementia
257618|NCT01855152|Care Homes|care homes
257619|NCT01855152|Quality of life|quality of life
257620|NCT01855152|Antipsychotic medication|antipsychotic medication
257621|NCT01855152|Behavioural symptoms|behavioural symptoms
257622|NCT01855152|Cost effectiveness|cost effectiveness
257623|NCT01855152|Implementation|implementation
258128|NCT01853345|Recurrent|recurrent
257624|NCT01855152|Person centred care|person centred care
257625|NCT01855152|Social interaction|social interaction
257626|NCT01855139|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
257627|NCT01855139|Stroke|stroke
257628|NCT01855139|Systemic embolism|systemic embolism
257629|NCT01855139|Oral anticoagulation|oral anticoagulation
257630|NCT01855139|Real-life setting|real-life setting
257631|NCT01855139|Preventive measure|preventive measure
257632|NCT01855126|light|light
257633|NCT01855126|circadian rhythms|circadian rhythms
257634|NCT01855126|dim light melatonin onset|dim light melatonin onset
257635|NCT01855126|sleep|sleep
257636|NCT01855113|PAIN|pain
257637|NCT01855113|ORTHODONTIC TREATMENT|orthodontic treatment
257638|NCT01855113|INVISALIGN|invisalign
257639|NCT01855100|Treatment of acute deep vein thrombosis|treatment of acute deep vein thrombosis
257640|NCT01855100|Prevention of recurrence|prevention of recurrence
257641|NCT01855100|Oral anticoagulation|oral anticoagulation
257642|NCT01855100|Real-life setting|real-life setting
257643|NCT01855074|Schizophrenia|schizophrenia
257644|NCT01855074|Schizophreniform Disorder|schizophreniform disorder
257645|NCT01855074|Schizoaffective Disorder|schizoaffective disorder
257646|NCT01855074|Risperidone|risperidone
257647|NCT01855074|Risperdal consta|risperdal consta
257648|NCT01855061|Feasibility studies|feasibility studies
257649|NCT01855061|Sequence analysis, DNA|sequence analysis, dna
257650|NCT01855061|Biological markers|biological markers
257651|NCT01855061|Solid tumors|solid tumors
257652|NCT01855061|Neoplasm metastasis|neoplasm metastasis
257653|NCT01855061|Irinotecan|irinotecan
257654|NCT01855061|Pharmacokinetics SN-38|pharmacokinetics sn-38
257655|NCT01855061|Carboxylesterase activity within metastasis|carboxylesterase activity within metastasis
257656|NCT01855048|N-Rephasin® SAL200|n-rephasin® sal200
257657|NCT01855048|endolysin|endolysin
257658|NCT01855048|Placebo|placebo
257659|NCT01855035|ischemic stroke|ischemic stroke
257660|NCT01855035|ECG monitoring|ecg monitoring
257661|NCT01855035|atrial fibrillation (/flutter)|atrial fibrillation (/flutter)
257662|NCT01855022|Motivational interviewing|motivational interviewing
257663|NCT01855022|Interactive voice response|interactive voice response
257664|NCT01855022|Hospital readmission|hospital readmission
257665|NCT01855009|Quality of Life|quality of life
257666|NCT01855009|Body Weight and Measures|body weight and measures
257667|NCT01855009|Malnutrition|malnutrition
257668|NCT01855009|Adolescent Nutrition Sciences|adolescent nutrition sciences
257669|NCT01855009|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
257670|NCT01855009|Motor Activity|motor activity
257671|NCT01855009|Drinking|drinking
257672|NCT01854983|fluorescence colposcopy|fluorescence colposcopy
257673|NCT01854983|cervical cancer|cervical cancer
257674|NCT01854957|Multiple sclerosis|multiple sclerosis
257675|NCT01854957|Mesenchymal stem cells|mesenchymal stem cells
257676|NCT01854931|Tai Ji Quan|tai ji quan
257677|NCT01854931|fall prevention|fall prevention
257678|NCT01854931|community dissemination|community dissemination
257679|NCT01854918|High cholesterol|high cholesterol
257680|NCT01854918|Raised cholesterol|raised cholesterol
257681|NCT01854918|Cholesterol|cholesterol
257682|NCT01854918|Elevated Cholesterol|elevated cholesterol
257683|NCT01854892|low back pain|low back pain
257684|NCT01854892|manipulation|manipulation
257685|NCT01854892|laser therapy|laser therapy
257686|NCT01854892|osteopathic|osteopathic
257687|NCT01854892|chiropractic|chiropractic
257688|NCT01854892|mobilization|mobilization
257689|NCT01854892|muscle energy|muscle energy
257690|NCT01854892|physical therapy|physical therapy
257691|NCT01854892|muscle|muscle
257692|NCT01854892|spine|spine
257693|NCT01854892|adjustment|adjustment
257694|NCT01854892|rehabilitation|rehabilitation
257695|NCT01853813|colorectal cancer|colorectal cancer
257696|NCT01853813|advanced disease|advanced disease
257697|NCT01853813|LDH|ldh
257698|NCT01853800|Relative bioavailability|relative bioavailability
257699|NCT01853800|Rivaroxaban|rivaroxaban
257700|NCT01853787|COPD|copd
257701|NCT01853787|bronchial inflammation|bronchial inflammation
257702|NCT01853787|NO concentration|no concentration
257703|NCT01853787|small airways|small airways
257704|NCT01853787|LABA|laba
257705|NCT01853787|Small Airways Stretching|small airways stretching
257706|NCT01853787|Stretch and strain of small airways in COPD|stretch and strain of small airways in copd
257707|NCT01853787|Acute LABA effect on NO production|acute laba effect on no production
257708|NCT01853787|Pulmonary desufflation|pulmonary desufflation
257709|NCT01853774|Tailored navigation|tailored navigation
257710|NCT01853774|Tailored messages|tailored messages
257711|NCT01853761|abdominal fat|abdominal fat
257712|NCT01853761|metabolic syndrome|metabolic syndrome
257713|NCT01853761|microcurrent|microcurrent
257714|NCT01853761|aerobic exercise|aerobic exercise
257715|NCT01854866|Pleural Effusion|pleural effusion
257717|NCT01854866|Malignant|malignant
257718|NCT01854853|unsafe sex|unsafe sex
257719|NCT01854853|safer sex|safer sex
257720|NCT01854853|HIV|hiv
257721|NCT01854853|STI|sti
257722|NCT01854853|Pregnancy|pregnancy
258129|NCT01853345|High Risk|high risk
257723|NCT01854840|hyaline membrane disease|hyaline membrane disease
257724|NCT01854840|placenta|placenta
257725|NCT01854840|betamethasone|betamethasone
257726|NCT01854827|Biliary atresia|biliary atresia
257727|NCT01854827|Hepatic portoenterostomy|hepatic portoenterostomy
257728|NCT01854827|Intravenous immunoglobulin|intravenous immunoglobulin
257729|NCT01854801|IEI-EMF|iei-emf
257730|NCT01854801|WI-FI|wi-fi
257731|NCT01854801|DECT|dect
257732|NCT01854801|Electro-sensitivity|electro-sensitivity
257733|NCT01854801|Radiofrequency|radiofrequency
257734|NCT01854801|EHS|ehs
257735|NCT01854801|Idiopathic|idiopathic
257736|NCT01854801|Environmental|environmental
257737|NCT01854801|Intolerance fields|intolerance fields
257738|NCT01854801|Mobile phone|mobile phone
257739|NCT01854788|Airway clearance techniques|airway clearance techniques
257740|NCT01854788|Mucus clearance|mucus clearance
257741|NCT01854788|Chest physiotherapy|chest physiotherapy
257742|NCT01854788|Autogenic drainage|autogenic drainage
257743|NCT01854788|Slow expiration with glottis opened in lateral posture(ELTGOL)|slow expiration with glottis opened in lateral posture(eltgol)
257744|NCT01854788|Temporary-positive expiratory pressure (T-PEP)|temporary-positive expiratory pressure (t-pep)
257745|NCT01854788|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
257746|NCT01854775|Adolescents|adolescents
257748|NCT01854775|HIV|hiv
257749|NCT01854775|Treatment-naive|treatment-naive
257750|NCT01854762|HIV|hiv
257751|NCT01854762|Treatment|treatment
257752|NCT01854762|Pregnancy|pregnancy
257753|NCT01854749|ESCC|escc
257754|NCT01854736|Allergy|allergy
257755|NCT01854736|Phleum pratense|phleum pratense
257756|NCT01854736|Rhinoconjunctivitis|rhinoconjunctivitis
257757|NCT01854736|asthma|asthma
257758|NCT01854736|positive SPT to Phleum pratense|positive spt to phleum pratense
257759|NCT01854723|Diabetes|diabetes
257760|NCT01854723|Insulin glargine|insulin glargine
257761|NCT01854723|NPH insulin|nph insulin
257762|NCT01854710|ADASUVE|adasuve
257763|NCT01854710|inhaled loxapine|inhaled loxapine
257764|NCT01854710|thorough QT/QTc study|thorough qt/qtc study
257765|NCT01854697|Chronic Hepatitis C|chronic hepatitis c
257766|NCT01854697|Interferon Free|interferon free
257767|NCT01854697|Hepatitis C Treatment Naive|hepatitis c treatment naive
257768|NCT01854697|Hepatitis C Virus|hepatitis c virus
257769|NCT01854697|Hepatitis C Genotype 1|hepatitis c genotype 1
257770|NCT01854671|postpartum contraception|postpartum contraception
257771|NCT01854671|contraceptive counseling|contraceptive counseling
257772|NCT01854632|influenza vaccine|influenza vaccine
257773|NCT01854632|trivalent live-attenuated influenza vaccine|trivalent live-attenuated influenza vaccine
257774|NCT01854632|efficacy|efficacy
257775|NCT01854632|Africa|africa
257776|NCT01854632|Senegal|senegal
257777|NCT01854619|chronic rhinosinusitis|chronic rhinosinusitis
257778|NCT01854619|sinusitis|sinusitis
257779|NCT01854619|photodisinfection|photodisinfection
257780|NCT01854619|photodynamic therapy|photodynamic therapy
257781|NCT01854619|antimicrobial photodynamic therapy|antimicrobial photodynamic therapy
257782|NCT01854619|aPDT|apdt
257783|NCT01854619|PDT|pdt
257784|NCT01854619|paranasal sinus diseases|paranasal sinus diseases
257785|NCT01854619|respiratory tract infections|respiratory tract infections
257786|NCT01854619|respiratory tract diseases|respiratory tract diseases
257787|NCT01854606|Diffuse Large B-Cell Lymphoma, DBCL, AEB071, Everolimus|diffuse large b-cell lymphoma, dbcl, aeb071, everolimus
257788|NCT01854580|Comparative effectiveness research|comparative effectiveness research
257789|NCT01854580|health economic evaluation|health economic evaluation
257790|NCT01854567|Cord Blood|cord blood
257791|NCT01854567|Stem Cells|stem cells
257792|NCT01854567|MPC|mpc
257793|NCT01854567|Mesoblast|mesoblast
257794|NCT01854567|Expanded|expanded
257795|NCT01854567|AML|aml
257796|NCT01854567|ALL|all
257797|NCT01854567|NHL|nhl
257798|NCT01854567|Leukemia|leukemia
257799|NCT01854567|Lymphoma|lymphoma
257800|NCT01854554|Brain cancer|brain cancer
257801|NCT01854554|Glioblastoma|glioblastoma
257802|NCT01854554|Glioblastoma Multiforme|glioblastoma multiforme
257803|NCT01854554|GBM|gbm
257804|NCT01854554|Intensity Modulated Proton Radiotherapy|intensity modulated proton radiotherapy
257805|NCT01854554|IMPT|impt
257806|NCT01854554|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
257807|NCT01854554|IMRT|imrt
257808|NCT01854554|Radiotherapy|radiotherapy
257809|NCT01854554|XRT|xrt
257810|NCT01854554|Cognitive tests|cognitive tests
257811|NCT01854554|Thinking skills tests|thinking skills tests
257812|NCT01854554|Questionnaires|questionnaires
257813|NCT01854554|Surveys|surveys
257814|NCT01854554|Quality of life|quality of life
257815|NCT01854554|QOL|qol
257816|NCT01854541|Cancer|cancer
257817|NCT01854541|Radiotherapy|radiotherapy
257818|NCT01854528|Partial responder|partial responder
257819|NCT01854528|Interferon free|interferon free
257820|NCT01854528|Treatment-experienced|treatment-experienced
257821|NCT01854528|Relapser|relapser
257822|NCT01854528|Hepatitis C Virus|hepatitis c virus
257823|NCT01854528|Null responder|null responder
257824|NCT01854528|Hepatitis C Genotype 1|hepatitis c genotype 1
258229|NCT01852955|Surgery|surgery
257825|NCT01854528|paritaprevir|paritaprevir
257826|NCT01854528|ombitasvir|ombitasvir
257827|NCT01854528|dasabuvir|dasabuvir
257828|NCT01854528|ribavirin|ribavirin
257829|NCT01854528|Viekira PAK|viekira pak
257830|NCT01854528|Chronic hepatitis C|chronic hepatitis c
257831|NCT01854502|Young children|young children
257832|NCT01854502|counseling|counseling
257833|NCT01854502|fluoride|fluoride
257834|NCT01854502|xylitol|xylitol
257835|NCT01854489|Buprenorphine|buprenorphine
257836|NCT01854489|Rifampicin|rifampicin
257837|NCT01854489|Interactions|interactions
257838|NCT01854489|Pharmakokinetics|pharmakokinetics
257839|NCT01854489|Pharmakodynamics|pharmakodynamics
257840|NCT01854476|Hemodialysis|hemodialysis
257841|NCT01854476|Bleeding|bleeding
257842|NCT01854476|Hemostatic dressing|hemostatic dressing
257843|NCT01854476|Tranexamic Acid|tranexamic acid
257844|NCT01854463|DIABETES MELLITUS|diabetes mellitus
257845|NCT01854463|VITAMIN D|vitamin d
257846|NCT01854463|ARTERIAL STIFFNESS|arterial stiffness
257847|NCT01854463|FATTY LIVER|fatty liver
257848|NCT01854463|BONE TURNOVER|bone turnover
257849|NCT01854450|Occipitoposterior position|occipitoposterior position
257850|NCT01854450|Maternal posturing|maternal posturing
257851|NCT01854450|Labor|labor
257852|NCT01854437|mg oxide|mg oxide
257853|NCT01854437|hyperphosphatemia|hyperphosphatemia
257854|NCT01854437|plasma phosphor level|plasma phosphor level
257855|NCT01854424|Fibrocyte|fibrocyte
257856|NCT01854424|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
257857|NCT01854424|Serum Amyloid P|serum amyloid p
257858|NCT01854424|Fibrosis|fibrosis
257859|NCT01854424|Mortality|mortality
257860|NCT01854411|Analgesics|analgesics
257861|NCT01854411|Ibuprofene|ibuprofene
257862|NCT01854411|Ketoprofene|ketoprofene
257863|NCT01854411|Breastmilk|breastmilk
257864|NCT01854411|Relative Infant Dose|relative infant dose
257865|NCT01854411|Theoric Infant Dose|theoric infant dose
257866|NCT01854398|Obstructive sleep apnea|obstructive sleep apnea
257867|NCT01854398|Continuous positive airway pressure|continuous positive airway pressure
257868|NCT01854398|diastolic function|diastolic function
257869|NCT01854385|Post-traumatic headache|post-traumatic headache
257870|NCT01854385|Traumatic brain injury|traumatic brain injury
257871|NCT01854385|Sumatriptan|sumatriptan
257872|NCT01854359|Multiple Sclerosis|multiple sclerosis
257873|NCT01854359|Extension Trial|extension trial
257874|NCT01854346|Autism spectrum disorder|autism spectrum disorder
257875|NCT01854346|Social skills training|social skills training
257876|NCT01854346|Group training|group training
257877|NCT01854346|Comorbidity|comorbidity
257878|NCT01854346|Intervention|intervention
257879|NCT01854346|Evidence-based|evidence-based
257880|NCT01854333|Diagnostics|diagnostics
257881|NCT01854333|ADOS|ados
257882|NCT01854333|ADI-R|adi-r
257883|NCT01854333|Psychometrics|psychometrics
257884|NCT01854333|Autism spectrum disorders|autism spectrum disorders
257885|NCT01854333|Autism|autism
257886|NCT01854307|Difference of|difference of
257887|NCT01854307|measurements|measurements
257888|NCT01854307|before and after|before and after
257889|NCT01854294|ALS|als
257890|NCT01854294|motorneuron disease|motorneuron disease
257891|NCT01854294|Central Nervous System (CNS) disease|central nervous system (cns) disease
257892|NCT01854294|neurodegeneration|neurodegeneration
257893|NCT01854294|neuroprotective|neuroprotective
257894|NCT01854294|mechanisms of action|mechanisms of action
257895|NCT01854294|pathways|pathways
257896|NCT01854294|biomarkers|biomarkers
257897|NCT01854294|Cerebral Spinal Fluid (CSF)|cerebral spinal fluid (csf)
257898|NCT01854294|blood biomarkers|blood biomarkers
257899|NCT01854294|multi-factorial|multi-factorial
257900|NCT01854294|multisystem|multisystem
257901|NCT01854294|single target|single target
257902|NCT01854294|pathogenic mechanisms|pathogenic mechanisms
257903|NCT01854294|Protein Bands Selection by Function|protein bands selection by function
257904|NCT01854294|in silico analysis|in silico analysis
257905|NCT01854294|active site|active site
257907|NCT01854294|peptide|peptide
257908|NCT01854294|embryonic stage|embryonic stage
257909|NCT01854294|endogenous|endogenous
257910|NCT01854294|master regulators|master regulators
257911|NCT01854294|fetal development|fetal development
257912|NCT01854294|embryonic development|embryonic development
257913|NCT01854294|common pathways|common pathways
257914|NCT01854294|Blood Brain Barrier (BBB)|blood brain barrier (bbb)
257915|NCT01854294|anti-inflammatory|anti-inflammatory
257916|NCT01854294|anti-apoptotic|anti-apoptotic
257917|NCT01854294|anti-oxidative|anti-oxidative
257918|NCT01854294|regenerative|regenerative
257919|NCT01854294|distress signals|distress signals
257920|NCT01854294|neurotrophin|neurotrophin
257921|NCT01854294|Motoneuronotrophic factor (MNTF)|motoneuronotrophic factor (mntf)
257922|NCT01854294|ALS model|als model
257923|NCT01854294|life span|life span
257924|NCT01854294|disease onset|disease onset
257925|NCT01854294|grip strength|grip strength
257926|NCT01854294|protein expression|protein expression
257927|NCT01854294|DNA microarray|dna microarray
257928|NCT01854294|differential expression|differential expression
257929|NCT01854294|Phase 1 clinical trial|phase 1 clinical trial
257930|NCT01854294|rare disease|rare disease
257931|NCT01854294|common underlying pathogenic mechanisms|common underlying pathogenic mechanisms
257932|NCT01854294|neurological deficits|neurological deficits
257933|NCT01854294|gene mutation|gene mutation
257934|NCT01854294|misfolded proteins|misfolded proteins
257935|NCT01854294|inadvertent errors|inadvertent errors
257936|NCT01854294|modulation of genes|modulation of genes
257937|NCT01854294|master regulator peptide drug|master regulator peptide drug
257938|NCT01854294|ALS related genes|als related genes
257939|NCT01854294|mitochondria dysfunction|mitochondria dysfunction
257940|NCT01854294|excitotoxicity|excitotoxicity
693813|NCT00942435|VTE|vte
257941|NCT01854294|axonal transport|axonal transport
257942|NCT01854294|oxidative stress|oxidative stress
257943|NCT01854294|protein aggregation|protein aggregation
257944|NCT01854294|pathogenesis|pathogenesis
257945|NCT01854294|target biomarkers|target biomarkers
257946|NCT01854294|efficacy biomarkers|efficacy biomarkers
257947|NCT01854281|Patent foramen ovale|patent foramen ovale
257948|NCT01854281|Catheter-based closure|catheter-based closure
257949|NCT01854281|Nitrogen bubbles|nitrogen bubbles
257950|NCT01854281|Decompression sickness|decompression sickness
257951|NCT01854268|cough|cough
257952|NCT01854255|Gastric|gastric
257953|NCT01854255|Cancer|cancer
257954|NCT01854255|Chemotherapy|chemotherapy
257955|NCT01854255|Intraperitoneal|intraperitoneal
257956|NCT01854229|Morphine|morphine
257957|NCT01854229|Implantable Infusion Pumps|implantable infusion pumps
257958|NCT01854229|Intrathecal Pump|intrathecal pump
257959|NCT01854216|Rotigotine|rotigotine
257960|NCT01854216|Neupro|neupro
257961|NCT01854216|Japanese|japanese
257962|NCT01854216|Caucasian|caucasian
257963|NCT01854216|Male|male
257964|NCT01854216|Female|female
257965|NCT01854216|Single dose|single dose
257966|NCT01854216|Pharmacokinetics|pharmacokinetics
257967|NCT01854203|Cisplatin|cisplatin
257968|NCT01854203|neoadjuvant chemotherapy|neoadjuvant chemotherapy
257969|NCT01854203|intensity-modulated radiation therapy|intensity-modulated radiation therapy
257970|NCT01854203|concurrent chemoradiotherapy|concurrent chemoradiotherapy
257971|NCT01854190|Obstructive sleep apnea|obstructive sleep apnea
257972|NCT01854190|Resistent hypertension|resistent hypertension
257973|NCT01854190|Endothelial function|endothelial function
257974|NCT01854190|Blood pressure|blood pressure
257975|NCT01854177|breathlessness; substance P; beta-endorphin|breathlessness; substance p; beta-endorphin
257976|NCT01854164|HGE, impaired fasting glucose, clinical trial|hge, impaired fasting glucose, clinical trial
257977|NCT01854151|Medication errors|medication errors
257978|NCT01854151|Medication dosing|medication dosing
257979|NCT01854138|primary knee arthroplasty|primary knee arthroplasty
257980|NCT01854138|primary hip arthroplasty|primary hip arthroplasty
257981|NCT01854138|negative pressure wound therapy|negative pressure wound therapy
257982|NCT01854125|immun function|immun function
257983|NCT01854125|liver function|liver function
257984|NCT01854125|ascites|ascites
257985|NCT01854125|quality of life|quality of life
257986|NCT01854125|Child-Pugh score|child-pugh score
257987|NCT01854112|Helical tomotherapy|helical tomotherapy
257988|NCT01854112|total skin electron therapy|total skin electron therapy
257989|NCT01854112|TSEB|tseb
257990|NCT01854112|irradiation 5.|irradiation 5.
257991|NCT01854099|Brain Tumor|brain tumor
257992|NCT01854086|osteoporosis|osteoporosis
257993|NCT01854086|postmenopausal|postmenopausal
257994|NCT01854086|patient compliance|patient compliance
257995|NCT01854086|compliance|compliance
257996|NCT01854086|diphosphonates|diphosphonates
257997|NCT01854086|bisphosphonates|bisphosphonates
257998|NCT01854060|Irritable bowel syndrome|irritable bowel syndrome
257999|NCT01854060|Epidimiology|epidimiology
258000|NCT01854060|Deterioration in the severity of irritable bowel syndrome|deterioration in the severity of irritable bowel syndrome
258001|NCT01854034|Advanced disease|advanced disease
258002|NCT01854034|EGFR mutation|egfr mutation
258003|NCT01854021|Anesthesia|anesthesia
258004|NCT01854021|general|general
258005|NCT01854021|Immunity|immunity
258006|NCT01854021|Tongue neoplasms|tongue neoplasms
258007|NCT01854021|immune|immune
258008|NCT01854021|general anesthesia|general anesthesia
258009|NCT01854008|Exercise, Physical activity, Rehabilitation, COPD.|exercise, physical activity, rehabilitation, copd.
258010|NCT01853995|Fixed Lingual Mandibular Growth Modificator (FLMGM)|fixed lingual mandibular growth modificator (flmgm)
258011|NCT01853995|Class II division 1 malocclusion|class ii division 1 malocclusion
258012|NCT01853995|Sagittal Occlusal Correction|sagittal occlusal correction
258013|NCT01853995|Skeletal changes|skeletal changes
258014|NCT01853995|Dental changes|dental changes
258015|NCT01853956|Mexico|mexico
258016|NCT01853956|Bioequivalence|bioequivalence
258017|NCT01853956|Alprazolam|alprazolam
258018|NCT01853956|Pharmacokinetics|pharmacokinetics
258019|NCT01853943|Transradial approach|transradial approach
258020|NCT01853943|radial occlusion|radial occlusion
258021|NCT01853943|hand grip|hand grip
258022|NCT01853943|coronary angiography|coronary angiography
258023|NCT01853930|reading rehabilitation|reading rehabilitation
258024|NCT01853930|macular degeneration|macular degeneration
258025|NCT01853930|eccentric viewing|eccentric viewing
258026|NCT01853904|Bronchoscopy|bronchoscopy
258027|NCT01853904|BAL|bal
258028|NCT01853904|Suction|suction
258029|NCT01853878|Non-Small Cell Lung Cancer|non-small cell lung cancer
258030|NCT01853878|Immunotherapy|immunotherapy
258031|NCT01853878|Antigen-Specific|antigen-specific
258032|NCT01853865|Endometrial cancer|endometrial cancer
258033|NCT01853865|Follow-up examination|follow-up examination
258034|NCT01853722|DCN01|dcn01
693908|NCT00942812|Children|children
258035|NCT01853722|Ocular Surgical Preparation|ocular surgical preparation
258036|NCT01853722|Prophylaxis against infection|prophylaxis against infection
258037|NCT01853722|Pre-operative prep|pre-operative prep
258038|NCT01853683|General Surgery|general surgery
258039|NCT01853644|Cancer|cancer
258040|NCT01853644|Recurrent|recurrent
258041|NCT01853644|Ovary|ovary
258042|NCT01853644|Fallopian Tube|fallopian tube
258043|NCT01853644|Primary Peritioneal|primary peritioneal
258044|NCT01853644|Phase II|phase ii
258045|NCT01853644|Platinum Resistant|platinum resistant
258046|NCT01853631|chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
258047|NCT01853631|refractory|refractory
258048|NCT01853631|recurrent|recurrent
258049|NCT01853631|aggressive B-cell Lymphoma|aggressive b-cell lymphoma
258050|NCT01853631|CD19|cd19
258051|NCT01853631|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
258052|NCT01853631|CD28|cd28
258053|NCT01853631|CD137|cd137
258054|NCT01853631|4-1BB|4-1bb
258055|NCT01853631|acute lymphocytic leukemia|acute lymphocytic leukemia
258056|NCT01853618|Liver Cancer|liver cancer
258057|NCT01853618|Monoclonal Antibody|monoclonal antibody
258058|NCT01853618|CTLA-4|ctla-4
258059|NCT01853618|Ablative Therapy|ablative therapy
258060|NCT01853592|Gadolinium Contrast|gadolinium contrast
258061|NCT01853592|Cardiac MRI|cardiac mri
258063|NCT01853592|MRI|mri
258064|NCT01853592|MRI Safety|mri safety
258065|NCT01853579|Randomized controlled trial|randomized controlled trial
258066|NCT01853579|Subclinical hypothyroidism|subclinical hypothyroidism
258067|NCT01853579|Levothyroxine|levothyroxine
258068|NCT01853579|Depression|depression
258069|NCT01853566|Muscle Strength|muscle strength
258070|NCT01853566|Growth Hormone|growth hormone
258071|NCT01853566|men|men
258072|NCT01853540|Ciliary Beat Frequency (CBF)|ciliary beat frequency (cbf)
258073|NCT01853540|Nasal Nitric Oxide (nNO)|nasal nitric oxide (nno)
258074|NCT01853540|Mucociliary Dysfunction|mucociliary dysfunction
258075|NCT01853527|CT coronary angiography|ct coronary angiography
258076|NCT01853527|Contrast stress echocardiography|contrast stress echocardiography
258077|NCT01853527|Arterial stiffness|arterial stiffness
258078|NCT01853527|Quality of life|quality of life
258079|NCT01853527|Biochemical and genetic markers|biochemical and genetic markers
258080|NCT01853514|Low income|low income
258081|NCT01853514|Fruit and vegetables|fruit and vegetables
258082|NCT01853514|Conventional produce|conventional produce
258083|NCT01853514|Organic produce|organic produce
258084|NCT01853514|Pesticide|pesticide
258085|NCT01853514|Purchasing behavior|purchasing behavior
258086|NCT01853514|Message framing|message framing
258087|NCT01853501|POF|pof
258088|NCT01853488|Osteoporosis|osteoporosis
258089|NCT01853488|BMD|bmd
258090|NCT01853488|SCI|sci
258091|NCT01853488|DXA|dxa
258092|NCT01853488|pQCT|pqct
258093|NCT01853475|pharmacokinetics|pharmacokinetics
258094|NCT01853475|safety|safety
258095|NCT01853475|tolerability|tolerability
258096|NCT01853475|bioavailability|bioavailability
258097|NCT01853449|Fentanyl Citrate|fentanyl citrate
258098|NCT01853449|Opioids|opioids
258099|NCT01853449|Exercise|exercise
258100|NCT01853436|Breast Cancer|breast cancer
258101|NCT01853436|Reconstructive Tissue Matrix|reconstructive tissue matrix
258102|NCT01853436|Acellular Dermal Matrices (ADM)|acellular dermal matrices (adm)
258103|NCT01853423|Rapamune|rapamune
258104|NCT01853423|Topical|topical
258105|NCT01853423|Pediatric|pediatric
258106|NCT01853423|Safety|safety
258107|NCT01853423|Efficiency|efficiency
258108|NCT01853423|Angiofibroma|angiofibroma
258109|NCT01853423|Skin Cream|skin cream
258110|NCT01853410|coronary artery disease|coronary artery disease
258111|NCT01853410|coronary flow reserve|coronary flow reserve
258112|NCT01853410|endothelial function|endothelial function
258113|NCT01853384|Venous leg ulcer|venous leg ulcer
258114|NCT01853384|ulcer|ulcer
258115|NCT01853384|venous stasis|venous stasis
258116|NCT01853384|compression|compression
258117|NCT01853384|venous|venous
258118|NCT01853384|venous stasis ulcer|venous stasis ulcer
258119|NCT01853384|vlu|vlu
258120|NCT01853384|wound|wound
258121|NCT01853384|varicose veins|varicose veins
258122|NCT01853384|venous insufficiency|venous insufficiency
258123|NCT01853384|dvt|dvt
259027|NCT01849796|Neuralgia|neuralgia
258124|NCT01853384|deep vein thrombosis|deep vein thrombosis
258125|NCT01853358|hematological malignancy|hematological malignancy
258126|NCT01853358|stem cell transplantation|stem cell transplantation
258127|NCT01853345|Refractory|refractory
258130|NCT01853332|Cardiovascular Disease|cardiovascular disease
258131|NCT01853332|Diabetes|diabetes
258132|NCT01853332|Adjustment|adjustment
258133|NCT01853332|Adversity|adversity
258134|NCT01853332|Psychology|psychology
258135|NCT01853332|Midlife|midlife
258136|NCT01853332|Functioning|functioning
258137|NCT01853332|Socioeconomic|socioeconomic
258138|NCT01853332|Psychosocial outcomes|psychosocial outcomes
258139|NCT01853319|Regorafenib|regorafenib
258140|NCT01853319|Metastatic colorectal cancer|metastatic colorectal cancer
258141|NCT01853306|High grade serous ovarian cancer|high grade serous ovarian cancer
258142|NCT01853306|BRCA mutated breast cancer|brca mutated breast cancer
258143|NCT01853306|BRCA mutated|brca mutated
258144|NCT01853306|Oncology|oncology
258145|NCT01853293|Alcohol Abuse|alcohol abuse
258146|NCT01853293|Alcohol Dependence|alcohol dependence
258147|NCT01853293|Heavy drinking days|heavy drinking days
258148|NCT01853293|Kudzu|kudzu
258149|NCT01853280|ADHD|adhd
258150|NCT01853280|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
258151|NCT01853280|Deplin|deplin
258152|NCT01853280|L-methylfolate|l-methylfolate
258153|NCT01853280|Natural Treatments|natural treatments
258154|NCT01853280|Medical Food|medical food
258155|NCT01853267|Colorectal|colorectal
258156|NCT01853267|Surgery|surgery
258157|NCT01853267|Perianal|perianal
258158|NCT01853267|Abscess|abscess
258159|NCT01853241|small intestine|small intestine
258160|NCT01853241|endoscopy, gastrointestinal|endoscopy, gastrointestinal
258161|NCT01853228|Acute myeloid leukemia|acute myeloid leukemia
258162|NCT01853228|Relapsed or refractory acute myeloid leukemia|relapsed or refractory acute myeloid leukemia
258163|NCT01853228|Children|children
258164|NCT01853228|Decitabine|decitabine
258165|NCT01853228|DACOGEN|dacogen
258166|NCT01853228|Cytarabine|cytarabine
258167|NCT01853215|sternal intraosseous infusion study|sternal intraosseous infusion study
258168|NCT01853202|Cancer|cancer
258169|NCT01853202|Chemotherapy|chemotherapy
258170|NCT01853202|Thrombosis|thrombosis
258171|NCT01853202|Prevention|prevention
258172|NCT01853202|Exercise|exercise
258173|NCT01853189|pediatrics|pediatrics
258174|NCT01853189|asthma|asthma
258175|NCT01853189|osteopathic manipulative treatment|osteopathic manipulative treatment
258176|NCT01853176|Pain, Postoperative|pain, postoperative
258177|NCT01853176|Analgesia|analgesia
258178|NCT01853176|Anesthesia, local|anesthesia, local
258179|NCT01853176|Abdominoplasty|abdominoplasty
258180|NCT01853163|Gadolinium|gadolinium
258181|NCT01853163|Contrast Agent|contrast agent
258182|NCT01853163|Long-term retention|long-term retention
258183|NCT01853137|Class II division 1 malocclusion|class ii division 1 malocclusion
258184|NCT01853137|Dentofacial orthopedics|dentofacial orthopedics
258185|NCT01853137|Fixed Lingual Mandibular Growth Modificator (FLMGM)|fixed lingual mandibular growth modificator (flmgm)
258186|NCT01853124|Diarrhea|diarrhea
258187|NCT01853098|loving-kindness meditation|loving-kindness meditation
258188|NCT01853098|mindfulness meditation|mindfulness meditation
258189|NCT01853098|compassion|compassion
258190|NCT01853072|Diabetes Type I|diabetes type i
258191|NCT01853072|Diabetes Type II|diabetes type ii
258192|NCT01853072|non-proliferative diabetic retinopathy|non-proliferative diabetic retinopathy
258193|NCT01853072|macular edema|macular edema
258194|NCT01853072|Cataract|cataract
258195|NCT01853059|Anal cancer|anal cancer
258196|NCT01853059|Squamous cell cancer|squamous cell cancer
258197|NCT01853059|Radiotherapy|radiotherapy
258198|NCT01853059|Chemoradiotherapy|chemoradiotherapy
258199|NCT01853059|Conformational radiotherapy|conformational radiotherapy
258200|NCT01853059|Intensity modulated radiation therapy|intensity modulated radiation therapy
258201|NCT01853059|IMRT|imrt
258202|NCT01853046|Regorafenib|regorafenib
258203|NCT01853046|pharmacokinetics|pharmacokinetics
258204|NCT01853046|safety|safety
258205|NCT01853046|severe renal impairment|severe renal impairment
258206|NCT01853046|Solid tumors|solid tumors
258207|NCT01853033|Tolerability|tolerability
258208|NCT01853033|Immunogenicity|immunogenicity
258209|NCT01853033|Safety|safety
258210|NCT01853033|Rheumatoid Arthritis|rheumatoid arthritis
258211|NCT01853033|Pharmacokinetics|pharmacokinetics
258212|NCT01853020|Cannabinoids|cannabinoids
258213|NCT01853020|Eyeblink Conditioning|eyeblink conditioning
258214|NCT01853020|EBC|ebc
258215|NCT01853007|End stage renal disease|end stage renal disease
258216|NCT01853007|Kidney transplantation|kidney transplantation
258217|NCT01853007|Transplant options (living and deceased donor)|transplant options (living and deceased donor)
258218|NCT01853007|Patient education|patient education
258219|NCT01853007|Communication skills training|communication skills training
258220|NCT01852981|Physical activity promotion|physical activity promotion
258221|NCT01852981|Intervention|intervention
258222|NCT01852981|Public Health|public health
258223|NCT01852968|hypoglycemia|hypoglycemia
258224|NCT01852968|hypoglycemia unawareness|hypoglycemia unawareness
258225|NCT01852968|type 1 diabetes, hippocampus|type 1 diabetes, hippocampus
258226|NCT01852968|glucose transport|glucose transport
258227|NCT01852968|cognitive dysfunction|cognitive dysfunction
258228|NCT01852955|Outpatient|outpatient
258233|NCT01852942|HIV 1|hiv 1
258234|NCT01852942|HIV|hiv
258235|NCT01852942|Losartan|losartan
258236|NCT01852942|Fibrosis|fibrosis
258237|NCT01852942|Immune Activation|immune activation
258238|NCT01852942|Immune Reconstitution|immune reconstitution
258239|NCT01852929|Memory|memory
258240|NCT01852916|RDS|rds
258241|NCT01852903|vitamin C|vitamin c
258242|NCT01852903|calcium ascorbate|calcium ascorbate
258243|NCT01852903|ascorbic acid|ascorbic acid
258244|NCT01852903|bioavailability|bioavailability
258245|NCT01852890|Ascorbate|ascorbate
258246|NCT01852890|Vitamin C|vitamin c
258247|NCT01852890|Radiation|radiation
258248|NCT01852890|Gemcitabine|gemcitabine
258249|NCT01852890|Ascorbic Acid|ascorbic acid
258250|NCT01852877|HIV Diagnosis|hiv diagnosis
258251|NCT01852877|Case Management|case management
258252|NCT01852877|Telemedicine|telemedicine
258253|NCT01852877|Patient Compliance|patient compliance
258254|NCT01852877|Prisoners|prisoners
258255|NCT01852864|Prostate cancer|prostate cancer
258256|NCT01852864|testosterone|testosterone
258257|NCT01852864|castration|castration
258258|NCT01852864|degarelix|degarelix
258259|NCT01852864|proliferation|proliferation
258260|NCT01852838|lung cancer|lung cancer
258261|NCT01852838|volatile organic compounds|volatile organic compounds
258262|NCT01852838|Warburg effect|warburg effect
258263|NCT01852838|early detection|early detection
258264|NCT01852799|Multiple myeloma|multiple myeloma
258265|NCT01852799|PAD|pad
258266|NCT01852799|ASCT|asct
258267|NCT01852799|Bone metabolites|bone metabolites
258268|NCT01852799|Bone marker|bone marker
258269|NCT01852786|Contraception|contraception
258270|NCT01852786|Hyperandrogenism|hyperandrogenism
258271|NCT01852786|Female sexual function|female sexual function
258272|NCT01852773|blunt|blunt
258273|NCT01852773|injury|injury
258274|NCT01852773|aorta|aorta
258275|NCT01852773|endovascular|endovascular
258276|NCT01852760|endoscopic ultrasound|endoscopic ultrasound
258277|NCT01852760|ulcerative colitis|ulcerative colitis
258278|NCT01852760|inflammatory bowel disease|inflammatory bowel disease
258279|NCT01852747|Spinal Deformity|spinal deformity
258280|NCT01852747|Multilevel|multilevel
258281|NCT01852747|Posterior|posterior
258282|NCT01852747|Lumbar|lumbar
258283|NCT01852747|Fusion|fusion
258284|NCT01852747|Levoscoliosis|levoscoliosis
258285|NCT01852747|Dextroscoliosis|dextroscoliosis
258286|NCT01852747|Graft|graft
258287|NCT01852721|Cardiovascular diseases|cardiovascular diseases
258288|NCT01852721|Nutritional intervention program|nutritional intervention program
258289|NCT01852721|Self-Determination Theory|self-determination theory
258290|NCT01852721|Motivational interviewing|motivational interviewing
258291|NCT01852721|Gender differences|gender differences
258292|NCT01852721|Women|women
258294|NCT01852721|Motivation|motivation
258295|NCT01852721|Dietary intakes|dietary intakes
258296|NCT01852721|Mediterranean diet|mediterranean diet
258297|NCT01852721|Eating behaviors|eating behaviors
258298|NCT01852721|Lipid profile|lipid profile
258299|NCT01852708|22q|22q
258300|NCT01852708|1p36|1p36
258301|NCT01852708|Angelman|angelman
258302|NCT01852708|Cri-du-chat|cri-du-chat
258303|NCT01852708|Prader-Willi|prader-willi
258304|NCT01852708|DiGeorge|digeorge
258305|NCT01852708|Turner syndrome|turner syndrome
258306|NCT01852708|Patau syndrome|patau syndrome
258307|NCT01852708|Edwards syndrome|edwards syndrome
258308|NCT01852708|Down syndrome|down syndrome
258309|NCT01852695|Family integrated Care|family integrated care
258310|NCT01852695|Family centered care|family centered care
258311|NCT01852695|NICU family centered care|nicu family centered care
258312|NCT01852695|NICU parent program|nicu parent program
258313|NCT01851915|Major depression|major depression
258314|NCT01851915|Interpersonal psychotherapy|interpersonal psychotherapy
258315|NCT01851915|Cognitive Behavioral Therapy|cognitive behavioral therapy
258316|NCT01851915|Alliance|alliance
258317|NCT01851915|Return to Work|return to work
258318|NCT01851902|Atrial Fibrillation|atrial fibrillation
258319|NCT01851902|Atrial Flutter|atrial flutter
258320|NCT01851902|Arrhythmia|arrhythmia
258321|NCT01851863|functional dyspepsia|functional dyspepsia
258322|NCT01851863|depression|depression
258323|NCT01851863|compliance|compliance
258324|NCT01851850|PD|pd
258325|NCT01851850|Off periods|off periods
258326|NCT01851850|quality of life|quality of life
318745|NCT01581398|HCV|hcv
258327|NCT01851850|dyskinesia|dyskinesia
258328|NCT01851850|end-off-dose motor fluctuations|end-off-dose motor fluctuations
258329|NCT01851811|OSA|osa
258330|NCT01851798|OSA|osa
258331|NCT01851798|Sleep disordered breathing|sleep disordered breathing
258332|NCT01851798|anesthesia|anesthesia
258333|NCT01851798|ambulatory orthopedic surgery|ambulatory orthopedic surgery
258334|NCT01851785|Knee Arthroplasty|knee arthroplasty
258335|NCT01851785|Knee Osteoarthritis|knee osteoarthritis
258336|NCT01851785|Osteoarthritis|osteoarthritis
258337|NCT01851785|disparity|disparity
258338|NCT01851785|joint replacement|joint replacement
258339|NCT01851772|cervical|cervical
258340|NCT01851772|cancer|cancer
258341|NCT01851772|brachytherapy|brachytherapy
258342|NCT01851772|electronic|electronic
258343|NCT01851772|device|device
258344|NCT01851772|applicator|applicator
258345|NCT01851772|toxicity|toxicity
258346|NCT01851772|gynecologic|gynecologic
258347|NCT01851772|high-dose-rate (HDR)|high-dose-rate (hdr)
258348|NCT01851772|x-ray|x-ray
258349|NCT01851772|safety|safety
258350|NCT01851772|external beam radiation therapy (EBRT)|external beam radiation therapy (ebrt)
258351|NCT01851746|recurrent ovarian cancer|recurrent ovarian cancer
258352|NCT01851746|lobaplatin|lobaplatin
258353|NCT01851746|docetaxel|docetaxel
258354|NCT01851746|carboplatin|carboplatin
258355|NCT01852682|Peritoneal Dialysis|peritoneal dialysis
258356|NCT01852682|Hyperphosphatemia|hyperphosphatemia
258357|NCT01852656|Influenza, Human|influenza, human
258358|NCT01852656|Immunization|immunization
258359|NCT01852643|Rhinoplasty|rhinoplasty
258360|NCT01852643|Spreader graft technique|spreader graft technique
258361|NCT01852643|Lateral crural overlay technique|lateral crural overlay technique
258362|NCT01852643|Rhinomanometry|rhinomanometry
258363|NCT01852617|Smoking Cessation|smoking cessation
258364|NCT01852617|Pregnancy|pregnancy
258365|NCT01852617|Implementation|implementation
258366|NCT01852617|Knowledge translation|knowledge translation
258367|NCT01852604|HCV|hcv
258368|NCT01852604|Hepatitis C|hepatitis c
258369|NCT01852604|chronic hepatitis C|chronic hepatitis c
258370|NCT01852604|antiviral|antiviral
258371|NCT01852591|autologous transplant|autologous transplant
258372|NCT01852591|multiple myeloma|multiple myeloma
258373|NCT01852578|Metastatic NSCLC|metastatic nsclc
258374|NCT01852578|2nd Line|2nd line
258375|NCT01852578|Docetaxel-based treatment|docetaxel-based treatment
258376|NCT01852578|Progressed|progressed
258377|NCT01852578|Refractory|refractory
258378|NCT01852565|CYP3A4|cyp3a4
258379|NCT01852565|Lp-PLA2|lp-pla2
258380|NCT01852565|Atherosclerosis|atherosclerosis
258381|NCT01852565|healthy volunteer|healthy volunteer
258382|NCT01852565|Drug interaction|drug interaction
258383|NCT01852552|Aortic stenosis|aortic stenosis
258384|NCT01852552|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
258385|NCT01852552|Aortic valve replacement|aortic valve replacement
258386|NCT01852552|Costs|costs
258387|NCT01852552|Cognitive function|cognitive function
258388|NCT01852552|Quality of life|quality of life
258389|NCT01852539|LMA insertion|lma insertion
258390|NCT01852539|dexmedetomidine|dexmedetomidine
258391|NCT01852539|propofol|propofol
258392|NCT01852526|degenerative disc disease|degenerative disc disease
258393|NCT01852526|spondylolisthesis|spondylolisthesis
258394|NCT01852526|Lumbar spine|lumbar spine
258395|NCT01852526|fusion|fusion
258396|NCT01852526|adjacent instability|adjacent instability
258397|NCT01852487|Pumpkin seed oil|pumpkin seed oil
258398|NCT01852487|Hair growth|hair growth
258399|NCT01852487|Men|men
258400|NCT01852474|motor learning|motor learning
258401|NCT01852474|cortical plasticity|cortical plasticity
258402|NCT01852474|direct current stimulation|direct current stimulation
258403|NCT01852461|natural surfactants; perfusion index|natural surfactants; perfusion index
258404|NCT01852435|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
258405|NCT01852435|follicular lymphoma grade 3B|follicular lymphoma grade 3b
258406|NCT01852409|refractory malignant ascites|refractory malignant ascites
258407|NCT01852409|Bevacizumab|bevacizumab
258408|NCT01852409|intraperitoneal|intraperitoneal
258409|NCT01852409|phase I|phase i
258410|NCT01852396|Infraclavicular block|infraclavicular block
258411|NCT01852396|Brachial Plexus|brachial plexus
258412|NCT01852396|Retroclavicular Approach|retroclavicular approach
258413|NCT01852396|Complications of retroclavicular approach|complications of retroclavicular approach
258414|NCT01852396|Success of retroclavicular approach|success of retroclavicular approach
258415|NCT01852383|Duloxetine|duloxetine
258416|NCT01852383|Antidepressant|antidepressant
258417|NCT01852383|Depression|depression
258418|NCT01852383|Dysthymic Disorder|dysthymic disorder
258419|NCT01852383|Side Effects|side effects
258420|NCT01852383|Elderly|elderly
258421|NCT01852370|Lung transplantation|lung transplantation
258422|NCT01852370|Bone Marrow Transplantation|bone marrow transplantation
258423|NCT01852370|Unrelated Donor|unrelated donor
258424|NCT01852370|Cadaveric Donor|cadaveric donor
258425|NCT01852370|Deceased Donor|deceased donor
258426|NCT01852370|HLA-mismatch|hla-mismatch
258427|NCT01852370|BOLT|bolt
258428|NCT01852370|BMT|bmt
258429|NCT01852370|HSCT|hsct
258430|NCT01852344|Methylphenidate|methylphenidate
258431|NCT01852344|Effortful Control|effortful control
259126|NCT01849029|Unsafe Sex|unsafe sex
258432|NCT01852344|Attention Control|attention control
258433|NCT01852344|Cognitive functions|cognitive functions
258434|NCT01852331|Schizophrenia|schizophrenia
258435|NCT01852331|Schizophrenic Disorder|schizophrenic disorder
258436|NCT01852331|Hyperprolactinemia|hyperprolactinemia
258437|NCT01852331|Hyperprolactinaemia|hyperprolactinaemia
258438|NCT01852331|Chinese herbal medicine|chinese herbal medicine
258439|NCT01852331|Traditional Chinese medicine|traditional chinese medicine
259542|NCT01847287|Tysabri|tysabri
258440|NCT01852331|Peony-Glycyrrhiza Decoction|peony-glycyrrhiza decoction
258441|NCT01852331|PGD|pgd
258442|NCT01852331|Glycyrrhiza Radix|glycyrrhiza radix
258443|NCT01852331|Liquorice Root|liquorice root
258444|NCT01852331|Gancao|gancao
258445|NCT01852331|Paeoniae Alba Radix|paeoniae alba radix
258446|NCT01852331|White Peony Root|white peony root
258447|NCT01852331|Baishao|baishao
258448|NCT01852318|uremic pruritus|uremic pruritus
258449|NCT01852318|pregabalin|pregabalin
258450|NCT01852318|gabapentin|gabapentin
258451|NCT01852318|fexofenadine|fexofenadine
258452|NCT01852305|Obstructive sleep apnea|obstructive sleep apnea
258453|NCT01852305|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
258454|NCT01852305|Oximetry|oximetry
258455|NCT01852305|Bariatric Surgery|bariatric surgery
258456|NCT01852305|Anesthesia|anesthesia
258457|NCT01852305|Oxygen desaturation index (ODI)|oxygen desaturation index (odi)
258458|NCT01852292|platinum pre-treated recurrent or metastatic|platinum pre-treated recurrent or metastatic
258459|NCT01852292|Head and neck squamous cell carcinoma,|head and neck squamous cell carcinoma,
258460|NCT01852292|recurrent|recurrent
258461|NCT01852292|metastatic|metastatic
258462|NCT01852292|BKM120|bkm120
258463|NCT01852253|Dental implants|dental implants
258464|NCT01852253|Periodontal diseases|periodontal diseases
258465|NCT01852253|Peri-implantitis|peri-implantitis
258466|NCT01852253|Chlorhexidine|chlorhexidine
258467|NCT01852253|Microbiology|microbiology
258468|NCT01852214|Diabetes mellitus|diabetes mellitus
258469|NCT01852214|Coronary artery disease|coronary artery disease
258470|NCT01852214|prasugrel|prasugrel
258471|NCT01852214|ticagrelor|ticagrelor
258472|NCT01852188|Intrapartum|intrapartum
258473|NCT01852188|Glove|glove
258474|NCT01852188|Chorioamnionitis|chorioamnionitis
258475|NCT01852175|Coronary artery disease|coronary artery disease
258476|NCT01852175|Dual antiplatelet therapy|dual antiplatelet therapy
258477|NCT01852175|prasugrel|prasugrel
258478|NCT01852175|ticagrelor|ticagrelor
258479|NCT01852162|Coronary artery disease|coronary artery disease
258480|NCT01852162|antiplatelet therapy|antiplatelet therapy
258481|NCT01852162|anticoagulant therapy|anticoagulant therapy
258482|NCT01852149|Mitral Valve Regurgitation|mitral valve regurgitation
258483|NCT01852149|Coaptation|coaptation
258484|NCT01852149|Mitral Valve Repair|mitral valve repair
258485|NCT01852149|Plication|plication
258486|NCT01852149|Leaflet|leaflet
258487|NCT01852149|Annulus|annulus
258488|NCT01852149|Mitral Annuloplasty|mitral annuloplasty
258489|NCT01852136|pen needle|pen needle
258490|NCT01852136|insulin|insulin
258491|NCT01852123|High-sensitivity troponin assay|high-sensitivity troponin assay
258492|NCT01852123|Myocardial infarction|myocardial infarction
258493|NCT01852123|Unstable angina|unstable angina
258494|NCT01852123|Myocardial injury|myocardial injury
258495|NCT01852123|Cluster randomized trial|cluster randomized trial
258496|NCT01852097|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
258497|NCT01852097|Crohn's disease|crohn's disease
258498|NCT01852097|Ulcerative colitis|ulcerative colitis
258499|NCT01852097|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
258500|NCT01852097|Medication adherence|medication adherence
258501|NCT01852071|gene therapy, hematopoietic stem cell, SCID, lentivirus|gene therapy, hematopoietic stem cell, scid, lentivirus
258502|NCT01852032|Breast Cancer|breast cancer
258504|NCT01851993|Ondansetron|ondansetron
258505|NCT01851993|Exercise|exercise
258506|NCT01851980|Furosemide|furosemide
258507|NCT01851980|Exercise|exercise
258508|NCT01851980|Restrictive pulmonary disorder|restrictive pulmonary disorder
258509|NCT01851967|Major depressive disorder|major depressive disorder
258510|NCT01851967|Cognitive behavioral therapy|cognitive behavioral therapy
258511|NCT01851967|Computerized CBT|computerized cbt
258512|NCT01851967|Online CBT|online cbt
258513|NCT01851694|Cystic Fibrosis|cystic fibrosis
258514|NCT01851694|Diabetes|diabetes
258515|NCT01851694|Pancreatic insufficiency|pancreatic insufficiency
258516|NCT01851681|dental implants|dental implants
258517|NCT01851681|wound healing|wound healing
258518|NCT01851681|amoxicillin|amoxicillin
258519|NCT01851681|pain|pain
258520|NCT01851668|vibration|vibration
258521|NCT01851668|noise|noise
258522|NCT01851668|transfer|transfer
258523|NCT01851668|intraventricular hemorrhage|intraventricular hemorrhage
258524|NCT01851655|rehabilitation|rehabilitation
258525|NCT01851655|plyometric|plyometric
258526|NCT01851642|Macrophage|macrophage
258527|NCT01851642|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
258528|NCT01851642|Cystic Fibrosis|cystic fibrosis
258529|NCT01851629|Locomotor training|locomotor training
258530|NCT01851629|Walking recovery|walking recovery
258531|NCT01851629|Neuroplasticity|neuroplasticity
258532|NCT01851616|glucose, blood|glucose, blood
258533|NCT01851603|Schizophrenia|schizophrenia
258534|NCT01851590|Dermatophyte onychomycosis|dermatophyte onychomycosis
258535|NCT01851590|Fungal nail infection|fungal nail infection
258536|NCT01851590|Resin Lacquer|resin lacquer
258537|NCT01851590|Amorolfine|amorolfine
258538|NCT01851590|Terbinafine|terbinafine
258539|NCT01851577|Coparenting|coparenting
258540|NCT01851577|Problem solving|problem solving
258541|NCT01851577|Child development|child development
258542|NCT01851577|Father involvement|father involvement
258543|NCT01851564|Gastrointestinal Haemorrhage|gastrointestinal haemorrhage
258544|NCT01851564|Varices|varices
258545|NCT01851564|Liver Cirrhosis|liver cirrhosis
258546|NCT01851564|Stent|stent
258547|NCT01851551|NHL|nhl
258548|NCT01851551|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
258549|NCT01851551|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
258550|NCT01851551|mantle cell lymphoma|mantle cell lymphoma
258551|NCT01851538|Heart failure|heart failure
258552|NCT01851538|Biomarkers|biomarkers
258553|NCT01851538|Echocardiography|echocardiography
258554|NCT01851525|Atrial fibrillation|atrial fibrillation
258555|NCT01851525|Ablation|ablation
258556|NCT01851499|Neuropathic pain following spinal cord injury|neuropathic pain following spinal cord injury
258557|NCT01851473|Cocaine|cocaine
258558|NCT01851473|Pharmacokinetics|pharmacokinetics
258559|NCT01851473|Pharmacodynamics|pharmacodynamics
258560|NCT01851473|Drug Interactions|drug interactions
258561|NCT01851473|Acetazolamide|acetazolamide
258562|NCT01851460|Staphylococcus Infection|staphylococcus infection
258563|NCT01851460|RFA|rfa
258564|NCT01851460|Hepatic|hepatic
258565|NCT01851460|CGD|cgd
258566|NCT01851447|Muscle|muscle
258567|NCT01851447|Inflammatory Cytokines|inflammatory cytokines
258568|NCT01851447|Exercise|exercise
258569|NCT01851447|Biomarkers|biomarkers
258570|NCT01851447|Predictors of Outcome|predictors of outcome
258571|NCT01851434|OCT|oct
258572|NCT01851434|Multiple Sclerosis|multiple sclerosis
258573|NCT01851434|Optic Neuritis|optic neuritis
258574|NCT01851434|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
258575|NCT01851421|Body Fat|body fat
258576|NCT01851421|Adult|adult
258577|NCT01851421|Obesity|obesity
258578|NCT01851421|Free Fatty Acids|free fatty acids
258579|NCT01851421|Melanocortin-3 Receptor|melanocortin-3 receptor
258580|NCT01851408|Sorafenib|sorafenib
258581|NCT01851408|Temsirolimus|temsirolimus
258582|NCT01851408|Stage IV|stage iv
258583|NCT01851408|recurrent|recurrent
258584|NCT01851408|unresectable|unresectable
258585|NCT01851408|non-choroidal origin|non-choroidal origin
258586|NCT01851408|CCI-779|cci-779
258587|NCT01851408|BAY43-9006|bay43-9006
258588|NCT01851408|metastatic melanoma|metastatic melanoma
258589|NCT01851395|Palliative|palliative
258590|NCT01851395|Tumor Heterogeneity|tumor heterogeneity
258591|NCT01851395|Genomic and Proteomic Alterations|genomic and proteomic alterations
258592|NCT01851395|Deep Sequencing and Global Analysis|deep sequencing and global analysis
258593|NCT01851395|Clonal Evolution|clonal evolution
258594|NCT01851382|ELISA|elisa
258595|NCT01851382|Spectrometry|spectrometry
258596|NCT01851382|Protein Biomarkers|protein biomarkers
258597|NCT01851382|Proteomic Analyses|proteomic analyses
258598|NCT01851369|Solid Tumors|solid tumors
258599|NCT01851369|Lymphomas|lymphomas
258600|NCT01851369|DNA Damage|dna damage
258601|NCT01851369|Pharmacodynamics|pharmacodynamics
258602|NCT01851369|Pharmacokinetics|pharmacokinetics
258603|NCT01851356|PBR28|pbr28
258604|NCT01851356|Depression|depression
258605|NCT01851356|PET Imaging|pet imaging
258606|NCT01851356|Neuroinflammation|neuroinflammation
258607|NCT01851343|Stem Cell Infusion|stem cell infusion
258608|NCT01851343|Crohns|crohns
258609|NCT01851343|Ulcerative Colitis|ulcerative colitis
258610|NCT01851343|Inflammation|inflammation
258611|NCT01851343|Diarrhea|diarrhea
258612|NCT01851330|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
258613|NCT01851330|HCV|hcv
258614|NCT01851330|Sustained Virologic Response|sustained virologic response
258615|NCT01851330|Direct Acting Antiviral|direct acting antiviral
258616|NCT01851330|Combination Therapy|combination therapy
258617|NCT01851330|GS-7977|gs-7977
258618|NCT01851330|GS-5885|gs-5885
258619|NCT01851330|Ribavirin|ribavirin
258620|NCT01851330|Open Label|open label
258621|NCT01851330|Sofosbuvir|sofosbuvir
258622|NCT01851330|Additional relevant MeSH terms:|additional relevant mesh terms:
258623|NCT01851330|Hepatitis|hepatitis
258624|NCT01851330|Hepatitis, Chronic|hepatitis, chronic
258625|NCT01851330|Hepatitis C|hepatitis c
258626|NCT01851330|Hepatitis C, Chronic|hepatitis c, chronic
258627|NCT01851330|Liver Diseases|liver diseases
258628|NCT01851330|Digestive System Diseases|digestive system diseases
258629|NCT01851330|Hepatitis, Viral, Human|hepatitis, viral, human
258630|NCT01851330|Virus Diseases|virus diseases
258631|NCT01851330|Enterovirus Infections|enterovirus infections
258632|NCT01851330|Picornaviridae Infections|picornaviridae infections
258633|NCT01851330|RNA Virus Infections|rna virus infections
260328|NCT01843504|ultrasound|ultrasound
258634|NCT01851330|Flaviviridae Infections|flaviviridae infections
258635|NCT01851330|Antiviral Agents|antiviral agents
258636|NCT01851330|Anti-Infective Agents|anti-infective agents
258637|NCT01851330|Therapeutic Uses|therapeutic uses
258638|NCT01851330|Pharmacologic Actions|pharmacologic actions
258639|NCT01851330|Antimetabolites|antimetabolites
693909|NCT00942812|Recovery|recovery
258640|NCT01851330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
258641|NCT01851304|beta-Glucans|beta-glucans
258644|NCT01851304|Coffee|coffee
258645|NCT01851304|Gentiana lutea|gentiana lutea
258646|NCT01851304|Melanoidins|melanoidins
258647|NCT01851304|Microencapsulation|microencapsulation
258648|NCT01851278|injection|injection
258649|NCT01851278|arthritis|arthritis
258650|NCT01851278|corticosteroid|corticosteroid
258651|NCT01851265|oncology, cancer, tumour, neoplasm, anticancer drug, food effect, area under the curve, pharmacokinetics, olaparib, solid tumour, metabolites, drug availability|oncology, cancer, tumour, neoplasm, anticancer drug, food effect, area under the curve, pharmacokinetics, olaparib, solid tumour, metabolites, drug availability
258652|NCT01851252|Cirrhotics|cirrhotics
258653|NCT01851252|Esophageal varices|esophageal varices
258654|NCT01851252|Portal Hypertension|portal hypertension
258655|NCT01851239|Venous Thromboembolism Prophylaxis|venous thromboembolism prophylaxis
258656|NCT01851239|ICU|icu
258657|NCT01851213|genomics|genomics
258658|NCT01851213|cancer|cancer
258659|NCT01851213|registry|registry
258660|NCT01851213|neoplasm metastasis|neoplasm metastasis
258661|NCT01851200|Testicular neoplasms|testicular neoplasms
258662|NCT01851200|Germ Cell cancers|germ cell cancers
258663|NCT01851200|Embryonal Carcinoma|embryonal carcinoma
258664|NCT01851200|Metastatic|metastatic
258665|NCT01851200|Brentuximab Vedotin|brentuximab vedotin
258666|NCT01851187|Psychological intervention,|psychological intervention,
258667|NCT01851187|prenatal period,|prenatal period,
258668|NCT01851187|cesarean section rate,|cesarean section rate,
258669|NCT01851187|stage of labor|stage of labor
258670|NCT01851148|osteopathic manipulative treatment|osteopathic manipulative treatment
258671|NCT01851148|migraine|migraine
258672|NCT01851135|Quality of life|quality of life
258673|NCT01851135|Neuropsychological disorders|neuropsychological disorders
258674|NCT01851135|Neurofibromatosis type 1|neurofibromatosis type 1
258675|NCT01851122|l-theanine|l-theanine
258676|NCT01851122|alertness|alertness
258677|NCT01851122|well-being|well-being
258678|NCT01851109|ovarian cancer|ovarian cancer
258679|NCT01851109|prevention|prevention
258680|NCT01851109|prophylactic surgery|prophylactic surgery
258681|NCT01851109|risk|risk
258682|NCT01851109|biomarkers|biomarkers
258683|NCT01851109|screening|screening
258684|NCT01851109|symptoms|symptoms
258685|NCT01851096|Hsp90|hsp90
258686|NCT01851096|SNX-5422|snx-5422
258687|NCT01851096|Erlotinib|erlotinib
258688|NCT01851096|Lung adenocarcinoma|lung adenocarcinoma
258689|NCT01851083|Traumatic Brain Injury|traumatic brain injury
258690|NCT01851083|TBI|tbi
258691|NCT01851083|pediatric|pediatric
258692|NCT01851083|acute|acute
258693|NCT01851083|stem cells|stem cells
258694|NCT01851057|Epilepsy|epilepsy
258695|NCT01851044|Platelet Rich Plasma|platelet rich plasma
258696|NCT01851044|Whole Blood Injection|whole blood injection
258697|NCT01851044|Lateral Epicondylitis|lateral epicondylitis
258698|NCT01851044|Tennis Elbow|tennis elbow
258699|NCT01851031|medial or low condylar fractures|medial or low condylar fractures
258700|NCT01851031|the minor parotid anterior approach|the minor parotid anterior approach
258701|NCT01851031|the retromandibular approach|the retromandibular approach
258702|NCT01851018|Prostate cancer|prostate cancer
258703|NCT01851018|brachytherapy|brachytherapy
258704|NCT01851018|hypofractionated radiation therapy|hypofractionated radiation therapy
258705|NCT01851018|hormonal therapy|hormonal therapy
258706|NCT01851005|Dexmedetomidine|dexmedetomidine
258707|NCT01851005|Anesthesia|anesthesia
258708|NCT01851005|Recovery profile|recovery profile
258709|NCT01850992|Obstructive sleep apnea.|obstructive sleep apnea.
258710|NCT01850992|sleep|sleep
258711|NCT01850992|male hormones|male hormones
258712|NCT01850979|CYCLOSPORINE/TACROLIMUS [VA Drug Interaction]|cyclosporine/tacrolimus [va drug interaction]
258713|NCT01850966|Arthritis, Rheumatoid, Iguratimod|arthritis, rheumatoid, iguratimod
258714|NCT01850953|Varenicline|varenicline
258715|NCT01850953|Schizophrenia|schizophrenia
258716|NCT01850953|smoking|smoking
258717|NCT01850953|Lapse|lapse
258718|NCT01850940|Cirrhotic Patients|cirrhotic patients
258719|NCT01850940|Hyponatremia|hyponatremia
258720|NCT01850940|tolvaptan|tolvaptan
319235|NCT01579396|septeX|septex
258721|NCT01850914|Normal pressure hydrocephalus|normal pressure hydrocephalus
258722|NCT01850914|Vascular risk factors|vascular risk factors
258723|NCT01850901|Hypertension|hypertension
258724|NCT01850901|Renal denervation|renal denervation
258725|NCT01850901|Sympathetic denervation|sympathetic denervation
258726|NCT01850888|neuroblastoma|neuroblastoma
258727|NCT01850888|pheochromocytoma|pheochromocytoma
258728|NCT01850875|Eye-Movement-Desensitization and Reprocessing|eye-movement-desensitization and reprocessing
258729|NCT01850875|EMDR|emdr
258730|NCT01850875|Chronic back pain|chronic back pain
258731|NCT01850875|CBP|cbp
258732|NCT01850875|treatment|treatment
258733|NCT01850836|Aphasia, Stroke, repetitive transcranial magnetic stimulation.|aphasia, stroke, repetitive transcranial magnetic stimulation.
258734|NCT01850797|oral anticoagulants|oral anticoagulants
258735|NCT01850797|ischemic stroke|ischemic stroke
258736|NCT01850797|blood thinner|blood thinner
258737|NCT01850797|intracranial hemorrhage|intracranial hemorrhage
259544|NCT01847287|Natalizumab|natalizumab
258738|NCT01850784|Congenital heart disease, Growth,Neurodevelopment|congenital heart disease, growth,neurodevelopment
258739|NCT01850771|Lumbar Radiculopathy|lumbar radiculopathy
258740|NCT01850771|Disc bulge|disc bulge
258741|NCT01850771|Disc herniation|disc herniation
258742|NCT01850771|Disc degeneration|disc degeneration
258743|NCT01850758|ACL|acl
258744|NCT01850758|Anterior Cruciate Ligament|anterior cruciate ligament
258745|NCT01850758|ACL Tear|acl tear
258746|NCT01850758|Anterior Cruciate Ligament Tear|anterior cruciate ligament tear
258747|NCT01850758|Partial ACL Tear|partial acl tear
258748|NCT01850745|Chronic hepatitis C virus infection (CHC)|chronic hepatitis c virus infection (chc)
258749|NCT01850719|Tibial meniscus|tibial meniscus
258750|NCT01850719|Arthroscopy|arthroscopy
258751|NCT01850719|Meniscectomy|meniscectomy
258752|NCT01850719|Conservative treatment|conservative treatment
258753|NCT01850719|Physical therapy|physical therapy
258754|NCT01850719|Osteoarthritis knee joint|osteoarthritis knee joint
258755|NCT01850706|uNGF|ungf
258756|NCT01850706|urinary nerve growth factor|urinary nerve growth factor
258757|NCT01850706|detrusor overactivity|detrusor overactivity
258758|NCT01850706|InterStim|interstim
258759|NCT01850706|sacral neuromodulation|sacral neuromodulation
258760|NCT01850706|sacral nerve stimulation|sacral nerve stimulation
258761|NCT01850706|quality of life|quality of life
258762|NCT01850706|questionnaire|questionnaire
258763|NCT01850706|urodynamic detrusor overactivity|urodynamic detrusor overactivity
258764|NCT01850706|overactive bladder|overactive bladder
258765|NCT01850693|coronary artery disease|coronary artery disease
258766|NCT01850693|stroke|stroke
258767|NCT01850693|coronary CT angiography|coronary ct angiography
258768|NCT01850667|Hepatocellular carcinoma|hepatocellular carcinoma
258769|NCT01850667|Stereotactic body radiotherapy|stereotactic body radiotherapy
258770|NCT01850667|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
258771|NCT01850654|colorectal cancer|colorectal cancer
258772|NCT01850654|colon cancer|colon cancer
258773|NCT01850654|rectal cancer|rectal cancer
258774|NCT01850654|endometrial cancer|endometrial cancer
258775|NCT01850654|Lynch syndrome|lynch syndrome
258776|NCT01850654|Ohio colon cancer study|ohio colon cancer study
258777|NCT01850654|OSU colon study|osu colon study
258778|NCT01849679|Dysphagia|dysphagia
258779|NCT01849679|extubation|extubation
258780|NCT01849679|aspiration|aspiration
258781|NCT01849653|vaginal swabs|vaginal swabs
258782|NCT01849653|diagnosis|diagnosis
258783|NCT01849640|Malaria|malaria
258784|NCT01849640|Drug resistance|drug resistance
258785|NCT01849640|DHA-piperaquine|dha-piperaquine
258786|NCT01849640|Cambodia|cambodia
258787|NCT01849640|Transmission Blocking|transmission blocking
258788|NCT01849627|weight loss maintenance|weight loss maintenance
258789|NCT01849588|Hepatitis C positive|hepatitis c positive
258791|NCT01849575|Cardiovascular diseases|cardiovascular diseases
258792|NCT01849575|Prevention|prevention
258793|NCT01849575|Risk communication|risk communication
258794|NCT01849575|Risk assessment|risk assessment
258795|NCT01849575|Behavioral change|behavioral change
258796|NCT01849562|Hepatitis C, Chronic|hepatitis c, chronic
258797|NCT01849562|Genotype 1|genotype 1
258798|NCT01849562|Hepatitis C|hepatitis c
258799|NCT01849562|Liver Diseases|liver diseases
258800|NCT01849562|Hepatitis, viral, human|hepatitis, viral, human
258801|NCT01849562|ribavirin|ribavirin
258802|NCT01849562|antiviral agents|antiviral agents
258803|NCT01849562|anti-infective agents|anti-infective agents
258804|NCT01849562|protease inhibitors|protease inhibitors
258805|NCT01849562|NS5a inhibitors|ns5a inhibitors
258806|NCT01849549|neuropsychological Study|neuropsychological study
258807|NCT01849549|brain Imaging|brain imaging
258808|NCT01849536|Open angle glaucoma|open angle glaucoma
258809|NCT01849536|Corneal biomechanics|corneal biomechanics
258810|NCT01849536|Intra ocular pressure|intra ocular pressure
258811|NCT01849536|IOP|iop
258812|NCT01849536|IOP fluctuation|iop fluctuation
258813|NCT01849536|Continuous IOP monitoring|continuous iop monitoring
258814|NCT01849536|SENSIMED Triggerfish®|sensimed triggerfish®
258815|NCT01849523|Neuroendocrine tumor|neuroendocrine tumor
258816|NCT01849523|Website|website
258817|NCT01849523|Information|information
258818|NCT01849523|Psychosocial support|psychosocial support
258819|NCT01849510|spinal metastases|spinal metastases
258820|NCT01849510|vertebral body|vertebral body
258821|NCT01849510|stereotaxis|stereotaxis
258822|NCT01849510|image-guided radiotherapy|image-guided radiotherapy
258823|NCT01849510|hypofractionated|hypofractionated
258824|NCT01849510|dose intensified|dose intensified
258825|NCT01849510|dose elevation|dose elevation
258826|NCT01849497|LDL-C, triglycerides, high cholesterol|ldl-c, triglycerides, high cholesterol
258827|NCT01850641|Hemodialysis|hemodialysis
258828|NCT01850641|Hyperphosphatemia|hyperphosphatemia
258829|NCT01850628|National Surgical Adjuvant Breast and Bowel Project (NSABP)|national surgical adjuvant breast and bowel project (nsabp)
258830|NCT01850628|paclitaxel|paclitaxel
258831|NCT01850628|trastuzumab|trastuzumab
258832|NCT01850628|pertuzumab|pertuzumab
258833|NCT01850628|HER2 positive (human epidermal growth factor receptor 2)|her2 positive (human epidermal growth factor receptor 2)
258834|NCT01850628|Proteomics|proteomics
258835|NCT01850628|Neoadjuvant Therapy|neoadjuvant therapy
258836|NCT01850628|Anthracycline therapy|anthracycline therapy
258837|NCT01850628|Locally advanced|locally advanced
258838|NCT01850628|Operable|operable
258839|NCT01850628|Biomarkers|biomarkers
258840|NCT01850602|Hemodialysis|hemodialysis
258841|NCT01850602|Hyperphosphatemia|hyperphosphatemia
258842|NCT01850576|prevention|prevention
258843|NCT01850576|testing|testing
258844|NCT01850576|counseling|counseling
258845|NCT01850576|linkage|linkage
258846|NCT01850563|Demonstrate coordination of HBO with SRS treatments is feasible.|demonstrate coordination of hbo with srs treatments is feasible.
258847|NCT01850563|Demonstrate outcomes for patients treated with combination of HBO and SRS are non-inferior .|demonstrate outcomes for patients treated with combination of hbo and srs are non-inferior .
258848|NCT01850550|Weight loss|weight loss
258850|NCT01850537|PROW|prow
258851|NCT01850537|FUSION|fusion
258852|NCT01850537|eSPIN|espin
258853|NCT01850537|Cage|cage
258854|NCT01850537|IBF|ibf
258855|NCT01850537|Discectomy|discectomy
258856|NCT01850537|Lumbar Fusion|lumbar fusion
258857|NCT01850537|TLIF|tlif
258858|NCT01850537|MIS|mis
258859|NCT01850524|Newly Diagnosed multiple myeloma|newly diagnosed multiple myeloma
258860|NCT01850524|multiple myeloma|multiple myeloma
258861|NCT01850524|MLN9708|mln9708
258862|NCT01850524|IXAZOMIB|ixazomib
258863|NCT01850524|Proteasome inhibitor|proteasome inhibitor
258864|NCT01850524|Tourmaline MM2|tourmaline mm2
258865|NCT01850511|Nasal obstruction|nasal obstruction
258866|NCT01850511|Vibrissae|vibrissae
258867|NCT01850511|Nasal hair|nasal hair
258868|NCT01850498|Epilepsy|epilepsy
258869|NCT01850498|Seizure|seizure
258870|NCT01850498|Motor|motor
258871|NCT01850498|Motion|motion
258872|NCT01850498|Accelerometer|accelerometer
258873|NCT01850485|cardiac arrest|cardiac arrest
258874|NCT01850485|therapeutic hypothermia|therapeutic hypothermia
258875|NCT01850485|microcirculation|microcirculation
258876|NCT01850472|Anhedonia|anhedonia
258877|NCT01850472|Depression|depression
258878|NCT01850472|Stress|stress
258879|NCT01850472|Cortisol|cortisol
258880|NCT01850472|Inflammatory cytokines|inflammatory cytokines
258881|NCT01850472|Learning|learning
258882|NCT01850472|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
258883|NCT01850433|BDD|bdd
258884|NCT01850433|CBT|cbt
258885|NCT01850420|fibromyalgia|fibromyalgia
258886|NCT01850420|Myofascial|myofascial
258887|NCT01850407|Lack of Preparation for Abused Children during Medical Examination|lack of preparation for abused children during medical examination
258888|NCT01850381|Parkinson Disease|parkinson disease
258889|NCT01850381|Efficacy|efficacy
258891|NCT01850381|Tolerability|tolerability
258892|NCT01850381|Phase 2A|phase 2a
258893|NCT01850381|Pilot trial|pilot trial
258894|NCT01850381|human Motoneuronotrophic Factor|human motoneuronotrophic factor
258895|NCT01850381|neuroprotective agent|neuroprotective agent
258896|NCT01850381|neurodegenerative diseases|neurodegenerative diseases
258897|NCT01850381|rate of clinical progression of PD|rate of clinical progression of pd
258898|NCT01850381|UPDRS|updrs
258899|NCT01850381|Proof of principle|proof of principle
258900|NCT01850368|Hepatocellular carcinoma|hepatocellular carcinoma
258901|NCT01850368|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
258902|NCT01850368|Stereotactic body radiotherapy|stereotactic body radiotherapy
258903|NCT01850368|Portal vein tumor thrombus|portal vein tumor thrombus
258904|NCT01850355|Autism Spectrum Disorders|autism spectrum disorders
258905|NCT01850355|Anxiety|anxiety
258906|NCT01850355|Children|children
258907|NCT01850355|Adolescents|adolescents
258908|NCT01850355|Buspar|buspar
258909|NCT01850355|Buspirone|buspirone
258910|NCT01850355|Pervasive Developmental Disorders|pervasive developmental disorders
258911|NCT01850342|Male stress urinary incontinence|male stress urinary incontinence
258912|NCT01850342|Cell-assisted lipotransfer|cell-assisted lipotransfer
319480|NCT01578317|HV|hv
258913|NCT01850342|Adipose-derived regenerative cells|adipose-derived regenerative cells
258914|NCT01850342|ADRC|adrc
258915|NCT01850342|Micrograft|micrograft
258916|NCT01850342|Fat tissue|fat tissue
258917|NCT01850342|Stem cells|stem cells
258918|NCT01850303|Elderly|elderly
258919|NCT01850303|lung cancer|lung cancer
258920|NCT01850303|switch|switch
258921|NCT01850303|maintenance|maintenance
258922|NCT01850303|Elderly patients (between 70 and 89 years)|elderly patients (between 70 and 89 years)
258923|NCT01850303|NSCLC|nsclc
258924|NCT01850290|TBI|tbi
258925|NCT01850277|Atrial fibrillation|atrial fibrillation
258926|NCT01850277|Cardiac resynchronization therapy|cardiac resynchronization therapy
258927|NCT01850277|Heart failure|heart failure
258928|NCT01850277|Rhythm control strategy|rhythm control strategy
258929|NCT01850264|cardiac resynchronization therapy; heart failure, congestive|cardiac resynchronization therapy; heart failure, congestive
258930|NCT01850251|Hip fractures|hip fractures
258931|NCT01850251|Ageing|ageing
258932|NCT01850251|Sarcopenia|sarcopenia
258933|NCT01850251|Function|function
258934|NCT01850238|Alzheimer disease|alzheimer disease
258935|NCT01850238|tau protein|tau protein
258936|NCT01850238|neurofibrillary degeneration|neurofibrillary degeneration
258937|NCT01850238|disease-modifying|disease-modifying
258938|NCT01850212|Treatment Experienced|treatment experienced
258939|NCT01850212|Male greater than or equal to 50 years|male greater than or equal to 50 years
258940|NCT01850212|Female postmenopausal|female postmenopausal
258941|NCT01850199|Gestational diabetes|gestational diabetes
258942|NCT01850199|Telemedicine|telemedicine
258943|NCT01850199|Artificial Intelligence|artificial intelligence
258944|NCT01850160|Hypertension|hypertension
258945|NCT01850160|High blood pressure|high blood pressure
258946|NCT01850160|Drug therapy combination|drug therapy combination
258947|NCT01850160|Valsartan|valsartan
258948|NCT01850160|Chlorthalidone|chlorthalidone
258949|NCT01850160|Safety|safety
258950|NCT01850160|Efficacy|efficacy
258951|NCT01850147|sunitinib|sunitinib
258952|NCT01850147|chemotherapy|chemotherapy
258953|NCT01850147|non-small cell lung cancer|non-small cell lung cancer
258954|NCT01850147|NSCLC|nsclc
258955|NCT01850121|Ankylosing Spondylitis|ankylosing spondylitis
258956|NCT01850121|infiximab|infiximab
258957|NCT01850121|single armed trial|single armed trial
258958|NCT01850095|acne|acne
258959|NCT01850095|adult|adult
258960|NCT01850095|women|women
258961|NCT01850095|TLR|tlr
258962|NCT01850095|CD1d|cd1d
258963|NCT01850095|androgens|androgens
258964|NCT01850082|Coronary artery disease|coronary artery disease
258965|NCT01850082|CABG|cabg
258966|NCT01850082|Coronary revascularization|coronary revascularization
258967|NCT01850082|Endoscopic vein harvest|endoscopic vein harvest
258968|NCT01850082|Saphenous vein graft|saphenous vein graft
258969|NCT01850082|Graft failure|graft failure
258970|NCT01850069|Intracranial hypertension|intracranial hypertension
258971|NCT01850069|intracranial elastance|intracranial elastance
258972|NCT01850056|drug eluting balloon catheter|drug eluting balloon catheter
258973|NCT01850017|Opiate consumption|opiate consumption
258974|NCT01850017|Visual Analogue Scale|visual analogue scale
258975|NCT01849991|Crying|crying
258976|NCT01849991|Fussiness|fussiness
258977|NCT01849991|Gas|gas
258978|NCT01849991|Hydrogen Breath|hydrogen breath
258979|NCT01849991|Fecal Calprotectin|fecal calprotectin
258980|NCT01849978|breast cancer|breast cancer
258981|NCT01849978|survivor|survivor
258982|NCT01849978|exercise|exercise
258983|NCT01849978|physical activity|physical activity
258984|NCT01849978|strenuous exercise|strenuous exercise
258985|NCT01849978|moderate exercise|moderate exercise
258986|NCT01849978|enjoyable exercise|enjoyable exercise
258987|NCT01849978|enjoy exercise|enjoy exercise
258988|NCT01849978|breast cancer survivor|breast cancer survivor
258989|NCT01849965|diabetic foot ulcers|diabetic foot ulcers
258990|NCT01849965|Wagner Grade 1 or 2 ulcers|wagner grade 1 or 2 ulcers
258992|NCT01849952|miRNA|mirna
258993|NCT01849952|GBM|gbm
258994|NCT01849952|astrocytoma|astrocytoma
258995|NCT01849939|Allogeneic transplantation of hematopoietic stem cells transplantation|allogeneic transplantation of hematopoietic stem cells transplantation
258996|NCT01849939|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
258997|NCT01849939|Donor Lymphocyte Injection|donor lymphocyte injection
258998|NCT01849939|Preemptive immunointervention|preemptive immunointervention
258999|NCT01849913|neck pain|neck pain
259000|NCT01849913|hydrocortisone|hydrocortisone
259001|NCT01849913|stress|stress
259002|NCT01849913|electromyography|electromyography
259003|NCT01849913|adolescent|adolescent
259004|NCT01849913|low-level laser therapy|low-level laser therapy
259005|NCT01849900|Menstrual cycle|menstrual cycle
259006|NCT01849900|Ovulation time|ovulation time
259007|NCT01849900|pregnancy recognition|pregnancy recognition
259008|NCT01849900|Community-based participatory research|community-based participatory research
259009|NCT01849900|Unintended pregnancy|unintended pregnancy
259010|NCT01849861|Cardiopulmonary Capacity|cardiopulmonary capacity
259011|NCT01849861|Ranges of TSH|ranges of tsh
259012|NCT01849861|Elderly Population|elderly population
259013|NCT01849835|rate of positive detection|rate of positive detection
259014|NCT01849822|neural|neural
259015|NCT01849822|prosthetic|prosthetic
259016|NCT01849822|brain machine interface|brain machine interface
259017|NCT01849822|brain computer interface|brain computer interface
259018|NCT01849822|brain control|brain control
259019|NCT01849822|paralysis|paralysis
259020|NCT01849822|tetraplegia|tetraplegia
259021|NCT01849822|quadriplegia|quadriplegia
259022|NCT01849822|spinal cord injury|spinal cord injury
259023|NCT01849796|tDCS|tdcs
259024|NCT01849796|Neuropathic|neuropathic
259025|NCT01849796|Facial|facial
259026|NCT01849796|Pain|pain
259028|NCT01849796|deafferentation|deafferentation
259029|NCT01849796|Trigeminal|trigeminal
259030|NCT01849770|SALS|sals
259031|NCT01849770|Mexiletine|mexiletine
259032|NCT01849770|Safety|safety
259033|NCT01849757|Cardiopulmonary bypass|cardiopulmonary bypass
259034|NCT01849757|prime|prime
259035|NCT01849757|crystalloid|crystalloid
259036|NCT01849757|albumin|albumin
259037|NCT01849757|HES 130/0.4|hes 130/0.4
259038|NCT01849744|Focal Adhesion Kinase inhibitor|focal adhesion kinase inhibitor
259039|NCT01849744|FAK inhibitor|fak inhibitor
259040|NCT01849744|Cancer Stem Cells|cancer stem cells
259041|NCT01849744|CSC|csc
259042|NCT01849731|Diabetes Mellitus type 2;|diabetes mellitus type 2;
259043|NCT01849731|Primary Care, healthcare inequalities;|primary care, healthcare inequalities;
259044|NCT01849731|Diabetes self-management,|diabetes self-management,
259045|NCT01849731|Quality of diabetes care|quality of diabetes care
259046|NCT01849705|Obesity|obesity
259047|NCT01849705|MC4R|mc4r
259048|NCT01849705|Blood pressure|blood pressure
259049|NCT01849705|Blood glucose|blood glucose
259050|NCT01849692|Exudative Age-Related Macular Degeneration|exudative age-related macular degeneration
259051|NCT01849692|Wet AMD|wet amd
259052|NCT01849692|Choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
259053|NCT01849692|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
259054|NCT01849484|meningioma|meningioma
259055|NCT01849484|skull base meningioma|skull base meningioma
259056|NCT01849484|pituitary adenoma|pituitary adenoma
259057|NCT01849484|brain metastases|brain metastases
259058|NCT01849484|small cell lung carcinoma|small cell lung carcinoma
259059|NCT01849471|socioeconomic aspects|socioeconomic aspects
259060|NCT01849471|costs of therapy|costs of therapy
259061|NCT01849471|follow-up costs|follow-up costs
259062|NCT01849471|primary radiation|primary radiation
259063|NCT01849471|percutaneous|percutaneous
259064|NCT01849471|interstitial|interstitial
259065|NCT01849393|Adolescents|adolescents
259066|NCT01849393|Medication Compliance|medication compliance
259067|NCT01849393|Rewards-Based Incentive Programs|rewards-based incentive programs
259068|NCT01849380|Local Advanced Breast Neoplasms|local advanced breast neoplasms
259069|NCT01849380|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
259070|NCT01849380|S-1|s-1
259071|NCT01849341|COPD|copd
259072|NCT01849302|Appetite|appetite
259073|NCT01849302|Satiety hormones|satiety hormones
259074|NCT01849302|Dietary Protein|dietary protein
259075|NCT01849237|Mesenchymal Stromal Cells|mesenchymal stromal cells
259076|NCT01849237|Septic Shock|septic shock
259077|NCT01849237|Neutropenia|neutropenia
259078|NCT01849237|Procalcitonin|procalcitonin
259079|NCT01849237|Interleukin-6|interleukin-6
259080|NCT01849237|Interleukin-10|interleukin-10
259081|NCT01849237|C-reactive protein|c-reactive protein
259082|NCT01849237|Survival|survival
259083|NCT01849237|Organ dysfunction|organ dysfunction
259084|NCT01849224|Lower extremity edema|lower extremity edema
259085|NCT01849224|Lower leg lymphedema|lower leg lymphedema
259086|NCT01849224|Lower leg edema|lower leg edema
259087|NCT01849224|Lymphedema|lymphedema
259088|NCT01849224|Pelvic lymphadenectomy|pelvic lymphadenectomy
259089|NCT01849224|Exercise|exercise
259090|NCT01849211|ventilation|ventilation
259091|NCT01849211|face mask|face mask
259092|NCT01849211|NMBA|nmba
259093|NCT01849198|accelerometry|accelerometry
259094|NCT01849198|neuromuscular block|neuromuscular block
259095|NCT01849198|m. trapezius|m. trapezius
259096|NCT01849185|Hypercholesterolemia|hypercholesterolemia
259097|NCT01849159|Mesenchymal stem cells|mesenchymal stem cells
259098|NCT01849159|Hypoxia|hypoxia
259099|NCT01849159|Emphysema|emphysema
259100|NCT01849133|Breast cancer|breast cancer
259101|NCT01849133|conservative surgery|conservative surgery
259102|NCT01849133|intraoperative radiation therapy|intraoperative radiation therapy
259103|NCT01849133|mobile linear accelerator|mobile linear accelerator
259104|NCT01849120|near infrared spectroscopy (NIRS)|near infrared spectroscopy (nirs)
259105|NCT01849120|EQUANOX Advance 8004CB probes|equanox advance 8004cb probes
259106|NCT01849120|cerebral vascular circulation|cerebral vascular circulation
259107|NCT01849120|peripheral perfusion|peripheral perfusion
259108|NCT01849107|Radiation-induced small bowel toxicity|radiation-induced small bowel toxicity
259109|NCT01849107|Plasma citrulline|plasma citrulline
259110|NCT01849081|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
259111|NCT01849081|Obstructive sleep apnea|obstructive sleep apnea
259112|NCT01849029|Post traumatic Stress Disorders|post traumatic stress disorders
259113|NCT01849029|PTSD|ptsd
259114|NCT01849029|HIV risk|hiv risk
259115|NCT01849029|sexual risk|sexual risk
259116|NCT01849029|substance use|substance use
259117|NCT01849029|alcohol misuse|alcohol misuse
259118|NCT01849029|Substance Abuse|substance abuse
259119|NCT01849029|Substance Addiction|substance addiction
259120|NCT01849029|Substance Dependence|substance dependence
259121|NCT01849029|Substance Use Disorders|substance use disorders
259122|NCT01849029|Alcohol-Related Disorders|alcohol-related disorders
259123|NCT01849029|Binge Drinking|binge drinking
259124|NCT01849029|Sexual Partners|sexual partners
259125|NCT01849029|Sexual Behavior|sexual behavior
259127|NCT01849016|Sickle Cell Disease|sickle cell disease
259128|NCT01849016|Sickle Cell Anemia|sickle cell anemia
259129|NCT01849016|Pain|pain
259130|NCT01849016|N-Acetylcysteine|n-acetylcysteine
259131|NCT01849016|Acetylcysteine|acetylcysteine
259132|NCT01849016|Oxidative stress|oxidative stress
259133|NCT01849003|Long QT Syndrome|long qt syndrome
259134|NCT01849003|LQTS|lqts
259135|NCT01849003|Long QT-3 Syndrome|long qt-3 syndrome
259136|NCT01849003|LQT-3|lqt-3
259137|NCT01849003|prolonged QT interval|prolonged qt interval
259138|NCT01849003|GS-6615|gs-6615
259139|NCT01849003|late sodium current inhibitor|late sodium current inhibitor
259140|NCT01848990|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
259141|NCT01848990|Sub Cutaneous Insulin Infusion|sub cutaneous insulin infusion
259142|NCT01848990|Rapid Acting Analog Insulin|rapid acting analog insulin
259143|NCT01848990|Hylenex|hylenex
259144|NCT01848990|Halozyme|halozyme
259145|NCT01848990|Phase 4|phase 4
259146|NCT01848977|Measures|measures
259147|NCT01848977|near-Infrared spectroscopy|near-infrared spectroscopy
259148|NCT01848977|ischemia|ischemia
259149|NCT01848977|reperfusion|reperfusion
259150|NCT01848964|amputation|amputation
259151|NCT01848964|prosthesis|prosthesis
259152|NCT01848964|stump|stump
259153|NCT01848964|socket|socket
259154|NCT01848964|pressure|pressure
259155|NCT01848964|gait|gait
259156|NCT01848964|posture|posture
259157|NCT01848938|female|female
259158|NCT01848938|stress urinary incontinence|stress urinary incontinence
259159|NCT01848938|treatment|treatment
259160|NCT01848938|pelvic floor muscle training|pelvic floor muscle training
259161|NCT01848938|smartphone|smartphone
259162|NCT01848938|internet|internet
259163|NCT01848938|life style|life style
259164|NCT01848938|eHealth|ehealth
259165|NCT01848925|SANGUINATE|sanguinate
259166|NCT01848899|Coronary angiography|coronary angiography
259167|NCT01848899|Percutaneous coronary intervention|percutaneous coronary intervention
259168|NCT01848899|Contrast media|contrast media
259169|NCT01848899|Platelet activity|platelet activity
259170|NCT01848899|Thrombin generation|thrombin generation
259171|NCT01848899|Fibrinolysis|fibrinolysis
259172|NCT01848886|ERAH|erah
259173|NCT01848886|Endoscopic Radial Artery Harvest|endoscopic radial artery harvest
259174|NCT01848886|Y-graft|y-graft
259175|NCT01848886|Radial Artery Harvest|radial artery harvest
259176|NCT01848886|Total Arterial Revascularisation|total arterial revascularisation
259177|NCT01848886|CABG|cabg
259178|NCT01848886|Radial Artery Conduit|radial artery conduit
259179|NCT01848873|Hyperhomocysteinemia|hyperhomocysteinemia
259180|NCT01848873|Amlodipine-folic acid tablets|amlodipine-folic acid tablets
259181|NCT01848873|Hypertension|hypertension
259182|NCT01848873|MTHFR C677T|mthfr c677t
259183|NCT01848860|Pneumothorax|pneumothorax
259184|NCT01848860|thoracoscopy|thoracoscopy
259185|NCT01848860|mesh|mesh
259186|NCT01848860|pleurodesis|pleurodesis
259187|NCT01848860|treatment|treatment
259188|NCT01848847|Hysteroscopy|hysteroscopy
259189|NCT01848847|Bladder|bladder
259191|NCT01848847|Feasibility|feasibility
259192|NCT01848847|Duration|duration
259193|NCT01848834|PD-1|pd-1
259194|NCT01848834|PD1|pd1
259195|NCT01848834|PD-L1|pd-l1
259196|NCT01848834|PDL1|pdl1
259197|NCT01848821|OASIS ultra|oasis ultra
259198|NCT01848821|faster healing time|faster healing time
259199|NCT01848821|better healing quality|better healing quality
259200|NCT01848821|standard of care|standard of care
259201|NCT01848795|Type 2 Diabetes|type 2 diabetes
259202|NCT01848795|Obesity|obesity
259203|NCT01848795|gastrointestinal hormones|gastrointestinal hormones
259204|NCT01848795|intestinal bypass|intestinal bypass
259205|NCT01848795|endoscopy|endoscopy
259206|NCT01848782|abstract|abstract
259207|NCT01848782|meta-analysis|meta-analysis
259208|NCT01848782|systematic review|systematic review
259209|NCT01848782|interpretation|interpretation
259210|NCT01848782|results|results
259211|NCT01848782|quality|quality
259212|NCT01848782|bias|bias
259213|NCT01848782|spin|spin
249818|NCT01889940|Psychological Distress|psychological distress
249836|NCT01889862|PKU|pku
259214|NCT01848782|limits|limits
259215|NCT01848782|limitation|limitation
259216|NCT01848782|risk of bias|risk of bias
259217|NCT01848769|Asthma|asthma
259218|NCT01848769|ICS+LABA|ics+laba
259219|NCT01848769|Children|children
259220|NCT01848769|Inhalation|inhalation
259221|NCT01848769|pMDI|pmdi
259222|NCT01848756|SNX-5422|snx-5422
259223|NCT01848756|HER2 positive cancer|her2 positive cancer
259224|NCT01848743|tenofovir, lamivudine, hepatitis B, acute exacerbation|tenofovir, lamivudine, hepatitis b, acute exacerbation
259225|NCT01848704|spin|spin
259226|NCT01848704|interpretation|interpretation
259227|NCT01848704|bias|bias
259228|NCT01848652|cerebral lymphoma B cell refractory|cerebral lymphoma b cell refractory
259229|NCT01848652|Myocet|myocet
259230|NCT01848652|efficacy|efficacy
259231|NCT01848652|safety|safety
259232|NCT01848639|chronic kidney disease|chronic kidney disease
259233|NCT01848639|end-stage renal disease|end-stage renal disease
260725|NCT01841476|volunteers|volunteers
259234|NCT01848639|hemodialysis (ESRD)|hemodialysis (esrd)
259235|NCT01848639|cardiovascular morbimortality|cardiovascular morbimortality
259236|NCT01848639|aldosterone antagonist|aldosterone antagonist
259237|NCT01848639|spironolactone|spironolactone
259238|NCT01848600|limitation|limitation
259239|NCT01848600|quality|quality
259240|NCT01848600|bias|bias
259241|NCT01848600|meta-analysis|meta-analysis
259242|NCT01848600|interpretation|interpretation
259243|NCT01848600|abstract|abstract
259244|NCT01848587|Pregnancy|pregnancy
259245|NCT01848587|Acupuncture|acupuncture
259246|NCT01848587|Pelvic and low back pain|pelvic and low back pain
259247|NCT01848587|Impairment|impairment
259248|NCT01848587|Economic evaluation|economic evaluation
259249|NCT01848574|Understanding|understanding
259250|NCT01848574|Patients|patients
259251|NCT01848574|Emergency|emergency
259252|NCT01848574|Information|information
259253|NCT01848561|Inflammatory Bowel Diseases|inflammatory bowel diseases
259254|NCT01848561|Gastroenteritis|gastroenteritis
259255|NCT01848561|Adalimumab|adalimumab
259256|NCT01848561|Ulcerative Colitis|ulcerative colitis
259257|NCT01848561|Registry|registry
259258|NCT01848561|Gastrointestinal Diseases|gastrointestinal diseases
259259|NCT01848561|Colitis|colitis
259260|NCT01848535|intestinal microbiota composition|intestinal microbiota composition
259261|NCT01848535|intestinal microbiota activity|intestinal microbiota activity
259262|NCT01848535|gastro-intestinal complains|gastro-intestinal complains
259263|NCT01848522|qualitative study|qualitative study
259264|NCT01848522|rehabilitation|rehabilitation
259265|NCT01848522|physical therapy|physical therapy
259266|NCT01848522|patient education|patient education
259267|NCT01848522|health care|health care
259268|NCT01848522|administration|administration
259269|NCT01848522|patient satisfaction|patient satisfaction
259270|NCT01848522|handicap|handicap
259271|NCT01848509|CPAP|cpap
259272|NCT01848509|adherence|adherence
259273|NCT01848509|SAOS|saos
259274|NCT01848509|telemedicine|telemedicine
259275|NCT01848483|Early Palliative Care|early palliative care
259276|NCT01848483|Motivational Interviewing|motivational interviewing
259277|NCT01848483|Persons Living With Human immunodeficiency virus(HIV)|persons living with human immunodeficiency virus(hiv)
259278|NCT01848483|Acquired Immunodeficiency Syndrome (AIDS)|acquired immunodeficiency syndrome (aids)
259279|NCT01848457|Osteosarcoma|osteosarcoma
259280|NCT01848457|Cancer|cancer
259281|NCT01848457|Nephrotoxicity|nephrotoxicity
259282|NCT01848457|Ototoxicity|ototoxicity
259283|NCT01848457|Cisplatin|cisplatin
259284|NCT01848457|High-dose methotrexate|high-dose methotrexate
259285|NCT01848457|Biomarkers|biomarkers
259286|NCT01848457|Patient reported outcomes|patient reported outcomes
259287|NCT01848444|Public Health|public health
259288|NCT01848444|Epidemiology|epidemiology
259289|NCT01848444|Pharmacy Toxicology|pharmacy toxicology
259290|NCT01848444|Perinatal period|perinatal period
259291|NCT01848418|ICF|icf
259292|NCT01848418|Core sets|core sets
259293|NCT01848418|Systemic sclerosis|systemic sclerosis
259294|NCT01848418|Function|function
259295|NCT01848418|Evaluation|evaluation
259296|NCT01848392|Cystic fibrosis|cystic fibrosis
259297|NCT01848392|Adults|adults
259298|NCT01848392|Physical activity|physical activity
259299|NCT01848366|Frequency|frequency
259300|NCT01848366|urgency|urgency
259301|NCT01848366|incontinence|incontinence
259302|NCT01848340|mass balance|mass balance
259303|NCT01848340|GSK1265744|gsk1265744
259304|NCT01848340|supratherapeutic|supratherapeutic
259305|NCT01848340|integrase inhibitor|integrase inhibitor
259306|NCT01848340|healthy volunteer|healthy volunteer
259307|NCT01848327|Cognition|cognition
259308|NCT01848327|Neuropsychology|neuropsychology
259309|NCT01848327|Multiple Sclerosis|multiple sclerosis
259310|NCT01848301|Optical Coherence Tomography|optical coherence tomography
259312|NCT01848301|Coronary Allograft Vasculopathy|coronary allograft vasculopathy
259313|NCT01848301|Donor Specific Antibodies|donor specific antibodies
259314|NCT01848301|Acetylcholine|acetylcholine
259315|NCT01848301|Coronary endothelial function|coronary endothelial function
259316|NCT01848301|Brachial Artery Flow Mediated Dilation|brachial artery flow mediated dilation
259317|NCT01848301|Heart transplantation|heart transplantation
259318|NCT01848288|Cataract|cataract
259319|NCT01848288|Phacoemulsification|phacoemulsification
259320|NCT01848288|Cumulative Dissipated Energy (CDE)|cumulative dissipated energy (cde)
259321|NCT01848262|ECALMIST|ecalmist
259322|NCT01848262|InSurE|insure
259323|NCT01848262|CPAP|cpap
259324|NCT01848262|Ventilation|ventilation
259325|NCT01848262|Vascular Catheter|vascular catheter
259326|NCT01848249|deceased donors|deceased donors
259327|NCT01848249|kidney donor|kidney donor
259328|NCT01848249|transplant recipients|transplant recipients
259329|NCT01848249|kidney transplant|kidney transplant
259330|NCT01848249|delayed graft function|delayed graft function
259331|NCT01848249|biomarkers|biomarkers
259332|NCT01848249|end stage renal disease|end stage renal disease
259333|NCT01848249|graft failure|graft failure
259334|NCT01848223|quality of life|quality of life
259335|NCT01848223|QoL|qol
259336|NCT01848223|late menopause|late menopause
259337|NCT01848210|Drug therapy|drug therapy
259338|NCT01848184|PARIETEX Composite Ventral Patch|parietex composite ventral patch
259339|NCT01848184|PCO VP OR PCOVP|pco vp or pcovp
259340|NCT01848184|Primary ventral hernia repair|primary ventral hernia repair
259341|NCT01848184|Panacea|panacea
259342|NCT01848171|Hypothyroidism|hypothyroidism
259343|NCT01848171|Lipid|lipid
259344|NCT01848171|Atherosclerosis|atherosclerosis
259345|NCT01848171|Oxidative Stress|oxidative stress
259346|NCT01848171|Chronic Inflammation|chronic inflammation
259347|NCT01848171|Endothelial Function|endothelial function
259348|NCT01848171|Adipocytokine|adipocytokine
259349|NCT01848171|L-thyroxine|l-thyroxine
259350|NCT01848158|acupuncture|acupuncture
259351|NCT01848158|pediatric|pediatric
259352|NCT01848158|critical care|critical care
259353|NCT01848158|mechanical ventilation|mechanical ventilation
259354|NCT01848158|sedation|sedation
259355|NCT01848158|comfort|comfort
259356|NCT01848145|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
259357|NCT01848145|Ofatumumab|ofatumumab
259358|NCT01848145|Rapid Infusion|rapid infusion
259359|NCT01848132|Lymphoma|lymphoma
259360|NCT01848132|Large B-Cell|large b-cell
259361|NCT01848119|Gabapentin|gabapentin
259362|NCT01848119|Cesarean section|cesarean section
259363|NCT01848106|Percutaneous Coronary Intervention|percutaneous coronary intervention
259364|NCT01848106|Coronary Artery Disease|coronary artery disease
259365|NCT01848106|Acute Coronary Syndrome|acute coronary syndrome
259366|NCT01848106|Regado|regado
259367|NCT01848106|Reg 1|reg 1
259368|NCT01848106|bivalirudin|bivalirudin
259369|NCT01848093|lung|lung
259370|NCT01848093|airway|airway
259371|NCT01848093|pulmonary exacerbation|pulmonary exacerbation
259372|NCT01848093|mucus|mucus
259373|NCT01848080|Telemedicine|telemedicine
259374|NCT01848080|Telerehabilitation|telerehabilitation
259375|NCT01848080|Acute Stroke|acute stroke
259376|NCT01848080|Tai Chi|tai chi
259377|NCT01848080|Tai Ji|tai ji
259378|NCT01848080|Rehabilitation|rehabilitation
259379|NCT01848080|Home care services|home care services
259380|NCT01848080|Single blind method|single blind method
259381|NCT01848080|Randomized controlled trial|randomized controlled trial
259382|NCT01848054|opioid dependence, buprenorphine/naloxone, sublingual|opioid dependence, buprenorphine/naloxone, sublingual
259383|NCT01848041|Blepharoptosis|blepharoptosis
259384|NCT01848041|Ptosis|ptosis
259385|NCT01848028|Patient registry|patient registry
259386|NCT01848028|Germany|germany
259387|NCT01848028|Psoriasis|psoriasis
259388|NCT01848028|psoriatic-arthritis|psoriatic-arthritis
259389|NCT01848028|Efalizumab|efalizumab
259390|NCT01848028|Psonet|psonet
259391|NCT01848028|Effectiveness|effectiveness
259392|NCT01848028|Safety|safety
259393|NCT01848015|CTCs before and after gastrectomy|ctcs before and after gastrectomy
259394|NCT01847976|breast|breast
259395|NCT01847976|bone pain|bone pain
259396|NCT01847963|Urolithiasis|urolithiasis
259397|NCT01847963|Kalladaippu Kudineer|kalladaippu kudineer
259398|NCT01847963|Siddha|siddha
259399|NCT01847963|Sindhuvallathy|sindhuvallathy
259400|NCT01847963|Kidney stones|kidney stones
259401|NCT01847911|self instructed resuscitation training|self instructed resuscitation training
259402|NCT01847898|Osteoporosis|osteoporosis
259403|NCT01847898|Vertebral Body|vertebral body
259404|NCT01847898|Compression Fracture|compression fracture
259405|NCT01847898|Kyphoplasty|kyphoplasty
259406|NCT01847885|electrical stimulation|electrical stimulation
259407|NCT01847885|neurostimulation|neurostimulation
259408|NCT01847885|neuromodulation|neuromodulation
259409|NCT01847885|post-stroke shoulder pain|post-stroke shoulder pain
259410|NCT01847885|hemiplegic shoulder pain|hemiplegic shoulder pain
259411|NCT01847872|Inactivated Poliovirus Vaccine|inactivated poliovirus vaccine
320129|NCT01575691|MDS|mds
259412|NCT01847872|Randomised Control Phase IV Study|randomised control phase iv study
259413|NCT01847872|Gambia|gambia
259414|NCT01847872|IPV|ipv
259415|NCT01847872|Safety and Immunogenicity|safety and immunogenicity
259416|NCT01847872|Non-interference study|non-interference study
259417|NCT01847872|IM Jet injector|im jet injector
259418|NCT01847872|ID Jet Injector|id jet injector
259419|NCT01847859|Cardiothoracic surgery|cardiothoracic surgery
259420|NCT01847859|Post-operative|post-operative
259421|NCT01847859|Nurses|nurses
259422|NCT01847859|Cardiac|cardiac
259423|NCT01847859|Echocardiography|echocardiography
259424|NCT01847859|Pocket-size|pocket-size
259425|NCT01847859|Hand-held|hand-held
259426|NCT01847820|ROM|rom
259427|NCT01847820|PROM|prom
259428|NCT01847820|PPROM (preterm premature rupture of membranes)|pprom (preterm premature rupture of membranes)
259429|NCT01847807|5-10 gram astragalus per day|5-10 gram astragalus per day
259430|NCT01847781|Opsonophagocytic antibodies|opsonophagocytic antibodies
259431|NCT01847781|Cellular immunity|cellular immunity
259432|NCT01847781|Vaccine immunity|vaccine immunity
259433|NCT01847781|Antimicrobial peptides|antimicrobial peptides
259434|NCT01847768|asthma|asthma
259435|NCT01847768|rhinovirus|rhinovirus
259436|NCT01847768|remodeling mediators|remodeling mediators
259437|NCT01847768|human rhinovirus infection|human rhinovirus infection
259438|NCT01847729|Opiate dependence|opiate dependence
259439|NCT01847729|Opiate substitution treatment|opiate substitution treatment
259440|NCT01847729|co-addictions|co-addictions
259441|NCT01847729|Patients addicted to opiates|patients addicted to opiates
259442|NCT01847729|methadone|methadone
259443|NCT01847729|buprenorhine|buprenorhine
259444|NCT01847729|morphine|morphine
259445|NCT01847729|OST in place|ost in place
259446|NCT01847729|pathological gambling|pathological gambling
259447|NCT01847729|pharmacokinetic|pharmacokinetic
259448|NCT01847729|pharmacogenetic|pharmacogenetic
259449|NCT01847729|polymorphism|polymorphism
259450|NCT01847729|cytochrome P450 2D6|cytochrome p450 2d6
259451|NCT01847729|Therapeutic Drug Monitoring|therapeutic drug monitoring
259452|NCT01847716|Muscle weakness|muscle weakness
259453|NCT01847716|Pulmonary arterial hypertension|pulmonary arterial hypertension
259454|NCT01847716|Transforming growth factor beta|transforming growth factor beta
259455|NCT01847716|Growth and differentiation factor 15|growth and differentiation factor 15
259456|NCT01847690|Addison Disease|addison disease
259457|NCT01847677|ovarian cancer|ovarian cancer
259458|NCT01847677|neoadyuvant|neoadyuvant
259459|NCT01847677|bevacizumab|bevacizumab
259460|NCT01847651|hepatic encephalopathy|hepatic encephalopathy
259461|NCT01847651|minimal hepatic encephalopathy|minimal hepatic encephalopathy
259462|NCT01847651|cirrhosis|cirrhosis
259463|NCT01847651|lateral vastus|lateral vastus
259464|NCT01847651|muscle biopsy|muscle biopsy
259465|NCT01847651|L ornithine L aspartate|l ornithine l aspartate
259466|NCT01847651|functional magnetic resonance imaging|functional magnetic resonance imaging
259467|NCT01847651|magnetic resonance spectroscopy|magnetic resonance spectroscopy
259468|NCT01847651|cognitive testing|cognitive testing
259469|NCT01847651|Paper and pencil Hepatic Encephalopathy score (PHES)|paper and pencil hepatic encephalopathy score (phes)
259470|NCT01847651|Cogstate|cogstate
259471|NCT01847651|urine metabonomics|urine metabonomics
259472|NCT01847651|plasma metabonomics|plasma metabonomics
259473|NCT01847651|muscle metabonomics|muscle metabonomics
259474|NCT01847638|Retinal edema|retinal edema
259475|NCT01847638|Cataract|cataract
259476|NCT01847638|inflammation|inflammation
259477|NCT01847612|per operative cholangiography|per operative cholangiography
259478|NCT01847612|liver resection|liver resection
259479|NCT01847612|biliary fistula|biliary fistula
259480|NCT01847599|educational intervention|educational intervention
259481|NCT01847599|adherence|adherence
259482|NCT01847599|capecitabine|capecitabine
259483|NCT01847599|lapatinib|lapatinib
259484|NCT01847586|Alzheimer's Disease|alzheimer's disease
259485|NCT01847586|Brain stimulation|brain stimulation
259486|NCT01847586|transcranial magnetic stimulation|transcranial magnetic stimulation
259487|NCT01847573|halofuginone hydrobromide|halofuginone hydrobromide
259488|NCT01847573|anti-fibrotic|anti-fibrotic
259489|NCT01847573|anti-inflammatory|anti-inflammatory
259490|NCT01847573|muscle regeneration|muscle regeneration
259491|NCT01847573|protein synthesis inhibitor|protein synthesis inhibitor
259492|NCT01847495|Stage IV Colorectal Carcinoma|stage iv colorectal carcinoma
259493|NCT01847495|Liver metastasis|liver metastasis
259495|NCT01847495|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
259496|NCT01847495|SBRT|sbrt
259497|NCT01847495|Irinotecan HCl|irinotecan hcl
259498|NCT01847495|CPT-11|cpt-11
259499|NCT01847482|Cardiac arrest|cardiac arrest
259500|NCT01847482|Return of Spontaneous Circulation (ROSC)|return of spontaneous circulation (rosc)
259501|NCT01847482|IntraVascular Temperature Management (IVTM)|intravascular temperature management (ivtm)
259502|NCT01847482|Therapeutic Hypothermia|therapeutic hypothermia
259503|NCT01847482|Japan|japan
259504|NCT01847469|Alcohol Dependence|alcohol dependence
250140|NCT01888484|PID|pid
259505|NCT01847469|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
259506|NCT01847469|Zonisamide|zonisamide
259507|NCT01847469|Cognitive Processing Therapy (CPT)|cognitive processing therapy (cpt)
259508|NCT01847456|whole body insulin sensitivity|whole body insulin sensitivity
259509|NCT01847456|insulin action in the brain|insulin action in the brain
259510|NCT01847443|nicotine|nicotine
259511|NCT01847443|nicotine replacement therapy|nicotine replacement therapy
259512|NCT01847443|nicotine gum|nicotine gum
259513|NCT01847430|Healthy|healthy
259514|NCT01847430|Hepatitis B|hepatitis b
259515|NCT01847430|Adolescents|adolescents
259516|NCT01847430|Engerix™-B Kinder|engerix™-b kinder
259517|NCT01847417|Acetylsalicylic acid|acetylsalicylic acid
259518|NCT01847417|Pantoprazole|pantoprazole
259519|NCT01847417|Fixed dose combination|fixed dose combination
259520|NCT01847404|Fixed dose combination|fixed dose combination
259521|NCT01847404|Acetylsalicylic acid|acetylsalicylic acid
259522|NCT01847404|Pantoprazole|pantoprazole
259523|NCT01847391|Ischemic Heart Disease|ischemic heart disease
259524|NCT01847391|Heart Disease|heart disease
259525|NCT01847378|ventricular tachycardia|ventricular tachycardia
259526|NCT01847378|catheter ablation|catheter ablation
259527|NCT01847378|chagas disease|chagas disease
259528|NCT01847378|epicardial mapping|epicardial mapping
259529|NCT01847378|magnetic resonance imaging|magnetic resonance imaging
259530|NCT01847365|Retinitis Pigmentosa|retinitis pigmentosa
261227|NCT01839227|elderly|elderly
259535|NCT01847352|Iron deficiency|iron deficiency
259536|NCT01847352|Hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
259537|NCT01847300|alcohol abuse|alcohol abuse
259538|NCT01847300|tobacco dependence|tobacco dependence
259539|NCT01847300|substance abuse|substance abuse
259540|NCT01847300|SBIRT|sbirt
259541|NCT01847287|Multiple sclerosis|multiple sclerosis
259545|NCT01847274|ovarian cancer|ovarian cancer
259546|NCT01847274|platinum sensitive|platinum sensitive
259547|NCT01847274|gBRCAmut|gbrcamut
259548|NCT01847274|BRCA|brca
259549|NCT01847274|high-grade serous histology|high-grade serous histology
259550|NCT01847274|PARP inhibitor|parp inhibitor
259551|NCT01847261|soy|soy
259552|NCT01847261|whey|whey
259553|NCT01847261|muscle|muscle
259554|NCT01847261|older|older
259555|NCT01847261|mTOR|mtor
259556|NCT01847261|sarcopenia|sarcopenia
259557|NCT01847248|sepsis|sepsis
259558|NCT01847248|biomarker|biomarker
259559|NCT01847248|HSPA12B|hspa12b
259560|NCT01847235|Temozolomide|temozolomide
259561|NCT01847209|lung nodule|lung nodule
259562|NCT01847209|lung cancer|lung cancer
259563|NCT01847209|lung mass|lung mass
259564|NCT01847196|Pulmonary Embolism|pulmonary embolism
259565|NCT01847196|PE|pe
259566|NCT01847196|DVT|dvt
259567|NCT01847196|Deep Vein Thrombosis|deep vein thrombosis
259568|NCT01847196|VTE|vte
259569|NCT01847196|Venous Thromboembolism|venous thromboembolism
259570|NCT01847196|prophylaxis|prophylaxis
259571|NCT01847196|thromboprophylaxis|thromboprophylaxis
259572|NCT01847196|contraindications to thromboprophylaxis|contraindications to thromboprophylaxis
259573|NCT01847196|prophylactic|prophylactic
259574|NCT01847196|prevention|prevention
259575|NCT01847196|Inferior vena cava filter|inferior vena cava filter
259576|NCT01847196|IVC filter|ivc filter
259577|NCT01847196|filter|filter
259578|NCT01847196|prevention of pulmonary embolism|prevention of pulmonary embolism
259579|NCT01847196|trauma|trauma
259580|NCT01847196|critically-ill|critically-ill
259581|NCT01847183|heavy drinking|heavy drinking
259582|NCT01847183|prevention|prevention
259583|NCT01847183|high school|high school
259584|NCT01847183|adolescence|adolescence
259585|NCT01847157|recovery of function|recovery of function
259586|NCT01847157|stroke|stroke
259587|NCT01847157|Upper extremity|upper extremity
259588|NCT01847157|Motor|motor
259589|NCT01847157|transcranial direct current stimulation|transcranial direct current stimulation
259590|NCT01847131|Rhinitis|rhinitis
259591|NCT01847131|Oxymetazoline|oxymetazoline
259592|NCT01847092|albuminuria|albuminuria
259593|NCT01847066|wrinkles|wrinkles
259594|NCT01847066|acne scars|acne scars
259595|NCT01847066|pigmentation|pigmentation
259596|NCT01847053|Cinnamon|cinnamon
259597|NCT01847053|Bioavailability|bioavailability
259598|NCT01847053|Glucose|glucose
259599|NCT01847053|Proanthocyanidins|proanthocyanidins
259600|NCT01847040|Traumatic Brain Injury|traumatic brain injury
259601|NCT01847040|Epidemiology|epidemiology
259602|NCT01847040|Concussion|concussion
259603|NCT01847040|Outcomes|outcomes
259604|NCT01847040|PTSD|ptsd
259605|NCT01847040|Prospective|prospective
259606|NCT01847040|Longitudinal|longitudinal
259607|NCT01847040|Military|military
259608|NCT01847040|Symptoms|symptoms
259609|NCT01847040|Validation|validation
259610|NCT01847040|Screening|screening
259611|NCT01847040|Mild Traumatic Brain Injury|mild traumatic brain injury
259612|NCT01847027|Healthy|healthy
259613|NCT01847027|Stem cells|stem cells
259614|NCT01847027|Aging|aging
259615|NCT01847027|Increase stem cell replacement|increase stem cell replacement
259616|NCT01847027|decreased stem cell proliferation|decreased stem cell proliferation
259617|NCT01847014|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
259618|NCT01847014|psychometric instrument|psychometric instrument
259619|NCT01847014|PAH-SYMPACT|pah-sympact
259625|NCT01846988|Obstructive Sleep Apnea|obstructive sleep apnea
259626|NCT01846988|Pediatric Obstructive Sleep Apnea|pediatric obstructive sleep apnea
259627|NCT01846988|Auto PAP|auto pap
259628|NCT01846988|Auto-adjustable Positive Airway Pressure|auto-adjustable positive airway pressure
259629|NCT01846988|APAP|apap
259630|NCT01846988|CPAP|cpap
259631|NCT01846975|Abatacept|abatacept
259632|NCT01846975|Low disease activity|low disease activity
259633|NCT01846975|Intravenous|intravenous
259634|NCT01846975|Subcutaneous|subcutaneous
259635|NCT01846975|Rheumatoid arthritis|rheumatoid arthritis
259636|NCT01846962|Eosinophilic esophagitis (EoE)|eosinophilic esophagitis (eoe)
259637|NCT01846962|budesonide|budesonide
259638|NCT01846962|fluticasione|fluticasione
259639|NCT01846962|six-foods elimination diet|six-foods elimination diet
259640|NCT01846936|one lung ventilation|one lung ventilation
259641|NCT01846936|efficacy|efficacy
259642|NCT01846936|bronchial blocker|bronchial blocker
259643|NCT01846910|Cessation|cessation
259644|NCT01846845|Amputee|amputee
259645|NCT01846832|Hepatitis C, Chronic|hepatitis c, chronic
259646|NCT01846832|Infection|infection
259647|NCT01846832|Triple therapy|triple therapy
259648|NCT01846832|TMC435|tmc435
259649|NCT01846832|simeprevir|simeprevir
259650|NCT01846832|Pegylated interferon alfa-2a (PegIFNα-2a)|pegylated interferon alfa-2a (pegifnα-2a)
259651|NCT01846832|ribavirin (RBV)|ribavirin (rbv)
259652|NCT01846832|PEGASYS|pegasys
259653|NCT01846832|COPEGUS|copegus
259654|NCT01846806|Hepatic Encephalopathy|hepatic encephalopathy
259655|NCT01846793|Benign prostatic hyperplasia|benign prostatic hyperplasia
259656|NCT01846793|BPH|bph
259657|NCT01846793|Lower urinary tract symptoms|lower urinary tract symptoms
259658|NCT01846793|LUTS|luts
259659|NCT01846793|LUTS secondary to BPH|luts secondary to bph
259660|NCT01846793|LUTS/BPH|luts/bph
259661|NCT01846793|Benign prostatic obstruction (BPO)|benign prostatic obstruction (bpo)
259662|NCT01846793|BPO|bpo
259663|NCT01846793|Bladder outlet obstruction|bladder outlet obstruction
259664|NCT01846793|BOO|boo
259665|NCT01846767|13CO2|13co2
259666|NCT01846767|Breath test|breath test
259667|NCT01846767|Glucose oxidation|glucose oxidation
259668|NCT01846767|Diabetes mellitus|diabetes mellitus
259669|NCT01846754|Hemodialysis|hemodialysis
259670|NCT01846754|Fatigue|fatigue
259671|NCT01846754|Muscle strength|muscle strength
259672|NCT01846754|Metabolomics|metabolomics
259673|NCT01846741|Automatic Magnet Mode (AMM)|automatic magnet mode (amm)
259674|NCT01846741|Vagus Nerve Stimulation (VNS)|vagus nerve stimulation (vns)
259675|NCT01846715|Kidney disease|kidney disease
259676|NCT01846715|Renal insufficiency|renal insufficiency
259677|NCT01846715|CKD|ckd
259678|NCT01846715|Autologous cell therapy|autologous cell therapy
259679|NCT01846676|Hearing loss, rehabilitation programs, adherence to hearing aids.|hearing loss, rehabilitation programs, adherence to hearing aids.
259680|NCT01846663|Hepatic Encephalopathy|hepatic encephalopathy
259681|NCT01846663|Liver Failure|liver failure
259682|NCT01846663|Hepatic Insufficiency|hepatic insufficiency
259683|NCT01846663|Liver Diseases|liver diseases
259684|NCT01846663|Brain Diseases|brain diseases
259685|NCT01846663|Rifaximin|rifaximin
259686|NCT01846663|Cirrhosis|cirrhosis
259687|NCT01846611|Ovarian neoplasms|ovarian neoplasms
259688|NCT01846611|Peritoneal neoplasms|peritoneal neoplasms
259689|NCT01846611|Fallopian tube neoplasms|fallopian tube neoplasms
259690|NCT01846611|Advanced-relapsed epithelial ovarian cancer|advanced-relapsed epithelial ovarian cancer
259691|NCT01846611|Advanced-relapsed primary peritoneal cancer|advanced-relapsed primary peritoneal cancer
259692|NCT01846611|Advanced-relapsed fallopian tube cancer|advanced-relapsed fallopian tube cancer
259693|NCT01846611|Trabectedin|trabectedin
259694|NCT01846611|Yondelis|yondelis
259695|NCT01846611|Doxil|doxil
259696|NCT01846611|Caelyx|caelyx
259697|NCT01846611|Platinum sensitive|platinum sensitive
259698|NCT01846611|Tthird-line|tthird-line
259699|NCT01846611|BRCA|brca
259700|NCT01846611|Patient related outcome|patient related outcome
259701|NCT01846572|Stroke|stroke
259702|NCT01846572|Clopidogrel|clopidogrel
259703|NCT01846572|Aggregometry|aggregometry
259707|NCT01846546|Traumatic brain injury;|traumatic brain injury;
259708|NCT01846546|Endostatin/collagen XVIII;|endostatin/collagen xviii;
259709|NCT01846546|Cerebrospinal fluid;|cerebrospinal fluid;
259711|NCT01846507|Heavy Menstrual Bleeding|heavy menstrual bleeding
259712|NCT01846507|HMB|hmb
259713|NCT01846507|Lysteda|lysteda
259714|NCT01846481|Cocaine|cocaine
259715|NCT01846468|Healthy volunteers and patients,|healthy volunteers and patients,
259716|NCT01846468|renal insufficiency,|renal insufficiency,
259717|NCT01846455|Hepatic|hepatic
259718|NCT01846455|Hepatitis C Virus|hepatitis c virus
259719|NCT01846455|Suboxone|suboxone
259720|NCT01846455|Buprenorphine|buprenorphine
259721|NCT01846455|Naloxone|naloxone
259722|NCT01846442|Vulvar/vaginal atrophy|vulvar/vaginal atrophy
259723|NCT01846442|Atrophic Vaginitis|atrophic vaginitis
259724|NCT01846442|Dehydroepiandrosterone|dehydroepiandrosterone
259725|NCT01846442|DHEA|dhea
259726|NCT01846442|Prasterone|prasterone
259727|NCT01846442|Vaginorm|vaginorm
259728|NCT01846442|Menopause|menopause
259729|NCT01846442|Intrarosa|intrarosa
259730|NCT01846429|cancer|cancer
259731|NCT01846429|pain fibers|pain fibers
259732|NCT01846429|acid levels|acid levels
259733|NCT01846429|tumor related pain|tumor related pain
259734|NCT01846429|cancer related pain|cancer related pain
259735|NCT01846429|sodium bicarbonate|sodium bicarbonate
259736|NCT01846429|pain reliever|pain reliever
259737|NCT01846429|metastatic|metastatic
259738|NCT01846429|unresectable|unresectable
259739|NCT01846429|solid malignancy|solid malignancy
259740|NCT01846429|hematologic malignancy|hematologic malignancy
259741|NCT01846429|multiple myeloma|multiple myeloma
259742|NCT01846429|lymphoma|lymphoma
259743|NCT01846377|video game|video game
259745|NCT01846377|physical activity|physical activity
259746|NCT01846377|sedentary behavior|sedentary behavior
259747|NCT01846377|obesity|obesity
259748|NCT01846377|diabetes|diabetes
259749|NCT01846364|Thyroid|thyroid
259750|NCT01846364|DIM|dim
259751|NCT01846351|choroidal neovascularization|choroidal neovascularization
259752|NCT01846351|epiretinal membrane|epiretinal membrane
259753|NCT01846351|anti-VEGF|anti-vegf
259754|NCT01846338|acne, EGCG, green tea|acne, egcg, green tea
259755|NCT01846299|Vision Impairment|vision impairment
259756|NCT01846286|Neuropathic Pain|neuropathic pain
259757|NCT01846286|Squamous cell cancer of the head and neck|squamous cell cancer of the head and neck
259758|NCT01846286|acute pain|acute pain
259759|NCT01846286|pain management|pain management
259760|NCT01846286|genome-wide analyses|genome-wide analyses
259860|NCT01845688|Randomized Control Trial|randomized control trial
259761|NCT01846286|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
259762|NCT01846286|chronic pain|chronic pain
259763|NCT01846286|neuropathic|neuropathic
259764|NCT01846286|locoregional squamous cell carcinoma of the head and neck|locoregional squamous cell carcinoma of the head and neck
259765|NCT01846247|stroke|stroke
259766|NCT01846234|Multiple Sclerosis|multiple sclerosis
259767|NCT01846234|Salt|salt
259768|NCT01846221|Analgesia|analgesia
259769|NCT01846221|Epidural|epidural
259770|NCT01846221|Pregnancy|pregnancy
259771|NCT01846221|Labor|labor
259772|NCT01846221|Clonidine|clonidine
259773|NCT01846221|Fentanyl|fentanyl
259774|NCT01846221|Bupivacaine|bupivacaine
259775|NCT01846221|Childbirth|childbirth
259776|NCT01846208|Egg Allergy|egg allergy
259777|NCT01846208|Egg Oral Immunotherapy|egg oral immunotherapy
259778|NCT01846208|Food Allergy|food allergy
259779|NCT01846195|blood loss|blood loss
259780|NCT01846182|Gulf War Illness|gulf war illness
259781|NCT01846182|Pregabalin|pregabalin
259782|NCT01846182|Duloxetine|duloxetine
259783|NCT01846182|Gulf War Veterans|gulf war veterans
259784|NCT01846182|Cymbalta|cymbalta
259785|NCT01846182|Lyrica|lyrica
259786|NCT01846169|food insecurity|food insecurity
259787|NCT01846169|older adults|older adults
259788|NCT01846169|nutrition|nutrition
259789|NCT01846169|food deliveries|food deliveries
259790|NCT01846156|convulsion rate|convulsion rate
259791|NCT01846130|Bed rest,|bed rest,
259792|NCT01846117|lignans|lignans
259793|NCT01846117|oxidative stress|oxidative stress
259794|NCT01846117|inflammation|inflammation
259795|NCT01846117|aging|aging
259796|NCT01846117|muscle weakness|muscle weakness
259797|NCT01846117|pain|pain
259798|NCT01846052|achromatopsia, CNGB3|achromatopsia, cngb3
259799|NCT01846013|Sit-Stand Workstations|sit-stand workstations
259800|NCT01846013|Increase Workplace Physical Activity|increase workplace physical activity
259801|NCT01846000|temporomandibular joint|temporomandibular joint
259802|NCT01846000|temporomandibular disorder|temporomandibular disorder
259803|NCT01846000|electromyography|electromyography
259804|NCT01846000|low-level laser therapy|low-level laser therapy
259805|NCT01845987|Palmoplantaris Pustulosis|palmoplantaris pustulosis
259806|NCT01845987|CNTO 1959|cnto 1959
259807|NCT01845987|Psoriasis|psoriasis
259808|NCT01845987|Anti-IL 23 Monoclonal Antibody|anti-il 23 monoclonal antibody
259809|NCT01845974|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
259810|NCT01845974|Atrial Fibrillation|atrial fibrillation
259811|NCT01845948|parents|parents
259812|NCT01845948|school transition|school transition
259813|NCT01845948|parental-child relationship|parental-child relationship
259814|NCT01845935|Cryoablation|cryoablation
259815|NCT01845935|Venous vascular malformation|venous vascular malformation
259816|NCT01845935|MRI|mri
259817|NCT01845935|safety|safety
259818|NCT01845935|pain|pain
259819|NCT01845922|Refeeding Syndrome|refeeding syndrome
259820|NCT01845922|low sodium|low sodium
259821|NCT01845922|slowly absorbed carbohydrates|slowly absorbed carbohydrates
320656|NCT01573429|HV|hv
259822|NCT01845922|hypopotassemia|hypopotassemia
259823|NCT01845922|hypophosphatemia|hypophosphatemia
259824|NCT01845909|Sudden cardiac death|sudden cardiac death
259825|NCT01845909|Young adults|young adults
259826|NCT01845909|Cardiac Disease|cardiac disease
259827|NCT01845909|Arrhythmia|arrhythmia
259828|NCT01845909|Sports|sports
259829|NCT01845896|high intensity interval training|high intensity interval training
259830|NCT01845896|combined training|combined training
259831|NCT01845896|insulin resistance|insulin resistance
259832|NCT01845896|muscle contractile properties|muscle contractile properties
259833|NCT01845857|Long term health problems|long term health problems
259834|NCT01845857|chronic disease|chronic disease
259835|NCT01845831|Diabetes|diabetes
259836|NCT01845831|DPP4 inhibitors|dpp4 inhibitors
259837|NCT01845831|Sitagliptin|sitagliptin
259838|NCT01845831|Glargine|glargine
259839|NCT01845831|RCT|rct
259840|NCT01845831|basal insulin|basal insulin
259841|NCT01845831|hospital hyperglycemia|hospital hyperglycemia
259842|NCT01845831|inpatient diabetes|inpatient diabetes
259843|NCT01845818|work productivity|work productivity
259844|NCT01845818|multicenter study|multicenter study
259845|NCT01845792|Metastatic Castrate Resistant Prostate Cancer|metastatic castrate resistant prostate cancer
259846|NCT01845766|sepsis, septic shock, rehabilitation, exercise|sepsis, septic shock, rehabilitation, exercise
259847|NCT01845740|systemic lupus erythematoses|systemic lupus erythematoses
259848|NCT01845740|lupus|lupus
259849|NCT01845740|SLE|sle
259850|NCT01845727|Cutaneous leishmaniasis|cutaneous leishmaniasis
259851|NCT01845727|Topical treatment|topical treatment
259852|NCT01845727|Colombia|colombia
259853|NCT01845714|Keratoconus|keratoconus
259854|NCT01845714|Corneal cross Linking|corneal cross linking
259855|NCT01845714|Topo guided PRK|topo guided prk
259856|NCT01845714|Quality of Life|quality of life
259857|NCT01845701|malaria, cure rate, efficacy, safety|malaria, cure rate, efficacy, safety
259858|NCT01845688|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
259859|NCT01845688|Traditional Chinese Medicine|traditional chinese medicine
259861|NCT01845675|temozolomide|temozolomide
259862|NCT01845675|endostatin|endostatin
259863|NCT01845675|advanced|advanced
259864|NCT01845675|well-differentiated|well-differentiated
259865|NCT01845675|pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
259866|NCT01845662|splenectomy|splenectomy
259867|NCT01845662|embolization|embolization
259868|NCT01845662|observation|observation
259869|NCT01845662|blood transfusion|blood transfusion
259870|NCT01845649|Vulvovaginal Atrophy|vulvovaginal atrophy
259871|NCT01845649|Dyspareunia|dyspareunia
259872|NCT01845649|Postmenopausal|postmenopausal
259873|NCT01845636|Olfaction|olfaction
259874|NCT01845636|Donepezil|donepezil
259875|NCT01845636|Alzheimer's Disease|alzheimer's disease
259876|NCT01845636|Mild Cognitive Impairment|mild cognitive impairment
259877|NCT01845636|Memory|memory
259878|NCT01845623|Asthma|asthma
259879|NCT01845623|Indacaterol|indacaterol
259880|NCT01845623|QAB149|qab149
259881|NCT01845584|IVIG in Neuromyelitis Optica spectrum disorder|ivig in neuromyelitis optica spectrum disorder
259882|NCT01845584|Patients with Neuromyelitis Optica spectrum disorder|patients with neuromyelitis optica spectrum disorder
259883|NCT01845558|Muscle soreness|muscle soreness
259884|NCT01845558|Exercise induced muscle damage|exercise induced muscle damage
259885|NCT01845558|Inflammation|inflammation
259886|NCT01845558|Proteolytic enzymes|proteolytic enzymes
259887|NCT01845558|Muscle strength Dynamometer|muscle strength dynamometer
259888|NCT01845545|microfinance|microfinance
259889|NCT01845545|under five mortality|under five mortality
259890|NCT01845545|underweight|underweight
259891|NCT01845545|malnutrition|malnutrition
259892|NCT01845506|wireless pressure sensor|wireless pressure sensor
259893|NCT01845506|Elderly|elderly
259894|NCT01845493|asthma|asthma
259895|NCT01845493|Asthmatics|asthmatics
259896|NCT01845493|allergic|allergic
259897|NCT01845493|allergies|allergies
259898|NCT01845480|health promotion|health promotion
259899|NCT01845480|obesity prevention|obesity prevention
259900|NCT01845480|Childhood obesity|childhood obesity
259901|NCT01845480|home-based|home-based
259902|NCT01845480|Lifestyle intervention|lifestyle intervention
259903|NCT01845480|Body composition|body composition
259904|NCT01845480|quality of life|quality of life
259905|NCT01845480|physical activity|physical activity
259906|NCT01845480|nutrition|nutrition
259907|NCT01845467|Secretin MRCP, diagnosis, Autoimmune pancreatitis|secretin mrcp, diagnosis, autoimmune pancreatitis
259908|NCT01845454|Barrett's Esophagus|barrett's esophagus
259909|NCT01845454|Spray cryotherapy|spray cryotherapy
259910|NCT01845441|Dexmedetomidine|dexmedetomidine
259911|NCT01845441|Endovascular procedure|endovascular procedure
259912|NCT01845441|Stroke|stroke
259913|NCT01845441|Vasospasm, intracranial|vasospasm, intracranial
259914|NCT01845441|Conscious sedation|conscious sedation
259915|NCT01845428|nephrotic|nephrotic
259916|NCT01845428|hyperlipidemia|hyperlipidemia
259917|NCT01845428|oxLDL|oxldl
259918|NCT01845428|kidney|kidney
259919|NCT01845402|Kidney Failure, Chronic|kidney failure, chronic
259920|NCT01845402|Adolescent|adolescent
259921|NCT01845402|Heart Defects, Congenital|heart defects, congenital
259922|NCT01845389|Anesthesia|anesthesia
259923|NCT01845389|Regional|regional
259924|NCT01845389|Epidural|epidural
259925|NCT01845389|Continuous spinal|continuous spinal
259926|NCT01845389|Wiley Catheter|wiley catheter
259927|NCT01845389|Geriatric|geriatric
259928|NCT01845389|TURP|turp
259929|NCT01845376|Inflammatory Markers after Inguinal Hernia Repair|inflammatory markers after inguinal hernia repair
259930|NCT01845376|Anesthetic technique for hernia repair|anesthetic technique for hernia repair
259931|NCT01845363|Obesity|obesity
259932|NCT01845363|Bariatric surgery|bariatric surgery
259933|NCT01845363|Cefazolin|cefazolin
694013|NCT00943150|Medtronic|medtronic
259934|NCT01845363|antimicrobial prophylaxis|antimicrobial prophylaxis
259935|NCT01845363|administration and dosage|administration and dosage
259936|NCT01845324|Pregnancy|pregnancy
259937|NCT01845324|Diabetes Mellitus|diabetes mellitus
259938|NCT01845285|transcatheter valve replacement|transcatheter valve replacement
259939|NCT01845285|aortic valve disease|aortic valve disease
259940|NCT01845285|aortic stenosis|aortic stenosis
259941|NCT01845285|Aortic regurgitation,catheter|aortic regurgitation,catheter
259942|NCT01845285|Effective orifice area|effective orifice area
259943|NCT01845246|Colistin|colistin
259944|NCT01845246|Polymyxins|polymyxins
259945|NCT01845246|Therapeutic drug monitoring|therapeutic drug monitoring
259946|NCT01845246|Multi Drug resistant Gram negative bacterial infections|multi drug resistant gram negative bacterial infections
259947|NCT01845220|Broccoli sprouts|broccoli sprouts
259948|NCT01845220|alcohol sensitivity|alcohol sensitivity
259949|NCT01845220|sulforaphane|sulforaphane
259950|NCT01845220|alcohol metabolism|alcohol metabolism
259951|NCT01845220|in the Asian Community|in the asian community
259952|NCT01845207|Aortic stenosis|aortic stenosis
259953|NCT01845207|Aortic valve replacement|aortic valve replacement
259954|NCT01845207|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
259955|NCT01845207|Outcomes|outcomes
259956|NCT01845207|Frailty|frailty
259957|NCT01845207|Elderly|elderly
259958|NCT01845194|pharmacokinetic|pharmacokinetic
259959|NCT01845194|heritability|heritability
259960|NCT01845194|drug membrane transport|drug membrane transport
259961|NCT01845194|drug biotransformation|drug biotransformation
259962|NCT01845181|Adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
259963|NCT01845181|Asthma|asthma
259964|NCT01845181|adenosine receptor modulator|adenosine receptor modulator
259965|NCT01845181|COPD|copd
259966|NCT01845168|Bleeding peptic ulcer|bleeding peptic ulcer
259967|NCT01845168|NSAID and Aspirin|nsaid and aspirin
259968|NCT01845168|Computer-alert|computer-alert
259969|NCT01845168|General practitioner|general practitioner
259970|NCT01845155|Tinnitus|tinnitus
259971|NCT01845155|music therapy|music therapy
259972|NCT01845155|directive counselling|directive counselling
259973|NCT01845155|acoustic stimulation|acoustic stimulation
259974|NCT01845155|group comparison|group comparison
259975|NCT01845155|subjective evaluation|subjective evaluation
259976|NCT01845155|pitch|pitch
259977|NCT01845142|vitamin D|vitamin d
259978|NCT01845142|vitamin D deficiency|vitamin d deficiency
259979|NCT01845142|immune cells|immune cells
259980|NCT01845142|pharmacokinetic|pharmacokinetic
259981|NCT01845142|< 50 nmol/L 25(OH)D serum concentration|< 50 nmol/l 25(oh)d serum concentration
259982|NCT01845116|PNALD|pnald
259983|NCT01845116|Cholestasis|cholestasis
259984|NCT01845116|Omegaven®|omegaven®
259985|NCT01845116|Short Bowel Syndrome|short bowel syndrome
259986|NCT01845103|ANGINA|angina
259987|NCT01845103|Thoracoscopic|thoracoscopic
259988|NCT01845064|type 2 diabetes|type 2 diabetes
259989|NCT01845064|diabetes mellitus|diabetes mellitus
259990|NCT01845064|type 2 diabetes mellitus|type 2 diabetes mellitus
259991|NCT01845064|HbA1c|hba1c
259992|NCT01845064|blood glucose|blood glucose
259993|NCT01845064|glucose control|glucose control
259994|NCT01845064|DiaMedica|diamedica
259995|NCT01845064|DM-199|dm-199
259996|NCT01845064|DM199|dm199
259997|NCT01845064|recombinant human tissue kallikrein-1|recombinant human tissue kallikrein-1
259998|NCT01845064|tissue kallikrein-1|tissue kallikrein-1
259999|NCT01845051|Migraine|migraine
260000|NCT01845051|allergic rhinitis|allergic rhinitis
260001|NCT01845051|Specific Immunoglobulin E (IgE)|specific immunoglobulin e (ige)
260002|NCT01845051|nasal symptoms|nasal symptoms
260003|NCT01845051|signs of allergy.|signs of allergy.
260004|NCT01845025|Asthma|asthma
260005|NCT01845025|formoterol fumarate|formoterol fumarate
260006|NCT01845025|Foradil|foradil
260007|NCT01845025|inhaled corticosteroid|inhaled corticosteroid
260008|NCT01845025|fluticasone propionate|fluticasone propionate
260009|NCT01845025|safety|safety
260010|NCT01845012|Short daily hemodialysis|short daily hemodialysis
260011|NCT01845012|Low dialysate flow|low dialysate flow
260012|NCT01845012|End stage renal disease|end stage renal disease
260013|NCT01844999|Prostate cancer|prostate cancer
260014|NCT01844999|Decision|decision
260015|NCT01844986|BRCA|brca
260016|NCT01844986|Ovarian Cancer|ovarian cancer
260017|NCT01844986|Chemotherapy|chemotherapy
260018|NCT01844986|PARP inhibitor|parp inhibitor
260019|NCT01844986|First Line|first line
260020|NCT01844986|FIGO Stage III|figo stage iii
260021|NCT01844986|FIGO Stage IV|figo stage iv
260022|NCT01844960|Single Incision Surgery|single incision surgery
260023|NCT01844960|SILS|sils
260024|NCT01844960|Laparoscopic Gastric Band|laparoscopic gastric band
260025|NCT01844960|Morbid Obesity|morbid obesity
260026|NCT01844960|Bariatric Surgery|bariatric surgery
260027|NCT01844934|Knee Arthroplasty|knee arthroplasty
260028|NCT01844934|Knee Replacement|knee replacement
260029|NCT01844934|Prehabilitation|prehabilitation
260030|NCT01844882|The effects|the effects
260031|NCT01844882|dietary|dietary
260032|NCT01844882|fiber|fiber
260033|NCT01844882|kidney function|kidney function
260034|NCT01844882|CKD patients|ckd patients
260035|NCT01844869|omacetaxine|omacetaxine
260036|NCT01844869|omacetaxine mepesuccinate|omacetaxine mepesuccinate
260037|NCT01844869|pharmacokinetics|pharmacokinetics
260038|NCT01844869|hematologic malignancies|hematologic malignancies
260039|NCT01844869|advanced solid tumors|advanced solid tumors
260040|NCT01844843|Drug eluting stents|drug eluting stents
260041|NCT01844843|coronary artery disease|coronary artery disease
260042|NCT01844843|Percutaneous Coronary Intervention|percutaneous coronary intervention
260043|NCT01844843|Tomography, Optical Coherence|tomography, optical coherence
260044|NCT01844830|operative|operative
260045|NCT01844830|dental procedure|dental procedure
260046|NCT01844817|untreated|untreated
260047|NCT01844817|metastatic|metastatic
260048|NCT01844817|OGX-427|ogx-427
260049|NCT01844804|Bioequivalence|bioequivalence
260050|NCT01844804|Biosimilarity|biosimilarity
260051|NCT01844804|Similarity|similarity
260053|NCT01844804|Phase 1|phase 1
260054|NCT01844804|Infliximab|infliximab
260055|NCT01844804|Healthy Volunteers|healthy volunteers
260056|NCT01844804|Single-dose|single-dose
260057|NCT01844804|Immunology|immunology
260058|NCT01844791|Non-small cell lung cancer|non-small cell lung cancer
260059|NCT01844791|OCZ103-OS|ocz103-os
260060|NCT01844791|Pentamidine bis(2-hydroxyethanesulfonate)|pentamidine bis(2-hydroxyethanesulfonate)
260061|NCT01844791|platinum-gemcitabine based doublet first line therapy|platinum-gemcitabine based doublet first line therapy
260062|NCT01844778|Cystic Fibrosis, Pseudomonas aeruginosa, FEV1, tobramycin inhalation powder, TOBI,|cystic fibrosis, pseudomonas aeruginosa, fev1, tobramycin inhalation powder, tobi,
260063|NCT01844778|colistimethate|colistimethate
260064|NCT01844778|Cystic Fibrosis, Pseudomonas aeruginosa, FEV1, tobramycin inhalation powder, TOBI, colistimethate|cystic fibrosis, pseudomonas aeruginosa, fev1, tobramycin inhalation powder, tobi, colistimethate
260065|NCT01844765|Tasigna|tasigna
260066|NCT01844765|nilotinib treatment|nilotinib treatment
260067|NCT01844765|chronic phase|chronic phase
260068|NCT01844765|Ph+ CML|ph+ cml
260069|NCT01844765|accelerated phase|accelerated phase
260070|NCT01844765|newly diagnosed Ph+ CML|newly diagnosed ph+ cml
260071|NCT01844765|pediatric|pediatric
260072|NCT01844765|24 month treatment|24 month treatment
260073|NCT01844752|acne|acne
260074|NCT01844739|Propionibacterium acnes|propionibacterium acnes
260075|NCT01844739|acne|acne
260076|NCT01844726|healthy individuals|healthy individuals
260077|NCT01844726|schizophrenia|schizophrenia
260078|NCT01844726|schizoaffective disorder|schizoaffective disorder
260079|NCT01844726|learning|learning
260080|NCT01844726|memory|memory
260081|NCT01844726|cognitive enhancement|cognitive enhancement
260082|NCT01844726|fMRI|fmri
260083|NCT01844713|Kidney transplant|kidney transplant
260084|NCT01844713|Renal transplant|renal transplant
260085|NCT01844713|Sun protection|sun protection
260086|NCT01844713|Skin cancer|skin cancer
260087|NCT01844700|MC4R genotype|mc4r genotype
260088|NCT01844700|antipsychotic induced weight gain|antipsychotic induced weight gain
260089|NCT01844700|pediatric population|pediatric population
260090|NCT01844687|reinforcement, good drug effect, high, mood, cannabidiol|reinforcement, good drug effect, high, mood, cannabidiol
260091|NCT01844661|Mesenchymal stem cells|mesenchymal stem cells
260092|NCT01844661|Oncolytic adenovirus|oncolytic adenovirus
260093|NCT01844648|Parkinson's disease|parkinson's disease
260094|NCT01844648|Sialorrhea|sialorrhea
260095|NCT01844648|Tropicamide|tropicamide
260096|NCT01844648|Non-motor symptoms|non-motor symptoms
260097|NCT01844648|Thin strip delivery|thin strip delivery
260098|NCT01844622|Digestive System Diseases Disease|digestive system diseases disease
260099|NCT01844609|Comprehension|comprehension
260100|NCT01844609|Verbal Learning|verbal learning
260101|NCT01844609|Writing|writing
260102|NCT01844609|Testing|testing
260103|NCT01844596|linkage to care|linkage to care
260104|NCT01844596|hypertension management|hypertension management
260105|NCT01844596|behavioral science|behavioral science
260106|NCT01844596|cardiovascular health|cardiovascular health
260107|NCT01844596|global health|global health
260108|NCT01844596|multi-disciplinary implementation research approach|multi-disciplinary implementation research approach
250724|NCT01885637|SPC|spc
260109|NCT01844596|linking and retaining|linking and retaining
260110|NCT01844596|community health workers|community health workers
260111|NCT01844596|CHWs|chws
260112|NCT01844596|behavioral communication strategy|behavioral communication strategy
260113|NCT01844596|smartphone-based tool|smartphone-based tool
260114|NCT01844596|electronic health record|electronic health record
260115|NCT01844596|retention to care|retention to care
260116|NCT01844557|Head And Neck Cancer|head and neck cancer
260117|NCT01844557|Nasopharyngeal cancer|nasopharyngeal cancer
260118|NCT01844557|Oropharyngeal cancer|oropharyngeal cancer
260119|NCT01844557|Hypopharyngeal cancer|hypopharyngeal cancer
260120|NCT01844557|Laryngeal cancer|laryngeal cancer
260121|NCT01844557|Primary cancer with cervical metastases|primary cancer with cervical metastases
260122|NCT01844557|Swallowing exercises|swallowing exercises
260123|NCT01844557|Videotape|videotape
260124|NCT01844557|Videocamera|videocamera
260125|NCT01844557|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
260126|NCT01844557|Questionnaires|questionnaires
260127|NCT01844557|Surveys|surveys
260128|NCT01844544|drug related problems|drug related problems
260129|NCT01844544|clinical pharmacist|clinical pharmacist
260130|NCT01844544|femoral neck fractures|femoral neck fractures
260131|NCT01844544|orthopedic patients|orthopedic patients
260132|NCT01844492|decision making for incapacitated patients|decision making for incapacitated patients
260133|NCT01844492|intensive care|intensive care
260134|NCT01844492|surrogate decision making|surrogate decision making
260135|NCT01844492|patient centered care|patient centered care
260136|NCT01844492|Palliative Care|palliative care
260137|NCT01844492|End of Life|end of life
260138|NCT01844492|Quality of Communication|quality of communication
260139|NCT01844479|diabetic foot ulcer|diabetic foot ulcer
260140|NCT01844479|diabetic foot|diabetic foot
260141|NCT01844466|course of motor and visual rehabilitation|course of motor and visual rehabilitation
260142|NCT01844466|improvement of deficits|improvement of deficits
260143|NCT01844466|stroke patients|stroke patients
260144|NCT01844453|Subfertility|subfertility
260145|NCT01844453|Recurrent Implantation Failure|recurrent implantation failure
260146|NCT01844440|GERD|gerd
260147|NCT01844440|tLESR|tlesr
260148|NCT01844440|impedance|impedance
260149|NCT01844440|manometry|manometry
260150|NCT01844427|ADHD|adhd
260151|NCT01844427|Executive function deficits|executive function deficits
260152|NCT01844427|Psychiatry|psychiatry
260153|NCT01844427|Psychopharmacology|psychopharmacology
260154|NCT01844427|Namenda|namenda
260155|NCT01844414|Homeless Men|homeless men
260156|NCT01844414|Parolees|parolees
260157|NCT01844414|Hepatitis B|hepatitis b
260158|NCT01844414|Hepatitis C|hepatitis c
260159|NCT01844414|HIV|hiv
260160|NCT01844414|Community Drug Treatment|community drug treatment
260161|NCT01844414|Recidivism|recidivism
260162|NCT01844401|persistent asthma|persistent asthma
260163|NCT01844401|Albuterol Spiromax®|albuterol spiromax®
260164|NCT01844401|ProAir® HFA|proair® hfa
260165|NCT01844401|Pediatric Patients|pediatric patients
260166|NCT01844401|Phase 1|phase 1
260167|NCT01844375|oral carbohydrate loading|oral carbohydrate loading
260168|NCT01844375|walking capacity|walking capacity
260169|NCT01844362|uterus|uterus
260170|NCT01844362|transplantation|transplantation
260171|NCT01844362|infertility|infertility
260172|NCT01844349|North Africa|north africa
260173|NCT01844349|Urban women|urban women
260174|NCT01844349|Double burden of malnutrition|double burden of malnutrition
260175|NCT01844349|Iron depletion|iron depletion
260176|NCT01844349|Overweight/obesity|overweight/obesity
260177|NCT01844349|Metabolic syndrome|metabolic syndrome
260178|NCT01844349|Abdominal obesity|abdominal obesity
260179|NCT01844349|Excess body fat|excess body fat
260180|NCT01844284|Absorb™ BVS|absorb™ bvs
260181|NCT01844284|Angioplasty|angioplasty
260182|NCT01844284|Bioabsorbable|bioabsorbable
260183|NCT01844284|Bioreabsorbable|bioreabsorbable
260184|NCT01844284|BVS|bvs
260185|NCT01844284|Coronary Artery Disease|coronary artery disease
260186|NCT01844284|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
260187|NCT01844284|Coronary artery restenosis|coronary artery restenosis
260188|NCT01844284|Coronary artery stenosis|coronary artery stenosis
260189|NCT01844284|Coronary scaffold|coronary scaffold
260190|NCT01844284|Coronary Stent|coronary stent
260191|NCT01844284|Drug eluting stents|drug eluting stents
260192|NCT01844284|Everolimus|everolimus
260193|NCT01844284|Myocardial ischemia|myocardial ischemia
260194|NCT01844284|Stent thrombosis|stent thrombosis
260195|NCT01844284|Stents|stents
260196|NCT01844271|LLLT|lllt
260197|NCT01844271|muscle fatigue and recovery|muscle fatigue and recovery
260198|NCT01844271|phototherapy parameter|phototherapy parameter
260199|NCT01844258|pediatric cataract|pediatric cataract
260200|NCT01844258|lens regeneration|lens regeneration
260201|NCT01844258|endogenous lens epithelial stem cells|endogenous lens epithelial stem cells
260202|NCT01844258|visual axis opacification|visual axis opacification
260203|NCT01844258|visual function|visual function
250893|NCT01884779|HIV|hiv
260204|NCT01844245|Cholangiocarcinoma|cholangiocarcinoma
260205|NCT01844245|Ampullary carcinoma|ampullary carcinoma
260206|NCT01844245|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
260207|NCT01844245|Radiofrequency ablation|radiofrequency ablation
260208|NCT01844232|Multiple sclerosis|multiple sclerosis
260209|NCT01844232|spasticity|spasticity
260210|NCT01844232|arbaclofen|arbaclofen
260211|NCT01844219|aortic surgery|aortic surgery
260212|NCT01844219|acute kidney injury|acute kidney injury
260213|NCT01844219|gray zone approach|gray zone approach
260214|NCT01844206|Post-cesarean analgesia|post-cesarean analgesia
260215|NCT01844206|Second dose of epidural morphine after surgery|second dose of epidural morphine after surgery
260216|NCT01844206|Post-operative analgesia|post-operative analgesia
260217|NCT01844206|Self-administered epidural morphine|self-administered epidural morphine
260218|NCT01844206|Pain management after cesarean|pain management after cesarean
260219|NCT01844180|Irritable Bowel Syndrome|irritable bowel syndrome
260220|NCT01844180|IBS|ibs
260221|NCT01844180|ONO-2952|ono-2952
260222|NCT01844167|noxipoint|noxipoint
260223|NCT01844167|physical therapy|physical therapy
260224|NCT01844167|cervical pain|cervical pain
260225|NCT01844167|trigger point|trigger point
260226|NCT01844167|neck pain|neck pain
260227|NCT01844167|TENS|tens
260228|NCT01844167|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
260229|NCT01844141|phenol|phenol
260230|NCT01844141|ingrown toenail|ingrown toenail
260231|NCT01844141|chemical matricectomy|chemical matricectomy
260232|NCT01844128|MMA, AFC, Ovarian reserve|mma, afc, ovarian reserve
260233|NCT01844115|Generalized Anxiety Disorder, GAD|generalized anxiety disorder, gad
260234|NCT01844102|HIV Prevention, PrePex, voluntary medical circumcision, non-surgical,|hiv prevention, prepex, voluntary medical circumcision, non-surgical,
260235|NCT01844102|medical device, wound healing, Zambia|medical device, wound healing, zambia
260236|NCT01844089|Postpartum hemorrhage|postpartum hemorrhage
260237|NCT01844089|Bakri Postpartum Balloon|bakri postpartum balloon
260238|NCT01844076|advanced stage colorectal adenocarcinoma|advanced stage colorectal adenocarcinoma
260239|NCT01844050|Chinese herbal medicine|chinese herbal medicine
260240|NCT01844050|diabetes symptoms|diabetes symptoms
260241|NCT01844011|fetal movement|fetal movement
260242|NCT01844011|pregnancy|pregnancy
260243|NCT01843998|Early stage|early stage
260244|NCT01843998|Stage 1A|stage 1a
260245|NCT01843998|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
260246|NCT01843998|CTCL|ctcl
260247|NCT01843985|Stage IV cancer|stage iv cancer
260248|NCT01843985|Survival|survival
260249|NCT01843959|adenovirus-36|adenovirus-36
260250|NCT01843959|Emirati population|emirati population
260251|NCT01843920|eye|eye
260252|NCT01843920|pneumatic retinopexy|pneumatic retinopexy
260253|NCT01843920|topical|topical
260254|NCT01843894|sever dry eye,keratoconjunctivitis sicca|sever dry eye,keratoconjunctivitis sicca
260255|NCT01843881|Gastric Bypass|gastric bypass
260256|NCT01843881|bariatric surgery|bariatric surgery
260257|NCT01843881|carbohydrate metabolism|carbohydrate metabolism
260258|NCT01843868|Lymphoma|lymphoma
260259|NCT01843868|Non-Hodgkin|non-hodgkin
260260|NCT01843868|Emesis|emesis
260261|NCT01843868|Chemotherapy|chemotherapy
260262|NCT01843868|Nausea|nausea
260263|NCT01843868|Vomiting|vomiting
260264|NCT01843868|Aprepitant|aprepitant
260265|NCT01843855|Gastric Bypass|gastric bypass
260266|NCT01843855|bariatric surgery|bariatric surgery
260267|NCT01843855|glucose metabolism|glucose metabolism
260268|NCT01843829|Oesophageal cancer|oesophageal cancer
260269|NCT01843816|Tragus-to-wall distance|tragus-to-wall distance
260270|NCT01843816|obesity|obesity
260271|NCT01843816|body shape|body shape
260272|NCT01843816|height|height
260273|NCT01843816|weight|weight
260274|NCT01843803|patient centered care|patient centered care
260275|NCT01843803|collaborative decision making|collaborative decision making
260276|NCT01843803|cost impact|cost impact
260277|NCT01843777|hearing loss|hearing loss
260278|NCT01843777|hearing aids|hearing aids
260279|NCT01843777|motivational interviewing|motivational interviewing
260280|NCT01843777|counseling|counseling
260281|NCT01843777|rehabilitation|rehabilitation
260282|NCT01843764|RDT|rdt
260283|NCT01843764|malaria|malaria
260284|NCT01843764|treatment follow up|treatment follow up
260285|NCT01843764|diagnosis|diagnosis
260286|NCT01843725|breast cancer|breast cancer
260287|NCT01843725|digestive cancer|digestive cancer
260288|NCT01843712|Caloric compensation|caloric compensation
260289|NCT01843712|Eating in the absence of hunger|eating in the absence of hunger
260290|NCT01843712|Children|children
260291|NCT01843712|Parental feeding practices|parental feeding practices
260292|NCT01843686|Acute 2nd and 3rd Degree Burns|acute 2nd and 3rd degree burns
260293|NCT01843686|Autologous Platelet Rich Plasma (PRP)|autologous platelet rich plasma (prp)
260294|NCT01843686|Skin Grafting|skin grafting
260295|NCT01843686|Magellan® System|magellan® system
260296|NCT01843686|Wounds|wounds
260297|NCT01843673|Lip, Oral Cavity and Pharynx|lip, oral cavity and pharynx
260298|NCT01843673|Larynx|larynx
260299|NCT01843660|Low back pain|low back pain
260300|NCT01843660|Shoulder pain|shoulder pain
260301|NCT01843660|Neck pain|neck pain
260302|NCT01843660|Tramadol hydrochloride|tramadol hydrochloride
260303|NCT01843660|Paracetamol|paracetamol
260304|NCT01843621|Dengue, Vaccine, Thailand|dengue, vaccine, thailand
260305|NCT01843608|Physical treatment|physical treatment
260306|NCT01843608|Exercise prescription to breast cancer survival|exercise prescription to breast cancer survival
260307|NCT01843608|Side cancer effect treatment|side cancer effect treatment
260308|NCT01843582|Keyword: blind spot|keyword: blind spot
260309|NCT01843569|In Vitro Maturation|in vitro maturation
260310|NCT01843569|IVM|ivm
260311|NCT01843569|Natural cycle IVF|natural cycle ivf
260312|NCT01843569|PCOS|pcos
260313|NCT01843543|Functional MRI (fMRI)|functional mri (fmri)
260314|NCT01843543|Resting state functional connectivity MRI (rs-fcMRI)|resting state functional connectivity mri (rs-fcmri)
260315|NCT01843543|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
260316|NCT01843517|Pain|pain
260317|NCT01843517|Facilitation|facilitation
260318|NCT01843517|Inhibition|inhibition
260319|NCT01843517|Oxytocin|oxytocin
260320|NCT01843517|Postpartum|postpartum
260321|NCT01843504|platelet rich plasma|platelet rich plasma
260322|NCT01843504|PRP|prp
260323|NCT01843504|plasma|plasma
260324|NCT01843504|plasma injection|plasma injection
260325|NCT01843504|patellar tendinopathy|patellar tendinopathy
260326|NCT01843504|patella tendon|patella tendon
260327|NCT01843504|patella|patella
260329|NCT01843504|shear wave ultrasound|shear wave ultrasound
260330|NCT01843504|tendinosis|tendinosis
260331|NCT01843504|tendinopathy|tendinopathy
260332|NCT01843504|tendinitis|tendinitis
260333|NCT01843504|jumper's knee|jumper's knee
260334|NCT01843478|women|women
260335|NCT01843478|human immunodeficiency virus|human immunodeficiency virus
260336|NCT01843478|cervical cancer screening|cervical cancer screening
260337|NCT01843478|Pap testing|pap testing
260338|NCT01843478|human papillomavirus|human papillomavirus
260339|NCT01843465|atrial fibrillation|atrial fibrillation
260340|NCT01843465|balloon cryoablation|balloon cryoablation
260341|NCT01843465|pulmonary veins|pulmonary veins
260342|NCT01843439|Acute exacerbation|acute exacerbation
260343|NCT01843439|Quality of life|quality of life
260344|NCT01843439|Magnesium deficiency|magnesium deficiency
260345|NCT01843439|Multidisciplinary intervention|multidisciplinary intervention
260346|NCT01843426|Comorbidity|comorbidity
260347|NCT01843413|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
260348|NCT01843400|Regorafenib|regorafenib
260349|NCT01843400|Colorectal Neoplasms|colorectal neoplasms
260350|NCT01843387|Diabetic nephropathy|diabetic nephropathy
260351|NCT01843387|Chronic kidney disease|chronic kidney disease
260352|NCT01843387|Metabolic disease|metabolic disease
260353|NCT01843387|Diabetes mellitus, type 2|diabetes mellitus, type 2
260354|NCT01843374|tremelimumab|tremelimumab
260355|NCT01843374|pleural, peritoneal|pleural, peritoneal
260356|NCT01843374|malignant mesothelioma|malignant mesothelioma
260357|NCT01843374|CTLA-4|ctla-4
260358|NCT01843361|Stroke|stroke
260359|NCT01843361|Clopidogrel|clopidogrel
260360|NCT01843361|Aggregometry|aggregometry
260361|NCT01843361|Antiplatelet therapy|antiplatelet therapy
260362|NCT01843361|Platelet function tests|platelet function tests
260363|NCT01843348|Transplant|transplant
260364|NCT01843348|Renal transplant|renal transplant
260365|NCT01843348|Rejection,allograf|rejection,allograf
260366|NCT01843348|Rejection|rejection
260367|NCT01843348|Xenograft rejection|xenograft rejection
260368|NCT01843348|Host vs graft disease|host vs graft disease
260369|NCT01843348|Kidney Transplant|kidney transplant
260370|NCT01843335|Cardiovascular Diagnostic Technique|cardiovascular diagnostic technique
260371|NCT01843335|Ultrasound|ultrasound
260372|NCT01843322|Image guided therapy|image guided therapy
260373|NCT01843322|Endovascular procedures|endovascular procedures
260374|NCT01843322|Angiography|angiography
260375|NCT01843322|Vascular surgical procedures|vascular surgical procedures
260376|NCT01843296|Spinal Anesthesia|spinal anesthesia
260377|NCT01843296|Bupivacaine|bupivacaine
260378|NCT01843296|Fentanyl|fentanyl
260379|NCT01843296|Magnesium sulfate|magnesium sulfate
260380|NCT01843296|Postoperative Pain|postoperative pain
260381|NCT01843283|Mild Cognitive Impairment|mild cognitive impairment
260382|NCT01843283|Family Caregivers|family caregivers
260383|NCT01843283|Intervention studies|intervention studies
260384|NCT01843270|general anesthesia|general anesthesia
260385|NCT01843270|body weight|body weight
260386|NCT01843270|laryngeal mask airway size|laryngeal mask airway size
260387|NCT01843257|Alcohol intake after bariatric surgery|alcohol intake after bariatric surgery
260388|NCT01843257|Alcohol and bariatric surgery|alcohol and bariatric surgery
260389|NCT01843244|plethysmography|plethysmography
260390|NCT01843231|g-Cath EZ Suture Anchor Delivery Catheter|g-cath ez suture anchor delivery catheter
260391|NCT01843231|Weight Loss Intervention|weight loss intervention
251014|NCT01884259|Larynx|larynx
260392|NCT01843218|Localized rectal cancer in a male patient|localized rectal cancer in a male patient
260393|NCT01843179|Newly diagnosed|newly diagnosed
260394|NCT01843179|Complete Remission|complete remission
260395|NCT01843166|Pessary|pessary
260396|NCT01843166|Patient Satisfaction|patient satisfaction
260397|NCT01843166|Estrogen Cream|estrogen cream
260398|NCT01843153|pain score|pain score
260399|NCT01843140|cancer|cancer
260400|NCT01843140|fertility preservation|fertility preservation
260401|NCT01843140|infertility|infertility
260402|NCT01843140|pregnancy|pregnancy
260403|NCT01843114|Retinal blood flow|retinal blood flow
260404|NCT01843114|Retinal vessel diameter|retinal vessel diameter
260405|NCT01843114|Fourier Domain Optical Coherence Tomography|fourier domain optical coherence tomography
260406|NCT01843114|Retinal blood velocities|retinal blood velocities
260407|NCT01843101|Optical Coherence Tomography|optical coherence tomography
260408|NCT01843101|Cornea|cornea
260409|NCT01843101|Imaging|imaging
260410|NCT01843088|Pain|pain
260411|NCT01843088|exercise|exercise
260412|NCT01843088|muscle|muscle
260413|NCT01843062|Selumetinib, Differentiated Thyroid Cancer , AZD6244|selumetinib, differentiated thyroid cancer , azd6244
260414|NCT01843036|Child Abuse|child abuse
260415|NCT01843036|Child Neglect|child neglect
260416|NCT01843036|Child Emergency Medical Care Presentations|child emergency medical care presentations
260417|NCT01843036|Child Well-Care Compliance|child well-care compliance
260418|NCT01843036|Mother Well-Care Compliance|mother well-care compliance
260419|NCT01843036|Mother Emergency Medical Care Presentations|mother emergency medical care presentations
260420|NCT01843036|Mother Mental Health|mother mental health
260421|NCT01843036|Family Connections to Community Resources|family connections to community resources
260422|NCT01843036|Parent-Child Relationship Quality|parent-child relationship quality
260423|NCT01843023|opioid dependence|opioid dependence
260424|NCT01843010|NSAIDs|nsaids
260425|NCT01843010|Hyperalgesia|hyperalgesia
260426|NCT01843010|Postlaparoscopic shoulder pain|postlaparoscopic shoulder pain
260428|NCT01842997|non-adjuvanted H1N1 vaccine|non-adjuvanted h1n1 vaccine
260429|NCT01842997|Safety|safety
260430|NCT01842997|pregnant women|pregnant women
260431|NCT01842984|Loneliness|loneliness
260432|NCT01842984|Social isolation|social isolation
260433|NCT01842984|Depression|depression
260434|NCT01842984|Older adults|older adults
260435|NCT01842984|Social competence|social competence
260436|NCT01842984|Social integration|social integration
260437|NCT01842971|two stage hepatectomy|two stage hepatectomy
260438|NCT01842971|liver metastasis|liver metastasis
260439|NCT01842971|colorectal cancer|colorectal cancer
260440|NCT01842958|Dental Implant|dental implant
260441|NCT01842945|Procrastination|procrastination
260745|NCT01841385|Exercise|exercise
260442|NCT01842945|internet based cognitive behavior therapy|internet based cognitive behavior therapy
260443|NCT01842945|randomized controlled trial|randomized controlled trial
260444|NCT01842932|Colonoscopy|colonoscopy
260445|NCT01842932|Anticholinergics|anticholinergics
260446|NCT01842906|positive end expiratory pressure|positive end expiratory pressure
260447|NCT01842906|acute mountain sickness|acute mountain sickness
260448|NCT01842906|prevention|prevention
260449|NCT01842906|high altitude|high altitude
260450|NCT01842893|fentanyl|fentanyl
260451|NCT01842893|breakthrough pain|breakthrough pain
260452|NCT01842893|opioid treated cancer patients|opioid treated cancer patients
260453|NCT01842880|MicroRNAs|micrornas
260454|NCT01842880|Chagas disease|chagas disease
260455|NCT01842880|Biomarkers|biomarkers
260456|NCT01842867|Syndecan-4|syndecan-4
260457|NCT01842867|Chagas disease|chagas disease
260458|NCT01842867|Biomarkers|biomarkers
260459|NCT01842854|Galectin-3|galectin-3
260460|NCT01842854|Chagas disease|chagas disease
260461|NCT01842854|Biomarkers|biomarkers
260462|NCT01842789|Acessa|acessa
260463|NCT01842789|Fibroids|fibroids
260464|NCT01842789|Halt|halt
260465|NCT01842789|Targeting Animation|targeting animation
260466|NCT01842789|Image Overlay|image overlay
260467|NCT01842789|Radiofrequency Ablation|radiofrequency ablation
260469|NCT01842763|Chronic daily headache|chronic daily headache
260470|NCT01842763|treated by occipital nerves stimulation|treated by occipital nerves stimulation
260471|NCT01842763|peripheral neuromodulation|peripheral neuromodulation
260472|NCT01842763|occipital nerves|occipital nerves
260473|NCT01842763|network|network
260474|NCT01842763|database|database
260475|NCT01842737|Low Back Pain|low back pain
260476|NCT01842737|Chiropractic|chiropractic
260477|NCT01842737|Spinal Manipulation|spinal manipulation
260478|NCT01842737|Massage|massage
260479|NCT01842698|Thoracotomy surgery|thoracotomy surgery
260480|NCT01842698|Anesthesia|anesthesia
260481|NCT01842698|Ultrasound-guided PVB|ultrasound-guided pvb
260482|NCT01842698|Post-operative pain|post-operative pain
260483|NCT01842685|Overactive Bladder|overactive bladder
260484|NCT01842685|Bladder Distention|bladder distention
260485|NCT01842672|pediatric non-hodgkins lymphoma|pediatric non-hodgkins lymphoma
260486|NCT01842672|pediatric acute leukemia|pediatric acute leukemia
260487|NCT01842672|clofarabine|clofarabine
260488|NCT01842672|mitoxantrone|mitoxantrone
260489|NCT01842659|MI|mi
260490|NCT01842659|amniocentesis|amniocentesis
260491|NCT01842659|cord blood|cord blood
260492|NCT01842659|placenta|placenta
260493|NCT01842659|Silver Russell Syndrome|silver russell syndrome
260494|NCT01842659|Beckwith Wiedemann Syndrome|beckwith wiedemann syndrome
260495|NCT01842646|Leukemia|leukemia
260496|NCT01842646|Myeloid Malignancies|myeloid malignancies
260497|NCT01842620|Metformin|metformin
260498|NCT01842620|Bioequivalence|bioequivalence
260499|NCT01842607|eosinophils|eosinophils
260500|NCT01842607|mepolizumab|mepolizumab
260501|NCT01842607|SB-240563|sb-240563
260502|NCT01842607|safety|safety
260503|NCT01842607|extension study|extension study
260504|NCT01842607|Severe refractory asthma|severe refractory asthma
260505|NCT01842594|Sarcoma, Hydroxychloroquine, Sirolimus, PET|sarcoma, hydroxychloroquine, sirolimus, pet
260506|NCT01842581|Liver Failure|liver failure
260507|NCT01842581|Hepatic Insufficiency|hepatic insufficiency
260508|NCT01842581|Liver Diseases|liver diseases
694109|NCT00943579|treatment|treatment
260509|NCT01842581|Brain Diseases|brain diseases
260510|NCT01842581|Rifaximin|rifaximin
260511|NCT01842581|Cirrhosis|cirrhosis
260512|NCT01842568|Cardiac surgery|cardiac surgery
260513|NCT01842568|Troponin|troponin
260514|NCT01842568|Vascular events|vascular events
260515|NCT01842568|Myocardial injury|myocardial injury
260516|NCT01842568|Observational cohort study|observational cohort study
260517|NCT01842568|Public health|public health
260518|NCT01842555|PDT|pdt
260519|NCT01842555|Photodynamic therapy|photodynamic therapy
260520|NCT01842542|Postpartum Depression, NeuroStar TMS Therapy, TMS|postpartum depression, neurostar tms therapy, tms
260521|NCT01842503|alcohol dependence|alcohol dependence
260522|NCT01842503|cue reactivity|cue reactivity
261228|NCT01839201|anesthesia|anesthesia
260523|NCT01842503|alcohol self administration|alcohol self administration
260524|NCT01842490|Biomarker|biomarker
260525|NCT01842490|Carotid enhanced ultrasound|carotid enhanced ultrasound
260526|NCT01842490|Intraplaque neovascularization|intraplaque neovascularization
260527|NCT01842438|Sexual Dysfunctions, Psychological|sexual dysfunctions, psychological
260528|NCT01842425|Liver volume|liver volume
260529|NCT01842425|Gastric bypass|gastric bypass
260530|NCT01842425|Magnetic resonance imaging|magnetic resonance imaging
260531|NCT01842412|Mitochondria, Muscle|mitochondria, muscle
260532|NCT01842412|Exercise|exercise
260533|NCT01842399|Vascular Stiffness|vascular stiffness
260534|NCT01842399|Aging|aging
260535|NCT01842399|Resveratrol|resveratrol
260536|NCT01842399|Aerobic Capacity|aerobic capacity
260537|NCT01842399|Inflammation|inflammation
260538|NCT01842386|Anti-CD20|anti-cd20
260539|NCT01842386|Anticytokine Autoanitbody-Associated Disease|anticytokine autoanitbody-associated disease
260540|NCT01842386|Rituximab|rituximab
260541|NCT01842373|topical anesthetics|topical anesthetics
260542|NCT01842373|laser resurfacing|laser resurfacing
260543|NCT01842360|Vaccine|vaccine
260544|NCT01842360|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
260545|NCT01842334|Nicotine Dependence|nicotine dependence
260546|NCT01842334|Smoking Cessation|smoking cessation
260547|NCT01842334|D-cycloserine|d-cycloserine
260548|NCT01842321|locally advanced|locally advanced
260549|NCT01842321|metastatic|metastatic
260550|NCT01842321|Breast Cancer|breast cancer
260551|NCT01842321|Molecular Apocrine|molecular apocrine
260552|NCT01842321|HER2-negative|her2-negative
260553|NCT01842321|Abiraterone acetate|abiraterone acetate
260554|NCT01842295|Obesity|obesity
260555|NCT01842295|Bariatric surgery|bariatric surgery
260556|NCT01842295|Sperm quality|sperm quality
260557|NCT01842295|Fertility|fertility
260558|NCT01842282|diabetes mellitus type 2|diabetes mellitus type 2
260559|NCT01842282|non alcoholic fatty liver disease|non alcoholic fatty liver disease
260560|NCT01842282|obesity|obesity
260561|NCT01842282|amlexanox|amlexanox
260562|NCT01842269|Mycophenolate Mofetil|mycophenolate mofetil
260563|NCT01842269|MMF|mmf
260564|NCT01842256|Telminouveau|telminouveau
260565|NCT01842256|Atorvastatin|atorvastatin
260566|NCT01842256|Pharmacokinetic|pharmacokinetic
260567|NCT01842256|Healthy volunteers|healthy volunteers
260568|NCT01842243|Ventricular dysfunction|ventricular dysfunction
260569|NCT01842243|MRI|mri
260570|NCT01842243|Echocardiography|echocardiography
260571|NCT01842243|Pacemakers|pacemakers
260572|NCT01842230|Telminuvo|telminuvo
260573|NCT01842230|Telmisartan|telmisartan
260574|NCT01842230|S-amlodipine|s-amlodipine
260575|NCT01842230|Atorvastatin|atorvastatin
260576|NCT01842230|pharmacokinetics|pharmacokinetics
260577|NCT01842230|Healthy volunteers|healthy volunteers
260578|NCT01842217|18F-FES PET|18f-fes pet
260579|NCT01842217|Nuclear Medicine|nuclear medicine
260580|NCT01842217|Premenopausal|premenopausal
260581|NCT01842217|Postmenopausal|postmenopausal
260582|NCT01842217|Estrogen receptor|estrogen receptor
260583|NCT01842217|Anxiety|anxiety
260584|NCT01842217|Depression|depression
260585|NCT01842217|Cognition|cognition
260586|NCT01842204|inguinal hernia|inguinal hernia
260587|NCT01842191|R-R MS|r-r ms
260588|NCT01842165|Peptide Receptor Radionuclide Therapy (PRRT)|peptide receptor radionuclide therapy (prrt)
260589|NCT01842165|Neuroendocrine Tumors|neuroendocrine tumors
260590|NCT01842126|Sciatica|sciatica
260591|NCT01842100|Induced abortion|induced abortion
260592|NCT01842100|Postaboral pelvic inflammatory disease|postaboral pelvic inflammatory disease
260593|NCT01842100|Sexually transmitted infections|sexually transmitted infections
260594|NCT01842100|Universal antibiotic prophylaxis|universal antibiotic prophylaxis
260595|NCT01842100|Screen-and-treat approach|screen-and-treat approach
260596|NCT01842087|Chronic Kidney Disease|chronic kidney disease
260597|NCT01842087|Fiber|fiber
260598|NCT01842087|BUN|bun
260599|NCT01842087|Serum Creatinine|serum creatinine
260600|NCT01842087|Uremic Symptoms|uremic symptoms
260601|NCT01842087|Quality of Life|quality of life
260602|NCT01842074|bortezomib|bortezomib
260603|NCT01842074|desensitization|desensitization
260604|NCT01842074|living kidney transplantation|living kidney transplantation
260605|NCT01842061|active living|active living
260606|NCT01842061|retirement|retirement
260607|NCT01842048|External-beam radiotherapy|external-beam radiotherapy
260608|NCT01842048|Hyperthermia|hyperthermia
260609|NCT01842035|Implantable cardiac defibrillator|implantable cardiac defibrillator
260610|NCT01842035|regadenoson|regadenoson
260611|NCT01842035|sudden cardiac death|sudden cardiac death
260612|NCT01842035|heart rate response|heart rate response
260613|NCT01842022|Glycemic load|glycemic load
260614|NCT01842022|memory|memory
260615|NCT01842022|mood|mood
260616|NCT01842009|transcranial stimulation|transcranial stimulation
260617|NCT01842009|direct current|direct current
260618|NCT01841983|Total worker health|total worker health
260619|NCT01841983|Sleep|sleep
260620|NCT01841983|MSDs|msds
260621|NCT01841983|Diet|diet
260622|NCT01841983|Physical Activity|physical activity
260623|NCT01841957|Bilateral Cataract|bilateral cataract
260624|NCT01841957|Simultaneous Cataract Surgery|simultaneous cataract surgery
260625|NCT01841957|ISBCS|isbcs
260626|NCT01841944|Fatty Acids, Omega-3|fatty acids, omega-3
260627|NCT01841944|Aged|aged
260628|NCT01841944|Myocardial Infarction|myocardial infarction
260629|NCT01841931|Opioids|opioids
260630|NCT01841931|Dependence|dependence
260631|NCT01841931|Buprenorphine|buprenorphine
260632|NCT01841931|Pain|pain
260633|NCT01841905|Alzheimer's Disease|alzheimer's disease
260634|NCT01841905|Family History|family history
260635|NCT01841905|Memory Concerns|memory concerns
260636|NCT01841866|post operative sore throat|post operative sore throat
260637|NCT01841866|laryngeal mask airway|laryngeal mask airway
260638|NCT01841866|children|children
260639|NCT01841853|Elderly|elderly
260640|NCT01841853|Health promotion|health promotion
260641|NCT01841853|Randomized controlled study|randomized controlled study
260642|NCT01841853|Immigrant|immigrant
260643|NCT01841853|Vulnerable population|vulnerable population
260644|NCT01841853|ADL|adl
260645|NCT01841853|KASAM|kasam
260646|NCT01841853|Implementation|implementation
260647|NCT01841840|Stroke|stroke
260648|NCT01841840|Hemiparetic|hemiparetic
260649|NCT01841840|Passive Vibration|passive vibration
260650|NCT01841840|Arterial Stiffness|arterial stiffness
260651|NCT01841840|Pulse Wave Velocity|pulse wave velocity
260652|NCT01841840|Wave Reflection|wave reflection
260653|NCT01841840|Body Composition|body composition
260654|NCT01841840|Autonomic Function|autonomic function
260655|NCT01841814|Lymphoma|lymphoma
260656|NCT01841814|Osteoporosis|osteoporosis
260657|NCT01841814|Chemotherapy|chemotherapy
260658|NCT01841814|Patient with|patient with
260659|NCT01841775|Hepatitis C, Chronic|hepatitis c, chronic
260660|NCT01841775|Genotype 2/3|genotype 2/3
260661|NCT01841775|Interferon α 2b|interferon α 2b
260662|NCT01841775|Ribavirin|ribavirin
260663|NCT01841775|Pharmacovigilance|pharmacovigilance
260664|NCT01841762|PAH-SYMPACT|pah-sympact
260665|NCT01841762|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
260666|NCT01841762|psychometric instrument|psychometric instrument
260667|NCT01841749|Breast cancer|breast cancer
260668|NCT01841710|Bitter Taste|bitter taste
260669|NCT01841710|Pediatric Medications|pediatric medications
260670|NCT01841697|Diabetes Mellitus|diabetes mellitus
260671|NCT01841697|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
260672|NCT01841697|Glucose Metabolism Disorders|glucose metabolism disorders
260673|NCT01841697|Metabolic Diseases|metabolic diseases
260674|NCT01841697|Endocrine System Diseases|endocrine system diseases
260675|NCT01841697|Glimepiride|glimepiride
260676|NCT01841697|Metformin|metformin
260677|NCT01841697|Hypoglycemic Agents|hypoglycemic agents
260678|NCT01841697|Physiological Effects of Drugs|physiological effects of drugs
260679|NCT01841697|Pharmacologic Actions|pharmacologic actions
260680|NCT01841684|HoFH|hofh
260681|NCT01841671|Polio|polio
260682|NCT01841671|IPV|ipv
260683|NCT01841671|bOPV|bopv
260684|NCT01841671|mOPV|mopv
260685|NCT01841671|vaccination|vaccination
260686|NCT01841658|Folate Status|folate status
321799|NCT01568749|otc|otc
260687|NCT01841658|Folate Biomarkers|folate biomarkers
260688|NCT01841645|CLA-enriched butter|cla-enriched butter
260689|NCT01841645|CLA metabolism|cla metabolism
260690|NCT01841645|inflammation|inflammation
260691|NCT01841632|Liver transplantation|liver transplantation
260692|NCT01841632|Allogeneic liver transplantation|allogeneic liver transplantation
260693|NCT01841632|Solid organ transplantation|solid organ transplantation
260694|NCT01841619|skin, lupus, intravenous immunoglobulin, ivig|skin, lupus, intravenous immunoglobulin, ivig
260695|NCT01841606|Spinal anesthesia|spinal anesthesia
260696|NCT01841606|Elective cesarean deliveries|elective cesarean deliveries
260697|NCT01841606|Ondansetron|ondansetron
260698|NCT01841580|Tear proteins profiles|tear proteins profiles
260699|NCT01841580|Longitudinal|longitudinal
260700|NCT01841580|Ocular surface damage|ocular surface damage
260701|NCT01841580|Trabeculectomy|trabeculectomy
260702|NCT01841567|hip|hip
260703|NCT01841567|knee|knee
260704|NCT01841554|Mitral Valve|mitral valve
260705|NCT01841554|Annuloplasty|annuloplasty
260706|NCT01841541|Tuberculosis|tuberculosis
260707|NCT01841541|Informal providers|informal providers
260708|NCT01841541|Informal carers|informal carers
260709|NCT01841541|Barriers to health system|barriers to health system
260710|NCT01841528|Polycystic Ovary Syndrome|polycystic ovary syndrome
260711|NCT01841528|Infertility|infertility
260712|NCT01841528|In-vitro fertilization|in-vitro fertilization
260713|NCT01841528|fresh embryo transfer|fresh embryo transfer
260714|NCT01841528|frozen-thawed embryo transfer|frozen-thawed embryo transfer
260715|NCT01841502|telaprevir|telaprevir
260716|NCT01841502|paroxetine|paroxetine
260717|NCT01841502|interaction|interaction
260718|NCT01841502|pharmacokinetics|pharmacokinetics
260719|NCT01841489|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
260720|NCT01841489|CLL|cll
260721|NCT01841476|Peripheral blood|peripheral blood
260722|NCT01841476|HSC|hsc
260723|NCT01841476|Mobilization|mobilization
260724|NCT01841476|CXCR4|cxcr4
260726|NCT01841463|Malignant Melanoma|malignant melanoma
260727|NCT01841450|Primary open-angle glaucoma (POAG)|primary open-angle glaucoma (poag)
260728|NCT01841450|Trabecular meshwork|trabecular meshwork
260729|NCT01841450|iStent|istent
260730|NCT01841437|Primary open-angle glaucoma (POAG)|primary open-angle glaucoma (poag)
260731|NCT01841437|Trabecular meshwork|trabecular meshwork
260732|NCT01841437|iStent|istent
260733|NCT01841424|dietary counseling|dietary counseling
260734|NCT01841424|food diary|food diary
260735|NCT01841424|obesity|obesity
260736|NCT01841424|pregnancy|pregnancy
260737|NCT01841424|weight gain|weight gain
260738|NCT01841411|bacterial vaginosis, recurrence, N-Acetyl cysteine|bacterial vaginosis, recurrence, n-acetyl cysteine
260739|NCT01841398|Cardiovascular|cardiovascular
260740|NCT01841398|Prevention|prevention
260741|NCT01841398|Ethnicity|ethnicity
260742|NCT01841398|Culture|culture
260743|NCT01841398|Internet|internet
260744|NCT01841398|Text Message|text message
260746|NCT01841385|spirometry|spirometry
260747|NCT01841385|muscle strength|muscle strength
260748|NCT01841385|physical therapy modalities|physical therapy modalities
260749|NCT01841372|Obesity|obesity
260750|NCT01841372|Overweight|overweight
260751|NCT01841372|Weight Maintenance|weight maintenance
260752|NCT01841359|Hypoglycemia|hypoglycemia
260753|NCT01841359|Gastric bypass surgery|gastric bypass surgery
260754|NCT01841346|Outcome after PCI|outcome after pci
260755|NCT01841346|Middle Eastern Patients|middle eastern patients
260756|NCT01841333|Lymphoblastic leukemia in remission|lymphoblastic leukemia in remission
260757|NCT01841333|Myeloid leukemia in remission|myeloid leukemia in remission
260758|NCT01841333|Recurrent lymphoblastic leukemia|recurrent lymphoblastic leukemia
260759|NCT01841333|Recurrent myeloid leukemia|recurrent myeloid leukemia
260760|NCT01841281|Asthma|asthma
260761|NCT01841281|Severe Asthma|severe asthma
260762|NCT01841268|premature, preterm, premie, skin|premature, preterm, premie, skin
260763|NCT01841255|Preoxygenation|preoxygenation
260764|NCT01841255|Device|device
260765|NCT01841255|Tolerability|tolerability
260766|NCT01841255|Efficacy|efficacy
260767|NCT01841242|Infection|infection
260768|NCT01841242|Cardiac Resynchronization Device|cardiac resynchronization device
260769|NCT01841242|Heart Failure|heart failure
260770|NCT01841216|Gluteus Maximus|gluteus maximus
260771|NCT01841216|Gluteus Medius|gluteus medius
260773|NCT01841216|EMG|emg
260774|NCT01841216|Perceived Exertion|perceived exertion
260775|NCT01841216|Thera-Band|thera-band
260776|NCT01841203|Diagnosis|diagnosis
260777|NCT01841203|Rapid tests|rapid tests
260778|NCT01841203|non-treponemal serology|non-treponemal serology
260779|NCT01841203|eradication|eradication
260780|NCT01841190|Prognosis|prognosis
260781|NCT01841190|Sepsis|sepsis
260782|NCT01841190|Septic shock|septic shock
260783|NCT01841190|Procalcitonin|procalcitonin
260784|NCT01841190|SOFA|sofa
260785|NCT01841177|Congenital Heart Disease|congenital heart disease
260786|NCT01841177|Pediatrics|pediatrics
260787|NCT01841177|Milrinone|milrinone
260788|NCT01841177|Cardiopulmonary Bypass|cardiopulmonary bypass
260789|NCT01841177|Therapeutic Drug Monitoring|therapeutic drug monitoring
260790|NCT01841164|Leukotriene responsiveness|leukotriene responsiveness
260792|NCT01841164|asthma|asthma
260793|NCT01841164|airway hyperresponsiveness|airway hyperresponsiveness
260794|NCT01841164|bronchoprovocation|bronchoprovocation
260795|NCT01841164|anti-asthmatic agents|anti-asthmatic agents
260796|NCT01841164|human|human
260797|NCT01841151|AD/HD in Children and Adolescents|ad/hd in children and adolescents
260798|NCT01841138|colonoscopy|colonoscopy
260799|NCT01841138|bowel preparation|bowel preparation
260800|NCT01841138|electrolytes|electrolytes
260801|NCT01841138|osmolality|osmolality
260802|NCT01841138|water|water
260803|NCT01841125|Alzheimer's Disease|alzheimer's disease
260804|NCT01841125|depressive disorder|depressive disorder
260805|NCT01841073|Prediabetes|prediabetes
260806|NCT01841073|Fermentable carbohydrate|fermentable carbohydrate
260807|NCT01841073|Appetite|appetite
260808|NCT01841073|Glucose homeostasis|glucose homeostasis
260809|NCT01841073|Weight management|weight management
260810|NCT01841060|Malignant Non-small Cell Neoplasm of Lung|malignant non-small cell neoplasm of lung
260811|NCT01841047|Retroperitoneal liposarcoma operable|retroperitoneal liposarcoma operable
260812|NCT01841034|Male|male
260813|NCT01841021|Peripheral T-Cell Lymphoma (PTCL)|peripheral t-cell lymphoma (ptcl)
260814|NCT01841021|Relapsed|relapsed
260815|NCT01841021|Refractory|refractory
260816|NCT01841021|CD30 Receptor|cd30 receptor
260817|NCT01841021|Large B-Cell Lymphoma|large b-cell lymphoma
260818|NCT01841008|[C17.800.621]|[c17.800.621]
260819|NCT01840995|stellate ganglion block|stellate ganglion block
260820|NCT01840982|Mixed grains|mixed grains
260821|NCT01840982|Glycemic index|glycemic index
260822|NCT01840982|Giant embryonic brown rice|giant embryonic brown rice
260823|NCT01840982|Giant embryonic rice|giant embryonic rice
260824|NCT01840982|diabetes|diabetes
260825|NCT01840969|off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
260826|NCT01840969|common carotid artery|common carotid artery
260827|NCT01840969|speckle tracking analysis|speckle tracking analysis
260828|NCT01840969|peak strain|peak strain
260829|NCT01840956|End-stage Renal Disease|end-stage renal disease
260830|NCT01840956|Hemodialysis|hemodialysis
260831|NCT01840956|Chronic Renal Insufficiency|chronic renal insufficiency
260832|NCT01840956|Renal Dialysis|renal dialysis
260833|NCT01840956|Hemodiafiltration|hemodiafiltration
260834|NCT01840956|Blood Vessel Prosthesis|blood vessel prosthesis
260835|NCT01840956|Tissue-Engineered Vascular Graft|tissue-engineered vascular graft
260836|NCT01840956|Vascular Prosthesis Implantation|vascular prosthesis implantation
260837|NCT01840956|Kidney Diseases|kidney diseases
260838|NCT01840956|Kidney Failure, Chronic|kidney failure, chronic
260839|NCT01840956|Renal Insufficiency|renal insufficiency
260840|NCT01840956|Urologic Diseases|urologic diseases
260841|NCT01840943|Epithelial ovarian cancer|epithelial ovarian cancer
260842|NCT01840943|Recurrent epithelial ovarian carcinoma|recurrent epithelial ovarian carcinoma
260843|NCT01840943|Carcinoma|carcinoma
260844|NCT01840943|Malignancy|malignancy
260845|NCT01840943|Ovarian carcinoma|ovarian carcinoma
260846|NCT01840943|CAELYX|caelyx
260847|NCT01840943|Topotecan hydrochloride|topotecan hydrochloride
260848|NCT01840943|Topotecan|topotecan
260849|NCT01840943|Platinum-based regimen chemotherapy|platinum-based regimen chemotherapy
260850|NCT01840943|Chinese patients|chinese patients
260851|NCT01840930|Cohort|cohort
260852|NCT01840930|Cerebral Palsy|cerebral palsy
260853|NCT01840930|Children|children
260854|NCT01840930|Pain|pain
260855|NCT01840930|Orthopedic complications|orthopedic complications
260856|NCT01840930|Epidemiology|epidemiology
260857|NCT01840865|young healthy subjects|young healthy subjects
260858|NCT01840865|brain stimulation|brain stimulation
260859|NCT01840865|tSOS|tsos
260860|NCT01840865|tDCS|tdcs
260861|NCT01840865|sleep|sleep
260862|NCT01840865|daytime sleep|daytime sleep
260863|NCT01840865|nap|nap
260864|NCT01840865|memory|memory
260865|NCT01840865|memory consolidation|memory consolidation
260866|NCT01840839|aging|aging
260867|NCT01840839|cognitive decline|cognitive decline
260868|NCT01840839|brain stimulation|brain stimulation
260869|NCT01840839|tSOS|tsos
260870|NCT01840839|tDCS|tdcs
260871|NCT01840839|sleep|sleep
260872|NCT01840839|nap|nap
260873|NCT01840839|daytime sleep|daytime sleep
260874|NCT01840839|memory|memory
260875|NCT01840839|memory consolidation|memory consolidation
260876|NCT01840826|Rehospitalization|rehospitalization
260877|NCT01840826|Reutilization|reutilization
260878|NCT01840826|Depressive Symptoms|depressive symptoms
260879|NCT01840826|Pharmacotherapy|pharmacotherapy
260880|NCT01840826|Cognitive Therapy|cognitive therapy
260881|NCT01840826|Self-help|self-help
260882|NCT01840826|Complementary Therapies|complementary therapies
260883|NCT01840813|Intraumbilical misoprostol|intraumbilical misoprostol
260884|NCT01840813|Retained placenta|retained placenta
260885|NCT01840813|Active management of third stage of labour|active management of third stage of labour
260886|NCT01840800|Postoperative pain|postoperative pain
260887|NCT01840800|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
260888|NCT01840800|ultrasound guided nerve blocks|ultrasound guided nerve blocks
260889|NCT01840800|opioid consumption|opioid consumption
260890|NCT01840761|delayed vasospasm,|delayed vasospasm,
260892|NCT01840761|standardization|standardization
260893|NCT01840735|CF|cf
260894|NCT01840735|Cystic Fibrosis|cystic fibrosis
260895|NCT01840735|PK|pk
260896|NCT01840722|HIV|hiv
260897|NCT01840722|HCV|hcv
260898|NCT01840722|Substance abuse|substance abuse
260899|NCT01840722|women|women
260900|NCT01840709|Systemic lupus erythematosus|systemic lupus erythematosus
260901|NCT01840709|Psychotherapy|psychotherapy
260902|NCT01840683|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
260903|NCT01840683|Age Related Eye Disease Study (AREDS)|age related eye disease study (areds)
260904|NCT01840683|Best-Corrected Visual Acuity (BCVA)|best-corrected visual acuity (bcva)
402010|NCT01233492|adult giant cell glioblastoma|adult giant cell glioblastoma
260905|NCT01840683|Early Treatment Diabetic Retinopathy Study (ETDRS)|early treatment diabetic retinopathy study (etdrs)
260906|NCT01840683|Heparin-Induced Extracorporeal LDL-Cholesterol Precipitation (HELP)|heparin-induced extracorporeal ldl-cholesterol precipitation (help)
260907|NCT01840683|Visual Function Questionnaire (VFQ)|visual function questionnaire (vfq)
260908|NCT01840670|Inferior Vena Cava|inferior vena cava
260909|NCT01840670|Central Venous Pressure|central venous pressure
260910|NCT01840670|Abdominal Pressure|abdominal pressure
260911|NCT01840657|CMDIR (Congenital Muscle Disease International Registry)|cmdir (congenital muscle disease international registry)
260912|NCT01840657|X-linked myotubular myopathy|x-linked myotubular myopathy
260913|NCT01840657|centronuclear myopathy|centronuclear myopathy
260914|NCT01840657|myotubularin|myotubularin
260915|NCT01840657|MTM1 gene|mtm1 gene
260916|NCT01840657|mutation|mutation
260917|NCT01840657|survival|survival
260918|NCT01840657|adverse event|adverse event
260919|NCT01840657|disease complication|disease complication
260920|NCT01840657|hospital admission|hospital admission
260921|NCT01840657|emergency room visit|emergency room visit
260922|NCT01840657|motor function|motor function
260923|NCT01840657|respiratory function|respiratory function
260924|NCT01840657|natural history study|natural history study
260925|NCT01840631|Obesity|obesity
260926|NCT01840631|Nutritional counseling|nutritional counseling
260927|NCT01840631|Physical activity|physical activity
260928|NCT01840631|Food diary|food diary
260929|NCT01840618|insulin function|insulin function
260930|NCT01840618|sleep apnea|sleep apnea
260931|NCT01840618|girls|girls
260932|NCT01840618|PCOS|pcos
260933|NCT01840618|insulin action|insulin action
260934|NCT01840592|Liver|liver
260935|NCT01840592|Sorafenib|sorafenib
260936|NCT01840592|Doxorubicin|doxorubicin
260937|NCT01840592|12-259|12-259
260938|NCT01840566|Relapsed|relapsed
260939|NCT01840566|Refractory|refractory
260940|NCT01840566|Autologous Stem Cell Transplantation|autologous stem cell transplantation
260941|NCT01840566|HIGH DOSE CHEMOTHERAPY|high dose chemotherapy
260942|NCT01840566|19-28z T cells/kg|19-28z t cells/kg
260943|NCT01840566|12-117|12-117
260944|NCT01840540|renal artery stenosis|renal artery stenosis
260945|NCT01840540|renovascular hypertension|renovascular hypertension
260946|NCT01840540|ischemic nephropathy|ischemic nephropathy
260947|NCT01840540|chronic kidney disease|chronic kidney disease
260948|NCT01840527|Biomarker|biomarker
260949|NCT01840527|BRAF|braf
260950|NCT01840527|blood-based|blood-based
260951|NCT01840514|recipient|recipient
260952|NCT01840501|Healthy|healthy
260953|NCT01840501|JNJ-42721458|jnj-42721458
260954|NCT01840501|Male|male
260955|NCT01840501|Safety|safety
260956|NCT01840501|Tolerability|tolerability
260957|NCT01840501|Pharmacokinetics|pharmacokinetics
260958|NCT01840501|Pharmacodynamics|pharmacodynamics
260959|NCT01840501|Immunogenicity|immunogenicity
260960|NCT01840436|MUCIPLIQ|mucipliq
260961|NCT01840436|Matrix therapy|matrix therapy
260962|NCT01840436|RGTA|rgta
260963|NCT01840436|Oral mucositis|oral mucositis
260964|NCT01840423|First in man study|first in man study
260965|NCT01840423|Volunteer study|volunteer study
260966|NCT01840410|Vision Impairment|vision impairment
260967|NCT01840410|Abnormal growth of blood vessels|abnormal growth of blood vessels
260968|NCT01840397|S-100B|s-100b
260969|NCT01840397|NSE|nse
260970|NCT01840384|Healthy infants|healthy infants
260971|NCT01840384|Anemia, iron-deficiency|anemia, iron-deficiency
260972|NCT01840371|ERCP|ercp
260973|NCT01840371|Sedation|sedation
260974|NCT01840371|Fentanyl|fentanyl
260975|NCT01840371|Propofol|propofol
260976|NCT01840358|Hypoglycemias|hypoglycemias
260977|NCT01840358|Insulin pump|insulin pump
260978|NCT01840358|Children|children
260979|NCT01840345|uncontrolled|uncontrolled
260980|NCT01840345|neuropathic pain|neuropathic pain
260981|NCT01840332|thyroid cancer|thyroid cancer
260982|NCT01840280|carcinoma|carcinoma
260983|NCT01840280|colorectal cancer|colorectal cancer
260984|NCT01840280|ambulant chemotherapy|ambulant chemotherapy
260985|NCT01840280|treatment cycles|treatment cycles
260987|NCT01840280|Irinotecan onkovis|irinotecan onkovis
260988|NCT01840280|Quantity of Irinotecan|quantity of irinotecan
260989|NCT01840280|Packaging Sizes|packaging sizes
260990|NCT01840267|pneumoperitoneum|pneumoperitoneum
260991|NCT01840267|pediatric laparoscopy|pediatric laparoscopy
260992|NCT01840267|optic nerve sheath diameter|optic nerve sheath diameter
260993|NCT01840267|intracranial pressure|intracranial pressure
260994|NCT01840254|PONV|ponv
260995|NCT01840254|IV PCA|iv pca
260996|NCT01840254|dexmedetomidine|dexmedetomidine
260997|NCT01840254|Female|female
260998|NCT01840254|non-smoking|non-smoking
260999|NCT01840254|lumbar spine surgery|lumbar spine surgery
261000|NCT01840241|sodium bicarbonate|sodium bicarbonate
261001|NCT01840241|acute kidney injury|acute kidney injury
261002|NCT01840241|OPCAB|opcab
261003|NCT01840228|Preterm|preterm
261004|NCT01840228|Progesterone|progesterone
261005|NCT01840189|Addison disease|addison disease
261006|NCT01840189|Type 1 diabetes|type 1 diabetes
261007|NCT01840189|treatment|treatment
261008|NCT01840176|McCall culdoplasty|mccall culdoplasty
261009|NCT01840176|Total laparoscopic hysterectomy|total laparoscopic hysterectomy
261010|NCT01840176|Vaginal vault prolapse|vaginal vault prolapse
261011|NCT01840176|Sexual function|sexual function
261012|NCT01840124|Fibroids|fibroids
261013|NCT01840124|Radiofrequency ablation|radiofrequency ablation
261014|NCT01840111|smoking environment|smoking environment
261015|NCT01840111|cue-exposure|cue-exposure
261016|NCT01840111|cigarettes|cigarettes
261017|NCT01840111|nicotine|nicotine
261018|NCT01840111|fMRI|fmri
261019|NCT01840085|Diabetic foot ulcer|diabetic foot ulcer
261020|NCT01840085|plantar neuropathic ulcer|plantar neuropathic ulcer
261021|NCT01840085|plantar neuroischemic ulcer|plantar neuroischemic ulcer
261022|NCT01840085|Wagner Grade 1 or Grade 2 DFU|wagner grade 1 or grade 2 dfu
261023|NCT01840072|Ischemic stroke|ischemic stroke
261024|NCT01840072|Hypertension|hypertension
261025|NCT01840072|Antihypertensive Agents|antihypertensive agents
261026|NCT01840072|Randomized Controlled Trial|randomized controlled trial
261027|NCT01840059|Cardiac Failure|cardiac failure
261028|NCT01840059|Autonomic Denervation|autonomic denervation
261029|NCT01840020|bariatric surgery|bariatric surgery
261030|NCT01840020|alcohol drinking|alcohol drinking
261031|NCT01840020|alcoholism|alcoholism
261032|NCT01840020|ethanol|ethanol
261033|NCT01840020|metabolism|metabolism
261034|NCT01839994|prostate cancer,|prostate cancer,
261035|NCT01839994|high-dose-rate brachytherapy boost,|high-dose-rate brachytherapy boost,
261036|NCT01839994|stereotactic body radiotherapy boost,|stereotactic body radiotherapy boost,
261037|NCT01839994|conformal radiotherapy,|conformal radiotherapy,
261038|NCT01839994|randomized trial|randomized trial
261039|NCT01839942|Hernia, Ventral|hernia, ventral
261040|NCT01839929|tacrolimus|tacrolimus
261041|NCT01839929|immunosuppressant|immunosuppressant
261042|NCT01839929|FK506|fk506
261043|NCT01839903|Smoking|smoking
261044|NCT01839903|Tobacco|tobacco
261045|NCT01839903|Emergency Department|emergency department
261046|NCT01839890|Paclitaxel|paclitaxel
261047|NCT01839890|stent|stent
261048|NCT01839890|Acute infarction|acute infarction
261049|NCT01839890|Systolic time elevation|systolic time elevation
261050|NCT01839877|Metastatic colorectal Cancer|metastatic colorectal cancer
261051|NCT01839864|Promotoras|promotoras
261052|NCT01839864|Hispanic Adults|hispanic adults
261053|NCT01839864|metabolic syndrome|metabolic syndrome
261054|NCT01839864|rural|rural
261055|NCT01839864|patient attitudes|patient attitudes
261056|NCT01839864|provider cultural competency|provider cultural competency
261057|NCT01839864|patient activation measure|patient activation measure
261058|NCT01839851|Hair cortisol|hair cortisol
261059|NCT01839851|asthma|asthma
261060|NCT01839851|allergic rhinitis|allergic rhinitis
261061|NCT01839851|inhaled corticosteroids|inhaled corticosteroids
261062|NCT01839851|intranasal glucocorticoids|intranasal glucocorticoids
261063|NCT01839838|Women|women
261064|NCT01839838|age 50 and above|age 50 and above
261065|NCT01839838|with|with
261066|NCT01839838|that has been|that has been
261067|NCT01839838|surgically excised|surgically excised
261068|NCT01839825|elderly|elderly
261069|NCT01839825|fall|fall
261070|NCT01839825|acute illness|acute illness
261071|NCT01839825|care giver|care giver
261072|NCT01839812|Cardiopulmonary bypass|cardiopulmonary bypass
261073|NCT01839812|Cortisol|cortisol
261074|NCT01839812|Dexamethasone|dexamethasone
261075|NCT01839799|Patients|patients
261076|NCT01839799|with|with
261077|NCT01839799|resected|resected
261078|NCT01839786|Pulmonary Hypertension|pulmonary hypertension
261079|NCT01839786|Doppler|doppler
261080|NCT01839786|Valsalva|valsalva
261081|NCT01839773|Stomach Neoplasms|stomach neoplasms
261082|NCT01839773|Cancer of Stomach|cancer of stomach
261083|NCT01839773|Gastric Cancer|gastric cancer
261084|NCT01839773|Gastric Neoplasms|gastric neoplasms
251697|NCT01881425|POAG|poag
261085|NCT01839773|Neoplasms, Gastric|neoplasms, gastric
261086|NCT01839773|Neoplasms, Stomach|neoplasms, stomach
261087|NCT01839773|Stomach Cancer|stomach cancer
261088|NCT01839773|paclitaxel|paclitaxel
261089|NCT01839773|Taxol|taxol
261090|NCT01839760|Influenza|influenza
261091|NCT01839760|Virus|virus
261092|NCT01839760|Viral shedding|viral shedding
261093|NCT01839760|Epidemiology|epidemiology
261094|NCT01839747|Pediatric|pediatric
261095|NCT01839734|CD4+|cd4+
261096|NCT01839721|Probiotics|probiotics
261097|NCT01839721|radiation-induced enteritis|radiation-induced enteritis
261098|NCT01839721|radiation-induced diarrhea|radiation-induced diarrhea
261099|NCT01839721|radiation, diarrhea, enteritis|radiation, diarrhea, enteritis
261100|NCT01839721|diet|diet
261101|NCT01839721|nutrition|nutrition
261102|NCT01839708|Intervention|intervention
261103|NCT01839695|Thoracic Aneurysm|thoracic aneurysm
261104|NCT01839695|Endovascular Aortic Repair|endovascular aortic repair
261105|NCT01839695|TEVAR|tevar
261106|NCT01839682|StabiliT|stabilit
261107|NCT01839682|Kyphoplasty|kyphoplasty
261108|NCT01839682|Vertebral|vertebral
261109|NCT01839682|Compression|compression
261110|NCT01839682|Fracture|fracture
261111|NCT01839682|Osteoporosis|osteoporosis
261112|NCT01839669|conservative therapy|conservative therapy
261113|NCT01839669|Foot-Function-Index|foot-function-index
261114|NCT01839669|functional movement changes|functional movement changes
261115|NCT01839669|non-surgical treatment|non-surgical treatment
261116|NCT01839669|pes planovalgus|pes planovalgus
261117|NCT01839669|posterior tibial tendon dysfunction|posterior tibial tendon dysfunction
261118|NCT01839656|Spinal Muscular Atrophy|spinal muscular atrophy
261120|NCT01839656|SMN|smn
261121|NCT01839656|SMNRx|smnrx
261122|NCT01839656|ISIS-SMNRx|isis-smnrx
261123|NCT01839656|ISIS 396443|isis 396443
261124|NCT01839656|IONIS-SMNRx|ionis-smnrx
261125|NCT01839656|Spinraza|spinraza
261126|NCT01839643|pharmacokinetic|pharmacokinetic
261127|NCT01839630|Sorafenib|sorafenib
261128|NCT01839630|Hepatocellular cancer|hepatocellular cancer
261129|NCT01839630|TACE combination|tace combination
261130|NCT01839630|Treatment pattern|treatment pattern
261131|NCT01839630|Safety|safety
261132|NCT01839630|Effectiveness|effectiveness
261133|NCT01839617|parenteral nutrition|parenteral nutrition
261134|NCT01839617|early nutrition|early nutrition
261135|NCT01839617|abdominal surgery|abdominal surgery
261136|NCT01839617|cancer|cancer
261137|NCT01839604|Child-Pugh A to B7,|child-pugh a to b7,
261261|NCT01839045|Ultrasound|ultrasound
261138|NCT01839604|Advanced/Metastatic Hepatocellular Carcinoma,|advanced/metastatic hepatocellular carcinoma,
261139|NCT01839604|AZD9150,|azd9150,
261140|NCT01839604|Antisense Oligonucleotide Inhibitor of STAT3|antisense oligonucleotide inhibitor of stat3
261141|NCT01839578|cytokines|cytokines
261142|NCT01839578|blood purification|blood purification
261143|NCT01839578|super high flux hemodialysis|super high flux hemodialysis
261144|NCT01839565|Adverse events|adverse events
261145|NCT01839565|Osteosynthesis|osteosynthesis
261146|NCT01839565|Quality of life|quality of life
261147|NCT01839552|Fentanyl Citrate Nasal Spray (FCNS)|fentanyl citrate nasal spray (fcns)
261148|NCT01839552|Lazanda|lazanda
261149|NCT01839552|Breakthrough pain in cancer patients|breakthrough pain in cancer patients
261150|NCT01839539|colorectal cancer|colorectal cancer
261151|NCT01839539|DC-CIK|dc-cik
261152|NCT01839539|CRC|crc
261153|NCT01839526|Fabry disease|fabry disease
261154|NCT01839513|Analgesia/nociception index|analgesia/nociception index
261155|NCT01839513|Desflurane|desflurane
261156|NCT01839513|Remifentanil|remifentanil
261157|NCT01839513|Orthopedic surgery|orthopedic surgery
261158|NCT01839513|Ear-nose-throat surgery|ear-nose-throat surgery
261159|NCT01839513|Hemodynamic reactivity|hemodynamic reactivity
261160|NCT01839487|pancreatic ductal carcinoma(PDA)|pancreatic ductal carcinoma(pda)
261161|NCT01839487|Pancreatic ductal carcinoma|pancreatic ductal carcinoma
261162|NCT01839487|PEGPH20|pegph20
261163|NCT01839487|Gemcitabine|gemcitabine
261164|NCT01839487|Nab-paclitaxel|nab-paclitaxel
261165|NCT01839474|Continuous Positive Airway Pressure|continuous positive airway pressure
261166|NCT01839474|Controlled trial|controlled trial
261167|NCT01839474|Pneumonia|pneumonia
261168|NCT01839474|Children|children
261169|NCT01839461|Pharmacogenetics|pharmacogenetics
261170|NCT01839461|postoperative|postoperative
261171|NCT01839461|pediatric|pediatric
261172|NCT01839461|opioid|opioid
261173|NCT01839461|perioperative|perioperative
261174|NCT01839461|respiratory depression|respiratory depression
261175|NCT01839461|chronic pain|chronic pain
261176|NCT01839448|post partum diabetes|post partum diabetes
261177|NCT01839448|impaired fasting glucose|impaired fasting glucose
261178|NCT01839435|appendectomy|appendectomy
261179|NCT01839435|acute appendicitis|acute appendicitis
261180|NCT01839435|outpatient|outpatient
261181|NCT01839409|Circadian Rhythm|circadian rhythm
261182|NCT01839409|Exercise|exercise
261183|NCT01839409|Reflex, Vestibular Ocular|reflex, vestibular ocular
322324|NCT01566396|RF,|rf,
261184|NCT01839409|Postural Balance|postural balance
261185|NCT01839396|Intrepid, Vercise, PD, DBS, Boston Scientific|intrepid, vercise, pd, dbs, boston scientific
261186|NCT01839370|Pramlintide|pramlintide
261187|NCT01839370|Closed Loop|closed loop
261188|NCT01839370|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
261189|NCT01839370|Diabetes Assistant (DiAs)|diabetes assistant (dias)
261190|NCT01839357|Rivaroxaban|rivaroxaban
261191|NCT01839357|Oral anticoagulant|oral anticoagulant
261192|NCT01839357|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
261193|NCT01839357|Left atrial thrombus|left atrial thrombus
261194|NCT01839357|Transesophageal echocardiography|transesophageal echocardiography
261195|NCT01839357|Thrombus resolution|thrombus resolution
261196|NCT01839357|Stroke|stroke
261197|NCT01839357|Thromboembolism|thromboembolism
261198|NCT01839344|hyperglycemia|hyperglycemia
261199|NCT01839344|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
261200|NCT01839344|endothelial dysfunction|endothelial dysfunction
261201|NCT01839344|quercetin|quercetin
261202|NCT01839344|Acarbose|acarbose
261203|NCT01839344|glucose tolerance|glucose tolerance
261204|NCT01839344|maltose|maltose
261205|NCT01839331|osteoarthritis|osteoarthritis
261206|NCT01839331|osteoarthrisis of the knee|osteoarthrisis of the knee
261207|NCT01839318|Soft contact lenses|soft contact lenses
261208|NCT01839318|Daily disposable contact lenses|daily disposable contact lenses
261209|NCT01839318|Tear Film Break Up Time|tear film break up time
261210|NCT01839318|Contact lens wettability|contact lens wettability
261211|NCT01839305|Kinematics|kinematics
261212|NCT01839305|Fibromyalgia|fibromyalgia
261213|NCT01839305|Physical Therapy|physical therapy
261214|NCT01839305|3D Kinematics|3d kinematics
261215|NCT01839305|Heart Rate Frequency|heart rate frequency
261216|NCT01839305|Hydrotherapy|hydrotherapy
261217|NCT01839292|gastric outlet obstruction|gastric outlet obstruction
261218|NCT01839292|palliative treatment|palliative treatment
261219|NCT01839292|stent|stent
261220|NCT01839266|acute PTE, prognostic factors|acute pte, prognostic factors
261221|NCT01839253|antihypertensive agents|antihypertensive agents
261222|NCT01839253|hemodynamic|hemodynamic
261223|NCT01839253|anesthetics reduction|anesthetics reduction
261224|NCT01839253|orthognathic surgery|orthognathic surgery
261225|NCT01839227|Post-operative cognitive dysfunction|post-operative cognitive dysfunction
261226|NCT01839227|regional cerebral oxygen saturation|regional cerebral oxygen saturation
261229|NCT01839201|modification of dreaming|modification of dreaming
261230|NCT01839201|suggestions|suggestions
261231|NCT01839162|Transradial approach|transradial approach
261232|NCT01839162|shield drape|shield drape
261233|NCT01839162|radiation|radiation
261234|NCT01839162|PTCA|ptca
261235|NCT01839149|Refractory Chronic Migraine|refractory chronic migraine
261236|NCT01839149|Medically Intractable Chronic Migraine|medically intractable chronic migraine
261237|NCT01839149|Oxytocin|oxytocin
261238|NCT01839149|Intranasal oxytocin|intranasal oxytocin
261239|NCT01839136|Assisted Reproductive Techniques|assisted reproductive techniques
261240|NCT01839136|Health Services Accessibility|health services accessibility
261241|NCT01839136|Ovulation Induction|ovulation induction
261242|NCT01839136|Embryo Transfer|embryo transfer
261243|NCT01839123|Amputee|amputee
261244|NCT01839110|pulmonary hypertension|pulmonary hypertension
261245|NCT01839110|right ventricular function|right ventricular function
261246|NCT01839110|ranolazine|ranolazine
261247|NCT01839097|PTCL|ptcl
261248|NCT01839097|Maximum Tolerated Dose|maximum tolerated dose
261249|NCT01839097|Belinostat|belinostat
261250|NCT01839084|Xenon|xenon
261251|NCT01839084|Isoflurane|isoflurane
261252|NCT01839084|Anesthetics, Inhalation|anesthetics, inhalation
261253|NCT01839084|Nephroprotection|nephroprotection
261254|NCT01839084|Partial nephrectomy|partial nephrectomy
261255|NCT01839084|Xenon versus Isoflurane anesthesia|xenon versus isoflurane anesthesia
261256|NCT01839058|Non Cardiac Chest Pain|non cardiac chest pain
261257|NCT01839045|Woman|woman
261258|NCT01839045|Breast Cancer|breast cancer
261259|NCT01839045|Cancer|cancer
261260|NCT01839045|Mammogram|mammogram
261262|NCT01839045|Imaging|imaging
261263|NCT01839045|Biomarkers|biomarkers
261264|NCT01839045|ACR BI RAD Category 3|acr bi rad category 3
261265|NCT01839045|ACR BI RAD Category 4|acr bi rad category 4
261266|NCT01839019|Healthy volunteers|healthy volunteers
261267|NCT01839006|hydronephrosis|hydronephrosis
261268|NCT01839006|ultrasonography|ultrasonography
261269|NCT01839006|Kidney Function Test|kidney function test
261270|NCT01839006|Patients with unilateral UPJO and patients with preop HN in USG and supranormal renal function in DTPA renography|patients with unilateral upjo and patients with preop hn in usg and supranormal renal function in dtpa renography
261271|NCT01838993|anesthetics,|anesthetics,
261272|NCT01838993|local,|local,
261273|NCT01838993|lidocaine;|lidocaine;
261274|NCT01838993|nebulizers and vaporizers;|nebulizers and vaporizers;
261275|NCT01838993|complications,|complications,
261276|NCT01838993|intubation,|intubation,
261277|NCT01838993|intratracheal.|intratracheal.
261278|NCT01838980|Colonoscopy Cleaning|colonoscopy cleaning
261279|NCT01838967|cilnidipin and valsartn|cilnidipin and valsartn
261280|NCT01838967|pharmacokinetic drug drug interaction|pharmacokinetic drug drug interaction
261281|NCT01838967|oral administration|oral administration
261282|NCT01838967|healthy male subjects|healthy male subjects
261283|NCT01838954|hand osteoarthritis|hand osteoarthritis
261284|NCT01838954|short-wave diathermy|short-wave diathermy
261285|NCT01838941|Peroxisome Biogenesis Disorder|peroxisome biogenesis disorder
261286|NCT01838941|PBD|pbd
261287|NCT01838941|neonatal adrenoleukodystrophy|neonatal adrenoleukodystrophy
261288|NCT01838941|infantile Refsum disease|infantile refsum disease
261289|NCT01838941|PEX1 mutation|pex1 mutation
261290|NCT01838941|Betaine|betaine
261291|NCT01838928|Axillary brachial plexus block|axillary brachial plexus block
261292|NCT01838928|Ultrasound|ultrasound
261293|NCT01838928|Minimum effective concentration|minimum effective concentration
261294|NCT01838928|Bupivacaine|bupivacaine
261295|NCT01838928|ultrasound-guided axillary brachial plexus block|ultrasound-guided axillary brachial plexus block
261296|NCT01838915|HIV|hiv
261297|NCT01838915|immunoactivation|immunoactivation
261298|NCT01838915|bacterial translocation|bacterial translocation
261299|NCT01838915|prebiotics|prebiotics
261300|NCT01838915|glutamine|glutamine
261301|NCT01838915|microbiota|microbiota
261302|NCT01838902|Malaria|malaria
261303|NCT01838902|Falciparum|falciparum
261304|NCT01838902|Direct membrane feeding|direct membrane feeding
261305|NCT01838902|QT-NASBA|qt-nasba
261306|NCT01838902|Asexual parasite|asexual parasite
261307|NCT01838902|Asymptomatic carrier|asymptomatic carrier
261308|NCT01838902|Gametocytocidal, Gametocyte|gametocytocidal, gametocyte
261309|NCT01838902|Transmission blocking|transmission blocking
261310|NCT01838902|Sexual stage|sexual stage
261311|NCT01838902|Primaquine|primaquine
261312|NCT01838902|Dihydroartemisinin|dihydroartemisinin
261313|NCT01838902|Piperaquine|piperaquine
261314|NCT01838902|Gambia|gambia
261315|NCT01838902|Africa|africa
261316|NCT01838889|Culturally adapted|culturally adapted
261317|NCT01838889|Group psychological intervention|group psychological intervention
261318|NCT01838889|British South Asian women|british south asian women
261319|NCT01838889|CBT|cbt
261320|NCT01838876|Major Depressive Disorder|major depressive disorder
261321|NCT01838876|MDD|mdd
261322|NCT01838876|Depression|depression
261323|NCT01838863|coagulopathy|coagulopathy
261324|NCT01838863|hemorrhagic shock|hemorrhagic shock
261325|NCT01838863|plasma|plasma
261326|NCT01838863|blood product transfusion|blood product transfusion
261327|NCT01838824|Processing Speed|processing speed
261328|NCT01838824|Intervention|intervention
261329|NCT01838824|Multiple Sclerosis|multiple sclerosis
261330|NCT01838824|Cognition|cognition
261331|NCT01838811|Processing Speed|processing speed
261332|NCT01838811|Intervention|intervention
261333|NCT01838811|Traumatic Brain Injury|traumatic brain injury
261334|NCT01838811|Cognition|cognition
261335|NCT01838798|cognitive disorders|cognitive disorders
261336|NCT01838798|quality of life|quality of life
261337|NCT01838798|Intensive care|intensive care
261338|NCT01838785|18F-DTBZ AV-133 imaging|18f-dtbz av-133 imaging
261339|NCT01838772|HCV and HIV co-infection|hcv and hiv co-infection
261340|NCT01838759|Bioimpedance spectroscopy|bioimpedance spectroscopy
261341|NCT01838759|Hypervolemia|hypervolemia
261342|NCT01838759|Hypovolemia|hypovolemia
261343|NCT01838746|Percutaneous coronary intervention|percutaneous coronary intervention
261344|NCT01838746|Coronary artery bypass grafting|coronary artery bypass grafting
261345|NCT01838746|Coronary artery bypass surgery|coronary artery bypass surgery
261346|NCT01838746|Survival|survival
261347|NCT01838746|Acute coronary syndrome|acute coronary syndrome
261348|NCT01838746|ST segment elevation myocardial infarction|st segment elevation myocardial infarction
261349|NCT01838746|Non-ST segment elevation myocardial infarction|non-st segment elevation myocardial infarction
261350|NCT01838746|Younge patient|younge patient
261351|NCT01838720|renal cell carcinoma|renal cell carcinoma
261352|NCT01838720|ischemia|ischemia
261353|NCT01838720|radio frequency ablation|radio frequency ablation
261354|NCT01838707|postoperative|postoperative
261355|NCT01838707|spine surgery|spine surgery
261356|NCT01838655|Albinism|albinism
261357|NCT01838655|Nitisinone|nitisinone
261358|NCT01838655|Melanin|melanin
261359|NCT01838655|Vision Loss|vision loss
261360|NCT01838642|Monoclonal Antibody|monoclonal antibody
261361|NCT01838642|AP24534|ap24534
261362|NCT01838642|RET Mutation Positive|ret mutation positive
261363|NCT01838642|RET Mutation Negative|ret mutation negative
261364|NCT01838642|RET Inhibitor|ret inhibitor
261365|NCT01838616|Severe chronic low back pain|severe chronic low back pain
261366|NCT01838616|Neuropathic pain|neuropathic pain
261367|NCT01838616|Constipation|constipation
261368|NCT01838590|Liver Diseases|liver diseases
261369|NCT01838590|Digestive System Diseases|digestive system diseases
261370|NCT01838590|Hepatitis, Viral, Human|hepatitis, viral, human
261371|NCT01838590|Virus Diseases|virus diseases
261372|NCT01838590|Enterovirus Infections|enterovirus infections
261373|NCT01838590|Picornaviridae Infections|picornaviridae infections
261374|NCT01838590|RNA Virus Infections|rna virus infections
261375|NCT01838590|Flaviviridae Infections|flaviviridae infections
261376|NCT01838590|Antiviral Agents|antiviral agents
261377|NCT01838590|Anti-Infective Agents|anti-infective agents
261378|NCT01838590|Therapeutic Uses|therapeutic uses
261379|NCT01838590|Pharmacologic Actions|pharmacologic actions
261380|NCT01838590|Antimetabolites|antimetabolites
261381|NCT01838590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
261382|NCT01838590|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
261383|NCT01838590|HCV|hcv
261384|NCT01838590|Sustained Virologic Response|sustained virologic response
261385|NCT01838590|Direct Acting Antiviral|direct acting antiviral
261386|NCT01838590|Combination Therapy|combination therapy
261387|NCT01838590|GS-7977|gs-7977
261388|NCT01838590|Ribavirin|ribavirin
261389|NCT01838590|Open Label|open label
261390|NCT01838590|Sofosbuvir|sofosbuvir
261391|NCT01838590|Additional relevant MeSH terms:|additional relevant mesh terms:
261392|NCT01838590|Hepatitis|hepatitis
261393|NCT01838590|Hepatitis, Chronic|hepatitis, chronic
261394|NCT01838590|Hepatitis C|hepatitis c
261395|NCT01838590|Hepatitis C, Chronic|hepatitis c, chronic
261396|NCT01838564|Pediatric Advanced Cancer|pediatric advanced cancer
261397|NCT01838564|Children|children
261398|NCT01838564|Quality of Life|quality of life
261399|NCT01838564|Health Information technology|health information technology
261400|NCT01838564|Patient reported outcomes|patient reported outcomes
261401|NCT01838525|sepsis|sepsis
261402|NCT01838525|alpha-1-acid glycoprotein (AGP)|alpha-1-acid glycoprotein (agp)
261403|NCT01838525|diagnosis|diagnosis
261404|NCT01838525|prognosis|prognosis
261405|NCT01838525|SIRS|sirs
261406|NCT01838486|Interstitial cystitis|interstitial cystitis
261407|NCT01838486|painful bladder syndrome|painful bladder syndrome
261408|NCT01838486|bladder hydrodistention|bladder hydrodistention
261409|NCT01838486|hyperthermia|hyperthermia
261410|NCT01838473|smokeless tobacco|smokeless tobacco
261411|NCT01838473|Nicotine|nicotine
261412|NCT01838473|Cadmium|cadmium
261413|NCT01838473|lead|lead
261414|NCT01838473|Tobacco Specific Nitrosamines|tobacco specific nitrosamines
261415|NCT01838447|Vitamin D|vitamin d
261416|NCT01838447|Congenital Heart Disease|congenital heart disease
261417|NCT01838447|Cardiac Surgery|cardiac surgery
261418|NCT01838447|Pediatrics|pediatrics
261419|NCT01838447|Phase II Clinical Trial|phase ii clinical trial
261420|NCT01838408|screening colonoscopy|screening colonoscopy
261421|NCT01838408|surveillance colonoscopy|surveillance colonoscopy
261422|NCT01838408|colonoscopy|colonoscopy
261423|NCT01838395|AML|aml
261426|NCT01838395|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
261427|NCT01838382|pain|pain
261428|NCT01838382|total laparoscopic hysterectomy|total laparoscopic hysterectomy
261429|NCT01838356|Depression|depression
261430|NCT01838356|Vascular depression|vascular depression
261431|NCT01838356|Intracranial atherosclerosis|intracranial atherosclerosis
261432|NCT01838356|Coronary artery disease|coronary artery disease
261433|NCT01838356|Coronary artery bypass graft|coronary artery bypass graft
261434|NCT01838356|Cognitive impairment|cognitive impairment
261435|NCT01838330|Kidney Disease|kidney disease
261436|NCT01838330|Fiber|fiber
261437|NCT01838330|Dietary Intervention|dietary intervention
261438|NCT01838304|propofol sedation endoscopy|propofol sedation endoscopy
261439|NCT01838291|Ferriprox|ferriprox
261440|NCT01838291|Deferiprone|deferiprone
261442|NCT01838291|L1|l1
261443|NCT01838278|Vojta therapy|vojta therapy
261444|NCT01838278|Exercise Movement Technique|exercise movement technique
261445|NCT01838278|Early intervention|early intervention
261446|NCT01838252|Ectropion|ectropion
261447|NCT01838252|Hyaluronic Acid|hyaluronic acid
261448|NCT01838252|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
261449|NCT01838252|Lower eyelid retraction|lower eyelid retraction
261450|NCT01838239|Fish oil|fish oil
261451|NCT01838239|Omega-3 fatty acids|omega-3 fatty acids
261455|NCT01838213|Urinary tract infection|urinary tract infection
261456|NCT01838213|ESBL|esbl
261457|NCT01838213|treatment|treatment
261458|NCT01838213|carriage|carriage
261459|NCT01838213|risk factors|risk factors
261460|NCT01838213|water contamination|water contamination
261461|NCT01838200|BCG|bcg
261462|NCT01838200|Bacillus Calmette-Guérin|bacillus calmette-guérin
261463|NCT01838200|Ipilimumab|ipilimumab
261464|NCT01838200|YERVOY|yervoy
261465|NCT01838200|Advanced Metastatic Melanoma|advanced metastatic melanoma
261466|NCT01838200|Metastatic Melanoma|metastatic melanoma
261467|NCT01838174|Optic Neuritis|optic neuritis
261468|NCT01838161|adolescents|adolescents
261469|NCT01838161|immunizations|immunizations
261470|NCT01838148|coronary artery disease|coronary artery disease
261471|NCT01838148|angina, stable|angina, stable
261472|NCT01838148|exercise test|exercise test
261473|NCT01838148|biological Markers|biological markers
261474|NCT01838148|SPECT|spect
261475|NCT01838135|wheelchair|wheelchair
261476|NCT01838135|manual wheelchair|manual wheelchair
261477|NCT01838135|rehabilitation|rehabilitation
261478|NCT01838135|self-efficacy|self-efficacy
261479|NCT01838135|older adults|older adults
261480|NCT01838135|feasibility|feasibility
261481|NCT01838135|intervention|intervention
261482|NCT01838135|training|training
261483|NCT01838122|PCOS|pcos
261484|NCT01838122|HbA1C|hba1c
261485|NCT01838122|Insulin resistance|insulin resistance
261486|NCT01838122|OGTT|ogtt
261487|NCT01838122|HOMA-IR|homa-ir
261488|NCT01838122|HOMA-B-cell|homa-b-cell
261489|NCT01838070|Hepatitis A|hepatitis a
261490|NCT01838070|Hepatitis A vaccine|hepatitis a vaccine
261491|NCT01838070|AVAXIM 160U|avaxim 160u
261492|NCT01838031|antenatal thyroid screening|antenatal thyroid screening
261493|NCT01838031|subclinical hypothyroidism|subclinical hypothyroidism
261494|NCT01838031|thyroid function|thyroid function
261495|NCT01838031|thyroid antibody|thyroid antibody
261496|NCT01838031|pregnancy outcome|pregnancy outcome
261497|NCT01838031|childhood cognitive function|childhood cognitive function
261499|NCT01838018|brain iron|brain iron
261500|NCT01838018|NBIA|nbia
402011|NCT01233492|adult gliosarcoma|adult gliosarcoma
261501|NCT01838018|neurodegeneration with brain iron accumulation|neurodegeneration with brain iron accumulation
261502|NCT01838018|Hallervorden Spatz Syndrome|hallervorden spatz syndrome
261503|NCT01838005|Contingency management|contingency management
261504|NCT01838005|conditional cash transfer|conditional cash transfer
261505|NCT01838005|PMTCT|pmtct
261506|NCT01838005|Retention|retention
261507|NCT01838005|HIV|hiv
261508|NCT01837979|prenatal testing for fetal aneuploidy|prenatal testing for fetal aneuploidy
261509|NCT01837979|dried blood spots|dried blood spots
261510|NCT01837979|cell-free fetal DNA|cell-free fetal dna
261511|NCT01837979|detection rate|detection rate
261512|NCT01837979|cost-effectiveness|cost-effectiveness
261513|NCT01837966|re-operative anxiety|re-operative anxiety
261514|NCT01837966|breast surgery|breast surgery
261515|NCT01837966|lavender oil|lavender oil
261516|NCT01837966|aromatherapy|aromatherapy
261517|NCT01837927|Efficacy, NVA237, Tiotropium, Chronic Obstructive Pulmonary Disease, COPD|efficacy, nva237, tiotropium, chronic obstructive pulmonary disease, copd
261518|NCT01837901|transcorneal electrostimulation|transcorneal electrostimulation
261519|NCT01837888|wheelchair|wheelchair
261520|NCT01837888|manual wheelchair|manual wheelchair
261521|NCT01837888|rehabilitation|rehabilitation
261522|NCT01837888|self-efficacy|self-efficacy
261523|NCT01837888|older adults|older adults
261524|NCT01837888|feasibility|feasibility
261525|NCT01837888|intervention|intervention
261526|NCT01837888|training|training
261527|NCT01837888|Wheelchair mobility|wheelchair mobility
261528|NCT01837875|Intervention|intervention
261529|NCT01837875|Quality of life|quality of life
261530|NCT01837875|African American|african american
261531|NCT01837875|Stress|stress
261532|NCT01837862|pilomyxoid astrocytoma|pilomyxoid astrocytoma
261533|NCT01837862|Pilocytic Astrocytoma|pilocytic astrocytoma
261534|NCT01837862|Glioma|glioma
261535|NCT01837862|Optic Nerve Glioma|optic nerve glioma
261536|NCT01837862|mebendazole|mebendazole
261537|NCT01837862|Pleomorphic Xanthoastrocytoma|pleomorphic xanthoastrocytoma
261538|NCT01837862|glioblastoma multiforme|glioblastoma multiforme
261539|NCT01837862|anaplastic astrocytoma|anaplastic astrocytoma
261540|NCT01837862|gliosarcoma|gliosarcoma
261541|NCT01837862|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
261542|NCT01837862|DIPG|dipg
261543|NCT01837862|low-grade glioma|low-grade glioma
261544|NCT01837862|high-grade glioma|high-grade glioma
261545|NCT01837862|brainstem glioma|brainstem glioma
261546|NCT01837862|pediatric|pediatric
261547|NCT01837849|heart failure|heart failure
261548|NCT01837849|rhBNP|rhbnp
261549|NCT01837849|Dobutamine|dobutamine
261550|NCT01837836|Health education|health education
261551|NCT01837836|water handling practices|water handling practices
261552|NCT01837836|Bacteriological quality of water|bacteriological quality of water
261553|NCT01837823|Coronary artery disease|coronary artery disease
261554|NCT01837823|Lipid|lipid
261555|NCT01837823|Regression|regression
261556|NCT01837823|Plaque|plaque
261557|NCT01837810|Post tonsillectomy hemorrhage|post tonsillectomy hemorrhage
261558|NCT01837810|post operative hemorrhage|post operative hemorrhage
261559|NCT01837810|complications|complications
261560|NCT01837810|tonsillectomy|tonsillectomy
261561|NCT01837758|Platelet function|platelet function
261562|NCT01837758|hemofiltration|hemofiltration
261563|NCT01837758|Multiplate|multiplate
261564|NCT01837732|Chronic pain|chronic pain
261565|NCT01837732|elderly|elderly
261566|NCT01837732|relational touch|relational touch
261567|NCT01837706|Empathy|empathy
261568|NCT01837706|Communication|communication
261569|NCT01837706|Physician litigation|physician litigation
261570|NCT01837693|cervical cancer screening|cervical cancer screening
261571|NCT01837693|CIN|cin
261572|NCT01837693|cervical cancer|cervical cancer
261573|NCT01837693|biomarkers|biomarkers
261574|NCT01837693|sensitivity and specificity|sensitivity and specificity
261575|NCT01837680|Insulin, Long-Acting|insulin, long-acting
261576|NCT01837654|Detrusor Overactivity|detrusor overactivity
261577|NCT01837654|Plantarflexion|plantarflexion
261578|NCT01837654|Urgency|urgency
261579|NCT01837628|Urodynamic|urodynamic
261580|NCT01837628|Paraffin oil|paraffin oil
261581|NCT01837628|Lidocaine gel|lidocaine gel
261582|NCT01837628|Pain|pain
261583|NCT01837615|Ulcerative Colitis|ulcerative colitis
261584|NCT01837615|Ulcerative Proctitis|ulcerative proctitis
261585|NCT01837615|Low Level Light Therapy|low level light therapy
261586|NCT01837615|Safety|safety
261590|NCT01837602|with operable triple negative breast cancer|with operable triple negative breast cancer
261591|NCT01837589|Cystic fibrosis-DXA-QCT-Osteopenia- Osteoporosis|cystic fibrosis-dxa-qct-osteopenia- osteoporosis
261592|NCT01837576|Psoriasis Vulgaris|psoriasis vulgaris
261593|NCT01837576|Calcipotriol|calcipotriol
261594|NCT01837576|Betamethasone Dipropionate|betamethasone dipropionate
261595|NCT01837550|audiologic rehabilitation|audiologic rehabilitation
694110|NCT00943592|Melphalan|melphalan
261596|NCT01837550|hearing loss|hearing loss
261597|NCT01837550|patient education|patient education
261598|NCT01837550|patient participation|patient participation
261599|NCT01837550|structured rehabilitation|structured rehabilitation
261600|NCT01837550|counseling|counseling
261601|NCT01837550|Internet|internet
261602|NCT01837524|Dietary advice|dietary advice
261603|NCT01837524|Nutritional knowledge|nutritional knowledge
261604|NCT01837524|Self-efficacy|self-efficacy
261605|NCT01837524|Nutrition|nutrition
261606|NCT01837511|Tumor antigens|tumor antigens
261607|NCT01837511|Asiatic patients|asiatic patients
261608|NCT01837511|Reverse Transciptase-Polymerase chain reaction (RT-PCR)|reverse transciptase-polymerase chain reaction (rt-pcr)
261609|NCT01837511|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
261610|NCT01837498|residual neuromuscular blockade, sugammadex, neostigmine, thoracic surgery|residual neuromuscular blockade, sugammadex, neostigmine, thoracic surgery
261611|NCT01837485|Irritable bowel syndrome|irritable bowel syndrome
261612|NCT01837485|Functional gastrointestinal disorders|functional gastrointestinal disorders
261613|NCT01837485|Gut flora|gut flora
261614|NCT01837485|Probiotics|probiotics
261615|NCT01837472|Irritable bowel syndrome|irritable bowel syndrome
261616|NCT01837472|Functional gastrointestinal disorders|functional gastrointestinal disorders
261617|NCT01837472|Gut flora|gut flora
261618|NCT01837472|Probiotics|probiotics
261619|NCT01837459|Obstructive Sleep Apnea|obstructive sleep apnea
261620|NCT01837459|Sleep Disordered Breathing|sleep disordered breathing
261621|NCT01837459|Vascular function|vascular function
261622|NCT01837459|Arterial stiffness|arterial stiffness
261623|NCT01837459|Polysomnography|polysomnography
261624|NCT01837459|Cytokines|cytokines
261625|NCT01837446|mucositis|mucositis
261626|NCT01837446|topical morphine|topical morphine
261627|NCT01837446|pain|pain
261628|NCT01837446|head and neck carcinoma|head and neck carcinoma
261629|NCT01837433|Efficacy|efficacy
261630|NCT01837433|safety|safety
261631|NCT01837433|short|short
261632|NCT01837433|term|term
261633|NCT01837433|subacute thyroiditis|subacute thyroiditis
261634|NCT01837407|Soft tissue loss|soft tissue loss
261635|NCT01837407|nerve defect|nerve defect
261636|NCT01837407|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
261637|NCT01837407|heterodigital arterialized nerve pedicle flap|heterodigital arterialized nerve pedicle flap
261638|NCT01837407|Composite Flap|composite flap
261639|NCT01837407|nerve flap|nerve flap
261640|NCT01837407|nerve transfer|nerve transfer
261641|NCT01837394|Nerve block|nerve block
261642|NCT01837394|Ultrasound|ultrasound
261643|NCT01837394|postoperative pain|postoperative pain
261644|NCT01837394|Saphenous nerve|saphenous nerve
261645|NCT01837394|Obturator nerve|obturator nerve
261646|NCT01837329|Non-Squamous|non-squamous
261647|NCT01837329|NSCLC|nsclc
261648|NCT01837329|Adenocarcinoma|adenocarcinoma
261649|NCT01837329|Lung Cancer|lung cancer
261650|NCT01837329|Tetrathiomolybdate|tetrathiomolybdate
261651|NCT01837329|Copper|copper
261652|NCT01837329|Carboplatin|carboplatin
261653|NCT01837329|Pemetrexed Platinum|pemetrexed platinum
261654|NCT01837329|Newly Diagnosed|newly diagnosed
261655|NCT01837329|Chemo-naive|chemo-naive
261656|NCT01837316|pharmacodynamics|pharmacodynamics
261657|NCT01837316|FF/VI|ff/vi
261658|NCT01837316|asthma|asthma
261659|NCT01837316|duration of action|duration of action
261660|NCT01837303|Cervical dysplasia|cervical dysplasia
261661|NCT01837303|Cervical cancer|cervical cancer
261662|NCT01837290|Renal failure,|renal failure,
261663|NCT01837290|hip fracture,|hip fracture,
261664|NCT01837290|spinal anesthesia,|spinal anesthesia,
261665|NCT01837290|dexmedetomidine|dexmedetomidine
261666|NCT01837290|patient|patient
261667|NCT01837264|Magellan MAR01|magellan mar01
261668|NCT01837264|Autologous Platelet Rich Plasma|autologous platelet rich plasma
261669|NCT01837264|Compartment Syndrome|compartment syndrome
261670|NCT01837264|Battlefield Trauma|battlefield trauma
261671|NCT01837264|Fasciotomy|fasciotomy
261672|NCT01837251|Ovarian Carcinoma|ovarian carcinoma
261673|NCT01837251|Bevacizumab|bevacizumab
261674|NCT01837251|Gemcitabine|gemcitabine
261676|NCT01837251|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
261677|NCT01837251|Carboplatin|carboplatin
261678|NCT01837251|best therapeutic index|best therapeutic index
261679|NCT01837251|progression-free survival|progression-free survival
261680|NCT01837238|hemodialysis|hemodialysis
261681|NCT01837238|physical function|physical function
261682|NCT01837225|Fluorescence Imaging|fluorescence imaging
261683|NCT01837225|Breast Tumor Margins|breast tumor margins
261684|NCT01837225|Real-time Assessment|real-time assessment
261685|NCT01837199|Periodontal disease|periodontal disease
261686|NCT01837199|Scaling and root planing|scaling and root planing
261687|NCT01837199|Metronidazole|metronidazole
261688|NCT01837199|Amoxicillin|amoxicillin
261689|NCT01837199|Generalized chronic periodontitis|generalized chronic periodontitis
261690|NCT01837199|Periodontal treatment|periodontal treatment
261692|NCT01837186|NSCLC|nsclc
261693|NCT01837173|Adenocarcinoma|adenocarcinoma
261694|NCT01837173|Squamous Cell Carcinoma|squamous cell carcinoma
261695|NCT01837173|Neoadjuvant treatment|neoadjuvant treatment
261696|NCT01837173|Esophagectomy|esophagectomy
261697|NCT01837160|Angiogenesis|angiogenesis
261698|NCT01837160|Fibrosis|fibrosis
261699|NCT01837160|Aortic Stenosis|aortic stenosis
261700|NCT01837160|Imaging|imaging
261701|NCT01837160|CT-PET|ct-pet
261702|NCT01837160|PET-CT|pet-ct
261703|NCT01837160|Cardiac MRI|cardiac mri
261704|NCT01837147|primary prevention|primary prevention
261705|NCT01837147|sedentary|sedentary
261706|NCT01837147|overweight|overweight
261707|NCT01837147|obesity|obesity
261708|NCT01837147|breast cancer|breast cancer
261709|NCT01837147|post-menopausal|post-menopausal
261710|NCT01837147|women|women
261711|NCT01837134|telemedicine|telemedicine
261712|NCT01837134|overweight|overweight
261713|NCT01837134|obesity|obesity
261714|NCT01837121|not-attended rate|not-attended rate
261715|NCT01837121|re-visit|re-visit
261716|NCT01837121|vision|vision
261717|NCT01837121|knowledge|knowledge
261718|NCT01837121|satisfaction|satisfaction
261719|NCT01837108|healthy|healthy
261720|NCT01837095|Overall survival|overall survival
261721|NCT01837095|Progression free survival|progression free survival
261722|NCT01837082|Heart Failure|heart failure
261723|NCT01837082|Iron Deficiency|iron deficiency
261724|NCT01837082|Anemia|anemia
261822|NCT01836718|HCV|hcv
261725|NCT01837082|Ferric Carboxymaltose|ferric carboxymaltose
261726|NCT01837069|Hypertension|hypertension
261727|NCT01837069|Diabetes|diabetes
261728|NCT01837069|Coronary Artery Disease|coronary artery disease
261729|NCT01837069|Peripheral Vascular Disease|peripheral vascular disease
261730|NCT01837056|Toxoplasma gondii|toxoplasma gondii
261731|NCT01837056|Toxocara canis|toxocara canis
261732|NCT01837043|Delayed Graft Function|delayed graft function
261733|NCT01837043|Renal Transplantation|renal transplantation
261734|NCT01837043|Kidney Transplant|kidney transplant
261735|NCT01837017|Falls,|falls,
261736|NCT01837017|Balance,|balance,
261737|NCT01837017|Gait,|gait,
261738|NCT01837017|Older adults|older adults
261739|NCT01837004|adherence|adherence
261740|NCT01837004|cognition|cognition
261741|NCT01837004|exercise|exercise
261742|NCT01837004|aging|aging
261743|NCT01836991|gastric cancer|gastric cancer
261744|NCT01836991|surgery|surgery
261745|NCT01836991|surgery safety|surgery safety
261746|NCT01836991|effect|effect
261747|NCT01836965|Aspergers|aspergers
261748|NCT01836965|Social Skills|social skills
261749|NCT01836965|Adolescents|adolescents
261750|NCT01836965|High-functioning Autism|high-functioning autism
261751|NCT01836939|psoriasis, oral therapy|psoriasis, oral therapy
261752|NCT01836939|ova|ova
261753|NCT01836939|Trichuris suis ova|trichuris suis ova
261754|NCT01836939|TSO|tso
261755|NCT01836939|CNDO 201 Trichuris suis ova|cndo 201 trichuris suis ova
261756|NCT01836926|sphincter sparing procedures|sphincter sparing procedures
261757|NCT01836926|intersphincteric resection|intersphincteric resection
261758|NCT01836926|rectal cancer|rectal cancer
261759|NCT01836926|low rectal cancer|low rectal cancer
261760|NCT01836926|sphincter preserving procedures|sphincter preserving procedures
261761|NCT01836926|Abdominoperineal resection|abdominoperineal resection
261762|NCT01836926|laparoscopic resection of rectal cancer|laparoscopic resection of rectal cancer
261888|NCT01836237|Wound protector use|wound protector use
261763|NCT01836926|laparoscopic versus open colorectal resection|laparoscopic versus open colorectal resection
261764|NCT01836926|laparoscopic versus open rectal surgery|laparoscopic versus open rectal surgery
261765|NCT01836926|neoadjuvant chemo-radiotherapy for rectal cancer|neoadjuvant chemo-radiotherapy for rectal cancer
261766|NCT01836913|PET/CT|pet/ct
261767|NCT01836913|Esophageal cancer|esophageal cancer
261768|NCT01836913|Radiotherapy|radiotherapy
261769|NCT01836900|OTSC|otsc
261770|NCT01836900|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
261771|NCT01836887|Polyphenol|polyphenol
261772|NCT01836887|Fruit|fruit
261773|NCT01836887|Metabolic|metabolic
261774|NCT01836887|Healthy|healthy
261775|NCT01836874|Migraine|migraine
252392|NCT01878630|CHF|chf
261776|NCT01836874|Indian|indian
261777|NCT01836874|Topiramate|topiramate
261778|NCT01836861|Phase I|phase i
261779|NCT01836861|healthy male volunteers|healthy male volunteers
261780|NCT01836861|ADME|adme
261781|NCT01836861|Bioavailability|bioavailability
261782|NCT01836861|PI3K inhibitor|pi3k inhibitor
261784|NCT01836861|Distribution|distribution
261785|NCT01836861|Metabolism|metabolism
261786|NCT01836861|Excretion|excretion
261787|NCT01836861|safety|safety
261788|NCT01836848|subarachnoid hemorrhage|subarachnoid hemorrhage
261789|NCT01836848|near-infrared-spectroscopy|near-infrared-spectroscopy
261790|NCT01836848|indocyanine green|indocyanine green
261791|NCT01836848|secondary ischemia|secondary ischemia
261792|NCT01836835|Hyperemesis gravidarum|hyperemesis gravidarum
261793|NCT01836835|Pregnancy|pregnancy
261794|NCT01836835|Nausea|nausea
261795|NCT01836835|Nutritional status|nutritional status
261796|NCT01836835|Questionnaire|questionnaire
261797|NCT01836835|Case-control|case-control
261798|NCT01836822|mediastinal lymph node enlargement|mediastinal lymph node enlargement
261799|NCT01836822|sarcoidosis|sarcoidosis
261800|NCT01836822|bronchoscopy|bronchoscopy
261801|NCT01836822|EBUS guided transbronchial needle aspiration (EBUS-TBNA)|ebus guided transbronchial needle aspiration (ebus-tbna)
261802|NCT01836822|transbronchial needle aspiration (EBUS-TBNA)|transbronchial needle aspiration (ebus-tbna)
261803|NCT01836822|EBUS guided transbronchial forceps biopsy EBUS-TBFB)|ebus guided transbronchial forceps biopsy ebus-tbfb)
261804|NCT01836809|Total Artificial Heart|total artificial heart
261805|NCT01836809|Left Ventricular Assist Device|left ventricular assist device
261806|NCT01836809|Natriuretic peptides|natriuretic peptides
261807|NCT01836809|Heart Failure|heart failure
261808|NCT01836809|Cardiorenal Syndrome|cardiorenal syndrome
261809|NCT01836783|Allograft|allograft
261810|NCT01836783|Amnion Allograft|amnion allograft
261811|NCT01836770|Transforaminal Epidural Steroid Injections|transforaminal epidural steroid injections
261812|NCT01836757|osteoarthritis|osteoarthritis
261813|NCT01836757|CAM treatments|cam treatments
261814|NCT01836757|MSM|msm
261815|NCT01836731|weight-for age|weight-for age
261816|NCT01836731|height-for-age|height-for-age
261817|NCT01836731|water sanitation facilities|water sanitation facilities
261818|NCT01836731|hygiene behavior|hygiene behavior
261819|NCT01836718|Hepatitis C Virus|hepatitis c virus
261820|NCT01836718|Liver Transplantation|liver transplantation
261821|NCT01836718|Antiviral Therapy|antiviral therapy
261826|NCT01836653|KRAS wild type colorectal cancer|kras wild type colorectal cancer
261827|NCT01836653|RAS wild type colorectal cancer|ras wild type colorectal cancer
261828|NCT01836653|liver metastasis|liver metastasis
261829|NCT01836627|Congenital Muscular Dystrophy|congenital muscular dystrophy
261830|NCT01836627|Collagen VI Deficiency|collagen vi deficiency
261831|NCT01836627|Hyperinsufflation|hyperinsufflation
261832|NCT01836627|Cough Assist|cough assist
261833|NCT01836627|LAMA2- Muscular Dystrophy|lama2- muscular dystrophy
261834|NCT01836601|safety|safety
261835|NCT01836601|patient experience|patient experience
261836|NCT01836601|family-centered rounds|family-centered rounds
261837|NCT01836575|Advanced NSCLC|advanced nsclc
261839|NCT01836575|Pemetrexed|pemetrexed
261840|NCT01836575|First line|first line
261841|NCT01836575|non squamous|non squamous
261842|NCT01836562|Autism stem cell MNCs|autism stem cell mncs
261843|NCT01836536|High grade glioma|high grade glioma
261844|NCT01836536|Bevacizumab|bevacizumab
261845|NCT01836536|Chemotherapy|chemotherapy
261846|NCT01836536|Myeloid Cells|myeloid cells
261847|NCT01836536|Treg|treg
261848|NCT01836510|Heart Failure|heart failure
261849|NCT01836510|Remote Monitoring|remote monitoring
261850|NCT01836510|Lung Edema|lung edema
261851|NCT01836510|Patient Monitoring|patient monitoring
261852|NCT01836510|Prediction|prediction
261855|NCT01836458|Malaria, KAE609|malaria, kae609
261856|NCT01836432|Pancreatic Cancer|pancreatic cancer
261857|NCT01836432|Immunotherapy|immunotherapy
261858|NCT01836432|Vaccine Therapy|vaccine therapy
261859|NCT01836419|classic laryngeal mask airway|classic laryngeal mask airway
261860|NCT01836419|elderly patients|elderly patients
261861|NCT01836406|ketorolac|ketorolac
261862|NCT01836406|remote ischemic preconditioning|remote ischemic preconditioning
261863|NCT01836406|partial nephrectomy|partial nephrectomy
261864|NCT01836393|Plai|plai
261865|NCT01836393|Efficacy|efficacy
261866|NCT01836393|OA knee|oa knee
261867|NCT01836393|The efficacy study of Plai cream for OA knee|the efficacy study of plai cream for oa knee
261868|NCT01836367|Actinic Keratosis|actinic keratosis
261869|NCT01836367|Face|face
261870|NCT01836367|Scalp|scalp
261871|NCT01836367|Ingenol Mebutate|ingenol mebutate
261872|NCT01836354|stroke|stroke
261873|NCT01836354|interactive educational intervention|interactive educational intervention
261874|NCT01836354|acute ischemic stroke|acute ischemic stroke
261875|NCT01836354|transient ischemic attack|transient ischemic attack
261876|NCT01836341|Afatinib|afatinib
261877|NCT01836341|Cisplatin|cisplatin
261878|NCT01836341|Carboplatin|carboplatin
323228|NCT01562275|MEK|mek
252494|NCT01876602|fitness|fitness
261879|NCT01836341|Pemetrexed|pemetrexed
261880|NCT01836341|Radiation therapy|radiation therapy
261881|NCT01836341|EGFR mutation|egfr mutation
261882|NCT01836341|12-279|12-279
261883|NCT01836328|Methadone|methadone
261884|NCT01836328|Pain|pain
261885|NCT01836328|Neoplasms|neoplasms
261886|NCT01836328|Ratio|ratio
261887|NCT01836237|Surgical site infection rate|surgical site infection rate
261889|NCT01836237|Whipple|whipple
261890|NCT01836211|Chest pain|chest pain
261891|NCT01836211|Acute coronary syndrome|acute coronary syndrome
261892|NCT01836211|Cardiac biomarkers|cardiac biomarkers
261893|NCT01836211|Computed coronary tomography angiography|computed coronary tomography angiography
261894|NCT01836211|Emergency department|emergency department
261895|NCT01836172|The treatment of diabetic complication|the treatment of diabetic complication
261896|NCT01836159|Stroke Rehabilitation|stroke rehabilitation
261898|NCT01836159|Fine Motor Function|fine motor function
261899|NCT01836159|Ischemic Stroke|ischemic stroke
261900|NCT01836159|Visual Neglect|visual neglect
261901|NCT01836120|second-line chemotherapy|second-line chemotherapy
261902|NCT01836120|Raltitrexed|raltitrexed
261903|NCT01836107|Clinical notes|clinical notes
261904|NCT01836107|Communication between physicians|communication between physicians
261905|NCT01836107|Quality|quality
261906|NCT01836107|Cross-cultural adaptation|cross-cultural adaptation
261907|NCT01836094|Methylene Blue|methylene blue
261908|NCT01836094|Memory|memory
261909|NCT01836094|Mental Fatigue|mental fatigue
261910|NCT01836094|Brain metabolism|brain metabolism
261911|NCT01836094|fMRI|fmri
261912|NCT01836094|psychomotor vigilance task (PVT)|psychomotor vigilance task (pvt)
261913|NCT01836094|delayed match-to-sample memory task|delayed match-to-sample memory task
261914|NCT01836094|PVT|pvt
261915|NCT01836094|DMS|dms
261916|NCT01836081|fluid responsiveness|fluid responsiveness
261917|NCT01836081|carotid artery peak velocity variation|carotid artery peak velocity variation
261918|NCT01836081|coronary disease|coronary disease
261919|NCT01836068|HIV positive|hiv positive
261920|NCT01836068|HIV-1|hiv-1
261921|NCT01836068|Bone Marrow Transplant|bone marrow transplant
261922|NCT01836068|Allogeneic BMT|allogeneic bmt
261923|NCT01836068|BMT|bmt
261924|NCT01836055|Multiple Sclerosis|multiple sclerosis
261925|NCT01836055|White Matter Lesions|white matter lesions
261926|NCT01836055|Contrast Agent|contrast agent
261927|NCT01836055|Magnetic Resonance Imaging|magnetic resonance imaging
261928|NCT01836042|Primary open-angle glaucoma (POAG)|primary open-angle glaucoma (poag)
261929|NCT01836042|Trabecular meshwork|trabecular meshwork
261930|NCT01836042|iStent|istent
261931|NCT01836029|SCCHN|scchn
261932|NCT01836029|HNSCC|hnscc
261933|NCT01836016|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
261934|NCT01836016|Comparative effectiveness research|comparative effectiveness research
261935|NCT01836016|Medicine, Chinese Traditional|medicine, chinese traditional
261936|NCT01836016|Humans|humans
261937|NCT01836016|Treatment Outcome|treatment outcome
261938|NCT01836003|Pregnancy|pregnancy
261939|NCT01836003|Prevention of Mother to Child Transmission|prevention of mother to child transmission
261940|NCT01836003|Short Message Service (SMS)|short message service (sms)
261941|NCT01836003|HIV infection|hiv infection
261942|NCT01836003|CD4 testing|cd4 testing
261943|NCT01836003|Antiretroviral therapy|antiretroviral therapy
261944|NCT01835990|venous thromboembolism|venous thromboembolism
261945|NCT01835990|trauma|trauma
261946|NCT01835990|mechanical methods of prophylaxis|mechanical methods of prophylaxis
261947|NCT01835977|Focal therapy|focal therapy
261948|NCT01835977|Irreversible electroporation|irreversible electroporation
261949|NCT01835977|Unilateral prostate cancer|unilateral prostate cancer
261950|NCT01835964|Glucose Variability (GV)|glucose variability (gv)
261951|NCT01835964|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
261952|NCT01835951|Simulation|simulation
261953|NCT01835951|Debriefing|debriefing
261954|NCT01835951|Anaesthesia Crisis Management|anaesthesia crisis management
261955|NCT01835951|Cardiac Arrest|cardiac arrest
261956|NCT01835951|Pregnancy|pregnancy
261957|NCT01835938|Hepatitis C Virus infection|hepatitis c virus infection
261958|NCT01835938|entry inhibitor|entry inhibitor
261959|NCT01835938|kinase inhibitor|kinase inhibitor
261960|NCT01835925|adenocarcinoma of rectum|adenocarcinoma of rectum
261961|NCT01835925|rectal cancer|rectal cancer
261962|NCT01835925|stage II|stage ii
261963|NCT01835925|stage III|stage iii
261964|NCT01835912|performance|performance
261965|NCT01835912|speed|speed
261966|NCT01835912|exertion|exertion
261967|NCT01835860|BPH|bph
261968|NCT01835834|zirconia crown|zirconia crown
261969|NCT01835821|zirconia|zirconia
261970|NCT01835821|crown|crown
261971|NCT01835821|IPS e.max CAD|ips e.max cad
261972|NCT01835808|Fractional flow reserve|fractional flow reserve
261973|NCT01835795|Myofascial Pain Syndromes|myofascial pain syndromes
261974|NCT01835795|Myofascial Trigger Point|myofascial trigger point
261975|NCT01835795|Low Back Pain|low back pain
261976|NCT01835795|Lumbago|lumbago
261977|NCT01835795|Shock Waves, High-Energy|shock waves, high-energy
261978|NCT01835795|High-Energy Shock Waves|high-energy shock waves
261979|NCT01835795|Interdisciplinary Health Team|interdisciplinary health team
261980|NCT01835795|Multidisciplinary Pain Centers|multidisciplinary pain centers
261981|NCT01835782|ALS|als
261982|NCT01835782|L-Serine|l-serine
261983|NCT01835782|BMAA|bmaa
261984|NCT01835717|Preclinical phase of Alzheimer's disease|preclinical phase of alzheimer's disease
261987|NCT01835717|Exogenous factors|exogenous factors
261988|NCT01835717|Endogenous factors|endogenous factors
261989|NCT01835717|Episodic memory test|episodic memory test
261990|NCT01835717|Executive function test|executive function test
261991|NCT01835717|Memory binding test validation into Spanish|memory binding test validation into spanish
261992|NCT01835717|Memory binding test validation into Catalan|memory binding test validation into catalan
261993|NCT01835691|Chronic Kidney Disease|chronic kidney disease
261995|NCT01835691|Vitamin D2|vitamin d2
261996|NCT01835691|Vitamin D3|vitamin d3
261997|NCT01835652|Exercise|exercise
261998|NCT01835652|Parkinson's Disease|parkinson's disease
261999|NCT01835652|Positron Emission Tomography|positron emission tomography
262000|NCT01835652|fMRI|fmri
262001|NCT01835639|Glomerular Disease|glomerular disease
262002|NCT01835639|Vitamin D|vitamin d
262003|NCT01835639|Steroid-resistant nephrotic syndrome|steroid-resistant nephrotic syndrome
262004|NCT01835639|Minimal change disease|minimal change disease
262005|NCT01835639|Focal segmental glomerulosclerosis (FSGS)|focal segmental glomerulosclerosis (fsgs)
262006|NCT01835639|Membranous Nephropathy|membranous nephropathy
262007|NCT01835639|Membranoprolfierative Glomerulonephritis|membranoprolfierative glomerulonephritis
262008|NCT01835639|immunoglobulin A (IgA) Nephropathy|immunoglobulin a (iga) nephropathy
262009|NCT01835639|FSGS|fsgs
262010|NCT01835639|IgA Nephropathy|iga nephropathy
262011|NCT01835626|Locally advanced basal cell carcinoma|locally advanced basal cell carcinoma
262012|NCT01835626|Skin cancer|skin cancer
262013|NCT01835626|Radiation therapy|radiation therapy
262014|NCT01835626|Vismodegib|vismodegib
262015|NCT01835626|Head and neck cancer|head and neck cancer
262016|NCT01835626|Cutaneous malignancy|cutaneous malignancy
262017|NCT01835613|Rheumatoid Arthritis|rheumatoid arthritis
262018|NCT01835613|Early RA|early ra
262019|NCT01835613|RA|ra
262020|NCT01835613|IL-6|il-6
262021|NCT01835613|IL-6R|il-6r
262022|NCT01835613|Inhibitor|inhibitor
262023|NCT01835613|Inhibition|inhibition
262024|NCT01835613|Tocilizumab|tocilizumab
262025|NCT01835613|Biomarkers|biomarkers
262026|NCT01835613|DMARDs|dmards
262027|NCT01835613|Biological|biological
262028|NCT01835613|DAS|das
262029|NCT01835613|SDAI|sdai
262030|NCT01835613|AR/BIOM|ar/biom
262031|NCT01835613|OEG|oeg
262032|NCT01835587|Acute myeloid leukemia,|acute myeloid leukemia,
262033|NCT01835587|myelodysplastic syndromes,|myelodysplastic syndromes,
262034|NCT01835587|CC-486, oral Azacitidine,|cc-486, oral azacitidine,
262035|NCT01835587|transplantation,|transplantation,
262036|NCT01835587|allogeneic,|allogeneic,
262037|NCT01835587|HSCT.|hsct.
262038|NCT01835574|Amphetamine-type substance use|amphetamine-type substance use
262039|NCT01835561|Hepatic, Liver disease; Pharmacokinetic; Healthy|hepatic, liver disease; pharmacokinetic; healthy
262040|NCT01835509|Childhood Cancer Survivors|childhood cancer survivors
262041|NCT01835496|sickle cell disease|sickle cell disease
262042|NCT01835496|iron overload|iron overload
262043|NCT01835496|pharmacokinetics|pharmacokinetics
262044|NCT01835496|Ferriprox|ferriprox
262045|NCT01835496|deferiprone|deferiprone
262046|NCT01835457|Endotoxemia|endotoxemia
262047|NCT01835457|Autonomic Nervous System|autonomic nervous system
262048|NCT01835457|Inflammation|inflammation
262049|NCT01835457|Meditation|meditation
262050|NCT01835457|Concentration|concentration
262051|NCT01835457|Iceman|iceman
262052|NCT01835457|LPS|lps
262053|NCT01835457|Cortisol|cortisol
262054|NCT01835457|Catecholamines|catecholamines
262055|NCT01835444|Physician Assistant|physician assistant
262056|NCT01835444|Substitution|substitution
262057|NCT01835444|Hospital ward care|hospital ward care
262058|NCT01835444|Secondary health care|secondary health care
262059|NCT01835418|managed with bedtime administration of lisinopril versus amlodipine|managed with bedtime administration of lisinopril versus amlodipine
262060|NCT01835392|Remote ischemic preconditioning|remote ischemic preconditioning
262061|NCT01835392|Heart defects, congenital|heart defects, congenital
262062|NCT01835392|cardiac surgery|cardiac surgery
262063|NCT01835392|Neurodevelopmental outcomes|neurodevelopmental outcomes
262064|NCT01835379|Diabetes|diabetes
262065|NCT01835379|Diabetic Foot Ulcer|diabetic foot ulcer
262066|NCT01835379|Diabetic Foot Wound|diabetic foot wound
262067|NCT01835379|Non-healing foot wound|non-healing foot wound
262068|NCT01835379|Oasis|oasis
262069|NCT01835379|Diabetic neuropathy|diabetic neuropathy
262070|NCT01835353|prasugrel|prasugrel
262071|NCT01835353|ST elevation myocardial infarction|st elevation myocardial infarction
262072|NCT01835327|intraoperative, post-operative recovery|intraoperative, post-operative recovery
262073|NCT01835327|thoracic surgery|thoracic surgery
262074|NCT01835327|cerebral oximetry|cerebral oximetry
262075|NCT01835262|pain|pain
262076|NCT01835262|Ketamine|ketamine
262077|NCT01835262|Emergency Medicine|emergency medicine
262079|NCT01835249|Hypertension|hypertension
262080|NCT01835249|Nighttime blood pressure|nighttime blood pressure
262081|NCT01835236|Breast cancer|breast cancer
262082|NCT01835236|HER2-positive|her2-positive
262083|NCT01835236|Metastases|metastases
262084|NCT01835197|Phase 1|phase 1
262085|NCT01835197|Randomized|randomized
262086|NCT01835197|Double Blind|double blind
262087|NCT01835197|Placebo-Controlled|placebo-controlled
262088|NCT01835197|Single- & Multiple Dose Escalation|single- & multiple dose escalation
262089|NCT01835197|Safety|safety
262090|NCT01835197|Tolerability|tolerability
262091|NCT01835197|PK|pk
262092|NCT01835197|PD|pd
262093|NCT01835197|Pf-04965842|pf-04965842
262094|NCT01835132|Scleritis|scleritis
262095|NCT01835132|IL-1|il-1
262096|NCT01835119|gynecological malignancies|gynecological malignancies
262097|NCT01835119|postoperative|postoperative
262098|NCT01835119|bowel activity|bowel activity
262099|NCT01835119|gum chewing|gum chewing
262100|NCT01835106|Postoperative Care|postoperative care
262101|NCT01835080|Obstructive Sleep Apnea, OSA, Pulmonary Arterial Hypertension, PAH, sleep study, polysomnogram, Respiratory Disturbance Index, RDI|obstructive sleep apnea, osa, pulmonary arterial hypertension, pah, sleep study, polysomnogram, respiratory disturbance index, rdi
262102|NCT01835067|Macular degeneration|macular degeneration
262103|NCT01835067|Submacular haemorrhage|submacular haemorrhage
262104|NCT01835054|Mitral regurgitation|mitral regurgitation
262105|NCT01835054|Mitral valve prolapse|mitral valve prolapse
262106|NCT01835054|Echocardiography, Doppler|echocardiography, doppler
262107|NCT01835054|Stress echocardiography|stress echocardiography
262108|NCT01835054|Cardiopulmonary exercice testing|cardiopulmonary exercice testing
262109|NCT01835054|Magnetic Resonance Imaging|magnetic resonance imaging
262110|NCT01835054|Cardiac neurohormones|cardiac neurohormones
262111|NCT01835054|Visceral obesity|visceral obesity
262112|NCT01835054|Cardiometabolic risk|cardiometabolic risk
262113|NCT01835054|Risk stratification|risk stratification
262114|NCT01835028|Aortic Stenosis|aortic stenosis
262115|NCT01835028|Low Flow|low flow
262116|NCT01835028|Low Gradient|low gradient
262117|NCT01835028|Left Ventricle|left ventricle
262118|NCT01835028|Echocardiography, Doppler|echocardiography, doppler
262119|NCT01835015|First in human|first in human
262120|NCT01835015|Safety|safety
262121|NCT01835015|Tolerability|tolerability
262122|NCT01835015|Serum PK|serum pk
262123|NCT01835015|Intravitreal (IVT)|intravitreal (ivt)
262124|NCT01835015|Age-related macular degeneration|age-related macular degeneration
262125|NCT01835015|AMD|amd
262126|NCT01835015|Geographic Atrophy|geographic atrophy
262127|NCT01835015|Choroidal neovascularization|choroidal neovascularization
262128|NCT01835002|transcorneal electrostimulation|transcorneal electrostimulation
262129|NCT01834976|cardiac biomarker|cardiac biomarker
262130|NCT01834976|congenital heart disease|congenital heart disease
262131|NCT01834976|surgery|surgery
262132|NCT01834937|ExAblate|exablate
262133|NCT01834937|MRgFUS|mrgfus
262134|NCT01834937|Bone Metastases|bone metastases
262135|NCT01834937|Pain Palliation|pain palliation
262136|NCT01834924|Health literacy|health literacy
262137|NCT01834924|Patient education|patient education
262138|NCT01834911|Huntington disease|huntington disease
262139|NCT01834911|HD|hd
262140|NCT01834911|tetrabenazine|tetrabenazine
262141|NCT01834911|Stroop|stroop
262142|NCT01834898|postoperative|postoperative
262143|NCT01834898|analgesia|analgesia
262144|NCT01834898|adverse effects|adverse effects
262145|NCT01834898|opioid|opioid
262146|NCT01834898|oxycodone|oxycodone
262147|NCT01834885|COPD|copd
262148|NCT01834859|weight reduction programs|weight reduction programs
262149|NCT01834859|diet|diet
262150|NCT01834859|Caloric restriction|caloric restriction
262151|NCT01834859|weight loss|weight loss
262152|NCT01834859|weight gain|weight gain
262153|NCT01834846|comparative study|comparative study
262154|NCT01834846|Cardiac Surgical Procedures|cardiac surgical procedures
262250|NCT01834352|Tree nut hypersensitivity|tree nut hypersensitivity
262155|NCT01834833|Acute heart failure; rehospitalisation; education; follow-up|acute heart failure; rehospitalisation; education; follow-up
262156|NCT01834820|Bronchiolitis|bronchiolitis
262157|NCT01834820|Epinephrine|epinephrine
262158|NCT01834820|Dexamethasone|dexamethasone
262159|NCT01834820|Hospitalization|hospitalization
262160|NCT01834820|Hypertonic Saline|hypertonic saline
262161|NCT01834794|Tobacco Use|tobacco use
262162|NCT01834781|multiple chemical sensitivity, re5 therapy, pulsed electromagnetic fields|multiple chemical sensitivity, re5 therapy, pulsed electromagnetic fields
262163|NCT01834742|Moviprep|moviprep
262164|NCT01834742|PEG3350|peg3350
262165|NCT01834742|Laxative|laxative
262166|NCT01834742|Stool Output|stool output
262167|NCT01834690|Liver transplantation/epidemiology|liver transplantation/epidemiology
262168|NCT01834690|Liver transplantation/pharmacology|liver transplantation/pharmacology
262169|NCT01834690|Health status/drug effects|health status/drug effects
262170|NCT01834690|Agents, immunosuppressive agents|agents, immunosuppressive agents
262171|NCT01834677|Depression|depression
262172|NCT01834677|Neurocognition|neurocognition
262173|NCT01834677|Electroconvulsive Therapy (ECT)|electroconvulsive therapy (ect)
262174|NCT01834677|Parkinson's Disease|parkinson's disease
262175|NCT01834664|Ataxic Infantile Cerebral Palsy stem cell therapy|ataxic infantile cerebral palsy stem cell therapy
262176|NCT01834651|liver metastasis|liver metastasis
262177|NCT01834651|lung metastasis|lung metastasis
262178|NCT01834651|metastatic castrate-resistant|metastatic castrate-resistant
262179|NCT01834651|prostate cancer|prostate cancer
262180|NCT01834638|schizophrenia|schizophrenia
262181|NCT01834612|blood loss, hemorrhage, hemorrhagic shcok|blood loss, hemorrhage, hemorrhagic shcok
262182|NCT01834599|placental oxygenation|placental oxygenation
262183|NCT01834599|obstetric anesthesia|obstetric anesthesia
262184|NCT01834599|NIRS|nirs
262185|NCT01834599|cerebral oximetry|cerebral oximetry
262186|NCT01834599|cerebral oximeter|cerebral oximeter
262187|NCT01834573|inflammatory bowel disease|inflammatory bowel disease
262188|NCT01834573|IBD|ibd
262189|NCT01834573|quality of life|quality of life
262190|NCT01834573|Inflammatory Bowel Disease Questionnaire|inflammatory bowel disease questionnaire
262191|NCT01834560|deep brain stimulation|deep brain stimulation
262192|NCT01834560|subgenual cortex (CG25)|subgenual cortex (cg25)
262193|NCT01834547|chess, cognition|chess, cognition
262194|NCT01834521|Breast cancer|breast cancer
262195|NCT01834521|psychosocial|psychosocial
262196|NCT01834521|website|website
262197|NCT01834521|empowerment|empowerment
262198|NCT01834508|Experienced Treatment|experienced treatment
262199|NCT01834495|Peripheral artery disease|peripheral artery disease
262200|NCT01834495|atherosclerosis|atherosclerosis
262201|NCT01834495|stent|stent
262202|NCT01834482|seizures|seizures
262203|NCT01834482|epilepsy|epilepsy
262204|NCT01834482|adult|adult
262205|NCT01834482|intractable|intractable
262206|NCT01834482|medically refractory|medically refractory
262207|NCT01834482|Atkins|atkins
262208|NCT01834482|ketogenic|ketogenic
262209|NCT01834482|diet|diet
262210|NCT01834469|Ovarian,metastasis|ovarian,metastasis
262211|NCT01834456|Medically Complex Children|medically complex children
262212|NCT01834456|Family Experience in Healthcare|family experience in healthcare
262213|NCT01834456|Patient Centered Care|patient centered care
262214|NCT01834456|Family Centered Care|family centered care
262215|NCT01834456|Case Management|case management
262216|NCT01834456|Care Management|care management
262217|NCT01834456|Care Coordination|care coordination
262218|NCT01834456|Care Plan|care plan
262219|NCT01834456|Extensivist|extensivist
262220|NCT01834456|Medical Home|medical home
262221|NCT01834456|Children with Special Health Care Needs|children with special health care needs
262222|NCT01834456|Coordinated Care|coordinated care
262223|NCT01834456|Quality in Healthcare|quality in healthcare
262224|NCT01834456|Satisfaction in Healthcare|satisfaction in healthcare
262225|NCT01834456|Cost|cost
262226|NCT01834456|Utilization|utilization
262227|NCT01834456|Impact on Family|impact on family
262228|NCT01834456|Quality of Life|quality of life
262229|NCT01834456|Palliative Care|palliative care
262230|NCT01834456|Complex Chronic Conditions|complex chronic conditions
262231|NCT01834456|Life-limiting illness|life-limiting illness
262232|NCT01834456|Integrative Care|integrative care
262233|NCT01834456|Primary Care|primary care
262234|NCT01834456|Comprehensive Care|comprehensive care
262235|NCT01834456|Behavioral Care|behavioral care
262236|NCT01834443|spatial neglect|spatial neglect
262237|NCT01834443|galvanic vestibular stimulation as therapy|galvanic vestibular stimulation as therapy
262238|NCT01834417|Pressure ulcer, spinal cord injury, on-board device|pressure ulcer, spinal cord injury, on-board device
262239|NCT01834404|Obesity|obesity
262240|NCT01834404|BMI|bmi
262241|NCT01834404|Incretin|incretin
262242|NCT01834404|Satiety|satiety
262243|NCT01834404|Phentermine|phentermine
262244|NCT01834404|Topiramate|topiramate
262245|NCT01834378|diabetes|diabetes
262246|NCT01834378|insulin resistance|insulin resistance
262247|NCT01834378|exercise|exercise
262248|NCT01834365|Hypertension|hypertension
262249|NCT01834352|Walnut hypersensitivity|walnut hypersensitivity
262761|NCT01832181|Diabetes|diabetes
262251|NCT01834339|vestibuloplasty|vestibuloplasty
262252|NCT01834326|dental implants|dental implants
262253|NCT01834326|deficient keratinized oral mucosa|deficient keratinized oral mucosa
262254|NCT01834313|Willingness-to-pay|willingness-to-pay
262255|NCT01834313|Patient-centredness|patient-centredness
262256|NCT01834313|Health insurers|health insurers
262257|NCT01834313|Fertility care|fertility care
262258|NCT01834300|Hepatic insulin sensitivity|hepatic insulin sensitivity
262259|NCT01834300|Muscle insulin sensitivity|muscle insulin sensitivity
262260|NCT01834300|B cell function|b cell function
262261|NCT01834300|VLDL1 TG metabolism|vldl1 tg metabolism
262262|NCT01834300|VLDL2 TG metabolism|vldl2 tg metabolism
323725|NCT01560299|I-131|i-131
262263|NCT01834287|Physical Activity|physical activity
262264|NCT01834287|Latinas|latinas
262265|NCT01834287|Web-based|web-based
262266|NCT01834287|Spanish-language|spanish-language
262267|NCT01834274|Drug Therapy|drug therapy
262268|NCT01834261|oxytocin|oxytocin
262269|NCT01834261|trust|trust
262270|NCT01834261|kinship|kinship
262271|NCT01834261|kin selection|kin selection
262272|NCT01834235|Pancreatic neoplasms|pancreatic neoplasms
262273|NCT01834235|Pancreatic cancer|pancreatic cancer
262274|NCT01834235|Pancreatic cancer, adult|pancreatic cancer, adult
262275|NCT01834235|Adenoma of the pancreas|adenoma of the pancreas
262276|NCT01834235|Carcinoma of the pancreas|carcinoma of the pancreas
262277|NCT01834209|Prostate neoplasms|prostate neoplasms
262278|NCT01834209|Prostate cancer|prostate cancer
262279|NCT01834209|Metastatic prostate cancer|metastatic prostate cancer
262280|NCT01834209|Metatatic castration resistant prostate cancer|metatatic castration resistant prostate cancer
262281|NCT01834209|Abiraterone acetate|abiraterone acetate
262282|NCT01834209|Prednisone|prednisone
262283|NCT01834209|Prednisolone|prednisolone
262284|NCT01834209|Early access program|early access program
262285|NCT01834196|retinal vascular disease|retinal vascular disease
262286|NCT01834196|Swept-Source Ocular Coherence Tomography|swept-source ocular coherence tomography
262287|NCT01834196|SSOCT|ssoct
262288|NCT01834183|Metastatic|metastatic
262289|NCT01834170|Pancreatic cancer|pancreatic cancer
262290|NCT01834170|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
262291|NCT01834170|Endoscopic ultrasound|endoscopic ultrasound
262292|NCT01834144|Type 1 Diabetes|type 1 diabetes
262293|NCT01834144|Hypoglycaemia|hypoglycaemia
262294|NCT01834144|Glycaemic variability|glycaemic variability
262295|NCT01834144|Vigorous Intensity Physical Activity|vigorous intensity physical activity
262296|NCT01834144|Continuous Glucose Monitoring|continuous glucose monitoring
262297|NCT01834131|hypertension|hypertension
262298|NCT01834131|community health worker|community health worker
262299|NCT01834131|home health education|home health education
262300|NCT01834131|medication adherence|medication adherence
262301|NCT01834131|mobile health|mobile health
262302|NCT01834131|physician education|physician education
262303|NCT01834131|home blood pressure monitoring|home blood pressure monitoring
262304|NCT01834131|implementation|implementation
262305|NCT01834105|Postmenopausal osteoporosis; Kidney Yin deficiency syndrome; Liuwei dihuang pill; CLCF1; JAK - STAT signal pathway|postmenopausal osteoporosis; kidney yin deficiency syndrome; liuwei dihuang pill; clcf1; jak - stat signal pathway
262306|NCT01834092|Abdominal Aortic Aneurism|abdominal aortic aneurism
262307|NCT01834092|Endothelia|endothelia
262308|NCT01834092|Glycocalyx|glycocalyx
262309|NCT01834092|Reperfusion|reperfusion
262310|NCT01834092|Plasma|plasma
262311|NCT01834079|Optic Atrophy,Stem cell therapy|optic atrophy,stem cell therapy
262312|NCT01834066|muscular Dystrophy stem cell|muscular dystrophy stem cell
262313|NCT01834053|Huntington Disease,stem cell therapy|huntington disease,stem cell therapy
262314|NCT01834040|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
262315|NCT01834040|Muscular Dystrophy|muscular dystrophy
262316|NCT01834040|Myopathy|myopathy
262317|NCT01834027|music|music
262318|NCT01834027|stress|stress
262319|NCT01834027|anxiety|anxiety
262320|NCT01834027|post-surgical|post-surgical
262321|NCT01834027|pain|pain
262322|NCT01834014|Liver only metastasis from KRAS Exon 2 wild type|liver only metastasis from kras exon 2 wild type
262323|NCT01834014|Liver only metastasis from RAS wild type|liver only metastasis from ras wild type
262325|NCT01834001|Prostate Cancer|prostate cancer
262326|NCT01834001|MRI-Guided Biopsy|mri-guided biopsy
262327|NCT01834001|Radiation|radiation
262328|NCT01834001|Biochemical Failure|biochemical failure
262329|NCT01833988|bionic pancreas|bionic pancreas
262330|NCT01833988|artificial pancreas|artificial pancreas
262331|NCT01833988|insulin|insulin
262332|NCT01833988|glucagon|glucagon
262333|NCT01833988|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
262334|NCT01833988|outpatient|outpatient
262335|NCT01833988|insulin pump|insulin pump
262336|NCT01833988|pediatrics|pediatrics
262337|NCT01833988|children|children
262338|NCT01833988|camp|camp
262339|NCT01833988|summer camp|summer camp
262340|NCT01833975|Spinal Cord Injury stem cell|spinal cord injury stem cell
262341|NCT01833962|Lumbar fusion rates|lumbar fusion rates
262342|NCT01833962|Actifuse synthetic bone graft|actifuse synthetic bone graft
262343|NCT01833962|Baxter Healthcare|baxter healthcare
262344|NCT01833962|Other synthetic bone graft|other synthetic bone graft
262345|NCT01833949|polycystic ovary syndrome,laparoscopic ovarian drilling|polycystic ovary syndrome,laparoscopic ovarian drilling
262346|NCT01833936|Achilles|achilles
262347|NCT01833923|Advanced cancer|advanced cancer
262348|NCT01833910|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
262349|NCT01833910|Education|education
262350|NCT01833897|Bipolar Disorder|bipolar disorder
262351|NCT01833884|Hodgkin Lymphoma, Adult|hodgkin lymphoma, adult
262352|NCT01833884|Cytokines|cytokines
262353|NCT01833884|TARC|tarc
323855|NCT01559714|MRI|mri
262354|NCT01833884|IL-6|il-6
262355|NCT01833884|IL1-RA|il1-ra
262356|NCT01833884|sCD30|scd30
262357|NCT01833884|TNFR1|tnfr1
262359|NCT01833845|Hepatitis C|hepatitis c
262360|NCT01833845|Hep-C|hep-c
262361|NCT01833832|Synergy for Cisplatin and Hyperthermia|synergy for cisplatin and hyperthermia
262362|NCT01833832|Rare Tumor|rare tumor
262363|NCT01833832|Poor Prognosis|poor prognosis
262364|NCT01833819|Laparoscopic cholecystectomy,|laparoscopic cholecystectomy,
262365|NCT01833819|Total intravenous anesthesia,|total intravenous anesthesia,
262366|NCT01833819|Propofol,|propofol,
262367|NCT01833819|Dexmedetomidine,|dexmedetomidine,
262368|NCT01833819|Lidocaine,|lidocaine,
262369|NCT01833819|Remifentanil,|remifentanil,
262370|NCT01833819|Postoperative analgesic consumption,|postoperative analgesic consumption,
262371|NCT01833819|Postoperative nausea and vomiting|postoperative nausea and vomiting
262372|NCT01833793|Mirena|mirena
262373|NCT01833793|Contraception|contraception
262374|NCT01833793|Amenorrhea|amenorrhea
262375|NCT01833780|carriage status|carriage status
262376|NCT01833780|Culture|culture
262377|NCT01833780|PCR|pcr
262378|NCT01833754|Osteoporosis, Bone, Renal, Insufficiency, Kidney, Hemodialysis, Impairment|osteoporosis, bone, renal, insufficiency, kidney, hemodialysis, impairment
262379|NCT01833715|Pain, Postoperative|pain, postoperative
262380|NCT01833715|Analgesics, Opioid|analgesics, opioid
262381|NCT01833715|Methadone|methadone
262382|NCT01833715|Morphine|morphine
262383|NCT01833702|Sickle cell|sickle cell
262384|NCT01833702|Pain|pain
262385|NCT01833689|glucose response|glucose response
262386|NCT01833689|glycaemic index|glycaemic index
262387|NCT01833676|sevoflurane|sevoflurane
262388|NCT01833676|desflurane|desflurane
262389|NCT01833676|protective airway reflexes|protective airway reflexes
262390|NCT01833676|elderly|elderly
262391|NCT01833663|Overactive Bladder|overactive bladder
262392|NCT01833663|Solifenacin Succinate Tablets|solifenacin succinate tablets
262393|NCT01833663|Estrogen|estrogen
262394|NCT01833650|thyroid cancer|thyroid cancer
262395|NCT01833650|radioiodine treatment|radioiodine treatment
262396|NCT01833650|xerostomia|xerostomia
262397|NCT01833650|sialadenitis|sialadenitis
262398|NCT01833637|Advanced Care Planning|advanced care planning
262399|NCT01833637|Palliative Care|palliative care
262400|NCT01833637|Women|women
262401|NCT01833598|Chronic tendinopathy|chronic tendinopathy
262402|NCT01833598|platelet rich plasma|platelet rich plasma
262403|NCT01833598|tendonitis|tendonitis
262404|NCT01833598|percutaneous tendon tenotomy|percutaneous tendon tenotomy
262405|NCT01833598|pain|pain
262406|NCT01833598|shoulder|shoulder
262407|NCT01833598|knee|knee
262408|NCT01833598|ankle|ankle
262409|NCT01833598|foot|foot
262410|NCT01833585|critical limb ischemia|critical limb ischemia
262411|NCT01833585|atherosclerosis|atherosclerosis
262412|NCT01833585|ischemic ulcer|ischemic ulcer
262413|NCT01833585|rest pain|rest pain
262414|NCT01833585|gangrene|gangrene
262415|NCT01833572|epidermal growth factor receptor|epidermal growth factor receptor
262416|NCT01833572|EGFR mutation|egfr mutation
262417|NCT01833572|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
262418|NCT01833572|gefitinib|gefitinib
262419|NCT01833572|neo-adjuvant therapy|neo-adjuvant therapy
262420|NCT01833546|Solid tumor|solid tumor
262421|NCT01833546|Pancreatic cancer|pancreatic cancer
262422|NCT01833546|TH-302|th-302
262423|NCT01833546|gemcitabine|gemcitabine
262424|NCT01833546|Evofosfamide|evofosfamide
262425|NCT01833533|Chronic Hepatitis C|chronic hepatitis c
262426|NCT01833533|Hepatitis C Virus|hepatitis c virus
262427|NCT01833533|Hepatitis C Genotype 1a|hepatitis c genotype 1a
262428|NCT01833533|Hepatitis C|hepatitis c
262429|NCT01833533|Treatment-Naïve|treatment-naïve
262430|NCT01833533|Interferon-Free|interferon-free
262431|NCT01833533|Paritaprevir|paritaprevir
262432|NCT01833533|Ombitasvir|ombitasvir
262433|NCT01833533|Dasabuvir|dasabuvir
262434|NCT01833533|Ribavirin|ribavirin
262435|NCT01833533|Viekira PAK|viekira pak
262436|NCT01833520|Sarcoma|sarcoma
262437|NCT01833520|Osteosarcoma|osteosarcoma
262438|NCT01833520|recurrent or metastatic|recurrent or metastatic
262439|NCT01833520|Ra-223 dichloride|ra-223 dichloride
262440|NCT01833520|Radium-223 chloride|radium-223 chloride
262441|NCT01833520|Alpharadin|alpharadin
262442|NCT01833507|increased activity|increased activity
262443|NCT01833507|weight loss|weight loss
262444|NCT01833507|obesity|obesity
262445|NCT01833494|Hemodialysis|hemodialysis
262446|NCT01833494|Hyperphosphatemia|hyperphosphatemia
262447|NCT01833481|Surgical approach|surgical approach
262448|NCT01833481|Direct-anterior|direct-anterior
262449|NCT01833481|Anterior-lateral|anterior-lateral
262450|NCT01833481|Posterior-lateral|posterior-lateral
262451|NCT01833481|Hip implant|hip implant
262452|NCT01833481|Total Hip Arthroplasty|total hip arthroplasty
262453|NCT01833481|Total Hip replacement|total hip replacement
262454|NCT01833481|Hip replacement|hip replacement
262455|NCT01833481|Hip prosthesis|hip prosthesis
262456|NCT01833468|ankylosing spondylitis|ankylosing spondylitis
262457|NCT01833468|Psoriatic arthritis|psoriatic arthritis
262458|NCT01833468|Foot|foot
262459|NCT01833468|FAOS|faos
262460|NCT01833468|SpA-TRI|spa-tri
262461|NCT01833442|OCD|ocd
262462|NCT01833442|YBOCS|ybocs
262463|NCT01833429|Resistant hypertension|resistant hypertension
262464|NCT01833429|White-coat phenomenon|white-coat phenomenon
262465|NCT01833429|Heart rate variability|heart rate variability
262466|NCT01833429|autonomic activity|autonomic activity
262467|NCT01833416|CMV infection|cmv infection
262468|NCT01833416|CMV disease|cmv disease
262469|NCT01833416|Natural history|natural history
262470|NCT01833416|Kidney transplant|kidney transplant
262471|NCT01833403|bariatric surgery, l|bariatric surgery, l
262472|NCT01833403|liver insulin resistance,|liver insulin resistance,
262473|NCT01833390|Hyperpolarized Xenon|hyperpolarized xenon
262475|NCT01833390|MagniXene|magnixene
262476|NCT01833377|obesity|obesity
262477|NCT01833377|overweight|overweight
262478|NCT01833377|BMI|bmi
262479|NCT01833364|Parkinson's Disease|parkinson's disease
262480|NCT01833364|Deep Brain Stimulation|deep brain stimulation
262481|NCT01833364|Peripheral Nerve Graft|peripheral nerve graft
262482|NCT01833351|Phase I|phase i
262483|NCT01833351|safety and pharmacokinetics,|safety and pharmacokinetics,
262484|NCT01833351|intravenous ascorbate,|intravenous ascorbate,
262485|NCT01833351|IV Vitamin C,|iv vitamin c,
262486|NCT01833351|Oncology|oncology
262487|NCT01833338|Non ST elevation myocardial infarction|non st elevation myocardial infarction
262488|NCT01833338|optical coherence tomography|optical coherence tomography
262489|NCT01833338|intravascular ultrasound|intravascular ultrasound
262490|NCT01833338|multi-slice computed tomography|multi-slice computed tomography
262491|NCT01833325|Age-Related Macular Degeneration|age-related macular degeneration
262492|NCT01833325|Macular Degeneration|macular degeneration
262493|NCT01833325|Proton radiation|proton radiation
262494|NCT01833325|Choroidal Neovascular Membranes|choroidal neovascular membranes
262495|NCT01833312|acute ischemic stroke|acute ischemic stroke
262496|NCT01833312|hypothermia|hypothermia
262497|NCT01833299|TACE|tace
262498|NCT01833299|Sorafenib|sorafenib
262499|NCT01833299|overall survival|overall survival
262500|NCT01833299|time to progression|time to progression
262501|NCT01833286|hepatocellular carcinoma|hepatocellular carcinoma
262502|NCT01833286|repeat hepatectomy|repeat hepatectomy
262503|NCT01833286|radiofrequency ablation|radiofrequency ablation
262504|NCT01833286|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
262505|NCT01833247|epilepsy|epilepsy
262506|NCT01833247|lactic acid|lactic acid
262507|NCT01833247|saliva|saliva
262508|NCT01833247|postictal|postictal
262509|NCT01833234|epilepsy|epilepsy
262510|NCT01833234|quality of life|quality of life
262511|NCT01833234|seizure severity|seizure severity
262512|NCT01833234|antiepileptic drug side effects|antiepileptic drug side effects
262513|NCT01833234|questionnaire|questionnaire
262514|NCT01833234|patient reported outcomes|patient reported outcomes
262515|NCT01833221|facial palsy|facial palsy
262516|NCT01833221|lengthening temporalis myoplasty|lengthening temporalis myoplasty
262517|NCT01833221|neurotization of facial muscles|neurotization of facial muscles
262518|NCT01833195|molecular diagnostics|molecular diagnostics
262519|NCT01833195|heart transplantation|heart transplantation
262520|NCT01833195|risk factors|risk factors
262521|NCT01833195|prognosis|prognosis
262522|NCT01833182|falls in community dwelling older adults|falls in community dwelling older adults
262523|NCT01833182|falls and ADL performance|falls and adl performance
262524|NCT01833182|tailored home intervention|tailored home intervention
262525|NCT01833169|Solid tumor|solid tumor
262526|NCT01833169|malignancy|malignancy
262527|NCT01833169|hematologi malignancy|hematologi malignancy
262528|NCT01833169|PI3K pathway activation|pi3k pathway activation
262530|NCT01833169|signature|signature
262531|NCT01833169|AML, acute myelogenous leukemia|aml, acute myelogenous leukemia
262532|NCT01833169|cervical, ovarian|cervical, ovarian
262533|NCT01833169|hepatobiliary|hepatobiliary
262534|NCT01833169|buparlisib|buparlisib
262535|NCT01833156|local edema|local edema
262536|NCT01833156|dielectric constant values|dielectric constant values
262537|NCT01833156|validation study|validation study
262538|NCT01833143|KRAS-Mutant|kras-mutant
262539|NCT01833143|Bortezomib|bortezomib
262540|NCT01833143|KRAS G12D|kras g12d
262541|NCT01833143|12-222|12-222
262542|NCT01833117|Dry eye|dry eye
262543|NCT01833117|Tear film|tear film
262544|NCT01833117|Tear break-up time|tear break-up time
262545|NCT01833117|Ocular surface|ocular surface
262546|NCT01833117|Eye drops|eye drops
262547|NCT01833104|Healthy subjects|healthy subjects
262548|NCT01833039|Mantle Cell Lymphoma|mantle cell lymphoma
262549|NCT01833039|Ibrutinib|ibrutinib
262550|NCT01833026|pulmonary disease|pulmonary disease
262551|NCT01833026|chronic obstructive airflow|chronic obstructive airflow
262552|NCT01833026|spirometry|spirometry
262553|NCT01833026|primary healthcare|primary healthcare
262554|NCT01833026|guideline-based therapy|guideline-based therapy
262555|NCT01833013|Endometriosis|endometriosis
262556|NCT01833013|Cohort study|cohort study
262557|NCT01833013|fertility|fertility
262558|NCT01833013|pregnancy|pregnancy
262559|NCT01833013|assisted reproductive technics|assisted reproductive technics
262560|NCT01833013|laparoscopy|laparoscopy
262561|NCT01833000|rectal bleeding|rectal bleeding
262562|NCT01833000|necrotizing enterolitis|necrotizing enterolitis
262563|NCT01833000|splanchnic oxygenation|splanchnic oxygenation
262564|NCT01833000|mesenteric doppler|mesenteric doppler
262565|NCT01832987|co-trimoxazole|co-trimoxazole
262566|NCT01832987|sulfamethoxazole|sulfamethoxazole
262567|NCT01832987|tuberculosis|tuberculosis
262568|NCT01832987|pharmacokinetics|pharmacokinetics
262569|NCT01832974|Adrenal Gland Cancer|adrenal gland cancer
262570|NCT01832974|Treatment Refractory Malignancies|treatment refractory malignancies
262571|NCT01832974|Metastatic Cancer|metastatic cancer
262572|NCT01832961|COPD|copd
262573|NCT01832961|physiotherapy care|physiotherapy care
262574|NCT01832961|lung function testing|lung function testing
262575|NCT01832961|inflammation|inflammation
262576|NCT01832935|Glargin|glargin
262578|NCT01832935|Cost-effectiveness|cost-effectiveness
262579|NCT01832922|bendamustine|bendamustine
262580|NCT01832922|rituximab|rituximab
262581|NCT01832922|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
262582|NCT01832922|comorbidities|comorbidities
262583|NCT01832922|renal insufficiency|renal insufficiency
262584|NCT01832909|metabolizable energy|metabolizable energy
262585|NCT01832909|walnuts|walnuts
262586|NCT01832909|Atwater factors|atwater factors
262587|NCT01832909|energy value|energy value
262588|NCT01832896|Hereditary Angioedema|hereditary angioedema
262589|NCT01832896|Children|children
262590|NCT01832896|Adolescents|adolescents
262591|NCT01832896|Ecallantide|ecallantide
262592|NCT01832857|metastatic|metastatic
262593|NCT01832857|advanced|advanced
262594|NCT01832857|solid tumor|solid tumor
262595|NCT01832857|cancer|cancer
262596|NCT01832857|colon cancer|colon cancer
262597|NCT01832857|hepatocellular carcinoma|hepatocellular carcinoma
262598|NCT01832857|breast cancer|breast cancer
262599|NCT01832857|lung cancer|lung cancer
262600|NCT01832857|gastric cancer|gastric cancer
262601|NCT01832857|esophageal cancer|esophageal cancer
262602|NCT01832844|Scan control|scan control
262603|NCT01832844|Epidural infiltration|epidural infiltration
262604|NCT01832844|visual analogue scale (VAS)|visual analogue scale (vas)
262605|NCT01832818|Total Disc Replacement|total disc replacement
262606|NCT01832805|depression|depression
262607|NCT01832779|Achalasia|achalasia
262608|NCT01832766|schizophrenia|schizophrenia
262609|NCT01832766|dronabinol|dronabinol
262610|NCT01832766|P50|p50
262611|NCT01832766|cannabis|cannabis
262612|NCT01832766|memory|memory
262613|NCT01832766|symptoms|symptoms
262614|NCT01832753|Down syndrome|down syndrome
262615|NCT01832753|subclinical hypothyroidism|subclinical hypothyroidism
262616|NCT01832753|thyroid|thyroid
262617|NCT01832753|levothyroxine|levothyroxine
262618|NCT01832740|young healthy subjects|young healthy subjects
262619|NCT01832740|brain stimulation|brain stimulation
262620|NCT01832740|tSOS|tsos
262621|NCT01832740|tDCS|tdcs
262622|NCT01832740|sleep|sleep
262623|NCT01832740|memory|memory
262624|NCT01832740|memory consolidation|memory consolidation
262625|NCT01832727|multiple myeloma|multiple myeloma
262626|NCT01832727|oprozomib|oprozomib
262627|NCT01832727|OPZ|opz
262628|NCT01832727|ONX 0912|onx 0912
262629|NCT01832727|Onyx|onyx
262630|NCT01832727|proteasome inhibitor|proteasome inhibitor
262631|NCT01832727|oprozomib tablets|oprozomib tablets
262632|NCT01832714|Concussion|concussion
262633|NCT01832714|mTBI|mtbi
262634|NCT01832714|military|military
262635|NCT01832714|MACE|mace
262636|NCT01832714|NKI|nki
262637|NCT01832714|NOTC|notc
262638|NCT01832714|VNG|vng
262639|NCT01832714|VOG|vog
262640|NCT01832714|Neuro Kinetics|neuro kinetics
262641|NCT01832714|oculomotor|oculomotor
262642|NCT01832714|vestibular|vestibular
262643|NCT01832714|reaction time|reaction time
262644|NCT01832714|I-Portal|i-portal
262645|NCT01832714|eye tracking|eye tracking
262646|NCT01832714|Dizziness Handicap Inventory|dizziness handicap inventory
262647|NCT01832688|iron and folic acid supplements|iron and folic acid supplements
262648|NCT01832688|anemia|anemia
262649|NCT01832688|gestational weight gain|gestational weight gain
262650|NCT01832675|Endoscopy|endoscopy
262651|NCT01832675|Anesthetics, Local|anesthetics, local
262652|NCT01832675|Bupivacaine|bupivacaine
262653|NCT01832675|Lidocaine|lidocaine
262654|NCT01832649|Exercise|exercise
262655|NCT01832649|Cocaine dependence|cocaine dependence
262656|NCT01832636|L-Alanyl-L-Glutamine|l-alanyl-l-glutamine
262657|NCT01832636|Environmental enteric dysfunction|environmental enteric dysfunction
262658|NCT01832636|Tropical enteropathy|tropical enteropathy
262659|NCT01832623|Vitamin D|vitamin d
262660|NCT01832623|bone|bone
262661|NCT01832623|cardiovascular status|cardiovascular status
262662|NCT01832623|nutritional status|nutritional status
262663|NCT01832584|Red Grapes|red grapes
262664|NCT01832584|polyphenols|polyphenols
262665|NCT01832584|cyclists|cyclists
262666|NCT01832584|resveratrol|resveratrol
262667|NCT01832584|aerobic fitness|aerobic fitness
262668|NCT01832584|trained|trained
262669|NCT01832571|HIV|hiv
262670|NCT01832571|PrEP|prep
262671|NCT01832571|Female Sex Workers|female sex workers
262672|NCT01832571|Kenya|kenya
262673|NCT01832545|Aquatic exercise|aquatic exercise
262674|NCT01832545|Knee Osteoarthritis|knee osteoarthritis
262675|NCT01832545|Exercise|exercise
262676|NCT01832545|Pain|pain
262677|NCT01832545|Obesity.|obesity.
262679|NCT01832532|Sleep Disordered Breathing|sleep disordered breathing
262680|NCT01832532|liraglutide|liraglutide
262681|NCT01832532|glucagon-like peptide-1 agonist|glucagon-like peptide-1 agonist
262682|NCT01832532|Orexin|orexin
262683|NCT01832532|leptin,|leptin,
262684|NCT01832519|Cystic Fibrosis|cystic fibrosis
262685|NCT01832519|CF|cf
262686|NCT01832519|MRI|mri
262687|NCT01832519|vascularization|vascularization
262688|NCT01832519|perfusion|perfusion
262689|NCT01832506|Solid Tumors|solid tumors
262690|NCT01832506|MSC2156119J|msc2156119j
262691|NCT01832506|c-Met inhibitor|c-met inhibitor
262692|NCT01832506|Japanese|japanese
262693|NCT01832506|Phase 1|phase 1
262694|NCT01832480|Trichomonas vaginalis|trichomonas vaginalis
262695|NCT01832480|metronidazole|metronidazole
262696|NCT01832467|cetuximab-based chemotherapy|cetuximab-based chemotherapy
262697|NCT01832467|previously treated|previously treated
262698|NCT01832454|cerebral palsy stem cells [MNCS]|cerebral palsy stem cells [mncs]
262699|NCT01832441|Diabetes Mellitus stem cells [MNCS ]|diabetes mellitus stem cells [mncs ]
262700|NCT01832415|First line treatment|first line treatment
262701|NCT01832415|Ovarian cancer|ovarian cancer
262702|NCT01832415|Avastin|avastin
262703|NCT01832415|fallopian tube or primary peritoneal|fallopian tube or primary peritoneal
262704|NCT01832402|Advanced Cancers|advanced cancers
262705|NCT01832402|Exercise-Induced Breakthrough Dyspnea|exercise-induced breakthrough dyspnea
262706|NCT01832402|Shortness of breath|shortness of breath
262707|NCT01832402|Fentanyl pectin nasal spray|fentanyl pectin nasal spray
262708|NCT01832402|Placebo nasal spray|placebo nasal spray
262709|NCT01832402|Walk test|walk test
262710|NCT01832402|Questionnaires|questionnaires
262711|NCT01832402|Surveys|surveys
262712|NCT01832402|Mental ability tests|mental ability tests
262713|NCT01832389|Subarachnoid Haemorrhage (SAH)|subarachnoid haemorrhage (sah)
262714|NCT01832389|vasospasm|vasospasm
262715|NCT01832389|delayed cerebral ischaemia (DCI)|delayed cerebral ischaemia (dci)
262716|NCT01832389|goal directed therapy (GDT)|goal directed therapy (gdt)
262717|NCT01832389|Pulse Contour Cardiac Output (PiCCO)|pulse contour cardiac output (picco)
262718|NCT01832376|Calcific tendinitis|calcific tendinitis
262719|NCT01832376|Shoulder|shoulder
262720|NCT01832376|Needle lavage|needle lavage
262721|NCT01832376|Ultrasound-guided|ultrasound-guided
262722|NCT01832363|Severe asthma|severe asthma
262723|NCT01832363|Bronchial thermoplasty|bronchial thermoplasty
262724|NCT01832363|MagniXene|magnixene
262725|NCT01832363|Hyperpolarized Xenon|hyperpolarized xenon
262726|NCT01832363|HXe|hxe
262727|NCT01832363|HyXe|hyxe
262728|NCT01832324|Food Allergy|food allergy
262729|NCT01832324|Eosinophilic Esophagitis|eosinophilic esophagitis
262730|NCT01832324|Food Protein Induced Enterocolitis|food protein induced enterocolitis
262731|NCT01832324|iNKT Cells|inkt cells
262732|NCT01832324|T cells|t cells
262733|NCT01832311|type 2 diabetes mellitus|type 2 diabetes mellitus
262734|NCT01832311|cataract|cataract
262735|NCT01832311|cytokines|cytokines
262736|NCT01832311|chemokines|chemokines
262737|NCT01832311|aqueous humor|aqueous humor
262738|NCT01832298|Tolerability|tolerability
262739|NCT01832298|Pharmacokinetics|pharmacokinetics
262740|NCT01832285|fluvoxamine|fluvoxamine
262741|NCT01832285|cognition|cognition
262742|NCT01832285|schizophrenia|schizophrenia
262743|NCT01832285|protein expression|protein expression
262744|NCT01832272|Osteoarthritis|osteoarthritis
262745|NCT01832272|Knee|knee
262746|NCT01832272|Total knee arthroplasty|total knee arthroplasty
262747|NCT01832272|Tourniquet|tourniquet
262748|NCT01832272|Early release|early release
262749|NCT01832272|Reinflation|reinflation
262750|NCT01832246|endoscopy|endoscopy
262751|NCT01832246|endosonography|endosonography
262752|NCT01832246|stomach cancer|stomach cancer
262753|NCT01832246|tumor staging|tumor staging
262754|NCT01832220|Genomics|genomics
262755|NCT01832220|Microbiome|microbiome
262756|NCT01832220|Microflora|microflora
262757|NCT01832220|Virome|virome
262758|NCT01832220|Alpha-1|alpha-1
262759|NCT01832194|Scrotal pain|scrotal pain
262760|NCT01832194|Botox|botox
262762|NCT01832181|MiTy|mity
262763|NCT01832181|Metformin in Women|metformin in women
262764|NCT01832181|Type 2 Diabetes Pregnancy|type 2 diabetes pregnancy
262765|NCT01832155|Yoga|yoga
262766|NCT01832155|Knee osteoarthritis|knee osteoarthritis
262767|NCT01832155|Symptom management|symptom management
262768|NCT01832155|Older women|older women
262769|NCT01832155|Pain|pain
262770|NCT01832155|Stiffness|stiffness
262771|NCT01832155|Physical function)|physical function)
262772|NCT01832155|Physical function of the lower extremities|physical function of the lower extremities
262773|NCT01832155|Quality of sleep|quality of sleep
262774|NCT01832155|Quality of life|quality of life
262775|NCT01832116|Pancreatic cancer|pancreatic cancer
262776|NCT01832116|Ovarian cancer|ovarian cancer
262777|NCT01832077|sensibility|sensibility
262778|NCT01832077|specificity|specificity
262779|NCT01832077|positive predictive value|positive predictive value
262780|NCT01832077|negative predictive value|negative predictive value
262781|NCT01832077|Cost-effectiveness|cost-effectiveness
262782|NCT01832064|chronic disease|chronic disease
262783|NCT01832064|patient education|patient education
262784|NCT01832064|self management|self management
262785|NCT01832051|HER2-PET|her2-pet
262786|NCT01832051|89Zr-trastuzumab|89zr-trastuzumab
262787|NCT01832051|metastatic breast cancer|metastatic breast cancer
262788|NCT01832051|clinical dilemma|clinical dilemma
262789|NCT01832038|Lacosamide|lacosamide
262790|NCT01832038|Epilepsy|epilepsy
262791|NCT01832038|Partial-onset Seizures|partial-onset seizures
262792|NCT01832025|intraoperative|intraoperative
262793|NCT01832025|postoperative|postoperative
262794|NCT01832025|complications|complications
262795|NCT01832025|discomfort|discomfort
262796|NCT01832025|external|external
262797|NCT01832025|internal|internal
262798|NCT01832025|maxillary|maxillary
262799|NCT01832025|elevation|elevation
262800|NCT01832025|implant|implant
262801|NCT01832025|reconstruction|reconstruction
262802|NCT01832025|bone|bone
262803|NCT01832025|sinus|sinus
262804|NCT01832012|Eliciting which type of refresher provides the greatest improvement in BLS CPR skills.|eliciting which type of refresher provides the greatest improvement in bls cpr skills.
262805|NCT01831999|Web-based|web-based
262806|NCT01831999|HIV Assessment|hiv assessment
262807|NCT01831999|Outreach|outreach
262808|NCT01831999|Retention|retention
262809|NCT01831999|Substance Abuse Treatment|substance abuse treatment
262810|NCT01831986|Schizophrenia|schizophrenia
262811|NCT01831986|Schizoaffective disorder|schizoaffective disorder
262812|NCT01831986|Pregnenolone|pregnenolone
262813|NCT01831986|L-Theanine|l-theanine
262814|NCT01831986|Augmentation|augmentation
262815|NCT01831960|Intrepid|intrepid
262816|NCT01831960|cortexolone|cortexolone
262817|NCT01831960|cortexolone 17α-propionate|cortexolone 17α-propionate
262818|NCT01831960|anti-androgen|anti-androgen
262819|NCT01831947|age-related macular degeneration|age-related macular degeneration
262820|NCT01831947|Ranibizumab|ranibizumab
262821|NCT01831934|Mitochondrial disorder|mitochondrial disorder
262822|NCT01831934|Trivalent inactivated influenza vaccine|trivalent inactivated influenza vaccine
262823|NCT01831934|Adolescents and adults|adolescents and adults
262824|NCT01831934|Immune response|immune response
262825|NCT01831934|Metabolic response|metabolic response
262826|NCT01831921|pre diabetes|pre diabetes
262827|NCT01831921|obesity|obesity
262828|NCT01831921|weight loss|weight loss
262829|NCT01831921|lifestyle|lifestyle
262830|NCT01831921|prevention|prevention
262831|NCT01831908|cardiovascular health, stroke, ischemic heart disease|cardiovascular health, stroke, ischemic heart disease
262832|NCT01831895|Hypertension|hypertension
262833|NCT01831895|Carotid Sinus|carotid sinus
262834|NCT01831869|Subclinical hypothyroidism|subclinical hypothyroidism
262835|NCT01831869|L-thyroxine|l-thyroxine
262836|NCT01831869|Lipid|lipid
262837|NCT01831869|endothelial function|endothelial function
262838|NCT01831869|inflammatory factor|inflammatory factor
262839|NCT01831869|adipocytokine|adipocytokine
262840|NCT01831856|Cardiovascular diseases|cardiovascular diseases
262841|NCT01831856|Chronic Heart Failure|chronic heart failure
262842|NCT01831843|core body temperature|core body temperature
262843|NCT01831843|humidity|humidity
262844|NCT01831843|circuit temperature|circuit temperature
262845|NCT01831830|traumatic brain injury|traumatic brain injury
262846|NCT01831830|occupational therapy|occupational therapy
262847|NCT01831830|family|family
262848|NCT01831804|diabetic foot ulcer|diabetic foot ulcer
262849|NCT01831804|pharmacodynamics|pharmacodynamics
262850|NCT01831804|pharmacokinetics|pharmacokinetics
262851|NCT01831804|ischemic|ischemic
262852|NCT01831791|male pattern hair loss|male pattern hair loss
262853|NCT01831791|safety|safety
262854|NCT01831791|Dutasteride|dutasteride
262855|NCT01831791|efficacy|efficacy
262856|NCT01831791|hair growth|hair growth
262857|NCT01831791|Androgenetic alopecia|androgenetic alopecia
262858|NCT01831791|hair restoration|hair restoration
262859|NCT01831778|mammography|mammography
262860|NCT01831778|screening|screening
262861|NCT01831752|Diabetes|diabetes
262862|NCT01831752|Type 1|type 1
262863|NCT01831752|Continuous glucose monitor|continuous glucose monitor
262864|NCT01831739|Genomics|genomics
262865|NCT01831739|Microbiome|microbiome
262866|NCT01831739|Microflora|microflora
324489|NCT01557400|DMD|dmd
262867|NCT01831739|Virome|virome
262868|NCT01831726|Solid tumor malignancy|solid tumor malignancy
262869|NCT01831726|hematologic malignancy|hematologic malignancy
262870|NCT01831726|mutation|mutation
262871|NCT01831726|translocations|translocations
262872|NCT01831726|FGFR|fgfr
262873|NCT01831726|PDGFR|pdgfr
262874|NCT01831726|VEGF|vegf
262875|NCT01831726|cKIT|ckit
262876|NCT01831726|FLT3|flt3
262877|NCT01831726|CSR1|csr1
262879|NCT01831726|RET|ret
262880|NCT01831726|TKI258|tki258
262881|NCT01831726|dovitinib|dovitinib
262882|NCT01831726|signature|signature
262883|NCT01831726|AML|aml
262884|NCT01831726|acute myelogenous leukemia|acute myelogenous leukemia
262885|NCT01831726|GIST|gist
262886|NCT01831726|gastrointestinal stromal tumor|gastrointestinal stromal tumor
262887|NCT01831726|Head and Neck cancer|head and neck cancer
262888|NCT01831726|Melanoma|melanoma
262889|NCT01831726|NSCLC|nsclc
262890|NCT01831726|non-small cell lung carcinoma|non-small cell lung carcinoma
262891|NCT01831726|lung cancer|lung cancer
262892|NCT01831726|ovarian cancer|ovarian cancer
262893|NCT01831726|thyroid cancer|thyroid cancer
262894|NCT01831726|amplification|amplification
262895|NCT01831648|IGF1|igf1
262896|NCT01831648|standards|standards
262897|NCT01831648|Assays|assays
262898|NCT01831648|Z-score|z-score
262899|NCT01831648|Healthy volunteers|healthy volunteers
262900|NCT01831648|Population|population
262901|NCT01831622|Decision-Making|decision-making
262902|NCT01831622|functional MRI|functional mri
262903|NCT01831622|pharmacological MRI|pharmacological mri
262904|NCT01831622|Reinforcement Learning|reinforcement learning
262905|NCT01831622|Methylphenidate|methylphenidate
262906|NCT01831609|Gastrointestinal|gastrointestinal
262907|NCT01831609|Genitourinary|genitourinary
262908|NCT01831609|Rare Cancer|rare cancer
262909|NCT01831583|sleep apnea|sleep apnea
262910|NCT01831570|Hand osteoarthritis|hand osteoarthritis
262911|NCT01831570|predictive factors|predictive factors
262912|NCT01831570|erosive hand OA|erosive hand oa
262913|NCT01831544|Heart Failure|heart failure
262914|NCT01831518|Heart Failure|heart failure
262915|NCT01831518|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
262916|NCT01831518|ECG Imaging|ecg imaging
262917|NCT01831518|Body Surface Mapping|body surface mapping
262918|NCT01831505|personalized medicine|personalized medicine
262919|NCT01831505|in vivo drug sensitivity|in vivo drug sensitivity
262920|NCT01831505|chemotherapy|chemotherapy
262921|NCT01831505|lymphoma|lymphoma
262922|NCT01831505|microinjection|microinjection
262923|NCT01831492|performance|performance
262924|NCT01831492|acidosis|acidosis
262925|NCT01831492|oxidative stress|oxidative stress
262926|NCT01831492|inflammation|inflammation
262927|NCT01831492|oxygen uptake|oxygen uptake
262928|NCT01831479|Pharmacokinetics, drug-drug interaction|pharmacokinetics, drug-drug interaction
262929|NCT01831466|plaque psoriasis|plaque psoriasis
262930|NCT01831466|vulgaris|vulgaris
262931|NCT01831466|topical treatment|topical treatment
262932|NCT01831466|skin diseases|skin diseases
262933|NCT01831466|papulosquamous|papulosquamous
262934|NCT01831466|Tofacitinib|tofacitinib
262935|NCT01831466|CP-690550|cp-690550
262936|NCT01831466|Xeljanz|xeljanz
262937|NCT01831466|psoriasis|psoriasis
262938|NCT01831466|moderate|moderate
262939|NCT01831466|severe|severe
262940|NCT01831466|itch|itch
262941|NCT01831466|nail psoriasis|nail psoriasis
262942|NCT01831453|omega-3|omega-3
262943|NCT01831453|recurrent aphthous stomatitis|recurrent aphthous stomatitis
262944|NCT01831453|quality of life|quality of life
262945|NCT01831440|depression|depression
262946|NCT01831440|remission|remission
262947|NCT01831440|Pharmacotherapy|pharmacotherapy
262948|NCT01831440|psychotherapy|psychotherapy
262949|NCT01831440|neuroimaging|neuroimaging
262950|NCT01831440|psychology|psychology
262951|NCT01831427|ulcerative colitis|ulcerative colitis
262952|NCT01831427|moderate|moderate
262953|NCT01831427|severe|severe
262954|NCT01831414|Lung function|lung function
262955|NCT01831414|Water immersion|water immersion
262956|NCT01831414|Balneotherapy|balneotherapy
262957|NCT01831401|Acetabular component inclination|acetabular component inclination
262958|NCT01831388|Dyspnea|dyspnea
262959|NCT01831388|Breath Training Exercise|breath training exercise
262960|NCT01831388|12-261|12-261
262961|NCT01831336|International|international
262962|NCT01831336|Multicenter|multicenter
262963|NCT01831336|Observational registry|observational registry
262964|NCT01831336|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
262965|NCT01831336|Stenting|stenting
262966|NCT01831336|Treatment of Coronary Artery Disease|treatment of coronary artery disease
262967|NCT01831336|Coronary revascularization|coronary revascularization
262968|NCT01831336|Percutaneous Coronary Intervention|percutaneous coronary intervention
262969|NCT01831336|STEMI|stemi
262970|NCT01831336|NSTEMI|nstemi
262971|NCT01831336|Ischemia|ischemia
324607|NCT01556841|5T4|5t4
262972|NCT01831336|Angina|angina
262973|NCT01831336|Subgroups|subgroups
262974|NCT01831336|Acute Myocardial Infarction|acute myocardial infarction
262975|NCT01831336|Diabetes|diabetes
262976|NCT01831336|Small Vessels|small vessels
262977|NCT01831336|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
262978|NCT01831310|Colorectal cancer|colorectal cancer
262979|NCT01831310|nutrition|nutrition
262980|NCT01831310|neutrophil phagocytosis|neutrophil phagocytosis
262981|NCT01831310|neutrophil adhesivity|neutrophil adhesivity
262982|NCT01831310|glutamine|glutamine
262983|NCT01831310|omega 3 fatty acids|omega 3 fatty acids
262984|NCT01831271|Exercise, Physical|exercise, physical
262985|NCT01831271|Physical Activity|physical activity
262986|NCT01831271|Outcome Measures|outcome measures
262987|NCT01831219|osteoarthritis|osteoarthritis
262988|NCT01831219|arthroplasty|arthroplasty
262989|NCT01831219|hip arthroplasty|hip arthroplasty
262990|NCT01831206|corneal ulcer|corneal ulcer
262991|NCT01831206|keratitis|keratitis
262992|NCT01831180|hair|hair
262993|NCT01831180|scalp|scalp
262994|NCT01831180|blood flow|blood flow
262995|NCT01831180|Caucasian|caucasian
262996|NCT01831180|Histamine stimulation|histamine stimulation
262997|NCT01831180|Wake Forest|wake forest
262998|NCT01831167|dynamic light application|dynamic light application
262999|NCT01831167|sustained attention|sustained attention
263000|NCT01831167|divided attention|divided attention
263001|NCT01831167|nursing|nursing
263002|NCT01831154|Glycemic control|glycemic control
263003|NCT01831141|Congenital Solitary Kidney|congenital solitary kidney
263004|NCT01831141|Glomerular filtration rate|glomerular filtration rate
263005|NCT01831141|Chronic kidney damage|chronic kidney damage
263006|NCT01831141|Hypertension|hypertension
263007|NCT01831141|Proteinuria|proteinuria
263008|NCT01831128|Congestive Heart Failure|congestive heart failure
263009|NCT01831128|Central Sleep Apnea|central sleep apnea
263010|NCT01831128|Sleep-Disordered Breathing|sleep-disordered breathing
263011|NCT01831115|heart failure|heart failure
263012|NCT01831115|BNP|bnp
263013|NCT01831115|acute dyspnoea|acute dyspnoea
263014|NCT01831102|insulin resistance|insulin resistance
263015|NCT01831102|ethnic disparities|ethnic disparities
263016|NCT01831102|adiponectin|adiponectin
263017|NCT01831076|Breast cancer|breast cancer
263018|NCT01831076|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
263019|NCT01831076|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
263020|NCT01831076|Postmenopausal|postmenopausal
263021|NCT01831076|Exemestane|exemestane
263022|NCT01831076|Tamoxifen|tamoxifen
263023|NCT01831063|Seizure|seizure
263024|NCT01831063|Caregivers|caregivers
263025|NCT01831063|Family Centered Care|family centered care
263026|NCT01831063|Learning modality|learning modality
263027|NCT01831050|Poliovirus|poliovirus
263028|NCT01831050|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
263029|NCT01831050|Trivalent oral polio vaccine|trivalent oral polio vaccine
263030|NCT01831050|Bivalent oral polio vaccine|bivalent oral polio vaccine
263031|NCT01831050|Stool shedding index|stool shedding index
263032|NCT01831050|Polio eradication|polio eradication
263033|NCT01831037|Hepatocellular carcinoma|hepatocellular carcinoma
263034|NCT01831037|Regressed cirrhosis|regressed cirrhosis
263035|NCT01831037|Hepatitis C|hepatitis c
263036|NCT01831037|Hepatitis B|hepatitis b
263037|NCT01831037|Noninvasive markers of fibrosis|noninvasive markers of fibrosis
263038|NCT01831037|FibroTest|fibrotest
263039|NCT01831037|FibroSure|fibrosure
263040|NCT01831037|FibroScan|fibroscan
263041|NCT01831037|Transient elastography|transient elastography
263042|NCT01831024|Cold cap|cold cap
263043|NCT01831024|Scalp cooling|scalp cooling
263044|NCT01831024|Chemotherapy induced alopecia|chemotherapy induced alopecia
263045|NCT01831024|Breast cancer|breast cancer
263046|NCT01831011|randomized trial|randomized trial
263047|NCT01831011|acute ischemic stroke|acute ischemic stroke
263048|NCT01831011|mildronate|mildronate
263049|NCT01830998|Dementia|dementia
263050|NCT01830998|Olfactory|olfactory
263051|NCT01830959|Sarcoidosis, fibrosis, bronchiectasis|sarcoidosis, fibrosis, bronchiectasis
263052|NCT01830946|Protein|protein
263053|NCT01830946|Metabolism|metabolism
263054|NCT01830946|Nighttime eating|nighttime eating
263055|NCT01830946|Exercise Training|exercise training
263056|NCT01830933|Breast cancer concern, breast cancer risk perception, breast cancer risk|breast cancer concern, breast cancer risk perception, breast cancer risk
263057|NCT01830920|Acute Kidney Injury|acute kidney injury
263058|NCT01830920|AKI|aki
263059|NCT01830920|Cardiac surgery|cardiac surgery
263060|NCT01830907|Malnutrition|malnutrition
263061|NCT01830907|Gastric cancer|gastric cancer
263062|NCT01830907|preoperative nutrition|preoperative nutrition
263063|NCT01830881|pain|pain
263064|NCT01830881|anxiety|anxiety
263065|NCT01830881|surgical abortion|surgical abortion
263066|NCT01830881|midazolam|midazolam
263067|NCT01830881|benzodiazepine|benzodiazepine
263068|NCT01830868|ZNS|zns
263069|NCT01830868|AED|aed
263070|NCT01830868|Partial Onset Seizures|partial onset seizures
263071|NCT01830868|Retention Rate|retention rate
263072|NCT01830868|Seizure Control|seizure control
263073|NCT01830868|Antiepileptic|antiepileptic
263074|NCT01830868|Secondary generalization|secondary generalization
263075|NCT01830868|Seizure freedom rates|seizure freedom rates
263076|NCT01830842|Nicotine|nicotine
263077|NCT01830842|Smoking|smoking
263078|NCT01830842|Cigarettes|cigarettes
263079|NCT01830842|Reinforcement Learning|reinforcement learning
263080|NCT01830842|fMRI|fmri
263081|NCT01830829|BPH|bph
263082|NCT01830829|CPPS|cpps
263083|NCT01830816|Relapsed|relapsed
263084|NCT01830816|Refractory|refractory
263085|NCT01830816|Multiple Myeloma|multiple myeloma
263086|NCT01830816|Advanced solid tumors|advanced solid tumors
263087|NCT01830803|howRU|howru
263088|NCT01830803|howRwe|howrwe
263089|NCT01830803|reliability|reliability
263090|NCT01830803|quality of life|quality of life
263092|NCT01830803|patient satisfaction|patient satisfaction
263093|NCT01830751|self treatment technique|self treatment technique
263094|NCT01830751|chronic|chronic
263095|NCT01830751|non specific|non specific
263096|NCT01830751|LBP|lbp
263097|NCT01830751|control trunk flexion|control trunk flexion
263098|NCT01830751|diurnal|diurnal
263099|NCT01830738|laparoscopy|laparoscopy
263100|NCT01830738|hysterectomy|hysterectomy
263101|NCT01830738|single-port trocar|single-port trocar
263102|NCT01830738|surgical technique|surgical technique
263103|NCT01830738|trocar|trocar
263104|NCT01830725|Xanthine Oxidase|xanthine oxidase
263105|NCT01830725|Gout|gout
263106|NCT01830725|Hyperuricemia|hyperuricemia
263107|NCT01830725|SNP|snp
263108|NCT01830725|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
263109|NCT01830699|Rilonacept|rilonacept
263110|NCT01830699|Subacromial Bursitis treatment|subacromial bursitis treatment
263111|NCT01830699|Corticosteroid Injection|corticosteroid injection
263112|NCT01830686|Sugarcane bagasse, glucose tolerance, insulin resistance|sugarcane bagasse, glucose tolerance, insulin resistance
263113|NCT01830673|T-regulatory cells|t-regulatory cells
263114|NCT01830673|TH1, TH2 cells|th1, th2 cells
263115|NCT01830673|specific IgE|specific ige
263116|NCT01830673|specific IgG|specific igg
263117|NCT01830673|specific IgG4|specific igg4
263118|NCT01830673|IL2|il2
263119|NCT01830673|IL5|il5
263120|NCT01830673|IL10|il10
263121|NCT01830673|IL12/23|il12/23
263122|NCT01830673|Y-IFN|y-ifn
263123|NCT01830673|TNF-a|tnf-a
263124|NCT01830634|Community-dwelling elderly|community-dwelling elderly
263125|NCT01830634|Rehabilitation|rehabilitation
263126|NCT01830634|Theraband|theraband
263127|NCT01830634|Strengthening and stretching exercise|strengthening and stretching exercise
263128|NCT01830582|MRI|mri
263129|NCT01830582|rectum|rectum
263130|NCT01830582|13-019|13-019
263131|NCT01830569|Decision Support Systems, Clinical|decision support systems, clinical
263132|NCT01830569|Evidence-Based practice|evidence-based practice
263133|NCT01830569|Family Practice|family practice
263134|NCT01830543|Atrial Fibrillation|atrial fibrillation
263135|NCT01830543|Irregular heart beat|irregular heart beat
263136|NCT01830543|rivaroxaban|rivaroxaban
263137|NCT01830543|aspirin|aspirin
263138|NCT01830543|clopidogrel|clopidogrel
263139|NCT01830543|prasugrel|prasugrel
263140|NCT01830543|ticagrelor|ticagrelor
263141|NCT01830543|vitamin K antagonist|vitamin k antagonist
263142|NCT01830530|arterial hypertension|arterial hypertension
263143|NCT01830530|high altitude|high altitude
263144|NCT01830530|hypobaric hypoxia|hypobaric hypoxia
263145|NCT01830530|combination treatment|combination treatment
263146|NCT01830530|angiotensin receptor blocker|angiotensin receptor blocker
263147|NCT01830530|calcium antagonist|calcium antagonist
263148|NCT01830504|thyroid cancers|thyroid cancers
263149|NCT01830504|refractory|refractory
263150|NCT01830504|PI3K inhibitor|pi3k inhibitor
263151|NCT01830465|Non Hodgkin's Follicular Lymphoma|non hodgkin's follicular lymphoma
263152|NCT01830465|relapsed|relapsed
263153|NCT01830465|progressed|progressed
263154|NCT01830452|Chronic pain|chronic pain
263155|NCT01830452|Progrip Mesh|progrip mesh
263156|NCT01830452|Self gripping mesh|self gripping mesh
263157|NCT01830452|Lichtenstein|lichtenstein
263158|NCT01830439|tuberculosis|tuberculosis
263160|NCT01830439|PA-824|pa-824
263161|NCT01830439|food effect|food effect
263162|NCT01830439|pretomanid|pretomanid
263163|NCT01830439|CL-009|cl-009
263164|NCT01830413|stent, systematic Intracranial artery stenosis|stent, systematic intracranial artery stenosis
263165|NCT01830400|ESL|esl
263166|NCT01830400|Partial onset seizures|partial onset seizures
263167|NCT01830400|Retention Rate|retention rate
263168|NCT01830400|Seizure Control|seizure control
263169|NCT01830400|Antiepileptic|antiepileptic
263170|NCT01830400|Secondary Generalisation|secondary generalisation
263171|NCT01830387|Polymetric Clips (Hem-o-Lok)|polymetric clips (hem-o-lok)
263172|NCT01830387|Laparoscopic Appendectomy|laparoscopic appendectomy
263173|NCT01830387|Endoscopic Staplers|endoscopic staplers
263174|NCT01830374|Bulimia nervosa|bulimia nervosa
263175|NCT01830374|Eating disorder|eating disorder
263176|NCT01830374|Weight suppression|weight suppression
263177|NCT01830374|Dieting|dieting
263178|NCT01830361|AML|aml
263179|NCT01830361|Acute Myeloid Leukemia|acute myeloid leukemia
263180|NCT01830361|c-KIT|c-kit
263181|NCT01830361|FLT3-ITD|flt3-itd
263182|NCT01830361|t(8;21)|t(8;21)
263183|NCT01830361|chemotherapy|chemotherapy
263184|NCT01830361|midostaurin|midostaurin
263185|NCT01830348|diabetic foot ulcers|diabetic foot ulcers
263186|NCT01830348|Wagner Grade 1 or 2 foot ulcers|wagner grade 1 or 2 foot ulcers
263187|NCT01830322|metastatic|metastatic
263188|NCT01830322|pancreatic|pancreatic
263189|NCT01830322|adenocarcinoma|adenocarcinoma
263190|NCT01830322|cancer|cancer
263191|NCT01830309|Food-Effect|food-effect
263192|NCT01830309|Pharmacokinetics|pharmacokinetics
263193|NCT01830309|Pharmacodynamics|pharmacodynamics
263194|NCT01830296|Postthoracotomy pain,|postthoracotomy pain,
263195|NCT01830296|patient controlled analgesia,|patient controlled analgesia,
263196|NCT01830296|remifentanil and|remifentanil and
263197|NCT01830296|morphine.|morphine.
263198|NCT01830270|medical oncology|medical oncology
263199|NCT01830270|chemotherapy optimization|chemotherapy optimization
263200|NCT01830270|dose density|dose density
263201|NCT01830244|chemotherapy|chemotherapy
263202|NCT01830244|nab paclitaxel|nab paclitaxel
263203|NCT01830244|neoadjuvant therapy|neoadjuvant therapy
263204|NCT01830244|breast cancer|breast cancer
263205|NCT01830244|pathologic complete response|pathologic complete response
263206|NCT01830231|TCCU|tccu
263207|NCT01830231|Vinflunine|vinflunine
263208|NCT01830231|Cabazitaxel|cabazitaxel
263209|NCT01830231|Metastatic|metastatic
263210|NCT01830231|Locally advance|locally advance
263211|NCT01830192|endometrial cancer|endometrial cancer
263212|NCT01830192|score|score
263213|NCT01830192|nomogram|nomogram
263214|NCT01830192|ultrasound|ultrasound
263215|NCT01830192|HE4|he4
263216|NCT01830153|Soft tissue sarcomas|soft tissue sarcomas
263217|NCT01830153|Bone sarcomas|bone sarcomas
263218|NCT01830153|RAD001|rad001
263219|NCT01830153|Refractory to conventional chemotherapy|refractory to conventional chemotherapy
263220|NCT01830114|alcohol abuse|alcohol abuse
263221|NCT01830114|drug abuse|drug abuse
263222|NCT01830114|hazardous alcohol use|hazardous alcohol use
263223|NCT01830114|hazardous drug use|hazardous drug use
263224|NCT01830101|recurrent glioblastoma|recurrent glioblastoma
263225|NCT01830101|re-irradiation|re-irradiation
263226|NCT01830101|continuous low-dose temozolomide|continuous low-dose temozolomide
263227|NCT01830036|cardiological treatment|cardiological treatment
263228|NCT01830036|sleep Apnea|sleep apnea
263229|NCT01830023|cardiac ultrasound|cardiac ultrasound
263230|NCT01830023|vitality|vitality
263231|NCT01830023|data|data
263232|NCT01830023|patients|patients
263233|NCT01830023|examined|examined
263234|NCT01829984|Injection Teaching|injection teaching
263235|NCT01829984|13-057|13-057
263236|NCT01829971|microRNA|microrna
263237|NCT01829971|Advanced cancer|advanced cancer
263238|NCT01829958|Geriatric|geriatric
263239|NCT01829958|Toxicity|toxicity
263240|NCT01829958|rituximab|rituximab
263241|NCT01829958|prednisone|prednisone
263242|NCT01829958|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
263243|NCT01829958|13-028|13-028
263244|NCT01829932|Diet|diet
263245|NCT01829919|Menopause|menopause
263246|NCT01829919|Hot flashes|hot flashes
263247|NCT01829919|Vasomotor symptoms|vasomotor symptoms
263248|NCT01829919|Climacteric symptoms|climacteric symptoms
263249|NCT01829919|perimenopause|perimenopause
263250|NCT01829919|Mesafem|mesafem
263251|NCT01829919|Brisdelle|brisdelle
263252|NCT01829919|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
263253|NCT01829906|weight loss|weight loss
263254|NCT01829906|bariatric surgery|bariatric surgery
263255|NCT01829906|gastric bypass|gastric bypass
263256|NCT01829906|health education|health education
263257|NCT01829906|nutrition therapy|nutrition therapy
263258|NCT01829906|diet|diet
263259|NCT01829906|exercise|exercise
263260|NCT01829906|cognitive therapy|cognitive therapy
263261|NCT01829893|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
263262|NCT01829893|pharmacokinetics|pharmacokinetics
263263|NCT01829893|bioequivalence|bioequivalence
263264|NCT01829893|finasteirde|finasteirde
263265|NCT01829893|tamsulosin|tamsulosin
263266|NCT01829880|Chronic heart failure|chronic heart failure
263267|NCT01829880|Bisoprolol|bisoprolol
263268|NCT01829880|Ramipril|ramipril
263269|NCT01829880|Pharmacokinetic|pharmacokinetic
263270|NCT01829880|Cachexia|cachexia
263271|NCT01829880|Body composition|body composition
263272|NCT01829880|Renal function|renal function
263273|NCT01829880|Iohexol|iohexol
263274|NCT01829841|MRCC|mrcc
263275|NCT01829841|Metastatic Renal Cell Cancer|metastatic renal cell cancer
263276|NCT01829841|Famitinib|famitinib
263277|NCT01829841|Sunitinib|sunitinib
253870|NCT01872156|Smoking|smoking
263278|NCT01829828|Pain|pain
263279|NCT01829828|Cancer pain|cancer pain
263280|NCT01829828|Self-reported pain scoring tool|self-reported pain scoring tool
263281|NCT01829828|Opioid analgesics|opioid analgesics
263282|NCT01829815|Child|child
263283|NCT01829815|Parents|parents
263284|NCT01829815|Parenting|parenting
263285|NCT01829815|Child Development|child development
263286|NCT01829815|Parent Child Relations|parent child relations
263287|NCT01829815|Malaria|malaria
263288|NCT01829815|Primary Prevention|primary prevention
263289|NCT01829815|Punishment|punishment
263290|NCT01829815|Education|education
263291|NCT01829802|HIV|hiv
263292|NCT01829802|Raltegravir|raltegravir
263293|NCT01829802|Boosted atazanavir|boosted atazanavir
263294|NCT01829789|Adolescents|adolescents
263295|NCT01829789|Teens|teens
263296|NCT01829789|Parents|parents
263297|NCT01829789|Parenting|parenting
263298|NCT01829789|Substance Abuse|substance abuse
263299|NCT01829789|Treatment Efficacy|treatment efficacy
263300|NCT01829776|Accidental falls|accidental falls
263301|NCT01829776|Multiple Sclerosis|multiple sclerosis
263302|NCT01829776|Education|education
263303|NCT01829776|Exercise|exercise
263304|NCT01829776|Postural balance|postural balance
263305|NCT01829750|Univentricular heart|univentricular heart
263306|NCT01829737|Asymptomatic Parasitemia|asymptomatic parasitemia
263307|NCT01829737|RBC Polymorphism|rbc polymorphism
263308|NCT01829737|Acquired Immunity|acquired immunity
263309|NCT01829724|Functional Brain Imaging|functional brain imaging
263310|NCT01829724|Cerebral Palsy|cerebral palsy
263311|NCT01829724|Motion Analysis|motion analysis
263312|NCT01829724|Macro- EMG|macro- emg
263313|NCT01829711|Moxetumomab Paudotox|moxetumomab paudotox
263314|NCT01829711|CAT-8015|cat-8015
263315|NCT01829711|anti-CD22 recombination immunotoxin|anti-cd22 recombination immunotoxin
263316|NCT01829711|Biologic Therapy|biologic therapy
263317|NCT01829711|Recombinant Immunotoxin|recombinant immunotoxin
263318|NCT01829711|Monoclonal Antibody|monoclonal antibody
263319|NCT01829711|Pseudomonas Exotoxin|pseudomonas exotoxin
263320|NCT01829711|Targeted Therapy|targeted therapy
263321|NCT01829698|tudca PBC Cholestasis tauroursodeoxycholic acid taurolite|tudca pbc cholestasis tauroursodeoxycholic acid taurolite
263322|NCT01829672|Early diagnosis of pulmonary arterial hypertension|early diagnosis of pulmonary arterial hypertension
263323|NCT01829672|dynamic dual-energy computed tomography|dynamic dual-energy computed tomography
263325|NCT01829646|DCE MRI|dce mri
263326|NCT01829646|ADC|adc
263327|NCT01829646|FDG PET|fdg pet
263328|NCT01829646|Hypoxia|hypoxia
263329|NCT01829646|Prognostic and predictive model|prognostic and predictive model
263330|NCT01829620|suicide|suicide
263331|NCT01829620|suicide intervention|suicide intervention
263332|NCT01829620|suicide prevention|suicide prevention
263333|NCT01829620|military|military
263334|NCT01829620|military suicide|military suicide
263335|NCT01829620|caring letters|caring letters
263336|NCT01829620|caring contacts|caring contacts
263337|NCT01829620|text messages|text messages
263338|NCT01829594|Case Management|case management
263339|NCT01829594|Frail Elderly|frail elderly
263340|NCT01829594|Health Services Administration|health services administration
263341|NCT01829594|Delivery of Health Care|delivery of health care
263342|NCT01829594|Accidental Falls|accidental falls
263343|NCT01829594|Health Status|health status
263344|NCT01829594|Health Care Economics|health care economics
263345|NCT01829542|flow-mediated dilation|flow-mediated dilation
263346|NCT01829542|blueberry polyphenols|blueberry polyphenols
263347|NCT01829542|dose-dependency|dose-dependency
263348|NCT01829529|Antibiotic prophylaxis|antibiotic prophylaxis
263349|NCT01829503|Phase II|phase ii
263350|NCT01829503|decitabine|decitabine
263351|NCT01829503|cytarabine|cytarabine
263352|NCT01829503|older patients|older patients
263353|NCT01829503|newly diagnosed|newly diagnosed
263354|NCT01829503|AML|aml
263355|NCT01829503|Newly Diagnosed AML|newly diagnosed aml
263356|NCT01829490|Vaccine|vaccine
263357|NCT01829490|Immunogenicity|immunogenicity
263358|NCT01829477|Drug Therapy|drug therapy
263359|NCT01829464|Drug Therapy|drug therapy
263360|NCT01829438|exercise tolerance|exercise tolerance
263361|NCT01829438|6MWT|6mwt
263362|NCT01829425|Hypnosis|hypnosis
263363|NCT01829425|Mind-Body Therapy|mind-body therapy
263364|NCT01829425|Anticholinergics|anticholinergics
263365|NCT01829425|fMRI|fmri
263366|NCT01829425|Functional Neuroimaging|functional neuroimaging
263367|NCT01829425|Gyrus Cinguli|gyrus cinguli
263368|NCT01829425|Female Urogenital Diseases|female urogenital diseases
263369|NCT01829399|Tourniquet pain|tourniquet pain
263370|NCT01829399|Subcutaneous axillary local anesthetic|subcutaneous axillary local anesthetic
263371|NCT01829399|ability to tolerate tourniquet discomfort.|ability to tolerate tourniquet discomfort.
263372|NCT01829373|lung cancer|lung cancer
263373|NCT01829347|liver failure|liver failure
263374|NCT01829347|acute alcoholic hepatitis|acute alcoholic hepatitis
263375|NCT01829347|patients failing steroid therapy|patients failing steroid therapy
325118|NCT01554397|IMRT|imrt
263376|NCT01829347|alcoholic hepatitis|alcoholic hepatitis
263377|NCT01829347|steroid failure|steroid failure
263378|NCT01829347|Lille criteria|lille criteria
263379|NCT01829347|ELAD|elad
263380|NCT01829334|dental caries|dental caries
263381|NCT01829308|implementation|implementation
263382|NCT01829308|SBIRT|sbirt
263383|NCT01829308|alcohol screening|alcohol screening
263384|NCT01829308|drug screening|drug screening
263385|NCT01829308|Brief Intervention|brief intervention
263386|NCT01829308|Referral to Treatment|referral to treatment
263387|NCT01829308|adolescents|adolescents
263388|NCT01829308|Federally Qualified Health Centers|federally qualified health centers
263389|NCT01829295|antimetabolite, noninfectious|antimetabolite, noninfectious
263390|NCT01829282|Implementation|implementation
263391|NCT01829282|HIV|hiv
263392|NCT01829282|serodiscordant couples|serodiscordant couples
263393|NCT01829282|African American|african american
263394|NCT01829282|Cultural congruency|cultural congruency
263395|NCT01829243|Milnacipran|milnacipran
263396|NCT01829243|Fibromyalgia|fibromyalgia
263397|NCT01829243|Neurocognition|neurocognition
263398|NCT01829178|cisplatin|cisplatin
263399|NCT01829178|nephrotoxicity|nephrotoxicity
263400|NCT01829178|antioxidant|antioxidant
263401|NCT01829178|urine neutrophil gelatinase-associated lipocalin (NGAL)|urine neutrophil gelatinase-associated lipocalin (ngal)
263402|NCT01829152|heart failure|heart failure
263403|NCT01829139|Common bile duct stone|common bile duct stone
263404|NCT01829139|Gallbladder in situ|gallbladder in situ
263405|NCT01829139|Choleretics|choleretics
263406|NCT01829113|Recurrent Lung Cancer|recurrent lung cancer
263407|NCT01829113|Stage IV Lung Cancer|stage iv lung cancer
263408|NCT01829113|OGX-427|ogx-427
263409|NCT01829113|Sarah Cannon Research Institute|sarah cannon research institute
263410|NCT01829113|SCRI|scri
263411|NCT01829113|OncoGenex|oncogenex
263412|NCT01829113|NSCLC|nsclc
263413|NCT01829113|Non Small Cell Lung Cancer|non small cell lung cancer
263414|NCT01829100|Adolescent|adolescent
263415|NCT01829100|Transdiagnostic therapy|transdiagnostic therapy
263416|NCT01829100|Behavioral activation|behavioral activation
263417|NCT01829100|Exposure therapy|exposure therapy
263418|NCT01829100|Depressive Disorder|depressive disorder
263419|NCT01829100|Anxiety Disorders|anxiety disorders
263420|NCT01829074|Laryngopharyngeal Reflux|laryngopharyngeal reflux
263421|NCT01829074|Hoarseness|hoarseness
263422|NCT01829074|Throat Clearing|throat clearing
263423|NCT01829074|Globus Sensation|globus sensation
263424|NCT01829061|Type I Diabetes|type i diabetes
263425|NCT01829061|Type II Diabetes|type ii diabetes
263426|NCT01829061|HbA1C|hba1c
263427|NCT01829048|PF-02545920|pf-02545920
263428|NCT01829048|safety|safety
263429|NCT01829048|schizophrenia|schizophrenia
263430|NCT01829035|TACE|tace
263431|NCT01829035|Sorafenib|sorafenib
263432|NCT01829022|Myoma|myoma
263433|NCT01829022|Uterine myomectomy|uterine myomectomy
263434|NCT01829009|Sarcopenia|sarcopenia
263435|NCT01829009|Elderly|elderly
263436|NCT01829009|Women|women
263437|NCT01829009|Resistance|resistance
263438|NCT01829009|Exercise|exercise
263439|NCT01828996|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
263440|NCT01828996|Chronic prostatitis|chronic prostatitis
263441|NCT01828996|Shock wave therapy|shock wave therapy
263442|NCT01828996|Prostate|prostate
263443|NCT01828996|Pelvic floor|pelvic floor
263444|NCT01828996|Pain|pain
263445|NCT01828983|Telephone|telephone
263446|NCT01828983|Support groups|support groups
263447|NCT01828983|Social support|social support
263448|NCT01828983|Depression|depression
263449|NCT01828970|Diabetes Mellitus|diabetes mellitus
263450|NCT01828970|Hemodialysis|hemodialysis
263451|NCT01828970|Continuous glucose monitoring|continuous glucose monitoring
263452|NCT01828970|Insulin analogues|insulin analogues
263453|NCT01828957|Human Umbilical Cord Blood Derived Mesenchymal Stem Cells|human umbilical cord blood derived mesenchymal stem cells
263454|NCT01828957|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
263455|NCT01828957|Premature infants|premature infants
263456|NCT01828944|Vitamin D|vitamin d
263457|NCT01828944|bone loss|bone loss
263458|NCT01828918|early diagnosis|early diagnosis
263459|NCT01828918|prediction|prediction
263460|NCT01828918|prognosis|prognosis
263461|NCT01828905|tibia fracture|tibia fracture
263462|NCT01828905|bone graft|bone graft
263463|NCT01828905|iliac crest|iliac crest
263464|NCT01828905|bone graft substitute|bone graft substitute
263465|NCT01828905|Cerament|cerament
263466|NCT01828905|void filler|void filler
263467|NCT01828905|quality of life|quality of life
263468|NCT01828905|pain|pain
263469|NCT01828905|costs of care|costs of care
263470|NCT01828892|Autologous platelet rich fibrin glue|autologous platelet rich fibrin glue
263471|NCT01828892|Enterocutaneous fistulas|enterocutaneous fistulas
263472|NCT01828892|Single low output GI fistulas|single low output gi fistulas
263473|NCT01828879|Dermatitis, Atopic|dermatitis, atopic
263474|NCT01828879|Tacrolimus|tacrolimus
254066|NCT01870986|Phase 1|phase 1
263475|NCT01828866|EMDR|emdr
263476|NCT01828866|Alcohol|alcohol
263477|NCT01828866|Relapse|relapse
263478|NCT01828866|Craving|craving
263479|NCT01828853|Membrane sweeping|membrane sweeping
263480|NCT01828853|Membrane stripping|membrane stripping
263481|NCT01828853|Maternal outcomes|maternal outcomes
263482|NCT01828853|Neonatal outcomes|neonatal outcomes
263483|NCT01828840|morphine|morphine
263484|NCT01828840|fentanyl|fentanyl
263485|NCT01828840|methadone|methadone
263486|NCT01828840|epidural|epidural
263487|NCT01828840|intravenous|intravenous
263488|NCT01828840|pain|pain
263489|NCT01828840|analgesia|analgesia
263490|NCT01828827|tuberculosis|tuberculosis
263491|NCT01828827|PK|pk
263492|NCT01828827|PA-824|pa-824
263493|NCT01828827|food effect,|food effect,
263494|NCT01828827|bioavailability|bioavailability
263495|NCT01828827|pretomanid|pretomanid
263496|NCT01828827|CL-003|cl-003
263497|NCT01828814|pediatrics|pediatrics
263498|NCT01828814|Ready-to-use Supplementary Food|ready-to-use supplementary food
263499|NCT01828814|corn soy blend|corn soy blend
263500|NCT01828814|cash transfer|cash transfer
263501|NCT01828814|prevention of malnutrition|prevention of malnutrition
263502|NCT01828814|Niger|niger
751918|NCT01171222|veteran athletes|veteran athletes
263503|NCT01828801|Adverse Local Tissue Reaction|adverse local tissue reaction
263504|NCT01828801|Metal Ions|metal ions
263505|NCT01828801|Serum|serum
263506|NCT01828801|Whole Blood|whole blood
263507|NCT01828801|Metal-on-Metal|metal-on-metal
263508|NCT01828801|Total Hip Arthroplasty|total hip arthroplasty
263509|NCT01828788|Sternotomy|sternotomy
263510|NCT01828788|Anesthesia|anesthesia
263511|NCT01828788|Post-operative pain|post-operative pain
263512|NCT01828762|DC|dc
263513|NCT01828762|Immunotherapy|immunotherapy
263514|NCT01828762|TC|tc
263515|NCT01828749|blunt abdominal trauma|blunt abdominal trauma
263516|NCT01828749|CT|ct
263517|NCT01828749|radiation exposure, pediatric|radiation exposure, pediatric
263518|NCT01828736|Urothelial carcinoma|urothelial carcinoma
263519|NCT01828736|Trastuzumab|trastuzumab
263520|NCT01828736|Treatment|treatment
263521|NCT01828723|Autologous Adult Stem Cell|autologous adult stem cell
263522|NCT01828723|Adipose Derived Stem Cell|adipose derived stem cell
263523|NCT01828723|Stromal Vascular Fraction|stromal vascular fraction
263524|NCT01828723|SVF|svf
263525|NCT01828723|Antria|antria
263526|NCT01828723|Shah Rahimian|shah rahimian
263527|NCT01828723|Leonard Maliver|leonard maliver
263528|NCT01828723|David Bizousky|david bizousky
263529|NCT01828723|Rahul Gore|rahul gore
263530|NCT01828723|Lee Quist|lee quist
263531|NCT01828723|Dudley McNitt|dudley mcnitt
263532|NCT01828710|Myo-inositol|myo-inositol
263533|NCT01828710|oligoasthenoteratospermia|oligoasthenoteratospermia
263534|NCT01828710|semen parameters|semen parameters
263535|NCT01828710|IVF|ivf
263536|NCT01828697|Low-molecular-weight heparin|low-molecular-weight heparin
263537|NCT01828697|Pregnancy|pregnancy
263538|NCT01828697|Venous thrombosis|venous thrombosis
263539|NCT01828684|Migraine with Aura|migraine with aura
263540|NCT01828684|Migraine without Aura|migraine without aura
263541|NCT01828684|Photophobia|photophobia
263542|NCT01828684|Chronic Daily Headache|chronic daily headache
263543|NCT01828671|Soy|soy
263544|NCT01828671|Corn|corn
263545|NCT01828671|Flour|flour
263546|NCT01828671|Tortilla|tortilla
263547|NCT01828671|Glycemic|glycemic
263548|NCT01828671|Glucose,|glucose,
263645|NCT01828203|minocycline|minocycline
263549|NCT01828671|glycemic index|glycemic index
263550|NCT01828658|hemodialysis|hemodialysis
263551|NCT01828658|fluid management|fluid management
263552|NCT01828658|bioimpedance|bioimpedance
263553|NCT01828658|mortality|mortality
263554|NCT01828658|arterial stiffness|arterial stiffness
263555|NCT01828645|gastric emptying|gastric emptying
263556|NCT01828645|whey protein|whey protein
263557|NCT01828645|carbohydrate|carbohydrate
263558|NCT01828645|fasting|fasting
263559|NCT01828632|Obesity, Morbid; Hypoxemia; Postoperative complications; Bariatric surgery; Respiratory physical therapy; Preoperative care.|obesity, morbid; hypoxemia; postoperative complications; bariatric surgery; respiratory physical therapy; preoperative care.
263560|NCT01828619|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
263561|NCT01828619|Busulfan|busulfan
263562|NCT01828619|Fludarabine|fludarabine
263563|NCT01828606|leg lymphedema|leg lymphedema
263564|NCT01828606|volume measurement|volume measurement
263565|NCT01828606|compression therapy|compression therapy
263566|NCT01828606|interface pressure|interface pressure
263567|NCT01828606|static stiffness index (SSI)|static stiffness index (ssi)
263568|NCT01828606|volume change|volume change
263569|NCT01828580|laparoscopic Cholecystectomy|laparoscopic cholecystectomy
263570|NCT01828580|Gallbladder removal|gallbladder removal
263571|NCT01828580|laparoscope holder|laparoscope holder
263572|NCT01828567|veterans|veterans
263573|NCT01828567|health risk assessment|health risk assessment
263574|NCT01828567|primary prevention|primary prevention
263575|NCT01828567|shared decision making|shared decision making
263576|NCT01828567|Healthy Living Assessment|healthy living assessment
263577|NCT01828554|Capecitabine pharmacokinetics PK|capecitabine pharmacokinetics pk
263578|NCT01828554|Elevated Body Mass Index (BMI)|elevated body mass index (bmi)
263579|NCT01828554|Advanced Solid Tumors|advanced solid tumors
263580|NCT01828541|Burn injuries|burn injuries
263581|NCT01828528|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
263582|NCT01828528|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
263583|NCT01828528|Obesity|obesity
263584|NCT01828528|Bariatric surgery|bariatric surgery
263585|NCT01828528|Weight loss|weight loss
263586|NCT01828502|Cotinine|cotinine
263587|NCT01828502|Secondhand Smoke Exposure (SHSE)|secondhand smoke exposure (shse)
263588|NCT01828502|Secondhand Smoke (SHS)|secondhand smoke (shs)
263589|NCT01828476|prostate cancer|prostate cancer
694111|NCT00943592|Alemtuzumab|alemtuzumab
263590|NCT01828476|hormone-resistant prostate cancer|hormone-resistant prostate cancer
263591|NCT01828476|recurrent prostate cancer|recurrent prostate cancer
263592|NCT01828476|stage IV prostate cancer|stage iv prostate cancer
263593|NCT01828424|acute pain|acute pain
263594|NCT01828411|Cardiac surgery|cardiac surgery
263595|NCT01828411|Echocardiography|echocardiography
263596|NCT01828411|Cerebral perfusion|cerebral perfusion
263597|NCT01828411|Intraoperative period|intraoperative period
751919|NCT01171222|exercise|exercise
263598|NCT01828385|Physiological Effects of Drugs|physiological effects of drugs
263599|NCT01828385|Rocuronium|rocuronium
263600|NCT01828385|Sugammadex sodium|sugammadex sodium
263601|NCT01828385|Magnesium|magnesium
263602|NCT01828385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
263603|NCT01828385|Neuromuscular block, antagonism|neuromuscular block, antagonism
263604|NCT01828385|Pharmacologic Actions|pharmacologic actions
263605|NCT01828372|concomitant diseases|concomitant diseases
263606|NCT01828372|multiple drug consumption|multiple drug consumption
263607|NCT01828372|therapeutic drug monitoring|therapeutic drug monitoring
263608|NCT01828372|TDM|tdm
263609|NCT01828372|drug monitoring|drug monitoring
263610|NCT01828372|drug level|drug level
263611|NCT01828372|quantification|quantification
263612|NCT01828372|drug|drug
263613|NCT01828372|drug concentration|drug concentration
263614|NCT01828372|concentration|concentration
263615|NCT01828372|therapeutic range|therapeutic range
263616|NCT01828372|therapeutic index|therapeutic index
263617|NCT01828346|TL32711|tl32711
263618|NCT01828346|Birinapant|birinapant
263619|NCT01828346|5-Azacitidine|5-azacitidine
263620|NCT01828346|Myelodysplastic syndrome|myelodysplastic syndrome
263621|NCT01828346|MDS|mds
263622|NCT01828346|Relapsed|relapsed
263623|NCT01828346|Refractory|refractory
263624|NCT01828346|Failed|failed
263625|NCT01828346|open-label|open-label
263626|NCT01828346|non-Randomized|non-randomized
263627|NCT01828346|dose-escalation|dose-escalation
263628|NCT01828346|dose-expansion|dose-expansion
263629|NCT01828333|Malaria|malaria
263630|NCT01828333|Severe|severe
263631|NCT01828333|Artesunate|artesunate
263632|NCT01828333|Quinine|quinine
263633|NCT01828333|Democratic Republic of Congo|democratic republic of congo
263634|NCT01828320|Risk: Emotional, Cognitive, Behavioral, Social, Physical|risk: emotional, cognitive, behavioral, social, physical
263635|NCT01828294|MG|mg
263636|NCT01828268|HIV|hiv
263637|NCT01828268|Metabolomics Fingerprinting|metabolomics fingerprinting
263638|NCT01828242|HbA1C|hba1c
263639|NCT01828229|Inactivity|inactivity
263640|NCT01828229|Obesity|obesity
263641|NCT01828229|Type 2 diabetes|type 2 diabetes
263642|NCT01828229|glucose metabolism|glucose metabolism
263643|NCT01828229|Lipid metabolism|lipid metabolism
263644|NCT01828229|Cognitive function|cognitive function
263646|NCT01828203|randomized control trial|randomized control trial
263647|NCT01828203|phase 3|phase 3
263648|NCT01828203|spinal cord injury|spinal cord injury
263649|NCT01828190|crohn's disease|crohn's disease
263650|NCT01828190|perianal fistulas|perianal fistulas
263651|NCT01828190|TNF alpha blockers|tnf alpha blockers
263652|NCT01828190|hyperbaric oxygen therapy|hyperbaric oxygen therapy
263653|NCT01828177|PreCision|precision
263654|NCT01828177|PDI-320|pdi-320
263655|NCT01828177|Foam|foam
263656|NCT01828164|Orthodontics|orthodontics
263657|NCT01828164|Braces|braces
263658|NCT01828164|Tooth|tooth
263659|NCT01828151|Pressure ulcer|pressure ulcer
263660|NCT01828151|Noninvasive ventilation|noninvasive ventilation
263661|NCT01828138|Proteinuria|proteinuria
263662|NCT01828138|Pregnancy|pregnancy
263663|NCT01828138|Hypertension|hypertension
263664|NCT01828138|Plasmin|plasmin
263665|NCT01828138|Plasminogen|plasminogen
263666|NCT01828138|Aldosterone|aldosterone
263667|NCT01828138|Angiotensin|angiotensin
263668|NCT01828138|Renin|renin
263669|NCT01828138|sodium chloride|sodium chloride
263670|NCT01828138|epithelial sodium channel|epithelial sodium channel
263671|NCT01828138|Placenta|placenta
263672|NCT01828125|Type 1 diabetes|type 1 diabetes
263673|NCT01828125|Hypoglycemia|hypoglycemia
263674|NCT01828125|Glucagon|glucagon
263675|NCT01828125|Hypoglycaemic hyperinsulinemic clamp|hypoglycaemic hyperinsulinemic clamp
263676|NCT01828112|Non-Small Cell Lung Cancer|non-small cell lung cancer
263677|NCT01828112|ALK|alk
263678|NCT01828112|LDK378|ldk378
263679|NCT01828112|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
263680|NCT01828112|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
263681|NCT01828112|lung cancer|lung cancer
263682|NCT01828112|lung adenocarcinoma|lung adenocarcinoma
263683|NCT01828112|Non small cell lung carcinoma|non small cell lung carcinoma
263684|NCT01828112|Non small cell lung cancer|non small cell lung cancer
263685|NCT01828112|NSCLC|nsclc
263686|NCT01828112|chemotherapy|chemotherapy
263687|NCT01828112|ALK-positive|alk-positive
263688|NCT01828112|ALK-rearranged advanced non-small cell lung cancer|alk-rearranged advanced non-small cell lung cancer
263689|NCT01828112|crizotinib|crizotinib
586542|NCT00516659|diarrhea prevention|diarrhea prevention
263690|NCT01828099|Non-Small Cell Lung Cancer, ALK, LDK378|non-small cell lung cancer, alk, ldk378
263691|NCT01828086|Psoriasis, chronic plaque-type psoriasis, IL17, monoclonal antibody|psoriasis, chronic plaque-type psoriasis, il17, monoclonal antibody
263692|NCT01828034|Gemcitabine|gemcitabine
263693|NCT01828034|Cisplatin|cisplatin
263695|NCT01828034|13-004|13-004
263696|NCT01828021|HER2 2+|her2 2+
263697|NCT01828021|FISH non-amplified|fish non-amplified
263698|NCT01828021|Relapsed|relapsed
263699|NCT01828021|Refractory|refractory
263700|NCT01828021|Advanced|advanced
263701|NCT01828021|Margetuximab|margetuximab
263702|NCT01828021|MGAH22|mgah22
263703|NCT01828008|Mabthera|mabthera
263704|NCT01828008|cytokine induced killer cell|cytokine induced killer cell
263705|NCT01827995|Low sensitivity urinary hCG|low sensitivity urinary hcg
263706|NCT01827995|follow up|follow up
263707|NCT01827995|medical abortion|medical abortion
263708|NCT01827995|rural India|rural india
263709|NCT01827995|RCT|rct
263710|NCT01827982|Healthy|healthy
263711|NCT01827982|Safety|safety
263712|NCT01827982|Tolerability|tolerability
263713|NCT01827982|Pharmacokinetic|pharmacokinetic
263714|NCT01827982|Alzheimer's Disease|alzheimer's disease
263715|NCT01827982|JNJ-54861911|jnj-54861911
263716|NCT01827969|Women|women
263717|NCT01827969|breast tumor|breast tumor
263718|NCT01827969|planned mastectomy|planned mastectomy
263719|NCT01827956|Upper aero-digestive tract tumours|upper aero-digestive tract tumours
263720|NCT01827956|FCGR3A and FCGR2A receptor polymorphism|fcgr3a and fcgr2a receptor polymorphism
263721|NCT01827956|Cetuximab efficacy|cetuximab efficacy
263722|NCT01827943|Relapsed bladder cancer|relapsed bladder cancer
263723|NCT01827930|chronic myeloid leukemia in chronic phase|chronic myeloid leukemia in chronic phase
263724|NCT01827904|ExAblate Transcranial MRgFUS|exablate transcranial mrgfus
263725|NCT01827891|acute kidney injury|acute kidney injury
263726|NCT01827891|percutaneous coronary intervention|percutaneous coronary intervention
263727|NCT01827891|remote ischemic preconditioning|remote ischemic preconditioning
263728|NCT01827839|Adults|adults
263729|NCT01827839|Safety|safety
263730|NCT01827839|Immunogenicity|immunogenicity
263731|NCT01827839|Zoster|zoster
263732|NCT01827826|Intervention|intervention
263733|NCT01827826|Telephone|telephone
263734|NCT01827826|Diabetes|diabetes
263735|NCT01827826|Prevention|prevention
263736|NCT01827813|prostate-specific antigen|prostate-specific antigen
263737|NCT01827813|digital rectal examination|digital rectal examination
263738|NCT01827813|transrectal ultrasonography|transrectal ultrasonography
263739|NCT01827813|needle biopsy|needle biopsy
263740|NCT01827813|prostate cancer|prostate cancer
263741|NCT01827800|weight loss|weight loss
263742|NCT01827800|primary care|primary care
263743|NCT01827800|eHealth|ehealth
263744|NCT01827774|Pelvic organ prolapse|pelvic organ prolapse
263745|NCT01827774|Graft repair|graft repair
266035|NCT01816945|Depression|depression
263746|NCT01827761|chemotherapy teaching|chemotherapy teaching
263747|NCT01827761|questionnaire|questionnaire
263748|NCT01827748|Autorefractor|autorefractor
263749|NCT01827735|Interleukin 2|interleukin 2
263750|NCT01827735|Type 1 diabetes|type 1 diabetes
263751|NCT01827735|T regulatory cells|t regulatory cells
263752|NCT01827735|Adaptive trial|adaptive trial
263753|NCT01827722|Macular edema|macular edema
263754|NCT01827722|Central retinal vein occlusion|central retinal vein occlusion
263755|NCT01827722|CRVO|crvo
263756|NCT01827722|Retinal vein occlusion|retinal vein occlusion
263757|NCT01827722|RVO|rvo
263758|NCT01827722|Ozurdex|ozurdex
263759|NCT01827722|Dexamethasone intravitreal implant|dexamethasone intravitreal implant
263760|NCT01827722|Lucentis|lucentis
263761|NCT01827722|Ranibizumab|ranibizumab
263762|NCT01827709|DWI|dwi
263763|NCT01827709|ADC|adc
263764|NCT01827709|DCE-MRI|dce-mri
263765|NCT01827709|FDG-PET|fdg-pet
263766|NCT01827709|SUV|suv
263767|NCT01827709|Hypoxia|hypoxia
263768|NCT01827709|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
263769|NCT01827696|Muscle|muscle
263770|NCT01827696|Soreness|soreness
263771|NCT01827696|Muscle function|muscle function
263772|NCT01827696|Damage|damage
263773|NCT01827696|Ginseng|ginseng
263774|NCT01827683|hyperbaric oxygen|hyperbaric oxygen
263775|NCT01827683|fibromyalgia|fibromyalgia
263776|NCT01827683|chronic pain syndrome|chronic pain syndrome
263777|NCT01827657|plasma|plasma
263778|NCT01827657|tolerability|tolerability
263779|NCT01827657|safety|safety
263780|NCT01827657|matched control|matched control
263781|NCT01827657|GSK2336805|gsk2336805
263782|NCT01827657|hepatic impairment|hepatic impairment
263783|NCT01827657|pharmacokinetics|pharmacokinetics
263784|NCT01827644|AKT inhibitor|akt inhibitor
263785|NCT01827644|formulation|formulation
263786|NCT01827644|food effect|food effect
263787|NCT01827644|bioavailability|bioavailability
263788|NCT01827644|GSK2110183|gsk2110183
263789|NCT01827631|healthy|healthy
263790|NCT01827631|GSK1605786|gsk1605786
263791|NCT01827631|CCR9 receptor antagonist|ccr9 receptor antagonist
263792|NCT01827631|Chinese subjects|chinese subjects
263793|NCT01827631|pharmacokinetics|pharmacokinetics
263794|NCT01827618|bladder|bladder
263795|NCT01827618|Cancer|cancer
263796|NCT01827618|Cystectomy|cystectomy
263797|NCT01827618|Rapamycin|rapamycin
263798|NCT01827605|Relapsed follicular Lymphoma|relapsed follicular lymphoma
263799|NCT01827605|RIT|rit
263800|NCT01827605|Zevalin|zevalin
263801|NCT01827579|Transplant|transplant
263802|NCT01827579|CD25/71 allodepleted donor T cells|cd25/71 allodepleted donor t cells
263803|NCT01827579|Infection|infection
263804|NCT01827579|Acute Myeloid Leukaemia|acute myeloid leukaemia
263805|NCT01827579|Acute Lymphoblastic Leukaemia|acute lymphoblastic leukaemia
263807|NCT01827579|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
263808|NCT01827579|Mantle Cell Lymphoma|mantle cell lymphoma
263809|NCT01827566|Celiac Disease|celiac disease
263810|NCT01827566|Gluten Sensitivity|gluten sensitivity
263811|NCT01827566|Gluten|gluten
263812|NCT01827566|Double-blind challenge, placebo-controlled challenge|double-blind challenge, placebo-controlled challenge
263813|NCT01827566|Gluten free flour|gluten free flour
263814|NCT01827553|pancreatic cancer|pancreatic cancer
263815|NCT01827553|chemoradiotherapy|chemoradiotherapy
263816|NCT01827553|chemotherapy|chemotherapy
263817|NCT01827553|FOLFIRINOX|folfirinox
263818|NCT01827553|gemcitabine|gemcitabine
263819|NCT01827540|HIV/AIDS|hiv/aids
263820|NCT01827540|Cenicriviroc (CVC)|cenicriviroc (cvc)
263821|NCT01827540|Dolutegravir (DTG)|dolutegravir (dtg)
263822|NCT01827540|Midazolam|midazolam
263823|NCT01827540|Healthy Subjects|healthy subjects
263824|NCT01827527|Adenosine Triphosphate|adenosine triphosphate
263825|NCT01827527|Validation|validation
263826|NCT01827527|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
263827|NCT01827527|Optical Spectroscopy|optical spectroscopy
263828|NCT01827514|cancer, erythropoetin|cancer, erythropoetin
263829|NCT01827501|postoperative delirium|postoperative delirium
263830|NCT01827501|hemodynamic management|hemodynamic management
263831|NCT01827501|goal directed therapy|goal directed therapy
263832|NCT01827475|musculoskeletal pain|musculoskeletal pain
263833|NCT01827475|acetaminophen|acetaminophen
263834|NCT01827475|ibuprofen|ibuprofen
263835|NCT01827462|Inactivated, trivalent influenza vaccine|inactivated, trivalent influenza vaccine
263836|NCT01827462|elderly|elderly
263837|NCT01827462|immunosenescence|immunosenescence
263838|NCT01827462|longitudinal study|longitudinal study
263839|NCT01827462|Inactivated, High-Dose trivalent influenza vaccine|inactivated, high-dose trivalent influenza vaccine
263840|NCT01827462|Inactivated, quadrivalent influenza vaccine|inactivated, quadrivalent influenza vaccine
263841|NCT01827462|young adults|young adults
263842|NCT01827449|rewarming|rewarming
263843|NCT01827449|core cooling|core cooling
263844|NCT01827449|afterdrop|afterdrop
263845|NCT01827449|hospital treatment|hospital treatment
263846|NCT01827449|hypothermia|hypothermia
263847|NCT01827436|pediatric stroke|pediatric stroke
263848|NCT01827436|hemiplegia|hemiplegia
263849|NCT01827436|physical therapy|physical therapy
263850|NCT01827436|gait training|gait training
263851|NCT01827436|transcranial magnetic stimulation|transcranial magnetic stimulation
263852|NCT01827436|gait asymmetry|gait asymmetry
263853|NCT01827423|squamous cell carcinoma antigen|squamous cell carcinoma antigen
263854|NCT01827423|sinonasal inverted papilloma|sinonasal inverted papilloma
263855|NCT01827423|clinical marker|clinical marker
263856|NCT01827423|hidden reccurence|hidden reccurence
263857|NCT01827423|surgery|surgery
263858|NCT01827397|Safety of this HIV vaccine|safety of this hiv vaccine
263859|NCT01827371|Smallpox, vaccine, IMVAMUNE, Stratis, parent protocol|smallpox, vaccine, imvamune, stratis, parent protocol
263860|NCT01827358|antibacterial agent|antibacterial agent
263861|NCT01827358|children|children
263862|NCT01827358|colonisation|colonisation
263863|NCT01827358|critically ill|critically ill
263864|NCT01827358|infants|infants
263865|NCT01827358|mupirocin|mupirocin
263866|NCT01827358|prevention|prevention
263867|NCT01827358|Staphylococcus aureus|staphylococcus aureus
263868|NCT01827345|Vitamin D|vitamin d
263869|NCT01827345|Falls|falls
263870|NCT01827345|Balance|balance
263871|NCT01827345|Physical Function|physical function
263872|NCT01827332|marijuana|marijuana
263873|NCT01827332|substance abuse|substance abuse
263874|NCT01827332|drug abuse|drug abuse
263875|NCT01827332|marijuana dependence|marijuana dependence
263876|NCT01827332|drug addiction|drug addiction
263877|NCT01827319|Angina|angina
263878|NCT01827319|Transmyocardial revascularization|transmyocardial revascularization
263879|NCT01827280|endothelial function|endothelial function
263880|NCT01827280|microvascular function|microvascular function
263881|NCT01827280|incretins|incretins
263882|NCT01827280|diabetes mellitus|diabetes mellitus
263883|NCT01827280|postprandial lipemia|postprandial lipemia
263884|NCT01827267|Lung cancer|lung cancer
263885|NCT01827267|Puma|puma
263886|NCT01827267|neratinib|neratinib
694112|NCT00943592|Clofarabine|clofarabine
263887|NCT01827254|sutent rechallenge|sutent rechallenge
263888|NCT01827241|Gastroenterology|gastroenterology
263889|NCT01827241|Colonoscopy|colonoscopy
263890|NCT01827241|Screening|screening
263891|NCT01827241|Surveillance|surveillance
263892|NCT01827241|Symptom evaluation|symptom evaluation
263893|NCT01827241|Chart review|chart review
263894|NCT01827241|Data review|data review
263895|NCT01827241|Examination findings|examination findings
263896|NCT01827241|Resection techniques|resection techniques
263897|NCT01827241|Pathology reports|pathology reports
263898|NCT01827228|HIV|hiv
263899|NCT01827228|transmission prevention|transmission prevention
263900|NCT01827228|social network and venue|social network and venue
263901|NCT01827228|community intervention|community intervention
263902|NCT01827228|treatment as prevention|treatment as prevention
263903|NCT01827228|recent infection|recent infection
263904|NCT01827228|phylogenetics|phylogenetics
263905|NCT01827228|infection chains|infection chains
263906|NCT01827215|Preconception Care|preconception care
263907|NCT01827215|Racial Disparities|racial disparities
263908|NCT01827215|Health Information Technology|health information technology
263909|NCT01827202|renin-angiotensin-system|renin-angiotensin-system
263910|NCT01827202|RAS blockade|ras blockade
263911|NCT01827189|primary care, Medicare costs, hospitalizations|primary care, medicare costs, hospitalizations
263912|NCT01827176|Characteristic|characteristic
263913|NCT01827176|Recurrent Acute Rhinosinusitis|recurrent acute rhinosinusitis
263914|NCT01827176|Children|children
263915|NCT01827163|Paclitaxel|paclitaxel
263916|NCT01827163|Trastuzumab|trastuzumab
263917|NCT01827163|Lapatinib|lapatinib
263918|NCT01827163|HER2|her2
263919|NCT01827163|13-002|13-002
263920|NCT01827137|WT1 Analog Peptide Vaccine|wt1 analog peptide vaccine
263921|NCT01827137|12-288|12-288
263922|NCT01827124|CARBETOCIN AND OXYTOCIN AND SECOND TRIMESTER INTERRUPTION|carbetocin and oxytocin and second trimester interruption
263923|NCT01827111|Melanoma|melanoma
263924|NCT01827111|Metastatic Melanoma|metastatic melanoma
263925|NCT01827111|Advanced stage IV melanoma|advanced stage iv melanoma
263926|NCT01827111|Unresectable stage III mucosal melanoma|unresectable stage iii mucosal melanoma
263927|NCT01827111|Cutaneous melanoma|cutaneous melanoma
263928|NCT01827111|Progression-free survival|progression-free survival
263929|NCT01827111|(PFS)|(pfs)
263930|NCT01827111|ABI-007|abi-007
263931|NCT01827111|Nab-paclitaxel|nab-paclitaxel
263932|NCT01827111|Paclitaxel|paclitaxel
263933|NCT01827111|Abraxane|abraxane
263934|NCT01827111|Ipilimumab|ipilimumab
263935|NCT01827111|Yervoy|yervoy
263936|NCT01827111|BMS-734016|bms-734016
263937|NCT01827111|MDX010|mdx010
263938|NCT01827098|Immature teeth|immature teeth
263939|NCT01827098|Calcium Hydroxide|calcium hydroxide
263940|NCT01827098|Blood clot|blood clot
263941|NCT01827098|Revascularization|revascularization
263942|NCT01827098|Revitalization|revitalization
263943|NCT01827072|IVIG in Multifocal Motor Neuropathy|ivig in multifocal motor neuropathy
263944|NCT01827072|Patients with Multifocal Motor Neuropathy|patients with multifocal motor neuropathy
263945|NCT01827046|intracerebral hemorrhage|intracerebral hemorrhage
263946|NCT01827046|ICH|ich
263947|NCT01827046|brain hemorrhage|brain hemorrhage
263948|NCT01827046|minimally invasive surgery|minimally invasive surgery
263949|NCT01827046|rt-PA|rt-pa
263950|NCT01827007|norepinephrine infusion|norepinephrine infusion
263951|NCT01827007|under 48 hours in ICU|under 48 hours in icu
263952|NCT01826968|Lung recruitment, cesarean, lung compliance, atelectasis|lung recruitment, cesarean, lung compliance, atelectasis
263953|NCT01826955|pneumoperitoneum, cognitive function|pneumoperitoneum, cognitive function
263954|NCT01826942|Scar prevention|scar prevention
263955|NCT01826942|CO2 fractional laser|co2 fractional laser
263956|NCT01826929|Health Services Research|health services research
263957|NCT01826929|Cardiovascular Diseases|cardiovascular diseases
263958|NCT01826929|Primary Care|primary care
263959|NCT01826929|Secondary Prevention.|secondary prevention.
263960|NCT01826903|Depression|depression
263961|NCT01826903|Cognitive Behavior Therapy|cognitive behavior therapy
263962|NCT01826903|Child Development|child development
263963|NCT01826890|Ventilator Weaning|ventilator weaning
263964|NCT01826890|Mechanical Ventilation|mechanical ventilation
263965|NCT01826890|Critical Care|critical care
263966|NCT01826890|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
263967|NCT01826890|Diaphragm|diaphragm
263968|NCT01826851|Pain management|pain management
263969|NCT01826851|Anesthetic, local|anesthetic, local
263970|NCT01826851|Nerve blockade|nerve blockade
263971|NCT01826851|Coronary Artery Bypass Surgery|coronary artery bypass surgery
263972|NCT01826851|Analgesics, opioid|analgesics, opioid
263973|NCT01826851|Postoperative complications|postoperative complications
263974|NCT01826851|Bupivacaine|bupivacaine
263975|NCT01826838|Prostate Cancer|prostate cancer
263976|NCT01826825|aging|aging
263977|NCT01826825|cognition|cognition
263978|NCT01826825|surgery|surgery
263979|NCT01826799|sleep|sleep
263980|NCT01826799|noise|noise
263981|NCT01826799|ICU|icu
263982|NCT01826799|delirium|delirium
263983|NCT01826799|RCSQ|rcsq
263984|NCT01826786|Healthy|healthy
263985|NCT01826786|Anxiety Disorders|anxiety disorders
263986|NCT01826786|Anxiety Modulation|anxiety modulation
263987|NCT01826786|Male|male
263988|NCT01826773|CardioPET|cardiopet
263989|NCT01826773|Coronary Artery Disease|coronary artery disease
263990|NCT01826773|Myocardial Perfusion Imaging|myocardial perfusion imaging
263991|NCT01826773|Coronary Angiography|coronary angiography
263992|NCT01826773|Myocardial Fatty Acid Utilization|myocardial fatty acid utilization
263993|NCT01826747|intrauterine insemination|intrauterine insemination
263994|NCT01826747|luteal phase|luteal phase
263995|NCT01826747|gonadotrophins|gonadotrophins
263996|NCT01826734|dacryolith|dacryolith
263997|NCT01826734|dacryocystorhinostomy|dacryocystorhinostomy
263998|NCT01826734|composition|composition
263999|NCT01826734|chemical analysis|chemical analysis
264000|NCT01826734|infrared spectrometry|infrared spectrometry
264001|NCT01826734|scanning electron microscopy|scanning electron microscopy
264002|NCT01826734|elemental analysis|elemental analysis
264003|NCT01826721|Solid organ transplantation|solid organ transplantation
264004|NCT01826721|Immunosuppression|immunosuppression
264005|NCT01826721|Education|education
264006|NCT01826721|E-learning|e-learning
264007|NCT01826721|Medication knowledge|medication knowledge
264008|NCT01826721|Patient satisfaction|patient satisfaction
264009|NCT01826721|Medication adherence|medication adherence
264010|NCT01826708|Chromosomal translocations|chromosomal translocations
264011|NCT01826708|psychomotor delay|psychomotor delay
264012|NCT01826695|Fibromyalgia, neurodynamic, dexterity|fibromyalgia, neurodynamic, dexterity
264013|NCT01826682|COPD, physiotherapy, exacerbation|copd, physiotherapy, exacerbation
264014|NCT01826656|intramembranous bone healing|intramembranous bone healing
264015|NCT01826656|post-menopausal osteoporosis|post-menopausal osteoporosis
264016|NCT01826656|tooth extraction|tooth extraction
264017|NCT01826630|CLn Body Wash|cln body wash
264018|NCT01826630|CLn BodyWash|cln bodywash
264019|NCT01826617|Prostate Disease Nomogram|prostate disease nomogram
264020|NCT01826617|Asian Men|asian men
264021|NCT01826604|cesarean section|cesarean section
264022|NCT01826604|Pregnant|pregnant
264023|NCT01826565|success|success
264024|NCT01826552|Orsiro hybrid stent|orsiro hybrid stent
264025|NCT01826552|Drug-eluting stent|drug-eluting stent
264026|NCT01826552|Zotarolimus-eluting stent|zotarolimus-eluting stent
264027|NCT01826552|Coronary heart disease|coronary heart disease
264028|NCT01826552|Cobalt chromium|cobalt chromium
264029|NCT01826539|Dorsal digital nerve|dorsal digital nerve
264030|NCT01826539|dorsal branch of the digital nerve|dorsal branch of the digital nerve
264031|NCT01826539|dorsal branch of the digital artery|dorsal branch of the digital artery
264032|NCT01826539|dorsal digital island flap|dorsal digital island flap
264033|NCT01826539|finger pulp defect.|finger pulp defect.
264034|NCT01826513|Obstructive sleep apnea|obstructive sleep apnea
264035|NCT01826513|Efficacy|efficacy
264036|NCT01826513|Subjective feedback|subjective feedback
264037|NCT01826513|Preference|preference
264038|NCT01826500|embryo transfer|embryo transfer
264039|NCT01826500|IVF cycle|ivf cycle
264040|NCT01826500|endometriosis|endometriosis
264041|NCT01826487|Duchenne muscular dystrophy|duchenne muscular dystrophy
264042|NCT01826487|Dystrophinopathy|dystrophinopathy
264043|NCT01826487|Nonsense mutation|nonsense mutation
264044|NCT01826487|Premature stop codon|premature stop codon
264045|NCT01826487|Becker muscular dystrophy|becker muscular dystrophy
264046|NCT01826487|DMD/BMD|dmd/bmd
264047|NCT01826487|PTC124|ptc124
264048|NCT01826487|Ataluren|ataluren
264049|NCT01826474|Duchenne muscular dystrophy|duchenne muscular dystrophy
264050|NCT01826474|DMD|dmd
264051|NCT01826474|Prosensa|prosensa
264052|NCT01826474|Duchenne|duchenne
264053|NCT01826461|atopic dermatitis|atopic dermatitis
264054|NCT01826461|eczema|eczema
264055|NCT01826461|PDI-192|pdi-192
264056|NCT01826461|Precision|precision
264057|NCT01826422|Muscular Dystrophy|muscular dystrophy
264058|NCT01826422|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
264059|NCT01826422|Becker Muscular Dystrophy|becker muscular dystrophy
264060|NCT01826422|Omega 3|omega 3
264061|NCT01826422|Eicosapentaenoic fatty acid|eicosapentaenoic fatty acid
264062|NCT01826422|Docosahexaenoic fatty acid|docosahexaenoic fatty acid
264063|NCT01826383|Infant|infant
264064|NCT01826383|Immunization|immunization
264065|NCT01826357|metabolic syndrome|metabolic syndrome
264066|NCT01826357|cluster analysis|cluster analysis
264067|NCT01826357|PCOS|pcos
264068|NCT01826318|Stress|stress
264069|NCT01826318|coping|coping
264070|NCT01826318|simulation|simulation
264071|NCT01826292|Post anesthesia care unit length of stay|post anesthesia care unit length of stay
264072|NCT01826279|Obesity|obesity
264073|NCT01826279|Gastric bypass surgery|gastric bypass surgery
264074|NCT01826279|Resveratrol|resveratrol
264075|NCT01826279|Insulin sensitivity|insulin sensitivity
264076|NCT01826279|Lipid turnover|lipid turnover
264077|NCT01826279|VLDL-triglyceride uptake|vldl-triglyceride uptake
264078|NCT01826279|Liver|liver
264079|NCT01826266|PER977|per977
264080|NCT01826266|Activated partial thromboplastin time|activated partial thromboplastin time
264081|NCT01826266|Assessment|assessment
264082|NCT01826266|D-dimer|d-dimer
264083|NCT01826266|Enrollment|enrollment
264084|NCT01826266|Investigational drug|investigational drug
264085|NCT01826266|Investigational treatment|investigational treatment
264086|NCT01826266|Period|period
264087|NCT01826266|Premature subject withdrawal|premature subject withdrawal
264088|NCT01826266|Prothrombin time|prothrombin time
264089|NCT01826266|Randomization number|randomization number
264090|NCT01826266|Study discontinuation|study discontinuation
264091|NCT01826266|Study drug|study drug
264092|NCT01826266|Subject number|subject number
264093|NCT01826266|Study treatment|study treatment
264094|NCT01826266|Thromboelastography-reaction time|thromboelastography-reaction time
264095|NCT01826253|Hypovolemia|hypovolemia
264096|NCT01826253|Fluid challenge|fluid challenge
264097|NCT01826253|Fluid expansion|fluid expansion
264098|NCT01826253|Oxygene delivery|oxygene delivery
264099|NCT01826253|Cardiac output|cardiac output
264100|NCT01826227|PET (Positron Emission Tomography)|pet (positron emission tomography)
264102|NCT01826227|Cytoreductive Surgery|cytoreductive surgery
264103|NCT01826227|13-017|13-017
264104|NCT01826214|acute myeloid leukemia|acute myeloid leukemia
264105|NCT01826214|AML|aml
264106|NCT01826214|acute lymphoblastic leukemia|acute lymphoblastic leukemia
264107|NCT01826214|ALL|all
264108|NCT01826214|leukemia|leukemia
264109|NCT01826214|acute|acute
264110|NCT01826214|LDE225|lde225
264111|NCT01826214|adult patients|adult patients
264112|NCT01826214|relapsed/refractory|relapsed/refractory
264113|NCT01826201|psoriasis|psoriasis
264114|NCT01826188|Crohn's disease|crohn's disease
264115|NCT01826188|IBD Cannabis|ibd cannabis
264116|NCT01826188|THC|thc
264117|NCT01826188|CBD|cbd
264118|NCT01826175|Optical Coherence Tomography|optical coherence tomography
264119|NCT01826175|ticagrelor|ticagrelor
264120|NCT01826175|clopidogrel|clopidogrel
264121|NCT01826123|Coagulopathy|coagulopathy
264122|NCT01826123|Hemorrhage|hemorrhage
264123|NCT01826123|Cardiac surgery|cardiac surgery
264124|NCT01826123|Point-of-Care testing|point-of-care testing
264125|NCT01826123|POC|poc
264126|NCT01826123|ROTEM|rotem
264127|NCT01826123|multiplate|multiplate
264128|NCT01826123|Multiple electrode aggregometry (MEA)|multiple electrode aggregometry (mea)
264129|NCT01826097|Cytology|cytology
264130|NCT01826097|Whole body massage vibration|whole body massage vibration
264131|NCT01826071|Osgood-Schlatter syndrome (OSS)|osgood-schlatter syndrome (oss)
264132|NCT01826071|Sinding-Larsen and Johansson syndrome (SLJ)|sinding-larsen and johansson syndrome (slj)
264133|NCT01826071|Sever's disease|sever's disease
264134|NCT01826071|apophysitis|apophysitis
264135|NCT01826058|Stereotactic body radiation therapy|stereotactic body radiation therapy
264136|NCT01826058|Radiosurgery|radiosurgery
264137|NCT01826045|Treatment of Cervical Intraepithelial Neoplasia(CIN1)|treatment of cervical intraepithelial neoplasia(cin1)
264138|NCT01826006|Myocardial Infarction|myocardial infarction
264139|NCT01826006|No-reflow|no-reflow
264140|NCT01826006|Primary PCI|primary pci
264141|NCT01826006|Coronary no-reflow phenomenon|coronary no-reflow phenomenon
264142|NCT01826006|Primary percoutaneous coronary intervention (primary PCI)|primary percoutaneous coronary intervention (primary pci)
266036|NCT01816945|Stress|stress
264143|NCT01825993|Peridural catheter|peridural catheter
264144|NCT01825993|Morphine PCA|morphine pca
264145|NCT01825993|Transabdominal Block|transabdominal block
264146|NCT01825993|laparoscopic sigmoidectomy|laparoscopic sigmoidectomy
264147|NCT01825954|Fibromyalgia|fibromyalgia
264149|NCT01825954|Brain|brain
264150|NCT01825954|Stimulation|stimulation
264151|NCT01825954|Device|device
264152|NCT01825941|migraine|migraine
264153|NCT01825941|headache|headache
264154|NCT01825941|metoclopramide|metoclopramide
264155|NCT01825941|diphenhydramine|diphenhydramine
264156|NCT01825928|Methamphetamine|methamphetamine
264157|NCT01825928|paliperidone|paliperidone
264158|NCT01825915|Laparoscopic|laparoscopic
264159|NCT01825915|Hysterectomy|hysterectomy
264160|NCT01825915|Total|total
264161|NCT01825915|Subtotal|subtotal
254845|NCT01867359|DNA|dna
264162|NCT01825915|Recovery|recovery
264163|NCT01825915|Outcomes|outcomes
264164|NCT01825915|Surgery|surgery
264165|NCT01825863|Laparoscopy|laparoscopy
264167|NCT01825863|Nerve block|nerve block
264168|NCT01825863|Ultrasonography|ultrasonography
264169|NCT01825837|bipolar I disorder|bipolar i disorder
264170|NCT01825837|Eslicarbazepine acetate|eslicarbazepine acetate
264171|NCT01825837|BIA 2-093|bia 2-093
264172|NCT01825824|Hepatocellular carcinoma|hepatocellular carcinoma
264173|NCT01825824|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
264174|NCT01825824|Stereotactic body radiotherapy|stereotactic body radiotherapy
264175|NCT01825811|Cell mediated gene therapy|cell mediated gene therapy
264176|NCT01825811|Osteoarthritis|osteoarthritis
264177|NCT01825811|Fibrin-glue|fibrin-glue
264178|NCT01825811|Degenerative Arthritis|degenerative arthritis
264179|NCT01825798|Metformin|metformin
264180|NCT01825798|Overweight|overweight
264181|NCT01825798|Atypical Antipsychotic|atypical antipsychotic
264182|NCT01825798|Medication|medication
264183|NCT01825798|Randomized Clinical Trial|randomized clinical trial
264184|NCT01825798|Children|children
264185|NCT01825772|Cross-Sectional Studies|cross-sectional studies
264186|NCT01825772|Prevalence|prevalence
264187|NCT01825772|Peri-Implantitis|peri-implantitis
264188|NCT01825733|palonosetron, ramosetron, PONV, opioid|palonosetron, ramosetron, ponv, opioid
264189|NCT01825720|GIK, valvular heart surgery, lactate|gik, valvular heart surgery, lactate
264190|NCT01825694|Substance Abuse|substance abuse
264191|NCT01825694|Traumatic Stress|traumatic stress
264192|NCT01825681|positive affect|positive affect
264193|NCT01825681|caregivers|caregivers
264194|NCT01825681|caregiving|caregiving
264195|NCT01825681|stress|stress
264196|NCT01825681|mood|mood
264197|NCT01825681|dementia|dementia
264200|NCT01825681|Lewy|lewy
264201|NCT01825681|mindfulness|mindfulness
264202|NCT01825681|help|help
264203|NCT01825642|Prostate cancer|prostate cancer
264204|NCT01825642|sexual function|sexual function
264205|NCT01825642|seminal vesicle sparing|seminal vesicle sparing
264206|NCT01825642|nerve-sparing|nerve-sparing
264207|NCT01825642|radical prostatectomy|radical prostatectomy
264208|NCT01825629|Pain|pain
264209|NCT01825629|Temporomandibular joint|temporomandibular joint
264210|NCT01825629|Manual therapy|manual therapy
264211|NCT01825629|Physical therapy|physical therapy
264212|NCT01825629|Fibromyalgia Syndrome|fibromyalgia syndrome
264213|NCT01825616|Strength|strength
264214|NCT01825616|Anaerobic power|anaerobic power
264215|NCT01825616|Muscle soreness|muscle soreness
264216|NCT01825616|Immune function|immune function
264217|NCT01825590|hemodialysis|hemodialysis
264218|NCT01825590|dialysate and serum sodium|dialysate and serum sodium
264219|NCT01825577|Alzheimer Dementia|alzheimer dementia
264220|NCT01825577|Gait|gait
264221|NCT01825564|G-tube|g-tube
264222|NCT01825564|Feeding tube|feeding tube
264223|NCT01825564|Feeding tube placement verification|feeding tube placement verification
264224|NCT01825564|Enteral feeding|enteral feeding
264225|NCT01825551|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
264226|NCT01825551|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
264227|NCT01825538|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
264228|NCT01825538|Pulmonary fibrosis|pulmonary fibrosis
264229|NCT01825538|Advanced care planning|advanced care planning
264230|NCT01825512|chronic iron overload|chronic iron overload
264231|NCT01825512|hereditary haemoglobinopathy|hereditary haemoglobinopathy
264232|NCT01825512|beta thalassaemia major|beta thalassaemia major
264233|NCT01825512|chelating agents|chelating agents
264234|NCT01825512|deferiprone|deferiprone
264235|NCT01825512|deferasirox|deferasirox
264236|NCT01825512|children|children
264237|NCT01825512|paediatrics|paediatrics
264238|NCT01825499|Birth weight|birth weight
264239|NCT01825499|Gestational age|gestational age
264240|NCT01825499|Very low birth weight|very low birth weight
264241|NCT01825486|Balance|balance
264242|NCT01825486|Gait characteristics|gait characteristics
264243|NCT01825473|neonate|neonate
264244|NCT01825473|apnea|apnea
264245|NCT01825473|preterm|preterm
264246|NCT01825473|reflux|reflux
264247|NCT01825473|gastroesophageal reflux|gastroesophageal reflux
264248|NCT01825473|impedance|impedance
264249|NCT01825473|erythromycin|erythromycin
264250|NCT01825473|desaturation|desaturation
264251|NCT01825473|bradycardia|bradycardia
264252|NCT01825473|hypoxia|hypoxia
264253|NCT01825460|Cervical spine|cervical spine
264254|NCT01825460|Neck pain|neck pain
264255|NCT01825460|Manual therapy|manual therapy
264256|NCT01825460|Controlled clinical trial|controlled clinical trial
264257|NCT01825447|abuse potential|abuse potential
264258|NCT01825447|abuse liability|abuse liability
264259|NCT01825447|drug liking|drug liking
264260|NCT01825447|oxycodone|oxycodone
264261|NCT01825447|naltrexone|naltrexone
264262|NCT01825447|intravenous|intravenous
264263|NCT01825447|pharmacodynamic|pharmacodynamic
264264|NCT01825434|chronic constipation|chronic constipation
264265|NCT01825434|Lactobacillus acidophilus NCFM|lactobacillus acidophilus ncfm
264266|NCT01825434|Bifidobacterium lactis HN019|bifidobacterium lactis hn019
264267|NCT01825421|Infant|infant
264268|NCT01825421|Infection|infection
264269|NCT01825421|Newborn|newborn
264270|NCT01825421|Antibiotics|antibiotics
264271|NCT01825421|Neutrophil CD64|neutrophil cd64
264272|NCT01825421|Blood Culture|blood culture
264273|NCT01825369|congenital heart disease|congenital heart disease
264274|NCT01825369|ventricular septal defect|ventricular septal defect
264275|NCT01825369|atrioventricular septal defect|atrioventricular septal defect
264276|NCT01825369|increased pulmonary blood flow|increased pulmonary blood flow
264277|NCT01825369|nitric oxide|nitric oxide
264278|NCT01825343|fall|fall
264279|NCT01825343|burn|burn
264280|NCT01825343|road traffic crash|road traffic crash
264281|NCT01825330|Alzheimer's Disease|alzheimer's disease
264282|NCT01825330|Alzheimer's|alzheimer's
264283|NCT01825330|TMS|tms
264284|NCT01825330|Cognitive Training|cognitive training
264285|NCT01825330|NeuroAD|neuroad
264286|NCT01825317|Alzheimer's disease|alzheimer's disease
264287|NCT01825317|TMS|tms
264288|NCT01825317|NeuroAd|neuroad
264289|NCT01825317|cognitive training|cognitive training
264290|NCT01825317|ADAS-Cog|adas-cog
264291|NCT01825304|mechanical ventilation|mechanical ventilation
264292|NCT01825304|Intra-abdominal hypertension|intra-abdominal hypertension
264293|NCT01825304|positive end-expiratory pressure|positive end-expiratory pressure
264294|NCT01825291|sleep apnea|sleep apnea
264295|NCT01825291|co-morbidities of sleep apnea|co-morbidities of sleep apnea
264296|NCT01825291|CPAP treatment|cpap treatment
264297|NCT01825278|respiratory rate|respiratory rate
264298|NCT01825278|tidal volume|tidal volume
264299|NCT01825278|minute ventilation|minute ventilation
264300|NCT01825278|obese patients|obese patients
264302|NCT01825265|Neoplasm Metastasis|neoplasm metastasis
264303|NCT01825265|Breast Cancer|breast cancer
264304|NCT01825265|Docetaxel|docetaxel
264305|NCT01825265|RAD001|rad001
264306|NCT01825265|Taxotere|taxotere
264307|NCT01825252|HIV|hiv
264308|NCT01825252|sexually transmitted diseases|sexually transmitted diseases
264309|NCT01825239|ischemic cardiomyopathy|ischemic cardiomyopathy
264310|NCT01825239|cardiomyopathy|cardiomyopathy
264311|NCT01825239|left ventricular lead|left ventricular lead
264312|NCT01825239|cardiac electrophysiologic studies|cardiac electrophysiologic studies
264313|NCT01825213|Liver disease|liver disease
264314|NCT01825213|Multi Spectral CT|multi spectral ct
264315|NCT01825200|Influenza|influenza
264316|NCT01825148|Diabetes|diabetes
264317|NCT01825135|muscle strength|muscle strength
264318|NCT01825135|muscle function|muscle function
264319|NCT01825135|functional status|functional status
264320|NCT01825109|Rotavirus|rotavirus
264321|NCT01825109|Immunogenicity|immunogenicity
264322|NCT01825109|vaccine, Bangladesh|vaccine, bangladesh
264323|NCT01825096|cerebral metabolism|cerebral metabolism
264324|NCT01825096|functional magnetic resonance imaging|functional magnetic resonance imaging
264325|NCT01825096|near infrared spectroscopy|near infrared spectroscopy
264326|NCT01825083|Hypercarbia|hypercarbia
264327|NCT01825083|TOSCA monitor|tosca monitor
264328|NCT01825083|Ketamine|ketamine
264329|NCT01825083|Fentanyl|fentanyl
264330|NCT01825083|Intraoperative monitoring|intraoperative monitoring
264331|NCT01825070|Montmorency tart cherries|montmorency tart cherries
264332|NCT01825070|Inflammation|inflammation
264333|NCT01825070|Uric acid|uric acid
264334|NCT01825057|implementation study|implementation study
264335|NCT01825057|motivational interviewing|motivational interviewing
264336|NCT01825057|substance use|substance use
264337|NCT01825044|Traumatic Brain Injury|traumatic brain injury
264338|NCT01825044|TBI|tbi
264339|NCT01825044|ciclosporin|ciclosporin
264340|NCT01825044|pharmacokinetic|pharmacokinetic
264341|NCT01825044|safety|safety
264342|NCT01825044|microdialysis|microdialysis
264343|NCT01825044|mitochondrial protection|mitochondrial protection
264344|NCT01825031|HIV|hiv
264345|NCT01825018|HIV|hiv
264346|NCT01825018|AIDS|aids
264347|NCT01825018|treatment adherence|treatment adherence
264348|NCT01825005|cervical cancer|cervical cancer
264349|NCT01824966|Esophagectomy|esophagectomy
264350|NCT01824966|Signet Ring Cells|signet ring cells
264351|NCT01824953|Gastric atrophy|gastric atrophy
264352|NCT01824953|Helicobacter pylori|helicobacter pylori
264353|NCT01824953|Pepsinogen|pepsinogen
264354|NCT01824953|Gastric cancer|gastric cancer
264355|NCT01824953|Gastric adenoma|gastric adenoma
264356|NCT01824940|Cluster randomized trial|cluster randomized trial
264357|NCT01824940|Nutrition|nutrition
264358|NCT01824940|Water Sanitation Hygiene|water sanitation hygiene
264359|NCT01824940|Environmental enteropathy|environmental enteropathy
264360|NCT01824914|videolaryngoscope|videolaryngoscope
264361|NCT01824914|tracheal intubation|tracheal intubation
264362|NCT01824914|Cormack-Lehane grade|cormack-lehane grade
264363|NCT01824914|airway evaluation|airway evaluation
264364|NCT01824914|sedation|sedation
264365|NCT01824914|anesthesia|anesthesia
264366|NCT01824901|AZD4547|azd4547
264367|NCT01824901|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
264368|NCT01824888|JUC|juc
264369|NCT01824888|hand rub|hand rub
264370|NCT01824888|European standard|european standard
264371|NCT01824862|clinically significant macular edema|clinically significant macular edema
264372|NCT01824862|foveal thickness|foveal thickness
264373|NCT01824862|foveal sensitivity|foveal sensitivity
264374|NCT01824862|perimetry|perimetry
264375|NCT01824862|diabetic retinopathy|diabetic retinopathy
264376|NCT01824849|Vocal cords|vocal cords
264377|NCT01824849|Vocal cord paralysis|vocal cord paralysis
264378|NCT01824849|Arytenoid cartilage|arytenoid cartilage
264379|NCT01824823|afatinib|afatinib
264380|NCT01824823|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
264381|NCT01824810|Intramuscular Stimulation|intramuscular stimulation
264382|NCT01824810|myoActivation|myoactivation
264383|NCT01824810|Neural Prolotherapy|neural prolotherapy
264384|NCT01824810|Whiplash-Associated Disorders|whiplash-associated disorders
264385|NCT01824810|myofascial pain|myofascial pain
264386|NCT01824797|Bone mineral density|bone mineral density
264387|NCT01824797|sleeve gastrectomy|sleeve gastrectomy
264388|NCT01824797|roux-en-y|roux-en-y
264389|NCT01824797|postmenopausal females|postmenopausal females
264390|NCT01824797|bone loss|bone loss
264391|NCT01823809|Coronary Artery Disease|coronary artery disease
264392|NCT01823809|Computed Tomography|computed tomography
264393|NCT01823809|Cardiac Magnetic Resonance|cardiac magnetic resonance
264394|NCT01823809|Fractional Flow Reserve|fractional flow reserve
264395|NCT01823796|Fibromyalgia|fibromyalgia
264396|NCT01823796|balance|balance
264397|NCT01823796|falls|falls
264398|NCT01823783|Duchenne muscular distrophy|duchenne muscular distrophy
264399|NCT01823783|Endomysial Fibrosis|endomysial fibrosis
264400|NCT01823783|Muscular Inflammatory Response|muscular inflammatory response
264401|NCT01823783|Calcium Homeostasis Dysfunction|calcium homeostasis dysfunction
264402|NCT01823783|Muscle biopsy|muscle biopsy
264403|NCT01823770|Restless Legs Syndrome (RLS)|restless legs syndrome (rls)
264404|NCT01823770|Rotigotine|rotigotine
264405|NCT01823770|HTA|hta
264406|NCT01823770|Cardiovascular diseases|cardiovascular diseases
264407|NCT01823770|Periodic Limb Movements in Sleep (PLMS)|periodic limb movements in sleep (plms)
264408|NCT01823770|dopaminergic agonist|dopaminergic agonist
264409|NCT01823770|Sympathetic overactivity|sympathetic overactivity
264410|NCT01823770|blood pressure|blood pressure
264411|NCT01823757|elderly|elderly
264412|NCT01823757|potential inappropriate medications|potential inappropriate medications
264413|NCT01823757|pharmaceutical care|pharmaceutical care
264414|NCT01823757|quality of life|quality of life
264415|NCT01823757|medical expenditure|medical expenditure
264416|NCT01823744|micronutrient|micronutrient
264417|NCT01823744|genomic|genomic
264418|NCT01823744|SAM/SAH ratio|sam/sah ratio
264419|NCT01823731|PCI,SOTOC, Ovarian cancer|pci,sotoc, ovarian cancer
264420|NCT01823692|Radius Fracture|radius fracture
264421|NCT01823692|Sensitivity|sensitivity
264422|NCT01823692|Reduction|reduction
264423|NCT01823692|Adequacy|adequacy
264424|NCT01823666|Dementia|dementia
264425|NCT01823666|Alzheimer's disease|alzheimer's disease
264426|NCT01823666|mild cognitive impairment|mild cognitive impairment
264427|NCT01823640|HRV|hrv
264428|NCT01823640|Pharmacodynamics / kinetics|pharmacodynamics / kinetics
264429|NCT01823640|Resistance|resistance
264430|NCT01823627|COPD|copd
264431|NCT01823627|Psychiatric inpatient|psychiatric inpatient
264432|NCT01823627|Smoking|smoking
264433|NCT01823614|HIV infection|hiv infection
264434|NCT01823614|tropism determination|tropism determination
264435|NCT01823614|genotypic methodic|genotypic methodic
264436|NCT01823614|R5-tropic variant|r5-tropic variant
264437|NCT01823614|X4-tropic variant|x4-tropic variant
264438|NCT01823601|Well-Being|well-being
264439|NCT01823601|Life Management Program|life management program
264440|NCT01823601|Breathing|breathing
264441|NCT01823601|Meditation|meditation
264442|NCT01823601|Cognitive-Behavioral Training|cognitive-behavioral training
264443|NCT01823575|malignant ureteral obstruction|malignant ureteral obstruction
264444|NCT01823575|silicone-covered metallic ureteral stent|silicone-covered metallic ureteral stent
264445|NCT01823575|double-J stent|double-j stent
264446|NCT01823562|Lyophilized Black Raspberry|lyophilized black raspberry
264451|NCT01824771|Plasma lactate|plasma lactate
264452|NCT01824771|Critical illness|critical illness
264453|NCT01824771|Acute kidney injurytissue perfusion|acute kidney injurytissue perfusion
264454|NCT01824771|Multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
264455|NCT01824758|esmolol, injection pain, lidocaine, rocuronium|esmolol, injection pain, lidocaine, rocuronium
264456|NCT01824706|cranial prosthesis|cranial prosthesis
264457|NCT01824680|Obesity|obesity
264458|NCT01824680|Appetite regulation|appetite regulation
264459|NCT01824680|Hormones|hormones
264460|NCT01824680|Adolescents|adolescents
264461|NCT01824680|Exercise|exercise
264462|NCT01824654|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
264463|NCT01824654|Imaging, Three-Dimensional|imaging, three-dimensional
264464|NCT01824654|Tomography Scanners, X-Ray Computed|tomography scanners, x-ray computed
255073|NCT01866072|ACLF|aclf
264465|NCT01824654|Angiography, Digital Subtraction|angiography, digital subtraction
264466|NCT01824654|Endovascular Procedures|endovascular procedures
264467|NCT01824654|Radiography, Interventional|radiography, interventional
264468|NCT01824641|Acute myocardial infarction|acute myocardial infarction
264469|NCT01824641|Manual thrombus aspiration|manual thrombus aspiration
264470|NCT01824641|Coronary physiology|coronary physiology
264471|NCT01824615|Sunitinib|sunitinib
264472|NCT01824615|recurrent ovarian cancer|recurrent ovarian cancer
264473|NCT01824615|clear cell carcinoma|clear cell carcinoma
264474|NCT01824602|BIPOLAR I DISORDER, Eslicarbazepine acetate|bipolar i disorder, eslicarbazepine acetate
264475|NCT01824589|traumatic brain injury|traumatic brain injury
264476|NCT01824589|TBI|tbi
264477|NCT01824589|ITPR|itpr
264478|NCT01824589|intrathoracic pressure regulator|intrathoracic pressure regulator
264479|NCT01824589|hepatic encephalopathy|hepatic encephalopathy
264480|NCT01824589|pseudotumorcerebri|pseudotumorcerebri
264481|NCT01824589|obstructive hydrocephalus|obstructive hydrocephalus
264482|NCT01824589|intracranial hemorrhage|intracranial hemorrhage
264483|NCT01824576|ITPR|itpr
264484|NCT01824576|CPP|cpp
264485|NCT01824576|TBI|tbi
264590|NCT01823978|BPX201|bpx201
264486|NCT01824576|traumatic brain injury|traumatic brain injury
264487|NCT01824576|cerebral perfusion pressure|cerebral perfusion pressure
264488|NCT01824576|intrathoracic pressure regulator|intrathoracic pressure regulator
264489|NCT01824537|Human papillomavirus (HPV)|human papillomavirus (hpv)
264490|NCT01824537|Vaccination|vaccination
264491|NCT01824537|Cervical cancer prevention|cervical cancer prevention
264492|NCT01824537|Herd immunity|herd immunity
264493|NCT01824524|Pain|pain
264494|NCT01824524|Hydromorphone|hydromorphone
264495|NCT01824524|OROS|oros
264496|NCT01824511|smoking|smoking
264497|NCT01824511|nicotine|nicotine
264498|NCT01824511|tobacco|tobacco
264499|NCT01824511|anhedonia|anhedonia
264500|NCT01824511|reward|reward
264501|NCT01824511|withdrawal|withdrawal
264502|NCT01824498|omega-3 fatty acids|omega-3 fatty acids
264503|NCT01824498|sex hormones|sex hormones
264504|NCT01824498|urinary sex hormone metabolites|urinary sex hormone metabolites
264505|NCT01824485|Osteoarthritis|osteoarthritis
264506|NCT01824485|Knee|knee
264507|NCT01824485|Viscosupplementation|viscosupplementation
264508|NCT01824485|Clinical Trial|clinical trial
264509|NCT01824459|Diffuse-type gastric cancer|diffuse-type gastric cancer
264510|NCT01824459|Advance Gastric Cancer|advance gastric cancer
264511|NCT01824459|Recurrent Gastric Cancer|recurrent gastric cancer
264512|NCT01824459|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
264513|NCT01824459|SOX, S-1+Oxaliplatin|sox, s-1+oxaliplatin
264514|NCT01824459|OS,|os,
264515|NCT01824459|ORR,|orr,
264516|NCT01824459|TTP,|ttp,
264517|NCT01824459|TTF,|ttf,
264518|NCT01824459|safety|safety
264523|NCT01824420|Refractory overactive bladder syndrome|refractory overactive bladder syndrome
264524|NCT01824420|Antimuscarinic agent|antimuscarinic agent
264525|NCT01824407|foot|foot
264526|NCT01824407|ulcers|ulcers
264527|NCT01824407|diabetes|diabetes
264528|NCT01824407|wound|wound
264529|NCT01824407|healing|healing
264530|NCT01824394|nMARQ|nmarq
264531|NCT01824394|Atrial Fibrillation|atrial fibrillation
264532|NCT01824394|Drug Refractory|drug refractory
264533|NCT01824394|Radio Frequency|radio frequency
264534|NCT01824381|extensive wounds|extensive wounds
264535|NCT01824381|amniotic membrane|amniotic membrane
264536|NCT01824381|healing|healing
264537|NCT01824381|patients|patients
264538|NCT01824381|phase granulation|phase granulation
264539|NCT01824329|Bladder Cancer|bladder cancer
264540|NCT01824329|Transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
264541|NCT01824264|Type 2 Diabetes mellitus, SGLT inhibitors, dose-response|type 2 diabetes mellitus, sglt inhibitors, dose-response
264542|NCT01824251|IVIG in Chronic Inflammatory Demyelinating Polyneuropathy|ivig in chronic inflammatory demyelinating polyneuropathy
264543|NCT01824251|Patients with Chronic Inflammatory Demyelinating Polyneuropathy|patients with chronic inflammatory demyelinating polyneuropathy
264544|NCT01824225|aflibercept|aflibercept
264545|NCT01824225|intravitreal injection|intravitreal injection
264546|NCT01824212|Ventricular fibrillation|ventricular fibrillation
264547|NCT01824212|Cardiac arrest|cardiac arrest
264548|NCT01824212|Mobile technology|mobile technology
264549|NCT01824199|Esophagitis|esophagitis
264550|NCT01824173|muscle|muscle
264551|NCT01824173|mitochondria|mitochondria
264552|NCT01824173|amino acids|amino acids
264553|NCT01824173|exercise|exercise
264554|NCT01824147|ASS-Nonresponse|ass-nonresponse
264555|NCT01824147|cardiac|cardiac
264556|NCT01824147|surgery|surgery
264557|NCT01824121|Progressive Supranuclear palsy|progressive supranuclear palsy
264558|NCT01824121|stem cell therapy|stem cell therapy
264559|NCT01824108|Lumbar disc herniation|lumbar disc herniation
264560|NCT01824108|Wallis interspinous implants|wallis interspinous implants
264561|NCT01824108|lumbar discectomy|lumbar discectomy
264562|NCT01824108|interspinous dynamic stability system|interspinous dynamic stability system
264563|NCT01824082|phantom pain|phantom pain
264564|NCT01824082|traumatic limb amputation|traumatic limb amputation
264565|NCT01824082|amputees|amputees
264566|NCT01824069|Critical Ischemia|critical ischemia
264567|NCT01824069|Amputation|amputation
264568|NCT01824056|18F-FDG|18f-fdg
264569|NCT01824043|diabetic retinopathy|diabetic retinopathy
264570|NCT01824043|vitreous hemorrhage|vitreous hemorrhage
264571|NCT01824043|intravitreal ranibizumab|intravitreal ranibizumab
264572|NCT01824030|FFR, OCT, Seattle Angina Questionnaire|ffr, oct, seattle angina questionnaire
264573|NCT01824017|Type 2 diabetes|type 2 diabetes
264574|NCT01824017|metabolic syndrome|metabolic syndrome
264575|NCT01824017|oxidative stress|oxidative stress
264577|NCT01824004|Gastric cancer|gastric cancer
264578|NCT01824004|Adjuvant|adjuvant
264579|NCT01824004|Chemoradiotherapy|chemoradiotherapy
264580|NCT01824004|S-1|s-1
264581|NCT01824004|Cisplatin|cisplatin
264582|NCT01823991|polyphenolics|polyphenolics
264583|NCT01823991|anthocyanins|anthocyanins
264584|NCT01823991|n-3 fatty acids|n-3 fatty acids
264585|NCT01823978|metastatic|metastatic
264586|NCT01823978|castration resistant prostate cancer|castration resistant prostate cancer
264587|NCT01823978|Therapeutic Vaccine|therapeutic vaccine
264588|NCT01823978|Dendritic cell|dendritic cell
264589|NCT01823978|BPX-201|bpx-201
264591|NCT01823978|AP1903|ap1903
264592|NCT01823952|HAMS|hams
264593|NCT01823952|ORS|ors
264594|NCT01823952|Cholera|cholera
264595|NCT01823952|Diarrhea|diarrhea
264596|NCT01823939|Cholera|cholera
264597|NCT01823939|V. Cholerae O1|v. cholerae o1
264598|NCT01823939|iOWH032|iowh032
264599|NCT01823939|diarrhoea|diarrhoea
264600|NCT01823939|pharmacokinetic|pharmacokinetic
264601|NCT01823939|Bangladesh|bangladesh
264602|NCT01823926|vibrating mesh nebulizers|vibrating mesh nebulizers
264603|NCT01823926|noninvasive ventilation|noninvasive ventilation
264604|NCT01823926|residual volume|residual volume
264609|NCT01823900|Pharmacokinetics|pharmacokinetics
264610|NCT01823887|Heart Failure|heart failure
264611|NCT01823887|Vagus Nerve|vagus nerve
264612|NCT01823887|VNS|vns
264613|NCT01823874|Virtual reality analgesia|virtual reality analgesia
264614|NCT01823874|pain control|pain control
264615|NCT01823848|constipation|constipation
264616|NCT01823848|enema|enema
264617|NCT01823822|Anorexia nervosa|anorexia nervosa
264618|NCT01823822|Protein supplements|protein supplements
264619|NCT01823822|IGF-I|igf-i
264620|NCT01823549|CAM|cam
264621|NCT01823549|Alternative Medicine|alternative medicine
264622|NCT01823536|Meningitis|meningitis
264623|NCT01823510|Antiplatelet|antiplatelet
264624|NCT01823510|Ticagrelor|ticagrelor
264625|NCT01823510|Clopidogrel|clopidogrel
264626|NCT01823510|Thrombosis|thrombosis
264627|NCT01823510|Diabetes|diabetes
264628|NCT01823510|Coronary Artery Disease|coronary artery disease
264629|NCT01823497|Neonatal Intensive Care Unit|neonatal intensive care unit
264630|NCT01823497|neonate|neonate
264631|NCT01823497|pain|pain
264632|NCT01823497|morphine|morphine
264633|NCT01823497|Parent/Nurse Controlled Analgesia|parent/nurse controlled analgesia
264634|NCT01823484|hemofilter|hemofilter
264635|NCT01823484|coagulation|coagulation
264636|NCT01823484|CRRT|crrt
264637|NCT01823484|critically ill|critically ill
264638|NCT01823471|HNPCC|hnpcc
264639|NCT01823471|Hereditary non-polyposis colon carcinoma|hereditary non-polyposis colon carcinoma
264640|NCT01823471|Lynch syndrome|lynch syndrome
264641|NCT01823471|i-scan|i-scan
264642|NCT01823471|virtual chromo-endoscopy|virtual chromo-endoscopy
264643|NCT01823471|chromo-endoscopy|chromo-endoscopy
264644|NCT01823471|high definition endoscopy|high definition endoscopy
264645|NCT01823471|polyp detection|polyp detection
264646|NCT01823471|adenoma detection|adenoma detection
264647|NCT01823471|adenoma miss rate|adenoma miss rate
264648|NCT01823458|behavioral economics|behavioral economics
264649|NCT01823458|incentives|incentives
264650|NCT01823458|health behavior|health behavior
264651|NCT01823458|exercise|exercise
264652|NCT01823445|Xylitol|xylitol
264653|NCT01823445|Dental caries|dental caries
264654|NCT01823393|balloon aortic valvuloplasty indication|balloon aortic valvuloplasty indication
264655|NCT01823393|heparin|heparin
264656|NCT01823393|hemorrhagic|hemorrhagic
264657|NCT01823393|ischemic|ischemic
264658|NCT01823380|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
264659|NCT01823380|Vitamin D|vitamin d
264660|NCT01823380|Blood Levels|blood levels
264661|NCT01823367|type 2 diabetes mellitus prevention|type 2 diabetes mellitus prevention
264662|NCT01823367|gestational diabetes mellitus|gestational diabetes mellitus
264663|NCT01823367|pre-diabetes|pre-diabetes
264664|NCT01823367|lifestyle interventions|lifestyle interventions
264665|NCT01823367|pediatric primary prevention of type 2 diabetes|pediatric primary prevention of type 2 diabetes
264666|NCT01823354|Restless Legs Syndrome|restless legs syndrome
264667|NCT01823354|Polysomnography|polysomnography
264668|NCT01823354|Executive cognition|executive cognition
264669|NCT01823341|Type 1 Diabetes|type 1 diabetes
326741|NCT01547624|Spine|spine
264670|NCT01823341|Hypoglycemia|hypoglycemia
264671|NCT01823341|Continuous Glucose Monitoring|continuous glucose monitoring
264672|NCT01823341|Pump Suspension|pump suspension
264673|NCT01823328|Intubation|intubation
264674|NCT01823328|Airway|airway
264675|NCT01823328|Emergent intubation|emergent intubation
264676|NCT01823328|Rapid sequence intubation|rapid sequence intubation
264677|NCT01823328|Rapid sequence induction|rapid sequence induction
264678|NCT01823328|RSI|rsi
264679|NCT01823328|Ketamine|ketamine
264680|NCT01823328|Etomidate|etomidate
264681|NCT01823328|Sepsis|sepsis
264682|NCT01823328|Sedative|sedative
264683|NCT01823328|Sedation|sedation
264684|NCT01823302|Children with picky-eating behaviors|children with picky-eating behaviors
264685|NCT01823302|Children aged 2.5 - 5 years|children aged 2.5 - 5 years
264686|NCT01823302|reported by caregivers|reported by caregivers
264687|NCT01823302|with weight-for-height z-scores ≤ 25th percentile at enrollment|with weight-for-height z-scores ≤ 25th percentile at enrollment
264688|NCT01823289|Invasive Pulmonary Fungal Infection|invasive pulmonary fungal infection
264689|NCT01823289|Itraconazole|itraconazole
264690|NCT01823250|Hispanic|hispanic
264691|NCT01823250|adolescent|adolescent
264692|NCT01823250|drug abuse treatment|drug abuse treatment
264693|NCT01823250|evidence-based|evidence-based
264694|NCT01823250|family therapy|family therapy
264695|NCT01823250|adaptive family treatment|adaptive family treatment
264696|NCT01823250|Culturally Informed Family-Based Treatment for Adolescents|culturally informed family-based treatment for adolescents
264697|NCT01823237|Dystonia|dystonia
264698|NCT01823237|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
264699|NCT01823237|Rehabilitation|rehabilitation
264700|NCT01823237|Plasticity|plasticity
264701|NCT01823211|ICD (Implantable cardioverter-defibrillator)|icd (implantable cardioverter-defibrillator)
264702|NCT01823211|Heart rate variability|heart rate variability
264703|NCT01823211|MTWA (Microvolt T-alternans)|mtwa (microvolt t-alternans)
264704|NCT01823211|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
264705|NCT01823198|Leukemia|leukemia
264706|NCT01823198|Acute myeloid leukemia|acute myeloid leukemia
264708|NCT01823198|Myelodysplastic syndromes|myelodysplastic syndromes
264710|NCT01823198|Blood And Marrow Transplantation|blood and marrow transplantation
264711|NCT01823198|Myeloproliferative Diseases|myeloproliferative diseases
264712|NCT01823198|High Risk Myeloid Malignancies|high risk myeloid malignancies
264713|NCT01823198|Allogeneic stem cell transplant|allogeneic stem cell transplant
264714|NCT01823198|Natural Killer Cells|natural killer cells
264715|NCT01823198|NK|nk
264716|NCT01823198|Immune cells|immune cells
264717|NCT01823198|Stem cell transplant|stem cell transplant
264718|NCT01823198|Busulfan|busulfan
264719|NCT01823198|Busulfex|busulfex
264720|NCT01823198|Myleran|myleran
264721|NCT01823198|Interleukin-2|interleukin-2
264722|NCT01823198|IL-2|il-2
264723|NCT01823198|Aldesleukin|aldesleukin
264724|NCT01823198|Proleukin|proleukin
264725|NCT01823198|Thymoglobulin|thymoglobulin
264726|NCT01823198|Antithymocyte globulin|antithymocyte globulin
264727|NCT01823198|ATG|atg
264728|NCT01823198|G-CSF|g-csf
264729|NCT01823198|Filgrastim|filgrastim
264730|NCT01823198|Neupogen|neupogen
264731|NCT01823198|Tacrolimus|tacrolimus
264732|NCT01823198|Prograf|prograf
264733|NCT01823198|Methotrexate|methotrexate
264734|NCT01823185|Clopidogrel|clopidogrel
264735|NCT01823185|Ticagrelor|ticagrelor
264736|NCT01823185|Prasugrel|prasugrel
264737|NCT01823185|Platelet aggregation inhibitor|platelet aggregation inhibitor
264738|NCT01823185|Dammam University|dammam university
264739|NCT01823185|King Fahd Hospital|king fahd hospital
264740|NCT01823185|Purinergic P2 receptor Antagonists|purinergic p2 receptor antagonists
264741|NCT01823172|breast cancer|breast cancer
264742|NCT01823172|melanoma|melanoma
264743|NCT01823172|sentinel lymph node biopsy|sentinel lymph node biopsy
264744|NCT01823172|lymphadenectomy|lymphadenectomy
264745|NCT01823159|retigabine|retigabine
264746|NCT01823159|cortical excitability|cortical excitability
264747|NCT01823159|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
264748|NCT01823146|oxytocin|oxytocin
264749|NCT01823146|socioemotional functioning|socioemotional functioning
264750|NCT01823146|trust|trust
264751|NCT01823146|amygdala|amygdala
264752|NCT01823146|aging|aging
264753|NCT01823120|Self harm|self harm
264754|NCT01823120|Emergency Department|emergency department
264755|NCT01823120|Repetition|repetition
264756|NCT01823120|Supportive Text messages|supportive text messages
264757|NCT01823120|Interactive|interactive
264758|NCT01823107|Meso BioMatrix|meso biomatrix
264759|NCT01823107|Breast|breast
264760|NCT01823107|Breast Cancer|breast cancer
264761|NCT01823107|Mastectomy|mastectomy
264762|NCT01823107|Biologic Mesh|biologic mesh
264763|NCT01823107|Breast Reconstruction|breast reconstruction
264764|NCT01823094|lung cancer|lung cancer
264765|NCT01823094|computed tomography|computed tomography
264766|NCT01823094|blood flow|blood flow
255393|NCT01864681|PFS|pfs
264767|NCT01823068|Lung cancer|lung cancer
264768|NCT01823068|RET fusion|ret fusion
264769|NCT01823068|Vandetanib|vandetanib
264770|NCT01823042|Crohn's Disease|crohn's disease
264771|NCT01823042|maintain remission|maintain remission
264772|NCT01823042|postoperative recurrence|postoperative recurrence
264773|NCT01823042|surgery|surgery
264774|NCT01823042|living quality|living quality
264775|NCT01823029|Crohn's Disease|crohn's disease
264776|NCT01823029|intravenous iron|intravenous iron
264777|NCT01823029|iron deficiency anaemia|iron deficiency anaemia
264778|NCT01823029|Oxidative Stress|oxidative stress
264779|NCT01823029|inflammation|inflammation
264780|NCT01823016|Uncontrolled, persistent asthma|uncontrolled, persistent asthma
264781|NCT01823003|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
264782|NCT01823003|Neoplasm Metastasis|neoplasm metastasis
264783|NCT01823003|Radiosurgery|radiosurgery
264784|NCT01822990|Anti-beta2-glycoprotein antibodies|anti-beta2-glycoprotein antibodies
264785|NCT01822990|Peripheral arterial disease|peripheral arterial disease
264786|NCT01822990|Inflammation|inflammation
264787|NCT01822990|Nitric oxide|nitric oxide
264788|NCT01822990|Endothelial dysfunction|endothelial dysfunction
264789|NCT01822977|gut microbiota|gut microbiota
264790|NCT01822977|proton pump inhibitor|proton pump inhibitor
264791|NCT01822977|Clostridium difficile infection|clostridium difficile infection
264792|NCT01822977|Fecal microbiome|fecal microbiome
264793|NCT01822977|single episode of CDI|single episode of cdi
264794|NCT01822951|DAT Study|dat study
264795|NCT01822925|Diabetes|diabetes
264796|NCT01822925|Pain|pain
264797|NCT01822925|Neuropathy|neuropathy
264798|NCT01822912|Skilled Nursing Facility|skilled nursing facility
264799|NCT01822912|Heart Failure|heart failure
264800|NCT01822912|Transitional Care|transitional care
264801|NCT01822899|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
264802|NCT01822899|umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
264804|NCT01822899|lung function|lung function
264805|NCT01822899|GW642444|gw642444
264806|NCT01822899|salmeterol (SAL)|salmeterol (sal)
264807|NCT01822899|fluticasone propionate (FP)|fluticasone propionate (fp)
264808|NCT01822899|vilanterol (VI)|vilanterol (vi)
264809|NCT01822899|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
264810|NCT01822886|T-cell lymphoma|t-cell lymphoma
264811|NCT01822886|Romidepsin|romidepsin
264812|NCT01822860|Hypertension|hypertension
264813|NCT01822860|Endothelial dysfunction|endothelial dysfunction
264814|NCT01822847|adrenal|adrenal
264815|NCT01822847|steroids|steroids
264816|NCT01822847|cortisol|cortisol
264817|NCT01822847|stress|stress
264818|NCT01822821|Males or females|males or females
264819|NCT01822821|18 years of age or older.|18 years of age or older.
264820|NCT01822821|Non-emergency|non-emergency
264821|NCT01822821|cardiac surgery|cardiac surgery
264822|NCT01822821|midline sternotomy.|midline sternotomy.
264823|NCT01822808|acute heart failure|acute heart failure
264824|NCT01822808|left ventricular dysfunction|left ventricular dysfunction
264825|NCT01822808|hydralazine|hydralazine
264826|NCT01822808|isosorbide dinitrate|isosorbide dinitrate
264827|NCT01822795|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
264828|NCT01822795|Endoscopic lung volume reduction|endoscopic lung volume reduction
264829|NCT01822782|Perineal tear|perineal tear
264830|NCT01822782|Perineal lesion|perineal lesion
264831|NCT01822782|Vaginal flora|vaginal flora
264832|NCT01822782|Birth|birth
264833|NCT01822769|congenital heart disease|congenital heart disease
264834|NCT01822769|adult congenital heart disease|adult congenital heart disease
264835|NCT01822769|cardiac rehabilitation|cardiac rehabilitation
264836|NCT01822769|cardiopulmonary rehabilitation|cardiopulmonary rehabilitation
264837|NCT01822769|exercise|exercise
264838|NCT01822769|cardiopulmonary exercise testing|cardiopulmonary exercise testing
264839|NCT01822769|peak vO2|peak vo2
264840|NCT01822769|quality of life|quality of life
264841|NCT01822743|Osteopathy|osteopathy
264842|NCT01822743|Sleep Apnea Syndromes|sleep apnea syndromes
264843|NCT01822743|Obstructive Sleep Apnea|obstructive sleep apnea
264844|NCT01822743|Pcrit|pcrit
264845|NCT01822743|Polysomnography|polysomnography
264846|NCT01822730|Methamphetamine-Associated Psychosis|methamphetamine-associated psychosis
264847|NCT01822730|Aripiprazole|aripiprazole
264848|NCT01822730|Risperidone|risperidone
264849|NCT01822717|Diabetes|diabetes
264850|NCT01822717|Visual Impairment|visual impairment
264851|NCT01822717|Blindness|blindness
264852|NCT01822717|Foot Care|foot care
264853|NCT01822717|Self-Management|self-management
264854|NCT01822704|Stroke|stroke
264855|NCT01822704|Exercise|exercise
264856|NCT01822704|Rehabilitation|rehabilitation
264857|NCT01822704|Vibration|vibration
264858|NCT01822691|myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
264859|NCT01822691|neoplastic stem cell disorders|neoplastic stem cell disorders
264860|NCT01822691|refractory cytopenias|refractory cytopenias
264861|NCT01822691|dysplastic morphological features|dysplastic morphological features
264862|NCT01822691|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
264863|NCT01822652|Neuroblastoma|neuroblastoma
264864|NCT01822652|Solid tumor|solid tumor
264865|NCT01822652|Neuroblastoma-specific immunotherapy targeting GD2|neuroblastoma-specific immunotherapy targeting gd2
264866|NCT01822652|CAR T cells|car t cells
264867|NCT01822652|Gene Therapy|gene therapy
264868|NCT01822652|Relapsed|relapsed
264869|NCT01822652|Refractory|refractory
264870|NCT01822639|Hypertension|hypertension
264871|NCT01822639|enalapril maleate|enalapril maleate
264872|NCT01822639|healthy volunteers|healthy volunteers
264873|NCT01822639|amlodipine|amlodipine
264874|NCT01822639|pharmacokinetics|pharmacokinetics
264875|NCT01822626|overweight|overweight
264876|NCT01822626|obesity|obesity
264877|NCT01822626|children|children
264878|NCT01822626|BMI|bmi
264879|NCT01822626|counseling|counseling
264880|NCT01822626|pediatrician|pediatrician
264881|NCT01822613|esophageal cancer|esophageal cancer
264882|NCT01822600|hypoalbuminemia|hypoalbuminemia
264883|NCT01822600|peptic ulcer|peptic ulcer
264884|NCT01822600|rebleeding|rebleeding
264885|NCT01822600|hospitalization|hospitalization
264886|NCT01822587|Drug Abuse|drug abuse
264887|NCT01822587|Cocaine|cocaine
264888|NCT01822587|Addiction|addiction
264889|NCT01822561|Central Serous Chorioretinopathy|central serous chorioretinopathy
264890|NCT01822561|Eplerenone|eplerenone
264891|NCT01822561|Optical Coherence Tomography|optical coherence tomography
264892|NCT01822561|Enhanced Depth Imaging|enhanced depth imaging
264893|NCT01822561|Subretinal Fluid|subretinal fluid
264894|NCT01822548|EPC|epc
264895|NCT01822548|diabetes|diabetes
264896|NCT01822548|DPP IV inhibitors|dpp iv inhibitors
264897|NCT01822535|Quadriplegia|quadriplegia
264898|NCT01822535|Spinal Cord Injuries|spinal cord injuries
264899|NCT01822535|Body Temperature Regulation|body temperature regulation
264900|NCT01822535|Mild Cognitive Impairment|mild cognitive impairment
264901|NCT01822483|Renal transplantation|renal transplantation
264902|NCT01822483|mycophenolic acid|mycophenolic acid
264903|NCT01822483|mycophenolate mofetil|mycophenolate mofetil
264904|NCT01822483|mycophenolate sodium|mycophenolate sodium
264905|NCT01822483|area under the curve|area under the curve
264906|NCT01822470|functional dyspepsia|functional dyspepsia
264907|NCT01822470|post prandial distress syndrome|post prandial distress syndrome
264908|NCT01822470|small bowel bacteria overgrowth|small bowel bacteria overgrowth
264909|NCT01822470|epigastric pain syndrome|epigastric pain syndrome
264910|NCT01822470|diarrhea|diarrhea
264911|NCT01822470|bloating|bloating
264912|NCT01822470|post prandial fullness|post prandial fullness
264913|NCT01822470|weight loss|weight loss
264914|NCT01822444|Colorectal Cancer|colorectal cancer
264915|NCT01822444|Advanced Colorectal Cancer|advanced colorectal cancer
264916|NCT01822444|Metastatic Colorectal Cancer|metastatic colorectal cancer
264917|NCT01822444|Locally Advanced Colorectal Cancer|locally advanced colorectal cancer
264918|NCT01822444|Colon Cancer|colon cancer
264919|NCT01822444|Rectal Cancer|rectal cancer
264920|NCT01822418|Schizophrenia|schizophrenia
264921|NCT01822418|Depression|depression
264922|NCT01822418|Cognition|cognition
264923|NCT01822418|Agomelatine|agomelatine
264924|NCT01822418|Antidepressant|antidepressant
264925|NCT01822392|Online treatment|online treatment
264926|NCT01822392|Treatment of conduct problems|treatment of conduct problems
264927|NCT01822392|Parent training|parent training
264928|NCT01822366|Children|children
264929|NCT01822366|Adolescents|adolescents
264930|NCT01822366|Trauma-focused Cognitive Behavioral Therapy (TF-CBT)|trauma-focused cognitive behavioral therapy (tf-cbt)
264931|NCT01822366|Low- and Middle-Income Countries (LAMIC)|low- and middle-income countries (lamic)
264932|NCT01822366|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
264933|NCT01822366|Evidence-Based Practice (EBP)|evidence-based practice (ebp)
264934|NCT01822366|Childhood Traumatic Grief (CTG)|childhood traumatic grief (ctg)
264935|NCT01822366|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
264936|NCT01822366|Kenya|kenya
264937|NCT01822366|Tanzania|tanzania
264938|NCT01822366|East Africa|east africa
264939|NCT01822366|Mental Health|mental health
264940|NCT01822353|food allergy|food allergy
264941|NCT01822353|milk allergy|milk allergy
264942|NCT01822353|egg allergy|egg allergy
264943|NCT01822353|nut allergy|nut allergy
264944|NCT01822340|AGHD|aghd
264945|NCT01822314|breast|breast
264946|NCT01822314|cancer|cancer
264947|NCT01822314|unilateral|unilateral
264948|NCT01822314|non metastatic|non metastatic
264949|NCT01822314|HER2 negative|her2 negative
264950|NCT01822301|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
264951|NCT01822301|Facial Trauma|facial trauma
264952|NCT01822301|Fat Grafts|fat grafts
264953|NCT01822301|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
264954|NCT01822301|Wounded warriors|wounded warriors
264955|NCT01822288|Menopause|menopause
264956|NCT01822288|Tibolone|tibolone
264957|NCT01822288|Estradiol|estradiol
264958|NCT01822288|Hormone therapy|hormone therapy
264959|NCT01822275|GBM|gbm
264960|NCT01822262|Cholecystolithotomy with gallbladder reservation|cholecystolithotomy with gallbladder reservation
264961|NCT01822262|cholecystolithiasis|cholecystolithiasis
264962|NCT01822249|Rett syndrome|rett syndrome
264963|NCT01822249|EPI-743|epi-743
264964|NCT01822249|Edison|edison
264965|NCT01822236|low back pain|low back pain
264966|NCT01822236|Manual Therapy|manual therapy
264967|NCT01822236|Randomized Controlled Trial|randomized controlled trial
264968|NCT01822236|Quality of life|quality of life
694113|NCT00943605|Mastectomy|mastectomy
264969|NCT01822223|Dental Implants|dental implants
264970|NCT01822223|Implant abutments|implant abutments
264971|NCT01822210|Botulinum Toxins|botulinum toxins
264972|NCT01822210|Injections|injections
264973|NCT01822210|Stomach|stomach
264974|NCT01822210|Tomography, X-Ray Computed|tomography, x-ray computed
264975|NCT01822197|Phototherapy|phototherapy
264976|NCT01822184|Neurodevelopmental Status|neurodevelopmental status
264977|NCT01822184|Pediatric Hunter syndrome patients|pediatric hunter syndrome patients
264978|NCT01822184|Central Nervous System (CNS) involvement|central nervous system (cns) involvement
264979|NCT01822184|Observational study|observational study
264980|NCT01822184|Cognitive impairment|cognitive impairment
264981|NCT01822171|Heart Failure|heart failure
264982|NCT01822171|Medication Therapy Management|medication therapy management
264983|NCT01822158|Vaginal Delivery|vaginal delivery
264984|NCT01822158|Debrief|debrief
264985|NCT01822158|Medical Team Communication|medical team communication
264986|NCT01822158|Obstetrical Safety|obstetrical safety
264987|NCT01822145|implantable-cardioverter-defibrillator|implantable-cardioverter-defibrillator
264988|NCT01822145|ventricular tachycardia|ventricular tachycardia
264989|NCT01822145|ventricular fibrillation|ventricular fibrillation
265594|NCT01819155|Africa|africa
264990|NCT01822145|sudden cardiac arrest|sudden cardiac arrest
264991|NCT01822080|Endometriosis|endometriosis
264992|NCT01822080|Efficacy|efficacy
264993|NCT01822080|Safety|safety
264994|NCT01822080|Dienogest|dienogest
264995|NCT01822041|healthy volunteers|healthy volunteers
264996|NCT01822041|mass balance study|mass balance study
264997|NCT01822041|Pharmacokinetics|pharmacokinetics
264998|NCT01822028|diarrhea|diarrhea
264999|NCT01822002|Vertigo|vertigo
265000|NCT01822002|Nystagmus|nystagmus
265001|NCT01822002|BPPV = benign paroxysmal positional vertigo|bppv = benign paroxysmal positional vertigo
265002|NCT01822002|Treatment outcome|treatment outcome
265003|NCT01821963|Infection|infection
265004|NCT01821963|Hepatitis C Genotype 1 Infection|hepatitis c genotype 1 infection
265005|NCT01821963|Hepatitis C virus|hepatitis c virus
265007|NCT01821963|Hepatocellular Carcinoma|hepatocellular carcinoma
265009|NCT01821963|Liver Transplantation|liver transplantation
265010|NCT01821963|Pegylated Interferon Alfa 2a|pegylated interferon alfa 2a
265011|NCT01821963|PegIFN alfa-2a|pegifn alfa-2a
265012|NCT01821963|Ribavirin|ribavirin
265013|NCT01821963|RBV|rbv
265014|NCT01821963|Telaprevir|telaprevir
265015|NCT01821963|Incivek|incivek
265016|NCT01821963|Antiviral drugs|antiviral drugs
265017|NCT01821950|Mental health|mental health
265018|NCT01821950|Substance use|substance use
265019|NCT01821950|Substance use initiation|substance use initiation
265020|NCT01821950|Education|education
265021|NCT01821950|Mind Body Therapies|mind body therapies
265022|NCT01821950|Yoga|yoga
265023|NCT01821950|Meditation|meditation
265024|NCT01821950|Adolescent|adolescent
265025|NCT01821950|Adolescence|adolescence
265026|NCT01821950|Child|child
265027|NCT01821950|Children|children
265028|NCT01821950|Middle School|middle school
265029|NCT01821898|Eosinophil|eosinophil
265030|NCT01821898|Reflux|reflux
265031|NCT01821898|Esophagus|esophagus
265032|NCT01821898|Food allergy|food allergy
265033|NCT01821898|Trouble Swallowing|trouble swallowing
265034|NCT01821898|Pediatrics|pediatrics
265035|NCT01821885|Spirometry|spirometry
265036|NCT01821885|screening|screening
265037|NCT01821885|smoking cessation|smoking cessation
265038|NCT01821885|tobacco|tobacco
265039|NCT01821885|COPD|copd
265040|NCT01821872|paracetamol|paracetamol
265041|NCT01821872|acetaminophen|acetaminophen
265042|NCT01821872|AM404|am404
265043|NCT01821872|CSF|csf
265044|NCT01821872|pharmacokinetics|pharmacokinetics
265045|NCT01821833|omega-3|omega-3
265046|NCT01821833|fatty acids|fatty acids
265047|NCT01821833|paclitaxel|paclitaxel
265048|NCT01821833|acute pain syndrome|acute pain syndrome
265049|NCT01821833|peripheral neuropathy|peripheral neuropathy
265050|NCT01821833|chemotherapy induced neuropathy|chemotherapy induced neuropathy
265051|NCT01821820|Inflammation|inflammation
265052|NCT01821820|Oxidative stress|oxidative stress
265053|NCT01821820|Immune dysfunction|immune dysfunction
265054|NCT01821820|Metabolites|metabolites
265055|NCT01821807|spinal anesthesia|spinal anesthesia
265056|NCT01821807|spinal needle|spinal needle
265057|NCT01821807|cesarean section|cesarean section
265058|NCT01821807|headache|headache
265059|NCT01821807|backache|backache
265060|NCT01821781|Immune deficiency|immune deficiency
265061|NCT01821781|Immune disorders|immune disorders
327225|NCT01545674|Trisomy|trisomy
265062|NCT01821781|Immune dysregulatory|immune dysregulatory
265063|NCT01821781|Reduced Intensity|reduced intensity
265064|NCT01821781|Alemtuzumab|alemtuzumab
265065|NCT01821781|Campath|campath
265066|NCT01821742|Shock|shock
265067|NCT01821742|Fluid bolus|fluid bolus
265068|NCT01821742|Cardiac output|cardiac output
265069|NCT01821742|Children in intensive care|children in intensive care
265070|NCT01821729|Locally Advanced|locally advanced
265071|NCT01821690|Traumatic Brain Injury|traumatic brain injury
265072|NCT01821690|Buspirone|buspirone
265073|NCT01821690|Behavior|behavior
265074|NCT01821690|Irritability|irritability
265075|NCT01821690|Aggression|aggression
265076|NCT01821664|Prosthetic vascular graft infection|prosthetic vascular graft infection
265077|NCT01821664|negative pressure wound therapy|negative pressure wound therapy
265078|NCT01821664|microbiology|microbiology
265079|NCT01821664|antimicrobial therapy|antimicrobial therapy
265080|NCT01821651|TAVI|tavi
265081|NCT01821651|MitraClip|mitraclip
265082|NCT01821651|image modality|image modality
265083|NCT01821651|echocardiography|echocardiography
265084|NCT01821651|angiography|angiography
265085|NCT01821638|Heart failure|heart failure
265086|NCT01821638|Cognition|cognition
265087|NCT01821638|Brain|brain
265088|NCT01821638|Older adults|older adults
265089|NCT01821625|Thrombocytopenia|thrombocytopenia
265090|NCT01821625|HCV|hcv
265091|NCT01821625|Hepatitis|hepatitis
265092|NCT01821625|Platelets|platelets
265093|NCT01821625|Eltrombopag|eltrombopag
265094|NCT01821625|Liver Disease|liver disease
265095|NCT01821625|Antiviral Treatment|antiviral treatment
265096|NCT01821599|Anterior Cruciate Ligament|anterior cruciate ligament
265097|NCT01821599|Knee|knee
265098|NCT01821599|Rehabilitation|rehabilitation
265099|NCT01821586|Diarrhoea;|diarrhoea;
265100|NCT01821586|Severe malnutrition;|severe malnutrition;
265102|NCT01821586|ReSoMal;|resomal;
265103|NCT01821586|modified ORS|modified ors
265104|NCT01821573|botulinum toxin injection,3D motion analysis, muscular lengthening,muscle strength|botulinum toxin injection,3d motion analysis, muscular lengthening,muscle strength
265105|NCT01821560|Nicotine Addiction|nicotine addiction
265106|NCT01821560|fMRI|fmri
265107|NCT01821560|Baclofen|baclofen
265108|NCT01821508|Gastroplasty, Diabetes Mellitus Type II, Obesity|gastroplasty, diabetes mellitus type ii, obesity
265109|NCT01821495|NPC,DC-CIK|npc,dc-cik
265110|NCT01821482|Hepatocellular carcinoma, DC-CIK|hepatocellular carcinoma, dc-cik
265111|NCT01821469|bipolar disorders|bipolar disorders
265112|NCT01821469|euthymic|euthymic
265113|NCT01821469|psychotherapy|psychotherapy
265114|NCT01821469|Functional magnetic resonance imaging|functional magnetic resonance imaging
265115|NCT01821456|hematological malignancies|hematological malignancies
265116|NCT01821456|cancer|cancer
265117|NCT01821456|chemotherapy|chemotherapy
265118|NCT01821456|anti-infectives|anti-infectives
265119|NCT01821456|treatment|treatment
265120|NCT01821456|outcome|outcome
265121|NCT01821443|1 to 10 measurable brain metastases|1 to 10 measurable brain metastases
265122|NCT01821430|Chronic Pain|chronic pain
265123|NCT01821430|Narcotic Abuse|narcotic abuse
265124|NCT01821430|Opioid related disorders|opioid related disorders
265125|NCT01821430|Opiate substitution treatment|opiate substitution treatment
265126|NCT01821430|Buprenorphrine|buprenorphrine
265127|NCT01821430|Pregabalin|pregabalin
265128|NCT01821430|Methadone|methadone
265129|NCT01821417|dental implants|dental implants
265130|NCT01821417|screw-vent dental implants|screw-vent dental implants
265131|NCT01821404|Apoptosis|apoptosis
265132|NCT01821404|Atorvastatin|atorvastatin
265133|NCT01821404|Inflammation|inflammation
265134|NCT01821404|Pre-surgical trial|pre-surgical trial
265135|NCT01821404|Proliferation|proliferation
265136|NCT01821404|Prostate cancer|prostate cancer
265137|NCT01821391|actinic keratoses|actinic keratoses
265138|NCT01821391|photodynamic therapy|photodynamic therapy
265139|NCT01821391|natural daylight|natural daylight
265140|NCT01821378|Schizophrenia|schizophrenia
265141|NCT01821378|Lurasidone|lurasidone
265142|NCT01821378|Latuda|latuda
265143|NCT01821365|COPD,PETCO2,PaCO2|copd,petco2,paco2
265144|NCT01821326|capsule endoscopy|capsule endoscopy
265145|NCT01821326|obscure gastrointestinal bleeding|obscure gastrointestinal bleeding
265146|NCT01821326|rebleeding|rebleeding
265147|NCT01821326|risk factors|risk factors
265148|NCT01821313|Childhood obesity|childhood obesity
265149|NCT01821313|Inflammation|inflammation
265150|NCT01821313|Endothelial function|endothelial function
265151|NCT01821313|Exercise|exercise
265152|NCT01821300|Down syndrome|down syndrome
265153|NCT01821300|Philadelphia|philadelphia
265154|NCT01821300|The Children's Hospital of Philadelphia|the children's hospital of philadelphia
265155|NCT01821300|Body composition|body composition
265156|NCT01821300|Obesity|obesity
265157|NCT01821300|Cardiovascular|cardiovascular
265158|NCT01821222|Maternal health|maternal health
265159|NCT01821222|Neonatal health|neonatal health
327350|NCT01545245|RSV|rsv
265160|NCT01821222|mHealth|mhealth
265161|NCT01821222|Mobile phones|mobile phones
265162|NCT01821222|Access to health services|access to health services
265163|NCT01821222|Health behavior|health behavior
265164|NCT01821209|prostate cancer, robotic surgery, urethral sling,|prostate cancer, robotic surgery, urethral sling,
265165|NCT01821196|Tumor Markers, Biological|tumor markers, biological
265166|NCT01821196|PGP9.5 protein, human|pgp9.5 protein, human
265167|NCT01821196|adenocarcinoma|adenocarcinoma
265168|NCT01821170|ADHD|adhd
265169|NCT01821170|children|children
265170|NCT01821170|cognitive remediation|cognitive remediation
265171|NCT01821170|virtual reality|virtual reality
265172|NCT01821157|crown lengthening|crown lengthening
265173|NCT01821157|gingivoplasty|gingivoplasty
265174|NCT01821157|surgical procedures|surgical procedures
265175|NCT01821157|gingivectomy|gingivectomy
265176|NCT01821157|esthetic surgery|esthetic surgery
265177|NCT01821144|dietary salt|dietary salt
265178|NCT01821144|24 hour urinary sodium|24 hour urinary sodium
265179|NCT01821144|blood pressure|blood pressure
265180|NCT01821131|flax|flax
265181|NCT01821131|muffin|muffin
265182|NCT01821131|cholesterol|cholesterol
265183|NCT01821131|lignan|lignan
265184|NCT01821131|ALA|ala
265185|NCT01821118|Cerebral amyloid angiopathy (CAA)|cerebral amyloid angiopathy (caa)
265186|NCT01821118|cerebrovascular reactivity|cerebrovascular reactivity
265187|NCT01821118|functional MRI|functional mri
265188|NCT01821118|randomized|randomized
265189|NCT01821118|double blind|double blind
265190|NCT01821118|safety|safety
265191|NCT01821118|efficacy|efficacy
265192|NCT01821105|computed tomography|computed tomography
265193|NCT01821105|CT scan|ct scan
265194|NCT01821105|positron emission tomography|positron emission tomography
265195|NCT01821105|PET|pet
265196|NCT01821105|Metastatic Colorectal Cancer|metastatic colorectal cancer
265197|NCT01821092|osseointegrated Implant, bone level|osseointegrated implant, bone level
265198|NCT01821079|Single dose|single dose
265199|NCT01821079|Relative Bioavailability|relative bioavailability
265200|NCT01821079|Food effect|food effect
265201|NCT01821079|Healthy subjects|healthy subjects
265202|NCT01821079|Diabetes Mellitus Type 2|diabetes mellitus type 2
265203|NCT01821066|PD-0332991|pd-0332991
265204|NCT01821066|palbociclib|palbociclib
265205|NCT01821066|tamoxifen|tamoxifen
265206|NCT01821066|drug-drug interaction (DDI) study|drug-drug interaction (ddi) study
265207|NCT01821053|Preeclampsia|preeclampsia
265208|NCT01821053|Pregestational Type 1 diabetes|pregestational type 1 diabetes
265209|NCT01821053|diabetes mellitus|diabetes mellitus
265210|NCT01821053|proteinuria|proteinuria
265211|NCT01821053|plasminogen|plasminogen
265212|NCT01821053|plasmin|plasmin
265213|NCT01821053|renin|renin
265214|NCT01821053|aldosterone|aldosterone
265215|NCT01821053|angiotensin|angiotensin
265216|NCT01821053|epithelial sodium channel|epithelial sodium channel
265217|NCT01821053|ENaC|enac
265218|NCT01821040|Polymyalgia rheumatica|polymyalgia rheumatica
265219|NCT01821040|PMR|pmr
265220|NCT01821040|Modified release prednisone|modified release prednisone
265221|NCT01821027|Healthy|healthy
265222|NCT01821027|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
265223|NCT01821027|Pharmacokinetics|pharmacokinetics
265224|NCT01821027|Pharmacodynamics|pharmacodynamics
265225|NCT01821027|Simvastatin (ZOCOR)|simvastatin (zocor)
265226|NCT01821014|Diagnostic concordance|diagnostic concordance
265227|NCT01821014|Treatment concordance|treatment concordance
265228|NCT01821014|patient satisfaction|patient satisfaction
265229|NCT01821014|physician satisfaction|physician satisfaction
265230|NCT01821014|Medical Outreach Clinics|medical outreach clinics
265231|NCT01821014|Medical Brigades|medical brigades
265232|NCT01821014|Medical Missions|medical missions
265233|NCT01821014|Telemedicine|telemedicine
265234|NCT01821014|Videoconference|videoconference
265235|NCT01821014|diagnoses|diagnoses
265236|NCT01821014|treatments|treatments
265237|NCT01821014|Satellite Internet|satellite internet
265238|NCT01821014|VSAT|vsat
265239|NCT01821014|cross cultural telemedicine|cross cultural telemedicine
265240|NCT01821001|Adenomyosis|adenomyosis
265241|NCT01821001|Dysmenorrhea|dysmenorrhea
265242|NCT01821001|Abnormal Uterine bleeding|abnormal uterine bleeding
265243|NCT01821001|Heavy Menstrual Bleeding|heavy menstrual bleeding
265244|NCT01821001|Menorrhagia|menorrhagia
266337|NCT01815606|cancer|cancer
265245|NCT01820975|Muscle protein synthesis|muscle protein synthesis
265246|NCT01820975|Dietary protein|dietary protein
265247|NCT01820962|hematological patients|hematological patients
265248|NCT01820962|central venous catheters|central venous catheters
265249|NCT01820962|catheter related thrombosis|catheter related thrombosis
265250|NCT01820962|catheter related infections|catheter related infections
265251|NCT01820962|concentrated citrate|concentrated citrate
265252|NCT01820949|patient blood management|patient blood management
265253|NCT01820949|patients safety|patients safety
265254|NCT01820936|Healthy volunteers|healthy volunteers
265255|NCT01820936|PCI-32765|pci-32765
255885|NCT01862666|EMR|emr
265256|NCT01820936|PCI-45227|pci-45227
265257|NCT01820936|Pharmacokinetics|pharmacokinetics
265258|NCT01820871|T2DM|t2dm
265259|NCT01820871|smartphone application|smartphone application
265260|NCT01820871|serum fasting glucose|serum fasting glucose
265261|NCT01820871|HbA1c|hba1c
265262|NCT01820845|Plethysmographic Variability Index|plethysmographic variability index
265263|NCT01820845|Esophageal Doppler|esophageal doppler
265264|NCT01820845|Scoliosis|scoliosis
265265|NCT01820845|Children|children
265266|NCT01820845|Age < 18 years|age < 18 years
694114|NCT00943605|PlasmaBlade|plasmablade
265267|NCT01820845|Scheduled for Scoliosis Surgery|scheduled for scoliosis surgery
265268|NCT01820832|mild proteinuria|mild proteinuria
265269|NCT01820832|calcitriol|calcitriol
265270|NCT01820832|renal function|renal function
265271|NCT01820832|blood pressure|blood pressure
265272|NCT01820819|Inpatient|inpatient
265273|NCT01820819|Liver cirrhosis|liver cirrhosis
265274|NCT01820819|Liver Cirrhosis, Alcoholic|liver cirrhosis, alcoholic
265275|NCT01820819|Physician's Practice Patterns|physician's practice patterns
265276|NCT01820819|Liver Transplantation|liver transplantation
265277|NCT01820819|Delivery of Health Care|delivery of health care
265278|NCT01820819|Resource Allocation|resource allocation
265279|NCT01820793|antibiotic resistance|antibiotic resistance
265280|NCT01820793|E.coli|e.coli
265281|NCT01820793|cefoxitin|cefoxitin
265282|NCT01820793|pyelonephritis|pyelonephritis
265283|NCT01820780|Heart failure|heart failure
265284|NCT01820780|Disease management program|disease management program
265285|NCT01820767|Chronic Kidney Disease|chronic kidney disease
265286|NCT01820767|Vd-stadium.|vd-stadium.
265287|NCT01820767|Inflammatory patterns|inflammatory patterns
265288|NCT01820767|Paricalcitol|paricalcitol
265289|NCT01820767|Atorvastatin|atorvastatin
265290|NCT01820754|Non Small Cell Lung Cancer|non small cell lung cancer
265291|NCT01820754|Lung Cancer|lung cancer
265292|NCT01820754|Non Small Cell|non small cell
265293|NCT01820702|bone metabolism|bone metabolism
265294|NCT01820702|acid base balance|acid base balance
265295|NCT01820702|bed rest|bed rest
265296|NCT01820663|stroke|stroke
265297|NCT01820663|ketones|ketones
265298|NCT01820663|ketogenic diet|ketogenic diet
265299|NCT01820663|impairment|impairment
265300|NCT01820663|disability|disability
265301|NCT01820650|osteoarthritis|osteoarthritis
265302|NCT01820650|knee replacement|knee replacement
265303|NCT01820650|patient-specific|patient-specific
265304|NCT01820637|atherosclerosis|atherosclerosis
265305|NCT01820637|SFA|sfa
265306|NCT01820637|PPA|ppa
265307|NCT01820637|lower extremities|lower extremities
265308|NCT01820637|stenting|stenting
265309|NCT01820637|paclitaxel|paclitaxel
265310|NCT01820585|fibromyalgia|fibromyalgia
265311|NCT01820585|Eslicarbazepine acetate (BIA 2-093)|eslicarbazepine acetate (bia 2-093)
265312|NCT01820585|ESL|esl
265313|NCT01820559|migraine; ESL; eslicarbazepine acetate|migraine; esl; eslicarbazepine acetate
265314|NCT01820533|Smoking|smoking
265315|NCT01820533|Cellular phones|cellular phones
265316|NCT01820533|Low income population|low income population
265317|NCT01820507|Post-extubation respiratory failure|post-extubation respiratory failure
265318|NCT01820507|Endotracheal intubation|endotracheal intubation
265319|NCT01820507|Mechanical ventilation|mechanical ventilation
265320|NCT01820494|growth|growth
265321|NCT01820494|infants|infants
265322|NCT01820481|Asthma|asthma
265323|NCT01820481|Bronchial Diseases|bronchial diseases
265324|NCT01820481|Respiratory Tract Diseases|respiratory tract diseases
265325|NCT01820481|Lung Diseases, Obstructive|lung diseases, obstructive
265326|NCT01820481|Lung Diseases|lung diseases
265327|NCT01820455|MRSA decolonization|mrsa decolonization
265328|NCT01820455|MRSA subtyping|mrsa subtyping
265329|NCT01820455|MRSA infection rates|mrsa infection rates
265330|NCT01820442|lofexidine|lofexidine
265331|NCT01820442|buprenorphine|buprenorphine
265332|NCT01820442|interaction|interaction
265333|NCT01820442|pharmacodynamic|pharmacodynamic
265334|NCT01820442|ECG|ecg
265335|NCT01820442|QTc|qtc
265336|NCT01820429|Platelet aggregation|platelet aggregation
265337|NCT01820429|Aspirin|aspirin
265338|NCT01820416|Hearing Loss, Bilateral|hearing loss, bilateral
265339|NCT01820416|Hearing Loss, Sensorineural|hearing loss, sensorineural
265340|NCT01820390|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
265341|NCT01820390|Parkinson's Disease|parkinson's disease
265342|NCT01820390|Essential Tremor|essential tremor
265343|NCT01820377|Peer-mentoring|peer-mentoring
265344|NCT01820377|Obesity|obesity
265345|NCT01820377|Type 2 Diabetes|type 2 diabetes
265346|NCT01820377|Physical Activity|physical activity
265347|NCT01820377|After-school program|after-school program
265348|NCT01820364|open-label study|open-label study
265349|NCT01820364|BRAF inhibitor|braf inhibitor
265350|NCT01820364|LGX818|lgx818
265351|NCT01820364|MEK1620|mek1620
265352|NCT01820364|MAPK1/2 inhibitor|mapk1/2 inhibitor
265353|NCT01820364|Pi3K inhibitor|pi3k inhibitor
265354|NCT01820364|FGFR|fgfr
265355|NCT01820364|c-Met|c-met
255960|NCT01862315|Dexamethasone (DEX)|dexamethasone (dex)
265356|NCT01820364|CDK4/6|cdk4/6
265357|NCT01820364|metastatic melanoma|metastatic melanoma
265358|NCT01820364|BRAF|braf
265359|NCT01820364|V600|v600
265360|NCT01820338|Children, Obesity, Intervention|children, obesity, intervention
265361|NCT01820325|Squamous non-small cell lung cancer|squamous non-small cell lung cancer
265362|NCT01820325|NSCLC|nsclc
265363|NCT01820325|stage IV|stage iv
265364|NCT01820325|BKM120|bkm120
265365|NCT01820286|Bipolar disorder|bipolar disorder
265366|NCT01820286|Depression|depression
265367|NCT01820286|Positive psychology|positive psychology
265368|NCT01820273|Type 2 diabetes|type 2 diabetes
265369|NCT01820273|Bariatric surgery|bariatric surgery
265370|NCT01820273|incretines|incretines
265371|NCT01820273|GLP-1|glp-1
265372|NCT01820273|GIP|gip
265373|NCT01820273|gastric bypass|gastric bypass
265374|NCT01820273|foregut|foregut
265375|NCT01820273|hindgut|hindgut
265376|NCT01820247|Crohn's Disease|crohn's disease
265377|NCT01820247|enteral nutrition|enteral nutrition
265378|NCT01820247|Tripterygium Glycosides|tripterygium glycosides
265379|NCT01820247|induction remission|induction remission
265380|NCT01820234|Skin cancer|skin cancer
265381|NCT01820234|Teledermatology|teledermatology
265382|NCT01820234|Screening|screening
265383|NCT01820234|Store-and-forward|store-and-forward
265384|NCT01820221|cesarean delivery|cesarean delivery
265385|NCT01820221|wound complications|wound complications
265386|NCT01820221|skin closure methods|skin closure methods
265387|NCT01820195|Contrast Nephropathy|contrast nephropathy
265388|NCT01820195|N-Acetyl Cystein|n-acetyl cystein
265389|NCT01820195|Prophylaxy|prophylaxy
265390|NCT01820117|long-term health outcomes|long-term health outcomes
265391|NCT01820078|Chronic|chronic
265392|NCT01820078|Kidney|kidney
265393|NCT01820078|Disease|disease
265394|NCT01820078|Proteinuria|proteinuria
265395|NCT01820078|Albuminuria|albuminuria
265396|NCT01820078|Paricalcitol|paricalcitol
265397|NCT01820052|Fibromyalgia|fibromyalgia
265595|NCT01819155|Senegal|senegal
265398|NCT01820039|e-health intervention|e-health intervention
265399|NCT01820039|infertility|infertility
265400|NCT01820039|primary care|primary care
265401|NCT01820039|referral rate|referral rate
265402|NCT01820026|healthcare infection cirrhosis antibiotic|healthcare infection cirrhosis antibiotic
265403|NCT01820013|Pelvic Girdle pain|pelvic girdle pain
265404|NCT01820013|Symphysis Pubis Dysfunction|symphysis pubis dysfunction
265405|NCT01820013|Sacroiliac Joint|sacroiliac joint
265406|NCT01820013|Sacroiliitis|sacroiliitis
265407|NCT01820013|Physiotherapy|physiotherapy
265408|NCT01820013|Physical Therapy|physical therapy
265409|NCT01820013|Orthotic Devices|orthotic devices
265410|NCT01819987|Overweight|overweight
265411|NCT01819987|mother|mother
265412|NCT01819987|childhood obesity prevention|childhood obesity prevention
265413|NCT01819987|Chinese American|chinese american
265414|NCT01819948|Breast cancer|breast cancer
265415|NCT01819948|Stage 0-IIIA|stage 0-iiia
265416|NCT01819948|No evidence of disease|no evidence of disease
265417|NCT01819935|MRSA. pneumonia|mrsa. pneumonia
265418|NCT01819935|outcomes|outcomes
265419|NCT01819922|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
265420|NCT01819922|metabolic parameters|metabolic parameters
265421|NCT01819922|Diabetes Mellitus Type 2|diabetes mellitus type 2
265422|NCT01819909|Rotator cuff repair|rotator cuff repair
265423|NCT01819909|Shoulder|shoulder
265424|NCT01819909|Surgery|surgery
265425|NCT01819909|Rehabilitation|rehabilitation
265426|NCT01819909|Pulleys|pulleys
265427|NCT01819909|Jackins|jackins
265428|NCT01819870|Carvedilol|carvedilol
265429|NCT01819870|Dilatrend SR capsule|dilatrend sr capsule
265430|NCT01819870|Dilatrend Tablet|dilatrend tablet
265431|NCT01819870|Pharmacokinetics|pharmacokinetics
265432|NCT01819870|Healthy male subjects|healthy male subjects
265433|NCT01819844|Closed-loop blood glucose control|closed-loop blood glucose control
265434|NCT01819844|Continuous glucose monitoring|continuous glucose monitoring
265435|NCT01819844|Bionic pancreas|bionic pancreas
265436|NCT01819844|Artificial pancreas|artificial pancreas
265437|NCT01819831|extremity soft tissue sarcoma|extremity soft tissue sarcoma
265438|NCT01819831|proton radiation|proton radiation
265439|NCT01819831|preoperative radiation|preoperative radiation
265440|NCT01819818|Schizophrenia|schizophrenia
265441|NCT01819818|Paliperidone palmitate|paliperidone palmitate
265442|NCT01819818|Invega|invega
265443|NCT01819818|Sustenna|sustenna
265444|NCT01819818|Korea|korea
265445|NCT01819805|Chronic pain|chronic pain
265446|NCT01819805|Chronic non-malignant pain|chronic non-malignant pain
265447|NCT01819805|Non-malignant|non-malignant
265448|NCT01819805|Pain|pain
266338|NCT01815606|EUS-FNA|eus-fna
265449|NCT01819805|Extended release tablet|extended release tablet
265450|NCT01819805|Tramadol hydrochloride|tramadol hydrochloride
265451|NCT01819805|Tramadol HCl|tramadol hcl
265452|NCT01819805|Acetaminophen|acetaminophen
265453|NCT01819805|Ultracet ER|ultracet er
327740|NCT01543607|RFA|rfa
265454|NCT01819792|Acute Myeloid Leukemia|acute myeloid leukemia
265455|NCT01819766|Cancer|cancer
265456|NCT01819766|Colorectal Cancer|colorectal cancer
265457|NCT01819766|Neoplasm|neoplasm
265458|NCT01819766|Colorectal Neoplasm|colorectal neoplasm
265459|NCT01819766|Intestinal Neoplasms|intestinal neoplasms
265460|NCT01819766|Gastrointestinal Neoplasms|gastrointestinal neoplasms
265461|NCT01819766|Digestive System Neoplasms|digestive system neoplasms
265462|NCT01819766|Neoplasms by Site|neoplasms by site
265463|NCT01819766|Neoplasms|neoplasms
265464|NCT01819766|Digestive System Diseases|digestive system diseases
265465|NCT01819766|Gastrointestinal Diseases|gastrointestinal diseases
265466|NCT01819766|Colonic Diseases|colonic diseases
265467|NCT01819766|Intestinal Diseases|intestinal diseases
265468|NCT01819766|Inflammatory Bowel Disease|inflammatory bowel disease
265469|NCT01819766|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
265470|NCT01819753|percutaneous nephrolithotomy|percutaneous nephrolithotomy
265471|NCT01819753|urinary Stones|urinary stones
265472|NCT01819753|99m-Technetium-Dimercaptosuccinic Acid|99m-technetium-dimercaptosuccinic acid
265473|NCT01819727|PKU|pku
265474|NCT01819727|PEG-PAL|peg-pal
265475|NCT01819727|BioMarin|biomarin
265476|NCT01819727|rAv-PAL PEG|rav-pal peg
265477|NCT01819727|BMN 165|bmn 165
265478|NCT01819727|open label|open label
265479|NCT01819727|Prism301|prism301
265480|NCT01819727|Pegvaliase|pegvaliase
265481|NCT01819714|Snoezelen|snoezelen
265482|NCT01819714|Multi-sensorial care session|multi-sensorial care session
265483|NCT01819714|Alzheimer's-type neurodegenerative disease|alzheimer's-type neurodegenerative disease
265484|NCT01819714|Dementia|dementia
265485|NCT01819688|laparoscopic liver resection|laparoscopic liver resection
265486|NCT01819688|cytokine release|cytokine release
265487|NCT01819675|Neuronal plasticity|neuronal plasticity
265488|NCT01819675|Neurotransmitter agents|neurotransmitter agents
265489|NCT01819675|Receptors, neurotransmitter|receptors, neurotransmitter
265490|NCT01819675|Transcranial magnetic stimulation|transcranial magnetic stimulation
265491|NCT01819675|Stroke|stroke
265492|NCT01819675|gamma-Aminobutyric Acid|gamma-aminobutyric acid
265596|NCT01819142|non healing wound|non healing wound
265493|NCT01819662|Pacemaker, heart failure, hospitalisation|pacemaker, heart failure, hospitalisation
265494|NCT01819649|selenium|selenium
265495|NCT01819649|selenium supplementation|selenium supplementation
265496|NCT01819649|randomised controlled trial|randomised controlled trial
265497|NCT01819649|prevention|prevention
265498|NCT01819636|Blood triglyceride|blood triglyceride
265499|NCT01819636|Bicarbonated mineral wate|bicarbonated mineral wate
265500|NCT01819636|Post-prandial triglyceridemia|post-prandial triglyceridemia
265501|NCT01819636|lipid metabolism|lipid metabolism
265502|NCT01819636|Cardiovascular risk|cardiovascular risk
265503|NCT01819623|Mild Cognitive Impairment|mild cognitive impairment
265504|NCT01819623|Cognitive training|cognitive training
265505|NCT01819610|Postoperative pain management|postoperative pain management
265506|NCT01819597|Intracranial Arterial Stenosis|intracranial arterial stenosis
265507|NCT01819597|Atherosclerosis|atherosclerosis
265508|NCT01819597|Stroke|stroke
265509|NCT01819597|EDAS|edas
265510|NCT01819597|Angiogenesis|angiogenesis
265511|NCT01819571|pulse pressure variation|pulse pressure variation
265512|NCT01819571|fluid responsiveness|fluid responsiveness
265513|NCT01819571|diastolic dysfunction|diastolic dysfunction
265514|NCT01819558|acute myeloid leukemia|acute myeloid leukemia
265515|NCT01819558|chronic myeloid leukemia|chronic myeloid leukemia
265516|NCT01819558|myelodysplastic syndrome|myelodysplastic syndrome
265517|NCT01819558|allograft|allograft
265518|NCT01819558|WT1 expression|wt1 expression
265519|NCT01819545|Alzheimer's disease|alzheimer's disease
265520|NCT01819545|diagnosis|diagnosis
265521|NCT01819545|MicRNA|micrna
265522|NCT01819545|mRNA|mrna
265523|NCT01819532|neonate|neonate
265524|NCT01819532|umbilical cord|umbilical cord
265525|NCT01819532|cord milking|cord milking
265526|NCT01819532|prematurity|prematurity
265527|NCT01819519|Intervention studies|intervention studies
265528|NCT01819519|Pregnancy|pregnancy
265529|NCT01819519|Cytomegalovirus Infections|cytomegalovirus infections
265530|NCT01819506|rehabilitation|rehabilitation
265531|NCT01819506|occupational therapy|occupational therapy
265532|NCT01819506|upper extremity|upper extremity
265533|NCT01819493|Diabetes Prevention|diabetes prevention
265534|NCT01819493|Lifestyle Intervention|lifestyle intervention
265535|NCT01819493|African American Families|african american families
265536|NCT01819480|Surgery|surgery
265537|NCT01819480|Robotic|robotic
265538|NCT01819480|Carcinoma|carcinoma
265539|NCT01819480|squamous cell of head and neck|squamous cell of head and neck
265540|NCT01819454|chronic rhinosinusitis|chronic rhinosinusitis
265541|NCT01819454|extraesophageal reflux|extraesophageal reflux
265542|NCT01819454|Restech system|restech system
265543|NCT01819454|antireflux therapy|antireflux therapy
265641|NCT01818921|ZGN-440 for injectable suspension|zgn-440 for injectable suspension
265544|NCT01819441|cerebral small Vessel diseases, blood pressure,CCB, ACEI|cerebral small vessel diseases, blood pressure,ccb, acei
256148|NCT01861457|general bacteria|general bacteria
256149|NCT01861457|nasal carriage|nasal carriage
256150|NCT01861457|decolonization|decolonization
256152|NCT01861418|chronic low back pain|chronic low back pain
265545|NCT01819428|EGFR mutation|egfr mutation
265546|NCT01819428|Lung Adenocarcinoma|lung adenocarcinoma
265547|NCT01819428|Firstline therapy|firstline therapy
265674|NCT01818765|Pacing|pacing
265548|NCT01819428|Second generation of tyrosine kinase|second generation of tyrosine kinase
265549|NCT01819415|wet AMD|wet amd
265550|NCT01819415|Omega-3|omega-3
265551|NCT01819415|VEGF|vegf
265552|NCT01819415|Lipidomics|lipidomics
265554|NCT01819415|EPA|epa
265555|NCT01819402|visceral fat metabolism; FDG-PET/CT; pioglitazone; glimepiride; adiponectin|visceral fat metabolism; fdg-pet/ct; pioglitazone; glimepiride; adiponectin
265556|NCT01819389|Chronic myeloid leukemia|chronic myeloid leukemia
265557|NCT01819389|suboptimal response|suboptimal response
265564|NCT01819376|Facebook|facebook
265565|NCT01819376|Social Networks|social networks
265566|NCT01819363|Pleural effusion|pleural effusion
265567|NCT01819363|Pleural elastance|pleural elastance
265568|NCT01819363|Pleurodesis|pleurodesis
265569|NCT01819363|Quality of life|quality of life
265570|NCT01819363|Computed Tomography|computed tomography
265571|NCT01819350|Dental caries|dental caries
265572|NCT01819350|Sucrose|sucrose
265573|NCT01819350|Oral administration|oral administration
265574|NCT01819350|Ion Concentration of Hydrogen|ion concentration of hydrogen
265575|NCT01819350|Pediatric medicines|pediatric medicines
265576|NCT01819324|breast cancer survivors|breast cancer survivors
265577|NCT01819324|lifestyle intervention|lifestyle intervention
265578|NCT01819324|health behaviors|health behaviors
265579|NCT01819285|Malignant Neoplasm of Prostate|malignant neoplasm of prostate
265580|NCT01819285|Tumor-node-metastasis (TNM) Staging Regional Lymph Nodes (N0-2)|tumor-node-metastasis (tnm) staging regional lymph nodes (n0-2)
265581|NCT01819285|Not suitable for local treatment with curative intent|not suitable for local treatment with curative intent
265587|NCT01819181|TAVI|tavi
265588|NCT01819181|women|women
265589|NCT01819181|aortic stenosis|aortic stenosis
265590|NCT01819181|VARC2|varc2
265591|NCT01819155|influenza|influenza
265592|NCT01819155|influenza vaccine|influenza vaccine
265593|NCT01819155|immunogenicity|immunogenicity
265597|NCT01819142|pressure ulcer|pressure ulcer
265598|NCT01819116|Tissue Oxygen Saturation|tissue oxygen saturation
265599|NCT01819116|Management of the DNC Organ Donor|management of the dnc organ donor
265600|NCT01819103|Mortality|mortality
265601|NCT01819103|Acute Myocardial Infarction|acute myocardial infarction
265602|NCT01819103|Drug Adherence|drug adherence
265603|NCT01819103|Drug Compliance|drug compliance
265604|NCT01819103|Health-related quality of life|health-related quality of life
265605|NCT01819090|Neuromuscular disorder|neuromuscular disorder
265606|NCT01819090|Mechanical ventilation|mechanical ventilation
265608|NCT01819090|Respiratory failure|respiratory failure
265609|NCT01819077|Cervical cancer|cervical cancer
265610|NCT01819077|TMMR|tmmr
265611|NCT01819077|therapeutic lymphadenectomy|therapeutic lymphadenectomy
265612|NCT01819077|register study|register study
265613|NCT01819064|Atropine|atropine
265614|NCT01819064|bradycardia|bradycardia
265615|NCT01819064|tachycardia|tachycardia
265616|NCT01819025|Depression|depression
265617|NCT01819025|Behavioral activation|behavioral activation
265618|NCT01819025|Smartphone application|smartphone application
265619|NCT01819025|Face-to-face|face-to-face
265620|NCT01819025|Blended therapy|blended therapy
265621|NCT01819012|Isoflurane|isoflurane
265622|NCT01819012|mitral valve annular velocity|mitral valve annular velocity
265623|NCT01819012|tissue Doppler imaging|tissue doppler imaging
265624|NCT01819012|Monitoring|monitoring
265625|NCT01819012|echocardiography|echocardiography
265626|NCT01818999|METASTATIC BREAST CANCER|metastatic breast cancer
265627|NCT01818973|Rectal Cancer|rectal cancer
265628|NCT01818973|Bevacizumab|bevacizumab
265629|NCT01818973|capecitabine|capecitabine
265630|NCT01818973|oxaliplatin|oxaliplatin
265631|NCT01818973|preoporative IMRT|preoporative imrt
265632|NCT01818960|Stent, Myocardial Infarction, Coronary Intervention|stent, myocardial infarction, coronary intervention
265633|NCT01818947|Lung cancer|lung cancer
265634|NCT01818947|epidermal growth factor receptor mutation|epidermal growth factor receptor mutation
265635|NCT01818947|gefitinib|gefitinib
265636|NCT01818947|Iressa|iressa
265637|NCT01818934|hip dysplasia|hip dysplasia
265638|NCT01818934|screening|screening
265639|NCT01818921|Beloranib|beloranib
265640|NCT01818921|ZGN-440|zgn-440
265642|NCT01818921|ZGN-433|zgn-433
265643|NCT01818908|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
265644|NCT01818908|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
265645|NCT01818908|DA-EPOCH|da-epoch
327981|NCT01542567|BCG|bcg
256245|NCT01860937|13-052|13-052
265646|NCT01818908|rituximab|rituximab
265647|NCT01818895|Mechanical ventilation|mechanical ventilation
265648|NCT01818895|End of life|end of life
265649|NCT01818895|Extubation|extubation
265650|NCT01818895|Terminal weaning|terminal weaning
265651|NCT01818895|Complicated grief|complicated grief
265652|NCT01818882|Vscan|vscan
265653|NCT01818882|portable ultrasound|portable ultrasound
265654|NCT01818882|emergency care|emergency care
265655|NCT01818882|emergency room|emergency room
265656|NCT01818869|Safety,|safety,
265657|NCT01818869|tolerability,|tolerability,
265658|NCT01818869|Phase I,|phase i,
265659|NCT01818869|pharmacokinetic,|pharmacokinetic,
265660|NCT01818869|pharmacodynamic,|pharmacodynamic,
265661|NCT01818869|inhaled|inhaled
265662|NCT01818856|Chronic hepatitis C|chronic hepatitis c
265663|NCT01818856|HIV-infection|hiv-infection
265664|NCT01818856|Drug interaction|drug interaction
265665|NCT01818843|Carbon monoxide|carbon monoxide
265666|NCT01818843|safety|safety
265667|NCT01818843|Adverse Reaction|adverse reaction
265668|NCT01818843|newborn|newborn
265669|NCT01818817|Ultrasound-guided paravertebral block|ultrasound-guided paravertebral block
265670|NCT01818817|regional anesthesia|regional anesthesia
265671|NCT01818817|breast surgery|breast surgery
265672|NCT01818765|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
265673|NCT01818765|Endocardial|endocardial
265675|NCT01818739|Endometrial Cancer|endometrial cancer
265676|NCT01818739|Robotic-Assisted Staging|robotic-assisted staging
265677|NCT01818726|Aplastic anemia, deferasirox, renal function|aplastic anemia, deferasirox, renal function
265678|NCT01818713|2B3-101, liposomal doxorubicin, leptomeningeal metastases|2b3-101, liposomal doxorubicin, leptomeningeal metastases
265679|NCT01818661|apraxia of speech|apraxia of speech
265680|NCT01818661|non-fluent aphasia|non-fluent aphasia
265681|NCT01818661|aphasia|aphasia
265682|NCT01818622|Bipolar disorder|bipolar disorder
265683|NCT01818622|Mania|mania
265684|NCT01818622|Blue-blockers|blue-blockers
265685|NCT01818622|Virtual darkness therapy|virtual darkness therapy
265686|NCT01818622|Actigraphy|actigraphy
265687|NCT01818622|Randomized controlled trial|randomized controlled trial
265688|NCT01818609|sarcopenia|sarcopenia
265689|NCT01818609|muscle|muscle
265690|NCT01818609|reduced activity|reduced activity
265691|NCT01818609|insulin sensitivity|insulin sensitivity
265692|NCT01818609|protein|protein
265693|NCT01818609|step reduction|step reduction
265694|NCT01818609|muscle protein synthesis|muscle protein synthesis
265695|NCT01818609|whey protein|whey protein
265696|NCT01818609|leg strength|leg strength
265697|NCT01818609|whole body protein|whole body protein
265698|NCT01818596|HIV|hiv
265699|NCT01818596|HIV-1 Infected|hiv-1 infected
265700|NCT01818596|Treatment Experienced|treatment experienced
265701|NCT01818596|Treatment Naive|treatment naive
265702|NCT01818583|Atrial fibrillation|atrial fibrillation
265703|NCT01818583|Atrial flutter|atrial flutter
265704|NCT01818583|Potassium|potassium
265705|NCT01818583|Cardioversion|cardioversion
265706|NCT01818570|Gastroesophageal Reflux|gastroesophageal reflux
265707|NCT01818557|glucose monitoring|glucose monitoring
265708|NCT01818557|gestational diabetes|gestational diabetes
265709|NCT01818544|Elastase Inhibition|elastase inhibition
265710|NCT01818531|Partial knee replacement|partial knee replacement
265711|NCT01818518|Preterm delivery|preterm delivery
265712|NCT01818518|Premature delivery|premature delivery
265714|NCT01818505|antiphospholipid syndrome|antiphospholipid syndrome
265715|NCT01818505|gouty arthritis|gouty arthritis
265716|NCT01818505|Hyperuricemia|hyperuricemia
265717|NCT01818505|metabolic syndrome|metabolic syndrome
265718|NCT01818505|osteoarthritis|osteoarthritis
265719|NCT01818505|cardiovascular co-morbidities|cardiovascular co-morbidities
265720|NCT01818453|Mood Disorders|mood disorders
265721|NCT01818453|Depression|depression
265722|NCT01818453|Genetics|genetics
265723|NCT01818453|Treatment response|treatment response
265724|NCT01818453|Treatment study|treatment study
265725|NCT01818440|Surgical Navigation|surgical navigation
265726|NCT01818440|Liver|liver
265727|NCT01818440|Cancer|cancer
265728|NCT01818440|Image-guided Therapy|image-guided therapy
265729|NCT01818427|hemmorhagic shock, plasma, air medical transport, randomized, multicenter|hemmorhagic shock, plasma, air medical transport, randomized, multicenter
265730|NCT01818414|Misoprostol administration & dosage|misoprostol administration & dosage
265731|NCT01818414|Abortion techniques|abortion techniques
265732|NCT01818414|Abortion Induced methods|abortion induced methods
265733|NCT01818414|Dilatation and Curettage|dilatation and curettage
265734|NCT01818401|Ancillary tailored|ancillary tailored
265735|NCT01818401|medico-economic study,|medico-economic study,
265736|NCT01818401|total knee replacement|total knee replacement
265737|NCT01818401|primary or secondary osteoarthritis|primary or secondary osteoarthritis
265738|NCT01818362|Influenza|influenza
265739|NCT01818362|T cells|t cells
265740|NCT01818349|stroke|stroke
265741|NCT01818349|exercise|exercise
265742|NCT01818349|muscle strength|muscle strength
265743|NCT01818349|gait|gait
265744|NCT01818349|rehabilitation|rehabilitation
265745|NCT01818336|penicillin allergy|penicillin allergy
265746|NCT01818323|Chimeric antigen receptor|chimeric antigen receptor
265747|NCT01818323|Immunotherapy|immunotherapy
265748|NCT01818323|Head and Neck Cancer|head and neck cancer
265749|NCT01818323|Phase I trial|phase i trial
265750|NCT01818323|Maximum tolerated dose|maximum tolerated dose
265751|NCT01818310|ischemia|ischemia
265752|NCT01818310|diabetes mellitus|diabetes mellitus
265753|NCT01818310|bone marrow aspirate concentrate (BMAC)|bone marrow aspirate concentrate (bmac)
265754|NCT01818284|Blood And Marrow Transplantation|blood and marrow transplantation
265755|NCT01818284|Normal allogeneic donors|normal allogeneic donors
265756|NCT01818284|Stem cell mobilization|stem cell mobilization
265757|NCT01818284|peripheral blood progenitor cells|peripheral blood progenitor cells
265759|NCT01818284|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
265760|NCT01818284|HSCT|hsct
265761|NCT01818284|Donating blood stem cells|donating blood stem cells
265762|NCT01818284|C-CSF|c-csf
265763|NCT01818284|Neupogen|neupogen
265764|NCT01818284|Filgrastim|filgrastim
265765|NCT01818284|Plerixafor|plerixafor
265766|NCT01818284|Mobozil|mobozil
265767|NCT01818284|Apheresis|apheresis
265768|NCT01818271|community-stroke-rehabilitation,|community-stroke-rehabilitation,
265769|NCT01818271|group-exercise,|group-exercise,
265770|NCT01818271|balance-mobility-exercise,|balance-mobility-exercise,
265771|NCT01818271|instrumented treadmill|instrumented treadmill
265772|NCT01818258|HIV|hiv
265773|NCT01818258|Children|children
265774|NCT01818258|HAART|haart
265775|NCT01818258|Malnourished|malnourished
265776|NCT01818219|Electrical activity of the diaphragm|electrical activity of the diaphragm
265777|NCT01818219|Neuro regulation of breathing|neuro regulation of breathing
265778|NCT01818219|Abnormal respiratory mechanics|abnormal respiratory mechanics
265779|NCT01818219|Assisted mechanical ventilation|assisted mechanical ventilation
265780|NCT01818219|Pressure support|pressure support
265781|NCT01818219|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
265782|NCT01818206|Cystic Fibrosis|cystic fibrosis
265783|NCT01818206|Bacteriophages|bacteriophages
265784|NCT01818206|Pseudomonas aeruginosa|pseudomonas aeruginosa
265785|NCT01818206|Sputum|sputum
265786|NCT01818193|Pulmonary transplant|pulmonary transplant
265787|NCT01818167|Hidradenitis Suppurativa|hidradenitis suppurativa
265788|NCT01818167|HS|hs
265789|NCT01818167|Acne Inversa|acne inversa
265790|NCT01818167|Velpeau's disease|velpeau's disease
265791|NCT01818167|Verneuil's disease|verneuil's disease
265792|NCT01818154|phototherapy|phototherapy
265793|NCT01818154|light emitting diode|light emitting diode
265794|NCT01818154|minimal erythema dose|minimal erythema dose
265795|NCT01818154|narrowband UVB|narrowband uvb
265796|NCT01818115|POAG|poag
265797|NCT01818115|PXG|pxg
265798|NCT01818115|IOL Surgery|iol surgery
265799|NCT01818115|CE Surgery|ce surgery
265800|NCT01818024|healthy volunteer|healthy volunteer
265801|NCT01818024|TNFR1|tnfr1
265802|NCT01818024|domain antibody|domain antibody
265803|NCT01818024|Lung injury|lung injury
265804|NCT01818011|Japanese, GSK1322322, pharmacokinetics, relative bioavailability, single dose, repeat dose, healthy subjects, dose-escalation, antimicrobial, over granulation,|japanese, gsk1322322, pharmacokinetics, relative bioavailability, single dose, repeat dose, healthy subjects, dose-escalation, antimicrobial, over granulation,
265805|NCT01817985|Hepatitis C (HCV) Infection|hepatitis c (hcv) infection
265806|NCT01817985|Moderate Hepatic Impairment|moderate hepatic impairment
265807|NCT01817985|Severe Hepatic Impairment|severe hepatic impairment
265808|NCT01817972|Crohn's Disease|crohn's disease
265809|NCT01817972|Crohn's colitis|crohn's colitis
265810|NCT01817972|Crohn's ileocolitis|crohn's ileocolitis
265811|NCT01817959|Pancreatic islet transplantation|pancreatic islet transplantation
265812|NCT01817959|Diabetes Mellitus Type 1|diabetes mellitus type 1
265813|NCT01817959|Islet transplantation graft survival & function|islet transplantation graft survival & function
265814|NCT01817946|Congenital Myopathy|congenital myopathy
265815|NCT01817946|Centronuclear Myopathy|centronuclear myopathy
265816|NCT01817946|Myotubular Myopathy|myotubular myopathy
265817|NCT01817946|Myotubularin|myotubularin
265818|NCT01817946|MTM1 Gene|mtm1 gene
265819|NCT01817946|Genetic testing|genetic testing
265820|NCT01817946|Sequencing|sequencing
265821|NCT01817946|Deletion/Duplication Mutation|deletion/duplication mutation
265822|NCT01817946|CGH array|cgh array
265823|NCT01817907|Apnea- Hypopnea index|apnea- hypopnea index
265824|NCT01817907|Arousal Threshold|arousal threshold
265825|NCT01817894|Unwanted facial hair growth|unwanted facial hair growth
265826|NCT01817868|Hemophilia|hemophilia
265827|NCT01817868|Turkey|turkey
265828|NCT01817868|Observational|observational
265829|NCT01817868|Adult|adult
265830|NCT01817855|Phase 1,|phase 1,
265831|NCT01817855|Safety,|safety,
265832|NCT01817855|Tolerability,|tolerability,
265833|NCT01817855|Healthy,|healthy,
265834|NCT01817855|COPD patients|copd patients
265835|NCT01817842|mHealth|mhealth
265836|NCT01817842|EMA|ema
265837|NCT01817842|Ecological Momentary Assessment|ecological momentary assessment
265838|NCT01817842|Personal Informatics|personal informatics
265839|NCT01817842|Tobacco Quitline|tobacco quitline
265840|NCT01817803|Heart failure|heart failure
265841|NCT01817803|diuretics|diuretics
265842|NCT01817803|kidney|kidney
265843|NCT01817803|glomerular filtration rate|glomerular filtration rate
265844|NCT01817777|Socioeconomic category|socioeconomic category
265845|NCT01817777|Medication compliance|medication compliance
265846|NCT01817777|Metformin|metformin
265847|NCT01817777|small pack|small pack
265848|NCT01817764|umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
265849|NCT01817764|vilanterol (VI)|vilanterol (vi)
265850|NCT01817764|salmeterol (SAL)|salmeterol (sal)
265851|NCT01817764|fluticasone propionate (FP)|fluticasone propionate (fp)
265852|NCT01817764|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
265853|NCT01817764|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
265854|NCT01817764|GW642444|gw642444
265855|NCT01817764|GSK573719|gsk573719
265856|NCT01817764|lung function|lung function
265857|NCT01817751|central nervous system|central nervous system
265858|NCT01817751|Brain and Nervous System|brain and nervous system
265859|NCT01817738|Metastatic|metastatic
265860|NCT01817738|Castrate-refractory|castrate-refractory
265861|NCT01817725|Therapeutic vaccine|therapeutic vaccine
265862|NCT01817725|HBsAg clearance|hbsag clearance
265863|NCT01817725|Immune clearance|immune clearance
265864|NCT01817725|HBsAg clearance induced by vaccination|hbsag clearance induced by vaccination
265865|NCT01817725|s seroconversion in carriers after vaccination|s seroconversion in carriers after vaccination
265866|NCT01817712|Posttraumatic neuroses|posttraumatic neuroses
265867|NCT01817712|posttraumatic stress disorder|posttraumatic stress disorder
265868|NCT01817712|PTSD|ptsd
265869|NCT01817712|Supported employment|supported employment
265870|NCT01817712|IPS|ips
265871|NCT01817712|CWT|cwt
265872|NCT01817712|TWP|twp
265873|NCT01817712|Individual placement and support|individual placement and support
265874|NCT01817712|Compensated work therapy|compensated work therapy
265875|NCT01817712|Transitional work program|transitional work program
265876|NCT01817699|Cholecalciferol|cholecalciferol
265877|NCT01817699|Methoxy polyethylene glycol-epoetin beta|methoxy polyethylene glycol-epoetin beta
265878|NCT01817699|Hematinics|hematinics
265879|NCT01817699|Bone Diseases, Metabolic|bone diseases, metabolic
265880|NCT01817699|Neoplasms|neoplasms
265881|NCT01817699|Cardiovascular Diseases|cardiovascular diseases
265882|NCT01817699|Graft Rejection|graft rejection
265883|NCT01817660|popliteal artery aneurysm|popliteal artery aneurysm
265884|NCT01817660|endovascular repair|endovascular repair
265885|NCT01817660|open surgical repair|open surgical repair
265886|NCT01817660|comparative study|comparative study
265887|NCT01817647|AL|al
265888|NCT01817647|Enhanced recovery after surgery (ERAS)|enhanced recovery after surgery (eras)
265889|NCT01817647|reduce postoperative complications|reduce postoperative complications
265890|NCT01817647|increased risk of delayed diagnosis and treatment of AL|increased risk of delayed diagnosis and treatment of al
265891|NCT01817647|diagnose anastomotic leak|diagnose anastomotic leak
265892|NCT01817634|Malnutrition.|malnutrition.
265893|NCT01817621|Body Image Disturbance|body image disturbance
265894|NCT01817621|Medication Adherence|medication adherence
265895|NCT01817621|Sexual Risk Behavior|sexual risk behavior
265896|NCT01817621|HIV|hiv
265897|NCT01817621|MSM|msm
265898|NCT01817608|sf-36|sf-36
265899|NCT01817608|Katz|katz
265900|NCT01817595|Type 2 Diabetes|type 2 diabetes
265901|NCT01817595|Internet Blood Glucose Monitoring|internet blood glucose monitoring
265902|NCT01817595|iphone|iphone
265903|NCT01817595|meter|meter
265904|NCT01817582|Dry Eye Disease|dry eye disease
265905|NCT01817569|Diabetes Mellitus (DM)|diabetes mellitus (dm)
265906|NCT01817569|Byetta|byetta
265907|NCT01817569|Exenatide|exenatide
265908|NCT01817543|venous leg ulcers|venous leg ulcers
265909|NCT01817543|non healing wounds|non healing wounds
265910|NCT01817530|Uterine Fibroids|uterine fibroids
265911|NCT01817530|Leiomyomata|leiomyomata
265912|NCT01817530|Elagolix|elagolix
265913|NCT01817530|Menorrhagia|menorrhagia
265914|NCT01817530|Elagolix sodium|elagolix sodium
265915|NCT01817530|Heavy Uterine Bleeding|heavy uterine bleeding
265916|NCT01817530|ABT-620|abt-620
265917|NCT01817504|Renal failure,|renal failure,
265918|NCT01817504|Transplantectomy|transplantectomy
265919|NCT01817504|Immunosuppression|immunosuppression
265920|NCT01817504|Sensitization|sensitization
265921|NCT01817491|Vegan Diet|vegan diet
265922|NCT01817491|Hypercholesterolemia|hypercholesterolemia
265923|NCT01817491|American Heart Association Diet|american heart association diet
265924|NCT01817491|Cardiovascular Risk|cardiovascular risk
265925|NCT01817491|Obesity|obesity
265926|NCT01817478|conjunctival flora|conjunctival flora
265927|NCT01817439|oral Amiodarone|oral amiodarone
265928|NCT01817439|IV Amiodarone|iv amiodarone
265929|NCT01817439|phlebitis|phlebitis
265930|NCT01817439|thrombophlebitis|thrombophlebitis
265931|NCT01817439|adverse events|adverse events
265932|NCT01817413|Calcium hydroxide|calcium hydroxide
265933|NCT01817413|Pulp regeneration|pulp regeneration
265934|NCT01817413|Regenerative endodontics|regenerative endodontics
265935|NCT01817413|Pulp revitalisation|pulp revitalisation
265936|NCT01817413|Triple antibiotic paste|triple antibiotic paste
265937|NCT01817413|Root canal therapy|root canal therapy
265938|NCT01817413|Root end closure|root end closure
265939|NCT01817413|Tooth root|tooth root
265940|NCT01817413|Tooth apex|tooth apex
265941|NCT01817413|Dental trauma|dental trauma
265942|NCT01817413|Non-vital|non-vital
265943|NCT01817413|Immature|immature
265944|NCT01817413|Incisor|incisor
265945|NCT01817413|Periapical periodontitis|periapical periodontitis
265946|NCT01817413|Dental pulp|dental pulp
265947|NCT01817374|Breast Cancer|breast cancer
265948|NCT01817374|Definity|definity
265949|NCT01817374|Ultrasound|ultrasound
265950|NCT01817361|oral health|oral health
265951|NCT01817348|Adhesive capsulitis|adhesive capsulitis
265952|NCT01817348|Frozen shoulder|frozen shoulder
265953|NCT01817348|Shoulder pain|shoulder pain
265954|NCT01817348|Intra-articular injection|intra-articular injection
265955|NCT01817348|Lidocaine injection|lidocaine injection
265956|NCT01817348|Physiotherapy|physiotherapy
265957|NCT01817348|Manipulation|manipulation
265958|NCT01817348|Stretch exercise|stretch exercise
265959|NCT01817322|kidney transplantation|kidney transplantation
265960|NCT01817309|renal failure|renal failure
265961|NCT01817309|survival|survival
265962|NCT01817309|peritoneal failure|peritoneal failure
265963|NCT01817296|Klinefelter|klinefelter
265964|NCT01817296|Fertility|fertility
265965|NCT01817283|HIV-infected immunological non-responders|hiv-infected immunological non-responders
265966|NCT01817283|Triptolide|triptolide
265967|NCT01817283|immune activation|immune activation
265968|NCT01817283|inflammation|inflammation
265969|NCT01817283|CD4 T cell|cd4 t cell
265970|NCT01817257|Cancer|cancer
265971|NCT01817257|Thrombosis|thrombosis
265972|NCT01817257|Venous thromboembolism|venous thromboembolism
265973|NCT01817257|Deep vein thrombosis|deep vein thrombosis
265974|NCT01817257|Pulmonary embolus|pulmonary embolus
265975|NCT01817244|care management|care management
265976|NCT01817244|depression|depression
265977|NCT01817244|elderly|elderly
265978|NCT01817244|Korea|korea
265979|NCT01817231|breast cancer|breast cancer
265980|NCT01817231|vitamin D|vitamin d
265981|NCT01817231|25 OH vitamin D|25 oh vitamin d
265982|NCT01817218|PRP|prp
265983|NCT01817218|chronic vascular ulcer|chronic vascular ulcer
265984|NCT01817218|primary care|primary care
265985|NCT01817192|Non-Squamous|non-squamous
265986|NCT01817192|Adjuvant Chemotherapy|adjuvant chemotherapy
265987|NCT01817179|hemiplegia, cerebral palsy, neuroprosthesis, children|hemiplegia, cerebral palsy, neuroprosthesis, children
265988|NCT01817166|cholecalciferol|cholecalciferol
265989|NCT01817166|vitamin D|vitamin d
265990|NCT01817166|immune disease|immune disease
266283|NCT01815853|treatment|treatment
265991|NCT01817166|clinically isolated syndrome|clinically isolated syndrome
265992|NCT01817140|oral cancer|oral cancer
265993|NCT01817140|mandibular invasion|mandibular invasion
265994|NCT01817140|SWIFT MRI|swift mri
265995|NCT01817114|Remote Ischemic Conditioning|remote ischemic conditioning
265996|NCT01817114|PCI|pci
265997|NCT01817114|STEMI|stemi
265998|NCT01817114|LAD|lad
265999|NCT01817088|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
266000|NCT01817088|Parkinson disease|parkinson disease
266001|NCT01817088|Stereotaxis Technique|stereotaxis technique
266002|NCT01817088|Subthalamic nucleus|subthalamic nucleus
266003|NCT01817062|Capillary leakage|capillary leakage
266004|NCT01817062|Acute Abdomen|acute abdomen
266005|NCT01817062|Low birth weight|low birth weight
266006|NCT01817049|prevention|prevention
266007|NCT01817049|sport injury|sport injury
266008|NCT01817049|soccer|soccer
266009|NCT01817049|youth|youth
266010|NCT01817049|neuromuscular training|neuromuscular training
266011|NCT01817049|intervention|intervention
266012|NCT01817049|behaviour|behaviour
266013|NCT01817036|vitamin D|vitamin d
266014|NCT01817036|deficiency|deficiency
266015|NCT01817036|dose response|dose response
266016|NCT01817023|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
266017|NCT01817023|current chemotherapy|current chemotherapy
266018|NCT01817023|intensity-modulated radiotherapy|intensity-modulated radiotherapy
266019|NCT01817023|low-risk|low-risk
266020|NCT01817010|Total Hip Arthroplasty|total hip arthroplasty
266021|NCT01817010|Muscle Strength|muscle strength
266022|NCT01817010|Hip Osteoarthritis|hip osteoarthritis
266023|NCT01816997|Statins|statins
266024|NCT01816997|Glucose homeostasis|glucose homeostasis
266025|NCT01816997|Diabetes|diabetes
266026|NCT01816997|Impaired fasting glucose|impaired fasting glucose
266027|NCT01816958|thalamocortical dysrhythmia|thalamocortical dysrhythmia
266028|NCT01816958|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
266029|NCT01816958|transcranial Electrical Stimulation (tES)|transcranial electrical stimulation (tes)
266030|NCT01816958|(N-methyl-D-aspartate) NMDA-R antagonist|(n-methyl-d-aspartate) nmda-r antagonist
266031|NCT01816958|ketamine infusion|ketamine infusion
266032|NCT01816958|neuromodulation|neuromodulation
266033|NCT01816958|synergistic effect|synergistic effect
266034|NCT01816958|remission|remission
266037|NCT01816945|Social support|social support
266038|NCT01816945|Social capital|social capital
266039|NCT01816945|Maternal|maternal
266040|NCT01816893|Hypoglycemia|hypoglycemia
266041|NCT01816893|Autonomic Nervous System|autonomic nervous system
266042|NCT01816867|hernia|hernia
266043|NCT01816867|Treatment|treatment
266044|NCT01816867|laparoscopic|laparoscopic
266045|NCT01816867|open technique|open technique
266046|NCT01816854|SFA,|sfa,
266047|NCT01816854|stent,|stent,
266048|NCT01816854|endovascular|endovascular
266049|NCT01816854|Patient outcome|patient outcome
266050|NCT01816841|Direct Visual Fluorescense|direct visual fluorescense
266051|NCT01816841|Oral Examination|oral examination
266052|NCT01816841|oral cancer|oral cancer
266053|NCT01816828|HIV, MSM, unprotected anal intercourse, sexual health|hiv, msm, unprotected anal intercourse, sexual health
266054|NCT01816815|PK/PD|pk/pd
266055|NCT01816815|BAY1002670|bay1002670
266056|NCT01816802|In vitro fertilization|in vitro fertilization
266057|NCT01816802|Assisted reproductive therapy|assisted reproductive therapy
266058|NCT01816802|Time-lapse image recording|time-lapse image recording
266059|NCT01816802|Image analysis software|image analysis software
266060|NCT01816789|Starting dose|starting dose
266061|NCT01816789|rFSH|rfsh
266062|NCT01816789|controlled|controlled
266063|NCT01816789|ovarian|ovarian
266064|NCT01816789|stimulation|stimulation
266065|NCT01816789|IVF/ICSI|ivf/icsi
266066|NCT01816789|cycles|cycles
266067|NCT01816763|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
266068|NCT01816763|Primary Health Care|primary health care
266069|NCT01816763|Medical Informatics|medical informatics
266070|NCT01816750|CT coronary angiography|ct coronary angiography
266071|NCT01816750|Coronary disease|coronary disease
266072|NCT01816750|Gemstone Spectral Imaging|gemstone spectral imaging
266073|NCT01816750|Diagnostic value|diagnostic value
266074|NCT01816750|Adaptive statistical iterative reconstruction|adaptive statistical iterative reconstruction
266075|NCT01816750|iterative reconstruction|iterative reconstruction
266076|NCT01816750|Feasibility of coronary and myocardial assessment|feasibility of coronary and myocardial assessment
266077|NCT01816750|novel Cardiac CT GSI protocol|novel cardiac ct gsi protocol
266078|NCT01816724|NOCTURIA|nocturia
266079|NCT01816724|SYMPTOMATIC QUESTIONNAIRE|symptomatic questionnaire
266080|NCT01816724|N-QOL|n-qol
266081|NCT01816711|Frail elderly|frail elderly
266082|NCT01816711|Hip fracture|hip fracture
266083|NCT01816711|Vitamin D|vitamin d
266084|NCT01816711|Geriatrics|geriatrics
266085|NCT01816698|Hypertension|hypertension
266086|NCT01816698|Taurine|taurine
266087|NCT01816698|Metabolism|metabolism
266088|NCT01816672|Wagner 1|wagner 1
266089|NCT01816672|Wagner 2|wagner 2
266090|NCT01816672|Non healing diabetic foot wound|non healing diabetic foot wound
266091|NCT01816659|Colorectal Carcinoma|colorectal carcinoma
266092|NCT01816659|Endoscopically Non- Resectable Adenomas|endoscopically non- resectable adenomas
266093|NCT01816659|Colonic lesion|colonic lesion
266094|NCT01816659|Biomarker|biomarker
266095|NCT01816659|Metformin-ER|metformin-er
266096|NCT01816659|Metformin|metformin
266097|NCT01816659|Extended release|extended release
266098|NCT01816659|Colonoscopy|colonoscopy
266099|NCT01816659|Colon cancer surgery|colon cancer surgery
266100|NCT01816646|Blood And Marrow Transplantation|blood and marrow transplantation
266101|NCT01816646|Hemorrhagic Cystitis|hemorrhagic cystitis
266102|NCT01816646|Bleeding from bladder|bleeding from bladder
266103|NCT01816646|Foley catheter|foley catheter
266104|NCT01816646|Probenecid|probenecid
266105|NCT01816646|Cidofovir|cidofovir
266106|NCT01816646|Vistide|vistide
266107|NCT01816633|non healing wound|non healing wound
266108|NCT01816620|POEMS Syndrome|poems syndrome
266109|NCT01816620|lenalidomide|lenalidomide
266110|NCT01816620|newly diagnosed|newly diagnosed
266111|NCT01816620|plasma cell disorder|plasma cell disorder
266112|NCT01816620|Dexamethasone|dexamethasone
266113|NCT01816607|Magnetic Resonance Imaging|magnetic resonance imaging
266114|NCT01816607|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
266115|NCT01816594|HER2, breast cancer, neoadjuvant, PI3K inhibitor, first line chemotherapy, trastuzumab, GBG, SOLTI, BIG|her2, breast cancer, neoadjuvant, pi3k inhibitor, first line chemotherapy, trastuzumab, gbg, solti, big
266116|NCT01816568|appendicitis, laparoscopy, single incision|appendicitis, laparoscopy, single incision
266117|NCT01816542|patch-testing|patch-testing
266118|NCT01816542|personal-care|personal-care
266119|NCT01816542|cosmetic|cosmetic
266120|NCT01816542|dermatitis|dermatitis
266121|NCT01816542|allergy|allergy
266122|NCT01816542|sensitive skin|sensitive skin
266123|NCT01816516|childhood obesity|childhood obesity
266124|NCT01816516|low-income|low-income
266125|NCT01816516|maternal responsiveness|maternal responsiveness
266126|NCT01816516|infant feeding|infant feeding
266127|NCT01816516|infant feeding practices|infant feeding practices
266128|NCT01816516|infant feeding style|infant feeding style
266129|NCT01816516|primary prevention|primary prevention
266130|NCT01816503|Pain|pain
266131|NCT01816503|Cancer pain|cancer pain
266132|NCT01816503|Fentanyl|fentanyl
266133|NCT01816503|Fentanyl matrix|fentanyl matrix
266134|NCT01816503|Opioid analgesic|opioid analgesic
266135|NCT01816464|Influenza|influenza
266136|NCT01816464|Vaccination|vaccination
266137|NCT01816451|aerobic capacity|aerobic capacity
694600|NCT00944541|maraviroc|maraviroc
266138|NCT01816451|cardiorespiratory training|cardiorespiratory training
266139|NCT01816451|blood lactate concentration|blood lactate concentration
266140|NCT01816451|heart rate|heart rate
266141|NCT01816438|abnormal histological colorectal lesions|abnormal histological colorectal lesions
266142|NCT01816425|Dental Prosthesis|dental prosthesis
266143|NCT01816425|Dental Prosthesis Design|dental prosthesis design
266144|NCT01816412|Arms|arms
266145|NCT01816412|Experimental|experimental
266146|NCT01816412|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
266147|NCT01816412|Active Comparator|active comparator
266148|NCT01816412|Standard angioplasty balloon|standard angioplasty balloon
266149|NCT01816386|acupuncture|acupuncture
266150|NCT01816386|anaesthetic recovery|anaesthetic recovery
266151|NCT01816386|perioperative care|perioperative care
266152|NCT01816386|Age 18+|age 18+
266153|NCT01816386|ASA-score ≤ 2|asa-score ≤ 2
266154|NCT01816386|Surgery: Uterus|surgery: uterus
266155|NCT01816386|Surgery: Adnex|surgery: adnex
266156|NCT01816386|Surgery: Ovaries|surgery: ovaries
266157|NCT01816373|Chest wall; Chest, funnel; pectus excavatum; congenital abnormality|chest wall; chest, funnel; pectus excavatum; congenital abnormality
266158|NCT01816360|Womens health|womens health
266159|NCT01816360|Menopause|menopause
266160|NCT01816360|Complementary therapies|complementary therapies
266161|NCT01816360|Aromatherapy|aromatherapy
266162|NCT01816360|Essential oils|essential oils
266163|NCT01816360|Yogatherapy|yogatherapy
266164|NCT01816360|Psychoneuroendocrineimmunology|psychoneuroendocrineimmunology
266165|NCT01816334|sciatica|sciatica
266166|NCT01816334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
266167|NCT01816334|Glucocorticoids|glucocorticoids
266168|NCT01816308|AF|af
266169|NCT01816308|MCI|mci
266170|NCT01816282|TKR|tkr
266171|NCT01816282|Blood loss|blood loss
266172|NCT01816282|Fibrin Sealant|fibrin sealant
266173|NCT01816269|Helicobacter pylori|helicobacter pylori
266174|NCT01816269|Dental scaling|dental scaling
266175|NCT01816269|Eradication|eradication
266176|NCT01816269|Reinfection|reinfection
266177|NCT01816269|Helicobacter status|helicobacter status
266178|NCT01816243|Chronic Pain|chronic pain
266179|NCT01816243|Chronic Non-Malignant Pain|chronic non-malignant pain
266180|NCT01816243|TTS-fentanyl|tts-fentanyl
266181|NCT01816243|Durogesic|durogesic
266182|NCT01816217|Difficult intubation|difficult intubation
266183|NCT01816217|Complications|complications
266184|NCT01816217|Intensive care units|intensive care units
266185|NCT01816217|Videolaryngoscope|videolaryngoscope
266186|NCT01816217|Laryngoscopy|laryngoscopy
266187|NCT01816204|anxiety treatment|anxiety treatment
266188|NCT01816204|anxiety online treatment|anxiety online treatment
266189|NCT01816204|anxiety electronic treatment|anxiety electronic treatment
266190|NCT01816204|anxiety therapist assisted|anxiety therapist assisted
266191|NCT01816178|Autism spectrum Disorders|autism spectrum disorders
266192|NCT01816178|Voice Output Communication|voice output communication
266193|NCT01816165|diabetes|diabetes
266194|NCT01816165|insulin|insulin
266195|NCT01816165|blood vessel|blood vessel
266196|NCT01816165|type 1|type 1
266197|NCT01816152|light treatment|light treatment
266198|NCT01816152|circadian rhythms|circadian rhythms
266199|NCT01816152|sleep|sleep
266200|NCT01816152|agitation|agitation
266201|NCT01816152|depression|depression
266202|NCT01816139|vaginal dryness|vaginal dryness
266203|NCT01816139|vaginal atrophy|vaginal atrophy
266204|NCT01816139|estrogen|estrogen
266205|NCT01816113|PvDBP|pvdbp
266206|NCT01816113|Malaria|malaria
266207|NCT01816113|Plasmodium vivax|plasmodium vivax
266208|NCT01816100|multiple sclerosis|multiple sclerosis
266209|NCT01816100|exercise|exercise
266210|NCT01816100|MEG|meg
266211|NCT01816100|DTI|dti
266212|NCT01816100|Brain changes|brain changes
266213|NCT01816074|Mothers|mothers
266214|NCT01816074|ADHD|adhd
266215|NCT01816074|Treatment|treatment
266216|NCT01816074|Child|child
266217|NCT01816061|Veterans Health|veterans health
266218|NCT01816061|Social Adjustment|social adjustment
266219|NCT01816061|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
266220|NCT01816061|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
266221|NCT01816061|Independent Living|independent living
266222|NCT01816061|Goals|goals
266223|NCT01816061|Education|education
266224|NCT01816048|prostate, prostate cancer|prostate, prostate cancer
266225|NCT01816022|CMPN|cmpn
266226|NCT01816022|Fracture|fracture
266227|NCT01816022|Osteoporosis|osteoporosis
328727|NCT01539109|SCI|sci
256850|NCT01858324|Patient education|patient education
256851|NCT01858324|Educationnal tools|educationnal tools
256852|NCT01858324|Pamphlet|pamphlet
256853|NCT01858324|Video|video
256868|NCT01858285|Dravet|dravet
266228|NCT01816022|Biochemical Bone Markers|biochemical bone markers
266229|NCT01816009|infection|infection
266230|NCT01816009|antibiotic|antibiotic
266231|NCT01816009|prosthesis|prosthesis
266232|NCT01815996|Pregnancy|pregnancy
266233|NCT01815996|pulmonary embolism|pulmonary embolism
266234|NCT01815996|myocardial infarction|myocardial infarction
266235|NCT01815996|autoimmune disease|autoimmune disease
266236|NCT01815996|healthy controls|healthy controls
266237|NCT01815983|Laryngoscopy|laryngoscopy
266238|NCT01815983|Tracheal Intubation|tracheal intubation
266239|NCT01815983|Video Laryngoscopy|video laryngoscopy
266240|NCT01815970|dyspnea|dyspnea
266241|NCT01815970|exercise|exercise
266242|NCT01815970|neuromechanical uncoupling|neuromechanical uncoupling
266243|NCT01815970|COPD|copd
266244|NCT01815970|pulmonary rehabilitation|pulmonary rehabilitation
266245|NCT01815957|coronary microcirculation|coronary microcirculation
266246|NCT01815957|coronary artery disease|coronary artery disease
266247|NCT01815957|myocardial disease|myocardial disease
266248|NCT01815957|ischemia|ischemia
266249|NCT01815944|onset time|onset time
266250|NCT01815944|ultrasound-guided supraclavicular block|ultrasound-guided supraclavicular block
266251|NCT01815944|ropivacaine|ropivacaine
266252|NCT01815944|normal saline|normal saline
266253|NCT01815944|dextrose 5%|dextrose 5%
266254|NCT01815918|Orthopedic Procedures|orthopedic procedures
266255|NCT01815918|Prostheses and Implants|prostheses and implants
266256|NCT01815918|Joint Prosthesis|joint prosthesis
266257|NCT01815918|Knee Prosthesis|knee prosthesis
266258|NCT01815918|Arthroplasty, Knee|arthroplasty, knee
266259|NCT01815918|Thromboembolism|thromboembolism
266260|NCT01815918|Inflammation|inflammation
266261|NCT01815918|B-Cell Differentiation Factor-2|b-cell differentiation factor-2
266262|NCT01815918|Differentiation Factor-2, B-Cell|differentiation factor-2, b-cell
266263|NCT01815918|B-Cell Stimulatory Factor-2|b-cell stimulatory factor-2
266264|NCT01815918|BSF-2|bsf-2
266265|NCT01815918|IFN-beta 2|ifn-beta 2
266266|NCT01815918|MGI-2|mgi-2
266267|NCT01815918|Interleukin-6 (IL-6)|interleukin-6 (il-6)
266268|NCT01815918|Steroids|steroids
266269|NCT01815918|Pregnenediones|pregnenediones
266270|NCT01815918|Hydrocortisone|hydrocortisone
266271|NCT01815918|Physiological Effects of Drugs|physiological effects of drugs
266272|NCT01815918|Therapeutic Uses|therapeutic uses
266273|NCT01815892|Hemodialysis|hemodialysis
266274|NCT01815892|Response to Furosemide|response to furosemide
266275|NCT01815879|metastatic colorectal cancer|metastatic colorectal cancer
266276|NCT01815879|liver metastases|liver metastases
266277|NCT01815879|90Y resin microsphere radioembolization|90y resin microsphere radioembolization
266278|NCT01815879|retrospective data analysis|retrospective data analysis
266279|NCT01815866|Positive Nontuberculous Mycobacteria|positive nontuberculous mycobacteria
266280|NCT01815853|pre-operative,|pre-operative,
266281|NCT01815853|chemoradiotherapy,|chemoradiotherapy,
266282|NCT01815853|chemotherapy,|chemotherapy,
266284|NCT01815853|outcome|outcome
266285|NCT01815814|spasticity|spasticity
266286|NCT01815814|cerebral palsy|cerebral palsy
266287|NCT01815814|hemiplegia|hemiplegia
266288|NCT01815814|hemiparesis|hemiparesis
266289|NCT01815814|diplegia|diplegia
266290|NCT01815814|paraplegia|paraplegia
266291|NCT01815814|quadriplegia|quadriplegia
266292|NCT01815814|quadriparesis|quadriparesis
266293|NCT01815775|Normal pressure hydrocephalus|normal pressure hydrocephalus
266294|NCT01815775|flow MRI|flow mri
266295|NCT01815775|dementia|dementia
266296|NCT01815775|cerebrospinal fluid|cerebrospinal fluid
266297|NCT01815775|shunt|shunt
266298|NCT01815762|bioimpedance|bioimpedance
266299|NCT01815762|overhydration|overhydration
266300|NCT01815762|hemodialysis|hemodialysis
266301|NCT01815762|arterial stiffness|arterial stiffness
266302|NCT01815762|mortality|mortality
266303|NCT01815736|HIV|hiv
266304|NCT01815736|HIV 1 Infected|hiv 1 infected
266305|NCT01815736|Virologically-Suppressed|virologically-suppressed
266306|NCT01815723|Psoriasis|psoriasis
266307|NCT01815723|Dimethyl fumarate|dimethyl fumarate
266308|NCT01815723|Fumaderm®|fumaderm®
266309|NCT01815710|Clinical Pathways|clinical pathways
266310|NCT01815710|Knowledge translation|knowledge translation
266311|NCT01815710|Evaluation|evaluation
266312|NCT01815697|Lower Urinary Tract Symptoms|lower urinary tract symptoms
266313|NCT01815697|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
266314|NCT01815697|Urinary Retention|urinary retention
266315|NCT01815697|Vascular Endothelium|vascular endothelium
266316|NCT01815697|Counterpulsation, External|counterpulsation, external
266317|NCT01815684|Phase I|phase i
266318|NCT01815684|ASP3652|asp3652
266319|NCT01815684|Dose escalation|dose escalation
266320|NCT01815684|Maximum Tolerated Dose (MTD)|maximum tolerated dose (mtd)
266321|NCT01815671|colonoscopy|colonoscopy
266322|NCT01815671|technique|technique
266323|NCT01815671|tilt|tilt
266324|NCT01815671|insertion|insertion
266325|NCT01815671|safety|safety
266326|NCT01815671|efficacy|efficacy
266327|NCT01815645|Cocaine related disorders|cocaine related disorders
266328|NCT01815645|Contingency Management|contingency management
266329|NCT01815645|psychosocial treatment|psychosocial treatment
266330|NCT01815632|multiple sclerosis|multiple sclerosis
266331|NCT01815632|progressive MS|progressive ms
266332|NCT01815632|stem cell|stem cell
266333|NCT01815632|cell therapy|cell therapy
266334|NCT01815632|neurodegeneration|neurodegeneration
266335|NCT01815632|CNS repair|cns repair
266336|NCT01815606|Pancreas|pancreas
266339|NCT01815606|19Gauge|19gauge
266340|NCT01815606|25Gauge|25gauge
266344|NCT01815593|Counterpulsation, External|counterpulsation, external
266348|NCT01815567|Hypertension|hypertension
266349|NCT01815567|Retinal Disorder|retinal disorder
266350|NCT01815567|Cognitive impairment|cognitive impairment
266351|NCT01815554|Tetraplegia|tetraplegia
266352|NCT01815554|Spinal Cord Injury|spinal cord injury
266353|NCT01815554|Ventilator|ventilator
266354|NCT01815554|Diaphragmatic Pacing System|diaphragmatic pacing system
266355|NCT01815541|subcutaneous teicoplanin|subcutaneous teicoplanin
266356|NCT01815541|osteoarticular|osteoarticular
266357|NCT01815541|infections|infections
266358|NCT01815541|tolerance|tolerance
266359|NCT01815541|teicoplanin|teicoplanin
266360|NCT01815528|recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
266361|NCT01815515|Metastatic Prostate Cancer|metastatic prostate cancer
266362|NCT01815502|Single ventricle|single ventricle
266363|NCT01815502|Fontan|fontan
266364|NCT01815502|Sildenafil|sildenafil
266365|NCT01815502|Pressure-Volume Loops|pressure-volume loops
266366|NCT01815489|Necrotizing Pancreatitis|necrotizing pancreatitis
266367|NCT01815489|Pancreatitis|pancreatitis
266368|NCT01815489|Infection|infection
266369|NCT01815489|Bacteria|bacteria
266370|NCT01815489|Microbiology|microbiology
266371|NCT01815476|DCIS|dcis
266372|NCT01815476|Early Stage Invasive breast cancer|early stage invasive breast cancer
266373|NCT01815476|Prone breast radiotherapy|prone breast radiotherapy
266374|NCT01815463|stool|stool
266375|NCT01815463|monoclonal antibody|monoclonal antibody
266376|NCT01815463|Adnab-9|adnab-9
266377|NCT01815463|FOBT|fobt
266379|NCT01815463|iFOBT|ifobt
266380|NCT01815463|colonoscopy|colonoscopy
266381|NCT01815463|barium enema|barium enema
266382|NCT01815463|flexible sigmoidoscopy|flexible sigmoidoscopy
266383|NCT01815424|Tofacitinib|tofacitinib
266384|NCT01815424|CP-690|cp-690
266385|NCT01815424|550|550
266386|NCT01815424|Xeljanz|xeljanz
266387|NCT01815424|Jak-Inhibitor|jak-inhibitor
266388|NCT01815424|Oral Treatment|oral treatment
266389|NCT01815424|Psoriasis vulgaris|psoriasis vulgaris
266390|NCT01815424|Pruritus|pruritus
266391|NCT01815424|Itch|itch
266392|NCT01815424|DLQI|dlqi
266393|NCT01815424|moderate|moderate
266394|NCT01815424|severe|severe
266395|NCT01815424|chronic|chronic
266396|NCT01815424|plaque psoriasis|plaque psoriasis
266397|NCT01815411|Rheumatoid arthritis|rheumatoid arthritis
266398|NCT01815411|symptom score|symptom score
266399|NCT01815411|fatigue|fatigue
266400|NCT01815411|life quality|life quality
266401|NCT01815411|cytokines|cytokines
266402|NCT01815411|mRNA expression|mrna expression
266403|NCT01815411|Quality of Life|quality of life
266404|NCT01815411|Signs and Symptoms|signs and symptoms
266405|NCT01815411|Indication for Modification of Patient Physical Status|indication for modification of patient physical status
266406|NCT01815385|Term gestation|term gestation
266407|NCT01815385|Environmental exposure|environmental exposure
266408|NCT01815385|Benzo(a)pyrene|benzo(a)pyrene
266409|NCT01815385|Polycyclic aromatic hydrocarbons|polycyclic aromatic hydrocarbons
266410|NCT01815385|Adiposity|adiposity
266411|NCT01815385|Cytosine methylation|cytosine methylation
266412|NCT01815372|nerve blocks|nerve blocks
266413|NCT01815372|ultrasound-guided|ultrasound-guided
266414|NCT01815372|leg surgery|leg surgery
266415|NCT01815359|ICARuS|icarus
266416|NCT01815359|Intraperitoneal Chemotherapy|intraperitoneal chemotherapy
266417|NCT01815359|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
266418|NCT01815359|Optimal Surgical Debulking|optimal surgical debulking
266419|NCT01815359|Leucovorin|leucovorin
266420|NCT01815359|Floxuridine (FUDR)|floxuridine (fudr)
266421|NCT01815359|Mitomycin|mitomycin
266422|NCT01815359|12-289|12-289
266423|NCT01815346|Breast Cancer|breast cancer
266424|NCT01815346|Breast cancer survivors|breast cancer survivors
266547|NCT01814865|Stage I-IIIA|stage i-iiia
402979|NCT01228760|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
328971|NCT01538368|ERCP|ercp
266425|NCT01815346|Chronic, taxane-based chemotherapy-induced peripheral neuropathy|chronic, taxane-based chemotherapy-induced peripheral neuropathy
266426|NCT01815346|CIPN|cipn
266427|NCT01815346|Acupuncture treatments|acupuncture treatments
266428|NCT01815346|Quality of life|quality of life
266429|NCT01815346|Hand function|hand function
266430|NCT01815346|Balance|balance
266431|NCT01815346|Questionnaires|questionnaires
266432|NCT01815346|Surveys|surveys
266433|NCT01815333|Cancer of Lymph Node|cancer of lymph node
266434|NCT01815333|Magnetic resonance imaging|magnetic resonance imaging
266436|NCT01815333|Ultrasuperparamagnetic nanoparticle iron oxide|ultrasuperparamagnetic nanoparticle iron oxide
266437|NCT01815333|USPIO|uspio
266438|NCT01815333|Feraheme|feraheme
266439|NCT01815333|Ferumoxytole|ferumoxytole
266440|NCT01815320|Renal Transplant|renal transplant
266441|NCT01815320|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
266442|NCT01815320|Acute allograft rejection|acute allograft rejection
266443|NCT01815294|Ovarian cancer|ovarian cancer
266444|NCT01815294|Breast cancer|breast cancer
266445|NCT01815294|Solid malignancy|solid malignancy
266446|NCT01815294|Advanced or refractory solid malignancy|advanced or refractory solid malignancy
266447|NCT01815294|Metastatic cancer|metastatic cancer
266448|NCT01815294|DOXIL/CAELYX|doxil/caelyx
266449|NCT01815294|Doxorubicin HCL|doxorubicin hcl
266450|NCT01815294|Bioequivalence|bioequivalence
266451|NCT01815268|Randomized Controlled Trial|randomized controlled trial
266452|NCT01815268|Influenza|influenza
266453|NCT01815268|Influenza vaccine|influenza vaccine
266454|NCT01815268|Flu Vaccine|flu vaccine
266455|NCT01815268|Fluzone|fluzone
266456|NCT01815268|HD Fluzone|hd fluzone
266457|NCT01815268|Nursing Home|nursing home
266458|NCT01815268|Hospitalization|hospitalization
266459|NCT01815268|Mortality|mortality
266460|NCT01815268|Health Care worker vaccination|health care worker vaccination
266461|NCT01815268|ADL decline|adl decline
266462|NCT01815268|Effectiveness|effectiveness
266463|NCT01815268|Elderly|elderly
266464|NCT01815268|Morbidity|morbidity
266465|NCT01815268|Nursing Home resident|nursing home resident
266466|NCT01815268|Frail|frail
266467|NCT01815268|Institutionalized|institutionalized
266468|NCT01815268|Epidemiology|epidemiology
266469|NCT01815268|CDC|cdc
266470|NCT01815268|US|us
266471|NCT01815268|city|city
266472|NCT01815255|TDF-based regimen|tdf-based regimen
266473|NCT01815255|HIV-infected children|hiv-infected children
266474|NCT01815255|Thai|thai
266475|NCT01815255|generic|generic
266476|NCT01815255|safety and efficacy|safety and efficacy
266477|NCT01815255|renal status|renal status
266478|NCT01815255|To assess effect of TDF on renal problem in HIV-infected children receiving TDF-based once daily regimen|to assess effect of tdf on renal problem in hiv-infected children receiving tdf-based once daily regimen
266479|NCT01815255|To compare the effectiveness and clinical usefulness of different tools of adherence|to compare the effectiveness and clinical usefulness of different tools of adherence
266480|NCT01815229|endotracheal|endotracheal
266481|NCT01815229|intubation|intubation
266482|NCT01815216|Bariatric surgery|bariatric surgery
266483|NCT01815216|Cognition|cognition
266484|NCT01815216|Satiety hormones|satiety hormones
266485|NCT01815216|Brain networks|brain networks
266486|NCT01815216|Inhibitory control|inhibitory control
266487|NCT01815216|Food intake|food intake
266488|NCT01815203|Caffeine effects|caffeine effects
266489|NCT01815203|Inhibitory control|inhibitory control
266490|NCT01815190|immune complex vasculitis|immune complex vasculitis
266491|NCT01815190|cutaneous vasculitis|cutaneous vasculitis
266492|NCT01815190|IgA vasculitis|iga vasculitis
266493|NCT01815190|IgA nephropathy|iga nephropathy
266494|NCT01815138|OHSS, GnRH agonist trigger, low dose hCG, PCOS, IVF|ohss, gnrh agonist trigger, low dose hcg, pcos, ivf
266495|NCT01815125|Mild traumatic brain injury|mild traumatic brain injury
266496|NCT01815125|Brain concussion|brain concussion
266497|NCT01815125|Post-concussion syndrome|post-concussion syndrome
266498|NCT01815125|Emergency department|emergency department
266499|NCT01815125|Ondansetron|ondansetron
266500|NCT01815112|Neurodegenerative disease|neurodegenerative disease
266501|NCT01815112|Elderly|elderly
266502|NCT01815112|Dementia|dementia
266503|NCT01815112|FDG-PET|fdg-pet
266504|NCT01815112|MRI|mri
266505|NCT01815112|Neuroimaging|neuroimaging
266506|NCT01815086|Radioimmunoimaging|radioimmunoimaging
266507|NCT01815086|AL Amyloidosis|al amyloidosis
266508|NCT01815086|PET/CT|pet/ct
266509|NCT01815047|Vitamin D|vitamin d
266510|NCT01815047|Pregnancy|pregnancy
266511|NCT01815047|Inflammation|inflammation
266512|NCT01815047|Infection|infection
266513|NCT01815047|Placenta|placenta
266514|NCT01815047|Cytokine|cytokine
266515|NCT01815047|Microbiome|microbiome
266516|NCT01815008|Platelet aggregation|platelet aggregation
266517|NCT01815008|Clopidogrel|clopidogrel
266518|NCT01815008|Platelet transcriptome|platelet transcriptome
266519|NCT01814995|behavioural|behavioural
266520|NCT01814995|diabetes prevention|diabetes prevention
266521|NCT01814995|overweight|overweight
266522|NCT01814995|physical activity|physical activity
266523|NCT01814995|gestational diabetes|gestational diabetes
266524|NCT01814982|Traumatic brain injury|traumatic brain injury
266525|NCT01814982|JNJ-17299425|jnj-17299425
266526|NCT01814982|Intracranial pressure|intracranial pressure
266527|NCT01814982|Intravascular bolus injection|intravascular bolus injection
266528|NCT01814969|Rectal neoplasm|rectal neoplasm
266529|NCT01814969|Preoperative hyperfractionated radiotherapy|preoperative hyperfractionated radiotherapy
266530|NCT01814969|Preoperative hyperfractionated radiochemotherapy|preoperative hyperfractionated radiochemotherapy
266531|NCT01814943|Uncomplicated peptic ulcer|uncomplicated peptic ulcer
266532|NCT01814943|Acid-suppressing drugs|acid-suppressing drugs
266533|NCT01814943|Epidemiology|epidemiology
266534|NCT01814891|vitamin A|vitamin a
266535|NCT01814891|maize|maize
266536|NCT01814891|total body reserves|total body reserves
266537|NCT01814891|Condition is vitamin A status.|condition is vitamin a status.
266538|NCT01814891|Focus: change in vitamin A status with maize feeding.|focus: change in vitamin a status with maize feeding.
266539|NCT01814891|Focus: feeding orange maize to children for 90 days.|focus: feeding orange maize to children for 90 days.
266540|NCT01814891|Focus: total body reserves of vitamin A.|focus: total body reserves of vitamin a.
266541|NCT01814878|Pain, Postoperative|pain, postoperative
266542|NCT01814878|Tramadol Hydrochloride|tramadol hydrochloride
266543|NCT01814878|Acetaminophen|acetaminophen
266544|NCT01814878|Ultracet|ultracet
266545|NCT01814865|Post-menopausal|post-menopausal
266546|NCT01814865|ER+|er+
266548|NCT01814865|Operable|operable
266549|NCT01814865|Breast Cancer|breast cancer
266550|NCT01814852|Low Intensity Shockwave|low intensity shockwave
266551|NCT01814852|Extracorporeal shockwave therapy|extracorporeal shockwave therapy
266552|NCT01814852|Erectile dysfunction|erectile dysfunction
266553|NCT01814839|RNAi therapeutic|rnai therapeutic
266554|NCT01814826|MLN4924|mln4924
266555|NCT01814826|Acute|acute
266556|NCT01814826|Myelogenous|myelogenous
266557|NCT01814826|Leukemia|leukemia
266558|NCT01814800|PIDD, PID, humoral immunity, antibody deficiency|pidd, pid, humoral immunity, antibody deficiency
266559|NCT01814787|Type 2 Diabetes|type 2 diabetes
266560|NCT01814787|Pediatrics|pediatrics
266561|NCT01814787|Computerized Decision Support System|computerized decision support system
266562|NCT01814748|Diabetes Mellitus|diabetes mellitus
266563|NCT01814748|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
266564|NCT01814748|Glucose Metabolism Disorders|glucose metabolism disorders
266565|NCT01814748|Metabolic Diseases|metabolic diseases
266566|NCT01814748|Endocrine System Diseases|endocrine system diseases
266567|NCT01814748|Metformin|metformin
266568|NCT01814748|Hypoglycemic Agents|hypoglycemic agents
266569|NCT01814748|Pharmacologic Actions|pharmacologic actions
266570|NCT01814748|Therapeutic Uses|therapeutic uses
266571|NCT01814722|HIV Infections|hiv infections
266572|NCT01814722|Anti-HIV Agents|anti-hiv agents
266573|NCT01814722|Anti-Retroviral Agents|anti-retroviral agents
266574|NCT01814722|Nucleoside Reverse Transcriptase Inhibitors|nucleoside reverse transcriptase inhibitors
266575|NCT01814722|Non-nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
266576|NCT01814722|Protease inhibitors|protease inhibitors
266577|NCT01814696|Heart Failure|heart failure
266578|NCT01814696|Congestive Heart Failure|congestive heart failure
266579|NCT01814696|Medication Adherence|medication adherence
266580|NCT01814696|Medication Compliance|medication compliance
266581|NCT01814696|Telemedicine|telemedicine
266582|NCT01814696|Telehealth|telehealth
266583|NCT01814683|Vivax malaria|vivax malaria
266584|NCT01814683|Primaquine|primaquine
266585|NCT01814683|Placebo|placebo
266586|NCT01814683|Recurrence|recurrence
266587|NCT01814657|Infertility|infertility
266588|NCT01814605|Sciatic Nerve Block|sciatic nerve block
266785|NCT01813682|anemia|anemia
266589|NCT01814605|Subgluteal space|subgluteal space
266590|NCT01814605|Infragluteal space|infragluteal space
266591|NCT01814592|coronally positioned flap|coronally positioned flap
266592|NCT01814592|connective tissue|connective tissue
266593|NCT01814592|gingival margin|gingival margin
266594|NCT01814592|gingival recession/ treatment|gingival recession/ treatment
266595|NCT01814592|gingival recession/ surgery|gingival recession/ surgery
266596|NCT01814592|subepithelial connective tissue graft|subepithelial connective tissue graft
266597|NCT01814592|randomized controlled clinical trial|randomized controlled clinical trial
266598|NCT01814592|surgical flaps|surgical flaps
266599|NCT01814592|Treatment outcome|treatment outcome
266601|NCT01814579|cuff|cuff
266602|NCT01814579|robotic|robotic
266603|NCT01814579|hysterectomy|hysterectomy
266604|NCT01814579|vloc|vloc
266605|NCT01814579|v-loc|v-loc
266606|NCT01814579|vicryl|vicryl
266607|NCT01814579|unidirectional|unidirectional
266608|NCT01814579|barbed|barbed
266609|NCT01814579|suture|suture
266610|NCT01814527|Fish oil|fish oil
266611|NCT01814527|Omega 3 Fatty acids|omega 3 fatty acids
266612|NCT01814527|Docosahexaenoic acid|docosahexaenoic acid
266613|NCT01814527|Mild Concussion|mild concussion
266614|NCT01814527|Brain Concussion|brain concussion
266615|NCT01814527|Cerebral Concussion|cerebral concussion
266616|NCT01814514|hypertensive|hypertensive
266617|NCT01814514|phase|phase
266618|NCT01814514|success rate|success rate
266619|NCT01814514|AGV|agv
266620|NCT01814501|Metastatic colon cancer|metastatic colon cancer
266621|NCT01814488|Active acute leukemia|active acute leukemia
266622|NCT01814488|PIF|pif
266623|NCT01814488|Allogeneic transplant|allogeneic transplant
266624|NCT01814488|Acute Myeloid Leukemia|acute myeloid leukemia
266625|NCT01814488|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
266626|NCT01814488|Marrow Unrelated Donor|marrow unrelated donor
266627|NCT01814488|Cord Blood|cord blood
266628|NCT01814488|Family Haploidentical donor|family haploidentical donor
266629|NCT01814475|myelofibrosis|myelofibrosis
266630|NCT01814475|unfavourable prognostic factors|unfavourable prognostic factors
694693|NCT00948753|Maraviroc|maraviroc
266631|NCT01814475|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
266632|NCT01814475|Progression Free Survival|progression free survival
266633|NCT01814475|thrombocythemia vera|thrombocythemia vera
266634|NCT01814475|polycythemia vera|polycythemia vera
266635|NCT01814475|Reduced-intensity conditioning|reduced-intensity conditioning
266636|NCT01814462|Obstructive Sleep Apnea|obstructive sleep apnea
266637|NCT01814462|Pulse wave analysis|pulse wave analysis
266638|NCT01814449|Breast cancer|breast cancer
266639|NCT01814449|Hypoxia|hypoxia
266640|NCT01814449|Hypoxia related gene|hypoxia related gene
266641|NCT01814449|Endocrine therapy|endocrine therapy
266642|NCT01814449|Treatment resistance|treatment resistance
266643|NCT01814423|Plasmodium falciparum|plasmodium falciparum
266644|NCT01814423|malaria|malaria
266645|NCT01814423|chloroquine|chloroquine
266646|NCT01814423|pharmacokinetic|pharmacokinetic
266647|NCT01814423|children|children
266648|NCT01814410|Intravenous Ethanol|intravenous ethanol
266649|NCT01814410|Intravenous Nicotine|intravenous nicotine
266650|NCT01814410|Interactive effects|interactive effects
266651|NCT01814410|cognition|cognition
266652|NCT01814410|subjective effects|subjective effects
266653|NCT01814410|healthy subjects|healthy subjects
266654|NCT01814397|Aromatase inhibitor|aromatase inhibitor
266655|NCT01814397|Pain threshold|pain threshold
266656|NCT01814384|Ancillary tailored|ancillary tailored
266657|NCT01814384|medico-economic study,|medico-economic study,
266658|NCT01814384|total knee replacement|total knee replacement
266659|NCT01814384|primary or secondary osteoarthritis|primary or secondary osteoarthritis
266660|NCT01814371|Abscesses|abscesses
266661|NCT01814371|Furunculosis|furunculosis
266662|NCT01814371|Staphylococcus aureus colonization|staphylococcus aureus colonization
266663|NCT01814371|Staphylococcal Skin Infection|staphylococcal skin infection
266664|NCT01814371|MRSA|mrsa
266665|NCT01814345|Her2 testing (Human Epidermal Growth Factor Receptor 2)|her2 testing (human epidermal growth factor receptor 2)
266666|NCT01814332|Stress disorders, Post-traumatic|stress disorders, post-traumatic
266667|NCT01814332|Sleep|sleep
266668|NCT01814319|heart failure|heart failure
266669|NCT01814319|ejection fraction equal or less than 40%|ejection fraction equal or less than 40%
266794|NCT01813643|Aripiprazole|aripiprazole
266670|NCT01814306|LMA Supreme,LMA Proseal,airway management,prone position|lma supreme,lma proseal,airway management,prone position
266671|NCT01814293|Pediatric|pediatric
266672|NCT01814293|Upper Respiratory infection|upper respiratory infection
266673|NCT01814293|Over the Counter Drugs|over the counter drugs
266674|NCT01814293|Drugs, Non-Prescription|drugs, non-prescription
266675|NCT01814293|Vaporizer|vaporizer
266676|NCT01814280|Medication errors|medication errors
266677|NCT01814280|Medication review|medication review
266678|NCT01814280|Risk stratification|risk stratification
266679|NCT01814280|Patient safety|patient safety
266680|NCT01814267|innovative care|innovative care
266681|NCT01814267|telemedicine|telemedicine
266682|NCT01814267|cost effectiveness|cost effectiveness
266683|NCT01814267|diabetes|diabetes
266684|NCT01814241|Peanut allergy|peanut allergy
266685|NCT01814215|Obesity|obesity
266686|NCT01814215|Prevention and Control|prevention and control
266687|NCT01814215|Diet|diet
266688|NCT01814215|Motor Activity|motor activity
266689|NCT01814215|Intervention Studies|intervention studies
266690|NCT01814215|Child, Preschool|child, preschool
266691|NCT01814215|Child Care|child care
266692|NCT01814215|Food Habits|food habits
266693|NCT01814215|Feeding Behavior|feeding behavior
266694|NCT01814215|Child Behavior|child behavior
266695|NCT01814163|First line treatment|first line treatment
266696|NCT01814163|Non small cell lung cancer, non squamous|non small cell lung cancer, non squamous
266697|NCT01814150|Docetaxel|docetaxel
266698|NCT01814150|Alpha 1 Acid Glycoprotein|alpha 1 acid glycoprotein
266699|NCT01814150|Outcome|outcome
266700|NCT01814111|Hypertension|hypertension
266701|NCT01814111|Atrial Fibrillation|atrial fibrillation
266702|NCT01814111|Arrhythmias, Cardiac|arrhythmias, cardiac
266703|NCT01814111|Heart Diseases|heart diseases
266704|NCT01814111|Cardiovascular Diseases|cardiovascular diseases
266705|NCT01814098|Depressive Disorder, Major|depressive disorder, major
266706|NCT01814098|Escitalopram|escitalopram
266707|NCT01814098|Lexapro|lexapro
266708|NCT01814085|Major Depressive Disorder|major depressive disorder
266709|NCT01814085|Escitalopram|escitalopram
266710|NCT01814085|Lexapro|lexapro
266711|NCT01814059|Sirolimus|sirolimus
266712|NCT01814059|Eosinophilic Esophagitis|eosinophilic esophagitis
266713|NCT01814059|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
266714|NCT01814059|T -Cells|t -cells
266715|NCT01814059|Food Allergy|food allergy
266716|NCT01814046|Metastatic|metastatic
266717|NCT01814046|Ocular Melanoma|ocular melanoma
266718|NCT01814046|Autologous Tumor-Infiltrating Lymphocytes|autologous tumor-infiltrating lymphocytes
266719|NCT01814046|Uveal Melanoma|uveal melanoma
266720|NCT01814046|Adoptive Cell Therapy|adoptive cell therapy
266721|NCT01814033|LRU|lru
266722|NCT01814033|Total Knee Arthroplasty|total knee arthroplasty
266724|NCT01814033|Acute Rehabilitation Total Knee|acute rehabilitation total knee
266725|NCT01814033|Total Knee Range of Motion|total knee range of motion
266726|NCT01814033|Total Knee Acute care Outcomes|total knee acute care outcomes
266727|NCT01814020|DSO|dso
266728|NCT01814007|Lipolysis|lipolysis
266729|NCT01814007|Cryolipolysis|cryolipolysis
266730|NCT01814007|Fat Reduction|fat reduction
266731|NCT01813994|Statin; Gastric inflammation; Gastric cancer|statin; gastric inflammation; gastric cancer
266732|NCT01813968|Ischemic postconditioning|ischemic postconditioning
266733|NCT01813968|Adult cardiac surgery|adult cardiac surgery
266734|NCT01813968|Aortic valve surgery|aortic valve surgery
266735|NCT01813968|Swan-Ganz|swan-ganz
266736|NCT01813968|Cardiac index|cardiac index
266737|NCT01813955|phosphodiesterase inhibitor|phosphodiesterase inhibitor
266738|NCT01813955|Psychophysiology|psychophysiology
266739|NCT01813955|Cognition|cognition
266740|NCT01813955|Schizophrenia|schizophrenia
266741|NCT01813955|Papaverine|papaverine
266742|NCT01813942|clinical narrative report|clinical narrative report
266743|NCT01813942|time series data|time series data
266744|NCT01813942|missing value|missing value
266745|NCT01813929|Diabetes|diabetes
266746|NCT01813929|Insulin|insulin
266747|NCT01813929|Metformin|metformin
266748|NCT01813929|Vascular|vascular
266749|NCT01813929|Vessels|vessels
266750|NCT01813929|Type 1|type 1
266751|NCT01813916|Osteoarthritis|osteoarthritis
266752|NCT01813916|synovial fluid|synovial fluid
266753|NCT01813916|hyaluronic acid|hyaluronic acid
266754|NCT01813890|Bunionectomy|bunionectomy
266755|NCT01813890|Acute pain|acute pain
266756|NCT01813890|Post-operative pain|post-operative pain
266757|NCT01813890|Tapentadol IR|tapentadol ir
266758|NCT01813890|Analgesia|analgesia
266759|NCT01813890|Hallux valgus|hallux valgus
266760|NCT01813864|treatment planning|treatment planning
266761|NCT01813864|resource guide|resource guide
266762|NCT01813864|service matching|service matching
266763|NCT01813864|Service matching for substance abuse clients|service matching for substance abuse clients
266764|NCT01813864|CASPAR resource guide|caspar resource guide
266765|NCT01813864|Improved treatment planning|improved treatment planning
266766|NCT01813851|Dialysis, Exercise, Protein Energy Wasting, Nutrition and Physical Fitness|dialysis, exercise, protein energy wasting, nutrition and physical fitness
266767|NCT01813825|Mammosite|mammosite
266768|NCT01813799|Diabetic Neuropathies|diabetic neuropathies
266769|NCT01813734|RET gene mutation|ret gene mutation
266771|NCT01813721|Breast Cancer|breast cancer
266772|NCT01813721|Lung Cancer|lung cancer
266773|NCT01813708|Type 2 Diabetes|type 2 diabetes
266774|NCT01813708|Intensive Life-Style|intensive life-style
266775|NCT01813708|Collaborative Education|collaborative education
266776|NCT01813708|Clinical Trial|clinical trial
266777|NCT01813708|Metabolic Control|metabolic control
266778|NCT01813695|Preemptive genetic testing|preemptive genetic testing
266779|NCT01813695|Pain|pain
266780|NCT01813695|Pediatrics|pediatrics
266781|NCT01813695|Orthopedics|orthopedics
266782|NCT01813695|Pectus excavatum|pectus excavatum
266783|NCT01813695|Scoliosis|scoliosis
266784|NCT01813682|preterm infant|preterm infant
266786|NCT01813682|iron fortified TPN|iron fortified tpn
266787|NCT01813669|Childhood anxiety|childhood anxiety
266788|NCT01813669|Pediatric Pain|pediatric pain
266789|NCT01813669|Yoga|yoga
266790|NCT01813669|Cognitive behavioral therapy|cognitive behavioral therapy
266791|NCT01813656|Methamphetamine-Associated Psychosis|methamphetamine-associated psychosis
266792|NCT01813656|Aripiprazole|aripiprazole
266793|NCT01813643|Methamphetamine-Associated Psychosis|methamphetamine-associated psychosis
266795|NCT01813643|Risperidone|risperidone
266796|NCT01813630|Turner's Syndrome|turner's syndrome
266797|NCT01813630|Short Stature|short stature
266798|NCT01813630|Dwarfism|dwarfism
266799|NCT01813617|Polymyositis|polymyositis
266800|NCT01813617|Dermatomyositis|dermatomyositis
266801|NCT01813617|Muscle endurance|muscle endurance
266802|NCT01813617|Muscle stength|muscle stength
266803|NCT01813617|Outcome|outcome
266804|NCT01813604|Polio|polio
266805|NCT01813604|Inactivated polio vaccine|inactivated polio vaccine
266806|NCT01813604|oral polio vaccine|oral polio vaccine
266807|NCT01813604|vaccine trial|vaccine trial
257446|NCT01856036|Estrogen Receptor Positive|estrogen receptor positive
257447|NCT01856036|her2neu negative|her2neu negative
266808|NCT01813591|Chronic Migraine|chronic migraine
266809|NCT01813591|Headache|headache
266810|NCT01813591|Refractory Chronic Migraine|refractory chronic migraine
266811|NCT01813578|Systemic sclerosis|systemic sclerosis
266812|NCT01813578|Exercise|exercise
266813|NCT01813578|Physical capacity|physical capacity
266814|NCT01813578|Aerobic capacity|aerobic capacity
266815|NCT01813578|Muscle function|muscle function
266816|NCT01813578|Fatigue|fatigue
266817|NCT01813552|HCV|hcv
266818|NCT01813552|Hepatitis C|hepatitis c
266819|NCT01813552|antiviral drugs|antiviral drugs
266820|NCT01813552|liver|liver
266822|NCT01813513|HCV|hcv
266823|NCT01813513|Hepatitis C Virus|hepatitis c virus
266824|NCT01813513|Hepatitis C|hepatitis c
266825|NCT01813513|antiviral drugs|antiviral drugs
266826|NCT01813513|liver|liver
266827|NCT01813474|Cancer|cancer
266828|NCT01813474|Tumour|tumour
266829|NCT01813474|Solid Malignancies|solid malignancies
266830|NCT01813461|BAL8557|bal8557
266831|NCT01813461|14C-labeled isavuconazole|14c-labeled isavuconazole
266832|NCT01813461|14C-labeled prodrug isavuconazonium sulfate (BAL8557)/([cyano-14C]ASP9766 sulfate)|14c-labeled prodrug isavuconazonium sulfate (bal8557)/([cyano-14c]asp9766 sulfate)
266833|NCT01813448|Fidaxomicin|fidaxomicin
266834|NCT01813448|OPT-80|opt-80
266835|NCT01813448|Healthy Subjects|healthy subjects
266836|NCT01813435|CAD|cad
266837|NCT01813435|ACS|acs
266838|NCT01813435|All comers|all comers
266839|NCT01813435|DAPT|dapt
266840|NCT01813435|PCI|pci
266841|NCT01813422|Cholesterol|cholesterol
266842|NCT01813422|High Cholesterol|high cholesterol
266843|NCT01813422|Elevated Cholesterol|elevated cholesterol
266844|NCT01813422|Raised Cholesterol|raised cholesterol
266845|NCT01813396|shoulder|shoulder
266846|NCT01813396|muscle stiffness|muscle stiffness
266847|NCT01813396|shoulder physical activity|shoulder physical activity
266848|NCT01813396|range of motion|range of motion
266849|NCT01813396|joint mobility|joint mobility
266850|NCT01813383|Celiac disease|celiac disease
266851|NCT01813383|HLA-DQ2.2|hla-dq2.2
266852|NCT01813383|HLA-DQ2.5|hla-dq2.5
266853|NCT01813383|HLA-DR7-DQ2|hla-dr7-dq2
266854|NCT01813383|HLA-DR3-DQ2|hla-dr3-dq2
266855|NCT01813370|TAX 3503|tax 3503
266856|NCT01813370|MSKCC IRB#07-101|mskcc irb#07-101
266857|NCT01813370|12-225|12-225
266858|NCT01813357|HIV|hiv
266859|NCT01813357|Cardiovascular disease|cardiovascular disease
266860|NCT01813357|Inflammation|inflammation
266861|NCT01813357|Statin|statin
266862|NCT01813344|Adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
266863|NCT01813344|Hyper-CVAD|hyper-cvad
266864|NCT01813344|first-line treatment|first-line treatment
266865|NCT01813305|Diabetic Foot Ulcer|diabetic foot ulcer
266866|NCT01813305|Diabetes Mellitus|diabetes mellitus
266867|NCT01813305|Debridement|debridement
266868|NCT01813305|Standard of Care|standard of care
266869|NCT01813305|wounds|wounds
266870|NCT01813292|male patients|male patients
266871|NCT01813292|treated by TRUVADA® or VIREAD® for more than 60 months|treated by truvada® or viread® for more than 60 months
266872|NCT01813253|epidermal growth factor receptor|epidermal growth factor receptor
266873|NCT01813253|second line|second line
266874|NCT01813214|melanoma|melanoma
266875|NCT01813214|vemurafenib|vemurafenib
266876|NCT01813214|cobitmetinib|cobitmetinib
266877|NCT01813201|Testosterone|testosterone
266878|NCT01813201|Anabolic deterioration|anabolic deterioration
266879|NCT01813188|Fractures|fractures
266880|NCT01813188|Bone|bone
266881|NCT01813188|Stem Cells|stem cells
266882|NCT01813149|Complex Regional Pain Syndrome (CRPS)|complex regional pain syndrome (crps)
266883|NCT01813136|radioiodine refractory Differentiated Thyroid Carcinoma|radioiodine refractory differentiated thyroid carcinoma
266884|NCT01813136|pazopanib|pazopanib
266885|NCT01813136|intermittent administration|intermittent administration
266886|NCT01813136|time to treatment failure|time to treatment failure
266887|NCT01813136|TUTHYREF|tuthyref
266888|NCT01813123|gender-specific|gender-specific
266889|NCT01813123|web-based|web-based
266890|NCT01813123|drug abuse|drug abuse
266891|NCT01813123|prevention|prevention
266892|NCT01813110|inflammation|inflammation
266893|NCT01813110|omega-3|omega-3
266894|NCT01813110|fish oil|fish oil
266895|NCT01813097|To detective the effect of the treatment of combination iodine 125 seed implants and LHRH agonists for the patients with locally advanced prostate cancer.|to detective the effect of the treatment of combination iodine 125 seed implants and lhrh agonists for the patients with locally advanced prostate cancer.
266896|NCT01813071|Enterobacteriaceae Infections|enterobacteriaceae infections
266897|NCT01813071|Gram-Negative Bacterial Infections|gram-negative bacterial infections
266898|NCT01813071|Bacterial Infections|bacterial infections
266900|NCT01813071|Gastrointestinal Diseases|gastrointestinal diseases
266901|NCT01813071|Digestive System Diseases|digestive system diseases
266902|NCT01813071|Intestinal Diseases|intestinal diseases
257545|NCT01855451|HPV|hpv
266903|NCT01813071|Shigellosis|shigellosis
266904|NCT01813058|Tranexamic acid, Blood loss|tranexamic acid, blood loss
266905|NCT01813045|Angiogenesis|angiogenesis
266906|NCT01813045|Fibrosis|fibrosis
266907|NCT01813045|Myocardial Infarction|myocardial infarction
266908|NCT01813045|Imaging|imaging
266909|NCT01813045|CT-PET|ct-pet
266910|NCT01813045|PET-CT|pet-ct
266911|NCT01813045|Cardiac MRI|cardiac mri
266912|NCT01813032|firefighters|firefighters
266913|NCT01813032|police officers|police officers
266914|NCT01813032|emergency service professionals|emergency service professionals
266915|NCT01813032|myocardial infarction|myocardial infarction
266916|NCT01813032|endothelial function|endothelial function
266917|NCT01813032|thrombosis|thrombosis
586543|NCT00516659|epidemiology ETEC|epidemiology etec
266918|NCT01813019|Obsessive compulsive disorder (OCD), obsessive fears, obsessions,|obsessive compulsive disorder (ocd), obsessive fears, obsessions,
266919|NCT01813019|compulsions, OCD SSRI resistant|compulsions, ocd ssri resistant
266920|NCT01812993|Ischemic stroke, sleep apnea, non-invasive ventilatory treatment|ischemic stroke, sleep apnea, non-invasive ventilatory treatment
266921|NCT01812980|Influenza|influenza
266922|NCT01812980|Human Immunodeficiency Virus|human immunodeficiency virus
266923|NCT01812954|moderate-to-severe psoriasis|moderate-to-severe psoriasis
266924|NCT01812954|cost utility analysis|cost utility analysis
267217|NCT01811680|Hemiplegia|hemiplegia
266925|NCT01812954|cost effectiveness analysis|cost effectiveness analysis
266926|NCT01812954|systemic treatment|systemic treatment
266927|NCT01812941|burns|burns
266928|NCT01812941|trauma|trauma
266929|NCT01812928|Flexible Cystoscopy|flexible cystoscopy
266930|NCT01812928|Pain control|pain control
266931|NCT01812928|Diclofenac|diclofenac
266932|NCT01812928|Non steroidal anti inflammatory drug|non steroidal anti inflammatory drug
266933|NCT01812915|Cuff pressure|cuff pressure
266934|NCT01812915|Cylindrical cuff|cylindrical cuff
266935|NCT01812915|Endotracheal tube|endotracheal tube
266936|NCT01812915|Nitrous oxide|nitrous oxide
266937|NCT01812915|Tapered cuff|tapered cuff
266938|NCT01812902|Prostate cancer|prostate cancer
266939|NCT01812902|Prostate specific antigen|prostate specific antigen
266940|NCT01812902|lymphadenectomy|lymphadenectomy
266941|NCT01812902|Limited lymphadenectomy|limited lymphadenectomy
266942|NCT01812902|Extended lymphadenectomy|extended lymphadenectomy
266943|NCT01812902|Immunohistochemistry|immunohistochemistry
266944|NCT01812889|bacterial vaginosis, vulvovaginal candidiasis, TOL-463, intravaginal therapy, vaginitis, women, cross-over|bacterial vaginosis, vulvovaginal candidiasis, tol-463, intravaginal therapy, vaginitis, women, cross-over
266945|NCT01812863|Pain Management|pain management
266946|NCT01812863|Child|child
266947|NCT01812863|Surgery|surgery
266948|NCT01812850|Temporomandibular joint|temporomandibular joint
266949|NCT01812850|Orofacial muscular complex|orofacial muscular complex
266950|NCT01812850|Bruxism|bruxism
266951|NCT01812850|Clenching|clenching
266952|NCT01812850|Orthodontic treatment|orthodontic treatment
266953|NCT01812850|Invisalign®|invisalign®
266954|NCT01812837|actinic keratosis|actinic keratosis
266955|NCT01812837|microneedles|microneedles
266956|NCT01812837|photodynamic therapy|photodynamic therapy
266957|NCT01812837|levulan|levulan
266958|NCT01812837|Aminolevulinic acid|aminolevulinic acid
266959|NCT01812824|Preconception Health|preconception health
266960|NCT01812824|Health Information Technology|health information technology
266961|NCT01812824|Reproductive Life Plan|reproductive life plan
266962|NCT01812824|Healthcare Disparities|healthcare disparities
266963|NCT01812824|Low birth-weight|low birth-weight
266964|NCT01812824|Preterm Delivery|preterm delivery
266965|NCT01812811|pulse wave analysis|pulse wave analysis
266966|NCT01812811|pulse wave velocity|pulse wave velocity
266967|NCT01812811|Arteriograph24|arteriograph24
266968|NCT01812811|Ambulatory|ambulatory
266969|NCT01812811|diabetes|diabetes
266970|NCT01812811|reproducibility|reproducibility
266971|NCT01812811|diurnal variation|diurnal variation
266972|NCT01812798|Peanut allergy|peanut allergy
266973|NCT01812798|Threshold|threshold
266974|NCT01812798|Modelling|modelling
266975|NCT01812798|Risk assessment|risk assessment
266976|NCT01812785|Fever|fever
266977|NCT01812785|Children|children
267373|NCT01810926|MRD|mrd
266978|NCT01812785|Non-malaria fevers|non-malaria fevers
266979|NCT01812785|Diagnosis|diagnosis
266980|NCT01812772|urinary stents|urinary stents
266981|NCT01812772|ureteroscopy|ureteroscopy
266982|NCT01812759|Pain|pain
266983|NCT01812759|Breakthrough cancer pain|breakthrough cancer pain
266984|NCT01812759|Emergency Department|emergency department
266985|NCT01812759|ED|ed
266986|NCT01812759|Fentanyl nasal spray|fentanyl nasal spray
266987|NCT01812759|Lazanda|lazanda
266988|NCT01812759|Placebo nasal spray|placebo nasal spray
266770|NCT01813721|NHL|nhl
266989|NCT01812759|Hydromorphone PCA|hydromorphone pca
266990|NCT01812759|Dilaudid|dilaudid
266991|NCT01812694|Pregnancy|pregnancy
266992|NCT01812694|Weight Control|weight control
266993|NCT01812694|Weight Gain|weight gain
402980|NCT01228760|ASG-5ME|asg-5me
266994|NCT01812681|vitamin D, Respiratory distress syndrome, sepsis, preterm|vitamin d, respiratory distress syndrome, sepsis, preterm
266995|NCT01812655|pain|pain
266996|NCT01812655|anxiety|anxiety
266997|NCT01812655|children|children
266998|NCT01812655|adolescents|adolescents
266999|NCT01812655|burn|burn
267000|NCT01812655|virtual reality|virtual reality
267001|NCT01812655|distraction|distraction
267002|NCT01812642|Schizophrenia|schizophrenia
267003|NCT01812642|JNJ-37822681|jnj-37822681
267004|NCT01812642|Placebo|placebo
267005|NCT01812616|Cancer|cancer
267006|NCT01812616|Safety|safety
267007|NCT01812603|Cancer|cancer
267008|NCT01812603|Safety|safety
267009|NCT01812564|Platelet rich plasma|platelet rich plasma
267010|NCT01812564|Interventional|interventional
267011|NCT01812564|Randomized|randomized
267012|NCT01812564|Double-blind|double-blind
267013|NCT01812551|cystic fibrosis|cystic fibrosis
267014|NCT01812551|children|children
267015|NCT01812551|adolescents|adolescents
267016|NCT01812551|low bone mass|low bone mass
267017|NCT01812551|osteoporosis|osteoporosis
267018|NCT01812551|alendronate|alendronate
267019|NCT01812551|fractures|fractures
267020|NCT01812525|Bronchiolitis|bronchiolitis
267021|NCT01812525|Moderate to Severe|moderate to severe
267022|NCT01812525|Hypertonic saline|hypertonic saline
267023|NCT01812525|NaCl 3% inhalations|nacl 3% inhalations
267024|NCT01812525|Standard therapy|standard therapy
267025|NCT01812525|Wang score|wang score
267026|NCT01812525|in-patients|in-patients
267027|NCT01812512|Heart Failure|heart failure
267028|NCT01812512|Communication|communication
267029|NCT01812512|Telemedicine|telemedicine
267030|NCT01812512|Veterans|veterans
267031|NCT01812512|Nurse-patient relations|nurse-patient relations
267032|NCT01812499|blood transfusion|blood transfusion
267033|NCT01812499|adverse event|adverse event
267034|NCT01812499|incident reporting|incident reporting
267035|NCT01812473|protein binding|protein binding
267036|NCT01812473|voriconazole|voriconazole
267037|NCT01812473|pediatrics|pediatrics
267038|NCT01812473|hematology|hematology
267039|NCT01812473|intensive care|intensive care
267040|NCT01812473|albumin|albumin
267041|NCT01812473|alpha-1-acid-glycoprotein|alpha-1-acid-glycoprotein
267042|NCT01812460|COPD|copd
267043|NCT01812460|muscle strength|muscle strength
267044|NCT01812460|resistance training|resistance training
267045|NCT01812460|Physiotherapi|physiotherapi
267046|NCT01812460|m. quadriceps|m. quadriceps
267047|NCT01812460|Acute exacerbation|acute exacerbation
267048|NCT01812447|Endobronchial Valves|endobronchial valves
267049|NCT01812447|Intrabronchial Valves|intrabronchial valves
267050|NCT01812447|Bronchial Valve|bronchial valve
267051|NCT01812447|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
267052|NCT01812447|COPD|copd
267053|NCT01812447|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
267054|NCT01812447|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
267055|NCT01812447|BLVR|blvr
267056|NCT01812447|TLVR|tlvr
267057|NCT01812447|Emphysema|emphysema
267058|NCT01812447|Pulmonary Emphysema|pulmonary emphysema
267059|NCT01812447|Pathologic Process|pathologic process
267060|NCT01812447|Lung Diseases|lung diseases
267061|NCT01812447|Respiratory Tract Disease|respiratory tract disease
267062|NCT01812395|thyroidectomy|thyroidectomy
267063|NCT01812395|ultrasonic dissector|ultrasonic dissector
267064|NCT01812395|harmonic focus device|harmonic focus device
267065|NCT01812395|superior laryngeal nerve|superior laryngeal nerve
267066|NCT01812382|Penetration|penetration
267067|NCT01812382|Antibiotic|antibiotic
267068|NCT01812382|Microdialysis|microdialysis
267069|NCT01812382|Formulation Pharmacokinetics|formulation pharmacokinetics
267070|NCT01812382|Feasibility|feasibility
267071|NCT01812356|Atrial fibrillation|atrial fibrillation
267072|NCT01812356|maze operation|maze operation
267073|NCT01812356|cryoablation|cryoablation
267074|NCT01812343|Ankle Brachial Index|ankle brachial index
267075|NCT01812343|Maximal Exercise Test|maximal exercise test
267076|NCT01812330|ACS|acs
267077|NCT01812330|CR|cr
267078|NCT01812330|PCI|pci
267079|NCT01812330|Platelet funtion|platelet funtion
267080|NCT01812330|Ticagrelor|ticagrelor
267081|NCT01812317|firefighters|firefighters
267082|NCT01812317|fire-simulation training|fire-simulation training
267083|NCT01812317|myocardial infarction|myocardial infarction
267084|NCT01812317|endothelial function|endothelial function
267085|NCT01812317|thrombosis|thrombosis
267086|NCT01812291|Major Depression|major depression
267087|NCT01812291|Minor Depression|minor depression
267088|NCT01812291|Sub-Threshold Depression|sub-threshold depression
267089|NCT01812291|Affective Condition|affective condition
267090|NCT01812291|Mood Disorder|mood disorder
267091|NCT01812291|Light Affective Disorder|light affective disorder
267092|NCT01812291|Subclinical Depressive Symptoms|subclinical depressive symptoms
267093|NCT01812291|Diabetes Mellitus|diabetes mellitus
267094|NCT01812291|Diabetes-Related Distress|diabetes-related distress
257747|NCT01854775|HIV-1|hiv-1
267095|NCT01812291|Self-Care Behaviour|self-care behaviour
267096|NCT01812291|Glycaemic Control|glycaemic control
267097|NCT01812291|Inflammatory Markers|inflammatory markers
267098|NCT01812252|myelodysplastic syndrome|myelodysplastic syndrome
267099|NCT01812252|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
267100|NCT01812252|bone marrow transplant|bone marrow transplant
267101|NCT01812252|hypomethylating agent|hypomethylating agent
267102|NCT01812252|induction chemotherapy|induction chemotherapy
267103|NCT01812239|premature birth|premature birth
267105|NCT01812239|short cervix|short cervix
267106|NCT01812213|Mild Cognitive Impairment|mild cognitive impairment
267107|NCT01812187|Alcohol|alcohol
267108|NCT01812187|Alcohol Abuse|alcohol abuse
267109|NCT01812187|Alcohol Dependence|alcohol dependence
267110|NCT01812187|Veterans|veterans
267111|NCT01812174|heart valve|heart valve
267112|NCT01812161|Electro-acupuncture|electro-acupuncture
267113|NCT01812161|HCG stimulation test|hcg stimulation test
267114|NCT01812161|Menstrual frequency|menstrual frequency
267115|NCT01812161|polycystic ovary syndrome|polycystic ovary syndrome
267116|NCT01812161|Randomized|randomized
267117|NCT01812161|controlled|controlled
267118|NCT01812161|trial|trial
267119|NCT01812148|Peritoneal Mesotheliomas|peritoneal mesotheliomas
267120|NCT01812148|hyperthermic intra-peritoneal chemotherapy (HIPEC)|hyperthermic intra-peritoneal chemotherapy (hipec)
267121|NCT01812148|Oxaliplatin|oxaliplatin
267122|NCT01812148|Cytoreductive surgery|cytoreductive surgery
267123|NCT01812148|Oxaliplatin HIPEC|oxaliplatin hipec
267124|NCT01812109|Acute Scrotum|acute scrotum
267125|NCT01812109|Testicular Torsion|testicular torsion
267423|NCT01810705|myeloid|myeloid
267126|NCT01812096|multiple myeloma|multiple myeloma
267127|NCT01812096|bortezomib|bortezomib
267128|NCT01812096|Subcutaneous|subcutaneous
267129|NCT01812083|Periodontitis; adverse pregnancy outcomes; IL-1 polymorphism|periodontitis; adverse pregnancy outcomes; il-1 polymorphism
267130|NCT01812070|smoking cessation|smoking cessation
267131|NCT01812070|quit smoking|quit smoking
267132|NCT01812057|Anesthesia|anesthesia
267133|NCT01812057|Cesarean Section|cesarean section
267134|NCT01812057|Pain, Postoperative|pain, postoperative
267135|NCT01812057|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
267136|NCT01812057|Dexamethasone|dexamethasone
267137|NCT01812057|Injections, Spinal|injections, spinal
267138|NCT01812057|morphine|morphine
267139|NCT01812031|PET/CT|pet/ct
267140|NCT01812031|18F-fluoro-2-deoxyglucose|18f-fluoro-2-deoxyglucose
267141|NCT01812031|lung neoplasms|lung neoplasms
267142|NCT01812031|respiratory motion|respiratory motion
267143|NCT01812018|Soft Tissue Sarcoma|soft tissue sarcoma
267144|NCT01812018|Pulmonary metastases|pulmonary metastases
267145|NCT01812005|MLN8237|mln8237
267146|NCT01812005|B-cell Non Hodgkin Lymphoma|b-cell non hodgkin lymphoma
267147|NCT01812005|Rituximab|rituximab
267148|NCT01811979|eye examination, oral sucrose, premature infant pain scale|eye examination, oral sucrose, premature infant pain scale
267149|NCT01811966|preoperative volume substitution|preoperative volume substitution
267150|NCT01811966|hypovolemia|hypovolemia
267151|NCT01811966|preoperative fasting|preoperative fasting
267152|NCT01811940|cocaine dependence|cocaine dependence
267153|NCT01811940|adderall|adderall
267154|NCT01811940|topiramate|topiramate
267155|NCT01811914|focused TTE|focused tte
267156|NCT01811914|intraoperative TTE|intraoperative tte
267157|NCT01811914|transthoracic echocardiography|transthoracic echocardiography
267158|NCT01811914|high risk non-cardiac surgery|high risk non-cardiac surgery
267159|NCT01811914|hemodynamic instabilities|hemodynamic instabilities
267160|NCT01811901|inhospital delays, door-to-needle time, thrombolysis, acute ischemic stroke, SITS, SITS-WATCH, stroke registry|inhospital delays, door-to-needle time, thrombolysis, acute ischemic stroke, sits, sits-watch, stroke registry
267161|NCT01811875|Haemophilia A|haemophilia a
267162|NCT01811862|Acupuncture|acupuncture
267163|NCT01811862|Hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
267164|NCT01811862|13-038|13-038
267165|NCT01811849|diabetes|diabetes
267166|NCT01811823|Tuberculosis|tuberculosis
267167|NCT01811823|HIV infection|hiv infection
267676|NCT01809483|bandage contact lens|bandage contact lens
267168|NCT01811823|Immune responses to Influenza vaccination|immune responses to influenza vaccination
267169|NCT01811810|Men under the age of 75 with histologically confirmed high risk|men under the age of 75 with histologically confirmed high risk
267170|NCT01811797|Erectile Dysfunction|erectile dysfunction
267171|NCT01811797|Extracorporeal shockwave|extracorporeal shockwave
267172|NCT01811797|Low intensity shockwaves|low intensity shockwaves
267173|NCT01811784|Nipah virus infection|nipah virus infection
267174|NCT01811784|date palm sap|date palm sap
267175|NCT01811784|community intervention|community intervention
267176|NCT01811784|capacity building|capacity building
267177|NCT01811784|disease prevention|disease prevention
267178|NCT01811784|Bangladesh|bangladesh
267179|NCT01811784|Healthy Community people|healthy community people
267180|NCT01811784|Sap harvesters|sap harvesters
329991|NCT01533701|pH|ph
267181|NCT01811784|Date palm three owners|date palm three owners
267182|NCT01811784|Date palm sap consumers|date palm sap consumers
267183|NCT01811758|Culturally Specific Cognitive Behavioral Therapy|culturally specific cognitive behavioral therapy
267184|NCT01811758|Standard Cognitive Behavioral Therapy|standard cognitive behavioral therapy
267186|NCT01811745|Cognition|cognition
267187|NCT01811745|Exercise|exercise
267188|NCT01811745|Falls|falls
267189|NCT01811745|Gait|gait
267190|NCT01811745|Physical function|physical function
267191|NCT01811745|Dual-task|dual-task
267192|NCT01811745|Music|music
267193|NCT01811745|Postural Balance|postural balance
267194|NCT01811745|Randomized controlled trial|randomized controlled trial
267195|NCT01811732|Bacterial skin infection|bacterial skin infection
267196|NCT01811732|skin infection|skin infection
267197|NCT01811732|infection|infection
267198|NCT01811732|skin|skin
267199|NCT01811732|delafloxacin|delafloxacin
267200|NCT01811732|vancomycin|vancomycin
267201|NCT01811732|aztreonam|aztreonam
267202|NCT01811732|MRSA bacteria|mrsa bacteria
267203|NCT01811732|bacterial infection|bacterial infection
267204|NCT01811732|Anti-Infective Agents|anti-infective agents
267205|NCT01811732|Anti-Bacterial Agents|anti-bacterial agents
267206|NCT01811719|Intimate Partner Physical Violence|intimate partner physical violence
267207|NCT01811719|Intimate Partner Emotional Abuse|intimate partner emotional abuse
267208|NCT01811719|Intimate Partner Controlling Behaivor|intimate partner controlling behaivor
267209|NCT01811719|Pregnancy Outcomes|pregnancy outcomes
267210|NCT01811719|Quality of Parental Care Giving|quality of parental care giving
267211|NCT01811719|Maternal Life Course|maternal life course
267212|NCT01811693|Stroke|stroke
267213|NCT01811693|Intracerebral Hemorrhage|intracerebral hemorrhage
267214|NCT01811693|Prehospital|prehospital
267215|NCT01811693|Antihypertensive|antihypertensive
267216|NCT01811680|Stroke|stroke
267218|NCT01811680|Variable automated treadmill treadmill|variable automated treadmill treadmill
267219|NCT01811667|Vascular Abnormalities|vascular abnormalities
267220|NCT01811654|Patellofemoral|patellofemoral
267221|NCT01811654|Hyaluronan|hyaluronan
267222|NCT01811654|Intra-articular|intra-articular
267223|NCT01811654|Hyaluronic acid|hyaluronic acid
267224|NCT01811641|season of conception|season of conception
267225|NCT01811641|maternal nutritional status|maternal nutritional status
267226|NCT01811641|infant DNA methylation|infant dna methylation
267227|NCT01811628|Cancer Prevention|cancer prevention
267228|NCT01811628|Tobacco Use Cessation|tobacco use cessation
267229|NCT01811628|Smokers|smokers
267230|NCT01811628|Recent quitters|recent quitters
267231|NCT01811628|Latino|latino
267232|NCT01811628|Hispanic|hispanic
267233|NCT01811628|Information|information
267234|NCT01811628|Interview|interview
267235|NCT01811628|Questionnaire|questionnaire
267236|NCT01811628|Survey|survey
267237|NCT01811628|Audio-recorded|audio-recorded
267238|NCT01811602|Training|training
267239|NCT01811602|Physiotherapy|physiotherapy
267240|NCT01811602|Pelvic floor muscles|pelvic floor muscles
267241|NCT01811589|ventricular catheter, hydrocephalus, shunt, brain disease|ventricular catheter, hydrocephalus, shunt, brain disease
267242|NCT01811576|Growth hormone deficiency|growth hormone deficiency
267243|NCT01811576|Insulin-like growth factor I (IGF-I)|insulin-like growth factor i (igf-i)
267244|NCT01811576|TV-1106|tv-1106
267245|NCT01811563|Total Knee Replacement|total knee replacement
267246|NCT01811563|Lower Quarter Y-Balance Test|lower quarter y-balance test
267247|NCT01811563|Functional Outcomes|functional outcomes
267248|NCT01811563|Patient Reported Outcomes|patient reported outcomes
267249|NCT01811537|Artificial Chordae|artificial chordae
267250|NCT01811537|Mitral Valve Repair|mitral valve repair
267251|NCT01811524|Brain tumor|brain tumor
267252|NCT01811524|Glioma|glioma
267253|NCT01811524|Meningioma|meningioma
267254|NCT01811524|Diagnosis|diagnosis
267255|NCT01811524|Prognosis|prognosis
267256|NCT01811524|Heredity|heredity
267257|NCT01811472|Multi-center,|multi-center,
267258|NCT01811472|randomized,|randomized,
267259|NCT01811472|double-blind,|double-blind,
267260|NCT01811472|NAFLD,|nafld,
267261|NCT01811472|elevated triglycerides|elevated triglycerides
267262|NCT01811459|Delirium|delirium
267263|NCT01811459|ICU|icu
267264|NCT01811459|Burn patients|burn patients
267265|NCT01811459|Antipsychotics|antipsychotics
267266|NCT01811459|Haloperidol|haloperidol
267267|NCT01811459|Quetiapine|quetiapine
267268|NCT01811433|Postoperative Period|postoperative period
267269|NCT01811433|Anesthesia Recovery Period|anesthesia recovery period
267481|NCT01810419|ultrasound|ultrasound
267270|NCT01811433|Postoperative Complications|postoperative complications
267271|NCT01811433|Pulse Oximetry|pulse oximetry
267272|NCT01811420|dental caries|dental caries
267273|NCT01811420|caries removal|caries removal
267274|NCT01811420|chemomechanical caries removal|chemomechanical caries removal
267275|NCT01811394|sacral chordoma|sacral chordoma
267276|NCT01811394|chordoma|chordoma
267277|NCT01811394|carbon ion therapy|carbon ion therapy
267278|NCT01811394|proton therapy|proton therapy
330098|NCT01533259|HIV|hiv
267279|NCT01811394|hypofractionation|hypofractionation
267280|NCT01811381|Alzheimer|alzheimer
267281|NCT01811381|Prevention|prevention
267282|NCT01811381|mild cognitive impairment|mild cognitive impairment
267284|NCT01811381|synergism|synergism
267285|NCT01811381|curcumin|curcumin
267286|NCT01811381|dietary supplement|dietary supplement
267287|NCT01811381|anti-inflammatory|anti-inflammatory
267288|NCT01811381|anti-tau|anti-tau
267289|NCT01811381|subjective memory complaints without MCI|subjective memory complaints without mci
267290|NCT01811381|plasma-exosomes|plasma-exosomes
267291|NCT01811381|plasm- extracellular-derived-vesicles|plasm- extracellular-derived-vesicles
267292|NCT01811355|Muscle cramps|muscle cramps
267293|NCT01811355|Cramp|cramp
267295|NCT01811355|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
267296|NCT01811355|Lou Gehrig's disease|lou gehrig's disease
267297|NCT01811355|Motor Neuron Disease|motor neuron disease
267298|NCT01811355|MND|mnd
267299|NCT01811342|Hemoglobin|hemoglobin
267300|NCT01811342|Patient Monitoring|patient monitoring
267301|NCT01811277|palliative chemotherapy|palliative chemotherapy
267302|NCT01811277|ORR|orr
267303|NCT01811277|PFS|pfs
267304|NCT01811277|OS|os
267305|NCT01811277|safety|safety
267306|NCT01811277|advanced Biliary Tract Carcinoma|advanced biliary tract carcinoma
267307|NCT01811264|Metastatic|metastatic
267308|NCT01811264|Quality of life|quality of life
267309|NCT01811264|Decision making|decision making
267310|NCT01811251|Co-analgesia|co-analgesia
267311|NCT01811251|Dexamethasone|dexamethasone
267312|NCT01811251|Pregabalin|pregabalin
267313|NCT01811251|Lumbar slipped disc surgery|lumbar slipped disc surgery
267314|NCT01811251|Post-operative pain|post-operative pain
267315|NCT01811238|spinal disorders|spinal disorders
267316|NCT01811225|Women|women
267317|NCT01811225|Pregnancy|pregnancy
267318|NCT01811225|Smoking|smoking
267319|NCT01811199|Thyroid cancer|thyroid cancer
267320|NCT01811199|Breast cancer|breast cancer
267321|NCT01811199|Dexamethasone|dexamethasone
267322|NCT01811199|Emesis|emesis
267323|NCT01811186|moderate to severe non-malignant chronic pain|moderate to severe non-malignant chronic pain
267324|NCT01811173|multimorbidity|multimorbidity
267325|NCT01811173|primary care|primary care
267326|NCT01811173|physician - nurse team|physician - nurse team
267327|NCT01811173|proactive monitoring|proactive monitoring
267328|NCT01811173|support for self-care|support for self-care
267329|NCT01811173|primary caregiver|primary caregiver
267330|NCT01811160|Melatonin|melatonin
267331|NCT01811160|Second generation antipsychotic|second generation antipsychotic
267332|NCT01811160|bipolar disorder|bipolar disorder
267333|NCT01811160|schizophrenia|schizophrenia
267334|NCT01811160|Metabolic|metabolic
267335|NCT01811147|Bipolar|bipolar
267336|NCT01811147|Depression|depression
267337|NCT01811147|Mania|mania
267338|NCT01811147|Hypomania|hypomania
267339|NCT01811147|fMRI|fmri
267340|NCT01811147|antidepressant|antidepressant
267341|NCT01811134|endovascular procedure; flow diverter stent|endovascular procedure; flow diverter stent
267342|NCT01811121|Glioblastoma|glioblastoma
267343|NCT01811121|5ALA|5ala
267344|NCT01811121|fluorescence|fluorescence
267345|NCT01811121|resection|resection
267346|NCT01811108|mCRC|mcrc
267347|NCT01811108|KRAS mutation|kras mutation
267348|NCT01811108|Chemotherapy|chemotherapy
267349|NCT01811108|Anti-angiogenic agent|anti-angiogenic agent
267350|NCT01811108|Bevacizumab|bevacizumab
267351|NCT01811108|1st Line|1st line
267352|NCT01811095|Robotics|robotics
267353|NCT01811095|Computer-assisted surgery|computer-assisted surgery
267354|NCT01811095|Computer simulation|computer simulation
267355|NCT01811095|Gynecology|gynecology
267356|NCT01811095|General surgery|general surgery
267357|NCT01811069|Obese patients|obese patients
267358|NCT01811069|Upper airway patency|upper airway patency
267359|NCT01811056|medical abortion|medical abortion
267360|NCT01811056|mifepristone|mifepristone
267361|NCT01811043|breast biopsy|breast biopsy
267362|NCT01811043|anxiety|anxiety
267363|NCT01810978|congenital heart disease, probiotic, prebiotic|congenital heart disease, probiotic, prebiotic
267364|NCT01810965|Hemochromatosis type 1|hemochromatosis type 1
267365|NCT01810952|glucocorticoids|glucocorticoids
267366|NCT01810952|hyperglycemia|hyperglycemia
267367|NCT01810952|diabetes mellitus|diabetes mellitus
267368|NCT01810939|Chronic Kidney Disease|chronic kidney disease
267369|NCT01810939|Treatment of Hyperkalemia|treatment of hyperkalemia
267370|NCT01810939|Hyperkalemia|hyperkalemia
267371|NCT01810926|indication for HSCT|indication for hsct
267372|NCT01810926|matched related donor|matched related donor
267374|NCT01810926|Matched Unrelated Donor|matched unrelated donor
267375|NCT01810926|MUD|mud
267376|NCT01810900|anti-adhesive effect and safety, laparoscopic myomectomy|anti-adhesive effect and safety, laparoscopic myomectomy
267377|NCT01810887|Healthy|healthy
267378|NCT01810887|Darunavir|darunavir
267379|NCT01810887|JNS011|jns011
267380|NCT01810887|Ritonavir|ritonavir
258062|NCT01853592|MRA|mra
267381|NCT01810874|extraperitoneal|extraperitoneal
267382|NCT01810874|transperitoneal|transperitoneal
267383|NCT01810874|laparoscopic aortic lymphadenectomy|laparoscopic aortic lymphadenectomy
267384|NCT01810874|endometrial ovarian cancer|endometrial ovarian cancer
267385|NCT01810874|ovarian cancer|ovarian cancer
267386|NCT01810874|surgical staging|surgical staging
267387|NCT01810861|serotype distribution|serotype distribution
267388|NCT01810861|streptococcus pneumoniae|streptococcus pneumoniae
267389|NCT01810861|pneumonia|pneumonia
267390|NCT01810848|Knee Osteoarthritis|knee osteoarthritis
267391|NCT01810848|Osteoarthritis|osteoarthritis
267392|NCT01810848|Synvisc|synvisc
267393|NCT01810848|Hylan G-F 20|hylan g-f 20
267394|NCT01810848|Exercise|exercise
267395|NCT01810848|Cardiovascular risk|cardiovascular risk
267396|NCT01810848|Knee pain|knee pain
267397|NCT01810848|Pain|pain
267398|NCT01810835|HBV mother-to-child transmission|hbv mother-to-child transmission
267399|NCT01810835|women with HBV DNA > 105 I.U./mL|women with hbv dna > 105 i.u./ml
267400|NCT01810835|France|france
267401|NCT01810822|oxidative stress|oxidative stress
267402|NCT01810822|genetic susceptibility|genetic susceptibility
267403|NCT01810822|GPX4|gpx4
267404|NCT01810822|NOX2|nox2
267405|NCT01810809|Osteoarthritis|osteoarthritis
267406|NCT01810809|Hip|hip
267407|NCT01810809|Viscosupplementation|viscosupplementation
267408|NCT01810809|Clinical Trial|clinical trial
267409|NCT01810770|Radium-223 Dichloride|radium-223 dichloride
267410|NCT01810770|Prostatic Neoplasms|prostatic neoplasms
267411|NCT01810770|Bone Metastasis|bone metastasis
267412|NCT01810731|influenza vaccine immunogenicity|influenza vaccine immunogenicity
267413|NCT01810731|HIV|hiv
267414|NCT01810731|pregnancy|pregnancy
267415|NCT01810731|influenza vaccine safety|influenza vaccine safety
267416|NCT01810718|cGVHD|cgvhd
267417|NCT01810718|steroid therapy|steroid therapy
267418|NCT01810718|Nilotinib|nilotinib
267419|NCT01810718|cGVHD steroid refractory|cgvhd steroid refractory
267420|NCT01810718|intolerant to steroid therapy|intolerant to steroid therapy
267421|NCT01810718|Tasigna|tasigna
267424|NCT01810705|leukemia|leukemia
267425|NCT01810679|aortic valve replacement|aortic valve replacement
267426|NCT01810679|aortic stenosis|aortic stenosis
267427|NCT01810679|aortic steno-insufficiency|aortic steno-insufficiency
267428|NCT01810679|Perceval|perceval
267429|NCT01810679|Sutureless aortic heart valve|sutureless aortic heart valve
267430|NCT01810653|Macrogol|macrogol
267431|NCT01810640|Liver biopsy|liver biopsy
267432|NCT01810640|organ donation|organ donation
267433|NCT01810640|donor management|donor management
267434|NCT01810627|Prostate|prostate
267435|NCT01810627|Cancer|cancer
267436|NCT01810614|ADPKD|adpkd
267437|NCT01810614|PKD|pkd
267438|NCT01810614|Kidney Disease|kidney disease
267439|NCT01810614|ADPKD diet|adpkd diet
267440|NCT01810601|Embryo transfer, transabdominal ultrasound, IVF, ICSI|embryo transfer, transabdominal ultrasound, ivf, icsi
267441|NCT01810588|Allogeneic transplant|allogeneic transplant
267442|NCT01810588|Hematologic Malignancies|hematologic malignancies
267443|NCT01810588|Acute Leukemia|acute leukemia
267444|NCT01810588|Myeloproliferative disorders|myeloproliferative disorders
267445|NCT01810588|Lymphoma|lymphoma
267446|NCT01810588|Myeloma|myeloma
267447|NCT01810562|Stroke|stroke
267448|NCT01810562|Tactile|tactile
267449|NCT01810562|Sensibility|sensibility
267450|NCT01810562|Stimulation|stimulation
267451|NCT01810562|Extremities|extremities
267452|NCT01810562|Arm|arm
267453|NCT01810562|Leg|leg
267454|NCT01810549|Fatigue|fatigue
267455|NCT01810536|Cystic fibrosis|cystic fibrosis
267456|NCT01810536|oxygen|oxygen
267457|NCT01810536|respiratory failure|respiratory failure
267458|NCT01810523|Acute|acute
267459|NCT01810523|lower|lower
267460|NCT01810523|extremity|extremity
267461|NCT01810523|not requiring|not requiring
267462|NCT01810523|diagnostic|diagnostic
267463|NCT01810523|imaging|imaging
267464|NCT01810510|respiration, artificial|respiration, artificial
267465|NCT01810497|External ear|external ear
267466|NCT01810497|Ear abnormalities|ear abnormalities
267467|NCT01810497|External ear cartilages|external ear cartilages
267468|NCT01810484|Ulthera® System|ulthera® system
267469|NCT01810484|Ultherapy® Treatment|ultherapy® treatment
267470|NCT01810484|Ulthera, Inc.|ulthera, inc.
267471|NCT01810484|Ultrasound treatment for skin|ultrasound treatment for skin
267472|NCT01810458|Liver|liver
267473|NCT01810458|Fibrosis|fibrosis
267474|NCT01810458|Alpha-1|alpha-1
267475|NCT01810458|AAT|aat
267476|NCT01810458|AATD|aatd
267477|NCT01810445|Bladder Cancer|bladder cancer
267478|NCT01810445|Laser|laser
267479|NCT01810445|Optical|optical
267480|NCT01810419|splenomegaly|splenomegaly
267482|NCT01810419|Vscan|vscan
267483|NCT01810367|PFS|pfs
267484|NCT01810354|Cefazolin|cefazolin
267485|NCT01810354|Tissue concentration|tissue concentration
267486|NCT01810354|infection|infection
267487|NCT01810354|cesarean section|cesarean section
267488|NCT01810354|obese|obese
267489|NCT01810341|Autism|autism
267490|NCT01810341|Autism Spectrum Disorders|autism spectrum disorders
267491|NCT01810341|RNA|rna
267492|NCT01810341|Gene expression|gene expression
267493|NCT01810341|Developmental Delay|developmental delay
267494|NCT01810341|Metabolites|metabolites
267495|NCT01810341|DNA|dna
267496|NCT01810302|Vasospasm|vasospasm
267497|NCT01810302|Subarachnoid hemorrhage|subarachnoid hemorrhage
267498|NCT01810302|Aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
267499|NCT01810302|Nicardipine|nicardipine
267500|NCT01810302|Intrathecal|intrathecal
267501|NCT01810302|SAH|sah
267502|NCT01810302|aSAH|asah
267503|NCT01810289|HIV, ART, CD4|hiv, art, cd4
267504|NCT01810276|traumatic head injury|traumatic head injury
267505|NCT01810276|intracranial hemorrhage|intracranial hemorrhage
267506|NCT01810276|platelets|platelets
267507|NCT01810276|anti-platelet therapy|anti-platelet therapy
267508|NCT01810276|plavix|plavix
267509|NCT01810276|asprin|asprin
267510|NCT01810263|stroke|stroke
267511|NCT01810263|malnutrition|malnutrition
267512|NCT01810263|high protein|high protein
267513|NCT01810211|Shoulder|shoulder
267514|NCT01810211|Surgery|surgery
267515|NCT01810211|Posterior Shoulder Tightness|posterior shoulder tightness
267516|NCT01810211|Flexibility|flexibility
267517|NCT01810211|Range of Motion|range of motion
267518|NCT01810198|Coronary Artery Disease|coronary artery disease
267519|NCT01810198|Cardiac CT|cardiac ct
267520|NCT01810198|Catheterization|catheterization
267521|NCT01810185|Inflammatory Bowel Disease|inflammatory bowel disease
267522|NCT01810185|Crohn's disease|crohn's disease
267523|NCT01810185|Ulcerative colitis|ulcerative colitis
267524|NCT01810185|Naltrexone|naltrexone
267525|NCT01810185|Low Dose Naltrexone|low dose naltrexone
267526|NCT01810185|Inflammatory Bowel Disease Questionnaire|inflammatory bowel disease questionnaire
267527|NCT01810172|lobectomy|lobectomy
267528|NCT01810172|segmentectomy|segmentectomy
267529|NCT01810172|pneumothorax|pneumothorax
267530|NCT01810172|pleural|pleural
267531|NCT01810172|digital|digital
267532|NCT01810172|air leak|air leak
267535|NCT01810159|collaborative care|collaborative care
267536|NCT01810159|opiate disorders|opiate disorders
267537|NCT01810159|alcohol disorders|alcohol disorders
267538|NCT01810146|Patients eligible for bariatric surgery (BMI>40kg/m2)|patients eligible for bariatric surgery (bmi>40kg/m2)
267540|NCT01810120|Hematologic|hematologic
267541|NCT01810120|Malignant|malignant
267542|NCT01810120|Non-Malignant|non-malignant
267543|NCT01810120|Allogeneic|allogeneic
267544|NCT01810120|Transplant|transplant
267545|NCT01810120|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
267546|NCT01810120|Pediatric|pediatric
267547|NCT01810120|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
267548|NCT01810120|Acute Myeloid leukemia|acute myeloid leukemia
267549|NCT01810120|Myelodysplastic Syndromes|myelodysplastic syndromes
267550|NCT01810120|T cells receptor alfa beta|t cells receptor alfa beta
267551|NCT01810094|thoracolumbar fracture|thoracolumbar fracture
267552|NCT01810094|fixation|fixation
267553|NCT01810094|fixateur interne|fixateur interne
267554|NCT01810094|minimal invasive|minimal invasive
267555|NCT01810094|percutaneous|percutaneous
267556|NCT01810081|Cholelithiasis|cholelithiasis
267557|NCT01810081|Gastric H.Pylori infection|gastric h.pylori infection
267558|NCT01810081|H.Pylori infection|h.pylori infection
267559|NCT01810081|Gastric mucosa|gastric mucosa
267560|NCT01810068|BPH- Erectile function- Transurethral- Laser|bph- erectile function- transurethral- laser
267561|NCT01810042|age-related macular degeneration|age-related macular degeneration
267562|NCT01810042|choroidal neovascularization|choroidal neovascularization
267563|NCT01810042|ranibizumab|ranibizumab
267564|NCT01810042|indocyanine angiography|indocyanine angiography
267565|NCT01810029|transcendental meditation|transcendental meditation
267566|NCT01810029|cardiac rehabilitation|cardiac rehabilitation
267567|NCT01810016|NY-ESO-1|ny-eso-1
267568|NCT01810016|Metastatic Melanoma|metastatic melanoma
267569|NCT01810016|Ipilimumab|ipilimumab
267570|NCT01810016|Phase I|phase i
267571|NCT01810016|Adjuvant|adjuvant
267572|NCT01810016|Immunologic|immunologic
267573|NCT01810016|Vaccination|vaccination
267574|NCT01810016|Immunotherapy|immunotherapy
267575|NCT01810016|Neoplasm|neoplasm
267579|NCT01809990|cognitive behavior therapy|cognitive behavior therapy
267580|NCT01809990|pediatric obsessive-compulsive disorder|pediatric obsessive-compulsive disorder
267581|NCT01809990|internet-delivered cognitive behavior therapy|internet-delivered cognitive behavior therapy
267582|NCT01809977|Keratoconus|keratoconus
267583|NCT01809977|remove|remove
267584|NCT01809977|cornea|cornea
267585|NCT01809977|visual acuity|visual acuity
267586|NCT01809938|Gastrointestinal tract emptying|gastrointestinal tract emptying
267587|NCT01809938|Pre-operative fasting|pre-operative fasting
267588|NCT01809938|Ultrasound|ultrasound
267589|NCT01809938|Paracetamol Absorption|paracetamol absorption
267590|NCT01809912|solid tumor|solid tumor
267591|NCT01809899|Trauma|trauma
267592|NCT01809899|Abuse|abuse
267593|NCT01809899|Domestic Violence|domestic violence
267594|NCT01809899|Rape|rape
267595|NCT01809899|Assault|assault
267597|NCT01809886|Neuromuscular relaxants|neuromuscular relaxants
267598|NCT01809886|short-term pediatric surgery|short-term pediatric surgery
267599|NCT01809886|reverses neuromuscular blockade|reverses neuromuscular blockade
267600|NCT01809873|Malaria|malaria
267601|NCT01809873|Diagnostics|diagnostics
267602|NCT01809873|Health Services|health services
267603|NCT01809860|isavuconazole|isavuconazole
267604|NCT01809860|sirolimus|sirolimus
267605|NCT01809860|BAL8557|bal8557
267606|NCT01809860|Healthy Volunteers|healthy volunteers
267607|NCT01809847|CLL|cll
267608|NCT01809847|Chronic Lymphatic Leukemia|chronic lymphatic leukemia
267609|NCT01809847|Leukemia|leukemia
267610|NCT01809847|HLA|hla
267611|NCT01809847|Histocompatibility|histocompatibility
267612|NCT01809847|HCT|hct
267613|NCT01809847|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
267614|NCT01809847|Ofatumumab|ofatumumab
267615|NCT01809847|CD20|cd20
267616|NCT01809821|Hypertension|hypertension
267617|NCT01809821|Sleep Disorders|sleep disorders
267618|NCT01809821|Insomnia|insomnia
267619|NCT01809821|Cardiovascular Diseases|cardiovascular diseases
267620|NCT01809821|Internet treatment|internet treatment
267621|NCT01809808|Acromegaly|acromegaly
267622|NCT01809808|Pituitary tumor|pituitary tumor
267623|NCT01809795|Obesity|obesity
267624|NCT01809795|Exercise|exercise
267625|NCT01809795|Blueberry Plant|blueberry plant
267626|NCT01809743|Coronary artery disease|coronary artery disease
267627|NCT01809743|Regadenoson|regadenoson
267628|NCT01809743|Adenosine|adenosine
267629|NCT01809743|Maximal hyperemia|maximal hyperemia
267630|NCT01809743|Fractional flow reserve|fractional flow reserve
267631|NCT01809743|FFR|ffr
267632|NCT01809691|Prostate cancer|prostate cancer
267633|NCT01809691|TAK-700|tak-700
267634|NCT01809691|Bicalutamide|bicalutamide
267635|NCT01809691|S1216|s1216
267636|NCT01809691|androgen therapy|androgen therapy
267637|NCT01809691|Phase III|phase iii
267638|NCT01809678|Smoking|smoking
267639|NCT01809678|Tobacco|tobacco
267640|NCT01809678|Yoga|yoga
267641|NCT01809665|ICD therapy|icd therapy
267642|NCT01809665|CRT-P therapy|crt-p therapy
267643|NCT01809665|MRI|mri
267644|NCT01809652|Pacemaker|pacemaker
267645|NCT01809652|Defibrillator|defibrillator
267646|NCT01809652|Remote Consultation|remote consultation
267647|NCT01809639|Concussion|concussion
267648|NCT01809613|Parkinson disease|parkinson disease
267649|NCT01809613|Deep Brain Stimulation|deep brain stimulation
267650|NCT01809613|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
267651|NCT01809574|Interstitial lung disease|interstitial lung disease
267652|NCT01809574|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
267653|NCT01809574|Connective tissue disease|connective tissue disease
267654|NCT01809561|endometriosis|endometriosis
267655|NCT01809561|telomere|telomere
267656|NCT01809561|telomerase|telomerase
267657|NCT01809548|complementary feeding|complementary feeding
267658|NCT01809548|premature infant|premature infant
267659|NCT01809548|body composition|body composition
267660|NCT01809548|atopy|atopy
267661|NCT01809548|neurodevelopmental outcome|neurodevelopmental outcome
267662|NCT01809548|obesity|obesity
267663|NCT01809535|endoscopic variceal ligation|endoscopic variceal ligation
267664|NCT01809535|post-EVL ulcer|post-evl ulcer
267665|NCT01809535|variceal bleeding|variceal bleeding
267666|NCT01809522|Robotic-assisted radical prostatectomy|robotic-assisted radical prostatectomy
267667|NCT01809522|Urinary continence|urinary continence
267668|NCT01809522|Posterior reconstruction of the rhabdosphincter|posterior reconstruction of the rhabdosphincter
267669|NCT01809522|Posterior musculofascial plate reconstruction|posterior musculofascial plate reconstruction
267670|NCT01809509|CYTOKINES , IL11 IL6 IMLANTATION RATE IVF.|cytokines , il11 il6 imlantation rate ivf.
267671|NCT01809496|hearing loss|hearing loss
267672|NCT01809496|hearing aids|hearing aids
267673|NCT01809496|spouses|spouses
267674|NCT01809496|rehabilitation|rehabilitation
267675|NCT01809483|mechanical corneal erosion|mechanical corneal erosion
267677|NCT01809483|pressure patching|pressure patching
267678|NCT01809483|erosion area|erosion area
267679|NCT01809483|pain scale|pain scale
267680|NCT01809470|Blood pressure|blood pressure
267681|NCT01809470|Appetite|appetite
267682|NCT01809470|Heart rate|heart rate
267683|NCT01809470|Salivary cortisol|salivary cortisol
267684|NCT01809457|educational poster, knowledge, dental trauma,|educational poster, knowledge, dental trauma,
267685|NCT01809431|gestational diabetes|gestational diabetes
267686|NCT01809431|women|women
267687|NCT01809431|infants|infants
267688|NCT01809431|blood glucose|blood glucose
267689|NCT01809431|weight|weight
267690|NCT01809431|adiposity|adiposity
267691|NCT01809431|health behaviors|health behaviors
267692|NCT01809431|self-efficacy|self-efficacy
267693|NCT01809392|Decitabine|decitabine
267694|NCT01809392|hematopoietic stem cell transplant|hematopoietic stem cell transplant
267695|NCT01809392|Wilms' tumor 1|wilms' tumor 1
267696|NCT01809392|cytolytic T lymphocyte|cytolytic t lymphocyte
267697|NCT01809392|Regulatory T cell|regulatory t cell
267698|NCT01809379|ovarian cancer, recurrent, chemotherapy, intraperitoneal|ovarian cancer, recurrent, chemotherapy, intraperitoneal
267699|NCT01809366|seminal plasma/uterine receptivity|seminal plasma/uterine receptivity
267700|NCT01809353|Healthy|healthy
267701|NCT01809353|Japanese|japanese
267705|NCT01809353|JNJ-54452840|jnj-54452840
267706|NCT01809340|Depressive Disorder|depressive disorder
267707|NCT01809340|Major Depressive Disorder|major depressive disorder
267708|NCT01809340|Depression|depression
267709|NCT01809340|Bipolar Disorder Type II|bipolar disorder type ii
267710|NCT01809340|Anti-depressant|anti-depressant
267711|NCT01809340|Ketamine|ketamine
267712|NCT01809340|Minocycline|minocycline
267713|NCT01809327|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
267714|NCT01809327|Diabetes Mellitus|diabetes mellitus
267715|NCT01809327|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
267716|NCT01809327|Metformin|metformin
267717|NCT01809301|Bioavailability|bioavailability
267719|NCT01809288|Diet|diet
267720|NCT01809288|Obesity|obesity
267721|NCT01809288|African|african
267722|NCT01809288|African Americans|african americans
267723|NCT01809275|Crohn's Disease|crohn's disease
267724|NCT01809275|Inflammatory Bowel Disease|inflammatory bowel disease
267725|NCT01809275|CDAI|cdai
267726|NCT01809249|Living donor liver transplantation|living donor liver transplantation
267727|NCT01809249|Donar safety|donar safety
267728|NCT01809210|MEK1/2 inhibitor,|mek1/2 inhibitor,
267729|NCT01809210|Non Small Cell Lung Cancer,|non small cell lung cancer,
267730|NCT01809210|metastatic,|metastatic,
267731|NCT01809210|first line treatment for Non Small Cell Lung Cancer|first line treatment for non small cell lung cancer
267732|NCT01809197|Refractive error|refractive error
267733|NCT01809197|Myopia|myopia
267734|NCT01809197|Hyperopia|hyperopia
267735|NCT01809197|Astigmatism|astigmatism
267736|NCT01809197|Presbyopia|presbyopia
267737|NCT01809197|Contact lenses|contact lenses
267738|NCT01809197|Contact lens solution|contact lens solution
267739|NCT01809197|Comfort|comfort
267740|NCT01809145|sarcoidosis|sarcoidosis
267741|NCT01809145|occupational exposure|occupational exposure
267742|NCT01809145|MELISA|melisa
267743|NCT01809132|Hepatitis, alcoholic|hepatitis, alcoholic
267744|NCT01809132|pentoxifylline|pentoxifylline
267745|NCT01809132|zinc|zinc
267746|NCT01809132|anakinra|anakinra
267747|NCT01809132|glucocorticoids|glucocorticoids
267748|NCT01809132|MELD score|meld score
267749|NCT01809132|Intestinal mucosa|intestinal mucosa
267750|NCT01809119|Kidney Neoplasms, Minimally invasive surgery, Renal cell carcinoma|kidney neoplasms, minimally invasive surgery, renal cell carcinoma
267751|NCT01809106|cancer pain|cancer pain
267752|NCT01809106|major opioid|major opioid
267753|NCT01809106|analgesics|analgesics
267754|NCT01809093|PEDF|pedf
267755|NCT01809093|TSP1|tsp1
267756|NCT01809093|Thrombospondin|thrombospondin
267757|NCT01809093|pigment epithelium derived factor|pigment epithelium derived factor
267758|NCT01809093|Wills Eye Institute|wills eye institute
267759|NCT01809093|Pars plana vitrectomy|pars plana vitrectomy
267760|NCT01809093|Vitreous levels|vitreous levels
267761|NCT01809093|Mid Atlantic Retina|mid atlantic retina
267762|NCT01809093|Blood draw|blood draw
267763|NCT01809093|Blood test|blood test
267764|NCT01809067|stress|stress
267765|NCT01809067|anxiety|anxiety
267766|NCT01809067|MRI|mri
267767|NCT01809067|aromatherapy|aromatherapy
267768|NCT01809054|Hip, Knee, Arthroplasty, venous thromboembolic events, blood loss|hip, knee, arthroplasty, venous thromboembolic events, blood loss
267769|NCT01809028|cell block, number of passes|cell block, number of passes
267770|NCT01809015|Oral Anticoagulation|oral anticoagulation
267771|NCT01809015|Regular Medical Care|regular medical care
267772|NCT01809015|Coagulation Service|coagulation service
267773|NCT01809015|Vitamin-K Antagonists|vitamin-k antagonists
267774|NCT01809015|Quality of therapy|quality of therapy
267775|NCT01809015|Atrial fibrillation|atrial fibrillation
267776|NCT01809015|Venous thromboembolism|venous thromboembolism
267777|NCT01809015|Bypass surgery|bypass surgery
267778|NCT01809015|Prosthetic heart valve|prosthetic heart valve
267779|NCT01808989|peripheral artery disease|peripheral artery disease
267780|NCT01808989|tcpo2|tcpo2
267781|NCT01808989|treadmill walking test|treadmill walking test
267782|NCT01808989|intermittent claudication|intermittent claudication
267783|NCT01808963|Enthalpy|enthalpy
267784|NCT01808963|Physiologic Monitors|physiologic monitors
267785|NCT01808963|Critical Care Medicine|critical care medicine
267786|NCT01808911|Acquired haemophilia|acquired haemophilia
267787|NCT01808911|Comparative and randomized study|comparative and randomized study
267788|NCT01808911|Cyclophosphamide|cyclophosphamide
267789|NCT01808911|Rituximab|rituximab
267790|NCT01808898|Ablation|ablation
267791|NCT01808898|Outpatient|outpatient
267792|NCT01808885|safety|safety
267793|NCT01808885|multiple sclerosis|multiple sclerosis
267794|NCT01808885|olesoxime|olesoxime
267795|NCT01808885|double-blind|double-blind
267796|NCT01808885|randomized|randomized
267797|NCT01808859|Total Knee Arthroplasty|total knee arthroplasty
267798|NCT01808859|Thigh Tourniquet|thigh tourniquet
267799|NCT01808846|Obesity|obesity
267800|NCT01808846|Insulin Resistance|insulin resistance
267801|NCT01808846|functional magnetic resonance imaging|functional magnetic resonance imaging
267802|NCT01808846|glucose|glucose
267803|NCT01808846|fructose|fructose
267804|NCT01808846|hypothalamus|hypothalamus
267805|NCT01808846|neuronal circuits|neuronal circuits
267806|NCT01808846|feeding behavior|feeding behavior
267807|NCT01808833|Frailty|frailty
267808|NCT01808833|Geriatric oncology|geriatric oncology
267809|NCT01808820|Malignant Glioma|malignant glioma
267810|NCT01808820|Glioblastoma Multiforme|glioblastoma multiforme
267811|NCT01808820|Anaplastic Astrocytoma|anaplastic astrocytoma
267812|NCT01808820|High Grade Glioma|high grade glioma
267813|NCT01808820|HGG|hgg
267814|NCT01808820|Dendritic Cell Vaccine|dendritic cell vaccine
267815|NCT01808820|DC Vaccine|dc vaccine
267816|NCT01808820|Leukapheresis|leukapheresis
267817|NCT01808807|cesarean section rate|cesarean section rate
267818|NCT01808807|the cesarean section rate audit|the cesarean section rate audit
267819|NCT01808794|membranes|membranes
267820|NCT01808794|Mucograft|mucograft
267821|NCT01808794|Dynamatrixw|dynamatrixw
267822|NCT01808794|ridge|ridge
267823|NCT01808794|preservation|preservation
267824|NCT01808794|bone|bone
267825|NCT01808794|allograft|allograft
267826|NCT01808794|extraction|extraction
267827|NCT01808794|site|site
267828|NCT01808794|healing|healing
267829|NCT01808781|Power|power
267830|NCT01808781|muscle strength|muscle strength
267831|NCT01808781|total knee replacement|total knee replacement
267832|NCT01808781|physical activity behavior|physical activity behavior
267833|NCT01808755|recurrent urinary tract infections|recurrent urinary tract infections
267834|NCT01808755|D Mannose|d mannose
267835|NCT01808755|cystitis|cystitis
267836|NCT01808755|antibiotic treatment|antibiotic treatment
267837|NCT01808729|fibromuscular dysplasia|fibromuscular dysplasia
267838|NCT01808729|coronary artery disease|coronary artery disease
267839|NCT01808716|low-level laser therapy|low-level laser therapy
267840|NCT01808716|muscle damage|muscle damage
267841|NCT01808703|Periodontitis|periodontitis
267842|NCT01808703|Periodontal pocket|periodontal pocket
267843|NCT01808703|Periodontal diseases|periodontal diseases
267844|NCT01808690|Adolescent|adolescent
267845|NCT01808690|Youth|youth
267846|NCT01808690|Diabetes|diabetes
267847|NCT01808690|Insulin Resistance|insulin resistance
267848|NCT01808690|Cardiovascular|cardiovascular
267849|NCT01808690|Metformin|metformin
267850|NCT01808677|Non-Small Cell Lung Cancer|non-small cell lung cancer
267851|NCT01808677|NSCLC|nsclc
267852|NCT01808677|Thoracic reirradiation|thoracic reirradiation
267853|NCT01808677|Proton beam therapy|proton beam therapy
267854|NCT01808677|PBT|pbt
267855|NCT01808677|Intensity modulated radiation therapy|intensity modulated radiation therapy
267856|NCT01808677|IMRT|imrt
267857|NCT01808677|Registry|registry
267858|NCT01808677|Data|data
267859|NCT01808638|Adenocarcinoma|adenocarcinoma
267860|NCT01808638|Pancreas|pancreas
267861|NCT01808638|Gemcitabine|gemcitabine
267862|NCT01808638|Atu027|atu027
267863|NCT01808625|BRAIN MALIGNANCIES , RADIATION THERAPY|brain malignancies , radiation therapy
267864|NCT01808586|Neck|neck
267865|NCT01808586|chronic pain|chronic pain
267866|NCT01808586|facet injection|facet injection
267867|NCT01808573|Neratinib|neratinib
267868|NCT01808573|Nerlynx|nerlynx
267869|NCT01808521|Purpura, Thrombotic Thrombocytopenic|purpura, thrombotic thrombocytopenic
267870|NCT01808521|TTP|ttp
267871|NCT01808508|Down syndrome|down syndrome
267872|NCT01808508|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
267873|NCT01808508|Continuous positive airway pressure|continuous positive airway pressure
267874|NCT01808508|sham or placebo CPAP|sham or placebo cpap
267875|NCT01808495|Human corneal fibroblasts|human corneal fibroblasts
267876|NCT01808495|Fibulin-1|fibulin-1
267877|NCT01808495|Nuclear accumulation|nuclear accumulation
267878|NCT01808482|monoclonal antibody|monoclonal antibody
267879|NCT01808482|Multiple Sclerosis|multiple sclerosis
267880|NCT01808482|Interleukin-7 Receptor|interleukin-7 receptor
267881|NCT01808456|kidney transplant|kidney transplant
267882|NCT01808456|heart transplant|heart transplant
267883|NCT01808456|lung transplant|lung transplant
267884|NCT01808456|influenza vaccine|influenza vaccine
267885|NCT01808443|cryotherapy|cryotherapy
267886|NCT01808443|laser|laser
267887|NCT01808443|cutaneous warts|cutaneous warts
267888|NCT01808430|NSCLC|nsclc
267889|NCT01808404|Acceptance and Commitment Therapy|acceptance and commitment therapy
267890|NCT01808404|Mindfulness|mindfulness
267891|NCT01808404|Guided Self-Help|guided self-help
267892|NCT01808404|College|college
267893|NCT01808391|Coronary artery disease|coronary artery disease
267894|NCT01808391|Heart disease|heart disease
267895|NCT01808391|Myocardial ischemia|myocardial ischemia
267896|NCT01808391|Cardiovascular disease|cardiovascular disease
267897|NCT01808391|Arteriosclerosis|arteriosclerosis
267898|NCT01808391|Vascular disease|vascular disease
267899|NCT01808378|Bilateral limbic associated keratopathy|bilateral limbic associated keratopathy
751920|NCT01171222|Cardiovascular|cardiovascular
267900|NCT01808378|Expanded Adipose Derived Stem Cells|expanded adipose derived stem cells
267901|NCT01808365|Philippines|philippines
267902|NCT01808365|carriage|carriage
267903|NCT01808365|Neisseria meningitidis|neisseria meningitidis
267904|NCT01808365|meningococcus|meningococcus
267905|NCT01808352|AE adverse event|ae adverse event
267906|NCT01808352|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
267907|NCT01808352|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
267908|NCT01808352|ART antiretroviral therapy|art antiretroviral therapy
267909|NCT01808352|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
267910|NCT01808352|DCF data collection forms|dcf data collection forms
267911|NCT01808352|DMC Data Monitoring Committee|dmc data monitoring committee
267912|NCT01808352|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
267913|NCT01808352|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
267914|NCT01808352|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
267915|NCT01808352|ICH International Conference of Harmonisation|ich international conference of harmonisation
267916|NCT01808352|IND Investigational New Drug Application|ind investigational new drug application
267917|NCT01808352|IRB Institutional Review Board|irb institutional review board
267918|NCT01808352|IU International units|iu international units
267919|NCT01808352|mg milligram(s)|mg milligram(s)
267920|NCT01808352|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
267921|NCT01808352|PCR polymerase chain reaction|pcr polymerase chain reaction
267922|NCT01808352|SAE serious adverse event|sae serious adverse event
267923|NCT01808352|µg microgram|µg microgram
267924|NCT01808352|ULN upper limit of the normal range|uln upper limit of the normal range
267925|NCT01808352|WB Western Blot|wb western blot
267926|NCT01808339|Fluticasone Furoate, FF Inhalation Powder, morning dosing, evening dosing, efficacy, FEV1|fluticasone furoate, ff inhalation powder, morning dosing, evening dosing, efficacy, fev1
268226|NCT01806857|ALS|als
267927|NCT01808287|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
267928|NCT01808287|Aortic Stenosis|aortic stenosis
267929|NCT01808274|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
267930|NCT01808274|Aortic Stenosis|aortic stenosis
267931|NCT01808261|Ischemic Stroke|ischemic stroke
267932|NCT01808248|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
267933|NCT01808248|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
267934|NCT01808248|HCV|hcv
267935|NCT01808248|Sustained Virologic Response|sustained virologic response
267936|NCT01808248|Direct Acting Antiviral|direct acting antiviral
267937|NCT01808248|Combination Therapy|combination therapy
267938|NCT01808248|Treatment-Naïve|treatment-naïve
267939|NCT01808248|GS-7977|gs-7977
267940|NCT01808248|Ribavirin|ribavirin
267941|NCT01808248|RBV|rbv
267942|NCT01808248|Peginterferon Alfa 2a|peginterferon alfa 2a
267943|NCT01808248|PEG|peg
267944|NCT01808248|Additional relevant MeSH terms:|additional relevant mesh terms:
267945|NCT01808248|Hepatitis|hepatitis
267946|NCT01808248|Hepatitis A|hepatitis a
267947|NCT01808248|Hepatitis, Chronic|hepatitis, chronic
267948|NCT01808248|Hepatitis C|hepatitis c
267949|NCT01808248|Hepatitis C, Chronic|hepatitis c, chronic
267950|NCT01808248|Liver Diseases|liver diseases
267951|NCT01808248|Digestive System Diseases|digestive system diseases
267952|NCT01808248|Hepatitis, Viral, Human|hepatitis, viral, human
267953|NCT01808248|Virus Diseases|virus diseases
267954|NCT01808248|Enterovirus Infections|enterovirus infections
267955|NCT01808248|Picornaviridae Infections|picornaviridae infections
267956|NCT01808248|RNA Virus Infections|rna virus infections
267957|NCT01808248|Flaviviridae Infections|flaviviridae infections
267958|NCT01808248|Peginterferon alfa-2a|peginterferon alfa-2a
267959|NCT01808248|Interferon-alpha|interferon-alpha
267960|NCT01808248|Antiviral Agents|antiviral agents
267961|NCT01808248|Anti-Infective Agents|anti-infective agents
267962|NCT01808248|Therapeutic Uses|therapeutic uses
267963|NCT01808248|Pharmacologic Actions|pharmacologic actions
267964|NCT01808248|Antimetabolites|antimetabolites
267965|NCT01808248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
267966|NCT01808248|Immunologic Factors|immunologic factors
267967|NCT01808248|Physiological Effects of Drugs|physiological effects of drugs
267968|NCT01808196|Eosinophilic Esophagitis|eosinophilic esophagitis
267969|NCT01808196|Connective Tissue Disorders|connective tissue disorders
267970|NCT01808196|Drug trial|drug trial
267971|NCT01808183|supracondylar|supracondylar
267972|NCT01808183|pediatric|pediatric
267973|NCT01808183|humerus|humerus
267974|NCT01808183|NIRS|nirs
267975|NCT01808183|near Infrared spectroscopy|near infrared spectroscopy
267976|NCT01808183|compartment perfusion|compartment perfusion
267977|NCT01808170|Laparoscopy|laparoscopy
267978|NCT01808170|AMH|amh
267979|NCT01808170|AFC|afc
267980|NCT01808170|Endometrioma|endometrioma
267981|NCT01808170|ovarian reserve|ovarian reserve
267982|NCT01808170|Ovarian cystectomy|ovarian cystectomy
258643|NCT01851304|Bread|bread
267983|NCT01808170|ovarian cyst deroofing|ovarian cyst deroofing
267984|NCT01808157|atopic dermatitis|atopic dermatitis
267985|NCT01808157|pruritus|pruritus
267986|NCT01808144|Gout|gout
267987|NCT01808131|Gout|gout
267988|NCT01808118|Musculoskeletal Diseases|musculoskeletal diseases
267989|NCT01808118|Joint Diseases|joint diseases
267991|NCT01808118|Spondylarthropathy|spondylarthropathy
267992|NCT01808118|Arthritis|arthritis
267993|NCT01808118|Anti-Inflammatory Agents|anti-inflammatory agents
267994|NCT01808118|Spondyloarthritis|spondyloarthritis
267995|NCT01808118|Spinal Diseases|spinal diseases
267996|NCT01808118|Antirheumatic Agents|antirheumatic agents
267997|NCT01808118|Ankylosing Spondyloarthritis|ankylosing spondyloarthritis
267998|NCT01808118|Spondylitis|spondylitis
267999|NCT01808092|Ceftazidime,|ceftazidime,
268000|NCT01808092|Meropenem,|meropenem,
268001|NCT01808092|Anti-Bacterial Agents,|anti-bacterial agents,
268002|NCT01808092|Anti-Infective Agents,|anti-infective agents,
268003|NCT01808092|Therapeutic Uses,|therapeutic uses,
268004|NCT01808092|Pharmacologic Actions,|pharmacologic actions,
268005|NCT01808092|Physiological Effects of Drugs|physiological effects of drugs
268006|NCT01808040|breast cancer|breast cancer
268007|NCT01808040|ER positive|er positive
268008|NCT01808040|PR positive|pr positive
268009|NCT01808040|post menopausal|post menopausal
268010|NCT01808027|quality of life drug adherence drug compliance mortality|quality of life drug adherence drug compliance mortality
268011|NCT01808014|nefopam, spinal surgery, postoperative pain control|nefopam, spinal surgery, postoperative pain control
268012|NCT01807988|Relapse, Recurrence, Depression, Internet, Sick-leave|relapse, recurrence, depression, internet, sick-leave
268013|NCT01807962|Injections, Subcutaneous|injections, subcutaneous
268014|NCT01807962|Cortisone|cortisone
268015|NCT01807962|Anesthetics, Local|anesthetics, local
268016|NCT01807936|Esophageal Neoplasms|esophageal neoplasms
268017|NCT01807936|lymphadenectomy|lymphadenectomy
268018|NCT01807910|Obesity|obesity
268019|NCT01807910|NAFLD|nafld
268020|NCT01807910|NASH|nash
268021|NCT01807910|Steatosis|steatosis
268022|NCT01807897|Heart Failure|heart failure
268023|NCT01807897|Sleep Apnea|sleep apnea
268024|NCT01807897|Ventricular Ejection Fraction|ventricular ejection fraction
268025|NCT01807897|Exercise Test|exercise test
268026|NCT01807884|Microaspiration|microaspiration
268027|NCT01807884|Ventilator acquired Pneumonia|ventilator acquired pneumonia
268028|NCT01807884|Amylase|amylase
268029|NCT01807884|Mechanical ventilation|mechanical ventilation
268030|NCT01807884|Suction|suction
268031|NCT01807871|nicotine dependence|nicotine dependence
268032|NCT01807871|smoking cessation|smoking cessation
268033|NCT01807871|lapse|lapse
268034|NCT01807871|relapse|relapse
268035|NCT01807871|tobacco|tobacco
268036|NCT01807871|nicotine patch|nicotine patch
268037|NCT01807871|nicotine replacement therapy|nicotine replacement therapy
268038|NCT01807871|NRT|nrt
268039|NCT01807858|Necrotizing enterocolitis|necrotizing enterocolitis
268040|NCT01807858|Sepsis|sepsis
268041|NCT01807858|Length of hospital stay|length of hospital stay
268042|NCT01807858|Mortality|mortality
268043|NCT01807845|Casein micelles|casein micelles
268044|NCT01807845|vitamin D3 (cholecalciferol)|vitamin d3 (cholecalciferol)
268045|NCT01807845|Bioavailability|bioavailability
268046|NCT01807845|Nanoencapsulation|nanoencapsulation
268047|NCT01807845|Nutrition|nutrition
268048|NCT01807832|chronic cough|chronic cough
268049|NCT01807832|cough reflex hypersensitivity|cough reflex hypersensitivity
268050|NCT01807832|capsaicin|capsaicin
268051|NCT01807819|Heart Failure|heart failure
268052|NCT01807819|Myocardial Strain|myocardial strain
268053|NCT01807819|Functional Capacity|functional capacity
268054|NCT01807806|veterans, military, families|veterans, military, families
268055|NCT01807793|Stroke|stroke
268056|NCT01807793|TIA|tia
268057|NCT01807793|African American|african american
268058|NCT01807754|automated ultrasound imaging (AUS)|automated ultrasound imaging (aus)
268059|NCT01807754|digital breast tomosynthesis (DBT)|digital breast tomosynthesis (dbt)
268060|NCT01807754|photoacoustic imaging (PAT)|photoacoustic imaging (pat)
268061|NCT01807741|Bipolar Disorder|bipolar disorder
268062|NCT01807741|Depression|depression
268063|NCT01807728|Quality of life|quality of life
268064|NCT01807728|Participation|participation
268065|NCT01807728|Training|training
268066|NCT01807715|first trimester|first trimester
268067|NCT01807715|surgical abortion|surgical abortion
268068|NCT01807715|contraception|contraception
268069|NCT01807702|dichloroacetate|dichloroacetate
268070|NCT01807702|pyruvate|pyruvate
268071|NCT01807702|lactate|lactate
268072|NCT01807702|pyruvate dehydrogenase|pyruvate dehydrogenase
268073|NCT01807689|Dry mouth|dry mouth
268074|NCT01807689|Dry eyes|dry eyes
268075|NCT01807689|Saliva|saliva
268076|NCT01807689|Salivary gland biopsy|salivary gland biopsy
268077|NCT01807663|neuromuscular disease|neuromuscular disease
268078|NCT01807650|Split-Thickness Skin Graft Donor Site|split-thickness skin graft donor site
268079|NCT01807650|Split-thickness skin graft|split-thickness skin graft
268080|NCT01807650|STSG|stsg
268081|NCT01807650|Wound healing|wound healing
268082|NCT01807650|Skin grafting|skin grafting
268083|NCT01807650|Superficial wound|superficial wound
268084|NCT01807650|Partial-thickness wound|partial-thickness wound
268085|NCT01807650|Time to wound closure|time to wound closure
268086|NCT01807624|Pharmacokinetic|pharmacokinetic
268087|NCT01807611|Haploidentical donor transplantation|haploidentical donor transplantation
268088|NCT01807611|NK cell|nk cell
268089|NCT01807585|GSV|gsv
268090|NCT01807559|Single Sided Deafness|single sided deafness
268091|NCT01807559|Conductive Hearing Loss|conductive hearing loss
268092|NCT01807559|Unilateral Hearing Loss|unilateral hearing loss
268093|NCT01807559|SSD|ssd
268094|NCT01807546|Head and neck cancer|head and neck cancer
268095|NCT01807546|Platinum-resistant|platinum-resistant
268096|NCT01807546|Squamous cell carcinoma|squamous cell carcinoma
268097|NCT01807533|Environment|environment
268098|NCT01807533|Gene|gene
268099|NCT01807533|Intervention|intervention
268100|NCT01807533|Neurodevelopment|neurodevelopment
268101|NCT01807533|Pathways|pathways
268102|NCT01807533|Preterm infants|preterm infants
268103|NCT01807520|Moderate nail psoriasis|moderate nail psoriasis
268104|NCT01807520|Severe nail psoriasis|severe nail psoriasis
268105|NCT01807520|psoriasis|psoriasis
268106|NCT01807520|Secukinumab|secukinumab
268107|NCT01807507|Veins|veins
268108|NCT01807507|Vascular Access|vascular access
268109|NCT01807481|Mircera|mircera
268110|NCT01807481|PD|pd
268111|NCT01807481|Maitenance|maitenance
268112|NCT01807468|haploidentical stem cell transplantation|haploidentical stem cell transplantation
268113|NCT01807468|natural killer cell therapy|natural killer cell therapy
268114|NCT01807468|pediatric solid tumor|pediatric solid tumor
268115|NCT01807442|Acute Coronary Syndrome|acute coronary syndrome
268116|NCT01807442|Positive Psychology|positive psychology
268117|NCT01807442|Adherence to Health Behaviors|adherence to health behaviors
268118|NCT01807429|Ketamine,|ketamine,
268119|NCT01807429|Midazolam,|midazolam,
268120|NCT01807429|Morphine,|morphine,
268121|NCT01807429|visual analogue score|visual analogue score
268122|NCT01807416|Osseointegrated Implant, Bone level|osseointegrated implant, bone level
268123|NCT01807403|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
268124|NCT01807403|Deep brain stimulation|deep brain stimulation
268125|NCT01807403|Subthalamic nucleus|subthalamic nucleus
268126|NCT01807403|Caudate nucleus|caudate nucleus
268127|NCT01807403|Nucleus accumbens|nucleus accumbens
268128|NCT01807390|Minimally invasive surgery|minimally invasive surgery
268129|NCT01807390|Patient perspectives|patient perspectives
268130|NCT01807390|Lung cancer|lung cancer
268131|NCT01807390|Esophageal cancer|esophageal cancer
268132|NCT01807390|Pain|pain
268133|NCT01807364|Congenital adrenal hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
268134|NCT01807364|Cardiovascular risk|cardiovascular risk
268135|NCT01807364|Microvascular dysfunction|microvascular dysfunction
268136|NCT01807351|Diabetes Mellitus|diabetes mellitus
268137|NCT01807351|Hypertension|hypertension
268138|NCT01807351|Impaired Fasting Glucose|impaired fasting glucose
268139|NCT01807351|Primary Health Care|primary health care
268140|NCT01807351|Chinese|chinese
268141|NCT01807312|colonoscopy|colonoscopy
268142|NCT01807299|Physical Training|physical training
268143|NCT01807299|ADHD-Attention deficit hyperactivity disorder|adhd-attention deficit hyperactivity disorder
268144|NCT01807299|Omega 3|omega 3
268145|NCT01807286|Myeloma|myeloma
268146|NCT01807286|Untreated Systemic AL Amyloidosis|untreated systemic al amyloidosis
268147|NCT01807286|Amyloid light-chain (AL) amyloidosis|amyloid light-chain (al) amyloidosis
268148|NCT01807286|Pomalidomide|pomalidomide
268149|NCT01807286|Melphalan|melphalan
268150|NCT01807286|Alkeran|alkeran
268151|NCT01807286|Dexamethasone|dexamethasone
268152|NCT01807286|Decadron|decadron
268153|NCT01807286|Questionnaires|questionnaires
268154|NCT01807286|Surveys|surveys
268155|NCT01807273|hemiplegic|hemiplegic
268156|NCT01807273|time up and go test|time up and go test
268157|NCT01807273|motion analysis|motion analysis
268158|NCT01807273|center of mass|center of mass
268159|NCT01807247|Strengthening muscle|strengthening muscle
268160|NCT01807247|Central nervous system diseases|central nervous system diseases
268161|NCT01807247|Gait|gait
268162|NCT01807221|Heart Decompensation|heart decompensation
268163|NCT01807208|Acute myocardial infarction|acute myocardial infarction
268164|NCT01807208|patient education|patient education
268165|NCT01807208|prevention|prevention
268166|NCT01807195|contrast|contrast
268167|NCT01807195|Intensive care unit|intensive care unit
268168|NCT01807195|Acute kidney injury|acute kidney injury
268169|NCT01807169|colon|colon
268170|NCT01807169|endoscopy|endoscopy
268171|NCT01807169|resection|resection
268172|NCT01807169|clopidogrel|clopidogrel
268173|NCT01807156|Tivozanib|tivozanib
268304|NCT01806558|breast lesion|breast lesion
268174|NCT01807156|Advanced hepatocellular cancer|advanced hepatocellular cancer
268175|NCT01807156|Angiogenesis|angiogenesis
268176|NCT01807130|Heart Failure|heart failure
268177|NCT01807130|Medical Therapy|medical therapy
258849|NCT01850537|DDD|ddd
268178|NCT01807130|ICD|icd
268179|NCT01807130|CRT|crt
268180|NCT01807104|Anterior Approach|anterior approach
268181|NCT01807104|Posterior Approach|posterior approach
268182|NCT01807078|Coronary artery disease|coronary artery disease
268183|NCT01807039|hip fracture|hip fracture
268184|NCT01807039|proximal femur|proximal femur
268185|NCT01807039|pertrochanteric fracture|pertrochanteric fracture
268186|NCT01807039|subtrochanteric fracture|subtrochanteric fracture
268187|NCT01807039|subcapital fracture|subcapital fracture
268188|NCT01807039|safety issue|safety issue
268189|NCT01807039|anesthesia|anesthesia
268190|NCT01807013|cirrhosis|cirrhosis
268191|NCT01807013|liver|liver
268192|NCT01807013|elastometry|elastometry
268193|NCT01807013|ultrasound|ultrasound
268194|NCT01807013|laparoscopy|laparoscopy
268195|NCT01807013|diagnosis|diagnosis
268196|NCT01806987|school readiness|school readiness
268197|NCT01806987|literacy|literacy
268198|NCT01806987|social emotional skills|social emotional skills
268199|NCT01806987|self regulation|self regulation
268200|NCT01806987|caregiver involvement|caregiver involvement
268201|NCT01806987|socioeconomic disadvantage|socioeconomic disadvantage
268202|NCT01806974|Periodontitis|periodontitis
268203|NCT01806974|rheumatoid arthritis|rheumatoid arthritis
268204|NCT01806974|anti-interleukin 6|anti-interleukin 6
268205|NCT01806974|immunotherapy|immunotherapy
268206|NCT01806974|inflammation|inflammation
268207|NCT01806974|bacteria|bacteria
268208|NCT01806974|periodontal sulci|periodontal sulci
268209|NCT01806974|periodontal pockets|periodontal pockets
268210|NCT01806935|associated|associated
268211|NCT01806935|aged population|aged population
268212|NCT01806922|Yoga|yoga
268213|NCT01806922|Stroke|stroke
268214|NCT01806922|Standing balance|standing balance
268215|NCT01806922|Depression|depression
268216|NCT01806909|Flu Vaccine|flu vaccine
268217|NCT01806909|Healthy Volunteer|healthy volunteer
268218|NCT01806883|Hemiparesis,|hemiparesis,
268219|NCT01806883|Rehabilitation,|rehabilitation,
268220|NCT01806883|WII,|wii,
268221|NCT01806883|Upper limb,|upper limb,
268222|NCT01806883|Movement strategies.|movement strategies.
268223|NCT01806870|HIV|hiv
268224|NCT01806870|ART|art
268225|NCT01806857|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
268227|NCT01806857|Nuedexta|nuedexta
268228|NCT01806857|Bulbar function|bulbar function
268229|NCT01806857|motor neurons|motor neurons
268230|NCT01806844|Cardiac arrest|cardiac arrest
268231|NCT01806844|Cerebral oxygenation|cerebral oxygenation
268232|NCT01806844|Pre-hospital|pre-hospital
268233|NCT01806805|Movement disorder|movement disorder
268234|NCT01806805|Myoclonus dystonia|myoclonus dystonia
268235|NCT01806805|DYT 11|dyt 11
268236|NCT01806805|Antiepileptic drugs|antiepileptic drugs
268237|NCT01806805|Zonisamide|zonisamide
268238|NCT01806805|Clinical Trial|clinical trial
268239|NCT01806805|Double-mind method|double-mind method
268240|NCT01806792|Osteoporosis|osteoporosis
268241|NCT01806779|Nicotine addiction|nicotine addiction
268242|NCT01806779|Cigarette smoking|cigarette smoking
268243|NCT01806779|Smoking cessation|smoking cessation
268244|NCT01806779|Zyban|zyban
268245|NCT01806779|Chantix|chantix
268246|NCT01806779|Nicotine patches|nicotine patches
268247|NCT01806779|varenicline|varenicline
268248|NCT01806779|bupropion|bupropion
268249|NCT01806766|cementless total hip arthroplasty|cementless total hip arthroplasty
268250|NCT01806766|ceramic on ceramic bearing|ceramic on ceramic bearing
268251|NCT01806766|ceramic on highly cross linked polyethylene|ceramic on highly cross linked polyethylene
268252|NCT01806766|young patient|young patient
268253|NCT01806753|Endoscopic submucosal dissection|endoscopic submucosal dissection
268254|NCT01806753|Sedation|sedation
268255|NCT01806753|Propofol|propofol
268256|NCT01806753|Midazolam|midazolam
268257|NCT01806740|DCE-MRI|dce-mri
268258|NCT01806740|Sorafenib response|sorafenib response
268259|NCT01806727|Diabetes|diabetes
268260|NCT01806727|Diabetes Self Management|diabetes self management
268261|NCT01806727|LIFT Diabetes|lift diabetes
268262|NCT01806727|Weight Loss|weight loss
268263|NCT01806727|Diet|diet
268264|NCT01806727|Physical Activity|physical activity
268265|NCT01806727|Overweight|overweight
268266|NCT01806727|Obese|obese
268267|NCT01806714|HPV vaccination|hpv vaccination
268268|NCT01806714|Adolescent well care|adolescent well care
268269|NCT01806714|Adolescent HPV immunization|adolescent hpv immunization
268270|NCT01806714|HPV|hpv
268271|NCT01806701|fMRI|fmri
268272|NCT01806701|neuroimaging|neuroimaging
268273|NCT01806701|PTSD|ptsd
268274|NCT01806701|adolescent|adolescent
268275|NCT01806701|trauma|trauma
268276|NCT01806701|brain|brain
268277|NCT01806688|satiety|satiety
268278|NCT01806688|appetite|appetite
268279|NCT01806688|snack|snack
268280|NCT01806662|Atopic Dermatitis|atopic dermatitis
268281|NCT01806662|Eczema|eczema
268282|NCT01806649|esophageal cancer|esophageal cancer
268283|NCT01806649|second line therapy|second line therapy
268284|NCT01806649|BKM120|bkm120
268285|NCT01806636|Coil|coil
268286|NCT01806636|RePneu|repneu
268287|NCT01806636|PneumRx|pneumrx
268288|NCT01806636|LVRC|lvrc
268289|NCT01806610|Randomized|randomized
268290|NCT01806610|Placebo-controlled trial|placebo-controlled trial
268291|NCT01806610|BPS804|bps804
268879|NCT01804244|Healthy|healthy
268292|NCT01806610|Safety, tolerability, and PK|safety, tolerability, and pk
268293|NCT01806610|Patients with late-stage chronic kidney disease.|patients with late-stage chronic kidney disease.
268294|NCT01806597|Moderate palmoplantar psoriasis|moderate palmoplantar psoriasis
268295|NCT01806597|Severe palmoplantar psoriasis|severe palmoplantar psoriasis
268296|NCT01806597|psoriasis|psoriasis
268297|NCT01806597|Secukinumab|secukinumab
268298|NCT01806584|Vascular Injury|vascular injury
268299|NCT01806584|Arteriovenous Graft Surgery|arteriovenous graft surgery
268300|NCT01806584|Hemodialysis Access|hemodialysis access
268301|NCT01806558|Breast cancer|breast cancer
268302|NCT01806558|molecular breast imaging|molecular breast imaging
268303|NCT01806558|breast|breast
268305|NCT01806545|Arteriovenous Fistula Surgery|arteriovenous fistula surgery
268306|NCT01806545|Vascular Injury|vascular injury
268307|NCT01806545|Hemodialysis Access|hemodialysis access
268308|NCT01806532|computed tomography and positron emission tomography|computed tomography and positron emission tomography
268309|NCT01806532|respiration, artificial|respiration, artificial
268310|NCT01806532|respiratory distress syndrome, adult|respiratory distress syndrome, adult
268311|NCT01806519|neck pain|neck pain
268312|NCT01806519|motor control|motor control
268313|NCT01806519|intervention|intervention
268314|NCT01806519|forward head posture|forward head posture
268315|NCT01806506|Bariatric surgery|bariatric surgery
268316|NCT01806506|Gastric bypass|gastric bypass
268317|NCT01806506|Sleeve gastrectomy|sleeve gastrectomy
268318|NCT01806506|Weight loss|weight loss
268319|NCT01806506|Lipoproteins|lipoproteins
268320|NCT01806506|Insulin resistance|insulin resistance
268321|NCT01806506|Incretins|incretins
268322|NCT01806506|Quality of life|quality of life
268323|NCT01806493|body composition|body composition
268324|NCT01806493|obesity|obesity
268325|NCT01806480|Breastfeeding, Preterm Infant, Neonatal Care, Support, Mothers.|breastfeeding, preterm infant, neonatal care, support, mothers.
268326|NCT01806415|Fenobam,|fenobam,
268327|NCT01806415|Pharmacokinetics|pharmacokinetics
268328|NCT01806415|side effects|side effects
268329|NCT01806389|Breast milk|breast milk
268330|NCT01806389|Breastfeeding|breastfeeding
268331|NCT01806389|Lactation|lactation
268332|NCT01806389|Buprenorphine|buprenorphine
268333|NCT01806389|Opioid|opioid
268334|NCT01806363|Pharmacokinetics|pharmacokinetics
268335|NCT01806363|Safety|safety
268336|NCT01806363|Male|male
268337|NCT01806350|Pelvic floor muscle training; incontinence; quality of life|pelvic floor muscle training; incontinence; quality of life
268338|NCT01806337|peripheral T cell lymphoma|peripheral t cell lymphoma
268339|NCT01806337|alemtuzumab|alemtuzumab
268340|NCT01806337|consolidation|consolidation
268341|NCT01806311|Pharmacokinetics|pharmacokinetics
268342|NCT01806311|Safety|safety
268343|NCT01806311|Male|male
268344|NCT01806298|Adult Growth hormone deficiency|adult growth hormone deficiency
268345|NCT01806298|Saizen®|saizen®
268346|NCT01806298|Recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
268347|NCT01806298|Somatropin|somatropin
268348|NCT01806285|Respiratory Virus|respiratory virus
268349|NCT01806272|rhGM-CSF|rhgm-csf
268350|NCT01806272|Oral Mucositis|oral mucositis
268351|NCT01806272|Primary Nasopharyngeal Cancers|primary nasopharyngeal cancers
268352|NCT01806272|Chemoradiotherapy|chemoradiotherapy
268353|NCT01806246|rehabilitation|rehabilitation
268354|NCT01806246|adolescent|adolescent
268355|NCT01806246|heart rate variability biofeedback|heart rate variability biofeedback
268356|NCT01806246|psychoeducation|psychoeducation
268357|NCT01806220|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
268358|NCT01806220|Chronic Laryngitis|chronic laryngitis
268359|NCT01806220|Epidermal Growth factor receptor|epidermal growth factor receptor
268360|NCT01806168|Post-traumatic stress disorder|post-traumatic stress disorder
268361|NCT01806168|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
268362|NCT01806168|Civilians|civilians
268363|NCT01806168|Neurostimulation|neurostimulation
268364|NCT01806168|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
268365|NCT01806155|craniotomy|craniotomy
268366|NCT01806155|headache|headache
268367|NCT01806155|postoperative|postoperative
268368|NCT01806116|myelodysplastic syndrome|myelodysplastic syndrome
268369|NCT01806116|higher-risk|higher-risk
268370|NCT01806116|acute myeloid leukemia|acute myeloid leukemia
268371|NCT01806116|relapsed /refractory|relapsed /refractory
268372|NCT01806116|decitabine|decitabine
268373|NCT01806116|hematopoietic cell transplantation|hematopoietic cell transplantation
268374|NCT01806116|bridge therapy|bridge therapy
268375|NCT01806103|antimicrobial stewardship program|antimicrobial stewardship program
402981|NCT01228760|Pharmacokinetics of ASG-5ME|pharmacokinetics of asg-5me
268376|NCT01806103|inappropriate prescribing of antibiotics|inappropriate prescribing of antibiotics
268377|NCT01806103|physician prescribing|physician prescribing
268378|NCT01806103|antibiotic prescribing for respiratory tract infections|antibiotic prescribing for respiratory tract infections
268379|NCT01806103|respiratory tract infections|respiratory tract infections
268380|NCT01806077|Cardiovascular Diseases|cardiovascular diseases
268381|NCT01806077|Vascular Diseases|vascular diseases
268382|NCT01806077|Coronary Artery Disease|coronary artery disease
268383|NCT01806077|Coronary Disease|coronary disease
268384|NCT01806077|Arteriosclerosis|arteriosclerosis
268385|NCT01806077|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
268386|NCT01806064|TRC105|trc105
268387|NCT01806064|CD105|cd105
268388|NCT01806064|RCC|rcc
268389|NCT01806064|Renal Cell Carcinoma|renal cell carcinoma
268390|NCT01806064|Axitinib|axitinib
268391|NCT01806064|INLYTA|inlyta
268392|NCT01806064|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
268393|NCT01806038|Adverse events|adverse events
696101|NCT00944957|Tritherapy|tritherapy
268394|NCT01806038|Drug interactions|drug interactions
268395|NCT01806038|Healthcare utilization|healthcare utilization
268396|NCT01806038|Discharge medication counseling|discharge medication counseling
268397|NCT01806025|Cystic Fibrosis|cystic fibrosis
268398|NCT01806025|Haptoglobin|haptoglobin
268399|NCT01806012|Supracervical Hysterectomy|supracervical hysterectomy
268400|NCT01806012|Leiomyomas|leiomyomas
268401|NCT01806012|Adenomyosis|adenomyosis
268402|NCT01805999|Ispaghula|ispaghula
268403|NCT01805999|Gastrointestinal physiology|gastrointestinal physiology
268404|NCT01805999|Gastrointestinal response to sugars|gastrointestinal response to sugars
268405|NCT01805999|MRI|mri
268406|NCT01805999|gastrointestinal|gastrointestinal
268407|NCT01805999|stomach|stomach
268408|NCT01805999|small bowel|small bowel
268409|NCT01805999|colon|colon
268410|NCT01805986|Multiple Sclerosis, other neurological conditions|multiple sclerosis, other neurological conditions
268411|NCT01805934|Helicobacter pylori, rescue, quadruple therapy，dual therapy|helicobacter pylori, rescue, quadruple therapy，dual therapy
268412|NCT01805921|Respiratory Syncytial Virus|respiratory syncytial virus
268413|NCT01805921|RSV|rsv
268414|NCT01805921|Vaccine|vaccine
268415|NCT01805908|metastatic|metastatic
268416|NCT01805908|breast cancer|breast cancer
268417|NCT01805908|herceptin|herceptin
268418|NCT01805908|imaging|imaging
268419|NCT01805908|tumour response|tumour response
268420|NCT01805908|adenocarcinoma|adenocarcinoma
268421|NCT01805908|SPECT-CT|spect-ct
268422|NCT01805908|pertuzumab|pertuzumab
268423|NCT01805908|trastuzumab|trastuzumab
268424|NCT01805908|locally advanced|locally advanced
268425|NCT01805895|Stroke|stroke
268426|NCT01805895|Acute Intracerebral Hemorrhage|acute intracerebral hemorrhage
268427|NCT01805895|Intracerebral Hemorrhage|intracerebral hemorrhage
268428|NCT01805895|Hemorrhagic stroke|hemorrhagic stroke
268429|NCT01805895|Hemorrhage|hemorrhage
268430|NCT01805895|Minocycline|minocycline
268431|NCT01805882|Interferon Sparing|interferon sparing
268432|NCT01805882|Directly Acting Antiviral|directly acting antiviral
268433|NCT01805882|Ribavarin Sparing|ribavarin sparing
268434|NCT01805869|Third Molar|third molar
268435|NCT01805869|Specimen Acquisition|specimen acquisition
268436|NCT01805856|antimicrobial prophylaxis|antimicrobial prophylaxis
268437|NCT01805856|AMP|amp
268438|NCT01805856|surgical site infection|surgical site infection
268439|NCT01805856|SSI|ssi
268440|NCT01805856|thyroid|thyroid
268441|NCT01805856|thyroidectomy|thyroidectomy
268442|NCT01805856|parathyroid|parathyroid
268443|NCT01805856|surgery|surgery
268444|NCT01805843|Pulmonary hypertension|pulmonary hypertension
268445|NCT01805843|chronic myeloid leukemia|chronic myeloid leukemia
268446|NCT01805843|dasatinib|dasatinib
268447|NCT01805843|nilotinib|nilotinib
268448|NCT01805830|Type2DM / DPP-IV inhibitors|type2dm / dpp-iv inhibitors
268449|NCT01805817|lipid profile|lipid profile
268450|NCT01805817|bleeding scores|bleeding scores
268451|NCT01805817|menstrual pattern|menstrual pattern
268452|NCT01805817|beneficial|beneficial
268453|NCT01805817|side effects|side effects
268454|NCT01805817|changes in a year period|changes in a year period
268455|NCT01805804|dual chamber pacing, left ventricle remodeling, valsartan|dual chamber pacing, left ventricle remodeling, valsartan
268456|NCT01805791|Ulcerative Colitis,|ulcerative colitis,
268457|NCT01805791|UC|uc
268458|NCT01805791|Patients|patients
268459|NCT01805791|active|active
268460|NCT01805791|mild|mild
268461|NCT01805791|moderate|moderate
268462|NCT01805765|menopausal syndrome|menopausal syndrome
268463|NCT01805765|climacteric syndrome|climacteric syndrome
268464|NCT01805765|Hot flashes|hot flashes
268465|NCT01805765|Sweat|sweat
268466|NCT01805752|Prevention of mother to child HIV transmission|prevention of mother to child hiv transmission
268467|NCT01805752|HIV/AIDS|hiv/aids
268468|NCT01805739|transcatheter aortic valve implantation|transcatheter aortic valve implantation
268469|NCT01805739|CT|ct
268470|NCT01805739|MRI|mri
268471|NCT01805739|angiography|angiography
268472|NCT01805739|echocardiography|echocardiography
268473|NCT01805739|rotational C-arm CT|rotational c-arm ct
268474|NCT01805726|bronchoscopy|bronchoscopy
268475|NCT01805726|sedation|sedation
268476|NCT01805726|pulmonary function|pulmonary function
268477|NCT01805726|tolerance|tolerance
268478|NCT01805726|xylocain|xylocain
268479|NCT01805726|dexmedetomidine|dexmedetomidine
268480|NCT01805726|alfentanil|alfentanil
268481|NCT01805713|Biomarkers|biomarkers
268482|NCT01805700|type 1|type 1
268483|NCT01805700|diabetes|diabetes
268484|NCT01805700|caffeine-enhanced energy drink|caffeine-enhanced energy drink
268485|NCT01805700|cardiac output|cardiac output
268486|NCT01805700|glucose|glucose
268487|NCT01805700|cognitive performance|cognitive performance
268488|NCT01805674|menopause|menopause
268489|NCT01805674|quality of life|quality of life
268490|NCT01805674|soy isoflavones|soy isoflavones
268491|NCT01805674|magnolia extract|magnolia extract
268492|NCT01805661|early ambulation|early ambulation
268493|NCT01805661|knee arthroplasty|knee arthroplasty
268494|NCT01805648|ITP|itp
268495|NCT01805648|rhTPO|rhtpo
268496|NCT01805635|Children|children
268497|NCT01805635|Asthma|asthma
268498|NCT01805635|Allergic rhinitis|allergic rhinitis
268499|NCT01805635|Atopic dermatitis|atopic dermatitis
268500|NCT01805635|Urticaria|urticaria
268501|NCT01805635|Healthy|healthy
268502|NCT01805622|community-based participatory research|community-based participatory research
268503|NCT01805622|colorectal cancer screening|colorectal cancer screening
268504|NCT01805609|practice nurse|practice nurse
268505|NCT01805609|clinical Nurse|clinical nurse
268506|NCT01805609|inpatient staff|inpatient staff
268507|NCT01805609|inpatient social worker|inpatient social worker
268508|NCT01805609|didactic training sessions|didactic training sessions
268509|NCT01805609|13-030|13-030
268510|NCT01805596|coronary artery disease|coronary artery disease
268511|NCT01805596|endothelial function|endothelial function
268512|NCT01805596|antiplatelet agent|antiplatelet agent
268513|NCT01805570|platelet inhibitor|platelet inhibitor
268514|NCT01805570|ST-segment Elevation|st-segment elevation
268515|NCT01805570|Myocardial Infarction|myocardial infarction
268516|NCT01805570|stent|stent
268517|NCT01805570|prasugrel|prasugrel
268518|NCT01805570|ticagrelor|ticagrelor
268519|NCT01805557|Diffuse Large B-cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
268520|NCT01805557|Bortezomib|bortezomib
268521|NCT01805544|SF36 questionnaire|sf36 questionnaire
268522|NCT01805544|Anti Clot Treatment Scale|anti clot treatment scale
268523|NCT01805544|Satisfaction|satisfaction
268524|NCT01805544|Quality of Life|quality of life
268525|NCT01805544|Rivaroxaban|rivaroxaban
268526|NCT01805544|Prevention & control|prevention & control
268817|NCT01804426|bio-Markers|bio-markers
268527|NCT01805544|Pulmonary embolism|pulmonary embolism
268528|NCT01805531|SF36 questionnaire|sf36 questionnaire
268529|NCT01805531|Anti Clot Treatment Scale|anti clot treatment scale
268530|NCT01805531|Satisfaction|satisfaction
268531|NCT01805531|Quality of Life|quality of life
268532|NCT01805531|Rivaroxaban|rivaroxaban
268533|NCT01805531|Stroke prevention|stroke prevention
268535|NCT01805518|Tower of London|tower of london
268536|NCT01805518|Letter-Number Test|letter-number test
268537|NCT01805518|Trail Making Test|trail making test
268538|NCT01805518|Vital signs|vital signs
268539|NCT01805518|Mood|mood
268540|NCT01805518|Suicidal ideation|suicidal ideation
268541|NCT01805518|ECG|ecg
268542|NCT01805518|Physical exam|physical exam
268543|NCT01805518|Blood|blood
268544|NCT01805518|Urine (Including pregnancy and drug screen)|urine (including pregnancy and drug screen)
268545|NCT01805518|Cytokines|cytokines
268546|NCT01805518|Side effects|side effects
268547|NCT01805518|Brief Psychiatric Rating Scale|brief psychiatric rating scale
268548|NCT01805518|Positive and Negative Symptom Scale|positive and negative symptom scale
268549|NCT01805505|Female infertility|female infertility
268550|NCT01805505|Oocyte donation|oocyte donation
268551|NCT01805505|Embryo transfer|embryo transfer
268552|NCT01805505|Transvaginal ultrasonography|transvaginal ultrasonography
268553|NCT01805505|Transabdominal ultrasonography|transabdominal ultrasonography
268554|NCT01805492|Heart diseases|heart diseases
268555|NCT01805492|Cardiovascular diseases|cardiovascular diseases
268556|NCT01805492|Lifestyle modification|lifestyle modification
268557|NCT01805492|Diet|diet
268558|NCT01805492|Exercise|exercise
268559|NCT01805479|exercise|exercise
268560|NCT01805479|depression|depression
268561|NCT01805479|traumatic brain injury|traumatic brain injury
268562|NCT01805466|Extracorporeal Vacuum Assisted Device Optimised (EVADO)|extracorporeal vacuum assisted device optimised (evado)
268563|NCT01805453|Glioblastoma|glioblastoma
268564|NCT01805453|Angiotensin-II inhibitors|angiotensin-ii inhibitors
268565|NCT01805453|Losartan|losartan
268566|NCT01805453|steroids|steroids
268567|NCT01805453|Radiotherapy|radiotherapy
268568|NCT01805453|Edema|edema
268569|NCT01805453|Randomized trial|randomized trial
268570|NCT01805440|Adolescent|adolescent
268571|NCT01805440|Bipolar Disorder|bipolar disorder
268572|NCT01805440|Bipolar Depression|bipolar depression
268573|NCT01805440|Manic Depression|manic depression
268574|NCT01805440|Neuroimaging|neuroimaging
268575|NCT01805440|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
268576|NCT01805440|Uridine|uridine
268577|NCT01805440|Pyrimidines|pyrimidines
268578|NCT01805427|trough concentration|trough concentration
268579|NCT01805427|weight|weight
268580|NCT01805427|HIV|hiv
268581|NCT01805427|virological failure|virological failure
268582|NCT01805414|inpatient diabetes|inpatient diabetes
268583|NCT01805414|inpatient diabetes nutrition|inpatient diabetes nutrition
268584|NCT01805401|Decision-making|decision-making
268585|NCT01805401|Impulse control|impulse control
268586|NCT01805401|Transcranial direct current stimulation|transcranial direct current stimulation
268587|NCT01805401|Brain stimulation|brain stimulation
268588|NCT01805401|Neuromodulation|neuromodulation
268589|NCT01805401|tDCS|tdcs
268590|NCT01805401|Iowa Gambling Task|iowa gambling task
268591|NCT01805401|Stroop Word-Color Task|stroop word-color task
696102|NCT00944957|compliance|compliance
268592|NCT01805388|Dental Pulp Regeneration|dental pulp regeneration
268593|NCT01805375|Phase I, Cancer, CD19 positive, B-Cell lymphoma, chronic lymphocytic leukaemia|phase i, cancer, cd19 positive, b-cell lymphoma, chronic lymphocytic leukaemia
268594|NCT01805375|Waldenström Macroglobulinaemia|waldenström macroglobulinaemia
268595|NCT01805336|Relapsing-Remitting MS|relapsing-remitting ms
268596|NCT01805336|cognitive impairment|cognitive impairment
268597|NCT01805336|virtual reality|virtual reality
268598|NCT01805310|Pelvic organ prolapse|pelvic organ prolapse
268599|NCT01805310|Prolapse|prolapse
268600|NCT01805310|Cathartics|cathartics
268601|NCT01805310|Mechanical bowel preparation|mechanical bowel preparation
268602|NCT01805297|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
268603|NCT01805284|pneumonia|pneumonia
268604|NCT01805271|ER-positive HER2-negative|er-positive her2-negative
268605|NCT01805258|India|india
268606|NCT01805258|Nevirapine|nevirapine
268607|NCT01805258|Rifampicin|rifampicin
268608|NCT01805258|Efavirenz|efavirenz
268609|NCT01805258|HIV|hiv
268610|NCT01805258|TB|tb
268611|NCT01805232|severe|severe
268612|NCT01805232|Falciaparum|falciaparum
268613|NCT01805232|Malaria|malaria
268614|NCT01805206|Prematurity|prematurity
268615|NCT01805206|Necrotizing Enterocolitis|necrotizing enterocolitis
268616|NCT01805206|Biomarkers|biomarkers
268617|NCT01805206|Intestinal Fatty Acid Binding Protein|intestinal fatty acid binding protein
268618|NCT01805206|Feeding|feeding
268619|NCT01805193|Coronary heart disease|coronary heart disease
268620|NCT01805193|computed tomography myocardial perfusion|computed tomography myocardial perfusion
268621|NCT01805193|positron emission tomography|positron emission tomography
268622|NCT01805193|oxygen 15 labelled water|oxygen 15 labelled water
268623|NCT01805193|myocardial perfusion|myocardial perfusion
268624|NCT01805193|myocardial blood flow|myocardial blood flow
268625|NCT01805167|Subject with cochlear implant|subject with cochlear implant
268626|NCT01805141|Cervix Uteri|cervix uteri
268627|NCT01805128|Schizophrenia|schizophrenia
268628|NCT01805128|Autistic Disorder|autistic disorder
268629|NCT01805128|social cognition|social cognition
268630|NCT01805115|hysteroscopy|hysteroscopy
268631|NCT01805115|misoprostol|misoprostol
268632|NCT01805102|In vitro fertilization|in vitro fertilization
268633|NCT01805102|implantation|implantation
268634|NCT01805102|miscarriage|miscarriage
268635|NCT01805102|live birth|live birth
268636|NCT01805063|firefighters|firefighters
268637|NCT01805063|myocardial infarction|myocardial infarction
268638|NCT01805063|endothelial function|endothelial function
268639|NCT01805063|thrombosis|thrombosis
268640|NCT01805063|fire suppression|fire suppression
268641|NCT01805063|non-fire emergency duty|non-fire emergency duty
268642|NCT01805063|sedentary shift|sedentary shift
268643|NCT01805050|HAGL|hagl
268644|NCT01805050|Shoulder instability|shoulder instability
268645|NCT01804998|laparoscopic sentinel lymph node biopsy|laparoscopic sentinel lymph node biopsy
268646|NCT01804998|phase 3|phase 3
268647|NCT01804998|early gastric cancer|early gastric cancer
268648|NCT01804972|Patient information|patient information
268649|NCT01804972|Vascular disease|vascular disease
268650|NCT01804972|Abdominal aortic aneurysm|abdominal aortic aneurysm
268651|NCT01804972|Varicose veins|varicose veins
268652|NCT01804972|Web based information|web based information
268653|NCT01804933|profound muscle relaxation|profound muscle relaxation
268654|NCT01804933|muscle trauma|muscle trauma
268655|NCT01804933|postoperative analgesic demand|postoperative analgesic demand
268656|NCT01804933|postoperative pulmonary function|postoperative pulmonary function
268657|NCT01804907|HAART adherence|haart adherence
268658|NCT01804907|HIV|hiv
268659|NCT01804907|Fatigue|fatigue
268660|NCT01804907|treatment|treatment
268661|NCT01804868|case vignette|case vignette
268662|NCT01804868|nurse|nurse
268663|NCT01804868|critical assessment|critical assessment
268664|NCT01804868|randomized controlled trial|randomized controlled trial
268665|NCT01804855|Obesity; mobile health; telemedicine; family-based treatment|obesity; mobile health; telemedicine; family-based treatment
268666|NCT01804829|HCV Liver Transplant Immunoglobulin PCR SVR|hcv liver transplant immunoglobulin pcr svr
268667|NCT01804816|Chronic Heart Failure|chronic heart failure
268668|NCT01804816|Heart Failure|heart failure
268669|NCT01804803|glycated hemoglobin|glycated hemoglobin
268670|NCT01804803|hyperglycemia|hyperglycemia
268671|NCT01804803|hypoglycemia|hypoglycemia
268672|NCT01804803|insulin|insulin
268673|NCT01804803|self-monitoring of blood glucose|self-monitoring of blood glucose
268674|NCT01804803|telemedicine|telemedicine
268675|NCT01804790|rectum|rectum
268676|NCT01804790|cancer|cancer
268677|NCT01804790|locally advanced|locally advanced
268678|NCT01804777|ENaC|enac
268679|NCT01804777|Amiloride|amiloride
268680|NCT01804777|Hydrochlorothiazide(HCTZ)|hydrochlorothiazide(hctz)
268681|NCT01804777|Hypertension|hypertension
268682|NCT01804777|Type II Diabetes|type ii diabetes
268683|NCT01804777|Natriuresis|natriuresis
268685|NCT01804764|Severe Sepsis|severe sepsis
268686|NCT01804764|Septic Shock|septic shock
268687|NCT01804764|Sepsis Six bundle|sepsis six bundle
268688|NCT01804738|Ethnic differences|ethnic differences
268689|NCT01804738|Inter-individual variability|inter-individual variability
268690|NCT01804738|Glycemic response|glycemic response
268691|NCT01804738|Insulin response|insulin response
268692|NCT01804738|Mastication|mastication
268693|NCT01804738|Salivary alpha-amylase|salivary alpha-amylase
268694|NCT01804738|Gastric emptying|gastric emptying
268695|NCT01804738|Metagenome|metagenome
268696|NCT01804725|bike seats|bike seats
268697|NCT01804725|Erectile dysfunction|erectile dysfunction
268698|NCT01804725|Perineum|perineum
268699|NCT01804725|Impotence|impotence
268700|NCT01804712|Prostate|prostate
268701|NCT01804712|Cancer|cancer
268702|NCT01804712|Castration-resistant|castration-resistant
268703|NCT01804712|Rituximab|rituximab
268704|NCT01804712|neoadjuvant|neoadjuvant
268705|NCT01804712|Rituxan|rituxan
268706|NCT01804699|ARVC, Cardiomyopathy|arvc, cardiomyopathy
268707|NCT01804686|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
268708|NCT01804686|Small lymphocytic lymphoma|small lymphocytic lymphoma
268709|NCT01804686|Mantle cell lymphoma|mantle cell lymphoma
268710|NCT01804686|Follicular lymphoma|follicular lymphoma
268711|NCT01804686|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
268712|NCT01804686|PCI-32765|pci-32765
268713|NCT01804686|Ibrutinib|ibrutinib
268714|NCT01804686|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
268715|NCT01804686|IMBRUVICA|imbruvica
268716|NCT01804686|JNJ-54179060|jnj-54179060
268717|NCT01804673|Postoperative Pain|postoperative pain
268718|NCT01804673|Fentanyl Hydrochloride|fentanyl hydrochloride
268719|NCT01804673|IONSYS|ionsys
268720|NCT01804660|Multiple Sclerosis (MS)|multiple sclerosis (ms)
268721|NCT01804660|Multiple Sclerosis associated RetroVirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
268722|NCT01804660|MSRV envelop protein (MSRV-Env)|msrv envelop protein (msrv-env)
268723|NCT01804647|Multiple sclerosis (MS)|multiple sclerosis (ms)
268724|NCT01804647|Relapsing-Remitting MS|relapsing-remitting ms
268725|NCT01804647|Primary progressive MS|primary progressive ms
268726|NCT01804647|Secondary progressive MS|secondary progressive ms
268727|NCT01804647|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
268728|NCT01804647|Multiple Sclerosis associated RetroVirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
268729|NCT01804647|MSRV envelop protein (MSRV-Env)|msrv envelop protein (msrv-env)
268730|NCT01804634|Solid Tumors|solid tumors
268731|NCT01804634|Neuroblastoma|neuroblastoma
268732|NCT01804634|Osteosarcoma|osteosarcoma
268733|NCT01804634|Ewing Sarcoma|ewing sarcoma
268734|NCT01804634|Rhabdomyosarcoma|rhabdomyosarcoma
268735|NCT01804634|Hepatoblastoma|hepatoblastoma
268736|NCT01804634|Melanoma|melanoma
268737|NCT01804634|Desmoplastic Round Cell Tumor|desmoplastic round cell tumor
268738|NCT01804634|brain tumors|brain tumors
268739|NCT01804621|Exercise|exercise
268740|NCT01804621|Nutrition|nutrition
268741|NCT01804621|Mammography|mammography
268742|NCT01804621|Colorectal screening|colorectal screening
268743|NCT01804595|Worksite intervention|worksite intervention
268744|NCT01804595|Sun protection intervention|sun protection intervention
268745|NCT01804595|Operating Engineers|operating engineers
268746|NCT01804582|Family navigator|family navigator
268747|NCT01804582|Patient Centered Outcomes|patient centered outcomes
268748|NCT01804582|Pediatric Antipsychotic treatment|pediatric antipsychotic treatment
268749|NCT01804556|muscle cramps, trigger points, sleep disturbance|muscle cramps, trigger points, sleep disturbance
268750|NCT01804530|solid tumors|solid tumors
268751|NCT01804530|activating NTRK point or fusion mutations|activating ntrk point or fusion mutations
268752|NCT01804530|Tenosynovial giant cell tumor|tenosynovial giant cell tumor
268753|NCT01804530|TGCT|tgct
268754|NCT01804517|migraine|migraine
268755|NCT01804504|Metabolic syndrome|metabolic syndrome
268756|NCT01804504|Eating out of home|eating out of home
268757|NCT01804504|Nutrition education|nutrition education
268758|NCT01804465|castration resistant|castration resistant
268759|NCT01804465|prostate|prostate
268760|NCT01804465|cancer|cancer
268761|NCT01804465|ipilimumab|ipilimumab
268762|NCT01804465|provenge|provenge
268763|NCT01804465|SipT|sipt
268764|NCT01804452|Progressive Supranuclear Palsy|progressive supranuclear palsy
268765|NCT01804452|Corticobasal Degeneration|corticobasal degeneration
268766|NCT01804452|Biomarker|biomarker
268767|NCT01804452|Neuroimaging|neuroimaging
268768|NCT01804452|MRI|mri
268769|NCT01804452|Tau|tau
268770|NCT01804452|Oculomotor|oculomotor
268771|NCT01804439|Heart diseases|heart diseases
268772|NCT01804439|Cardiovascular diseases|cardiovascular diseases
268773|NCT01804439|Coronary heart disease not otherwise specified|coronary heart disease not otherwise specified
268774|NCT01804439|Cerebrovascular disorders|cerebrovascular disorders
268775|NCT01804439|Brain diseases|brain diseases
268776|NCT01804439|Central nervous system diseases|central nervous system diseases
268777|NCT01804439|Nervous system diseases|nervous system diseases
268778|NCT01804439|Atherosclerosis|atherosclerosis
268779|NCT01804439|Arteriosclerosis|arteriosclerosis
268780|NCT01804439|Pathologic processes|pathologic processes
268781|NCT01804439|Acute myocardial infarction|acute myocardial infarction
268782|NCT01804439|Myocardial infarction|myocardial infarction
268783|NCT01804439|Myocardial ischemia|myocardial ischemia
268784|NCT01804439|Infarction|infarction
268785|NCT01804439|Necrosis|necrosis
268786|NCT01804439|Unstable angina|unstable angina
268787|NCT01804439|Chronic stable angina|chronic stable angina
268788|NCT01804439|Stable angina|stable angina
268789|NCT01804439|Angina pectoris|angina pectoris
268790|NCT01804439|Chest pain|chest pain
268791|NCT01804439|Pain|pain
268792|NCT01804439|Signs and symptoms|signs and symptoms
268793|NCT01804439|Ischemia|ischemia
268794|NCT01804439|Ischemic stroke|ischemic stroke
268795|NCT01804439|Hemorrhagic stroke|hemorrhagic stroke
268796|NCT01804439|Stroke|stroke
268797|NCT01804439|Subarachnoid hemorrhage|subarachnoid hemorrhage
268798|NCT01804439|Transient ischemic attack|transient ischemic attack
268799|NCT01804439|Abdominal aortic aneurysm|abdominal aortic aneurysm
268800|NCT01804439|Aneurysm|aneurysm
268801|NCT01804439|Aortic aneurysm|aortic aneurysm
268802|NCT01804439|Aortic aneurysm, abdominal|aortic aneurysm, abdominal
268803|NCT01804439|Aortic diseases|aortic diseases
268804|NCT01804439|Peripheral arterial diseases|peripheral arterial diseases
268805|NCT01804439|Peripheral vascular diseases|peripheral vascular diseases
268806|NCT01804439|Vascular diseases|vascular diseases
268807|NCT01804439|Peripheral occlusive diseases|peripheral occlusive diseases
268808|NCT01804439|Sudden coronary death|sudden coronary death
268809|NCT01804439|Ventricular arrhythmia|ventricular arrhythmia
268810|NCT01804439|Sudden cardiac death|sudden cardiac death
268811|NCT01804439|Cardiac arrest|cardiac arrest
268812|NCT01804439|Heart failure|heart failure
268813|NCT01804426|PTSD|ptsd
268814|NCT01804426|Post Traumatic Stress Disorder|post traumatic stress disorder
268815|NCT01804426|Cortisol|cortisol
268816|NCT01804426|Alpha-Amylase|alpha-amylase
268818|NCT01804413|Pegvisomant|pegvisomant
268819|NCT01804413|Growth hormone|growth hormone
268820|NCT01804413|Cortisol|cortisol
268821|NCT01804413|Glucagon|glucagon
268822|NCT01804413|Insulin|insulin
268823|NCT01804387|Chronic Hepatitis B|chronic hepatitis b
268824|NCT01804387|Telbivudine|telbivudine
268825|NCT01804387|Adefovir|adefovir
268826|NCT01804387|Lamivudine resistance|lamivudine resistance
268827|NCT01804374|osteosarcoma|osteosarcoma
268828|NCT01804374|sorafenib|sorafenib
268829|NCT01804374|everolimus|everolimus
268830|NCT01804374|sarcoma|sarcoma
268831|NCT01804361|Dry Eye Syndromes|dry eye syndromes
268832|NCT01804348|PROM|prom
268833|NCT01804335|Lymphoma|lymphoma
268834|NCT01804335|Early Stage Cutaneous T-Cell Lymphoma|early stage cutaneous t-cell lymphoma
268835|NCT01804335|CTCL|ctcl
268836|NCT01804335|CD5789 0.01% cream|cd5789 0.01% cream
268837|NCT01804322|epilepsy|epilepsy
268838|NCT01804322|chronic comorbidities|chronic comorbidities
268839|NCT01804322|educational strategies|educational strategies
268840|NCT01804322|drug interactions|drug interactions
268841|NCT01804322|drug adverse effects|drug adverse effects
268842|NCT01804309|axyllary lymph node|axyllary lymph node
268843|NCT01804309|sentinel lymph node|sentinel lymph node
268844|NCT01804309|lymphatic drainage|lymphatic drainage
268845|NCT01804309|early breast cancer|early breast cancer
268846|NCT01804309|axillary lymph node dissection|axillary lymph node dissection
268847|NCT01804296|Teen|teen
268848|NCT01804296|Adolescent|adolescent
268849|NCT01804296|Depression|depression
268850|NCT01804296|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
268851|NCT01804296|TMS|tms
268852|NCT01804270|Teen|teen
268853|NCT01804270|Adolescent|adolescent
268854|NCT01804270|Depression|depression
268855|NCT01804270|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
268856|NCT01804270|TMS|tms
268857|NCT01804257|Adherence|adherence
268858|NCT01804257|Bipolar disorder|bipolar disorder
268859|NCT01804257|Cellular phone|cellular phone
268860|NCT01804257|Cloud computing|cloud computing
268861|NCT01804257|Computers|computers
268862|NCT01804257|Computers, handheld|computers, handheld
268863|NCT01804257|Digital health|digital health
268864|NCT01804257|Digital health feedback system|digital health feedback system
268865|NCT01804257|Ingestion Sensor|ingestion sensor
268866|NCT01804257|Medication adherence|medication adherence
268867|NCT01804257|Medication non-adherence|medication non-adherence
268868|NCT01804257|Medication nonadherence|medication nonadherence
268869|NCT01804257|Mobile phone|mobile phone
268870|NCT01804257|Mobile health|mobile health
268871|NCT01804257|Patient adherence|patient adherence
268872|NCT01804257|Patient non-adherence|patient non-adherence
268873|NCT01804257|Patient nonadherence|patient nonadherence
268874|NCT01804257|Schizophrenia|schizophrenia
268875|NCT01804257|Telehealth|telehealth
268876|NCT01804257|Telemedicine|telemedicine
268877|NCT01804257|Telenursing|telenursing
268878|NCT01804257|Wearable sensor|wearable sensor
696103|NCT00944957|stocrin|stocrin
268880|NCT01804244|Pharmacokinetics|pharmacokinetics
268881|NCT01804244|Japanese|japanese
268882|NCT01804231|Prostate Cancer|prostate cancer
268883|NCT01804231|PET|pet
268884|NCT01804231|MRI|mri
268885|NCT01804231|Hybrid|hybrid
268886|NCT01804231|Recurrence|recurrence
268887|NCT01804231|Fluorocholine|fluorocholine
268888|NCT01804205|magnesium sulfate|magnesium sulfate
268889|NCT01804205|rocuronium|rocuronium
268890|NCT01804205|neuromuscular block|neuromuscular block
268891|NCT01804205|onset time|onset time
268892|NCT01804205|elderly|elderly
268893|NCT01804192|Acu-TENS|acu-tens
268894|NCT01804192|MAP|map
268895|NCT01804192|HR|hr
268896|NCT01804192|HRV|hrv
268897|NCT01804179|colon|colon
268898|NCT01804179|rectum|rectum
268899|NCT01804179|cancer|cancer
268900|NCT01804179|screening|screening
268901|NCT01804179|questionnaire|questionnaire
268902|NCT01804179|testing|testing
268903|NCT01804179|educational materials|educational materials
268904|NCT01804166|Lymphoma, T-Cell, Peripheral, Infliximab, Golimumab, Remicade, Simponi, Ulcerative Colitis, Crohn's Disease, Inflammatory Bowel Disease|lymphoma, t-cell, peripheral, infliximab, golimumab, remicade, simponi, ulcerative colitis, crohn's disease, inflammatory bowel disease
268905|NCT01804153|Feminine stress urinary incontinence|feminine stress urinary incontinence
268906|NCT01804153|Autologous expanded stem cells|autologous expanded stem cells
268907|NCT01804127|DLBCL|dlbcl
268908|NCT01804127|R-CHOP|r-chop
268909|NCT01804127|PET/CT|pet/ct
268910|NCT01804088|Peripheral artery disease|peripheral artery disease
268911|NCT01804088|Iliac arteries|iliac arteries
268912|NCT01804088|Balloon-expandable stent|balloon-expandable stent
268913|NCT01804075|NAS|nas
268914|NCT01804075|NICU|nicu
268915|NCT01804075|EMMC|emmc
268916|NCT01804049|metformin|metformin
268917|NCT01804049|muscle|muscle
268918|NCT01804049|insulin resistance|insulin resistance
268919|NCT01804049|sarcopenia|sarcopenia
268920|NCT01804049|older adults|older adults
268921|NCT01804049|impaired fasting glucose|impaired fasting glucose
268922|NCT01803997|Child|child
268923|NCT01803997|Nutrition|nutrition
268924|NCT01803997|resonance Raman spectroscopy|resonance raman spectroscopy
268925|NCT01803997|Fruit & Vegetable|fruit & vegetable
268926|NCT01803997|Children Cooking|children cooking
268927|NCT01803984|Migraine|migraine
268928|NCT01803984|Brain structure|brain structure
268929|NCT01803984|MRI|mri
268930|NCT01803971|cardiac arrest|cardiac arrest
268931|NCT01803971|peripheral venous access|peripheral venous access
268932|NCT01803971|intraosseous access|intraosseous access
268933|NCT01803945|Parkinson's disease|parkinson's disease
268934|NCT01803945|cognitive impairment|cognitive impairment
268935|NCT01803945|movement disorder|movement disorder
268936|NCT01803932|intimate partner violence|intimate partner violence
268937|NCT01803932|gender|gender
268938|NCT01803932|primary prevention intervention|primary prevention intervention
268939|NCT01803932|conflict|conflict
268940|NCT01803932|Cote d'Ivoire|cote d'ivoire
268941|NCT01803932|Ivory Coast|ivory coast
268942|NCT01803919|Spinal cord injuries|spinal cord injuries
268943|NCT01803919|Urinary tract infection|urinary tract infection
268944|NCT01803919|Urinary catheters|urinary catheters
268945|NCT01803919|Protocol|protocol
268946|NCT01803919|Randomized clinical trial|randomized clinical trial
268947|NCT01803906|mitochondrial disorder|mitochondrial disorder
268948|NCT01803906|mitochondria|mitochondria
268949|NCT01803906|oxidative phosphorylation|oxidative phosphorylation
268950|NCT01803906|oxidative phosphorylation disorders|oxidative phosphorylation disorders
268951|NCT01803906|respiratory chain disorders|respiratory chain disorders
268952|NCT01803906|mitochondrial disease|mitochondrial disease
268953|NCT01803906|melas|melas
268954|NCT01803906|kearns sayer|kearns sayer
268955|NCT01803906|NARP|narp
268956|NCT01803906|MNGIE|mngie
268957|NCT01803906|LHON|lhon
268958|NCT01803906|Mitochondrial depletion syndrome|mitochondrial depletion syndrome
268959|NCT01803906|Leigh's disease|leigh's disease
268960|NCT01803893|In vitro fertilization|in vitro fertilization
268961|NCT01803893|implantation|implantation
268962|NCT01803893|miscarriage|miscarriage
268963|NCT01803893|live birth|live birth
268964|NCT01803880|Articular cartilage|articular cartilage
268965|NCT01803880|Cartilage lesion|cartilage lesion
268966|NCT01803880|Cartilage defect|cartilage defect
268967|NCT01803880|Radiofrequency|radiofrequency
268968|NCT01803880|Debridement|debridement
268969|NCT01803880|Cartilage|cartilage
268970|NCT01803880|Coblation|coblation
268971|NCT01803880|Knee|knee
268972|NCT01803880|Meniscus|meniscus
268973|NCT01803880|Meniscectomy|meniscectomy
268974|NCT01803880|MR imaging|mr imaging
268975|NCT01803880|Mechanical debridement|mechanical debridement
268976|NCT01803880|Mechanical shaver|mechanical shaver
268977|NCT01803880|Torn meniscus|torn meniscus
268978|NCT01803880|Arthroscopic knee surgery|arthroscopic knee surgery
268979|NCT01803880|Damaged cartilage|damaged cartilage
268980|NCT01803867|MS|ms
268981|NCT01803867|Multiple Sclerosis|multiple sclerosis
269083|NCT01803464|Botox|botox
268982|NCT01803841|Coronary artery disease|coronary artery disease
268983|NCT01803828|Diabetic Cardiomyopathy|diabetic cardiomyopathy
268984|NCT01803828|Genders|genders
268985|NCT01803828|Phosphodiesterase 5A inhibitors|phosphodiesterase 5a inhibitors
268986|NCT01803828|miRNAs|mirnas
268987|NCT01803828|Chemokines|chemokines
268988|NCT01803815|obstructive sleep apnea|obstructive sleep apnea
268989|NCT01803815|hypertension|hypertension
268990|NCT01803815|antihypertensive drugs|antihypertensive drugs
268991|NCT01803802|childhood sexual abuse|childhood sexual abuse
268992|NCT01803802|depression|depression
268993|NCT01803802|PTSD|ptsd
268994|NCT01803802|sexual function|sexual function
268995|NCT01803802|women|women
268996|NCT01803789|Metacarpal V Fractures|metacarpal v fractures
268997|NCT01803789|Single Kirschner Wires|single kirschner wires
268998|NCT01803789|Double Kirschner Wires|double kirschner wires
268999|NCT01803776|child|child
269000|NCT01803776|physical activity|physical activity
269001|NCT01803776|sedentary activity|sedentary activity
269002|NCT01803776|nutrition|nutrition
269003|NCT01803776|diet|diet
269004|NCT01803776|body composition|body composition
269005|NCT01803776|overweight|overweight
269006|NCT01803776|obesity|obesity
269007|NCT01803776|glucose metabolism disorders|glucose metabolism disorders
269008|NCT01803776|lipid metabolism disorders|lipid metabolism disorders
269009|NCT01803776|physical fitness|physical fitness
269010|NCT01803776|cardiovascular system|cardiovascular system
269011|NCT01803776|musculoskeletal system|musculoskeletal system
269012|NCT01803776|bone mineral density|bone mineral density
269013|NCT01803776|oral health|oral health
269014|NCT01803776|quality of life|quality of life
269015|NCT01803776|wellbeing|wellbeing
269016|NCT01803776|gene-lifestyle interaction|gene-lifestyle interaction
269017|NCT01803776|health economics|health economics
269018|NCT01803763|Omalizumab|omalizumab
269019|NCT01803763|Xolair|xolair
269020|NCT01803763|Urticaria|urticaria
269021|NCT01803763|basophils|basophils
269022|NCT01803763|chronic Urticaria|chronic urticaria
269023|NCT01803763|Fc Receptor|fc receptor
269024|NCT01803750|Primary Care Providers|primary care providers
269025|NCT01803750|Latino Populations|latino populations
269026|NCT01803750|Disseminate Cancer Prevention|disseminate cancer prevention
269027|NCT01803750|semi-structured interviews|semi-structured interviews
269029|NCT01803737|Weight Loss|weight loss
269030|NCT01803737|Physical Activity|physical activity
269031|NCT01803737|Dietary Intake|dietary intake
269032|NCT01803737|Weight Loss Self-Efficacy|weight loss self-efficacy
269033|NCT01803737|Motivation|motivation
269034|NCT01803724|Irritable Bowel Syndrome|irritable bowel syndrome
269035|NCT01803724|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
269036|NCT01803724|Lactulose breath test|lactulose breath test
269037|NCT01803724|Glucose breath test|glucose breath test
269038|NCT01803724|Rifaximin|rifaximin
269039|NCT01803711|Omega 3 fatty acid|omega 3 fatty acid
269040|NCT01803711|Fish oil|fish oil
269041|NCT01803711|Depression|depression
269042|NCT01803711|cancer|cancer
269043|NCT01803711|diabetes|diabetes
269044|NCT01803711|high blood pressure|high blood pressure
269045|NCT01803711|cardiovascular|cardiovascular
269046|NCT01803698|Pregnancy|pregnancy
269047|NCT01803698|Gestational weight gain|gestational weight gain
269048|NCT01803698|Primary care|primary care
269049|NCT01803698|Guidelines|guidelines
269050|NCT01803685|Intracranial Arteriovenous Malformations|intracranial arteriovenous malformations
269051|NCT01803685|Surgical removal|surgical removal
269052|NCT01803685|Endovascular embolism|endovascular embolism
269053|NCT01803685|Stereotaxic radiosurgery|stereotaxic radiosurgery
269054|NCT01803685|Outcomes|outcomes
269055|NCT01803672|Adventure-Based training|adventure-based training
269056|NCT01803672|Health education|health education
269057|NCT01803672|childhood cancer|childhood cancer
269058|NCT01803672|physical activity|physical activity
269059|NCT01803659|b-carotene|b-carotene
269060|NCT01803659|breastmilk|breastmilk
269061|NCT01803659|vitamin A|vitamin a
269062|NCT01803568|Myokine|myokine
259744|NCT01846377|diet|diet
269063|NCT01803568|Insulin sensitivity|insulin sensitivity
269064|NCT01803568|Exercise|exercise
269065|NCT01803568|Skeletal muscle|skeletal muscle
269066|NCT01803555|Budesonide/Formoterol SPIROMAX®|budesonide/formoterol spiromax®
269067|NCT01803555|SYMBICORT® TURBOHALER®|symbicort® turbohaler®
269068|NCT01803555|Asthma|asthma
269069|NCT01803542|Non-small Cell Lung Cancer|non-small cell lung cancer
269070|NCT01803542|Stereotactic radiation for Lung Cancer|stereotactic radiation for lung cancer
269071|NCT01803542|Cone beam CT for Lung Cancer|cone beam ct for lung cancer
269072|NCT01803542|PET/CT for Lung Cancer|pet/ct for lung cancer
269073|NCT01803529|thorax|thorax
269074|NCT01803529|Intercostal Muscles|intercostal muscles
269075|NCT01803529|massage|massage
269076|NCT01803529|heat-pack|heat-pack
269077|NCT01803529|hot temperature|hot temperature
269078|NCT01803516|Quality of Life|quality of life
269079|NCT01803516|Assessments|assessments
269080|NCT01803516|Radiation|radiation
269081|NCT01803516|Telangiectasias|telangiectasias
269082|NCT01803516|13-013|13-013
269084|NCT01803464|Muscle strength|muscle strength
269085|NCT01803451|gastric bypass|gastric bypass
269086|NCT01803451|glucose metabolism|glucose metabolism
269087|NCT01803451|hypoglycemia|hypoglycemia
269088|NCT01803438|paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
269089|NCT01803438|Cryoablation|cryoablation
269090|NCT01803438|Pulmonary Vein Isolation|pulmonary vein isolation
269091|NCT01803425|Post-marketing surveillance|post-marketing surveillance
269092|NCT01803425|Prescribing Information (PI)|prescribing information (pi)
269093|NCT01803425|Healthy infants and children|healthy infants and children
269094|NCT01803425|Streptococcus pneumoniae|streptococcus pneumoniae
269095|NCT01803425|Synflorix™|synflorix™
269096|NCT01803425|Sri Lanka|sri lanka
269097|NCT01803412|GSK2402968|gsk2402968
269098|NCT01803412|open-label extension|open-label extension
269100|NCT01803412|drisapersen|drisapersen
269101|NCT01803412|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
269102|NCT01803412|tolerability|tolerability
269103|NCT01803412|Quality of Life|quality of life
269104|NCT01803399|cardiac repolarization|cardiac repolarization
269105|NCT01803399|oral|oral
269107|NCT01803399|GSK1322322|gsk1322322
269108|NCT01803399|antibiotic|antibiotic
269109|NCT01803399|12-lead ECG|12-lead ecg
269110|NCT01803399|placebo|placebo
269111|NCT01803399|IV|iv
269112|NCT01803399|moxifloxacin|moxifloxacin
269113|NCT01803386|ALS|als
269114|NCT01803386|EIM|eim
269115|NCT01803373|Healthy|healthy
269116|NCT01803373|Biological Availability|biological availability
269117|NCT01803373|Bioavailability|bioavailability
269118|NCT01803373|TMC207|tmc207
269119|NCT01803373|Bedaquiline|bedaquiline
269120|NCT01803373|R207910|r207910
269121|NCT01803347|phase III|phase iii
269122|NCT01803347|Adipose derived stem cells|adipose derived stem cells
269123|NCT01803347|Anal fistula|anal fistula
269124|NCT01803347|Cell therapy|cell therapy
269125|NCT01803347|Stem cell therapy|stem cell therapy
269126|NCT01803334|surgical incision|surgical incision
269127|NCT01803334|laparoscopy|laparoscopy
269128|NCT01803334|pain|pain
269129|NCT01803321|SJIA|sjia
269130|NCT01803308|Hepatitis C Infection|hepatitis c infection
269131|NCT01803308|Treatment Naïve, Chronic|treatment naïve, chronic
269132|NCT01803308|First In Human|first in human
269133|NCT01803308|Single Ascending Dose|single ascending dose
269134|NCT01803308|Multiple Ascending Dose|multiple ascending dose
269135|NCT01803295|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
269136|NCT01803295|Intravesical instillation|intravesical instillation
269137|NCT01803295|Mitomycin C|mitomycin c
269138|NCT01803295|Hydrogel Reverse thermal gelation|hydrogel reverse thermal gelation
269139|NCT01803295|Drug retention|drug retention
269140|NCT01803295|Urinary Bladder Neoplasms|urinary bladder neoplasms
269141|NCT01803295|Urologic Neoplasms|urologic neoplasms
269142|NCT01803295|Urinary Bladder Diseases|urinary bladder diseases
269143|NCT01803295|Urologic Diseases|urologic diseases
269144|NCT01803295|Mitomycin|mitomycin
269145|NCT01803282|Solid Tumor|solid tumor
269146|NCT01803282|NSCLC|nsclc
269147|NCT01803282|Pancreatic|pancreatic
269148|NCT01803282|Esophagogastric|esophagogastric
269149|NCT01803282|Colorectal|colorectal
269150|NCT01803282|Breast|breast
269151|NCT01803230|children|children
269152|NCT01803204|Anxiety|anxiety
269153|NCT01803204|Orthognathic surgery|orthognathic surgery
269154|NCT01803204|Patient educational as topic|patient educational as topic
269155|NCT01803204|Patient educational handout|patient educational handout
269156|NCT01803204|Pamphlets|pamphlets
269157|NCT01803191|Transrectal ultrasound-guided prostate biopsy|transrectal ultrasound-guided prostate biopsy
269158|NCT01803191|Bacteriuria|bacteriuria
269159|NCT01803191|Antibiotic prophylaxis|antibiotic prophylaxis
269160|NCT01803191|Prostate-Specific antigen|prostate-specific antigen
269161|NCT01803178|vascular function|vascular function
269162|NCT01803178|plant sterols|plant sterols
269163|NCT01803178|blood lipids|blood lipids
269164|NCT01803165|emesis,post operative.|emesis,post operative.
269165|NCT01803165|cognitive dysfunction, post operative.|cognitive dysfunction, post operative.
269166|NCT01803165|wound infection, post operative.|wound infection, post operative.
269167|NCT01803165|pain, post operative.|pain, post operative.
269168|NCT01803165|Anesthesia, Conduction/methods|anesthesia, conduction/methods
269169|NCT01803165|Anesthesiology/methods|anesthesiology/methods
269170|NCT01803165|Arteriovenous Shunt, Surgical/adverse effects|arteriovenous shunt, surgical/adverse effects
269171|NCT01803165|Regional Blood Flow/drug effects|regional blood flow/drug effects
269172|NCT01803165|Risk Factors|risk factors
269173|NCT01803165|Thrombosis|thrombosis
269174|NCT01803165|Treatment Outcome|treatment outcome
269175|NCT01803165|Vascular Surgical Procedures/methods|vascular surgical procedures/methods
269176|NCT01803165|Vasodilation/drug effects|vasodilation/drug effects
269177|NCT01803152|Metastatic Sarcoma|metastatic sarcoma
269178|NCT01803152|Relapsed Sarcoma|relapsed sarcoma
269179|NCT01803152|Dendritic Cell|dendritic cell
269180|NCT01803152|Myeloid Derived Suppressor Cells|myeloid derived suppressor cells
269181|NCT01803152|MDSC|mdsc
269182|NCT01803152|MDSC Inhibition|mdsc inhibition
269787|NCT01800266|Children|children
269183|NCT01803139|Breast cancer radiotherapy IMRT|breast cancer radiotherapy imrt
269185|NCT01803113|Pregnancy|pregnancy
269187|NCT01803100|Bacterial Colonization|bacterial colonization
269188|NCT01803087|adolescents|adolescents
269189|NCT01803087|adults|adults
269190|NCT01803061|Head and neck cancer|head and neck cancer
269191|NCT01803061|Quality of life|quality of life
269192|NCT01803061|Symptom-burden|symptom-burden
269193|NCT01803061|Late effects|late effects
269194|NCT01803048|Traumatic Brain Injury|traumatic brain injury
269195|NCT01803048|Diffusion Weighted Imaging|diffusion weighted imaging
269196|NCT01803048|Resting State Functional Connectivity|resting state functional connectivity
269197|NCT01803048|Cognition|cognition
269198|NCT01803035|Impetigo|impetigo
269199|NCT01803035|LTX-109|ltx-109
269200|NCT01803035|Topical|topical
269201|NCT01803035|Antibiotic|antibiotic
269202|NCT01803035|Placebo|placebo
269203|NCT01803035|Lytic|lytic
269204|NCT01803035|Peptide|peptide
269205|NCT01803035|Gram Positive|gram positive
269206|NCT01803022|Venous Thromboembolism|venous thromboembolism
269207|NCT01803022|Cancer|cancer
269208|NCT01803022|Low Molecular Weight Heparin|low molecular weight heparin
269209|NCT01802983|Aged|aged
269210|NCT01802983|Multiple organ failure|multiple organ failure
269211|NCT01802983|Extubation|extubation
269212|NCT01802983|Prognosis|prognosis
269213|NCT01802983|MODS|mods
269214|NCT01802983|invasive mechanical ventilation|invasive mechanical ventilation
269215|NCT01802970|Anakinra|anakinra
269216|NCT01802970|Nab Paclitaxel|nab paclitaxel
269217|NCT01802970|Capecitabine|capecitabine
269218|NCT01802970|Eribulin|eribulin
269219|NCT01802970|Vinorelbin|vinorelbin
269220|NCT01802931|GSK239512|gsk239512
269221|NCT01802931|H3 receptor antagonist|h3 receptor antagonist
269222|NCT01802931|drug-drug interaction|drug-drug interaction
269223|NCT01802931|pharmacokinetics|pharmacokinetics
269224|NCT01802931|ketoconazole|ketoconazole
269225|NCT01802918|single dose|single dose
269226|NCT01802918|HIV|hiv
269227|NCT01802918|maturation inhibitor|maturation inhibitor
269228|NCT01802918|GSK2838232|gsk2838232
269229|NCT01802918|FTIH|ftih
269230|NCT01802918|healthy subjects|healthy subjects
269231|NCT01802905|neoplasm|neoplasm
269232|NCT01802905|metastatic cancer|metastatic cancer
269233|NCT01802905|cancer genome|cancer genome
269234|NCT01802905|genomic analysis|genomic analysis
269235|NCT01802905|adults|adults
269236|NCT01802892|ronacaleret|ronacaleret
269237|NCT01802892|parathyroid hormone (PTH)|parathyroid hormone (pth)
269238|NCT01802892|CD34+cells|cd34+cells
269239|NCT01802892|calcium sensing receptor antagonist|calcium sensing receptor antagonist
269240|NCT01802892|hematopoietic stem cells|hematopoietic stem cells
269241|NCT01802892|stem cell mobilization|stem cell mobilization
269242|NCT01802892|plerixafor|plerixafor
269243|NCT01802892|healthy human volunteer, phase Ib|healthy human volunteer, phase ib
269244|NCT01802879|Hematologic Neoplasms, LBH589,|hematologic neoplasms, lbh589,
269245|NCT01802879|Panobinostat,|panobinostat,
269246|NCT01802866|Geographic atrophy|geographic atrophy
269247|NCT01802866|GA|ga
269248|NCT01802866|Dry AMD|dry amd
269249|NCT01802827|airway colonization|airway colonization
269250|NCT01802827|tracheobronchitis|tracheobronchitis
269251|NCT01802827|pneumonia|pneumonia
269252|NCT01802814|ALL|all
269253|NCT01802788|Aortic Stenosis|aortic stenosis
269254|NCT01802788|Heart Valve Prosthesis|heart valve prosthesis
269255|NCT01802788|Trans Catheter Aortic Valve Replacement|trans catheter aortic valve replacement
269256|NCT01802788|TAVR|tavr
269257|NCT01802788|Trans Catheter Aortic Valve Implant|trans catheter aortic valve implant
269258|NCT01802788|TAVI|tavi
269259|NCT01802749|second line|second line
269260|NCT01802749|platinum sensitive|platinum sensitive
269261|NCT01802749|first line bevacizumab|first line bevacizumab
269262|NCT01802749|biologic factors|biologic factors
269263|NCT01802749|clinical factors|clinical factors
269264|NCT01802736|Alcohol HIV intervention counselling|alcohol hiv intervention counselling
269265|NCT01802736|Alcohol Use in HIV infected Persons|alcohol use in hiv infected persons
269266|NCT01802697|volunteers|volunteers
269267|NCT01802684|unresectable|unresectable
269268|NCT01802684|metastatic|metastatic
269269|NCT01802684|colorectal|colorectal
269270|NCT01802684|cancer|cancer
269271|NCT01802684|OPTIMOX|optimox
269272|NCT01802684|aflibercept|aflibercept
269273|NCT01802671|Low back pain|low back pain
269274|NCT01802671|Cognitive behavioural treatment|cognitive behavioural treatment
269275|NCT01802671|internet|internet
269276|NCT01802671|disability|disability
269277|NCT01802658|Bone marrow demineralization lesions,: efficacy and tolerability, zoledronic acid|bone marrow demineralization lesions,: efficacy and tolerability, zoledronic acid
269278|NCT01802645|neoadjuvant|neoadjuvant
269279|NCT01802645|cetuximab|cetuximab
269280|NCT01802645|irinotecan|irinotecan
269281|NCT01802645|bevacizumab|bevacizumab
269282|NCT01802645|oxaliplatin|oxaliplatin
269283|NCT01802645|5-FU|5-fu
269284|NCT01802645|Resection|resection
269028|NCT01803750|13-031|13-031
269285|NCT01802645|colorectal liver metastases|colorectal liver metastases
269788|NCT01800266|Adolescents|adolescents
269286|NCT01802645|liver resection|liver resection
269287|NCT01802645|Chemotherapy|chemotherapy
269288|NCT01802645|k-ras|k-ras
269289|NCT01802645|non-resectable|non-resectable
269290|NCT01802632|Oncology,|oncology,
269291|NCT01802632|Non Small Cell Lung Cancer,|non small cell lung cancer,
269292|NCT01802632|Metastatic,|metastatic,
269293|NCT01802632|EGFR sensitivity mutation,|egfr sensitivity mutation,
269294|NCT01802632|T790M resistance mutation|t790m resistance mutation
269295|NCT01802606|surgery|surgery
269296|NCT01802606|administration|administration
269297|NCT01802606|infection|infection
269298|NCT01802593|Pediatric|pediatric
269299|NCT01802593|Crohn's disease|crohn's disease
269300|NCT01802593|Infliximab|infliximab
269301|NCT01802593|Thiopurine|thiopurine
269302|NCT01802554|Behavioral Activation|behavioral activation
269303|NCT01802554|Caregiver|caregiver
269304|NCT01802554|Dementia|dementia
269305|NCT01802554|Cardiovascular Disease|cardiovascular disease
269306|NCT01802554|Alzheimer's Disease|alzheimer's disease
269307|NCT01802554|Coagulation|coagulation
269308|NCT01802541|diacylglycerol oil|diacylglycerol oil
269309|NCT01802541|insulin sensitivity|insulin sensitivity
269310|NCT01802541|type 2 diabetes|type 2 diabetes
269311|NCT01802541|cardiovascular disease|cardiovascular disease
269312|NCT01802541|risk factors|risk factors
269313|NCT01802528|obturator externus|obturator externus
269314|NCT01802515|addiction|addiction
269315|NCT01802515|cocaine|cocaine
269316|NCT01802515|methadone|methadone
269317|NCT01802515|opiates|opiates
269318|NCT01802515|atomoxetine|atomoxetine
269319|NCT01802502|tuberculous meningitis|tuberculous meningitis
269320|NCT01802502|rifampicin|rifampicin
269321|NCT01802502|bioequivalence|bioequivalence
269322|NCT01802502|oral administration|oral administration
269323|NCT01802502|intravenous administration|intravenous administration
269324|NCT01802489|Optic neuritis|optic neuritis
269325|NCT01802489|Multiple sclerosis|multiple sclerosis
269326|NCT01802489|Retinal nerve fibre layer|retinal nerve fibre layer
269327|NCT01802489|Axonal loss|axonal loss
269328|NCT01802489|Neuroprotection|neuroprotection
269329|NCT01802489|MRI|mri
269330|NCT01802489|Optical coherence tomography|optical coherence tomography
269331|NCT01802489|Amiloride|amiloride
269332|NCT01802489|Acid Sensing Ion Channels|acid sensing ion channels
269333|NCT01802476|PD-0332991|pd-0332991
269334|NCT01802476|Absolute Bioavailability Study|absolute bioavailability study
269335|NCT01802424|Open trial|open trial
269336|NCT01802424|Indicative prevention|indicative prevention
269337|NCT01802424|Youth anxiety|youth anxiety
269338|NCT01802424|Cognitive behavioral therapy|cognitive behavioral therapy
269339|NCT01802411|liposome bupivacaine|liposome bupivacaine
269340|NCT01802411|posterolateral thoracotomy|posterolateral thoracotomy
269341|NCT01802411|intercostal nerve block|intercostal nerve block
269342|NCT01802411|postoperative pain|postoperative pain
269343|NCT01802398|Risk Stratification|risk stratification
269344|NCT01802398|Syncope|syncope
269345|NCT01802398|Geriatric|geriatric
269346|NCT01802385|cryptococcal meningitis|cryptococcal meningitis
269347|NCT01802385|cryptococcus|cryptococcus
269348|NCT01802385|meningitis|meningitis
269349|NCT01802385|yeast|yeast
269350|NCT01802385|fungus|fungus
269351|NCT01802372|Hypertension|hypertension
269352|NCT01802372|High Blood Pressure|high blood pressure
269353|NCT01802372|Cardiovascular Diseases|cardiovascular diseases
269354|NCT01802372|Health Insurance Coverage|health insurance coverage
269355|NCT01802372|Low income countries|low income countries
269356|NCT01802372|Ghana|ghana
269357|NCT01802372|Low resource settings|low resource settings
269358|NCT01802372|Comparative Effectiveness|comparative effectiveness
269359|NCT01802372|Global Health|global health
269360|NCT01802359|Erectile dysfunction|erectile dysfunction
269361|NCT01802359|Mirodenafil|mirodenafil
269362|NCT01802359|Bravonto|bravonto
260052|NCT01844804|PK|pk
269363|NCT01802307|Focal therapy|focal therapy
269364|NCT01802307|Brachytherapy|brachytherapy
269365|NCT01802307|Active surveillance|active surveillance
269366|NCT01802307|low risk cancer|low risk cancer
269367|NCT01802294|Randomized Controlled Trials as Topic|randomized controlled trials as topic
269368|NCT01802294|Child|child
269369|NCT01802294|Parents|parents
269370|NCT01802268|sirolimus|sirolimus
269371|NCT01802268|tacrolimus|tacrolimus
269372|NCT01802268|early conversion|early conversion
269373|NCT01802255|Inhalatory sedation|inhalatory sedation
269374|NCT01802255|Sevoflurane|sevoflurane
269375|NCT01802255|AnaConDa|anaconda
269376|NCT01802255|Nephrotoxicity|nephrotoxicity
269377|NCT01802255|Hepatotoxicity|hepatotoxicity
269378|NCT01802255|Midazolam|midazolam
269379|NCT01802255|Propofol|propofol
269380|NCT01802242|Prostate Cancer|prostate cancer
269381|NCT01802242|Prostate tumour|prostate tumour
269382|NCT01802242|Prostate radiotherapy|prostate radiotherapy
269383|NCT01802242|prostate cancer treatment|prostate cancer treatment
269384|NCT01802216|chronic kidney disease progression|chronic kidney disease progression
269385|NCT01802216|periodontal disease|periodontal disease
269386|NCT01802216|intensive periodontal disease treatment|intensive periodontal disease treatment
269388|NCT01802203|Esophageal dysplasia|esophageal dysplasia
269389|NCT01802203|Upper gastrointestinal squamous dysplasia|upper gastrointestinal squamous dysplasia
269390|NCT01802203|Esophageal cancer|esophageal cancer
269391|NCT01802203|Endobronchial cancer|endobronchial cancer
269392|NCT01802203|Central airway cancer|central airway cancer
269393|NCT01802203|Central airway precancerous disease|central airway precancerous disease
269394|NCT01802203|Central airway granulation tissue|central airway granulation tissue
269395|NCT01802203|Central airway papillomatosis|central airway papillomatosis
269396|NCT01802203|Central airway sarcoidosis|central airway sarcoidosis
269397|NCT01802203|Central airway tuberculosis|central airway tuberculosis
269398|NCT01802203|Tracheal stenosis|tracheal stenosis
269399|NCT01802203|Bronchial stenosis|bronchial stenosis
269400|NCT01802190|Genetic deafness|genetic deafness
269401|NCT01802190|SLC17A8 et POU4F3 genes|slc17a8 et pou4f3 genes
269402|NCT01802177|Alopecia areata|alopecia areata
269403|NCT01802177|Excimer|excimer
269404|NCT01802177|UVB|uvb
269405|NCT01802151|probiotics|probiotics
269406|NCT01802151|microbiota|microbiota
269407|NCT01802151|survival|survival
269408|NCT01802151|gastrointestinal|gastrointestinal
269409|NCT01802151|wellness|wellness
269410|NCT01802138|refractory/relapsed neuroblastoma patients|refractory/relapsed neuroblastoma patients
269411|NCT01802112|Colonic transit|colonic transit
269412|NCT01802112|Dietary Fiber|dietary fiber
269413|NCT01802112|Radiopaque marker|radiopaque marker
269414|NCT01802099|mechanical ventilation|mechanical ventilation
269415|NCT01802099|early enteral nutrition|early enteral nutrition
269416|NCT01802099|intensive care unit|intensive care unit
269417|NCT01802099|early parenteral nutrition|early parenteral nutrition
269418|NCT01802099|critical care medicine|critical care medicine
269419|NCT01802099|nosocomial infection|nosocomial infection
269420|NCT01802099|mortality|mortality
269421|NCT01802099|shock|shock
269422|NCT01802099|vasoactive drug|vasoactive drug
269423|NCT01802086|Children|children
269424|NCT01802086|Pain|pain
269425|NCT01802086|Vaccination|vaccination
269426|NCT01802086|Emla|emla
269427|NCT01802086|Pneumococcal|pneumococcal
269428|NCT01802086|Painscale|painscale
269429|NCT01802073|Inflammation of the bile ducts|inflammation of the bile ducts
269430|NCT01802073|biliary scarring|biliary scarring
269431|NCT01802073|obstruction|obstruction
269432|NCT01802060|Persona|persona
269433|NCT01802060|E3G|e3g
269434|NCT01802060|LH|lh
269435|NCT01802060|ovulation|ovulation
269436|NCT01802047|Mothers of Preterms|mothers of preterms
269437|NCT01802047|Breastfeeding Mothers of Preterm infants|breastfeeding mothers of preterm infants
269438|NCT01802047|mother milk feeding|mother milk feeding
269439|NCT01802021|chinese medicine|chinese medicine
269440|NCT01802021|non-small cell lung cancer|non-small cell lung cancer
269441|NCT01802021|immunosuppression|immunosuppression
269442|NCT01802008|Polyp/adenoma detection rate|polyp/adenoma detection rate
269443|NCT01802008|Polyp/adenoma miss rate|polyp/adenoma miss rate
269444|NCT01802008|Colonoscopy withdrawal time|colonoscopy withdrawal time
269445|NCT01801982|PPHN; development progress after PPHN; developmental progress after sildenafil.|pphn; development progress after pphn; developmental progress after sildenafil.
269446|NCT01801969|Brain injuries|brain injuries
269447|NCT01801969|Rehabilitation services|rehabilitation services
269448|NCT01801969|Return to Work|return to work
269449|NCT01801969|Quality of life|quality of life
269450|NCT01801956|Maximum oxygen uptake|maximum oxygen uptake
269451|NCT01801956|Physical activity|physical activity
269452|NCT01801956|Physical inactivity|physical inactivity
269453|NCT01801956|Motivational interview|motivational interview
269454|NCT01801956|Cardiorespiratory fitness|cardiorespiratory fitness
269455|NCT01801956|Primary care|primary care
269456|NCT01801956|Community care|community care
269457|NCT01801930|OCV-C02|ocv-c02
269458|NCT01801930|Colorectal Cancer|colorectal cancer
269459|NCT01801930|Antigen specific cancer immunotherapeutic|antigen specific cancer immunotherapeutic
269460|NCT01801917|Polymyositis, Myositis, PM|polymyositis, myositis, pm
269461|NCT01801904|cetuximab-refractory|cetuximab-refractory
269462|NCT01801891|Venous ulceration|venous ulceration
269463|NCT01801891|Leg ulcers|leg ulcers
269464|NCT01801891|Venous haemodynamics|venous haemodynamics
269465|NCT01801891|Surface neuromuscular electrical stimulation|surface neuromuscular electrical stimulation
269466|NCT01801891|SNMES|snmes
269467|NCT01801878|breast cancer|breast cancer
269468|NCT01801878|loss of elasticity in irradiated breast skin|loss of elasticity in irradiated breast skin
269469|NCT01801878|Other Reconstructive Surgery|other reconstructive surgery
269470|NCT01801865|NICU|nicu
269471|NCT01801865|MRI|mri
269472|NCT01801865|Neonatal|neonatal
269473|NCT01801865|Cincinnati|cincinnati
269474|NCT01801813|Neuro-surgery|neuro-surgery
269475|NCT01801813|Post-operative complications|post-operative complications
269476|NCT01801813|Neuro-ICU resources|neuro-icu resources
269477|NCT01801800|Aneurysmal subarachnoid haemorrhage|aneurysmal subarachnoid haemorrhage
269478|NCT01801774|post-operative inflammation|post-operative inflammation
269479|NCT01801774|steroid|steroid
269480|NCT01801774|intraocular pressure|intraocular pressure
269481|NCT01801748|wheat allergy|wheat allergy
269482|NCT01801748|wheat outgrowing|wheat outgrowing
269483|NCT01801748|wheat hypersensitivity|wheat hypersensitivity
269484|NCT01801748|omega-5-gliadin|omega-5-gliadin
269485|NCT01801748|natural history of wheat hypersensitivity|natural history of wheat hypersensitivity
269486|NCT01801709|Brain Gene Therapy|brain gene therapy
269487|NCT01801709|Adeno Associated vector|adeno associated vector
269488|NCT01801709|Lysosomal sotage diseases|lysosomal sotage diseases
269489|NCT01801709|Leukodystrophies|leukodystrophies
269491|NCT01801696|effectiveness|effectiveness
269492|NCT01801696|autism|autism
269493|NCT01801696|parent stress|parent stress
269494|NCT01801683|EBM|ebm
269495|NCT01801683|general practice|general practice
269496|NCT01801670|itch|itch
269497|NCT01801670|pruritus|pruritus
269498|NCT01801670|skin|skin
269499|NCT01801670|vorinostat|vorinostat
269500|NCT01801670|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
269501|NCT01801670|mycosis fungoides|mycosis fungoides
269502|NCT01801657|bronchiectasis|bronchiectasis
269503|NCT01801657|exacerbation|exacerbation
269504|NCT01801657|virus|virus
269505|NCT01801644|bladder cancer|bladder cancer
269506|NCT01801644|neoadjuvant chemotherapy|neoadjuvant chemotherapy
269507|NCT01801644|gem/cis|gem/cis
269508|NCT01801631|Type 2 diabetes|type 2 diabetes
269509|NCT01801631|Acute Coronary Event (ACE)|acute coronary event (ace)
269510|NCT01801631|Distress|distress
269511|NCT01801631|Self-efficacy|self-efficacy
269512|NCT01801631|Quality of Life|quality of life
269513|NCT01801631|Depression|depression
269514|NCT01801631|Primary care|primary care
269515|NCT01801631|Illness representations|illness representations
269516|NCT01801618|HIV|hiv
269517|NCT01801618|PI based 2nd line ARV treatment|pi based 2nd line arv treatment
269518|NCT01801618|Virological failure|virological failure
269519|NCT01801618|Drug resistance|drug resistance
269520|NCT01801618|Cambodia|cambodia
269521|NCT01801618|Adherence|adherence
269619|NCT01801150|Prevalence|prevalence
269522|NCT01801605|IBS - rectal hypersensitivity - rectal barostat - rTMS.|ibs - rectal hypersensitivity - rectal barostat - rtms.
269523|NCT01801592|OBSTRUCTIVE SLEEP APNOEA|obstructive sleep apnoea
269524|NCT01801592|INTERMITTENT CLAUDICATION|intermittent claudication
269525|NCT01801592|Respiratory disease|respiratory disease
269526|NCT01801592|Peripheral artery disease|peripheral artery disease
269527|NCT01801579|Ankle Brachial Index|ankle brachial index
269528|NCT01801579|Maximal exercise|maximal exercise
269529|NCT01801566|Mandibular Prosthesis Implantation|mandibular prosthesis implantation
269530|NCT01801566|Prostheses and Implants|prostheses and implants
269531|NCT01801566|Denture, Complete, Lower|denture, complete, lower
269532|NCT01801553|spinal manipulation|spinal manipulation
269533|NCT01801553|low back pain|low back pain
269534|NCT01801553|manual therapy|manual therapy
269535|NCT01801553|clinical predictive rule|clinical predictive rule
269536|NCT01801527|Telehealth|telehealth
269537|NCT01801527|Fatigue|fatigue
269538|NCT01801527|Breast cancer|breast cancer
269539|NCT01801527|Exercise|exercise
269540|NCT01801527|Quality of life|quality of life
269541|NCT01801527|Telerehabilitation|telerehabilitation
269542|NCT01801475|Pharmacokinetics of ondansetron in women|pharmacokinetics of ondansetron in women
269543|NCT01801475|Pharmacokinetics of ondansetron in neonates|pharmacokinetics of ondansetron in neonates
269544|NCT01801475|Term pregnancy|term pregnancy
269545|NCT01801475|Cesarean section|cesarean section
269546|NCT01801462|Medical education|medical education
269547|NCT01801462|Simulation|simulation
269548|NCT01801462|Ultrasound training|ultrasound training
269549|NCT01801462|Patient safety|patient safety
269550|NCT01801449|DIRA|dira
269551|NCT01801449|Clinical Trial|clinical trial
269552|NCT01801449|IL-1|il-1
269553|NCT01801449|Autoinflammatory Syndrome|autoinflammatory syndrome
269554|NCT01801449|Rilonacept|rilonacept
269555|NCT01801436|Multiple Myeloma|multiple myeloma
269556|NCT01801436|Bortezomib|bortezomib
269557|NCT01801436|Velcade|velcade
269558|NCT01801423|transcranial Doppler|transcranial doppler
269559|NCT01801423|stroke|stroke
269560|NCT01801423|sickle cell anemia|sickle cell anemia
269561|NCT01801423|Nigeria|nigeria
269562|NCT01801423|hydroxyurea|hydroxyurea
269563|NCT01801423|low income country|low income country
269564|NCT01801410|pre-eclampsia|pre-eclampsia
269565|NCT01801410|labor induction|labor induction
269566|NCT01801410|misoprostol|misoprostol
269567|NCT01801410|Foley catheter|foley catheter
269568|NCT01801384|pregnancy|pregnancy
269569|NCT01801384|cigarette smoking|cigarette smoking
269570|NCT01801384|incentives|incentives
696400|NCT00946192|Osteopenia|osteopenia
269571|NCT01801384|smoking cessation|smoking cessation
269572|NCT01801384|birth outcomes|birth outcomes
269573|NCT01801371|Glioma|glioma
269574|NCT01801371|Diagnostic imaging|diagnostic imaging
269575|NCT01801371|Integrin receptor|integrin receptor
269576|NCT01801371|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
269577|NCT01801371|PET/CT|pet/ct
269578|NCT01801358|Melanoma,|melanoma,
269579|NCT01801358|melanoma of the eye,|melanoma of the eye,
269580|NCT01801358|uveal,|uveal,
269581|NCT01801358|MEK162,|mek162,
269582|NCT01801358|AEB071|aeb071
269583|NCT01801345|Human Performance|human performance
269584|NCT01801345|Clinical Performance|clinical performance
269585|NCT01801319|major depressive disorder (MDD)|major depressive disorder (mdd)
269586|NCT01801319|deep brain stimulation (DBS)|deep brain stimulation (dbs)
269587|NCT01801319|subcallosal cingulate gyrus|subcallosal cingulate gyrus
269588|NCT01801319|Therapy-Resistant Depression|therapy-resistant depression
269589|NCT01801319|Electrical Stimulation of the Brain|electrical stimulation of the brain
269590|NCT01801319|Brain Stimulation, Deep|brain stimulation, deep
269591|NCT01801293|RSV infection|rsv infection
269592|NCT01801280|immunosuppressive medication|immunosuppressive medication
269593|NCT01801280|mycophenolic acid|mycophenolic acid
269594|NCT01801280|interaction|interaction
269595|NCT01801280|proton pump inhibitor|proton pump inhibitor
269596|NCT01801280|pantoprazole|pantoprazole
269597|NCT01801280|renal transplant patients|renal transplant patients
269598|NCT01801280|pharmacokinetics|pharmacokinetics
269599|NCT01801280|pharmacodynamics|pharmacodynamics
269600|NCT01801280|bioavailability|bioavailability
269601|NCT01801267|Hydrocephalus|hydrocephalus
269602|NCT01801267|Pediatric|pediatric
269603|NCT01801267|Ventricular shunt|ventricular shunt
269604|NCT01801267|Ventriculoperitoneal shunt|ventriculoperitoneal shunt
269605|NCT01801267|Third ventriculostomy|third ventriculostomy
269606|NCT01801267|Randomized controlled trial|randomized controlled trial
269607|NCT01801254|Obesity|obesity
269608|NCT01801254|Type II diabetes|type ii diabetes
269609|NCT01801254|Cardiovascular disease|cardiovascular disease
269610|NCT01801254|Health behavior promotion|health behavior promotion
269611|NCT01801254|Neuroeconomics|neuroeconomics
269612|NCT01801254|EEG biofeedback|eeg biofeedback
269613|NCT01801254|Low-resolution electromagnetic tomography (LORETA)|low-resolution electromagnetic tomography (loreta)
269614|NCT01801254|EEG|eeg
269615|NCT01801176|proved by biopsy|proved by biopsy
269616|NCT01801150|Diabetes|diabetes
269617|NCT01801150|Apnea- hypopnea Syndrome|apnea- hypopnea syndrome
269618|NCT01801150|Glycemic control|glycemic control
269620|NCT01801150|SAHS|sahs
269621|NCT01801150|life quality|life quality
269622|NCT01801124|analgesia|analgesia
269623|NCT01801124|hernia repair|hernia repair
269624|NCT01801098|TAVI|tavi
269625|NCT01801098|complete AV-block|complete av-block
269626|NCT01801098|HV-interval|hv-interval
269627|NCT01801098|permanent pacemaker|permanent pacemaker
269628|NCT01801085|Time-and-Motion|time-and-motion
269629|NCT01801085|Neoplasm|neoplasm
269630|NCT01801085|Colorectal Cancer|colorectal cancer
269631|NCT01801059|colon cancer|colon cancer
269632|NCT01801059|Colorectal Cancer Screening|colorectal cancer screening
269633|NCT01801033|Trioodothyronine (T3)|trioodothyronine (t3)
269634|NCT01801033|Thyroid Hormone Action|thyroid hormone action
269635|NCT01801033|Deiodinases|deiodinases
269636|NCT01801033|Hypothyroid|hypothyroid
269637|NCT01801033|Propylthiouracil (PTU)|propylthiouracil (ptu)
269638|NCT01801020|temperature|temperature
269639|NCT01800994|convenience|convenience
269640|NCT01800981|Functionality|functionality
269641|NCT01800981|extremities|extremities
269642|NCT01800981|ROM|rom
269643|NCT01800981|Upper and lower Extremity for burned patients|upper and lower extremity for burned patients
269644|NCT01800955|physical therapy|physical therapy
269645|NCT01800955|diathermy|diathermy
269646|NCT01800955|knee|knee
269647|NCT01800955|osteoarthritis|osteoarthritis
269648|NCT01800955|pain|pain
269649|NCT01800955|physical function|physical function
269650|NCT01800942|prevention|prevention
269651|NCT01800942|bacterial infection|bacterial infection
269652|NCT01800942|neonates|neonates
269653|NCT01800942|women in labour|women in labour
269654|NCT01800942|Azithromycin|azithromycin
269655|NCT01800916|ileostomy|ileostomy
269656|NCT01800916|Subjects|subjects
269657|NCT01800890|stoma ileostomy|stoma ileostomy
269658|NCT01800877|hypotension|hypotension
269659|NCT01800877|vasopressors|vasopressors
269660|NCT01800877|titration|titration
269661|NCT01800877|tissue perfusion|tissue perfusion
269662|NCT01800877|organ failure|organ failure
269663|NCT01800851|Kidney transplantation|kidney transplantation
269664|NCT01800851|Energy expenditure|energy expenditure
269665|NCT01800851|Weight gain|weight gain
269666|NCT01800851|Insulin resistance|insulin resistance
269667|NCT01800825|Pregnancy|pregnancy
269668|NCT01800825|Prematurity|prematurity
269669|NCT01800825|Preterm birth|preterm birth
269670|NCT01800825|bacterial vaginosis|bacterial vaginosis
269671|NCT01800799|Urinary tract infection|urinary tract infection
269672|NCT01800799|Urothelium|urothelium
269673|NCT01800799|Inflammation|inflammation
269674|NCT01800799|Apoptosis|apoptosis
269676|NCT01800773|exposure treatment|exposure treatment
269677|NCT01800773|clinical trial|clinical trial
269678|NCT01800773|trauma|trauma
269679|NCT01800760|healthy|healthy
269680|NCT01800760|obese|obese
269681|NCT01800760|women|women
269682|NCT01800747|Delayed antibiotic treatment|delayed antibiotic treatment
269683|NCT01800747|Acute respiratory infections|acute respiratory infections
269685|NCT01800747|Satisfaction|satisfaction
269686|NCT01800734|Mixed meal test|mixed meal test
269687|NCT01800734|Insulin pump|insulin pump
269688|NCT01800734|Continuous glucose monitoring|continuous glucose monitoring
269689|NCT01800734|Metabolic control analysis|metabolic control analysis
269690|NCT01800734|Closed loop control|closed loop control
269691|NCT01800734|Artificial pancreas|artificial pancreas
269693|NCT01800721|testing|testing
269694|NCT01800721|Social Network|social network
269695|NCT01800721|African American|african american
269696|NCT01800721|MSM|msm
269697|NCT01800721|Men who have sex with men|men who have sex with men
269698|NCT01800695|GBM|gbm
269699|NCT01800682|Healthy|healthy
269700|NCT01800682|Tramodol|tramodol
269701|NCT01800682|Ultram|ultram
269702|NCT01800669|Computer based clinical decision support|computer based clinical decision support
269703|NCT01800669|medical legal partnership|medical legal partnership
269704|NCT01800669|child|child
269705|NCT01800669|pediatrics|pediatrics
269706|NCT01800643|Busulfan|busulfan
269707|NCT01800643|plasmatic dosage|plasmatic dosage
269708|NCT01800643|Stem Cell Transplantation|stem cell transplantation
269709|NCT01800578|Cerebral State Index Monitor|cerebral state index monitor
269710|NCT01800565|precocious puberty|precocious puberty
269711|NCT01800565|urinary LH|urinary lh
269712|NCT01800565|GnRH stimulation test|gnrh stimulation test
269713|NCT01800565|gonadotropins|gonadotropins
269714|NCT01800552|Infiltration|infiltration
269715|NCT01800552|Extravasation|extravasation
269716|NCT01800552|Leaking|leaking
269717|NCT01800552|PIV Infiltration|piv infiltration
269718|NCT01800552|IV Infiltration|iv infiltration
269719|NCT01800552|Ultrasound Detection of Infiltration|ultrasound detection of infiltration
269720|NCT01800552|Ultrasound Imaging|ultrasound imaging
269721|NCT01800539|Autism|autism
269722|NCT01800539|Early Intervention|early intervention
269723|NCT01800539|Minority|minority
269724|NCT01800526|Sickle Cell Disease|sickle cell disease
269725|NCT01800526|Sickle Cell Anemia|sickle cell anemia
269726|NCT01800513|Implantation Failure|implantation failure
269727|NCT01800513|In-vitro Fertilization|in-vitro fertilization
269728|NCT01800513|Infertility|infertility
269729|NCT01800513|Endometrial Biopsy|endometrial biopsy
269730|NCT01800487|Drug-induced liver injury|drug-induced liver injury
269731|NCT01800487|Tuberculosis|tuberculosis
269732|NCT01800487|Silymarin|silymarin
269733|NCT01800461|Participation|participation
269734|NCT01800461|Occupational Therapy|occupational therapy
269735|NCT01800461|Valued Activities|valued activities
269736|NCT01800448|Respiratory monitoring|respiratory monitoring
269737|NCT01800448|cardiac monitoring|cardiac monitoring
269738|NCT01800448|skin conductance monitoring|skin conductance monitoring
269739|NCT01800448|variability|variability
269740|NCT01800409|Tetraplegia|tetraplegia
269741|NCT01800396|Bacterial infection|bacterial infection
269742|NCT01800396|Dairy|dairy
269743|NCT01800396|Diarrhea|diarrhea
269744|NCT01800396|Diet|diet
269745|NCT01800396|E.Coli|e.coli
269746|NCT01800396|Gastroenteritis|gastroenteritis
269747|NCT01800396|Milk|milk
269748|NCT01800396|Stool consistency|stool consistency
269749|NCT01800383|posttraumatic stress disorder|posttraumatic stress disorder
269750|NCT01800383|fear conditioning|fear conditioning
269751|NCT01800383|proton magnetic resonance spectroscopy|proton magnetic resonance spectroscopy
269752|NCT01800383|GABA|gaba
269753|NCT01800370|Healthy|healthy
269754|NCT01800370|Male|male
269755|NCT01800357|randomized trial|randomized trial
269756|NCT01800357|acute ischemic stroke|acute ischemic stroke
269757|NCT01800357|mildronate|mildronate
269758|NCT01800344|Airway Cuff|airway cuff
269759|NCT01800344|LMA|lma
269760|NCT01800344|Ultra|ultra
269761|NCT01800344|Cuff Pressure|cuff pressure
269762|NCT01800344|Ventilation|ventilation
269763|NCT01800344|Anesthesia|anesthesia
269764|NCT01800344|Intubation|intubation
269765|NCT01800318|NESAP|nesap
269766|NCT01800318|sucrose|sucrose
269767|NCT01800318|pain|pain
269768|NCT01800318|infants|infants
269769|NCT01800305|PK & PD study|pk & pd study
269770|NCT01800305|rhEPO|rhepo
269771|NCT01800305|Pegylated rhEPO|pegylated rhepo
269772|NCT01800305|male healthy subject|male healthy subject
269773|NCT01800292|Pulmonary Artery Hypertension|pulmonary artery hypertension
269774|NCT01800292|pulmonary capillary wedge pressure|pulmonary capillary wedge pressure
269775|NCT01800292|sildenafil|sildenafil
269776|NCT01800292|echocardiography|echocardiography
269777|NCT01800292|left ventricular longitudinal wall strain|left ventricular longitudinal wall strain
269778|NCT01800292|strain rate pre and post medical therapy|strain rate pre and post medical therapy
269779|NCT01800292|speckle tracking|speckle tracking
269780|NCT01800279|Fibromyalgia Syndrome, Temporomandibular Joint, Pain.|fibromyalgia syndrome, temporomandibular joint, pain.
269781|NCT01800266|Supervision|supervision
269782|NCT01800266|Implementation|implementation
269783|NCT01800266|Community Based Mental Health Services|community based mental health services
269784|NCT01800266|Trauma Focused Cognitive Behavioral Therapy|trauma focused cognitive behavioral therapy
269785|NCT01800266|Skill Building and Behavioral Rehearsal|skill building and behavioral rehearsal
269786|NCT01800266|Symptom and Fidelity Monitoring|symptom and fidelity monitoring
269789|NCT01800214|neurodengeneration|neurodengeneration
269790|NCT01800214|neuroimaging|neuroimaging
269791|NCT01800201|Initial occurrence Acute Myocardial Infarction (AMI)|initial occurrence acute myocardial infarction (ami)
269792|NCT01800188|Dialysis|dialysis
269793|NCT01800188|Incretin hormones|incretin hormones
269794|NCT01800149|Tooth extraction|tooth extraction
269795|NCT01800149|Ridge Preservation|ridge preservation
269796|NCT01800149|Ridge Augmentation|ridge augmentation
269797|NCT01800149|Guided Bone Regeneration|guided bone regeneration
269798|NCT01800136|pain|pain
269799|NCT01800136|neuropathic|neuropathic
269800|NCT01800136|cortical stimulation|cortical stimulation
269801|NCT01800136|motor cortex|motor cortex
269802|NCT01800136|plasticity|plasticity
269803|NCT01800136|rTMS|rtms
269804|NCT01800136|tDCS|tdcs
269805|NCT01800123|Intoxication, overdose, poisoning, EtCO2, emergency medicine|intoxication, overdose, poisoning, etco2, emergency medicine
269806|NCT01800097|stroke|stroke
269807|NCT01800097|fatigue|fatigue
269808|NCT01800097|modafinil|modafinil
269809|NCT01800084|ASIR|asir
269810|NCT01800084|image acquisition|image acquisition
269811|NCT01800084|FBP|fbp
269812|NCT01800071|Nasopharyngeal cancer|nasopharyngeal cancer
269813|NCT01800071|Epstein Barr Virus Infections|epstein barr virus infections
269814|NCT01800071|Vaccination|vaccination
269815|NCT01800045|Narcolepsy|narcolepsy
269816|NCT01800045|Cataplexy|cataplexy
269817|NCT01800045|Sleep disorder|sleep disorder
269818|NCT01800045|Excessive daytime sleepiness|excessive daytime sleepiness
269819|NCT01800006|Atrial Fibrillation|atrial fibrillation
269820|NCT01800006|Observation|observation
269821|NCT01800006|Stroke|stroke
269822|NCT01800006|Embolism|embolism
269823|NCT01799993|Gram-negative pneumonia|gram-negative pneumonia
269824|NCT01799993|Intubation|intubation
269825|NCT01799993|Mechanical ventilation|mechanical ventilation
269826|NCT01799993|Amikacin|amikacin
269827|NCT01799980|Lung cancer|lung cancer
269828|NCT01799980|Cervical mediastinoscopy|cervical mediastinoscopy
269829|NCT01799980|Endobronchial ultrasound|endobronchial ultrasound
269830|NCT01799980|Staging|staging
269831|NCT01799967|gastro-esophageal junction|gastro-esophageal junction
269832|NCT01799967|minimally invasive|minimally invasive
269833|NCT01799967|Achalasia|achalasia
269834|NCT01799967|Paraesophageal hernia|paraesophageal hernia
269835|NCT01799967|GERD|gerd
269836|NCT01799967|Epiphrenic diverticula|epiphrenic diverticula
269837|NCT01799967|Zenker's diverticulum|zenker's diverticulum
269838|NCT01799967|All minimally invasive surgeries of the gastro-esophageal junction|all minimally invasive surgeries of the gastro-esophageal junction
269839|NCT01799902|Observational|observational
269840|NCT01799902|Non-Interventional Prospective|non-interventional prospective
269841|NCT01799902|Phase IV Treatment|phase iv treatment
269842|NCT01799902|Overactive Bladder Syndrome|overactive bladder syndrome
269843|NCT01799902|Solifenacin|solifenacin
269844|NCT01799889|GS-US-339-0102|gs-us-339-0102
269845|NCT01799889|SYK inhibitor|syk inhibitor
269846|NCT01799889|GS-9973|gs-9973
269847|NCT01799889|entospletinib|entospletinib
269849|NCT01799889|leukemia|leukemia
269850|NCT01799889|lymphoma|lymphoma
269851|NCT01799889|MCL|mcl
269852|NCT01799889|DLBCL|dlbcl
269853|NCT01799889|iNHL|inhl
269854|NCT01799889|FL|fl
269855|NCT01799889|MZL|mzl
269856|NCT01799889|LPL|lpl
269857|NCT01799889|SLL|sll
269858|NCT01799889|WM|wm
269859|NCT01799889|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
269860|NCT01799876|knee|knee
269861|NCT01799876|cartilage|cartilage
269862|NCT01799876|microfracture|microfracture
269863|NCT01799876|cell therapy|cell therapy
269864|NCT01799863|Conjunctivitis, Viral|conjunctivitis, viral
269865|NCT01799863|Ketorolac|ketorolac
269866|NCT01799863|Artificial tears|artificial tears
269867|NCT01799850|muscle|muscle
269868|NCT01799850|glucose transporters|glucose transporters
269869|NCT01799850|GLUT4|glut4
269870|NCT01799850|GLUT5|glut5
269871|NCT01799850|Actos|actos
269872|NCT01799837|PTSD|ptsd
269873|NCT01799811|allograft|allograft
269874|NCT01799811|limb salvage|limb salvage
269875|NCT01799811|patency|patency
269876|NCT01799811|Cryopreserved|cryopreserved
269877|NCT01799811|open bypass|open bypass
269878|NCT01799798|Osteogenesis imperfecta|osteogenesis imperfecta
269879|NCT01799798|COL1A1/A2|col1a1/a2
269880|NCT01799798|Denosumab|denosumab
269881|NCT01799798|Bisphosphonates|bisphosphonates
269882|NCT01799798|Children|children
269883|NCT01799798|Areal bone mineral density|areal bone mineral density
269884|NCT01799759|Body Mass Percentile|body mass percentile
269885|NCT01799759|Authoritative parenting|authoritative parenting
269886|NCT01799759|Online interventions|online interventions
269887|NCT01799759|Prevention|prevention
269888|NCT01799733|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
269890|NCT01799733|Depression|depression
269891|NCT01799733|Light therapy|light therapy
269892|NCT01799733|Wake therapy|wake therapy
269893|NCT01799733|Phase|phase
269894|NCT01799733|Chronobiology|chronobiology
270795|NCT01795729|Prognosis|prognosis
269895|NCT01799720|blood cholesterol|blood cholesterol
269896|NCT01799720|blood lipid profile|blood lipid profile
269897|NCT01799720|triglycerides|triglycerides
269898|NCT01799720|commercial pills|commercial pills
269899|NCT01799720|fish oil|fish oil
269900|NCT01799720|lipid peroxidation|lipid peroxidation
269901|NCT01799720|Circulating lipidic profile|circulating lipidic profile
269902|NCT01799707|vision|vision
269903|NCT01799707|restoration|restoration
269904|NCT01799707|visual field|visual field
269905|NCT01799694|Urinary incontinence|urinary incontinence
269906|NCT01799694|Autologous expanded stem cells|autologous expanded stem cells
269907|NCT01799694|Radical prostate cancer surgery|radical prostate cancer surgery
269908|NCT01799681|randomised controlled trial, postural balance, rehabilitation, exercise therapy, accidental falls|randomised controlled trial, postural balance, rehabilitation, exercise therapy, accidental falls
269909|NCT01799668|Psychotherapy|psychotherapy
269910|NCT01799668|Preferences|preferences
269911|NCT01799642|dyspnea|dyspnea
269912|NCT01799642|exercise|exercise
269913|NCT01799642|cystic fibrosis|cystic fibrosis
269914|NCT01799642|neuromechanical dissociation|neuromechanical dissociation
269915|NCT01799629|Glycerin suppositories|glycerin suppositories
269916|NCT01799629|Feeding intolerance|feeding intolerance
269917|NCT01799629|preterm infants|preterm infants
269918|NCT01799629|prophylactic use|prophylactic use
269919|NCT01799629|elimination of meconium|elimination of meconium
269920|NCT01799616|MODIC changes|modic changes
269921|NCT01799616|Chronic low back pain|chronic low back pain
269922|NCT01799616|Pamidronate|pamidronate
269923|NCT01799616|Magnetic resonance imaging|magnetic resonance imaging
269924|NCT01799616|Vertebrae|vertebrae
269925|NCT01799616|Intervertebral disc|intervertebral disc
269926|NCT01799603|Healthy|healthy
269927|NCT01799603|TMC435|tmc435
269928|NCT01799603|G008|g008
269929|NCT01799590|Migraine|migraine
269930|NCT01799590|Topiramate|topiramate
269931|NCT01799577|laparoscopy, accuracy, duration|laparoscopy, accuracy, duration
269932|NCT01799564|Geographic atrophy|geographic atrophy
269933|NCT01799564|Age-related macular degeneration|age-related macular degeneration
269934|NCT01799564|Fundus autofluorescence|fundus autofluorescence
269935|NCT01799551|Depression|depression
269936|NCT01799551|Culture|culture
269938|NCT01799551|Adaptation|adaptation
269939|NCT01799538|Albuterol|albuterol
269940|NCT01799538|Bronchodilator|bronchodilator
269941|NCT01799538|Nebulizer|nebulizer
269942|NCT01799538|Metered Dose Inhaler|metered dose inhaler
269943|NCT01799525|Aneurysm|aneurysm
269944|NCT01799525|subarachnoid hemorrhage|subarachnoid hemorrhage
269945|NCT01799525|vasospasm|vasospasm
269946|NCT01799525|cerebral ischemia|cerebral ischemia
269947|NCT01799525|stroke|stroke
269948|NCT01799512|medical ICU patients|medical icu patients
269949|NCT01799512|APACHE-II score ≥20|apache-ii score ≥20
269950|NCT01799499|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
269951|NCT01799499|Intravesical instillation|intravesical instillation
269952|NCT01799499|Mitomycin C|mitomycin c
269953|NCT01799499|Hydrogel|hydrogel
269954|NCT01799499|Reverse thermal gelation|reverse thermal gelation
269955|NCT01799499|Drug retention|drug retention
269956|NCT01799499|Urinary Bladder Neoplasms|urinary bladder neoplasms
269957|NCT01799499|Carcinoma|carcinoma
269958|NCT01799499|Urologic Neoplasms|urologic neoplasms
269959|NCT01799499|Urogenital Neoplasms|urogenital neoplasms
269960|NCT01799499|Neoplasms by Site|neoplasms by site
269961|NCT01799499|Neoplasms|neoplasms
269962|NCT01799499|Urinary Bladder Diseases|urinary bladder diseases
269963|NCT01799499|Urologic Diseases|urologic diseases
269964|NCT01799499|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
269965|NCT01799499|Neoplasms by Histologic Type Mitomycins|neoplasms by histologic type mitomycins
269966|NCT01799499|Mitomycin|mitomycin
269967|NCT01799499|Antibiotics, Antineoplastic|antibiotics, antineoplastic
269968|NCT01799499|Antineoplastic Agents|antineoplastic agents
269969|NCT01799499|Therapeutic Uses|therapeutic uses
269970|NCT01799499|Pharmacologic Actions|pharmacologic actions
269971|NCT01799499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors
269972|NCT01799499|Enzyme Inhibitors|enzyme inhibitors
269973|NCT01799499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
269974|NCT01799499|Alkylating Agents|alkylating agents
269975|NCT01799486|Telbivudine|telbivudine
269976|NCT01799486|renoprotective efficacy|renoprotective efficacy
269977|NCT01799486|liver cirrhosis|liver cirrhosis
269978|NCT01799473|Tyvaso|tyvaso
269979|NCT01799473|PAH|pah
269980|NCT01799460|single-nucleotide-polymorphism|single-nucleotide-polymorphism
269981|NCT01799460|Traditional Chinese Medicine|traditional chinese medicine
269982|NCT01799460|the Comprehensive Treatment Regimen|the comprehensive treatment regimen
269983|NCT01799447|Early intervention|early intervention
269984|NCT01799447|Intervention study|intervention study
269985|NCT01799447|Infant mother relations|infant mother relations
269986|NCT01799447|First time mothers|first time mothers
269987|NCT01799447|Parental program|parental program
269988|NCT01799447|Marte Meo method|marte meo method
269990|NCT01799369|Surgical Apgar Score|surgical apgar score
271422|NCT01793025|allogeneic|allogeneic
269991|NCT01799356|Treatment, moksifloksasin|treatment, moksifloksasin
269992|NCT01799343|Prenatal care|prenatal care
269993|NCT01799343|Blood flow velocity|blood flow velocity
269994|NCT01799343|Hydrotherapy|hydrotherapy
269995|NCT01799343|Fetalplacental circulation|fetalplacental circulation
269996|NCT01799343|Uteroplacental circulation|uteroplacental circulation
269997|NCT01799330|COPD|copd
269998|NCT01799330|Rehabilitation|rehabilitation
269999|NCT01799330|Exercise|exercise
270000|NCT01799330|TCEMS|tcems
270001|NCT01799304|Locomotion|locomotion
270002|NCT01799304|cerebral palsy|cerebral palsy
270003|NCT01799304|Postural; Defect|postural; defect
270004|NCT01799291|Decision Making|decision making
270005|NCT01799291|Pediatric Bipolar Disorder|pediatric bipolar disorder
270006|NCT01799291|Assessment|assessment
270007|NCT01799291|Intervention|intervention
270008|NCT01799278|Metastatic prostate carcinoma|metastatic prostate carcinoma
270009|NCT01799265|obstructive sleep apnea|obstructive sleep apnea
270010|NCT01799265|OSA|osa
270011|NCT01799265|AutoPAP|autopap
270012|NCT01799265|PAP|pap
270013|NCT01799265|sleep disordered breathing|sleep disordered breathing
270014|NCT01799265|CPAP|cpap
270015|NCT01799265|Apnea hypopnea index|apnea hypopnea index
270016|NCT01799265|AHI|ahi
270017|NCT01799252|medical abortion|medical abortion
270018|NCT01799252|doxycycline|doxycycline
270019|NCT01799252|antibiotics|antibiotics
270020|NCT01799252|adherence|adherence
270021|NCT01799252|nausea|nausea
270022|NCT01799239|stoma ileostomy|stoma ileostomy
270023|NCT01799213|Knee Osteoarthritis|knee osteoarthritis
270024|NCT01799213|NSAID|nsaid
270025|NCT01799213|Cognitive Behavioral Therapy|cognitive behavioral therapy
270026|NCT01799200|Collegiate Athletes|collegiate athletes
270027|NCT01799200|Hip Pathomorphology|hip pathomorphology
270028|NCT01799200|Age-Matched Controls|age-matched controls
270029|NCT01799200|Femoroacetabular Impingement|femoroacetabular impingement
270030|NCT01799200|Dysplasia|dysplasia
270031|NCT01799187|Immature Permanent Teeth|immature permanent teeth
270032|NCT01799161|NSCLC|nsclc
270033|NCT01799161|Lung Cancer|lung cancer
270034|NCT01799161|gp96|gp96
270035|NCT01799161|gp96 Vaccine|gp96 vaccine
270036|NCT01799161|AD100-gp96Ig-HLA A1|ad100-gp96ig-hla a1
270037|NCT01799148|Acute coronary syndrome|acute coronary syndrome
270038|NCT01799148|Air pollution.|air pollution.
270039|NCT01799148|Inflammation.|inflammation.
270040|NCT01799148|Oxidative Stress.|oxidative stress.
270041|NCT01799148|Prognosis|prognosis
270042|NCT01799109|magnesium sulfate|magnesium sulfate
270043|NCT01799109|nebulization|nebulization
270044|NCT01799109|lung function|lung function
270045|NCT01799083|Advanced solid tumors|advanced solid tumors
270046|NCT01799083|B cell lymphoma|b cell lymphoma
270047|NCT01799070|Prediction|prediction
270048|NCT01799070|Transcranial Doppler|transcranial doppler
270049|NCT01799057|Peripheral Arterial Disease|peripheral arterial disease
270050|NCT01799057|Intermittent Claudication|intermittent claudication
270051|NCT01799057|Peripheral Vascular Diseases|peripheral vascular diseases
270052|NCT01799057|Vascular Diseases|vascular diseases
270053|NCT01799057|Cardiovascular Diseases|cardiovascular diseases
270054|NCT01799057|Arterial Occlusive Diseases|arterial occlusive diseases
270055|NCT01799057|Atherosclerosis|atherosclerosis
270056|NCT01799057|Insulin Resistance|insulin resistance
270057|NCT01799057|Glucose Metabolism|glucose metabolism
270058|NCT01799057|Blood Glucose|blood glucose
270059|NCT01799057|Metformin|metformin
270060|NCT01799057|Biguanides|biguanides
270061|NCT01799057|Hypoglycemic Agents|hypoglycemic agents
270062|NCT01799057|Endothelium, Vascular|endothelium, vascular
270063|NCT01799057|Hemorheology|hemorheology
270064|NCT01799057|Blood Circulation|blood circulation
270065|NCT01799057|Regional Blood Flow|regional blood flow
270066|NCT01799057|Microcirculation|microcirculation
270067|NCT01799057|Exercise|exercise
270068|NCT01799057|Physical Fitness|physical fitness
270069|NCT01799057|Exercise Test|exercise test
270070|NCT01799057|Sedentary Lifestyle|sedentary lifestyle
270071|NCT01799057|Quality of Life|quality of life
270072|NCT01799057|Plethysmography|plethysmography
270073|NCT01799044|Irreversible electroporation|irreversible electroporation
270074|NCT01799044|IRE|ire
270075|NCT01799044|Electroporation|electroporation
270076|NCT01799044|Colorectal liver metastases|colorectal liver metastases
270077|NCT01799044|CRLM|crlm
270078|NCT01799044|Safety|safety
270079|NCT01799044|Feasibility|feasibility
270080|NCT01799044|Efficacy|efficacy
270081|NCT01799044|Single-center|single-center
270082|NCT01799044|Low Energy Direct Current|low energy direct current
270083|NCT01799044|Ablate-and-resect|ablate-and-resect
270084|NCT01799044|Nonthermal ablation|nonthermal ablation
270085|NCT01799044|Ablation|ablation
270086|NCT01799018|Xanthine Oxidase|xanthine oxidase
270087|NCT01799018|Cerebrospinal fluid|cerebrospinal fluid
270088|NCT01799005|flavanols|flavanols
270089|NCT01799005|diet|diet
270090|NCT01799005|endothelial function|endothelial function
270091|NCT01799005|blood pressure|blood pressure
270092|NCT01799005|FLAVIOLA|flaviola
270093|NCT01798992|ejection fraction|ejection fraction
270094|NCT01798992|beta-blocker|beta-blocker
270095|NCT01798992|carvedilol|carvedilol
270096|NCT01798992|metoprolol|metoprolol
270097|NCT01798992|myocardial gene expression|myocardial gene expression
270098|NCT01798992|human heart|human heart
270099|NCT01798992|ventricular remodeling|ventricular remodeling
270100|NCT01798992|wall stress|wall stress
270101|NCT01798992|adrenergic signaling|adrenergic signaling
270102|NCT01798992|myosin heavy chain|myosin heavy chain
270103|NCT01798953|Ulcerative Colitis|ulcerative colitis
270104|NCT01798953|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
270105|NCT01798953|Ileal pouch-anal anastomosis|ileal pouch-anal anastomosis
270106|NCT01798953|Ileorectal anastomosis|ileorectal anastomosis
270107|NCT01798953|Surgical outcome|surgical outcome
270108|NCT01798953|Functional outcome|functional outcome
270109|NCT01798953|Failure|failure
270110|NCT01798927|Parkinson's disease|parkinson's disease
270111|NCT01798927|ankle foot orthosis (AFO)|ankle foot orthosis (afo)
270112|NCT01798927|gait|gait
270113|NCT01798901|Acute Myeloid Leukemia|acute myeloid leukemia
270114|NCT01798901|AML|aml
270115|NCT01798901|AR-42|ar-42
270116|NCT01798901|Decitabine|decitabine
270117|NCT01798888|Deep Brain Stimulation|deep brain stimulation
270118|NCT01798888|Alcohol Dependence|alcohol dependence
270119|NCT01798875|pcos|pcos
270120|NCT01798875|metformin|metformin
270121|NCT01798875|oral contraception|oral contraception
270122|NCT01798875|cyproterone acetate|cyproterone acetate
270123|NCT01798862|Failed IVF cycles|failed ivf cycles
270124|NCT01798862|IVF outcome parameters|ivf outcome parameters
270125|NCT01798862|endometrial injury|endometrial injury
270126|NCT01798862|hysteroscopy|hysteroscopy
270127|NCT01798862|pipelle sampling|pipelle sampling
270128|NCT01798862|Repeated implantation failures|repeated implantation failures
270129|NCT01798836|IVF/ICSI cycles, poor responders, ultrashort flare protocol, antagonist protocol|ivf/icsi cycles, poor responders, ultrashort flare protocol, antagonist protocol
270130|NCT01798823|children|children
270131|NCT01798823|asthma|asthma
270132|NCT01798810|Surgical Site Infection Risk Prediction|surgical site infection risk prediction
270133|NCT01798810|Bacterial species type and antibacterial sensitivities|bacterial species type and antibacterial sensitivities
270134|NCT01798810|Resource Utilization and Cost|resource utilization and cost
270135|NCT01798797|Heart Failure|heart failure
270136|NCT01798797|HFRS|hfrs
270137|NCT01798797|OptiVol|optivol
270138|NCT01798797|ICD|icd
270139|NCT01798797|CRT-D|crt-d
270140|NCT01798771|primary brain tumor|primary brain tumor
270141|NCT01798771|malignant glioma|malignant glioma
270142|NCT01798771|intraoperative MRI|intraoperative mri
270143|NCT01798771|5-ALA|5-ala
270144|NCT01798745|Heart failure|heart failure
270145|NCT01798745|JNJ-54452840|jnj-54452840
270146|NCT01798745|Anti-beta-1 adrenergic receptor auto antibodies|anti-beta-1 adrenergic receptor auto antibodies
270147|NCT01798745|Beta-1 adrenergic receptor|beta-1 adrenergic receptor
270148|NCT01798745|Antibodies|antibodies
270149|NCT01798745|Auto antibodies|auto antibodies
270150|NCT01798745|Systolic function|systolic function
270151|NCT01798719|NAFLD|nafld
270152|NCT01798719|Clinical Trial|clinical trial
270153|NCT01798719|Mediterranean Diet|mediterranean diet
270154|NCT01798719|Low Glycemic Index|low glycemic index
270155|NCT01798693|Shoulder|shoulder
270156|NCT01798693|Supplement|supplement
270157|NCT01798693|Amino Acids|amino acids
270158|NCT01798693|Collagen|collagen
270159|NCT01798693|Standard of Care|standard of care
270160|NCT01798641|Hydrocephalus|hydrocephalus
270161|NCT01798641|Cross-over|cross-over
270162|NCT01798628|Healthy volunteers|healthy volunteers
270163|NCT01798628|Abiraterone acetate|abiraterone acetate
270164|NCT01798628|Pharmacokinetics|pharmacokinetics
270165|NCT01798602|H1N1|h1n1
270166|NCT01798602|Rosuvastatin|rosuvastatin
270167|NCT01798589|ethylenediamine dihydrochloride|ethylenediamine dihydrochloride
270168|NCT01798563|Parkinson|parkinson
270169|NCT01798563|Parkinson Disease|parkinson disease
270170|NCT01798550|Enoxaparin dosing|enoxaparin dosing
270172|NCT01798524|Transplant|transplant
270173|NCT01798524|Kidney|kidney
270174|NCT01798524|England|england
270175|NCT01798511|enteral nutrition|enteral nutrition
270176|NCT01798511|acute pancreatitis|acute pancreatitis
270177|NCT01798511|oral food intolerance|oral food intolerance
270178|NCT01798472|displaced femoral neck fractures|displaced femoral neck fractures
270179|NCT01798472|treatment|treatment
270180|NCT01798472|uncemented arthroplasty|uncemented arthroplasty
270181|NCT01798472|cemented arthroplasty|cemented arthroplasty
270182|NCT01798459|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
270183|NCT01798459|Methylphenidate|methylphenidate
270184|NCT01798459|Placebo|placebo
270185|NCT01798459|State anxiety|state anxiety
270186|NCT01798446|Renal cell carcinoma|renal cell carcinoma
270187|NCT01798446|Nonclear cell|nonclear cell
270188|NCT01798446|Temsirolimus resistance|temsirolimus resistance
270189|NCT01798433|Angioplasty|angioplasty
270190|NCT01798433|Transluminal|transluminal
270191|NCT01798433|Percutaneous Coronary|percutaneous coronary
270193|NCT01798420|Diabetes|diabetes
270194|NCT01798420|steroids|steroids
270195|NCT01798420|Hemoglobin A1C DIFFERENCE|hemoglobin a1c difference
270196|NCT01798407|Deep Brain Stimulation|deep brain stimulation
270197|NCT01798407|Major Depressive Disorder|major depressive disorder
270198|NCT01798407|Depression|depression
270199|NCT01798407|Lateral Habenula|lateral habenula
270200|NCT01798407|Intractable Depression|intractable depression
270201|NCT01798407|Treatment Resistant Depression (TRD)|treatment resistant depression (trd)
270202|NCT01798394|pregnant|pregnant
270203|NCT01798394|smoker|smoker
270204|NCT01798394|cigarette|cigarette
270205|NCT01798394|tobacco|tobacco
270206|NCT01798355|Dental Fear|dental fear
270207|NCT01798355|Dental Phobia|dental phobia
270208|NCT01798355|Cognitive Behavior Therapy|cognitive behavior therapy
270209|NCT01798355|Specific Phobia|specific phobia
270210|NCT01798355|Children and Adolescents anxiety|children and adolescents anxiety
270211|NCT01798355|Self Efficacy|self efficacy
270212|NCT01798342|preoperative care|preoperative care
270213|NCT01798342|maltodextrine|maltodextrine
270214|NCT01798342|glutamine|glutamine
270215|NCT01798342|gastric residual volume|gastric residual volume
270216|NCT01798342|MRI|mri
270217|NCT01798329|Minimal Hepatic Encephalopathy|minimal hepatic encephalopathy
270218|NCT01798329|Pre-hepatic Portal Hypertension|pre-hepatic portal hypertension
270219|NCT01798329|portal vein thrombosis|portal vein thrombosis
270220|NCT01798316|IV Acetaminophen|iv acetaminophen
270221|NCT01798316|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
270222|NCT01798316|Postoperative nausea|postoperative nausea
270223|NCT01798316|Postoperative vomiting|postoperative vomiting
270224|NCT01798277|Keywords provided by Newmarket Electrophysiology Research Group Inc:|keywords provided by newmarket electrophysiology research group inc:
270225|NCT01798277|Ventricular tachycardia|ventricular tachycardia
270226|NCT01798277|Ventricular tachyarrhythmia|ventricular tachyarrhythmia
270227|NCT01798277|Ablation|ablation
270228|NCT01798277|Coronary artery disease|coronary artery disease
270229|NCT01798277|Ischemic heart disease|ischemic heart disease
270230|NCT01798277|Amiodarone|amiodarone
270231|NCT01798277|Sotalol|sotalol
270232|NCT01798277|Anti-Arrhythmia Agents|anti-arrhythmia agents
270233|NCT01798277|Therapeutic Uses|therapeutic uses
270234|NCT01798277|Pharmacologic Actions|pharmacologic actions
270235|NCT01798277|Additional relevant MeSH terms:|additional relevant mesh terms:
270236|NCT01798277|Atrial Fibrillation|atrial fibrillation
270237|NCT01798277|Arrhythmias, Cardiac|arrhythmias, cardiac
270238|NCT01798277|Heart Diseases|heart diseases
270239|NCT01798277|Cardiovascular Diseases|cardiovascular diseases
270240|NCT01798277|Pathologic Processes|pathologic processes
270241|NCT01798277|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
270242|NCT01798251|Elderly Gastric Cancer|elderly gastric cancer
270243|NCT01798251|Capecitabine Maintenance|capecitabine maintenance
270244|NCT01798238|Type 2 Diabetes Mellitus / Dipeptidyl peptidase-IV inhibitors|type 2 diabetes mellitus / dipeptidyl peptidase-iv inhibitors
270245|NCT01798225|Periodontal Disease|periodontal disease
270246|NCT01798225|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
270247|NCT01798225|Gullah African Americans|gullah african americans
270248|NCT01798212|GERD|gerd
270249|NCT01798199|Alzheimer|alzheimer
270250|NCT01798199|virtual reality system|virtual reality system
270251|NCT01798199|Alzheimer's disease related conditions|alzheimer's disease related conditions
270252|NCT01798173|Hepatocellular carcinoma|hepatocellular carcinoma
270253|NCT01798173|Cirrhosis|cirrhosis
270254|NCT01798173|Environmental risk factors|environmental risk factors
270255|NCT01798173|Nutrition|nutrition
270256|NCT01798173|Metabolic syndrome|metabolic syndrome
270257|NCT01798147|Cholangiocellular Carcinoma|cholangiocellular carcinoma
270258|NCT01798147|TACE|tace
270259|NCT01798147|SIRT|sirt
270260|NCT01798134|To show safety|to show safety
270261|NCT01798134|and efficacy|and efficacy
270262|NCT01798134|investigational product|investigational product
270263|NCT01798121|PPD|ppd
270264|NCT01798121|Tuberculosis|tuberculosis
270265|NCT01798108|Advanced skeletal metastases|advanced skeletal metastases
270266|NCT01798108|Radium-223|radium-223
270267|NCT01798108|Radium-223 dichloride|radium-223 dichloride
270268|NCT01798108|Alpharadin|alpharadin
270269|NCT01798095|TB, Aplisol|tb, aplisol
270270|NCT01798056|≥18 years of age|≥18 years of age
270271|NCT01798056|Chemotherapy|chemotherapy
270272|NCT01798056|Solid tumours|solid tumours
270273|NCT01798056|Immunogenicity|immunogenicity
270274|NCT01798056|Herpes Zoster|herpes zoster
270275|NCT01798056|Safety|safety
270276|NCT01798056|Shingles|shingles
270277|NCT01798030|Vitamin D|vitamin d
270278|NCT01798030|Diabetes|diabetes
270279|NCT01798030|Osteoporosis|osteoporosis
270280|NCT01798030|Cardiovascular Risk|cardiovascular risk
270281|NCT01798017|menstrual regulation|menstrual regulation
270282|NCT01798017|mifepristone|mifepristone
270283|NCT01798017|misoprostol|misoprostol
270284|NCT01797991|Hypersensitivity, drug|hypersensitivity, drug
270285|NCT01797978|Sepsis|sepsis
270286|NCT01797978|Septic shock|septic shock
270287|NCT01797978|Methylene blue|methylene blue
270288|NCT01797952|lactobacillus CD 2|lactobacillus cd 2
270289|NCT01797952|oral mucositis|oral mucositis
272140|NCT01789216|Acute pain|acute pain
270290|NCT01797952|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
270291|NCT01797939|Erosive reflux disease (ERD)|erosive reflux disease (erd)
270292|NCT01797939|Non-erosive reflux disease (NERD)|non-erosive reflux disease (nerd)
270293|NCT01797939|Functional heartburn (FH)|functional heartburn (fh)
270294|NCT01797926|pharmacokinetics|pharmacokinetics
270295|NCT01797926|Hypertension|hypertension
270296|NCT01797926|losartan|losartan
270297|NCT01797926|healthy volunteers|healthy volunteers
270298|NCT01797926|amlodipine|amlodipine
270299|NCT01797900|adjuvants|adjuvants
270300|NCT01797900|inductive|inductive
270301|NCT01797900|concurrent|concurrent
270302|NCT01797900|chemoradiotherapy|chemoradiotherapy
270303|NCT01797900|high-risk|high-risk
270304|NCT01797900|locally advanced|locally advanced
270305|NCT01797900|NPC|npc
270306|NCT01797887|Burnout-Syndrome|burnout-syndrome
270307|NCT01797887|Ayurveda|ayurveda
270308|NCT01797887|Ayurvedic|ayurvedic
270309|NCT01797887|Traditional Indian Medicine|traditional indian medicine
270311|NCT01797887|Whole Medical System|whole medical system
270312|NCT01797887|Diet and Lifestyle Counseling|diet and lifestyle counseling
270313|NCT01797874|pazopanib maintenance|pazopanib maintenance
270314|NCT01797874|efficacy|efficacy
270315|NCT01797874|SCLC|sclc
270316|NCT01797861|chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
270317|NCT01797861|photodynamic therapy|photodynamic therapy
270318|NCT01797861|micropulse laser|micropulse laser
270319|NCT01797835|adolescents|adolescents
270320|NCT01797835|intervention|intervention
270321|NCT01797835|motivational interviewing|motivational interviewing
270322|NCT01797835|alcohol and drug use|alcohol and drug use
270323|NCT01797783|Myopia|myopia
270324|NCT01797783|Presbyopia|presbyopia
270325|NCT01797783|Refractive error|refractive error
270326|NCT01797783|Contact lenses|contact lenses
270327|NCT01797783|Multifocal|multifocal
270328|NCT01797770|mechanical bowel preparation|mechanical bowel preparation
270329|NCT01797770|Colon Cancer|colon cancer
270330|NCT01797757|EPA|epa
270331|NCT01797757|LC-PUFA|lc-pufa
270332|NCT01797757|Orlistat|orlistat
270333|NCT01797757|Obesity|obesity
270334|NCT01797744|Stroke|stroke
270335|NCT01797744|Dizziness|dizziness
270336|NCT01797744|Vestibular rehabiliation|vestibular rehabiliation
270337|NCT01797744|Balance|balance
270338|NCT01797731|Orthalign|orthalign
270339|NCT01797731|KneeAlign|kneealign
270340|NCT01797731|Total Knee Replacement|total knee replacement
270341|NCT01797731|Total Knee Arthroplasty|total knee arthroplasty
270342|NCT01797731|Degenerative joint disease|degenerative joint disease
270343|NCT01797731|Osteoarthritis|osteoarthritis
270344|NCT01797731|Unilateral|unilateral
270345|NCT01797718|Puberty|puberty
270346|NCT01797718|Constitutional|constitutional
270347|NCT01797718|Delay|delay
270348|NCT01797718|Letrozole|letrozole
270349|NCT01797718|Testosterone|testosterone
270350|NCT01797692|prostate cancer cured|prostate cancer cured
270351|NCT01797692|aged patients|aged patients
270352|NCT01797679|Osteoarthritis,Articular Cartilage, Relaxometry, Morphometry, MRI, T2 mapping, T1 rho|osteoarthritis,articular cartilage, relaxometry, morphometry, mri, t2 mapping, t1 rho
270353|NCT01797640|Tibia Fractures|tibia fractures
270354|NCT01797640|Medial Fractures|medial fractures
270355|NCT01797640|Posterior Malleolar Fractures|posterior malleolar fractures
270356|NCT01797627|Pediatric Hydrocephalus|pediatric hydrocephalus
270357|NCT01797627|Ventricular Size|ventricular size
270358|NCT01797627|Neuropsychological Outcomes|neuropsychological outcomes
270359|NCT01797627|Quality of Life|quality of life
270360|NCT01797614|intra-abdominal pressure|intra-abdominal pressure
270361|NCT01797614|spontaneous breathing trail|spontaneous breathing trail
270363|NCT01797588|Total Knee Arthroplasty|total knee arthroplasty
270364|NCT01797588|Pain|pain
270365|NCT01797588|Periarticular infiltration|periarticular infiltration
270366|NCT01797588|Adductor canal block|adductor canal block
270367|NCT01797588|Postoperative|postoperative
270368|NCT01797575|Bipolar Disorder|bipolar disorder
270369|NCT01797575|Mood Disorder|mood disorder
270370|NCT01797575|Bipolar Depression|bipolar depression
270371|NCT01797575|Mood Swings|mood swings
270372|NCT01797562|Contact dermatitis|contact dermatitis
270373|NCT01797562|Eczema|eczema
270374|NCT01797549|Traumatic brain injury|traumatic brain injury
270375|NCT01797549|functional near infrared spectroscopy|functional near infrared spectroscopy
270376|NCT01797523|Endometrial cancer|endometrial cancer
270377|NCT01797523|Advanced or Recurrent Endometrial Carcinoma|advanced or recurrent endometrial carcinoma
270378|NCT01797523|Metformin|metformin
270379|NCT01797523|Letrozole|letrozole
270380|NCT01797523|Femara|femara
270381|NCT01797523|Everolimus|everolimus
270382|NCT01797523|Afinitor|afinitor
270383|NCT01797523|Zortress|zortress
270384|NCT01797523|RAD001|rad001
270385|NCT01797497|Parents|parents
270386|NCT01797497|Primary Care Providers|primary care providers
270387|NCT01797497|Specialists|specialists
270388|NCT01797497|Children with Special Healthcare Needs|children with special healthcare needs
270389|NCT01797497|Referral|referral
270390|NCT01797497|Health Outcomes|health outcomes
270391|NCT01797497|Self-Efficacy|self-efficacy
270392|NCT01797497|Communication|communication
270393|NCT01797484|ischemia|ischemia
270394|NCT01797484|myocardium|myocardium
270395|NCT01797484|Ranolazine|ranolazine
270396|NCT01797484|dyskinesia|dyskinesia
270397|NCT01797484|speckle tracking echocardiography|speckle tracking echocardiography
270398|NCT01797471|Non-Small Cell Lung Cancer|non-small cell lung cancer
270399|NCT01797471|NSCLC|nsclc
270400|NCT01797471|Lung Cancer|lung cancer
270401|NCT01797458|class II carious primary molar|class ii carious primary molar
270402|NCT01797458|Opening-up cavities|opening-up cavities
270403|NCT01797458|Hall Technique|hall technique
270404|NCT01797458|Conventional restorations|conventional restorations
270405|NCT01797445|HIV|hiv
270406|NCT01797445|Treatment Naive|treatment naive
270407|NCT01797445|HIV 1 Infected|hiv 1 infected
270408|NCT01797445|Women|women
270409|NCT01797445|Female|female
270410|NCT01797419|Respiratory|respiratory
270411|NCT01797419|Syncytial|syncytial
270412|NCT01797419|Virus|virus
270413|NCT01797419|RSV|rsv
270414|NCT01797380|Depression|depression
270415|NCT01797380|HIV|hiv
270416|NCT01797367|HIV|hiv
270417|NCT01797367|COPD|copd
270418|NCT01797367|FEV1|fev1
270419|NCT01797367|respiratory function|respiratory function
270420|NCT01797354|patients at the end of treatment|patients at the end of treatment
270421|NCT01797341|Renal Transplantation|renal transplantation
270422|NCT01797341|Kidney transplantation|kidney transplantation
270423|NCT01797341|Pancreas Transplantation|pancreas transplantation
270424|NCT01797341|Tacrolimus|tacrolimus
270425|NCT01797341|Advagraf|advagraf
270426|NCT01797341|Prograf|prograf
270427|NCT01797341|Drug Adherence|drug adherence
270428|NCT01797328|brown adipose tissue, human|brown adipose tissue, human
270429|NCT01797302|Obesity|obesity
270430|NCT01797302|Vitamin D Deficiency|vitamin d deficiency
270431|NCT01797302|Vascular Function|vascular function
270432|NCT01797302|Insulin resistance|insulin resistance
270433|NCT01797302|metabolic syndrome|metabolic syndrome
270434|NCT01797289|syncope|syncope
270435|NCT01797289|pulmonary embolism|pulmonary embolism
270436|NCT01797276|Dichloroacetate (DCA)|dichloroacetate (dca)
270437|NCT01797276|Congenital Lactic Acidosis (CLA)|congenital lactic acidosis (cla)
270438|NCT01797276|acidosis|acidosis
270439|NCT01797276|orphan disease|orphan disease
270440|NCT01797263|fibromyalgia|fibromyalgia
270441|NCT01797263|yoga|yoga
270442|NCT01797263|exercise|exercise
270443|NCT01797263|pain|pain
270444|NCT01797237|surgery|surgery
270445|NCT01797237|fixation|fixation
270446|NCT01797237|intramedullary nail|intramedullary nail
270447|NCT01797224|Autoimmune disease|autoimmune disease
270448|NCT01797224|certolizumab pegol|certolizumab pegol
270449|NCT01797224|Cimzia|cimzia
270450|NCT01797224|pregnancy|pregnancy
270451|NCT01797224|birth defect|birth defect
270452|NCT01797224|birth outcome|birth outcome
270454|NCT01797224|Tumor necrosis factor|tumor necrosis factor
270455|NCT01797211|Mediterranean diet; FMD; obesity; cardiovascular risk.|mediterranean diet; fmd; obesity; cardiovascular risk.
270456|NCT01797198|Phase I|phase i
270457|NCT01797198|ASP3652|asp3652
270458|NCT01797198|Gemfibrozil|gemfibrozil
270459|NCT01797198|Repaglinide|repaglinide
270460|NCT01797198|Pharmacokinetics|pharmacokinetics
270461|NCT01797185|baclofen, spasticity|baclofen, spasticity
270462|NCT01797172|nucleoplasty|nucleoplasty
270463|NCT01797172|pulsed radio frequency|pulsed radio frequency
270464|NCT01797172|herniated disc|herniated disc
270465|NCT01797172|cervical|cervical
270466|NCT01797172|percutaneous disc decompression|percutaneous disc decompression
270467|NCT01797172|cervical radiculopathy|cervical radiculopathy
270468|NCT01797159|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
270469|NCT01797159|PCI|pci
270470|NCT01797159|Hippocampal-sparing irradiation|hippocampal-sparing irradiation
270471|NCT01797120|Post-Menopausal Patients|post-menopausal patients
270472|NCT01797120|Hormone-Receptor Positive|hormone-receptor positive
270473|NCT01797120|Resistant to Aromatase Inhibitor Therapy|resistant to aromatase inhibitor therapy
270474|NCT01797120|Fulvestrant|fulvestrant
270475|NCT01797120|Faslodex|faslodex
270476|NCT01797120|mTOR Inhibitor|mtor inhibitor
270477|NCT01797120|Everolimus|everolimus
270478|NCT01797120|RAD001|rad001
270479|NCT01797120|Afinitor|afinitor
270480|NCT01797107|Meibomian gland dysfunction|meibomian gland dysfunction
270481|NCT01797068|HEALTHCARE UTILIZATION|healthcare utilization
270482|NCT01797068|ED UTILIZATION|ed utilization
270483|NCT01797068|PRIMARY CARE UTILIZATION|primary care utilization
270484|NCT01797068|PATIENT NAVIGATION|patient navigation
270485|NCT01797068|UNDERSERVED POPULATIONS|underserved populations
270486|NCT01797068|HEALTH DISPARITIES|health disparities
270487|NCT01797055|transferrin|transferrin
270489|NCT01797055|iron overload|iron overload
270490|NCT01797042|Fructose|fructose
270491|NCT01797042|High fructose corn syrup|high fructose corn syrup
270492|NCT01797042|Energy regulation|energy regulation
270493|NCT01797042|Ectopic fat|ectopic fat
270494|NCT01797042|Understanding|understanding
270495|NCT01797042|potential|potential
270496|NCT01797016|Myocardial Infarction|myocardial infarction
270497|NCT01797016|flow cytometry|flow cytometry
270498|NCT01797016|Blood Cell Count|blood cell count
270499|NCT01797016|Platelet Activation|platelet activation
270500|NCT01797003|osteoarthritis|osteoarthritis
270501|NCT01797003|osteotomy|osteotomy
270502|NCT01797003|closing|closing
270503|NCT01797003|opening|opening
270504|NCT01797003|wedge|wedge
270505|NCT01797003|kne|kne
270506|NCT01797003|tibia|tibia
270507|NCT01796990|physical activity|physical activity
270508|NCT01796990|psychological well-being|psychological well-being
270509|NCT01796990|acceptance and commitment therapy|acceptance and commitment therapy
270510|NCT01796990|adults|adults
270511|NCT01796977|Nipple-sparing Mastectomy|nipple-sparing mastectomy
270512|NCT01796977|NSM|nsm
270513|NCT01796977|Nipple Sparing Mastectomy|nipple sparing mastectomy
270514|NCT01796964|Age-Related Macular Degeneration|age-related macular degeneration
270515|NCT01796964|Wet|wet
270516|NCT01796964|Exudative|exudative
270517|NCT01796964|AMD|amd
270518|NCT01796964|Intravitreal injection|intravitreal injection
270519|NCT01796964|Retina|retina
270520|NCT01796938|Lacosamide|lacosamide
270521|NCT01796938|Vimpat|vimpat
270522|NCT01796938|Single Dose|single dose
270523|NCT01796938|Pharmacokinetics|pharmacokinetics
270524|NCT01796938|Renal Impairment|renal impairment
270525|NCT01796925|Apnea|apnea
270526|NCT01796925|Respiration Disorders|respiration disorders
270527|NCT01796925|Signs and Symptoms|signs and symptoms
270528|NCT01796925|Signs and Symptoms, Respiratory|signs and symptoms, respiratory
270529|NCT01796925|Sleep Apnea Syndromes|sleep apnea syndromes
270530|NCT01796925|Sleep Apnea, Obstructive|sleep apnea, obstructive
270531|NCT01796925|Respiratory Tract Diseases|respiratory tract diseases
270532|NCT01796925|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
270533|NCT01796925|Sleep Disorders|sleep disorders
270534|NCT01796925|Nervous System Diseases|nervous system diseases
270535|NCT01796899|Healthy Volunteers|healthy volunteers
270536|NCT01796899|Brivaracetam|brivaracetam
270537|NCT01796873|Female|female
270538|NCT01796873|Hispanic|hispanic
270539|NCT01796873|Percutaneous Coronary Intervention|percutaneous coronary intervention
270540|NCT01796860|Gait|gait
270541|NCT01796860|AFO|afo
270542|NCT01796860|MS|ms
270543|NCT01796847|ICU|icu
270544|NCT01796847|Hyperglycemia|hyperglycemia
270545|NCT01796847|Length of stay|length of stay
270546|NCT01796834|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
270547|NCT01796834|Diabetes Management|diabetes management
270548|NCT01796834|Stress Reduction|stress reduction
270549|NCT01796834|Diabetes Testing|diabetes testing
270550|NCT01796821|Condyloma acuminata|condyloma acuminata
270551|NCT01796821|Genital warts|genital warts
270552|NCT01796821|Condylomata acuminata|condylomata acuminata
270553|NCT01796821|Venereal warts|venereal warts
270554|NCT01796808|pedal|pedal
270555|NCT01796808|atrophy|atrophy
270556|NCT01796808|fat grafting|fat grafting
270557|NCT01796808|adipose tissue|adipose tissue
270558|NCT01796795|common wart|common wart
270559|NCT01796795|verruca vulgaris|verruca vulgaris
270560|NCT01796769|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
270561|NCT01796769|Telemedicine|telemedicine
270562|NCT01796769|Patient Compliance|patient compliance
270563|NCT01796756|Handover|handover
270564|NCT01796756|Handoff|handoff
270565|NCT01796756|Signout|signout
270566|NCT01796756|Quality Improvement|quality improvement
270567|NCT01796756|General Internal Medicine|general internal medicine
270569|NCT01796743|Double Inversion radial fast Spin Echo T2 mapping|double inversion radial fast spin echo t2 mapping
270570|NCT01796743|Heart failure risk stratification|heart failure risk stratification
270571|NCT01796743|30 day post hospitalization outcome|30 day post hospitalization outcome
270572|NCT01796730|efficacy|efficacy
270573|NCT01796730|safety|safety
270574|NCT01796730|Bambuterol tablets|bambuterol tablets
270575|NCT01796730|COPD|copd
270576|NCT01796717|Piperacillin/tazobactam|piperacillin/tazobactam
270578|NCT01796704|functional capacity|functional capacity
270579|NCT01796704|NYHA class|nyha class
270580|NCT01796691|Clopidogrel|clopidogrel
270581|NCT01796691|aspirin|aspirin
270582|NCT01796691|low response|low response
270583|NCT01796691|platelet aggregation|platelet aggregation
270584|NCT01796691|Acute Coronary Syndrome|acute coronary syndrome
270585|NCT01796691|Coronary Stent Implantation|coronary stent implantation
270586|NCT01796678|sickle cell disease|sickle cell disease
270587|NCT01796678|vaso-occlusive pain episodes|vaso-occlusive pain episodes
270588|NCT01796678|arginine|arginine
270589|NCT01796678|nitric oxide|nitric oxide
270590|NCT01796652|Acute interstitial pancreatitis|acute interstitial pancreatitis
270592|NCT01796600|distal limbs fracture, acute trauma, imaging, cone beam computed tomography,|distal limbs fracture, acute trauma, imaging, cone beam computed tomography,
270593|NCT01796574|status epilepticus|status epilepticus
270594|NCT01796574|seizure|seizure
270595|NCT01796574|epilepsy|epilepsy
270596|NCT01796574|ketogenic diet|ketogenic diet
270597|NCT01796574|modified Atkins diet|modified atkins diet
270598|NCT01796548|Detrusor function, overactive|detrusor function, overactive
270599|NCT01796548|Urinary incontinence|urinary incontinence
270600|NCT01796548|Oxybutynin|oxybutynin
270601|NCT01796548|Lyrinel|lyrinel
270602|NCT01796509|Quality of life,|quality of life,
270603|NCT01796509|Sequela disorders,|sequela disorders,
270604|NCT01796509|Socio-professional impact,|socio-professional impact,
270605|NCT01796509|Anxiety, depression,|anxiety, depression,
270606|NCT01796509|Post traumatic stress disorder,|post traumatic stress disorder,
270607|NCT01796509|ICU acquired paresis.|icu acquired paresis.
270608|NCT01796496|Low back pain.|low back pain.
270609|NCT01796496|Manipulative therapy techniques.|manipulative therapy techniques.
270610|NCT01796496|Randomized controlled trial.|randomized controlled trial.
270611|NCT01796496|Chronic pain.|chronic pain.
270612|NCT01796483|Parkinson disease|parkinson disease
270613|NCT01796483|STN-DBS|stn-dbs
270614|NCT01796483|Impulsivity|impulsivity
270615|NCT01796483|Akinesia|akinesia
270616|NCT01796483|Noradrenergic|noradrenergic
270617|NCT01796483|system|system
270618|NCT01796470|GS-US-339-0103|gs-us-339-0103
270619|NCT01796470|SYK inhibitor|syk inhibitor
270620|NCT01796470|PI3K inhibitor|pi3k inhibitor
270621|NCT01796470|GS-9973|gs-9973
270622|NCT01796470|GS 9973|gs 9973
270623|NCT01796470|GS-1101|gs-1101
270624|NCT01796470|GS 1101|gs 1101
270625|NCT01796470|Cal-101|cal-101
270626|NCT01796470|Cal 101|cal 101
270627|NCT01796470|idelalisib|idelalisib
270628|NCT01796470|leukemia|leukemia
270629|NCT01796470|lymphoma|lymphoma
270630|NCT01796470|CLL|cll
270631|NCT01796470|MCL|mcl
270632|NCT01796470|DLBCL|dlbcl
270633|NCT01796470|iNHL|inhl
270634|NCT01796470|FL|fl
270635|NCT01796470|MZL|mzl
270636|NCT01796470|LPL|lpl
270637|NCT01796470|SLL|sll
270638|NCT01796470|WM|wm
270639|NCT01796470|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
270640|NCT01796457|Hepatitis B|hepatitis b
270641|NCT01796457|Immunology|immunology
270642|NCT01796457|HBV|hbv
270643|NCT01796457|Immune tolerant|immune tolerant
270644|NCT01796457|Immune active|immune active
270645|NCT01796444|Breast Cancer|breast cancer
270646|NCT01796444|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
270647|NCT01796444|Axillary Lymph Node Dissection|axillary lymph node dissection
270648|NCT01796392|emphysema|emphysema
270649|NCT01796392|endobronchial valve|endobronchial valve
270650|NCT01796392|treatments|treatments
270651|NCT01796392|pulmonary rehabilitation|pulmonary rehabilitation
270652|NCT01796392|lung volume reduction|lung volume reduction
270653|NCT01796353|heart disease|heart disease
270654|NCT01796353|sexual dysfunction|sexual dysfunction
270655|NCT01796353|exercise test|exercise test
270656|NCT01796353|comprehensive rehabilitation|comprehensive rehabilitation
270657|NCT01796353|complex intervention|complex intervention
334393|NCT01514773|ICD|icd
270658|NCT01796340|cue exposure|cue exposure
270659|NCT01796340|childhood|childhood
270660|NCT01796340|overeating|overeating
270661|NCT01796340|overweight|overweight
270662|NCT01796340|obese|obese
270663|NCT01796340|treatment|treatment
270664|NCT01796327|dacomitinib|dacomitinib
270665|NCT01796327|PF-00299804|pf-00299804
270666|NCT01796327|pharmacokinetics|pharmacokinetics
270667|NCT01796327|bioavailability|bioavailability
270668|NCT01796314|Therapeutic educational programme for Alzheimer's disease patients and their caregiver|therapeutic educational programme for alzheimer's disease patients and their caregiver
270669|NCT01796314|Alzheimer's disease, mild to moderately severe stages|alzheimer's disease, mild to moderately severe stages
270670|NCT01796314|Community dwelling patients with family caregiver|community dwelling patients with family caregiver
270671|NCT01796314|Alzheimer's disease patient's quality of life|alzheimer's disease patient's quality of life
270672|NCT01796301|Postmenopausal Osteoporosis|postmenopausal osteoporosis
270673|NCT01796288|NSCLC|nsclc
270674|NCT01796288|oligometastatic|oligometastatic
270675|NCT01796288|second-line|second-line
270676|NCT01796288|Radiotherapy|radiotherapy
270677|NCT01796288|Erlotinib|erlotinib
270678|NCT01796262|ADHD|adhd
270679|NCT01796262|DHA|dha
270680|NCT01796262|neuropsychological task|neuropsychological task
270681|NCT01796262|fNIRS|fnirs
270682|NCT01796262|Docosahexaenoic Acid|docosahexaenoic acid
270683|NCT01796262|n-3 polyunsaturated fatty acid|n-3 polyunsaturated fatty acid
270684|NCT01796262|cognition|cognition
270685|NCT01796262|behavior|behavior
270686|NCT01796249|Analgesia Nociception Index|analgesia nociception index
270687|NCT01796249|ANI|ani
270688|NCT01796236|Bone anchored hearing aid|bone anchored hearing aid
270689|NCT01796236|Bone anchored implant|bone anchored implant
270690|NCT01796236|Abbreviated Profile of Hearing Aid Benefit (APHAB)|abbreviated profile of hearing aid benefit (aphab)
270691|NCT01796236|Health Utility Index (HUI)|health utility index (hui)
270692|NCT01796236|Holgers Index|holgers index
270693|NCT01796236|Implant stability|implant stability
270694|NCT01796223|Community mental health services|community mental health services
270695|NCT01796223|Psychotherapy|psychotherapy
270696|NCT01796223|Physician-Patient Relations|physician-patient relations
270697|NCT01796223|Norway|norway
270698|NCT01796210|Analgesia/nociception index|analgesia/nociception index
270699|NCT01796210|Bispectral index|bispectral index
270700|NCT01796210|Propofol|propofol
270701|NCT01796210|Remifentanil|remifentanil
270702|NCT01796210|Suspension laryngoscopy|suspension laryngoscopy
270703|NCT01796210|Endoscopy|endoscopy
270704|NCT01796210|Ear-nose-throat|ear-nose-throat
270705|NCT01796184|Inflammation|inflammation
270706|NCT01796184|Glycation|glycation
270707|NCT01796184|Continuous glucose monitoring|continuous glucose monitoring
270708|NCT01796184|Adult population|adult population
270709|NCT01796171|Radioimmunotherapy|radioimmunotherapy
270710|NCT01796171|Lu-177|lu-177
270711|NCT01796171|Phase I study|phase i study
270712|NCT01796171|Phase II study|phase ii study
270713|NCT01796171|Betalutin|betalutin
270714|NCT01796158|adolescents|adolescents
270715|NCT01796158|alcohol abuse|alcohol abuse
270716|NCT01796158|drug abuse|drug abuse
270717|NCT01796158|substance use|substance use
270718|NCT01796132|Depression|depression
270719|NCT01796132|Lactation|lactation
270720|NCT01796132|Breastfeeding|breastfeeding
270721|NCT01796132|Pharmacokinetics|pharmacokinetics
270722|NCT01796132|Antidepressant|antidepressant
270723|NCT01796119|Dental implants, Ridge splitting, Ridge expansion|dental implants, ridge splitting, ridge expansion
270724|NCT01796106|caries infiltration|caries infiltration
270725|NCT01796106|caries progression|caries progression
270726|NCT01796106|Icon|icon
270727|NCT01796093|Digoxin|digoxin
270728|NCT01796093|Ivabradine|ivabradine
270729|NCT01796093|Cardiac failure|cardiac failure
270730|NCT01796093|Economics|economics
270731|NCT01796067|Motivational intervention|motivational intervention
270732|NCT01796067|Positive Parenting Intervention|positive parenting intervention
270733|NCT01796067|Obesity|obesity
270734|NCT01796067|Physical Activity|physical activity
270735|NCT01796067|Diet|diet
270736|NCT01796067|African American|african american
270737|NCT01796067|Adolescent|adolescent
270738|NCT01796054|Perceived stress|perceived stress
270739|NCT01796054|Burnout|burnout
270740|NCT01796054|Mindfulness|mindfulness
270741|NCT01796054|Intent to leave nursing|intent to leave nursing
270742|NCT01796028|Prostate Cancer|prostate cancer
270743|NCT01796015|paediatrics|paediatrics
270744|NCT01796015|optic nerve sheath diameter|optic nerve sheath diameter
270745|NCT01796015|ultrasound|ultrasound
270746|NCT01796002|PTCL|ptcl
270747|NCT01795989|Coil|coil
270748|NCT01795989|MRI|mri
270749|NCT01795989|safety|safety
270750|NCT01795989|efficacy|efficacy
270751|NCT01795989|musculoskeletal imaging|musculoskeletal imaging
270752|NCT01795989|Cincinnati|cincinnati
402982|NCT01228747|Levetiracetam|levetiracetam
402983|NCT01228747|epilepsy|epilepsy
270753|NCT01795989|Safety and efficacy of a new elbow coil on pediatric patients and healthy participants|safety and efficacy of a new elbow coil on pediatric patients and healthy participants
270754|NCT01795976|Oesophageal cancer|oesophageal cancer
270755|NCT01795963|intimate partner violence|intimate partner violence
270756|NCT01795950|cell therapy|cell therapy
270757|NCT01795950|Pulmonary arterial hypertension|pulmonary arterial hypertension
270758|NCT01795898|Osteoarthritis|osteoarthritis
270759|NCT01795898|Low back pain|low back pain
270760|NCT01795898|Fentanyl transdermal patch|fentanyl transdermal patch
270761|NCT01795898|Durogesic-D-Trans|durogesic-d-trans
270762|NCT01795885|Pregnancy in Adolescence|pregnancy in adolescence
270763|NCT01795885|Contraception|contraception
270764|NCT01795859|Huntington disease|huntington disease
270765|NCT01795859|Chorea|chorea
270766|NCT01795859|Tetrabenazine|tetrabenazine
270767|NCT01795846|allergen specific immunotherapy, house dust mite (Der p), monosensitization, polysensitization, allergic rhinitis, asthma,|allergen specific immunotherapy, house dust mite (der p), monosensitization, polysensitization, allergic rhinitis, asthma,
270768|NCT01795833|Prediabetes|prediabetes
270769|NCT01795833|Prediabetic State|prediabetic state
270770|NCT01795820|ticagrelor|ticagrelor
270771|NCT01795820|clopidogrel|clopidogrel
270772|NCT01795820|platelet aggregation|platelet aggregation
270773|NCT01795781|Anticoagulant measurement|anticoagulant measurement
270774|NCT01795781|Anticoagulant reversal|anticoagulant reversal
270775|NCT01795781|Dabigatran|dabigatran
270776|NCT01795781|Rivaroxaban|rivaroxaban
270777|NCT01795768|Non randomised|non randomised
270778|NCT01795768|Open label|open label
270779|NCT01795768|Multicentre|multicentre
270780|NCT01795768|Phase II biomarker study|phase ii biomarker study
270781|NCT01795755|Horse Assisted Therapy (HAT)|horse assisted therapy (hat)
270782|NCT01795755|Equine Assisted Psychotherapy (EAP)|equine assisted psychotherapy (eap)
270783|NCT01795755|clinical trial|clinical trial
270784|NCT01795755|Randomised Controlled Trial (RCT)|randomised controlled trial (rct)
270785|NCT01795755|psychotherapy|psychotherapy
270786|NCT01795742|Asthma|asthma
270787|NCT01795742|Nebulizers|nebulizers
270788|NCT01795742|Salbutamol|salbutamol
270789|NCT01795742|Developing Countries|developing countries
270790|NCT01795729|Heart transplant|heart transplant
270791|NCT01795729|Coronary artery disease|coronary artery disease
270792|NCT01795729|Allograft vascular disease|allograft vascular disease
270793|NCT01795729|Coronary stent|coronary stent
270794|NCT01795729|Optimal medical therapy|optimal medical therapy
270796|NCT01795703|Prostate Cancer|prostate cancer
270797|NCT01795703|Abiraterone Acetate|abiraterone acetate
270798|NCT01795703|JNJ-212082|jnj-212082
270799|NCT01795690|Anemia|anemia
270800|NCT01795690|Cancer|cancer
270801|NCT01795690|Hemoglobin|hemoglobin
270802|NCT01795690|Quality of Life|quality of life
270803|NCT01795690|FACT-An|fact-an
270804|NCT01795690|FACT-GP|fact-gp
270805|NCT01795690|Erythropoiesis-Stimulating Agents (ESA)|erythropoiesis-stimulating agents (esa)
270806|NCT01795690|Epoetin|epoetin
270807|NCT01795690|Ferric Carboxymaltose|ferric carboxymaltose
270808|NCT01795690|Blood Transfusions|blood transfusions
270809|NCT01795677|JAK2 inhibitor RUXOLITINIB|jak2 inhibitor ruxolitinib
270810|NCT01795677|Primary or secondary myelofibrosis|primary or secondary myelofibrosis
270811|NCT01795664|Asthma|asthma
271187|NCT01794026|diffusion weighted|diffusion weighted
270812|NCT01795664|Salmeterol xinafoate and Fluticasone propionate|salmeterol xinafoate and fluticasone propionate
270813|NCT01795664|Seretide Evohaler|seretide evohaler
270814|NCT01795664|Functional Respiratory Imaging|functional respiratory imaging
270815|NCT01795664|Computational Fluid Dynamic|computational fluid dynamic
270816|NCT01795651|teaching|teaching
270817|NCT01795651|knowledge translation|knowledge translation
270818|NCT01795651|ICU|icu
270819|NCT01795651|postgraduate|postgraduate
270820|NCT01795651|lecture|lecture
270821|NCT01795638|anthropometrics|anthropometrics
270822|NCT01795638|weight|weight
270823|NCT01795638|nutrition|nutrition
270824|NCT01795586|breast - female|breast - female
270825|NCT01795586|advanced breast cancer|advanced breast cancer
270826|NCT01795586|histologically confirmed|histologically confirmed
270827|NCT01795586|cytologically confirmed|cytologically confirmed
270828|NCT01795586|metastatic|metastatic
271031|NCT01794715|Pocket-size|pocket-size
270829|NCT01795586|locally advanced|locally advanced
270830|NCT01795586|unresectable|unresectable
270831|NCT01795573|GVHD|gvhd
270832|NCT01795573|AML|aml
270833|NCT01795573|ALL|all
270834|NCT01795573|MDS|mds
270835|NCT01795573|CLL|cll
270836|NCT01795573|NHL|nhl
270837|NCT01795573|HL|hl
270838|NCT01795573|MM|mm
270839|NCT01795560|Periappendicular abscess|periappendicular abscess
270840|NCT01795560|Ultrasound|ultrasound
270841|NCT01795521|NSCLC, SBRT, PET, Medically Inoperable|nsclc, sbrt, pet, medically inoperable
270842|NCT01795508|Parent training|parent training
270843|NCT01795508|Child behavior|child behavior
270844|NCT01795508|Randomized Controlled Trials|randomized controlled trials
270845|NCT01795495|Spinal Fusion|spinal fusion
270846|NCT01795495|Scoliosis|scoliosis
270847|NCT01795495|Methadone|methadone
270848|NCT01795495|Magnesium|magnesium
270849|NCT01795495|Adolescents|adolescents
270850|NCT01795495|Back Surgery|back surgery
270851|NCT01795482|perioperative hypothermia|perioperative hypothermia
270852|NCT01795482|prewarming|prewarming
270853|NCT01795482|preoperative warming|preoperative warming
270854|NCT01795482|general anaesthesia|general anaesthesia
270855|NCT01795482|epidural anaesthesia|epidural anaesthesia
270856|NCT01795482|temperature measurement|temperature measurement
270857|NCT01795469|POTS|pots
270858|NCT01795469|Orthostatic|orthostatic
270859|NCT01795469|Adolescent|adolescent
270860|NCT01795456|Takayasu's arteritis|takayasu's arteritis
270861|NCT01795456|Giant Cell arteritis|giant cell arteritis
270862|NCT01795456|Arteritis|arteritis
270863|NCT01795456|Vasculitis|vasculitis
270864|NCT01795456|Aortitis|aortitis
270865|NCT01795456|Disease Activity|disease activity
270866|NCT01795456|Carotidynia|carotidynia
270867|NCT01795456|Neovascularization|neovascularization
270868|NCT01795456|Carotid Intima Media Thickness|carotid intima media thickness
270869|NCT01795443|vibration|vibration
270870|NCT01795443|proprioception|proprioception
270871|NCT01795417|wrinkles|wrinkles
270872|NCT01795417|rhytids|rhytids
270873|NCT01795417|periorbital|periorbital
270874|NCT01795404|IBSR|ibsr
270875|NCT01795404|Cancer Survivors|cancer survivors
270876|NCT01795404|Katie Byron|katie byron
270877|NCT01795404|Quality of Life|quality of life
270878|NCT01795404|Stress|stress
270879|NCT01795404|Stress reduction|stress reduction
270880|NCT01795391|Prevention|prevention
270881|NCT01795391|Dressings|dressings
270882|NCT01795391|Catheters|catheters
270883|NCT01795378|acute myelogenous leukemia|acute myelogenous leukemia
270884|NCT01795378|acute lymphoblastic leukemia|acute lymphoblastic leukemia
270885|NCT01795378|donor natural killer cells|donor natural killer cells
270886|NCT01795378|HLA-haploidentical hematopoietic cell transplantation|hla-haploidentical hematopoietic cell transplantation
270887|NCT01795352|EGFR,|egfr,
270888|NCT01795352|lung cancer,|lung cancer,
270889|NCT01795352|mutated|mutated
270890|NCT01795339|AZD3293|azd3293
270891|NCT01795339|Healthy volunteers|healthy volunteers
270892|NCT01795339|Elderly volunteers|elderly volunteers
270893|NCT01795339|Alzheimer's Disease patients|alzheimer's disease patients
270894|NCT01795339|AD patients|ad patients
270895|NCT01795339|Phase 1|phase 1
270896|NCT01795339|Multiple Ascending Dose Study|multiple ascending dose study
270897|NCT01795326|Effectiveness of risk minimization|effectiveness of risk minimization
270898|NCT01795326|Metabolic monitoring|metabolic monitoring
270899|NCT01795326|Seroquel®|seroquel®
270900|NCT01795326|Seroquel® XR/quetiapine fumarate|seroquel® xr/quetiapine fumarate
270901|NCT01795287|tibial fracture|tibial fracture
270902|NCT01795287|intramedullary nailing|intramedullary nailing
270903|NCT01795287|spinal anesthesia|spinal anesthesia
270904|NCT01795287|patient safety|patient safety
270905|NCT01795261|HIV|hiv
270906|NCT01795248|gestational diabetes mellitus|gestational diabetes mellitus
270907|NCT01795248|incretin|incretin
270908|NCT01795248|glucose homeostasis|glucose homeostasis
270909|NCT01795248|GLP-1|glp-1
270910|NCT01795248|type 2 diabetes mellitus|type 2 diabetes mellitus
270911|NCT01795248|liraglutide|liraglutide
270912|NCT01795248|Victoza|victoza
270913|NCT01795235|men|men
270914|NCT01795222|conscious sedation|conscious sedation
270915|NCT01795222|stress psychological|stress psychological
270916|NCT01795222|dental care for children|dental care for children
270917|NCT01795222|child behavior|child behavior
270918|NCT01795222|saliva|saliva
270919|NCT01795209|Branch retinal vein occlusion|branch retinal vein occlusion
270920|NCT01795209|Macular edema|macular edema
270921|NCT01795209|Ranibizumab|ranibizumab
270922|NCT01795196|pediatric extubation failure|pediatric extubation failure
270923|NCT01795196|weaning|weaning
270924|NCT01795196|integrated pulmonary index|integrated pulmonary index
270925|NCT01795196|mechanical ventilation|mechanical ventilation
270926|NCT01795196|extubation readiness|extubation readiness
270927|NCT01795196|respiratory monitoring tool|respiratory monitoring tool
270928|NCT01795196|Endotracheal Extubation|endotracheal extubation
270929|NCT01795196|Pediatric Intensive Care Unit|pediatric intensive care unit
270930|NCT01795196|Rapid Shallow Breathing Index|rapid shallow breathing index
270931|NCT01795196|Physiologic Deadspace|physiologic deadspace
270932|NCT01795170|Pyridoxine Dependant Epilepsy|pyridoxine dependant epilepsy
270933|NCT01795170|Antiquitin Deficiency|antiquitin deficiency
270934|NCT01795170|Lysine Restricted Diet|lysine restricted diet
270935|NCT01795157|decision support systems, clinical|decision support systems, clinical
270936|NCT01795157|decision making, computer assisted|decision making, computer assisted
270937|NCT01795157|evidence based practice|evidence based practice
270938|NCT01795157|practice guidelines as topic|practice guidelines as topic
270939|NCT01795131|Nutritional anemia|nutritional anemia
270940|NCT01795131|Vitamin B12|vitamin b12
270941|NCT01795131|flu vaccine|flu vaccine
270942|NCT01795131|immunity|immunity
270943|NCT01795092|Cellulitis|cellulitis
334757|NCT01513018|OLV|olv
261675|NCT01837251|PLD|pld
270944|NCT01795092|Outpatient Medicine|outpatient medicine
270945|NCT01795079|transcranial stimulation|transcranial stimulation
270946|NCT01795079|direct current|direct current
270947|NCT01795053|ADHD preschoolers|adhd preschoolers
270948|NCT01795053|playtraining|playtraining
270949|NCT01795053|child-focused intervention|child-focused intervention
270950|NCT01795040|omega-3/omega-6 fatty acids|omega-3/omega-6 fatty acids
270951|NCT01795040|Pre-school children with ADHD symptoms|pre-school children with adhd symptoms
270952|NCT01795040|randomized controlled trial|randomized controlled trial
270953|NCT01795027|gastric cancer|gastric cancer
270954|NCT01795027|chemotherapy|chemotherapy
270955|NCT01795027|D2 resection|d2 resection
270956|NCT01795027|S-1|s-1
270957|NCT01795001|pathophysiology|pathophysiology
270958|NCT01794988|Acute Pain|acute pain
270959|NCT01794988|Low Back Pain|low back pain
270960|NCT01794988|Back Pain|back pain
270961|NCT01794988|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
270962|NCT01794988|Cognitive Behavioral Therapy|cognitive behavioral therapy
270963|NCT01794988|Pain Education|pain education
270965|NCT01794975|striatum|striatum
270966|NCT01794975|receptor occupancy|receptor occupancy
270967|NCT01794975|noradrenaline|noradrenaline
270968|NCT01794975|alpha2c|alpha2c
270969|NCT01794962|Classification|classification
270970|NCT01794962|LBP|lbp
270971|NCT01794962|Cognitive functional therapy|cognitive functional therapy
270972|NCT01794962|Manual Therapy|manual therapy
270973|NCT01794949|Angioplasty|angioplasty
270974|NCT01794949|Atherosclerosis|atherosclerosis
270975|NCT01794949|Wound Healing|wound healing
270976|NCT01794936|Prostate cancer|prostate cancer
270977|NCT01794936|Nerve Sparing Prostatectomy|nerve sparing prostatectomy
270978|NCT01794936|VTI Probe|vti probe
270979|NCT01794923|Delayed onset muscle soreness|delayed onset muscle soreness
270980|NCT01794923|ibuprofen|ibuprofen
270981|NCT01794923|topical|topical
270982|NCT01794910|Pregnancy|pregnancy
270983|NCT01794910|Pelvic Floor|pelvic floor
270984|NCT01794910|Muscle strength|muscle strength
270985|NCT01794910|Exercise therapy|exercise therapy
270986|NCT01794910|natural childbirth|natural childbirth
270987|NCT01794910|cesarean section|cesarean section
270988|NCT01794910|physiotherapy|physiotherapy
270989|NCT01794884|Glutamine|glutamine
270990|NCT01794884|Cardiosurgery|cardiosurgery
270991|NCT01794884|Cardiopulmonary bypass|cardiopulmonary bypass
270992|NCT01794884|Cardiac function|cardiac function
270993|NCT01794884|Recovery|recovery
270994|NCT01794845|SCCHN|scchn
272143|NCT01789216|unilateral|unilateral
270995|NCT01794845|Head and Neck Cancer|head and neck cancer
270996|NCT01794845|Squamous Cell Carcinoma|squamous cell carcinoma
270997|NCT01794845|Recurrent|recurrent
270998|NCT01794832|HRQoL|hrqol
270999|NCT01794832|Aortic stenosis|aortic stenosis
271000|NCT01794832|Aortic valve surgery|aortic valve surgery
271001|NCT01794819|antibiotics|antibiotics
271002|NCT01794819|primary care|primary care
271003|NCT01794819|radiology/radiography|radiology/radiography
271004|NCT01794819|respiratory tract infections|respiratory tract infections
271005|NCT01794793|SOM230,|som230,
271006|NCT01794793|roll-over study|roll-over study
271007|NCT01794793|pasireotide LAR|pasireotide lar
271008|NCT01794793|Cushing's disease|cushing's disease
271009|NCT01794793|Acromegaly|acromegaly
271010|NCT01794793|neuroendocrine tumorsNETs|neuroendocrine tumorsnets
271011|NCT01794793|pituitary tumors|pituitary tumors
271012|NCT01794793|Ectopic ACTH secreting|ectopic acth secreting
271013|NCT01794793|EAS|eas
271014|NCT01794793|Dumping Syndrome|dumping syndrome
271015|NCT01794793|metastatic prostate cancer, metastatic melanoma|metastatic prostate cancer, metastatic melanoma
271016|NCT01794793|bRAF|braf
271017|NCT01794793|nRAS|nras
271018|NCT01794767|peripheral venous catheter, children.|peripheral venous catheter, children.
271019|NCT01794754|Hand osteoarthritis|hand osteoarthritis
271020|NCT01794754|CMC1-joint|cmc1-joint
271021|NCT01794754|surgery|surgery
271022|NCT01794754|occupational therapy|occupational therapy
271023|NCT01794754|hand exercises|hand exercises
271024|NCT01794754|assistive devices|assistive devices
271025|NCT01794754|orthoses|orthoses
271026|NCT01794728|Pain Management|pain management
271027|NCT01794715|Heart failure|heart failure
271028|NCT01794715|Nurse led|nurse led
271029|NCT01794715|Outpatient clinic|outpatient clinic
271030|NCT01794715|Echocardiography|echocardiography
271032|NCT01794715|Ultrasound|ultrasound
271033|NCT01794702|Leukemia|leukemia
271034|NCT01794702|Acute Leukemia|acute leukemia
271035|NCT01794702|Acute myelogenous leukemia|acute myelogenous leukemia
271036|NCT01794702|AML|aml
271037|NCT01794702|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
271038|NCT01794702|ALL|all
271039|NCT01794702|Maximum Tolerated Dose|maximum tolerated dose
271040|NCT01794702|MTD|mtd
271041|NCT01794702|Response Rate|response rate
271042|NCT01794702|Decitabine|decitabine
271043|NCT01794702|Dacogen|dacogen
261691|NCT01837186|Surgery|surgery
271044|NCT01794702|Idarubicin|idarubicin
271045|NCT01794702|Idamycin|idamycin
271046|NCT01794702|Cytarabine|cytarabine
271047|NCT01794702|Ara-C|ara-c
271048|NCT01794702|Cytosar|cytosar
271049|NCT01794702|DepoCyt|depocyt
271050|NCT01794702|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
271051|NCT01794676|Pancreatic cancer|pancreatic cancer
271052|NCT01794676|Thymic cancer|thymic cancer
271053|NCT01794676|Parathyroid disease|parathyroid disease
271054|NCT01794676|MEN1 syndrome|men1 syndrome
271055|NCT01794676|Genomic DNA|genomic dna
271056|NCT01794676|MEN1 gene sequence|men1 gene sequence
271057|NCT01794663|Early kidney graft dysfunction|early kidney graft dysfunction
271058|NCT01794663|renal transplantation|renal transplantation
271059|NCT01794650|T1DM, Exercise, Hypoglycaemia|t1dm, exercise, hypoglycaemia
271068|NCT01794624|Pain Catastrophizing|pain catastrophizing
271069|NCT01794624|Cognitive Therapy|cognitive therapy
271070|NCT01794624|Behavioral Therapy|behavioral therapy
271071|NCT01794598|Heart failure|heart failure
271072|NCT01794598|depression|depression
271073|NCT01794598|depression care education|depression care education
271074|NCT01794585|traumatic brain injury|traumatic brain injury
271075|NCT01794585|balance deficits|balance deficits
271076|NCT01794585|virtual reality|virtual reality
271077|NCT01794585|home-based therapy|home-based therapy
271078|NCT01794572|Multiple Myeloma|multiple myeloma
271079|NCT01794572|Relapse|relapse
271080|NCT01794572|Complete Remission|complete remission
271081|NCT01794572|Very Good Partial Remission|very good partial remission
271082|NCT01794546|pediatric obesity|pediatric obesity
271083|NCT01794546|telehealth|telehealth
271084|NCT01794533|Irreversible Pulpitis|irreversible pulpitis
271085|NCT01794533|Infiltration injection|infiltration injection
271086|NCT01794533|Fentanyl|fentanyl
271087|NCT01794533|Lidocaine|lidocaine
271088|NCT01794520|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
271089|NCT01794520|multiple myeloma|multiple myeloma
271090|NCT01794520|refractory multiple myeloma|refractory multiple myeloma
271091|NCT01794520|relapsed multiple myeloma|relapsed multiple myeloma
271092|NCT01794507|refractory multiple myeloma|refractory multiple myeloma
271093|NCT01794507|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
271094|NCT01794507|relapsed multiple myeloma|relapsed multiple myeloma
271095|NCT01794507|multiple myeloma|multiple myeloma
271096|NCT01794494|Peripheal arterial disease|peripheal arterial disease
271097|NCT01794494|Critical limb ischemia|critical limb ischemia
271098|NCT01794494|Bypass surgery|bypass surgery
271099|NCT01794494|Subintimal angioplasty|subintimal angioplasty
271100|NCT01794494|Health related cost|health related cost
271101|NCT01794468|Dermal blood flow|dermal blood flow
272144|NCT01789216|Grade I|grade i
271102|NCT01794468|critically ill|critically ill
271103|NCT01794455|Depression|depression
271104|NCT01794455|Depressive Disorder|depressive disorder
271105|NCT01794455|Geriatrics|geriatrics
271106|NCT01794455|Hypertension|hypertension
271107|NCT01794429|Obesity|obesity
271108|NCT01794429|The Metabolic Syndrome/disturbances|the metabolic syndrome/disturbances
271109|NCT01794429|Drug-induced adipositas|drug-induced adipositas
271110|NCT01794429|Schizophrenia|schizophrenia
271111|NCT01794429|GLP-1 analogue|glp-1 analogue
271112|NCT01794429|cerebral effects|cerebral effects
271121|NCT01794390|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
271122|NCT01794390|Asthma|asthma
271123|NCT01794390|Pulmojet|pulmojet
271124|NCT01794390|Inhalers|inhalers
271125|NCT01794390|Respiratory|respiratory
271126|NCT01794390|Inhaler Technique|inhaler technique
271127|NCT01794390|Critical Errors|critical errors
271128|NCT01794377|Obesity|obesity
271129|NCT01794364|T2DM|t2dm
271134|NCT01794299|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
271135|NCT01794299|Graft-versus-host disease|graft-versus-host disease
271136|NCT01794299|Immune reconstitution|immune reconstitution
271137|NCT01794299|Alloreactive T-cells|alloreactive t-cells
271138|NCT01794299|Photodepletion|photodepletion
271139|NCT01794299|Photodynamic treatment|photodynamic treatment
271140|NCT01794299|TH9402|th9402
271141|NCT01794299|Transplant-related mortality|transplant-related mortality
271142|NCT01794299|Hematologic malignancy|hematologic malignancy
271143|NCT01794273|Ephedrine|ephedrine
271144|NCT01794273|Phenylephrine|phenylephrine
271145|NCT01794273|Vasopressor|vasopressor
271146|NCT01794273|Carotid surgery|carotid surgery
271147|NCT01794273|Hypotension|hypotension
271148|NCT01794273|Haemodynamics|haemodynamics
271149|NCT01794273|Brain ischemia|brain ischemia
271150|NCT01794273|Tissue perfusion|tissue perfusion
271151|NCT01794273|Stroke|stroke
271152|NCT01794273|anaesthesia;|anaesthesia;
271153|NCT01794260|Osteoarthritis|osteoarthritis
271154|NCT01794260|Moderate ot severe pain|moderate ot severe pain
271155|NCT01794260|ZINGIBER CASSUMUNAR ROXB|zingiber cassumunar roxb
271156|NCT01794221|circumcision|circumcision
271157|NCT01794221|2 octyl cyanoacrylate|2 octyl cyanoacrylate
271160|NCT01794208|reproductive disorder|reproductive disorder
271161|NCT01794195|Parkinson's disease|parkinson's disease
271162|NCT01794195|Apathy|apathy
271163|NCT01794195|diffusion tensor imaging|diffusion tensor imaging
271164|NCT01794195|tractography|tractography
271165|NCT01794156|Inference-based therapy|inference-based therapy
271166|NCT01794156|Cognitive behavior therapy|cognitive behavior therapy
271167|NCT01794156|Obsessive compulsive disorder|obsessive compulsive disorder
271168|NCT01794156|Randomized clinical trial|randomized clinical trial
271169|NCT01794143|Treatment of Type 2 diabetes|treatment of type 2 diabetes
271170|NCT01794143|Comparative effectiveness research|comparative effectiveness research
271171|NCT01794143|Clinical trial|clinical trial
271172|NCT01794143|Patient-centered outcomes|patient-centered outcomes
271173|NCT01794117|Anakinra|anakinra
271174|NCT01794117|Pustular Psoriasis|pustular psoriasis
271175|NCT01794117|Palmoplantar Pustulosis|palmoplantar pustulosis
271176|NCT01794117|DITRA|ditra
271177|NCT01794117|Subcorneal Pustular Dermatosis|subcorneal pustular dermatosis
271178|NCT01794104|Topoisomerase Inhibitor|topoisomerase inhibitor
271179|NCT01794104|Advanced Malignancies|advanced malignancies
271180|NCT01794104|Pharmacodynamics|pharmacodynamics
271181|NCT01794104|DNA Damage|dna damage
271182|NCT01794104|Pharmacokinetics|pharmacokinetics
271183|NCT01794091|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
271184|NCT01794091|Diabetes|diabetes
271185|NCT01794078|Acute Mountain Sickness|acute mountain sickness
271186|NCT01794078|High altitude induced fatigue|high altitude induced fatigue
271188|NCT01794026|magnetic resonance imaging|magnetic resonance imaging
271189|NCT01794026|surgery|surgery
271190|NCT01794026|histopathology|histopathology
271191|NCT01794013|Parent training|parent training
271192|NCT01794013|DIR/ Floortime Approach|dir/ floortime approach
271193|NCT01794013|Children with developmental disabilities|children with developmental disabilities
271194|NCT01793987|blood loss between two groups|blood loss between two groups
271195|NCT01793974|LADA|lada
271196|NCT01793974|Latent Autoimmune Diabetes in Adults|latent autoimmune diabetes in adults
271197|NCT01793974|Latent Autoimmune Diabetes|latent autoimmune diabetes
271198|NCT01793974|Latent Diabetes in Adults|latent diabetes in adults
271199|NCT01793935|Schizophrenia|schizophrenia
271200|NCT01793935|Sensoril|sensoril
271201|NCT01793935|Withania Somnifera extract|withania somnifera extract
271202|NCT01793935|Total/ Positive / Negative Symptoms|total/ positive / negative symptoms
271203|NCT01793935|Stress|stress
271204|NCT01793935|Inflammation|inflammation
271205|NCT01793935|Immunomodulation|immunomodulation
271211|NCT01793896|Metabolic syndrome|metabolic syndrome
271212|NCT01793896|Ageing|ageing
271213|NCT01793896|Mitochondrial density|mitochondrial density
271214|NCT01793896|Oxidative damage|oxidative damage
271215|NCT01793896|Inflammatory mediators|inflammatory mediators
271216|NCT01793896|AMPK|ampk
271217|NCT01793896|Adipogenesis|adipogenesis
271219|NCT01793870|pharmacokinetic|pharmacokinetic
271220|NCT01793870|carvedilol|carvedilol
271221|NCT01793870|Stable isotope technique|stable isotope technique
271222|NCT01793857|Primary caregiver|primary caregiver
271223|NCT01793857|Survey|survey
271224|NCT01793857|Acute Otitis Media|acute otitis media
271225|NCT01793857|Ear infection|ear infection
271226|NCT01793857|Panama|panama
271227|NCT01793857|Healthcare seeking behaviour|healthcare seeking behaviour
271228|NCT01793844|diffuse large B cell lymphoma|diffuse large b cell lymphoma
271230|NCT01793844|OS|os
271231|NCT01793831|Crohn's diseases|crohn's diseases
271232|NCT01793831|Inflammatory bowel disease|inflammatory bowel disease
271233|NCT01793831|Fecal transplantation|fecal transplantation
271234|NCT01793831|Fecal bacteriotherapy|fecal bacteriotherapy
271235|NCT01793831|Fecal microbiota transplantation|fecal microbiota transplantation
271236|NCT01793818|Vaccine|vaccine
271237|NCT01793818|HIV-1|hiv-1
271238|NCT01793818|Tat|tat
271239|NCT01793792|intracranial, saccular, aneurysms, stenting, coiling|intracranial, saccular, aneurysms, stenting, coiling
271240|NCT01793740|sickle cell disease|sickle cell disease
271241|NCT01793740|pediatric|pediatric
271242|NCT01793740|learning disability|learning disability
271243|NCT01793740|cognitive impairment|cognitive impairment
271244|NCT01793740|memory|memory
271245|NCT01793740|attention|attention
271246|NCT01793740|Children with sickle cell disease|children with sickle cell disease
271247|NCT01793727|infants|infants
271248|NCT01793727|general anesthesia|general anesthesia
271249|NCT01793727|tracheal intubation|tracheal intubation
271250|NCT01793714|Magnetic Resonance Imaging|magnetic resonance imaging
271251|NCT01793701|Cervical Cancer, Intensity-modulated radiotherapy|cervical cancer, intensity-modulated radiotherapy
271252|NCT01793688|UNASYN-S|unasyn-s
271253|NCT01793688|High Dose|high dose
271254|NCT01793662|Aortobifemoral bypass|aortobifemoral bypass
271255|NCT01793662|Laparoscopic aortic surgery|laparoscopic aortic surgery
271256|NCT01793662|Aortoiliac occlusive disease|aortoiliac occlusive disease
271257|NCT01793662|TASC Type D Lesions|tasc type d lesions
271258|NCT01793662|Open aortic surgery|open aortic surgery
271259|NCT01793649|Respiratory health|respiratory health
271260|NCT01793649|Cystic Fibrosis|cystic fibrosis
261897|NCT01836159|iPad|ipad
271261|NCT01793649|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
271262|NCT01793623|atrial fibrillation|atrial fibrillation
271263|NCT01793623|genetics|genetics
271264|NCT01793623|cardiac arrhythmias|cardiac arrhythmias
271265|NCT01793623|heart disease|heart disease
271266|NCT01793610|MDMA|mdma
271267|NCT01793610|Posttraumatic stress disorder|posttraumatic stress disorder
271268|NCT01793610|sleep|sleep
271269|NCT01793610|Depression|depression
271270|NCT01793610|Safety|safety
271271|NCT01793597|ticagrelor|ticagrelor
271272|NCT01793597|Coronary artery bypass surgery|coronary artery bypass surgery
271273|NCT01793597|platelet function|platelet function
271274|NCT01793597|receptor binding|receptor binding
271275|NCT01793597|platelet reactivity|platelet reactivity
271276|NCT01793597|reversible binding|reversible binding
271277|NCT01793584|Comparative effectiveness|comparative effectiveness
271278|NCT01793584|Surgical success|surgical success
271279|NCT01793571|Abdominal Muscles/Ultrasonography|abdominal muscles/ultrasonography
271280|NCT01793571|Adult|adult
271281|NCT01793571|Ambulatory Surgical Procedures|ambulatory surgical procedures
271282|NCT01793571|Anesthetics, Local/Administration & Dosage|anesthetics, local/administration & dosage
271283|NCT01793571|Levobupivacaine/Administration & Dosage|levobupivacaine/administration & dosage
271284|NCT01793571|Levobupivacaine/Analogs & Derivatives|levobupivacaine/analogs & derivatives
271285|NCT01793571|Hernia, Inguinal/Surgery|hernia, inguinal/surgery
271286|NCT01793571|Humans|humans
271287|NCT01793571|Nerve Block/Methods|nerve block/methods
271288|NCT01793571|Pain Measurement/Methods|pain measurement/methods
271289|NCT01793571|Pain, Postoperative/Prevention & Control|pain, postoperative/prevention & control
271290|NCT01793571|Ultrasonography, Interventional|ultrasonography, interventional
271291|NCT01793558|Thermoregulation Impairment|thermoregulation impairment
271292|NCT01793558|hypothermia|hypothermia
271293|NCT01793558|Postoperative shivering|postoperative shivering
271294|NCT01793558|cesarean section|cesarean section
271295|NCT01793558|newborn|newborn
271296|NCT01793545|Endometrial Cancer|endometrial cancer
271297|NCT01793545|Gynecological Cancers|gynecological cancers
271298|NCT01793545|Screening|screening
271299|NCT01793532|PET Imaging|pet imaging
271300|NCT01793532|Epilepsy|epilepsy
271301|NCT01793532|Inflammation|inflammation
271302|NCT01793532|Brain Imaging|brain imaging
271303|NCT01793519|Rheumatoid Arthritis|rheumatoid arthritis
271304|NCT01793519|Autoimmune Diseases|autoimmune diseases
271305|NCT01793519|Anti-TNF|anti-tnf
271311|NCT01793493|Randomized Controlled Trial|randomized controlled trial
271312|NCT01793480|Methadone in cancer pain|methadone in cancer pain
271313|NCT01793428|adults admitted in vital emergency unit|adults admitted in vital emergency unit
271314|NCT01793389|gingival recession|gingival recession
271316|NCT01793389|connective tissue|connective tissue
271317|NCT01793389|root coverage|root coverage
271318|NCT01793389|microsurgery|microsurgery
271319|NCT01793389|case-control studies|case-control studies
271320|NCT01793363|Tracheotomy|tracheotomy
271321|NCT01793363|Weaning from mechanical ventilation|weaning from mechanical ventilation
271322|NCT01793363|Lung ultrasound score|lung ultrasound score
271323|NCT01793350|Diabetes|diabetes
271324|NCT01793350|Mellitus|mellitus
271325|NCT01793350|Painful|painful
271326|NCT01793350|Neuropathy|neuropathy
271327|NCT01793350|Peripheral|peripheral
271328|NCT01793324|Effectiveness of risk minimization|effectiveness of risk minimization
271329|NCT01793324|Metabolic monitoring|metabolic monitoring
271330|NCT01793324|Seroquel® or Seroquel® XR/quetiapine fumarate|seroquel® or seroquel® xr/quetiapine fumarate
271331|NCT01793311|intraocular pressure|intraocular pressure
271332|NCT01793311|caffeine|caffeine
271333|NCT01793311|dosage|dosage
271334|NCT01793246|lung cancer|lung cancer
271335|NCT01793246|lung neoplasms|lung neoplasms
271336|NCT01793246|lung transplant|lung transplant
271337|NCT01793194|venous insufficiency|venous insufficiency
271338|NCT01793194|varicose veins|varicose veins
271339|NCT01793194|pregnancy|pregnancy
271340|NCT01793194|DVT|dvt
271341|NCT01793194|superficial thrombophlebitis|superficial thrombophlebitis
271342|NCT01793181|Vitamin d deficiency|vitamin d deficiency
271343|NCT01793181|Central retinal vein occlusion|central retinal vein occlusion
271344|NCT01793168|Rare Diseases|rare diseases
271345|NCT01793168|Neglected Diseases|neglected diseases
271346|NCT01793168|Orphan Diseases|orphan diseases
271347|NCT01793168|Rare Disease Research|rare disease research
271348|NCT01793168|Registries|registries
271349|NCT01793168|WAGR Syndrome|wagr syndrome
271351|NCT01793168|Cornelia de Lange Syndrome|cornelia de lange syndrome
271352|NCT01793168|Stickler Syndrome|stickler syndrome
271353|NCT01793168|Ataxia Telangiectasia|ataxia telangiectasia
271354|NCT01793168|Kawasaki Disease|kawasaki disease
271355|NCT01793168|Batten Disease|batten disease
271356|NCT01793168|Mucolipidosis IV|mucolipidosis iv
271357|NCT01793168|Klippel-Feil|klippel-feil
271358|NCT01793155|Lung cancer surgery|lung cancer surgery
271359|NCT01793155|Inspiratory muscle training|inspiratory muscle training
271360|NCT01793155|Postoperative pulmonary complications|postoperative pulmonary complications
271361|NCT01793155|Functional outcomes|functional outcomes
271362|NCT01793155|Health related quality of life|health related quality of life
271363|NCT01793142|Osteoporosis|osteoporosis
271364|NCT01793142|postmenopausal|postmenopausal
271365|NCT01793142|SERM|serm
271366|NCT01793129|NICHD Neonatal Research Network|nichd neonatal research network
271367|NCT01793129|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
271368|NCT01793129|Hypothermia|hypothermia
271369|NCT01793129|Neonatal depression|neonatal depression
271370|NCT01793129|Perinatal asphyxia|perinatal asphyxia
271371|NCT01793116|NICHD Neonatal Research Network|nichd neonatal research network
271372|NCT01793116|Moderately Preterm|moderately preterm
271373|NCT01793090|Cobalamin C defect|cobalamin c defect
271374|NCT01793090|methylmalonic aciduria with homocystinuria|methylmalonic aciduria with homocystinuria
271375|NCT01793090|Visual function|visual function
271376|NCT01793090|VEP|vep
271377|NCT01793090|ERG|erg
271378|NCT01793090|antioxidant drugs|antioxidant drugs
271379|NCT01793077|Prostate Cancer|prostate cancer
271380|NCT01793077|Phase 4|phase 4
271381|NCT01793077|Data collection|data collection
271382|NCT01793077|Observational|observational
271383|NCT01793077|Depo-Eligard|depo-eligard
271384|NCT01793077|Prospective|prospective
271385|NCT01793077|Non-interventional|non-interventional
271386|NCT01793077|Treatment|treatment
271387|NCT01793064|Pedometer,|pedometer,
271388|NCT01793064|adaptive,|adaptive,
271389|NCT01793064|exercise,|exercise,
271390|NCT01793064|reinforcement,|reinforcement,
271391|NCT01793064|goal setting,|goal setting,
271392|NCT01793064|technology,|technology,
271393|NCT01793064|email,|email,
271394|NCT01793064|weight loss|weight loss
271395|NCT01793064|mHealth|mhealth
271396|NCT01793064|eHealth|ehealth
271397|NCT01793051|Myeloma|myeloma
271398|NCT01793051|Multiple Myeloma|multiple myeloma
271399|NCT01793051|MM|mm
271400|NCT01793051|Symptom Burden|symptom burden
271401|NCT01793051|Symptom reduction|symptom reduction
271402|NCT01793051|Maintenance therapy with lenalidomide|maintenance therapy with lenalidomide
271403|NCT01793051|Minocycline|minocycline
271404|NCT01793051|Dynacin|dynacin
271405|NCT01793051|Minocin|minocin
271406|NCT01793051|Minocin PAC|minocin pac
271407|NCT01793051|Myrac|myrac
271408|NCT01793051|Solodyn|solodyn
271409|NCT01793051|Placebo|placebo
271410|NCT01793051|Sugar pill|sugar pill
271411|NCT01793051|MD Anderson Symptom Inventory|md anderson symptom inventory
271412|NCT01793051|MDASI|mdasi
271413|NCT01793051|Questionnaires|questionnaires
271414|NCT01793051|Surveys|surveys
271415|NCT01793038|PCOS|pcos
271416|NCT01793038|clomiphene citrate resistant PCOS|clomiphene citrate resistant pcos
271417|NCT01793038|Aromatase inhibitors|aromatase inhibitors
271418|NCT01793025|leukemia|leukemia
271419|NCT01793025|myeloid|myeloid
271420|NCT01793025|acute|acute
271421|NCT01793025|acute myeloid leukemia|acute myeloid leukemia
272145|NCT01789216|Grade II|grade ii
271423|NCT01793025|transient chimerism|transient chimerism
271424|NCT01793025|cell therapy|cell therapy
271425|NCT01793025|immunotherapy|immunotherapy
271426|NCT01793012|therapeutic drug monitoring|therapeutic drug monitoring
271427|NCT01793012|antibiotics|antibiotics
271428|NCT01793012|inflammation parameters|inflammation parameters
271429|NCT01793012|critically ill patients|critically ill patients
271430|NCT01793012|septicaemia|septicaemia
271431|NCT01793012|intensive care unit|intensive care unit
271432|NCT01792986|Diabetes|diabetes
271433|NCT01792986|Fasting|fasting
271434|NCT01792986|Pre-diabetes|pre-diabetes
271435|NCT01792986|Hemoglobin A1C|hemoglobin a1c
271436|NCT01792973|HIV|hiv
271437|NCT01792973|HPV|hpv
271438|NCT01792973|Women|women
271439|NCT01792973|Thailand|thailand
271440|NCT01792973|Antiretrovirals|antiretrovirals
271441|NCT01792973|Cervical cancer|cervical cancer
271442|NCT01792934|Debulking, cytoreduction, RFA, SABR, palliative chemotherapy|debulking, cytoreduction, rfa, sabr, palliative chemotherapy
271443|NCT01792921|Age 7-10 years old|age 7-10 years old
271444|NCT01792921|regular education system|regular education system
271445|NCT01792921|no moderate or severe neurological and/or psychiatric disorders|no moderate or severe neurological and/or psychiatric disorders
271446|NCT01792908|ankle lateral ligament|ankle lateral ligament
271447|NCT01792908|athletic tape|athletic tape
271448|NCT01792908|position sense|position sense
271449|NCT01792908|Proprioception|proprioception
271450|NCT01792895|Posterior Neck Pain|posterior neck pain
271451|NCT01792895|Cervical spine pain|cervical spine pain
271452|NCT01792895|Manual therapy|manual therapy
271453|NCT01792856|coaching|coaching
271454|NCT01792856|early psychosis|early psychosis
271455|NCT01792856|schizophrenia|schizophrenia
271456|NCT01792830|Coronary Artery Bypass Graft surgery|coronary artery bypass graft surgery
271457|NCT01792817|Cluster Headache|cluster headache
271458|NCT01792817|GammaCore|gammacore
271459|NCT01792817|vagal nerve stimulation|vagal nerve stimulation
271460|NCT01792817|nVNS|nvns
271462|NCT01792817|non invasive|non invasive
271463|NCT01792817|vagus nerve stimulation|vagus nerve stimulation
271464|NCT01792804|Staphylococcus aureus|staphylococcus aureus
271465|NCT01792804|Bloodstream infection|bloodstream infection
271466|NCT01792804|Oral switch|oral switch
271467|NCT01792778|IV Catheters|iv catheters
271468|NCT01792778|Blood control|blood control
271469|NCT01792765|urolithiasis|urolithiasis
271470|NCT01792765|radiation free|radiation free
271471|NCT01792765|ultrasound guidance|ultrasound guidance
271472|NCT01792765|ureteroscopy|ureteroscopy
271473|NCT01792752|HIV/AIDS|hiv/aids
271474|NCT01792752|Drug Users|drug users
271475|NCT01792752|Puerto Rico|puerto rico
271476|NCT01792739|Probiotics|probiotics
271477|NCT01792739|Diarrhea|diarrhea
271478|NCT01792739|Intentive care units|intentive care units
271479|NCT01792726|breast cancer|breast cancer
271480|NCT01792726|radiotherapy|radiotherapy
271481|NCT01792726|TARGIT|targit
271482|NCT01792726|Intrabeam|intrabeam
271483|NCT01792713|Skin alterations|skin alterations
271484|NCT01792713|Atopic Dermatitis|atopic dermatitis
271485|NCT01792687|Metastatic castrate resistant prostate cancer (CRPC)|metastatic castrate resistant prostate cancer (crpc)
271486|NCT01792674|Education|education
271487|NCT01792674|Patient simulation|patient simulation
271488|NCT01792674|In situ simulation|in situ simulation
271489|NCT01792674|Stress|stress
271490|NCT01792661|Chronic Kidney Disease|chronic kidney disease
271491|NCT01792661|Electronic Health Record|electronic health record
271492|NCT01792661|Personal Health Record|personal health record
271493|NCT01792661|Chronic Kidney Disease registry|chronic kidney disease registry
271494|NCT01792661|Glomerular Filtration Rate|glomerular filtration rate
271495|NCT01792661|Patient Navigator|patient navigator
271496|NCT01792648|Almond|almond
271497|NCT01792648|Carbohydrate|carbohydrate
271498|NCT01792648|Diet|diet
271499|NCT01792648|Cholesterol|cholesterol
271500|NCT01792635|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
271501|NCT01792635|Pharmacodynamics|pharmacodynamics
271502|NCT01792635|Safety & Tolerability|safety & tolerability
271503|NCT01792622|Instrument Development|instrument development
271504|NCT01792622|Patient Reported Outcomes|patient reported outcomes
271505|NCT01792622|Pulmonary Arterial Hypertension.|pulmonary arterial hypertension.
271506|NCT01792609|Scoliosis|scoliosis
271507|NCT01792609|Cobb Angle|cobb angle
271508|NCT01792609|Screw Density|screw density
271509|NCT01792609|Outcomes Measures|outcomes measures
271510|NCT01792583|pregnancy|pregnancy
271511|NCT01792570|HIV-1|hiv-1
271512|NCT01792570|darunavir|darunavir
271513|NCT01792570|rilpivirine|rilpivirine
271514|NCT01792570|strategic study|strategic study
271515|NCT01792557|Pilonidal sinus|pilonidal sinus
271516|NCT01792557|Crystallized phenol|crystallized phenol
271517|NCT01792557|Limberg Flap|limberg flap
271518|NCT01792557|Modified Limberg Flap|modified limberg flap
271519|NCT01792557|Karydakis|karydakis
271520|NCT01792557|Recurrence|recurrence
271521|NCT01792557|Complications|complications
271522|NCT01792557|Recovery duration|recovery duration
271523|NCT01792557|Time to return to work|time to return to work
271529|NCT01792492|Optical Devices|optical devices
271530|NCT01792492|Spectrum Analysis|spectrum analysis
271531|NCT01792492|Thyroid diseases|thyroid diseases
271532|NCT01792479|NSCLC|nsclc
271533|NCT01792479|lung cancer|lung cancer
271534|NCT01792466|difficult biliary cannulation|difficult biliary cannulation
271535|NCT01792453|Gastrointestinal physiology|gastrointestinal physiology
271536|NCT01792453|MRI|mri
271537|NCT01792453|Small bowel water volumes|small bowel water volumes
271538|NCT01792453|Gastric volumes|gastric volumes
271539|NCT01792401|Critical illness|critical illness
271540|NCT01792401|Dietary supplements|dietary supplements
271541|NCT01792401|Gastrointestinal tract/physio-pathology|gastrointestinal tract/physio-pathology
271542|NCT01792388|Crohn's Disease|crohn's disease
271543|NCT01792388|Vitamin D|vitamin d
271544|NCT01792388|Intestinal Permeability|intestinal permeability
271545|NCT01792388|Tara Raftery|tara raftery
271546|NCT01792375|Cervical ripening|cervical ripening
271547|NCT01792375|Dinoprostone|dinoprostone
271548|NCT01792375|Labor induction|labor induction
271549|NCT01792375|Membrane sweeping|membrane sweeping
271550|NCT01792375|Nulliparous women|nulliparous women
271551|NCT01792375|Trial|trial
271552|NCT01792362|Anti-mullerian hormone (AMH) level, poly cystic ovarian syndrome obese infertility weight loss diet|anti-mullerian hormone (amh) level, poly cystic ovarian syndrome obese infertility weight loss diet
271553|NCT01792336|Repetitive TMS (rTMS)|repetitive tms (rtms)
271554|NCT01792336|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
271555|NCT01792336|Motor Cortex|motor cortex
271556|NCT01792336|Focal Hand Dystonia|focal hand dystonia
271557|NCT01792336|Facilitation|facilitation
271558|NCT01792323|insulin pump therapy|insulin pump therapy
271559|NCT01792323|insulin bolus|insulin bolus
271560|NCT01792323|rapid acting insulin|rapid acting insulin
271561|NCT01792323|insulin lispro|insulin lispro
271562|NCT01792323|pharmacodynamics|pharmacodynamics
271563|NCT01792323|pharmacokinetics|pharmacokinetics
271564|NCT01792323|glucose clamp|glucose clamp
271565|NCT01792310|Glioma|glioma
271566|NCT01792310|Solid Tumours|solid tumours
271567|NCT01792310|Minerval|minerval
271568|NCT01792297|Sarcopenia|sarcopenia
271569|NCT01792297|Osteoporosis|osteoporosis
271570|NCT01792297|Cognition|cognition
271571|NCT01792297|Inflammation|inflammation
271572|NCT01792271|COPD|copd
271573|NCT01792271|Chronic Bronchitis|chronic bronchitis
271574|NCT01792271|Hypertonic Saline|hypertonic saline
271575|NCT01792258|Percutaneous tracheostomy|percutaneous tracheostomy
271576|NCT01792258|Intensive Care Unit|intensive care unit
271577|NCT01792258|Ineffective Airway Clearance|ineffective airway clearance
271578|NCT01792258|Weaning failure|weaning failure
271579|NCT01792245|narrow band UVB; PUVA; psoriasis; eczema; hand|narrow band uvb; puva; psoriasis; eczema; hand
271580|NCT01792232|Diesel exhaust|diesel exhaust
271581|NCT01792232|Air pollution|air pollution
271582|NCT01792232|Airway responsiveness|airway responsiveness
271583|NCT01792232|Allergies|allergies
271584|NCT01792219|interprofessional learning|interprofessional learning
271585|NCT01792219|interprofessional collaboration|interprofessional collaboration
271586|NCT01792219|residents|residents
271587|NCT01792219|nursing homes|nursing homes
271588|NCT01792206|Stage 3 chronic kidney disease (CKD)|stage 3 chronic kidney disease (ckd)
271589|NCT01792206|Stage 4 chronic kidney disease (CKD)|stage 4 chronic kidney disease (ckd)
271591|NCT01792180|Gait speed|gait speed
271592|NCT01792180|Mobility|mobility
271593|NCT01792180|Falls|falls
271594|NCT01792180|Fall risk|fall risk
271595|NCT01792180|Self-management|self-management
271596|NCT01792180|Mental wellbeing|mental wellbeing
271597|NCT01792180|Elderly|elderly
271602|NCT01792102|Multiple Myeloma|multiple myeloma
271603|NCT01792102|Carfilzomib|carfilzomib
271604|NCT01792102|Krypolis|krypolis
271605|NCT01792102|60 minute infusion|60 minute infusion
271606|NCT01792089|de novo lipogenesis|de novo lipogenesis
271607|NCT01792089|fructose|fructose
271608|NCT01792089|roux-en-Y gastric bypass|roux-en-y gastric bypass
271609|NCT01792089|post-prandial triglycerides|post-prandial triglycerides
271610|NCT01792050|IDO|ido
271611|NCT01792050|IDO Inhibitor|ido inhibitor
271612|NCT01792050|Metastatic Breast Cancer|metastatic breast cancer
271613|NCT01792011|Elective living donor liver transplantation|elective living donor liver transplantation
271614|NCT01791985|Breast Cancer|breast cancer
271615|NCT01791985|AZD4547|azd4547
271616|NCT01791985|Safety Run-In|safety run-in
271617|NCT01791985|FGFR1|fgfr1
271618|NCT01791985|ER positive breast cancer|er positive breast cancer
271619|NCT01791985|Single arm phase IIa study|single arm phase iia study
271620|NCT01791972|Exercise-Induced Bronchoconstriction (EIB)|exercise-induced bronchoconstriction (eib)
271621|NCT01791972|Spiromax®|spiromax®
271622|NCT01791972|Albuterol sulfate|albuterol sulfate
271623|NCT01791946|lazy eye|lazy eye
271624|NCT01791946|cross eye|cross eye
271625|NCT01791946|cross eyed|cross eyed
271626|NCT01791933|LBP|lbp
271627|NCT01791933|Neck pain|neck pain
271628|NCT01791933|Integrative package|integrative package
271629|NCT01791933|CAM|cam
271630|NCT01791868|Generalized convulsive status epilepticus|generalized convulsive status epilepticus
271631|NCT01791868|Sodium valproate|sodium valproate
271632|NCT01791868|Refractory status epilepticus|refractory status epilepticus
271633|NCT01791868|Mortality|mortality
271634|NCT01791868|Epilepsy|epilepsy
271635|NCT01791868|Intensive Care Unit|intensive care unit
271636|NCT01791868|Neurological sequela|neurological sequela
271637|NCT01791868|Quality of life|quality of life
271638|NCT01791868|Adult|adult
271639|NCT01791855|Subjects with Renal Impairment|subjects with renal impairment
271640|NCT01791855|healthy|healthy
271641|NCT01791842|fibrous dysplasia of bone|fibrous dysplasia of bone
271642|NCT01791842|tocilizumab|tocilizumab
271643|NCT01791842|McCune-Albright syndrome|mccune-albright syndrome
271644|NCT01791829|Luminal A|luminal a
271645|NCT01791829|Ipsilateral Breast Tumour Recurrence|ipsilateral breast tumour recurrence
271646|NCT01791816|Vasovagal Syncope|vasovagal syncope
271647|NCT01791816|Postural Tachycardia Syndrome|postural tachycardia syndrome
271648|NCT01791816|Orthostatic Intolerance|orthostatic intolerance
271649|NCT01791816|Nitric Oxide (NO)|nitric oxide (no)
271650|NCT01791816|Orthostatic Stress|orthostatic stress
271651|NCT01791816|L-Ng-monomethyl Arginine (L-NMMA)|l-ng-monomethyl arginine (l-nmma)
271652|NCT01791816|Phenylephrine|phenylephrine
271653|NCT01791816|Sodium Nitroprusside|sodium nitroprusside
271654|NCT01791803|Smoking cessation|smoking cessation
271655|NCT01791803|Tobacco abstinence|tobacco abstinence
271656|NCT01791803|hypnotherapy|hypnotherapy
271657|NCT01791803|Nicotine replacement therapy|nicotine replacement therapy
271658|NCT01791790|old Subjects|old subjects
271659|NCT01791790|Controls|controls
271660|NCT01791790|brain stimulation|brain stimulation
271661|NCT01791790|tSOS|tsos
271662|NCT01791790|tDCS|tdcs
271663|NCT01791790|sleep|sleep
271664|NCT01791790|memory|memory
271665|NCT01791790|memory consolidation|memory consolidation
271666|NCT01791777|fidelity|fidelity
262324|NCT01834001|MRI|mri
271667|NCT01791777|implementation science|implementation science
271668|NCT01791777|competence|competence
271669|NCT01791777|training|training
271670|NCT01791777|coaching|coaching
271671|NCT01791738|Total Hip Arthroplasty (THA)|total hip arthroplasty (tha)
271672|NCT01791738|Patient-Specific Instruments|patient-specific instruments
271673|NCT01791738|Acetabular Cup Placement|acetabular cup placement
271674|NCT01791738|Accuracy|accuracy
271675|NCT01791699|atrial fibrillation|atrial fibrillation
271676|NCT01791699|paroxysmal|paroxysmal
271677|NCT01791699|persistent|persistent
271678|NCT01791699|ablation|ablation
271679|NCT01791699|pulmonary vein isolation|pulmonary vein isolation
271680|NCT01791699|recurrence|recurrence
271681|NCT01791686|Dense Deposit Disease|dense deposit disease
271683|NCT01791673|Glaucoma|glaucoma
271684|NCT01791673|Cyclocoagulation|cyclocoagulation
271685|NCT01791673|HIFU - High Intensity Focused Ultrasound|hifu - high intensity focused ultrasound
271686|NCT01791673|Ciliary Body|ciliary body
271687|NCT01791647|Polycystic ovary syndrome|polycystic ovary syndrome
271688|NCT01791647|myoinositol|myoinositol
271689|NCT01791647|metformin|metformin
271690|NCT01791647|glucose-insulinemic metabolism|glucose-insulinemic metabolism
271691|NCT01791647|menstrual pattern|menstrual pattern
271692|NCT01791647|insulin-lowering therapies|insulin-lowering therapies
271693|NCT01791621|Irritable Bowel Syndrome|irritable bowel syndrome
271694|NCT01791621|Elimination diet|elimination diet
271695|NCT01791621|Food allergies|food allergies
271696|NCT01791608|Child, Preschool|child, preschool
271697|NCT01791608|Dietary Zinc|dietary zinc
271698|NCT01791608|Zinc sulfate|zinc sulfate
271699|NCT01791608|zinc-glycine chelate|zinc-glycine chelate
271700|NCT01791595|Phase I|phase i
271701|NCT01791595|Cancer|cancer
271702|NCT01791595|Solid Tumours|solid tumours
271703|NCT01791595|Prostate Cancer|prostate cancer
271704|NCT01791595|Gastric Cancer|gastric cancer
271705|NCT01791595|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
271706|NCT01791595|Monocarboxylate Transporter 1 Inhibitor|monocarboxylate transporter 1 inhibitor
271707|NCT01791595|lactate|lactate
271708|NCT01791556|HIV|hiv
271709|NCT01791556|AIDS|aids
271710|NCT01791556|Kenya|kenya
271711|NCT01791556|viral load|viral load
271716|NCT01791556|HIV resistance|hiv resistance
271717|NCT01791543|ventricular tachycardia|ventricular tachycardia
271718|NCT01791543|ablation|ablation
271719|NCT01791543|ventricular arrhythmia|ventricular arrhythmia
271720|NCT01791530|VAT|vat
271721|NCT01791530|VAP|vap
271821|NCT01790932|Metastatic|metastatic
271722|NCT01791530|Transition from VAT to VAP|transition from vat to vap
271723|NCT01791504|Abdominoplasty|abdominoplasty
271724|NCT01791478|-Metastatic breast cancer, PI3K inhibitor, Endocrine therapy|-metastatic breast cancer, pi3k inhibitor, endocrine therapy
271725|NCT01791465|HIV|hiv
271726|NCT01791465|Diabetes|diabetes
271727|NCT01791400|Metoclopramide|metoclopramide
271728|NCT01791400|Sumatriptan|sumatriptan
271729|NCT01791400|migraine|migraine
271730|NCT01791400|headache|headache
271731|NCT01791387|Renal cell|renal cell
271732|NCT01791387|Kidney|kidney
271733|NCT01791387|Cancer|cancer
271734|NCT01791387|Metastatic carcinoma|metastatic carcinoma
271735|NCT01791374|Advanced Solid Tumors|advanced solid tumors
271736|NCT01791374|Advanced or Metastatic Gastric Cancer|advanced or metastatic gastric cancer
271737|NCT01791374|Advanced or Metastatic GEJ|advanced or metastatic gej
271738|NCT01791374|Gastric Cancer|gastric cancer
271739|NCT01791361|Metastatic colorectal cancer|metastatic colorectal cancer
271740|NCT01791335|Glottis|glottis
271741|NCT01791335|Respiratory Muscles|respiratory muscles
271742|NCT01791335|Upper airway|upper airway
271743|NCT01791335|Noninvasive ventilation|noninvasive ventilation
271744|NCT01791309|Vemurafenib|vemurafenib
271745|NCT01791309|Panitumumab|panitumumab
271746|NCT01791309|V600E BRAF mutation|v600e braf mutation
271747|NCT01791309|colon|colon
271748|NCT01791309|12-221|12-221
271749|NCT01791296|sedation|sedation
271750|NCT01791296|sleep|sleep
271751|NCT01791296|delirium|delirium
271752|NCT01791296|critical illness|critical illness
271753|NCT01791296|sub-syndromal delirium|sub-syndromal delirium
271755|NCT01791283|Left ventricular stroke volume|left ventricular stroke volume
271756|NCT01791283|Arterial waveform analysis|arterial waveform analysis
271758|NCT01791283|Ultrasound|ultrasound
271759|NCT01791283|Cardiac magnetic Imaging|cardiac magnetic imaging
271760|NCT01791283|Limits of agreement|limits of agreement
271761|NCT01791270|Obstructive Sleep Apnea|obstructive sleep apnea
271762|NCT01791270|Hypertension|hypertension
271763|NCT01791270|β1 Subunit of Maxi-k+Channel|β1 subunit of maxi-k+channel
271764|NCT01791270|Cardiovascular Risk|cardiovascular risk
271765|NCT01791257|delayed|delayed
271766|NCT01791257|cerebral|cerebral
271767|NCT01791257|ischemia|ischemia
271768|NCT01791257|microrna|microrna
271769|NCT01791257|cerebrospinal fluid|cerebrospinal fluid
271770|NCT01791257|subarachnoid|subarachnoid
271771|NCT01791257|hemorrhage|hemorrhage
271772|NCT01791244|Multiple Sclerosis|multiple sclerosis
271773|NCT01791244|Relapsing-Remitting|relapsing-remitting
271774|NCT01791244|Rebif|rebif
271775|NCT01791244|RebiSmart|rebismart
271776|NCT01791244|Patient support program|patient support program
271777|NCT01791231|Healthy|healthy
271778|NCT01791231|Male|male
271779|NCT01791231|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
271780|NCT01791231|Radiolabeled 14C-canagliflozin|radiolabeled 14c-canagliflozin
271781|NCT01791231|Absorption|absorption
271782|NCT01791231|Metabolism|metabolism
271783|NCT01791231|Excretion|excretion
271784|NCT01791231|Radioactivity|radioactivity
271785|NCT01791218|Pulmonary vein isolation|pulmonary vein isolation
271786|NCT01791218|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
271787|NCT01791218|Quality of life|quality of life
271788|NCT01791192|Uveitis, Fingolimod, Phase II, Visual Acuity, Vitreous Haze, OCT|uveitis, fingolimod, phase ii, visual acuity, vitreous haze, oct
271789|NCT01791114|Insulin sensitivity|insulin sensitivity
271790|NCT01791114|Diabetes Prevention|diabetes prevention
271791|NCT01791114|Obesity|obesity
271792|NCT01791114|Brown adipose tissue|brown adipose tissue
271795|NCT01791075|DSAEK|dsaek
271796|NCT01791075|Tan Endoglide|tan endoglide
271797|NCT01791075|Endosaver/Endoserter|endosaver/endoserter
271798|NCT01791062|cartilage tissue engineering|cartilage tissue engineering
271799|NCT01791062|hyaluronan|hyaluronan
271800|NCT01791062|hyaluronic acid|hyaluronic acid
271801|NCT01791049|Gram-positive|gram-positive
271802|NCT01791049|Infections|infections
271803|NCT01791049|Bacterial infections|bacterial infections
271804|NCT01791036|Adductor canal block|adductor canal block
271805|NCT01791036|Femoral Nerve Block|femoral nerve block
271806|NCT01791023|Depression|depression
271807|NCT01791023|Physical exercise|physical exercise
271808|NCT01791023|Stress|stress
271809|NCT01791010|Breathing exercises|breathing exercises
271810|NCT01791010|Aged|aged
271812|NCT01790997|Lumbrokinase|lumbrokinase
271813|NCT01790997|Acute ischemic stroke|acute ischemic stroke
271814|NCT01790997|Bleeding profile|bleeding profile
271815|NCT01790997|Clinical outcome|clinical outcome
271816|NCT01790997|Aspirin|aspirin
271817|NCT01790997|Clopidogrel|clopidogrel
271818|NCT01790984|Dietary extrinsic sugars, atherogenic lipoprotein phenotype, lipoprotein kinetics, fatty liver|dietary extrinsic sugars, atherogenic lipoprotein phenotype, lipoprotein kinetics, fatty liver
271819|NCT01790971|Obstructive sleep apnea|obstructive sleep apnea
271820|NCT01790971|Spinal morphine|spinal morphine
271822|NCT01790932|Triple Negative|triple negative
271823|NCT01790919|Depression, Adults|depression, adults
271824|NCT01790906|Chronic Heart Failure|chronic heart failure
271825|NCT01790906|Renal Sympathetic Denervation|renal sympathetic denervation
271826|NCT01790893|Histoplasmosis|histoplasmosis
271827|NCT01790880|Aphasia|aphasia
271828|NCT01790880|Stroke|stroke
271829|NCT01790880|Speech Rehabilitation|speech rehabilitation
271830|NCT01790854|prasugrel|prasugrel
271831|NCT01790854|antiplatelet|antiplatelet
271832|NCT01790854|Acute Coronary Syndrome|acute coronary syndrome
271833|NCT01790815|Acute Malnutrition|acute malnutrition
271834|NCT01790815|Mid Upper Arm Circumference|mid upper arm circumference
271835|NCT01790815|Screening|screening
271836|NCT01790802|laser treatment, high risk, early AMD|laser treatment, high risk, early amd
271837|NCT01790776|urethrography|urethrography
271838|NCT01790763|Burn|burn
271839|NCT01790763|Second-degree|second-degree
271840|NCT01790750|PDA|pda
271841|NCT01790750|Echo|echo
271842|NCT01790750|PES|pes
271843|NCT01790750|Handheld echo system|handheld echo system
271844|NCT01790737|myeloma, stem cell mobilization, autologous stem cell transplantation|myeloma, stem cell mobilization, autologous stem cell transplantation
271845|NCT01790737|induction treatment, maintenance treatment|induction treatment, maintenance treatment
271846|NCT01790711|Gut bacteria|gut bacteria
271847|NCT01790711|Bacteria|bacteria
271848|NCT01790711|Fecal transplant|fecal transplant
271849|NCT01790711|Bacteriotherapy|bacteriotherapy
271850|NCT01790698|Necrotizing fasciitis|necrotizing fasciitis
271851|NCT01790698|Streptococcus pyogenes|streptococcus pyogenes
271852|NCT01790698|Staphylococcus aureus|staphylococcus aureus
271853|NCT01790698|Immunopathogenesis|immunopathogenesis
271854|NCT01790672|Antioxidants|antioxidants
271855|NCT01790672|Central Nervous System Agents|central nervous system agents
271856|NCT01790672|Wine|wine
271857|NCT01790659|leishmaniasis|leishmaniasis
271858|NCT01790659|cutaneous leishmaniasis|cutaneous leishmaniasis
271859|NCT01790659|Leishmania panamensis|leishmania panamensis
271860|NCT01790659|L panamensis|l panamensis
271861|NCT01790659|Paromomycin|paromomycin
271862|NCT01790659|Paromomycin/Gentamicin|paromomycin/gentamicin
271863|NCT01790633|rapid test|rapid test
271864|NCT01790633|screening|screening
271865|NCT01790633|ELISA|elisa
271866|NCT01790633|hepatitis B virus|hepatitis b virus
271867|NCT01790633|hepatitis C virus|hepatitis c virus
271868|NCT01790633|human immunodeficiency virus|human immunodeficiency virus
271869|NCT01790633|access to care|access to care
335887|NCT01508273|AA|aa
271870|NCT01790620|Severe sepsis|severe sepsis
271871|NCT01790620|Septic shock|septic shock
271872|NCT01790620|Acute renal failure|acute renal failure
271873|NCT01790620|Acute kidney injury|acute kidney injury
271874|NCT01790620|Continuous renal replacement therapies CRRT|continuous renal replacement therapies crrt
271875|NCT01790607|Adult healthy subjects will be matched with individual subjects by age (± 5 years, gender, and BMI (± 15%)|adult healthy subjects will be matched with individual subjects by age (± 5 years, gender, and bmi (± 15%)
271876|NCT01790594|transplantation|transplantation
271877|NCT01790594|kidney|kidney
271878|NCT01790594|pancreas|pancreas
271879|NCT01790594|immunosuppression|immunosuppression
271880|NCT01790594|calcineurin inhibitor (CNI)|calcineurin inhibitor (cni)
271881|NCT01790581|Chronic Ankle Instability|chronic ankle instability
271882|NCT01790555|Postsurgical|postsurgical
271883|NCT01790555|Pain|pain
271884|NCT01790555|THC|thc
271885|NCT01790555|Sensitization|sensitization
271886|NCT01790542|Iron|iron
271887|NCT01790542|Intestinal inflammation|intestinal inflammation
271888|NCT01790542|ROS|ros
271889|NCT01790516|Head and neck cancer|head and neck cancer
271890|NCT01790516|genetic testing|genetic testing
271891|NCT01790516|cisplatin|cisplatin
271892|NCT01790516|erbitux|erbitux
271893|NCT01790516|radiation therapy|radiation therapy
271894|NCT01790503|glioblastoma|glioblastoma
271895|NCT01790503|GBM|gbm
271896|NCT01790477|Tonsillectomy|tonsillectomy
271897|NCT01790477|Acupuncture|acupuncture
271898|NCT01790464|Glossopharyngeal nerve block|glossopharyngeal nerve block
271899|NCT01790464|Airway anesthesia|airway anesthesia
271900|NCT01790464|Awake intubation|awake intubation
271901|NCT01790451|focal therapy|focal therapy
271902|NCT01790451|irreversible electroporation|irreversible electroporation
271903|NCT01790451|prostate cancer|prostate cancer
271904|NCT01790412|pregnancy, exercise, gestational diabetes|pregnancy, exercise, gestational diabetes
271905|NCT01790399|SENTINEL NODE|sentinel node
271906|NCT01790386|hemostasis|hemostasis
271907|NCT01790386|thromboelastography|thromboelastography
271908|NCT01790386|coagulation|coagulation
271909|NCT01790386|TEG|teg
271910|NCT01790373|Suubi|suubi
271911|NCT01790373|Adolescents|adolescents
271912|NCT01790373|Poverty|poverty
271913|NCT01790373|Economic empowerment interventions|economic empowerment interventions
271914|NCT01790373|Adherence to HIV antiretroviral therapy|adherence to hiv antiretroviral therapy
271915|NCT01790373|Wisepill|wisepill
271916|NCT01790373|HIV/AIDS infected Children|hiv/aids infected children
271917|NCT01790373|Medical event monitoring system|medical event monitoring system
271918|NCT01790373|Uganda|uganda
271919|NCT01790360|MSM|msm
271920|NCT01790360|HIV|hiv
271921|NCT01790360|Substance Abuse|substance abuse
271922|NCT01790360|Sexual Behavior|sexual behavior
271923|NCT01790347|Exercise|exercise
271924|NCT01790347|Aerobic|aerobic
271925|NCT01790347|Resistance training|resistance training
271926|NCT01790347|Pregnancy|pregnancy
271927|NCT01790347|Maternal weight gain|maternal weight gain
271928|NCT01790347|IOM recommendations|iom recommendations
271929|NCT01790295|Myelofibrosis|myelofibrosis
271930|NCT01790295|Stem cell transplant|stem cell transplant
271931|NCT01790295|Ruxolitinib|ruxolitinib
271932|NCT01790282|luteal support|luteal support
271933|NCT01790282|high responder|high responder
271934|NCT01790282|ICSI|icsi
271935|NCT01790282|ivf|ivf
271936|NCT01790282|cycle outcome|cycle outcome
272141|NCT01789216|Chronic pain|chronic pain
271937|NCT01790269|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
271938|NCT01790269|NK cells|nk cells
271939|NCT01790269|Fingolimod|fingolimod
271940|NCT01790204|mutant p53|mutant p53
271941|NCT01790204|watercress|watercress
271942|NCT01790204|Phenethyl isothyocyanate|phenethyl isothyocyanate
271943|NCT01790204|oral cells of smokers|oral cells of smokers
271944|NCT01790191|Children|children
271945|NCT01790191|Eating behaviour|eating behaviour
271946|NCT01790191|Intake|intake
271947|NCT01790191|Liking|liking
271948|NCT01790191|Conditioned liking|conditioned liking
271949|NCT01790191|Flavour|flavour
271950|NCT01790191|Nutrient|nutrient
271951|NCT01790191|Vegetable|vegetable
271952|NCT01790165|Onychomycosis|onychomycosis
271953|NCT01790165|Open Label|open label
271955|NCT01790126|Men with Biochemically Relapsed Hormone Sensitive Prostate Cancer|men with biochemically relapsed hormone sensitive prostate cancer
271956|NCT01790074|cervicogenic headache|cervicogenic headache
271957|NCT01790074|trigger point|trigger point
271958|NCT01790074|sternocleidomastoid|sternocleidomastoid
271959|NCT01790074|manual therapy|manual therapy
271960|NCT01790061|Gut bacteria|gut bacteria
271961|NCT01790061|Gut flora|gut flora
271962|NCT01790061|Bacteriotherapy|bacteriotherapy
271963|NCT01790061|Fecal Microbiota Transplantation|fecal microbiota transplantation
271964|NCT01790061|Inflammatory bowel disease|inflammatory bowel disease
271965|NCT01790061|Ulcerative colitis|ulcerative colitis
271966|NCT01790048|MAM|mam
271967|NCT01790009|ADME|adme
271968|NCT01790009|Flavanols|flavanols
271969|NCT01790009|Age|age
271970|NCT01790009|Pharmacokinetics|pharmacokinetics
271971|NCT01789996|6 minute walk test|6 minute walk test
271972|NCT01789996|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
271973|NCT01789996|pulmonary arterial hypertension|pulmonary arterial hypertension
271974|NCT01789983|Physical Activity|physical activity
271975|NCT01789983|Chemotherapy|chemotherapy
271976|NCT01789983|Elderly|elderly
271977|NCT01789983|Geriatric|geriatric
271978|NCT01789983|Walking|walking
271979|NCT01789983|Geriatric Assessment|geriatric assessment
271980|NCT01789983|Geriatric Oncology|geriatric oncology
271981|NCT01789970|chronic low back pain|chronic low back pain
271982|NCT01789970|hydrocodone bitartrate|hydrocodone bitartrate
271983|NCT01789970|opioids|opioids
271984|NCT01789944|Childhood Obesity|childhood obesity
271985|NCT01789918|Hypertension|hypertension
271986|NCT01789918|Blood pressure|blood pressure
271987|NCT01789918|Renal denervation|renal denervation
271988|NCT01789905|Tygacil|tygacil
271989|NCT01789905|Tigecycline|tigecycline
271990|NCT01789905|Post marketing surveillance|post marketing surveillance
271991|NCT01789905|Japanese|japanese
271992|NCT01789905|Infection|infection
271993|NCT01789879|Levonorgestrel|levonorgestrel
271994|NCT01789879|Efavirenz|efavirenz
271995|NCT01789879|Nevirapine|nevirapine
271996|NCT01789879|Pharmacokinetics|pharmacokinetics
271997|NCT01789866|DHA|dha
271998|NCT01789866|lutein|lutein
271999|NCT01789866|cognitive development|cognitive development
272000|NCT01789866|fMRI|fmri
272001|NCT01789853|stroke, rehabilitation, gait training|stroke, rehabilitation, gait training
272002|NCT01789840|BPH|bph
272003|NCT01789840|Prostate|prostate
272004|NCT01789840|Prostatic Hyperplasia|prostatic hyperplasia
272005|NCT01789840|enlarged prostate|enlarged prostate
272006|NCT01789840|LUTS|luts
272007|NCT01789840|urinary retention|urinary retention
272008|NCT01789814|Percutaneous Coronary Intervention|percutaneous coronary intervention
272009|NCT01789814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
272010|NCT01789814|bivalirudin|bivalirudin
272011|NCT01789762|Platelet transfusions|platelet transfusions
272012|NCT01789762|Pathogen reduction|pathogen reduction
272013|NCT01789762|Haemorrhagic episodes|haemorrhagic episodes
272015|NCT01789736|Ocular hypertension|ocular hypertension
272016|NCT01789736|AR-12286|ar-12286
272017|NCT01789736|Travoprost|travoprost
272018|NCT01789710|smoking|smoking
272019|NCT01789710|homelessness|homelessness
272020|NCT01789710|contingency management|contingency management
272021|NCT01789684|cluster|cluster
272022|NCT01789684|genetic counseling|genetic counseling
272023|NCT01789684|breast cancer|breast cancer
272024|NCT01789684|HBOC|hboc
272025|NCT01789684|provider intervention|provider intervention
272026|NCT01789671|Childhood Obesity|childhood obesity
272027|NCT01789658|Oral Mucositis|oral mucositis
272028|NCT01789658|Children|children
272029|NCT01789658|Cryotherapy|cryotherapy
272030|NCT01789658|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
272031|NCT01789645|Carpal tunnel|carpal tunnel
272032|NCT01789645|Physical therapy|physical therapy
272033|NCT01789645|Surgery|surgery
272034|NCT01789645|Efficacy|efficacy
272035|NCT01789606|Self-selection and actual use/compliance trial.|self-selection and actual use/compliance trial.
272036|NCT01789580|Experimental study, moderators, online gambling,|experimental study, moderators, online gambling,
272037|NCT01789580|problem gambling prevention|problem gambling prevention
272038|NCT01789554|Out of hospital cardiac arrest|out of hospital cardiac arrest
272142|NCT01789216|Isolated|isolated
272039|NCT01789554|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
272040|NCT01789554|Bystander CPR|bystander cpr
272041|NCT01789554|Mobile phone positioning system|mobile phone positioning system
272042|NCT01789528|Phase I,|phase i,
272043|NCT01789528|open label,|open label,
272044|NCT01789528|CAZ-AVI,|caz-avi,
272045|NCT01789528|CXL,|cxl,
272046|NCT01789528|healthy volunteers,|healthy volunteers,
272047|NCT01789528|intestinal flora.|intestinal flora.
272048|NCT01789502|self-expandable metal stent; plastic stent|self-expandable metal stent; plastic stent
272049|NCT01789476|pain|pain
272050|NCT01789476|acute pain|acute pain
272051|NCT01789476|kappa agonis|kappa agonis
272052|NCT01789476|opioid analgesia|opioid analgesia
272053|NCT01789476|bunionectomy|bunionectomy
272054|NCT01789476|peripheral nervous system agents|peripheral nervous system agents
272055|NCT01789476|physiological effects of drugs|physiological effects of drugs
272056|NCT01789476|surgery|surgery
272057|NCT01789476|post-operative|post-operative
272058|NCT01789476|post-operative complications|post-operative complications
272059|NCT01789450|sensitivity|sensitivity
272060|NCT01789450|section of periareolar dermis|section of periareolar dermis
272061|NCT01789450|breast reduction|breast reduction
272062|NCT01789437|retinal vein occlusion|retinal vein occlusion
272063|NCT01789437|systemic hypertension|systemic hypertension
272064|NCT01789437|arteriolar diameter|arteriolar diameter
272065|NCT01789385|Deep brain stimulation|deep brain stimulation
272066|NCT01789385|Parkinson|parkinson
272067|NCT01789372|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
272068|NCT01789372|yoga|yoga
272069|NCT01789372|quality of life|quality of life
272070|NCT01789372|blood pressure|blood pressure
272071|NCT01789372|heart rate|heart rate
272072|NCT01789372|heart rate variability|heart rate variability
272073|NCT01789359|anthocyanin|anthocyanin
272074|NCT01789359|bioavailability|bioavailability
272075|NCT01789359|urine|urine
272076|NCT01789359|long-term|long-term
272077|NCT01789346|Scar|scar
272078|NCT01789346|Scars|scars
272079|NCT01789346|Surgical Scar|surgical scar
272080|NCT01789346|Surgical Scars|surgical scars
272081|NCT01789346|Cicatrix|cicatrix
272082|NCT01789346|Hypertrophic Cicatrix|hypertrophic cicatrix
272083|NCT01789346|Keloid|keloid
272084|NCT01789346|Hypertrophic Scar|hypertrophic scar
272085|NCT01789346|Surgical Incision|surgical incision
272086|NCT01789346|Scarring|scarring
272087|NCT01789346|Abdominoplasty|abdominoplasty
272088|NCT01789346|Tummy Tuck|tummy tuck
272089|NCT01789346|Augmentation Mammoplasty|augmentation mammoplasty
272090|NCT01789346|Breast Augmentation|breast augmentation
272091|NCT01789346|Thyroidectomy|thyroidectomy
272092|NCT01789333|Keratoconus|keratoconus
272093|NCT01789333|Ectasia|ectasia
272094|NCT01789333|UVA light|uva light
272095|NCT01789333|riboflavin|riboflavin
272096|NCT01789333|post-LASIK|post-lasik
272097|NCT01789333|irregular astigmatism|irregular astigmatism
272098|NCT01789320|uveitis|uveitis
272099|NCT01789320|intermediate uveitis|intermediate uveitis
272100|NCT01789320|posterior uveitis|posterior uveitis
272101|NCT01789320|panuveitis|panuveitis
272102|NCT01789320|noninfectious uveitis|noninfectious uveitis
272103|NCT01789320|microneedle|microneedle
272104|NCT01789320|suprachoroidal space|suprachoroidal space
272106|NCT01789320|inflammation|inflammation
272107|NCT01789320|ocular inflammatory conditions|ocular inflammatory conditions
272108|NCT01789320|triamcinolone acetonide|triamcinolone acetonide
272109|NCT01789320|TA|ta
272110|NCT01789320|Triesence|triesence
272111|NCT01789320|injection|injection
272112|NCT01789320|IVT|ivt
272113|NCT01789320|intravitreal|intravitreal
272114|NCT01789320|corticosteroid|corticosteroid
272115|NCT01789320|sympathetic ophthalmia|sympathetic ophthalmia
272116|NCT01789320|temporal arteritis|temporal arteritis
272117|NCT01789320|vitreous haze|vitreous haze
272118|NCT01789294|lymphoid nodular hyperplasia|lymphoid nodular hyperplasia
272119|NCT01789294|food allergy|food allergy
272120|NCT01789281|Neoplasms, Carcinoid tumor, Neuroendocrine tumor|neoplasms, carcinoid tumor, neuroendocrine tumor
272121|NCT01789268|acute|acute
272122|NCT01789268|adaptive cellular immune phenotypes|adaptive cellular immune phenotypes
272123|NCT01789268|infants|infants
272124|NCT01789268|Lymphocyte|lymphocyte
272125|NCT01789268|premature|premature
272126|NCT01789268|respiratory viral infections|respiratory viral infections
272127|NCT01789229|Breast cancer|breast cancer
272128|NCT01789229|Ovarian cancer|ovarian cancer
272129|NCT01789229|Endometrium carcinoma|endometrium carcinoma
272130|NCT01789229|Cervix carcinoma,|cervix carcinoma,
272131|NCT01789229|Mamma carcinoma,|mamma carcinoma,
272132|NCT01789229|Prostata carcinoma|prostata carcinoma
272133|NCT01789229|Colon carcinoma|colon carcinoma
272134|NCT01789229|Rectal carcinoma|rectal carcinoma
272135|NCT01789229|Bronchus carcinoma|bronchus carcinoma
272136|NCT01789229|NSCLC (non small cell lung cancer) & SCLC (small cell lung cancer)|nsclc (non small cell lung cancer) & sclc (small cell lung cancer)
272137|NCT01789229|Prostate carcinoma|prostate carcinoma
272138|NCT01789216|Pilon fractures|pilon fractures
272139|NCT01789216|Calcaneus fractures|calcaneus fractures
272146|NCT01789216|open|open
272147|NCT01789216|closed|closed
272148|NCT01789203|BK infection|bk infection
272149|NCT01789203|BK viremia|bk viremia
272150|NCT01789203|BK nephropathy|bk nephropathy
272151|NCT01789203|polyomavirus|polyomavirus
272152|NCT01789203|fluoroquinolone|fluoroquinolone
272153|NCT01789203|ciprofloxacin|ciprofloxacin
272154|NCT01789190|Honeymoon|honeymoon
272155|NCT01789190|Type 1 diabetes|type 1 diabetes
272156|NCT01789177|Spirometry|spirometry
272157|NCT01789177|Postoperative Care|postoperative care
272158|NCT01789164|TBI|tbi
272159|NCT01789164|fNIRS|fnirs
272160|NCT01789164|hypercapnea|hypercapnea
272161|NCT01789164|Cerebrovascular reactivity|cerebrovascular reactivity
272162|NCT01789151|arthritis|arthritis
272163|NCT01789151|nuclear imaging|nuclear imaging
272164|NCT01789151|rheumatoid|rheumatoid
272165|NCT01789151|ankylosing spondylitis|ankylosing spondylitis
272166|NCT01789151|glucosamine|glucosamine
272167|NCT01789138|Antiretroviral Therapy|antiretroviral therapy
272168|NCT01789138|Adherence|adherence
272169|NCT01789138|Intervention|intervention
272170|NCT01789125|anxiety|anxiety
272171|NCT01789125|stress|stress
272172|NCT01789125|smoking|smoking
272173|NCT01789125|cessation|cessation
336256|NCT01506778|Pipelle|pipelle
262878|NCT01831726|Trk|trk
272174|NCT01789099|Lung cancer|lung cancer
272175|NCT01789099|Peptide vaccine|peptide vaccine
272176|NCT01789073|Postoperative|postoperative
272177|NCT01789073|Complications|complications
272178|NCT01789073|Elective|elective
272179|NCT01789073|Surgery|surgery
272180|NCT01789073|GI surgery|gi surgery
272181|NCT01789073|Immunonutrition|immunonutrition
272182|NCT01789073|Immune-enhancing|immune-enhancing
272183|NCT01789073|Immune-modulating|immune-modulating
272184|NCT01789073|Nutrition|nutrition
272185|NCT01789073|Pancreatic cancer|pancreatic cancer
272186|NCT01789073|Postoperative complications and length of hospital stay after major gastrointestinal (GI) elective surgery.|postoperative complications and length of hospital stay after major gastrointestinal (gi) elective surgery.
272187|NCT01789047|Parkinson's disease|parkinson's disease
272188|NCT01789047|dyskinesia|dyskinesia
272189|NCT01789047|Indonesia|indonesia
272190|NCT01789047|amantadine|amantadine
272191|NCT01789021|blood glucose monitoring systems|blood glucose monitoring systems
272192|NCT01789021|ISO 15197|iso 15197
272193|NCT01789021|system accuracy|system accuracy
272194|NCT01789008|Transient elastography|transient elastography
272195|NCT01789008|Alcoholic liver disease|alcoholic liver disease
272196|NCT01789008|liver fibrosis|liver fibrosis
272197|NCT01788982|Thyroid Cancer|thyroid cancer
272198|NCT01788982|Medullary thyroid cancer (MTC)|medullary thyroid cancer (mtc)
272199|NCT01788982|Differentiated thyroid cancer (DTC)|differentiated thyroid cancer (dtc)
272200|NCT01788969|Gait training|gait training
272201|NCT01788969|Lexapro|lexapro
272202|NCT01788969|Tizanidine|tizanidine
272203|NCT01788956|venous oximeter|venous oximeter
272204|NCT01788956|CO-Oximeter|co-oximeter
272205|NCT01788956|ICU Patients|icu patients
272206|NCT01788956|Sepsis|sepsis
272207|NCT01788956|non-invasive device|non-invasive device
272208|NCT01788943|positron emission tomography|positron emission tomography
272209|NCT01788943|nicotine receptor|nicotine receptor
272210|NCT01788917|n-3 LC-PUFA, vegetarians, fatty acids, blood lipids|n-3 lc-pufa, vegetarians, fatty acids, blood lipids
272211|NCT01788904|Acute mesenteric ischemia|acute mesenteric ischemia
272212|NCT01788904|Percutaneous endovascular revascularization|percutaneous endovascular revascularization
272213|NCT01788904|Intestinal plasma fatty acid binding protein (i-FABP)|intestinal plasma fatty acid binding protein (i-fabp)
272214|NCT01788904|Bowel necrosis|bowel necrosis
272215|NCT01788891|longitudinal observational cohort study|longitudinal observational cohort study
272216|NCT01788891|multicenter|multicenter
272217|NCT01788891|pediatrics|pediatrics
272218|NCT01788891|Asian|asian
272219|NCT01788891|treatment failure|treatment failure
272220|NCT01788891|renal status|renal status
272221|NCT01788891|toxicities|toxicities
272222|NCT01788891|therapeutic drug monitoring (TDM)|therapeutic drug monitoring (tdm)
272223|NCT01788891|drug levels in blood and hair|drug levels in blood and hair
272224|NCT01788878|socio-professional future|socio-professional future
272225|NCT01788865|covered Metal stent|covered metal stent
272226|NCT01788865|ureteral obstruction|ureteral obstruction
272228|NCT01788852|HIV|hiv
272229|NCT01788852|cervical/anal dysplasia|cervical/anal dysplasia
272230|NCT01788852|intraepithelial neoplasia|intraepithelial neoplasia
272231|NCT01788852|E6/E7 biomarker|e6/e7 biomarker
272232|NCT01788852|perinatally HIV-infected adolescents|perinatally hiv-infected adolescents
272233|NCT01788852|behaviorally HIV-infected adolescents|behaviorally hiv-infected adolescents
272234|NCT01788852|anal and pap smear|anal and pap smear
272235|NCT01788839|Sexual and Reproductive Health|sexual and reproductive health
272236|NCT01788839|premenopausal|premenopausal
272237|NCT01788839|postmenopausal|postmenopausal
272238|NCT01788839|12-249|12-249
272239|NCT01788839|Fertility|fertility
272240|NCT01788826|Ventral hernia|ventral hernia
272241|NCT01788826|surgical meshes|surgical meshes
272242|NCT01788826|polypropylenes|polypropylenes
272243|NCT01788813|Repeat Dose Safety|repeat dose safety
272244|NCT01788813|Allergic Asthma|allergic asthma
272245|NCT01788813|Effect on Allergen Reactivity|effect on allergen reactivity
272246|NCT01788813|Allergic Rhinitis|allergic rhinitis
272247|NCT01788813|TLR7 Agonist|tlr7 agonist
272248|NCT01788813|Pharmacodynamics|pharmacodynamics
272249|NCT01788800|Panic disorder|panic disorder
272250|NCT01788800|Physical activity|physical activity
272251|NCT01788787|Cancer Prevention|cancer prevention
272252|NCT01788787|Tobacco Use Cessation|tobacco use cessation
272253|NCT01788787|Ask Advise Connect|ask advise connect
272255|NCT01788787|Smoking Cessation Treatment|smoking cessation treatment
272256|NCT01788787|Texas Quitline|texas quitline
272257|NCT01788787|Saliva sample|saliva sample
272258|NCT01788787|Telephone Counseling|telephone counseling
272259|NCT01788787|Nicotine replacement|nicotine replacement
272260|NCT01788787|Interviews|interviews
272261|NCT01788774|Pharmacokinetics|pharmacokinetics
272262|NCT01788774|Safety|safety
272263|NCT01788774|Risperidone ISM®|risperidone ism®
272264|NCT01788774|Intramuscular|intramuscular
272265|NCT01788774|Schizophrenia|schizophrenia
272266|NCT01788761|Probiotics|probiotics
272267|NCT01788761|Feeding Tolerance|feeding tolerance
272268|NCT01788761|Extremely Low Birthweight Infants|extremely low birthweight infants
272269|NCT01788748|fractional|fractional
272270|NCT01788748|bipolar|bipolar
272271|NCT01788748|radiofrequency|radiofrequency
272272|NCT01788748|striae|striae
272273|NCT01788748|infrared|infrared
272274|NCT01788748|combined|combined
272275|NCT01788735|unexplained infertility|unexplained infertility
272276|NCT01788735|asthma|asthma
272277|NCT01788735|allergy|allergy
272278|NCT01788709|colonoscopy|colonoscopy
272279|NCT01788709|preparation|preparation
272280|NCT01788696|Parkinsonism|parkinsonism
272281|NCT01788696|Idiopathic Parkinson Disease|idiopathic parkinson disease
272282|NCT01788683|Rotator Cuff|rotator cuff
272283|NCT01788683|Rotator Cuff Tear|rotator cuff tear
272284|NCT01788683|Supraspinatus Tear|supraspinatus tear
272285|NCT01788670|Antioxidants, Central Nervous System Agents|antioxidants, central nervous system agents
272286|NCT01788657|Depression|depression
272287|NCT01788657|Internet|internet
272288|NCT01788657|Cognitive Behavior Therapy|cognitive behavior therapy
272289|NCT01788644|Child adiposity|child adiposity
272290|NCT01788644|Infancy|infancy
272291|NCT01788644|Motor activity|motor activity
272292|NCT01788644|Feeding behavior|feeding behavior
272293|NCT01788644|Sleep|sleep
272294|NCT01788644|Stress, Physiological|stress, physiological
272295|NCT01788618|Cognitive functions|cognitive functions
272296|NCT01788618|Quality of life|quality of life
272297|NCT01788618|Cancer|cancer
272298|NCT01788605|hematologic malignancies|hematologic malignancies
272299|NCT01788605|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
272300|NCT01788605|ramosetron|ramosetron
272301|NCT01788605|emesis|emesis
272302|NCT01788592|coronary artery disease|coronary artery disease
272303|NCT01788592|drug eluting stent|drug eluting stent
272304|NCT01788579|Intimate Partner Violence (IPV)|intimate partner violence (ipv)
272305|NCT01788579|Drug Abuse|drug abuse
272306|NCT01788579|Criminal Justice|criminal justice
272307|NCT01788553|remission|remission
272308|NCT01788553|generalized anxiety disorder|generalized anxiety disorder
272309|NCT01788540|Recurrent miscarriage|recurrent miscarriage
272310|NCT01788540|Implantation failure|implantation failure
272311|NCT01788540|Intralipid|intralipid
272312|NCT01788540|ICSI / IVF failure|icsi / ivf failure
272314|NCT01788527|Type 1|type 1
272315|NCT01788527|CGM|cgm
272316|NCT01788527|Continuous Glucose Monitor|continuous glucose monitor
272317|NCT01788527|HGM|hgm
272318|NCT01788527|HbA1c|hba1c
272319|NCT01788488|procalcitonin|procalcitonin
272320|NCT01788488|antimicrobial stewardship|antimicrobial stewardship
272321|NCT01788488|pneumonia|pneumonia
272322|NCT01788475|Diabetic Macular Edema|diabetic macular edema
272323|NCT01788475|DME|dme
272324|NCT01788475|Pars Plana Vitrectomy|pars plana vitrectomy
272325|NCT01788462|Tesamorelin|tesamorelin
272326|NCT01788462|Egrifta|egrifta
272327|NCT01788462|HIV|hiv
272328|NCT01788462|Lipodystrophy|lipodystrophy
272329|NCT01788462|Sleep Apnea|sleep apnea
272330|NCT01788449|Antibiotic Bacterial Resistance|antibiotic bacterial resistance
272331|NCT01788436|Schizophrenia|schizophrenia
272332|NCT01788436|Young healthy volunteers|young healthy volunteers
272333|NCT01788436|Elderly healthy volunteers|elderly healthy volunteers
272334|NCT01788436|Learning performance|learning performance
272335|NCT01788423|presbycusis|presbycusis
272336|NCT01788423|hearing aids|hearing aids
272337|NCT01788410|Cryoablation|cryoablation
272338|NCT01788410|Nerves|nerves
272339|NCT01788410|Facet joint|facet joint
272340|NCT01788410|Pain|pain
272341|NCT01788410|Neuralgia|neuralgia
272342|NCT01788410|Neuropathy|neuropathy
272343|NCT01788410|Image-guided|image-guided
272344|NCT01788397|physical disabilities|physical disabilities
272345|NCT01788397|rehabilitation|rehabilitation
272346|NCT01788384|acne|acne
272347|NCT01788384|Clindamycin Phosphate/Benzoyl Peroxide|clindamycin phosphate/benzoyl peroxide
272348|NCT01788384|Acanya|acanya
272349|NCT01788384|Mild to severe acne vulgaris|mild to severe acne vulgaris
272350|NCT01788358|Drug combination|drug combination
272351|NCT01788358|Nifedipine GITS|nifedipine gits
272352|NCT01788358|Candesartan Cilexetil|candesartan cilexetil
272353|NCT01788358|Hypertension|hypertension
272354|NCT01788358|Combination therapy|combination therapy
272355|NCT01788345|non-invasion ventilation|non-invasion ventilation
272356|NCT01788345|Boussignac|boussignac
272357|NCT01788332|NSCLC|nsclc
272358|NCT01788332|non-small cell|non-small cell
272359|NCT01788332|lung cancer|lung cancer
272360|NCT01788319|laser trabeculoplasty|laser trabeculoplasty
272361|NCT01788319|glaucoma|glaucoma
272362|NCT01788306|Elevated risk|elevated risk
272363|NCT01788306|opioid overdose|opioid overdose
272364|NCT01788293|Fluid management|fluid management
272365|NCT01788293|Pleth Variability Index (PVI)|pleth variability index (pvi)
272366|NCT01788293|monitoring|monitoring
272367|NCT01788293|high-risk surgery|high-risk surgery
272368|NCT01788267|Cystic Fibrosis|cystic fibrosis
272369|NCT01788267|High-Resolution peripheral Quantitative Computed Tomography|high-resolution peripheral quantitative computed tomography
272370|NCT01788267|Bone Mass Density|bone mass density
272371|NCT01788254|pharmacokinetic/genetic|pharmacokinetic/genetic
272372|NCT01788254|Cyp450 polymorphisms|cyp450 polymorphisms
272373|NCT01788254|Noninvasive functional characterization of liver heart and kidneys using MRI|noninvasive functional characterization of liver heart and kidneys using mri
272374|NCT01788241|coronary artery disease|coronary artery disease
272375|NCT01788241|Atherosclerosis|atherosclerosis
272376|NCT01788241|Coronary Stenosis|coronary stenosis
272377|NCT01788241|Cardiovascular Diseases|cardiovascular diseases
272378|NCT01788241|Non-significant coronary artery disease|non-significant coronary artery disease
272379|NCT01788241|Mild Stenosis|mild stenosis
272380|NCT01788241|Vascular Irregularities|vascular irregularities
272381|NCT01788241|Psychosocial factors|psychosocial factors
272382|NCT01788241|Personality|personality
272383|NCT01788241|Type D personality|type d personality
272384|NCT01788241|Hostility|hostility
272385|NCT01788241|Depression|depression
272386|NCT01788241|Anxiety|anxiety
272387|NCT01788241|Fatigue|fatigue
272388|NCT01788241|Social Support|social support
272389|NCT01788241|Socioeconomic Status|socioeconomic status
272390|NCT01788241|Patient Reported Outcomes|patient reported outcomes
272391|NCT01788241|Patient Perceived Symptoms|patient perceived symptoms
272392|NCT01788241|Health Status|health status
272393|NCT01788241|Quality of Life|quality of life
272394|NCT01788241|Chest pain|chest pain
272395|NCT01788241|Cardiac risk factors|cardiac risk factors
272396|NCT01788241|Metabolic Syndrome|metabolic syndrome
272398|NCT01788241|Obesity|obesity
272399|NCT01788241|Waist Circumference|waist circumference
272400|NCT01788241|Lifestyle|lifestyle
272401|NCT01788241|Smoking|smoking
272402|NCT01788241|Alcohol use|alcohol use
272403|NCT01788241|Activity|activity
272404|NCT01788241|Hypertension|hypertension
272405|NCT01788241|Diabetes|diabetes
272406|NCT01788241|Familial Cardiovascular Disease|familial cardiovascular disease
272407|NCT01788241|Coronary angiography|coronary angiography
272408|NCT01788241|Computed Tomography|computed tomography
272409|NCT01788228|Vaccine|vaccine
272410|NCT01788228|Occupational exposure|occupational exposure
272411|NCT01788228|Influenza|influenza
272412|NCT01788228|H5N1|h5n1
272413|NCT01788215|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
272414|NCT01788215|Irregular Menstrual Cycles|irregular menstrual cycles
272415|NCT01788215|Androgen Excess in Women|androgen excess in women
272416|NCT01788202|cocaine and general anesthesia|cocaine and general anesthesia
272418|NCT01788189|CD20|cd20
272419|NCT01788189|Relapse|relapse
272420|NCT01788189|Lenalidomide|lenalidomide
272421|NCT01788176|Complex Regional Pain Syndromes|complex regional pain syndromes
272422|NCT01788176|drug therapy|drug therapy
272423|NCT01788176|zoledronic acid|zoledronic acid
272424|NCT01788163|EGFR|egfr
272425|NCT01788163|aNSCLC|ansclc
272426|NCT01788163|mutation status|mutation status
272427|NCT01788163|diagnostic study|diagnostic study
272428|NCT01788163|Russia|russia
272429|NCT01788163|China|china
272430|NCT01788163|Asia|asia
272431|NCT01788137|T-cell lymphoma,DFS,OS|t-cell lymphoma,dfs,os
272432|NCT01788124|Speculum|speculum
272433|NCT01788124|Metal|metal
272434|NCT01788124|Plastic|plastic
272435|NCT01788124|Visual Analoge Scale|visual analoge scale
272436|NCT01788124|Discomfort|discomfort
272437|NCT01788085|GERD|gerd
272438|NCT01788072|Autism Spectrum Disorders|autism spectrum disorders
272439|NCT01788072|Oxytocin|oxytocin
272440|NCT01788072|Adults|adults
272441|NCT01788059|nonunion|nonunion
272442|NCT01788059|mesenchymal stem cell|mesenchymal stem cell
272443|NCT01788059|long bone|long bone
272565|NCT01787552|Smoothened inhibitor|smoothened inhibitor
272566|NCT01787552|JAK inhibitor|jak inhibitor
272446|NCT01788007|Imiquimod Topical Cream 3.75%|imiquimod topical cream 3.75%
272447|NCT01788007|Zyclara® (imiquimod) Topical Cream 3.75%|zyclara® (imiquimod) topical cream 3.75%
272448|NCT01787968|Congenital transmission|congenital transmission
272449|NCT01787968|Trypanosoma cruzi|trypanosoma cruzi
272450|NCT01787968|Chagas disease|chagas disease
272451|NCT01787955|Pylorus preserving pancreaticoduodenectomy(PPPD), Delayed gastric emptying syndrome(DGE), Braun anastomosis|pylorus preserving pancreaticoduodenectomy(pppd), delayed gastric emptying syndrome(dge), braun anastomosis
272452|NCT01787942|Lipid thickness|lipid thickness
272453|NCT01787942|Blepharoplasty|blepharoplasty
272454|NCT01787942|Tear break up time|tear break up time
272455|NCT01787942|Corneal staining|corneal staining
272456|NCT01787916|type 1 diabetes|type 1 diabetes
272457|NCT01787916|overweight|overweight
272459|NCT01787916|liraglutide|liraglutide
272460|NCT01787903|Type 1 diabetes mellitus|type 1 diabetes mellitus
272461|NCT01787903|Hypoglycemia unawareness|hypoglycemia unawareness
272462|NCT01787903|Real-time continuous glucose monitoring|real-time continuous glucose monitoring
272463|NCT01787903|Glucose control|glucose control
272464|NCT01787877|Cerebrovascular Accident, Inflammatory biomarkers|cerebrovascular accident, inflammatory biomarkers
272465|NCT01787864|Barrett's Esophagus|barrett's esophagus
272466|NCT01787864|Intestinal metaplasia|intestinal metaplasia
272467|NCT01787864|Intramucosal Adenocarcinoma|intramucosal adenocarcinoma
272468|NCT01787864|Gastric Cardia|gastric cardia
272469|NCT01787864|High Cardia Dysplasia|high cardia dysplasia
272470|NCT01787864|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
272471|NCT01787851|Heart failure|heart failure
272472|NCT01787851|Anaplerosis|anaplerosis
272473|NCT01787851|Medium-chain fatty acid|medium-chain fatty acid
272474|NCT01787838|Pneumococcal vaccination rates, ambulatory settings|pneumococcal vaccination rates, ambulatory settings
272475|NCT01787825|intestinal disease|intestinal disease
272476|NCT01787825|inflammatory bowel disease|inflammatory bowel disease
272477|NCT01787825|crohn disease|crohn disease
272478|NCT01787825|ulcer|ulcer
272479|NCT01787825|celiac disease|celiac disease
272480|NCT01787825|angioectasia|angioectasia
272481|NCT01787825|polyp|polyp
272482|NCT01787799|Drug-eluting stents|drug-eluting stents
272483|NCT01787786|Crohn's Disease|crohn's disease
272484|NCT01787786|Ulcerative Colitis|ulcerative colitis
272485|NCT01787786|Optimal Use of infliximab|optimal use of infliximab
272486|NCT01787773|Inferior Vena Cava Filter|inferior vena cava filter
272487|NCT01787773|Vena Cava Filters|vena cava filters
272488|NCT01787747|Pharmacokinetics|pharmacokinetics
272489|NCT01787747|Healthy Volunteers|healthy volunteers
272490|NCT01787747|dextromethorphan with quinidine|dextromethorphan with quinidine
272491|NCT01787747|deuterated dextromethorphan|deuterated dextromethorphan
272492|NCT01787721|Gait|gait
272493|NCT01787721|Ankle joint|ankle joint
272494|NCT01787721|Manipulation, Chiropractic|manipulation, chiropractic
272495|NCT01787708|Vitiligo|vitiligo
272496|NCT01787708|red|red
272497|NCT01787708|laser|laser
272498|NCT01787708|light|light
272499|NCT01787695|Vitiligo|vitiligo
272500|NCT01787695|UVA1|uva1
272501|NCT01787695|Phototherapy|phototherapy
272508|NCT01787669|diabetic macular oedema|diabetic macular oedema
272509|NCT01787669|diabetic macular edema|diabetic macular edema
272510|NCT01787669|diabetic retinopathy|diabetic retinopathy
272511|NCT01787669|dexamethasone|dexamethasone
272512|NCT01787669|Ozurdex|ozurdex
272513|NCT01787669|Avastin|avastin
272514|NCT01787669|bevacizumab|bevacizumab
272515|NCT01787669|DME|dme
272516|NCT01787669|DMO|dmo
272517|NCT01787643|height-adjustable desk|height-adjustable desk
272227|NCT01788852|HPV|hpv
272518|NCT01787643|office workers|office workers
272821|NCT01786434|pain|pain
272519|NCT01787643|sitting occupations|sitting occupations
272520|NCT01787643|energy expenditure|energy expenditure
272521|NCT01787643|BMI|bmi
272522|NCT01787643|Weight|weight
272523|NCT01787643|Lower fat diet|lower fat diet
272524|NCT01787630|Prostatic cancer|prostatic cancer
272525|NCT01787630|Radiotherapy|radiotherapy
272526|NCT01787630|Hyaluronic acid|hyaluronic acid
272527|NCT01787617|Exercise Training|exercise training
272528|NCT01787617|Strength Training|strength training
272529|NCT01787617|African American Men|african american men
272530|NCT01787617|Insulin Resistance|insulin resistance
272531|NCT01787604|Valve-sparing|valve-sparing
272532|NCT01787604|Valve repair|valve repair
272533|NCT01787591|Vitamin E|vitamin e
272534|NCT01787591|Metabolic syndrome|metabolic syndrome
272535|NCT01787591|Liver disease|liver disease
272536|NCT01787591|Non-alcoholic liver steatohepatitis|non-alcoholic liver steatohepatitis
272537|NCT01787591|Fatty liver|fatty liver
272538|NCT01787591|Dairy consumption|dairy consumption
272539|NCT01787578|X-linked adrenoleukodystrophy|x-linked adrenoleukodystrophy
272540|NCT01787578|adrenomyeloneuropathy|adrenomyeloneuropathy
272541|NCT01787578|sobetirome|sobetirome
272542|NCT01787578|thyroid|thyroid
272543|NCT01787578|thyromimetic|thyromimetic
272544|NCT01787565|non-interventional|non-interventional
272545|NCT01787565|clinical|clinical
272546|NCT01787565|investigation|investigation
272547|NCT01787565|low|low
272548|NCT01787565|back|back
272549|NCT01787565|pain|pain
272550|NCT01787565|painPREMIER|painpremier
272551|NCT01787552|Dose escalation|dose escalation
272552|NCT01787552|Maximum Tolerated Dose|maximum tolerated dose
272553|NCT01787552|MTD|mtd
272554|NCT01787552|Safety Expansion|safety expansion
272555|NCT01787552|Safety|safety
272556|NCT01787552|Efficacy|efficacy
272557|NCT01787552|Myelofibrosis|myelofibrosis
272558|NCT01787552|Post-polycythemia vera myelofbrosis (Post PV-PMF)|post-polycythemia vera myelofbrosis (post pv-pmf)
272559|NCT01787552|Post essential thrombocythemia myelofibrosis (Post ET-MF)|post essential thrombocythemia myelofibrosis (post et-mf)
272560|NCT01787552|Primary myelofibrosis (PMF)|primary myelofibrosis (pmf)
272561|NCT01787552|Intermediate risk myelofibrosis|intermediate risk myelofibrosis
272562|NCT01787552|High risk myelofibrosis|high risk myelofibrosis
272563|NCT01787552|Combination Treatment|combination treatment
272564|NCT01787552|Hedgehog Signaling Pathway|hedgehog signaling pathway
272567|NCT01787539|gastric cancer|gastric cancer
272568|NCT01787539|perioperative chemotherapy|perioperative chemotherapy
272569|NCT01787539|combined modality therapy|combined modality therapy
272570|NCT01787539|gastrectomy|gastrectomy
272571|NCT01787526|iron depletion|iron depletion
272572|NCT01787526|donor safety|donor safety
272573|NCT01787526|blood donation|blood donation
272574|NCT01787526|transfusion medicine|transfusion medicine
272575|NCT01787526|iron deficiency|iron deficiency
272576|NCT01787526|intravenous iron|intravenous iron
272577|NCT01787526|fatigue|fatigue
272578|NCT01787526|restless legs syndrome|restless legs syndrome
272579|NCT01787526|anemia|anemia
272580|NCT01787500|Advanced Cancers|advanced cancers
272581|NCT01787500|Advanced Solid Cancers|advanced solid cancers
272582|NCT01787500|BRAF V600 Mutant Advanced Solid Malignancies|braf v600 mutant advanced solid malignancies
272583|NCT01787500|Metastatic|metastatic
272584|NCT01787500|Unresectable|unresectable
272585|NCT01787500|BRAF mutant, KRAS wild type colorectal cancer|braf mutant, kras wild type colorectal cancer
272586|NCT01787500|BRAF mutant, KRAS wild type solid tumor cancers|braf mutant, kras wild type solid tumor cancers
272587|NCT01787500|Vemurafenib|vemurafenib
272588|NCT01787500|PLX4032|plx4032
272589|NCT01787500|RO5185426|ro5185426
272590|NCT01787500|Cetuximab|cetuximab
272591|NCT01787500|C225|c225
272592|NCT01787500|Erbitux|erbitux
272593|NCT01787500|IMC-C225|imc-c225
272594|NCT01787500|Irinotecan|irinotecan
272595|NCT01787500|CPT-11|cpt-11
272596|NCT01787500|Camptosar|camptosar
272597|NCT01787487|Leukemia|leukemia
272598|NCT01787487|Myelofibrosis|myelofibrosis
272599|NCT01787487|Myelodysplastic syndrome|myelodysplastic syndrome
272600|NCT01787487|Myeloproliferative neoplasm|myeloproliferative neoplasm
272601|NCT01787487|Ruxolitinib|ruxolitinib
272602|NCT01787487|RUX|rux
272603|NCT01787487|Jakafi|jakafi
272604|NCT01787487|INCB018424|incb018424
272605|NCT01787487|INC424|inc424
272606|NCT01787487|Azacitidine|azacitidine
272607|NCT01787487|AZA|aza
272608|NCT01787487|5-Azacitidine|5-azacitidine
272609|NCT01787487|5-aza|5-aza
272610|NCT01787487|Vidaza|vidaza
272611|NCT01787487|5-AZC|5-azc
272612|NCT01787487|AZA-CR|aza-cr
272613|NCT01787487|Ladakamycin|ladakamycin
272614|NCT01787487|NSC-102816|nsc-102816
272615|NCT01787474|Leukemia|leukemia
272616|NCT01787474|Acute Myeloid Leukemia|acute myeloid leukemia
272617|NCT01787474|Blood And Marrow Transplantation|blood and marrow transplantation
272618|NCT01787474|Natural killer cells|natural killer cells
272619|NCT01787474|NK|nk
272620|NCT01787474|mbIL21-expanded haploidentical NK cells|mbil21-expanded haploidentical nk cells
272621|NCT01787474|G-CSF|g-csf
272622|NCT01787474|Filgrastim|filgrastim
272623|NCT01787474|Neupogen|neupogen
272624|NCT01787474|Fludarabine monophosphate|fludarabine monophosphate
272625|NCT01787474|Fludarabine Phosphate|fludarabine phosphate
272626|NCT01787474|Fludara|fludara
272627|NCT01787474|Cytarabine|cytarabine
272628|NCT01787474|Ara-C|ara-c
272629|NCT01787474|Cytosar|cytosar
272630|NCT01787474|DepoCyt|depocyt
272631|NCT01787474|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
272632|NCT01787461|Trial assessing effects of an oral dietary supplement on overall facial appearance among healthy women with photodamaged skin.|trial assessing effects of an oral dietary supplement on overall facial appearance among healthy women with photodamaged skin.
272633|NCT01787448|repeat insult patch test|repeat insult patch test
272634|NCT01787435|Asthma,|asthma,
696746|NCT00947271|Prevention|prevention
272635|NCT01787435|acid-suppressing drugs,|acid-suppressing drugs,
272636|NCT01787435|pregnancy,|pregnancy,
272637|NCT01787435|epidemiology|epidemiology
272638|NCT01787422|Telemedicine|telemedicine
272639|NCT01787383|Actinic Keratosis|actinic keratosis
272640|NCT01787383|Ingenol mebutate gel|ingenol mebutate gel
272641|NCT01787370|coronary artery disease, endothelial dysfunction|coronary artery disease, endothelial dysfunction
272642|NCT01787357|Healthy|healthy
272643|NCT01787357|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
272644|NCT01787357|Pharmacokinetics|pharmacokinetics
272645|NCT01787357|Moxifloxacin|moxifloxacin
272646|NCT01787357|Electrocardiogram Parameters|electrocardiogram parameters
272647|NCT01787357|QT/QTc Interval|qt/qtc interval
272648|NCT01787357|Therapeutic dose|therapeutic dose
272649|NCT01787357|Supra-Therapeutic dose|supra-therapeutic dose
272650|NCT01787344|Other Infantile Cerebral Palsy|other infantile cerebral palsy
272651|NCT01787331|biochemically relapsed|biochemically relapsed
272652|NCT01787331|hormone sensitive|hormone sensitive
272653|NCT01787331|non-metastatic|non-metastatic
272654|NCT01787331|prostate cancer|prostate cancer
272655|NCT01787331|after prior definitive local therapy|after prior definitive local therapy
272656|NCT01787331|PSA|psa
272657|NCT01787331|Hedgehog-signaling pathway|hedgehog-signaling pathway
272658|NCT01787305|microbiome|microbiome
272659|NCT01787305|commensals|commensals
272660|NCT01787305|autoantibodies|autoantibodies
272661|NCT01787305|autoreactive T cells|autoreactive t cells
272662|NCT01787292|Exercise|exercise
272663|NCT01787292|Magnetic Resonance Imaging|magnetic resonance imaging
272664|NCT01787292|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
272665|NCT01787292|Aging|aging
272666|NCT01787214|glucose variability|glucose variability
272667|NCT01787214|glycemia|glycemia
272668|NCT01787214|type-2 diabetes|type-2 diabetes
272669|NCT01787175|Medication Therapy Management|medication therapy management
272670|NCT01787175|Clinical Decision Support Systems|clinical decision support systems
272671|NCT01787175|Medical Informatics|medical informatics
272672|NCT01787175|Patient Care Management|patient care management
272673|NCT01787175|United States Department of Veterans Affairs|united states department of veterans affairs
272674|NCT01787162|Myeloproliferative disorders|myeloproliferative disorders
272675|NCT01787162|pulmonary hypertension|pulmonary hypertension
272676|NCT01787162|pulmonary vascular diseases|pulmonary vascular diseases
272677|NCT01787149|ENIA11|enia11
272678|NCT01787149|DMARDs|dmards
272679|NCT01787149|RA|ra
272680|NCT01787149|TNF|tnf
272681|NCT01787110|Acute coronary syndrome|acute coronary syndrome
272682|NCT01787110|Acute myocardial infarction|acute myocardial infarction
272683|NCT01787110|Non ST-segment Myocardial Infarction|non st-segment myocardial infarction
272684|NCT01787110|ST-segment Myocardial Infarction|st-segment myocardial infarction
272685|NCT01787110|STEMI|stemi
272686|NCT01787110|NSTEMI|nstemi
272687|NCT01787110|Oxygen|oxygen
272688|NCT01787110|Unstable angina|unstable angina
272689|NCT01787110|Randomised trial|randomised trial
272690|NCT01787110|CMR|cmr
272691|NCT01787110|Mortality|mortality
272692|NCT01787110|RCRT|rcrt
272693|NCT01787110|RRCT|rrct
272694|NCT01787084|Aortic Stenosis|aortic stenosis
272695|NCT01787084|TAVR|tavr
272696|NCT01787071|fluids|fluids
272697|NCT01787071|crtically ill patients|crtically ill patients
272698|NCT01787071|functional hemodynamics|functional hemodynamics
272700|NCT01787058|WASH|wash
272701|NCT01787058|schoolchildren|schoolchildren
272702|NCT01787058|absenteeism|absenteeism
272703|NCT01787045|SEPSIS|sepsis
272704|NCT01787006|non resectable|non resectable
272705|NCT01787006|locally advanced|locally advanced
272706|NCT01787006|Cetuximab|cetuximab
272707|NCT01787006|radiation|radiation
272708|NCT01786967|overactive bladder|overactive bladder
272709|NCT01786967|urge urinary incontinence|urge urinary incontinence
272710|NCT01786967|pharmacogenetics|pharmacogenetics
272711|NCT01786954|vitreoretinal surgery|vitreoretinal surgery
272712|NCT01786954|intraocular pressure|intraocular pressure
272713|NCT01786954|applanation|applanation
272714|NCT01786954|rebound|rebound
272715|NCT01786954|tonometry|tonometry
272716|NCT01786941|Branched-chain Amino Acids|branched-chain amino acids
272717|NCT01786941|Insulin Sensitivity|insulin sensitivity
272718|NCT01786941|Exercise|exercise
272719|NCT01786941|Leucine|leucine
272720|NCT01786928|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
272721|NCT01786928|exacerbation|exacerbation
272722|NCT01786928|resistance training|resistance training
272723|NCT01786928|muscle force|muscle force
272724|NCT01786902|growth hormone|growth hormone
272726|NCT01786876|Radiolabelled|radiolabelled
272727|NCT01786850|Locally advanced Pancreatic Cancer|locally advanced pancreatic cancer
272728|NCT01786850|Noninvasive treatment|noninvasive treatment
272729|NCT01786850|High Intensity focused ultrasound|high intensity focused ultrasound
272730|NCT01786850|Magnetic Resonance|magnetic resonance
272731|NCT01786837|constipation|constipation
272732|NCT01786837|gastric emptying|gastric emptying
697052|NCT00954954|Replacement|replacement
272733|NCT01786824|contrast induced nephropathy|contrast induced nephropathy
272734|NCT01786824|hydration strategy|hydration strategy
272735|NCT01786824|L-carnitine|l-carnitine
272736|NCT01786798|Transvaginal sonography|transvaginal sonography
272737|NCT01786798|Endometrial thickness|endometrial thickness
272738|NCT01786798|Endometrial pattern|endometrial pattern
272739|NCT01786798|Abnormal uterine bleeding|abnormal uterine bleeding
272740|NCT01786798|Endometrial hyperplasia|endometrial hyperplasia
272741|NCT01786798|Endometrial cancer|endometrial cancer
272742|NCT01786772|arthroscopic partial meniscectomy|arthroscopic partial meniscectomy
272743|NCT01786772|meniscus|meniscus
272744|NCT01786772|quadriceps strength|quadriceps strength
272745|NCT01786772|quadriceps voluntary activation|quadriceps voluntary activation
272746|NCT01786772|cryotherapy|cryotherapy
272747|NCT01786772|compression|compression
272748|NCT01786772|vasopneumatic compression|vasopneumatic compression
272749|NCT01786772|intermittent pneumatic compression|intermittent pneumatic compression
272750|NCT01786759|lipids|lipids
272751|NCT01786759|preterm infants|preterm infants
273444|NCT01783561|caffeine|caffeine
272752|NCT01786759|parenteral nutrition|parenteral nutrition
272753|NCT01786759|liver function|liver function
272754|NCT01786746|depression|depression
272755|NCT01786746|cognitive behavioral therapy|cognitive behavioral therapy
272756|NCT01786746|culture|culture
272757|NCT01786746|Chinese Americans|chinese americans
272758|NCT01786746|psychotherapy|psychotherapy
272759|NCT01786733|Acute Inpatient Psychiatry|acute inpatient psychiatry
272760|NCT01786733|Continuity of Care|continuity of care
272761|NCT01786733|Behavioral Activation|behavioral activation
272762|NCT01786733|Depression|depression
272763|NCT01786720|COPD|copd
272764|NCT01786720|Triple Therapy|triple therapy
272765|NCT01786720|ICS|ics
272766|NCT01786720|LABA|laba
272767|NCT01786720|LAMA|lama
337008|NCT01504009|ALS|als
272768|NCT01786707|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
272769|NCT01786707|Hyperbaric oxygen therapy (HOT)|hyperbaric oxygen therapy (hot)
272770|NCT01786707|Autologous Bone Marrow-Derived Buffy Coat|autologous bone marrow-derived buffy coat
272771|NCT01786707|Stem cells (SC)|stem cells (sc)
272772|NCT01786694|rectum|rectum
272773|NCT01786694|microdialysis|microdialysis
272774|NCT01786694|quality of life|quality of life
272775|NCT01786681|Morbid obesity|morbid obesity
272776|NCT01786681|Bariatric Surgery|bariatric surgery
272777|NCT01786681|Pulmonary Atelectasis|pulmonary atelectasis
272778|NCT01786681|Spirometry|spirometry
272779|NCT01786681|Continuous Positive Airway Pressure|continuous positive airway pressure
272780|NCT01786681|Physical Therapy Specialty|physical therapy specialty
272781|NCT01786668|Ankylosing Spondylitis|ankylosing spondylitis
272782|NCT01786668|Spondylitis|spondylitis
272783|NCT01786668|Ankylosing|ankylosing
272784|NCT01786668|Spondyloarthritis|spondyloarthritis
272785|NCT01786668|Spondyloarthropathy|spondyloarthropathy
272786|NCT01786668|Oral preparation|oral preparation
272787|NCT01786655|local anesthetic|local anesthetic
272788|NCT01786655|neosaxitoxin|neosaxitoxin
272789|NCT01786655|neoSTX|neostx
272790|NCT01786655|bupivacaine|bupivacaine
272791|NCT01786655|safety|safety
272792|NCT01786655|phase 1|phase 1
272793|NCT01786655|pharmacokinetic|pharmacokinetic
272794|NCT01786577|Neuroimaging Biomarkers|neuroimaging biomarkers
272795|NCT01786577|Cognitive Decline in Elderly|cognitive decline in elderly
272796|NCT01786577|Memory, Thinking problems for Older Adults|memory, thinking problems for older adults
272797|NCT01786577|Executive Decline|executive decline
272798|NCT01786577|Post-operative cognitive change|post-operative cognitive change
272799|NCT01786564|diabetes|diabetes
272800|NCT01786564|sleep|sleep
272801|NCT01786525|Live Donor Kidney Transplantation|live donor kidney transplantation
272802|NCT01786525|LDKT|ldkt
272803|NCT01786525|African American|african american
272804|NCT01786525|Disparity|disparity
272805|NCT01786525|Education|education
272806|NCT01786525|Patient Support|patient support
272807|NCT01786512|Pharmacokinetics|pharmacokinetics
272808|NCT01786512|Omecamtiv mecarbil|omecamtiv mecarbil
272809|NCT01786512|AMG 423|amg 423
272810|NCT01786512|Double-blind|double-blind
272811|NCT01786512|Randomized|randomized
272812|NCT01786512|Placebo-controlled|placebo-controlled
272813|NCT01786512|Oral forumlation|oral forumlation
272814|NCT01786512|CK-1827452|ck-1827452
272815|NCT01786512|Cardiac myosin activator|cardiac myosin activator
272816|NCT01786499|Burnout|burnout
272817|NCT01786499|Stress|stress
272818|NCT01786499|Provider|provider
272819|NCT01786499|Relaxation Response|relaxation response
272820|NCT01786434|colonoscopy|colonoscopy
272822|NCT01786421|Ethanol|ethanol
272823|NCT01786421|Lipemia|lipemia
272824|NCT01786421|Postprandial|postprandial
272825|NCT01786421|Triglyceride|triglyceride
272826|NCT01786395|UF-021|uf-021
272827|NCT01786395|unoprostone|unoprostone
272828|NCT01786395|rp|rp
272829|NCT01786369|Schizophrenia|schizophrenia
272830|NCT01786369|Psychotic Disorders|psychotic disorders
272831|NCT01786369|Bipolar Disorder|bipolar disorder
272832|NCT01786369|Antipsychotic Agents|antipsychotic agents
272833|NCT01786369|Drug Monitoring|drug monitoring
272834|NCT01786356|posterior capsule opacification|posterior capsule opacification
272836|NCT01786356|after cataract|after cataract
272837|NCT01786356|intraocular lens|intraocular lens
272838|NCT01786343|Leukemia|leukemia
272839|NCT01786343|Acute myeloid leukemia|acute myeloid leukemia
272840|NCT01786343|AML|aml
272841|NCT01786343|Response rates|response rates
272842|NCT01786343|Decitabine|decitabine
272843|NCT01786343|Dacogen|dacogen
272844|NCT01786317|Fecal incontinence, ano-rectal manometry|fecal incontinence, ano-rectal manometry
272845|NCT01786304|Fecal incontinence, sacral nerve stimulation|fecal incontinence, sacral nerve stimulation
272846|NCT01786291|obstructive sleep apnea|obstructive sleep apnea
272847|NCT01786291|continuous positive airway pressure|continuous positive airway pressure
272848|NCT01786291|cardiopulmonary exercise test|cardiopulmonary exercise test
272849|NCT01786291|VE/VCO2|ve/vco2
272850|NCT01786278|adenocarcinoma|adenocarcinoma
272851|NCT01786278|esophago-gastric junction|esophago-gastric junction
272852|NCT01786278|dysphagia|dysphagia
272853|NCT01786278|brachytherapy|brachytherapy
272854|NCT01786278|endoscopic stenting|endoscopic stenting
272855|NCT01786265|Prostate Cancer|prostate cancer
272856|NCT01786265|PSA Progression After Prostatectomy and/or Radiotherapy|psa progression after prostatectomy and/or radiotherapy
272857|NCT01786265|Prostate specific antigen|prostate specific antigen
272858|NCT01786265|PSA|psa
272859|NCT01786265|Luteinizing-hormone-releasing hormone|luteinizing-hormone-releasing hormone
272860|NCT01786265|LHRH|lhrh
272861|NCT01786265|Finite maximal androgen ablation|finite maximal androgen ablation
272862|NCT01786265|Lupron|lupron
272863|NCT01786265|Leuprolide Acetate|leuprolide acetate
272864|NCT01786265|Lupron Depot|lupron depot
272865|NCT01786265|Zoladex|zoladex
272866|NCT01786265|Goserelin|goserelin
272867|NCT01786265|Degarelix|degarelix
272868|NCT01786265|Abiraterone Acetate|abiraterone acetate
272869|NCT01786265|Zytiga|zytiga
272870|NCT01786265|Prednisone|prednisone
272871|NCT01786252|embryo|embryo
272872|NCT01786252|implantation|implantation
272873|NCT01786252|blastocyst|blastocyst
272874|NCT01786252|in vitro fertilization|in vitro fertilization
272875|NCT01786252|human chorionic gonadotropin|human chorionic gonadotropin
272876|NCT01786239|Adolescence|adolescence
272877|NCT01786239|Adult|adult
272878|NCT01786239|Antipsychotic Agents|antipsychotic agents
272879|NCT01786239|Female|female
272880|NCT01786239|Human|human
272881|NCT01786239|Male|male
272882|NCT01786239|Risperidone|risperidone
272883|NCT01786239|Omega-3|omega-3
272884|NCT01786239|Schizophrenia|schizophrenia
272885|NCT01786239|Schizophreniform|schizophreniform
272886|NCT01786239|Schizoaffective|schizoaffective
272887|NCT01786239|Schizophrenia -- *drug therapy|schizophrenia -- *drug therapy
272888|NCT01786226|leiomyoma, fibroid, mifepristone, antiprogestins|leiomyoma, fibroid, mifepristone, antiprogestins
272889|NCT01786213|adenoma detection rate, colonoscopy, trainee, learning curve|adenoma detection rate, colonoscopy, trainee, learning curve
272890|NCT01786200|colon|colon
272891|NCT01786200|cancer|cancer
272892|NCT01786200|NSAID|nsaid
272893|NCT01786200|inflammation|inflammation
272894|NCT01786187|Lung Cancer|lung cancer
272895|NCT01786187|Symptoms|symptoms
272896|NCT01786174|ALS|als
272897|NCT01786174|Gilenya|gilenya
272898|NCT01786174|Fingolimod|fingolimod
272899|NCT01786148|HIV/AIDS|hiv/aids
272900|NCT01786148|Adherence|adherence
272901|NCT01786148|Self-management|self-management
272902|NCT01786148|Antiretroviral therapy|antiretroviral therapy
272903|NCT01786135|Antibodies, Monoclonal|antibodies, monoclonal
272904|NCT01786135|Antibody-Drug Conjugate|antibody-drug conjugate
272905|NCT01786135|Antigens, CD19|antigens, cd19
272906|NCT01786135|B-Lineage Lymphoblastic Lymphoma|b-lineage lymphoblastic lymphoma
272907|NCT01786135|Burkitt Lymphoma|burkitt lymphoma
272908|NCT01786135|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
272909|NCT01786135|Mantle Cell Lymphoma|mantle cell lymphoma
272910|NCT01786135|B-Cell Lymphoma|b-cell lymphoma
272911|NCT01786135|Drug Therapy|drug therapy
272912|NCT01786135|Monomethylauristatin F|monomethylauristatin f
272913|NCT01786135|Follicular Lymphoma Grade 3|follicular lymphoma grade 3
272914|NCT01786122|physical exercise|physical exercise
272915|NCT01786122|Health Related Quality of Life|health related quality of life
272916|NCT01786122|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
272917|NCT01786122|digestive system neoplasms|digestive system neoplasms
272918|NCT01786122|breast neoplasms|breast neoplasms
272919|NCT01786109|anandamide|anandamide
272921|NCT01786109|fatty acid amide hydrolase|fatty acid amide hydrolase
272922|NCT01786109|gastric|gastric
272923|NCT01786109|motility|motility
272924|NCT01786109|small bowel|small bowel
272925|NCT01786109|sensory|sensory
272926|NCT01786109|motor|motor
272927|NCT01786096|Burkitt Lymphoma|burkitt lymphoma
272928|NCT01786096|Antibodies, Monoclonal|antibodies, monoclonal
272929|NCT01786096|Antibody-Drug Conjugate|antibody-drug conjugate
272930|NCT01786096|B-Lineage Acute Lymphoblastic Leukemia|b-lineage acute lymphoblastic leukemia
272931|NCT01786096|B-Lineage Lymphoblastic Lymphoma|b-lineage lymphoblastic lymphoma
272932|NCT01786096|Burkitt Leukemia|burkitt leukemia
272933|NCT01786096|Monomethylauristatin F|monomethylauristatin f
272934|NCT01786096|Antigens, CD19|antigens, cd19
272935|NCT01786096|Drug Therapy|drug therapy
272936|NCT01786083|family caregivers|family caregivers
272937|NCT01786083|dependency|dependency
272938|NCT01786083|Problem Solving Technique|problem solving technique
272939|NCT01786083|home based nursing|home based nursing
272940|NCT01786044|patient education|patient education
272941|NCT01786044|primary health care|primary health care
272942|NCT01786018|Non Hodgkin lymphomas|non hodgkin lymphomas
272943|NCT01786018|Allogeneic Transplantation|allogeneic transplantation
272944|NCT01786018|Thiotepa|thiotepa
272945|NCT01786018|Busulfan|busulfan
272946|NCT01786018|Fludarabin|fludarabin
272947|NCT01785992|Oestrogen receptor|oestrogen receptor
272948|NCT01785992|Locally advanced|locally advanced
272949|NCT01785992|Metastatic|metastatic
272950|NCT01785992|Breast cancer|breast cancer
272951|NCT01785992|Sulfatase inhibitor|sulfatase inhibitor
272952|NCT01785966|Critical care|critical care
272953|NCT01785966|quality improvement|quality improvement
272954|NCT01785966|checklist|checklist
272955|NCT01785940|Interscalene Block|interscalene block
272956|NCT01785940|Perineural catheter|perineural catheter
272957|NCT01785940|Ropivacaine|ropivacaine
272958|NCT01785940|Postoperative pain|postoperative pain
272959|NCT01785940|Home regional|home regional
272960|NCT01785927|Antituberculosis|antituberculosis
272961|NCT01785927|Dry powder aerosols|dry powder aerosols
272962|NCT01785927|Inhalation|inhalation
272964|NCT01785901|control rate|control rate
272965|NCT01785901|budesonide/formoterol|budesonide/formoterol
272966|NCT01785901|Non-Interventional study|non-interventional study
272967|NCT01785888|EGFR,|egfr,
272968|NCT01785888|aNSCLC,|ansclc,
272969|NCT01785888|mutation status,|mutation status,
272970|NCT01785888|diagnostic study,|diagnostic study,
272971|NCT01785888|Europe,|europe,
272972|NCT01785888|Japan|japan
272973|NCT01785875|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
272974|NCT01785862|sore throat pain|sore throat pain
272975|NCT01785862|tonsillopharyngitis|tonsillopharyngitis
272976|NCT01785862|upper respiratory tract infection|upper respiratory tract infection
272977|NCT01785849|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
272978|NCT01785823|analgesia|analgesia
272979|NCT01785823|fentanyl|fentanyl
272980|NCT01785823|total intravenous anesthesia|total intravenous anesthesia
272981|NCT01785758|complications, renal;|complications, renal;
272982|NCT01785758|kidney, failure;|kidney, failure;
272983|NCT01785758|neuromuscular block, antagonism;|neuromuscular block, antagonism;
272984|NCT01785758|neuromuscular block, rocuronium;|neuromuscular block, rocuronium;
272985|NCT01785758|safety, drug|safety, drug
272986|NCT01785758|sugammadex|sugammadex
272987|NCT01785745|conservative treatment|conservative treatment
272988|NCT01785745|shoulder|shoulder
272989|NCT01785745|neurocognitive therapeutic exercise|neurocognitive therapeutic exercise
272990|NCT01785745|traditional therapeutic exercise|traditional therapeutic exercise
272991|NCT01785745|pain|pain
272992|NCT01785719|Weight Loss|weight loss
272993|NCT01785719|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
272994|NCT01785719|Ovarian Follicle Development|ovarian follicle development
272995|NCT01785719|Metabolism|metabolism
272996|NCT01785693|Nerve block|nerve block
272997|NCT01785693|Femoropopliteal bypass|femoropopliteal bypass
272998|NCT01785693|Postoperative analgesia|postoperative analgesia
272999|NCT01785693|Peripheral circulation|peripheral circulation
273000|NCT01785693|Levobupivacaine|levobupivacaine
273001|NCT01785693|Clonidine|clonidine
273002|NCT01785693|Pain|pain
273003|NCT01785680|MAM|mam
273004|NCT01785680|SAM|sam
273005|NCT01785654|Reventilation collapse|reventilation collapse
273006|NCT01785654|Rate of reventilation collapse|rate of reventilation collapse
273007|NCT01785654|Risk factor of reventilation collapse|risk factor of reventilation collapse
273008|NCT01785654|Hemodynamic profile of reventilation collapse|hemodynamic profile of reventilation collapse
273009|NCT01785654|Biologic approach of reventilation collapse|biologic approach of reventilation collapse
272725|NCT01786876|AME|ame
273010|NCT01785641|peritoneal dialysis|peritoneal dialysis
273011|NCT01785641|peritonitis|peritonitis
273012|NCT01785628|Parkinson's disease|parkinson's disease
273013|NCT01785628|dementia|dementia
273014|NCT01785628|NMDA|nmda
273015|NCT01785628|event related potential|event related potential
273016|NCT01785628|Bereitschaftspotential|bereitschaftspotential
273017|NCT01785615|metabolic syndrome|metabolic syndrome
273018|NCT01785615|atorvastatin|atorvastatin
273019|NCT01785615|women|women
273020|NCT01785602|Atopic eczema|atopic eczema
273021|NCT01785602|Skin Diseases|skin diseases
273022|NCT01785589|coronary artery disease|coronary artery disease
273023|NCT01785589|cardiac nuclear medicine|cardiac nuclear medicine
273024|NCT01785589|myocardial perfusion imaging|myocardial perfusion imaging
273025|NCT01785589|invasive coronary angiography|invasive coronary angiography
273026|NCT01785576|couples|couples
273027|NCT01785576|head and neck cancer|head and neck cancer
273028|NCT01785576|oncology|oncology
273029|NCT01785576|spousal support|spousal support
273030|NCT01785563|NAVA|nava
273031|NCT01785563|NIV-NAVA|niv-nava
273032|NCT01785563|VLBW|vlbw
273033|NCT01785563|electrical activity of the diaphragm|electrical activity of the diaphragm
273034|NCT01785563|neural trigger, mechanical ventilation|neural trigger, mechanical ventilation
273035|NCT01785563|respiratory distress syndrome|respiratory distress syndrome
273036|NCT01785537|e-cigarette smoking|e-cigarette smoking
273037|NCT01785537|cigarette smoking|cigarette smoking
273038|NCT01785537|cardiovascular disease|cardiovascular disease
273039|NCT01785537|hospitalization|hospitalization
273040|NCT01785537|chronic obstructive pulmonary diseases|chronic obstructive pulmonary diseases
273041|NCT01785537|observational study|observational study
273042|NCT01785537|efficacy|efficacy
273043|NCT01785537|safety|safety
273044|NCT01785524|Cardiovascular Diseases|cardiovascular diseases
273045|NCT01785524|Vascular Diseases|vascular diseases
273046|NCT01785524|Arterial Occlusive Diseases|arterial occlusive diseases
273047|NCT01785524|Diabetes|diabetes
273048|NCT01785524|Exercise|exercise
273049|NCT01785524|Functional Capacity|functional capacity
273050|NCT01785511|hypertension|hypertension
273051|NCT01785511|UV radiation|uv radiation
273052|NCT01785511|coronary flow reserve|coronary flow reserve
273053|NCT01785511|nitric oxide|nitric oxide
273054|NCT01785498|children|children
263694|NCT01828034|MEK162|mek162
273055|NCT01785498|quality of life|quality of life
273056|NCT01785498|physical activity|physical activity
273057|NCT01785498|healthy lifestyle|healthy lifestyle
273058|NCT01785485|Integrative medicine|integrative medicine
273059|NCT01785485|primary care|primary care
273060|NCT01785485|cost-effectiveness|cost-effectiveness
273061|NCT01785472|Essential hypertension|essential hypertension
273062|NCT01785472|LCZ696|lcz696
273063|NCT01785459|headache|headache
273064|NCT01785459|migraine|migraine
273065|NCT01785459|bupivacaine|bupivacaine
273066|NCT01785446|Dexmedetomidine|dexmedetomidine
273067|NCT01785446|Cisatracurion infusion|cisatracurion infusion
273068|NCT01785446|Sufentanil|sufentanil
273069|NCT01785446|Recovery Index|recovery index
273070|NCT01785446|Closed loop computer control system|closed loop computer control system
273071|NCT01785433|COPD, pharmacokinetics, tiotropium|copd, pharmacokinetics, tiotropium
273072|NCT01785420|Pre-operative Trastuzumab Protocol|pre-operative trastuzumab protocol
273073|NCT01785407|Iron bio availability|iron bio availability
273074|NCT01785407|Hepcidin|hepcidin
273075|NCT01785407|Iron absorption|iron absorption
273076|NCT01785394|pollinosis|pollinosis
273077|NCT01785394|sublingual immunotherapy|sublingual immunotherapy
273078|NCT01785394|exhaled breath temperature|exhaled breath temperature
273079|NCT01785381|Osteoporosis, hip fracture, fractures, Bone density|osteoporosis, hip fracture, fractures, bone density
273080|NCT01785368|guidelines|guidelines
273081|NCT01785368|referral guidelines|referral guidelines
273082|NCT01785368|exam delays|exam delays
273083|NCT01785368|exam relevance|exam relevance
273084|NCT01785355|periodontal disease|periodontal disease
273085|NCT01785355|CKD|ckd
273086|NCT01785355|nutrition|nutrition
273087|NCT01785355|inflammation|inflammation
273088|NCT01785355|anemia response to ESA|anemia response to esa
273089|NCT01785355|quality of life|quality of life
273090|NCT01785355|hemodialysis|hemodialysis
273091|NCT01785316|Perfusion Cancer Chemotherapy, Regional|perfusion cancer chemotherapy, regional
273092|NCT01785303|CBT|cbt
273093|NCT01785303|CPAP|cpap
273094|NCT01785303|Multidisciplinary Treatment|multidisciplinary treatment
273095|NCT01785303|Combination treatment|combination treatment
273096|NCT01785290|Delirium|delirium
273097|NCT01785290|Survival|survival
273098|NCT01785290|Side-effects|side-effects
273099|NCT01785290|QoL|qol
273100|NCT01785277|Spinal Cord Independence Measure|spinal cord independence measure
273101|NCT01785277|SCIM|scim
273102|NCT01785277|Spinal cord injury|spinal cord injury
273103|NCT01785277|Traumatic spine injury|traumatic spine injury
273104|NCT01785264|Achilles|achilles
273105|NCT01785264|Tendon|tendon
273106|NCT01785264|Rupture|rupture
273107|NCT01785264|Acute|acute
273108|NCT01785264|Treatment|treatment
273109|NCT01785264|Outcome measure|outcome measure
273110|NCT01785251|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
273111|NCT01785251|NMES|nmes
273814|NCT01781988|lung cancer|lung cancer
273112|NCT01785251|Deep vein thrombosis|deep vein thrombosis
273113|NCT01785251|DVT|dvt
273114|NCT01785251|total hip arthroplasty|total hip arthroplasty
273115|NCT01785251|lower limb hemodynamics|lower limb hemodynamics
273116|NCT01785238|preterm infants|preterm infants
273117|NCT01785238|acute renal failure|acute renal failure
273118|NCT01785238|nephronic reduction|nephronic reduction
273119|NCT01785199|apnea-hypopnea index|apnea-hypopnea index
273120|NCT01785199|obstructive sleep apnea|obstructive sleep apnea
273121|NCT01785199|body posture|body posture
273122|NCT01785199|ultra-wideband|ultra-wideband
273123|NCT01785186|TB|tb
273124|NCT01785186|Tuberculosis|tuberculosis
273125|NCT01785186|MAMS - Multiple-arm, multiple-stage|mams - multiple-arm, multiple-stage
273126|NCT01785186|Pulmonary|pulmonary
273127|NCT01785186|SQ109|sq109
273128|NCT01785186|High dose rifampicin|high dose rifampicin
273129|NCT01785186|moxifloxacin|moxifloxacin
273130|NCT01785173|Endoscopes|endoscopes
273131|NCT01785173|Esophago-gastro-duodenoscopy|esophago-gastro-duodenoscopy
273132|NCT01785173|Transnasal endoscopy|transnasal endoscopy
273133|NCT01785173|Nasal anesthesia|nasal anesthesia
273134|NCT01785147|Tobacco addition|tobacco addition
273135|NCT01785134|Obesity|obesity
273136|NCT01785134|Bariatric Surgery|bariatric surgery
273137|NCT01785134|Insulin Sensitivity|insulin sensitivity
273138|NCT01785108|Diamyd|diamyd
273139|NCT01785108|Diabetes|diabetes
273140|NCT01785108|Juvenile Diabetes|juvenile diabetes
273141|NCT01785108|Diabetes type 1|diabetes type 1
273142|NCT01785108|Autoimmune Diabetes|autoimmune diabetes
273143|NCT01785108|Insulin dependent Diabetes|insulin dependent diabetes
273144|NCT01785108|Type 1 diabetes|type 1 diabetes
273145|NCT01785108|Type 1 diabetes mellitus|type 1 diabetes mellitus
273146|NCT01785108|rhGAD65|rhgad65
273147|NCT01785108|GAD|gad
273148|NCT01785108|GAD65|gad65
273149|NCT01785108|GAD-alum|gad-alum
273150|NCT01785108|Diabetes Mellitus|diabetes mellitus
273151|NCT01785108|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
337547|NCT01501734|CHF|chf
273152|NCT01785108|Glucose Metabolism Disorders|glucose metabolism disorders
273153|NCT01785108|Metabolic Diseases|metabolic diseases
273154|NCT01785108|Vitamin D|vitamin d
273155|NCT01785108|Ibuprofen|ibuprofen
273156|NCT01785082|13-C-Methacetin|13-c-methacetin
273157|NCT01785082|partial liver resection|partial liver resection
273158|NCT01785082|liver function tests|liver function tests
273159|NCT01785056|Systemic Sclerosis|systemic sclerosis
273160|NCT01785056|Diffuse Scleroderma|diffuse scleroderma
273161|NCT01785056|SSc|ssc
273162|NCT01785043|DIABETES Mellitus Type 2|diabetes mellitus type 2
273163|NCT01785043|Difficult control|difficult control
273164|NCT01785017|critical|critical
273165|NCT01785017|asthma|asthma
273166|NCT01785017|children|children
273167|NCT01785004|Adiposity|adiposity
273168|NCT01785004|Body composition|body composition
273169|NCT01785004|Vitamin D|vitamin d
273170|NCT01785004|Adipokines|adipokines
273171|NCT01785004|Omega-3 fatty acid|omega-3 fatty acid
273172|NCT01784991|Pain|pain
273173|NCT01784991|Opioids|opioids
273174|NCT01784991|Hydromorphone|hydromorphone
273175|NCT01784991|regimen|regimen
273176|NCT01784978|cancer|cancer
273177|NCT01784978|renal|renal
273178|NCT01784978|metastatic|metastatic
273179|NCT01784978|clear|clear
273180|NCT01784978|cell|cell
273181|NCT01784978|Sunitinib|sunitinib
273182|NCT01784978|Everolimus|everolimus
273183|NCT01784978|Alternating|alternating
273184|NCT01784939|hereditary hemochromatosis C282Y homozygous|hereditary hemochromatosis c282y homozygous
273185|NCT01784939|Iron Reabsorption Index (IRI)|iron reabsorption index (iri)
273186|NCT01784939|Hepcidin / ferritin (H / F) ratio|hepcidin / ferritin (h / f) ratio
273187|NCT01784926|cataract surgery|cataract surgery
273188|NCT01784926|scleral suturing|scleral suturing
273189|NCT01784926|Verisyse|verisyse
273190|NCT01784926|Late in-the-bag IOL dislocation|late in-the-bag iol dislocation
273191|NCT01784913|Prostate|prostate
273193|NCT01784913|vaccine|vaccine
273194|NCT01784874|Rabies|rabies
273195|NCT01784874|Human Diploid Cell Vaccine|human diploid cell vaccine
273196|NCT01784874|Imovax® Rabies|imovax® rabies
273197|NCT01784848|high blood pressure|high blood pressure
273198|NCT01784848|hypertension|hypertension
273199|NCT01784848|bariatric surgery|bariatric surgery
273200|NCT01784848|Laparoscopic Roux-en-Y gastric bypass (LRYGB)|laparoscopic roux-en-y gastric bypass (lrygb)
273201|NCT01784848|obesity|obesity
273202|NCT01784835|Osteopathic manipulative treatment|osteopathic manipulative treatment
273203|NCT01784835|neonatology|neonatology
273204|NCT01784835|neonatal care|neonatal care
273205|NCT01784835|prematurity|prematurity
273206|NCT01784835|complementary and alternative medicine|complementary and alternative medicine
273207|NCT01784835|length of stay|length of stay
273208|NCT01784822|Ventral hernia|ventral hernia
273209|NCT01784822|Graft repair|graft repair
273210|NCT01784809|HIV|hiv
273211|NCT01784809|STIs|stis
273212|NCT01784809|Condom Use|condom use
273213|NCT01784809|Criminal Justice|criminal justice
273214|NCT01784809|Drug Use|drug use
273215|NCT01784796|cardiovascular disease|cardiovascular disease
273216|NCT01784796|women's health|women's health
273217|NCT01784796|psychological stress|psychological stress
273218|NCT01784796|Veterans|veterans
273219|NCT01784796|stroke|stroke
273220|NCT01784783|HIV transmission|hiv transmission
273221|NCT01784783|PMTCT|pmtct
273222|NCT01784783|Discordancy|discordancy
273223|NCT01784783|Home-based testing|home-based testing
273224|NCT01784783|Couple counseling|couple counseling
273225|NCT01784783|Couple testing|couple testing
273226|NCT01784783|Facility delivery|facility delivery
273227|NCT01784783|Exclusive breastfeeding|exclusive breastfeeding
273228|NCT01784783|Family planning|family planning
273229|NCT01784783|Postpartum contraceptives|postpartum contraceptives
273230|NCT01784783|Linkage to care|linkage to care
273231|NCT01784783|ART initiation|art initiation
273232|NCT01784770|Legionnaires' disease|legionnaires' disease
273233|NCT01784770|Legionella pneumophila|legionella pneumophila
273234|NCT01784770|Zithromax|zithromax
273235|NCT01784770|Zithromac|zithromac
273236|NCT01784770|Japanese|japanese
273237|NCT01784770|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
273238|NCT01784744|Autism|autism
273240|NCT01784744|Aspergers|aspergers
273241|NCT01784744|Autism Spectrum Disorder|autism spectrum disorder
273242|NCT01784692|Immulina|immulina
273243|NCT01784692|Elderly|elderly
273244|NCT01784692|Immune|immune
273245|NCT01784679|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
273246|NCT01784679|GNE Myopathy|gne myopathy
273247|NCT01784679|Nonaka Disease|nonaka disease
273248|NCT01784679|Quadriceps Sparing Myopathy|quadriceps sparing myopathy
273249|NCT01784679|distal myopathy with rimmed vacuoles|distal myopathy with rimmed vacuoles
273250|NCT01784679|ultragenyx|ultragenyx
273251|NCT01784679|rare disease|rare disease
273252|NCT01784666|Bipolar Disorder|bipolar disorder
273253|NCT01784666|Depression|depression
337622|NCT01501435|Safety|safety
273254|NCT01784666|Lithium|lithium
273255|NCT01784666|Valproate|valproate
273256|NCT01784666|Isradipine|isradipine
273257|NCT01784653|Substance abuse|substance abuse
273258|NCT01784653|Drug abuse|drug abuse
273259|NCT01784653|Alcohol abuse|alcohol abuse
273260|NCT01784653|Tobacco|tobacco
273261|NCT01784653|Adolescent|adolescent
273262|NCT01784627|substance use|substance use
273263|NCT01784627|alcohol abuse|alcohol abuse
273264|NCT01784627|cannabis abuse|cannabis abuse
273265|NCT01784627|nicotine dependence|nicotine dependence
273266|NCT01784627|adolescents|adolescents
273267|NCT01784601|Interscalene block|interscalene block
273268|NCT01784601|Hemidiaphragm palsy|hemidiaphragm palsy
273269|NCT01784575|Quality of care|quality of care
273270|NCT01784575|Pediatric|pediatric
273271|NCT01784575|Pregnancy|pregnancy
273272|NCT01784575|Low-income|low-income
273273|NCT01784575|Low literacy|low literacy
273274|NCT01784562|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
273275|NCT01784549|NSCL|nscl
273276|NCT01784549|biomarkers|biomarkers
273277|NCT01784549|Customized Neoadjuvant Therapy|customized neoadjuvant therapy
273278|NCT01784523|antiphospholipid autoantibodies|antiphospholipid autoantibodies
273279|NCT01784523|antiphospholipid positive|antiphospholipid positive
273280|NCT01784497|Health Related Quality of Life (HRQL)|health related quality of life (hrql)
273281|NCT01784497|Living Donor Liver Transplantation(LDLT)|living donor liver transplantation(ldlt)
273282|NCT01784471|Foot Symptoms|foot symptoms
273283|NCT01784471|Diabetes|diabetes
273284|NCT01784471|Peripheral Vascular Disease|peripheral vascular disease
273285|NCT01784471|Magic Foot shoe|magic foot shoe
273286|NCT01784458|severe sepsis|severe sepsis
273287|NCT01784458|intra-abdominal hypertension|intra-abdominal hypertension
273288|NCT01784458|intra-abdominal pressure|intra-abdominal pressure
273289|NCT01784445|Endoscopic Retrograde Cholangiopancreatography,|endoscopic retrograde cholangiopancreatography,
273290|NCT01784432|low-level laser therapy|low-level laser therapy
273291|NCT01784432|muscle performance|muscle performance
273292|NCT01784432|strength training|strength training
273293|NCT01784432|gene expression|gene expression
273294|NCT01784432|microarrays|microarrays
273295|NCT01784419|Cystic fibrosis|cystic fibrosis
273296|NCT01784419|Ivacaftor|ivacaftor
273297|NCT01784419|Genotype|genotype
273298|NCT01784419|Phenotype|phenotype
273299|NCT01784419|Sweat chloride|sweat chloride
273300|NCT01784419|Pancreatic sufficient|pancreatic sufficient
273301|NCT01784406|Self-management intervention|self-management intervention
273302|NCT01784406|Psychosocial care|psychosocial care
273303|NCT01784406|Autonomy-supportive|autonomy-supportive
273304|NCT01784406|Gynaecological cancer survivors|gynaecological cancer survivors
273305|NCT01784406|Guided self-Determination|guided self-determination
273306|NCT01784367|Hypercapnia|hypercapnia
273307|NCT01784367|noninvasive ventilation|noninvasive ventilation
273308|NCT01784367|acute respiratory failure|acute respiratory failure
273309|NCT01784367|endotracheal intubation|endotracheal intubation
273310|NCT01784367|invasive mechanical ventilation|invasive mechanical ventilation
751921|NCT01171235|Laryngeal Neoplasms|laryngeal neoplasms
273311|NCT01784341|Bipolar, Circadian, Melatonin|bipolar, circadian, melatonin
273312|NCT01784328|Peristeen Bowel Irrigation System|peristeen bowel irrigation system
273815|NCT01781988|gemcitabine|gemcitabine
273313|NCT01784328|Cauda Equina Syndrome|cauda equina syndrome
273314|NCT01784328|Lower Motor Neuron Neurogenic Bowel|lower motor neuron neurogenic bowel
273315|NCT01784315|The presence of parasites in the blood|the presence of parasites in the blood
273316|NCT01784289|Interleukin 7|interleukin 7
273317|NCT01784289|adipose tissue|adipose tissue
273318|NCT01784276|Children|children
273319|NCT01784276|Autism Spectrum Disorders|autism spectrum disorders
273320|NCT01784276|Electronic Screen Media|electronic screen media
273321|NCT01784276|Dental fear|dental fear
273322|NCT01784263|Intervention|intervention
273324|NCT01784263|Treatment sensitivity|treatment sensitivity
273325|NCT01784263|School aged|school aged
273326|NCT01784263|Cognitive behavioral therapy|cognitive behavioral therapy
273327|NCT01784250|Clonidine|clonidine
273328|NCT01784250|Propranolol|propranolol
273329|NCT01784250|Third molar|third molar
273330|NCT01784250|Anxiety|anxiety
273331|NCT01784237|Endoscopes|endoscopes
273332|NCT01784237|Esophago-gastro-duodenoscopy|esophago-gastro-duodenoscopy
273333|NCT01784237|Transnasal endoscopy|transnasal endoscopy
273334|NCT01784237|Anterior meatoscopy|anterior meatoscopy
273335|NCT01784198|pregnancy|pregnancy
273336|NCT01784198|protein requirements|protein requirements
273337|NCT01784198|Indicator Amino acid oxidation|indicator amino acid oxidation
273338|NCT01784198|Stable isotopes|stable isotopes
273339|NCT01784185|EBUS guided transbronchial needle aspiration (EBUS-TBNA)|ebus guided transbronchial needle aspiration (ebus-tbna)
273340|NCT01784185|virtual bronchoscopy (VB)|virtual bronchoscopy (vb)
273445|NCT01783561|intubation|intubation
273341|NCT01784185|VB guided transbronchial needle aspiration VB-TBNA)|vb guided transbronchial needle aspiration vb-tbna)
273342|NCT01784185|mediastinal sampling|mediastinal sampling
273343|NCT01784185|transbronchial needle aspiration (TBNA)|transbronchial needle aspiration (tbna)
273344|NCT01784172|efficacy|efficacy
273345|NCT01784172|safety|safety
273346|NCT01784172|electroacupuncture|electroacupuncture
273347|NCT01784172|simple female stress urinary incontinence|simple female stress urinary incontinence
273348|NCT01784133|rosacea|rosacea
273349|NCT01784120|breast cancer|breast cancer
273350|NCT01784120|doxorubicin|doxorubicin
273351|NCT01784120|genexol-PM|genexol-pm
273352|NCT01784120|paclitaxel|paclitaxel
273353|NCT01784107|SCLC|sclc
273354|NCT01784107|belotecan|belotecan
273355|NCT01784107|Ifosfamide|ifosfamide
273356|NCT01784081|palliative care|palliative care
273357|NCT01784081|decision aid|decision aid
273358|NCT01784068|Ph+ CML-CP|ph+ cml-cp
273359|NCT01784068|chronic phase|chronic phase
273360|NCT01784068|nilotinib treatment|nilotinib treatment
273361|NCT01784068|2 years treatment|2 years treatment
273362|NCT01784068|MR 4.5|mr 4.5
273363|NCT01784068|Loss of MR 4|loss of mr 4
273364|NCT01784068|Loss of MMR|loss of mmr
273365|NCT01784055|NeoChord|neochord
273366|NCT01784055|DS1000|ds1000
273367|NCT01784055|Mitral Valve|mitral valve
273368|NCT01784055|Mitral Valve Regurgitation|mitral valve regurgitation
273370|NCT01784055|Mitral Valve Repair|mitral valve repair
273371|NCT01784055|Mitral Valve Prolapse|mitral valve prolapse
273372|NCT01784055|Artificial Chordae|artificial chordae
273373|NCT01784042|breast cancer|breast cancer
273374|NCT01784042|omega-3 fatty acids|omega-3 fatty acids
273375|NCT01784029|adolescents|adolescents
273376|NCT01784029|minority|minority
273377|NCT01783964|Elacytarabine|elacytarabine
273378|NCT01783964|pharmacokinetic|pharmacokinetic
273379|NCT01783964|Microdose|microdose
273380|NCT01783964|Mass Balance Recovery|mass balance recovery
273381|NCT01783951|Gastric cancer|gastric cancer
273383|NCT01783951|DC-CIK|dc-cik
273384|NCT01783912|Smoking|smoking
273385|NCT01783912|Nicotine Dependence|nicotine dependence
273386|NCT01783912|Mental Disorders|mental disorders
273387|NCT01783886|Diabetic Macular Edema|diabetic macular edema
273388|NCT01783886|DME|dme
273389|NCT01783886|VEGF Trap-Eye|vegf trap-eye
273390|NCT01783886|best-corrected visual acuity (BCVA)|best-corrected visual acuity (bcva)
273391|NCT01783860|Azithromycin|azithromycin
273392|NCT01783860|Doxycycline|doxycycline
273393|NCT01783860|Posterior Blepharitis|posterior blepharitis
273394|NCT01783847|Erythropoietin|erythropoietin
273395|NCT01783847|Traumatic Optic Neuropathy|traumatic optic neuropathy
273396|NCT01783847|Visual function|visual function
273397|NCT01783834|Pemetrexed|pemetrexed
273398|NCT01783834|Gefitinib|gefitinib
273399|NCT01783834|iressa|iressa
273400|NCT01783834|alimta|alimta
273401|NCT01783821|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
273402|NCT01783808|COPD|copd
273403|NCT01783808|Physical capacity|physical capacity
273404|NCT01783808|Physical activity|physical activity
273405|NCT01783808|Inflammatory markers|inflammatory markers
273406|NCT01783808|Health related quality of life|health related quality of life
273407|NCT01783795|Dent|dent
273408|NCT01783795|Dents|dents
273409|NCT01783795|Dent Disease|dent disease
273410|NCT01783795|Dent genetic testing|dent genetic testing
273411|NCT01783795|CLCN5|clcn5
273412|NCT01783795|OCRL1|ocrl1
273413|NCT01783795|Genetic testing for Dent Disease|genetic testing for dent disease
273414|NCT01783795|Hereditary study for Dent Disease|hereditary study for dent disease
273415|NCT01783782|Capsule Endoscopy|capsule endoscopy
273416|NCT01783782|colon cleansing|colon cleansing
273417|NCT01783782|children|children
273418|NCT01783782|age 2 -18 years|age 2 -18 years
273419|NCT01783769|neurosurgery|neurosurgery
273420|NCT01783769|operating room personnel|operating room personnel
273421|NCT01783769|sterile procedures|sterile procedures
273422|NCT01783769|infection|infection
273423|NCT01783769|Conditions requiring surgery|conditions requiring surgery
273424|NCT01783743|Trichiasis|trichiasis
273425|NCT01783743|Trachoma|trachoma
273426|NCT01783743|Mass treatment|mass treatment
273427|NCT01783730|Rheumatoid arthritis|rheumatoid arthritis
273428|NCT01783704|hip fracture|hip fracture
273429|NCT01783704|randomized controlled trial|randomized controlled trial
273430|NCT01783704|exercise|exercise
273431|NCT01783691|Sickle cell disease|sickle cell disease
273432|NCT01783652|Adolescent depression|adolescent depression
273433|NCT01783652|internet intervention|internet intervention
273434|NCT01783639|Carotid|carotid
273435|NCT01783639|Carotid artery stenting|carotid artery stenting
273436|NCT01783639|Stent|stent
273437|NCT01783639|Embolic protection|embolic protection
273438|NCT01783639|Atherosclerotic Disease|atherosclerotic disease
273439|NCT01783600|Peripheral Arterial Disease|peripheral arterial disease
273440|NCT01783600|Infrapopliteal lesions|infrapopliteal lesions
273441|NCT01783600|balloon catheter|balloon catheter
273442|NCT01783574|Depression|depression
273443|NCT01783574|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
337857|NCT01500434|DES|des
273446|NCT01783561|hemodynamic|hemodynamic
273447|NCT01783548|allergic rhinitis|allergic rhinitis
273448|NCT01783548|pediatric subjects|pediatric subjects
273449|NCT01783548|BDP nasal aerosol|bdp nasal aerosol
273450|NCT01783535|intraocular retinoblastoma|intraocular retinoblastoma
273451|NCT01783509|GENETICALLY CONFIRMED limb girdle muscular dystrophy|genetically confirmed limb girdle muscular dystrophy
273452|NCT01783483|CABG|cabg
273453|NCT01783483|Valve replacement|valve replacement
273454|NCT01783483|sternal closure|sternal closure
273455|NCT01783483|midline sternotomy|midline sternotomy
273456|NCT01783483|sternal plates|sternal plates
273457|NCT01783470|adipose tissue, brown|adipose tissue, brown
273458|NCT01783470|obesity|obesity
273459|NCT01783470|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists
273460|NCT01783470|thermogenesis|thermogenesis
273461|NCT01783470|metabolism|metabolism
273462|NCT01783457|First psychotic episode|first psychotic episode
273463|NCT01783457|Individual psychoeducation|individual psychoeducation
273464|NCT01783457|Telemedicine|telemedicine
273465|NCT01783457|BDNF|bdnf
273466|NCT01783457|Oxidative stress|oxidative stress
273467|NCT01783444|Estrogen receptor positive, locally advanced, metastatic breast cancer|estrogen receptor positive, locally advanced, metastatic breast cancer
273468|NCT01783418|mindfulness-based meditation|mindfulness-based meditation
273469|NCT01783418|pediatric cancer|pediatric cancer
273470|NCT01783418|adolescence|adolescence
273471|NCT01783418|quality of life|quality of life
273472|NCT01783418|sleep|sleep
273473|NCT01783418|affect|affect
273474|NCT01783418|health psychology|health psychology
273475|NCT01783405|LDLR mutation|ldlr mutation
273476|NCT01783405|Statin|statin
273477|NCT01783405|Cardiovascular disease|cardiovascular disease
273478|NCT01783392|overactive bladder|overactive bladder
273479|NCT01783392|transcutaneous posterior tibial nerve stimulation|transcutaneous posterior tibial nerve stimulation
273480|NCT01783392|placebo PTNS|placebo ptns
273481|NCT01783379|invasive fungal infection|invasive fungal infection
273482|NCT01783379|micafungin|micafungin
273483|NCT01783379|intensive care|intensive care
273484|NCT01783379|pharmacokinetics|pharmacokinetics
273485|NCT01783366|nasogastric tube, tube exchange catheter|nasogastric tube, tube exchange catheter
273486|NCT01783353|Recalcitrant cutaneous warts|recalcitrant cutaneous warts
273487|NCT01783353|verruca|verruca
273488|NCT01783340|Malaria|malaria
273489|NCT01783340|P falciparum|p falciparum
273490|NCT01783340|Chloroquine|chloroquine
273491|NCT01783340|Azithromycin|azithromycin
273492|NCT01783340|Immunization|immunization
273493|NCT01783327|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
273494|NCT01783327|Self care|self care
273495|NCT01783327|Coping skills|coping skills
273496|NCT01783327|Adolescent|adolescent
273497|NCT01783327|Internet|internet
273498|NCT01783327|Intervention Studies|intervention studies
273499|NCT01783327|Chronic Disease|chronic disease
273500|NCT01783314|hepatic fibrosis|hepatic fibrosis
273501|NCT01783314|Eovist|eovist
273502|NCT01783314|gadoxetate disodium|gadoxetate disodium
273503|NCT01783314|biomarker|biomarker
273504|NCT01783314|liver biopsy|liver biopsy
273505|NCT01783314|liver function|liver function
273506|NCT01783314|MRI|mri
273507|NCT01783314|Hepatitis C|hepatitis c
273508|NCT01783301|follicle stimulating hormone|follicle stimulating hormone
273509|NCT01783301|ovarian stimulation|ovarian stimulation
273510|NCT01783301|antimullerian hormone|antimullerian hormone
273511|NCT01783301|antral follicle count|antral follicle count
273512|NCT01783301|assisted reproductive technologies|assisted reproductive technologies
273513|NCT01783288|Postural tachycardia syndrome|postural tachycardia syndrome
273514|NCT01783288|orthostatic intolerance|orthostatic intolerance
273515|NCT01783288|orthostatic tachycardia|orthostatic tachycardia
273516|NCT01783288|POTS|pots
273517|NCT01783275|Obesity|obesity
273518|NCT01783275|Type 2 diabetes|type 2 diabetes
273519|NCT01783275|Liver|liver
273520|NCT01783236|VATS|vats
273521|NCT01783236|thoracic surgery|thoracic surgery
273522|NCT01783236|acetaminophen|acetaminophen
273523|NCT01783236|ofirmev|ofirmev
273524|NCT01783236|lung surgery|lung surgery
273525|NCT01783236|thoracoscopic|thoracoscopic
273526|NCT01783236|intravenous acetaminophen|intravenous acetaminophen
273527|NCT01783158|head and neck carcinoma|head and neck carcinoma
273528|NCT01783158|chromoendoscopy|chromoendoscopy
273529|NCT01783158|Lugol's solution|lugol's solution
273530|NCT01783158|esophageal carcinoma|esophageal carcinoma
273531|NCT01783158|synchronous tumors|synchronous tumors
273532|NCT01783158|deglutition|deglutition
273533|NCT01783158|deglutition disorders|deglutition disorders
273534|NCT01783158|Newly diagnosed HNSCC|newly diagnosed hnscc
273535|NCT01783145|survivorship care|survivorship care
273536|NCT01783145|testicular cancer|testicular cancer
273537|NCT01783145|shared care model|shared care model
273538|NCT01783119|Ulcerative Colitis|ulcerative colitis
273539|NCT01783119|Aloe Vera|aloe vera
273540|NCT01783106|Crohn's|crohn's
273541|NCT01783106|antibiotics|antibiotics
264199|NCT01825681|FTD|ftd
273542|NCT01783106|hydroxychloroquine|hydroxychloroquine
273543|NCT01783106|ciprofloxacin|ciprofloxacin
273544|NCT01783106|doxycycline|doxycycline
273545|NCT01783080|Chronic depression|chronic depression
273546|NCT01783080|Dysthymic disorder|dysthymic disorder
273547|NCT01783080|Double Depression|double depression
273548|NCT01783080|Behavioral Activation therapy|behavioral activation therapy
273549|NCT01783080|Work impairment|work impairment
273550|NCT01783080|Unemployment|unemployment
273551|NCT01783067|Biofortification|biofortification
273552|NCT01783067|Pearl millet|pearl millet
273553|NCT01783067|Iron absorption|iron absorption
273554|NCT01783067|Zinc absorption|zinc absorption
273555|NCT01783054|NEOADJUVANT GEMCITABINE AND ABRAXANE CHEMOTHERAPY|neoadjuvant gemcitabine and abraxane chemotherapy
273556|NCT01783054|SURGERY|surgery
273557|NCT01783054|RESECTABLE ADENOCARCINOMA OF THE PANCREAS|resectable adenocarcinoma of the pancreas
273558|NCT01783041|Prematurity|prematurity
273559|NCT01783041|Carnitine supplementation|carnitine supplementation
273560|NCT01783041|Neonatal Intensive Care|neonatal intensive care
273562|NCT01783041|Amplitude-integrated EEG|amplitude-integrated eeg
273563|NCT01783041|NICU Network Neurobehavioral Scale|nicu network neurobehavioral scale
273564|NCT01783041|Bayley Scale of Infant Development III|bayley scale of infant development iii
273565|NCT01783028|asthma|asthma
273566|NCT01783015|Rheumatoid arthritis|rheumatoid arthritis
273567|NCT01783015|etanercept|etanercept
273568|NCT01783015|methotrexate|methotrexate
273569|NCT01783015|infliximab|infliximab
273570|NCT01783015|adalimumab|adalimumab
273571|NCT01783015|anti-drug antibody|anti-drug antibody
273572|NCT01782989|geographic atrophy|geographic atrophy
273573|NCT01782989|non-exudative age-related macular degeneration|non-exudative age-related macular degeneration
273574|NCT01782989|macular degeneration|macular degeneration
273575|NCT01782989|dry macular degeneration|dry macular degeneration
273576|NCT01782989|dry AMD|dry amd
273577|NCT01782976|Glioblastoma|glioblastoma
273578|NCT01782976|GBM|gbm
273579|NCT01782976|Intracranial glioblastoma|intracranial glioblastoma
273580|NCT01782976|Recurrent|recurrent
273581|NCT01782976|MD Anderson Symptom Inventory for Brain Tumors|md anderson symptom inventory for brain tumors
273582|NCT01782976|MDASI-BT|mdasi-bt
273583|NCT01782976|Questionnaire|questionnaire
273584|NCT01782976|Survey|survey
273585|NCT01782963|Newly diagnosed|newly diagnosed
273586|NCT01782950|HIV|hiv
273587|NCT01782950|Tuberculosis|tuberculosis
273588|NCT01782950|Antituberculosis drugs|antituberculosis drugs
273589|NCT01782911|Androgen|androgen
273590|NCT01782911|IVF|ivf
273591|NCT01782911|Resveratrol|resveratrol
273592|NCT01782911|PCOS.|pcos.
273593|NCT01782898|Anesthesia|anesthesia
273594|NCT01782898|MEDOC neuro sensory analyzer|medoc neuro sensory analyzer
273595|NCT01782898|Pain|pain
273596|NCT01782898|Quality of recovery|quality of recovery
273597|NCT01782885|Osteoarthritis|osteoarthritis
273598|NCT01782885|Platelet-Rich Plasma|platelet-rich plasma
273599|NCT01782885|Intra-articular|intra-articular
273600|NCT01782885|Injection|injection
273601|NCT01782807|Ovarian function|ovarian function
273602|NCT01782807|Hysterectomy|hysterectomy
273603|NCT01782807|Salpingectomy|salpingectomy
273604|NCT01782807|Anti mullerian hormone|anti mullerian hormone
273605|NCT01782794|Vaccination|vaccination
273606|NCT01782794|Acceptability|acceptability
273607|NCT01782794|General population|general population
273608|NCT01782794|Hepatitis B|hepatitis b
273609|NCT01782794|Vaccine coverage|vaccine coverage
273610|NCT01782781|Analgesia|analgesia
273611|NCT01782781|Local infiltration analgesia|local infiltration analgesia
273612|NCT01782781|Pain, relief|pain, relief
273613|NCT01782781|Pain, Postoperative|pain, postoperative
273614|NCT01782781|Ropivacaine|ropivacaine
273615|NCT01782781|Ketorolac|ketorolac
273616|NCT01782781|Epinephrine|epinephrine
273617|NCT01782781|Adrenergic Agonists|adrenergic agonists
273618|NCT01782781|Sympathomimetics|sympathomimetics
273619|NCT01782781|Therapeutic Uses|therapeutic uses
273620|NCT01782781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
273621|NCT01782781|Analgesics, Non-Narcotic|analgesics, non-narcotic
273622|NCT01782781|Analgesics|analgesics
273623|NCT01782781|Opioids|opioids
273624|NCT01782781|Morphine|morphine
273625|NCT01782781|Pain|pain
273626|NCT01782781|Postoperative Complications|postoperative complications
273627|NCT01782781|Physiological Effects of Drugs|physiological effects of drugs
273628|NCT01782781|Anesthetics, Local|anesthetics, local
273629|NCT01782781|Anesthetics|anesthetics
273630|NCT01782768|Neural respiratory drive in different level of NPPV|neural respiratory drive in different level of nppv
273631|NCT01782755|Probiotics|probiotics
273632|NCT01782755|Ventilator Associated Pneumonia (VAP)|ventilator associated pneumonia (vap)
273633|NCT01782755|Infection|infection
273634|NCT01782755|Antibiotic-Associated Diarrhea|antibiotic-associated diarrhea
273635|NCT01782755|C-Difficile|c-difficile
273636|NCT01782742|Mild to Moderate Alzheimer's Disease|mild to moderate alzheimer's disease
273637|NCT01782729|Dermatitis, Atopic|dermatitis, atopic
273638|NCT01782729|Tacrolimus|tacrolimus
273639|NCT01782716|Mortality|mortality
273640|NCT01782716|Length|length
273641|NCT01782716|hospitalization|hospitalization
273642|NCT01782716|cardiac surgery|cardiac surgery
273643|NCT01782716|patients|patients
273644|NCT01782703|Atopic Dermatitis|atopic dermatitis
273645|NCT01782703|Filaggrin|filaggrin
273646|NCT01782703|Biomarkers|biomarkers
273647|NCT01782703|Eczema|eczema
273648|NCT01782664|PASI|pasi
273649|NCT01782664|DLQI|dlqi
273650|NCT01782664|GSK2586184|gsk2586184
273651|NCT01782664|plaque-type psoriasis|plaque-type psoriasis
273652|NCT01782664|PGA|pga
273653|NCT01782664|inflammatory gene transcription|inflammatory gene transcription
273654|NCT01782664|JAK-1 inhibitor|jak-1 inhibitor
273655|NCT01782664|serum neopterin|serum neopterin
273656|NCT01782664|skin biopsy|skin biopsy
273657|NCT01782664|ACR response criteria|acr response criteria
273658|NCT01782664|VAS itch score|vas itch score
273659|NCT01782651|HER2 positive|her2 positive
273660|NCT01782651|Breast Cancer|breast cancer
273661|NCT01782651|treatment patterns|treatment patterns
273662|NCT01782638|Parkinson's disease|parkinson's disease
273663|NCT01782638|Deep brain stimulation|deep brain stimulation
273664|NCT01782638|Gait|gait
273665|NCT01782638|Freezing|freezing
273666|NCT01782638|Electrode placements|electrode placements
273667|NCT01782625|diving|diving
273668|NCT01782625|cognitive impairment|cognitive impairment
273669|NCT01782625|nitrogen narcosis|nitrogen narcosis
273670|NCT01782625|narcosis|narcosis
273671|NCT01782625|end tidal carbon dioxide|end tidal carbon dioxide
273672|NCT01782625|arterial carbon dioxide|arterial carbon dioxide
273673|NCT01782625|immersion|immersion
273674|NCT01782612|Balanced Anesthesia|balanced anesthesia
273675|NCT01782612|Nerve Block|nerve block
273676|NCT01782612|Postoperative Recovery|postoperative recovery
273677|NCT01782612|Delirium|delirium
273678|NCT01782612|Postoperative Complications|postoperative complications
273679|NCT01782612|Stress|stress
273680|NCT01782612|Inflammation|inflammation
273681|NCT01782586|kidney transplant|kidney transplant
273682|NCT01782586|gene expression markers|gene expression markers
273683|NCT01782586|renal allograft function|renal allograft function
273684|NCT01782573|pre - disinfection scrubbing solution|pre - disinfection scrubbing solution
273685|NCT01782573|surgical site culture|surgical site culture
273686|NCT01782573|surgical site infection|surgical site infection
273687|NCT01782573|liver tumors|liver tumors
273688|NCT01782573|hepatectomy|hepatectomy
273689|NCT01782573|chlorhexidine gluconate|chlorhexidine gluconate
273690|NCT01782560|Laryngomalacia|laryngomalacia
273691|NCT01782560|Acid-reflux|acid-reflux
273692|NCT01782547|diabetes mellitus|diabetes mellitus
273693|NCT01782547|adolescents|adolescents
273694|NCT01782521|Bracket failure rate|bracket failure rate
273695|NCT01782521|Orthodontic bonding|orthodontic bonding
273696|NCT01782521|Primer|primer
273697|NCT01782508|melanoma,adjuvant therapy,kit mutated melanoma|melanoma,adjuvant therapy,kit mutated melanoma
273698|NCT01782495|Hepatitis C Genotype 4|hepatitis c genotype 4
273699|NCT01782495|Chronic Hepatitis|chronic hepatitis
273700|NCT01782495|Interferon-Free|interferon-free
273701|NCT01782495|Hepatitis C Virus|hepatitis c virus
273702|NCT01782495|Renal Transplant|renal transplant
273703|NCT01782495|Liver Transplant|liver transplant
273704|NCT01782495|Hepatitis C Genotype 1|hepatitis c genotype 1
273705|NCT01782482|Color contact lenses|color contact lenses
273706|NCT01782482|Refractive error|refractive error
273707|NCT01782482|Myopia|myopia
273708|NCT01782469|Synovitis|synovitis
273709|NCT01782469|Rheumatoid Arthritis|rheumatoid arthritis
273710|NCT01782443|Progressive|progressive
273711|NCT01782443|Metastatic|metastatic
273712|NCT01782430|Preoxygenation|preoxygenation
273713|NCT01782430|Intubation|intubation
273714|NCT01782417|osteoarthritis|osteoarthritis
273715|NCT01782417|Hispanic|hispanic
273716|NCT01782417|behavior|behavior
273717|NCT01782417|intervention|intervention
273718|NCT01782417|Spanish|spanish
273719|NCT01782391|mild cognitive impairment|mild cognitive impairment
273720|NCT01782391|dementia|dementia
273722|NCT01782391|brain stimulation|brain stimulation
273723|NCT01782391|tSOS|tsos
273724|NCT01782391|tDCS|tdcs
273725|NCT01782391|sleep|sleep
273726|NCT01782391|memory|memory
273727|NCT01782391|memory consolidation|memory consolidation
273728|NCT01782378|Persian Gulf Syndrome|persian gulf syndrome
273729|NCT01782378|Veterans Health|veterans health
273730|NCT01782378|Executive Function|executive function
273731|NCT01782378|Memory|memory
273732|NCT01782378|Attention|attention
273733|NCT01782378|Cognition|cognition
273734|NCT01782378|Laser Therapy, Low-Level|laser therapy, low-level
273735|NCT01782378|Phototherapy|phototherapy
273736|NCT01782378|Light Therapy|light therapy
273737|NCT01782378|Depression|depression
273738|NCT01782365|mild cognitive impairment|mild cognitive impairment
273739|NCT01782365|dementia|dementia
273740|NCT01782365|MCI|mci
273741|NCT01782365|brain stimulation|brain stimulation
273742|NCT01782365|tSOS|tsos
273743|NCT01782365|tDCS|tdcs
273744|NCT01782365|sleep|sleep
273745|NCT01782365|nap|nap
273746|NCT01782365|daytime sleep|daytime sleep
273747|NCT01782365|memory|memory
273748|NCT01782365|memory consolidation|memory consolidation
273749|NCT01782352|age-related macular degeneration|age-related macular degeneration
273750|NCT01782352|incidence|incidence
273751|NCT01782352|progression|progression
273752|NCT01782326|COPD, QVA149, FLAME( EFfect of Indacaterol Glycopyronium Vs Fluticasone salmeterol on COPD Exacerbations)|copd, qva149, flame( effect of indacaterol glycopyronium vs fluticasone salmeterol on copd exacerbations)
273753|NCT01782287|Neoplasm Metastasis|neoplasm metastasis
273754|NCT01782287|Brain metastasis|brain metastasis
273755|NCT01782287|Lung cancer|lung cancer
273756|NCT01782274|Neoplasm Metastasis|neoplasm metastasis
273757|NCT01782274|Brain metastasis|brain metastasis
273758|NCT01782274|Breast cancer|breast cancer
273759|NCT01782261|autoimmune disease|autoimmune disease
273760|NCT01782261|diabetes type 1|diabetes type 1
273761|NCT01782261|incretin effect|incretin effect
273762|NCT01782222|Parkinson's Disease|parkinson's disease
273763|NCT01782222|Rotigotine|rotigotine
273764|NCT01782222|Apathy|apathy
273765|NCT01782222|Nonmotor|nonmotor
273766|NCT01782222|Motor|motor
273767|NCT01782222|Neupro|neupro
273768|NCT01782209|BK virus viremia|bk virus viremia
273769|NCT01782209|renal transplant|renal transplant
273770|NCT01782209|other viral pathogens|other viral pathogens
273771|NCT01782183|sore throat|sore throat
273772|NCT01782183|thermal camera photo|thermal camera photo
273773|NCT01782183|normal tonsils and pharynx|normal tonsils and pharynx
273774|NCT01782183|redness of tonsils and/or pharynx|redness of tonsils and/or pharynx
273775|NCT01782183|exudates on tonsils|exudates on tonsils
273776|NCT01782183|petechiae of the palate|petechiae of the palate
273777|NCT01782170|Gingivitis|gingivitis
273778|NCT01782170|Biomarkers|biomarkers
273779|NCT01782170|Biological Markers of Inflammation|biological markers of inflammation
273780|NCT01782157|dementia|dementia
273781|NCT01782144|Obesity|obesity
273782|NCT01782144|Foot pain|foot pain
273783|NCT01782105|weight gain|weight gain
273784|NCT01782105|healthy lifestyle|healthy lifestyle
273785|NCT01782105|gestational diabetes|gestational diabetes
273786|NCT01782105|adipokins|adipokins
273787|NCT01782105|glycemic regulation|glycemic regulation
273788|NCT01782092|diabetes|diabetes
273789|NCT01782079|Lactobacillus brevis|lactobacillus brevis
273790|NCT01782079|Oral health|oral health
273791|NCT01782079|Bacterial adhesion|bacterial adhesion
273792|NCT01782040|Premenstrual syndrome|premenstrual syndrome
273793|NCT01782040|Physical distress|physical distress
273794|NCT01782040|Behavioral changes|behavioral changes
273795|NCT01782027|healthy controls|healthy controls
273796|NCT01782027|Tangier Disease|tangier disease
273797|NCT01782027|Adenosine triphosphate-binding cassette transporter 1 (ABCA1)|adenosine triphosphate-binding cassette transporter 1 (abca1)
273798|NCT01782027|apoA-I|apoa-i
273799|NCT01782027|LCAT deficiency|lcat deficiency
273800|NCT01782027|Scavenger receptor BI (SRBI) deficiency|scavenger receptor bi (srbi) deficiency
273801|NCT01782027|CETP deficiency|cetp deficiency
273802|NCT01782014|Screening colonoscopy|screening colonoscopy
273803|NCT01782014|Water method|water method
273804|NCT01782014|Carbon dioxide method|carbon dioxide method
273805|NCT01782014|Air method|air method
402012|NCT01233479|untreated childhood medulloblastoma|untreated childhood medulloblastoma
273806|NCT01782014|Water versus carbon dioxide versus air insufflation colonoscopy|water versus carbon dioxide versus air insufflation colonoscopy
273807|NCT01782014|Adenoma Detection Rate|adenoma detection rate
273808|NCT01782014|Pain Scores in colonoscopy|pain scores in colonoscopy
273809|NCT01782001|Vitamin A|vitamin a
273811|NCT01782001|Malaria|malaria
273812|NCT01782001|Morbidity|morbidity
273813|NCT01782001|MRDR|mrdr
273816|NCT01781988|carboplatin|carboplatin
273817|NCT01781988|pemetrexed|pemetrexed
273818|NCT01781949|HIV infection|hiv infection
273819|NCT01781949|Targeted screening|targeted screening
273820|NCT01781949|Nontargeted screening|nontargeted screening
273821|NCT01781949|Emergency department|emergency department
273822|NCT01781949|Urgent care|urgent care
273823|NCT01781949|Effectiveness|effectiveness
273824|NCT01781923|Cognitive remediation|cognitive remediation
273825|NCT01781923|Social Cognition|social cognition
273826|NCT01781910|branched chain amino acids, exercise, delayed onset muscle soreness|branched chain amino acids, exercise, delayed onset muscle soreness
273827|NCT01781897|acupuncture|acupuncture
273828|NCT01781897|electro-acupuncture|electro-acupuncture
273829|NCT01781871|Pneumococcal vaccination|pneumococcal vaccination
273830|NCT01781871|immunogenicity|immunogenicity
273831|NCT01781871|solid organ transplant|solid organ transplant
273832|NCT01781858|Pulmonary embolism|pulmonary embolism
273833|NCT01781858|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
273834|NCT01781858|Venous thromboembolism|venous thromboembolism
273835|NCT01781793|dyspnea, exercise endurance, lung disease|dyspnea, exercise endurance, lung disease
273836|NCT01781780|Obesity|obesity
273837|NCT01781780|Weight Loss|weight loss
273838|NCT01781780|Breakfast|breakfast
273839|NCT01781767|UCP2|ucp2
273840|NCT01781767|Thyroid function|thyroid function
273841|NCT01781767|Thyroid carcinoma|thyroid carcinoma
273842|NCT01781754|Glycemic control|glycemic control
273843|NCT01781754|Metabolic control|metabolic control
273844|NCT01781754|Oxidative stress|oxidative stress
273845|NCT01781754|Diabetes|diabetes
273846|NCT01781728|recurrent|recurrent
273847|NCT01781728|unresectable|unresectable
273848|NCT01781728|residual|residual
273849|NCT01781728|stereotactic body radiation therapy (SBRT)|stereotactic body radiation therapy (sbrt)
273850|NCT01781728|palliative management|palliative management
273851|NCT01781715|STEMI, Multivessel Coronary Artery Disease, Primary PCI, multivessel stenting, zotarolimus-eluting stent|stemi, multivessel coronary artery disease, primary pci, multivessel stenting, zotarolimus-eluting stent
273852|NCT01781689|cortical activation|cortical activation
273853|NCT01781689|motor function|motor function
273854|NCT01781689|activity of daily living|activity of daily living
273855|NCT01781650|Warm Water Infusion colonoscopy|warm water infusion colonoscopy
273856|NCT01781650|Water Immersion colonoscopy|water immersion colonoscopy
273857|NCT01781650|Water Exchange colonoscopy|water exchange colonoscopy
273858|NCT01781650|Painless unsedated colonoscopy|painless unsedated colonoscopy
273859|NCT01781650|Adenoma detection rate|adenoma detection rate
273860|NCT01781650|Adenoma resection rate|adenoma resection rate
273861|NCT01781637|Xolair|xolair
273862|NCT01781637|omalizumab|omalizumab
273863|NCT01781637|peanut|peanut
273864|NCT01781637|oral desensitization|oral desensitization
273865|NCT01781611|lupus|lupus
273866|NCT01781611|dipyridamole|dipyridamole
273867|NCT01781598|Total knee arthroplasty|total knee arthroplasty
273868|NCT01781598|Patient specific instruments|patient specific instruments
273869|NCT01781598|Patient matched cutting blocks|patient matched cutting blocks
273870|NCT01781598|Alignment|alignment
273871|NCT01781598|Learning curve|learning curve
273872|NCT01781598|VISIONAIRE|visionaire
273873|NCT01781585|Sustained low-efficiency dialysis;|sustained low-efficiency dialysis;
273874|NCT01781585|Continuous venovenous hemofiltration;|continuous venovenous hemofiltration;
273875|NCT01781585|hemodynamic stability,|hemodynamic stability,
273876|NCT01781585|Intracranial pressure|intracranial pressure
273877|NCT01781546|drug eluting balloon|drug eluting balloon
273878|NCT01781546|bare metal stent|bare metal stent
273879|NCT01781546|coronary artery disease|coronary artery disease
273880|NCT01781546|acute coronary syndrome|acute coronary syndrome
273881|NCT01781546|percutaneous coronary intervention|percutaneous coronary intervention
273882|NCT01781546|DEB|deb
273883|NCT01781546|BMS|bms
273884|NCT01781520|Pancreatic Cancer|pancreatic cancer
273885|NCT01781520|S1|s1
273886|NCT01781520|DC-CIK|dc-cik
273887|NCT01781507|Asthma|asthma
273888|NCT01781507|Allergic rhinitis|allergic rhinitis
273889|NCT01781507|Cetirizine|cetirizine
273890|NCT01781507|Impulse oscillometry|impulse oscillometry
273891|NCT01781481|Psychosocial Stress and Adjustment|psychosocial stress and adjustment
273892|NCT01781481|Pediatric Chronic Illness|pediatric chronic illness
273893|NCT01781481|Decision-support tool|decision-support tool
273894|NCT01781481|Integrated Health Care|integrated health care
273895|NCT01781481|Case Complexity|case complexity
273896|NCT01781442|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
273897|NCT01781416|cardiovascular risk|cardiovascular risk
273898|NCT01781416|SCORE|score
273899|NCT01781416|cardiovascular primary prevention|cardiovascular primary prevention
273900|NCT01781416|risk factors|risk factors
273901|NCT01781403|Temozolomide|temozolomide
273902|NCT01781403|capecitabine|capecitabine
273903|NCT01781403|rectal cancer|rectal cancer
273904|NCT01781390|Acute Myocardial Infarction|acute myocardial infarction
273905|NCT01781390|STEMI|stemi
273906|NCT01781390|Heart Attack|heart attack
273908|NCT01781390|Stem Cells|stem cells
273909|NCT01781377|NAUSEA|nausea
273910|NCT01781377|VOMITING|vomiting
273911|NCT01781377|CESAREAN SECTION|cesarean section
273912|NCT01781377|PREVENTION|prevention
273913|NCT01781377|PROPOFOL|propofol
273914|NCT01781364|Brain Oscillations|brain oscillations
273915|NCT01781364|Cognitive Performance|cognitive performance
273916|NCT01781325|musculoskeletal, physical therapy|musculoskeletal, physical therapy
273917|NCT01781299|Breast Cancer|breast cancer
273918|NCT01781299|Mastectomy|mastectomy
273919|NCT01781299|Immediate reconstruction|immediate reconstruction
273920|NCT01781286|Obesity|obesity
273921|NCT01781286|Snacking|snacking
273922|NCT01781286|Appetite|appetite
273923|NCT01781286|Protein|protein
273924|NCT01781286|Soy|soy
273925|NCT01781286|Reward driven eating|reward driven eating
273926|NCT01781286|Satiety|satiety
273927|NCT01781273|impaired driving|impaired driving
273928|NCT01781260|Prone position|prone position
273929|NCT01781260|Cardiac output|cardiac output
273930|NCT01781260|Liver Circulation|liver circulation
273931|NCT01781247|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
273932|NCT01781247|Myocardial Infarction|myocardial infarction
273933|NCT01781247|Psychotherapy|psychotherapy
264576|NCT01824017|GSH|gsh
273934|NCT01781247|Preventive Therapy|preventive therapy
273935|NCT01781247|Randomized Controlled Trial|randomized controlled trial
273936|NCT01781247|Cardiovascular Diseases|cardiovascular diseases
273937|NCT01781247|Psychological Stress|psychological stress
273938|NCT01781247|Biomarkers|biomarkers
273939|NCT01781195|Advagraf|advagraf
273940|NCT01781195|MELD-score|meld-score
273941|NCT01781195|Na-MELD-score|na-meld-score
273942|NCT01781195|liver function|liver function
273943|NCT01781195|LiMAx-test|limax-test
273944|NCT01781195|infection rate|infection rate
273945|NCT01781195|HLA-DR status|hla-dr status
273946|NCT01781195|immunostatus|immunostatus
273947|NCT01781169|Vitamin D,|vitamin d,
273948|NCT01781169|Oral supplementation,|oral supplementation,
273949|NCT01781169|Obese males|obese males
273950|NCT01781156|phosphorus|phosphorus
273951|NCT01781156|hemodialysis|hemodialysis
273952|NCT01781156|cardiac biomarkers|cardiac biomarkers
273953|NCT01781117|Benign prostatic obstruction (BPO)|benign prostatic obstruction (bpo)
273954|NCT01781117|Detrusor overactivity (DO)|detrusor overactivity (do)
273955|NCT01781117|Urinary nerve growth factor (NGF)|urinary nerve growth factor (ngf)
273956|NCT01781104|constipation gastric emptying gastrointestinal motility ghrelin|constipation gastric emptying gastrointestinal motility ghrelin
273957|NCT01781078|Single chamber pacing|single chamber pacing
273958|NCT01781078|Dual chamber pacing|dual chamber pacing
273959|NCT01781078|MRI|mri
273960|NCT01781078|MR scans|mr scans
273961|NCT01781052|Iloprost Compliance|iloprost compliance
273962|NCT01781039|"hair cell"|"hair cell"
273963|NCT01781039|"spiral ganglion"|"spiral ganglion"
273964|NCT01781039|"hearing aid"|"hearing aid"
273965|NCT01781039|"hearing loss"|"hearing loss"
273966|NCT01781026|B-raf V600E|b-raf v600e
273967|NCT01781026|V600K mutation|v600k mutation
273968|NCT01781026|metastatic melanoma|metastatic melanoma
273969|NCT01781013|Depression screening|depression screening
273970|NCT01781013|Depression monitoring|depression monitoring
273971|NCT01781013|Chronic illness|chronic illness
273972|NCT01781013|Behavioral health|behavioral health
273973|NCT01781013|Care management|care management
273974|NCT01781013|Automatic telephone assessment|automatic telephone assessment
273975|NCT01781013|Clinical decision support|clinical decision support
273976|NCT01781013|Suicide alert|suicide alert
273977|NCT01781000|Cognitive Training|cognitive training
273978|NCT01781000|Neuroplasticity|neuroplasticity
273979|NCT01781000|MEG|meg
273980|NCT01781000|MATRICS|matrics
273981|NCT01780987|DVT|dvt
273982|NCT01780987|PE|pe
273983|NCT01780987|VTE|vte
273984|NCT01780974|Hypertension|hypertension
273985|NCT01780974|Vascular Risk|vascular risk
273986|NCT01780974|Alzheimer's Risk|alzheimer's risk
273987|NCT01780974|fish oil|fish oil
273988|NCT01780974|Lipoic acid|lipoic acid
273989|NCT01780961|Esophageal Cancer|esophageal cancer
273990|NCT01780961|ESBX|esbx
273991|NCT01780948|Drug Interaction|drug interaction
273992|NCT01780948|Pharmacokinetics|pharmacokinetics
273993|NCT01780948|Everolimus|everolimus
273994|NCT01780948|Atorvastatin|atorvastatin
273995|NCT01780922|Inflammation|inflammation
273996|NCT01780922|Oxidative Stress|oxidative stress
273997|NCT01780922|Vaccinium macrocarpon|vaccinium macrocarpon
273998|NCT01780896|Topographical Memory|topographical memory
273999|NCT01780896|Non-Topographical Memory|non-topographical memory
274000|NCT01780896|Vestibular Function|vestibular function
274001|NCT01780896|Alzheimer's Disease|alzheimer's disease
274002|NCT01780883|melatonin|melatonin
274003|NCT01780883|childhood autism|childhood autism
274004|NCT01780883|6-Sulphatoxymelatonin|6-sulphatoxymelatonin
274005|NCT01780883|autistic disorder|autistic disorder
274006|NCT01780883|dose-effect relation|dose-effect relation
274007|NCT01780870|Overweight|overweight
274008|NCT01780870|Obesity|obesity
274009|NCT01780870|Obese|obese
274010|NCT01780870|Weight loss|weight loss
274011|NCT01780857|palmoplantar pustulosis|palmoplantar pustulosis
274012|NCT01780857|psoriasis|psoriasis
274013|NCT01780844|Kidney Transplantation|kidney transplantation
274014|NCT01780844|de novo Kidney Transplantation|de novo kidney transplantation
274015|NCT01780844|ASKP1240|askp1240
274016|NCT01780818|Warm Water Infusion colonoscopy|warm water infusion colonoscopy
274017|NCT01780818|Water Immersion colonoscopy|water immersion colonoscopy
274018|NCT01780818|Water Exchange colonoscopy|water exchange colonoscopy
274019|NCT01780818|Painless unsedated colonoscopy|painless unsedated colonoscopy
274020|NCT01780818|Adenoma detection rate|adenoma detection rate
274021|NCT01780818|Adenoma resection rate|adenoma resection rate
274022|NCT01780792|multiple sclerosis|multiple sclerosis
274023|NCT01780792|mobility|mobility
274024|NCT01780792|cognition|cognition
274025|NCT01780792|neuroplasticity|neuroplasticity
274026|NCT01780792|videogame play|videogame play
274027|NCT01780779|Diffusion weighted MRI|diffusion weighted mri
274028|NCT01780779|Patient outcome assessment|patient outcome assessment
274029|NCT01780779|Treatment response|treatment response
274030|NCT01780779|Histopathology|histopathology
264707|NCT01823198|AML|aml
274031|NCT01780766|Whole body MRI|whole body mri
274032|NCT01780766|Multiple myeloma|multiple myeloma
274033|NCT01780766|Diffusion Weighted MRI|diffusion weighted mri
274034|NCT01780766|Whole body scan|whole body scan
274035|NCT01780753|Primaquine|primaquine
274036|NCT01780753|Vivax malaria|vivax malaria
274037|NCT01780753|G6PD|g6pd
274038|NCT01780740|Bypass Surgery, Coronary Artery|bypass surgery, coronary artery
274039|NCT01780740|Atrial fibrillation|atrial fibrillation
274040|NCT01780740|Ischaemia-reperfusion injury|ischaemia-reperfusion injury
274041|NCT01780740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
274042|NCT01780740|Statins, HMG-CoA|statins, hmg-coa
274043|NCT01780727|echocardiography|echocardiography
274044|NCT01780727|hemodynamic management|hemodynamic management
274045|NCT01780714|smoking|smoking
274046|NCT01780714|cigarette|cigarette
274047|NCT01780714|exposure|exposure
274048|NCT01780714|biomarker|biomarker
274049|NCT01780714|human smoking topography (HST)|human smoking topography (hst)
274050|NCT01780714|modified risk tobacco product (MRTP)|modified risk tobacco product (mrtp)
274051|NCT01780714|THS 2.1|ths 2.1
274052|NCT01780701|prostate cancer aggressiveness|prostate cancer aggressiveness
274053|NCT01780701|magnetic resonance imaging|magnetic resonance imaging
274054|NCT01780701|fatty acid synthase|fatty acid synthase
274055|NCT01780688|Modified risk tobacco product (MRTP)|modified risk tobacco product (mrtp)
274056|NCT01780688|Smoking|smoking
274057|NCT01780688|Nicotine profile|nicotine profile
274058|NCT01780675|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
274059|NCT01780675|Hippocampal Avoidance Prophylactic Cranial Irradiation|hippocampal avoidance prophylactic cranial irradiation
274060|NCT01780649|IMSI|imsi
274061|NCT01780649|ICSI|icsi
274062|NCT01780649|ART Assisted reproductive technology|art assisted reproductive technology
274063|NCT01780649|Spermatozoa|spermatozoa
274064|NCT01780649|male infertility|male infertility
274065|NCT01780649|vacuoles|vacuoles
274066|NCT01780636|Non relaxing puborectalis syndrome|non relaxing puborectalis syndrome
274067|NCT01780636|Botulinum toxin A|botulinum toxin a
274068|NCT01780636|Botox|botox
274069|NCT01780636|Constipation|constipation
274070|NCT01780623|fatigue|fatigue
274071|NCT01780623|sleep|sleep
274072|NCT01780623|quality of life|quality of life
274073|NCT01780623|light|light
274074|NCT01780623|cancer|cancer
274075|NCT01780610|endometrium preparation protocols|endometrium preparation protocols
274076|NCT01780610|frozen-thawed embryo transfer|frozen-thawed embryo transfer
274077|NCT01780610|irregular cycle|irregular cycle
274078|NCT01780610|randomized controlled trial|randomized controlled trial
274079|NCT01780597|Heart transplantation|heart transplantation
274080|NCT01780597|Ev Vivo Perfusion|ev vivo perfusion
274081|NCT01780597|Cardiac function|cardiac function
274082|NCT01780584|congenital heart surgery, thyroid hormones|congenital heart surgery, thyroid hormones
274083|NCT01780571|Obesity|obesity
274084|NCT01780571|general anaesthesia|general anaesthesia
274085|NCT01780571|preoxygenation|preoxygenation
274086|NCT01780571|atelectasis|atelectasis
274087|NCT01780558|endometrium preparation protocols|endometrium preparation protocols
274088|NCT01780558|frozen-thawed embryo transfer|frozen-thawed embryo transfer
274089|NCT01780558|natural cycles|natural cycles
274090|NCT01780558|hormone replacement therapy cycles|hormone replacement therapy cycles
274091|NCT01780558|randomized controlled trial|randomized controlled trial
274092|NCT01780545|OGX-427|ogx-427
274093|NCT01780545|Docetaxel|docetaxel
274094|NCT01780519|Alzheimer's disease (AD)|alzheimer's disease (ad)
274096|NCT01780506|Treatment Naive|treatment naive
274097|NCT01780506|HIV 1 Infected|hiv 1 infected
274098|NCT01780506|Female|female
274099|NCT01780506|Women|women
274100|NCT01780493|Nipple|nipple
274101|NCT01780493|Technique|technique
274103|NCT01780493|Vesicoureteral Reflux|vesicoureteral reflux
274104|NCT01780480|Ischemic Stroke|ischemic stroke
274105|NCT01780480|Convalescence|convalescence
274106|NCT01780480|Randomized Controlled Trial|randomized controlled trial
274107|NCT01780480|Pilot Study|pilot study
274108|NCT01780480|Traditional Chinese Medicine|traditional chinese medicine
274109|NCT01780467|Loss aversion|loss aversion
274110|NCT01780467|Dopamine|dopamine
274111|NCT01780467|Parkinson's disease|parkinson's disease
274112|NCT01780454|End Stage Renal Disease|end stage renal disease
274113|NCT01780454|Renal Transplant|renal transplant
274114|NCT01780454|Bone Marrow Transplant|bone marrow transplant
274115|NCT01780454|Tolerance|tolerance
274116|NCT01780454|Chimerism|chimerism
274117|NCT01780454|ESRD|esrd
274118|NCT01780441|Tuberous Sclerosis Complex|tuberous sclerosis complex
274119|NCT01780441|TSC|tsc
274120|NCT01780441|Autism|autism
274121|NCT01780441|ASD|asd
274122|NCT01780441|Biomarkers|biomarkers
274123|NCT01780441|Infants|infants
274124|NCT01780428|Pain|pain
274125|NCT01780428|Nausea|nausea
274126|NCT01780428|Vomiting|vomiting
274127|NCT01780415|Blastocoele fluid|blastocoele fluid
274128|NCT01780415|Human DNA|human dna
274129|NCT01780415|molecular diagnosis|molecular diagnosis
274130|NCT01780402|feeding difficulty|feeding difficulty
274131|NCT01780402|eating difficulty|eating difficulty
274132|NCT01780402|dementia|dementia
274133|NCT01780402|nursing home|nursing home
274134|NCT01780402|careful hand feeding|careful hand feeding
274135|NCT01780389|Knee|knee
274136|NCT01780389|Pain|pain
274137|NCT01780389|Osteoarthritis|osteoarthritis
274138|NCT01780376|whole-body vibration|whole-body vibration
274139|NCT01780376|latency|latency
274140|NCT01780376|reflex response|reflex response
274141|NCT01780376|muscle|muscle
274142|NCT01780337|Oxytocin|oxytocin
274143|NCT01780337|Arrhythmia|arrhythmia
274144|NCT01780298|COPD|copd
274145|NCT01780298|Biomarkers|biomarkers
274146|NCT01780298|Cigarette Smoke|cigarette smoke
274147|NCT01780298|Lung Inflammation|lung inflammation
274148|NCT01780298|FEV|fev
274149|NCT01780298|Sputum|sputum
274150|NCT01780285|Hiatal hernia|hiatal hernia
274151|NCT01780285|Gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
274152|NCT01780285|Laparoscopic hiatal repair|laparoscopic hiatal repair
274153|NCT01780285|Laparoscopic anti-reflux surgery|laparoscopic anti-reflux surgery
274154|NCT01780285|Partially absorbable lightweight mesh|partially absorbable lightweight mesh
274155|NCT01780285|Polytetrafluoroethylene|polytetrafluoroethylene
274156|NCT01780285|PTFE|ptfe
274157|NCT01780285|Nitinol|nitinol
274158|NCT01780285|Nitinol-framed lightweight PTFE mesh|nitinol-framed lightweight ptfe mesh
274159|NCT01780259|Healthy|healthy
274160|NCT01780259|Esketamine|esketamine
274161|NCT01780259|Pharmacokinetics|pharmacokinetics
274162|NCT01780259|Intranasal|intranasal
274163|NCT01780246|Spinal Muscular Atrophy|spinal muscular atrophy
274164|NCT01780246|SMA|sma
274165|NCT01780246|SMN|smn
274166|NCT01780246|SMNRx|smnrx
274167|NCT01780246|ISIS-SMNRx|isis-smnrx
274168|NCT01780246|ISIS 396443|isis 396443
274169|NCT01780220|abiraterone|abiraterone
274170|NCT01780220|biochemically-relapsing|biochemically-relapsing
274171|NCT01780220|prostate adenocarcinoma|prostate adenocarcinoma
274172|NCT01780181|lung cancer|lung cancer
274173|NCT01780181|traditional Chinese medicine|traditional chinese medicine
274174|NCT01780168|Inborn Error of Metabolism|inborn error of metabolism
274175|NCT01780168|Metabolism|metabolism
274176|NCT01780168|UCD|ucd
274177|NCT01780168|Immunity|immunity
274178|NCT01780168|Nutrition|nutrition
274179|NCT01780168|Mitochondrial Disease|mitochondrial disease
274180|NCT01780155|Oxidative Stress|oxidative stress
274181|NCT01780155|Hyperoxia|hyperoxia
274182|NCT01780155|Brochopulmonary Dysplasia|brochopulmonary dysplasia
274183|NCT01780155|Retinopathy of Prematurity|retinopathy of prematurity
274184|NCT01780155|Very Low Birth Rate|very low birth rate
274185|NCT01780142|Airflow Obstruction|airflow obstruction
274186|NCT01780142|Airflow Inflammation|airflow inflammation
274187|NCT01780142|Corticosteroid Resistance|corticosteroid resistance
274188|NCT01780142|Exacerbations|exacerbations
274189|NCT01780142|Quality of Life|quality of life
274190|NCT01780116|schizophrenia|schizophrenia
274191|NCT01780116|adherence therapy|adherence therapy
274192|NCT01780116|medication|medication
274193|NCT01780116|randomized controlled trial|randomized controlled trial
274194|NCT01780116|cost-effectiveness|cost-effectiveness
274195|NCT01780090|autism|autism
274196|NCT01780090|prosody|prosody
274197|NCT01780090|speech|speech
697246|NCT00956436|Sorafenib|sorafenib
274198|NCT01780090|autism spectrum disorder|autism spectrum disorder
274199|NCT01780077|Scar|scar
274200|NCT01780077|Scar prevention|scar prevention
274201|NCT01780077|Fibrosis|fibrosis
274202|NCT01780051|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
274203|NCT01780051|Pharmacokinetics|pharmacokinetics
274204|NCT01780038|Cigarette Smoking|cigarette smoking
274205|NCT01780038|Nicotine Dependence|nicotine dependence
274206|NCT01780038|Smoking Abstinence|smoking abstinence
274207|NCT01780038|Health Literacy|health literacy
274208|NCT01780038|Genetic Predisposition Testing|genetic predisposition testing
274209|NCT01780038|Heredity|heredity
274210|NCT01780025|Hearing|hearing
274211|NCT01780025|Thresholds|thresholds
274212|NCT01780025|Coupling to the inner ear|coupling to the inner ear
274213|NCT01780012|osteoporosis|osteoporosis
274214|NCT01780012|fragility fracture|fragility fracture
274215|NCT01780012|secondary prevention|secondary prevention
274216|NCT01779999|central venous catheters|central venous catheters
274217|NCT01779999|thrombosis|thrombosis
274218|NCT01779999|secondary prevention|secondary prevention
274219|NCT01779973|Skype|skype
274220|NCT01779973|compliance|compliance
274221|NCT01779973|remote dosing|remote dosing
274222|NCT01779973|suboxone|suboxone
274223|NCT01779973|opiate|opiate
274224|NCT01779973|opiates|opiates
274225|NCT01779973|heroin|heroin
274226|NCT01779973|oxycontin|oxycontin
274227|NCT01779973|Philadelphia|philadelphia
274228|NCT01779960|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
274229|NCT01779960|Motor activity|motor activity
274230|NCT01779960|Climatologic station|climatologic station
274231|NCT01779908|Vitamin D supplementation|vitamin d supplementation
274232|NCT01779908|Insulin resistance|insulin resistance
274233|NCT01779895|Dust mite|dust mite
274234|NCT01779895|Perennial allergic rhinitis|perennial allergic rhinitis
274235|NCT01779869|PET MR myocardial perfusion imaging|pet mr myocardial perfusion imaging
274236|NCT01779856|End Stage Renal Disease, Hemodialysis, Arrhythmia, Reveal ICM|end stage renal disease, hemodialysis, arrhythmia, reveal icm
274237|NCT01779843|Newly diagnosed|newly diagnosed
274238|NCT01779804|foot , ankle, injury|foot , ankle, injury
274239|NCT01779791|Lymphoma|lymphoma
274240|NCT01779791|Refractory follicular lymphoma|refractory follicular lymphoma
274734|NCT01777711|diet|diet
274241|NCT01779791|Chemoimmunotherapy-resistant follicular lymphoma|chemoimmunotherapy-resistant follicular lymphoma
274242|NCT01779791|PCI-32765|pci-32765
274243|NCT01779791|Ibrutinib|ibrutinib
274244|NCT01779791|IMBRUVICA|imbruvica
274246|NCT01779765|Diarrhea|diarrhea
274247|NCT01779765|Constipation|constipation
274248|NCT01779765|Fibers|fibers
274249|NCT01779739|vaginal prolapse|vaginal prolapse
274250|NCT01779739|sexual function|sexual function
274251|NCT01779739|sexual dysfunction|sexual dysfunction
274252|NCT01779739|prolapse surgery|prolapse surgery
274253|NCT01779726|Organization|organization
274254|NCT01779726|of fast track|of fast track
274255|NCT01779713|Aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
274256|NCT01779713|Vasospasm|vasospasm
274257|NCT01779713|Transcriptomic|transcriptomic
274258|NCT01779713|Case-Control Study|case-control study
274259|NCT01779700|psychosis|psychosis
274260|NCT01779700|schizophrenia|schizophrenia
274261|NCT01779700|cognition|cognition
274262|NCT01779700|fingolimod|fingolimod
274263|NCT01779687|pharmacokinetic|pharmacokinetic
274264|NCT01779687|interaction|interaction
274265|NCT01779687|cholesterol|cholesterol
274266|NCT01779687|raltegravir|raltegravir
274267|NCT01779687|atorvastatin|atorvastatin
274268|NCT01779661|Neurodevelopment, Infant-Aquatics, Prematurity|neurodevelopment, infant-aquatics, prematurity
274269|NCT01779648|deep vein thrombosis|deep vein thrombosis
274270|NCT01779648|intermittent pneumatic compression|intermittent pneumatic compression
274271|NCT01779648|venous hemodynamics|venous hemodynamics
274272|NCT01779635|Heparin-grafted membrane|heparin-grafted membrane
274273|NCT01779635|Circuit lifespan|circuit lifespan
274274|NCT01779635|Continuous renal replacement therapy|continuous renal replacement therapy
274275|NCT01779635|Anticoagulation free|anticoagulation free
274276|NCT01779635|Bleeding risk|bleeding risk
274277|NCT01779635|Acute kidney injury|acute kidney injury
274278|NCT01779635|Critical illness|critical illness
274279|NCT01779622|mixed meal¨|mixed meal¨
274280|NCT01779622|insulin|insulin
274281|NCT01779622|glucagon|glucagon
274283|NCT01779622|GLP-1|glp-1
274284|NCT01779596|diabetes|diabetes
274285|NCT01779596|endothelial function|endothelial function
274286|NCT01779596|exercise|exercise
274287|NCT01779596|blood flow|blood flow
274288|NCT01779596|bosentan|bosentan
274289|NCT01779583|Advanced gastric cancer|advanced gastric cancer
274290|NCT01779570|Influenza|influenza
274291|NCT01779570|Macrolide|macrolide
274292|NCT01779570|Anti-inflammatory|anti-inflammatory
274293|NCT01779557|CAPD|capd
274294|NCT01779557|efficacy|efficacy
274295|NCT01779557|safety|safety
274296|NCT01779557|survival rate|survival rate
274297|NCT01779544|rehabilitation,surgery,brief intervention, exercises|rehabilitation,surgery,brief intervention, exercises
274298|NCT01779531|HER2-negative Luminal B breast cancer|her2-negative luminal b breast cancer
274299|NCT01779518|HCV|hcv
274300|NCT01779518|Sustained Virologic Response|sustained virologic response
274301|NCT01779518|Direct Acting Antiviral|direct acting antiviral
274302|NCT01779518|GS-7977|gs-7977
274303|NCT01779518|Pegylated interferon|pegylated interferon
274304|NCT01779518|Ribavirin|ribavirin
274305|NCT01779518|Open Label|open label
274306|NCT01779518|Sofosbuvir|sofosbuvir
274307|NCT01779518|Liver transplant|liver transplant
274308|NCT01779518|Hepatitis|hepatitis
274309|NCT01779518|Hepatitis, Chronic|hepatitis, chronic
274310|NCT01779518|Hepatitis C|hepatitis c
274311|NCT01779518|Hepatitis C, Chronic|hepatitis c, chronic
274312|NCT01779518|Liver Diseases|liver diseases
275115|NCT01776151|HIV|hiv
274313|NCT01779518|Digestive System Diseases|digestive system diseases
274314|NCT01779518|Hepatitis, Viral, Human|hepatitis, viral, human
274315|NCT01779518|Virus Diseases|virus diseases
274316|NCT01779518|Enterovirus Infections|enterovirus infections
274317|NCT01779518|Picornaviridae Infections|picornaviridae infections
274318|NCT01779518|RNA Virus Infections|rna virus infections
274319|NCT01779518|Flaviviridae Infections|flaviviridae infections
274320|NCT01779518|Antiviral Agents|antiviral agents
274321|NCT01779518|Anti-Infective Agents|anti-infective agents
274322|NCT01779518|Therapeutic Uses|therapeutic uses
274323|NCT01779518|Pharmacologic Actions|pharmacologic actions
274324|NCT01779518|Antimetabolites|antimetabolites
274325|NCT01779518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
274326|NCT01779492|Oxycodone, controlled release formulation|oxycodone, controlled release formulation
265006|NCT01821963|HCV|hcv
274327|NCT01779479|German Breast Group|german breast group
274328|NCT01779479|GBG Forschungs GmbH|gbg forschungs gmbh
274329|NCT01779479|GBG|gbg
274330|NCT01779479|GBG 74|gbg 74
274331|NCT01779479|Genevieve|genevieve
274332|NCT01779479|Breast Cancer|breast cancer
274333|NCT01779479|Primary Breast Cancer|primary breast cancer
274334|NCT01779479|Cabazitaxel|cabazitaxel
274335|NCT01779479|Paclitaxel|paclitaxel
274336|NCT01779479|neo-adjuvant|neo-adjuvant
274337|NCT01779479|triple negative|triple negative
274338|NCT01779479|luminal B|luminal b
274339|NCT01779453|Atorvastatin|atorvastatin
274340|NCT01779453|Drug-drug interaction|drug-drug interaction
274341|NCT01779453|Combination therapy|combination therapy
274342|NCT01779440|Mental Illness|mental illness
274343|NCT01779440|Tobacco Smoking|tobacco smoking
274344|NCT01779440|Young Adults|young adults
274345|NCT01779440|Treatment Engagement|treatment engagement
274346|NCT01779440|Motivational Intervention|motivational intervention
274347|NCT01779427|traumatic brain injury (TBI)|traumatic brain injury (tbi)
274348|NCT01779427|intracranial edema|intracranial edema
274349|NCT01779427|brain edema|brain edema
274350|NCT01779427|craniocerebral trauma|craniocerebral trauma
274351|NCT01779427|head injury|head injury
274352|NCT01779427|brain hemorrhage, traumatic|brain hemorrhage, traumatic
274353|NCT01779427|subdural hematoma|subdural hematoma
274354|NCT01779427|brain concussion|brain concussion
274355|NCT01779427|head injuries, closed|head injuries, closed
274356|NCT01779427|epidural hematoma|epidural hematoma
274357|NCT01779427|extra-axial hemorrhage|extra-axial hemorrhage
274358|NCT01779427|cortical contusion|cortical contusion
274359|NCT01779427|wounds and injuries|wounds and injuries
274360|NCT01779427|disorders of environmental origin|disorders of environmental origin
274361|NCT01779427|trauma, nervous system|trauma, nervous system
274362|NCT01779427|brain injuries|brain injuries
274363|NCT01779427|attention deficit hyperactivity disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
274364|NCT01779427|attention|attention
274365|NCT01779414|Suicide Ideation|suicide ideation
274366|NCT01779401|PCI|pci
274367|NCT01779401|platelet function monitoring|platelet function monitoring
274368|NCT01779401|Thrombelastography|thrombelastography
274369|NCT01779401|clopidogrel|clopidogrel
274370|NCT01779401|cilostazol|cilostazol
274371|NCT01779401|in-stent thrombosis|in-stent thrombosis
274372|NCT01779388|Lung nodule|lung nodule
274373|NCT01779388|PET scanner|pet scanner
274374|NCT01779388|Bronchoscopy|bronchoscopy
274375|NCT01779388|Electromagnetic navigation|electromagnetic navigation
274376|NCT01779375|Children|children
274377|NCT01779375|Pediatric|pediatric
274378|NCT01779349|benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
274379|NCT01779349|acoustic vibration|acoustic vibration
274380|NCT01779336|Advanced Refractory Solid Tumors|advanced refractory solid tumors
274381|NCT01779323|SUI|sui
274382|NCT01779323|stress urinary incontinence|stress urinary incontinence
274383|NCT01779323|male|male
274384|NCT01779323|transobturator sling|transobturator sling
274385|NCT01779297|new integrative weaning indexes|new integrative weaning indexes
274386|NCT01779297|mechanical ventilation|mechanical ventilation
274387|NCT01779297|ICU|icu
274388|NCT01779284|glaucoma|glaucoma
274389|NCT01779284|fixed combinations|fixed combinations
274390|NCT01779284|24-hour monitoring|24-hour monitoring
274391|NCT01779271|Pelubi|pelubi
274392|NCT01779271|Pelubiprofen|pelubiprofen
274393|NCT01779271|Loxoprofen|loxoprofen
274394|NCT01779271|Anti-pyretic|anti-pyretic
274395|NCT01779271|Fever|fever
274396|NCT01779258|xerosis|xerosis
274397|NCT01779258|dry skin|dry skin
274398|NCT01779258|dermatitis|dermatitis
274399|NCT01779258|eczema|eczema
274400|NCT01779258|emollient|emollient
274401|NCT01779258|corticosteroid|corticosteroid
274402|NCT01779258|flare|flare
274403|NCT01779232|endometriosis|endometriosis
274404|NCT01779232|ivf|ivf
274405|NCT01779232|ovarian reserve|ovarian reserve
274407|NCT01779219|intraoperative magnetic resonance|intraoperative magnetic resonance
274408|NCT01779219|stereotactic biopsy|stereotactic biopsy
274409|NCT01779219|brain tumor|brain tumor
274410|NCT01779219|frameless stereotaxy|frameless stereotaxy
274411|NCT01779219|image-guided neurosurgery|image-guided neurosurgery
274412|NCT01779193|group B streptococcus|group b streptococcus
274413|NCT01779193|pregnancy|pregnancy
274414|NCT01779193|probiotics|probiotics
274415|NCT01779180|Vitamin A supplementation|vitamin a supplementation
274416|NCT01779180|BCG vaccination|bcg vaccination
274417|NCT01779180|diphtheria-tetanus-pertussis vaccination|diphtheria-tetanus-pertussis vaccination
274418|NCT01779180|measles vaccination|measles vaccination
274419|NCT01779180|atopy|atopy
274420|NCT01779167|WM|wm
274421|NCT01779154|eosinophilic esophagitis|eosinophilic esophagitis
274422|NCT01779154|eosinophilic gastritis|eosinophilic gastritis
274423|NCT01779154|eosinophilic enteritis|eosinophilic enteritis
274424|NCT01779154|eosinophilic colitis|eosinophilic colitis
274425|NCT01779141|Type 1 Diabetes Mellitus - T1DM|type 1 diabetes mellitus - t1dm
274426|NCT01779141|Pregnancy|pregnancy
274427|NCT01779141|Insulin Pump|insulin pump
274428|NCT01779141|Glucose Sensor|glucose sensor
274429|NCT01779141|Continuous Subcutaneous Insulin Infusion - CSII|continuous subcutaneous insulin infusion - csii
274430|NCT01779141|Sensor Augmented Pump - SAP|sensor augmented pump - sap
274431|NCT01779141|Continuous Glucose Monitoring - CGM|continuous glucose monitoring - cgm
274432|NCT01779115|Registry,Diabetes,Health Maintenance Organization|registry,diabetes,health maintenance organization
274433|NCT01779089|diabetic nephropathy|diabetic nephropathy
274434|NCT01779089|diabetic kidney disease|diabetic kidney disease
274435|NCT01779089|minocycline|minocycline
274436|NCT01779089|proteinuria|proteinuria
274437|NCT01779089|albuminuria|albuminuria
274438|NCT01779063|lymphedema|lymphedema
274439|NCT01779063|self-care|self-care
274440|NCT01779063|breast cancer|breast cancer
274441|NCT01779024|Addiction|addiction
274442|NCT01779024|Alcohol|alcohol
274443|NCT01779024|Alcohol Clamp|alcohol clamp
274444|NCT01778998|incision|incision
274445|NCT01778998|pre-cut|pre-cut
274446|NCT01778998|wound architecture|wound architecture
274448|NCT01778985|Pelvic organ prolapse|pelvic organ prolapse
274449|NCT01778985|Menopause|menopause
274450|NCT01778985|Estrogen|estrogen
274451|NCT01778985|Premarin|premarin
274452|NCT01778972|Fall prevention|fall prevention
274453|NCT01778972|Home exercise|home exercise
274454|NCT01778972|Strength training|strength training
274455|NCT01778972|Balance training|balance training
274456|NCT01778946|Nicotine|nicotine
274457|NCT01778946|Down Syndrome|down syndrome
274458|NCT01778946|Mild Cognitive Impairment|mild cognitive impairment
274459|NCT01778946|Event Related Potential|event related potential
274460|NCT01778946|Memory|memory
274461|NCT01778946|Attention|attention
274462|NCT01778946|Trisomy 21|trisomy 21
274463|NCT01778946|Neuroprotection|neuroprotection
274464|NCT01778946|Cognitive Enhancement|cognitive enhancement
274465|NCT01778946|Alzheimer's Disease|alzheimer's disease
274466|NCT01778946|Dementia|dementia
274467|NCT01778946|APOE|apoe
274468|NCT01778933|Renal cell carcinoma|renal cell carcinoma
274469|NCT01778933|Renal nodules|renal nodules
274470|NCT01778907|Pharmacogenetics|pharmacogenetics
274471|NCT01778907|Depression|depression
274472|NCT01778907|Depressive Disorder|depressive disorder
274473|NCT01778907|Cytochrome P-450 CYP2D6|cytochrome p-450 cyp2d6
274474|NCT01778907|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic
274475|NCT01778907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation
274476|NCT01778907|Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant|poor metabolizer due to cytochrome p450 cyp2d6 variant
274477|NCT01778907|Intermediate Metabolizer Due to Cytochrome P450 CYP2D6 Variant|intermediate metabolizer due to cytochrome p450 cyp2d6 variant
274478|NCT01778907|Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant|ultrarapid metabolizer due to cytochrome p450 cyp2d6 variant
274479|NCT01778907|Multicenter studies|multicenter studies
274480|NCT01778894|Diastolic Dysfunction, Diastolic Heart Failure, Diastolic|diastolic dysfunction, diastolic heart failure, diastolic
274481|NCT01778894|Echocardiography|echocardiography
274482|NCT01778881|Bruxism|bruxism
274483|NCT01778881|Physical therapy modalities|physical therapy modalities
274484|NCT01778881|Massage|massage
274485|NCT01778881|Muscle stretching exercises|muscle stretching exercises
274486|NCT01778881|Relaxation therapy|relaxation therapy
274487|NCT01778881|Imagination|imagination
274488|NCT01778855|stroke|stroke
274489|NCT01778855|hypothermia|hypothermia
274490|NCT01778855|thrombolysis|thrombolysis
274491|NCT01778855|imaging|imaging
274492|NCT01778855|collateral circulation|collateral circulation
274493|NCT01778855|recanalization|recanalization
274494|NCT01778855|reperfusion|reperfusion
274495|NCT01778842|antiplatelet effect|antiplatelet effect
274496|NCT01778842|prasugrel|prasugrel
274497|NCT01778842|clopidogrel|clopidogrel
274498|NCT01778842|acute coronary syndrome|acute coronary syndrome
5872|NCT03253861|Pancreatitis, Acute Necrotizing/complications|pancreatitis, acute necrotizing/complications
274499|NCT01778816|Achilles tendon, muscle volume, Achilles tendon length, force, ATRS, Hannover, AOFAS|achilles tendon, muscle volume, achilles tendon length, force, atrs, hannover, aofas
274500|NCT01778777|rotator cuff tear arthropathy|rotator cuff tear arthropathy
274501|NCT01778777|inverse prosthesis|inverse prosthesis
274502|NCT01778777|safety|safety
274503|NCT01778777|universe reverse|universe reverse
274504|NCT01778751|Self-Management Support|self-management support
274505|NCT01778751|Depression|depression
274506|NCT01778751|Home Telehealth|home telehealth
274507|NCT01778725|Chorioamnionitis, S100B, Brain, Neuro-development|chorioamnionitis, s100b, brain, neuro-development
274508|NCT01778712|Multi-level intervention|multi-level intervention
274509|NCT01778712|Menopause|menopause
274510|NCT01778712|Body composition|body composition
274511|NCT01778712|Abdominal adipose tissue|abdominal adipose tissue
274512|NCT01778712|Visceral adipose tissue|visceral adipose tissue
274513|NCT01778712|Perceived stress|perceived stress
274514|NCT01778712|Computed tomography|computed tomography
274515|NCT01778712|Dual energy X-ray absorptiometry|dual energy x-ray absorptiometry
274516|NCT01778699|Lactobacillus brevis CD2|lactobacillus brevis cd2
274517|NCT01778699|caries incidence|caries incidence
274518|NCT01778699|plaque-pH|plaque-ph
274519|NCT01778686|Positron Emission Tomography|positron emission tomography
274520|NCT01778686|Serotonin|serotonin
274521|NCT01778686|5-HT2A|5-ht2a
274522|NCT01778686|Radioligand|radioligand
274523|NCT01778660|Fecal Incontinence|fecal incontinence
274524|NCT01778660|Treatment options|treatment options
274525|NCT01778660|Patient Satisfaction|patient satisfaction
274526|NCT01778647|ADHD|adhd
274527|NCT01778647|Omega- 3 Fatty acids|omega- 3 fatty acids
274528|NCT01778647|CGI|cgi
274529|NCT01778647|Conners rating scale|conners rating scale
274530|NCT01778647|Stimulants|stimulants
274531|NCT01778634|Ureaplasma parvum|ureaplasma parvum
274532|NCT01778634|Ureaplasma urealyticum|ureaplasma urealyticum
274533|NCT01778634|prematurity|prematurity
274534|NCT01778634|bronchopulmonary dysplasia|bronchopulmonary dysplasia
274535|NCT01778634|azithromycin|azithromycin
274536|NCT01778621|Acupuncture|acupuncture
274537|NCT01778621|AMH|amh
274538|NCT01778621|Infertility|infertility
274539|NCT01778621|PCOS|pcos
274540|NCT01778621|Pregnancy rate|pregnancy rate
274541|NCT01778608|Sedation|sedation
274542|NCT01778595|Microbiome|microbiome
274543|NCT01778595|Feces|feces
274544|NCT01778595|Cancer Screening|cancer screening
274545|NCT01778582|Emotion|emotion
274546|NCT01778582|Informed Consent|informed consent
274547|NCT01778569|Psoriasis|psoriasis
274548|NCT01778569|Cardiovascular Risk Factors|cardiovascular risk factors
274549|NCT01778569|Inflammation|inflammation
274550|NCT01778569|Lipoproteins|lipoproteins
274551|NCT01778569|Metabolic Dysfunction|metabolic dysfunction
274552|NCT01778556|Lipodystrophy|lipodystrophy
274553|NCT01778556|Leptin|leptin
274554|NCT01778556|Energy Expenditure|energy expenditure
274555|NCT01778556|Diabetes|diabetes
274556|NCT01778556|Hypertriglyceridemia|hypertriglyceridemia
274557|NCT01778543|Coloboma|coloboma
274558|NCT01778530|Glioblastoma|glioblastoma
274559|NCT01778530|Anti-Angiogenesis|anti-angiogenesis
274560|NCT01778530|Radiotherapy|radiotherapy
274561|NCT01778530|Malignant Glioma|malignant glioma
274562|NCT01778530|Progression|progression
274563|NCT01778517|Psychogenic Movement Disorders|psychogenic movement disorders
274564|NCT01778504|Children and Adolescents|children and adolescents
274565|NCT01778504|Natural History Study|natural history study
274566|NCT01778504|Neurodevelopmental Disorders|neurodevelopmental disorders
274567|NCT01778504|Autism|autism
274568|NCT01778504|Obsessive Compulsive Disorder|obsessive compulsive disorder
274569|NCT01778491|Phenotype-Genotype correlation|phenotype-genotype correlation
274570|NCT01778491|Phenotype|phenotype
274571|NCT01778491|Phenotypes|phenotypes
274572|NCT01778491|Age Related Macular Degeneration|age related macular degeneration
274573|NCT01778478|Anxiety|anxiety
274574|NCT01778478|Depression|depression
274575|NCT01778478|Adolescents and Adults|adolescents and adults
274576|NCT01778478|Cancer Diagnosis|cancer diagnosis
274577|NCT01778465|Chronic Rhinosinusitis|chronic rhinosinusitis
274578|NCT01778465|Aspirin exacerbated respiratory disease|aspirin exacerbated respiratory disease
274579|NCT01778465|Asthma|asthma
274580|NCT01778465|Aspirin sensitivity|aspirin sensitivity
274581|NCT01778465|Salicylate|salicylate
274582|NCT01778452|Endometrial priming, genomic expression. Natural cycle. Antagonist GnRH.|endometrial priming, genomic expression. natural cycle. antagonist gnrh.
274583|NCT01778439|Phase 1|phase 1
274584|NCT01778439|Dose escalation|dose escalation
274585|NCT01778439|relapsed or refractory|relapsed or refractory
274586|NCT01778439|solid tumor|solid tumor
274587|NCT01778426|Chronic neuropathic pain syndrome|chronic neuropathic pain syndrome
274588|NCT01778426|Spinal Cord Stimulation|spinal cord stimulation
274589|NCT01778426|Painstim devices|painstim devices
274590|NCT01778426|Efficacy|efficacy
274591|NCT01778426|Safety|safety
274592|NCT01778400|Ultrasound|ultrasound
274593|NCT01778400|Radiofrequency|radiofrequency
274594|NCT01778400|Ethanol|ethanol
6050|NCT03252470|2D laparoscopic surgery|2d laparoscopic surgery
274595|NCT01778400|Predominantly cystic thyroid nodule|predominantly cystic thyroid nodule
274596|NCT01778400|Thyroid nodule|thyroid nodule
274597|NCT01778400|Thyroid|thyroid
274598|NCT01778374|Emergency Medicine|emergency medicine
274599|NCT01778374|Screening|screening
274600|NCT01778374|Point of care testing|point of care testing
274601|NCT01778374|Video assisted counseling|video assisted counseling
274602|NCT01778361|Human immunodeficiency virus|human immunodeficiency virus
274603|NCT01778361|low bone mineral density|low bone mineral density
274604|NCT01778361|osteopenia|osteopenia
274605|NCT01778361|osteoporosis|osteoporosis
274606|NCT01778361|fracture|fracture
274607|NCT01778348|Type 1 diabetes|type 1 diabetes
274608|NCT01778348|Closed-loop glucose control|closed-loop glucose control
274609|NCT01778348|Artificial Pancreas|artificial pancreas
274610|NCT01778348|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
274611|NCT01778348|Continuous glucose monitoring|continuous glucose monitoring
274612|NCT01778335|recanalization|recanalization
339364|NCT01494142|GWAS|gwas
274613|NCT01778335|endovascular|endovascular
274614|NCT01778335|thrombectomy|thrombectomy
274615|NCT01778309|aseptic inflammation|aseptic inflammation
274616|NCT01778309|skeletal muscle function|skeletal muscle function
274617|NCT01778309|exercise|exercise
274618|NCT01778296|Dorsal branch of the digital nerve;|dorsal branch of the digital nerve;
274619|NCT01778296|dorsal digital artery;|dorsal digital artery;
274620|NCT01778296|dorsal digital island flap;|dorsal digital island flap;
274621|NCT01778296|neurocutaneous island flap.|neurocutaneous island flap.
274622|NCT01778270|pleural effusion|pleural effusion
274623|NCT01778270|pleural drainage|pleural drainage
274624|NCT01778270|thorax impedance|thorax impedance
274625|NCT01778270|respiration parameters|respiration parameters
274626|NCT01778270|heart sounds analysis|heart sounds analysis
274627|NCT01778257|Mate extracts|mate extracts
274629|NCT01778257|abdominal fat|abdominal fat
274630|NCT01778244|schizophrenia; dyslipidemia|schizophrenia; dyslipidemia
274631|NCT01778231|Focus|focus
274632|NCT01778231|uptake|uptake
274633|NCT01778231|Lutein|lutein
274634|NCT01778231|Zeaxanthin|zeaxanthin
274635|NCT01778231|individuals|individuals
274636|NCT01778218|Coronary Artery Disease|coronary artery disease
274637|NCT01778218|CAD|cad
274638|NCT01778192|Bowel preparation|bowel preparation
274639|NCT01778192|Polyethylene glycol|polyethylene glycol
274640|NCT01778192|Sodium picosulphate|sodium picosulphate
274641|NCT01778179|Lentigines|lentigines
274642|NCT01778179|Cryotherapy|cryotherapy
274643|NCT01778179|hyperpigmentation|hyperpigmentation
274644|NCT01778166|Early enteral nutrition|early enteral nutrition
274645|NCT01778166|Laparoscopic gastrointestinal surgery|laparoscopic gastrointestinal surgery
274646|NCT01778166|Immuno-enhanced nutrition|immuno-enhanced nutrition
274647|NCT01778153|Fitness training|fitness training
274648|NCT01778153|Personal training|personal training
274649|NCT01778140|Clinical Decision Support Systems|clinical decision support systems
274650|NCT01778140|Contrast-induced nephropathy|contrast-induced nephropathy
274651|NCT01778127|Cancer Survivor|cancer survivor
274652|NCT01778127|Physical Activity|physical activity
274653|NCT01778127|Health Outcomes|health outcomes
274654|NCT01778127|Rewards-Based Intervention|rewards-based intervention
274655|NCT01778127|Cardiovascular Health|cardiovascular health
274656|NCT01778127|Musculoskeletal Health|musculoskeletal health
274657|NCT01778127|Exercise|exercise
274658|NCT01778114|Vitamin D2|vitamin d2
274659|NCT01778114|Vitamin D3|vitamin d3
274660|NCT01778114|Vitamin D|vitamin d
274661|NCT01778114|Orange Juice|orange juice
274662|NCT01778101|preterm infants|preterm infants
274663|NCT01778101|reflux|reflux
274664|NCT01778101|impedance|impedance
274665|NCT01778101|pH|ph
274666|NCT01778101|monitoring|monitoring
274667|NCT01778101|lansoprazole|lansoprazole
274668|NCT01778075|Healthy|healthy
274669|NCT01778075|Ultracet extended release (ER)|ultracet extended release (er)
274670|NCT01778075|Tramadol hydrochloride|tramadol hydrochloride
274671|NCT01778075|Acetaminophen|acetaminophen
274672|NCT01778075|Bioequivalence|bioequivalence
274673|NCT01778036|Neck movement|neck movement
274674|NCT01778036|motor control|motor control
274675|NCT01778036|disability|disability
274676|NCT01778036|psychological variables|psychological variables
274677|NCT01778036|Head Movements|head movements
274678|NCT01778036|Physical therapy|physical therapy
274679|NCT01778036|Fear avoidance|fear avoidance
274680|NCT01778036|Self Efficacy|self efficacy
274681|NCT01778036|Catastrophizing|catastrophizing
274682|NCT01778036|Fly test|fly test
274683|NCT01778036|Postural sway|postural sway
274685|NCT01778010|modafinil|modafinil
274686|NCT01778010|self-administration|self-administration
274687|NCT01778010|DRD4|drd4
274688|NCT01777906|nasal polyps|nasal polyps
274689|NCT01777906|nasal steriod sprays|nasal steriod sprays
274690|NCT01777893|Type-2 diabetes mellitus|type-2 diabetes mellitus
274691|NCT01777893|Obesity|obesity
274692|NCT01777893|High protein diet|high protein diet
274693|NCT01777893|Low GI|low gi
274694|NCT01777893|Physical activity|physical activity
274695|NCT01777815|NeoChord|neochord
274696|NCT01777815|DS1000|ds1000
274697|NCT01777815|Mitral Valve|mitral valve
274698|NCT01777815|Mitral Valve Regurgitation|mitral valve regurgitation
274700|NCT01777815|Mitral Valve Repair|mitral valve repair
274701|NCT01777815|Mitral Valve Prolapse|mitral valve prolapse
274702|NCT01777815|Artificial Chordae|artificial chordae
274703|NCT01777789|fMRI|fmri
274704|NCT01777789|Dementia|dementia
274705|NCT01777789|Alzheimer's disease|alzheimer's disease
274706|NCT01777789|functional neuroimaging|functional neuroimaging
274707|NCT01777789|Memory|memory
274708|NCT01777776|Open-label dose escalation|open-label dose escalation
274709|NCT01777776|BRAF inhibitor|braf inhibitor
274710|NCT01777776|LEE011|lee011
274711|NCT01777776|CDK4/6|cdk4/6
274712|NCT01777776|LGX818|lgx818
274713|NCT01777776|RAF kinase inhibitor|raf kinase inhibitor
274714|NCT01777776|Metastatic melanoma|metastatic melanoma
339495|NCT01493427|OAG|oag
274715|NCT01777776|BRAF|braf
274716|NCT01777776|V600|v600
274717|NCT01777750|Myocardial Infarction|myocardial infarction
274718|NCT01777750|Myocardial Reperfusion Injury|myocardial reperfusion injury
274719|NCT01777750|Reperfusion Injury|reperfusion injury
274720|NCT01777750|Anterior Wall Myocardial Infarction|anterior wall myocardial infarction
274721|NCT01777750|Inferior Wall Myocardial Infarction|inferior wall myocardial infarction
274722|NCT01777750|Pathologic Processes|pathologic processes
274723|NCT01777750|Myocardial Ischemia|myocardial ischemia
274724|NCT01777737|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
274725|NCT01777737|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
274726|NCT01777737|Pneumocystis jiroveci|pneumocystis jiroveci
274727|NCT01777711|mental contrasting|mental contrasting
274728|NCT01777711|weight loss|weight loss
274729|NCT01777711|obese couples|obese couples
274730|NCT01777711|obesity|obesity
274731|NCT01777711|overweight|overweight
274732|NCT01777711|planning|planning
274733|NCT01777711|health|health
274735|NCT01777711|exercise|exercise
274736|NCT01777711|physical activity|physical activity
274737|NCT01777711|goal|goal
274738|NCT01777711|goal-setting|goal-setting
274739|NCT01777698|body composition|body composition
274740|NCT01777698|hepatocellular carcinoma|hepatocellular carcinoma
274741|NCT01777698|chemoembolization|chemoembolization
274742|NCT01777685|Sulpiride|sulpiride
274743|NCT01777685|Therapeutic drug monitoring|therapeutic drug monitoring
274744|NCT01777685|Pharmacokinetics|pharmacokinetics
274745|NCT01777659|exercise|exercise
274746|NCT01777659|neuromodulation|neuromodulation
274747|NCT01777659|blood flow|blood flow
274748|NCT01777659|exercise capacity|exercise capacity
274749|NCT01777646|Mesenchymal Strmal Cells (MSC)|mesenchymal strmal cells (msc)
274750|NCT01777646|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
274751|NCT01777646|Neuroprotection|neuroprotection
274752|NCT01777646|Neurodegeneration|neurodegeneration
274753|NCT01777646|Stem cells|stem cells
274754|NCT01777594|hepatocellular carcinoma|hepatocellular carcinoma
274755|NCT01777594|HCC|hcc
274756|NCT01777594|liver|liver
274757|NCT01777594|liver cancer|liver cancer
274758|NCT01777594|sorafenib|sorafenib
274759|NCT01777581|sciatica radiculopathy lumbar disc lumbosacral disc|sciatica radiculopathy lumbar disc lumbosacral disc
274760|NCT01777555|Parkinson's Disease|parkinson's disease
274761|NCT01777555|Motor fluctuations|motor fluctuations
274762|NCT01777555|levodopa|levodopa
274763|NCT01777555|inhaled drugs|inhaled drugs
274764|NCT01777555|Off episodes|off episodes
274765|NCT01777542|Rett syndrome|rett syndrome
274766|NCT01777542|RTT|rtt
274767|NCT01777542|IGF-1|igf-1
274768|NCT01777542|autism spectrum disorder|autism spectrum disorder
274769|NCT01777529|Measles|measles
274770|NCT01777529|Mumps|mumps
274771|NCT01777529|Rubella|rubella
274772|NCT01777516|Platelet Aggregation|platelet aggregation
274773|NCT01777516|Cardiovascular Diseases|cardiovascular diseases
274774|NCT01777516|Salicylic Acid|salicylic acid
274775|NCT01777503|acute coronary syndrome|acute coronary syndrome
274776|NCT01777503|elderly|elderly
274777|NCT01777503|percutaneous revascularization|percutaneous revascularization
274778|NCT01777503|antiaggregant drugs|antiaggregant drugs
274779|NCT01777490|Caregivers - Not professionals|caregivers - not professionals
274780|NCT01777490|Frail Elderly|frail elderly
274781|NCT01777490|Long-term Care|long-term care
274782|NCT01777490|Quality of Life|quality of life
274783|NCT01777451|Whole Body Imaging|whole body imaging
274784|NCT01777451|Magnetic Resonance Imaging|magnetic resonance imaging
274785|NCT01777451|Neurofibromatosis 1|neurofibromatosis 1
274786|NCT01777451|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
274787|NCT01777451|Peripheral Nerve Sheath Tumors, Malignant|peripheral nerve sheath tumors, malignant
274788|NCT01777412|NMO|nmo
274789|NCT01777412|NMOSD|nmosd
274790|NCT01777412|NMO-IgG|nmo-igg
274791|NCT01777412|Aquaporin-4|aquaporin-4
274792|NCT01777412|AQP4|aqp4
274793|NCT01777412|anti-AQP4|anti-aqp4
274794|NCT01777386|scar|scar
274795|NCT01777386|contracture|contracture
274796|NCT01777386|perforator flap|perforator flap
274797|NCT01777386|preexpanded perforator flap|preexpanded perforator flap
274799|NCT01777386|artery diameter|artery diameter
274800|NCT01777373|conducting airway, bronchiolization|conducting airway, bronchiolization
274801|NCT01777360|severe|severe
274802|NCT01777360|uncontrolled|uncontrolled
274803|NCT01777347|Keywords provided by ASSISTANCE PUBLIQUE HOPITAUX DE PARIS:|keywords provided by assistance publique hopitaux de paris:
274804|NCT01777347|Acute Viral bronchiolitis|acute viral bronchiolitis
274805|NCT01777347|Hypertonic saline|hypertonic saline
274806|NCT01777347|Hospitalization|hospitalization
274807|NCT01777347|Infants|infants
274808|NCT01777347|Hospital admissions|hospital admissions
274809|NCT01777347|Additional relevant MeSH terms:|additional relevant mesh terms:
274810|NCT01777347|Bronchiolitis|bronchiolitis
274811|NCT01777347|Bronchiolitis, Viral|bronchiolitis, viral
274812|NCT01777347|Bronchial Diseases|bronchial diseases
274813|NCT01777347|Respiratory Tract Diseases|respiratory tract diseases
274814|NCT01777347|Lung Diseases, Obstructive|lung diseases, obstructive
274815|NCT01777347|Respiratory Tract Infections|respiratory tract infections
274816|NCT01777347|Virus Diseases|virus diseases
274817|NCT01777321|Herpes Zoster|herpes zoster
274818|NCT01777321|Intramuscular|intramuscular
274819|NCT01777321|Subcutaneous|subcutaneous
274820|NCT01777321|Safety|safety
274821|NCT01777321|≥50 years of age|≥50 years of age
274822|NCT01777321|Adults|adults
274823|NCT01777321|Immunogenicity|immunogenicity
274824|NCT01777321|Elderly|elderly
274825|NCT01777308|Immunogenicity|immunogenicity
274826|NCT01777308|Booster|booster
274827|NCT01777308|Healthy|healthy
274828|NCT01777308|Vaccine response|vaccine response
274829|NCT01777308|Safety|safety
274830|NCT01777308|Neisseria meningiditis|neisseria meningiditis
274831|NCT01777308|Antibody persistence|antibody persistence
274832|NCT01777308|Meningococcal conjugate vaccine|meningococcal conjugate vaccine
274833|NCT01777295|Adults|adults
274834|NCT01777295|Reactogenicity|reactogenicity
274835|NCT01777295|Naive|naive
274932|NCT01777009|SF-36|sf-36
274836|NCT01777295|Immune responses|immune responses
274837|NCT01777295|Read-outs|read-outs
274838|NCT01777295|Hepatitis B|hepatitis b
274839|NCT01777295|Healthy|healthy
274840|NCT01777282|albiglutide|albiglutide
274841|NCT01777282|Japanese|japanese
274842|NCT01777282|glucagon-like peptide-1|glucagon-like peptide-1
274843|NCT01777282|GSK716155|gsk716155
274844|NCT01777256|systemic lupus erythematosus|systemic lupus erythematosus
274845|NCT01777256|adaptive design|adaptive design
274846|NCT01777256|clinical safety and efficacy|clinical safety and efficacy
274847|NCT01777256|pharmacodynamics|pharmacodynamics
274848|NCT01777243|pharmacokinetic|pharmacokinetic
274849|NCT01777243|systemic amyloidosis|systemic amyloidosis
274850|NCT01777243|safety|safety
274851|NCT01777243|dose escalation|dose escalation
274852|NCT01777243|Carboxy Pyrrolidine Hexanoyl Pyrrolidine Carboxylate (CPHPC)|carboxy pyrrolidine hexanoyl pyrrolidine carboxylate (cphpc)
274853|NCT01777243|biomarker|biomarker
274854|NCT01777243|GSK2315698|gsk2315698
274855|NCT01777243|GSK2398852|gsk2398852
274856|NCT01777243|SAP|sap
274857|NCT01777243|pharmacodynamic|pharmacodynamic
274858|NCT01777243|co-administration|co-administration
274859|NCT01777243|intravenous|intravenous
274860|NCT01777217|Urination Disorder|urination disorder
274861|NCT01777217|Overactive Bladder|overactive bladder
274862|NCT01777217|Prostate Cancer Radiation|prostate cancer radiation
274863|NCT01777217|Vesicare|vesicare
274864|NCT01777204|Renal transplant, Gastrointestinal motility, Biomagnetism|renal transplant, gastrointestinal motility, biomagnetism
274865|NCT01777178|bicarbonate|bicarbonate
274866|NCT01777178|dialysis|dialysis
274867|NCT01777165|GFR|gfr
274868|NCT01777165|Acute Kidney Injury|acute kidney injury
274869|NCT01777165|High Risk cardiac surgery|high risk cardiac surgery
274870|NCT01777152|Antibodies, Monoclonal|antibodies, monoclonal
274871|NCT01777152|Antibody-Drug Conjugate|antibody-drug conjugate
274872|NCT01777152|Antigens, CD30|antigens, cd30
274873|NCT01777152|Drug Therapy|drug therapy
274874|NCT01777152|Hematologic Diseases|hematologic diseases
274875|NCT01777152|Lymphoma|lymphoma
274876|NCT01777152|Monomethyl auristatin E|monomethyl auristatin e
274877|NCT01777152|Lymphoma, T-Cell|lymphoma, t-cell
274878|NCT01777152|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
274879|NCT01777152|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
274880|NCT01777139|Retigabine|retigabine
274881|NCT01777139|Drug-Resistant|drug-resistant
274882|NCT01777139|Epilepsy|epilepsy
274883|NCT01777139|Partial-Onset Seizures|partial-onset seizures
274884|NCT01777139|Safety and Tolerability|safety and tolerability
274885|NCT01777139|Immediate Release|immediate release
274886|NCT01777139|Long-Term|long-term
274887|NCT01777139|Adjunctive Therapy|adjunctive therapy
274888|NCT01777139|Asian Subjects|asian subjects
274889|NCT01777139|Efficacy|efficacy
274890|NCT01777139|GW582892|gw582892
274891|NCT01777126|cystectomy|cystectomy
274892|NCT01777126|parenteral nutrition|parenteral nutrition
274893|NCT01777126|discharge|discharge
274894|NCT01777126|outcome|outcome
274895|NCT01777113|Chronic Stroke|chronic stroke
274896|NCT01777113|Gait|gait
274897|NCT01777113|Exercise|exercise
274898|NCT01777113|High intensity aerobic training|high intensity aerobic training
274899|NCT01777113|Strength training|strength training
274900|NCT01777113|Randomized controlled trial|randomized controlled trial
274901|NCT01777100|Postoperative pain|postoperative pain
274902|NCT01777100|Patient controlled analgesia|patient controlled analgesia
274903|NCT01777100|Hyperalgesia|hyperalgesia
274904|NCT01777100|Remifentanil|remifentanil
274905|NCT01777100|Sufentanil|sufentanil
274906|NCT01777100|Morphine|morphine
274909|NCT01777087|Pain|pain
274910|NCT01777087|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
274911|NCT01777074|Vaccination|vaccination
274912|NCT01777074|Acceptability|acceptability
274913|NCT01777074|Hepatitis B|hepatitis b
265558|NCT01819389|imatinib|imatinib
265559|NCT01819389|nilotinib|nilotinib
265560|NCT01819376|Obesity|obesity
265561|NCT01819376|Overweight|overweight
265562|NCT01819376|Adolescents|adolescents
265563|NCT01819376|Teenagers|teenagers
274914|NCT01777061|Prostate Cancer|prostate cancer
274915|NCT01777061|Recurrent Prostate Cancer|recurrent prostate cancer
274916|NCT01777061|PET Scan|pet scan
274917|NCT01777061|FDG-PET|fdg-pet
274918|NCT01777061|[11C]Acetate|[11c]acetate
274919|NCT01777061|C11-Acetate|c11-acetate
274920|NCT01777035|mechanical ventilation|mechanical ventilation
274921|NCT01777035|physical therapy|physical therapy
274922|NCT01777035|occupational therapy|occupational therapy
274923|NCT01777035|ICU acquired weakness|icu acquired weakness
274924|NCT01777035|critical illness myopathy|critical illness myopathy
274925|NCT01777022|Education, Stillbirth, Prevention, Management|education, stillbirth, prevention, management
274926|NCT01777009|Total Knee Replacement|total knee replacement
274927|NCT01777009|Patellar Eversion|patellar eversion
274928|NCT01777009|Surgical Exposure|surgical exposure
274929|NCT01777009|Outcomes|outcomes
274930|NCT01777009|Quadriceps Strength|quadriceps strength
274931|NCT01777009|Straight Leg Raise|straight leg raise
274933|NCT01776996|Expanded access, HIV, maraviroc|expanded access, hiv, maraviroc
274934|NCT01776970|Motor Neuron Disease|motor neuron disease
274935|NCT01776970|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
274936|NCT01776970|Cannabinoids|cannabinoids
274937|NCT01776970|Sativex|sativex
274938|NCT01776970|Spasticity|spasticity
274939|NCT01776957|Abortion rate|abortion rate
274940|NCT01776957|Intrauterine device|intrauterine device
274941|NCT01776944|Resting energy expenditure|resting energy expenditure
274942|NCT01776944|Handheld calorimeter|handheld calorimeter
274943|NCT01776944|Obese and overweight|obese and overweight
274944|NCT01776944|Pediatrics|pediatrics
274945|NCT01776931|Indicator Amino acid technique|indicator amino acid technique
274946|NCT01776931|Lysine requirements|lysine requirements
274947|NCT01776931|Pregnancy|pregnancy
274948|NCT01776931|Dietary protein|dietary protein
274949|NCT01776918|POLG1 Mutation|polg1 mutation
274950|NCT01776918|Phenylketonuria|phenylketonuria
274953|NCT01776892|Collagenase|collagenase
274954|NCT01776892|Needle aponeurotomy|needle aponeurotomy
274955|NCT01776866|Coronary Angiography|coronary angiography
274956|NCT01776866|Rotational Coronary Angiography|rotational coronary angiography
274957|NCT01776866|Contrast Media|contrast media
274958|NCT01776866|Radiation|radiation
274959|NCT01776866|Quantitative Coronary Angiography|quantitative coronary angiography
274960|NCT01776853|Irritable Bowel Syndrome|irritable bowel syndrome
274961|NCT01776853|Fructose|fructose
274962|NCT01776853|Fructans|fructans
274964|NCT01776853|Fermentation|fermentation
274965|NCT01776853|Breath Tests|breath tests
274966|NCT01776853|Flatulence|flatulence
274967|NCT01776853|Abdominal Pain|abdominal pain
274968|NCT01776853|Diarrhoea|diarrhoea
274969|NCT01776840|Mantle cell lymphoma|mantle cell lymphoma
274970|NCT01776840|Ibrutinib|ibrutinib
274971|NCT01776840|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
274972|NCT01776840|Bendamustine hydrochloride|bendamustine hydrochloride
274973|NCT01776840|Rituximab|rituximab
274974|NCT01776827|GERD|gerd
274975|NCT01776827|Hiatal Hernia|hiatal hernia
274976|NCT01776827|Paraesophageal Hernia|paraesophageal hernia
274977|NCT01776827|Biologic Mesh|biologic mesh
274978|NCT01776814|Entecair|entecair
274979|NCT01776814|Tenofovir|tenofovir
274980|NCT01776801|intracranial baroreflex|intracranial baroreflex
274981|NCT01776762|Nutrition|nutrition
274982|NCT01776762|Rehabilitation|rehabilitation
274983|NCT01776762|Weightloss|weightloss
274999|NCT01776710|Randomized controlled trial|randomized controlled trial
275001|NCT01776658|Dry Eye Syndrome|dry eye syndrome
275002|NCT01776658|siRNA|sirna
275003|NCT01776658|RNAi|rnai
275004|NCT01776658|TRPV1|trpv1
275005|NCT01776619|Safety|safety
275006|NCT01776619|tolerability|tolerability
275007|NCT01776619|PK|pk
275008|NCT01776593|bladder capacity; bladder diary; bladder oversensitivity; lower urinary tract symptoms|bladder capacity; bladder diary; bladder oversensitivity; lower urinary tract symptoms
275009|NCT01776580|Pelvic organ prolapse|pelvic organ prolapse
275010|NCT01776580|lower urinary tract symptoms|lower urinary tract symptoms
275011|NCT01776580|sexual dysfunction|sexual dysfunction
275012|NCT01776567|coronary artery disease|coronary artery disease
275013|NCT01776567|stents|stents
275014|NCT01776567|optical imaging|optical imaging
275015|NCT01776554|Influenza, Pandemic, H5N1, Children|influenza, pandemic, h5n1, children
275016|NCT01776541|Influenza, Pandemic, H5N1, Adults|influenza, pandemic, h5n1, adults
275017|NCT01776515|Low back pain|low back pain
275018|NCT01776515|Wontran|wontran
275019|NCT01776515|Wontran SR Tab.|wontran sr tab.
339952|NCT01491555|DMD|dmd
275020|NCT01776515|Tramadol Hydrochloride/Acetaminophen|tramadol hydrochloride/acetaminophen
275021|NCT01776489|Food allergy|food allergy
275022|NCT01776489|Sphingosine-1-phosphate|sphingosine-1-phosphate
275023|NCT01776489|Biomarker|biomarker
275024|NCT01776489|Double-blind placebo-controlled food challenge|double-blind placebo-controlled food challenge
275025|NCT01776489|Anaphylaxis|anaphylaxis
275026|NCT01776476|glutamine dipeptide|glutamine dipeptide
275027|NCT01776476|randomized controlled trial|randomized controlled trial
275028|NCT01776476|insulin resistance|insulin resistance
275029|NCT01776476|critical illness|critical illness
275030|NCT01776476|trauma|trauma
275031|NCT01776463|Z-360|z-360
275032|NCT01776463|Japanese|japanese
275033|NCT01776463|pK|pk
275034|NCT01776450|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
275053|NCT01776398|COPD|copd
275054|NCT01776398|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
275055|NCT01776398|Lung disease|lung disease
275056|NCT01776398|Emphysema|emphysema
275057|NCT01776398|Smoking|smoking
275058|NCT01776398|Healthy Smoker|healthy smoker
275059|NCT01776398|Smoker|smoker
275060|NCT01776398|Non-smoker|non-smoker
275061|NCT01776385|[C08.785.640]|[c08.785.640]
275062|NCT01776385|(C08.528.778)|(c08.528.778)
275063|NCT01776385|[C19.642.713]|[c19.642.713]
275064|NCT01776385|mesothelium|mesothelium
275065|NCT01776372|Drainage|drainage
275066|NCT01776372|Chest tubes|chest tubes
275067|NCT01776372|Randomized Controlled Trial|randomized controlled trial
275068|NCT01776359|Muscle|muscle
275069|NCT01776359|Protein|protein
275070|NCT01776359|Diet|diet
275071|NCT01776359|Exercise|exercise
275072|NCT01776333|ICU|icu
275073|NCT01776320|Erectile Dysfunction|erectile dysfunction
275074|NCT01776320|Topical Alprostadil|topical alprostadil
275075|NCT01776307|BBI608|bbi608
275076|NCT01776294|Prehypertension|prehypertension
275077|NCT01776294|Prevalence|prevalence
275078|NCT01776294|Cardiovascular Risk Factors|cardiovascular risk factors
275079|NCT01776281|effects|effects
275080|NCT01776281|KMC|kmc
275081|NCT01776281|LBW|lbw
275082|NCT01776281|preterm|preterm
275083|NCT01776281|temperature|temperature
275084|NCT01776281|breastfeeding|breastfeeding
275085|NCT01776281|secondary hospitals|secondary hospitals
697247|NCT00956436|HCC|hcc
275086|NCT01776268|antimicrobial proteins|antimicrobial proteins
275087|NCT01776255|Obesity|obesity
275088|NCT01776255|Overweight|overweight
275089|NCT01776255|Lifestyle|lifestyle
275090|NCT01776255|American Indian|american indian
275091|NCT01776242|low back pain|low back pain
275092|NCT01776242|elderly|elderly
275093|NCT01776242|back pain|back pain
275094|NCT01776242|lumbar pain|lumbar pain
275095|NCT01776242|over 65|over 65
275096|NCT01776229|nightmare|nightmare
275097|NCT01776229|PTSD|ptsd
275098|NCT01776229|trauma|trauma
275099|NCT01776229|children|children
275100|NCT01776229|cognitive behavior therapy|cognitive behavior therapy
275101|NCT01776229|stress|stress
275102|NCT01776229|sleep|sleep
275103|NCT01776216|Endothelial function|endothelial function
275104|NCT01776216|Dairy|dairy
275105|NCT01776177|Allergic asthma|allergic asthma
275106|NCT01776177|Omalizumab therapy|omalizumab therapy
275107|NCT01776177|IgE profile|ige profile
275108|NCT01776164|Friedreich|friedreich
275109|NCT01776164|ataxia|ataxia
275110|NCT01776164|FRDA|frda
275111|NCT01776164|FA|fa
275112|NCT01776164|recessive|recessive
275113|NCT01776164|neurodegenerative|neurodegenerative
275114|NCT01776164|cerebellum|cerebellum
275116|NCT01776151|cardiovascular diseases|cardiovascular diseases
275117|NCT01776151|vascular stiffness|vascular stiffness
275119|NCT01776138|Chemotherapy|chemotherapy
275120|NCT01776138|Cystectomy|cystectomy
275121|NCT01776138|Radical Cystectomy|radical cystectomy
275122|NCT01776138|University of North Carolina|university of north carolina
275123|NCT01776138|Cancer|cancer
275124|NCT01776138|Bladder Cancer|bladder cancer
275125|NCT01776138|Bladder|bladder
275126|NCT01776125|Neurofibromatosis Type One|neurofibromatosis type one
275127|NCT01776125|Scoliosis|scoliosis
275128|NCT01776112|schizophrenia|schizophrenia
275129|NCT01776112|negative symptoms|negative symptoms
275130|NCT01776112|cognitive deficits|cognitive deficits
275131|NCT01776112|synaptic plasticity|synaptic plasticity
275132|NCT01776099|type 2 diabetes|type 2 diabetes
275133|NCT01776099|nutrition|nutrition
275134|NCT01776099|fibers|fibers
275135|NCT01776073|Transplantation|transplantation
275136|NCT01776073|Healthcare Disparities|healthcare disparities
275137|NCT01776073|Quality Assurance|quality assurance
275138|NCT01776060|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
275139|NCT01776060|Multiple Sclerosis|multiple sclerosis
275140|NCT01776060|biomarker|biomarker
275141|NCT01776060|'omic|'omic
275142|NCT01776060|progression|progression
275143|NCT01776034|Self Care|self care
275146|NCT01776021|Urinary tract infection|urinary tract infection
265758|NCT01818284|PBPC|pbpc
275147|NCT01776021|Recurrent urinary tract infection|recurrent urinary tract infection
275148|NCT01776021|Cranberry|cranberry
275149|NCT01776021|Prevention|prevention
275150|NCT01776021|E-coli|e-coli
275151|NCT01775995|Chronic Pain|chronic pain
275152|NCT01775995|Low Back Pain|low back pain
275153|NCT01775982|French language validation|french language validation
275154|NCT01775982|The Confusion Assessment Method (CAM)|the confusion assessment method (cam)
275155|NCT01775943|Epidermal growth factor receptor|epidermal growth factor receptor
275156|NCT01775943|Mutation|mutation
275157|NCT01775943|Lung cancer|lung cancer
275158|NCT01775943|Drug sensitivity|drug sensitivity
275159|NCT01775930|Kidney Cancer|kidney cancer
275160|NCT01775930|Refractory Renal Cell Carcinoma|refractory renal cell carcinoma
275161|NCT01775930|RCC|rcc
275162|NCT01775930|Clear cell kidney cancer with metastatic disease|clear cell kidney cancer with metastatic disease
275163|NCT01775930|Carfilzomib|carfilzomib
275164|NCT01775891|pilsicainide|pilsicainide
275165|NCT01775891|class IC antiarrhythmic drug|class ic antiarrhythmic drug
275166|NCT01775891|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
275167|NCT01775891|catheter ablation|catheter ablation
275168|NCT01775878|Diabetes|diabetes
275169|NCT01775878|HbA1c|hba1c
275170|NCT01775878|Fructosamine|fructosamine
275171|NCT01775878|Blood Pressure|blood pressure
275172|NCT01775878|Telemonitoring|telemonitoring
275173|NCT01775865|aortic stiffness|aortic stiffness
275174|NCT01775865|endothelium-dependent dilation|endothelium-dependent dilation
275175|NCT01775865|vascular aging|vascular aging
275176|NCT01775865|oxidative stress|oxidative stress
275177|NCT01775865|inflammation|inflammation
275178|NCT01775865|nitric oxide|nitric oxide
275179|NCT01775865|nuclear factor kappa B|nuclear factor kappa b
275180|NCT01775852|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
275181|NCT01775852|Depression|depression
275182|NCT01775852|Illness Management|illness management
275183|NCT01775852|Behavioral treatment|behavioral treatment
275184|NCT01775852|Impairment|impairment
275185|NCT01775826|physical activity|physical activity
275186|NCT01775826|sedentary behavior|sedentary behavior
275187|NCT01775826|accelerometer|accelerometer
275188|NCT01775826|GPS|gps
275189|NCT01775826|GIS|gis
275190|NCT01775826|machine learning|machine learning
275191|NCT01775813|Insulin resistance|insulin resistance
275192|NCT01775813|Puberty|puberty
275193|NCT01775813|Obesity|obesity
275194|NCT01775813|Hypogonadism|hypogonadism
275195|NCT01775813|Gonadal dysfunction|gonadal dysfunction
275196|NCT01775813|Metformin|metformin
275197|NCT01775787|smoking|smoking
275198|NCT01775774|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
275199|NCT01775774|Acute Lung Injury|acute lung injury
275325|NCT01775150|mobile phone text messaging|mobile phone text messaging
275200|NCT01775774|Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells|allogeneic bone marrow-derived human mesenchymal stem cells
275201|NCT01775761|Thorough QTc evaluation of tafamidis compared to the effects of moxifloxacin and placebo in healthy volunteers.|thorough qtc evaluation of tafamidis compared to the effects of moxifloxacin and placebo in healthy volunteers.
275202|NCT01775735|headache|headache
275203|NCT01775735|pain|pain
275204|NCT01775735|chronic|chronic
275205|NCT01775709|middler ear infection|middler ear infection
275206|NCT01775696|Alzheimer's disease|alzheimer's disease
275207|NCT01775696|Pittsburgh binding Compound (PiB)|pittsburgh binding compound (pib)
275208|NCT01775696|Positron Emission Tomography (PET)|positron emission tomography (pet)
275209|NCT01775696|Inflammation|inflammation
275210|NCT01775696|Anti Abeta immune responses|anti abeta immune responses
275228|NCT01775553|High-Dose Carfilzomib|high-dose carfilzomib
275229|NCT01775553|Standard Dose Carfilzomib|standard dose carfilzomib
275230|NCT01775553|Carfilzomib|carfilzomib
275231|NCT01775540|Dry eye|dry eye
275232|NCT01775540|Artificial tears|artificial tears
275233|NCT01775540|Ocular surface inflammation|ocular surface inflammation
275234|NCT01775501|sorafenib|sorafenib
275235|NCT01775501|FOLFOX|folfox
275236|NCT01775488|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
275237|NCT01775488|BPH|bph
275238|NCT01775488|LUTS|luts
275239|NCT01775488|Vortx Rx|vortx rx
275240|NCT01775488|Histotripsy|histotripsy
275241|NCT01775462|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
275242|NCT01775462|XLHED|xlhed
275243|NCT01775449|Anticancer drug;|anticancer drug;
275244|NCT01775449|Oxaliplatin;|oxaliplatin;
275245|NCT01775449|Digestive cancer system|digestive cancer system
275246|NCT01775449|Acute oxaliplatin-induced hypersensitivity|acute oxaliplatin-induced hypersensitivity
275247|NCT01775449|Hyperalgesia;|hyperalgesia;
275248|NCT01775449|Allodynia;|allodynia;
275249|NCT01775449|Dysesthesia|dysesthesia
275250|NCT01775449|Polyamines depleted diet|polyamines depleted diet
275267|NCT01775397|Clostridium|clostridium
275268|NCT01775397|Difficile|difficile
275269|NCT01775397|Infections|infections
275270|NCT01775397|Immunosuppression|immunosuppression
275271|NCT01775397|Fidaxomicin|fidaxomicin
275272|NCT01775397|Vancomycin|vancomycin
275273|NCT01775397|Efficacy|efficacy
275274|NCT01775397|Stem Cells|stem cells
275275|NCT01775397|Transplantation|transplantation
275276|NCT01775397|Adult|adult
275277|NCT01775397|Dificid|dificid
275278|NCT01775384|Inflammation|inflammation
275279|NCT01775384|Oxidative stress|oxidative stress
275280|NCT01775384|Immune dysfunction|immune dysfunction
275281|NCT01775384|Metabolomics.|metabolomics.
275282|NCT01775371|Pain|pain
275283|NCT01775371|Emergency|emergency
275284|NCT01775371|Analgesia|analgesia
275285|NCT01775371|ED patients|ed patients
275286|NCT01775371|acute pain|acute pain
275287|NCT01775371|IV opioid|iv opioid
275288|NCT01775345|Partial meniscectomy|partial meniscectomy
275289|NCT01775345|Physiotherapy|physiotherapy
275290|NCT01775345|Isokinetics|isokinetics
275291|NCT01775345|Cost-effectiveness|cost-effectiveness
275292|NCT01775319|Zinc|zinc
275293|NCT01775293|Non-absorbable polypropylene mesh|non-absorbable polypropylene mesh
275294|NCT01775293|WSRS|wsrs
275295|NCT01775293|Rhytidectomy|rhytidectomy
275296|NCT01775254|Colon Cancer|colon cancer
275297|NCT01775254|FOLFOX|folfox
275298|NCT01775254|Laparoscopic Colectomy|laparoscopic colectomy
275299|NCT01775254|Open Colectomy|open colectomy
275300|NCT01775254|Robotic Colectomy|robotic colectomy
275301|NCT01775254|Quality of Life|quality of life
275302|NCT01775254|Sexual Function|sexual function
275303|NCT01775254|Peripheral Neuropathy|peripheral neuropathy
275304|NCT01775254|Demands of Illness|demands of illness
275305|NCT01775254|Cancer Survivor|cancer survivor
275306|NCT01775228|Depression, peer support, recovery, health services|depression, peer support, recovery, health services
275307|NCT01775215|Left Ventricular Function|left ventricular function
275308|NCT01775215|Aortic Valve Replacement|aortic valve replacement
275309|NCT01775215|Late Gadolinium Enhancement|late gadolinium enhancement
275310|NCT01775215|Cardiac I123 MIBG|cardiac i123 mibg
275311|NCT01775215|Longitudinal Strain|longitudinal strain
275312|NCT01775215|Brain Natriuretic Peptide|brain natriuretic peptide
275313|NCT01775215|High Sensitivity Troponin I|high sensitivity troponin i
275419|NCT01774695|IBS|ibs
275314|NCT01775189|Relative abuse potential study|relative abuse potential study
275315|NCT01775189|Chronic pain|chronic pain
275316|NCT01775189|oxycodone|oxycodone
275317|NCT01775189|naltrexone|naltrexone
697248|NCT00956436|BIIB022|biib022
275318|NCT01775189|opioid-related disorders|opioid-related disorders
275319|NCT01775189|drug abusers|drug abusers
275320|NCT01775176|PCOS, Weight, Insulin Sensitivity, Reproductive Function|pcos, weight, insulin sensitivity, reproductive function
275321|NCT01775163|Energy|energy
275322|NCT01775163|Metabolism|metabolism
275323|NCT01775163|Weight Loss|weight loss
275324|NCT01775163|Exercise|exercise
275326|NCT01775150|maternality|maternality
275328|NCT01775150|death rate|death rate
275329|NCT01775137|CF, Open-label, TIP, phase IV, extension study|cf, open-label, tip, phase iv, extension study
275330|NCT01775111|strength training|strength training
275331|NCT01775111|protein supplementation|protein supplementation
275332|NCT01775111|sarcopenia|sarcopenia
275333|NCT01775098|Gout|gout
275334|NCT01775098|uric acid|uric acid
275335|NCT01775098|allopurinol|allopurinol
275336|NCT01775085|Interventions|interventions
275337|NCT01775085|Meaning-Centered Group (MCG)|meaning-centered group (mcg)
275338|NCT01775085|Discussion Group (DG)|discussion group (dg)
275339|NCT01775085|Modules|modules
275340|NCT01775085|Sessions|sessions
275341|NCT01775085|12-291|12-291
275342|NCT01775072|tissue|tissue
275343|NCT01775072|blood|blood
275344|NCT01775072|salvia|salvia
275345|NCT01775072|buccal swab|buccal swab
275346|NCT01775072|Genomic Profiling|genomic profiling
275347|NCT01775072|Solid Tumors|solid tumors
275348|NCT01775072|hematologic cancer|hematologic cancer
275349|NCT01775072|Clinical Assay|clinical assay
275350|NCT01775072|Research Assay|research assay
275351|NCT01775072|12-245|12-245
275352|NCT01775046|Valiant|valiant
275353|NCT01775046|Captivia|captivia
275354|NCT01775046|Stent Graft|stent graft
275355|NCT01775046|Thoracic|thoracic
275356|NCT01775046|Aortic|aortic
275357|NCT01775033|Pediatrics|pediatrics
275358|NCT01775033|Emergency medical services|emergency medical services
275359|NCT01775033|Emergency Treatment|emergency treatment
275360|NCT01775033|Telemedicine|telemedicine
275361|NCT01775007|Lens|lens
275362|NCT01775007|Cornea|cornea
275363|NCT01775007|Stiffness|stiffness
275364|NCT01775007|Brillouin Shift|brillouin shift
275365|NCT01775007|Young Modulus|young modulus
275366|NCT01774994|volunteers|volunteers
275367|NCT01774942|Diabetes Mellitus|diabetes mellitus
275368|NCT01774942|C-Reactive Protein|c-reactive protein
275369|NCT01774942|Dental Implants, Single-Tooth|dental implants, single-tooth
275370|NCT01774942|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
275371|NCT01774929|Osteoarthritis|osteoarthritis
275372|NCT01774929|Transdermal Therapeutic System (TTS)-fentanyl|transdermal therapeutic system (tts)-fentanyl
275374|NCT01774903|Low Back Pain|low back pain
275375|NCT01774903|TTS-fentanyl|tts-fentanyl
275376|NCT01774903|Durogesic|durogesic
275377|NCT01774877|xinfeng capsule;|xinfeng capsule;
275378|NCT01774877|rheumatoid arthritis (RA);|rheumatoid arthritis (ra);
275379|NCT01774877|randomized;|randomized;
275380|NCT01774877|double-blind;|double-blind;
275381|NCT01774851|HER-2 Gene Amplification|her-2 gene amplification
275382|NCT01774851|Esophagus Cancer|esophagus cancer
275383|NCT01774851|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
275384|NCT01774851|Stomach Cancer|stomach cancer
275385|NCT01774851|Her2 Positive|her2 positive
275386|NCT01774851|Her2+|her2+
275387|NCT01774851|Esophageal Cancer|esophageal cancer
275388|NCT01774851|Metastatic|metastatic
275389|NCT01774825|Irritable bowel syndrome|irritable bowel syndrome
275391|NCT01774812|vitamin D|vitamin d
275392|NCT01774812|hemodialysis|hemodialysis
275393|NCT01774812|sudden cardiac death|sudden cardiac death
275394|NCT01774812|heart rate variability|heart rate variability
275395|NCT01774812|cardiac autonomic tone|cardiac autonomic tone
275396|NCT01774799|advanced dementia|advanced dementia
275397|NCT01774799|advance care planning|advance care planning
275398|NCT01774799|nursing home|nursing home
275399|NCT01774760|18F-EF5|18f-ef5
275400|NCT01774760|PET/CT|pet/ct
275401|NCT01774760|Reproducibility|reproducibility
275402|NCT01774747|Pharmacokinetics|pharmacokinetics
275403|NCT01774734|Chronic neck pain|chronic neck pain
275404|NCT01774734|Neck strength exerciser|neck strength exerciser
275405|NCT01774734|Biofeedback|biofeedback
275406|NCT01774734|Physiotherapy|physiotherapy
275407|NCT01774734|Strengthening exercise|strengthening exercise
275408|NCT01774734|Randomized trials|randomized trials
275409|NCT01774721|first-line|first-line
275410|NCT01774721|locally advanced or metastatic|locally advanced or metastatic
275411|NCT01774721|non-small cell lung cancer|non-small cell lung cancer
275721|NCT01773252|ASD|asd
275412|NCT01774721|epidermal growth factor receptor|epidermal growth factor receptor
275413|NCT01774721|EGFR|egfr
275414|NCT01774721|Archer|archer
275415|NCT01774721|mutation|mutation
275416|NCT01774721|dacomitinib|dacomitinib
275417|NCT01774721|SFJ|sfj
275418|NCT01774721|PF-00299804|pf-00299804
275420|NCT01774695|physical activity|physical activity
275421|NCT01774695|exercise|exercise
275422|NCT01774682|obesity|obesity
275423|NCT01774682|surgery|surgery
275424|NCT01774669|ischemic stroke|ischemic stroke
275425|NCT01774669|hemorrhagic stroke|hemorrhagic stroke
275426|NCT01774669|upper limb|upper limb
275427|NCT01774669|virtual reality|virtual reality
275428|NCT01774669|physiotherapy|physiotherapy
275429|NCT01774669|occupational therapy|occupational therapy
275430|NCT01774656|heart-assist device|heart-assist device
275431|NCT01774643|Pancreatic cancer|pancreatic cancer
275432|NCT01774643|Liver metastases|liver metastases
275433|NCT01774643|Tumor tissue biopsy|tumor tissue biopsy
275434|NCT01774643|Blood samples|blood samples
275435|NCT01774643|Xenografts|xenografts
275436|NCT01774643|Murine|murine
275437|NCT01774643|Genomic profiling|genomic profiling
275438|NCT01774643|Circulating biomarkers|circulating biomarkers
275439|NCT01774630|Treatment, relapse, complete molecular response|treatment, relapse, complete molecular response
275440|NCT01774617|portal hypertension|portal hypertension
275441|NCT01774617|elastography|elastography
275442|NCT01774617|Hepatic venous pressure gradient measurement|hepatic venous pressure gradient measurement
275443|NCT01774604|Post ERCP acute pancreatitis|post ercp acute pancreatitis
275444|NCT01774604|Post Fine Needle Aspiration (FNA) acute pancreatitis|post fine needle aspiration (fna) acute pancreatitis
275445|NCT01774604|Indomethacin|indomethacin
275446|NCT01774604|Rectal Non Steroidal Anti-Inflammatory Drugs (NSAIDs)|rectal non steroidal anti-inflammatory drugs (nsaids)
275447|NCT01774591|Post Menopause|post menopause
275448|NCT01774591|Female|female
275449|NCT01774591|Obese|obese
275450|NCT01774578|Non-small Cell Lung Cancer|non-small cell lung cancer
275451|NCT01774578|Vaccine Therapy|vaccine therapy
275452|NCT01774578|Immunotherapy|immunotherapy
275453|NCT01774578|Second line therapy|second line therapy
275454|NCT01774578|Progressive|progressive
275455|NCT01774578|Relapsed|relapsed
275456|NCT01774565|Diabetes|diabetes
275457|NCT01774565|Insulin|insulin
275458|NCT01774565|Closed-Loop|closed-loop
275459|NCT01774565|Real-time CGM|real-time cgm
275460|NCT01774565|Subcutaneous insulin pump|subcutaneous insulin pump
275461|NCT01774565|Hospital|hospital
275462|NCT01774539|Fracture|fracture
275463|NCT01774539|Physeal injury|physeal injury
275464|NCT01774539|Diffusion MRI|diffusion mri
275465|NCT01774500|biomarkers|biomarkers
275466|NCT01774500|Emergency Department|emergency department
275467|NCT01774500|Seizures|seizures
275468|NCT01774500|epilepsy|epilepsy
275469|NCT01774500|S100b|s100b
275470|NCT01774500|copeptin|copeptin
275471|NCT01774487|Biliary Atresia|biliary atresia
275472|NCT01774487|Pentoxifylline|pentoxifylline
275473|NCT01774487|Trental|trental
275474|NCT01774487|Serum bilirubin|serum bilirubin
275118|NCT01776138|Elderly|elderly
340419|NCT01489722|AML|aml
275491|NCT01774422|Respiratory Distress Syndrome|respiratory distress syndrome
275492|NCT01774422|Extracorporeal CO2 remover|extracorporeal co2 remover
275493|NCT01774422|Noninvasive ventilation|noninvasive ventilation
275494|NCT01774409|all advanced malignant tumor|all advanced malignant tumor
275495|NCT01774396|Hands Rejuvenation, fillers|hands rejuvenation, fillers
275496|NCT01774383|Parkinson's disease|parkinson's disease
275497|NCT01774383|sub-thalamic nucleus|sub-thalamic nucleus
275498|NCT01774383|oscillation|oscillation
275499|NCT01774383|local field potential|local field potential
275500|NCT01774344|Regorafenib|regorafenib
275501|NCT01774344|BAY73-4506|bay73-4506
275502|NCT01774318|sleep-wake-cycles|sleep-wake-cycles
275503|NCT01774318|preterm infants|preterm infants
275504|NCT01774318|aEEG|aeeg
275505|NCT01774318|conventional EEG|conventional eeg
275506|NCT01774318|polysomnography|polysomnography
275507|NCT01774292|Impact of alkalized lidocaine on coughing at extubation|impact of alkalized lidocaine on coughing at extubation
275508|NCT01774266|Gastric Cancer|gastric cancer
275509|NCT01774266|DNA methylation|dna methylation
275510|NCT01774266|Reprimo|reprimo
275511|NCT01774266|cell-free DNA|cell-free dna
275512|NCT01774266|non-invasive|non-invasive
275513|NCT01774253|DIPG|dipg
275514|NCT01774240|Delirium|delirium
275515|NCT01774240|Cardiac surgery|cardiac surgery
275516|NCT01774240|DOS scale|dos scale
275517|NCT01774227|Refractory glaucoma|refractory glaucoma
275518|NCT01774227|Transcleral cyclophotocoagulation (TSCPC)|transcleral cyclophotocoagulation (tscpc)
275519|NCT01774227|Dark iris|dark iris
276108|NCT01771887|HbA1c|hba1c
275520|NCT01774227|Pops-titration|pops-titration
275521|NCT01774227|Slow-coagulation|slow-coagulation
275522|NCT01774214|Resuscitation|resuscitation
275523|NCT01774214|Shock|shock
275524|NCT01774214|Fluid Therapy|fluid therapy
275525|NCT01774214|Pediatrics|pediatrics
275526|NCT01774201|Multiple sclerosis|multiple sclerosis
275527|NCT01774201|Self-assessment|self-assessment
275528|NCT01774201|Physical endurance|physical endurance
275529|NCT01774201|Respiratory function|respiratory function
275530|NCT01774201|Fatigue|fatigue
275531|NCT01774188|Enhanced Extracorporeal Counterpulsation|enhanced extracorporeal counterpulsation
275532|NCT01774188|intraocular pressure|intraocular pressure
275533|NCT01774188|Pen type tonometer|pen type tonometer
275534|NCT01774175|Bowel preparation|bowel preparation
275535|NCT01774175|PEG with ascorbic acid|peg with ascorbic acid
275536|NCT01774175|Picosulfate|picosulfate
275537|NCT01774162|Endoscopic Ultrasound|endoscopic ultrasound
275538|NCT01774162|Fine needle aspiration|fine needle aspiration
275539|NCT01774162|Fine needle biopsy|fine needle biopsy
275540|NCT01774162|ProCore|procore
275541|NCT01774136|community health workers|community health workers
275542|NCT01774136|HIV|hiv
275543|NCT01774136|PMTCT|pmtct
275544|NCT01774136|antenatal|antenatal
275545|NCT01774136|postnatal|postnatal
275546|NCT01774136|breastfeeding|breastfeeding
275547|NCT01774136|South Africa|south africa
275548|NCT01774110|stroke|stroke
275549|NCT01774110|gait|gait
275550|NCT01774110|acute|acute
275551|NCT01774097|Peripheral Artery Disease|peripheral artery disease
275552|NCT01774097|Intermittent Claudication|intermittent claudication
275553|NCT01774097|Autologous Stem Cells|autologous stem cells
275554|NCT01774097|ALDH cells|aldh cells
275555|NCT01774097|Claudicants|claudicants
275556|NCT01774097|PAD|pad
275557|NCT01774097|Peak Walking Time|peak walking time
275558|NCT01774097|MRI|mri
275559|NCT01774097|Vascular Flow|vascular flow
275560|NCT01774097|Anatomy|anatomy
275561|NCT01774097|Perfusion|perfusion
275562|NCT01774084|Insulin sensitivity|insulin sensitivity
275563|NCT01774084|Beta cell function|beta cell function
275564|NCT01774084|Carbohydrate preload|carbohydrate preload
275565|NCT01774084|Elective hip replacement|elective hip replacement
275566|NCT01774084|Double-blind randomized control study|double-blind randomized control study
275567|NCT01774071|89Zr-DFO-MSTP2109A|89zr-dfo-mstp2109a
275568|NCT01774071|tracer|tracer
275569|NCT01774071|pet scan|pet scan
275570|NCT01774071|12-178|12-178
275571|NCT01774058|blood flow volume|blood flow volume
275572|NCT01774058|ilomedin|ilomedin
275573|NCT01774058|measurement|measurement
275574|NCT01774058|intraarterial|intraarterial
275575|NCT01774058|neuropathy|neuropathy
275576|NCT01774045|Major depressive disorder|major depressive disorder
275577|NCT01774045|Depression|depression
275578|NCT01774019|Pancreatic|pancreatic
275579|NCT01774019|Periampullary Cancer|periampullary cancer
275580|NCT01774019|Preoperative Biliary Drainage|preoperative biliary drainage
275581|NCT01774019|Resectable|resectable
275582|NCT01774006|In vitro fertilization|in vitro fertilization
275583|NCT01774006|Embryo transfer|embryo transfer
275584|NCT01774006|Embryo culture|embryo culture
275585|NCT01774006|individual culture|individual culture
275586|NCT01774006|Group culture|group culture
275587|NCT01774006|embryo quality|embryo quality
275588|NCT01774006|Pregnancy rate|pregnancy rate
275589|NCT01774006|Implantation|implantation
275591|NCT01773993|pregabalin|pregabalin
275592|NCT01773993|Good post marketing practice|good post marketing practice
275593|NCT01773993|Post Marketing Surveillance|post marketing surveillance
275594|NCT01773993|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
275595|NCT01773993|Fibromyalgia|fibromyalgia
275596|NCT01773967|Lactobacillus rhamnosus GG|lactobacillus rhamnosus gg
275597|NCT01773967|LGG|lgg
275598|NCT01773967|Probiotic|probiotic
275599|NCT01773967|Gastroenteritis|gastroenteritis
275600|NCT01773967|acute gastroenteritis|acute gastroenteritis
275601|NCT01773967|child|child
275602|NCT01773967|pediatric|pediatric
275603|NCT01773967|RCT|rct
275604|NCT01773954|amd|amd
275605|NCT01773954|age related macular degeneration|age related macular degeneration
275606|NCT01773954|macular degeneration|macular degeneration
275607|NCT01773954|neovascular|neovascular
275608|NCT01773928|Active immunization against influenza disease|active immunization against influenza disease
275609|NCT01773889|Epithelial Ovarian Cancer|epithelial ovarian cancer
275610|NCT01773889|FIGO (International Federation of Gynecology and Obstetrics )Stage III or Stage IV|figo (international federation of gynecology and obstetrics )stage iii or stage iv
275611|NCT01773889|Extraovarian Peritoneal Cancer|extraovarian peritoneal cancer
275612|NCT01773889|Fallopian Tube Carcinoma Failing|fallopian tube carcinoma failing
275613|NCT01773876|survival without proven invasive candidiasis|survival without proven invasive candidiasis
275614|NCT01773876|effectiveness|effectiveness
275615|NCT01773876|micafungin versus placebo|micafungin versus placebo
275616|NCT01773876|pharmacokinetic|pharmacokinetic
275617|NCT01773876|pharmacodynamic|pharmacodynamic
275618|NCT01773876|tolerance|tolerance
697249|NCT00956436|Open-Label|open-label
275811|NCT01773031|MR pancreatography|mr pancreatography
275619|NCT01773863|Community-acquired pneumonia|community-acquired pneumonia
275620|NCT01773863|Acute myocardial infarction|acute myocardial infarction
275621|NCT01773863|Platelet activation|platelet activation
275622|NCT01773863|Coagulation abnormalities,|coagulation abnormalities,
275623|NCT01773863|Thrombosis|thrombosis
275624|NCT01773863|Isoprosantes|isoprosantes
275625|NCT01773863|NADPH oxidase|nadph oxidase
275626|NCT01773863|Major adverse cardiac and cerebrovascular events|major adverse cardiac and cerebrovascular events
275627|NCT01773850|breast cancer|breast cancer
275628|NCT01773837|asthenia|asthenia
275629|NCT01773837|advanced cancer|advanced cancer
275630|NCT01773837|randomized controlled trial|randomized controlled trial
275631|NCT01773824|antibiotic|antibiotic
275632|NCT01773824|prescription rate|prescription rate
275633|NCT01773811|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
275634|NCT01773811|Narrative Writing|narrative writing
275635|NCT01773759|Immunizations|immunizations
275636|NCT01773759|Child care|child care
275637|NCT01773759|School health promotion|school health promotion
275638|NCT01773746|neonatal|neonatal
275639|NCT01773746|resuscitation|resuscitation
275640|NCT01773746|room air|room air
275641|NCT01773720|cardiac index|cardiac index
275642|NCT01773720|coronary artery bypass|coronary artery bypass
275643|NCT01773720|uncalibrated pulse contour analysis|uncalibrated pulse contour analysis
275644|NCT01773720|hemodynamic monitoring|hemodynamic monitoring
275645|NCT01773707|prevention of type 1 diabetes|prevention of type 1 diabetes
275646|NCT01773707|prevention of abnormal glucose tolerance|prevention of abnormal glucose tolerance
275647|NCT01773694|Post-operative management|post-operative management
275648|NCT01773694|Post-operative complications|post-operative complications
275649|NCT01773694|Post-operative treatment|post-operative treatment
275650|NCT01773694|water|water
275651|NCT01773694|skin|skin
275652|NCT01773694|Dermatologic Surgical Procedures|dermatologic surgical procedures
275653|NCT01773655|somatic|somatic
275654|NCT01773655|germline|germline
275655|NCT01773655|mutations|mutations
275656|NCT01773655|BAP1 (BRCA associated protein-1)|bap1 (brca associated protein-1)
275657|NCT01773655|12-235|12-235
275658|NCT01773642|pediatric HIV diagnosis disclosure|pediatric hiv diagnosis disclosure
275659|NCT01773642|cognitive behavioral intervention|cognitive behavioral intervention
275660|NCT01773642|Uganda|uganda
275661|NCT01773629|Depression|depression
275662|NCT01773629|Pregnancy|pregnancy
275663|NCT01773629|Postpartum|postpartum
275664|NCT01773629|Perinatal|perinatal
275665|NCT01773616|Systemic lupus erythematosus|systemic lupus erythematosus
275666|NCT01773616|Lupus|lupus
275667|NCT01773616|Nephritis|nephritis
275668|NCT01773603|Time-lapse|time-lapse
275669|NCT01773603|morphokinetics|morphokinetics
275670|NCT01773603|blastocyst transfer|blastocyst transfer
275671|NCT01773603|eSET|eset
275672|NCT01773577|EHR|ehr
275673|NCT01773577|VHR|vhr
275674|NCT01773577|Electronic Health Record|electronic health record
275675|NCT01773564|Dressings, Prevention,|dressings, prevention,
275676|NCT01773538|quality of life|quality of life
275677|NCT01773512|Intravascular ultrasound|intravascular ultrasound
275678|NCT01773512|Virtual histology|virtual histology
275679|NCT01773512|Optical coherence tomography|optical coherence tomography
275680|NCT01773512|Coronary atherosclerosis|coronary atherosclerosis
275681|NCT01773512|Statins|statins
275682|NCT01773512|Retinal imaging|retinal imaging
275683|NCT01773499|cellulitis|cellulitis
275684|NCT01773499|ultrasound|ultrasound
275685|NCT01773486|Obesity|obesity
275686|NCT01773486|Insulin Resistance|insulin resistance
275687|NCT01773486|Endothelial dysfunction|endothelial dysfunction
275688|NCT01773486|Blood pressure|blood pressure
275689|NCT01773460|everolimus progress exemestane|everolimus progress exemestane
275690|NCT01773460|treated with exemestane and everolimus|treated with exemestane and everolimus
275691|NCT01773460|progress under this treatment|progress under this treatment
275692|NCT01773395|Advanced|advanced
275693|NCT01773369|cerebral palsy|cerebral palsy
275694|NCT01773369|physical therapy|physical therapy
275695|NCT01773369|rehabilitation|rehabilitation
275696|NCT01773356|Obesity|obesity
275697|NCT01773356|Body Weight|body weight
275698|NCT01773356|Body Composition|body composition
275699|NCT01773356|Metabolism|metabolism
275700|NCT01773356|Resting Energy Expenditure|resting energy expenditure
275701|NCT01773343|skin texture, efficacy, adverse effects|skin texture, efficacy, adverse effects
275702|NCT01773330|high resolution manometry|high resolution manometry
275703|NCT01773330|provocative swallow|provocative swallow
275704|NCT01773330|impedence|impedence
275705|NCT01773304|Obesity|obesity
275706|NCT01773304|Adults|adults
275707|NCT01773304|Bone metabolism|bone metabolism
275708|NCT01773304|Metabolic profile|metabolic profile
275709|NCT01773304|Dairy protein|dairy protein
275710|NCT01773304|Meat protein|meat protein
275711|NCT01773291|Acupuncture; laser acupuncture; traumatic brain injury|acupuncture; laser acupuncture; traumatic brain injury
275712|NCT01773278|Antioxidant treatment|antioxidant treatment
275713|NCT01773278|Oxysterols|oxysterols
275714|NCT01773278|Cholesterol deficiency|cholesterol deficiency
276012|NCT01772199|GSK239512|gsk239512
275715|NCT01773278|Accumulation of 7-dehydrocholesterol|accumulation of 7-dehydrocholesterol
275716|NCT01773278|electroretinogram (ERG)|electroretinogram (erg)
275717|NCT01773278|Auditory Brainstem Response (ABR)|auditory brainstem response (abr)
275718|NCT01773252|RLS|rls
275719|NCT01773252|RTLS|rtls
275720|NCT01773252|PFO|pfo
275722|NCT01773252|shunt|shunt
275723|NCT01773252|cardiac|cardiac
275724|NCT01773252|paradoxical thromboembolism|paradoxical thromboembolism
275725|NCT01773252|interventional cardiology|interventional cardiology
275726|NCT01773252|stroke|stroke
275727|NCT01773252|migraine|migraine
275728|NCT01773252|aura|aura
275729|NCT01773252|obstructive sleep apnea|obstructive sleep apnea
275730|NCT01773252|decompression illness|decompression illness
275731|NCT01773252|neurology|neurology
275732|NCT01773252|transesophageal echocardiography|transesophageal echocardiography
275733|NCT01773252|TEE|tee
275734|NCT01773252|transthoracic echocardiography|transthoracic echocardiography
275735|NCT01773252|TTE|tte
275736|NCT01773252|transcranial Doppler|transcranial doppler
275737|NCT01773252|ultrasound|ultrasound
275738|NCT01773252|TCD|tcd
275739|NCT01773252|power m Mode|power m mode
275740|NCT01773252|indocyanine green dye|indocyanine green dye
275741|NCT01773252|ICG|icg
275742|NCT01773252|Valsalva|valsalva
275743|NCT01773239|social cognition|social cognition
275744|NCT01773239|cognitive deficits|cognitive deficits
275745|NCT01773239|prodromal schizophrenia|prodromal schizophrenia
275746|NCT01773239|recent-onset schizophrenia|recent-onset schizophrenia
275747|NCT01773239|remediation|remediation
275748|NCT01773239|computer training|computer training
275749|NCT01773239|cognitive training exercises|cognitive training exercises
275750|NCT01773226|Autologous Protein Solution|autologous protein solution
275751|NCT01773226|APS|aps
275752|NCT01773226|Osteoarthritis|osteoarthritis
275753|NCT01773226|Injection|injection
275754|NCT01773213|Lower urinary tract|lower urinary tract
275756|NCT01773213|Neuropathic bladder|neuropathic bladder
275757|NCT01773213|Overactive bladder|overactive bladder
275758|NCT01773200|endothelial progenitor cells|endothelial progenitor cells
275759|NCT01773200|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
275760|NCT01773200|vasospasm|vasospasm
275761|NCT01773200|BNP|bnp
275762|NCT01773187|Myelofibrosis|myelofibrosis
275763|NCT01773187|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
275764|NCT01773187|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
275765|NCT01773187|Primary Myelofibrosis|primary myelofibrosis
275766|NCT01773187|Polycythemia|polycythemia
275767|NCT01773187|Polycythemia Vera|polycythemia vera
275768|NCT01773187|Thrombocythemia, Essential|thrombocythemia, essential
275769|NCT01773187|Thrombocythemia|thrombocythemia
275770|NCT01773187|Myeloproliferative Disorders|myeloproliferative disorders
275771|NCT01773187|Bone Marrow Disease|bone marrow disease
275772|NCT01773187|Hematologic Diseases|hematologic diseases
275773|NCT01773187|Blood Platelet Disorders|blood platelet disorders
275774|NCT01773187|Hemorrhagic Disorders|hemorrhagic disorders
275775|NCT01773187|Splenomegaly|splenomegaly
275776|NCT01773187|Pacritinib|pacritinib
275777|NCT01773187|MPN-SAF|mpn-saf
266341|NCT01815606|35mm mass|35mm mass
266342|NCT01815593|Erectile Dysfunction|erectile dysfunction
266343|NCT01815593|Vascular Endothelium|vascular endothelium
266378|NCT01815463|FIT|fit
275778|NCT01773187|MPN-SAF TSS|mpn-saf tss
275779|NCT01773187|Anemia|anemia
275780|NCT01773187|Myeloproliferative|myeloproliferative
275781|NCT01773187|Myeloproliferative Neoplasm|myeloproliferative neoplasm
275782|NCT01773187|Spleen|spleen
275783|NCT01773187|Spleen volume|spleen volume
275784|NCT01773187|Thrombocytopenia|thrombocytopenia
275785|NCT01773187|SB1518|sb1518
275786|NCT01773161|Cerebral Palsy|cerebral palsy
275787|NCT01773161|Hip surgery|hip surgery
275788|NCT01773161|Quality of Life|quality of life
275789|NCT01773135|threatened preterm labor|threatened preterm labor
275790|NCT01773135|ACTH|acth
275791|NCT01773135|PTL|ptl
275792|NCT01773109|Male and female subjects 18 years of age and older|male and female subjects 18 years of age and older
275793|NCT01773109|metastatic or recurrent NSCLC|metastatic or recurrent nsclc
275794|NCT01773109|who have failed 2nd line therapy (with up to two prior cytotoxic regimens and one prior exposure to an oral TKI).|who have failed 2nd line therapy (with up to two prior cytotoxic regimens and one prior exposure to an oral tki).
275795|NCT01773096|opioid-induced|opioid-induced
275796|NCT01773083|Inhalation trauma|inhalation trauma
275797|NCT01773083|pulmonary coagulopathy|pulmonary coagulopathy
275798|NCT01773083|heparin nebulization|heparin nebulization
275799|NCT01773083|mechanical ventilation|mechanical ventilation
275800|NCT01773070|Chronic Hepatitis C|chronic hepatitis c
275801|NCT01773070|Hepatitis C virus|hepatitis c virus
275802|NCT01773070|Direct Acting Antiviral|direct acting antiviral
275803|NCT01773070|Sustained Virologic Response|sustained virologic response
275804|NCT01773070|Hepatitis C|hepatitis c
275805|NCT01773057|Computerized Decision Support System|computerized decision support system
275806|NCT01773057|Heart failure|heart failure
275807|NCT01773057|Effects on quality of care|effects on quality of care
275808|NCT01773057|Process of care|process of care
275809|NCT01773057|Patient outcomes|patient outcomes
275810|NCT01773031|Autoimmune pancreatitis|autoimmune pancreatitis
275812|NCT01773005|Anesthetics, Intravenous|anesthetics, intravenous
275813|NCT01772992|HIV couples adherence linkage to care viral suppression|hiv couples adherence linkage to care viral suppression
275814|NCT01772979|Trabectedin|trabectedin
275815|NCT01772979|BRCA1 and BRCA2|brca1 and brca2
275816|NCT01772979|BRCAness|brcaness
275817|NCT01772979|Ovarian cancer|ovarian cancer
275818|NCT01772966|neck|neck
275819|NCT01772966|pain|pain
275820|NCT01772966|chronic|chronic
275821|NCT01772966|manipulation|manipulation
275822|NCT01772966|control|control
275823|NCT01772966|randomized trial|randomized trial
275824|NCT01772953|AML|aml
275825|NCT01772953|MDS|mds
275826|NCT01772953|Treosulfan|treosulfan
275827|NCT01772940|First-line therapy|first-line therapy
275828|NCT01772940|Protease inhibitor|protease inhibitor
275829|NCT01772940|Non-Nucleoside Reverse transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
275830|NCT01772940|Resource-limited setting|resource-limited setting
275831|NCT01772927|parenteral nutrition|parenteral nutrition
275832|NCT01772927|Very low birth weight infants|very low birth weight infants
275833|NCT01772927|preterm infants|preterm infants
275834|NCT01772927|biochemical tolerance|biochemical tolerance
275835|NCT01772927|nutritional intake|nutritional intake
275836|NCT01772914|Copeptin|copeptin
275837|NCT01772914|eating|eating
275838|NCT01772914|glucose tolerance test|glucose tolerance test
275839|NCT01772914|mixed meal test|mixed meal test
275840|NCT01772914|physiological|physiological
275841|NCT01772901|influenza|influenza
275842|NCT01772901|influenza vaccines|influenza vaccines
275843|NCT01772901|infectious disease|infectious disease
275844|NCT01772901|pregnancy|pregnancy
275845|NCT01772875|urinary catheter|urinary catheter
275846|NCT01772875|UTI|uti
275847|NCT01772875|bladder lavage|bladder lavage
275848|NCT01772862|childhood|childhood
275849|NCT01772862|cancer|cancer
275850|NCT01772862|physical activity|physical activity
275851|NCT01772862|quality of life|quality of life
275852|NCT01772849|childhood|childhood
275853|NCT01772849|cancer|cancer
275854|NCT01772849|education|education
275855|NCT01772849|physical activity|physical activity
275856|NCT01772849|quality of life|quality of life
275857|NCT01772823|HIV, PrEP, FTC/TDF, Truvada|hiv, prep, ftc/tdf, truvada
275858|NCT01772810|Paralysis due to chronic spinal cord injury (SCI)|paralysis due to chronic spinal cord injury (sci)
275859|NCT01772797|anaplastic lymphoma kinase, ALK-rearranged lung cancer, non-small cell lung cancer|anaplastic lymphoma kinase, alk-rearranged lung cancer, non-small cell lung cancer
275860|NCT01772784|subjects|subjects
275861|NCT01772771|Cancer|cancer
275862|NCT01772771|Molecular testing|molecular testing
275863|NCT01772771|Personalized Cancer Therapy Program|personalized cancer therapy program
275864|NCT01772771|Bladder|bladder
275865|NCT01772771|Bone|bone
340890|NCT01487746|APS|aps
275866|NCT01772771|Breast|breast
275867|NCT01772771|Cytology|cytology
275868|NCT01772771|Endocrine|endocrine
275869|NCT01772771|Gynecology|gynecology
275870|NCT01772771|Endocrine - Neoplasia|endocrine - neoplasia
275871|NCT01772771|genitourinary|genitourinary
275872|NCT01772771|Research Biorepository|research biorepository
275873|NCT01772771|Head and Neck|head and neck
275874|NCT01772771|Aerodigestive Tract|aerodigestive tract
275875|NCT01772771|Hematopathology|hematopathology
275876|NCT01772771|Human Cancer Genetics|human cancer genetics
275877|NCT01772771|Kidney|kidney
275878|NCT01772771|Leukemia|leukemia
275879|NCT01772771|Lower Gastrointestinal|lower gastrointestinal
275880|NCT01772771|Lymphoma|lymphoma
275881|NCT01772771|Melanoma|melanoma
275882|NCT01772771|Neurology|neurology
275883|NCT01772771|Brain|brain
275884|NCT01772771|Non-Melanoma Skin|non-melanoma skin
275885|NCT01772771|Pancreas|pancreas
275886|NCT01772771|Pediatrics|pediatrics
275887|NCT01772771|Prostate|prostate
275888|NCT01772771|Breast Cancer Patients, Serum|breast cancer patients, serum
275889|NCT01772771|Plasma|plasma
275890|NCT01772771|Soft Tissue Sarcoma|soft tissue sarcoma
275891|NCT01772771|Thoracic|thoracic
275892|NCT01772771|Lung|lung
275893|NCT01772771|S.P.O.R.E.|s.p.o.r.e.
275894|NCT01772771|Upper Gastrointestinal|upper gastrointestinal
275895|NCT01772745|single incision|single incision
275896|NCT01772745|cholecystectomy|cholecystectomy
275897|NCT01772745|laparoscopy|laparoscopy
275898|NCT01772732|Simotinib|simotinib
275899|NCT01772732|Non-small Cell Lung Cancer|non-small cell lung cancer
275900|NCT01772719|refractory multiple myeloma|refractory multiple myeloma
275901|NCT01772706|Head and neck cancer|head and neck cancer
275902|NCT01772706|Low level laser therapy|low level laser therapy
275903|NCT01772706|Mucositis induced by radiochemotherpy|mucositis induced by radiochemotherpy
275904|NCT01772693|ExAblate Transcranial MRgFUS|exablate transcranial mrgfus
275905|NCT01772680|Thalassemia|thalassemia
275906|NCT01772680|Diabetes|diabetes
275907|NCT01772680|Zinc|zinc
275908|NCT01772680|Iron-Overload|iron-overload
275909|NCT01772667|pulmonary fibrosis|pulmonary fibrosis
275910|NCT01772667|interstitial lung disease|interstitial lung disease
275911|NCT01772667|pulmonary rehabilitation|pulmonary rehabilitation
275912|NCT01772667|exercise capacity|exercise capacity
275913|NCT01772667|physical activity|physical activity
275914|NCT01772667|quality of life|quality of life
275915|NCT01772654|Epilepsy|epilepsy
276209|NCT01771276|POSE|pose
275916|NCT01772654|Arterial Spin Labeled MRI|arterial spin labeled mri
275917|NCT01772654|Brain lesions|brain lesions
275918|NCT01772654|Cerebral blood flow|cerebral blood flow
275919|NCT01772641|cigarette|cigarette
275920|NCT01772641|smoking|smoking
275921|NCT01772641|cessation|cessation
275922|NCT01772641|varenicline|varenicline
275923|NCT01772641|scheduled reduction|scheduled reduction
275924|NCT01772641|craving|craving
275925|NCT01772628|Communication|communication
275926|NCT01772628|Healthy sexual behaviour|healthy sexual behaviour
275927|NCT01772628|Sexual and reproductive health|sexual and reproductive health
275928|NCT01772628|Adolescents|adolescents
275929|NCT01772615|EcN, Nissle, Mutaflor, Ulcerative Colitis, antibiotics, Inflammatory Bowel Diseases|ecn, nissle, mutaflor, ulcerative colitis, antibiotics, inflammatory bowel diseases
275930|NCT01772602|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
275931|NCT01772602|Lou Gehrig's Disease|lou gehrig's disease
275932|NCT01772602|Motor Neuron Disease|motor neuron disease
275933|NCT01772576|Reliance|reliance
275934|NCT01772576|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
275935|NCT01772576|Cardiac Resynchronization Therapy - Defibrillator (CRT-D)|cardiac resynchronization therapy - defibrillator (crt-d)
275936|NCT01772550|CECT, catheter, contrast|cect, catheter, contrast
275937|NCT01772537|thoracoabdominal|thoracoabdominal
275938|NCT01772537|aneurysm|aneurysm
275939|NCT01772537|open|open
275940|NCT01772537|stent|stent
275941|NCT01772537|cardiopulmonary|cardiopulmonary
275942|NCT01772537|abdominal|abdominal
275943|NCT01772537|bypass|bypass
275944|NCT01772524|Migraine Disorders|migraine disorders
275945|NCT01772524|Phase 1|phase 1
275946|NCT01772524|ALD403|ald403
275947|NCT01772511|questionnaire|questionnaire
275948|NCT01772511|prior therapy|prior therapy
275949|NCT01772511|prior study volunteer|prior study volunteer
275950|NCT01772511|prior study patient|prior study patient
275951|NCT01772511|cancer|cancer
275952|NCT01772511|oncology|oncology
275953|NCT01772498|depression|depression
275954|NCT01772498|anxiety|anxiety
275955|NCT01772498|sleep|sleep
275956|NCT01772498|pain|pain
275957|NCT01772498|biofeedback|biofeedback
275958|NCT01772498|breathing|breathing
275959|NCT01772498|resonant|resonant
275960|NCT01772459|Scoliosis|scoliosis
275961|NCT01772459|Adolescents|adolescents
275962|NCT01772459|Questionnaire|questionnaire
275963|NCT01772459|Reliability|reliability
275964|NCT01772446|diabetes|diabetes
275965|NCT01772446|management|management
275966|NCT01772446|glycated hemoglobin|glycated hemoglobin
275967|NCT01772446|preventive activities|preventive activities
275968|NCT01772433|Low Back Pain|low back pain
275969|NCT01772433|Topical Olive Oil|topical olive oil
275970|NCT01772433|Phonophoresis|phonophoresis
275971|NCT01772407|Colon Cancer Surgery|colon cancer surgery
275972|NCT01772407|Laparoscopy|laparoscopy
275973|NCT01772407|Open surgery|open surgery
275974|NCT01772407|Costs|costs
275975|NCT01772407|Mortality|mortality
275976|NCT01772407|Morbidity|morbidity
275977|NCT01772407|Quality of life|quality of life
275978|NCT01772394|Anorexia Nervosa|anorexia nervosa
275979|NCT01772394|Cognitive remediation therapy|cognitive remediation therapy
275980|NCT01772394|Randomized clinical trial|randomized clinical trial
275981|NCT01772381|Dexamethasone, term, elective cesarean section|dexamethasone, term, elective cesarean section
275982|NCT01772368|Asthma|asthma
275983|NCT01772368|dry powder inhaler|dry powder inhaler
275984|NCT01772368|long-acting beta2-agonist|long-acting beta2-agonist
275985|NCT01772368|bronchodilation|bronchodilation
275986|NCT01772368|bronchodilator|bronchodilator
275987|NCT01772368|metered dose inhaler|metered dose inhaler
275988|NCT01772368|inhaled corticosteroid|inhaled corticosteroid
275989|NCT01772355|orbit; tumor; core biopsy|orbit; tumor; core biopsy
275990|NCT01772342|Sleep Fragmentation|sleep fragmentation
275991|NCT01772342|Quality of Life|quality of life
275992|NCT01772342|Air Filters|air filters
275993|NCT01772303|Pressure Ulcers, diabetic Ulcers, post operational wounds|pressure ulcers, diabetic ulcers, post operational wounds
275994|NCT01772277|Endoscopic dacryocystorhinostomy|endoscopic dacryocystorhinostomy
275995|NCT01772277|Mitomycin C|mitomycin c
275996|NCT01772251|Diabetes Mellitus|diabetes mellitus
275997|NCT01772251|Oral Insulin|oral insulin
275998|NCT01772238|Mexico|mexico
275999|NCT01772238|Respiratory infections|respiratory infections
276000|NCT01772238|Amoxicillin-Clavulanic Acid|amoxicillin-clavulanic acid
276001|NCT01772238|Bioequivalence|bioequivalence
276002|NCT01772225|Observational Retrospective|observational retrospective
697250|NCT00956436|IGF-1R|igf-1r
276003|NCT01772225|Health-related quality of life (HRQoL)|health-related quality of life (hrqol)
276004|NCT01772225|Patients|patients
276005|NCT01772225|Stage IB-IIIA|stage ib-iiia
276006|NCT01772225|Burden of Illness|burden of illness
276007|NCT01772225|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
276008|NCT01772212|Mexico|mexico
276009|NCT01772212|terbinafine|terbinafine
276010|NCT01772212|mycoses|mycoses
276011|NCT01772212|pharmacokinetics|pharmacokinetics
276013|NCT01772199|remyelination|remyelination
276210|NCT01771263|Anesthesia|anesthesia
276014|NCT01772199|magnetic resonance imaging|magnetic resonance imaging
276015|NCT01772199|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
276016|NCT01772199|Histamine 3 Receptor Antagonist|histamine 3 receptor antagonist
276017|NCT01772199|magnetization transfer ratio|magnetization transfer ratio
276018|NCT01772186|Freezing of gait|freezing of gait
276019|NCT01772186|Parkinson's disease|parkinson's disease
276020|NCT01772186|Somatosensory stimulation|somatosensory stimulation
276021|NCT01772186|Fall prevention|fall prevention
276022|NCT01772173|diabetes|diabetes
276023|NCT01772173|computer|computer
276024|NCT01772173|retina|retina
276025|NCT01772173|vessel|vessel
276026|NCT01772173|analysis|analysis
276027|NCT01772160|Adults|adults
276028|NCT01772160|Italy|italy
276029|NCT01772160|Herpes Zoster|herpes zoster
276030|NCT01772160|Complications|complications
276031|NCT01772160|Quality of life|quality of life
276032|NCT01772160|Surveillance|surveillance
276033|NCT01772160|Burden|burden
276034|NCT01772160|Cost|cost
276035|NCT01772160|Incidence|incidence
276036|NCT01772121|HBV, HCV, chronic, India, observational study, prevalence,|hbv, hcv, chronic, india, observational study, prevalence,
276037|NCT01772121|genotypes, SNPs, viral hepatitis|genotypes, snps, viral hepatitis
276038|NCT01772108|Heart Valve Diseases|heart valve diseases
276039|NCT01772095|Donepezil (Dementis)|donepezil (dementis)
276040|NCT01772095|Elderly|elderly
276041|NCT01772069|systemic lupus erythematosus, disease activity, sleep, quality of life|systemic lupus erythematosus, disease activity, sleep, quality of life
276042|NCT01772056|Dermatitis, Atopic|dermatitis, atopic
276043|NCT01772056|Randomized Controlled Trial|randomized controlled trial
276044|NCT01772056|Child|child
276045|NCT01772056|Fluticasone|fluticasone
276046|NCT01772056|Preventive therapy|preventive therapy
276047|NCT01772043|muscular dystrophy|muscular dystrophy
276048|NCT01772043|tissue bank|tissue bank
276049|NCT01772030|Atrial Fibrillation|atrial fibrillation
276050|NCT01772030|Cryoballoon Ablation|cryoballoon ablation
276051|NCT01772017|Obstructive Sleep Apnea|obstructive sleep apnea
276052|NCT01772017|OSA|osa
276053|NCT01772017|Snoring|snoring
276054|NCT01772017|Tongue Advancement Retainer Device|tongue advancement retainer device
276055|NCT01772004|Solid Tumors|solid tumors
276056|NCT01772004|MSB0010718C|msb0010718c
276057|NCT01772004|Phase 1|phase 1
276058|NCT01772004|Pharmacokinetic|pharmacokinetic
276059|NCT01772004|anti PD-L1|anti pd-l1
276060|NCT01772004|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
341127|NCT01486784|AML|aml
276061|NCT01772004|Metastatic breast cancer (MBC)|metastatic breast cancer (mbc)
276062|NCT01772004|Gastric and gastroesophageal junction (GEJ) cancer|gastric and gastroesophageal junction (gej) cancer
276063|NCT01772004|Ovarian cancer|ovarian cancer
276064|NCT01772004|Colorectal cancer (CRC)|colorectal cancer (crc)
276065|NCT01772004|Castrate-resistant prostate cancer (CRPC)|castrate-resistant prostate cancer (crpc)
276066|NCT01772004|Melanoma|melanoma
276067|NCT01772004|Urothelial carcinoma|urothelial carcinoma
276068|NCT01772004|Bladder cancer|bladder cancer
276069|NCT01772004|Head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
276070|NCT01772004|Renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
276071|NCT01772004|Adrenocortical carcinoma (ACC)|adrenocortical carcinoma (acc)
276072|NCT01771991|fibrosis|fibrosis
276073|NCT01771991|radiation|radiation
276074|NCT01771991|neck|neck
276075|NCT01771991|cancer|cancer
276076|NCT01771991|Sodermix|sodermix
276077|NCT01771978|ischaemia-reperfusion injury|ischaemia-reperfusion injury
276078|NCT01771978|cardiac surgery|cardiac surgery
276079|NCT01771978|oxidative stress markers|oxidative stress markers
276080|NCT01771978|troponin|troponin
276081|NCT01771978|diltiazem|diltiazem
276082|NCT01771978|acetylcystein|acetylcystein
276083|NCT01771952|Patellofemoral Chondromalacia|patellofemoral chondromalacia
276084|NCT01771952|Anterior Knee Pain|anterior knee pain
276085|NCT01771952|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
276086|NCT01771952|Synvisc-One|synvisc-one
276087|NCT01771952|Hyaluronic Acid|hyaluronic acid
276088|NCT01771939|Idiopathic epiretinal membranes|idiopathic epiretinal membranes
276089|NCT01771939|25-G surgery in idiopathic epiretinal membranes|25-g surgery in idiopathic epiretinal membranes
276090|NCT01771926|resistant starch|resistant starch
276091|NCT01771926|lifestyle intervention|lifestyle intervention
276092|NCT01771913|adipocytes|adipocytes
276093|NCT01771913|cell transplantations|cell transplantations
276094|NCT01771913|mesenchymal stem cell|mesenchymal stem cell
276095|NCT01771913|immunophenotyping|immunophenotyping
276096|NCT01771913|adipose tissue|adipose tissue
276097|NCT01771913|breast reconstruction|breast reconstruction
276098|NCT01771913|mammaplasty|mammaplasty
276099|NCT01771913|magnetic resonance imaging|magnetic resonance imaging
276100|NCT01771913|fat necrosis|fat necrosis
276101|NCT01771900|heart failure|heart failure
276102|NCT01771900|exercise|exercise
276103|NCT01771900|adherence to exercise|adherence to exercise
276104|NCT01771887|Diabetic Type2|diabetic type2
276105|NCT01771887|education|education
276106|NCT01771887|self-management behaviors|self-management behaviors
276107|NCT01771887|self-efficacy|self-efficacy
276111|NCT01771874|pharmacodynamics|pharmacodynamics
276113|NCT01771874|Mechanism of action of MDMA|mechanism of action of mdma
276114|NCT01771874|Interaction study|interaction study
276115|NCT01771874|Effect of MDMA and bupropion on emotions|effect of mdma and bupropion on emotions
276116|NCT01771848|Malaria|malaria
276117|NCT01771848|Plasmodium falciparum|plasmodium falciparum
276118|NCT01771835|diabetes mellitus|diabetes mellitus
276119|NCT01771835|retinal venous pressure|retinal venous pressure
276120|NCT01771835|endothelin-1|endothelin-1
276121|NCT01771822|cumulative irritancy patch test (CIPT)|cumulative irritancy patch test (cipt)
276122|NCT01771809|Anti-TNF Refractory|anti-tnf refractory
276123|NCT01771809|Immunosuppressant Refractory|immunosuppressant refractory
276124|NCT01771809|Active Ulcerative Colitis|active ulcerative colitis
276125|NCT01771796|Exercise; lung cancer; aerobic training, resistance training; respiratory muscle training|exercise; lung cancer; aerobic training, resistance training; respiratory muscle training
276126|NCT01771783|RAS-Peptide Profile|ras-peptide profile
276127|NCT01771783|Renin-Angiotensin-System|renin-angiotensin-system
276128|NCT01771783|Angiotensin-Converting-Enzyme-Inhibitor|angiotensin-converting-enzyme-inhibitor
276129|NCT01771783|Angiotensin-Receptor-Antagonist|angiotensin-receptor-antagonist
276130|NCT01771783|Renin-inhibitor|renin-inhibitor
276131|NCT01771770|retinal venous pressure (RVP)|retinal venous pressure (rvp)
276132|NCT01771770|chronically reduced ambient pressure|chronically reduced ambient pressure
276133|NCT01771770|oxygen partial pressure|oxygen partial pressure
276134|NCT01771770|mountain sickness|mountain sickness
276135|NCT01771757|retinal venous pressure|retinal venous pressure
276136|NCT01771757|reduced ambient pressure|reduced ambient pressure
276137|NCT01771757|oxygen partial pressure|oxygen partial pressure
276138|NCT01771757|short-term hypoxic changes|short-term hypoxic changes
276139|NCT01771705|Transplantation|transplantation
276140|NCT01771705|Kidney|kidney
276141|NCT01771705|calcineurin inhibitor|calcineurin inhibitor
276142|NCT01771705|NFAT|nfat
276143|NCT01771705|tacrolimus|tacrolimus
276144|NCT01771692|Orthodontics|orthodontics
276145|NCT01771679|Mesenchymal Stem Cells|mesenchymal stem cells
276146|NCT01771679|Bone Marrow Cells|bone marrow cells
276147|NCT01771679|Allogeneic Transplantation|allogeneic transplantation
276148|NCT01771679|Skin Wrinkling|skin wrinkling
276149|NCT01771679|Solar Aging of Skin|solar aging of skin
276150|NCT01771679|Intravenous Administration|intravenous administration
266723|NCT01814033|Total Knee Replacement|total knee replacement
276151|NCT01771653|Hepatitis C infection|hepatitis c infection
276152|NCT01771653|Hepatitis C Virus|hepatitis c virus
276154|NCT01771640|ALS intrathecal injection bone marrow mesenchymal stem cell|als intrathecal injection bone marrow mesenchymal stem cell
276155|NCT01771614|Glucotoxicity|glucotoxicity
276156|NCT01771614|Exercise|exercise
276157|NCT01771614|Beta-cell function|beta-cell function
276158|NCT01771601|Near-infrared spectroscopy, cerebral oxygenation, term newborn, reproducibility,|near-infrared spectroscopy, cerebral oxygenation, term newborn, reproducibility,
276159|NCT01771562|HIV-1|hiv-1
276160|NCT01771562|Child|child
276161|NCT01771562|Adolescent|adolescent
276162|NCT01771562|Growth|growth
276163|NCT01771562|Lipodystrophy|lipodystrophy
276164|NCT01771562|ARV treatment|arv treatment
276165|NCT01771562|Senegal|senegal
276166|NCT01771549|Adriamycin|adriamycin
276167|NCT01771549|Trastuzumab|trastuzumab
276168|NCT01771549|Brain Natriuretic Peptide (BNP)|brain natriuretic peptide (bnp)
276169|NCT01771549|Troponin|troponin
276170|NCT01771523|thyroidectomy|thyroidectomy
276171|NCT01771523|drain use|drain use
276172|NCT01771497|Breast CT|breast ct
276173|NCT01771484|tachycardia|tachycardia
276174|NCT01771484|pots|pots
276175|NCT01771484|orthostatic intolerance|orthostatic intolerance
276179|NCT01771458|Metastatic/Reccurent|metastatic/reccurent
276180|NCT01771458|Solid Tumor|solid tumor
276181|NCT01771458|Refractory|refractory
276182|NCT01771458|Molecular profile|molecular profile
276183|NCT01771458|Targeted treatment|targeted treatment
276184|NCT01771445|IL-1|il-1
276185|NCT01771445|IL-6|il-6
276186|NCT01771445|Inflammation|inflammation
276187|NCT01771419|loop-tip|loop-tip
276188|NCT01771419|ERCP|ercp
276189|NCT01771419|cannulation of CBD|cannulation of cbd
276190|NCT01771393|arthroscanner|arthroscanner
276191|NCT01771393|cone-beam computed tomodensitometry|cone-beam computed tomodensitometry
276192|NCT01771354|Volunteers|volunteers
276193|NCT01771354|Identify|identify
276194|NCT01771354|Biomarkers|biomarkers
276195|NCT01771354|Vaccine Safety|vaccine safety
276196|NCT01771341|NAVA|nava
276197|NCT01771341|post operative|post operative
276198|NCT01771328|Adrenal Hyperplasia, Congenital|adrenal hyperplasia, congenital
276199|NCT01771315|total knee arthroplasty|total knee arthroplasty
276200|NCT01771315|telephone follow-up|telephone follow-up
276201|NCT01771315|physical function|physical function
276202|NCT01771315|health related quality of life|health related quality of life
276203|NCT01771315|self-efficacy|self-efficacy
276204|NCT01771302|PRGF-Endoret|prgf-endoret
276205|NCT01771302|Bone graft|bone graft
276206|NCT01771302|Maxillary sinus|maxillary sinus
276207|NCT01771302|Vertical bone augmentation|vertical bone augmentation
276208|NCT01771289|Lung Cancer|lung cancer
276211|NCT01771263|Propofol|propofol
276212|NCT01771263|Remifentanil|remifentanil
276213|NCT01771263|NeuroSENSE|neurosense
276214|NCT01771237|HIV infection|hiv infection
276215|NCT01771224|Palmitoleic acid ulcerative colitis|palmitoleic acid ulcerative colitis
276216|NCT01771211|MCI|mci
276217|NCT01771211|Word-retrieval|word-retrieval
276218|NCT01771211|tDCS|tdcs
276219|NCT01771211|fMRI|fmri
276220|NCT01771198|Chronic rhinosinusitis|chronic rhinosinusitis
276221|NCT01771198|Refractory to treatment|refractory to treatment
276222|NCT01771198|SIMVASTATIN|simvastatin
276223|NCT01771185|Diabetes|diabetes
276224|NCT01771185|metabolic surgery|metabolic surgery
276225|NCT01771185|insulin resistance|insulin resistance
276226|NCT01771159|Spinal cord injury|spinal cord injury
276227|NCT01771159|Urinary dysfunction|urinary dysfunction
276228|NCT01771159|Bladder drainage|bladder drainage
276229|NCT01771146|Non-metastatic Pancreas Cancer|non-metastatic pancreas cancer
276230|NCT01771146|Pancreatic Cancer|pancreatic cancer
276231|NCT01771146|Cancer of Pancreas|cancer of pancreas
276232|NCT01771146|Adenocarcinoma of Pancreas|adenocarcinoma of pancreas
276233|NCT01771146|Neoadjuvant|neoadjuvant
276234|NCT01771133|Obesity|obesity
276235|NCT01771133|Maternal Welfare|maternal welfare
276236|NCT01771133|Child Welfare|child welfare
276237|NCT01771133|Nutritional Sciences|nutritional sciences
276238|NCT01771133|Clinical Trial|clinical trial
276239|NCT01771133|Pregnancy|pregnancy
276240|NCT01771133|Physical activity|physical activity
276241|NCT01771133|Fetal Development|fetal development
276242|NCT01771133|Metabolic Diseases|metabolic diseases
276243|NCT01771133|Life style|life style
276244|NCT01771133|Behavior and Behavior Mechanisms|behavior and behavior mechanisms
276245|NCT01771133|LIFE-Moms|life-moms
276246|NCT01771120|Asthma|asthma
276247|NCT01771120|Rhinitis|rhinitis
276248|NCT01771120|Control|control
276249|NCT01771120|Burden|burden
276250|NCT01771081|Longitudinal Studies,|longitudinal studies,
276251|NCT01771081|Observation|observation
276252|NCT01771081|Epidemiology|epidemiology
276253|NCT01771055|Trauma|trauma
276254|NCT01771055|Hypovolemia|hypovolemia
341359|NCT01485835|Velcade|velcade
276255|NCT01771042|weight loss|weight loss
276256|NCT01771042|metabolic syndrome|metabolic syndrome
276257|NCT01771042|sympathetic nervous system|sympathetic nervous system
276258|NCT01771042|insulin resistance|insulin resistance
276259|NCT01771042|glucose tolerance|glucose tolerance
276260|NCT01771029|Procalcitonin|procalcitonin
276261|NCT01771029|Infection|infection
276262|NCT01771029|Point-of-Care|point-of-care
276263|NCT01771016|Emergency contraception|emergency contraception
276264|NCT01771016|Emergency hormonal contraception|emergency hormonal contraception
276265|NCT01771016|Community pharmacies|community pharmacies
276266|NCT01771016|Pharmaceutical care|pharmaceutical care
276267|NCT01771016|Time to access|time to access
276268|NCT01771016|Written assessments|written assessments
276269|NCT01771016|Switzerland|switzerland
276270|NCT01771003|Partial nephrectomy|partial nephrectomy
276271|NCT01771003|renal cell carcinoma|renal cell carcinoma
276272|NCT01771003|Renal Function|renal function
276273|NCT01771003|Remote ischemia preconditioning|remote ischemia preconditioning
276274|NCT01770990|depression|depression
276275|NCT01770990|telephone-based psychotherapy|telephone-based psychotherapy
276276|NCT01770990|cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
276277|NCT01770990|manualized psychotherapy|manualized psychotherapy
276278|NCT01770990|telephone counseling|telephone counseling
276279|NCT01770990|telephone psychological treatment|telephone psychological treatment
276280|NCT01770990|telephone-administered therapy|telephone-administered therapy
276281|NCT01770990|low-intensity treatment|low-intensity treatment
276282|NCT01770990|motivational mail|motivational mail
276283|NCT01770990|reminder|reminder
276284|NCT01770990|letter|letter
276285|NCT01770977|Light-emitting diode therapy|light-emitting diode therapy
276286|NCT01770977|Muscle performance|muscle performance
276287|NCT01770977|Aerobic performance|aerobic performance
276288|NCT01770977|Lactate|lactate
276289|NCT01770977|Creatine kinase|creatine kinase
276290|NCT01770938|Light-emitting diode therapy|light-emitting diode therapy
276291|NCT01770938|Muscle performance|muscle performance
276292|NCT01770938|Gene expression|gene expression
276293|NCT01770938|Functional performance|functional performance
276294|NCT01770912|facial pain|facial pain
276295|NCT01770912|temporomandibular joint|temporomandibular joint
276296|NCT01770912|arthrocentesis|arthrocentesis
276297|NCT01770912|steroid|steroid
276298|NCT01770899|Montelukast|montelukast
276299|NCT01770899|Singulair|singulair
276300|NCT01770899|status asthmaticus|status asthmaticus
276301|NCT01770886|Drug Safety|drug safety
276302|NCT01770873|Youth|youth
276303|NCT01770873|Violence|violence
276304|NCT01770873|Assault-injured|assault-injured
276305|NCT01770873|Mentoring|mentoring
277000|NCT01767883|TRANSLATE|translate
276306|NCT01770873|Emergency Room|emergency room
276307|NCT01770873|Urban|urban
276308|NCT01770860|Adhesive Bandages|adhesive bandages
276309|NCT01770860|Dermabrasion Wounds|dermabrasion wounds
276310|NCT01770821|sip drink|sip drink
276311|NCT01770821|protein|protein
276312|NCT01770821|muscle strength|muscle strength
276313|NCT01770821|6 minutes walking test|6 minutes walking test
276314|NCT01770808|Bloating|bloating
276315|NCT01770808|Flatulence|flatulence
276316|NCT01770808|Stomach discomfort|stomach discomfort
276317|NCT01770795|non-small cell lung cancer|non-small cell lung cancer
276318|NCT01770795|gemcitabine|gemcitabine
276319|NCT01770795|genexol-PM|genexol-pm
276320|NCT01770795|paclitaxel|paclitaxel
276321|NCT01770782|Palatal Expansion Technique|palatal expansion technique
276322|NCT01770782|Orthognathic Surgery|orthognathic surgery
276323|NCT01770782|Three Dimensional images|three dimensional images
276324|NCT01770769|Femoral Neck Fracture|femoral neck fracture
276325|NCT01770769|undisplaced|undisplaced
276326|NCT01770769|minimally displaced|minimally displaced
276327|NCT01770769|internal fixation|internal fixation
276328|NCT01770769|hemiarthroplasty|hemiarthroplasty
276329|NCT01770769|harris hip score|harris hip score
276330|NCT01770769|hospital cost|hospital cost
276331|NCT01770769|society cost|society cost
276332|NCT01770769|quality of life|quality of life
276333|NCT01770769|Timed Up and go test|timed up and go test
276334|NCT01770756|Hypertension|hypertension
276335|NCT01770756|High blood pressure|high blood pressure
276336|NCT01770756|Willpower|willpower
276337|NCT01770756|Self care|self care
276338|NCT01770743|post-exposure prophylaxis|post-exposure prophylaxis
276339|NCT01770743|toxin neutralization assay|toxin neutralization assay
276340|NCT01770730|urine LAM strip test|urine lam strip test
276341|NCT01770730|diagnostics|diagnostics
276342|NCT01770730|tuberculosis|tuberculosis
276343|NCT01770704|Bipolar disorder|bipolar disorder
276344|NCT01770704|Clinical management|clinical management
276345|NCT01770704|Clinical outcomes|clinical outcomes
276346|NCT01770678|Children|children
276349|NCT01770678|Constraint Induced Movement Therapy|constraint induced movement therapy
276351|NCT01770652|Kidney Impairment|kidney impairment
276352|NCT01770652|Kidney Disease|kidney disease
276353|NCT01770652|Ferriprox|ferriprox
276354|NCT01770652|Deferiprone|deferiprone
276355|NCT01770652|DFP (deferiprone)|dfp (deferiprone)
276357|NCT01770639|charcot foot|charcot foot
276358|NCT01770639|charcot neuroarthropathy|charcot neuroarthropathy
276359|NCT01770639|midfoot arthrodesis|midfoot arthrodesis
276360|NCT01770639|midfoot fusion|midfoot fusion
276361|NCT01770613|Adult|adult
276362|NCT01770613|Allogeneic|allogeneic
276363|NCT01770613|Stem|stem
276364|NCT01770613|Cells|cells
276365|NCT01770613|Myocardial|myocardial
276366|NCT01770613|Infarction|infarction
276367|NCT01770600|Age 19 to 64|age 19 to 64
276368|NCT01770600|Medically stable|medically stable
276369|NCT01770600|No current or history of psychosis|no current or history of psychosis
276370|NCT01770600|No alcohol or benzodiazepine withdrawal|no alcohol or benzodiazepine withdrawal
276371|NCT01770587|Insomnia|insomnia
276372|NCT01770587|Sleep|sleep
276373|NCT01770587|Behavioral Medicine|behavioral medicine
276374|NCT01770587|Suicide|suicide
276375|NCT01770587|Suicidal Ideation|suicidal ideation
276376|NCT01770574|calcaneal lengthening|calcaneal lengthening
276377|NCT01770574|calcium ceramics|calcium ceramics
276378|NCT01770574|noninferiority|noninferiority
276379|NCT01770574|radiostereometric analysis|radiostereometric analysis
276380|NCT01770535|Ovarian cancer, paclitaxel|ovarian cancer, paclitaxel
276381|NCT01770522|Bodyweight|bodyweight
276382|NCT01770522|Physical Acivitiy|physical acivitiy
276383|NCT01770522|Diet|diet
276384|NCT01770522|Bodymass index|bodymass index
276385|NCT01770522|Pregnancy|pregnancy
276386|NCT01770522|Postnatal|postnatal
276387|NCT01770509|Chronic venous leg ulcers|chronic venous leg ulcers
276388|NCT01770509|Venous ulcer|venous ulcer
276389|NCT01770509|Stasis ulcer|stasis ulcer
276390|NCT01770509|Varicose ulcer|varicose ulcer
276391|NCT01770496|immunization|immunization
276392|NCT01770496|vaccination|vaccination
276393|NCT01770496|immunization information system|immunization information system
276394|NCT01770496|immunization registry|immunization registry
276395|NCT01770496|reminder / recall|reminder / recall
276396|NCT01770483|Nitazoxanide,|nitazoxanide,
276397|NCT01770483|Sustained viral response|sustained viral response
276398|NCT01770483|Type 2 DIABETICS|type 2 diabetics
276399|NCT01770470|serum phosphate|serum phosphate
276400|NCT01770470|chitosan|chitosan
276401|NCT01770470|kidney disease|kidney disease
276402|NCT01770470|salivary phosphate|salivary phosphate
276403|NCT01770457|ICU population|icu population
276404|NCT01770444|Acute coronary syndrome|acute coronary syndrome
276405|NCT01770444|Cardiac computed tomographic angiography|cardiac computed tomographic angiography
276406|NCT01770444|Radiation dose reduction|radiation dose reduction
277303|NCT01766544|COPD|copd
276407|NCT01770444|Medical radiation exposure|medical radiation exposure
276408|NCT01770431|Huaier Granule;|huaier granule;
276409|NCT01770431|After radical hepatectomy;|after radical hepatectomy;
276410|NCT01770431|Prevention of Recurrence and Metastasis;|prevention of recurrence and metastasis;
276412|NCT01770418|Non Small Cell Lung Cancer|non small cell lung cancer
276413|NCT01770418|Cancer|cancer
276414|NCT01770418|Lung|lung
276415|NCT01770418|Proton|proton
276416|NCT01770418|Radiation|radiation
276417|NCT01770405|endomicroscopy|endomicroscopy
276418|NCT01770405|needle-based|needle-based
276419|NCT01770405|pancreatic|pancreatic
276420|NCT01770405|cyst|cyst
276421|NCT01770405|mass|mass
276422|NCT01770405|EUSFNA|eusfna
276423|NCT01770379|Rheumatoid Arthritis, RA, IL-17 blocker, subcutaneous, self-injection, AIN457, AIN457F, secukinumab, anti-TNFα, pre-filled syringe|rheumatoid arthritis, ra, il-17 blocker, subcutaneous, self-injection, ain457, ain457f, secukinumab, anti-tnfα, pre-filled syringe
276424|NCT01770366|obesity|obesity
276425|NCT01770366|weight loss surgery|weight loss surgery
276426|NCT01770366|virtual support|virtual support
276427|NCT01770366|wireless devices|wireless devices
276428|NCT01770366|Internet|internet
276429|NCT01770353|solid tumors|solid tumors
276430|NCT01770353|Triple Negative Breast Cancer|triple negative breast cancer
276431|NCT01770353|Colorectal Cancer|colorectal cancer
276432|NCT01770353|MM-398|mm-398
276433|NCT01770353|nanoliposomal irinotecan|nanoliposomal irinotecan
276434|NCT01770353|Ferumoxytol|ferumoxytol
276435|NCT01770353|ER/PR positive Breast Cancer|er/pr positive breast cancer
276436|NCT01770353|Pancreatic Cancer|pancreatic cancer
276437|NCT01770353|Ovarian Cancer|ovarian cancer
276438|NCT01770353|Gastric Cancer|gastric cancer
276439|NCT01770353|Gastro-Esophageal Junction Adenocarcinoma|gastro-esophageal junction adenocarcinoma
276440|NCT01770353|Head and Neck Cancer|head and neck cancer
276441|NCT01770353|TNBC|tnbc
276442|NCT01770340|radical prostatectomy|radical prostatectomy
276443|NCT01770340|erectile function|erectile function
276444|NCT01770340|nerve grafting|nerve grafting
276445|NCT01770340|allogenic|allogenic
276446|NCT01770340|prostate cancer|prostate cancer
276447|NCT01770340|Allogenic nerve graft|allogenic nerve graft
276448|NCT01770340|Time required for nerve grafting|time required for nerve grafting
276449|NCT01770314|Opioid Pain Medication|opioid pain medication
341623|NCT01484756|zinc|zinc
276450|NCT01770314|Medication Safety|medication safety
276451|NCT01770314|Correct storage|correct storage
276452|NCT01770314|Correct disposal|correct disposal
276453|NCT01770314|Correct Use|correct use
276454|NCT01770288|Anerobic exercise|anerobic exercise
276455|NCT01770288|Pain|pain
276456|NCT01770288|Analgesia|analgesia
276457|NCT01770288|Diffuse Noxious Inhibitory Control (DNIC)|diffuse noxious inhibitory control (dnic)
276458|NCT01770288|psychological stress|psychological stress
276459|NCT01770275|esophagus|esophagus
276460|NCT01770249|dysphagia|dysphagia
276461|NCT01770210|hypercholesterolemia|hypercholesterolemia
276462|NCT01770210|atorvastatin|atorvastatin
276463|NCT01770210|cardiovascular events|cardiovascular events
276464|NCT01770197|China|china
276465|NCT01770197|Stroke|stroke
276466|NCT01770197|Thrombolytic therapy|thrombolytic therapy
276467|NCT01770184|Self-management|self-management
276468|NCT01770184|Rehabilitation|rehabilitation
276469|NCT01770184|Occupational Therapy|occupational therapy
276470|NCT01770171|endometrial cancer|endometrial cancer
276471|NCT01770171|recurrent endometrial cancer|recurrent endometrial cancer
276472|NCT01770171|bevacizumab|bevacizumab
276473|NCT01770158|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
276474|NCT01770158|Histamine Dihydrochloride|histamine dihydrochloride
276475|NCT01770158|Interleukin-2|interleukin-2
276476|NCT01770145|Motor symptoms|motor symptoms
276477|NCT01770145|Parkinson's Disease|parkinson's disease
276478|NCT01770145|Delayed Onset|delayed onset
276479|NCT01770145|Akinesia|akinesia
276480|NCT01770145|Hypomobility|hypomobility
276481|NCT01770145|Unified Parkinson Disease Rating Scale (UPDRS) motor scores|unified parkinson disease rating scale (updrs) motor scores
276482|NCT01770145|Dopamine agonist|dopamine agonist
276483|NCT01770145|Apomorphine|apomorphine
276484|NCT01770145|Apokyn|apokyn
276485|NCT01770145|Levodopa|levodopa
276486|NCT01770119|Measles|measles
276487|NCT01770119|Mumps|mumps
276488|NCT01770119|Rubella|rubella
276489|NCT01770119|Pediatric|pediatric
276490|NCT01770119|Solid-organ transplant|solid-organ transplant
276491|NCT01770119|serology|serology
276492|NCT01770119|vaccine|vaccine
276493|NCT01770106|Rheumatoid arthritis|rheumatoid arthritis
276494|NCT01770106|Bone density|bone density
276495|NCT01770106|Bone microarchitecture|bone microarchitecture
276496|NCT01770106|HR-pQCT|hr-pqct
276497|NCT01770067|Cardiac Resynchronization Therapy Devices|cardiac resynchronization therapy devices
276498|NCT01770054|metabolic syndrome|metabolic syndrome
276499|NCT01770054|diabetes mellitus|diabetes mellitus
276500|NCT01770028|Obesity|obesity
276501|NCT01770028|Pregnancy|pregnancy
276502|NCT01770028|Spouse|spouse
276503|NCT01770028|Weight loss|weight loss
276504|NCT01770028|Behavioral|behavioral
276505|NCT01770015|patient ventilated for at least five days|patient ventilated for at least five days
276506|NCT01769963|Advanced glycation end-products|advanced glycation end-products
276507|NCT01769963|chronic kidney disease|chronic kidney disease
276508|NCT01769963|nutrition|nutrition
276509|NCT01769963|inflammation|inflammation
276510|NCT01769963|insulin resistance|insulin resistance
276511|NCT01769963|endothelial function|endothelial function
276512|NCT01769950|Choline PET|choline pet
276513|NCT01769950|Choline PET-CT|choline pet-ct
276514|NCT01769950|Positron emission tomography|positron emission tomography
276515|NCT01769950|Prostate cancer|prostate cancer
276517|NCT01769937|SLE|sle
276518|NCT01769937|ACTH|acth
276519|NCT01769937|Acthar|acthar
276520|NCT01769924|kidney donors|kidney donors
276521|NCT01769924|arterial stiffness|arterial stiffness
276522|NCT01769924|blood pressure|blood pressure
276523|NCT01769898|Bronchiectasis|bronchiectasis
276524|NCT01769898|Theophylline|theophylline
276525|NCT01769898|Therapeutic Uses|therapeutic uses
276526|NCT01769898|HDAC|hdac
276527|NCT01769898|HAT|hat
276528|NCT01769898|Random placebo study|random placebo study
276529|NCT01769898|ICS(inhaled corticosteroid)|ics(inhaled corticosteroid)
276530|NCT01769898|corticosteroid|corticosteroid
276531|NCT01769898|Inhaled corticosteroid|inhaled corticosteroid
276532|NCT01769859|Bipolar Disorder|bipolar disorder
276533|NCT01769859|Major Depressive Disorder|major depressive disorder
276534|NCT01769859|Genetics|genetics
276535|NCT01769833|HBsAg|hbsag
276536|NCT01769833|Chronic hepatitis B|chronic hepatitis b
276537|NCT01769833|PEGinterferon Alfa-2A|peginterferon alfa-2a
276538|NCT01769820|Heavy menstrual bleeding (HMB)|heavy menstrual bleeding (hmb)
276539|NCT01769820|Dexamethasone|dexamethasone
276540|NCT01769820|glucocorticoid|glucocorticoid
276541|NCT01769807|Sleep apnea|sleep apnea
276542|NCT01769807|CPAP treatment|cpap treatment
276543|NCT01769807|Plasma nitrate|plasma nitrate
276544|NCT01769807|Urinary norepinephrine|urinary norepinephrine
276545|NCT01769807|Blood pressure|blood pressure
276546|NCT01769794|Hand, Foot and Mouth Disease|hand, foot and mouth disease
276547|NCT01769794|Medicine, Chinese Traditional|medicine, chinese traditional
276548|NCT01769794|Enterovirus|enterovirus
276550|NCT01769781|endometriosis recurrence|endometriosis recurrence
276551|NCT01769781|pelvic pain|pelvic pain
276552|NCT01769781|aromatase inhibitor|aromatase inhibitor
276553|NCT01769768|Adults, Hh (Hedgehog) pathway inhibitor, LDE225, Warfarin, Bupropion, advanced solid tumor, drug-drug interaction, pharmacokinetic|adults, hh (hedgehog) pathway inhibitor, lde225, warfarin, bupropion, advanced solid tumor, drug-drug interaction, pharmacokinetic
276554|NCT01769755|Crohn's disease|crohn's disease
276555|NCT01769755|Fistula|fistula
276556|NCT01769755|Diarrhea|diarrhea
276557|NCT01769755|Colon|colon
276558|NCT01769755|Stem cells|stem cells
276559|NCT01769742|Pneumonia|pneumonia
276560|NCT01769742|promotion of activity|promotion of activity
276561|NCT01769729|integrated primary care|integrated primary care
276562|NCT01769729|depression|depression
276563|NCT01769729|chronic low back pain|chronic low back pain
276564|NCT01769716|Global developmental delay|global developmental delay
276565|NCT01769716|Umbilical cord blood|umbilical cord blood
276566|NCT01769716|Rehabilitation|rehabilitation
276567|NCT01769690|PD|pd
276568|NCT01769690|Parkinson's Disease|parkinson's disease
276569|NCT01769690|DBS|dbs
276570|NCT01769690|deep brain stimulation|deep brain stimulation
276571|NCT01769677|Bioequivalence|bioequivalence
276572|NCT01769677|Hydrocodone bitartrate extended-release tablets|hydrocodone bitartrate extended-release tablets
276573|NCT01769664|Acne vulgaris|acne vulgaris
276574|NCT01769664|Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel|clindamycin 1%/benzoyl peroxide 5% topical gel
276575|NCT01769664|Duac® Topical Gel|duac® topical gel
276576|NCT01769651|drug user patients|drug user patients
276577|NCT01769651|addiction nurses|addiction nurses
276578|NCT01769651|overdose risk|overdose risk
276579|NCT01769638|Orally disintegrating Film|orally disintegrating film
276580|NCT01769638|Film Coated Tablet|film coated tablet
276581|NCT01769638|Sildenafil|sildenafil
276582|NCT01769638|Pharmacokinetics|pharmacokinetics
276583|NCT01769625|breast|breast
276584|NCT01769625|high risk women|high risk women
276585|NCT01769625|biomarkers|biomarkers
276586|NCT01769625|vitamin D|vitamin d
697251|NCT00956436|Nexavar|nexavar
276587|NCT01769612|Leishmaniasis, Leishmania|leishmaniasis, leishmania
276588|NCT01769586|Sedation|sedation
276589|NCT01769586|Endoscopy|endoscopy
276590|NCT01769586|Diphenhydramine|diphenhydramine
276591|NCT01769586|Midazolam|midazolam
276592|NCT01769573|normal|normal
276593|NCT01769560|tailored intervention|tailored intervention
276594|NCT01769560|college aged students|college aged students
276595|NCT01769560|HPV|hpv
276596|NCT01769521|Glaucoma|glaucoma
276597|NCT01769521|IOP|iop
276598|NCT01769521|Blood pressure|blood pressure
276599|NCT01769521|ECG|ecg
276600|NCT01769508|Esophagogastric Adenocarcinoma|esophagogastric adenocarcinoma
276601|NCT01769508|5-Fluorouracil|5-fluorouracil
276602|NCT01769508|Oxaliplatin|oxaliplatin
276603|NCT01769508|Lapatinib|lapatinib
276604|NCT01769508|Radiation Therapy|radiation therapy
276605|NCT01769508|Surgery|surgery
276606|NCT01769495|Emergency department, Geriatrics, mortality, readmission rates.|emergency department, geriatrics, mortality, readmission rates.
276607|NCT01769495|Patients 75 years of age and older.|patients 75 years of age and older.
276608|NCT01769482|microvascular angina|microvascular angina
276609|NCT01769482|PDE-5 inhibitors|pde-5 inhibitors
276610|NCT01769482|Heart disease|heart disease
276611|NCT01769482|Ischemia|ischemia
276612|NCT01769482|Cardiac MRI|cardiac mri
276613|NCT01769469|Tenofovir|tenofovir
276614|NCT01769469|Emtricitabine|emtricitabine
276615|NCT01769469|Truvada|truvada
276616|NCT01769469|Renal, endocrine, bone changes|renal, endocrine, bone changes
276617|NCT01769469|HIV prevention|hiv prevention
276618|NCT01769469|PrEP|prep
276619|NCT01769456|HIV, PrEP, FTC/TDF, Truvada|hiv, prep, ftc/tdf, truvada
276620|NCT01769443|desensitization therapy|desensitization therapy
276621|NCT01769443|bortezomib (VELCADE®)|bortezomib (velcade®)
276622|NCT01769443|plasmapheresis|plasmapheresis
276623|NCT01769430|influenza virus|influenza virus
276624|NCT01769430|aerosol transmission|aerosol transmission
276625|NCT01769430|contact transmission|contact transmission
276626|NCT01769430|large droplet transmission|large droplet transmission
276627|NCT01769430|airborne infection|airborne infection
276628|NCT01769391|NSCLC|nsclc
276629|NCT01769365|Helicobacter pylori infection|helicobacter pylori infection
276630|NCT01769352|cystoid macular edema|cystoid macular edema
276631|NCT01769339|Vulvar Candidiasis|vulvar candidiasis
276632|NCT01769339|Miconazole|miconazole
276633|NCT01769339|Hydrocortisone|hydrocortisone
276634|NCT01769339|Daktacort Feminine Care Cream|daktacort feminine care cream
276635|NCT01769326|Stroke|stroke
276636|NCT01769313|Cataract|cataract
276637|NCT01769313|Laser-assisted|laser-assisted
276638|NCT01769313|Femtosecond|femtosecond
276639|NCT01769300|Clinical decision support|clinical decision support
276640|NCT01769300|Electronic health records|electronic health records
276641|NCT01769300|Electronic medical records|electronic medical records
276642|NCT01769300|Attention deficit-hyperactivity disorder|attention deficit-hyperactivity disorder
276643|NCT01769300|Primary care Pediatric research network|primary care pediatric research network
276644|NCT01769287|Atrial fibrillation|atrial fibrillation
276645|NCT01769287|Electrophysiological Assessment|electrophysiological assessment
276646|NCT01769287|12 months post-operatively|12 months post-operatively
276647|NCT01769287|High Intensity Ultrasound|high intensity ultrasound
276648|NCT01769261|quality of health care|quality of health care
276649|NCT01769261|continuity of patient care|continuity of patient care
276650|NCT01769261|adverse effects|adverse effects
276651|NCT01769261|outcome and process assessment (health care)|outcome and process assessment (health care)
276654|NCT01769248|FNB|fnb
276655|NCT01769235|Acne Vulgaris|acne vulgaris
276656|NCT01769235|Clindamycin Phosphate and Benzoyl Peroxide Gel|clindamycin phosphate and benzoyl peroxide gel
276657|NCT01769235|Acanya® Gel|acanya® gel
276658|NCT01769196|Idiopathic|idiopathic
276659|NCT01769196|Pulmonary|pulmonary
276660|NCT01769196|Fibrosis|fibrosis
276661|NCT01769196|IPF|ipf
276662|NCT01769183|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
276663|NCT01769170|CMV|cmv
276664|NCT01769170|Hematopoietic Stem Cell Transplant Recipients|hematopoietic stem cell transplant recipients
276665|NCT01769170|CMV seropositive|cmv seropositive
276666|NCT01769144|wound healing|wound healing
276667|NCT01769144|wound infection|wound infection
276668|NCT01769144|pain|pain
276669|NCT01769144|pruritus|pruritus
276670|NCT01769144|cicatrix|cicatrix
276671|NCT01769144|dressings|dressings
276672|NCT01769144|acticoat absorbent|acticoat absorbent
276673|NCT01769144|BCT|bct
276674|NCT01769144|KoCarbonAg|kocarbonag
276675|NCT01769131|cervix|cervix
276676|NCT01769131|Allis|allis
276677|NCT01769131|Tenaculum|tenaculum
276678|NCT01769131|gynecology|gynecology
276679|NCT01769118|Autonomic nervous system|autonomic nervous system
276680|NCT01769105|Meibomian Gland Dysfunction|meibomian gland dysfunction
276681|NCT01769105|Lipiflow|lipiflow
276682|NCT01769092|Epilepsy|epilepsy
276683|NCT01769092|Seizure|seizure
276684|NCT01769092|Fish Oil|fish oil
276685|NCT01769053|Acute Lung Injury|acute lung injury
276686|NCT01769053|Adult Respiratory Distress Syndrome|adult respiratory distress syndrome
276687|NCT01769053|Interactive Ventilatory Support|interactive ventilatory support
276688|NCT01769053|Positive-Pressure Respiration|positive-pressure respiration
276689|NCT01769053|Ventilator-Induced Lung Injury|ventilator-induced lung injury
276690|NCT01769040|Decompensated liver cirrhosis|decompensated liver cirrhosis
276692|NCT01769040|Haemodynamics|haemodynamics
276693|NCT01769040|Small intestinal bacterial overgrowth|small intestinal bacterial overgrowth
276694|NCT01769040|Pathophysiology|pathophysiology
276695|NCT01769014|adherence|adherence
276696|NCT01769001|Fabry disease|fabry disease
276697|NCT01769001|Alpha galactosidase deficiency|alpha galactosidase deficiency
276698|NCT01769001|Metabolic storage disease|metabolic storage disease
276699|NCT01768975|Knee|knee
276700|NCT01768975|Osteoarthritis|osteoarthritis
276701|NCT01768975|OA|oa
276702|NCT01768975|Knee pain|knee pain
276703|NCT01768975|Moderate pain|moderate pain
276704|NCT01768975|Severe pain|severe pain
276705|NCT01768975|Inflammation|inflammation
276706|NCT01768975|Safety|safety
276707|NCT01768975|Efficacy|efficacy
276708|NCT01768975|Randomized|randomized
276709|NCT01768975|Topical|topical
276710|NCT01768975|Gel|gel
276711|NCT01768975|Olatec|olatec
276712|NCT01768975|OLT1177|olt1177
276713|NCT01768975|Joint Diseases|joint diseases
276714|NCT01768975|Musculoskeletal Diseases|musculoskeletal diseases
276715|NCT01768975|Rheumatic Diseases|rheumatic diseases
276716|NCT01768975|Arthritis|arthritis
276717|NCT01768975|Therapeutic|therapeutic
276718|NCT01768975|Analgesic|analgesic
276719|NCT01768962|Microbicides|microbicides
276720|NCT01768962|Tenofovir|tenofovir
276721|NCT01768962|Reduced-glycerin|reduced-glycerin
276722|NCT01768962|Vaginal use|vaginal use
276723|NCT01768962|Rectal use|rectal use
276724|NCT01768962|Pharmacokinetics|pharmacokinetics
276725|NCT01768949|Acute respiratory distress syndrome|acute respiratory distress syndrome
276726|NCT01768949|Echocardiography|echocardiography
276727|NCT01768949|Recruitment maneuver|recruitment maneuver
276728|NCT01768936|on-demand relaparotomy|on-demand relaparotomy
276729|NCT01768936|PCT|pct
276730|NCT01768936|procalcitonin|procalcitonin
276731|NCT01768936|peritonitis|peritonitis
276732|NCT01768936|sepsis|sepsis
276733|NCT01768936|focus index|focus index
276734|NCT01768923|Early Rheumatoid Arthritis|early rheumatoid arthritis
276735|NCT01768923|Arterial stiffness|arterial stiffness
276736|NCT01768923|SDAI remission group|sdai remission group
276737|NCT01768923|Minimal disease activity remission group|minimal disease activity remission group
276738|NCT01768910|lower urinary tract|lower urinary tract
276739|NCT01768910|bladder|bladder
276740|NCT01768910|supraspinal control|supraspinal control
276741|NCT01768910|neuroimaging|neuroimaging
276411|NCT01770431|Safety.|safety.
276742|NCT01768910|functional magnetic resonance imaging|functional magnetic resonance imaging
276744|NCT01768910|functional connectivity|functional connectivity
276745|NCT01768910|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
276746|NCT01768910|overactive bladder|overactive bladder
276747|NCT01768910|multiple sclerosis|multiple sclerosis
276748|NCT01768910|spinal cord injury|spinal cord injury
276749|NCT01768884|Infants|infants
276750|NCT01768884|Bronchiolitis|bronchiolitis
276751|NCT01768884|NO|no
276752|NCT01768884|inhalation|inhalation
276753|NCT01768858|Arthritis|arthritis
276754|NCT01768858|Morbus Crohn|morbus crohn
276755|NCT01768858|Adherence|adherence
276756|NCT01768858|Spondylitis|spondylitis
276757|NCT01768858|Ulcerative colitis|ulcerative colitis
276758|NCT01768858|Monoclonals|monoclonals
276759|NCT01768858|Rheumatoid|rheumatoid
276760|NCT01768858|Antibodies|antibodies
276761|NCT01768858|Ankylosing|ankylosing
276762|NCT01768858|Plaque psoriasis|plaque psoriasis
276763|NCT01768858|Psoriatic|psoriatic
276764|NCT01768858|Crohn´s disease|crohn´s disease
276765|NCT01768858|Antirheumatic Agents|antirheumatic agents
276766|NCT01768845|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
276767|NCT01768845|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
276768|NCT01768845|Myelodysplastic syndrome|myelodysplastic syndrome
276769|NCT01768845|Multiple myeloma|multiple myeloma
276770|NCT01768845|Hodgkin lymphoma|hodgkin lymphoma
276771|NCT01768845|Non Hodgkin lymphoma|non hodgkin lymphoma
276772|NCT01768845|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
276773|NCT01768845|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
276774|NCT01768845|Severe Aplastic Anemia|severe aplastic anemia
276775|NCT01768845|Cord Blood|cord blood
276776|NCT01768845|Umbilical cord blood transplantation|umbilical cord blood transplantation
276777|NCT01768845|UBC transplantation|ubc transplantation
276778|NCT01768832|Parkinson disease|parkinson disease
276779|NCT01768832|walking|walking
276780|NCT01768832|fMRI|fmri
276781|NCT01768832|exercise|exercise
276782|NCT01768832|dance|dance
276783|NCT01768832|treadmill|treadmill
276784|NCT01768819|aging|aging
276785|NCT01768819|exercise|exercise
276786|NCT01768819|muscle strength|muscle strength
276787|NCT01768819|physical activity|physical activity
276788|NCT01768806|Autism|autism
276789|NCT01768806|Autism Spectrum Disorder|autism spectrum disorder
276790|NCT01768806|PLAY and Language for Autistic Youngsters|play and language for autistic youngsters
276791|NCT01768806|Intensive Early Intervention|intensive early intervention
276792|NCT01768806|Parent Training|parent training
276793|NCT01768793|Obesity|obesity
276794|NCT01768793|Pregnancy|pregnancy
276795|NCT01768793|Body Weight Changes|body weight changes
276796|NCT01768793|Diet Therapy|diet therapy
276797|NCT01768780|spinal anesthesia|spinal anesthesia
276798|NCT01768780|peripheral nerve stimulator|peripheral nerve stimulator
276799|NCT01768780|sensory block level|sensory block level
276800|NCT01768754|Exercise testing|exercise testing
277304|NCT01766544|guidelines|guidelines
276801|NCT01768754|Functional status|functional status
276802|NCT01768754|Pulmonary rehabilitation|pulmonary rehabilitation
276803|NCT01768741|hepatocellular carcinoma|hepatocellular carcinoma
276804|NCT01768715|Alcoholic hepatitis|alcoholic hepatitis
276805|NCT01768715|Liver transplantation|liver transplantation
276806|NCT01768715|Survival|survival
276807|NCT01768715|Alcoholism|alcoholism
276808|NCT01768702|Chronic Heart Failure of Ischemic Origin|chronic heart failure of ischemic origin
276809|NCT01768689|adherence|adherence
276810|NCT01768689|chronic myeloid leukemia|chronic myeloid leukemia
276916|NCT01768234|cognition|cognition
276811|NCT01768689|tyrosine kinase inhibitors|tyrosine kinase inhibitors
276812|NCT01768676|healthy male|healthy male
276813|NCT01768650|traumatic brain injury|traumatic brain injury
276814|NCT01768650|chronic pain|chronic pain
276815|NCT01768650|headache|headache
276816|NCT01768650|Veteran|veteran
276817|NCT01768637|Chronic kidney disease|chronic kidney disease
276818|NCT01768637|Platelet function|platelet function
276819|NCT01768637|aspirin|aspirin
276820|NCT01768637|antiplatelet agent|antiplatelet agent
276821|NCT01768624|chronic kidney disease|chronic kidney disease
276822|NCT01768624|dialysis|dialysis
276823|NCT01768624|pre dialysis education|pre dialysis education
276824|NCT01768624|transplantation|transplantation
276825|NCT01768624|conservative care|conservative care
276826|NCT01768598|Wrist Fracture|wrist fracture
276827|NCT01768598|Adolescents|adolescents
276828|NCT01768598|Risk Taking Behaviour|risk taking behaviour
276829|NCT01768598|Bone Microstructure|bone microstructure
276830|NCT01768546|Diabetes Prevention Program|diabetes prevention program
276831|NCT01768546|obesity|obesity
276832|NCT01768546|activity|activity
276833|NCT01768546|diabetes|diabetes
276834|NCT01768533|pediatric|pediatric
276835|NCT01768533|obesity|obesity
276836|NCT01768533|prevention|prevention
276837|NCT01768533|health behaviors|health behaviors
276838|NCT01768533|guidelines|guidelines
276840|NCT01768481|Dyslipidemia|dyslipidemia
276841|NCT01768481|Cholesterol|cholesterol
276842|NCT01768481|Intima media thickness|intima media thickness
276843|NCT01768468|LAYLA|layla
276844|NCT01768468|Non-inferiority|non-inferiority
276845|NCT01768468|100mm pain VAS|100mm pain vas
342116|NCT01482351|apnea|apnea
276846|NCT01768442|Head and neck cancer|head and neck cancer
276847|NCT01768403|Hypercholesterolemia|hypercholesterolemia
276848|NCT01768403|Cardiovascular disease|cardiovascular disease
276849|NCT01768403|Hypertension|hypertension
276850|NCT01768403|Coronary Heart disease|coronary heart disease
276851|NCT01768403|Peripheral Arterial disease|peripheral arterial disease
276852|NCT01768390|caries|caries
276853|NCT01768390|prevention|prevention
276854|NCT01768390|orthodontics|orthodontics
276855|NCT01768390|fixed appliances|fixed appliances
276856|NCT01768390|adolescents|adolescents
276857|NCT01768377|Awake intubation|awake intubation
276858|NCT01768377|Nerve block|nerve block
276859|NCT01768377|Sedation|sedation
276860|NCT01768377|Physician satisfaction|physician satisfaction
276861|NCT01768351|anemia|anemia
276862|NCT01768351|chronic kidney disease|chronic kidney disease
276863|NCT01768351|vitamin D|vitamin d
276864|NCT01768351|paricalcitol|paricalcitol
276865|NCT01768351|hyperparathyroidism|hyperparathyroidism
276866|NCT01768325|ProCore Needle|procore needle
276867|NCT01768299|abortion|abortion
276868|NCT01768299|medical abortion|medical abortion
276869|NCT01768299|mifepristone|mifepristone
276870|NCT01768299|misoprostol|misoprostol
276871|NCT01768286|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
276873|NCT01768286|Sustained Virologic Response|sustained virologic response
276874|NCT01768286|Direct Acting Antiviral|direct acting antiviral
276875|NCT01768286|Combination Therapy|combination therapy
276876|NCT01768286|GS-7977|gs-7977
276877|NCT01768286|GS-5885|gs-5885
276878|NCT01768286|Ribavirin|ribavirin
276879|NCT01768286|Open Label|open label
276880|NCT01768286|Sofosbuvir|sofosbuvir
276881|NCT01768286|Additional relevant MeSH terms:|additional relevant mesh terms:
276882|NCT01768286|Hepatitis|hepatitis
276883|NCT01768286|Hepatitis, Chronic|hepatitis, chronic
276884|NCT01768286|Hepatitis C|hepatitis c
276885|NCT01768286|Hepatitis C, Chronic|hepatitis c, chronic
276886|NCT01768286|Liver Diseases|liver diseases
276887|NCT01768286|Digestive System Diseases|digestive system diseases
276888|NCT01768286|Hepatitis, Viral, Human|hepatitis, viral, human
276889|NCT01768286|Virus Diseases|virus diseases
276890|NCT01768286|Enterovirus Infections|enterovirus infections
276891|NCT01768286|Picornaviridae Infections|picornaviridae infections
276892|NCT01768286|RNA Virus Infections|rna virus infections
276893|NCT01768286|Flaviviridae Infections|flaviviridae infections
276894|NCT01768286|Antiviral Agents|antiviral agents
276895|NCT01768286|Anti-Infective Agents|anti-infective agents
276896|NCT01768286|Therapeutic Uses|therapeutic uses
276897|NCT01768286|Pharmacologic Actions|pharmacologic actions
276898|NCT01768286|Antimetabolites|antimetabolites
276899|NCT01768286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
276901|NCT01768273|midazolam|midazolam
276902|NCT01768273|drug-drug interaction|drug-drug interaction
276903|NCT01768273|pharmacokinetics|pharmacokinetics
276904|NCT01768273|pretomanid|pretomanid
276906|NCT01768260|visual acuity|visual acuity
276907|NCT01768260|artery flow velocity|artery flow velocity
276908|NCT01768260|Enhanced External Counterpulsation|enhanced external counterpulsation
276909|NCT01768260|Ischemic|ischemic
276910|NCT01768260|Optic Neuropathy|optic neuropathy
276911|NCT01768247|endometrium|endometrium
276912|NCT01768247|thickness|thickness
276913|NCT01768247|pregnancy|pregnancy
276914|NCT01768247|HCG|hcg
276915|NCT01768247|frozen cycles|frozen cycles
276917|NCT01768234|hydration|hydration
276918|NCT01768234|schoolchildren|schoolchildren
276919|NCT01768221|Palliative Care|palliative care
276920|NCT01768221|Caregiver Outlook|caregiver outlook
276921|NCT01768195|Lymphoma|lymphoma
276922|NCT01768195|Hepatitis B Virus|hepatitis b virus
276923|NCT01768195|Therapeutic Uses|therapeutic uses
276924|NCT01768195|Antiviral Agents|antiviral agents
276925|NCT01768195|rituximab|rituximab
276926|NCT01768182|folic acid; folates; Vascular Reactivity; HIV|folic acid; folates; vascular reactivity; hiv
276927|NCT01768169|metabolic syndrome,|metabolic syndrome,
276928|NCT01768169|waist, blood pressure,|waist, blood pressure,
276929|NCT01768169|fasting plasma glucose,|fasting plasma glucose,
276930|NCT01768169|HDL cholesterol,|hdl cholesterol,
276931|NCT01768169|triglycerides|triglycerides
276932|NCT01768156|ovarian cancer|ovarian cancer
276933|NCT01768156|biomarker|biomarker
276934|NCT01768156|metastatic|metastatic
276935|NCT01768143|Propofol|propofol
276936|NCT01768143|Sedation|sedation
276937|NCT01768143|Endoscopy|endoscopy
276938|NCT01768143|nonanesthesiologist|nonanesthesiologist
276939|NCT01768104|upper gastrointestinal submucosal tumors|upper gastrointestinal submucosal tumors
276940|NCT01768104|SMTs|smts
276941|NCT01768104|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
276942|NCT01768104|GISTs|gists
276943|NCT01768104|Leiomyoma|leiomyoma
276944|NCT01768104|Endoscopic submucosal tunnel dissection|endoscopic submucosal tunnel dissection
276945|NCT01768104|ESTD|estd
276946|NCT01768104|Submucosal tunneling endoscopic resection|submucosal tunneling endoscopic resection
276947|NCT01768104|STER|ster
276948|NCT01768104|Submucosal endoscopic tumor resection|submucosal endoscopic tumor resection
276949|NCT01768104|SET|set
276950|NCT01768091|Esophageal achalasia|esophageal achalasia
276951|NCT01768091|Peroral endoscopic myotomy|peroral endoscopic myotomy
276952|NCT01768091|POEM|poem
276953|NCT01768091|Pneumatic dilation|pneumatic dilation
276954|NCT01768065|NEPAP|nepap
276955|NCT01768065|CPAP|cpap
276956|NCT01768065|alternative|alternative
276957|NCT01768065|OSAS|osas
276958|NCT01768052|MDD, major depression, treatment-resistant|mdd, major depression, treatment-resistant
276959|NCT01768039|Multiple sclerosis|multiple sclerosis
276960|NCT01768039|Vitamin D|vitamin d
276961|NCT01768039|EDSS|edss
276962|NCT01768039|ARR|arr
276963|NCT01768026|Dystrophic Epidermolysis Bullosa|dystrophic epidermolysis bullosa
276964|NCT01768026|Type VII Collagen|type vii collagen
276965|NCT01768026|QOL Evaluation in Epidermolysis Bullosa|qol evaluation in epidermolysis bullosa
276966|NCT01768026|Instrument for Scoring Clinical Outcomes for Research of Epidermolysis Bullosa|instrument for scoring clinical outcomes for research of epidermolysis bullosa
276967|NCT01768026|Birmingham Epidermolysis Bullosa Severity Score|birmingham epidermolysis bullosa severity score
276968|NCT01768000|Psychosis|psychosis
276969|NCT01768000|Psychosis NOS|psychosis nos
276970|NCT01768000|Schizophrenia|schizophrenia
276971|NCT01768000|Schizoaffective Disorder|schizoaffective disorder
276972|NCT01768000|Bipolar Disorder|bipolar disorder
276973|NCT01767987|Acute Coronary Syndrome|acute coronary syndrome
276974|NCT01767987|ACS|acs
276975|NCT01767987|Percutaneous Coronary Intervention|percutaneous coronary intervention
276976|NCT01767987|PCI|pci
276977|NCT01767987|Ranolazine|ranolazine
276978|NCT01767987|Coronary Angiogram|coronary angiogram
276979|NCT01767987|Cardioprotectant|cardioprotectant
276980|NCT01767974|Non-Small Cell lung cancer|non-small cell lung cancer
276981|NCT01767948|Hepatic Impairment|hepatic impairment
276982|NCT01767948|PCI 32765|pci 32765
276983|NCT01767948|Metabolite PCI-45227|metabolite pci-45227
276984|NCT01767948|Pharmacokinetics|pharmacokinetics
276985|NCT01767922|Super-Oxyd-Dismutase|super-oxyd-dismutase
276986|NCT01767922|SOD|sod
276987|NCT01767922|melon juce|melon juce
276988|NCT01767922|perceived stress|perceived stress
276989|NCT01767909|Intranasal insulin|intranasal insulin
276990|NCT01767909|Alzheimer's disease|alzheimer's disease
276991|NCT01767909|Amnestic mild cognitive impairment|amnestic mild cognitive impairment
276992|NCT01767909|Dementia|dementia
276993|NCT01767909|Brain diseases|brain diseases
276994|NCT01767909|Memory problems|memory problems
276995|NCT01767909|Mental disorders|mental disorders
276996|NCT01767909|Cognitive disorders|cognitive disorders
276997|NCT01767896|Influenza vaccine|influenza vaccine
276998|NCT01767883|Chronic Kidney Disease|chronic kidney disease
276999|NCT01767883|CKD|ckd
277001|NCT01767883|Practice Facilitation|practice facilitation
277002|NCT01767883|Practice-based research|practice-based research
277003|NCT01767883|CKD Guidelines|ckd guidelines
277004|NCT01767870|advanced colorectal adenoma|advanced colorectal adenoma
277005|NCT01767870|colonoscopy|colonoscopy
277006|NCT01767870|sigmoidoscopy|sigmoidoscopy
277007|NCT01767870|fecal immunochemical test|fecal immunochemical test
277008|NCT01767857|Pivotal|pivotal
277009|NCT01767857|Colorectal|colorectal
277010|NCT01767857|Survival|survival
277011|NCT01767857|Phase 3|phase 3
277012|NCT01767844|Rheumatoid Arthritis|rheumatoid arthritis
277013|NCT01767844|Arthritis|arthritis
277014|NCT01767844|Rheumatology|rheumatology
277015|NCT01767844|Creatine|creatine
277016|NCT01767831|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
277017|NCT01767831|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
277018|NCT01767831|Simulation-based Education|simulation-based education
277019|NCT01767818|Parkinson's Disease|parkinson's disease
277020|NCT01767792|Neurofibromatosis Type 2|neurofibromatosis type 2
277021|NCT01767792|Progressive Vestibular Schwannomas|progressive vestibular schwannomas
277022|NCT01767779|Epilepsy|epilepsy
277023|NCT01767779|TSC|tsc
277024|NCT01767779|Tuberous Sclerosis Complex|tuberous sclerosis complex
277025|NCT01767779|Infants|infants
277026|NCT01767779|Seizures|seizures
277027|NCT01767779|Biomarkers|biomarkers
277028|NCT01767779|EEG|eeg
277029|NCT01767753|Glaucoma|glaucoma
277030|NCT01767753|SLT|slt
277031|NCT01767740|Rotator Cuff Tear|rotator cuff tear
277032|NCT01767740|Supraspinatus Tear|supraspinatus tear
277033|NCT01767727|surgical flap;|surgical flap;
277034|NCT01767727|dorsal branch of the digital artery|dorsal branch of the digital artery
277035|NCT01767714|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
277036|NCT01767701|raltegravir|raltegravir
277037|NCT01767701|MS|ms
277038|NCT01767701|RRMS|rrms
277039|NCT01767701|Charcot Project|charcot project
277040|NCT01767688|Diabetes Mellitus|diabetes mellitus
277041|NCT01767688|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
277042|NCT01767688|Glucose Metabolism Disorders|glucose metabolism disorders
277043|NCT01767688|Metabolic Diseases|metabolic diseases
277044|NCT01767688|Endocrine System Diseases|endocrine system diseases
277045|NCT01767675|Secondary Cytoreductive Surgery|secondary cytoreductive surgery
277046|NCT01767675|Carboplatin|carboplatin
277047|NCT01767675|Hyperthermic Intraperitoneal Chemotherapy (HIPEC)|hyperthermic intraperitoneal chemotherapy (hipec)
277048|NCT01767675|12-275|12-275
277049|NCT01767662|TCV|tcv
277050|NCT01767649|Pregnancy|pregnancy
277051|NCT01767649|Remodelling|remodelling
277052|NCT01767649|Extracellular matrix|extracellular matrix
277053|NCT01767649|Biomarkers|biomarkers
277054|NCT01767597|rapid test|rapid test
277055|NCT01767597|screening|screening
277056|NCT01767597|ELISA|elisa
277057|NCT01767597|hepatitis B virus|hepatitis b virus
277058|NCT01767597|access to care|access to care
277059|NCT01767584|Pharmacokinetics|pharmacokinetics
277060|NCT01767584|Bioequivalence|bioequivalence
277061|NCT01767584|Mexico|mexico
277062|NCT01767584|Cephalexin|cephalexin
277063|NCT01767571|Mexico|mexico
277064|NCT01767571|Respiratory infections|respiratory infections
277065|NCT01767571|Bioequivalence|bioequivalence
277066|NCT01767571|Cepphalexin|cepphalexin
277067|NCT01767532|Cephalexin|cephalexin
277068|NCT01767532|Respiratory infections|respiratory infections
277069|NCT01767532|Mexico|mexico
277070|NCT01767532|Bioequivalence|bioequivalence
277071|NCT01767506|Trachoma|trachoma
277072|NCT01767506|Azithromycin|azithromycin
277073|NCT01767506|Mass treatment|mass treatment
277074|NCT01767493|Multiple sclerosis|multiple sclerosis
277075|NCT01767480|Intensive Robot Assisted Therapy|intensive robot assisted therapy
277076|NCT01767480|Subacute Stroke|subacute stroke
277077|NCT01767480|Brain Reorganization|brain reorganization
277078|NCT01767480|Sensory Motor|sensory motor
277079|NCT01767480|Physiological Marker|physiological marker
277080|NCT01767467|Immunogenicity|immunogenicity
277081|NCT01767467|Safety|safety
277082|NCT01767467|Herpes zoster|herpes zoster
277083|NCT01767467|Vaccination|vaccination
277084|NCT01767467|Haematologic malignancies|haematologic malignancies
277085|NCT01767454|BRAF V600E|braf v600e
277086|NCT01767454|Melanoma|melanoma
277087|NCT01767454|V600K|v600k
277088|NCT01767454|Trametinib|trametinib
277089|NCT01767454|Dabrafenib|dabrafenib
277090|NCT01767454|Ipilimumab|ipilimumab
277091|NCT01767441|bariatric surgery|bariatric surgery
277092|NCT01767441|gastric bypass|gastric bypass
277093|NCT01767441|gastric banding|gastric banding
277094|NCT01767441|sleeve gastrectomy|sleeve gastrectomy
277095|NCT01767441|weight loss|weight loss
277096|NCT01767441|Type 2 Diabetes mellitus|type 2 diabetes mellitus
277097|NCT01767441|GLP1|glp1
277098|NCT01767441|obesity|obesity
277099|NCT01767441|mixed meal test|mixed meal test
277100|NCT01767415|brain tumor|brain tumor
277101|NCT01767415|resection|resection
277102|NCT01767415|indigo carmine dye|indigo carmine dye
277103|NCT01767402|Safety|safety
277104|NCT01767402|Pneumococcal Infections|pneumococcal infections
277105|NCT01767402|Immunogenicity|immunogenicity
277106|NCT01767402|PhtD vaccine|phtd vaccine
277107|NCT01767402|Healthy adults|healthy adults
277108|NCT01767402|Reactogenicity|reactogenicity
277109|NCT01767389|utilization|utilization
277110|NCT01767389|acute pancreatitis|acute pancreatitis
277111|NCT01767389|Exenatide|exenatide
277112|NCT01767389|DPP-4 inhibitors|dpp-4 inhibitors
277113|NCT01767389|liraglutide|liraglutide
277114|NCT01767389|GLP-1 receptor agonist|glp-1 receptor agonist
277115|NCT01767389|adherence|adherence
277116|NCT01767376|Young adults|young adults
277117|NCT01767376|Adolescents|adolescents
277118|NCT01767376|Reactogenicity|reactogenicity
277119|NCT01767376|Diphtheria|diphtheria
277120|NCT01767376|pertussis|pertussis
277121|NCT01767376|Immunogenicity|immunogenicity
277122|NCT01767376|Tetanus|tetanus
277123|NCT01767376|Meningococcal vaccines|meningococcal vaccines
277124|NCT01767376|Safety|safety
277125|NCT01767376|Neisseria meningitidis|neisseria meningitidis
277126|NCT01767376|Healthy|healthy
277127|NCT01767363|5-alpha reductase inhibitor|5-alpha reductase inhibitor
277128|NCT01767363|benign prostatic hyperplasia treatment|benign prostatic hyperplasia treatment
277129|NCT01767363|Prostate cancer mortality|prostate cancer mortality
277130|NCT01767350|Pediatric transplantation|pediatric transplantation
277131|NCT01767350|Pharmacogenetics|pharmacogenetics
277132|NCT01767350|Pharmacokinetics|pharmacokinetics
277133|NCT01767350|Calcineurin inhibitors|calcineurin inhibitors
277134|NCT01767350|CYP3A|cyp3a
277135|NCT01767350|Pgp|pgp
277136|NCT01767337|microneedle-based delivery|microneedle-based delivery
277137|NCT01767337|hollow microneedle|hollow microneedle
277138|NCT01767337|intracutaneous|intracutaneous
277139|NCT01767337|drug delivery|drug delivery
277140|NCT01767324|microneedle-based array|microneedle-based array
277141|NCT01767324|hollow microneedle|hollow microneedle
277142|NCT01767324|intracutaneous|intracutaneous
277143|NCT01767324|drug delivery|drug delivery
277144|NCT01767324|vaccine delivery|vaccine delivery
277146|NCT01767311|BAN2401|ban2401
277147|NCT01767298|Fixed dose combination|fixed dose combination
277148|NCT01767298|Pharmacokinetics|pharmacokinetics
277149|NCT01767298|Valsartan|valsartan
277150|NCT01767298|Hydrochlorothiazide|hydrochlorothiazide
277151|NCT01767285|Etonogestrel Implant|etonogestrel implant
277152|NCT01767285|Implanon|implanon
277153|NCT01767285|Nexplanon|nexplanon
277154|NCT01767285|Long Acting Reversible Contraception|long acting reversible contraception
277155|NCT01767272|Fexofenadine|fexofenadine
277156|NCT01767272|Pharmacokinetics|pharmacokinetics
277157|NCT01767272|Bioavailability|bioavailability
277158|NCT01767272|Linearity|linearity
277159|NCT01767272|HPLC|hplc
277160|NCT01767272|Dose proportionality of fexofenadine in Egyptian volunteers|dose proportionality of fexofenadine in egyptian volunteers
277161|NCT01767259|Fixed dose combination|fixed dose combination
277162|NCT01767259|Pharmacokinetics|pharmacokinetics
277163|NCT01767259|Valsartan|valsartan
277164|NCT01767259|Hydrochlorothiazide|hydrochlorothiazide
277165|NCT01767233|Acute necrotizing pancreatitis|acute necrotizing pancreatitis
277166|NCT01767233|ERCP|ercp
277167|NCT01767233|Pancreatic stenting|pancreatic stenting
277168|NCT01767220|ventricular tachycardia|ventricular tachycardia
277169|NCT01767220|endocardial ablation|endocardial ablation
277170|NCT01767220|epicardial ablation|epicardial ablation
277171|NCT01767181|Light therapy|light therapy
277172|NCT01767181|physical exercise|physical exercise
277173|NCT01767181|night shift workers|night shift workers
277174|NCT01767181|genetic markers|genetic markers
277175|NCT01767181|PBMCs|pbmcs
277176|NCT01767142|Lipolysis|lipolysis
277177|NCT01767142|Cryolipolysis|cryolipolysis
277178|NCT01767142|Fat Reduction|fat reduction
277179|NCT01767129|levodopa|levodopa
277180|NCT01767129|dyskinesia|dyskinesia
277181|NCT01767129|parkinson's disease|parkinson's disease
277182|NCT01767129|AVP-923|avp-923
277183|NCT01767129|dextromethorphan|dextromethorphan
277184|NCT01767129|quinidine|quinidine
277185|NCT01767116|Interferon-Free|interferon-free
277186|NCT01767116|Hepatitis C Genotype 1b|hepatitis c genotype 1b
277187|NCT01767116|Chronic Hepatitis C|chronic hepatitis c
277188|NCT01767116|Hepatitis C Virus|hepatitis c virus
277189|NCT01767116|Hepatitis C|hepatitis c
277190|NCT01767116|Treatment-Naive|treatment-naive
277191|NCT01767116|Paritaprevir|paritaprevir
277192|NCT01767116|Ombitasvir|ombitasvir
277193|NCT01767116|Dasabuvir|dasabuvir
277194|NCT01767116|Viekira PAK|viekira pak
277195|NCT01767116|Ribavirin|ribavirin
277196|NCT01767103|Hepatic Impairment|hepatic impairment
277197|NCT01767103|Liver Impairment|liver impairment
277198|NCT01767103|Liver Disease|liver disease
277199|NCT01767103|Ferriprox®|ferriprox®
277200|NCT01767103|LI|li
277201|NCT01767103|DFP|dfp
277202|NCT01767103|Deferiprone|deferiprone
277203|NCT01767090|Endometriosis|endometriosis
277204|NCT01767090|ASP1707|asp1707
277205|NCT01767090|Pelvic pain|pelvic pain
277206|NCT01767090|Double-blind|double-blind
277207|NCT01767090|Placebo-controlled|placebo-controlled
277208|NCT01767090|Phase 2|phase 2
277209|NCT01767077|Saturated fat|saturated fat
277210|NCT01767077|Dairy products|dairy products
277211|NCT01767077|Milk fat globule membrane|milk fat globule membrane
277212|NCT01767077|Cholesterol|cholesterol
277213|NCT01767077|Butter|butter
277214|NCT01767077|Cream|cream
277215|NCT01767064|ARIs, antibiotics, public commitment, quality improvement|aris, antibiotics, public commitment, quality improvement
277216|NCT01767051|PCOS|pcos
277217|NCT01767051|Children|children
277218|NCT01767051|Cardiovascular|cardiovascular
277219|NCT01767051|Follow-up|follow-up
277220|NCT01767025|Influence|influence
277221|NCT01767025|oxytocin|oxytocin
277222|NCT01767025|automatic imitation|automatic imitation
277223|NCT01767025|behaviour|behaviour
277224|NCT01767025|volunteers|volunteers
277225|NCT01766999|pulse oximetry|pulse oximetry
277226|NCT01766999|tumescent anesthesia|tumescent anesthesia
277227|NCT01766960|Bile acids|bile acids
277228|NCT01766960|Pharmacokinetics|pharmacokinetics
277229|NCT01766947|Glaucoma|glaucoma
277230|NCT01766947|Deep sclerectomy|deep sclerectomy
277231|NCT01766934|Peripheral blood progenitor cell mobilization|peripheral blood progenitor cell mobilization
277232|NCT01766934|allogenic hematopoetic stem cell transplantation|allogenic hematopoetic stem cell transplantation
277233|NCT01766934|recombinant human granulocyte colony stimulating factor|recombinant human granulocyte colony stimulating factor
277234|NCT01766934|filgrastim|filgrastim
277235|NCT01766921|Influenza, Pandemic, H5N1, Elderly adults|influenza, pandemic, h5n1, elderly adults
277236|NCT01766908|Timing of Umbilical Cord clamping|timing of umbilical cord clamping
277237|NCT01766908|Cord Clamp 20 seconds|cord clamp 20 seconds
277238|NCT01766908|Cord Clamp 40 seconds|cord clamp 40 seconds
277239|NCT01766908|Cord Clamp 60 seconds|cord clamp 60 seconds
277240|NCT01766895|uremia|uremia
277242|NCT01766895|HCV|hcv
277243|NCT01766895|seroclearance|seroclearance
277244|NCT01766882|Hemodialysis|hemodialysis
277245|NCT01766882|Blood Pressure|blood pressure
277246|NCT01766882|Hydration Status|hydration status
277247|NCT01766882|Low-sodium diet|low-sodium diet
277248|NCT01766869|Prostate Cancer|prostate cancer
342650|NCT01480258|Hib|hib
277249|NCT01766869|MRI/MRS|mri/mrs
277250|NCT01766856|perforation|perforation
277251|NCT01766856|tympanoplasty|tympanoplasty
277252|NCT01766856|myringoplasty|myringoplasty
277253|NCT01766856|Eustachian tube function|eustachian tube function
277254|NCT01766856|tympanostomy tube|tympanostomy tube
277255|NCT01766817|IPF|ipf
277256|NCT01766804|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
277257|NCT01766804|Bovine Colostrum|bovine colostrum
277258|NCT01766804|Inflammation|inflammation
277259|NCT01766804|Infection|infection
277260|NCT01766804|Toxicity|toxicity
277261|NCT01766791|resistance exercise|resistance exercise
277262|NCT01766791|muscle mass|muscle mass
277263|NCT01766791|abdominal fat|abdominal fat
277264|NCT01766791|strength|strength
277265|NCT01766791|Coronary Heart Disease (CHD)-risk|coronary heart disease (chd)-risk
277266|NCT01766791|myocardial mass|myocardial mass
277267|NCT01766778|type-2 diabetes mellitus, inadequately controlled Metformin|type-2 diabetes mellitus, inadequately controlled metformin
277268|NCT01766739|GL-ONC1|gl-onc1
277269|NCT01766739|pleural effusion|pleural effusion
277270|NCT01766739|12-169|12-169
277271|NCT01766726|HIV|hiv
277272|NCT01766726|Atherosclerosis|atherosclerosis
277273|NCT01766700|Obesity, weight loss, weight maintenance|obesity, weight loss, weight maintenance
277274|NCT01766687|Chronic Kidney Disease|chronic kidney disease
277275|NCT01766687|estimated glomerular filtration rate|estimated glomerular filtration rate
277276|NCT01766687|water intake|water intake
277277|NCT01766687|fluid intake|fluid intake
277278|NCT01766687|renal decline|renal decline
277279|NCT01766674|Kyphosis|kyphosis
277280|NCT01766648|Distal|distal
277281|NCT01766648|Femur|femur
277282|NCT01766648|Locking|locking
277283|NCT01766648|Screw|screw
277284|NCT01766648|Fracture|fracture
277285|NCT01766648|Healing|healing
277286|NCT01766622|Apoptosis|apoptosis
277287|NCT01766622|Pro-Apoptotic Effects|pro-apoptotic effects
277288|NCT01766622|PET Imaging|pet imaging
277289|NCT01766622|TL32711|tl32711
277290|NCT01766622|Relapsed Platinum Resistant or Refractory Epithelial Ovarian Cancer|relapsed platinum resistant or refractory epithelial ovarian cancer
277291|NCT01766609|Vitiligo; Intralesional; Triamcinolone acetonide|vitiligo; intralesional; triamcinolone acetonide
277292|NCT01766596|Ophthalmology|ophthalmology
277293|NCT01766596|Age-related ocular pathologies|age-related ocular pathologies
277294|NCT01766583|Open label, 3 + 3 dose escalation study followed by an expansion phase.|open label, 3 + 3 dose escalation study followed by an expansion phase.
277295|NCT01766570|insulin sensitivity,|insulin sensitivity,
277296|NCT01766570|glucose tolerance,|glucose tolerance,
277297|NCT01766570|inflammatory markers,|inflammatory markers,
277298|NCT01766570|lipid profile,|lipid profile,
277299|NCT01766570|oxidative stress,|oxidative stress,
277300|NCT01766570|pancreatic β-cell function|pancreatic β-cell function
277301|NCT01766557|Polycystic ovarian syndrome, sex hormones, ovarian function, women, fish protein, insulin sensitivity, glucose tolerance, β-cell function, inflammation|polycystic ovarian syndrome, sex hormones, ovarian function, women, fish protein, insulin sensitivity, glucose tolerance, β-cell function, inflammation
277302|NCT01766544|asthma|asthma
277305|NCT01766544|knowledge transfer|knowledge transfer
277306|NCT01766544|medical education|medical education
277307|NCT01766544|care gaps|care gaps
277308|NCT01766531|Bioelectrical impedance|bioelectrical impedance
277309|NCT01766531|Nutrition|nutrition
277310|NCT01766531|Phase angle|phase angle
277311|NCT01766531|ICU patients|icu patients
277312|NCT01766518|liver transplantation|liver transplantation
277313|NCT01766518|LT|lt
277314|NCT01766518|Mycophenolate mofetil|mycophenolate mofetil
277315|NCT01766518|MMF|mmf
277316|NCT01766505|hypertension, heart failure, candesartan, losartan|hypertension, heart failure, candesartan, losartan
277317|NCT01766492|prostate cancer|prostate cancer
277318|NCT01766492|CyberKnife|cyberknife
277319|NCT01766479|Colorectal cancer|colorectal cancer
277320|NCT01766479|colorectal neoplasia|colorectal neoplasia
277321|NCT01766479|CT colonography|ct colonography
277322|NCT01766479|advanced neoplasia|advanced neoplasia
277323|NCT01766479|colonoscopy|colonoscopy
277324|NCT01766479|family history|family history
277325|NCT01766453|South Asian|south asian
277326|NCT01766453|Cardiovascular|cardiovascular
277327|NCT01766453|Exercise|exercise
277328|NCT01766453|Obesity|obesity
277329|NCT01766453|Visceral Adipose Tissue|visceral adipose tissue
277330|NCT01766401|Generalized Anxiety Disorder|generalized anxiety disorder
277331|NCT01766401|GAD|gad
277332|NCT01766375|idarubicin|idarubicin
277333|NCT01766375|busulfan|busulfan
277334|NCT01766375|cyclophosphamide|cyclophosphamide
277335|NCT01766375|pretreatment|pretreatment
277336|NCT01766375|high-risk acute myeloid leukemia patient|high-risk acute myeloid leukemia patient
277337|NCT01766349|Esophageal cancer|esophageal cancer
277338|NCT01766349|Respiratory muscle strength|respiratory muscle strength
277339|NCT01766349|Pulmonary function testing|pulmonary function testing
277340|NCT01766349|Functional exercise capacity|functional exercise capacity
277341|NCT01766336|Agitation|agitation
277342|NCT01766336|Aggression|aggression
277343|NCT01766336|AD patients|ad patients
277344|NCT01766323|Morphine|morphine
277345|NCT01766323|Palliation|palliation
277346|NCT01766323|Cancer|cancer
277347|NCT01766323|Hospice|hospice
277348|NCT01766323|Sleepiness|sleepiness
277349|NCT01766323|Modafinil|modafinil
277350|NCT01766310|Folic acid|folic acid
277351|NCT01766310|Folate|folate
277352|NCT01766310|Homocysteine|homocysteine
277353|NCT01766310|Obese|obese
277354|NCT01766310|Children|children
277355|NCT01766297|Breast Cancer|breast cancer
277356|NCT01766297|Proton|proton
277357|NCT01766297|Radiation|radiation
277358|NCT01766284|Human Papillomavirus|human papillomavirus
277359|NCT01766284|Optical Coherence Tomography|optical coherence tomography
277360|NCT01766284|Imaging Systems|imaging systems
277361|NCT01766284|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
277362|NCT01766284|Cervical Cancer|cervical cancer
277363|NCT01766284|Cervical Dysplasia|cervical dysplasia
277364|NCT01766271|Coronary heart disease|coronary heart disease
277365|NCT01766271|cardiovascular disease|cardiovascular disease
277366|NCT01766271|risk|risk
277367|NCT01766258|Parkinson's Disease|parkinson's disease
277368|NCT01766258|Motor-fluctuation|motor-fluctuation
277369|NCT01766258|Wearing-off|wearing-off
277370|NCT01766245|mm|mm
277371|NCT01766206|conjugate vaccine|conjugate vaccine
277372|NCT01766206|phase IV clinical trial|phase iv clinical trial
277373|NCT01766206|Neisseria meningitidis|neisseria meningitidis
277374|NCT01766193|Delivery, obstetric|delivery, obstetric
277375|NCT01766193|Obstetric Surgical Procedures|obstetric surgical procedures
277376|NCT01766193|Vacuum Extraction, Obstetrical|vacuum extraction, obstetrical
277377|NCT01766193|Cesarean Section|cesarean section
277378|NCT01766193|Obstetrical Forceps|obstetrical forceps
697252|NCT00956449|flu|flu
277379|NCT01766193|Epidemiology|epidemiology
277380|NCT01766193|Norway|norway
277381|NCT01766180|Memory|memory
277382|NCT01766180|Fruitflow|fruitflow
277383|NCT01766180|Resveratrol (resVida)|resveratrol (resvida)
277384|NCT01766180|Cerebral blood flow|cerebral blood flow
277385|NCT01766180|Cardiopulmonary exercise test|cardiopulmonary exercise test
277386|NCT01766180|Maximal VO2|maximal vo2
277387|NCT01766167|Genotype 2|genotype 2
277388|NCT01766154|tirofiban|tirofiban
277389|NCT01766154|pharmacokinetic|pharmacokinetic
277390|NCT01766154|renal insufficiency|renal insufficiency
277391|NCT01766154|Phase 1|phase 1
277392|NCT01766154|pharmacodynamic|pharmacodynamic
277393|NCT01766141|Spinal manipulation|spinal manipulation
277394|NCT01766141|Tumor necrosis factor|tumor necrosis factor
277395|NCT01766141|Interleukin 1|interleukin 1
277396|NCT01766141|Interleukin 10|interleukin 10
277397|NCT01766141|Inflammatory cytokines|inflammatory cytokines
277398|NCT01766128|Parkinson disease|parkinson disease
277399|NCT01766128|Early stage|early stage
277400|NCT01766128|Zonisamide|zonisamide
277401|NCT01766128|UPDRS|updrs
277402|NCT01766115|HCV|hcv
277403|NCT01766115|needlestick|needlestick
277404|NCT01766115|occupational|occupational
277405|NCT01766115|transmission|transmission
277406|NCT01766115|health care worker|health care worker
277407|NCT01766115|telaprevir|telaprevir
277408|NCT01766102|Mammography|mammography
277409|NCT01766089|Caesarean delivery|caesarean delivery
277410|NCT01766089|severe pre-eclampsia|severe pre-eclampsia
277411|NCT01766089|remifentanil|remifentanil
277412|NCT01766089|dexmedetomidine|dexmedetomidine
277413|NCT01766089|cardiovascular response|cardiovascular response
277414|NCT01766076|immune activation|immune activation
277415|NCT01766076|antiretroviral therapy|antiretroviral therapy
277416|NCT01766076|atorvastatin|atorvastatin
277417|NCT01766076|immune exhaustion|immune exhaustion
277418|NCT01766076|adults|adults
277419|NCT01766076|Africa|africa
277420|NCT01766063|Multiple Sclerosis|multiple sclerosis
277421|NCT01766063|Sleep|sleep
277422|NCT01766063|Quality of life|quality of life
277423|NCT01766063|Observational study|observational study
277424|NCT01766037|obesity|obesity
277425|NCT01766037|obese|obese
277426|NCT01766037|weight loss|weight loss
277427|NCT01766024|interferon beta-1a|interferon beta-1a
277428|NCT01766024|pharmacokinetics|pharmacokinetics
277429|NCT01766024|pharmacodynamics|pharmacodynamics
277430|NCT01766024|volunteers|volunteers
277431|NCT01765998|Crohn's disease, endothelial progenitor cells, probiotic|crohn's disease, endothelial progenitor cells, probiotic
277432|NCT01765985|palmoplantar|palmoplantar
277433|NCT01765959|Insomnia|insomnia
277434|NCT01765959|Auricular acupuncture|auricular acupuncture
277435|NCT01765959|CBT|cbt
277436|NCT01765946|Insulin resistance|insulin resistance
277437|NCT01765946|Prediabetes|prediabetes
277438|NCT01765946|Longevity genes|longevity genes
277439|NCT01765946|Inflammation|inflammation
277440|NCT01765946|Metformin|metformin
277441|NCT01765933|1,3-dimethylamylamine|1,3-dimethylamylamine
277442|NCT01765894|glucose homeostasis|glucose homeostasis
277443|NCT01765894|endogenous glucose production|endogenous glucose production
277444|NCT01765894|moderate exercise|moderate exercise
277445|NCT01765894|type 2 diabetes|type 2 diabetes
277446|NCT01765894|metformin|metformin
277447|NCT01765881|Induction of labor|induction of labor
277448|NCT01765881|cervical ripening|cervical ripening
277449|NCT01765881|misoprostol,|misoprostol,
277450|NCT01765881|prostaglandin|prostaglandin
277451|NCT01765881|cost-effectiveness|cost-effectiveness
277452|NCT01764893|Overactive Bladder|overactive bladder
277453|NCT01764880|Heparanase inhibitor|heparanase inhibitor
277454|NCT01764880|Multiple myeloma|multiple myeloma
277455|NCT01764867|major depressive disorder|major depressive disorder
277456|NCT01764867|algorithm guided treatment|algorithm guided treatment
277457|NCT01764867|treatment as usual|treatment as usual
277458|NCT01764867|escitalopram|escitalopram
277459|NCT01764867|mirtazapine|mirtazapine
277460|NCT01764867|transcranial magnetic stimulation (rTMS)|transcranial magnetic stimulation (rtms)
277461|NCT01764867|modified electroconvulsive therapy (mECT)|modified electroconvulsive therapy (mect)
277462|NCT01764867|remission|remission
277463|NCT01764867|relapse|relapse
277464|NCT01764867|quality of life|quality of life
277465|NCT01764854|Hemodialysis|hemodialysis
277466|NCT01764841|Ciprofloxacin|ciprofloxacin
277467|NCT01764841|Dry Powder for Inhalation|dry powder for inhalation
277468|NCT01764841|Exacerbation|exacerbation
277469|NCT01764841|Bronchiectasis|bronchiectasis
277470|NCT01764828|Phase I|phase i
277471|NCT01764828|Pharmacokinetics|pharmacokinetics
277472|NCT01764828|Safety measurements|safety measurements
277473|NCT01764802|Psychosexual Intervention|psychosexual intervention
277474|NCT01764802|Cancer|cancer
277475|NCT01764802|Gynecologic Cancer|gynecologic cancer
277476|NCT01764802|Breast Cancer|breast cancer
277477|NCT01764789|psychological intervention|psychological intervention
277478|NCT01764789|breast cancer|breast cancer
277479|NCT01764789|gynecologic cancer|gynecologic cancer
277480|NCT01764776|LDE225|lde225
277481|NCT01764776|Pharmacokinetics|pharmacokinetics
277482|NCT01764776|PK|pk
277483|NCT01764776|Postmenopausal women|postmenopausal women
277484|NCT01764776|normal hepatic function|normal hepatic function
277485|NCT01764776|mild hepatic impairment|mild hepatic impairment
277486|NCT01764776|moderate hepatic impairment|moderate hepatic impairment
277487|NCT01764776|severe hepatic impairment|severe hepatic impairment
277488|NCT01764750|Intrasite|intrasite
277489|NCT01764750|Antibiotic|antibiotic
277490|NCT01764750|Vancomycin|vancomycin
277491|NCT01764750|Infection|infection
277492|NCT01764750|Pharmacokinetics|pharmacokinetics
277493|NCT01764737|VX15/2503|vx15/2503
277494|NCT01764737|Semaphorin 4D|semaphorin 4d
277495|NCT01764737|SEMA4D|sema4d
277496|NCT01764737|CD100|cd100
277497|NCT01764737|safety|safety
277498|NCT01764737|tolerability|tolerability
277499|NCT01764737|pharmacokinetics|pharmacokinetics
277500|NCT01764737|immunogenicity|immunogenicity
277501|NCT01764737|multiple sclerosis|multiple sclerosis
277502|NCT01764737|monoclonal antibody|monoclonal antibody
277503|NCT01764724|Attitudes and understanding of sodium claims|attitudes and understanding of sodium claims
277504|NCT01764724|General canadian population|general canadian population
277505|NCT01764711|POTS|pots
277506|NCT01764698|anxiety disorders|anxiety disorders
277507|NCT01764698|substance use disorders|substance use disorders
277508|NCT01764698|treatment effectiveness|treatment effectiveness
277509|NCT01764698|cognitive behavioral therapy|cognitive behavioral therapy
277510|NCT01764672|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
277511|NCT01764672|Healthy Adults|healthy adults
277512|NCT01764672|Methylphenidate|methylphenidate
277513|NCT01764672|Functional connectivity|functional connectivity
277514|NCT01764672|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
277515|NCT01765868|Betrixaban|betrixaban
277516|NCT01765868|Healthy|healthy
277517|NCT01765868|Bioavailability|bioavailability
277518|NCT01765855|Betrixaban|betrixaban
277519|NCT01765855|Healthy|healthy
277520|NCT01765855|Mass Balance|mass balance
277521|NCT01765842|Lupus Nephritis|lupus nephritis
277522|NCT01765842|remission|remission
277523|NCT01765842|immunosuppressive treatment|immunosuppressive treatment
277524|NCT01765829|Non Affective Psychosis|non affective psychosis
277525|NCT01765829|First episode|first episode
277526|NCT01765829|Discontinuation scheme|discontinuation scheme
277527|NCT01765816|Exercise|exercise
277528|NCT01765816|Elderly|elderly
277529|NCT01765816|Blood volume|blood volume
277530|NCT01765816|Hemoglobin|hemoglobin
277531|NCT01765803|Mellaril|mellaril
277532|NCT01765803|Thioridazine|thioridazine
277533|NCT01765803|CD34+|cd34+
277534|NCT01765803|Stem cells|stem cells
277535|NCT01765803|Progenitor cells|progenitor cells
277536|NCT01765803|Peripheral blood|peripheral blood
277537|NCT01765803|mobilization|mobilization
277538|NCT01765803|circulation|circulation
277539|NCT01765777|Low back pain|low back pain
277540|NCT01765777|Lower back pain|lower back pain
277541|NCT01765777|Chronic back pain|chronic back pain
277542|NCT01765751|Cervical pain|cervical pain
277543|NCT01765751|Neck pain|neck pain
277544|NCT01765751|Arm pain|arm pain
277545|NCT01765738|PICC|picc
277546|NCT01765725|Chronic Fatigue Syndrome|chronic fatigue syndrome
277547|NCT01765725|Coping|coping
277548|NCT01765725|Patient education|patient education
277549|NCT01765712|PRP|prp
277550|NCT01765712|BPTB|bptb
277551|NCT01765712|VAS|vas
277552|NCT01765712|Anterior Knee Pain|anterior knee pain
277553|NCT01765673|Swallowing|swallowing
277554|NCT01765673|Dysphagia|dysphagia
277555|NCT01765673|Stroke|stroke
277556|NCT01765673|Sensory stimulation|sensory stimulation
277557|NCT01765673|Home based therapy|home based therapy
277558|NCT01765660|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
277559|NCT01765660|Mesenchymal Stem Cells|mesenchymal stem cells
277560|NCT01765660|Chronic Graft-versus-host disease|chronic graft-versus-host disease
277561|NCT01765647|Celiac disease|celiac disease
277562|NCT01765647|AGY|agy
277563|NCT01765634|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
277564|NCT01765634|Mesenchymal Stem Cells|mesenchymal stem cells
277565|NCT01765634|Acute Graft-versus-host disease|acute graft-versus-host disease
277566|NCT01765621|health care expenditure|health care expenditure
277567|NCT01765621|drug drug interactions|drug drug interactions
277568|NCT01765621|electronic decision support systems|electronic decision support systems
277569|NCT01765621|pharmacogenetics|pharmacogenetics
277570|NCT01765621|Potential Reduction|potential reduction
277571|NCT01765608|Zonisamide|zonisamide
277572|NCT01765608|Zonegran|zonegran
277573|NCT01765608|Obstructive Sleep apnea|obstructive sleep apnea
277574|NCT01765608|Apnea|apnea
277575|NCT01765608|Respiration Disorders|respiration disorders
277576|NCT01765608|Sleep Disorders|sleep disorders
277577|NCT01765608|Obesity|obesity
277578|NCT01765608|Anti-Obesity Agents|anti-obesity agents
277579|NCT01765608|Carbonic Anhydrase|carbonic anhydrase
697253|NCT00956449|influenza|influenza
277580|NCT01765608|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors
277581|NCT01765608|Enzyme Inhibitors|enzyme inhibitors
277582|NCT01765608|Sulfonamides|sulfonamides
277583|NCT01765608|Therapeutic Uses|therapeutic uses
277584|NCT01765608|Pharmacologic Actions|pharmacologic actions
277585|NCT01765595|health care expenditure|health care expenditure
277586|NCT01765595|drug drug interactions|drug drug interactions
277587|NCT01765595|electronic decision support systems|electronic decision support systems
277588|NCT01765595|Potential reduction|potential reduction
277589|NCT01765530|Medical Devices|medical devices
277590|NCT01765530|Ventilator-Associated Pneumonia (VAP)|ventilator-associated pneumonia (vap)
277591|NCT01765530|Ventilator-Associated Events (VAE)|ventilator-associated events (vae)
277592|NCT01765530|Endotracheal Tube|endotracheal tube
277593|NCT01765530|Microbial Diversity|microbial diversity
277594|NCT01765530|Anti-Resistance|anti-resistance
277595|NCT01765530|Computed Tomography (CT)|computed tomography (ct)
277596|NCT01765517|Diabetes Mellitus|diabetes mellitus
277597|NCT01765504|Cardiac surgery; near infrared spectroscopy|cardiac surgery; near infrared spectroscopy
277598|NCT01765491|colonoscopy|colonoscopy
277599|NCT01765491|bowel preparation|bowel preparation
277600|NCT01765491|polyethylene glycol|polyethylene glycol
277601|NCT01765478|Rheumatoid Arthritis|rheumatoid arthritis
277602|NCT01765465|postcholecystectomy syndrome|postcholecystectomy syndrome
277603|NCT01765465|laparoscopic cholecystectomy|laparoscopic cholecystectomy
277604|NCT01765465|Rowachol|rowachol
277605|NCT01765439|bile acids|bile acids
277606|NCT01765439|metabolism|metabolism
277607|NCT01765439|probiotics|probiotics
277608|NCT01765426|Prophylactic vaccination|prophylactic vaccination
277609|NCT01765413|To identify|to identify
277610|NCT01765413|biomarkers|biomarkers
277611|NCT01765413|of vaccine safety|of vaccine safety
277612|NCT01765413|Volunteers|volunteers
277613|NCT01765400|Heart failure|heart failure
277614|NCT01765400|Antiplatelet therapy|antiplatelet therapy
277615|NCT01765400|Platelet aggregation|platelet aggregation
277616|NCT01765400|Clopidogrel|clopidogrel
277617|NCT01765400|Prasugrel|prasugrel
277618|NCT01765387|Spatherpy|spatherpy
277619|NCT01765387|Aerobic exercise|aerobic exercise
277620|NCT01765374|rituximab|rituximab
277621|NCT01765374|sonography|sonography
277622|NCT01765374|clinical response|clinical response
277623|NCT01765348|language impairment|language impairment
277624|NCT01765348|language disorders|language disorders
277625|NCT01765348|syntax treatment|syntax treatment
277626|NCT01765348|narrative-based treatment|narrative-based treatment
277627|NCT01765335|heart failure, BNP, NICaS system, readmition|heart failure, bnp, nicas system, readmition
277628|NCT01765309|Tissue expanders|tissue expanders
277629|NCT01765309|Botulinum toxin|botulinum toxin
277630|NCT01765309|Botox|botox
277631|NCT01765283|CN,|cn,
277632|NCT01765283|UCD|ucd
277633|NCT01765270|Diabetes|diabetes
277634|NCT01765270|Diabetes Mellitus|diabetes mellitus
277635|NCT01765270|Type 2 Diabetes|type 2 diabetes
277636|NCT01765270|Cardiovascular Disease|cardiovascular disease
277637|NCT01765270|Coronary Artery Bypass Surgery|coronary artery bypass surgery
402984|NCT01228747|generalized tonic-clonic|generalized tonic-clonic
277638|NCT01765257|Drug-naïve patients with Parkinson's disease|drug-naïve patients with parkinson's disease
277639|NCT01765257|Apathy|apathy
277640|NCT01765257|Rasagiline|rasagiline
277641|NCT01765244|Corneal trophic ulcers|corneal trophic ulcers
277642|NCT01765231|Lymphoma|lymphoma
277643|NCT01765231|Hepatitis B virus|hepatitis b virus
277644|NCT01765231|Therapeutic Uses|therapeutic uses
277645|NCT01765231|Antiviral Agents|antiviral agents
277646|NCT01765218|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
277647|NCT01765218|HIE|hie
277648|NCT01765218|Perinatal depression|perinatal depression
277649|NCT01765218|Whole body cooling|whole body cooling
277650|NCT01765218|Therapeutic hypothermia|therapeutic hypothermia
277651|NCT01765205|congenital cardiovascular malformation|congenital cardiovascular malformation
277652|NCT01765205|newborn|newborn
277653|NCT01765192|Drug therapy|drug therapy
277654|NCT01765179|testosterone|testosterone
277655|NCT01765179|male hypogonadism|male hypogonadism
277656|NCT01765179|low testosterone|low testosterone
277657|NCT01765166|Social Skill Training|social skill training
277658|NCT01765166|Social Interaction|social interaction
277659|NCT01765166|Peer relations|peer relations
277660|NCT01765153|physical therapy|physical therapy
277661|NCT01765153|rehabilitation|rehabilitation
277662|NCT01765153|neuroplasticity|neuroplasticity
277663|NCT01765140|3,4 diaminopyridine (DAP)|3,4 diaminopyridine (dap)
277664|NCT01765101|knee osteoarthritis|knee osteoarthritis
277665|NCT01765101|therapeutic effect|therapeutic effect
277666|NCT01765101|insole|insole
277667|NCT01765088|High-grade glioma|high-grade glioma
277668|NCT01765088|chemotherapy|chemotherapy
277669|NCT01765088|Temozolomide|temozolomide
277670|NCT01765088|Interferon-alpha|interferon-alpha
277671|NCT01765075|Electrophysiological mapping|electrophysiological mapping
277672|NCT01765075|Multi-electrode catheter|multi-electrode catheter
277673|NCT01765062|Rapid maxillary expansion|rapid maxillary expansion
277674|NCT01765062|Cross bite|cross bite
277675|NCT01765062|Haas appliance|haas appliance
277676|NCT01765062|Lateral cephalograms|lateral cephalograms
277677|NCT01765049|breast density change|breast density change
277678|NCT01765049|endocrine therapy response|endocrine therapy response
277679|NCT01765049|aromatase inhibitor|aromatase inhibitor
277680|NCT01765036|contrast-enhanced endoscopic ultrasound|contrast-enhanced endoscopic ultrasound
277681|NCT01765036|pancreatic adenocarcinoma|pancreatic adenocarcinoma
277682|NCT01765010|Vitamin D|vitamin d
277683|NCT01765010|Serum sclerostin|serum sclerostin
277684|NCT01765010|Serum dickkopf1|serum dickkopf1
277685|NCT01764984|total knee arthroplasty|total knee arthroplasty
277686|NCT01764984|trabecular metal|trabecular metal
277687|NCT01764984|bone mineral density|bone mineral density
277688|NCT01764971|Chronic ITP, Cerebral dysfunction|chronic itp, cerebral dysfunction
277689|NCT01764958|mother-infant interaction|mother-infant interaction
277690|NCT01764958|general movements|general movements
277691|NCT01764958|preterm infants|preterm infants
277693|NCT01764659|Contrast Enhanced CT|contrast enhanced ct
277694|NCT01764659|Radiotherapy Simulation|radiotherapy simulation
277695|NCT01764646|Prostate cancer|prostate cancer
277696|NCT01764646|Radiation therapy|radiation therapy
277697|NCT01764633|High cholesterol|high cholesterol
277698|NCT01764633|Treatment for high cholesterol|treatment for high cholesterol
277699|NCT01764633|Lowering cholesterol|lowering cholesterol
277700|NCT01764633|Lowering high cholesterol|lowering high cholesterol
277701|NCT01764633|Hypercholesterolemia|hypercholesterolemia
277702|NCT01764620|shoulder|shoulder
277703|NCT01764620|muscle fatigue|muscle fatigue
277704|NCT01764620|kinematics|kinematics
277705|NCT01764620|athletes|athletes
277706|NCT01764607|Squamous|squamous
277707|NCT01764607|Renal|renal
277708|NCT01764607|Transplant|transplant
277709|NCT01764594|Lupus|lupus
277710|NCT01764594|SLE|sle
277711|NCT01764581|immune monitoring|immune monitoring
277712|NCT01764581|immune cell function ImmuKnow|immune cell function immuknow
277713|NCT01764581|randomized controlled trial|randomized controlled trial
277714|NCT01764581|immunosuppression management|immunosuppression management
277715|NCT01764581|infection|infection
277716|NCT01764581|rejection|rejection
277717|NCT01764581|liver transplantation|liver transplantation
277718|NCT01764581|Cylex|cylex
277719|NCT01764568|Metacognitive training|metacognitive training
277720|NCT01764568|Cognitive behavioral therapy|cognitive behavioral therapy
277721|NCT01764568|Clinical trial|clinical trial
277722|NCT01764568|Group intervention|group intervention
277723|NCT01764568|Group therapy|group therapy
277724|NCT01764568|Schizophrenia|schizophrenia
277725|NCT01764568|Psychosis|psychosis
277726|NCT01764568|Cognitive remediation|cognitive remediation
277727|NCT01764542|Ulcerative colitis|ulcerative colitis
277728|NCT01764542|dysplasia|dysplasia
277729|NCT01764542|risk factor|risk factor
277730|NCT01764542|surgery|surgery
277731|NCT01764516|zinc|zinc
277732|NCT01764516|selenium|selenium
277733|NCT01764516|serum|serum
277734|NCT01764516|epilepsy|epilepsy
277735|NCT01764516|antioxidants|antioxidants
277736|NCT01764503|ampullary tumors|ampullary tumors
277737|NCT01764503|endoscopic treatment|endoscopic treatment
277738|NCT01764490|Bloodstream infections caused by multidrug-resistant Enterobacteriaceae, extended-spectrum β-lactamase-producers, carbapenemase-producing organisms|bloodstream infections caused by multidrug-resistant enterobacteriaceae, extended-spectrum β-lactamase-producers, carbapenemase-producing organisms
277739|NCT01764464|post laminectomy pain syndrome, failed back surgery syndrome|post laminectomy pain syndrome, failed back surgery syndrome
277740|NCT01764451|Hispanic|hispanic
277741|NCT01764425|P7435|p7435
277742|NCT01764425|Healthy,overweight and or obese subjects|healthy,overweight and or obese subjects
277743|NCT01764425|Single ascending dose|single ascending dose
277744|NCT01764425|Multiple ascending dose|multiple ascending dose
277745|NCT01764425|Pharmacokinetics|pharmacokinetics
277746|NCT01764412|Healthy women|healthy women
277747|NCT01764412|Menstrual cycle|menstrual cycle
277748|NCT01764412|Hepcidin|hepcidin
277749|NCT01764412|Seric iron|seric iron
277750|NCT01764399|cardiovascular risk factors|cardiovascular risk factors
277751|NCT01764386|obesity, overweight|obesity, overweight
277752|NCT01764373|Pain|pain
277753|NCT01764373|Fitness|fitness
277754|NCT01764373|Diabetes|diabetes
277755|NCT01764373|Aerobic Exercise|aerobic exercise
277756|NCT01764334|NonST elevation myocardial infarction (NSTEMI)|nonst elevation myocardial infarction (nstemi)
277757|NCT01764334|Fractional flow reserve (FFR)|fractional flow reserve (ffr)
277758|NCT01764334|Coronary angiogram|coronary angiogram
277759|NCT01764334|Diagnosis|diagnosis
277760|NCT01764334|Coronary revascularization|coronary revascularization
277761|NCT01764334|Prognosis|prognosis
277762|NCT01764334|Health economics|health economics
277763|NCT01764321|Certolizumab Pegol|certolizumab pegol
277764|NCT01764321|Cimzia®|cimzia®
277765|NCT01764321|TNF inhibitor|tnf inhibitor
277766|NCT01764321|DMARD|dmard
277767|NCT01764321|Rheumatoid Arthritis|rheumatoid arthritis
277768|NCT01764308|acne; omega-3; isotretinoin; placebo|acne; omega-3; isotretinoin; placebo
277769|NCT01764282|HIV|hiv
277770|NCT01764282|serodiscordant couples HIV sero-conversion|serodiscordant couples hiv sero-conversion
277771|NCT01764282|anti-retroviral therapy|anti-retroviral therapy
277772|NCT01764282|intervention|intervention
277773|NCT01764256|rotavirus|rotavirus
277774|NCT01764256|vaccine|vaccine
277775|NCT01764243|Alzheimer's Disease|alzheimer's disease
277776|NCT01764243|Nicotinic Acetylcholine Receptor Agonist|nicotinic acetylcholine receptor agonist
277777|NCT01764243|Cognitive function|cognitive function
277778|NCT01764243|Dementia|dementia
277779|NCT01764243|Central Nervous System Agents|central nervous system agents
277780|NCT01764230|Hodgkin lymphoma|hodgkin lymphoma
277781|NCT01764230|Hodgkin disease|hodgkin disease
277782|NCT01764217|Cervix Cancer|cervix cancer
277783|NCT01764217|SUV|suv
277784|NCT01764217|Radiotherapy|radiotherapy
277785|NCT01764217|Outcome Prediction|outcome prediction
277786|NCT01764217|Imaging|imaging
277787|NCT01764217|PET|pet
277788|NCT01764178|Pitavastatin|pitavastatin
277789|NCT01764178|Valsartan|valsartan
277790|NCT01764165|COPD|copd
277791|NCT01764165|Sleep|sleep
277792|NCT01764165|Supplemental oxygen|supplemental oxygen
277793|NCT01764165|Breathing mechanics|breathing mechanics
277794|NCT01764165|nasal insufflation|nasal insufflation
277795|NCT01764152|Prevention,|prevention,
277796|NCT01764152|influenza,|influenza,
277797|NCT01764152|adults hospitalized,|adults hospitalized,
277798|NCT01764152|vaccines,|vaccines,
277799|NCT01764152|Effectiveness|effectiveness
277800|NCT01764139|Minimal knee changes|minimal knee changes
277801|NCT01764126|Safety|safety
277891|NCT01763775|weight|weight
277802|NCT01764126|immunogenicity|immunogenicity
277803|NCT01764126|pneumococcal|pneumococcal
277804|NCT01764126|protein|protein
277805|NCT01764126|vaccine|vaccine
277806|NCT01764113|Obesity|obesity
277807|NCT01764113|Adolescence|adolescence
277808|NCT01764113|Mindful Eating|mindful eating
277809|NCT01764087|Stomach Neoplasms|stomach neoplasms
277810|NCT01764087|Breast Neoplasms|breast neoplasms
277811|NCT01764087|Carcinoma|carcinoma
277812|NCT01764087|Neoplasms|neoplasms
277813|NCT01764087|Paclitaxel|paclitaxel
277903|NCT01763723|skin type,|skin type,
277814|NCT01764087|Tubulin Modulators|tubulin modulators
277815|NCT01764087|Antimitotic Agents|antimitotic agents
277816|NCT01764087|Protein Kinase Inhibitors|protein kinase inhibitors
277817|NCT01764087|Enzyme Inhibitors|enzyme inhibitors
277818|NCT01764087|Pharmacologic Actions|pharmacologic actions
277819|NCT01764074|Bipolar Disorder|bipolar disorder
277820|NCT01764074|Sleep Intervention|sleep intervention
277821|NCT01764074|Suicide|suicide
277822|NCT01764074|Cognitive Behavioral Therapy|cognitive behavioral therapy
277823|NCT01764074|Sleep Quality|sleep quality
277824|NCT01764061|Red Cells|red cells
277825|NCT01764061|Blood donors|blood donors
277826|NCT01764048|pain management|pain management
277827|NCT01764048|cesarean section|cesarean section
277828|NCT01764035|Psychotherapy|psychotherapy
277829|NCT01764035|Bipolar Disorder|bipolar disorder
277830|NCT01764035|Sleep Problems|sleep problems
277831|NCT01764035|Insomnia|insomnia
277832|NCT01764035|Hypersomnia|hypersomnia
277833|NCT01764035|Mindfulness|mindfulness
277834|NCT01764035|Meditation|meditation
277835|NCT01764035|Sleep Disturbance|sleep disturbance
277836|NCT01764022|breast cancer|breast cancer
277837|NCT01764022|trastuzumab|trastuzumab
277838|NCT01764009|Advanced Melanoma|advanced melanoma
277839|NCT01764009|Metastatic Melanoma|metastatic melanoma
277840|NCT01764009|Melanoma Stage III and IV|melanoma stage iii and iv
277841|NCT01763996|Drug therapy|drug therapy
277842|NCT01763983|Multiple Sclerosis|multiple sclerosis
277843|NCT01763983|Stress, Psychological|stress, psychological
277844|NCT01763983|Psychological Stress|psychological stress
277845|NCT01763983|Emotional Stress|emotional stress
277846|NCT01763983|Cognitive Deficits|cognitive deficits
277847|NCT01763983|Cognitive Dysfunction|cognitive dysfunction
277848|NCT01763970|Stereotactic|stereotactic
277849|NCT01763970|Radiotherapy|radiotherapy
277850|NCT01763970|Hypofractionated|hypofractionated
277852|NCT01763944|prostate cancer|prostate cancer
277853|NCT01763944|carbohydrate|carbohydrate
277854|NCT01763944|lifestyle|lifestyle
277855|NCT01763931|Digoxin|digoxin
277856|NCT01763918|High cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
277857|NCT01763905|High Cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
277858|NCT01763892|Pediatric|pediatric
277859|NCT01763892|Traumatic Brain Injury|traumatic brain injury
277861|NCT01763892|Apolipoprotein E|apolipoprotein e
277862|NCT01763892|apo-E|apo-e
277863|NCT01763892|Vasospasm|vasospasm
277864|NCT01763892|Genetics|genetics
277865|NCT01763892|Physiologic Mechanisms|physiologic mechanisms
277866|NCT01763892|Neurocognitive Outcomes|neurocognitive outcomes
277867|NCT01763892|Endothelin 1|endothelin 1
277868|NCT01763879|Thoracic surgery|thoracic surgery
277869|NCT01763879|one lung ventilation|one lung ventilation
277870|NCT01763879|pressure-controlled ventilation|pressure-controlled ventilation
277871|NCT01763879|volume-controlled ventilation|volume-controlled ventilation
277872|NCT01763879|right ventricular function|right ventricular function
277873|NCT01763866|High cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
277874|NCT01763853|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
277875|NCT01763853|Pulmonary edema|pulmonary edema
277876|NCT01763853|Alveolar fluid clearance|alveolar fluid clearance
277877|NCT01763853|Alveolar epithelial dysfunction|alveolar epithelial dysfunction
277878|NCT01763853|Receptor for advanced glycation end-products (RAGE)|receptor for advanced glycation end-products (rage)
277879|NCT01763853|Fluid resuscitation therapy|fluid resuscitation therapy
277880|NCT01763853|Hypovolemia|hypovolemia
277881|NCT01763853|Crystalloid|crystalloid
277882|NCT01763853|Hydroxyethyl Starch|hydroxyethyl starch
277883|NCT01763853|Intensive care unit|intensive care unit
277884|NCT01763840|Pediatric Abdominal Trauma Ultrasound Contrast|pediatric abdominal trauma ultrasound contrast
277885|NCT01763827|High cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
277886|NCT01763801|chemo port|chemo port
277887|NCT01763801|intravenous electrocardiographic guidance|intravenous electrocardiographic guidance
277888|NCT01763801|P maximal wave|p maximal wave
277889|NCT01763801|P submaximal wave|p submaximal wave
277890|NCT01763801|catheter tip|catheter tip
277892|NCT01763775|total body water|total body water
277893|NCT01763775|body fat|body fat
277894|NCT01763775|muscle mass|muscle mass
277895|NCT01763775|bone mass|bone mass
277896|NCT01763762|Electrical pudendal nerve stimulation|electrical pudendal nerve stimulation
277897|NCT01763762|Pelvic floor muscle training|pelvic floor muscle training
277898|NCT01763762|Transvaginal electrical stimulation|transvaginal electrical stimulation
277899|NCT01763762|Stress urinary incontinence|stress urinary incontinence
277900|NCT01763762|Comparative study|comparative study
277901|NCT01763723|Intense pulsed light,|intense pulsed light,
277902|NCT01763723|UV-exposure,|uv-exposure,
277904|NCT01763723|safety,|safety,
277905|NCT01763723|pigment,|pigment,
277906|NCT01763723|home-use|home-use
277907|NCT01763723|subjects|subjects
277908|NCT01763710|Breast cancer|breast cancer
277909|NCT01763710|Neurotoxicity|neurotoxicity
277910|NCT01763697|Taste acuity|taste acuity
277911|NCT01763697|Feeding behavior|feeding behavior
277912|NCT01763697|opioid|opioid
277913|NCT01763697|Quantitative assessment|quantitative assessment
277914|NCT01763684|Osteoarthritis|osteoarthritis
277915|NCT01763684|Osteoarthritis, Knee|osteoarthritis, knee
277916|NCT01763684|Osteonecrosis|osteonecrosis
277917|NCT01763684|Arthritis|arthritis
277918|NCT01763684|Knee Arthritis|knee arthritis
343616|NCT01476696|SCD|scd
277919|NCT01763684|Knee Replacement|knee replacement
277920|NCT01763671|Lung cancer|lung cancer
277921|NCT01763671|Paclitaxel bevacizumab|paclitaxel bevacizumab
277922|NCT01763658|ITP, antioxidant therapy, oxidant status|itp, antioxidant therapy, oxidant status
277923|NCT01763645|NSCLC|nsclc
277924|NCT01763645|bevacizumab|bevacizumab
277925|NCT01763645|pharmacokinetics|pharmacokinetics
277926|NCT01763632|Hyperbilirubinemia|hyperbilirubinemia
277927|NCT01763632|Neonatal|neonatal
277928|NCT01763632|Transcutaneous Bilirubin|transcutaneous bilirubin
277929|NCT01763619|Cervical DDD|cervical ddd
277931|NCT01763619|degenerative disc disease|degenerative disc disease
277932|NCT01763619|C3-C7|c3-c7
277933|NCT01763606|Enoxaparin|enoxaparin
277934|NCT01763606|Aspirin|aspirin
277935|NCT01763606|stroke|stroke
277936|NCT01763606|12-264|12-264
277937|NCT01763593|Patients having cataract|patients having cataract
277938|NCT01763580|Glomerulonephritis|glomerulonephritis
277939|NCT01763580|Tacrolimus|tacrolimus
277940|NCT01763580|Nephrotic syndrome|nephrotic syndrome
277941|NCT01763567|Medtronic|medtronic
277942|NCT01763567|Diabetes|diabetes
277943|NCT01763567|Hospital|hospital
277944|NCT01763567|Continuous Glucose Monitor|continuous glucose monitor
277945|NCT01763567|Intensive Care Unit|intensive care unit
277946|NCT01763554|Lu-177|lu-177
277947|NCT01763554|Lutetium-177|lutetium-177
277948|NCT01763554|DOTA-TATE|dota-tate
277949|NCT01763554|Neuroendocrine tumors|neuroendocrine tumors
277950|NCT01763554|radiopharmaceutical|radiopharmaceutical
277951|NCT01763541|Natriuretic Peptides|natriuretic peptides
277952|NCT01763528|body weight|body weight
277953|NCT01763528|Low-density-lipoprotein-type|low-density-lipoprotein-type
277954|NCT01763515|Joint Diseases|joint diseases
277955|NCT01763515|Arthritis|arthritis
277956|NCT01763515|Osteoarthritis|osteoarthritis
277957|NCT01763502|Cognitive development|cognitive development
277958|NCT01763502|Anemia|anemia
277959|NCT01763502|Preschool|preschool
277960|NCT01763502|Food transfers|food transfers
277961|NCT01763502|Cash transfers|cash transfers
277962|NCT01763502|Early childhood|early childhood
277963|NCT01763502|Nutrition|nutrition
277964|NCT01763489|randomized controlled trial|randomized controlled trial
277965|NCT01763489|applicability|applicability
277966|NCT01763489|ASSIST tool|assist tool
277967|NCT01763489|surgery|surgery
277968|NCT01763489|digestive cancer|digestive cancer
277969|NCT01763476|long infrapopliteal artery lesions|long infrapopliteal artery lesions
277970|NCT01763476|drug-coated balloon angioplasty|drug-coated balloon angioplasty
277971|NCT01763476|atherectomy|atherectomy
277972|NCT01763463|pneumonia requiring hospitalization|pneumonia requiring hospitalization
277973|NCT01763463|COPD|copd
277974|NCT01763463|long-acting bronchodilators (LABD)|long-acting bronchodilators (labd)
277975|NCT01763463|Inhaled Corticosteroids (ICS)|inhaled corticosteroids (ics)
277976|NCT01763450|Bevacizumab|bevacizumab
277977|NCT01763450|conversion therapy|conversion therapy
277978|NCT01763450|liver metastases|liver metastases
277979|NCT01763450|colorectal cancer|colorectal cancer
277980|NCT01763450|objective response rate|objective response rate
277981|NCT01763437|Chalazia|chalazia
277982|NCT01763437|Chalazion|chalazion
277983|NCT01763437|Meibomian gland dysfunction|meibomian gland dysfunction
277984|NCT01763437|Rosacea|rosacea
277985|NCT01763437|Ocular rosacea|ocular rosacea
277986|NCT01763411|Cataract|cataract
277987|NCT01763411|Vision|vision
277988|NCT01763411|Intraocular lens|intraocular lens
277989|NCT01763411|Multifocal|multifocal
277990|NCT01763411|Monofocal|monofocal
277991|NCT01763385|Erlotinib|erlotinib
277992|NCT01763385|brain radiotherapy|brain radiotherapy
277993|NCT01763385|NSCLC|nsclc
277994|NCT01763385|brain metastases|brain metastases
277995|NCT01763372|Arthroscopic|arthroscopic
277996|NCT01763372|Iliopsoas|iliopsoas
277997|NCT01763372|MRI|mri
277998|NCT01763359|acetabular fracture|acetabular fracture
277999|NCT01763359|pelvic fracture|pelvic fracture
278000|NCT01763359|hip adductor strength|hip adductor strength
278001|NCT01763359|obturator nerve palsy|obturator nerve palsy
278002|NCT01763359|modified Stoppa approach|modified stoppa approach
278003|NCT01763346|type 2 diabetes|type 2 diabetes
278004|NCT01763346|prediabetes|prediabetes
278005|NCT01763346|obesity|obesity
278006|NCT01763346|gastric banding|gastric banding
278007|NCT01763346|metformin|metformin
278101|NCT01762878|GSK2269557|gsk2269557
278008|NCT01763320|ischemic stroke|ischemic stroke
278009|NCT01763320|intracranial stenting|intracranial stenting
278010|NCT01763320|vascular risk factor management|vascular risk factor management
278011|NCT01763307|EGFRI|egfri
278012|NCT01763307|COLON CANCER|colon cancer
278013|NCT01763307|SKIN TOXICITY|skin toxicity
278014|NCT01763307|RECONVAL K1 cream|reconval k1 cream
278015|NCT01763294|multifocal refractory epilepsy|multifocal refractory epilepsy
278016|NCT01763294|tDCS|tdcs
278017|NCT01763294|neurostimulation|neurostimulation
278018|NCT01763294|seizures|seizures
278019|NCT01763268|Immunogenicity|immunogenicity
278020|NCT01763268|Reactogenicity|reactogenicity
278021|NCT01763268|Trivivac|trivivac
278022|NCT01763268|Measles|measles
278023|NCT01763268|Mump|mump
278024|NCT01763268|Rubella|rubella
278025|NCT01763255|cerebral palsy CD133 cells intrathecal injection|cerebral palsy cd133 cells intrathecal injection
278026|NCT01763242|CKD, Anaemia, Synchronization, Monthly dosing, Home Delivery|ckd, anaemia, synchronization, monthly dosing, home delivery
278027|NCT01763216|depressive symptoms|depressive symptoms
278028|NCT01763216|clinical depression|clinical depression
278029|NCT01763216|visual processing speed|visual processing speed
278030|NCT01763216|anxiety|anxiety
278031|NCT01763216|pain|pain
278032|NCT01763216|health-related quality of life|health-related quality of life
278033|NCT01763203|Self-management|self-management
278034|NCT01763203|Chronic Care Model|chronic care model
278035|NCT01763203|Community health worker|community health worker
278036|NCT01763177|nebulizer|nebulizer
278037|NCT01763177|oxygen|oxygen
278038|NCT01763177|post-operative sore throat|post-operative sore throat
278039|NCT01763164|Melanoma|melanoma
278040|NCT01763164|Cutaneous melanoma|cutaneous melanoma
278041|NCT01763164|Skin disease|skin disease
278042|NCT01763164|Skin cancer|skin cancer
278043|NCT01763164|Skin Neoplasms|skin neoplasms
278044|NCT01763164|Neoplasm Metastasis|neoplasm metastasis
278045|NCT01763151|cataract surgery, astigmatism, opposite clear corneal incision, toric IOL, IOL rotational stability|cataract surgery, astigmatism, opposite clear corneal incision, toric iol, iol rotational stability
278046|NCT01763125|Breast cancer|breast cancer
278047|NCT01763125|Ovarian cancer|ovarian cancer
278048|NCT01763125|Endometrium carcinoma|endometrium carcinoma
278049|NCT01763125|Cervix carcinoma,|cervix carcinoma,
278050|NCT01763125|Mamma carcinoma,|mamma carcinoma,
278051|NCT01763125|Prostata carcinoma|prostata carcinoma
278052|NCT01763125|Colon carcinoma|colon carcinoma
278053|NCT01763125|Rectal carcinoma|rectal carcinoma
278054|NCT01763125|Bronchus carcinoma|bronchus carcinoma
278055|NCT01763125|NSCLC & SCLC (Non Small Cell Lung Cancer & Small Cell Lung Cancer))|nsclc & sclc (non small cell lung cancer & small cell lung cancer))
278056|NCT01763125|Prostate carcinoma|prostate carcinoma
278057|NCT01763112|Influence of training with whole body vibration device|influence of training with whole body vibration device
278058|NCT01763099|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
278059|NCT01763099|Mesenchymal Stem Cells|mesenchymal stem cells
278060|NCT01763099|Cord Blood|cord blood
278061|NCT01763099|Graft failure|graft failure
278062|NCT01763086|Poor Graft Function|poor graft function
278063|NCT01763086|Mesenchymal Stem Cells|mesenchymal stem cells
278064|NCT01763086|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
278065|NCT01763086|Third-party Donors|third-party donors
278066|NCT01763060|ards|ards
278067|NCT01763060|ecmo|ecmo
278068|NCT01763060|h1n1|h1n1
278069|NCT01763060|pandemics|pandemics
278070|NCT01763021|Healthy participants|healthy participants
278071|NCT01763021|PCI-32765|pci-32765
278072|NCT01763021|Rifampin|rifampin
278073|NCT01763021|PCI-45227|pci-45227
278074|NCT01763021|CYP3A4|cyp3a4
278075|NCT01763008|Pneumonia, Bacterial|pneumonia, bacterial
278076|NCT01763008|Nosocomial Infection|nosocomial infection
278077|NCT01763008|Intraabdominal Infections|intraabdominal infections
278078|NCT01763008|Urinary Tract Infection|urinary tract infection
278079|NCT01763008|Ventilator-associated pneumonia|ventilator-associated pneumonia
278080|NCT01763008|Doripenem|doripenem
278081|NCT01763008|Doribax|doribax
278082|NCT01763008|Filipino|filipino
278083|NCT01762995|Dolutegravir, pharmacokinetics, calcium, iron, drug interaction, healthy volunteers|dolutegravir, pharmacokinetics, calcium, iron, drug interaction, healthy volunteers
278084|NCT01762956|Pelvic floor|pelvic floor
278085|NCT01762956|Physical Therapy|physical therapy
278086|NCT01762956|Prostate cancer|prostate cancer
278087|NCT01762956|Radiotherapy|radiotherapy
278088|NCT01762956|Nuclear magnetic resonance|nuclear magnetic resonance
278089|NCT01762904|Antiseptics|antiseptics
278090|NCT01762904|Administration cutaneously|administration cutaneously
278091|NCT01762904|Anti-infecting agents, local|anti-infecting agents, local
278092|NCT01762891|Coumadin|coumadin
278093|NCT01762891|celecoxib|celecoxib
278094|NCT01762891|rofecoxib|rofecoxib
278095|NCT01762891|acetaminophen|acetaminophen
278096|NCT01762891|antiphospholipid syndrome and INR|antiphospholipid syndrome and inr
278097|NCT01762878|pharmacodynamics|pharmacodynamics
278098|NCT01762878|pharmacokinetics|pharmacokinetics
278099|NCT01762878|healthy volunteers|healthy volunteers
278100|NCT01762878|Pi3K-delta|pi3k-delta
278102|NCT01762878|safety|safety
278103|NCT01762878|dry powder inhaler|dry powder inhaler
278104|NCT01762865|acute bronchitis, bacteria, virus, clinical symoptoms|acute bronchitis, bacteria, virus, clinical symoptoms
278105|NCT01762852|Benlysta|benlysta
278106|NCT01762852|efficacy|efficacy
278107|NCT01762852|proteinuria|proteinuria
278108|NCT01762852|Idiopathic membranous nephropathy|idiopathic membranous nephropathy
278109|NCT01762852|GSK1550188|gsk1550188
343772|NCT01475877|PRK|prk
278110|NCT01762852|anti-phospholipase A2 receptor antibodies|anti-phospholipase a2 receptor antibodies
278111|NCT01762852|safety|safety
278112|NCT01762852|placebo|placebo
278113|NCT01762852|BLyS|blys
278114|NCT01762852|belimumab|belimumab
278115|NCT01762852|Lymphostat-B|lymphostat-b
278116|NCT01762852|membrane attack complex|membrane attack complex
278117|NCT01762826|Inositol|inositol
278119|NCT01762813|Colon cancer|colon cancer
278120|NCT01762813|rectal cancer|rectal cancer
278121|NCT01762813|liver metastasis|liver metastasis
278122|NCT01762813|survival|survival
278123|NCT01762813|biomarker|biomarker
277860|NCT01763892|TBI|tbi
278124|NCT01762813|molecular profile|molecular profile
278125|NCT01762774|COPD|copd
278126|NCT01762774|forearm blood flow|forearm blood flow
278127|NCT01762774|soluble Epoxide Hydrolase inhibitor|soluble epoxide hydrolase inhibitor
278128|NCT01762761|eltrombopag|eltrombopag
278129|NCT01762761|TPO-R agonist|tpo-r agonist
278130|NCT01762761|Chronic ITP|chronic itp
278131|NCT01762748|Probiotic|probiotic
278132|NCT01762748|liver|liver
278133|NCT01762748|transplant|transplant
278134|NCT01762748|permeability|permeability
278135|NCT01762722|Spectroscopy, near infrared|spectroscopy, near infrared
278136|NCT01762722|Oximetry|oximetry
278137|NCT01762722|Hypoxemia|hypoxemia
278138|NCT01762722|Tissue oxygenation|tissue oxygenation
278139|NCT01762709|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
278140|NCT01762709|one lung ventilation|one lung ventilation
278141|NCT01762709|low tidal volume|low tidal volume
278142|NCT01762709|acute lung injury|acute lung injury
278143|NCT01762709|lung water content|lung water content
278144|NCT01762696|marijuana|marijuana
278145|NCT01762696|intervention|intervention
278146|NCT01762696|adolescent, young adult|adolescent, young adult
278147|NCT01762696|primary care|primary care
278148|NCT01762696|mobile|mobile
278149|NCT01762683|pregnancy|pregnancy
278150|NCT01762683|obesity|obesity
278155|NCT01762657|Insulin Independence|insulin independence
278156|NCT01762657|Beta Regeneration|beta regeneration
278157|NCT01762657|Immune Tolerance Agent|immune tolerance agent
278158|NCT01762657|Lanzoprazole|lanzoprazole
278159|NCT01762657|Cyclosporine|cyclosporine
278160|NCT01762644|Type 1 Diabetes|type 1 diabetes
278161|NCT01762644|Insulin Independence|insulin independence
278162|NCT01762644|Beta Regeneration|beta regeneration
278163|NCT01762644|Immune Tolerance Agent|immune tolerance agent
278164|NCT01762644|Omeprazole|omeprazole
278165|NCT01762644|Cyclosporine|cyclosporine
278166|NCT01762618|Group Cognitive Behavior Therapy, Alzheimer's disease, Caregivers¡|group cognitive behavior therapy, alzheimer's disease, caregivers¡
278167|NCT01762579|Not-celiac wheat sensitivity|not-celiac wheat sensitivity
278168|NCT01762579|Gluten|gluten
278169|NCT01762579|esophagogastroduodenoscopy|esophagogastroduodenoscopy
278170|NCT01762579|Rectoscopy|rectoscopy
278171|NCT01762566|Not-celiac gluten (wheat) sensitivity|not-celiac gluten (wheat) sensitivity
278172|NCT01762566|Bioelectrical impedance analysis|bioelectrical impedance analysis
278173|NCT01762566|Bloating|bloating
278174|NCT01762566|Swelling|swelling
278175|NCT01762540|Protein breakdown|protein breakdown
278176|NCT01762540|Insulin resistance|insulin resistance
278177|NCT01762540|Glucose intolerance|glucose intolerance
278178|NCT01762540|Lipolysis|lipolysis
278179|NCT01762527|Adaptive radiotherapy|adaptive radiotherapy
278180|NCT01762527|Bladder cancer|bladder cancer
278181|NCT01762514|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
278182|NCT01762514|Amifostine|amifostine
278183|NCT01762514|Myelosuppression|myelosuppression
278184|NCT01762514|Xerostomia|xerostomia
278185|NCT01762514|Mucositis|mucositis
278186|NCT01762501|Hypertension|hypertension
278187|NCT01762488|Treatment Resistant Hypertension|treatment resistant hypertension
278188|NCT01762488|Renal Denervation|renal denervation
278192|NCT01762475|Endothelial progenitor cells|endothelial progenitor cells
278193|NCT01762449|Scleroderma|scleroderma
278194|NCT01762449|interstitial lung disease|interstitial lung disease
278195|NCT01762410|Advanced refractory solid tumors|advanced refractory solid tumors
278196|NCT01762371|ACL|acl
278197|NCT01762371|Knee|knee
278198|NCT01762371|Ligament|ligament
278199|NCT01762371|Cruciate|cruciate
278200|NCT01762371|Anterior|anterior
278201|NCT01762358|ACL|acl
278202|NCT01762358|Ligament|ligament
278203|NCT01762358|Knee|knee
278204|NCT01762345|Stress urinary incontinence|stress urinary incontinence
278205|NCT01762345|SUI|sui
278209|NCT01762293|CRC|crc
278210|NCT01762293|Famitinib|famitinib
278211|NCT01762293|Phase II|phase ii
278212|NCT01762293|Colorectal Cancer|colorectal cancer
278213|NCT01762280|Famitinib|famitinib
278214|NCT01762280|Advanced Solid tumor|advanced solid tumor
278215|NCT01762280|Phase I|phase i
278216|NCT01762254|pain score|pain score
278217|NCT01762254|complication|complication
278218|NCT01762241|Prostate cancer|prostate cancer
278219|NCT01762241|Androgen deprivation therapy|androgen deprivation therapy
278220|NCT01762241|Exercise|exercise
278221|NCT01762241|Xbox|xbox
278222|NCT01762228|Oropharyngeal dysphagia|oropharyngeal dysphagia
278223|NCT01762228|Elderly|elderly
278224|NCT01762228|Transcutaneous electrical stimulation|transcutaneous electrical stimulation
278225|NCT01762228|TRPV1 agonist|trpv1 agonist
278226|NCT01762215|Epilepsy|epilepsy
278227|NCT01762215|Seizure|seizure
278228|NCT01762215|Veteran|veteran
278233|NCT01762189|Hyperbilirubinemia|hyperbilirubinemia
278234|NCT01762189|Neonatal|neonatal
278235|NCT01762189|Incidence|incidence
278236|NCT01762189|Risk factors|risk factors
278237|NCT01762176|Early Rheumatoid Arthritis|early rheumatoid arthritis
278238|NCT01762176|Usual care|usual care
278239|NCT01762176|Intensive Care|intensive care
278240|NCT01762176|Boolean criteria|boolean criteria
278241|NCT01762163|Ischemic Stroke,adaptive design, randomized, double-blind|ischemic stroke,adaptive design, randomized, double-blind
278242|NCT01762150|collected duct carcinoma|collected duct carcinoma
278243|NCT01762150|sorafenib|sorafenib
278244|NCT01762137|Aneurysm|aneurysm
278245|NCT01762137|Coiling|coiling
278246|NCT01762137|Flow Diversion|flow diversion
278247|NCT01762124|Pulmonary valve|pulmonary valve
278248|NCT01762124|Congenital heart disease|congenital heart disease
278249|NCT01762124|Transcatheter pulmonary valve|transcatheter pulmonary valve
278250|NCT01762124|Percutaneous pulmonary valve|percutaneous pulmonary valve
278251|NCT01762111|Anti-Mullerian Hormone|anti-mullerian hormone
278252|NCT01762111|In-Vitro fertilization|in-vitro fertilization
278253|NCT01762098|In vitro fertilization|in vitro fertilization
278254|NCT01762098|Hysteroscopy|hysteroscopy
278255|NCT01762098|Endometrial biopsy|endometrial biopsy
278258|NCT01762072|homocysteine-vitamin B12-fish oil-ferritin|homocysteine-vitamin b12-fish oil-ferritin
278260|NCT01762059|artificial pancreas|artificial pancreas
278261|NCT01762059|insulin|insulin
278262|NCT01762059|glucagon|glucagon
278263|NCT01762059|continuous glucose monitoring|continuous glucose monitoring
278265|NCT01762059|outpatient|outpatient
278266|NCT01762059|insulin pump|insulin pump
278267|NCT01762046|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
278268|NCT01762046|Pharmacogenetics|pharmacogenetics
278269|NCT01762046|Genetics|genetics
278270|NCT01762046|Obesity|obesity
278271|NCT01762033|Renal cell carcinoma|renal cell carcinoma
278272|NCT01762033|Renal cell cancer|renal cell cancer
278273|NCT01762033|ASONEP|asonep
278274|NCT01762033|Sonepcizumab|sonepcizumab
278275|NCT01762020|Women with Breast Cancer|women with breast cancer
278276|NCT01762020|Receiving Adjuvant Radiation Therapy|receiving adjuvant radiation therapy
278277|NCT01762007|hypospadias, bladder outlet obstruction, ultrasonography|hypospadias, bladder outlet obstruction, ultrasonography
278278|NCT01761994|nafamostat mesilate|nafamostat mesilate
278279|NCT01761994|heparin|heparin
278280|NCT01761994|continuous renal replacement therapy|continuous renal replacement therapy
278281|NCT01761981|Haemorrhagic Hereditary Telangiectasia|haemorrhagic hereditary telangiectasia
278282|NCT01761981|Rendu Osler Weber Syndrome|rendu osler weber syndrome
278283|NCT01761981|Osler Weber Rendu Syndrome|osler weber rendu syndrome
278284|NCT01761981|HHT|hht
278285|NCT01761968|chronic myeloproliferative neoplasms|chronic myeloproliferative neoplasms
278286|NCT01761968|Polycythemia Vera|polycythemia vera
278287|NCT01761968|Essential Thrombocythemia|essential thrombocythemia
278288|NCT01761968|Primary Myelofibrosis|primary myelofibrosis
278289|NCT01761968|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
278290|NCT01761968|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
278291|NCT01761968|Givinostat|givinostat
278292|NCT01761955|body weight|body weight
278293|NCT01761955|lipids|lipids
278294|NCT01761955|glucose|glucose
278295|NCT01761955|insulin|insulin
278296|NCT01761942|omega-3 fatty acids|omega-3 fatty acids
278297|NCT01761942|anorexia nervosa|anorexia nervosa
278298|NCT01761942|efficacy|efficacy
278299|NCT01761942|safety|safety
278300|NCT01761929|oligometastatic|oligometastatic
278301|NCT01761929|oligometastases|oligometastases
278302|NCT01761929|stereotactic body radiotherapy|stereotactic body radiotherapy
278303|NCT01761929|radiation therapy|radiation therapy
278304|NCT01761929|Oligometastasis|oligometastasis
278305|NCT01761929|Stereotactic ablative body|stereotactic ablative body
278306|NCT01761929|radiotherapy|radiotherapy
278307|NCT01761916|captopril, clonidine, pregnancy-induced hypertension,|captopril, clonidine, pregnancy-induced hypertension,
278312|NCT01761877|breast cancer, nonsteroidal antiinflammatory drug , breast density, chemoprevention, aromatase inhibitors|breast cancer, nonsteroidal antiinflammatory drug , breast density, chemoprevention, aromatase inhibitors
278313|NCT01761851|Resting metabolic rate|resting metabolic rate
278314|NCT01761851|nutrition status|nutrition status
278315|NCT01761851|dietary intake|dietary intake
278316|NCT01761838|spinal manipulative therapy|spinal manipulative therapy
279196|NCT01757717|12-260|12-260
278317|NCT01761838|low back pain|low back pain
278318|NCT01761838|experimental pain|experimental pain
278319|NCT01761838|spinal stiffness|spinal stiffness
278320|NCT01761838|lumbar multifidus|lumbar multifidus
278321|NCT01761838|degeneration|degeneration
278322|NCT01761812|Prostate cancer|prostate cancer
278323|NCT01761812|MRI|mri
278324|NCT01761812|Elastography|elastography
278325|NCT01761812|Gadofosveset|gadofosveset
278326|NCT01761799|Influenza|influenza
278327|NCT01761799|Pertussis|pertussis
278328|NCT01761799|Vaccination|vaccination
278329|NCT01761786|Myocardial Infarction|myocardial infarction
278330|NCT01761786|Thrombosis|thrombosis
278331|NCT01761786|Acute Coronary Syndrome|acute coronary syndrome
278332|NCT01761786|Myocardial Ischemia|myocardial ischemia
278333|NCT01761786|Heart Diseases|heart diseases
278334|NCT01761786|Cardiovascular Diseases|cardiovascular diseases
278335|NCT01761786|Vascular Diseases|vascular diseases
278336|NCT01761786|Embolism and Thrombosis|embolism and thrombosis
278337|NCT01761786|Genetic Testing|genetic testing
278338|NCT01761786|Clopidogrel|clopidogrel
278339|NCT01761786|Prasugrel|prasugrel
278340|NCT01761786|Ticagrelor|ticagrelor
278341|NCT01761786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
278342|NCT01761786|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists
278343|NCT01761747|Squamous Cell Carcinoma|squamous cell carcinoma
278344|NCT01761734|Influenza vaccination|influenza vaccination
278345|NCT01761721|Endometrial cancer (MeSH)|endometrial cancer (mesh)
278346|NCT01761721|Robotics (MeSH)|robotics (mesh)
697566|NCT00957333|ketamine|ketamine
278347|NCT01761708|primary ventral hernia repair with mesh|primary ventral hernia repair with mesh
278348|NCT01761708|umbilical hernia repair|umbilical hernia repair
278349|NCT01761708|epigastric hernia repair|epigastric hernia repair
278350|NCT01761708|C-Qur V-patch|c-qur v-patch
278351|NCT01761708|Size tailored repair|size tailored repair
278352|NCT01761708|preperitoneal repair|preperitoneal repair
278353|NCT01761708|abdominal hernia|abdominal hernia
278354|NCT01761708|dual sided mesh|dual sided mesh
278355|NCT01761708|trocar-site hernia|trocar-site hernia
278356|NCT01761656|stable angina|stable angina
278357|NCT01761656|unstable angina|unstable angina
278358|NCT01761656|acute non-ST-segment elevation myocardial infarction|acute non-st-segment elevation myocardial infarction
278359|NCT01761656|PCI|pci
278360|NCT01761656|perioperative myocardial infarction|perioperative myocardial infarction
278361|NCT01761656|major adverse cardiac events|major adverse cardiac events
278362|NCT01761643|PrEP|prep
278363|NCT01761643|Pre exposure Prophylaxis|pre exposure prophylaxis
278364|NCT01761643|Text Messaging|text messaging
278365|NCT01761643|Truvada|truvada
278366|NCT01761643|iTab|itab
278367|NCT01761643|CCTG|cctg
278368|NCT01761643|595|595
278369|NCT01761630|Asthma|asthma
278370|NCT01761630|Severe Asthma|severe asthma
278371|NCT01761630|SARP|sarp
278372|NCT01761617|Yoga|yoga
278373|NCT01761617|Chronic Low Back Pain|chronic low back pain
278374|NCT01761617|CAM|cam
278375|NCT01761617|Complementary and Alternative Medicine|complementary and alternative medicine
278376|NCT01761617|Minorities|minorities
278377|NCT01761591|CAD|cad
278378|NCT01761591|PCI|pci
278379|NCT01761591|BMS|bms
278380|NCT01761591|Svelte|svelte
278381|NCT01761591|Acrobat|acrobat
278382|NCT01761591|direct stenting|direct stenting
278383|NCT01761591|RCT|rct
278384|NCT01761578|Bioresorbable|bioresorbable
278385|NCT01761578|Coronary|coronary
278386|NCT01761578|Stent|stent
278387|NCT01761578|Vascular Remodeling|vascular remodeling
278388|NCT01761578|Angioplasty|angioplasty
278389|NCT01761578|Coronary Artery Disease|coronary artery disease
278390|NCT01761552|in ASA 4 AND ASA 4E patients|in asa 4 and asa 4e patients
278391|NCT01761539|pancreatitis|pancreatitis
278392|NCT01761539|pancreatitis, alcoholic|pancreatitis, alcoholic
278393|NCT01761526|Rotigotine|rotigotine
278394|NCT01761526|Neupro|neupro
278395|NCT01761526|Japanese|japanese
278396|NCT01761526|Caucasian|caucasian
278397|NCT01761526|Male|male
278398|NCT01761526|Female|female
278399|NCT01761526|Single dose|single dose
278400|NCT01761526|Pharmacokinetics|pharmacokinetics
278401|NCT01761500|Non-Hodgkin's lymphoma;|non-hodgkin's lymphoma;
278402|NCT01761500|Childhood and adolescence;|childhood and adolescence;
278403|NCT01761500|Survival Rate|survival rate
278404|NCT01761474|Carbon dioxide insufflation|carbon dioxide insufflation
278405|NCT01761474|Air insufflatioin|air insufflatioin
278406|NCT01761474|ERCP|ercp
278407|NCT01761474|Sedation|sedation
278408|NCT01761448|Coronary Artery Disease|coronary artery disease
278409|NCT01761448|Cardiac rehabilitation program|cardiac rehabilitation program
278410|NCT01761448|telemedical homely rehabilitation|telemedical homely rehabilitation
278411|NCT01761448|guided exercise|guided exercise
278412|NCT01761448|ECG- vest|ecg- vest
278413|NCT01761435|Influenza|influenza
278414|NCT01761435|Solid Organ Transplant Recipients|solid organ transplant recipients
278415|NCT01761396|Anxiety|anxiety
278416|NCT01761396|Fear|fear
278417|NCT01761396|Worry|worry
278418|NCT01761396|Therapy|therapy
279403|NCT01756625|nicotine|nicotine
278419|NCT01761396|Cognitive behavioral therapy|cognitive behavioral therapy
278420|NCT01761383|Chronic Schizophrenia|chronic schizophrenia
278421|NCT01761383|Nintendo Wii|nintendo wii
278422|NCT01761383|Quality of Life|quality of life
278423|NCT01761370|Non alcoholic Steatohepatitis|non alcoholic steatohepatitis
278424|NCT01761370|Intra-gastric balloon|intra-gastric balloon
278425|NCT01761357|Aortic valve stenosis|aortic valve stenosis
278426|NCT01761357|Quality of life|quality of life
278427|NCT01761357|Burden co morbidities|burden co morbidities
278428|NCT01761357|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
278429|NCT01761357|Geriatric assessment|geriatric assessment
278430|NCT01761331|infant, colic, crying, acupuncture, stooling, sleep|infant, colic, crying, acupuncture, stooling, sleep
278431|NCT01761318|Diabetes mellitus type 2|diabetes mellitus type 2
278432|NCT01761318|Glucagon-Like Peptide 1|glucagon-like peptide 1
278433|NCT01761318|Magnetic Resonance Imaging|magnetic resonance imaging
278434|NCT01761318|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
278435|NCT01761318|Steatosis|steatosis
278436|NCT01761305|Idiopathic scoliosis|idiopathic scoliosis
278441|NCT01761266|Hepatocellular Carcinoma|hepatocellular carcinoma
278442|NCT01761266|Neoplasms|neoplasms
278443|NCT01761266|Cancer|cancer
402013|NCT01233479|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
278444|NCT01761253|comorbidity, multiple chronic conditions, Medicaid, prediction of cost|comorbidity, multiple chronic conditions, medicaid, prediction of cost
278445|NCT01761253|Predictive models, cost containment, managed care|predictive models, cost containment, managed care
278446|NCT01761227|Vascular dementia|vascular dementia
278447|NCT01761227|Fufangdanshen Tablets|fufangdanshen tablets
278448|NCT01761227|Randomized Controlled trial|randomized controlled trial
278449|NCT01761227|Chinese Medicine|chinese medicine
278450|NCT01761214|bacteriology, inflammation, bronchiectasis, exacerbation|bacteriology, inflammation, bronchiectasis, exacerbation
278451|NCT01761201|Prophylaxis|prophylaxis
278452|NCT01761201|Tuberculosis|tuberculosis
278453|NCT01761201|Transplant recipients|transplant recipients
278454|NCT01761201|Transplant waiting list|transplant waiting list
278455|NCT01761188|Persistent Atrial fibrillation;LA substrate;ablation;voltage mapping|persistent atrial fibrillation;la substrate;ablation;voltage mapping
278456|NCT01761149|remifentanil,|remifentanil,
278457|NCT01761149|opioid,|opioid,
278458|NCT01761149|hyperalgesia,|hyperalgesia,
278459|NCT01761149|visual analogue score|visual analogue score
278460|NCT01761149|thyroidectomy,|thyroidectomy,
278461|NCT01761123|Prevention of Influenza|prevention of influenza
278462|NCT01761110|Opioid dependence|opioid dependence
278463|NCT01761110|Injection drug use|injection drug use
278464|NCT01761110|Buprenorphine|buprenorphine
278465|NCT01761110|Opioid agonist treatment|opioid agonist treatment
278466|NCT01761110|Access to care|access to care
278467|NCT01761110|HIV risk behaviors|hiv risk behaviors
278468|NCT01761110|Opioids|opioids
278469|NCT01761097|Adenoma, polyp, colonoscopy.|adenoma, polyp, colonoscopy.
278470|NCT01761084|Osteoporosis|osteoporosis
278471|NCT01761084|Spine fracture|spine fracture
278472|NCT01761084|Vertebral fracture|vertebral fracture
278473|NCT01761084|Exercise Interventions|exercise interventions
278474|NCT01761084|Exercise|exercise
278475|NCT01761058|Asthma|asthma
278476|NCT01761058|Bronchial Diseases|bronchial diseases
278477|NCT01761058|Respiratory Tract Diseases|respiratory tract diseases
278478|NCT01761058|Lung Diseases, Obstructive|lung diseases, obstructive
278479|NCT01761058|Lung Diseases|lung diseases
278480|NCT01761058|Respiratory Hypersensitivity|respiratory hypersensitivity
278481|NCT01761058|Hypersensitivity, Immediate|hypersensitivity, immediate
278482|NCT01761058|Hypersensitivity|hypersensitivity
278483|NCT01761058|Immune System Disease|immune system disease
278484|NCT01761045|Monosodium L-Glutamate (MSG)|monosodium l-glutamate (msg)
278485|NCT01761045|Nucleic Acid (IMP)|nucleic acid (imp)
278487|NCT01761045|Gastrointestinal Sensation|gastrointestinal sensation
278488|NCT01761045|Consommé Soups|consommé soups
278489|NCT01761045|Snack Intake|snack intake
278490|NCT01761032|Tanning|tanning
278491|NCT01761032|neuroimaging|neuroimaging
278492|NCT01761032|dopamine|dopamine
278493|NCT01761032|MRI|mri
278494|NCT01761032|SPECT|spect
278495|NCT01761019|psoriasis|psoriasis
278496|NCT01761019|Taclonex|taclonex
278497|NCT01761019|Acitretin|acitretin
278498|NCT01761019|Methotrexate|methotrexate
278499|NCT01761006|COPD|copd
278500|NCT01761006|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
278501|NCT01761006|Exhaled Nitric Oxide|exhaled nitric oxide
278502|NCT01761006|NIOX MINO|niox mino
278503|NCT01761006|Acute COPD exacerbation|acute copd exacerbation
278504|NCT01760993|Not Required|not required
278505|NCT01760980|Rate and extend of absorption of Exemestane|rate and extend of absorption of exemestane
278506|NCT01760967|Dexmedetomidine|dexmedetomidine
278507|NCT01760967|sepsis|sepsis
278508|NCT01760967|mortality|mortality
278509|NCT01760967|duration of mechanical ventilation|duration of mechanical ventilation
278510|NCT01760967|organ failure|organ failure
278511|NCT01760954|Gonadotropin-Releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
278512|NCT01760954|Non-Menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
278513|NCT01760954|Dysmenorrhea (DYS)|dysmenorrhea (dys)
269106|NCT01803399|QTc|qtc
278514|NCT01760954|Endometriosis associated pain|endometriosis associated pain
278515|NCT01760954|Elagolix|elagolix
278516|NCT01760941|Urology|urology
278517|NCT01760941|Prostate|prostate
278518|NCT01760941|Breast|breast
278519|NCT01760941|Lung|lung
278520|NCT01760941|Chest|chest
278521|NCT01760915|asthma|asthma
278522|NCT01760915|severe|severe
278523|NCT01760902|Inflammation|inflammation
278524|NCT01760876|Optical Coherence Tomography|optical coherence tomography
278525|NCT01760876|Biofreedom Stent|biofreedom stent
278526|NCT01760863|Revision|revision
278527|NCT01760863|Knee|knee
278528|NCT01760863|Hip|hip
278529|NCT01760863|Arthroplasty|arthroplasty
278530|NCT01760863|Oral|oral
278531|NCT01760863|Antibiotics|antibiotics
278532|NCT01760863|Infection|infection
278533|NCT01760837|cow's milk allergy|cow's milk allergy
278534|NCT01760837|baked milk|baked milk
278535|NCT01760837|tolerance|tolerance
278536|NCT01760837|infants and children|infants and children
278537|NCT01760824|Sequential|sequential
278538|NCT01760824|Quadruple|quadruple
278539|NCT01760824|First|first
278540|NCT01760824|Line|line
278541|NCT01760824|Helicobacter|helicobacter
278542|NCT01760824|pylori|pylori
278543|NCT01760824|infection|infection
278544|NCT01760811|tongue|tongue
278545|NCT01760811|Squamous cell carcinoma|squamous cell carcinoma
278546|NCT01760811|locally advanced|locally advanced
278547|NCT01760811|cetuximab|cetuximab
278548|NCT01760798|osteoporosis|osteoporosis
278549|NCT01760798|Teriparatide|teriparatide
278550|NCT01760785|Veterans|veterans
278551|NCT01760785|Traumatic Brain Injury(TBI)|traumatic brain injury(tbi)
278552|NCT01760785|Alcoholism|alcoholism
278553|NCT01760772|heart disease|heart disease
278554|NCT01760772|GLP-1|glp-1
278555|NCT01760772|Exendin-9|exendin-9
278556|NCT01760772|postprandial lipids|postprandial lipids
278557|NCT01760759|HIV|hiv
278558|NCT01760759|Antiretroviral therapy adherence|antiretroviral therapy adherence
278559|NCT01760746|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
278560|NCT01760746|Vitrectomy|vitrectomy
278561|NCT01760746|Inflammatory Cytokines|inflammatory cytokines
278562|NCT01760707|Diabetes mellitus|diabetes mellitus
278563|NCT01760707|Peripheral neuropathy|peripheral neuropathy
278564|NCT01760707|Exercise|exercise
278565|NCT01760707|Balance performance|balance performance
278566|NCT01760694|Pancreatic|pancreatic
278567|NCT01760694|Pancreas|pancreas
278568|NCT01760694|Intraoperative Radiation Therapy|intraoperative radiation therapy
278569|NCT01760694|Chemotherapy|chemotherapy
278570|NCT01760668|Sex chromosome|sex chromosome
278571|NCT01760668|Turner Syndrome|turner syndrome
278572|NCT01760668|Marfan syndrome|marfan syndrome
278573|NCT01760668|Bicuspid aortic valve|bicuspid aortic valve
278574|NCT01760668|Aortic Aneurysm|aortic aneurysm
278575|NCT01760668|Epigenetics|epigenetics
278576|NCT01760668|Transcriptome|transcriptome
278577|NCT01760668|non-coding RNA|non-coding rna
278578|NCT01760668|Electron microscopy|electron microscopy
278579|NCT01760668|Proteomics|proteomics
278580|NCT01760642|metabolite profiles|metabolite profiles
278581|NCT01760642|pharmacokinetics|pharmacokinetics
278582|NCT01760642|CYP3A|cyp3a
278583|NCT01760642|metabolomics|metabolomics
278584|NCT01760629|Encephalopathy, Newborn, Low and Middle-income countries, Hypothermia|encephalopathy, newborn, low and middle-income countries, hypothermia
278585|NCT01760616|Huaier Granule;|huaier granule;
278586|NCT01760616|After non-radical hepatectomy;|after non-radical hepatectomy;
278587|NCT01760616|Prevention of Disease Progression of Hepatocarcinoma;|prevention of disease progression of hepatocarcinoma;
278588|NCT01760616|Safety.|safety.
278589|NCT01760603|pelvic organ prolapse|pelvic organ prolapse
278590|NCT01760590|neck pain|neck pain
278591|NCT01760590|cervical pain|cervical pain
278592|NCT01760590|pain pressure thresholds|pain pressure thresholds
278593|NCT01760590|pain catastrophizing|pain catastrophizing
278594|NCT01760577|osteoarthritis, botulinum toxin, hyaluronate|osteoarthritis, botulinum toxin, hyaluronate
278595|NCT01760564|Niemann-Pick disease type C|niemann-pick disease type c
278596|NCT01760564|miglustat|miglustat
278597|NCT01760551|Fracture|fracture
278598|NCT01760551|Trauma|trauma
278599|NCT01760551|impairment|impairment
278600|NCT01760538|Cardiac transplant recipients|cardiac transplant recipients
278601|NCT01760538|Heart rate variability|heart rate variability
278602|NCT01760538|Exercise training|exercise training
278603|NCT01760525|p53, solid tumor|p53, solid tumor
278604|NCT01760512|Gastric bypass|gastric bypass
278605|NCT01760512|Robot-assisted surgery|robot-assisted surgery
278606|NCT01760512|Conventional laparoscopy|conventional laparoscopy
278607|NCT01760512|Pain assessment|pain assessment
278608|NCT01760512|Health economics outcomes|health economics outcomes
278609|NCT01760499|skin|skin
278610|NCT01760499|metastatic|metastatic
278611|NCT01760473|opioid dependence|opioid dependence
278612|NCT01760434|scoliosis|scoliosis
278613|NCT01760434|long-term outcomes|long-term outcomes
269186|NCT01803113|hCG|hcg
278614|NCT01760434|sagittal plane|sagittal plane
278615|NCT01760434|quality of life|quality of life
278616|NCT01760434|curve progression|curve progression
278617|NCT01760434|pulmonary function|pulmonary function
278618|NCT01760382|Acute myocardial infarction|acute myocardial infarction
278619|NCT01760382|ST elevation myocardial infarction|st elevation myocardial infarction
278620|NCT01760382|primary PCI|primary pci
278621|NCT01760382|reperfusion therapy|reperfusion therapy
278622|NCT01760382|angioplasty|angioplasty
278623|NCT01760382|stent|stent
278624|NCT01760356|Liver transplantation|liver transplantation
278625|NCT01760356|Calcineurin inhibitors|calcineurin inhibitors
278626|NCT01760356|Pharmacodynamic biomarkers|pharmacodynamic biomarkers
278627|NCT01760356|Calcineurin pathway|calcineurin pathway
278628|NCT01760356|Tacrolimus|tacrolimus
278629|NCT01760356|interindividual variability|interindividual variability
278630|NCT01760304|COPD|copd
278631|NCT01760278|Time-lapse monitoring of embryos.|time-lapse monitoring of embryos.
278632|NCT01760278|Embryoscope|embryoscope
278633|NCT01760278|IVF-ET/ICSI|ivf-et/icsi
278634|NCT01760278|Cetrorelix|cetrorelix
278635|NCT01760278|Gonal-F|gonal-f
278636|NCT01760265|dysbetalipoproteinemia|dysbetalipoproteinemia
278637|NCT01760265|artery calcium score|artery calcium score
278638|NCT01760265|carotid intima media|carotid intima media
278639|NCT01760265|ankle brachial index|ankle brachial index
278640|NCT01760265|dysbetalipoproteinemic patients|dysbetalipoproteinemic patients
278641|NCT01760252|Pancreatic Cancer|pancreatic cancer
278642|NCT01760239|Adolescent Hypertension|adolescent hypertension
278643|NCT01760239|Adolescent Pre Hypertension|adolescent pre hypertension
278644|NCT01760239|Adolescent Pre Hypertension and Obesity|adolescent pre hypertension and obesity
278645|NCT01760226|DLBCL|dlbcl
278646|NCT01760226|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
278647|NCT01760226|dose adjusted|dose adjusted
278648|NCT01760226|EPOCH|epoch
278649|NCT01760226|Etoposide|etoposide
278650|NCT01760226|Doxorubicin|doxorubicin
278651|NCT01760226|Vincristine|vincristine
278652|NCT01760226|Cyclophosphamide|cyclophosphamide
278653|NCT01760226|Prednisone|prednisone
278654|NCT01760226|Rituximab|rituximab
278655|NCT01760200|Coronary angioplasty|coronary angioplasty
278656|NCT01760200|Coronary stent|coronary stent
278657|NCT01760200|paclitaxel drug-eluting stent|paclitaxel drug-eluting stent
278658|NCT01760200|drug eluting balloon|drug eluting balloon
278659|NCT01760174|Transversus abdominis plane catheter|transversus abdominis plane catheter
278660|NCT01760161|postoperative pain|postoperative pain
278661|NCT01760161|opioid consumption|opioid consumption
278662|NCT01760161|termanalgesia|termanalgesia
278663|NCT01760161|plasmaropivacain level|plasmaropivacain level
278664|NCT01760148|Hepatitis C Virus|hepatitis c virus
278666|NCT01760148|Interferon|interferon
278667|NCT01760148|Prediction|prediction
278668|NCT01760148|SVR|svr
278669|NCT01760148|Sustained Virus Response|sustained virus response
278670|NCT01760135|trauma|trauma
278671|NCT01760135|nutrition|nutrition
278672|NCT01760135|hyperglycemia|hyperglycemia
278673|NCT01760122|peginterferon|peginterferon
278674|NCT01760122|HBeAg Positive|hbeag positive
278675|NCT01760122|Chronic hepatitis B|chronic hepatitis b
278676|NCT01760109|Respiratory and urinary tract infections|respiratory and urinary tract infections
278677|NCT01760109|Piperacillin Sodium and Sulbactam Sodium for Injection (2:1)|piperacillin sodium and sulbactam sodium for injection (2:1)
278678|NCT01760109|Phase IV|phase iv
278679|NCT01760096|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
278680|NCT01760096|Anemia|anemia
278681|NCT01760096|Hematologic Diseases|hematologic diseases
278682|NCT01760096|bone marrow failure|bone marrow failure
278683|NCT01760096|Immunologic Factors|immunologic factors
278684|NCT01760096|Physiological Effects of Drugs|physiological effects of drugs
278685|NCT01760096|Levamisole|levamisole
278686|NCT01760096|cyclosporine A|cyclosporine a
278687|NCT01760070|cancer|cancer
278688|NCT01760070|endoscopy|endoscopy
278689|NCT01760070|endoscopic submucosal dissection|endoscopic submucosal dissection
278690|NCT01760044|tissue oxygenation|tissue oxygenation
278691|NCT01760044|perfusion status|perfusion status
278692|NCT01760031|preconditioning|preconditioning
278693|NCT01760031|contrast-induced acute kidney injury|contrast-induced acute kidney injury
278694|NCT01760031|renal faliure|renal faliure
278695|NCT01760018|desflurane, total intravenous anesthesia, QoR-40|desflurane, total intravenous anesthesia, qor-40
278696|NCT01760005|Alzheimer's|alzheimer's
278697|NCT01760005|Alzheimer's Disease|alzheimer's disease
278698|NCT01760005|Dementia|dementia
278699|NCT01760005|Mutation|mutation
278700|NCT01760005|Genetic Mutation|genetic mutation
278701|NCT01760005|Dominantly Inherited Alzheimer's Disease|dominantly inherited alzheimer's disease
278702|NCT01760005|Dominantly Inherited Alzheimer's Network|dominantly inherited alzheimer's network
278703|NCT01760005|Autosomal Dominant Alzheimer's Disease|autosomal dominant alzheimer's disease
278704|NCT01760005|Early Onset Alzheimer's Disease|early onset alzheimer's disease
278705|NCT01760005|DIAN|dian
278706|NCT01760005|DIAN-TU|dian-tu
278707|NCT01760005|DIAN TU|dian tu
278708|NCT01759992|Frail elderly|frail elderly
278709|NCT01759992|Muscle weakness|muscle weakness
278710|NCT01759992|Institutionalization|institutionalization
278711|NCT01759992|Respiratory muscle training|respiratory muscle training
278712|NCT01759979|Cholelithiasis, Common Bile Duct|cholelithiasis, common bile duct
278713|NCT01759979|Choledocholithiasis|choledocholithiasis
278714|NCT01759966|Heart transplantation|heart transplantation
278715|NCT01759966|Autonomic cardiovascular control|autonomic cardiovascular control
278716|NCT01759966|Acute rejection|acute rejection
278717|NCT01759966|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
278718|NCT01759953|Diabetes Mellitus|diabetes mellitus
278719|NCT01759953|Insulin|insulin
278720|NCT01759953|Video Games|video games
278721|NCT01759953|Medical Education|medical education
278722|NCT01759953|Educational Technology|educational technology
278723|NCT01759953|Continuing Medical Education|continuing medical education
278725|NCT01759940|endarterectomy|endarterectomy
278726|NCT01759940|cervical block|cervical block
278727|NCT01759927|Physical activity counselor|physical activity counselor
278728|NCT01759927|Workplace intervention|workplace intervention
278729|NCT01759927|Active and healthy lifestyle|active and healthy lifestyle
278730|NCT01759901|hepatectomy|hepatectomy
278731|NCT01759901|vascular inflow occlusion|vascular inflow occlusion
278732|NCT01759862|kidney transplant|kidney transplant
278733|NCT01759862|Aminophylline|aminophylline
278734|NCT01759862|pediatric|pediatric
278735|NCT01759849|Asthma|asthma
278736|NCT01759849|β-chain signaling|β-chain signaling
278737|NCT01759849|allergen inhalation challenges|allergen inhalation challenges
278738|NCT01759849|sputum|sputum
278739|NCT01759849|bone marrow aspirate|bone marrow aspirate
278740|NCT01759849|blood collection|blood collection
278741|NCT01759849|-methacholine challenge|-methacholine challenge
278742|NCT01759836|Prostatectomy|prostatectomy
278743|NCT01759836|Statins|statins
278744|NCT01759810|Glioblastoma, recurrent glioblastoma|glioblastoma, recurrent glioblastoma
278745|NCT01759797|ALS bone marrow mesenchymal stem cell intravenous injection|als bone marrow mesenchymal stem cell intravenous injection
278746|NCT01759784|mesenchymal stem cell intraventricular injection ALS|mesenchymal stem cell intraventricular injection als
278747|NCT01759771|Prostate Cancer|prostate cancer
278748|NCT01759771|Vitamin D3|vitamin d3
278749|NCT01759771|Active surveillance|active surveillance
278750|NCT01759758|boxer's fracture|boxer's fracture
278751|NCT01759758|metacarpal neck fracture|metacarpal neck fracture
278752|NCT01759758|metacarpal fracture|metacarpal fracture
278753|NCT01759732|Aplastic anemia|aplastic anemia
278754|NCT01759732|T cell dose|t cell dose
278755|NCT01759732|CD3 depletion|cd3 depletion
278756|NCT01759732|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
278757|NCT01759719|platinum-chromium stents|platinum-chromium stents
278758|NCT01759719|concertina effect|concertina effect
278759|NCT01759719|stent deformation|stent deformation
278760|NCT01759719|everolimus eluting stents|everolimus eluting stents
278761|NCT01759719|stent lenght|stent lenght
278762|NCT01759693|Platelet activation|platelet activation
278763|NCT01759680|Risk of falls|risk of falls
278764|NCT01759680|Whole Body Vibration|whole body vibration
278765|NCT01759680|Nursing Home|nursing home
278766|NCT01759667|Diet-induced Thermogenesis;|diet-induced thermogenesis;
278767|NCT01759667|Respiratory Quotient;|respiratory quotient;
278768|NCT01759667|Roux-en-Y Gastric Bypass;|roux-en-y gastric bypass;
278769|NCT01759667|Energy Expenditure.|energy expenditure.
278770|NCT01759641|Dialysis|dialysis
278771|NCT01759641|Monitoring|monitoring
278772|NCT01759641|Cardiovascular stability|cardiovascular stability
278773|NCT01759641|biosignals|biosignals
278774|NCT01759628|Steatohepatitis,|steatohepatitis,
278775|NCT01759628|Helicobacter pylori,|helicobacter pylori,
278776|NCT01759628|Insulin resistance,|insulin resistance,
278777|NCT01759628|Alanine aminotransferase,|alanine aminotransferase,
278778|NCT01759628|Aspartate aminotransferase,|aspartate aminotransferase,
278779|NCT01759615|Preterm|preterm
278781|NCT01759615|AREDF|aredf
278782|NCT01759615|Early feeding|early feeding
278783|NCT01759615|Late feeding|late feeding
278784|NCT01759615|Feed intolerence|feed intolerence
278785|NCT01759615|Necrotizing enterocolitis|necrotizing enterocolitis
278786|NCT01759602|Neuromyelitis optica|neuromyelitis optica
278787|NCT01759602|Devic's disease|devic's disease
278789|NCT01759602|Devic|devic
278790|NCT01759589|electroconvulsive therapy,sevoflurane,propofol,remifentanil|electroconvulsive therapy,sevoflurane,propofol,remifentanil
278791|NCT01759576|Renal Insufficiency|renal insufficiency
278792|NCT01759576|Healthy|healthy
278793|NCT01759576|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
278794|NCT01759576|Pharmacokinetics|pharmacokinetics
278795|NCT01759576|Pharmacodynamics|pharmacodynamics
278796|NCT01759576|Dialysis|dialysis
278797|NCT01759550|Gastric Procedures|gastric procedures
278798|NCT01759550|Force Triad|force triad
278799|NCT01759550|LigaSure Advance Pistol Grip|ligasure advance pistol grip
278800|NCT01759550|LigaSure Blunt Tip|ligasure blunt tip
278801|NCT01759524|local anaesthesia|local anaesthesia
278802|NCT01759524|analgesia|analgesia
278803|NCT01759524|bupivacaine|bupivacaine
278804|NCT01759524|lidocaine|lidocaine
278805|NCT01759524|clonidine|clonidine
278806|NCT01759524|sciatic nerve|sciatic nerve
278807|NCT01759524|saphenous nerve|saphenous nerve
278808|NCT01759511|Idiopathic|idiopathic
278809|NCT01759511|Pulmonary|pulmonary
278810|NCT01759511|Fibrosis|fibrosis
278812|NCT01759498|Inflammation|inflammation
278813|NCT01759498|Pain intensity|pain intensity
278814|NCT01759498|Flexibility|flexibility
278815|NCT01759498|RICE protocol|rice protocol
278816|NCT01759498|Swelling|swelling
278817|NCT01759485|Clozapine|clozapine
278818|NCT01759485|Schizophrenia|schizophrenia
278819|NCT01759485|Vitamin-D|vitamin-d
278820|NCT01759485|Treatment-resistant|treatment-resistant
278486|NCT01761045|Satiety|satiety
278821|NCT01759472|leukotriene|leukotriene
278822|NCT01759472|leukotriene receptor antagonist|leukotriene receptor antagonist
278823|NCT01759420|Ondansetron|ondansetron
278824|NCT01759420|QT interval|qt interval
278826|NCT01759420|QT prolongation|qt prolongation
278827|NCT01759420|Drug induced QT prolongation|drug induced qt prolongation
278828|NCT01759381|Spinal Deformity|spinal deformity
278829|NCT01759381|Complex Spinal Surgery|complex spinal surgery
278830|NCT01759381|Negative Pressure Wound Therapy|negative pressure wound therapy
278831|NCT01759381|Post-Operative Infection|post-operative infection
278832|NCT01759368|self-care, heart failure, telemonitoring, health care utilization|self-care, heart failure, telemonitoring, health care utilization
278833|NCT01759342|Cystic fibrosis; pulmonary exacerbation, exercise|cystic fibrosis; pulmonary exacerbation, exercise
278834|NCT01759329|overweight|overweight
278835|NCT01759329|body weight|body weight
278836|NCT01759329|coffee|coffee
278837|NCT01759290|Angioplasty|angioplasty
278838|NCT01759290|Bioabsorbable|bioabsorbable
278839|NCT01759290|Bioresorbable|bioresorbable
278840|NCT01759290|BVS|bvs
278841|NCT01759290|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
278842|NCT01759290|Coronary Scaffold|coronary scaffold
278843|NCT01759290|Coronary Stent|coronary stent
278844|NCT01759264|Fecal Calprotectin|fecal calprotectin
278845|NCT01759264|Crohn's Disease|crohn's disease
278846|NCT01759264|Adalimumab|adalimumab
278847|NCT01759251|Meniere Disease|meniere disease
278848|NCT01759251|Betahistine Dihydrochloride|betahistine dihydrochloride
278849|NCT01759251|Vertigo|vertigo
278850|NCT01759238|colorectal cancer|colorectal cancer
278851|NCT01759238|metastases|metastases
278852|NCT01759238|non resectable|non resectable
278853|NCT01759238|chemoradiation|chemoradiation
278854|NCT01759225|Registry, Cardiovascular, CVD, Health Maintenance Organization|registry, cardiovascular, cvd, health maintenance organization
278855|NCT01759212|stem cell implantation|stem cell implantation
278856|NCT01759212|coronary artery disease|coronary artery disease
278857|NCT01759212|left ventricular assist device|left ventricular assist device
278858|NCT01759199|COPD|copd
278859|NCT01759199|ST6: The six minute Stepper Test|st6: the six minute stepper test
278860|NCT01759199|Conventional respiratory rehabilitation|conventional respiratory rehabilitation
278861|NCT01759199|Pulmonary rehabilitation|pulmonary rehabilitation
278862|NCT01759186|Asthma|asthma
278863|NCT01759186|Biomakers|biomakers
278864|NCT01759186|Phenotype|phenotype
278865|NCT01759173|Minor traumatic brain injury (TBI)|minor traumatic brain injury (tbi)
278866|NCT01759173|Concussion|concussion
278867|NCT01759160|Target control infusion|target control infusion
278868|NCT01759160|propofol|propofol
278869|NCT01759160|cardiac depression|cardiac depression
278870|NCT01759160|induction of anesthesia|induction of anesthesia
278871|NCT01759160|hemodynamics|hemodynamics
278872|NCT01759134|Premature neonate|premature neonate
278873|NCT01759134|Post-discharge|post-discharge
278874|NCT01759134|Formula|formula
278875|NCT01759121|severe non-proliferative diabetic retinopathy|severe non-proliferative diabetic retinopathy
278876|NCT01759121|subthreshold|subthreshold
278877|NCT01759121|panretinal photocoagulation|panretinal photocoagulation
278878|NCT01759121|PASCAL|pascal
278879|NCT01759121|endpoint management|endpoint management
278880|NCT01759108|xerostomia|xerostomia
278881|NCT01759108|rebamipide|rebamipide
278882|NCT01759108|efficacy|efficacy
278883|NCT01759108|safety|safety
278884|NCT01759095|adherence|adherence
278885|NCT01759095|electronic monitoring|electronic monitoring
278886|NCT01759095|primary care|primary care
278887|NCT01759095|community pharmacy|community pharmacy
278888|NCT01759095|multidrug blister pack|multidrug blister pack
278889|NCT01759095|pill box|pill box
278890|NCT01759056|Ulcerative colitis|ulcerative colitis
278891|NCT01759043|coronary artery disease|coronary artery disease
278892|NCT01759043|Myocardial Infarction|myocardial infarction
278893|NCT01759043|Radial Artery|radial artery
278894|NCT01759043|Catheters|catheters
278895|NCT01759030|rheumatoid arthritis, DMARDs|rheumatoid arthritis, dmards
278896|NCT01759030|rituximab|rituximab
278897|NCT01759030|biosimilar|biosimilar
278898|NCT01759030|interchangeability|interchangeability
278899|NCT01759017|Crohn's disease|crohn's disease
278900|NCT01759017|Inflammatory bowel disease|inflammatory bowel disease
278901|NCT01759017|IBD|ibd
278902|NCT01759017|Infliximab|infliximab
278903|NCT01759017|PET|pet
278904|NCT01759017|PET/CT|pet/ct
278905|NCT01759004|lipoedema|lipoedema
278906|NCT01759004|obesity|obesity
278907|NCT01758978|bioequivalence, hydrocodone bitartrate extended-release tablets|bioequivalence, hydrocodone bitartrate extended-release tablets
278908|NCT01758952|Peri-operative stroke|peri-operative stroke
278909|NCT01758952|incidence|incidence
278910|NCT01758952|risk factors|risk factors
278911|NCT01758952|prospective|prospective
278912|NCT01758939|Peg Interferon,|peg interferon,
278913|NCT01758939|Ribavirin,|ribavirin,
278914|NCT01758939|HCV,|hcv,
278915|NCT01758939|Genotype IV.|genotype iv.
278916|NCT01758926|Inflammatory Bowel Disease|inflammatory bowel disease
278917|NCT01758926|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
278918|NCT01758913|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
278919|NCT01758913|patent ductus arteriosus|patent ductus arteriosus
278920|NCT01758913|prostaglandin|prostaglandin
697662|NCT00957697|Pain|pain
278921|NCT01758913|Respiratory distress syndrome|respiratory distress syndrome
278922|NCT01758900|Single-Balloon Enteroscopy|single-balloon enteroscopy
278923|NCT01758874|Critical limb ischemia|critical limb ischemia
278924|NCT01758874|Phlebotomy|phlebotomy
278925|NCT01758874|Amputation|amputation
278926|NCT01758874|Rutherford classification Grade 3, Category 5 or 6|rutherford classification grade 3, category 5 or 6
278927|NCT01758874|Fontaine stage IV|fontaine stage iv
278928|NCT01758861|Erythropoietin|erythropoietin
278929|NCT01758861|acute kidney injury|acute kidney injury
278930|NCT01758861|valvular heart surgery|valvular heart surgery
278931|NCT01758848|overactive bladder|overactive bladder
278932|NCT01758848|pelvic floor muscles|pelvic floor muscles
278933|NCT01758848|deep abdominal muscles|deep abdominal muscles
278934|NCT01758835|ER-stress-test negative|er-stress-test negative
278935|NCT01758835|unimalleolar|unimalleolar
278936|NCT01758835|fibula|fibula
278937|NCT01758835|Weber-B fractures|weber-b fractures
278938|NCT01758822|meconium stained amniotic fluid|meconium stained amniotic fluid
278939|NCT01758822|endotracheal suction|endotracheal suction
278940|NCT01758822|non vigorous neonates|non vigorous neonates
278941|NCT01758809|Video Assisted Thoracic Surgery|video assisted thoracic surgery
278942|NCT01758809|Postoperative Pain|postoperative pain
278943|NCT01758809|Intravenous Patient Controlled Analgesia|intravenous patient controlled analgesia
278944|NCT01758809|Bupivacaine|bupivacaine
278945|NCT01758809|Major Pulmonary Resection|major pulmonary resection
278946|NCT01758809|Post Pulmonary Resection|post pulmonary resection
278947|NCT01758796|ER-stress positive|er-stress positive
278948|NCT01758796|Unimalleolar fibula fracture|unimalleolar fibula fracture
278949|NCT01758796|Operative vs non-operative treatment|operative vs non-operative treatment
278950|NCT01758770|osteoporosis|osteoporosis
278951|NCT01758770|osteoarthritis|osteoarthritis
278952|NCT01758770|bone mineral density|bone mineral density
278953|NCT01758770|computed xray tomography|computed xray tomography
278954|NCT01758770|liver steatosis|liver steatosis
278955|NCT01758770|obesity|obesity
278956|NCT01758757|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
278957|NCT01758757|Vitrectomy|vitrectomy
278958|NCT01758744|COPD PH|copd ph
278959|NCT01758744|COPD associated Pulmonary Hypertension|copd associated pulmonary hypertension
278960|NCT01758744|COPD and Pulmonary Hypertension|copd and pulmonary hypertension
278961|NCT01758744|Disease|disease
278962|NCT01758731|Stage IVA-B Squamous Cell Carcinomas|stage iva-b squamous cell carcinomas
278963|NCT01758731|Head and Neck Cancer|head and neck cancer
278964|NCT01758731|Heavy drinking|heavy drinking
278965|NCT01758731|Smoking|smoking
278966|NCT01758718|Down's syndrome|down's syndrome
278967|NCT01758718|entropion|entropion
278968|NCT01758718|lid plasty|lid plasty
278969|NCT01758705|Psoriasis|psoriasis
278970|NCT01758705|Related to Health Quality of Life|related to health quality of life
278971|NCT01758705|Patient Reported Outcomes|patient reported outcomes
278972|NCT01758705|Venezuelan Patients|venezuelan patients
278973|NCT01758692|spinal cord injury|spinal cord injury
278974|NCT01758692|autonomic integrity|autonomic integrity
278975|NCT01758692|autonomic dysreflexia|autonomic dysreflexia
278976|NCT01758692|baroreceptor integrity|baroreceptor integrity
278977|NCT01758692|sympathetic integrity|sympathetic integrity
278978|NCT01758692|vagal integrity|vagal integrity
278979|NCT01758679|Iodine[131I] Metuximab Injection|iodine[131i] metuximab injection
278980|NCT01758653|CO poisoning|co poisoning
278981|NCT01758640|mechanical heart valve|mechanical heart valve
278982|NCT01758640|pregnancy|pregnancy
278983|NCT01758640|warfarin|warfarin
278984|NCT01758640|phenindione|phenindione
278985|NCT01758627|Peritoneal dialysis,|peritoneal dialysis,
278986|NCT01758627|chronic kidney disease,|chronic kidney disease,
278987|NCT01758627|refractory heart failure|refractory heart failure
278988|NCT01758614|carotid artery occlusion|carotid artery occlusion
278989|NCT01758614|middle cerebral artery occlusion|middle cerebral artery occlusion
278990|NCT01758614|EC-IC bypass surgery|ec-ic bypass surgery
278991|NCT01758614|stroke|stroke
278992|NCT01758601|white fish|white fish
278993|NCT01758601|Metabolic syndrome|metabolic syndrome
278994|NCT01758601|Cardiovascular risk|cardiovascular risk
278995|NCT01758588|Primary myelofibrosis|primary myelofibrosis
278996|NCT01758588|PMF|pmf
278997|NCT01758575|Patients|patients
278998|NCT01758549|pancreatitis|pancreatitis
278999|NCT01758549|cholangiopancreatography, endoscopic retrograde|cholangiopancreatography, endoscopic retrograde
279000|NCT01758549|hyperamylasemia|hyperamylasemia
279001|NCT01758536|ischemic stroke|ischemic stroke
279002|NCT01758536|neural function|neural function
279003|NCT01758536|life quality|life quality
279004|NCT01758523|neuroactive steroids|neuroactive steroids
279005|NCT01758510|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
279006|NCT01758510|ALS|als
279007|NCT01758510|Neurodegenerative disease|neurodegenerative disease
279008|NCT01758510|Motor Neuron Disease|motor neuron disease
279009|NCT01758510|Central Nervous System Disease|central nervous system disease
279010|NCT01758510|Neuromuscular Disease|neuromuscular disease
697802|NCT00957801|Androgen|androgen
279011|NCT01758510|Bone marrow derived stem cell|bone marrow derived stem cell
279012|NCT01758510|stem cell therapy|stem cell therapy
279013|NCT01758510|intrathecal injection|intrathecal injection
279014|NCT01758497|Fascia Iliaca compartment block, Pain, Sensorial blockade|fascia iliaca compartment block, pain, sensorial blockade
279015|NCT01758484|Hematopoietic cell transplantation|hematopoietic cell transplantation
279016|NCT01758484|Supportive/palliative care|supportive/palliative care
279017|NCT01758471|Type 2 Diabetes|type 2 diabetes
279018|NCT01758471|gut microbiome|gut microbiome
279019|NCT01758471|incretin|incretin
279020|NCT01758471|Sulfonylurea|sulfonylurea
279021|NCT01758471|α-glucosidase inhibitor|α-glucosidase inhibitor
279023|NCT01758445|Cancer|cancer
279024|NCT01758445|Radiation|radiation
279025|NCT01758445|Proton|proton
279026|NCT01758432|Healthy volunteers|healthy volunteers
279027|NCT01758419|post-RT|post-rt
279028|NCT01758419|myocardial perfusion images|myocardial perfusion images
279029|NCT01758406|Cardiac stem ce heart failure cardiac function intracoronary transplantation|cardiac stem ce heart failure cardiac function intracoronary transplantation
279030|NCT01758393|IgG4-related disease|igg4-related disease
279031|NCT01758393|IgG4-RD|igg4-rd
279032|NCT01758380|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
279033|NCT01758380|Ramadan|ramadan
279034|NCT01758380|Vildagliptin|vildagliptin
279035|NCT01758380|Hypoglycemia|hypoglycemia
279036|NCT01758367|demethylating agent|demethylating agent
279037|NCT01758367|immunogenicity|immunogenicity
279038|NCT01758367|decitabine(DAC)|decitabine(dac)
279039|NCT01758367|donor lymphocyte infusion(DLI)|donor lymphocyte infusion(dli)
279040|NCT01758367|AML|aml
279041|NCT01758354|Pompe disease|pompe disease
279042|NCT01758354|alpha glucosidase deficiency|alpha glucosidase deficiency
279043|NCT01758341|Malignant biliary obstruction|malignant biliary obstruction
279044|NCT01758341|Endoscopic radiofrequency ablation|endoscopic radiofrequency ablation
279045|NCT01758341|Therapeutic endoscopy|therapeutic endoscopy
279046|NCT01758328|BUSULFAN|busulfan
279047|NCT01758328|FLUDARABINE|fludarabine
279048|NCT01758328|G-CSF|g-csf
279049|NCT01758328|MELPHALAN|melphalan
279050|NCT01758328|RABBIT ATG WT1|rabbit atg wt1
279051|NCT01758328|PEPTIDE SPECIFIC T CELLS|peptide specific t cells
279052|NCT01758328|12-175|12-175
279053|NCT01758315|Ambulatory|ambulatory
279054|NCT01758315|Outpatient|outpatient
279055|NCT01758315|Malpractice|malpractice
279056|NCT01758315|Quality Improvement|quality improvement
279057|NCT01758315|Patient Safety|patient safety
279058|NCT01758302|taste test|taste test
279059|NCT01758302|food consumption|food consumption
279060|NCT01758302|hunger|hunger
279061|NCT01758289|Venezuelan Patients|venezuelan patients
279062|NCT01758289|Depressive Symptoms|depressive symptoms
279063|NCT01758289|Health Related Quality of Life|health related quality of life
279064|NCT01758276|smoking, pregnancy|smoking, pregnancy
279065|NCT01758263|Hypertension|hypertension
279066|NCT01758263|Health Care Cost|health care cost
279067|NCT01758263|Monthly health care cost|monthly health care cost
279068|NCT01758250|Autoimmune diseases with cutaneous involvement|autoimmune diseases with cutaneous involvement
279069|NCT01758250|Systemic sclerosis|systemic sclerosis
279070|NCT01758250|Scleroderma|scleroderma
279071|NCT01758250|Morphea|morphea
279072|NCT01758250|Dermatomyositis|dermatomyositis
279073|NCT01758250|Cutaneous lupus|cutaneous lupus
279074|NCT01758250|Vasculitis|vasculitis
279075|NCT01758250|Sickle Cell Disease|sickle cell disease
279076|NCT01758250|Graft versus Host Disease|graft versus host disease
279077|NCT01758237|Laser Peripheral Iridotomy|laser peripheral iridotomy
279078|NCT01758237|Visual Dysphotopsia|visual dysphotopsia
279079|NCT01758237|Visual Disturbances|visual disturbances
279080|NCT01758237|Angle Closure Glaucoma|angle closure glaucoma
279081|NCT01758224|Multiple Sclerosis|multiple sclerosis
279082|NCT01758224|Functional Magnetic Stimulation|functional magnetic stimulation
269675|NCT01800773|PTSD|ptsd
279083|NCT01758224|Pulmonary Function|pulmonary function
279084|NCT01758211|Intracranial Arteriovenous Malformations|intracranial arteriovenous malformations
279085|NCT01758211|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
279086|NCT01758211|Neuronavigation|neuronavigation
279087|NCT01758185|Inactivated split influenza vaccine|inactivated split influenza vaccine
279088|NCT01758185|Immunogenicity|immunogenicity
279089|NCT01758185|Safety|safety
279090|NCT01758185|Consistence|consistence
279091|NCT01758172|pancreaticoduodenectomy|pancreaticoduodenectomy
279092|NCT01758172|postoperative patient|postoperative patient
279093|NCT01758172|colloid|colloid
279094|NCT01758172|albumin|albumin
279095|NCT01758172|hetastarch|hetastarch
279096|NCT01758146|Breast cancer|breast cancer
279097|NCT01758146|obesity|obesity
279098|NCT01758146|aromatase inhibitors|aromatase inhibitors
279099|NCT01758146|postmenopausal|postmenopausal
279100|NCT01758120|IgA nephropathy|iga nephropathy
279101|NCT01758120|Cyclophosphamide|cyclophosphamide
279102|NCT01758120|prednisone|prednisone
279103|NCT01758094|hypogonadism|hypogonadism
279104|NCT01758094|Retinol binding globulin 4|retinol binding globulin 4
279105|NCT01758094|Testosterone treatment|testosterone treatment
279106|NCT01758068|Preterms|preterms
279107|NCT01758068|Coconut Oil application|coconut oil application
279108|NCT01758068|Trans epidermal water loss|trans epidermal water loss
279109|NCT01758068|Weight gain|weight gain
279110|NCT01758055|Mesenchymal stem cell, emphysema, lung function|mesenchymal stem cell, emphysema, lung function
279111|NCT01758042|Kidney|kidney
279112|NCT01758042|Chronic Kidney Disease|chronic kidney disease
279114|NCT01758042|Bone Marrow|bone marrow
279115|NCT01758042|Bone Marrow Transplant|bone marrow transplant
279116|NCT01758042|BMT|bmt
279117|NCT01758042|Leukemia|leukemia
279118|NCT01758042|AML|aml
279119|NCT01758042|ALL|all
279120|NCT01758042|CML|cml
279121|NCT01758042|CLL|cll
279122|NCT01758042|MM|mm
279123|NCT01758042|NHL|nhl
279124|NCT01758042|MDS|mds
279125|NCT01758029|quality of life|quality of life
279126|NCT01758029|Testosterone Undecanoate|testosterone undecanoate
279127|NCT01758029|partner|partner
279128|NCT01758029|questionnaire|questionnaire
279129|NCT01758003|Physical Activity|physical activity
279130|NCT01758003|Sedentary Behaviour|sedentary behaviour
279131|NCT01758003|Healthy Volunteer|healthy volunteer
279132|NCT01758003|Quality of Life|quality of life
279133|NCT01758003|Exercise Capacity|exercise capacity
279134|NCT01758003|Transtheoretical Model|transtheoretical model
279135|NCT01757990|dental caries|dental caries
279136|NCT01757990|Stevioside|stevioside
279137|NCT01757990|Rebaudioside|rebaudioside
279138|NCT01757990|plaque pH|plaque ph
279139|NCT01757990|Streptococcus mutans|streptococcus mutans
279140|NCT01757977|Vivasight DL|vivasight dl
279141|NCT01757977|double lumen endotracheal tube|double lumen endotracheal tube
279142|NCT01757977|fiberoptic confirmation of tube position|fiberoptic confirmation of tube position
279143|NCT01757964|Crohns Disease|crohns disease
279144|NCT01757964|Ulcerative Colitis|ulcerative colitis
279145|NCT01757964|Inflammatory Bowel Disease|inflammatory bowel disease
279146|NCT01757964|IBD|ibd
279147|NCT01757951|Ankle|ankle
279148|NCT01757951|Fracture|fracture
279149|NCT01757951|medial malleolus|medial malleolus
279150|NCT01757951|Osteosynthesis|osteosynthesis
279151|NCT01757938|HIV|hiv
279152|NCT01757938|Prevention|prevention
279153|NCT01757938|Adult Male Circumcision|adult male circumcision
279154|NCT01757938|Uganda|uganda
279155|NCT01757938|Shang Ring|shang ring
279156|NCT01757925|activity|activity
279157|NCT01757925|gaming|gaming
279158|NCT01757925|obesity|obesity
279159|NCT01757925|Active Gaming|active gaming
279160|NCT01757925|Control|control
279161|NCT01757912|mechanical ventilation|mechanical ventilation
279162|NCT01757899|ALI|ali
279163|NCT01757899|Acute Lung Injury|acute lung injury
279164|NCT01757899|ARDS|ards
279165|NCT01757899|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
279166|NCT01757899|Pediatric Critical Care Medicine|pediatric critical care medicine
279167|NCT01757899|Inflammatory Response|inflammatory response
279168|NCT01757886|Myocardial infarction, Inflammation, Thrombus, Coronary angioplasty.|myocardial infarction, inflammation, thrombus, coronary angioplasty.
279169|NCT01757847|Binge-Eating Disorder|binge-eating disorder
279170|NCT01757847|Obesity|obesity
279171|NCT01757847|emotional eating|emotional eating
279172|NCT01757834|Thyroid Nodule|thyroid nodule
279173|NCT01757834|Thyroid Neoplasm|thyroid neoplasm
279174|NCT01757834|Differential Diagnosis|differential diagnosis
279175|NCT01757834|Elastography|elastography
279176|NCT01757834|Elasticity Imaging Technique|elasticity imaging technique
279177|NCT01757834|Sonoelastography|sonoelastography
279178|NCT01757821|Stroke|stroke
279179|NCT01757821|rTMS|rtms
279180|NCT01757821|TMS|tms
279181|NCT01757808|PAH|pah
279182|NCT01757808|Ranolazine|ranolazine
279183|NCT01757808|right ventricle|right ventricle
279184|NCT01757808|Safety|safety
279185|NCT01757808|cardiopulmonary exercise testing|cardiopulmonary exercise testing
279186|NCT01757795|acute ischemic stroke|acute ischemic stroke
279187|NCT01757795|ischemic stroke|ischemic stroke
279188|NCT01757795|stroke|stroke
279189|NCT01757769|Lower urinary tract symptoms|lower urinary tract symptoms
279190|NCT01757769|benign prostatic hyperplasia|benign prostatic hyperplasia
279191|NCT01757743|Heart Septal Defects, Atrial|heart septal defects, atrial
279192|NCT01757743|Oedema formation|oedema formation
279193|NCT01757717|radiation therapy|radiation therapy
279194|NCT01757717|HDR brachytherapy|hdr brachytherapy
279195|NCT01757717|Ir-192 high dose rate|ir-192 high dose rate
279197|NCT01757704|Cardiac de-airing|cardiac de-airing
279198|NCT01757704|Air emboli|air emboli
279199|NCT01757704|Trans-cranial Echo-Doppler|trans-cranial echo-doppler
279200|NCT01757704|Intraoperative Trans-esophageal Echocardiography|intraoperative trans-esophageal echocardiography
279201|NCT01757691|Acute demyelinating optic neuritis|acute demyelinating optic neuritis
279202|NCT01757691|Optic neuritis|optic neuritis
279203|NCT01757665|Aortic valve replacement|aortic valve replacement
279204|NCT01757665|Mitral valve replacement|mitral valve replacement
279205|NCT01757626|Bone Marrow|bone marrow
279206|NCT01757626|Hu3F8|hu3f8
279207|NCT01757626|GM-CSF|gm-csf
279214|NCT01757574|demyelinating neuropathy|demyelinating neuropathy
279215|NCT01757574|alemtuzumab|alemtuzumab
279216|NCT01757561|jugular bulb oxygen saturation|jugular bulb oxygen saturation
279217|NCT01757561|postoperative cognitive dysfunction|postoperative cognitive dysfunction
279218|NCT01757561|propofol|propofol
279219|NCT01757561|sevoflurane|sevoflurane
279220|NCT01757548|varicocele; male infertile;varicocelectomy|varicocele; male infertile;varicocelectomy
279227|NCT01757509|Parkinson's disease|parkinson's disease
279228|NCT01757509|Set dancing|set dancing
279229|NCT01757496|Bronchiolitis|bronchiolitis
279230|NCT01757496|Respiratory Syncytial Virus|respiratory syncytial virus
279231|NCT01757496|Cough Assist|cough assist
279232|NCT01757496|Physiotherapy|physiotherapy
279233|NCT01757470|effectiveness of risk mitigation,|effectiveness of risk mitigation,
279234|NCT01757470|knowledge and understanding survey,|knowledge and understanding survey,
279235|NCT01757470|drug utilisation study,|drug utilisation study,
279236|NCT01757470|post marketing commitments|post marketing commitments
279237|NCT01757457|inflammation|inflammation
279238|NCT01757457|thrombosis|thrombosis
279239|NCT01757457|platelets|platelets
279240|NCT01757457|adhesion molecules|adhesion molecules
279241|NCT01757457|endothelium|endothelium
279242|NCT01757418|Sickle Cell Disease|sickle cell disease
279243|NCT01757418|Pain|pain
279244|NCT01757418|Immune Globulin|immune globulin
279245|NCT01757405|with Factor VIII (FVIII) or Factor IX (FIX) inhibitors|with factor viii (fviii) or factor ix (fix) inhibitors
279246|NCT01757392|Treatment|treatment
279247|NCT01757392|common wart lesions|common wart lesions
279248|NCT01757392|(verruca vulgaris)|(verruca vulgaris)
279249|NCT01757379|Short chain fatty acids|short chain fatty acids
279250|NCT01757379|Acetate|acetate
279251|NCT01757379|Propionate|propionate
279252|NCT01757379|Butyrate|butyrate
279253|NCT01757379|Bioavailability|bioavailability
279254|NCT01757314|arterial lines|arterial lines
279255|NCT01757301|Pain|pain
279256|NCT01757301|Depression|depression
279257|NCT01757301|Anxiety|anxiety
279258|NCT01757301|Musculoskeletal|musculoskeletal
279259|NCT01757301|Fibromyalgia|fibromyalgia
279463|NCT01756339|CAP|cap
279260|NCT01757288|STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER|stage iiia/b nsclc / inoperable lung cancer
279261|NCT01757275|peptic ulcer bleeding|peptic ulcer bleeding
279262|NCT01757275|prevention of rebleeding|prevention of rebleeding
279263|NCT01757275|successful endoscopic haemostatic therapy|successful endoscopic haemostatic therapy
279264|NCT01757262|Coronary Heart Disease|coronary heart disease
279265|NCT01757236|Antibiotic|antibiotic
279266|NCT01757236|linezolid|linezolid
279267|NCT01757236|linezolid/rifampin|linezolid/rifampin
279268|NCT01757223|Diffuse Coronary Artery Disease (CAD)|diffuse coronary artery disease (cad)
279269|NCT01757210|Aprepitant|aprepitant
279270|NCT01757210|Pediatrics|pediatrics
279271|NCT01757210|Chemotherapy-induced nausea/vomiting|chemotherapy-induced nausea/vomiting
279272|NCT01757210|Survey|survey
279273|NCT01757184|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
279274|NCT01757184|Lysosomal Storage Disease|lysosomal storage disease
279275|NCT01757184|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
279276|NCT01757184|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
279277|NCT01757184|Acid lipase disease|acid lipase disease
279278|NCT01757184|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
279279|NCT01757184|LAL Deficiency|lal deficiency
279280|NCT01757184|LIPA Deficiency|lipa deficiency
279281|NCT01757184|Wolman disease|wolman disease
279282|NCT01757171|Gastric Cancer|gastric cancer
279283|NCT01757158|lung cancer|lung cancer
279284|NCT01757158|lobectomy|lobectomy
279285|NCT01757158|local recurrence|local recurrence
279286|NCT01757145|Cord blood transplantation|cord blood transplantation
279287|NCT01757145|Eltrombopag|eltrombopag
279288|NCT01757145|Platelet engraftment|platelet engraftment
279289|NCT01757106|xenon anesthesia|xenon anesthesia
279290|NCT01757106|sevoflurane anesthesia|sevoflurane anesthesia
279291|NCT01757106|off-pump coronary artery bypass graft surgery|off-pump coronary artery bypass graft surgery
279292|NCT01757093|INDIRECT CALORIMETRY|indirect calorimetry
279293|NCT01757093|MECHANICAL VENTILATION|mechanical ventilation
279294|NCT01757093|WEANING VENTILATOR|weaning ventilator
279295|NCT01757093|AUTOMATIC TUBE COMPENSATION|automatic tube compensation
279296|NCT01757067|ablations|ablations
279297|NCT01757067|CHF|chf
279298|NCT01757067|PVC|pvc
279299|NCT01757054|probiotic|probiotic
279300|NCT01757054|LGG|lgg
279301|NCT01757054|BB-12|bb-12
279302|NCT01757054|fecal recovery|fecal recovery
279303|NCT01757054|healthy subjects|healthy subjects
279304|NCT01757041|Streptococcus agalactiae|streptococcus agalactiae
279305|NCT01757041|Maternal|maternal
279306|NCT01757041|Newborn|newborn
279307|NCT01757041|Africa|africa
279308|NCT01757028|Maternal and newborn health|maternal and newborn health
279309|NCT01757028|Africa|africa
279310|NCT01757015|COPD|copd
279311|NCT01757015|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
279312|NCT01757015|Moderate to severe airflow limitation|moderate to severe airflow limitation
6051|NCT03252470|3D laparascopic surgery|3d laparascopic surgery
279313|NCT01757015|GOLD spirometric classification 2 and 3|gold spirometric classification 2 and 3
279314|NCT01757015|GOLD group B and D|gold group b and d
279315|NCT01757015|NVA237|nva237
279316|NCT01757015|Salmeterol fluticasone propionate|salmeterol fluticasone propionate
279317|NCT01757002|Urban adolescents|urban adolescents
279318|NCT01757002|Acute asthma|acute asthma
279319|NCT01757002|Asthma|asthma
279320|NCT01757002|Computer tailoring|computer tailoring
279321|NCT01757002|Web-based intervention|web-based intervention
279322|NCT01757002|Puff City|puff city
279323|NCT01756950|Influenza|influenza
279324|NCT01756950|Virus|virus
279325|NCT01756950|Monoclonal|monoclonal
279326|NCT01756950|Antibody|antibody
279327|NCT01756950|Immunization|immunization
279328|NCT01756950|Treatment|treatment
279329|NCT01756937|osteoarthritis of the knee|osteoarthritis of the knee
279330|NCT01756924|prosthetic joint infection|prosthetic joint infection
279331|NCT01756924|hip arthroplasty|hip arthroplasty
279332|NCT01756924|MRSA|mrsa
279333|NCT01756924|knee arthroplasty|knee arthroplasty
279334|NCT01756911|MFM|mfm
279335|NCT01756911|Multilayer Flow Modulator|multilayer flow modulator
279336|NCT01756911|Multilayer stent|multilayer stent
279337|NCT01756911|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
279338|NCT01756898|Atopic Dermatitis|atopic dermatitis
279339|NCT01756898|eczema|eczema
279340|NCT01756885|Smoking cessation|smoking cessation
279341|NCT01756885|Nicotine dependence|nicotine dependence
279342|NCT01756885|Varenicline|varenicline
279343|NCT01756885|Chantix|chantix
279344|NCT01756885|Cancer|cancer
279345|NCT01756872|infertility|infertility
279346|NCT01756872|Assisted reproductive technology|assisted reproductive technology
279347|NCT01756872|ovarian reserve|ovarian reserve
279348|NCT01756859|Portal hypertension|portal hypertension
279349|NCT01756859|HVPG|hvpg
279350|NCT01756859|MRI|mri
279351|NCT01756846|HEART score|heart score
279352|NCT01756846|risk score|risk score
279353|NCT01756846|impact|impact
279354|NCT01756846|chest pain|chest pain
279355|NCT01756833|abdominal|abdominal
279356|NCT01756833|aortic|aortic
279357|NCT01756833|aneurysm|aneurysm
279358|NCT01756820|Carpal Tunnel Syndrome|carpal tunnel syndrome
279359|NCT01756820|transverse ligament|transverse ligament
279360|NCT01756820|carpal tunnel release|carpal tunnel release
279361|NCT01756820|endoscopic|endoscopic
279362|NCT01756820|minimal invasive|minimal invasive
279363|NCT01756820|mini-open|mini-open
279364|NCT01756820|median nerve|median nerve
279365|NCT01756807|Optical Coherence Tomography|optical coherence tomography
279366|NCT01756807|Geneous Stent|geneous stent
279367|NCT01756807|Combo Stent|combo stent
279368|NCT01756794|Alcoholic hepatitis|alcoholic hepatitis
279369|NCT01756794|Liver transplantation|liver transplantation
279370|NCT01756794|Alcohol relapse|alcohol relapse
279371|NCT01756794|Alcoholic cirrhosis|alcoholic cirrhosis
279372|NCT01756781|PD-0332991|pd-0332991
279373|NCT01756781|Midazolam|midazolam
279374|NCT01756781|Drug-Drug Interaction Study|drug-drug interaction study
279375|NCT01756781|Healthy Adult Volunteer|healthy adult volunteer
279376|NCT01756768|Phase 1|phase 1
279377|NCT01756768|Mass Balance study|mass balance study
279378|NCT01756768|Radio-labeled dose|radio-labeled dose
279379|NCT01756768|PD-0332991|pd-0332991
279380|NCT01756755|Sepsis|sepsis
279381|NCT01756742|Pleural Effusion|pleural effusion
279382|NCT01756742|Respiratory physiotherapy|respiratory physiotherapy
279383|NCT01756742|Length of stay|length of stay
279384|NCT01756729|Brain tumor|brain tumor
279385|NCT01756729|Treatment|treatment
279386|NCT01756729|Minimal toxicity|minimal toxicity
279387|NCT01756729|GBM|gbm
345419|NCT01468935|HV|hv
279388|NCT01756729|Glioblastoma|glioblastoma
279389|NCT01756729|Recurrent|recurrent
279390|NCT01756729|TTFields|ttfields
279391|NCT01756716|Diabetic Nephropathy|diabetic nephropathy
279392|NCT01756703|Diabetic Nephropathy|diabetic nephropathy
279393|NCT01756690|respiratory distress syndrome, adult|respiratory distress syndrome, adult
279394|NCT01756690|blood component transfusion|blood component transfusion
279395|NCT01756690|gastrointestinal hemorrhage|gastrointestinal hemorrhage
279396|NCT01756690|blood coagulation|blood coagulation
279397|NCT01756651|Intranasal fentanyl|intranasal fentanyl
279398|NCT01756651|Cystoscopy|cystoscopy
279399|NCT01756638|Prostate cancer|prostate cancer
279400|NCT01756638|Abiraterone acetate|abiraterone acetate
279401|NCT01756638|JNJ-212082|jnj-212082
279402|NCT01756625|cetuximab|cetuximab
279404|NCT01756625|magnesium|magnesium
279405|NCT01756586|popliteal block|popliteal block
279406|NCT01756586|analgesia duration|analgesia duration
279407|NCT01756573|block duration|block duration
279408|NCT01756573|analgesia|analgesia
279409|NCT01756560|anterior cruciate ligament|anterior cruciate ligament
279410|NCT01756560|block duration|block duration
279411|NCT01756547|Nephrocalcinosis|nephrocalcinosis
279412|NCT01756547|Extreme premature|extreme premature
279413|NCT01756521|QT,|qt,
279414|NCT01756521|QTc,|qtc,
279415|NCT01756521|electrocardiogram,|electrocardiogram,
279416|NCT01756521|moxifloxacin|moxifloxacin
279417|NCT01756508|eculizumab|eculizumab
279418|NCT01756508|kidney transplantation|kidney transplantation
279419|NCT01756508|reperfusion|reperfusion
279420|NCT01756508|rejection|rejection
279421|NCT01756508|infection|infection
279422|NCT01756495|QTc,|qtc,
279423|NCT01756495|GW856553 .|gw856553 .
279424|NCT01756495|P38,|p38,
279425|NCT01756482|Respiratory|respiratory
279426|NCT01756482|Syncytial|syncytial
279427|NCT01756482|Virus|virus
279428|NCT01756482|Infections|infections
279430|NCT01756456|Keratitis|keratitis
279431|NCT01756456|Corneal Ulcer|corneal ulcer
279432|NCT01756443|sciatic nerve block|sciatic nerve block
279433|NCT01756443|ORIF lateral malleolus|orif lateral malleolus
279434|NCT01756443|sequential injection|sequential injection
279435|NCT01756443|premixed injection|premixed injection
279436|NCT01756443|local anaesthetics|local anaesthetics
279437|NCT01756430|Carvedilol SR|carvedilol sr
279438|NCT01756430|Carvedilol IR|carvedilol ir
279439|NCT01756430|Hypertension|hypertension
279440|NCT01756430|Essential Hypertension|essential hypertension
279441|NCT01756417|Healthy|healthy
279442|NCT01756417|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
279443|NCT01756417|Metformin|metformin
279444|NCT01756417|Pharmacokinetics|pharmacokinetics
279445|NCT01756417|Pharmacodynamics|pharmacodynamics
279446|NCT01756404|Healthy|healthy
279447|NCT01756404|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
279448|NCT01756404|Pharmacokinetics|pharmacokinetics
279449|NCT01756404|Pharmacodynamics|pharmacodynamics
279450|NCT01756404|Obesity|obesity
279451|NCT01756391|pediatric|pediatric
279452|NCT01756391|childhood|childhood
279453|NCT01756391|allergy|allergy
279454|NCT01756378|Mobilization with movement,knee osteoarthritis,|mobilization with movement,knee osteoarthritis,
279455|NCT01756352|FET|fet
279456|NCT01756352|Fluoroethyl tyrosine|fluoroethyl tyrosine
279457|NCT01756352|GBM|gbm
279458|NCT01756352|Response to treatment|response to treatment
279459|NCT01756352|Avastin|avastin
279460|NCT01756352|Brain Tumor|brain tumor
279461|NCT01756339|Pneumonia|pneumonia
279462|NCT01756339|CABP|cabp
279464|NCT01756339|Macrolide|macrolide
279465|NCT01756326|Non-Union Fractures|non-union fractures
279466|NCT01756326|Impaired Healing|impaired healing
279467|NCT01756326|Fractures|fractures
279468|NCT01756326|Orthopedics|orthopedics
279470|NCT01756326|Musculoskeletal Disorders|musculoskeletal disorders
279471|NCT01756300|Essential Hypertension|essential hypertension
279472|NCT01756300|Renal Denervation|renal denervation
279473|NCT01756300|Vascular Disease|vascular disease
279474|NCT01756300|Renal Catheter Ablation|renal catheter ablation
279475|NCT01756300|Primary Hypertension|primary hypertension
279476|NCT01756261|EYLEA|eylea
279477|NCT01756261|Age-Related Macular Degeneration|age-related macular degeneration
279478|NCT01756261|QOL|qol
279479|NCT01756248|EYLEA|eylea
279480|NCT01756248|Age-Related Macular Degeneration|age-related macular degeneration
279481|NCT01756235|Post-marketing observational study (PMOS) Protocol|post-marketing observational study (pmos) protocol
279482|NCT01756235|Rheumatoid Arthritis|rheumatoid arthritis
279483|NCT01756235|Physical Activity|physical activity
279484|NCT01756235|Adalimumab|adalimumab
279485|NCT01756235|Humira®|humira®
279486|NCT01756222|Bicuspid Aortic Valve Disease|bicuspid aortic valve disease
279487|NCT01756222|Bicuspid Aortic Valve|bicuspid aortic valve
279488|NCT01756222|BAV|bav
402985|NCT01228734|Metastatic colorectal cancer|metastatic colorectal cancer
402986|NCT01228734|RAS wild type|ras wild type
279489|NCT01756196|Spinal injection; Steroid; Systemic reaction; Complication; Side effect; Diabetes mellitus; Hypertension; Risk factor|spinal injection; steroid; systemic reaction; complication; side effect; diabetes mellitus; hypertension; risk factor
279490|NCT01756170|cervical cancer|cervical cancer
279491|NCT01756170|radiotherapy|radiotherapy
279492|NCT01756170|postoperative therapy|postoperative therapy
279493|NCT01756170|chemotherapy|chemotherapy
279494|NCT01756157|Crossover|crossover
279495|NCT01756157|Prevention|prevention
279496|NCT01756157|Hereditary Angioedema|hereditary angioedema
279497|NCT01756157|C1 esterase inhibitor|c1 esterase inhibitor
279498|NCT01756157|C1 inhibitor|c1 inhibitor
279499|NCT01756157|Subcutaneous|subcutaneous
279500|NCT01756157|Recombinant human hyaluronidase|recombinant human hyaluronidase
279501|NCT01756092|Breast Cancer|breast cancer
279502|NCT01756092|Lumpectomy|lumpectomy
279503|NCT01756092|Mastectomy, Segmental|mastectomy, segmental
279504|NCT01756066|Obesity|obesity
279505|NCT01756066|Weight loss program|weight loss program
279506|NCT01756066|incentives|incentives
279507|NCT01756053|Smoking|smoking
279508|NCT01756053|Tobacco|tobacco
279509|NCT01756040|intestinal permeability|intestinal permeability
279510|NCT01756040|preterm infants|preterm infants
279511|NCT01756040|dual sugar test|dual sugar test
279512|NCT01756027|Rosacea|rosacea
279513|NCT01756027|Ulthera System|ulthera system
279514|NCT01756027|Ultherapy™ Treatment|ultherapy™ treatment
279515|NCT01756027|Ulthera, Inc.|ulthera, inc.
279516|NCT01756027|Ultrasound treatment for the skin|ultrasound treatment for the skin
279517|NCT01755988|Telemedicine|telemedicine
279518|NCT01755988|Heart Failure|heart failure
279519|NCT01755988|Self care|self care
279520|NCT01755988|Quality of life|quality of life
279521|NCT01755988|Mortality|mortality
279522|NCT01755988|Hospitalization|hospitalization
279523|NCT01755975|LENALIDOMIDE (CC-5013)|lenalidomide (cc-5013)
279524|NCT01755975|Romidepsin (Istodax)|romidepsin (istodax)
279525|NCT01755975|12-170|12-170
279526|NCT01755962|diet|diet
279527|NCT01755962|obese|obese
279528|NCT01755962|overweight|overweight
279529|NCT01755962|exercise|exercise
279530|NCT01755962|resistance training|resistance training
279531|NCT01755962|nutrition|nutrition
279532|NCT01755962|glycemic load|glycemic load
279533|NCT01755962|body composition|body composition
279534|NCT01755962|weight training|weight training
279535|NCT01755962|lifestyle|lifestyle
279536|NCT01755949|atrial fibrillation|atrial fibrillation
279537|NCT01755949|catheter ablation|catheter ablation
279538|NCT01755949|colchicine|colchicine
279539|NCT01755949|c reactive protein|c reactive protein
279541|NCT01755936|Aortic Stenosis|aortic stenosis
279542|NCT01755936|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
279543|NCT01755936|Late Gadolinium enhancement|late gadolinium enhancement
279544|NCT01755936|T1 mapping techniques|t1 mapping techniques
279545|NCT01755936|Replacement fibrosis|replacement fibrosis
279546|NCT01755936|Diffuse interstitial fibrosis|diffuse interstitial fibrosis
279547|NCT01755923|non-small cell lung cancer|non-small cell lung cancer
279548|NCT01755923|wild-type EGFR|wild-type egfr
279549|NCT01755923|gefitinib|gefitinib
279550|NCT01755923|docetaxel|docetaxel
279551|NCT01755923|second-line therapy|second-line therapy
279552|NCT01755910|Breast Surgery|breast surgery
279553|NCT01755910|Thoracic Paravertebral Block|thoracic paravertebral block
279554|NCT01755910|HRV|hrv
279555|NCT01755910|Autonomic Nervous System|autonomic nervous system
279556|NCT01755884|Wheat allergy|wheat allergy
279557|NCT01755884|Immunotherapy|immunotherapy
279558|NCT01755884|Desensitization|desensitization
279559|NCT01755884|Food allergy|food allergy
279560|NCT01755884|T cells|t cells
279561|NCT01755858|elamipretide|elamipretide
279562|NCT01755845|cervical cancer|cervical cancer
279563|NCT01755845|radiotherapy|radiotherapy
279564|NCT01755845|postoperative therapy|postoperative therapy
279565|NCT01755845|chemotherapy|chemotherapy
279566|NCT01755832|inflammatory rheumatic joint disease|inflammatory rheumatic joint disease
279567|NCT01755832|text message|text message
279568|NCT01755832|> 18 years|> 18 years
279569|NCT01755832|Norwegian speaking|norwegian speaking
279570|NCT01755806|Aortic annulus|aortic annulus
279571|NCT01755806|Aortic calcification|aortic calcification
279572|NCT01755806|Multislice computed tomography|multislice computed tomography
279573|NCT01755806|Cardiac cycle|cardiac cycle
279574|NCT01755767|MET diagnostic-high|met diagnostic-high
279575|NCT01755767|Unresectable|unresectable
279576|NCT01755767|Hepatocellular|hepatocellular
279577|NCT01755767|Carcinoma|carcinoma
279578|NCT01755767|c-Met inhibitor|c-met inhibitor
279579|NCT01755728|Paracetamol|paracetamol
279580|NCT01755728|Acetaminophen|acetaminophen
279581|NCT01755728|PDA|pda
279582|NCT01755728|Preterm infants|preterm infants
279583|NCT01755715|Abortion|abortion
279584|NCT01755715|Contraception|contraception
279585|NCT01755715|Intrauterine Devices|intrauterine devices
279586|NCT01755715|Intrauterine Device Expulsion|intrauterine device expulsion
279587|NCT01755702|caffeine|caffeine
279588|NCT01755702|paracetamol|paracetamol
270171|NCT01798550|Obesity|obesity
279589|NCT01755702|tension headache|tension headache
279590|NCT01755689|pertussis|pertussis
279591|NCT01755689|Meningococcal meningitis|meningococcal meningitis
279592|NCT01755689|Meningococcal infections|meningococcal infections
279593|NCT01755689|HPV|hpv
279594|NCT01755689|Neisseria meningitidis|neisseria meningitidis
279595|NCT01755689|Vaccines, conjugate|vaccines, conjugate
279596|NCT01755689|tetanus|tetanus
279597|NCT01755689|diphtheria|diphtheria
279598|NCT01755689|Meningococcal vaccines|meningococcal vaccines
279599|NCT01755689|Immunogenicity|immunogenicity
279600|NCT01755663|CT coronary|ct coronary
279601|NCT01755663|Coronary arterial disease|coronary arterial disease
279602|NCT01755663|ivabradine|ivabradine
279603|NCT01755663|metoprolol|metoprolol
279604|NCT01755650|18F FPM|18f fpm
279605|NCT01755650|PET/CT|pet/ct
279606|NCT01755650|microdosing|microdosing
279607|NCT01755624|Non-Small Cell Lung Cancer|non-small cell lung cancer
279608|NCT01755624|NSCLC|nsclc
279609|NCT01755624|Brain metastases|brain metastases
279610|NCT01755624|Treatment|treatment
279611|NCT01755624|Minimal toxicity|minimal toxicity
279612|NCT01755624|TTFields|ttfields
279613|NCT01755624|TTF|ttf
279614|NCT01755624|Tumor Treating Fields|tumor treating fields
279615|NCT01755624|NovoCure|novocure
279616|NCT01755611|Minocycline|minocycline
279617|NCT01755611|Mexico|mexico
279618|NCT01755611|Acne|acne
279619|NCT01755611|bioequivalence|bioequivalence
279620|NCT01755598|Positive Interferon-γ release assay|positive interferon-γ release assay
279621|NCT01755598|Efficacy|efficacy
279622|NCT01755598|Adults|adults
279623|NCT01755598|Tuberculosis vaccine|tuberculosis vaccine
279624|NCT01755598|Endemic region|endemic region
279625|NCT01755585|Radiation therapy|radiation therapy
279626|NCT01755585|5-fluorouracil|5-fluorouracil
279627|NCT01755585|Cisplatin|cisplatin
279628|NCT01755585|Pharmacokinetics|pharmacokinetics
279629|NCT01755585|Matrix Metalloproteinase|matrix metalloproteinase
279630|NCT01755572|Type 2 Diabetes|type 2 diabetes
279631|NCT01755572|Hypertension|hypertension
279632|NCT01755572|Liraglutide|liraglutide
279633|NCT01755572|GLP-1|glp-1
279634|NCT01755559|malaria|malaria
279635|NCT01755559|artemisinin|artemisinin
279636|NCT01755559|artemisinin-based combination therapies|artemisinin-based combination therapies
279637|NCT01755559|Plasmodium falciparum|plasmodium falciparum
279638|NCT01755559|efficacy|efficacy
279639|NCT01755546|Chronic Pain|chronic pain
279640|NCT01755546|CLBP|clbp
279641|NCT01755546|Chronic Low Back Pain|chronic low back pain
279642|NCT01755546|Back Pain|back pain
279643|NCT01755546|Osteoarthritis|osteoarthritis
279645|NCT01755546|Neuropathic Pain|neuropathic pain
279646|NCT01755546|Nerve pain|nerve pain
279647|NCT01755546|Painful neuropathy|painful neuropathy
279648|NCT01755533|adolescent substance use|adolescent substance use
279649|NCT01755533|rural substance use|rural substance use
279650|NCT01755533|middle school prevention|middle school prevention
279651|NCT01755533|implementation processes|implementation processes
279652|NCT01755533|implementation quality|implementation quality
279653|NCT01755533|adaptation of prevention curricula|adaptation of prevention curricula
279654|NCT01755533|dissemination|dissemination
279655|NCT01755520|CABG|cabg
279656|NCT01755520|CAD|cad
279657|NCT01755520|antiplatelet drug|antiplatelet drug
279658|NCT01755520|Ticagrelor|ticagrelor
279659|NCT01755520|Aspirin|aspirin
279660|NCT01755507|PSC|psc
279661|NCT01755494|Type 2 diabetes, Saxagliptin, Metformin,Fixed dose combination tablet, Bioequivalence, pharmacokinetic, safety, tolerability|type 2 diabetes, saxagliptin, metformin,fixed dose combination tablet, bioequivalence, pharmacokinetic, safety, tolerability
279662|NCT01755468|beta-cell function, type 2 diabetes, intermittent insulin|beta-cell function, type 2 diabetes, intermittent insulin
279663|NCT01755455|Cystic fibrosis|cystic fibrosis
279664|NCT01755455|Iron|iron
279665|NCT01755455|Hepcidin|hepcidin
279666|NCT01755455|Anemia|anemia
279667|NCT01755455|Erythropoiesis|erythropoiesis
279668|NCT01755442|Ambulatory blood pressure|ambulatory blood pressure
279669|NCT01755442|Type 2 diabetes|type 2 diabetes
279670|NCT01755416|Type 1 diabetes|type 1 diabetes
279671|NCT01755416|closed loop|closed loop
279672|NCT01755416|artificial pancreas|artificial pancreas
279673|NCT01755416|insulin|insulin
279674|NCT01755416|victoza|victoza
279675|NCT01755416|liraglutide|liraglutide
279676|NCT01755338|cerebrospinal fluid|cerebrospinal fluid
279677|NCT01755338|inflammatory markers|inflammatory markers
279678|NCT01755338|heart surgery|heart surgery
279679|NCT01755338|neuronal damage|neuronal damage
279680|NCT01755338|blood brain barrier|blood brain barrier
279681|NCT01755299|Energy drinks|energy drinks
279682|NCT01755299|Wakefulness|wakefulness
279683|NCT01755299|Caffeine|caffeine
279684|NCT01755273|Pancreaticoduodenectomy|pancreaticoduodenectomy
279685|NCT01755273|Diabetes|diabetes
279686|NCT01755260|POPF|popf
279687|NCT01755260|pancreaticoduodenectomy|pancreaticoduodenectomy
279688|NCT01755260|enteral nutrition|enteral nutrition
279689|NCT01755260|parenteral nutrition|parenteral nutrition
279690|NCT01755247|acne|acne
279691|NCT01755234|Outpatient|outpatient
279692|NCT01755234|Surgery|surgery
279693|NCT01755234|Anesthesia|anesthesia
279694|NCT01755221|Laryngopharyngeal reflux (LPR)|laryngopharyngeal reflux (lpr)
279695|NCT01755221|Extraesophageal reflux|extraesophageal reflux
279696|NCT01755221|Reflux laryngitis|reflux laryngitis
279697|NCT01755221|Posterior laryngitis|posterior laryngitis
279698|NCT01755221|Proton pump inhibitor (PPI) medication|proton pump inhibitor (ppi) medication
279699|NCT01755221|Restech pH probe|restech ph probe
279700|NCT01755195|Dual Inhibitor of MET and VEGFR|dual inhibitor of met and vegfr
279701|NCT01755195|XL184|xl184
279702|NCT01755195|Metastatic Refractory|metastatic refractory
697803|NCT00957801|Cytokines|cytokines
279703|NCT01755195|Soft Tissue Sarcoma|soft tissue sarcoma
279704|NCT01755195|Rare Heterogeneous Tumor|rare heterogeneous tumor
279705|NCT01755182|locoregional treatment|locoregional treatment
279706|NCT01755182|liver metastases|liver metastases
279707|NCT01755182|transarterial embolization|transarterial embolization
279708|NCT01755182|upfront treatment|upfront treatment
279709|NCT01755182|inoperable|inoperable
279710|NCT01755182|octreotide|octreotide
279711|NCT01755182|gastroenteropancreatic (GEP)primary|gastroenteropancreatic (gep)primary
279712|NCT01755182|pulmonary primary|pulmonary primary
279713|NCT01755182|primary unknown origin|primary unknown origin
279714|NCT01755182|systemic therapy|systemic therapy
279715|NCT01755169|Chronic pain|chronic pain
279716|NCT01755169|Child|child
279717|NCT01755169|Pediatric|pediatric
279718|NCT01755169|Ketamine|ketamine
279719|NCT01755130|Breast Cancer|breast cancer
279720|NCT01755130|LOUIS-3D|louis-3d
279721|NCT01755130|Breast Study|breast study
279722|NCT01755130|x-ray|x-ray
279723|NCT01755130|Multimode Laser Optoacoustic Ultrasonic Tomography System|multimode laser optoacoustic ultrasonic tomography system
279725|NCT01755130|Breast lesions|breast lesions
279726|NCT01755130|Ductal carcinomas|ductal carcinomas
279727|NCT01755130|Lobular carcinomas|lobular carcinomas
279728|NCT01755130|Fibroadenomas|fibroadenomas
279729|NCT01755078|Phosphate binder|phosphate binder
279730|NCT01755065|laparoscopic surgery|laparoscopic surgery
279731|NCT01755065|teenager|teenager
279732|NCT01755052|Acute Myocardial Infarction|acute myocardial infarction
279733|NCT01755052|Geriatrics|geriatrics
279734|NCT01755052|Cardiology|cardiology
279735|NCT01755052|Aging|aging
279736|NCT01755052|Heart Attack|heart attack
279737|NCT01755052|Risk Factors|risk factors
279738|NCT01755052|Quality of Care|quality of care
279739|NCT01755052|Risk Models|risk models
279740|NCT01755026|Cesarean Delivery|cesarean delivery
279741|NCT01755026|Wound infection|wound infection
279742|NCT01755026|Obesity|obesity
279743|NCT01755026|Prophylactic antibiotics|prophylactic antibiotics
279744|NCT01755013|Cholangiocarcinoma|cholangiocarcinoma
279745|NCT01755013|Biliary Stricture|biliary stricture
279746|NCT01755013|Biliary obstruction|biliary obstruction
279747|NCT01755013|Bile Duct Cancer|bile duct cancer
279748|NCT01755013|PDT|pdt
279749|NCT01755013|Photodynamic Therapy|photodynamic therapy
279750|NCT01755013|Plastic optic Diffuser|plastic optic diffuser
279751|NCT01755013|Laser|laser
279752|NCT01754987|Vitamins|vitamins
279753|NCT01754987|Malignant Tumor, Tumour|malignant tumor, tumour
279754|NCT01754987|Integrative Medicine|integrative medicine
279755|NCT01754987|Complementary Medicine|complementary medicine
279756|NCT01754987|Alternative Medicine Antioxidants|alternative medicine antioxidants
279757|NCT01754987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
279758|NCT01754987|Pharmacologic Actions|pharmacologic actions
279759|NCT01754987|Protective Agents|protective agents
279760|NCT01754987|Physiological Effects of Drugs|physiological effects of drugs
279761|NCT01754987|Micronutrients|micronutrients
279762|NCT01754987|Growth Substances|growth substances
279862|NCT01754532|Stress|stress
279763|NCT01754987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
279764|NCT01754987|Antineoplastic Agents|antineoplastic agents
279765|NCT01754987|Therapeutic Uses|therapeutic uses
279766|NCT01754987|Radiation-Sensitizing Agents|radiation-sensitizing agents
279767|NCT01754987|Liver Cancer|liver cancer
279768|NCT01754948|asthma|asthma
279769|NCT01754948|reactive airway disease|reactive airway disease
279770|NCT01754948|cough|cough
279771|NCT01754948|air pollution|air pollution
279772|NCT01754948|nano particles|nano particles
279773|NCT01754922|exercise tolerance|exercise tolerance
279774|NCT01754922|Veterans|veterans
279775|NCT01754922|operation enduring freedom|operation enduring freedom
279776|NCT01754922|operation Iraqi freedom|operation iraqi freedom
279777|NCT01754909|lung cancer|lung cancer
279778|NCT01754909|radiation pneumonitis|radiation pneumonitis
279779|NCT01754909|mitigation|mitigation
279780|NCT01754909|enalapril|enalapril
279781|NCT01754909|placebo|placebo
279782|NCT01754896|colorectal cancer|colorectal cancer
279783|NCT01754896|fecal immunochemical test|fecal immunochemical test
270362|NCT01797614|weaning|weaning
279784|NCT01754896|fecal occult blood test|fecal occult blood test
279785|NCT01754896|screening|screening
279786|NCT01754883|Posttraumatic Stess Disorder|posttraumatic stess disorder
279787|NCT01754883|Lithium|lithium
279788|NCT01754870|CLL|cll
279789|NCT01754870|SLL|sll
279790|NCT01754857|Lymphoid Leukemia|lymphoid leukemia
279791|NCT01754857|Bendamustine|bendamustine
279792|NCT01754857|Rituximab|rituximab
279793|NCT01754857|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
279794|NCT01754844|Phase 1|phase 1
279795|NCT01754844|Healthy Volunteers|healthy volunteers
279796|NCT01754844|Single Ascending Dose (SAD)|single ascending dose (sad)
279797|NCT01754844|First Time in Man|first time in man
279798|NCT01754844|Pharmacokinetics|pharmacokinetics
279799|NCT01754844|Pharmacodynamics|pharmacodynamics
279800|NCT01754831|children|children
279801|NCT01754831|fluoride varnish|fluoride varnish
279802|NCT01754818|Pharmacokinetics|pharmacokinetics
279803|NCT01754818|volunteers|volunteers
279804|NCT01754805|ASP015K|asp015k
279805|NCT01754805|Rheumatoid Arthritis|rheumatoid arthritis
279806|NCT01754779|calcium phosphate|calcium phosphate
279807|NCT01754779|urolithiasis|urolithiasis
279808|NCT01754779|kidney stones|kidney stones
279809|NCT01754779|hypercalciuria|hypercalciuria
279810|NCT01754753|Mental well-being|mental well-being
279811|NCT01754753|Befriending|befriending
279812|NCT01754740|Xerostomia, Salivary flow, Burning Mouth Syndrome.|xerostomia, salivary flow, burning mouth syndrome.
279813|NCT01754727|Ankylosing Spondylitis|ankylosing spondylitis
279814|NCT01754727|Effectiveness|effectiveness
279815|NCT01754727|Post-marketing observational study (PMOS)|post-marketing observational study (pmos)
279816|NCT01754727|Adalimumab|adalimumab
279817|NCT01754727|Humira®|humira®
279818|NCT01754714|Steatohepatitis|steatohepatitis
279819|NCT01754662|Type 2 diabetes|type 2 diabetes
279820|NCT01754662|Cardiovascular risk|cardiovascular risk
279821|NCT01754662|Endothelial function|endothelial function
279822|NCT01754662|Insulin resistance|insulin resistance
279823|NCT01754662|Soy|soy
279824|NCT01754662|Isoflavones|isoflavones
279825|NCT01754662|Cocoa|cocoa
279826|NCT01754662|Diet|diet
279827|NCT01754649|intrauterine device|intrauterine device
279828|NCT01754649|insertion failure|insertion failure
279829|NCT01754636|Colorectal neoplasms|colorectal neoplasms
279830|NCT01754636|Elderly|elderly
279831|NCT01754636|Randomized clinical trials|randomized clinical trials
279832|NCT01754636|Inclusion.|inclusion.
279833|NCT01754623|Pancreas|pancreas
279834|NCT01754623|Pancreatic|pancreatic
279835|NCT01754623|Neoplasms|neoplasms
279836|NCT01754623|Stereotactic|stereotactic
279837|NCT01754623|Radiosurgery|radiosurgery
279838|NCT01754623|Borderline|borderline
279839|NCT01754623|Resectable|resectable
279840|NCT01754623|Gastrointestinal|gastrointestinal
279841|NCT01754623|Gemcitabine|gemcitabine
279842|NCT01754623|Capecitabine|capecitabine
279843|NCT01754623|Fluorouracil|fluorouracil
279844|NCT01754623|Docetaxel|docetaxel
279845|NCT01754623|SBRT|sbrt
279846|NCT01754623|GTX Chemotherapy|gtx chemotherapy
279847|NCT01754610|family trauma|family trauma
279848|NCT01754610|multi-family therapy|multi-family therapy
279849|NCT01754610|Posttraumatic Stress Disorder|posttraumatic stress disorder
279850|NCT01754610|poverty|poverty
279851|NCT01754597|Patients with breast cancer requiring surgical management with general anesthesia|patients with breast cancer requiring surgical management with general anesthesia
279852|NCT01754584|hyaluronan including concentrations|hyaluronan including concentrations
279853|NCT01754584|molecular weight|molecular weight
279854|NCT01754584|mucociliary differentiation|mucociliary differentiation
279855|NCT01754584|human respiratory epithelial cells|human respiratory epithelial cells
279856|NCT01754571|medication overuse headache|medication overuse headache
279857|NCT01754545|Infusions, Intravenous|infusions, intravenous
279858|NCT01754545|Plasma|plasma
279859|NCT01754545|ADAMTS-13 protein, human|adamts-13 protein, human
279860|NCT01754532|Schizophrenia|schizophrenia
279861|NCT01754532|Schizo-Affective Disorder|schizo-affective disorder
279863|NCT01754532|Cortisol|cortisol
279864|NCT01754532|PANSS|panss
279865|NCT01754506|leg ulcers|leg ulcers
279866|NCT01754506|wounds|wounds
279867|NCT01754506|fish oil|fish oil
279868|NCT01754506|lipid mediators|lipid mediators
279869|NCT01754506|chronic venous stasis ulcers|chronic venous stasis ulcers
279870|NCT01754493|Major Depression|major depression
279871|NCT01754493|Irritable Bowel Syndrome|irritable bowel syndrome
279872|NCT01754493|Somatization|somatization
279873|NCT01754493|Cymbalta|cymbalta
279874|NCT01754493|Duloxetine|duloxetine
279875|NCT01754480|Fibrin Sealant|fibrin sealant
279876|NCT01754480|Parenchymous tissue open surgery|parenchymous tissue open surgery
279877|NCT01754480|Hepatic Resection|hepatic resection
279878|NCT01754480|Oxidized cellulose pads|oxidized cellulose pads
279879|NCT01754441|Spinal Muscular Atrophy|spinal muscular atrophy
279880|NCT01754441|SMA|sma
279881|NCT01754441|Motor Neuron Abnormalities|motor neuron abnormalities
279882|NCT01754428|Respiratory|respiratory
279883|NCT01754428|Syncytial|syncytial
279884|NCT01754428|Virus|virus
279885|NCT01754428|RSV|rsv
279886|NCT01754415|Aging|aging
279887|NCT01754415|Chronic illness|chronic illness
279888|NCT01754415|Resistance circuit training|resistance circuit training
279889|NCT01754402|Multiple Myeloma|multiple myeloma
279890|NCT01754376|Metastatic|metastatic
279891|NCT01754376|Unresectable|unresectable
279892|NCT01754376|V600E mutation|v600e mutation
279893|NCT01754363|Osteoarthritis|osteoarthritis
279894|NCT01754350|ketogenic diet|ketogenic diet
279895|NCT01754350|glioma|glioma
279896|NCT01754350|fasting|fasting
279897|NCT01754350|reirradiation|reirradiation
279898|NCT01754350|nutrition|nutrition
279899|NCT01754337|Type 1 diabetes|type 1 diabetes
279900|NCT01754337|Hypoglycemia|hypoglycemia
279901|NCT01754337|Insulin|insulin
279902|NCT01754337|Glucagon|glucagon
279903|NCT01754337|Closed-loop system|closed-loop system
279904|NCT01754337|Artificial pancreas|artificial pancreas
279905|NCT01754324|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
279906|NCT01754324|Pharmacokinetics|pharmacokinetics
279907|NCT01754324|Methadone|methadone
279908|NCT01754324|Neonate|neonate
279909|NCT01754324|Newborn|newborn
279910|NCT01754311|HTLV-I|htlv-i
279911|NCT01754298|osteochondritis dissecans (OCD)|osteochondritis dissecans (ocd)
279912|NCT01754298|juvenile osteochondritis dissecans (JOCD)|juvenile osteochondritis dissecans (jocd)
279913|NCT01754298|knee osteochondritis dissecans|knee osteochondritis dissecans
279914|NCT01754298|retro-articular drilling|retro-articular drilling
279915|NCT01754298|trans-articular drilling|trans-articular drilling
279916|NCT01754298|stable osteochondritis dissecans lesion|stable osteochondritis dissecans lesion
279917|NCT01754272|metastatic colorectal cancer|metastatic colorectal cancer
279918|NCT01754272|mCRC|mcrc
279919|NCT01754272|Aflibercept|aflibercept
279920|NCT01754272|FOLFIRI|folfiri
279921|NCT01754272|translational research|translational research
279922|NCT01754272|retrospective|retrospective
279923|NCT01754272|noninterventional|noninterventional
279924|NCT01754272|biomarkers|biomarkers
279925|NCT01754272|angiogenesis|angiogenesis
279926|NCT01754259|type 1 diabetes|type 1 diabetes
279927|NCT01754259|type 2 diabetes|type 2 diabetes
279928|NCT01754259|exertion angina|exertion angina
279929|NCT01754259|suspected CAD|suspected cad
279930|NCT01754259|known CAD|known cad
279931|NCT01754194|Gastric Sleeve|gastric sleeve
279932|NCT01754194|Gastric Bypass|gastric bypass
279933|NCT01754194|Roux en Y|roux en y
279934|NCT01754194|Morbid Obesity|morbid obesity
279935|NCT01754194|Laparoscopy|laparoscopy
279936|NCT01754181|Glycemic control algorithm|glycemic control algorithm
279937|NCT01754181|closed loop|closed loop
279938|NCT01754181|artificial pancreas|artificial pancreas
279939|NCT01754168|Parkinson disease|parkinson disease
279940|NCT01754168|Cognition|cognition
279941|NCT01754155|Vitamin E|vitamin e
279942|NCT01754155|Zimmer|zimmer
279943|NCT01754155|RSA|rsa
279944|NCT01754155|Radiostereometric Analysis|radiostereometric analysis
279945|NCT01754129|Caregiver|caregiver
279946|NCT01754129|Quality of Life|quality of life
279947|NCT01754129|Parkinson's Disease|parkinson's disease
279948|NCT01754116|healthy subjects|healthy subjects
279949|NCT01754116|GSK1265744 LAP|gsk1265744 lap
279950|NCT01754116|integrase inhibitor|integrase inhibitor
279951|NCT01754116|HIV-1 infection|hiv-1 infection
279952|NCT01754116|long acting retroviral|long acting retroviral
279953|NCT01754116|relative bioavailability|relative bioavailability
279954|NCT01754103|blind|blind
279955|NCT01754103|tactile stimulation|tactile stimulation
279956|NCT01754103|cross-modality|cross-modality
279957|NCT01754103|visual qualia|visual qualia
279958|NCT01754103|resting state MRI|resting state mri
279959|NCT01754103|functional connectivity|functional connectivity
279960|NCT01754103|neuroplasticity|neuroplasticity
279961|NCT01754090|alcohol|alcohol
279962|NCT01754090|online intervention|online intervention
279963|NCT01754090|hazardous drinking|hazardous drinking
279964|NCT01754090|harmful drinking|harmful drinking
279965|NCT01754090|early intervention|early intervention
280271|NCT01752543|Conivaptan|conivaptan
279966|NCT01754090|behavior change intervention|behavior change intervention
279967|NCT01754077|Language|language
279968|NCT01754077|Behavior change|behavior change
279969|NCT01754077|Intervention|intervention
279970|NCT01754077|Home visiting|home visiting
279971|NCT01754077|Child language development|child language development
279972|NCT01754064|Bradycardia|bradycardia
279973|NCT01754064|Tachycardia|tachycardia
279974|NCT01754064|Arrhythimas|arrhythimas
279975|NCT01754064|ICD|icd
279976|NCT01754064|pacemaker|pacemaker
279977|NCT01754064|pacing lead|pacing lead
279978|NCT01754038|Patient Reported Outcomes|patient reported outcomes
279979|NCT01754038|PRO|pro
279980|NCT01754038|Registry|registry
279981|NCT01754025|Gene Mutation|gene mutation
279982|NCT01754012|Nutrition|nutrition
279983|NCT01754012|Dietary intervention|dietary intervention
279984|NCT01754012|Aging|aging
279985|NCT01754012|Inflammation|inflammation
270577|NCT01796717|MIC|mic
279986|NCT01754012|Elderly|elderly
279987|NCT01754012|Europe|europe
279988|NCT01753999|World Trade Center (WTC)|world trade center (wtc)
279989|NCT01753999|nasal symptoms|nasal symptoms
279990|NCT01753999|nasal inflammation|nasal inflammation
279991|NCT01753999|CPAP|cpap
279992|NCT01753973|Metabolic syndrome|metabolic syndrome
279993|NCT01753973|Renal transplantation|renal transplantation
279994|NCT01753895|Healthy Volunteers|healthy volunteers
279995|NCT01753882|Gait training|gait training
279996|NCT01753882|Lexapro|lexapro
279997|NCT01753882|Tizanidine|tizanidine
279998|NCT01753843|Preterm Birth|preterm birth
279999|NCT01753830|Double-blind|double-blind
280000|NCT01753830|Randomized|randomized
280001|NCT01753830|Intraarticular injection|intraarticular injection
280002|NCT01753830|Hyaluronic acid|hyaluronic acid
280003|NCT01753830|Placebo|placebo
280004|NCT01753830|Knee osteoarthritis|knee osteoarthritis
280005|NCT01753817|Coronary catheterization|coronary catheterization
280006|NCT01753817|Transradial patency|transradial patency
280007|NCT01753804|DMD|dmd
280008|NCT01753804|Myopathy|myopathy
280009|NCT01753804|Natural History|natural history
280010|NCT01753804|Muscular dystrophy|muscular dystrophy
280011|NCT01753804|Biomarkers|biomarkers
280012|NCT01753804|Muscle testing|muscle testing
280105|NCT01753141|Cognitive Behavioral Therapy|cognitive behavioral therapy
280013|NCT01753778|Nerve Entrapment, Morton's neuroma, entrapment neuropathy|nerve entrapment, morton's neuroma, entrapment neuropathy
280014|NCT01753765|occipital neuralgia|occipital neuralgia
280015|NCT01753726|stretching, diaphragm, spinal movement, thoracic movement|stretching, diaphragm, spinal movement, thoracic movement
280016|NCT01753700|crossover|crossover
280017|NCT01753700|UHT milk|uht milk
280018|NCT01753700|Pasteurised milk|pasteurised milk
280019|NCT01753700|supplement|supplement
280020|NCT01753687|break up time|break up time
280021|NCT01753687|tear film thickness|tear film thickness
280022|NCT01753687|tear film osmolarity|tear film osmolarity
280023|NCT01753687|objective scattering index|objective scattering index
280024|NCT01753687|impression cytology|impression cytology
280025|NCT01753687|tear cytokines/chemokines|tear cytokines/chemokines
280026|NCT01753687|visual acuity|visual acuity
280027|NCT01753687|fluorescein staining|fluorescein staining
280028|NCT01753674|metabolic syndrome, insulin resistance, HDL cholesterol,|metabolic syndrome, insulin resistance, hdl cholesterol,
280029|NCT01753661|Hearing loss|hearing loss
280030|NCT01753661|Language|language
280031|NCT01753661|Behavior change|behavior change
280032|NCT01753661|Early Intervention|early intervention
280033|NCT01753661|Home visiting|home visiting
280034|NCT01753648|retinal blood flow|retinal blood flow
280035|NCT01753648|retinal blood velocity|retinal blood velocity
280036|NCT01753648|retinal oxygen saturation|retinal oxygen saturation
280037|NCT01753648|retinal vessel diameter|retinal vessel diameter
280038|NCT01753648|ocular perfusion pressure|ocular perfusion pressure
280039|NCT01753635|Baska mask|baska mask
280040|NCT01753635|LMA|lma
280041|NCT01753635|single use LMA device|single use lma device
280042|NCT01753635|laryngeal mask airway|laryngeal mask airway
280043|NCT01753635|supraglottic airway device|supraglottic airway device
280044|NCT01753622|Overweight, obese, pregnant, depression, outcomes|overweight, obese, pregnant, depression, outcomes
280045|NCT01753609|Over weight|over weight
280046|NCT01753609|Obesity|obesity
280047|NCT01753596|topical lubricants|topical lubricants
280048|NCT01753596|tear film thickness|tear film thickness
280049|NCT01753596|break up time|break up time
280050|NCT01753596|ocular surface disease index|ocular surface disease index
280051|NCT01753596|Schirmer I test|schirmer i test
280052|NCT01753583|optical coherence tomography|optical coherence tomography
280053|NCT01753583|corneal abrasion|corneal abrasion
280054|NCT01753583|corneal infiltrate|corneal infiltrate
280055|NCT01753570|Feron|feron
280056|NCT01753557|Pegasys|pegasys
280057|NCT01753531|Ultra Influenza A and B|ultra influenza a and b
280058|NCT01753531|Influenza Type A|influenza type a
280059|NCT01753531|Influenza Type B|influenza type b
280060|NCT01753531|Flu|flu
280061|NCT01753531|Sekisui Diagnostics|sekisui diagnostics
280062|NCT01753518|Subcuticular suture|subcuticular suture
280063|NCT01753518|Subcuticular staple|subcuticular staple
280064|NCT01753518|Skin closure|skin closure
280272|NCT01752530|ADHD|adhd
280065|NCT01753518|Incision closure|incision closure
280066|NCT01753518|Wound|wound
280067|NCT01753505|multidetector coronary CT angiography, renal transplantation|multidetector coronary ct angiography, renal transplantation
280068|NCT01753492|Intraocular pressure|intraocular pressure
280069|NCT01753492|glaucoma|glaucoma
280070|NCT01753492|trabeculectomy|trabeculectomy
280071|NCT01753492|Ologen|ologen
280072|NCT01753479|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
280073|NCT01753453|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
280074|NCT01753453|Tumour cell mobilization|tumour cell mobilization
280075|NCT01753440|coronary artery disease|coronary artery disease
280076|NCT01753440|heart failure|heart failure
280077|NCT01753440|stem cells implantation|stem cells implantation
280078|NCT01753427|COPD,|copd,
280079|NCT01753427|symptoms,|symptoms,
280080|NCT01753427|Non-Interventional study,|non-interventional study,
280081|NCT01753414|Lung Cancer|lung cancer
280082|NCT01753401|SLE|sle
280083|NCT01753401|Lupus|lupus
280084|NCT01753375|Multiple Sclerosis|multiple sclerosis
280085|NCT01753375|Relapsing rate|relapsing rate
280086|NCT01753375|Expanded disability status scale|expanded disability status scale
280087|NCT01753375|Vitamin D3|vitamin d3
280088|NCT01753323|acute malaria, KAF156|acute malaria, kaf156
280089|NCT01753245|Anti-TNF drugs efficacy|anti-tnf drugs efficacy
280090|NCT01753245|Moderate-to-severe psoriasis vulgaris|moderate-to-severe psoriasis vulgaris
280091|NCT01753245|Gene polymorphism|gene polymorphism
280092|NCT01753232|DALI adsorber|dali adsorber
698003|NCT00951249|MSM|msm
280093|NCT01753232|MONET lipoprotein filter|monet lipoprotein filter
280094|NCT01753193|Systemic Lupus Erythematosus|systemic lupus erythematosus
280095|NCT01753180|CTO|cto
280096|NCT01753180|PCI|pci
280097|NCT01753180|Angioplasty|angioplasty
280098|NCT01753154|Peritoneal Dialysis|peritoneal dialysis
280099|NCT01753154|Biocompatible dialysis solution|biocompatible dialysis solution
280100|NCT01753154|Hydration status|hydration status
280101|NCT01753154|Residual renal function|residual renal function
280102|NCT01753154|Body composition monitor|body composition monitor
280103|NCT01753154|Bioimpedance spectroscopy|bioimpedance spectroscopy
280104|NCT01753154|Cancer antigen 125|cancer antigen 125
280106|NCT01753141|Smoking Cessation|smoking cessation
280107|NCT01753115|post-exposure prophylaxis|post-exposure prophylaxis
280108|NCT01753115|toxin neutralization assay|toxin neutralization assay
280109|NCT01753102|Estradiol|estradiol
280110|NCT01753102|Vulvar atrophy|vulvar atrophy
280111|NCT01753102|vaginal atrophy|vaginal atrophy
280112|NCT01753089|Metastatic|metastatic
280113|NCT01753076|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
280114|NCT01753076|efficacy|efficacy
280115|NCT01753076|ozanezumab|ozanezumab
280116|NCT01753076|safety|safety
280117|NCT01753063|Obesity|obesity
280118|NCT01753063|Children|children
280119|NCT01753063|Adolescents|adolescents
280120|NCT01753063|Attrition|attrition
280121|NCT01753037|Hyperandrogenism|hyperandrogenism
280122|NCT01753037|Inflammation|inflammation
280123|NCT01753037|Insulin sensitivity|insulin sensitivity
280124|NCT01753037|Body composition|body composition
280125|NCT01753024|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
280126|NCT01753024|fecal elastase-1|fecal elastase-1
280127|NCT01753024|amylase|amylase
280128|NCT01753024|lipase|lipase
280129|NCT01753024|critical illness|critical illness
280130|NCT01753024|enteral nutrition|enteral nutrition
280131|NCT01753024|malnutrition|malnutrition
280132|NCT01753024|sepsis|sepsis
280133|NCT01753024|diabetes|diabetes
280134|NCT01753024|hyperlactacidemia|hyperlactacidemia
280135|NCT01753024|hemodialysis|hemodialysis
280136|NCT01753024|mechanical ventilation|mechanical ventilation
280137|NCT01753011|Stress urinary Incontinence|stress urinary incontinence
280138|NCT01753011|Transobturator sling|transobturator sling
280139|NCT01753011|TOT|tot
280140|NCT01752998|pain|pain
280141|NCT01752998|depression|depression
280142|NCT01752998|substance use|substance use
280143|NCT01752972|Arsenic|arsenic
280144|NCT01752972|Keratosis|keratosis
280145|NCT01752972|Linoleic acid|linoleic acid
280146|NCT01752972|Palm|palm
280147|NCT01752972|Spirulina|spirulina
280148|NCT01752972|Vitamin E|vitamin e
280149|NCT01752972|Zinc|zinc
280150|NCT01752920|FGFR|fgfr
280151|NCT01752920|ARQ 087|arq 087
280152|NCT01752920|Targeted therapy|targeted therapy
280153|NCT01752920|Molecular therapy|molecular therapy
280154|NCT01752920|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
280155|NCT01752920|TKI|tki
280156|NCT01752920|Receptor tyrosine kinase|receptor tyrosine kinase
280157|NCT01752920|RTK|rtk
280158|NCT01752920|Biomarker|biomarker
280159|NCT01752920|Phase 1|phase 1
280160|NCT01752920|Phase I|phase i
280161|NCT01752920|Solid tumor|solid tumor
280162|NCT01752920|Liver Cancer|liver cancer
280163|NCT01752920|Hepatobiliary carcinoma|hepatobiliary carcinoma
280164|NCT01752920|Biliary tract cancer|biliary tract cancer
280165|NCT01752920|Cholangiocarcinoma|cholangiocarcinoma
280273|NCT01752517|small cell lung cancer|small cell lung cancer
280166|NCT01752920|Intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
280167|NCT01752920|FGFR inhibitor|fgfr inhibitor
280168|NCT01752920|Targeted FGFR kinase inhibitor|targeted fgfr kinase inhibitor
280169|NCT01752920|Pan-FGFR inhibitor|pan-fgfr inhibitor
280170|NCT01752920|Selective FGFR inhibitor|selective fgfr inhibitor
280171|NCT01752920|FGFR pathway|fgfr pathway
280172|NCT01752920|FGFR signaling|fgfr signaling
280173|NCT01752920|Fibroblast growth factor|fibroblast growth factor
280174|NCT01752920|FGFR1|fgfr1
280175|NCT01752920|FGFR2|fgfr2
280176|NCT01752920|FGFR3|fgfr3
280177|NCT01752920|FGFR4|fgfr4
280178|NCT01752920|FGF|fgf
280179|NCT01752920|FGF19|fgf19
280180|NCT01752920|FGF21|fgf21
280181|NCT01752920|FGF23|fgf23
280182|NCT01752920|FGFR mutation|fgfr mutation
280183|NCT01752920|FGFR gene fusion|fgfr gene fusion
280184|NCT01752920|FGFR gene translocation|fgfr gene translocation
280185|NCT01752920|FGFR genetic aberration|fgfr genetic aberration
280186|NCT01752920|FGFR2 fusion|fgfr2 fusion
280187|NCT01752920|FGFR2 translocation|fgfr2 translocation
280188|NCT01752920|Phase 1 Clinical Trial|phase 1 clinical trial
280189|NCT01752920|Phase I Clinical Trial|phase i clinical trial
280190|NCT01752920|Clinical oncology|clinical oncology
280191|NCT01752920|Tumor|tumor
280192|NCT01752920|Tumour|tumour
280193|NCT01752907|Breast cancer|breast cancer
700606|NCT00961805|Treatment|treatment
280194|NCT01752907|Chemotherapy|chemotherapy
280195|NCT01752907|Pegfilgrastim|pegfilgrastim
280196|NCT01752907|Neulasta|neulasta
280197|NCT01752907|Bone Pain|bone pain
280198|NCT01752907|Education|education
280199|NCT01752881|Influenza|influenza
280200|NCT01752881|Vaccine|vaccine
280201|NCT01752881|Immunogenicity|immunogenicity
280202|NCT01752855|Rheumatoid Arthritis|rheumatoid arthritis
280203|NCT01752842|Diabetes|diabetes
280204|NCT01752842|Diabetic Cardiomyopathy|diabetic cardiomyopathy
280205|NCT01752842|Triglycerides|triglycerides
280206|NCT01752829|Obesity|obesity
280207|NCT01752829|gastric|gastric
280208|NCT01752829|banding|banding
280209|NCT01752829|Weight|weight
280210|NCT01752829|co-morbidities|co-morbidities
280211|NCT01752829|dilatation|dilatation
280212|NCT01752829|Excess weight loss|excess weight loss
280213|NCT01752829|adjustable gastric banding|adjustable gastric banding
280214|NCT01752816|endurance training,|endurance training,
280215|NCT01752816|strength training,|strength training,
280216|NCT01752816|aerobic capacity,|aerobic capacity,
280217|NCT01752816|muscle strenght|muscle strenght
280218|NCT01752816|physical capacity|physical capacity
280219|NCT01752790|Pediatric Crohn's disease|pediatric crohn's disease
280220|NCT01752790|Biologics|biologics
280221|NCT01752790|Immunomodulators|immunomodulators
280222|NCT01752790|Top-down|top-down
280223|NCT01752790|step-up|step-up
280224|NCT01752777|HIV/AIDS, HIV infectiousness, Medication adherence, Sexual risks reduction|hiv/aids, hiv infectiousness, medication adherence, sexual risks reduction
280225|NCT01752751|Neck cancer|neck cancer
280226|NCT01752751|Head cancer|head cancer
280227|NCT01752751|Lung cancer|lung cancer
280228|NCT01752725|supracervical hysterectomy|supracervical hysterectomy
280229|NCT01752725|vessel sealing|vessel sealing
280230|NCT01752725|bipolar electrocoagulation|bipolar electrocoagulation
280231|NCT01752712|Oxytocin|oxytocin
280232|NCT01752712|Social function|social function
280233|NCT01752712|CBSST|cbsst
280234|NCT01752699|neuropathic pain,|neuropathic pain,
280235|NCT01752699|post-herpetic neuralgia,|post-herpetic neuralgia,
280236|NCT01752699|methadone,|methadone,
280237|NCT01752686|Triple negative breast cancer|triple negative breast cancer
280238|NCT01752686|adjuvant chemotherapy|adjuvant chemotherapy
280239|NCT01752673|randomized controlled study|randomized controlled study
280240|NCT01752660|Exercise therapy|exercise therapy
280241|NCT01752660|Aerobic training|aerobic training
280242|NCT01752660|Endurance training|endurance training
280243|NCT01752647|lung cancer|lung cancer
280244|NCT01752647|screening|screening
280245|NCT01752647|low dose|low dose
280246|NCT01752647|computed tomography|computed tomography
280247|NCT01752634|Psoriatic arthritis, PsA, ACR, CASPAR, PASDAS|psoriatic arthritis, psa, acr, caspar, pasdas
280248|NCT01752621|Acromegaly|acromegaly
280249|NCT01752621|mortality|mortality
280250|NCT01752621|morbidity|morbidity
280251|NCT01752621|incidence|incidence
280252|NCT01752621|prevalence|prevalence
280253|NCT01752608|Depression|depression
280254|NCT01752608|Real-time|real-time
280255|NCT01752608|iPhone|iphone
280256|NCT01752608|CBT|cbt
280257|NCT01752608|Cognitive behavioral therapy|cognitive behavioral therapy
280258|NCT01752582|BuMA|buma
280259|NCT01752582|EXCEL|excel
280260|NCT01752582|OCT|oct
280261|NCT01752582|stent|stent
280262|NCT01752582|neointima formation|neointima formation
280263|NCT01752569|HIV|hiv
280264|NCT01752569|Kaposi's sarcoma|kaposi's sarcoma
280265|NCT01752569|Anti-retroviral therapy|anti-retroviral therapy
280266|NCT01752569|HAART|haart
280267|NCT01752569|AIDS|aids
280268|NCT01752556|Sleep apnea, Portable monitor,autoCPAP|sleep apnea, portable monitor,autocpap
280269|NCT01752543|Vasopressin|vasopressin
280270|NCT01752543|Exercise capacity|exercise capacity
280274|NCT01752517|chemotherapy|chemotherapy
280275|NCT01752517|vinorelbine|vinorelbine
280276|NCT01752517|ifosfamide|ifosfamide
280277|NCT01752517|third-line treatment|third-line treatment
280278|NCT01752504|HIV prevention|hiv prevention
280279|NCT01752504|HIV positive communities|hiv positive communities
280280|NCT01752491|Ascorbate|ascorbate
280281|NCT01752491|Ascorbic acid|ascorbic acid
280282|NCT01752491|Vitamin C|vitamin c
280283|NCT01752491|Radiation|radiation
280284|NCT01752491|Temozolomide|temozolomide
280285|NCT01752478|ptosis|ptosis
346509|NCT01464567|Weaning|weaning
280286|NCT01752478|retina surgery|retina surgery
280287|NCT01752478|droopy eye lid|droopy eye lid
280288|NCT01752465|Health behaviour|health behaviour
280289|NCT01752465|Antipsychotic agents|antipsychotic agents
280290|NCT01752465|Adverse effects|adverse effects
280291|NCT01752465|Goals|goals
280292|NCT01752465|Life style|life style
280293|NCT01752439|Chronic Migraine|chronic migraine
280294|NCT01752439|Medication Overuse Headache|medication overuse headache
280295|NCT01752439|Refractory|refractory
280296|NCT01752439|transcranial direct current stimulation|transcranial direct current stimulation
280297|NCT01752426|Leukemia|leukemia
280298|NCT01752426|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
280300|NCT01752426|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
280301|NCT01752426|SLL|sll
280302|NCT01752426|PCI-32765|pci-32765
280303|NCT01752426|Ibrutinib|ibrutinib
280304|NCT01752426|Btk inhibitor|btk inhibitor
280305|NCT01752426|Heavy water|heavy water
280306|NCT01752426|2H2O|2h2o
280307|NCT01752413|Iron depletion|iron depletion
280308|NCT01752413|blood donors|blood donors
280309|NCT01752413|iron replacement|iron replacement
280310|NCT01752400|Advanced|advanced
280311|NCT01752361|Gastrointestinal Motility|gastrointestinal motility
280312|NCT01752361|Inflammatory Bowel Disease|inflammatory bowel disease
280313|NCT01752361|Transit time|transit time
280314|NCT01752348|sepsis|sepsis
280315|NCT01752348|cytokine release|cytokine release
280316|NCT01752348|fever|fever
280415|NCT01751854|rehabilitation|rehabilitation
280317|NCT01752335|Rheumatoid Arthritis, tocilizumab, cardiovascular risk factors|rheumatoid arthritis, tocilizumab, cardiovascular risk factors
280318|NCT01752309|Early Rheumatoid arthritis|early rheumatoid arthritis
280319|NCT01752309|Rheumatoid arthritis|rheumatoid arthritis
280320|NCT01752309|Ultrasound|ultrasound
280321|NCT01752309|Predictive|predictive
280322|NCT01752309|Prognosis|prognosis
280323|NCT01752296|Morquio|morquio
280324|NCT01752296|Mucopolysaccharidosis IV|mucopolysaccharidosis iv
280325|NCT01752296|Psychological health|psychological health
280326|NCT01752283|Videoassited|videoassited
280327|NCT01752283|Thyroidectomy|thyroidectomy
280328|NCT01752283|Minimal invasive surgery|minimal invasive surgery
280329|NCT01752283|General anesthesia|general anesthesia
280330|NCT01752283|Hypnosis|hypnosis
280331|NCT01752257|Melanoma|melanoma
280332|NCT01752244|Obesity, vitamin D analogue, VDR, PPARg, PGC1a|obesity, vitamin d analogue, vdr, pparg, pgc1a
280333|NCT01752218|Femto-second Laser|femto-second laser
280334|NCT01752218|arcuate incision|arcuate incision
280335|NCT01752218|corneal astigmatism|corneal astigmatism
280336|NCT01752218|astigmatic keratotomy|astigmatic keratotomy
280337|NCT01752218|Cataract|cataract
280338|NCT01752205|Esophageal Squamous Carcinoma|esophageal squamous carcinoma
280339|NCT01752205|Erlotinib|erlotinib
280340|NCT01752205|Chemoradiotherapy|chemoradiotherapy
280341|NCT01752192|Rehabilitation|rehabilitation
280342|NCT01752192|Telemedicine|telemedicine
280343|NCT01752192|Heart patients|heart patients
280344|NCT01752192|Social media|social media
280345|NCT01752192|Organisational aspects|organisational aspects
280346|NCT01752179|Kinesio taping|kinesio taping
280347|NCT01752179|Piriformis syndrome|piriformis syndrome
280348|NCT01752179|Trigger point|trigger point
280350|NCT01752166|Candidemia|candidemia
280351|NCT01752166|Blood culture|blood culture
280352|NCT01752166|Diagnostics|diagnostics
280353|NCT01752153|Focus|focus
280354|NCT01752153|immunomodulatory effect|immunomodulatory effect
280355|NCT01752153|of silymarin|of silymarin
280356|NCT01752153|on cell mediated immunity|on cell mediated immunity
280357|NCT01752153|Beta-Thalassemia|beta-thalassemia
280358|NCT01752153|major patients.|major patients.
280359|NCT01752140|Prostate cancer|prostate cancer
280360|NCT01752140|Prostate biopsy|prostate biopsy
280361|NCT01752140|Vienna nomogram|vienna nomogram
280362|NCT01752127|Drug-eluting stent|drug-eluting stent
280363|NCT01752127|diabetes|diabetes
280364|NCT01752127|small vessel disease|small vessel disease
280365|NCT01752114|Precancerous conditions|precancerous conditions
280366|NCT01752114|Carcinoma|carcinoma
280367|NCT01752101|Precancerous Conditions|precancerous conditions
280368|NCT01752101|Carcinoma|carcinoma
280369|NCT01752088|apularis, MRI clinical, results|apularis, mri clinical, results
280370|NCT01752075|Multiple myeloma|multiple myeloma
280371|NCT01752062|Chronic Myeloid Leukemia|chronic myeloid leukemia
280372|NCT01752062|CML|cml
280373|NCT01752062|Pregnancy|pregnancy
280374|NCT01752049|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
280375|NCT01752049|Anti-angiogenic Therapy|anti-angiogenic therapy
280376|NCT01752049|vascular malformations|vascular malformations
280377|NCT01752049|HHT|hht
280378|NCT01752036|stereotactic radiotherapy|stereotactic radiotherapy
280379|NCT01752036|SRS|srs
280380|NCT01751984|lipid-lowering drugs|lipid-lowering drugs
280381|NCT01751984|statin intolerance|statin intolerance
280382|NCT01751945|EmONC|emonc
280383|NCT01751945|Neonatal mortality|neonatal mortality
280384|NCT01751945|Perinatal mortality|perinatal mortality
270964|NCT01794975|PET|pet
280385|NCT01751919|CML|cml
280386|NCT01751919|GIST|gist
280387|NCT01751906|Absorb™ BVS|absorb™ bvs
280388|NCT01751906|Angioplasty|angioplasty
280389|NCT01751906|Bioabsorbable|bioabsorbable
280390|NCT01751906|BVS|bvs
280391|NCT01751906|Bioresorbable|bioresorbable
280392|NCT01751906|Coronary Artery Disease|coronary artery disease
280393|NCT01751906|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
280394|NCT01751906|Coronary artery restenosis|coronary artery restenosis
280395|NCT01751906|Coronary artery stenosis|coronary artery stenosis
280396|NCT01751906|Coronary scaffold|coronary scaffold
280397|NCT01751906|Coronary Stent|coronary stent
280398|NCT01751906|Drug eluting stents|drug eluting stents
280399|NCT01751906|Everolimus|everolimus
280400|NCT01751906|Myocardial ischemia|myocardial ischemia
280401|NCT01751906|Stent thrombosis|stent thrombosis
280402|NCT01751906|Stents|stents
280403|NCT01751893|Hand-foot syndrome|hand-foot syndrome
280404|NCT01751893|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
280405|NCT01751893|capecitabine|capecitabine
280406|NCT01751893|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
280407|NCT01751893|henna|henna
280408|NCT01751880|Gastric cancer, minimally invasive gastrectomy, Physical activity intervention|gastric cancer, minimally invasive gastrectomy, physical activity intervention
280409|NCT01751867|Myelodysplastic Syndrome|myelodysplastic syndrome
280410|NCT01751867|Dacogen|dacogen
280411|NCT01751867|Oncology|oncology
280412|NCT01751867|Decitabine|decitabine
280413|NCT01751867|Bone marrow disorders|bone marrow disorders
280414|NCT01751854|pharmacology|pharmacology
280416|NCT01751854|locomotion|locomotion
280417|NCT01751828|Depression|depression
280418|NCT01751828|Major Depressive Disorder|major depressive disorder
280419|NCT01751802|Lesch Nyhan Disease|lesch nyhan disease
280420|NCT01751802|Self-Injury|self-injury
280421|NCT01751789|illicit opioid drug use|illicit opioid drug use
280422|NCT01751789|health service utilization|health service utilization
280423|NCT01751737|prostate|prostate
280424|NCT01751737|cancer|cancer
280425|NCT01751737|biopsy|biopsy
280426|NCT01751737|18F-choline|18f-choline
280427|NCT01751737|PET|pet
280428|NCT01751737|MRI|mri
280429|NCT01751724|Premature infants|premature infants
280430|NCT01751724|Caffeine|caffeine
280431|NCT01751724|Methylxanthines|methylxanthines
280432|NCT01751724|Mechanical ventilation|mechanical ventilation
280433|NCT01751724|Oxygen|oxygen
280434|NCT01751724|Weaning|weaning
280435|NCT01751724|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
280436|NCT01751698|Autism|autism
280437|NCT01751698|Minimally Verbal|minimally verbal
280438|NCT01751698|School Age|school age
280439|NCT01751685|kyphosis|kyphosis
280440|NCT01751672|SBIRT|sbirt
280441|NCT01751672|Substance Use|substance use
280442|NCT01751672|Screening|screening
280443|NCT01751672|Brief Intervention|brief intervention
280444|NCT01751672|Primary Care|primary care
280445|NCT01751633|Burst fractures|burst fractures
280446|NCT01751633|Thoracic or Lumbar Vertebrae/injuries [MeSH]|thoracic or lumbar vertebrae/injuries [mesh]
280447|NCT01751633|Thoracic or Lumbar Vertebrae/surgery [MeSH]|thoracic or lumbar vertebrae/surgery [mesh]
280448|NCT01751633|Spinal Fusion/methods [MeSH]|spinal fusion/methods [mesh]
280449|NCT01751633|Thoracolumbar fracture management|thoracolumbar fracture management
280450|NCT01751633|Quality of life|quality of life
280451|NCT01751633|Functional outcome|functional outcome
280452|NCT01751607|AF, catheter ablation, non-PV triggers, SNP|af, catheter ablation, non-pv triggers, snp
280453|NCT01751581|Obesity|obesity
280454|NCT01751581|Resting Metabolic Rate|resting metabolic rate
280455|NCT01751581|Sleep|sleep
280456|NCT01751581|Eating|eating
280457|NCT01751555|HBV co-infection ART TDF|hbv co-infection art tdf
280458|NCT01751529|renal malignancy|renal malignancy
280459|NCT01751529|Pilot Study|pilot study
280460|NCT01751529|LCCC 1219|lccc 1219
280461|NCT01751529|UNC Lineberger|unc lineberger
280462|NCT01751529|kidney cancer|kidney cancer
280463|NCT01751529|contrast-enhanced ultrasound|contrast-enhanced ultrasound
280464|NCT01751529|ultrasound|ultrasound
280465|NCT01751503|Foot drop deformity|foot drop deformity
280466|NCT01751503|gold standard treatment|gold standard treatment
280467|NCT01751503|Tibialis posterior tendon transfer|tibialis posterior tendon transfer
280468|NCT01751503|Interosseous route|interosseous route
280469|NCT01751503|Extramembranous or circumtibial route|extramembranous or circumtibial route
280470|NCT01751490|shoulder|shoulder
280471|NCT01751490|instability|instability
280472|NCT01751490|atraumatic|atraumatic
280473|NCT01751477|Very Low Birth Weight Infants|very low birth weight infants
280474|NCT01751477|Probiotics|probiotics
280475|NCT01751477|Necrotizing Enterocolitis|necrotizing enterocolitis
280477|NCT01751464|violence|violence
280478|NCT01751464|injury|injury
280479|NCT01751464|emergency department|emergency department
280480|NCT01751464|intervention|intervention
280481|NCT01751451|ABIRATERONE ACETATE (CB 7630)|abiraterone acetate (cb 7630)
271060|NCT01794637|End stage liver disease|end stage liver disease
271061|NCT01794637|Peripheral microcirculatory dysfunction|peripheral microcirculatory dysfunction
271062|NCT01794637|Liver transplantation|liver transplantation
271063|NCT01794637|Near infrared spectroscopy|near infrared spectroscopy
271064|NCT01794624|TMD|tmd
271065|NCT01794624|TMJD|tmjd
271066|NCT01794624|Temporomandibular Joint Disorders|temporomandibular joint disorders
271067|NCT01794624|Sleep Continuity Disturbance|sleep continuity disturbance
280482|NCT01751451|DEGARELIX|degarelix
280483|NCT01751451|PREDNISONE|prednisone
280484|NCT01751451|12-187|12-187
280485|NCT01751438|Prostate cancer|prostate cancer
280486|NCT01751438|Prostate carcinoma|prostate carcinoma
280487|NCT01751438|Metastatic|metastatic
280488|NCT01751438|M1|m1
280489|NCT01751438|Best Systemic Therapy|best systemic therapy
280490|NCT01751438|BST|bst
280491|NCT01751438|Androgen deprivation therapy|androgen deprivation therapy
280492|NCT01751438|Bilateral orchiectomy|bilateral orchiectomy
280493|NCT01751438|Radiation|radiation
280494|NCT01751438|Radiation Therapy|radiation therapy
280495|NCT01751438|External beam radiation therapy|external beam radiation therapy
280496|NCT01751438|External-beam radiotherapy|external-beam radiotherapy
280497|NCT01751438|Xray therapy|xray therapy
280498|NCT01751438|XRT|xrt
280499|NCT01751438|Surgery|surgery
280500|NCT01751425|Leukemia|leukemia
280501|NCT01751425|Chronic Myeloid Leukemia|chronic myeloid leukemia
280502|NCT01751425|CML|cml
280503|NCT01751425|Minimal Residual Disease|minimal residual disease
280504|NCT01751425|Philadelphia chromosome|philadelphia chromosome
280505|NCT01751425|(Ph)-positive|(ph)-positive
280506|NCT01751425|BCR/ABL-positive|bcr/abl-positive
280507|NCT01751425|Ruxolitinib|ruxolitinib
280508|NCT01751425|Jakafi|jakafi
280509|NCT01751425|INCB018424|incb018424
280510|NCT01751425|INC424|inc424
280511|NCT01751425|TKI|tki
280512|NCT01751425|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
280513|NCT01751412|Hodgkin|hodgkin
280514|NCT01751412|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
280515|NCT01751412|Mediastinal|mediastinal
280516|NCT01751412|Adult Lymphoma|adult lymphoma
280517|NCT01751412|Pediatric Lymphoma|pediatric lymphoma
280518|NCT01751386|Addiction|addiction
280519|NCT01751386|Cue-Induced Craving|cue-induced craving
280520|NCT01751386|Craving|craving
280521|NCT01751386|Anxiety|anxiety
280522|NCT01751386|Alcohol Consumption|alcohol consumption
280523|NCT01751373|Botulinum Toxin|botulinum toxin
280524|NCT01751373|Rehabilitation|rehabilitation
280525|NCT01751373|Electromyography|electromyography
280526|NCT01751373|Electroencephalography|electroencephalography
280527|NCT01751373|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
280528|NCT01751347|Local anesthetics|local anesthetics
280529|NCT01751347|Elective hand surgeries|elective hand surgeries
280530|NCT01751334|Arthroplasty|arthroplasty
280531|NCT01751334|Replacement|replacement
280532|NCT01751334|Knee|knee
280533|NCT01751334|Rotational Alignment|rotational alignment
280534|NCT01751282|Stem Cells|stem cells
280535|NCT01751282|chronic wounds|chronic wounds
280536|NCT01751282|fibrin|fibrin
280537|NCT01751282|Bone marrow-derived mesenchymal stem cells|bone marrow-derived mesenchymal stem cells
280538|NCT01751256|Postcesarean Section|postcesarean section
280539|NCT01751256|Postoperative Pain|postoperative pain
280540|NCT01751256|Care, Postoperative|care, postoperative
280541|NCT01751256|Anesthesia, Local|anesthesia, local
280542|NCT01751256|Breast Feeding|breast feeding
280543|NCT01751256|Morphine|morphine
280544|NCT01751256|Pain Measurement|pain measurement
280545|NCT01751256|levobupivacaine|levobupivacaine
280546|NCT01751230|pregnancy|pregnancy
280547|NCT01751230|weight loss|weight loss
280548|NCT01751217|Substance Abuse|substance abuse
280549|NCT01751217|Adolescents|adolescents
280550|NCT01751217|Families|families
280551|NCT01751217|Functional Family Therapy|functional family therapy
280552|NCT01751217|Video|video
280553|NCT01751217|Teleconferencing|teleconferencing
280554|NCT01751217|Telemedicine|telemedicine
280555|NCT01751165|≥ 50 years of age|≥ 50 years of age
280556|NCT01751165|Herpes zoster|herpes zoster
280557|NCT01751165|Safety|safety
280558|NCT01751165|Immunogenicity|immunogenicity
280559|NCT01751165|Adults|adults
280560|NCT01751139|Endemic regions|endemic regions
280561|NCT01751139|Brazil|brazil
280562|NCT01751139|Incidence|incidence
280563|NCT01751139|Surveillance|surveillance
280564|NCT01751139|Dengue|dengue
280565|NCT01751126|vernal keratoconjunctivitis|vernal keratoconjunctivitis
280566|NCT01751126|ciclosporin|ciclosporin
280567|NCT01751126|cyclosporine|cyclosporine
271158|NCT01794221|phimosis|phimosis
271159|NCT01794208|in-vitro fertilization|in-vitro fertilization
280568|NCT01751087|abortion, induced|abortion, induced
280569|NCT01751074|Drug interaction, rosuvastatin, healthy volunteer, Lp-PLA2, atherosclerosis, darapladib, pharmacokinetics.|drug interaction, rosuvastatin, healthy volunteer, lp-pla2, atherosclerosis, darapladib, pharmacokinetics.
280570|NCT01751061|prolonged mechanical ventilation|prolonged mechanical ventilation
280571|NCT01751061|chronic critical illness|chronic critical illness
280572|NCT01751061|decision making|decision making
280573|NCT01751061|decision aid|decision aid
280574|NCT01751061|decisional support|decisional support
280575|NCT01751061|critical illness|critical illness
280576|NCT01751061|intensive care unit|intensive care unit
280577|NCT01751048|GLA-SE,LEISH-F3,leishmaniasis,MPL-SE,parent protocol,vaccine|gla-se,leish-f3,leishmaniasis,mpl-se,parent protocol,vaccine
280578|NCT01751022|heart failure|heart failure
280579|NCT01751022|cardiac pacing|cardiac pacing
280580|NCT01751022|cardiac resynchronization therapy|cardiac resynchronization therapy
280581|NCT01751022|left ventricular lead|left ventricular lead
280582|NCT01751009|vitamin A, complementary foods, malnutrition, children|vitamin a, complementary foods, malnutrition, children
280583|NCT01750983|Advanced Cancers|advanced cancers
280584|NCT01750983|Advanced Malignancies|advanced malignancies
280585|NCT01750983|Metastatic cancers|metastatic cancers
280586|NCT01750983|Ipilimumab|ipilimumab
280587|NCT01750983|Yervoy|yervoy
280588|NCT01750983|BMS-734016|bms-734016
280589|NCT01750983|MDX010|mdx010
280590|NCT01750983|Lenalidomide|lenalidomide
280591|NCT01750983|CC-5013|cc-5013
280592|NCT01750983|Revlimid|revlimid
280593|NCT01750944|Blood pressure site|blood pressure site
280594|NCT01750944|Good health|good health
280595|NCT01750944|Brachial blood pressure|brachial blood pressure
280600|NCT01750931|BE study of Meloxicam GSK 15mg|be study of meloxicam gsk 15mg
280606|NCT01750879|allergy|allergy
280607|NCT01750879|food|food
280608|NCT01750879|immunotherapy|immunotherapy
280609|NCT01750879|tolerance|tolerance
280610|NCT01750879|desensitization|desensitization
280611|NCT01750866|Prostrate Cancer|prostrate cancer
280612|NCT01750866|Castrate-resistant metastatic prostate cancer|castrate-resistant metastatic prostate cancer
280613|NCT01750866|Cabazitaxel|cabazitaxel
280614|NCT01750827|platelet function|platelet function
280615|NCT01750827|atherosclerosis,|atherosclerosis,
280616|NCT01750827|SB-659032|sb-659032
280617|NCT01750801|clinical trial|clinical trial
280618|NCT01750801|mouthwash|mouthwash
280619|NCT01750801|propolis|propolis
280620|NCT01750801|plaque|plaque
280621|NCT01750801|gingivitis|gingivitis
280622|NCT01750801|compliance|compliance
280623|NCT01750788|Stroke|stroke
280624|NCT01750788|Embolism|embolism
280625|NCT01750788|Atrial Fibrillation|atrial fibrillation
280626|NCT01750775|sinus bradycardia|sinus bradycardia
280627|NCT01750775|ventricular premature contraction|ventricular premature contraction
280628|NCT01750749|Venous ulcer|venous ulcer
280629|NCT01750749|Cell therapy|cell therapy
280630|NCT01750736|Augmented Exercise|augmented exercise
280631|NCT01750736|Cervicalgia|cervicalgia
280632|NCT01750736|Manual Therapy|manual therapy
280633|NCT01750736|Manipulation|manipulation
280634|NCT01750736|Quantitative Sensory|quantitative sensory
280635|NCT01750723|Acetazolamide|acetazolamide
280636|NCT01750723|Headache|headache
280637|NCT01750723|Migraine|migraine
280638|NCT01750710|Charcot-Marie-Tooth disease type 1A neuropathy|charcot-marie-tooth disease type 1a neuropathy
280639|NCT01750710|Isokinetic|isokinetic
280640|NCT01750710|Electromyography|electromyography
280641|NCT01750710|Walking|walking
280642|NCT01750684|Acute|acute
280643|NCT01750684|Traumatic|traumatic
280644|NCT01750684|SCI|sci
280645|NCT01750684|Spinal Cord Injury|spinal cord injury
280646|NCT01750671|ICU|icu
280647|NCT01750671|Body composition|body composition
280648|NCT01750671|Nutrition|nutrition
280649|NCT01750671|Survival|survival
280650|NCT01750671|Morbidity|morbidity
280651|NCT01750658|Biomarkers|biomarkers
280652|NCT01750658|Exacerbations|exacerbations
280653|NCT01750658|COPD|copd
280654|NCT01750593|radiofrequency|radiofrequency
280655|NCT01750593|thyroid|thyroid
280656|NCT01750593|nodule|nodule
280657|NCT01750567|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
280658|NCT01750567|untreated CLL patients|untreated cll patients
280659|NCT01750567|genomic deletion 11q|genomic deletion 11q
280660|NCT01750554|SpHb; hemoglobin monitoring;bupivacaine digital nerve block|sphb; hemoglobin monitoring;bupivacaine digital nerve block
280661|NCT01750515|Acupuncture|acupuncture
280662|NCT01750515|Hepatitis C (HCV)|hepatitis c (hcv)
280663|NCT01750489|COPD|copd
280664|NCT01750476|oral contraception|oral contraception
280665|NCT01750476|Depo-Provera|depo-provera
280666|NCT01750476|Mirena|mirena
280667|NCT01750463|Pediatric critically ill|pediatric critically ill
280668|NCT01750463|Masimo|masimo
280669|NCT01750463|hemoglobin|hemoglobin
280670|NCT01750463|monitoring|monitoring
280671|NCT01750463|UNC|unc
280672|NCT01750463|PICU|picu
280673|NCT01750450|Pressure Volume Area|pressure volume area
280674|NCT01750450|Pressure Flow Area|pressure flow area
280675|NCT01750450|Myocardial Work|myocardial work
280676|NCT01750437|NERD|nerd
280677|NCT01750424|Scar|scar
280678|NCT01750424|Fat Grafting|fat grafting
280679|NCT01750424|Adipose Grafting|adipose grafting
280680|NCT01750424|3-D imaging|3-d imaging
280681|NCT01750424|Manchester Scar Scale|manchester scar scale
280682|NCT01750411|Severe Asthma|severe asthma
280683|NCT01750411|SARP|sarp
280684|NCT01750398|Testosterone, Leuprolide, Goserelin|testosterone, leuprolide, goserelin
280685|NCT01750385|Esophageal Achalasia|esophageal achalasia
280686|NCT01750385|antibiotic prophylaxis|antibiotic prophylaxis
280687|NCT01750385|blood culture|blood culture
280688|NCT01750385|procalcitonin levels|procalcitonin levels
280689|NCT01750372|Artificial limbs|artificial limbs
280690|NCT01750372|Questionnaires|questionnaires
280691|NCT01750372|Mobility limitation|mobility limitation
280692|NCT01750359|antioxidants|antioxidants
280693|NCT01750359|curcumin|curcumin
280694|NCT01750359|depression|depression
280695|NCT01750346|Blepharospasm|blepharospasm
280696|NCT01750346|Treatment|treatment
280697|NCT01750346|Dystonia|dystonia
280698|NCT01750346|Acetyl-Hexapeptide|acetyl-hexapeptide
280699|NCT01750307|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
280700|NCT01750307|Essential fatty acids (EFAs)|essential fatty acids (efas)
280701|NCT01750307|Electroencephalography (EEG)|electroencephalography (eeg)
280702|NCT01750307|Event-related potential (ERP)|event-related potential (erp)
280703|NCT01750307|Omega 3|omega 3
280704|NCT01750307|Randomised Control Trial|randomised control trial
280705|NCT01750307|Fish oil|fish oil
280706|NCT01750307|Supplementation|supplementation
280707|NCT01750307|Reading|reading
280708|NCT01750307|Spelling|spelling
280709|NCT01750307|Behaviour|behaviour
280710|NCT01750307|Emotional lability|emotional lability
280711|NCT01750294|hypertension|hypertension
280712|NCT01750294|kidney disease|kidney disease
280713|NCT01750281|Mitogen-Activated Protein Kinase Kinase inhibitor|mitogen-activated protein kinase kinase inhibitor
280714|NCT01750281|Non Small Cell Lung Cancer|non small cell lung cancer
280715|NCT01750281|Metastatic|metastatic
280716|NCT01750281|Second line treatment for Non Small Cell Lung Cancer|second line treatment for non small cell lung cancer
280717|NCT01750268|TBI|tbi
280718|NCT01750268|hazardous and harmful alcohol use|hazardous and harmful alcohol use
280719|NCT01750268|veterans|veterans
280720|NCT01750268|co-occurring disorders|co-occurring disorders
280721|NCT01750268|pharmacotherapy|pharmacotherapy
280722|NCT01750255|Pharmaceutical care|pharmaceutical care
280723|NCT01750255|Pharmacotherapy follow-up|pharmacotherapy follow-up
280724|NCT01750255|Bipolar disorder|bipolar disorder
280725|NCT01750255|Pharmacy services|pharmacy services
280726|NCT01750203|Diabetic foot ulcers, venous leg ulcers, pressure sores, acute wounds|diabetic foot ulcers, venous leg ulcers, pressure sores, acute wounds
280727|NCT01750190|anemia|anemia
280728|NCT01750190|chronic kidney disease (CKD)|chronic kidney disease (ckd)
280729|NCT01750190|non-dialysis|non-dialysis
280730|NCT01750190|Hemoglobin (Hb)|hemoglobin (hb)
280731|NCT01750190|End-Stage Renal Disease|end-stage renal disease
280732|NCT01750190|erythropoeitin|erythropoeitin
280733|NCT01750190|ASP1517|asp1517
280734|NCT01750190|erythropoeisis stimulating-agent|erythropoeisis stimulating-agent
280735|NCT01750190|AZD9941|azd9941
280736|NCT01750164|Breast Cancer|breast cancer
280737|NCT01750125|Doppler|doppler
280738|NCT01750112|Pectus excavatum|pectus excavatum
280739|NCT01750112|funnel chest|funnel chest
280740|NCT01750112|sunken chest|sunken chest
280741|NCT01750099|Labor|labor
280742|NCT01750099|analgesia|analgesia
280743|NCT01750099|epidural|epidural
280744|NCT01750099|spinal|spinal
280745|NCT01750086|osteoporosis|osteoporosis
280746|NCT01750086|postmenopausal|postmenopausal
280747|NCT01750086|denosumab|denosumab
280748|NCT01750086|teriparatide|teriparatide
280749|NCT01750086|alendronate|alendronate
280750|NCT01750086|Forteo®|forteo®
280751|NCT01750086|Prolia®|prolia®
280752|NCT01750047|pain perception|pain perception
280753|NCT01750047|postoperative pain|postoperative pain
280754|NCT01750047|demography|demography
280755|NCT01750047|smoking|smoking
280756|NCT01750047|alcohol|alcohol
280757|NCT01750034|Burns|burns
280758|NCT01750034|Wounds and injuries|wounds and injuries
280759|NCT01750034|Bandages|bandages
280760|NCT01750008|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
280761|NCT01750008|Menorrhagia|menorrhagia
280762|NCT01750008|Heavy Bleeding|heavy bleeding
280763|NCT01750008|Myomas|myomas
280764|NCT01750008|Radiofrequency Ablation|radiofrequency ablation
280766|NCT01750008|Leiomyoma|leiomyoma
280767|NCT01750008|Fibroids|fibroids
280768|NCT01749995|Elderly cancer patients|elderly cancer patients
280769|NCT01749995|Screening tool|screening tool
402987|NCT01228734|Cetuximab|cetuximab
271350|NCT01793168|Ataxia|ataxia
280770|NCT01749995|Cognitive impairment|cognitive impairment
280771|NCT01749995|Freund Clock Drawing Test|freund clock drawing test
280772|NCT01749982|arsenic|arsenic
280773|NCT01749982|Bangladesh|bangladesh
280774|NCT01749982|choline|choline
280775|NCT01749982|betaine|betaine
280776|NCT01749982|methylation|methylation
280777|NCT01749956|Rectal Cancer|rectal cancer
280778|NCT01749956|Chemoradiation|chemoradiation
280779|NCT01749956|Aflibercept|aflibercept
280780|NCT01749956|Surgery|surgery
280982|NCT01748994|Obesity|obesity
280781|NCT01749930|Intraocular pressure|intraocular pressure
280782|NCT01749917|Parkinson.|parkinson.
280783|NCT01749917|Dexterity.|dexterity.
280784|NCT01749917|Balance.|balance.
280785|NCT01749917|Exercises.|exercises.
280786|NCT01749904|Intraocular pressure|intraocular pressure
280787|NCT01749891|Age Related Wet Macular Degeneration|age related wet macular degeneration
280788|NCT01748864|Volunteers|volunteers
280789|NCT01748825|MK-1775|mk-1775
280790|NCT01748825|Refractory|refractory
280791|NCT01748825|Solid Tumors|solid tumors
280792|NCT01748825|Wee1 Inhibitor|wee1 inhibitor
280793|NCT01748825|Tyrosine Kinase|tyrosine kinase
280794|NCT01748812|Tumor Induced Osteomalacia|tumor induced osteomalacia
280795|NCT01748812|Hypophosphatemic Rickets|hypophosphatemic rickets
280796|NCT01748799|Cannabis dependence|cannabis dependence
280797|NCT01748799|Sativex|sativex
280798|NCT01748786|Fibromyalgia|fibromyalgia
280799|NCT01748786|Mindfulness|mindfulness
700607|NCT00961805|Dance|dance
280800|NCT01748786|On-line intervention|on-line intervention
280801|NCT01748786|Chronic pain|chronic pain
280802|NCT01748760|Suicide Attempts|suicide attempts
280803|NCT01748760|Suicidal Ideation|suicidal ideation
280804|NCT01749813|Carbohydrate Specific Diet|carbohydrate specific diet
280805|NCT01749813|Crohn's Disease|crohn's disease
280806|NCT01749813|Immunomodulators|immunomodulators
280808|NCT01749800|Attention deficits|attention deficits
280809|NCT01749800|Upper extremity weakness|upper extremity weakness
280810|NCT01749787|arthritis|arthritis
280811|NCT01749787|rheumatoid|rheumatoid
280812|NCT01749787|methotrexate|methotrexate
280813|NCT01749787|leflunomide|leflunomide
280814|NCT01749774|Physical activity|physical activity
280815|NCT01749774|Testicular cancer|testicular cancer
280816|NCT01749774|Chemotherapy|chemotherapy
280817|NCT01749774|Feasibility|feasibility
280818|NCT01749761|IDH, intradialytic hypotension,|idh, intradialytic hypotension,
281018|NCT01748877|shingles,|shingles,
280819|NCT01749761|hypotension on hemodialysis,|hypotension on hemodialysis,
280820|NCT01749761|hemodialysis,|hemodialysis,
280821|NCT01749761|Blood pressure guided biofeedback|blood pressure guided biofeedback
280822|NCT01749748|Breast diseases|breast diseases
280823|NCT01749748|magnetic resonance spectroscopy|magnetic resonance spectroscopy
280824|NCT01749722|Colorectal Cancer|colorectal cancer
280825|NCT01749722|Polyp|polyp
280826|NCT01749722|Adenoma|adenoma
280827|NCT01749722|Detection Rate|detection rate
280828|NCT01749722|Colonoscopy|colonoscopy
280829|NCT01749722|NaviAid™ G-Eye procedure|naviaid™ g-eye procedure
280830|NCT01749722|NaviAid™ G-Eye system|naviaid™ g-eye system
280831|NCT01749722|G-Eye procedure|g-eye procedure
280832|NCT01749722|G-Eye system|g-eye system
280833|NCT01749709|Stroke|stroke
280834|NCT01749709|Recovery|recovery
280835|NCT01749709|Music|music
280836|NCT01749696|Pelvic organ prolapse|pelvic organ prolapse
280837|NCT01749696|Connective tissue|connective tissue
280838|NCT01749696|Elastin|elastin
280839|NCT01749696|Collagen|collagen
280840|NCT01749670|Autism Spectrum Disorder|autism spectrum disorder
280841|NCT01749670|Exosomal miRNA expression|exosomal mirna expression
280842|NCT01749657|biomechanics|biomechanics
280843|NCT01749657|outcomes|outcomes
280844|NCT01749657|foot|foot
280845|NCT01749657|orthotic device|orthotic device
280846|NCT01749644|Cystic Fibrosis, Chronic Pseudomonas Infection, Inhaled Tobramycin|cystic fibrosis, chronic pseudomonas infection, inhaled tobramycin
280847|NCT01749631|Patients suspected to have difficult intubation|patients suspected to have difficult intubation
280848|NCT01749631|Intratracheal intubation|intratracheal intubation
280849|NCT01749631|Difficult to intubate|difficult to intubate
280850|NCT01749618|Seronegative Inflammatory Arthritis|seronegative inflammatory arthritis
280851|NCT01749618|SpA|spa
280852|NCT01749618|PsA|psa
280853|NCT01749618|Randomized|randomized
280854|NCT01749618|Behavioural Change|behavioural change
280855|NCT01749592|hearing loss|hearing loss
280856|NCT01749592|cochlear implant|cochlear implant
280857|NCT01749592|PET|pet
280858|NCT01749592|EEG|eeg
280859|NCT01749592|MEG|meg
280860|NCT01749579|propofol|propofol
280861|NCT01749579|midazolam|midazolam
280862|NCT01749579|duration of recovery|duration of recovery
280863|NCT01749579|emergency procedure|emergency procedure
280864|NCT01749566|HIV/AIDS, preexposure prophylaxis, women's health|hiv/aids, preexposure prophylaxis, women's health
280865|NCT01749527|24-hour pad test|24-hour pad test
280866|NCT01749527|Activity|activity
280867|NCT01749527|Stress urinary incontinence|stress urinary incontinence
280868|NCT01749514|Myelodysplastic Syndrome|myelodysplastic syndrome
280869|NCT01749488|Dietitian|dietitian
280870|NCT01749488|Nutritional recommendations|nutritional recommendations
280871|NCT01749488|ICU nutrition|icu nutrition
280872|NCT01749462|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
280873|NCT01749462|COPD,|copd,
280874|NCT01749462|Oxis,|oxis,
280875|NCT01749449|high protein|high protein
280876|NCT01749449|high carbohydrate|high carbohydrate
280877|NCT01749449|meal frequency|meal frequency
280878|NCT01749449|abdominal body fat|abdominal body fat
280879|NCT01749449|postprandial thermogenesis|postprandial thermogenesis
280880|NCT01749436|Atelectasis|atelectasis
280881|NCT01749436|Pneumoperitoneum|pneumoperitoneum
280882|NCT01749436|Hypoxemia|hypoxemia
280883|NCT01749371|Alpha-Tocopherol|alpha-tocopherol
280884|NCT01749371|Gamma-Tocopherol|gamma-tocopherol
280885|NCT01749371|Inflammation|inflammation
280886|NCT01749371|Oxidative Stress|oxidative stress
280887|NCT01749371|Malondialdehyde|malondialdehyde
280888|NCT01749371|Isoprostanes|isoprostanes
280889|NCT01749371|Lung Dysfunction|lung dysfunction
280890|NCT01749371|Wound Healing|wound healing
280891|NCT01749358|stroke|stroke
280892|NCT01749358|hemiparesis|hemiparesis
280893|NCT01749358|physical therapy|physical therapy
280894|NCT01749358|occupational therapy|occupational therapy
280895|NCT01749358|neurorehabilitation|neurorehabilitation
280896|NCT01749358|patient focused|patient focused
280897|NCT01749358|motor learning|motor learning
280898|NCT01749358|motor control|motor control
280899|NCT01749358|skill acquisition|skill acquisition
280900|NCT01749358|skill training|skill training
280901|NCT01749358|motor recovery|motor recovery
280902|NCT01749358|task oriented training|task oriented training
280903|NCT01749358|task specific training|task specific training
280904|NCT01749358|arm function|arm function
280905|NCT01749358|hand function|hand function
280906|NCT01749358|upper extremity|upper extremity
280907|NCT01749358|arm therapy|arm therapy
280908|NCT01749358|physical rehabilitation|physical rehabilitation
280909|NCT01749358|arm rehabilitation|arm rehabilitation
280910|NCT01749358|motor function|motor function
280911|NCT01749332|blood draw|blood draw
280912|NCT01749332|Perihepatic Phlebotomy|perihepatic phlebotomy
280913|NCT01749332|12-236|12-236
280914|NCT01749319|baclofen, withdrawal, interuption, spasticity, pharmacokinetics, tolerability, intravenous, oral|baclofen, withdrawal, interuption, spasticity, pharmacokinetics, tolerability, intravenous, oral
281019|NCT01748877|neuropathic pain|neuropathic pain
281020|NCT01748877|post herpetic neuralgia|post herpetic neuralgia
280915|NCT01749306|epidermolysis bullosa, chronic wound, wound healing, dermal repair, fibroblasts, Dermagraft|epidermolysis bullosa, chronic wound, wound healing, dermal repair, fibroblasts, dermagraft
280916|NCT01749280|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
280917|NCT01749280|MRI|mri
280918|NCT01749280|USPIO|uspio
280919|NCT01749267|dentin remineralization|dentin remineralization
280920|NCT01749267|caries regression|caries regression
280921|NCT01749254|Culprit plaques|culprit plaques
280922|NCT01749254|Vulnerable Plaques|vulnerable plaques
280923|NCT01749254|PET|pet
280924|NCT01749254|calcification|calcification
280925|NCT01749254|inflammation|inflammation
280926|NCT01749228|Fed|fed
280927|NCT01749215|pharmacotherapy|pharmacotherapy
280928|NCT01749215|alcohol dependence|alcohol dependence
280929|NCT01749215|Veterans|veterans
280930|NCT01749202|Omega 3 fatty acids|omega 3 fatty acids
280931|NCT01749202|Omega 3 Index|omega 3 index
280932|NCT01749202|Stearidonic acid (SDA)|stearidonic acid (sda)
280933|NCT01749202|Red Blood Cells|red blood cells
280934|NCT01749202|Lipids|lipids
280935|NCT01749189|soy|soy
280936|NCT01749189|whey|whey
280937|NCT01749189|casein|casein
280938|NCT01749189|muscle|muscle
280939|NCT01749189|strength|strength
280940|NCT01749189|protein|protein
280941|NCT01749176|High risk Latino patients with diabetes|high risk latino patients with diabetes
280942|NCT01749137|Overweight|overweight
280943|NCT01749124|mental illness|mental illness
280944|NCT01749124|depression|depression
280945|NCT01749124|schizophrenia|schizophrenia
280946|NCT01749124|bipolar disorder|bipolar disorder
280947|NCT01749124|IVR|ivr
280948|NCT01749124|automated|automated
280949|NCT01749124|telephone|telephone
280950|NCT01749111|bone marrow transplantation|bone marrow transplantation
280951|NCT01749111|graft versus host disease|graft versus host disease
280952|NCT01749111|Acute myelogenous leukemia|acute myelogenous leukemia
280953|NCT01749111|Acute lymphoid leukemia|acute lymphoid leukemia
280954|NCT01749111|Myeloproliferative disease|myeloproliferative disease
280955|NCT01749111|Myelodysplastic syndrome|myelodysplastic syndrome
280956|NCT01749111|Chronic myeloid leukemia|chronic myeloid leukemia
280957|NCT01749111|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
280958|NCT01749098|PF-04958242|pf-04958242
280959|NCT01749098|ketamine|ketamine
280960|NCT01749098|cognition|cognition
280961|NCT01749098|healthy volunteers|healthy volunteers
280962|NCT01749085|PF-04449913|pf-04449913
280963|NCT01749085|Food Effect|food effect
280964|NCT01749085|Drug-drug interaction|drug-drug interaction
280965|NCT01749085|CYP3A4 inhibitor|cyp3a4 inhibitor
280966|NCT01749085|Pharmacokinetics|pharmacokinetics
280967|NCT01749072|non small cell lung cancer|non small cell lung cancer
280968|NCT01749072|chemotherapy|chemotherapy
280969|NCT01749072|gefitinib|gefitinib
280970|NCT01749072|vinorelbine|vinorelbine
280971|NCT01749072|ifosfamide|ifosfamide
280972|NCT01749046|Epileptic seizures, Partial seizures|epileptic seizures, partial seizures
280973|NCT01749033|Intubation|intubation
280974|NCT01749033|Airway|airway
280975|NCT01749033|Laryngeal Mask Airway|laryngeal mask airway
280976|NCT01749020|Diabetes type II, Insulin sensitivity|diabetes type ii, insulin sensitivity
280977|NCT01749007|Veterans|veterans
280979|NCT01749007|AIDS|aids
280980|NCT01749007|Cognitive Functioning|cognitive functioning
280981|NCT01749007|Suicide|suicide
280983|NCT01748994|Fat distribution|fat distribution
280984|NCT01748994|Adipogenesis|adipogenesis
280985|NCT01748994|Adipocyte|adipocyte
280986|NCT01748994|Preadipocyte|preadipocyte
280987|NCT01748994|Ectopic fat|ectopic fat
280988|NCT01748981|Pulmonary function|pulmonary function
280989|NCT01748981|Maximal oxygen uptake|maximal oxygen uptake
280990|NCT01748981|Cardiorespiratory fitness|cardiorespiratory fitness
280991|NCT01748981|High-intensity training|high-intensity training
280992|NCT01748981|Surgery|surgery
280993|NCT01748968|Veterans|veterans
280994|NCT01748968|Human Immunodeficiency Virus Infection(HIV)/Acquired Immunodeficiency Syndrome (AIDS)|human immunodeficiency virus infection(hiv)/acquired immunodeficiency syndrome (aids)
280995|NCT01748968|Self-Directed Violence|self-directed violence
280996|NCT01748955|Major Depressive Disorder|major depressive disorder
280997|NCT01748955|MDD|mdd
280998|NCT01748955|Reward|reward
280999|NCT01748955|BOLD signal|bold signal
281000|NCT01748955|Suicide|suicide
281001|NCT01748929|Global Health|global health
281002|NCT01748929|Deworming|deworming
281003|NCT01748929|Postpartum|postpartum
281004|NCT01748929|Soil-Transmitted Helminths|soil-transmitted helminths
281005|NCT01748929|Pregnant Women|pregnant women
281006|NCT01748916|Papaya|papaya
281007|NCT01748916|Carrot|carrot
281008|NCT01748916|Tomato|tomato
281009|NCT01748916|Carotenoids|carotenoids
281010|NCT01748916|Lycopene|lycopene
281011|NCT01748916|Beta-carotene|beta-carotene
281012|NCT01748916|Beta-cryptoxanthin|beta-cryptoxanthin
281013|NCT01748903|intracranial aneurysm|intracranial aneurysm
281014|NCT01748903|cerebral aneurysm|cerebral aneurysm
281015|NCT01748903|packing density|packing density
281016|NCT01748903|Target Coils|target coils
281017|NCT01748903|aneurysm embolization|aneurysm embolization
281021|NCT01748877|sleep|sleep
281022|NCT01748734|Depression|depression
281023|NCT01748708|Magnetic seizure therapy|magnetic seizure therapy
281024|NCT01748708|Electroconvulsive therapy|electroconvulsive therapy
281025|NCT01748708|Treatment resistant depression|treatment resistant depression
281026|NCT01748708|Treatment resistance|treatment resistance
281027|NCT01748708|Randomized controlled trial|randomized controlled trial
281028|NCT01748695|Neuropathic pain|neuropathic pain
281029|NCT01748695|Spinal cord injury|spinal cord injury
281030|NCT01748682|Very low calorie diet|very low calorie diet
281031|NCT01748682|liquid diet|liquid diet
281032|NCT01748682|visceral fat|visceral fat
281033|NCT01748682|liver fat.|liver fat.
281034|NCT01748669|Arsenic|arsenic
281035|NCT01748669|Arsenicosis|arsenicosis
281036|NCT01748669|Garlic oil|garlic oil
281037|NCT01748669|Keratosis|keratosis
281038|NCT01748656|Noninvasive ventilation|noninvasive ventilation
281039|NCT01748656|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
281040|NCT01748630|scoliosis, sedation, children, fentanyl consumption, pain|scoliosis, sedation, children, fentanyl consumption, pain
281041|NCT01748604|Lymphedema|lymphedema
281042|NCT01748604|Physical Therapies|physical therapies
281043|NCT01748604|Randomized controlled study|randomized controlled study
281044|NCT01748604|Decongestive lymphatic therapy|decongestive lymphatic therapy
281045|NCT01748604|Manual lymph drainage|manual lymph drainage
281046|NCT01748604|Intermittent pneumatic compression|intermittent pneumatic compression
281047|NCT01748604|Multilayer bandages|multilayer bandages
281048|NCT01748578|Healthy|healthy
281049|NCT01748578|Interleukin 1 Receptor Inhibitor|interleukin 1 receptor inhibitor
281050|NCT01748578|Dry Eye|dry eye
281051|NCT01748565|biomarkers|biomarkers
281052|NCT01748565|oxidative stress|oxidative stress
281054|NCT01748565|prematurity|prematurity
281055|NCT01748526|Healthy|healthy
281056|NCT01748526|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
281057|NCT01748526|Pharmacokinetics|pharmacokinetics
281058|NCT01748526|Pharmacodynamics|pharmacodynamics
281059|NCT01748526|Indian|indian
281060|NCT01748513|morbidly obese patients,|morbidly obese patients,
281061|NCT01748513|preoperative volume-challenge,|preoperative volume-challenge,
281062|NCT01748513|transthoracic echocardiography,|transthoracic echocardiography,
281063|NCT01748513|TTE,|tte,
281064|NCT01748513|rapid weight loss,|rapid weight loss,
281065|NCT01748513|venous return,|venous return,
347564|NCT01460238|CLL|cll
271682|NCT01791686|DDD|ddd
281066|NCT01748513|bariatric surgery,|bariatric surgery,
281067|NCT01748513|left ventricular outflow tract,|left ventricular outflow tract,
281068|NCT01748513|stroke volume,|stroke volume,
281069|NCT01748513|diastolic function,|diastolic function,
281070|NCT01748513|hypervolemia,|hypervolemia,
281071|NCT01748513|hypovolemia|hypovolemia
281072|NCT01748500|metastatic|metastatic
281073|NCT01748461|intervention study in elderly (65+)|intervention study in elderly (65+)
281074|NCT01748461|cycle ergometer|cycle ergometer
281075|NCT01748461|physical activity|physical activity
281076|NCT01748461|physical fitness|physical fitness
281077|NCT01748461|assisted living facility|assisted living facility
281078|NCT01748448|Cutaneous malignant melanoma|cutaneous malignant melanoma
281079|NCT01748448|Vitamin D|vitamin d
281080|NCT01748448|Cholecalciferol|cholecalciferol
281081|NCT01748435|Neuropathic pain|neuropathic pain
281082|NCT01748435|Lower limb amputation|lower limb amputation
281083|NCT01748435|Pre-emptive analgesia|pre-emptive analgesia
281084|NCT01748422|Neuropathic pain|neuropathic pain
281085|NCT01748422|Arteriovenous fistulae|arteriovenous fistulae
281086|NCT01748422|End stage renal disease|end stage renal disease
281087|NCT01748409|Autonomic failure, Parkinson's disease, electrophysiological assessment, neuropathological assessment|autonomic failure, parkinson's disease, electrophysiological assessment, neuropathological assessment
281088|NCT01748396|FGF-23|fgf-23
281089|NCT01748396|Calcitriol|calcitriol
701186|NCT00972205|Solid Tumor|solid tumor
281090|NCT01748396|Calcium carbonate|calcium carbonate
281091|NCT01748396|CKD Stage 3|ckd stage 3
281092|NCT01748383|Bone marrow cells|bone marrow cells
281093|NCT01748383|Acute myocardial infarction|acute myocardial infarction
281094|NCT01748383|Transplantation of autologous mononuclear|transplantation of autologous mononuclear
281095|NCT01748383|Transplantation of autologous CD133 + cells|transplantation of autologous cd133 + cells
281096|NCT01748370|vitamin D|vitamin d
281097|NCT01748370|hypogonadism|hypogonadism
281098|NCT01748370|testosterone|testosterone
281099|NCT01748370|intervention|intervention
281100|NCT01748357|Tuberculosis|tuberculosis
281101|NCT01748357|Volatile organic compounds|volatile organic compounds
281102|NCT01748357|exhaled breath|exhaled breath
281103|NCT01748357|Siemens|siemens
281104|NCT01748331|Heart Failure|heart failure
281105|NCT01748331|Hyponatremia|hyponatremia
281106|NCT01748331|Fluid restriction|fluid restriction
281107|NCT01748318|Community acquired MRSA|community acquired mrsa
281108|NCT01748318|New Mexico Honey|new mexico honey
281110|NCT01748305|A1GDM|a1gdm
281111|NCT01748305|A2GDM|a2gdm
281112|NCT01748292|Age related|age related
281113|NCT01748292|Macular|macular
281114|NCT01748292|sub retinal fluid|sub retinal fluid
281215|NCT01747915|Blinded|blinded
281115|NCT01748292|Age related Macular degeneration|age related macular degeneration
281116|NCT01748279|COPD|copd
281117|NCT01748279|Atorvastatin|atorvastatin
281118|NCT01748279|statins|statins
281119|NCT01748279|COPD treatment|copd treatment
281120|NCT01748279|microarrays|microarrays
281121|NCT01748266|StO2|sto2
281122|NCT01748266|microcirculation|microcirculation
281123|NCT01748266|NIRS|nirs
281124|NCT01748227|self-management|self-management
281125|NCT01748227|peer support|peer support
281126|NCT01748227|social support|social support
281127|NCT01748214|continuous positive airway pressure|continuous positive airway pressure
281128|NCT01748214|high flow nasal cannula|high flow nasal cannula
281129|NCT01748214|hearing outcomes|hearing outcomes
281130|NCT01748214|noise exposure|noise exposure
281131|NCT01748214|preterm infants|preterm infants
281132|NCT01748201|Osteoarthritis|osteoarthritis
281133|NCT01748201|Hemarthrosis|hemarthrosis
281134|NCT01748201|Hemophilia A|hemophilia a
281135|NCT01748201|Hemophilia B|hemophilia b
281136|NCT01748201|Viscosupplementation|viscosupplementation
281137|NCT01748188|Subacromial syndrome|subacromial syndrome
281138|NCT01748188|Dexketoprofen|dexketoprofen
281139|NCT01748188|Phonophoresis|phonophoresis
281140|NCT01748188|Iontophoresis|iontophoresis
281141|NCT01748188|Ultrasounds|ultrasounds
281143|NCT01748188|DASH score|dash score
281144|NCT01748188|Constant score|constant score
281145|NCT01748175|Severe asthma|severe asthma
281146|NCT01748175|longitudinal study|longitudinal study
281147|NCT01748175|phenotypes|phenotypes
281148|NCT01748162|croup|croup
281149|NCT01748162|recurrent croup|recurrent croup
281150|NCT01748162|barky cough|barky cough
281151|NCT01748149|recurrent/refractory BRAFV600E-mutant gliomas|recurrent/refractory brafv600e-mutant gliomas
281152|NCT01748149|pediatrics|pediatrics
281153|NCT01748149|children|children
281154|NCT01748149|neo-adjuvant vemurafenib|neo-adjuvant vemurafenib
281155|NCT01748123|Pragmatic|pragmatic
281156|NCT01748123|Comparative Effectiveness|comparative effectiveness
281157|NCT01748110|quality of life|quality of life
281158|NCT01748110|erectile function|erectile function
281159|NCT01748097|infiltration|infiltration
281160|NCT01748097|extravasation|extravasation
281161|NCT01748097|sodium bicarbonate|sodium bicarbonate
271754|NCT01791296|intensive care|intensive care
271757|NCT01791283|Esofageal doppler|esofageal doppler
281162|NCT01748097|capnography|capnography
281163|NCT01748097|end tidal carbon dioxide|end tidal carbon dioxide
281164|NCT01748097|chemotherapy|chemotherapy
281165|NCT01748084|Systemic sclerosis|systemic sclerosis
281166|NCT01748084|Arthritis|arthritis
281167|NCT01748084|B-cell therapy, Anti-CD20 therapy|b-cell therapy, anti-cd20 therapy
281168|NCT01748084|Quality of life|quality of life
281169|NCT01748084|Scleroderma|scleroderma
281170|NCT01748084|Lung fibrosis|lung fibrosis
281171|NCT01748084|Randomised controled trial|randomised controled trial
281172|NCT01748071|fentanyl|fentanyl
281173|NCT01748071|sufentanil|sufentanil
281174|NCT01748071|individual variation|individual variation
281175|NCT01748071|pain threshold|pain threshold
281176|NCT01748071|nacro-trend index|nacro-trend index
281177|NCT01748045|Inhaled Nitric Oxide|inhaled nitric oxide
281178|NCT01748045|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
281179|NCT01748045|Late Prematurity|late prematurity
281180|NCT01748045|Chronic Respiratory Morbidity|chronic respiratory morbidity
281181|NCT01748032|depression|depression
281182|NCT01748032|intervention studies|intervention studies
281183|NCT01748019|ST1968|st1968
281184|NCT01748019|Camptothecin|camptothecin
281185|NCT01748019|Solid tumors|solid tumors
281186|NCT01748019|Topoisomerase I|topoisomerase i
281187|NCT01747993|Urinary retention; urinary catheterization; alpha blocking agents; women; elder|urinary retention; urinary catheterization; alpha blocking agents; women; elder
281188|NCT01747980|Gaucher disease|gaucher disease
701285|NCT00972686|lymphoma|lymphoma
281189|NCT01747980|human glucocerebrosidase|human glucocerebrosidase
281190|NCT01747980|plant recombinant human glucocerebrosidase|plant recombinant human glucocerebrosidase
281191|NCT01747967|Antibodies|antibodies
281192|NCT01747967|Beta cells|beta cells
281193|NCT01747967|C-peptide|c-peptide
281194|NCT01747967|GAD|gad
281195|NCT01747967|Glucose|glucose
281196|NCT01747967|Glycemia|glycemia
281197|NCT01747967|Insulin|insulin
281198|NCT01747967|Meal test|meal test
281199|NCT01747967|Pancreas|pancreas
281200|NCT01747967|Proinsulin,|proinsulin,
281201|NCT01747967|T lymphocytes|t lymphocytes
281202|NCT01747954|Respiratory Insufficiency|respiratory insufficiency
281203|NCT01747954|Physiotherapy Techniques|physiotherapy techniques
281204|NCT01747954|Respiratory Mechanics|respiratory mechanics
281205|NCT01747928|usability study|usability study
281206|NCT01747915|Primary Generalized Tonic Clonic Seizures|primary generalized tonic clonic seizures
281207|NCT01747915|Epilepsy|epilepsy
281209|NCT01747915|Efficacy|efficacy
281210|NCT01747915|Tolerability|tolerability
281211|NCT01747915|Pregabalin|pregabalin
281212|NCT01747915|Lyrica|lyrica
281213|NCT01747915|Adjunctive treatment|adjunctive treatment
281214|NCT01747915|Placebo Controlled|placebo controlled
281216|NCT01747889|chest tube|chest tube
281217|NCT01747889|lung resection|lung resection
281218|NCT01747889|patient satisfaction|patient satisfaction
281219|NCT01747889|mobility|mobility
281220|NCT01747876|Phase 1|phase 1
281221|NCT01747876|pediatric|pediatric
281222|NCT01747876|CDK4/6 inhibitor|cdk4/6 inhibitor
281223|NCT01747876|dose escalation|dose escalation
281224|NCT01747876|malignant rhabdoid tumors|malignant rhabdoid tumors
281225|NCT01747876|MRT|mrt
281226|NCT01747876|neuroblastoma|neuroblastoma
281227|NCT01747863|Hypoxic Ischemic encephalopathy|hypoxic ischemic encephalopathy
281228|NCT01747837|Renal sympathetic denervation|renal sympathetic denervation
281229|NCT01747837|Renal catheter ablation|renal catheter ablation
281230|NCT01747837|Ventricular tachycardia|ventricular tachycardia
281231|NCT01747824|agitation|agitation
281232|NCT01747824|excited delirium|excited delirium
281233|NCT01747824|pain|pain
281234|NCT01747824|unexplained-in-custody-death|unexplained-in-custody-death
281235|NCT01747824|UICD|uicd
281236|NCT01747824|visual analog scale|visual analog scale
281237|NCT01747824|VAS|vas
281238|NCT01747824|altered mental status|altered mental status
281239|NCT01747824|AMS|ams
281240|NCT01747811|Mild traumatic brain injury|mild traumatic brain injury
281241|NCT01747811|Concussion|concussion
281243|NCT01747811|brain imaging|brain imaging
281244|NCT01747811|functional magnetic resonance imaging (FMRI)|functional magnetic resonance imaging (fmri)
281245|NCT01747785|Heart failure|heart failure
281246|NCT01747785|HFpEF|hfpef
281247|NCT01747785|Dyspnea|dyspnea
281248|NCT01747785|Fatigue|fatigue
281249|NCT01747785|Shortness of Breath|shortness of breath
281250|NCT01747785|exercise|exercise
281251|NCT01747785|strain|strain
281252|NCT01747785|myocardial deformation|myocardial deformation
281253|NCT01747785|cardiac rehabilitation|cardiac rehabilitation
281254|NCT01747785|cardiac hemodynamics|cardiac hemodynamics
281255|NCT01747772|Non-focal Liver Disease|non-focal liver disease
281256|NCT01747772|Fibrosis|fibrosis
281257|NCT01747772|Shear Wave Sonoelastography|shear wave sonoelastography
281258|NCT01747772|Metavir Liver Fibrosis Grading|metavir liver fibrosis grading
281259|NCT01747759|• Knee osteoarthritis|• knee osteoarthritis
281260|NCT01747759|Total knee arthroplasty|total knee arthroplasty
281261|NCT01747759|Selfcare|selfcare
281262|NCT01747759|Booklet|booklet
281263|NCT01747759|Rehabilitation|rehabilitation
281264|NCT01747746|Rivaroxaban|rivaroxaban
281265|NCT01747746|Warfarin|warfarin
281266|NCT01747746|Anticoagulation|anticoagulation
281267|NCT01747746|Stroke|stroke
281268|NCT01747746|Thrombo-embolism|thrombo-embolism
281269|NCT01747746|Bleeding|bleeding
281270|NCT01747746|Atrial Fibrillation|atrial fibrillation
281271|NCT01747746|Cardioversion|cardioversion
281272|NCT01747733|Endoscopy|endoscopy
281273|NCT01747733|ERCP|ercp
281274|NCT01747733|PCS|pcs
281275|NCT01747733|Sedation|sedation
281276|NCT01747733|Bispectral index|bispectral index
281277|NCT01747720|breast cancer|breast cancer
281278|NCT01747720|mammographic breast density|mammographic breast density
281279|NCT01747720|vitamin D|vitamin d
281280|NCT01747720|prevention|prevention
281281|NCT01747720|randomized controlled trial|randomized controlled trial
281282|NCT01747707|gastric cancer|gastric cancer
281283|NCT01747707|gastroesophageal junction cancer|gastroesophageal junction cancer
281284|NCT01747707|chemotherapy|chemotherapy
281285|NCT01747707|docetaxel|docetaxel
281286|NCT01747707|cisplatin|cisplatin
281287|NCT01747707|S-1|s-1
281288|NCT01747694|COPD,Respiratory muscle training,Exercise tolerance|copd,respiratory muscle training,exercise tolerance
281289|NCT01747681|chondral defect|chondral defect
281290|NCT01747681|microfracture|microfracture
281291|NCT01747681|arthroscopy|arthroscopy
281292|NCT01747681|cartilage repair|cartilage repair
281293|NCT01747681|outcome study|outcome study
281294|NCT01747681|Lysholm score|lysholm score
281295|NCT01747668|Mother and Infant Pairs|mother and infant pairs
281296|NCT01747655|Early Observational Advanced|early observational advanced
281297|NCT01747655|Parkinson's Disease|parkinson's disease
281298|NCT01747642|Hepatocellular carcinoma|hepatocellular carcinoma
281299|NCT01747642|Oncoxin|oncoxin
281300|NCT01747642|Surafenib|surafenib
281301|NCT01747629|Asthma|asthma
281302|NCT01747629|dry powder inhaler|dry powder inhaler
281303|NCT01747629|short-acting beta2-agonist|short-acting beta2-agonist
281304|NCT01747629|SABA|saba
281305|NCT01747629|bronchoconstriction|bronchoconstriction
281306|NCT01747629|bronchodilation|bronchodilation
281307|NCT01747629|bronchodilator|bronchodilator
281308|NCT01747629|metered dose inhaler|metered dose inhaler
281309|NCT01747629|Albuterol Spiromax®|albuterol spiromax®
281310|NCT01747616|Chitosan-N-Acetylcysteine|chitosan-n-acetylcysteine
281311|NCT01747616|contact lenses|contact lenses
281312|NCT01747616|safety and tolerability|safety and tolerability
281313|NCT01747603|Late preterm infant|late preterm infant
281314|NCT01747603|Complications|complications
281315|NCT01747603|Hospital readmissions|hospital readmissions
281316|NCT01747603|Follow-up|follow-up
281317|NCT01747603|Pilot study|pilot study
281318|NCT01747577|Muscarine antagonist|muscarine antagonist
281319|NCT01747577|Prostatectomy|prostatectomy
281320|NCT01747577|Uroflowmetry|uroflowmetry
281321|NCT01747564|Pharmacokinetics|pharmacokinetics
281322|NCT01747564|Mirabegron|mirabegron
281323|NCT01747564|Phase 1|phase 1
281324|NCT01747564|YM178|ym178
281325|NCT01747551|Advanced|advanced
281326|NCT01747538|Uveitis|uveitis
281327|NCT01747538|Non-infectious Uveitis|non-infectious uveitis
281328|NCT01747538|Intermediate Uveitis|intermediate uveitis
281329|NCT01747538|Posterior Uveitis|posterior uveitis
281330|NCT01747538|Panuveitis|panuveitis
281331|NCT01747512|99mTc Pertechnetate|99mtc pertechnetate
281332|NCT01747512|thyroidectomy|thyroidectomy
281333|NCT01747512|thyroid neoplasms|thyroid neoplasms
281334|NCT01747473|Subjects|subjects
281335|NCT01747460|Subjects|subjects
281336|NCT01747408|subarachnoid hemorrhage|subarachnoid hemorrhage
281337|NCT01747395|Heart Failure|heart failure
281338|NCT01747395|Exercise and Physical Fitness|exercise and physical fitness
281339|NCT01747382|Treatment-resistant Hypertension|treatment-resistant hypertension
281340|NCT01747382|Chronic Kidney Disease|chronic kidney disease
281341|NCT01747382|Symplicity catheters|symplicity catheters
281342|NCT01747382|Renal denervation|renal denervation
281343|NCT01747369|surveillance study|surveillance study
281344|NCT01747369|prospective|prospective
281345|NCT01747369|observational|observational
281346|NCT01747369|health center-based|health center-based
281347|NCT01747369|pneumonia, bacterial|pneumonia, bacterial
281348|NCT01747369|pneumonia, viral|pneumonia, viral
281349|NCT01747369|meningitis, bacterial|meningitis, bacterial
281350|NCT01747369|Africa south of the Sahara|africa south of the sahara
281351|NCT01747343|Incontinence|incontinence
281352|NCT01747343|Enuresis|enuresis
281353|NCT01747330|cystic fibrosis|cystic fibrosis
281355|NCT01747317|fractional flow reserve|fractional flow reserve
281356|NCT01747317|CT|ct
281357|NCT01747317|Computed Tomography|computed tomography
281358|NCT01747304|Atypical Femur Fracture|atypical femur fracture
271954|NCT01790165|PK|pk
281359|NCT01747304|DXA|dxa
281360|NCT01747278|Pneumocystis carinii pneumonia|pneumocystis carinii pneumonia
281361|NCT01747278|prophylaxis|prophylaxis
281362|NCT01747278|trimethoprim/sulfamethoxazole|trimethoprim/sulfamethoxazole
281363|NCT01747239|Ovarian cancer|ovarian cancer
281364|NCT01747239|Platinum refractory|platinum refractory
281365|NCT01747226|Oral malodor|oral malodor
281366|NCT01747226|Halitosis|halitosis
281367|NCT01747226|Bad Breath|bad breath
281368|NCT01747226|Mouth rinses|mouth rinses
281369|NCT01747226|Mouthwashes|mouthwashes
281370|NCT01747226|Amine fluoride/Stannous fluoride|amine fluoride/stannous fluoride
281371|NCT01747226|Zinc ions|zinc ions
281372|NCT01747226|Chlorhexidine|chlorhexidine
281373|NCT01747213|Neurodegenerative|neurodegenerative
281374|NCT01747213|Cholinergic|cholinergic
281375|NCT01747213|Single Dose|single dose
281376|NCT01747213|Inhibitor|inhibitor
281377|NCT01747213|Tolerability|tolerability
281378|NCT01747200|Repetitive TMS (rTMS)|repetitive tms (rtms)
281379|NCT01747187|Septic shock|septic shock
281380|NCT01747187|Critical care|critical care
281381|NCT01747187|cardiac failure|cardiac failure
281382|NCT01747174|STEMI|stemi
281383|NCT01747174|Microvascular Obstruction|microvascular obstruction
281384|NCT01747174|No-reflow|no-reflow
281385|NCT01747174|Adenosine|adenosine
281386|NCT01747174|Sodium Nitroprusside|sodium nitroprusside
281387|NCT01747148|Antisense|antisense
281388|NCT01747148|Influenza|influenza
281389|NCT01747148|IV Injection|iv injection
281390|NCT01747148|RNA Based Therapeutic|rna based therapeutic
281391|NCT01747148|RNA Interference|rna interference
703387|NCT00979303|Pediatric|pediatric
281392|NCT01747135|2-Hydroxypropyl-B-Cyclodextrin|2-hydroxypropyl-b-cyclodextrin
281393|NCT01747135|Niemann-Pick Disease, Type C1|niemann-pick disease, type c1
281394|NCT01747135|Neurodegeneration|neurodegeneration
281395|NCT01747122|epidurals|epidurals
281396|NCT01747122|wound catheters|wound catheters
281397|NCT01747122|liver resection|liver resection
281398|NCT01747122|liver surgery|liver surgery
281399|NCT01747109|Acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
281400|NCT01747109|Preoxygenation|preoxygenation
281401|NCT01747109|Crash induction|crash induction
281402|NCT01747096|Gastroenteropancreatic Neuroendocrine Tumors|gastroenteropancreatic neuroendocrine tumors
281403|NCT01747096|immuno PET (iPET)|immuno pet (ipet)
281404|NCT01747096|Gallium (68-Ga)|gallium (68-ga)
281405|NCT01747096|DOTANOC|dotanoc
281406|NCT01747070|Electro Acupuncture|electro acupuncture
281407|NCT01747070|Knee Osteoarthritis|knee osteoarthritis
281408|NCT01747070|Chronic pain|chronic pain
281409|NCT01747070|Cortical Excitability|cortical excitability
281410|NCT01747044|Fibromyalgia|fibromyalgia
281411|NCT01747044|Diffuse Noxious Inhibitory Controls|diffuse noxious inhibitory controls
281412|NCT01747044|Milnacipran|milnacipran
281413|NCT01747031|iFR|ifr
281414|NCT01747031|FFR|ffr
281415|NCT01747031|instantaneous wave-free ratio|instantaneous wave-free ratio
281416|NCT01747031|fractional flow reserve|fractional flow reserve
281417|NCT01747018|Platelet-Rich Plasma|platelet-rich plasma
281418|NCT01747018|Knee pain|knee pain
281419|NCT01747018|osteoarthritis|osteoarthritis
281420|NCT01747018|degenerative chondropathy|degenerative chondropathy
281421|NCT01747018|Intraarticular injection|intraarticular injection
281422|NCT01747005|abdominal hysterectomy|abdominal hysterectomy
281423|NCT01747005|enhanced recovery after surgery|enhanced recovery after surgery
281424|NCT01747005|inflammatory response|inflammatory response
281425|NCT01747005|ERAS|eras
281426|NCT01747005|combined spinal-epidural anesthesia|combined spinal-epidural anesthesia
281427|NCT01746979|TH-302|th-302
281428|NCT01746979|Evofosfamide|evofosfamide
281429|NCT01746979|Pancreatic Cancer|pancreatic cancer
281430|NCT01746979|EMR200592-001|emr200592-001
281431|NCT01746966|gleno-humeral joint synovitis|gleno-humeral joint synovitis
281432|NCT01746966|anterior shoulder US|anterior shoulder us
281433|NCT01746966|rotator interval|rotator interval
281434|NCT01746940|Surgery|surgery
281435|NCT01746940|Surgeries|surgeries
281436|NCT01746940|Nasal|nasal
281437|NCT01746940|Cavities|cavities
281438|NCT01746940|Diagnosis|diagnosis
281439|NCT01746940|Diagnostic|diagnostic
281440|NCT01746940|Nose|nose
281441|NCT01746940|Rhinoplasty|rhinoplasty
281442|NCT01746940|Endoscopy|endoscopy
281443|NCT01746940|Bronchoscopy|bronchoscopy
281444|NCT01746927|cricoid pressure, glidescope|cricoid pressure, glidescope
281445|NCT01746901|Relative abuse potential study; oxycodone; nalteone; Opioid-related disorders; drug abusers|relative abuse potential study; oxycodone; nalteone; opioid-related disorders; drug abusers
281446|NCT01746901|Chronic pain|chronic pain
281447|NCT01746875|Angiogenesis inhibitors|angiogenesis inhibitors
281448|NCT01746875|Photochemotherapy|photochemotherapy
281449|NCT01746875|Vascular Endothelium Growth Factors|vascular endothelium growth factors
281450|NCT01746875|Aflibercept|aflibercept
281451|NCT01746862|Saizen®|saizen®
281452|NCT01746862|Recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
272105|NCT01789320|SCS|scs
281453|NCT01746862|Idiopathic short stature|idiopathic short stature
281454|NCT01746862|Height velocity|height velocity
281455|NCT01746862|Bone age|bone age
281456|NCT01746849|LUPRON DEPOT|lupron depot
281457|NCT01746849|PALIFERMIN|palifermin
281458|NCT01746849|12-077|12-077
281459|NCT01746836|Leukemia|leukemia
281460|NCT01746836|Chronic Myeloid Leukemia|chronic myeloid leukemia
281461|NCT01746836|CML|cml
281462|NCT01746836|Imatinib-resistant or intolerant|imatinib-resistant or intolerant
281463|NCT01746836|Imatinib failure|imatinib failure
281464|NCT01746836|Ph-positive (by cytogenetics or FISH)|ph-positive (by cytogenetics or fish)
281465|NCT01746836|BCR-ABL-positive (by PCR) CML in chronic phase|bcr-abl-positive (by pcr) cml in chronic phase
281466|NCT01746836|Ponatinib|ponatinib
281467|NCT01746836|AP24534|ap24534
281468|NCT01746823|Keratoconus|keratoconus
281469|NCT01746823|Proteomics|proteomics
281470|NCT01746810|Metastatic|metastatic
281471|NCT01746810|Lung Cancer|lung cancer
281472|NCT01746810|NSCLC|nsclc
281473|NCT01746797|infertility|infertility
281474|NCT01746797|depression|depression
281475|NCT01746797|IVF|ivf
281476|NCT01746797|IUI|iui
281477|NCT01746797|fertility treatment|fertility treatment
281478|NCT01746784|Cystic Fibrosis|cystic fibrosis
281479|NCT01746784|F508del-CFTR|f508del-cftr
281480|NCT01746784|N6022|n6022
281481|NCT01746784|S-Nitrosoglutathione|s-nitrosoglutathione
281482|NCT01746771|HM781-36B, Paclitaxel, Trastuzumab|hm781-36b, paclitaxel, trastuzumab
281785|NCT01745198|depression|depression
281483|NCT01746758|Reproductive health, mHealth, Cluster randomised trial|reproductive health, mhealth, cluster randomised trial
281484|NCT01746693|retinal vessel diameter|retinal vessel diameter
281485|NCT01746693|retinal oxygen saturation|retinal oxygen saturation
281486|NCT01746693|high resolution functional and anatomical imaging|high resolution functional and anatomical imaging
281487|NCT01746693|inner retinal function|inner retinal function
281488|NCT01746693|flicker response|flicker response
281489|NCT01746680|rheumatoid arthritis|rheumatoid arthritis
281491|NCT01746680|tacrolimus|tacrolimus
281492|NCT01746680|Disease Activity Score 28|disease activity score 28
281494|NCT01746667|Social Anxiety Disorder|social anxiety disorder
281495|NCT01746667|Social Phobia|social phobia
281496|NCT01746667|Virtual Reality|virtual reality
281497|NCT01746667|Exposure|exposure
281498|NCT01746654|S.aureus|s.aureus
281499|NCT01746654|Methicillin Resistant S.aureus (MRSA)|methicillin resistant s.aureus (mrsa)
281500|NCT01746654|Nasal carrier status|nasal carrier status
281501|NCT01746654|Prophylaxis|prophylaxis
281502|NCT01746641|Remifentanil|remifentanil
281503|NCT01746641|Propofol|propofol
281504|NCT01746641|Sedation|sedation
281505|NCT01746641|Endoscopy|endoscopy
281506|NCT01746641|Gastroenterology|gastroenterology
281507|NCT01746641|Target controlled infusion effect site|target controlled infusion effect site
281508|NCT01746628|type 0 myomata|type 0 myomata
281509|NCT01746628|type 1 myomata|type 1 myomata
281510|NCT01746628|type 2 myomata|type 2 myomata
281511|NCT01746628|bleeding|bleeding
281512|NCT01746628|hemorrhage|hemorrhage
281513|NCT01746628|hysteroscopy|hysteroscopy
281514|NCT01746628|FloSeal|floseal
281515|NCT01746615|branch retinal vein occlusion|branch retinal vein occlusion
281516|NCT01746615|dynamic vessel analyzer|dynamic vessel analyzer
281517|NCT01746615|fourier-domain OCT|fourier-domain oct
281518|NCT01746615|retinal oxygen saturation|retinal oxygen saturation
281519|NCT01746602|topical lubricants|topical lubricants
281520|NCT01746602|tear film thickness|tear film thickness
281521|NCT01746602|anti-glaucoma drugs|anti-glaucoma drugs
281522|NCT01746602|break up time|break up time
281523|NCT01746602|anti-glaucoma treatment|anti-glaucoma treatment
281524|NCT01746589|LASIK|lasik
281525|NCT01746576|volunteers|volunteers
281526|NCT01746563|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
281527|NCT01746563|Ranibizumab|ranibizumab
281528|NCT01746563|Panretinal Photocoagulation|panretinal photocoagulation
281529|NCT01746524|Arthroplasty|arthroplasty
281530|NCT01746524|Replacement|replacement
281531|NCT01746524|Knee|knee
281532|NCT01746511|glycerin suppositories|glycerin suppositories
281533|NCT01746511|glycerin shaves|glycerin shaves
281534|NCT01746511|neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
281535|NCT01746511|idiopathic hyperbilirubinemia|idiopathic hyperbilirubinemia
281536|NCT01746511|jaundice|jaundice
281537|NCT01746511|neonatal jaundice|neonatal jaundice
281538|NCT01746511|prematurity|prematurity
281539|NCT01746498|Alzheimer disease|alzheimer disease
281540|NCT01746498|Direct current stimulation|direct current stimulation
281541|NCT01746498|cognitive function|cognitive function
281542|NCT01746498|memory|memory
281543|NCT01746485|Volunteers|volunteers
281544|NCT01746459|Sustainability of Innovations|sustainability of innovations
281545|NCT01746459|Knowledge Translation|knowledge translation
281546|NCT01746459|Gerontology|gerontology
281547|NCT01746459|Mobility|mobility
281548|NCT01746420|elbow|elbow
281549|NCT01746407|Emergency Department|emergency department
348155|NCT01457768|SOF|sof
281550|NCT01746407|Infection|infection
281551|NCT01746407|Sepsis|sepsis
281552|NCT01746394|obesity|obesity
281553|NCT01746394|pregnant women|pregnant women
281554|NCT01746394|nutrition assessment|nutrition assessment
281555|NCT01746394|health behavior|health behavior
281556|NCT01746381|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
281557|NCT01746381|non-invasive ventilation|non-invasive ventilation
281558|NCT01746381|home ventilation|home ventilation
281559|NCT01746381|IVAPS|ivaps
281560|NCT01746381|neuromuscular diseases|neuromuscular diseases
281561|NCT01746368|advance directives|advance directives
281562|NCT01746355|atypical facial pain|atypical facial pain
281563|NCT01746355|atypical odontalgia|atypical odontalgia
281564|NCT01746355|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
281565|NCT01746355|neuropathic pain|neuropathic pain
281566|NCT01746355|chronic pain|chronic pain
281567|NCT01746355|assessment|assessment
281568|NCT01746329|Obesity, insulin resistance, muscle perfusion|obesity, insulin resistance, muscle perfusion
281569|NCT01746303|Working memory|working memory
281570|NCT01746303|Long-term memory|long-term memory
281571|NCT01746303|Neurocognition|neurocognition
281572|NCT01746303|Dietary supplementation|dietary supplementation
281573|NCT01746303|dementia|dementia
281574|NCT01746290|Cardiac Arrest, cardiopulmonary resuscitation, automated external defibrillators, smartphones|cardiac arrest, cardiopulmonary resuscitation, automated external defibrillators, smartphones
281575|NCT01746277|non small cell lung cancer|non small cell lung cancer
281576|NCT01746277|chemotherapy|chemotherapy
281786|NCT01745198|vitamin B12|vitamin b12
281577|NCT01746277|epidermal growth factor receptor tyrosine kinase inhibitor|epidermal growth factor receptor tyrosine kinase inhibitor
281578|NCT01746277|retreatment|retreatment
281579|NCT01746264|Obesity|obesity
281580|NCT01746264|Endothelial dysfunction|endothelial dysfunction
281581|NCT01746264|Vitamin D deficiency|vitamin d deficiency
281582|NCT01746251|EGFR mutation|egfr mutation
281583|NCT01746251|Resected|resected
281584|NCT01746238|soft tissue|soft tissue
281585|NCT01746238|high grade|high grade
281586|NCT01746225|Metastatic|metastatic
281587|NCT01746225|Breast|breast
281588|NCT01746225|Cancer|cancer
281589|NCT01746225|HER2-negative Stage IV|her2-negative stage iv
281590|NCT01746225|No previous chemotherapy|no previous chemotherapy
281591|NCT01746212|Degenerative Disc Disease|degenerative disc disease
281592|NCT01746212|InQu Bone Graft Extender and Substitute|inqu bone graft extender and substitute
281593|NCT01746212|Anterior Lumbar Interbody Fusion|anterior lumbar interbody fusion
281594|NCT01746212|Oswestry Disability Index|oswestry disability index
281595|NCT01746212|Visual Analog Scale|visual analog scale
281596|NCT01746212|Stand-alone ALIF|stand-alone alif
281597|NCT01746212|Bone Marrow Aspirate Concentrate|bone marrow aspirate concentrate
281598|NCT01746212|Fusion rate|fusion rate
281599|NCT01746212|Disc Height|disc height
281600|NCT01746212|Mean Optical Density|mean optical density
281601|NCT01746212|Integrated Optical Density|integrated optical density
281602|NCT01746173|T Cell lymphoma|t cell lymphoma
281603|NCT01746160|dental implant|dental implant
281604|NCT01746160|healing|healing
281605|NCT01746160|implant stability|implant stability
281606|NCT01746147|MDS|mds
281607|NCT01746147|AML|aml
281608|NCT01746147|allogeneic SCT|allogeneic sct
281609|NCT01746108|Pneumococcal infection|pneumococcal infection
281610|NCT01746108|Synflorix|synflorix
281611|NCT01746108|Children|children
281612|NCT01746108|Immunogenicity|immunogenicity
281613|NCT01746108|Safety|safety
281614|NCT01746095|Cystic Fibrosis|cystic fibrosis
281615|NCT01746095|MRSA|mrsa
281616|NCT01746095|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
281617|NCT01746095|Lung infection|lung infection
281618|NCT01746095|AeroVanc|aerovanc
281619|NCT01746095|Vancomycin|vancomycin
281620|NCT01746082|influenza, H3N2, H3N2v, vaccine, unadjuvanted, Parent Protocol|influenza, h3n2, h3n2v, vaccine, unadjuvanted, parent protocol
281621|NCT01746069|smoking|smoking
281622|NCT01746069|smoke cessation|smoke cessation
281623|NCT01746069|sms|sms
281624|NCT01746069|quit smoke|quit smoke
281625|NCT01746056|Warts|warts
281626|NCT01746056|Verruca|verruca
281627|NCT01746056|Heat patch|heat patch
281628|NCT01746043|Esophageal cancer|esophageal cancer
281629|NCT01746043|Chemotherapy|chemotherapy
281630|NCT01746043|Radiation therapy|radiation therapy
281631|NCT01746043|XRT|xrt
281632|NCT01746043|Chemoradiation|chemoradiation
281633|NCT01746043|CXRT|cxrt
281634|NCT01746043|Symptom Burden|symptom burden
281635|NCT01746043|Armodafinil|armodafinil
281636|NCT01746043|Nuvigil|nuvigil
281637|NCT01746043|Minocycline|minocycline
281639|NCT01746043|Minocin|minocin
281640|NCT01746043|Minocin PAC|minocin pac
281641|NCT01746043|Myrac|myrac
281642|NCT01746043|Solodyn|solodyn
281643|NCT01746043|Placebo|placebo
281644|NCT01746043|Sugar pill|sugar pill
281645|NCT01746043|Questionnaires|questionnaires
281646|NCT01746043|Surveys|surveys
281647|NCT01745952|Epilepsies, Partial|epilepsies, partial
272254|NCT01788787|AAC|aac
281648|NCT01745952|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
281649|NCT01745939|Back pain|back pain
281650|NCT01745913|Leukemia|leukemia
281651|NCT01745913|Lymphoma|lymphoma
281652|NCT01745900|Diabetes|diabetes
281653|NCT01745900|Gestational Diabetes|gestational diabetes
281654|NCT01745900|Female|female
281655|NCT01745887|Dry Eye Syndrome|dry eye syndrome
281656|NCT01745887|Interleukin 1 Receptor Inhibitor|interleukin 1 receptor inhibitor
281657|NCT01745874|Rectal cancer|rectal cancer
281658|NCT01745874|Whole-body MRI|whole-body mri
281659|NCT01745874|FDG-PET-CT|fdg-pet-ct
281660|NCT01745874|preoperative staging|preoperative staging
281661|NCT01745848|Roflumilast|roflumilast
281662|NCT01745848|COPD|copd
281663|NCT01745822|Hepatitis B|hepatitis b
281664|NCT01745822|Hepatitis B sAg|hepatitis b sag
281665|NCT01745822|Hepatitis B eAg|hepatitis b eag
281666|NCT01745822|pregnancy|pregnancy
281667|NCT01745796|Pseudomonas Aeruginosa|pseudomonas aeruginosa
281668|NCT01745796|Ventilated Acquired Pneumonia|ventilated acquired pneumonia
281669|NCT01745796|Transmission modes|transmission modes
281670|NCT01745718|prostate cancer|prostate cancer
281671|NCT01745718|targeted biopsies|targeted biopsies
281672|NCT01745718|cytological imprints|cytological imprints
281673|NCT01745718|histology|histology
281674|NCT01745705|Manipulation|manipulation
281675|NCT01745705|Balance|balance
281676|NCT01745705|Proprioception|proprioception
281677|NCT01745679|Ceftriaxone|ceftriaxone
281678|NCT01745679|Adverse drug effects|adverse drug effects
281679|NCT01745679|Therapeutic monitoring|therapeutic monitoring
281680|NCT01745679|Meningitis|meningitis
281787|NCT01745198|folate|folate
281681|NCT01745666|Long QT syndrome, stress tests|long qt syndrome, stress tests
281682|NCT01745640|Multiple myeloma|multiple myeloma
281683|NCT01745640|dexamethasone|dexamethasone
281684|NCT01745640|pomalidomide|pomalidomide
281685|NCT01745640|response|response
281686|NCT01745640|safety|safety
281687|NCT01745640|del 17p|del 17p
281688|NCT01745640|t 4-14|t 4-14
281689|NCT01745614|Bioequivalence|bioequivalence
281690|NCT01745614|Nimesulide|nimesulide
281691|NCT01745614|Pharmacokinetics|pharmacokinetics
281692|NCT01745614|Mexico|mexico
281693|NCT01745588|CC-4047(Pomalidomide)Pomalyst|cc-4047(pomalidomide)pomalyst
281694|NCT01745588|Clarithromycin|clarithromycin
281695|NCT01745588|Biaxin|biaxin
281696|NCT01745588|DEXAMETHASONE|dexamethasone
281697|NCT01745588|(ClaPD)|(clapd)
281698|NCT01745588|Stem cell|stem cell
281699|NCT01745588|12-138|12-138
281700|NCT01745575|Bioequivalence|bioequivalence
281701|NCT01745575|Alprazolam|alprazolam
281702|NCT01745575|Anxiety disorders|anxiety disorders
281703|NCT01745575|Mexico|mexico
281704|NCT01745562|Alprazolam|alprazolam
281705|NCT01745562|Anxiety disorders|anxiety disorders
281706|NCT01745562|Bioequivalence|bioequivalence
281707|NCT01745562|Mexico|mexico
281708|NCT01745549|diabetes|diabetes
281709|NCT01745549|insulin therapy|insulin therapy
281710|NCT01745549|needle|needle
281711|NCT01745536|Oocyte vitrification|oocyte vitrification
281712|NCT01745536|survival rate|survival rate
281713|NCT01745536|egg banking|egg banking
281714|NCT01745536|ovum donation|ovum donation
281715|NCT01745523|Oocyte vitrification|oocyte vitrification
281716|NCT01745523|survival rate|survival rate
281717|NCT01745523|egg banking|egg banking
283017|NCT01740115|Alcohol Use|alcohol use
281718|NCT01745523|ovum donation|ovum donation
281719|NCT01745510|docosahexaenoic acid|docosahexaenoic acid
281720|NCT01745510|n-3 fatty acids|n-3 fatty acids
281721|NCT01745510|necrotizing enterocolitis|necrotizing enterocolitis
281722|NCT01745510|preterm infants|preterm infants
281723|NCT01745497|Autism Spectrum Disorder|autism spectrum disorder
281724|NCT01745497|Insomnia|insomnia
281725|NCT01745484|SPECT|spect
281726|NCT01745484|Toxicity|toxicity
281727|NCT01745484|Non-small-cell lung cancer|non-small-cell lung cancer
281728|NCT01745484|Definitive Radiotherapy|definitive radiotherapy
281729|NCT01745484|Radiation pneumonitis|radiation pneumonitis
281730|NCT01745484|Randomized study|randomized study
281731|NCT01745471|Abdominal Adipose|abdominal adipose
281732|NCT01745471|Gluteal Adipose|gluteal adipose
281733|NCT01745471|Polycystic Ovary Syndrome|polycystic ovary syndrome
281734|NCT01745471|Obesity|obesity
281735|NCT01745471|Women|women
281736|NCT01745445|limited-stage small cell lung cancer|limited-stage small cell lung cancer
281737|NCT01745445|concurrent chemo-radiotherapy|concurrent chemo-radiotherapy
281738|NCT01745432|ADBLOCK|adblock
281739|NCT01745432|Adhesion Barrier System|adhesion barrier system
281740|NCT01745432|laparoscopic surgery|laparoscopic surgery
281741|NCT01745432|myomectomy|myomectomy
281742|NCT01745419|COPD|copd
281744|NCT01745419|Haptoglobin|haptoglobin
281745|NCT01745393|Smoking Cessation|smoking cessation
281746|NCT01745393|Secondhand Smoke|secondhand smoke
281747|NCT01745393|Passive Smoking|passive smoking
281748|NCT01745393|Cotinine|cotinine
281749|NCT01745393|Nicotine Replacement Products|nicotine replacement products
348404|NCT01456780|MGD|mgd
272397|NCT01788241|BMI|bmi
281750|NCT01745380|operative|operative
281751|NCT01745380|dental procedure|dental procedure
281752|NCT01745367|Tivozanib hydrochloride|tivozanib hydrochloride
281753|NCT01745367|triple negative breast cancer|triple negative breast cancer
281754|NCT01745367|paclitaxel|paclitaxel
281755|NCT01745367|pharmacokinetics|pharmacokinetics
281756|NCT01745367|biomarkers|biomarkers
281757|NCT01745367|metastatic breast cancer|metastatic breast cancer
281758|NCT01745367|mBC|mbc
281759|NCT01745367|TNBC|tnbc
281760|NCT01745328|recurrent urinary tract infection|recurrent urinary tract infection
281761|NCT01745328|antibiotics|antibiotics
281762|NCT01745328|traditional chinese medicine|traditional chinese medicine
281763|NCT01745315|total laparoscopic hysterectomy|total laparoscopic hysterectomy
281764|NCT01745315|LigaSure|ligasure
281765|NCT01745315|EnSeal|enseal
281766|NCT01745315|Halo PKS Cutting forceps|halo pks cutting forceps
281767|NCT01745315|electrothermal bipolar vessel sealer|electrothermal bipolar vessel sealer
281768|NCT01745315|advanced bipolar device|advanced bipolar device
281769|NCT01745302|lung cancer|lung cancer
281770|NCT01745302|traditional Chinese medicine|traditional chinese medicine
281771|NCT01745302|EGFR-TKI|egfr-tki
281772|NCT01745289|Breast Cancer|breast cancer
281773|NCT01745289|Survival|survival
281774|NCT01745289|Recurrence|recurrence
281775|NCT01745276|Pin fixation|pin fixation
281776|NCT01745276|Osteotomy|osteotomy
281777|NCT01745276|hemicallotasis|hemicallotasis
281778|NCT01745250|lip|lip
281779|NCT01745250|fillers|fillers
281780|NCT01745250|Hyaluronic acid|hyaluronic acid
281781|NCT01745237|Sarcoidosis|sarcoidosis
281782|NCT01745237|Cardiac Magnetic Resonance|cardiac magnetic resonance
281783|NCT01745198|homocysteinemia|homocysteinemia
281784|NCT01745198|dementia|dementia
281788|NCT01745198|mild cognitive impairment|mild cognitive impairment
281789|NCT01745198|alzheimer's|alzheimer's
281790|NCT01745198|homocysteine|homocysteine
281791|NCT01745185|Fabry Disease|fabry disease
281792|NCT01745185|immunity|immunity
281793|NCT01745185|antibody|antibody
281794|NCT01745159|tacrolimus|tacrolimus
281795|NCT01745159|Protopic|protopic
281796|NCT01745159|pediatric|pediatric
281797|NCT01745159|atopic dermatitis|atopic dermatitis
281798|NCT01745159|China|china
281799|NCT01745146|traumatic brain injury|traumatic brain injury
281800|NCT01745146|TBI|tbi
281801|NCT01745146|head injury|head injury
281802|NCT01745146|brain injury|brain injury
281803|NCT01745146|Psych-educational treatment|psych-educational treatment
281804|NCT01745146|Anger|anger
281805|NCT01745146|irritability|irritability
281806|NCT01745146|anger management|anger management
281807|NCT01745133|Olux E foam|olux e foam
281808|NCT01745133|Sorilux foam|sorilux foam
281809|NCT01745120|gene therapy|gene therapy
281810|NCT01745120|beta thalassemia|beta thalassemia
281811|NCT01745120|hemoglobin|hemoglobin
281812|NCT01745120|anemia|anemia
281813|NCT01745120|CD34|cd34
281814|NCT01745107|T2-3N0M0 disease of esophageal neoplasm|t2-3n0m0 disease of esophageal neoplasm
281815|NCT01745107|postoperative radiotherapy|postoperative radiotherapy
281816|NCT01745107|intensity modulated radiation therapy|intensity modulated radiation therapy
281817|NCT01745107|survival|survival
281818|NCT01745094|mirabegron|mirabegron
281819|NCT01745094|solifenacin|solifenacin
281820|NCT01745068|fragility fracture|fragility fracture
281821|NCT01745068|osteoporosis|osteoporosis
281822|NCT01745068|fall prevention|fall prevention
281823|NCT01745068|integrated program|integrated program
281824|NCT01745068|interorganizational collaboration|interorganizational collaboration
281825|NCT01745068|Canada|canada
281826|NCT01745068|controlled clinical trial|controlled clinical trial
281827|NCT01745068|evaluation|evaluation
281828|NCT01745055|Pharmacokinetics|pharmacokinetics
281829|NCT01745055|oral JAK inhibitor|oral jak inhibitor
281830|NCT01745055|methotrexate (MTX)|methotrexate (mtx)
281831|NCT01745055|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
281832|NCT01745042|Postmenopausal Women|postmenopausal women
281833|NCT01745042|Body Composition|body composition
281834|NCT01745042|Metabolic Syndrome|metabolic syndrome
281835|NCT01745042|Menopause Symptoms|menopause symptoms
281836|NCT01745029|Gastrointestinal Motility|gastrointestinal motility
281837|NCT01745029|Inflammatory Bowel Disease|inflammatory bowel disease
281838|NCT01745029|Transit time|transit time
281839|NCT01745016|dietary supplement|dietary supplement
281840|NCT01745016|carnosine|carnosine
281841|NCT01745003|Fibromyalgia|fibromyalgia
281842|NCT01744990|Nuts|nuts
281843|NCT01744990|allergy|allergy
281844|NCT01744990|Oral food challenge|oral food challenge
281845|NCT01744990|skin testing|skin testing
281846|NCT01744990|basophil activation tests|basophil activation tests
281848|NCT01744964|apomorphine|apomorphine
281849|NCT01744964|dopamine transporter gene|dopamine transporter gene
281850|NCT01744964|SLC6A3|slc6a3
281851|NCT01744964|cold pressor test|cold pressor test
348591|NCT01456000|AF|af
272444|NCT01788046|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
272445|NCT01788007|Actinic Keratosis|actinic keratosis
281852|NCT01744964|tolerance|tolerance
281853|NCT01744964|experimental pain|experimental pain
281854|NCT01744964|dopamine agonist|dopamine agonist
281855|NCT01744951|Adoption|adoption
281856|NCT01744951|Foster care|foster care
281857|NCT01744951|Substance abuse|substance abuse
281858|NCT01744951|Older children|older children
281859|NCT01744951|Mental health|mental health
281860|NCT01744938|Postoperative Complications,|postoperative complications,
281861|NCT01744938|mortality,|mortality,
281862|NCT01744938|length of Stay,|length of stay,
281863|NCT01744938|economics|economics
281864|NCT01744912|Lymphoma|lymphoma
281865|NCT01744912|monoclonal antibody|monoclonal antibody
281866|NCT01744912|immunomodulatory agent|immunomodulatory agent
281867|NCT01744912|ublituximab|ublituximab
281868|NCT01744912|lenalidomide|lenalidomide
281869|NCT01744899|Lumbosacral spine|lumbosacral spine
281870|NCT01744899|Nerve roots|nerve roots
281871|NCT01744899|Sitting|sitting
281872|NCT01744899|H-reflex|h-reflex
281873|NCT01744886|One-Lung Ventilation|one-lung ventilation
281874|NCT01744886|Thoracic Surgical Procedures|thoracic surgical procedures
281875|NCT01744886|Cardiac Surgical Procedures|cardiac surgical procedures
281876|NCT01744834|Reward-based learning|reward-based learning
281877|NCT01744834|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
281878|NCT01744834|Functional imaging|functional imaging
281879|NCT01744834|alcohol use disorder risk|alcohol use disorder risk
281880|NCT01744821|High Risk|high risk
281881|NCT01744808|Healthy|healthy
281882|NCT01744808|Normal|normal
281883|NCT01744795|cardiac output|cardiac output
281884|NCT01744795|thermodilution|thermodilution
281885|NCT01744795|esophageal doppler|esophageal doppler
281886|NCT01744795|trending ability|trending ability
281887|NCT01744782|Nephropathic Cystinosis|nephropathic cystinosis
281888|NCT01744782|Cysteamine|cysteamine
281889|NCT01744782|Delayed-release Cysteamine|delayed-release cysteamine
281890|NCT01744782|CTNS Protein, Human|ctns protein, human
281891|NCT01744782|Orphan Disease|orphan disease
281892|NCT01744769|thyroid cancer|thyroid cancer
281893|NCT01744769|hypothyroidism|hypothyroidism
281894|NCT01744769|metabolic parameters|metabolic parameters
281895|NCT01744769|Hypothyroidism after levothyroxine withdrawal|hypothyroidism after levothyroxine withdrawal
281896|NCT01744756|Subconjunctival Bevacizumab|subconjunctival bevacizumab
281897|NCT01744756|Recurrent pterygium|recurrent pterygium
281898|NCT01744743|preconception|preconception
281899|NCT01744743|hypothyroidism|hypothyroidism
281900|NCT01744743|neurocognitive development|neurocognitive development
281901|NCT01744730|Bacterial infections|bacterial infections
281902|NCT01744730|Obesity|obesity
281903|NCT01744730|pharmacokinetics|pharmacokinetics
281904|NCT01744730|clindamycin|clindamycin
281905|NCT01744717|Pain|pain
281906|NCT01744717|mechanical ventilation|mechanical ventilation
281907|NCT01744717|uncommunicative|uncommunicative
281908|NCT01744717|Adult ICU patients pain|adult icu patients pain
281909|NCT01744704|Nerve Growth Factor|nerve growth factor
281910|NCT01744704|Ophthalmic Solutions|ophthalmic solutions
281911|NCT01744704|Eye Drops|eye drops
281912|NCT01744704|rh-NGF|rh-ngf
281914|NCT01744691|SLL|sll
281915|NCT01744665|CML, chronic myeloid leukemia, stop, niotinib, discontinue, imatinib, switch, MR4.5, undetectable, bcr-abl|cml, chronic myeloid leukemia, stop, niotinib, discontinue, imatinib, switch, mr4.5, undetectable, bcr-abl
281916|NCT01744652|Advanced Cancers|advanced cancers
281917|NCT01744652|Advanced Malignancies|advanced malignancies
281918|NCT01744652|Unresectable|unresectable
281919|NCT01744652|Metastatic|metastatic
281920|NCT01744652|Crizotinib|crizotinib
281921|NCT01744652|PF-02341066|pf-02341066
281922|NCT01744652|Xalkori|xalkori
281923|NCT01744652|Dasatinib|dasatinib
281924|NCT01744652|BMS-354825|bms-354825
281925|NCT01744652|Sprycel|sprycel
281926|NCT01744639|Hepatocellular carcinoma|hepatocellular carcinoma
281927|NCT01744639|Radioablation|radioablation
281928|NCT01744626|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
281929|NCT01744626|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
281930|NCT01744613|Clopidogrel|clopidogrel
281931|NCT01744613|platelet inhibition|platelet inhibition
281932|NCT01744613|antiplatelet therapy|antiplatelet therapy
281933|NCT01744613|peripheral arterial disease|peripheral arterial disease
281934|NCT01744613|endovascular treatment|endovascular treatment
281935|NCT01744613|angioplasty|angioplasty
281936|NCT01744613|stenting|stenting
281937|NCT01744600|Dementia|dementia
281938|NCT01744600|Music Therapy|music therapy
281939|NCT01744587|EBV|ebv
281940|NCT01744587|EGCG|egcg
281941|NCT01744561|Exercise|exercise
281942|NCT01744561|Motivation|motivation
281943|NCT01744561|Feedback|feedback
281944|NCT01744561|web-based diary|web-based diary
281945|NCT01744561|pedometer|pedometer
281946|NCT01744535|smartphone|smartphone
281947|NCT01744535|smartphone app|smartphone app
281948|NCT01744535|smartphone application|smartphone application
281950|NCT01744535|overweight|overweight
281951|NCT01744535|self monitoring|self monitoring
281952|NCT01744496|Parkinson's Disease|parkinson's disease
281953|NCT01744496|Rotigotine|rotigotine
281954|NCT01744496|Chronic Pain|chronic pain
281955|NCT01744496|Nonmotor symptoms|nonmotor symptoms
281956|NCT01744483|pneumonia|pneumonia
281957|NCT01744483|endotracheal intubation|endotracheal intubation
281958|NCT01744470|Renal|renal
281959|NCT01744470|Transplantation|transplantation
281960|NCT01744470|Tacrolimus|tacrolimus
281961|NCT01744457|tear film osmolarity|tear film osmolarity
281962|NCT01744457|objective scattering index|objective scattering index
281963|NCT01744457|tear break up time|tear break up time
281964|NCT01744457|Schirmer I test|schirmer i test
281965|NCT01744418|ESRD|esrd
281966|NCT01744418|HEMODIALYSIS|hemodialysis
281967|NCT01744418|CHRONIC RENAL INSUFFICIENCY|chronic renal insufficiency
281968|NCT01744418|Renal Dialysis|renal dialysis
281969|NCT01744418|Hemodiafiltration|hemodiafiltration
281970|NCT01744418|Blood Vessel Prosthesis|blood vessel prosthesis
281971|NCT01744418|Tissue-Engineered Vascular Graft|tissue-engineered vascular graft
281972|NCT01744418|Vascular Prosthesis Implantation|vascular prosthesis implantation
281973|NCT01744405|Chagas disease|chagas disease
281974|NCT01744405|lactation|lactation
281975|NCT01744405|breastmilk|breastmilk
281976|NCT01744405|postpartum period|postpartum period
281977|NCT01744405|infants|infants
281978|NCT01744405|pediatric clinical pharmacology|pediatric clinical pharmacology
281979|NCT01744405|developmental clinical pharmacology|developmental clinical pharmacology
281980|NCT01744405|parasitology|parasitology
281981|NCT01744405|trypanosoma cruzi|trypanosoma cruzi
281982|NCT01744405|nifurtimox|nifurtimox
281983|NCT01744353|newly diagnosed|newly diagnosed
281984|NCT01744353|advanced pancreatic cancer|advanced pancreatic cancer
281985|NCT01744353|pancreatic cancer|pancreatic cancer
704184|NCT00974402|Trauma|trauma
281986|NCT01744353|metastatic pancreatic cancer|metastatic pancreatic cancer
281987|NCT01744353|pancreas|pancreas
281988|NCT01744340|Head and Neck|head and neck
281989|NCT01744340|Colon|colon
281990|NCT01744314|Elbow trauma,Heterotopic Ossification,Indomethacin, Prophylaxis|elbow trauma,heterotopic ossification,indomethacin, prophylaxis
281991|NCT01744301|Seizure|seizure
281992|NCT01744301|Acid-suppressing drugs|acid-suppressing drugs
281993|NCT01744301|Epidemiology|epidemiology
281994|NCT01744288|Phase 1 Safety ,|phase 1 safety ,
281995|NCT01744288|pharmacodynamic,|pharmacodynamic,
281996|NCT01744288|Ticagrelor,|ticagrelor,
281997|NCT01744288|Clopidogrel,|clopidogrel,
281998|NCT01744288|Platelets|platelets
281999|NCT01744275|Epilepsy|epilepsy
282000|NCT01744275|Omega 3 fatty acids|omega 3 fatty acids
282001|NCT01744262|intraocular pressure, total intravenous anesthesia, laparoscopic prostatectomy|intraocular pressure, total intravenous anesthesia, laparoscopic prostatectomy
282002|NCT01744249|Advanced neuroendocrine tumours of non-pancreatic origin|advanced neuroendocrine tumours of non-pancreatic origin
282003|NCT01744249|axitinib|axitinib
282004|NCT01744236|GLP-1 Receptor Agonists, DPP-4 inhibitors|glp-1 receptor agonists, dpp-4 inhibitors
282005|NCT01744223|iCaspase9|icaspase9
282006|NCT01744223|iCasp9|icasp9
282007|NCT01744223|Inducible Caspase|inducible caspase
282008|NCT01744223|AP1903|ap1903
282009|NCT01744223|Dimerizer drug|dimerizer drug
282010|NCT01744223|T depleted|t depleted
282011|NCT01744223|Suicide gene|suicide gene
282012|NCT01744223|CD-34 selection|cd-34 selection
282013|NCT01744223|haplotransplantation|haplotransplantation
282014|NCT01744223|Graft versus host disease|graft versus host disease
282015|NCT01744223|Allogenic transplantation|allogenic transplantation
282016|NCT01744197|Pain control|pain control
282017|NCT01744197|Needle stick pain|needle stick pain
282018|NCT01744197|Venipuncture pain|venipuncture pain
282019|NCT01744184|gastroscopy|gastroscopy
282020|NCT01744184|diagnostic|diagnostic
282021|NCT01744184|entonox|entonox
282022|NCT01744158|cerebral palsy|cerebral palsy
282023|NCT01744158|spasticity|spasticity
282024|NCT01744158|dystonia|dystonia
282025|NCT01744158|hypertonia|hypertonia
282026|NCT01744158|register|register
282027|NCT01744158|motor function|motor function
282028|NCT01744132|eye care utilization|eye care utilization
282029|NCT01744132|ophthalmology|ophthalmology
282030|NCT01744132|educational intervention|educational intervention
282031|NCT01744132|public health screening|public health screening
282032|NCT01744093|HIV|hiv
282033|NCT01744093|COPD|copd
282034|NCT01744093|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
282035|NCT01744093|Emphysema|emphysema
282036|NCT01744080|Rotator cuff|rotator cuff
282037|NCT01744067|Renal transplantation|renal transplantation
282038|NCT01744067|Interventional study|interventional study
282039|NCT01744067|Glomerular filtration rate|glomerular filtration rate
282040|NCT01744067|Renal function|renal function
282041|NCT01744067|Proteinuria|proteinuria
282042|NCT01744067|Cardiovascular risk markers|cardiovascular risk markers
282043|NCT01744067|Blood pressure|blood pressure
282044|NCT01744067|Flow mediated vasodilation|flow mediated vasodilation
282045|NCT01744067|Heart rate variability|heart rate variability
282046|NCT01744067|Pulse wave velocity|pulse wave velocity
282047|NCT01744067|Lipids|lipids
282048|NCT01744067|Blood glucose|blood glucose
282049|NCT01744067|Bone mineral density|bone mineral density
282050|NCT01744067|Body composition|body composition
282051|NCT01744067|Fat distribution|fat distribution
282052|NCT01744067|Body mass index|body mass index
282053|NCT01744067|Fatty acid composition|fatty acid composition
282054|NCT01744067|Tacrolimus pharmacokinetics|tacrolimus pharmacokinetics
282055|NCT01744067|Omega-3 fatty acids|omega-3 fatty acids
282056|NCT01744067|Marine n-3 fatty acids|marine n-3 fatty acids
282057|NCT01744067|Fatty acids|fatty acids
282058|NCT01744067|Gas chromatography|gas chromatography
282059|NCT01744067|Interstitial fibrosis|interstitial fibrosis
282060|NCT01744067|Inflammation|inflammation
282061|NCT01744041|depression|depression
282062|NCT01744041|pregnancy|pregnancy
282063|NCT01744041|postpartum|postpartum
282064|NCT01744041|psychotherapy|psychotherapy
282065|NCT01744028|COPD, remote patient monitoring, Hub, exacerbations, EXACT|copd, remote patient monitoring, hub, exacerbations, exact
282066|NCT01744015|Low back pain|low back pain
282067|NCT01744002|Shoulder, Impingement syndrome, Neck|shoulder, impingement syndrome, neck
282068|NCT01743976|neuropathic pain|neuropathic pain
282069|NCT01743976|diabetic neuropathy|diabetic neuropathy
282070|NCT01743976|neuropathic pain after back surgery|neuropathic pain after back surgery
282071|NCT01743963|efficacy|efficacy
282072|NCT01743963|glucocorticoid|glucocorticoid
282073|NCT01743950|Glioblastoma|glioblastoma
282074|NCT01743950|anaplastic glioma|anaplastic glioma
282075|NCT01743937|Ischemic preconditioning|ischemic preconditioning
282076|NCT01743937|Ticagrelor|ticagrelor
282077|NCT01743937|Antiplatelet therapy|antiplatelet therapy
282078|NCT01743937|Acute coronary syndrome|acute coronary syndrome
282079|NCT01743924|Broccoli; Isothiocyanates; Pharmacokinetics; Sulforaphane; Myrosinase|broccoli; isothiocyanates; pharmacokinetics; sulforaphane; myrosinase
282080|NCT01743911|Tadalafil|tadalafil
282081|NCT01743911|Resistant Hypertension|resistant hypertension
282082|NCT01743911|Left Ventricle Diastolic Dysfunction|left ventricle diastolic dysfunction
282083|NCT01743911|Brain natriuretic peptide|brain natriuretic peptide
282084|NCT01743885|Hemangioma|hemangioma
282085|NCT01743885|Beta-blocker|beta-blocker
282086|NCT01743885|Acebutolol|acebutolol
282087|NCT01743885|Propranolol|propranolol
282088|NCT01743885|Randomized controlled trial|randomized controlled trial
282089|NCT01743885|Infants|infants
282090|NCT01743872|Optical Coherence Tomography|optical coherence tomography
282091|NCT01743872|Contrast|contrast
282092|NCT01743872|Dextran|dextran
282093|NCT01743872|Carbon Dioxide|carbon dioxide
282094|NCT01743872|Imaging|imaging
282095|NCT01743872|Catheter|catheter
282096|NCT01743872|Lower Extremity Artery|lower extremity artery
282097|NCT01743859|Myeloid|myeloid
282098|NCT01743859|Leukemia|leukemia
282099|NCT01743807|Relapsed|relapsed
282100|NCT01743807|Minimal Residual Disease|minimal residual disease
282101|NCT01743807|MRD|mrd
282102|NCT01743807|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
282103|NCT01743807|Acute Myelogenous Leukemia|acute myelogenous leukemia
282104|NCT01743807|ALL|all
282105|NCT01743807|AML|aml
282106|NCT01743807|GNKG168|gnkg168
282107|NCT01743807|Pediatric|pediatric
282108|NCT01743807|Childhood|childhood
282109|NCT01743781|comprehensive eye examination|comprehensive eye examination
282110|NCT01743781|acceptance|acceptance
282111|NCT01743781|glaucoma|glaucoma
282112|NCT01743781|diabetic retinopathy|diabetic retinopathy
282113|NCT01743768|Antisense oligonucleotide|antisense oligonucleotide
282114|NCT01743768|Asthma|asthma
282115|NCT01743768|Healthy subjects|healthy subjects
282116|NCT01743768|Phase 1|phase 1
282117|NCT01743768|Transcription factor GATA-3|transcription factor gata-3
282118|NCT01743768|Oral inhalation|oral inhalation
282119|NCT01743755|Community-acquired pneumonia|community-acquired pneumonia
282120|NCT01743755|Dexamethasone|dexamethasone
282121|NCT01743755|Corticosteroid|corticosteroid
282122|NCT01743742|Oral vitamin E and vitamin C|oral vitamin e and vitamin c
282123|NCT01743729|SAR 1118|sar 1118
282124|NCT01743716|Major Depressive Disorder|major depressive disorder
282125|NCT01743716|MDD|mdd
282126|NCT01743716|depression|depression
282127|NCT01743716|adolescent|adolescent
282128|NCT01743703|traumatic injuries|traumatic injuries
282129|NCT01743703|Whole-body MRI|whole-body mri
282130|NCT01743703|Skeletal survey|skeletal survey
282131|NCT01743703|Children|children
282132|NCT01743703|Diagnostic|diagnostic
282133|NCT01743690|Probiotic|probiotic
282134|NCT01743690|Candida|candida
282135|NCT01743690|Oral Lichen Planus|oral lichen planus
282136|NCT01743677|TQT study|tqt study
282137|NCT01743677|CP-690,550|cp-690,550
282138|NCT01743664|Posttraumatic Stress Disorders|posttraumatic stress disorders
282139|NCT01743664|Multiple Sclerosis|multiple sclerosis
282140|NCT01743664|Eye Movement Desensitization Reprocessing|eye movement desensitization reprocessing
282141|NCT01743664|Psychotherapy|psychotherapy
282142|NCT01743664|Anxiety|anxiety
282144|NCT01743664|Quality of Life|quality of life
282145|NCT01743651|spasticity|spasticity
282146|NCT01743651|multiple sclerosis|multiple sclerosis
282147|NCT01743651|arbaclofen|arbaclofen
282148|NCT01743612|healthy subject|healthy subject
282149|NCT01743612|hand blood flow|hand blood flow
282150|NCT01743612|laser speckle contrast imaging|laser speckle contrast imaging
282151|NCT01743586|Lung cancer|lung cancer
282152|NCT01743586|Chest physiotherapy|chest physiotherapy
282153|NCT01743586|Respiratory muscle strength|respiratory muscle strength
282154|NCT01743586|Dyspnea, Functional capacity|dyspnea, functional capacity
282155|NCT01743586|Quality of life|quality of life
282156|NCT01743560|Breast Neoplasms|breast neoplasms
282157|NCT01743560|Neoplasms|neoplasms
282158|NCT01743560|Breast diseases|breast diseases
282159|NCT01743560|Skin diseases|skin diseases
282160|NCT01743560|Exemestane|exemestane
282161|NCT01743560|Antibiotics, Antineoplastic|antibiotics, antineoplastic
282162|NCT01743560|Everolimus|everolimus
282163|NCT01743560|Antineoplastic Agents|antineoplastic agents
282164|NCT01743560|Therapeutic Uses|therapeutic uses
282165|NCT01743560|Pharmacologic Actions|pharmacologic actions
282166|NCT01743560|Immunosuppressive Agents|immunosuppressive agents
282167|NCT01743560|Physiological Effects of Drugs|physiological effects of drugs
282168|NCT01743560|Aromatase Inhibitors|aromatase inhibitors
282169|NCT01743560|Enzyme Inhibitors|enzyme inhibitors
282170|NCT01743560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
282171|NCT01743547|Women|women
282172|NCT01743547|Yoga|yoga
282173|NCT01743547|Ovarian Cancer|ovarian cancer
282174|NCT01743547|Lifestyle|lifestyle
282175|NCT01743521|Hepatitis C|hepatitis c
282176|NCT01743521|Individualised therapy|individualised therapy
282177|NCT01743521|Response-guided therapy|response-guided therapy
282178|NCT01743521|Telaprevir|telaprevir
282179|NCT01743521|PEG-IFN|peg-ifn
282180|NCT01743521|Ribavirin|ribavirin
282181|NCT01743521|Hepatitis|hepatitis
282182|NCT01743508|incomplete abortion|incomplete abortion
282183|NCT01743508|misoprostol treatment|misoprostol treatment
282184|NCT01743508|midwife|midwife
282185|NCT01743508|uganda|uganda
282186|NCT01743495|Medical Costs|medical costs
282187|NCT01743495|improved IADLs|improved iadls
282188|NCT01743495|and/or ADL's|and/or adl's
282189|NCT01743495|decreased nursing home admissions|decreased nursing home admissions
282190|NCT01743482|Testicular Cancer|testicular cancer
282191|NCT01743482|Germ Cell Tumors|germ cell tumors
282192|NCT01743482|Salvage Therapy|salvage therapy
282193|NCT01743482|Pazopanib|pazopanib
282194|NCT01743456|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
282195|NCT01743456|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
282196|NCT01743456|Postoperative cognitive improvement|postoperative cognitive improvement
282197|NCT01743456|Postoperative delirium|postoperative delirium
282198|NCT01743443|Corneal sensitivity|corneal sensitivity
282199|NCT01743443|Cross-linking|cross-linking
282200|NCT01743443|Keratoconus|keratoconus
282201|NCT01743430|telerehabilitation|telerehabilitation
282202|NCT01743430|stroke|stroke
282203|NCT01743430|Berg balance scale|berg balance scale
282204|NCT01743430|stroke impact scale|stroke impact scale
282205|NCT01743430|mobility|mobility
282206|NCT01743417|Cognitive rehabilitation|cognitive rehabilitation
282207|NCT01743417|malaria|malaria
282208|NCT01743417|neuropsychology|neuropsychology
282209|NCT01743417|attention|attention
282210|NCT01743417|working memory|working memory
282211|NCT01743404|atherosclerosis|atherosclerosis
282212|NCT01743404|inflammation|inflammation
282213|NCT01743404|intima-media thickness|intima-media thickness
282214|NCT01743391|IVF treatment|ivf treatment
282215|NCT01743391|Office-hysteroscopy|office-hysteroscopy
282216|NCT01743391|Endometrial biopsy|endometrial biopsy
282217|NCT01743352|Large arteries|large arteries
282218|NCT01743352|stiffness|stiffness
282219|NCT01743352|intima media thickness|intima media thickness
282220|NCT01743352|ultrasound imaging|ultrasound imaging
282221|NCT01743339|Randomized Controlled Trial|randomized controlled trial
282222|NCT01743339|Cognitive Therapy|cognitive therapy
282223|NCT01743339|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
282224|NCT01743339|Depression|depression
282225|NCT01743339|Sleep|sleep
282226|NCT01743326|Zygapophyseal Joint|zygapophyseal joint
282227|NCT01743313|glucose metabolism disorders|glucose metabolism disorders
282228|NCT01743313|metabolic syndrome|metabolic syndrome
282229|NCT01743313|joint replacement|joint replacement
282230|NCT01743313|osteoarthritis|osteoarthritis
282231|NCT01743300|sunitinib|sunitinib
272835|NCT01786356|PCO|pco
282232|NCT01743300|pharmacokinetics|pharmacokinetics
282233|NCT01743300|phenotyping|phenotyping
282234|NCT01743300|interaction|interaction
282235|NCT01743287|osteoarthritis of the knee|osteoarthritis of the knee
282236|NCT01743274|acute coronary syndromes|acute coronary syndromes
282237|NCT01743274|non-ST elevation myocardial infarction|non-st elevation myocardial infarction
282238|NCT01743274|angioplasty|angioplasty
282239|NCT01743274|fractional flow reserve|fractional flow reserve
281913|NCT01744691|CLL|cll
282240|NCT01743274|optical coherence tomography|optical coherence tomography
282241|NCT01743261|severe brain injury|severe brain injury
282242|NCT01743261|graded intensive rehabilitation|graded intensive rehabilitation
282243|NCT01743248|vestibular schwannoma|vestibular schwannoma
282245|NCT01743248|psychological factors|psychological factors
282246|NCT01743235|HSDD|hsdd
282247|NCT01743209|androgen antagonists|androgen antagonists
282248|NCT01743196|Folic acid|folic acid
282249|NCT01743196|Folate|folate
282250|NCT01743196|Pharmacokinetics|pharmacokinetics
282251|NCT01743196|Women of Child Bearing Age|women of child bearing age
282252|NCT01743183|hypertension|hypertension
282253|NCT01743170|Blood pressure control|blood pressure control
282254|NCT01743170|Hypertension|hypertension
282255|NCT01743170|Office blood pressure|office blood pressure
282256|NCT01743170|Self-measured blood pressure|self-measured blood pressure
282257|NCT01743170|Telemonitoring|telemonitoring
282258|NCT01743144|emergence agitation in children|emergence agitation in children
282259|NCT01743144|sevoflurane|sevoflurane
282260|NCT01743144|general anesthesia|general anesthesia
282261|NCT01743144|magnesium sulphate|magnesium sulphate
282262|NCT01743105|diaphragm movement|diaphragm movement
282263|NCT01743105|ultrasound|ultrasound
282264|NCT01743105|emergency room|emergency room
282265|NCT01743092|Pathological gambling|pathological gambling
282266|NCT01743092|treatment|treatment
282267|NCT01743092|online counselling|online counselling
282268|NCT01743092|webinar|webinar
282269|NCT01743092|workbook|workbook
282270|NCT01743079|Telbivudine|telbivudine
282271|NCT01743079|Lamivudine|lamivudine
282272|NCT01743079|safety|safety
282273|NCT01743079|efficacy|efficacy
282274|NCT01743079|pregnancy|pregnancy
282275|NCT01743066|Arsenic|arsenic
282276|NCT01743066|Arsenicosis|arsenicosis
282277|NCT01743066|Buccal cells|buccal cells
282278|NCT01743066|Serum|serum
282279|NCT01743066|Vitamin E|vitamin e
282280|NCT01743066|Cholesterol|cholesterol
282281|NCT01743040|Coronary Artery Disease|coronary artery disease
282282|NCT01743040|Nuclear Stress Test|nuclear stress test
282283|NCT01743040|CT Angiography|ct angiography
282284|NCT01743040|Angiography|angiography
282285|NCT01743027|Allergic conjunctivitis|allergic conjunctivitis
282286|NCT01743027|Olopatadine HCl solution|olopatadine hcl solution
282574|NCT01741831|AIDS|aids
282287|NCT01743027|Conjunctival Allergen Challenge|conjunctival allergen challenge
282288|NCT01743027|Itching eyes|itching eyes
282289|NCT01743027|Ocular allergies|ocular allergies
282290|NCT01743027|PATADAY|pataday
282291|NCT01743027|PATANOL|patanol
282292|NCT01743014|diabetes|diabetes
282293|NCT01743014|diabetic nephropathy|diabetic nephropathy
282294|NCT01743014|vascular inflammation|vascular inflammation
282295|NCT01743014|oxidative stress|oxidative stress
282296|NCT01743014|endothelial dysfunction|endothelial dysfunction
282297|NCT01743014|Asymmetric dimethylarginine|asymmetric dimethylarginine
282298|NCT01743014|High sensitivity CRP|high sensitivity crp
282299|NCT01743014|albumine to creatinine ratio|albumine to creatinine ratio
282300|NCT01743014|isoprostane|isoprostane
282301|NCT01743014|clopidogrel|clopidogrel
282302|NCT01743014|ramipril|ramipril
282303|NCT01743014|carotid intima media thickness|carotid intima media thickness
282304|NCT01743001|exercise capacity|exercise capacity
282305|NCT01743001|Eisenmenger Syndrome|eisenmenger syndrome
282306|NCT01742988|PI3K|pi3k
282307|NCT01742988|HDAC|hdac
282308|NCT01742988|Open-Label|open-label
282309|NCT01742988|Dose-Escalation|dose-escalation
282310|NCT01742962|Prostatectomy|prostatectomy
282311|NCT01742962|Prostate cancer|prostate cancer
282312|NCT01742962|Orgasm|orgasm
282313|NCT01742962|Urinary incontinence|urinary incontinence
282409|NCT01742546|myofascial pain syndrome|myofascial pain syndrome
282314|NCT01742962|Climacturia(orgasm related urinary incontinence)|climacturia(orgasm related urinary incontinence)
282315|NCT01742962|Penis|penis
282316|NCT01742962|Dysorgasmia (pain in relation to orgasm)|dysorgasmia (pain in relation to orgasm)
282317|NCT01742962|Pain|pain
282318|NCT01742962|Anorgasmia|anorgasmia
282319|NCT01742962|Penile shortening|penile shortening
282320|NCT01742962|Erectile dysfunction|erectile dysfunction
282321|NCT01742923|hypertension|hypertension
282322|NCT01742923|medication adherence|medication adherence
282323|NCT01742923|motivational interviewing|motivational interviewing
282324|NCT01742897|Osteoarthritis, Knee|osteoarthritis, knee
282325|NCT01742897|Transdermal therapeutic system (TTS) fentanyl|transdermal therapeutic system (tts) fentanyl
282326|NCT01742897|Durogesic|durogesic
282327|NCT01742884|Dry Eye Syndrome|dry eye syndrome
272963|NCT01785901|asthma|asthma
282328|NCT01742871|Antivitamin K|antivitamin k
282329|NCT01742871|Bleeding|bleeding
282330|NCT01742871|Haemorrhage|haemorrhage
282331|NCT01742871|Nutritional status|nutritional status
282332|NCT01742871|impedancemetry|impedancemetry
282333|NCT01742845|Ultrasound-guided|ultrasound-guided
282334|NCT01742845|regional anaesthesia|regional anaesthesia
282335|NCT01742845|Cervical block|cervical block
282336|NCT01742832|Vilazodone|vilazodone
282337|NCT01742832|Citalopram|citalopram
282338|NCT01742832|Major Depressive Disorder|major depressive disorder
282339|NCT01742819|Glaucoma, Optical Coherence Tomography, Progression|glaucoma, optical coherence tomography, progression
282340|NCT01742806|Gastric cancer|gastric cancer
282341|NCT01742806|Minimally invasive surgery|minimally invasive surgery
282342|NCT01742806|Distal gastrectomy|distal gastrectomy
282343|NCT01742806|Bio-absorbable Felt|bio-absorbable felt
282344|NCT01742793|relapsed /refractory Hodgkin lymphoma|relapsed /refractory hodgkin lymphoma
282345|NCT01742793|mature T-cell lymphoma|mature t-cell lymphoma
282346|NCT01742793|multiple myeloma|multiple myeloma
282347|NCT01742780|Intraosseous Vascular Access|intraosseous vascular access
282349|NCT01742780|IO Vascular Access|io vascular access
282350|NCT01742780|EZ-IO|ez-io
282351|NCT01742767|NSCLC; split dose Cisplatinum; Pemetrexed|nsclc; split dose cisplatinum; pemetrexed
282352|NCT01742741|Diabetes Mellitus, Type 1 (T1DM)|diabetes mellitus, type 1 (t1dm)
282353|NCT01742741|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
282354|NCT01742741|Artificial Pancreas (AP)|artificial pancreas (ap)
282355|NCT01742741|Insulin Pump|insulin pump
282356|NCT01742741|Closed Loop Control (CLC)|closed loop control (clc)
282357|NCT01742741|Open Loop treatment|open loop treatment
282358|NCT01742741|Diabetes Assistant|diabetes assistant
282359|NCT01742741|DiAs|dias
282360|NCT01742728|oxidative stress, antioxidant, periodontitis, serum immunoglobulin G|oxidative stress, antioxidant, periodontitis, serum immunoglobulin g
282361|NCT01742728|antibody titer|antibody titer
282362|NCT01742715|ARDS|ards
282363|NCT01742715|Lung compliance|lung compliance
282364|NCT01742702|Blood pressure|blood pressure
282365|NCT01742702|Hypertension|hypertension
282366|NCT01742702|Arterial stiffness|arterial stiffness
282367|NCT01742702|Cardiac output|cardiac output
282368|NCT01742702|Vascular resistance|vascular resistance
282369|NCT01742702|Pulse wave reflection|pulse wave reflection
282370|NCT01742702|Head-up tilt|head-up tilt
282371|NCT01742689|Renal colic|renal colic
282372|NCT01742689|Pain|pain
282373|NCT01742689|Desmopressin|desmopressin
282374|NCT01742689|Urinary obstruction|urinary obstruction
282375|NCT01742689|Indomethacin|indomethacin
282376|NCT01742676|tacrolimus|tacrolimus
282377|NCT01742676|kidney|kidney
282378|NCT01742663|Diclofenac Sodium Gel 3%|diclofenac sodium gel 3%
282379|NCT01742663|Solaraze® (diclofenac sodium) Gel 3%|solaraze® (diclofenac sodium) gel 3%
282380|NCT01742663|Actinic Keratosis|actinic keratosis
282575|NCT01741831|TMC114|tmc114
282381|NCT01742650|ankle; fracture; syndesmosis;|ankle; fracture; syndesmosis;
282382|NCT01742637|Acne Vulgaris|acne vulgaris
282383|NCT01742637|Adapalene and Benzoyl Peroxide Gel 0.1%/2.5%|adapalene and benzoyl peroxide gel 0.1%/2.5%
282384|NCT01742637|Epiduo®|epiduo®
282385|NCT01742624|immunosuppressant|immunosuppressant
282386|NCT01742624|new-onset diabetes after kidney transplantation|new-onset diabetes after kidney transplantation
282387|NCT01742624|NODAT|nodat
282389|NCT01742611|Not on dialysis|not on dialysis
282390|NCT01742611|ASP1585|asp1585
282391|NCT01742611|Bixalomer|bixalomer
282392|NCT01742598|TAVI|tavi
282393|NCT01742598|TAVR|tavr
282394|NCT01742598|aortic stenosis|aortic stenosis
282395|NCT01742598|Transcatheter|transcatheter
282396|NCT01742598|valvular heart disease|valvular heart disease
282397|NCT01742598|aortic valve stenosis|aortic valve stenosis
282398|NCT01742598|aortic valve replacement|aortic valve replacement
282399|NCT01742598|transcatheter aortic valve implantation|transcatheter aortic valve implantation
282400|NCT01742585|CKD|ckd
282401|NCT01742585|Not on dialysis|not on dialysis
282402|NCT01742585|ASP1585|asp1585
282403|NCT01742585|Bixalomer|bixalomer
282404|NCT01742572|weight loss|weight loss
282405|NCT01742572|obesity|obesity
282406|NCT01742572|overweight|overweight
282407|NCT01742572|diet|diet
282408|NCT01742559|Treatment|treatment
282607|NCT01741766|stretching|stretching
282410|NCT01742546|therapeutic ultrasound|therapeutic ultrasound
282411|NCT01742546|combine therapy|combine therapy
282412|NCT01742533|Hormone Replacement Therapy，|hormone replacement therapy，
282413|NCT01742533|Premature Ovarian Failure，|premature ovarian failure，
282414|NCT01742533|Stem Cell Therapy|stem cell therapy
282415|NCT01742520|Preterm infant|preterm infant
282416|NCT01742520|pain|pain
282417|NCT01742520|neurodevelopment|neurodevelopment
282418|NCT01742507|Stent, OCT|stent, oct
282419|NCT01742494|Esophageal Achalasia,|esophageal achalasia,
282420|NCT01742494|Peroral endoscopic myotomy,|peroral endoscopic myotomy,
282421|NCT01742494|Water-jet assisted|water-jet assisted
349317|NCT01453114|CBT|cbt
282422|NCT01742481|childhood cancer survivors|childhood cancer survivors
282423|NCT01742481|long-term follow-up care|long-term follow-up care
282424|NCT01742481|health communication|health communication
282425|NCT01742481|ethnic/racial minorities|ethnic/racial minorities
282426|NCT01742481|longterm survivors|longterm survivors
282427|NCT01742468|n-3 LC-PUFA, DHA, rheumatoid arthritis|n-3 lc-pufa, dha, rheumatoid arthritis
282428|NCT01742455|Peripheral artery disease|peripheral artery disease
282429|NCT01742455|Arterial Occlusive Diseases|arterial occlusive diseases
282430|NCT01742455|Vascular Diseases|vascular diseases
282431|NCT01742455|Cardiovascular Diseases|cardiovascular diseases
282432|NCT01742455|Coronary Artery Disease|coronary artery disease
282433|NCT01742455|Myocardial Ischemia|myocardial ischemia
282434|NCT01742455|Arteriosclerosis|arteriosclerosis
282435|NCT01742455|Pathologic Processes|pathologic processes
282436|NCT01742442|Cancer|cancer
282437|NCT01742442|elderly OR older|elderly or older
282438|NCT01742442|chemotherapy|chemotherapy
282439|NCT01742442|geriatric assessment|geriatric assessment
282440|NCT01742429|Helicobacter pylori|helicobacter pylori
282441|NCT01742429|second line treatment|second line treatment
282442|NCT01742416|Arterial Cannulation|arterial cannulation
282443|NCT01742416|Ultrasound|ultrasound
282444|NCT01742416|Palpation Method|palpation method
282445|NCT01742416|Pediatrics|pediatrics
282446|NCT01742416|Cardiac Surgery|cardiac surgery
282447|NCT01742416|Craniotomies|craniotomies
282448|NCT01742416|Cranial Vault Surgery|cranial vault surgery
282449|NCT01742416|Abdominal Procedures|abdominal procedures
282450|NCT01742403|Prostate|prostate
282451|NCT01742403|IGRT|igrt
282452|NCT01742403|VMAT|vmat
282453|NCT01742390|schizophrenia|schizophrenia
282454|NCT01742390|risperidone|risperidone
282455|NCT01742390|paliperidone|paliperidone
282456|NCT01742390|aripiprazole|aripiprazole
282457|NCT01742377|GERD|gerd
282458|NCT01742377|Dyspepsia|dyspepsia
282459|NCT01742377|Ambulatory 24-hour Esophageal pH Monitoring|ambulatory 24-hour esophageal ph monitoring
282460|NCT01742377|Minimal change erosions|minimal change erosions
282586|NCT01741792|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
282461|NCT01742364|disposable syringe jet injector (DSJI)|disposable syringe jet injector (dsji)
282462|NCT01742364|DSJI|dsji
282463|NCT01742364|BCG|bcg
282464|NCT01742364|tuberculosis|tuberculosis
282465|NCT01742364|intradermal delivery|intradermal delivery
282466|NCT01742364|South Africa|south africa
282467|NCT01742338|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
282469|NCT01742338|Chronic bronchitis|chronic bronchitis
282470|NCT01742338|emphysema|emphysema
282471|NCT01742338|Corticosteroids|corticosteroids
282472|NCT01742325|fatigue|fatigue
282473|NCT01742325|walking|walking
282474|NCT01742325|childhood cancer|childhood cancer
282475|NCT01742325|sleep disturbance|sleep disturbance
282476|NCT01742312|neoadjuvant chemotherapy|neoadjuvant chemotherapy
282477|NCT01742312|oesophageal cancer|oesophageal cancer
282576|NCT01741831|Darunavir|darunavir
282478|NCT01742312|cardiorespiratory performance|cardiorespiratory performance
282479|NCT01742299|Glivec/Gleevec|glivec/gleevec
282480|NCT01742299|CML|cml
282481|NCT01742299|GIST|gist
282482|NCT01742299|Imatinib mesylate|imatinib mesylate
282483|NCT01742286|pediatric|pediatric
282484|NCT01742286|anaplastic lymphoma kinase|anaplastic lymphoma kinase
282485|NCT01742286|ALK|alk
282486|NCT01742286|ALK-activated tumors|alk-activated tumors
282487|NCT01742286|neuroblastoma|neuroblastoma
282488|NCT01742286|rhabdomyosarcoma|rhabdomyosarcoma
282489|NCT01742286|anaplastic large-cell lymphoma|anaplastic large-cell lymphoma
282490|NCT01742286|inflammatory myofibroblastic tumor|inflammatory myofibroblastic tumor
282491|NCT01742260|Cranioplasty|cranioplasty
282492|NCT01742260|Mesenchymal stromal cells|mesenchymal stromal cells
282493|NCT01742260|Bioceramic polymer|bioceramic polymer
282494|NCT01742247|Moisturizer, laser|moisturizer, laser
282495|NCT01742221|Safety and Tolerability, Cytokines, Acute Radiation Syndrome, Hematopoietic Syndrome, Radiation Countermeasure|safety and tolerability, cytokines, acute radiation syndrome, hematopoietic syndrome, radiation countermeasure
282496|NCT01742195|Endobronchial ultrasound|endobronchial ultrasound
282497|NCT01742195|Bronchoscopy|bronchoscopy
282498|NCT01742195|Patient satisfaction|patient satisfaction
282499|NCT01742182|Parkinson's Disease|parkinson's disease
282500|NCT01742182|Excessive Daytime Sleepiness|excessive daytime sleepiness
282501|NCT01742182|Circadian Rhythms|circadian rhythms
282502|NCT01742182|Light Therapy|light therapy
282503|NCT01742169|Colorectal Cancer Screening|colorectal cancer screening
282504|NCT01742169|Fecal Occult Blood Testing|fecal occult blood testing
282505|NCT01742156|CAD|cad
282506|NCT01742156|microangiopathy|microangiopathy
282507|NCT01742156|patients|patients
282508|NCT01742156|more likely|more likely
282509|NCT01742156|to have tortuosity|to have tortuosity
282510|NCT01742156|of conjunctival vessels|of conjunctival vessels
282511|NCT01742143|Quality of life|quality of life
282512|NCT01742143|cancer|cancer
282513|NCT01742143|12-223|12-223
349433|NCT01452308|GSI|gsi
282514|NCT01742130|Contrast-induced nephropathy|contrast-induced nephropathy
282515|NCT01742130|Contrast media|contrast media
282516|NCT01742130|Angiography|angiography
282517|NCT01742130|Coronary percutaneous intervention|coronary percutaneous intervention
282518|NCT01742117|percutaneous coronary intervention|percutaneous coronary intervention
282519|NCT01742117|angioplasty|angioplasty
282520|NCT01742104|glaucoma|glaucoma
282521|NCT01742104|primary open-angle glaucoma|primary open-angle glaucoma
282522|NCT01742104|observational study|observational study
282523|NCT01742104|quality of life|quality of life
282524|NCT01742091|Postmenopausal females|postmenopausal females
282525|NCT01742091|Volunteers|volunteers
282526|NCT01742078|Postmenopausal females|postmenopausal females
282527|NCT01742078|Volunteers|volunteers
282528|NCT01742065|Colorectal Cancer Screening|colorectal cancer screening
282529|NCT01742065|Cancer Screening|cancer screening
282530|NCT01742065|Pragmatic Trial|pragmatic trial
282531|NCT01742052|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
282532|NCT01742052|RRMS|rrms
282533|NCT01742026|High risk aspergillosis infection patients|high risk aspergillosis infection patients
282534|NCT01742013|Chronic Fatigue|chronic fatigue
282536|NCT01742013|ICF|icf
282537|NCT01742013|human placenta|human placenta
282538|NCT01742000|postmenopause|postmenopause
282539|NCT01742000|phytoestrogen|phytoestrogen
282540|NCT01742000|atherosclerosis|atherosclerosis
282541|NCT01742000|intima-media thickness|intima-media thickness
282542|NCT01741974|perimenopause|perimenopause
282543|NCT01741974|phytoestrogen|phytoestrogen
282544|NCT01741974|atherosclerosis|atherosclerosis
282545|NCT01741974|intima-media thickness|intima-media thickness
282546|NCT01741961|uncontrolled glaucoma|uncontrolled glaucoma
282547|NCT01741961|glaucoma drainage device|glaucoma drainage device
282548|NCT01741948|Provoked vestibulodynia|provoked vestibulodynia
282549|NCT01741948|Hormonal contraceptives|hormonal contraceptives
282550|NCT01741922|Low dose|low dose
282551|NCT01741922|aspirin|aspirin
282552|NCT01741922|ASA|asa
282553|NCT01741922|Hypertension|hypertension
282554|NCT01741922|blood pressure|blood pressure
282555|NCT01741909|azythromycin|azythromycin
282556|NCT01741909|community acquired pneumonia|community acquired pneumonia
282557|NCT01741909|intravenous|intravenous
282558|NCT01741909|oral|oral
282559|NCT01741883|Randomized Controlled Trial|randomized controlled trial
282560|NCT01741883|Patients´ Expectations|patients´ expectations
282561|NCT01741883|Breast Cancer|breast cancer
282562|NCT01741883|Adjuvant Endocrine Treatment|adjuvant endocrine treatment
282563|NCT01741883|Nocebo|nocebo
282564|NCT01741870|Nutritional supplement|nutritional supplement
282565|NCT01741870|Nutritional status|nutritional status
282566|NCT01741870|Physical functional activity|physical functional activity
282567|NCT01741870|Nursing home elderly|nursing home elderly
282568|NCT01741844|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
282569|NCT01741844|TMC125|tmc125
282570|NCT01741844|Etravirine|etravirine
282571|NCT01741844|Intelence|intelence
282572|NCT01741844|AIDS|aids
282573|NCT01741831|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
282577|NCT01741831|Prezista|prezista
282578|NCT01741818|IVC|ivc
282579|NCT01741818|ultrasonography|ultrasonography
282580|NCT01741818|IVC collapsibility index|ivc collapsibility index
282581|NCT01741818|IVC diameter|ivc diameter
282582|NCT01741792|Relapsed DLBCL|relapsed dlbcl
282583|NCT01741792|Refractory DLBCL|refractory dlbcl
282584|NCT01741792|adult DLBCL|adult dlbcl
282585|NCT01741792|Lymphoma|lymphoma
282587|NCT01741792|Lymphatic diseases|lymphatic diseases
282588|NCT01741792|Lymphoproliferative disorders|lymphoproliferative disorders
282589|NCT01741792|bispecific antibody|bispecific antibody
282590|NCT01741792|anti-CD19|anti-cd19
282591|NCT01741792|Immunotherapeutic treatment|immunotherapeutic treatment
282592|NCT01741792|Immunoproliferative disorders|immunoproliferative disorders
282593|NCT01741779|whole body vibration training|whole body vibration training
282594|NCT01741779|hypocaloric diet|hypocaloric diet
282595|NCT01741779|prehypertension|prehypertension
282596|NCT01741779|hypertension|hypertension
282597|NCT01741779|obesity|obesity
282598|NCT01741779|arterial function|arterial function
282599|NCT01741779|arterial stiffness|arterial stiffness
282600|NCT01741779|pulse wave velocity|pulse wave velocity
282601|NCT01741779|autonomic function|autonomic function
282602|NCT01741779|endothelial function|endothelial function
282603|NCT01741779|adipocytokines|adipocytokines
282604|NCT01741766|prehypertension|prehypertension
282605|NCT01741766|hypertension|hypertension
282606|NCT01741766|obesity|obesity
282608|NCT01741766|arterial function|arterial function
282609|NCT01741766|arterial stiffness|arterial stiffness
282610|NCT01741766|pulse wave velocity|pulse wave velocity
282611|NCT01741766|autonomic function|autonomic function
282612|NCT01741766|endothelial function|endothelial function
282613|NCT01741753|Docetaxel Pretreated|docetaxel pretreated
282614|NCT01741753|Castrate Resistant|castrate resistant
273239|NCT01784744|ASD|asd
282615|NCT01741753|Metastatic|metastatic
282616|NCT01741740|pain, hernia, chronic, discomfort, retrospective|pain, hernia, chronic, discomfort, retrospective
282617|NCT01741675|Questionnaires|questionnaires
282618|NCT01741675|Quality of Life|quality of life
282619|NCT01741675|Response rate|response rate
282620|NCT01741649|Surgical wound infection|surgical wound infection
282621|NCT01741649|Clorhexidine|clorhexidine
282622|NCT01741649|Povidone|povidone
282623|NCT01741610|Anaesthesia Spinal|anaesthesia spinal
282624|NCT01741610|Ephedrine|ephedrine
282625|NCT01741610|Fluid Therapy|fluid therapy
282626|NCT01741610|Hypotension|hypotension
282627|NCT01741558|Myocardial Ischemia|myocardial ischemia
282628|NCT01741558|Myocardial Infarction|myocardial infarction
282629|NCT01741558|Methotrexate|methotrexate
282630|NCT01741558|Inflammation|inflammation
282631|NCT01741558|Anti-Inflammatory Agents|anti-inflammatory agents
282632|NCT01741558|Inflammation Mediators|inflammation mediators
282633|NCT01741532|Pantothenate Kinase-associated Neurodegeneration|pantothenate kinase-associated neurodegeneration
282634|NCT01741532|PKAN|pkan
282635|NCT01741532|NBIA|nbia
282636|NCT01741532|Deferiprone|deferiprone
282637|NCT01741532|Ferriprox|ferriprox
282638|NCT01741519|PK|pk
282639|NCT01741519|PD|pd
282640|NCT01741519|landiolol|landiolol
282641|NCT01741519|esmolol|esmolol
282642|NCT01741519|healthy volunteers phase I study|healthy volunteers phase i study
282643|NCT01741506|Lung cancer|lung cancer
282644|NCT01741506|Surgery|surgery
282645|NCT01741506|Thromboembolism|thromboembolism
282646|NCT01741506|Bleeding|bleeding
282647|NCT01741493|Rheumatoid Arthritis|rheumatoid arthritis
282648|NCT01741493|Methotrexate|methotrexate
282649|NCT01741493|Tolerability|tolerability
282650|NCT01741493|Pharmacokinetics|pharmacokinetics
282651|NCT01741493|Safety|safety
282652|NCT01741493|Tofacitinib|tofacitinib
282653|NCT01741480|Outcomes|outcomes
282654|NCT01741480|Early warning systems|early warning systems
282655|NCT01741480|ICU transfer|icu transfer
282656|NCT01741454|Tolterodine|tolterodine
282657|NCT01741454|Tamsulosin|tamsulosin
282658|NCT01741454|Ureteral Obstruction|ureteral obstruction
282659|NCT01741441|Duodenogastroesophageal reflux|duodenogastroesophageal reflux
282660|NCT01741441|Weakly acidic reflux|weakly acidic reflux
282661|NCT01741441|Gastric emptying|gastric emptying
704380|NCT00982891|opioids|opioids
282662|NCT01741441|Laparoscopic fundoplication|laparoscopic fundoplication
282663|NCT01741428|CVD Risk score|cvd risk score
282664|NCT01741428|Physical activity|physical activity
282665|NCT01741428|Overweight|overweight
282666|NCT01741428|Cholesterol|cholesterol
282667|NCT01741428|LDL-Cholesterol|ldl-cholesterol
282668|NCT01741428|HDL-Cholesterol|hdl-cholesterol
282669|NCT01741428|Triglycerides|triglycerides
282670|NCT01741428|HbA1C|hba1c
282671|NCT01741428|Quality of life|quality of life
282672|NCT01741402|Control posture|control posture
282673|NCT01741402|Gait|gait
282674|NCT01741402|Virtual Reality|virtual reality
282675|NCT01741402|Elderly|elderly
282676|NCT01741389|Circadian variation, hemostasis, melatonin, tetraplegia|circadian variation, hemostasis, melatonin, tetraplegia
282677|NCT01741363|iFOBT|ifobt
282678|NCT01741363|one-day sample|one-day sample
282679|NCT01741363|two-day sample|two-day sample
282680|NCT01741363|Helicobacter pylori stool antigen|helicobacter pylori stool antigen
282681|NCT01741350|Methadone-maintenance|methadone-maintenance
282682|NCT01741350|HIV|hiv
282683|NCT01741350|Risk behavior|risk behavior
282684|NCT01741350|Injection drug use|injection drug use
282685|NCT01741350|Condom use|condom use
282686|NCT01741350|Health care participation|health care participation
282687|NCT01741350|Opioid replacement therapy|opioid replacement therapy
282688|NCT01741337|central sleep apneas syndrome|central sleep apneas syndrome
282689|NCT01741337|heart failure|heart failure
282690|NCT01741337|all coronary reperfusions|all coronary reperfusions
282691|NCT01741337|adaptive servo-ventilation treatment|adaptive servo-ventilation treatment
282692|NCT01741311|viral load|viral load
282693|NCT01741311|HIV|hiv
282694|NCT01741311|CD4|cd4
282695|NCT01741311|methadone maintenance|methadone maintenance
282696|NCT01741311|substance use|substance use
282697|NCT01741311|Antiretroviral therapy (ART)|antiretroviral therapy (art)
282698|NCT01741298|Metabolic syndrome|metabolic syndrome
282699|NCT01741285|Asthma|asthma
282700|NCT01741285|Adenosine|adenosine
282701|NCT01741285|Small airways|small airways
282702|NCT01741285|Smokers|smokers
282703|NCT01741285|Ex-smokers|ex-smokers
282704|NCT01741272|rotator cuff tear|rotator cuff tear
282705|NCT01741272|arthroscopically assisted|arthroscopically assisted
282706|NCT01741272|health related quality of life(HRQL)|health related quality of life(hrql)
282707|NCT01741272|functional outcome|functional outcome
282708|NCT01741259|analgesia|analgesia
282709|NCT01741259|meperidine|meperidine
282710|NCT01741259|epidural|epidural
282711|NCT01741246|Episodic migraine|episodic migraine
282712|NCT01741246|Chronic migraine|chronic migraine
282713|NCT01741246|Magnetic resonance imaging|magnetic resonance imaging
282714|NCT01741246|Positron emission tomography|positron emission tomography
282715|NCT01741233|SNPs|snps
282716|NCT01741233|vitamin D|vitamin d
282717|NCT01741233|Vitamin D status|vitamin d status
282718|NCT01741233|UVB irradiation|uvb irradiation
282719|NCT01741233|genetics|genetics
282720|NCT01741181|25(OH)Vitamin D|25(oh)vitamin d
282721|NCT01741181|Diabetes mellitus|diabetes mellitus
282722|NCT01741181|Endothelial Function|endothelial function
282723|NCT01741142|Major Depressive Disorder|major depressive disorder
282724|NCT01741129|Nasal CPAP|nasal cpap
282725|NCT01741129|Nasal IMV|nasal imv
282726|NCT01741129|Surfactant|surfactant
282727|NCT01741129|Preterm infants|preterm infants
282728|NCT01741116|castration-resistant prostate cancer|castration-resistant prostate cancer
282729|NCT01741116|TKI258|tki258
282730|NCT01741116|FGF23|fgf23
282731|NCT01741090|Autologous Mesenchymal stem cell|autologous mesenchymal stem cell
282732|NCT01741090|alcoholic liver cirrhosis|alcoholic liver cirrhosis
282734|NCT01741077|folic acid supplementation|folic acid supplementation
282735|NCT01741077|reproduction|reproduction
282736|NCT01741077|folate|folate
282737|NCT01741064|Secondary Hyperparathyroidism|secondary hyperparathyroidism
282738|NCT01741064|Renal Transplantation|renal transplantation
282739|NCT01741064|Myocardial Infarction|myocardial infarction
282740|NCT01741064|Fracture|fracture
282741|NCT01741064|Graft Failure|graft failure
282742|NCT01741051|Air pollution|air pollution
282743|NCT01741051|Particulate matter|particulate matter
282744|NCT01741051|Mongolia|mongolia
282745|NCT01741051|Pregnancy|pregnancy
282746|NCT01741051|Intrauterine growth restriction (IUGR)|intrauterine growth restriction (iugr)
282747|NCT01741051|Fetal growth|fetal growth
282748|NCT01741051|Birth weight|birth weight
282749|NCT01741051|Gestational age|gestational age
282750|NCT01741038|Cancer Vaccine|cancer vaccine
282751|NCT01741038|AlloStim®|allostim®
282752|NCT01741038|Immunovative|immunovative
282753|NCT01741038|Immunotherapy|immunotherapy
282754|NCT01741038|Allogeneic Cell Therapy|allogeneic cell therapy
282755|NCT01741038|Cryoablation|cryoablation
282756|NCT01741012|Lupus|lupus
282757|NCT01740986|Asthma|asthma
282758|NCT01740973|SILC|silc
282759|NCT01740973|lap. cholecystectomy|lap. cholecystectomy
282760|NCT01740973|trocar-site hernia|trocar-site hernia
704664|NCT00983983|Diet|diet
282761|NCT01740960|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
282763|NCT01740960|Cannabis|cannabis
282764|NCT01740947|Selective decontamination of the digestive tract|selective decontamination of the digestive tract
282765|NCT01740947|anastomotic leakage|anastomotic leakage
282766|NCT01740947|colorectal cancer|colorectal cancer
282767|NCT01740934|rosacea|rosacea
282768|NCT01740934|anatabine|anatabine
282769|NCT01740934|Anatabloc|anatabloc
282770|NCT01740934|dermatology|dermatology
282771|NCT01740921|GLP-1 analogues|glp-1 analogues
282772|NCT01740921|microvascular|microvascular
282773|NCT01740921|inflammation|inflammation
282774|NCT01740921|fat tissue|fat tissue
282775|NCT01740921|clot structure|clot structure
282776|NCT01740908|hyperbaric oxygen|hyperbaric oxygen
282777|NCT01740908|stem cell|stem cell
282778|NCT01740882|incisional hernia|incisional hernia
282779|NCT01740882|mesh fixation|mesh fixation
282780|NCT01740882|absorbable tacks|absorbable tacks
282782|NCT01740869|autism spectrum|autism spectrum
282783|NCT01740869|stem cells|stem cells
282784|NCT01740869|children|children
282785|NCT01740856|cardiac catheterization|cardiac catheterization
282786|NCT01740856|safety|safety
282787|NCT01740856|nursing care|nursing care
282788|NCT01740856|rest|rest
282789|NCT01740856|Patients|patients
282790|NCT01740817|diabetes|diabetes
282791|NCT01740817|obesity|obesity
282792|NCT01740817|inflammation|inflammation
282793|NCT01740804|Circulating tumor cell|circulating tumor cell
282794|NCT01740804|Non-small cell lung cancer|non-small cell lung cancer
282795|NCT01740804|chemotherapy|chemotherapy
282796|NCT01740791|Hepatitis C|hepatitis c
282797|NCT01740791|HCV|hcv
282798|NCT01740791|Genotype 1|genotype 1
282799|NCT01740791|Genotype 2|genotype 2
282800|NCT01740791|Genotype 3|genotype 3
282801|NCT01740791|Genotype 4|genotype 4
282802|NCT01740791|Genotype 5|genotype 5
282803|NCT01740791|Genotype 6|genotype 6
282804|NCT01740791|Liver Disease|liver disease
282805|NCT01740778|Diabetes|diabetes
282806|NCT01740778|Medical Device|medical device
282807|NCT01740778|Lancing|lancing
282808|NCT01740752|anorexia nervosa|anorexia nervosa
282809|NCT01740752|eating disorder|eating disorder
282810|NCT01740752|couples|couples
282811|NCT01740752|relationships|relationships
282812|NCT01740752|couple therapy|couple therapy
282813|NCT01740739|Health Risk Appraisal|health risk appraisal
282814|NCT01740739|HCardiac Risk Factors|hcardiac risk factors
282815|NCT01740726|Depression|depression
282816|NCT01740726|Behavioral Activation|behavioral activation
282817|NCT01740726|Fluoxetine|fluoxetine
282818|NCT01740726|Prozac|prozac
282819|NCT01740726|Treatment|treatment
282820|NCT01740726|Therapy|therapy
282821|NCT01740726|Psychotherapy|psychotherapy
282822|NCT01740726|Antidepressant|antidepressant
282823|NCT01740726|Intervention|intervention
282824|NCT01740713|chronic iron overload|chronic iron overload
282825|NCT01740713|hereditary haemoglobinopathy|hereditary haemoglobinopathy
282826|NCT01740713|beta thalassaemia major|beta thalassaemia major
282827|NCT01740700|Abdominal aortic aneurysm|abdominal aortic aneurysm
282828|NCT01740700|Endovascular|endovascular
282829|NCT01740700|Fenestration|fenestration
282830|NCT01740700|Juxtarenal|juxtarenal
282831|NCT01740700|Off-the-shelf|off-the-shelf
282832|NCT01740700|Pararenal|pararenal
282833|NCT01740687|Endometrial Ablation|endometrial ablation
282834|NCT01740687|Permanent Sterilization|permanent sterilization
282835|NCT01740687|Essure|essure
282836|NCT01740687|NovaSure|novasure
282837|NCT01740687|Prevention of Pregnancy|prevention of pregnancy
282838|NCT01740674|internet data collection|internet data collection
282839|NCT01740674|longitudinal research|longitudinal research
282840|NCT01740674|cohort retention|cohort retention
282841|NCT01740648|MEK Inhibitor|mek inhibitor
282842|NCT01740648|Trametinib|trametinib
282843|NCT01740648|Rectal Cancers|rectal cancers
282844|NCT01740648|KRAS|kras
282845|NCT01740648|BRAF|braf
282846|NCT01740648|NRAS Mutant|nras mutant
282847|NCT01740648|Fluorouracil|fluorouracil
282848|NCT01740635|rehabilitation|rehabilitation
282849|NCT01740635|wheelchair|wheelchair
282850|NCT01740635|manual wheelchair|manual wheelchair
282851|NCT01740635|wheelchair users|wheelchair users
282852|NCT01740635|older adults|older adults
282853|NCT01740635|cognitive computer games|cognitive computer games
282854|NCT01740635|home-based training|home-based training
282855|NCT01740635|community mobility|community mobility
282856|NCT01740622|Injury|injury
282857|NCT01740622|Injury Prevention|injury prevention
282858|NCT01740622|Cincinnati Home Injury Prevention|cincinnati home injury prevention
282859|NCT01740622|Injury Hazards|injury hazards
282860|NCT01740622|Modifiable Injury Hazards|modifiable injury hazards
282861|NCT01740609|Phase 1|phase 1
282862|NCT01740609|RN168|rn168
282863|NCT01740609|Healthy Volunteers|healthy volunteers
282864|NCT01740596|NYHA III|nyha iii
282865|NCT01740596|NYHA IV|nyha iv
282866|NCT01740596|ACC Stage C|acc stage c
282867|NCT01740596|Heart Failure|heart failure
282868|NCT01740596|Congestive Heart Failure|congestive heart failure
282869|NCT01740596|C-Pulse|c-pulse
282870|NCT01740596|Counterpulsation|counterpulsation
282871|NCT01740596|Heart Assist|heart assist
282872|NCT01740596|Sunshine Heart|sunshine heart
282873|NCT01740596|Left Heart Failure|left heart failure
282874|NCT01740583|mitral valve, regurgitation, annuloplasty|mitral valve, regurgitation, annuloplasty
282875|NCT01740570|Brain cancer|brain cancer
282876|NCT01740570|Malignant glioma|malignant glioma
282877|NCT01740570|Glioblastoma multiforme|glioblastoma multiforme
282878|NCT01740570|Gliosarcoma|gliosarcoma
282879|NCT01740570|Anaplastic astrocytoma|anaplastic astrocytoma
282880|NCT01740570|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
282881|NCT01740570|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
282882|NCT01740570|Cabazitaxel|cabazitaxel
282883|NCT01740570|Jevtana|jevtana
282884|NCT01740557|Melanoma|melanoma
282885|NCT01740557|Metastatic Melanoma|metastatic melanoma
282886|NCT01740557|Stage III in-transit, subcutaneous, or regional nodal disease|stage iii in-transit, subcutaneous, or regional nodal disease
282887|NCT01740557|Cytoxan|cytoxan
282888|NCT01740557|Cyclophosphamide|cyclophosphamide
282889|NCT01740557|Neosar|neosar
282890|NCT01740557|Mesna|mesna
282891|NCT01740557|Mesnex|mesnex
282892|NCT01740557|Fludarabine|fludarabine
282893|NCT01740557|Fludarabine Phosphate|fludarabine phosphate
282894|NCT01740557|Fludara|fludara
282895|NCT01740557|IL-2|il-2
282896|NCT01740557|Interleukin-2|interleukin-2
282897|NCT01740557|Aldesleukin|aldesleukin
282898|NCT01740557|Proleukin|proleukin
282899|NCT01740557|T-cells|t-cells
282900|NCT01740557|Autologous tumor infiltrating lymphocytes|autologous tumor infiltrating lymphocytes
282902|NCT01740557|CXCR2|cxcr2
282903|NCT01740531|S303 treated RBCs|s303 treated rbcs
282904|NCT01740505|energy cost of walking|energy cost of walking
282905|NCT01740505|energy metabolism|energy metabolism
282906|NCT01740505|aged|aged
282907|NCT01740505|older adult|older adult
282908|NCT01740505|exercise|exercise
282909|NCT01740505|gait|gait
282910|NCT01740505|walking|walking
282911|NCT01740505|aerobic|aerobic
282912|NCT01740505|motor skill|motor skill
282913|NCT01740492|Ketamine|ketamine
282914|NCT01740492|Acute pain|acute pain
282915|NCT01740492|Pain control|pain control
282916|NCT01740492|Pain|pain
282917|NCT01740479|STEMI|stemi
282918|NCT01740479|ticagrelor|ticagrelor
283016|NCT01740115|HIV|hiv
282919|NCT01740479|multi-vessel disease|multi-vessel disease
282920|NCT01740479|culprit lesion|culprit lesion
282921|NCT01740466|Prevalence|prevalence
282922|NCT01740466|Vision disorders|vision disorders
273561|NCT01783041|MRI|mri
282923|NCT01740466|Eye diseases|eye diseases
282924|NCT01740466|Visual acuity|visual acuity
282925|NCT01740466|Primary health care|primary health care
282926|NCT01740440|Healthy females|healthy females
282927|NCT01740427|breast cancer|breast cancer
282928|NCT01740427|postmenopausal women|postmenopausal women
282929|NCT01740427|estrogen-receptor positive|estrogen-receptor positive
282930|NCT01740427|HER2 negative|her2 negative
282931|NCT01740427|locoregionally recurrent|locoregionally recurrent
282932|NCT01740427|metastatic|metastatic
282933|NCT01740427|Palbociclib (PD-0332991)|palbociclib (pd-0332991)
282934|NCT01740427|PALOMA-2|paloma-2
282935|NCT01740414|prescription opioid abuse|prescription opioid abuse
282936|NCT01740414|pain|pain
282937|NCT01740414|opioid withdrawal|opioid withdrawal
282938|NCT01740414|oxycodone|oxycodone
282939|NCT01740414|ibudilast|ibudilast
282940|NCT01740401|Melanoma|melanoma
282941|NCT01740401|Advanced Malignant Melanoma|advanced malignant melanoma
282942|NCT01740401|Anti CTLA4 Blockade|anti ctla4 blockade
282943|NCT01740401|Progression Free Survival|progression free survival
282944|NCT01740401|Interventional Therapy|interventional therapy
282945|NCT01740401|Phase II Clinical Trial|phase ii clinical trial
282946|NCT01740401|Immunotherapy|immunotherapy
282947|NCT01740401|T Cell Activation|t cell activation
282948|NCT01740362|CP-690|cp-690
282949|NCT01740362|550|550
282950|NCT01740362|pharmacokinetics|pharmacokinetics
282951|NCT01740362|renal impairment|renal impairment
282952|NCT01740323|Breast Cancer|breast cancer
282953|NCT01740323|Chemotherapy|chemotherapy
282954|NCT01740323|Radiotherapy|radiotherapy
282955|NCT01740323|NF-kB|nf-kb
282956|NCT01740323|DNA Binding|dna binding
282957|NCT01740323|Curcumin|curcumin
282958|NCT01740323|IL-6|il-6
282959|NCT01740323|TNF|tnf
282960|NCT01740323|sTNFR2|stnfr2
282961|NCT01740323|IL-1-ra|il-1-ra
282962|NCT01740323|Fatigue|fatigue
282963|NCT01740323|Cytokine|cytokine
282964|NCT01740310|pregnancy,|pregnancy,
282965|NCT01740310|vaccine acceptance,|vaccine acceptance,
282966|NCT01740310|vaccination,|vaccination,
282967|NCT01740310|influenza,|influenza,
282968|NCT01740310|pertussis,|pertussis,
282969|NCT01740310|Tdap,|tdap,
282970|NCT01740310|minority,|minority,
282971|NCT01740310|African-American|african-american
283092|NCT01739816|Adherence|adherence
283093|NCT01739816|Polypharmacy|polypharmacy
282972|NCT01740297|melanoma, talimogene laherparepvec, ipilimumab, metastatic melanoma, melanoma, immunotherapy, unresectable melanoma, oncolytic immunotherapy,|melanoma, talimogene laherparepvec, ipilimumab, metastatic melanoma, melanoma, immunotherapy, unresectable melanoma, oncolytic immunotherapy,
282973|NCT01740271|breast cancer|breast cancer
282974|NCT01740271|non-metastatic carcinoma of the breast chemotherapy|non-metastatic carcinoma of the breast chemotherapy
282975|NCT01740271|adjuvant therapy|adjuvant therapy
282976|NCT01740271|neoadjuvant|neoadjuvant
282977|NCT01740258|malignant glioma|malignant glioma
282978|NCT01740258|Grade 4 malignant glioma|grade 4 malignant glioma
282979|NCT01740258|glioblastoma|glioblastoma
282980|NCT01740258|gliosarcoma|gliosarcoma
282981|NCT01740258|adult brain tumor|adult brain tumor
282982|NCT01740245|Laser therapy|laser therapy
282983|NCT01740245|Cervical lesions|cervical lesions
282984|NCT01740245|Polyhexamethylene biguanide|polyhexamethylene biguanide
282985|NCT01740245|Chlorhexidine|chlorhexidine
282986|NCT01740219|Health promotion|health promotion
282987|NCT01740219|Religion and medicine|religion and medicine
282988|NCT01740219|Hispanic Americans|hispanic americans
282989|NCT01740219|Randomized controlled trial|randomized controlled trial
282990|NCT01740219|Program evaluation|program evaluation
282991|NCT01740219|Neoplasms/prevention & control|neoplasms/prevention & control
282992|NCT01740219|Mass screening|mass screening
282993|NCT01740219|Female|female
282994|NCT01740219|Male|male
282995|NCT01740219|Preventive Health Services/methods|preventive health services/methods
282996|NCT01740219|Adult|adult
282997|NCT01740219|Organizations|organizations
282998|NCT01740193|Pain|pain
282999|NCT01740193|Regional Anesthesia|regional anesthesia
283000|NCT01740193|ultrasound|ultrasound
283001|NCT01740193|transversus abdominis plane|transversus abdominis plane
283002|NCT01740193|herniorrhaphy|herniorrhaphy
283003|NCT01740193|pediatrics|pediatrics
283004|NCT01740167|prodrome|prodrome
283005|NCT01740167|mental illness|mental illness
283006|NCT01740167|health promotion|health promotion
283007|NCT01740167|lifestyle behavior|lifestyle behavior
283008|NCT01740141|Pain|pain
283009|NCT01740128|spinal cord injuries|spinal cord injuries
283010|NCT01740128|paraplegia|paraplegia
283011|NCT01740128|postural balance|postural balance
283012|NCT01740128|locomotor activity|locomotor activity
283013|NCT01740128|exercise therapy|exercise therapy
283014|NCT01740128|electromyography|electromyography
283015|NCT01740128|transcranial magnetic stimulation, single pulse|transcranial magnetic stimulation, single pulse
283018|NCT01740115|Bone Disease|bone disease
283019|NCT01740115|Bone Mineral Density|bone mineral density
283020|NCT01740115|Bone Microarchitecture|bone microarchitecture
283021|NCT01740115|Substance Dependence|substance dependence
283022|NCT01740102|Ischemic preconditioning|ischemic preconditioning
283023|NCT01740102|Coronary artery bypass|coronary artery bypass
283024|NCT01740102|Preoperative care|preoperative care
283025|NCT01740102|Postoperative period|postoperative period
283026|NCT01740089|Hepatitis C|hepatitis c
283027|NCT01740089|Cepeginterferon alfa|cepeginterferon alfa
283028|NCT01740089|Peginterferon|peginterferon
283029|NCT01740089|Treatment|treatment
283030|NCT01740076|isoflavones, hypertension, soy, diet, nutrition, women, inflammation, hot flashes|isoflavones, hypertension, soy, diet, nutrition, women, inflammation, hot flashes
283031|NCT01740037|Chronic care program|chronic care program
283032|NCT01740037|Nurse specialist|nurse specialist
283033|NCT01740037|Atrial Fibrillation guideline|atrial fibrillation guideline
283034|NCT01740024|Immunotherapy|immunotherapy
283035|NCT01740024|Subcutaneous immunotherapy|subcutaneous immunotherapy
283036|NCT01740024|Skin Prick Test|skin prick test
283037|NCT01740024|Dose Response Prick Test|dose response prick test
283039|NCT01739985|Vomiting|vomiting
283040|NCT01739985|Children|children
283041|NCT01739985|Prophylaxis|prophylaxis
283042|NCT01739985|Droperidol|droperidol
283043|NCT01739985|Ondansetron|ondansetron
283044|NCT01739985|Dexamethasone|dexamethasone
283045|NCT01739972|Desiccated thyroid extract and levothyroxine|desiccated thyroid extract and levothyroxine
283046|NCT01739959|Necrotizing fasciitis|necrotizing fasciitis
283047|NCT01739959|Fournier's gangrene|fournier's gangrene
283048|NCT01739959|Cellulitis|cellulitis
283049|NCT01739959|Serum Lactate|serum lactate
283050|NCT01739933|Delirium|delirium
283051|NCT01739933|Delirium/coma-free days|delirium/coma-free days
283052|NCT01739933|Long term cognitive impairment|long term cognitive impairment
283053|NCT01739933|Sedation|sedation
283054|NCT01739933|Intensive care|intensive care
283055|NCT01739933|Mechanical Ventilation|mechanical ventilation
283056|NCT01739933|Dexmedetomidine|dexmedetomidine
283057|NCT01739933|Propofol|propofol
283058|NCT01739933|Coma-free days|coma-free days
283059|NCT01739933|Sepsis|sepsis
283060|NCT01739933|Organ dysfunction|organ dysfunction
283061|NCT01739933|Acute Respiratory Distress|acute respiratory distress
283062|NCT01739933|Markers of inflammation|markers of inflammation
283063|NCT01739920|Povidone-Iodine|povidone-iodine
283064|NCT01739920|Ophthalmic Solutions|ophthalmic solutions
283065|NCT01739920|Endophthalmitis|endophthalmitis
283066|NCT01739920|Preoperative procedures|preoperative procedures
283067|NCT01739907|Iron deficiency|iron deficiency
283068|NCT01739907|Menstruating women|menstruating women
283069|NCT01739907|Vitamin D|vitamin d
283070|NCT01739907|Functional food|functional food
283071|NCT01739894|Advanced gastric cancer|advanced gastric cancer
283072|NCT01739894|unresectable gastric cancer|unresectable gastric cancer
283073|NCT01739894|recurrent gastric cancer|recurrent gastric cancer
283074|NCT01739894|with peritoneal metastasis|with peritoneal metastasis
283075|NCT01739894|cancer cells on peritoneal cytology|cancer cells on peritoneal cytology
283076|NCT01739881|Exhaled breath condensate (EBC) method|exhaled breath condensate (ebc) method
283077|NCT01739881|Volatile Organic Compounds (VOCs)|volatile organic compounds (vocs)
283078|NCT01739881|Endobronchial Ultrasound (EBUS)|endobronchial ultrasound (ebus)
283079|NCT01739881|Confocal Endoscopy|confocal endoscopy
283080|NCT01739881|Exhaled alveolar gas|exhaled alveolar gas
283081|NCT01739868|Pre-diabetes|pre-diabetes
283082|NCT01739868|Type 2 diabetes|type 2 diabetes
283083|NCT01739868|Biomarkers|biomarkers
283084|NCT01739868|Diabetes risk score|diabetes risk score
283085|NCT01739842|Alcohol consumption|alcohol consumption
283086|NCT01739842|Kudzu extract|kudzu extract
283087|NCT01739842|Cerebral blood flow|cerebral blood flow
283088|NCT01739829|xenotransplantation|xenotransplantation
283089|NCT01739829|type 1 diabetes|type 1 diabetes
283090|NCT01739829|porcine islets|porcine islets
283091|NCT01739816|Compliance|compliance
283094|NCT01739816|Medicines use|medicines use
283095|NCT01739816|Medication review|medication review
283096|NCT01739816|Pharmaceutical care|pharmaceutical care
283097|NCT01739816|Primary care|primary care
283098|NCT01739816|Drug related problem|drug related problem
283099|NCT01739816|Patient safety|patient safety
283100|NCT01739803|Immunosuppressant therapy adherence|immunosuppressant therapy adherence
283101|NCT01739803|Quality of life|quality of life
283102|NCT01739803|Economic outcomes|economic outcomes
283103|NCT01739790|COPD|copd
283104|NCT01739790|Chronic Bronchitis|chronic bronchitis
283105|NCT01739790|N-acetylcysteine|n-acetylcysteine
283106|NCT01739777|Heart Failure|heart failure
283107|NCT01739777|Coronary Heart Disease|coronary heart disease
283108|NCT01739777|Adult Stem Cells|adult stem cells
283109|NCT01739777|Umbilical Progenitor Cells|umbilical progenitor cells
283110|NCT01739777|Umbilical Cord Stem Cells Allogenic|umbilical cord stem cells allogenic
283111|NCT01739777|Left Ventricular Function|left ventricular function
283112|NCT01739777|Intravenous Injection|intravenous injection
283113|NCT01739751|COPD|copd
283114|NCT01739751|Physical activity|physical activity
283115|NCT01739751|Pedometers|pedometers
283116|NCT01739751|steps|steps
283117|NCT01739751|non pharmacological treatment|non pharmacological treatment
283118|NCT01739751|rehabilitation|rehabilitation
283119|NCT01739751|exercise|exercise
283120|NCT01739738|peristalsis, kidney stones, hydronephrosis, ureteral stent|peristalsis, kidney stones, hydronephrosis, ureteral stent
283121|NCT01739725|kidney stones, ureteral stent, pain,|kidney stones, ureteral stent, pain,
283122|NCT01739712|Diabetes|diabetes
283123|NCT01739712|Sleep problems|sleep problems
283124|NCT01739712|School|school
283125|NCT01739712|Neurobehavioral|neurobehavioral
283126|NCT01739699|craniotomy|craniotomy
283127|NCT01739699|brain surgery|brain surgery
283128|NCT01739699|acetaminophen|acetaminophen
283129|NCT01739699|Tylenol|tylenol
283130|NCT01739686|Quality of Life|quality of life
283131|NCT01739686|Symptoms|symptoms
283132|NCT01739686|Palliative care|palliative care
283133|NCT01739686|Symptom management|symptom management
283134|NCT01739686|Disease management|disease management
283135|NCT01739686|Health delivery|health delivery
283136|NCT01739673|Infectious Keratitis|infectious keratitis
283137|NCT01739660|Chronic Kidney Disease Stage 5|chronic kidney disease stage 5
283139|NCT01739660|pegloticase|pegloticase
283140|NCT01739647|AZD3293|azd3293
283141|NCT01739647|Healthy volunteers|healthy volunteers
283142|NCT01739647|Elderly volunteers|elderly volunteers
283143|NCT01739647|Phase 1|phase 1
283144|NCT01739647|Single Ascending Dose Study|single ascending dose study
283145|NCT01739634|Diarrhea|diarrhea
283146|NCT01739634|Medullary thyroid cancer|medullary thyroid cancer
283147|NCT01739608|CRC|crc
283148|NCT01739569|Diet treatment|diet treatment
283149|NCT01739569|Mental Health|mental health
283150|NCT01739569|Reaction time|reaction time
283151|NCT01739569|State of moods|state of moods
283152|NCT01739569|Working hours|working hours
283153|NCT01739569|Medical Hospital Staff|medical hospital staff
283154|NCT01739556|antiplatelet therapy|antiplatelet therapy
283155|NCT01739556|primary PCI|primary pci
283156|NCT01739556|modification|modification
283157|NCT01739517|Short bowel syndrome|short bowel syndrome
283158|NCT01739517|Cholestasis|cholestasis
283159|NCT01739517|Omegaven|omegaven
283160|NCT01739517|Parenteral nutrition-associated Liver Disease|parenteral nutrition-associated liver disease
283161|NCT01739504|Arthritis|arthritis
283162|NCT01739504|Joint pain|joint pain
283163|NCT01739504|Articular cartilage|articular cartilage
283164|NCT01739504|Mesenchymal stem cells|mesenchymal stem cells
283165|NCT01739504|Autologous|autologous
283166|NCT01739504|Adipose tissue|adipose tissue
283167|NCT01739491|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
283168|NCT01739491|Bendamustine hydrochloride|bendamustine hydrochloride
283169|NCT01739491|Leukemia|leukemia
283170|NCT01739491|Filipino|filipino
283171|NCT01739465|Cholangiocarcinoma|cholangiocarcinoma
283172|NCT01739465|Pathologic|pathologic
283173|NCT01739465|Digestive System|digestive system
283174|NCT01739465|Neoplasms|neoplasms
283175|NCT01739465|Neoplasms by Site|neoplasms by site
283176|NCT01739465|Digestive System Diseases|digestive system diseases
283177|NCT01739465|Bile Duct Diseases|bile duct diseases
283178|NCT01739465|Biliary Tract Diseases|biliary tract diseases
283179|NCT01739465|Pathological Conditions|pathological conditions
283180|NCT01739465|Constriction|constriction
283181|NCT01739465|Adenocarcinoma|adenocarcinoma
283182|NCT01739465|Carcinoma|carcinoma
283183|NCT01739452|Low-risk MDS|low-risk mds
283184|NCT01739452|myelodysplastic syndrome|myelodysplastic syndrome
283185|NCT01739452|retrospective|retrospective
283186|NCT01739426|LigaSure V (TM)|ligasure v (tm)
283187|NCT01739400|Eisenmenger Syndrome|eisenmenger syndrome
283188|NCT01739400|exercise capacity|exercise capacity
283189|NCT01739387|Flutiform®|flutiform®
283191|NCT01739387|COPD|copd
283192|NCT01739374|pelvic floor reconstruction|pelvic floor reconstruction
283193|NCT01739374|mesh implants|mesh implants
283194|NCT01739335|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
283195|NCT01739335|Mifepristone|mifepristone
283196|NCT01739335|Veterans|veterans
283197|NCT01739335|Clinical Trial|clinical trial
283198|NCT01739309|Non- Hodgkins Lymphoma|non- hodgkins lymphoma
283199|NCT01739296|osteoarthritis|osteoarthritis
283200|NCT01739296|osteoarthritis, knee|osteoarthritis, knee
283201|NCT01739296|foot orthoses|foot orthoses
283202|NCT01739296|orthotic insoles|orthotic insoles
283203|NCT01739270|analgesia|analgesia
283204|NCT01739270|regional anesthesia|regional anesthesia
283205|NCT01739270|surgery|surgery
283206|NCT01739270|duration of analgesia|duration of analgesia
283207|NCT01739270|dexamethasone added to levobupivacaine compared to levobupivacaine alone|dexamethasone added to levobupivacaine compared to levobupivacaine alone
283208|NCT01739244|Glaucoma|glaucoma
283209|NCT01739244|Open Angle Glaucoma|open angle glaucoma
283210|NCT01739244|Ocular Hypertension|ocular hypertension
283211|NCT01739244|IOP|iop
283212|NCT01739244|RNAi|rnai
283213|NCT01739244|siRNA|sirna
283214|NCT01739244|beta inhibitor|beta inhibitor
283215|NCT01739205|Type 2 diabetes and depression|type 2 diabetes and depression
283316|NCT01738750|pediatric|pediatric
283216|NCT01739179|Ventricular peritoneal Shunt|ventricular peritoneal shunt
283217|NCT01739179|Shunt Complications|shunt complications
283218|NCT01739179|Shunt Failure|shunt failure
283219|NCT01739179|Hydrocephalus|hydrocephalus
283220|NCT01739166|Health Services Research|health services research
283221|NCT01739166|Quality Assurance|quality assurance
283222|NCT01739153|Dairy|dairy
283223|NCT01739153|Cheese|cheese
283224|NCT01739153|Blood lipid concentrations|blood lipid concentrations
283225|NCT01739153|Blood lipid sizes|blood lipid sizes
283226|NCT01739153|Fecal fat|fecal fat
283227|NCT01739153|Fat digestibility|fat digestibility
283228|NCT01739153|bile acids|bile acids
283229|NCT01739127|Antipsychotic agents|antipsychotic agents
283230|NCT01739127|Adverse effects|adverse effects
283231|NCT01739127|Magnetic Resonance Imaging|magnetic resonance imaging
283232|NCT01739114|Lung aeration|lung aeration
283233|NCT01739114|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
283234|NCT01739114|Positive Pressure Respiration|positive pressure respiration
283235|NCT01739114|Sustained Inflation|sustained inflation
283236|NCT01739114|Continuous Positive Airway Pressure|continuous positive airway pressure
283237|NCT01739088|Congenital heart disease|congenital heart disease
283238|NCT01739088|pediatrics|pediatrics
283239|NCT01739088|ischemia-reperfusion injury|ischemia-reperfusion injury
283240|NCT01739088|long term outcomes|long term outcomes
283241|NCT01739062|PSA test|psa test
283242|NCT01739062|Prostate cancer|prostate cancer
283243|NCT01739062|Genetic screening|genetic screening
283244|NCT01739036|Malaria|malaria
283245|NCT01739036|Vaccine|vaccine
283246|NCT01739036|Plasmodium|plasmodium
283247|NCT01739036|Falciparum|falciparum
283248|NCT01739023|paraplegia|paraplegia
283249|NCT01739023|cell therapy|cell therapy
283250|NCT01739023|Schwann cells|schwann cells
283251|NCT01739023|spinal cord injury|spinal cord injury
283252|NCT01738997|Benign|benign
283253|NCT01738997|Esophageal strictures|esophageal strictures
283254|NCT01738997|Esophagus|esophagus
283255|NCT01738997|Balloon Dilation|balloon dilation
283256|NCT01738984|exercise|exercise
283257|NCT01738984|video|video
283258|NCT01738984|DVD|dvd
283259|NCT01738984|mother|mother
283260|NCT01738984|infant|infant
704665|NCT00983983|Tube feed|tube feed
283261|NCT01738971|emergency contraception|emergency contraception
283262|NCT01738971|community pharmacy|community pharmacy
283263|NCT01738958|Probiotic bacteria|probiotic bacteria
283264|NCT01738958|Caries dentalis|caries dentalis
283265|NCT01738958|QLF|qlf
283266|NCT01738932|endometriosis|endometriosis
283267|NCT01738932|mannan-binding lectin|mannan-binding lectin
283268|NCT01738932|immunology|immunology
283269|NCT01738893|Gabapentin|gabapentin
283270|NCT01738893|Bioequivalence|bioequivalence
283271|NCT01738893|Pharmacokinetics|pharmacokinetics
283272|NCT01738893|Mexico|mexico
283273|NCT01738867|Pharmacogenetics|pharmacogenetics
283274|NCT01738867|OPRM1|oprm1
283275|NCT01738867|Pharmacodynamics|pharmacodynamics
283276|NCT01738867|Addiction|addiction
283277|NCT01738867|mu opioid receptors|mu opioid receptors
283278|NCT01738854|laryngeal mask airway supreme|laryngeal mask airway supreme
283279|NCT01738854|airway sealing|airway sealing
283280|NCT01738854|intracuff pressure|intracuff pressure
283281|NCT01738841|Combined measles-mumps-rubella-varicella vaccine|combined measles-mumps-rubella-varicella vaccine
283282|NCT01738841|Priorix-Tetra™|priorix-tetra™
283283|NCT01738841|MMRV|mmrv
283284|NCT01738841|children|children
283285|NCT01738841|Post-marketing surveillance|post-marketing surveillance
283286|NCT01738841|Philippines|philippines
283287|NCT01738815|bladder cancer|bladder cancer
283288|NCT01738815|hematuria|hematuria
283289|NCT01738815|sodium valproate|sodium valproate
283290|NCT01738815|valproic acid|valproic acid
283291|NCT01738802|Type 2 Diabetes|type 2 diabetes
283292|NCT01738802|carotid intima medial thickness|carotid intima medial thickness
283293|NCT01738802|micronutrient|micronutrient
283294|NCT01738802|anti-oxidant|anti-oxidant
283295|NCT01738789|Adnexal masses|adnexal masses
283296|NCT01738789|Magnetic resonance imaging|magnetic resonance imaging
283297|NCT01738789|Ovarian tumor|ovarian tumor
283298|NCT01738776|hip fracture|hip fracture
283299|NCT01738776|risk factors|risk factors
283300|NCT01738776|vitamin K1|vitamin k1
283301|NCT01738776|vitamin D|vitamin d
283302|NCT01738776|bone turnover markers|bone turnover markers
283303|NCT01738776|osteocalcin|osteocalcin
283304|NCT01738776|undercarboxylated osteocalcin|undercarboxylated osteocalcin
283305|NCT01738776|bone specific alkaline phosphatase (BALP)|bone specific alkaline phosphatase (balp)
283306|NCT01738776|insulin like growth factor 1 (IGF1)|insulin like growth factor 1 (igf1)
283307|NCT01738776|parathyroid hormone (PTH)|parathyroid hormone (pth)
283308|NCT01738763|Glucose|glucose
283309|NCT01738763|Insulin|insulin
283310|NCT01738763|3-O-methyl-D-chiro-inositol|3-o-methyl-d-chiro-inositol
283311|NCT01738750|surgical choice|surgical choice
283312|NCT01738750|cost of care|cost of care
273907|NCT01781390|AMI|ami
283313|NCT01738750|decision making|decision making
283314|NCT01738750|health care|health care
283315|NCT01738750|health care cost|health care cost
283317|NCT01738750|children|children
283318|NCT01738750|appendicitis|appendicitis
283319|NCT01738750|patient satisfaction|patient satisfaction
283320|NCT01738711|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
283321|NCT01738711|Cognitive behavioural therapy|cognitive behavioural therapy
283322|NCT01738711|Anxiety|anxiety
283323|NCT01738711|Quality of life|quality of life
283324|NCT01738685|Breast Cancer.|breast cancer.
283325|NCT01738685|Adjuvant Endocrine therapy.|adjuvant endocrine therapy.
283326|NCT01738672|Nitrous oxide|nitrous oxide
283327|NCT01738672|labor and delivery|labor and delivery
283328|NCT01738672|analgesia|analgesia
283329|NCT01738659|sodium ,diuretics, PCWP|sodium ,diuretics, pcwp
283330|NCT01738646|vorinostat|vorinostat
283331|NCT01738646|SAHA|saha
283332|NCT01738646|bevacizumab|bevacizumab
283333|NCT01738646|AVASTIN|avastin
283334|NCT01738646|malignant glioma|malignant glioma
283335|NCT01738646|GBM|gbm
283336|NCT01738646|glioblastoma multiforme|glioblastoma multiforme
283338|NCT01738633|Esophageal Cancer|esophageal cancer
283339|NCT01738633|Quality of Life|quality of life
283340|NCT01738620|esophageal cancer|esophageal cancer
283341|NCT01738620|sleep disturbance|sleep disturbance
283342|NCT01738620|quality of life|quality of life
283343|NCT01738607|fecal incontinence, dietary fiber|fecal incontinence, dietary fiber
283344|NCT01738581|focal hand dystonia (FHD)|focal hand dystonia (fhd)
283473|NCT01738204|fertility|fertility
283345|NCT01738581|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
283346|NCT01738581|sensorimotor retraining|sensorimotor retraining
283347|NCT01738568|High intensity aerobic training|high intensity aerobic training
283348|NCT01738555|amdoxovir|amdoxovir
283349|NCT01738555|zidovudine|zidovudine
283350|NCT01738555|HIV|hiv
283351|NCT01738555|HAART|haart
283352|NCT01738555|antiretroviral|antiretroviral
283353|NCT01738542|Bosentan|bosentan
283354|NCT01738542|Peripheral Arterial Disease|peripheral arterial disease
283355|NCT01738529|confocal laser endomicroscopy|confocal laser endomicroscopy
283356|NCT01738529|Crohn´disease|crohn´disease
402014|NCT01233479|untreated childhood cerebral astrocytoma|untreated childhood cerebral astrocytoma
283369|NCT01738477|BoostrixTM|boostrixtm
283370|NCT01738477|Persistence|persistence
283371|NCT01738464|Pelvic Pain|pelvic pain
283372|NCT01738464|Interstitial Cystitis|interstitial cystitis
283373|NCT01738464|Microbiome|microbiome
283374|NCT01738464|Prostatitis|prostatitis
283375|NCT01738464|Chronic|chronic
283376|NCT01738464|Depression|depression
283377|NCT01738451|Holter monitor|holter monitor
283378|NCT01738451|cancer|cancer
283379|NCT01738451|BRAF inhibitor|braf inhibitor
283380|NCT01738451|BRAF-mutation positive tumor|braf-mutation positive tumor
283381|NCT01738451|pharmacokinetics|pharmacokinetics
283383|NCT01738451|ECG intervals and morphology|ecg intervals and morphology
283384|NCT01738451|GSK2118436|gsk2118436
283385|NCT01738451|safety|safety
283386|NCT01738438|Metastatic|metastatic
283387|NCT01738438|Triple Negative|triple negative
283388|NCT01738438|Stage IV|stage iv
283389|NCT01738425|GIC-1001|gic-1001
283390|NCT01738425|opioid agonist|opioid agonist
283391|NCT01738425|sulfide|sulfide
283392|NCT01738425|colonoscopy|colonoscopy
283393|NCT01738425|gicare|gicare
283394|NCT01738425|Phase I|phase i
283395|NCT01738425|safety|safety
283396|NCT01738425|tolerability|tolerability
283397|NCT01738425|pharmacokinetics|pharmacokinetics
283398|NCT01738425|healthy subjects|healthy subjects
283399|NCT01738425|single ascending dose|single ascending dose
283400|NCT01738425|multiple ascending dose|multiple ascending dose
283401|NCT01738425|SAD|sad
283402|NCT01738425|MAD|mad
283403|NCT01738425|food effect|food effect
283404|NCT01738412|Stroke|stroke
283405|NCT01738399|Insulin resistance|insulin resistance
283406|NCT01738399|Coffee|coffee
283407|NCT01738399|Glucose metabolism|glucose metabolism
283408|NCT01738386|Adaptation|adaptation
283409|NCT01738386|Coping|coping
283410|NCT01738386|Presenile Dementia|presenile dementia
283411|NCT01738386|Caregiver Burden|caregiver burden
283412|NCT01738373|autologous stem cell transplantation|autologous stem cell transplantation
283413|NCT01738373|lymphoma|lymphoma
283414|NCT01738373|multiple myeloma|multiple myeloma
283415|NCT01738360|Arsenic trioxide|arsenic trioxide
283416|NCT01738360|Systemic Lupus|systemic lupus
283417|NCT01738360|clinically|clinically
283418|NCT01738360|biologically active|biologically active
283419|NCT01738334|Meditation|meditation
283420|NCT01738334|Cognition|cognition
283421|NCT01738334|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
283422|NCT01738308|Healing Touch|healing touch
283423|NCT01738308|Pediatrics|pediatrics
283424|NCT01738308|surgery|surgery
283425|NCT01738308|stress|stress
283426|NCT01738308|pain|pain
283427|NCT01738308|Pediatric Stress|pediatric stress
283428|NCT01738308|maladaptive behaviors|maladaptive behaviors
283429|NCT01738308|energy medicine|energy medicine
283430|NCT01738308|emergence delirium|emergence delirium
283431|NCT01738308|emergence agitation|emergence agitation
283432|NCT01738308|length of stay|length of stay
283433|NCT01738308|ease of wake up|ease of wake up
283434|NCT01738308|distress parents|distress parents
283435|NCT01738308|distress pediatric patients|distress pediatric patients
283436|NCT01738308|Pediatric Post-Traumatic Stress Disorder|pediatric post-traumatic stress disorder
283437|NCT01738295|acetylcholine|acetylcholine
283438|NCT01738295|cholinergic system|cholinergic system
283439|NCT01738295|visual perception|visual perception
283440|NCT01738295|visual attention|visual attention
283441|NCT01738295|multiple objects tracking|multiple objects tracking
283442|NCT01738295|perceptual learning|perceptual learning
283443|NCT01738295|vision training|vision training
283444|NCT01738282|baclofene|baclofene
283445|NCT01738282|Alcohol dependence|alcohol dependence
283446|NCT01738282|Maintenance of abstinence|maintenance of abstinence
283447|NCT01738269|Ovarian cancer, HE4, normal range|ovarian cancer, he4, normal range
283448|NCT01738256|Cognitive Behavior Therapy|cognitive behavior therapy
283449|NCT01738256|Acceptance Commitment Therapy|acceptance commitment therapy
283451|NCT01738256|Metabolic Syndrome|metabolic syndrome
283452|NCT01738256|Overweight|overweight
283453|NCT01738256|Life Style|life style
283454|NCT01738243|Thyroid|thyroid
283455|NCT01738243|Thyroid Eye Disease|thyroid eye disease
283456|NCT01738243|Thyroid Orbitopathy|thyroid orbitopathy
283457|NCT01738243|Eyelid Retraction|eyelid retraction
283458|NCT01738243|Upper Eyelid Retraction|upper eyelid retraction
283459|NCT01738217|Intra-operative imaging|intra-operative imaging
283460|NCT01738217|NIR Fluorescence|nir fluorescence
283461|NCT01738217|Liver surgery|liver surgery
283462|NCT01738217|Tumoral margins|tumoral margins
283463|NCT01738204|endometriosis|endometriosis
283464|NCT01738204|dysmenorrhea|dysmenorrhea
283465|NCT01738204|pelvic pain|pelvic pain
283466|NCT01738204|women's health|women's health
283467|NCT01738204|adolescence|adolescence
283468|NCT01738204|biorepository|biorepository
283469|NCT01738204|observational|observational
283470|NCT01738204|women|women
283471|NCT01738204|female|female
283472|NCT01738204|gynecology|gynecology
283474|NCT01738204|infertility|infertility
283475|NCT01738191|Parkinson's disease|parkinson's disease
283476|NCT01738165|Prospective|prospective
283477|NCT01738165|Multi-Center|multi-center
283478|NCT01738165|Pilot Study|pilot study
283479|NCT01738165|Single Arm|single arm
283480|NCT01738165|Safety|safety
283481|NCT01738165|Efficacy|efficacy
283482|NCT01738152|HYALOGYN VAGINAL GEL|hyalogyn vaginal gel
283483|NCT01738152|vaginal dryness|vaginal dryness
283484|NCT01738152|12-232|12-232
283485|NCT01738139|Advanced Cancers|advanced cancers
283486|NCT01738139|Advanced Malignancies|advanced malignancies
283487|NCT01738139|Metastatic|metastatic
283488|NCT01738139|Unresectable|unresectable
283489|NCT01738139|Ipilimumab|ipilimumab
283490|NCT01738139|Yervoy|yervoy
283491|NCT01738139|BMS-734016|bms-734016
283492|NCT01738139|MDX010|mdx010
283493|NCT01738139|Imatinib Mesylate|imatinib mesylate
283494|NCT01738139|Imatinib|imatinib
283495|NCT01738139|Gleevec|gleevec
283496|NCT01738139|STI 571|sti 571
283497|NCT01738139|NSC-716051|nsc-716051
283498|NCT01738126|cerebellum|cerebellum
283499|NCT01738126|fMRI|fmri
283501|NCT01738126|pain|pain
283502|NCT01738126|heat|heat
283503|NCT01738126|noxious|noxious
283504|NCT01738126|aversion|aversion
283505|NCT01738126|unpleasantness|unpleasantness
283506|NCT01738126|anger|anger
283507|NCT01738126|aversive stimulus|aversive stimulus
283508|NCT01738126|motor|motor
283509|NCT01738126|human|human
283510|NCT01738126|image analysis|image analysis
283511|NCT01738126|perception|perception
283512|NCT01738126|central nervous system|central nervous system
283513|NCT01738126|sensory|sensory
283514|NCT01738126|somatosensory cortex|somatosensory cortex
283515|NCT01738126|trigeminal system|trigeminal system
283516|NCT01738126|white matter|white matter
283517|NCT01738113|Ilizarov|ilizarov
283518|NCT01738113|distraction osteogenesis|distraction osteogenesis
283519|NCT01738113|Muscle architecture|muscle architecture
283520|NCT01738113|muscle mechanics|muscle mechanics
283521|NCT01738113|Rehabilitation|rehabilitation
283522|NCT01738087|patients|patients
283523|NCT01738087|Adult|adult
283524|NCT01738074|rotavirus|rotavirus
283525|NCT01738074|trivalent genetic reassortment vaccine|trivalent genetic reassortment vaccine
283526|NCT01738074|Phase three clinical trials|phase three clinical trials
283527|NCT01738061|Older workers|older workers
283528|NCT01738061|Multidimensional intervention|multidimensional intervention
283529|NCT01738061|Worksite health promotion|worksite health promotion
283530|NCT01738061|Taiwan|taiwan
283531|NCT01738048|Pain|pain
283532|NCT01738048|Neuropathic pain|neuropathic pain
283533|NCT01738048|Chronic pain|chronic pain
283534|NCT01738035|IgA nephropathy|iga nephropathy
283535|NCT01738022|Sleep apnea|sleep apnea
283536|NCT01738022|Pathophysiology|pathophysiology
283537|NCT01738009|Sleep Apnea|sleep apnea
283538|NCT01738009|Pathophysiology|pathophysiology
283539|NCT01737983|cystic fibrosis|cystic fibrosis
283540|NCT01737983|probiotics|probiotics
283919|NCT01736397|CKD|ckd
283541|NCT01737983|Lactobacillus reuteri|lactobacillus reuteri
283542|NCT01737957|Proliferative Diabetic retinopathy|proliferative diabetic retinopathy
283543|NCT01737957|Pan-retinal photocoagulation|pan-retinal photocoagulation
283544|NCT01737944|methotrexate injection, subcutaneous, autoinjector|methotrexate injection, subcutaneous, autoinjector
283545|NCT01737931|SPM 962|spm 962
283546|NCT01737931|rotigotine|rotigotine
283547|NCT01737931|application site reaction|application site reaction
283548|NCT01737918|urge urinary incontinence, cesa, vasa, TOT, solifenacin|urge urinary incontinence, cesa, vasa, tot, solifenacin
283549|NCT01737905|Asthma|asthma
283550|NCT01737905|Safety|safety
283551|NCT01737905|Efficacy|efficacy
283552|NCT01737905|Epinephrine|epinephrine
283553|NCT01737905|Bronchodilator|bronchodilator
283554|NCT01737905|Metered dose inhaler|metered dose inhaler
283555|NCT01737892|Asthma|asthma
283556|NCT01737892|Pharmacokinetics|pharmacokinetics
283557|NCT01737892|Epinephrine|epinephrine
283558|NCT01737892|Bronchodilator|bronchodilator
283559|NCT01737892|Metered dose inhaler|metered dose inhaler
283560|NCT01737879|Anemia, Chronic Kidney Disease, End Stage Renal Disease, erythropoiesis-stimulating agents, Hemodialysis, Hemoglobin|anemia, chronic kidney disease, end stage renal disease, erythropoiesis-stimulating agents, hemodialysis, hemoglobin
402015|NCT01233479|untreated childhood brain stem glioma|untreated childhood brain stem glioma
283561|NCT01737866|Heart, Failure, Renal, Insufficiency, Cardiac, Kidney, Hemodialysis, Impairment, omecamtiv mecarbil, cardiac myosin activator, CK-1827452|heart, failure, renal, insufficiency, cardiac, kidney, hemodialysis, impairment, omecamtiv mecarbil, cardiac myosin activator, ck-1827452
283562|NCT01737853|Primary Open-Angle Glaucoma|primary open-angle glaucoma
283563|NCT01737853|Ocular Hypertension|ocular hypertension
283564|NCT01737853|Ganfort|ganfort
283565|NCT01737840|dyspepsia|dyspepsia
283566|NCT01737840|pantoprazole|pantoprazole
283567|NCT01737840|ranitidine|ranitidine
283568|NCT01737840|emergency department|emergency department
283569|NCT01737827|INC280, advanced hepatocellular carcinoma, c-MET pathway dysregulation|inc280, advanced hepatocellular carcinoma, c-met pathway dysregulation
283570|NCT01737814|sickle cell disease|sickle cell disease
283571|NCT01737814|vaso-occlusive crisis|vaso-occlusive crisis
283572|NCT01737801|Lung function|lung function
283573|NCT01737801|Physiotherapy|physiotherapy
283574|NCT01737788|Cervical cerclage|cervical cerclage
283575|NCT01737788|Uterine Cervical Incompetence|uterine cervical incompetence
283576|NCT01737775|diaphragmatic dysfunction|diaphragmatic dysfunction
283577|NCT01737775|ultrasonography|ultrasonography
283578|NCT01737775|respiratory distress|respiratory distress
283579|NCT01737775|abdominal surgery|abdominal surgery
283580|NCT01737775|Age|age
283581|NCT01737775|gender|gender
283582|NCT01737775|biometric|biometric
283583|NCT01737775|body mass index|body mass index
283584|NCT01737775|ASA score|asa score
283585|NCT01737775|smoking status|smoking status
283586|NCT01737775|history of respiratory disease|history of respiratory disease
283587|NCT01737762|Venous leg ulcer|venous leg ulcer
283588|NCT01737762|ulcer|ulcer
283589|NCT01737762|Venous stasis|venous stasis
283590|NCT01737762|compression|compression
283591|NCT01737762|venous|venous
283592|NCT01737762|venous stasis ulcer|venous stasis ulcer
283593|NCT01737762|vlu|vlu
283594|NCT01737762|wound|wound
283595|NCT01737762|varicose veins|varicose veins
283596|NCT01737762|venous insufficiency|venous insufficiency
283597|NCT01737762|dvt|dvt
283598|NCT01737762|deep vein thrombosis|deep vein thrombosis
283599|NCT01737749|Stroke|stroke
283600|NCT01737736|Stroke|stroke
283601|NCT01737723|Stroke|stroke
283602|NCT01737710|Influenza Vaccines|influenza vaccines
283603|NCT01737710|Dermatitis|dermatitis
283604|NCT01737710|Injections, Intradermal|injections, intradermal
283605|NCT01737710|Injections, Intramuscular|injections, intramuscular
283606|NCT01737710|Skin Diseases|skin diseases
283607|NCT01737710|Skin Diseases, Eczematous|skin diseases, eczematous
283608|NCT01737710|Hypersensitivity, Immediate|hypersensitivity, immediate
283609|NCT01737710|Hypersensitivity|hypersensitivity
283610|NCT01737710|Immune System Diseases|immune system diseases
283611|NCT01737710|Genetic Diseases, Inborn|genetic diseases, inborn
283612|NCT01737710|Skin Diseases, Genetic|skin diseases, genetic
283613|NCT01737671|Brain tumor|brain tumor
283614|NCT01737671|Malignant Fourth Ventricular Brain Tumors|malignant fourth ventricular brain tumors
283615|NCT01737671|Ependymoma involving brain|ependymoma involving brain
283616|NCT01737671|Ependymoma involving spine|ependymoma involving spine
283617|NCT01737671|Recurrent ependymoma involving brain and/or spine|recurrent ependymoma involving brain and/or spine
283618|NCT01737671|Recurrent atypical teratoid/rhabdoid tumor involving brain|recurrent atypical teratoid/rhabdoid tumor involving brain
283619|NCT01737671|Recurrent atypical teratoid/rhabdoid tumor involving spine|recurrent atypical teratoid/rhabdoid tumor involving spine
283620|NCT01737671|AT/RT|at/rt
350826|NCT01446666|MRI|mri
283621|NCT01737671|Ommaya reservoir catheter|ommaya reservoir catheter
283622|NCT01737671|Methotrexate|methotrexate
283623|NCT01737671|Medulloblastoma|medulloblastoma
283624|NCT01737671|ATRT|atrt
283625|NCT01737671|Atypical teratoid rhabdoid tumor|atypical teratoid rhabdoid tumor
283626|NCT01737671|Ependymoma|ependymoma
283627|NCT01737671|Pediatric brain tumor|pediatric brain tumor
283628|NCT01737671|Intraventricular chemotherapy|intraventricular chemotherapy
283629|NCT01737632|Adolescents|adolescents
283630|NCT01737632|Residential Treatment|residential treatment
283631|NCT01737632|Outpatient Treatment|outpatient treatment
283632|NCT01737632|Substance Abuse|substance abuse
283633|NCT01737632|Delinquency|delinquency
283634|NCT01737632|Family Therapy|family therapy
283635|NCT01737632|Multidimensional Family therapy|multidimensional family therapy
283636|NCT01737619|Gynecologic cancer|gynecologic cancer
283637|NCT01737619|Endometrial Cancer|endometrial cancer
283638|NCT01737619|Lymph Nodes Metastasis|lymph nodes metastasis
283639|NCT01737619|Surgical Staging|surgical staging
283640|NCT01737619|False negative rate|false negative rate
283641|NCT01737619|Detection of positive lymph nodes|detection of positive lymph nodes
283642|NCT01737619|Histologically confirmed high grade endometrial cancer|histologically confirmed high grade endometrial cancer
283643|NCT01737619|Sentinel lymph node mapping|sentinel lymph node mapping
283644|NCT01737606|Cerebral pulsatility|cerebral pulsatility
283645|NCT01737606|Fast Cerebral Pulsatility Imaging or FCPI|fast cerebral pulsatility imaging or fcpi
283646|NCT01737606|MRI|mri
283647|NCT01737606|Arteriel Spin Labelling|arteriel spin labelling
283648|NCT01737606|Cognitive tasks|cognitive tasks
283649|NCT01737606|Aging|aging
283650|NCT01737593|acetaminophen|acetaminophen
283651|NCT01737593|emergence agitation|emergence agitation
283652|NCT01737593|children|children
283653|NCT01737593|sevoflurane|sevoflurane
283654|NCT01737580|influenza, human|influenza, human
283655|NCT01737580|influenza vaccines|influenza vaccines
283656|NCT01737580|older adults|older adults
283657|NCT01737580|immune response|immune response
283658|NCT01737554|Central venous access device|central venous access device
283659|NCT01737554|Catheter resistance monitoring|catheter resistance monitoring
283660|NCT01737541|Cerebrovascular Disorders|cerebrovascular disorders
283661|NCT01737541|Cardiovascular Diseases|cardiovascular diseases
283662|NCT01737541|Intracerebral Hemorrhage|intracerebral hemorrhage
283663|NCT01737541|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
283664|NCT01737541|Therapeutic Uses|therapeutic uses
283665|NCT01737528|severe symptomatic native aortic valve stenosis|severe symptomatic native aortic valve stenosis
283666|NCT01737528|inoperable or high risk for open aortic valve replacement|inoperable or high risk for open aortic valve replacement
283667|NCT01737476|age 18-65|age 18-65
283668|NCT01737463|Ampulla of Vater adenoma|ampulla of vater adenoma
283669|NCT01737450|Metastatic head and neck cancer|metastatic head and neck cancer
283670|NCT01737450|PI3K inhibitor|pi3k inhibitor
283671|NCT01737450|Recurrent head and meck cancer|recurrent head and meck cancer
283672|NCT01737450|Progressive head and neck cancer|progressive head and neck cancer
283673|NCT01737450|BKM120|bkm120
283674|NCT01737411|surgery, solifenacin, urge urinary incontinence|surgery, solifenacin, urge urinary incontinence
283676|NCT01737398|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
283677|NCT01737398|TTR|ttr
283678|NCT01737398|Transthyretin|transthyretin
283679|NCT01737398|Amyloidosis|amyloidosis
283680|NCT01737385|microcirculation|microcirculation
283681|NCT01737385|proximal humeral fractures|proximal humeral fractures
283682|NCT01737385|O2C|o2c
283683|NCT01737372|Multiple Sclerosis|multiple sclerosis
283684|NCT01737372|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
283685|NCT01737372|Clinically Isolated Syndrome|clinically isolated syndrome
283686|NCT01737359|amdoxovir|amdoxovir
283687|NCT01737359|zidovudine|zidovudine
283688|NCT01737359|tenofovir DF|tenofovir df
283689|NCT01737359|HIV|hiv
283690|NCT01737359|HAART|haart
283691|NCT01737359|antiretroviral|antiretroviral
283692|NCT01737346|glioblastoma, recurrent, refractory, CCNU, procarbazine|glioblastoma, recurrent, refractory, ccnu, procarbazine
283693|NCT01737320|gram negative bacteremia|gram negative bacteremia
283694|NCT01737320|Duration of antibiotic treatment|duration of antibiotic treatment
283695|NCT01737320|safety|safety
283696|NCT01737320|efficacy|efficacy
283697|NCT01737320|short-course|short-course
283698|NCT01737307|Fluoride Varnish|fluoride varnish
283699|NCT01737307|CPP-ACP paste|cpp-acp paste
283700|NCT01737307|Dry mouth|dry mouth
283701|NCT01737307|Burning sensation|burning sensation
283702|NCT01737307|Chemotherapy|chemotherapy
283703|NCT01737294|Phase IV|phase iv
283704|NCT01737294|Peripheral Neuropathic Pain|peripheral neuropathic pain
283705|NCT01737294|QUTENZA|qutenza
283706|NCT01737281|Smoking|smoking
283707|NCT01737281|Tobacco control|tobacco control
283708|NCT01737281|Counseling|counseling
283709|NCT01737281|mental health|mental health
283710|NCT01737268|patients|patients
283711|NCT01737268|Major depressive episode|major depressive episode
283712|NCT01737268|FK949E|fk949e
283713|NCT01737255|Li-Fraumeni Syndrome|li-fraumeni syndrome
283714|NCT01737255|Whole Body Magnetic Resonance Imaging|whole body magnetic resonance imaging
283715|NCT01737255|TP53|tp53
283716|NCT01737255|Psychological Impact|psychological impact
283717|NCT01737242|Prostate cancer|prostate cancer
283718|NCT01737242|PSA|psa
283719|NCT01737216|Aged|aged
283720|NCT01737216|patients|patients
283721|NCT01737203|Viagra|viagra
283722|NCT01737203|ODT|odt
283723|NCT01737203|bioquivalence|bioquivalence
283724|NCT01737190|esophageal pressure|esophageal pressure
283725|NCT01737190|ARDSnet protocol|ardsnet protocol
283726|NCT01737177|MCL|mcl
283727|NCT01737177|Mantle Cell Lymphoma|mantle cell lymphoma
283728|NCT01737177|RELAPSED-REFRACTORY|relapsed-refractory
283729|NCT01737164|Glucose|glucose
283730|NCT01737164|Lipid|lipid
283731|NCT01737164|Metabolism|metabolism
283732|NCT01737164|Non Diabetic|non diabetic
283733|NCT01737164|Healthy|healthy
283734|NCT01737138|Resistant hypertension|resistant hypertension
283735|NCT01737138|All-cause mortality|all-cause mortality
283736|NCT01737138|Renal function|renal function
283737|NCT01737112|Lung Cancer|lung cancer
283738|NCT01737112|integrin αvβ3 receptor|integrin αvβ3 receptor
283739|NCT01737112|99mTc-3PRGD2|99mtc-3prgd2
283740|NCT01737112|SPECT/CT|spect/ct
283741|NCT01737112|efficacy and safety|efficacy and safety
283742|NCT01737099|omega-3|omega-3
283743|NCT01737099|DHA|dha
283744|NCT01737099|triglycerides|triglycerides
283745|NCT01737099|lipids|lipids
283746|NCT01737099|cardiovascular|cardiovascular
283747|NCT01737099|hypertriglyceridemia|hypertriglyceridemia
283748|NCT01737073|chronic pain|chronic pain
283749|NCT01737073|opioid|opioid
283750|NCT01737073|cognitive behavior therapy|cognitive behavior therapy
283751|NCT01737060|Reversed prosthesis, Philos, Severe displaced|reversed prosthesis, philos, severe displaced
283752|NCT01737047|HIV|hiv
283753|NCT01737047|Ageing|ageing
283754|NCT01737034|partitioning of weight gain|partitioning of weight gain
283755|NCT01737034|refeeding|refeeding
283756|NCT01737034|catch-up fat phenomenon|catch-up fat phenomenon
283757|NCT01737034|glycemic index|glycemic index
283758|NCT01737021|PICU|picu
283759|NCT01737021|Critical illness|critical illness
283760|NCT01737021|Outcomes|outcomes
283761|NCT01737021|Mental health|mental health
283762|NCT01737021|Education|education
283763|NCT01737021|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
283764|NCT01737021|Pilot|pilot
283765|NCT01737021|Feasibility|feasibility
283766|NCT01737008|Head and neck|head and neck
283767|NCT01737008|Squamous cell carcinoma|squamous cell carcinoma
283768|NCT01737008|Phase 1|phase 1
283769|NCT01737008|Dacomitinib|dacomitinib
283770|NCT01737008|Radiation|radiation
283771|NCT01737008|Radiotherapy|radiotherapy
283772|NCT01737008|Chemotherapy|chemotherapy
283773|NCT01737008|Chemoradiation|chemoradiation
283774|NCT01737008|Chemoradiotherapy|chemoradiotherapy
283775|NCT01737008|Cisplatin|cisplatin
283776|NCT01737008|Pharmacokinetics|pharmacokinetics
283777|NCT01737008|Maximum tolerated dose|maximum tolerated dose
283778|NCT01737008|Safety|safety
283779|NCT01737008|Human epidermal growth factor receptor|human epidermal growth factor receptor
283780|NCT01737008|Previously Untreated|previously untreated
283781|NCT01737008|Local or Locally Advanced|local or locally advanced
283782|NCT01736995|Substance Abuse|substance abuse
283783|NCT01736995|Adolescents|adolescents
283784|NCT01736995|Families|families
283785|NCT01736995|Functional Family Therapy|functional family therapy
283786|NCT01736995|Cognitive Behavioral Therapy|cognitive behavioral therapy
283787|NCT01736995|Motivational Therapy|motivational therapy
283788|NCT01736995|Contingency Management|contingency management
283789|NCT01736982|Cigarette Smoking|cigarette smoking
283790|NCT01736982|Homeless|homeless
283791|NCT01736982|Contingency Management|contingency management
283792|NCT01736982|Smoking Cessation|smoking cessation
283793|NCT01736956|aortic stenosis|aortic stenosis
283794|NCT01736956|hypoplastic left heart syndrome|hypoplastic left heart syndrome
283795|NCT01736956|fetal aortic valvuloplasty|fetal aortic valvuloplasty
283796|NCT01736943|Bortezomib|bortezomib
283797|NCT01736943|Doxil|doxil
283798|NCT01736930|Type 1 Diabetes|type 1 diabetes
283799|NCT01736930|Hypoglycemia|hypoglycemia
283800|NCT01736930|Continuous Glucose Monitoring|continuous glucose monitoring
283801|NCT01736930|Pump Suspension|pump suspension
283802|NCT01736917|Fosaprepitant|fosaprepitant
283803|NCT01736917|5HT3 Receptor Antagonists|5ht3 receptor antagonists
283804|NCT01736917|Dexamethasone|dexamethasone
283805|NCT01736917|Germ Cell Tumors|germ cell tumors
283806|NCT01736917|Testis Cancer|testis cancer
283807|NCT01736917|Rescue Medications|rescue medications
283808|NCT01736904|advanced colorectal cancer|advanced colorectal cancer
283809|NCT01736904|FOLFIRI|folfiri
283810|NCT01736904|XELIRI|xeliri
283811|NCT01736891|Motor fluctuations|motor fluctuations
283812|NCT01736891|Parkinson´s Disease|parkinson´s disease
283813|NCT01736891|Rasagiline|rasagiline
283814|NCT01736878|Medullary Thyroid Carcinoma|medullary thyroid carcinoma
283815|NCT01736878|Sorafenib|sorafenib
283816|NCT01736878|Efficacy|efficacy
283817|NCT01736852|Premature Rupture of Membrane (Pregnancy)|premature rupture of membrane (pregnancy)
283818|NCT01736852|PROM|prom
283819|NCT01736852|Cervical Ripening|cervical ripening
283820|NCT01736852|Induced Labor|induced labor
283821|NCT01736826|plasma nucleosome concentration|plasma nucleosome concentration
283822|NCT01736826|plasma free DNA concentration|plasma free dna concentration
283823|NCT01736813|colorectal cancer|colorectal cancer
283824|NCT01736813|liver metastases|liver metastases
283825|NCT01736813|chemotherapy|chemotherapy
283826|NCT01736813|chemokine|chemokine
283827|NCT01736813|CCR5 inhibition|ccr5 inhibition
283828|NCT01736800|Temozolomide|temozolomide
283829|NCT01736800|Topotecan|topotecan
283830|NCT01736800|Central Nervous System Metastases|central nervous system metastases
283831|NCT01736800|Chemotherapy|chemotherapy
283832|NCT01736800|Brain Metastases|brain metastases
283833|NCT01736800|Solid Tumors|solid tumors
283834|NCT01736787|Cauliflower Mushroom extract|cauliflower mushroom extract
283835|NCT01736787|immunity|immunity
283836|NCT01736774|Manual therapy|manual therapy
283837|NCT01736774|Exercise|exercise
283838|NCT01736748|obesity|obesity
283839|NCT01736748|physical activity|physical activity
283840|NCT01736748|metabolism|metabolism
283841|NCT01736748|environment|environment
751922|NCT01171235|Pharyngeal Neoplasms|pharyngeal neoplasms
283842|NCT01736748|obese children, as defined by a body mass index > 95th percentile|obese children, as defined by a body mass index > 95th percentile
283844|NCT01736722|Laser Induced Thermal Therapy|laser induced thermal therapy
283845|NCT01736722|Metastatic cancer|metastatic cancer
283846|NCT01736722|Brain Tumor|brain tumor
283847|NCT01736722|Visualase|visualase
283848|NCT01736722|Treatment resistant|treatment resistant
283849|NCT01736722|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
283850|NCT01736722|Magnetic Imaging|magnetic imaging
283851|NCT01736709|2012-2013 trivalent seasonal influenza vaccine|2012-2013 trivalent seasonal influenza vaccine
283852|NCT01736709|immunogenicity,|immunogenicity,
283853|NCT01736709|safety|safety
283854|NCT01736696|Psoriasis|psoriasis
283855|NCT01736696|PASI|pasi
283856|NCT01736696|plaques|plaques
283857|NCT01736696|skin biopsy|skin biopsy
283858|NCT01736696|immunomodulation|immunomodulation
283859|NCT01736683|ACE-011|ace-011
283860|NCT01736683|anemia|anemia
283861|NCT01736683|dose-ranging|dose-ranging
283862|NCT01736683|intermediate-1 risk myelodysplastic syndromes|intermediate-1 risk myelodysplastic syndromes
283863|NCT01736683|low risk myelodysplastic syndromes (MDS)|low risk myelodysplastic syndromes (mds)
283864|NCT01736683|multicenter|multicenter
283865|NCT01736683|open-label|open-label
283866|NCT01736683|parallel|parallel
283867|NCT01736683|phase 2|phase 2
283868|NCT01736683|randomized|randomized
283869|NCT01736683|Sotatercept|sotatercept
283870|NCT01736683|Non-proliferative chronic myelomonocytic leukemia (CMML)|non-proliferative chronic myelomonocytic leukemia (cmml)
283871|NCT01736683|hemoglobin|hemoglobin
283872|NCT01736683|transfusions|transfusions
283873|NCT01736644|blood loss|blood loss
283874|NCT01736644|bipolar sealer|bipolar sealer
283875|NCT01736644|aquamantys|aquamantys
283876|NCT01736644|total knee replacement|total knee replacement
283877|NCT01736644|primary total knee arthroplasty|primary total knee arthroplasty
283878|NCT01736631|social phobia|social phobia
283879|NCT01736631|bipolar disorder|bipolar disorder
283975|NCT01736176|carbidopa|carbidopa
283881|NCT01736618|subcutaneous implantable defibrillator, post approval study, sudden cardiac arrest, Cameron Health defibrillator|subcutaneous implantable defibrillator, post approval study, sudden cardiac arrest, cameron health defibrillator
283882|NCT01736605|Massage|massage
283883|NCT01736605|Meditation|meditation
283884|NCT01736605|Breast Cancer|breast cancer
283885|NCT01736605|Breast Surgery|breast surgery
283886|NCT01736605|Breast Reconstruction|breast reconstruction
283887|NCT01736566|Primary Care|primary care
283888|NCT01736566|Cardiology|cardiology
283889|NCT01736566|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
283890|NCT01736566|Dilated Cardiomyopathy|dilated cardiomyopathy
283891|NCT01736566|Whole Genome Sequencing|whole genome sequencing
283892|NCT01736553|Spinal Muscular Atrophy (SMA) Biomarkers|spinal muscular atrophy (sma) biomarkers
283893|NCT01736553|Healthy controls|healthy controls
283894|NCT01736553|Infants|infants
283895|NCT01736540|iron overload, liver iron concentration (LIC), cardiac siderosis, transfusional siderosis, magnetic resonance imaging (MRI)|iron overload, liver iron concentration (lic), cardiac siderosis, transfusional siderosis, magnetic resonance imaging (mri)
283896|NCT01736514|xanthine oxidase inhibitor|xanthine oxidase inhibitor
283897|NCT01736514|Uric acid lowering drug|uric acid lowering drug
283898|NCT01736488|Hypertension|hypertension
283899|NCT01736488|Antihypertensive efficacy|antihypertensive efficacy
283900|NCT01736488|Neurohormonal markers|neurohormonal markers
283901|NCT01736488|Blood Pressure Response|blood pressure response
283902|NCT01736488|Exercise|exercise
283903|NCT01736462|Cornea|cornea
283904|NCT01736462|Endothelial cell density|endothelial cell density
283905|NCT01736449|pterygium|pterygium
283906|NCT01736449|bevacizumab|bevacizumab
283907|NCT01736449|recurrence of pterygium|recurrence of pterygium
283909|NCT01736436|Myelodysplastic syndrome|myelodysplastic syndrome
283910|NCT01736436|Low and intermediate risk|low and intermediate risk
283911|NCT01736436|Transfusion-dependent patients|transfusion-dependent patients
283912|NCT01736436|Transfusion|transfusion
283913|NCT01736436|Anemia|anemia
283914|NCT01736423|YM060|ym060
283915|NCT01736423|Ramosetron|ramosetron
283916|NCT01736423|long term study|long term study
283917|NCT01736423|Diarrhea-predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
283918|NCT01736423|Female|female
283920|NCT01736397|Chronic Kidney Disease|chronic kidney disease
283921|NCT01736397|Phosphorus|phosphorus
283922|NCT01736397|Iron Deficiency|iron deficiency
283923|NCT01736397|Iron Deficiency Anemia|iron deficiency anemia
283924|NCT01736397|Elevated Phosphorus|elevated phosphorus
283925|NCT01736371|Sevoflurane|sevoflurane
283926|NCT01736371|Cisatracurium infusion consumption|cisatracurium infusion consumption
283927|NCT01736371|Closed loop computer control system|closed loop computer control system
283928|NCT01736371|Recovery Index|recovery index
283929|NCT01736358|Sprix|sprix
283930|NCT01736358|Intranasal ketoralac|intranasal ketoralac
283931|NCT01736358|Ketoralac|ketoralac
283932|NCT01736358|Urolithiasis|urolithiasis
283933|NCT01736358|Kidney stone|kidney stone
283934|NCT01736358|Uretal stone|uretal stone
283935|NCT01736358|Ureteroscopic removal of stones|ureteroscopic removal of stones
283936|NCT01736358|URS|urs
283937|NCT01736358|Pain management|pain management
283938|NCT01736358|Pain|pain
283939|NCT01736332|Methamphetamine|methamphetamine
283940|NCT01736332|Amphetamines|amphetamines
283941|NCT01736332|Opiates|opiates
283942|NCT01736332|Oral Opiates (poppy seeds)|oral opiates (poppy seeds)
283943|NCT01736332|Intranasal amphetamines|intranasal amphetamines
283944|NCT01736319|Artemisinin-based Combination Therapies|artemisinin-based combination therapies
283945|NCT01736319|Recrudescence|recrudescence
283946|NCT01736319|DHA-PPQ|dha-ppq
283947|NCT01736319|Parasite Clearance Rate|parasite clearance rate
283948|NCT01736306|Breast Cancer|breast cancer
283949|NCT01736306|Breast Milk|breast milk
283950|NCT01736306|Epigenetics|epigenetics
283952|NCT01736280|Symptoms|symptoms
283953|NCT01736280|Immunogenetics|immunogenetics
283954|NCT01736280|Digestive Disorders|digestive disorders
283955|NCT01736280|Gastrointestinal|gastrointestinal
283956|NCT01736267|Auditory Brainstem Implant|auditory brainstem implant
283957|NCT01736267|ABI|abi
283958|NCT01736267|Nucleus 24|nucleus 24
283959|NCT01736267|Deafness|deafness
283960|NCT01736267|Hearing loss|hearing loss
283961|NCT01736267|Non-tumor|non-tumor
283962|NCT01736267|Non-NF2|non-nf2
283963|NCT01736267|ABI541|abi541
283964|NCT01736228|xenotransplantation|xenotransplantation
283965|NCT01736228|type 1 diabetes|type 1 diabetes
283966|NCT01736228|porcine islets|porcine islets
283967|NCT01736215|Anemia - cancer related|anemia - cancer related
283968|NCT01736215|Eprex (Erythropoietin alfa)|eprex (erythropoietin alfa)
283969|NCT01736202|oral fat|oral fat
283970|NCT01736202|insulin sensitivity|insulin sensitivity
283971|NCT01736189|Rheumatoid arthritis|rheumatoid arthritis
283972|NCT01736176|Safety and efficacy|safety and efficacy
283973|NCT01736176|Advanced Parkinson's disease|advanced parkinson's disease
283974|NCT01736176|levodopa-carbidopa intestinal gel,|levodopa-carbidopa intestinal gel,
283976|NCT01736176|levodopa|levodopa
283977|NCT01736176|Non-Motor Symptom Scale|non-motor symptom scale
283978|NCT01736150|Hemodialysis|hemodialysis
283979|NCT01736137|Heart failure|heart failure
283980|NCT01736137|Autonomic Nervous System|autonomic nervous system
283981|NCT01736137|Heart rate|heart rate
283982|NCT01736137|Quality of life|quality of life
283983|NCT01736124|computerize cognitive training|computerize cognitive training
283984|NCT01736124|dementia|dementia
283985|NCT01736124|cognitive decline|cognitive decline
283986|NCT01736124|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
283987|NCT01736111|obesity|obesity
283988|NCT01736111|weight loss|weight loss
283989|NCT01736111|text message|text message
283990|NCT01736085|tobacco cessation|tobacco cessation
283991|NCT01736085|smoking cessation|smoking cessation
283992|NCT01736085|nicotine|nicotine
283993|NCT01736085|telephone counseling|telephone counseling
283994|NCT01736085|self-help|self-help
283995|NCT01736085|smoking abstinence|smoking abstinence
283996|NCT01736085|tobacco use disorder|tobacco use disorder
283997|NCT01736085|nicotine replacement therapy|nicotine replacement therapy
283998|NCT01736085|voucher|voucher
283999|NCT01736072|Rectal Cancer|rectal cancer
284000|NCT01736072|Colorectal Cancer|colorectal cancer
284001|NCT01736072|Laparoscopic Surgery|laparoscopic surgery
284002|NCT01736072|Robotic Surgery|robotic surgery
284003|NCT01736072|Robotic Assisted Laparoscopic Surgery|robotic assisted laparoscopic surgery
284004|NCT01736059|Stem cells|stem cells
284005|NCT01736059|intravitreal|intravitreal
284006|NCT01736059|bone marrow CD34+ cells|bone marrow cd34+ cells
284007|NCT01736059|retinal disease|retinal disease
284008|NCT01736059|clinical trial|clinical trial
284009|NCT01736059|autologous|autologous
284010|NCT01736046|CT Enterography|ct enterography
284011|NCT01736046|Crohn's Disease|crohn's disease
284012|NCT01736046|Inflammatory Bowel Disease|inflammatory bowel disease
284013|NCT01736033|Lower Urinary Tracts Symptoms|lower urinary tracts symptoms
284014|NCT01736033|5 alpha reductase inhibitor|5 alpha reductase inhibitor
284015|NCT01736033|Proscar|proscar
284016|NCT01736033|Finasteride|finasteride
284017|NCT01736033|alpha blocker|alpha blocker
284018|NCT01736033|Tamsulosin|tamsulosin
284019|NCT01736033|Harnal D|harnal d
284020|NCT01736007|alopecia areata child|alopecia areata child
284021|NCT01736007|scalp|scalp
284022|NCT01735994|Eating disorders|eating disorders
284023|NCT01735994|body image|body image
284024|NCT01735994|female athletes|female athletes
284025|NCT01735994|female athlete triad|female athlete triad
284026|NCT01735994|eating disorder prevention|eating disorder prevention
284027|NCT01735994|cluster randomization|cluster randomization
284028|NCT01735994|risk factors|risk factors
284029|NCT01735994|prevention|prevention
284030|NCT01735981|Huntington's Disease|huntington's disease
284031|NCT01735981|gait|gait
284032|NCT01735981|exercise|exercise
284033|NCT01735981|balance|balance
284034|NCT01735981|video game|video game
284035|NCT01735968|Imatinib mesylate|imatinib mesylate
284036|NCT01735968|BYL719|byl719
284037|NCT01735968|GIST|gist
284038|NCT01735955|Tasigna|tasigna
284039|NCT01735955|CML|cml
284040|NCT01735955|GIST|gist
284041|NCT01735955|nilotinib|nilotinib
284042|NCT01735890|Safety|safety
284043|NCT01735890|Pharmacokinetics|pharmacokinetics
284044|NCT01735877|Hemispatial neglect, Stroke|hemispatial neglect, stroke
284045|NCT01735864|Indigo naturalis extract in oil|indigo naturalis extract in oil
284046|NCT01735851|Thoracic epidural analgesia|thoracic epidural analgesia
284047|NCT01735851|Paravertebral block|paravertebral block
284048|NCT01735851|pain|pain
284049|NCT01735851|postoperative|postoperative
284050|NCT01735825|coronary artery disease|coronary artery disease
284051|NCT01735825|stent|stent
284052|NCT01735825|restenosis|restenosis
284053|NCT01735812|cryoablation|cryoablation
284054|NCT01735812|uterine fibroid|uterine fibroid
284055|NCT01735812|uterine myoma|uterine myoma
284056|NCT01735812|who completed her family planning|who completed her family planning
284057|NCT01735812|but wishes to preserve her uterus|but wishes to preserve her uterus
284058|NCT01735786|Endoscopic Hemostasis|endoscopic hemostasis
284059|NCT01735786|EndoClot Absorbable Polysaccharide Hemostat|endoclot absorbable polysaccharide hemostat
284060|NCT01735786|Colonic Polyps|colonic polyps
284061|NCT01735773|hemodialysis|hemodialysis
284062|NCT01735773|inflammation|inflammation
284063|NCT01735773|iron|iron
284064|NCT01735773|peritoneal dialysis|peritoneal dialysis
284065|NCT01735773|prohepcidin|prohepcidin
284066|NCT01735773|uremia|uremia
284067|NCT01735760|airway management|airway management
284068|NCT01735760|cricothyroid membrane|cricothyroid membrane
284069|NCT01735747|Lymphoma|lymphoma
284070|NCT01735734|Skin disease|skin disease
284071|NCT01735734|Capillary Malformation|capillary malformation
284072|NCT01735734|Laser therapy|laser therapy
284073|NCT01735721|Sinus Floor Augmentation|sinus floor augmentation
284074|NCT01735721|Bone Transplantation|bone transplantation
284075|NCT01735721|Bone Substitute|bone substitute
284076|NCT01735708|pain|pain
284077|NCT01735708|depression|depression
284078|NCT01735708|HIV|hiv
284079|NCT01735708|adherence|adherence
284080|NCT01735695|Meconium|meconium
284081|NCT01735695|concentration|concentration
284082|NCT01735695|level|level
284083|NCT01735682|older adults|older adults
284084|NCT01735682|exercise|exercise
284085|NCT01735682|balance|balance
284086|NCT01735682|gait|gait
284087|NCT01735682|fall|fall
284088|NCT01735682|rehabilitation|rehabilitation
284089|NCT01735682|vibration|vibration
284090|NCT01735682|muscle|muscle
284091|NCT01735669|Remifentanil|remifentanil
284092|NCT01735669|Breech presentation|breech presentation
284093|NCT01735669|Nitrous oxide|nitrous oxide
284094|NCT01735669|Pregnancy complications|pregnancy complications
284095|NCT01735669|Caesarean section|caesarean section
284096|NCT01735669|Fetal version|fetal version
284097|NCT01735656|Coronary heart disease;|coronary heart disease;
284474|NCT01733849|Children|children
284098|NCT01735656|Percutaneous coronary intervention;|percutaneous coronary intervention;
284099|NCT01735656|Bifurcation lesion;|bifurcation lesion;
284100|NCT01735656|Double kissing culotte technique;|double kissing culotte technique;
284101|NCT01735656|clinical trial|clinical trial
284102|NCT01735643|type 2 diabetes mellitus|type 2 diabetes mellitus
284103|NCT01735643|physical activity|physical activity
284104|NCT01735643|lifestyle change|lifestyle change
284105|NCT01735643|motivation|motivation
284106|NCT01735643|patient empowerment|patient empowerment
284107|NCT01735630|Agitation|agitation
284108|NCT01735630|Aggression|aggression
284109|NCT01735630|patients|patients
274684|NCT01778010|cocaine|cocaine
284110|NCT01735617|congenital adrenal hyperplasia|congenital adrenal hyperplasia
284111|NCT01735617|glucocorticoids|glucocorticoids
284112|NCT01735617|cortisol|cortisol
284113|NCT01735617|adrenal|adrenal
284114|NCT01735591|Liver cirrhosis|liver cirrhosis
284115|NCT01735591|Liver transplantation|liver transplantation
284116|NCT01735591|Probiotics|probiotics
284117|NCT01735591|Mortality|mortality
284118|NCT01735591|Liver function|liver function
284119|NCT01735591|Infections|infections
284120|NCT01735578|splanchnic oxygen saturations|splanchnic oxygen saturations
284121|NCT01735565|NET formation|net formation
284122|NCT01735565|neutraphil extracellular traps|neutraphil extracellular traps
284123|NCT01735565|post-engraftment immune system|post-engraftment immune system
284124|NCT01735552|gut reperfusion injury|gut reperfusion injury
284125|NCT01735552|blood transfusions|blood transfusions
284126|NCT01735552|premature infants|premature infants
284127|NCT01735552|anemia|anemia
284128|NCT01735552|regional oxygen saturations|regional oxygen saturations
284129|NCT01735552|necrotizing enterocolitis|necrotizing enterocolitis
284130|NCT01735552|mesenteric oxygenation|mesenteric oxygenation
284131|NCT01735539|old age|old age
284132|NCT01735539|sarcopenia|sarcopenia
284133|NCT01735539|essential amino acid|essential amino acid
284134|NCT01735539|arginine|arginine
284135|NCT01735539|contrast enhanced ultrasound|contrast enhanced ultrasound
284136|NCT01735539|muscle microcirculation|muscle microcirculation
284137|NCT01735539|muscle protein synthesis|muscle protein synthesis
284138|NCT01735526|Allogeneic and autologous|allogeneic and autologous
586544|NCT00516659|Escherichia coli|escherichia coli
284140|NCT01735526|Lung diffusing capacity|lung diffusing capacity
284141|NCT01735526|for nitric oxide|for nitric oxide
284142|NCT01735526|carbon monoxide|carbon monoxide
284143|NCT01735526|Lung tissue density|lung tissue density
284144|NCT01735526|microvascular damage|microvascular damage
284145|NCT01735513|transaortic TAVI or TAVR|transaortic tavi or tavr
284146|NCT01735513|embolic protection device|embolic protection device
284148|NCT01735513|efficacy|efficacy
284149|NCT01735513|during transaortic TAVI|during transaortic tavi
284150|NCT01735513|reduce the incidence of new foci of restricted diffusion on diffusion-weighted MRI|reduce the incidence of new foci of restricted diffusion on diffusion-weighted mri
284151|NCT01735500|Prei-procedural|prei-procedural
284152|NCT01735500|Elevation|elevation
284153|NCT01735500|cardia Troponin T|cardia troponin t
284154|NCT01735500|in stable|in stable
284155|NCT01735500|unknown|unknown
284156|NCT01735474|manual therapy|manual therapy
284157|NCT01735474|respiratory disease|respiratory disease
284158|NCT01735474|thoracic movement|thoracic movement
284159|NCT01735448|smoking cessation|smoking cessation
284160|NCT01735448|tobacco|tobacco
284161|NCT01735448|addiction|addiction
284162|NCT01735448|Aboriginal|aboriginal
284163|NCT01735448|youth|youth
284164|NCT01735448|Indigenous|indigenous
284165|NCT01735448|pharmacological|pharmacological
284166|NCT01735448|focus group|focus group
284167|NCT01735448|interview|interview
284168|NCT01735435|geriatric patients|geriatric patients
284169|NCT01735435|nutritional support|nutritional support
284170|NCT01735422|Infertility|infertility
284171|NCT01735422|Ovulation induction|ovulation induction
284172|NCT01735422|Recombinant human Luteinizing Hormone (r-hLH)|recombinant human luteinizing hormone (r-hlh)
284173|NCT01735422|Urinary human Chorionic Gonadotrophin (u-hCG)|urinary human chorionic gonadotrophin (u-hcg)
284174|NCT01735422|Recombinant human Follicle Stimulating Hormone (Gonal-f®)|recombinant human follicle stimulating hormone (gonal-f®)
284175|NCT01735409|Advanced Nasopharyngeal Carcinoma|advanced nasopharyngeal carcinoma
284176|NCT01735409|Abraxane|abraxane
284177|NCT01735409|Cisplatin|cisplatin
284178|NCT01735409|Dose|dose
284179|NCT01735396|African American men|african american men
284180|NCT01735396|metastatic prostate cancer|metastatic prostate cancer
284181|NCT01735396|castration resistant|castration resistant
284182|NCT01735357|Eicosapentaenoic acid|eicosapentaenoic acid
284183|NCT01735357|Docosahexaenoic acid|docosahexaenoic acid
284184|NCT01735357|Cardiovascular risk|cardiovascular risk
284185|NCT01735357|Platelet function|platelet function
284186|NCT01735357|Endothelial function|endothelial function
284187|NCT01735357|Vascular function|vascular function
284188|NCT01735357|young males|young males
284189|NCT01735331|Vascular endothelial growth factor, Recurrent Pregnancy Loss|vascular endothelial growth factor, recurrent pregnancy loss
284190|NCT01735305|Coronary Artery Disease|coronary artery disease
284191|NCT01735305|antiplatelet therapy|antiplatelet therapy
284192|NCT01735292|Ventilation, timer|ventilation, timer
284193|NCT01735279|tobacco dependence|tobacco dependence
284194|NCT01735279|tobacco treatment|tobacco treatment
284195|NCT01735279|omega 3 series|omega 3 series
284196|NCT01735279|polyunsaturated fatty acids|polyunsaturated fatty acids
284197|NCT01735266|Colonoscopy|colonoscopy
284198|NCT01735253|metabolic surgery|metabolic surgery
284199|NCT01735253|gastric bypass|gastric bypass
284200|NCT01735253|duodenojejunal bypass|duodenojejunal bypass
284201|NCT01735253|type 2 DM|type 2 dm
284202|NCT01735240|Phase I,|phase i,
284203|NCT01735240|healthy volunteers,|healthy volunteers,
284204|NCT01735240|fixed-sequence,|fixed-sequence,
284205|NCT01735240|open-label,|open-label,
284206|NCT01735240|ketoconazole,|ketoconazole,
284207|NCT01735240|combination,|combination,
284208|NCT01735240|safety|safety
284209|NCT01735227|pantoprazole|pantoprazole
284210|NCT01735227|omeprazole|omeprazole
284211|NCT01735227|anti - platelet effect|anti - platelet effect
284212|NCT01735188|Natural history study|natural history study
284213|NCT01735175|biosimilars|biosimilars
284214|NCT01735175|Pegfilgrastim,|pegfilgrastim,
284215|NCT01735175|G-CSF,|g-csf,
284216|NCT01735175|neutropenia,|neutropenia,
284217|NCT01735175|breast cancer,|breast cancer,
284218|NCT01735175|myelosuppressive chemotherapy,|myelosuppressive chemotherapy,
284219|NCT01735175|supportive care|supportive care
284220|NCT01735175|granulocyte-colony-stimulating factor|granulocyte-colony-stimulating factor
284221|NCT01735162|Renal angina|renal angina
284222|NCT01735162|AKI|aki
284223|NCT01735162|Pediatric Intensive Care|pediatric intensive care
284224|NCT01735123|infant formula|infant formula
284225|NCT01735123|diet|diet
284226|NCT01735123|diabetes mellitus, type 1|diabetes mellitus, type 1
284227|NCT01735123|autoimmunity|autoimmunity
284228|NCT01735097|Arsenic|arsenic
284229|NCT01735097|Keratosis|keratosis
284230|NCT01735097|Nigella sativa|nigella sativa
284231|NCT01735097|Palm|palm
284232|NCT01735097|Vitamin E|vitamin e
284233|NCT01735084|randomized controlled trial|randomized controlled trial
284235|NCT01735084|booster dose|booster dose
284236|NCT01735084|immunogenicity|immunogenicity
284237|NCT01735084|nasopharyngeal carriage|nasopharyngeal carriage
284238|NCT01735084|Australian Indigenous|australian indigenous
284240|NCT01735071|ovarian cancer|ovarian cancer
284241|NCT01735071|bevacizumab|bevacizumab
284242|NCT01735071|trabectedin|trabectedin
284243|NCT01735071|carboplatin|carboplatin
284244|NCT01735071|randomized trial|randomized trial
284245|NCT01735071|phase II|phase ii
284246|NCT01735032|focal epilepsy|focal epilepsy
284247|NCT01735032|pre-surgical evaluation|pre-surgical evaluation
284248|NCT01735032|multimodal imaging|multimodal imaging
284249|NCT01735032|SEEG|seeg
284250|NCT01735019|EC95, effective concentration in 95% of subjects|ec95, effective concentration in 95% of subjects
284251|NCT01735006|Human Papillomavirus 16|human papillomavirus 16
284252|NCT01735006|Human Papillomavirus 18|human papillomavirus 18
284253|NCT01735006|vaccine|vaccine
284254|NCT01735006|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
284255|NCT01735006|cervical Cancer|cervical cancer
284256|NCT01735006|Vaginal intraepithelial neoplasia|vaginal intraepithelial neoplasia
284257|NCT01735006|Vulvar intraepithelial neoplasia|vulvar intraepithelial neoplasia
284258|NCT01734980|Endobronchial Ultrasound|endobronchial ultrasound
284259|NCT01734980|transbronchial needle aspiration|transbronchial needle aspiration
284260|NCT01734967|confocal laser endomicroscopy|confocal laser endomicroscopy
284261|NCT01734967|Pancreatic Neoplasms|pancreatic neoplasms
284262|NCT01734967|CHRONIC PANCREATITIS|chronic pancreatitis
284263|NCT01734967|Endoscopic ultrasound|endoscopic ultrasound
284264|NCT01734954|Nerve block|nerve block
284265|NCT01734954|Sciatic nerve|sciatic nerve
284266|NCT01734954|Ultrasonography|ultrasonography
284267|NCT01734954|Orthopedics|orthopedics
284268|NCT01734954|Hallux Valgus|hallux valgus
284269|NCT01734954|Amputation|amputation
284270|NCT01734954|Arthrodesis|arthrodesis
284271|NCT01734954|Arthroscopy|arthroscopy
284272|NCT01734954|Fracture fixation|fracture fixation
284273|NCT01734954|Osteotomy|osteotomy
284274|NCT01734954|Tendon transfer|tendon transfer
284275|NCT01734954|Tenodesis|tenodesis
284276|NCT01734954|Tenotomy|tenotomy
284277|NCT01734954|Orthopedic procedure|orthopedic procedure
284278|NCT01734941|Autism|autism
284279|NCT01734941|Trichuris Suis Ova|trichuris suis ova
284280|NCT01734941|Behavior|behavior
284281|NCT01734941|Irritability|irritability
284284|NCT01734915|Advanced|advanced
284285|NCT01734915|EGFR mutation|egfr mutation
284286|NCT01734889|nitisinone|nitisinone
284287|NCT01734889|Orfadin|orfadin
284288|NCT01734889|suspension|suspension
284289|NCT01734889|taste|taste
284290|NCT01734889|acceptability|acceptability
284291|NCT01734876|Parkinson´s disease|parkinson´s disease
284292|NCT01734876|Pain|pain
284293|NCT01734876|Sleep|sleep
284294|NCT01734876|HPA axis function|hpa axis function
284295|NCT01734876|Health Related Quality of Life|health related quality of life
284296|NCT01734850|HIV-1|hiv-1
284297|NCT01734837|Laparoscopic appendectomy|laparoscopic appendectomy
284298|NCT01734837|appendical stump closure|appendical stump closure
284299|NCT01734824|bone marrow edema, denosumab, PTH 1-84|bone marrow edema, denosumab, pth 1-84
284300|NCT01734811|Vaccine|vaccine
284301|NCT01734811|Bronchospasm|bronchospasm
284302|NCT01734798|locally advanced bladder cancer|locally advanced bladder cancer
284303|NCT01734798|Postoperative radiotherapy|postoperative radiotherapy
284304|NCT01734798|Adjuvant chemotherapy|adjuvant chemotherapy
274963|NCT01776853|MRI|mri
284305|NCT01734798|Radical Cystectomy|radical cystectomy
284306|NCT01734759|medication palatability|medication palatability
284307|NCT01734759|medication taste|medication taste
284308|NCT01734746|ovarian cancer|ovarian cancer
284309|NCT01734746|sentinel node|sentinel node
284310|NCT01734733|Parkinson's Disease|parkinson's disease
284311|NCT01734733|Xenotransplantation|xenotransplantation
284312|NCT01734733|choroid plexus|choroid plexus
284313|NCT01734707|atherosclerosis|atherosclerosis
284314|NCT01734707|regression|regression
284315|NCT01734707|Allicor|allicor
284316|NCT01734707|garlic|garlic
284317|NCT01734707|intima-media thickness|intima-media thickness
284318|NCT01734642|Medication errors, patients hospitalized, ADRs, adverse events|medication errors, patients hospitalized, adrs, adverse events
284319|NCT01734629|Coronary Disease|coronary disease
284320|NCT01734629|COPD|copd
284321|NCT01734629|Spirometry|spirometry
284322|NCT01734629|Coronary tomography|coronary tomography
284323|NCT01734616|Microvascular|microvascular
284324|NCT01734616|Muscle|muscle
284325|NCT01734616|Nutrition|nutrition
284326|NCT01734616|Exercise|exercise
284327|NCT01734616|Ageing|ageing
284328|NCT01734603|Assessment|assessment
284329|NCT01734603|Rehabilitation|rehabilitation
284330|NCT01734603|Walking Constant Test|walking constant test
284331|NCT01734603|Walking Graded test|walking graded test
586545|NCT00516672|lapatinib,|lapatinib,
284332|NCT01734603|Six minute Walking test|six minute walking test
284333|NCT01734603|Walking Distance|walking distance
284334|NCT01734590|Flour,|flour,
284335|NCT01734590|carbohydrate,|carbohydrate,
284336|NCT01734590|digestibility|digestibility
284337|NCT01734590|subjects|subjects
284338|NCT01734577|Back pain|back pain
284339|NCT01734551|Prenatal opiate exposure|prenatal opiate exposure
284340|NCT01734551|neonatal withdrawal|neonatal withdrawal
284341|NCT01734551|Pharmacologic treatment|pharmacologic treatment
284342|NCT01734525|candidemia|candidemia
284343|NCT01734525|intensive care unit|intensive care unit
284344|NCT01734525|1,3 beta-D-glucan|1,3 beta-d-glucan
284345|NCT01734512|pediatric recurrent progressive low-grade gliomas|pediatric recurrent progressive low-grade gliomas
284346|NCT01734512|pediatric progressive low-grade gliomas|pediatric progressive low-grade gliomas
284347|NCT01734512|everolimus|everolimus
284348|NCT01734512|mTOR inhibition|mtor inhibition
284349|NCT01734499|Breast cancer|breast cancer
284350|NCT01734499|Survivorship|survivorship
284351|NCT01734499|Coping|coping
284352|NCT01734499|Quality of Life|quality of life
284353|NCT01734473|COPD|copd
284354|NCT01734473|Protein synthesis|protein synthesis
284355|NCT01734473|Protein breakdown|protein breakdown
284356|NCT01734473|Muscle wasting|muscle wasting
284357|NCT01734473|Leucine|leucine
284358|NCT01734473|Hydrolyzed|hydrolyzed
284359|NCT01734473|Casein protein|casein protein
284360|NCT01734473|Carbohydrates|carbohydrates
284361|NCT01734460|pregnancy, snoring, fetal growth|pregnancy, snoring, fetal growth
284362|NCT01734434|Health care access, Pregnant women|health care access, pregnant women
284363|NCT01734421|Smoking cessation|smoking cessation
284364|NCT01734421|Primary health care|primary health care
284365|NCT01734421|Young people|young people
284366|NCT01734421|Cellular phone|cellular phone
284367|NCT01734408|immunogenicity|immunogenicity
284368|NCT01734408|safety|safety
284369|NCT01734408|inactivated EV71 vaccine|inactivated ev71 vaccine
284370|NCT01734395|Alzheimer's disease|alzheimer's disease
284371|NCT01734395|Caregiver's Burden in Alzheimer's disease|caregiver's burden in alzheimer's disease
284372|NCT01734395|Galantamine|galantamine
284373|NCT01734395|Razadyne|razadyne
284374|NCT01734395|Reminyl|reminyl
284375|NCT01734369|Dermatomyositis|dermatomyositis
284376|NCT01734369|Inclusion Body Myositis|inclusion body myositis
284377|NCT01734369|Myositis|myositis
284378|NCT01734369|Polymyositis|polymyositis
284379|NCT01734369|Military|military
284380|NCT01734356|iPS|ips
284381|NCT01734356|fibroblast|fibroblast
284382|NCT01734356|arrhythmias|arrhythmias
284383|NCT01734356|valvulopathies|valvulopathies
284384|NCT01734356|electrophysiology|electrophysiology
284385|NCT01734356|genetics|genetics
284386|NCT01734343|posterior capsule opacification|posterior capsule opacification
284387|NCT01734343|PCO|pco
284388|NCT01734343|after cataract|after cataract
284389|NCT01734343|intraocular lens|intraocular lens
284390|NCT01734330|behavior cognitive therapy|behavior cognitive therapy
284391|NCT01734330|Smokers|smokers
284392|NCT01734330|randomized clinical trial|randomized clinical trial
284393|NCT01734304|vaccination|vaccination
284394|NCT01734304|postremission therapy|postremission therapy
284395|NCT01734304|acute myeloid leukemia|acute myeloid leukemia
284396|NCT01734304|dendritic cells|dendritic cells
284397|NCT01734291|Family psychoeducation|family psychoeducation
284398|NCT01734291|Major depressive disorder|major depressive disorder
284399|NCT01734291|Family burden|family burden
284400|NCT01734174|transesophageal and transthoracic echocardiogram|transesophageal and transthoracic echocardiogram
284401|NCT01734174|thermodilution|thermodilution
274984|NCT01776749|low back pain|low back pain
274985|NCT01776749|failed back surgery syndrome|failed back surgery syndrome
274986|NCT01776749|spinal cord stimulation|spinal cord stimulation
274987|NCT01776749|subcutaneous stimulation|subcutaneous stimulation
274988|NCT01776749|peripheral nerve field stimulation|peripheral nerve field stimulation
274989|NCT01776736|Scoliosis|scoliosis
274990|NCT01776736|Posture correction|posture correction
274991|NCT01776723|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
274992|NCT01776723|CMML|cmml
274993|NCT01776723|Leukemia|leukemia
274994|NCT01776710|Intermittent claudication|intermittent claudication
274995|NCT01776710|Behavior therapy|behavior therapy
274996|NCT01776710|Walking|walking
274997|NCT01776710|Exercise|exercise
274998|NCT01776710|Patient education|patient education
275000|NCT01776658|Ocular pain|ocular pain
284402|NCT01734174|left ventricular volume|left ventricular volume
284403|NCT01734174|ejection volume|ejection volume
284404|NCT01734161|cesarean section|cesarean section
284405|NCT01734161|nausea|nausea
284406|NCT01734161|vomiting|vomiting
284407|NCT01734161|dexamethasone|dexamethasone
284408|NCT01734161|postoperative nausea and vomiting|postoperative nausea and vomiting
284409|NCT01734161|antiemetics|antiemetics
284410|NCT01734148|pediatric|pediatric
284411|NCT01734148|sleep difficulties in children|sleep difficulties in children
284412|NCT01734148|Sleep Education|sleep education
284413|NCT01734135|B type natriuretic peptide|b type natriuretic peptide
284414|NCT01734135|heart failure|heart failure
284415|NCT01734135|cardiac imaging|cardiac imaging
284416|NCT01734135|quality of care|quality of care
284417|NCT01734122|Stereotactic Radiosurgery|stereotactic radiosurgery
284418|NCT01734122|Essential Tremor|essential tremor
284419|NCT01734122|Parkinsonian Tremor|parkinsonian tremor
284420|NCT01734122|Quality of Life|quality of life
284421|NCT01734122|Severity of Tremor|severity of tremor
284422|NCT01734109|Negative Pressure Wound Therapy|negative pressure wound therapy
284423|NCT01734109|Irrigation Therapy|irrigation therapy
284424|NCT01734109|Pressure Ulcers|pressure ulcers
284425|NCT01734109|Sacral Ulcers|sacral ulcers
284426|NCT01734096|hypertension|hypertension
284427|NCT01734096|obesity|obesity
284428|NCT01734096|white coat hypertension|white coat hypertension
284429|NCT01734096|resistant hypertension|resistant hypertension
284430|NCT01734083|rehabilitation|rehabilitation
284431|NCT01734083|exercise|exercise
284432|NCT01734083|fall|fall
284433|NCT01734083|muscle|muscle
284434|NCT01734083|vibration|vibration
284435|NCT01734083|mobility|mobility
284436|NCT01734083|cognition|cognition
284437|NCT01734070|anthocyanins|anthocyanins
284438|NCT01734070|catechins|catechins
284439|NCT01734070|chlorogenic acid|chlorogenic acid
284440|NCT01734070|flavanol glycosides|flavanol glycosides
284441|NCT01734057|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
284442|NCT01734057|rhTPO|rhtpo
284443|NCT01734057|Rituximab|rituximab
284444|NCT01734057|Dexamethasone|dexamethasone
284445|NCT01734044|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
284446|NCT01734044|rhTPO|rhtpo
284447|NCT01734044|Dexamethasone|dexamethasone
284448|NCT01733953|Cardiovascular Disease|cardiovascular disease
284449|NCT01733953|Childhood ALL|childhood all
284450|NCT01733953|Childhood NHL|childhood nhl
284451|NCT01733927|HIV screening|hiv screening
284452|NCT01733927|Rapid test for HIV|rapid test for hiv
284453|NCT01733914|shoulder pain|shoulder pain
284454|NCT01733914|acupuncture|acupuncture
284455|NCT01733901|Coronary heart disease|coronary heart disease
284456|NCT01733901|PCI|pci
284457|NCT01733901|Renal sympathetic denervation|renal sympathetic denervation
284458|NCT01733901|Hypertension|hypertension
284459|NCT01733901|Diabetes|diabetes
284460|NCT01733888|caries|caries
284461|NCT01733888|caries infiltration|caries infiltration
284462|NCT01733888|fluorosis treatment|fluorosis treatment
284463|NCT01733875|Safety|safety
284464|NCT01733875|Pharmacokinetics|pharmacokinetics
284465|NCT01733875|Food effect|food effect
284466|NCT01733875|Healthy subjects|healthy subjects
284467|NCT01733862|Impact|impact
284468|NCT01733862|Vaccination|vaccination
284469|NCT01733862|Hospitalizations|hospitalizations
284470|NCT01733862|Rotavirus gastroenteritis|rotavirus gastroenteritis
284471|NCT01733862|Japan|japan
284472|NCT01733849|Bulgaria|bulgaria
284473|NCT01733849|Primary care settings|primary care settings
284475|NCT01733849|Latvia|latvia
284476|NCT01733849|Acute gastroenteritis|acute gastroenteritis
284477|NCT01733810|Esophagitis|esophagitis
284478|NCT01733810|Reflux esophagitis|reflux esophagitis
284479|NCT01733810|Gastroesophageal reflux disease|gastroesophageal reflux disease
284480|NCT01733810|Acid|acid
284481|NCT01733810|Inflammation|inflammation
284482|NCT01733810|Esophagus|esophagus
284483|NCT01733810|Cytokines|cytokines
284484|NCT01733810|Esophageal squamous cell|esophageal squamous cell
284485|NCT01733810|Reflux|reflux
284486|NCT01733810|Squamous epithelium|squamous epithelium
284487|NCT01733797|Trismus|trismus
284488|NCT01733797|Therabite|therabite
284489|NCT01733797|Wooden spatula|wooden spatula
284490|NCT01733797|Head and Neck cancer|head and neck cancer
284491|NCT01733784|Sleep Apnea|sleep apnea
284492|NCT01733784|Pathophysiology|pathophysiology
284493|NCT01733771|complementary medicine|complementary medicine
284494|NCT01733771|hospitalized|hospitalized
284495|NCT01733758|albiglutide|albiglutide
284496|NCT01733758|Japanese|japanese
284497|NCT01733758|GSK716155|gsk716155
284498|NCT01733758|Type 2 diabetes mellitus|type 2 diabetes mellitus
284499|NCT01733758|glucagon-like peptide 1|glucagon-like peptide 1
284500|NCT01733745|dry eye|dry eye
284501|NCT01733745|lipid deficiency|lipid deficiency
284502|NCT01733745|meibomian gland|meibomian gland
284503|NCT01733732|Dry eye|dry eye
284504|NCT01733732|Lipid deficiency|lipid deficiency
284505|NCT01733732|Inflammatory markers|inflammatory markers
284506|NCT01733706|No Nicotine Electronic Cigarette|no nicotine electronic cigarette
284507|NCT01733706|Antismoke intervention|antismoke intervention
284508|NCT01733693|Buprenorphine|buprenorphine
284509|NCT01733693|Methadone|methadone
284510|NCT01733693|Cognition|cognition
284511|NCT01733680|ADHD|adhd
284512|NCT01733680|executive function|executive function
284513|NCT01733680|emotional self-regulation|emotional self-regulation
284514|NCT01733667|synechia|synechia
284515|NCT01733667|Fess|fess
284516|NCT01733667|sinus surgery|sinus surgery
284517|NCT01733654|depression|depression
284518|NCT01733654|major depressive disorder|major depressive disorder
284519|NCT01733628|Hypertension|hypertension
284520|NCT01733628|Bevacizumab Response Predictors|bevacizumab response predictors
284521|NCT01733628|Metastatic Breast Cancer|metastatic breast cancer
284522|NCT01733628|Metastatic Colon Cancer|metastatic colon cancer
284523|NCT01733615|Mucopolysaccharidosis Type IVA|mucopolysaccharidosis type iva
284524|NCT01733615|Mucopolysaccharidosis Type IV|mucopolysaccharidosis type iv
284525|NCT01733615|MPS Type IVA|mps type iva
284526|NCT01733615|MPS Type IV|mps type iv
284527|NCT01733615|Morquio Syndrome|morquio syndrome
284528|NCT01733615|Morquio Syndrome Type A|morquio syndrome type a
284529|NCT01733615|Urine biomarkers|urine biomarkers
284530|NCT01733589|Recombinant human endostatin|recombinant human endostatin
284531|NCT01733589|Non-small-Cell Lung Cancer|non-small-cell lung cancer
284532|NCT01733589|chemoradiotherapy|chemoradiotherapy
284533|NCT01733563|sugar sweetened beverages|sugar sweetened beverages
284534|NCT01733563|fructose|fructose
284535|NCT01733563|lipogenesis|lipogenesis
284536|NCT01733563|beta-oxidation|beta-oxidation
284537|NCT01733550|Intraocular Pressure|intraocular pressure
284538|NCT01733550|Tonometry, Ocular|tonometry, ocular
284539|NCT01733550|iCare|icare
284540|NCT01733537|traffic accidents, motorcycle, injury, conspicuity|traffic accidents, motorcycle, injury, conspicuity
284541|NCT01733524|adolescence|adolescence
284542|NCT01733524|self care|self care
284543|NCT01733485|Asthma|asthma
284544|NCT01733485|Electrophilic Fatty Acids|electrophilic fatty acids
284545|NCT01733485|Inflammation|inflammation
284546|NCT01733472|anaesthetic techniques|anaesthetic techniques
284547|NCT01733472|subarachnoid|subarachnoid
284548|NCT01733472|analgesia|analgesia
284549|NCT01733459|PCOS, DLBS3233, metformin,oral anti-hyperglycemic agent|pcos, dlbs3233, metformin,oral anti-hyperglycemic agent
284550|NCT01733446|High frequency jet ventilation|high frequency jet ventilation
284551|NCT01733407|inherited neuropathies|inherited neuropathies
284552|NCT01733394|Epilepsy|epilepsy
284553|NCT01733394|Generic|generic
284554|NCT01733381|Barefoot running, minimally shod running, non-invasive measures of autonomic nervous system (ANS) functioning and mood state.|barefoot running, minimally shod running, non-invasive measures of autonomic nervous system (ans) functioning and mood state.
284555|NCT01733368|CRT|crt
284556|NCT01733368|Optimization|optimization
284557|NCT01733368|Responders|responders
284558|NCT01733329|Buccal Misoprostol|buccal misoprostol
284559|NCT01733329|Uterine Atony|uterine atony
284560|NCT01733329|Postpartum Hemorrhage|postpartum hemorrhage
284561|NCT01733316|Nephropathic Cystinosis|nephropathic cystinosis
284562|NCT01733316|Cysteamine|cysteamine
284563|NCT01733316|Delayed-Release Cysteamine|delayed-release cysteamine
284564|NCT01733316|Orphan Disease|orphan disease
284565|NCT01733316|CTNS Protein, Human|ctns protein, human
284566|NCT01733290|Botulinum Toxin A (BoNT-A)|botulinum toxin a (bont-a)
284567|NCT01733290|Dysfunctional voiding|dysfunctional voiding
284568|NCT01733277|Neuropathic pain|neuropathic pain
284569|NCT01733277|Knee osteoarthritis|knee osteoarthritis
284570|NCT01733277|MRI|mri
284571|NCT01732419|Rehabilitation, exercise therapy, coronary artery disease|rehabilitation, exercise therapy, coronary artery disease
284572|NCT01732393|Quercetin|quercetin
284573|NCT01732393|Chemotherapy|chemotherapy
284574|NCT01732393|Mucositis|mucositis
284575|NCT01732393|Hematologic Malignancies|hematologic malignancies
284576|NCT01732367|Tenofovir|tenofovir
284577|NCT01732367|Lamivudine|lamivudine
284578|NCT01732367|Adefovir|adefovir
284579|NCT01732367|Chronic Hepatitis B|chronic hepatitis b
284580|NCT01732354|Hepatitis B virus, Tenofovir|hepatitis b virus, tenofovir
284581|NCT01732341|STEMI|stemi
284582|NCT01732341|BMS|bms
284583|NCT01732341|Self-expanding stent|self-expanding stent
284584|NCT01732315|Adolescent vaccination|adolescent vaccination
284585|NCT01732315|Immunization rates|immunization rates
284586|NCT01732315|Barriers to vaccination|barriers to vaccination
284587|NCT01732315|Attitudes|attitudes
284588|NCT01732315|Intentions|intentions
284589|NCT01732302|Drug Utilization Review|drug utilization review
284590|NCT01732302|Aged|aged
284591|NCT01732302|Aged, 80 and over|aged, 80 and over
284592|NCT01732302|Primary Health Care|primary health care
284593|NCT01732289|Age-related hearing loss|age-related hearing loss
284594|NCT01732289|Gene|gene
284595|NCT01732289|Single nucleotide polymorphism|single nucleotide polymorphism
284596|NCT01732289|environmental factors|environmental factors
284597|NCT01732276|Triple-negative breast cancer|triple-negative breast cancer
284598|NCT01732276|Epidermal growth factor receptor|epidermal growth factor receptor
284599|NCT01732276|Gefitinib|gefitinib
284600|NCT01732250|Gram-Negative Bacterial Infections|gram-negative bacterial infections
284601|NCT01732250|Resistant Bacteria|resistant bacteria
284602|NCT01732250|Drug Resistance, Bacterial|drug resistance, bacterial
284603|NCT01732250|Colistin|colistin
284604|NCT01732237|Healthy|healthy
284605|NCT01732237|JNJ-42396302|jnj-42396302
284606|NCT01732237|JNJ-42692507|jnj-42692507
284607|NCT01732237|JNJ-53773187|jnj-53773187
284608|NCT01732237|Pharmacokinetics|pharmacokinetics
284609|NCT01733238|PNT2258|pnt2258
284610|NCT01733238|Lymphoma|lymphoma
284611|NCT01733238|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
284612|NCT01733238|NHL|nhl
284613|NCT01733212|Nausea|nausea
284614|NCT01733212|Vomiting|vomiting
284615|NCT01733212|Cesaraen|cesaraen
284616|NCT01733212|Ginger|ginger
284617|NCT01733212|cesarean section|cesarean section
284618|NCT01733199|Parkinson's disease|parkinson's disease
284619|NCT01733199|Behavioural addictions|behavioural addictions
284620|NCT01733199|Pathological gambling|pathological gambling
284621|NCT01733199|Dopamine agonist|dopamine agonist
284622|NCT01733199|Dopamine dysregulation syndrome|dopamine dysregulation syndrome
284623|NCT01733199|Pharmacokinetic|pharmacokinetic
284624|NCT01733199|Pramipexole|pramipexole
284625|NCT01733186|human umbilical cord blood-derived mesenchymal stem cells|human umbilical cord blood-derived mesenchymal stem cells
284626|NCT01733186|MSC|msc
284627|NCT01733186|cartilage lesion|cartilage lesion
284628|NCT01733186|cartilage defect|cartilage defect
284629|NCT01733186|degenerative arthritis|degenerative arthritis
284630|NCT01733186|stem cell implantation|stem cell implantation
284631|NCT01733173|mass in posterior fossa|mass in posterior fossa
284632|NCT01733173|benign|benign
284633|NCT01733173|malignant|malignant
284634|NCT01733173|surgical resection|surgical resection
284635|NCT01733173|MRI|mri
284636|NCT01733173|fMRI|fmri
284637|NCT01733173|DTI|dti
284638|NCT01733173|12-121|12-121
284639|NCT01733160|Atrial Fibrillation|atrial fibrillation
284640|NCT01733160|Stroke|stroke
284641|NCT01733160|Anticoagulants|anticoagulants
284642|NCT01733147|Barrett's esophagus|barrett's esophagus
284643|NCT01733147|Obesity|obesity
284644|NCT01733147|Omega-3 fatty acid|omega-3 fatty acid
284645|NCT01733134|acute heart failure|acute heart failure
284646|NCT01733134|emergency department|emergency department
284647|NCT01733134|copeptin|copeptin
284648|NCT01733134|adh antagonists|adh antagonists
284649|NCT01733108|Healthy|healthy
284650|NCT01733108|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
284651|NCT01733108|Pharmacokinetics|pharmacokinetics
284652|NCT01733108|Pharmacodynamics|pharmacodynamics
284653|NCT01733108|Glyburide (MICRONASE)|glyburide (micronase)
284654|NCT01733056|Dermatology|dermatology
284655|NCT01733056|Influenza Vaccine|influenza vaccine
284656|NCT01733030|PTSD|ptsd
284657|NCT01733017|heart failure|heart failure
284658|NCT01733017|nutrition therapy|nutrition therapy
284659|NCT01733017|symptoms|symptoms
284660|NCT01733017|quality of life|quality of life
284661|NCT01733017|lycopene|lycopene
284662|NCT01733017|omega-3 fatty acids|omega-3 fatty acids
284663|NCT01733004|Cancer|cancer
284664|NCT01733004|Hepatocellular Carcinoma|hepatocellular carcinoma
284665|NCT01733004|Oncology|oncology
275390|NCT01774825|IBS|ibs
284666|NCT01733004|Phase I|phase i
284667|NCT01733004|ErbB3|erbb3
284668|NCT01733004|IGF-1R|igf-1r
284669|NCT01733004|Everolimus|everolimus
284670|NCT01733004|Gemcitabine|gemcitabine
284671|NCT01733004|Abraxane|abraxane
284672|NCT01732991|Prostatic Hypertrophy, Benign|prostatic hypertrophy, benign
284673|NCT01732991|Greenlight laser|greenlight laser
284674|NCT01732991|Prostatic photovaporization|prostatic photovaporization
284675|NCT01732991|Prostatic MRI|prostatic mri
284676|NCT01732991|Prostatic contrast-enhanced ultrasound|prostatic contrast-enhanced ultrasound
284677|NCT01732991|Urinary irritative signs|urinary irritative signs
284678|NCT01732991|Postoperative necrotic area|postoperative necrotic area
284679|NCT01732978|Crying record|crying record
284680|NCT01732978|Newborn|newborn
284681|NCT01732965|Vitiligo|vitiligo
284682|NCT01732965|Phototherapy|phototherapy
284683|NCT01732965|Photochemotherapy|photochemotherapy
284684|NCT01732952|the prevalence,lipid abnormalities,CV risks|the prevalence,lipid abnormalities,cv risks
284685|NCT01732926|iNHL|inhl
284686|NCT01732926|indolent NHL|indolent nhl
284687|NCT01732926|follicular lymphoma|follicular lymphoma
284688|NCT01732926|CAL-101|cal-101
284689|NCT01732926|rituximab|rituximab
284690|NCT01732926|bendamustine|bendamustine
284691|NCT01732926|small lymphocytic lymphoma|small lymphocytic lymphoma
284692|NCT01732926|lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
284693|NCT01732926|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
284694|NCT01732926|LPL|lpl
284695|NCT01732926|WM|wm
284696|NCT01732926|Marginal zone lymphoma|marginal zone lymphoma
284697|NCT01732926|MZL|mzl
284698|NCT01732926|SLL|sll
284699|NCT01732926|FL|fl
284700|NCT01732926|GS-1101|gs-1101
284701|NCT01732926|PI3K inhibitor|pi3k inhibitor
284702|NCT01732926|idelalisib|idelalisib
284703|NCT01732913|iNHL|inhl
284704|NCT01732913|indolent NHL|indolent nhl
284705|NCT01732913|follicular lymphoma|follicular lymphoma
284706|NCT01732913|CAL-101|cal-101
284707|NCT01732913|Rituximab|rituximab
284708|NCT01732913|Small lymphocytic lymphoma|small lymphocytic lymphoma
284709|NCT01732913|lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
284710|NCT01732913|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
284711|NCT01732913|LPL|lpl
284712|NCT01732913|WM|wm
284713|NCT01732913|Marginal zone lymphoma|marginal zone lymphoma
284714|NCT01732913|MZL|mzl
284715|NCT01732913|SLL|sll
284716|NCT01732913|FL|fl
284717|NCT01732913|GS-1101|gs-1101
284718|NCT01732913|idelalisib|idelalisib
284719|NCT01732900|In vitro fertilization|in vitro fertilization
284720|NCT01732900|Assisted reproduction|assisted reproduction
284721|NCT01732900|pregnancy outcome|pregnancy outcome
284722|NCT01732900|cumulus cells|cumulus cells
284723|NCT01732887|cochlear implants|cochlear implants
284724|NCT01732887|speech comprehension|speech comprehension
284725|NCT01732887|cognitive training|cognitive training
284726|NCT01732887|cognitive fitness|cognitive fitness
284727|NCT01732887|intervention|intervention
284728|NCT01732887|memory|memory
284729|NCT01732887|attention|attention
284730|NCT01732887|rehabilitation|rehabilitation
284731|NCT01732874|DHA|dha
284732|NCT01732874|Preterm infant|preterm infant
284733|NCT01732874|Inflammation|inflammation
284734|NCT01732874|Growth|growth
284735|NCT01732874|Developement|developement
284736|NCT01732861|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
284737|NCT01732861|Small Lymphocytic Leukemia|small lymphocytic leukemia
284738|NCT01732848|Volunteers|volunteers
284739|NCT01732835|Aortic Insufficiency (AI) Aortic Regurgitation (AR)|aortic insufficiency (ai) aortic regurgitation (ar)
284740|NCT01732822|Peripheral artery disease Atherothrombotic events Atherosclerosis|peripheral artery disease atherothrombotic events atherosclerosis
284741|NCT01732809|wrinkles|wrinkles
284742|NCT01732809|botulinum toxin|botulinum toxin
284743|NCT01732783|Wild-type RAS|wild-type ras
284744|NCT01732783|Metastatic Colorectal Cancer|metastatic colorectal cancer
284745|NCT01732783|Vectibix|vectibix
284746|NCT01732744|biofilm, castor bean, sodium hypochlorite, alkaline peroxide|biofilm, castor bean, sodium hypochlorite, alkaline peroxide
284747|NCT01732731|Cerebral palsy|cerebral palsy
284748|NCT01732731|treadmill training|treadmill training
284749|NCT01732718|sickle cell disease|sickle cell disease
284750|NCT01732718|endothelial function|endothelial function
284751|NCT01732718|albuminuria|albuminuria
284752|NCT01732718|atorvastatin|atorvastatin
284753|NCT01732718|soluble fms-like tyrosine kinase-1|soluble fms-like tyrosine kinase-1
284754|NCT01732705|Type 2 diabetes|type 2 diabetes
284755|NCT01732705|Insulin sensitivity|insulin sensitivity
284756|NCT01732705|High intensity interval training|high intensity interval training
284757|NCT01732692|Bowel preparation, MOVIPREP®|bowel preparation, moviprep®
284758|NCT01732679|stroke, rehabilitation, multidisciplinary, description|stroke, rehabilitation, multidisciplinary, description
284759|NCT01732666|Opioid-induced hyperalgesia (OIH)|opioid-induced hyperalgesia (oih)
284760|NCT01732653|virtual reality,|virtual reality,
284761|NCT01732653|falls,|falls,
284762|NCT01732653|elderly,|elderly,
284763|NCT01732653|Parkinson's disease,|parkinson's disease,
284764|NCT01732653|MCI|mci
284765|NCT01732640|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
284766|NCT01732627|Meningitis|meningitis
284767|NCT01732627|Meningococcal Meningitis|meningococcal meningitis
284768|NCT01732627|Menactra®|menactra®
284769|NCT01732627|Menomune® A/C/Y/W-135|menomune® a/c/y/w-135
284770|NCT01732614|Diabetic Macular Edema|diabetic macular edema
284771|NCT01732614|DME|dme
284772|NCT01732614|Laser|laser
284773|NCT01732614|Topcon|topcon
284774|NCT01732614|EndPoint Management|endpoint management
284775|NCT01732601|Suicide Attempt|suicide attempt
285565|NCT01728740|Metformin|metformin
284776|NCT01732601|Suicidal Ideation|suicidal ideation
284777|NCT01732601|NSSI|nssi
284778|NCT01732601|Substance Use|substance use
284779|NCT01732588|Bioavailability|bioavailability
284780|NCT01732575|everyday activities|everyday activities
284781|NCT01732575|rehabilitation|rehabilitation
284782|NCT01732575|mental illness|mental illness
284783|NCT01732575|occupational therapy|occupational therapy
284784|NCT01732562|Primary Total Knee Arthroplasty|primary total knee arthroplasty
284785|NCT01732562|Patient Expectations|patient expectations
284786|NCT01732562|Patient Satisfaction|patient satisfaction
284787|NCT01732562|Patient Education|patient education
284788|NCT01732562|e-Learning|e-learning
284789|NCT01732523|Carotid stenosis|carotid stenosis
284790|NCT01732523|Vasa Vasorum|vasa vasorum
284791|NCT01732523|Ultrasonography|ultrasonography
284792|NCT01732497|Underarm Hair|underarm hair
284793|NCT01732497|Underarm Hair Reduction|underarm hair reduction
284794|NCT01732497|Axillary Hair|axillary hair
284795|NCT01732497|Axillary Hair Reduction|axillary hair reduction
284796|NCT01732497|Underarm Odor|underarm odor
284797|NCT01732497|Axillary Odor|axillary odor
284798|NCT01732471|EMR 700733_510, Genetic disorder, Phenylketonuria, phenylalanine, Kuvan, sapropterin dihydrochloride|emr 700733_510, genetic disorder, phenylketonuria, phenylalanine, kuvan, sapropterin dihydrochloride
284799|NCT01732211|Phase 2|phase 2
284800|NCT01732211|Randomized|randomized
284801|NCT01732211|Double Blind|double blind
284802|NCT01732211|Placebo Controlled|placebo controlled
284803|NCT01732211|Parallel|parallel
284804|NCT01732211|20 Week Safety|20 week safety
284805|NCT01732211|Tolerability|tolerability
284806|NCT01732211|and Efficacy Study|and efficacy study
284807|NCT01732185|Congenital lung malformation|congenital lung malformation
284808|NCT01732185|Congenital Cystic Adenomatoid Malformation|congenital cystic adenomatoid malformation
284809|NCT01732185|Cystic lung disease|cystic lung disease
284810|NCT01732172|Urethritis|urethritis
284811|NCT01732172|Prevalence of a chronic inflammatory male genital tract|prevalence of a chronic inflammatory male genital tract
284812|NCT01732159|Ambulatory surgery|ambulatory surgery
284813|NCT01732159|Checklist|checklist
284814|NCT01732159|Cancellation|cancellation
284815|NCT01732146|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
284816|NCT01732146|Term neonate|term neonate
284817|NCT01732146|Neuroprotection|neuroprotection
284818|NCT01732146|erythropoietin|erythropoietin
284819|NCT01732133|Hypotension|hypotension
284820|NCT01732133|Cesarean delivery|cesarean delivery
284821|NCT01732120|off-clamp|off-clamp
284822|NCT01732120|partial nephrectomy|partial nephrectomy
284823|NCT01732120|renal cancer treatment|renal cancer treatment
284824|NCT01732120|renal ischemia|renal ischemia
284825|NCT01732107|Dovitinib|dovitinib
284826|NCT01732107|FGFR3 Mutations|fgfr3 mutations
284827|NCT01732107|BCG-Refractory Urothelial Carcinoma|bcg-refractory urothelial carcinoma
284828|NCT01732094|Poor ovarian response|poor ovarian response
284829|NCT01732094|Poor ovarian responders|poor ovarian responders
284830|NCT01732094|Bologna criteria for poor ovarian response|bologna criteria for poor ovarian response
284831|NCT01732081|Hepatitis B|hepatitis b
284832|NCT01732068|Poor ovarian response|poor ovarian response
284833|NCT01732068|Poor ovarian responders|poor ovarian responders
284834|NCT01732068|Bologna criteria for poor ovarian response|bologna criteria for poor ovarian response
284835|NCT01732055|Pregnancy|pregnancy
284836|NCT01732055|Antenatal|antenatal
284837|NCT01732055|Major Depressive Disorder|major depressive disorder
284838|NCT01732055|Psychotherapy|psychotherapy
284839|NCT01732055|Antidepressant Medication|antidepressant medication
284840|NCT01732055|Partners|partners
284841|NCT01732055|Spouses|spouses
284842|NCT01732055|Interpersonal Psychotherapy|interpersonal psychotherapy
284843|NCT01732042|retinal venous pressure|retinal venous pressure
284844|NCT01732029|pulse oximeter|pulse oximeter
284845|NCT01732029|oxygen saturation|oxygen saturation
284846|NCT01732029|heart rate|heart rate
284847|NCT01732029|calibration|calibration
284848|NCT01732029|accuracy|accuracy
284849|NCT01732016|pulse oximeter|pulse oximeter
284850|NCT01732016|oxygen saturation|oxygen saturation
284851|NCT01732016|heart rate|heart rate
284852|NCT01732016|calibration|calibration
284853|NCT01732016|accuracy|accuracy
284854|NCT01732003|Omega-3|omega-3
284855|NCT01732003|Skeletal Muscle|skeletal muscle
284856|NCT01732003|Eicosapentaenoic acid|eicosapentaenoic acid
284857|NCT01732003|Docosahexaenoic acid|docosahexaenoic acid
284858|NCT01732003|Exercise|exercise
284859|NCT01732003|Membrane Composition|membrane composition
284860|NCT01732003|Lipid Metabolism|lipid metabolism
284861|NCT01731990|Peripheral artery disease|peripheral artery disease
284862|NCT01731990|Intermittent claudication|intermittent claudication
284863|NCT01731990|magnetic resonance imaging|magnetic resonance imaging
284864|NCT01731977|Psychotherapy, Psychotic disorders, Caregiver|psychotherapy, psychotic disorders, caregiver
284865|NCT01731964|Macular Degeneration|macular degeneration
284866|NCT01731964|Visual Impairment|visual impairment
284867|NCT01731964|Implantable Telescope|implantable telescope
284868|NCT01731951|Myelofibrosis|myelofibrosis
284869|NCT01731951|Myelodysplastic Syndromes|myelodysplastic syndromes
284870|NCT01731951|Myeloproliferative Neoplasm|myeloproliferative neoplasm
284871|NCT01731951|Imetelstat|imetelstat
284873|NCT01731938|Fibrin Sealant|fibrin sealant
284874|NCT01731938|Soft tissue open surgery|soft tissue open surgery
284875|NCT01731938|Oxidized cellulose pads|oxidized cellulose pads
284876|NCT01731925|midgut carcinoid tumors|midgut carcinoid tumors
284877|NCT01731925|progressive|progressive
284878|NCT01731925|advanced|advanced
284879|NCT01731925|metastatic|metastatic
284880|NCT01731899|major depression|major depression
284881|NCT01731899|fibromyalgia|fibromyalgia
284882|NCT01731899|agomelatine|agomelatine
284883|NCT01731899|Becks' Depression Inventory (BDI)|becks' depression inventory (bdi)
284884|NCT01731899|Pittsburgh's Sleep Quality Index (PSQI)|pittsburgh's sleep quality index (psqi)
284885|NCT01731886|Stem cell transplant|stem cell transplant
284886|NCT01731886|plasma cell myeloma|plasma cell myeloma
284887|NCT01731886|multiple myeloma|multiple myeloma
284888|NCT01731873|postoperative pain|postoperative pain
284889|NCT01731873|children|children
284890|NCT01731873|pharmacogenetic|pharmacogenetic
284891|NCT01731873|opioid adverse effects|opioid adverse effects
284892|NCT01731873|respiratory depression|respiratory depression
284893|NCT01731873|analgesia|analgesia
284894|NCT01731873|genetic polymorphisms|genetic polymorphisms
284895|NCT01731860|PET/CT|pet/ct
284896|NCT01731860|Philips|philips
284897|NCT01731847|dysphagia,endoscopy, electrical stimulation,stroke|dysphagia,endoscopy, electrical stimulation,stroke
284898|NCT01731834|Pain|pain
284899|NCT01731834|Stress|stress
284900|NCT01731834|Physiotherapy|physiotherapy
284901|NCT01731834|Children|children
284902|NCT01731821|Pancreaticoduodenectomy|pancreaticoduodenectomy
284903|NCT01731821|Pancreaticojejunostomy|pancreaticojejunostomy
284904|NCT01731808|Nursing counseling|nursing counseling
284905|NCT01731808|diabetic foot|diabetic foot
284906|NCT01731795|acute respiratory distress syndrome, mechanical ventilation|acute respiratory distress syndrome, mechanical ventilation
284907|NCT01731782|colorectal surgery|colorectal surgery
284908|NCT01731769|Seroma Formation|seroma formation
284909|NCT01731769|Axillary Lymph Node Dissection|axillary lymph node dissection
284910|NCT01731769|Breast cancer|breast cancer
284911|NCT01731769|Early Vacuum Assisted Closure|early vacuum assisted closure
284912|NCT01731756|Palm|palm
284913|NCT01731756|Arsenic|arsenic
284914|NCT01731756|Keratosis|keratosis
284915|NCT01731756|Salicylic acid|salicylic acid
284916|NCT01731756|Azadirachta indica|azadirachta indica
284918|NCT01731730|Postsurgical pain|postsurgical pain
284919|NCT01731730|Total knee arthroplasty|total knee arthroplasty
284920|NCT01731730|Total knee replacement|total knee replacement
284921|NCT01731717|depression|depression
284922|NCT01731717|stepped care|stepped care
284923|NCT01731717|evidence-based medicine|evidence-based medicine
284924|NCT01731717|health services research|health services research
284925|NCT01731717|psychotherapy|psychotherapy
284926|NCT01731717|complex intervention|complex intervention
284927|NCT01731717|guideline|guideline
284928|NCT01731704|5 or more brain metastases|5 or more brain metastases
284929|NCT01731704|proven diagnosis of a non-hematopoietic malignancy|proven diagnosis of a non-hematopoietic malignancy
753197|NCT01175824|Insulin LISPRO|insulin lispro
284930|NCT01731704|non-small cell lung cancer or germ cell malignancy|non-small cell lung cancer or germ cell malignancy
284931|NCT01731665|Crohn's disease|crohn's disease
284932|NCT01731665|ulcerative colitis|ulcerative colitis
284933|NCT01731665|epidemiology|epidemiology
284934|NCT01731665|Korea|korea
284935|NCT01731652|bladder cancer|bladder cancer
284936|NCT01731652|carcinoma in situ|carcinoma in situ
284937|NCT01731652|non muscle invasive bladder cancer|non muscle invasive bladder cancer
284938|NCT01731587|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
284939|NCT01731587|exploratory study|exploratory study
284940|NCT01731587|L-BLP25|l-blp25
284941|NCT01731561|Granulomatosis with Polyangiitis|granulomatosis with polyangiitis
284942|NCT01731561|Microscopic polyangiitis|microscopic polyangiitis
284943|NCT01731561|Renal limited forms|renal limited forms
284944|NCT01731561|ANCA-associated vasculitis|anca-associated vasculitis
284945|NCT01731561|Rituximab|rituximab
284946|NCT01731535|osteoporosis, low trauma fracture, non-union fracture, delayed healing fracture, bisphosphonate|osteoporosis, low trauma fracture, non-union fracture, delayed healing fracture, bisphosphonate
284947|NCT01731509|congenital diaphragmatic hernia|congenital diaphragmatic hernia
284948|NCT01731509|fetoscopy|fetoscopy
284949|NCT01731509|fetal endoscopic tracheal occlusion|fetal endoscopic tracheal occlusion
284950|NCT01731509|pulmonary hypoplasia|pulmonary hypoplasia
284951|NCT01731509|fetal surgery|fetal surgery
284952|NCT01731509|fetal lung|fetal lung
284953|NCT01731496|Human Papillomavirus|human papillomavirus
284954|NCT01731483|virulence factors|virulence factors
284955|NCT01731457|ischemia, reperfusion, kidney, transplantation|ischemia, reperfusion, kidney, transplantation
284956|NCT01731444|blood loss|blood loss
284957|NCT01731444|burn|burn
284958|NCT01731444|hemostasis|hemostasis
284959|NCT01731431|Gestational Diabetes,|gestational diabetes,
284960|NCT01731431|Insulin,|insulin,
284961|NCT01731431|Glyburide,|glyburide,
284962|NCT01731431|Glycemia|glycemia
284963|NCT01731418|Post Traumatic Stress Disorder|post traumatic stress disorder
284964|NCT01731418|Depression|depression
284965|NCT01731418|Intimate Partner violence|intimate partner violence
284966|NCT01731418|Narrative Exposure Therapy|narrative exposure therapy
284967|NCT01731405|Medication Guides|medication guides
284968|NCT01731405|FDA|fda
284969|NCT01731405|Prototype|prototype
284970|NCT01731405|Format|format
284971|NCT01731392|Diarrhea|diarrhea
284972|NCT01731392|Children|children
284973|NCT01731392|Lactobacilli|lactobacilli
284974|NCT01731379|spectroscopy|spectroscopy
284975|NCT01731379|nerve|nerve
284976|NCT01731379|muscle|muscle
284977|NCT01731379|fat|fat
284978|NCT01731353|invasive fungal infection|invasive fungal infection
284979|NCT01731353|Web-based registry|web-based registry
284980|NCT01731340|Calcium Supplements|calcium supplements
284981|NCT01731340|Dairy Foods|dairy foods
284982|NCT01731340|Cardiovascular Diseases|cardiovascular diseases
284983|NCT01731340|Osteoporosis|osteoporosis
284984|NCT01731340|Postmenopause|postmenopause
284985|NCT01731340|Vitamin D|vitamin d
284986|NCT01731340|Micronutrients|micronutrients
284987|NCT01731340|Primary Prevention|primary prevention
284988|NCT01731340|Bone Health|bone health
284989|NCT01731327|Phase 1|phase 1
284990|NCT01731327|relative bioavailability|relative bioavailability
284991|NCT01731327|modified release|modified release
284992|NCT01731327|tofacitinib|tofacitinib
284993|NCT01731327|CP-690|cp-690
284994|NCT01731327|550|550
284995|NCT01731327|pharmacokinetic|pharmacokinetic
284996|NCT01731301|Chronic hepatitis C|chronic hepatitis c
284997|NCT01731301|HCV|hcv
284998|NCT01731301|End stage renal disease|end stage renal disease
284999|NCT01731301|ESRD|esrd
285000|NCT01731301|Boceprevir|boceprevir
285001|NCT01731301|Ribavirin|ribavirin
285002|NCT01731301|Peg-interferon|peg-interferon
285003|NCT01731301|Triple therapy|triple therapy
285004|NCT01731288|pregnancy|pregnancy
285005|NCT01731288|childbirth|childbirth
285006|NCT01731288|pain|pain
285007|NCT01731288|vulvodynia|vulvodynia
285008|NCT01731288|provoked vestibulodynia|provoked vestibulodynia
285009|NCT01731275|Healthy volunteers|healthy volunteers
285010|NCT01731275|immunogenicity|immunogenicity
285011|NCT01731275|anti-E6011 antibody|anti-e6011 antibody
285012|NCT01731262|Arthritis, Rheumatoid|arthritis, rheumatoid
285013|NCT01731262|Sonic hedgehog protein, human|sonic hedgehog protein, human
285014|NCT01731262|Neovascularization, Pathologic|neovascularization, pathologic
285015|NCT01731262|Synovitis|synovitis
285016|NCT01731249|Sublingual immunotherapy|sublingual immunotherapy
285017|NCT01731249|Birch pollen extract solution|birch pollen extract solution
285018|NCT01731249|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
285019|NCT01731236|Carnitine metabolism|carnitine metabolism
285020|NCT01731236|gut flora|gut flora
285021|NCT01731223|Insomnia|insomnia
285022|NCT01731223|Primary health care|primary health care
285023|NCT01731197|obesity, isolated soy protein, satiety, food intake|obesity, isolated soy protein, satiety, food intake
285024|NCT01731184|acute traumatic pain, pre-hospital setting, Midazolam|acute traumatic pain, pre-hospital setting, midazolam
285025|NCT01731171|mania|mania
285026|NCT01731171|manic episode|manic episode
285027|NCT01731171|mixed episode|mixed episode
285028|NCT01731171|bipolar disorder|bipolar disorder
285029|NCT01731171|schizoaffective disorder|schizoaffective disorder
285030|NCT01731171|probiotics|probiotics
285031|NCT01731171|probiotic supplement|probiotic supplement
285032|NCT01731171|relapse prevention|relapse prevention
285033|NCT01731171|new mood episode|new mood episode
285034|NCT01731171|re-hospitalization|re-hospitalization
285035|NCT01731145|Tremor|tremor
285036|NCT01731145|SNUMAP|snumap
285037|NCT01731145|accelerometry|accelerometry
285038|NCT01731145|gyroscope|gyroscope
285039|NCT01731145|clinical rating scale|clinical rating scale
285040|NCT01731132|HRQoL|hrqol
285041|NCT01731132|IUD|iud
285042|NCT01731132|Contraception|contraception
285043|NCT01731132|SEC-QoL|sec-qol
285044|NCT01731119|Latuda,lurasidone,antipsychotics,autism, mood, psychosis|latuda,lurasidone,antipsychotics,autism, mood, psychosis
285045|NCT01731093|aged|aged
285046|NCT01731093|health|health
285047|NCT01731093|brain|brain
285048|NCT01731054|lupus nephritis|lupus nephritis
285049|NCT01731054|normal healthy volunteer|normal healthy volunteer
285050|NCT01731054|MRI|mri
285051|NCT01731041|coronary disease, platelet function, platelet inhibitors|coronary disease, platelet function, platelet inhibitors
285052|NCT01731002|Glaucoma|glaucoma
285053|NCT01730989|menopause|menopause
285054|NCT01730989|Kupperman|kupperman
285055|NCT01730989|hot flushes|hot flushes
285056|NCT01730989|isoflavones|isoflavones
285057|NCT01730989|magnolia|magnolia
285058|NCT01730989|chaste tree|chaste tree
285059|NCT01730976|asthma, elderly, vitamin D|asthma, elderly, vitamin d
285060|NCT01730924|Atrial fibrillation|atrial fibrillation
285061|NCT01730924|Contact force|contact force
285062|NCT01730924|Ablation|ablation
285063|NCT01730911|Bleeding|bleeding
285064|NCT01730911|Cramping|cramping
285257|NCT01729949|Lipid Panels|lipid panels
285065|NCT01730911|Pregnancy with intrauterine device in place|pregnancy with intrauterine device in place
285066|NCT01730911|Intrauterine device expulsion|intrauterine device expulsion
285067|NCT01730911|Intrauterine device removal|intrauterine device removal
285068|NCT01730859|Balance exercise|balance exercise
285069|NCT01730859|Ankle|ankle
285070|NCT01730859|Postural stability|postural stability
285071|NCT01730859|Taping|taping
285072|NCT01730859|Biodex|biodex
285073|NCT01730846|smoking lapse behavior|smoking lapse behavior
285074|NCT01730846|smoking cessation|smoking cessation
285075|NCT01730846|doxazosin|doxazosin
285076|NCT01730846|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
285077|NCT01730846|medication effect on smoking cessation|medication effect on smoking cessation
285078|NCT01730846|stress|stress
285079|NCT01730807|Atrial Flutter|atrial flutter
285080|NCT01730807|Ablation|ablation
285081|NCT01730807|Type I Atrial Flutter|type i atrial flutter
285082|NCT01730807|Atrial Arrhythmia|atrial arrhythmia
285083|NCT01730794|Acute Respiratory Failure|acute respiratory failure
285084|NCT01730794|Mechanical Ventilation|mechanical ventilation
285085|NCT01730794|NAVA|nava
285086|NCT01730794|Lung protective ventilation|lung protective ventilation
285087|NCT01730794|invasive ventilation|invasive ventilation
285088|NCT01730794|noninvasive ventilation|noninvasive ventilation
285089|NCT01730781|Cannabis dependence|cannabis dependence
285090|NCT01730781|Brain Imaging|brain imaging
285091|NCT01730781|Schizophrenia|schizophrenia
285092|NCT01730768|schizophrenia, chronic stable schizophrenia, cognition, memory, visual learning, CogState|schizophrenia, chronic stable schizophrenia, cognition, memory, visual learning, cogstate
285093|NCT01730755|Polycythemia|polycythemia
285193|NCT01730261|Self-regulation|self-regulation
285094|NCT01730716|Human spinal cord derived neural stem cell transplantation|human spinal cord derived neural stem cell transplantation
285095|NCT01730716|ALS|als
285096|NCT01730703|walking|walking
285097|NCT01730703|incentives|incentives
285098|NCT01730703|elderly|elderly
285099|NCT01730690|Bacterial meningitis in adults|bacterial meningitis in adults
285100|NCT01730690|determinants of in-hospital mortality|determinants of in-hospital mortality
285101|NCT01730677|Lapatinib|lapatinib
285102|NCT01730677|Vinorelbine|vinorelbine
285103|NCT01730664|ertapenem|ertapenem
285104|NCT01730664|tuberculosis|tuberculosis
285105|NCT01730664|pharmacokinetics|pharmacokinetics
285106|NCT01730651|cervical cancer with metastatic lymphadenopathies|cervical cancer with metastatic lymphadenopathies
285107|NCT01730638|thyroid,|thyroid,
285108|NCT01730638|endocrine tumour|endocrine tumour
285109|NCT01730638|Nuclear medicine,|nuclear medicine,
285110|NCT01730638|molecular imaging|molecular imaging
285111|NCT01730638|ImmunoTEP|immunotep
285112|NCT01730625|Attention bias modification treatment (ABMT)|attention bias modification treatment (abmt)
285113|NCT01730625|Attention biases|attention biases
285114|NCT01730625|Anxious children|anxious children
285115|NCT01730625|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
285116|NCT01730612|ImmunoTEP|immunotep
285117|NCT01730612|HER2 negative|her2 negative
285118|NCT01730612|Breast Cancer|breast cancer
285119|NCT01730586|Colorectal Cancer|colorectal cancer
285120|NCT01730586|Cancer of Gastrointestinal Tract|cancer of gastrointestinal tract
285121|NCT01730586|CIMP-high Colorectal Adenocarcinoma|cimp-high colorectal adenocarcinoma
285122|NCT01730586|Small Bowel Adenocarcinomas|small bowel adenocarcinomas
285123|NCT01730586|Colorectal|colorectal
285124|NCT01730586|Small bowel cancer|small bowel cancer
285125|NCT01730586|Abraxane|abraxane
285126|NCT01730586|Nab-Paclitaxel|nab-paclitaxel
285127|NCT01730586|Paclitaxel (Protein-Bound)|paclitaxel (protein-bound)
285129|NCT01730573|interscalene|interscalene
285130|NCT01730573|suprascapular|suprascapular
285131|NCT01730573|axillary|axillary
285132|NCT01730547|Mesenchymal stem cells|mesenchymal stem cells
285133|NCT01730547|Multiple Sclerosis|multiple sclerosis
285134|NCT01730547|Autoimmune diseases|autoimmune diseases
285135|NCT01730534|Phase IIIb|phase iiib
285137|NCT01730534|cardiovascular events|cardiovascular events
285138|NCT01730495|Chronic fatigue syndrome|chronic fatigue syndrome
285139|NCT01730495|CFS|cfs
285140|NCT01730495|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
352803|NCT01438944|NRT|nrt
285141|NCT01730495|CFS/ME|cfs/me
285142|NCT01730495|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
285143|NCT01730495|TNF-alpha|tnf-alpha
285144|NCT01730495|Etanercept|etanercept
285145|NCT01730482|excretion|excretion
285146|NCT01730482|healthy volunteer|healthy volunteer
285147|NCT01730482|migalastat hydrochloride|migalastat hydrochloride
285148|NCT01730482|AT1001|at1001
285149|NCT01730482|pharmacokinetics|pharmacokinetics
285150|NCT01730482|Fabry disease|fabry disease
285151|NCT01730469|Pharmacokinetics|pharmacokinetics
285152|NCT01730469|GR181413|gr181413
285153|NCT01730469|Safety|safety
285154|NCT01730469|AT1001|at1001
285155|NCT01730469|Migalastat hydrochloride|migalastat hydrochloride
285156|NCT01730443|traumatic brain injury|traumatic brain injury
285157|NCT01730430|non-AD dementias|non-ad dementias
285158|NCT01730430|healthy elderly controls|healthy elderly controls
285159|NCT01730417|Phase 1|phase 1
285160|NCT01730417|no carrier added metaiodobenzylguanidine|no carrier added metaiodobenzylguanidine
285161|NCT01730417|radiation dosimetry|radiation dosimetry
285162|NCT01730378|Influenza vaccine|influenza vaccine
285163|NCT01730365|spectroscopy|spectroscopy
285165|NCT01730365|biopsy|biopsy
285166|NCT01730365|malignancy|malignancy
285167|NCT01730352|immune thrombocytopenic purpura|immune thrombocytopenic purpura
285168|NCT01730352|chronic immune thrombocytopenic purpura|chronic immune thrombocytopenic purpura
285169|NCT01730352|secondary immune thrombocytopenic purpura|secondary immune thrombocytopenic purpura
285170|NCT01730352|Helicobacter pylori infection|helicobacter pylori infection
285171|NCT01730352|Helicobacter pylori gastritis|helicobacter pylori gastritis
285172|NCT01730352|children|children
285173|NCT01730352|adolescents|adolescents
285174|NCT01730339|Skin scarring|skin scarring
285175|NCT01730339|cicatrix|cicatrix
285176|NCT01730339|breast scar|breast scar
285177|NCT01730339|hypertrophic scar|hypertrophic scar
285178|NCT01730326|Headache|headache
285179|NCT01730326|paracetamol|paracetamol
285180|NCT01730326|dexketoprofen|dexketoprofen
285181|NCT01730326|emergency department|emergency department
285182|NCT01730313|Nodding syndrome|nodding syndrome
285183|NCT01730287|Stepwise Excavation|stepwise excavation
285184|NCT01730287|Pulpal vitality|pulpal vitality
285185|NCT01730287|Deep caries lesions|deep caries lesions
285186|NCT01730287|Clinical symptoms|clinical symptoms
285187|NCT01730287|Radiographic evaluation|radiographic evaluation
285188|NCT01730261|Traumatic Brain Injury|traumatic brain injury
285189|NCT01730261|TBI|tbi
285190|NCT01730261|Executive Dysfunction|executive dysfunction
285191|NCT01730261|Emotional Regulation|emotional regulation
285192|NCT01730261|Problem Solving|problem solving
285194|NCT01730261|Cognitive Rehabilitation|cognitive rehabilitation
285195|NCT01730261|Metacognitive Strategies|metacognitive strategies
285196|NCT01730261|Cognitive-behavioral therapy|cognitive-behavioral therapy
285197|NCT01730261|Online Therapy|online therapy
285198|NCT01730261|Group therapy|group therapy
285199|NCT01730261|Group videoconference|group videoconference
285200|NCT01730261|Telehealth|telehealth
285201|NCT01730261|Telerehabilitation|telerehabilitation
285207|NCT01730248|Post-polycythemia vera myelofibrosis,|post-polycythemia vera myelofibrosis,
285208|NCT01730248|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
285213|NCT01730209|Tuberous Sclerosis Complex|tuberous sclerosis complex
285214|NCT01730209|TSC|tsc
285215|NCT01730209|Autism|autism
285216|NCT01730209|Learning problems|learning problems
285217|NCT01730209|Everolimus|everolimus
285219|NCT01730209|Treatment|treatment
285220|NCT01730209|Cognition|cognition
285221|NCT01730209|Intellectual disability|intellectual disability
285222|NCT01730170|Epilepsy|epilepsy
285223|NCT01730170|Pregnancy|pregnancy
285224|NCT01730144|Nasal Spray Vaccine|nasal spray vaccine
285225|NCT01730144|Nasal Cells|nasal cells
285226|NCT01730131|Immune Reconstitution Syndrome|immune reconstitution syndrome
285227|NCT01730131|Human Immunodeficiency Virus|human immunodeficiency virus
285228|NCT01730131|Multiple Sclerosis|multiple sclerosis
285229|NCT01730118|Metastatic Solid Tumors|metastatic solid tumors
284872|NCT01731951|GRN163L|grn163l
753198|NCT01175824|Insulin|insulin
285230|NCT01730118|Human Epidermal Growth Factor Receptor 2 Expression (HER2/neu)|human epidermal growth factor receptor 2 expression (her2/neu)
285231|NCT01730118|Trastuzumab Exposure|trastuzumab exposure
285232|NCT01730118|Dendritic Cell Vaccine|dendritic cell vaccine
285233|NCT01730118|Breast Cancer|breast cancer
285234|NCT01730105|Adaptive Thermogenesis|adaptive thermogenesis
285235|NCT01730105|Adipose Tissue|adipose tissue
285236|NCT01730105|Body Composition|body composition
285237|NCT01730105|Body Weight Regulation|body weight regulation
285238|NCT01730105|Brown Adipose Tissue|brown adipose tissue
285239|NCT01730092|Vascular Inflammation|vascular inflammation
285240|NCT01730092|Microarray|microarray
285241|NCT01730092|Right Ventricular Function|right ventricular function
285242|NCT01730092|Endothelial Dysfunction|endothelial dysfunction
285243|NCT01730092|Magnetic Resonance Imaging|magnetic resonance imaging
285244|NCT01730079|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
285245|NCT01730079|Autism|autism
285246|NCT01730079|Near Infrared Spectroscopy|near infrared spectroscopy
285247|NCT01730079|Brain Activity|brain activity
285248|NCT01730066|Probiotics|probiotics
285249|NCT01730066|Pathogenic enteric bacteria|pathogenic enteric bacteria
285250|NCT01730066|Oropharyngeal flora|oropharyngeal flora
285251|NCT01730066|CRP|crp
285252|NCT01730066|WBC|wbc
285253|NCT01729949|Nutrition|nutrition
285254|NCT01729949|Polyphenols|polyphenols
285255|NCT01729949|Berries|berries
285256|NCT01729949|Overweight|overweight
285258|NCT01729936|Sitting time|sitting time
285259|NCT01729936|Overweight|overweight
285260|NCT01729936|Obese|obese
285261|NCT01729936|Primary Health Care|primary health care
285262|NCT01729910|overweight|overweight
285263|NCT01729910|obesity|obesity
285264|NCT01729910|rural|rural
285265|NCT01729910|primary care|primary care
285266|NCT01729897|gastroscopy|gastroscopy
285267|NCT01729897|sedation|sedation
285268|NCT01729897|etomidate|etomidate
285269|NCT01729871|Atrial Fibrillation|atrial fibrillation
285270|NCT01729871|Irregular heart beat|irregular heart beat
285271|NCT01729871|Catheter Ablation|catheter ablation
285272|NCT01729871|Rivaroxaban|rivaroxaban
285273|NCT01729793|TNFalpha|tnfalpha
285275|NCT01729793|postprandial|postprandial
285276|NCT01729793|digestive|digestive
285277|NCT01729793|inflammation|inflammation
285278|NCT01729793|IL1beta|il1beta
285279|NCT01729793|CRP|crp
285280|NCT01729793|CBC|cbc
285281|NCT01729793|ESR|esr
285282|NCT01729780|EEG-NF|eeg-nf
285283|NCT01729780|Neurofeedback|neurofeedback
285284|NCT01729780|Prevention|prevention
285285|NCT01729780|ACS|acs
285286|NCT01729741|Drain or no drain|drain or no drain
285287|NCT01729741|Thyroid surgery|thyroid surgery
285288|NCT01729741|Randomized Trial|randomized trial
285289|NCT01729728|Tonsillectomy|tonsillectomy
285290|NCT01729728|Dental surgery|dental surgery
285291|NCT01729728|Ear surgery|ear surgery
285292|NCT01729728|Nose surgery|nose surgery
285293|NCT01729728|Throat surgery|throat surgery
285294|NCT01729715|Pediatric|pediatric
285295|NCT01729715|Insomnia|insomnia
285296|NCT01729702|1- Hypertrophic cardiomyopathy|1- hypertrophic cardiomyopathy
285297|NCT01729702|2- BNP|2- bnp
285298|NCT01729702|3- NT-proBNP|3- nt-probnp
285299|NCT01729702|4- Neurohormons|4- neurohormons
285300|NCT01729663|melanoma|melanoma
285301|NCT01729663|irradiated-allogeneic cells|irradiated-allogeneic cells
285302|NCT01729663|therapeutic vaccine|therapeutic vaccine
285303|NCT01729663|Interferon alpha 2-b|interferon alpha 2-b
285304|NCT01729650|Psychotic Disorders,|psychotic disorders,
285305|NCT01729650|Heart Diseases|heart diseases
285510|NCT01728961|nevirapine|nevirapine
285306|NCT01729637|Lung Transplantation|lung transplantation
285307|NCT01729637|Respiratory Mechanics|respiratory mechanics
285308|NCT01729637|Isolated lung perfusion|isolated lung perfusion
285309|NCT01729637|Ex-vivo lung perfusion|ex-vivo lung perfusion
285310|NCT01729637|Lung mechanics|lung mechanics
285311|NCT01729624|Wegener Granulomatosis|wegener granulomatosis
285312|NCT01729624|Microscopic Polyangiitis|microscopic polyangiitis
285313|NCT01729624|Churg-Strauss Syndrome|churg-strauss syndrome
285314|NCT01729624|Antibodies, Antineutrophil Cytoplasmic|antibodies, antineutrophil cytoplasmic
285315|NCT01729611|Scleroderma|scleroderma
285316|NCT01729611|Cirrhosis|cirrhosis
285317|NCT01729598|cognitively normal elderly population|cognitively normal elderly population
285318|NCT01729598|safety and tolerability|safety and tolerability
285319|NCT01729585|cystic fibrosis|cystic fibrosis
285320|NCT01729585|quality of life|quality of life
285321|NCT01729572|schizophrenia|schizophrenia
285322|NCT01729572|Schizoaffective Disorder|schizoaffective disorder
285323|NCT01729572|disease management|disease management
285324|NCT01729572|treatment|treatment
285325|NCT01729572|rehabilitation|rehabilitation
285326|NCT01729572|pharmacotherapy|pharmacotherapy
285327|NCT01729559|venous thromboembolic disease|venous thromboembolic disease
285328|NCT01729559|deep vein thrombosis|deep vein thrombosis
285329|NCT01729559|pulmonary embolism|pulmonary embolism
285331|NCT01729559|antithrombotic prophylaxis|antithrombotic prophylaxis
285332|NCT01729546|SMBG (self-monitoring of blood glucose)|smbg (self-monitoring of blood glucose)
285333|NCT01729546|POCT|poct
285335|NCT01729533|ICSI|icsi
285336|NCT01729533|IMSI|imsi
285337|NCT01729533|Pregnancy|pregnancy
285338|NCT01729533|Sperm morphology|sperm morphology
285339|NCT01729533|Unexplained infertility|unexplained infertility
285340|NCT01729520|Total knee arthroplasty|total knee arthroplasty
285341|NCT01729520|Total knee replacement|total knee replacement
285342|NCT01729520|Strength training|strength training
285343|NCT01729520|Resistance training|resistance training
285344|NCT01729520|Physical therapy modalities|physical therapy modalities
285345|NCT01729520|Fatigue|fatigue
285346|NCT01729507|Smoking cessation|smoking cessation
285347|NCT01729507|Add on and smoking cessation|add on and smoking cessation
402988|NCT01228734|First line treatment|first line treatment
285348|NCT01729507|Therapy for tobacco dependence|therapy for tobacco dependence
285349|NCT01729507|Transcranial direct current stimulation|transcranial direct current stimulation
285350|NCT01729494|belatacept|belatacept
285351|NCT01729494|rabbit antithymocyte globulin|rabbit antithymocyte globulin
285352|NCT01729494|alemtuzumab|alemtuzumab
285353|NCT01729494|corticosteroid withdrawal|corticosteroid withdrawal
285354|NCT01729468|Low Dose Acetylsalicylic Acid|low dose acetylsalicylic acid
285355|NCT01729468|Prevention|prevention
285356|NCT01729468|Pre-eclampsia|pre-eclampsia
285357|NCT01729468|Intra-uterine Growth Restriction|intra-uterine growth restriction
285358|NCT01729468|Primiparous Women|primiparous women
285359|NCT01729468|Bilateral Uterine Artery Notches|bilateral uterine artery notches
285360|NCT01729468|First Quarter|first quarter
285361|NCT01729455|Belimumab|belimumab
285362|NCT01729455|Connective Tissue Diseases|connective tissue diseases
285363|NCT01729455|Lupus|lupus
285364|NCT01729455|Additional relevant MeSH terms:|additional relevant mesh terms:
285365|NCT01729455|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
285366|NCT01729455|Autoimmune Diseases|autoimmune diseases
285367|NCT01729455|SLE|sle
285368|NCT01729455|Systemic Lupus Erythematosus|systemic lupus erythematosus
285369|NCT01729455|Autoimmune Disease|autoimmune disease
285370|NCT01729455|Antibodies|antibodies
285371|NCT01729455|Immune System Diseases|immune system diseases
285372|NCT01729429|Papillomavirus Vaccines|papillomavirus vaccines
285373|NCT01729429|Intervention Studies|intervention studies
285374|NCT01729429|Health Services Research|health services research
285375|NCT01729429|Cancer of Cervix|cancer of cervix
285376|NCT01729416|colon|colon
285377|NCT01729416|cancer|cancer
285378|NCT01729416|screening|screening
285379|NCT01729416|water exchange|water exchange
285380|NCT01729416|air|air
285381|NCT01729416|method|method
285382|NCT01729416|polyp|polyp
285383|NCT01729416|adenoma|adenoma
285384|NCT01729416|detection|detection
285385|NCT01729416|rate|rate
285386|NCT01729416|sedation|sedation
285387|NCT01729416|time|time
285388|NCT01729416|procedure|procedure
285389|NCT01729390|Feeding behavior|feeding behavior
285390|NCT01729364|elective CABG|elective cabg
285391|NCT01729364|renal impairment|renal impairment
285392|NCT01729364|GFR|gfr
285393|NCT01729364|renal blood flow|renal blood flow
285394|NCT01729364|colloid|colloid
285395|NCT01729364|crystalloid|crystalloid
285396|NCT01729364|thermodilution technique|thermodilution technique
285397|NCT01729364|oxygen supply demand|oxygen supply demand
285398|NCT01729351|Primary Care|primary care
285399|NCT01729351|Particle size|particle size
285400|NCT01729351|beclomethasone dipropionate|beclomethasone dipropionate
285401|NCT01729351|Asthma Management|asthma management
285402|NCT01729351|Maintenance Therapy|maintenance therapy
285403|NCT01729351|Metered-Dose Inhaler|metered-dose inhaler
285405|NCT01729325|Post-traumatic Stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
285406|NCT01729325|Aggressive Behavior|aggressive behavior
285407|NCT01729325|Appetitive Aggression|appetitive aggression
285408|NCT01729325|Resilience|resilience
285409|NCT01729325|Preventive Narrative Exposure Therapy|preventive narrative exposure therapy
285410|NCT01729299|ghrelin|ghrelin
285411|NCT01729299|glucose control|glucose control
285412|NCT01729299|GLP-1|glp-1
285413|NCT01729299|Exendin (9-39)|exendin (9-39)
285414|NCT01729299|insulin|insulin
285415|NCT01729260|Glioblastoma|glioblastoma
285416|NCT01729260|mebendazole|mebendazole
285417|NCT01729260|temozolomide|temozolomide
285418|NCT01729247|Asthma|asthma
285419|NCT01729234|age related Endothelial Dysfunction|age related endothelial dysfunction
285420|NCT01729221|Hepatocellular carcinoma|hepatocellular carcinoma
285421|NCT01729221|Hepatitis C virus|hepatitis c virus
285422|NCT01729208|myopia progression|myopia progression
285423|NCT01729208|myopia control|myopia control
285424|NCT01729195|bioabsorbable implant|bioabsorbable implant
285425|NCT01729195|bone screw|bone screw
285426|NCT01729195|local antibiotic prophylaxis|local antibiotic prophylaxis
285427|NCT01729195|syndesmosis injury|syndesmosis injury
285428|NCT01729195|ankle fracture|ankle fracture
285429|NCT01729195|ciprofloxacin|ciprofloxacin
285430|NCT01729182|Low dose Aspirin(LDA)|low dose aspirin(lda)
285431|NCT01729182|Gastric ulcer or duodenal ulcer|gastric ulcer or duodenal ulcer
285432|NCT01729182|Nexium|nexium
285433|NCT01729169|Sarcoidosis|sarcoidosis
285434|NCT01729169|Cardiac sarcoidosis|cardiac sarcoidosis
285435|NCT01729169|18-FDG PET|18-fdg pet
285436|NCT01729169|68Ga-DOTANOC PET|68ga-dotanoc pet
285437|NCT01729156|Type 2 diabetes|type 2 diabetes
285438|NCT01729156|Hepatic fatty acid oxidation|hepatic fatty acid oxidation
285439|NCT01729156|Dyslipidemia|dyslipidemia
285440|NCT01729156|Metformin|metformin
285441|NCT01729143|black pepper|black pepper
285442|NCT01729143|metabolic chamber|metabolic chamber
285443|NCT01729143|respiratory chamber|respiratory chamber
285444|NCT01729117|Type 2 diabetes|type 2 diabetes
285445|NCT01729117|Obesity|obesity
285446|NCT01729117|Insulin|insulin
285447|NCT01729117|Hispanic|hispanic
353185|NCT01437475|HBV|hbv
285448|NCT01729117|Low-income|low-income
285449|NCT01729117|Meal replacement|meal replacement
285450|NCT01729104|Lymphoma|lymphoma
285451|NCT01729104|Mantle cell lymphoma|mantle cell lymphoma
285453|NCT01729104|Relapsed|relapsed
285454|NCT01729104|Refractory|refractory
285455|NCT01729104|Carfilzomib|carfilzomib
285456|NCT01729104|Rituximab|rituximab
285457|NCT01729104|Rituxan|rituxan
285458|NCT01729104|Lenalidomide|lenalidomide
285459|NCT01729104|CC-5013|cc-5013
285460|NCT01729104|Revlimid|revlimid
285461|NCT01729091|Myeloma|myeloma
285462|NCT01729091|Multiple myeloma|multiple myeloma
285463|NCT01729091|MM|mm
285464|NCT01729091|Umbilical cord blood|umbilical cord blood
285465|NCT01729091|UCB|ucb
285466|NCT01729091|Natural killer cells|natural killer cells
285467|NCT01729091|NK|nk
285468|NCT01729091|Autologous stem cell transplant|autologous stem cell transplant
285469|NCT01729091|Stem cell infusion|stem cell infusion
285470|NCT01729091|High dose chemotherapy|high dose chemotherapy
285471|NCT01729091|Lenalidomide|lenalidomide
285472|NCT01729091|CC-5013|cc-5013
285473|NCT01729091|Revlimid|revlimid
285474|NCT01729091|Melphalan|melphalan
285475|NCT01729091|Alkeran|alkeran
285476|NCT01729091|G-CSF|g-csf
285477|NCT01729091|Filgrastim|filgrastim
285478|NCT01729091|Neupogen|neupogen
285479|NCT01729091|Elotuzumab|elotuzumab
285480|NCT01729091|Dexamethasone|dexamethasone
285481|NCT01729091|Decadron|decadron
285482|NCT01729065|Spinal Accessory Nerve Palsy, Cranial Nerve XI, shoulder weakness, neck stiffness, head and neck cancer, neck dissection|spinal accessory nerve palsy, cranial nerve xi, shoulder weakness, neck stiffness, head and neck cancer, neck dissection
285483|NCT01729052|Acupuncture|acupuncture
285484|NCT01729052|Children|children
285485|NCT01729052|Postoperative nausea and vomiting|postoperative nausea and vomiting
285486|NCT01729052|Postoperative pain|postoperative pain
285487|NCT01729052|Parental attitudes|parental attitudes
285488|NCT01729052|Parental expectations|parental expectations
285489|NCT01729039|rehabilitation|rehabilitation
285490|NCT01729039|aged|aged
285491|NCT01729039|aged, 80 and over|aged, 80 and over
285492|NCT01729039|vestibular diseases|vestibular diseases
285493|NCT01729026|Veterans|veterans
285494|NCT01729026|Posttraumatic Stress Disorder|posttraumatic stress disorder
285495|NCT01729026|dog adoption|dog adoption
285496|NCT01729026|companion animal|companion animal
285497|NCT01729013|vitamin D|vitamin d
285498|NCT01729013|fat|fat
285499|NCT01729013|biopsy|biopsy
285500|NCT01729000|prematurity|prematurity
285501|NCT01729000|infection control|infection control
285502|NCT01729000|necrotizing entercolitis|necrotizing entercolitis
285503|NCT01728974|Obstructive Sleep Apnea|obstructive sleep apnea
285505|NCT01728961|HIV 1|hiv 1
285506|NCT01728961|NVP|nvp
285507|NCT01728961|malaria|malaria
285508|NCT01728961|Children|children
285509|NCT01728961|Youth|youth
285511|NCT01728961|Coartem Dispersible|coartem dispersible
285512|NCT01728961|Artemether|artemether
285513|NCT01728961|Lumefantrine|lumefantrine
285514|NCT01728961|Pharmacokinetics|pharmacokinetics
285515|NCT01728948|Sorafenib|sorafenib
285516|NCT01728948|renal cell carcinoma(RCC)|renal cell carcinoma(rcc)
285517|NCT01728948|elderly|elderly
285518|NCT01728948|effectiveness|effectiveness
285519|NCT01728948|safety|safety
285520|NCT01728935|HBV|hbv
285521|NCT01728935|Tenofovir|tenofovir
285522|NCT01728935|HBV DNA|hbv dna
285523|NCT01728935|HBsAg|hbsag
285524|NCT01728935|Resistance|resistance
285525|NCT01728922|Clinically isolated syndrome|clinically isolated syndrome
285526|NCT01728922|Multiple sclerosis|multiple sclerosis
285527|NCT01728922|Vitamin D|vitamin d
285528|NCT01728922|Immune response|immune response
285529|NCT01728922|CD4 T cell subsets|cd4 t cell subsets
285530|NCT01728922|Cytokine|cytokine
285531|NCT01728909|Oxytocin|oxytocin
285532|NCT01728909|Syntocinon|syntocinon
285533|NCT01728909|Social Cognition|social cognition
285534|NCT01728909|Social Approach Behaviors|social approach behaviors
285535|NCT01728896|Acute pancreatitis, nutrition|acute pancreatitis, nutrition
285536|NCT01728883|Diabetic Retinopathy|diabetic retinopathy
285537|NCT01728883|Diabetic Macular Edema|diabetic macular edema
285538|NCT01728883|Macular Edema|macular edema
285539|NCT01728883|Maculopathy|maculopathy
285164|NCT01730365|tumour|tumour
285540|NCT01728883|home monitoring|home monitoring
285541|NCT01728883|shape discrimination hyperacuity|shape discrimination hyperacuity
285542|NCT01728883|Psychophysical Testing|psychophysical testing
285543|NCT01728870|Pediatric|pediatric
285544|NCT01728870|Crohn's disease|crohn's disease
285545|NCT01728870|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
285546|NCT01728870|Diet|diet
285547|NCT01728870|Enteral Nutrition|enteral nutrition
285548|NCT01728857|Lipolysis|lipolysis
285549|NCT01728857|Cryolipolysis|cryolipolysis
285550|NCT01728857|Fat Reduction|fat reduction
285551|NCT01728831|Red Cell Transfusion|red cell transfusion
353305|NCT01436877|BPH|bph
285552|NCT01728831|Cerebral tissue oxygenation|cerebral tissue oxygenation
285553|NCT01728831|Traumatic brain injury|traumatic brain injury
285554|NCT01728805|Cutaneous T-Cell Lymphoma (CTCL)|cutaneous t-cell lymphoma (ctcl)
285555|NCT01728805|myocis fungoides (MF)|myocis fungoides (mf)
285556|NCT01728805|Sezary Syndrome (SS)|sezary syndrome (ss)
285557|NCT01728792|Prophylactic vaccination|prophylactic vaccination
285558|NCT01728766|Breast milk zinc transfer|breast milk zinc transfer
285559|NCT01728766|Bangladeshi infants|bangladeshi infants
285560|NCT01728766|appropriate-for-gestational-age|appropriate-for-gestational-age
285561|NCT01728766|small-for-gestational-age|small-for-gestational-age
285562|NCT01728766|plasma zinc|plasma zinc
285563|NCT01728740|Bioequivalence|bioequivalence
285564|NCT01728740|Acarbose|acarbose
285567|NCT01728727|liver cirrhosis|liver cirrhosis
285568|NCT01728727|end stage liver disease|end stage liver disease
285569|NCT01728727|umbilical cord|umbilical cord
285570|NCT01728727|mesenchymal stem cells|mesenchymal stem cells
285573|NCT01728701|Malaria|malaria
285574|NCT01728701|Plasmodium falciparum|plasmodium falciparum
285575|NCT01728701|PfSPZ Challenge|pfspz challenge
285576|NCT01728701|Chemoprophylaxis|chemoprophylaxis
285577|NCT01728701|PfSPZ-CVac|pfspz-cvac
285578|NCT01728688|liver cirrhosis|liver cirrhosis
285579|NCT01728688|stem cell|stem cell
285580|NCT01728688|peripheral blood|peripheral blood
285581|NCT01728688|autologous|autologous
285582|NCT01728688|HBV|hbv
285583|NCT01728688|end stage liver disease|end stage liver disease
285584|NCT01728675|Aging|aging
285585|NCT01728675|Skeletal muscle|skeletal muscle
285586|NCT01728675|Biomarkers|biomarkers
285587|NCT01728675|Adaptation|adaptation
285588|NCT01728662|emphysema|emphysema
285589|NCT01728662|lung volume reduction therapy|lung volume reduction therapy
285590|NCT01728649|Acute Ischemic Stroke|acute ischemic stroke
285591|NCT01728649|Mild Hypothermia|mild hypothermia
285592|NCT01728649|Stroke|stroke
285593|NCT01728649|Hypothermia|hypothermia
285594|NCT01728623|Thyroid cancer|thyroid cancer
285595|NCT01728610|irritable bowel syndrome|irritable bowel syndrome
285596|NCT01728610|probiotic|probiotic
285597|NCT01728610|pain|pain
285598|NCT01728610|bloating|bloating
285599|NCT01728610|diarrhoea|diarrhoea
285600|NCT01728610|constipation|constipation
285601|NCT01728597|no history of cardiovascular diseases|no history of cardiovascular diseases
285602|NCT01728571|COPD|copd
285603|NCT01728571|asthma|asthma
285604|NCT01728571|pulmonary function|pulmonary function
285605|NCT01728571|pneumonia|pneumonia
285606|NCT01728558|Sedation|sedation
285607|NCT01728558|Delirium|delirium
285608|NCT01728558|Goal Directed|goal directed
285609|NCT01728558|Dexmedetomidine|dexmedetomidine
285610|NCT01728558|Mortality|mortality
285611|NCT01728558|Mechanical ventilation|mechanical ventilation
285612|NCT01728558|Intensive care|intensive care
285613|NCT01728558|Critically Ill|critically ill
285614|NCT01728545|Cord blood registry|cord blood registry
285615|NCT01728545|Umbilical Cord Blood|umbilical cord blood
285616|NCT01728545|fetal blood|fetal blood
285617|NCT01728545|placenta|placenta
285618|NCT01728545|Placental Blood Stem Cell Transplantation|placental blood stem cell transplantation
285619|NCT01728545|hematopoietic progenitor cells|hematopoietic progenitor cells
285620|NCT01728545|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
285621|NCT01728545|cord blood unit total nucleated cell|cord blood unit total nucleated cell
285622|NCT01728545|TNC|tnc
285623|NCT01728545|CD34-positive(+) cell|cd34-positive(+) cell
285624|NCT01728545|human leukocyte antigen|human leukocyte antigen
285625|NCT01728545|HLA|hla
285626|NCT01728545|allogeneic transplantation|allogeneic transplantation
285627|NCT01728519|Allergy|allergy
285628|NCT01728519|Birch Pollen|birch pollen
285629|NCT01728519|Immunotherapy|immunotherapy
285630|NCT01728506|breast cancer survivor|breast cancer survivor
285631|NCT01728506|Weight loss|weight loss
285632|NCT01728506|Exercise|exercise
285633|NCT01728493|Prevalence|prevalence
285634|NCT01728493|Primary aldosteronism|primary aldosteronism
285635|NCT01728493|Organ damage|organ damage
285636|NCT01728493|Mineralocorticoid receptor antagonists|mineralocorticoid receptor antagonists
285637|NCT01728441|PAD|pad
285638|NCT01728441|stenting|stenting
285639|NCT01728441|angioplasty|angioplasty
285640|NCT01728428|hemifacial spasm|hemifacial spasm
285641|NCT01728428|observational study|observational study
285642|NCT01728428|clinical manifestation|clinical manifestation
285643|NCT01728428|treatment|treatment
285644|NCT01728428|Chinese|chinese
285645|NCT01728415|Exercise|exercise
285646|NCT01728415|Hemodialysis|hemodialysis
285647|NCT01728415|Physical therapy|physical therapy
285648|NCT01728415|high-intensity|high-intensity
285649|NCT01728389|allogenic stem cell transplantation|allogenic stem cell transplantation
285650|NCT01728389|peripheral blood stem cells|peripheral blood stem cells
285651|NCT01728389|intrabone|intrabone
285652|NCT01728389|intra-bone|intra-bone
285653|NCT01728389|leukemia|leukemia
285654|NCT01728389|lymphoma|lymphoma
285655|NCT01728363|Staphylococcal|staphylococcal
285656|NCT01728350|traumatic brain injury|traumatic brain injury
285657|NCT01728350|volunteering|volunteering
285658|NCT01728350|well being|well being
285659|NCT01728350|cortisol|cortisol
285660|NCT01728337|botulinum toxin,|botulinum toxin,
285661|NCT01728337|wrinkles|wrinkles
285662|NCT01728298|House Dust Mite|house dust mite
285663|NCT01728298|allergy|allergy
285664|NCT01728298|rhinitis|rhinitis
285665|NCT01728298|asthma|asthma
285666|NCT01728285|specific allergen immunotherapy|specific allergen immunotherapy
285667|NCT01728285|sublingual immunotherapy|sublingual immunotherapy
285668|NCT01728285|allergen tablets|allergen tablets
285669|NCT01728285|compliance|compliance
286182|NCT01726062|Children|children
285674|NCT01728246|Tramadol|tramadol
285675|NCT01728246|Paracetamol|paracetamol
285676|NCT01728233|Molecular Targeted Therapy|molecular targeted therapy
285677|NCT01728233|Neoadjuvant therapy|neoadjuvant therapy
285678|NCT01728233|Dacomitinib|dacomitinib
285679|NCT01728220|Inhaled nitric oxide (iNO)|inhaled nitric oxide (ino)
285680|NCT01728220|Pulmonary hypertension (PH)|pulmonary hypertension (ph)
285681|NCT01728220|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
285682|NCT01728220|Long term oxygen therapy (LTOT)|long term oxygen therapy (ltot)
285683|NCT01728207|NHL|nhl
285684|NCT01728207|CLL|cll
285685|NCT01728207|follicular lymphoma|follicular lymphoma
285686|NCT01728207|mantle cell lymphoma|mantle cell lymphoma
285687|NCT01728207|marginal zone lymphoma|marginal zone lymphoma
285688|NCT01728207|chronic lymphocytic leukemia|chronic lymphocytic leukemia
285689|NCT01728207|small lymphocytic lymphoma|small lymphocytic lymphoma
285690|NCT01728194|Depression|depression
285691|NCT01728194|Depressive Disorder|depressive disorder
285692|NCT01728194|Behavioral Symptoms|behavioral symptoms
285693|NCT01728194|Mood Disorders|mood disorders
285694|NCT01728194|Mental Disorders|mental disorders
285695|NCT01728194|Escitalopram|escitalopram
285696|NCT01728194|Central Nervous System Agents|central nervous system agents
285697|NCT01728194|Therapeutic Uses|therapeutic uses
285698|NCT01728194|Pharmacologic Actions|pharmacologic actions
285699|NCT01728194|Physiological Effects of Drugs|physiological effects of drugs
285700|NCT01728194|Muscarinic Antagonists|muscarinic antagonists
285701|NCT01728194|Antidepressive Agents|antidepressive agents
285702|NCT01728194|Psychotropic Drugs|psychotropic drugs
285703|NCT01728194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
285704|NCT01728194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors
285705|NCT01728194|Serotonin Agents|serotonin agents
285706|NCT01728194|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
285707|NCT01728194|fMRI|fmri
285708|NCT01728194|Magnetic Resonance Imaging|magnetic resonance imaging
285709|NCT01728168|lupin|lupin
285710|NCT01728168|peanut|peanut
285711|NCT01728168|soy|soy
285712|NCT01728168|pea|pea
285713|NCT01728168|legumes|legumes
285714|NCT01728168|cross-reactivity|cross-reactivity
285715|NCT01728168|sensitization|sensitization
285716|NCT01728168|atopy|atopy
285822|NCT01727700|Tics|tics
285927|NCT01727193|leflunomide|leflunomide
285717|NCT01728155|NEUROBLASTOMA, LOW RISK, INTERMEDIATE RISK|neuroblastoma, low risk, intermediate risk
285718|NCT01728142|DANA|dana
285719|NCT01728142|ANAM|anam
285720|NCT01728142|Concussion|concussion
285721|NCT01728142|mild traumatic brain injury|mild traumatic brain injury
285722|NCT01728129|Concussion|concussion
285723|NCT01728129|Mild traumatic brain injury|mild traumatic brain injury
285724|NCT01728129|DANA|dana
285725|NCT01728129|MACE|mace
285726|NCT01728116|glycemic control, type 2 diabetes, device, obese|glycemic control, type 2 diabetes, device, obese
285727|NCT01728090|handwashing|handwashing
285728|NCT01728090|hand sanitizer|hand sanitizer
285729|NCT01728090|absenteeism|absenteeism
285730|NCT01728090|school age children|school age children
285731|NCT01728090|preschool children|preschool children
285732|NCT01728077|Brivaracetam|brivaracetam
285733|NCT01728077|Long-term Follow-up|long-term follow-up
285734|NCT01728077|Epilepsy|epilepsy
285735|NCT01728077|Partial Onset Seizures|partial onset seizures
285736|NCT01728077|Adjunctive treatment|adjunctive treatment
285737|NCT01728064|Friedreich's|friedreich's
285738|NCT01728064|Ataxia|ataxia
285739|NCT01728064|FRDA|frda
285740|NCT01728064|FA|fa
285741|NCT01728064|EPI-743|epi-743
285742|NCT01728064|Edison|edison
285748|NCT01728025|Long QT syndrome|long qt syndrome
285749|NCT01728025|Ranolazine|ranolazine
285750|NCT01728012|Successful transplantation|successful transplantation
285751|NCT01728012|Long-term observation|long-term observation
285752|NCT01727999|TPO response|tpo response
285753|NCT01727999|ITP|itp
285754|NCT01727999|immune thrombocytopenia|immune thrombocytopenia
285755|NCT01727973|Graves' orbitopathy|graves' orbitopathy
285756|NCT01727973|Graves´ ophthalmopathy|graves´ ophthalmopathy
285757|NCT01727973|Thyroid eye disease|thyroid eye disease
285758|NCT01727973|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
285759|NCT01727973|Doxycycline|doxycycline
285760|NCT01727973|EUGOGO|eugogo
285761|NCT01727973|CAS|cas
353570|NCT01435785|TCI|tci
285762|NCT01727960|Education|education
285763|NCT01727960|Neck pain|neck pain
285764|NCT01727960|Shoulder pain|shoulder pain
285765|NCT01727960|Prevalence|prevalence
285766|NCT01727960|Associated factors|associated factors
285767|NCT01727960|Students|students
285768|NCT01727934|Antisense|antisense
285769|NCT01727934|miR-122 antagonist|mir-122 antagonist
285770|NCT01727934|host factor|host factor
285771|NCT01727934|Chronic hepatitis C|chronic hepatitis c
285772|NCT01727934|Hepatitis C|hepatitis c
285773|NCT01727921|ProCore FNA biopsy|procore fna biopsy
285774|NCT01727908|Familial Gastric Cancer Screening|familial gastric cancer screening
285775|NCT01727895|Betaglucan, immune modulation, immunoparalysis, immune suppression|betaglucan, immune modulation, immunoparalysis, immune suppression
285776|NCT01727882|Paroled offenders|paroled offenders
285777|NCT01727882|Interactive Voice Response|interactive voice response
285778|NCT01727882|Stress|stress
285779|NCT01727882|Mental symptoms|mental symptoms
285780|NCT01727882|Alcohol consumption|alcohol consumption
285781|NCT01727882|Substance use|substance use
285782|NCT01727856|rehabilitation|rehabilitation
285783|NCT01727856|physical therapy|physical therapy
285784|NCT01727856|telemedicine|telemedicine
285785|NCT01727843|fracture|fracture
285786|NCT01727843|hip|hip
285787|NCT01727843|tranexamic acid|tranexamic acid
285788|NCT01727843|topical|topical
285789|NCT01727817|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
285790|NCT01727817|Continuous Glucose Monitor|continuous glucose monitor
285791|NCT01727817|Artificial Pancreas|artificial pancreas
285792|NCT01727817|Insulin Pump|insulin pump
285793|NCT01727817|Closed Loop|closed loop
285794|NCT01727817|Open Loop|open loop
285795|NCT01727817|Diabetes Assistant|diabetes assistant
285796|NCT01727817|DiAs|dias
285797|NCT01727817|Cell Phone|cell phone
285798|NCT01727791|pharmacokinetic|pharmacokinetic
285799|NCT01727791|pregabalin|pregabalin
285800|NCT01727791|lactation|lactation
285801|NCT01727765|Asthma, inspiratory muscle training|asthma, inspiratory muscle training
285802|NCT01727739|Tibial tunnel widening|tibial tunnel widening
285803|NCT01727739|Interference screws|interference screws
285804|NCT01727726|OPC-34712|opc-34712
285805|NCT01727726|brexpiprazole|brexpiprazole
285806|NCT01727726|Major Depressive Disorder|major depressive disorder
285807|NCT01727726|Adjunctive Treatment|adjunctive treatment
285808|NCT01727713|Tourette Syndrome|tourette syndrome
285809|NCT01727713|Basal Ganglia Diseases|basal ganglia diseases
285810|NCT01727713|Brain Diseases|brain diseases
285811|NCT01727713|Central Nervous System Diseases|central nervous system diseases
285812|NCT01727713|Tic Disorders|tic disorders
285813|NCT01727713|Tics|tics
586546|NCT00516672|cancer|cancer
285814|NCT01727713|Movement Disorders|movement disorders
285815|NCT01727713|Mental Disorders|mental disorders
285816|NCT01727713|Aripiprazole|aripiprazole
285817|NCT01727700|Tourette Syndrome|tourette syndrome
285818|NCT01727700|Basal Ganglia Diseases|basal ganglia diseases
285819|NCT01727700|Brain Diseases|brain diseases
285820|NCT01727700|Central Nervous System Diseases|central nervous system diseases
285821|NCT01727700|Tic Disorders|tic disorders
285823|NCT01727700|Movement Disorders|movement disorders
285824|NCT01727700|Mental Disorders|mental disorders
285825|NCT01727700|Aripiprazole|aripiprazole
285826|NCT01727687|To asses the training effects on traffic safety between normal and patients with Parkinson's disease|to asses the training effects on traffic safety between normal and patients with parkinson's disease
285827|NCT01727674|Depression|depression
285828|NCT01727674|experiences of communication|experiences of communication
285829|NCT01727661|diabetes mellitus|diabetes mellitus
285830|NCT01727661|cardiopulmonary fitness|cardiopulmonary fitness
285831|NCT01727661|lung function|lung function
285832|NCT01727661|muscular oxygenation|muscular oxygenation
285833|NCT01727648|Stroke rehabilitation|stroke rehabilitation
285834|NCT01727648|Comparative efficacy research|comparative efficacy research
285835|NCT01727648|Combined therapy|combined therapy
285836|NCT01727648|Robot-Assisted Therapy|robot-assisted therapy
285837|NCT01727648|Constraint-Induced Therapy|constraint-induced therapy
285838|NCT01727648|Kinematic analysis|kinematic analysis
285839|NCT01727635|Breast cancer, survivors, partners, group therapy|breast cancer, survivors, partners, group therapy
285840|NCT01727609|Preterm|preterm
285841|NCT01727609|Very low birth weight|very low birth weight
285842|NCT01727609|Feeding|feeding
285843|NCT01727609|Enteral|enteral
285844|NCT01727609|Milk|milk
285845|NCT01727609|Sepsis|sepsis
285846|NCT01727609|Necrotizing enterocolitis (NEC)|necrotizing enterocolitis (nec)
285847|NCT01727583|Healthy|healthy
285848|NCT01727570|Cancer|cancer
285849|NCT01727570|Colon|colon
285850|NCT01727570|Rectum|rectum
285851|NCT01727570|Surgery|surgery
285852|NCT01727557|Hemodialysis and AV fistula|hemodialysis and av fistula
285853|NCT01727544|superior semicircular canal|superior semicircular canal
285854|NCT01727544|non-vestibular dizziness|non-vestibular dizziness
285855|NCT01727544|vestibular dizziness|vestibular dizziness
285856|NCT01727531|chloroquine|chloroquine
285857|NCT01727531|WBRT|wbrt
285858|NCT01727531|survival|survival
285859|NCT01727531|brain metastasis|brain metastasis
285860|NCT01727531|radiotherapy|radiotherapy
285861|NCT01727531|SNPs|snps
285862|NCT01727531|gene coding|gene coding
285863|NCT01727531|immunoregulatory enzyme IDO2|immunoregulatory enzyme ido2
285864|NCT01727518|natural history|natural history
285865|NCT01727518|lung function|lung function
285866|NCT01727518|general population|general population
285867|NCT01727518|COPD|copd
285868|NCT01727505|hypoxemia|hypoxemia
285869|NCT01727505|desaturation|desaturation
285870|NCT01727505|mechanical ventilation|mechanical ventilation
285871|NCT01727505|preterm infants|preterm infants
285872|NCT01727505|volume guarantee ventilation|volume guarantee ventilation
285873|NCT01727492|prevention|prevention
285874|NCT01727492|noise-induced tinnitus|noise-induced tinnitus
285875|NCT01727492|noise-induced hearing loss|noise-induced hearing loss
285876|NCT01727492|young population|young population
285877|NCT01727479|Peak VO2 consumption|peak vo2 consumption
285878|NCT01727479|3km time trial|3km time trial
285879|NCT01727479|fatigue perception|fatigue perception
285880|NCT01727479|lactate|lactate
285881|NCT01727479|time to complete|time to complete
285882|NCT01727440|severe acne|severe acne
285883|NCT01727440|severe acne vulgaris|severe acne vulgaris
285884|NCT01727440|acne|acne
285885|NCT01727440|acne vulgaris|acne vulgaris
285886|NCT01727440|isotretinoin|isotretinoin
285887|NCT01727440|Accutane|accutane
285888|NCT01727440|Sortret|sortret
285889|NCT01727440|Amnesteem|amnesteem
285890|NCT01727440|Claravis|claravis
285891|NCT01727440|Clarus|clarus
285892|NCT01727440|Decutan|decutan
285893|NCT01727440|Isotane|isotane
285894|NCT01727440|Izotek|izotek
285895|NCT01727440|Oratane|oratane
285896|NCT01727440|Isotret|isotret
285897|NCT01727440|Roaccutane|roaccutane
285898|NCT01727427|Unsuspected|unsuspected
285899|NCT01727427|pulmonary embolism|pulmonary embolism
285900|NCT01727427|cancer|cancer
285901|NCT01727414|ADHD|adhd
285902|NCT01727414|Inattention|inattention
285903|NCT01727414|Methylphenidate|methylphenidate
285904|NCT01727414|Pharmacogenetics|pharmacogenetics
285905|NCT01727401|Fondaparinux|fondaparinux
285906|NCT01727401|medical patient|medical patient
285907|NCT01727401|vein thromboembolism|vein thromboembolism
285908|NCT01727401|prophylaxis|prophylaxis
285909|NCT01727401|thrombocytopenia|thrombocytopenia
285910|NCT01727388|rectal examination|rectal examination
285911|NCT01727388|colorectal cancer|colorectal cancer
285912|NCT01727375|delirium, light, ICU, sleep|delirium, light, icu, sleep
285913|NCT01727362|Breast Cancer|breast cancer
285914|NCT01727362|Acupuncture|acupuncture
285915|NCT01727362|Quality of Life|quality of life
285916|NCT01727258|Tooth Sensitivity|tooth sensitivity
285918|NCT01727232|Rituximab|rituximab
285919|NCT01727232|Efficacy|efficacy
285920|NCT01727232|Anti-CD20|anti-cd20
285921|NCT01727232|Regimen|regimen
285922|NCT01727206|Erdheim-Chester disease|erdheim-chester disease
285923|NCT01727206|Tocilizumab|tocilizumab
285924|NCT01727206|Treatment|treatment
285925|NCT01727206|Phase II|phase ii
285926|NCT01727193|myasthenia gravis|myasthenia gravis
285928|NCT01727167|cardiac disease|cardiac disease
285929|NCT01727167|mitochondrial biogenesis|mitochondrial biogenesis
285930|NCT01727167|carbon monoxide|carbon monoxide
285931|NCT01727141|COPD, QVA149|copd, qva149
285932|NCT01727128|Hepatic impairment|hepatic impairment
285933|NCT01727128|Clinical pharmacology study|clinical pharmacology study
285934|NCT01727128|Volunteer study|volunteer study
285935|NCT01727063|Chronic ischemic heart disease|chronic ischemic heart disease
285936|NCT01727063|Coronary artery disease|coronary artery disease
285937|NCT01727063|Angina pectoris|angina pectoris
285938|NCT01727063|Myocardial ischemia|myocardial ischemia
285939|NCT01727063|Cardiac surgery|cardiac surgery
285940|NCT01727037|Emphysema|emphysema
285941|NCT01727037|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
285942|NCT01727037|COPD|copd
285943|NCT01727037|Bulla|bulla
285944|NCT01727037|Interventional bronchoscopy|interventional bronchoscopy
285945|NCT01727037|Lung volume reduction|lung volume reduction
285946|NCT01727024|Breezhaler|breezhaler
285947|NCT01727024|Respimat|respimat
285948|NCT01727024|Indacaterol|indacaterol
285949|NCT01727024|Tiotropium|tiotropium
285950|NCT01727011|Single fraction|single fraction
285951|NCT01727011|Elderly|elderly
285952|NCT01727011|Breast Irradiation|breast irradiation
285953|NCT01726959|methotrexate|methotrexate
285954|NCT01726946|Chronic Hepatitis C|chronic hepatitis c
285955|NCT01726946|HCV|hcv
285956|NCT01726946|CHC|chc
285961|NCT01726907|submandibular gland|submandibular gland
285962|NCT01726907|robotic|robotic
285963|NCT01726907|endoscopic|endoscopic
285964|NCT01726907|face lift|face lift
285965|NCT01726907|hairline|hairline
285966|NCT01726894|Focal Therapy|focal therapy
285967|NCT01726881|chronic|chronic
353827|NCT01434706|HIV|hiv
285968|NCT01726881|Spinal Cord Injury patients|spinal cord injury patients
285969|NCT01726855|tendon repair|tendon repair
285970|NCT01726829|Type 1 Diabetes|type 1 diabetes
285971|NCT01726829|Artificial Pancreas|artificial pancreas
285972|NCT01726829|Closed Loop|closed loop
285973|NCT01726816|Diabetic nephropathy|diabetic nephropathy
285974|NCT01726816|Albumin creatinine ratio|albumin creatinine ratio
285975|NCT01726816|Probucol|probucol
285976|NCT01726803|Low Back Pain|low back pain
285977|NCT01726803|Primary Care|primary care
285978|NCT01726803|Physical Therapy|physical therapy
285979|NCT01726790|corneal endothelium|corneal endothelium
285980|NCT01726790|Bevacizumab|bevacizumab
285981|NCT01726790|Intravitreal injection|intravitreal injection
285982|NCT01726790|Confoscan|confoscan
285983|NCT01726777|Randomized controlled clinical trial|randomized controlled clinical trial
285984|NCT01726777|Diabetes|diabetes
285985|NCT01726777|Vitamin D|vitamin d
285986|NCT01726777|Oral glucose tolerance|oral glucose tolerance
285987|NCT01726777|Blood glucose|blood glucose
285988|NCT01726777|Insulin resistance|insulin resistance
285989|NCT01726751|Spinal cord stimulation|spinal cord stimulation
285990|NCT01726751|Irritable bowel syndrome|irritable bowel syndrome
285991|NCT01726751|Abdominal pain|abdominal pain
285992|NCT01726751|Diarrhea|diarrhea
285993|NCT01726738|Melanoma|melanoma
285994|NCT01726738|Stage III|stage iii
285995|NCT01726738|Stage IV|stage iv
285996|NCT01726738|Unresectable|unresectable
285997|NCT01726738|BRAF Mutant|braf mutant
285998|NCT01726738|Dabrafenib|dabrafenib
285999|NCT01726738|Trametinib|trametinib
286000|NCT01726738|Kinome|kinome
286001|NCT01726738|Resistance|resistance
286002|NCT01726738|Sequencing|sequencing
286003|NCT01726738|Mutations|mutations
286004|NCT01726738|Kinases|kinases
286005|NCT01726738|Mechanism|mechanism
286006|NCT01726725|hemifacial spasm|hemifacial spasm
286007|NCT01726725|microvascular decompression surgery|microvascular decompression surgery
286008|NCT01726725|desflurane|desflurane
286009|NCT01726712|Patient Care Management|patient care management
286010|NCT01726712|Primary Health Care|primary health care
286012|NCT01726712|Patient Acceptance of Health Care|patient acceptance of health care
286013|NCT01726686|Total Knee Arthroplasty|total knee arthroplasty
286014|NCT01726673|Stroke|stroke
286015|NCT01726673|Cerebrovascular Accident|cerebrovascular accident
286016|NCT01726673|Cerebral Stroke|cerebral stroke
286018|NCT01726673|Robotic therapy|robotic therapy
286019|NCT01726673|Upper extremity recovery|upper extremity recovery
286020|NCT01726673|tDCS|tdcs
286021|NCT01726673|Non-invasive brain stimulation|non-invasive brain stimulation
286022|NCT01726660|Stroke|stroke
286023|NCT01726660|Cerebrovascular Accident|cerebrovascular accident
286024|NCT01726660|Cerebral stroke|cerebral stroke
286026|NCT01726660|robotic therapy|robotic therapy
286027|NCT01726660|upper extremity recovery|upper extremity recovery
286028|NCT01726660|kinematic training|kinematic training
286029|NCT01726647|obese women|obese women
286030|NCT01726647|fat mass distribution|fat mass distribution
286031|NCT01726647|Metabolomic profiles|metabolomic profiles
286032|NCT01726634|upper limb|upper limb
286033|NCT01726634|functional test|functional test
286034|NCT01726634|elastic tape|elastic tape
286035|NCT01726595|critical care|critical care
286036|NCT01726595|severe sepsis|severe sepsis
286037|NCT01726595|microvascular function|microvascular function
286038|NCT01726595|ultrasound|ultrasound
286039|NCT01726582|pancreas|pancreas
286040|NCT01726582|adenocarcinoma|adenocarcinoma
286041|NCT01726582|molecular profile|molecular profile
286042|NCT01726582|molecular profiling|molecular profiling
286043|NCT01726582|pancreatic cancer|pancreatic cancer
286044|NCT01726582|pancreas cancer|pancreas cancer
286045|NCT01726582|cancer|cancer
286046|NCT01726582|molecular target|molecular target
286047|NCT01726582|pancreas head|pancreas head
286048|NCT01726582|pancreas neck|pancreas neck
286049|NCT01726582|pancreas uncinate|pancreas uncinate
286050|NCT01726582|pancreas body|pancreas body
286051|NCT01726582|pancreas tail|pancreas tail
286052|NCT01726569|glaucoma|glaucoma
286053|NCT01726569|educational intervention|educational intervention
286054|NCT01726569|post-operative satisfaction|post-operative satisfaction
286055|NCT01726569|knowledges|knowledges
286056|NCT01726556|Pleural effusion|pleural effusion
285673|NCT01728246|Celecoxib|celecoxib
286057|NCT01726556|Semirigid thoracoscopy|semirigid thoracoscopy
286058|NCT01726556|Rigid thoracoscopy|rigid thoracoscopy
286059|NCT01726543|canaloplasty|canaloplasty
286060|NCT01726543|non-penetrating deep sclerectomy|non-penetrating deep sclerectomy
286061|NCT01726543|glaucoma|glaucoma
286062|NCT01726543|cataract|cataract
286063|NCT01726543|ophthalmology|ophthalmology
286064|NCT01726543|glaucoma surgery|glaucoma surgery
286065|NCT01726530|transdermal fentanyl patch, postoperative pain,|transdermal fentanyl patch, postoperative pain,
286066|NCT01726517|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
286067|NCT01726517|HCV|hcv
276691|NCT01769040|Ascites|ascites
286068|NCT01726517|Sustained Virologic Response|sustained virologic response
286069|NCT01726517|Direct Acting Antiviral|direct acting antiviral
286070|NCT01726517|Combination Therapy|combination therapy
286071|NCT01726517|GS-7977|gs-7977
286072|NCT01726517|GS-5885|gs-5885
286073|NCT01726517|Ribavirin|ribavirin
286074|NCT01726517|Open Label|open label
286075|NCT01726517|Sofosbuvir|sofosbuvir
286076|NCT01726517|Treatment-Naïve|treatment-naïve
286077|NCT01726517|Protease Inhibitors|protease inhibitors
286078|NCT01726517|PI|pi
286183|NCT01726049|HFpEF|hfpef
286079|NCT01726504|chronic functional constipation|chronic functional constipation
286080|NCT01726504|electro-acupuncture|electro-acupuncture
286081|NCT01726504|multi-center randomized controlled trial|multi-center randomized controlled trial
286082|NCT01726504|efficacy|efficacy
286083|NCT01726504|safety|safety
286084|NCT01726491|Insulin resistance|insulin resistance
286085|NCT01726491|Exercise|exercise
286086|NCT01726491|Type 2 diabetes mellitus|type 2 diabetes mellitus
286087|NCT01726491|Obesity|obesity
286088|NCT01726491|Epigenetic studies|epigenetic studies
286089|NCT01726478|Oxytocin|oxytocin
286090|NCT01726478|Uterine tone|uterine tone
286091|NCT01726478|Mulago Hospital|mulago hospital
286092|NCT01726478|Dose|dose
286093|NCT01726478|Side effects|side effects
286094|NCT01726465|N-Acetylcysteine|n-acetylcysteine
286095|NCT01726465|Methylprednisolone|methylprednisolone
286096|NCT01726465|Liver ischemia reperfusion injury|liver ischemia reperfusion injury
286097|NCT01726465|Pringle manoeuvre|pringle manoeuvre
286098|NCT01726465|Hepatic resection|hepatic resection
286099|NCT01726426|Chronic arsenic poisoning|chronic arsenic poisoning
286100|NCT01726426|Palmer arsenical keratosis|palmer arsenical keratosis
286101|NCT01726413|Diabetic neuropathy|diabetic neuropathy
286102|NCT01726400|Hepatitis C|hepatitis c
286103|NCT01726400|Interferon|interferon
286104|NCT01726400|Ribavirin|ribavirin
286105|NCT01726400|Hepcidin|hepcidin
286106|NCT01726400|Iron metabolism|iron metabolism
286107|NCT01726361|Multidimension Treatment Foster Care|multidimension treatment foster care
286108|NCT01726361|Adolescents|adolescents
286109|NCT01726361|Disadvantaged families|disadvantaged families
286110|NCT01726361|Out-of-home placement|out-of-home placement
286111|NCT01726361|Conduct Disorder|conduct disorder
286112|NCT01726361|Family program|family program
286113|NCT01726361|Denmark|denmark
286114|NCT01726361|Youth|youth
286115|NCT01726348|Human Immunodeficiency Virus-Type 1|human immunodeficiency virus-type 1
286116|NCT01726348|HIV-1|hiv-1
286117|NCT01726348|TMC114|tmc114
286118|NCT01726348|Darunavir|darunavir
286119|NCT01726348|Ritonavir|ritonavir
286120|NCT01726348|Filipino|filipino
286121|NCT01726335|Schizophrenia|schizophrenia
286122|NCT01726335|Risperidone|risperidone
286123|NCT01726335|Risperdal consta|risperdal consta
286124|NCT01726283|fruste keratoconus|fruste keratoconus
286125|NCT01726283|ectasia|ectasia
286126|NCT01726257|Infrarenal|infrarenal
286127|NCT01726257|Abdominal|abdominal
286128|NCT01726257|Aortic|aortic
286129|NCT01726257|Aneurysm|aneurysm
286130|NCT01726257|AAA|aaa
286131|NCT01726257|Endologix|endologix
286132|NCT01726257|EVAS|evas
286133|NCT01726257|EndoVascular|endovascular
286134|NCT01726257|Sealing|sealing
286135|NCT01726257|System|system
286136|NCT01726231|Laparoscopic access|laparoscopic access
286137|NCT01726231|Abdominal wall lifting|abdominal wall lifting
286138|NCT01726231|Direct trocar insertion|direct trocar insertion
286139|NCT01726231|Safety endoscopy|safety endoscopy
286140|NCT01726218|Stroke|stroke
286141|NCT01726218|Physical Medicine & Rehabilitation|physical medicine & rehabilitation
286142|NCT01726218|Neurology|neurology
286143|NCT01726218|Neurophysiology|neurophysiology
286144|NCT01726218|Neuroscience|neuroscience
286145|NCT01726218|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
286146|NCT01726179|caries infiltration|caries infiltration
286147|NCT01726179|caries arrest|caries arrest
286148|NCT01726179|dental anxiety|dental anxiety
286149|NCT01726179|dental stress|dental stress
286150|NCT01726166|Infant|infant
286151|NCT01726166|contamination rates|contamination rates
286152|NCT01726166|urinary catheterization|urinary catheterization
286153|NCT01726166|suprapubic aspiration|suprapubic aspiration
286154|NCT01726153|Condom Use|condom use
286155|NCT01726153|HIV+ gay males|hiv+ gay males
286156|NCT01726153|Intervention|intervention
286157|NCT01726153|Tailored|tailored
286158|NCT01726153|On-line|on-line
286159|NCT01726153|Internet|internet
286160|NCT01726153|Web-based|web-based
286161|NCT01726140|intubation|intubation
286162|NCT01726140|respiratory failure|respiratory failure
286163|NCT01726140|cardiac surgery|cardiac surgery
286164|NCT01726114|Diabetes|diabetes
286165|NCT01726114|Diabetes Mellitus|diabetes mellitus
286166|NCT01726114|continuous Glucose Monitor|continuous glucose monitor
286167|NCT01726088|Modafinil|modafinil
286168|NCT01726088|p50|p50
286169|NCT01726088|Attentional Bias|attentional bias
276872|NCT01768286|HCV|hcv
286170|NCT01726075|diabetic retinopathy|diabetic retinopathy
286171|NCT01726062|Motivational Incentives|motivational incentives
286172|NCT01726062|Motivational Interviewing|motivational interviewing
286173|NCT01726062|Secondhand Smoke|secondhand smoke
286174|NCT01726062|Neonatal Intensive Care Unit|neonatal intensive care unit
286175|NCT01726062|NICU|nicu
286176|NCT01726062|High respiratory risk infants|high respiratory risk infants
286177|NCT01726062|Low birth weight infants|low birth weight infants
286178|NCT01726062|Environmental Tobacco Smoke|environmental tobacco smoke
286179|NCT01726062|Smoking|smoking
286180|NCT01726062|Contingency management|contingency management
286181|NCT01726062|Infants|infants
286184|NCT01726049|PH|ph
286185|NCT01726036|neonatal circumcision|neonatal circumcision
286186|NCT01726036|neonatal surgical pain|neonatal surgical pain
286187|NCT01726036|Mogen|mogen
286188|NCT01726036|Gomco|gomco
286189|NCT01726023|Ceftazidime-avibactam,|ceftazidime-avibactam,
286190|NCT01726023|Metronidazole,|metronidazole,
286191|NCT01726023|Meropenem,|meropenem,
286192|NCT01726023|Anti-Bacterial Agents,|anti-bacterial agents,
286193|NCT01726023|Anti-Infective Agents,|anti-infective agents,
286194|NCT01726023|Therapeutic Uses,|therapeutic uses,
286195|NCT01726023|Pharmacologic Actions,|pharmacologic actions,
286196|NCT01726023|Physiological Effects of Drugs|physiological effects of drugs
286197|NCT01725997|acromioclavicular joint dislocation|acromioclavicular joint dislocation
286198|NCT01725997|ac joint dislocation|ac joint dislocation
286199|NCT01725997|acromioclavicular joint separation|acromioclavicular joint separation
286200|NCT01725997|hook plate|hook plate
286201|NCT01725997|Rockwood|rockwood
286202|NCT01725984|Male Incontinence|male incontinence
286203|NCT01725984|AdVance Male Sling|advance male sling
286204|NCT01725984|AdVance XP Male Sling|advance xp male sling
286205|NCT01725984|Male Sling|male sling
286206|NCT01725971|Silicosis|silicosis
286207|NCT01725971|forced oscillations|forced oscillations
286208|NCT01725971|respiratory mechanics|respiratory mechanics
286209|NCT01725945|DASH|dash
286210|NCT01725945|diet|diet
286211|NCT01725945|asthma|asthma
286212|NCT01725945|adults|adults
286213|NCT01725945|asthma control|asthma control
286214|NCT01725932|culture, depression, cognitive therapy, behaviour therapy,|culture, depression, cognitive therapy, behaviour therapy,
286215|NCT01725919|motor|motor
286216|NCT01725919|stroke|stroke
286217|NCT01725919|hemiparesis|hemiparesis
286218|NCT01725919|rehabilitation|rehabilitation
286219|NCT01725919|constraint induced movement therapy|constraint induced movement therapy
286220|NCT01725919|CI therapy|ci therapy
286221|NCT01725906|genotypic resistance guided therapy|genotypic resistance guided therapy
286222|NCT01725893|Claw Toe|claw toe
286223|NCT01725880|Spinal Cord Injury|spinal cord injury
286224|NCT01725880|HuCNS-SC cells|hucns-sc cells
286225|NCT01725880|Human Neural Stem Cells|human neural stem cells
286226|NCT01725880|Neural Stem Cells|neural stem cells
286227|NCT01725880|Stem Cells|stem cells
286228|NCT01725867|temporomandibular joint disorder|temporomandibular joint disorder
286229|NCT01725867|myofascial pain|myofascial pain
286230|NCT01725867|manual myofascial release|manual myofascial release
286231|NCT01725867|physical therapy|physical therapy
286232|NCT01725867|oral appliance|oral appliance
286233|NCT01725841|To determine the prevalence of ESBL-producing among Enterobacteriaceae isolates in Taiwan|to determine the prevalence of esbl-producing among enterobacteriaceae isolates in taiwan
286354|NCT01725230|Healthy Subjects,|healthy subjects,
286320|NCT01725334|Mental Disorders|mental disorders
286321|NCT01725334|Brain Diseases|brain diseases
286234|NCT01725841|To determine the susceptibility of ertapenem and other antimicrobial agents against Enterobacteriaceae isolates with and without expression of ESBLs|to determine the susceptibility of ertapenem and other antimicrobial agents against enterobacteriaceae isolates with and without expression of esbls
286235|NCT01725841|To determine the molecular typing of the Enterobacteriaceae isolates with expression of ESBLs|to determine the molecular typing of the enterobacteriaceae isolates with expression of esbls
286236|NCT01725841|To analyze the association between geographic area, hospital types against the antimicrobial susceptibility|to analyze the association between geographic area, hospital types against the antimicrobial susceptibility
286237|NCT01725828|cricothyroid membrane|cricothyroid membrane
286238|NCT01725828|Ultrasound|ultrasound
286239|NCT01725828|Difficult Airway Management|difficult airway management
286240|NCT01725789|Acute isovolemic anemia after gastrectomy for gastric cancer|acute isovolemic anemia after gastrectomy for gastric cancer
286241|NCT01725776|Pulmonary hypertension|pulmonary hypertension
286242|NCT01725776|Cardiac surgery|cardiac surgery
286243|NCT01725776|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
286244|NCT01725750|Traumatic Brain Injury|traumatic brain injury
286245|NCT01725750|TBI|tbi
286246|NCT01725750|Fatigue|fatigue
286247|NCT01725750|Post-TBI Fatigue|post-tbi fatigue
286248|NCT01725750|PTBIF|ptbif
286249|NCT01725750|Depressed Mood|depressed mood
286250|NCT01725750|Excessive Daytime Sleepiness|excessive daytime sleepiness
286251|NCT01725750|Circadian Rhythm|circadian rhythm
286252|NCT01725750|Anxiety|anxiety
286253|NCT01725750|Cognitive Dysfunction|cognitive dysfunction
286254|NCT01725750|Intervention|intervention
286255|NCT01725750|Treatment|treatment
276900|NCT01768273|PA-824,|pa-824,
286256|NCT01725737|ADHD|adhd
286257|NCT01725737|GlyTI-M|glyti-m
286258|NCT01725724|Autologous blood transfusion|autologous blood transfusion
286259|NCT01725724|Allogeneic blood transfusion|allogeneic blood transfusion
286260|NCT01725724|Infection rate|infection rate
286261|NCT01725685|healthy volunteers|healthy volunteers
286262|NCT01725685|Umeclidinium|umeclidinium
286263|NCT01725685|tolerability|tolerability
286264|NCT01725685|Safety|safety
286265|NCT01725685|Fluticasone Furoate|fluticasone furoate
286266|NCT01725685|Pharmacokinetics|pharmacokinetics
286267|NCT01725672|healthy volunteers|healthy volunteers
286268|NCT01725672|Diabetes mellitus|diabetes mellitus
286269|NCT01725672|glimepiride|glimepiride
286270|NCT01725672|pharmacokinetics|pharmacokinetics
286271|NCT01725672|metformin|metformin
286272|NCT01725659|Stroke|stroke
286273|NCT01725659|electric stimulation|electric stimulation
286274|NCT01725659|robotics|robotics
286275|NCT01725659|motor learning|motor learning
286276|NCT01725646|Hypertriglyceridemia, omega-3-acid ethyl ester|hypertriglyceridemia, omega-3-acid ethyl ester
286277|NCT01725633|Stretching|stretching
286278|NCT01725633|Nonlinear Aerobic Training|nonlinear aerobic training
286279|NCT01725633|14-170|14-170
286280|NCT01725607|dexmedetomidine, thoracic epidural anesthesia|dexmedetomidine, thoracic epidural anesthesia
286281|NCT01725581|OSAT|osat
286282|NCT01725581|Pelvic Examination|pelvic examination
286283|NCT01725581|Validation|validation
286284|NCT01725581|Reliability|reliability
286285|NCT01725542|HCV-HIV Co-Infection|hcv-hiv co-infection
286286|NCT01725542|Quadruple therapy|quadruple therapy
286287|NCT01725542|null responder to a standard Pegylated interferon/Ribavirin regimen|null responder to a standard pegylated interferon/ribavirin regimen
286288|NCT01725529|Hepatitis C, Chronic|hepatitis c, chronic
286289|NCT01725529|TMC435|tmc435
286290|NCT01725529|Ribavirin|ribavirin
286291|NCT01725529|peginterferon-alpha (PegIFNα-2a)|peginterferon-alpha (pegifnα-2a)
286292|NCT01725503|creatine synthesis|creatine synthesis
286293|NCT01725490|chemoprevention, metformin, familial adenomatous polyposis|chemoprevention, metformin, familial adenomatous polyposis
286294|NCT01725464|thoracotomy|thoracotomy
286295|NCT01725464|oxygen saturation|oxygen saturation
286296|NCT01725464|postoperative|postoperative
286297|NCT01725438|Circulating Trophoblastic Cells|circulating trophoblastic cells
286298|NCT01725438|Non-Invasive Prenatal Diagnosis|non-invasive prenatal diagnosis
286299|NCT01725438|Genetic analysis|genetic analysis
286300|NCT01725438|Trisomy 21|trisomy 21
286301|NCT01725438|Down's Syndrome|down's syndrome
286302|NCT01725425|snack food (chips)|snack food (chips)
286303|NCT01725425|fruit (red grapes) consumed in each condition|fruit (red grapes) consumed in each condition
286304|NCT01725425|mood|mood
704666|NCT00983983|Gastrostomy|gastrostomy
286305|NCT01725399|post-operative vomiting|post-operative vomiting
286306|NCT01725373|left main, stent,angioplasty|left main, stent,angioplasty
286307|NCT01725360|asthma|asthma
286308|NCT01725360|airway hyperresponsiveness|airway hyperresponsiveness
286309|NCT01725347|nutrition assessment|nutrition assessment
286310|NCT01725347|children|children
286311|NCT01725347|preschool|preschool
286312|NCT01725347|eating behavior|eating behavior
286313|NCT01725347|Head Start|head start
286314|NCT01725347|digital technology|digital technology
286315|NCT01725334|Schizophrenia|schizophrenia
286316|NCT01725334|Negative Symptoms|negative symptoms
286317|NCT01725334|Treatment Resistance|treatment resistance
286318|NCT01725334|Deep Brain Stimulation|deep brain stimulation
286319|NCT01725334|Electrical Stimulation|electrical stimulation
286633|NCT01723852|Vitamin D|vitamin d
286322|NCT01725334|Neurologic Manifestations|neurologic manifestations
286323|NCT01725334|Signs and Symptoms|signs and symptoms
286324|NCT01725321|Colonoscopy|colonoscopy
286325|NCT01725321|colonic adenoma|colonic adenoma
286326|NCT01725321|serrated polyps|serrated polyps
286327|NCT01725308|FK949E|fk949e
286328|NCT01725308|Major depressive episode|major depressive episode
286329|NCT01725308|patients|patients
286330|NCT01725295|fibromyalgia treatment|fibromyalgia treatment
286331|NCT01725295|physical therapy|physical therapy
286332|NCT01725295|hydrotherapy|hydrotherapy
286333|NCT01725282|patients|patients
286334|NCT01725282|FK949E|fk949e
286335|NCT01725269|AIR001|air001
286336|NCT01725269|sodium nitrite|sodium nitrite
286337|NCT01725269|PAH|pah
286338|NCT01725269|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
286339|NCT01725269|inhaled sodium nitrite|inhaled sodium nitrite
286340|NCT01725256|AIR001|air001
286341|NCT01725256|sodium nitrite|sodium nitrite
286342|NCT01725256|PAH|pah
286343|NCT01725256|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
286344|NCT01725256|inhaled sodium nitrite|inhaled sodium nitrite
286345|NCT01725243|pregnancy|pregnancy
286346|NCT01725243|postpartum hemorrhage|postpartum hemorrhage
286347|NCT01725243|Cesarean delivery|cesarean delivery
286348|NCT01725243|carbetocin|carbetocin
286349|NCT01725243|failure to progress in labor|failure to progress in labor
286350|NCT01725230|Fostamatinib,|fostamatinib,
286351|NCT01725230|simvastatin,|simvastatin,
286352|NCT01725230|rosuvastatin,|rosuvastatin,
286353|NCT01725230|Phase I,|phase i,
286355|NCT01725230|Pharmacokinetics|pharmacokinetics
286356|NCT01725217|Meningitis|meningitis
286357|NCT01725217|children|children
286358|NCT01725217|adolescents|adolescents
286359|NCT01725217|adults|adults
286360|NCT01725217|MenACWY|menacwy
286361|NCT01725204|dasatinib|dasatinib
286362|NCT01725204|Protein Kinase Inhibitors|protein kinase inhibitors
286363|NCT01725204|pegylated IFN-alpha 2B|pegylated ifn-alpha 2b
286364|NCT01725204|Interferon-alpha|interferon-alpha
286365|NCT01725178|Mild Cognitive Impairment|mild cognitive impairment
286366|NCT01725178|Dementia|dementia
286367|NCT01725178|Memory disorders|memory disorders
286368|NCT01725178|Physical fitness|physical fitness
286369|NCT01725165|Lung cancer|lung cancer
286370|NCT01725165|Non-Small Cell Lung Cancer|non-small cell lung cancer
286371|NCT01725165|NSCLC|nsclc
286372|NCT01725165|Oligometastatic Disease|oligometastatic disease
286373|NCT01725165|Chemotherapy|chemotherapy
286374|NCT01725165|Surgical control|surgical control
286375|NCT01725165|primary and metastatic sites of disease|primary and metastatic sites of disease
286376|NCT01725165|Radiation therapy|radiation therapy
286377|NCT01725165|external beam radiation|external beam radiation
286378|NCT01725165|2D/conventional techniques|2d/conventional techniques
286379|NCT01725165|three-dimensional conformal therapy|three-dimensional conformal therapy
286380|NCT01725165|intensity modulated radiation therapy|intensity modulated radiation therapy
286381|NCT01725165|IMRT|imrt
286382|NCT01725165|stereotactic radiosurgery|stereotactic radiosurgery
286384|NCT01725165|proton beam therapy|proton beam therapy
286385|NCT01725165|PBT|pbt
286386|NCT01725152|fragile x syndrome|fragile x syndrome
286387|NCT01725152|ganaxolone|ganaxolone
286388|NCT01725152|anxiety|anxiety
286389|NCT01725152|attention|attention
286390|NCT01725152|pediatric|pediatric
286391|NCT01725126|metformin|metformin
286392|NCT01725126|diabetes|diabetes
286393|NCT01725126|obesity|obesity
286394|NCT01725126|liraglutide|liraglutide
286395|NCT01725100|MEK inhibitor|mek inhibitor
286396|NCT01725100|GSK1120212|gsk1120212
286397|NCT01725100|trametinib|trametinib
286398|NCT01725100|solid tumors|solid tumors
286399|NCT01725100|dissolution|dissolution
286400|NCT01725100|DMSO content|dmso content
286401|NCT01725100|relative bioavailability|relative bioavailability
286402|NCT01725100|pharmacokinetics|pharmacokinetics
286403|NCT01725074|Coronary Heart Disease, multimorbidity, primary care, case management, loneliness, depression, social support|coronary heart disease, multimorbidity, primary care, case management, loneliness, depression, social support
704667|NCT00983983|PEG|peg
286404|NCT01725048|Major depressive disorder|major depressive disorder
286405|NCT01725048|Neoplasms|neoplasms
286406|NCT01725035|De Novo Lipogenesis|de novo lipogenesis
286407|NCT01725035|Fatty Liver|fatty liver
286408|NCT01725035|Hepatic Steatosis|hepatic steatosis
286409|NCT01725035|Gene variants|gene variants
286410|NCT01725022|stem cell transplant|stem cell transplant
286411|NCT01725022|bowel microbiota|bowel microbiota
286412|NCT01725022|home care|home care
286413|NCT01725009|Healthy volunteers|healthy volunteers
286414|NCT01725009|Japanese|japanese
286415|NCT01725009|Caucasian|caucasian
286416|NCT01724983|pain|pain
286417|NCT01724983|mood|mood
286418|NCT01724983|depression|depression
286419|NCT01724983|respiration|respiration
286420|NCT01724970|anesthesia|anesthesia
286421|NCT01724970|postanesthetic recovery|postanesthetic recovery
286422|NCT01724970|ventilation|ventilation
286423|NCT01724970|bariatric surgery|bariatric surgery
286424|NCT01724957|Fractional flow reserve,|fractional flow reserve,
286425|NCT01724957|coronary bifurcation stenosis,|coronary bifurcation stenosis,
286426|NCT01724957|intracoronary ECG,|intracoronary ecg,
286427|NCT01724957|coronary stent|coronary stent
286428|NCT01724957|Coronary bifurcation lesions|coronary bifurcation lesions
286429|NCT01724957|icECG|icecg
286430|NCT01724944|Interval debulking surgery|interval debulking surgery
286431|NCT01724944|IDS|ids
286432|NCT01724944|NACT|nact
286433|NCT01724944|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
286434|NCT01724944|Lymphadenectomy|lymphadenectomy
286435|NCT01724944|Ovarian cancer|ovarian cancer
286436|NCT01724931|antifolate|antifolate
286437|NCT01724931|antiinflammatory|antiinflammatory
286438|NCT01724931|autoimmune disease|autoimmune disease
286439|NCT01724931|hematological treatment|hematological treatment
286440|NCT01724931|rheumatic disease|rheumatic disease
286441|NCT01724931|folic acid antagonist|folic acid antagonist
286442|NCT01724931|enzyme inhibitor|enzyme inhibitor
286443|NCT01724918|IV lacosamide|iv lacosamide
286444|NCT01724918|focal epilepsy|focal epilepsy
286445|NCT01724918|EEG|eeg
286446|NCT01724918|EKG|ekg
286447|NCT01724905|Diet|diet
286448|NCT01724905|Obesity|obesity
286449|NCT01724905|Chronic disease|chronic disease
286450|NCT01724879|philadelphia chromosome|philadelphia chromosome
286451|NCT01724879|BCR-ABL|bcr-abl
286452|NCT01724879|ALL|all
286453|NCT01724879|acute lymphoblastic leukemia|acute lymphoblastic leukemia
286454|NCT01724879|dasatinib|dasatinib
286455|NCT01724879|Sprycel|sprycel
286456|NCT01724853|Carpometacarpal|carpometacarpal
286457|NCT01724853|osteoarthritis|osteoarthritis
286458|NCT01724853|outcome measures|outcome measures
286459|NCT01724827|Dental caries|dental caries
286460|NCT01724827|inlays|inlays
286461|NCT01724827|composite resins|composite resins
286462|NCT01724827|IPS-Empress ceramic|ips-empress ceramic
286463|NCT01724827|bicuspid|bicuspid
286464|NCT01724827|FDI dental restorations evaluation criteria|fdi dental restorations evaluation criteria
286465|NCT01724801|EGFR mutant|egfr mutant
286466|NCT01724775|complete mesocolic excision|complete mesocolic excision
286467|NCT01724775|colon cancer|colon cancer
286468|NCT01724775|efficacy|efficacy
286469|NCT01724775|safety|safety
286470|NCT01724762|Baths|baths
286471|NCT01724762|Anxiety|anxiety
286472|NCT01724762|Acute Coronary Syndrome|acute coronary syndrome
286473|NCT01724762|Education, Nursing|education, nursing
286474|NCT01724749|Atherosclerosis|atherosclerosis
286475|NCT01724749|Sodium-Fluoride|sodium-fluoride
286476|NCT01724749|18F-Sodium Fluoride|18f-sodium fluoride
286477|NCT01724749|18F-NaF|18f-naf
286478|NCT01724749|fluorodeoxyglucose|fluorodeoxyglucose
286479|NCT01724749|18F-FDG|18f-fdg
286480|NCT01724749|FDG|fdg
286481|NCT01724749|Positron emission tomography|positron emission tomography
286482|NCT01724749|PET|pet
286483|NCT01724736|microbiome|microbiome
286484|NCT01724736|prebiotic|prebiotic
286485|NCT01724736|cobiotic|cobiotic
286486|NCT01724736|NM504|nm504
286487|NCT01724736|GI microbiome|gi microbiome
286488|NCT01724723|hepatitis during anti-tuberculous treatment|hepatitis during anti-tuberculous treatment
286489|NCT01724723|tuberculosis|tuberculosis
286490|NCT01724723|hepatitis B virus|hepatitis b virus
286491|NCT01724723|viral load|viral load
286492|NCT01724723|entecavir|entecavir
286493|NCT01724697|liver cirrhosis|liver cirrhosis
286494|NCT01724697|end stage liver disease|end stage liver disease
286495|NCT01724697|HBV|hbv
286496|NCT01724697|autologous|autologous
286497|NCT01724697|stem cell|stem cell
286498|NCT01724697|bone morrow|bone morrow
286499|NCT01724671|MRSA|mrsa
286500|NCT01724671|Bacteremia|bacteremia
286501|NCT01724671|ABSSSI|absssi
286502|NCT01724671|Pneumonia|pneumonia
286503|NCT01724671|Vancomycin|vancomycin
286504|NCT01724671|Ceftaroline|ceftaroline
286505|NCT01724658|female sexual function|female sexual function
286506|NCT01724658|postmenopause|postmenopause
286507|NCT01724658|testosterone|testosterone
286508|NCT01724645|Korean Traditional diets|korean traditional diets
286509|NCT01724645|hypertension|hypertension
286510|NCT01724645|diabetes|diabetes
286511|NCT01724632|Overweight|overweight
286512|NCT01724632|Obesity|obesity
286513|NCT01724632|Weight Loss|weight loss
286514|NCT01724606|Whole Brain Radiotherapy (WBRT)|whole brain radiotherapy (wbrt)
286515|NCT01724606|Sorafenib (BAY 43-9006)|sorafenib (bay 43-9006)
286516|NCT01724606|12-046|12-046
286517|NCT01724593|functional recovery, critical illness, pediatrics|functional recovery, critical illness, pediatrics
286518|NCT01724567|Interval Training|interval training
286519|NCT01724567|Weight Loss|weight loss
286520|NCT01724567|Secondary Prevention|secondary prevention
286521|NCT01724567|Rehabilitation|rehabilitation
286522|NCT01724567|Cardiovascular Risk Factors|cardiovascular risk factors
286523|NCT01724528|Febuxostat, Tumor lysis syndrome, leukemia, lymphoma|febuxostat, tumor lysis syndrome, leukemia, lymphoma
286524|NCT01724515|insulin resistance|insulin resistance
286525|NCT01724502|insulin resistance|insulin resistance
286526|NCT01724463|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
286527|NCT01724463|Sepsis|sepsis
286528|NCT01724463|Severe Sepsis|severe sepsis
286529|NCT01724463|Septic Shock|septic shock
286530|NCT01724463|Electronic Health Record|electronic health record
286531|NCT01724463|Health Screening|health screening
286532|NCT01724463|Goal Directed Therapy|goal directed therapy
286533|NCT01724463|Infant|infant
286534|NCT01724463|Child|child
286535|NCT01724463|Pediatric|pediatric
286536|NCT01724463|Adolescent|adolescent
286537|NCT01724463|Critical Illness|critical illness
286538|NCT01724463|Outcomes Research|outcomes research
286539|NCT01724463|Resource Utilization|resource utilization
286540|NCT01724450|Breast Cancer|breast cancer
286541|NCT01724450|Heart Failure|heart failure
286542|NCT01724450|Cardiotoxicity|cardiotoxicity
286543|NCT01724450|Biomarkers|biomarkers
286544|NCT01724411|Overweight and Obesity|overweight and obesity
286545|NCT01724411|Appetite|appetite
286546|NCT01724411|Gut hormones and obesity|gut hormones and obesity
286547|NCT01724411|Resistant Starch|resistant starch
286548|NCT01724411|Gut microbiota and obesity|gut microbiota and obesity
286549|NCT01724411|SmartPill|smartpill
286550|NCT01724398|mesenchymal stem cells|mesenchymal stem cells
286552|NCT01724398|liver failure|liver failure
286553|NCT01724398|hepatitis B virus|hepatitis b virus
286554|NCT01724385|bevacizumab,|bevacizumab,
286555|NCT01724385|proliferative diabetic retinopathy,|proliferative diabetic retinopathy,
286556|NCT01724385|vitreous hemorrhage,|vitreous hemorrhage,
286557|NCT01724359|Schizophrenia|schizophrenia
286558|NCT01724359|Paliperidone extended-release (ER)|paliperidone extended-release (er)
286559|NCT01724359|Antipsychotic agents|antipsychotic agents
286560|NCT01724346|CLL, SLL|cll, sll
286561|NCT01724333|EORTC QLQ-C30|eortc qlq-c30
286562|NCT01724333|Oral health|oral health
286563|NCT01724333|Quality of life|quality of life
286564|NCT01724333|Questionnaires|questionnaires
286565|NCT01724333|Patient reported|patient reported
286566|NCT01724333|outcomes|outcomes
286567|NCT01724320|solid tumors|solid tumors
286568|NCT01724320|first-in-man|first-in-man
286569|NCT01724320|phase I|phase i
286570|NCT01724320|cancer|cancer
286571|NCT01724320|galectin|galectin
286572|NCT01724281|lateral ventricles|lateral ventricles
286573|NCT01724281|Asymetry|asymetry
286574|NCT01724255|Caesarian section|caesarian section
286575|NCT01724255|Surgical Wound|surgical wound
286576|NCT01724242|Vaginal dryness|vaginal dryness
286577|NCT01724242|Breast Cancer|breast cancer
286578|NCT01724242|Urinary Incontinence|urinary incontinence
286579|NCT01724242|Quality of Life|quality of life
286580|NCT01724242|Sexual Satisfaction|sexual satisfaction
286581|NCT01724229|Incontinence-associated dermatitis|incontinence-associated dermatitis
286582|NCT01724229|Skin care regimen for moisture-associated conditions|skin care regimen for moisture-associated conditions
286583|NCT01724229|Perineal skin care|perineal skin care
286584|NCT01724229|Fungal infection in perineal area|fungal infection in perineal area
286585|NCT01724203|Probiotics for infants|probiotics for infants
286586|NCT01724203|Bacterial and viral infections in infants|bacterial and viral infections in infants
286587|NCT01724190|Type 1 Diabetes|type 1 diabetes
286588|NCT01724190|Vitamin D|vitamin d
286589|NCT01724190|Clinical Remission|clinical remission
286590|NCT01724177|Lenalidomide|lenalidomide
286591|NCT01724177|ATL|atl
286592|NCT01724177|ATLL|atll
286593|NCT01724138|deferasirox|deferasirox
286594|NCT01724125|serious mental illness|serious mental illness
286595|NCT01724099|Obesity|obesity
286596|NCT01724099|Herbal product|herbal product
286597|NCT01724099|Korean Medicine|korean medicine
286598|NCT01724086|Chronic hepatitis C|chronic hepatitis c
286599|NCT01724086|Chronic hepatitis C-infected patients|chronic hepatitis c-infected patients
286600|NCT01724086|TMC647055|tmc647055
286601|NCT01724086|TMC435|tmc435
286602|NCT01724086|Ritonavir|ritonavir
286603|NCT01724086|Ribavirin|ribavirin
286604|NCT01724086|Genotype 1a|genotype 1a
286605|NCT01724086|Genotype 1b|genotype 1b
286606|NCT01724086|GSK2336805|gsk2336805
704907|NCT00984516|Cicatrix|cicatrix
286607|NCT01724073|food to food fortification strategy|food to food fortification strategy
286608|NCT01724073|leafy vegetable|leafy vegetable
286609|NCT01724073|iron|iron
286610|NCT01724073|zinc|zinc
286611|NCT01724073|vitamin A|vitamin a
286612|NCT01724073|growth|growth
286613|NCT01724047|Autism|autism
286614|NCT01724047|School Based Intervention|school based intervention
286615|NCT01724034|Weaning|weaning
286616|NCT01724034|Mechanical Ventilation|mechanical ventilation
286617|NCT01724034|Lung Ultrasound|lung ultrasound
286618|NCT01723995|nipple/injure|nipple/injure
286619|NCT01723995|breastfeeding|breastfeeding
286620|NCT01723995|pain|pain
286621|NCT01723995|laser|laser
286622|NCT01723956|Cervical Dysplasia|cervical dysplasia
286623|NCT01723956|Cin 2|cin 2
286624|NCT01723956|Cin 3|cin 3
286625|NCT01723956|HIV positive women|hiv positive women
286626|NCT01723956|South Africa|south africa
286627|NCT01723904|Rotigotine|rotigotine
286628|NCT01723904|Neupro|neupro
286629|NCT01723865|Heart failure|heart failure
286630|NCT01723865|Remote Monitoring|remote monitoring
286632|NCT01723865|Follow-up|follow-up
286634|NCT01723852|Infectious diseases|infectious diseases
286635|NCT01723852|cognitive development|cognitive development
286636|NCT01723852|Bone mineral density|bone mineral density
286637|NCT01723852|Immunoregulation|immunoregulation
286638|NCT01723852|Allergy|allergy
286639|NCT01723852|Growth|growth
286640|NCT01723839|CLL|cll
286641|NCT01723839|FCR|fcr
286642|NCT01723839|Rituximab|rituximab
286643|NCT01723839|Lenalidomide|lenalidomide
286644|NCT01723839|Cyclophosphamide|cyclophosphamide
286645|NCT01723813|Immunotherapy|immunotherapy
286646|NCT01723813|Tumor-specific peptides|tumor-specific peptides
286647|NCT01723813|GM-CT-01|gm-ct-01
286648|NCT01723761|air pollution|air pollution
286649|NCT01723761|pacemaker|pacemaker
286650|NCT01723761|ICD|icd
286651|NCT01723761|remote monitoring|remote monitoring
286652|NCT01723761|supraventricular arrhythmias|supraventricular arrhythmias
286653|NCT01723761|ventricular arrhythmias|ventricular arrhythmias
286654|NCT01723748|Acromegaly|acromegaly
286655|NCT01723748|Somatostatin treatment|somatostatin treatment
286656|NCT01723748|metabolic effect|metabolic effect
286657|NCT01723722|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
286658|NCT01723722|Methadone|methadone
286659|NCT01723722|Diluted Deodorized Tincture of Opium|diluted deodorized tincture of opium
286660|NCT01723722|dDTO|ddto
286661|NCT01723722|Phenobarbital|phenobarbital
286662|NCT01723709|multiple sclerosis|multiple sclerosis
286663|NCT01723709|immune response|immune response
286664|NCT01723709|genetic|genetic
286665|NCT01723709|progression|progression
286666|NCT01723709|relapse|relapse
286667|NCT01723709|biomarkers|biomarkers
286668|NCT01723709|disease|disease
286669|NCT01723709|proteomics|proteomics
286670|NCT01723709|genome|genome
286671|NCT01723709|gene|gene
286672|NCT01723696|In-utero smoke;|in-utero smoke;
286673|NCT01723696|Pulmonary function testing;|pulmonary function testing;
286674|NCT01723696|Wheeze;|wheeze;
286675|NCT01723696|Vitamin C;|vitamin c;
286676|NCT01723696|Forced expiratory flows|forced expiratory flows
286677|NCT01723683|Preterm infants|preterm infants
286678|NCT01723683|RDS|rds
286679|NCT01723683|Surfactant|surfactant
286680|NCT01723683|MISTCPAP|mistcpap
286681|NCT01723683|CPAP|cpap
286682|NCT01723657|Leukemia|leukemia
286683|NCT01723657|Myeloid|myeloid
286684|NCT01723657|Acute|acute
286685|NCT01723657|Young|young
286686|NCT01723657|CETLAM|cetlam
286687|NCT01723644|antibiotherapy, community acquired pneumonia, procalcitonin guided guidelines, clinical reassessment|antibiotherapy, community acquired pneumonia, procalcitonin guided guidelines, clinical reassessment
286688|NCT01723631|Multiple sclerosis|multiple sclerosis
286689|NCT01723631|TRAP|trap
286690|NCT01723631|TRAP-Myéline|trap-myéline
286691|NCT01723605|insitu repair|insitu repair
286692|NCT01723605|intestinal motility|intestinal motility
286693|NCT01723592|chemotherapy|chemotherapy
286694|NCT01723592|vaginal flora|vaginal flora
286695|NCT01723553|aphasia|aphasia
286696|NCT01723553|logopenic|logopenic
286697|NCT01723553|PCA|pca
286698|NCT01723553|LPA|lpa
286699|NCT01723540|Cholecystectomy,minilaparotomy,laparascopy,ultrasonic dissection|cholecystectomy,minilaparotomy,laparascopy,ultrasonic dissection
286700|NCT01723527|Cocaine|cocaine
286701|NCT01723527|Heroin|heroin
286702|NCT01723527|HIV|hiv
286703|NCT01723527|Contingency Management|contingency management
286704|NCT01723527|Incentives|incentives
286705|NCT01723527|Criminal Justice|criminal justice
286706|NCT01723527|Methadone|methadone
286707|NCT01723527|Buprenorphine|buprenorphine
286708|NCT01723527|Employment|employment
286709|NCT01723527|Job Training|job training
286710|NCT01723527|Wage Subsidies|wage subsidies
286711|NCT01723514|Migraine|migraine
286712|NCT01723501|chlorhexidine|chlorhexidine
286713|NCT01723501|sepsis|sepsis
286714|NCT01723501|neonatal|neonatal
704908|NCT00984516|Scar|scar
286715|NCT01723501|whole-body skin cleansing|whole-body skin cleansing
286716|NCT01723488|AD|ad
286717|NCT01723475|Phase I|phase i
286718|NCT01723475|Dose Escalation|dose escalation
286719|NCT01723475|Prostate cancer|prostate cancer
286720|NCT01723475|Antibodies|antibodies
286721|NCT01723475|Bispecific T-cell Engager (BiTE)|bispecific t-cell engager (bite)
286722|NCT01723436|Decision fatigue|decision fatigue
286723|NCT01723423|breast cancer|breast cancer
286724|NCT01723423|evidence based medicine|evidence based medicine
286725|NCT01723423|reconstruction|reconstruction
286726|NCT01723423|mastectomy|mastectomy
286727|NCT01723423|outcomes|outcomes
286728|NCT01723423|quality of life|quality of life
286729|NCT01723384|methamphetamine|methamphetamine
286730|NCT01723384|alcohol|alcohol
286731|NCT01723384|HIV|hiv
286732|NCT01723384|sexual behavior|sexual behavior
286733|NCT01723371|Pulmonary Arterial Hypertension (PAH|pulmonary arterial hypertension (pah
286734|NCT01723371|Pediatrics|pediatrics
286735|NCT01723371|Right Heart Failure (RHF)|right heart failure (rhf)
286736|NCT01723371|Carvedilol|carvedilol
286737|NCT01723371|Beta-blockers|beta-blockers
286738|NCT01723358|pediatrics|pediatrics
286739|NCT01723358|dysphagia|dysphagia
286740|NCT01723345|elective percutaneous coronary intervention|elective percutaneous coronary intervention
286741|NCT01723345|omega 3 polyunsaturated fatty acids (PUFAs)|omega 3 polyunsaturated fatty acids (pufas)
286742|NCT01723345|short-term MACE|short-term mace
286743|NCT01723345|long-term MACE|long-term mace
286744|NCT01723332|Transition from pediatric to adult clinical care|transition from pediatric to adult clinical care
286745|NCT01723319|ADHD|adhd
286746|NCT01723319|TMS|tms
286747|NCT01723319|brain stimulation|brain stimulation
286748|NCT01723319|clinical improvement|clinical improvement
286749|NCT01723306|T cells|t cells
286750|NCT01723306|gene transfer|gene transfer
286751|NCT01723306|immunotherapy|immunotherapy
286752|NCT01723306|metastatic cancers|metastatic cancers
286753|NCT01723306|lung cancer|lung cancer
286754|NCT01723306|gastric cancer|gastric cancer
286755|NCT01723306|colorectal cancer|colorectal cancer
286756|NCT01723306|solid tumors|solid tumors
286757|NCT01723293|Fetal heart rate, pregnancy, fetus, cardiovascular system|fetal heart rate, pregnancy, fetus, cardiovascular system
286758|NCT01723267|IVF|ivf
286759|NCT01723267|3D ultrasound|3d ultrasound
286760|NCT01723267|SonoAVC|sonoavc
286761|NCT01723267|patients in IVF treatment|patients in ivf treatment
286762|NCT01723254|Vaccines|vaccines
286763|NCT01723254|Phase 1|phase 1
286764|NCT01723254|Allergic Rhinitis|allergic rhinitis
286765|NCT01723241|volunteers|volunteers
286766|NCT01723228|Parkinson's Disease|parkinson's disease
286767|NCT01723228|Cognition|cognition
286768|NCT01723228|Rasagiline|rasagiline
286769|NCT01723215|Attention bias modification|attention bias modification
286770|NCT01723215|resilience|resilience
286771|NCT01723215|combat|combat
286772|NCT01723215|PTSD|ptsd
286773|NCT01723215|Depression|depression
286774|NCT01723215|Anxiety|anxiety
286775|NCT01723202|BRAF|braf
286776|NCT01723202|BRAFi|brafi
286777|NCT01723202|thyroid cancer|thyroid cancer
286778|NCT01723202|thyroid carcinoma|thyroid carcinoma
286779|NCT01723189|central apnoeas|central apnoeas
286780|NCT01723189|stroke|stroke
286781|NCT01723176|goal-directed echocardiography|goal-directed echocardiography
286782|NCT01723176|cardiopulmonary failure|cardiopulmonary failure
286783|NCT01723176|critical care ultrasound|critical care ultrasound
286784|NCT01723163|veteran|veteran
286785|NCT01723163|smoking cessation|smoking cessation
286786|NCT01723150|Klebsiella pneumoniae|klebsiella pneumoniae
286787|NCT01723137|Pain|pain
286788|NCT01723137|Pain measurement|pain measurement
286789|NCT01723137|Visual analog scale|visual analog scale
286790|NCT01723137|Anxiety|anxiety
286791|NCT01723137|Stress|stress
286792|NCT01723137|Opioid|opioid
286793|NCT01723137|Emergency department|emergency department
286794|NCT01723137|Demographics|demographics
286795|NCT01723124|Dense breast tissue|dense breast tissue
286796|NCT01723124|breast cancer screening|breast cancer screening
286797|NCT01723124|molecular breast imaging|molecular breast imaging
286798|NCT01723124|breast cancer|breast cancer
286799|NCT01723124|breast|breast
286800|NCT01723111|hepcidin|hepcidin
286801|NCT01723111|ESA|esa
286802|NCT01723111|hemodialysis|hemodialysis
286803|NCT01723111|peritoneal dialysis|peritoneal dialysis
286804|NCT01723111|iron metabolism|iron metabolism
286805|NCT01723111|dialysis modality|dialysis modality
286806|NCT01723098|Pregnancy, cardiovascular system, physical exercise|pregnancy, cardiovascular system, physical exercise
286807|NCT01723085|Anti-Mullerian hormone|anti-mullerian hormone
286808|NCT01723085|Myomectomy|myomectomy
286809|NCT01723085|Laparotomy|laparotomy
286810|NCT01723072|Chronic spontanous urticaria, refractory CSU, Angioedema|chronic spontanous urticaria, refractory csu, angioedema
286811|NCT01723046|Upper extremity|upper extremity
286812|NCT01723046|Rehabilitation|rehabilitation
286813|NCT01723046|Robot assisted therapy|robot assisted therapy
286814|NCT01723046|Robotics|robotics
286815|NCT01723046|Devices|devices
286816|NCT01723046|Orthosis|orthosis
286817|NCT01723046|clinical outcome|clinical outcome
286818|NCT01723033|PTSD|ptsd
286819|NCT01723033|OCD|ocd
286820|NCT01723020|Solid Tumors|solid tumors
286821|NCT01723020|Multiple Myeloma|multiple myeloma
286822|NCT01723007|Weight loss|weight loss
286823|NCT01723007|cholesterol|cholesterol
286824|NCT01722968|Metastatic breast cancer|metastatic breast cancer
286825|NCT01722955|Prewarmed fluid|prewarmed fluid
286826|NCT01722955|monitored anesthesia care|monitored anesthesia care
286827|NCT01722955|core body temperature|core body temperature
286828|NCT01722955|anesthetic satisfaction|anesthetic satisfaction
286829|NCT01722942|Chagas cardiomyopathy|chagas cardiomyopathy
286830|NCT01722942|sudden cardiac death|sudden cardiac death
286831|NCT01722942|primary prevention of death|primary prevention of death
286832|NCT01722942|amiodarone|amiodarone
286833|NCT01722942|implantable cardioverter defibrillator|implantable cardioverter defibrillator
286834|NCT01722903|colorectal cancer|colorectal cancer
286835|NCT01722903|liver metastases|liver metastases
286836|NCT01722903|lung metastases|lung metastases
286837|NCT01722890|HER2-positive breast cancer|her2-positive breast cancer
286838|NCT01722890|durable complete response|durable complete response
286839|NCT01722890|cytogenetic characteristics|cytogenetic characteristics
286840|NCT01722890|molecular characteristics|molecular characteristics
286841|NCT01722890|trastuzumab|trastuzumab
286842|NCT01722877|Restenosis|restenosis
286843|NCT01722877|aspiration|aspiration
286844|NCT01722877|in-stent restenosis|in-stent restenosis
286845|NCT01722877|atherectomy|atherectomy
286846|NCT01722877|superficial femoral artery|superficial femoral artery
286847|NCT01722877|popliteal artery|popliteal artery
286848|NCT01722851|Breast Cancer|breast cancer
286849|NCT01722851|miRNAs|mirnas
286850|NCT01722851|Newly diagnosed|newly diagnosed
286851|NCT01722851|Recurrent|recurrent
286852|NCT01722838|Black MSM|black msm
286853|NCT01722838|HIV Prevention|hiv prevention
286854|NCT01722799|angioplasty|angioplasty
286855|NCT01722799|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
286856|NCT01722799|Drug elluting Balloon|drug elluting balloon
286857|NCT01722799|Coronary Balloon|coronary balloon
286858|NCT01722799|Dilatation|dilatation
286859|NCT01722786|severe bleeding|severe bleeding
286860|NCT01722786|dabigatran|dabigatran
286861|NCT01722786|rivaroxaban|rivaroxaban
286862|NCT01722786|apixaban|apixaban
286863|NCT01722786|edoxaban|edoxaban
286864|NCT01722786|PCC|pcc
286865|NCT01722786|aPCC|apcc
286866|NCT01722786|rVIIa|rviia
286867|NCT01722786|hemodialysis|hemodialysis
286868|NCT01722786|antidots|antidots
286869|NCT01722786|idarucizumab|idarucizumab
286870|NCT01722773|COPD|copd
286871|NCT01722760|Neonatal|neonatal
286872|NCT01722760|Preterm|preterm
286873|NCT01722760|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
286874|NCT01722760|Nasal Continuous Positive airway Pressure (CPAP)|nasal continuous positive airway pressure (cpap)
286875|NCT01722760|Oxygen|oxygen
286876|NCT01722760|Vitamin A|vitamin a
286877|NCT01722760|Vitamin D|vitamin d
286878|NCT01722760|Nitrogen oxide (NO)|nitrogen oxide (no)
286879|NCT01722760|Reference material|reference material
286880|NCT01722734|Malaria|malaria
286881|NCT01722734|ACTs|acts
286882|NCT01722708|Abnormal vaginal flora|abnormal vaginal flora
286883|NCT01722708|clindamycin Vs metronidazole|clindamycin vs metronidazole
286884|NCT01722708|High risk pregnancies for preterm labor|high risk pregnancies for preterm labor
286885|NCT01722708|Preterm labor|preterm labor
286886|NCT01722708|Late abortion|late abortion
286887|NCT01722708|bacterial vaginosis|bacterial vaginosis
286888|NCT01722682|Diabetes|diabetes
286889|NCT01722669|quercetin|quercetin
286890|NCT01722669|isoquercetin|isoquercetin
286891|NCT01722669|pharmacokinetic|pharmacokinetic
286892|NCT01722669|pharmacodynamic|pharmacodynamic
286893|NCT01722656|PED|ped
286894|NCT01722656|AMD|amd
286895|NCT01722656|CNV|cnv
286896|NCT01722630|dopamine|dopamine
286897|NCT01722630|laparoscopy|laparoscopy
286898|NCT01722630|fluid management|fluid management
286899|NCT01722578|Cirrhosis|cirrhosis
286900|NCT01722578|Encephalopathy|encephalopathy
286901|NCT01722578|L-ornithine L-aspartate|l-ornithine l-aspartate
286902|NCT01722565|Parastomal hernias|parastomal hernias
286903|NCT01722565|Tolerance of lightweight meshes|tolerance of lightweight meshes
286904|NCT01722565|laparoscopic abdominoperineal resection|laparoscopic abdominoperineal resection
286905|NCT01722552|HIV|hiv
286906|NCT01722552|AIDS|aids
286907|NCT01722552|antiretroviral therapy|antiretroviral therapy
286908|NCT01722552|adherence|adherence
286909|NCT01722552|China|china
286910|NCT01722539|intermittent|intermittent
286911|NCT01722539|preventive|preventive
286912|NCT01722539|treatment|treatment
286913|NCT01722539|malaria|malaria
286914|NCT01722539|soil transmitted helminths|soil transmitted helminths
286915|NCT01722539|schistosomiasis|schistosomiasis
286916|NCT01722539|schoolchildren|schoolchildren
286917|NCT01722526|Human acid sphingomyelinase deficiency|human acid sphingomyelinase deficiency
286918|NCT01722513|Contrast Induced Nephropathy|contrast induced nephropathy
286919|NCT01722500|International|international
286920|NCT01722500|Childhood|childhood
286921|NCT01722500|Obesity|obesity
286922|NCT01722500|ISCOLE|iscole
286923|NCT01722500|Pennington Biomedical Research Center|pennington biomedical research center
286924|NCT01722500|PBRC|pbrc
286925|NCT01722500|longitudinal|longitudinal
286926|NCT01722500|multinational|multinational
286927|NCT01722487|CLL, SLL|cll, sll
286928|NCT01722474|Pulse Wave Analysis|pulse wave analysis
286929|NCT01722474|Arterial Stiffness|arterial stiffness
286930|NCT01722461|Excessive underarm sweating|excessive underarm sweating
286931|NCT01722448|muscle|muscle
286932|NCT01722448|muscle dysfunction|muscle dysfunction
286933|NCT01722448|choline|choline
286934|NCT01722448|exercise|exercise
286935|NCT01722448|exertional rhabdomyolysis|exertional rhabdomyolysis
286936|NCT01722448|rhabdomyolysis|rhabdomyolysis
286937|NCT01722435|opioid dependence|opioid dependence
286938|NCT01722435|opiate substitution treatment|opiate substitution treatment
286939|NCT01722435|methadone|methadone
286940|NCT01722435|completion|completion
286941|NCT01722435|termination|termination
286942|NCT01722422|sepsis|sepsis
286943|NCT01722422|shock|shock
286944|NCT01722422|hyperoxia|hyperoxia
286945|NCT01722422|hypertonic saline|hypertonic saline
286946|NCT01722409|dexmedetomidine, endovascular coil embolization|dexmedetomidine, endovascular coil embolization
286947|NCT01722357|bariatric surgery|bariatric surgery
286948|NCT01722357|physical activity|physical activity
286949|NCT01722357|morbid obesity|morbid obesity
286950|NCT01722344|Severe mental illness|severe mental illness
286951|NCT01722344|Vocational rehabilitation|vocational rehabilitation
286952|NCT01722344|Supported employment|supported employment
286953|NCT01722344|Individual placement and support|individual placement and support
286954|NCT01722344|Cognitive remediation|cognitive remediation
286955|NCT01722344|Social skill training|social skill training
286956|NCT01722279|bariatric surgery|bariatric surgery
286957|NCT01722279|long-term outcomes|long-term outcomes
286958|NCT01722279|obesity|obesity
286959|NCT01722266|Liraglutide|liraglutide
286960|NCT01722266|Glucagon|glucagon
286961|NCT01722266|Systolic blood pressure|systolic blood pressure
286962|NCT01722266|Weight|weight
286963|NCT01722266|Carbohydrate intake|carbohydrate intake
286964|NCT01722266|Insulin dose|insulin dose
286965|NCT01722266|HbA1c|hba1c
286966|NCT01722266|Post-prandial glucagon|post-prandial glucagon
286967|NCT01722253|electroacupuncture|electroacupuncture
286968|NCT01722253|acupuncture|acupuncture
286969|NCT01722253|pain management|pain management
286970|NCT01722214|Psoriasis|psoriasis
286971|NCT01722214|Vascular Inflammation|vascular inflammation
286972|NCT01722214|Coronary Atherosclerosis|coronary atherosclerosis
286973|NCT01722214|Ascending aorta|ascending aorta
286974|NCT01722214|Pet scan|pet scan
286976|NCT01722188|Optim|optim
286977|NCT01722188|Insulation|insulation
286978|NCT01722149|malignant pleural mesothelioma|malignant pleural mesothelioma
286979|NCT01722149|re-directed T cells|re-directed t cells
286980|NCT01722149|FAP|fap
286981|NCT01722149|fibroblast activation protein|fibroblast activation protein
286982|NCT01722149|CD8 positive T cells|cd8 positive t cells
286983|NCT01722149|pleural effusion|pleural effusion
286984|NCT01722123|Decision fatigue|decision fatigue
286985|NCT01722071|Oxytocin|oxytocin
286986|NCT01722071|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
286987|NCT01722071|Social|social
286988|NCT01722071|Motivation|motivation
286989|NCT01722058|peptide|peptide
286990|NCT01722058|colon|colon
286991|NCT01722058|flat lesions|flat lesions
286992|NCT01722045|AMD|amd
286993|NCT01722032|childhood obesity, early childhood, nutrition|childhood obesity, early childhood, nutrition
286994|NCT01722019|venous insufficiency|venous insufficiency
286995|NCT01722006|methamphetamine|methamphetamine
286996|NCT01722006|subjective|subjective
286997|NCT01722006|conditioning|conditioning
286998|NCT01722006|preference|preference
286999|NCT01721993|oral zoledronic acid|oral zoledronic acid
287000|NCT01721967|chest pain|chest pain
287002|NCT01721954|colon|colon
287003|NCT01721954|rectum|rectum
287004|NCT01721954|metastatic colorectal cancer|metastatic colorectal cancer
287005|NCT01721954|liver metastases|liver metastases
287006|NCT01721941|hepatocellular carcinoma|hepatocellular carcinoma
287007|NCT01721941|HCC|hcc
287008|NCT01721941|liver cancer|liver cancer
287009|NCT01721941|hepatoma|hepatoma
287010|NCT01721941|TACE|tace
287011|NCT01721941|transarterial chemoembolization|transarterial chemoembolization
287012|NCT01721941|TH302|th302
287013|NCT01721928|Acute kidney injury|acute kidney injury
287014|NCT01721928|Deep venous thrombosis|deep venous thrombosis
287015|NCT01721928|Dialysis|dialysis
287016|NCT01721928|Prophylaxis|prophylaxis
287017|NCT01721915|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
287018|NCT01721915|glucose metabolism|glucose metabolism
705011|NCT00984971|Tenofovir|tenofovir
287019|NCT01721915|Vitamin D deficiency|vitamin d deficiency
287020|NCT01721915|vitamin D supplementation|vitamin d supplementation
287021|NCT01721915|pharmakogenetics|pharmakogenetics
287022|NCT01721915|women|women
287023|NCT01721863|Atrial Fibrillation|atrial fibrillation
287024|NCT01721863|Exercise Training|exercise training
287025|NCT01721863|Endothelial Function|endothelial function
287026|NCT01721863|Autonomic Nerve Modulation|autonomic nerve modulation
287027|NCT01721863|Exercise Capacity|exercise capacity
287028|NCT01721863|Quality of Life|quality of life
287029|NCT01721850|infant nutrition, infantile colic|infant nutrition, infantile colic
287030|NCT01721824|Supported employment|supported employment
287031|NCT01721824|Individual Placement and Support|individual placement and support
287032|NCT01721824|Workability|workability
287033|NCT01721824|Return to work|return to work
287034|NCT01721798|AE adverse event|ae adverse event
287035|NCT01721798|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
287036|NCT01721798|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
287037|NCT01721798|ART antiretroviral therapy|art antiretroviral therapy
287038|NCT01721798|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
287039|NCT01721798|DCF data collection forms|dcf data collection forms
287040|NCT01721798|DMC Data Monitoring Committee|dmc data monitoring committee
287041|NCT01721798|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
287042|NCT01721798|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
287043|NCT01721798|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
287044|NCT01721798|ICH International Conference of Harmonization|ich international conference of harmonization
287045|NCT01721798|IND Investigational New Drug Application|ind investigational new drug application
287046|NCT01721798|IRB Institutional Review Board|irb institutional review board
287047|NCT01721798|IU International units|iu international units
287048|NCT01721798|mg milligram(s)|mg milligram(s)
287049|NCT01721798|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
287050|NCT01721798|PCR polymerase chain reaction|pcr polymerase chain reaction
287051|NCT01721798|SAE serious adverse event|sae serious adverse event
287052|NCT01721798|µg microgram|µg microgram
287053|NCT01721798|ULN upper limit of the normal range|uln upper limit of the normal range
287054|NCT01721798|WB Western Blot|wb western blot
287055|NCT01721785|Nodal imaging|nodal imaging
287056|NCT01721785|Restaging|restaging
287057|NCT01721733|EPI743|epi743
277692|NCT01764659|4D-CT|4d-ct
287058|NCT01721733|Leigh syndrome|leigh syndrome
287059|NCT01721733|respiratory chain disease|respiratory chain disease
287060|NCT01721733|mitochondrial disorders|mitochondrial disorders
287061|NCT01721720|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
287062|NCT01721720|Behavioral Phenotype|behavioral phenotype
287063|NCT01721720|Brain Development|brain development
287064|NCT01721720|Complex Disease|complex disease
287065|NCT01721720|Social Networks|social networks
287066|NCT01721707|glaucoma|glaucoma
287067|NCT01721707|ocular hypertension|ocular hypertension
287068|NCT01721707|latanoprost|latanoprost
287069|NCT01721707|brinzolamide|brinzolamide
287070|NCT01721694|bacterial ocular inflammation|bacterial ocular inflammation
287071|NCT01721694|blepharitis|blepharitis
287072|NCT01721694|keratitis|keratitis
287073|NCT01721694|conjunctivitis|conjunctivitis
287074|NCT01721655|Spironolactone|spironolactone
287075|NCT01721655|Preterm Infants|preterm infants
287076|NCT01721655|Chronic Lung Disease|chronic lung disease
287077|NCT01721655|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
287078|NCT01721655|Electrolyte Supplementation|electrolyte supplementation
287079|NCT01721642|access|access
287080|NCT01721642|closure|closure
287081|NCT01721642|trans-apical|trans-apical
287082|NCT01721642|trans-catheter aortic valve implantation|trans-catheter aortic valve implantation
287083|NCT01721642|TAVI|tavi
287084|NCT01721642|trans-catheter aortic valve repair|trans-catheter aortic valve repair
287085|NCT01721642|TAVR|tavr
287086|NCT01721629|Nasal cpap weaning|nasal cpap weaning
287087|NCT01721629|Premature infants|premature infants
287088|NCT01721629|Respiratory distress syndrome|respiratory distress syndrome
287089|NCT01721629|Randomized controlled trial|randomized controlled trial
287090|NCT01721603|BRAFV600E melanoma patients|brafv600e melanoma patients
287091|NCT01721603|melanoma|melanoma
287092|NCT01721603|stereotactic radiosurgery|stereotactic radiosurgery
287093|NCT01721603|BRAFV600E melanoma brain metastases|brafv600e melanoma brain metastases
287094|NCT01721603|dabrafenib|dabrafenib
287095|NCT01721603|SRS|srs
287096|NCT01721590|high on-treatment platelet reactivity|high on-treatment platelet reactivity
287097|NCT01721590|Coronary Heart Disease|coronary heart disease
287098|NCT01721590|Tongxinluo|tongxinluo
287099|NCT01721577|glioblastoma|glioblastoma
287100|NCT01721577|gliosarcoma|gliosarcoma
287101|NCT01721577|anaplastic astrocytoma|anaplastic astrocytoma
287102|NCT01721577|anaplastic oligodendroglioma|anaplastic oligodendroglioma
287103|NCT01721577|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
287104|NCT01721577|AXL1717|axl1717
287105|NCT01721577|IGF-1 receptor inhibitor|igf-1 receptor inhibitor
287106|NCT01721577|picropodophyllin|picropodophyllin
287107|NCT01721551|Dialysis fatigue,|dialysis fatigue,
287108|NCT01721551|exercise intolerance,|exercise intolerance,
287109|NCT01721551|muscle atrophy,|muscle atrophy,
287110|NCT01721551|cachexia,|cachexia,
287111|NCT01721551|disability,|disability,
287112|NCT01721551|Sleep disorders|sleep disorders
287113|NCT01721551|Depression|depression
287114|NCT01721551|Mental Fatigue,|mental fatigue,
287115|NCT01721551|Cognitive function|cognitive function
287116|NCT01721551|Physical Fatigue|physical fatigue
287117|NCT01721538|stroke|stroke
287118|NCT01721538|prevention|prevention
287119|NCT01721538|obesity|obesity
287120|NCT01721538|weight reduction|weight reduction
287121|NCT01721525|BIBW2992 (AFATINIB)|bibw2992 (afatinib)
287122|NCT01721525|CARBOPLATIN|carboplatin
287123|NCT01721525|RIBAVIRIN-ICN (VIRAZOLE)|ribavirin-icn (virazole)
287124|NCT01721525|TAXOL (PACLITAXEL)|taxol (paclitaxel)
287125|NCT01721525|OROPHARYNX|oropharynx
287126|NCT01721525|HPV associated|hpv associated
287127|NCT01721525|12-150|12-150
287128|NCT01721512|Prospective observational study|prospective observational study
287129|NCT01721512|Breast feeding|breast feeding
287130|NCT01721512|Infant formula|infant formula
287131|NCT01721512|Infant|infant
287132|NCT01721512|Indonesia|indonesia
287133|NCT01721499|Stress|stress
287134|NCT01721499|obesity|obesity
287135|NCT01721499|overeating|overeating
287136|NCT01721486|tonsillitis|tonsillitis
287137|NCT01721486|recurrent tonsillitis|recurrent tonsillitis
287138|NCT01721486|obstructed air passages|obstructed air passages
287139|NCT01721486|swallowing difficulties|swallowing difficulties
287140|NCT01721473|Tobacco|tobacco
287141|NCT01721473|Positron Emission Tomography|positron emission tomography
287142|NCT01721473|Marijuana|marijuana
287143|NCT01721473|Caffeine|caffeine
287144|NCT01721473|Menthol|menthol
287145|NCT01721460|SubThalamic Nucleus|subthalamic nucleus
287146|NCT01721460|Microelectrode recording|microelectrode recording
287147|NCT01721460|Deep Brain Stimulation Electrode implantation|deep brain stimulation electrode implantation
287148|NCT01721447|Atrial fibrillation|atrial fibrillation
287149|NCT01721447|stroke|stroke
287150|NCT01721447|TEE|tee
287151|NCT01721447|Left atrial thrombus|left atrial thrombus
287152|NCT01721434|levosimendan|levosimendan
287153|NCT01721434|diaphragm function|diaphragm function
355292|NCT01429246|Tibet|tibet
287154|NCT01721434|mechanically ventilated patients|mechanically ventilated patients
287155|NCT01721434|neuro-mechanical efficiency|neuro-mechanical efficiency
287156|NCT01721421|haemodialysis|haemodialysis
287157|NCT01721421|Crossover|crossover
287158|NCT01721421|Treatment time|treatment time
287159|NCT01721421|nutritional status|nutritional status
287160|NCT01721395|Cough|cough
287161|NCT01721395|Nocturnal Cough|nocturnal cough
287162|NCT01721395|Agave|agave
287163|NCT01721395|Sleep Quality|sleep quality
287164|NCT01721395|Childhood cough|childhood cough
287165|NCT01721382|cystic fibrosis|cystic fibrosis
287166|NCT01721382|CF|cf
287167|NCT01721382|CFRD|cfrd
287168|NCT01721382|sitagliptin|sitagliptin
287169|NCT01721382|incretins|incretins
287170|NCT01721382|GLP1|glp1
287171|NCT01721382|GIP|gip
287172|NCT01721382|beta cell function|beta cell function
287173|NCT01721382|adolescents|adolescents
287174|NCT01721330|ADHD|adhd
287175|NCT01721330|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
287176|NCT01721330|Psychopharmacology|psychopharmacology
287177|NCT01721330|Psychiatry|psychiatry
287178|NCT01721330|Non-stimulant treatment|non-stimulant treatment
287179|NCT01721317|Ezogabine/Retigabine|ezogabine/retigabine
287180|NCT01721317|Adjunctive Treatment|adjunctive treatment
287181|NCT01721317|Safety|safety
287182|NCT01721317|Efficacy|efficacy
287183|NCT01721317|Epilepsy|epilepsy
287184|NCT01721317|Tolerability|tolerability
287185|NCT01721317|Immediate Release|immediate release
287186|NCT01721317|GW582892|gw582892
287187|NCT01721317|Dose-Optimization|dose-optimization
287497|NCT01719926|Colorectal|colorectal
287188|NCT01721317|Partial-Onset Seizures|partial-onset seizures
287189|NCT01721304|decision making|decision making
287190|NCT01721304|abnormal uterine bleeding|abnormal uterine bleeding
287191|NCT01721304|adaptive conjoint analysis|adaptive conjoint analysis
287192|NCT01721304|satisfaction|satisfaction
287193|NCT01721304|regret|regret
287194|NCT01721291|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|chronic obstructive pulmonary disease
287195|NCT01721291|ASTHMA|asthma
287196|NCT01721291|SALBUTAMOL|salbutamol
287197|NCT01721291|ALBUTEROL|albuterol
287198|NCT01721291|VENTOLIN|ventolin
287199|NCT01721291|LUNG PHYSIOLOGY|lung physiology
287200|NCT01721291|LUNG DEPOSITION|lung deposition
287201|NCT01721291|INHALERS|inhalers
287202|NCT01721291|DRUG THERAPY|drug therapy
287203|NCT01721265|HCV|hcv
287204|NCT01721265|Hepatitis C|hepatitis c
287205|NCT01721265|IDX184|idx184
287206|NCT01721265|IDX719|idx719
287207|NCT01721252|non-small cell lung cancer|non-small cell lung cancer
287208|NCT01721252|Erlotinib|erlotinib
287209|NCT01721252|TarcevaTM|tarcevatm
287210|NCT01721252|proteomic signature|proteomic signature
287211|NCT01721239|ICU|icu
287212|NCT01721239|Follow-up consultations|follow-up consultations
287213|NCT01721239|Quality of life|quality of life
287214|NCT01721239|Sense Of Coherence|sense of coherence
287215|NCT01721239|RCT multicenter study|rct multicenter study
287216|NCT01721226|Linkage to HIV care following release from prison|linkage to hiv care following release from prison
287217|NCT01721226|Anti-retroviral therapy adherence after release from prison|anti-retroviral therapy adherence after release from prison
287218|NCT01721226|HIV loads after release from prison|hiv loads after release from prison
287219|NCT01721226|information technology and ART adherence|information technology and art adherence
287220|NCT01721226|information technology and linkage to HIV care|information technology and linkage to hiv care
287221|NCT01721213|Epilepsy|epilepsy
287222|NCT01721213|survey|survey
287223|NCT01721213|retigabine|retigabine
287224|NCT01721213|patient information leaflet|patient information leaflet
287225|NCT01721213|physician's guide|physician's guide
287226|NCT01721213|Trobalt™|trobalt™
287227|NCT01721200|Rheumatoid Arthritis|rheumatoid arthritis
287228|NCT01721200|web based interactive learning tool|web based interactive learning tool
287229|NCT01721187|fMRI|fmri
287230|NCT01721187|Satiety|satiety
287231|NCT01721187|Willingness to Pay|willingness to pay
287232|NCT01721187|Incentive Delay|incentive delay
287233|NCT01721187|Dietary Disinhibition|dietary disinhibition
287234|NCT01721174|Pancreatic cancer|pancreatic cancer
287235|NCT01721174|Cholangiocarcinoma|cholangiocarcinoma
287236|NCT01721174|Endoscopic radiofrequency ablation|endoscopic radiofrequency ablation
287440|NCT01720212|YM178|ym178
287237|NCT01721161|Optic Neuritis|optic neuritis
287238|NCT01721135|moxifloxacin|moxifloxacin
287239|NCT01721135|GSK2190915|gsk2190915
287240|NCT01721135|pharmacokinetics|pharmacokinetics
287241|NCT01721135|QTc|qtc
287242|NCT01721109|Adolescents|adolescents
287243|NCT01721109|HIV-1|hiv-1
287244|NCT01721109|HIV|hiv
287245|NCT01721109|Treatment Naive|treatment naive
287246|NCT01721096|Angioplasty|angioplasty
287247|NCT01721096|Drug eluting stents|drug eluting stents
287248|NCT01721096|Stents|stents
287249|NCT01721096|Real world|real world
287250|NCT01721083|intramuscular injection|intramuscular injection
287251|NCT01721083|bunch|bunch
287252|NCT01721083|z-track|z-track
287253|NCT01721070|Area under curve, time to maximum concentration|area under curve, time to maximum concentration
287254|NCT01721031|Catheter Related Bladder Discomfort|catheter related bladder discomfort
287255|NCT01721031|Dorsal Penile Nerve Block|dorsal penile nerve block
287256|NCT01721018|Oncolytic virus|oncolytic virus
287257|NCT01721018|HSV1716|hsv1716
287258|NCT01721018|Mesothelioma|mesothelioma
287259|NCT01721018|MPM|mpm
287260|NCT01721018|Woll|woll
287261|NCT01721018|Sheffield|sheffield
287262|NCT01721018|Weston Park|weston park
287263|NCT01721018|Virttu|virttu
287264|NCT01721018|Crusade|crusade
287265|NCT01721005|atrial fibrillation|atrial fibrillation
287266|NCT01721005|thromboembolism|thromboembolism
287267|NCT01721005|patient education|patient education
287268|NCT01720979|TBI|tbi
287269|NCT01720979|Traumatic Brain Injury|traumatic brain injury
287270|NCT01720979|Children|children
287271|NCT01720979|Prognosis|prognosis
287272|NCT01720979|Neurocognition|neurocognition
287273|NCT01720966|Adhesions|adhesions
287274|NCT01720966|laparoscopy|laparoscopy
287275|NCT01720966|laparotomy|laparotomy
287276|NCT01720966|liver resection|liver resection
287277|NCT01720966|colorectal malignancy|colorectal malignancy
287278|NCT01720953|Borderline Personality Disorder|borderline personality disorder
287279|NCT01720953|Mentalization Based Therapy|mentalization based therapy
287280|NCT01720953|DNA methylation|dna methylation
287281|NCT01720953|BDNF|bdnf
287282|NCT01720953|Cortisol|cortisol
287283|NCT01720953|Neuropsychology|neuropsychology
287284|NCT01720927|Acute Pharyngitis, GABHS|acute pharyngitis, gabhs
287285|NCT01720888|Autologous|autologous
287286|NCT01720888|Bone Marrow|bone marrow
287287|NCT01720888|Mesenchymal Stem Cells|mesenchymal stem cells
287288|NCT01720888|Ischemic Dilated Cardiomyopathy|ischemic dilated cardiomyopathy
287289|NCT01720862|migraine|migraine
287290|NCT01720862|episodic migraine|episodic migraine
287291|NCT01720862|chronic migraine|chronic migraine
287292|NCT01720862|obesity|obesity
287293|NCT01720862|non-obese|non-obese
287294|NCT01720823|Obstructive Sleep Apnea syndrome|obstructive sleep apnea syndrome
287295|NCT01720823|polysomnography|polysomnography
287296|NCT01720823|Home monitoring|home monitoring
287297|NCT01720797|Malocclusion|malocclusion
287298|NCT01720797|Accelerated tooth movement|accelerated tooth movement
287299|NCT01720797|Braces|braces
287300|NCT01720797|Orthodontic treatment|orthodontic treatment
287301|NCT01720797|Propel|propel
287302|NCT01720771|bacteriotherapy|bacteriotherapy
287303|NCT01720771|caries|caries
287304|NCT01720771|preschool children|preschool children
287305|NCT01720771|probiotics|probiotics
287306|NCT01720745|EUS|eus
287307|NCT01720745|FNA|fna
287308|NCT01720745|Wet suction|wet suction
287309|NCT01720745|Dry suction|dry suction
287310|NCT01720745|Solid lesions|solid lesions
586547|NCT00516672|pharmacokinetics,|pharmacokinetics,
287311|NCT01720719|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
287312|NCT01720719|Dyslipidemias|dyslipidemias
287313|NCT01720719|Diabetes Mellitus|diabetes mellitus
287314|NCT01720719|atorvastatin|atorvastatin
287315|NCT01720719|Vitamin E|vitamin e
287316|NCT01720706|Liver tumour|liver tumour
287317|NCT01720706|Kidney tumour|kidney tumour
287318|NCT01720706|Hepatectomy|hepatectomy
287319|NCT01720706|Nephrectomy|nephrectomy
287320|NCT01720706|Metastatic Colon Cancer|metastatic colon cancer
287321|NCT01720706|Renal Cell Carcinoma|renal cell carcinoma
287322|NCT01720693|partial nephrectomy|partial nephrectomy
287323|NCT01720693|hypoperfusion|hypoperfusion
287324|NCT01720693|renal function|renal function
287325|NCT01720680|COPD|copd
287326|NCT01720680|Functional Imaging|functional imaging
287327|NCT01720680|Patient Reported Outcome (PRO)|patient reported outcome (pro)
287328|NCT01720680|Lung Function|lung function
287329|NCT01720680|AlphaCore|alphacore
287330|NCT01720680|Computational Fluid Dynamics|computational fluid dynamics
287331|NCT01720667|Seizures|seizures
287332|NCT01720667|Neonates|neonates
287333|NCT01720667|Anticonvulsants|anticonvulsants
287334|NCT01720667|Treatment|treatment
287335|NCT01720667|Levetiracetam|levetiracetam
287336|NCT01720667|Phenobarbital|phenobarbital
287337|NCT01720654|Expedited Partner Therapy|expedited partner therapy
287338|NCT01720654|MSM|msm
287339|NCT01720654|Peru|peru
287340|NCT01720654|Gonorrhea|gonorrhea
287341|NCT01720654|Chlamydia|chlamydia
287342|NCT01720641|MSM|msm
287343|NCT01720641|Transgender Women|transgender women
287344|NCT01720641|Partner Notification|partner notification
287345|NCT01720641|Syphilis|syphilis
287346|NCT01720641|Peru|peru
287347|NCT01720628|Angiogenin, Behçet's disease, bFGF, VEGF|angiogenin, behçet's disease, bfgf, vegf
287348|NCT01720615|EEG|eeg
287349|NCT01720615|AEP|aep
287350|NCT01720615|Propofol|propofol
287351|NCT01720615|Sevoflurane|sevoflurane
287352|NCT01720615|Remifentanil|remifentanil
287353|NCT01720615|General anesthesia|general anesthesia
287354|NCT01720589|Obesity|obesity
287355|NCT01720589|Dietary fat|dietary fat
287356|NCT01720589|Energy expenditure|energy expenditure
287357|NCT01720589|Food intake|food intake
287358|NCT01720563|Cancer-related fatigue|cancer-related fatigue
287359|NCT01720563|astragalus polysaccharides|astragalus polysaccharides
287360|NCT01720563|concurrent chemoradiotherapy|concurrent chemoradiotherapy
287361|NCT01720563|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
287362|NCT01720550|Cancer-related fatigue|cancer-related fatigue
287363|NCT01720550|Palliative Treatment|palliative treatment
287364|NCT01720550|Astragalus polysaccharides|astragalus polysaccharides
287365|NCT01720537|High Cholesterol|high cholesterol
287366|NCT01720537|Dyslipidemia|dyslipidemia
287367|NCT01720524|persistent pulmonary hypertension|persistent pulmonary hypertension
287368|NCT01720524|newborn|newborn
287369|NCT01720524|neonates|neonates
287370|NCT01720524|iv sildenafil|iv sildenafil
287501|NCT01719900|Dietary intervention|dietary intervention
287502|NCT01719900|Dietary fibre|dietary fibre
287371|NCT01720524|hypoxic respiratory failure and at risk of persistent pulmonary hypertension of the newborn|hypoxic respiratory failure and at risk of persistent pulmonary hypertension of the newborn
287372|NCT01720472|Aging|aging
287373|NCT01720472|Healthy Aging|healthy aging
287374|NCT01720472|Physical Performance|physical performance
287375|NCT01720472|Physical Functioning|physical functioning
287376|NCT01720472|Cognitive Functioning|cognitive functioning
287377|NCT01720472|Fitness|fitness
287378|NCT01720472|Physical Activity|physical activity
287379|NCT01720433|laparoscopic pain prospective blinded trial|laparoscopic pain prospective blinded trial
287380|NCT01720420|edentulous|edentulous
287381|NCT01720420|maxilla|maxilla
287382|NCT01720420|mandible|mandible
287383|NCT01720420|dental implant|dental implant
287384|NCT01720420|bar|bar
287385|NCT01720420|overdenture|overdenture
287386|NCT01720420|Oral Health Impact Profile (OHIP)|oral health impact profile (ohip)
287387|NCT01720420|survival rate|survival rate
287388|NCT01720420|technical complications|technical complications
287498|NCT01719926|Esophageal|esophageal
287389|NCT01720420|marginal bone level|marginal bone level
287390|NCT01720420|soft tissue|soft tissue
287391|NCT01720407|Dermatology/ Skin cancers/Lentigo maligna melanoma|dermatology/ skin cancers/lentigo maligna melanoma
287392|NCT01720381|monitoring|monitoring
287393|NCT01720381|blood glucose|blood glucose
287394|NCT01720381|intensive care unit|intensive care unit
287395|NCT01720368|IBD|ibd
287396|NCT01720368|Crohn's|crohn's
287397|NCT01720342|Medtronic Enable® aortic bioprosthesis|medtronic enable® aortic bioprosthesis
287398|NCT01720342|Aortic valve stenosis|aortic valve stenosis
287399|NCT01720342|Aortic valve insufficiency|aortic valve insufficiency
287400|NCT01720342|"Real world patients"|"real world patients"
287401|NCT01720316|Glycine|glycine
287402|NCT01720316|Glycine decarboxylase|glycine decarboxylase
287403|NCT01720316|Psychosis|psychosis
287404|NCT01720316|Mutation|mutation
586548|NCT00516672|safety,|safety,
287405|NCT01720277|Randomized Controlled Trial|randomized controlled trial
287406|NCT01720277|Influenza|influenza
287407|NCT01720277|Influenza vaccine|influenza vaccine
287408|NCT01720277|Flu Vaccine|flu vaccine
287409|NCT01720277|Fluzone|fluzone
287410|NCT01720277|HD Fluzone|hd fluzone
287411|NCT01720277|Nursing Homes|nursing homes
287412|NCT01720277|Hospitalization|hospitalization
287413|NCT01720277|Mortality|mortality
287414|NCT01720277|Health Care worker vaccination|health care worker vaccination
287415|NCT01720277|ADL decline|adl decline
287416|NCT01720277|Pilot|pilot
287417|NCT01720277|Effectiveness|effectiveness
287418|NCT01720251|allergic rhinitis|allergic rhinitis
287419|NCT01720251|birch pollen|birch pollen
287420|NCT01720251|immunotherapy|immunotherapy
287421|NCT01720238|Compensated Liver Cirrhosis|compensated liver cirrhosis
287422|NCT01720238|Early Antiviral Therapy|early antiviral therapy
287423|NCT01720238|Cost Effectiveness|cost effectiveness
287424|NCT01720225|Leukemia|leukemia
287425|NCT01720225|Myelodysplastic syndromes|myelodysplastic syndromes
287426|NCT01720225|MDS|mds
287427|NCT01720225|Low and Intermediate-1 Risk Disease|low and intermediate-1 risk disease
287428|NCT01720225|Decitabine|decitabine
287429|NCT01720225|DAC|dac
287430|NCT01720225|Dacogen|dacogen
287431|NCT01720225|Azacitidine|azacitidine
287432|NCT01720225|AZA|aza
287433|NCT01720225|5-azacytidine|5-azacytidine
287434|NCT01720225|5-aza|5-aza
287435|NCT01720225|Vidaza|vidaza
287436|NCT01720225|5-AZC|5-azc
287437|NCT01720225|AZA-CR|aza-cr
287438|NCT01720225|Ladakamycin|ladakamycin
287439|NCT01720225|NSC-102816|nsc-102816
287441|NCT01720212|Mirabegron|mirabegron
287442|NCT01720212|OCAS|ocas
287443|NCT01720212|Chinese Healthy Volunteers|chinese healthy volunteers
287444|NCT01720212|PK|pk
287445|NCT01720212|Safety|safety
287446|NCT01720199|universal prevention|universal prevention
287447|NCT01720199|primary prevention|primary prevention
287448|NCT01720199|health promotion|health promotion
287449|NCT01720199|wellbeing|wellbeing
287450|NCT01720199|smoking|smoking
287451|NCT01720199|alcohol|alcohol
287452|NCT01720199|diet|diet
287453|NCT01720199|physical activity|physical activity
287454|NCT01720199|emotional and social skills|emotional and social skills
287455|NCT01720186|Lung Cancer|lung cancer
287456|NCT01720186|PET/CT|pet/ct
287457|NCT01720186|FDG|fdg
287458|NCT01720186|Respiratory synchronization|respiratory synchronization
287459|NCT01720147|Fanconi Anemia|fanconi anemia
287460|NCT01720147|FA|fa
287461|NCT01720147|Quercetin|quercetin
287462|NCT01720043|multiple myeloma|multiple myeloma
287463|NCT01720030|Renal|renal
287464|NCT01720030|Acute Kidney Injury|acute kidney injury
287465|NCT01720030|AKI|aki
287466|NCT01720030|Levosimendan|levosimendan
287467|NCT01720030|Simdax|simdax
287468|NCT01720030|Renal perfusion|renal perfusion
287469|NCT01720030|Mortality|mortality
287470|NCT01720030|Renal flow|renal flow
287471|NCT01720017|Airtraq|airtraq
287472|NCT01720017|laryngoscope|laryngoscope
287473|NCT01720017|airway|airway
287474|NCT01720017|difficult|difficult
287475|NCT01720017|training|training
287476|NCT01720017|manikin|manikin
287477|NCT01720004|human labour|human labour
287478|NCT01720004|hands-and-knees positioning|hands-and-knees positioning
287479|NCT01720004|pilot trial|pilot trial
287480|NCT01719991|Primary care|primary care
287481|NCT01719991|Self-management|self-management
287482|NCT01719991|Self-support|self-support
287483|NCT01719991|Nurse case management|nurse case management
287484|NCT01719978|Local Anaesthetics|local anaesthetics
287485|NCT01719978|Mepivacaine|mepivacaine
287486|NCT01719978|hyaluronoglucosaminidase|hyaluronoglucosaminidase
287487|NCT01719978|Hemodynamic|hemodynamic
287488|NCT01719978|Electrocardiography and Dentistry.|electrocardiography and dentistry.
287489|NCT01719965|Community Advisory Board|community advisory board
287490|NCT01719965|Focus Group Discussion|focus group discussion
287491|NCT01719965|Interview|interview
287492|NCT01719965|Community Engagement|community engagement
287493|NCT01719965|Thailand|thailand
287494|NCT01719952|pregnancy|pregnancy
287495|NCT01719952|anaesthesia|anaesthesia
287496|NCT01719952|caesarean section|caesarean section
287499|NCT01719926|Indomethacin|indomethacin
287500|NCT01719926|PIFA|pifa
287503|NCT01719900|Obesity|obesity
287504|NCT01719900|Metabolic syndrome|metabolic syndrome
287505|NCT01719900|Weight loss|weight loss
287506|NCT01719900|Glucose regulation|glucose regulation
287507|NCT01719900|Pulse fibre|pulse fibre
287508|NCT01719887|humerus|humerus
287509|NCT01719887|humeral|humeral
287510|NCT01719887|shaft|shaft
287511|NCT01719887|diaphysis|diaphysis
287512|NCT01719887|fracture|fracture
287513|NCT01719887|RCT|rct
287514|NCT01719874|Influenza|influenza
287515|NCT01719874|monoclonal antibody|monoclonal antibody
287516|NCT01719848|Physical examinations, Percentage of glottic opening(POGO)|physical examinations, percentage of glottic opening(pogo)
287517|NCT01719835|T cell lymphoma|t cell lymphoma
287518|NCT01719835|untreated|untreated
287519|NCT01719822|Treatment Outcome [E01.789.800]|treatment outcome [e01.789.800]
287520|NCT01719822|Rehabilitation [N02.421.784]|rehabilitation [n02.421.784]
287521|NCT01719822|Physical Fitness [I03.621]|physical fitness [i03.621]
287522|NCT01719822|Lung Diseases, Obstructive [C08.381.495]|lung diseases, obstructive [c08.381.495]
287523|NCT01719822|Pulmonary Disease, Chronic Obstructive [C08.381.495.389]|pulmonary disease, chronic obstructive [c08.381.495.389]
287524|NCT01719822|Bronchitis, Chronic [C08.381.495.389.500]|bronchitis, chronic [c08.381.495.389.500]
287525|NCT01719809|Glaucoma|glaucoma
287526|NCT01719809|Eye Drop|eye drop
287527|NCT01719809|Eye Drop Technique|eye drop technique
287528|NCT01719809|Training|training
287529|NCT01719809|Instilling Eye Drops|instilling eye drops
287530|NCT01719783|influenza|influenza
287531|NCT01719783|vaccine|vaccine
287532|NCT01719783|pandemic|pandemic
287533|NCT01719770|cardiac arrest|cardiac arrest
287534|NCT01719770|therapeutic hypothermia|therapeutic hypothermia
287535|NCT01719770|skeletal muscle paralysis|skeletal muscle paralysis
287536|NCT01719770|shivering|shivering
287537|NCT01719770|serum drug levels|serum drug levels
287538|NCT01719770|basal metabolism|basal metabolism
287539|NCT01719757|Targin, Cancer Pain|targin, cancer pain
287540|NCT01719744|ENMD-2076|enmd-2076
287541|NCT01719744|advanced|advanced
287542|NCT01719744|metastatic|metastatic
287543|NCT01719744|soft tissue sarcoma|soft tissue sarcoma
287544|NCT01719731|BPD|bpd
287545|NCT01719718|ventral hernia|ventral hernia
287546|NCT01719705|caesarean delivery|caesarean delivery
287547|NCT01719705|spinal anesthesia|spinal anesthesia
287548|NCT01719705|pregabalin|pregabalin
287549|NCT01719705|postoperative pain|postoperative pain
287550|NCT01719705|morphine|morphine
287551|NCT01719679|school located vaccine program|school located vaccine program
287552|NCT01719666|MPFL|mpfl
287553|NCT01719666|patella|patella
287554|NCT01719666|dislocation|dislocation
287555|NCT01719666|release|release
287556|NCT01719653|Colonoscopy|colonoscopy
287557|NCT01719653|Bowel Preparation|bowel preparation
287558|NCT01719653|MiraLAX|miralax
287559|NCT01719653|Gatorade|gatorade
287560|NCT01719653|PEG-3350|peg-3350
287561|NCT01719653|MoviPrep|moviprep
278151|NCT01762683|differentiation|differentiation
278152|NCT01762670|Bacterial Vaginosis|bacterial vaginosis
278153|NCT01762670|BV|bv
278154|NCT01762657|Type 1 Diabetes|type 1 diabetes
287562|NCT01719653|SUPREP|suprep
287563|NCT01719653|Chicago Bowel Preparation Scale|chicago bowel preparation scale
287564|NCT01719653|Boston Bowel Preparation Scale|boston bowel preparation scale
287565|NCT01719640|mesenchymal stem cell|mesenchymal stem cell
287566|NCT01719640|central nervous system|central nervous system
287567|NCT01719627|HIV, Maraviroc, PrEP, Ex vivo infection, rectal mucosa.|hiv, maraviroc, prep, ex vivo infection, rectal mucosa.
287568|NCT01719614|Healthy participants|healthy participants
287569|NCT01719614|Rilpivirine|rilpivirine
287570|NCT01719614|Metformin|metformin
287571|NCT01719614|Pharmacokinetics|pharmacokinetics
287572|NCT01719601|Moderate to severe acute non-cancer pain|moderate to severe acute non-cancer pain
287573|NCT01719601|Immediate release tapentadol hydrochloride|immediate release tapentadol hydrochloride
287574|NCT01719601|Tapentadol IR|tapentadol ir
287575|NCT01719601|Nucynta IR|nucynta ir
287576|NCT01719588|Moderate to severe chronic non-cancer pain|moderate to severe chronic non-cancer pain
287577|NCT01719588|Prolonged release tapentadol hydrochloride|prolonged release tapentadol hydrochloride
287578|NCT01719588|Tapentadol PR|tapentadol pr
287579|NCT01719588|Extended release tapentadol hydrochloride|extended release tapentadol hydrochloride
287580|NCT01719588|Nucynta PR|nucynta pr
287581|NCT01719549|Gastric Cancer|gastric cancer
287582|NCT01719549|Dovitinib|dovitinib
287583|NCT01719523|Tourette syndrome|tourette syndrome
287584|NCT01719523|Tics|tics
287585|NCT01719523|Tic Disorders|tic disorders
287586|NCT01719510|Group B Streptococcus,|group b streptococcus,
287587|NCT01719510|Vaginal screening|vaginal screening
287588|NCT01719510|Per partum antibiotic prophylaxis|per partum antibiotic prophylaxis
287589|NCT01719510|Meningitis|meningitis
287590|NCT01719510|Neonatal infection|neonatal infection
287592|NCT01719510|Streptococcus agalactiae.|streptococcus agalactiae.
287593|NCT01719445|Energy Intake|energy intake
287594|NCT01719432|Filgrastim|filgrastim
287595|NCT01719432|Obese|obese
287596|NCT01719432|Non-obese|non-obese
287597|NCT01719432|Pharmacokinetics|pharmacokinetics
287598|NCT01719406|Gestational diabetes|gestational diabetes
287599|NCT01719406|Exercise|exercise
287600|NCT01719406|Diet|diet
287601|NCT01719406|Fruits|fruits
287602|NCT01719406|Vegetables|vegetables
287603|NCT01719406|Whole grains|whole grains
287604|NCT01719406|pregnancy weight|pregnancy weight
287605|NCT01719393|Asthma|asthma
287606|NCT01719393|Pulse spectrum analysis|pulse spectrum analysis
287607|NCT01719393|lung function|lung function
287608|NCT01719393|exhaled nitric oxide|exhaled nitric oxide
287609|NCT01719393|metabolites|metabolites
287610|NCT01719393|exhaled breath condensate|exhaled breath condensate
402016|NCT01233479|childhood medulloepithelioma|childhood medulloepithelioma
402017|NCT01233479|childhood infratentorial ependymoma|childhood infratentorial ependymoma
586549|NCT00516672|pazopanib,|pazopanib,
287611|NCT01719380|Open-label dose escalation; BRAF inhibitor; LGX818; PI3K inhibitor; BYL719; EGFR; cetuximab; metastatic colorectal cancer; KRAS; BRAF; V600|open-label dose escalation; braf inhibitor; lgx818; pi3k inhibitor; byl719; egfr; cetuximab; metastatic colorectal cancer; kras; braf; v600
287612|NCT01719367|Baseline (pre-atenolol)|baseline (pre-atenolol)
287613|NCT01719367|Post-atenolol|post-atenolol
287614|NCT01719354|Community Mental Health Centers|community mental health centers
287615|NCT01719354|Norway|norway
287616|NCT01719354|Aftercare|aftercare
287617|NCT01719328|yoga,|yoga,
287618|NCT01719328|exercise|exercise
287619|NCT01719328|affect|affect
287620|NCT01719328|mind/body therapies|mind/body therapies
287621|NCT01719328|stress, psychological|stress, psychological
287622|NCT01719302|Soft tissue sarcoma|soft tissue sarcoma
287623|NCT01719302|gemcitabine|gemcitabine
287624|NCT01719302|docetaxel|docetaxel
287625|NCT01719302|pazopanib|pazopanib
287626|NCT01719289|depression|depression
287627|NCT01719289|problem solving|problem solving
287628|NCT01719263|emphysema|emphysema
287629|NCT01719263|InterVapor|intervapor
287630|NCT01719263|treatments|treatments
287631|NCT01719263|pulmonary rehabilitation|pulmonary rehabilitation
287632|NCT01719263|lung volume reduction|lung volume reduction
287633|NCT01719263|endoscopic lung volume reduction|endoscopic lung volume reduction
287634|NCT01719237|Onset|onset
287635|NCT01719237|Duration|duration
287636|NCT01719237|Upper Limb Block|upper limb block
287637|NCT01719237|Ultrasound guided supraclavicular block|ultrasound guided supraclavicular block
287638|NCT01719237|Ropivacaine|ropivacaine
287639|NCT01719237|Chloroprocaine|chloroprocaine
287640|NCT01719211|MVP, mitral valve|mvp, mitral valve
287641|NCT01719198|adenoma|adenoma
287642|NCT01719198|calprotectin|calprotectin
287643|NCT01719159|Progressive multiple sclerosis|progressive multiple sclerosis
287644|NCT01719159|Monoclonal antibodies|monoclonal antibodies
287645|NCT01719159|Mabthera|mabthera
278256|NCT01762085|neuropathic diabetic foot ulcer|neuropathic diabetic foot ulcer
278257|NCT01762085|nerve decompression surgery|nerve decompression surgery
278259|NCT01762059|bionic pancreas|bionic pancreas
287646|NCT01719159|Intrathecal treatment|intrathecal treatment
287647|NCT01719146|Anemia|anemia
287648|NCT01719146|Chronic Kidney Disease|chronic kidney disease
287649|NCT01719146|Erythropoiesis Stimulating Agents|erythropoiesis stimulating agents
287650|NCT01719146|Erythropoietin|erythropoietin
287651|NCT01719146|Iron|iron
287652|NCT01719146|Iron Deficiency|iron deficiency
287653|NCT01719133|allergy|allergy
287654|NCT01719133|birch|birch
287655|NCT01719120|Insomnia|insomnia
287656|NCT01719120|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
287657|NCT01719120|Internet-Based|internet-based
287658|NCT01719120|Self-Help|self-help
287659|NCT01719120|Randomized Controlled Trial|randomized controlled trial
287660|NCT01719107|Functional abdominal pain|functional abdominal pain
287661|NCT01719107|Probiotics|probiotics
287662|NCT01719107|Lactobacilus reuteri|lactobacilus reuteri
287663|NCT01719081|Sacroiliac Joint|sacroiliac joint
287664|NCT01719081|Ultrasound|ultrasound
287665|NCT01719081|Fluoroscopy|fluoroscopy
287666|NCT01719081|Chronic Pain|chronic pain
287667|NCT01719068|Mesothelioma|mesothelioma
287668|NCT01719068|Lung Cancer|lung cancer
287669|NCT01719068|Early Detection|early detection
287670|NCT01719055|stimulation|stimulation
287671|NCT01719055|implantable|implantable
287672|NCT01719055|pulse generator|pulse generator
287673|NCT01719055|back pain|back pain
287674|NCT01719055|chronic pain|chronic pain
287675|NCT01719055|leg pain|leg pain
287676|NCT01719029|continuous glucose monitoring|continuous glucose monitoring
287677|NCT01719029|gestational diabetes|gestational diabetes
287678|NCT01719029|diet therapy|diet therapy
287679|NCT01719016|Reversible ischemia|reversible ischemia
287680|NCT01719016|microvascular dysfunction|microvascular dysfunction
287681|NCT01718977|Intervention|intervention
287682|NCT01718977|Body Weight Supported Treadmill Training|body weight supported treadmill training
287683|NCT01718977|Arm Cycle Ergometry Training|arm cycle ergometry training
287684|NCT01718977|Aortic Pulse Wave Velocity|aortic pulse wave velocity
287685|NCT01718951|spondyloarthropathy|spondyloarthropathy
287686|NCT01718951|ankylosing spondylitis|ankylosing spondylitis
287687|NCT01718938|Gastroparesis|gastroparesis
287688|NCT01718938|Diabetic|diabetic
287689|NCT01718938|Idiopathic|idiopathic
287690|NCT01718938|Delayed gastric emptying|delayed gastric emptying
287691|NCT01718912|periodontal disease|periodontal disease
287692|NCT01718912|bleeding on probing|bleeding on probing
287693|NCT01718912|periodontal pockets|periodontal pockets
287694|NCT01718912|disabled|disabled
287695|NCT01718886|Obesity|obesity
287696|NCT01718886|Weight loss|weight loss
287697|NCT01718886|Weight control|weight control
287698|NCT01718886|Intragastric balloon|intragastric balloon
287699|NCT01718886|gastric balloon|gastric balloon
287700|NCT01718873|metastatic|metastatic
287701|NCT01718873|stage IV|stage iv
287702|NCT01718860|Cost Analysis|cost analysis
287703|NCT01718860|Postoperative Complications|postoperative complications
287704|NCT01718860|Length of Stay|length of stay
287705|NCT01718860|Intensive Care Units|intensive care units
287706|NCT01718847|EGFR Tyrosine Kinase Inhibitor|egfr tyrosine kinase inhibitor
705113|NCT00977756|Treatment|treatment
287707|NCT01718847|Aquired resistance to EGFR TKI|aquired resistance to egfr tki
287708|NCT01718847|Pan-Her inhibitor|pan-her inhibitor
287709|NCT01718834|prophylactic vaccine|prophylactic vaccine
287710|NCT01718834|chronic HCV patients|chronic hcv patients
287711|NCT01718834|healthy risk volunteers|healthy risk volunteers
287712|NCT01718808|Metastatic Colorectal Cancer|metastatic colorectal cancer
287713|NCT01718808|KRAS|kras
287714|NCT01718808|BRAF|braf
287715|NCT01718808|Wild-type Metastatic|wild-type metastatic
287716|NCT01718808|Cetuximab|cetuximab
287717|NCT01718808|Capecitabine|capecitabine
287718|NCT01718808|Phase II Trial|phase ii trial
287719|NCT01718808|Elderly Patients|elderly patients
287720|NCT01718795|Airway|airway
287721|NCT01718795|Cardiac Arrest|cardiac arrest
287722|NCT01718795|CPR|cpr
287723|NCT01718795|Ventilation|ventilation
287724|NCT01718782|laryngeal mask, leakage pressure, ventilation|laryngeal mask, leakage pressure, ventilation
287725|NCT01718769|Nutritional assessment|nutritional assessment
287726|NCT01718769|children|children
287727|NCT01718769|malnutrition|malnutrition
287728|NCT01718756|Orthopaedic|orthopaedic
287729|NCT01718756|General anaesthesia|general anaesthesia
287730|NCT01718756|lornoxicam|lornoxicam
287731|NCT01718756|patient controlled analgesia|patient controlled analgesia
287732|NCT01718756|morphine consumption|morphine consumption
287733|NCT01718743|Myeloma|myeloma
287734|NCT01718743|Multiple Myeloma|multiple myeloma
287735|NCT01718743|MM|mm
287842|NCT01718275|Appendicitis|appendicitis
287736|NCT01718743|Post Autologous Stem Cell Transplant|post autologous stem cell transplant
287737|NCT01718743|Lenalidomide|lenalidomide
287738|NCT01718743|CC-5013|cc-5013
287739|NCT01718743|Revlimid|revlimid
287740|NCT01718743|MLN9708|mln9708
287741|NCT01718743|Questionnaire|questionnaire
287742|NCT01718743|Survey|survey
287743|NCT01718730|TMS|tms
287744|NCT01718730|Adolescent|adolescent
287745|NCT01718730|Child|child
287746|NCT01718730|MDD|mdd
287747|NCT01718730|Major depressive disorder|major depressive disorder
287748|NCT01718730|Mild MDD|mild mdd
287749|NCT01718730|Mild depression|mild depression
287750|NCT01718730|SSRI|ssri
287751|NCT01718730|Motor cortex|motor cortex
287752|NCT01718730|Cortical excitability|cortical excitability
287753|NCT01718730|Cortical inhibition|cortical inhibition
287754|NCT01718730|Cortical silent period|cortical silent period
287755|NCT01718730|Motor threshold|motor threshold
287756|NCT01718730|Intracortical facilitation|intracortical facilitation
287757|NCT01718730|Intracortical inhibition|intracortical inhibition
287758|NCT01718730|gamma-aminobutyric acid (GABA)|gamma-aminobutyric acid (gaba)
287759|NCT01718730|Glutamate|glutamate
287760|NCT01718730|N-methyl-D-aspartate (NMDA)|n-methyl-d-aspartate (nmda)
287761|NCT01718730|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
287762|NCT01718730|MRS|mrs
287763|NCT01718717|Thoracotomy|thoracotomy
287764|NCT01718717|Thoracic epidural analgesia|thoracic epidural analgesia
287765|NCT01718717|Arrythmiogenesis|arrythmiogenesis
287766|NCT01718717|Atrial fibrillation|atrial fibrillation
287767|NCT01718717|Sympathetic outflow|sympathetic outflow
287768|NCT01718704|rehabilitation|rehabilitation
287769|NCT01718704|erectile dysfunction|erectile dysfunction
287770|NCT01718704|incontinence|incontinence
287771|NCT01718678|Multiple sclerosis|multiple sclerosis
287772|NCT01718678|Melatonin|melatonin
287773|NCT01718678|Fatigue|fatigue
287774|NCT01718678|Quality of life|quality of life
287775|NCT01718652|Healthy|healthy
287776|NCT01718652|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
287777|NCT01718652|Pharmacokinetics|pharmacokinetics
287778|NCT01718652|Cyclosporine|cyclosporine
287779|NCT01718600|carotid artery stenting|carotid artery stenting
287780|NCT01718600|neuropsychological testing|neuropsychological testing
287781|NCT01718600|microembolization|microembolization
287782|NCT01718600|MRI|mri
287783|NCT01718587|umbilical cord mesenchyma stem cell|umbilical cord mesenchyma stem cell
287784|NCT01718587|liver cirrhosis|liver cirrhosis
287785|NCT01718587|antiviral therapy|antiviral therapy
287786|NCT01718574|self-help book|self-help book
287787|NCT01718574|support service|support service
287788|NCT01718561|Airway assessment|airway assessment
287789|NCT01718561|Intubation|intubation
287790|NCT01718561|Mask ventilation|mask ventilation
287791|NCT01718535|Cyp2C19|cyp2c19
287792|NCT01718535|Genotyping|genotyping
287793|NCT01718535|Spartan|spartan
287794|NCT01718535|Comparison|comparison
287795|NCT01718535|Sequencing|sequencing
287796|NCT01718496|dyspnea|dyspnea
287797|NCT01718496|COPD|copd
287798|NCT01718496|exercise tolerance|exercise tolerance
287799|NCT01718496|opioids|opioids
287800|NCT01718496|morphine|morphine
287801|NCT01718496|single dose oral Morphine|single dose oral morphine
287802|NCT01718470|Systolic blood pressure|systolic blood pressure
287803|NCT01718470|Heart rate|heart rate
287804|NCT01718470|Laryngeal mask|laryngeal mask
287805|NCT01718470|Endotracheal tube|endotracheal tube
287806|NCT01718470|craniotomy|craniotomy
287807|NCT01718457|Endobarrier|endobarrier
287808|NCT01718457|Diabetes|diabetes
287809|NCT01718457|Obesity|obesity
287810|NCT01718457|Weight|weight
287811|NCT01718457|BMI|bmi
287812|NCT01718457|Lipid profile|lipid profile
287813|NCT01718457|fatty liver|fatty liver
287814|NCT01718457|gut peptides|gut peptides
287815|NCT01718457|HbA1c|hba1c
287816|NCT01718444|PCOS|pcos
287817|NCT01718444|Polycystic ovary syndrome|polycystic ovary syndrome
287818|NCT01718444|Infertility|infertility
287819|NCT01718444|Anovulation|anovulation
287820|NCT01718444|Clomiphene citrate|clomiphene citrate
287821|NCT01718444|Clomid|clomid
287822|NCT01718444|Progestin|progestin
287823|NCT01718444|Provera|provera
287824|NCT01718444|Progesterone|progesterone
287825|NCT01718444|Endometrial shedding|endometrial shedding
287826|NCT01718392|combined training|combined training
287827|NCT01718392|insulin resistance|insulin resistance
287828|NCT01718379|Myelodysplasia|myelodysplasia
287829|NCT01718340|PCOS|pcos
287830|NCT01718340|Hyper insulinaemia|hyper insulinaemia
287831|NCT01718340|metformin|metformin
287832|NCT01718340|recurrent abortion|recurrent abortion
287833|NCT01718327|Cholangiocarcinoma|cholangiocarcinoma
287834|NCT01718314|Hysteroscopy|hysteroscopy
287835|NCT01718314|Misoprostol|misoprostol
287836|NCT01718314|Lidocaine|lidocaine
287837|NCT01718314|Visual analogue score|visual analogue score
287838|NCT01718301|HCV|hcv
287839|NCT01718301|HIV|hiv
287840|NCT01718301|Coinfection|coinfection
287841|NCT01718288|PAD; iloprost; walking distance; cardiovascular events|pad; iloprost; walking distance; cardiovascular events
287843|NCT01718275|Pediatrics|pediatrics
287844|NCT01718275|Children|children
287845|NCT01718275|Non-operative|non-operative
287846|NCT01718262|Ropivacaine Level|ropivacaine level
287847|NCT01718262|continuous peripheral nerve blocks.|continuous peripheral nerve blocks.
287848|NCT01718249|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
287849|NCT01718249|Post-coma|post-coma
287850|NCT01718249|Consciousness|consciousness
287851|NCT01718249|Vegetative state|vegetative state
287852|NCT01718249|Minimally conscious state|minimally conscious state
287853|NCT01718236|caesarean section|caesarean section
287854|NCT01718236|rocuronium|rocuronium
287855|NCT01718236|sugammadex|sugammadex
287856|NCT01718210|GM-CSF|gm-csf
287857|NCT01718210|recurrent implantation failure|recurrent implantation failure
287858|NCT01718210|pregnancy rate|pregnancy rate
287859|NCT01718210|IVF|ivf
287860|NCT01718197|Severe Asthma|severe asthma
287861|NCT01718197|Bronchoscopy|bronchoscopy
287862|NCT01718184|sulcoflex|sulcoflex
287863|NCT01718184|toric|toric
287864|NCT01718184|corneal implantation|corneal implantation
287865|NCT01718171|Appendicitis|appendicitis
287866|NCT01718171|SIRS|sirs
287867|NCT01718171|C-reactive protein|c-reactive protein
287868|NCT01718132|Quality of the anaesthetic care in a PACU|quality of the anaesthetic care in a pacu
287869|NCT01718132|reduction of postoperative pain|reduction of postoperative pain
287870|NCT01718132|reduction of postoperative nausea and vomiting|reduction of postoperative nausea and vomiting
287871|NCT01718132|quality markers|quality markers
287872|NCT01718106|coronary artery disease|coronary artery disease
287873|NCT01718106|drug eluting stent|drug eluting stent
287874|NCT01718106|bioabsorbable polymer|bioabsorbable polymer
287875|NCT01718106|percutaneous coronary intervention|percutaneous coronary intervention
287876|NCT01718106|restenosis|restenosis
287877|NCT01718106|late thrombosis|late thrombosis
287878|NCT01718093|Adolescents|adolescents
287879|NCT01718080|Obese, Lean, Pubertal, Prepubertal, Glucose, Adolescents, Type 2 Diabetes|obese, lean, pubertal, prepubertal, glucose, adolescents, type 2 diabetes
287880|NCT01718067|Chest physiotherapy|chest physiotherapy
287881|NCT01718067|Rehabilitation|rehabilitation
287882|NCT01718067|Chronic respiratory diseases|chronic respiratory diseases
287883|NCT01718054|Vascular function|vascular function
287884|NCT01718054|Ready to use supplementary foods|ready to use supplementary foods
287885|NCT01718054|Chloroquine|chloroquine
287886|NCT01718054|Children|children
287887|NCT01718054|Growth|growth
287888|NCT01718054|Nitric Oxide|nitric oxide
287889|NCT01718041|Growth hormone|growth hormone
287890|NCT01718041|Growth hormone deficiency|growth hormone deficiency
287891|NCT01718041|Growth|growth
287892|NCT01718041|Pediatric growth hormone deficiency|pediatric growth hormone deficiency
287893|NCT01718041|Long acting growth hormone|long acting growth hormone
287894|NCT01718041|GHD|ghd
287895|NCT01718041|PGHD|pghd
287896|NCT01718041|VRS 317|vrs 317
287897|NCT01718041|Exten|exten
287898|NCT01718041|Versartis|versartis
287899|NCT01718028|Systane BALANCE|systane balance
287900|NCT01718028|Dry eye|dry eye
287901|NCT01718028|lipid deficiency|lipid deficiency
287902|NCT01718028|NITFBUT|nitfbut
287903|NCT01718015|Vascular Endothelial Growth Factor|vascular endothelial growth factor
287904|NCT01718015|Brain-Derived Neurothropic Factor|brain-derived neurothropic factor
287905|NCT01718015|Diabetes Mellitus|diabetes mellitus
287907|NCT01718015|Cerebrospinal fluid|cerebrospinal fluid
287908|NCT01718015|Peripheral Nervous System Diseases|peripheral nervous system diseases
287909|NCT01718015|Mass spectrometry|mass spectrometry
287910|NCT01718002|Nursing|nursing
287911|NCT01718002|Simulation|simulation
287912|NCT01718002|Education|education
287913|NCT01717989|Dialysis|dialysis
287914|NCT01717989|Prospective Payment System|prospective payment system
287915|NCT01717989|Center for Medicare and Medicaide Services|center for medicare and medicaide services
287916|NCT01717989|End Stage Renal Disease|end stage renal disease
287917|NCT01717989|Concomitant Medications Dosage /Treatment patterns|concomitant medications dosage /treatment patterns
287918|NCT01717976|emergency department use|emergency department use
287919|NCT01717976|Veterans|veterans
287920|NCT01717950|Human Hookworm|human hookworm
287921|NCT01717950|Necator americanus|necator americanus
287922|NCT01717950|Hookworm|hookworm
287923|NCT01717950|Hookworm Disease|hookworm disease
287924|NCT01717950|Iron-deficiency anemia|iron-deficiency anemia
287925|NCT01717950|Soil-transmitted helminth infection|soil-transmitted helminth infection
287926|NCT01717950|Neglected Tropical Disease|neglected tropical disease
287927|NCT01717950|Na-APR-1|na-apr-1
287928|NCT01717937|retinovascular disease|retinovascular disease
287929|NCT01717937|imaging|imaging
287930|NCT01717937|fluorescein angiography|fluorescein angiography
287931|NCT01717937|FA|fa
287932|NCT01717937|angiography|angiography
287933|NCT01717937|optical coherence tomography|optical coherence tomography
287934|NCT01717937|OCT|oct
287935|NCT01717937|phase variance|phase variance
287936|NCT01717937|comparison|comparison
287937|NCT01717937|age-related macular degeneration|age-related macular degeneration
287938|NCT01717937|diabetic retinopathy|diabetic retinopathy
356294|NCT01425086|PCM|pcm
288538|NCT01715415|ombitasvir|ombitasvir
287939|NCT01717937|hypertensive retinopathy|hypertensive retinopathy
287940|NCT01717937|retinal vein occlusion|retinal vein occlusion
287941|NCT01717937|retinal artery occlusion|retinal artery occlusion
287942|NCT01717924|Signet ring cell|signet ring cell
287943|NCT01717924|gastric adenocarcinoma|gastric adenocarcinoma
287944|NCT01717924|peri-operative chemotherapy|peri-operative chemotherapy
287945|NCT01717924|surgery|surgery
287946|NCT01717911|Newly diagnosed type 2 diabetes|newly diagnosed type 2 diabetes
287947|NCT01717911|Insulin, metformin, sitagliptin|insulin, metformin, sitagliptin
287948|NCT01717911|beta-cell function, glycemic control|beta-cell function, glycemic control
287949|NCT01717898|Castrate-resistant prostate cancer|castrate-resistant prostate cancer
287950|NCT01717885|Pharmacokinetics|pharmacokinetics
287951|NCT01717885|Antimalarial|antimalarial
287952|NCT01717885|HIV|hiv
287953|NCT01717885|Antiretrovirals|antiretrovirals
287954|NCT01717885|Childhood development|childhood development
287955|NCT01717885|Pregnancy|pregnancy
287956|NCT01717872|glottis, laryngoscopy, laryngoscope blade|glottis, laryngoscopy, laryngoscope blade
287957|NCT01717859|Rheumatoid Arthritis|rheumatoid arthritis
287958|NCT01717846|Apoptosos|apoptosos
287959|NCT01717846|Rheumatoid Arthritis|rheumatoid arthritis
287960|NCT01717846|T cells, B cells|t cells, b cells
287961|NCT01717846|DAS28|das28
287962|NCT01717846|Clinical Disease activity Index|clinical disease activity index
287963|NCT01717846|CDAI|cdai
287964|NCT01717833|ICU acquired weakness|icu acquired weakness
287965|NCT01717833|Critical illness polyneuromyopathy|critical illness polyneuromyopathy
287966|NCT01717833|post ICU rehabilitation|post icu rehabilitation
287967|NCT01717833|neuromuscular electrical rehabilitation|neuromuscular electrical rehabilitation
287968|NCT01717833|handgrip|handgrip
287969|NCT01717820|Obesity|obesity
287970|NCT01717820|Postmenopausal women|postmenopausal women
287971|NCT01717820|Body composition|body composition
287972|NCT01717820|Resveratrol|resveratrol
287973|NCT01717820|Inflammatory biomarkers|inflammatory biomarkers
287974|NCT01717820|Bone formation|bone formation
287975|NCT01717820|Adipose metabolism|adipose metabolism
287976|NCT01717807|epithelial growth factor receptors|epithelial growth factor receptors
287977|NCT01717807|lung cancer|lung cancer
287978|NCT01717807|advanced tumor of pancrease|advanced tumor of pancrease
287979|NCT01717807|erlotinib|erlotinib
287980|NCT01717807|C11-Erlotinib PET/CT|c11-erlotinib pet/ct
287981|NCT01717794|operative time|operative time
287982|NCT01717794|laparoscopy|laparoscopy
287983|NCT01717794|total hysterectomy|total hysterectomy
287984|NCT01717794|pelvic lymphadenectomy|pelvic lymphadenectomy
287985|NCT01717794|endometrial cancer|endometrial cancer
287986|NCT01717794|Thunderbeat|thunderbeat
287987|NCT01717781|operative time|operative time
287988|NCT01717781|laparoscopy|laparoscopy
287989|NCT01717781|radical hysterectomy|radical hysterectomy
287990|NCT01717781|pelvic lymphadenectomy|pelvic lymphadenectomy
287991|NCT01717781|cervical cancer|cervical cancer
287992|NCT01717781|thunderbeat|thunderbeat
287993|NCT01717768|hypogonadism|hypogonadism
287994|NCT01717768|Gonadal Disorders|gonadal disorders
287995|NCT01717768|Endocrine System Diseases|endocrine system diseases
287996|NCT01717768|Testosterone|testosterone
287997|NCT01717768|Testosterone enanthate|testosterone enanthate
287998|NCT01717768|Testosterone undecanoate|testosterone undecanoate
287999|NCT01717768|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
288000|NCT01717768|Methyltestosterone|methyltestosterone
288001|NCT01717768|Androgens|androgens
288002|NCT01717768|Hormones|hormones
288003|NCT01717768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
288004|NCT01717768|Physiological Effects of Drugs|physiological effects of drugs
288005|NCT01717768|Pharmacologic Actions|pharmacologic actions
288006|NCT01717768|Therapeutic Uses|therapeutic uses
288007|NCT01717768|Anabolic Agents|anabolic agents
288008|NCT01717755|basilar|basilar
288009|NCT01717755|stroke|stroke
288010|NCT01717755|mechanical|mechanical
288011|NCT01717755|thrombolysis|thrombolysis
288012|NCT01717755|intra-arterial|intra-arterial
288013|NCT01717742|Randomized controlled trial|randomized controlled trial
288014|NCT01717742|Pleural Empyema|pleural empyema
288015|NCT01717742|tPA|tpa
288016|NCT01717742|DNase|dnase
288017|NCT01717729|HCC, RFA, Iodine-125, Recurrence|hcc, rfa, iodine-125, recurrence
288018|NCT01717716|boys|boys
288019|NCT01717716|obesity|obesity
288020|NCT01717716|glucose|glucose
288021|NCT01717716|sucrose|sucrose
288022|NCT01717716|high-fructose corn syrup-55|high-fructose corn syrup-55
288023|NCT01717703|prevention|prevention
288024|NCT01717690|MRSA|mrsa
288025|NCT01717690|chlorhexidine|chlorhexidine
288026|NCT01717664|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
288027|NCT01717664|MAP|map
288028|NCT01717664|antibiotic|antibiotic
288029|NCT01717664|Interferon beta 1-a|interferon beta 1-a
288030|NCT01717664|MS|ms
288031|NCT01717664|MRI|mri
288032|NCT01717664|EDSS|edss
288033|NCT01717664|relapse rate|relapse rate
278665|NCT01760148|HCV|hcv
288034|NCT01717651|Atrophy|atrophy
288035|NCT01717651|Muscle wasting|muscle wasting
288036|NCT01717651|Sepsis|sepsis
288037|NCT01717638|Meningococcal disease, vaccines, children, persistence|meningococcal disease, vaccines, children, persistence
288038|NCT01717625|montelukast|montelukast
288039|NCT01717625|BPD|bpd
288040|NCT01717625|singulair|singulair
288041|NCT01717625|prematurity|prematurity
288042|NCT01717612|gastric varices, thrombin, histoacryl|gastric varices, thrombin, histoacryl
288043|NCT01717599|Post ERCP pancreatitis|post ercp pancreatitis
288044|NCT01717599|Diclofenac|diclofenac
288045|NCT01717599|NSAID|nsaid
288046|NCT01717586|preeclampsia|preeclampsia
288047|NCT01717586|pravastatin|pravastatin
288048|NCT01717586|Pravachol®|pravachol®
288049|NCT01717586|statin|statin
288050|NCT01717586|high-risk pregnancy|high-risk pregnancy
288051|NCT01717586|safety|safety
288052|NCT01717586|fetal morbidity and mortality|fetal morbidity and mortality
288053|NCT01717586|maternal morbidity and mortality|maternal morbidity and mortality
288054|NCT01717586|neonatal mortality|neonatal mortality
288055|NCT01717586|premature delivery|premature delivery
288056|NCT01717586|preemie|preemie
288057|NCT01717573|STEMI|stemi
288058|NCT01717573|No-reflow|no-reflow
288059|NCT01717573|Primary percutaneous intervention|primary percutaneous intervention
288060|NCT01717573|Deferred stenting|deferred stenting
288061|NCT01717560|chronic hepatitis C|chronic hepatitis c
288062|NCT01717560|illicit drug use|illicit drug use
288063|NCT01717560|Substance-Related Disorders|substance-related disorders
288064|NCT01717560|multidisciplinary care|multidisciplinary care
288065|NCT01717560|integrated care|integrated care
288066|NCT01717560|mental health care|mental health care
288067|NCT01717560|intensive case management|intensive case management
288068|NCT01717547|Veterans|veterans
288070|NCT01717547|Stress|stress
288071|NCT01717534|Diarrhea|diarrhea
288072|NCT01717534|Children|children
288073|NCT01717534|Heat-treated lactobacilli|heat-treated lactobacilli
288074|NCT01717521|hysterectomy|hysterectomy
288075|NCT01717521|gynecological abdominal surgery|gynecological abdominal surgery
288076|NCT01717508|MDD|mdd
288077|NCT01717508|depression|depression
288078|NCT01717508|major depressive disorder|major depressive disorder
288079|NCT01717508|adolescent|adolescent
288080|NCT01717495|Pacemaker|pacemaker
288081|NCT01717495|Implantable-cardioverter defibrillator|implantable-cardioverter defibrillator
288082|NCT01717495|Cardiac Pacing, Artificial/adverse effects|cardiac pacing, artificial/adverse effects
288083|NCT01717495|Venous thrombosis|venous thrombosis
288084|NCT01717495|Pulmonary embolism|pulmonary embolism
288085|NCT01717495|Phlebography|phlebography
288086|NCT01717495|Biological markers|biological markers
288087|NCT01717495|Computed tomography angiography|computed tomography angiography
288088|NCT01717482|Bronchoscopy|bronchoscopy
288089|NCT01717482|Metformin|metformin
288090|NCT01717469|Pacemaker|pacemaker
288091|NCT01717469|Pacemaker implantation|pacemaker implantation
288092|NCT01717469|Coronary sinus|coronary sinus
288093|NCT01717469|Ventricular dysfunction|ventricular dysfunction
288094|NCT01717469|Right ventricular pacing|right ventricular pacing
288095|NCT01717469|Left ventricular pacing|left ventricular pacing
288096|NCT01717456|Fecal incontinence|fecal incontinence
288097|NCT01717456|Frail elders|frail elders
288098|NCT01717456|Home health care|home health care
288099|NCT01717456|Nurse|nurse
288100|NCT01717456|Patient education|patient education
288101|NCT01717443|Human Papillomavirus|human papillomavirus
288102|NCT01717443|Renal transplantation|renal transplantation
288103|NCT01717430|Injections, epidural|injections, epidural
288104|NCT01717430|Injections, intra-articular|injections, intra-articular
288105|NCT01717430|Chronic pain|chronic pain
288106|NCT01717430|Neck pain|neck pain
288107|NCT01717430|Back pain|back pain
288108|NCT01717430|Low back pain|low back pain
288109|NCT01717430|Sciatica|sciatica
288110|NCT01717430|Sacroiliac joint|sacroiliac joint
288111|NCT01717430|Corticosteroids|corticosteroids
288112|NCT01717430|Dexamethasone|dexamethasone
288113|NCT01717430|Adrenocorticotropic hormone|adrenocorticotropic hormone
288114|NCT01717430|Adrenal insufficiency|adrenal insufficiency
288115|NCT01717430|Hemoglobin A, glycosylated|hemoglobin a, glycosylated
288116|NCT01717417|impacted canine|impacted canine
288117|NCT01717417|miniscrew|miniscrew
288118|NCT01717417|cone beam|cone beam
288119|NCT01717404|IBS|ibs
288120|NCT01717391|radiotherapy|radiotherapy
288121|NCT01717391|Positron-Emission Tomography and Computed Tomography|positron-emission tomography and computed tomography
288122|NCT01717391|chemotherapy|chemotherapy
288123|NCT01717391|bone marrow|bone marrow
288124|NCT01717378|Patient Recruitment|patient recruitment
288125|NCT01717378|Research Subject Recruitment|research subject recruitment
288126|NCT01717378|Research Subject Selection|research subject selection
288127|NCT01717378|Selection of Subjects|selection of subjects
288128|NCT01717378|Health Surveys|health surveys
288129|NCT01717378|Health Questionnaires|health questionnaires
288130|NCT01717378|Health Interviews|health interviews
278811|NCT01759511|IPF|ipf
288131|NCT01717365|SCOPE|scope
288132|NCT01717352|Weight loss|weight loss
288133|NCT01717274|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
288134|NCT01717274|Hot water irrigation|hot water irrigation
288135|NCT01717261|breast cancer|breast cancer
288136|NCT01717261|early breast cancer|early breast cancer
288137|NCT01717261|partial breast irradiation|partial breast irradiation
288138|NCT01717261|preoperative radiation|preoperative radiation
288139|NCT01717222|Lignocaine|lignocaine
288140|NCT01717222|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
288141|NCT01717222|Pain relief|pain relief
288142|NCT01717209|heart failure|heart failure
288143|NCT01717209|hypertension, pulmonary|hypertension, pulmonary
288144|NCT01717209|heart failure, right-sided|heart failure, right-sided
288145|NCT01717209|heart-assist devices|heart-assist devices
288146|NCT01717209|Heart Transplantation|heart transplantation
288147|NCT01717196|sample adequacy|sample adequacy
288148|NCT01717196|diagnostic accuracy|diagnostic accuracy
288149|NCT01717196|complications|complications
288150|NCT01717183|Patient|patient
288151|NCT01717170|Non-infectious Uveitis, Tocilizumab|non-infectious uveitis, tocilizumab
288152|NCT01717157|Healthy|healthy
288153|NCT01717157|Fentanyl|fentanyl
288154|NCT01717157|Transdermal patch|transdermal patch
288155|NCT01717157|DUROGESIC|durogesic
288156|NCT01717144|therapeutic education|therapeutic education
288157|NCT01717144|Parkinson's disease|parkinson's disease
288158|NCT01717144|quality of life|quality of life
288159|NCT01717131|Invasive breast cancer|invasive breast cancer
288160|NCT01717118|Evaluation|evaluation
288162|NCT01717118|Levels|levels
288163|NCT01717118|Women|women
288164|NCT01717118|HPV|hpv
288165|NCT01717118|Vaccine|vaccine
288166|NCT01717118|Mexico|mexico
288167|NCT01717105|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
288168|NCT01717105|Epidermal growth factor receptor (EGFR) positive mutation|epidermal growth factor receptor (egfr) positive mutation
288169|NCT01717066|Hepatocellular Carcinoma|hepatocellular carcinoma
288170|NCT01717066|ginsenoside Rg3|ginsenoside rg3
288171|NCT01717040|Bipolar Disorder|bipolar disorder
288172|NCT01717040|Insulin Resistance|insulin resistance
288173|NCT01717027|pharmacokinetics|pharmacokinetics
288174|NCT01717027|bioavailability|bioavailability
288175|NCT01717027|oxycodone|oxycodone
288176|NCT01717027|management of moderate to severe pain|management of moderate to severe pain
288177|NCT01717014|rectal cancer|rectal cancer
288178|NCT01717014|stapler|stapler
288179|NCT01717001|kinematics|kinematics
288180|NCT01717001|knee joint|knee joint
288181|NCT01716988|Micafungin|micafungin
288182|NCT01716988|pharmacokinetics|pharmacokinetics
288183|NCT01716988|invasive candidiasis|invasive candidiasis
288184|NCT01716988|intensive care|intensive care
288185|NCT01716975|Schizophrenia|schizophrenia
288186|NCT01716975|Cognition|cognition
288187|NCT01716975|Cognition Impairment|cognition impairment
288188|NCT01716975|Alpha-7 nAChR|alpha-7 nachr
288189|NCT01716962|Acute respiratory distress syndrome, Fluid responsiveness, Pulse pressure variation|acute respiratory distress syndrome, fluid responsiveness, pulse pressure variation
288190|NCT01716962|Pleth variability index, Passive leg raising test|pleth variability index, passive leg raising test
288191|NCT01716949|rectal cancer|rectal cancer
288192|NCT01716949|recurrent rectal cancer|recurrent rectal cancer
288193|NCT01716949|hyperthermia|hyperthermia
288194|NCT01716949|radiation|radiation
288195|NCT01716949|chemoradiation|chemoradiation
288196|NCT01716949|5-FU|5-fu
288197|NCT01716949|capecitabine|capecitabine
288198|NCT01716949|oxaliplatin|oxaliplatin
288199|NCT01716936|Thoracic Insufficiency Syndrome|thoracic insufficiency syndrome
288200|NCT01716936|Early Onset Spinal Deformity|early onset spinal deformity
288201|NCT01716884|STEMI|stemi
288202|NCT01716884|reperfution|reperfution
288203|NCT01716884|primary PCI|primary pci
288204|NCT01716858|Schizophrenia|schizophrenia
288205|NCT01716858|Sulforaphane|sulforaphane
288206|NCT01716858|Psychosis|psychosis
288207|NCT01716858|Cognition|cognition
288208|NCT01716858|Oxidative stress|oxidative stress
288209|NCT01716858|Antioxidant|antioxidant
288210|NCT01716858|Anti-inflammatory|anti-inflammatory
288211|NCT01716845|autism|autism
288212|NCT01716845|autism spectrum disorders|autism spectrum disorders
288213|NCT01716845|RNA|rna
288214|NCT01716845|gene expression|gene expression
288215|NCT01716845|developmental delay|developmental delay
288216|NCT01716819|Heart failure, abdominal obesity, RAAS|heart failure, abdominal obesity, raas
288217|NCT01716806|Antibody-Drug Conjugate|antibody-drug conjugate
288218|NCT01716806|Antibodies, Monoclonal|antibodies, monoclonal
288219|NCT01716806|Hematologic Diseases|hematologic diseases
288220|NCT01716806|Hodgkin Disease|hodgkin disease
288221|NCT01716806|Antigens, CD30|antigens, cd30
288222|NCT01716806|Lymphoma|lymphoma
288223|NCT01716806|monomethylauristatin E|monomethylauristatin e
288224|NCT01716806|Drug Therapy|drug therapy
288225|NCT01716793|Primary AML|primary aml
288226|NCT01716793|Risk-adapted treatment|risk-adapted treatment
288227|NCT01716793|Hematopoietic transplantation|hematopoietic transplantation
288228|NCT01716793|CD34+ cell selection|cd34+ cell selection
288229|NCT01716767|Carpal tunnel syndrome|carpal tunnel syndrome
288230|NCT01716767|hand pain|hand pain
288231|NCT01716767|wrist pain|wrist pain
288232|NCT01716767|arm pain|arm pain
288233|NCT01716767|topical menthol|topical menthol
288234|NCT01716754|asthma|asthma
288235|NCT01716754|asthma control|asthma control
288236|NCT01716754|allergy|allergy
288237|NCT01716754|atopic|atopic
288238|NCT01716754|IgE|ige
288239|NCT01716754|double-blind|double-blind
288240|NCT01716754|placebo|placebo
288241|NCT01716754|omalizumab|omalizumab
288242|NCT01716741|Gaucher disease|gaucher disease
288243|NCT01716741|lysosomal storage disorder|lysosomal storage disorder
288244|NCT01716741|metabolic disease|metabolic disease
288245|NCT01716741|medical records review|medical records review
288246|NCT01716728|Lysosomal Acid Lipase Deficiency|lysosomal acid lipase deficiency
288247|NCT01716728|Cholesterol Ester Storage Disease|cholesterol ester storage disease
288248|NCT01716728|Wolman Disease|wolman disease
288249|NCT01716728|Lysosomal Storage Disorder|lysosomal storage disorder
288250|NCT01716728|Metabolic Disease|metabolic disease
288251|NCT01716728|Recessive Inheritance|recessive inheritance
288252|NCT01716702|Prostate Cancer|prostate cancer
288253|NCT01716702|Psychosocial Intervention|psychosocial intervention
288254|NCT01716702|Sexual Rehabilitation|sexual rehabilitation
288255|NCT01716702|Online Intervention|online intervention
288256|NCT01716663|Symptomatic paroxysmal|symptomatic paroxysmal
288257|NCT01716663|Atrial fibrillation|atrial fibrillation
288258|NCT01716663|Observational|observational
288259|NCT01716663|Acute procedural outcomes|acute procedural outcomes
288261|NCT01716650|ankle|ankle
288262|NCT01716650|saphenous nerve block|saphenous nerve block
288263|NCT01716637|Alzheimer's Disease|alzheimer's disease
288264|NCT01716637|Dementia|dementia
288265|NCT01716637|Cognitive decline|cognitive decline
288266|NCT01716637|Cognitive disorder|cognitive disorder
288267|NCT01716637|Degenerative brain disease|degenerative brain disease
288268|NCT01716637|Cognitive impairment|cognitive impairment
288269|NCT01716637|Memory loss|memory loss
288270|NCT01716637|TNF-alpha|tnf-alpha
288271|NCT01716624|Pediatric|pediatric
288272|NCT01716611|liver cirrhosis|liver cirrhosis
288273|NCT01716611|hyponatemia|hyponatemia
288274|NCT01716611|ascites|ascites
288275|NCT01716611|vaptans|vaptans
288276|NCT01716611|antidiuretic hormon|antidiuretic hormon
288277|NCT01716611|arginine vasopressin|arginine vasopressin
288278|NCT01716598|COPD|copd
288279|NCT01716598|TLD Therapy|tld therapy
288280|NCT01716598|Targeted Lung Denervation Therapy|targeted lung denervation therapy
288281|NCT01716598|IPS|ips
288282|NCT01716598|Innovative Pulmonary Solutions, Inc.|innovative pulmonary solutions, inc.
288283|NCT01716598|Holaira, Inc.|holaira, inc.
288284|NCT01716585|Hepatitis C Virus|hepatitis c virus
288285|NCT01716585|Hepatitis C Genotype 1|hepatitis c genotype 1
288286|NCT01716585|Hepatitis C|hepatitis c
288287|NCT01716585|Treatment-Naïve|treatment-naïve
288288|NCT01716585|Interferon-Free|interferon-free
288289|NCT01716585|Chronic Hepatitis C|chronic hepatitis c
288290|NCT01716585|Viekira Pak|viekira pak
288291|NCT01716585|ombitasvir|ombitasvir
288292|NCT01716585|paritaprevir|paritaprevir
288293|NCT01716585|dasabuvir|dasabuvir
288294|NCT01716572|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
288295|NCT01716572|Endoscopy|endoscopy
288296|NCT01716572|Erythromycin|erythromycin
288297|NCT01716572|Gastric lavage|gastric lavage
288298|NCT01716546|Advanced cancer of the stomach|advanced cancer of the stomach
288299|NCT01716546|Chemotherapy - naive patients|chemotherapy - naive patients
288300|NCT01716546|DCF|dcf
288301|NCT01716533|Serological|serological
288302|NCT01716533|Adults|adults
288303|NCT01716533|Clostridium difficile|clostridium difficile
288304|NCT01716533|Adult CDI patients|adult cdi patients
288305|NCT01716520|long-acting muscarinic antagonist|long-acting muscarinic antagonist
288306|NCT01716520|long-acting beta-agonist|long-acting beta-agonist
288307|NCT01716520|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
288308|NCT01716520|vilanterol|vilanterol
288309|NCT01716520|umeclidinium|umeclidinium
288310|NCT01716507|RRD|rrd
288311|NCT01716507|Rhegmatogenous|rhegmatogenous
288312|NCT01716507|Retinal|retinal
288313|NCT01716507|Detachment|detachment
288314|NCT01716507|PPV|ppv
288315|NCT01716507|Pars Plana Vitrectomy|pars plana vitrectomy
288316|NCT01716507|Gauge|gauge
288317|NCT01716494|asthma|asthma
288318|NCT01716481|Stroke|stroke
288319|NCT01716481|Mesenchymal stem cells|mesenchymal stem cells
288320|NCT01716481|Stem cells|stem cells
288321|NCT01716481|Neurogenesis|neurogenesis
288322|NCT01716468|Ketogenic Diet, Advanced Cancer, Neoplasm|ketogenic diet, advanced cancer, neoplasm
288323|NCT01716468|Low carbohydrate|low carbohydrate
288324|NCT01716442|rituximab|rituximab
288325|NCT01716442|nephrotic|nephrotic
288326|NCT01716442|refractory|refractory
288327|NCT01716429|vegetarian|vegetarian
288328|NCT01716429|vegan|vegan
288329|NCT01716429|low calorie|low calorie
288330|NCT01716429|weight Loss|weight loss
288331|NCT01716429|infertility|infertility
288332|NCT01716429|PCOS|pcos
288333|NCT01716403|C hepatitis, telaprevir concentration, ribavirin oncentration, anemia|c hepatitis, telaprevir concentration, ribavirin oncentration, anemia
288334|NCT01716377|Neck Pain|neck pain
288335|NCT01716377|Musculoskeletal pain|musculoskeletal pain
288336|NCT01716377|Venlafaxine|venlafaxine
288539|NCT01715415|ribavirin|ribavirin
288337|NCT01716351|Randomized Clinical Control Trial|randomized clinical control trial
288338|NCT01716351|Complementary and Alternative Medicine|complementary and alternative medicine
288339|NCT01716351|Yoga|yoga
288340|NCT01716351|Electrophysiology|electrophysiology
288341|NCT01716351|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
288342|NCT01716351|Psychosocial|psychosocial
288343|NCT01716351|Anxiety|anxiety
288344|NCT01716351|Self-Compassion|self-compassion
288345|NCT01716351|Anti-Tachycardia Pacing Events|anti-tachycardia pacing events
288346|NCT01716338|glyburide|glyburide
288347|NCT01716338|glybenclamide|glybenclamide
288348|NCT01716338|hypoglycemia|hypoglycemia
288349|NCT01716312|Safety Of Omalizumab In Patients With SLE|safety of omalizumab in patients with sle
288350|NCT01716312|Systemic Lupus Erythematosus|systemic lupus erythematosus
288351|NCT01716299|HIV|hiv
288352|NCT01716299|Diagnostics|diagnostics
288353|NCT01716247|Mammography (CESM)|mammography (cesm)
288354|NCT01716247|MRI|mri
288355|NCT01716247|Breast screening|breast screening
288356|NCT01716247|12-214|12-214
288357|NCT01716208|Fresh Frozen Plasma|fresh frozen plasma
288358|NCT01716208|Complement|complement
288359|NCT01716208|Monoclonal Antibody|monoclonal antibody
288360|NCT01716195|Human Papillomavirus|human papillomavirus
288361|NCT01716195|HPV|hpv
288362|NCT01716143|atrial fibrillation|atrial fibrillation
288363|NCT01716143|catheter ablation|catheter ablation
288364|NCT01716143|Mapping|mapping
288365|NCT01716130|Fluzone Intradermal vaccine|fluzone intradermal vaccine
288366|NCT01716117|Large aneurysm|large aneurysm
288367|NCT01716117|Giant aneurysm|giant aneurysm
288368|NCT01716117|Wide neck aneurysm|wide neck aneurysm
288369|NCT01716091|focus of study is postoperative enfectious morbidity and postoperative GİS functionally recovery|focus of study is postoperative enfectious morbidity and postoperative gis functionally recovery
288370|NCT01716078|Brachial Plexus|brachial plexus
288371|NCT01716078|Nerve Block|nerve block
288372|NCT01716078|Nerve Conduction|nerve conduction
288373|NCT01716065|Anesthesia, Circulating tumor cells|anesthesia, circulating tumor cells
288374|NCT01716052|Mammogram|mammogram
288375|NCT01716052|Ibuprofen|ibuprofen
288376|NCT01716052|Pain management|pain management
288377|NCT01716039|Moderately to severely active Ulcerative Colitis|moderately to severely active ulcerative colitis
288378|NCT01716026|high myopia|high myopia
288379|NCT01716026|choroidal neovascularization|choroidal neovascularization
288380|NCT01716000|vaginal gel|vaginal gel
288381|NCT01716000|vaginal coating|vaginal coating
288382|NCT01716000|sensory perceptions|sensory perceptions
288383|NCT01715987|Hepatitis B|hepatitis b
288384|NCT01715987|Antiviral|antiviral
288385|NCT01715987|Tubular dysfunction|tubular dysfunction
288386|NCT01715987|Entecavir|entecavir
288387|NCT01715987|Tenofovir|tenofovir
288388|NCT01715974|G-CSF, IVF failure,pregnancy|g-csf, ivf failure,pregnancy
288389|NCT01715961|70 years old|70 years old
288390|NCT01715961|DLBCL|dlbcl
288391|NCT01715961|Rituximab-CHOP|rituximab-chop
288392|NCT01715961|Sarcopenia|sarcopenia
288393|NCT01715948|CROS hearing aid|cros hearing aid
288394|NCT01715948|Bone-anchored hearing device|bone-anchored hearing device
288395|NCT01715935|Clear cells renal carcinoma|clear cells renal carcinoma
288396|NCT01715935|everolimus|everolimus
288397|NCT01715935|neo-adjuvant treatment|neo-adjuvant treatment
288398|NCT01715922|Cryptococcal meningitis|cryptococcal meningitis
288399|NCT01715922|HIV Infections|hiv infections
288400|NCT01715922|Oral treatment|oral treatment
288401|NCT01715922|High dose of fluconazole|high dose of fluconazole
288402|NCT01715922|Flucytosine|flucytosine
288404|NCT01715922|Ivory Coast|ivory coast
288405|NCT01715896|Rheumatoid Arthritis|rheumatoid arthritis
288406|NCT01715896|Golimumab|golimumab
288407|NCT01715896|Mavrilimumab|mavrilimumab
288408|NCT01715883|Lung transplant|lung transplant
288409|NCT01715883|Pulmonary Graft Dysfunction|pulmonary graft dysfunction
288410|NCT01715883|Sodium Nitrite|sodium nitrite
288411|NCT01715870|Age related macular degeneration|age related macular degeneration
288412|NCT01715870|Food habits|food habits
288413|NCT01715870|Life style|life style
288414|NCT01715870|Risk factors|risk factors
288415|NCT01715870|questionnaire|questionnaire
288416|NCT01715857|Economics, Pharmaceutical|economics, pharmaceutical
288417|NCT01715857|Physician's Practice Patterns|physician's practice patterns
288418|NCT01715857|Chinese|chinese
288419|NCT01715857|Sevoflurane|sevoflurane
288420|NCT01715844|L-citrulline|l-citrulline
288421|NCT01715844|ADMA|adma
288422|NCT01715844|Asthma|asthma
288423|NCT01715844|Obesity|obesity
288424|NCT01715805|MDD|mdd
288425|NCT01715805|Major Depressive Disorder|major depressive disorder
288426|NCT01715792|Solid organ transplant rejection|solid organ transplant rejection
288427|NCT01715792|United Kingdom|united kingdom
288428|NCT01715792|Influenza|influenza
288429|NCT01715792|H1N1|h1n1
288430|NCT01715792|Pandemrix™|pandemrix™
288431|NCT01715779|Liver transplantation|liver transplantation
288432|NCT01715779|ENABLE|enable
288433|NCT01715779|observational|observational
288434|NCT01715779|mortality|mortality
288435|NCT01715779|Thromboembolic Events|thromboembolic events
288540|NCT01715415|ritonavir|ritonavir
288436|NCT01715779|Hepatic decompensation|hepatic decompensation
288437|NCT01715779|Long-Term follow-up|long-term follow-up
288438|NCT01715779|TEE|tee
288439|NCT01715766|Proteomics study|proteomics study
288440|NCT01715766|biomarker study of pain|biomarker study of pain
288441|NCT01715753|Function|function
288442|NCT01715753|Muscle mass|muscle mass
288443|NCT01715740|Chinese herbal medicine|chinese herbal medicine
288444|NCT01715740|Urticaria|urticaria
288445|NCT01715740|Antipruritics|antipruritics
288446|NCT01715740|Phase III clinical trial|phase iii clinical trial
288447|NCT01715727|diffusion kurtosis imaging|diffusion kurtosis imaging
288448|NCT01715727|parkinson disease|parkinson disease
288449|NCT01715727|parkinsonism|parkinsonism
288450|NCT01715727|diagnosis|diagnosis
288451|NCT01715727|differential diagnosis|differential diagnosis
288452|NCT01715714|Coronary Artery Disease|coronary artery disease
288453|NCT01715714|Statins|statins
288454|NCT01715714|Coronary Artery Bypass Grafting|coronary artery bypass grafting
288455|NCT01715714|Cardiac Surgery|cardiac surgery
288456|NCT01715675|asthma|asthma
288457|NCT01715675|allergy|allergy
288458|NCT01715675|sitostanol|sitostanol
288459|NCT01715675|cytokines|cytokines
288460|NCT01715675|Th1|th1
288461|NCT01715675|Treg|treg
288462|NCT01715675|antibodies|antibodies
288464|NCT01715675|vaccination|vaccination
288465|NCT01715662|rehabilitation|rehabilitation
288466|NCT01715662|lower limb amputation|lower limb amputation
288467|NCT01715662|unilateral transtibial amputation|unilateral transtibial amputation
288468|NCT01715662|unilateral transfemoral amputation|unilateral transfemoral amputation
288469|NCT01715662|older adults|older adults
288470|NCT01715662|cognitive computer games|cognitive computer games
288471|NCT01715662|home-based training|home-based training
288472|NCT01715662|Nintendo Wii|nintendo wii
288473|NCT01715662|virtual reality|virtual reality
288474|NCT01715649|Type 2 diabetes|type 2 diabetes
288475|NCT01715649|self-management|self-management
288476|NCT01715649|remote patient monitoring|remote patient monitoring
288477|NCT01715623|polymorphism|polymorphism
288478|NCT01715623|serum Ig|serum ig
288479|NCT01715597|uterine leiomyoma|uterine leiomyoma
288480|NCT01715597|laparoscopic myomectomy|laparoscopic myomectomy
288481|NCT01715597|intraoperative blood loss|intraoperative blood loss
288482|NCT01715597|ascorbic acid|ascorbic acid
288483|NCT01715584|Hypertension|hypertension
288484|NCT01715584|Sevoflurane|sevoflurane
288485|NCT01715584|Inhaled Anesthetic|inhaled anesthetic
288486|NCT01715584|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
288487|NCT01715584|Angiotensin II Receptor Blocking Agent|angiotensin ii receptor blocking agent
288488|NCT01715571|erectile dysfunction|erectile dysfunction
288489|NCT01715571|vibratory stimulation|vibratory stimulation
288490|NCT01715571|viberect|viberect
288491|NCT01715545|day-3 poor quality embryo|day-3 poor quality embryo
288492|NCT01715545|vitrification|vitrification
288493|NCT01715545|clinical outcome|clinical outcome
288494|NCT01715532|Huachansu|huachansu
288495|NCT01715532|Na+/K+-ATPase α3|na+/k+-atpase α3
288496|NCT01715532|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
288497|NCT01715532|randomized controlled trial|randomized controlled trial
288498|NCT01715519|Vilazodone|vilazodone
288499|NCT01715519|PTSD|ptsd
288500|NCT01715519|Depression|depression
288501|NCT01715506|Dementia|dementia
288502|NCT01715506|Resident|resident
288503|NCT01715506|Nursinghome|nursinghome
288504|NCT01715506|Use of restraint|use of restraint
288505|NCT01715506|Agitation|agitation
288506|NCT01715493|COPD|copd
288507|NCT01715493|Asthma|asthma
288508|NCT01715493|Lysozyme Hydrochloride|lysozyme hydrochloride
288509|NCT01715480|broccoli sprout|broccoli sprout
288510|NCT01715480|sickle cell|sickle cell
288511|NCT01715480|NRF2|nrf2
288512|NCT01715467|Dupuytren|dupuytren
288513|NCT01715467|Contracture|contracture
288514|NCT01715467|Auxilium|auxilium
288515|NCT01715467|XIAFLEX|xiaflex
288516|NCT01714388|remifentanil|remifentanil
288517|NCT01714388|heart rate|heart rate
288518|NCT01714388|autonomic nervous system|autonomic nervous system
288519|NCT01714388|heart rate variability|heart rate variability
288520|NCT01714388|autonomic nervous activity|autonomic nervous activity
288521|NCT01714388|vagotonic effect|vagotonic effect
288522|NCT01714388|single dose|single dose
288523|NCT01715441|Metastatic colorectal cancer patients|metastatic colorectal cancer patients
288524|NCT01715441|KRAS mutation|kras mutation
288525|NCT01715441|Sorafenib|sorafenib
288526|NCT01715428|diabetes, cardiovascular risk|diabetes, cardiovascular risk
288527|NCT01715415|Hepatitis C|hepatitis c
288528|NCT01715415|Treatment-Experienced|treatment-experienced
288529|NCT01715415|Null responder|null responder
288530|NCT01715415|Partial Responder|partial responder
288531|NCT01715415|Chronic Hepatitis|chronic hepatitis
288532|NCT01715415|Hepatitis C Genotype 1|hepatitis c genotype 1
288533|NCT01715415|Interferon-Free|interferon-free
288534|NCT01715415|Hepatitis C Virus|hepatitis c virus
288535|NCT01715415|Relapser|relapser
288536|NCT01715415|Non responder|non responder
288537|NCT01715415|Viekira Pak|viekira pak
288541|NCT01715415|paritaprevir|paritaprevir
288542|NCT01715415|dasabuvir|dasabuvir
288543|NCT01715402|liver tumor|liver tumor
288544|NCT01715402|carcinoma|carcinoma
288545|NCT01715402|cholangiocarcinoma|cholangiocarcinoma
288546|NCT01715402|metastasis|metastasis
288547|NCT01715389|Asthma|asthma
288548|NCT01715389|Goals|goals
288549|NCT01715389|Shared Decision Making|shared decision making
288550|NCT01715389|Patient Portal|patient portal
288551|NCT01715389|Electronic Medical Record|electronic medical record
288552|NCT01715376|traditional chinese medicine|traditional chinese medicine
288553|NCT01715376|complementary therapies|complementary therapies
288554|NCT01715376|traditional chinese medicine syndrome scale|traditional chinese medicine syndrome scale
288555|NCT01715350|Alzheimer's Disease|alzheimer's disease
288556|NCT01715337|muscle fibre|muscle fibre
288557|NCT01715337|capillary|capillary
288558|NCT01715337|rehabilitation|rehabilitation
288559|NCT01715337|exercise training|exercise training
288560|NCT01715324|In vitro fertilization|in vitro fertilization
288561|NCT01715324|Antagonist protocol|antagonist protocol
288562|NCT01715324|Growth Hormone|growth hormone
288563|NCT01715311|COPD|copd
288564|NCT01715311|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
288565|NCT01715311|indacaterol|indacaterol
288566|NCT01715311|tiotropium|tiotropium
288567|NCT01715298|Anticholinergic|anticholinergic
288568|NCT01715298|Antimuscarinic|antimuscarinic
288569|NCT01715298|Chronic Obstructive Airway Disease|chronic obstructive airway disease
288570|NCT01715298|Chronic Obstructive Lung Disease|chronic obstructive lung disease
288571|NCT01715298|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
288572|NCT01715298|COPD|copd
288573|NCT01715298|LAMA|lama
288574|NCT01715298|Lung Disease|lung disease
288575|NCT01715298|Lung Diseases, Obstructive|lung diseases, obstructive
288576|NCT01715298|Lung Function|lung function
288577|NCT01715298|Muscarinic receptor antagonist|muscarinic receptor antagonist
288578|NCT01715298|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
288579|NCT01715298|Respiratory Tract Diseases|respiratory tract diseases
288580|NCT01715285|Prostate neoplasms|prostate neoplasms
288581|NCT01715285|Prostate cancer|prostate cancer
288582|NCT01715285|Metastatic prostate cancer|metastatic prostate cancer
288583|NCT01715285|Abiraterone acetate|abiraterone acetate
288584|NCT01715285|ZYTIGA|zytiga
288585|NCT01715285|Prednisone|prednisone
288586|NCT01715285|Androgen deprivation therapy|androgen deprivation therapy
288587|NCT01715259|Renal insufficiency|renal insufficiency
288588|NCT01715259|Renal impairment|renal impairment
288589|NCT01715259|End-stage renal disease|end-stage renal disease
288590|NCT01715259|Abiraterone acetate|abiraterone acetate
288591|NCT01715259|Pharmacokinetics|pharmacokinetics
288592|NCT01715246|healthy babbies|healthy babbies
288593|NCT01715246|infant formula|infant formula
288594|NCT01715246|growth|growth
288596|NCT01715220|Nitroglycerin|nitroglycerin
288597|NCT01715220|Biliary Colic|biliary colic
288598|NCT01715220|Cholelithiasis|cholelithiasis
288599|NCT01715220|Abdominal Pain.|abdominal pain.
288600|NCT01715194|OSAS|osas
288601|NCT01715194|CPAP|cpap
288602|NCT01715194|Adherence|adherence
288603|NCT01715194|Telemedicine|telemedicine
288604|NCT01715168|Doxil generic|doxil generic
288605|NCT01715168|Caelyx generic|caelyx generic
288606|NCT01715168|generic treatment|generic treatment
288607|NCT01715168|ovarian cancer|ovarian cancer
288608|NCT01715168|ovary|ovary
288609|NCT01715168|progressed|progressed
288610|NCT01715168|recurred cancer|recurred cancer
288611|NCT01715168|platinum based therapy|platinum based therapy
288612|NCT01715155|Metastatic Breast Cancer,|metastatic breast cancer,
288613|NCT01715155|retrospective study,|retrospective study,
288614|NCT01715155|disease progression,|disease progression,
288615|NCT01715155|clinical management|clinical management
288616|NCT01715142|Pancreatic cancer|pancreatic cancer
288617|NCT01715142|Nab-paclitaxel|nab-paclitaxel
288618|NCT01715142|Gemcitabine|gemcitabine
288619|NCT01715142|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
288620|NCT01715116|Cardiac arrhythmias|cardiac arrhythmias
288621|NCT01715116|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
288622|NCT01715116|Patient Safety|patient safety
288623|NCT01715116|Quality of life|quality of life
288624|NCT01715103|HIV infection|hiv infection
288625|NCT01715103|mucosa|mucosa
288626|NCT01715103|immunological parameters|immunological parameters
279208|NCT01757626|12-230|12-230
279209|NCT01757587|Type 2 Diabetes|type 2 diabetes
279210|NCT01757587|Galvus|galvus
279211|NCT01757587|basal insulin|basal insulin
279212|NCT01757587|HbA1c|hba1c
279213|NCT01757574|CIDP- chronic inflammatory demyelinating neuropathy|cidp- chronic inflammatory demyelinating neuropathy
288627|NCT01715103|genital sampling|genital sampling
288628|NCT01715103|healthy women volunteers|healthy women volunteers
288629|NCT01715077|melanoma|melanoma
288630|NCT01715077|stage IV|stage iv
288631|NCT01715077|stage III|stage iii
288632|NCT01715077|unresectable|unresectable
288633|NCT01715064|Prostate Cancer|prostate cancer
288634|NCT01715064|Exercise|exercise
288832|NCT01714089|RR-MS|rr-ms
288635|NCT01715064|Cortical Inhibition|cortical inhibition
288636|NCT01715064|Cortical Silent Period|cortical silent period
288637|NCT01715064|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
288638|NCT01715051|cocaine|cocaine
288639|NCT01715051|D-serine|d-serine
288640|NCT01715051|Drug dependence|drug dependence
288641|NCT01715038|malnutrition|malnutrition
288642|NCT01715038|stunting|stunting
288643|NCT01715038|LNS|lns
288644|NCT01715038|micronutrient powder|micronutrient powder
288645|NCT01715038|hemoglobin|hemoglobin
288646|NCT01715025|measured|measured
288647|NCT01715025|heavy menstrual bleeding|heavy menstrual bleeding
288648|NCT01715025|combined oral contraceptive|combined oral contraceptive
288649|NCT01715025|alkaline haematin method|alkaline haematin method
288650|NCT01715012|Burn|burn
288651|NCT01715012|Diabetes|diabetes
288652|NCT01715012|Skin graft|skin graft
288653|NCT01715012|Donor site|donor site
288654|NCT01714999|olecranon|olecranon
288655|NCT01714999|prepatellar|prepatellar
288656|NCT01714999|bursa|bursa
288657|NCT01714999|trauma|trauma
288658|NCT01714999|laceration|laceration
288659|NCT01714999|bursectomy|bursectomy
288660|NCT01714999|bursa reconstruction|bursa reconstruction
288661|NCT01714986|Diabetes mellitus|diabetes mellitus
288662|NCT01714986|Depression|depression
288663|NCT01714986|Anxiety|anxiety
288664|NCT01714986|Alexithymia|alexithymia
288665|NCT01714986|Self Image|self image
288666|NCT01714986|HbA1c|hba1c
288667|NCT01714986|Psychoeducation|psychoeducation
288668|NCT01714934|IDIOPATHIC PULMONARY FIBROSIS|idiopathic pulmonary fibrosis
288669|NCT01714934|MICROASPIRATION|microaspiration
288670|NCT01714908|NSCLC|nsclc
288671|NCT01714908|EGFR mutation|egfr mutation
288672|NCT01714908|unresectable|unresectable
288673|NCT01714908|erlotinib|erlotinib
288674|NCT01714908|concurrent radiotherapy|concurrent radiotherapy
288675|NCT01714895|Interstitial glucose dynamics|interstitial glucose dynamics
288676|NCT01714895|Accuracy of continuous glucose monitoring under hypoglycemia|accuracy of continuous glucose monitoring under hypoglycemia
288677|NCT01714895|Glucose clamp|glucose clamp
288678|NCT01714882|Infertility|infertility
288679|NCT01714882|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
288680|NCT01714882|Stress Management|stress management
288681|NCT01714882|Stress Reduction|stress reduction
288682|NCT01714869|Swedish massage|swedish massage
288683|NCT01714869|massage|massage
288684|NCT01714869|osteoarthritis|osteoarthritis
288685|NCT01714869|knee|knee
288686|NCT01714843|ASP0456|asp0456
288687|NCT01714843|constipation|constipation
288688|NCT01714843|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
288689|NCT01714843|linaclotide|linaclotide
288690|NCT01714791|Coronary Artery Bypass Graft|coronary artery bypass graft
288691|NCT01714791|Osteopathic Medicine|osteopathic medicine
288692|NCT01714791|Vital Capacity|vital capacity
288693|NCT01714791|Quality of Life|quality of life
288694|NCT01714791|Cardiac rehabilitation|cardiac rehabilitation
402018|NCT01233479|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
288695|NCT01714765|Metastatic Clear Cell Renal Cancer Dovitinib Everolimus Cohort Maximum administered dose maximum tolerated dose|metastatic clear cell renal cancer dovitinib everolimus cohort maximum administered dose maximum tolerated dose
288696|NCT01714752|Diagnosis|diagnosis
288697|NCT01714752|Left ventricular end diastolic pressure (LVEDP)|left ventricular end diastolic pressure (lvedp)
288698|NCT01714752|Exercise echocardiography|exercise echocardiography
288699|NCT01714752|Left atrial remodeling|left atrial remodeling
288700|NCT01714726|MEDI2070|medi2070
288701|NCT01714726|inflammatory bowel disease|inflammatory bowel disease
288702|NCT01714726|moderate to severe Crohn's disease|moderate to severe crohn's disease
288703|NCT01714713|Schizophrenia|schizophrenia
288704|NCT01714713|Cognition|cognition
288705|NCT01714713|Cognition Impairment|cognition impairment
288706|NCT01714713|Alpha-7 nAChR|alpha-7 nachr
288708|NCT01714700|resistance exercise ghrelin|resistance exercise ghrelin
288709|NCT01714700|overweight|overweight
288710|NCT01714674|cardiac troponin T|cardiac troponin t
288711|NCT01714674|cTnT|ctnt
357309|NCT01421342|Relapse|relapse
288712|NCT01714674|exercise|exercise
288713|NCT01714674|dietary nitrate|dietary nitrate
288714|NCT01714661|Schizophrenia|schizophrenia
288715|NCT01714661|Cognition|cognition
288716|NCT01714661|Cognition Impairment|cognition impairment
288717|NCT01714661|Alpha-7 nAChR|alpha-7 nachr
288718|NCT01714648|OVULATION INDUCTION|ovulation induction
288719|NCT01714635|cataract|cataract
288720|NCT01714635|IOL|iol
288721|NCT01714635|intraocular lens|intraocular lens
288722|NCT01714622|metabolic syndrome|metabolic syndrome
288723|NCT01714622|insulin resistance|insulin resistance
288724|NCT01714622|gastric cancer|gastric cancer
288725|NCT01714609|portal hypertension|portal hypertension
288726|NCT01714609|sorafenib|sorafenib
288727|NCT01714596|Oral Antibiotic|oral antibiotic
288728|NCT01714596|Intravenous Antibiotic|intravenous antibiotic
288729|NCT01714596|Wound infection|wound infection
288730|NCT01714596|Randomized Controlled Trial|randomized controlled trial
288731|NCT01714583|Mechanical ventilation|mechanical ventilation
288732|NCT01714583|ARDS|ards
288733|NCT01714583|acute lung injury|acute lung injury
288734|NCT01714583|cardiac function|cardiac function
288735|NCT01714583|cardiac index|cardiac index
288736|NCT01714583|heart-lung interaction|heart-lung interaction
288737|NCT01714531|Mild TBI|mild tbi
288738|NCT01714518|Interstitial Lung Disease|interstitial lung disease
288739|NCT01714518|Diagnosis|diagnosis
288740|NCT01714518|Cryobiopsy|cryobiopsy
288741|NCT01714518|Video-assisted thoracic surgery|video-assisted thoracic surgery
288742|NCT01714518|Lung biopsy|lung biopsy
288743|NCT01714505|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
288744|NCT01714505|Continuous Glucose Monitor|continuous glucose monitor
288745|NCT01714505|Artificial Pancreas|artificial pancreas
288746|NCT01714505|Insulin Pump|insulin pump
288747|NCT01714505|Closed Loop control|closed loop control
288748|NCT01714505|Open Loop treatment|open loop treatment
288749|NCT01714492|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
288750|NCT01714492|in vivo mechanics|in vivo mechanics
288751|NCT01714492|kinematics|kinematics
288752|NCT01714492|fluoroscopy|fluoroscopy
288753|NCT01714440|genomics of kidney transplantation|genomics of kidney transplantation
288754|NCT01714440|genetic variation|genetic variation
288755|NCT01714440|recipient genotypes|recipient genotypes
288756|NCT01714440|donor genotypes|donor genotypes
288757|NCT01714414|HIV|hiv
288758|NCT01714414|Fozivudine|fozivudine
288759|NCT01714414|Zidovudine|zidovudine
288760|NCT01714414|FATI|fati
288761|NCT01714362|oculocardiac effect|oculocardiac effect
288762|NCT01714362|bradycardia|bradycardia
288764|NCT01714349|Spinal cord injury|spinal cord injury
288765|NCT01714349|nerve transfer|nerve transfer
288766|NCT01714349|tetraplegia|tetraplegia
288767|NCT01714349|quadriplegia|quadriplegia
288768|NCT01714336|Arbeitsgemeinschaft für Osteosynthesefragen (AO) fracture|arbeitsgemeinschaft für osteosynthesefragen (ao) fracture
288769|NCT01714336|Orthopaedic Trauma Association (OTA) fracture|orthopaedic trauma association (ota) fracture
288770|NCT01714323|Cigarette smoking|cigarette smoking
288771|NCT01714323|Tobacco smoking|tobacco smoking
288772|NCT01714323|Tobacco use disorder|tobacco use disorder
288773|NCT01714310|severe mood dysregulation|severe mood dysregulation
288774|NCT01714310|irritability|irritability
288775|NCT01714310|lisdexamfetamine|lisdexamfetamine
288776|NCT01714310|fluoxetine|fluoxetine
288777|NCT01714310|newly recognized syndrome|newly recognized syndrome
288778|NCT01714297|cemented total hip arthroplasty|cemented total hip arthroplasty
288779|NCT01714297|blood loss|blood loss
288780|NCT01714297|wound discharge|wound discharge
288781|NCT01714297|thromboprophylaxis|thromboprophylaxis
288782|NCT01714297|biomarkers|biomarkers
288783|NCT01714284|psoriasis|psoriasis
288784|NCT01714258|cardiac output|cardiac output
288785|NCT01714258|fick method|fick method
288786|NCT01714258|thermodilution|thermodilution
288787|NCT01714245|Eczema|eczema
288788|NCT01714245|Atopic Dermatitis|atopic dermatitis
288789|NCT01714245|Compromised Skin|compromised skin
288790|NCT01714245|Inflamed Skin|inflamed skin
288791|NCT01714219|prostatic neoplasms|prostatic neoplasms
288792|NCT01714219|prostatectomy|prostatectomy
288793|NCT01714219|robotics|robotics
288794|NCT01714219|urinary incontinence|urinary incontinence
288796|NCT01714206|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
288797|NCT01714206|Pharmacokinetics|pharmacokinetics
288798|NCT01714206|Digoxin (LANOXIN)|digoxin (lanoxin)
288799|NCT01714193|Healthy|healthy
288800|NCT01714193|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
288801|NCT01714193|Pharmacokinetics|pharmacokinetics
288802|NCT01714193|Contraceptives, Oral|contraceptives, oral
288803|NCT01714193|Ethinyl Estradiol|ethinyl estradiol
288804|NCT01714193|Levonorgestrel|levonorgestrel
288805|NCT01714193|LEVORA|levora
288806|NCT01714180|Acyclovir|acyclovir
288807|NCT01714180|Pharmacokinetics|pharmacokinetics
288808|NCT01714180|Obese|obese
288809|NCT01714180|Non-obese|non-obese
288810|NCT01714180|Weight|weight
288811|NCT01714180|Distribution|distribution
357424|NCT01421004|cancer|cancer
288812|NCT01714180|Clearance|clearance
288813|NCT01714167|Chronic|chronic
288814|NCT01714167|Ischemic Stroke|ischemic stroke
288815|NCT01714167|Intracerebral Hemorrhage|intracerebral hemorrhage
288816|NCT01714167|Bone Marrow Mesenchymal Stem Cell|bone marrow mesenchymal stem cell
288817|NCT01714141|Technology based intervention|technology based intervention
288818|NCT01714141|Emerging adults|emerging adults
288819|NCT01714141|African Americans|african americans
288820|NCT01714141|Asthma|asthma
288821|NCT01714141|Controller medications|controller medications
288822|NCT01714141|Motivational intervention|motivational intervention
288823|NCT01714128|NCI protocol #8762|nci protocol #8762
288824|NCT01714128|Estrogen receptor positive breast cancer|estrogen receptor positive breast cancer
288825|NCT01714128|recurrent breast cancer|recurrent breast cancer
288826|NCT01714128|stage IV breast cancer|stage iv breast cancer
288827|NCT01714102|Obesity|obesity
288828|NCT01714102|Insulin resistance|insulin resistance
288829|NCT01714102|Metabolic syndrome|metabolic syndrome
288830|NCT01714102|Pre-diabetes|pre-diabetes
288831|NCT01714089|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
288833|NCT01714063|pediatric|pediatric
288834|NCT01714063|asthma|asthma
288835|NCT01714063|metered dose inhaler|metered dose inhaler
288836|NCT01714063|valved holding chamber|valved holding chamber
288837|NCT01714063|pMDI|pmdi
288838|NCT01714063|VHC|vhc
288839|NCT01714050|seasonal affective disorder|seasonal affective disorder
288840|NCT01714050|winter depression|winter depression
288841|NCT01714050|cognitive-behavioral therapy|cognitive-behavioral therapy
288842|NCT01714050|light therapy|light therapy
288843|NCT01714037|Safety|safety
288844|NCT01714037|Efficacy|efficacy
288845|NCT01714037|HSP90|hsp90
288846|NCT01714037|Debio 0932|debio 0932
288847|NCT01714037|Standard of care treatment, NSCLC|standard of care treatment, nsclc
288848|NCT01714024|Dental|dental
288849|NCT01714024|Implant|implant
288850|NCT01714024|UNC Dental School|unc dental school
288851|NCT01714024|Trabecular Metal|trabecular metal
288852|NCT01714024|Titanium|titanium
288853|NCT01714024|Healthy Volunteers|healthy volunteers
288854|NCT01714024|Diabetic|diabetic
288855|NCT01714024|Osteopenic|osteopenic
288856|NCT01714024|Bone Inductive Properties|bone inductive properties
288857|NCT01714024|Osseous Healing|osseous healing
288858|NCT01714024|GO Health|go health
288859|NCT01714024|Offenbacher|offenbacher
288860|NCT01714024|Zimmer Dental, Inc.|zimmer dental, inc.
288861|NCT01714011|Randomized|randomized
288862|NCT01714011|Controlled|controlled
288863|NCT01714011|Trial|trial
288864|NCT01714011|Safety|safety
288865|NCT01714011|Efficacy|efficacy
288866|NCT01714011|Aripiprazole|aripiprazole
288867|NCT01714011|Ziprasidone|ziprasidone
288868|NCT01714011|Metabolic Syndrome|metabolic syndrome
288869|NCT01713998|Ulthera® System|ulthera® system
288870|NCT01713998|Ultherapy™ Treatment|ultherapy™ treatment
288871|NCT01713998|Ulthera, Inc.|ulthera, inc.
288872|NCT01713998|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
288873|NCT01713985|Ulthera® System|ulthera® system
288874|NCT01713985|Ultherapy™ Treatment|ultherapy™ treatment
288875|NCT01713985|Ulthera, Inc.|ulthera, inc.
288876|NCT01713985|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
288877|NCT01713972|BRAFi|brafi
288878|NCT01713972|BRAF-mutated|braf-mutated
288879|NCT01713959|Underarm sweating|underarm sweating
288880|NCT01713946|TSC seizures,|tsc seizures,
288881|NCT01713946|TSC epilepsy,|tsc epilepsy,
288882|NCT01713946|mTOR inhibitor,|mtor inhibitor,
288883|NCT01713946|RAD001,|rad001,
288884|NCT01713946|Everolimus|everolimus
288885|NCT01713933|Ulthera® System|ulthera® system
288886|NCT01713933|Ultherapy™ treatment|ultherapy™ treatment
288887|NCT01713933|Ulthera, Inc.|ulthera, inc.
288888|NCT01713907|Ultherapy™ treatment|ultherapy™ treatment
288889|NCT01713907|Ulthera® System|ulthera® system
288890|NCT01713907|Ulthera, Inc.|ulthera, inc.
288891|NCT01713907|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
288892|NCT01713894|Counseling|counseling
288893|NCT01713894|Limits of viability|limits of viability
288894|NCT01713881|Polyp|polyp
288895|NCT01713881|colonoscopy|colonoscopy
288896|NCT01713881|surveillance|surveillance
288897|NCT01713868|Breastfeeding|breastfeeding
288898|NCT01713868|Safe Sleep|safe sleep
288899|NCT01713868|Messaging|messaging
288900|NCT01713868|Social Media|social media
288902|NCT01713855|Rituximab|rituximab
288903|NCT01713855|Vaccine|vaccine
288904|NCT01713855|Immune Reconstitution|immune reconstitution
288905|NCT01713842|Tocilizumab|tocilizumab
288906|NCT01713842|Polymyalgia Rheumatica|polymyalgia rheumatica
288907|NCT01713842|Glucocorticotherapy|glucocorticotherapy
288908|NCT01713842|PMR-AS|pmr-as
288909|NCT01713829|cranberry|cranberry
288910|NCT01713829|gamma delta T cell|gamma delta t cell
279540|NCT01755949|CRP|crp
288911|NCT01713829|improvement in immune cell function in healthy humans|improvement in immune cell function in healthy humans
288912|NCT01713829|proliferation|proliferation
288913|NCT01713816|Glutathione|glutathione
288914|NCT01713816|Ascorbate|ascorbate
288915|NCT01713816|Alzheimer's disease|alzheimer's disease
288916|NCT01713816|Aging|aging
288917|NCT01713816|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
288918|NCT01713790|physical functional performance|physical functional performance
288919|NCT01713790|postural balance|postural balance
288920|NCT01713790|reaction time|reaction time
288921|NCT01713790|mobility|mobility
288922|NCT01713790|muscle strength|muscle strength
288923|NCT01713790|cognition|cognition
288924|NCT01713777|Seizures|seizures
288925|NCT01713764|diabetes|diabetes
288926|NCT01713764|obesity|obesity
288927|NCT01713764|mindful eating|mindful eating
288928|NCT01713764|positive affect|positive affect
288929|NCT01713764|low carbohydrate|low carbohydrate
288930|NCT01713764|diet|diet
288931|NCT01713751|Surgical site infection|surgical site infection
288932|NCT01713751|Cesarean section|cesarean section
288933|NCT01713738|ITP|itp
288934|NCT01713738|rituximab|rituximab
288935|NCT01713738|bleeding score|bleeding score
288936|NCT01713738|platelet count|platelet count
289230|NCT01712295|Warts|warts
288937|NCT01713738|health-related quality of life|health-related quality of life
288938|NCT01713738|HRQL|hrql
288939|NCT01713725|Chronic urticaria|chronic urticaria
288940|NCT01713725|Chronic spontaneous urticaria|chronic spontaneous urticaria
288941|NCT01713725|Autoimmune and non autoimmune urticaria|autoimmune and non autoimmune urticaria
288942|NCT01713725|UAS7|uas7
288943|NCT01713712|Pregnancy|pregnancy
288944|NCT01713712|Obesity|obesity
288945|NCT01713712|Nutrition therapy|nutrition therapy
288946|NCT01713699|CTC, cytology, meningeal carcinomatosis, leptomeningeal metastases|ctc, cytology, meningeal carcinomatosis, leptomeningeal metastases
288947|NCT01713686|Ulthera® System|ulthera® system
288948|NCT01713686|Ultherapy™ Treatment|ultherapy™ treatment
288949|NCT01713686|Ulthera, Inc.|ulthera, inc.
288950|NCT01713686|Micro-focused Ultrasound with Visualization (MFU-V)|micro-focused ultrasound with visualization (mfu-v)
288951|NCT01713673|Hyperhidrosis|hyperhidrosis
288952|NCT01713673|Axillary sweating|axillary sweating
288953|NCT01713673|Ulthera® System|ulthera® system
288954|NCT01713673|Ultherapy™ Treatment|ultherapy™ treatment
288955|NCT01713673|Ulthera, Inc.|ulthera, inc.
288956|NCT01713660|Cataract surgery|cataract surgery
288957|NCT01713660|Femtosecond laser|femtosecond laser
288958|NCT01713660|Corneal incisions|corneal incisions
288959|NCT01713647|Bio-equivalence, crossover|bio-equivalence, crossover
288960|NCT01713634|Bone resorption|bone resorption
288961|NCT01713634|Diet|diet
288962|NCT01713621|P. falciparum|p. falciparum
288963|NCT01713621|malaria|malaria
288964|NCT01713608|malaria|malaria
288965|NCT01713608|dose escalation|dose escalation
288966|NCT01713608|safety|safety
288967|NCT01713608|tolerability|tolerability
288968|NCT01713608|maximum tolerated dose|maximum tolerated dose
288969|NCT01713595|Acute Lung Injury|acute lung injury
288970|NCT01713595|Mechanical Ventilation|mechanical ventilation
288971|NCT01713569|Ulthera® System|ulthera® system
288972|NCT01713569|Ultherapy™ Treatment|ultherapy™ treatment
288973|NCT01713569|Ulthera, Inc.|ulthera, inc.
288974|NCT01713569|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
288975|NCT01713556|PTSD, Propranolol|ptsd, propranolol
288976|NCT01713543|falls|falls
288977|NCT01713517|Mosquito Control|mosquito control
288978|NCT01713517|Insecticide Resistance|insecticide resistance
288979|NCT01713491|brain ischemia|brain ischemia
288980|NCT01713491|thrombolytic therapy|thrombolytic therapy
288981|NCT01713491|Impaired cognition|impaired cognition
288982|NCT01713491|dementia|dementia
288983|NCT01713478|hepatic cirrhosis|hepatic cirrhosis
288984|NCT01713478|subclinical myocardial dysfunction|subclinical myocardial dysfunction
288985|NCT01713478|echocardiography|echocardiography
288986|NCT01713478|specific biomarkers|specific biomarkers
288987|NCT01713478|vascular assessment|vascular assessment
288988|NCT01713465|Diabetes|diabetes
288989|NCT01713465|Hypertension|hypertension
288990|NCT01713465|Hypercholesterolemia|hypercholesterolemia
288991|NCT01713465|Obesity|obesity
288992|NCT01713452|Surgical Stomas|surgical stomas
288993|NCT01713452|ileostomy|ileostomy
288994|NCT01713452|surgical site infection|surgical site infection
288995|NCT01713439|Relapsed/Refractory Neuroblastoma|relapsed/refractory neuroblastoma
288996|NCT01713439|Retroviral vector injections|retroviral vector injections
288997|NCT01713439|Allogeneic neuroblastoma cells|allogeneic neuroblastoma cells
289193|NCT01712503|Cataract|cataract
288998|NCT01713439|Lymphotactin|lymphotactin
288999|NCT01713439|Interleukin-2 (IL-2)|interleukin-2 (il-2)
289000|NCT01713426|Post herpetic neuralgia|post herpetic neuralgia
289001|NCT01713426|Peripheral Neuropathic Pain|peripheral neuropathic pain
289002|NCT01713426|Qutenza|qutenza
289003|NCT01713426|Pregabalin|pregabalin
289004|NCT01713426|NGX-4010|ngx-4010
289005|NCT01713413|Oxymizer|oxymizer
289006|NCT01713413|endurance time|endurance time
289007|NCT01713413|exercise test|exercise test
289008|NCT01713413|nasal cannula|nasal cannula
289009|NCT01713413|COPD|copd
289010|NCT01713413|ILD|ild
289011|NCT01713413|oxygenation|oxygenation
289012|NCT01713400|Acute Graft vs. Host Disease (aGVHD)|acute graft vs. host disease (agvhd)
289013|NCT01713400|Graft vs. Host Disease (GVHD)|graft vs. host disease (gvhd)
289014|NCT01713387|adjuvant chemotherapy|adjuvant chemotherapy
289015|NCT01713374|endothelial function|endothelial function
289016|NCT01713374|sympathetic nervous system|sympathetic nervous system
289017|NCT01713361|total knee arthroplasty|total knee arthroplasty
289018|NCT01713361|Prophylaxis|prophylaxis
289019|NCT01713348|CGM|cgm
289020|NCT01713348|MDI|mdi
289021|NCT01713322|parent education|parent education
289022|NCT01713322|pain management|pain management
289023|NCT01713322|immunization|immunization
289024|NCT01713322|infant|infant
289025|NCT01713309|Filgrastim|filgrastim
289026|NCT01713309|G-CSF|g-csf
289027|NCT01713309|Heparin-binding protein|heparin-binding protein
289028|NCT01713309|critically ill|critically ill
289029|NCT01713309|acute respiratory failure|acute respiratory failure
289030|NCT01713296|SCLC|sclc
289031|NCT01713296|2nd Line|2nd line
289032|NCT01713296|Relapsed or Refractory|relapsed or refractory
289033|NCT01713270|Hypertension|hypertension
289034|NCT01713270|Atrial Fibrillation|atrial fibrillation
289035|NCT01713270|Arrhythmias, Cardiac|arrhythmias, cardiac
289036|NCT01713270|Heart Diseases|heart diseases
289037|NCT01713257|Critically ill patients|critically ill patients
289038|NCT01713244|Hepatocellular Carcinoma|hepatocellular carcinoma
289039|NCT01713244|Radiofrequency Ablation|radiofrequency ablation
289040|NCT01713244|Hepatectomy|hepatectomy
289041|NCT01713244|Recurrence|recurrence
289042|NCT01713231|osteogenesis imperfecta|osteogenesis imperfecta
289043|NCT01713231|high-dose vitamin D|high-dose vitamin d
289044|NCT01713231|bone density|bone density
289045|NCT01713231|muscle function|muscle function
289046|NCT01713218|Pancreas|pancreas
289047|NCT01713218|Cancer|cancer
289048|NCT01713218|Hedgehog inhibitor|hedgehog inhibitor
289049|NCT01713218|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
289050|NCT01713218|Dynamic imaging|dynamic imaging
289051|NCT01713205|trauma ; sepsis; Multiple Organ Dysfunction Syndrome; Prediction; risk|trauma ; sepsis; multiple organ dysfunction syndrome; prediction; risk
289052|NCT01713153|postpartum hemorrhage|postpartum hemorrhage
289053|NCT01713153|prevention|prevention
289054|NCT01713153|misoprostol|misoprostol
289055|NCT01713153|Uniject|uniject
289056|NCT01713153|oxytocin|oxytocin
289057|NCT01713140|strength training|strength training
289058|NCT01713140|resistance training|resistance training
289059|NCT01713140|fatigue|fatigue
289060|NCT01713140|knee extension|knee extension
289061|NCT01713140|total knee arthroplasty|total knee arthroplasty
289062|NCT01713140|total knee replacement|total knee replacement
289063|NCT01713140|electromyography|electromyography
289064|NCT01713140|physical therapy modalities|physical therapy modalities
289065|NCT01713101|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
289066|NCT01713101|Peptic Ulcer Hemorrhage|peptic ulcer hemorrhage
289067|NCT01713101|Hematemesis|hematemesis
289068|NCT01713101|Melena|melena
289069|NCT01713101|Tranexamic acid|tranexamic acid
289070|NCT01713088|multisystemic therapy, RCT, young offenders, U.K.|multisystemic therapy, rct, young offenders, u.k.
289071|NCT01713075|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
289072|NCT01713075|Symbicort|symbicort
289073|NCT01713075|long-term use|long-term use
289074|NCT01713049|FLT PET|flt pet
289075|NCT01713049|breast neoplasms|breast neoplasms
289076|NCT01713049|mammography|mammography
289077|NCT01713049|breast ultrasound|breast ultrasound
289078|NCT01713036|Mass balance, bioavailability, cancer, 14C|mass balance, bioavailability, cancer, 14c
289079|NCT01713023|type 1 diabetes|type 1 diabetes
289080|NCT01713023|fructose|fructose
289081|NCT01713023|glucose|glucose
289082|NCT01713023|TAS1R2|tas1r2
289083|NCT01713023|oxidative stress|oxidative stress
586550|NCT00516672|Japanese patients,|japanese patients,
289084|NCT01713010|Keywords provided by Atlantic Health System:|keywords provided by atlantic health system:
289085|NCT01713010|Rapid Shallow Breathing Index|rapid shallow breathing index
289086|NCT01713010|Mechanical Ventilation|mechanical ventilation
289087|NCT01713010|Additional relevant MeSH terms:|additional relevant mesh terms:
289088|NCT01713010|Respiration Disorders|respiration disorders
289089|NCT01713010|Traumatic Brain Injury|traumatic brain injury
289090|NCT01713010|Weaning Failure|weaning failure
289091|NCT01713010|Mechanical ventilation complication|mechanical ventilation complication
289092|NCT01712997|Treatment of|treatment of
289093|NCT01712984|Influenza|influenza
289094|NCT01712984|Fluzone® Intradermal vaccine|fluzone® intradermal vaccine
289192|NCT01712516|COPD, QVA149|copd, qva149
289095|NCT01712984|Influenza Virus Vaccine USP Quadrivalent|influenza virus vaccine usp quadrivalent
289096|NCT01712984|Influenza Virus Vaccine USP Trivalent Types A and B|influenza virus vaccine usp trivalent types a and b
289097|NCT01712971|surgery|surgery
289098|NCT01712971|pancreas|pancreas
289099|NCT01712971|tumour|tumour
289100|NCT01712971|blood loss|blood loss
289101|NCT01712958|CRC miRNA|crc mirna
289102|NCT01712945|Alemtuzumab|alemtuzumab
289103|NCT01712945|Palifermin|palifermin
289104|NCT01712945|Reconstitution|reconstitution
289105|NCT01712945|Thymus|thymus
289106|NCT01712919|Locoregionally advanced nasopharyngeal carcinoma|locoregionally advanced nasopharyngeal carcinoma
289107|NCT01712919|cetuximab|cetuximab
289108|NCT01712919|chemoradiation|chemoradiation
289109|NCT01712893|breast cancer|breast cancer
289110|NCT01712893|adjuvant therapy|adjuvant therapy
289111|NCT01712893|Ovarian suppression|ovarian suppression
289112|NCT01712854|COPD|copd
289113|NCT01712854|Chronic Obstructive Lung Disease|chronic obstructive lung disease
289114|NCT01712854|Long acting beta agonist|long acting beta agonist
289115|NCT01712841|Dry AMD|dry amd
289116|NCT01712841|Age-related macular degeneration|age-related macular degeneration
289117|NCT01712841|Optical coherenece tomography|optical coherenece tomography
289118|NCT01712841|Imaging|imaging
289119|NCT01712841|Blood flow|blood flow
289120|NCT01712828|Lenalidomide,|lenalidomide,
289121|NCT01712828|Revlimid,|revlimid,
289122|NCT01712828|pharmacokinetics,|pharmacokinetics,
289123|NCT01712828|healthy male subjects|healthy male subjects
289124|NCT01712789|Multiple Myeloma|multiple myeloma
289125|NCT01712789|Relapsed Multiple Myeloma|relapsed multiple myeloma
289126|NCT01712789|Relapsed and refractory Multiple Myeloma|relapsed and refractory multiple myeloma
289127|NCT01712789|Pomalidomide|pomalidomide
289128|NCT01712789|Dexamethasone|dexamethasone
289129|NCT01712776|Vapocoolant|vapocoolant
289130|NCT01712763|Endometriosis|endometriosis
289131|NCT01712763|long acting GnRH antagonist|long acting gnrh antagonist
289132|NCT01712763|Degarelix|degarelix
289133|NCT01712763|Recurrence|recurrence
289134|NCT01712763|Pelvic Pain|pelvic pain
289135|NCT01712750|Regional tissue oximetry|regional tissue oximetry
289136|NCT01712750|Cardiopulmonary bypass|cardiopulmonary bypass
289137|NCT01712750|Cardiac surgical procedures|cardiac surgical procedures
289138|NCT01712737|raisins, grapes, snacks, appetite, food intake|raisins, grapes, snacks, appetite, food intake
289139|NCT01712724|exercise therapy|exercise therapy
289140|NCT01712724|rehabilitation|rehabilitation
289141|NCT01712711|Steatohepatitis,|steatohepatitis,
289142|NCT01712711|Helicobacter pylori,|helicobacter pylori,
289143|NCT01712711|Insulin resistance,|insulin resistance,
289144|NCT01712711|Alanine aminotransferase,|alanine aminotransferase,
289145|NCT01712711|Aspartate aminotransferase,|aspartate aminotransferase,
289146|NCT01712698|trauma|trauma
289147|NCT01712698|spinal cord injury|spinal cord injury
289148|NCT01712698|cervical spine|cervical spine
289149|NCT01712685|Kidney Neoplasm|kidney neoplasm
289150|NCT01712685|RCC|rcc
289151|NCT01712685|Biodistribution of 18F-VM4-037|biodistribution of 18f-vm4-037
289152|NCT01712685|CAIX Staining|caix staining
289153|NCT01712685|Tumor Angiogenesis|tumor angiogenesis
289154|NCT01712672|Dental Plaque|dental plaque
289156|NCT01712672|Bacterial Interactions|bacterial interactions
289157|NCT01712672|Receptor Polysaccharide|receptor polysaccharide
289158|NCT01712672|Oral Streptococci|oral streptococci
289159|NCT01712659|JAK 1/2|jak 1/2
289160|NCT01712659|Human T-Cell Lymphotropic Virus 1|human t-cell lymphotropic virus 1
289161|NCT01712659|HTLV-1|htlv-1
289162|NCT01712659|Janus Kinase Inhibitor|janus kinase inhibitor
289163|NCT01712646|Oxytocin|oxytocin
289164|NCT01712646|Childhood Onset Schizophrenia|childhood onset schizophrenia
289165|NCT01712646|Double Blind|double blind
289166|NCT01712633|fMRI|fmri
289167|NCT01712633|Brain Perfusion|brain perfusion
289168|NCT01712620|Microarray|microarray
289169|NCT01712620|Magnetic Resonance Imaging|magnetic resonance imaging
289170|NCT01712620|Mineralocorticoid Receptor Antagonist|mineralocorticoid receptor antagonist
289171|NCT01712620|Neurohormonal Axis|neurohormonal axis
289172|NCT01712620|Vascular Inflammation|vascular inflammation
289173|NCT01712620|Pulmonary Hypertension|pulmonary hypertension
289174|NCT01712620|Cardiovascular Disease|cardiovascular disease
289175|NCT01712620|Vascular Disease|vascular disease
289176|NCT01712607|laparoscopy|laparoscopy
289177|NCT01712607|surgery|surgery
289178|NCT01712607|warm-up|warm-up
289179|NCT01712607|preoperative|preoperative
289180|NCT01712607|surgical skills|surgical skills
289181|NCT01712594|United Kingdom Overnight closed loop|united kingdom overnight closed loop
289182|NCT01712581|normal myocardial T1, T2 and T2* values|normal myocardial t1, t2 and t2* values
289183|NCT01712555|Anophthalmic orbits|anophthalmic orbits
289184|NCT01712555|autologous fat|autologous fat
289185|NCT01712555|platelet rich plasma|platelet rich plasma
289186|NCT01712555|orbital atrophy|orbital atrophy
289187|NCT01712555|anophthalmos|anophthalmos
289188|NCT01712555|cannula|cannula
289189|NCT01712529|Systemic lupus erythematosus|systemic lupus erythematosus
289190|NCT01712529|endothelium|endothelium
289191|NCT01712529|exercise|exercise
289194|NCT01712503|Astigmatism|astigmatism
289195|NCT01712503|Toric|toric
289196|NCT01712503|Phacoemulsification|phacoemulsification
289197|NCT01712503|Intraocular lens|intraocular lens
357927|NCT01419028|HPP|hpp
289198|NCT01712490|Hodgkin Lymphoma|hodgkin lymphoma
289199|NCT01712490|Hodgkins Lymphoma|hodgkins lymphoma
289200|NCT01712490|Antibody, Monoclonal|antibody, monoclonal
289201|NCT01712490|Antibody-Drug Conjugate|antibody-drug conjugate
289202|NCT01712490|Antigens, CD-30|antigens, cd-30
289203|NCT01712490|Immunotherapy|immunotherapy
289204|NCT01712490|Lymphoma|lymphoma
289205|NCT01712490|Lymphoma, Classical|lymphoma, classical
289206|NCT01712490|ECHELON-1|echelon-1
289207|NCT01712451|adiposity|adiposity
289208|NCT01712438|Previously untreated patients|previously untreated patients
289209|NCT01712425|vaccine|vaccine
289210|NCT01712425|recently HIV-1 infected individuals|recently hiv-1 infected individuals
289211|NCT01712373|Multiple sclerosis|multiple sclerosis
289212|NCT01712373|Ginseng|ginseng
289213|NCT01712373|Fatigue|fatigue
289214|NCT01712373|Quality of life|quality of life
289215|NCT01712360|Tinea Pedis|tinea pedis
289216|NCT01712360|Tinea Cruris|tinea cruris
289217|NCT01712360|Athlete foot|athlete foot
289218|NCT01712360|Jock itch|jock itch
289219|NCT01712321|Social Anxiety Disorder|social anxiety disorder
289220|NCT01712321|Social Anxiety|social anxiety
289221|NCT01712321|Social Phobia|social phobia
289222|NCT01712321|SAD|sad
289223|NCT01712308|Leukemia|leukemia
289224|NCT01712308|Myeloproliferative Neoplasm|myeloproliferative neoplasm
289225|NCT01712308|MPN|mpn
289226|NCT01712308|Associated Myelofibrosis|associated myelofibrosis
289227|NCT01712308|Anemia|anemia
289228|NCT01712308|Sotatercept|sotatercept
289229|NCT01712308|ACE-011|ace-011
289231|NCT01712295|salicylic acid|salicylic acid
289232|NCT01712295|ethyl pyruvate|ethyl pyruvate
289233|NCT01712282|Physical Activity|physical activity
289234|NCT01712282|Accelerometer|accelerometer
289235|NCT01712256|CD4|cd4
289236|NCT01712256|Clinical trial|clinical trial
289237|NCT01712256|Human immunodeficiency virus-1 (HIV-1)|human immunodeficiency virus-1 (hiv-1)
289238|NCT01712256|HIV|hiv
289239|NCT01712256|Immunomodulary|immunomodulary
289240|NCT01712256|Infection|infection
289241|NCT01712256|Phase II|phase ii
289242|NCT01712256|Re-boost|re-boost
289243|NCT01712256|Vaccine|vaccine
289244|NCT01712256|Vacc-4x|vacc-4x
289245|NCT01712230|hormone therapy|hormone therapy
289246|NCT01712230|obesity|obesity
289247|NCT01712230|menopause|menopause
289248|NCT01712230|disease /disorder proneness /risk|disease /disorder proneness /risk
289249|NCT01712230|insulin sensitivity /resistance|insulin sensitivity /resistance
289250|NCT01712230|metabolic syndrome|metabolic syndrome
289251|NCT01712230|women's health|women's health
289252|NCT01712217|Non-small cell lung cancer|non-small cell lung cancer
289253|NCT01712204|Prophylaxis of Acute Gout Flares|prophylaxis of acute gout flares
289254|NCT01712204|Urate-Lowering Therapy|urate-lowering therapy
289255|NCT01712204|Hyperuricemia|hyperuricemia
289256|NCT01712204|Gouty arthritis|gouty arthritis
289257|NCT01712191|NUsurface|nusurface
289258|NCT01712191|Meniscus|meniscus
289259|NCT01712191|Knee|knee
289260|NCT01712191|KOOS|koos
289261|NCT01712178|Pharmacodynamic,Pharmacokinetic|pharmacodynamic,pharmacokinetic
289262|NCT01712165|Folic acid supplement|folic acid supplement
289263|NCT01712165|Neural tube defect-affected pregnancy|neural tube defect-affected pregnancy
289264|NCT01712165|Homocysteine concentration|homocysteine concentration
289265|NCT01712165|Plasma Folate concentration|plasma folate concentration
289266|NCT01712165|Plasma vitamin B12 concentration|plasma vitamin b12 concentration
289267|NCT01712152|Duchenne muscular dystrophy|duchenne muscular dystrophy
289268|NCT01712152|carrier|carrier
289269|NCT01712152|cardiac MRI|cardiac mri
289270|NCT01712152|myocardial fibrosis|myocardial fibrosis
289271|NCT01712152|female|female
289272|NCT01712087|spasticity|spasticity
289273|NCT01712087|muscle spasticity|muscle spasticity
289274|NCT01712087|muscle rigidity|muscle rigidity
289275|NCT01712087|motor neuron disease|motor neuron disease
289276|NCT01712087|hyperreflexia|hyperreflexia
289277|NCT01712074|Randomized|randomized
289278|NCT01712074|Double Blind|double blind
289279|NCT01712074|Safety and Efficacy|safety and efficacy
289280|NCT01712061|Diabetic nephropathy|diabetic nephropathy
289281|NCT01712061|type 2 diabetes|type 2 diabetes
289282|NCT01712061|albuminuria|albuminuria
289283|NCT01712061|chemokine antagonist|chemokine antagonist
289284|NCT01712035|Wet AMD|wet amd
289285|NCT01712035|Age-related macular degeneration|age-related macular degeneration
289286|NCT01712035|Optical coherenece tomography|optical coherenece tomography
289287|NCT01712035|Imaging|imaging
289288|NCT01712035|Blood flow|blood flow
289289|NCT01712009|Breast cancer|breast cancer
289290|NCT01712009|Chemotherapy|chemotherapy
289291|NCT01712009|Neulasta|neulasta
289292|NCT01712009|Pegfilgrastim|pegfilgrastim
289293|NCT01712009|Naproxen|naproxen
289294|NCT01712009|Loratadine|loratadine
289295|NCT01712009|Non-steroidal antiinflammatory drug (NSAID)|non-steroidal antiinflammatory drug (nsaid)
289296|NCT01712009|Anti-histamine|anti-histamine
289297|NCT01712009|Bone Pain|bone pain
289298|NCT01711996|hydronephrosis|hydronephrosis
289299|NCT01711996|biopsy|biopsy
289300|NCT01711996|biomarker|biomarker
289301|NCT01711957|Complications|complications
289302|NCT01711957|Mortality|mortality
289303|NCT01711957|Liver transplantation|liver transplantation
289304|NCT01711957|Platelet count|platelet count
289305|NCT01711957|Survival|survival
289306|NCT01711944|childhood cancer|childhood cancer
289307|NCT01711944|Internet communication|internet communication
289308|NCT01711944|parents|parents
289309|NCT01711944|caregivers|caregivers
289310|NCT01711944|problem solving|problem solving
289311|NCT01711931|percutaneous coronary intervention|percutaneous coronary intervention
289312|NCT01711931|bioresorbable vascular scaffold stents|bioresorbable vascular scaffold stents
289313|NCT01711931|everolimus|everolimus
289314|NCT01711931|biolimus|biolimus
289315|NCT01711918|gastroparesis|gastroparesis
289316|NCT01711918|domperidone|domperidone
289317|NCT01711918|nausea|nausea
289318|NCT01711918|vomiting|vomiting
289319|NCT01711892|Prostatic Neoplasms|prostatic neoplasms
289320|NCT01711892|Prostate Cancer|prostate cancer
289321|NCT01711892|Exercise|exercise
289322|NCT01711892|Soccer|soccer
289323|NCT01711892|Androgen Deprivation Therapy|androgen deprivation therapy
289324|NCT01711892|Body Composition|body composition
289325|NCT01711892|Cardiovascular fitness|cardiovascular fitness
289326|NCT01711892|Bone Health|bone health
289327|NCT01711892|Health Related Quality of Life|health related quality of life
289328|NCT01711866|Rotigotine|rotigotine
289329|NCT01711866|Neupro|neupro
289330|NCT01711866|Switch|switch
289331|NCT01711866|Dopamine agonists|dopamine agonists
289332|NCT01711840|Bronchial asthma|bronchial asthma
289333|NCT01711840|Symbicort Turbuhaler|symbicort turbuhaler
289334|NCT01711827|isavuconazole|isavuconazole
289335|NCT01711827|prednisone|prednisone
289336|NCT01711827|prednisolone|prednisolone
289337|NCT01711827|BAL8557|bal8557
289338|NCT01711827|healthy volunteers|healthy volunteers
289339|NCT01711814|Rheumatoid Arthritis|rheumatoid arthritis
289340|NCT01711814|ASP015K|asp015k
289341|NCT01711788|Hematopoietic stem cells|hematopoietic stem cells
289342|NCT01711788|Umbilical cord blood transplantation|umbilical cord blood transplantation
289343|NCT01711788|Intrabone infusion|intrabone infusion
289344|NCT01711788|Platelet recovery|platelet recovery
289345|NCT01711788|Neutrophil recovery|neutrophil recovery
289346|NCT01711788|Pediatric patients|pediatric patients
289347|NCT01711736|Immunogenicity|immunogenicity
289348|NCT01711736|Children|children
289349|NCT01711736|Safety|safety
289350|NCT01711736|Seasonal influenza|seasonal influenza
289351|NCT01711736|Fluarix|fluarix
289352|NCT01711723|darapladib|darapladib
289353|NCT01711723|Lp-PLA2- inhibitor|lp-pla2- inhibitor
289354|NCT01711723|healthy volunteer|healthy volunteer
289355|NCT01711723|renal impairment|renal impairment
289356|NCT01711723|pharmacokinetics|pharmacokinetics
289357|NCT01711710|Breast cancer|breast cancer
289358|NCT01711710|reconstruction|reconstruction
289359|NCT01711710|augmentation|augmentation
289360|NCT01711710|cohesive silicone gel|cohesive silicone gel
289361|NCT01711710|breast implant|breast implant
289362|NCT01711710|rupture|rupture
289363|NCT01711710|capsular contracture|capsular contracture
289364|NCT01711684|Neoplasm Metastasis|neoplasm metastasis
289365|NCT01711684|Melanoma|melanoma
289366|NCT01711645|Acellular|acellular
289367|NCT01711645|Adacel®|adacel®
289368|NCT01711645|Diptheria toxoids|diptheria toxoids
289369|NCT01711645|Pertussis|pertussis
289370|NCT01711645|postpartum|postpartum
289371|NCT01711645|Tdap|tdap
289372|NCT01711645|Tetanus|tetanus
289373|NCT01711645|women|women
289374|NCT01711632|VEMURAFENIB|vemurafenib
289375|NCT01711632|BRAF Inhibitor|braf inhibitor
289376|NCT01711632|12-200|12-200
289377|NCT01711632|Zelboraf™|zelboraf™
289378|NCT01711606|Fragile-X Syndrome|fragile-x syndrome
289379|NCT01711606|registry|registry
289380|NCT01711606|non-interventional trial|non-interventional trial
289381|NCT01711606|patient-related outcome study|patient-related outcome study
289382|NCT01711606|drug utilization|drug utilization
289383|NCT01711606|effectiveness|effectiveness
289384|NCT01711606|treatment patterns|treatment patterns
289385|NCT01711606|patient characteristics under real life conditions|patient characteristics under real life conditions
289386|NCT01711606|quality of life|quality of life
289387|NCT01711606|economics|economics
289388|NCT01711593|Asthma|asthma
289389|NCT01711593|Allergic|allergic
289390|NCT01711593|Inflammation|inflammation
289391|NCT01711593|Airway|airway
289392|NCT01711593|Challenge|challenge
289393|NCT01711593|Chemokines|chemokines
289394|NCT01711593|Tolerization|tolerization
289395|NCT01711580|Recurrent glioma|recurrent glioma
289396|NCT01711580|Quality of life|quality of life
289397|NCT01711580|Glioblastoma multiforme|glioblastoma multiforme
289398|NCT01711580|Anaplastic glioma|anaplastic glioma
289399|NCT01711580|Cognition|cognition
289400|NCT01711580|Re-irradiation|re-irradiation
289401|NCT01711567|Chronic Hepatitis B|chronic hepatitis b
358196|NCT01417637|TMD|tmd
289402|NCT01711567|TENOFOVIR|tenofovir
289403|NCT01711567|ENTECAVIR|entecavir
289404|NCT01711567|PARTIAL RESPONDER|partial responder
289405|NCT01711502|metastatic breast cancer,|metastatic breast cancer,
289406|NCT01711502|epidemiology,|epidemiology,
289407|NCT01711502|retrospective cohort|retrospective cohort
289408|NCT01711489|isavuconazole|isavuconazole
289409|NCT01711489|mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
289410|NCT01711489|BAL8557|bal8557
289411|NCT01711489|BAL4815|bal4815
289412|NCT01711489|healthy volunteers|healthy volunteers
289413|NCT01711489|Mycophenolic acid (MPA)|mycophenolic acid (mpa)
289414|NCT01711489|Phenolic glucuronide of MPA (MPAG)|phenolic glucuronide of mpa (mpag)
289415|NCT01711489|CellCept|cellcept
289416|NCT01711476|PCOS|pcos
289417|NCT01711476|Bdiet|bdiet
289418|NCT01711476|Ddiet|ddiet
289419|NCT01711476|OGTT|ogtt
289420|NCT01711463|Pharmacodynamics|pharmacodynamics
289421|NCT01711463|Fluticasone furoate (FF)|fluticasone furoate (ff)
289422|NCT01711463|novel dry powder device|novel dry powder device
289423|NCT01711463|Safety and tolerability|safety and tolerability
289424|NCT01711463|vilanterol(VI)|vilanterol(vi)
289425|NCT01711463|Healthy Chinese subjects|healthy chinese subjects
289426|NCT01711463|Pharmacokinetics|pharmacokinetics
289427|NCT01711437|colonoscopy|colonoscopy
289428|NCT01711437|colon cleansing|colon cleansing
289429|NCT01711437|children|children
289430|NCT01711437|age 2 -18 years|age 2 -18 years
289431|NCT01711411|HIV prevention|hiv prevention
289432|NCT01711411|PrePex|prepex
289433|NCT01711411|voluntary medical male circumcision|voluntary medical male circumcision
289434|NCT01711411|non-surgical|non-surgical
289435|NCT01711411|medical device|medical device
289436|NCT01711411|wound healing|wound healing
289437|NCT01711411|Kenya|kenya
289438|NCT01711398|solid tumor|solid tumor
289439|NCT01711398|peptide|peptide
289440|NCT01711385|Oral Health|oral health
289441|NCT01711385|Prediabetes|prediabetes
289442|NCT01711385|Diabetes|diabetes
289443|NCT01711385|Periodontitis|periodontitis
289444|NCT01711385|Early Identification|early identification
289445|NCT01711385|Prevention|prevention
289446|NCT01711372|ADHD|adhd
289447|NCT01711320|Omeprazole|omeprazole
289448|NCT01711320|Metformin|metformin
289449|NCT01711307|Achilles|achilles
289450|NCT01711307|Rupture|rupture
289451|NCT01711294|Pancreatic Cystic Lesions|pancreatic cystic lesions
289452|NCT01711294|PCL|pcl
289453|NCT01711294|EUS-FNA|eus-fna
289454|NCT01711281|Heart Failure|heart failure
289455|NCT01711281|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
289456|NCT01711281|Intracardiac Impedance Measurement|intracardiac impedance measurement
289457|NCT01711281|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
289458|NCT01711281|Home Monitoring|home monitoring
289459|NCT01711281|Reverse Remodeling|reverse remodeling
289460|NCT01711268|Sunitinib|sunitinib
289461|NCT01711268|Renal Cell Carcinoma|renal cell carcinoma
289462|NCT01711268|Therapeutic Drug Monitoring|therapeutic drug monitoring
289463|NCT01711268|Pharmacokinetic|pharmacokinetic
289464|NCT01711268|Treatment toxicity|treatment toxicity
289465|NCT01711255|Multiple sclerosis|multiple sclerosis
289466|NCT01711255|Coagulation|coagulation
289467|NCT01711255|Alternative Medicine|alternative medicine
289468|NCT01711255|Clotting|clotting
289469|NCT01711255|Complementary Medicine|complementary medicine
289470|NCT01711255|Inflammation|inflammation
289471|NCT01711242|gastric cancer|gastric cancer
289472|NCT01711242|radiotherapy|radiotherapy
289473|NCT01711242|postoperative therapy|postoperative therapy
289474|NCT01711242|chemotherapy|chemotherapy
289475|NCT01711229|oral acetaminophen|oral acetaminophen
289476|NCT01711229|IV acetaminophen|iv acetaminophen
289477|NCT01711229|Ofirmev|ofirmev
289478|NCT01711229|equianalgesic|equianalgesic
289479|NCT01711229|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
289480|NCT01711216|Dydrogesterone|dydrogesterone
289481|NCT01711216|Irregular Menstrual Cycle|irregular menstrual cycle
289482|NCT01711216|Progestins|progestins
289483|NCT01711203|Spondylolysis|spondylolysis
289484|NCT01711203|Spondylolisthesis|spondylolisthesis
289485|NCT01711203|Rehabilitation|rehabilitation
289486|NCT01711203|Physical Therapy|physical therapy
289487|NCT01711203|Children|children
289488|NCT01711190|glaucoma|glaucoma
289489|NCT01711190|trabeculectomy|trabeculectomy
289490|NCT01711190|astigmatism|astigmatism
289491|NCT01711190|intraocular pressure|intraocular pressure
289492|NCT01711177|primary open angle glaucoma|primary open angle glaucoma
289493|NCT01711177|retinal oximetry|retinal oximetry
289495|NCT01711164|T regulatory cells (Tregs)|t regulatory cells (tregs)
289496|NCT01711164|FGL2|fgl2
289497|NCT01711151|ILD|ild
289498|NCT01711138|Physical Activity|physical activity
289499|NCT01711138|Physical Fitness|physical fitness
289500|NCT01711138|Transportation|transportation
289501|NCT01711138|Environment Design|environment design
289502|NCT01711138|Child|child
289503|NCT01711138|Adolescent|adolescent
358307|NCT01417104|MI|mi
289504|NCT01711086|asthma|asthma
289505|NCT01711086|dry powder inhaler|dry powder inhaler
289506|NCT01711047|catheter ablation|catheter ablation
289507|NCT01711047|atrial fibrillation|atrial fibrillation
289508|NCT01711047|pulmonary vein isolation|pulmonary vein isolation
289509|NCT01711047|linear ablation|linear ablation
289510|NCT01711047|CFAE ablation|cfae ablation
289511|NCT01711034|Solid tumors|solid tumors
289512|NCT01711021|ADHD|adhd
289513|NCT01711008|Breakfast size|breakfast size
289514|NCT01711008|Exercise|exercise
289515|NCT01711008|Cognitive performance|cognitive performance
289516|NCT01711008|Mood|mood
289517|NCT01711008|Appetite|appetite
289518|NCT01711008|Active women|active women
289519|NCT01710956|concurrent chemoradiation in patients with limited disease small cell lung cancer|concurrent chemoradiation in patients with limited disease small cell lung cancer
289520|NCT01710943|Web-based CBT|web-based cbt
289522|NCT01710943|Alcohol Misuse|alcohol misuse
289523|NCT01710943|Substance Misuse|substance misuse
289524|NCT01710943|Integrated Primary Care|integrated primary care
289525|NCT01710943|OEF/OIF Veterans|oef/oif veterans
289526|NCT01710930|Allergic Broncho-Pulmonary Aspergillosis|allergic broncho-pulmonary aspergillosis
289527|NCT01710917|Chronic pain|chronic pain
289528|NCT01710917|Severe pain|severe pain
289529|NCT01710917|Oxycodon|oxycodon
289530|NCT01710917|Naloxon|naloxon
289531|NCT01710917|Opioid-induced constipation|opioid-induced constipation
289532|NCT01710917|Opioid|opioid
289533|NCT01710917|Quality of life|quality of life
289534|NCT01710917|Laxative|laxative
289535|NCT01710917|Analgesic rescue medication|analgesic rescue medication
289536|NCT01710904|Chronic pain|chronic pain
289537|NCT01710904|Severe pain|severe pain
289538|NCT01710904|Oxycodone|oxycodone
289539|NCT01710904|Naloxone|naloxone
289540|NCT01710904|Opioid-induced constipation|opioid-induced constipation
289541|NCT01710904|Opioid|opioid
289542|NCT01710904|Quality of life|quality of life
289543|NCT01710904|Laxative|laxative
289544|NCT01710904|Analgesic rescue medication|analgesic rescue medication
289545|NCT01710891|endotracheal intubation|endotracheal intubation
289546|NCT01710891|direct laryngoscopy|direct laryngoscopy
289547|NCT01710891|video laryngoscopy|video laryngoscopy
289548|NCT01710865|Caries prevention|caries prevention
289549|NCT01710865|pit and fissure sealants|pit and fissure sealants
289550|NCT01710852|Atrial Fibrillation|atrial fibrillation
289551|NCT01710852|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
289552|NCT01710852|AF|af
289553|NCT01710839|CRVO|crvo
289554|NCT01710839|BRVO|brvo
289555|NCT01710839|HRVO|hrvo
289556|NCT01710839|Macular edema|macular edema
289557|NCT01710839|vein occlusion|vein occlusion
289558|NCT01710813|pompe disease|pompe disease
289559|NCT01710813|alglucosidase alfa|alglucosidase alfa
289560|NCT01710813|anaphylaxis|anaphylaxis
289561|NCT01710813|severe cutaneous|severe cutaneous
289562|NCT01710813|systemic immune complex-mediated reactions|systemic immune complex-mediated reactions
289563|NCT01710800|impedance|impedance
289564|NCT01710800|reflux|reflux
289565|NCT01710800|GERD|gerd
289566|NCT01710787|operative|operative
289567|NCT01710787|dental procedure|dental procedure
289568|NCT01710774|Diabetic Foot|diabetic foot
289569|NCT01710774|Diabetes Mellitus|diabetes mellitus
289571|NCT01710774|Wound Healing|wound healing
289572|NCT01710774|Delivery of Health Care|delivery of health care
289573|NCT01710774|Depression|depression
289574|NCT01710774|sequela|sequela
289575|NCT01710774|Sick Leave|sick leave
289576|NCT01710774|Quality of Life|quality of life
289577|NCT01710774|Amputation|amputation
289578|NCT01710761|nitric oxide|nitric oxide
289579|NCT01710761|cycling performance|cycling performance
289580|NCT01710761|lactate|lactate
289581|NCT01710761|VO2|vo2
289582|NCT01710748|Percutaneous coronary intervention|percutaneous coronary intervention
289583|NCT01710748|Drug eluting stent|drug eluting stent
289584|NCT01710748|Neointimal hyperplasia|neointimal hyperplasia
289585|NCT01710748|Diabetes Mellitus|diabetes mellitus
289586|NCT01710735|TP|tp
289587|NCT01710735|Myofascial pain|myofascial pain
289588|NCT01710709|Aripiprazole, Intramuscular (IM) Depot, Bipolar|aripiprazole, intramuscular (im) depot, bipolar
289589|NCT01710683|Discectomy|discectomy
289590|NCT01710683|1st postoperative day|1st postoperative day
289591|NCT01710683|Intensive exercise training|intensive exercise training
289592|NCT01710683|Randomized controlled trial|randomized controlled trial
289593|NCT01710670|Brivaracetam|brivaracetam
289594|NCT01710670|Ethanol|ethanol
289595|NCT01710670|Pharmacodynamics|pharmacodynamics
289596|NCT01710670|Pharmacokinetic|pharmacokinetic
289597|NCT01710670|Interaction|interaction
289598|NCT01710657|Lacosamide|lacosamide
289599|NCT01710657|Epilepsy|epilepsy
289600|NCT01710657|Partial Onset Seizures|partial onset seizures
289601|NCT01710631|Sleep|sleep
289602|NCT01710618|Protein Expression of Sciatic Nerve|protein expression of sciatic nerve
289603|NCT01710618|traumatized sciatic nerve|traumatized sciatic nerve
289604|NCT01710605|Circulating tumor cells|circulating tumor cells
358453|NCT01416623|phase I|phase i
289605|NCT01710605|Breast Cancer|breast cancer
289606|NCT01710605|Hormone-receptors positive|hormone-receptors positive
289708|NCT01710111|Modes of transmission|modes of transmission
289607|NCT01710579|Primary esophageal achalasia|primary esophageal achalasia
289608|NCT01710579|endoscopic myotomy|endoscopic myotomy
289609|NCT01710579|high resolution manometry|high resolution manometry
289610|NCT01710566|Postpartum hemorrhage|postpartum hemorrhage
289611|NCT01710566|prevention|prevention
289612|NCT01710566|oxytocin|oxytocin
289613|NCT01710566|misoprostol|misoprostol
289614|NCT01710566|Uniject|uniject
289615|NCT01710566|community|community
289616|NCT01710527|Healthy Volunteers|healthy volunteers
289617|NCT01710488|COPD exacerbation|copd exacerbation
289618|NCT01710488|fluoroquinolones,|fluoroquinolones,
289619|NCT01710449|Lung Transplant|lung transplant
289620|NCT01710423|Obesity|obesity
289621|NCT01710423|Nutrition|nutrition
289622|NCT01710423|Home Food Preparation|home food preparation
289623|NCT01710423|Peer Mentoring|peer mentoring
289624|NCT01710423|Early Head Start|early head start
289625|NCT01710423|Cooking|cooking
289626|NCT01710423|Diet|diet
289627|NCT01710410|transcranial direct current stimulation|transcranial direct current stimulation
289628|NCT01710410|nicotine dependence|nicotine dependence
289629|NCT01710410|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
289630|NCT01710410|nicotine replacement therapy|nicotine replacement therapy
289631|NCT01710410|nicotine patch|nicotine patch
289632|NCT01710410|addiction|addiction
289633|NCT01710410|smoking cessation|smoking cessation
289634|NCT01710410|neuroplasticity|neuroplasticity
289635|NCT01710397|Antiretroviral therapy|antiretroviral therapy
289636|NCT01710397|South Africa|south africa
289637|NCT01710384|late preterm, betamethasone,|late preterm, betamethasone,
289638|NCT01710332|Persistent|persistent
289639|NCT01710332|Central|central
289640|NCT01710332|Serous|serous
289641|NCT01710332|Chorioretinopathy|chorioretinopathy
289642|NCT01710332|Regeneron|regeneron
289643|NCT01710332|CSR|csr
289644|NCT01710332|CSCR|cscr
289645|NCT01710319|Immunoregulation|immunoregulation
289646|NCT01710319|Natural Killer Cells|natural killer cells
289647|NCT01710306|Women|women
289648|NCT01710306|Veterans|veterans
289649|NCT01710306|PTSD|ptsd
289650|NCT01710293|Electronic Health Records|electronic health records
289651|NCT01710293|Diagnostic Delay|diagnostic delay
289652|NCT01710293|Triggers|triggers
289653|NCT01710280|Lipemia|lipemia
289654|NCT01710280|Vascular function|vascular function
289655|NCT01710280|Blood pressure|blood pressure
289656|NCT01710254|MRI|mri
289657|NCT01710254|Atrial Fibrillation|atrial fibrillation
289658|NCT01710228|MS|ms
289659|NCT01710228|Natalizumab|natalizumab
289660|NCT01710228|copaxone|copaxone
289661|NCT01710215|Colorectal Neoplasms|colorectal neoplasms
289662|NCT01710215|Colorectal Cancer|colorectal cancer
289663|NCT01710215|Colon Cancer|colon cancer
289664|NCT01710215|Mass Screening|mass screening
289665|NCT01710215|Health Services Research|health services research
289666|NCT01710215|Comparative Effectiveness Research|comparative effectiveness research
289667|NCT01710202|Hydrocortisone|hydrocortisone
289668|NCT01710202|Cortisol|cortisol
289669|NCT01710202|Testosterone|testosterone
289671|NCT01710202|Serotonin|serotonin
289672|NCT01710202|5-HTTLPR|5-httlpr
289673|NCT01710202|Amygdala|amygdala
289674|NCT01710202|Depression|depression
289675|NCT01710189|Tick-Borne Encephalitis Virus|tick-borne encephalitis virus
289676|NCT01710163|Lithium Carbonate|lithium carbonate
289677|NCT01710163|Lithium|lithium
289678|NCT01710163|Central Nervous System Agents|central nervous system agents
289679|NCT01710163|Therapeutic Uses|therapeutic uses
289680|NCT01710163|Pharmacologic Actions|pharmacologic actions
289681|NCT01710163|Enzyme Inhibitors|enzyme inhibitors
289682|NCT01710163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
289683|NCT01710163|Neurotransmitter Agents|neurotransmitter agents
289684|NCT01710163|Physiological Effects of Drugs|physiological effects of drugs
289685|NCT01710163|Antimanic Agents|antimanic agents
289686|NCT01710163|Tranquilizing Agents|tranquilizing agents
289687|NCT01710163|Central Nervous System Depressants|central nervous system depressants
289688|NCT01710163|Psychotropic Drugs|psychotropic drugs
289689|NCT01710163|Sensory System Agents|sensory system agents
289690|NCT01710163|Antipsychotic Agents|antipsychotic agents
289691|NCT01710163|Antidepressive Agents|antidepressive agents
289692|NCT01710150|typical aflutter (AFLT)|typical aflutter (aflt)
289693|NCT01710150|CTI ablation|cti ablation
289694|NCT01710150|Atrial Fibrillation (AF)|atrial fibrillation (af)
289695|NCT01710150|PVI|pvi
289696|NCT01710137|Smoking cessation|smoking cessation
289697|NCT01710137|Nicotine dependence|nicotine dependence
289698|NCT01710137|Varenicline|varenicline
289699|NCT01710137|Chantix|chantix
289700|NCT01710137|HIV|hiv
289701|NCT01710137|AIDS|aids
289702|NCT01710124|grocery purchases|grocery purchases
280299|NCT01752426|CLL|cll
289703|NCT01710124|financial incentives|financial incentives
289704|NCT01710124|obesogenic home food environment|obesogenic home food environment
289705|NCT01710111|Human challenge model|human challenge model
289706|NCT01710111|Quarantine study|quarantine study
289707|NCT01710111|Influenza virus|influenza virus
289709|NCT01710111|Droplet spray|droplet spray
289710|NCT01710111|Droplet nuclei|droplet nuclei
289711|NCT01710111|Secondary attack rate|secondary attack rate
289712|NCT01710111|Face shield|face shield
289713|NCT01710111|Hand hygiene|hand hygiene
289715|NCT01710111|Environmental deposition|environmental deposition
289716|NCT01710111|Environmental dispersion|environmental dispersion
289717|NCT01710098|testosterone|testosterone
289718|NCT01710098|S3-Adherence|s3-adherence
289719|NCT01710098|Quality of Life|quality of life
289720|NCT01710085|Diffusion weighted MRI|diffusion weighted mri
289721|NCT01710085|Curative surgery|curative surgery
289722|NCT01710085|Recurrence|recurrence
289723|NCT01710072|aneurysm, inflammation, MRI|aneurysm, inflammation, mri
289724|NCT01710059|Health Status Disparities|health status disparities
289725|NCT01710059|Minority Health|minority health
289726|NCT01710059|Pediatrics|pediatrics
289727|NCT01710059|Behavioral Intervention|behavioral intervention
289728|NCT01710059|Cellular Phone|cellular phone
289729|NCT01710059|Peer Group|peer group
289730|NCT01710046|plaque psoriasis|plaque psoriasis
289731|NCT01710046|tofacitinib|tofacitinib
289732|NCT01710046|biopsy|biopsy
289733|NCT01710046|Janus Kinase|janus kinase
289734|NCT01710046|randomized placebo controlled clinical trial|randomized placebo controlled clinical trial
289735|NCT01710046|psoriasis vulgaris|psoriasis vulgaris
289736|NCT01710033|CP-690,550|cp-690,550
289737|NCT01710033|kidney transplant|kidney transplant
289738|NCT01710020|CP-690|cp-690
289739|NCT01710020|550|550
289740|NCT01710020|pharmacokinetics|pharmacokinetics
289741|NCT01710020|end-stage renal disease|end-stage renal disease
289742|NCT01710007|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
289743|NCT01709994|cardiovascular events|cardiovascular events
289744|NCT01709994|chronic kidney disease|chronic kidney disease
289745|NCT01709994|bleedings|bleedings
289746|NCT01709994|progression|progression
289747|NCT01709994|antiinflammatory effects|antiinflammatory effects
289748|NCT01709968|Nocturnal Leg Cramps|nocturnal leg cramps
289749|NCT01709968|Quality of life|quality of life
289750|NCT01709968|Quality of sleep|quality of sleep
289751|NCT01709955|Obesity|obesity
289752|NCT01709955|Overweight|overweight
289753|NCT01709955|Glucomannan|glucomannan
289754|NCT01709942|GnRH antagonist|gnrh antagonist
289755|NCT01709942|PCOS|pcos
289756|NCT01709942|OHSS|ohss
289757|NCT01709942|COH|coh
289758|NCT01709942|IVF|ivf
289759|NCT01709916|Glaucoma|glaucoma
289760|NCT01709916|intra ocular pressure|intra ocular pressure
289761|NCT01709916|diurnal fluctuations|diurnal fluctuations
289762|NCT01709903|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
289763|NCT01709877|Multiport laparoscopy|multiport laparoscopy
289764|NCT01709877|Single Port Laparoscopy|single port laparoscopy
289765|NCT01709877|Symptomatic Gallstones|symptomatic gallstones
289766|NCT01709864|Anticholinergic|anticholinergic
289767|NCT01709864|Antimuscarinic|antimuscarinic
289768|NCT01709864|Chronic Obstructive Airway Disease|chronic obstructive airway disease
289769|NCT01709864|Chronic Obstructive Lung Disease|chronic obstructive lung disease
289898|NCT01709201|Juvenile Arthritis|juvenile arthritis
289770|NCT01709864|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
289771|NCT01709864|COPD|copd
289772|NCT01709864|LAMA|lama
289773|NCT01709864|Lung Disease|lung disease
289774|NCT01709864|Lung Diseases, Obstructive|lung diseases, obstructive
289775|NCT01709864|Lung Function|lung function
289776|NCT01709864|Muscarinic receptor antagonist|muscarinic receptor antagonist
289777|NCT01709864|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
289778|NCT01709864|Respiratory Tract Diseases|respiratory tract diseases
289779|NCT01709851|Type 1 diabetes|type 1 diabetes
289780|NCT01709851|Intravascular continuous glucose monitoring|intravascular continuous glucose monitoring
586551|NCT00516685|LUNG CANCER|lung cancer
289781|NCT01709851|Subcutaneous continuous glucose monitoring|subcutaneous continuous glucose monitoring
289782|NCT01709838|Non-transfusion dependent thalassemia, NTDT|non-transfusion dependent thalassemia, ntdt
289783|NCT01709825|probiotics|probiotics
289784|NCT01709825|cold|cold
289785|NCT01709825|flu|flu
289786|NCT01709825|immune function|immune function
289787|NCT01709825|microbiota|microbiota
289788|NCT01709799|Cognitive Training|cognitive training
289789|NCT01709799|Aging|aging
289790|NCT01709799|Seniors|seniors
289791|NCT01709786|Hemorrhage|hemorrhage
289792|NCT01709786|Hemoglobin|hemoglobin
289793|NCT01709786|Non-invasive monitoring|non-invasive monitoring
289794|NCT01709786|Medical device accuracy|medical device accuracy
289795|NCT01709760|ENIA11|enia11
289796|NCT01709760|MTX|mtx
289797|NCT01709760|RA|ra
289798|NCT01709760|TNF|tnf
289799|NCT01709747|Hydromorphone Hydrochloride|hydromorphone hydrochloride
289800|NCT01709747|Hydromorphone|hydromorphone
289801|NCT01709747|Pain|pain
289802|NCT01709747|Chronic Pain|chronic pain
289803|NCT01709747|Implantable Pump|implantable pump
289804|NCT01709747|Pump|pump
289805|NCT01709747|Intrathecal|intrathecal
289806|NCT01709734|prostate cancer CRPC|prostate cancer crpc
289807|NCT01709721|Hydromorphone|hydromorphone
289808|NCT01709721|Hydromorphone Hydrochloride|hydromorphone hydrochloride
289809|NCT01709721|Pain Management|pain management
289810|NCT01709721|Non-narcotic analgesics|non-narcotic analgesics
289811|NCT01709708|Migraine|migraine
289812|NCT01709708|Headache|headache
289813|NCT01709708|Chronic Migraine|chronic migraine
289814|NCT01709708|Marcaine|marcaine
289815|NCT01709708|Tx360|tx360
289816|NCT01709695|Intuniv|intuniv
289817|NCT01709695|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
289818|NCT01709695|fMRI|fmri
289819|NCT01709682|atrial fibrillation|atrial fibrillation
289820|NCT01709682|arrhythmias|arrhythmias
289821|NCT01709682|anti-arrhythmic agents|anti-arrhythmic agents
289822|NCT01709669|acute coronary syndrome|acute coronary syndrome
289823|NCT01709669|gratitude|gratitude
289824|NCT01709669|health behavior|health behavior
289825|NCT01709669|myocardial infarction|myocardial infarction
289826|NCT01709669|unstable angina|unstable angina
289827|NCT01709617|carbohydrate, glycogen, glucose|carbohydrate, glycogen, glucose
289828|NCT01709604|acute paraquat poisoning|acute paraquat poisoning
289829|NCT01709604|hemoperfusion|hemoperfusion
289830|NCT01709604|continuous blood purification|continuous blood purification
289831|NCT01709591|intrapartum pain management, epidural|intrapartum pain management, epidural
289832|NCT01709565|Sepsis|sepsis
289833|NCT01709565|Lactic acid|lactic acid
289834|NCT01709565|Shock|shock
289835|NCT01709565|Resuscitation|resuscitation
289836|NCT01709539|Cancer diagnosis center|cancer diagnosis center
289837|NCT01709539|Time to diagnosis|time to diagnosis
289838|NCT01709539|Survival|survival
289839|NCT01709539|Health economics|health economics
289840|NCT01709539|Biomarkers|biomarkers
289841|NCT01709526|Psychosocial functioning|psychosocial functioning
289842|NCT01709526|Cognitive performance of inpatients|cognitive performance of inpatients
289843|NCT01709526|Psychiatric diseases|psychiatric diseases
289844|NCT01709487|HIPEC|hipec
289845|NCT01709487|ovarian carcinoma|ovarian carcinoma
289846|NCT01709487|Bordet|bordet
289847|NCT01709474|SLE|sle
289848|NCT01709474|Vitamin D3|vitamin d3
289849|NCT01709474|Vitamin D deficiency|vitamin d deficiency
289850|NCT01709474|IFN alpha expression|ifn alpha expression
289851|NCT01709448|Neoplasms, Squamous Cell|neoplasms, squamous cell
289852|NCT01709448|Papillomavirus Infections|papillomavirus infections
289853|NCT01709448|HIV|hiv
289854|NCT01709422|Propofol|propofol
289855|NCT01709422|Midazolam|midazolam
289856|NCT01709422|Meperidine|meperidine
289857|NCT01709409|Prematurity|prematurity
289858|NCT01709383|Aphasia|aphasia
289859|NCT01709383|Stroke|stroke
289860|NCT01709383|Transcranial Direct Current Stimulation|transcranial direct current stimulation
289861|NCT01709383|Neuroplasticity|neuroplasticity
289862|NCT01709357|manual therapy|manual therapy
289863|NCT01709357|trigger point|trigger point
289864|NCT01709357|range of motion|range of motion
289865|NCT01709357|pain threshold|pain threshold
289866|NCT01709357|pain perception|pain perception
289867|NCT01709292|Thyroid Cancer|thyroid cancer
289868|NCT01709292|ERK|erk
289869|NCT01709292|Extracellular-signal-regulated kinase|extracellular-signal-regulated kinase
289870|NCT01709292|Biomarkers|biomarkers
289871|NCT01709292|Papillary thyroid cancer|papillary thyroid cancer
289872|NCT01709292|PTC|ptc
289873|NCT01709292|BRAF mutated|braf mutated
289874|NCT01709292|Vemurafenib|vemurafenib
289875|NCT01709292|PLX4032|plx4032
289876|NCT01709292|RO5185426|ro5185426
289877|NCT01709292|Zelboraf™|zelboraf™
289878|NCT01709279|Ischemic heart failure|ischemic heart failure
289879|NCT01709279|Myocardial regeneration|myocardial regeneration
289880|NCT01709279|ADRC|adrc
289881|NCT01709253|hpofractionation study using proton beam therapy|hpofractionation study using proton beam therapy
289882|NCT01709240|Chitosan|chitosan
289883|NCT01709240|Plasma|plasma
289884|NCT01709240|Incision Closure|incision closure
289885|NCT01709227|Acute kidney injury|acute kidney injury
289886|NCT01709227|AKI|aki
289887|NCT01709227|cardiopulmonary bypass|cardiopulmonary bypass
289888|NCT01709214|Osteoarthritis|osteoarthritis
289889|NCT01709214|Knee|knee
289890|NCT01709214|Pain|pain
289891|NCT01709214|Chronic|chronic
289892|NCT01709214|OA|oa
289893|NCT01709214|Arthritis|arthritis
289894|NCT01709201|Alcohol abuse|alcohol abuse
289895|NCT01709201|Drug abuse|drug abuse
289896|NCT01709201|Diabetes Mellitus|diabetes mellitus
289897|NCT01709201|Persistent Asthma|persistent asthma
289899|NCT01709201|Ulcerative Colitis|ulcerative colitis
289900|NCT01709188|Musical Dual Task Training|musical dual task training
289901|NCT01709188|dementia|dementia
289902|NCT01709188|attention control|attention control
289903|NCT01709188|dual task cost|dual task cost
289904|NCT01709188|gait stability|gait stability
289905|NCT01709175|Cancer|cancer
289906|NCT01709175|Breast Cancer|breast cancer
289907|NCT01709175|Gynecologic Cancer|gynecologic cancer
289908|NCT01709175|Strength Training|strength training
289909|NCT01709175|Exercise|exercise
289910|NCT01709175|Physical Activity|physical activity
289911|NCT01709175|Fatigue|fatigue
289912|NCT01709175|Quality of Life|quality of life
289913|NCT01709175|Strength|strength
289914|NCT01709175|Fitness|fitness
289915|NCT01709175|Cancer Survivor|cancer survivor
289916|NCT01709175|Survivor|survivor
289917|NCT01709123|Diabetes Mellitus, Juvenile Onset|diabetes mellitus, juvenile onset
289918|NCT01709123|Cardiovascular Diseases|cardiovascular diseases
289919|NCT01709123|Hyperglycemia|hyperglycemia
289920|NCT01709123|Hyperketonemia|hyperketonemia
289921|NCT01709110|Bone Loss|bone loss
289922|NCT01709110|Vertebral fractures|vertebral fractures
289923|NCT01709097|Adherence|adherence
289924|NCT01709097|Compliance|compliance
289925|NCT01709097|Kidney Transplant Recipient|kidney transplant recipient
289926|NCT01709097|An electronic drug dispenser|an electronic drug dispenser
289927|NCT01709097|The Portal|the portal
289928|NCT01709084|Human immunodeficiency virus-type 1 infection|human immunodeficiency virus-type 1 infection
289929|NCT01709084|HIV-1|hiv-1
289930|NCT01709084|Infectious diseases|infectious diseases
289931|NCT01709084|Ribonucleic acid|ribonucleic acid
289932|NCT01709084|RNA|rna
289933|NCT01709084|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
289934|NCT01709084|Emtricitabine|emtricitabine
289935|NCT01709084|Rilpivirine|rilpivirine
289936|NCT01709084|Efavirenz|efavirenz
289937|NCT01709084|Edurant|edurant
289938|NCT01709084|TMC278|tmc278
289939|NCT01709084|R278474|r278474
289940|NCT01709084|Fixed dose combination|fixed dose combination
289941|NCT01709071|Vaccination|vaccination
289942|NCT01709071|Inactivated poliomyelitis vaccine|inactivated poliomyelitis vaccine
289943|NCT01709071|poliomyelitis|poliomyelitis
289944|NCT01709071|Sabin strains|sabin strains
289945|NCT01709058|Back Pain|back pain
289946|NCT01709058|Therapeutics|therapeutics
289947|NCT01709058|Aged|aged
289948|NCT01709058|Injections, Intramuscular|injections, intramuscular
289949|NCT01709058|Oxygen|oxygen
289950|NCT01709058|Ozone|ozone
289951|NCT01709058|Geriatric Assessment|geriatric assessment
289952|NCT01709058|Trace Elements|trace elements
289953|NCT01709058|Oxidative stress|oxidative stress
289954|NCT01709045|Endarterectomy, Carotid|endarterectomy, carotid
289955|NCT01709045|Carotid Arteries|carotid arteries
289956|NCT01709032|Thalassemia|thalassemia
289957|NCT01709032|Chelation|chelation
289958|NCT01709032|Transfusion|transfusion
289959|NCT01709032|Safety|safety
289960|NCT01709006|Head and neck cancer|head and neck cancer
289961|NCT01708980|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
289962|NCT01708980|Electromyography|electromyography
289963|NCT01708980|Resistance training|resistance training
289964|NCT01708980|Physical Therapy Modalities|physical therapy modalities
289965|NCT01708967|transnasal endoscopy|transnasal endoscopy
289966|NCT01708967|pretreatment method|pretreatment method
289967|NCT01708954|erlotinib|erlotinib
289968|NCT01708954|cabozantinib|cabozantinib
289969|NCT01708954|non-small cell lung cancer|non-small cell lung cancer
289970|NCT01708928|Ulthera® System|ulthera® system
289971|NCT01708928|Ultherapy™ Treatment|ultherapy™ treatment
289972|NCT01708928|Ulthera, Inc.|ulthera, inc.
289973|NCT01708928|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
289974|NCT01708876|uncomplicated|uncomplicated
289976|NCT01708876|knowlesi|knowlesi
289977|NCT01708876|malaria|malaria
289978|NCT01708876|infection|infection
289979|NCT01708863|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
289980|NCT01708863|Stage II palliative surgery|stage ii palliative surgery
289981|NCT01708863|Glenn procedure|glenn procedure
289982|NCT01708863|Congenital heart defect|congenital heart defect
289983|NCT01708863|Congenital heart disease|congenital heart disease
289984|NCT01708863|Underdeveloped left ventricle|underdeveloped left ventricle
586552|NCT00516685|NSCLC|nsclc
289985|NCT01708837|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
289986|NCT01708837|Bispectral index|bispectral index
289987|NCT01708824|colorectal cancer|colorectal cancer
289988|NCT01708824|cancer survivor|cancer survivor
289989|NCT01708824|western pattern diet|western pattern diet
289990|NCT01708824|physical activity|physical activity
289991|NCT01708824|behavioral intervention|behavioral intervention
289992|NCT01708824|acceptability|acceptability
289993|NCT01708824|feasibility|feasibility
289994|NCT01708824|randomized controlled trial|randomized controlled trial
289995|NCT01708824|compliance|compliance
289996|NCT01708811|Contractility|contractility
289997|NCT01708811|human|human
289998|NCT01708811|myometrium|myometrium
289999|NCT01708811|hyponatraemia|hyponatraemia
290000|NCT01708798|Diastolic heart failure|diastolic heart failure
290001|NCT01708785|obesity|obesity
290002|NCT01708785|overweight|overweight
280596|NCT01750944|Ankle|ankle
280597|NCT01750944|Toe|toe
280598|NCT01750944|Walking test|walking test
280599|NCT01750944|Exercise|exercise
280605|NCT01750879|peanut|peanut
290003|NCT01708785|overweight children|overweight children
290004|NCT01708785|overweight parents|overweight parents
290005|NCT01708785|overeating|overeating
290006|NCT01708785|eating in the absence of hunger|eating in the absence of hunger
290007|NCT01708785|families with overweight child|families with overweight child
290008|NCT01708785|body mass index|body mass index
290009|NCT01708785|BMI|bmi
290010|NCT01708785|weight|weight
290011|NCT01708785|childhood obesity|childhood obesity
290012|NCT01708785|treatment|treatment
290313|NCT01707537|cholera|cholera
290013|NCT01708785|cue exposure treatment|cue exposure treatment
290014|NCT01708785|cravings|cravings
290015|NCT01708785|habituation to food cues|habituation to food cues
290016|NCT01708785|psychophysiological response to food cues|psychophysiological response to food cues
290017|NCT01708785|intervention|intervention
290018|NCT01708785|experiments|experiments
290019|NCT01708785|family based treatment|family based treatment
290020|NCT01708785|behavioral treatment|behavioral treatment
290021|NCT01708772|TNF alpha|tnf alpha
290022|NCT01708772|SOFA score|sofa score
290023|NCT01708759|Serum Il-8|serum il-8
290024|NCT01708759|IL8 polymorphism|il8 polymorphism
290025|NCT01708759|critically ill patients|critically ill patients
290026|NCT01708733|HCV carrier|hcv carrier
290027|NCT01708733|Chinese herbal medicine|chinese herbal medicine
290028|NCT01708733|Liver function|liver function
290029|NCT01708733|HCV RNA titer|hcv rna titer
290030|NCT01708720|Vaccination|vaccination
290031|NCT01708720|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
290032|NCT01708720|Polio|polio
290033|NCT01708720|Sabin|sabin
290034|NCT01708681|Seafood|seafood
290035|NCT01708681|Meat|meat
290036|NCT01708681|Egg|egg
290037|NCT01708681|Milk|milk
290038|NCT01708681|Postprandial lipid metabolism|postprandial lipid metabolism
290039|NCT01708681|Postprandial glucose metabolism|postprandial glucose metabolism
290040|NCT01708681|Triglycerides|triglycerides
290041|NCT01708681|Cholesterol|cholesterol
290042|NCT01708681|Postprandial incretins|postprandial incretins
290043|NCT01708681|Postprandial hormones|postprandial hormones
290044|NCT01708668|Fever|fever
290045|NCT01708668|Patient controlled epidural analgesia|patient controlled epidural analgesia
290046|NCT01708668|Labor analgesia|labor analgesia
290047|NCT01708668|Epidural analgesia|epidural analgesia
290048|NCT01708668|Combined spinal-epidural analgesia|combined spinal-epidural analgesia
290049|NCT01708655|Cystic Fibrosis|cystic fibrosis
290050|NCT01708655|Sweat Evaporimeter|sweat evaporimeter
290051|NCT01708629|psoriasis, brodalumab, AMG 827|psoriasis, brodalumab, amg 827
290052|NCT01708603|psoriasis, brodalumab, AMG 827|psoriasis, brodalumab, amg 827
290053|NCT01708590|psoriasis, brodalumab (AMG 827)|psoriasis, brodalumab (amg 827)
290054|NCT01708577|heart rate|heart rate
290055|NCT01708577|sweating|sweating
290056|NCT01708577|respiration|respiration
290057|NCT01708577|acceleration of body movement|acceleration of body movement
290058|NCT01708577|heart activity.|heart activity.
290059|NCT01708551|Hyperhidrosis|hyperhidrosis
290060|NCT01708551|Axillary sweating|axillary sweating
290061|NCT01708551|Ulthera® System|ulthera® system
290062|NCT01708551|Ultherapy™ Treatment|ultherapy™ treatment
290063|NCT01708551|Ulthera, Inc.|ulthera, inc.
290064|NCT01708538|keratoconus, corneal collagen crosslinking, riboflavin, corneal ectasia|keratoconus, corneal collagen crosslinking, riboflavin, corneal ectasia
290065|NCT01708525|Ulthera® System|ulthera® system
290066|NCT01708525|Ultherapy® Treatment|ultherapy® treatment
290067|NCT01708525|Ulthera, Inc.|ulthera, inc.
290068|NCT01708525|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
290069|NCT01708512|Ulthera® System|ulthera® system
290070|NCT01708512|Ultherapy™ Treatment|ultherapy™ treatment
290071|NCT01708512|Ulthera, Inc.|ulthera, inc.
290072|NCT01708512|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
290073|NCT01708499|Ulthera® System|ulthera® system
290074|NCT01708499|Ultherapy™ Treatment|ultherapy™ treatment
290075|NCT01708499|Ulthera, Inc.|ulthera, inc.
290076|NCT01708499|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
290077|NCT01708486|asthma|asthma
290078|NCT01708486|Dry Powder Inhalers|dry powder inhalers
290079|NCT01708486|FSI-10 questionnaire|fsi-10 questionnaire
290080|NCT01708460|Ulthera® System|ulthera® system
290081|NCT01708460|Ultherapy™ Treatment|ultherapy™ treatment
290082|NCT01708460|Ulthera, Inc.|ulthera, inc.
290083|NCT01708460|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
290084|NCT01708434|Skin laxity|skin laxity
290085|NCT01708434|Knees|knees
290086|NCT01708408|biorepository|biorepository
290087|NCT01708408|biobank|biobank
290088|NCT01708408|registry|registry
290089|NCT01708408|community|community
290090|NCT01708408|biospecimens|biospecimens
290091|NCT01708408|volunteers|volunteers
290092|NCT01708408|chronic disease|chronic disease
290093|NCT01708408|longitudinal|longitudinal
290094|NCT01708408|blood|blood
290095|NCT01708408|electronic health records|electronic health records
290096|NCT01708408|follow-up|follow-up
290097|NCT01708395|Ulcerative colitis|ulcerative colitis
290098|NCT01708382|Ulthera® System|ulthera® system
290099|NCT01708382|Ultherapy™ Treatment|ultherapy™ treatment
290100|NCT01708382|Ulthera, Inc.|ulthera, inc.
290101|NCT01708382|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
290102|NCT01708369|human carboxylesterase-1|human carboxylesterase-1
290103|NCT01708369|human carboxylesterase-2|human carboxylesterase-2
290104|NCT01708369|alcohol|alcohol
290105|NCT01708369|pharmacokinetics|pharmacokinetics
290106|NCT01708356|Air Pollution|air pollution
290107|NCT01708356|Particulate Matter|particulate matter
290108|NCT01708356|Exercise|exercise
290109|NCT01708356|Respiratory Rate|respiratory rate
290110|NCT01708356|Inflammation|inflammation
290111|NCT01708356|Oxidative Stress|oxidative stress
290112|NCT01708356|Plethysmography|plethysmography
290113|NCT01708343|Myofascial Pain Syndrome,|myofascial pain syndrome,
290114|NCT01708343|intramuscular stimulation,|intramuscular stimulation,
290115|NCT01708343|acupuncture,|acupuncture,
290116|NCT01708343|sleep quality,|sleep quality,
290117|NCT01708343|pain threshold.|pain threshold.
290118|NCT01708330|manual vacuum aspiration|manual vacuum aspiration
290119|NCT01708330|missed abortion|missed abortion
290120|NCT01708330|incomplete abortion|incomplete abortion
290121|NCT01708330|nonviable pregnancy|nonviable pregnancy
290122|NCT01708330|topical lidocaine|topical lidocaine
290124|NCT01708317|Gonorrhea|gonorrhea
290125|NCT01708317|Chlamydia|chlamydia
290126|NCT01708317|Emergency Department|emergency department
290127|NCT01708317|Youth|youth
290128|NCT01708317|Adolescents|adolescents
290129|NCT01708317|Computer|computer
290130|NCT01708317|Questionnaire|questionnaire
290131|NCT01708304|Dementia|dementia
290132|NCT01708304|Alzheimer's Disease|alzheimer's disease
290133|NCT01708304|Exercise|exercise
290134|NCT01708304|Caregiver|caregiver
290135|NCT01708304|Behavior modification|behavior modification
290136|NCT01708291|youth|youth
290137|NCT01708291|Stress|stress
290138|NCT01708291|mindfulness|mindfulness
290139|NCT01708291|foster care|foster care
290140|NCT01708291|stress reduction|stress reduction
290141|NCT01708291|high risk teens|high risk teens
290142|NCT01708278|COPD|copd
290143|NCT01708278|Emphysema|emphysema
290144|NCT01708278|chronic bronchitis|chronic bronchitis
290145|NCT01708278|Quercetin|quercetin
290146|NCT01708278|flavonoids|flavonoids
290147|NCT01708265|Mitral Valve Insufficiency|mitral valve insufficiency
290148|NCT01708265|Mitral Valve Regurgitation|mitral valve regurgitation
290149|NCT01708265|Asymptomatic Mitral Valve Regurgitation|asymptomatic mitral valve regurgitation
290150|NCT01708265|Asymptomatic Mitral Valve Insufficiency|asymptomatic mitral valve insufficiency
290151|NCT01708265|Mitral Valve Repair|mitral valve repair
290152|NCT01708265|Watchful Waiting|watchful waiting
290153|NCT01708252|Ulthera® System|ulthera® system
290154|NCT01708252|Ultherapy™ Treatment|ultherapy™ treatment
290155|NCT01708252|Ulthera, Inc.|ulthera, inc.
290156|NCT01708252|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
290157|NCT01708239|Pregnancy|pregnancy
290158|NCT01708239|Deep vein thrombosis|deep vein thrombosis
290159|NCT01708239|Clinical probability|clinical probability
290160|NCT01708239|D-Dimer|d-dimer
290161|NCT01708239|Compression ultrasonography|compression ultrasonography
290163|NCT01708226|obsessive compulsive disorder|obsessive compulsive disorder
290164|NCT01708226|children|children
290165|NCT01708213|soft tissue|soft tissue
290166|NCT01708213|augmentation|augmentation
290167|NCT01708213|correction|correction
290168|NCT01708213|wrinkles|wrinkles
290169|NCT01708200|Memory|memory
290170|NCT01708200|Intervention|intervention
290171|NCT01708200|Computerized|computerized
290172|NCT01708200|Psychoeducational|psychoeducational
290173|NCT01708200|Mental Illness|mental illness
290174|NCT01708187|Peroneal tendon|peroneal tendon
290175|NCT01708174|medulloblastoma,|medulloblastoma,
290176|NCT01708174|relapsed,|relapsed,
290177|NCT01708174|pediatric,|pediatric,
290178|NCT01708174|children,|children,
290179|NCT01708174|adults,|adults,
290180|NCT01708174|Hh pathway inhibitor,|hh pathway inhibitor,
290181|NCT01708174|LDE225|lde225
290182|NCT01708161|PIK3CA mutation|pik3ca mutation
290183|NCT01708161|advanced solid tumor|advanced solid tumor
290184|NCT01708161|breast cancer|breast cancer
290185|NCT01708161|ovarian cancer|ovarian cancer
290186|NCT01708122|Intranasal fentanyl|intranasal fentanyl
290187|NCT01708122|Cystoscopy|cystoscopy
290188|NCT01708070|asthma|asthma
290189|NCT01708070|depression|depression
290190|NCT01708070|anxiety|anxiety
290191|NCT01708057|COPD|copd
280807|NCT01749800|TBI|tbi
290192|NCT01708057|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
290193|NCT01708044|Pramlintide,|pramlintide,
290194|NCT01708044|insulin,|insulin,
290195|NCT01708044|type 1 diabetes,|type 1 diabetes,
290196|NCT01708044|reduction in postprandial glucose,|reduction in postprandial glucose,
290197|NCT01708044|pramlintide:insulin dose-ratio|pramlintide:insulin dose-ratio
290198|NCT01708018|Pregnancy|pregnancy
290199|NCT01708018|Stress, Psychological|stress, psychological
290200|NCT01708018|Low Back Pain|low back pain
290201|NCT01708018|Breech Presentation|breech presentation
290202|NCT01708018|Relaxation|relaxation
290203|NCT01708018|Hydrotherapy|hydrotherapy
290204|NCT01708018|Acupressure|acupressure
290205|NCT01708018|WATSU|watsu
290206|NCT01708005|Mild Cognitive Impairment|mild cognitive impairment
290207|NCT01708005|Vitamin D|vitamin d
290208|NCT01708005|Cholecalciferol|cholecalciferol
290209|NCT01708005|Lecitone®Se-Vitamin D3|lecitone®se-vitamin d3
290210|NCT01707979|Near infrared light|near infrared light
290211|NCT01707979|Diabetic neuropathy|diabetic neuropathy
290212|NCT01707979|Sensory neuropathy|sensory neuropathy
290213|NCT01707979|Autonomic neuropathy|autonomic neuropathy
290214|NCT01707979|Vagus|vagus
290215|NCT01707979|Sudomotor function|sudomotor function
290216|NCT01707979|Monofilament|monofilament
290217|NCT01707979|Impedance|impedance
290218|NCT01707966|adenocarcinoma of the prostate|adenocarcinoma of the prostate
290219|NCT01707966|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
290220|NCT01707966|maintenance therapy|maintenance therapy
290221|NCT01707966|orteronel|orteronel
290222|NCT01707966|TAK-700|tak-700
290223|NCT01707927|EOA|eoa
290224|NCT01707914|oxidative stress|oxidative stress
290225|NCT01707914|dyslipidemia|dyslipidemia
290226|NCT01707914|inflammation|inflammation
290227|NCT01707901|GERD|gerd
290228|NCT01707862|Intravenous leiomyomatosis|intravenous leiomyomatosis
290229|NCT01707862|Surgery|surgery
290230|NCT01707862|Smooth muscle tumor|smooth muscle tumor
290231|NCT01707849|Hepatitis C|hepatitis c
290232|NCT01707849|Liver Fibrosis|liver fibrosis
290233|NCT01707849|m-TOR inhibitors|m-tor inhibitors
290234|NCT01707810|Liver transplatation|liver transplatation
290235|NCT01707797|dental caries|dental caries
290236|NCT01707797|high risk|high risk
290237|NCT01707797|dental cavities|dental cavities
290238|NCT01707797|children dental care|children dental care
290239|NCT01707784|Pregnancy|pregnancy
290240|NCT01707784|Stress|stress
290241|NCT01707784|Anxiety|anxiety
290242|NCT01707784|Cortisol|cortisol
290243|NCT01707784|Copeptin|copeptin
290244|NCT01707784|Gestational diabetes|gestational diabetes
290245|NCT01707758|pancreatic cancer|pancreatic cancer
290246|NCT01707758|nanoparticle|nanoparticle
290247|NCT01707758|proteases|proteases
290248|NCT01707758|cell survival|cell survival
290249|NCT01707758|tumor progression|tumor progression
290250|NCT01707758|angiogenesis|angiogenesis
290251|NCT01707758|tissue remodeling/invasion|tissue remodeling/invasion
290252|NCT01707732|Obesity|obesity
290253|NCT01707732|thromboprophylaxis|thromboprophylaxis
290254|NCT01707732|Enoxaparin|enoxaparin
290255|NCT01707719|Alzheimer's disease|alzheimer's disease
290256|NCT01707719|Oxidative stress|oxidative stress
290257|NCT01707719|HPA axis|hpa axis
290258|NCT01707706|Insomnia|insomnia
290259|NCT01707706|Depression|depression
290260|NCT01707706|Electroacupuncture|electroacupuncture
290261|NCT01707706|Acupuncture|acupuncture
290262|NCT01707706|Randomized Clinical Trial|randomized clinical trial
290263|NCT01707706|Traditional Chinese Medicine|traditional chinese medicine
290264|NCT01707693|physical activity|physical activity
290265|NCT01707693|prevention|prevention
290266|NCT01707693|coronary heart disease|coronary heart disease
290267|NCT01707693|women|women
290268|NCT01707680|weaning|weaning
290269|NCT01707680|mechanical ventilation|mechanical ventilation
290270|NCT01707680|dexmedetomidine|dexmedetomidine
290271|NCT01707680|propofol|propofol
290272|NCT01707680|midazolam|midazolam
290273|NCT01707654|defect;|defect;
290274|NCT01707654|dorsal branch of the proper digital nerve;|dorsal branch of the proper digital nerve;
290275|NCT01707654|proper digital nerve;|proper digital nerve;
290276|NCT01707654|finger sensory reconstruction.|finger sensory reconstruction.
290278|NCT01707628|influenza vaccination|influenza vaccination
290279|NCT01707628|rituximab|rituximab
290280|NCT01707615|proanthocyanidin,atherosclerosis, carotid plaque|proanthocyanidin,atherosclerosis, carotid plaque
290281|NCT01707602|Intradermal|intradermal
290282|NCT01707602|transcutaneous|transcutaneous
290283|NCT01707602|influenza|influenza
290284|NCT01707602|routes of vaccination|routes of vaccination
290285|NCT01707602|T cell responses|t cell responses
290286|NCT01707602|humoral responses|humoral responses
290288|NCT01707602|clinical trial|clinical trial
290289|NCT01707602|Novel application of influenza vaccine|novel application of influenza vaccine
290290|NCT01707602|Transcutaneous vaccination(hair follicular targeting)|transcutaneous vaccination(hair follicular targeting)
359302|NCT01413087|BC-819|bc-819
290291|NCT01707602|Intradermal vaccination(micro-needle)|intradermal vaccination(micro-needle)
290292|NCT01707589|monitoring|monitoring
290293|NCT01707589|heart rate|heart rate
290294|NCT01707589|respiration rate|respiration rate
290295|NCT01707589|temperature|temperature
290296|NCT01707589|motion|motion
290297|NCT01707589|noninvasive|noninvasive
290298|NCT01707589|physiologic parameters|physiologic parameters
290299|NCT01707589|NICU|nicu
290300|NCT01707576|Follow-Up Studies|follow-up studies
290301|NCT01707576|Adolescent|adolescent
290302|NCT01707576|Depressive Disorder, Major/diagnosis|depressive disorder, major/diagnosis
290303|NCT01707576|Attempted/prevention & control|attempted/prevention & control
290304|NCT01707576|Self-report questionnaire|self-report questionnaire
290305|NCT01707576|emmergency department|emmergency department
290306|NCT01707576|parental perception|parental perception
290307|NCT01707576|Emergency|emergency
290308|NCT01707563|Marfan syndrome|marfan syndrome
290309|NCT01707563|Variability|variability
290310|NCT01707563|Fibrillin 1|fibrillin 1
290311|NCT01707563|clinical expression|clinical expression
290312|NCT01707537|OCV|ocv
290314|NCT01707511|Arterial carbondioxide pressure|arterial carbondioxide pressure
290315|NCT01707511|Colon surgery|colon surgery
290316|NCT01707511|End-tidal carbondioxide|end-tidal carbondioxide
290317|NCT01707511|Laparoscopic Trendelenburg|laparoscopic trendelenburg
290318|NCT01707498|BCI|bci
290319|NCT01707498|TETRAPLEGIA|tetraplegia
290320|NCT01707498|COMMUNICATION|communication
290321|NCT01707498|P300|p300
290322|NCT01707498|ASSISTIVE TECHNOLOGIE|assistive technologie
290323|NCT01707485|Antibiotics|antibiotics
290324|NCT01707472|Liver Fibrosis|liver fibrosis
290325|NCT01707472|Fibrosis|fibrosis
290326|NCT01707472|HIV|hiv
290327|NCT01707472|HCV|hcv
290328|NCT01707472|GS-6624|gs-6624
290329|NCT01707472|Hepatitis|hepatitis
290330|NCT01707472|Hepatitis C|hepatitis c
290331|NCT01707459|platelet function|platelet function
290332|NCT01707459|perioperative complications|perioperative complications
290333|NCT01707459|major adverse cardiac events (MACE)|major adverse cardiac events (mace)
290334|NCT01707459|thromboelastography|thromboelastography
290335|NCT01707459|polymorphism analysis|polymorphism analysis
290336|NCT01707459|coronary stents|coronary stents
290337|NCT01707459|non-cardiac surgery|non-cardiac surgery
290338|NCT01707446|Cardiac surgery|cardiac surgery
290339|NCT01707446|Delirium|delirium
290340|NCT01707446|Cerebral Oximetry|cerebral oximetry
290341|NCT01707433|spondyloepiphyseal dysplasia|spondyloepiphyseal dysplasia
290342|NCT01707433|multiple epiphyseal dysplasia|multiple epiphyseal dysplasia
290343|NCT01707433|bilateral Legg Calve Perthes|bilateral legg calve perthes
290550|NCT01706510|Vascular Diseases|vascular diseases
290344|NCT01707433|bilateral proximal femoral epiphyseal dysplasia|bilateral proximal femoral epiphyseal dysplasia
290345|NCT01707433|GALNS|galns
290346|NCT01707420|pediatric pain|pediatric pain
290347|NCT01707420|post operative pain|post operative pain
290348|NCT01707420|opioids|opioids
290349|NCT01707420|emergence agitation|emergence agitation
290350|NCT01707420|preoperative anxiety|preoperative anxiety
290351|NCT01707420|pharmacogenomics|pharmacogenomics
290352|NCT01707407|CC-4047|cc-4047
290353|NCT01707407|Pomalidomide|pomalidomide
290354|NCT01707407|Ketoconazole|ketoconazole
290355|NCT01707407|Fluvoxamine|fluvoxamine
290356|NCT01707407|Carbamazepine|carbamazepine
290357|NCT01707407|DDI|ddi
290358|NCT01707407|safety|safety
290359|NCT01707407|tolerability|tolerability
290360|NCT01707407|pharmacokinetic|pharmacokinetic
290361|NCT01707368|Psoriasis|psoriasis
290362|NCT01707368|Psoriasis vulgaris|psoriasis vulgaris
290363|NCT01707368|Plaque Psoriasis|plaque psoriasis
290364|NCT01707368|Daivobet® Gel|daivobet® gel
290365|NCT01707368|Germany|germany
290366|NCT01707355|education, knowledge, poster, dental trauma|education, knowledge, poster, dental trauma
290367|NCT01707342|Healthy male participants|healthy male participants
290368|NCT01707342|Absolute bioavailability|absolute bioavailability
290369|NCT01707342|Bioavailability|bioavailability
290370|NCT01707342|Pharmacokinetics|pharmacokinetics
290371|NCT01707342|Simeprevir|simeprevir
290372|NCT01707342|TMC435|tmc435
290373|NCT01707342|[3H]-TMC435|[3h]-tmc435
290375|NCT01707342|HCV|hcv
290376|NCT01707316|Healthy|healthy
290377|NCT01707316|JNJ-28431754|jnj-28431754
290378|NCT01707316|Canagliflozin|canagliflozin
290379|NCT01707316|Pharmacokinetics|pharmacokinetics
290380|NCT01707316|Pharmacodynamics|pharmacodynamics
290381|NCT01707303|ICU|icu
290382|NCT01707303|Critical Care|critical care
290383|NCT01707303|Intensive Care|intensive care
290384|NCT01707303|Critical Illness|critical illness
290385|NCT01707303|Acute Respiratory Failure|acute respiratory failure
290386|NCT01707303|Mechanical Ventilation|mechanical ventilation
290387|NCT01707303|Physical Therapy|physical therapy
290388|NCT01707303|Strength|strength
290389|NCT01707303|Functional Status|functional status
290390|NCT01707303|Short Physical Performance Battery|short physical performance battery
290391|NCT01707277|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
290392|NCT01707277|Inspiratory muscle training|inspiratory muscle training
290393|NCT01707277|Exercise capacity|exercise capacity
290394|NCT01707264|AL amyloidosis|al amyloidosis
290395|NCT01707264|Primary amyloidosis|primary amyloidosis
290396|NCT01707251|Obesity, Morbid|obesity, morbid
290397|NCT01707251|Bariatric Surgery|bariatric surgery
290398|NCT01707251|Laparoscopy|laparoscopy
290399|NCT01707251|Intravenous Ibuprofen|intravenous ibuprofen
290400|NCT01707251|Analgesia|analgesia
290401|NCT01707251|Morphine|morphine
290402|NCT01707225|GI Bleeding|gi bleeding
290403|NCT01707225|Gastrointestinal bleeding|gastrointestinal bleeding
290404|NCT01707225|LVAD|lvad
290405|NCT01707212|parent education|parent education
290406|NCT01707212|pain management|pain management
290407|NCT01707212|immunization|immunization
290408|NCT01707212|infant|infant
290409|NCT01707199|P. falciparum|p. falciparum
290410|NCT01707199|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
290411|NCT01707199|Artesunate|artesunate
290412|NCT01707199|Artemisinin Combination Therapy (ACT)|artemisinin combination therapy (act)
290413|NCT01707173|SIDS|sids
290414|NCT01707121|morbidity|morbidity
290415|NCT01707121|sick-leave|sick-leave
290416|NCT01707121|hospital stay|hospital stay
290417|NCT01707108|dental implants|dental implants
290418|NCT01707108|bone loss|bone loss
290419|NCT01707095|Electrosurgery|electrosurgery
290420|NCT01707095|Radiofrequency energy|radiofrequency energy
290421|NCT01707095|Monopolar instruments|monopolar instruments
290422|NCT01707095|Capacitive coupling|capacitive coupling
290423|NCT01707095|Thermal injury|thermal injury
290424|NCT01707095|Surgical complications|surgical complications
290425|NCT01707056|levothyroxine|levothyroxine
290426|NCT01707056|synthroid|synthroid
290427|NCT01707056|coffee|coffee
290428|NCT01707056|absorption|absorption
290430|NCT01707056|thyroid carcinoma|thyroid carcinoma
290431|NCT01707043|plaque psoriasis|plaque psoriasis
290432|NCT01707043|taclonex|taclonex
290433|NCT01707043|crossover|crossover
290434|NCT01707030|clinical trial|clinical trial
290435|NCT01707030|veteran|veteran
290436|NCT01707030|substance use disorder|substance use disorder
290437|NCT01706978|rotator cuff tear|rotator cuff tear
290438|NCT01706952|Endoscopic sinus surgery|endoscopic sinus surgery
290439|NCT01706952|Bleeding|bleeding
290440|NCT01706952|Topical Vasocontriction|topical vasocontriction
290441|NCT01706952|Cocaine|cocaine
290442|NCT01706952|Adrenaline|adrenaline
290443|NCT01706939|Reduced radiotherapy|reduced radiotherapy
290444|NCT01706939|Randomization, Phase III|randomization, phase iii
290445|NCT01706939|Reduced radiation therapy|reduced radiation therapy
290446|NCT01706939|head and neck|head and neck
290447|NCT01706939|oropharynx|oropharynx
290650|NCT01706146|apixaban|apixaban
290448|NCT01706939|unknown primary (cervical lymph nodes)|unknown primary (cervical lymph nodes)
290449|NCT01706939|nasopharynx primary|nasopharynx primary
290450|NCT01706939|HPV|hpv
290451|NCT01706939|p16|p16
290452|NCT01706926|Rheumatoid Arthritis|rheumatoid arthritis
290453|NCT01706926|Mavrilimumab|mavrilimumab
290454|NCT01706926|CAM-3001|cam-3001
290455|NCT01706887|Nedd4-2|nedd4-2
290456|NCT01706887|blood pressure|blood pressure
290457|NCT01706887|polymorphism|polymorphism
290458|NCT01706887|salt intake|salt intake
290459|NCT01706887|between 18 and 35 years old|between 18 and 35 years old
290460|NCT01706887|BMI between 18 and 28 Kg per m2|bmi between 18 and 28 kg per m2
290461|NCT01706887|no active disease|no active disease
290462|NCT01706887|no alcool or drug abuse or smoke|no alcool or drug abuse or smoke
290463|NCT01706874|Rheumatoid arthritis|rheumatoid arthritis
290464|NCT01706874|P.gingivalis|p.gingivalis
290465|NCT01706874|Periodontal disease|periodontal disease
290466|NCT01706874|Plaque control|plaque control
290467|NCT01706874|Prophylaxis|prophylaxis
290468|NCT01706874|Oral hygiene instruction|oral hygiene instruction
290469|NCT01706835|solid tumor|solid tumor
290470|NCT01706835|aldoxorubicin|aldoxorubicin
290471|NCT01706835|phase 1|phase 1
290472|NCT01706835|pharmacokinetic|pharmacokinetic
290473|NCT01706835|INNO-206|inno-206
290474|NCT01706796|Pain|pain
290475|NCT01706744|Hospital Readmissions|hospital readmissions
290476|NCT01706744|Community Health Services|community health services
290477|NCT01706744|Preventive Health Services|preventive health services
290478|NCT01706744|Norway|norway
290479|NCT01706731|Buddhist monks|buddhist monks
290480|NCT01706731|CBT|cbt
290481|NCT01706731|elderly|elderly
290482|NCT01706731|depression|depression
290483|NCT01706718|Beetroot|beetroot
290484|NCT01706718|Blood pressure|blood pressure
290485|NCT01706718|Vascular function|vascular function
290486|NCT01706705|Cervical Cancer|cervical cancer
290487|NCT01706705|Radiation therapy|radiation therapy
290488|NCT01706705|XRT|xrt
290489|NCT01706705|External beam therapy|external beam therapy
290490|NCT01706705|Brachytherapy|brachytherapy
290491|NCT01706705|Intracavitary brachytherapy|intracavitary brachytherapy
290492|NCT01706705|ICBT|icbt
290493|NCT01706705|MRI compatible intracavitary applicators|mri compatible intracavitary applicators
290494|NCT01706705|Computed tomography|computed tomography
290495|NCT01706705|CT|ct
290496|NCT01706705|Magnetic resonance imaging|magnetic resonance imaging
290497|NCT01706705|MRI|mri
290498|NCT01706705|MRI compatible applicators|mri compatible applicators
290499|NCT01706705|3D image guided treatment planning|3d image guided treatment planning
290500|NCT01706705|2D treatment planning|2d treatment planning
290501|NCT01706692|Methotrexate|methotrexate
290502|NCT01706692|Acitretin|acitretin
290503|NCT01706692|Cyclosporine A|cyclosporine a
290504|NCT01706692|Systemic PUVA|systemic puva
290505|NCT01706692|Infliximab|infliximab
290506|NCT01706692|Adalimumab|adalimumab
290507|NCT01706692|Etanercept|etanercept
290508|NCT01706692|Ustekinumab|ustekinumab
290509|NCT01706692|Fumaric acids|fumaric acids
290510|NCT01706692|Psoriasis|psoriasis
290511|NCT01706692|Psoriatic arthritis|psoriatic arthritis
290512|NCT01706692|Skin disease|skin disease
290513|NCT01706679|Healthy volunteers|healthy volunteers
290514|NCT01706666|Maintenance|maintenance
290515|NCT01706666|Consolidation|consolidation
290516|NCT01706653|Polyphenol|polyphenol
290517|NCT01706653|Fruit|fruit
290518|NCT01706653|Metabolic|metabolic
290519|NCT01706653|Healthy|healthy
290520|NCT01706627|cancer|cancer
290521|NCT01706627|melatonin|melatonin
290522|NCT01706627|adjuvant therapy|adjuvant therapy
290523|NCT01706627|quality of life|quality of life
290524|NCT01706627|survival|survival
290525|NCT01706627|adverse events|adverse events
290526|NCT01706627|oxidative stress|oxidative stress
290527|NCT01706588|diclofenac, postsurgical pain, oral surgery|diclofenac, postsurgical pain, oral surgery
290528|NCT01706562|Neutropenia|neutropenia
290529|NCT01706562|Hematologic malignancy|hematologic malignancy
290530|NCT01706562|Itraconazole|itraconazole
290531|NCT01706562|Fungal infection|fungal infection
290532|NCT01706562|Antifungal agent|antifungal agent
290533|NCT01706562|Neutropenic fever|neutropenic fever
290534|NCT01706549|Chronic pain|chronic pain
290535|NCT01706549|Hysterectomy|hysterectomy
290536|NCT01706549|Quality of life|quality of life
290537|NCT01706523|Autism Spectrum Disorders|autism spectrum disorders
290538|NCT01706523|Autism|autism
290539|NCT01706523|Asperger|asperger
290540|NCT01706523|Pervasive Developmental Disorder - Not otherwise specified|pervasive developmental disorder - not otherwise specified
290541|NCT01706510|Clopidogrel|clopidogrel
290542|NCT01706510|Ticagrelor|ticagrelor
290543|NCT01706510|Coronary Artery Disease|coronary artery disease
290544|NCT01706510|Myocardial Ischemia|myocardial ischemia
290545|NCT01706510|Coronary Disease|coronary disease
290546|NCT01706510|Heart Diseases|heart diseases
290547|NCT01706510|Cardiovascular Diseases|cardiovascular diseases
290548|NCT01706510|Arteriosclerosis|arteriosclerosis
290549|NCT01706510|Arterial Occlusive Diseases|arterial occlusive diseases
290551|NCT01706510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
290552|NCT01706510|Hematologic Agents|hematologic agents
290553|NCT01706510|Therapeutic Uses|therapeutic uses
290554|NCT01706510|Pharmacologic Actions|pharmacologic actions
290555|NCT01706510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists
290556|NCT01706510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists
290557|NCT01706510|Purinergic Antagonists|purinergic antagonists
290558|NCT01706510|Purinergic Agents|purinergic agents
290559|NCT01706510|Physiological Effects of Drugs|physiological effects of drugs
290560|NCT01706497|cerebral tissue oxygen saturation|cerebral tissue oxygen saturation
290561|NCT01706497|congenital cardiac surgery|congenital cardiac surgery
290562|NCT01706497|pediatric intensive care unit|pediatric intensive care unit
290563|NCT01706497|Near Infra-Red Spectroscopy|near infra-red spectroscopy
290564|NCT01706497|early warning monitor|early warning monitor
290565|NCT01706497|outcome prediction|outcome prediction
290566|NCT01706484|randomized clinical trial|randomized clinical trial
290567|NCT01706484|chronic rhinosinusitis|chronic rhinosinusitis
290568|NCT01706484|herbal extract BNO 1016|herbal extract bno 1016
290569|NCT01706484|exacerbation|exacerbation
290570|NCT01706484|pharmacoeconomic|pharmacoeconomic
290571|NCT01706484|quality of life|quality of life
290572|NCT01706471|verLowCNI|verlowcni
290573|NCT01706458|Vaccine|vaccine
290574|NCT01706458|pTVG-HP|ptvg-hp
290575|NCT01706458|Prostate Cancer|prostate cancer
290576|NCT01706458|Castrate Resistant|castrate resistant
290577|NCT01706445|cystic fibrosis|cystic fibrosis
290579|NCT01706445|children|children
290580|NCT01706445|cardiorespiratory fitness|cardiorespiratory fitness
290581|NCT01706445|muscle strength|muscle strength
290582|NCT01706445|pulmonary function|pulmonary function
290583|NCT01706445|quality of life|quality of life
290584|NCT01706419|vitamin A|vitamin a
290586|NCT01706419|zinc|zinc
290587|NCT01706419|school children|school children
290588|NCT01706419|fortified rice|fortified rice
290589|NCT01706419|morbidity|morbidity
290590|NCT01706419|growth|growth
290591|NCT01706406|female sexual arousal|female sexual arousal
290592|NCT01706406|female sexual desire|female sexual desire
290593|NCT01706406|psychoeducational intervention|psychoeducational intervention
290594|NCT01706393|probiotics|probiotics
290595|NCT01706393|intestinal microbiome|intestinal microbiome
290596|NCT01706393|radiotherapy|radiotherapy
290597|NCT01706380|Substance use disorders|substance use disorders
290598|NCT01706380|Adolescents|adolescents
290599|NCT01706380|Retention|retention
290600|NCT01706380|Mobile telephone|mobile telephone
290601|NCT01706380|Follow-up|follow-up
290602|NCT01706380|Interactive voice response|interactive voice response
290603|NCT01706367|Clostridium difficile|clostridium difficile
290604|NCT01706367|vaccine|vaccine
290605|NCT01706354|end stage renal disease|end stage renal disease
290606|NCT01706354|vascular access|vascular access
290607|NCT01706354|regional anaesthesia|regional anaesthesia
290608|NCT01706341|cesarean section|cesarean section
290609|NCT01706341|intravenous fluid|intravenous fluid
290610|NCT01706341|a glucose-containing solution|a glucose-containing solution
290611|NCT01706341|fetal hypoglycemia|fetal hypoglycemia
290612|NCT01706341|neonatal hypoglycemia|neonatal hypoglycemia
290613|NCT01706328|Vilanterol (VI)|vilanterol (vi)
290614|NCT01706328|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
290615|NCT01706328|FEV1|fev1
290616|NCT01706328|Fluticasone Furoate (FF)|fluticasone furoate (ff)
290617|NCT01706328|COPD|copd
290618|NCT01706302|General Practice Research Database|general practice research database
290619|NCT01706302|Burden of Disease|burden of disease
290620|NCT01706302|Clinical Practice Research Datalink|clinical practice research datalink
290621|NCT01706302|Hospital Episode Statistics|hospital episode statistics
290622|NCT01706302|Office of National Statistics|office of national statistics
290623|NCT01706302|RSV|rsv
290624|NCT01706289|diabetes|diabetes
290625|NCT01706289|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
290626|NCT01706289|VAP 1|vap 1
290627|NCT01706237|Myopia|myopia
290628|NCT01706237|LASIK|lasik
290629|NCT01706224|Pertussis antibodies|pertussis antibodies
290630|NCT01706224|Bordetella pertussis|bordetella pertussis
290631|NCT01706224|sero-prevalence|sero-prevalence
290632|NCT01706224|Healthcare professionals (HCP)|healthcare professionals (hcp)
290633|NCT01706224|Spain|spain
290634|NCT01706211|non insulin dependent diabetes mellitus, rosiglitazone|non insulin dependent diabetes mellitus, rosiglitazone
290635|NCT01706198|respiratory|respiratory
290636|NCT01706198|adult|adult
290637|NCT01706198|asthma|asthma
290638|NCT01706185|Patients|patients
290639|NCT01706185|Tumor antigens|tumor antigens
290640|NCT01706185|Bladder cancer|bladder cancer
290641|NCT01706172|TMD|tmd
290642|NCT01706172|temporomandibular|temporomandibular
290643|NCT01706172|dextrose|dextrose
290644|NCT01706172|prolotherapy|prolotherapy
290645|NCT01706146|atrial fibrillation|atrial fibrillation
290646|NCT01706146|reveal xt|reveal xt
290647|NCT01706146|oral anticoagulation|oral anticoagulation
290648|NCT01706146|dabigatran|dabigatran
290649|NCT01706146|rivaroxaban|rivaroxaban
290651|NCT01706133|Frailty, emergency services, elderly|frailty, emergency services, elderly
290652|NCT01706120|prognostic factors|prognostic factors
290653|NCT01706120|biologic factors|biologic factors
290654|NCT01706120|clinical factors|clinical factors
290908|NCT01704833|Delusions|delusions
290655|NCT01706120|routine clinical practice|routine clinical practice
290656|NCT01706107|Quality of life|quality of life
290657|NCT01706094|stroke|stroke
290658|NCT01706094|head position|head position
290659|NCT01706081|acupuncture|acupuncture
290660|NCT01706068|acute ECG changes|acute ecg changes
290661|NCT01706068|acute illness of gallbladder|acute illness of gallbladder
290662|NCT01706068|acute illness of biliary tract|acute illness of biliary tract
290663|NCT01706055|Multiple Sclerosis (MS)|multiple sclerosis (ms)
290664|NCT01706055|Interferon|interferon
290665|NCT01706003|Migraine|migraine
290666|NCT01706003|Headaches|headaches
290667|NCT01706003|Telemedicine|telemedicine
290668|NCT01705990|HIV|hiv
290669|NCT01705990|AIDS|aids
290670|NCT01705990|HIV vaccine|hiv vaccine
290671|NCT01705990|HIV prevention|hiv prevention
290672|NCT01705977|Antibodies|antibodies
290673|NCT01705977|Lupus|lupus
290674|NCT01705977|SLE|sle
290675|NCT01705977|Systemic Lupus Erythematosus|systemic lupus erythematosus
290676|NCT01705977|Autoimmune Disease|autoimmune disease
290677|NCT01705977|Belimumab|belimumab
290678|NCT01705964|Status asthmaticus|status asthmaticus
290679|NCT01705964|Asthma exacerbation|asthma exacerbation
290680|NCT01705964|Epinephrine|epinephrine
290681|NCT01705964|Adjunctive therapy|adjunctive therapy
290682|NCT01705951|Smoking|smoking
290683|NCT01705951|Insulin resistance|insulin resistance
290684|NCT01705951|Metabolic Syndrome|metabolic syndrome
290685|NCT01705951|Endothelial Function|endothelial function
290686|NCT01705951|Smoking Cessation|smoking cessation
290687|NCT01705951|Resistance Training|resistance training
290688|NCT01705951|Nicotine Replacement|nicotine replacement
290689|NCT01705951|Exercise|exercise
290690|NCT01705951|Cardiovascular Disease|cardiovascular disease
290691|NCT01705951|Arterial Stiffness|arterial stiffness
290692|NCT01705951|Body Composition|body composition
290693|NCT01705912|fall|fall
290694|NCT01705912|prevention|prevention
290695|NCT01705899|Type 1 Diabetes|type 1 diabetes
290696|NCT01705899|Islet transplant|islet transplant
290697|NCT01705899|Kidney transplant|kidney transplant
290698|NCT01705886|Osteoarthritis|osteoarthritis
290699|NCT01705886|Joint Disease|joint disease
290700|NCT01705886|Arthritis|arthritis
290701|NCT01705886|Musculoskeletal Disease|musculoskeletal disease
290702|NCT01705873|HIV|hiv
290703|NCT01705873|cardiovascular|cardiovascular
290704|NCT01705873|risk|risk
290705|NCT01705873|mortality|mortality
290706|NCT01705860|Collagen, collagenase, scar|collagen, collagenase, scar
290707|NCT01705847|chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
290708|NCT01705847|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
290709|NCT01705847|Hodgkin lymphoma (HL)|hodgkin lymphoma (hl)
290710|NCT01705847|indolent non-Hodgkin lymphoma (iNHL)|indolent non-hodgkin lymphoma (inhl)
290711|NCT01705847|diffuse large B-cell lymphoma-activated B-cell (DLBCL-ABC)|diffuse large b-cell lymphoma-activated b-cell (dlbcl-abc)
290712|NCT01705847|DLBCL-germinal center B-cell (GCB)|dlbcl-germinal center b-cell (gcb)
290713|NCT01705847|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
290714|NCT01705847|GS-9820|gs-9820
290820|NCT01705418|Parkinson disease|parkinson disease
290715|NCT01705847|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
290716|NCT01705834|Arthritis|arthritis
290717|NCT01705834|Stiffness|stiffness
290718|NCT01705834|Range of movement|range of movement
290719|NCT01705834|Goniometry|goniometry
290720|NCT01705834|Digital|digital
290721|NCT01705834|Dataglove|dataglove
290722|NCT01705834|Outcome|outcome
290723|NCT01705821|Skull base|skull base
290724|NCT01705821|Pituitary|pituitary
290725|NCT01705821|Robotics|robotics
290726|NCT01705821|Endonasal surgery|endonasal surgery
290727|NCT01705821|Sinus surgery|sinus surgery
290728|NCT01705769|treatment|treatment
290729|NCT01705769|severe acute malnutrition|severe acute malnutrition
290730|NCT01705756|Colchicine|colchicine
290731|NCT01705756|Anakinra|anakinra
290732|NCT01705756|Colchicine resistance|colchicine resistance
290733|NCT01705756|Familial Mediterranean fever|familial mediterranean fever
290734|NCT01705743|anaesthesia|anaesthesia
290735|NCT01705743|middle aged|middle aged
290736|NCT01705743|minimal alveolar concentration|minimal alveolar concentration
290737|NCT01705743|sevoflurane|sevoflurane
290738|NCT01705743|nitrous oxide|nitrous oxide
290739|NCT01705743|isoelectric EEG|isoelectric eeg
290740|NCT01705678|Males|males
290741|NCT01705678|Metabolic syndrome|metabolic syndrome
290742|NCT01705678|Otherwise healthy|otherwise healthy
290743|NCT01705652|nexrutine|nexrutine
290744|NCT01705652|prostate cancer|prostate cancer
290745|NCT01705639|diabetes|diabetes
290746|NCT01705639|melatonin|melatonin
290747|NCT01705639|glucose tolerance|glucose tolerance
290748|NCT01705639|sleep|sleep
290749|NCT01705626|Peripheral Nervous System Diseases|peripheral nervous system diseases
290750|NCT01705626|Neuromuscular Diseases|neuromuscular diseases
290751|NCT01705626|Nervous System Diseases|nervous system diseases
290752|NCT01705626|Metabolism, Inborn Errors|metabolism, inborn errors
290753|NCT01705626|Genetic Diseases, Inborn|genetic diseases, inborn
290754|NCT01705613|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
290755|NCT01705613|ADHD|adhd
290756|NCT01705613|Methylphenidate Immediate-release|methylphenidate immediate-release
290757|NCT01705613|Cost-effectiveness|cost-effectiveness
290758|NCT01705613|Cost-utility|cost-utility
290759|NCT01705613|QALYs|qalys
290760|NCT01705600|Central Sensitization|central sensitization
290761|NCT01705600|Low Back Pain|low back pain
290762|NCT01705600|Pain|pain
290763|NCT01705600|Pain Catastrophizing|pain catastrophizing
290764|NCT01705600|Brence|brence
290765|NCT01705587|osteoporosis|osteoporosis
290766|NCT01705587|atypical femoral fractures|atypical femoral fractures
290767|NCT01705587|prior bisphosphonate treatment|prior bisphosphonate treatment
290768|NCT01705587|postmenopausal women|postmenopausal women
290769|NCT01705587|bone loss|bone loss
290770|NCT01705574|HIV-1|hiv-1
290771|NCT01705574|HIV|hiv
290772|NCT01705574|Treatment-Naive|treatment-naive
290773|NCT01705574|Women|women
290774|NCT01705574|WAVES|waves
290775|NCT01705561|fertility|fertility
290776|NCT01705561|chemotherapy|chemotherapy
290777|NCT01705561|breast cancer|breast cancer
290778|NCT01705561|latin american women|latin american women
290779|NCT01705561|pre menopausal|pre menopausal
290780|NCT01705548|Brain metastasis|brain metastasis
290781|NCT01705535|Fecal incontinence|fecal incontinence
290782|NCT01705535|Pelvic floor muscle exercises|pelvic floor muscle exercises
290783|NCT01705535|Physiotherapy|physiotherapy
290785|NCT01705522|ulcerative colitis|ulcerative colitis
290786|NCT01705522|Crohn's disease|crohn's disease
290788|NCT01705522|biomarkers|biomarkers
290789|NCT01705522|vitamin D|vitamin d
290790|NCT01705509|The Effects of Ranolazine on CPET Parameters in Ischemic|the effects of ranolazine on cpet parameters in ischemic
290791|NCT01705509|Cardiomyopathy Patients|cardiomyopathy patients
290792|NCT01705496|Phase II|phase ii
290793|NCT01705496|FIAU|fiau
290794|NCT01705496|Fialuridine|fialuridine
290795|NCT01705496|Prosthetic|prosthetic
290796|NCT01705496|Joint|joint
290797|NCT01705496|Infection|infection
290798|NCT01705496|PET-CT|pet-ct
290799|NCT01705483|ASP9853|asp9853
290800|NCT01705483|Docetaxel|docetaxel
290801|NCT01705483|Paclitaxel|paclitaxel
290802|NCT01705470|Furosemide|furosemide
290803|NCT01705470|Anemia|anemia
290804|NCT01705470|LV dysfunction|lv dysfunction
290805|NCT01705470|blood transfusion|blood transfusion
290806|NCT01705457|multiple sclerosis|multiple sclerosis
290807|NCT01705457|Vitamin A|vitamin a
290808|NCT01705457|retinoic acid receptor|retinoic acid receptor
290809|NCT01705457|retinoic x receptor|retinoic x receptor
290810|NCT01705444|Urinary retention|urinary retention
290811|NCT01705444|Foley catheter|foley catheter
290812|NCT01705444|The Spanner|the spanner
290813|NCT01705444|Quality of life|quality of life
290814|NCT01705431|Emotional Disturbance|emotional disturbance
290815|NCT01705431|Behavioral Disturbance|behavioral disturbance
290816|NCT01705431|EBD|ebd
290817|NCT01705431|Middle School|middle school
290818|NCT01705431|Special Education|special education
290819|NCT01705431|School Psychology|school psychology
290821|NCT01705418|Deep brain stimulation|deep brain stimulation
290822|NCT01705418|behavior and psychiatric symptoms improvement|behavior and psychiatric symptoms improvement
290824|NCT01705405|prostate|prostate
290825|NCT01705379|Neisseria meningitidis, conjugate vaccine, phase IV clinical trial|neisseria meningitidis, conjugate vaccine, phase iv clinical trial
290826|NCT01705366|Osteoarthritis|osteoarthritis
290827|NCT01705366|Joint Disease|joint disease
290828|NCT01705366|Arthritis|arthritis
290829|NCT01705366|Musculoskeletal Disease|musculoskeletal disease
290830|NCT01705353|Stroke|stroke
290831|NCT01705353|Cerebrovascular Accident|cerebrovascular accident
290832|NCT01705353|HMGB-1|hmgb-1
290833|NCT01705353|cytokines|cytokines
290834|NCT01705353|functional recovery|functional recovery
290835|NCT01705353|inflammation|inflammation
290836|NCT01705353|immune response|immune response
290837|NCT01705327|Parkinson's|parkinson's
290838|NCT01705327|Biomarkers|biomarkers
290839|NCT01705327|Neurodegenerative disorder|neurodegenerative disorder
290840|NCT01705314|human influenza children|human influenza children
290841|NCT01705288|laparotomy|laparotomy
290842|NCT01705288|hysterectomy|hysterectomy
290843|NCT01705262|compliance|compliance
290844|NCT01705262|Bowel preparations|bowel preparations
290845|NCT01705262|Moviprep|moviprep
290846|NCT01705262|Phosphoral|phosphoral
290847|NCT01705223|prophylactic|prophylactic
290848|NCT01705223|vaccine|vaccine
290849|NCT01705184|Stop and go|stop and go
290850|NCT01705184|Non-small cell lung cancer|non-small cell lung cancer
290851|NCT01705184|Non-squamous|non-squamous
290852|NCT01705184|Bevacizumab|bevacizumab
290853|NCT01705171|IBS|ibs
290854|NCT01705171|fructose intolerance|fructose intolerance
290855|NCT01705171|GLUT 5|glut 5
290856|NCT01705171|GLUT 2|glut 2
290857|NCT01705158|ovarian cancer in relapse|ovarian cancer in relapse
290858|NCT01705158|sensitive in platin|sensitive in platin
290859|NCT01705145|Cystic Fibrosis|cystic fibrosis
290860|NCT01705119|Mechanically Ventilated|mechanically ventilated
290861|NCT01705119|Critical Care|critical care
290862|NCT01705093|strawberry, cardiovascular, obesity, adolescent|strawberry, cardiovascular, obesity, adolescent
290863|NCT01705080|Renal Denervation|renal denervation
290864|NCT01705080|Renal artery|renal artery
290865|NCT01705067|Osteoarthritis, Degenerative Knee Disease, TKA|osteoarthritis, degenerative knee disease, tka
290866|NCT01705054|Angina|angina
290867|NCT01705054|Stable ischemic heart disease|stable ischemic heart disease
290868|NCT01705054|Quality of Life|quality of life
290869|NCT01705054|Seattle Angina Questionnaire (SAQ)|seattle angina questionnaire (saq)
290870|NCT01705015|exercise|exercise
290871|NCT01705002|phase 1|phase 1
290872|NCT01705002|dose escalating|dose escalating
290873|NCT01705002|prodrug|prodrug
290874|NCT01705002|mitomycin C|mitomycin c
290875|NCT01705002|Capecitabine|capecitabine
290876|NCT01704989|Glaucoma, SLT|glaucoma, slt
290877|NCT01704963|Recurrent mature B-cell neoplasms|recurrent mature b-cell neoplasms
290878|NCT01704963|B-cell malignancies|b-cell malignancies
290879|NCT01704963|Bruton's Tyrosine Kinase (Btk) Inhibitor|bruton's tyrosine kinase (btk) inhibitor
290880|NCT01704963|PCI-32765|pci-32765
290881|NCT01704963|Tumor|tumor
290882|NCT01704963|Pharmacokinetics|pharmacokinetics
290883|NCT01704963|Japanese|japanese
290884|NCT01704937|Fecal Microbiota Transplant|fecal microbiota transplant
290885|NCT01704937|Clostridium difficile|clostridium difficile
290886|NCT01704937|Diarrhea|diarrhea
290887|NCT01704924|Prevena|prevena
290888|NCT01704924|negative pressure wound therapy|negative pressure wound therapy
290889|NCT01704924|Incisional wound vac|incisional wound vac
290890|NCT01704911|Transradial|transradial
360088|NCT01410136|OCD|ocd
281493|NCT01746680|EULAR|eular
290891|NCT01704911|Transfemoral|transfemoral
290892|NCT01704911|Coronary Intervention|coronary intervention
290893|NCT01704898|efavirenz|efavirenz
290894|NCT01704898|bioequivalence|bioequivalence
290895|NCT01704898|fasting|fasting
290896|NCT01704898|healthy volunteers|healthy volunteers
290897|NCT01704885|Childhood Cancer|childhood cancer
290898|NCT01704885|Sibling Play intervention|sibling play intervention
290899|NCT01704885|Sibling Behavioral Intervention|sibling behavioral intervention
290900|NCT01704885|Siblings of Cancer Patients|siblings of cancer patients
290901|NCT01704872|Neuroblastoma|neuroblastoma
290902|NCT01704872|Refractory neuroblastoma|refractory neuroblastoma
290903|NCT01704872|ch14.18/CHO|ch14.18/cho
290904|NCT01704859|fracture|fracture
290905|NCT01704833|Psychosis|psychosis
290906|NCT01704833|Paranoia|paranoia
290907|NCT01704833|Cognitive Behavioral Therapy|cognitive behavioral therapy
290909|NCT01704833|Group Therapy|group therapy
290910|NCT01704820|Colon Polyps|colon polyps
290911|NCT01704820|Colon Cancer screening|colon cancer screening
290912|NCT01704820|Colonoscopy|colonoscopy
290913|NCT01704807|Low Back Pain|low back pain
290914|NCT01704807|Chronic|chronic
290915|NCT01704807|Orthotic Device|orthotic device
290916|NCT01704807|Applied Kinesiology|applied kinesiology
290917|NCT01704807|Manual Muscle Testing|manual muscle testing
290918|NCT01704807|Chiropractic|chiropractic
290919|NCT01704794|Sickle Cell Anemia|sickle cell anemia
290920|NCT01704794|Quality of Life|quality of life
290921|NCT01704794|Antioxidant|antioxidant
290922|NCT01704794|Anti inflammatory|anti inflammatory
290923|NCT01704794|Sorghum bicolor|sorghum bicolor
290925|NCT01704781|Clinical trial|clinical trial
290926|NCT01704781|Dose escalation assessment lenalidomide|dose escalation assessment lenalidomide
290927|NCT01704781|Human immunodeficiency virus-1 (HIV-1)|human immunodeficiency virus-1 (hiv-1)
290928|NCT01704781|HIV|hiv
290929|NCT01704781|Immunomodulatory|immunomodulatory
290930|NCT01704781|Infection|infection
290931|NCT01704781|Lenalidomide|lenalidomide
290932|NCT01704781|Phase I/II|phase i/ii
290933|NCT01704781|Vaccine|vaccine
290934|NCT01704781|Vacc-4x|vacc-4x
290935|NCT01704768|Randomized Controlled Trial|randomized controlled trial
290936|NCT01704768|School-Based Intervention|school-based intervention
290937|NCT01704755|Cirrhosis|cirrhosis
290938|NCT01704755|Hepatitis C|hepatitis c
290939|NCT01704755|Child Pugh A|child pugh a
290940|NCT01704755|Compensated Cirrhosis|compensated cirrhosis
290941|NCT01704755|Hepatitis C Genotype 1|hepatitis c genotype 1
290942|NCT01704755|Cirrhotic|cirrhotic
290943|NCT01704755|Chronic Hepatitis C|chronic hepatitis c
290944|NCT01704755|Hepatitis C Virus|hepatitis c virus
290945|NCT01704755|ombitasvir|ombitasvir
290946|NCT01704755|paritaprevir|paritaprevir
290947|NCT01704755|dasabuvir|dasabuvir
290948|NCT01704755|Interferon-Free|interferon-free
290949|NCT01704755|Viekira Pak|viekira pak
290950|NCT01704742|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
290951|NCT01704742|Hodgkin's Lymphoma|hodgkin's lymphoma
290952|NCT01704742|Kenya|kenya
290953|NCT01704742|Epstein Barr Virus (EBV)|epstein barr virus (ebv)
290954|NCT01704742|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
291651|NCT01701986|Rituximab|rituximab
290955|NCT01704742|Kaposi's Sarcoma Herpes Virus (KSHV)|kaposi's sarcoma herpes virus (kshv)
290956|NCT01704729|Myopia|myopia
290957|NCT01704729|Focus groups|focus groups
290958|NCT01704729|refraction|refraction
290959|NCT01704729|Glasses|glasses
290960|NCT01704729|spectacles|spectacles
290961|NCT01704716|neuroblastoma|neuroblastoma
290962|NCT01704716|immunotherapy|immunotherapy
290963|NCT01704716|MAT|mat
290964|NCT01704716|antibody treatment|antibody treatment
290965|NCT01704703|colorectal cancer|colorectal cancer
290966|NCT01704703|FOLFIRI|folfiri
290967|NCT01704703|Panitumumab|panitumumab
290968|NCT01704703|KRAS, PIK3Ca,BRAF and NRAS genes|kras, pik3ca,braf and nras genes
290969|NCT01704703|highly sensitive techniques|highly sensitive techniques
290970|NCT01704690|Esophageal cancer|esophageal cancer
290971|NCT01704690|Chemotherapy|chemotherapy
290972|NCT01704690|Efficacy|efficacy
290973|NCT01704690|Toxicity|toxicity
290974|NCT01704677|Chronic low back pain|chronic low back pain
290975|NCT01704677|Degenerated disc|degenerated disc
290976|NCT01704677|Total disc replacement|total disc replacement
290977|NCT01704677|Multidisciplinary rehabilitation|multidisciplinary rehabilitation
290978|NCT01704677|Long term results|long term results
290979|NCT01704664|malnutrition,|malnutrition,
586553|NCT00516685|EGF|egf
753199|NCT01175863|intravascular ultrasound|intravascular ultrasound
290980|NCT01704664|perioperative artificial nutrition,|perioperative artificial nutrition,
290982|NCT01704664|gastrectomy,|gastrectomy,
290983|NCT01704664|lymphocytes,|lymphocytes,
290984|NCT01704664|interleukin,|interleukin,
290985|NCT01704664|blood platelets,|blood platelets,
290986|NCT01704664|phagocytic and bactericidal activity of blood platelets|phagocytic and bactericidal activity of blood platelets
290987|NCT01704651|Ovary|ovary
290988|NCT01704651|Ovarian|ovarian
290989|NCT01704651|Fallopian|fallopian
290990|NCT01704651|Peritoneal|peritoneal
290991|NCT01704651|Cancer|cancer
290992|NCT01704651|Gynecological|gynecological
290993|NCT01704651|Female|female
290994|NCT01704625|pain|pain
290995|NCT01704625|headache|headache
290996|NCT01704612|local anesthetic|local anesthetic
290997|NCT01704612|sciatic|sciatic
290998|NCT01704612|diabetes|diabetes
290999|NCT01704612|block|block
291000|NCT01704612|duration|duration
291001|NCT01704599|Psoriasis|psoriasis
291002|NCT01704599|Adalimumab|adalimumab
291003|NCT01704599|B vitamins|b vitamins
291004|NCT01704599|Homocysteine|homocysteine
291005|NCT01704599|Folic acid|folic acid
291006|NCT01704599|Cyanocobalamin|cyanocobalamin
291007|NCT01704599|Pyridoxine|pyridoxine
291008|NCT01704599|Vitamin B6|vitamin b6
291009|NCT01704599|Vitamin B9|vitamin b9
291010|NCT01704599|Vitamin B12|vitamin b12
291011|NCT01704586|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
291012|NCT01704586|PET/CT|pet/ct
291013|NCT01704586|Radioiodine Remnant Ablation|radioiodine remnant ablation
291014|NCT01704586|I-124|i-124
291015|NCT01704586|Quality of life|quality of life
291016|NCT01704573|PET Scan|pet scan
291017|NCT01704547|Breast cancer|breast cancer
291018|NCT01704547|Lumpectomy|lumpectomy
291019|NCT01704547|Breast Irradiation|breast irradiation
291020|NCT01704534|Hidradenitis suppurativa|hidradenitis suppurativa
291021|NCT01704534|Acne ectopica|acne ectopica
291022|NCT01704534|Inverse acne|inverse acne
291023|NCT01704534|Ustekinumab|ustekinumab
291024|NCT01704534|Stelara|stelara
291025|NCT01704521|Hepatitis C|hepatitis c
291026|NCT01704521|HCV|hcv
291027|NCT01704521|Hemophilia|hemophilia
291028|NCT01704508|Falciparum malaria|falciparum malaria
291029|NCT01704508|children|children
291030|NCT01704508|treatment|treatment
291031|NCT01704495|Uncontrolled Asthma,|uncontrolled asthma,
291032|NCT01704495|Exacerbation,|exacerbation,
291033|NCT01704495|Safety|safety
291034|NCT01704469|Opioid induced hyperalgesia|opioid induced hyperalgesia
291035|NCT01704456|provoked vestibulodynia|provoked vestibulodynia
291036|NCT01704456|dyspareunia|dyspareunia
291037|NCT01704456|vulvodynia|vulvodynia
291038|NCT01704456|mindfulness|mindfulness
291039|NCT01704456|cognitive behavioural therapy|cognitive behavioural therapy
291040|NCT01704443|provoked vestibulodynia|provoked vestibulodynia
291041|NCT01704443|dyspareunia|dyspareunia
291042|NCT01704443|vulvodynia|vulvodynia
291043|NCT01704443|mindfulness|mindfulness
291044|NCT01704443|cognitive behavioural therapy|cognitive behavioural therapy
291045|NCT01704430|Cardiac surgery|cardiac surgery
291046|NCT01704430|Cardiac bypass|cardiac bypass
291047|NCT01704430|Intensive Care|intensive care
291048|NCT01704430|Nosocomial infection|nosocomial infection
291049|NCT01704430|Glutamine|glutamine
291050|NCT01704430|Randomized trial|randomized trial
291051|NCT01704404|Long acting muscarinic antagonist|long acting muscarinic antagonist
291052|NCT01704404|Chronic Bronchitis|chronic bronchitis
291053|NCT01704404|Emphysema|emphysema
291054|NCT01704404|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
291055|NCT01704404|COPD|copd
291056|NCT01704352|Cognitive Behavioral Therapy|cognitive behavioral therapy
291057|NCT01704352|CBT-I|cbt-i
291652|NCT01701986|Rituxan|rituxan
291058|NCT01704339|End stage renal failure|end stage renal failure
291059|NCT01704339|Neuropathic pain|neuropathic pain
291060|NCT01704339|Critical digital ischaemia|critical digital ischaemia
291061|NCT01704326|Deuce|deuce
291062|NCT01704326|Journey Deuce|journey deuce
291063|NCT01704326|Knee pain|knee pain
291064|NCT01704326|Osteoarthritis|osteoarthritis
291065|NCT01704326|Bicompartmental|bicompartmental
291066|NCT01704326|Femoral|femoral
291067|NCT01704326|Medial|medial
291068|NCT01704313|Vascular access|vascular access
291069|NCT01704313|Haemodialysis|haemodialysis
291070|NCT01704313|Suturing technique|suturing technique
291071|NCT01704300|Abdominal aortic aneurysm|abdominal aortic aneurysm
291072|NCT01704300|Acute Myocardial Infarction|acute myocardial infarction
291073|NCT01704300|Coronary heart disease not otherwise specified|coronary heart disease not otherwise specified
291074|NCT01704300|Haemorrhagic stroke|haemorrhagic stroke
291075|NCT01704300|Heart failure|heart failure
291076|NCT01704300|Ischaemic stroke|ischaemic stroke
291077|NCT01704300|Peripheral arterial disease|peripheral arterial disease
291078|NCT01704300|Stable angina|stable angina
291079|NCT01704300|Unheralded coronary death|unheralded coronary death
291080|NCT01704300|Unstable angina|unstable angina
402019|NCT01233479|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
291081|NCT01704300|Ventricular arrhythmias, cardiac arrest and sudden cardiac death|ventricular arrhythmias, cardiac arrest and sudden cardiac death
291082|NCT01704300|Transient Ischemic Attack|transient ischemic attack
291084|NCT01704287|PD1|pd1
291085|NCT01704287|PD-L1|pd-l1
291086|NCT01704287|PDL1|pdl1
291087|NCT01704274|biochemical|biochemical
291088|NCT01704274|recurrence|recurrence
291089|NCT01704274|prostate|prostate
291090|NCT01704274|cancer|cancer
291091|NCT01704274|active|active
291092|NCT01704274|surveillence|surveillence
291093|NCT01704248|eye drops self-instillation|eye drops self-instillation
291094|NCT01704235|screening|screening
291095|NCT01704222|Children|children
291096|NCT01704222|nursery|nursery
291097|NCT01704222|CMV|cmv
291098|NCT01704222|Infection|infection
291099|NCT01704183|relapse-remitting multiple sclerosis|relapse-remitting multiple sclerosis
291100|NCT01704183|heart rate variability|heart rate variability
291101|NCT01704183|fingolimod|fingolimod
291102|NCT01704183|cardiac autonomic regulation|cardiac autonomic regulation
291103|NCT01704157|Osteoarthritis|osteoarthritis
291104|NCT01704157|knee|knee
291105|NCT01704157|chronic pain|chronic pain
291106|NCT01704144|Efavirenz|efavirenz
291107|NCT01704144|rifampin|rifampin
291108|NCT01704144|Pharmacokinetics|pharmacokinetics
291109|NCT01704144|Drug-drug interactions|drug-drug interactions
291110|NCT01704144|Drug-gene interactions|drug-gene interactions
291111|NCT01704144|Children|children
291112|NCT01704131|Levosimendan|levosimendan
291113|NCT01704131|Children|children
291114|NCT01704131|Pharmacokinetics|pharmacokinetics
291115|NCT01704118|I-gel|i-gel
291116|NCT01704118|ProSeal laryngeal mask|proseal laryngeal mask
291117|NCT01704118|small infants|small infants
291118|NCT01704118|neonates|neonates
291119|NCT01704105|Chlorine water treatment|chlorine water treatment
291120|NCT01704105|Point-of-use water treatment|point-of-use water treatment
291121|NCT01704105|Household water treatment with safe storage|household water treatment with safe storage
291122|NCT01704105|Handwashing with soap|handwashing with soap
291123|NCT01704105|Hand hygiene|hand hygiene
291124|NCT01704105|Latrines|latrines
291125|NCT01704105|Water|water
291126|NCT01704105|Sanitation|sanitation
291127|NCT01704105|Handwashing|handwashing
291128|NCT01704105|Breast Feeding|breast feeding
291129|NCT01704105|Complementary Feeding|complementary feeding
291130|NCT01704105|Micronutrients|micronutrients
291131|NCT01704105|Malnutrition|malnutrition
291132|NCT01704105|Nutrition Disorders|nutrition disorders
291133|NCT01704105|Diarrhea|diarrhea
291134|NCT01704105|Child Development|child development
291135|NCT01704105|Child potties|child potties
291136|NCT01704105|Point-of-use fortification|point-of-use fortification
291137|NCT01704105|Lipid-based nutrient supplement|lipid-based nutrient supplement
291138|NCT01704105|Exclusive breastfeeding|exclusive breastfeeding
291139|NCT01704105|Environmental enteropathy|environmental enteropathy
291140|NCT01704105|Tropical enteropathy|tropical enteropathy
291141|NCT01704105|Gut function|gut function
291142|NCT01704105|Intestinal parasitic infection|intestinal parasitic infection
291143|NCT01704105|Soil transmitted helminths|soil transmitted helminths
291144|NCT01704105|Intestinal protozoans|intestinal protozoans
291145|NCT01704105|Antibody response|antibody response
291146|NCT01704079|Parathyroid Diseases|parathyroid diseases
291147|NCT01704079|Renal Insufficiency|renal insufficiency
291148|NCT01704079|Kidney Failure, Chronic|kidney failure, chronic
291149|NCT01704079|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
291150|NCT01704079|Vitamin D|vitamin d
291151|NCT01704079|Hyperparathyroidism|hyperparathyroidism
291152|NCT01704079|Kidney Diseases|kidney diseases
291153|NCT01704079|Kidney Failure|kidney failure
291154|NCT01704079|Renal Insufficiency, Chronic|renal insufficiency, chronic
291155|NCT01704066|ARDS|ards
291156|NCT01704066|Chest radiograph|chest radiograph
291157|NCT01704066|Berlin Definition|berlin definition
291158|NCT01704066|Inter-observer agreement|inter-observer agreement
291159|NCT01704053|New Oral Anticoagulants|new oral anticoagulants
291160|NCT01704053|Dabigatran|dabigatran
291161|NCT01704053|Rivaroxaban|rivaroxaban
291162|NCT01704053|Thrombelastometry/-graphy (ROTEM, TEG)|thrombelastometry/-graphy (rotem, teg)
291163|NCT01704053|Multiple Platelet Function Analyzer (Multiplate)|multiple platelet function analyzer (multiplate)
291164|NCT01704040|Healthy volunteers and asthma|healthy volunteers and asthma
291165|NCT01704040|CNTO 3157|cnto 3157
291166|NCT01704040|Rhinovirus|rhinovirus
291167|NCT01704027|Localized|localized
291168|NCT01704027|High risk|high risk
291169|NCT01704014|occurrence of|occurrence of
291170|NCT01704001|ART-123|art-123
291171|NCT01704001|Disseminated Intravascular Coagulation|disseminated intravascular coagulation
291172|NCT01704001|Pharmacokinetics|pharmacokinetics
291173|NCT01703988|Spinal Muscular Atrophy|spinal muscular atrophy
291174|NCT01703988|SMA|sma
291175|NCT01703988|SMN|smn
291176|NCT01703988|SMNRx|smnrx
291177|NCT01703988|ISIS-SMNRx|isis-smnrx
291178|NCT01703988|ISIS 396443|isis 396443
705114|NCT00977756|Children|children
291179|NCT01703975|Simulation efficiency|simulation efficiency
291180|NCT01703975|Collaborative learning|collaborative learning
291181|NCT01703962|Glioma|glioma
291182|NCT01703962|IDH1|idh1
291183|NCT01703962|Spectroscopy|spectroscopy
291184|NCT01703962|Plasma|plasma
291185|NCT01703936|economic intervention|economic intervention
291186|NCT01703936|ex-combatant|ex-combatant
291187|NCT01703936|agriculture|agriculture
291188|NCT01703936|life skills|life skills
291189|NCT01703910|Genomic expression profile in tumor samples|genomic expression profile in tumor samples
291190|NCT01703910|Adult patients|adult patients
291191|NCT01703910|metastatic disease status and progression after two lines of systemic therapy|metastatic disease status and progression after two lines of systemic therapy
291192|NCT01703897|gastric by-pass surgery|gastric by-pass surgery
291193|NCT01703884|Malria diagnosis|malria diagnosis
291194|NCT01703884|Malaria prevention in pregnancy|malaria prevention in pregnancy
291195|NCT01703884|ANC services improvement|anc services improvement
291196|NCT01703832|acute stress reaction|acute stress reaction
291197|NCT01703832|stress|stress
291198|NCT01703832|stress perception|stress perception
291199|NCT01703832|physiological stress response|physiological stress response
291200|NCT01703832|Neurexan|neurexan
291201|NCT01703819|acute stress reaction|acute stress reaction
291202|NCT01703819|stress|stress
291203|NCT01703819|stress perception|stress perception
291204|NCT01703819|physiological stress response|physiological stress response
291205|NCT01703819|Neurexan|neurexan
291206|NCT01703806|Mitral regurgitation|mitral regurgitation
291207|NCT01703806|Mitral valve repair|mitral valve repair
291208|NCT01703806|Watchful waiting|watchful waiting
291209|NCT01703767|patient satisfaction|patient satisfaction
291210|NCT01703767|Gulf War 1 Veteran|gulf war 1 veteran
291211|NCT01703767|Desert Storm Veteran|desert storm veteran
291212|NCT01703754|Genetically Modified Organism|genetically modified organism
291213|NCT01703754|Metastatic Breast Cancer|metastatic breast cancer
291214|NCT01703754|Recurrent Breast Cancer|recurrent breast cancer
291215|NCT01703754|Breast Cancer|breast cancer
291216|NCT01703754|Palifosfamide|palifosfamide
291217|NCT01703754|INXN1001|inxn1001
291218|NCT01703754|INXN2001|inxn2001
291219|NCT01703754|Adenoviral vector|adenoviral vector
291220|NCT01703715|Hydration|hydration
291221|NCT01703715|Elderly patients|elderly patients
291617|NCT01702077|fMRI|fmri
291222|NCT01703715|Age 65 years and over|age 65 years and over
291223|NCT01703715|Admitted acutely to medical admissions ward|admitted acutely to medical admissions ward
291224|NCT01703689|Quality indicators|quality indicators
291225|NCT01703689|quality of care|quality of care
291226|NCT01703689|nursing home|nursing home
291227|NCT01703689|long-term care unit|long-term care unit
291228|NCT01703689|nursing home organisation|nursing home organisation
291229|NCT01703689|nursing home structure|nursing home structure
291230|NCT01703689|disability|disability
291231|NCT01703689|dependence|dependence
291232|NCT01703689|functional decline|functional decline
291233|NCT01703689|functional impairment|functional impairment
291234|NCT01703689|older adults|older adults
291235|NCT01703689|elderly|elderly
291236|NCT01703689|audit and feedback|audit and feedback
291237|NCT01703689|cooperative work|cooperative work
291238|NCT01703689|geriatrician|geriatrician
291239|NCT01703689|medication|medication
291240|NCT01703689|hospitalisation|hospitalisation
291241|NCT01703689|comorbidity|comorbidity
291242|NCT01703676|Hypogonadism, Klinefelter Syndrome, Cardiovascular Risk, Epigenetics, Methylation of Genes|hypogonadism, klinefelter syndrome, cardiovascular risk, epigenetics, methylation of genes
291243|NCT01703676|Cardiovascular risk factors|cardiovascular risk factors
291244|NCT01703676|Gonadal status|gonadal status
291245|NCT01703676|Gene expression|gene expression
291246|NCT01703676|Methylation|methylation
291247|NCT01703663|Stroke|stroke
291248|NCT01703663|Sleep Apnea|sleep apnea
291249|NCT01703650|CT|ct
291653|NCT01701986|Filgrastim|filgrastim
291250|NCT01703650|pancreas adenocarcinoma|pancreas adenocarcinoma
291251|NCT01703650|RECIST|recist
291252|NCT01703650|perfusion|perfusion
291253|NCT01703637|Sitagliptin|sitagliptin
291254|NCT01703637|Vildagliptin|vildagliptin
291255|NCT01703637|Saxagliptin|saxagliptin
291256|NCT01703637|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
291257|NCT01703624|glycopyrronium bromide|glycopyrronium bromide
291258|NCT01703624|glycopyrrolate|glycopyrrolate
291259|NCT01703624|oral inhalation|oral inhalation
291260|NCT01703624|COPD|copd
291261|NCT01703624|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
291262|NCT01703624|lung function|lung function
291263|NCT01703624|pharmacokinetics|pharmacokinetics
291264|NCT01703624|tolerability|tolerability
291265|NCT01703624|safety|safety
291266|NCT01703624|cross-over|cross-over
291267|NCT01703624|single-dose|single-dose
291268|NCT01703624|dose-ranging|dose-ranging
291269|NCT01703611|Nutrition|nutrition
291270|NCT01703611|Medical Nutrition Therapy|medical nutrition therapy
291271|NCT01703611|Diabetes Mellitus|diabetes mellitus
291272|NCT01703611|Nutrition outcomes|nutrition outcomes
291273|NCT01703611|Evidence Based Guidelines|evidence based guidelines
291274|NCT01703598|Parkinson's disease|parkinson's disease
291275|NCT01703598|Deep Brain Stimulation|deep brain stimulation
291276|NCT01703585|genomic analysis|genomic analysis
291279|NCT01703585|tissue|tissue
291280|NCT01703585|archival|archival
291281|NCT01703585|biopsy|biopsy
291282|NCT01703585|core needle|core needle
291283|NCT01703585|fine needle|fine needle
291284|NCT01703585|DNA|dna
360603|NCT01408186|PPI|ppi
291285|NCT01703585|gene|gene
291286|NCT01703585|expression|expression
291287|NCT01703585|sequencing|sequencing
291288|NCT01703572|Phase 1|phase 1
291289|NCT01703572|Dose escalation|dose escalation
291290|NCT01703572|relapsed or refractory|relapsed or refractory
291291|NCT01703572|lymphoid malignancies|lymphoid malignancies
291292|NCT01703559|Glare|glare
291293|NCT01703559|Starburst|starburst
291294|NCT01703559|Halos|halos
291295|NCT01703559|Reduced contrast sensitivity|reduced contrast sensitivity
291296|NCT01703546|Morbid Obesity|morbid obesity
291297|NCT01703546|Weight Loss Surgery|weight loss surgery
291298|NCT01703546|Laparoscopic Adjustable Gastric Band|laparoscopic adjustable gastric band
291299|NCT01703546|Laparoscopic Gastric Plication|laparoscopic gastric plication
291300|NCT01703546|Imbrication|imbrication
291301|NCT01703533|Autism|autism
291302|NCT01703533|Rett's Syndrome|rett's syndrome
291303|NCT01703533|Rett Disorder|rett disorder
291304|NCT01703533|Rett's Disorder|rett's disorder
291305|NCT01703533|Ataxia|ataxia
291306|NCT01703520|Males breast cancer|males breast cancer
291307|NCT01703520|Finasteride|finasteride
291308|NCT01703520|PROSCAR®|proscar®
291309|NCT01703520|PROPECIA®|propecia®
291310|NCT01703494|C. difficile|c. difficile
291311|NCT01703494|fecal transplant|fecal transplant
291312|NCT01703494|stool transplant|stool transplant
291313|NCT01703494|fecal flora reconstitution|fecal flora reconstitution
291314|NCT01703494|fecal microbiota transplant|fecal microbiota transplant
291315|NCT01703494|FMT|fmt
291316|NCT01703481|Tumor|tumor
291317|NCT01703481|Fibroblast Growth Factor Receptor (FGFR)|fibroblast growth factor receptor (fgfr)
291318|NCT01703481|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
291319|NCT01703481|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
291320|NCT01703481|JNJ-42756493|jnj-42756493
291321|NCT01703455|Salivary gland cancer metastatic disease recurrent disease clinical trial|salivary gland cancer metastatic disease recurrent disease clinical trial
291322|NCT01703429|Multiple Sclerosis|multiple sclerosis
291323|NCT01703429|MS|ms
291324|NCT01703429|Complementary and Alternative|complementary and alternative
291325|NCT01703429|CAM|cam
291326|NCT01703416|COPD|copd
291327|NCT01703416|GOLD group C and D|gold group c and d
291328|NCT01703416|CDLM questionnaire|cdlm questionnaire
291329|NCT01703416|visual scale - physician evaluation|visual scale - physician evaluation
291330|NCT01703403|physical therapy|physical therapy
291331|NCT01703403|treated at NTUH and received rehabilitation at the PTC in recent ten years.|treated at ntuh and received rehabilitation at the ptc in recent ten years.
291332|NCT01703390|metastatic colorectal cancer|metastatic colorectal cancer
291333|NCT01703390|mCRC|mcrc
291334|NCT01703390|ERCC-1|ercc-1
291335|NCT01703390|ERCC1|ercc1
291336|NCT01703390|AGMT|agmt
291337|NCT01703364|CLL|cll
291338|NCT01703364|Lenalidomide|lenalidomide
291339|NCT01703364|Revlimid|revlimid
291340|NCT01703364|AGMT|agmt
291341|NCT01703364|T cell|t cell
291342|NCT01703351|pain control, VATS|pain control, vats
291343|NCT01703338|assessment model|assessment model
291344|NCT01703338|biomechanical changes|biomechanical changes
291345|NCT01703338|functional activities|functional activities
291346|NCT01703338|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
291347|NCT01703338|causal relationship|causal relationship
291348|NCT01703338|core muscles activation pattern|core muscles activation pattern
291349|NCT01703338|pathological changes|pathological changes
291350|NCT01703338|early rehabilitation|early rehabilitation
291351|NCT01703338|core stability exercise|core stability exercise
291352|NCT01703338|minimally invasive lumbar spinal fusion surgery|minimally invasive lumbar spinal fusion surgery
291353|NCT01703325|Psoriatic nails|psoriatic nails
291354|NCT01703325|Triamcinolone injection|triamcinolone injection
291355|NCT01703325|clobetasol propionate|clobetasol propionate
291356|NCT01703312|Allergies, asthma, IgE|allergies, asthma, ige
291357|NCT01703299|imipenem|imipenem
291358|NCT01703299|ertapenem|ertapenem
291359|NCT01703299|resistance|resistance
291360|NCT01703299|commensal flora|commensal flora
291361|NCT01703273|Extreme Obesity Keywords: obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life|extreme obesity keywords: obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life
291362|NCT01703260|Drug therapy|drug therapy
291363|NCT01703247|Arrhythmias|arrhythmias
291364|NCT01703247|Ablation|ablation
291365|NCT01703234|FGF-23 , ramipril, endothelial dysfunction|fgf-23 , ramipril, endothelial dysfunction
291366|NCT01703195|Vaginal Cancer|vaginal cancer
291367|NCT01703195|Malignancies involving the vagina|malignancies involving the vagina
291368|NCT01703195|Middle third and the distal third of the vagina|middle third and the distal third of the vagina
291369|NCT01703195|Pre and post radiation therapy|pre and post radiation therapy
291370|NCT01703195|Diffusion weighted magnetic resonance imaging|diffusion weighted magnetic resonance imaging
291371|NCT01703195|DWMR|dwmr
291372|NCT01703195|Magnetic resonance imaging|magnetic resonance imaging
291373|NCT01703195|MRI|mri
291374|NCT01703195|Tumor involvement|tumor involvement
291375|NCT01703195|Response to radiation therapy|response to radiation therapy
291376|NCT01703195|XRT|xrt
291377|NCT01703182|transcutaneous oximetry|transcutaneous oximetry
291378|NCT01703182|transcutaneous carbon dioxide|transcutaneous carbon dioxide
291379|NCT01703182|leg amputation|leg amputation
291380|NCT01703182|wound healing failure|wound healing failure
291381|NCT01703182|amputation revision|amputation revision
291382|NCT01703169|severe aplastic anemia|severe aplastic anemia
291383|NCT01703169|very severe aplastic anemia|very severe aplastic anemia
291384|NCT01703169|moderate aplastic anemia|moderate aplastic anemia
291385|NCT01703169|bleeding|bleeding
291386|NCT01703156|Low Risk ACS, Acute Coronary Syndrome, Stress Testing, Non-Stress Testing|low risk acs, acute coronary syndrome, stress testing, non-stress testing
291387|NCT01703130|ISPB|ispb
291388|NCT01703130|Brachial Plexus Block|brachial plexus block
291389|NCT01703130|Anesthesia|anesthesia
291390|NCT01703130|Pain Management|pain management
291391|NCT01703130|Surgery|surgery
291392|NCT01703117|Alzheimer's Disease|alzheimer's disease
291393|NCT01703117|Dementia|dementia
291394|NCT01703104|Sorghum bicolor|sorghum bicolor
291395|NCT01703104|sickle cell anaemia|sickle cell anaemia
291396|NCT01703104|haematological parameters|haematological parameters
291397|NCT01703065|Prostate cancer|prostate cancer
291398|NCT01703065|Bone metastases|bone metastases
291399|NCT01703039|Major Depression|major depression
291400|NCT01703039|Major Depressive Disorder|major depressive disorder
291401|NCT01703039|Depression|depression
291402|NCT01703039|Riluzole|riluzole
291403|NCT01703039|Glutamate|glutamate
291404|NCT01703039|Sertraline|sertraline
291405|NCT01703013|Demonstrate that DEFA4 is a reliable biomarker for the prediction of adrenal insufficiency|demonstrate that defa4 is a reliable biomarker for the prediction of adrenal insufficiency
291406|NCT01703000|drug eluting coronary stent|drug eluting coronary stent
291407|NCT01702987|ubiquinol (coenzyme Q10)|ubiquinol (coenzyme q10)
291408|NCT01702974|HIV|hiv
291409|NCT01702974|cholecalciferol|cholecalciferol
291410|NCT01702974|sodium phenylbutyrate|sodium phenylbutyrate
291411|NCT01702974|antimicrobial peptides|antimicrobial peptides
291618|NCT01702064|CML|cml
291412|NCT01702974|immune response|immune response
291413|NCT01702974|inflammation|inflammation
291414|NCT01702961|Lymphoma|lymphoma
291415|NCT01702961|Hodgkin's Disease|hodgkin's disease
291416|NCT01702948|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
291417|NCT01702948|Nicotine|nicotine
291418|NCT01702948|Repetitive TMS (rTMS)|repetitive tms (rtms)
291419|NCT01702948|fMRI|fmri
291420|NCT01702935|Ovarian Failure|ovarian failure
291421|NCT01702935|Premature Ovarian Failure|premature ovarian failure
291422|NCT01702935|Infertility|infertility
291423|NCT01702935|Primary Ovarian Insufficiency|primary ovarian insufficiency
291424|NCT01702935|Stem Cells|stem cells
291425|NCT01702922|Stress|stress
291426|NCT01702922|Marriage|marriage
291427|NCT01702922|Dyadic Coping|dyadic coping
291428|NCT01702922|Mother|mother
291429|NCT01702922|Father|father
291430|NCT01702909|Metastatic Renal Cell|metastatic renal cell
291431|NCT01702909|Metastatic Kidney Cancer|metastatic kidney cancer
291432|NCT01702896|Metastatic Melanoma|metastatic melanoma
291433|NCT01702883|prescriptions|prescriptions
291434|NCT01702883|hypertension|hypertension
291435|NCT01702883|high cholesterol|high cholesterol
291436|NCT01702883|diabetes|diabetes
291437|NCT01702883|depression|depression
291438|NCT01702883|adherence|adherence
291439|NCT01702870|Magnetic resonance imaging|magnetic resonance imaging
291440|NCT01702857|Dengue|dengue
291441|NCT01702857|Dengue fever|dengue fever
291654|NCT01701986|G-CSF|g-csf
291442|NCT01702857|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
291443|NCT01702857|Flavivirus|flavivirus
291444|NCT01702844|Nab paclitaxel|nab paclitaxel
291445|NCT01702844|Abraxane|abraxane
291446|NCT01702844|First Line|first line
291447|NCT01702844|Non small cell lung cancer|non small cell lung cancer
291448|NCT01702844|NSCLC|nsclc
291449|NCT01702844|Phase II|phase ii
291450|NCT01702844|Non-Randomized|non-randomized
291451|NCT01702844|Elderly|elderly
291452|NCT01702844|Lineberger|lineberger
291453|NCT01702844|UNC|unc
291454|NCT01702844|LCCC 1210|lccc 1210
291455|NCT01702831|Newly Diagnosed multiple myeloma|newly diagnosed multiple myeloma
291456|NCT01702818|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
291457|NCT01702818|HSDD|hsdd
291458|NCT01702818|Cortisol|cortisol
291459|NCT01702818|DHEA|dhea
291460|NCT01702818|Stress Hormones|stress hormones
291461|NCT01702818|Sexual Desire|sexual desire
291462|NCT01702818|Mood|mood
291463|NCT01702818|Sexual Function|sexual function
291464|NCT01702818|Childhood Maltreatment|childhood maltreatment
291465|NCT01702818|Childhood Abuse|childhood abuse
291466|NCT01702805|NICHD Neonatal Research Network|nichd neonatal research network
291467|NCT01702805|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
291468|NCT01702805|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
291469|NCT01702805|Transfusions|transfusions
291470|NCT01702792|Immunotherapy, cancer vaccine, glioblastoma, hybridoma|immunotherapy, cancer vaccine, glioblastoma, hybridoma
360811|NCT01407497|HIV|hiv
291471|NCT01702779|Weaning from mechanical ventilation|weaning from mechanical ventilation
291472|NCT01702779|Lung ultrasound|lung ultrasound
291473|NCT01702779|Oxygen inhalation therapy|oxygen inhalation therapy
291474|NCT01702740|Cutaneous lupus erythematosus|cutaneous lupus erythematosus
291475|NCT01702740|Systemic lupus erythematosus|systemic lupus erythematosus
291476|NCT01702740|Lupus erythematosus|lupus erythematosus
291477|NCT01702740|Human anti-IL 6 monoclonal antibody|human anti-il 6 monoclonal antibody
291478|NCT01702740|Sirukumab|sirukumab
291479|NCT01702727|Amblyopia|amblyopia
291480|NCT01702727|I-BiT TM|i-bit tm
291481|NCT01702727|Interactive games|interactive games
291482|NCT01702727|Binocular|binocular
291483|NCT01702675|Safety|safety
291484|NCT01702675|Pharmacokinetics|pharmacokinetics
291485|NCT01702675|Tolerability|tolerability
291486|NCT01702675|Healthy men|healthy men
291487|NCT01702636|Intracerebral Hemorrhage|intracerebral hemorrhage
291488|NCT01702636|ICH|ich
291489|NCT01702636|Stroke|stroke
291490|NCT01702636|Cerebrovascular Disorders|cerebrovascular disorders
291491|NCT01702636|Brain Diseases|brain diseases
291492|NCT01702636|Central Nervous System Diseases|central nervous system diseases
291493|NCT01702636|Nervous System Diseases|nervous system diseases
291494|NCT01702636|Vascular Diseases|vascular diseases
291495|NCT01702636|Cardiovascular Diseases|cardiovascular diseases
291496|NCT01702636|Tranexamic Acid|tranexamic acid
291497|NCT01702636|Antifibrinolytic Agents|antifibrinolytic agents
291498|NCT01702636|Fibrin Modulating Agents|fibrin modulating agents
291499|NCT01702636|Pharmacologic Actions|pharmacologic actions
291500|NCT01702636|Cardiovascular Agents|cardiovascular agents
291501|NCT01702636|Therapeutic Uses|therapeutic uses
291502|NCT01702636|Hematologic Agents|hematologic agents
291503|NCT01702636|Hemostatics|hemostatics
291504|NCT01702636|Contrast Media|contrast media
291505|NCT01702636|Angiography|angiography
291506|NCT01702636|Cerebral Angiography|cerebral angiography
291507|NCT01702636|Tomography, X-Ray Computed|tomography, x-ray computed
291508|NCT01702584|stent|stent
291509|NCT01702584|intracranial aneurysm|intracranial aneurysm
291510|NCT01702584|embolization|embolization
291619|NCT01702064|CP-CML|cp-cml
291511|NCT01702584|adverse event|adverse event
291512|NCT01702532|provoked craving|provoked craving
291513|NCT01702506|Dacomitinib|dacomitinib
291514|NCT01702506|PF-00299804|pf-00299804
291516|NCT01702506|fasted|fasted
291517|NCT01702506|antacid|antacid
291518|NCT01702506|relative Bioavailability|relative bioavailability
291519|NCT01702493|SRT2104|srt2104
291520|NCT01702493|Modified Release|modified release
291521|NCT01702493|Bioavailability|bioavailability
291522|NCT01702493|Crossover|crossover
291523|NCT01702480|Consumer Healthcare|consumer healthcare
291524|NCT01702480|Ketones|ketones
291525|NCT01702480|Medium Chain Triglycerides|medium chain triglycerides
291526|NCT01702480|Age related cognitive decline|age related cognitive decline
291527|NCT01702480|GSK Nutrition|gsk nutrition
291528|NCT01702467|Lp-PLA2|lp-pla2
291529|NCT01702467|Alzheimer's disease|alzheimer's disease
291530|NCT01702454|GSK Biologicals quadrivalent influenza vaccine|gsk biologicals quadrivalent influenza vaccine
291531|NCT01702454|Influenza|influenza
291532|NCT01702454|Children|children
291533|NCT01702454|Safety|safety
291534|NCT01702454|Immunogenicity|immunogenicity
291535|NCT01702428|Safety|safety
291536|NCT01702428|Consistency study|consistency study
291537|NCT01702428|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
291538|NCT01702428|Healthy children|healthy children
291539|NCT01702428|Immunogenicity|immunogenicity
291540|NCT01702415|Cystic fibrosis|cystic fibrosis
291541|NCT01702415|Bone density|bone density
291542|NCT01702402|intervention|intervention
291543|NCT01702389|opioid induced hyperalgesia|opioid induced hyperalgesia
291544|NCT01702389|Pain|pain
291545|NCT01702389|Postoperative pain|postoperative pain
291546|NCT01702389|Hyperalgesia|hyperalgesia
291547|NCT01702363|Chronic Obstructive Pulmonary Disease (COPD), GSK573719, Pharmacogenetics|chronic obstructive pulmonary disease (copd), gsk573719, pharmacogenetics
291548|NCT01702350|Healthy Subjects|healthy subjects
291549|NCT01702350|Relative Bioavailability|relative bioavailability
291550|NCT01702350|Pharmacokinetics|pharmacokinetics
291551|NCT01702350|Elderly Subjects|elderly subjects
291552|NCT01702337|Gardasil|gardasil
291553|NCT01702337|Prevalence-model|prevalence-model
291554|NCT01702337|Cervarix|cervarix
291555|NCT01702337|economic|economic
291556|NCT01702337|health|health
291557|NCT01702324|Psoriasis Vulgaris|psoriasis vulgaris
291558|NCT01702324|Plaque|plaque
291559|NCT01702324|Topical|topical
291560|NCT01702324|Treatment|treatment
291561|NCT01702311|Diabetes|diabetes
291562|NCT01702311|Point of care testing|point of care testing
291563|NCT01702311|Hypoglycemia|hypoglycemia
291564|NCT01702311|Basal bolus insulin|basal bolus insulin
291565|NCT01702285|Advanced Solid Tumors|advanced solid tumors
291567|NCT01702285|HDAC|hdac
291568|NCT01702285|Her2|her2
291569|NCT01702285|Open-Label|open-label
291570|NCT01702285|Dose-Escalation|dose-escalation
291571|NCT01702246|sickle cell disease|sickle cell disease
291572|NCT01702246|statins|statins
291573|NCT01702246|vaso-occlusive pain|vaso-occlusive pain
291574|NCT01702246|inflammation|inflammation
291575|NCT01702246|biomarkers|biomarkers
291576|NCT01702220|Generalized Anxiety Disorder|generalized anxiety disorder
291577|NCT01702220|Geriatric|geriatric
291578|NCT01702207|Prograf®|prograf®
291579|NCT01702207|Advagraf®|advagraf®
291580|NCT01702207|tacrolimus|tacrolimus
291581|NCT01702207|kidney transplant|kidney transplant
291582|NCT01702207|renal transplant|renal transplant
291583|NCT01702207|cardiovascular risk|cardiovascular risk
291584|NCT01702207|Framingham Risk|framingham risk
291585|NCT01702207|Reynolds Risk|reynolds risk
291586|NCT01702207|immunosuppression|immunosuppression
291587|NCT01702194|OIC|oic
291588|NCT01702194|Opioid Induced Constipation|opioid induced constipation
291589|NCT01702194|Constipation|constipation
291590|NCT01702181|Atopic Dermatitis, Eczema|atopic dermatitis, eczema
291591|NCT01702168|PTSD|ptsd
291592|NCT01702168|EBT|ebt
291593|NCT01702168|EST|est
291594|NCT01702168|Community|community
291595|NCT01702168|Latino|latino
291596|NCT01702142|Addiction Treatment|addiction treatment
291597|NCT01702129|EGFR|egfr
291598|NCT01702129|liposomes|liposomes
291599|NCT01702129|immunoliposomes|immunoliposomes
291600|NCT01702116|rectal adenocarcinoma|rectal adenocarcinoma
291601|NCT01702116|Standard APR|standard apr
291602|NCT01702116|Extralevator APR|extralevator apr
291603|NCT01702090|HIV-1|hiv-1
291604|NCT01702090|TMC114|tmc114
291605|NCT01702090|Darunavir|darunavir
291606|NCT01702090|PREZISTA|prezista
291607|NCT01702090|Ritonavir|ritonavir
291608|NCT01702090|Antiretrovirals|antiretrovirals
291609|NCT01702090|Early access|early access
291610|NCT01702090|Early treatment|early treatment
291611|NCT01702090|Treatment naive|treatment naive
291612|NCT01702077|neurofeedback|neurofeedback
291613|NCT01702077|biofeedback|biofeedback
291614|NCT01702077|real-time fMRI|real-time fmri
291615|NCT01702077|rt-fMRI|rt-fmri
291616|NCT01702077|functional connectivity|functional connectivity
291620|NCT01702064|Chronic Phase-CML (CP-CML)|chronic phase-cml (cp-cml)
291621|NCT01702064|chronic myeloid leukemia|chronic myeloid leukemia
291622|NCT01702051|Pancreatogenic diabetes|pancreatogenic diabetes
291623|NCT01702051|Autologou Islet Transplantation|autologou islet transplantation
291624|NCT01702051|Pancreas|pancreas
291625|NCT01702051|Pancreatectomy|pancreatectomy
291626|NCT01702025|Hypoxia|hypoxia
291627|NCT01702025|Altitude|altitude
291628|NCT01702025|Exercise|exercise
291629|NCT01702012|Diabetes-Obesity|diabetes-obesity
291630|NCT01701999|Botulism Vaccine|botulism vaccine
291631|NCT01701986|Lymphoma|lymphoma
291632|NCT01701986|Aggressive lymphomas|aggressive lymphomas
291633|NCT01701986|Allogeneic stem-cell transplant|allogeneic stem-cell transplant
291634|NCT01701986|alloSCT|allosct
291635|NCT01701986|Refractory B-cell|refractory b-cell
291636|NCT01701986|T-cell|t-cell
291637|NCT01701986|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
291638|NCT01701986|Hodgkin's lymphoma|hodgkin's lymphoma
291639|NCT01701986|Gemcitabine|gemcitabine
291640|NCT01701986|Gemcitabine Hydrochloride|gemcitabine hydrochloride
291641|NCT01701986|Gemzar|gemzar
291642|NCT01701986|Clofarabine|clofarabine
291643|NCT01701986|Clofarex|clofarex
291644|NCT01701986|Clolar|clolar
291645|NCT01701986|Busulfan|busulfan
291646|NCT01701986|Busulfex|busulfex
291647|NCT01701986|Myleran|myleran
291648|NCT01701986|Anti-Thymocyte Globulin|anti-thymocyte globulin
291649|NCT01701986|ATG|atg
291650|NCT01701986|Thymoglobulin|thymoglobulin
291655|NCT01701986|Neupogen|neupogen
291656|NCT01701986|Tacrolimus|tacrolimus
291657|NCT01701986|Prograf|prograf
291658|NCT01701986|Mycophenolate Mofetil|mycophenolate mofetil
291659|NCT01701986|MMF|mmf
291660|NCT01701986|CellCept|cellcept
291661|NCT01701973|obesity|obesity
291662|NCT01701973|growth hormone|growth hormone
291663|NCT01701947|Factor XI deficiency|factor xi deficiency
291664|NCT01701947|EAP|eap
291665|NCT01701947|postpartum hemorrhage|postpartum hemorrhage
291666|NCT01701947|surgery|surgery
291667|NCT01701947|delivery|delivery
291668|NCT01701947|Child birth|child birth
291669|NCT01701934|COPD|copd
291670|NCT01701934|Intrabdominal adiposity|intrabdominal adiposity
291671|NCT01701934|Body composition|body composition
291672|NCT01701934|Triglycerides|triglycerides
291673|NCT01701934|Cholesterol|cholesterol
291674|NCT01701921|cardiac surgery|cardiac surgery
291675|NCT01701921|pregabalin|pregabalin
291676|NCT01701921|postoperative pain|postoperative pain
291677|NCT01701908|PPCs|ppcs
291678|NCT01701908|abdominal surgery|abdominal surgery
291679|NCT01701908|postoperative infections|postoperative infections
291680|NCT01701908|postoperative residual curarization|postoperative residual curarization
291681|NCT01701908|tracheal re-intubation|tracheal re-intubation
291682|NCT01701908|mortality|mortality
291683|NCT01701908|ICU stay|icu stay
291684|NCT01701895|Complera|complera
291685|NCT01701895|short-term|short-term
291686|NCT01701895|long-term|long-term
291687|NCT01701895|compliance|compliance
291688|NCT01701895|caloric|caloric
291689|NCT01701895|intake|intake
291690|NCT01701895|HIV|hiv
291691|NCT01701895|positive|positive
291692|NCT01701895|women|women
291693|NCT01701856|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
291694|NCT01701856|natalizumab|natalizumab
291695|NCT01701856|de-escalation|de-escalation
291696|NCT01701856|interferon beta-1b|interferon beta-1b
291697|NCT01701830|omentin-1|omentin-1
291698|NCT01701830|carotid atherosclerosis|carotid atherosclerosis
291699|NCT01701830|kidney disease|kidney disease
291700|NCT01701817|Atrial Fibrillation|atrial fibrillation
291701|NCT01701817|Irregular heart beat|irregular heart beat
291702|NCT01701804|Failed Back Surgery Syndrome|failed back surgery syndrome
291703|NCT01701791|Depression|depression
291704|NCT01701791|Primary care|primary care
291705|NCT01701791|Computerized decision support system|computerized decision support system
291706|NCT01701791|General practitioner|general practitioner
291707|NCT01701778|Dexmedetomidine|dexmedetomidine
291708|NCT01701778|Postoperative pain reaction|postoperative pain reaction
291709|NCT01701778|anesthesia|anesthesia
291710|NCT01701778|children|children
291711|NCT01701765|Severe mental disorders|severe mental disorders
291712|NCT01701765|Discharge|discharge
291713|NCT01701765|Outcome evaluation|outcome evaluation
291714|NCT01701752|Influenza A|influenza a
291715|NCT01701726|Essential Hypertension|essential hypertension
291716|NCT01701726|Acupuncture|acupuncture
291717|NCT01701726|Specificity|specificity
291718|NCT01701726|Acupoints effect|acupoints effect
291719|NCT01701726|randomized controlled trials|randomized controlled trials
291720|NCT01701713|TDCS|tdcs
291721|NCT01701713|STROKE|stroke
291722|NCT01701713|APHASIA|aphasia
291723|NCT01701713|NAMING|naming
291724|NCT01701700|portable electronic magnifiers|portable electronic magnifiers
291725|NCT01701687|Cirrhosis|cirrhosis
291824|NCT01701336|Hepatitis|hepatitis
291726|NCT01701687|Alcoholic liver disease|alcoholic liver disease
291727|NCT01701687|Decompensated liver cirrhosis|decompensated liver cirrhosis
291728|NCT01701687|Hazardous alcohol|hazardous alcohol
291729|NCT01701674|skin cancer|skin cancer
291730|NCT01701661|venous surgery|venous surgery
291731|NCT01701661|compression therapy|compression therapy
291732|NCT01701648|Vitiligo, amniotic membrane, malanocytes, C02 laser.|vitiligo, amniotic membrane, malanocytes, c02 laser.
291733|NCT01701635|Disclosure|disclosure
291734|NCT01701635|HIV-infected children|hiv-infected children
291735|NCT01701635|Resource-limited settings|resource-limited settings
291736|NCT01701622|Blood Pressure|blood pressure
291737|NCT01701622|Gout|gout
291738|NCT01701622|allopurinol|allopurinol
291739|NCT01701622|febuxostat|febuxostat
291740|NCT01701622|uric acid|uric acid
291741|NCT01701609|early-onset schizophrenia|early-onset schizophrenia
291742|NCT01701609|adolescents|adolescents
291743|NCT01701609|cognition|cognition
291744|NCT01701609|cognitive remediation therapy|cognitive remediation therapy
291745|NCT01701596|Rotational atherectomy|rotational atherectomy
291746|NCT01701596|Coronary dissection|coronary dissection
291747|NCT01701596|Percutaneous coronary intervention|percutaneous coronary intervention
291748|NCT01701596|Calcification|calcification
291749|NCT01701583|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
291750|NCT01701583|CIU|ciu
291751|NCT01701583|Urticaria|urticaria
291752|NCT01701583|Chronic Hives|chronic hives
291753|NCT01701583|Xolair|xolair
291754|NCT01701570|Type 2 Diabetes|type 2 diabetes
291755|NCT01701570|Exercise|exercise
291756|NCT01701570|Rate of Perceived Exertion|rate of perceived exertion
291956|NCT01700790|Rifampin|rifampin
291757|NCT01701557|Ketoacidosis Fluids|ketoacidosis fluids
291758|NCT01701518|Ozurdex|ozurdex
291759|NCT01701518|Dexamethasone|dexamethasone
291760|NCT01701518|Epiretinal membrane|epiretinal membrane
291761|NCT01701518|Macular edema|macular edema
291762|NCT01701505|operative|operative
291763|NCT01701505|dental procedure|dental procedure
291764|NCT01701492|pediatric|pediatric
291765|NCT01701492|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
291766|NCT01701492|allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
291767|NCT01701479|Neuroblastoma|neuroblastoma
291768|NCT01701479|Refractory neuroblastoma|refractory neuroblastoma
291769|NCT01701479|Relapsed neuroblastoma|relapsed neuroblastoma
291770|NCT01701479|ch14.18/CHO|ch14.18/cho
291771|NCT01701479|Aldesleukin (IL-2)|aldesleukin (il-2)
291772|NCT01701466|Patients|patients
291773|NCT01701466|with|with
291774|NCT01701453|duration of DAPT|duration of dapt
291775|NCT01701427|Hyperalgesia|hyperalgesia
291776|NCT01701427|Persistent pain|persistent pain
291777|NCT01701427|deep pain|deep pain
291778|NCT01701427|electrical stimulation|electrical stimulation
291779|NCT01701427|groin hernia|groin hernia
282388|NCT01742611|CKD|ckd
291781|NCT01701414|Hip|hip
291782|NCT01701414|Fracture|fracture
291783|NCT01701414|Femoral neck|femoral neck
291784|NCT01701414|Femoral head|femoral head
291785|NCT01701401|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
291786|NCT01701401|HCV|hcv
291787|NCT01701401|Sustained Virologic Response|sustained virologic response
291788|NCT01701401|Direct Acting Antiviral|direct acting antiviral
291789|NCT01701401|Combination Therapy|combination therapy
291790|NCT01701401|GS-7977|gs-7977
291791|NCT01701401|GS-5885|gs-5885
291792|NCT01701401|Ribavirin|ribavirin
291793|NCT01701401|Open Label|open label
291794|NCT01701401|Sofosbuvir|sofosbuvir
291795|NCT01701401|Additional relevant MeSH terms:|additional relevant mesh terms:
291796|NCT01701401|Hepatitis|hepatitis
291797|NCT01701401|Hepatitis, Chronic|hepatitis, chronic
291798|NCT01701401|Hepatitis C|hepatitis c
291799|NCT01701401|Hepatitis C, Chronic|hepatitis c, chronic
291800|NCT01701401|Liver Diseases|liver diseases
291801|NCT01701401|Digestive System Diseases|digestive system diseases
291802|NCT01701401|Hepatitis, Viral, Human|hepatitis, viral, human
291803|NCT01701401|Virus Diseases|virus diseases
291804|NCT01701401|Enterovirus Infections|enterovirus infections
291805|NCT01701401|Picornaviridae Infections|picornaviridae infections
291806|NCT01701401|RNA Virus Infections|rna virus infections
291807|NCT01701401|Flaviviridae Infections|flaviviridae infections
291808|NCT01701401|Antiviral Agents|antiviral agents
291809|NCT01701401|Anti-Infective Agents|anti-infective agents
291810|NCT01701401|Therapeutic Uses|therapeutic uses
291811|NCT01701401|Pharmacologic Actions|pharmacologic actions
291812|NCT01701401|Antimetabolites|antimetabolites
291813|NCT01701401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
291814|NCT01701388|Ekso|ekso
291815|NCT01701388|Exoskeleton|exoskeleton
291816|NCT01701388|Spinal Cord Injury|spinal cord injury
291817|NCT01701388|Motor Complete Incomplete|motor complete incomplete
291818|NCT01701362|post-traumatic peripheral neuropathic pain|post-traumatic peripheral neuropathic pain
291819|NCT01701349|ATC|atc
291820|NCT01701349|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
291821|NCT01701349|Stage IVC Anaplastic Thyroid Cancer|stage ivc anaplastic thyroid cancer
291822|NCT01701349|Thyroid Cancer|thyroid cancer
291823|NCT01701349|Head and Neck Tumors|head and neck tumors
291825|NCT01701336|Hepatitis C|hepatitis c
291826|NCT01701336|HCV|hcv
291827|NCT01701336|vaccine|vaccine
291828|NCT01701336|adenovirus|adenovirus
291829|NCT01701336|MVA|mva
291830|NCT01701336|T cells|t cells
291831|NCT01701336|ELISpot|elispot
291832|NCT01701310|Adenocarcinoma|adenocarcinoma
291833|NCT01701310|Anemia|anemia
291834|NCT01701310|Blood Transfusion|blood transfusion
291835|NCT01701310|Colorectal surgery|colorectal surgery
291836|NCT01701310|Preoperative care|preoperative care
291837|NCT01701310|Perioperative care|perioperative care
291838|NCT01701310|Postoperative care|postoperative care
291839|NCT01701310|Iron|iron
291840|NCT01701310|Hematinics|hematinics
291841|NCT01701310|Hepcidin|hepcidin
291842|NCT01701310|Quality of life|quality of life
291843|NCT01701310|Postoperative complications|postoperative complications
291844|NCT01701297|Cirrhosis, ascites, infection|cirrhosis, ascites, infection
291845|NCT01701284|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
291846|NCT01701284|Cancer Survivors|cancer survivors
291847|NCT01701284|Depression|depression
291848|NCT01701284|Anxiety|anxiety
291849|NCT01701271|Baldness|baldness
291850|NCT01701271|Androgenetic Alopecia|androgenetic alopecia
291851|NCT01701271|Alopecia|alopecia
291852|NCT01701258|Depression|depression
291853|NCT01701258|Childhood Sexual Abuse|childhood sexual abuse
291854|NCT01701258|Dopamine|dopamine
291855|NCT01701258|MRI|mri
291856|NCT01701258|PET|pet
291857|NCT01701258|ERP|erp
291858|NCT01701258|Stress|stress
291859|NCT01701258|Reward|reward
291860|NCT01701258|Childhood trauma|childhood trauma
291861|NCT01701245|vagus nerve stimulation|vagus nerve stimulation
291862|NCT01701245|vagal nerve stimulation|vagal nerve stimulation
291863|NCT01701245|nVNS|nvns
291864|NCT01701245|VNS|vns
291865|NCT01701245|cluster headache|cluster headache
291866|NCT01701245|chronic|chronic
291867|NCT01701245|non invasive|non invasive
291868|NCT01701245|gammacore|gammacore
291869|NCT01701232|lymphoma, non-Hodgkin's|lymphoma, non-hodgkin's
291870|NCT01701219|Staphylococcus aureus bacteremia|staphylococcus aureus bacteremia
402020|NCT01233414|Pervasive Developmental Disorder|pervasive developmental disorder
291871|NCT01701219|Methicillin-resistant Staphylococcus aureus bacteremia|methicillin-resistant staphylococcus aureus bacteremia
291872|NCT01701219|MRSA bacteremia|mrsa bacteremia
291873|NCT01701219|Blood|blood
291874|NCT01701219|Adult|adult
291875|NCT01701219|Infections|infections
291876|NCT01701219|Blood Culture|blood culture
291877|NCT01701206|HIV|hiv
291878|NCT01701206|social networking|social networking
291879|NCT01701206|at-risk populations|at-risk populations
282468|NCT01742338|COPD|copd
291880|NCT01701206|sexual risk behaviors|sexual risk behaviors
291881|NCT01701180|Male Volunteers|male volunteers
291882|NCT01701154|Pompe respiratory|pompe respiratory
291883|NCT01701141|Positron Emission Tomography (PET)|positron emission tomography (pet)
291884|NCT01701141|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
291885|NCT01701141|reward|reward
291886|NCT01701141|stress|stress
291887|NCT01701141|learning|learning
291888|NCT01701141|Major Depressive Disorder|major depressive disorder
291889|NCT01701141|Anhedonia|anhedonia
291890|NCT01701128|Physical activity, treadmill training, rehabilitation|physical activity, treadmill training, rehabilitation
291891|NCT01701115|Interscalene Block|interscalene block
291892|NCT01701076|Relapsed / refractory multiple myeloma|relapsed / refractory multiple myeloma
291893|NCT01701076|2nd line treatment|2nd line treatment
291894|NCT01701050|circulating tumor cells|circulating tumor cells
291895|NCT01701050|CTC|ctc
291896|NCT01701050|metastatic breast cancer|metastatic breast cancer
291897|NCT01701050|endocrine therapy|endocrine therapy
291898|NCT01701050|hormone therapy|hormone therapy
291899|NCT01701037|Melanoma, B-RAF, biomarkers, targeted therapy, resistance|melanoma, b-raf, biomarkers, targeted therapy, resistance
291900|NCT01701024|Acne|acne
291901|NCT01701011|coping|coping
291902|NCT01701011|intervention|intervention
291903|NCT01701011|waiting-period|waiting-period
291904|NCT01700985|psoriasis|psoriasis
291905|NCT01700985|plaque psoriasis|plaque psoriasis
291906|NCT01700985|122-0551|122-0551
291907|NCT01700985|steroid|steroid
291908|NCT01700959|Melatonin|melatonin
291909|NCT01700959|Neurocognitive impairment|neurocognitive impairment
291910|NCT01700959|Sleep disturbance|sleep disturbance
291911|NCT01700959|Childhood cancer survivors|childhood cancer survivors
291912|NCT01700946|leukemia|leukemia
291913|NCT01700946|lymphoma|lymphoma
291914|NCT01700946|Non-Hodgkins|non-hodgkins
291915|NCT01700920|Osteonecrosis of the femoral head|osteonecrosis of the femoral head
291916|NCT01700920|Stem Cell|stem cell
291917|NCT01700920|Mesenchymal Stem Cells|mesenchymal stem cells
291918|NCT01700920|Femoral Head|femoral head
291919|NCT01700907|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
291920|NCT01700907|elderly patients|elderly patients
291921|NCT01700907|long surgery|long surgery
291922|NCT01700894|Physical Activity|physical activity
291923|NCT01700894|African American|african american
291924|NCT01700894|Adherence|adherence
291925|NCT01700881|Rheumatoid Arthritis, Diet, Fat-Restricted, Diet, Vegetarian|rheumatoid arthritis, diet, fat-restricted, diet, vegetarian
291926|NCT01700868|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
291927|NCT01700868|Diet, Vegetarian|diet, vegetarian
291928|NCT01700868|Diet, Fat-Restricted|diet, fat-restricted
291929|NCT01700868|Glycemic Index|glycemic index
291930|NCT01700855|Electroacupuncture|electroacupuncture
291931|NCT01700855|Analgesia|analgesia
291932|NCT01700855|Anesthesia|anesthesia
291933|NCT01700855|Nasal septoplasty|nasal septoplasty
291934|NCT01700855|Mammaplasty|mammaplasty
291935|NCT01700842|ceftaroline, infection, CAPB, CAP, ABSSSI, cSSTI|ceftaroline, infection, capb, cap, absssi, cssti
291936|NCT01700829|Ketamine|ketamine
291937|NCT01700829|Midazolam|midazolam
291938|NCT01700829|Major Depressive Disorder|major depressive disorder
291939|NCT01700829|Suicidal ideation|suicidal ideation
291940|NCT01700829|Suicide|suicide
291941|NCT01700829|Depression|depression
291942|NCT01700829|Treatment|treatment
291943|NCT01700829|Ketamine Treatment|ketamine treatment
291944|NCT01700816|Delirium|delirium
291945|NCT01700816|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
291946|NCT01700816|Bone marrow transplantation|bone marrow transplantation
291947|NCT01700816|Bright Light Therapy|bright light therapy
291948|NCT01700803|Betadine|betadine
291949|NCT01700803|Povidine Iodine|povidine iodine
291950|NCT01700803|Hand scrubbing|hand scrubbing
291951|NCT01700803|Cesarean section wound infections|cesarean section wound infections
291952|NCT01700803|post cesarean section|post cesarean section
291953|NCT01700790|HIV|hiv
291954|NCT01700790|AIDS|aids
291955|NCT01700790|Tuberculosis|tuberculosis
291957|NCT01700790|Lopinavir|lopinavir
291958|NCT01700790|Pharmacokinetic|pharmacokinetic
291959|NCT01700777|bimanual training|bimanual training
291960|NCT01700777|lower limb|lower limb
291961|NCT01700777|intensive rehabilitation|intensive rehabilitation
291962|NCT01700777|regular rehabilitation|regular rehabilitation
291963|NCT01700777|hemiplegia|hemiplegia
291964|NCT01699724|JZoloft|jzoloft
291965|NCT01699724|Sertraline hydrochloride|sertraline hydrochloride
291967|NCT01699724|bioequivalence|bioequivalence
291968|NCT01699711|APP function (amyloid precursor protein, cognitive stimulation, alzheimer disease. program|app function (amyloid precursor protein, cognitive stimulation, alzheimer disease. program
291969|NCT01699698|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
291970|NCT01700725|Gulf War Illness|gulf war illness
291971|NCT01700725|xylitol|xylitol
291972|NCT01700725|nasal irrigation|nasal irrigation
291973|NCT01700725|Desert Storm|desert storm
291974|NCT01700725|Persian Gulf Conflicts|persian gulf conflicts
291975|NCT01700725|neti pot|neti pot
291976|NCT01700725|cytokines|cytokines
291977|NCT01700725|nasal mucus|nasal mucus
291978|NCT01700725|inflammatory mediator|inflammatory mediator
291979|NCT01700725|lactoferrin|lactoferrin
291980|NCT01700725|lysozyme|lysozyme
291981|NCT01700712|Caries, probiotic bacteria|caries, probiotic bacteria
291982|NCT01700699|thyroid cancer|thyroid cancer
291983|NCT01700699|tyrosine kinase inhibitors|tyrosine kinase inhibitors
291984|NCT01700699|BRAF|braf
291985|NCT01700699|Sorafenib|sorafenib
291986|NCT01700699|Pazopanib|pazopanib
291987|NCT01700699|Sunitinib|sunitinib
291988|NCT01700699|Cabozantinib|cabozantinib
291989|NCT01700673|maintenance treatment|maintenance treatment
291990|NCT01700673|stem cell transplant|stem cell transplant
291991|NCT01700673|cytarabine-based chemotherapy|cytarabine-based chemotherapy
291992|NCT01700647|Larynx cancer|larynx cancer
291993|NCT01700647|Volatile organic compounds|volatile organic compounds
291994|NCT01700647|Diagnosis|diagnosis
291995|NCT01700647|Bronchoscopy|bronchoscopy
291996|NCT01700647|Cancer staging|cancer staging
291997|NCT01700634|fMRI, BOLD, pressure stimuli|fmri, bold, pressure stimuli
291998|NCT01700621|rotavirus|rotavirus
291999|NCT01700582|lung cancer|lung cancer
292000|NCT01700582|biomarkers|biomarkers
292001|NCT01700582|EGFR|egfr
292002|NCT01700582|KRAS|kras
292003|NCT01700582|ALK|alk
292004|NCT01700582|HER2|her2
292005|NCT01700582|PI3K|pi3k
292006|NCT01700582|BRAF|braf
292007|NCT01700569|high-grade|high-grade
292008|NCT01700569|glioma|glioma
292009|NCT01700569|epigenetic|epigenetic
292010|NCT01700556|Alzheimer Disease|alzheimer disease
292011|NCT01700556|Family Caregiver|family caregiver
292012|NCT01700556|Caregiver Burden|caregiver burden
292013|NCT01700556|Home Care Services|home care services
292014|NCT01700556|Assistive Technologies|assistive technologies
292015|NCT01700543|Stemless shoulder implant|stemless shoulder implant
292016|NCT01700543|Osteoarthritis|osteoarthritis
292017|NCT01700543|Rheumatoid Arthritis|rheumatoid arthritis
292018|NCT01700543|Hemi Shoulder Arthroplasty|hemi shoulder arthroplasty
292019|NCT01700543|Total Shoulder Arthroplasty|total shoulder arthroplasty
292020|NCT01700543|Prospective|prospective
292021|NCT01700543|Multi-center|multi-center
292022|NCT01700543|Europe|europe
292023|NCT01700543|Non-Controlled|non-controlled
292024|NCT01700543|Good Bone Stock|good bone stock
292025|NCT01700530|mitochondria|mitochondria
292026|NCT01700530|fitness|fitness
292027|NCT01700530|statins|statins
292028|NCT01700530|cholesterol|cholesterol
292029|NCT01700530|metabolic syndrome|metabolic syndrome
292030|NCT01700517|total knee arthroplasty, analgesia, ultrasonography|total knee arthroplasty, analgesia, ultrasonography
292031|NCT01700504|Axillary drainage volume|axillary drainage volume
292032|NCT01700504|Lavage with gentamicin solution|lavage with gentamicin solution
292033|NCT01700491|Paravertebral Catheter|paravertebral catheter
292034|NCT01700491|Epidural Catheter|epidural catheter
292035|NCT01700491|Analgesia|analgesia
292036|NCT01700491|Hypotension|hypotension
292037|NCT01700491|Analgesia,Epidural|analgesia,epidural
292038|NCT01700491|Analgesia,Paravertebral|analgesia,paravertebral
292039|NCT01700478|Myomectomy|myomectomy
292040|NCT01700465|Hemodialysis|hemodialysis
292041|NCT01700465|Hemodynamics|hemodynamics
292042|NCT01700452|Lung cancer|lung cancer
292043|NCT01700452|Pulmonary nodules|pulmonary nodules
292044|NCT01700452|FISH Test|fish test
292045|NCT01700439|Aortic valve|aortic valve
292046|NCT01700439|Heart valve|heart valve
292047|NCT01700439|Tissue valve|tissue valve
292048|NCT01700439|Bioprosthesis|bioprosthesis
292049|NCT01700439|Valve disorder|valve disorder
292050|NCT01700439|Valve disease|valve disease
292051|NCT01700439|Cardiac surgery|cardiac surgery
292052|NCT01700439|Less invasive cardiac surgery|less invasive cardiac surgery
292053|NCT01700439|Aortic valve stenosis|aortic valve stenosis
292054|NCT01700439|Aortic valve regurgitation|aortic valve regurgitation
292055|NCT01700439|Bovine pericardium|bovine pericardium
292056|NCT01700426|Iron Deficiency|iron deficiency
292057|NCT01700426|Iron Deficiency Anemia|iron deficiency anemia
292058|NCT01700413|acute|acute
292059|NCT01700413|myeloid|myeloid
292060|NCT01700413|leukemia|leukemia
292061|NCT01700413|CETLAM|cetlam
292062|NCT01700413|Idarubicin|idarubicin
292063|NCT01700400|Lung Cancer|lung cancer
292064|NCT01700400|Non Small Cell Lung Cancer|non small cell lung cancer
292065|NCT01700400|Advanced Lung Cancer|advanced lung cancer
292066|NCT01700387|Migraine|migraine
292067|NCT01700387|Chronic Migraine|chronic migraine
292068|NCT01700387|Cognitive Efficiency|cognitive efficiency
292069|NCT01700387|Pilot Study|pilot study
292070|NCT01700387|Long Term Effect|long term effect
292071|NCT01700374|pregnancy|pregnancy
292072|NCT01700374|stress, psychological|stress, psychological
292073|NCT01700374|stress, physiological|stress, physiological
292074|NCT01700374|maternal-fetal relations|maternal-fetal relations
292075|NCT01700361|sexual arousal|sexual arousal
292076|NCT01700361|pelvic floor sEMG|pelvic floor semg
292077|NCT01700348|moderate gingivitis|moderate gingivitis
292078|NCT01700322|Coronary artery disease|coronary artery disease
292079|NCT01700322|coronary stenting|coronary stenting
292080|NCT01700322|platelet aggregation|platelet aggregation
292081|NCT01700309|Obesity prevention; Adolescent; Physical activity; Health counselling|obesity prevention; adolescent; physical activity; health counselling
292082|NCT01700283|Colorectal Cancer、Fatigue、Muscle strength、Metabolomics|colorectal cancer、fatigue、muscle strength、metabolomics
292083|NCT01700257|Lung cancer screening|lung cancer screening
292084|NCT01700257|Smokers or former smokers|smokers or former smokers
292085|NCT01700257|Family history of lung cancer|family history of lung cancer
292086|NCT01700231|hepatorenal syndrome, liver regeneration, liver dysfunction|hepatorenal syndrome, liver regeneration, liver dysfunction
292087|NCT01700218|telemonitoring|telemonitoring
292088|NCT01700205|Formula Feeding|formula feeding
292089|NCT01700205|Mother|mother
292090|NCT01700205|Moms|moms
292091|NCT01700205|Infants|infants
292092|NCT01700205|Babies|babies
292093|NCT01700205|Baby|baby
292094|NCT01700205|growth|growth
292095|NCT01700205|energy balance|energy balance
292096|NCT01700166|Autologous|autologous
292097|NCT01700166|Cord Blood|cord blood
292098|NCT01700166|Stem Cells|stem cells
292099|NCT01700166|Pediatric stroke|pediatric stroke
292100|NCT01700166|Children with ischemic stroke|children with ischemic stroke
292101|NCT01700166|Cerebral Palsy|cerebral palsy
292102|NCT01700166|Perinatal AIS|perinatal ais
292103|NCT01700153|Robotic-assisted therapy|robotic-assisted therapy
292104|NCT01700153|cerebral palsy|cerebral palsy
292105|NCT01700153|ICF|icf
292106|NCT01700127|immune response|immune response
292107|NCT01700127|infants|infants
292108|NCT01700127|rotavirus vaccine|rotavirus vaccine
292109|NCT01700114|Pigmented Skin Lesions|pigmented skin lesions
292110|NCT01700114|Dermatology|dermatology
292111|NCT01700114|Skin Cancer|skin cancer
292112|NCT01700114|Melanoma|melanoma
292113|NCT01700114|MelaFind|melafind
292114|NCT01700088|hypoxemia|hypoxemia
292115|NCT01700088|Post Pulmonary Resection|post pulmonary resection
292116|NCT01700075|atherosclerosis, development of concept, weight loss therapy|atherosclerosis, development of concept, weight loss therapy
292117|NCT01700062|medium-calorie|medium-calorie
292118|NCT01700062|standard calorie|standard calorie
292119|NCT01700062|parenteral nutrition|parenteral nutrition
292120|NCT01700049|advanced BCC|advanced bcc
292121|NCT01700049|high risk|high risk
292122|NCT01700049|locally advanced|locally advanced
292123|NCT01700023|acute heart failure|acute heart failure
292124|NCT01700010|Urothelial|urothelial
292125|NCT01700010|Bladder|bladder
292127|NCT01699997|Schizophrenia|schizophrenia
292128|NCT01699997|Oxytocin|oxytocin
292129|NCT01699997|RCT|rct
292130|NCT01699984|Cognitive impairment.|cognitive impairment.
292131|NCT01699984|Geriatrics.|geriatrics.
292132|NCT01699984|Hospital admission.|hospital admission.
292133|NCT01699984|Hospital discharge.|hospital discharge.
292134|NCT01699958|Problem solving therapy|problem solving therapy
292135|NCT01699958|Behavior change|behavior change
292136|NCT01699945|Verbal autopsies|verbal autopsies
292137|NCT01699945|Maternal deaths|maternal deaths
292138|NCT01699945|Still births|still births
292139|NCT01699919|perioperative lignocaine infusion|perioperative lignocaine infusion
292140|NCT01699919|elective open abdominal surgeries|elective open abdominal surgeries
292141|NCT01699919|postoperative pain|postoperative pain
292142|NCT01699906|Obesity|obesity
292143|NCT01699880|tracheal intubation|tracheal intubation
292144|NCT01699880|preoxygenation|preoxygenation
292145|NCT01699880|desaturation|desaturation
292146|NCT01699880|hypoxemia|hypoxemia
292147|NCT01699880|oxygen therapy|oxygen therapy
292148|NCT01699880|high flow nasal cannula oxygen therapy|high flow nasal cannula oxygen therapy
292149|NCT01699867|lumpectomy|lumpectomy
292150|NCT01699867|breast cancer|breast cancer
292151|NCT01699867|optical coherence tomography|optical coherence tomography
292152|NCT01699867|tumor margin|tumor margin
292153|NCT01699867|imaging|imaging
292154|NCT01699828|buspirone|buspirone
292155|NCT01699828|smoking cessation|smoking cessation
292156|NCT01699828|dopamine|dopamine
292157|NCT01699828|PET imaging|pet imaging
292158|NCT01699828|[11C]-(+)-PHNO|[11c]-(+)-phno
292159|NCT01699815|acetaminophen|acetaminophen
292160|NCT01699815|timing|timing
292161|NCT01699815|arthroplasty|arthroplasty
292162|NCT01699789|Community Partnered Participatory Research|community partnered participatory research
292163|NCT01699789|Community Engagement|community engagement
292164|NCT01699789|Implementation|implementation
292165|NCT01699789|Community Based Participatory Research|community based participatory research
292166|NCT01699789|Quality Improvement|quality improvement
292167|NCT01699789|Evidence Based Practice|evidence based practice
292168|NCT01699789|Patient Centered Outcomes Research|patient centered outcomes research
292169|NCT01699776|Digoxin|digoxin
292170|NCT01699776|Ivabradine|ivabradine
292171|NCT01699776|with atrial fibrillation.|with atrial fibrillation.
282762|NCT01740960|THC|thc
292172|NCT01699750|contact lenses|contact lenses
292173|NCT01699750|contact lens solution|contact lens solution
292174|NCT01699750|myopia|myopia
292175|NCT01699750|astigmatism|astigmatism
292176|NCT01699737|Diabetes|diabetes
292177|NCT01699685|Moderate to severe COPD patients are included|moderate to severe copd patients are included
292178|NCT01699685|NVA|nva
292179|NCT01699685|QAB|qab
292180|NCT01699672|Patient education|patient education
292181|NCT01699672|information|information
292182|NCT01699672|communication|communication
292183|NCT01699659|Allergic Rhinitis|allergic rhinitis
292184|NCT01699659|Allergen Immunotherapy|allergen immunotherapy
292185|NCT01699646|Intrapartum fetal surveillance|intrapartum fetal surveillance
292186|NCT01699646|CTG|ctg
292187|NCT01699646|cardiotocography|cardiotocography
292188|NCT01699646|STAN|stan
292189|NCT01699646|ST-Analysis|st-analysis
292190|NCT01699646|metabolic acidosis in umbilical artery|metabolic acidosis in umbilical artery
292191|NCT01699646|operative delivery|operative delivery
292192|NCT01699633|Drug-drug interactions|drug-drug interactions
292193|NCT01699633|Drug-gene interactions|drug-gene interactions
292194|NCT01699633|Nevirapine|nevirapine
292195|NCT01699633|Rifampicin|rifampicin
292196|NCT01699633|children|children
292197|NCT01699620|Bone anchored hearing aid|bone anchored hearing aid
292198|NCT01699620|Soft tissue healing|soft tissue healing
292199|NCT01699620|Implant stability|implant stability
292200|NCT01699620|Linear incision|linear incision
292201|NCT01699620|Dermatome technique|dermatome technique
292202|NCT01699620|Hearing Aids|hearing aids
292203|NCT01699620|Implants, Artificial|implants, artificial
292204|NCT01699620|Surgical Procedures, Operative|surgical procedures, operative
292205|NCT01699607|Cigarette Smokers|cigarette smokers
292206|NCT01699607|Healthy Non Smokers|healthy non smokers
292207|NCT01699607|Amphetamine|amphetamine
292208|NCT01699607|PET|pet
292209|NCT01699607|Controls|controls
292210|NCT01699594|asthma|asthma
292211|NCT01699594|allergies|allergies
292212|NCT01699594|mannitol|mannitol
292213|NCT01699594|methacholine|methacholine
292214|NCT01699581|Hodgkin's Lymphoma|hodgkin's lymphoma
292215|NCT01699581|Multiple Myeloma|multiple myeloma
292216|NCT01699581|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
292217|NCT01699568|dental implant stability|dental implant stability
292218|NCT01699568|dental implant surface treatment|dental implant surface treatment
292219|NCT01699568|resonance frequence analysis|resonance frequence analysis
292220|NCT01699555|Multiple sclerosis|multiple sclerosis
292221|NCT01699555|GNbAC1|gnbac1
292222|NCT01699555|Monoclonal antibody|monoclonal antibody
292223|NCT01699555|Multiple Sclerosis Associated Retrovirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
292319|NCT01699165|allergic|allergic
292224|NCT01699542|Refractory Anastomotic esophageal strictures|refractory anastomotic esophageal strictures
292225|NCT01699516|allogeneic transplantation; intestinal graft-vs.-host disease; contrast enhanced ultrasound sonography|allogeneic transplantation; intestinal graft-vs.-host disease; contrast enhanced ultrasound sonography
292226|NCT01699503|Dementia|dementia
292227|NCT01699503|Alzheimer's Disease|alzheimer's disease
292228|NCT01699503|Mild Cognitive Impairment|mild cognitive impairment
292229|NCT01699503|Screening|screening
292230|NCT01699490|Major Depressive Disorder|major depressive disorder
292231|NCT01699490|Antidepressants|antidepressants
292232|NCT01699490|Insulin|insulin
292233|NCT01699490|Fluoxetine|fluoxetine
292235|NCT01699477|focused ultrasound|focused ultrasound
292236|NCT01699477|functional brain disorders|functional brain disorders
292237|NCT01699477|neuropathic pain|neuropathic pain
292238|NCT01699477|movement disorders|movement disorders
292239|NCT01699464|Glaucoma|glaucoma
292240|NCT01699438|Irritable Bowel Syndrome|irritable bowel syndrome
292241|NCT01699438|Inflammation|inflammation
292242|NCT01699438|Mesalazine|mesalazine
292243|NCT01699425|Stress urinary incontinence.|stress urinary incontinence.
292244|NCT01699425|Suburethral sling.|suburethral sling.
292245|NCT01699425|Single-incision suburethral sling.|single-incision suburethral sling.
292246|NCT01699425|Ajust.|ajust.
292247|NCT01699425|Transobturator tape.|transobturator tape.
292248|NCT01699412|Bone Marrow Transplantation|bone marrow transplantation
292249|NCT01699412|Graft vs Host Disease|graft vs host disease
292250|NCT01699412|Oral Manifestations|oral manifestations
292251|NCT01699399|colonoscopy|colonoscopy
292252|NCT01699399|pain|pain
292253|NCT01699399|sedation|sedation
292254|NCT01699399|water|water
292255|NCT01699360|Kidney Transplantation|kidney transplantation
292256|NCT01699360|Immunosuppressive Agents|immunosuppressive agents
292261|NCT01699334|patient education|patient education
292262|NCT01699334|illness perceptions|illness perceptions
292263|NCT01699334|RCT|rct
292264|NCT01699334|motor vehicle accidents|motor vehicle accidents
292265|NCT01699321|physical activity|physical activity
292266|NCT01699321|barbershop|barbershop
292267|NCT01699321|cancer prevention|cancer prevention
292268|NCT01699321|exercise|exercise
292269|NCT01699321|men's health|men's health
292270|NCT01699321|African American men|african american men
292271|NCT01699308|Traumatic Brain Injury|traumatic brain injury
292272|NCT01699308|Growth Hormone|growth hormone
292273|NCT01699308|Neuroimaging|neuroimaging
292274|NCT01699295|academic achievement|academic achievement
292275|NCT01699295|elementary school|elementary school
292276|NCT01699295|physical activity|physical activity
292277|NCT01699295|exercise|exercise
292278|NCT01699282|oral anticoagulant|oral anticoagulant
292279|NCT01699282|in the long term (> 12 months)|in the long term (> 12 months)
292280|NCT01699269|High grade brain tumor|high grade brain tumor
292282|NCT01699269|Glioblastoma Multiform|glioblastoma multiform
292283|NCT01699269|Brain Cancer|brain cancer
292284|NCT01699269|Diffusion-Weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
292285|NCT01699269|High order diffusion tensor|high order diffusion tensor
292286|NCT01699269|Imaging guided biopsy|imaging guided biopsy
292287|NCT01699269|Histopathologic evaluation|histopathologic evaluation
292288|NCT01699269|Infiltration percentage|infiltration percentage
292289|NCT01699256|General Practice|general practice
292290|NCT01699256|Low Back Pain|low back pain
292291|NCT01699256|Guideline|guideline
292292|NCT01699256|Health Plan Implementation|health plan implementation
292293|NCT01699256|Referral and Consultation|referral and consultation
292294|NCT01699243|pregnancy|pregnancy
292295|NCT01699243|labor|labor
292296|NCT01699243|epidural|epidural
292297|NCT01699243|fetal intervention|fetal intervention
292298|NCT01699230|Elective cardiac surgery|elective cardiac surgery
292299|NCT01699230|with sternotomy and|with sternotomy and
292300|NCT01699230|cardiopulmonary bypass|cardiopulmonary bypass
292301|NCT01699230|for coronary artery|for coronary artery
292302|NCT01699230|bypass graft.|bypass graft.
292306|NCT01699204|Air pollution|air pollution
292307|NCT01699204|Diesel exhaust|diesel exhaust
292308|NCT01699204|Airway responsiveness|airway responsiveness
292309|NCT01699204|Asthma|asthma
292310|NCT01699204|Anti-oxidant|anti-oxidant
292311|NCT01699191|Irritable Bowel Syndrome|irritable bowel syndrome
292312|NCT01699191|Celiac Desease|celiac desease
292313|NCT01699191|Probiotic|probiotic
292314|NCT01699191|Lactobacillus plantarum|lactobacillus plantarum
292315|NCT01699191|Bifidobacterium breve|bifidobacterium breve
292316|NCT01699191|Lactobacillus casei|lactobacillus casei
292317|NCT01699191|Bifidobacterium animalis|bifidobacterium animalis
292318|NCT01699165|rhinitis|rhinitis
292320|NCT01699165|seasonal|seasonal
292321|NCT01699165|double blind|double blind
292322|NCT01699165|doubleblind|doubleblind
292323|NCT01699165|randomized|randomized
292324|NCT01699165|randomised|randomised
292325|NCT01699165|placebo|placebo
292326|NCT01699165|crossover|crossover
292327|NCT01699165|clinical|clinical
292328|NCT01699165|nasal|nasal
292329|NCT01699165|filter|filter
292330|NCT01699165|controlled|controlled
292331|NCT01699165|trial|trial
292332|NCT01699165|hayfever|hayfever
292333|NCT01699165|hay|hay
292334|NCT01699165|fever|fever
292335|NCT01699165|efficacy|efficacy
292336|NCT01699165|safety|safety
292337|NCT01699165|prevention|prevention
292338|NCT01699165|adult|adult
292339|NCT01699165|grass|grass
292340|NCT01699165|pollen|pollen
292341|NCT01699165|symptom|symptom
292342|NCT01699165|Total nasal symptom score|total nasal symptom score
292343|NCT01699165|acoustic rhinometry|acoustic rhinometry
292344|NCT01699152|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
292345|NCT01699152|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
292346|NCT01699139|supine position|supine position
292347|NCT01699126|Obstructive Sleep Apnea|obstructive sleep apnea
292348|NCT01699126|CPAP|cpap
292349|NCT01699126|Endothelium dysfunction|endothelium dysfunction
292350|NCT01699126|Hypertension|hypertension
292351|NCT01699113|YF476|yf476
292352|NCT01699113|gastrin receptor antagonist|gastrin receptor antagonist
292353|NCT01699113|gastric pH|gastric ph
292354|NCT01699113|gastrin|gastrin
292355|NCT01699113|rabeprazole|rabeprazole
292356|NCT01699113|proton-pump inhibitor|proton-pump inhibitor
292357|NCT01699113|gastric function|gastric function
292358|NCT01699113|healthy subjects|healthy subjects
292359|NCT01699100|offloading|offloading
292360|NCT01699100|plantar pressure|plantar pressure
292361|NCT01699100|insole|insole
292362|NCT01699100|foot ulcer|foot ulcer
292363|NCT01699087|PRK|prk
292364|NCT01699087|myopia|myopia
292365|NCT01699087|astigmatism|astigmatism
292366|NCT01699074|Korean White Ginseng|korean white ginseng
292367|NCT01699074|Type 2 diabetes|type 2 diabetes
292368|NCT01699074|Metabolic syndrome|metabolic syndrome
292369|NCT01699048|multivessel PCI,MIDCAB,CABG|multivessel pci,midcab,cabg
292370|NCT01699048|Hybrid coronary revascularization|hybrid coronary revascularization
292371|NCT01699035|stroke|stroke
292372|NCT01699035|work|work
292373|NCT01699035|vocational rehabilitation|vocational rehabilitation
292374|NCT01699022|Contraceptive|contraceptive
292375|NCT01699022|Injectable|injectable
292376|NCT01699009|Migraines, diet, vegan, vegetarian, plant-based|migraines, diet, vegan, vegetarian, plant-based
292377|NCT01698996|abscess|abscess
292378|NCT01698996|packing|packing
292379|NCT01698996|emergency medicine|emergency medicine
292380|NCT01698996|wound care|wound care
292381|NCT01698996|incision and drainage|incision and drainage
292382|NCT01698970|Probiotic|probiotic
292383|NCT01698970|capsules|capsules
292384|NCT01698970|Crohn's disease|crohn's disease
292385|NCT01698970|recurrent endoscopic ileo-colonic lesions|recurrent endoscopic ileo-colonic lesions
292386|NCT01698957|Pregnant women|pregnant women
292387|NCT01698957|Uterine Artery Doppler Velocimetry|uterine artery doppler velocimetry
292388|NCT01698918|metastatic breast cancer, locally advanced breast cancer, HER2-, ER+, everolimus, Afinitor|metastatic breast cancer, locally advanced breast cancer, her2-, er+, everolimus, afinitor
292389|NCT01698905|Phase II, single arm, open label, nilotinib, treatment-free remission, MR4.5, confirmed loss of MR4, loss of MMR, Ph+ CML-CP|phase ii, single arm, open label, nilotinib, treatment-free remission, mr4.5, confirmed loss of mr4, loss of mmr, ph+ cml-cp
292390|NCT01698892|I.V. sedation, midazolam, bronchoscopy|i.v. sedation, midazolam, bronchoscopy
292391|NCT01698866|Low grade lymphoma|low grade lymphoma
292392|NCT01698866|follicular lymphoma|follicular lymphoma
292393|NCT01698866|indolent lymphoproliferative disorders|indolent lymphoproliferative disorders
292394|NCT01698866|Vaccin GenHevac B Pasteur|vaccin genhevac b pasteur
292395|NCT01698840|Vitamin D|vitamin d
292396|NCT01698840|Transitional Formula|transitional formula
292397|NCT01698827|gastrostomy|gastrostomy
292399|NCT01698827|endoscopic|endoscopic
292400|NCT01698827|replacement|replacement
292401|NCT01698827|tube rupture|tube rupture
292402|NCT01698827|durability|durability
292403|NCT01698827|tube loss|tube loss
292404|NCT01698827|balloon rupture|balloon rupture
292405|NCT01698814|ocular safety|ocular safety
292406|NCT01698814|allergic conjunctivitis|allergic conjunctivitis
292407|NCT01698801|Lenalidomide|lenalidomide
292408|NCT01698801|dexamethasone|dexamethasone
292409|NCT01698801|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
292410|NCT01698788|diabetic macular edema|diabetic macular edema
292411|NCT01698788|taut posterior hyaloid membrane|taut posterior hyaloid membrane
292412|NCT01698788|ozurdex|ozurdex
292413|NCT01698762|Musculoskeletal Diseases|musculoskeletal diseases
292414|NCT01698762|Osteoarthritis|osteoarthritis
292415|NCT01698762|OA|oa
292416|NCT01698762|Rheumatoid Arthritis|rheumatoid arthritis
292418|NCT01698762|Osteoporosis|osteoporosis
292419|NCT01698762|OP|op
292420|NCT01698762|Multimedia Patient Decision Aids|multimedia patient decision aids
292421|NCT01698762|MM-PtDAs|mm-ptdas
292422|NCT01698762|DVD|dvd
292423|NCT01698762|Comparative Effectiveness Research Summary Guide|comparative effectiveness research summary guide
292424|NCT01698762|CERSG|cersg
292425|NCT01698762|Booklet|booklet
292426|NCT01698762|Questionnaires|questionnaires
292427|NCT01698762|Surveys|surveys
292428|NCT01698749|Ozurdex|ozurdex
292429|NCT01698749|Diabetic macular edema|diabetic macular edema
292430|NCT01698749|Central macular thickness|central macular thickness
292431|NCT01698736|ABO isoagglutinins|abo isoagglutinins
292432|NCT01698736|ABO incompatible transplantation|abo incompatible transplantation
292433|NCT01698736|immunoadsorption|immunoadsorption
292434|NCT01698736|membrane filtration|membrane filtration
292435|NCT01698736|plasmapheresis|plasmapheresis
292436|NCT01698723|ACLF|aclf
292437|NCT01698723|HEV|hev
292438|NCT01698723|Ribavirin|ribavirin
292439|NCT01698710|Premalignant|premalignant
292440|NCT01698710|Malignant|malignant
292441|NCT01698684|ED|ed
292442|NCT01698645|quality of life|quality of life
292443|NCT01698645|PecFent|pecfent
292444|NCT01698645|Lazanda|lazanda
292445|NCT01698645|fentanyl|fentanyl
292446|NCT01698645|intranasal|intranasal
292447|NCT01698645|breakthrough cancer pain|breakthrough cancer pain
292448|NCT01698632|Adnexal masses|adnexal masses
292449|NCT01698632|Ovarian cysts|ovarian cysts
292450|NCT01698632|Ovarian tumors|ovarian tumors
292451|NCT01698606|childhood obesity|childhood obesity
292452|NCT01698606|multidisciplinary|multidisciplinary
292453|NCT01698606|preschool children|preschool children
292454|NCT01698606|community-based|community-based
292455|NCT01698606|lifestyle intervention|lifestyle intervention
292456|NCT01698606|family-centered|family-centered
292457|NCT01698593|Bupivacaine|bupivacaine
292458|NCT01698593|digital nerve block|digital nerve block
292459|NCT01698593|epinephrine|epinephrine
292460|NCT01698593|duration of action|duration of action
292461|NCT01698593|pain|pain
292462|NCT01698593|touch|touch
292463|NCT01698593|pressure|pressure
292464|NCT01698593|temperature|temperature
292465|NCT01698580|accidental falls|accidental falls
292466|NCT01698580|aged|aged
292467|NCT01698580|aged, 80 and over|aged, 80 and over
292468|NCT01698580|prevention and control|prevention and control
292469|NCT01698567|Infants|infants
292470|NCT01698567|Cardiopulmonary bypass|cardiopulmonary bypass
292471|NCT01698567|anticoaglution|anticoaglution
292472|NCT01698541|Renal|renal
292473|NCT01698541|Transplantation|transplantation
292474|NCT01698541|Elderly|elderly
292475|NCT01698528|Diabetes|diabetes
292476|NCT01698528|diabetes technologies|diabetes technologies
292477|NCT01698528|telemedicine|telemedicine
292478|NCT01698502|Incretin|incretin
292479|NCT01698502|Training|training
292480|NCT01698502|Glucagon like peptide|glucagon like peptide
292481|NCT01698502|glucose dependent insulinotropic peptide|glucose dependent insulinotropic peptide
292482|NCT01698502|Gut|gut
292483|NCT01698502|Exercise|exercise
292484|NCT01698502|Insulin|insulin
292485|NCT01698502|Focus:|focus:
292486|NCT01698502|Gut hormone|gut hormone
292487|NCT01698502|adaptations|adaptations
292488|NCT01698476|pulmonary TB|pulmonary tb
292489|NCT01698476|cholecalciferol|cholecalciferol
292490|NCT01698476|sodium phenylbutyrate|sodium phenylbutyrate
292491|NCT01698476|antimicrobial peptides|antimicrobial peptides
292492|NCT01698476|immune response|immune response
292493|NCT01698463|Falls, Fractures, Osteoporosis, Frailty, Older Adults.|falls, fractures, osteoporosis, frailty, older adults.
292495|NCT01698450|focused ultrasound|focused ultrasound
292496|NCT01698450|functional brain disorder|functional brain disorder
292497|NCT01698450|neuropathic pain|neuropathic pain
292498|NCT01698450|movement disorders|movement disorders
292499|NCT01698450|malignant brain tumors|malignant brain tumors
292500|NCT01698437|FUS|fus
292501|NCT01698437|focused ultrasound|focused ultrasound
292502|NCT01698437|functional brain disorders|functional brain disorders
292503|NCT01698437|neuropathic pain|neuropathic pain
292504|NCT01698437|movement disorders|movement disorders
292505|NCT01698437|malignant of brain tumors|malignant of brain tumors
292506|NCT01698411|hypertension|hypertension
292507|NCT01698411|sleep|sleep
292508|NCT01698411|insomnia|insomnia
292509|NCT01698372|Cardiac surgery.|cardiac surgery.
292510|NCT01698372|Wound healing.|wound healing.
292511|NCT01698372|Leg wound infection.|leg wound infection.
292512|NCT01698372|Wound care.|wound care.
292513|NCT01698346|Pertussis|pertussis
292514|NCT01698346|Infants|infants
292515|NCT01698346|Vaccination|vaccination
292516|NCT01698346|Pregnancy|pregnancy
292517|NCT01698333|122-0551|122-0551
292518|NCT01698333|steroid|steroid
292519|NCT01698333|HPA|hpa
292520|NCT01698307|Crohn's Disease|crohn's disease
292521|NCT01698307|Deep Remission|deep remission
292522|NCT01698307|Complications|complications
292523|NCT01698294|gut microbiome|gut microbiome
292524|NCT01698294|hormones|hormones
292525|NCT01698294|women|women
292526|NCT01698294|race|race
292527|NCT01698294|phytoestrogens|phytoestrogens
292528|NCT01698255|Depression|depression
292529|NCT01698255|Geriatrics|geriatrics
292530|NCT01698242|Heart failure|heart failure
292531|NCT01698242|Self-Management|self-management
292532|NCT01698242|Behavioral Clinical Trial|behavioral clinical trial
292533|NCT01698229|Cerebrospinal fluid|cerebrospinal fluid
292534|NCT01698229|Lumbar puncture|lumbar puncture
292535|NCT01698229|Spinal tap|spinal tap
292536|NCT01698229|Late infantile neuronal ceroid lipofuscinosis|late infantile neuronal ceroid lipofuscinosis
292537|NCT01698229|Batten disease|batten disease
292538|NCT01698216|Paliperidone|paliperidone
292539|NCT01698216|Palmitate|palmitate
292540|NCT01698216|switching|switching
292541|NCT01698216|schizophrenia|schizophrenia
292542|NCT01698216|subjective well-being|subjective well-being
292543|NCT01698177|Influenza|influenza
292545|NCT01698177|Vaccination|vaccination
292546|NCT01698177|Immune response to influenza vaccination|immune response to influenza vaccination
292547|NCT01698164|lipid profiles|lipid profiles
292548|NCT01698164|coronary heart disease|coronary heart disease
292549|NCT01698164|menopausal syndrome|menopausal syndrome
292550|NCT01698164|MMSE|mmse
292551|NCT01698164|MENQOL|menqol
292552|NCT01698164|HAD|had
292553|NCT01698151|Chronic obstructive Pulmonary Disease|chronic obstructive pulmonary disease
292554|NCT01698151|COPD|copd
292555|NCT01698138|Spinal cord injury|spinal cord injury
292556|NCT01698138|Neurogenic overactive bladder|neurogenic overactive bladder
292557|NCT01698138|Onabotulinum toxin A|onabotulinum toxin a
292558|NCT01698138|Prevention|prevention
292559|NCT01698138|Botulinum Toxins, Type A|botulinum toxins, type a
292560|NCT01698125|Delirium|delirium
292561|NCT01698125|Autonomic cardiovascular control|autonomic cardiovascular control
292562|NCT01698125|Abdominal surgery|abdominal surgery
292563|NCT01698125|Tilt-test|tilt-test
292564|NCT01698086|Multiple Sclerosis|multiple sclerosis
292565|NCT01698086|Balance|balance
292566|NCT01698086|Fatigue|fatigue
292567|NCT01698086|Eye movement|eye movement
292568|NCT01698073|Teen pregnancy prevention|teen pregnancy prevention
292569|NCT01698073|American Indian|american indian
292570|NCT01698073|Group-randomized trial|group-randomized trial
292571|NCT01698060|Prevention of Avian Influenza|prevention of avian influenza
292572|NCT01698047|Depressive symptoms|depressive symptoms
292573|NCT01698047|sub-threshold depression|sub-threshold depression
292574|NCT01698047|resiliency|resiliency
292575|NCT01698047|Health Promotion|health promotion
292576|NCT01698047|minority health|minority health
292577|NCT01698034|volunteering|volunteering
292578|NCT01698034|cardiovascular health|cardiovascular health
292579|NCT01698021|Creatine Kinase, MB form|creatine kinase, mb form
292580|NCT01698021|Troponin|troponin
292581|NCT01698021|Acute coronary syndrome|acute coronary syndrome
292582|NCT01698021|myocardial infarction|myocardial infarction
292583|NCT01698021|Unstable angina|unstable angina
292584|NCT01697995|right ventricle|right ventricle
292585|NCT01697995|radiotracer uptake|radiotracer uptake
292586|NCT01697995|Myocardial Perfusion Imaging|myocardial perfusion imaging
292234|NCT01699477|FUS|fus
292587|NCT01697995|balanced ischemia|balanced ischemia
292588|NCT01697982|pilot study|pilot study
292589|NCT01697982|psychosocial intervention|psychosocial intervention
292590|NCT01697982|advanced cancer|advanced cancer
292591|NCT01697969|allergic conjunctivitis|allergic conjunctivitis
292592|NCT01697969|Pataday|pataday
292593|NCT01697969|Olopatadine|olopatadine
292594|NCT01697956|Pediatric Subjects|pediatric subjects
292595|NCT01697943|Gastric Malignant Tumor|gastric malignant tumor
292596|NCT01697943|Total Gastrectomy|total gastrectomy
292597|NCT01697943|Reconstruction|reconstruction
292598|NCT01697930|PET Imaging|pet imaging
292599|NCT01697930|18F] 4-L-Fluoroglutam (2S,4R)|18f] 4-l-fluoroglutam (2s,4r)
292600|NCT01697930|12-168|12-168
292601|NCT01697917|Adenocarcinoma of Esophagogastric Junction|adenocarcinoma of esophagogastric junction
292602|NCT01697917|Total Gastrectomy|total gastrectomy
292603|NCT01697917|Proximal Gastrectomy|proximal gastrectomy
292604|NCT01697891|Radiation Treatment|radiation treatment
292605|NCT01697891|Head and Neck Cancer|head and neck cancer
292606|NCT01697891|Dysphagia|dysphagia
292607|NCT01697878|obstructive sleep apnea|obstructive sleep apnea
292608|NCT01697878|obesity|obesity
292609|NCT01697878|respiratory function|respiratory function
292610|NCT01697878|weight loss surgery|weight loss surgery
292611|NCT01697865|Reverse total shoulder|reverse total shoulder
292612|NCT01697852|vector control|vector control
292613|NCT01697852|LLIN|llin
292614|NCT01697852|IRS|irs
292615|NCT01697826|Clindamycin|clindamycin
292616|NCT01697826|Clotrimazole|clotrimazole
292617|NCT01697826|Vaginal formulation|vaginal formulation
292618|NCT01697826|Bacterial vaginosis|bacterial vaginosis
292619|NCT01697826|Candidiasis|candidiasis
292620|NCT01697826|Trichomoniasis|trichomoniasis
292621|NCT01697826|Mixed vaginitis|mixed vaginitis
292622|NCT01697826|Infective vaginitis|infective vaginitis
292623|NCT01697787|Treatment, diagnosis|treatment, diagnosis
292624|NCT01697761|Crohn's disease,acupuncture,moxibustion,inflammation factors|crohn's disease,acupuncture,moxibustion,inflammation factors
292625|NCT01697722|Primary care|primary care
292626|NCT01697722|Asthma management|asthma management
292627|NCT01697722|Inhaled corticosteroids|inhaled corticosteroids
292628|NCT01697722|Extra-fine hydrofluoroalkane|extra-fine hydrofluoroalkane
292629|NCT01697722|Long-acting beta-agonist|long-acting beta-agonist
292630|NCT01697722|Fixed-dose combination therapy|fixed-dose combination therapy
292631|NCT01697709|cannabis|cannabis
292632|NCT01697709|marijuana|marijuana
292633|NCT01697709|pharmacotherapy|pharmacotherapy
292634|NCT01697696|COPD, NVA237, QAB149, glycopyrronium bromide|copd, nva237, qab149, glycopyrronium bromide
292635|NCT01697605|Phase I, open-label, dose escalation, BGJ398, Japanese, Asian, FGF-R|phase i, open-label, dose escalation, bgj398, japanese, asian, fgf-r
292636|NCT01697566|Gynecology|gynecology
292637|NCT01697566|Endometrial Cancer Chemoprevention|endometrial cancer chemoprevention
292638|NCT01697566|Obese|obese
292639|NCT01697566|Body Mass Index (BMI) >/= 35 kg.m2|body mass index (bmi) >/= 35 kg.m2
292640|NCT01697566|Post-menopausal|post-menopausal
292641|NCT01697566|Hyperinsulinemia|hyperinsulinemia
292642|NCT01697566|Metformin|metformin
292643|NCT01697566|Placebo|placebo
292644|NCT01697566|Sugar pill|sugar pill
292645|NCT01697566|Lifestyle intervention|lifestyle intervention
292646|NCT01697566|Diet|diet
292647|NCT01697566|Exercise|exercise
292648|NCT01697514|recurrent medulloblastoma|recurrent medulloblastoma
292649|NCT01697397|Irritable bowel syndrome|irritable bowel syndrome
292650|NCT01697397|IBS|ibs
292651|NCT01697397|Gastrointestinal pain|gastrointestinal pain
292652|NCT01697397|Gastrointestinal functional disorder|gastrointestinal functional disorder
292653|NCT01697384|prostate cancer, PSA|prostate cancer, psa
292654|NCT01697358|FBSS|fbss
292655|NCT01697358|post laminectomy syndrome|post laminectomy syndrome
292656|NCT01697358|SCS|scs
292657|NCT01697358|RCT|rct
292658|NCT01697358|back pain|back pain
292659|NCT01697345|Vaginal Testosterone|vaginal testosterone
292660|NCT01697345|Vaginal atrophy|vaginal atrophy
292661|NCT01697345|Female Sexual Dysfunction|female sexual dysfunction
292662|NCT01697345|Aromatase Inhibitors|aromatase inhibitors
292663|NCT01697332|COPD|copd
292664|NCT01697319|Mucopolysaccharidosis IVA Type A|mucopolysaccharidosis iva type a
292665|NCT01697319|MPS IVA Type A|mps iva type a
292666|NCT01697319|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
292667|NCT01697319|MPS IVA|mps iva
292668|NCT01697319|Morquio A Syndrome|morquio a syndrome
292669|NCT01697319|Lysosomal Storage Disorder|lysosomal storage disorder
292671|NCT01697319|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
292672|NCT01697319|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
292673|NCT01697319|sulfatase|sulfatase
292674|NCT01697319|galactose-6-sulfatase|galactose-6-sulfatase
292675|NCT01697319|GALNS|galns
292676|NCT01697319|enzyme replacement therapy|enzyme replacement therapy
292677|NCT01697319|ERT|ert
292678|NCT01697319|MOR-006|mor-006
292679|NCT01697319|CPET|cpet
292680|NCT01697319|Limited ambulation|limited ambulation
292681|NCT01697319|Grip/ Pinch|grip/ pinch
292682|NCT01697306|non muscle invasive bladder cancer|non muscle invasive bladder cancer
753200|NCT01175863|fractional flow reserve|fractional flow reserve
292683|NCT01697280|Polio supplementary immunization activities|polio supplementary immunization activities
292684|NCT01697280|Routine EPI vaccine|routine epi vaccine
292685|NCT01697280|Integration of polio NID and routine EPI|integration of polio nid and routine epi
292686|NCT01697267|vasculitis|vasculitis
292687|NCT01697267|ANCA vasculitis|anca vasculitis
292688|NCT01697267|microscopic polyangiitis|microscopic polyangiitis
292689|NCT01697267|granulomatosis|granulomatosis
292690|NCT01697267|Wegener's|wegener's
292691|NCT01697267|AAV|aav
292692|NCT01697267|vasculitides|vasculitides
292693|NCT01697241|Exercise Therapy|exercise therapy
292694|NCT01697241|Education|education
292695|NCT01697241|Osteoarthritis|osteoarthritis
292696|NCT01697241|Hip|hip
292697|NCT01697241|Hip replacement|hip replacement
292698|NCT01697228|Diabetes|diabetes
292699|NCT01697228|Vitamin D|vitamin d
292700|NCT01697228|Proinflammatory markers|proinflammatory markers
292701|NCT01697189|professional drivers|professional drivers
292702|NCT01697189|sleepiness|sleepiness
292703|NCT01697189|stress|stress
292704|NCT01697189|safe driving|safe driving
292705|NCT01697189|training|training
292706|NCT01697163|De Novo Resistance|de novo resistance
292707|NCT01697163|Iressa|iressa
292708|NCT01697163|EGFR mutation|egfr mutation
292709|NCT01697163|lung cancer|lung cancer
292710|NCT01697150|Type 1 diabetes mellitus|type 1 diabetes mellitus
292711|NCT01697150|closed loop artificial pancreas|closed loop artificial pancreas
292712|NCT01697124|Physical activity|physical activity
292713|NCT01697124|children|children
292714|NCT01697124|Head Start|head start
292715|NCT01697124|SPARK-EC|spark-ec
292716|NCT01697111|YAZ|yaz
292717|NCT01697111|Flexible regimen|flexible regimen
292718|NCT01697111|Drospirenone|drospirenone
292719|NCT01697111|Ethinylestradiol Betadex|ethinylestradiol betadex
292720|NCT01697111|Endometriosis|endometriosis
292721|NCT01697111|Dienogest|dienogest
292722|NCT01697111|Japanese Patients|japanese patients
292723|NCT01697098|Dexamethasone|dexamethasone
292724|NCT01697098|preterm labour|preterm labour
292825|NCT01696578|PTSD|ptsd
292725|NCT01697098|respiratory distress|respiratory distress
292726|NCT01697085|sea buckthorn|sea buckthorn
292727|NCT01697085|mucous membrane|mucous membrane
292728|NCT01697085|dryness|dryness
292729|NCT01697085|metabolic syndrome|metabolic syndrome
292730|NCT01697085|vaginal atrophy|vaginal atrophy
292731|NCT01697072|Gastric Cancer|gastric cancer
292732|NCT01697072|First Line Treatment Gastroesophageal Junction (GEJ)|first line treatment gastroesophageal junction (gej)
292733|NCT01697072|Gastroesophageal Junction Cancer (GEJ)|gastroesophageal junction cancer (gej)
292734|NCT01697072|GEJ Cancer|gej cancer
292735|NCT01697059|appendicitis|appendicitis
292736|NCT01697046|peri-exposure|peri-exposure
292737|NCT01697046|chemoprophylaxis|chemoprophylaxis
292738|NCT01696942|Crohn's disease|crohn's disease
292739|NCT01696942|certolizumab|certolizumab
292740|NCT01696942|mesalamine|mesalamine
292741|NCT01696942|recurrence|recurrence
292742|NCT01696929|tocilizumab|tocilizumab
292743|NCT01696929|safety|safety
292744|NCT01696929|tolerability|tolerability
292745|NCT01696929|efficacy|efficacy
292746|NCT01696929|schizophrenia|schizophrenia
292747|NCT01696929|improvement|improvement
292748|NCT01696929|cognition|cognition
292749|NCT01696929|psychotic symptoms|psychotic symptoms
292750|NCT01696929|baseline IL-6 levels|baseline il-6 levels
292751|NCT01696916|COPD|copd
292752|NCT01696916|carbon dioxide|carbon dioxide
292753|NCT01696916|6-minute walking test|6-minute walking test
402021|NCT01233414|Autism|autism
292754|NCT01696903|Postoperative pancreatic fistula|postoperative pancreatic fistula
292755|NCT01696903|Pancreatic texture|pancreatic texture
292756|NCT01696903|Pancreatic duct diameter|pancreatic duct diameter
292757|NCT01696903|Pancreatic consistency|pancreatic consistency
292758|NCT01696903|Pancreaticoduodenectomy|pancreaticoduodenectomy
292759|NCT01696890|chronic heart failure|chronic heart failure
292760|NCT01696890|telemonitoring|telemonitoring
292761|NCT01696890|first line practitioners|first line practitioners
292762|NCT01696890|integrated approach|integrated approach
292763|NCT01696890|efficacy|efficacy
292764|NCT01696838|Crohn's disease|crohn's disease
292765|NCT01696838|acupuncture|acupuncture
292766|NCT01696838|moxibustion|moxibustion
292767|NCT01696838|fMRI|fmri
292768|NCT01696838|Gut|gut
292769|NCT01696812|electrodeposition|electrodeposition
292770|NCT01696812|Subthalamic Nucleus|subthalamic nucleus
283357|NCT01738503|Opioid Dependence, Buprenorphine, Depot, SUBUTEX, RBP-6000|opioid dependence, buprenorphine, depot, subutex, rbp-6000
283364|NCT01738477|Booster|booster
283365|NCT01738477|Tdap|tdap
283366|NCT01738477|Immunogenicity|immunogenicity
283367|NCT01738477|Repeat dose|repeat dose
283368|NCT01738477|Safety|safety
283382|NCT01738451|QTc|qtc
292771|NCT01696812|Deep Brain Stimulation|deep brain stimulation
292772|NCT01696812|Parkinson Disease|parkinson disease
292773|NCT01696773|tomato|tomato
292774|NCT01696773|tangerine tomato|tangerine tomato
292775|NCT01696773|carotenoids|carotenoids
292776|NCT01696773|lycopene|lycopene
292777|NCT01696773|flavonoids|flavonoids
292778|NCT01696747|gastroparesis|gastroparesis
292779|NCT01696747|idiopathic gastroparesis|idiopathic gastroparesis
292780|NCT01696747|diabetic gastroparesis|diabetic gastroparesis
292781|NCT01696747|post-Nissen gastroparesis|post-nissen gastroparesis
292782|NCT01696734|Gastrointestinal diseases|gastrointestinal diseases
292783|NCT01696734|GI|gi
292785|NCT01696734|GI motility disorders|gi motility disorders
292786|NCT01696734|GI disorders|gi disorders
292787|NCT01696734|Gastroparesis|gastroparesis
292788|NCT01696734|Gastroesophageal reflux disease|gastroesophageal reflux disease
292789|NCT01696734|GERD|gerd
292790|NCT01696734|Chronic nausea and vomiting|chronic nausea and vomiting
292791|NCT01696734|Questionnaires|questionnaires
292792|NCT01696734|Surveys|surveys
292793|NCT01696734|Phone calls|phone calls
292794|NCT01696734|Domperidone|domperidone
292795|NCT01696721|Proton Therapy|proton therapy
292796|NCT01696721|Pediatrics|pediatrics
292797|NCT01696721|Radiation Oncology|radiation oncology
292798|NCT01696682|minimally invasive esophagectomy|minimally invasive esophagectomy
292799|NCT01696682|anastomotic leakage|anastomotic leakage
292800|NCT01696682|gastric conduit|gastric conduit
292801|NCT01696669|Ewing's Sarcoma|ewing's sarcoma
292802|NCT01696669|P6 protocol MSKCC|p6 protocol mskcc
292803|NCT01696669|Gemcitabine|gemcitabine
292804|NCT01696669|Docetaxel|docetaxel
292805|NCT01696656|Gastrointestinal drugs|gastrointestinal drugs
292806|NCT01696656|Antibiotics|antibiotics
292807|NCT01696656|Vitamins|vitamins
292808|NCT01696656|Minerals|minerals
292809|NCT01696656|Intestinal insufficiency|intestinal insufficiency
292810|NCT01696656|Short Bowel syndrome|short bowel syndrome
292811|NCT01696656|Adjuvant therapy|adjuvant therapy
292812|NCT01696656|Antacids|antacids
292813|NCT01696656|Gastrointestinal motility modifiers|gastrointestinal motility modifiers
292814|NCT01696656|Micronutrients|micronutrients
292815|NCT01696643|Opioid|opioid
292816|NCT01696643|Constipation|constipation
292817|NCT01696643|Chronic|chronic
292818|NCT01696643|Pain|pain
292819|NCT01696630|anesthesia, epidural anagesia, colorectal surgery, xenon, hemodynamic change|anesthesia, epidural anagesia, colorectal surgery, xenon, hemodynamic change
292820|NCT01696604|safety|safety
292821|NCT01696604|pharmacokinetics|pharmacokinetics
292822|NCT01696604|FTIH|ftih
292823|NCT01696604|SARM|sarm
292824|NCT01696591|Alzheimer, Mesenchymal Stem Cells, Umbilical Cord Blood|alzheimer, mesenchymal stem cells, umbilical cord blood
292826|NCT01696578|Depression|depression
292827|NCT01696578|Anxiety|anxiety
292828|NCT01696578|Chronic pain|chronic pain
292829|NCT01696578|Anger|anger
292830|NCT01696578|Heart rate variability|heart rate variability
292831|NCT01696578|Disability|disability
292832|NCT01696565|myelosuppression|myelosuppression
292833|NCT01696565|chemotherapy|chemotherapy
292834|NCT01696565|Astragalus membranaceus|astragalus membranaceus
292835|NCT01696565|hematopoietic response|hematopoietic response
292836|NCT01696552|Gonarthritis|gonarthritis
292838|NCT01696552|Conventional|conventional
292839|NCT01696552|Positioning Guides|positioning guides
292840|NCT01696552|PSPG|pspg
292841|NCT01696552|CT Perth|ct perth
292842|NCT01696539|Prostate Cancer|prostate cancer
292843|NCT01696526|vitamin D|vitamin d
292844|NCT01696526|bioeffiency|bioeffiency
292845|NCT01696526|vitamin d fortified fish|vitamin d fortified fish
292846|NCT01696500|IVIG in Stevens-Johnson syndrome|ivig in stevens-johnson syndrome
292847|NCT01696500|Toxic Epidermal Necrolysis|toxic epidermal necrolysis
292848|NCT01696500|Patients with Stevens-Johnson syndrome|patients with stevens-johnson syndrome
292849|NCT01696500|Toxic Epidermal Necrolysis unresponsive to corticosteroids|toxic epidermal necrolysis unresponsive to corticosteroids
292850|NCT01696487|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
292851|NCT01696487|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
292852|NCT01696487|NAFLD|nafld
292853|NCT01696487|NASH|nash
292854|NCT01696474|Refractory cold agglutinin disease|refractory cold agglutinin disease
292855|NCT01696474|Bortezomib|bortezomib
292856|NCT01696474|blood-transfusion|blood-transfusion
283500|NCT01738126|DTI|dti
292857|NCT01696448|Appetite Suppression|appetite suppression
292858|NCT01696448|CAR-191|car-191
292859|NCT01696435|Depression|depression
292860|NCT01696435|Depressive Symptoms|depressive symptoms
292861|NCT01696435|Mood|mood
292862|NCT01696435|Geriatric|geriatric
292863|NCT01696435|Prevention|prevention
292864|NCT01696422|Dengue|dengue
292865|NCT01696422|tetravalent attenuated Vaccine|tetravalent attenuated vaccine
292866|NCT01696422|Healthy adults|healthy adults
292867|NCT01696396|IBD, Crohn's Disease|ibd, crohn's disease
292868|NCT01696383|Intraocular Pressure (IOP)|intraocular pressure (iop)
292869|NCT01696383|Glaucoma|glaucoma
292870|NCT01696383|Ocular hypertension|ocular hypertension
292871|NCT01696383|DuoTrav|duotrav
292872|NCT01696383|Prostaglandin analogue|prostaglandin analogue
292873|NCT01696383|Beta-blocker|beta-blocker
292874|NCT01696370|Trimetazidine|trimetazidine
292875|NCT01696357|Asthma|asthma
292876|NCT01696357|Adolescents|adolescents
292877|NCT01696357|Self-monitoring|self-monitoring
292878|NCT01696357|Quality of life|quality of life
292879|NCT01696357|Biomedical device|biomedical device
292880|NCT01696357|Symptom monitoring|symptom monitoring
292881|NCT01696357|Self-management|self-management
292882|NCT01696344|LSPAF|lspaf
292883|NCT01696344|AF termination|af termination
292884|NCT01696344|PVAI|pvai
292885|NCT01696344|nonPV triggers|nonpv triggers
292886|NCT01696344|Long-standing persistent|long-standing persistent
292887|NCT01696305|Thyroid disease|thyroid disease
292888|NCT01696305|Hyalobarrier|hyalobarrier
292889|NCT01696305|Thyroidectomy|thyroidectomy
292890|NCT01696305|anti-adhesive effect|anti-adhesive effect
292891|NCT01696240|Pulmonary Hypertension|pulmonary hypertension
292892|NCT01696240|Exercise Capacity|exercise capacity
292893|NCT01696240|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
292894|NCT01696240|Udenafil (Zydena)|udenafil (zydena)
292895|NCT01696240|Phosphodiesterase Type 5 Inhibitors|phosphodiesterase type 5 inhibitors
292896|NCT01696227|Nissle 1917|nissle 1917
292897|NCT01696227|Probiotic|probiotic
292898|NCT01696227|Uropathogen|uropathogen
292899|NCT01696214|asthma,smokers|asthma,smokers
292900|NCT01696201|Pregnancy, outcomes, depression, mood, physical exercise|pregnancy, outcomes, depression, mood, physical exercise
292901|NCT01696188|Interscalene|interscalene
292902|NCT01696188|nerve block|nerve block
292903|NCT01696188|nerve catheter|nerve catheter
292904|NCT01696188|in-plane|in-plane
292905|NCT01696188|out-of-plane|out-of-plane
292906|NCT01696188|anterolateral approach|anterolateral approach
292907|NCT01696188|posterior approach|posterior approach
292908|NCT01696188|shoulder surgery|shoulder surgery
292909|NCT01696175|ScvO2|scvo2
292910|NCT01696175|venous|venous
292911|NCT01696175|oxymetry|oxymetry
292912|NCT01696175|lactate|lactate
292913|NCT01696175|children|children
292914|NCT01696175|PICU|picu
292915|NCT01696175|Admission parameters of shock|admission parameters of shock
292916|NCT01696162|Knee pain|knee pain
292917|NCT01696162|Anterior knee pain|anterior knee pain
292918|NCT01696162|Patellofemoral|patellofemoral
292919|NCT01696162|Patellofemoral syndrome|patellofemoral syndrome
292920|NCT01696162|Runners knee|runners knee
292921|NCT01696149|TENS, sympathetic skin response, skin temperature|tens, sympathetic skin response, skin temperature
292922|NCT01696136|Ablation|ablation
292923|NCT01696136|Multi-electrode catheter|multi-electrode catheter
292924|NCT01696136|Single-tip catheter|single-tip catheter
292925|NCT01696136|Holter|holter
292926|NCT01696123|Alzheimer disease|alzheimer disease
292927|NCT01696123|Cholinesterase inhibitors|cholinesterase inhibitors
292928|NCT01696123|MLC601|mlc601
292929|NCT01696123|NeuroAiD|neuroaid
292930|NCT01696123|neuroprotection|neuroprotection
292931|NCT01696123|neuroregeneration|neuroregeneration
292932|NCT01696110|Bivalirudin|bivalirudin
292933|NCT01696110|Acute myocardial infarction|acute myocardial infarction
292934|NCT01696110|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
292936|NCT01696084|Acute Myeloid Leukemia|acute myeloid leukemia
292937|NCT01696084|high risk AML|high risk aml
292938|NCT01696084|secondary AML|secondary aml
292939|NCT01696084|AML in elderly|aml in elderly
292940|NCT01696032|Ovarian Cancer|ovarian cancer
292941|NCT01696019|magnetic resonance imaging|magnetic resonance imaging
292942|NCT01696019|cognition|cognition
292943|NCT01696019|Tai Chi|tai chi
292944|NCT01696019|physical exercise|physical exercise
292945|NCT01696019|mental exercise|mental exercise
292946|NCT01696019|intervention trial|intervention trial
292947|NCT01696019|prevention|prevention
292948|NCT01696019|dementia|dementia
292949|NCT01696019|Alzheimer disease|alzheimer disease
292950|NCT01696019|mild cognitive impairment|mild cognitive impairment
292951|NCT01696006|perfusion computed tomography|perfusion computed tomography
292952|NCT01696006|coronary artery disease|coronary artery disease
292953|NCT01695993|Nausea|nausea
292954|NCT01695993|Quality of life|quality of life
292955|NCT01695993|Chemotherapy|chemotherapy
292956|NCT01695993|Expectancy|expectancy
292957|NCT01695980|adenotonsillectomy|adenotonsillectomy
292958|NCT01695967|nasal obstruction|nasal obstruction
292959|NCT01695954|HIV|hiv
292960|NCT01695954|Hyperlipidemia|hyperlipidemia
292961|NCT01695954|Pharmacokinetics|pharmacokinetics
292962|NCT01695954|Statins|statins
292963|NCT01695954|Darunavir|darunavir
292964|NCT01695954|Efavirenz|efavirenz
292965|NCT01695954|Pitavastatin|pitavastatin
292966|NCT01695928|Velocity|velocity
292967|NCT01695928|Location|location
292968|NCT01695928|Periodontal status|periodontal status
292969|NCT01695915|constipation|constipation
292970|NCT01695915|children|children
292971|NCT01695915|healthy|healthy
292972|NCT01695915|rectal diameter|rectal diameter
292973|NCT01695863|Miralax with gatorade and dulcolax|miralax with gatorade and dulcolax
292974|NCT01695863|Movi pre|movi pre
292975|NCT01695863|Patient satisfaction and efficacy|patient satisfaction and efficacy
292976|NCT01695850|Randomized controlled trial|randomized controlled trial
292977|NCT01695850|Drugs,Chinese Herbal|drugs,chinese herbal
292978|NCT01695850|Constipation/drug therapy|constipation/drug therapy
292979|NCT01695837|Diet counseling|diet counseling
292980|NCT01695837|primary care|primary care
292981|NCT01695824|catheter ablation|catheter ablation
292982|NCT01695811|Keratoconus, PKP, femtosecond laser assisted keratoplasty|keratoconus, pkp, femtosecond laser assisted keratoplasty
292983|NCT01695798|poliomyelitis|poliomyelitis
292984|NCT01695798|oral polio vaccine|oral polio vaccine
292985|NCT01695798|OPV|opv
292986|NCT01695798|seroconversion|seroconversion
292987|NCT01695798|mucosal immunity|mucosal immunity
292988|NCT01695798|malnutrition|malnutrition
292989|NCT01695798|IPV|ipv
292990|NCT01695798|Inactivated polio vaccine|inactivated polio vaccine
292991|NCT01695798|Pakistan|pakistan
292992|NCT01695759|Anemia Secondary|anemia secondary
292993|NCT01695759|Chronic Kidney Disease|chronic kidney disease
292994|NCT01695720|Knee Injuries|knee injuries
292995|NCT01695720|Meniscus Injuries|meniscus injuries
292996|NCT01695720|Articular Cartilage Injuries|articular cartilage injuries
292997|NCT01695720|Orthopaedic Diagnostic|orthopaedic diagnostic
292998|NCT01695720|Magnetic Resonance Imaging|magnetic resonance imaging
292999|NCT01695707|atopic dermatitis|atopic dermatitis
293000|NCT01695707|eczema|eczema
293001|NCT01695681|Quality of life|quality of life
293002|NCT01695681|Celiac Disease/diet therapy|celiac disease/diet therapy
293003|NCT01695681|Celiac Disease/diagnosis|celiac disease/diagnosis
293004|NCT01695681|Prospective Studies|prospective studies
293005|NCT01695668|Graft versus Host Disease (GVHD)|graft versus host disease (gvhd)
293006|NCT01695668|dry eyes|dry eyes
293007|NCT01695668|Bone marrow transplant (BMT)|bone marrow transplant (bmt)
293008|NCT01695668|Restasis|restasis
293009|NCT01695668|Lotemax|lotemax
293010|NCT01695642|lasik, intralase, microkeratome|lasik, intralase, microkeratome
293011|NCT01695603|Brain injury|brain injury
293012|NCT01695603|Controlled ventilation|controlled ventilation
293013|NCT01695603|Intellivent|intellivent
293014|NCT01695603|Capnia control|capnia control
293015|NCT01695590|Myeloma|myeloma
293016|NCT01695590|PRLX93936|prlx93936
293017|NCT01695577|Traumatic brain injury|traumatic brain injury
293018|NCT01695577|Dizziness|dizziness
293019|NCT01695577|Vestibular rehabilitation|vestibular rehabilitation
293020|NCT01695577|Balance rehabilitation|balance rehabilitation
293021|NCT01695564|atrial enlargement|atrial enlargement
293022|NCT01695564|left atrial appendage|left atrial appendage
293023|NCT01695551|Radiofrequency ablation|radiofrequency ablation
293024|NCT01695551|fast heart rhythm|fast heart rhythm
293025|NCT01695551|ventricle|ventricle
293026|NCT01695551|catheter ablation|catheter ablation
293027|NCT01695551|ablation|ablation
293028|NCT01695538|Yoga|yoga
293029|NCT01695538|atrial tachycardia|atrial tachycardia
293030|NCT01695525|Neurocardiogenic Syncope|neurocardiogenic syncope
293031|NCT01695525|Yoga|yoga
293032|NCT01695486|BIS|bis
293033|NCT01695486|Comfort|comfort
293034|NCT01695486|open muscle biopsy|open muscle biopsy
293035|NCT01695473|Prostate cancer|prostate cancer
293036|NCT01695473|High-risk prostate cancer|high-risk prostate cancer
293037|NCT01695473|Radical prostatectomy|radical prostatectomy
293038|NCT01695473|BKM120|bkm120
293039|NCT01695460|Migraine|migraine
293040|NCT01695460|Vitamin D|vitamin d
293041|NCT01695434|multiple sclerosis|multiple sclerosis
293042|NCT01695434|MRI|mri
293043|NCT01695434|Copaxone|copaxone
293044|NCT01695434|healthy controls|healthy controls
293045|NCT01695434|glatiramer acetate|glatiramer acetate
293046|NCT01695421|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
293047|NCT01695421|Oxygen Consumption|oxygen consumption
293048|NCT01695421|Heart Failure|heart failure
293049|NCT01695408|Drug Treatment|drug treatment
293050|NCT01695408|Treatment pathways|treatment pathways
293051|NCT01695408|Clinical routine|clinical routine
293052|NCT01695408|Registry|registry
293053|NCT01695408|Outcomes|outcomes
293054|NCT01695408|Survival|survival
293055|NCT01695408|Patient-related outcomes|patient-related outcomes
283675|NCT01737398|FAP|fap
293056|NCT01695408|Quality of life|quality of life
293057|NCT01695408|Steroids|steroids
293058|NCT01695408|Azathioprine|azathioprine
293059|NCT01695408|N-Acetylcysteine|n-acetylcysteine
293060|NCT01695408|Pirfenidone|pirfenidone
293061|NCT01695408|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
293062|NCT01695408|Nintedanib|nintedanib
293063|NCT01695408|multicenter|multicenter
293064|NCT01695408|Germany|germany
293065|NCT01695408|Safety|safety
293066|NCT01695408|Adverse event|adverse event
293067|NCT01695395|intellectual disability|intellectual disability
293068|NCT01695395|mental disorder|mental disorder
293069|NCT01695395|dual diagnosis|dual diagnosis
293070|NCT01695395|provision|provision
293071|NCT01695395|needs assessment|needs assessment
293072|NCT01695395|quality of life|quality of life
293073|NCT01695382|Cancer|cancer
293074|NCT01695382|Palliative Care|palliative care
293075|NCT01695382|Patient Navigation|patient navigation
293076|NCT01695356|Melasma|melasma
293077|NCT01695356|sunscreens|sunscreens
293078|NCT01695356|visible light|visible light
293079|NCT01695356|ultraviolet light|ultraviolet light
293080|NCT01695343|Cystic Fibrosis|cystic fibrosis
293081|NCT01695343|Pseudomonas aeruginosa (Pa)|pseudomonas aeruginosa (pa)
293082|NCT01695343|CF|cf
293083|NCT01695330|Multiple Myeloma|multiple myeloma
293084|NCT01695330|Relapsed|relapsed
293085|NCT01695330|Refractory|refractory
293086|NCT01695330|Bortezomib|bortezomib
293087|NCT01695330|Subcutaneous|subcutaneous
753201|NCT01175876|MMSE|mmse
293088|NCT01695330|Oncotherapeutics|oncotherapeutics
293089|NCT01695317|Migraine|migraine
293090|NCT01695317|Preventive medication|preventive medication
293091|NCT01695304|Cryptosporidiosis|cryptosporidiosis
293092|NCT01695304|Waterborne disease|waterborne disease
293093|NCT01695304|Diarrheal disease|diarrheal disease
293094|NCT01695304|Ceramic water filters|ceramic water filters
293096|NCT01695304|young children|young children
293097|NCT01695304|drinking water|drinking water
293098|NCT01695304|Kenya|kenya
293099|NCT01695291|Obsessive compulsive disorder|obsessive compulsive disorder
293100|NCT01695278|motivational interviewing|motivational interviewing
293101|NCT01695278|telephone counseling|telephone counseling
293102|NCT01695278|medical education|medical education
293103|NCT01695278|diabetes self management|diabetes self management
293104|NCT01695265|Airflow Obstruction|airflow obstruction
293105|NCT01695226|Celecoxib|celecoxib
293106|NCT01695226|Clinical trial, Phase II|clinical trial, phase ii
293107|NCT01695226|Oligonucleotide Array Sequence Analysis|oligonucleotide array sequence analysis
293108|NCT01695213|uncemented hip|uncemented hip
293109|NCT01695213|bone remodeling|bone remodeling
293110|NCT01695213|DEXA|dexa
293111|NCT01695213|clinical evaluation|clinical evaluation
293112|NCT01695187|Herpes, Herpes Labialis, nanoemulsion, NanoBio, NB-001|herpes, herpes labialis, nanoemulsion, nanobio, nb-001
293113|NCT01695174|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
293114|NCT01695174|Xifaxan|xifaxan
293115|NCT01695161|Mucopolysaccharidosis|mucopolysaccharidosis
293116|NCT01695161|Fabry disease|fabry disease
293117|NCT01695148|beta-carotene biofortified maize|beta-carotene biofortified maize
293118|NCT01695148|micronutrients|micronutrients
293119|NCT01695148|vitamin A|vitamin a
293120|NCT01695148|serum retinol|serum retinol
293121|NCT01695148|dark adaptation|dark adaptation
293122|NCT01695135|Prostate neoplasms|prostate neoplasms
293123|NCT01695135|Prostate cancer|prostate cancer
293124|NCT01695135|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
293125|NCT01695135|Abiraterone acetate|abiraterone acetate
293126|NCT01695135|JNJ-212082|jnj-212082
293127|NCT01695122|Head and Neck Cancer|head and neck cancer
293128|NCT01695122|Oropharyngeal cancer|oropharyngeal cancer
293129|NCT01695122|Oral cavity cancer|oral cavity cancer
293130|NCT01695122|Chemoradiation|chemoradiation
293131|NCT01695122|valproic acid|valproic acid
293132|NCT01695122|histone deacetylase|histone deacetylase
293133|NCT01695109|GLP1|glp1
293134|NCT01695109|obesity|obesity
293135|NCT01695109|fMRI|fmri
293136|NCT01695109|ghrelin|ghrelin
293137|NCT01695083|Non alcoholic steatohepatitis|non alcoholic steatohepatitis
293138|NCT01695083|Liver fibrosis,Steatosis|liver fibrosis,steatosis
293139|NCT01695083|Liver inflammation|liver inflammation
293140|NCT01695083|Morbid obesity|morbid obesity
293141|NCT01695083|Non invasive tests|non invasive tests
293142|NCT01695031|Urban adolescents|urban adolescents
293143|NCT01695031|Acute asthma|acute asthma
293144|NCT01695031|Emergency department|emergency department
293145|NCT01695031|Computer tailoring|computer tailoring
293146|NCT01695031|Web-based intervention|web-based intervention
293147|NCT01695018|oral epithelial dysplasia|oral epithelial dysplasia
293148|NCT01695018|p16 methylation|p16 methylation
293149|NCT01695018|diagnostic reagents|diagnostic reagents
293150|NCT01695018|early diagnosis|early diagnosis
293151|NCT01694992|Stroke|stroke
293152|NCT01694992|Early Ambulation|early ambulation
293153|NCT01694992|Rehabilitation|rehabilitation
293154|NCT01694992|Physical Therapy|physical therapy
293155|NCT01694992|Randomized controlled trial|randomized controlled trial
293156|NCT01694979|Pelvic floor|pelvic floor
293157|NCT01694979|Rehabilitation|rehabilitation
293158|NCT01694979|Respiration|respiration
293159|NCT01694979|Urinary incontinence|urinary incontinence
293160|NCT01694953|MNGIE|mngie
293161|NCT01694953|Mitochondrial|mitochondrial
293550|NCT01693380|Adolescents|adolescents
293162|NCT01694953|Mitochondrial Neurogastrointestinal encephalopathy|mitochondrial neurogastrointestinal encephalopathy
293163|NCT01694940|mitochondrial disorders|mitochondrial disorders
293164|NCT01694940|Mito Disease|mito disease
293165|NCT01694940|Mitochondria|mitochondria
293166|NCT01694940|Mitochondrial disease|mitochondrial disease
293167|NCT01694940|Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke (MELAS) Syndrome|mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke (melas) syndrome
293168|NCT01694940|Myoclonic Epilepsy with Ragged Red Fibers (MERRF)|myoclonic epilepsy with ragged red fibers (merrf)
293169|NCT01694940|Leber Hereditary Optic Neuropathy (LHON)|leber hereditary optic neuropathy (lhon)
293170|NCT01694940|Leigh Syndrome|leigh syndrome
293171|NCT01694940|Neuropathy, ataxia, and retinitis pigmentosa (NARP)|neuropathy, ataxia, and retinitis pigmentosa (narp)
293172|NCT01694940|Kearns Sayre syndrome|kearns sayre syndrome
293173|NCT01694940|Alpers Huttenlocher|alpers huttenlocher
293174|NCT01694940|Pearson|pearson
293175|NCT01694940|Mitochondrial Neurogastrointestinal Encephalopathy (MNGIE)|mitochondrial neurogastrointestinal encephalopathy (mngie)
293176|NCT01694940|Barth Syndrome|barth syndrome
293177|NCT01694940|Coenzyme Q (CoQ) Deficiency|coenzyme q (coq) deficiency
292837|NCT01696552|TKR|tkr
753202|NCT01175876|NSE|nse
293178|NCT01694940|Chronic progressive external ophthalmoplegia (CPEO)|chronic progressive external ophthalmoplegia (cpeo)
293180|NCT01694940|Diabetes and Deafness|diabetes and deafness
293181|NCT01694940|Encephalopathy|encephalopathy
293182|NCT01694940|Encephalomyopathy|encephalomyopathy
293183|NCT01694940|Familial Bilateral Striatal Necrosis (FBSN)|familial bilateral striatal necrosis (fbsn)
293184|NCT01694940|Hepatocerebral Disease|hepatocerebral disease
293185|NCT01694940|Leukoencephalopathy|leukoencephalopathy
293186|NCT01694940|Maternally Inherited Leigh Syndrome (MILS)|maternally inherited leigh syndrome (mils)
293187|NCT01694940|Complex I Deficiency|complex i deficiency
293188|NCT01694940|Complex II Deficiency|complex ii deficiency
293189|NCT01694940|Complex III Deficiency|complex iii deficiency
293190|NCT01694940|Complex IV Deficiency|complex iv deficiency
293191|NCT01694940|Complex V Deficiency|complex v deficiency
293192|NCT01694940|mitochondrial DNA depletion syndrome|mitochondrial dna depletion syndrome
293193|NCT01694940|mtDNA depletion syndrome|mtdna depletion syndrome
293194|NCT01694927|Mesenchymal stem cell|mesenchymal stem cell
293195|NCT01694927|Spinal cord injury|spinal cord injury
293196|NCT01694914|Corneal Transplantation|corneal transplantation
293197|NCT01694914|corneal organ culture medium|corneal organ culture medium
293198|NCT01694914|free animal compound medium|free animal compound medium
293199|NCT01694888|Students practice, Lecture; Nursing records; Nursing education; Midwifery|students practice, lecture; nursing records; nursing education; midwifery
293200|NCT01694875|cervix cancer|cervix cancer
293201|NCT01694875|HPV|hpv
293202|NCT01694875|APTIMA|aptima
293203|NCT01694862|quasi experimental|quasi experimental
293204|NCT01694862|evaluation|evaluation
293205|NCT01694862|intervention|intervention
293206|NCT01694862|service integration|service integration
293207|NCT01694862|cost analysis|cost analysis
293208|NCT01694862|HIV|hiv
293209|NCT01694862|FP|fp
293210|NCT01694862|PNC|pnc
293211|NCT01694862|Sub-Saharan Africa|sub-saharan africa
293212|NCT01694849|PPARs|ppars
293213|NCT01694849|NASH|nash
293214|NCT01694849|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
293215|NCT01694849|Liver Diseases|liver diseases
293216|NCT01694849|Fibrosis|fibrosis
293217|NCT01694836|Allergic rhinitis|allergic rhinitis
293218|NCT01694836|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
293219|NCT01694836|Allergy induced asthma|allergy induced asthma
293220|NCT01694836|Birch (Betula alba)|birch (betula alba)
293221|NCT01694836|Hayfever|hayfever
293222|NCT01694836|Immunotherapy|immunotherapy
293223|NCT01694823|Cartilage repair|cartilage repair
293224|NCT01694823|Cartilage defects|cartilage defects
293225|NCT01694823|cell sheet|cell sheet
293226|NCT01694823|Autologous chondrocyte implantation|autologous chondrocyte implantation
293227|NCT01694810|acne vulgaris|acne vulgaris
293228|NCT01694758|Benchmarking could improve quality of patient care|benchmarking could improve quality of patient care
293229|NCT01694758|ESC and ATP III Guidelines|esc and atp iii guidelines
293230|NCT01694745|Newborns|newborns
293231|NCT01694745|Premature|premature
293232|NCT01694745|Pain|pain
293233|NCT01694745|Pain assessment|pain assessment
293234|NCT01694745|Endotracheal Intubation|endotracheal intubation
293235|NCT01694745|Analgesia|analgesia
293236|NCT01694745|Sedation|sedation
293237|NCT01694745|Longterm effects of pain|longterm effects of pain
293238|NCT01694745|Epidemiology|epidemiology
293239|NCT01694732|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
293240|NCT01694732|Varenicline|varenicline
283908|NCT01736436|MDS|mds
293241|NCT01694732|Smoking cessation|smoking cessation
293242|NCT01694719|Depression|depression
293243|NCT01694719|Major Depressive Disorder|major depressive disorder
293244|NCT01694719|Behavioral Activation|behavioral activation
293245|NCT01694719|Cognitive Training|cognitive training
293246|NCT01694680|AMD|amd
293247|NCT01694680|Lutein|lutein
293248|NCT01694680|Visual function|visual function
293249|NCT01694680|Early signs of AMD|early signs of amd
293250|NCT01694680|AREDS-category 2|areds-category 2
293251|NCT01694641|time lapse monitoring|time lapse monitoring
293252|NCT01694641|blastocyst|blastocyst
293253|NCT01694641|single embryo transfer|single embryo transfer
293254|NCT01694641|clinical pregnancy|clinical pregnancy
293255|NCT01694641|implantation rate|implantation rate
293256|NCT01694615|Lung Transplantation|lung transplantation
293257|NCT01694615|Acute Rejection|acute rejection
293258|NCT01694602|Cachexia|cachexia
293259|NCT01694602|Sarcopenia|sarcopenia
293260|NCT01694602|De Novo|de novo
293261|NCT01694602|Deuterated|deuterated
293262|NCT01694589|pancreatic cancer|pancreatic cancer
293263|NCT01694589|resectable pancreatic cancer|resectable pancreatic cancer
293264|NCT01694576|Nasopharyngeal carcinoma staged N2-3M0|nasopharyngeal carcinoma staged n2-3m0
293265|NCT01694576|Adjuvant chemotherapy|adjuvant chemotherapy
293266|NCT01694563|Atrial Fibrillation|atrial fibrillation
293267|NCT01694550|pacemaker|pacemaker
293268|NCT01694550|ICD / CRTD|icd / crtd
293269|NCT01694550|corrected QT-interval|corrected qt-interval
293270|NCT01694537|lumbrokinase|lumbrokinase
293271|NCT01694537|fibrinolytic|fibrinolytic
293272|NCT01694537|plasmin-antiplasmin complex|plasmin-antiplasmin complex
293273|NCT01694537|euglobulin clot lysis time|euglobulin clot lysis time
293274|NCT01694537|platelet aggregation|platelet aggregation
293275|NCT01694511|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
293276|NCT01694485|Ulcerative Colitis, IBD|ulcerative colitis, ibd
293277|NCT01694459|angioplasty|angioplasty
293278|NCT01694459|heparin|heparin
293279|NCT01694459|trial|trial
293280|NCT01694446|Intestinal lipoprotein|intestinal lipoprotein
293281|NCT01694446|Apo B48 and apoB100|apo b48 and apob100
293282|NCT01694446|Pancreatic clamp|pancreatic clamp
293283|NCT01694407|Prevention|prevention
293284|NCT01694394|atrial fibrillation|atrial fibrillation
293285|NCT01694394|implantable cardiac monitor|implantable cardiac monitor
293286|NCT01694394|left atrial enlargement|left atrial enlargement
293287|NCT01694394|CHA2DS2 VASc Score|cha2ds2 vasc score
293288|NCT01694394|cardiovascular risk|cardiovascular risk
293289|NCT01694381|Acute Ischemic Stroke|acute ischemic stroke
293290|NCT01694381|TS01|ts01
293291|NCT01694381|Mutant pro-urokinase|mutant pro-urokinase
293292|NCT01694381|M5|m5
293293|NCT01694381|C1 inhibitor|c1 inhibitor
293294|NCT01694381|Safety|safety
293295|NCT01694381|Stroke|stroke
293296|NCT01694381|Tolerability|tolerability
293297|NCT01694381|Ischemia|ischemia
293298|NCT01694381|Cerebral Infarction|cerebral infarction
293299|NCT01694381|Cerebrovascular Disorders|cerebrovascular disorders
293300|NCT01694381|Vascular Diseases|vascular diseases
293301|NCT01694381|Cardiovascular Diseases|cardiovascular diseases
293302|NCT01694381|Brain Infarction|brain infarction
293303|NCT01694381|Brain Ischemia|brain ischemia
293304|NCT01694381|Fibrinolytic Agents|fibrinolytic agents
293305|NCT01694381|Thrombolytic Agents|thrombolytic agents
293306|NCT01694381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
293307|NCT01694381|Pharmacologic Actions|pharmacologic actions
293308|NCT01694381|Cardiovascular Agents|cardiovascular agents
293309|NCT01694381|Therapeutic Uses|therapeutic uses
293310|NCT01694381|Hematologic Agents|hematologic agents
293311|NCT01694368|Near infrared spectroscopy; lipid core; vulnerable plaque|near infrared spectroscopy; lipid core; vulnerable plaque
293312|NCT01694329|Streptococcus pneumoniae|streptococcus pneumoniae
293313|NCT01694329|Pneumococcal Conjugate Vaccines|pneumococcal conjugate vaccines
293314|NCT01694329|Immunization|immunization
293315|NCT01694329|Otitis media|otitis media
293316|NCT01694316|Computerized neurobehavioral intervention|computerized neurobehavioral intervention
293317|NCT01694277|Gastrointestinal Stromal Tumour|gastrointestinal stromal tumour
293318|NCT01694277|GIST|gist
293319|NCT01694277|non-resectable|non-resectable
293320|NCT01694277|metastatic|metastatic
293321|NCT01694277|second line treatment|second line treatment
293322|NCT01694277|resistance to imatinib|resistance to imatinib
293323|NCT01694264|HBV surface antigen|hbv surface antigen
293324|NCT01694264|Anti-HBc positive|anti-hbc positive
293325|NCT01694264|Anti-TNFα Treatment|anti-tnfα treatment
293326|NCT01694264|Reactivation|reactivation
293327|NCT01694251|mitral valve area|mitral valve area
293328|NCT01694251|pressure half time|pressure half time
293329|NCT01694251|3 dimensional transesophageal echocardiography|3 dimensional transesophageal echocardiography
293330|NCT01694251|computed tomography|computed tomography
293331|NCT01694238|Colostomy|colostomy
293332|NCT01694238|Surgical technique|surgical technique
293333|NCT01694225|Breast cancer|breast cancer
293334|NCT01694225|Anti-estrogen therapy|anti-estrogen therapy
293335|NCT01694212|Macular edema|macular edema
293336|NCT01694212|Cataract|cataract
293337|NCT01694212|Diabetic retinopathy|diabetic retinopathy
293338|NCT01694212|Anti-inflammatory agents,Non-steroidal|anti-inflammatory agents,non-steroidal
293339|NCT01694199|Pulsed Radiofrequency Energy (PRFE)|pulsed radiofrequency energy (prfe)
293340|NCT01694199|Pain|pain
293341|NCT01694199|Postsurgical|postsurgical
293342|NCT01694199|Opioids|opioids
293343|NCT01694199|Pain relief|pain relief
293344|NCT01694199|Medical device|medical device
293345|NCT01694199|Endorphins|endorphins
293649|NCT01691924|Cancer|cancer
293346|NCT01694173|Type 2 diabetes mellitus, F18-FDG labelled stem cells|type 2 diabetes mellitus, f18-fdg labelled stem cells
293347|NCT01694160|kidney transplant patients|kidney transplant patients
293348|NCT01694160|Albuminuria|albuminuria
293349|NCT01694147|relationship|relationship
293350|NCT01694147|endothelial injury|endothelial injury
293351|NCT01694147|vascular permeability|vascular permeability
293352|NCT01694147|severe sepsis related ALI/ARDS|severe sepsis related ali/ards
293353|NCT01694134|Discopathy|discopathy
293354|NCT01694134|Modic I|modic i
293355|NCT01694134|Corticoids|corticoids
293356|NCT01694134|Local Anaesthetic|local anaesthetic
293357|NCT01694134|Intradiscal injection|intradiscal injection
293358|NCT01694121|HIV prevention|hiv prevention
293359|NCT01694121|African American men|african american men
293360|NCT01694121|evaluation study|evaluation study
293361|NCT01694095|Geographic atrophy, prognosis, risk factors, natural history|geographic atrophy, prognosis, risk factors, natural history
293362|NCT01694082|brief intervention|brief intervention
293363|NCT01694082|web-based interventions|web-based interventions
293364|NCT01694082|computer-based interventions|computer-based interventions
293365|NCT01694082|harm reduction|harm reduction
293366|NCT01694082|young adult|young adult
293367|NCT01694082|college student|college student
293368|NCT01694069|piperacillin|piperacillin
293369|NCT01694069|tazobactam|tazobactam
293370|NCT01694069|pseudomonas aeruginosa|pseudomonas aeruginosa
293371|NCT01694069|cystic fibrosis|cystic fibrosis
293372|NCT01694069|pulmonary exacerbation|pulmonary exacerbation
293373|NCT01694069|continuous infusion|continuous infusion
293374|NCT01694069|beta lactam|beta lactam
293375|NCT01694030|Attachment security priming|attachment security priming
293376|NCT01694030|depressed mood|depressed mood
293377|NCT01694017|HIV,treatment,cost effectiveness,drug toxicity,QOL,costs|hiv,treatment,cost effectiveness,drug toxicity,qol,costs
293378|NCT01694004|Nutrient absorption|nutrient absorption
293379|NCT01694004|Duodenal feeding tube|duodenal feeding tube
293380|NCT01694004|Gut-brain-gut axis|gut-brain-gut axis
293381|NCT01693978|PTSD|ptsd
293382|NCT01693978|Prolonged Exposure|prolonged exposure
293383|NCT01693978|Comorbidity|comorbidity
293384|NCT01693978|Treatment|treatment
293385|NCT01693978|Methadone Maintenance|methadone maintenance
293386|NCT01693978|Substance Use Disorder|substance use disorder
293387|NCT01693939|Lasik|lasik
293388|NCT01693939|Myopia|myopia
293389|NCT01693939|Femtosecond Laser|femtosecond laser
293390|NCT01693926|Obesity|obesity
293391|NCT01693926|Children|children
293392|NCT01693926|Physical activity|physical activity
293393|NCT01693926|Stress|stress
293394|NCT01693926|Snacking|snacking
293395|NCT01693900|joint replacement|joint replacement
293396|NCT01693900|total hip replacement|total hip replacement
293397|NCT01693900|regional pain block|regional pain block
293398|NCT01693900|ultrasound guidance|ultrasound guidance
293399|NCT01693900|fascia iliaca compartment block|fascia iliaca compartment block
293400|NCT01693887|IFI|ifi
293401|NCT01693887|empirical therapy|empirical therapy
293402|NCT01693887|preemptive therapy|preemptive therapy
293403|NCT01693887|Itraconazole|itraconazole
293404|NCT01693874|anxiety|anxiety
293405|NCT01693874|depression|depression
293406|NCT01693874|cognition|cognition
293407|NCT01693874|MBSR|mbsr
293408|NCT01693874|mindfulness|mindfulness
293409|NCT01693874|stress|stress
293410|NCT01693874|elderly|elderly
293411|NCT01693861|Colorectal|colorectal
293412|NCT01693861|Cancer|cancer
293413|NCT01693861|Metastatic|metastatic
293514|NCT01693484|Calcaneus|calcaneus
293414|NCT01693861|Chronotherapy|chronotherapy
293415|NCT01693861|Urine|urine
293416|NCT01693861|Nucleosides|nucleosides
293417|NCT01693861|Chemotherapy|chemotherapy
293418|NCT01693861|Treated with chemotherapy|treated with chemotherapy
293419|NCT01693848|Colorectal|colorectal
293420|NCT01693848|Cancer|cancer
293421|NCT01693848|Metastatic|metastatic
293422|NCT01693848|Control|control
293423|NCT01693848|Urine|urine
293424|NCT01693848|Nucleosides|nucleosides
293425|NCT01693848|Surgery|surgery
293426|NCT01693848|General anesthesia|general anesthesia
293427|NCT01693848|Scheduled for surgery|scheduled for surgery
293428|NCT01693835|Colorectal|colorectal
293429|NCT01693835|Cancer|cancer
293430|NCT01693835|Metastatic|metastatic
293431|NCT01693835|Healthy|healthy
293432|NCT01693835|Control|control
293433|NCT01693835|Circadian|circadian
293434|NCT01693835|Urine|urine
293435|NCT01693835|Nucleosides|nucleosides
293436|NCT01693822|metastatic renal cell carcinoma|metastatic renal cell carcinoma
293437|NCT01693822|predominant clear cell histology|predominant clear cell histology
293438|NCT01693822|Unsuitable for nephrectomy|unsuitable for nephrectomy
293439|NCT01693822|unsuitable for 'watch and wait' policy|unsuitable for 'watch and wait' policy
293440|NCT01693809|Caffeine|caffeine
293441|NCT01693809|Vestibular Evoked Myogenic Potentials|vestibular evoked myogenic potentials
293442|NCT01693809|dizziness|dizziness
293443|NCT01693809|vertigo|vertigo
293444|NCT01693809|tinnitus|tinnitus
293445|NCT01693770|Bone Metastasis|bone metastasis
293446|NCT01693770|Pain Palliation|pain palliation
293447|NCT01693770|High Intensity Focused Ultrasound|high intensity focused ultrasound
293448|NCT01693757|Anterior Cruciate Ligament|anterior cruciate ligament
293449|NCT01693757|Hamstrings versus patellar tendon|hamstrings versus patellar tendon
293450|NCT01693757|Hop test|hop test
293451|NCT01693757|Return to sports|return to sports
293452|NCT01693744|Pseudoexfoliation, chronic kidney disease|pseudoexfoliation, chronic kidney disease
293453|NCT01693731|Breast cancer|breast cancer
293454|NCT01693731|Periodontal Diseases|periodontal diseases
293455|NCT01693731|Aromatase Inhibitors|aromatase inhibitors
293456|NCT01693731|Oral Health Related Quality of Life|oral health related quality of life
293457|NCT01693718|cancer|cancer
293458|NCT01693718|advanced|advanced
293459|NCT01693718|oral cavity|oral cavity
293460|NCT01693718|larynx|larynx
293461|NCT01693705|Tracheostomy|tracheostomy
293462|NCT01693692|Fibromyalgia|fibromyalgia
293463|NCT01693679|Tebivudine eGFR non-Tebivudine|tebivudine egfr non-tebivudine
293464|NCT01693666|Pregnancy|pregnancy
293465|NCT01693666|Obesity|obesity
293466|NCT01693666|Weight gain|weight gain
293467|NCT01693666|Obstetric complications|obstetric complications
293468|NCT01693666|Lifestyle intervention|lifestyle intervention
293469|NCT01693653|Behcet's syndrome|behcet's syndrome
293470|NCT01693653|oral ulcers|oral ulcers
293471|NCT01693640|Behcet's|behcet's
293472|NCT01693614|Diffuse large B-cell lymphoma, Mantle cell lymphoma, Follicular lymphoma, PI3K inhibitor, Non-Hodgkin lymphoma, NHL|diffuse large b-cell lymphoma, mantle cell lymphoma, follicular lymphoma, pi3k inhibitor, non-hodgkin lymphoma, nhl
293473|NCT01693601|Myelofibrosis|myelofibrosis
293474|NCT01693601|Panobinostat|panobinostat
293475|NCT01693601|Ruxolitinib|ruxolitinib
293477|NCT01693588|Postoperative Pain|postoperative pain
293478|NCT01693588|Surgical Pain|surgical pain
293479|NCT01693588|Neurosurgical Pain|neurosurgical pain
293480|NCT01693575|Small pupil cataract surgery|small pupil cataract surgery
293481|NCT01693575|Intraoperative floppy iris syndrome (IFIS)|intraoperative floppy iris syndrome (ifis)
293482|NCT01693562|Advanced solid tumors|advanced solid tumors
293483|NCT01693549|HER-2 negative|her-2 negative
293484|NCT01693549|Metastatic breast adenocarcinoma|metastatic breast adenocarcinoma
293485|NCT01693536|Elderly|elderly
293486|NCT01693536|Sodium reduction|sodium reduction
293487|NCT01693536|Fitness increase|fitness increase
293488|NCT01693536|Primary Care|primary care
293489|NCT01693523|Pancreatic Cancer|pancreatic cancer
293490|NCT01693523|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
293491|NCT01693523|Locally advanced|locally advanced
293492|NCT01693523|Metastatic disease|metastatic disease
293493|NCT01693523|Symptom reduction|symptom reduction
293494|NCT01693523|Minocycline|minocycline
293495|NCT01693523|Dynacin|dynacin
293496|NCT01693523|Minocin|minocin
293497|NCT01693523|Minocin PAC|minocin pac
293498|NCT01693523|Myrac|myrac
293499|NCT01693523|Solodyn|solodyn
293500|NCT01693523|Placebo|placebo
293501|NCT01693523|Sugar Pill|sugar pill
293502|NCT01693523|Questionnaires|questionnaires
293503|NCT01693523|Surveys|surveys
293504|NCT01693510|Excess gestational weight gain (GWG)|excess gestational weight gain (gwg)
293505|NCT01693510|Obesity|obesity
293506|NCT01693510|Type 2 diabetes|type 2 diabetes
293507|NCT01693510|Elevated fats in the blood|elevated fats in the blood
293508|NCT01693510|High blood pressure|high blood pressure
293509|NCT01693497|Posttraumatic Stress Disorder|posttraumatic stress disorder
293510|NCT01693497|PTSD|ptsd
293511|NCT01693497|psychotherapy|psychotherapy
293512|NCT01693497|randomized trial|randomized trial
293513|NCT01693497|gestalt|gestalt
293515|NCT01693484|Fracture|fracture
293516|NCT01693484|Indocyanine Green|indocyanine green
293517|NCT01693484|Angiography|angiography
293518|NCT01693484|Open Reduction and Internal Fixation|open reduction and internal fixation
293520|NCT01693471|SF-36|sf-36
293521|NCT01693471|HRQOL|hrqol
293522|NCT01693458|HIV|hiv
293523|NCT01693458|prevention|prevention
293524|NCT01693458|HIV-positive|hiv-positive
293525|NCT01693458|education|education
293526|NCT01693445|Gastrointestinal neoplasms|gastrointestinal neoplasms
293527|NCT01693445|Oxaliplatin|oxaliplatin
293528|NCT01693445|Irinotecan|irinotecan
293529|NCT01693445|S-1|s-1
293530|NCT01693432|Esophageal neoplasms|esophageal neoplasms
293531|NCT01693432|Docetaxel|docetaxel
293532|NCT01693432|S-1|s-1
293533|NCT01693419|pancreas neoplasm|pancreas neoplasm
293534|NCT01693419|gemcitabine|gemcitabine
284147|NCT01735513|EmbolX|embolx
293535|NCT01693419|erlotinib|erlotinib
293536|NCT01693419|S-1|s-1
293537|NCT01693406|human milk|human milk
293538|NCT01693406|infant growth|infant growth
293539|NCT01693406|obesity|obesity
293540|NCT01693406|diabetes|diabetes
293541|NCT01693406|breastfeeding|breastfeeding
293542|NCT01693393|primary Sjogren´s Syndrome|primary sjogren´s syndrome
293543|NCT01693393|Cyclosporine|cyclosporine
293544|NCT01693380|Influenza|influenza
293545|NCT01693380|Vaccination|vaccination
293546|NCT01693380|Vaccines|vaccines
293547|NCT01693380|Schoolchildren|schoolchildren
293548|NCT01693380|Effectiveness|effectiveness
293549|NCT01693380|Intervention studies|intervention studies
293551|NCT01693380|Laboratory Confirmed Influenza|laboratory confirmed influenza
293552|NCT01693367|Femoral fracture|femoral fracture
293553|NCT01693367|Periprosthetic fracture|periprosthetic fracture
293554|NCT01693367|Fracture fixation, internal|fracture fixation, internal
293555|NCT01693367|Distal femur fractures|distal femur fractures
293556|NCT01693367|Dynamic Locking Screw|dynamic locking screw
293557|NCT01693367|WOMAC|womac
293558|NCT01693354|dialysis|dialysis
293559|NCT01693354|mortality|mortality
293560|NCT01693354|cardiovascular stability|cardiovascular stability
293561|NCT01693354|inflammation|inflammation
293562|NCT01693354|quality of life|quality of life
293563|NCT01693341|Chronic stroke patients|chronic stroke patients
293564|NCT01693341|Stroke rehabilitation|stroke rehabilitation
293565|NCT01693341|Caregiver|caregiver
293566|NCT01693341|Caregiver-mediated intervention|caregiver-mediated intervention
293567|NCT01693328|quality of life|quality of life
293568|NCT01693328|PecFent|pecfent
293569|NCT01693328|Lazanda|lazanda
293570|NCT01693328|fentanyl|fentanyl
293571|NCT01693328|intranasal|intranasal
293572|NCT01693328|breakthrough cancer pain|breakthrough cancer pain
293573|NCT01693302|Blood Glucose|blood glucose
293574|NCT01693302|Meal insulin|meal insulin
293575|NCT01693289|Metformin|metformin
293576|NCT01693289|letrozole|letrozole
293577|NCT01693289|ovarian drilling|ovarian drilling
293578|NCT01693289|clomiphene resistance|clomiphene resistance
293579|NCT01693289|polycystic ovary.|polycystic ovary.
293580|NCT01693276|pancreatic cancer|pancreatic cancer
293581|NCT01693263|end stage renal disease (ESRD)|end stage renal disease (esrd)
293582|NCT01693263|brachiocephalic fistula (BCF)|brachiocephalic fistula (bcf)
293583|NCT01693263|cephalic arch stenosis (CAS)|cephalic arch stenosis (cas)
293584|NCT01693263|dialysis|dialysis
293585|NCT01693250|technology|technology
293586|NCT01693250|healthy weight management|healthy weight management
293587|NCT01693250|primary care setting|primary care setting
293588|NCT01693224|Tests, Diagnostic|tests, diagnostic
293589|NCT01693224|Mycobacterium tuberculosis|mycobacterium tuberculosis
293590|NCT01693224|Mycobacterium tuberculosis antigens|mycobacterium tuberculosis antigens
293591|NCT01693224|TB|tb
293592|NCT01693224|Tuberculosis|tuberculosis
293593|NCT01693224|Tuberculosis, Pulmonary|tuberculosis, pulmonary
293594|NCT01693224|Tuberculosis, Miliary|tuberculosis, miliary
293595|NCT01693224|Lipoarabinomannan|lipoarabinomannan
293596|NCT01693211|femtosecond laser|femtosecond laser
293597|NCT01693211|cataract|cataract
293598|NCT01693211|control study|control study
293599|NCT01693211|prospective|prospective
293600|NCT01693198|allergy|allergy
293601|NCT01693198|cyanobacteria|cyanobacteria
293602|NCT01693198|sweet water swimming|sweet water swimming
293603|NCT01693185|colonoscopy|colonoscopy
293604|NCT01693185|remifentanil|remifentanil
293605|NCT01693185|midazolam|midazolam
293606|NCT01693185|meperidine|meperidine
293607|NCT01693172|exercise|exercise
293608|NCT01693172|neoplasm|neoplasm
293609|NCT01693159|Painful cetuximab-induced rhagades|painful cetuximab-induced rhagades
293610|NCT01693159|Radioimmunotherapy|radioimmunotherapy
293611|NCT01693159|Head and neck cancer|head and neck cancer
293612|NCT01693146|Oxygen|oxygen
293613|NCT01693146|High Flow|high flow
293614|NCT01693146|COPD|copd
293615|NCT01693146|Hypercapnia|hypercapnia
293616|NCT01693120|ablation|ablation
293617|NCT01693120|atrial fibrillation|atrial fibrillation
293618|NCT01693120|Radio frequency|radio frequency
293619|NCT01693107|Atrial Fibrillation|atrial fibrillation
293620|NCT01693107|Catheter Ablation|catheter ablation
293621|NCT01693107|Electrophysiology|electrophysiology
293622|NCT01693107|Cardiac Arrhythmias|cardiac arrhythmias
293623|NCT01693081|Parkinson's disease|parkinson's disease
293624|NCT01693081|inhaled apomorphine|inhaled apomorphine
293625|NCT01693081|"convert off to on"|"convert off to on"
293626|NCT01693068|Cutaneous Melanoma|cutaneous melanoma
293627|NCT01693068|Dacarbazine|dacarbazine
293628|NCT01693068|Pimasertib|pimasertib
293629|NCT01693068|N-Ras|n-ras
293630|NCT01693055|orbital Computed Tomography|orbital computed tomography
293631|NCT01693055|baggy eyelids|baggy eyelids
293632|NCT01693055|orbital fat prolapse|orbital fat prolapse
293633|NCT01693055|UltheraTM|ultheratm
284234|NCT01735084|pneumococcal conjugate vaccines|pneumococcal conjugate vaccines
284239|NCT01735084|pediatric|pediatric
293634|NCT01693055|high intensity focused ultrasound|high intensity focused ultrasound
293635|NCT01693042|heart failure|heart failure
293636|NCT01693042|old myocardial infarction|old myocardial infarction
293637|NCT01693042|bone marrow-derived mononuclear cells|bone marrow-derived mononuclear cells
293639|NCT01693042|ischemic|ischemic
293640|NCT01693029|erythropoietin alfa|erythropoietin alfa
293641|NCT01693029|CKD 5d|ckd 5d
293642|NCT01693016|non-invasive Hb measurement in children|non-invasive hb measurement in children
293643|NCT01693003|COPD|copd
293644|NCT01692990|Appetite|appetite
293645|NCT01692990|Fish oil|fish oil
293646|NCT01692990|Long-chain n-3 fatty acids|long-chain n-3 fatty acids
293647|NCT01691924|Adenosine A2a receptor antagonist|adenosine a2a receptor antagonist
293648|NCT01691924|adenosine receptor modulator|adenosine receptor modulator
293650|NCT01691911|Vascular disease|vascular disease
293651|NCT01691911|Open aortic aneurysm repair|open aortic aneurysm repair
293652|NCT01691911|Endovascular aneurysm repair|endovascular aneurysm repair
293653|NCT01691911|Carotid endartrectomy|carotid endartrectomy
293654|NCT01691911|Lower limb surgical revascularisation|lower limb surgical revascularisation
293655|NCT01691911|Major lower limb amputation|major lower limb amputation
293656|NCT01691859|extension study|extension study
293657|NCT01691859|Severe refractory asthma|severe refractory asthma
293658|NCT01691859|safety|safety
293659|NCT01691859|SB-240563|sb-240563
293660|NCT01691859|mepolizumab|mepolizumab
293661|NCT01691859|eosinophils|eosinophils
293662|NCT01691833|Vitamin D|vitamin d
293663|NCT01691833|nonunion|nonunion
293664|NCT01691833|long bone fracture|long bone fracture
293665|NCT01691833|hypovitaminosis D|hypovitaminosis d
293666|NCT01691820|Adolescent females|adolescent females
293667|NCT01691820|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
293668|NCT01692912|Psoriatic Arthritis|psoriatic arthritis
293669|NCT01692912|Randomized|randomized
293670|NCT01692912|Single blind|single blind
293671|NCT01692912|Treat to target|treat to target
293672|NCT01692899|Retention Rates|retention rates
293673|NCT01692899|of Adalimumab|of adalimumab
293674|NCT01692899|Etanercept and Infliximab|etanercept and infliximab
293675|NCT01692899|as First and Second-Line Biotherapy|as first and second-line biotherapy
293676|NCT01692899|in Patients with Rheumatoid Arthritis|in patients with rheumatoid arthritis
293677|NCT01692899|in Daily Practice.|in daily practice.
293678|NCT01692899|TNF inhibitors|tnf inhibitors
293679|NCT01692899|biotherapy|biotherapy
293680|NCT01692899|retrospective study|retrospective study
293682|NCT01692886|7vPnC|7vpnc
293683|NCT01692886|Healthy subjects|healthy subjects
293684|NCT01692886|China|china
293685|NCT01692873|pancreatic tumor|pancreatic tumor
293686|NCT01692860|the impact of a higher dairy-based protein diet in|the impact of a higher dairy-based protein diet in
293687|NCT01692860|combination with energy restriction on muscle health,|combination with energy restriction on muscle health,
293688|NCT01692860|metabolic health (including blood pressure) in overweight|metabolic health (including blood pressure) in overweight
293689|NCT01692860|and obese, middle aged adults|and obese, middle aged adults
293690|NCT01692847|patient deterioration|patient deterioration
293691|NCT01692847|rapid response teams|rapid response teams
293692|NCT01692847|acute care teams|acute care teams
293693|NCT01692847|early warning scoring|early warning scoring
293694|NCT01692834|bioequivalence|bioequivalence
293695|NCT01692834|pharmacokinetics|pharmacokinetics
293696|NCT01692834|tolerability|tolerability
293697|NCT01692834|safety|safety
293698|NCT01692834|ciclosporin|ciclosporin
293699|NCT01692834|cyclosporine|cyclosporine
293700|NCT01692834|cyclosporine A|cyclosporine a
293701|NCT01692834|Sandimmune|sandimmune
293702|NCT01692834|Sandimmun|sandimmun
293703|NCT01692834|CicloMulsion|ciclomulsion
293704|NCT01692834|NeuroSTAT|neurostat
293705|NCT01692821|retinal oxygen saturation|retinal oxygen saturation
293706|NCT01692821|retinal blood flow|retinal blood flow
293707|NCT01692821|hyperoxia|hyperoxia
293708|NCT01692821|hypoxia|hypoxia
293709|NCT01692808|Crohn|crohn
293710|NCT01692808|vitamin D|vitamin d
293711|NCT01692808|remission|remission
293712|NCT01692808|inflammation|inflammation
293713|NCT01692808|tolerance|tolerance
293714|NCT01692795|Myocardial infarction|myocardial infarction
293715|NCT01692795|Antiplatelets|antiplatelets
293909|NCT01692067|Rape|rape
293716|NCT01692795|Lipid lowering agents|lipid lowering agents
293717|NCT01692795|ACE inhibitors|ace inhibitors
293718|NCT01692795|Angiotensin Receptor Blockers|angiotensin receptor blockers
293719|NCT01692795|Beta blockers|beta blockers
293720|NCT01692795|Blood pressure lowering drugs|blood pressure lowering drugs
293722|NCT01692782|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
293723|NCT01692769|Trauma|trauma
293724|NCT01692769|Pediatric|pediatric
293725|NCT01692769|Intravenous Fluid|intravenous fluid
363688|NCT01394965|ECG|ecg
293726|NCT01692769|Normal Saline|normal saline
293727|NCT01692769|Ringer's Lactate|ringer's lactate
293728|NCT01692743|Telemedicine|telemedicine
293729|NCT01692743|Inflammatory bowel disease|inflammatory bowel disease
293730|NCT01692743|Crohn's disease|crohn's disease
293731|NCT01692743|Ulcerative colitis|ulcerative colitis
293732|NCT01692743|Quality of life|quality of life
293733|NCT01692743|Health care utilization|health care utilization
293734|NCT01692730|Smoking Cessation|smoking cessation
293735|NCT01692730|Web Assisted Tobacco Intervention|web assisted tobacco intervention
293736|NCT01692691|Melanoma Metastatic|melanoma metastatic
293737|NCT01692678|Advanced or Metastatic liposarcoma or leiomyosarcoma|advanced or metastatic liposarcoma or leiomyosarcoma
293739|NCT01692678|L-sarcoma|l-sarcoma
293740|NCT01692678|Liposarcoma|liposarcoma
293741|NCT01692678|Leiomyosarcoma|leiomyosarcoma
293742|NCT01692678|Trabectedin|trabectedin
293743|NCT01692678|Dacarbazine|dacarbazine
293744|NCT01692678|Yondelis|yondelis
293745|NCT01692678|Chinese patients|chinese patients
293746|NCT01692678|Overall survival|overall survival
293747|NCT01692678|Pharmacokinetics|pharmacokinetics
293748|NCT01692665|meibomian gland dysfunction|meibomian gland dysfunction
293749|NCT01692665|keratometric value|keratometric value
293750|NCT01692665|ocular aberration|ocular aberration
293751|NCT01692626|Cetuximab rash|cetuximab rash
293752|NCT01692626|Erbitux rash|erbitux rash
293753|NCT01692626|Rash|rash
293754|NCT01692626|Pimecrolimus|pimecrolimus
293755|NCT01692626|1% Topical pimecrolimus cream|1% topical pimecrolimus cream
293756|NCT01692600|Late oral radiation toxicity|late oral radiation toxicity
293757|NCT01692600|head and neck cancer patients|head and neck cancer patients
293758|NCT01692600|optical coherence tomography|optical coherence tomography
293759|NCT01692600|subsurface imaging|subsurface imaging
293760|NCT01692600|mirometer-resolution imaging|mirometer-resolution imaging
293761|NCT01692600|vascular imaging|vascular imaging
293762|NCT01692600|Doppler optical coherence tomography|doppler optical coherence tomography
293763|NCT01692600|speckle variance optical coherence tomography|speckle variance optical coherence tomography
293764|NCT01692587|PSA|psa
293765|NCT01692587|protein|protein
293766|NCT01692587|prostate|prostate
293767|NCT01692574|depression and obesity treatment|depression and obesity treatment
293768|NCT01692561|Dysautonomia|dysautonomia
293769|NCT01692561|Postural orthostatic tachycardic hypotension|postural orthostatic tachycardic hypotension
293770|NCT01692561|Neurocardiogenic vasovagal syncope|neurocardiogenic vasovagal syncope
293771|NCT01692509|Non invasive ventilation|non invasive ventilation
293772|NCT01692509|Respiratory failure|respiratory failure
293773|NCT01692509|Respiratory comfort|respiratory comfort
293774|NCT01692496|Advanced|advanced
293775|NCT01692496|Metastatic|metastatic
293776|NCT01692496|Liposarcoma|liposarcoma
293777|NCT01692496|Pazopanib|pazopanib
293778|NCT01692483|Prostate neoplasms|prostate neoplasms
293779|NCT01692483|Prostate cancer|prostate cancer
293780|NCT01692483|Castration resistant prostate cancer|castration resistant prostate cancer
293781|NCT01692483|Hormone refractory prostate cancer|hormone refractory prostate cancer
293782|NCT01692483|Abiraterone acetate|abiraterone acetate
293784|NCT01692470|Human immunodeficiency virus type 1 (HIV-1) infection|human immunodeficiency virus type 1 (hiv-1) infection
293785|NCT01692470|HIV-1|hiv-1
293786|NCT01692470|Anti-retroviral naive|anti-retroviral naive
293787|NCT01692470|ARV|arv
293788|NCT01692470|Filipino patients|filipino patients
293789|NCT01692470|Rilpivirine hydrochloride|rilpivirine hydrochloride
293790|NCT01692470|Edurant|edurant
293791|NCT01692457|Rheumatoid Arthritis|rheumatoid arthritis
293792|NCT01692457|Psoriatic Arthritis|psoriatic arthritis
293793|NCT01692457|Ankylosing Spondylitis|ankylosing spondylitis
293794|NCT01692457|Arthritis|arthritis
293795|NCT01692457|Spondylitis|spondylitis
293796|NCT01692457|Joint pain|joint pain
293797|NCT01692457|CNTO148|cnto148
293798|NCT01692457|Golimumab|golimumab
293799|NCT01692457|Simponi|simponi
293800|NCT01692457|Filipino|filipino
293801|NCT01692457|Post-Marketing|post-marketing
293802|NCT01692457|Surveillance|surveillance
293803|NCT01692444|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
293804|NCT01692444|Fibrosis|fibrosis
293805|NCT01692444|Fibroblast|fibroblast
293806|NCT01692444|Lung attenuation|lung attenuation
293807|NCT01692444|Pletysmography|pletysmography
293808|NCT01692418|Anaemia|anaemia
293809|NCT01692418|Blood transfusion|blood transfusion
293810|NCT01692418|Surgery|surgery
293811|NCT01692418|Iron|iron
293812|NCT01692418|Ferric carboxymaltose|ferric carboxymaltose
293813|NCT01692392|Pectus carinatum|pectus carinatum
293814|NCT01692392|Quality of life|quality of life
293815|NCT01692392|Pain, postoperative|pain, postoperative
293816|NCT01692392|Somatosensory disorders|somatosensory disorders
293817|NCT01692379|Acute ischemic stroke|acute ischemic stroke
293818|NCT01692379|endovascular treatment|endovascular treatment
293819|NCT01692379|clinical trial|clinical trial
293820|NCT01692353|Flow mediated dilation|flow mediated dilation
293821|NCT01692353|Carotid intima-media thickness|carotid intima-media thickness
293822|NCT01692353|Ankle-brachial index|ankle-brachial index
293823|NCT01692353|Smokeless tobacco|smokeless tobacco
293824|NCT01692353|Biological markers|biological markers
293825|NCT01692353|Nicotine|nicotine
293826|NCT01692353|Tobacco-specific nitrosamines|tobacco-specific nitrosamines
293827|NCT01692353|Polycyclic aromatic hydrocarbons|polycyclic aromatic hydrocarbons
293828|NCT01692353|Aromatic amines|aromatic amines
293829|NCT01692353|Mercapturic acid metabolites|mercapturic acid metabolites
293830|NCT01692353|Cholesterol|cholesterol
293831|NCT01692353|Blood lipids|blood lipids
293832|NCT01692353|Oxidative stress|oxidative stress
293833|NCT01692353|Inflammation|inflammation
293834|NCT01692353|Cytokines|cytokines
293835|NCT01692340|tomato|tomato
293836|NCT01692340|prostate cancer|prostate cancer
293837|NCT01692340|metabolism|metabolism
293838|NCT01692327|glucose intolerance (20)|glucose intolerance (20)
293839|NCT01692327|Control (20)|control (20)
293840|NCT01692314|Endothelial function|endothelial function
293841|NCT01692314|Microvascular reactivity|microvascular reactivity
293842|NCT01692314|Obesity|obesity
293843|NCT01692314|Adolescents|adolescents
293944|NCT01691768|Tenofovir gel|tenofovir gel
293844|NCT01692301|hypertension, elderly, central aortic pulse pressure, central pulse pressure, pulse wave velocity|hypertension, elderly, central aortic pulse pressure, central pulse pressure, pulse wave velocity
293845|NCT01692262|Metastatic Castrate-Resistant Prostate Cancer (mCRPC),|metastatic castrate-resistant prostate cancer (mcrpc),
293846|NCT01692262|adenocarcinoma of the prostate,|adenocarcinoma of the prostate,
293847|NCT01692262|prostate cancer,|prostate cancer,
293848|NCT01692262|progressive disease,|progressive disease,
293849|NCT01692262|advanced disease.|advanced disease.
293850|NCT01692249|chronic shoulder pain|chronic shoulder pain
293851|NCT01692249|rotator cuff tendinopathy|rotator cuff tendinopathy
293852|NCT01692249|sap therapy|sap therapy
293853|NCT01692249|balneotherapy|balneotherapy
293854|NCT01692236|MRI|mri
293855|NCT01692236|HIV|hiv
293856|NCT01692236|Neurocognitive Disorders|neurocognitive disorders
293857|NCT01692236|Major Depression|major depression
293858|NCT01692236|Vasculopathy|vasculopathy
293859|NCT01692223|Personal genomics|personal genomics
293860|NCT01692223|Genome Sequencing Results|genome sequencing results
293861|NCT01692223|12-167|12-167
293862|NCT01692210|Breast Cancer|breast cancer
293863|NCT01692210|Dexmedetomidine|dexmedetomidine
293864|NCT01692210|Unilateral mastectomy|unilateral mastectomy
293865|NCT01692210|Blood sample collections|blood sample collections
293866|NCT01692210|Immune system|immune system
293867|NCT01692210|White blood cell levels|white blood cell levels
293868|NCT01692197|Leukemia|leukemia
293869|NCT01692197|Acute Myeloid Leukemia|acute myeloid leukemia
293870|NCT01692197|Acute Myelogenous Leukemia|acute myelogenous leukemia
293871|NCT01692197|AML|aml
293872|NCT01692197|Relapsed or Refractory|relapsed or refractory
293873|NCT01692197|High-Risk Myelodysplastic Syndromes|high-risk myelodysplastic syndromes
293874|NCT01692197|HRMDS|hrmds
293875|NCT01692197|E7070|e7070
293876|NCT01692197|Idarubicin|idarubicin
293877|NCT01692197|Idamycin|idamycin
293878|NCT01692197|Cytarabine|cytarabine
293879|NCT01692197|ARA-C|ara-c
293880|NCT01692197|Cytosar|cytosar
293881|NCT01692197|DepoCyt|depocyt
293882|NCT01692197|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
293883|NCT01692197|Dexamethasone|dexamethasone
293884|NCT01692197|Decadron|decadron
293885|NCT01692184|AVL-292|avl-292
293886|NCT01692184|Safety|safety
293887|NCT01692184|Pharmacokinetics|pharmacokinetics
293888|NCT01692184|Pharmacodynamics|pharmacodynamics
293889|NCT01692184|Pharmacology, Clinical|pharmacology, clinical
293890|NCT01692171|Subjects|subjects
293891|NCT01692158|subjects|subjects
293892|NCT01692145|Dry eye syndromes|dry eye syndromes
293893|NCT01692145|Corneal diseases|corneal diseases
293894|NCT01692145|Conjunctival diseases|conjunctival diseases
293895|NCT01692132|Chronic Constipation|chronic constipation
293896|NCT01692132|Prucalopride|prucalopride
293897|NCT01692132|Post Marketing Surveillance|post marketing surveillance
293898|NCT01692119|chronic heart failure|chronic heart failure
293899|NCT01692119|medication adherence|medication adherence
293900|NCT01692119|pharmacy|pharmacy
293901|NCT01692119|interdisciplinary care|interdisciplinary care
293902|NCT01692119|randomized controlled trial|randomized controlled trial
293903|NCT01692119|mortality|mortality
293904|NCT01692119|hospitalization|hospitalization
293905|NCT01692106|Heller myotomy|heller myotomy
293906|NCT01692093|SCORAD|scorad
293907|NCT01692093|Atopic dermatits|atopic dermatits
293908|NCT01692093|Skin health|skin health
293910|NCT01692067|Women|women
293911|NCT01692067|Military|military
293912|NCT01692067|Veterans|veterans
293913|NCT01692067|Post-traumatic Stress Disorder|post-traumatic stress disorder
293914|NCT01692067|Traumatic Brain Injury|traumatic brain injury
293915|NCT01692041|asthma|asthma
293916|NCT01692041|children|children
293917|NCT01692028|vitamin D|vitamin d
293918|NCT01692028|Associational study|associational study
293919|NCT01691976|Mild cognitive impairment|mild cognitive impairment
293920|NCT01691976|Androgen deprivation therapy|androgen deprivation therapy
293921|NCT01691963|Epiglottis|epiglottis
293922|NCT01691963|Intubation|intubation
293923|NCT01691963|Laryngoscopy|laryngoscopy
293924|NCT01691950|Trauma|trauma
293925|NCT01691950|Limb reconstruction|limb reconstruction
293926|NCT01691950|Amputation|amputation
293927|NCT01691950|Functional outcome|functional outcome
293928|NCT01691950|Sensing|sensing
293929|NCT01691937|Thoracic paravertebral block|thoracic paravertebral block
293930|NCT01691937|Postoperative pain|postoperative pain
293931|NCT01691937|Right lobe hepatectomy|right lobe hepatectomy
293932|NCT01691937|Patient controlled analgesia|patient controlled analgesia
293933|NCT01691807|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
293934|NCT01691807|drug-drug interaction|drug-drug interaction
293935|NCT01691807|ofatumumab|ofatumumab
293936|NCT01691807|bendamustine|bendamustine
293937|NCT01691781|Hyperparathyroidism|hyperparathyroidism
293938|NCT01691781|Renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
293939|NCT01691781|ACE inhibitors|ace inhibitors
293940|NCT01691768|microbicides|microbicides
293941|NCT01691768|women|women
293942|NCT01691768|HIV prevention|hiv prevention
293943|NCT01691768|PrEP|prep
293945|NCT01691742|Postoperative constipation|postoperative constipation
293946|NCT01691742|Urogynecologic Surgery|urogynecologic surgery
293947|NCT01691742|MiraLax|miralax
293948|NCT01691742|Docusate Sodium|docusate sodium
293949|NCT01691716|Achilles tendinopathy|achilles tendinopathy
293950|NCT01691716|Tendoactive|tendoactive
293951|NCT01691716|Eccentric training|eccentric training
293952|NCT01691703|Fiber Optic Technology/methods|fiber optic technology/methods
293953|NCT01691703|Intubation, Intratracheal/methods|intubation, intratracheal/methods
293954|NCT01691703|Laryngoscopy/methods|laryngoscopy/methods
293955|NCT01691664|Esophageal Cancer|esophageal cancer
293956|NCT01691664|DC-CIK|dc-cik
293957|NCT01691664|immunotherapy|immunotherapy
293958|NCT01691664|cellular therapy|cellular therapy
293959|NCT01691664|radiation therapy|radiation therapy
293960|NCT01691651|Keratoconus|keratoconus
293961|NCT01691651|Tetanus toxin|tetanus toxin
293962|NCT01691625|Locally advanced esophageal carcinoma|locally advanced esophageal carcinoma
293963|NCT01691625|DC-CIK|dc-cik
293964|NCT01691625|Immunotherapy|immunotherapy
293965|NCT01691612|Role of Pin-1 enzyme in Asthma|role of pin-1 enzyme in asthma
293966|NCT01691599|Infection|infection
293967|NCT01691599|Open tibia fractures|open tibia fractures
293968|NCT01691599|Closed tibia fractures|closed tibia fractures
293969|NCT01691599|Wound infection|wound infection
293970|NCT01691586|implantable defibrillators|implantable defibrillators
293971|NCT01691586|remote patient monitoring|remote patient monitoring
293972|NCT01691586|patient-reported outcomes|patient-reported outcomes
293973|NCT01691586|cost-effectiveness|cost-effectiveness
293974|NCT01691573|ablation|ablation
293975|NCT01691573|procedure|procedure
293976|NCT01691573|pediatric|pediatric
293977|NCT01691573|european|european
293979|NCT01691573|arrhythmias|arrhythmias
293980|NCT01691573|registry|registry
293981|NCT01691573|observational|observational
293982|NCT01691573|prospective|prospective
293983|NCT01691573|catheter|catheter
293984|NCT01691573|cryoablation|cryoablation
293985|NCT01691573|atrioventricular|atrioventricular
293986|NCT01691547|GW642444 (Vilanterol)|gw642444 (vilanterol)
293987|NCT01691547|pharmacokinetics|pharmacokinetics
293988|NCT01691547|pharmacodynamics|pharmacodynamics
293989|NCT01691547|GSK573719 (Umeclidinium)|gsk573719 (umeclidinium)
293990|NCT01691547|healthy subjects|healthy subjects
293991|NCT01691547|GW685698 (Fluticasone Furoate)|gw685698 (fluticasone furoate)
293992|NCT01691534|Tuberculosis|tuberculosis
293993|NCT01691534|EBA|eba
293994|NCT01691534|PA824|pa824
293995|NCT01691534|pretomanid|pretomanid
293996|NCT01691534|TMC207|tmc207
293997|NCT01691521|safety|safety
293998|NCT01691521|SB-240563|sb-240563
293999|NCT01691521|efficacy|efficacy
294000|NCT01691521|placebo|placebo
294001|NCT01691521|eosinophils|eosinophils
294002|NCT01691521|mepolizumab|mepolizumab
294003|NCT01691521|Severe refractory asthma|severe refractory asthma
294004|NCT01691508|Safety|safety
294005|NCT01691508|Steroid Reduction|steroid reduction
294006|NCT01691508|Efficacy|efficacy
294007|NCT01691508|SB-240563|sb-240563
294008|NCT01691508|Eosinophils|eosinophils
294009|NCT01691508|Quality of Life|quality of life
294010|NCT01691508|Mepolizumab|mepolizumab
294011|NCT01691508|Severe Refractory Asthma|severe refractory asthma
294214|NCT01690559|sepsis|sepsis
294012|NCT01691495|Physician Adherence|physician adherence
294013|NCT01691495|superficial vein thrombosis|superficial vein thrombosis
294014|NCT01691495|Fondaparinux|fondaparinux
294015|NCT01691469|Bioequivalence|bioequivalence
294016|NCT01691469|Montelukast Sodium|montelukast sodium
294017|NCT01691469|crossover|crossover
294018|NCT01691456|Bioequivalence|bioequivalence
294019|NCT01691456|Montelukast Sodium|montelukast sodium
294020|NCT01691456|crossover|crossover
294021|NCT01691404|Flavonoids|flavonoids
294022|NCT01691404|Quercetin|quercetin
294023|NCT01691404|Epicatechin|epicatechin
294024|NCT01691404|Vascular function|vascular function
294025|NCT01691404|Blood pressure|blood pressure
294026|NCT01691404|Endothelial function|endothelial function
294027|NCT01691391|Advanced CRC|advanced crc
294028|NCT01691378|Veterans|veterans
294029|NCT01691378|Window to Hope|window to hope
294030|NCT01691378|Cognitive Behavioral Therapy|cognitive behavioral therapy
294031|NCT01691378|Traumatic Brain Injury|traumatic brain injury
294032|NCT01691378|Hopelessness|hopelessness
294033|NCT01691378|Suicide|suicide
294034|NCT01691365|Antioxidant|antioxidant
294035|NCT01691365|vitamins|vitamins
294036|NCT01691365|Diet|diet
294037|NCT01691352|Wound infection|wound infection
294038|NCT01691352|Ostomy reversal|ostomy reversal
294039|NCT01691339|Influenza|influenza
294040|NCT01691339|Influenza virus vaccine|influenza virus vaccine
294041|NCT01691339|Fluzone® (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® (influenza virus vaccine) 2012-2013 formulation
294042|NCT01691339|Fluzone® High-Dose (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® high-dose (influenza virus vaccine) 2012-2013 formulation
294043|NCT01691339|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
294143|NCT01690949|COPD|copd
294144|NCT01690949|respiratory disease|respiratory disease
294044|NCT01691339|Fluzone® Intradermal (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® intradermal (influenza virus vaccine) 2012-2013 formulation
294045|NCT01691326|Influenza|influenza
294046|NCT01691326|Fluzone® (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® (influenza virus vaccine) 2012-2013 formulation
294047|NCT01691326|Influenza virus vaccine|influenza virus vaccine
294048|NCT01691326|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
294049|NCT01691313|vanoxerine|vanoxerine
294050|NCT01691313|atrial fibrillation|atrial fibrillation
294051|NCT01691313|atrial flutter|atrial flutter
294052|NCT01691313|a-fib|a-fib
294053|NCT01691300|C11-acetate PET/CT|c11-acetate pet/ct
294054|NCT01691300|Multiple myeloma|multiple myeloma
294055|NCT01691300|Pretreatment staging|pretreatment staging
294056|NCT01691300|Response assessment|response assessment
294057|NCT01691287|Type 1 Diabetes|type 1 diabetes
294058|NCT01691287|Metabolic Control|metabolic control
294059|NCT01691287|Quality of Life|quality of life
294060|NCT01691274|Epilepsy|epilepsy
294061|NCT01691274|Phase 1|phase 1
294062|NCT01691274|Multiple Dose|multiple dose
294063|NCT01691274|Safety|safety
293721|NCT01692782|ADHD|adhd
294064|NCT01691274|Pharmacokinetics|pharmacokinetics
294065|NCT01691274|Toleration|toleration
294066|NCT01691248|Clostridium difficile|clostridium difficile
294067|NCT01691248|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
294068|NCT01691248|Prophylaxis|prophylaxis
294069|NCT01691248|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
294070|NCT01691235|SIMpill|simpill
294071|NCT01691235|HCV|hcv
294072|NCT01691235|Chronic Hepatitis C Virus|chronic hepatitis c virus
294073|NCT01691222|Bedside percutaneous tracheostomy|bedside percutaneous tracheostomy
294074|NCT01691222|Intensive Care Unit|intensive care unit
294075|NCT01691222|Dedicated Double-lumen tube|dedicated double-lumen tube
294076|NCT01691222|Ineffective Airway Clearance|ineffective airway clearance
294077|NCT01691222|weaning failure|weaning failure
294078|NCT01691209|Phoenix|phoenix
294079|NCT01691209|Hydrocortison|hydrocortison
294080|NCT01691209|mild atopic dermatitis|mild atopic dermatitis
294081|NCT01691209|efficacy|efficacy
294082|NCT01691209|safety|safety
294083|NCT01691196|Obesity|obesity
294084|NCT01691196|Peritoneal dialysis|peritoneal dialysis
294085|NCT01691196|Inflammation|inflammation
294086|NCT01691196|Macrophages|macrophages
294087|NCT01691196|Innate immunity|innate immunity
294088|NCT01691183|Hertel|hertel
294089|NCT01691183|exophthalmometer|exophthalmometer
294090|NCT01691183|proptosis|proptosis
294091|NCT01691183|eye disease|eye disease
294092|NCT01691170|Pattelofemoral pain syndrome|pattelofemoral pain syndrome
294093|NCT01691170|Stretching|stretching
294094|NCT01691170|Strengthening|strengthening
294095|NCT01691157|Subacromial impingement syndrome|subacromial impingement syndrome
294096|NCT01691157|Rotator cuff|rotator cuff
294097|NCT01691157|Exercise|exercise
294098|NCT01691157|Physiotherapy|physiotherapy
294099|NCT01691144|cancer|cancer
294100|NCT01691144|gynecological|gynecological
294101|NCT01691144|expectations|expectations
294102|NCT01691144|satisfaction|satisfaction
294103|NCT01691144|cooperation|cooperation
294104|NCT01691131|Physical activity in daily life|physical activity in daily life
294105|NCT01691131|Balance|balance
294106|NCT01691131|COPD|copd
294107|NCT01691131|Exercise training|exercise training
294108|NCT01691118|Hypertension|hypertension
294213|NCT01690559|Ciprofloxacin|ciprofloxacin
294109|NCT01691118|Angiotensin Receptor Blocker|angiotensin receptor blocker
294110|NCT01691118|Diastolic Dysfunction|diastolic dysfunction
294111|NCT01691105|Tobacco Use Cessation|tobacco use cessation
294112|NCT01691105|Smoking Cessation|smoking cessation
294113|NCT01691105|Nicotine Replacement Therapy|nicotine replacement therapy
294114|NCT01691105|Hospitalized Smokers|hospitalized smokers
294115|NCT01691092|Depression|depression
294116|NCT01691092|Ketamine|ketamine
294118|NCT01691092|PTSD|ptsd
294119|NCT01691053|End stage renal disease|end stage renal disease
294120|NCT01691053|Hemodialysis|hemodialysis
294121|NCT01691053|Spironolactone|spironolactone
294122|NCT01691053|Left ventricular hypertrophy|left ventricular hypertrophy
294123|NCT01691040|Hepcidin|hepcidin
294124|NCT01691040|Iron|iron
294125|NCT01691040|Anemia of Chronic Disease|anemia of chronic disease
294126|NCT01691040|Anemia|anemia
294127|NCT01691040|Cancer|cancer
294128|NCT01691040|Interleukin-6|interleukin-6
294129|NCT01691040|Iron restriction|iron restriction
294130|NCT01691040|Lymphoma|lymphoma
294131|NCT01691040|CLL|cll
294132|NCT01691040|Multiple Myeloma|multiple myeloma
294133|NCT01691040|Hodgkin|hodgkin
294134|NCT01691040|anti-hepcidin|anti-hepcidin
294135|NCT01691027|scotoma, central|scotoma, central
294136|NCT01691027|visual motor coordination|visual motor coordination
294137|NCT01690988|Delirium|delirium
294138|NCT01690988|ketamine|ketamine
294139|NCT01690988|surgery|surgery
294140|NCT01690988|neurological complications|neurological complications
294141|NCT01690962|diabetic neuropathy, diet, vegan, vegetarian|diabetic neuropathy, diet, vegan, vegetarian
294142|NCT01690949|inflammation|inflammation
294145|NCT01690949|healthy volunteers|healthy volunteers
294146|NCT01690936|Almonds|almonds
294147|NCT01690936|Body weight|body weight
294148|NCT01690936|Snacking|snacking
294149|NCT01690910|Ventilator|ventilator
294150|NCT01690910|Mobility Limitations|mobility limitations
294151|NCT01690910|Critical Care|critical care
294152|NCT01690910|Rifton Gait Trainer|rifton gait trainer
294153|NCT01690897|Female sexual desire|female sexual desire
294154|NCT01690897|Psychoeducational intervention|psychoeducational intervention
294155|NCT01690897|Mindfulness|mindfulness
294156|NCT01690884|Adenosine|adenosine
294157|NCT01690884|Ticagrelor|ticagrelor
294158|NCT01690884|Microdialysis|microdialysis
294159|NCT01690871|Malignant PEComa|malignant pecoma
294160|NCT01690871|Angiomyolipoma|angiomyolipoma
294161|NCT01690871|Tuberous Sclerosis Complex|tuberous sclerosis complex
294162|NCT01690871|Pi3kinase /m-tor inhibitors|pi3kinase /m-tor inhibitors
294163|NCT01690858|Foetal loss|foetal loss
294164|NCT01690858|complement|complement
294165|NCT01690858|antiangiogenic factors|antiangiogenic factors
294166|NCT01690858|Repeated fetal losses|repeated fetal losses
294167|NCT01690832|Contrast induced acute kidney injury|contrast induced acute kidney injury
294168|NCT01690819|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
294169|NCT01690819|Acute Brain Injury|acute brain injury
294170|NCT01690793|ASTHMA|asthma
294171|NCT01690793|ACUTE EXACERBATION OF ASTHMA|acute exacerbation of asthma
294172|NCT01690780|fracture|fracture
294173|NCT01690780|pediatric|pediatric
294174|NCT01690780|oral morphine|oral morphine
294175|NCT01690780|ibuprofen|ibuprofen
294176|NCT01690767|Urethral catheterization|urethral catheterization
294177|NCT01690767|Lidocaine|lidocaine
294178|NCT01690754|SMS|sms
294179|NCT01690754|tuberculosis|tuberculosis
294180|NCT01690754|impact evaluation|impact evaluation
294181|NCT01690741|Cancer|cancer
294182|NCT01690741|Malignancy|malignancy
294183|NCT01690741|Solid tumors|solid tumors
294184|NCT01690728|Obesity|obesity
294185|NCT01690728|Gastric bypass|gastric bypass
294186|NCT01690715|Hepatocellular Carcinoma|hepatocellular carcinoma
294187|NCT01690715|Thrombosis|thrombosis
294188|NCT01690715|Portal Vein Invasion|portal vein invasion
294189|NCT01690702|breast cancer|breast cancer
294190|NCT01690702|tailored|tailored
294191|NCT01690702|high-risk|high-risk
294192|NCT01690676|FMD|fmd
294193|NCT01690676|epicatechin|epicatechin
294194|NCT01690676|apple polyphenol|apple polyphenol
294195|NCT01690676|borderline hypertension|borderline hypertension
294196|NCT01690650|Preterm|preterm
294197|NCT01690650|Newborn|newborn
294198|NCT01690650|Neonate|neonate
294199|NCT01690650|Cerebral oxygenation|cerebral oxygenation
294200|NCT01690650|Oxygen|oxygen
294201|NCT01690637|Oseltamivir|oseltamivir
294202|NCT01690637|Tamiflu|tamiflu
294203|NCT01690611|Balance Training|balance training
294204|NCT01690611|Walking|walking
294205|NCT01690611|Falls|falls
294206|NCT01690598|Epithelial ovarian cancer|epithelial ovarian cancer
294207|NCT01690598|BRCA mutation|brca mutation
294208|NCT01690598|Platinum resistant|platinum resistant
294209|NCT01690598|Platinum sensitive|platinum sensitive
294210|NCT01690598|Relapsed ovarian cancer|relapsed ovarian cancer
294211|NCT01690572|drug eluting balloon|drug eluting balloon
294212|NCT01690572|constrictive remodeling|constrictive remodeling
294215|NCT01690559|infection|infection
294216|NCT01690559|pneumonia|pneumonia
294217|NCT01690559|peritonitis|peritonitis
294218|NCT01690559|cholecystitis|cholecystitis
285566|NCT01728740|FDC|fdc
294219|NCT01690559|cholangitis|cholangitis
294220|NCT01690559|anthrax|anthrax
294221|NCT01690546|Opioid Addiction|opioid addiction
294222|NCT01690546|Addiction|addiction
294223|NCT01690546|Drug Dependence|drug dependence
294224|NCT01690533|Avelox|avelox
294225|NCT01690533|Laryngopharyngitis|laryngopharyngitis
294226|NCT01690533|Tonsillitis|tonsillitis
294227|NCT01690533|Bronchitis acute|bronchitis acute
294228|NCT01690533|Pneumonia|pneumonia
294229|NCT01690533|Secondary infection in chronic respiratory diseases Sinusitis|secondary infection in chronic respiratory diseases sinusitis
294230|NCT01690507|demethylating agent|demethylating agent
294231|NCT01690507|immunogenicity|immunogenicity
294232|NCT01690494|STI|sti
294233|NCT01690494|sexually transmitted infection|sexually transmitted infection
294234|NCT01690494|HIV|hiv
294235|NCT01690494|criminal justice|criminal justice
294236|NCT01690494|probation|probation
294237|NCT01690494|couples|couples
294238|NCT01690494|drug use|drug use
294239|NCT01690442|HIV|hiv
294240|NCT01690442|AIDS|aids
294241|NCT01690442|Prevention|prevention
294242|NCT01690429|Arousal detection|arousal detection
294243|NCT01690429|Pulse Wave Amplitude|pulse wave amplitude
294244|NCT01690429|Obstructive Sleep Apnea|obstructive sleep apnea
294245|NCT01690429|Daytime sleepiness|daytime sleepiness
294246|NCT01690429|Cardiorespiratory risk|cardiorespiratory risk
294247|NCT01690377|Dendritic Cells|dendritic cells
294248|NCT01690364|Motor evoked potential monitoring|motor evoked potential monitoring
294249|NCT01690364|General Anesthesia|general anesthesia
294250|NCT01690364|Neurosurgery|neurosurgery
294251|NCT01690364|Cisatracurium|cisatracurium
294252|NCT01690364|Vecuronium|vecuronium
294253|NCT01690338|TOFr (train of four ratio)|tofr (train of four ratio)
294254|NCT01690338|airway extubation|airway extubation
294255|NCT01690338|PACU (postanesthesia care unit)|pacu (postanesthesia care unit)
294256|NCT01690338|PORC (postoperative residual curarization)|porc (postoperative residual curarization)
294257|NCT01690325|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
294258|NCT01690325|Neoadjuvant cytotoxic-antiangiogenic therapy|neoadjuvant cytotoxic-antiangiogenic therapy
294259|NCT01690325|Bevacizumab|bevacizumab
294260|NCT01690325|PET|pet
294261|NCT01690312|Humans|humans
294262|NCT01690312|Cardiovascular Disease|cardiovascular disease
294263|NCT01690312|Statins|statins
294264|NCT01690312|Fish Oil|fish oil
294265|NCT01690312|DHA|dha
294266|NCT01690312|EPA|epa
294267|NCT01690312|High-DHA|high-dha
294268|NCT01690312|Triglycerides|triglycerides
294269|NCT01690312|Total cholesterol [TC]|total cholesterol [tc]
294270|NCT01690312|Lipoproteins|lipoproteins
753203|NCT01175876|S100B|s100b
294271|NCT01690312|High-density lipoprotein [HDL2, HDL3]|high-density lipoprotein [hdl2, hdl3]
294272|NCT01690312|Low-density lipoprotein [LDL1+2+3+4]|low-density lipoprotein [ldl1+2+3+4]
294273|NCT01690312|Lipoprotein A [Lp(a)]|lipoprotein a [lp(a)]
294274|NCT01690312|Intermediate-density lipoprotein (IDL)|intermediate-density lipoprotein (idl)
294275|NCT01690312|Very low-density lipoprotein (VLDL1+2, VLDL3)|very low-density lipoprotein (vldl1+2, vldl3)
294276|NCT01690312|Remnant Lipoproteins|remnant lipoproteins
294277|NCT01690312|High-sensitivity C-Reactive Protein [hs-CRP]|high-sensitivity c-reactive protein [hs-crp]
294278|NCT01690312|Homocysteine|homocysteine
294279|NCT01690312|Essential Fatty Acid Profile|essential fatty acid profile
294280|NCT01690312|Apolipoprotein B|apolipoprotein b
294281|NCT01690312|Apolipoprotein A-1|apolipoprotein a-1
294282|NCT01690312|Glucose|glucose
294283|NCT01690312|Insulin|insulin
294284|NCT01690312|Fasted|fasted
294285|NCT01690312|Post-Prandial|post-prandial
294286|NCT01690299|Psoriasis|psoriasis
294287|NCT01690299|arthritis|arthritis
294288|NCT01690299|psoriatic|psoriatic
294289|NCT01690299|palmoplantar|palmoplantar
294290|NCT01690299|scalp|scalp
294291|NCT01690299|psoriasis pill|psoriasis pill
294292|NCT01690299|psoriasis tablet|psoriasis tablet
294293|NCT01690299|plaque psoriasis|plaque psoriasis
294294|NCT01690299|plaque type psoriasis|plaque type psoriasis
294295|NCT01690299|moderate to severe plaque type psoriasis|moderate to severe plaque type psoriasis
294296|NCT01690299|psoriatic arthritis|psoriatic arthritis
294297|NCT01690286|Healthy|healthy
294298|NCT01690286|Ketoconazole|ketoconazole
294299|NCT01690286|JNJ-38518168|jnj-38518168
294300|NCT01690286|Pharmacokinetics|pharmacokinetics
294301|NCT01690273|exercise|exercise
294302|NCT01690273|mobility|mobility
294303|NCT01690273|strengthening|strengthening
294304|NCT01690273|physiotherapy|physiotherapy
294305|NCT01690260|Bone|bone
294306|NCT01690260|Morphogenetic|morphogenetic
294307|NCT01690260|Protein|protein
294308|NCT01690260|Ilizarow|ilizarow
294309|NCT01690260|Autologous|autologous
294310|NCT01690260|Osteoarthritis|osteoarthritis
294311|NCT01690247|mesenchymal stem cells|mesenchymal stem cells
294312|NCT01690247|liver transplantation|liver transplantation
294313|NCT01690247|clinical trial|clinical trial
294314|NCT01690247|rejection|rejection
294315|NCT01690234|Low back pain|low back pain
284917|NCT01731756|Neem|neem
294316|NCT01690234|Return to work|return to work
294317|NCT01690234|Sickness absence|sickness absence
294318|NCT01690234|Rehabilitation|rehabilitation
294319|NCT01690234|Multidisciplinary intervention|multidisciplinary intervention
294320|NCT01690221|Anal|anal
294321|NCT01690221|Fissure|fissure
294322|NCT01690221|Pain|pain
294323|NCT01690208|Diabetes|diabetes
294324|NCT01690208|Structure Care|structure care
294325|NCT01690182|Gastrointestinal physiology|gastrointestinal physiology
294327|NCT01690182|gastric volumes|gastric volumes
294328|NCT01690182|satiety|satiety
294329|NCT01690156|In-plane|in-plane
294330|NCT01690156|Ultrasound-guided regional anesthesia performance|ultrasound-guided regional anesthesia performance
294331|NCT01690156|Probe position|probe position
294332|NCT01690156|Needle visualization|needle visualization
294333|NCT01690130|nicotine|nicotine
294334|NCT01690130|craving|craving
294335|NCT01690130|smoking|smoking
294336|NCT01690130|TMS|tms
294337|NCT01690130|prefrontal cortex|prefrontal cortex
294338|NCT01690117|family caregiver|family caregiver
294339|NCT01690117|dementia|dementia
294340|NCT01690117|intervention|intervention
294341|NCT01690117|implementation|implementation
294342|NCT01690104|rifampicin|rifampicin
294343|NCT01690104|pregnane X receptor|pregnane x receptor
294344|NCT01690104|blood pressure|blood pressure
294345|NCT01690091|chronic heart failure|chronic heart failure
294346|NCT01690091|type 2 diabetes|type 2 diabetes
294347|NCT01690091|metformin|metformin
294348|NCT01690091|insulin resistance|insulin resistance
294349|NCT01690078|Airway modeling|airway modeling
294350|NCT01690078|Pierre Robin Sequence or PRS|pierre robin sequence or prs
294351|NCT01690078|Micrognathia|micrognathia
294352|NCT01690078|Subglottic Stenosis or SGS|subglottic stenosis or sgs
294353|NCT01690065|chronic myeloid leukemia|chronic myeloid leukemia
294354|NCT01690065|myeloid blastic phase|myeloid blastic phase
294355|NCT01690065|bcr-abl(+) acute myeloid leukemia|bcr-abl(+) acute myeloid leukemia
294356|NCT01690065|nilotinib|nilotinib
294357|NCT01690052|dry mouth|dry mouth
294358|NCT01690039|renal tubular acidosis|renal tubular acidosis
294359|NCT01690039|V-ATPase|v-atpase
294360|NCT01690039|kidney stones|kidney stones
294361|NCT01689974|Metastatic Melanoma|metastatic melanoma
294362|NCT01689974|Radiation Therapy|radiation therapy
294363|NCT01689974|Immunology|immunology
294364|NCT01689974|Abscopal|abscopal
294365|NCT01689961|Nutrition|nutrition
294366|NCT01689961|Physical activity|physical activity
294367|NCT01689961|Gestational weight gain|gestational weight gain
294368|NCT01689961|Pregnancy outcomes|pregnancy outcomes
294369|NCT01689961|Birth|birth
294370|NCT01689948|Home care, rehabilitation therapy, Alzheimer's disease|home care, rehabilitation therapy, alzheimer's disease
294371|NCT01689935|Acne vulgaris|acne vulgaris
294372|NCT01689935|Photodynamic Therapy|photodynamic therapy
294373|NCT01689935|Side-effects|side-effects
294374|NCT01689935|Pain|pain
294375|NCT01689909|Insomnia|insomnia
294376|NCT01689909|Depression|depression
294377|NCT01689909|Suicidal ideation|suicidal ideation
294378|NCT01689909|Zolpidem CR|zolpidem cr
294379|NCT01689909|Placebo|placebo
294380|NCT01689896|Hypogonadism|hypogonadism
294381|NCT01689896|Low testosterone|low testosterone
294382|NCT01689896|Pain|pain
294383|NCT01689883|stroke|stroke
294384|NCT01689883|electrical stimulation|electrical stimulation
294385|NCT01689870|OX40|ox40
294386|NCT01689870|Anti-OX40|anti-ox40
294387|NCT01689870|Ipilimumab|ipilimumab
294388|NCT01689870|Melanoma|melanoma
294389|NCT01689857|hypertropic scar, Vancouver scar scale, silicon gel sheet|hypertropic scar, vancouver scar scale, silicon gel sheet
294390|NCT01689844|controlled high blood pressure|controlled high blood pressure
294391|NCT01689818|insomnia, elderly, exercise training|insomnia, elderly, exercise training
294392|NCT01689805|Atopic dermatitis|atopic dermatitis
294393|NCT01689805|Filaggrin|filaggrin
294394|NCT01689779|vitamin D|vitamin d
294395|NCT01689779|surgery|surgery
294396|NCT01689779|acute stress|acute stress
294397|NCT01689766|Renal Cell|renal cell
294398|NCT01689753|Renal dialyse|renal dialyse
294399|NCT01689753|Catheter, indwelling|catheter, indwelling
294400|NCT01689753|Catheter-related infection|catheter-related infection
294401|NCT01689740|MDMA|mdma
294402|NCT01689740|Posttraumatic stress disorder|posttraumatic stress disorder
294403|NCT01689740|PTSD|ptsd
294404|NCT01689740|Israel|israel
294405|NCT01689740|psychotherapy|psychotherapy
294406|NCT01689727|Pituitary Tumors|pituitary tumors
294407|NCT01689714|Ovarian Carcinoma|ovarian carcinoma
294408|NCT01689714|Recurrent Endometrial Carcinoma|recurrent endometrial carcinoma
294409|NCT01689701|Erosive Gastritis|erosive gastritis
294410|NCT01689701|Hizikia Fusiformis|hizikia fusiformis
294411|NCT01689675|musculoskeletal|musculoskeletal
294412|NCT01689675|pain|pain
294413|NCT01689675|pain management|pain management
294414|NCT01689675|computer based intervention|computer based intervention
294415|NCT01689662|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
294416|NCT01689649|Epilepsy|epilepsy
294417|NCT01689649|Seizures|seizures
294418|NCT01689649|Topiramate|topiramate
294419|NCT01689649|Anti-epileptic drug|anti-epileptic drug
294420|NCT01689649|Nervous disorder|nervous disorder
294421|NCT01689636|Ovarian Cancer|ovarian cancer
294422|NCT01689623|Healthy participants|healthy participants
294423|NCT01689623|TMC435|tmc435
294424|NCT01689623|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
294425|NCT01689623|Atorvastatin|atorvastatin
294426|NCT01689623|Simvastatin|simvastatin
294427|NCT01689623|Pharmacokinetic interaction|pharmacokinetic interaction
294428|NCT01689610|Nab-Paclitaxel|nab-paclitaxel
294429|NCT01689610|Abraxane|abraxane
294430|NCT01689610|Nabucco|nabucco
294431|NCT01689610|safety|safety
294432|NCT01689610|breast cancer|breast cancer
294433|NCT01689610|daily routine|daily routine
294434|NCT01689610|peripheral neuropathy|peripheral neuropathy
294435|NCT01689610|iOMEDICO|iomedico
294436|NCT01689584|BRCA1|brca1
294437|NCT01689584|BRCA2|brca2
294438|NCT01689584|VUS|vus
294439|NCT01689584|co-segregation|co-segregation
294440|NCT01689584|genetic counseling|genetic counseling
294441|NCT01689571|PDE4 inhibitor|pde4 inhibitor
294442|NCT01689571|Allergen Challenge|allergen challenge
294443|NCT01689571|Asthma|asthma
294444|NCT01689558|nasopharynx cancer,Image department of nose pharynx ministry|nasopharynx cancer,image department of nose pharynx ministry
294445|NCT01689545|HIV|hiv
294446|NCT01689545|drug abuse|drug abuse
294447|NCT01689545|social stigma|social stigma
294448|NCT01689545|Vietnam|vietnam
294449|NCT01689532|Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine|active rheumatoid arthritis unresponsive to methotrexate or sulfasalazine
294450|NCT01689532|Sirukumab|sirukumab
294764|NCT01688232|CD8|cd8
294451|NCT01689532|Human Anti-IL-6 Monoclonal Antibody|human anti-il-6 monoclonal antibody
294452|NCT01689519|Zelboraf|zelboraf
294453|NCT01689519|vemurafenib|vemurafenib
294454|NCT01689519|RG7204|rg7204
294455|NCT01689519|PLX4032|plx4032
294456|NCT01689519|Genentech MEK inhibitor|genentech mek inhibitor
294457|NCT01689519|Genentech BRAF inhibitor|genentech braf inhibitor
294458|NCT01689519|Roche MEK inhibitor|roche mek inhibitor
294459|NCT01689519|Roche BRAF inhibitor|roche braf inhibitor
294460|NCT01689519|RO5185426|ro5185426
294461|NCT01689519|metastatic melanoma|metastatic melanoma
294462|NCT01689519|BRAF positive melanoma|braf positive melanoma
294463|NCT01689519|BRAF mutant melanoma|braf mutant melanoma
294464|NCT01689519|advanced melanoma|advanced melanoma
294465|NCT01689519|Genentech RAF inhibitor|genentech raf inhibitor
294466|NCT01689519|Roche RAF inhibitor|roche raf inhibitor
294467|NCT01689519|BRAF V600E kinase inhibitor|braf v600e kinase inhibitor
294468|NCT01689519|Oncogenic BRAF inhibitor|oncogenic braf inhibitor
294469|NCT01689519|BRAF kinase inhibitor|braf kinase inhibitor
294470|NCT01689519|GDC-0973|gdc-0973
294471|NCT01689519|XL518|xl518
294472|NCT01689519|melanoma|melanoma
294473|NCT01689480|Muscular Dystrophy|muscular dystrophy
294474|NCT01689480|Facioscapulohumeral|facioscapulohumeral
294475|NCT01689480|Physical training|physical training
294476|NCT01689480|Exercise|exercise
294477|NCT01689454|IVF|ivf
294478|NCT01689454|embryo culture|embryo culture
294479|NCT01689454|Ongoing pregnancy rate|ongoing pregnancy rate
294480|NCT01689454|Ongoing implantation rate|ongoing implantation rate
294481|NCT01689454|Miscarriage|miscarriage
294482|NCT01689428|IVF|ivf
294483|NCT01689428|Embryo culture|embryo culture
294484|NCT01689428|Ongoing Pregnancy rate|ongoing pregnancy rate
294485|NCT01689428|Ongoing Implantation rate|ongoing implantation rate
294486|NCT01689428|Miscarriage|miscarriage
294487|NCT01689415|Renal nerve denervation|renal nerve denervation
294488|NCT01689389|Schizophrenia|schizophrenia
294489|NCT01689389|Bipolar episodes|bipolar episodes
294490|NCT01689389|France|france
294491|NCT01689389|Xeroquel|xeroquel
294492|NCT01689389|Real-life|real-life
294493|NCT01689363|hyaluronidase|hyaluronidase
294494|NCT01689363|enzymes with tissue spreading activity|enzymes with tissue spreading activity
294495|NCT01689363|allergic reaction|allergic reaction
294496|NCT01689363|intradermal skin testing|intradermal skin testing
294497|NCT01689350|Cyclophosphamide|cyclophosphamide
294498|NCT01689350|genotype-based therapy|genotype-based therapy
294499|NCT01689350|prospective study|prospective study
294500|NCT01689337|Microfracture surgery|microfracture surgery
294501|NCT01689337|Cartilage repair|cartilage repair
294502|NCT01689337|Knee surgery|knee surgery
294503|NCT01689324|Pertussis|pertussis
294504|NCT01689324|Tetanus|tetanus
294505|NCT01689324|Diphtheria|diphtheria
294506|NCT01689324|Acellular pertussis|acellular pertussis
294507|NCT01689324|ADACEL®|adacel®
294508|NCT01689324|Tdap vaccine|tdap vaccine
294509|NCT01689311|Uterine contraction|uterine contraction
294510|NCT01689311|Dose response|dose response
294511|NCT01689311|Non-laboring|non-laboring
294512|NCT01689311|Laboring|laboring
294513|NCT01689311|Laboring with oxytocin augmentation|laboring with oxytocin augmentation
294514|NCT01689311|Oxytocin|oxytocin
285128|NCT01730586|ABI-007|abi-007
294515|NCT01689311|Ergonovine|ergonovine
294516|NCT01689311|Prostaglandin F2alpha|prostaglandin f2alpha
294517|NCT01689311|Misoprostol|misoprostol
294518|NCT01689298|Uterine contraction|uterine contraction
294519|NCT01689298|Dose response|dose response
294520|NCT01689298|Oxytocin pretreatment|oxytocin pretreatment
294521|NCT01689298|Oxytocin|oxytocin
294527|NCT01689272|Kidney transplantation,functional status,survival.|kidney transplantation,functional status,survival.
294529|NCT01689246|Alzheimer Disease|alzheimer disease
294530|NCT01689246|TRx0237|trx0237
294532|NCT01689246|Neurodegenerative Diseases|neurodegenerative diseases
294533|NCT01689246|Dementia|dementia
294534|NCT01689246|Brain Diseases|brain diseases
294535|NCT01689233|Alzheimer's Disease|alzheimer's disease
294536|NCT01689233|Alzheimer Disease|alzheimer disease
294537|NCT01689233|TRx0237|trx0237
294539|NCT01689233|Neurodegenerative Diseases|neurodegenerative diseases
294540|NCT01689233|Dementia|dementia
294541|NCT01689233|Brain Diseases|brain diseases
294542|NCT01689207|Phase I, Safety, tolerability, healthy.|phase i, safety, tolerability, healthy.
294543|NCT01689155|Meningitis|meningitis
294544|NCT01689155|Meningococcal Infection|meningococcal infection
294545|NCT01689155|Menactra®|menactra®
294546|NCT01689103|Alcohol use disorders|alcohol use disorders
294547|NCT01689103|Treatment|treatment
294548|NCT01689103|Outpatient|outpatient
294549|NCT01689103|Therapeutic alliance|therapeutic alliance
294550|NCT01689051|Type 2 diabetes|type 2 diabetes
294551|NCT01689051|Blod pressure|blod pressure
294552|NCT01689051|Glucagon-like peptide-1|glucagon-like peptide-1
294553|NCT01689051|Human physiology|human physiology
294554|NCT01689051|Blood flow|blood flow
294555|NCT01688999|Kidney Cancer|kidney cancer
294556|NCT01688999|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
294557|NCT01688999|Bladder Cancer|bladder cancer
294558|NCT01688986|Complex Disease|complex disease
294559|NCT01688986|DNA Biorepository|dna biorepository
294560|NCT01688986|Genotype-Phenotype Correlation|genotype-phenotype correlation
294561|NCT01688986|Genetics|genetics
294562|NCT01688986|Environmental Factors|environmental factors
294564|NCT01688947|Neuralgia, Postherpetic|neuralgia, postherpetic
294565|NCT01688934|Pain|pain
294566|NCT01688934|Osteoarthritis|osteoarthritis
294567|NCT01688934|Knee|knee
294568|NCT01688921|Injections, Jet|injections, jet
294569|NCT01688921|Influenza Vaccines|influenza vaccines
294570|NCT01688908|Esophageal Squamous Cell carcinomas|esophageal squamous cell carcinomas
294571|NCT01688908|Endoscopy Screening|endoscopy screening
294572|NCT01688908|High risk region|high risk region
294573|NCT01688908|China|china
294574|NCT01688895|erythropoietic|erythropoietic
294575|NCT01688895|protoporphyria|protoporphyria
294576|NCT01688895|cutaneous|cutaneous
294577|NCT01688895|porphyria|porphyria
294578|NCT01688882|bullous pemphigoid|bullous pemphigoid
294579|NCT01688882|QGE031|qge031
294580|NCT01688869|brain concussion|brain concussion
294588|NCT01688843|bradycardia|bradycardia
294589|NCT01688843|sinus node dysfunction|sinus node dysfunction
294590|NCT01688817|Colorectal Neoplasms|colorectal neoplasms
294591|NCT01688817|Colonoscopy|colonoscopy
294592|NCT01688817|Early Detection of Cancer|early detection of cancer
294593|NCT01688817|Patient Selection|patient selection
294594|NCT01688817|Patient Participation|patient participation
294595|NCT01688817|Physicians, Primary Care|physicians, primary care
294596|NCT01688817|Conscious Sedation|conscious sedation
294597|NCT01688804|Sedentary behavior|sedentary behavior
294598|NCT01688804|Physical activity|physical activity
294599|NCT01688804|Obesity|obesity
294600|NCT01688804|Mobile health|mobile health
294601|NCT01688804|Smartphone|smartphone
294602|NCT01688778|Type 2 diabetes|type 2 diabetes
294603|NCT01688778|Quality of life|quality of life
294604|NCT01688778|Lifestyle intervention|lifestyle intervention
294605|NCT01688778|Telemedicine|telemedicine
294606|NCT01688778|Videoconference|videoconference
294607|NCT01688765|Schizophrenia|schizophrenia
294608|NCT01688765|Schizoaffective disorder|schizoaffective disorder
294609|NCT01688765|Bipolar disorder|bipolar disorder
294610|NCT01688739|Migraine|migraine
294611|NCT01688726|Dry eye|dry eye
294612|NCT01688726|Ocular surface|ocular surface
294613|NCT01688726|Vision complaint|vision complaint
294614|NCT01688726|Tear film stability|tear film stability
294615|NCT01688726|Time controlled functional visual acuity|time controlled functional visual acuity
294616|NCT01688726|Tear film kinetics|tear film kinetics
294617|NCT01688700|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
294618|NCT01688700|neoadjuvant therapy|neoadjuvant therapy
294619|NCT01688700|Nimotuzumab|nimotuzumab
294620|NCT01687699|cardiovascular event|cardiovascular event
294621|NCT01687699|hemodialysis|hemodialysis
294622|NCT01687699|spironolactone|spironolactone
294623|NCT01687673|Advanced HCC|advanced hcc
294624|NCT01687673|Temsirolimus|temsirolimus
294626|NCT01687673|Sorafenib|sorafenib
294627|NCT01687660|acupuncture|acupuncture
294628|NCT01687660|migraine prophylaxis|migraine prophylaxis
285202|NCT01730248|Myelofibrosis,|myelofibrosis,
285203|NCT01730248|PMF,|pmf,
285204|NCT01730248|PPV-MF,|ppv-mf,
285205|NCT01730248|PET-MF,|pet-mf,
285206|NCT01730248|Primary Myelofibrosis,|primary myelofibrosis,
294629|NCT01687647|Lung cancer screening|lung cancer screening
294630|NCT01687647|Asbestos exposed workers|asbestos exposed workers
294631|NCT01687647|Sputum analysis|sputum analysis
294632|NCT01687647|Automated cytometry|automated cytometry
294633|NCT01687647|Predictive biomarkers|predictive biomarkers
294634|NCT01687634|pregnancy|pregnancy
294635|NCT01687634|home healthcare visits|home healthcare visits
294636|NCT01687634|breast feeding|breast feeding
294637|NCT01687634|nutrition|nutrition
294638|NCT01687634|community health workers|community health workers
294639|NCT01688648|Coronary artery bypass graft|coronary artery bypass graft
294640|NCT01688648|dexmedetomidine|dexmedetomidine
294641|NCT01688648|lidocaine|lidocaine
294642|NCT01688648|myocardial injury|myocardial injury
294643|NCT01688648|arrhythmia|arrhythmia
294644|NCT01688648|blood electrolyte balance|blood electrolyte balance
294645|NCT01688635|Volunteers|volunteers
294646|NCT01688596|Local|local
294647|NCT01688596|Anesthesia|anesthesia
294648|NCT01688596|Pain|pain
294649|NCT01688596|Laparoscopic hysterectomy|laparoscopic hysterectomy
294650|NCT01688596|Trocar site|trocar site
294651|NCT01688596|Port site|port site
294652|NCT01688583|Chronic pain|chronic pain
294653|NCT01688583|Chronic non-cancer pain|chronic non-cancer pain
294654|NCT01688583|Fentanyl matrix|fentanyl matrix
294655|NCT01688583|Transdermal system|transdermal system
294656|NCT01688570|neuromuscular fatigue|neuromuscular fatigue
294657|NCT01688570|motor impairment|motor impairment
294658|NCT01688557|narrow band imaging|narrow band imaging
294659|NCT01688557|dual focus|dual focus
294660|NCT01688557|responsive insertion technique|responsive insertion technique
294661|NCT01688557|scope guide|scope guide
294662|NCT01688557|colonoscopy|colonoscopy
294663|NCT01688557|colorectal cancer screening|colorectal cancer screening
294664|NCT01688544|Ilaprazole|ilaprazole
294665|NCT01688544|Intragastric pH|intragastric ph
294666|NCT01688544|Serum Gastrin|serum gastrin
294667|NCT01688544|Pharmacokinetics|pharmacokinetics
294668|NCT01688518|Evaluation|evaluation
294669|NCT01688518|Depth and Duration|depth and duration
294670|NCT01688518|Anesthesia|anesthesia
294671|NCT01688505|cerebral small vessel diseases|cerebral small vessel diseases
294672|NCT01688505|cognitive impairment|cognitive impairment
294673|NCT01688505|Blood pressure variability|blood pressure variability
294674|NCT01688492|MDX-010 (Ipilimumab)|mdx-010 (ipilimumab)
294675|NCT01688492|ABIRATERONE ACETATE (CB 7630)|abiraterone acetate (cb 7630)
294676|NCT01688492|PREDNISONE|prednisone
294677|NCT01688492|Immunotherapy-naïve|immunotherapy-naïve
294678|NCT01688492|castration resistant prostate cancer (CRPC)|castration resistant prostate cancer (crpc)
294679|NCT01688492|12-120|12-120
294680|NCT01688479|Postoperative radiotherapy|postoperative radiotherapy
294681|NCT01688479|breast cancer|breast cancer
294682|NCT01688466|Immune Modulatory|immune modulatory
294683|NCT01688466|Systemic Absorption|systemic absorption
294684|NCT01688466|Oral Agent|oral agent
294685|NCT01688453|overweight/obesity|overweight/obesity
294686|NCT01688453|adolescence|adolescence
294687|NCT01688453|care management|care management
294688|NCT01688440|Endotracheal Cares|endotracheal cares
294689|NCT01688440|Neonate|neonate
294690|NCT01688440|TAC's|tac's
294691|NCT01688440|Endotracheal Suctioning|endotracheal suctioning
294692|NCT01688440|Tracheal Aspirate Culture|tracheal aspirate culture
294693|NCT01688440|Oral Cares|oral cares
294694|NCT01688440|Neonate oxygen Therapy|neonate oxygen therapy
294695|NCT01688401|diffuse intrinsic pontine glioma (DIPG)|diffuse intrinsic pontine glioma (dipg)
294696|NCT01688401|intra-arterial chemotherapy|intra-arterial chemotherapy
294697|NCT01688401|angiography|angiography
294698|NCT01688388|Breast Cancer|breast cancer
294699|NCT01688388|Carcinoma|carcinoma
294700|NCT01688388|Radiotherapy|radiotherapy
294701|NCT01688388|Intraoperative Radiotherapy|intraoperative radiotherapy
294702|NCT01688388|IORT|iort
294703|NCT01688375|obstructive jaundice|obstructive jaundice
294704|NCT01688375|ursodeoxycholic acid|ursodeoxycholic acid
294705|NCT01688362|Prospective Randomized Controlled Double Blinded Trial|prospective randomized controlled double blinded trial
294706|NCT01688362|Rotator Cuff Tear|rotator cuff tear
294707|NCT01688362|Platelet Rich Plasma|platelet rich plasma
294708|NCT01688362|Corticosteroid|corticosteroid
294709|NCT01688362|Ultrasound|ultrasound
294710|NCT01688349|Glucocorticoids|glucocorticoids
294711|NCT01688349|adipose tissue|adipose tissue
294712|NCT01688349|Cushing|cushing
294713|NCT01688349|lipodystrophy|lipodystrophy
294714|NCT01688349|11 beta-HSD1|11 beta-hsd1
294715|NCT01688336|Pancreatic|pancreatic
294716|NCT01688336|Phase II|phase ii
294717|NCT01688336|FOLFIRINOX|folfirinox
285330|NCT01729559|trauma|trauma
294718|NCT01688336|Unresectable|unresectable
294719|NCT01688336|Regimen|regimen
294720|NCT01688336|First-line|first-line
294721|NCT01688336|Resectable|resectable
294722|NCT01688336|Borderline|borderline
294723|NCT01688336|Oxaliplatin|oxaliplatin
294724|NCT01688336|Leucovorin|leucovorin
294725|NCT01688336|Irinotecan|irinotecan
294726|NCT01688336|5FU|5fu
294727|NCT01688336|Lineberger|lineberger
294728|NCT01688336|University of North Carolina|university of north carolina
294729|NCT01688323|Geriatrics|geriatrics
294730|NCT01688323|Oncology|oncology
294731|NCT01688323|Biological Markers|biological markers
294732|NCT01688323|Survey Instruments|survey instruments
294733|NCT01688323|p16|p16
294734|NCT01688323|Geriatric Oncology|geriatric oncology
294735|NCT01688323|Biological Markers of Aging|biological markers of aging
294736|NCT01688323|Symptom Assessment|symptom assessment
294737|NCT01688323|Cancer|cancer
294738|NCT01688323|Older Persons|older persons
294739|NCT01688323|Head and Neck Cancer|head and neck cancer
294740|NCT01688310|Gomco clamp instrument|gomco clamp instrument
294741|NCT01688310|Tissue adhesive|tissue adhesive
294742|NCT01688310|Open surgical circumcision|open surgical circumcision
294743|NCT01688310|Minimally-invasive circumcision|minimally-invasive circumcision
294744|NCT01688297|Influenza|influenza
294745|NCT01688297|H1N1|h1n1
294746|NCT01688297|flu|flu
294747|NCT01688297|seasonal|seasonal
294748|NCT01688284|uterine natural killer cells|uterine natural killer cells
294749|NCT01688284|recurrent miscarriages|recurrent miscarriages
294750|NCT01688284|alloimmunity|alloimmunity
294751|NCT01688271|simulation|simulation
294752|NCT01688271|ultrasound|ultrasound
294753|NCT01688271|perineural infusion|perineural infusion
294754|NCT01688271|continuous peripheral nerve block|continuous peripheral nerve block
294755|NCT01688245|young adults|young adults
294756|NCT01688245|alcohol consumption|alcohol consumption
294757|NCT01688245|mobile health|mobile health
294758|NCT01688245|text message|text message
294759|NCT01688232|colorectal cancer|colorectal cancer
294760|NCT01688232|tumor resection|tumor resection
294761|NCT01688232|immunoscore|immunoscore
294762|NCT01688232|lymphocytic density|lymphocytic density
294763|NCT01688232|CD3|cd3
294765|NCT01688232|CD45RO|cd45ro
294766|NCT01688232|biopsy|biopsy
294767|NCT01688232|genetic feature of the tumor|genetic feature of the tumor
294768|NCT01688232|relapse|relapse
294769|NCT01688232|immunohistochemistry|immunohistochemistry
294770|NCT01688232|image analysis software|image analysis software
294771|NCT01688219|SAPHO syndrome|sapho syndrome
294772|NCT01688219|Innate immunity|innate immunity
294773|NCT01688219|TNF alpha|tnf alpha
294774|NCT01688219|Polymorphonuclear neutrophils|polymorphonuclear neutrophils
294775|NCT01688219|Propionibacterium acnes|propionibacterium acnes
294776|NCT01688219|Interleukin-8|interleukin-8
294777|NCT01688180|bronchiectasis|bronchiectasis
294778|NCT01688180|depression|depression
294779|NCT01688180|anxiety|anxiety
294780|NCT01688167|HIV|hiv
294781|NCT01688167|Male circumcision|male circumcision
294782|NCT01688167|Sexual risk reduction|sexual risk reduction
294783|NCT01688167|Stages of change|stages of change
294784|NCT01688141|CKD|ckd
294785|NCT01688128|Mild cognitive impairment|mild cognitive impairment
294786|NCT01688128|Cognitive rehabilitation|cognitive rehabilitation
294787|NCT01688128|Cognitive therapy|cognitive therapy
294788|NCT01688128|Spaced retrieval Training|spaced retrieval training
294789|NCT01688128|Alzheimer's disease|alzheimer's disease
294790|NCT01688128|Memory enhancement|memory enhancement
294791|NCT01688128|U-healthcare|u-healthcare
294792|NCT01688089|volunteer|volunteer
294794|NCT01688063|Skin Elasticity|skin elasticity
294795|NCT01688063|Scar Elasticity|scar elasticity
294796|NCT01688063|Cutometer|cutometer
294797|NCT01688063|Dermal Torque Meter|dermal torque meter
294798|NCT01688050|Blunt thoracic aortic injury|blunt thoracic aortic injury
294799|NCT01688050|Transection|transection
294800|NCT01688050|Endovascular graft|endovascular graft
294801|NCT01688024|mitomycin C|mitomycin c
294802|NCT01688011|Myelodysplastic Syndromes|myelodysplastic syndromes
294803|NCT01688011|MDS|mds
294804|NCT01688011|Acute Myeloid Leukemia|acute myeloid leukemia
294805|NCT01688011|AML|aml
294806|NCT01688011|Registry|registry
294807|NCT01688011|Connect®|connect®
294808|NCT01687972|cesarean section|cesarean section
294809|NCT01687972|insorb staples|insorb staples
294810|NCT01687972|absorbable staples|absorbable staples
294811|NCT01687972|transverse skin incision|transverse skin incision
294812|NCT01687959|cholelithiasis|cholelithiasis
294813|NCT01687959|laparoscopic cholecystectomy|laparoscopic cholecystectomy
294814|NCT01687959|endoscopic sphincterotomy|endoscopic sphincterotomy
294815|NCT01687959|choledocholithiasis|choledocholithiasis
294816|NCT01687946|Biology of Fibrosis|biology of fibrosis
294817|NCT01687933|Labor pain|labor pain
294818|NCT01687933|Virtual reality|virtual reality
294819|NCT01687933|the first stage of labor|the first stage of labor
285404|NCT01729351|Smoking|smoking
294820|NCT01687933|Pain relief|pain relief
294821|NCT01687933|Simulator|simulator
294822|NCT01687920|Cardiac disorders|cardiac disorders
294823|NCT01687907|fear of childbirth|fear of childbirth
294824|NCT01687907|outcome of delivery|outcome of delivery
294825|NCT01687907|music|music
294826|NCT01687907|mother-baby relationship|mother-baby relationship
294827|NCT01687894|cerebral oxygen saturation|cerebral oxygen saturation
294828|NCT01687894|beach chair position|beach chair position
294829|NCT01687894|hemodynamic|hemodynamic
294830|NCT01687894|jugular venous oximetry|jugular venous oximetry
294831|NCT01687881|Chiropractic|chiropractic
294832|NCT01687881|Manipulative therapy|manipulative therapy
294833|NCT01687881|Cervicogenic headache|cervicogenic headache
294834|NCT01687855|Obstructive Sleep|obstructive sleep
294836|NCT01687855|tongue|tongue
294837|NCT01687855|alteration|alteration
294838|NCT01687829|Macular Holes|macular holes
294839|NCT01687829|Internal limiting membrane|internal limiting membrane
294840|NCT01687829|peeling|peeling
294841|NCT01687829|Surgery|surgery
294842|NCT01687816|Influenza-Like-Illness|influenza-like-illness
294843|NCT01687816|nasal swabs|nasal swabs
294844|NCT01687816|Detection of influenza|detection of influenza
294845|NCT01687816|sensitivity of detection assays|sensitivity of detection assays
294846|NCT01687803|Obesity|obesity
294847|NCT01687803|Sedentary lifestyle|sedentary lifestyle
294848|NCT01687803|Body weight|body weight
294849|NCT01687803|Physical fitness|physical fitness
294850|NCT01687790|molecular breast imaging|molecular breast imaging
294851|NCT01687790|breast disease|breast disease
294852|NCT01687790|breast biopsy|breast biopsy
294853|NCT01687777|Supraspinatus tendon|supraspinatus tendon
294854|NCT01687777|Mesenchymal stem cells|mesenchymal stem cells
294855|NCT01687777|OrthADAPT|orthadapt
294856|NCT01687777|Rotator cuff|rotator cuff
294857|NCT01687764|Generalized Anxiety Disorder (GAD)|generalized anxiety disorder (gad)
294858|NCT01687764|Separation Anxiety Disorder (SeAD)|separation anxiety disorder (sead)
294859|NCT01687764|Social Anxiety Disorder (SoAD)|social anxiety disorder (soad)
294860|NCT01687751|feasibility studies|feasibility studies
294861|NCT01687751|conscious sedation/|conscious sedation/
294862|NCT01687751|dexmedetomidine/|dexmedetomidine/
294863|NCT01687751|midazolam/|midazolam/
294864|NCT01687751|infusions, subcutaneous/|infusions, subcutaneous/
294865|NCT01687751|palliative care/|palliative care/
294866|NCT01687751|terminal care/|terminal care/
294867|NCT01687751|terminally ill/|terminally ill/
294868|NCT01687751|neoplasms/|neoplasms/
294869|NCT01687751|treatment outcome|treatment outcome
294870|NCT01687751|Precedex|precedex
294871|NCT01687751|"end of life"|"end of life"
294872|NCT01687751|Dying|dying
294873|NCT01687751|Advanced cancer|advanced cancer
294874|NCT01687751|mood/delirium/delirious|mood/delirium/delirious
294875|NCT01687738|non small cell lung cancer|non small cell lung cancer
294876|NCT01687738|health disparities|health disparities
294877|NCT01687712|IVF|ivf
294878|NCT01687712|In vitro fertilization|in vitro fertilization
294879|NCT01687712|Controlled ovarian stimulation|controlled ovarian stimulation
294880|NCT01687712|Follitropin|follitropin
294881|NCT01687712|AFOLIA|afolia
294882|NCT01687712|Finox|finox
294883|NCT01687621|Omphalitis|omphalitis
294884|NCT01687621|Neonate|neonate
294885|NCT01687621|Zambia|zambia
294886|NCT01687621|Neonatal mortality|neonatal mortality
294887|NCT01687621|Umbilical cord infection|umbilical cord infection
294888|NCT01687608|Hemophilia B|hemophilia b
294889|NCT01687608|factor IX deficiency|factor ix deficiency
294890|NCT01687608|gene therapy|gene therapy
294891|NCT01687595|herpes simplex virus type 2,|herpes simplex virus type 2,
294892|NCT01687595|genital herpes|genital herpes
294893|NCT01687582|type 2 diabetes|type 2 diabetes
294895|NCT01687582|exenatide|exenatide
294896|NCT01687582|liraglutide|liraglutide
294897|NCT01687569|Glycaemic Response|glycaemic response
294898|NCT01687556|EGCG|egcg
294899|NCT01687556|green tea|green tea
294900|NCT01687543|Clostridium difficile|clostridium difficile
294901|NCT01687543|WBC|wbc
294902|NCT01687543|CRP|crp
294903|NCT01687543|Lactate|lactate
294904|NCT01687543|Urea|urea
294905|NCT01687543|Creatinine|creatinine
294906|NCT01687517|sarcoidosis|sarcoidosis
294907|NCT01687517|healthy volunteers|healthy volunteers
294908|NCT01687504|pharmacokinetics|pharmacokinetics
294909|NCT01687504|children|children
294910|NCT01687504|HIV|hiv
294911|NCT01687504|Tuberculosis|tuberculosis
294912|NCT01687504|Pharmacogenetics|pharmacogenetics
294913|NCT01687491|Enoxaparin|enoxaparin
294914|NCT01687491|Acute Coronary Syndrome|acute coronary syndrome
294915|NCT01687491|Factor X|factor x
294916|NCT01687465|glaucoma|glaucoma
294917|NCT01687465|laser|laser
294918|NCT01687465|SLT|slt
294919|NCT01687465|ALT|alt
294920|NCT01687374|proximal humeral fracture|proximal humeral fracture
294921|NCT01687335|chemotherapy|chemotherapy
294922|NCT01687322|quality of life|quality of life
365206|NCT01388452|HIV|hiv
285504|NCT01728974|Pathophysiology|pathophysiology
294923|NCT01687322|functioning|functioning
294924|NCT01687296|PEF|pef
294925|NCT01687296|inhaled|inhaled
294926|NCT01687296|Fluticasone Propionate|fluticasone propionate
294927|NCT01687296|safety|safety
294928|NCT01687296|prednisone|prednisone
294929|NCT01687296|acute exacerbation|acute exacerbation
294930|NCT01687296|asthma|asthma
294931|NCT01687296|efficacy|efficacy
294932|NCT01687283|fluticasone propionate inhalation solution|fluticasone propionate inhalation solution
294933|NCT01687283|budesonide suspension for inhalation|budesonide suspension for inhalation
294934|NCT01687283|efficacy|efficacy
294935|NCT01687283|severe persistent asthma|severe persistent asthma
294936|NCT01687283|pharmacokinetics|pharmacokinetics
294937|NCT01687283|safety|safety
294938|NCT01687244|BCG Refractory or Relapsed Superficial Bladder Cancer|bcg refractory or relapsed superficial bladder cancer
294939|NCT01687244|rAd-IFN|rad-ifn
294940|NCT01687244|Syn3|syn3
294941|NCT01687244|Intravesical|intravesical
294942|NCT01687244|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
294943|NCT01687244|superficial non-muscle invasive tumor|superficial non-muscle invasive tumor
294944|NCT01687244|Interferon alpha2b|interferon alpha2b
294945|NCT01687244|INSTILADRIN|instiladrin
294946|NCT01687231|Neutropenic Diet, Non-Neutropenic Diet, Allogeneic SCT|neutropenic diet, non-neutropenic diet, allogeneic sct
294947|NCT01687192|Seroconversion|seroconversion
294948|NCT01687192|Immunosuppressed treatment|immunosuppressed treatment
294949|NCT01687192|HPV vaccination|hpv vaccination
294950|NCT01687192|Immunogenicity|immunogenicity
294951|NCT01687179|LAM|lam
294952|NCT01687179|TSC|tsc
294953|NCT01687179|lymphangioleiomyomatosis|lymphangioleiomyomatosis
294954|NCT01687166|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
294955|NCT01687166|Cardiac Arrhythmias|cardiac arrhythmias
294956|NCT01687166|Heart Disease|heart disease
294957|NCT01687166|Cardiovascular Disease|cardiovascular disease
294958|NCT01687166|Radiofrequency Ablation|radiofrequency ablation
294959|NCT01687153|traumatic brain injury (TBI)|traumatic brain injury (tbi)
294960|NCT01687153|post traumatic stress disorder (PTSD)|post traumatic stress disorder (ptsd)
294961|NCT01687153|Alzheimer's disease (AD)|alzheimer's disease (ad)
294962|NCT01687153|mild cognitive impairment (MCI)|mild cognitive impairment (mci)
294963|NCT01687153|dementia|dementia
294964|NCT01687153|biomarkers|biomarkers
294965|NCT01687153|amyloid|amyloid
294966|NCT01687153|neuroimaging|neuroimaging
294967|NCT01687153|cognition disorder|cognition disorder
294968|NCT01687153|tau|tau
294969|NCT01687127|folic acid|folic acid
294970|NCT01687127|folate|folate
294971|NCT01687127|5-methyltetrahydrofolate|5-methyltetrahydrofolate
294972|NCT01687127|supplements|supplements
294973|NCT01687127|women|women
294974|NCT01687127|one-carbon metabolism|one-carbon metabolism
294975|NCT01687127|methionine|methionine
294976|NCT01687127|DNA methylation|dna methylation
294977|NCT01687127|in vivo kinetics|in vivo kinetics
294978|NCT01687114|compliance, proanthocyanidin, phenoic acids, cranberry|compliance, proanthocyanidin, phenoic acids, cranberry
294979|NCT01687101|acute migraine|acute migraine
294980|NCT01687101|acute migraine treatment|acute migraine treatment
294981|NCT01687101|topical treatment|topical treatment
294982|NCT01687075|coronary angioplasty|coronary angioplasty
294983|NCT01687075|de novo lesion|de novo lesion
294984|NCT01687062|NaFeEDTA|nafeedta
294985|NCT01687062|phytate|phytate
294986|NCT01687062|injera|injera
294987|NCT01687062|iron absorption|iron absorption
294988|NCT01687049|nonmetastatic|nonmetastatic
294989|NCT01687049|localized|localized
294990|NCT01687049|prostate|prostate
294991|NCT01687049|active surveillance|active surveillance
294992|NCT01687036|Atrial fibrillation|atrial fibrillation
294993|NCT01687036|Cryoablation|cryoablation
294994|NCT01687023|Tai Chi|tai chi
294995|NCT01687023|Wearable sensors|wearable sensors
294996|NCT01687023|Movement|movement
294997|NCT01687010|CRP, PCT, IL-6, Diagnosis, Prediction|crp, pct, il-6, diagnosis, prediction
294998|NCT01686997|Bariatric surgery|bariatric surgery
294999|NCT01686997|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
295000|NCT01686958|Prostate Cancer|prostate cancer
295001|NCT01686958|High intensity transurethral ultrasound ablation|high intensity transurethral ultrasound ablation
295002|NCT01686958|MRI-guided|mri-guided
295003|NCT01686958|Minimally invasive|minimally invasive
295004|NCT01686958|Real-time temperature feedback control|real-time temperature feedback control
295005|NCT01686932|vildagliptin|vildagliptin
295006|NCT01686932|sitagliptin|sitagliptin
295007|NCT01686932|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
295008|NCT01686932|glycemic fluctuations|glycemic fluctuations
295009|NCT01686932|MAGE|mage
295010|NCT01686932|impact of hypoglycemia on heart function (cardiac dysfuction measured via ECG)|impact of hypoglycemia on heart function (cardiac dysfuction measured via ecg)
295011|NCT01686932|difference in glycemic profile of vildagliptin compared to sitagliptin|difference in glycemic profile of vildagliptin compared to sitagliptin
295012|NCT01686919|Gastric bypass|gastric bypass
295013|NCT01686919|Questionnaires|questionnaires
295014|NCT01686919|Diet|diet
295015|NCT01686919|Milk|milk
295016|NCT01686906|Keratoconus|keratoconus
295017|NCT01686906|Bowman layer|bowman layer
295018|NCT01686893|Oxygen, Insufflation, COPD, High Flow Treatment|oxygen, insufflation, copd, high flow treatment
402022|NCT01233414|Children|children
295019|NCT01686880|Hepatocellular Carcinoma|hepatocellular carcinoma
295020|NCT01686880|Liver Cirrhosis|liver cirrhosis
295021|NCT01686880|radioembolization|radioembolization
295022|NCT01686880|SIRT|sirt
295023|NCT01686880|TARE|tare
295024|NCT01686880|Sirspheres|sirspheres
295025|NCT01686880|neoadjuvant|neoadjuvant
295026|NCT01686880|liver cancer|liver cancer
295027|NCT01686867|improved cookstove|improved cookstove
295028|NCT01686867|ventilated cookstove|ventilated cookstove
295029|NCT01686867|behavior change|behavior change
295030|NCT01686867|adoption|adoption
295031|NCT01686867|indoor air pollution|indoor air pollution
295032|NCT01686867|DLCO|dlco
295033|NCT01686867|spirometry|spirometry
295034|NCT01686867|biomass fuel|biomass fuel
295035|NCT01686854|cognitive-behavioral approach|cognitive-behavioral approach
295036|NCT01686854|obesity treatment|obesity treatment
295037|NCT01686841|Lipolysis|lipolysis
295038|NCT01686841|Cryolipolysis|cryolipolysis
295039|NCT01686841|Fat Reduction|fat reduction
295040|NCT01686828|insulin|insulin
295041|NCT01686828|androgens|androgens
295042|NCT01686828|insulin resistance|insulin resistance
295043|NCT01686828|testosterone|testosterone
295044|NCT01686828|estradiol|estradiol
295045|NCT01686828|obesity|obesity
295046|NCT01686815|metabolic side effects|metabolic side effects
295047|NCT01686815|atypical antipsychotics|atypical antipsychotics
295048|NCT01686815|FSIVGTT|fsivgtt
295049|NCT01686802|oral morphine|oral morphine
295050|NCT01686802|ibuprofen|ibuprofen
295051|NCT01686802|post-operative pain|post-operative pain
295052|NCT01686776|Plasma albumine|plasma albumine
295053|NCT01686776|Plasma volume|plasma volume
295054|NCT01686776|Transcapillary escape rate|transcapillary escape rate
295055|NCT01686776|Inflammation|inflammation
295056|NCT01686776|Circulation|circulation
295058|NCT01686750|injection drug use|injection drug use
295059|NCT01686750|men who have sex with men|men who have sex with men
295060|NCT01686750|voluntary counselling and testing|voluntary counselling and testing
295061|NCT01686750|risk reduction|risk reduction
295062|NCT01686750|sexually transmitted infections|sexually transmitted infections
295063|NCT01686750|community viral load|community viral load
295064|NCT01686750|antiretroviral therapy|antiretroviral therapy
295166|NCT01686282|Pulse Wave Velocity|pulse wave velocity
295065|NCT01686724|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
295066|NCT01686724|Psychosocial Intervention|psychosocial intervention
295067|NCT01686724|Behavioral Intervention|behavioral intervention
295068|NCT01686724|School-home collaborative intervention|school-home collaborative intervention
295069|NCT01686698|cirrhosis, VSL#3, cognitive function, falls, quality of life|cirrhosis, vsl#3, cognitive function, falls, quality of life
295070|NCT01686685|ASD|asd
295071|NCT01686685|autism|autism
295072|NCT01686685|prematurity|prematurity
295073|NCT01686685|oxygen-dependant gene activation|oxygen-dependant gene activation
295074|NCT01686685|CXCR4|cxcr4
295075|NCT01686685|Language delay|language delay
295076|NCT01686685|Cognitive delay|cognitive delay
295077|NCT01686672|Cystic Fibrosis|cystic fibrosis
295078|NCT01686672|Behavioral Intervention|behavioral intervention
295079|NCT01686672|Children|children
295080|NCT01686659|Transfusion|transfusion
295081|NCT01686659|Continuous Hemoglobin Monitoring|continuous hemoglobin monitoring
295082|NCT01686659|SpHb|sphb
295083|NCT01686646|alertness|alertness
295084|NCT01686633|asthma|asthma
295085|NCT01686633|pharmacogenetics|pharmacogenetics
295086|NCT01686633|adult|adult
295087|NCT01686633|vilanterol|vilanterol
295088|NCT01686633|adolescents|adolescents
295089|NCT01686633|fluticasone furoate|fluticasone furoate
295090|NCT01686620|Mealtime insulin|mealtime insulin
753204|NCT01175876|hsCRP|hscrp
295091|NCT01686620|Ultra-rapid acting insulin|ultra-rapid acting insulin
295093|NCT01686607|Hepatic toxicity|hepatic toxicity
295094|NCT01686607|Renal toxicity|renal toxicity
295095|NCT01686607|Micafungin|micafungin
295096|NCT01686607|Hepatocellular carcinoma|hepatocellular carcinoma
295097|NCT01686607|Antifungals (parenteral)|antifungals (parenteral)
295098|NCT01686594|Mycosis fungoides|mycosis fungoides
295099|NCT01686594|Psoralen and UVA (PUVA)|psoralen and uva (puva)
295100|NCT01686594|Photochemotherapy|photochemotherapy
295101|NCT01686594|Maintenance treatment|maintenance treatment
295102|NCT01686594|Immune function|immune function
295103|NCT01686542|atrial fibrillation|atrial fibrillation
295104|NCT01686529|Pterygium|pterygium
295105|NCT01686529|bevacizumab|bevacizumab
295106|NCT01686529|autoconjunctival graft|autoconjunctival graft
295107|NCT01686516|age|age
295108|NCT01686516|microstructure|microstructure
295109|NCT01686516|diffusion MRI|diffusion mri
295110|NCT01686490|AICD|aicd
295111|NCT01686490|focus groups|focus groups
295112|NCT01686490|cognitive-behavioral video/workbook training|cognitive-behavioral video/workbook training
295113|NCT01686490|pre-implant concern/distress about upcoming AICD|pre-implant concern/distress about upcoming aicd
295114|NCT01686464|magnetic|magnetic
295115|NCT01686464|oxygen|oxygen
295116|NCT01686464|Bell's Palsy|bell's palsy
295117|NCT01686464|acupuncture|acupuncture
295118|NCT01686438|cost effectiveness|cost effectiveness
295119|NCT01686438|patient satisfaction|patient satisfaction
295120|NCT01686425|Cholestasis|cholestasis
295121|NCT01686425|Malignancy|malignancy
295122|NCT01686425|ERCP|ercp
295123|NCT01686425|PTC|ptc
295124|NCT01686425|EUS-BD|eus-bd
295125|NCT01686412|Breast Cancer|breast cancer
295126|NCT01686412|Hepatocellular carcinoma|hepatocellular carcinoma
295127|NCT01686399|Sustainable diet|sustainable diet
295128|NCT01686399|Health promotion|health promotion
295129|NCT01686399|Obesity|obesity
295130|NCT01686386|Relapsed|relapsed
295131|NCT01686386|Multiple Myeloma|multiple myeloma
295132|NCT01686386|Lenalidomide|lenalidomide
295133|NCT01686386|Bendamustine|bendamustine
295134|NCT01686373|Aphasia|aphasia
295135|NCT01686373|Brain|brain
295136|NCT01686373|Stimulation|stimulation
295137|NCT01686373|Communication|communication
295138|NCT01686373|Stoke|stoke
295139|NCT01686373|Post|post
295140|NCT01686373|Phase II Clinical Trial|phase ii clinical trial
295141|NCT01686373|Treatment|treatment
295142|NCT01686373|tDCS|tdcs
295143|NCT01686373|Fridriksson|fridriksson
295144|NCT01686347|epidural analgesia|epidural analgesia
295145|NCT01686347|fetal cardiac rythm|fetal cardiac rythm
295146|NCT01686347|ropivacaine|ropivacaine
295147|NCT01686347|sufentanil|sufentanil
295148|NCT01686334|in complete remission|in complete remission
295149|NCT01686334|Adult (>18 years) at very high risk of relapse|adult (>18 years) at very high risk of relapse
295150|NCT01686321|elderly patients|elderly patients
295151|NCT01686321|bendamustine|bendamustine
295152|NCT01686308|cataract|cataract
295153|NCT01686308|circadian rhythm|circadian rhythm
295154|NCT01686308|pupillometry|pupillometry
295155|NCT01686308|blue light transmission|blue light transmission
295156|NCT01686308|questionnaire|questionnaire
295157|NCT01686308|sleep|sleep
295158|NCT01686295|androgenetic alopecia|androgenetic alopecia
295159|NCT01686295|Baldness|baldness
295160|NCT01686282|Blood pressure|blood pressure
295161|NCT01686282|Arterial Stiffness|arterial stiffness
295162|NCT01686282|Blueberry Supplementation|blueberry supplementation
295163|NCT01686282|Aortic Blood Pressure|aortic blood pressure
295164|NCT01686282|Hypertension|hypertension
295165|NCT01686282|Postmenopausal|postmenopausal
295267|NCT01685762|Pilot|pilot
295167|NCT01686269|Endothelial progenitor cell|endothelial progenitor cell
295168|NCT01686269|coronary artery bypass|coronary artery bypass
295169|NCT01686256|Ovarian Cancer|ovarian cancer
295170|NCT01686256|Endometrial Cancer|endometrial cancer
295171|NCT01686243|epidural|epidural
295172|NCT01686230|acupuncture|acupuncture
295173|NCT01686230|Angina|angina
295174|NCT01686230|Stable Angina Pectoris|stable angina pectoris
295175|NCT01686217|ASP015K Extended Release|asp015k extended release
295176|NCT01686217|ASP015K Immediate Release|asp015k immediate release
295177|NCT01686217|Food Effect|food effect
295178|NCT01686217|Healthy Volunteers|healthy volunteers
295179|NCT01686204|Yogurt|yogurt
295180|NCT01686204|Intestine|intestine
295181|NCT01686204|Inflammation|inflammation
295182|NCT01686204|Obese|obese
295183|NCT01686191|heart transplantation|heart transplantation
295184|NCT01686191|chronic renal insufficiency|chronic renal insufficiency
295185|NCT01686191|pharmacogenomics|pharmacogenomics
295186|NCT01686191|cyclosporine|cyclosporine
295187|NCT01686191|tacrolimus|tacrolimus
295188|NCT01686178|Smoking|smoking
295189|NCT01686178|Smoking Cessation|smoking cessation
295190|NCT01686178|Tobacco Use Cessation|tobacco use cessation
295191|NCT01686178|Social Networks|social networks
294835|NCT01687855|Apnoea|apnoea
295192|NCT01686178|Social Control, Informal|social control, informal
295193|NCT01686139|Diabetic mellitus|diabetic mellitus
295194|NCT01686139|Diabetic foot ulcers|diabetic foot ulcers
295195|NCT01686139|Ischemic Limb|ischemic limb
295196|NCT01686126|endometrial hyperplasia|endometrial hyperplasia
295197|NCT01686126|endometrial adenocarcinoma|endometrial adenocarcinoma
295198|NCT01686126|Gynecological Cancer|gynecological cancer
295199|NCT01686113|Taste|taste
295200|NCT01686113|Fat Taste|fat taste
295201|NCT01686113|Threshold Testing|threshold testing
295202|NCT01686100|Coronary artery bypass grafting|coronary artery bypass grafting
295203|NCT01686100|Saphenous vein grafts|saphenous vein grafts
295204|NCT01686074|Motor control|motor control
295205|NCT01686074|walking|walking
295206|NCT01686074|physical activity|physical activity
295207|NCT01686074|Muscle activity|muscle activity
295208|NCT01686022|Grass|grass
295209|NCT01686022|Major allergen|major allergen
295210|NCT01686022|cross-reactivity|cross-reactivity
295211|NCT01686009|pain|pain
295212|NCT01686009|analgesia|analgesia
295213|NCT01686009|ketamine|ketamine
295214|NCT01686009|intranasal|intranasal
295215|NCT01686009|emergency|emergency
295216|NCT01685996|tobacco|tobacco
295217|NCT01685996|smoking cessation|smoking cessation
295218|NCT01685996|nicotine|nicotine
295219|NCT01685996|cigarettes|cigarettes
705218|NCT00978159|aspirin|aspirin
295220|NCT01685996|nicotine withdrawal|nicotine withdrawal
295221|NCT01685983|Prostate Cancer|prostate cancer
295222|NCT01685983|Metastatic-castration resistant prostate cancer|metastatic-castration resistant prostate cancer
295223|NCT01685983|Prostate specific antigen|prostate specific antigen
295224|NCT01685983|Abiraterone acetate|abiraterone acetate
295225|NCT01685983|JNJ-212082|jnj-212082
295226|NCT01685983|Abiraterone|abiraterone
295227|NCT01685983|Prednisolone|prednisolone
295228|NCT01685983|Androgen Deprivation|androgen deprivation
295229|NCT01685983|Docetaxel-based chemotherapy|docetaxel-based chemotherapy
295230|NCT01685970|Bowel preparation|bowel preparation
295231|NCT01685970|colonoscopy|colonoscopy
295232|NCT01685970|polyethylene glycol|polyethylene glycol
295233|NCT01685970|picosulfate|picosulfate
295234|NCT01685957|Weight loss|weight loss
295235|NCT01685957|Dietary intervention|dietary intervention
295236|NCT01685957|Self-help book|self-help book
295237|NCT01685957|Cooking|cooking
295238|NCT01685957|Dietitian|dietitian
295239|NCT01685957|Dietary therapy|dietary therapy
295240|NCT01685931|Schizophrenia|schizophrenia
295241|NCT01685931|Paliperidone Palmitate|paliperidone palmitate
295242|NCT01685931|Oral Antipsychotics|oral antipsychotics
295243|NCT01685931|Invega Sustenna|invega sustenna
295244|NCT01685918|Rheumatoid arthritis|rheumatoid arthritis
295245|NCT01685918|aged|aged
295246|NCT01685905|rheumatic disease, latent tuberculosis|rheumatic disease, latent tuberculosis
295247|NCT01685879|postprandial glycemic response|postprandial glycemic response
295248|NCT01685879|postprandial insulin response|postprandial insulin response
295249|NCT01685879|rice|rice
295250|NCT01685879|appetite|appetite
295251|NCT01685879|hunger|hunger
295252|NCT01685866|anesthesia|anesthesia
295253|NCT01685866|venous access|venous access
295254|NCT01685840|Heart Failure|heart failure
295255|NCT01685814|multiple myeloma|multiple myeloma
295256|NCT01685814|autologous stem cell transplant|autologous stem cell transplant
295257|NCT01685814|allogeneic stem cell transplant|allogeneic stem cell transplant
295258|NCT01685814|lenalidomide|lenalidomide
295259|NCT01685814|bortezomib|bortezomib
295260|NCT01685775|Gallbladder|gallbladder
295261|NCT01685775|cholecystectomy|cholecystectomy
295262|NCT01685775|NOTES|notes
295263|NCT01685775|natural orifice transluminal endoscopic surgery|natural orifice transluminal endoscopic surgery
295264|NCT01685775|gallstone|gallstone
295265|NCT01685762|Endometrial hyperplasia|endometrial hyperplasia
295266|NCT01685762|Uterus|uterus
295268|NCT01685762|Metformin|metformin
295269|NCT01685723|Cancer patients|cancer patients
295270|NCT01685723|Smoking cessation|smoking cessation
295271|NCT01685723|Risk communication|risk communication
295272|NCT01685710|Arteriovenous fistula|arteriovenous fistula
295273|NCT01685710|Patency|patency
295274|NCT01685710|GTN patch|gtn patch
295275|NCT01685684|Low back pain|low back pain
295276|NCT01685684|Chronic back pain|chronic back pain
295277|NCT01685684|Back pain|back pain
295278|NCT01685684|Opioid|opioid
295279|NCT01685684|Oxycodone|oxycodone
295280|NCT01685684|DETERx|deterx
295281|NCT01685684|Chronic pain|chronic pain
295282|NCT01685684|Chronic low back pain|chronic low back pain
295283|NCT01685684|CLBP|clbp
295284|NCT01685684|Xtampza|xtampza
295285|NCT01685671|CKD-11101|ckd-11101
295286|NCT01685671|NESP|nesp
295287|NCT01685671|Darbepoetin alfa|darbepoetin alfa
295288|NCT01685671|Anemia|anemia
295289|NCT01685671|subcutaneous|subcutaneous
295290|NCT01685671|Pharmacokinetics|pharmacokinetics
295291|NCT01685671|Phase 1|phase 1
295292|NCT01685632|intra peritonal chemo hyperthermia|intra peritonal chemo hyperthermia
295293|NCT01685632|peritoneal carcinomatosis|peritoneal carcinomatosis
295294|NCT01685632|colorectal cancer|colorectal cancer
295295|NCT01685632|ovarian cancer|ovarian cancer
295297|NCT01685619|Acute Myeloid Leukemia|acute myeloid leukemia
295298|NCT01685619|MDS|mds
295299|NCT01685619|Myelodysplastic Syndrome|myelodysplastic syndrome
295300|NCT01685619|Prognostic|prognostic
295301|NCT01685619|Economic|economic
295302|NCT01685606|Leukemia|leukemia
295303|NCT01685606|Lymphoma|lymphoma
295304|NCT01685606|Mantle cell|mantle cell
295305|NCT01685606|DLBCL|dlbcl
295306|NCT01685606|DLBC|dlbc
295307|NCT01685606|Diffuse large B cell|diffuse large b cell
295308|NCT01685606|T cell|t cell
295309|NCT01685606|AML|aml
295310|NCT01685606|ALL|all
295311|NCT01685593|abdominal binder|abdominal binder
295312|NCT01685580|primary lung cancer|primary lung cancer
295313|NCT01685580|lobectomy|lobectomy
295314|NCT01685580|pneumonectomy|pneumonectomy
295315|NCT01685580|non-invasive ventilation|non-invasive ventilation
295316|NCT01685567|carotid artery disease|carotid artery disease
285917|NCT01727232|ITP|itp
295317|NCT01685567|reverse flow|reverse flow
295318|NCT01685554|perfusion|perfusion
295319|NCT01685554|cardiopulmonary bypass|cardiopulmonary bypass
295320|NCT01685554|hypothermia|hypothermia
705219|NCT00978159|dyspepsia|dyspepsia
295321|NCT01685554|cerebral oxygenation|cerebral oxygenation
295322|NCT01685528|Anxiety|anxiety
295323|NCT01685528|Depression|depression
295324|NCT01685528|Geriatric|geriatric
295325|NCT01685528|Veteran|veteran
295326|NCT01685502|Glucobay OD|glucobay od
295327|NCT01685502|Diabetes Mellitus|diabetes mellitus
295328|NCT01685489|Prostate|prostate
295329|NCT01685489|Neoplasm|neoplasm
295330|NCT01685489|Adenocarcinoma|adenocarcinoma
295331|NCT01685489|Cancer|cancer
295332|NCT01685489|Metastatic|metastatic
295333|NCT01685489|Castrate resistant|castrate resistant
295334|NCT01685489|Docetaxel|docetaxel
295336|NCT01685489|Krestin|krestin
295337|NCT01685489|Trametes versicolor|trametes versicolor
295338|NCT01685489|Safety|safety
295339|NCT01685489|Maximum tolerated dose|maximum tolerated dose
295340|NCT01685489|Mushroom|mushroom
295341|NCT01685489|Natural|natural
295342|NCT01685489|Immunotherapy|immunotherapy
295343|NCT01685476|Cochlear microphonic potential|cochlear microphonic potential
295344|NCT01685476|non invasive method|non invasive method
295345|NCT01685476|indirect monitoring|indirect monitoring
295346|NCT01685476|intracranial pressure|intracranial pressure
295347|NCT01685463|methamphetamine, craving, TMS, cortical excitability, prefrontal cortex|methamphetamine, craving, tms, cortical excitability, prefrontal cortex
295348|NCT01685450|Cochlear microphonic potential|cochlear microphonic potential
295349|NCT01685450|non invasive method|non invasive method
295350|NCT01685450|indirect measurement|indirect measurement
295351|NCT01685450|intracranial pressure|intracranial pressure
295352|NCT01685450|adults|adults
295353|NCT01685437|Peyronie's disease, penile plaque, penile curvature|peyronie's disease, penile plaque, penile curvature
295354|NCT01685424|Etoricoxib|etoricoxib
295355|NCT01685424|ARCOXIA|arcoxia
295356|NCT01685424|Osteoarthritis|osteoarthritis
295357|NCT01685424|Rheumatoid Arthritis|rheumatoid arthritis
295358|NCT01685424|Ankylosing Spondylitis|ankylosing spondylitis
295359|NCT01685424|Gout|gout
295360|NCT01685424|Arthritis|arthritis
295361|NCT01685385|Dyspnoea|dyspnoea
295362|NCT01685385|BNP|bnp
295363|NCT01685385|Chronic heart failure|chronic heart failure
295364|NCT01685385|congestive heart failure|congestive heart failure
295365|NCT01685346|advanced (stage IV) non-small cell lung cancer (NSCLC)|advanced (stage iv) non-small cell lung cancer (nsclc)
295366|NCT01685346|biofeedback-mediated stress management (BFSM)|biofeedback-mediated stress management (bfsm)
295367|NCT01685333|subject|subject
295368|NCT01685320|Force|force
295369|NCT01685320|Pressure|pressure
295370|NCT01685320|Intubation|intubation
295371|NCT01685320|laryngoscopy|laryngoscopy
295372|NCT01685307|ileal digestibility|ileal digestibility
295373|NCT01685307|metabolism|metabolism
295374|NCT01685307|stable isotopes|stable isotopes
295375|NCT01685294|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
295376|NCT01685294|Suicidality|suicidality
295377|NCT01685294|Incarcerated Populations|incarcerated populations
295378|NCT01685294|Prisons|prisons
295379|NCT01685294|Interpersonal Psychotherapy (IPT)|interpersonal psychotherapy (ipt)
295380|NCT01685281|ADHD , Inattention|adhd , inattention
295381|NCT01685268|Prostate Cancer|prostate cancer
295382|NCT01685255|FIGO Stage III or IV EOC|figo stage iii or iv eoc
295383|NCT01685255|PPC FTC|ppc ftc
295384|NCT01685255|increasing CA 125|increasing ca 125
295385|NCT01685216|VPRIV|vpriv
295386|NCT01685216|velaglucerase alfa|velaglucerase alfa
295387|NCT01685203|Hepatitis C Virus|hepatitis c virus
295388|NCT01685203|Ribavirin-Free|ribavirin-free
295389|NCT01685203|Hepatitis C Genotype 1|hepatitis c genotype 1
295390|NCT01685203|Hepatitis C|hepatitis c
295391|NCT01685203|Interferon-Free|interferon-free
295392|NCT01685203|Chronic Hepatitis C|chronic hepatitis c
295393|NCT01685203|Compensated cirrhosis|compensated cirrhosis
295394|NCT01685203|Hepatitis C Genotype 4|hepatitis c genotype 4
295395|NCT01685203|Paritaprevir|paritaprevir
295396|NCT01685203|Ombitasvir|ombitasvir
295397|NCT01685203|Ritonavir|ritonavir
295398|NCT01685203|Ribavirin|ribavirin
295399|NCT01685177|Morbid obesity|morbid obesity
295400|NCT01685177|Sleeve gastrectomy|sleeve gastrectomy
295401|NCT01685177|Duodenal Switch|duodenal switch
295402|NCT01685177|SADI-S|sadi-s
295403|NCT01685164|nulliparous|nulliparous
295404|NCT01685164|IUD|iud
295405|NCT01685164|IUS|ius
295406|NCT01685164|insertion|insertion
295407|NCT01685164|expulsion|expulsion
295408|NCT01685151|Drug therapy|drug therapy
295409|NCT01685138|Non-Small Cell Lung Cancer, ALK, LDK378|non-small cell lung cancer, alk, ldk378
295410|NCT01685112|adults|adults
295411|NCT01685112|ECMO|ecmo
295412|NCT01685099|diagnosis, inflammation-associated markers, pleural effusion, tuberculosis, tuberculous pleurisy|diagnosis, inflammation-associated markers, pleural effusion, tuberculosis, tuberculous pleurisy
752601|NCT01173276|Sexually Transmitted Diseases|sexually transmitted diseases
286025|NCT01726660|CVA|cva
295413|NCT01685086|latent tuberculosis infection, tuberculosis, chronic kidney disease, peritoneal dialysis, hemodialysis|latent tuberculosis infection, tuberculosis, chronic kidney disease, peritoneal dialysis, hemodialysis
295414|NCT01685073|marijuana|marijuana
295415|NCT01685073|cannabis|cannabis
295416|NCT01685073|treatment|treatment
295417|NCT01685073|insomnia|insomnia
295418|NCT01685073|relapse|relapse
295419|NCT01685060|Non-Small Cell Lung Cancer|non-small cell lung cancer
295420|NCT01685060|NSCLC|nsclc
295421|NCT01685060|ALK|alk
295422|NCT01685060|LDK378|ldk378
295423|NCT01685060|Ceritinib|ceritinib
295424|NCT01685047|Coronary Artery Disease|coronary artery disease
295425|NCT01685047|Ventricular Arrhythmias|ventricular arrhythmias
295426|NCT01685047|ST Segment Changes|st segment changes
295427|NCT01685034|Eosinophilic esophagitis|eosinophilic esophagitis
295428|NCT01685034|Environmental allergens|environmental allergens
295429|NCT01685034|Allergy immunotherapy|allergy immunotherapy
295430|NCT01685034|Tolerance|tolerance
295431|NCT01685034|Allergic rhinitis|allergic rhinitis
295433|NCT01685034|Seasonal variation|seasonal variation
295434|NCT01685021|B-ALL|b-all
295435|NCT01685021|CD19|cd19
295436|NCT01685021|MOR208|mor208
295437|NCT01685021|MOR00208|mor00208
295438|NCT01685021|Xmab5574|xmab5574
295439|NCT01685021|B-cell acute lymphoblastic leukemia|b-cell acute lymphoblastic leukemia
295440|NCT01685021|Fc-optimized Anti-CD19 Antibody|fc-optimized anti-cd19 antibody
295441|NCT01685008|NHL|nhl
295442|NCT01685008|CD19|cd19
295443|NCT01685008|MOR208|mor208
295444|NCT01685008|MOR00208|mor00208
295445|NCT01685008|Xmab5574|xmab5574
295446|NCT01685008|B-Cell Non-Hodgkin´s Lymphoma|b-cell non-hodgkin´s lymphoma
295447|NCT01685008|Fc-optimized Anti-CD19 Antibody|fc-optimized anti-cd19 antibody
295448|NCT01684982|Primary PCI|primary pci
295449|NCT01684982|Drug Eluting Stent|drug eluting stent
295450|NCT01684969|Nausea|nausea
295451|NCT01684969|vomiting|vomiting
295452|NCT01684969|gastrointestinal symptoms|gastrointestinal symptoms
295453|NCT01684969|palliative care|palliative care
295454|NCT01684956|intradermal|intradermal
295455|NCT01684956|pharmacokinetics|pharmacokinetics
295456|NCT01684956|microneedle|microneedle
295457|NCT01684956|insulin|insulin
295458|NCT01684956|glucagon|glucagon
295459|NCT01684943|Pharmacokinetics|pharmacokinetics
295460|NCT01684930|Cardiovascular Diseases|cardiovascular diseases
295461|NCT01684930|Vascular Diseases|vascular diseases
295462|NCT01684930|Arterial Occlusive Diseases|arterial occlusive diseases
295463|NCT01684930|Exercise|exercise
295464|NCT01684930|Functional Capacity|functional capacity
295465|NCT01684852|dry eye, sicca, HA, Hyaluronic Acid, ectoin, ectoine, bitop|dry eye, sicca, ha, hyaluronic acid, ectoin, ectoine, bitop
295466|NCT01684839|Painful digital neuroma|painful digital neuroma
295467|NCT01684839|nerve defect|nerve defect
295468|NCT01684839|dorsal branch of the digital nerve|dorsal branch of the digital nerve
295469|NCT01684839|digital nerve|digital nerve
295470|NCT01684839|pedicled nerve flap|pedicled nerve flap
295471|NCT01684839|Pain Disorder Associated with Psychological and Physical Factors|pain disorder associated with psychological and physical factors
295472|NCT01684826|X-rays|x-rays
295473|NCT01684826|Image processing|image processing
295474|NCT01684826|Cardiovascular procedure|cardiovascular procedure
295475|NCT01684813|Diabetes mellitus.|diabetes mellitus.
295476|NCT01684813|Acute coronary syndrome.|acute coronary syndrome.
295477|NCT01684813|Percutaneous coronary intervention.|percutaneous coronary intervention.
295478|NCT01684787|chronic hepatitis C|chronic hepatitis c
295479|NCT01684787|normal ALT|normal alt
295480|NCT01684787|HIV/HCV patients|hiv/hcv patients
295481|NCT01684761|Multicenter Study|multicenter study
295482|NCT01684761|Randomized Controlled Trial|randomized controlled trial
295483|NCT01684761|Individualized Medicine|individualized medicine
295484|NCT01684761|Immunotherapy|immunotherapy
295485|NCT01684761|Myelin Proteins|myelin proteins
295486|NCT01684761|Biological Agents|biological agents
295487|NCT01684748|angiotensin II|angiotensin ii
295488|NCT01684748|obesity|obesity
295489|NCT01684748|diabetes|diabetes
295490|NCT01684735|diffusion-weighted magnetic resonance imaging|diffusion-weighted magnetic resonance imaging
295491|NCT01684722|vitamin D3|vitamin d3
295492|NCT01684722|omega-3 fatty acids|omega-3 fatty acids
295493|NCT01684722|fish oil|fish oil
295494|NCT01684722|diabetes|diabetes
295495|NCT01684722|kidney disease|kidney disease
295496|NCT01684722|albuminuria|albuminuria
295497|NCT01684722|urine albumin excretion|urine albumin excretion
295498|NCT01684722|glomerular filtration rate|glomerular filtration rate
295499|NCT01684722|diabetic kidney disease|diabetic kidney disease
295500|NCT01684709|Type 2 Diabetes|type 2 diabetes
295501|NCT01684709|Informal Caregivers|informal caregivers
295502|NCT01684709|Self Care|self care
295503|NCT01684709|Quality of Life|quality of life
295504|NCT01684709|Health Information Technology|health information technology
295505|NCT01684696|Lung cancer|lung cancer
295506|NCT01684696|stigma|stigma
295507|NCT01684696|virtual intervention|virtual intervention
295508|NCT01684696|mHealth|mhealth
295509|NCT01684683|Bronchiectasis|bronchiectasis
295510|NCT01684683|Theophylline|theophylline
295511|NCT01684683|Therapeutic Uses|therapeutic uses
295512|NCT01684683|HDAC|hdac
295513|NCT01684683|HAT|hat
295514|NCT01684683|Random placebo study|random placebo study
295515|NCT01684657|Stuttering|stuttering
295516|NCT01684644|ADHD|adhd
295517|NCT01684644|Parent Training|parent training
295518|NCT01684644|RCT|rct
295519|NCT01684644|Preschool|preschool
295520|NCT01684618|Preterm|preterm
295521|NCT01684618|Neonate|neonate
295522|NCT01684618|Newborn|newborn
295523|NCT01684618|Cerebral oxygenation|cerebral oxygenation
295524|NCT01684618|CPAP|cpap
295525|NCT01684605|CKD-11101|ckd-11101
295526|NCT01684605|NESP|nesp
295527|NCT01684605|Darbepoetin alfa|darbepoetin alfa
295528|NCT01684605|Anemia|anemia
295529|NCT01684605|intravenous|intravenous
295530|NCT01684605|Pharmacokinetics|pharmacokinetics
295531|NCT01684605|Phase 1|phase 1
295532|NCT01684592|smoking cessation|smoking cessation
295533|NCT01684592|relapse prevention|relapse prevention
295534|NCT01684592|pregnancy|pregnancy
295535|NCT01684592|postpartum|postpartum
295536|NCT01684579|Breast Cancer|breast cancer
295537|NCT01684579|African-American Women|african-american women
295538|NCT01684579|Aerobic Exercise|aerobic exercise
295539|NCT01684553|Eating speed|eating speed
295540|NCT01684553|energy intake|energy intake
295541|NCT01684540|sinusitis, rhinosinusitis, ectoin, ectoine, bitop, SNS, SNS01|sinusitis, rhinosinusitis, ectoin, ectoine, bitop, sns, sns01
295542|NCT01684514|confocal laser endomicroscopy|confocal laser endomicroscopy
295543|NCT01684514|inflammatory bowel disease|inflammatory bowel disease
295544|NCT01684514|colitis, ulcerative|colitis, ulcerative
295545|NCT01684501|prosthesis|prosthesis
295546|NCT01684501|amputees|amputees
295547|NCT01684501|gait|gait
295548|NCT01684488|Depression/therapy;|depression/therapy;
295549|NCT01684488|Developing Countries;|developing countries;
295550|NCT01684488|Interpersonal Relations;|interpersonal relations;
295551|NCT01684488|Life Change Events;|life change events;
295552|NCT01684488|Psychotherapy, Group;|psychotherapy, group;
295553|NCT01684488|Resilience, Psychological;|resilience, psychological;
295554|NCT01684488|Sierra Leone;|sierra leone;
295555|NCT01684488|Survivors/psychology;|survivors/psychology;
295556|NCT01684488|Social Adjustment;|social adjustment;
295557|NCT01684488|Social Behavior;|social behavior;
295558|NCT01684488|War|war
295559|NCT01684475|Novel Treatment Parkinson's disease|novel treatment parkinson's disease
295560|NCT01684462|Acute Ischemic Stroke|acute ischemic stroke
295561|NCT01684462|Albumin|albumin
295562|NCT01684449|Soft tissue sarcoma|soft tissue sarcoma
295563|NCT01684449|Gemcitabine|gemcitabine
295564|NCT01684449|Rapamycin|rapamycin
295565|NCT01684449|Sirolimus|sirolimus
295566|NCT01684449|mTOR inhibitor|mtor inhibitor
295567|NCT01684449|Molecular biomarkers|molecular biomarkers
295568|NCT01684410|Cystic Fibrosis|cystic fibrosis
295569|NCT01684410|Alpha1-proteinase inhibitor|alpha1-proteinase inhibitor
295570|NCT01684410|Alpha1-antitrypsin|alpha1-antitrypsin
295876|NCT01683149|Malignancy|malignancy
295571|NCT01684384|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
295572|NCT01684384|COPD|copd
295573|NCT01684384|Exacerbation|exacerbation
295574|NCT01684384|Functional Respiratory Imaging|functional respiratory imaging
295575|NCT01684384|High Resolution Computed Tomography|high resolution computed tomography
295576|NCT01684384|HRCT scan|hrct scan
295577|NCT01684384|Patient Reported Outcome|patient reported outcome
295578|NCT01684384|PRO|pro
295579|NCT01684384|Computational Fluid Dynamic|computational fluid dynamic
295580|NCT01684384|CFD|cfd
295581|NCT01684384|Lung function parameters|lung function parameters
295582|NCT01684371|Osteoarthritis|osteoarthritis
295583|NCT01684371|Osteoarthritic pain|osteoarthritic pain
295584|NCT01684371|Arthritic pain|arthritic pain
295585|NCT01684371|Arthritis|arthritis
295586|NCT01684371|joint inflammation|joint inflammation
295587|NCT01684371|Arthralgia|arthralgia
295588|NCT01684358|Prostate-specific antigen|prostate-specific antigen
295589|NCT01684358|Contraceptive implant|contraceptive implant
295590|NCT01684358|Biological marker|biological marker
295591|NCT01684358|Condoms|condoms
295592|NCT01684358|Women|women
295593|NCT01684345|Uveitis|uveitis
295594|NCT01684345|Non-infectious Uveitis|non-infectious uveitis
295595|NCT01684345|Intermediate Uveitis|intermediate uveitis
295596|NCT01684345|Posterior Uveitis|posterior uveitis
295597|NCT01684345|Panuveitis|panuveitis
295598|NCT01684332|Antioxidant|antioxidant
295599|NCT01684332|glucose metabolism|glucose metabolism
295601|NCT01684332|polyphenols|polyphenols
295602|NCT01684332|postprandial|postprandial
295603|NCT01684332|strawberry|strawberry
295604|NCT01684319|Constipation|constipation
295605|NCT01684319|Gastroeosphageal reflux|gastroeosphageal reflux
295606|NCT01684319|Colics|colics
295607|NCT01684306|RsfMRI, brain plasticity, cognitive enhancer|rsfmri, brain plasticity, cognitive enhancer
295608|NCT01684293|Cocaine|cocaine
295609|NCT01684293|Cognitive Impairment|cognitive impairment
295610|NCT01684293|Cognitive Rehabilitation|cognitive rehabilitation
295611|NCT01684280|abdominal adipose tissue; microRNA|abdominal adipose tissue; microrna
295612|NCT01684267|Stroke|stroke
295613|NCT01684267|Gait|gait
295614|NCT01684267|Rehabilitation|rehabilitation
295615|NCT01684254|Cerebral Palsy|cerebral palsy
295616|NCT01684254|Home monitoring|home monitoring
295617|NCT01684254|Gait|gait
295618|NCT01684254|Sensorized Shoe|sensorized shoe
295619|NCT01684241|Biontech|biontech
295620|NCT01684241|Biontech RNA Pharmaceuticals GmbH|biontech rna pharmaceuticals gmbh
295621|NCT01684241|Biontech RNA|biontech rna
295622|NCT01684241|MERIT|merit
295623|NCT01684241|RNA|rna
295624|NCT01684241|Immuno Therapy|immuno therapy
295625|NCT01684241|RB_0001-01|rb_0001-01
295626|NCT01684241|Ribological|ribological
295627|NCT01684241|Melanoma|melanoma
295628|NCT01684241|RBL001|rbl001
295629|NCT01684241|RBL002|rbl002
295630|NCT01684241|cancer vaccine|cancer vaccine
295631|NCT01684228|End stage renal disease|end stage renal disease
295632|NCT01684228|hemodialysis|hemodialysis
295633|NCT01684228|breath test|breath test
295634|NCT01684228|volatile organic compound|volatile organic compound
295635|NCT01684228|dialysis adequacy|dialysis adequacy
295636|NCT01684215|Phase 1/2|phase 1/2
295637|NCT01684215|PD-0332991|pd-0332991
295638|NCT01684215|palbociclib|palbociclib
295639|NCT01684215|Cyclin Dependent Kinase 4/6 inhibitor|cyclin dependent kinase 4/6 inhibitor
295640|NCT01684215|Japanese|japanese
295641|NCT01684215|solid tumors|solid tumors
295642|NCT01684215|breast cancer|breast cancer
295643|NCT01684215|A5481010|a5481010
295644|NCT01684176|Stroke|stroke
295645|NCT01684176|Ischemic Attack, Transient|ischemic attack, transient
295646|NCT01684176|Medication adherence|medication adherence
295647|NCT01684176|Motivational interviewing|motivational interviewing
295648|NCT01684176|Stroke prevention|stroke prevention
295649|NCT01684163|depression|depression
295650|NCT01684163|MDD|mdd
295651|NCT01684163|GLYX-13|glyx-13
295652|NCT01684163|HDRS-17|hdrs-17
295653|NCT01684163|HAMD-17|hamd-17
295654|NCT01684150|Leukemia|leukemia
295655|NCT01684150|Advanced hematologic malignancies|advanced hematologic malignancies
295656|NCT01684150|Epizyme|epizyme
295657|NCT01684150|Phase 1|phase 1
295658|NCT01684150|Mixed Lineage Leukemia (MLL)|mixed lineage leukemia (mll)
295659|NCT01684137|Food supplements|food supplements
295660|NCT01684137|Asthma bronchiale|asthma bronchiale
295661|NCT01684124|oxygen|oxygen
295662|NCT01684124|critical illness|critical illness
295663|NCT01684124|mechanical ventilation|mechanical ventilation
295664|NCT01684111|Non Small Cell Lung Cancer - Stage IV|non small cell lung cancer - stage iv
295665|NCT01684111|NSCLC Stage IV|nsclc stage iv
295666|NCT01684098|recurrent or metastatic cancer|recurrent or metastatic cancer
295667|NCT01684098|head and neck cancer|head and neck cancer
295668|NCT01684098|pancreas cancer|pancreas cancer
295669|NCT01684098|bladder cancer|bladder cancer
295670|NCT01684098|testicular cancer|testicular cancer
295671|NCT01684085|sleep deprivation, PTSD,prevention|sleep deprivation, ptsd,prevention
295672|NCT01684072|varicella vaccine|varicella vaccine
295673|NCT01684072|gelatin|gelatin
295674|NCT01684046|multi-purpose solution|multi-purpose solution
295675|NCT01684046|silicone hydrogel|silicone hydrogel
295676|NCT01684046|contact lenses|contact lenses
295677|NCT01684046|comfort|comfort
295678|NCT01684046|Opti-Free|opti-free
295679|NCT01684046|RevitaLens|revitalens
295680|NCT01684033|multi-purpose solution|multi-purpose solution
295681|NCT01684033|silicone hydrogel|silicone hydrogel
295682|NCT01684033|contact lenses|contact lenses
295683|NCT01684033|comfort|comfort
295684|NCT01684033|Opti-Free|opti-free
295685|NCT01684033|Biotrue|biotrue
295686|NCT01684020|rhinoplasty|rhinoplasty
295687|NCT01684020|external rhinoplasty|external rhinoplasty
295688|NCT01684020|open rhinoplasty|open rhinoplasty
295689|NCT01684020|nose job|nose job
295690|NCT01684007|Intraocular lens|intraocular lens
295691|NCT01684007|Multifocal intraocular lens (MIOL)|multifocal intraocular lens (miol)
295692|NCT01683994|Angiogenesis Inhibitors|angiogenesis inhibitors
295693|NCT01683994|Small Molecules|small molecules
295694|NCT01683994|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
295695|NCT01683981|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
295696|NCT01683981|Eisenmenger Syndrome|eisenmenger syndrome
295697|NCT01683981|Exercise Capacity|exercise capacity
295698|NCT01683981|Quality of Life|quality of life
295699|NCT01683955|Tranexamic Acid|tranexamic acid
295700|NCT01683955|Blood transfusion|blood transfusion
295701|NCT01683955|Total hip arthroplasty|total hip arthroplasty
295702|NCT01682954|lifestyle risk reduction|lifestyle risk reduction
295703|NCT01682941|soy, isoflavones, functional food, prostate cancer|soy, isoflavones, functional food, prostate cancer
295704|NCT01682928|Oligohydramnios|oligohydramnios
295705|NCT01682928|Hydrotherapy|hydrotherapy
295707|NCT01682915|ADHD|adhd
295708|NCT01682915|endophenotype|endophenotype
295709|NCT01682915|executive function|executive function
295710|NCT01682915|diffusion spectrum imaging|diffusion spectrum imaging
295711|NCT01682915|resting-state fMRI|resting-state fmri
295712|NCT01682915|frontostriatal and frontoparietal circuitries|frontostriatal and frontoparietal circuitries
295713|NCT01682915|DAT1|dat1
295714|NCT01682876|Prevention of meningococcal disease, children, vaccine|prevention of meningococcal disease, children, vaccine
295715|NCT01682863|COPD, QAB149, QVA149, indacaterol maleate, gylcopyrronium bromide|copd, qab149, qva149, indacaterol maleate, gylcopyrronium bromide
295716|NCT01682850|COPD|copd
295717|NCT01682850|Chronic Obstructive Lung Disease|chronic obstructive lung disease
295718|NCT01682850|lung cancer|lung cancer
295719|NCT01682850|emphysema|emphysema
295720|NCT01682850|Pulmonary Rehabilitation|pulmonary rehabilitation
295721|NCT01683942|cup disc ratio measurement|cup disc ratio measurement
295722|NCT01683942|digital stereo optic disc images|digital stereo optic disc images
295723|NCT01683929|Obesity|obesity
295724|NCT01683929|Overweight|overweight
295725|NCT01683929|Sugar consumption|sugar consumption
295726|NCT01683929|Metabolic syndrome|metabolic syndrome
295727|NCT01683929|Artificially sweetened foods and beverages|artificially sweetened foods and beverages
295728|NCT01683916|spinal cord injury|spinal cord injury
295729|NCT01683916|stress hormone|stress hormone
295730|NCT01683916|surgery|surgery
295731|NCT01683916|bispectral index value|bispectral index value
295732|NCT01683916|volatile anesthetic|volatile anesthetic
295733|NCT01683903|heart failure|heart failure
295734|NCT01683903|cardiac rehabilitation|cardiac rehabilitation
295735|NCT01683903|myocardial infarction|myocardial infarction
295736|NCT01683890|Bladder symptoms|bladder symptoms
295737|NCT01683890|Sexual function|sexual function
295738|NCT01683890|Quality of life|quality of life
295739|NCT01683890|Simple hysterectomy|simple hysterectomy
295740|NCT01683851|pediatric|pediatric
295741|NCT01683851|conscious sedation|conscious sedation
295742|NCT01683851|mouthpiece|mouthpiece
295743|NCT01683851|airway|airway
295744|NCT01683851|isolite system|isolite system
295745|NCT01683838|spinal cord injury|spinal cord injury
295746|NCT01683838|muscle spasticity|muscle spasticity
295747|NCT01683825|Amyloidosis|amyloidosis
295748|NCT01683825|Cardiac|cardiac
295749|NCT01683825|Heart|heart
295750|NCT01683825|Imaging|imaging
295751|NCT01683825|Diagnosis|diagnosis
295752|NCT01683799|Osteoarthritis|osteoarthritis
295753|NCT01683799|Insomnia|insomnia
295754|NCT01683799|Chronic pain|chronic pain
295755|NCT01683799|Cognitive Behavioral Therapy for Insomnia|cognitive behavioral therapy for insomnia
295756|NCT01683799|Inflammation|inflammation
295757|NCT01683799|Inflammatory cytokines|inflammatory cytokines
295758|NCT01683773|Tuberculosis|tuberculosis
295759|NCT01683773|Phase I|phase i
295760|NCT01683773|MVA85A|mva85a
295761|NCT01683773|AERAS-402|aeras-402
295762|NCT01683760|Fluconazole|fluconazole
295763|NCT01683747|sepsis|sepsis
295764|NCT01683747|shock|shock
295765|NCT01683747|placebo controlled|placebo controlled
295766|NCT01683747|double blinded|double blinded
295767|NCT01683747|interventional|interventional
295768|NCT01683708|sepsis|sepsis
295769|NCT01683708|jaundice|jaundice
295770|NCT01683708|symbiotic|symbiotic
295771|NCT01683708|translocation|translocation
295772|NCT01683708|abdominal collection|abdominal collection
295773|NCT01683708|morbidity|morbidity
295774|NCT01683695|Lupus Arthritis, Systemic Lupus Erythematosus, AMG 557, Lupus|lupus arthritis, systemic lupus erythematosus, amg 557, lupus
295775|NCT01683682|Non-Small Lung Cancer|non-small lung cancer
295776|NCT01683682|NSCLC Stage IV|nsclc stage iv
295777|NCT01683669|ALI|ali
295778|NCT01683669|ARDS|ards
295779|NCT01683669|Noisy pressure support ventilation|noisy pressure support ventilation
295780|NCT01683656|HIV|hiv
295781|NCT01683656|Atherosclerosis|atherosclerosis
295782|NCT01683656|Niacin/laropiprant|niacin/laropiprant
295783|NCT01683656|HDL|hdl
295784|NCT01683630|Influenza|influenza
295785|NCT01683630|Influenza type A|influenza type a
295786|NCT01683630|Influenza type B|influenza type b
295787|NCT01683630|hospitalization|hospitalization
295788|NCT01683630|Manitoba|manitoba
295789|NCT01683630|Canada|canada
295790|NCT01683617|Psychological stress|psychological stress
295791|NCT01683591|Acute stroke|acute stroke
295792|NCT01683591|Dysphagia|dysphagia
295793|NCT01683591|High-resolution manometry|high-resolution manometry
295794|NCT01683578|mechanical ventilation|mechanical ventilation
295795|NCT01683578|lung function|lung function
295432|NCT01685034|Asthma|asthma
295796|NCT01683578|abdominal surgery, open|abdominal surgery, open
295797|NCT01683578|systemic inflammation|systemic inflammation
295798|NCT01683552|ITCH|itch
295799|NCT01683539|Schizophrenia|schizophrenia
295800|NCT01683539|Chronic Mental Disorder|chronic mental disorder
295801|NCT01683539|Employment|employment
295802|NCT01683539|Cognitive remediation|cognitive remediation
295803|NCT01683539|Vocational rehabilitation|vocational rehabilitation
295804|NCT01683526|Urgent endotrachel intubation|urgent endotrachel intubation
295805|NCT01683526|Direct laryngoscopy|direct laryngoscopy
295806|NCT01683526|Video laryngoscopy|video laryngoscopy
295807|NCT01683526|Glidescope|glidescope
295808|NCT01683526|Critical Care|critical care
295809|NCT01683513|OHSS|ohss
295810|NCT01683513|mataphase II oocytes (MII)|mataphase ii oocytes (mii)
295811|NCT01683513|good quality embryo's|good quality embryo's
295812|NCT01683513|pregnancy|pregnancy
295813|NCT01683474|aortic valve stenosis|aortic valve stenosis
295814|NCT01683474|Calcification|calcification
295815|NCT01683474|TAVI|tavi
295816|NCT01683474|aortic valve Prosthesis|aortic valve prosthesis
295817|NCT01683461|HIV|hiv
295818|NCT01683461|AIDS|aids
295819|NCT01683448|Perioperative medications|perioperative medications
295820|NCT01683448|cardiac surgery|cardiac surgery
295821|NCT01683448|outcomes|outcomes
295822|NCT01683396|Erosive Osteoarthritis|erosive osteoarthritis
295823|NCT01683396|Osteoarthritis|osteoarthritis
295824|NCT01683396|Osteoarthritis of the Hand|osteoarthritis of the hand
295825|NCT01683383|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
295826|NCT01683383|Therapeutic hypothermia|therapeutic hypothermia
295827|NCT01683383|Whole body cooling|whole body cooling
295828|NCT01683383|Transport cooling|transport cooling
295829|NCT01683357|Liver Metastases|liver metastases
295830|NCT01683357|Surgery|surgery
295831|NCT01683357|Intraoperative Ultrasound|intraoperative ultrasound
295832|NCT01683331|Kidney transplant|kidney transplant
295833|NCT01683331|New onset diabetes|new onset diabetes
295834|NCT01683331|Prevention|prevention
295836|NCT01683305|biomarker,|biomarker,
295838|NCT01683305|Subjects|subjects
295839|NCT01683292|apomorphine|apomorphine
295840|NCT01683292|inhaled|inhaled
295841|NCT01683292|motor fluctuations|motor fluctuations
295842|NCT01683279|pediatric|pediatric
295843|NCT01683279|acute lymphoblastic leukemia|acute lymphoblastic leukemia
295844|NCT01683279|CD19|cd19
295845|NCT01683279|Chimeric Antigen Receptor|chimeric antigen receptor
295846|NCT01683240|cholangiography|cholangiography
295847|NCT01683240|cholangioscopy|cholangioscopy
295848|NCT01683240|mother-baby|mother-baby
295849|NCT01683240|cholangioscope|cholangioscope
295850|NCT01683240|Frimberger cholangioscope|frimberger cholangioscope
295851|NCT01683240|short access cholangioscopy|short access cholangioscopy
295852|NCT01683240|ERCP|ercp
295853|NCT01683240|gallstone therapy|gallstone therapy
295854|NCT01683227|drug use; emergency department; brief intervention|drug use; emergency department; brief intervention
295855|NCT01683201|Total hip replacement|total hip replacement
295856|NCT01683201|Functional exercise class|functional exercise class
295857|NCT01683201|Randomised controlled trial|randomised controlled trial
295858|NCT01683188|melanoma|melanoma
295859|NCT01683188|skin cancer|skin cancer
295860|NCT01683188|Stage IV|stage iv
295861|NCT01683175|Erlotinib|erlotinib
295862|NCT01683175|adjuvant therapy|adjuvant therapy
295863|NCT01683175|radical operation|radical operation
295864|NCT01683175|IIIA NSCLC|iiia nsclc
295865|NCT01683175|EGFR mutation|egfr mutation
295866|NCT01683162|parenteral nutrition|parenteral nutrition
295867|NCT01683162|lipid emulsion|lipid emulsion
295868|NCT01683162|olive oil|olive oil
295869|NCT01683162|liver function|liver function
295870|NCT01683162|fatty acid|fatty acid
295871|NCT01683162|clinical outcomes|clinical outcomes
295872|NCT01683149|Refractory|refractory
295873|NCT01683149|Relapsed|relapsed
295874|NCT01683149|Recurrent|recurrent
295875|NCT01683149|Pediatric|pediatric
295877|NCT01683123|Allogeneic HSCT|allogeneic hsct
295878|NCT01683123|Busulfan|busulfan
295879|NCT01683123|Fludarabina|fludarabina
295880|NCT01683084|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
295881|NCT01683084|AAA|aaa
295882|NCT01683084|telmisartan|telmisartan
295883|NCT01683071|Total knee arthroplasty|total knee arthroplasty
295884|NCT01683071|Analgesia|analgesia
295885|NCT01683071|Pain management|pain management
295886|NCT01683058|Schizophrenia|schizophrenia
295887|NCT01683045|non-paroxysmal atrial fibrillation|non-paroxysmal atrial fibrillation
295888|NCT01683045|persistent atrial fibrillation|persistent atrial fibrillation
295889|NCT01683045|atrial fibrillation|atrial fibrillation
295890|NCT01683045|heart palpitations|heart palpitations
295891|NCT01683045|irregular heart beat|irregular heart beat
295892|NCT01683045|temperature-controlled radiofrequency ablation|temperature-controlled radiofrequency ablation
295893|NCT01683045|radiofrequency energy|radiofrequency energy
295894|NCT01683045|TCRF energy|tcrf energy
295895|NCT01683045|RF energy|rf energy
295896|NCT01683045|epicardial and endocardial lesions|epicardial and endocardial lesions
753205|NCT01175876|DWI-MRI|dwi-mri
295897|NCT01683045|concomitant heart surgery|concomitant heart surgery
295898|NCT01683045|surgical ablation|surgical ablation
295899|NCT01683019|Depression|depression
295900|NCT01683019|magnetic field|magnetic field
295901|NCT01683019|alpha frequency|alpha frequency
295902|NCT01683019|EEG|eeg
295903|NCT01683019|NeoSync EEG Synchronization Therapy|neosync eeg synchronization therapy
295904|NCT01682993|corneal cross linking|corneal cross linking
295905|NCT01682993|topography guided excimer laser|topography guided excimer laser
295906|NCT01682993|Keratoconus|keratoconus
295907|NCT01682993|Pellucid marginal degeneration|pellucid marginal degeneration
295908|NCT01682993|Post Excimer ectasia|post excimer ectasia
295909|NCT01682980|Osteoarthritis|osteoarthritis
295910|NCT01682980|Pain|pain
295911|NCT01682980|Exercise|exercise
295912|NCT01682980|Function|function
295913|NCT01682980|Cartilage quality|cartilage quality
295914|NCT01682967|Parturients|parturients
295915|NCT01682967|Analgesia, epidural|analgesia, epidural
295916|NCT01682967|Headache, post-dural puncture|headache, post-dural puncture
295917|NCT01682824|Central Nervous System|central nervous system
295918|NCT01682824|CNS|cns
295919|NCT01682824|CNS tumor|cns tumor
295920|NCT01682824|Adolescent or Young Adult|adolescent or young adult
295921|NCT01682824|AYA|aya
295922|NCT01682824|Survivors|survivors
295923|NCT01682824|Eating Questionnaire-Ecological Momentary Assessment|eating questionnaire-ecological momentary assessment
295924|NCT01682824|EQ-EMA|eq-ema
295925|NCT01682824|Cognitive restraint|cognitive restraint
295926|NCT01682824|CR|cr
295927|NCT01682824|Uncontrollable eating|uncontrollable eating
295928|NCT01682824|UE|ue
295929|NCT01682824|Three Factor Eating Questionnaire-R18v2|three factor eating questionnaire-r18v2
295930|NCT01682824|TFEQ-R18v2|tfeq-r18v2
295931|NCT01682824|Web-based questionnaire|web-based questionnaire
295932|NCT01682824|Multifactor Screener|multifactor screener
295933|NCT01682785|Major depressive disorder|major depressive disorder
295934|NCT01682785|Metabolic syndrome|metabolic syndrome
295935|NCT01682785|Thyroid dysfunction|thyroid dysfunction
295936|NCT01682785|incidence|incidence
295937|NCT01682772|Olaparib|olaparib
295938|NCT01682772|Adenocarcinoma|adenocarcinoma
295939|NCT01682772|Prostate|prostate
295940|NCT01682759|diabetes|diabetes
295941|NCT01682746|Brain Tumor|brain tumor
295942|NCT01682746|Photodynamic Therapy|photodynamic therapy
295943|NCT01682746|Photochemotherapy|photochemotherapy
295944|NCT01682746|Astrocytoma|astrocytoma
295945|NCT01682746|Pilocytic Astrocytoma|pilocytic astrocytoma
295946|NCT01682746|Low grade Astrocytoma|low grade astrocytoma
295947|NCT01682746|Anaplastic Astrocytoma|anaplastic astrocytoma
295948|NCT01682746|Glioblastoma|glioblastoma
295950|NCT01682746|Chordoma|chordoma
295951|NCT01682746|Germinoma|germinoma
295952|NCT01682746|Germ Cell Tumor|germ cell tumor
295953|NCT01682746|Non-germinaoma|non-germinaoma
295954|NCT01682746|CNS Lymphoma|cns lymphoma
295955|NCT01682746|Craniopharyngioma|craniopharyngioma
295956|NCT01682746|Brain Stem Glioma|brain stem glioma
295957|NCT01682746|Ependymoma|ependymoma
295958|NCT01682746|Mixed Glioma|mixed glioma
295959|NCT01682746|Optic Nerve Glioma|optic nerve glioma
295960|NCT01682746|Subependymoma|subependymoma
295961|NCT01682746|Medulloblastoma|medulloblastoma
295962|NCT01682746|Meningioma|meningioma
295963|NCT01682746|Metastatic Brain Tumors|metastatic brain tumors
295964|NCT01682746|Oligodendroglioma|oligodendroglioma
295965|NCT01682746|Pituitary Tumors|pituitary tumors
295966|NCT01682746|Primitive Neuroectodermal|primitive neuroectodermal
295967|NCT01682746|PNET|pnet
295968|NCT01682746|Desmoplastic Neuroepithelial Tumor|desmoplastic neuroepithelial tumor
295969|NCT01682746|DNET|dnet
295970|NCT01682733|Obesity|obesity
295971|NCT01682733|Weight loss|weight loss
295972|NCT01682733|Gastric reduction (volume)|gastric reduction (volume)
295973|NCT01682733|BMI 30-40|bmi 30-40
295974|NCT01682720|HCV|hcv
295975|NCT01682720|Genotype 2|genotype 2
295976|NCT01682720|Genotype 3|genotype 3
295977|NCT01682707|intubation|intubation
295978|NCT01682707|coronary disease|coronary disease
295979|NCT01682707|hemodynamic response|hemodynamic response
295980|NCT01682707|anesthesia with tracheal intubation|anesthesia with tracheal intubation
295981|NCT01682707|assessment of hemodynamic response|assessment of hemodynamic response
295982|NCT01682681|Epilepsy|epilepsy
295983|NCT01682681|Topiramate|topiramate
295984|NCT01682681|Topmax|topmax
295985|NCT01682668|parkinson's disease|parkinson's disease
295986|NCT01682668|subthalamic nucleus|subthalamic nucleus
295987|NCT01682668|akinesia|akinesia
295988|NCT01682668|gait initiation|gait initiation
295989|NCT01682668|neuronal activity|neuronal activity
295990|NCT01682668|before STN stimulation|before stn stimulation
295991|NCT01682668|with STN stimulation|with stn stimulation
295992|NCT01682668|functional MRI|functional mri
295993|NCT01682642|endometriosis|endometriosis
295994|NCT01682642|pregnancy|pregnancy
295995|NCT01682642|In Vitro Fertilization (IVF)/Intra Cytoplastic Sperm Injection (ICSI)|in vitro fertilization (ivf)/intra cytoplastic sperm injection (icsi)
295996|NCT01682642|peritoneal implants|peritoneal implants
295997|NCT01682642|embryo quality|embryo quality
295998|NCT01682629|Pediatric|pediatric
295999|NCT01682629|Cardiac|cardiac
296000|NCT01682629|Arrest|arrest
296001|NCT01682629|Simulation|simulation
296002|NCT01682629|Debriefing|debriefing
296003|NCT01682629|Realism|realism
296004|NCT01682616|Venetoclax|venetoclax
296005|NCT01682616|ABT-199|abt-199
296006|NCT01682616|Rituximab|rituximab
296007|NCT01682616|Maximum Tolerated Dose|maximum tolerated dose
296008|NCT01682616|Efficacy|efficacy
296009|NCT01682616|Preliminary|preliminary
296010|NCT01682616|Pharmacokinetics|pharmacokinetics
296011|NCT01682616|Tolerability|tolerability
296012|NCT01682616|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
296013|NCT01682616|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
296014|NCT01682616|Safety|safety
296015|NCT01682616|Cancer|cancer
296016|NCT01682603|Nerve growth factor|nerve growth factor
296017|NCT01682603|P2X3 receptor|p2x3 receptor
402023|NCT01233414|Behavior Therapy|behavior therapy
402024|NCT01233414|Aggression|aggression
296018|NCT01682603|Transient Receptor Potential Vanilloid 1 (TRPV-1) receptor|transient receptor potential vanilloid 1 (trpv-1) receptor
296019|NCT01682603|Bladder function|bladder function
296020|NCT01682603|Glomerular filtration rate|glomerular filtration rate
296021|NCT01682603|Detrusor overactivity|detrusor overactivity
296022|NCT01682603|Spinal cord injury|spinal cord injury
296023|NCT01682590|septic shock; acute renal failure; renal remplacement therapy; mortality; intensive care; critical care; acute kidney injury|septic shock; acute renal failure; renal remplacement therapy; mortality; intensive care; critical care; acute kidney injury
296024|NCT01682577|Perindopril|perindopril
296025|NCT01682577|Perindoprilat|perindoprilat
296026|NCT01682577|Bioequivalence|bioequivalence
296027|NCT01682577|Pharmacokinetic|pharmacokinetic
296028|NCT01682577|Angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
296029|NCT01682564|Candemore|candemore
296030|NCT01682564|Atacand|atacand
296031|NCT01682564|Candesartan cilexetil|candesartan cilexetil
296032|NCT01682564|Primary Hypertension|primary hypertension
296033|NCT01682564|Congestive Hypertension|congestive hypertension
296034|NCT01682551|High altitude illness|high altitude illness
296035|NCT01682551|Chinese medicine body constitution|chinese medicine body constitution
296036|NCT01682551|Chinese Medicine|chinese medicine
296037|NCT01682551|High altitude medicine|high altitude medicine
296038|NCT01682551|Mountain trekking|mountain trekking
296039|NCT01682538|Orfadin|orfadin
296040|NCT01682538|Nitisinone|nitisinone
296041|NCT01682538|Bioequivalence|bioequivalence
296042|NCT01682538|Bioavailability|bioavailability
296043|NCT01682525|Fertility preservation|fertility preservation
296044|NCT01682525|Ovarian Tissue|ovarian tissue
296045|NCT01682525|Cryopreservation|cryopreservation
296046|NCT01682525|Assisted Reproductive Technology|assisted reproductive technology
296047|NCT01682499|neuropathy|neuropathy
296048|NCT01682499|taxane|taxane
296049|NCT01682499|paclitaxel|paclitaxel
296050|NCT01682499|calcium|calcium
296051|NCT01682499|magnesium|magnesium
296052|NCT01682499|prevention|prevention
296053|NCT01682486|Medical device|medical device
296054|NCT01682486|Endotracheal Tube(s), ETT|endotracheal tube(s), ett
296055|NCT01682486|Bactiguard Coated ETT|bactiguard coated ett
296056|NCT01682486|Tolerability|tolerability
296057|NCT01682486|Safety|safety
296058|NCT01682486|Performance|performance
296059|NCT01682486|Bacterial colonization on ETT surface|bacterial colonization on ett surface
296060|NCT01682486|Hospital Acquired Infections, HAI|hospital acquired infections, hai
296061|NCT01682486|Ventilator Associated Pneumonia, VAP|ventilator associated pneumonia, vap
296062|NCT01682473|PI3K inhibitor|pi3k inhibitor
296063|NCT01682473|clinical trial|clinical trial
296064|NCT01682447|COPD|copd
296065|NCT01682447|Cognitive Dysfunction|cognitive dysfunction
296066|NCT01682447|Pulmonary Rehabilitation|pulmonary rehabilitation
296067|NCT01682447|Quality of life|quality of life
296068|NCT01682447|Cognitive rehabilitation|cognitive rehabilitation
296069|NCT01682408|R406,|r406,
296070|NCT01682408|Fostamatinib,|fostamatinib,
296071|NCT01682408|Phase I,|phase i,
296072|NCT01682408|Healthy Subjects,|healthy subjects,
296073|NCT01682408|Pharmacokinetics,|pharmacokinetics,
296074|NCT01682408|Fed/Fasted|fed/fasted
296075|NCT01682395|Intestinal volvulus|intestinal volvulus
296076|NCT01682395|Colon, sigmoid|colon, sigmoid
296077|NCT01682395|Anastomosis, surgical|anastomosis, surgical
296078|NCT01682395|Anastomotic leak|anastomotic leak
296079|NCT01682395|Malawi|malawi
296080|NCT01682395|Developing Country|developing country
296081|NCT01682382|age-related macular degeneration|age-related macular degeneration
296082|NCT01682382|choroidal neovascular age-related macular degeneration|choroidal neovascular age-related macular degeneration
296083|NCT01682382|genetics|genetics
296084|NCT01682382|macular pigment optical density (MPOD)|macular pigment optical density (mpod)
296085|NCT01682356|heart failure|heart failure
296086|NCT01682356|hypertension, pulmonary|hypertension, pulmonary
296087|NCT01682356|oxygen consumption|oxygen consumption
296088|NCT01682356|exercise tolerance|exercise tolerance
296089|NCT01682317|eating frequency|eating frequency
296090|NCT01682304|preeclampsia|preeclampsia
296091|NCT01682304|hypertension|hypertension
296093|NCT01682304|pregnancy induced hypertension|pregnancy induced hypertension
296094|NCT01682304|chronic hypertension|chronic hypertension
296095|NCT01682291|Prehypertension|prehypertension
296096|NCT01682291|Life-style modifications|life-style modifications
296097|NCT01682291|Dietary supplementation|dietary supplementation
296098|NCT01682278|Health complaints|health complaints
296099|NCT01682278|Amalgam|amalgam
296100|NCT01682278|Mercury|mercury
296101|NCT01682278|Plasma|plasma
296102|NCT01682278|Cytokine|cytokine
296103|NCT01682226|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
296104|NCT01682226|CYCLOSPORINE|cyclosporine
296105|NCT01682226|FLUDARABINE|fludarabine
296106|NCT01682226|G-CSF|g-csf
296107|NCT01682226|MYCOPHENOLATE MOFETIL (MMF)|mycophenolate mofetil (mmf)
296108|NCT01682226|Cord Blood Transplantation|cord blood transplantation
296109|NCT01682226|CliniMACS|clinimacs
296110|NCT01682226|12-153|12-153
296111|NCT01682213|Dabrafenib|dabrafenib
296112|NCT01682213|(GSK2118436)|(gsk2118436)
296113|NCT01682213|BRAFV600E/K|brafv600e/k
296114|NCT01682213|Resected AJCC Stage IIIC|resected ajcc stage iiic
296115|NCT01682213|12-124|12-124
296116|NCT01682200|moderate|moderate
296117|NCT01682200|facial acne|facial acne
296118|NCT01682200|acne vulgaris|acne vulgaris
296119|NCT01682161|Schizophrenia|schizophrenia
296120|NCT01682161|Paliperidone Palmitate|paliperidone palmitate
296121|NCT01682161|Invega Sustenna|invega sustenna
296122|NCT01682161|Antipsychotics|antipsychotics
296123|NCT01682161|Atypical antipsychotics|atypical antipsychotics
296124|NCT01682161|Medication Satisfaction and Adherence|medication satisfaction and adherence
296125|NCT01682122|Blood Pressure|blood pressure
296126|NCT01682122|Pediatrics|pediatrics
296127|NCT01682122|Infant, Newborn|infant, newborn
296128|NCT01682122|Cardiology|cardiology
296129|NCT01682109|prophylaxis|prophylaxis
296130|NCT01682109|herpes zoster|herpes zoster
296131|NCT01682109|herpes simplex|herpes simplex
296132|NCT01682109|valacyclovir|valacyclovir
296133|NCT01682109|palatability|palatability
296149|NCT01682070|Dose range finding|dose range finding
296150|NCT01682070|Dose tolerability|dose tolerability
296151|NCT01682070|grass pollen|grass pollen
296152|NCT01682070|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
296153|NCT01682070|Safety|safety
296154|NCT01682070|Immunogenicity|immunogenicity
296155|NCT01682057|High Blood Pressure|high blood pressure
296156|NCT01682057|Hypertension|hypertension
296157|NCT01682057|Resistant Hypertension|resistant hypertension
296158|NCT01682018|emphysema|emphysema
296159|NCT01682018|lung transplantation|lung transplantation
296160|NCT01682005|Cost|cost
296161|NCT01682005|Children|children
296162|NCT01682005|Rotavirus|rotavirus
296163|NCT01682005|Rotavirus vaccination|rotavirus vaccination
296164|NCT01682005|Clinical|clinical
296165|NCT01681992|Safety|safety
296166|NCT01681992|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
296167|NCT01681992|Immunogenicity|immunogenicity
296168|NCT01681979|fluticasone propionate|fluticasone propionate
296169|NCT01681979|asthma|asthma
296170|NCT01681979|pregnancy|pregnancy
296171|NCT01681979|major congenital malformations|major congenital malformations
296172|NCT01681927|idiopathic edema nocturia|idiopathic edema nocturia
296173|NCT01681914|adult HIV positive patients|adult hiv positive patients
296174|NCT01681875|Biomarkers of exposure|biomarkers of exposure
296175|NCT01681875|Compensatory smoking|compensatory smoking
296176|NCT01681875|Nicotine dependence|nicotine dependence
296177|NCT01681875|Reduced nicotine cigarettes|reduced nicotine cigarettes
296178|NCT01681875|Tobacco withdrawal|tobacco withdrawal
296179|NCT01681862|Hypertension|hypertension
296180|NCT01681862|African American|african american
296181|NCT01681862|Personal Health Record|personal health record
296182|NCT01681862|Faith-based Organizations|faith-based organizations
296183|NCT01681849|PTSD|ptsd
296184|NCT01681849|childhood abuse|childhood abuse
296185|NCT01681823|Prostate Cancer|prostate cancer
296186|NCT01681823|Prostatic Neoplasms|prostatic neoplasms
296187|NCT01681823|Prostate Specific Antigen|prostate specific antigen
296188|NCT01681823|Modified Citrus Pectin|modified citrus pectin
296189|NCT01681823|PectaSol-C|pectasol-c
296190|NCT01681823|Biochemical Relapse|biochemical relapse
296191|NCT01681797|fluorescent angiography|fluorescent angiography
296192|NCT01681797|reconstructive surgery|reconstructive surgery
296193|NCT01681797|perforator flap|perforator flap
296194|NCT01681784|lower urinary tract symptoms|lower urinary tract symptoms
296195|NCT01681784|biomarkers|biomarkers
296196|NCT01681784|urodynamic studies|urodynamic studies
296197|NCT01681758|cardiac surgery|cardiac surgery
296198|NCT01681758|Pulse pressure variation|pulse pressure variation
296199|NCT01681758|intravenous fluids|intravenous fluids
296200|NCT01681732|Asthma|asthma
296201|NCT01681732|child|child
296202|NCT01681732|pediatric|pediatric
296204|NCT01681719|VCO2|vco2
296205|NCT01681719|VE/VO2|ve/vo2
296206|NCT01681719|heart rate|heart rate
296207|NCT01681706|HIV|hiv
296208|NCT01681706|Indicator disease|indicator disease
296209|NCT01681654|Head/Neck Cancer|head/neck cancer
296210|NCT01681654|Exercise|exercise
296211|NCT01681654|Progressive Strength Training|progressive strength training
296212|NCT01681654|Quality of Life|quality of life
296213|NCT01681654|Cancer|cancer
296214|NCT01681654|Randomized Controlled Trial|randomized controlled trial
296215|NCT01681654|Nutrition|nutrition
296216|NCT01681654|Lifestyle Intervention|lifestyle intervention
296217|NCT01681641|Patients|patients
296218|NCT01681641|Nursing|nursing
296219|NCT01681641|Parkinsons disease|parkinsons disease
296220|NCT01681641|Deep Brain Stimulation|deep brain stimulation
296221|NCT01681641|Spouses|spouses
296222|NCT01681628|Thought Field Therapy.|thought field therapy.
296223|NCT01681628|Post-traumatic stress disorder.|post-traumatic stress disorder.
296224|NCT01681628|Post-traumatic stress disorder check list for Civilians.|post-traumatic stress disorder check list for civilians.
296225|NCT01681628|Uganda|uganda
296226|NCT01681628|Ugandan therapists.|ugandan therapists.
296227|NCT01681628|Community treatment.|community treatment.
296228|NCT01681615|Challenge test for Aspirin Hypersensitivity|challenge test for aspirin hypersensitivity
296229|NCT01681615|Challenge test for Acetylsalicylic Hypersensitivity|challenge test for acetylsalicylic hypersensitivity
296230|NCT01681602|Alzheimer Disease|alzheimer disease
296231|NCT01681602|Exercise|exercise
296232|NCT01681602|Cognition|cognition
296233|NCT01681602|Quality of life|quality of life
296234|NCT01681602|Cardiovascular fitness|cardiovascular fitness
296235|NCT01681602|Behavioural or psychological symptoms|behavioural or psychological symptoms
296236|NCT01681602|Physical fitness|physical fitness
296238|NCT01681589|Traumatic Brain Injury|traumatic brain injury
296239|NCT01681589|Rehabilitation|rehabilitation
296240|NCT01681589|Therapy|therapy
296241|NCT01681576|hypertension, salt sensitivity, valsartan, LCZ696|hypertension, salt sensitivity, valsartan, lcz696
296242|NCT01681537|Relapsed|relapsed
296243|NCT01681537|Refractory|refractory
296244|NCT01681524|Flurpiridaz F18 Injection|flurpiridaz f18 injection
296245|NCT01681524|Positron Emission Tomography Myocardial Perfusion Imaging|positron emission tomography myocardial perfusion imaging
296246|NCT01681524|Single Positron Emission Computed Tomography|single positron emission computed tomography
296247|NCT01681524|Coronary Artery Disease|coronary artery disease
296248|NCT01681524|Myocardia Ischemia|myocardia ischemia
296249|NCT01681524|Coronary Disease|coronary disease
296250|NCT01681524|Heart Diseases|heart diseases
296251|NCT01681524|Cardiovascular Diseases|cardiovascular diseases
296252|NCT01681524|Arteriosclerosis|arteriosclerosis
296253|NCT01681524|Arterial Occlusive Diseases|arterial occlusive diseases
296254|NCT01681524|Vascular Diseases|vascular diseases
296255|NCT01681511|Catheter Associated Urinary Tract Infections|catheter associated urinary tract infections
296256|NCT01681511|CAUTI|cauti
296257|NCT01681498|pregnant|pregnant
296258|NCT01681498|fetal ecg|fetal ecg
296259|NCT01681498|ecg|ecg
296260|NCT01681485|Traditional Chinese medicine|traditional chinese medicine
296261|NCT01681485|Non small cell lung cancer|non small cell lung cancer
296262|NCT01681485|Surgery|surgery
296263|NCT01681485|Chemotherapy|chemotherapy
296264|NCT01681485|Radiation therapy|radiation therapy
296265|NCT01681472|Colon cancer|colon cancer
296266|NCT01681472|5,10-methylenetetrahydrofolate|5,10-methylenetetrahydrofolate
296267|NCT01681472|Rectal Neoplasms|rectal neoplasms
296268|NCT01681472|Colorectal Neoplasms|colorectal neoplasms
296269|NCT01681472|Intestinal Neoplasms|intestinal neoplasms
296270|NCT01681472|Gastrointestinal Neoplasms|gastrointestinal neoplasms
296271|NCT01681472|Digestive System Neoplasms|digestive system neoplasms
296272|NCT01681472|Gastrointestinal Diseases|gastrointestinal diseases
296273|NCT01681472|Therapeutic Uses|therapeutic uses
296274|NCT01681472|Pharmacokinetics|pharmacokinetics
296275|NCT01681472|Pharmacodynamics|pharmacodynamics
296276|NCT01681459|Free fatty acid|free fatty acid
296277|NCT01681459|Triglyceride|triglyceride
296278|NCT01681459|Gastric emptying|gastric emptying
296279|NCT01681459|Satiety hormones|satiety hormones
296280|NCT01681459|Appetite|appetite
296281|NCT01681459|Severe obesity|severe obesity
296282|NCT01681446|hepatocellular carcinoma|hepatocellular carcinoma
296283|NCT01681446|interferon-alpha|interferon-alpha
296284|NCT01681446|miR-26|mir-26
296285|NCT01681433|OGX-427|ogx-427
296286|NCT01681433|Abiraterone Acetate|abiraterone acetate
296287|NCT01681420|HIV counseling|hiv counseling
296288|NCT01681420|Blood donor HIV testing|blood donor hiv testing
296289|NCT01681420|Brazil|brazil
296290|NCT01681420|Blood banks|blood banks
296291|NCT01681420|Blood donors|blood donors
296292|NCT01681407|Depression|depression
296293|NCT01681407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
296294|NCT01681407|MicroRNAs|micrornas
296295|NCT01681407|Proteome|proteome
296296|NCT01681368|NF-Kappa B Pathway|nf-kappa b pathway
296297|NCT01681368|Response Biomarkers|response biomarkers
296298|NCT01681368|Progression-Free Survival|progression-free survival
296299|NCT01681368|Pharmacokinetics|pharmacokinetics
296300|NCT01681368|Pharmacodynamics|pharmacodynamics
296301|NCT01681355|Healthy, term, Asian infants|healthy, term, asian infants
296302|NCT01681355|Infant formula|infant formula
296303|NCT01681342|stade Ib to IV cervix cancer|stade ib to iv cervix cancer
296304|NCT01681342|ambulatory high dose rate brachytherapy|ambulatory high dose rate brachytherapy
296305|NCT01681329|Cognitive-behavioral therapy|cognitive-behavioral therapy
296306|NCT01681329|Interpretation modification training|interpretation modification training
296307|NCT01681329|Randomized clinical trial|randomized clinical trial
296308|NCT01681329|Adults|adults
296309|NCT01681316|Chronic Stable Angina|chronic stable angina
296310|NCT01681316|Randomized Controlled Trial|randomized controlled trial
296311|NCT01681316|Traditional Chinese Medicine|traditional chinese medicine
296312|NCT01681264|Pain|pain
296313|NCT01681264|Pain Management|pain management
296314|NCT01681264|Back pain|back pain
296315|NCT01681264|Neck pain|neck pain
296316|NCT01681238|perioperative fluid optimization|perioperative fluid optimization
296317|NCT01681238|goal-directed therapy|goal-directed therapy
296318|NCT01681238|elderly|elderly
296319|NCT01681238|high-risk surgery|high-risk surgery
296320|NCT01681225|ARDS|ards
296321|NCT01681225|mechanical ventilation|mechanical ventilation
296323|NCT01681225|esophageal pressure|esophageal pressure
296324|NCT01681199|statin|statin
296325|NCT01681199|atherosclerosis|atherosclerosis
296331|NCT01681173|Diabetes prevention|diabetes prevention
296333|NCT01681173|Healthy life style|healthy life style
296334|NCT01681173|Weight loss|weight loss
296335|NCT01681160|MAGGOT THERAPY|maggot therapy
296336|NCT01681160|DIABETIC FOOT|diabetic foot
296337|NCT01681160|NURSING CARE|nursing care
296338|NCT01681160|DRESSING|dressing
296339|NCT01681147|Gestational Diabetes|gestational diabetes
296340|NCT01681147|postpartum|postpartum
296341|NCT01681147|nutrition|nutrition
296342|NCT01681147|exercise|exercise
296343|NCT01681134|tacrolimus|tacrolimus
296344|NCT01681134|Advagraf®|advagraf®
296345|NCT01681134|Prograf®|prograf®
296346|NCT01681134|Glomerular Filtration Rate|glomerular filtration rate
296347|NCT01681134|Effective Renal Plasma Flow|effective renal plasma flow
296348|NCT01681134|Pharmacokinetics|pharmacokinetics
296349|NCT01681134|Pharmacodynamics|pharmacodynamics
296350|NCT01681095|Physiological Effects of Drugs|physiological effects of drugs
296351|NCT01681095|Cardiovascular Agents|cardiovascular agents
296352|NCT01681095|Therapeutic Uses|therapeutic uses
296353|NCT01681095|Pharmacologic Actions|pharmacologic actions
296354|NCT01681095|Mannitol|mannitol
296355|NCT01681095|Cardiac Surgery|cardiac surgery
296356|NCT01681095|Cardioplegic Solutions|cardioplegic solutions
296357|NCT01681095|HTK solution|htk solution
296358|NCT01681095|Myocardial protection|myocardial protection
296359|NCT01681095|Coronary Artery Disease|coronary artery disease
296360|NCT01681095|Myocardial Ischemia|myocardial ischemia
296361|NCT01681095|Coronary Disease|coronary disease
296362|NCT01681095|Heart Diseases|heart diseases
296363|NCT01681056|autosuggestion|autosuggestion
296364|NCT01681056|quality of life|quality of life
296365|NCT01681056|geriatric|geriatric
296366|NCT01681056|serum cortisol|serum cortisol
296367|NCT01681056|Interferon gamma|interferon gamma
296368|NCT01681056|interleukin-2|interleukin-2
296369|NCT01681056|interleukin-6|interleukin-6
296370|NCT01681056|neuroplasticity|neuroplasticity
296371|NCT01681043|Sleep|sleep
296372|NCT01681017|Perinatal Mortality|perinatal mortality
296373|NCT01681017|Asphyxia|asphyxia
296374|NCT01681017|Stillbirth|stillbirth
296375|NCT01681017|Neonatal Death|neonatal death
296376|NCT01681017|Resuscitation|resuscitation
296377|NCT01681017|Helping Babies Breathe|helping babies breathe
296378|NCT01681017|among births greater than one thousand five hundred grams|among births greater than one thousand five hundred grams
296379|NCT01681004|si joint|si joint
296380|NCT01681004|si joint pain|si joint pain
296381|NCT01681004|si joint injury|si joint injury
296382|NCT01681004|si joint treatment|si joint treatment
296383|NCT01681004|si joint injections|si joint injections
296384|NCT01681004|si joint inflammation|si joint inflammation
296385|NCT01681004|si joint problems|si joint problems
296386|NCT01681004|si joint symptoms|si joint symptoms
296387|NCT01681004|hypermobile si joint|hypermobile si joint
296388|NCT01681004|si joint arthritis|si joint arthritis
296389|NCT01681004|si joint pain treatment|si joint pain treatment
296390|NCT01681004|inflamed si joint|inflamed si joint
296391|NCT01681004|si joint sclerosis|si joint sclerosis
296392|NCT01681004|locked si joint|locked si joint
296393|NCT01681004|si joint injuries|si joint injuries
296394|NCT01681004|si joint disease|si joint disease
296395|NCT01681004|si joint infection|si joint infection
296396|NCT01681004|sacroiliac joint pelvic pain|sacroiliac joint pelvic pain
296397|NCT01681004|sacroiliac joint arthritis treatment|sacroiliac joint arthritis treatment
296403|NCT01680952|RECORD study|record study
296404|NCT01680939|Pediatrics|pediatrics
296405|NCT01680939|Obstructive Sleep Apnea|obstructive sleep apnea
296406|NCT01680939|Adenotonsillectomy|adenotonsillectomy
296407|NCT01680939|Analgesia|analgesia
296408|NCT01680926|type 2 diabetes mellitus|type 2 diabetes mellitus
296409|NCT01680926|insulin|insulin
296410|NCT01680926|hbA1c|hba1c
296411|NCT01680926|body weight|body weight
296421|NCT01680874|Lactobacillus acidophilus|lactobacillus acidophilus
296422|NCT01680874|Lactobacillus paracasei|lactobacillus paracasei
296423|NCT01680874|Bifidobacterium lactis|bifidobacterium lactis
296424|NCT01680874|Yogurt|yogurt
296425|NCT01680874|Probiotics|probiotics
296814|NCT01679093|PainMatcher|painmatcher
296426|NCT01680861|Kidney transplant patients|kidney transplant patients
296427|NCT01680848|Dental caries,|dental caries,
296428|NCT01680848|Caries diagnosis,|caries diagnosis,
296429|NCT01680848|Caries treatment,|caries treatment,
296430|NCT01680848|Caries risk,|caries risk,
296431|NCT01680848|Practice pattern,|practice pattern,
296432|NCT01680848|Clinical epidemiology,|clinical epidemiology,
296433|NCT01680848|Dental Practice-Based Research Network|dental practice-based research network
296434|NCT01680822|Nontuberculous, Atypical, Mycobacterial|nontuberculous, atypical, mycobacterial
296435|NCT01680809|Venous insufficiency|venous insufficiency
296436|NCT01680809|Venous stasis ulcerations|venous stasis ulcerations
296437|NCT01680809|Compression stockings|compression stockings
296438|NCT01680809|Compression stocking compliance|compression stocking compliance
296439|NCT01680796|Multiple Myeloma|multiple myeloma
296440|NCT01680796|Relapsed Multiple Myeloma|relapsed multiple myeloma
296441|NCT01680796|Refractory Multiple Myeloma|refractory multiple myeloma
296442|NCT01680783|noninvasive ventilation|noninvasive ventilation
296443|NCT01680783|acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
296444|NCT01680783|Acute respiratory distress syndrome|acute respiratory distress syndrome
296445|NCT01680783|shock|shock
296446|NCT01680770|shock|shock
296447|NCT01680770|transthoracic echocardiography|transthoracic echocardiography
296448|NCT01680770|critical care|critical care
296449|NCT01680757|Left Atrial Appendage|left atrial appendage
296450|NCT01680757|LARIAT|lariat
296451|NCT01680757|atrial fibrillation|atrial fibrillation
296452|NCT01680757|contraindication to oral anticoagulation therapy|contraindication to oral anticoagulation therapy
296453|NCT01680744|Transplantation|transplantation
296454|NCT01680744|Terminal creatinine|terminal creatinine
296455|NCT01680744|Renal function|renal function
296456|NCT01680744|GFR|gfr
296457|NCT01680731|Pelvic floor injury|pelvic floor injury
296458|NCT01680731|Levator ani muscle|levator ani muscle
296459|NCT01680718|oxytocin|oxytocin
296460|NCT01680718|vasopressin|vasopressin
296461|NCT01680718|intranasal administration|intranasal administration
296462|NCT01680718|healthy sample|healthy sample
296463|NCT01680705|Chronic Rhinosinusitis|chronic rhinosinusitis
296464|NCT01680705|Endoscopic Sinus Surgery|endoscopic sinus surgery
296465|NCT01680705|Sinonasal saline irrigation|sinonasal saline irrigation
296466|NCT01680705|Frequency|frequency
296467|NCT01680705|Postoperative|postoperative
296468|NCT01680705|High Volume|high volume
296469|NCT01680705|Randomized Control Trial|randomized control trial
296470|NCT01680705|Single Blinded|single blinded
296471|NCT01680705|Prospective Study|prospective study
296472|NCT01680705|Quality of Life|quality of life
296473|NCT01680705|Endoscopic Sinus Score|endoscopic sinus score
296474|NCT01680692|Analgesia TKA|analgesia tka
296475|NCT01680692|Total knee arthroplasty|total knee arthroplasty
296476|NCT01680692|Continuous femoral catheter|continuous femoral catheter
296477|NCT01680692|Continuous tibial catheter|continuous tibial catheter
296478|NCT01680692|Single shot sciatic|single shot sciatic
296479|NCT01680679|Influenza|influenza
296480|NCT01680679|India|india
296481|NCT01680679|Children|children
296482|NCT01680679|Trivalent Influenza Vaccine (TIV)|trivalent influenza vaccine (tiv)
296483|NCT01680679|Inactivated poliovirus vaccine (IPV)|inactivated poliovirus vaccine (ipv)
296484|NCT01680679|Direct influenza vaccine effectiveness|direct influenza vaccine effectiveness
296485|NCT01680679|Total influenza vaccine effectiveness|total influenza vaccine effectiveness
296486|NCT01680679|Indirect influenza vaccine effectiveness|indirect influenza vaccine effectiveness
296487|NCT01680640|non alcoholic fatty liver disease|non alcoholic fatty liver disease
296488|NCT01680640|NAFLD|nafld
296489|NCT01680640|synbiotic|synbiotic
296490|NCT01680640|gut microbiota|gut microbiota
296491|NCT01680640|intervention|intervention
296492|NCT01680640|RCT|rct
296493|NCT01680640|biomarkers|biomarkers
296494|NCT01680588|Alzheimer|alzheimer
296495|NCT01680575|Neutropenia|neutropenia
296496|NCT01680575|Paclitaxel|paclitaxel
296497|NCT01680575|Carboplatin|carboplatin
296498|NCT01680575|Epithelial ovarian cancer|epithelial ovarian cancer
296499|NCT01680562|in-vivo skin imaging|in-vivo skin imaging
296500|NCT01680562|non-invasive non-melanoma skin cancer diagnostics|non-invasive non-melanoma skin cancer diagnostics
296501|NCT01680523|cervical cancer|cervical cancer
296502|NCT01680523|bulky early-stage|bulky early-stage
296503|NCT01680523|locally advanced|locally advanced
296504|NCT01680523|radical hysterectomy|radical hysterectomy
296505|NCT01680523|concurrent chemoradiation therapy|concurrent chemoradiation therapy
296506|NCT01680484|non-stress test|non-stress test
296507|NCT01680471|emergence agitation|emergence agitation
296508|NCT01680471|midazolam|midazolam
296509|NCT01680471|sevoflurane|sevoflurane
296510|NCT01680471|strabismus|strabismus
296511|NCT01680458|antifungal treatment|antifungal treatment
296512|NCT01680458|prophylaxis|prophylaxis
296513|NCT01680458|administration|administration
296514|NCT01680458|Japanese|japanese
296515|NCT01680458|infants|infants
296516|NCT01680458|fluconazole|fluconazole
296517|NCT01680458|Diflucan|diflucan
402025|NCT01233414|Tantrums|tantrums
296518|NCT01680458|Regulatory Post Marketing Commitment Plan.|regulatory post marketing commitment plan.
296520|NCT01680432|constipation|constipation
296521|NCT01680432|probiotics|probiotics
296522|NCT01680432|bifidobacterium|bifidobacterium
296523|NCT01680432|cheese|cheese
296524|NCT01680419|Veterans|veterans
296525|NCT01680419|Reintegration|reintegration
296526|NCT01680419|Resilience|resilience
296527|NCT01680419|Marital|marital
296528|NCT01680419|Spouse|spouse
296529|NCT01680419|Behavioral intervention|behavioral intervention
296530|NCT01680419|PTSD|ptsd
296531|NCT01680419|Integrative therapies|integrative therapies
296532|NCT01680419|Complementary therapies|complementary therapies
296533|NCT01680419|Massage|massage
296534|NCT01680419|Meditation|meditation
296535|NCT01680419|Mindfulness|mindfulness
296536|NCT01680419|Compassion|compassion
296537|NCT01680419|Mental health|mental health
296538|NCT01680406|Plasmodium vivax|plasmodium vivax
296539|NCT01680406|malaria|malaria
296540|NCT01680406|Ethiopia|ethiopia
296541|NCT01680406|Sub-Saharan Africa|sub-saharan africa
296542|NCT01680406|primaquine|primaquine
296543|NCT01680406|artemether lumefantrine|artemether lumefantrine
296544|NCT01680406|chloroquine|chloroquine
296545|NCT01680380|sleep apnea|sleep apnea
296546|NCT01680380|snoring|snoring
296547|NCT01680315|Satiety,|satiety,
296548|NCT01680315|satiation,|satiation,
296549|NCT01680315|anticipation,|anticipation,
296550|NCT01680315|food intake|food intake
296551|NCT01680302|Atrial fibrillation|atrial fibrillation
296552|NCT01680302|Prevention|prevention
296553|NCT01680302|Exercise|exercise
296554|NCT01680289|Dentin bonding agents|dentin bonding agents
296555|NCT01680289|Composite restorations|composite restorations
296556|NCT01680289|Dental restoration failure|dental restoration failure
296557|NCT01680276|intellectual disability|intellectual disability
296558|NCT01680276|developmental disability|developmental disability
296559|NCT01680276|challenging behaviour|challenging behaviour
296560|NCT01680276|behavioural intervention|behavioural intervention
296561|NCT01680276|training|training
296562|NCT01680263|Kinesiotaping|kinesiotaping
296563|NCT01680263|pes anserinus tendino-bursitis|pes anserinus tendino-bursitis
296564|NCT01680263|nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
296565|NCT01680263|physical therapy|physical therapy
296566|NCT01680250|Total liver volume|total liver volume
296567|NCT01680250|Liver cyst|liver cyst
296568|NCT01680237|cognitive behavior therapy|cognitive behavior therapy
296569|NCT01680237|exposure in-vivo|exposure in-vivo
296570|NCT01680237|panic disorder with agoraphobia|panic disorder with agoraphobia
296571|NCT01680224|Obesity|obesity
296572|NCT01680224|Weight Gain|weight gain
296573|NCT01680224|Dissonance|dissonance
296574|NCT01680224|College,University Students|college,university students
296575|NCT01680224|Eating Disorders|eating disorders
296576|NCT01680224|Obesity Prevention|obesity prevention
296577|NCT01680224|Selective Prevention|selective prevention
296578|NCT01680224|Effectiveness|effectiveness
296579|NCT01680211|Blood Sugar,|blood sugar,
296580|NCT01680211|Lipoproteins,|lipoproteins,
296581|NCT01680211|Salacia,|salacia,
296582|NCT01680211|Sesame,|sesame,
296583|NCT01680211|Prediabetes,|prediabetes,
296584|NCT01680211|Hyperlipidemia,|hyperlipidemia,
296585|NCT01680211|Herbal supplement|herbal supplement
296586|NCT01680198|Vitamin D|vitamin d
296587|NCT01680198|Paracalcitol|paracalcitol
296588|NCT01680198|Chronic kidney disease|chronic kidney disease
296589|NCT01680198|Endothelial dysfunction|endothelial dysfunction
296590|NCT01680198|Flow mediated vasodilation|flow mediated vasodilation
296591|NCT01680185|Hyperglycemia|hyperglycemia
296592|NCT01680185|NODAT|nodat
296593|NCT01680185|Insulin pump|insulin pump
296594|NCT01680185|Semiclosed loop|semiclosed loop
296595|NCT01680172|cancer|cancer
296596|NCT01680172|depression|depression
296597|NCT01680172|anxiety|anxiety
296598|NCT01680172|palliative care|palliative care
296599|NCT01680159|Infliximab|infliximab
296600|NCT01680159|REMICADE|remicade
296605|NCT01680094|Panobinostat|panobinostat
296606|NCT01680094|Lentivirus Infections|lentivirus infections
296607|NCT01680094|Retroviridae Infections|retroviridae infections
296608|NCT01680094|RNA Virus Infections|rna virus infections
296609|NCT01680094|Virus Diseases|virus diseases
296610|NCT01680094|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
296611|NCT01680094|Sexually Transmitted Diseases|sexually transmitted diseases
296612|NCT01680094|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
296613|NCT01680094|Immune System Diseases|immune system diseases
296614|NCT01680094|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
296615|NCT01680094|Therapeutic Uses|therapeutic uses
296616|NCT01680068|Macular hole|macular hole
296617|NCT01680068|Vitreoretinal surgery|vitreoretinal surgery
296618|NCT01680068|Macular surgery|macular surgery
296619|NCT01680068|Air tamponade|air tamponade
296620|NCT01680042|inflammatory halo|inflammatory halo
296622|NCT01680016|Rabies virus, postexposure, vaccine schedule, children, older adults|rabies virus, postexposure, vaccine schedule, children, older adults
296623|NCT01679964|HIV infection|hiv infection
296625|NCT01679964|Adverse event|adverse event
296626|NCT01679964|Life quality|life quality
296627|NCT01679951|Rheumatoid arthritis|rheumatoid arthritis
296628|NCT01679951|Swollen and tender joints|swollen and tender joints
296629|NCT01679951|Methotrexate|methotrexate
296630|NCT01679951|Immunology|immunology
296631|NCT01679951|Dose range finding study|dose range finding study
296632|NCT01679938|obesity prevention|obesity prevention
296633|NCT01679938|cluster-randomized controlled trial|cluster-randomized controlled trial
296634|NCT01679938|preschool-aged children|preschool-aged children
296635|NCT01679925|Early puberty|early puberty
296636|NCT01679925|Psychosocial impact|psychosocial impact
296637|NCT01679925|Qualitative assessment|qualitative assessment
296638|NCT01679912|Hereditary angioedema|hereditary angioedema
296639|NCT01679912|Emergency Medical Service|emergency medical service
296640|NCT01679912|Health care coast|health care coast
296641|NCT01679912|Telephone|telephone
296642|NCT01679899|diabetes|diabetes
296643|NCT01679899|type 2 diabetes mellitus|type 2 diabetes mellitus
296644|NCT01679899|osteopenia|osteopenia
296645|NCT01679899|osteoporosis|osteoporosis
296646|NCT01679899|glycemic variability|glycemic variability
296647|NCT01679899|bone markers|bone markers
296648|NCT01679899|osteocalcin|osteocalcin
296649|NCT01679899|NTX|ntx
296650|NCT01679899|CTX|ctx
296651|NCT01679899|BALP|balp
296652|NCT01679886|Position emission tomography;|position emission tomography;
296653|NCT01679886|Rubidium;|rubidium;
296654|NCT01679886|Women;|women;
296655|NCT01679886|Overweighted patients|overweighted patients
296656|NCT01679873|confidence|confidence
296657|NCT01679873|funding sources|funding sources
296658|NCT01679873|conflicts of interests|conflicts of interests
296659|NCT01679873|general practitioner|general practitioner
296660|NCT01679847|Elemene|elemene
296661|NCT01679847|pharmacokinetics|pharmacokinetics
296662|NCT01679847|Blood-brain barrier|blood-brain barrier
296663|NCT01679821|Temporomandibular disorders.|temporomandibular disorders.
296664|NCT01679821|Dental prosthesis.|dental prosthesis.
296665|NCT01679821|Dental students|dental students
296666|NCT01679808|copd|copd
296667|NCT01679808|airway obstruction|airway obstruction
296668|NCT01679808|Tracheobronchomalacia|tracheobronchomalacia
296669|NCT01679795|hormone replacement therapy; Dopplervelocimetry; Flow-mediated dilation; menopause; tibolone|hormone replacement therapy; dopplervelocimetry; flow-mediated dilation; menopause; tibolone
296670|NCT01679782|COPD, nervous system, peripheral muscle dysfunction|copd, nervous system, peripheral muscle dysfunction
296671|NCT01679756|Colorectal cancer|colorectal cancer
296672|NCT01679756|Laparoscopic right hemicolectomy|laparoscopic right hemicolectomy
296673|NCT01679756|Intracorporeal anastomosis|intracorporeal anastomosis
296674|NCT01679743|Metastatic Breast Cancer|metastatic breast cancer
296675|NCT01679743|Metastatic Lung Cancer|metastatic lung cancer
296676|NCT01679743|Monoclonal Antibody|monoclonal antibody
296677|NCT01679743|18FLT|18flt
296678|NCT01679743|Surgery|surgery
296679|NCT01679717|Osteoarthritis|osteoarthritis
296680|NCT01679717|CMC1-joint|cmc1-joint
296681|NCT01679717|Postoperative therapy|postoperative therapy
296682|NCT01679717|Interposition arthroplasty of the thumb|interposition arthroplasty of the thumb
296683|NCT01679717|Occupational therapy|occupational therapy
296684|NCT01679652|Essential hypertension|essential hypertension
296685|NCT01679652|Nitric oxide|nitric oxide
296686|NCT01679652|Nebivolol|nebivolol
296687|NCT01679652|Fractional excretion of sodium|fractional excretion of sodium
296327|NCT01681199|OPN|opn
296688|NCT01679626|cricoid pressure (CP)|cricoid pressure (cp)
296689|NCT01679626|backward upward rightward pressure (BURP)|backward upward rightward pressure (burp)
296690|NCT01679626|AP-rima distances|ap-rima distances
296691|NCT01679626|Glottic area|glottic area
296692|NCT01679626|Extralaryngeal manoeuvres|extralaryngeal manoeuvres
296693|NCT01679600|Rehabilitation|rehabilitation
296694|NCT01679600|Robotics-assisted Treadmill Exercise|robotics-assisted treadmill exercise
296695|NCT01679600|Aerobic Capacity|aerobic capacity
296696|NCT01679600|Exercise Testing|exercise testing
296697|NCT01679574|PCO|pco
296698|NCT01679561|implantation failure|implantation failure
296699|NCT01679561|recurrent abortion|recurrent abortion
296700|NCT01679561|intralipid|intralipid
296701|NCT01679535|Infant nutrition disorder|infant nutrition disorder
296702|NCT01679535|Child nutrition disorders|child nutrition disorders
296703|NCT01679535|Malnutrition|malnutrition
296704|NCT01679535|Protein-energy malnutrition|protein-energy malnutrition
296705|NCT01679522|endometrial cancer|endometrial cancer
296706|NCT01679522|laparoscopic surgical staging|laparoscopic surgical staging
296708|NCT01679522|four-port|four-port
296709|NCT01679496|LDL-cholesterol|ldl-cholesterol
296710|NCT01679470|cancer|cancer
296711|NCT01679470|lung|lung
296712|NCT01679470|laser|laser
296713|NCT01679470|ablation|ablation
296714|NCT01679470|airway obstruction|airway obstruction
296715|NCT01679444|MRS|mrs
296716|NCT01679444|Heavy dose drinkers|heavy dose drinkers
296717|NCT01679444|Alcohol|alcohol
296718|NCT01679444|NIAAA|niaaa
296719|NCT01679431|Aortic Stenosis|aortic stenosis
296720|NCT01679431|Obesity, Abdominal|obesity, abdominal
296721|NCT01679431|Metabolic Syndrome X|metabolic syndrome x
296722|NCT01679431|Insulin Resistance|insulin resistance
296723|NCT01679431|Echocardiography, Doppler|echocardiography, doppler
296724|NCT01679431|Multidetector Computed Tomography|multidetector computed tomography
296725|NCT01679431|Magnetic Resonance Imaging|magnetic resonance imaging
296726|NCT01679418|PONV|ponv
296727|NCT01679418|thyroid|thyroid
296728|NCT01679418|surgery|surgery
296729|NCT01679418|nausea and vomiting|nausea and vomiting
296730|NCT01679418|postoperative|postoperative
296731|NCT01679405|metastatic biliary tract cancer|metastatic biliary tract cancer
296732|NCT01679392|Transversus abdominis plane block|transversus abdominis plane block
296733|NCT01679392|Ultrasound guided nerve block|ultrasound guided nerve block
296734|NCT01679379|Cesarean Section|cesarean section
296735|NCT01679379|Obese Women|obese women
296736|NCT01679379|Surgical Site Infection|surgical site infection
296737|NCT01679353|inguinal hernia, caudal analgesia, magnesium|inguinal hernia, caudal analgesia, magnesium
296738|NCT01679340|Gastric cancer|gastric cancer
296739|NCT01679340|D2 surgery|d2 surgery
296740|NCT01679340|S-1|s-1
296741|NCT01679340|Oxaliplatin|oxaliplatin
296742|NCT01679340|cisplatin|cisplatin
296743|NCT01679314|COPD|copd
296744|NCT01679314|vagus nerve stimulation|vagus nerve stimulation
296745|NCT01679314|vagal nerve stimulation|vagal nerve stimulation
296746|NCT01679314|nVNS|nvns
296747|NCT01679314|VNS|vns
296748|NCT01679314|non invasive|non invasive
296749|NCT01679314|gammacore|gammacore
296750|NCT01679301|oxygen|oxygen
296751|NCT01679288|Hand-Held ultrasonography|hand-held ultrasonography
296752|NCT01679288|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
296753|NCT01679288|Abdominal Aortic Atherosclerosis|abdominal aortic atherosclerosis
296754|NCT01679288|Cardiovascular risk|cardiovascular risk
296755|NCT01679288|Primary Health Care|primary health care
296756|NCT01679275|Heart Defects, congenital|heart defects, congenital
296757|NCT01679275|Patient Monitoring|patient monitoring
296758|NCT01679275|Infant, Newborn|infant, newborn
296759|NCT01679275|Physiology|physiology
296760|NCT01679249|extracellular fluid volume|extracellular fluid volume
296761|NCT01679249|hypotension|hypotension
296762|NCT01679249|hemodialysis|hemodialysis
296763|NCT01679236|Smoking|smoking
296764|NCT01679236|Smoking cessation|smoking cessation
296765|NCT01679236|Nicotine|nicotine
296766|NCT01679236|Tobacco|tobacco
296767|NCT01679236|Mindfulness|mindfulness
296768|NCT01679236|Meditation|meditation
296769|NCT01679236|MBSR|mbsr
296770|NCT01679236|Mindfulness Training|mindfulness training
296771|NCT01679236|Behavioral Intervention|behavioral intervention
296772|NCT01679236|Alcohol|alcohol
296773|NCT01679236|Young Adults|young adults
296774|NCT01679223|Breast reconstruction|breast reconstruction
296775|NCT01679223|Hydroxyproline concentration|hydroxyproline concentration
296776|NCT01679223|neoangiogenesis|neoangiogenesis
296777|NCT01679223|collagen deposition|collagen deposition
296778|NCT01679197|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
296779|NCT01679197|NAFLD|nafld
296780|NCT01679197|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
296781|NCT01679197|NASH|nash
296782|NCT01679197|Lipodystrophy|lipodystrophy
296783|NCT01679197|Leptin|leptin
296784|NCT01679197|Metreleptin|metreleptin
296785|NCT01679197|Hypertriglyceridemia|hypertriglyceridemia
296786|NCT01679197|Diabetes mellitus|diabetes mellitus
296787|NCT01679171|Elderly|elderly
296788|NCT01679171|Intensive care unit|intensive care unit
296790|NCT01679171|Comprehensive geriatric assessment|comprehensive geriatric assessment
296791|NCT01679158|Using POSE as a treatment for Obesity|using pose as a treatment for obesity
296792|NCT01679145|Reward- based learning|reward- based learning
296793|NCT01679145|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
296794|NCT01679145|Functional imaging|functional imaging
296795|NCT01679145|Relapse risk|relapse risk
296796|NCT01679132|Hypertension|hypertension
296797|NCT01679132|High Blood Pressure|high blood pressure
296798|NCT01679132|Blood Pressure|blood pressure
296799|NCT01679132|Cardiovascular Disease|cardiovascular disease
296800|NCT01679132|Resistant Hypertension|resistant hypertension
296801|NCT01679119|Diffuse large b cell lymphoma|diffuse large b cell lymphoma
296802|NCT01679119|Inotuzumab Ozogamicin|inotuzumab ozogamicin
296803|NCT01679119|Gemcitabine|gemcitabine
296804|NCT01679119|Rituximab|rituximab
296805|NCT01679119|Cyclophosphamide|cyclophosphamide
296806|NCT01679119|Vincristine|vincristine
296807|NCT01679119|Prednisolone|prednisolone
296808|NCT01679106|renal transplant|renal transplant
296809|NCT01679106|flank incision|flank incision
296810|NCT01679093|postoperative analgesia|postoperative analgesia
296811|NCT01679093|paracetamol|paracetamol
296812|NCT01679093|5-HT3 antagonist|5-ht3 antagonist
296813|NCT01679093|ondansetron|ondansetron
296815|NCT01679080|Drug therapy|drug therapy
296816|NCT01679080|Adult|adult
296817|NCT01679067|HIV|hiv
296818|NCT01679067|GALT|galt
296819|NCT01679054|Neoplasm|neoplasm
296820|NCT01679054|Gastric Cancer|gastric cancer
296821|NCT01679054|Cost|cost
296822|NCT01679028|T89 Safety in Healthy Japanese population|t89 safety in healthy japanese population
296823|NCT01679015|Burning|burning
296824|NCT01679015|Dryness|dryness
296825|NCT01679015|Itching|itching
296826|NCT01679015|Blurry Vision|blurry vision
296827|NCT01679002|Epilepsy|epilepsy
296828|NCT01679002|Oxcarbazepine|oxcarbazepine
296829|NCT01679002|Eslicarbazepine Acetate|eslicarbazepine acetate
296830|NCT01679002|BIA 2-093|bia 2-093
296831|NCT01678989|Bipolar disorder|bipolar disorder
296832|NCT01678989|Children|children
296833|NCT01678989|Cranial MRI|cranial mri
296834|NCT01678976|Eslicarbazepine acetate|eslicarbazepine acetate
296835|NCT01678976|Epilepsy|epilepsy
296836|NCT01678976|Oxcarbazepine|oxcarbazepine
296837|NCT01678963|Neovascular AMD|neovascular amd
296838|NCT01678963|Wet AMD|wet amd
296839|NCT01678963|AMD|amd
296840|NCT01678963|Age related macular degeneration|age related macular degeneration
296841|NCT01678950|Cardiac output monitoring|cardiac output monitoring
296842|NCT01678950|Echocardiography|echocardiography
296843|NCT01678950|Pulse contour system|pulse contour system
296844|NCT01678937|Immunosuppression|immunosuppression
296845|NCT01678911|Pelvic Pain|pelvic pain
296846|NCT01678911|Chronic Pelvic Pain|chronic pelvic pain
296847|NCT01678911|Irritable Bowel Syndrome|irritable bowel syndrome
296848|NCT01678911|IBS|ibs
296849|NCT01678911|Ulcerative Colitis|ulcerative colitis
296850|NCT01678911|UC|uc
296851|NCT01678911|Interstitial Cystitis|interstitial cystitis
296852|NCT01678911|IC|ic
296853|NCT01678911|Prostatitis|prostatitis
296854|NCT01678911|Pain|pain
296855|NCT01678898|Fabry disease|fabry disease
296856|NCT01678898|Alpha galactosidase deficiency|alpha galactosidase deficiency
296857|NCT01678898|Metabolic storage disease|metabolic storage disease
296858|NCT01678859|infertility|infertility
296859|NCT01678859|cervical|cervical
296860|NCT01678859|mucus|mucus
296861|NCT01678859|sperm|sperm
296862|NCT01678859|interaction|interaction
296863|NCT01678846|corporal punishment|corporal punishment
296864|NCT01678846|violence|violence
296865|NCT01678846|education|education
296866|NCT01678846|depression|depression
296867|NCT01678846|anxiety|anxiety
296868|NCT01678846|conduct disorder|conduct disorder
296869|NCT01678833|Drug Abuse/Dependence|drug abuse/dependence
296870|NCT01678794|Chronic heart failure (CHF)|chronic heart failure (chf)
296871|NCT01678794|cardiac and renal dysfunction|cardiac and renal dysfunction
296872|NCT01678781|Abdominal pain|abdominal pain
296873|NCT01678781|Diarrhea|diarrhea
296874|NCT01678781|Mebeverine hydrochloride|mebeverine hydrochloride
296875|NCT01678781|Constipation|constipation
296876|NCT01678781|Pinaverium bromide|pinaverium bromide
296877|NCT01678781|Irritable bowel syndrome|irritable bowel syndrome
296878|NCT01678781|Bloating|bloating
296879|NCT01678781|Quality of life|quality of life
296880|NCT01678755|schizophrenia|schizophrenia
296881|NCT01678742|Diet|diet
296882|NCT01678742|Incretins|incretins
296883|NCT01678742|Gastrointestinal Hormones|gastrointestinal hormones
296884|NCT01678742|Fish Proteins|fish proteins
296885|NCT01678729|refractive surgery|refractive surgery
296886|NCT01678729|pupil|pupil
296887|NCT01678729|Pupil size|pupil size
296888|NCT01678716|Anemia|anemia
296889|NCT01678716|Breastfeeding|breastfeeding
296890|NCT01678716|Complementary feeding|complementary feeding
296891|NCT01678716|Stunting|stunting
296892|NCT01678716|Wasting|wasting
296893|NCT01678716|Underweight|underweight
296894|NCT01678716|Micronutrient powder|micronutrient powder
296895|NCT01678716|Behavior change counseling|behavior change counseling
296896|NCT01678716|Frontline health worker|frontline health worker
296897|NCT01678703|late abortion|late abortion
296898|NCT01678703|laminaria|laminaria
296899|NCT01678703|Misoprostol|misoprostol
296900|NCT01678703|Cervical preparation|cervical preparation
296901|NCT01678677|non-typeable Haemophilus influenzae|non-typeable haemophilus influenzae
296902|NCT01678677|immunogenicity|immunogenicity
296903|NCT01678677|reactogenicity|reactogenicity
296904|NCT01678677|safety|safety
296905|NCT01678664|cancer|cancer
296906|NCT01678664|neuroendocrine tumors|neuroendocrine tumors
296907|NCT01678664|gastrointestinal tract|gastrointestinal tract
296908|NCT01678664|metastases|metastases
296909|NCT01678664|liver|liver
296910|NCT01678664|hepatic|hepatic
296911|NCT01678651|time-lapse, FSH, kinetics|time-lapse, fsh, kinetics
296912|NCT01678638|inguinal hernia|inguinal hernia
296913|NCT01678638|premature infants|premature infants
296914|NCT01678638|anesthesia safety|anesthesia safety
296915|NCT01678638|neurodevelopmental outcome|neurodevelopmental outcome
296916|NCT01678638|preterm infants|preterm infants
296917|NCT01678638|neonatal prematurity|neonatal prematurity
296918|NCT01678625|Residual neuromuscular blockade|residual neuromuscular blockade
296919|NCT01678625|Train-of-four|train-of-four
296920|NCT01678625|Acceleromyography|acceleromyography
296921|NCT01678625|Electromyography|electromyography
296923|NCT01678612|Health-Acquired Infections|health-acquired infections
296924|NCT01678612|Bacterial Load|bacterial load
296925|NCT01678612|Intensive Care Units, Pediatric|intensive care units, pediatric
296926|NCT01678599|Chagas Disease|chagas disease
296927|NCT01678599|PCR|pcr
296928|NCT01678599|diagnosis|diagnosis
296929|NCT01678586|Pain|pain
296930|NCT01678586|Pain management|pain management
296931|NCT01678573|Healthy|healthy
296932|NCT01678573|Pharmacokinetics|pharmacokinetics
296933|NCT01678573|Abiraterone acetate|abiraterone acetate
296934|NCT01678573|Abiraterone|abiraterone
296935|NCT01678573|JNJ-212082|jnj-212082
296936|NCT01678573|Zytiga|zytiga
296937|NCT01678573|Chinese|chinese
296938|NCT01678573|Fasted|fasted
296939|NCT01678560|Obstructive sleep apnea PAP adherence efficacy economics|obstructive sleep apnea pap adherence efficacy economics
296940|NCT01678547|Stroke|stroke
296941|NCT01678547|Robot|robot
296942|NCT01678547|Treatment|treatment
296943|NCT01678547|Rehabilitation|rehabilitation
296944|NCT01678534|Cerebral infarction|cerebral infarction
296945|NCT01678534|Cellular therapy|cellular therapy
296946|NCT01678521|Hypercholesterolemia|hypercholesterolemia
296947|NCT01678521|LDL-apheresis|ldl-apheresis
296948|NCT01678521|Coronary artery disease|coronary artery disease
296949|NCT01678521|PTX3|ptx3
296950|NCT01678521|CRP|crp
296951|NCT01678521|IL6|il6
296952|NCT01678521|IL10|il10
296953|NCT01678482|Acne, LED, blue light|acne, led, blue light
296954|NCT01678456|Atrial Fibrillation|atrial fibrillation
296955|NCT01678456|Critical Event Committee|critical event committee
296956|NCT01678456|Serious adverse events|serious adverse events
296957|NCT01678456|Thromboembolic complications|thromboembolic complications
296958|NCT01678456|Cardiac and noncardiac complications|cardiac and noncardiac complications
296959|NCT01678456|Bleeding complications|bleeding complications
296960|NCT01678456|Acute heart failure|acute heart failure
296961|NCT01678456|Syncope|syncope
296962|NCT01678456|Resuscitation|resuscitation
296963|NCT01678430|Chronic Lymphocytic Leukaemia|chronic lymphocytic leukaemia
296964|NCT01678430|Less fit|less fit
296965|NCT01678430|CD20 antibody|cd20 antibody
296966|NCT01678430|Ofatumumab|ofatumumab
296967|NCT01678430|Chlorambucil|chlorambucil
296968|NCT01678430|Bendamustine|bendamustine
296969|NCT01678378|Adolescent|adolescent
296970|NCT01678378|Intervention|intervention
296971|NCT01678378|Female|female
296972|NCT01678378|Male|male
296973|NCT01678378|Interpersonal Relations|interpersonal relations
296974|NCT01678378|School Health Services|school health services
296975|NCT01678378|Community-Based Participatory Research|community-based participatory research
296976|NCT01678378|Randomized Controlled Trial|randomized controlled trial
296977|NCT01678378|Health Care Provider|health care provider
296978|NCT01678378|Training Program|training program
296979|NCT01678378|Harm Reduction|harm reduction
296980|NCT01678378|Prevention|prevention
296981|NCT01678378|Reproductive Coercion|reproductive coercion
296982|NCT01678378|Tech-Based Abuse|tech-based abuse
296983|NCT01678378|Social Environment|social environment
296984|NCT01678378|Sexual Partners|sexual partners
296985|NCT01678365|complicated appendicitis|complicated appendicitis
296986|NCT01678365|Children|children
296987|NCT01678365|conservative therapy|conservative therapy
296988|NCT01678365|Study population: Children 1 month - 14 years with Complicated appendicitis|study population: children 1 month - 14 years with complicated appendicitis
296989|NCT01678365|Type of the study: prospective, open randomized|type of the study: prospective, open randomized
296990|NCT01678352|Glioma|glioma
296991|NCT01678352|Vaccine|vaccine
296992|NCT01678352|Immunotherapy|immunotherapy
296993|NCT01678352|WHO Grade II|who grade ii
296994|NCT01678339|ACS|acs
296995|NCT01678339|AMI|ami
296996|NCT01678326|Diseases Classified Elsewhere|diseases classified elsewhere
296997|NCT01678313|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
296998|NCT01678313|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
296999|NCT01678313|Prostatic specific antigen (PSA)|prostatic specific antigen (psa)
297000|NCT01678313|Cyclooxygenase-2 (COX-2)|cyclooxygenase-2 (cox-2)
297001|NCT01678300|Ulcerative Colitis|ulcerative colitis
297002|NCT01678287|ASP1941|asp1941
297003|NCT01678274|Turner Syndrome|turner syndrome
297004|NCT01678274|Aortic Aneurysm|aortic aneurysm
297005|NCT01678274|Ischemic heart disease|ischemic heart disease
297006|NCT01678274|Hypertension|hypertension
297007|NCT01678274|Congenital Heart Defect|congenital heart defect
297008|NCT01678274|Pulse Wave Velocity|pulse wave velocity
705322|NCT00978484|PTSD|ptsd
297009|NCT01678274|Augmentation Index|augmentation index
297010|NCT01678274|Central Blood Pressure|central blood pressure
297011|NCT01678274|Agatston Score|agatston score
297012|NCT01678274|Segment involvement score|segment involvement score
297013|NCT01678261|Sex chromosome|sex chromosome
297014|NCT01678261|Turner Syndrome|turner syndrome
297015|NCT01678261|Klinefelter Syndrome|klinefelter syndrome
297016|NCT01678261|Triple X Syndrome|triple x syndrome
297017|NCT01678261|47 XYY syndrome|47 xyy syndrome
297018|NCT01678261|Aortic Aneurysm|aortic aneurysm
297019|NCT01678261|Epigenetics|epigenetics
297020|NCT01678261|Transcriptome|transcriptome
297021|NCT01678261|non-coding RNA|non-coding rna
297022|NCT01678235|diabetes|diabetes
297023|NCT01678235|insulin pump|insulin pump
297024|NCT01678235|glulisine|glulisine
297025|NCT01678235|aspart|aspart
297026|NCT01678235|glycemic index|glycemic index
297027|NCT01678222|Lymphocyte|lymphocyte
297028|NCT01678222|Cyclooxygenase 2|cyclooxygenase 2
297029|NCT01678222|Eicosanoid|eicosanoid
297030|NCT01678222|Prostaglandin|prostaglandin
297031|NCT01678209|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
297032|NCT01678209|Stimulant|stimulant
297033|NCT01678209|Non-stimulant|non-stimulant
297034|NCT01678209|Drug|drug
297035|NCT01678209|Methylphenidate|methylphenidate
297036|NCT01678209|Atomoxetine|atomoxetine
297037|NCT01678209|Strattera|strattera
297038|NCT01678209|Concerta|concerta
297039|NCT01678209|MACRO|macro
297040|NCT01678209|Medication|medication
297041|NCT01678209|Treatment|treatment
297042|NCT01678209|Youth|youth
297043|NCT01678209|Adolescent|adolescent
297044|NCT01678209|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
297045|NCT01678209|Brain scan|brain scan
297046|NCT01678209|Imaging|imaging
297047|NCT01678209|Response inhibition|response inhibition
297048|NCT01678209|Inattentive|inattentive
297049|NCT01678209|Hyperactive|hyperactive
297050|NCT01678209|Combined|combined
297051|NCT01678209|Medication Treatment|medication treatment
297052|NCT01678209|Brain Imaging|brain imaging
297053|NCT01678196|Family Members|family members
297054|NCT01678196|Community Outreach|community outreach
297055|NCT01678196|Internet|internet
297056|NCT01678170|blood-oxygen functional imaging technology|blood-oxygen functional imaging technology
297057|NCT01678170|diagnosis|diagnosis
297058|NCT01678157|Esophageal Hernia|esophageal hernia
297059|NCT01678157|Hernia, Esophageal|hernia, esophageal
297060|NCT01678157|Hernia, Paraesophageal|hernia, paraesophageal
297061|NCT01678157|Hiatal Hernia|hiatal hernia
297062|NCT01678157|Paraesophageal Hiatal Hernia|paraesophageal hiatal hernia
297063|NCT01678157|Sliding Esophageal Hernia|sliding esophageal hernia
297064|NCT01678157|Sliding Hiatal Hernia|sliding hiatal hernia
297065|NCT01678144|mitral valve|mitral valve
297066|NCT01678144|mitral surgery|mitral surgery
297067|NCT01678144|mitral repair|mitral repair
297068|NCT01678144|mitral annuloplasty|mitral annuloplasty
297069|NCT01678118|Patient Navigation|patient navigation
297070|NCT01678118|Tobacco dependent|tobacco dependent
297071|NCT01678118|smoking|smoking
297072|NCT01678118|Cessation|cessation
297073|NCT01678118|11-028|11-028
297074|NCT01678105|Recurrent Adenoid Cystic Carcinoma of the Salivary Glands|recurrent adenoid cystic carcinoma of the salivary glands
297075|NCT01678105|Metastatic Adenoid Cystic Carcinoma of the Salivary Glands|metastatic adenoid cystic carcinoma of the salivary glands
297076|NCT01678105|Salivary Gland Cancers|salivary gland cancers
297077|NCT01678105|ACC|acc
297078|NCT01678105|Dovitinib|dovitinib
297079|NCT01678105|TKI258|tki258
297080|NCT01678105|RTK Inhibitor|rtk inhibitor
297081|NCT01678079|Pregnancy|pregnancy
297082|NCT01678079|Micronutrient Powder|micronutrient powder
297083|NCT01678079|Calcium|calcium
297084|NCT01678079|Iron|iron
297085|NCT01678079|Bangladesh|bangladesh
297086|NCT01678066|Noninvasive cardiac output.|noninvasive cardiac output.
297087|NCT01678066|Pediatrics.|pediatrics.
297088|NCT01678053|Botulinum Toxins, Type A|botulinum toxins, type a
297089|NCT01678040|Ventricular Volume|ventricular volume
297090|NCT01678040|Cardiac Magnetic Resonance|cardiac magnetic resonance
297091|NCT01678040|Echocardiogram|echocardiogram
297092|NCT01678027|Family history|family history
297093|NCT01678014|Anorexia|anorexia
297094|NCT01678014|DBS|dbs
297095|NCT01678014|Capsulotomy|capsulotomy
297096|NCT01678014|Signs and Symptoms|signs and symptoms
297097|NCT01678001|plantar fascia|plantar fascia
297098|NCT01678001|plantar fascitis|plantar fascitis
297099|NCT01678001|botulinum toxin|botulinum toxin
297100|NCT01678001|Xeomin|xeomin
297101|NCT01677988|NEOADJUVANT FOLFIRINOX CHEMOTHERAPY|neoadjuvant folfirinox chemotherapy
297102|NCT01677988|LOCALIZED PANCREATIC HEAD ADENOCARCINOMA|localized pancreatic head adenocarcinoma
297103|NCT01677988|RADIATION THERAPY|radiation therapy
297708|NCT01674946|CDCA|cdca
297104|NCT01677962|locally advanced, unresectable pancreatic adenocarcinoma|locally advanced, unresectable pancreatic adenocarcinoma
297105|NCT01677962|Poly ICLC|poly iclc
297106|NCT01677962|dendritic cells|dendritic cells
297107|NCT01677936|diabetes|diabetes
297108|NCT01677936|blood pressure|blood pressure
297115|NCT01677923|glucose profile|glucose profile
297116|NCT01677845|Localized Prostate Cancer|localized prostate cancer
297117|NCT01677845|Radiation|radiation
297118|NCT01677806|Percutaneous vertebroplasty|percutaneous vertebroplasty
297126|NCT01677728|colorectal liver metastases|colorectal liver metastases
297127|NCT01677728|chemotherapy|chemotherapy
297128|NCT01677728|cetuximab|cetuximab
297129|NCT01677728|bevacizumab|bevacizumab
297130|NCT01677689|oral temperature|oral temperature
297131|NCT01677689|respiratory symptom|respiratory symptom
297132|NCT01677689|cough|cough
297133|NCT01677689|nasal obstruction|nasal obstruction
297134|NCT01677689|sore throat|sore throat
297135|NCT01677689|fever|fever
297136|NCT01677676|Influenza A|influenza a
297137|NCT01677663|autism|autism
297138|NCT01677663|clinical phenotypes|clinical phenotypes
297139|NCT01677663|neuropsychology|neuropsychology
297140|NCT01677663|imaging endophenotypes|imaging endophenotypes
297141|NCT01677663|family-based cohort|family-based cohort
297142|NCT01677663|knoutout mice|knoutout mice
297143|NCT01677650|Spinal Fusion|spinal fusion
297144|NCT01677650|Opioid Analgesia|opioid analgesia
297145|NCT01677637|osteopenia, postmenopausal|osteopenia, postmenopausal
297146|NCT01677624|Hypervascular tumor|hypervascular tumor
297147|NCT01677624|arteriovenous malformation|arteriovenous malformation
297148|NCT01677624|arterial embolization|arterial embolization
297149|NCT01677611|Resveratrol|resveratrol
297150|NCT01677611|SIRT1|sirt1
297151|NCT01677611|AMPK|ampk
297152|NCT01677598|Plaque Psoriasis|plaque psoriasis
297153|NCT01677598|Ustekinumab|ustekinumab
297154|NCT01677598|CNTO 1275|cnto 1275
297155|NCT01677598|Asia-Pacific|asia-pacific
297156|NCT01677546|diabetes|diabetes
297157|NCT01677546|insulin pump|insulin pump
297158|NCT01677546|bolus calculator|bolus calculator
297159|NCT01677546|Contour Link|contour link
297160|NCT01677533|Panel management|panel management
297161|NCT01677533|Clinical microsystems|clinical microsystems
297162|NCT01677533|Hypertension management|hypertension management
297163|NCT01677533|Smoking cessation|smoking cessation
297164|NCT01677533|Continuing medical education|continuing medical education
297165|NCT01677533|Quality improvement,|quality improvement,
297166|NCT01677533|Population health|population health
297167|NCT01677520|adipose-derived stem cells|adipose-derived stem cells
297168|NCT01677520|viable ADSCs|viable adscs
297169|NCT01677520|apoptosis|apoptosis
297170|NCT01677520|necrosis|necrosis
297171|NCT01677520|cryopreservation|cryopreservation
297172|NCT01677507|glaucoma|glaucoma
297173|NCT01677507|aqueous humor dynamics|aqueous humor dynamics
297174|NCT01677507|intraocular pressure|intraocular pressure
297175|NCT01677468|Hepatocellular carcinoma|hepatocellular carcinoma
297176|NCT01677468|Transarterial chemoembolization|transarterial chemoembolization
297177|NCT01677455|Hsp90 inhibitor|hsp90 inhibitor
297178|NCT01677455|ganetespib|ganetespib
297179|NCT01677455|STA 9090|sta 9090
297180|NCT01677442|nonintubated|nonintubated
297181|NCT01677442|anaesthesia|anaesthesia
297182|NCT01677442|VATS|vats
297183|NCT01677429|panic disorder|panic disorder
297184|NCT01677429|balance impairment|balance impairment
297185|NCT01677429|virtual reality|virtual reality
297186|NCT01677416|Rheumatoid arthritis|rheumatoid arthritis
297187|NCT01677416|Ultrasonography|ultrasonography
297188|NCT01677416|Synovitis|synovitis
297189|NCT01677416|Foot joints|foot joints
297190|NCT01677403|Bronchiectasis|bronchiectasis
297191|NCT01677403|Tobramycin|tobramycin
297192|NCT01677403|nebulised|nebulised
297193|NCT01677390|Antibody-Drug Conjugate|antibody-drug conjugate
297194|NCT01677390|monomethylauristatin F|monomethylauristatin f
297195|NCT01677390|Carcinoma, Renal Cell|carcinoma, renal cell
297196|NCT01677390|Antigens, CD70|antigens, cd70
297197|NCT01677390|Drug Therapy|drug therapy
297198|NCT01677377|Schizophrenia|schizophrenia
297199|NCT01677377|Schizophrenic|schizophrenic
297200|NCT01677377|Schizophrenias|schizophrenias
297201|NCT01677364|induction of labour|induction of labour
297202|NCT01677364|heart disease patients|heart disease patients
297203|NCT01677351|clonidine|clonidine
297204|NCT01677351|cataract surgery|cataract surgery
297205|NCT01677351|arrythmia|arrythmia
297206|NCT01677351|anesthesic medication|anesthesic medication
297207|NCT01677286|AL Amyloidosis|al amyloidosis
297209|NCT01677286|Hereditary Amyloidosis|hereditary amyloidosis
297210|NCT01677286|Familial Amyloidosis|familial amyloidosis
297211|NCT01677286|SSA Amyloidosis|ssa amyloidosis
705323|NCT00978484|Depression|depression
297212|NCT01677286|Senile Systemic Amyloidosis|senile systemic amyloidosis
297213|NCT01677286|AA Amyloidosis|aa amyloidosis
297214|NCT01677286|Secondary Amyloidosis|secondary amyloidosis
297215|NCT01677286|Localized Amyloidosis|localized amyloidosis
297216|NCT01677286|Systemic Amyloidosis|systemic amyloidosis
297217|NCT01677273|Respiratory chambers|respiratory chambers
297218|NCT01677273|Energy expenditure|energy expenditure
297219|NCT01677273|Appetite|appetite
297220|NCT01677273|Dairy proteins|dairy proteins
297221|NCT01677273|Diet induced thermogenesis|diet induced thermogenesis
297223|NCT01677260|Biguanide|biguanide
297224|NCT01677260|anti-hyperglycaemic|anti-hyperglycaemic
297225|NCT01677260|bioavailability|bioavailability
297226|NCT01677260|bioequivalence|bioequivalence
297227|NCT01677260|metformin|metformin
297228|NCT01677260|pharmacokinetics|pharmacokinetics
297229|NCT01677247|sulphonylurea|sulphonylurea
297230|NCT01677247|anti-hyperglycaemic|anti-hyperglycaemic
297231|NCT01677247|bioavailability|bioavailability
297232|NCT01677247|bioequivalence|bioequivalence
297233|NCT01677247|glimepiride|glimepiride
297234|NCT01677247|pharmacokinetics|pharmacokinetics
297235|NCT01677234|Blood pressure|blood pressure
297237|NCT01677221|inflammatory acne|inflammatory acne
297238|NCT01677221|intense pulsed light|intense pulsed light
297239|NCT01677208|Acute Ischemic Stroke|acute ischemic stroke
297240|NCT01677208|Randomized Controlled Trial|randomized controlled trial
297241|NCT01677208|Traditional Chinese Medicine|traditional chinese medicine
297242|NCT01677195|Mycotoxins|mycotoxins
297243|NCT01677195|Aflatoxin|aflatoxin
297244|NCT01677195|Fumonisin|fumonisin
297245|NCT01677195|Aflatoxicosis|aflatoxicosis
297246|NCT01677195|Dietary|dietary
297247|NCT01677195|Cancer|cancer
297248|NCT01677182|Drug therapy|drug therapy
297249|NCT01677143|Local anesthetic|local anesthetic
297250|NCT01677143|Preemptive analgesia|preemptive analgesia
297251|NCT01677143|Postoperative pain|postoperative pain
297252|NCT01677143|Laparoscopy|laparoscopy
297253|NCT01677143|Gynecological surgery|gynecological surgery
297254|NCT01677143|Day-case surgery|day-case surgery
297255|NCT01677130|Clinical efficacy|clinical efficacy
297256|NCT01677130|safety|safety
297257|NCT01677130|of HFOV treatment|of hfov treatment
297258|NCT01677130|of patients|of patients
297259|NCT01677104|GLP-1|glp-1
297260|NCT01677104|DPP-IV inhibitor|dpp-iv inhibitor
297261|NCT01677104|microcirculation|microcirculation
297262|NCT01677104|Exenatide|exenatide
297263|NCT01677104|Liraglutide|liraglutide
297264|NCT01677104|Linagliptin|linagliptin
297265|NCT01677091|Balance,Hemiplegia,Cervical vibration,Prism adaptation,Rehabilitation|balance,hemiplegia,cervical vibration,prism adaptation,rehabilitation
297266|NCT01677078|Major depressive disorder|major depressive disorder
297267|NCT01677078|rTMS|rtms
297268|NCT01677078|Neuronavigation|neuronavigation
297269|NCT01677065|Bioavailability|bioavailability
297270|NCT01677065|Oxycodone|oxycodone
297271|NCT01677065|Healthy Volunteers|healthy volunteers
297272|NCT01677039|Bioavailability|bioavailability
297273|NCT01677039|oxycodone|oxycodone
297274|NCT01677039|ethanol interaction|ethanol interaction
297275|NCT01677039|healthy volunteers|healthy volunteers
297276|NCT01677013|Type 2; diabetes mellitus; stem cell; safety; efficacy|type 2; diabetes mellitus; stem cell; safety; efficacy
297277|NCT01677000|bone infection|bone infection
297278|NCT01677000|staphylococcus aureus|staphylococcus aureus
297279|NCT01677000|registry|registry
297280|NCT01676987|Asthma|asthma
297281|NCT01676987|Budesonide|budesonide
297282|NCT01676987|Adrenergic beta-2 receptor agonists.|adrenergic beta-2 receptor agonists.
297283|NCT01676974|Drug Resistance, Microbial|drug resistance, microbial
297284|NCT01676974|Enterobacteriaceae|enterobacteriaceae
297285|NCT01676974|ESBL|esbl
297286|NCT01676974|Carbapenemase|carbapenemase
297287|NCT01676974|Travel|travel
297288|NCT01676948|SJIA|sjia
297289|NCT01676948|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
297290|NCT01676948|children|children
297291|NCT01676948|systemic autoinflammatory disease, ACZ885, canakinumab|systemic autoinflammatory disease, acz885, canakinumab
297292|NCT01676948|human monoclonal anti-interleukin-1β (IL-1 β) antibody|human monoclonal anti-interleukin-1β (il-1 β) antibody
297293|NCT01676948|hildhood immunizations vaccinations|hildhood immunizations vaccinations
297294|NCT01676909|self-management|self-management
297295|NCT01676896|children|children
297296|NCT01676896|asthma|asthma
297297|NCT01676896|quality of life|quality of life
297298|NCT01676896|self-management|self-management
297299|NCT01676883|Body constitution|body constitution
297300|NCT01676883|Anthropometry|anthropometry
297301|NCT01676883|Electric impedance|electric impedance
297302|NCT01676870|exercise training|exercise training
297303|NCT01676870|exercise therapy|exercise therapy
297304|NCT01676870|physical fitness|physical fitness
297305|NCT01676870|risk factors|risk factors
297306|NCT01676857|chronic pain, prostatitis, pelvic pain|chronic pain, prostatitis, pelvic pain
297307|NCT01676844|Phosphorus|phosphorus
297308|NCT01676844|Phosphate|phosphate
297309|NCT01676844|Hypophosphataemia|hypophosphataemia
297310|NCT01676844|Osteopenia|osteopenia
297311|NCT01676844|Prematurity|prematurity
297312|NCT01676805|Developing Novel Treatment Approaches|developing novel treatment approaches
297313|NCT01676805|Developing Therapeutic Agents|developing therapeutic agents
297314|NCT01676805|Analysis of Genetic and Genomic Biology|analysis of genetic and genomic biology
297315|NCT01676805|New Prognostic and Diagnostic Models|new prognostic and diagnostic models
297709|NCT01674946|bile acids|bile acids
297316|NCT01676805|Analysis of Cellular and Molecular Biology|analysis of cellular and molecular biology
297317|NCT01676792|condyloma acuminate|condyloma acuminate
297318|NCT01676792|ano-genital warts|ano-genital warts
297319|NCT01676792|genital warts|genital warts
297320|NCT01676792|cutaneous condyloma|cutaneous condyloma
297321|NCT01676792|Vulva pre-cancerous lesions|vulva pre-cancerous lesions
297322|NCT01676792|Vulvar Intraepitheral Neoplasia|vulvar intraepitheral neoplasia
297323|NCT01676792|VIN|vin
297324|NCT01676792|EGW|egw
297325|NCT01676779|melanoma|melanoma
297326|NCT01676779|no evidence of disease|no evidence of disease
297327|NCT01676779|resection|resection
297328|NCT01676779|macro-metastases|macro-metastases
297329|NCT01676766|Stargardt Disease|stargardt disease
297330|NCT01676766|Macular degeneration|macular degeneration
297331|NCT01676766|Retinal dystrophy|retinal dystrophy
297332|NCT01676740|hematinic therapy|hematinic therapy
297333|NCT01676740|blood transfusion|blood transfusion
297334|NCT01676740|joint replacement|joint replacement
297335|NCT01676727|Transcatheter Aortic valve Implantation|transcatheter aortic valve implantation
297336|NCT01676727|Heart Valve Diseases|heart valve diseases
297337|NCT01676727|Cardiovascular Diseases|cardiovascular diseases
297338|NCT01676714|Dovitinib|dovitinib
297339|NCT01676714|Fibroblast Growth Factor Receptor Biomarkers|fibroblast growth factor receptor biomarkers
297340|NCT01676714|Anti-Vascular Endothelial Growth Factor Therapy|anti-vascular endothelial growth factor therapy
297341|NCT01676688|alpha-1 antitrypsin|alpha-1 antitrypsin
297342|NCT01676688|deficiency|deficiency
297343|NCT01676688|Alfalastin|alfalastin
297344|NCT01676688|safety|safety
297345|NCT01676675|whole virus|whole virus
297346|NCT01676675|inactivated|inactivated
297347|NCT01676675|influenza|influenza
297348|NCT01676675|H5N1 vaccine|h5n1 vaccine
297349|NCT01676675|safety|safety
297350|NCT01676675|immunogenicity|immunogenicity
297351|NCT01676662|Urinary Incontinence|urinary incontinence
297352|NCT01676662|Urinary Incontinence, Stress|urinary incontinence, stress
297353|NCT01676662|Urination Disorders|urination disorders
297354|NCT01676662|Urologic Diseases|urologic diseases
297355|NCT01676662|Urological Manifestations|urological manifestations
297356|NCT01676662|Signs and Symptoms|signs and symptoms
297357|NCT01676636|Pregnancy|pregnancy
297358|NCT01676636|Calcium|calcium
297359|NCT01676636|Supplements|supplements
297360|NCT01676623|Child nutrition|child nutrition
297361|NCT01676623|Stunting|stunting
297362|NCT01676623|Exclusive breastfeeding|exclusive breastfeeding
297363|NCT01676623|Complementary feeding|complementary feeding
297364|NCT01676623|Social franchise|social franchise
297365|NCT01676623|Mass media|mass media
297366|NCT01676623|Counseling|counseling
297367|NCT01676623|Facility-based|facility-based
297368|NCT01676610|Pulse Oximetry|pulse oximetry
297369|NCT01676610|Pediatrics|pediatrics
297370|NCT01676610|Pakistan|pakistan
297371|NCT01676610|Hypoxemia|hypoxemia
297372|NCT01676610|Neonatal Sepsis|neonatal sepsis
297373|NCT01676610|Pneumonia|pneumonia
297374|NCT01676558|diffuse large B cell lymphoma|diffuse large b cell lymphoma
297375|NCT01676558|radioimmunotherapy|radioimmunotherapy
297376|NCT01676558|131I-rituximab|131i-rituximab
297377|NCT01676532|School Board Health Center|school board health center
297378|NCT01676532|Pediatrics|pediatrics
297379|NCT01676506|Wet AMD|wet amd
297380|NCT01676506|genetic polymorphisms|genetic polymorphisms
297381|NCT01676506|Ranibizumab|ranibizumab
297382|NCT01676480|Prostate cancer|prostate cancer
297383|NCT01676480|ADT|adt
297384|NCT01676480|Endurance training|endurance training
297385|NCT01676454|Vasopressin|vasopressin
297386|NCT01676454|Trauma|trauma
297387|NCT01676454|Injury|injury
297388|NCT01676441|spinal cord injury|spinal cord injury
297389|NCT01676441|mesenchymal stem cell|mesenchymal stem cell
297390|NCT01676428|Kidney|kidney
297391|NCT01676428|Renal|renal
297392|NCT01676428|Radiotherapy|radiotherapy
297393|NCT01676428|Stereotactic|stereotactic
297394|NCT01676428|Cancer|cancer
297395|NCT01676415|Sinus disease|sinus disease
297396|NCT01676415|Sinonasal complaints|sinonasal complaints
297397|NCT01676415|Chronic sinusitis|chronic sinusitis
297398|NCT01676415|Nasal polyps|nasal polyps
297399|NCT01676415|Chronic rhinosinusitis without nasal polyps|chronic rhinosinusitis without nasal polyps
297400|NCT01676415|Glucocorticoids|glucocorticoids
297401|NCT01676415|Prednisone|prednisone
297402|NCT01676415|Topical mometasone|topical mometasone
297403|NCT01676415|Anti-inflammatory agents|anti-inflammatory agents
297404|NCT01676402|Influenza A (H1)|influenza a (h1)
705324|NCT00978484|Anxiety|anxiety
297405|NCT01676402|Influenza A (H3)|influenza a (h3)
297406|NCT01676402|Influenza B|influenza b
297407|NCT01676402|DNA Vaccine|dna vaccine
297408|NCT01676402|Trivalent Inactivated Vaccine (TIV)|trivalent inactivated vaccine (tiv)
297409|NCT01676402|Healthy Adults|healthy adults
297410|NCT01676402|Intradermal (ID)|intradermal (id)
297411|NCT01676389|Autism Spectrum Disorders|autism spectrum disorders
297413|NCT01676376|SVG|svg
297414|NCT01676376|nitinol mesh|nitinol mesh
297415|NCT01676376|external saphenous vein graft support|external saphenous vein graft support
297416|NCT01676363|diflunisal|diflunisal
297417|NCT01676363|anti-inflammatory agents, non-steroidal|anti-inflammatory agents, non-steroidal
297418|NCT01676363|antiviral agents|antiviral agents
297419|NCT01676350|Intraosseous (IO) vascular access|intraosseous (io) vascular access
297420|NCT01676337|Text messaging|text messaging
297514|NCT01675843|Infertility|infertility
297421|NCT01676337|Clinic appointment attendance|clinic appointment attendance
297422|NCT01676337|Emergency department|emergency department
297423|NCT01676337|Primary care|primary care
297424|NCT01676324|Fecal Calprotectin|fecal calprotectin
297425|NCT01676311|cognition|cognition
297426|NCT01676311|seizures|seizures
297427|NCT01676311|electroencephalography|electroencephalography
297428|NCT01676311|transcranial magnetic stimulation|transcranial magnetic stimulation
297429|NCT01676311|huperzine|huperzine
297430|NCT01676311|chinese club moss|chinese club moss
297431|NCT01676298|Cyp2C19|cyp2c19
297432|NCT01676298|Genotyping|genotyping
297433|NCT01676298|Spartan|spartan
297434|NCT01676298|Reproducibility|reproducibility
297435|NCT01676285|Cirrhosis|cirrhosis
297436|NCT01676285|cirrhotic cardiomyopathy|cirrhotic cardiomyopathy
297437|NCT01676285|cardiac remodeling|cardiac remodeling
297438|NCT01676285|cardiomyopathy|cardiomyopathy
297439|NCT01676285|metoprolol succinate|metoprolol succinate
297440|NCT01676285|betablockers|betablockers
297441|NCT01676259|siRNA|sirna
297442|NCT01676259|RNA interference (RNAi)|rna interference (rnai)
297443|NCT01676259|Cancer|cancer
297444|NCT01676259|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
297445|NCT01676259|Locally Advanced Pancreatic cancer|locally advanced pancreatic cancer
297446|NCT01676259|Solid tumor|solid tumor
297447|NCT01676259|Non operable pancreatic ductal adenocarcinoma|non operable pancreatic ductal adenocarcinoma
297448|NCT01676207|coronary collateral circulation|coronary collateral circulation
297449|NCT01676207|extracardiac coronary collaterals|extracardiac coronary collaterals
297450|NCT01676207|coronary artery disease|coronary artery disease
297451|NCT01676207|coronary circulation|coronary circulation
297452|NCT01676207|internal mammary artery|internal mammary artery
297453|NCT01676194|Transarterial Chemoembolization|transarterial chemoembolization
297454|NCT01676194|Liver transplantation|liver transplantation
297455|NCT01676194|Hepatocellular carcinoma|hepatocellular carcinoma
297456|NCT01676181|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
297457|NCT01676181|Children|children
297458|NCT01676181|Polysomnography|polysomnography
297459|NCT01676181|Surgery|surgery
297460|NCT01676181|Coblation|coblation
297461|NCT01676181|Tonsils|tonsils
297462|NCT01676181|Tonsillectomy|tonsillectomy
297463|NCT01676155|Tuberculosis, latent tuberculosis infection, apoptosis, predictor|tuberculosis, latent tuberculosis infection, apoptosis, predictor
297464|NCT01676129|temporomandibular joint disorders|temporomandibular joint disorders
297465|NCT01676129|nocipoint|nocipoint
297466|NCT01676129|physical therapy|physical therapy
297467|NCT01676103|Parkinson's Disease (PD)|parkinson's disease (pd)
297468|NCT01676103|Orthostatic hypotension (OH)|orthostatic hypotension (oh)
297469|NCT01676077|LGMD2B|lgmd2b
297470|NCT01676077|Miyoshi Myopathy|miyoshi myopathy
297471|NCT01676077|Dysferlin|dysferlin
297472|NCT01676077|Dysferlinopathy|dysferlinopathy
297473|NCT01676077|Limb Girdle muscular dystrophy type 2b|limb girdle muscular dystrophy type 2b
297474|NCT01676077|Muscular Dystrophy|muscular dystrophy
297475|NCT01676064|intraocular pressure|intraocular pressure
297476|NCT01676064|perioperative fluid|perioperative fluid
297477|NCT01676064|trendelenburg position|trendelenburg position
297478|NCT01676064|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
297479|NCT01676038|Total Knee Replacement, Computer-Assisted Surgery|total knee replacement, computer-assisted surgery
297480|NCT01676025|pheochromocytoma|pheochromocytoma
297481|NCT01676025|aldosteronism|aldosteronism
297482|NCT01676025|cushing's syndrome|cushing's syndrome
297483|NCT01676025|adrenal incidentaloma|adrenal incidentaloma
297484|NCT01676025|Conn's syndrome|conn's syndrome
297485|NCT01675999|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
297486|NCT01675999|Locally advanced malignant neoplasm|locally advanced malignant neoplasm
297487|NCT01675999|colon cancer|colon cancer
297488|NCT01675973|Ranolazine|ranolazine
297489|NCT01675973|renal impairment|renal impairment
297490|NCT01675960|chronic irritability|chronic irritability
297491|NCT01675960|chronic pain|chronic pain
297492|NCT01675960|Neurologically impaired|neurologically impaired
297493|NCT01675960|gabapentin|gabapentin
297494|NCT01675921|Asthma|asthma
297495|NCT01675921|Facebook|facebook
297496|NCT01675921|teenagers|teenagers
297498|NCT01675895|Hyperbaric Levobupivacaine|hyperbaric levobupivacaine
297499|NCT01675895|İntrathecal|intrathecal
297500|NCT01675895|Lidocaine|lidocaine
297501|NCT01675895|TUR-P|tur-p
297502|NCT01675882|Food allergy|food allergy
297503|NCT01675882|Immediate hypersensitivity|immediate hypersensitivity
297504|NCT01675882|Whole peanut extract|whole peanut extract
297505|NCT01675882|Allergenic product|allergenic product
297506|NCT01675882|Specific Immunotherapy|specific immunotherapy
297507|NCT01675882|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
297508|NCT01675869|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
297509|NCT01675869|Executive function|executive function
297510|NCT01675869|Preschooler|preschooler
297511|NCT01675869|Metacognition|metacognition
297512|NCT01675856|Glasgow-Blatchford score|glasgow-blatchford score
297513|NCT01675856|Gastrointestinal bleeding|gastrointestinal bleeding
297515|NCT01675843|PCOS|pcos
297516|NCT01675843|IUI|iui
297517|NCT01675817|heparin rebound|heparin rebound
297518|NCT01675817|protamine|protamine
297519|NCT01675817|cardiopulmonary bypass|cardiopulmonary bypass
297520|NCT01675817|cardiac surgery|cardiac surgery
297521|NCT01675817|anti-Xa|anti-xa
297522|NCT01675817|anti-IIa|anti-iia
297523|NCT01675804|ADHD|adhd
297524|NCT01675778|hydromorphone|hydromorphone
297525|NCT01675778|acute pain|acute pain
297526|NCT01675778|emergency department|emergency department
297527|NCT01675765|Cancer|cancer
297528|NCT01675765|Cancer vaccine|cancer vaccine
297529|NCT01675765|Listeria monocytogenes|listeria monocytogenes
297530|NCT01675765|Listeria-based vaccines|listeria-based vaccines
297531|NCT01675765|Pemetrexed|pemetrexed
297532|NCT01675765|Cisplatin|cisplatin
297533|NCT01675765|T regulatory cells|t regulatory cells
297534|NCT01675765|Mesothelin|mesothelin
297535|NCT01675765|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
297536|NCT01675765|Chemotherapy|chemotherapy
297537|NCT01675765|Standard of care|standard of care
297538|NCT01675765|Naive|naive
297539|NCT01675765|Front-line|front-line
297540|NCT01675765|Immunotherapy|immunotherapy
297541|NCT01675765|MPM|mpm
297542|NCT01675752|colonoscopy, narrow-band imaging|colonoscopy, narrow-band imaging
297543|NCT01675739|colonoscopy|colonoscopy
297544|NCT01675739|bowel preparation|bowel preparation
297545|NCT01675739|short message service|short message service
297546|NCT01675713|Lifestyle|lifestyle
297547|NCT01675713|Physical activity|physical activity
297548|NCT01675700|Myofascial pain|myofascial pain
297549|NCT01675700|Trigger point|trigger point
297550|NCT01675700|Nitroglycerin|nitroglycerin
297551|NCT01675687|dietary habits and obesity|dietary habits and obesity
297552|NCT01675687|exercise habits and obesity|exercise habits and obesity
297553|NCT01675687|cognition and obesity|cognition and obesity
297554|NCT01675674|Mucopolysaccharidoses|mucopolysaccharidoses
297555|NCT01675674|Prevalence|prevalence
297556|NCT01675674|Pediatric|pediatric
297557|NCT01675674|Rheumatology|rheumatology
297558|NCT01675674|Mucopolysaccharidosis I|mucopolysaccharidosis i
297559|NCT01675674|Mucopolysaccharidosis II|mucopolysaccharidosis ii
297560|NCT01675674|Mucopolysaccharidosis IV|mucopolysaccharidosis iv
297561|NCT01675674|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
297562|NCT01675648|Opiate dependent|opiate dependent
297563|NCT01675648|inpatient detoxification|inpatient detoxification
297564|NCT01675622|Cancer Pain|cancer pain
297565|NCT01675596|Aortic Stenosis|aortic stenosis
297566|NCT01675596|Transfemoral|transfemoral
297567|NCT01675596|Transcatheter Heart Valve|transcatheter heart valve
297568|NCT01675583|Diabetic Wounds|diabetic wounds
297569|NCT01675583|Hyperbaric Oxygen|hyperbaric oxygen
297570|NCT01675583|Laser Speckle Imaging|laser speckle imaging
297571|NCT01675583|Hyperbaric Oxygenation|hyperbaric oxygenation
297572|NCT01675570|RX-10045|rx-10045
297573|NCT01675570|Dry Eye Disease|dry eye disease
297574|NCT01675557|chronic kidney disease|chronic kidney disease
297575|NCT01675544|Heart failure|heart failure
297576|NCT01675531|Targin|targin
297577|NCT01675531|Chemotherapy Induced Peripheral Neuropathy (CIPN)|chemotherapy induced peripheral neuropathy (cipn)
297578|NCT01675518|Plasma concentration|plasma concentration
297579|NCT01675518|ASP7991|asp7991
297580|NCT01675518|food effect|food effect
297581|NCT01675518|PTH (parathyroid hormone)|pth (parathyroid hormone)
297582|NCT01675492|Astigmatism|astigmatism
297583|NCT01675492|refractive|refractive
297584|NCT01675492|error|error
297585|NCT01675492|LASIK|lasik
297586|NCT01675479|refractive|refractive
297587|NCT01675479|errors|errors
297588|NCT01675466|non-specific abdominal pain|non-specific abdominal pain
297589|NCT01675466|undifferentiated abdominal pain|undifferentiated abdominal pain
297590|NCT01675466|appendicitis|appendicitis
297591|NCT01675466|appendicectomy|appendicectomy
297592|NCT01675466|appendectomy|appendectomy
297593|NCT01675466|surgery|surgery
297594|NCT01675466|laparoscopy|laparoscopy
297595|NCT01675466|antibiotics|antibiotics
297596|NCT01675466|randomised controlled trial|randomised controlled trial
297597|NCT01675466|randomized controlled trial|randomized controlled trial
297598|NCT01675466|controlled clinical trial|controlled clinical trial
297599|NCT01675466|randomised|randomised
297600|NCT01675466|placebo|placebo
297601|NCT01675453|Organ dysfunction|organ dysfunction
297602|NCT01675453|Hypertonic solution|hypertonic solution
297603|NCT01675453|Extravascular water|extravascular water
297604|NCT01675453|Cardiopulmonary Bypass|cardiopulmonary bypass
297605|NCT01675414|ASD|asd
297606|NCT01675414|autism|autism
297607|NCT01675414|gastrointestinal|gastrointestinal
297608|NCT01675414|gastrointestinal conditions in children with ASD|gastrointestinal conditions in children with asd
297609|NCT01675401|Body Weight|body weight
297610|NCT01675401|Obesity|obesity
297611|NCT01675401|Weight Loss|weight loss
297612|NCT01675401|Vascular Function Markers|vascular function markers
297613|NCT01675388|Neonatal hypoxemic respiratory failure|neonatal hypoxemic respiratory failure
297614|NCT01675388|Extra Corporeal Membrane Oxygenation|extra corporeal membrane oxygenation
297714|NCT01674933|caries|caries
297615|NCT01675388|Neurodevelopmental outcomes|neurodevelopmental outcomes
297616|NCT01675388|Neuroimaging|neuroimaging
297617|NCT01675362|Extracorporeal shockwave lithotripsy (ESWL)|extracorporeal shockwave lithotripsy (eswl)
297618|NCT01675362|Kidney calculi|kidney calculi
297619|NCT01675362|Renal protection|renal protection
297620|NCT01675362|Antioxidants|antioxidants
297621|NCT01675362|Calcium channel blockers|calcium channel blockers
297622|NCT01675362|Angiotensin receptor blockers|angiotensin receptor blockers
297623|NCT01675349|Standardization|standardization
297624|NCT01675349|Immunotherapy|immunotherapy
297625|NCT01675349|Skin prick test|skin prick test
297626|NCT01675323|Restless Legs Syndrome|restless legs syndrome
297627|NCT01675323|RLS|rls
297628|NCT01675310|obesity, polycystic ovary syndrome, gestational diabetes|obesity, polycystic ovary syndrome, gestational diabetes
297629|NCT01675297|Risedronate, cholecalciferol, BMD|risedronate, cholecalciferol, bmd
297630|NCT01675284|Avian Influenza|avian influenza
297631|NCT01675284|Influenza A Virus Subtype H5N1|influenza a virus subtype h5n1
297632|NCT01675284|Inactivated H5N1 Influenza Virion Vaccine|inactivated h5n1 influenza virion vaccine
297633|NCT01675284|Phase I|phase i
297634|NCT01675284|Preventive H5N1 vaccination|preventive h5n1 vaccination
297635|NCT01675271|gestational diabetes|gestational diabetes
297636|NCT01675271|inflammation|inflammation
297637|NCT01675271|autonomic nervous system|autonomic nervous system
297638|NCT01675245|Multiple Myeloma|multiple myeloma
297639|NCT01675245|Cancer|cancer
297640|NCT01675245|Velcade|velcade
297641|NCT01675245|Bortezomib|bortezomib
297642|NCT01675245|Chinese patients|chinese patients
297643|NCT01675232|Atopic dermatitis|atopic dermatitis
297644|NCT01675232|Topical corticosteroid|topical corticosteroid
297645|NCT01675232|Pediatric|pediatric
297646|NCT01675232|Eczema|eczema
297647|NCT01675219|bladder cancer|bladder cancer
297648|NCT01675219|recurrence|recurrence
297649|NCT01675219|photodynamic diagnosis|photodynamic diagnosis
297650|NCT01675219|PDD|pdd
297651|NCT01675219|cost analysis|cost analysis
297652|NCT01675206|Vascular calcification|vascular calcification
297653|NCT01675206|Hemodialysis|hemodialysis
297654|NCT01675206|Matrix Gla Protein|matrix gla protein
297655|NCT01675206|Vitamin K2|vitamin k2
297656|NCT01675193|Amblyopia|amblyopia
297657|NCT01675193|Vision-Screening|vision-screening
297658|NCT01675180|pregnancy, oral health, attitude, awareness, streptococcus mutans, lactobacilli|pregnancy, oral health, attitude, awareness, streptococcus mutans, lactobacilli
297659|NCT01675167|CLBP|clbp
297660|NCT01675167|Chronic Low Back Pain|chronic low back pain
297661|NCT01675167|Chronic Pain|chronic pain
297662|NCT01675167|Back Pain|back pain
297663|NCT01675154|hypertriglyceridemia|hypertriglyceridemia
297664|NCT01675141|NK Cell Function|nk cell function
297665|NCT01675141|Immunomodulatory Drugs|immunomodulatory drugs
297666|NCT01675141|T Cell Activity|t cell activity
297667|NCT01675141|Immune Stimulatory Effects|immune stimulatory effects
297668|NCT01675141|Extended Dosing|extended dosing
297669|NCT01675128|Human Eukaryotic Translation Initiation Factor 4E (eIF4E) protein|human eukaryotic translation initiation factor 4e (eif4e) protein
297670|NCT01675128|Refractory|refractory
297671|NCT01675128|Oncogene|oncogene
297672|NCT01675128|Maximum Tolerated Dose|maximum tolerated dose
297673|NCT01675128|Safety|safety
297674|NCT01675115|Ischemic stroke|ischemic stroke
297675|NCT01675115|Traditional Chinese Medication|traditional chinese medication
297676|NCT01675115|Aspirin|aspirin
297677|NCT01675102|del 17p|del 17p
297678|NCT01675102|chronic lymphocytic leukemia|chronic lymphocytic leukemia
297679|NCT01675102|cll|cll
297680|NCT01675102|mutation|mutation
297681|NCT01675102|p53|p53
297682|NCT01675089|bone disease|bone disease
297683|NCT01675089|kidney transplantation|kidney transplantation
297684|NCT01675089|bisphosphonates|bisphosphonates
297685|NCT01675076|Hematoma|hematoma
297686|NCT01675076|novel oral anti-coagulant (NOAC)|novel oral anti-coagulant (noac)
297687|NCT01675076|Device surgery|device surgery
297688|NCT01675037|hypothalamic|hypothalamic
297689|NCT01675037|pituitary,|pituitary,
297690|NCT01675037|endoscopic third ventriculostomy|endoscopic third ventriculostomy
297691|NCT01675037|hydrocephalus|hydrocephalus
297692|NCT01675024|Neupro, Pharmacokinetics, healthy Chinese subjects|neupro, pharmacokinetics, healthy chinese subjects
297693|NCT01674998|REM Sleep Behavior Disorder|rem sleep behavior disorder
297695|NCT01674998|Dream|dream
297696|NCT01674998|Dreams|dreams
297697|NCT01674985|Decitabine|decitabine
297698|NCT01674985|microtransplantation|microtransplantation
297699|NCT01674985|myelodysplastic syndromes|myelodysplastic syndromes
297700|NCT01674985|chemotherapy|chemotherapy
297701|NCT01674972|NAFLD|nafld
297702|NCT01674972|NASH|nash
297703|NCT01674972|GLP-1|glp-1
297704|NCT01674959|gastric cancer|gastric cancer
297705|NCT01674959|radiation|radiation
297706|NCT01674959|chemotherapy|chemotherapy
297707|NCT01674946|GI-physiology|gi-physiology
297710|NCT01674946|TGR5|tgr5
297711|NCT01674946|satiation peptides|satiation peptides
297712|NCT01674933|dental|dental
297713|NCT01674933|prevention|prevention
297716|NCT01674933|children|children
297717|NCT01674920|Pediatric obesity|pediatric obesity
297718|NCT01674920|resiliency|resiliency
297719|NCT01674920|physical activity|physical activity
297720|NCT01674920|dietary patterns|dietary patterns
297721|NCT01674920|children|children
297722|NCT01674881|Mindfulness|mindfulness
297723|NCT01674881|breast cancer|breast cancer
297724|NCT01674881|chronic pain|chronic pain
297725|NCT01674881|mediators|mediators
297726|NCT01674881|distress|distress
297727|NCT01674881|Breast cancer survivors|breast cancer survivors
297728|NCT01674881|Effectiveness of MBCT on chronic pain|effectiveness of mbct on chronic pain
297729|NCT01674881|Potential mediators and moderators|potential mediators and moderators
297730|NCT01674881|Effectiveness of MBCT on psychological symptoms|effectiveness of mbct on psychological symptoms
297731|NCT01674868|stroke|stroke
297732|NCT01674868|recovery|recovery
297733|NCT01674868|fluoxetine|fluoxetine
297734|NCT01674868|aphasia|aphasia
297735|NCT01674868|neglect|neglect
297736|NCT01674868|motor|motor
297737|NCT01674855|PEG-G-CSF|peg-g-csf
297738|NCT01674842|Triple negative|triple negative
297739|NCT01674842|Stage II|stage ii
297740|NCT01674842|Stage III|stage iii
297741|NCT01674803|drug-eluting stent|drug-eluting stent
297742|NCT01674803|zotarolimus|zotarolimus
297743|NCT01674803|everolimus|everolimus
297744|NCT01674803|sirolimus|sirolimus
297745|NCT01674803|all comers population|all comers population
297746|NCT01674803|target vessel failure|target vessel failure
297747|NCT01674803|coronary artery disease|coronary artery disease
297748|NCT01674803|durable polymer|durable polymer
297749|NCT01674803|biodegradable polymer|biodegradable polymer
297750|NCT01674777|ASP1941|asp1941
297751|NCT01674777|Food effect|food effect
297752|NCT01674777|Pharmacokinetics|pharmacokinetics
297753|NCT01674751|pre-ordering|pre-ordering
297754|NCT01674751|healthy eating|healthy eating
297755|NCT01674751|mindfulness|mindfulness
297756|NCT01674751|incentives|incentives
297757|NCT01674751|employees|employees
297758|NCT01674738|Non Small Cell Lung Cancer|non small cell lung cancer
297759|NCT01674738|NSCLC Stage IV|nsclc stage iv
297760|NCT01674738|Non-Squamous Advanced Non-Small-Cell Lung-Cancer (Stage IV)|non-squamous advanced non-small-cell lung-cancer (stage iv)
297761|NCT01674725|Hepatitis C virus|hepatitis c virus
297762|NCT01674725|Hepatitis C Genotype 1|hepatitis c genotype 1
297763|NCT01674725|Hepatitis C|hepatitis c
297764|NCT01674725|Interferon-Free|interferon-free
297765|NCT01674725|Chronic Hepatitis C|chronic hepatitis c
297766|NCT01674725|Ombitasvir|ombitasvir
297767|NCT01674725|Ribavirin|ribavirin
297768|NCT01674725|Viekira PAK|viekira pak
297769|NCT01674725|Dasabuvir|dasabuvir
297770|NCT01674725|Paritaprevir|paritaprevir
297771|NCT01674712|Fibrates|fibrates
297772|NCT01674712|Dyslipidemia|dyslipidemia
297773|NCT01674686|Vasospasm|vasospasm
297774|NCT01674686|Sarpogrelate|sarpogrelate
297775|NCT01674686|Statin|statin
297776|NCT01674673|panic disorder|panic disorder
297777|NCT01674673|SSRIs pharmacotherapy|ssris pharmacotherapy
297778|NCT01674673|Cognitive Behavioral therapy|cognitive behavioral therapy
297779|NCT01674660|hemodialysis|hemodialysis
297780|NCT01674660|blood pressure variability|blood pressure variability
297781|NCT01674660|volume status|volume status
297782|NCT01674647|rivaroxaban|rivaroxaban
297783|NCT01674647|oral anticoagulant|oral anticoagulant
297784|NCT01674647|nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
297785|NCT01674647|cardioversion|cardioversion
297786|NCT01674647|stroke|stroke
297787|NCT01674647|transient ischemic attack|transient ischemic attack
297788|NCT01674647|thromboembolism|thromboembolism
297789|NCT01674647|cardiovascular event|cardiovascular event
297790|NCT01674634|XIAFLEX|xiaflex
297792|NCT01674634|Dupuytren's disease|dupuytren's disease
297793|NCT01674634|contracture|contracture
297794|NCT01674621|BA058|ba058
297795|NCT01674621|Abaloparatide-SC|abaloparatide-sc
297796|NCT01674621|abaloparatide|abaloparatide
297797|NCT01674621|Abaloparatide-TD|abaloparatide-td
297798|NCT01674621|Osteo|osteo
297799|NCT01674621|Osteoporosis|osteoporosis
297800|NCT01674621|Transdermal|transdermal
297801|NCT01674621|Patch|patch
297802|NCT01674608|intensive care|intensive care
297803|NCT01674608|mobilization|mobilization
297804|NCT01674608|rehabilitation|rehabilitation
297805|NCT01674608|critical care|critical care
297806|NCT01674595|Olea sensitization|olea sensitization
297808|NCT01674582|Brain tumors|brain tumors
297809|NCT01674582|Brain metastases|brain metastases
297810|NCT01674582|MRI|mri
297811|NCT01674582|Cognitive measurement|cognitive measurement
297812|NCT01674582|Neuropsychological evaluation|neuropsychological evaluation
297813|NCT01674582|DW-MRI|dw-mri
297814|NCT01674582|P-MRI|p-mri
297815|NCT01674582|MRS|mrs
297816|NCT01674569|VEGF|vegf
297817|NCT01674569|PDGF|pdgf
297818|NCT01674569|AMD|amd
297819|NCT01674556|pancreatic|pancreatic
297820|NCT01674556|cancer|cancer
297821|NCT01674556|adenocarcinoma|adenocarcinoma
297822|NCT01674556|Ultrasound|ultrasound
297823|NCT01674556|CEUS|ceus
297824|NCT01674543|Physical exercise|physical exercise
297825|NCT01674543|Schizophrenia|schizophrenia
288403|NCT01715922|Burundi|burundi
297826|NCT01674543|symptoms|symptoms
297827|NCT01674543|IGF-1|igf-1
297828|NCT01674517|Bioequivalence|bioequivalence
297829|NCT01674517|Montelukast Sodium|montelukast sodium
297830|NCT01674517|crossover|crossover
297831|NCT01674504|Bioequivalence|bioequivalence
297832|NCT01674504|Montelukast Sodium|montelukast sodium
297833|NCT01674504|crossover|crossover
297834|NCT01674478|NEC, SBS, enterostomy, fish oil, Microlipid, Intralipid,|nec, sbs, enterostomy, fish oil, microlipid, intralipid,
297835|NCT01674478|enteral fat|enteral fat
297836|NCT01674465|Kidney fibrosis|kidney fibrosis
297837|NCT01674465|Kidney hypoxia|kidney hypoxia
297838|NCT01674465|Calcineurin inhibitors|calcineurin inhibitors
297839|NCT01674452|Stroke|stroke
297840|NCT01674452|Exercise and Physical Fitness|exercise and physical fitness
297841|NCT01674439|Adipose-derived regenerative cells|adipose-derived regenerative cells
297842|NCT01674439|Cell therapy|cell therapy
297843|NCT01674439|Autologous fat transfer|autologous fat transfer
297844|NCT01674439|Tissue engineering|tissue engineering
297845|NCT01674439|Craniofacial microsomia|craniofacial microsomia
297846|NCT01674426|functional hypothalamic amenorrhea|functional hypothalamic amenorrhea
297847|NCT01674426|stress induced anovulation|stress induced anovulation
297848|NCT01674413|Crohn's Disease|crohn's disease
297849|NCT01674413|Crohn's|crohn's
297850|NCT01674413|Crohns|crohns
297851|NCT01674413|Inflammatory Bowel Disease|inflammatory bowel disease
297852|NCT01674413|IBD|ibd
297853|NCT01674413|Humira|humira
297854|NCT01674413|Adalimumab|adalimumab
297855|NCT01674413|Adalimumab injection|adalimumab injection
297856|NCT01674413|Higgins|higgins
297857|NCT01674413|Calprotectin|calprotectin
297858|NCT01674413|biomarkers|biomarkers
297859|NCT01674413|Gastroenterology|gastroenterology
297860|NCT01674413|University of Michigan|university of michigan
297861|NCT01674413|U of M|u of m
297862|NCT01674387|electroacupuncture therapy|electroacupuncture therapy
297863|NCT01674387|neck pain|neck pain
297864|NCT01674387|McGill Pain Questionnaire|mcgill pain questionnaire
297865|NCT01674387|Acupuncture Therapy|acupuncture therapy
297866|NCT01674387|Electroacupuncture|electroacupuncture
297867|NCT01674387|Meridians|meridians
297868|NCT01674348|Diabetes Mellitus|diabetes mellitus
297869|NCT01674335|Fibromyalgia|fibromyalgia
297870|NCT01674335|Chronic pain|chronic pain
297871|NCT01674335|Chronic fatigue|chronic fatigue
297872|NCT01674335|Activity pacing|activity pacing
297873|NCT01674335|Operant learning|operant learning
297874|NCT01674335|Energy conservation|energy conservation
297875|NCT01674335|Treatment|treatment
297876|NCT01674335|Intervention|intervention
297877|NCT01674335|Biopsychosocial factors|biopsychosocial factors
297878|NCT01674335|Coping|coping
297879|NCT01674335|Mood|mood
297880|NCT01674335|Quality of life|quality of life
297881|NCT01674322|Healthy participants|healthy participants
297882|NCT01674322|Ibrutinib|ibrutinib
297883|NCT01674322|PCI-32765|pci-32765
297884|NCT01674322|B-cell malignancies|b-cell malignancies
297885|NCT01674322|CYP3A4|cyp3a4
297886|NCT01674296|Body Weight/physiology*|body weight/physiology*
297887|NCT01674296|Diet*/statistics & numerical data|diet*/statistics & numerical data
297888|NCT01674296|Diet*/trends|diet*/trends
297889|NCT01674296|Exercise/physiology*|exercise/physiology*
297890|NCT01674296|Female|female
297891|NCT01674296|Humans|humans
297892|NCT01674296|Longitudinal Studies|longitudinal studies
297893|NCT01674296|Middle Aged|middle aged
297894|NCT01674296|Obesity/epidemiology*|obesity/epidemiology*
297895|NCT01674296|Seasons*|seasons*
297896|NCT01674296|Time Factors|time factors
297897|NCT01674257|Atherosclerosis|atherosclerosis
297898|NCT01674257|Stroke|stroke
297899|NCT01674257|Positron-emission tomography|positron-emission tomography
297900|NCT01674257|Ferumoxytol|ferumoxytol
297901|NCT01674257|Magnetic resonance imaging|magnetic resonance imaging
297902|NCT01674257|Genetics|genetics
297903|NCT01674257|Calcification|calcification
297904|NCT01674257|Inflammation|inflammation
297905|NCT01674257|Flurodeoxyglucose F18|flurodeoxyglucose f18
297906|NCT01674257|Radiopharmaceuticals|radiopharmaceuticals
297907|NCT01674218|tuberculosis, safety, PA-824, QTc interval, moxifloxacin, healthy volunteers, crossover|tuberculosis, safety, pa-824, qtc interval, moxifloxacin, healthy volunteers, crossover
297909|NCT01674179|qEEG|qeeg
297910|NCT01674179|Sleep|sleep
297911|NCT01674179|Pain|pain
297912|NCT01674153|Intra-dialytic exercise|intra-dialytic exercise
297913|NCT01674153|Toxin removal|toxin removal
297914|NCT01674153|Hemodiafiltration|hemodiafiltration
297915|NCT01674153|Inter-compartmental resistance|inter-compartmental resistance
297916|NCT01674153|Cardiac output|cardiac output
297917|NCT01674140|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
297918|NCT01674140|HER2-negative breast cancer|her2-negative breast cancer
297919|NCT01674140|stage IA breast cancer|stage ia breast cancer
298020|NCT01673529|TRPV1|trpv1
297920|NCT01674140|stage IB breast cancer|stage ib breast cancer
297921|NCT01674140|stage II breast cancer|stage ii breast cancer
297922|NCT01674140|stage IIIA breast cancer|stage iiia breast cancer
297923|NCT01674140|stage IIIB breast cancer|stage iiib breast cancer
297924|NCT01674140|stage IIIC breast cancer|stage iiic breast cancer
297925|NCT01674140|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
297926|NCT01674140|male breast cancer|male breast cancer
297927|NCT01674114|Cesarean Section|cesarean section
297928|NCT01674114|Anesthetics, Local|anesthetics, local
297929|NCT01674101|Lower extremity malignancy|lower extremity malignancy
297930|NCT01674088|Irritable Bowel Syndrome|irritable bowel syndrome
297931|NCT01674088|breath testing|breath testing
297932|NCT01674088|carbon-13|carbon-13
297933|NCT01674075|safety|safety
297934|NCT01674075|J-Tip Delivery System|j-tip delivery system
297935|NCT01674075|pharmacokinetic profile|pharmacokinetic profile
297936|NCT01674049|nutrition|nutrition
297937|NCT01674049|nutrient|nutrient
297938|NCT01674049|timing|timing
297939|NCT01674049|diabetes|diabetes
297940|NCT01674049|family history|family history
297941|NCT01674049|dairy|dairy
297942|NCT01673971|hemangioma|hemangioma
297943|NCT01673958|Eccentric exercise|eccentric exercise
297944|NCT01673958|Aging|aging
297945|NCT01673958|Heart failure|heart failure
297946|NCT01673958|Muscle strength loss|muscle strength loss
297947|NCT01673958|Sarcopenia|sarcopenia
297948|NCT01673945|EUS-FNA, Forward viewing EUS scope, accuracy, Curvilinear EUS scope|eus-fna, forward viewing eus scope, accuracy, curvilinear eus scope
297949|NCT01673932|stroke|stroke
297950|NCT01673932|chronic stroke|chronic stroke
297951|NCT01673932|ischemic stroke|ischemic stroke
297952|NCT01673932|umbilical cord blood|umbilical cord blood
297953|NCT01673932|mononuclear cell|mononuclear cell
297954|NCT01673932|transplant|transplant
297955|NCT01673906|positron-emission tomography|positron-emission tomography
297956|NCT01673906|neuroendocrine tumors|neuroendocrine tumors
297957|NCT01673906|endosonography|endosonography
297958|NCT01673906|tomography, X-ray computed|tomography, x-ray computed
297959|NCT01673906|biopsy, fine needle|biopsy, fine needle
297960|NCT01673906|sensitivity and sensibility|sensitivity and sensibility
297961|NCT01673893|ClearWay|clearway
297962|NCT01673893|Glycoprotein|glycoprotein
297963|NCT01673893|Primary Coronary Intervention|primary coronary intervention
297964|NCT01673893|Abciximab|abciximab
297965|NCT01673893|ST Elevation Myocardial Infarction|st elevation myocardial infarction
297966|NCT01673893|Non-ST Elevation Myocardial Infarction|non-st elevation myocardial infarction
297967|NCT01673893|STEMI|stemi
297968|NCT01673893|NSTEMI|nstemi
297969|NCT01673893|Medicare|medicare
297970|NCT01673893|Medicaid|medicaid
297971|NCT01673893|Registry|registry
297972|NCT01673893|catheterization|catheterization
297973|NCT01673893|readmission|readmission
297974|NCT01673893|Acute Coronary Syndrome|acute coronary syndrome
297975|NCT01673893|ClearwayRx Catheter|clearwayrx catheter
297976|NCT01673841|bypass grafting|bypass grafting
297977|NCT01673828|Brain Injuries|brain injuries
297978|NCT01673828|Pregnanolone|pregnanolone
297979|NCT01673828|Epilepsy|epilepsy
297980|NCT01673815|optic disk|optic disk
297981|NCT01673815|fundoscopy|fundoscopy
297982|NCT01673815|pediatric|pediatric
297983|NCT01673815|clinical examination|clinical examination
297984|NCT01673802|Cholangiocarcinoma|cholangiocarcinoma
297985|NCT01673789|Stem Cell Educator|stem cell educator
297986|NCT01673789|Cord blood stem cells|cord blood stem cells
297987|NCT01673789|Immune modulation|immune modulation
297988|NCT01673789|Alopecia Areata|alopecia areata
297989|NCT01673776|Proximal femoral fracture|proximal femoral fracture
297990|NCT01673776|multimodal intervention|multimodal intervention
297991|NCT01673776|goal directed therapy (GDT)|goal directed therapy (gdt)
297992|NCT01673776|hemodynamic intervention|hemodynamic intervention
297993|NCT01673776|outcome|outcome
297994|NCT01673763|ERCP|ercp
297995|NCT01673763|endoscopy|endoscopy
297996|NCT01673763|pancreatitis|pancreatitis
297997|NCT01673750|Adolescents|adolescents
297998|NCT01673750|Body Image|body image
297999|NCT01673698|obesity|obesity
298000|NCT01673698|weight loss|weight loss
298001|NCT01673685|COPD|copd
298002|NCT01673685|Oxygen cylinder|oxygen cylinder
298003|NCT01673685|Portable oxygen cylinder|portable oxygen cylinder
298004|NCT01673685|Battery powered delivery device|battery powered delivery device
298006|NCT01673685|dyspnoea|dyspnoea
298007|NCT01673685|Quality of Life|quality of life
298008|NCT01673685|Cost effectiveness|cost effectiveness
298009|NCT01673646|SOM230, Pasireotide, acromegaly, Phase II|som230, pasireotide, acromegaly, phase ii
298010|NCT01673594|ADHD|adhd
298011|NCT01673594|Naltrexone|naltrexone
298012|NCT01673594|SODAS MPH|sodas mph
298013|NCT01673594|Stimulant-Induced Euphoria|stimulant-induced euphoria
298014|NCT01673594|Substance Abuse|substance abuse
298015|NCT01673594|Adults|adults
298016|NCT01673581|Low Risk|low risk
298017|NCT01673555|GSK1278863|gsk1278863
298018|NCT01673555|Pulmonary artery pressure|pulmonary artery pressure
298019|NCT01673529|Pruritus|pruritus
298021|NCT01673529|Cowhage|cowhage
298022|NCT01673529|Atopic Dermatitis|atopic dermatitis
369157|NCT01371734|MDD|mdd
298023|NCT01673529|Capsaicin|capsaicin
298024|NCT01673529|Itch|itch
298025|NCT01673529|Histamine|histamine
298026|NCT01673529|healthy volunteers|healthy volunteers
298027|NCT01673529|SB705498|sb705498
298028|NCT01673529|Clinical|clinical
298029|NCT01673516|Renal sympathetic denervation|renal sympathetic denervation
298030|NCT01673516|Impedance cardiography|impedance cardiography
298031|NCT01673503|Myopia|myopia
298032|NCT01673503|refractive surgery|refractive surgery
298033|NCT01673503|all femtosecond laser|all femtosecond laser
298034|NCT01673503|ReLEx flex|relex flex
298035|NCT01673503|ReLEx smile|relex smile
298036|NCT01673490|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
298037|NCT01673490|dutasteride and tamsulosin|dutasteride and tamsulosin
298038|NCT01673464|mild Traumatic Brain Injury|mild traumatic brain injury
298039|NCT01673464|mTBI|mtbi
298040|NCT01673464|Concussion|concussion
298041|NCT01673451|insomnia|insomnia
298042|NCT01673438|solid tumor|solid tumor
298043|NCT01673438|aldoxorubicin|aldoxorubicin
298044|NCT01673438|phase 1|phase 1
298045|NCT01673438|INNO-206|inno-206
298046|NCT01673438|doxorubicin|doxorubicin
298047|NCT01673425|Influenza|influenza
298048|NCT01673425|Influenza Vaccines|influenza vaccines
298049|NCT01673425|Vaccines, Attenuated|vaccines, attenuated
298050|NCT01673425|Immunity, Mucosal|immunity, mucosal
298051|NCT01673412|venous leg ulcer healing prognostic factors|venous leg ulcer healing prognostic factors
298052|NCT01673399|repeated implantation failure (RIF)|repeated implantation failure (rif)
298053|NCT01673399|atosiban|atosiban
298054|NCT01673399|pregnancy|pregnancy
298055|NCT01673386|Tivozanib hydrochloride|tivozanib hydrochloride
298056|NCT01673386|renal cell carcinoma|renal cell carcinoma
298057|NCT01673386|subject preference|subject preference
298058|NCT01673386|quality of life|quality of life
298059|NCT01673373|Renal Artery Stenosis|renal artery stenosis
298060|NCT01673373|Renal Artery Obstruction|renal artery obstruction
298061|NCT01673373|Renovascular Hypertension|renovascular hypertension
298062|NCT01673373|Resistant Hypertension|resistant hypertension
298063|NCT01673373|Renal Revascularization|renal revascularization
298064|NCT01673373|Atherosclerotic Renal Artery Stenosis|atherosclerotic renal artery stenosis
298065|NCT01673373|ARAS (Atherosclerotic Renal Artery Stenosis)|aras (atherosclerotic renal artery stenosis)
298066|NCT01673373|RAS (Renal Artery Stenosis)|ras (renal artery stenosis)
298067|NCT01673373|Uncontrolled hypertension|uncontrolled hypertension
298068|NCT01673373|Hypertension|hypertension
298069|NCT01673373|systolic blood pressure|systolic blood pressure
298070|NCT01673373|blood pressure|blood pressure
298071|NCT01673360|vaginal repair|vaginal repair
298072|NCT01673360|urinary slings|urinary slings
298073|NCT01673360|POP|pop
298074|NCT01673360|SUI|sui
298075|NCT01673360|prolapse|prolapse
298076|NCT01673360|incontinence|incontinence
298077|NCT01673347|allograft|allograft
298078|NCT01673347|great toe|great toe
298079|NCT01673334|Pancreas Tumor EUS FNA Core Biopsy Procore FNB|pancreas tumor eus fna core biopsy procore fnb
298080|NCT01673321|Yogurt|yogurt
298081|NCT01673321|Milk|milk
298082|NCT01673321|Protein|protein
298083|NCT01673321|Food intake|food intake
298084|NCT01673321|Appetite|appetite
298085|NCT01673321|Glucose|glucose
298086|NCT01673321|Insulin|insulin
298087|NCT01673295|Lupus Nephritis|lupus nephritis
298088|NCT01673295|Rituximab|rituximab
298089|NCT01673282|Lacosamide|lacosamide
298090|NCT01673282|Vimpat|vimpat
298091|NCT01673282|Focal Epilepsy|focal epilepsy
298092|NCT01673282|Drug Load|drug load
298094|NCT01673282|SP1065|sp1065
298095|NCT01673269|ERCP|ercp
298096|NCT01673269|Direct cholangioscopic examination of the common bile duct|direct cholangioscopic examination of the common bile duct
298097|NCT01673269|Choledocholithiasis|choledocholithiasis
298098|NCT01673269|Cholangiocarcinoma|cholangiocarcinoma
298099|NCT01673269|Benign stricture of common bile duct|benign stricture of common bile duct
298100|NCT01673243|Smoking cessation|smoking cessation
298101|NCT01673243|Household smoking bans|household smoking bans
298102|NCT01673243|Cancer|cancer
298103|NCT01673243|Sickle cell disease|sickle cell disease
297715|NCT01674933|oral|oral
298104|NCT01673204|surrogate marker,|surrogate marker,
298105|NCT01673204|circulating soluble TNF receptor,|circulating soluble tnf receptor,
298106|NCT01673204|diabetic nephropathy|diabetic nephropathy
298107|NCT01673178|Type 2 diabetes|type 2 diabetes
298108|NCT01673178|safety|safety
298109|NCT01673178|multiple dose|multiple dose
298110|NCT01673178|intravenous|intravenous
298111|NCT01673152|Obesity|obesity
298112|NCT01673152|Overweight|overweight
298113|NCT01673152|Satiety|satiety
298114|NCT01673152|Oligofructose|oligofructose
298115|NCT01673152|Prebiotic|prebiotic
298116|NCT01673139|Atrial fibrillation|atrial fibrillation
298117|NCT01673139|Exercise|exercise
298118|NCT01673126|vegetative state|vegetative state
298119|NCT01673126|minimally conscious state|minimally conscious state
298120|NCT01673126|disorders of consciousness|disorders of consciousness
288707|NCT01714700|protein|protein
298121|NCT01673126|transcranial direct current stimulation|transcranial direct current stimulation
298122|NCT01673113|cryolipolysis, sensory nerve function, Zeltiq|cryolipolysis, sensory nerve function, zeltiq
298123|NCT01673100|physical activity|physical activity
298124|NCT01673100|percutaneous coronary intervention|percutaneous coronary intervention
298125|NCT01673100|heart disease|heart disease
298126|NCT01673087|stress biology|stress biology
298127|NCT01673087|cortisol|cortisol
298128|NCT01673087|adrenocorticotropin|adrenocorticotropin
298129|NCT01673087|salivary biomarkers|salivary biomarkers
298130|NCT01673061|Abscess|abscess
298131|NCT01673061|Boils|boils
298132|NCT01673061|Anesthetics, Local|anesthetics, local
298133|NCT01673061|Lidocaine|lidocaine
298134|NCT01673061|Vapocoolant|vapocoolant
298135|NCT01673061|1,1,1,3,3-Pentafluoropropane|1,1,1,3,3-pentafluoropropane
298136|NCT01673061|1,1,1,2-Tetrafluoroethane|1,1,1,2-tetrafluoroethane
298137|NCT01673048|Elastic stable intramedullary nailing|elastic stable intramedullary nailing
298138|NCT01673048|biomechanical testing|biomechanical testing
298139|NCT01673048|fracture|fracture
298140|NCT01673048|femur|femur
298141|NCT01673048|treatment|treatment
298142|NCT01673048|children|children
298143|NCT01673048|adolescents|adolescents
298144|NCT01673009|Gleevec|gleevec
298145|NCT01672996|Use in Abdominal|use in abdominal
298146|NCT01672996|Contrast Enhanced|contrast enhanced
298147|NCT01672996|Computed Tomography|computed tomography
298148|NCT01672996|Optimize concentration|optimize concentration
298149|NCT01672996|dosage of Ioforminol Injection|dosage of ioforminol injection
298150|NCT01672983|Japanese|japanese
298151|NCT01672983|Hepatitis C|hepatitis c
298152|NCT01672983|Genotype 2|genotype 2
298153|NCT01672983|Genotype 1b|genotype 1b
298154|NCT01672983|paritaprevir|paritaprevir
298155|NCT01672983|ombitasvir|ombitasvir
298156|NCT01672983|ritonavir|ritonavir
298157|NCT01672983|VIEKIRAX Combination Tablets|viekirax combination tablets
298158|NCT01672944|Biological specimen banks|biological specimen banks
298159|NCT01672944|Health education|health education
298160|NCT01672944|Tissue banks|tissue banks
298161|NCT01672944|Health care survey|health care survey
298162|NCT01672944|Tissue|tissue
298163|NCT01672918|PET/CT|pet/ct
298164|NCT01672918|Lymphoma|lymphoma
298165|NCT01672918|Lymphadenopathy|lymphadenopathy
298166|NCT01672918|ALPS|alps
298167|NCT01672905|recurrent prostate cancer|recurrent prostate cancer
298168|NCT01672905|stage I prostate cancer|stage i prostate cancer
298169|NCT01672905|stage IIA prostate cancer|stage iia prostate cancer
298170|NCT01672905|stage IIB prostate cancer|stage iib prostate cancer
298171|NCT01672905|stage III prostate cancer|stage iii prostate cancer
298172|NCT01672892|gastrointestinal complications|gastrointestinal complications
298173|NCT01672892|perioperative/postoperative complications|perioperative/postoperative complications
298174|NCT01672892|radiation toxicity|radiation toxicity
298175|NCT01672892|urinary complications|urinary complications
298176|NCT01672892|urinary tract toxicity|urinary tract toxicity
298177|NCT01672892|endometrial clear cell carcinoma|endometrial clear cell carcinoma
298178|NCT01672892|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
298179|NCT01672892|stage IA endometrial carcinoma|stage ia endometrial carcinoma
298180|NCT01672892|stage IB endometrial carcinoma|stage ib endometrial carcinoma
298181|NCT01672892|stage II endometrial carcinoma|stage ii endometrial carcinoma
298182|NCT01672892|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
298183|NCT01672892|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
298184|NCT01672892|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
298185|NCT01672892|endometrial adenocarcinoma|endometrial adenocarcinoma
298186|NCT01672892|cervical adenocarcinoma|cervical adenocarcinoma
298187|NCT01672892|stage IB cervical cancer|stage ib cervical cancer
298188|NCT01672892|stage IIA cervical cancer|stage iia cervical cancer
298189|NCT01672892|stage IIB cervical cancer|stage iib cervical cancer
298190|NCT01672879|NASH|nash
298191|NCT01672879|cirrhosis|cirrhosis
298192|NCT01672879|Compensated Liver disease|compensated liver disease
298193|NCT01672879|Monoclonal antibody|monoclonal antibody
298194|NCT01672879|LOXL2|loxl2
298195|NCT01672879|Simtuzumab|simtuzumab
298196|NCT01672879|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
298197|NCT01672879|Hepatic venous pressure gradient|hepatic venous pressure gradient
298198|NCT01672879|HVPG|hvpg
298199|NCT01672879|NAFLD|nafld
298200|NCT01672879|MRE|mre
298201|NCT01672879|Liver biopsy|liver biopsy
298202|NCT01672866|NASH|nash
298203|NCT01672866|non cirrhotic|non cirrhotic
298204|NCT01672866|Monoclonal antibody|monoclonal antibody
298205|NCT01672866|LOXL2|loxl2
298206|NCT01672866|Simtuzumab|simtuzumab
298207|NCT01672866|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
298208|NCT01672866|NAFLD|nafld
298209|NCT01672866|Liver biopsy|liver biopsy
298210|NCT01672866|MRE|mre
298211|NCT01672853|PSC|psc
298212|NCT01672853|Sclerosis|sclerosis
298213|NCT01672853|Monoclonal antibody|monoclonal antibody
288795|NCT01714206|Healthy|healthy
298214|NCT01672853|LOXL2|loxl2
298215|NCT01672853|Simtuzumab|simtuzumab
299051|NCT01669213|hypotension|hypotension
298216|NCT01672853|Primary sclerosing cholangitis|primary sclerosing cholangitis
298217|NCT01672853|Liver fibrosis|liver fibrosis
298218|NCT01672853|Liver disease|liver disease
298219|NCT01672853|MRCP|mrcp
298221|NCT01672853|Liver biopsy|liver biopsy
298222|NCT01672840|Stage 1 Hypertension|stage 1 hypertension
298223|NCT01672840|cocoa consumption|cocoa consumption
298224|NCT01672840|Blood pressure|blood pressure
298225|NCT01672840|Endothelial function|endothelial function
298226|NCT01672840|arterial stiffness|arterial stiffness
298227|NCT01672827|Alzheimer's Disease|alzheimer's disease
298228|NCT01672827|Mild Cognitive Impairment|mild cognitive impairment
298229|NCT01672827|Positron Emission Tomography (PET)|positron emission tomography (pet)
298230|NCT01672827|PET Images|pet images
298231|NCT01672814|Keratoconus|keratoconus
298232|NCT01672814|Collagen Crosslinking|collagen crosslinking
298233|NCT01672814|Riboflavin|riboflavin
298234|NCT01672814|Microwave|microwave
298235|NCT01672814|Keraflex|keraflex
298236|NCT01672775|Renal Cell Carcinoma|renal cell carcinoma
298237|NCT01672775|AGS-16C3F|ags-16c3f
298238|NCT01672775|Pharmacokinetics of AGS-16C3F|pharmacokinetics of ags-16c3f
298239|NCT01672762|diabetes mellitus|diabetes mellitus
298240|NCT01672762|serum Insulin|serum insulin
298241|NCT01672762|blood glucose|blood glucose
298242|NCT01672762|glucose excretion|glucose excretion
298243|NCT01672762|hypoglycemic agents|hypoglycemic agents
298244|NCT01672762|ipragliflozin|ipragliflozin
298245|NCT01672749|Scoliosis [MESH]|scoliosis [mesh]
298246|NCT01672749|Pediatrics [MESH]|pediatrics [mesh]
298247|NCT01672749|Early onset|early onset
298248|NCT01672749|Growth guidance|growth guidance
298249|NCT01672749|Growing rod|growing rod
298250|NCT01672749|Trolley|trolley
298251|NCT01672749|Dual growing rod technique|dual growing rod technique
298252|NCT01672736|Relapsed or relapse/refractory Multiple Myeloma|relapsed or relapse/refractory multiple myeloma
298253|NCT01672723|opioids|opioids
298254|NCT01672723|social connection|social connection
298255|NCT01672710|Hubbard detoxification|hubbard detoxification
298256|NCT01672710|Exercise|exercise
298257|NCT01672710|Sauna therapy|sauna therapy
298258|NCT01672710|Niacin|niacin
298259|NCT01672697|anal incontinence|anal incontinence
298260|NCT01672697|genital trauma|genital trauma
298261|NCT01672697|physical therapy|physical therapy
298262|NCT01672697|anal manometry|anal manometry
298263|NCT01672684|quality of life|quality of life
298264|NCT01672658|TBI,|tbi,
298265|NCT01672658|vestibular|vestibular
298266|NCT01672645|Smoking cessation|smoking cessation
298267|NCT01672645|vaccine|vaccine
298268|NCT01672645|Phase 1|phase 1
298269|NCT01672619|craniosynostoses|craniosynostoses
298270|NCT01672619|Osteogenesis Distraction|osteogenesis distraction
298271|NCT01672619|craniotomy|craniotomy
298272|NCT01672593|Autologous platelet rich fibrin glue;|autologous platelet rich fibrin glue;
298273|NCT01672593|Enterocutaneous fistulas;|enterocutaneous fistulas;
298274|NCT01672593|Single low output GI fistulas;|single low output gi fistulas;
298275|NCT01672580|social networks|social networks
298276|NCT01672580|nutrition|nutrition
298277|NCT01672580|vitamins|vitamins
298278|NCT01672580|chlorine|chlorine
298279|NCT01672567|Coronary Artery Disease|coronary artery disease
298280|NCT01672567|Egg Consumption|egg consumption
298281|NCT01672567|Endothelial Function|endothelial function
298282|NCT01672554|Schizophrenia|schizophrenia
298283|NCT01672554|Anxiety disorder|anxiety disorder
298284|NCT01672541|dating violence|dating violence
705625|NCT00985595|Adolescent|adolescent
298285|NCT01672541|healthy relationship behaviors|healthy relationship behaviors
298286|NCT01672528|Patient Reported Outcome Measures|patient reported outcome measures
298287|NCT01672528|PROMs|proms
298288|NCT01672528|Cardiac arrhythmia|cardiac arrhythmia
298289|NCT01672528|Cardiac ablation|cardiac ablation
298290|NCT01672502|sleep|sleep
298291|NCT01672502|firefighter|firefighter
298292|NCT01672502|fire|fire
298293|NCT01672502|apnea|apnea
298294|NCT01672502|insomnia|insomnia
298295|NCT01672502|shift|shift
298296|NCT01672502|narcolepsy|narcolepsy
298297|NCT01672502|restless leg|restless leg
298298|NCT01672502|rls|rls
298299|NCT01672502|fatigue|fatigue
298300|NCT01672502|Optalert|optalert
298301|NCT01672502|actigraph|actigraph
298302|NCT01672502|actigraphy|actigraphy
298303|NCT01672502|actiwatch|actiwatch
298304|NCT01672502|safety|safety
298305|NCT01672502|sleepiness|sleepiness
298306|NCT01672502|sleepy|sleepy
298307|NCT01672502|work|work
298308|NCT01672502|hours|hours
298309|NCT01672502|FEMA|fema
298310|NCT01672502|drowsy|drowsy
298311|NCT01672489|Drowsy|drowsy
298312|NCT01672489|Drive|drive
298313|NCT01672489|Driving|driving
298314|NCT01672489|Shift Work Disorder|shift work disorder
298315|NCT01672489|SWD|swd
298316|NCT01672489|EEG|eeg
298317|NCT01672489|ECG|ecg
298318|NCT01672489|Actiwatch|actiwatch
298319|NCT01672489|Diary|diary
298320|NCT01672489|Bioharness|bioharness
298321|NCT01672489|Q-Sensor|q-sensor
298322|NCT01672489|Q Sensor|q sensor
298323|NCT01672489|Liberty Mutual|liberty mutual
298324|NCT01672489|sleep|sleep
298325|NCT01672489|impaired|impaired
298326|NCT01672489|Optalert|optalert
298327|NCT01672489|tracker|tracker
298328|NCT01672489|vehicle|vehicle
298329|NCT01672489|questionnaire|questionnaire
298330|NCT01672489|survey|survey
298331|NCT01672476|Fimasartan|fimasartan
298332|NCT01672450|Histologically or cytologically proven melanoma; Stages III-IV; accessible cutaneous, subcutaneous, and/or nodal lesions; ECOG performance status 0 to 2|histologically or cytologically proven melanoma; stages iii-iv; accessible cutaneous, subcutaneous, and/or nodal lesions; ecog performance status 0 to 2
298333|NCT01672437|Birth and parent preparation|birth and parent preparation
298334|NCT01672437|Parenting stress|parenting stress
298335|NCT01672437|Depression|depression
298336|NCT01672437|self-efficacy|self-efficacy
298337|NCT01672437|social network and support|social network and support
298338|NCT01672424|NPO|npo
298339|NCT01672424|Gastric Emptying|gastric emptying
298340|NCT01672424|Ice Chips|ice chips
298341|NCT01672424|Protein Drink|protein drink
298342|NCT01672424|Ultrasound|ultrasound
298343|NCT01672411|prostate cancer, PSA, markers, diagnosis, prognosis, pro-PSA|prostate cancer, psa, markers, diagnosis, prognosis, pro-psa
298344|NCT01672398|CarePartner|carepartner
298345|NCT01672398|informal caregiver|informal caregiver
298346|NCT01672398|interactive voice response|interactive voice response
298347|NCT01672398|transition|transition
298348|NCT01672398|post-discharge|post-discharge
298349|NCT01672398|chronic illness|chronic illness
298350|NCT01672398|readmission|readmission
298351|NCT01672398|self-care|self-care
298352|NCT01672385|CarePartner|carepartner
298353|NCT01672385|informal caregiver|informal caregiver
298354|NCT01672385|interactive voice response|interactive voice response
298355|NCT01672385|transition|transition
298356|NCT01672385|post-discharge|post-discharge
298357|NCT01672385|chronic illness|chronic illness
298358|NCT01672385|readmission|readmission
298359|NCT01672385|self-care|self-care
298360|NCT01672359|cognitive functioning|cognitive functioning
298361|NCT01672359|immune function|immune function
298362|NCT01672359|cytokines|cytokines
298363|NCT01672359|growth factors|growth factors
298364|NCT01672359|quality of life|quality of life
298365|NCT01672359|dietary supplementation|dietary supplementation
298366|NCT01672359|Ginkgo biloba|ginkgo biloba
298367|NCT01672359|Improvement of cognitive function|improvement of cognitive function
298368|NCT01672346|PAF|paf
298369|NCT01672320|Robotic|robotic
298370|NCT01672320|Arthroplasty|arthroplasty
298371|NCT01672320|Total Hip Arthroplasty|total hip arthroplasty
298372|NCT01672320|Cup Positioning|cup positioning
298373|NCT01672320|Outcomes|outcomes
298374|NCT01672307|hypotrichosis of eyebrows|hypotrichosis of eyebrows
298375|NCT01672307|thinning eyebrows|thinning eyebrows
298376|NCT01672307|minoxidil|minoxidil
298377|NCT01672307|placebo|placebo
298378|NCT01672307|randomized|randomized
298379|NCT01672294|caregiver|caregiver
298380|NCT01672294|end of life|end of life
298381|NCT01672294|self-disclosure|self-disclosure
298382|NCT01672268|cardiac computed tomography|cardiac computed tomography
298383|NCT01672268|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
298384|NCT01672268|safety and efficacy|safety and efficacy
298385|NCT01672255|exercise|exercise
298386|NCT01672255|diabetes|diabetes
298387|NCT01672255|SSRIs|ssris
298388|NCT01672216|Exercise Therapy|exercise therapy
298389|NCT01672216|Biofeedback (Psychology)|biofeedback (psychology)
298390|NCT01672216|Adult|adult
298391|NCT01672216|Chronic Obstipation/*therapy|chronic obstipation/*therapy
298392|NCT01672216|EMG - Biofeedback|emg - biofeedback
298393|NCT01672216|EMG - Triggered Stimulation|emg - triggered stimulation
298394|NCT01672216|Augmented biofeedback|augmented biofeedback
298395|NCT01672177|Geriatrics|geriatrics
298396|NCT01672177|Aged|aged
298397|NCT01672177|Aging|aging
298398|NCT01672177|Chronic disease|chronic disease
298399|NCT01672177|Self management|self management
298400|NCT01672164|proteogenomic biomarker panels|proteogenomic biomarker panels
298401|NCT01672151|Refractory Immune Thrombocytopenic Purpura|refractory immune thrombocytopenic purpura
298402|NCT01672151|rapamycin|rapamycin
298403|NCT01672151|regulatory T cells|regulatory t cells
298404|NCT01672138|PVAI|pvai
298405|NCT01672138|CFAE|cfae
298406|NCT01672138|NPAF|npaf
298407|NCT01672112|analgesic efficacy|analgesic efficacy
298408|NCT01672112|oral codeine|oral codeine
298409|NCT01672112|oral oxycodone|oral oxycodone
298410|NCT01672112|postcraniotomy|postcraniotomy
298411|NCT01672099|vitamin K2|vitamin k2
298412|NCT01672099|menaquinone-7|menaquinone-7
298413|NCT01672099|vascular health|vascular health
298414|NCT01672073|pressure|pressure
298415|NCT01672073|waveform|waveform
298416|NCT01672073|arterial|arterial
298417|NCT01672047|The 25(OH) vitamin D level|the 25(oh) vitamin d level
298418|NCT01672047|The 1.25(OH) vitamin D level|the 1.25(oh) vitamin d level
298419|NCT01672047|The intact PTH level|the intact pth level
298420|NCT01672047|The calcification score of coronary artery|the calcification score of coronary artery
298421|NCT01672047|The microalbuminuria level|the microalbuminuria level
298422|NCT01672021|Breast Cancer|breast cancer
298423|NCT01672021|MRI PET-CT|mri pet-ct
298424|NCT01672008|NOX-100|nox-100
298425|NCT01671995|Heart failure|heart failure
298426|NCT01671995|Quality of life|quality of life
298427|NCT01671969|determine effects of diet on renal and other parameters|determine effects of diet on renal and other parameters
298429|NCT01671956|UC|uc
298430|NCT01671956|Colitis|colitis
298431|NCT01671956|Ulcerative Colitis|ulcerative colitis
298432|NCT01671943|small malignant invasive breast tumors|small malignant invasive breast tumors
298433|NCT01671917|Total knee arthroplasty|total knee arthroplasty
298434|NCT01671917|Total knee replacement|total knee replacement
298435|NCT01671917|Knee osteoarthritis|knee osteoarthritis
298436|NCT01671917|Education|education
298437|NCT01671917|Exercise|exercise
298438|NCT01671917|Handicap|handicap
298439|NCT01671917|Function|function
298440|NCT01671917|Cost-effectiveness|cost-effectiveness
298441|NCT01671917|Cost-utility|cost-utility
298442|NCT01671917|Quality of life|quality of life
298443|NCT01671891|rectal cancer|rectal cancer
298444|NCT01671891|circulating tumor cells|circulating tumor cells
298445|NCT01671891|predict responses|predict responses
298446|NCT01671865|FSHD|fshd
298447|NCT01671865|magnetic resonance imaging|magnetic resonance imaging
298448|NCT01671865|magnetic resonance spectroscopy|magnetic resonance spectroscopy
298449|NCT01671826|Multiple Myeloma|multiple myeloma
298450|NCT01671826|Autologous Stem Cell Transplantation|autologous stem cell transplantation
298451|NCT01671826|Elderly Patients|elderly patients
298452|NCT01671813|positive|positive
298453|NCT01671813|diffuse|diffuse
298454|NCT01671813|B-Cell|b-cell
298455|NCT01671813|elderly|elderly
298456|NCT01671813|EBV|ebv
298457|NCT01671813|DLBCL|dlbcl
298458|NCT01671813|malignant|malignant
298459|NCT01671813|pilot|pilot
298460|NCT01671800|Hyperhidrosis|hyperhidrosis
298461|NCT01671800|Botulinum Toxin|botulinum toxin
298462|NCT01671800|Amputation|amputation
298463|NCT01671800|Phantom limb pain|phantom limb pain
298464|NCT01671787|Hepatitis B|hepatitis b
298465|NCT01671787|HBV|hbv
298466|NCT01671787|GS-7340|gs-7340
298467|NCT01671787|TDF|tdf
298468|NCT01671787|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
298469|NCT01671787|Gilead|gilead
298470|NCT01671787|Viread|viread
298471|NCT01671761|Healthy|healthy
298472|NCT01671761|Control|control
298473|NCT01671748|Venous Leg Ulcer|venous leg ulcer
298474|NCT01671748|Varicose Ulcer|varicose ulcer
298475|NCT01671748|Chronic ulcer|chronic ulcer
298476|NCT01671748|Chronic wound|chronic wound
298477|NCT01671748|Ultrasound therapy|ultrasound therapy
298478|NCT01671748|MIST device|mist device
298479|NCT01671748|Wound healing|wound healing
298480|NCT01671748|Low frequency non contact ultrasound|low frequency non contact ultrasound
298481|NCT01671735|prevention|prevention
298482|NCT01671735|diabetes|diabetes
298483|NCT01671722|Bioequivalence|bioequivalence
298484|NCT01671722|Montelukast Sodium|montelukast sodium
298485|NCT01671722|crossover|crossover
298486|NCT01671709|Bioequivalence|bioequivalence
298487|NCT01671709|Montelukast Sodium|montelukast sodium
298488|NCT01671709|crossover|crossover
298489|NCT01671683|rectal cancer|rectal cancer
298490|NCT01671683|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
298491|NCT01671683|Capecitabine|capecitabine
298492|NCT01671670|Functional dyspepsia|functional dyspepsia
298493|NCT01671670|postprandial distress syndrome|postprandial distress syndrome
298494|NCT01671657|In vitro fertilization|in vitro fertilization
298495|NCT01671657|Assisted reproductive therapy|assisted reproductive therapy
298496|NCT01671657|Time-lapse image recording|time-lapse image recording
298497|NCT01671657|Image analysis software|image analysis software
298498|NCT01671644|In vitro fertilization|in vitro fertilization
298499|NCT01671644|Assisted reproductive therapy|assisted reproductive therapy
298500|NCT01671644|Time-lapse image recording|time-lapse image recording
298501|NCT01671644|Image analysis software|image analysis software
298502|NCT01671618|Aortic dissection|aortic dissection
298503|NCT01671618|Aortic dilation|aortic dilation
298504|NCT01671618|Aortic Aneurysm|aortic aneurysm
298505|NCT01671618|ultrasound|ultrasound
298506|NCT01671618|point-of-care|point-of-care
298507|NCT01671618|echocardiography|echocardiography
298508|NCT01671592|Cancer|cancer
298509|NCT01671592|colorectal|colorectal
298510|NCT01671592|tumor|tumor
298511|NCT01671592|neoplasms|neoplasms
298512|NCT01671592|carcinoma|carcinoma
298514|NCT01671566|Congenital Heart defect|congenital heart defect
298515|NCT01671566|Exercise and Physical fitness|exercise and physical fitness
298516|NCT01671566|Rehabilitation|rehabilitation
298517|NCT01671566|Quality of life|quality of life
298518|NCT01671566|Behaviour|behaviour
298519|NCT01671540|COPD|copd
298521|NCT01671527|Deep Brain Stimulation|deep brain stimulation
298522|NCT01671527|DBS|dbs
298523|NCT01671527|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
298524|NCT01671527|TMS|tms
298525|NCT01671527|Cervical Dystonia|cervical dystonia
298526|NCT01671527|Dystonia|dystonia
298527|NCT01671527|Control|control
298528|NCT01671527|Healthy|healthy
298529|NCT01671514|mitochondrial biogenesis|mitochondrial biogenesis
298530|NCT01671514|skeletal muscle|skeletal muscle
298531|NCT01671514|epicatechin|epicatechin
298533|NCT01671501|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
298534|NCT01671501|Alcoholism|alcoholism
298535|NCT01671501|Alcoholic Intoxication|alcoholic intoxication
298536|NCT01671501|Substance-Related Disorders|substance-related disorders
298537|NCT01671501|Intervention Studies|intervention studies
298538|NCT01671501|Primary Health Care|primary health care
298539|NCT01671501|therapy|therapy
298540|NCT01671501|prevention & control|prevention & control
298541|NCT01671488|Anal Cancer|anal cancer
298542|NCT01671488|Mitomycin|mitomycin
298543|NCT01671488|5-Fluorouracil|5-fluorouracil
298544|NCT01671488|5-FU|5-fu
298545|NCT01671488|IMRT|imrt
298546|NCT01671488|ADXS11-001|adxs11-001
298547|NCT01671475|Altered Mental Status|altered mental status
298548|NCT01671475|Non-convulsive seizure|non-convulsive seizure
298549|NCT01671475|Electroencephalography|electroencephalography
298550|NCT01671462|HPV|hpv
298551|NCT01671462|Cervical Cancer|cervical cancer
298552|NCT01671462|Cervical Neoplasms|cervical neoplasms
298553|NCT01671449|Gastric cancer|gastric cancer
298554|NCT01671449|S-1|s-1
298555|NCT01671449|Cisplatin|cisplatin
298556|NCT01671449|Oxaliplatin|oxaliplatin
298557|NCT01671436|Depression|depression
298558|NCT01671436|Guided Imagery|guided imagery
298559|NCT01671436|Psychotherapy|psychotherapy
298560|NCT01671436|Meditation|meditation
298561|NCT01671423|Cellulitis|cellulitis
298562|NCT01671423|Skin infection|skin infection
298563|NCT01671423|Prednisone|prednisone
298564|NCT01671423|Steroid|steroid
298565|NCT01671423|Anti-inflammatory|anti-inflammatory
298566|NCT01671410|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
298567|NCT01671410|buprenorphine|buprenorphine
298568|NCT01671410|morphine|morphine
298569|NCT01671410|benzodiazepine|benzodiazepine
298570|NCT01671397|Obesity|obesity
298571|NCT01671397|weight loss|weight loss
298572|NCT01671397|sleep hygiene|sleep hygiene
298573|NCT01671397|diet|diet
298574|NCT01671397|exercise|exercise
298575|NCT01671384|Valproate|valproate
298576|NCT01671384|levocarnitine|levocarnitine
298577|NCT01671384|SMA|sma
298578|NCT01671384|physiotherapy|physiotherapy
298579|NCT01671384|placebo|placebo
298580|NCT01671371|syncope|syncope
298581|NCT01671371|point of care|point of care
298582|NCT01671371|ultrasound|ultrasound
298583|NCT01671371|echocardiography|echocardiography
298584|NCT01671358|MRSA|mrsa
298585|NCT01671358|Contamination|contamination
298586|NCT01671358|Isolation|isolation
298587|NCT01671332|Carcinoma, non small cell lung|carcinoma, non small cell lung
298588|NCT01671332|Second line|second line
298589|NCT01671332|Third line|third line
298590|NCT01671319|breast cancer|breast cancer
298592|NCT01671319|women|women
298593|NCT01671319|adjuvant|adjuvant
298594|NCT01671306|Coronary collaterals|coronary collaterals
298595|NCT01671306|diabetes mellitus|diabetes mellitus
298596|NCT01671306|monocyte subsets|monocyte subsets
298597|NCT01671280|pneumonia|pneumonia
298598|NCT01671280|pelvic inflammatory disease|pelvic inflammatory disease
298599|NCT01671280|Zithromax|zithromax
298600|NCT01671280|Zithromac|zithromac
298601|NCT01671280|Japanese|japanese
298602|NCT01671280|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
298603|NCT01671228|dialysis|dialysis
298604|NCT01671228|chronic kidney failure|chronic kidney failure
298605|NCT01671228|informed choice|informed choice
298606|NCT01671228|patient decision making|patient decision making
298607|NCT01671228|decision aid|decision aid
298608|NCT01671215|endometrium|endometrium
298609|NCT01671215|myometrium|myometrium
298610|NCT01671215|fibroids|fibroids
298611|NCT01671215|uterine malformations|uterine malformations
298612|NCT01671176|Wide diameter implant|wide diameter implant
298614|NCT01671176|Ponto|ponto
298615|NCT01671176|Bone anchored implant|bone anchored implant
298616|NCT01671163|Cancer|cancer
298617|NCT01671163|Radiation therapy|radiation therapy
298618|NCT01671163|Fiducial markers|fiducial markers
298619|NCT01671150|inflammation|inflammation
298620|NCT01671150|depression|depression
298621|NCT01671150|social cognition|social cognition
298622|NCT01671150|neural activity|neural activity
298623|NCT01671137|Lactobacillus GG|lactobacillus gg
298624|NCT01671137|Functional Abdominal Pain|functional abdominal pain
298625|NCT01671137|Children|children
298627|NCT01671137|Gastroenteritis|gastroenteritis
298628|NCT01671124|TG|tg
298629|NCT01671124|TC|tc
298630|NCT01671124|HDL|hdl
298631|NCT01671124|LDL|ldl
298632|NCT01671124|Albumin|albumin
298633|NCT01671124|Hemoglobin|hemoglobin
298634|NCT01671124|Hematocrit|hematocrit
298635|NCT01671124|Uric acid|uric acid
298636|NCT01671124|Sodium|sodium
298637|NCT01671124|Potassium|potassium
298638|NCT01671124|Calcium|calcium
298639|NCT01671098|nitric oxide|nitric oxide
298640|NCT01671098|sinuplasty|sinuplasty
298641|NCT01671072|Chondrocyte cells|chondrocyte cells
298642|NCT01671072|Osteoarthritis|osteoarthritis
298643|NCT01671072|Gene therapy|gene therapy
298644|NCT01671033|Panic disorder|panic disorder
298645|NCT01671033|cognitive behavior therapy|cognitive behavior therapy
298646|NCT01671033|Internet|internet
298647|NCT01671020|fimasartan|fimasartan
298648|NCT01671020|absolute bioavailability|absolute bioavailability
298649|NCT01670994|cancer|cancer
298650|NCT01670994|immunotherapy|immunotherapy
298651|NCT01670994|immunochemotherapy|immunochemotherapy
298652|NCT01670994|targeted|targeted
298653|NCT01670994|metastatic|metastatic
298654|NCT01670994|interleukin-2|interleukin-2
298655|NCT01670994|antitumor|antitumor
298656|NCT01670994|TCR|tcr
298657|NCT01670994|T-cell receptor|t-cell receptor
298658|NCT01670994|p53|p53
298659|NCT01670994|p53 gene|p53 gene
298660|NCT01670994|p53 tumor supressor protein|p53 tumor supressor protein
298661|NCT01670994|HLA-A2 positive|hla-a2 positive
298662|NCT01670994|HLA-A*0201/p53 aa264-272|hla-a*0201/p53 aa264-272
298663|NCT01670994|HLA complex|hla complex
298664|NCT01670994|multiple myeloma|multiple myeloma
298665|NCT01670994|IFN-γ and TNF-α|ifn-γ and tnf-α
298666|NCT01670994|refractory|refractory
298667|NCT01670994|relapsed|relapsed
298668|NCT01670981|Ischemic dilated cardiomyopathy|ischemic dilated cardiomyopathy
298669|NCT01670981|Heart failure|heart failure
298670|NCT01670981|ixCELL|ixcell
298671|NCT01670981|ixCELL DCM|ixcell dcm
298672|NCT01670981|IDCM|idcm
298673|NCT01670981|DCM|dcm
298674|NCT01670981|stem cells|stem cells
298675|NCT01670981|MSC|msc
298676|NCT01670981|cell therapy|cell therapy
298677|NCT01670955|Anemia|anemia
298678|NCT01670955|preoperative|preoperative
298679|NCT01670955|gynecological patients|gynecological patients
298680|NCT01670955|Sorghum bicolor|sorghum bicolor
298681|NCT01670955|Packed Cells Volume|packed cells volume
298682|NCT01670942|pneumothorax|pneumothorax
298683|NCT01670942|trauma|trauma
298684|NCT01670942|commercial air travel|commercial air travel
298685|NCT01670929|recurrent miscarriages|recurrent miscarriages
298686|NCT01670929|progesterone|progesterone
298687|NCT01670916|Necrotizing enterocolitis|necrotizing enterocolitis
298688|NCT01670916|Probiotics|probiotics
298689|NCT01670916|Preterm|preterm
298690|NCT01670916|Infant|infant
298691|NCT01670890|temozolomide(TMZ)|temozolomide(tmz)
298692|NCT01670890|cisplatin(CDDP)|cisplatin(cddp)
298693|NCT01670890|recurrent malignant gliomas|recurrent malignant gliomas
298694|NCT01670851|eLAPE,|elape,
298695|NCT01670851|perineum,|perineum,
298696|NCT01670851|pelvic floor reconstruction|pelvic floor reconstruction
298697|NCT01670838|subarachnoid haemorrhage|subarachnoid haemorrhage
298698|NCT01670838|cardiopulmonary complications|cardiopulmonary complications
298699|NCT01670825|Occipital neuralgia|occipital neuralgia
298700|NCT01670825|corticosteroid injection|corticosteroid injection
298701|NCT01670825|pulsed radiofrequency|pulsed radiofrequency
298702|NCT01670812|chronic lymphocytic leukemia|chronic lymphocytic leukemia
298703|NCT01670812|ultra-high risk|ultra-high risk
298704|NCT01670812|fresh frozen plasma|fresh frozen plasma
298705|NCT01670812|methylprednisolone|methylprednisolone
298706|NCT01670812|rituximab|rituximab
298707|NCT01670799|Ketorolac|ketorolac
298708|NCT01670799|Bioavailability|bioavailability
298710|NCT01670760|Deep Tissue Temperature|deep tissue temperature
298711|NCT01670760|Zero Heat Flux Thermometry|zero heat flux thermometry
298712|NCT01670760|Thermometry|thermometry
298713|NCT01670760|Core Temperature|core temperature
298714|NCT01670708|Substance Use|substance use
298715|NCT01670708|Illicit Drug Use|illicit drug use
298716|NCT01670708|Criminal Behavior|criminal behavior
298717|NCT01670695|IgG4-related disease|igg4-related disease
298718|NCT01670695|IgG4-RD|igg4-rd
298719|NCT01670682|Stage III|stage iii
298720|NCT01670643|AMD|amd
298721|NCT01670643|vision rehabilitation|vision rehabilitation
298722|NCT01670643|video camera magnifier|video camera magnifier
298723|NCT01670643|IVI|ivi
298724|NCT01670643|DASS|dass
298725|NCT01670630|speculum|speculum
298726|NCT01670630|vagina|vagina
298727|NCT01670630|cervix|cervix
298728|NCT01670630|examination|examination
298729|NCT01670578|P.R.P.|p.r.p.
298730|NCT01670578|viscosupplementation|viscosupplementation
298731|NCT01670578|double-blind randomized|double-blind randomized
298732|NCT01670578|intra-articular injections|intra-articular injections
298733|NCT01670578|knee degenerative pathology|knee degenerative pathology
298734|NCT01670578|early osteoarthritis|early osteoarthritis
298735|NCT01670565|Diffuse cutaneous systemic sclerosis|diffuse cutaneous systemic sclerosis
298736|NCT01670565|Early Diffuse cutaneous systemic sclerosis|early diffuse cutaneous systemic sclerosis
298737|NCT01670539|Lung Cancer|lung cancer
298738|NCT01670539|Telemonitoring|telemonitoring
298739|NCT01670539|Rural|rural
298740|NCT01670539|Nursing|nursing
298741|NCT01670526|Traumatic Brain Injury|traumatic brain injury
298742|NCT01670526|Cognitive Impairment|cognitive impairment
298743|NCT01670526|Rivastigmine|rivastigmine
298744|NCT01670526|Pharmacologic Actions|pharmacologic actions
298745|NCT01670526|TBI|tbi
298746|NCT01670526|Memory|memory
298747|NCT01670526|Cholinesterase Inhibitors|cholinesterase inhibitors
298748|NCT01670526|Cognition|cognition
298749|NCT01670526|Head Trauma|head trauma
298750|NCT01670513|Psoriasis|psoriasis
298751|NCT01670500|germline mutation|germline mutation
298752|NCT01670500|BRCA1 mutation|brca1 mutation
298753|NCT01670500|BRCA2 mutation|brca2 mutation
298754|NCT01670487|Vapocoolant|vapocoolant
298755|NCT01670474|Temporary hemodialysis catheters|temporary hemodialysis catheters
298756|NCT01670474|Non-cuffed hemodialysis catheters|non-cuffed hemodialysis catheters
298757|NCT01670474|Thrombolysis|thrombolysis
298758|NCT01670474|rt-PA|rt-pa
298759|NCT01670474|Thrombosis|thrombosis
298760|NCT01670474|Lifespan|lifespan
298761|NCT01670474|Blood flow rate|blood flow rate
298762|NCT01670474|Catheter related bacteriemia|catheter related bacteriemia
298763|NCT01670461|advance care planning, palliative care, pediatric|advance care planning, palliative care, pediatric
298764|NCT01670448|Postoperative pain|postoperative pain
298765|NCT01670448|Chronic pain prevention|chronic pain prevention
298766|NCT01670448|Regional anesthesia|regional anesthesia
298767|NCT01670448|Mastectomy|mastectomy
298768|NCT01670435|Ciprofloxacin|ciprofloxacin
298769|NCT01670435|sepsis|sepsis
298770|NCT01670435|infection|infection
298771|NCT01670435|pneumonia|pneumonia
298772|NCT01670435|peritonitis|peritonitis
298773|NCT01670435|cholecystitis|cholecystitis
298774|NCT01670435|cholangitis|cholangitis
298775|NCT01670435|anthrax|anthrax
298776|NCT01670422|CSOJ|csoj
298777|NCT01670422|recurrence|recurrence
298778|NCT01670422|life-threatening complications|life-threatening complications
298779|NCT01670422|risk factors|risk factors
298780|NCT01670409|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
298781|NCT01670409|SMART|smart
298782|NCT01670409|IMRT|imrt
298783|NCT01670409|Chemotherapy|chemotherapy
298784|NCT01670396|coronary stent implant|coronary stent implant
298785|NCT01670396|polymorphism|polymorphism
298786|NCT01670396|G protein|g protein
298787|NCT01670396|drug-eluting stent|drug-eluting stent
298788|NCT01670396|restenosis|restenosis
298789|NCT01670383|Cardiac Arrest|cardiac arrest
298790|NCT01670383|Sepsis|sepsis
298791|NCT01670383|Biological Markers|biological markers
298792|NCT01670383|Anti-Inflammation Agents|anti-inflammation agents
298793|NCT01670383|Antioxidants|antioxidants
298794|NCT01670370|Rituximab|rituximab
298795|NCT01670370|Gemcitabine|gemcitabine
298796|NCT01670370|Oxaliplatin|oxaliplatin
298797|NCT01670370|aggressive B cell lymphoma|aggressive b cell lymphoma
298798|NCT01670357|Dry Eye Syndrome|dry eye syndrome
298799|NCT01670318|Chronic total occlusion|chronic total occlusion
298800|NCT01670318|Bifurcation lesion|bifurcation lesion
298801|NCT01670318|Left main trunk lesion|left main trunk lesion
298802|NCT01670318|Small vessel disease|small vessel disease
298803|NCT01670318|Multi vessel disease|multi vessel disease
298804|NCT01670292|Low Back Pain|low back pain
298805|NCT01670279|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
298806|NCT01670266|ONO-9054|ono-9054
298807|NCT01670266|ocular hypertension|ocular hypertension
298808|NCT01670266|OHT|oht
298809|NCT01670266|Open angle-glaucoma|open angle-glaucoma
298810|NCT01670266|OAG|oag
298811|NCT01670266|Glaucoma|glaucoma
298812|NCT01670266|Eye diseases|eye diseases
298813|NCT01670240|IPAA|ipaa
298814|NCT01670240|Pouchitis|pouchitis
298815|NCT01670240|Ulcerative colitis|ulcerative colitis
298816|NCT01670240|Pouch|pouch
298817|NCT01670240|Adalimumab|adalimumab
298818|NCT01670240|Humira|humira
298819|NCT01670227|EARLY CHILDHOOD|early childhood
298820|NCT01670227|UNIVERSAL PREVENTION|universal prevention
298821|NCT01670214|RM|rm
298822|NCT01670214|R-CM|r-cm
298823|NCT01670214|based on ICHD-2 criteria|based on ichd-2 criteria
298824|NCT01670188|Pneumatic sequential compression device (SCD)|pneumatic sequential compression device (scd)
298825|NCT01670188|Peripherally Inserted Central Catheters (PICC)|peripherally inserted central catheters (picc)
298826|NCT01670175|Histologic verification of solid tumor, including lymphomas|histologic verification of solid tumor, including lymphomas
298827|NCT01670175|Original diagnosis or relapse|original diagnosis or relapse
298828|NCT01670162|Pigment Epithelium of Eye|pigment epithelium of eye
298829|NCT01670162|Wet macular degeneration|wet macular degeneration
298830|NCT01670162|Macular degeneration|macular degeneration
298831|NCT01670149|Clostridium difficile|clostridium difficile
298833|NCT01670149|Rifaximin|rifaximin
298834|NCT01670136|sildenafil|sildenafil
298835|NCT01670136|preterm infants|preterm infants
298836|NCT01670136|persistent pulmonary hypertension of the newborn|persistent pulmonary hypertension of the newborn
298837|NCT01670123|Mobile phone|mobile phone
298838|NCT01670123|electronic intervention|electronic intervention
298839|NCT01670123|behavioral intervention|behavioral intervention
298840|NCT01670123|telehealth|telehealth
298841|NCT01670123|bipolar disorder|bipolar disorder
298842|NCT01670110|Polycystic Liver Disease|polycystic liver disease
298843|NCT01670110|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
298844|NCT01670110|Autosomal dominant polycystic liver disease|autosomal dominant polycystic liver disease
299653|NCT01666496|video games|video games
298845|NCT01670110|Somatostatin analogs|somatostatin analogs
298846|NCT01670110|Pasireotide LAR|pasireotide lar
298847|NCT01670110|SOM230|som230
298848|NCT01670097|Advanced Cancers|advanced cancers
298849|NCT01670097|Hematologic Disorder|hematologic disorder
298850|NCT01670097|Solid Tumors|solid tumors
298851|NCT01670097|Dyspnea|dyspnea
298852|NCT01670097|Difficulty breathing|difficulty breathing
298853|NCT01670097|Shortness of breath|shortness of breath
298854|NCT01670097|Dexamethasone|dexamethasone
298855|NCT01670097|Decadron|decadron
298856|NCT01670097|Placebo|placebo
298857|NCT01670097|Sugar pill|sugar pill
298858|NCT01670097|Questionnaires|questionnaires
298859|NCT01670097|Surveys|surveys
298860|NCT01670097|Spirometer|spirometer
298861|NCT01670097|Phone calls|phone calls
298862|NCT01670071|Schizophrenia|schizophrenia
298863|NCT01670071|Paliperidone|paliperidone
298864|NCT01670071|Risperidone|risperidone
298865|NCT01670071|Paliperidone extended-release (ER)|paliperidone extended-release (er)
298866|NCT01670071|Risperidone immediate-release (IR)|risperidone immediate-release (ir)
298867|NCT01670019|Depression|depression
298868|NCT01670019|Antidepressant|antidepressant
298869|NCT01670019|Antipsychotic|antipsychotic
298870|NCT01668953|Lateral Epicondylitis|lateral epicondylitis
298871|NCT01668953|Tennis Elbow|tennis elbow
298872|NCT01668953|Platelet Rich Plasma|platelet rich plasma
298873|NCT01668953|Whole Blood|whole blood
298874|NCT01668953|Tendon Fenestration|tendon fenestration
298875|NCT01669993|Outcomes|outcomes
298876|NCT01669993|Quality improvement|quality improvement
298877|NCT01669993|Patient Safety|patient safety
298878|NCT01669993|PACU|pacu
298879|NCT01669993|Complications|complications
298880|NCT01669993|Adverse events|adverse events
298881|NCT01669993|Respiratory arrest|respiratory arrest
298882|NCT01669993|Pain|pain
298883|NCT01669993|PONV|ponv
298885|NCT01669993|Neonate|neonate
298886|NCT01669993|Infant|infant
298887|NCT01669993|Child|child
298888|NCT01669993|Ambulatory|ambulatory
298889|NCT01669993|Inpatient|inpatient
298890|NCT01669993|General Anesthesia|general anesthesia
298891|NCT01669993|Otolaryngology|otolaryngology
298892|NCT01669993|Tonsillectomy|tonsillectomy
298893|NCT01669993|Obstructive sleep apnea|obstructive sleep apnea
298894|NCT01669980|Infections|infections
298895|NCT01669980|Pediatrics|pediatrics
298896|NCT01669980|Teflaro|teflaro
298897|NCT01669980|Ceftriaxone|ceftriaxone
298898|NCT01669980|cephalosporin|cephalosporin
298899|NCT01669980|Vancomycin|vancomycin
298900|NCT01669980|Clindamycin|clindamycin
298901|NCT01669980|Amoxicillin Clavulanate|amoxicillin clavulanate
298902|NCT01669980|Linezolid|linezolid
298903|NCT01669980|MRSA|mrsa
298904|NCT01669980|pneumonia|pneumonia
298905|NCT01669954|HIV|hiv
298906|NCT01669954|Bone mineral density|bone mineral density
298907|NCT01669954|Osteoporosis|osteoporosis
298908|NCT01669954|Vitamin D|vitamin d
298909|NCT01669954|Fractures|fractures
298910|NCT01669941|Pregnancy|pregnancy
298911|NCT01669941|Plasmodium|plasmodium
298912|NCT01669941|Malaria|malaria
298913|NCT01669941|Prevention|prevention
298914|NCT01669941|Kenya|kenya
298915|NCT01669941|Piperaquine|piperaquine
298916|NCT01669941|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
298917|NCT01669941|Sulfadoxine Pyrimethamine|sulfadoxine pyrimethamine
298918|NCT01669876|Randomized|randomized
298919|NCT01669876|Double-Blind|double-blind
298920|NCT01669876|Dietary Supplements|dietary supplements
298921|NCT01669863|ARDS|ards
298922|NCT01669850|Chronic kidney disease|chronic kidney disease
298923|NCT01669850|Arteriovenous fistula|arteriovenous fistula
298924|NCT01669850|Surgical anastomosis|surgical anastomosis
298925|NCT01669850|Complications|complications
298926|NCT01669850|Patency|patency
298927|NCT01669850|Dialysis access|dialysis access
298928|NCT01669837|Inguinal hernia|inguinal hernia
298929|NCT01669837|Laparoscopy|laparoscopy
298930|NCT01669837|Surgical tissue glue|surgical tissue glue
298931|NCT01669811|Refractory Reflux Esophagitis,|refractory reflux esophagitis,
298932|NCT01669811|Japanese,|japanese,
298933|NCT01669811|Nexium,|nexium,
298934|NCT01669811|twice daily,|twice daily,
298935|NCT01669811|oral administration|oral administration
298936|NCT01669798|Recurrent epithelial ovarian carcinoma|recurrent epithelial ovarian carcinoma
298937|NCT01669798|Persistent epithelial ovarian carcinoma|persistent epithelial ovarian carcinoma
298938|NCT01669798|Bevacizumab resistant epithelial ovarian carcinoma|bevacizumab resistant epithelial ovarian carcinoma
298939|NCT01669746|Androgenetic Alopecia|androgenetic alopecia
289494|NCT01711164|HCV|hcv
298940|NCT01669746|Male Pattern Baldness|male pattern baldness
298941|NCT01669746|Female Pattern Baldness|female pattern baldness
298942|NCT01669746|Hair Loss|hair loss
298943|NCT01669746|Baldness|baldness
298944|NCT01669733|Breast Surgery|breast surgery
298945|NCT01669733|Breast Biopsy|breast biopsy
298946|NCT01669733|Music Therapy|music therapy
298947|NCT01669720|Metastatic|metastatic
298948|NCT01669720|Colorectal|colorectal
298949|NCT01669720|Colorectal Cancer|colorectal cancer
299052|NCT01669213|spinal anesthesia|spinal anesthesia
298950|NCT01669720|Resected or Ablated Metastatic Colorectal Cancer|resected or ablated metastatic colorectal cancer
298951|NCT01669707|Endostar|endostar
298952|NCT01669707|advanced Non-small cell lung cancer|advanced non-small cell lung cancer
298953|NCT01669707|Continued Pumping into vein|continued pumping into vein
298954|NCT01669707|Gemcitabine|gemcitabine
298955|NCT01669707|Carboplatin|carboplatin
298956|NCT01669694|Pelvic Pain|pelvic pain
298957|NCT01669694|Pelvic Floor Physical Therapy|pelvic floor physical therapy
298958|NCT01669694|Biomarkers|biomarkers
298959|NCT01669681|Severe asthma|severe asthma
298960|NCT01669681|Medical economic|medical economic
298961|NCT01669681|care|care
298962|NCT01669681|Cost efficiency|cost efficiency
298963|NCT01669681|CPAM|cpam
298964|NCT01669681|EQ5D|eq5d
298965|NCT01669642|ketamine sedation|ketamine sedation
298966|NCT01669642|pediatric|pediatric
298967|NCT01669642|abscess drainage|abscess drainage
298968|NCT01669642|fracture reduction|fracture reduction
298969|NCT01669616|Type 2 Diabetes|type 2 diabetes
298970|NCT01669616|Adults 18 years and older|adults 18 years and older
298971|NCT01669603|Common cold|common cold
298972|NCT01669577|predictors|predictors
298973|NCT01669577|trauma|trauma
298974|NCT01669577|mortality|mortality
298975|NCT01669564|Quality of Life|quality of life
298976|NCT01669564|Tobacco Use Cessation|tobacco use cessation
298977|NCT01669564|Physical Activity|physical activity
298978|NCT01669538|Galantamine|galantamine
298979|NCT01669538|Nicotine Bitartrate|nicotine bitartrate
298980|NCT01669538|Nicotine Tartrate|nicotine tartrate
298981|NCT01669538|Nicotine dependence|nicotine dependence
298982|NCT01669538|Tobacco Dependence|tobacco dependence
298983|NCT01669512|Malaria vaccine|malaria vaccine
298984|NCT01669512|Matrix M|matrix m
298985|NCT01669499|Bone metastases, radiotherapy, dexamethasone, pain flare|bone metastases, radiotherapy, dexamethasone, pain flare
298986|NCT01669486|Pain|pain
298987|NCT01669486|ICU|icu
298988|NCT01669486|Mechanical ventilation|mechanical ventilation
298989|NCT01669486|CPOT|cpot
298990|NCT01669486|BPS|bps
298991|NCT01669473|Diabetes|diabetes
298992|NCT01669447|dmri, mnvc, lucentis|dmri, mnvc, lucentis
298993|NCT01669434|Perioperative Period|perioperative period
298994|NCT01669421|Alpha 1|alpha 1
298995|NCT01669408|ischemic stroke|ischemic stroke
298996|NCT01669408|hemorrhagic stroke|hemorrhagic stroke
298997|NCT01669408|prehospital cooling|prehospital cooling
298998|NCT01669408|induction of cooling|induction of cooling
298999|NCT01669408|ambulance|ambulance
299000|NCT01669408|emergency room|emergency room
299001|NCT01669408|cold infusions|cold infusions
299002|NCT01669408|hypothermia|hypothermia
299003|NCT01669408|normothermia|normothermia
299004|NCT01669395|Severe heart failure|severe heart failure
705719|NCT00986323|Asthma|asthma
299005|NCT01669395|Homebased rehabilitation|homebased rehabilitation
299006|NCT01669395|Physical exercise|physical exercise
299007|NCT01669395|Activities of daily living|activities of daily living
299008|NCT01669395|Intersectoral Cooperation|intersectoral cooperation
299009|NCT01669382|AngioSeal, ExoSeal, PCI, puncture site|angioseal, exoseal, pci, puncture site
299010|NCT01669369|Lithium Carbonate|lithium carbonate
299011|NCT01669369|Chemotherapy|chemotherapy
299012|NCT01669369|prognosis|prognosis
299013|NCT01669356|malnutrition|malnutrition
299014|NCT01669356|parenteral supplement|parenteral supplement
299015|NCT01669356|rest metabolic rate|rest metabolic rate
299016|NCT01669356|postoperative complications|postoperative complications
299017|NCT01669343|Aromatase Inhibitors|aromatase inhibitors
299018|NCT01669330|Gastroesophageal Reflux|gastroesophageal reflux
299019|NCT01669330|Fundoplication|fundoplication
299020|NCT01669330|Surgical Procedures|surgical procedures
299021|NCT01669317|Cherry Juice Pilot|cherry juice pilot
299022|NCT01669304|migraine variant|migraine variant
299023|NCT01669304|chronic dizziness|chronic dizziness
299024|NCT01669304|pharmacologic dissection|pharmacologic dissection
299025|NCT01669278|sheath|sheath
299026|NCT01669278|flexible|flexible
299027|NCT01669278|endoscopy|endoscopy
299028|NCT01669278|otolaryngology|otolaryngology
299029|NCT01669278|office|office
299030|NCT01669265|Breast cancer|breast cancer
299031|NCT01669265|OSNA|osna
299032|NCT01669265|sentinel lymph node|sentinel lymph node
299033|NCT01669252|Breast cancer|breast cancer
299034|NCT01669252|Eribulin|eribulin
299035|NCT01669252|Neoadjuvant|neoadjuvant
299036|NCT01669252|PAM50|pam50
299037|NCT01669252|Triple-negative|triple-negative
299038|NCT01669252|Luminal A|luminal a
299039|NCT01669252|Luminal B|luminal b
299040|NCT01669239|Breast Cancer|breast cancer
299041|NCT01669239|HER2 positive|her2 positive
299042|NCT01669239|Neoadjuvant|neoadjuvant
299043|NCT01669239|Liposomal doxorubicin|liposomal doxorubicin
299044|NCT01669239|Paclitaxel|paclitaxel
299045|NCT01669239|Trastuzumab|trastuzumab
299046|NCT01669239|Pertuzumab|pertuzumab
299047|NCT01669239|Safety|safety
299048|NCT01669226|Ovarian Cancer|ovarian cancer
299049|NCT01669226|intraperitoneal chemotherapy|intraperitoneal chemotherapy
299050|NCT01669213|5-HT3 receptor antagonist|5-ht3 receptor antagonist
299053|NCT01669174|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
299054|NCT01669174|COPD; cachexia; muscle wasting|copd; cachexia; muscle wasting
299055|NCT01669161|Upper|upper
299056|NCT01669161|Limb|limb
299057|NCT01669161|Deficits|deficits
299058|NCT01669161|Rehabilitation|rehabilitation
299060|NCT01669148|breast cancer|breast cancer
299061|NCT01669148|imaging|imaging
299062|NCT01669135|cerebral oximetry|cerebral oximetry
299063|NCT01669135|cesarean delivery|cesarean delivery
299064|NCT01669109|Yoga|yoga
299065|NCT01669109|Colorectal Neoplasms|colorectal neoplasms
299066|NCT01669109|Quality of Life|quality of life
299067|NCT01669109|Randomized Controlled Trial|randomized controlled trial
299068|NCT01669096|adults|adults
299069|NCT01669096|healthy|healthy
299070|NCT01669096|Tuberculosis vaccine|tuberculosis vaccine
299071|NCT01669096|mRNA expression|mrna expression
299072|NCT01669096|HIV negative|hiv negative
299073|NCT01669083|Oxytocin Antagonist|oxytocin antagonist
299074|NCT01669083|Embryo/Blastocyst Implantation|embryo/blastocyst implantation
299075|NCT01669070|bioavailability|bioavailability
299076|NCT01669070|Fluticasone Furoate|fluticasone furoate
299077|NCT01669070|pharmacokinetics|pharmacokinetics
299078|NCT01669070|dose proportionality|dose proportionality
299079|NCT01669057|Congenital heart disease|congenital heart disease
299080|NCT01669057|DNA variation|dna variation
299081|NCT01669057|methylation|methylation
299082|NCT01669057|risk factors|risk factors
299083|NCT01669057|supplements|supplements
299084|NCT01669031|automated perimetry|automated perimetry
299085|NCT01669031|visual fields|visual fields
299086|NCT01669031|reliability|reliability
299087|NCT01669031|vision tests/standards|vision tests/standards
299088|NCT01669031|randomized controlled trial|randomized controlled trial
299089|NCT01669031|false positive reactions|false positive reactions
299090|NCT01669031|false negative reactions|false negative reactions
299091|NCT01669031|fixation, ocular|fixation, ocular
299092|NCT01669031|mean deviation|mean deviation
299093|NCT01669031|variability|variability
299094|NCT01669031|program|program
299095|NCT01669031|software|software
299096|NCT01669031|glaucoma/diagnosis|glaucoma/diagnosis
299097|NCT01669031|visual field tests/methods|visual field tests/methods
299098|NCT01669031|aged|aged
299099|NCT01669031|humans|humans
299100|NCT01669031|female|female
299101|NCT01669031|male|male
299102|NCT01669031|prospective studies|prospective studies
299103|NCT01669031|reproducibility of results|reproducibility of results
299104|NCT01669005|neutropenia|neutropenia
299105|NCT01669005|multiplex PCR|multiplex pcr
299106|NCT01669005|infection|infection
299107|NCT01668992|Parenting|parenting
299108|NCT01668992|Discipline|discipline
299109|NCT01668992|Family interventions|family interventions
299110|NCT01668992|Thailand|thailand
299111|NCT01668992|Migration|migration
299112|NCT01668940|Morning Sickness|morning sickness
299113|NCT01668940|Lillipops Iced Soothies|lillipops iced soothies
299114|NCT01668940|Pregnancy|pregnancy
299115|NCT01668940|Obstetrics|obstetrics
299116|NCT01668914|Breast Cancer|breast cancer
299117|NCT01668914|Clinically Axillary Node -Positive|clinically axillary node -positive
299118|NCT01668914|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
299119|NCT01668914|Internal Mammary|internal mammary
299120|NCT01668901|warfarin|warfarin
299122|NCT01668875|head down postural drainage|head down postural drainage
299123|NCT01668849|Plant exosomes|plant exosomes
299124|NCT01668849|Grape exosomes|grape exosomes
299125|NCT01668849|Grape extract|grape extract
299126|NCT01668849|Oral mucositis|oral mucositis
299127|NCT01668849|Head and Neck Cancer|head and neck cancer
299128|NCT01668849|Immune response|immune response
299129|NCT01668836|sirtuin|sirtuin
299130|NCT01668836|atherosclerosis|atherosclerosis
299131|NCT01668836|longevity|longevity
299132|NCT01668836|calorie restriction|calorie restriction
299133|NCT01668836|resveratrol|resveratrol
299134|NCT01668836|vascular reactivity|vascular reactivity
299135|NCT01668810|prescription|prescription
299136|NCT01668810|schizophrenia|schizophrenia
299137|NCT01668810|depression|depression
299138|NCT01668810|bipolar disorder|bipolar disorder
299140|NCT01668771|Affect|affect
299141|NCT01668771|Alcohol|alcohol
299142|NCT01668758|Near Infrared Spectroscopy|near infrared spectroscopy
299143|NCT01668758|Traumatic Brain Injury|traumatic brain injury
370498|NCT01366209|IPF|ipf
299144|NCT01668745|Child mortality|child mortality
299145|NCT01668745|Measles vaccine|measles vaccine
299146|NCT01668745|Non-specific effects|non-specific effects
299147|NCT01668693|Endometrial receptivity|endometrial receptivity
299148|NCT01668693|recurrent implantation failure|recurrent implantation failure
299149|NCT01668693|predictor tool|predictor tool
299151|NCT01668693|customized microarray|customized microarray
299152|NCT01668693|personalized embryo transfer|personalized embryo transfer
299153|NCT01668680|Metronomic Chemotherapy|metronomic chemotherapy
299154|NCT01668680|Anti-Angiogenic|anti-angiogenic
299155|NCT01668680|Maintenance Treatment|maintenance treatment
299156|NCT01668680|Colorectal Cancer Metastatic|colorectal cancer metastatic
299652|NCT01666496|HIV|hiv
299157|NCT01668667|gabapentin enacarbil|gabapentin enacarbil
299158|NCT01668667|Horizant|horizant
299159|NCT01668654|Epilepsy|epilepsy
299160|NCT01668654|Partial Onset epilepsy|partial onset epilepsy
299161|NCT01668654|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
299162|NCT01668654|Open-label extension study|open-label extension study
299163|NCT01668641|Methotrexate insufficient responders|methotrexate insufficient responders
299164|NCT01668628|quality of life|quality of life
299165|NCT01668628|depression|depression
299166|NCT01668628|BCM (body composition minitor)|bcm (body composition minitor)
299167|NCT01668628|hydrational status|hydrational status
299168|NCT01668615|idiopathicthrombocytopenic purpura|idiopathicthrombocytopenic purpura
299169|NCT01668615|all-trans retinoic acid|all-trans retinoic acid
299170|NCT01668615|regulory T cells|regulory t cells
299171|NCT01668576|mesenchymal stem cells|mesenchymal stem cells
299172|NCT01668576|Lung transplantation|lung transplantation
299173|NCT01668563|Aneurysm|aneurysm
299174|NCT01668563|Intracranial Aneurysm|intracranial aneurysm
299175|NCT01668563|Vascular Diseases|vascular diseases
299176|NCT01668563|Cardiovascular Diseases|cardiovascular diseases
299177|NCT01668563|Intracranial Arterial Diseases|intracranial arterial diseases
299178|NCT01668563|Cerebrovascular Disorders|cerebrovascular disorders
299179|NCT01668563|Brain Diseases|brain diseases
299180|NCT01668563|Central Nervous System Diseases|central nervous system diseases
299181|NCT01668563|Nervous System Diseases|nervous system diseases
299182|NCT01668550|Phase I|phase i
299183|NCT01668550|Src/Abl inhibitor|src/abl inhibitor
299184|NCT01668550|Solid Tumours|solid tumours
299185|NCT01668550|Cancer|cancer
299186|NCT01668511|Immunogenicity|immunogenicity
299187|NCT01668511|Safety|safety
299188|NCT01668511|Tolerability|tolerability
299189|NCT01668511|Osteoarthritis|osteoarthritis
299190|NCT01668511|Pharmacokinetics|pharmacokinetics
299191|NCT01668498|Can preemptive treatment of panitumumab mediated skin|can preemptive treatment of panitumumab mediated skin
299192|NCT01668498|toxicity with oral doxycycline be replaced by local treatment with erythromycin?|toxicity with oral doxycycline be replaced by local treatment with erythromycin?
299193|NCT01668498|Panitumumab|panitumumab
299194|NCT01668485|Type 1 diabetes mellitus|type 1 diabetes mellitus
299195|NCT01668485|hypoglycemia counterregulation,|hypoglycemia counterregulation,
299196|NCT01668485|pancreatic islet transplantation|pancreatic islet transplantation
299197|NCT01668472|Pregnant|pregnant
299198|NCT01668472|leaking fluid|leaking fluid
299199|NCT01668459|Transitional cell carcinoma|transitional cell carcinoma
299200|NCT01668459|Bladder cancer|bladder cancer
299201|NCT01668459|Cancer|cancer
299202|NCT01668459|Oncology|oncology
299203|NCT01668459|Cabazitaxel|cabazitaxel
299204|NCT01668446|Sildenafil|sildenafil
299205|NCT01668446|Endometrial thickness|endometrial thickness
299206|NCT01668446|Frozen embryo transfer|frozen embryo transfer
299207|NCT01668446|ultrasonographic endometrial thickness|ultrasonographic endometrial thickness
299208|NCT01668446|endometrial pattern|endometrial pattern
299209|NCT01668446|Implantation rate|implantation rate
299210|NCT01668446|chemical pregnancy rate|chemical pregnancy rate
299211|NCT01668433|G6PD|g6pd
299212|NCT01668433|Primaquine|primaquine
299213|NCT01668433|Methylene blue|methylene blue
299214|NCT01668420|thermal stimulation|thermal stimulation
299215|NCT01668420|lower extremity|lower extremity
299216|NCT01668420|temperature|temperature
299217|NCT01668420|efficacy|efficacy
299218|NCT01668407|Parkinson's disease|parkinson's disease
299219|NCT01668407|PSP|psp
299220|NCT01668407|Robot|robot
299221|NCT01668407|Gait rehabilitation|gait rehabilitation
299222|NCT01668381|hepatocellular carcinoma|hepatocellular carcinoma
299223|NCT01668381|Catheter Ablation|catheter ablation
299224|NCT01668381|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
299225|NCT01668381|IL-10|il-10
299226|NCT01668381|TGF-β|tgf-β
299227|NCT01668381|IFN-γ|ifn-γ
299228|NCT01668368|ARDS|ards
299229|NCT01668368|Esophageal pressure|esophageal pressure
299230|NCT01668368|pleural pressure|pleural pressure
299231|NCT01668368|pulmonary compliance|pulmonary compliance
299232|NCT01668355|Delivery of Healthcare|delivery of healthcare
298884|NCT01669993|Age|age
299233|NCT01668355|Health Services Research|health services research
299234|NCT01668355|Integrated Healthcare Systems|integrated healthcare systems
752602|NCT01173276|Sperm Washing|sperm washing
299235|NCT01668355|Healthcare Quality, Access, and Evaluation|healthcare quality, access, and evaluation
299236|NCT01668329|Septic shock|septic shock
299237|NCT01668329|Inflammatory process|inflammatory process
299238|NCT01668329|Cytokines|cytokines
299239|NCT01668329|Hormonal response|hormonal response
299240|NCT01668329|Oxydative stress|oxydative stress
299241|NCT01668316|Overweight|overweight
299242|NCT01668316|Obese|obese
299243|NCT01668316|Postpartum|postpartum
299244|NCT01668316|Weight loss|weight loss
299245|NCT01668316|Inflammation|inflammation
299246|NCT01668316|Obesity|obesity
299247|NCT01668316|Cardiovascular|cardiovascular
299248|NCT01668303|juvenile drug court|juvenile drug court
299249|NCT01668303|adolescents|adolescents
299250|NCT01668303|substance abuse|substance abuse
299251|NCT01668303|delinquency|delinquency
299252|NCT01668303|family therapy|family therapy
299253|NCT01668303|multidimensional family therapy|multidimensional family therapy
299254|NCT01668290|Coronary Artery Disease|coronary artery disease
299255|NCT01668290|Stress Echocardiography|stress echocardiography
299256|NCT01668290|Single Photon Emission Computed Tomography|single photon emission computed tomography
299257|NCT01668290|Cardiac Computed Tomographic Angiography|cardiac computed tomographic angiography
299258|NCT01668290|outcomes|outcomes
299259|NCT01668277|Pulmonary Hypertensive Crisis|pulmonary hypertensive crisis
299260|NCT01668277|Pediatrics|pediatrics
299261|NCT01668277|Hypertonic Saline|hypertonic saline
299262|NCT01668264|Pediatrics|pediatrics
299263|NCT01668264|Congenital Heart Disease|congenital heart disease
299264|NCT01668264|Diastolic Function|diastolic function
299265|NCT01668264|Echocardiograph|echocardiograph
299266|NCT01668264|MRI|mri
299267|NCT01668251|Turner syndrome|turner syndrome
299268|NCT01668251|Diagnosis, prenatal|diagnosis, prenatal
299269|NCT01668238|Thyroid tumor|thyroid tumor
299270|NCT01668238|Breast tumor|breast tumor
299271|NCT01668238|Fourier Transform Infrared Spectrometry|fourier transform infrared spectrometry
299272|NCT01668238|Tumor Diagnosis|tumor diagnosis
299273|NCT01668186|Peroxisome biogenesis disorders|peroxisome biogenesis disorders
299274|NCT01668186|PBD|pbd
299275|NCT01668186|Zellweger spectrum|zellweger spectrum
299276|NCT01668186|Rhizomelic chondrodysplasia punctata|rhizomelic chondrodysplasia punctata
299277|NCT01668186|RCDP|rcdp
299278|NCT01668173|HSP90 Inhibitor|hsp90 inhibitor
299279|NCT01668173|AUY922|auy922
299280|NCT01668173|12-076|12-076
299281|NCT01668160|clinical outcomes|clinical outcomes
299282|NCT01668160|radiographic outcomes|radiographic outcomes
299283|NCT01668160|total hip arthroplasty|total hip arthroplasty
299284|NCT01668160|survivorship|survivorship
299285|NCT01668147|PET Imaging|pet imaging
299286|NCT01668147|Efavirenz|efavirenz
299287|NCT01668147|Ritonavior|ritonavior
299288|NCT01668147|[11C] desmethyl-loperamide|[11c] desmethyl-loperamide
299289|NCT01668147|Healthy volunteers|healthy volunteers
299290|NCT01668108|carcinoma|carcinoma
299291|NCT01668108|breast cancer|breast cancer
299292|NCT01668108|non-small cell lung cancer|non-small cell lung cancer
299293|NCT01668108|ovarial cancer|ovarial cancer
299294|NCT01668108|ambulant chemotherapy|ambulant chemotherapy
299295|NCT01668108|treatment cycles|treatment cycles
299296|NCT01668108|Paclitaxel|paclitaxel
299297|NCT01668108|Paclitaxel onkovis|paclitaxel onkovis
299298|NCT01668108|Quantity of Paclitaxel|quantity of paclitaxel
299299|NCT01668108|Packaging Sizes|packaging sizes
299300|NCT01668082|Patients with newly identified brain mass|patients with newly identified brain mass
299302|NCT01668069|vomiting|vomiting
299303|NCT01668069|pregnancy|pregnancy
299304|NCT01668069|ondansetron|ondansetron
299305|NCT01668069|doxylamine|doxylamine
299306|NCT01668069|vitamin B6|vitamin b6
299307|NCT01668069|pyridoxine|pyridoxine
299308|NCT01668056|in vitro fertilization|in vitro fertilization
299309|NCT01668056|ovarian stimulation|ovarian stimulation
299310|NCT01668056|follicular waves|follicular waves
299311|NCT01668056|luteal phase|luteal phase
299312|NCT01668043|HIV-1|hiv-1
299313|NCT01668043|CD4|cd4
299314|NCT01668043|antibody|antibody
299315|NCT01668043|immunotherapy|immunotherapy
299316|NCT01668030|Facial|facial
299317|NCT01668030|Partial thickness|partial thickness
299318|NCT01668017|Advanced solid tumors|advanced solid tumors
299319|NCT01668017|Hepatocellular carcinoma|hepatocellular carcinoma
299320|NCT01668017|cancer, liver|cancer, liver
299321|NCT01667991|Colonization|colonization
299322|NCT01667991|infection|infection
299323|NCT01667991|multidrug-resistant bacteria|multidrug-resistant bacteria
299324|NCT01667991|guideline|guideline
299325|NCT01667978|contraception|contraception
299326|NCT01667978|mini pill|mini pill
299327|NCT01667978|norethindrone|norethindrone
299328|NCT01667978|atazanavir|atazanavir
299329|NCT01667978|ritonavir|ritonavir
299330|NCT01667978|norvir|norvir
299331|NCT01667978|reyataz|reyataz
299332|NCT01667978|pregnancy prevent|pregnancy prevent
299333|NCT01667978|birth control|birth control
299334|NCT01667978|HIV|hiv
299335|NCT01667978|AIDS|aids
299337|NCT01667978|antiretroviral|antiretroviral
299338|NCT01667965|palliative radiation|palliative radiation
299339|NCT01667965|12-172|12-172
299340|NCT01667952|Family History Questionnaire (FHQ)|family history questionnaire (fhq)
299341|NCT01667952|Blood sample|blood sample
299342|NCT01667952|Salvia sample|salvia sample
299343|NCT01667952|12-145|12-145
299344|NCT01667939|adequacy|adequacy
299345|NCT01667939|diet|diet
299346|NCT01667939|pregnancy|pregnancy
299347|NCT01667913|Hip Fracture|hip fracture
299348|NCT01667913|6-minutes walking test|6-minutes walking test
299349|NCT01667913|Reliability|reliability
299350|NCT01667887|Far Cortical Locking|far cortical locking
299351|NCT01667887|Distal Femur Fracture|distal femur fracture
299352|NCT01667887|Locking Plate|locking plate
299353|NCT01667887|MotionLoc|motionloc
299354|NCT01667887|Fracture Fixation|fracture fixation
299355|NCT01667874|Randomized controlled trial|randomized controlled trial
299356|NCT01667874|early joint infection|early joint infection
299357|NCT01667874|gentamicin impregnated sponges|gentamicin impregnated sponges
299358|NCT01667861|Glaucoma|glaucoma
299359|NCT01667861|Wind instruments|wind instruments
299360|NCT01667848|pain|pain
299361|NCT01667835|yoga|yoga
299362|NCT01667835|postmenopausal, sedentary South Asian women|postmenopausal, sedentary south asian women
299363|NCT01667796|Multiple sclerosis|multiple sclerosis
299364|NCT01667796|Healthy controls|healthy controls
299365|NCT01667796|Pharmacokinetics|pharmacokinetics
299366|NCT01667796|Vitamin D|vitamin d
299367|NCT01667783|Obesity|obesity
299368|NCT01667783|Diabetes|diabetes
299369|NCT01667757|coronary atherosclerosis|coronary atherosclerosis
299370|NCT01667757|drug eluting stent|drug eluting stent
299371|NCT01667757|intravascular ultrasound|intravascular ultrasound
299372|NCT01667757|fractional flow reserve|fractional flow reserve
299373|NCT01667744|Angina|angina
299374|NCT01667744|Acute Coronary Syndrome|acute coronary syndrome
299375|NCT01667744|Emotional Distress|emotional distress
299376|NCT01667744|Citalopram|citalopram
299377|NCT01667744|Health Care Utilization|health care utilization
299378|NCT01667731|Hepatitis C|hepatitis c
299379|NCT01667731|Chronic|chronic
299380|NCT01667731|HCV|hcv
299381|NCT01667731|HIV|hiv
299382|NCT01667731|Human Immunodeficiency Virus|human immunodeficiency virus
299383|NCT01667731|Co-Infected|co-infected
299384|NCT01667718|eradication|eradication
299385|NCT01667718|helicobacter pylori|helicobacter pylori
299386|NCT01667718|bismuth|bismuth
299387|NCT01667705|Stress|stress
299388|NCT01667705|Anxiety|anxiety
299389|NCT01667705|Skyceiling|skyceiling
299390|NCT01667705|Nature|nature
299391|NCT01667692|H-pylori|h-pylori
299392|NCT01667692|eradication|eradication
299393|NCT01667692|azithromycin|azithromycin
299394|NCT01667692|clarithromycin|clarithromycin
299395|NCT01667679|Migraine|migraine
299396|NCT01667679|Headaches|headaches
299397|NCT01667679|Sumatriptan|sumatriptan
299398|NCT01667666|trauma|trauma
299399|NCT01667666|acute lung injury|acute lung injury
299400|NCT01667666|adult respiratory distress syndrome|adult respiratory distress syndrome
299401|NCT01667640|Brain metastases|brain metastases
299402|NCT01667640|radiation|radiation
299403|NCT01667640|sector|sector
299404|NCT01667640|singular|singular
299405|NCT01667640|solitary|solitary
299406|NCT01667640|neurocognition|neurocognition
299407|NCT01667627|IBS|ibs
299408|NCT01667627|Probiotic|probiotic
299409|NCT01667627|hs-CRP|hs-crp
299410|NCT01667627|Cholinergic status|cholinergic status
299411|NCT01667627|Micro-inflammation|micro-inflammation
299412|NCT01667601|mindfulness-based program|mindfulness-based program
299413|NCT01667601|Psychoeducation|psychoeducation
299414|NCT01667601|schizophrenia|schizophrenia
299415|NCT01667601|Chinese|chinese
299416|NCT01667601|outpatients|outpatients
299417|NCT01667588|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
299418|NCT01667588|Pediatrics|pediatrics
299419|NCT01667588|Sleep Disorders|sleep disorders
299420|NCT01667549|Breastfeeding|breastfeeding
299421|NCT01667549|Flavor learning|flavor learning
299422|NCT01667549|Mother|mother
299423|NCT01667549|Moms|moms
299424|NCT01667549|Infants|infants
299425|NCT01667549|Babies|babies
299426|NCT01667549|Baby|baby
299427|NCT01667549|Food Habits|food habits
299428|NCT01667549|Fruits|fruits
299429|NCT01667549|Vegetables|vegetables
299430|NCT01667536|PROSTATE CANCER|prostate cancer
299431|NCT01667536|HIGH-RISK|high-risk
299432|NCT01667536|PROSTATECTOMY SURGERY|prostatectomy surgery
299433|NCT01667536|NEWLY DIAGNOSED|newly diagnosed
299434|NCT01667523|capsaicin|capsaicin
299435|NCT01667523|cinnamaldehyde|cinnamaldehyde
299436|NCT01667510|Prehypertension|prehypertension
299437|NCT01667510|anti oxidation|anti oxidation
299438|NCT01667510|lycopene|lycopene
299439|NCT01667497|Cognitive fatigue|cognitive fatigue
299440|NCT01667497|multiple sclerosis|multiple sclerosis
299441|NCT01667484|Cognitive Impairment|cognitive impairment
299442|NCT01667484|Multiple Sclerosis|multiple sclerosis
299443|NCT01667484|Processing Speed|processing speed
299444|NCT01667484|Treatment|treatment
299445|NCT01667445|total knee arthroplasty|total knee arthroplasty
299446|NCT01667445|epimorph|epimorph
299447|NCT01667445|analgesia|analgesia
299448|NCT01667406|kisspeptin|kisspeptin
299449|NCT01667406|infertility|infertility
299450|NCT01667406|in vitro fertilisation|in vitro fertilisation
299451|NCT01667354|Parental Childhood Vaccine Hesitancy|parental childhood vaccine hesitancy
299452|NCT01667341|HSV|hsv
299453|NCT01667341|Herpes|herpes
299454|NCT01667341|genital infection|genital infection
299455|NCT01667341|vaccine|vaccine
299456|NCT01667328|Anxiety|anxiety
299457|NCT01667328|Presurgical anxiety|presurgical anxiety
299458|NCT01667328|Breast Cancer|breast cancer
299459|NCT01667302|NK/T-cell lymphoma|nk/t-cell lymphoma
299460|NCT01667302|Radiotherapy|radiotherapy
299461|NCT01667302|Adjuvant chemotherapy|adjuvant chemotherapy
299462|NCT01667289|NK/T-cell lymphoma|nk/t-cell lymphoma
299463|NCT01667289|Methotrexate|methotrexate
299464|NCT01667289|Radiotherapy|radiotherapy
299465|NCT01667289|Concurrent chemoradiation|concurrent chemoradiation
299466|NCT01667276|AE adverse event|ae adverse event
299467|NCT01667276|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
299468|NCT01667276|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
299469|NCT01667276|ART antiretroviral therapy|art antiretroviral therapy
299470|NCT01667276|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
299471|NCT01667276|DCF data collection forms|dcf data collection forms
299472|NCT01667276|DMC Data Monitoring Committee|dmc data monitoring committee
299473|NCT01667276|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
299474|NCT01667276|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
299475|NCT01667276|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
299476|NCT01667276|ICH International Conference of Harmonisation|ich international conference of harmonisation
299477|NCT01667276|IND Investigational New Drug Application|ind investigational new drug application
299478|NCT01667276|IRB Institutional Review Board|irb institutional review board
299479|NCT01667276|IU international units|iu international units
299480|NCT01667276|mg milligram(s)|mg milligram(s)
299481|NCT01667276|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
299482|NCT01667276|PCR polymerase chain reaction|pcr polymerase chain reaction
299483|NCT01667276|SAE serious adverse event|sae serious adverse event
299484|NCT01667276|µg microgram|µg microgram
299485|NCT01667276|ULN upper limit of the normal range|uln upper limit of the normal range
299486|NCT01667276|WB Western Blot|wb western blot
299487|NCT01667263|All-trans retinoic acid|all-trans retinoic acid
299488|NCT01667263|primary immune thrombocytopenia|primary immune thrombocytopenia
299489|NCT01667263|corticosteroid-resistant|corticosteroid-resistant
299490|NCT01667263|refractory|refractory
299491|NCT01667263|danazol|danazol
299492|NCT01667250|vagus nerve stimulation|vagus nerve stimulation
299493|NCT01667250|vagal nerve stimulation|vagal nerve stimulation
299494|NCT01667250|nVNS|nvns
299496|NCT01667250|chronic migraine|chronic migraine
299497|NCT01667250|migraine|migraine
299498|NCT01667250|non invasive|non invasive
299499|NCT01667250|gammacore|gammacore
299500|NCT01667237|Pulmonary rehabilitation program|pulmonary rehabilitation program
299501|NCT01667237|Lung cancer|lung cancer
299502|NCT01667237|Lung resection surgery|lung resection surgery
299503|NCT01667237|Home-based|home-based
299504|NCT01667224|Actiponin|actiponin
299505|NCT01667224|Obesity|obesity
299506|NCT01667224|Abdominal fat|abdominal fat
299507|NCT01667211|Advanced uterine cervical cancer|advanced uterine cervical cancer
299508|NCT01667185|pediatric|pediatric
299509|NCT01667185|diabetes mellitus|diabetes mellitus
299510|NCT01667159|Depression|depression
299511|NCT01667159|Alcohol Use|alcohol use
299512|NCT01667159|Outpatient Therapy|outpatient therapy
299513|NCT01667133|Leukemia|leukemia
299514|NCT01667133|Leukemia, Myeloid|leukemia, myeloid
299515|NCT01667133|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
299516|NCT01667133|Neoplasms by Histologic Type|neoplasms by histologic type
299517|NCT01667133|Neoplasms|neoplasms
299518|NCT01667133|Lymphoproliferative Disorders|lymphoproliferative disorders
299519|NCT01667133|Lymphatic Diseases|lymphatic diseases
299520|NCT01667133|Immunoproliferative Disorders|immunoproliferative disorders
299521|NCT01667133|Immune System Diseases|immune system diseases
299522|NCT01667133|Myeloproliferative Disorders|myeloproliferative disorders
299523|NCT01667133|Bone Marrow Diseases|bone marrow diseases
299524|NCT01667133|Hematologic Diseases|hematologic diseases
299525|NCT01667120|Ketorolac|ketorolac
299526|NCT01667120|postoperative pain|postoperative pain
299527|NCT01667120|bleeding events|bleeding events
299528|NCT01667094|Pulmonary exacerbation|pulmonary exacerbation
299529|NCT01667094|Continuous infusion|continuous infusion
299530|NCT01667094|Antipseudomonal beta-lactams|antipseudomonal beta-lactams
299531|NCT01667068|Cardiac Diseases|cardiac diseases
299532|NCT01667068|HIV-Infection|hiv-infection
299533|NCT01667068|AIDS|aids
299534|NCT01667068|Antiretroviral Therapy|antiretroviral therapy
299535|NCT01667068|Cardiovascular Medication|cardiovascular medication
290277|NCT01707628|NHL|nhl
299536|NCT01667068|Risk Factors|risk factors
299537|NCT01667068|coronary heart disease|coronary heart disease
299538|NCT01667068|heart failure|heart failure
299539|NCT01667068|metabolic syndrome|metabolic syndrome
299540|NCT01667055|drug allergy|drug allergy
299541|NCT01667055|drug hypersensitivity|drug hypersensitivity
299542|NCT01667055|beta-lactam allergy|beta-lactam allergy
299543|NCT01667055|penicillin allergy|penicillin allergy
299544|NCT01667055|adverse drug reaction|adverse drug reaction
299545|NCT01667042|Scleroderma Lung|scleroderma lung
299546|NCT01667042|Gastroesophageal Reflux|gastroesophageal reflux
299547|NCT01667042|Microaspiration|microaspiration
299548|NCT01667042|Cough|cough
299549|NCT01667016|International|international
299550|NCT01667016|Multicenter|multicenter
299551|NCT01667016|Observational registry|observational registry
299552|NCT01667016|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
299553|NCT01667016|Stenting|stenting
299554|NCT01667016|Treatment of Coronary Artery Disease|treatment of coronary artery disease
299555|NCT01667016|Coronary revascularization|coronary revascularization
299556|NCT01667016|Percutaneous Coronary Intervention|percutaneous coronary intervention
299557|NCT01667016|STEMI|stemi
299558|NCT01667016|NSTEMI|nstemi
299559|NCT01667016|Ischemia|ischemia
299560|NCT01667016|Angina|angina
299561|NCT01667016|Subgroups|subgroups
299562|NCT01667016|Acute Myocardial Infarction|acute myocardial infarction
299563|NCT01667016|Diabetes|diabetes
299564|NCT01667016|Small Vessels|small vessels
299565|NCT01667016|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
299566|NCT01667003|International|international
299567|NCT01667003|Multicenter|multicenter
299568|NCT01667003|Observational registry|observational registry
299569|NCT01667003|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
299570|NCT01667003|Stenting|stenting
299571|NCT01667003|Treatment of Coronary Artery Disease|treatment of coronary artery disease
299572|NCT01667003|Coronary revascularization|coronary revascularization
299573|NCT01667003|Percutaneous Coronary Intervention|percutaneous coronary intervention
299574|NCT01667003|STEMI|stemi
299575|NCT01667003|NSTEMI|nstemi
299576|NCT01667003|Ischemia|ischemia
299577|NCT01667003|Angina|angina
299578|NCT01667003|Subgroups|subgroups
299579|NCT01667003|Acute Myocardial Infarction|acute myocardial infarction
299580|NCT01667003|Diabetes|diabetes
299581|NCT01667003|Small Vessels|small vessels
299582|NCT01666990|Tripterygium wilfordii Hook F (TwHF)|tripterygium wilfordii hook f (twhf)
299583|NCT01666990|HIV|hiv
299584|NCT01666990|CD4|cd4
299585|NCT01666990|immune over-activation|immune over-activation
299586|NCT01666964|Traumatic brain injury|traumatic brain injury
299587|NCT01666964|hypopituitarism|hypopituitarism
299588|NCT01666938|Diabetes Mellitus|diabetes mellitus
299589|NCT01666938|Telephone|telephone
299590|NCT01666938|Physical activity|physical activity
299591|NCT01666912|adolescence|adolescence
299592|NCT01666912|contraception|contraception
299593|NCT01666912|postpartum|postpartum
299594|NCT01666912|rapid repeat pregnancy|rapid repeat pregnancy
299595|NCT01666873|osteoarthritis|osteoarthritis
299596|NCT01666860|anterior lumbar interbody fusion|anterior lumbar interbody fusion
299597|NCT01666847|Umbilical Cord Milking|umbilical cord milking
299598|NCT01666847|Extremely Low Birth Weight Infant (ELBW)|extremely low birth weight infant (elbw)
402026|NCT01233414|Noncompliance|noncompliance
299599|NCT01666834|mechanical ventilation, ARDS, Ventilator strategy, outcome|mechanical ventilation, ards, ventilator strategy, outcome
299600|NCT01666821|macular degeneration; choroidal neovascularization|macular degeneration; choroidal neovascularization
299601|NCT01666782|Influenza vaccine|influenza vaccine
299602|NCT01666782|Oncology|oncology
299603|NCT01666782|Chemotherapy|chemotherapy
299604|NCT01666769|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
299605|NCT01666769|ECMO|ecmo
299606|NCT01666769|Extracorporeal life support|extracorporeal life support
299607|NCT01666769|Micafungin|micafungin
299608|NCT01666769|Mycamine|mycamine
299609|NCT01666769|Pharmacokinetics|pharmacokinetics
299610|NCT01666743|Community-Acquired Pneumonia|community-acquired pneumonia
299611|NCT01666743|Lung|lung
299612|NCT01666743|Adult|adult
299613|NCT01666743|Infections|infections
299614|NCT01666691|Obese|obese
299615|NCT01666691|Obesity|obesity
299616|NCT01666691|Overweight|overweight
299617|NCT01666691|Weight loss|weight loss
299618|NCT01666691|Weight reduction|weight reduction
299619|NCT01666691|Beloranib|beloranib
299620|NCT01666678|Bioequivalence|bioequivalence
299621|NCT01666665|Burn|burn
299622|NCT01666652|Dengue|dengue
299623|NCT01666652|Dengue fever|dengue fever
299624|NCT01666652|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
299625|NCT01666652|Flavivirus|flavivirus
299626|NCT01666626|crohn's disease|crohn's disease
299627|NCT01666626|ultrasound|ultrasound
299628|NCT01666626|intestinal fibrosis|intestinal fibrosis
299629|NCT01666626|shear wave imaging|shear wave imaging
299630|NCT01666626|acoustic radiation force impulse|acoustic radiation force impulse
299631|NCT01666613|Phase I, Healthy volunteers, pharmacokinetics|phase i, healthy volunteers, pharmacokinetics
299632|NCT01666613|Bioavailability|bioavailability
299633|NCT01666613|AUC|auc
299634|NCT01666548|haemolytic uraemic syndrome|haemolytic uraemic syndrome
299635|NCT01666548|complications of HUS|complications of hus
299636|NCT01666548|renal replacement treatment|renal replacement treatment
299637|NCT01666548|renal function outcome|renal function outcome
299638|NCT01666548|neuropsychological sequelae|neuropsychological sequelae
299639|NCT01666548|psychological adjustment|psychological adjustment
299640|NCT01666548|quality of life|quality of life
299641|NCT01666535|Influenza vaccine|influenza vaccine
299642|NCT01666535|Immune response|immune response
299643|NCT01666535|Remicade (infliximab)|remicade (infliximab)
299644|NCT01666535|Inflammatory bowel disease|inflammatory bowel disease
299645|NCT01666522|sarcopenia|sarcopenia
299646|NCT01666522|osteopenia/osteoporosis|osteopenia/osteoporosis
299647|NCT01666522|older adults|older adults
299648|NCT01666522|vitamin D supplementation|vitamin d supplementation
299649|NCT01666522|physical activity|physical activity
299650|NCT01666496|Adolescent|adolescent
299651|NCT01666496|risk|risk
299654|NCT01666483|hysterectomy|hysterectomy
299655|NCT01666483|single-port|single-port
299656|NCT01666483|micro-laparoscopy|micro-laparoscopy
299657|NCT01666470|Quality of life|quality of life
299658|NCT01666457|Supporting Oral Feeding in Fragile Infants (SOFFI)|supporting oral feeding in fragile infants (soffi)
299659|NCT01666457|Infant Oral Feeding|infant oral feeding
299660|NCT01666457|Infant Growth|infant growth
299661|NCT01666457|Preterm infant oral feeding|preterm infant oral feeding
299662|NCT01666457|Preterm infant growth|preterm infant growth
299663|NCT01666457|Neonatal Intensive Care Unit (NICU)|neonatal intensive care unit (nicu)
299664|NCT01666444|recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
299665|NCT01666444|recurrent fallopian tube cancer|recurrent fallopian tube cancer
299666|NCT01666444|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
299667|NCT01666444|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
299668|NCT01666444|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
299669|NCT01666444|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
299670|NCT01666444|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
299671|NCT01666444|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
299672|NCT01666444|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
299673|NCT01666444|Brenner tumor|brenner tumor
299674|NCT01666405|Fecal Incontinence|fecal incontinence
299675|NCT01666405|Bowel Incontinence|bowel incontinence
299676|NCT01666392|Omega-3 fatty acid|omega-3 fatty acid
299677|NCT01666392|Fish oil|fish oil
299678|NCT01666392|Muscle mass|muscle mass
299679|NCT01666392|Muscle strength|muscle strength
299680|NCT01666392|Older adults|older adults
299681|NCT01666392|Circulating inflammatory cytokines|circulating inflammatory cytokines
299682|NCT01666392|Skeletal muscle mass|skeletal muscle mass
299683|NCT01666392|Upper body strength|upper body strength
299684|NCT01666392|Lower body strength|lower body strength
299685|NCT01666379|Hallux valgus|hallux valgus
299686|NCT01666379|Forefoot|forefoot
299687|NCT01666379|transdermal fentanyl|transdermal fentanyl
299688|NCT01666340|Exercise|exercise
299689|NCT01666340|Elderly|elderly
299690|NCT01666340|Mortality|mortality
299691|NCT01666340|Morbidity|morbidity
299692|NCT01666340|Prognosis|prognosis
299693|NCT01666340|Longevity|longevity
299694|NCT01666327|Crohn's Disease|crohn's disease
299695|NCT01666327|Ulcerative Colitis|ulcerative colitis
299696|NCT01666314|castrate resistant prostate cancer,|castrate resistant prostate cancer,
299697|NCT01666314|CRPC,|crpc,
299698|NCT01666314|orteronel,|orteronel,
299699|NCT01666314|TAK-700|tak-700
299700|NCT01666301|Erythropoietin stimulating agents|erythropoietin stimulating agents
299701|NCT01666301|Hemoglobin|hemoglobin
299702|NCT01666301|Reticulocytes|reticulocytes
299703|NCT01666301|Variability|variability
299704|NCT01666262|FLU|flu
299705|NCT01666262|H1N1|h1n1
299706|NCT01666262|GPO|gpo
299707|NCT01666262|PLAIV|plaiv
299708|NCT01666249|FMH; anti-Rh; efficacy|fmh; anti-rh; efficacy
299709|NCT01666236|Age-Related Macular Degeneration|age-related macular degeneration
299710|NCT01666236|Pigment Epithelial Detachment|pigment epithelial detachment
299711|NCT01666236|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
299712|NCT01666223|Type 2 diabetes|type 2 diabetes
299713|NCT01666223|GLP-1|glp-1
299714|NCT01666223|Bile acid|bile acid
299715|NCT01666223|TGR-5|tgr-5
299716|NCT01666197|Acute Joint Pain|acute joint pain
299717|NCT01666184|Biomarkers study|biomarkers study
299718|NCT01666171|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
299719|NCT01666171|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
299720|NCT01666171|stage IB breast cancer|stage ib breast cancer
299721|NCT01666171|stage II breast cancer|stage ii breast cancer
299722|NCT01666171|stage IIIA breast cancer|stage iiia breast cancer
299723|NCT01666171|stage IIIC breast cancer|stage iiic breast cancer
299724|NCT01666145|Hepatocellular Cancer|hepatocellular cancer
299725|NCT01666145|Hepatocellular Carcinoma|hepatocellular carcinoma
299726|NCT01666145|Hepatoma|hepatoma
299727|NCT01666145|Liver Cancer, Adult|liver cancer, adult
299728|NCT01666145|Liver Cell Carcinoma, Adult|liver cell carcinoma, adult
299729|NCT01666132|LVEF < 40%|lvef < 40%
299730|NCT01666119|Opioid dependence|opioid dependence
299731|NCT01666119|Suboxone|suboxone
299732|NCT01666119|addiction|addiction
299733|NCT01666119|BEMA Buprenorphine NX|bema buprenorphine nx
299734|NCT01666119|oral transmucosal|oral transmucosal
299735|NCT01666093|peripheral artery disease|peripheral artery disease
299736|NCT01666093|endovascular procedure|endovascular procedure
299737|NCT01666093|non-healing ulcer|non-healing ulcer
299738|NCT01666080|second stem cell transplant|second stem cell transplant
299739|NCT01666080|donor hematopoietic engraftment|donor hematopoietic engraftment
299740|NCT01666080|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
299741|NCT01666080|inherited metabolic disorder|inherited metabolic disorder
299742|NCT01666067|insulin resistance|insulin resistance
299743|NCT01666054|Weaning|weaning
299744|NCT01666054|mechanical ventilation|mechanical ventilation
299745|NCT01666054|Proportional Assist Ventilation|proportional assist ventilation
299746|NCT01666041|insulin resistance|insulin resistance
299747|NCT01666028|Type 1 Diabetes|type 1 diabetes
299748|NCT01666028|Closed Loop glucose control|closed loop glucose control
299749|NCT01666028|Artificial Pancreas|artificial pancreas
299750|NCT01666028|CSII|csii
299752|NCT01666015|pediatric|pediatric
299753|NCT01666015|exercise|exercise
299754|NCT01666015|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
299755|NCT01666015|cancer|cancer
299756|NCT01666015|quality of life|quality of life
299757|NCT01666015|immune system|immune system
299758|NCT01666015|physical activity levels|physical activity levels
299759|NCT01665937|liver cancer|liver cancer
299760|NCT01665937|advanced liver cancer|advanced liver cancer
299761|NCT01665937|advanced hepatocellular cancer|advanced hepatocellular cancer
299762|NCT01665911|Caries|caries
299763|NCT01665898|cold biopsy forceps|cold biopsy forceps
299764|NCT01665898|cold snare biopsy|cold snare biopsy
299765|NCT01665885|hypothermia|hypothermia
299766|NCT01665885|induction of hypothermia|induction of hypothermia
299767|NCT01665885|non invasive cooling|non invasive cooling
299768|NCT01665885|external cooling|external cooling
299769|NCT01665885|surface cooling|surface cooling
299770|NCT01665885|endovascular cooling|endovascular cooling
299771|NCT01665885|cooling catheter|cooling catheter
299772|NCT01665885|stroke|stroke
299773|NCT01665885|shivering|shivering
299774|NCT01665885|neuro monitoring|neuro monitoring
299775|NCT01665885|coagulation|coagulation
299776|NCT01665872|Mothers|mothers
299777|NCT01665872|Depression|depression
299778|NCT01665872|Stress|stress
299779|NCT01665872|Trauma|trauma
299780|NCT01665872|Public Housing|public housing
299781|NCT01665859|readmission|readmission
299782|NCT01665859|recurrence|recurrence
299783|NCT01665859|umbilical|umbilical
299784|NCT01665859|epigastric|epigastric
299785|NCT01665859|hernia|hernia
299786|NCT01665859|outcome|outcome
299787|NCT01665859|morbidity|morbidity
299788|NCT01665846|HIV associated neurocognitive disorders|hiv associated neurocognitive disorders
299789|NCT01665846|MRI|mri
299790|NCT01665846|Ferumoxytol|ferumoxytol
299791|NCT01665833|Angina|angina
299792|NCT01665833|SYNTAX|syntax
299793|NCT01665833|Coronary|coronary
299794|NCT01665833|PCI|pci
299795|NCT01665833|CABG|cabg
299796|NCT01665820|chest|chest
299797|NCT01665820|pathology|pathology
299798|NCT01665807|influenza|influenza
299799|NCT01665807|vaccine|vaccine
299800|NCT01665807|administration|administration
299801|NCT01665781|Hemoglobin|hemoglobin
299802|NCT01665781|Erythropoietin|erythropoietin
299803|NCT01665781|Acute Mountain sickness|acute mountain sickness
299804|NCT01665742|Obesity|obesity
299805|NCT01665742|Chronic inflammation|chronic inflammation
299806|NCT01665742|Anti-inflammatory dietary intervention|anti-inflammatory dietary intervention
299807|NCT01665742|Genetic susceptibility|genetic susceptibility
299808|NCT01665729|etiology|etiology
299809|NCT01665729|pathogenesis|pathogenesis
299810|NCT01665729|minor ischaemic stroke|minor ischaemic stroke
299811|NCT01665729|types|types
299812|NCT01665729|intervention|intervention
299813|NCT01665703|[18F]|[18f]
299814|NCT01665703|Fluorodeoxyglucose Positron Emission Tomography-Magnetic Resonance Imaging|fluorodeoxyglucose positron emission tomography-magnetic resonance imaging
299815|NCT01665703|FDG-PET-MRI|fdg-pet-mri
299816|NCT01665703|Renal Cell Carcinoma|renal cell carcinoma
299817|NCT01665703|Pilot Study|pilot study
299818|NCT01665703|LCCC 1213|lccc 1213
299819|NCT01665703|UNC Lineberger|unc lineberger
299820|NCT01665690|patient delivered partner therapy|patient delivered partner therapy
299821|NCT01665690|expedited partner therapy|expedited partner therapy
299822|NCT01665690|partner notification|partner notification
371365|NCT01362803|NF1|nf1
290429|NCT01707056|tea|tea
299823|NCT01665690|gonorrhea|gonorrhea
299824|NCT01665690|chlamydia|chlamydia
299825|NCT01665677|Graft vs Host Disease|graft vs host disease
299826|NCT01665677|GVHD|gvhd
299827|NCT01665677|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
299828|NCT01665677|HSCT|hsct
299829|NCT01665677|Atorvastatin|atorvastatin
299830|NCT01665664|Indirect calorimetry|indirect calorimetry
299831|NCT01665664|hypocaloric feeding|hypocaloric feeding
299832|NCT01665638|Healthy|healthy
299833|NCT01665638|Clearance|clearance
299834|NCT01665638|Canagliflozin|canagliflozin
299835|NCT01665638|JNJ-28431754|jnj-28431754
299836|NCT01665638|Placebo|placebo
299837|NCT01665638|Somatostatin|somatostatin
299838|NCT01665638|C-peptide|c-peptide
299839|NCT01665625|Pancreatic cancer|pancreatic cancer
299840|NCT01665625|Intra-arterial infusion|intra-arterial infusion
299841|NCT01665625|Gemcitabine|gemcitabine
299842|NCT01665612|Contact lens|contact lens
299843|NCT01665612|Care solution|care solution
299844|NCT01665612|MPDS|mpds
299845|NCT01665612|comfort|comfort
299846|NCT01665586|dexmedetomidine|dexmedetomidine
299847|NCT01665586|sedation in elderly patient|sedation in elderly patient
299848|NCT01665586|spinal anesthesia|spinal anesthesia
299849|NCT01665573|Fear Conditioning|fear conditioning
299850|NCT01665573|Cannabinoids|cannabinoids
299851|NCT01665573|Fear Response|fear response
299852|NCT01665560|smoking|smoking
299853|NCT01665560|fMRI|fmri
299854|NCT01665560|odors|odors
299855|NCT01665560|taste|taste
299856|NCT01665547|clomiphene resistant|clomiphene resistant
299857|NCT01665547|pcos|pcos
299858|NCT01665547|induction of ovulation|induction of ovulation
299859|NCT01665547|l-carnitine|l-carnitine
299860|NCT01665534|hypertension|hypertension
299861|NCT01665534|inflammation|inflammation
299862|NCT01665534|salt intake|salt intake
299863|NCT01665521|Acute Coronary Syndrome|acute coronary syndrome
299864|NCT01665521|Chest pain|chest pain
299865|NCT01665521|Risk Stratification|risk stratification
299866|NCT01665521|HEART Pathway|heart pathway
299867|NCT01665521|Emergency Department|emergency department
299868|NCT01665508|angina|angina
299869|NCT01665508|cardiopulmonary testing|cardiopulmonary testing
299870|NCT01665508|metabolomics|metabolomics
299871|NCT01665508|nebivolol|nebivolol
299872|NCT01665495|pericardial effusion|pericardial effusion
299873|NCT01665495|cardiac tamponade|cardiac tamponade
299874|NCT01665495|pericardiocentesis|pericardiocentesis
299875|NCT01665495|pericardial drainage|pericardial drainage
299876|NCT01665495|prevention|prevention
299877|NCT01665482|Inflammation|inflammation
299878|NCT01665482|Insulin sensitivity|insulin sensitivity
299879|NCT01665482|Interleukin-6 (IL-6)|interleukin-6 (il-6)
299880|NCT01665482|C-peptide|c-peptide
299881|NCT01665482|Saturated fatty acid (SFA)|saturated fatty acid (sfa)
299882|NCT01665482|Monounsaturated fatty acid (MUFA)|monounsaturated fatty acid (mufa)
299883|NCT01665482|Carbohydrate (CARB)|carbohydrate (carb)
299884|NCT01665469|anti oxidation|anti oxidation
299885|NCT01665469|lycopene|lycopene
299886|NCT01665469|Ox-LDL|ox-ldl
299887|NCT01665456|complications|complications
299888|NCT01665417|Icotinib|icotinib
299889|NCT01665417|EGFR positive mutation|egfr positive mutation
299890|NCT01665417|First-line treatment|first-line treatment
299891|NCT01665417|Maintenance treatment|maintenance treatment
299892|NCT01665378|prepregnancy|prepregnancy
299893|NCT01665378|micronutrient|micronutrient
299894|NCT01665378|supplementation|supplementation
299895|NCT01665378|maternal|maternal
299896|NCT01665378|child|child
299897|NCT01665378|health|health
299898|NCT01665365|Myocardial infarction|myocardial infarction
299899|NCT01665365|Remote ischemic conditioning|remote ischemic conditioning
299900|NCT01665365|Clinical outcome|clinical outcome
299901|NCT01665339|preload|preload
299902|NCT01665339|anthropometric measures|anthropometric measures
299903|NCT01665339|cardiovascular risk factors|cardiovascular risk factors
299904|NCT01665326|Pompe disease|pompe disease
299905|NCT01665326|Glycogen Storage Disease Type II|glycogen storage disease type ii
299906|NCT01665326|Acid Maltase Deficiency|acid maltase deficiency
299907|NCT01665326|CRIM Status|crim status
299908|NCT01665326|Acid Alpha-Glucosidase Deficiency|acid alpha-glucosidase deficiency
299909|NCT01665326|Alglucosidase alfa|alglucosidase alfa
299910|NCT01665326|Myozyme|myozyme
299911|NCT01665326|Enzyme replacement therapy|enzyme replacement therapy
299912|NCT01665326|Immune Tolerance Induction|immune tolerance induction
299913|NCT01665313|attention|attention
299914|NCT01665300|myocardial deformation imaging|myocardial deformation imaging
299915|NCT01665300|Trastuzumab|trastuzumab
299916|NCT01665287|Cerebral Oximetry|cerebral oximetry
299917|NCT01665287|Near infrared spectroscopy|near infrared spectroscopy
299918|NCT01665287|Fullterm|fullterm
299919|NCT01665287|Infant|infant
299920|NCT01665274|xelox|xelox
299921|NCT01665274|advanced gastric cancer|advanced gastric cancer
299922|NCT01665261|Congenital heart disease|congenital heart disease
299923|NCT01665261|Newborn|newborn
299924|NCT01665261|Pulse oximetry|pulse oximetry
299925|NCT01665261|Screening|screening
299926|NCT01665248|18-F Sodium Fluoride|18-f sodium fluoride
299927|NCT01665248|Acute coronary syndrome|acute coronary syndrome
299928|NCT01665248|Stable Angina|stable angina
299929|NCT01665196|IgG4-related disease|igg4-related disease
299930|NCT01665196|IgG4-RD|igg4-rd
299931|NCT01665196|18F-FDG|18f-fdg
299932|NCT01665196|PET/CT|pet/ct
299933|NCT01665183|argininosuccinate synthetase|argininosuccinate synthetase
299934|NCT01665183|arginine|arginine
299935|NCT01665183|arginine deiminase|arginine deiminase
299936|NCT01665170|Pascoflair|pascoflair
299937|NCT01665170|tsst|tsst
299938|NCT01665170|passiflora incarnata|passiflora incarnata
299939|NCT01665170|non smoking male|non smoking male
299940|NCT01665170|and female volunteers|and female volunteers
299941|NCT01665157|Diet Control before Colonoscopy|diet control before colonoscopy
299942|NCT01665144|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
299943|NCT01665118|Radio frequency|radio frequency
299944|NCT01665118|thigh|thigh
299945|NCT01665118|circumference|circumference
299946|NCT01665118|reduction|reduction
299947|NCT01665105|Pulse Rate Variability|pulse rate variability
299948|NCT01665105|Skin Blood Flow|skin blood flow
299949|NCT01665105|Skin Temperature|skin temperature
299950|NCT01665105|Electroacupuncture|electroacupuncture
299951|NCT01665105|Zusanli|zusanli
299952|NCT01665105|Yanglingquan|yanglingquan
299953|NCT01665079|anaesthetics iv|anaesthetics iv
299954|NCT01665079|propofol|propofol
299955|NCT01665079|pharmacokinetics|pharmacokinetics
299956|NCT01665079|pharmacodynamic|pharmacodynamic
299957|NCT01665053|Drug-Eluting Stents|drug-eluting stents
299958|NCT01665040|neurostimulation|neurostimulation
299959|NCT01665040|spinal cord stimulation|spinal cord stimulation
299960|NCT01665040|peripheral nerve stimulation|peripheral nerve stimulation
299961|NCT01665027|caesarean section,|caesarean section,
299962|NCT01665027|vacuum,|vacuum,
299963|NCT01665027|fetal head extraction,|fetal head extraction,
299964|NCT01665027|maternal complication,|maternal complication,
299965|NCT01665027|fetal complication|fetal complication
299966|NCT01665014|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
299967|NCT01665014|total marrow irradiation|total marrow irradiation
299968|NCT01665014|melphalan|melphalan
299969|NCT01665014|multiple myeloma|multiple myeloma
299970|NCT01665001|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
299971|NCT01665001|Induction|induction
299972|NCT01665001|Consolidation|consolidation
299973|NCT01665001|Minimal residual disease|minimal residual disease
299974|NCT01665001|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
299975|NCT01664975|Peripheral T-cell lymphoma;chemotherapy;|peripheral t-cell lymphoma;chemotherapy;
299976|NCT01664975|RR;PFS;OS|rr;pfs;os
299977|NCT01664936|18F-FDG PET/CT scan|18f-fdg pet/ct scan
299978|NCT01664936|131I therapy|131i therapy
299979|NCT01664936|Cerenkov Luminescence Imaging|cerenkov luminescence imaging
299980|NCT01664936|12-050|12-050
299981|NCT01664936|Lymphoma|lymphoma
299982|NCT01664936|Leukemia|leukemia
299983|NCT01664936|Metastatic Lymph Nodes|metastatic lymph nodes
299984|NCT01664923|prostate cancer|prostate cancer
299985|NCT01664923|enzalutamide|enzalutamide
299986|NCT01664923|MDV3100|mdv3100
299987|NCT01664910|Lymphoma|lymphoma
299988|NCT01664910|CD22 Positive-Lymphoid Malignancies|cd22 positive-lymphoid malignancies
299989|NCT01664910|Leukemia|leukemia
586554|NCT00516685|CANCER VACCINE|cancer vaccine
299990|NCT01664910|Allogeneic stem cell transplant|allogeneic stem cell transplant
299991|NCT01664910|CMC-544|cmc-544
299992|NCT01664910|Inotuzumab Ozogamicin|inotuzumab ozogamicin
299993|NCT01664910|Fludarabine|fludarabine
299994|NCT01664910|Fludarabine Phosphate|fludarabine phosphate
299995|NCT01664910|Fludara|fludara
299996|NCT01664910|Bendamustine|bendamustine
299997|NCT01664910|Bendamustine Hydrochloride|bendamustine hydrochloride
299998|NCT01664910|Bendamustine HCL|bendamustine hcl
299999|NCT01664910|CEP-18083|cep-18083
300000|NCT01664910|SDX105|sdx105
300001|NCT01664910|Treanda|treanda
300002|NCT01664910|G-CSF|g-csf
300003|NCT01664910|Filgrastim|filgrastim
300004|NCT01664910|Neupogen|neupogen
300005|NCT01664910|Methotrexate|methotrexate
300006|NCT01664910|Rituximab|rituximab
300007|NCT01664910|Rituxan|rituxan
300008|NCT01664910|Thymoglobulin|thymoglobulin
300009|NCT01664910|ATG|atg
300010|NCT01664910|Antithymocyte Globulin|antithymocyte globulin
300011|NCT01664910|Tacrolimus|tacrolimus
300012|NCT01664910|Prograf|prograf
300013|NCT01664897|Leukemia|leukemia
300014|NCT01664897|Acute myeloid leukemia|acute myeloid leukemia
300015|NCT01664897|AML|aml
300016|NCT01664897|refractory|refractory
300017|NCT01664897|relapsed|relapsed
300018|NCT01664897|Erlotinib|erlotinib
300019|NCT01664897|Erlotinib Hydrochloride|erlotinib hydrochloride
290585|NCT01706419|iron|iron
300020|NCT01664897|OSI-774|osi-774
300021|NCT01664897|CP358774|cp358774
300022|NCT01664897|Tarceva|tarceva
300023|NCT01664884|INTERNALIZED STIGMA|internalized stigma
300024|NCT01664884|INSIGHT|insight
300025|NCT01664884|SOCIAL ADEQUACY|social adequacy
300026|NCT01664884|BIPOLAR DISORDER|bipolar disorder
300027|NCT01664884|SCHIZOPHRENIA|schizophrenia
300028|NCT01664858|Coronary Heart Disease|coronary heart disease
300029|NCT01664858|Ischaemic Heart Disease|ischaemic heart disease
300030|NCT01664858|Angina|angina
300031|NCT01664858|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
300032|NCT01664845|hepatitis c|hepatitis c
300033|NCT01664845|metformin|metformin
300034|NCT01664845|pegylated interferon|pegylated interferon
300035|NCT01664832|Premature Infants|premature infants
300036|NCT01664832|snychronized ventilation|snychronized ventilation
300037|NCT01664832|non-invasive ventilation|non-invasive ventilation
300038|NCT01664832|RDS|rds
300039|NCT01664806|Electrosurgery|electrosurgery
300040|NCT01664806|Radiofrequency energy|radiofrequency energy
300041|NCT01664806|Monopolar instruments|monopolar instruments
300042|NCT01664806|Capacitive coupling|capacitive coupling
300043|NCT01664806|Thermal injury|thermal injury
300044|NCT01664806|Surgical complications|surgical complications
300045|NCT01664793|influenza|influenza
300046|NCT01664793|vaccination|vaccination
300047|NCT01664793|strategies|strategies
300048|NCT01664793|children/adolescents|children/adolescents
300049|NCT01664780|standard|standard
300050|NCT01664780|values|values
300051|NCT01664780|share|share
300052|NCT01664780|wave velocity|wave velocity
300053|NCT01664780|in ARFI imaging|in arfi imaging
300054|NCT01664767|COPD|copd
300055|NCT01664767|Thermal water|thermal water
300056|NCT01664767|Oxidative stress|oxidative stress
300057|NCT01664767|Inflammation|inflammation
300058|NCT01664741|Nicotine dependence|nicotine dependence
300059|NCT01664741|cigarette|cigarette
300060|NCT01664741|smoking|smoking
300061|NCT01664741|nicotine replacement therapy|nicotine replacement therapy
300062|NCT01664741|positron emission tomography|positron emission tomography
300063|NCT01664728|Prostate neoplasms|prostate neoplasms
300064|NCT01664728|Hormone refractory prostate cancer|hormone refractory prostate cancer
300065|NCT01664728|Castration resistant prostate cancer|castration resistant prostate cancer
300066|NCT01664728|Castration refractory prostate cancer|castration refractory prostate cancer
300067|NCT01664728|Abiraterone acetate|abiraterone acetate
300068|NCT01664728|CB7630|cb7630
300069|NCT01664715|Overweight|overweight
300070|NCT01664715|Obesity|obesity
300071|NCT01664715|Exercise|exercise
300072|NCT01664715|Weight Loss|weight loss
300073|NCT01664702|Dairy|dairy
300074|NCT01664702|obesity|obesity
300075|NCT01664676|liraglutide|liraglutide
300076|NCT01664676|victoza|victoza
300077|NCT01664676|GLP-1|glp-1
300078|NCT01664676|kidney|kidney
300079|NCT01664676|diabetes|diabetes
300080|NCT01664676|renal|renal
300081|NCT01664676|diabetic nephropathy|diabetic nephropathy
300082|NCT01664663|Radiotherapy|radiotherapy
300083|NCT01664663|Dose escalation|dose escalation
300084|NCT01664663|Normal tissue constraints|normal tissue constraints
300085|NCT01664663|Locally advanced disease|locally advanced disease
300086|NCT01664663|Good performance status|good performance status
300087|NCT01664650|menopause|menopause
300088|NCT01664650|pre-diabetes|pre-diabetes
300089|NCT01664637|diabetic gastroparesis|diabetic gastroparesis
300090|NCT01664637|delayed gastric emptying|delayed gastric emptying
300091|NCT01664637|gastroparesis|gastroparesis
300092|NCT01664637|diabetes mellitus, Type 1|diabetes mellitus, type 1
300093|NCT01664637|diabetes mellitus, Type 2|diabetes mellitus, type 2
300094|NCT01664624|Drug Therapy|drug therapy
300095|NCT01664611|Remote Ischaemic Conditioning|remote ischaemic conditioning
300096|NCT01664611|Remodeling|remodeling
300097|NCT01664611|Heart Failure|heart failure
300098|NCT01664611|Myocardial Infarction|myocardial infarction
300099|NCT01664611|Ischaemia/Reperfusion Injury|ischaemia/reperfusion injury
300100|NCT01664611|successful primary percutaneous coronary intervention following a first STEMI|successful primary percutaneous coronary intervention following a first stemi
300101|NCT01664585|headache|headache
300102|NCT01664585|women|women
300103|NCT01664585|exercise|exercise
300104|NCT01664585|fear avoidance|fear avoidance
300105|NCT01664585|physical activity|physical activity
300106|NCT01664572|laser Doppler flowmetry, skin blood flow|laser doppler flowmetry, skin blood flow
300107|NCT01664559|intrauterine device|intrauterine device
300108|NCT01664559|ketorolac|ketorolac
300109|NCT01664559|toradol|toradol
300110|NCT01664559|mirena|mirena
300111|NCT01664559|paragard|paragard
300112|NCT01664559|pain control|pain control
300113|NCT01664520|Subarachnoid hemorrhage|subarachnoid hemorrhage
300114|NCT01664520|Dexmedetomidine|dexmedetomidine
300115|NCT01664520|Autoregulation|autoregulation
300116|NCT01664520|Intracranial pressure|intracranial pressure
300117|NCT01664520|Cerebral oxygenation|cerebral oxygenation
300118|NCT01664507|croup, dose, epinephrine|croup, dose, epinephrine
300119|NCT01664273|electroporation|electroporation
300120|NCT01664273|gen electrotransfer|gen electrotransfer
300121|NCT01664273|muscle|muscle
300122|NCT01664273|plasmid AMEP|plasmid amep
300123|NCT01664260|Posttraumatic Stress Disorder|posttraumatic stress disorder
300124|NCT01664260|N-acetylcysteine|n-acetylcysteine
300125|NCT01664260|Magnetic Resonance Imaging|magnetic resonance imaging
300126|NCT01664234|infants with cleft palate|infants with cleft palate
300127|NCT01664234|Pierre Robin|pierre robin
300128|NCT01664234|Treacher Collins|treacher collins
300129|NCT01664234|trisomy 21|trisomy 21
300130|NCT01664221|subject|subject
300131|NCT01664195|subjects|subjects
300132|NCT01664169|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
300133|NCT01664169|recurrent pancreatic cancer|recurrent pancreatic cancer
300134|NCT01664169|stage III pancreatic cancer|stage iii pancreatic cancer
300135|NCT01664169|stage IV pancreatic cancer|stage iv pancreatic cancer
300136|NCT01664169|stage IIB pancreatic cancer|stage iib pancreatic cancer
300137|NCT01664156|Cold hypersensitivity|cold hypersensitivity
300138|NCT01664156|Korean red ginseng|korean red ginseng
300139|NCT01664156|Infrared thermography|infrared thermography
300140|NCT01664156|Cold stress test|cold stress test
300141|NCT01664156|Distal-dorsal difference|distal-dorsal difference
300143|NCT01664091|acellular dermal matrix|acellular dermal matrix
300144|NCT01664078|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
300145|NCT01664065|Patient Safety|patient safety
300146|NCT01664065|Tolerability|tolerability
300147|NCT01664065|Pharmacokinetics|pharmacokinetics
300148|NCT01664039|Glaucoma|glaucoma
300149|NCT01664039|Ocular hypertension|ocular hypertension
300150|NCT01664000|Tumors|tumors
300151|NCT01664000|carcinoma|carcinoma
300152|NCT01664000|apoptosis|apoptosis
300153|NCT01664000|p53|p53
300154|NCT01664000|p21|p21
300155|NCT01664000|Caspase3|caspase3
300156|NCT01664000|PARP|parp
300157|NCT01664000|MDM2|mdm2
300158|NCT01664000|PUMA|puma
300159|NCT01663974|Bipolar Disorders|bipolar disorders
300160|NCT01663974|Sub-syndromal symptoms|sub-syndromal symptoms
300161|NCT01663974|Acute depressive episode|acute depressive episode
300162|NCT01663974|Symptomatic remission|symptomatic remission
300163|NCT01663974|Functioning remission|functioning remission
300164|NCT01663961|Phase I|phase i
300165|NCT01663961|Pharmacokinetics|pharmacokinetics
300166|NCT01663961|YM178 Oral Controlled Absorption System (OCAS)|ym178 oral controlled absorption system (ocas)
300167|NCT01663961|Digoxin (Lanoxin)|digoxin (lanoxin)
300168|NCT01663961|DDI (Drug-drug interaction)|ddi (drug-drug interaction)
300169|NCT01663961|Open-label|open-label
300170|NCT01663961|Steady-state|steady-state
300171|NCT01663961|subjects|subjects
300172|NCT01663948|Plastic bronchitis|plastic bronchitis
300173|NCT01663948|PB|pb
300174|NCT01663935|levodopa|levodopa
300175|NCT01663935|Albinism|albinism
300176|NCT01663935|dopamine|dopamine
300177|NCT01663935|oculocutaneous albinism|oculocutaneous albinism
300178|NCT01663935|vision|vision
300179|NCT01663935|retina function|retina function
300180|NCT01663909|Pain|pain
300181|NCT01663909|Scoliosis|scoliosis
300182|NCT01663909|Rehabilitation|rehabilitation
300183|NCT01663909|Cognitive-behavioral interventions|cognitive-behavioral interventions
300184|NCT01663909|Adolescents|adolescents
300185|NCT01663883|Blood flow autoregulation|blood flow autoregulation
300186|NCT01663883|optic nerve head blood flow|optic nerve head blood flow
300187|NCT01663883|isometric exercise|isometric exercise
300188|NCT01663883|Autoregulation|autoregulation
300189|NCT01663883|ocular physiology|ocular physiology
300190|NCT01663870|Cancer Prevention|cancer prevention
706403|NCT00982748|Breathing|breathing
300191|NCT01663870|Breast cancer survivors|breast cancer survivors
300192|NCT01663870|Cancer survivorship clinic|cancer survivorship clinic
300193|NCT01663870|eHealth technology|ehealth technology
300194|NCT01663870|Internet|internet
300195|NCT01663870|HealthATM website|healthatm website
300196|NCT01663870|Questionnaire|questionnaire
300197|NCT01663870|Clinic stakeholders|clinic stakeholders
300198|NCT01663870|Clinic nurses|clinic nurses
300199|NCT01663870|Physicians|physicians
300200|NCT01663870|Case managers|case managers
300201|NCT01663870|Oncology patient navigators|oncology patient navigators
300202|NCT01663870|Audio recorded interviews|audio recorded interviews
300203|NCT01663844|Cognitive behavior therapy|cognitive behavior therapy
300204|NCT01663844|Internet treatment|internet treatment
300205|NCT01663844|Self-help treatment|self-help treatment
300206|NCT01663844|Insomnia|insomnia
300207|NCT01663844|Depression|depression
300208|NCT01663844|ICBT|icbt
300209|NCT01663844|CBT-i|cbt-i
300210|NCT01663844|CBT-d|cbt-d
300211|NCT01663831|Outdoor Malaria Transmission|outdoor malaria transmission
300212|NCT01663831|Anopheles|anopheles
300213|NCT01663831|Topical repellent|topical repellent
300214|NCT01663831|Early biting vector|early biting vector
300215|NCT01663831|Long Lasting Insecticidal Net (LLIN)|long lasting insecticidal net (llin)
300216|NCT01663831|Cambodia|cambodia
371877|NCT01361074|ICT|ict
300217|NCT01663805|Extended Criteria Donor|extended criteria donor
300218|NCT01663805|Delayed Graft Function|delayed graft function
300219|NCT01663805|DGF|dgf
300220|NCT01663805|Deceased donors aged ≥ 60 years|deceased donors aged ≥ 60 years
300221|NCT01663805|aged between 50 and 59 years|aged between 50 and 59 years
300222|NCT01663805|history of systemic hypertension|history of systemic hypertension
300223|NCT01663805|terminal creatinine levels > 1.5 mg/dL|terminal creatinine levels > 1.5 mg/dl
300224|NCT01663805|death by a cerebrovascular accident|death by a cerebrovascular accident
300225|NCT01663792|urokinase receptor|urokinase receptor
300226|NCT01663792|protein expression|protein expression
300227|NCT01663792|seaweed (Undaria pinnatifida)|seaweed (undaria pinnatifida)
300228|NCT01663766|GVHD (acute or chronic)|gvhd (acute or chronic)
300229|NCT01663766|acute myeloid or lymphoblastic leukemia (AML or ALL)|acute myeloid or lymphoblastic leukemia (aml or all)
300230|NCT01663766|myelodysplastic syndrome|myelodysplastic syndrome
300231|NCT01663766|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
300232|NCT01663766|Multiple Myeloma (MM)|multiple myeloma (mm)
300233|NCT01663766|Non-Hodgekin lymphoma (NHL-both follicular & diffuse large cell)|non-hodgekin lymphoma (nhl-both follicular & diffuse large cell)
300234|NCT01663766|Chronic lymphocytic leukemia or small lymphocytic leukemia (CLL or SLL)|chronic lymphocytic leukemia or small lymphocytic leukemia (cll or sll)
300235|NCT01663753|2-fluoro-2-deoxy-d-glucose-positron emission tomography|2-fluoro-2-deoxy-d-glucose-positron emission tomography
300236|NCT01663753|Positron emission tomography|positron emission tomography
300237|NCT01663753|Magnetic resonance imaging|magnetic resonance imaging
300238|NCT01663753|Diffusion weighted MRI|diffusion weighted mri
300239|NCT01663753|Squamous-cell cervical carcinoma|squamous-cell cervical carcinoma
300240|NCT01663753|Sensitivity|sensitivity
300241|NCT01663714|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
300349|NCT01663220|method standardization|method standardization
300242|NCT01663714|tositumomab and iodine I 131 tositumomab|tositumomab and iodine i 131 tositumomab
300243|NCT01663714|Bexxar|bexxar
300244|NCT01663714|cycolophosphamide, vacristine, and pednisone|cycolophosphamide, vacristine, and pednisone
300245|NCT01663701|Sepsis|sepsis
300246|NCT01663701|Severe sepsis|severe sepsis
300247|NCT01663701|Tuberculosis|tuberculosis
300248|NCT01663701|Bundle|bundle
300249|NCT01663701|Zambia|zambia
300250|NCT01663675|Down syndrome|down syndrome
300251|NCT01663649|Depression|depression
300252|NCT01663649|Online-Therapy|online-therapy
300253|NCT01663649|Deprexis|deprexis
300254|NCT01663649|Self-help|self-help
300255|NCT01663636|vaccines|vaccines
300256|NCT01663636|SMS|sms
300257|NCT01663636|mobile phones|mobile phones
300258|NCT01663623|Wegener's Granulomatosis|wegener's granulomatosis
300259|NCT01663623|anti-MPO|anti-mpo
300260|NCT01663623|WG|wg
300261|NCT01663623|Belimumab|belimumab
300262|NCT01663623|GPA|gpa
300263|NCT01663623|anti-proteinase 3|anti-proteinase 3
300264|NCT01663623|anti-neutrophil cytoplasmic antibody|anti-neutrophil cytoplasmic antibody
300265|NCT01663623|anti-myeloperoxidase|anti-myeloperoxidase
300266|NCT01663623|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
300267|NCT01663623|Vasculitis|vasculitis
300268|NCT01663623|Autoimmune Diseases|autoimmune diseases
300269|NCT01663623|Microscopic Polyangiitis|microscopic polyangiitis
300270|NCT01663623|anti-PR3|anti-pr3
300271|NCT01663623|ANCA|anca
300272|NCT01663623|MPA|mpa
300273|NCT01663623|Systemic Vasculitis|systemic vasculitis
300274|NCT01663584|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
300275|NCT01663584|Carrier Screening|carrier screening
300276|NCT01663584|Genetic Testing|genetic testing
300277|NCT01663558|anal dysplasia|anal dysplasia
300278|NCT01663558|HPV|hpv
300279|NCT01663558|HIV|hiv
300281|NCT01663545|Epilepsy|epilepsy
300282|NCT01663545|Epileptic Focus|epileptic focus
300283|NCT01663545|Inflammation|inflammation
300284|NCT01663545|P-Glycoprotein|p-glycoprotein
300285|NCT01663545|PET Imaging|pet imaging
300286|NCT01663532|Schizophrenia|schizophrenia
300287|NCT01663519|Diabetic foot|diabetic foot
300288|NCT01663519|Offloading|offloading
300289|NCT01663519|Prevention|prevention
300290|NCT01663519|Orthotics|orthotics
300291|NCT01663467|tinnitus|tinnitus
300292|NCT01663467|smartphone|smartphone
300293|NCT01663467|Web|web
300294|NCT01663441|Chemotherapy|chemotherapy
300295|NCT01663441|Thrombocytopenia|thrombocytopenia
300296|NCT01663441|Interleukin-11|interleukin-11
300297|NCT01663441|Platelet|platelet
300298|NCT01663428|birth related brachial plexus injury|birth related brachial plexus injury
300299|NCT01663428|brachial plexus|brachial plexus
300300|NCT01663428|splint|splint
300301|NCT01663415|MDV3100|mdv3100
300302|NCT01663415|prostate|prostate
300303|NCT01663415|cancer|cancer
300304|NCT01663415|enzalutamide|enzalutamide
300305|NCT01663389|mass balance|mass balance
300306|NCT01663389|radiolabel|radiolabel
300307|NCT01663389|oral|oral
300308|NCT01663389|IV|iv
300309|NCT01663389|GSK1322322|gsk1322322
300310|NCT01663389|healthy volunteer|healthy volunteer
300311|NCT01663389|antibiotic|antibiotic
300312|NCT01663363|refractive|refractive
300313|NCT01663363|LASIK|lasik
300314|NCT01663337|Posttraumatic Stress Disorder|posttraumatic stress disorder
300315|NCT01663337|PTSD|ptsd
300316|NCT01663337|Alcohol Abuse|alcohol abuse
300317|NCT01663337|Alcohol Dependance|alcohol dependance
300318|NCT01663337|Alcoholism|alcoholism
300319|NCT01663337|Comorbid|comorbid
300320|NCT01663337|Relapse Prevention (RP)|relapse prevention (rp)
300321|NCT01663337|Cognitive Processing Therapy (CPT)|cognitive processing therapy (cpt)
300322|NCT01663324|Tinnitus|tinnitus
300323|NCT01663324|chronic subjective Tinnitus|chronic subjective tinnitus
300324|NCT01663324|transcranial magnetic stimulation|transcranial magnetic stimulation
300325|NCT01663324|rTMS|rtms
300326|NCT01663324|hearing disorders|hearing disorders
300328|NCT01663311|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
300329|NCT01663311|chronic tinnitus|chronic tinnitus
300330|NCT01663311|subjective tinnitus|subjective tinnitus
300331|NCT01663311|double cone coil|double cone coil
300332|NCT01663298|DNA methylation|dna methylation
300333|NCT01663298|FGF2|fgf2
300334|NCT01663298|Wound healing|wound healing
300335|NCT01663298|Smoking|smoking
300336|NCT01663298|Diabetes|diabetes
300337|NCT01663298|Implant|implant
300338|NCT01663285|Urothelial|urothelial
300339|NCT01663285|Bladder|bladder
300340|NCT01663285|Cancer|cancer
300341|NCT01663272|oncology|oncology
300342|NCT01663272|pancrease|pancrease
300343|NCT01663233|Essential hypertension|essential hypertension
300344|NCT01663233|High blood pressure|high blood pressure
300345|NCT01663220|type 2 diabetes|type 2 diabetes
300346|NCT01663220|beta cell function|beta cell function
300347|NCT01663220|meal tolerance test|meal tolerance test
300348|NCT01663220|maximum stimulation test|maximum stimulation test
300350|NCT01663220|insulin secretion|insulin secretion
300351|NCT01663220|prediabetes|prediabetes
300352|NCT01663220|insulin sensitivity|insulin sensitivity
300353|NCT01663207|type 2 diabetes|type 2 diabetes
300354|NCT01663207|beta cell function|beta cell function
300355|NCT01663207|meal tolerance test|meal tolerance test
300356|NCT01663207|maximum stimulation test|maximum stimulation test
300357|NCT01663207|method standardization|method standardization
300358|NCT01663207|insulin secretion|insulin secretion
300359|NCT01663207|prediabetes|prediabetes
300360|NCT01663207|insulin sensitivity|insulin sensitivity
300361|NCT01663194|N/L ratio, STEMI, primary PCI, Long-term mortality|n/l ratio, stemi, primary pci, long-term mortality
300362|NCT01663168|HIV|hiv
300363|NCT01663168|Tuberculosis|tuberculosis
300364|NCT01663168|Rifabutin|rifabutin
300365|NCT01663168|HIV Protease Inhibitors|hiv protease inhibitors
300366|NCT01663168|EARNEST trial|earnest trial
300367|NCT01663168|Randomized Controlled Trial|randomized controlled trial
300368|NCT01663168|Pilot Projects|pilot projects
300369|NCT01663168|Second-line ART|second-line art
300370|NCT01663168|Drug Toxicity|drug toxicity
300371|NCT01663168|Pharmacokinetics|pharmacokinetics
300372|NCT01663168|Drug Interactions|drug interactions
300373|NCT01663155|lung cancer|lung cancer
300374|NCT01663155|chest x-ray|chest x-ray
300375|NCT01663155|CT scan|ct scan
300376|NCT01663155|computer aided detection (CAD)|computer aided detection (cad)
300377|NCT01663155|screening|screening
300378|NCT01663155|smokers|smokers
300379|NCT01663142|Crohn's disease|crohn's disease
300380|NCT01663142|gastrointestinal tract|gastrointestinal tract
300381|NCT01663129|Children|children
300382|NCT01663129|Osteoporosis|osteoporosis
300383|NCT01663129|Vertebral Compression Fractures|vertebral compression fractures
300384|NCT01663129|Chronic Illness|chronic illness
300385|NCT01663129|Glucocorticoids|glucocorticoids
300386|NCT01663129|Bone Fragility|bone fragility
300387|NCT01663116|Rheumatoid arthritis|rheumatoid arthritis
300388|NCT01663116|Expanded adipose derived allogeneic adult stem cells (eASCs)|expanded adipose derived allogeneic adult stem cells (eascs)
300389|NCT01663103|Interleukin-1|interleukin-1
300390|NCT01663103|Endothelium, Vascular|endothelium, vascular
300391|NCT01663103|Vascular Stiffness|vascular stiffness
300392|NCT01663103|Oxidative Stress|oxidative stress
300393|NCT01663103|Inflammation|inflammation
300394|NCT01663103|Endothelial cells|endothelial cells
300395|NCT01663090|Newly diagnosed|newly diagnosed
300396|NCT01663077|Clozapine|clozapine
300397|NCT01663077|Schizophrenia|schizophrenia
300398|NCT01663077|Remissia|remissia
300399|NCT01663077|polymorphism|polymorphism
300400|NCT01663064|Abdominal aortic aneurysm|abdominal aortic aneurysm
300401|NCT01663064|Endovascular|endovascular
300402|NCT01663064|Fenestration|fenestration
300403|NCT01663064|Juxtarenal|juxtarenal
300404|NCT01663064|Off-the-shelf|off-the-shelf
300405|NCT01663064|Pararenal|pararenal
300406|NCT01663038|Clopidogrel|clopidogrel
300407|NCT01663038|Aspirin|aspirin
300408|NCT01663038|Combination|combination
300409|NCT01663038|Pharmacokinetics|pharmacokinetics
300410|NCT01663038|Phase 1|phase 1
300411|NCT01663025|Randomised controlled trial|randomised controlled trial
300412|NCT01663025|Pain|pain
300413|NCT01663025|Anxiety|anxiety
300414|NCT01663025|Ambulatory surgery|ambulatory surgery
300415|NCT01663025|Hand massage|hand massage
300416|NCT01663025|Local anaesthetic|local anaesthetic
300417|NCT01662973|Primary Biliary Cirrhosis|primary biliary cirrhosis
300418|NCT01662973|Mesenchymal Stem Cells|mesenchymal stem cells
300419|NCT01662973|Serum alkaline phosphatase|serum alkaline phosphatase
300420|NCT01662973|Serum Bilirubin|serum bilirubin
300421|NCT01662960|stroke|stroke
300422|NCT01662960|hemiparesis|hemiparesis
300423|NCT01662960|arm movement|arm movement
300424|NCT01662960|sensory functioning|sensory functioning
300425|NCT01662947|blood pressure|blood pressure
300426|NCT01662934|dysmenorrhea|dysmenorrhea
300427|NCT01662934|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
300428|NCT01662934|heat therapy|heat therapy
300429|NCT01662921|bolus treatment|bolus treatment
300430|NCT01662895|Brain hemorrhage|brain hemorrhage
300431|NCT01662895|Cerebral Hemorrhage|cerebral hemorrhage
300432|NCT01662895|Deferoxamine|deferoxamine
300433|NCT01662895|Hi-DEF Trial|hi-def trial
300434|NCT01662856|Vascular Surgery|vascular surgery
300435|NCT01662856|Fibrin Sealant|fibrin sealant
300436|NCT01662856|Polytetrafluoroethylene (PTFE) grafts|polytetrafluoroethylene (ptfe) grafts
300437|NCT01662843|Dyspnea|dyspnea
300438|NCT01662843|Ultrasonography|ultrasonography
300439|NCT01662843|Emergencies|emergencies
300440|NCT01662843|Critical Care|critical care
300441|NCT01662830|Obesity|obesity
300442|NCT01662830|Meal replacements|meal replacements
300443|NCT01662804|INTERLEUKIN 2|interleukin 2
300444|NCT01662804|MAB 3F8|mab 3f8
300445|NCT01662804|GD2-positive tumor|gd2-positive tumor
300446|NCT01662804|12-116|12-116
300447|NCT01662791|Parkinson's Disease|parkinson's disease
300448|NCT01662791|Small Bowel Bacterial Overgrowth|small bowel bacterial overgrowth
300449|NCT01662791|Weight Loss|weight loss
300450|NCT01662791|Gastrointestinal|gastrointestinal
300451|NCT01662791|Rifaximin|rifaximin
300452|NCT01662778|Monodisperse aerosols|monodisperse aerosols
300453|NCT01662778|Asthmatics|asthmatics
300454|NCT01662778|Pharmacokinetics|pharmacokinetics
300455|NCT01662778|AMP Challenge|amp challenge
300456|NCT01662778|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
300457|NCT01662765|Umbilical pilonidal sinus|umbilical pilonidal sinus
300458|NCT01662765|Treatment|treatment
300459|NCT01662765|Surgery|surgery
300460|NCT01662765|Conservative|conservative
300461|NCT01662765|Investigational treatment|investigational treatment
300462|NCT01662765|After care|after care
300463|NCT01662752|Early colonic cancer|early colonic cancer
300464|NCT01662752|Sentinel lymph node mapping|sentinel lymph node mapping
300465|NCT01662752|Sentinel lymph node biopsy|sentinel lymph node biopsy
300466|NCT01662752|Near infrared imaging|near infrared imaging
300467|NCT01662752|Indocyanine green|indocyanine green
300468|NCT01662752|Laparoscopic|laparoscopic
300469|NCT01662739|Population-Based Cancer Registry|population-based cancer registry
300470|NCT01662739|Stomach|stomach
300471|NCT01662739|Epidemiology|epidemiology
300472|NCT01662739|Risk Factor|risk factor
300473|NCT01662739|Biomolecular Features|biomolecular features
300474|NCT01662713|skin cancer|skin cancer
300475|NCT01662713|optical imaging|optical imaging
300476|NCT01662713|optical coherence tomography|optical coherence tomography
300477|NCT01662713|optical frequency domain imaging|optical frequency domain imaging
300478|NCT01662700|P. vivax infection|p. vivax infection
300479|NCT01662700|Artesunate|artesunate
300480|NCT01662700|Chloroquine|chloroquine
300481|NCT01662700|Primaquine|primaquine
300482|NCT01662661|Healthy participants|healthy participants
300483|NCT01662661|Hepatitis C|hepatitis c
300484|NCT01662661|Relative bioavailability|relative bioavailability
300485|NCT01662661|Bioavailability|bioavailability
300486|NCT01662661|Pharmacokinetics|pharmacokinetics
300487|NCT01662661|JNJ-47910382|jnj-47910382
300488|NCT01662648|Schizophrenia|schizophrenia
300489|NCT01662648|Paliperidone|paliperidone
300490|NCT01662648|Paliperidone extended-release (ER)|paliperidone extended-release (er)
300491|NCT01662635|Non-small cell lung cancer.|non-small cell lung cancer.
300492|NCT01662635|Diagnosis,|diagnosis,
300493|NCT01662635|Adenocarcinoma,|adenocarcinoma,
300494|NCT01662635|ALK,|alk,
300495|NCT01662635|FISH,|fish,
300496|NCT01662635|IHC|ihc
300497|NCT01662635|RT-qPCR|rt-qpcr
300498|NCT01662622|anaesthesia|anaesthesia
300499|NCT01662622|middle aged|middle aged
300500|NCT01662622|minimal alveolar concentration|minimal alveolar concentration
300501|NCT01662622|sevoflurane|sevoflurane
300502|NCT01662622|isoelectric EEG|isoelectric eeg
300503|NCT01662609|pancreas|pancreas
300504|NCT01662609|high-risk|high-risk
300505|NCT01662596|Risk factors,|risk factors,
300506|NCT01662596|prenatal diagnosis,|prenatal diagnosis,
300507|NCT01662596|fetal malformations|fetal malformations
300508|NCT01662583|Influenza|influenza
300509|NCT01662583|text message|text message
300510|NCT01662583|vaccination|vaccination
300511|NCT01662570|Pediatric Obesity|pediatric obesity
300512|NCT01662570|Child Overweight|child overweight
300513|NCT01662557|Pediatric Obesity|pediatric obesity
300514|NCT01662544|Infants|infants
300515|NCT01662544|Bronchiolitis|bronchiolitis
300516|NCT01662544|Hypoxia|hypoxia
300517|NCT01662544|Emergency Department|emergency department
300518|NCT01662544|Length of Stay|length of stay
300519|NCT01662544|Pediatrics|pediatrics
300520|NCT01661426|Adults|adults
300521|NCT01661426|Weight loss|weight loss
300522|NCT01661426|Diet|diet
300523|NCT01661426|Insulin Resistance|insulin resistance
300524|NCT01661426|Fatty acid composition|fatty acid composition
300525|NCT01661413|Acute Leukemia|acute leukemia
300526|NCT01661413|Pediatrics|pediatrics
300527|NCT01661413|Intrathecal methotrexate|intrathecal methotrexate
300528|NCT01661413|Chemotherapy|chemotherapy
300529|NCT01661413|Nausea|nausea
300530|NCT01661413|Vomiting|vomiting
753206|NCT01175902|Normal tension glaucoma|normal tension glaucoma
300531|NCT01661400|Glioma includes ependymoma and medulloblastoma|glioma includes ependymoma and medulloblastoma
300532|NCT01661387|Adrenal insufficiency|adrenal insufficiency
300533|NCT01661387|DuoCort|duocort
300534|NCT01661387|Congenital adrenal hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
300535|NCT01661387|Modified release|modified release
300536|NCT01661387|Hydrocortisone|hydrocortisone
300537|NCT01661361|vancomycin|vancomycin
300538|NCT01661361|levels|levels
300539|NCT01661361|central venous port device|central venous port device
300540|NCT01661361|peripherally obtained levels|peripherally obtained levels
300541|NCT01661361|dose adjustments|dose adjustments
300542|NCT01661361|TDM|tdm
300543|NCT01662466|testosterone|testosterone
300544|NCT01662466|DHEA|dhea
300545|NCT01662466|IVF|ivf
300546|NCT01662466|egg quality|egg quality
300547|NCT01662466|pregnancy rates|pregnancy rates
300548|NCT01662453|epilepsy|epilepsy
300549|NCT01662453|seizures|seizures
300550|NCT01662453|mortality|mortality
300551|NCT01662453|sudep|sudep
300552|NCT01662453|risk factors|risk factors
300553|NCT01662440|Rabies|rabies
300554|NCT01662440|JE|je
300555|NCT01662440|accelerated schedule|accelerated schedule
300556|NCT01662427|Quality of life|quality of life
300557|NCT01662427|Noctural Parkinson's Disease Symptoms|noctural parkinson's disease symptoms
300558|NCT01662401|children|children
300559|NCT01662401|laparoscopic appendectomy|laparoscopic appendectomy
300560|NCT01662401|iliohypogastric nerve block|iliohypogastric nerve block
300561|NCT01662401|rectus sheath nerve block|rectus sheath nerve block
300562|NCT01662401|ilioinguinal nerve block|ilioinguinal nerve block
300563|NCT01662388|proximal caries, composite restoration, proximal contact|proximal caries, composite restoration, proximal contact
300564|NCT01662362|Chagas Disease|chagas disease
300565|NCT01662362|Trypanosoma cruzi|trypanosoma cruzi
300566|NCT01662362|American trypanosomiasis|american trypanosomiasis
300567|NCT01662362|South American trypanosomiasis|south american trypanosomiasis
300568|NCT01662362|kissing bugs|kissing bugs
300569|NCT01662362|reduviid bugs|reduviid bugs
300570|NCT01662336|Human Immunodeficiency Virus infection|human immunodeficiency virus infection
300571|NCT01662323|Heart failure, general practitioner, medical therapy, quality of live|heart failure, general practitioner, medical therapy, quality of live
300572|NCT01662310|Schizophrenia|schizophrenia
300573|NCT01662310|Paliperidone|paliperidone
300574|NCT01662310|Paliperidone Extended-Release|paliperidone extended-release
300575|NCT01662297|Quetiapine|quetiapine
300576|NCT01662297|Trazodone|trazodone
300577|NCT01662297|Insomnia|insomnia
300578|NCT01662297|Dual Diagnosis|dual diagnosis
300579|NCT01662271|obesity|obesity
300580|NCT01662271|adiposity|adiposity
300581|NCT01662271|psychosocial|psychosocial
300582|NCT01662271|healthcare|healthcare
300583|NCT01662271|co-morbidities|co-morbidities
300584|NCT01662271|youth with extreme obesity|youth with extreme obesity
300585|NCT01662271|weight loss|weight loss
300586|NCT01662258|Community-acquired pneumonia|community-acquired pneumonia
300587|NCT01662258|Targeted strategy|targeted strategy
300588|NCT01662258|Empiric therapy|empiric therapy
300589|NCT01662232|Green tea|green tea
300590|NCT01662232|EGCG|egcg
300591|NCT01662232|Cardiovascular diseases|cardiovascular diseases
300592|NCT01662232|Endothelial function|endothelial function
300593|NCT01662232|Flow-mediated dilation|flow-mediated dilation
300594|NCT01662219|superficial cervical plexus block|superficial cervical plexus block
300595|NCT01662219|quality of recovery|quality of recovery
300596|NCT01662206|adults|adults
300597|NCT01662206|probiotics|probiotics
300598|NCT01662206|immune function|immune function
300599|NCT01662206|microbiota|microbiota
300600|NCT01662206|digestive health|digestive health
300601|NCT01662193|Cholecalciferol|cholecalciferol
300602|NCT01662193|Calciol|calciol
300603|NCT01662193|vitamin D3|vitamin d3
300604|NCT01662193|Diabetes Mellitus|diabetes mellitus
300605|NCT01662193|Diabetes Mellitus Type 2|diabetes mellitus type 2
300606|NCT01662193|glucose metabolism disorders|glucose metabolism disorders
300607|NCT01662193|ergocalciferol|ergocalciferol
300608|NCT01662193|calcium|calcium
300609|NCT01662193|adipicytokines|adipicytokines
300610|NCT01662193|inflammatory biomarkers|inflammatory biomarkers
300611|NCT01662180|subfertility, IUI, rec FSH, FSH, E2, AMH|subfertility, iui, rec fsh, fsh, e2, amh
300612|NCT01662141|Cardiac output|cardiac output
300613|NCT01662141|Perivascular Probe|perivascular probe
300614|NCT01662128|Breast Cancer|breast cancer
300615|NCT01662115|ILEUS|ileus
300616|NCT01662089|Female pattern hair loss|female pattern hair loss
300617|NCT01662076|Cancer|cancer
300618|NCT01662076|Fatigue|fatigue
300619|NCT01662076|Chemotherapy|chemotherapy
300620|NCT01662076|Pediatrics|pediatrics
300621|NCT01662076|Homeopathy|homeopathy
300622|NCT01662050|MCL|mcl
300623|NCT01662050|Mantle Cell Lymphoma|mantle cell lymphoma
300624|NCT01662050|Older|older
300625|NCT01662037|Pulmonary vascular resistance|pulmonary vascular resistance
300626|NCT01662037|Heart defects, Congenital|heart defects, congenital
300627|NCT01662037|Receptors, endothelin|receptors, endothelin
300628|NCT01662037|Bosentan|bosentan
300629|NCT01662024|Obesity|obesity
300630|NCT01662024|BMI|bmi
300631|NCT01662024|Weight loss|weight loss
300632|NCT01662024|Gastric restriction|gastric restriction
300633|NCT01662024|Bariatrics|bariatrics
300634|NCT01662011|patient-ventilator interaction|patient-ventilator interaction
300635|NCT01662011|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
300636|NCT01662011|diaphragm electrical activity|diaphragm electrical activity
300637|NCT01662011|pressure support ventilation|pressure support ventilation
300638|NCT01661998|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
300639|NCT01661998|Spinal Deformity|spinal deformity
300640|NCT01661998|Treatment Outcomes|treatment outcomes
300641|NCT01661985|Mycoplasma genitalium|mycoplasma genitalium
300642|NCT01661985|Chlamydia trachomatis|chlamydia trachomatis
300643|NCT01661985|Treatment|treatment
300644|NCT01661985|Antibiotic resistance|antibiotic resistance
300645|NCT01661972|colorectal cancer|colorectal cancer
300646|NCT01661972|all solid tumors|all solid tumors
300647|NCT01661972|metastatic|metastatic
300648|NCT01661972|refractory|refractory
301227|NCT01658839|travoprost|travoprost
300649|NCT01661972|advanced solid tumors|advanced solid tumors
300650|NCT01661959|Scoliosis|scoliosis
300651|NCT01661959|Multi-center Database Registry|multi-center database registry
300652|NCT01661959|Spinal Deformity|spinal deformity
300653|NCT01661959|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
300654|NCT01661946|vascular endothelial growth factor|vascular endothelial growth factor
300655|NCT01661946|macular edema|macular edema
300656|NCT01661946|diabetic retinopathy|diabetic retinopathy
300657|NCT01661933|celiac disease|celiac disease
300658|NCT01661933|hookworm|hookworm
300659|NCT01661933|probiotic|probiotic
300660|NCT01661920|Community Acquired Pneumonia.|community acquired pneumonia.
300661|NCT01661920|Treatment duration|treatment duration
300662|NCT01661907|Elderly|elderly
300663|NCT01661907|Anesthesia and postoperative analgesia|anesthesia and postoperative analgesia
300664|NCT01661907|Postoperative period|postoperative period
300665|NCT01661907|Delirium|delirium
300666|NCT01661907|Postoperative complications|postoperative complications
300667|NCT01661881|Newly diagnosed|newly diagnosed
300668|NCT01661868|BRCA1 mutation|brca1 mutation
300669|NCT01661868|BRCA2 mutation|brca2 mutation
300670|NCT01661855|Autism Spectrum Disorders|autism spectrum disorders
300671|NCT01661842|Autoimmune Hepatitis|autoimmune hepatitis
300672|NCT01661842|Mesenchymal stem cells|mesenchymal stem cells
300673|NCT01661842|serum albumin|serum albumin
300674|NCT01661842|serum Tbil|serum tbil
300675|NCT01661842|serum immunoglobulin G(IgG)|serum immunoglobulin g(igg)
300676|NCT01661816|breast cancer|breast cancer
300677|NCT01661816|everyday issues|everyday issues
300678|NCT01661816|couple|couple
300679|NCT01661803|bupivacaine|bupivacaine
300680|NCT01661803|clonidine|clonidine
300681|NCT01661803|pediatric spinal|pediatric spinal
300682|NCT01661803|efficacy|efficacy
300683|NCT01661803|duration|duration
300684|NCT01661803|quality|quality
300685|NCT01661803|side effects|side effects
300686|NCT01661803|intrathecal bupivacaine alone|intrathecal bupivacaine alone
300687|NCT01661803|bupivacaine plus clonidine|bupivacaine plus clonidine
300688|NCT01661790|Bevacizumab;|bevacizumab;
300689|NCT01661790|non-small cell lung cancer;|non-small cell lung cancer;
300690|NCT01661790|malignant pleural effusion;|malignant pleural effusion;
300691|NCT01661790|intrapleural administration|intrapleural administration
300692|NCT01661777|Eustachian tube dysfunction|eustachian tube dysfunction
300693|NCT01661777|Endolymphatic hydrops|endolymphatic hydrops
300694|NCT01661777|Diuretic|diuretic
300695|NCT01661777|Low salt diet|low salt diet
300696|NCT01661777|Myringotomy|myringotomy
300697|NCT01661777|Pressure equalization tube|pressure equalization tube
300698|NCT01661777|Ear tube|ear tube
300699|NCT01661777|Ear fullness|ear fullness
300700|NCT01661777|Ear pressure|ear pressure
300701|NCT01661777|Allergy|allergy
300702|NCT01661777|Nasal steroid|nasal steroid
300703|NCT01661777|Antihistamine|antihistamine
300704|NCT01661764|Colorectal Neoplasm|colorectal neoplasm
300705|NCT01661751|Group ACYW135 Meninigococcal Polysaccharide Vaccine|group acyw135 meninigococcal polysaccharide vaccine
752603|NCT01173289|Thyroid Carcinoma|thyroid carcinoma
291277|NCT01703585|genome|genome
300706|NCT01661738|Group ACYW135 Meninigococcal Polysaccharide Vaccine|group acyw135 meninigococcal polysaccharide vaccine
300707|NCT01661725|Group ACYW135 Meningococcal Polysaccharide Vaccine|group acyw135 meningococcal polysaccharide vaccine
300708|NCT01661712|obstructive sleep apnoea,|obstructive sleep apnoea,
300709|NCT01661712|continuous transcutaneous electrical stimulation|continuous transcutaneous electrical stimulation
300710|NCT01661699|Obstructive Sleep Apnea|obstructive sleep apnea
300711|NCT01661686|esophageal cancer|esophageal cancer
300712|NCT01661686|esophageal stenosis|esophageal stenosis
300713|NCT01661686|stent|stent
300714|NCT01661686|endoscopy|endoscopy
300715|NCT01661634|Acute decompensated heart failure|acute decompensated heart failure
300716|NCT01661621|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
300717|NCT01661621|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
300718|NCT01661621|Antimuscarinics|antimuscarinics
300719|NCT01661621|α-blockers|α-blockers
300720|NCT01661608|Gastric Restriction|gastric restriction
300721|NCT01661595|Fatigue|fatigue
300722|NCT01661595|Fatigability|fatigability
300723|NCT01661595|Surface Electromyography (sEMG)|surface electromyography (semg)
300724|NCT01661595|cyclic guanosine monophosphate (cGMP)|cyclic guanosine monophosphate (cgmp)
300725|NCT01661595|Nitric Oxide (NO)|nitric oxide (no)
300726|NCT01661595|NO-cGMP|no-cgmp
300727|NCT01661595|Phosphodiesterase (PDE)|phosphodiesterase (pde)
300728|NCT01661595|Sildenafil|sildenafil
300729|NCT01661595|Tadalafil|tadalafil
300730|NCT01661595|Isotope|isotope
300731|NCT01661595|Infusion|infusion
300732|NCT01661595|Anabolism|anabolism
300733|NCT01661595|Upregulation|upregulation
300734|NCT01661595|Accelerometer|accelerometer
300735|NCT01661595|Placebo|placebo
300736|NCT01661595|Nitrosylation|nitrosylation
300737|NCT01661582|Air Pollution|air pollution
300738|NCT01661582|Myocardial Ischaemia|myocardial ischaemia
300739|NCT01661582|Coronary Blood Flow|coronary blood flow
300740|NCT01661582|Diesel Exhaust|diesel exhaust
300741|NCT01661582|Troponin|troponin
301960|NCT01655628|CIK cells|cik cells
300742|NCT01661582|Electrocardiography|electrocardiography
300743|NCT01661569|Mindfulness|mindfulness
300744|NCT01661569|meditation|meditation
300745|NCT01661569|stress|stress
300746|NCT01661569|well-being|well-being
300747|NCT01661569|work stress|work stress
300748|NCT01661569|blood pressure|blood pressure
300749|NCT01661569|cortisol|cortisol
300750|NCT01661556|Melasma, miconazole, hydroquinone|melasma, miconazole, hydroquinone
300751|NCT01661530|asthma|asthma
300752|NCT01661530|pregnancy|pregnancy
300753|NCT01661530|diet|diet
300754|NCT01661530|vitamin E|vitamin e
300755|NCT01661517|substance use treatment|substance use treatment
300756|NCT01661439|Recurrent miscarriages|recurrent miscarriages
300757|NCT01661439|recurrent pregnancy loss|recurrent pregnancy loss
300758|NCT01661439|aps|aps
300759|NCT01661439|anti coagulants in pregnancy|anti coagulants in pregnancy
300760|NCT01661348|Cesarian section|cesarian section
300761|NCT01661348|Pregnancy|pregnancy
300762|NCT01661348|Incision management|incision management
300763|NCT01661335|Nausea|nausea
300764|NCT01661335|Vomiting|vomiting
300765|NCT01661335|Children|children
300766|NCT01661335|Aprepitant|aprepitant
300767|NCT01661335|Emend®|emend®
300768|NCT01661322|Acute ischaemic stroke|acute ischaemic stroke
300769|NCT01661322|TIA|tia
300770|NCT01661309|Hyperhomocysteinemia|hyperhomocysteinemia
300771|NCT01661309|Methylcobalamin|methylcobalamin
300772|NCT01661309|Cardiovascular disease|cardiovascular disease
300773|NCT01661309|Plasma total homocysteine|plasma total homocysteine
300774|NCT01661309|Vegetarians|vegetarians
300775|NCT01661296|cutaneous leishmaniasis, heat therapy, antimony|cutaneous leishmaniasis, heat therapy, antimony
300776|NCT01661283|MPNST|mpnst
706404|NCT00982748|Cancer|cancer
300777|NCT01661283|malignant peripheral nerve sheath tumors|malignant peripheral nerve sheath tumors
300778|NCT01661283|RAD001|rad001
300779|NCT01661283|Everolimus|everolimus
300780|NCT01661283|Bevacizumab|bevacizumab
300781|NCT01661283|Sarcoma|sarcoma
300782|NCT01661283|Avastin|avastin
300783|NCT01661283|mTOR inhibitor|mtor inhibitor
300784|NCT01661257|Crohn's disease|crohn's disease
300785|NCT01661257|Infliximab|infliximab
300786|NCT01661257|T-cell immunoglobulin- and mucin-domain-containing molecule 3 (TIM-3)|t-cell immunoglobulin- and mucin-domain-containing molecule 3 (tim-3)
300787|NCT01661231|Vascular intervention|vascular intervention
300788|NCT01661231|Endovascular|endovascular
300789|NCT01661231|Peripheral stent|peripheral stent
300790|NCT01661218|catheters|catheters
300791|NCT01661218|Central Venous|central venous
300792|NCT01661218|complications|complications
300793|NCT01661218|cancer|cancer
300794|NCT01661205|Persistent AF|persistent af
300795|NCT01661205|Longstanding Persistent AF|longstanding persistent af
300796|NCT01661205|Ablation|ablation
300797|NCT01661205|catheter ablation|catheter ablation
300798|NCT01661192|Type 1 Diabetes|type 1 diabetes
300799|NCT01661192|newly diagnosed|newly diagnosed
300800|NCT01661192|Beta cell preservation|beta cell preservation
300801|NCT01661179|Medullary Thyroid Carcinoma|medullary thyroid carcinoma
300802|NCT01661179|Medullary Thyroid Cancer|medullary thyroid cancer
300803|NCT01661179|Vandetanib|vandetanib
300804|NCT01661166|Male adult subjects|male adult subjects
300805|NCT01661166|aged 30-90 years|aged 30-90 years
300806|NCT01661166|RARP|rarp
300807|NCT01661166|AUA symptom score greater than 7 will be included|aua symptom score greater than 7 will be included
300808|NCT01661114|Gemcitabine, Infusional 5-Fluorouracil,Cisplatin|gemcitabine, infusional 5-fluorouracil,cisplatin
300809|NCT01661114|Advanced Pancreatic and Biliary Cancers|advanced pancreatic and biliary cancers
300810|NCT01661114|untreated & previously treated pancreatic & biliary cancer.|untreated & previously treated pancreatic & biliary cancer.
300811|NCT01661101|Perioperative myocardial infarction|perioperative myocardial infarction
300812|NCT01661101|Myocardial injury|myocardial injury
300813|NCT01661101|noncardiac surgery|noncardiac surgery
300814|NCT01661088|Neoadjuvant FOLFIRINOX|neoadjuvant folfirinox
300815|NCT01661088|FDR-Gemcitabine|fdr-gemcitabine
300816|NCT01661088|Concurrent|concurrent
300817|NCT01661088|IMRT|imrt
300818|NCT01661088|Borderline Resectable Pancreatic Cancer|borderline resectable pancreatic cancer
300819|NCT01661075|mTBI|mtbi
300820|NCT01661075|concussion|concussion
300821|NCT01661075|mild traumatic brain injury|mild traumatic brain injury
300822|NCT01661075|athlete|athlete
300823|NCT01661075|college|college
300824|NCT01661075|football|football
300825|NCT01661075|soccer|soccer
300826|NCT01661036|Cognitive Testing|cognitive testing
300827|NCT01661036|Survey|survey
300828|NCT01661036|Interview|interview
300829|NCT01661023|Breast Cancer|breast cancer
300830|NCT01661023|Epidemiology|epidemiology
300831|NCT01661010|Infertility|infertility
300832|NCT01661010|Male Factor Infertility|male factor infertility
300833|NCT01661010|Female Factor Infertility|female factor infertility
300834|NCT01661010|Unexplained Infertility|unexplained infertility
300835|NCT01661010|Sex Chromosome|sex chromosome
300836|NCT01661010|Klinefelter Syndrome|klinefelter syndrome
300837|NCT01661010|Turner's Syndrome|turner's syndrome
300839|NCT01661010|Y Chromosome Deletion|y chromosome deletion
300840|NCT01661010|Aneuploidy|aneuploidy
300841|NCT01660997|Proteasome Inhibitor|proteasome inhibitor
300842|NCT01660997|Induction Combination Therapy|induction combination therapy
300843|NCT01660997|Maintenance Strategy|maintenance strategy
300844|NCT01660997|Potent Anti-Myeloma Effect|potent anti-myeloma effect
300845|NCT01660997|Precursor Disease|precursor disease
300846|NCT01660984|Thyroid Tumor|thyroid tumor
300847|NCT01660984|Multiple Endocrine Neoplasia 2|multiple endocrine neoplasia 2
300848|NCT01660984|Pheochromocytoma|pheochromocytoma
300849|NCT01660984|RET Mutations|ret mutations
300850|NCT01660958|Micronutrient Deficiencies|micronutrient deficiencies
300851|NCT01660958|Early Child Development|early child development
300852|NCT01660958|Infant Growth|infant growth
300853|NCT01660958|Iron Deficiency|iron deficiency
301097|NCT01659606|campath|campath
300854|NCT01660945|statins, insulin resistance|statins, insulin resistance
300855|NCT01660932|insulin resistance|insulin resistance
300856|NCT01660919|insulin resistance|insulin resistance
300857|NCT01660893|operative|operative
300858|NCT01660893|dental procedure|dental procedure
300859|NCT01660867|hospital admission within 7 days of 3% NaCl nebulizer vs dexamethasone|hospital admission within 7 days of 3% nacl nebulizer vs dexamethasone
300860|NCT01660854|Plasmodium|plasmodium
300861|NCT01660854|falciparum|falciparum
300862|NCT01660854|malaria|malaria
300863|NCT01660854|heterologous|heterologous
300864|NCT01660854|immunity|immunity
300865|NCT01660841|Magnetic resonance imaging|magnetic resonance imaging
300866|NCT01660841|central nervous system|central nervous system
300867|NCT01660841|contrast media|contrast media
300868|NCT01660841|gadobutrol|gadobutrol
402027|NCT01233401|Pertussis, Vaccination, Adult|pertussis, vaccination, adult
300869|NCT01660828|Exercise induced (high sensitive) troponin release|exercise induced (high sensitive) troponin release
300870|NCT01660828|Ischemia reperfusion injury|ischemia reperfusion injury
300871|NCT01660828|Remote ischemic preconditioning|remote ischemic preconditioning
300872|NCT01660789|Obesity|obesity
300873|NCT01660789|Diabetes|diabetes
300874|NCT01660789|Physical activity|physical activity
300875|NCT01660776|diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
300876|NCT01660776|Hodgkin lymphoma|hodgkin lymphoma
300877|NCT01660776|metastatic breast cancer.|metastatic breast cancer.
300878|NCT01660776|non-small cell lung cancer|non-small cell lung cancer
300879|NCT01660750|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
300880|NCT01660750|transplant eligible multiple myeloma|transplant eligible multiple myeloma
300881|NCT01660737|Hay fever|hay fever
300882|NCT01660737|Pascallerg|pascallerg
300883|NCT01660711|neoadjuvant|neoadjuvant
300884|NCT01660711|chemotherapy|chemotherapy
300885|NCT01660711|resectable|resectable
300886|NCT01660711|adjuvant|adjuvant
300887|NCT01660711|pancreas|pancreas
300888|NCT01660711|cancer|cancer
300889|NCT01660711|adenocarcinoma|adenocarcinoma
300890|NCT01660711|surgery|surgery
300891|NCT01660685|Weight loss|weight loss
300892|NCT01660685|Web-based|web-based
300893|NCT01660685|Journaling|journaling
300894|NCT01660685|Body Mass Index between 27 and 45|body mass index between 27 and 45
300895|NCT01660659|Indoor air pollution|indoor air pollution
300896|NCT01660659|pneumococcal carriage|pneumococcal carriage
300897|NCT01660646|Tuberculosis case finding|tuberculosis case finding
300898|NCT01660633|Multiple Myeloma|multiple myeloma
300899|NCT01660633|High-Dose Melphalan|high-dose melphalan
300900|NCT01660633|Propylene Glycol-Free|propylene glycol-free
300901|NCT01660633|Autologous Stem Cell Transplantation|autologous stem cell transplantation
300902|NCT01660633|Captisol|captisol
300903|NCT01660620|betaxolol/ retinopathy of prematurity|betaxolol/ retinopathy of prematurity
300904|NCT01660594|coronary disease|coronary disease
300905|NCT01660594|tomography, x-ray computed|tomography, x-ray computed
300906|NCT01660594|calcium|calcium
300907|NCT01660594|exercise test|exercise test
300908|NCT01660581|CD133+|cd133+
300909|NCT01660581|stem cells|stem cells
300910|NCT01660581|Coronary Artery Disease|coronary artery disease
300911|NCT01660581|Stable Angina Pectoris|stable angina pectoris
300912|NCT01659788|Advanced Reproductive Age|advanced reproductive age
300913|NCT01659788|poor ovarian response|poor ovarian response
300914|NCT01659788|Mitochondrial dysfunction|mitochondrial dysfunction
300915|NCT01659788|Mitochondrial nutrients|mitochondrial nutrients
300917|NCT01659788|Electron transfer chain|electron transfer chain
300918|NCT01659762|inflammatory bowel disease|inflammatory bowel disease
300919|NCT01659762|Crohn's disease|crohn's disease
300920|NCT01659749|Genetics|genetics
300921|NCT01659749|Metabolic|metabolic
300922|NCT01659749|Nutrition|nutrition
300923|NCT01659749|Maternal PKU|maternal pku
300924|NCT01659749|Phenylketonuria (PKU)|phenylketonuria (pku)
300925|NCT01659723|Radio therapy|radio therapy
300926|NCT01659723|STRI|stri
300927|NCT01659723|Urinary bladder|urinary bladder
300928|NCT01659723|Hyperbaric Oxygen|hyperbaric oxygen
300929|NCT01659697|lifestyle|lifestyle
300930|NCT01659697|diabetes prevention|diabetes prevention
300932|NCT01659697|physical activity|physical activity
300933|NCT01659684|congenital CMV infection|congenital cmv infection
300934|NCT01659684|standard immunoglobulins|standard immunoglobulins
302364|NCT01653717|Leukemia|leukemia
300935|NCT01659684|immunoglobulin therapy|immunoglobulin therapy
300936|NCT01659684|IgG CMV avidity index|igg cmv avidity index
300937|NCT01659684|Cytomegalovirus|cytomegalovirus
300938|NCT01659658|MLN9708|mln9708
300939|NCT01659658|Amyloidosis|amyloidosis
300940|NCT01659658|Light Chain|light chain
300941|NCT01659658|IXAZOMIB|ixazomib
300942|NCT01659658|Tourmaline AL1|tourmaline al1
300943|NCT01659658|Drug Therapy|drug therapy
300944|NCT01660555|Microbiota|microbiota
300945|NCT01660555|HITChip|hitchip
300946|NCT01660555|biopsies|biopsies
300947|NCT01660555|colon|colon
300948|NCT01660555|protected biopsies|protected biopsies
300949|NCT01660529|Subjects with metastatic breast cancer who have failed at least one standard|subjects with metastatic breast cancer who have failed at least one standard
300950|NCT01660529|of care regimen|of care regimen
300951|NCT01660516|Camellia sinensis|camellia sinensis
300952|NCT01660516|flavonoids|flavonoids
300953|NCT01660516|cardiovascular risk|cardiovascular risk
300954|NCT01660516|flow mediated dilation|flow mediated dilation
300955|NCT01660503|Calcium absorption|calcium absorption
300956|NCT01660503|Osteoporosis|osteoporosis
300957|NCT01660503|Bone Health|bone health
300958|NCT01660503|Adolescent|adolescent
300959|NCT01660490|Radiographic Image Enhancement,|radiographic image enhancement,
300960|NCT01660490|Intraoperative Care|intraoperative care
300961|NCT01660490|Femoral Fractures|femoral fractures
300962|NCT01660490|Femoral Neck Fractures|femoral neck fractures
300963|NCT01660490|Hip Fractures, Internal Fixators|hip fractures, internal fixators
300964|NCT01660490|Fracture Fixation Internal|fracture fixation internal
300965|NCT01660490|Fracture Fixation Intramedullary|fracture fixation intramedullary
300966|NCT01660490|Fractures Bone|fractures bone
300967|NCT01660477|Isavuconazole|isavuconazole
300968|NCT01660477|Lopinavir/ritonavir|lopinavir/ritonavir
300969|NCT01660477|Healthy Volunteers|healthy volunteers
300970|NCT01660477|BAL8557|bal8557
300971|NCT01660477|Kaletra ®|kaletra ®
300972|NCT01660464|Program evaluation|program evaluation
300973|NCT01660464|ADHD|adhd
300974|NCT01660451|Clinical trial, phase II|clinical trial, phase ii
300975|NCT01660451|Phosphatidylinositol 3-Kinase|phosphatidylinositol 3-kinase
300976|NCT01660451|Class I, Non-Hodgkin's lymphoma|class i, non-hodgkin's lymphoma
300977|NCT01660438|Stress urinary incontinence|stress urinary incontinence
300978|NCT01660438|Suburethral sling|suburethral sling
300979|NCT01660425|Attention deficit-/hyperactivity disorder|attention deficit-/hyperactivity disorder
300980|NCT01660425|parenting enhancement training|parenting enhancement training
300981|NCT01660425|guided self-help|guided self-help
300982|NCT01660425|methylphenidate|methylphenidate
300983|NCT01660412|Pain|pain
300984|NCT01660412|Alkalinization|alkalinization
300985|NCT01660412|Technetium 99m Sulfur Colloid|technetium 99m sulfur colloid
300986|NCT01660412|sentinel lymphoscintigraphy?|sentinel lymphoscintigraphy?
300987|NCT01660399|salvage chemotherapy|salvage chemotherapy
300988|NCT01660399|advanced squamous cell lung cancer|advanced squamous cell lung cancer
300989|NCT01660399|Boanmycin|boanmycin
300990|NCT01660386|Type 2 Diabetes|type 2 diabetes
300991|NCT01660386|Dpp-4 inhibitor|dpp-4 inhibitor
300992|NCT01660386|Sulfonylurea|sulfonylurea
300993|NCT01660386|beta cell function|beta cell function
300994|NCT01660373|ticagrelor|ticagrelor
300995|NCT01660373|tirofiban|tirofiban
300996|NCT01660373|glycoprotein IIa/IIIa inhibitors|glycoprotein iia/iiia inhibitors
300997|NCT01660373|P2Y12 blockers|p2y12 blockers
300998|NCT01660373|acute coronary syndrome|acute coronary syndrome
300999|NCT01660360|Tanibirumab Phase I trial|tanibirumab phase i trial
301000|NCT01660334|Systemic Mycosis|systemic mycosis
301001|NCT01660334|Scedosporium infection|scedosporium infection
301002|NCT01660334|Scedosporisis|scedosporisis
301003|NCT01660334|Japanese|japanese
301004|NCT01660334|voriconazole|voriconazole
301005|NCT01660334|VFEND|vfend
301006|NCT01660334|Regulatory Post Marketing Commitment Plan.|regulatory post marketing commitment plan.
301007|NCT01660321|Pediculosis capitis|pediculosis capitis
301008|NCT01660321|Head Lice|head lice
301009|NCT01660295|Severe renal insufficiency certoparin|severe renal insufficiency certoparin
301010|NCT01660295|Severe renal insufficiency|severe renal insufficiency
301011|NCT01660243|Pruritus|pruritus
301012|NCT01660243|Renal dialysis|renal dialysis
301013|NCT01660243|Receptors, Opioid, kappa|receptors, opioid, kappa
301014|NCT01660243|Sleep Disorders|sleep disorders
301015|NCT01660243|Quality of Life|quality of life
301016|NCT01660230|APC, 3K3A, 3K3A-APC, volunteer, healthy|apc, 3k3a, 3k3a-apc, volunteer, healthy
301017|NCT01660217|atopic dermatitis|atopic dermatitis
301018|NCT01660217|eczema action plan|eczema action plan
301019|NCT01660217|patient education|patient education
301020|NCT01660217|written handout|written handout
301021|NCT01660217|investigator's global assessment|investigator's global assessment
301022|NCT01660217|randomized controlled trial|randomized controlled trial
301023|NCT01660204|pneumonia, anti-bacterial agents, (cost)efficacy|pneumonia, anti-bacterial agents, (cost)efficacy
301024|NCT01660191|LDL, HDL|ldl, hdl
301025|NCT01660178|newborns|newborns
301026|NCT01660178|intensive care unit|intensive care unit
301027|NCT01660178|early stimulation|early stimulation
301028|NCT01660165|Nutritional status|nutritional status
301029|NCT01660165|Mental Health|mental health
301030|NCT01660165|Omega-3|omega-3
301031|NCT01660165|Pregnancy|pregnancy
301032|NCT01660165|Postpartum depression|postpartum depression
301033|NCT01660152|male erectile disorder|male erectile disorder
301034|NCT01660152|prostate cancer|prostate cancer
301035|NCT01660152|Laparoscopic prostatectomy|laparoscopic prostatectomy
301036|NCT01660126|Aged|aged
301037|NCT01660126|Cardiovascular disease|cardiovascular disease
301038|NCT01660126|Levothyroxine|levothyroxine
301039|NCT01660126|Randomised controlled trial|randomised controlled trial
301040|NCT01660126|Quality of life|quality of life
301041|NCT01660126|Subclinical hypothyroidism|subclinical hypothyroidism
301042|NCT01660100|Atrial fibrillation ablation|atrial fibrillation ablation
301043|NCT01660087|Exhaled breath condensate (EBC) method|exhaled breath condensate (ebc) method
301044|NCT01660087|Volatile Organic Compounds (VOCs)|volatile organic compounds (vocs)
301045|NCT01660087|Endobronchial Ultrasound (EBUS)|endobronchial ultrasound (ebus)
301046|NCT01660087|Confocal Endoscopy|confocal endoscopy
301047|NCT01660087|Exhaled alveolar gas|exhaled alveolar gas
301048|NCT01660074|glycemic index, resistant starch, glycemic response|glycemic index, resistant starch, glycemic response
301049|NCT01660061|Antiphospholipid syndrome|antiphospholipid syndrome
301050|NCT01660061|Antiphospholipid antibodies|antiphospholipid antibodies
301051|NCT01660061|Vitamin-K antagonists|vitamin-k antagonists
301052|NCT01660061|International normalized ratio|international normalized ratio
301053|NCT01660061|Chromogenic factor X|chromogenic factor x
402028|NCT01233375|cancer|cancer
301054|NCT01660048|Laparoscopic total extraperitoneal Inguinal hernia repair|laparoscopic total extraperitoneal inguinal hernia repair
301055|NCT01660022|Healthy|healthy
301056|NCT01660022|Volunteers|volunteers
301057|NCT01660009|Endothelial Function|endothelial function
301058|NCT01660009|Hypoglycemia|hypoglycemia
301059|NCT01660009|Mitochondria|mitochondria
301060|NCT01659996|Meningitis|meningitis
301061|NCT01659996|Meningococcal Infection|meningococcal infection
301062|NCT01659996|Diphtheria|diphtheria
301063|NCT01659996|Pertussis|pertussis
301064|NCT01659996|Menactra®|menactra®
301065|NCT01659996|Pentacel®|pentacel®
301066|NCT01659983|complicated appendicitis|complicated appendicitis
301067|NCT01659983|wound closure|wound closure
301068|NCT01659983|infection|infection
301069|NCT01659957|Alcoholism|alcoholism
301070|NCT01659957|Couples|couples
301071|NCT01659944|Drug-drug interaction|drug-drug interaction
301072|NCT01659879|Parents|parents
301073|NCT01659879|Caregivers|caregivers
301074|NCT01659879|Anxiety|anxiety
301075|NCT01659879|Consumer satisfaction|consumer satisfaction
301076|NCT01659866|Infection|infection
301077|NCT01659866|Antibiotic resistance|antibiotic resistance
301078|NCT01659866|Prostate biopsy|prostate biopsy
372984|NCT01355926|11-034|11-034
301079|NCT01659840|laser,|laser,
301080|NCT01659840|quality of life,|quality of life,
301081|NCT01659840|orofacial pain|orofacial pain
301082|NCT01659814|Major Depressive Disorder|major depressive disorder
301083|NCT01659814|Anhedonia|anhedonia
301084|NCT01659814|Dopamine|dopamine
301085|NCT01659814|Electroencephalography (EEG)|electroencephalography (eeg)
301086|NCT01659814|Positron Emission Tomography (PET)|positron emission tomography (pet)
301087|NCT01659814|Reward|reward
301088|NCT01659801|cataract|cataract
301089|NCT01659801|cataract surgery|cataract surgery
301090|NCT01659801|intaocular lens|intaocular lens
301091|NCT01659801|toric lens|toric lens
301092|NCT01659606|dyskeratosis congenita|dyskeratosis congenita
301093|NCT01659606|bone marrow failure|bone marrow failure
301094|NCT01659606|aplastic anemia|aplastic anemia
301095|NCT01659606|bone marrow transplantation|bone marrow transplantation
301096|NCT01659606|reduced intensity conditioning|reduced intensity conditioning
301098|NCT01659606|fludarabine|fludarabine
301099|NCT01659606|telomere|telomere
301100|NCT01659593|cognitive disorders|cognitive disorders
301101|NCT01659593|multiple sclerosis|multiple sclerosis
301102|NCT01659593|neuropsychology|neuropsychology
301103|NCT01659580|Angina Pectoris Treatment Prevention|angina pectoris treatment prevention
301104|NCT01659554|Primary peritoneal|primary peritoneal
301105|NCT01659541|spinal cord injury|spinal cord injury
301106|NCT01659541|paralysis|paralysis
301107|NCT01659541|cough|cough
301108|NCT01659541|cervical spinal cord injury|cervical spinal cord injury
301109|NCT01659541|thoracic spinal cord injury|thoracic spinal cord injury
301110|NCT01659528|Penis|penis
301111|NCT01659528|Micropenis|micropenis
301112|NCT01659528|Nomograms|nomograms
301113|NCT01659528|Ultrasound|ultrasound
301114|NCT01659528|Fetus|fetus
301115|NCT01659502|Patients|patients
301116|NCT01659489|adnexal torsion|adnexal torsion
301117|NCT01659489|laparoscopy|laparoscopy
301118|NCT01659476|methacholine|methacholine
301119|NCT01659476|deep inspiration|deep inspiration
301120|NCT01659476|bronchoprotective effect|bronchoprotective effect
301121|NCT01659476|bronchodilating effect|bronchodilating effect
301122|NCT01659463|CARIES INFILTRATION|caries infiltration
301123|NCT01659463|CARIES LESION|caries lesion
301124|NCT01659463|INFILTRANT|infiltrant
301125|NCT01659450|overweight|overweight
301126|NCT01659450|obesity|obesity
301127|NCT01659450|low energy dense|low energy dense
301128|NCT01659437|M. ulcerans|m. ulcerans
301129|NCT01659437|Buruli ulcer|buruli ulcer
301130|NCT01659437|drug trial|drug trial
301131|NCT01659437|clarithromycin|clarithromycin
301132|NCT01659424|Rectal cancer|rectal cancer
301133|NCT01659411|Congenital Heart Disease|congenital heart disease
301134|NCT01659411|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
301135|NCT01659398|Alzheimer's Disease|alzheimer's disease
301136|NCT01659398|cerebral blood flow|cerebral blood flow
301137|NCT01659398|ophthalmic blood flow|ophthalmic blood flow
301138|NCT01659398|blood viscosity|blood viscosity
301139|NCT01659372|temporomandibular disorder|temporomandibular disorder
301140|NCT01659372|myofascial pain syndrome|myofascial pain syndrome
301141|NCT01659333|Peritoneal, Dialysis|peritoneal, dialysis
301142|NCT01659307|Acute Lung Injury|acute lung injury
301143|NCT01659307|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
301144|NCT01659307|Aspirin|aspirin
301145|NCT01659294|Type 2 diabetes|type 2 diabetes
301146|NCT01659294|outcomes|outcomes
301147|NCT01659294|case management|case management
301148|NCT01659281|Artesunate|artesunate
301149|NCT01659281|Mefloquine|mefloquine
301150|NCT01659281|Plasmodium Falciparum|plasmodium falciparum
301151|NCT01659281|Thailand|thailand
301152|NCT01659281|Uncomplicated Plasmodium Falciparum malaria|uncomplicated plasmodium falciparum malaria
301153|NCT01659268|teaching|teaching
301154|NCT01659268|patient simulation|patient simulation
301155|NCT01659268|laryngeal masks|laryngeal masks
301156|NCT01659268|baccalaureate nursing education|baccalaureate nursing education
301157|NCT01659268|teaching strategies|teaching strategies
301158|NCT01659268|simulation|simulation
301159|NCT01659242|Rheumatoid arthritis|rheumatoid arthritis
301160|NCT01659242|Ultrasound|ultrasound
301161|NCT01659242|Magnetic Resonance Imaging|magnetic resonance imaging
301162|NCT01659229|knee osteoarthritis|knee osteoarthritis
301163|NCT01659216|Electrical Pudendal Nerve Stimulation|electrical pudendal nerve stimulation
301164|NCT01659216|Urgency-Frequency Syndrome|urgency-frequency syndrome
301165|NCT01659216|long-term efficacy|long-term efficacy
301166|NCT01659203|extraskeletal chondrosarcoma|extraskeletal chondrosarcoma
301167|NCT01659164|Cognitive Behavioral Therapy|cognitive behavioral therapy
301168|NCT01659164|Dialectical Behavioral Therapy|dialectical behavioral therapy
301169|NCT01659164|Group Treatment|group treatment
301170|NCT01659164|ADHD|adhd
301171|NCT01659151|metastatic|metastatic
301172|NCT01659151|melanoma|melanoma
301173|NCT01659151|cell transfer|cell transfer
301174|NCT01659151|ACT|act
301175|NCT01659151|T-cell|t-cell
301176|NCT01659151|immunotherapy|immunotherapy
301177|NCT01659151|antibodies|antibodies
301178|NCT01659151|lymphocytes|lymphocytes
301179|NCT01659112|core stabilization, upper extremity, kinetic chain, movement|core stabilization, upper extremity, kinetic chain, movement
301180|NCT01659099|DLBCL|dlbcl
301181|NCT01659099|aa-IPI > or equal to 1|aa-ipi > or equal to 1
301182|NCT01659099|Diagnosis|diagnosis
301183|NCT01659099|18 to 60 years|18 to 60 years
301184|NCT01659099|Lymphoma|lymphoma
301185|NCT01659086|Influenza|influenza
301186|NCT01659086|Immunogenicity|immunogenicity
301187|NCT01659086|H9N2|h9n2
301188|NCT01659086|Safety|safety
301189|NCT01659073|Caloric Vestibular Stimulation|caloric vestibular stimulation
301190|NCT01659073|Functional Imaging|functional imaging
301191|NCT01659060|Cacao|cacao
301192|NCT01659060|Chocolate|chocolate
301193|NCT01659060|Theobromine|theobromine
301194|NCT01659060|Flavonoids|flavonoids
301195|NCT01659060|Pregnant women|pregnant women
301196|NCT01659060|Hypertension pregnancy-induced|hypertension pregnancy-induced
301197|NCT01659060|Pre-eclampsia|pre-eclampsia
301198|NCT01659060|Epicatechin|epicatechin
301199|NCT01659047|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
301200|NCT01659047|CLL|cll
301201|NCT01659047|CAL-101|cal-101
301202|NCT01659047|Ofatumumab|ofatumumab
301203|NCT01659034|Anti-platelet therapy|anti-platelet therapy
301204|NCT01659021|CLL|cll
301205|NCT01659021|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
301206|NCT01659021|GS-1101|gs-1101
301207|NCT01659021|CAL-101|cal-101
301208|NCT01659021|Ofatumumab|ofatumumab
301209|NCT01659008|acute cyclical heavy menstrual bleeding|acute cyclical heavy menstrual bleeding
301210|NCT01658995|Implanon|implanon
301211|NCT01658995|Etonogestrel subdermal implant|etonogestrel subdermal implant
301212|NCT01658995|Nexplanon|nexplanon
301213|NCT01658995|Contraception|contraception
301214|NCT01658995|Irregular Bleeding|irregular bleeding
301215|NCT01658995|Menometrorrhagia|menometrorrhagia
301216|NCT01658956|GCSF|gcsf
301217|NCT01658956|Chemotherapy|chemotherapy
301218|NCT01658956|Breast cancer|breast cancer
301219|NCT01658956|Prophylaxis|prophylaxis
301220|NCT01658917|Tissue Acquisition|tissue acquisition
301221|NCT01658904|Autologous Transplant|autologous transplant
301222|NCT01658904|Proteasome Inhibitor|proteasome inhibitor
301223|NCT01658904|Melphalan|melphalan
301224|NCT01658904|Filgrastim|filgrastim
301225|NCT01658839|pediatric glaucoma|pediatric glaucoma
301226|NCT01658839|pediatric ocular hypertension|pediatric ocular hypertension
301229|NCT01658826|Viral shedding|viral shedding
301230|NCT01658813|Metastatic Gastrointestinal|metastatic gastrointestinal
301231|NCT01658813|Metastatic Kidney|metastatic kidney
301232|NCT01658813|Metastatic Lung|metastatic lung
301233|NCT01658800|H5N1 Influenza|h5n1 influenza
301234|NCT01658800|H5N1 Influenza vaccine|h5n1 influenza vaccine
301235|NCT01658787|Aorta|aorta
301236|NCT01658761|Myopic traction maculopathy|myopic traction maculopathy
301237|NCT01658761|vitrectomy|vitrectomy
301238|NCT01658761|internal limiting membrane|internal limiting membrane
301239|NCT01658761|Retrospective, case control study|retrospective, case control study
301240|NCT01658748|Pilot Study|pilot study
301241|NCT01658748|Longitudinal Study|longitudinal study
301242|NCT01658748|Amygdaloid Body|amygdaloid body
301243|NCT01658748|Insula of Reil|insula of reil
301244|NCT01658748|Cortex, prefrontal|cortex, prefrontal
301245|NCT01658748|Stimulation, Deep Brain|stimulation, deep brain
301246|NCT01658748|Chronic Post Traumatic Stress Disorder|chronic post traumatic stress disorder
301247|NCT01658748|Combat Stress Disorder|combat stress disorder
301248|NCT01658748|Social Adjustments|social adjustments
301249|NCT01658748|Positron-Emission Tomography, Computed Tomography|positron-emission tomography, computed tomography
301250|NCT01658735|Chronic low back pain|chronic low back pain
301251|NCT01658735|Electrotherapy|electrotherapy
301252|NCT01658735|H-Wave|h-wave
301253|NCT01658735|H wave|h wave
301254|NCT01658735|TENS|tens
301255|NCT01658735|Trial|trial
301256|NCT01658683|Coronary Artery Disease|coronary artery disease
301257|NCT01658683|Cardiac Rehabilitation|cardiac rehabilitation
301258|NCT01658683|Exercise Maintenance|exercise maintenance
301259|NCT01658683|Facilitator|facilitator
301260|NCT01658683|Managed Home Exercise|managed home exercise
301261|NCT01658683|Community Based Exercise|community based exercise
301262|NCT01658670|Heart failure|heart failure
301263|NCT01658670|exercise|exercise
301264|NCT01658670|adherence|adherence
301265|NCT01658670|quality of life|quality of life
301266|NCT01658644|Patient satisfaction|patient satisfaction
301267|NCT01658644|Memory recall|memory recall
301268|NCT01658644|Patient-clinician communication|patient-clinician communication
301269|NCT01658644|health communication|health communication
301270|NCT01658644|clinical care team recall|clinical care team recall
301271|NCT01658644|hospital quality of care|hospital quality of care
301272|NCT01658618|Venous leg ulcer|venous leg ulcer
301273|NCT01658618|ulcer|ulcer
301274|NCT01658618|venous stasis|venous stasis
301275|NCT01658618|compression|compression
373351|NCT01354314|HIV|hiv
301276|NCT01658618|venous|venous
301277|NCT01658618|venous stasis ulcer|venous stasis ulcer
301278|NCT01658618|vlu|vlu
301279|NCT01658618|hp802-247-09-029|hp802-247-09-029
301280|NCT01658605|GSK1605786|gsk1605786
301281|NCT01658605|ulcerative colitis|ulcerative colitis
301282|NCT01658605|CCR9 antagonist|ccr9 antagonist
301283|NCT01658605|proof of concept|proof of concept
301284|NCT01658592|Alcohol Addiction;|alcohol addiction;
301285|NCT01658592|Deep Brain Stimulation;|deep brain stimulation;
301286|NCT01658592|Nucleus Accumbens;|nucleus accumbens;
301287|NCT01658592|Ventral Anterior Internal capsule;|ventral anterior internal capsule;
301288|NCT01658553|solid tumors|solid tumors
301289|NCT01658540|Drug Eluting Balloon (DEB) technology|drug eluting balloon (deb) technology
301290|NCT01658540|long SFA lesions disease|long sfa lesions disease
301291|NCT01658527|metastatic|metastatic
301292|NCT01658527|prostate cancer|prostate cancer
301293|NCT01658488|Iron deficiency anemia|iron deficiency anemia
301294|NCT01658488|rice|rice
301295|NCT01658475|IgG titer|igg titer
301296|NCT01658475|periodontopathic bacteria|periodontopathic bacteria
301297|NCT01658462|locally recurrent or metastatic breast cancer|locally recurrent or metastatic breast cancer
301298|NCT01658462|Docetaxel|docetaxel
301299|NCT01658462|Nintedanib|nintedanib
301300|NCT01658436|advanced pancreatic neuroendocrine tumor|advanced pancreatic neuroendocrine tumor
301301|NCT01658436|BEZ235|bez235
301302|NCT01658436|pNET|pnet
301303|NCT01658423|pubic hair|pubic hair
301304|NCT01658423|sprint velocity|sprint velocity
301305|NCT01658423|vertical jump height|vertical jump height
301306|NCT01658423|body composition|body composition
301307|NCT01658423|maximal voluntary torque|maximal voluntary torque
301308|NCT01658410|Coronary artery disease|coronary artery disease
301309|NCT01658410|bypass grafting|bypass grafting
301310|NCT01658397|Healthy subjects|healthy subjects
301311|NCT01658397|Fasting|fasting
301312|NCT01658397|Weight loss|weight loss
301313|NCT01658371|HIV|hiv
301314|NCT01658358|ErbB receptor|erbb receptor
301315|NCT01658358|tyrosine kinase inhibitor|tyrosine kinase inhibitor
301316|NCT01658358|Anthracycline|anthracycline
301317|NCT01658345|aortic stenosis|aortic stenosis
301318|NCT01658345|asymptomatic|asymptomatic
301319|NCT01658345|microvascular dysfunction|microvascular dysfunction
301320|NCT01658345|Cardiac MRI|cardiac mri
301321|NCT01658332|lung cancer|lung cancer
301322|NCT01658332|circulating tumor cells|circulating tumor cells
301323|NCT01658332|prospective|prospective
301324|NCT01658332|monocentrique trial|monocentrique trial
301325|NCT01658306|remote ischemic preconditioning|remote ischemic preconditioning
301326|NCT01658306|random-controlled|random-controlled
301327|NCT01658306|double blind|double blind
301328|NCT01658306|RIPC|ripc
301329|NCT01658293|stroke|stroke
301330|NCT01658293|follow up|follow up
301331|NCT01658293|upper limb|upper limb
301332|NCT01658293|rehabilitation|rehabilitation
301433|NCT01657916|Urinary retention|urinary retention
301340|NCT01658228|Depression|depression
301341|NCT01658228|Dysthymia|dysthymia
301342|NCT01658228|Cognitive Impairment|cognitive impairment
301343|NCT01658228|Cognitive Decline|cognitive decline
301344|NCT01658228|Memory|memory
301345|NCT01658215|Smoking cessation|smoking cessation
301346|NCT01658215|Nicotine|nicotine
301347|NCT01658215|Tobacco Use Disorder|tobacco use disorder
301348|NCT01658215|Central Nervous System Agents|central nervous system agents
301349|NCT01658202|Smoking cessation|smoking cessation
301350|NCT01658202|Nicotine|nicotine
301351|NCT01658202|Tobacco Use Disorder|tobacco use disorder
301352|NCT01658202|Central Nervous System Agents|central nervous system agents
301353|NCT01658176|Estrogen receptor positive|estrogen receptor positive
301354|NCT01658176|Her-2 negative|her-2 negative
301355|NCT01658176|advanced breast cancer|advanced breast cancer
301356|NCT01658176|Breast Cancer|breast cancer
301357|NCT01658163|abdominoplasty,|abdominoplasty,
402029|NCT01233375|metastatic|metastatic
301358|NCT01658163|skin closure, dressings|skin closure, dressings
301359|NCT01658150|Cognition|cognition
301360|NCT01658150|Schizophrenia|schizophrenia
301361|NCT01658150|Schizoaffective disorder|schizoaffective disorder
301363|NCT01658137|dietary pattern|dietary pattern
301364|NCT01658137|gene|gene
301365|NCT01658137|gene expression|gene expression
301366|NCT01658137|epigenomics|epigenomics
301367|NCT01658137|diet-gene interaction|diet-gene interaction
301368|NCT01658137|inflammation|inflammation
301369|NCT01658137|9p21|9p21
301370|NCT01658137|fruits|fruits
301371|NCT01658137|vegetables|vegetables
301372|NCT01658124|haemorrhage,antifibrinolytic, clinical trial,|haemorrhage,antifibrinolytic, clinical trial,
301373|NCT01658111|Stroke|stroke
301374|NCT01658111|Robots|robots
301375|NCT01658111|EEG|eeg
301376|NCT01658111|EMG|emg
301377|NCT01658098|postpartum|postpartum
301378|NCT01658098|depression|depression
301379|NCT01658098|edinburgh postpartum depression scale|edinburgh postpartum depression scale
301380|NCT01658098|mexican population|mexican population
291966|NCT01699724|ODT|odt
301381|NCT01658085|Thyroidectomy|thyroidectomy
301382|NCT01658085|Multinodular goiter|multinodular goiter
301383|NCT01658085|Harmonic Focus|harmonic focus
301384|NCT01658085|budget impact|budget impact
301385|NCT01658085|Harmonic scalpel|harmonic scalpel
301386|NCT01658072|Total Hip Arthroplasty|total hip arthroplasty
301387|NCT01658072|Total Hip Replacement|total hip replacement
301388|NCT01658046|COPD|copd
301389|NCT01658046|exercise|exercise
301390|NCT01658046|neuromuscular electrical stimulation|neuromuscular electrical stimulation
301391|NCT01658033|Metastatic Breast Cancer, Her-2 negative Breast Cancer|metastatic breast cancer, her-2 negative breast cancer
301392|NCT01658033|Avastin, FOLFOX regimen|avastin, folfox regimen
301393|NCT01658020|Acute exacerbation of Chronic obstructive pulmonary disease|acute exacerbation of chronic obstructive pulmonary disease
301394|NCT01658020|Acute Exacerbation|acute exacerbation
301395|NCT01658020|Chronic obstructive pulmonary disease(COPD)|chronic obstructive pulmonary disease(copd)
301396|NCT01658020|Zabofloxacin|zabofloxacin
301397|NCT01658020|Moxifloxacin|moxifloxacin
301398|NCT01657994|cerebral palsy|cerebral palsy
301399|NCT01657994|gait training|gait training
301400|NCT01657994|robotic|robotic
301401|NCT01657994|functional electrical stimulation|functional electrical stimulation
301402|NCT01657981|Pharmacokinetics|pharmacokinetics
301403|NCT01657981|Phase 1|phase 1
301404|NCT01657981|14C-labeled|14c-labeled
301405|NCT01657968|Acute tonsillitis|acute tonsillitis
301406|NCT01657968|Procalcitonin|procalcitonin
301407|NCT01657968|Streptococcal antigen test|streptococcal antigen test
301408|NCT01657968|Centor Criteria|centor criteria
301409|NCT01657968|Infection marker|infection marker
301419|NCT01657929|Influenza|influenza
301420|NCT01657929|Avian|avian
301421|NCT01657929|H5N1|h5n1
301422|NCT01657929|H5-VLP|h5-vlp
301423|NCT01657929|GLA|gla
301424|NCT01657929|GLA-AF|gla-af
301425|NCT01657916|mid-urethral sling|mid-urethral sling
301426|NCT01657916|Align urethral support system|align urethral support system
301427|NCT01657916|tension free vaginal tape|tension free vaginal tape
301428|NCT01657916|cough stress test|cough stress test
301429|NCT01657916|pelvic exam|pelvic exam
301430|NCT01657916|PFDI-20|pfdi-20
301431|NCT01657916|PFIQ|pfiq
301432|NCT01657916|SSQ|ssq
301434|NCT01657916|mesh erosion|mesh erosion
301435|NCT01657916|urodynamics|urodynamics
301436|NCT01657890|isavuconazole|isavuconazole
301437|NCT01657890|BAL8557|bal8557
301438|NCT01657864|Aseptic Meningitis|aseptic meningitis
301439|NCT01657864|Epidemiology|epidemiology
301440|NCT01657864|Bipolar Disorder|bipolar disorder
301441|NCT01657864|Lamotrigine|lamotrigine
301442|NCT01657864|Epilepsy|epilepsy
301443|NCT01657838|Isavuconazole|isavuconazole
301444|NCT01657838|Ketoconazole|ketoconazole
301445|NCT01657838|Healthy Volunteers|healthy volunteers
301446|NCT01657838|BAL8557|bal8557
301447|NCT01657838|BAL4815|bal4815
301448|NCT01657825|isavuconazole|isavuconazole
301449|NCT01657825|warfarin|warfarin
301450|NCT01657825|Healthy Volunteers|healthy volunteers
301451|NCT01657825|BAL8557|bal8557
301452|NCT01657825|Coumadin|coumadin
301453|NCT01657812|dexmedetomidine|dexmedetomidine
301454|NCT01657812|Epidural Anesthesia|epidural anesthesia
301455|NCT01657812|stress response|stress response
301456|NCT01657812|anesthesia recovery|anesthesia recovery
301457|NCT01657786|ondanstron|ondanstron
301458|NCT01657786|gene polymorphism|gene polymorphism
301459|NCT01657786|postoperative nausea and vomiting|postoperative nausea and vomiting
301460|NCT01657786|laparoscopic surgery under general anesthesia|laparoscopic surgery under general anesthesia
301461|NCT01657760|craving|craving
301462|NCT01657760|dopamine|dopamine
301463|NCT01657760|citalopram|citalopram
301464|NCT01657760|ssri|ssri
301465|NCT01657747|Ovarian carcinoma|ovarian carcinoma
301466|NCT01657747|Staging|staging
301467|NCT01657747|Early treatment follow-up|early treatment follow-up
301468|NCT01657747|Identifying tumor recurrence|identifying tumor recurrence
301469|NCT01657747|Whole body diffusion-weighted MRI|whole body diffusion-weighted mri
301470|NCT01657734|therapy-induced inflammatory response with|therapy-induced inflammatory response with
301471|NCT01657734|magnetic resonance imaging|magnetic resonance imaging
301472|NCT01657695|HCC|hcc
301473|NCT01657695|Computed tomography|computed tomography
301474|NCT01657695|Gene expression|gene expression
301475|NCT01657695|Fractional growth|fractional growth
301476|NCT01657682|FLT3|flt3
301477|NCT01657682|Crenolanib|crenolanib
301478|NCT01657682|Acute|acute
301479|NCT01657682|Myeloid|myeloid
301480|NCT01657682|AML|aml
301481|NCT01657669|Choroidal neovascularization due to AMD|choroidal neovascularization due to amd
301482|NCT01657643|Health related quality of life|health related quality of life
301483|NCT01657643|Functional Status|functional status
301484|NCT01657630|Insulin Pump Therapy|insulin pump therapy
301485|NCT01657630|Type 1 Diabetes|type 1 diabetes
301486|NCT01657630|Treatment Satisfaction|treatment satisfaction
301487|NCT01657604|CML|cml
301488|NCT01657604|Tasigna|tasigna
301489|NCT01657604|Nilotinib|nilotinib
301490|NCT01657604|Interferon|interferon
301491|NCT01657591|skin cancer|skin cancer
301492|NCT01657591|unresectable|unresectable
301493|NCT01657591|BRAF|braf
301494|NCT01657578|neonates|neonates
301495|NCT01657578|reflux disease|reflux disease
301496|NCT01657578|population pharmacokinetics, omeprazole|population pharmacokinetics, omeprazole
301497|NCT01657565|LOS|los
301498|NCT01657565|Ileus|ileus
301499|NCT01657565|Fever|fever
301500|NCT01657565|reoperation|reoperation
301501|NCT01657552|Drug interaction|drug interaction
301502|NCT01657552|INCIVEK (telaprevir),|incivek (telaprevir),
301503|NCT01657552|SB-497115 (eltrombopag)|sb-497115 (eltrombopag)
301504|NCT01657552|Pharmacokinetics|pharmacokinetics
301505|NCT01657552|Thrombocytopenia|thrombocytopenia
301506|NCT01657552|VICTRELIS (boceprevir)|victrelis (boceprevir)
301507|NCT01657526|Healthy adults|healthy adults
301508|NCT01657526|Safety|safety
301509|NCT01657526|Reactogenicity|reactogenicity
301510|NCT01657526|Immunogenicity|immunogenicity
301511|NCT01657526|Non-typeable H. Influenzae (NTHi)|non-typeable h. influenzae (nthi)
301512|NCT01657513|psoriasis|psoriasis
301513|NCT01657513|treatment failure|treatment failure
301514|NCT01657513|tnf-alfa|tnf-alfa
301515|NCT01657500|endothelial keratoplasty|endothelial keratoplasty
301516|NCT01657487|COPD|copd
301517|NCT01657487|Fluticasone/Salmeterol|fluticasone/salmeterol
301518|NCT01657487|high dose|high dose
301519|NCT01657448|Symptom of Dysuria|symptom of dysuria
301520|NCT01657435|Total hip replacement|total hip replacement
301521|NCT01657435|Total hip arthroplasty|total hip arthroplasty
301522|NCT01657435|Hip joint replacement|hip joint replacement
301523|NCT01657435|Hip prosthesis replacement|hip prosthesis replacement
301524|NCT01657422|Nutrition|nutrition
301525|NCT01657422|Physical Activity|physical activity
301527|NCT01657409|botulinum toxin|botulinum toxin
301528|NCT01657409|detrusor overactivity|detrusor overactivity
301529|NCT01657396|Oral Care|oral care
301530|NCT01657396|Oral Hygiene|oral hygiene
301531|NCT01657396|Intensive Care|intensive care
301532|NCT01657396|Mechanical Ventilation|mechanical ventilation
301533|NCT01657396|Chlorhexidine|chlorhexidine
301534|NCT01657331|Hodgkin Lymphoma|hodgkin lymphoma
301535|NCT01657331|Hodgkin Disease|hodgkin disease
301536|NCT01657331|Hodgkin's Disease|hodgkin's disease
301537|NCT01657331|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
301538|NCT01657331|ALCL|alcl
301539|NCT01657331|SGN+Benda|sgn+benda
301540|NCT01657331|Bendamustine|bendamustine
301541|NCT01657331|Brentuximab Vedotin|brentuximab vedotin
301542|NCT01657318|diabetic foot|diabetic foot
301543|NCT01657318|leg ulcer|leg ulcer
301544|NCT01657305|Split-Thickness Skin Graft Donor Site|split-thickness skin graft donor site
301545|NCT01657305|Split-thickness skin graft|split-thickness skin graft
301546|NCT01657305|STSG|stsg
301547|NCT01657305|Wound healing|wound healing
301548|NCT01657305|Skin grafting|skin grafting
301549|NCT01657305|Superficial wound|superficial wound
301550|NCT01657305|Partial-thickness wound|partial-thickness wound
301551|NCT01657305|Time to wound closure|time to wound closure
301552|NCT01657292|Wound healing|wound healing
301553|NCT01657292|Burn wound|burn wound
301554|NCT01657292|Superficial partial-thickness burn wound|superficial partial-thickness burn wound
301555|NCT01657292|Grade 2a burn wounds|grade 2a burn wounds
301556|NCT01657292|Time to wound closure|time to wound closure
301557|NCT01657279|stroke|stroke
301558|NCT01657279|risk score|risk score
301559|NCT01657279|iScore|iscore
301560|NCT01657279|outcomes|outcomes
301561|NCT01657279|mortality|mortality
301562|NCT01657279|disability|disability
301563|NCT01657279|institutionalization|institutionalization
301564|NCT01657227|diabetes|diabetes
301565|NCT01657227|self-management|self-management
301566|NCT01657227|lifestyle|lifestyle
301567|NCT01657227|diet|diet
301568|NCT01657227|physical exercise|physical exercise
402030|NCT01233375|pancreatic|pancreatic
301569|NCT01657227|computer-assisted decision support systems|computer-assisted decision support systems
301570|NCT01657188|Heart failure, congestive|heart failure, congestive
301571|NCT01657188|Sleep apnea syndromes|sleep apnea syndromes
301572|NCT01657188|Adaptive servoventilation|adaptive servoventilation
301573|NCT01657188|Prognosis|prognosis
301574|NCT01657188|Cheyne-Stokes respiration|cheyne-stokes respiration
301575|NCT01657175|Cancer|cancer
301576|NCT01657175|long-term follow-up|long-term follow-up
301577|NCT01657175|quality of life|quality of life
301578|NCT01657175|Surgery|surgery
301579|NCT01657175|Nursing|nursing
301580|NCT01657162|BA058|ba058
301581|NCT01657162|Abaloparatide-SC|abaloparatide-sc
301582|NCT01657162|abaloparatide|abaloparatide
301583|NCT01657162|ACTIVExtend|activextend
301584|NCT01657162|osteoporosis|osteoporosis
301585|NCT01657162|fracture|fracture
301586|NCT01657162|bone loss|bone loss
301587|NCT01657136|Inappropriate sinus tachycardia|inappropriate sinus tachycardia
301588|NCT01657136|ivabradine|ivabradine
301589|NCT01657136|beta blockers|beta blockers
301590|NCT01657123|exercise capacity|exercise capacity
301591|NCT01657123|Addison's disease|addison's disease
301592|NCT01657110|acne|acne
301593|NCT01657110|inflamed lesions|inflamed lesions
301594|NCT01657110|non-inflamed lesions|non-inflamed lesions
301595|NCT01657110|complementary medicine|complementary medicine
301596|NCT01657110|essential oil|essential oil
301597|NCT01657058|soluble fiber|soluble fiber
301598|NCT01657058|second meal effect|second meal effect
301599|NCT01657058|glycemia|glycemia
301600|NCT01657058|satiety|satiety
301601|NCT01657058|Individuals|individuals
301602|NCT01657045|Cicatrix|cicatrix
301603|NCT01657045|Wound healing|wound healing
301604|NCT01657032|diarrhea|diarrhea
301605|NCT01657032|probiotics|probiotics
301606|NCT01657032|diosmectite|diosmectite
301607|NCT01657006|Heart rate variability|heart rate variability
301608|NCT01657006|ischemic heart disease|ischemic heart disease
301609|NCT01657006|myocardial ischemia|myocardial ischemia
301610|NCT01656993|Aspirin|aspirin
301612|NCT01656993|aortopulmonary shunt|aortopulmonary shunt
301613|NCT01656993|cavopulmonary shunt|cavopulmonary shunt
301614|NCT01656993|shunt|shunt
301615|NCT01656993|TEG|teg
301616|NCT01656993|Antiplatelet|antiplatelet
301617|NCT01656967|Laryngeal Mask Airway|laryngeal mask airway
301618|NCT01656967|LMA|lma
301619|NCT01656967|Intubation|intubation
301620|NCT01656967|AMBU|ambu
301621|NCT01656967|AScope|ascope
301622|NCT01656967|Aura-I|aura-i
301623|NCT01656967|Fastrach|fastrach
301624|NCT01656967|Fiberoptic|fiberoptic
301625|NCT01656967|Disposable Fiberoptic|disposable fiberoptic
301626|NCT01656967|Blind Intubation|blind intubation
301627|NCT01656967|Fiberoptic Intubation|fiberoptic intubation
301628|NCT01656954|stroke volume|stroke volume
301629|NCT01656954|cardiac output|cardiac output
301637|NCT01656941|single ventricle cardiac disease|single ventricle cardiac disease
301638|NCT01656941|hypoplastic left heart syndrome|hypoplastic left heart syndrome
301639|NCT01656941|hypoplastic right heart syndrome|hypoplastic right heart syndrome
301640|NCT01656941|d-Transposition of the Great Arteries|d-transposition of the great arteries
301642|NCT01656915|response|response
301643|NCT01656915|resilience|resilience
301644|NCT01656915|cytokines|cytokines
301645|NCT01656915|pre-diabetes|pre-diabetes
301646|NCT01656902|Autologous Chondrocyte Transplantation|autologous chondrocyte transplantation
301647|NCT01656902|NOVOCART 3D plus|novocart 3d plus
301648|NCT01656902|knee joint pain|knee joint pain
301649|NCT01656902|safety|safety
301650|NCT01656902|efficacy|efficacy
301651|NCT01656902|treatment|treatment
301652|NCT01656902|TETEC|tetec
301653|NCT01656902|cartilage|cartilage
301654|NCT01656902|ACT|act
301655|NCT01656902|cartilage repair|cartilage repair
301656|NCT01656902|tissue|tissue
301657|NCT01656902|MOCART|mocart
301658|NCT01656889|Venous leg ulcer|venous leg ulcer
301659|NCT01656889|ulcer|ulcer
301660|NCT01656889|venous stasis|venous stasis
301661|NCT01656889|compression|compression
301662|NCT01656889|venous|venous
301663|NCT01656889|venous stasis ulcer|venous stasis ulcer
301664|NCT01656889|vlu|vlu
301665|NCT01656876|Comparative effectiveness research|comparative effectiveness research
301666|NCT01656876|Mirror therapy|mirror therapy
301667|NCT01656876|Stroke rehabilitation|stroke rehabilitation
301668|NCT01656876|Clinical evaluation|clinical evaluation
301669|NCT01656876|Kinematic analysis|kinematic analysis
301670|NCT01656876|Mesh glove|mesh glove
301671|NCT01656876|Combined therapy|combined therapy
301672|NCT01656863|Dehydration|dehydration
301673|NCT01656850|hyperglycemia|hyperglycemia
301674|NCT01656850|hyperinsulinemia|hyperinsulinemia
301675|NCT01656837|Substance Abuse|substance abuse
301676|NCT01656837|Child Maltreatment|child maltreatment
301677|NCT01656837|Multisystemic Therapy|multisystemic therapy
301678|NCT01656837|Child Trauma|child trauma
301679|NCT01656824|Bv8/PK-2|bv8/pk-2
301680|NCT01656824|MDSC Myeloid Derived Suppressor Cells|mdsc myeloid derived suppressor cells
301681|NCT01656824|BMDC Bone Marrow Derived Cells|bmdc bone marrow derived cells
301682|NCT01656824|Angiogenesis|angiogenesis
301683|NCT01656824|Pancreatic Cancer|pancreatic cancer
301684|NCT01656785|stroke|stroke
301685|NCT01656785|cerebrovascular disease|cerebrovascular disease
301686|NCT01656785|angiogenesis imaging|angiogenesis imaging
301687|NCT01656785|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
301688|NCT01656785|PET/CT|pet/ct
301689|NCT01656772|magnetic navigation|magnetic navigation
301690|NCT01656772|robotic control|robotic control
301691|NCT01656772|RMT ThermoCool catheter|rmt thermocool catheter
301692|NCT01656759|Blood Loss|blood loss
301693|NCT01656759|Hemoglobin|hemoglobin
301694|NCT01656759|Hematocrit|hematocrit
301695|NCT01656759|Blood Transfusions|blood transfusions
301696|NCT01656746|Colorectal Disease|colorectal disease
301697|NCT01656746|SILS|sils
301698|NCT01656746|colorectal surgery|colorectal surgery
301699|NCT01656733|Smoking Cessation|smoking cessation
301700|NCT01656733|Pregnancy|pregnancy
301701|NCT01656733|Nicotrol Inhaler|nicotrol inhaler
292257|NCT01699360|Hydrocortisone|hydrocortisone
292258|NCT01699360|Cortisone|cortisone
292259|NCT01699347|OK432, CYSTIC MALFORMATION|ok432, cystic malformation
292260|NCT01699334|Whiplash injuries|whiplash injuries
301702|NCT01656733|Placebo Inhaler|placebo inhaler
301703|NCT01656733|Nicotine Inhaler|nicotine inhaler
301704|NCT01656720|Faecal Incontinence|faecal incontinence
301705|NCT01656720|Suppository|suppository
301706|NCT01656720|Wexner score|wexner score
301707|NCT01656707|Adolescents|adolescents
301708|NCT01656707|Substance Use Disorders|substance use disorders
301709|NCT01656694|Osteoarthritis|osteoarthritis
301710|NCT01656694|Knee|knee
301711|NCT01656694|Replacement|replacement
301712|NCT01656694|Unicompartmental|unicompartmental
301713|NCT01656694|DePuy|depuy
301714|NCT01656694|Sigma HP|sigma hp
301715|NCT01656668|Chronic|chronic
301716|NCT01656668|Acute|acute
301717|NCT01656668|Persistent|persistent
301718|NCT01656668|Longterm|longterm
301719|NCT01656668|Cough|cough
301720|NCT01656655|ptsd, parenting|ptsd, parenting
301721|NCT01656642|PD-L1|pd-l1
301722|NCT01656642|PD-1|pd-1
301723|NCT01656642|PDL1|pdl1
301724|NCT01656642|antiPD-L1|antipd-l1
301725|NCT01656642|MPDL3280A|mpdl3280a
301726|NCT01656642|Melanoma|melanoma
301727|NCT01656642|BRAF|braf
301728|NCT01656642|MPDL320A|mpdl320a
301729|NCT01656616|Pharmacoeconomics|pharmacoeconomics
301730|NCT01656616|Cost effectiveness|cost effectiveness
301731|NCT01656616|Cyanide|cyanide
301732|NCT01656616|Fire|fire
301733|NCT01656616|Emergency Medical Services|emergency medical services
301734|NCT01656616|Smoke Inhalation|smoke inhalation
301735|NCT01656603|cord blood|cord blood
301736|NCT01656603|transplantation|transplantation
301737|NCT01656603|stem cells|stem cells
301738|NCT01656603|adverse event|adverse event
301739|NCT01656590|Pompe disease|pompe disease
301740|NCT01656590|Acid Maltase Deficiency|acid maltase deficiency
301741|NCT01656577|CRF1 antagonist|crf1 antagonist
301742|NCT01656577|Stress|stress
301743|NCT01656577|Eating Behavior|eating behavior
301744|NCT01656577|Food Craving|food craving
301745|NCT01656564|HIV|hiv
301746|NCT01656564|Pediatric|pediatric
301747|NCT01656564|ART|art
301938|NCT01655706|MDD|mdd
301754|NCT01656512|Osteoporosis|osteoporosis
301755|NCT01656486|Pancreas|pancreas
301756|NCT01656486|Pancreatic fistula|pancreatic fistula
301757|NCT01656486|Stereotactic radiation|stereotactic radiation
301758|NCT01656473|Concurrent Disorders|concurrent disorders
301759|NCT01656473|Adolescents|adolescents
301760|NCT01656473|Motivational Interviewing|motivational interviewing
301761|NCT01656473|Dialectical Behaviour Therapy|dialectical behaviour therapy
301762|NCT01656473|Caregiver Burden|caregiver burden
301763|NCT01656460|Lung Cancer|lung cancer
301764|NCT01656447|Scleroderma|scleroderma
301765|NCT01656447|Scleroderma Registry|scleroderma registry
301766|NCT01656447|Hospital for Special Surgery Scleroderma|hospital for special surgery scleroderma
301767|NCT01656434|Combined Oral Contraceptives|combined oral contraceptives
301768|NCT01656382|ABLC|ablc
301769|NCT01656382|cryptococcosis|cryptococcosis
301770|NCT01656369|Delorme operation,incontinence|delorme operation,incontinence
301771|NCT01656356|Avian Flu|avian flu
301772|NCT01656356|H5N2|h5n2
301773|NCT01656330|Healthy|healthy
301774|NCT01656330|Rivaroxaban|rivaroxaban
301775|NCT01656330|JNJ-39039039|jnj-39039039
301776|NCT01656330|BAY59-7939|bay59-7939
301777|NCT01656330|Prothrombin Complex Concentrate (PCC)|prothrombin complex concentrate (pcc)
301778|NCT01656317|SAH|sah
301779|NCT01656317|Early rehabilitation|early rehabilitation
301780|NCT01656317|Mobilisation|mobilisation
301781|NCT01656278|Arthritis, Rheumatoid/drug therapy|arthritis, rheumatoid/drug therapy
301782|NCT01656278|Arthritis, Rheumatoid/pathology|arthritis, rheumatoid/pathology
301783|NCT01656278|Disease Progression|disease progression
301784|NCT01656278|Longitudinal Studies|longitudinal studies
301785|NCT01656278|Prospective Studies|prospective studies
301786|NCT01656278|Imaging, Magnetic Resonance|imaging, magnetic resonance
301787|NCT01656278|Remission Induction|remission induction
301788|NCT01656278|Synovitis/immunology|synovitis/immunology
301789|NCT01656278|Synovitis/pathology|synovitis/pathology
301790|NCT01656278|Wrist Joint/pathology|wrist joint/pathology
301791|NCT01656278|Wrist Joint/physiopathology|wrist joint/physiopathology
301792|NCT01656252|Acute Leukemia|acute leukemia
301793|NCT01656252|Complete Remission|complete remission
301794|NCT01656252|Consolidation|consolidation
301795|NCT01656252|Consolidation Chemotherapy|consolidation chemotherapy
301796|NCT01656252|Cytarabine|cytarabine
301797|NCT01656252|Eltrombopag|eltrombopag
301798|NCT01656252|Leukemia|leukemia
301799|NCT01656252|Thrombocytopenia|thrombocytopenia
301800|NCT01656252|Thrombopoietin|thrombopoietin
752604|NCT01173289|External Beam Radiotherapy|external beam radiotherapy
301801|NCT01656239|VA106483, fedovapagon, Nocturia, males, nocturnal voids, anti-diuretic|va106483, fedovapagon, nocturia, males, nocturnal voids, anti-diuretic
301802|NCT01656226|Actinic Keratosis|actinic keratosis
301803|NCT01656226|AK|ak
301804|NCT01656213|Stroke|stroke
301805|NCT01656213|End Stage Renal Disease|end stage renal disease
301806|NCT01656213|Recovery|recovery
301807|NCT01656213|Haemodialysis|haemodialysis
301808|NCT01656200|Japanese encephalitis|japanese encephalitis
301809|NCT01656200|Japanese encephalitis vaccine|japanese encephalitis vaccine
301810|NCT01656200|T lymphocyte|t lymphocyte
301811|NCT01656200|Immune response|immune response
301818|NCT01656148|Multiple sclerosis|multiple sclerosis
301819|NCT01656148|Walking disablility|walking disablility
301820|NCT01656148|Mobility|mobility
301821|NCT01656148|Six Spot Step Test|six spot step test
301822|NCT01656148|Outcome measures|outcome measures
301823|NCT01656148|Fampridine-SR|fampridine-sr
301824|NCT01656148|Fampyra|fampyra
301825|NCT01656135|gold standard treatment|gold standard treatment
301826|NCT01656135|immune monitoring|immune monitoring
301827|NCT01656135|acute rejection|acute rejection
301828|NCT01656135|graft rejection|graft rejection
301829|NCT01656135|living-donor|living-donor
301830|NCT01656135|renal transplantation|renal transplantation
301831|NCT01656135|kidney transplantation|kidney transplantation
301832|NCT01656122|pharmacokinetic paramters|pharmacokinetic paramters
301833|NCT01656122|abacavir|abacavir
301834|NCT01656122|lamuvidine|lamuvidine
301835|NCT01656122|HIV-infected children|hiv-infected children
301836|NCT01656109|pharmacokinetics|pharmacokinetics
301837|NCT01656109|atazanavir/ritonavir|atazanavir/ritonavir
301838|NCT01656109|HIV-infected children|hiv-infected children
301839|NCT01656083|Mobile phone text messaging (SM)|mobile phone text messaging (sm)
301840|NCT01656083|Varenicline|varenicline
301841|NCT01656083|The compliance|the compliance
301842|NCT01656083|The abstinence rate|the abstinence rate
301843|NCT01656070|HIV|hiv
301844|NCT01656070|children|children
301845|NCT01656070|adolescents|adolescents
301846|NCT01656070|Vitamin D|vitamin d
301847|NCT01656070|immunity|immunity
301848|NCT01656070|T cell phenotype|t cell phenotype
301849|NCT01656057|Bile acids|bile acids
301850|NCT01656057|Gall bladder emptying|gall bladder emptying
301851|NCT01656057|Human|human
301852|NCT01656057|Glucagon like peptide 1|glucagon like peptide 1
301853|NCT01656057|GLP-1|glp-1
301854|NCT01656031|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
301855|NCT01656031|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
301856|NCT01656031|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
301857|NCT01656031|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
301858|NCT01656031|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
301859|NCT01656031|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
301860|NCT01656031|adult acute basophilic leukemia|adult acute basophilic leukemia
301861|NCT01656031|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
301862|NCT01656031|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
301863|NCT01656031|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
302067|NCT01655160|Kinematic analysis|kinematic analysis
301864|NCT01656031|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
301865|NCT01656031|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
301866|NCT01656031|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
301867|NCT01656031|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
301868|NCT01656031|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
301869|NCT01656031|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
301870|NCT01656031|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
301871|NCT01656018|Healthy|healthy
301872|NCT01656018|TMC278|tmc278
301873|NCT01656018|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
301874|NCT01656018|HIV-1|hiv-1
301875|NCT01656018|Pharmacokinetics|pharmacokinetics
301876|NCT01656018|Ex-vivo pharmacodynamics|ex-vivo pharmacodynamics
301877|NCT01656005|COPD|copd
301878|NCT01656005|Beta blockers|beta blockers
301879|NCT01656005|Cardioselective|cardioselective
301880|NCT01656005|Non-cardioselective|non-cardioselective
301881|NCT01656005|Impulse oscillometry|impulse oscillometry
301882|NCT01655992|capecitabine|capecitabine
301883|NCT01655992|Tegafur，Gimeracil and Oteracil Potassium Capsules|tegafur，gimeracil and oteracil potassium capsules
301884|NCT01655966|chronic hepatitis c|chronic hepatitis c
301885|NCT01655966|hcv|hcv
301886|NCT01655966|vitamin d|vitamin d
301887|NCT01655927|Neoplasms|neoplasms
301888|NCT01655927|Tranexamic Acid|tranexamic acid
301889|NCT01655927|Brain Tumors|brain tumors
301890|NCT01655901|Active video games|active video games
301891|NCT01655901|Food intake|food intake
301892|NCT01655901|Energy balance|energy balance
301893|NCT01655901|Adolescents|adolescents
752605|NCT01173302|Rabies|rabies
301894|NCT01655888|Tremelimumab|tremelimumab
301895|NCT01655888|anti-CTLA-4 monoclonal antibody|anti-ctla-4 monoclonal antibody
301896|NCT01655888|malignant mesothelioma|malignant mesothelioma
301897|NCT01655875|Allogeneic Blood and Marrow Transplantation|allogeneic blood and marrow transplantation
301898|NCT01655823|Pain|pain
301899|NCT01655823|Puffer fish|puffer fish
301900|NCT01655823|Tetrodotoxin|tetrodotoxin
301901|NCT01655823|TTX|ttx
301902|NCT01655823|Neuropathy|neuropathy
301903|NCT01655823|Chemotherapy|chemotherapy
301904|NCT01655823|WEX Pharmaceuticals|wex pharmaceuticals
301905|NCT01655797|insomnia|insomnia
301906|NCT01655797|cognitive behavior therapy|cognitive behavior therapy
301907|NCT01655797|primary care|primary care
301908|NCT01655784|aneurysm|aneurysm
301909|NCT01655784|intracranial aneurysm|intracranial aneurysm
301910|NCT01655784|cerebral aneurysm|cerebral aneurysm
301911|NCT01655784|intracranial embolization|intracranial embolization
301912|NCT01655784|aneurysm embolization|aneurysm embolization
301913|NCT01655784|intracranial coil|intracranial coil
301914|NCT01655784|eighteen coils|eighteen coils
301915|NCT01655784|bare platinum coils|bare platinum coils
301916|NCT01655784|GDC Coil|gdc coil
301917|NCT01655784|Target Coil|target coil
301918|NCT01655771|Opioid induced constipation|opioid induced constipation
301919|NCT01655771|Constipation|constipation
301920|NCT01655758|glaucoma|glaucoma
301921|NCT01655758|24-hour IOP|24-hour iop
301922|NCT01655758|outflow drugs|outflow drugs
301923|NCT01655758|inflow drugs|inflow drugs
301924|NCT01655745|[18F]|[18f]
301925|NCT01655745|FDG Positron Emission Tomography-Magnetic Resonance Imaging|fdg positron emission tomography-magnetic resonance imaging
301926|NCT01655745|FDG-PET-MRI|fdg-pet-mri
301927|NCT01655745|Muscle-Invasive Bladder Cancer|muscle-invasive bladder cancer
301928|NCT01655745|Pilot Study|pilot study
301929|NCT01655745|LCCC 1209|lccc 1209
301930|NCT01655745|UNC Lineberger|unc lineberger
301931|NCT01655745|MDCT|mdct
301932|NCT01655732|Pregnancy|pregnancy
301933|NCT01655706|major depression|major depression
301934|NCT01655706|major depressive disorder|major depressive disorder
301935|NCT01655706|biomarkers|biomarkers
301936|NCT01655706|escitalopram|escitalopram
301937|NCT01655706|aripiprazole|aripiprazole
301939|NCT01655706|neuroimaging|neuroimaging
301940|NCT01655706|proteomic|proteomic
301941|NCT01655706|genomics|genomics
301942|NCT01655693|Intermediate/advanced hepatocellular carcinoma|intermediate/advanced hepatocellular carcinoma
301943|NCT01655693|After failure or intolerance to Sorafenib.|after failure or intolerance to sorafenib.
301944|NCT01655680|Schizophrenia|schizophrenia
301945|NCT01655667|Diagnosis|diagnosis
301946|NCT01655667|Primary Care|primary care
301947|NCT01655667|Comorbidities|comorbidities
301948|NCT01655667|Healthcare utilisation|healthcare utilisation
301949|NCT01655654|Hypertension|hypertension
301950|NCT01655654|Acute hospital staff|acute hospital staff
301951|NCT01655654|Exercise|exercise
301952|NCT01655654|Diet|diet
301953|NCT01655641|Blood transfusion|blood transfusion
301954|NCT01655641|Bleeding|bleeding
301955|NCT01655641|Major Gastro-intestinal surgery|major gastro-intestinal surgery
301956|NCT01655641|Tranexamic Acid|tranexamic acid
301957|NCT01655628|nasopharyngeal carcinoma|nasopharyngeal carcinoma
301958|NCT01655628|metastasis|metastasis
301959|NCT01655628|gemcitabine|gemcitabine
301961|NCT01655615|Adolescent cognitive development|adolescent cognitive development
301962|NCT01655615|mental disorders|mental disorders
301963|NCT01655615|Mood disorders|mood disorders
301964|NCT01655615|Alcohol-Related disorders|alcohol-related disorders
301965|NCT01655615|Mental disorders diagnosed in childhood|mental disorders diagnosed in childhood
301966|NCT01655615|Substance related disorders|substance related disorders
301967|NCT01655602|Trichophytic closure|trichophytic closure
301968|NCT01655602|hair transplantation|hair transplantation
301969|NCT01655602|donor site|donor site
301970|NCT01655602|Androgenetic alopecia|androgenetic alopecia
301971|NCT01655576|drainage|drainage
301972|NCT01655576|pregnancy|pregnancy
301973|NCT01655576|active management|active management
301974|NCT01655576|postpartum hemorrhage|postpartum hemorrhage
301975|NCT01655563|Transplant|transplant
301976|NCT01655563|Pediatrics|pediatrics
301977|NCT01655563|Tacrolimus|tacrolimus
301978|NCT01655563|Prograf|prograf
301979|NCT01655537|fibromyalgia|fibromyalgia
301980|NCT01655537|cognitive dysfunction|cognitive dysfunction
301981|NCT01655524|Regadenoson|regadenoson
301982|NCT01655524|Aminophylline|aminophylline
301983|NCT01655524|ASSUAGE|assuage
301984|NCT01655524|Myocardial Perfusion Imaging (MPI)|myocardial perfusion imaging (mpi)
301985|NCT01655511|Pharmacokinetic|pharmacokinetic
301986|NCT01655511|pharmacodynamic|pharmacodynamic
301987|NCT01655498|fecal incontinence|fecal incontinence
301988|NCT01655498|bowel control|bowel control
301989|NCT01655485|child anxiety|child anxiety
301990|NCT01655485|challenging behaviors|challenging behaviors
301991|NCT01655485|time|time
301992|NCT01655485|Parent anxiety|parent anxiety
301993|NCT01655472|schizophrenia|schizophrenia
301994|NCT01655472|imaging|imaging
301995|NCT01655459|ultrasound, LMA, fiberoptic bronchoscopy|ultrasound, lma, fiberoptic bronchoscopy
301996|NCT01655446|Comparative effectiveness research|comparative effectiveness research
301997|NCT01655446|Robotic rehabilitation|robotic rehabilitation
301998|NCT01655446|Mirror therapy|mirror therapy
301999|NCT01655446|Functional electrical therapy|functional electrical therapy
302000|NCT01655446|Combined therapy|combined therapy
302001|NCT01655446|Stroke rehabilitation|stroke rehabilitation
302002|NCT01655446|Translational science|translational science
302003|NCT01655433|ST-elevation MI|st-elevation mi
302004|NCT01655433|Hypothermia|hypothermia
302005|NCT01655420|Myopia|myopia
302006|NCT01655420|Hyperopia|hyperopia
302007|NCT01655420|Astigmatism|astigmatism
302008|NCT01655420|Patient-reported outcomes|patient-reported outcomes
302009|NCT01655420|Patient satisfaction|patient satisfaction
302010|NCT01655420|Refractive Error|refractive error
302011|NCT01655420|Emmetropia|emmetropia
302012|NCT01655420|Dry eyes|dry eyes
302013|NCT01655420|Glare|glare
302014|NCT01655420|Halos|halos
302015|NCT01655420|Patient expectations|patient expectations
302016|NCT01655407|Split-thickness Autograft|split-thickness autograft
302017|NCT01655407|Engraftment|engraftment
302018|NCT01655407|Wound Closure|wound closure
302019|NCT01655407|Engineered Skin Substitute|engineered skin substitute
302020|NCT01655407|ESS-W|ess-w
302021|NCT01655407|Cultured Skin Substitutes|cultured skin substitutes
302022|NCT01655407|Burn|burn
302023|NCT01655342|pulpotomy|pulpotomy
302024|NCT01655342|primary teeth|primary teeth
302025|NCT01655342|Biodentine®|biodentine®
302026|NCT01655342|formocresol|formocresol
302033|NCT01655329|chest|chest
302034|NCT01655329|radiographs|radiographs
302035|NCT01655264|Stroke|stroke
302036|NCT01655264|Tele-health|tele-health
302037|NCT01655264|Rehabilitation|rehabilitation
302038|NCT01655264|Intervention|intervention
302039|NCT01655264|Gesture recognition system|gesture recognition system
302040|NCT01655251|children|children
302041|NCT01655251|fever|fever
302042|NCT01655251|emergency department|emergency department
302043|NCT01655225|Advanced Breast Cancer|advanced breast cancer
302044|NCT01655225|Advanced Lung Cancer|advanced lung cancer
302045|NCT01655225|Mesothelioma|mesothelioma
302046|NCT01655225|Lymphoma|lymphoma
302047|NCT01655212|Cytomegalovirus|cytomegalovirus
302048|NCT01655212|Congenital infection|congenital infection
302049|NCT01655212|Sensorineural hearing loss|sensorineural hearing loss
302050|NCT01655212|Randomized controlled trial|randomized controlled trial
302051|NCT01655212|Valganciclovir|valganciclovir
302052|NCT01655199|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
302053|NCT01655199|Lung function|lung function
302054|NCT01655199|Exertional dyspnea|exertional dyspnea
302055|NCT01655199|Exercise capacity|exercise capacity
302056|NCT01655199|Pulmonary function|pulmonary function
302057|NCT01655199|Pleural pressures|pleural pressures
302058|NCT01655186|Chronic Kidney Disease|chronic kidney disease
302059|NCT01655186|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
302060|NCT01655173|Asperger syndrome|asperger syndrome
302061|NCT01655173|Autistic disorder|autistic disorder
302062|NCT01655173|Adult|adult
302063|NCT01655173|Psychotherapy|psychotherapy
302064|NCT01655160|Stroke rehabilitation|stroke rehabilitation
302065|NCT01655160|Mirror therapy|mirror therapy
302066|NCT01655160|Functional performance|functional performance
302068|NCT01655160|Functional magnetic resonance image|functional magnetic resonance image
302069|NCT01655160|Motor recovery|motor recovery
302070|NCT01655147|Healthy|healthy
302071|NCT01655147|Pharmacokinetics|pharmacokinetics
302072|NCT01655147|Abiraterone acetate|abiraterone acetate
302073|NCT01655147|Abiraterone|abiraterone
302074|NCT01655147|JNJ-589485|jnj-589485
302075|NCT01655147|JNJ-212082|jnj-212082
302076|NCT01655147|Zytiga|zytiga
302077|NCT01655147|Rifampicin|rifampicin
302078|NCT01655147|Rifadin|rifadin
302079|NCT01655147|CYP3A4 inducer|cyp3a4 inducer
302080|NCT01655134|Heart Failure|heart failure
302081|NCT01655134|Telemonitoring systems for congestive HF|telemonitoring systems for congestive hf
302082|NCT01655134|Biomarkers|biomarkers
302083|NCT01655108|Androgenetic Alopecia|androgenetic alopecia
302084|NCT01655108|Mesotherapy|mesotherapy
302085|NCT01655108|Minoxidil|minoxidil
302086|NCT01655108|Trichogram|trichogram
302087|NCT01655095|Colon capsule|colon capsule
302088|NCT01655095|Picosalax|picosalax
302090|NCT01655095|Prucalopride|prucalopride
302091|NCT01655082|Smoking cessation|smoking cessation
302092|NCT01655082|Nicotine|nicotine
302093|NCT01655082|Tobacco Use Disorder|tobacco use disorder
302094|NCT01655082|Central Nervous System Agents|central nervous system agents
302095|NCT01655069|Overactive bladder (OAB)|overactive bladder (oab)
302096|NCT01655069|Pediatric|pediatric
302097|NCT01655069|Solifenacin succinate suspension|solifenacin succinate suspension
302098|NCT01655069|Phase 3|phase 3
374339|NCT01350141|LDL|ldl
302099|NCT01655056|Pharmacokinetics|pharmacokinetics
302100|NCT01655056|Pharmacodynamics|pharmacodynamics
302101|NCT01655056|Phase 1|phase 1
302102|NCT01655056|YM150|ym150
302103|NCT01655056|Dose-escalating|dose-escalating
302104|NCT01655056|Ethnicity|ethnicity
302105|NCT01655056|Caucasian|caucasian
302106|NCT01655056|Japanese|japanese
302107|NCT01655043|Magnetic Resonance Imaging|magnetic resonance imaging
302108|NCT01655043|regadenoson|regadenoson
302109|NCT01655017|Obesity|obesity
302110|NCT01655017|adipose tissue fibrosis|adipose tissue fibrosis
302111|NCT01655017|Adipose tissue inflammation|adipose tissue inflammation
302112|NCT01655017|Low grade systemic inflammation|low grade systemic inflammation
302113|NCT01655017|non invasive device|non invasive device
302114|NCT01655017|Bariatric surgery|bariatric surgery
302115|NCT01655004|hormone receptor positive|hormone receptor positive
302116|NCT01655004|breast cancer|breast cancer
302117|NCT01654939|HIV|hiv
302118|NCT01654939|hepatitis C|hepatitis c
302119|NCT01654926|Feasibility of using the FlexFlowTM ultrafiltration pump in a non hospital environment|feasibility of using the flexflowtm ultrafiltration pump in a non hospital environment
302120|NCT01654913|hemoglobin determination|hemoglobin determination
302121|NCT01654913|oxygen|oxygen
302122|NCT01654887|Comparative Effectiveness|comparative effectiveness
301752|NCT01656512|ALL|all
302123|NCT01654887|Lung Ultrasound versus Chest X-ray|lung ultrasound versus chest x-ray
302124|NCT01654887|Pneumonia|pneumonia
302125|NCT01654887|Emergency Department|emergency department
302126|NCT01654848|liver transplantation|liver transplantation
302127|NCT01654848|thrombocytes|thrombocytes
302128|NCT01654848|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
302129|NCT01654848|multivariate analysis of associated factors of HIT 2 after OLT|multivariate analysis of associated factors of hit 2 after olt
302130|NCT01654848|laboratory investigations of HIT-antibodies|laboratory investigations of hit-antibodies
302131|NCT01654822|HPV|hpv
302132|NCT01654822|cervix|cervix
302133|NCT01654796|Depression|depression
302134|NCT01654796|Treatment Resistant Depression|treatment resistant depression
302135|NCT01654783|5-ASA, ulcerative colitis, active, remission, adherence|5-asa, ulcerative colitis, active, remission, adherence
302136|NCT01654770|VCE, DBE,OGIB|vce, dbe,ogib
302137|NCT01654770|consecutive|consecutive
302138|NCT01654770|patients|patients
302139|NCT01654731|PBC|pbc
302140|NCT01654731|Bezafibrate|bezafibrate
302141|NCT01654692|metastatic melanoma|metastatic melanoma
302142|NCT01654692|Ipilimumab|ipilimumab
302143|NCT01654679|wound infection|wound infection
302144|NCT01654679|surgery|surgery
302145|NCT01654679|surgical wound infection rate|surgical wound infection rate
302146|NCT01654679|wound healing|wound healing
302147|NCT01654666|Remote ischemic preconditioning|remote ischemic preconditioning
302148|NCT01654666|Stroke secondary prevention|stroke secondary prevention
302149|NCT01654666|Carotid artery stenting|carotid artery stenting
302150|NCT01654666|Carotid stenosis|carotid stenosis
302151|NCT01654666|Inflammation|inflammation
302152|NCT01654653|Heart disease|heart disease
302153|NCT01654653|cardiac surgery|cardiac surgery
302154|NCT01654653|CABG|cabg
302155|NCT01654653|Totilac|totilac
302156|NCT01654653|Voluven|voluven
302157|NCT01654653|6% HES|6% hes
302158|NCT01654640|schizophrenia|schizophrenia
302159|NCT01654640|obesity|obesity
302160|NCT01654640|clozapine|clozapine
302161|NCT01654640|metformin|metformin
302162|NCT01654627|Guided Tissue Regeneration|guided tissue regeneration
302163|NCT01654627|Dental Implants|dental implants
302164|NCT01654627|Membrane, Synthetic|membrane, synthetic
302165|NCT01654614|Keratoconus match index|keratoconus match index
302166|NCT01654614|keratoconus probability index|keratoconus probability index
302167|NCT01654614|ocular response analyzer|ocular response analyzer
302168|NCT01654614|Pentacam|pentacam
302169|NCT01654614|forme fruste keratoconus|forme fruste keratoconus
302170|NCT01654601|Schizophrenia|schizophrenia
402031|NCT01233375|pancreas|pancreas
302171|NCT01654588|BRONCHIAL CHALLANGE TEST, ASTHMA, METACHLINE, ADENOSINE|bronchial challange test, asthma, metachline, adenosine
302172|NCT01654575|Methotrexate|methotrexate
302173|NCT01654575|Knee Osteoarthritis|knee osteoarthritis
302174|NCT01654575|Synovitis|synovitis
302175|NCT01654575|Pain reduction|pain reduction
302176|NCT01654575|Function scores|function scores
302177|NCT01654549|Steatohepatitis,|steatohepatitis,
302178|NCT01654549|Helicobacter pylori,|helicobacter pylori,
302179|NCT01654549|Insulin resistance,|insulin resistance,
302180|NCT01654549|Alanine aminotransferase,|alanine aminotransferase,
302181|NCT01654549|Aspartate aminotransferase,|aspartate aminotransferase,
302183|NCT01654523|Trichotillomania|trichotillomania
302184|NCT01654497|Brain|brain
302185|NCT01654497|Glioma|glioma
302186|NCT01654497|glioblastoma|glioblastoma
302187|NCT01654497|metastases|metastases
302188|NCT01654497|cancer|cancer
302189|NCT01654497|ETS2101|ets2101
302190|NCT01654497|leptomeningeal|leptomeningeal
302191|NCT01654497|astrocytoma|astrocytoma
302192|NCT01654497|oligodendroglioma|oligodendroglioma
302193|NCT01654497|meningioma|meningioma
302194|NCT01654471|Walking Impairment Questionnaire|walking impairment questionnaire
302195|NCT01654471|Peripheral arterial occlusive disease|peripheral arterial occlusive disease
302196|NCT01654471|Korean version|korean version
302197|NCT01654458|Sexual Dysfunctions, Psychological|sexual dysfunctions, psychological
302198|NCT01654458|Psychotherapy, Group|psychotherapy, group
302199|NCT01654458|Genital Neoplasms, Female|genital neoplasms, female
302200|NCT01654458|Endometrial Neoplasms|endometrial neoplasms
302201|NCT01654458|Fallopian Tube Neoplasms|fallopian tube neoplasms
302202|NCT01654458|Ovarian Neoplasms|ovarian neoplasms
302203|NCT01654458|Urogenital Neoplasms|urogenital neoplasms
302204|NCT01654458|Uterine Cervical Neoplasms|uterine cervical neoplasms
302205|NCT01654458|Uterine Neoplasms|uterine neoplasms
302206|NCT01654458|Vaginal Neoplasms|vaginal neoplasms
302207|NCT01654458|Vulvar Neoplasms|vulvar neoplasms
302208|NCT01654445|Minor stroke|minor stroke
302209|NCT01654419|sliding jig|sliding jig
302210|NCT01654419|Class II malocclusion|class ii malocclusion
302211|NCT01654419|Distalization mechanics|distalization mechanics
302212|NCT01654419|Intermaxillary elastics|intermaxillary elastics
302213|NCT01654406|Cesarian scar|cesarian scar
302214|NCT01654406|Fractional CO2 laser|fractional co2 laser
302215|NCT01654393|Triage nurse|triage nurse
302216|NCT01654393|Ottawa ankle rules|ottawa ankle rules
6052|NCT03252470|laparoscopic roux-en-y gastric bypass|laparoscopic roux-en-y gastric bypass
6056|NCT03252444|Shoulder dyskinesis|shoulder dyskinesis
302217|NCT01654354|Qualitative Evaluation of abdominal CT image using 4 point scale: Excellent(4)/ Good(3) / Fair(2) / Unacceptable(1)|qualitative evaluation of abdominal ct image using 4 point scale: excellent(4)/ good(3) / fair(2) / unacceptable(1)
302218|NCT01654328|contrast media|contrast media
302219|NCT01654328|kidney injury|kidney injury
302220|NCT01654328|hydration|hydration
302221|NCT01654315|RTP Only Group|rtp only group
302222|NCT01654315|Myomo Only Group|myomo only group
302223|NCT01654315|Myom0 + RTP Group|myom0 + rtp group
302224|NCT01654289|respiratory tract infections|respiratory tract infections
302225|NCT01654289|common cold|common cold
302226|NCT01654289|exercise|exercise
302227|NCT01654289|influenza|influenza
302228|NCT01654289|meditation|meditation
302229|NCT01654263|13-valent|13-valent
302230|NCT01654263|23-valent|23-valent
302231|NCT01654263|elderly|elderly
302232|NCT01654263|parent protocol|parent protocol
302233|NCT01654263|Pneumococcal infections|pneumococcal infections
302234|NCT01654263|vaccine|vaccine
302235|NCT01654250|ADHD|adhd
302737|NCT01651884|Anomia|anomia
302236|NCT01654250|methylphenidate extended-release|methylphenidate extended-release
302237|NCT01654237|work|work
302238|NCT01654237|WMSD|wmsd
302239|NCT01654237|prevalence|prevalence
302240|NCT01654237|occupational risks|occupational risks
302241|NCT01654237|industry|industry
302242|NCT01654237|questionnaires|questionnaires
302243|NCT01654237|musculoskeletal pain|musculoskeletal pain
302244|NCT01654237|lifestyle|lifestyle
302245|NCT01654224|Influenza in Long Term Care Setting|influenza in long term care setting
302246|NCT01654224|High dose Inactivated influenza vaccine|high dose inactivated influenza vaccine
302247|NCT01654224|Standard dose inactivated influenza vaccine|standard dose inactivated influenza vaccine
302248|NCT01654172|Diabetes|diabetes
302249|NCT01654172|peripheral neuropathy|peripheral neuropathy
302250|NCT01654172|Cocoa flavanols|cocoa flavanols
302251|NCT01654159|intraocular lenses|intraocular lenses
302252|NCT01654159|evaluation|evaluation
302253|NCT01654159|cataract|cataract
302254|NCT01654146|Ovarian cancer|ovarian cancer
302255|NCT01654146|Epithelial ovarian carcinoma|epithelial ovarian carcinoma
302256|NCT01654146|Fallopian tube carcinoma|fallopian tube carcinoma
302257|NCT01654146|Primary serous peritoneal carcinoma|primary serous peritoneal carcinoma
302258|NCT01654146|Gynaecological carcinoma|gynaecological carcinoma
302259|NCT01654146|Randomised controlled trial|randomised controlled trial
302260|NCT01654133|Aortic Aneurysm, abdominal|aortic aneurysm, abdominal
302261|NCT01654120|insulin|insulin
302262|NCT01654120|Type II Diabetes|type ii diabetes
302263|NCT01654120|liraglutide|liraglutide
302264|NCT01654120|Glucagon-Like Peptide 1|glucagon-like peptide 1
302265|NCT01654107|tobacco|tobacco
302266|NCT01654107|smoking cessation|smoking cessation
302267|NCT01654107|nicotine dependence|nicotine dependence
302268|NCT01654081|Lung Cancer|lung cancer
302269|NCT01654081|POSITIVE NON SMALL CELL CARCINOMA|positive non small cell carcinoma
302270|NCT01654081|ISG15|isg15
302271|NCT01654081|IRINOTECAN|irinotecan
302272|NCT01654068|Female Breast Cancer|female breast cancer
302273|NCT01654068|Kidney Cancer|kidney cancer
302274|NCT01654068|Lung Cancer|lung cancer
302275|NCT01654068|Prostate Cancer|prostate cancer
302276|NCT01654068|Vertebral metastasis|vertebral metastasis
302277|NCT01654055|Morphine|morphine
302278|NCT01654055|Adverse events|adverse events
302279|NCT01654055|Predictive factors|predictive factors
302280|NCT01654042|anticoagulation|anticoagulation
302281|NCT01654042|warfarin|warfarin
302282|NCT01654042|monitoring|monitoring
302283|NCT01654042|bleeding|bleeding
302284|NCT01654042|thromboembolism|thromboembolism
302285|NCT01654029|Stroke|stroke
302286|NCT01654029|Communication impairments|communication impairments
302287|NCT01654029|Nurse-patient communication|nurse-patient communication
302288|NCT01654029|Patient-centred care|patient-centred care
302289|NCT01654016|varicose veins|varicose veins
302290|NCT01654016|inflammation|inflammation
302291|NCT01654003|Goal-directed therapy|goal-directed therapy
302292|NCT01654003|severe sepsis|severe sepsis
302293|NCT01654003|emergency surgery|emergency surgery
302294|NCT01654003|vasopressor|vasopressor
302295|NCT01654003|dynamic flow-related parameters|dynamic flow-related parameters
302296|NCT01653977|Hypovolemic shock|hypovolemic shock
302297|NCT01653977|trauma|trauma
302298|NCT01653977|emergency|emergency
302299|NCT01653977|surgery|surgery
302300|NCT01653977|GDT|gdt
302301|NCT01653977|Picco|picco
302302|NCT01653964|suspicious|suspicious
302303|NCT01653964|lesion|lesion
302304|NCT01653964|breast|breast
302305|NCT01653964|cancer|cancer
302306|NCT01653964|screening|screening
302307|NCT01653964|mammogram|mammogram
302308|NCT01653964|negative|negative
302309|NCT01653938|CHF|chf
302310|NCT01653925|Prostatic Neoplasms|prostatic neoplasms
302311|NCT01653925|Low grade prostate cancer|low grade prostate cancer
302312|NCT01653912|cancer|cancer
302313|NCT01653912|ovarian|ovarian
302314|NCT01653912|platinum-resistant|platinum-resistant
302315|NCT01653899|Type I Diabetes|type i diabetes
302316|NCT01653886|Palatability|palatability
302317|NCT01653886|Taste|taste
302318|NCT01653873|fracture|fracture
302319|NCT01653873|vertebral column|vertebral column
302320|NCT01653873|osteoporosis|osteoporosis
302321|NCT01653873|predictor|predictor
302322|NCT01653873|vertebroplasty|vertebroplasty
302323|NCT01653860|Behavior therapy|behavior therapy
302324|NCT01653860|Group therapy|group therapy
302325|NCT01653847|transplant|transplant
302326|NCT01653847|kidney|kidney
302327|NCT01653847|renal disease|renal disease
302328|NCT01653834|lymphopenia|lymphopenia
302329|NCT01653821|carotid body|carotid body
302330|NCT01653821|heart failure|heart failure
302331|NCT01653821|chemoreceptor|chemoreceptor
302332|NCT01653821|hypersensitivity|hypersensitivity
302333|NCT01653808|CKD dialysis|ckd dialysis
302334|NCT01653808|hemodialysis|hemodialysis
302335|NCT01653808|hemodiafiltration|hemodiafiltration
302336|NCT01653808|Elisio dialyzer|elisio dialyzer
302337|NCT01653808|efficacy|efficacy
302338|NCT01653808|biocompatibility|biocompatibility
302339|NCT01653782|LPB|lpb
302340|NCT01653782|RCT|rct
302341|NCT01653782|Intervention study|intervention study
302342|NCT01653782|Cost effectiveness|cost effectiveness
302344|NCT01653782|evidence based|evidence based
302345|NCT01653782|advice to stay active|advice to stay active
302346|NCT01653782|exercise training|exercise training
302347|NCT01653769|CoSeal|coseal
302348|NCT01653769|Surgical bleeding|surgical bleeding
302349|NCT01653769|hemostasis|hemostasis
302350|NCT01653769|Aortic anastamoses|aortic anastamoses
302351|NCT01653769|bleeding|bleeding
302352|NCT01653769|Cardiac surgery|cardiac surgery
302353|NCT01653769|Aneurysms|aneurysms
302354|NCT01653769|Aortic Dissection|aortic dissection
302355|NCT01653756|Asthma|asthma
302356|NCT01653756|Allergen Challenge|allergen challenge
302357|NCT01653743|Japanese|japanese
302358|NCT01653730|portable oxygen concentrator|portable oxygen concentrator
302359|NCT01653730|6-minute walk test|6-minute walk test
302485|NCT01653184|Vision loss|vision loss
302360|NCT01653730|chronic obstructive lung disease|chronic obstructive lung disease
302361|NCT01653730|pulmonary fibrosis|pulmonary fibrosis
302362|NCT01653730|long term oxygen therapy|long term oxygen therapy
302363|NCT01653717|Advanced Cancers|advanced cancers
302365|NCT01653717|B-cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
302366|NCT01653717|B-CLL|b-cll
302367|NCT01653717|CD19 positivity|cd19 positivity
302368|NCT01653717|CD19-specific T cells|cd19-specific t cells
706405|NCT00982748|Anxiety|anxiety
302369|NCT01653717|T-Cell Infusion|t-cell infusion
302370|NCT01653717|Gene Transfer|gene transfer
302371|NCT01653717|Leukapheresis|leukapheresis
302372|NCT01653717|Fludarabine|fludarabine
302373|NCT01653717|Fludarabine Phosphate|fludarabine phosphate
302374|NCT01653717|Fludara|fludara
302375|NCT01653717|Cyclophosphamide|cyclophosphamide
302376|NCT01653717|Cytoxan|cytoxan
302377|NCT01653717|Neosar|neosar
302378|NCT01653691|Pediatric|pediatric
302379|NCT01653691|Burns|burns
302380|NCT01653691|Scars|scars
302381|NCT01653691|Pulse Dye laser|pulse dye laser
302382|NCT01653678|vitamin D-3|vitamin d-3
302383|NCT01653678|omega-3 fatty acids|omega-3 fatty acids
302384|NCT01653678|fish oil|fish oil
302385|NCT01653678|hypertension|hypertension
302386|NCT01653678|blood pressure|blood pressure
302387|NCT01653652|grass pollen|grass pollen
302388|NCT01653652|allergic rhinitis|allergic rhinitis
302389|NCT01653652|TNSS|tnss
302390|NCT01653652|miniRQLQ|minirqlq
374632|NCT01349049|AML|aml
302391|NCT01653639|BAY14-2222|bay14-2222
302392|NCT01653639|Pharmacokinetics|pharmacokinetics
302393|NCT01653613|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
302394|NCT01653613|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
302395|NCT01653613|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
302396|NCT01653613|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
302397|NCT01653600|peripheral arterial disease|peripheral arterial disease
302398|NCT01653600|atherosclerosis|atherosclerosis
302399|NCT01653600|nitinol|nitinol
302400|NCT01653600|stents|stents
302401|NCT01653587|Transradial Approach|transradial approach
302402|NCT01653587|Transfemoral Approach|transfemoral approach
302403|NCT01653587|Vascular Closure Device|vascular closure device
302404|NCT01653574|Famitinib Malate|famitinib malate
302405|NCT01653574|Metastatic Breast Cancer|metastatic breast cancer
302406|NCT01653574|HER-2 negative|her-2 negative
302407|NCT01653561|Metastatic breast cancer|metastatic breast cancer
302408|NCT01653561|Apatinib|apatinib
302409|NCT01653561|non-triple-negative|non-triple-negative
302410|NCT01653548|emotion dysregulation|emotion dysregulation
302411|NCT01653548|borderline personality disorder|borderline personality disorder
302412|NCT01653548|anxiety|anxiety
302413|NCT01653548|depression|depression
302414|NCT01653548|negative emotions|negative emotions
302415|NCT01653548|outpatient interventions for negative emotions|outpatient interventions for negative emotions
302416|NCT01653548|psychological distress|psychological distress
302417|NCT01653548|emotion regulation problems|emotion regulation problems
302418|NCT01653535|Prevention|prevention
302419|NCT01653535|Health Service Use|health service use
302420|NCT01653535|Behavioral Intervention|behavioral intervention
302421|NCT01653535|Conduct Problems|conduct problems
302422|NCT01653535|Anti-Social Behavior|anti-social behavior
302423|NCT01653509|cold sore|cold sore
302424|NCT01653496|Gastric cancer|gastric cancer
302425|NCT01653496|Perioperative care|perioperative care
302426|NCT01653496|Enhanced recovery after surgery|enhanced recovery after surgery
302427|NCT01653496|Multimodal rehabilitation|multimodal rehabilitation
302428|NCT01653496|Fast track surgery|fast track surgery
302429|NCT01653496|Gastrectomy|gastrectomy
302430|NCT01653483|Asthma|asthma
302431|NCT01653483|Umeclidinium|umeclidinium
302432|NCT01653483|Adolescent|adolescent
302433|NCT01653483|Pharmacokinetics|pharmacokinetics
302434|NCT01653457|Fibromyalgia|fibromyalgia
302435|NCT01653457|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
302436|NCT01653457|Memantine|memantine
302437|NCT01653457|electroencephalic cordance|electroencephalic cordance
302438|NCT01653405|anticoagulants|anticoagulants
302439|NCT01653405|pharmacists|pharmacists
302440|NCT01653405|quality improvement|quality improvement
302441|NCT01653405|quality of health care|quality of health care
302442|NCT01653392|Maternal Mortality|maternal mortality
302443|NCT01653392|Obstetric Labor, Premature|obstetric labor, premature
302444|NCT01653392|Eclampsia|eclampsia
302445|NCT01653392|Pre-Eclampsia|pre-eclampsia
302446|NCT01653392|Abortion, Spontaneous|abortion, spontaneous
302447|NCT01653392|Diabetes, Gestational|diabetes, gestational
302448|NCT01653392|Pregnancy, Ectopic|pregnancy, ectopic
302449|NCT01653392|Hydatidiform Mole|hydatidiform mole
302450|NCT01653392|Fetal death|fetal death
302451|NCT01653392|Live birth|live birth
302452|NCT01653392|Still birth|still birth
302453|NCT01653392|Premature Birth|premature birth
302454|NCT01653392|Sex ratio|sex ratio
302455|NCT01653392|Birth weight|birth weight
302456|NCT01653366|Breast Cancer|breast cancer
302457|NCT01653353|nursing home|nursing home
302458|NCT01653353|vitamin D supplements|vitamin d supplements
302459|NCT01653353|calcium supplements|calcium supplements
302460|NCT01653353|guideline adherence|guideline adherence
302461|NCT01653340|Refractory Chronic Migraine|refractory chronic migraine
302462|NCT01653340|Medically Intractable Chronic Migraine|medically intractable chronic migraine
302463|NCT01653340|High Frequency Spinal Cord Stimulator|high frequency spinal cord stimulator
302464|NCT01653327|mucositis|mucositis
302465|NCT01653327|head and neck|head and neck
302466|NCT01653327|cancer|cancer
302467|NCT01653327|radiation therapy|radiation therapy
302468|NCT01653327|chemoradiation|chemoradiation
302469|NCT01653327|oral|oral
302470|NCT01653327|pain|pain
302471|NCT01653275|Mediterranean Diet|mediterranean diet
302472|NCT01653275|Bone turnover|bone turnover
302473|NCT01653275|postmenopausal women|postmenopausal women
302474|NCT01653262|Brivaracetam|brivaracetam
302475|NCT01653262|Levetiracetam|levetiracetam
302476|NCT01653262|Epilepsy|epilepsy
302477|NCT01653262|Nonpsychotic behavior|nonpsychotic behavior
302478|NCT01653249|human papillomavirus (HPV)|human papillomavirus (hpv)
302479|NCT01653249|vaccine|vaccine
302480|NCT01653249|treatment|treatment
302481|NCT01653210|Insulin Pump|insulin pump
302482|NCT01653210|Continuous Glucose Monitor|continuous glucose monitor
302483|NCT01653210|Premenopausal women|premenopausal women
302484|NCT01653184|AMD|amd
302486|NCT01653184|omega-3|omega-3
302487|NCT01653184|supplement|supplement
302488|NCT01653184|age related macular degeneration|age related macular degeneration
302489|NCT01653171|Acetylcysteine, Simethicone, Stomach Neoplasms|acetylcysteine, simethicone, stomach neoplasms
302490|NCT01653158|non-hematologic cancer|non-hematologic cancer
302491|NCT01653158|advanced solid tumors|advanced solid tumors
302492|NCT01653158|prostrate cancer|prostrate cancer
302493|NCT01653145|Appetite|appetite
302494|NCT01653145|Satiety|satiety
302495|NCT01653132|PD|pd
302496|NCT01653119|Acute coronary syndrome|acute coronary syndrome
302497|NCT01653119|Diabetes mellitus|diabetes mellitus
302498|NCT01653119|Statins|statins
302499|NCT01653119|High loading dose|high loading dose
302500|NCT01653119|Recurrent events|recurrent events
302501|NCT01653106|cryotherapy|cryotherapy
302502|NCT01653106|Melphalan|melphalan
302503|NCT01653106|Mucositis|mucositis
302504|NCT01653080|Solid Tumor|solid tumor
302505|NCT01653080|Eye|eye
302506|NCT01653080|Orbit|orbit
302507|NCT01653067|Non Hodgkin´s Lymphoma|non hodgkin´s lymphoma
302508|NCT01653067|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
302509|NCT01653067|Aggressive Lymphoma|aggressive lymphoma
302510|NCT01653067|Aggressive Non Hodgkin´s Lymphoma|aggressive non hodgkin´s lymphoma
302511|NCT01653067|NHL|nhl
302512|NCT01653067|aNHL|anhl
302513|NCT01653067|Temsirolimus|temsirolimus
302514|NCT01653067|Torisel|torisel
302515|NCT01653067|Relapsed Non Hodgkin´s Lymphoma|relapsed non hodgkin´s lymphoma
302516|NCT01653067|Relapsed Diffuse Large B-Cell Lymphoma|relapsed diffuse large b-cell lymphoma
302517|NCT01653067|aggressive NHL|aggressive nhl
302518|NCT01653067|B-NHL|b-nhl
302519|NCT01653067|aggressive B-NHL|aggressive b-nhl
302520|NCT01653041|immunosuppression, identical HLA, kidney transplantation, everolimus|immunosuppression, identical hla, kidney transplantation, everolimus
302521|NCT01653002|Lung cancer|lung cancer
302522|NCT01653002|EBUS-TBNA|ebus-tbna
302523|NCT01653002|Epigenetics|epigenetics
302524|NCT01653002|shox2 protein, human|shox2 protein, human
302525|NCT01652989|weight loss|weight loss
302526|NCT01652989|weight loss maintenance|weight loss maintenance
302527|NCT01652989|community based participatory research|community based participatory research
302528|NCT01652989|overweight|overweight
302529|NCT01652976|Metastatic|metastatic
302530|NCT01652976|Pancreatic Cancer|pancreatic cancer
302531|NCT01652976|Adenocarcinoma|adenocarcinoma
302532|NCT01652950|Physical activity|physical activity
302533|NCT01652950|health-insured|health-insured
302534|NCT01652950|Financial Incentives|financial incentives
302535|NCT01652950|Benefits design|benefits design
302536|NCT01652937|Rheumatoid Arthritis|rheumatoid arthritis
302537|NCT01652937|DMARD-IR|dmard-ir
302538|NCT01652924|mechanical ventilation|mechanical ventilation
302539|NCT01652924|manual ventilation|manual ventilation
302540|NCT01652911|Islet Transplantation|islet transplantation
302541|NCT01652911|Cell Pouch|cell pouch
302543|NCT01652885|atopic dermatitis|atopic dermatitis
302544|NCT01652872|anemia|anemia
302545|NCT01652872|chronic kidney disease|chronic kidney disease
302546|NCT01652872|kidney disease|kidney disease
302547|NCT01652872|renal failure|renal failure
302548|NCT01652833|Metastatic Colorectal Cancer|metastatic colorectal cancer
302549|NCT01652820|LUNG|lung
302550|NCT01652820|DOCETAXEL|docetaxel
302551|NCT01652820|GEMCITABINE|gemcitabine
302552|NCT01652820|CARBOPLATIN|carboplatin
302553|NCT01652820|RADIOTHERAPY|radiotherapy
302554|NCT01652781|myelodysplastic syndrome|myelodysplastic syndrome
302555|NCT01652781|azacitidine|azacitidine
302556|NCT01652781|dosing schedule|dosing schedule
302557|NCT01652768|Malignant Brain Tumors|malignant brain tumors
302558|NCT01652768|Malignant Glioma|malignant glioma
302559|NCT01652768|High-grade Gliomas|high-grade gliomas
302560|NCT01652768|Oncology|oncology
302561|NCT01652768|Cancer|cancer
302562|NCT01652768|Patient Caregiver|patient caregiver
302563|NCT01652768|Caregiver Stress, Anxiety, Depression|caregiver stress, anxiety, depression
302564|NCT01652768|Palliative Care Intervention|palliative care intervention
302565|NCT01652755|cystatin C,acute kidney injury,|cystatin c,acute kidney injury,
302566|NCT01652729|Diabetes, Type 2, exenatide, Sitagliptin|diabetes, type 2, exenatide, sitagliptin
302567|NCT01652703|Japanese, hypercholesterolemia, high risk for cardiovascular events|japanese, hypercholesterolemia, high risk for cardiovascular events
302568|NCT01652677|navigation transcranial magnetic stimulation|navigation transcranial magnetic stimulation
302569|NCT01652677|stroke rehabilitation|stroke rehabilitation
302570|NCT01652651|Learning Disorders|learning disorders
302571|NCT01652638|subjects|subjects
302572|NCT01652625|Yunnan Baiyao|yunnan baiyao
302573|NCT01652625|recurrent aphthous stomatitis|recurrent aphthous stomatitis
302574|NCT01652625|clinical trial|clinical trial
302575|NCT01652612|positive end expiratory pressure|positive end expiratory pressure
302576|NCT01652599|Eltrombopag|eltrombopag
302577|NCT01652599|Dexamethasone|dexamethasone
302578|NCT01652599|High-dose|high-dose
302579|NCT01652599|ITP|itp
302580|NCT01652586|cardiac ablation|cardiac ablation
302581|NCT01652573|X linked hypophosphatemia|x linked hypophosphatemia
302582|NCT01652573|calcitonin|calcitonin
302583|NCT01652573|FGF twenty three|fgf twenty three
302584|NCT01652560|bevacizumab|bevacizumab
302585|NCT01652560|neoadjuvant chemotherapy|neoadjuvant chemotherapy
302586|NCT01652560|HER2-negative breast cancer|her2-negative breast cancer
302587|NCT01652547|Melanoma|melanoma
302588|NCT01652547|Merkel cell carcinoma|merkel cell carcinoma
302589|NCT01652547|Metastatic skin cancer|metastatic skin cancer
302590|NCT01652534|Freezing of gait|freezing of gait
302591|NCT01652534|gait dysfunction|gait dysfunction
302592|NCT01652521|lung compliance|lung compliance
302593|NCT01652521|pleural effusion|pleural effusion
302594|NCT01652521|esophageal pressure|esophageal pressure
302595|NCT01652508|smoking cessation|smoking cessation
302596|NCT01652508|Acceptance and Commitment Therapy|acceptance and commitment therapy
302597|NCT01652508|primary care setting|primary care setting
302598|NCT01652508|randomised controlled trial|randomised controlled trial
302599|NCT01652495|rotatory cuff calcific tendonitis|rotatory cuff calcific tendonitis
302600|NCT01652495|corticosteroids|corticosteroids
302601|NCT01652495|US guided percutaneous treatment|us guided percutaneous treatment
302602|NCT01652495|methylprednisolone|methylprednisolone
302603|NCT01652495|triamcinolone|triamcinolone
302604|NCT01652495|hypothalamus pituitary adrenal axis|hypothalamus pituitary adrenal axis
302605|NCT01652469|squamous cell|squamous cell
302606|NCT01652469|NSCLC|nsclc
302607|NCT01652469|TKI|tki
302608|NCT01652469|Erlotinib|erlotinib
302609|NCT01652469|Docetaxel|docetaxel
302610|NCT01652469|VeriStrat|veristrat
302611|NCT01652469|protein signature|protein signature
302612|NCT01652456|addiction support|addiction support
302613|NCT01652456|addiction specialist|addiction specialist
302614|NCT01652456|lung cancer|lung cancer
302615|NCT01652456|head and neck cancer|head and neck cancer
302616|NCT01652443|OEF/OIF Veterans|oef/oif veterans
302617|NCT01652443|Relationships|relationships
302618|NCT01652430|PTSD|ptsd
302619|NCT01652430|Suicidal ideation|suicidal ideation
302620|NCT01652430|Cognitive processes|cognitive processes
302621|NCT01652417|Methylprednisolone|methylprednisolone
302622|NCT01652417|prednisone|prednisone
302623|NCT01652417|renal sarcoidosis treatment|renal sarcoidosis treatment
302625|NCT01652404|sepsis|sepsis
302626|NCT01652404|antibiotic therapy|antibiotic therapy
302627|NCT01652404|procalcitonin|procalcitonin
302628|NCT01652378|cocaine addiction|cocaine addiction
302629|NCT01652378|neuroimaging|neuroimaging
302630|NCT01652378|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
302631|NCT01652365|Malaria Diagnosis|malaria diagnosis
302632|NCT01652365|Rapid Diagnostic Tests|rapid diagnostic tests
302633|NCT01652365|RDTs|rdts
302634|NCT01652365|Private Sector|private sector
302635|NCT01652365|Retail Sector|retail sector
302636|NCT01652365|Drug Shops|drug shops
302637|NCT01652352|Disabled|disabled
302638|NCT01652352|Disability|disability
302639|NCT01652352|Power wheelchair|power wheelchair
302640|NCT01652352|Wheelchair|wheelchair
302641|NCT01652352|Wheelchair mounted robotic arm|wheelchair mounted robotic arm
302642|NCT01652352|WMRA|wmra
302643|NCT01652352|Assistive|assistive
302644|NCT01652352|Assistive robot|assistive robot
302645|NCT01652352|Assistive robotics|assistive robotics
302646|NCT01652352|Rehabilitation robot|rehabilitation robot
302647|NCT01652352|Rehabilitation engineering|rehabilitation engineering
302648|NCT01652352|Rehabilitation robotics|rehabilitation robotics
302649|NCT01652300|Oral health|oral health
302650|NCT01652300|education|education
302651|NCT01652300|knowledge|knowledge
302652|NCT01652300|attitude|attitude
302653|NCT01652300|performance|performance
302654|NCT01652274|Child Passenger Safety|child passenger safety
302655|NCT01652274|Parental perception of vulnerability|parental perception of vulnerability
302656|NCT01652274|Neonatology|neonatology
302657|NCT01652274|Newborn|newborn
302658|NCT01652261|advanced stage|advanced stage
302659|NCT01652248|Heart failure|heart failure
302660|NCT01652248|Pacemaker|pacemaker
302772|NCT01651793|energy|energy
302666|NCT01652235|Off-the-shelf|off-the-shelf
302667|NCT01652235|Pararenal|pararenal
302668|NCT01652222|Alzheimer|alzheimer
302669|NCT01652222|caregiver|caregiver
302670|NCT01652222|dementia|dementia
302671|NCT01652222|social support|social support
302672|NCT01652222|Montessori|montessori
302673|NCT01652222|Therapeutic game|therapeutic game
302674|NCT01652196|colorectal cancer|colorectal cancer
302675|NCT01652196|rectal cancer|rectal cancer
302676|NCT01652196|FOLFOX|folfox
302677|NCT01652196|Aflibercept|aflibercept
302678|NCT01652183|Intravenous paracetamol|intravenous paracetamol
302679|NCT01652183|catheter related bladder discomfort|catheter related bladder discomfort
302680|NCT01652183|urologic surgery|urologic surgery
302686|NCT01652131|general anesthesia|general anesthesia
302687|NCT01652131|volume kinetics|volume kinetics
302688|NCT01652118|bronchopulmonary dysplasia|bronchopulmonary dysplasia
302689|NCT01652118|clarithromycin|clarithromycin
302690|NCT01652118|preterm babies|preterm babies
302691|NCT01652105|Gastric bypass|gastric bypass
302692|NCT01652105|Preoperative diet|preoperative diet
302693|NCT01652105|Prodimed|prodimed
302694|NCT01652092|immunodeficiency disorder|immunodeficiency disorder
302695|NCT01652092|histiocytic disorder|histiocytic disorder
302696|NCT01652079|Epithelial|epithelial
302697|NCT01652079|Primary|primary
302698|NCT01652053|InterCushion|intercushion
302699|NCT01652040|Spinal Cord Injury|spinal cord injury
302700|NCT01652040|Rehabilitation|rehabilitation
302701|NCT01652040|Electrical Stimulation|electrical stimulation
302702|NCT01652040|Testosterone|testosterone
302703|NCT01652040|Body Composition|body composition
302704|NCT01652040|Lipid and Glucose profile|lipid and glucose profile
302705|NCT01652040|Ectopic Adiposity|ectopic adiposity
302706|NCT01652027|FVIII inhibitors|fviii inhibitors
302707|NCT01652014|Transplantation|transplantation
302708|NCT01652014|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
302709|NCT01652001|Xerostomia|xerostomia
302710|NCT01652001|Antidepressant agents|antidepressant agents
302711|NCT01652001|Antihypertensive agents|antihypertensive agents
302712|NCT01651988|ketamine|ketamine
302713|NCT01651988|propofol anesthesia|propofol anesthesia
302714|NCT01651975|Dysphagia|dysphagia
302715|NCT01651975|Thickening liquid|thickening liquid
302716|NCT01651975|Thickening agent|thickening agent
302717|NCT01651975|Fluoroscopic swallow study|fluoroscopic swallow study
302718|NCT01651975|Aspiration|aspiration
302719|NCT01651975|History of dysphagia|history of dysphagia
302720|NCT01651975|DSS|dss
302721|NCT01651975|Age > 18|age > 18
302722|NCT01651975|comprehensive DSS|comprehensive dss
302723|NCT01651975|informed consent|informed consent
302724|NCT01651962|Labor Pain|labor pain
302725|NCT01651962|Analgesia, Epidural|analgesia, epidural
302343|NCT01653782|Yoga|yoga
302726|NCT01651923|subjects|subjects
302727|NCT01651910|Cancer Pain|cancer pain
302728|NCT01651910|Breakthrough Pain|breakthrough pain
302729|NCT01651910|Unmet Needs|unmet needs
302730|NCT01651910|Supportive care needs|supportive care needs
302731|NCT01651897|delirium|delirium
302732|NCT01651897|emergency department|emergency department
302733|NCT01651897|natural course|natural course
302734|NCT01651897|outcomes|outcomes
302735|NCT01651897|elderly|elderly
302736|NCT01651884|Stroke|stroke
302738|NCT01651871|Agents, anti allergic|agents, anti allergic
302739|NCT01651871|Nasal congestion|nasal congestion
302740|NCT01651871|Sneezing|sneezing
302741|NCT01651871|Nasal discharge|nasal discharge
302742|NCT01651871|D prostanoid (DP) receptor antagonist|d prostanoid (dp) receptor antagonist
302743|NCT01651832|Colorectal Neoplasms/*drug therapy/*secondary|colorectal neoplasms/*drug therapy/*secondary
302744|NCT01651832|Health Services Accessibility|health services accessibility
302745|NCT01651832|Humans|humans
302746|NCT01651832|Supportive Care Needs|supportive care needs
302747|NCT01651832|Psychooncology|psychooncology
302748|NCT01651832|Rural Population|rural population
302749|NCT01651832|Primary Health Care/*methods|primary health care/*methods
302750|NCT01651832|Treatment Outcome|treatment outcome
302751|NCT01651832|Socioeconomic Factors|socioeconomic factors
302752|NCT01651832|Quality Assurance, Health Care|quality assurance, health care
302753|NCT01651832|Quality of Life|quality of life
302754|NCT01651832|Adult|adult
302755|NCT01651832|Aged|aged
302756|NCT01651832|Aged, 80 and over|aged, 80 and over
302757|NCT01651819|HTLV-1|htlv-1
302758|NCT01651819|neurogenic bladder|neurogenic bladder
302759|NCT01651819|physical therapy|physical therapy
706406|NCT00982748|Pranayama|pranayama
302760|NCT01651819|Tropical Spastic Paraparesis|tropical spastic paraparesis
302761|NCT01651806|Blood loss|blood loss
302762|NCT01651806|transfusion rates|transfusion rates
302763|NCT01651806|complications|complications
302764|NCT01651793|cacao|cacao
302765|NCT01651793|theobromine|theobromine
302766|NCT01651793|flavanols|flavanols
302767|NCT01651793|caffeine|caffeine
302768|NCT01651793|sustained attention|sustained attention
302769|NCT01651793|vigilance|vigilance
302770|NCT01651793|vigor|vigor
302771|NCT01651793|vitality|vitality
302773|NCT01651793|fatigue|fatigue
302774|NCT01651780|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
302775|NCT01651780|Aortic valve replacement|aortic valve replacement
302776|NCT01651780|Severe aortic stenosis|severe aortic stenosis
302777|NCT01651767|Chronic hepatitis C virus infection|chronic hepatitis c virus infection
302778|NCT01651767|JNJ-47910382|jnj-47910382
302779|NCT01651767|Pharmacokinetics|pharmacokinetics
302780|NCT01651767|Caucasian genotype-1|caucasian genotype-1
302781|NCT01651767|Non-structural protein 5A (NS5A) inhibitor|non-structural protein 5a (ns5a) inhibitor
302782|NCT01651741|Intestinal Microbiota|intestinal microbiota
302783|NCT01651741|Probiotics|probiotics
302784|NCT01651741|Seaweed|seaweed
302785|NCT01651741|Healthy Subject|healthy subject
302786|NCT01651728|Simvastatin|simvastatin
302787|NCT01651728|Pneumonia|pneumonia
302788|NCT01651728|Elderly|elderly
302789|NCT01651728|TNF-α|tnf-α
302790|NCT01651728|IFN-ϒ|ifn-ϒ
302791|NCT01651728|PAI-1|pai-1
302792|NCT01651728|CRP|crp
302793|NCT01651702|Arrhythmia|arrhythmia
302794|NCT01651702|Electroanatomical mapping|electroanatomical mapping
302795|NCT01651689|Scalp biopsy|scalp biopsy
302796|NCT01651689|Hair count|hair count
302797|NCT01651689|Vertical section|vertical section
302798|NCT01651689|Horizontal section|horizontal section
302799|NCT01651689|Thais|thais
302800|NCT01651676|VQ11 questionnaire|vq11 questionnaire
302801|NCT01651676|COPD|copd
302802|NCT01651676|LBD|lbd
302803|NCT01651663|Influenza|influenza
302804|NCT01651650|Asthma|asthma
302805|NCT01651650|PIF|pif
302806|NCT01651637|Respiratory Distress syndrome|respiratory distress syndrome
302807|NCT01651637|Complications of prematurity|complications of prematurity
302808|NCT01651624|Colorectal Cancer|colorectal cancer
302809|NCT01651624|Screening|screening
302810|NCT01651624|Fecal Occult Blood Test|fecal occult blood test
302811|NCT01651624|CT Colonography|ct colonography
302812|NCT01651624|Virtual Colonoscopy|virtual colonoscopy
302813|NCT01651624|Colonoscopy|colonoscopy
302814|NCT01651611|Tobacco Cessation|tobacco cessation
302815|NCT01651611|Public Housing|public housing
302816|NCT01651611|Community Health Workers|community health workers
302817|NCT01651611|Motivational Interviewing|motivational interviewing
302818|NCT01651611|Patient centered|patient centered
302819|NCT01651611|Low-income|low-income
302820|NCT01651611|Tobacco Treatment Advocates|tobacco treatment advocates
302821|NCT01651611|Social Epidemiology|social epidemiology
302822|NCT01651611|Smoking cessation predictors|smoking cessation predictors
302823|NCT01651611|Behavioral Intervention|behavioral intervention
302824|NCT01651611|Non-pharmacologic|non-pharmacologic
302825|NCT01651585|viral disease|viral disease
302826|NCT01651585|cytomegalovirus infection|cytomegalovirus infection
302827|NCT01651585|is the first cause|is the first cause
302828|NCT01651585|of congenital|of congenital
302829|NCT01651585|neurological handicap|neurological handicap
302830|NCT01651585|of infectious origin.|of infectious origin.
302831|NCT01651572|Postoperative residual curarization|postoperative residual curarization
302832|NCT01651572|Residual neuromuscular block|residual neuromuscular block
302833|NCT01651572|Complications|complications
302834|NCT01651572|Postoperative|postoperative
302835|NCT01651572|Neuromuscular function|neuromuscular function
302836|NCT01651572|Neuromuscular block|neuromuscular block
302837|NCT01651559|modified PASI|modified pasi
302838|NCT01651559|narrow band UVB phototherapy|narrow band uvb phototherapy
302839|NCT01651559|Dead Sea Minerals|dead sea minerals
302840|NCT01651559|Skin auto-Fluorescence|skin auto-fluorescence
302841|NCT01651559|Skin wash samples|skin wash samples
302842|NCT01651546|Clean Intermittent Self Catheterization|clean intermittent self catheterization
302843|NCT01651546|acceptance|acceptance
302844|NCT01651546|test|test
302845|NCT01651533|Mental practice group|mental practice group
302846|NCT01651533|Active control group|active control group
302847|NCT01651520|Neurodegeneration|neurodegeneration
302848|NCT01651520|Disability|disability
302849|NCT01651520|Cognition|cognition
302850|NCT01651520|Prognosis|prognosis
302851|NCT01651507|Pulmonary Langerhans cell histiocytosis|pulmonary langerhans cell histiocytosis
302852|NCT01651494|DAS181|das181
302853|NCT01651494|Influenza|influenza
302854|NCT01651494|inhalation|inhalation
302855|NCT01651494|inpatient clinic|inpatient clinic
302856|NCT01651494|Multi-Dose|multi-dose
302857|NCT01651494|recombinant neuraminidase|recombinant neuraminidase
302858|NCT01651481|Rhinitis|rhinitis
302859|NCT01651468|mild bleeding disorder|mild bleeding disorder
302860|NCT01651455|Cystic Fibrosis|cystic fibrosis
302861|NCT01651455|Pseudomonas Aeruginosa|pseudomonas aeruginosa
302862|NCT01651429|Sleep Deprivation|sleep deprivation
302863|NCT01651416|Home management of malaria|home management of malaria
302864|NCT01651416|Seasonal malaria chemoprevention|seasonal malaria chemoprevention
302865|NCT01651403|Hepatitis|hepatitis
302866|NCT01651403|Hepatitis B|hepatitis b
302867|NCT01651403|HBV|hbv
302868|NCT01651390|Restenosis|restenosis
302869|NCT01651390|Drug coated balloon|drug coated balloon
302870|NCT01651390|Drug eluting stent|drug eluting stent
302871|NCT01651390|Paclitaxel|paclitaxel
302872|NCT01651390|Sirolimus|sirolimus
302873|NCT01651377|Pramipexole|pramipexole
302874|NCT01651377|Mirapex|mirapex
302875|NCT01651377|Cocaine|cocaine
302876|NCT01651364|Cocaine|cocaine
302877|NCT01651364|Cabergoline|cabergoline
302878|NCT01651351|Condition:|condition:
302879|NCT01651351|for this study|for this study
302880|NCT01651351|Focus|focus
302881|NCT01651351|volunteers|volunteers
302882|NCT01651338|Acupuncture|acupuncture
302883|NCT01651338|quality of life|quality of life
302884|NCT01651325|Isavuconazole|isavuconazole
302885|NCT01651325|dextromethorphan|dextromethorphan
302886|NCT01651325|dextrorphan|dextrorphan
302887|NCT01651325|DXM|dxm
302888|NCT01651325|Healthy Volunteers|healthy volunteers
302889|NCT01651325|BAL4815|bal4815
302890|NCT01651312|Radioactivity|radioactivity
302891|NCT01651312|Excretion rate|excretion rate
302892|NCT01651312|Human subjects|human subjects
302893|NCT01651312|Pharmacokinetics|pharmacokinetics
302894|NCT01651312|YM178|ym178
302895|NCT01651312|Radio-labeled|radio-labeled
302896|NCT01651312|Phase 1|phase 1
302897|NCT01651299|copperhead snake envenomation|copperhead snake envenomation
302898|NCT01651286|General anesthesia|general anesthesia
302899|NCT01651286|Positive-pressure ventilation|positive-pressure ventilation
302900|NCT01651286|Masks|masks
302901|NCT01651247|Toddlers|toddlers
302902|NCT01651247|Retrospective|retrospective
302903|NCT01651247|Porcine circovirus type 1 (PCV-1)|porcine circovirus type 1 (pcv-1)
302904|NCT01651247|Infants|infants
302905|NCT01651247|Laboratory evaluations|laboratory evaluations
302906|NCT01651247|IPV|ipv
302907|NCT01651221|gustatory response|gustatory response
302908|NCT01651221|olfactory response|olfactory response
302909|NCT01651208|Coronary stents|coronary stents
302910|NCT01651208|Medication adherence|medication adherence
302911|NCT01651208|Antiplatelet medications|antiplatelet medications
302912|NCT01651208|Motivational Interviewing|motivational interviewing
302913|NCT01651182|Blood transfusion|blood transfusion
302914|NCT01651182|Blood loss|blood loss
302915|NCT01651182|Postoperative complications|postoperative complications
302916|NCT01651182|Outcome|outcome
302917|NCT01651169|Paired Transcranial Magnetic Stimulation|paired transcranial magnetic stimulation
302918|NCT01651169|Methamphetamine abuse, ADHD, Methylphenidate|methamphetamine abuse, adhd, methylphenidate
302919|NCT01651169|We study the effect of Methamphetamine abuse on Intracortical Inhibition, in ADHD patients, treated with Methylphenidate.|we study the effect of methamphetamine abuse on intracortical inhibition, in adhd patients, treated with methylphenidate.
302920|NCT01651130|pregnancy|pregnancy
302921|NCT01651130|postpartum hemorrhage|postpartum hemorrhage
302922|NCT01651130|Cesarean delivery|cesarean delivery
302923|NCT01651130|carbetocin|carbetocin
302924|NCT01651117|Diabetes Mellitus|diabetes mellitus
302925|NCT01651117|Mentors|mentors
302926|NCT01651117|Glucose control|glucose control
302927|NCT01651117|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
302928|NCT01651117|Randomized Controlled Trial|randomized controlled trial
302929|NCT01651117|Veterans|veterans
302930|NCT01651104|Influenza, Trivalent, Adjuvanted, Adjuvant, MF59, MF-59, Fluad, Seasonal|influenza, trivalent, adjuvanted, adjuvant, mf59, mf-59, fluad, seasonal
302931|NCT01651078|Metastatic Brain Tumors|metastatic brain tumors
302932|NCT01651078|Progression|progression
302933|NCT01651078|Radiation Necrosis|radiation necrosis
302934|NCT01651078|Quality of Life|quality of life
302935|NCT01651052|Aortic valve replacement/regurgitation|aortic valve replacement/regurgitation
302936|NCT01651039|Panobinostat|panobinostat
302937|NCT01651039|Lenalidomide|lenalidomide
302938|NCT01651039|Dexamethasone|dexamethasone
302939|NCT01651000|Parathyroid Diseases|parathyroid diseases
302940|NCT01651000|Renal Insufficiency|renal insufficiency
302941|NCT01651000|Kidney Failure, Chronic|kidney failure, chronic
302942|NCT01651000|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
302943|NCT01651000|Vitamin D|vitamin d
302944|NCT01651000|Hyperparathyroidism|hyperparathyroidism
302945|NCT01651000|Kidney Diseases|kidney diseases
302946|NCT01651000|Kidney Failure|kidney failure
302947|NCT01651000|Renal Insufficiency, Chronic|renal insufficiency, chronic
302948|NCT01650987|carcinoma|carcinoma
302949|NCT01650987|uterus|uterus
302950|NCT01650987|Not metastatic|not metastatic
302951|NCT01650974|high flow nasal oxygen therapy|high flow nasal oxygen therapy
302952|NCT01650974|diagnostic bronchoscopy|diagnostic bronchoscopy
302953|NCT01650948|age-related macular degeneration|age-related macular degeneration
302954|NCT01650948|AMD|amd
302955|NCT01650935|Nephrolithiasis|nephrolithiasis
302956|NCT01650935|Recurrent stone former|recurrent stone former
302957|NCT01650935|DASH|dash
302958|NCT01650935|Urine oxalate|urine oxalate
302959|NCT01650935|Urine calcium oxalate supersaturation|urine calcium oxalate supersaturation
302960|NCT01650896|Delirium|delirium
302961|NCT01650896|Dementia|dementia
302962|NCT01650896|Instrumental activities of daily living|instrumental activities of daily living
302963|NCT01650883|Vitamin D3|vitamin d3
302964|NCT01650883|Vitamin D 25 OH|vitamin d 25 oh
302965|NCT01650870|Cathartics|cathartics
302966|NCT01650870|Laxatives|laxatives
302967|NCT01650870|Lactulose|lactulose
302968|NCT01650870|Gastrointestinal Agents|gastrointestinal agents
302969|NCT01650870|Therapeutic Uses|therapeutic uses
302970|NCT01650870|Pharmacologic Actions|pharmacologic actions
302971|NCT01650857|Pulmonary hypertension|pulmonary hypertension
302972|NCT01650857|Rehabilitation|rehabilitation
302973|NCT01650857|Exercise capacity|exercise capacity
302974|NCT01650857|Body composition|body composition
302975|NCT01650857|Health related Quality of Life|health related quality of life
302976|NCT01650831|Helicobacter Pylori|helicobacter pylori
302977|NCT01650831|13C Urea Breath Test|13c urea breath test
302978|NCT01650831|BreathID|breathid
302979|NCT01650818|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
302980|NCT01650818|Aerobic training|aerobic training
302981|NCT01650818|Peak oxygen consumption|peak oxygen consumption
302982|NCT01650818|Quality of life|quality of life
302983|NCT01650805|Leukemia|leukemia
302984|NCT01650805|Leukemia, Myeloid|leukemia, myeloid
302985|NCT01650805|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
302986|NCT01650805|Neoplasms by Histologic Type|neoplasms by histologic type
302987|NCT01650805|Neoplasms|neoplasms
302988|NCT01650805|Lymphoproliferative Disorders|lymphoproliferative disorders
302989|NCT01650805|Lymphatic Diseases|lymphatic diseases
302990|NCT01650805|Immunoproliferative Disorders|immunoproliferative disorders
302991|NCT01650805|Immune System Diseases|immune system diseases
302992|NCT01650805|Myeloproliferative Disorders|myeloproliferative disorders
302993|NCT01650805|Bone Marrow Diseases|bone marrow diseases
302994|NCT01650805|Hematologic Diseases|hematologic diseases
302995|NCT01650792|Chagas disease|chagas disease
302996|NCT01650792|Heart failure|heart failure
302998|NCT01650792|Dementia|dementia
302999|NCT01650779|alpha-galactosidase A|alpha-galactosidase a
303000|NCT01650779|a-GAL|a-gal
303001|NCT01650779|Fabry|fabry
303002|NCT01650779|GL-3|gl-3
303003|NCT01650779|Fabrazyme|fabrazyme
303004|NCT01650701|follicular lymphoma|follicular lymphoma
303005|NCT01650701|non-hodgkins follicular lymphoma|non-hodgkins follicular lymphoma
303006|NCT01650701|treatment for follicular lymphoma|treatment for follicular lymphoma
303007|NCT01650701|rituximab treatment|rituximab treatment
303008|NCT01650701|rituximab and lenalidomide treatment|rituximab and lenalidomide treatment
303009|NCT01650688|Epiblepharon, general anesthesia, positional change|epiblepharon, general anesthesia, positional change
303010|NCT01650675|pregnancy|pregnancy
303011|NCT01650675|screening|screening
303012|NCT01650675|motivation|motivation
303013|NCT01650662|Acute Myocardial Infarction|acute myocardial infarction
303014|NCT01650662|Cyclosporine A|cyclosporine a
303015|NCT01650662|Reperfusion|reperfusion
303016|NCT01650662|Clinical Trial|clinical trial
303017|NCT01650649|lofexidine|lofexidine
303018|NCT01650649|methadone|methadone
303019|NCT01650649|interaction|interaction
303020|NCT01650649|pharmacodynamic|pharmacodynamic
303021|NCT01650649|ECG|ecg
303022|NCT01650649|QTc|qtc
303023|NCT01650636|Videophone-delivered stress management intervention|videophone-delivered stress management intervention
303024|NCT01650636|Chronic fatigue syndrome|chronic fatigue syndrome
303025|NCT01650636|Symptoms|symptoms
303026|NCT01650636|Neuroimmune processes|neuroimmune processes
303027|NCT01650636|Psychosocial|psychosocial
303028|NCT01650623|Parkinson´s Disease|parkinson´s disease
303029|NCT01650623|Rehabilitation|rehabilitation
303030|NCT01650623|Cognition|cognition
303136|NCT01650116|PiCCO|picco
303031|NCT01650610|Parkinson´s Disease|parkinson´s disease
303032|NCT01650610|Rehabilitation|rehabilitation
303033|NCT01650610|Cognition|cognition
303034|NCT01650597|Healthy volunteers|healthy volunteers
303035|NCT01650597|Pharmacokinetics|pharmacokinetics
303036|NCT01650597|Free fatty amides|free fatty amides
303037|NCT01650558|Malaria|malaria
303039|NCT01650558|Prophylaxis|prophylaxis
303040|NCT01650558|Antiretroviral therapy|antiretroviral therapy
303041|NCT01650545|case-control study|case-control study
303042|NCT01650545|aerosolized liposomal cyclosporine A|aerosolized liposomal cyclosporine a
303043|NCT01650545|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
303044|NCT01650545|Lung Transplantation|lung transplantation
303045|NCT01650545|Lung function|lung function
303046|NCT01650519|knee surgery, arthroscopy; orthopaedic, orthopedic surgery|knee surgery, arthroscopy; orthopaedic, orthopedic surgery
303047|NCT01650506|Triple Negative|triple negative
303048|NCT01650506|Basal-like|basal-like
303049|NCT01650493|remineralization|remineralization
303050|NCT01650493|demineralzation|demineralzation
303051|NCT01650493|in situ|in situ
303052|NCT01650493|dentrifice|dentrifice
303053|NCT01650480|COPD|copd
303054|NCT01650480|holistic|holistic
303055|NCT01650480|pilot|pilot
303056|NCT01650480|intervention|intervention
303057|NCT01650467|abl polymorphisms|abl polymorphisms
303058|NCT01650454|Alzheimer|alzheimer
303059|NCT01650454|Sleep|sleep
303060|NCT01650454|Somnolence|somnolence
303061|NCT01650441|Asthma|asthma
303062|NCT01650441|NEXThaler®|nexthaler®
303063|NCT01650441|Formoterol|formoterol
303064|NCT01650441|Beclomethasone Dipropionate|beclomethasone dipropionate
303065|NCT01650441|Computational Fluid Dynamics|computational fluid dynamics
303066|NCT01650441|Functional Imaging|functional imaging
303067|NCT01650441|Central and Peripheral Airways|central and peripheral airways
303068|NCT01650441|Asthma Control Test (ACT™)|asthma control test (act™)
303069|NCT01650441|Asthma Control Questionnaire (ACQ)|asthma control questionnaire (acq)
303070|NCT01650428|Rectal Cancer|rectal cancer
303071|NCT01650428|Bevacizumab|bevacizumab
303072|NCT01650428|Neoadjuvant|neoadjuvant
303073|NCT01650428|Chemotherapy|chemotherapy
303074|NCT01650428|Randomised|randomised
303075|NCT01650415|Cerebral Palsy|cerebral palsy
303076|NCT01650415|Erythropoietin|erythropoietin
303077|NCT01650415|Rehabilitation|rehabilitation
303078|NCT01650402|Hypertension, systolic|hypertension, systolic
303079|NCT01650402|Elderly (> or equal to 75 years)|elderly (> or equal to 75 years)
375507|NCT01345591|BTI|bti
293638|NCT01693042|chronic|chronic
303080|NCT01650402|Cerebrovascular disease|cerebrovascular disease
303081|NCT01650389|Tuberculosis|tuberculosis
303082|NCT01650389|HIV|hiv
303083|NCT01650389|BCG|bcg
303084|NCT01650389|Infant|infant
303085|NCT01650376|Ovarian Neoplasms|ovarian neoplasms
303086|NCT01650376|Cancer of the Ovary|cancer of the ovary
303087|NCT01650376|Ovarian Cancer|ovarian cancer
303088|NCT01650376|Uterine Neoplasms|uterine neoplasms
303089|NCT01650376|Cancer of the Uterus|cancer of the uterus
303090|NCT01650376|Uterine Cancer|uterine cancer
303091|NCT01650376|Olaparib|olaparib
303092|NCT01650376|AZD2281|azd2281
303093|NCT01650376|Carboplatin|carboplatin
303094|NCT01650376|Paclitaxel|paclitaxel
303095|NCT01650376|Relapsed|relapsed
303096|NCT01650363|Complementary and alternative medicine|complementary and alternative medicine
303097|NCT01650363|Post operative recovery|post operative recovery
303098|NCT01650363|Cardio- thoracic surgery|cardio- thoracic surgery
303099|NCT01650350|Melanoma|melanoma
303100|NCT01650350|Prostate Cancer|prostate cancer
303101|NCT01650350|Renal Cancer|renal cancer
303102|NCT01650324|DBPR108|dbpr108
303103|NCT01650324|DPP4|dpp4
303104|NCT01650324|Diabetes|diabetes
303105|NCT01650324|GLP-1|glp-1
303106|NCT01650324|Incretins|incretins
303107|NCT01650311|IBD, CD, UC, Serotonin, 5-HT|ibd, cd, uc, serotonin, 5-ht
303108|NCT01650285|Prostate Cancer|prostate cancer
303109|NCT01650285|Radical prostatectomy|radical prostatectomy
303110|NCT01650207|electroacupuncture|electroacupuncture
303111|NCT01650207|TENS|tens
303112|NCT01650207|shoulder disorder|shoulder disorder
303113|NCT01650207|hemiplegia|hemiplegia
303114|NCT01650194|abiraterone acetate|abiraterone acetate
303115|NCT01650194|prednisone|prednisone
303116|NCT01650194|enzalutamide|enzalutamide
303117|NCT01650194|cancer|cancer
303118|NCT01650194|prostate|prostate
303119|NCT01650194|MDV3100|mdv3100
303120|NCT01650181|nafld, nash, fatty liver|nafld, nash, fatty liver
303121|NCT01650168|NOMAC-E2|nomac-e2
303122|NCT01650168|Nomegestrol acetate|nomegestrol acetate
303123|NCT01650168|Estradiol|estradiol
303124|NCT01650168|Levonorgestrel|levonorgestrel
303125|NCT01650168|Safety|safety
303126|NCT01650142|Neurofibromatosis 1|neurofibromatosis 1
303127|NCT01650142|Phenotype|phenotype
303128|NCT01650142|Modifiers|modifiers
303129|NCT01650116|hypovolemia|hypovolemia
303130|NCT01650116|renal hypoperfusion|renal hypoperfusion
303131|NCT01650116|liver transplantation|liver transplantation
303132|NCT01650116|sodium|sodium
303133|NCT01650116|chloride|chloride
303134|NCT01650116|PuCO2|puco2
303137|NCT01650116|O2-delivery|o2-delivery
303138|NCT01650116|hemodynamic indexes|hemodynamic indexes
303139|NCT01650103|hypovolemia|hypovolemia
303140|NCT01650103|renal hypoperfusion|renal hypoperfusion
303141|NCT01650103|major surgery|major surgery
303142|NCT01650103|sodium|sodium
303143|NCT01650103|potassium|potassium
303144|NCT01650103|chloride|chloride
303145|NCT01650103|ScvO2|scvo2
303146|NCT01650103|hemodynamic indexes|hemodynamic indexes
303147|NCT01650090|Pulmonary relapse|pulmonary relapse
303148|NCT01650090|Osteosarcoma|osteosarcoma
303149|NCT01650090|Lung metastases|lung metastases
303150|NCT01650090|Pediatric osteosarcoma|pediatric osteosarcoma
303151|NCT01650090|Inhaled chemotherapy|inhaled chemotherapy
303152|NCT01650090|Inhaled Lipid Cisplatin|inhaled lipid cisplatin
303153|NCT01650077|Soft tissue sarcoma|soft tissue sarcoma
303154|NCT01650077|Yondelis|yondelis
706407|NCT00982748|Stress|stress
303155|NCT01650077|Intolerance to doxorubicin/ifosfamide|intolerance to doxorubicin/ifosfamide
303156|NCT01650077|CHOI criteria|choi criteria
303157|NCT01650064|Hip fracture|hip fracture
303158|NCT01650064|Mortality|mortality
303159|NCT01650038|faecal transplantation|faecal transplantation
303160|NCT01650038|ulcerative colitis|ulcerative colitis
303161|NCT01650038|inflammatory bowel disease|inflammatory bowel disease
303162|NCT01650025|probiotic, obesity, BMI, metabolic profile, metabolomics|probiotic, obesity, bmi, metabolic profile, metabolomics
303163|NCT01649999|Rheumatoid Arthritis|rheumatoid arthritis
303164|NCT01649999|ASP015K|asp015k
303165|NCT01649986|Hyperlipidemia|hyperlipidemia
303166|NCT01649986|Non-pharmacologic prevention|non-pharmacologic prevention
303167|NCT01649960|Aging|aging
303168|NCT01649960|Biomarkers|biomarkers
303169|NCT01649960|CAD|cad
303170|NCT01649947|Lung cancer|lung cancer
303171|NCT01649947|Non-small cell lung cancer|non-small cell lung cancer
303172|NCT01649947|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
303173|NCT01649947|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
303174|NCT01649934|Appointments and Schedules|appointments and schedules
303175|NCT01649921|Sepsis|sepsis
303176|NCT01649921|SIRS|sirs
303177|NCT01649921|Septic shock|septic shock
303178|NCT01649921|Immunoparalysis|immunoparalysis
303179|NCT01649921|Interferon-gamma|interferon-gamma
303180|NCT01649895|Obsessive-compulsive disorder|obsessive-compulsive disorder
293738|NCT01692678|Sarcoma|sarcoma
303181|NCT01649895|internet|internet
303182|NCT01649895|cognitive-behaviour therapy|cognitive-behaviour therapy
303183|NCT01649895|D-Cycloserine|d-cycloserine
303184|NCT01649882|endotracheal tube position|endotracheal tube position
303185|NCT01649882|intubation|intubation
303186|NCT01649843|Peroral endoscopic myotomy|peroral endoscopic myotomy
303187|NCT01649843|Esophageal Achalasia|esophageal achalasia
303188|NCT01649830|low-grade glioma|low-grade glioma
303189|NCT01649830|radiotherapy|radiotherapy
303190|NCT01649830|chemotherapy|chemotherapy
303191|NCT01649765|SLE Flare Index|sle flare index
303192|NCT01649765|SRI|sri
303193|NCT01649765|belimumab|belimumab
303194|NCT01649765|efficacy|efficacy
303195|NCT01649765|safety|safety
303196|NCT01649765|B lymphocyte|b lymphocyte
303197|NCT01649765|BLyS|blys
303198|NCT01649765|SELENA SLEDAI|selena sledai
303199|NCT01649765|BILAG|bilag
303200|NCT01649765|Lupus|lupus
303201|NCT01649765|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
303202|NCT01649765|PGA|pga
303203|NCT01649765|Pharmacokinetics|pharmacokinetics
303204|NCT01649765|placebo|placebo
303205|NCT01649765|PRINTO|printo
303206|NCT01649752|Stem cells|stem cells
303207|NCT01649752|Uterine cavity|uterine cavity
303208|NCT01649752|Implantation|implantation
303209|NCT01649752|ICSI|icsi
303210|NCT01649739|PAH|pah
303211|NCT01649713|Fluval AB|fluval ab
303212|NCT01649713|influenza|influenza
303213|NCT01649713|vaccine|vaccine
303214|NCT01649713|immunization|immunization
303215|NCT01649713|infections|infections
303216|NCT01649661|MRI|mri
303217|NCT01649661|12-125|12-125
303218|NCT01649661|premenopausal women|premenopausal women
303219|NCT01649661|postmenopausal women|postmenopausal women
303220|NCT01649661|questionnaire|questionnaire
303221|NCT01649648|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
303222|NCT01649648|Autologous cord blood|autologous cord blood
303223|NCT01649622|Leukemia|leukemia
303224|NCT01649622|Lymphoma|lymphoma
303225|NCT01649622|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
303226|NCT01649622|ALL|all
303227|NCT01649622|Relapsed or primary refractory B-cell/T-cell|relapsed or primary refractory b-cell/t-cell
303228|NCT01649622|Bendamustine|bendamustine
303229|NCT01649622|Bendamustine Hydrochloride|bendamustine hydrochloride
303230|NCT01649622|Bendamustine HCL|bendamustine hcl
303231|NCT01649622|CEP-18083|cep-18083
303232|NCT01649622|SDX-105|sdx-105
303233|NCT01649622|Treanda|treanda
303234|NCT01649609|BK Viremia|bk viremia
303235|NCT01649609|BK Nephropathy|bk nephropathy
303236|NCT01649609|mTOR inhibitor|mtor inhibitor
303237|NCT01649609|renal transplant|renal transplant
303238|NCT01649557|Schizophrenia|schizophrenia
303239|NCT01649544|Mitral valvulopathy|mitral valvulopathy
303240|NCT01649544|Atrial Fibrillation|atrial fibrillation
303241|NCT01649544|Amiodarone|amiodarone
303242|NCT01649544|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
303243|NCT01649544|Chronic Atrial Fibrillation|chronic atrial fibrillation
303244|NCT01649544|Ultrasound Technique|ultrasound technique
303245|NCT01649492|diclofenac|diclofenac
303246|NCT01649492|CYP2C9|cyp2c9
303247|NCT01649492|bromelain|bromelain
303248|NCT01649492|pineapple juice|pineapple juice
303249|NCT01649479|Obstetrical antiphospholipid syndrome|obstetrical antiphospholipid syndrome
303250|NCT01649479|Thrombophilia|thrombophilia
303251|NCT01649466|Type 2 diabetes mellitus, diabetes|type 2 diabetes mellitus, diabetes
303252|NCT01649453|Neoplasms|neoplasms
303253|NCT01649453|Neoplasm Metastasis|neoplasm metastasis
303254|NCT01649453|Neoplastic Processes|neoplastic processes
303255|NCT01649453|Pathologic Processes|pathologic processes
303256|NCT01649440|Metabolomics|metabolomics
303257|NCT01649440|serum|serum
303258|NCT01649440|sepsis|sepsis
303259|NCT01649440|biomarkers|biomarkers
303260|NCT01649427|Pharmacokinetics Study|pharmacokinetics study
303261|NCT01649427|Tacroliums|tacroliums
303263|NCT01649427|kdney|kdney
303264|NCT01649401|nebulizer|nebulizer
303265|NCT01649401|PARI LC Spring SP|pari lc spring sp
303266|NCT01649388|Kidney transplant|kidney transplant
303267|NCT01649388|Delayed tolerance|delayed tolerance
303268|NCT01649388|Marrow/enriched hematopoetic stem cell transplant|marrow/enriched hematopoetic stem cell transplant
303269|NCT01649375|Ankylosing spondylitis|ankylosing spondylitis
303270|NCT01649375|AS|as
303271|NCT01649375|Chronic inflammatory disease|chronic inflammatory disease
303272|NCT01649375|Inflammatory back pain|inflammatory back pain
303273|NCT01649375|Secukinumab|secukinumab
303274|NCT01649375|Prefilled syringe (PFS)|prefilled syringe (pfs)
303275|NCT01649375|Subcutaneous injection|subcutaneous injection
303276|NCT01649375|AIN457|ain457
303277|NCT01649375|AIN457F|ain457f
303278|NCT01649375|AIN457F2310|ain457f2310
303279|NCT01649362|preterm infant|preterm infant
303280|NCT01649362|feeding difficulties|feeding difficulties
303281|NCT01649362|prefeeding oral stimulation|prefeeding oral stimulation
752606|NCT01173302|Anti-rabies antibody|anti-rabies antibody
303282|NCT01649310|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
303283|NCT01649310|Muscle strenght|muscle strenght
303284|NCT01649310|Aged|aged
303285|NCT01649245|Chronic hepatitis C|chronic hepatitis c
303286|NCT01649245|Egyptian patients|egyptian patients
303287|NCT01649245|pegylated interferon|pegylated interferon
303288|NCT01649245|Ribavirin|ribavirin
303289|NCT01649245|Reiferon retard|reiferon retard
303290|NCT01649232|tdcs|tdcs
303291|NCT01649232|tms|tms
303292|NCT01649232|qeeg|qeeg
303293|NCT01649232|neuroplasticity|neuroplasticity
303294|NCT01649232|brain networks|brain networks
303295|NCT01649232|add|add
303296|NCT01649232|adhs|adhs
303297|NCT01649219|Prediabetes, objectively measured exercise, glucose and lipid metabolism, dose response, muscle metabolism.|prediabetes, objectively measured exercise, glucose and lipid metabolism, dose response, muscle metabolism.
303298|NCT01649206|Thyroid Nodule|thyroid nodule
303299|NCT01649206|Radiofrequency Thermal Ablation|radiofrequency thermal ablation
303300|NCT01649206|Pressure symptoms|pressure symptoms
303301|NCT01649206|Hyperthyroidism|hyperthyroidism
303302|NCT01649193|Rehabilitation [E02.831]|rehabilitation [e02.831]
303303|NCT01649193|Exercise [G11.427.394.380]|exercise [g11.427.394.380]
303304|NCT01649193|Health Education [I02.233.332]|health education [i02.233.332]
303305|NCT01649193|[C08]|[c08]
303306|NCT01649193|[C08.381]|[c08.381]
303307|NCT01649180|RCC|rcc
303308|NCT01649180|Clear Cell Renal Cell Carcinoma|clear cell renal cell carcinoma
303309|NCT01649180|ccRCC|ccrcc
303310|NCT01649180|Metastatic RCC|metastatic rcc
303311|NCT01649180|Recurrent RCC|recurrent rcc
303312|NCT01649180|Kidney Cancer|kidney cancer
303313|NCT01649180|Kidney Neoplasms|kidney neoplasms
303314|NCT01649180|Axitinib|axitinib
303315|NCT01649180|AG-013736|ag-013736
303316|NCT01649180|Tyrosine Kinase Inhibition|tyrosine kinase inhibition
303317|NCT01649180|TKI|tki
303318|NCT01649167|body mass index|body mass index
303319|NCT01649167|gestational diabetes|gestational diabetes
303320|NCT01649167|leptin|leptin
303321|NCT01649167|obesity|obesity
303322|NCT01649167|pregnancy.|pregnancy.
303323|NCT01649141|posttraumatic stress disorder|posttraumatic stress disorder
303324|NCT01649141|trauma-focused cognitive behavioral therapy|trauma-focused cognitive behavioral therapy
303325|NCT01649141|trauma|trauma
303326|NCT01649141|child abuse|child abuse
303327|NCT01649128|preeclampsia|preeclampsia
303328|NCT01649115|obesity|obesity
303329|NCT01649115|overweight|overweight
303330|NCT01649115|childhood obesity|childhood obesity
303331|NCT01649115|prevention|prevention
303333|NCT01649115|weight for length|weight for length
303334|NCT01649115|WFL|wfl
303335|NCT01649115|body mass index|body mass index
303336|NCT01649115|BMI|bmi
303337|NCT01649115|prenatal|prenatal
303338|NCT01649115|maternal|maternal
303339|NCT01649115|nutrition education|nutrition education
303340|NCT01649115|health education|health education
303341|NCT01649115|health literacy|health literacy
303342|NCT01649115|health numeracy|health numeracy
303343|NCT01649115|passport|passport
303344|NCT01649115|healthy lifestyles|healthy lifestyles
303346|NCT01649115|growth chart|growth chart
303347|NCT01649102|Chronic hemodialysis|chronic hemodialysis
303348|NCT01649102|Tunneled cuffed catheter|tunneled cuffed catheter
303349|NCT01649102|Catheter-related bloodstream infection|catheter-related bloodstream infection
303350|NCT01649102|Mechanical catheter dysfunction|mechanical catheter dysfunction
303351|NCT01649102|impact of catheter design on outcome|impact of catheter design on outcome
303352|NCT01649063|Uterine contraction;|uterine contraction;
303353|NCT01649063|Shape; Frequency;|shape; frequency;
303354|NCT01649063|First stage labor;|first stage labor;
303355|NCT01649063|Fall|fall
303356|NCT01649063|Rise ratio.|rise ratio.
303357|NCT01649050|Spasticity|spasticity
303358|NCT01649050|Multiple Sclerosis|multiple sclerosis
303359|NCT01649024|Tremelimumab|tremelimumab
303360|NCT01649024|Malignant Mesothelioma|malignant mesothelioma
303361|NCT01649024|anti-CTLA-4 mAb|anti-ctla-4 mab
303362|NCT01649011|Oswestry Disability Index|oswestry disability index
303363|NCT01649011|ODI|odi
303364|NCT01649011|Roland Morris Disability Questionnaire|roland morris disability questionnaire
303365|NCT01649011|RMDQ|rmdq
303366|NCT01648998|Mineralocorticoid receptor|mineralocorticoid receptor
303367|NCT01648998|Fludrocortisone|fludrocortisone
303368|NCT01648998|Information Processing|information processing
303369|NCT01648998|Cognition|cognition
303370|NCT01648998|Depression|depression
303371|NCT01648946|Strategies of transfusion|strategies of transfusion
303372|NCT01648946|Red blood cells|red blood cells
303373|NCT01648946|Liberal|liberal
303374|NCT01648946|Restrictive|restrictive
303375|NCT01648946|Oncologic critically ill patients|oncologic critically ill patients
303376|NCT01648933|sarcoidosis|sarcoidosis
303377|NCT01648933|heart|heart
303378|NCT01648933|Rubidium|rubidium
303379|NCT01648933|PET|pet
303380|NCT01648920|Asthma|asthma
303381|NCT01648920|Suspected but undiagnosed asthma|suspected but undiagnosed asthma
303382|NCT01648907|DESIR|desir
303383|NCT01648907|SPONDYLARTHRITIS|spondylarthritis
303384|NCT01648907|EARLY INFLAMMATORY RACHIIALGIA|early inflammatory rachiialgia
303385|NCT01648907|BACK PAIN|back pain
303386|NCT01648894|Rectal cancer|rectal cancer
303387|NCT01648894|radiochemotherapy|radiochemotherapy
303388|NCT01648894|complete pathological response|complete pathological response
303389|NCT01648868|TMSAutism|tmsautism
303390|NCT01648868|Eye-tracking|eye-tracking
303391|NCT01648868|Social perception|social perception
303392|NCT01648868|Social cognition|social cognition
303393|NCT01648855|Circulating antiangiogenic factors|circulating antiangiogenic factors
303394|NCT01648855|Preeclampsia|preeclampsia
303395|NCT01648855|Developing lung|developing lung
303396|NCT01648855|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
303397|NCT01648842|Preeclampsia|preeclampsia
303398|NCT01648842|Vitamin D deficiency|vitamin d deficiency
303399|NCT01648842|Pregnancy|pregnancy
303400|NCT01648842|First trimester|first trimester
303401|NCT01648777|Pneumonia|pneumonia
303402|NCT01648777|Postoperative infection|postoperative infection
303403|NCT01648777|Cardiac surgery|cardiac surgery
303404|NCT01648777|Multiperforated catheter|multiperforated catheter
303405|NCT01648777|Analgesia|analgesia
303406|NCT01648751|Pelvic organ prolapse|pelvic organ prolapse
303407|NCT01648751|Pelvic floor physical therapy|pelvic floor physical therapy
303408|NCT01648751|Vaginal estrogen|vaginal estrogen
303409|NCT01648751|Placebo|placebo
303410|NCT01648738|Subacute low back pain|subacute low back pain
303411|NCT01648738|Chronic low back pain|chronic low back pain
303412|NCT01648738|Low back pain|low back pain
303413|NCT01648738|Disability|disability
303414|NCT01648738|Education|education
303415|NCT01648738|Exercise|exercise
303416|NCT01648738|Spa therapy|spa therapy
303417|NCT01648738|Physiotherapy|physiotherapy
303418|NCT01648738|Multidisciplinary|multidisciplinary
303419|NCT01648738|Cost-effectiveness|cost-effectiveness
303420|NCT01648738|Sick leave|sick leave
303421|NCT01648725|Hypnosis|hypnosis
303422|NCT01648725|Anesthesia|anesthesia
303423|NCT01648725|Propofol|propofol
303424|NCT01648725|Closed-loop|closed-loop
303425|NCT01648712|extracorporeal circuit, platelet function|extracorporeal circuit, platelet function
303426|NCT01648699|Pain|pain
303427|NCT01648699|Cancer|cancer
303428|NCT01648699|Osmotic Release Oral System|osmotic release oral system
303429|NCT01648699|OROS Hydromorphone|oros hydromorphone
303430|NCT01648699|Jurnista|jurnista
303431|NCT01648686|Alendronate|alendronate
303432|NCT01648686|Dental extraction|dental extraction
303433|NCT01648686|Bone healing|bone healing
303434|NCT01648686|postmenopausal women|postmenopausal women
303435|NCT01648686|dental radiography|dental radiography
303436|NCT01648673|Coronary Artery Disease|coronary artery disease
303437|NCT01648673|Cardiac Rehabilitation|cardiac rehabilitation
303438|NCT01647594|Breast cancer|breast cancer
303439|NCT01647594|Young women|young women
303440|NCT01647594|Fertility|fertility
303441|NCT01647594|Physical activity|physical activity
303442|NCT01647594|Survivorship|survivorship
303443|NCT01647581|hemoclip|hemoclip
303444|NCT01647581|colonoscopy|colonoscopy
303445|NCT01647581|post-polypectomy bleed|post-polypectomy bleed
303446|NCT01647555|Cetuximab|cetuximab
303447|NCT01647555|radiotherapy|radiotherapy
303448|NCT01647555|epidermoid head and neck cancer|epidermoid head and neck cancer
303449|NCT01647542|Drug therapy|drug therapy
303450|NCT01647529|Cytomegalovirus|cytomegalovirus
303452|NCT01647529|endotheliitis|endotheliitis
303453|NCT01647529|ganciclovir|ganciclovir
303454|NCT01648634|Nebivolol|nebivolol
303455|NCT01648634|beta-blockade treatment|beta-blockade treatment
303456|NCT01648621|COPD|copd
303457|NCT01648621|case management|case management
303458|NCT01648595|Fentanyl|fentanyl
303459|NCT01648595|analgesia|analgesia
303460|NCT01648595|duration of the active phase|duration of the active phase
303461|NCT01648595|pain severity|pain severity
303462|NCT01648556|Purpura thrombopenic|purpura thrombopenic
303463|NCT01648556|Medullary cytogenetics|medullary cytogenetics
303464|NCT01648556|Myelodysplasic syndrome|myelodysplasic syndrome
303465|NCT01648556|bone marrow biopsy|bone marrow biopsy
303466|NCT01648517|on-small cell lung carcinoma|on-small cell lung carcinoma
303467|NCT01648517|chemotherapy naive patient|chemotherapy naive patient
303468|NCT01648504|Colonoscopy|colonoscopy
303469|NCT01648504|Screening colonoscopy|screening colonoscopy
303470|NCT01648504|Electronic education|electronic education
303472|NCT01648504|Patient education|patient education
303473|NCT01648478|IRAP|irap
303474|NCT01648478|insulin sensitivity marker|insulin sensitivity marker
303475|NCT01648465|metastatic|metastatic
303476|NCT01648465|unresectable|unresectable
303477|NCT01648465|well or moderately differentiated|well or moderately differentiated
303478|NCT01648465|advanced|advanced
303479|NCT01648452|Achromatopsia|achromatopsia
303480|NCT01648452|Ciliary Neurotrophic Factor|ciliary neurotrophic factor
303481|NCT01648452|CNTF|cntf
303482|NCT01648322|Breast Cancer|breast cancer
303483|NCT01648322|Taxotere Chemotherapy|taxotere chemotherapy
303484|NCT01648322|Neulasta|neulasta
303485|NCT01648322|efficacy and safety|efficacy and safety
303486|NCT01648322|single cycle doses of F-627|single cycle doses of f-627
303487|NCT01648322|pegfilgrastim|pegfilgrastim
303488|NCT01648309|aortic stenosis|aortic stenosis
303489|NCT01648309|TAVI|tavi
303490|NCT01648309|neuropsychological|neuropsychological
303491|NCT01648309|cognitive|cognitive
303492|NCT01648309|candidates for TAVI|candidates for tavi
303493|NCT01648296|Heart Failure|heart failure
303494|NCT01648296|Obesity|obesity
303495|NCT01648296|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
303496|NCT01648296|Health Normal Volunteer Subjects|health normal volunteer subjects
303497|NCT01648283|methadone polymorphisms|methadone polymorphisms
303498|NCT01648270|buprenorphine concentration-effect (miosis) relationship|buprenorphine concentration-effect (miosis) relationship
303499|NCT01648257|healthy subjects|healthy subjects
303500|NCT01648257|relative bioavailability|relative bioavailability
303501|NCT01648257|HIV|hiv
303502|NCT01648257|GSK1265744|gsk1265744
303503|NCT01648244|DM, T2DM, Diabetes|dm, t2dm, diabetes
303504|NCT01648231|Healthy Volunteer|healthy volunteer
303505|NCT01648218|glucocorticoid|glucocorticoid
303506|NCT01648218|diabetes mellitus|diabetes mellitus
303507|NCT01648218|post-transplant|post-transplant
303508|NCT01648218|insulin|insulin
303509|NCT01648205|ranolazine|ranolazine
303510|NCT01648205|clinical trial|clinical trial
303511|NCT01648179|GSK1322322, relative bioavailability, healthy subjects, open label, food effect, weight effect|gsk1322322, relative bioavailability, healthy subjects, open label, food effect, weight effect
303512|NCT01648166|trace|trace
303513|NCT01648166|element|element
303514|NCT01648166|lung|lung
303515|NCT01648166|cancer|cancer
303516|NCT01648166|Appalachia|appalachia
303517|NCT01648153|Efficacy|efficacy
303518|NCT01648153|Obese|obese
303519|NCT01648153|T2DM|t2dm
303520|NCT01648153|IL-18|il-18
303521|NCT01648153|Monoclonal antibody (mAb)|monoclonal antibody (mab)
303522|NCT01648140|Genotype 4|genotype 4
303523|NCT01648140|GSK2336805|gsk2336805
303524|NCT01648140|pegylated interferon|pegylated interferon
303525|NCT01648140|telaprevir|telaprevir
303526|NCT01648140|Genotype 1|genotype 1
303527|NCT01648140|chronic hepatitis C|chronic hepatitis c
303528|NCT01648140|ribavirin|ribavirin
303529|NCT01648140|NS5A inhibitor|ns5a inhibitor
303530|NCT01648140|hepatitis C virus (HCV) infection|hepatitis c virus (hcv) infection
303531|NCT01648127|Ceftaroline|ceftaroline
303532|NCT01648127|Pharmacokinetics|pharmacokinetics
303534|NCT01648114|breastfeeding|breastfeeding
303535|NCT01648114|pregnancy|pregnancy
303536|NCT01648114|antenatal|antenatal
303537|NCT01648114|exclusive breastfeeding|exclusive breastfeeding
303538|NCT01648114|education|education
303539|NCT01648101|Retigabine IR|retigabine ir
303540|NCT01648101|Asian Subjects|asian subjects
303541|NCT01648101|Adjunctive Therapy|adjunctive therapy
303542|NCT01648101|Efficacy|efficacy
303543|NCT01648101|Drug-Resistant|drug-resistant
303544|NCT01648101|Safety & tolerability|safety & tolerability
303545|NCT01648101|Partial-Onset Seizures|partial-onset seizures
303546|NCT01648101|Epilepsy|epilepsy
303547|NCT01648088|staphylococcus aureus|staphylococcus aureus
303548|NCT01648088|prosthetic joint implantation|prosthetic joint implantation
303549|NCT01648075|caries|caries
303550|NCT01648075|probiotics|probiotics
303551|NCT01648075|lactobacilli|lactobacilli
303552|NCT01648062|Sleep|sleep
303553|NCT01648062|self-regulation|self-regulation
303554|NCT01648062|Implementation intentions|implementation intentions
303555|NCT01648062|intervention|intervention
303556|NCT01648062|mental simulation|mental simulation
303557|NCT01648023|LC Bead|lc bead
303558|NCT01648023|Irinotecan|irinotecan
303559|NCT01648023|ONCOZENE BEAD|oncozene bead
303560|NCT01648010|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
303561|NCT01648010|Carcinoma of urinary bladder, invasive|carcinoma of urinary bladder, invasive
303562|NCT01648010|Intravesical instillation|intravesical instillation
303563|NCT01648010|Mitomycin C|mitomycin c
303564|NCT01648010|Hydrogel|hydrogel
303565|NCT01648010|Reverse thermal gelation|reverse thermal gelation
303566|NCT01648010|Drug retention|drug retention
303567|NCT01648010|radical cystectomy|radical cystectomy
303568|NCT01647997|bacterial lipopolysaccharides|bacterial lipopolysaccharides
303569|NCT01647997|hyperlactatemia|hyperlactatemia
303570|NCT01647997|muscle lactate|muscle lactate
303571|NCT01647984|Arrhythmias|arrhythmias
303572|NCT01647984|Life quality|life quality
303573|NCT01647971|Lymphoma|lymphoma
303575|NCT01647971|Relapsed|relapsed
303576|NCT01647971|Refractory|refractory
303577|NCT01647958|TEMPO|tempo
303578|NCT01647958|TIF|tif
303579|NCT01647958|Transoral Incisionless Fundoplication|transoral incisionless fundoplication
303580|NCT01647958|EsophyX System|esophyx system
303581|NCT01647958|refractory symptoms|refractory symptoms
303582|NCT01647958|proton pump inhibitors|proton pump inhibitors
303583|NCT01647958|EndoGastric Solutions|endogastric solutions
303584|NCT01647958|EGS|egs
303585|NCT01647958|Acid Reflux|acid reflux
303586|NCT01647958|Heartburn|heartburn
294117|NCT01691092|PET|pet
303587|NCT01647958|Regurgitation|regurgitation
303588|NCT01647945|PAH WHO group 1|pah who group 1
303589|NCT01647932|Heart Failure|heart failure
303590|NCT01647932|Diuretics|diuretics
303591|NCT01647932|Diuretic resistance|diuretic resistance
303592|NCT01647919|Cognition|cognition
303593|NCT01647919|Attention|attention
303594|NCT01647919|Memory|memory
303595|NCT01647919|Mood|mood
303596|NCT01647867|Met fragments expression|met fragments expression
303597|NCT01647854|emergency medical service|emergency medical service
303598|NCT01647854|telemedicine|telemedicine
303599|NCT01647854|teleconsultation|teleconsultation
303600|NCT01647854|safety|safety
303601|NCT01647828|Newly diagnosed Stage IV Pancreatic Cancer|newly diagnosed stage iv pancreatic cancer
303602|NCT01647815|Axillary vein ultrasound|axillary vein ultrasound
303603|NCT01647815|Subclavian vein ultrasound|subclavian vein ultrasound
303604|NCT01647802|standing devices|standing devices
303605|NCT01647802|transfer devices|transfer devices
303606|NCT01647789|prostate cancer, castration resistant,|prostate cancer, castration resistant,
303607|NCT01647776|Colon Neoplasia|colon neoplasia
303608|NCT01647776|Colorectal carcinoma|colorectal carcinoma
303609|NCT01647776|colon cancer|colon cancer
303610|NCT01647776|colon polyp|colon polyp
303611|NCT01647776|colonoscopy|colonoscopy
303612|NCT01647776|sDNA test|sdna test
303613|NCT01647776|FIT tests (fecal immunochemical test)|fit tests (fecal immunochemical test)
303614|NCT01647776|relating colon neoplasia to obesity, type 2 diabetes|relating colon neoplasia to obesity, type 2 diabetes
303615|NCT01647776|colonoscopy and pathology confirmed advanced adenomas|colonoscopy and pathology confirmed advanced adenomas
303616|NCT01647763|Hemorrhoids|hemorrhoids
303617|NCT01647737|Xerostomia|xerostomia
303618|NCT01647737|Sjogren syndrome|sjogren syndrome
303619|NCT01647737|dry mouth|dry mouth
303620|NCT01647724|cervical cancer|cervical cancer
303621|NCT01647724|prevention|prevention
303622|NCT01647724|screening|screening
303623|NCT01647698|Parkinson Disease|parkinson disease
303624|NCT01647698|near transfer|near transfer
303625|NCT01647698|far transfer|far transfer
303626|NCT01647698|working memory|working memory
303627|NCT01647698|fluid intelligence|fluid intelligence
303628|NCT01647698|cognitive training|cognitive training
303629|NCT01647698|dual n-back|dual n-back
303630|NCT01647685|Vesselwall inflammation|vesselwall inflammation
303631|NCT01647685|liposomal prednisolone|liposomal prednisolone
303632|NCT01647659|MEK inhibitor GSK1120212|mek inhibitor gsk1120212
303634|NCT01647659|powder for oral solution|powder for oral solution
303635|NCT01647659|Solid Tumors|solid tumors
303636|NCT01647659|pediatric formulation|pediatric formulation
303637|NCT01647646|asthma|asthma
303638|NCT01647646|SMART|smart
303639|NCT01647646|fixed dose|fixed dose
303640|NCT01647633|rhinitis|rhinitis
303641|NCT01647633|stuffy nose|stuffy nose
303642|NCT01647633|congestion|congestion
303643|NCT01647633|Sneezing|sneezing
303644|NCT01647607|Breast Cancer|breast cancer
303645|NCT01647607|Young Women|young women
303646|NCT01647607|Fertility|fertility
303647|NCT01647607|Physical Activity|physical activity
303648|NCT01647607|Survivorship|survivorship
303649|NCT01647503|parathyroid gland|parathyroid gland
303650|NCT01647503|primary hyperparathyroidism|primary hyperparathyroidism
303651|NCT01647503|proteins|proteins
303652|NCT01647477|non treated cancer|non treated cancer
303653|NCT01647477|oral cavity|oral cavity
303654|NCT01647477|oropharynx|oropharynx
303655|NCT01647477|hypopharynx|hypopharynx
303656|NCT01647477|larynx|larynx
303657|NCT01647477|first consultation|first consultation
303658|NCT01647438|South Asians|south asians
303659|NCT01647438|Diabetes|diabetes
303660|NCT01647438|Physical Activity|physical activity
303661|NCT01647438|Coronary Heart Disease|coronary heart disease
303662|NCT01647438|Lifestyle|lifestyle
303663|NCT01647425|head and neck cancer|head and neck cancer
303664|NCT01647425|lung cancer|lung cancer
303665|NCT01647425|tobacco use disorder|tobacco use disorder
303666|NCT01647425|alcoholism|alcoholism
303667|NCT01647412|Crohn's disease|crohn's disease
303668|NCT01647412|Inflammatory Bowel Disease|inflammatory bowel disease
303669|NCT01647412|Growth Hormone|growth hormone
303670|NCT01647412|Nutraceuticals|nutraceuticals
303671|NCT01647399|Obesity|obesity
303672|NCT01647399|Asthma|asthma
303673|NCT01647399|Vitamin D|vitamin d
303674|NCT01647399|Allergy|allergy
303675|NCT01647399|Genetic|genetic
303676|NCT01647399|Childhood|childhood
303677|NCT01647399|Pediatric|pediatric
303678|NCT01647399|cohort|cohort
303679|NCT01647399|observational|observational
303680|NCT01647399|prospective|prospective
303681|NCT01647399|molecular|molecular
303682|NCT01647373|retinal detachment|retinal detachment
303785|NCT01646554|Randomized|randomized
303683|NCT01647373|scleral buckle|scleral buckle
303684|NCT01647373|silicone sponge|silicone sponge
303685|NCT01647373|axial length|axial length
303686|NCT01647373|surgery included silicone sponge scleral buckling|surgery included silicone sponge scleral buckling
752607|NCT01173302|Persistence|persistence
303687|NCT01647373|retina currently attached|retina currently attached
303688|NCT01647373|at least 6 months after surgery|at least 6 months after surgery
303689|NCT01647360|Metrorrhagia|metrorrhagia
303690|NCT01647360|Menorrhagia|menorrhagia
303691|NCT01647347|bacteria|bacteria
303692|NCT01647347|bacteremia|bacteremia
303693|NCT01647347|PVP-iodine|pvp-iodine
303694|NCT01647347|periodontitis|periodontitis
303696|NCT01647295|visual exploration|visual exploration
303697|NCT01647295|pupil size|pupil size
303698|NCT01647295|social interactions|social interactions
303699|NCT01647295|faces|faces
303700|NCT01647295|human motion|human motion
303701|NCT01647256|Bioavailability|bioavailability
303703|NCT01647256|Fasting|fasting
303704|NCT01647243|Knee osteoarthritis|knee osteoarthritis
303705|NCT01647243|Total knee arthroplasty|total knee arthroplasty
303706|NCT01647243|Preoperative training|preoperative training
303707|NCT01647243|Strength training|strength training
303708|NCT01647230|Anaesthesia, spinal|anaesthesia, spinal
303709|NCT01647230|Cerebral oximetry|cerebral oximetry
303710|NCT01647230|Blood pressure|blood pressure
303711|NCT01647230|Heart rate|heart rate
303712|NCT01647230|Cognitive Symptom|cognitive symptom
303713|NCT01647217|Blepharitis|blepharitis
303714|NCT01647217|Demodex|demodex
303715|NCT01647217|Mites|mites
303716|NCT01647217|Tea Tree oil|tea tree oil
303717|NCT01647217|Terpinen|terpinen
303718|NCT01647204|Nutrition|nutrition
303719|NCT01647204|older|older
303720|NCT01647204|hospital|hospital
303721|NCT01647204|volunteer|volunteer
303722|NCT01647191|HCV，|hcv，
303723|NCT01647191|drug users，|drug users，
303724|NCT01647191|intervention|intervention
303725|NCT01647165|Maintenance Strategy|maintenance strategy
303726|NCT01647165|Plasma Cell Neoplasm|plasma cell neoplasm
303727|NCT01647165|Proteasome Inhibitor|proteasome inhibitor
303728|NCT01647165|Immunomodulatory Drugs|immunomodulatory drugs
303729|NCT01647165|Novel Therapy|novel therapy
303730|NCT01647152|Uveitis|uveitis
303731|NCT01647152|Ustekinumab|ustekinumab
303732|NCT01647152|IL 12/23|il 12/23
303733|NCT01647152|Stelara|stelara
303734|NCT01646866|autism|autism
303735|NCT01646866|siblings|siblings
303736|NCT01646866|genetic test|genetic test
303737|NCT01646866|screening|screening
303738|NCT01646840|PF-04958242|pf-04958242
303739|NCT01646840|bioequivalence|bioequivalence
303740|NCT01646840|pharmacokinetics|pharmacokinetics
303741|NCT01646840|Schizophrenia|schizophrenia
303742|NCT01646827|Schizophrenia, extended release antipsychotic|schizophrenia, extended release antipsychotic
303744|NCT01646814|comparison of incidence of|comparison of incidence of
303745|NCT01646814|treatment groups.|treatment groups.
303746|NCT01646775|opioid|opioid
303747|NCT01646775|malignancy|malignancy
303748|NCT01646775|epidural|epidural
303749|NCT01646749|Energy intake|energy intake
303750|NCT01646749|Beef protein|beef protein
303752|NCT01646749|Protein leverage hypothesis|protein leverage hypothesis
303753|NCT01646736|Lupus Nephritis|lupus nephritis
303754|NCT01646736|Cyclophosphamide|cyclophosphamide
303755|NCT01646736|Tripterygium|tripterygium
303756|NCT01646710|Tool|tool
303757|NCT01646710|FBR|fbr
303758|NCT01646710|Advocacy|advocacy
303759|NCT01646710|Development of a tool|development of a tool
303760|NCT01646710|advocacy materials|advocacy materials
303761|NCT01646697|pancreatic cancer|pancreatic cancer
303762|NCT01646697|adenocarcinoma|adenocarcinoma
303763|NCT01646697|pancreatic resection|pancreatic resection
402032|NCT01233375|adenocarcinoma|adenocarcinoma
303764|NCT01646684|Prostate cancer, pasireotide LAR, castration resistant prostatate cancer, CRPC, SOM230 LAR|prostate cancer, pasireotide lar, castration resistant prostatate cancer, crpc, som230 lar
303765|NCT01646671|Hypertension, Severe, LCZ696|hypertension, severe, lcz696
303766|NCT01646645|CMVpp65 specific T-cells|cmvpp65 specific t-cells
303767|NCT01646645|Stem Cell Transplantation|stem cell transplantation
303768|NCT01646645|12-086|12-086
303769|NCT01646632|institutionalized ADL fitness care-dependency|institutionalized adl fitness care-dependency
303770|NCT01646619|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
303771|NCT01646619|Therapeutic Hypothermia|therapeutic hypothermia
303772|NCT01646619|Therapeutic Hypothermia plus Adjuvant Therapy|therapeutic hypothermia plus adjuvant therapy
303773|NCT01646619|Cooling|cooling
303774|NCT01646606|Bronchiolitis|bronchiolitis
303775|NCT01646606|Length of stay|length of stay
303776|NCT01646606|Pilot Projects|pilot projects
303777|NCT01646606|Oxygen saturation monitoring|oxygen saturation monitoring
303778|NCT01646580|dermatomycoses, tinea, candidiasis, children|dermatomycoses, tinea, candidiasis, children
303779|NCT01646567|psoriasis|psoriasis
303780|NCT01646554|Liver metastases|liver metastases
303781|NCT01646554|Colorectal Cancer|colorectal cancer
303782|NCT01646554|KRAS mutated|kras mutated
303783|NCT01646554|FOLFOX|folfox
303784|NCT01646554|Aflibercept|aflibercept
303786|NCT01646554|Phase II-III|phase ii-iii
303787|NCT01646554|Perioperative treatment|perioperative treatment
303788|NCT01646554|Adjuvant|adjuvant
303789|NCT01646554|Neo-adjuvant|neo-adjuvant
303790|NCT01646554|Surgery|surgery
303791|NCT01646554|Progression Free Survival|progression free survival
303792|NCT01646528|Gastric Intestinal Metaplasia|gastric intestinal metaplasia
303793|NCT01646528|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
303794|NCT01646515|systolic heart failure|systolic heart failure
303795|NCT01646515|udenafil|udenafil
303796|NCT01646515|exercise capacity|exercise capacity
303797|NCT01646502|chronic wound|chronic wound
303798|NCT01646502|treatment|treatment
303799|NCT01646502|biofilms|biofilms
303800|NCT01646502|venous insufficiency|venous insufficiency
303802|NCT01646489|Antisense|antisense
303803|NCT01646489|miR-122 antagonist|mir-122 antagonist
303804|NCT01646489|Safety in healthy volunteers|safety in healthy volunteers
303805|NCT01646489|Hepatitis C|hepatitis c
303806|NCT01646463|mindfulness|mindfulness
303807|NCT01646463|stress|stress
303808|NCT01646463|coping|coping
303809|NCT01646463|emotion|emotion
303810|NCT01646463|depression|depression
303811|NCT01646463|group medical visits|group medical visits
303812|NCT01646463|prenatal healthcare|prenatal healthcare
303813|NCT01646463|preterm birth|preterm birth
303814|NCT01646463|birth weight|birth weight
303815|NCT01646463|postpartum depression|postpartum depression
303816|NCT01646463|cortisol|cortisol
303817|NCT01646463|neuroendocrine function|neuroendocrine function
303818|NCT01646463|blood pressure|blood pressure
303819|NCT01646463|health disparities|health disparities
303820|NCT01646450|NSCLC|nsclc
303821|NCT01646450|EGFR Mutation|egfr mutation
303822|NCT01646450|Elder patients|elder patients
303823|NCT01646424|COPD,|copd,
303824|NCT01646424|Patient satisfaction,|patient satisfaction,
303825|NCT01646424|fix combination,|fix combination,
303826|NCT01646424|NIS Turkey,|nis turkey,
303827|NCT01646424|turbuhaler,|turbuhaler,
303828|NCT01646424|FSI-10|fsi-10
303829|NCT01646411|cytomegalovirus (CMV) IgM &IgG|cytomegalovirus (cmv) igm &igg
303830|NCT01646411|Lyme|lyme
303831|NCT01646411|Toxoplasma|toxoplasma
303832|NCT01646411|Rubella|rubella
303833|NCT01646411|Rubeola IgM|rubeola igm
303834|NCT01646411|Rocky mountain Spotted Fever IgM|rocky mountain spotted fever igm
303835|NCT01646411|Ebv IgM|ebv igm
303836|NCT01646411|Herpes|herpes
303837|NCT01646411|Babesia|babesia
303838|NCT01646411|Measles|measles
303839|NCT01646411|Tetanus|tetanus
303840|NCT01646411|Mumps|mumps
303841|NCT01646411|Mycoplasma|mycoplasma
303842|NCT01646411|Legionella|legionella
303844|NCT01646411|Syphilis|syphilis
303845|NCT01646411|Bordetella Pertussis|bordetella pertussis
303846|NCT01646411|H Pylori|h pylori
303847|NCT01646411|Antibody Titre|antibody titre
303848|NCT01646411|Elevated IgG|elevated igg
303849|NCT01646411|Abnormal IgM|abnormal igm
303850|NCT01646411|SLE|sle
303851|NCT01646398|13VPNC|13vpnc
303852|NCT01646398|23VPS|23vps
303853|NCT01646385|observational|observational
303854|NCT01646385|non-interventional|non-interventional
303855|NCT01646385|cohort|cohort
303856|NCT01646385|retrospective|retrospective
303857|NCT01646385|register|register
303858|NCT01646385|rheumatoid arthritis|rheumatoid arthritis
303859|NCT01646372|Medical Education|medical education
303860|NCT01646372|Cognitive Aid|cognitive aid
303861|NCT01646372|Crisis Resource Management|crisis resource management
303862|NCT01646372|Advanced Cardiac Life Support|advanced cardiac life support
303863|NCT01646372|Skills Retention|skills retention
303864|NCT01646346|Breast Cancer|breast cancer
303865|NCT01646346|Radiation for Breast Cancer|radiation for breast cancer
303866|NCT01646333|Parkinson Disease|parkinson disease
303867|NCT01646333|Mild Cognitive Impairment|mild cognitive impairment
303868|NCT01646333|Cognition|cognition
303869|NCT01646333|Executive Function|executive function
303870|NCT01646333|Learning|learning
303872|NCT01646333|Problem Solving|problem solving
303873|NCT01646294|Pharmacokinetics|pharmacokinetics
303874|NCT01646294|Phase I|phase i
303875|NCT01646294|YM178|ym178
303876|NCT01646294|Modified release (Oral Controlled Absorption System (OCAS))|modified release (oral controlled absorption system (ocas))
303877|NCT01646294|Immediate release (IR)|immediate release (ir)
303878|NCT01646294|Fasted conditions|fasted conditions
303879|NCT01646294|Fed conditions|fed conditions
303880|NCT01646281|Atrial fibrillation|atrial fibrillation
303881|NCT01646281|Vernakalant|vernakalant
303882|NCT01646281|Flecainide|flecainide
303883|NCT01646281|Echocardiography|echocardiography
303884|NCT01646268|Rotigotine|rotigotine
303885|NCT01646268|Neupro phase 3|neupro phase 3
303886|NCT01646268|Early phase|early phase
303887|NCT01646268|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
303888|NCT01646255|Rotigotine|rotigotine
303889|NCT01646255|Neupro phase 3|neupro phase 3
303890|NCT01646255|Advanced-stage|advanced-stage
303891|NCT01646255|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
303892|NCT01646229|Hemoperfusion|hemoperfusion
303893|NCT01646229|Polymyxin-B|polymyxin-b
303894|NCT01646229|Emergency abdominal surgery|emergency abdominal surgery
303895|NCT01646229|Sepsis|sepsis
303896|NCT01646229|Endotoxin|endotoxin
303897|NCT01646216|stroke|stroke
303898|NCT01646216|treadmill|treadmill
303899|NCT01646216|walking|walking
303900|NCT01646216|hemiparesis|hemiparesis
303901|NCT01646216|training|training
303902|NCT01646203|Advanced Solid Tumors|advanced solid tumors
303903|NCT01646190|Fast-track|fast-track
303904|NCT01646190|multimodal perioperative care|multimodal perioperative care
303905|NCT01646190|enhanced recovery|enhanced recovery
303906|NCT01646190|colorectal surgery|colorectal surgery
303907|NCT01646190|elderly patients|elderly patients
303908|NCT01646190|seniors|seniors
303909|NCT01646164|Dill seed|dill seed
303910|NCT01646164|Pattern of uterus contractions|pattern of uterus contractions
303911|NCT01646164|Active phase of labor|active phase of labor
303912|NCT01646138|H1N1|h1n1
303913|NCT01646138|Influenza|influenza
303914|NCT01646138|Human|human
303915|NCT01646138|Challenge Study|challenge study
303916|NCT01646138|Healthy Volunteer|healthy volunteer
303917|NCT01646125|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
303918|NCT01646125|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
303919|NCT01646125|lung cancer|lung cancer
303920|NCT01646125|lung adenocarcinoma|lung adenocarcinoma
303921|NCT01646125|Squamous cell lung carcinoma|squamous cell lung carcinoma
303922|NCT01646125|Large-cell lung carcinoma|large-cell lung carcinoma
303923|NCT01646125|Non small cell lung carcinoma|non small cell lung carcinoma
303924|NCT01646125|Non small cell lung cancer|non small cell lung cancer
303925|NCT01646125|Non-small cell lung cancer|non-small cell lung cancer
303926|NCT01646125|NSCLC|nsclc
303927|NCT01646125|Large cell lung carcinoma|large cell lung carcinoma
303928|NCT01646125|Large cell lung cancer|large cell lung cancer
303929|NCT01646125|HSP90|hsp90
303930|NCT01646125|AUY922|auy922
303931|NCT01646125|Pemetrexed|pemetrexed
303932|NCT01646125|Docetaxel|docetaxel
303933|NCT01646125|EGFR TKI|egfr tki
303934|NCT01646125|EGFR mutations|egfr mutations
303935|NCT01646112|Uncertainty|uncertainty
303936|NCT01646112|HNPCC|hnpcc
303937|NCT01646112|Lynch Syndrome|lynch syndrome
303938|NCT01646112|Genetic Tests|genetic tests
303939|NCT01646099|Kidney transplant|kidney transplant
303940|NCT01646099|Renal transplant|renal transplant
303941|NCT01646099|Sun protection|sun protection
303942|NCT01646099|Skin cancer|skin cancer
303943|NCT01646086|Weight Loss|weight loss
303944|NCT01646086|Self-Weighing|self-weighing
303945|NCT01646086|Weight Tracking|weight tracking
303946|NCT01646073|Plaque Psoriasis|plaque psoriasis
303948|NCT01646073|Placebo Controlled|placebo controlled
303949|NCT01646073|Skin Disease|skin disease
303950|NCT01646073|Double Blind|double blind
303951|NCT01646060|blood|blood
303952|NCT01646060|loss|loss
303953|NCT01646060|healthy|healthy
303954|NCT01646060|volume|volume
303955|NCT01646060|To evaluate the ability of the Zynex BVM to non-invasively detect blood loss in healthy subjects during a blood draw.|to evaluate the ability of the zynex bvm to non-invasively detect blood loss in healthy subjects during a blood draw.
303956|NCT01646047|diabetes|diabetes
303957|NCT01646047|diabetic retinopathy|diabetic retinopathy
303958|NCT01646047|nutritional supplements|nutritional supplements
303959|NCT01646047|visual function|visual function
303960|NCT01646047|macular pigment|macular pigment
303961|NCT01646047|macular threshold sensitivity|macular threshold sensitivity
303962|NCT01646047|contrast sensitivity|contrast sensitivity
303963|NCT01646047|color vision|color vision
303964|NCT01646047|optical coherence tomography|optical coherence tomography
303965|NCT01646034|oligo metastatic|oligo metastatic
303966|NCT01646034|HRD deficiency|hrd deficiency
303967|NCT01646021|Mantle cell lymphoma|mantle cell lymphoma
303968|NCT01646021|Relapsed mantle cell lymphoma|relapsed mantle cell lymphoma
303969|NCT01646021|Refractory mantle cell lymphoma|refractory mantle cell lymphoma
303970|NCT01646021|Ibrutinib|ibrutinib
303971|NCT01646021|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
303972|NCT01646021|Temsirolimus|temsirolimus
303974|NCT01645956|exercise|exercise
303975|NCT01645956|energy intake|energy intake
303976|NCT01645956|physical activity|physical activity
303977|NCT01645943|Non-ST-elevation acute myocardial infarction|non-st-elevation acute myocardial infarction
303978|NCT01645943|Comorbidities|comorbidities
303979|NCT01645930|Relapsed multiple myeloma,|relapsed multiple myeloma,
303980|NCT01645930|Refractory multiple myeloma,|refractory multiple myeloma,
303981|NCT01645930|MLN9708,|mln9708,
303982|NCT01645930|Proteasome inhibitor|proteasome inhibitor
303983|NCT01645917|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
303984|NCT01645904|Hereditary Diseases|hereditary diseases
303985|NCT01645904|Genetic|genetic
303986|NCT01645904|Lynch syndrome|lynch syndrome
303987|NCT01645904|Positive or indeterminate test results for Lynch syndrome|positive or indeterminate test results for lynch syndrome
303988|NCT01645904|Social media|social media
303989|NCT01645904|Internet-based program|internet-based program
303990|NCT01645904|Questionnaire|questionnaire
303991|NCT01645904|Survey|survey
376668|NCT01340651|PMF|pmf
294522|NCT01689298|Carbetocin|carbetocin
294523|NCT01689285|bioequivalence|bioequivalence
294524|NCT01689285|pharmacokinetics|pharmacokinetics
294525|NCT01689285|valacyclovir|valacyclovir
294526|NCT01689285|paediatric formulation|paediatric formulation
294528|NCT01689246|Alzheimer's Disease|alzheimer's disease
294538|NCT01689233|AD|ad
303992|NCT01645904|My Family Garden website|my family garden website
303993|NCT01645904|Interview|interview
303994|NCT01645904|Focus group|focus group
303995|NCT01645904|Website Analysis and MeasureMent Inventory|website analysis and measurement inventory
303996|NCT01645904|WAMMI|wammi
303997|NCT01645891|Diabetic Foot Ulcer|diabetic foot ulcer
303998|NCT01645878|Primiparous Mothers|primiparous mothers
303999|NCT01645878|self-efficacy,|self-efficacy,
304000|NCT01645878|hands off,|hands off,
304001|NCT01645878|hands on ,|hands on ,
304002|NCT01645878|social cognitive theory|social cognitive theory
304003|NCT01645865|HIV|hiv
304004|NCT01645865|AIDS|aids
304005|NCT01645865|PMTCT|pmtct
304006|NCT01645865|Mobile Phone|mobile phone
304007|NCT01645865|SMS|sms
304008|NCT01645839|Leptomeningeal metastasis|leptomeningeal metastasis
304009|NCT01645839|Intrathecal chemotherapy|intrathecal chemotherapy
304010|NCT01645839|Depocyte|depocyte
304011|NCT01645800|Lysozyme hydrochloride|lysozyme hydrochloride
304012|NCT01645800|COPD|copd
304013|NCT01645787|Spinal Muscular Atrophy|spinal muscular atrophy
304014|NCT01645787|4-aminopyridine|4-aminopyridine
304015|NCT01645787|dalfampridine|dalfampridine
304016|NCT01645787|Ampyra|ampyra
304017|NCT01645774|subcutaneous injection heparin|subcutaneous injection heparin
304018|NCT01645774|injection duration|injection duration
304019|NCT01645774|bruising pain|bruising pain
304020|NCT01645774|decrease pain|decrease pain
304021|NCT01645774|decrease bruising|decrease bruising
304022|NCT01645761|Helicobacter pylori eradication|helicobacter pylori eradication
304023|NCT01645761|Peptic ulcer|peptic ulcer
304024|NCT01645748|head and neck cancer|head and neck cancer
304025|NCT01645748|docetaxel|docetaxel
304026|NCT01645748|cisplatin|cisplatin
304027|NCT01645748|S-1|s-1
304028|NCT01645735|Infections|infections
304029|NCT01645735|Teflaro|teflaro
304030|NCT01645735|cephalosporin|cephalosporin
304031|NCT01645735|Ceftaroline|ceftaroline
304032|NCT01645735|antibiotics|antibiotics
304033|NCT01645735|pneumonia|pneumonia
304034|NCT01645722|Fat Grafts|fat grafts
304035|NCT01645722|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
304036|NCT01645722|Wounded warriors|wounded warriors
304037|NCT01645722|Amputation pain|amputation pain
304038|NCT01645696|Diabetes|diabetes
304039|NCT01645696|Type 1 Diabetes|type 1 diabetes
304040|NCT01645696|Continuous glucose monitoring|continuous glucose monitoring
304041|NCT01645696|Blood glucose|blood glucose
303702|NCT01647256|Fed|fed
304042|NCT01645696|Blood glucose sensor|blood glucose sensor
304043|NCT01645696|Glucose Binding Protein (GBP)|glucose binding protein (gbp)
304044|NCT01645566|cardiopulmonary resuscitation|cardiopulmonary resuscitation
304045|NCT01645566|stress|stress
304046|NCT01645566|intervention|intervention
304047|NCT01645475|enuresis|enuresis
304048|NCT01645449|Bioequivalence|bioequivalence
304049|NCT01645449|Atorvastatin calcium|atorvastatin calcium
304050|NCT01645449|crossover|crossover
304051|NCT01645436|randomized controlled trial|randomized controlled trial
304052|NCT01645436|in-hospital exercise|in-hospital exercise
304053|NCT01645436|children|children
304054|NCT01645436|cancer|cancer
304055|NCT01645423|Bioequivalence|bioequivalence
304056|NCT01645423|Atorvastatin calcium|atorvastatin calcium
304057|NCT01645423|crossover|crossover
304058|NCT01645410|Bioequivalence|bioequivalence
304059|NCT01645410|Atorvastatin calcium|atorvastatin calcium
304060|NCT01645410|crossover|crossover
304061|NCT01645397|Asthma|asthma
304062|NCT01645397|Deep inhalation|deep inhalation
304063|NCT01645397|Exhaled nitric oxide|exhaled nitric oxide
304064|NCT01645384|Bioequivalence|bioequivalence
304065|NCT01645384|Atorvastatin calcium|atorvastatin calcium
304066|NCT01645384|crossover|crossover
304067|NCT01645371|opioid-induced constipation|opioid-induced constipation
304068|NCT01645358|COPD|copd
304069|NCT01645358|NIV|niv
304070|NCT01645358|Acute Hypercapnic Respiratory Failure|acute hypercapnic respiratory failure
304071|NCT01645358|COPD patients with hypercapnic respiratory failure|copd patients with hypercapnic respiratory failure
304072|NCT01645345|wrinkles|wrinkles
304073|NCT01645345|acne scars|acne scars
304074|NCT01645332|DLBS3233|dlbs3233
304075|NCT01645332|new onset|new onset
304076|NCT01645332|type-2-diabetes mellitus|type-2-diabetes mellitus
304077|NCT01645332|oral anti-hyperglycemic agent|oral anti-hyperglycemic agent
376755|NCT01340222|MCP-1|mcp-1
304078|NCT01645280|Active rheumatoid arthritis|active rheumatoid arthritis
304079|NCT01645280|Ustekinumab|ustekinumab
304080|NCT01645280|STELARA|stelara
304081|NCT01645280|CNTO 1959|cnto 1959
304082|NCT01645254|healthy volunteers|healthy volunteers
304083|NCT01645254|pharmacokinetics|pharmacokinetics
304084|NCT01645254|malaria|malaria
304085|NCT01645254|Argemone mexicana|argemone mexicana
304086|NCT01645241|Ovarian stimulation|ovarian stimulation
304087|NCT01645241|Luteal phase|luteal phase
304088|NCT01645241|Egg donors|egg donors
304089|NCT01645241|Fertility preservation|fertility preservation
304090|NCT01645202|Aortic stenosis|aortic stenosis
304091|NCT01645202|TAVI|tavi
304092|NCT01645202|Device success|device success
304093|NCT01645202|Aortic regurgitation|aortic regurgitation
304094|NCT01645189|Hunter syndrome|hunter syndrome
304095|NCT01645189|idursulfase-beta|idursulfase-beta
304096|NCT01645189|Hunterase|hunterase
304097|NCT01645189|GC1111|gc1111
304098|NCT01645176|OA|oa
304099|NCT01645176|Knee|knee
304100|NCT01645163|mHealth|mhealth
304101|NCT01645163|Complementary feeding|complementary feeding
304102|NCT01645163|ICDS|icds
304103|NCT01645150|physical activity|physical activity
304104|NCT01645150|exercise|exercise
304105|NCT01645150|training|training
304106|NCT01645150|fatigue|fatigue
304107|NCT01645150|cancer|cancer
304108|NCT01645150|TKI|tki
304109|NCT01645150|tyrosine kinase inhibitor|tyrosine kinase inhibitor
304110|NCT01645137|prematurity|prematurity
304111|NCT01645137|OMT|omt
304112|NCT01645137|complementary and alternative medicine|complementary and alternative medicine
304113|NCT01645137|neonates|neonates
304114|NCT01645137|length of stay|length of stay
304115|NCT01645124|Polycythemia|polycythemia
304116|NCT01645124|Hematocrit|hematocrit
304117|NCT01645124|Thrombosis|thrombosis
304118|NCT01645085|R406|r406
304119|NCT01645085|Fostamatinib|fostamatinib
304120|NCT01645085|Phase I|phase i
304121|NCT01645085|Healthy Subjects|healthy subjects
304122|NCT01645085|Pharmacokinetics|pharmacokinetics
304123|NCT01645085|Bioequivalence|bioequivalence
304124|NCT01645072|Drug refractory epilepsy|drug refractory epilepsy
304125|NCT01645072|Dietary therapy|dietary therapy
304126|NCT01645072|ketogenic diet|ketogenic diet
304127|NCT01645072|childhood epilepsy|childhood epilepsy
304128|NCT01645033|Cognitive Behavioral Therapy|cognitive behavioral therapy
304129|NCT01645033|computer|computer
304130|NCT01645020|absorbable mesh|absorbable mesh
304131|NCT01645020|Partially absorbed Mesh|partially absorbed mesh
304132|NCT01645020|Prolift|prolift
304133|NCT01645020|Prolift + M|prolift + m
304134|NCT01645020|mesh related complications|mesh related complications
304135|NCT01645007|Hepatitis B|hepatitis b
304136|NCT01645007|Prevalence|prevalence
304137|NCT01645007|HBsAg|hbsag
304138|NCT01645007|Vaccination|vaccination
304139|NCT01645007|Galilee|galilee
304140|NCT01644968|metastatic carcinoma|metastatic carcinoma
304141|NCT01644968|lymphoma|lymphoma
304142|NCT01644968|sarcoma|sarcoma
304143|NCT01644968|anti-OX40|anti-ox40
304144|NCT01644955|Gliomas|gliomas
304145|NCT01644955|Carboplatin|carboplatin
304146|NCT01644942|Obese|obese
304147|NCT01644942|insulin sensitive|insulin sensitive
304148|NCT01644942|insulin resistant|insulin resistant
304149|NCT01644942|myotubes|myotubes
304150|NCT01644942|lipid accumulation|lipid accumulation
304151|NCT01644929|hemiparesis|hemiparesis
304152|NCT01644929|bihemispheric transcranial direct current stimulation|bihemispheric transcranial direct current stimulation
304153|NCT01644929|ischemic stroke|ischemic stroke
304154|NCT01644929|subacute|subacute
304155|NCT01644929|rehabilitation|rehabilitation
304156|NCT01644929|physiotherapy|physiotherapy
304157|NCT01644929|ergotherapy|ergotherapy
304158|NCT01644916|COPD|copd
304159|NCT01644916|Integrated care|integrated care
304160|NCT01644916|IPCL|ipcl
304161|NCT01644890|NK105, Paclitaxel, Breast cancer, Micelle|nk105, paclitaxel, breast cancer, micelle
304162|NCT01644851|veterans|veterans
304163|NCT01644851|neuropsychology|neuropsychology
304164|NCT01644851|neuroimaging|neuroimaging
304165|NCT01644851|attention|attention
304166|NCT01644851|working memory|working memory
304167|NCT01644851|inhibition|inhibition
304168|NCT01644851|magnetic resonance imaging, functional|magnetic resonance imaging, functional
304169|NCT01644851|trauma|trauma
304170|NCT01644851|stress|stress
304171|NCT01644851|anxiety|anxiety
304172|NCT01644851|emotion|emotion
304173|NCT01644851|prefrontal cortex|prefrontal cortex
304174|NCT01644838|Hyoscine,|hyoscine,
304175|NCT01644838|Promethazine,|promethazine,
304176|NCT01644838|The first stage of labor,|the first stage of labor,
304177|NCT01644838|Labor pain|labor pain
304178|NCT01644825|platinum resistant|platinum resistant
304179|NCT01644825|platinum refractory|platinum refractory
304180|NCT01644799|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
304181|NCT01644799|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
304182|NCT01644799|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
304183|NCT01644786|head and neck|head and neck
304184|NCT01644786|HNSCC|hnscc
304185|NCT01644786|orophaynx|orophaynx
304186|NCT01644786|hypopharynx|hypopharynx
304187|NCT01644786|larynx|larynx
304188|NCT01644786|nasopharynx|nasopharynx
304189|NCT01644786|oral cavity|oral cavity
304190|NCT01644786|prospective study|prospective study
304191|NCT01644786|predictive models for HNSCC|predictive models for hnscc
304612|NCT01643057|Biomarkers|biomarkers
304192|NCT01644786|genomic analyses|genomic analyses
304193|NCT01644786|outcome prediction|outcome prediction
304194|NCT01644760|Diaphragmatic excursion|diaphragmatic excursion
304195|NCT01644760|normality|normality
304196|NCT01644747|Resistant Depression|resistant depression
304197|NCT01644747|Moods disorders|moods disorders
304198|NCT01644747|Unipolar depression|unipolar depression
304199|NCT01644747|Bipolar disorder|bipolar disorder
304200|NCT01644747|tDCS|tdcs
304201|NCT01644721|Child mortality|child mortality
304202|NCT01644721|Measles vaccine|measles vaccine
304203|NCT01644721|Non-specific effects|non-specific effects
304204|NCT01644708|Obesity|obesity
304205|NCT01644708|Overweight|overweight
304206|NCT01644708|Individual empowerment|individual empowerment
304207|NCT01644708|Physical parameters|physical parameters
304208|NCT01644708|Self esteem|self esteem
304209|NCT01644695|BARS|bars
304210|NCT01644695|Bony Anchoring Reinforcement System|bony anchoring reinforcement system
304211|NCT01644695|Hernia|hernia
304212|NCT01644695|Incisional|incisional
304213|NCT01644695|Recurrent|recurrent
304214|NCT01644695|abdominal wall reconstruction|abdominal wall reconstruction
304215|NCT01644695|abdominal wall defect|abdominal wall defect
304216|NCT01644695|mesh|mesh
304217|NCT01644695|component separation|component separation
304218|NCT01644682|Visceral leishmaniasis|visceral leishmaniasis
304219|NCT01644682|insecticide|insecticide
304220|NCT01644682|wall lining|wall lining
304221|NCT01644682|KO TAB123|ko tab123
304222|NCT01644682|Household|household
304223|NCT01644682|Kala-azar endemic area|kala-azar endemic area
304224|NCT01644656|portal hypertension|portal hypertension
304225|NCT01644656|cirrhosis|cirrhosis
304226|NCT01644656|ARFI|arfi
304227|NCT01644656|diagnostic study|diagnostic study
304228|NCT01644643|Ceftazidime,|ceftazidime,
304229|NCT01644643|avibactam,|avibactam,
304230|NCT01644643|metronidazone,|metronidazone,
304231|NCT01644643|Anti-Infectives|anti-infectives
304232|NCT01644604|Hypertension|hypertension
304233|NCT01644604|Vascular Diseases|vascular diseases
304234|NCT01644604|Cardiovascular Diseases|cardiovascular diseases
304235|NCT01644604|Renal denervation|renal denervation
304236|NCT01644591|Melanoma|melanoma
304237|NCT01644591|Malignant melanoma|malignant melanoma
304238|NCT01644591|Brain Metastases|brain metastases
304239|NCT01644591|Stereotactic Radiosurgery|stereotactic radiosurgery
304240|NCT01644591|SRS|srs
304241|NCT01644591|XRT|xrt
304242|NCT01644591|Questionnaires|questionnaires
304243|NCT01644591|Surveys|surveys
304244|NCT01644578|MRI|mri
304245|NCT01644578|real-time imaging|real-time imaging
304246|NCT01644578|workflow|workflow
304247|NCT01643564|Transplant|transplant
304248|NCT01643564|Cytokines|cytokines
304249|NCT01643564|Graft Dysfunction|graft dysfunction
304250|NCT01643551|Heart Failure|heart failure
304251|NCT01643551|Left Ventricular Assist Device|left ventricular assist device
304252|NCT01643551|Reperfusion Injury|reperfusion injury
304253|NCT01643551|Neuron Specific Enolase|neuron specific enolase
304254|NCT01643538|physical activity|physical activity
304255|NCT01643538|adults age 65 and older|adults age 65 and older
304256|NCT01643538|financial incentives|financial incentives
304257|NCT01643525|Ischemic Stroke|ischemic stroke
304258|NCT01644552|aniridia|aniridia
304259|NCT01644552|positive angle kappa|positive angle kappa
304260|NCT01644539|Satiation|satiation
304261|NCT01644539|Brain activation|brain activation
304262|NCT01644539|Gut peptides|gut peptides
304263|NCT01644526|dialysis|dialysis
304264|NCT01644526|vascular access|vascular access
304265|NCT01644526|arteriovenous grafts|arteriovenous grafts
304266|NCT01644526|valve system|valve system
402033|NCT01233375|gemcitabine|gemcitabine
304267|NCT01644513|Age Related Macular Degeneration|age related macular degeneration
304268|NCT01644513|Choroidal Neovascular|choroidal neovascular
304269|NCT01644513|anti-VEGF Therapy|anti-vegf therapy
304271|NCT01644409|Overactive bladder|overactive bladder
304272|NCT01644409|Urgency|urgency
304273|NCT01644409|Incontinence|incontinence
304274|NCT01644396|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
304275|NCT01644383|meaning of life|meaning of life
304276|NCT01644383|logotherapy|logotherapy
304277|NCT01644383|HIV-infected teenagers|hiv-infected teenagers
304278|NCT01644383|adherence|adherence
304279|NCT01644370|HIV-infected children|hiv-infected children
304280|NCT01644370|T cell response|t cell response
304281|NCT01644370|asthma|asthma
304282|NCT01644292|Mobility Impairment|mobility impairment
304283|NCT01644292|Manual Wheelchair|manual wheelchair
304284|NCT01644292|Older Adults|older adults
304285|NCT01644279|aging|aging
304286|NCT01644279|sarcopenia|sarcopenia
304287|NCT01644279|mitochondria|mitochondria
304288|NCT01644279|skeletal muscle|skeletal muscle
304289|NCT01644279|apoptosis|apoptosis
304290|NCT01644253|chronic lymphocytic leukemia|chronic lymphocytic leukemia
304292|NCT01644253|previously untreated chronic lymphocytic leukemia|previously untreated chronic lymphocytic leukemia
304293|NCT01644227|Hip surgery|hip surgery
304294|NCT01644227|dual mobility cup|dual mobility cup
304295|NCT01644227|dislocation|dislocation
304296|NCT01644227|total hip arthroplasty|total hip arthroplasty
304297|NCT01644214|Pelvic organ prolapse|pelvic organ prolapse
304298|NCT01644214|Pessary|pessary
304299|NCT01644162|Non-Invasive Positive-Pressure Ventilation|non-invasive positive-pressure ventilation
304300|NCT01644162|Disease Exacerbation|disease exacerbation
304301|NCT01644162|Respiratory Failure|respiratory failure
304302|NCT01644149|Jet Injector|jet injector
304303|NCT01644149|Stratis®|stratis®
304304|NCT01644149|PharmaJet|pharmajet
304305|NCT01644149|Jet Injection|jet injection
304306|NCT01644123|Spasticity|spasticity
304307|NCT01644123|Diagnostic Algorithm|diagnostic algorithm
304308|NCT01644097|Quality of Life|quality of life
304309|NCT01644084|albumin|albumin
304310|NCT01644084|hydroxyethyl starch 130/0.4|hydroxyethyl starch 130/0.4
304311|NCT01644084|cardiopulmonary bypass|cardiopulmonary bypass
304312|NCT01644071|violent video games|violent video games
304313|NCT01644071|serotonergic system|serotonergic system
304314|NCT01644058|immediate-loading|immediate-loading
304315|NCT01644058|patient-based outcomes|patient-based outcomes
304316|NCT01644045|Asthma|asthma
304317|NCT01644045|COPD|copd
304318|NCT01644045|emergency medical service|emergency medical service
304319|NCT01644045|teleconsultation|teleconsultation
304320|NCT01644045|telemedicine|telemedicine
304321|NCT01644032|telemedicine|telemedicine
304322|NCT01644032|teleconsultation|teleconsultation
304323|NCT01644032|analgesia|analgesia
304324|NCT01644032|emergency|emergency
304325|NCT01644032|prehospital|prehospital
304326|NCT01644019|stroke|stroke
304327|NCT01644019|teleconsultation|teleconsultation
304328|NCT01644019|telemedicine|telemedicine
304329|NCT01644019|emergency medical service|emergency medical service
304330|NCT01644006|acute coronary syndrome|acute coronary syndrome
304331|NCT01644006|telemedicine|telemedicine
304332|NCT01644006|teleconsultation|teleconsultation
304333|NCT01644006|emergency medical service|emergency medical service
304334|NCT01643993|IVF|ivf
304335|NCT01643993|embryo|embryo
304336|NCT01643967|Ozone|ozone
304337|NCT01643967|Sunflower oil|sunflower oil
304338|NCT01643967|diabetes Mellitus|diabetes mellitus
304339|NCT01643954|prostatectomy|prostatectomy
304340|NCT01643954|surgery|surgery
304341|NCT01643954|prostate cancer|prostate cancer
304342|NCT01643941|Staphylococcus aureus|staphylococcus aureus
304343|NCT01643941|vaccine|vaccine
304344|NCT01643941|Staphylococcal infection|staphylococcal infection
304345|NCT01643928|extension trial|extension trial
304346|NCT01643928|rheumatoid arthritis|rheumatoid arthritis
304347|NCT01643928|rituximab|rituximab
304348|NCT01643915|Audiovisual distraction|audiovisual distraction
304349|NCT01643915|Pediatric dentistry|pediatric dentistry
304350|NCT01643902|Stroke|stroke
304351|NCT01643902|Wake up|wake up
304352|NCT01643902|IV tPA|iv tpa
303973|NCT01645956|obesity|obesity
304353|NCT01643902|Thrombolytic|thrombolytic
304355|NCT01643889|Domperidone|domperidone
304356|NCT01643889|Cardiac Repolarization|cardiac repolarization
304357|NCT01643876|Denture stomatitis|denture stomatitis
304358|NCT01643876|Denture Plaque|denture plaque
304359|NCT01643876|Oral Candidiasis|oral candidiasis
304360|NCT01643876|Oral Hygiene|oral hygiene
304361|NCT01643850|Pigmented Villonodular Synovitis|pigmented villonodular synovitis
304362|NCT01643850|PVNS|pvns
304363|NCT01643850|Giant cell tumor of the tendon sheath|giant cell tumor of the tendon sheath
304364|NCT01643850|GCCTS|gccts
304365|NCT01643850|Tenosynovial giant cell tumor (localized or diffused type)|tenosynovial giant cell tumor (localized or diffused type)
304366|NCT01643850|GCTS|gcts
304367|NCT01643850|MCS110|mcs110
304368|NCT01643837|Mastalgia|mastalgia
304369|NCT01643837|Breast Pain|breast pain
304370|NCT01643837|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
304371|NCT01643837|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
304372|NCT01643811|early gastric cancer, diabetes, hypertension|early gastric cancer, diabetes, hypertension
304373|NCT01643785|therapeutic efficacy endonase addictive effect|therapeutic efficacy endonase addictive effect
304374|NCT01643759|osteoarthritis disorders|osteoarthritis disorders
304375|NCT01643733|Angioplasty|angioplasty
304376|NCT01643707|Sick Sinus Syndrome|sick sinus syndrome
304377|NCT01643707|Bradycardia|bradycardia
304378|NCT01643616|Sciatic Nerve|sciatic nerve
304379|NCT01643616|Ultrasound|ultrasound
304380|NCT01643616|Anesthesia, Regional|anesthesia, regional
304381|NCT01643616|Orthopedic Surgery|orthopedic surgery
304382|NCT01643603|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
304383|NCT01643603|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
304384|NCT01643603|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
304385|NCT01643603|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
304386|NCT01643603|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
304387|NCT01643603|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
304388|NCT01643603|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
304447|NCT01643603|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
304389|NCT01643603|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
304390|NCT01643603|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
304391|NCT01643603|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
304392|NCT01643603|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
304393|NCT01643603|anaplastic large cell lymphoma|anaplastic large cell lymphoma
304394|NCT01643603|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
304395|NCT01643603|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
304396|NCT01643603|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
304397|NCT01643603|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
304398|NCT01643603|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
304399|NCT01643603|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
304400|NCT01643603|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
304401|NCT01643603|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
304402|NCT01643603|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
304403|NCT01643603|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
304404|NCT01643603|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
304405|NCT01643603|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
304406|NCT01643603|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
304407|NCT01643603|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
304408|NCT01643603|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
304409|NCT01643603|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
304410|NCT01643603|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
304411|NCT01643603|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
304412|NCT01643603|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
304413|NCT01643603|intraocular lymphoma|intraocular lymphoma
304414|NCT01643603|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
304415|NCT01643603|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
304416|NCT01643603|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
304417|NCT01643603|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
304418|NCT01643603|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
304419|NCT01643603|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
304420|NCT01643603|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
304421|NCT01643603|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
304422|NCT01643603|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
304423|NCT01643603|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
304424|NCT01643603|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
304425|NCT01643603|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
304426|NCT01643603|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
707541|NCT00997854|Bolus|bolus
304427|NCT01643603|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
304428|NCT01643603|peripheral T-cell lymphoma|peripheral t-cell lymphoma
304429|NCT01643603|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
304430|NCT01643603|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
304431|NCT01643603|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
304432|NCT01643603|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
304433|NCT01643603|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
304434|NCT01643603|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
304435|NCT01643603|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
304436|NCT01643603|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
304437|NCT01643603|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
304438|NCT01643603|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
295057|NCT01686750|HIV|hiv
304439|NCT01643603|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
304440|NCT01643603|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
304441|NCT01643603|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
304442|NCT01643603|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
304443|NCT01643603|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
304444|NCT01643603|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
304445|NCT01643603|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
304446|NCT01643603|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
304611|NCT01643057|Prematurity|prematurity
304448|NCT01643603|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
304449|NCT01643603|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
304450|NCT01643603|refractory hairy cell leukemia|refractory hairy cell leukemia
304451|NCT01643603|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
304452|NCT01643603|small intestine lymphoma|small intestine lymphoma
304453|NCT01643603|splenic marginal zone lymphoma|splenic marginal zone lymphoma
304454|NCT01643603|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
304455|NCT01643603|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
304456|NCT01643603|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
304457|NCT01643603|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
304458|NCT01643603|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
304459|NCT01643603|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
304460|NCT01643603|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
304461|NCT01643603|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
304462|NCT01643603|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
304463|NCT01643603|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
304464|NCT01643603|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
304465|NCT01643603|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
304466|NCT01643603|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
304467|NCT01643603|stage I mantle cell lymphoma|stage i mantle cell lymphoma
304468|NCT01643603|stage I marginal zone lymphoma|stage i marginal zone lymphoma
304469|NCT01643603|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
304470|NCT01643603|stage IA mycosis fungoides/Sezary syndrome|stage ia mycosis fungoides/sezary syndrome
304471|NCT01643603|stage IB mycosis fungoides/Sezary syndrome|stage ib mycosis fungoides/sezary syndrome
304472|NCT01643603|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
304473|NCT01643603|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
304474|NCT01643603|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
304475|NCT01643603|stage IIA mycosis fungoides/Sezary syndrome|stage iia mycosis fungoides/sezary syndrome
304476|NCT01643603|stage IIB mycosis fungoides/Sezary syndrome|stage iib mycosis fungoides/sezary syndrome
304477|NCT01643603|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
304478|NCT01643603|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
304479|NCT01643603|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
304480|NCT01643603|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
304481|NCT01643603|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
304482|NCT01643603|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
304483|NCT01643603|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
304484|NCT01643603|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
304485|NCT01643603|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
304486|NCT01643603|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
304487|NCT01643603|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
304488|NCT01643603|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
586555|NCT00516685|IMMUNOTHERAPY|immunotherapy
304489|NCT01643603|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
304490|NCT01643603|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
304491|NCT01643603|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
304492|NCT01643603|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
304493|NCT01643603|stage IIIA mycosis fungoides/Sezary syndrome|stage iiia mycosis fungoides/sezary syndrome
304494|NCT01643603|stage IIIB mycosis fungoides/Sezary syndrome|stage iiib mycosis fungoides/sezary syndrome
304495|NCT01643603|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
304496|NCT01643603|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
304497|NCT01643603|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
304498|NCT01643603|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
304499|NCT01643603|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
752608|NCT01173315|Type 2 diabetes|type 2 diabetes
304500|NCT01643603|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
304501|NCT01643603|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
304502|NCT01643603|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
304503|NCT01643603|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
304504|NCT01643603|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
304505|NCT01643603|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
304506|NCT01643603|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
304507|NCT01643603|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
304508|NCT01643603|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
304509|NCT01643603|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
304510|NCT01643603|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
304511|NCT01643603|stage IVA mycosis fungoides/Sezary syndrome|stage iva mycosis fungoides/sezary syndrome
304512|NCT01643603|stage IVB mycosis fungoides/Sezary syndrome|stage ivb mycosis fungoides/sezary syndrome
304513|NCT01643603|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
304514|NCT01643603|testicular lymphoma|testicular lymphoma
304515|NCT01643603|Waldenström macroglobulinemia|waldenström macroglobulinemia
304516|NCT01643577|Idiopathic|idiopathic
304517|NCT01643577|gastroparesis|gastroparesis
304518|NCT01643577|delayed gastric emptying|delayed gastric emptying
304520|NCT01643577|vomiting|vomiting
304521|NCT01643577|abdominal pain|abdominal pain
304522|NCT01643577|bloating|bloating
304523|NCT01643486|peritoneal dialysis|peritoneal dialysis
304524|NCT01643486|phosphate|phosphate
304525|NCT01643486|iTouch|itouch
304526|NCT01643473|Hypertension|hypertension
304527|NCT01643473|Latinos|latinos
304528|NCT01643473|Medication Adherence|medication adherence
304529|NCT01643473|Blood Pressure Control|blood pressure control
304530|NCT01643473|Patient-centered|patient-centered
304531|NCT01643473|Black|black
304532|NCT01643460|Intraductal papillary mucinous neoplasms (IPMNs)|intraductal papillary mucinous neoplasms (ipmns)
304533|NCT01643460|Mucinous cystadenomas [MCN])|mucinous cystadenomas [mcn])
304534|NCT01643460|Invasive IPMNs or mucinous cystadenocarcinomas) tumors|invasive ipmns or mucinous cystadenocarcinomas) tumors
304535|NCT01643447|Hepatocellular Carcinoma|hepatocellular carcinoma
304536|NCT01643447|Ulinastatin|ulinastatin
304537|NCT01643447|Hepatic Failure|hepatic failure
304538|NCT01643434|Resistant Hypertension|resistant hypertension
304539|NCT01643408|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
304540|NCT01643408|Lymphoblastic Lymphoma|lymphoblastic lymphoma
304541|NCT01643408|Erwinaze|erwinaze
304542|NCT01643408|asparaginase|asparaginase
304543|NCT01643408|Eusa Pharma|eusa pharma
304544|NCT01643408|Pharmacokinetic study|pharmacokinetic study
304545|NCT01643408|NSAA|nsaa
304546|NCT01643395|Trauma|trauma
304547|NCT01643395|vertebral|vertebral
304548|NCT01643395|compression fracture|compression fracture
304549|NCT01643395|spinal|spinal
304550|NCT01643395|acute|acute
304551|NCT01643395|vertebroplasty|vertebroplasty
304552|NCT01643395|conservative treatment|conservative treatment
304553|NCT01643382|diabetes|diabetes
304554|NCT01643382|kidney transplant|kidney transplant
304555|NCT01643382|end stage renal disease|end stage renal disease
304556|NCT01643382|delayed draft function|delayed draft function
304557|NCT01643369|meditation|meditation
304558|NCT01643369|compassion|compassion
304559|NCT01643369|inflammation|inflammation
304560|NCT01643369|immune system|immune system
304561|NCT01643356|weight|weight
304562|NCT01643356|pregnancy|pregnancy
304563|NCT01643356|behavioral intervention|behavioral intervention
304564|NCT01643356|obesity|obesity
304565|NCT01643343|autism spectrum disorders|autism spectrum disorders
304566|NCT01643343|autism|autism
304567|NCT01643343|joint attention|joint attention
304568|NCT01643343|imitation|imitation
304569|NCT01643343|fluency|fluency
304570|NCT01643330|Cardiomegaly|cardiomegaly
304571|NCT01643330|Heart Diseases|heart diseases
304572|NCT01643330|Cardiovascular Diseases|cardiovascular diseases
304573|NCT01643304|Menorrhagia|menorrhagia
707542|NCT00997867|Pain|pain
304574|NCT01643304|Heavy menstrual bleeding|heavy menstrual bleeding
304575|NCT01643304|Uterine Hemorrhage|uterine hemorrhage
304576|NCT01643304|Menstruation Disturbancies|menstruation disturbancies
304577|NCT01643252|Corneal Ectasia|corneal ectasia
304578|NCT01643252|Refractive surgery|refractive surgery
304579|NCT01643252|Cross-Linking|cross-linking
304580|NCT01643239|Modified constraint-induced therapy|modified constraint-induced therapy
306159|NCT01635842|awareness|awareness
304581|NCT01643239|Children with cerebral palsy|children with cerebral palsy
304582|NCT01643239|Kinematic analysis|kinematic analysis
304583|NCT01643239|Group therapy|group therapy
304584|NCT01643200|Erectile Dysfunction|erectile dysfunction
304585|NCT01643200|Male|male
304586|NCT01643200|Zotarolimus|zotarolimus
304587|NCT01643200|Stent|stent
304588|NCT01643200|Stenosis|stenosis
304589|NCT01643200|Erection|erection
304590|NCT01643200|PDE5 Inhibitors|pde5 inhibitors
377497|NCT01337219|sputum|sputum
304591|NCT01643148|biomarker|biomarker
304593|NCT01643148|breast cancer|breast cancer
304594|NCT01643148|CA-15-3|ca-15-3
304595|NCT01643148|leptin|leptin
304596|NCT01643135|tranexamic acid|tranexamic acid
304597|NCT01643135|bleeding|bleeding
304598|NCT01643135|blood transfusion|blood transfusion
304599|NCT01643135|spine surgery|spine surgery
304600|NCT01643122|Endometriosis, Validation study|endometriosis, validation study
304601|NCT01643109|Cerebral Palsy|cerebral palsy
304602|NCT01643109|Hemiplegia|hemiplegia
304603|NCT01643109|Constraint Induced Movement Therapy|constraint induced movement therapy
304604|NCT01643096|Zataria multiflora Boiss Sumac TEF temperament|zataria multiflora boiss sumac tef temperament
304605|NCT01643083|Post-prandial distress syndrome|post-prandial distress syndrome
304606|NCT01643070|Rectal cancer|rectal cancer
304607|NCT01643070|Liver metastases|liver metastases
304608|NCT01643070|Capecitabine|capecitabine
304609|NCT01643070|Oxaliplatin|oxaliplatin
304610|NCT01643057|Apnea|apnea
304613|NCT01643057|Stochastic Resonance|stochastic resonance
304614|NCT01643057|Neonatal|neonatal
304615|NCT01643044|pregnancy|pregnancy
304616|NCT01643044|screening|screening
304617|NCT01643044|motivation|motivation
304618|NCT01643031|Diabetes|diabetes
304619|NCT01643031|Platelets aggregation inhibitors|platelets aggregation inhibitors
304620|NCT01643031|Platelet function tests|platelet function tests
304621|NCT01643018|cystic echinococcosis|cystic echinococcosis
304622|NCT01643018|liver cyst hydatique|liver cyst hydatique
304623|NCT01643018|treatment|treatment
304624|NCT01643018|surgery|surgery
304625|NCT01643018|laparoscopy|laparoscopy
304626|NCT01643005|HIV|hiv
304627|NCT01642992|Coronary bifurcation lesion|coronary bifurcation lesion
304628|NCT01642992|Drug-eluting stent|drug-eluting stent
304629|NCT01642979|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
304630|NCT01642979|Anemia|anemia
304631|NCT01642979|Hematologic Diseases|hematologic diseases
304632|NCT01642979|bone marrow failure|bone marrow failure
304633|NCT01642979|Immunologic Factors|immunologic factors
304634|NCT01642979|Physiological Effects of Drugs|physiological effects of drugs
304635|NCT01642979|Levamisole|levamisole
304636|NCT01642979|cyclosporine A|cyclosporine a
304637|NCT01642966|ticagrelor|ticagrelor
304638|NCT01642966|doppler echocardiography|doppler echocardiography
304639|NCT01642953|Gastric cancer surgery|gastric cancer surgery
304640|NCT01642953|Early oral feeding|early oral feeding
304641|NCT01642953|Fast track surgery|fast track surgery
304642|NCT01642927|LVAD|lvad
304643|NCT01642927|IABP|iabp
304644|NCT01642927|Heart Failure|heart failure
304645|NCT01642927|Thrombosis|thrombosis
304646|NCT01642927|Hemorrhage|hemorrhage
304647|NCT01642914|Chronic Constipation|chronic constipation
304648|NCT01642914|Abdominal Bloating|abdominal bloating
304649|NCT01642914|Linaclotide|linaclotide
304650|NCT01642901|spinal cord injury|spinal cord injury
304651|NCT01642901|bone mineral density|bone mineral density
304652|NCT01642875|Periampullary tumor|periampullary tumor
304653|NCT01642875|Chronic pancreatitis|chronic pancreatitis
304654|NCT01642875|Pancreatoduodenectomy|pancreatoduodenectomy
304655|NCT01642875|Oral Nutrition|oral nutrition
304656|NCT01642875|Enteral Nutrition|enteral nutrition
304657|NCT01642849|high protein diet|high protein diet
304658|NCT01642849|high carbohydrate diet|high carbohydrate diet
304659|NCT01642849|weight loss|weight loss
304660|NCT01642849|oxidative stress|oxidative stress
304661|NCT01642849|inflammation|inflammation
304662|NCT01642849|cardiovascular risk factors|cardiovascular risk factors
304663|NCT01642823|retinoblastoma|retinoblastoma
304664|NCT01642810|Online treatment for Fibromyalgia Syndrome|online treatment for fibromyalgia syndrome
304665|NCT01642810|Acceptance-based behavioural treatment|acceptance-based behavioural treatment
304666|NCT01642797|confocal laser endomicroscopy|confocal laser endomicroscopy
304667|NCT01642797|gastric intestinal metaplasia|gastric intestinal metaplasia
304668|NCT01642797|gastric intraepithelial neoplasia|gastric intraepithelial neoplasia
304669|NCT01642797|gastric carcinoma|gastric carcinoma
304670|NCT01642784|STEMI|stemi
304671|NCT01642784|NSTEMI|nstemi
304672|NCT01642784|revascularization|revascularization
304673|NCT01642784|stents|stents
304674|NCT01642771|Triple-negative Breast Cancer|triple-negative breast cancer
304675|NCT01642771|Post-operative adjuvant Chemotherapy|post-operative adjuvant chemotherapy
304676|NCT01642771|Docetaxel|docetaxel
304677|NCT01642771|Capecitabine|capecitabine
304678|NCT01642771|Epirubicin|epirubicin
304679|NCT01642771|Cyclophosphamide|cyclophosphamide
304680|NCT01642771|Fluorouracil|fluorouracil
304681|NCT01642758|Thalassemia intermedia|thalassemia intermedia
304682|NCT01642758|Fetal hemoglobin|fetal hemoglobin
304683|NCT01642758|Hemoglobin|hemoglobin
304684|NCT01642732|Prostate|prostate
304685|NCT01642732|Cancer|cancer
304686|NCT01642732|Everolimus|everolimus
304687|NCT01642732|Radiation|radiation
304688|NCT01642719|Sleep disturbance|sleep disturbance
304689|NCT01642719|Aging|aging
304690|NCT01642719|Sleep restriction|sleep restriction
304691|NCT01642719|Health status|health status
304692|NCT01642719|Glucose tolerance|glucose tolerance
304693|NCT01642719|Inflammation|inflammation
304694|NCT01642706|Regulatory B cells|regulatory b cells
304695|NCT01642706|Rheumatoid arthritis|rheumatoid arthritis
304696|NCT01642706|Biomarker|biomarker
304697|NCT01642693|root resorption|root resorption
304698|NCT01642693|low-power laser|low-power laser
304699|NCT01642693|orthodontic tooth movement|orthodontic tooth movement
304700|NCT01642693|pulp changes|pulp changes
304701|NCT01642680|Physical activity program|physical activity program
304702|NCT01642680|Chemotherapy|chemotherapy
304703|NCT01642680|Metabolic syndrome|metabolic syndrome
304704|NCT01642680|Reducing cardiovascular risk factors|reducing cardiovascular risk factors
304705|NCT01642680|low physical activity level|low physical activity level
304706|NCT01642628|Mirror|mirror
304707|NCT01642628|Body Image|body image
304708|NCT01642628|Mastectomy|mastectomy
304709|NCT01642615|Drug therapy|drug therapy
304710|NCT01642602|Drug Therapy|drug therapy
304711|NCT01642589|Meningitis|meningitis
304712|NCT01642589|Meningococcal disease|meningococcal disease
304713|NCT01642589|Menactra®|menactra®
304714|NCT01642589|Adacel®|adacel®
304715|NCT01642576|obesity|obesity
304716|NCT01642576|men|men
304717|NCT01642576|sexual function|sexual function
304718|NCT01642576|urinary tract symptoms|urinary tract symptoms
304719|NCT01642576|endothelial function|endothelial function
304720|NCT01642576|inflammation|inflammation
304721|NCT01642576|quality of life|quality of life
304722|NCT01642563|Platelet transfusion|platelet transfusion
304723|NCT01642563|Leukemia|leukemia
304724|NCT01642563|Transfusion transmissible infections|transfusion transmissible infections
304725|NCT01642563|Chemotherapy|chemotherapy
304726|NCT01642563|Allogeneic hemopoietic stem cell transplant|allogeneic hemopoietic stem cell transplant
304727|NCT01642550|Anorexia nervosa|anorexia nervosa
304728|NCT01642550|Anorexia|anorexia
304729|NCT01642550|Eating disorders|eating disorders
304730|NCT01642524|resuscitation|resuscitation
304731|NCT01642511|Breast Cancer|breast cancer
304732|NCT01642511|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
304733|NCT01642511|Internal Mammary|internal mammary
304734|NCT01642511|Lymphoscintigraphy|lymphoscintigraphy
304735|NCT01642498|High Blood Pressure|high blood pressure
304736|NCT01642498|Hypertension|hypertension
304737|NCT01642498|Resistant Hypertension|resistant hypertension
304738|NCT01642485|Insulin clamp|insulin clamp
304739|NCT01642485|Glucose clamp|glucose clamp
304740|NCT01642485|Moxifloxacin|moxifloxacin
304741|NCT01642485|Fed|fed
304742|NCT01642485|Fasted|fasted
304743|NCT01642485|QT/QTC interval|qt/qtc interval
304744|NCT01642485|TQT|tqt
304745|NCT01642485|ECG|ecg
304746|NCT01642485|Meal effects|meal effects
304747|NCT01642485|C Peptide|c peptide
304748|NCT01642485|Japanese Caucasian bridging|japanese caucasian bridging
304749|NCT01642485|TQT bridging|tqt bridging
304750|NCT01642485|FDA standard breakfast|fda standard breakfast
304751|NCT01642485|Adaptive study design|adaptive study design
304752|NCT01642459|arteriovenous fistula|arteriovenous fistula
304753|NCT01642459|hemodialysis|hemodialysis
304754|NCT01642459|aneurysm|aneurysm
304755|NCT01642459|vascular stenosis|vascular stenosis
304756|NCT01642459|cannulation|cannulation
304757|NCT01642446|precise hepatectomy|precise hepatectomy
304758|NCT01642446|hepatocellular carcinoma|hepatocellular carcinoma
304759|NCT01642446|cirrhotic|cirrhotic
304760|NCT01642446|portal hypertension|portal hypertension
304761|NCT01642446|safety|safety
304762|NCT01642446|combined interventional treatment|combined interventional treatment
304763|NCT01642394|Diabetes Mellitus|diabetes mellitus
304764|NCT01642394|Chronic Disease|chronic disease
304765|NCT01642394|Education|education
304766|NCT01642394|Primary Care|primary care
304767|NCT01642394|Self care|self care
304768|NCT01642394|Self Management|self management
304769|NCT01642381|Drinking|drinking
304770|NCT01642381|Alcohol Problems|alcohol problems
304771|NCT01642381|Alcoholism|alcoholism
707543|NCT00997867|Surgery|surgery
304772|NCT01642381|Moderation-Oriented Treatment|moderation-oriented treatment
304773|NCT01642381|Controlled Drinking|controlled drinking
304774|NCT01642381|Reduced Drinking|reduced drinking
304775|NCT01642381|Heavy Drinking|heavy drinking
304776|NCT01642381|Problematic Drinking|problematic drinking
304777|NCT01642381|Non-Abstinence-based Drinking|non-abstinence-based drinking
304778|NCT01642368|Omega-3 fatty acids|omega-3 fatty acids
304779|NCT01642368|Omega-3 to omega-6 ratio|omega-3 to omega-6 ratio
304780|NCT01642368|Cognitive response|cognitive response
304781|NCT01642368|Physical performance|physical performance
306263|NCT01635335|family|family
304782|NCT01642329|Myocardial Infarction|myocardial infarction
304783|NCT01642329|Angina, Unstable|angina, unstable
304784|NCT01642316|washback, reading comprehension|washback, reading comprehension
304785|NCT01642303|vodcasting,listening,language education|vodcasting,listening,language education
304786|NCT01642277|Overactive Bladder|overactive bladder
304787|NCT01642277|OAB|oab
304788|NCT01642277|Urinary Tract Infection|urinary tract infection
304789|NCT01642277|UTI|uti
304790|NCT01642277|Microbiome|microbiome
304791|NCT01642277|Bacteria|bacteria
304792|NCT01642277|Solifenacin|solifenacin
304793|NCT01642277|16S rRNA sequence|16s rrna sequence
304794|NCT01642264|Tobacco Cessation|tobacco cessation
304795|NCT01642264|Continuing Education|continuing education
304796|NCT01642264|Pediatric|pediatric
304797|NCT01642264|Respiratory Therapist|respiratory therapist
304798|NCT01642264|Nurse|nurse
304799|NCT01642238|Antiplatelet|antiplatelet
304800|NCT01642238|ticagrelor|ticagrelor
304801|NCT01642238|clopidogrel|clopidogrel
304802|NCT01642238|bivalirudin|bivalirudin
304803|NCT01642238|thrombosis|thrombosis
304804|NCT01642212|EoE|eoe
304805|NCT01642199|obesity|obesity
304806|NCT01642199|weight loss|weight loss
304807|NCT01642199|lay health coach|lay health coach
304808|NCT01642199|peer coach|peer coach
304809|NCT01642199|mentor coach|mentor coach
304810|NCT01642199|reduced intensity weight loss program|reduced intensity weight loss program
304811|NCT01642186|LETROZOLE|letrozole
304910|NCT01641627|vibrations|vibrations
304812|NCT01642186|LUPRON DEPOT|lupron depot
304813|NCT01642186|RAD001 (EVEROLIMUS)|rad001 (everolimus)
304814|NCT01642186|11-211|11-211
304815|NCT01642147|Cerebral blood flow|cerebral blood flow
304816|NCT01642147|Transcranial Doppler|transcranial doppler
304817|NCT01642147|Emergence from general anesthesia|emergence from general anesthesia
304818|NCT01642134|Antiplatelet|antiplatelet
304819|NCT01642134|Anticoagulation|anticoagulation
304820|NCT01642056|Fibroblasts|fibroblasts
304821|NCT01642056|Mitochondria|mitochondria
304822|NCT01642056|Energy|energy
304823|NCT01642056|Redox|redox
304824|NCT01642056|Metabolic Disease|metabolic disease
304825|NCT01642043|greater trochanteric pain syndrome|greater trochanteric pain syndrome
304826|NCT01642043|trochanteric bursitis|trochanteric bursitis
304827|NCT01642043|lateral hip pain|lateral hip pain
304828|NCT01642030|Quantitative sensory testing|quantitative sensory testing
304829|NCT01642030|Cold pressor test|cold pressor test
304830|NCT01642030|Opioid dependence|opioid dependence
304831|NCT01642030|Methadone maintenance|methadone maintenance
304832|NCT01642030|Buprenorphine maintenance|buprenorphine maintenance
304833|NCT01642030|Abuse liability|abuse liability
304834|NCT01642030|DNIC|dnic
304835|NCT01642030|Temporal Summation|temporal summation
304836|NCT01642017|Phase I, Pazopanib, Frail elderly patients, Pharmacokinetics|phase i, pazopanib, frail elderly patients, pharmacokinetics
304964|NCT01641458|Toxicity|toxicity
304837|NCT01641991|Bacillus anthracis, anthrax, vaccine, BioThrax®, dose-sparing|bacillus anthracis, anthrax, vaccine, biothrax®, dose-sparing
304838|NCT01641913|Eosinophilic Esophagitis|eosinophilic esophagitis
304839|NCT01641900|sleep|sleep
304840|NCT01641900|memory|memory
304841|NCT01641900|schizophrenia|schizophrenia
304842|NCT01641900|eszopiclone|eszopiclone
304843|NCT01641887|GERD|gerd
304844|NCT01641887|Heartburn|heartburn
304845|NCT01641887|Decision Aid|decision aid
304846|NCT01641874|Knee|knee
304847|NCT01641874|Osteoarthritis|osteoarthritis
304848|NCT01641874|McKenzie system|mckenzie system
304849|NCT01641874|Exercise|exercise
304850|NCT01641874|Mechanical Diagnosis and Therapy|mechanical diagnosis and therapy
304851|NCT01641874|Directional preference|directional preference
304852|NCT01641861|Chemo-mechanical caries removal|chemo-mechanical caries removal
304853|NCT01641861|Papacarie®|papacarie®
304854|NCT01641848|Total Ankle Arthroplasty|total ankle arthroplasty
304855|NCT01641809|HIV -1|hiv -1
304856|NCT01641809|GSK1265744|gsk1265744
304857|NCT01641809|maintenance phase|maintenance phase
304858|NCT01641809|dose selection|dose selection
304859|NCT01641796|Cutaneous Leishmaniasis|cutaneous leishmaniasis
304860|NCT01641796|CL|cl
304861|NCT01641796|Lesion|lesion
304862|NCT01641796|Topical|topical
304863|NCT01641796|Treatment|treatment
304864|NCT01641796|Cream|cream
304865|NCT01641796|Expanded Access|expanded access
304866|NCT01641783|advanced|advanced
304867|NCT01641783|paclitaxel|paclitaxel
304868|NCT01641783|capecitabine|capecitabine
707544|NCT00997867|Catheter|catheter
304869|NCT01641783|first line therapy|first line therapy
304870|NCT01641757|hemodialysis|hemodialysis
304871|NCT01641757|periodontitis|periodontitis
304872|NCT01641744|Parent Child Relationship|parent child relationship
304873|NCT01641744|Maltreatment|maltreatment
304874|NCT01641744|Risk Behaviors|risk behaviors
304875|NCT01641744|Social and Emotional Development|social and emotional development
304876|NCT01641744|Violence and Abuse|violence and abuse
304877|NCT01641744|Policy|policy
304878|NCT01641731|cow's milk protein allergy|cow's milk protein allergy
304879|NCT01641731|oral tolerance induction|oral tolerance induction
304880|NCT01641718|Hernia, Inguinal|hernia, inguinal
304881|NCT01641705|rheumatoid arthritis|rheumatoid arthritis
304882|NCT01641705|respiratory mechanics|respiratory mechanics
304883|NCT01641705|time of disease|time of disease
304884|NCT01641692|Asthma|asthma
304885|NCT01641692|Pharmacokinetics|pharmacokinetics
304886|NCT01641692|GSK573719|gsk573719
304887|NCT01641692|Adults|adults
304888|NCT01641692|Pharmacogenetics|pharmacogenetics
304889|NCT01641679|Recurrent differentiated thyroid cancer|recurrent differentiated thyroid cancer
304890|NCT01641679|I124-PET/CT|i124-pet/ct
304891|NCT01641679|FDG-PET/CT|fdg-pet/ct
304892|NCT01641653|Nondiabetics undergoing hernia repair.|nondiabetics undergoing hernia repair.
304893|NCT01641640|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
304894|NCT01641640|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
304895|NCT01641640|HCV genotype 5 (GT-5)|hcv genotype 5 (gt-5)
304896|NCT01641640|HCV genotype 6 (GT-6)|hcv genotype 6 (gt-6)
304897|NCT01641640|HCV|hcv
304898|NCT01641640|Sustained Virologic Response|sustained virologic response
304899|NCT01641640|Direct Acting Antiviral|direct acting antiviral
304900|NCT01641640|Combination Therapy|combination therapy
304901|NCT01641640|Treatment-Naïve|treatment-naïve
304902|NCT01641640|GS-7977|gs-7977
304903|NCT01641640|Ribavirin|ribavirin
304904|NCT01641640|RBV|rbv
304905|NCT01641640|Peginterferon Alfa 2a|peginterferon alfa 2a
304906|NCT01641640|PEG|peg
304907|NCT01641627|knee arthritis|knee arthritis
304908|NCT01641627|muscle atrophy|muscle atrophy
304909|NCT01641627|proprioceptive stimulation|proprioceptive stimulation
304911|NCT01641614|Mitral valve|mitral valve
304912|NCT01641614|valve replacement|valve replacement
304913|NCT01641614|arrested heart|arrested heart
304914|NCT01641614|beating heart|beating heart
304915|NCT01641601|Induction of labor|induction of labor
304916|NCT01641601|Outpatient cervical ripening|outpatient cervical ripening
304917|NCT01641588|cognitive executive function|cognitive executive function
304918|NCT01641588|posture|posture
304919|NCT01641588|cognitive performance|cognitive performance
304920|NCT01641588|heart rate|heart rate
304921|NCT01641588|eeg|eeg
304922|NCT01641575|CO-1.01|co-1.01
304923|NCT01641575|CO-101|co-101
304924|NCT01641575|gemcitabine elaidate|gemcitabine elaidate
304925|NCT01641575|hENT1|hent1
304926|NCT01641575|nucleoside equilibrative transporter|nucleoside equilibrative transporter
304927|NCT01641575|solid tumor|solid tumor
304928|NCT01641575|non-small-cell lung cancer|non-small-cell lung cancer
304929|NCT01641575|NSCLC|nsclc
304930|NCT01641575|lung cancer|lung cancer
304931|NCT01641562|BREAST CANCER,|breast cancer,
304932|NCT01641562|TAXANES,|taxanes,
304933|NCT01641562|SUBCLINICAL CARDIAC DYSFUNCTION ,|subclinical cardiac dysfunction ,
304934|NCT01641562|DIAGNOSTIC TOOLS,|diagnostic tools,
304935|NCT01641562|PREDICTIVE MODELS|predictive models
304936|NCT01641549|Prosthetic valve thrombosis|prosthetic valve thrombosis
304937|NCT01641549|Fibrinolytic therapy|fibrinolytic therapy
304938|NCT01641549|Emergency surgery|emergency surgery
304939|NCT01641536|Hepatitis, Chronic|hepatitis, chronic
304940|NCT01641536|Virus Diseases|virus diseases
304941|NCT01641536|DNA Virus Infections|dna virus infections
304942|NCT01641536|Hepatitis B|hepatitis b
304943|NCT01641536|Liver|liver
304944|NCT01641536|Chronic Disease|chronic disease
304945|NCT01641536|HBV|hbv
304946|NCT01641523|Cranioplasty prosthesis|cranioplasty prosthesis
304947|NCT01641523|Hydroxyapatite|hydroxyapatite
304948|NCT01641523|PolyMethylMethacrylate|polymethylmethacrylate
304949|NCT01641523|Autologous Bone|autologous bone
304950|NCT01641510|reduced-function CYP2C19 allele|reduced-function cyp2c19 allele
304951|NCT01641510|high platelet reactivity|high platelet reactivity
304952|NCT01641510|clopidogrel|clopidogrel
304953|NCT01641510|prasugrel|prasugrel
304954|NCT01641497|endometrial cancer|endometrial cancer
304955|NCT01641497|IMRT|imrt
304956|NCT01641497|age over 70|age over 70
304957|NCT01641471|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
304958|NCT01641471|Transcutaneous Electrical Nerve Stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
304960|NCT01641471|Function|function
304961|NCT01641471|Knee Osteoarthritis|knee osteoarthritis
304962|NCT01641458|Genotyping|genotyping
304963|NCT01641458|Area-under-the concentration-time curve|area-under-the concentration-time curve
304965|NCT01641458|5-fluorouracil|5-fluorouracil
304966|NCT01641458|Capecitabine|capecitabine
304967|NCT01641419|Pain|pain
304972|NCT01641406|NAC and Oncotype Guided Hormonal therapy for breast cancer|nac and oncotype guided hormonal therapy for breast cancer
304974|NCT01641406|NAC CCAM 1101|nac ccam 1101
304975|NCT01641393|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
304976|NCT01641393|Cystic Fibrosis|cystic fibrosis
304977|NCT01641393|Pancreatic Insufficiency|pancreatic insufficiency
304978|NCT01641380|Depoprovera|depoprovera
304979|NCT01641380|Contraception|contraception
304980|NCT01641380|Appointment adherence/attendance|appointment adherence/attendance
306748|NCT01632826|Relapsed|relapsed
304981|NCT01641380|Pregnancy Prevention|pregnancy prevention
304982|NCT01641354|Hemiepiphysiodesis|hemiepiphysiodesis
304983|NCT01641341|Irritable Bowel Syndrome|irritable bowel syndrome
304984|NCT01641341|Genova Diagnostics kit|genova diagnostics kit
304985|NCT01641341|Stool test|stool test
304986|NCT01641341|Rome III|rome iii
304987|NCT01641341|Practice-based research|practice-based research
304988|NCT01641341|treatable parasite|treatable parasite
304989|NCT01641341|Pancreatic insufficiency|pancreatic insufficiency
304990|NCT01641341|Bowel dysbiosis|bowel dysbiosis
304991|NCT01641341|High levels of inflammation, C. difficile, or H. pylori|high levels of inflammation, c. difficile, or h. pylori
304992|NCT01641328|Mild Cognitive Impairment|mild cognitive impairment
304994|NCT01641328|Meditation|meditation
304995|NCT01641328|Mindfulness|mindfulness
304996|NCT01641328|Cognitive Activation|cognitive activation
304997|NCT01641328|Cognitive Training|cognitive training
304998|NCT01641328|Tai Chi|tai chi
304999|NCT01641315|rabies|rabies
305000|NCT01641315|rabies immunoglobulin|rabies immunoglobulin
305001|NCT01641289|Falciparum malaria|falciparum malaria
305002|NCT01641289|Paracetamol|paracetamol
305003|NCT01641289|Renal function|renal function
305004|NCT01641289|Oxidative stress|oxidative stress
305005|NCT01641276|biofeedback response|biofeedback response
305006|NCT01641263|Depression Prevention|depression prevention
305007|NCT01641263|Sleep Disturbances|sleep disturbances
305008|NCT01641263|Inflammatory Markers|inflammatory markers
305009|NCT01641263|Treatments for Sleep Problems|treatments for sleep problems
305010|NCT01641224|Irritable bowel syndrome,|irritable bowel syndrome,
305011|NCT01641224|Pinaverium|pinaverium
305012|NCT01641224|Herbal medication for IBS,|herbal medication for ibs,
305115|NCT01640743|Rejection|rejection
305013|NCT01641224|Tong Xie Yao Fang (Formula for pain and diarrhea)|tong xie yao fang (formula for pain and diarrhea)
305014|NCT01641198|Dental implants, bone healing, fixed dental prostheses, implant surface|dental implants, bone healing, fixed dental prostheses, implant surface
305015|NCT01641185|prostate|prostate
305016|NCT01641185|IPI|ipi
305017|NCT01641185|hypofractionation|hypofractionation
305018|NCT01641185|carbon ions|carbon ions
305019|NCT01641185|proton|proton
305020|NCT01641172|taste|taste
305021|NCT01641172|smell|smell
305022|NCT01641172|cancer|cancer
305023|NCT01641172|nutrition|nutrition
305024|NCT01641159|Cocaine|cocaine
305025|NCT01641159|Crack|crack
305026|NCT01641159|Buspirone|buspirone
305027|NCT01641159|Relapse Prevention|relapse prevention
305028|NCT01641146|HIV risk reduction|hiv risk reduction
305029|NCT01641146|Stress reduction|stress reduction
305030|NCT01641146|Trauma reduction|trauma reduction
305031|NCT01641146|PTSD|ptsd
305032|NCT01641133|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
305033|NCT01641133|Synflorix™|synflorix™
305034|NCT01641133|Prevenar 13™|prevenar 13™
305035|NCT01641133|Pneumococcal diseases|pneumococcal diseases
305036|NCT01641120|Multiple Sclerosis|multiple sclerosis
305037|NCT01641120|Intramuscular Injections|intramuscular injections
305038|NCT01641120|Relapsing Remitting|relapsing remitting
305044|NCT01641094|Hepatitis C|hepatitis c
305045|NCT01641094|Liver|liver
305046|NCT01641094|Immunology|immunology
305047|NCT01641094|Genotype 1|genotype 1
305048|NCT01641094|Treatment|treatment
305049|NCT01641094|Chronic|chronic
305050|NCT01641094|RNA Virus Infections|rna virus infections
305051|NCT01641094|Ribavirin|ribavirin
305052|NCT01641094|Peginterferon alfa-2a|peginterferon alfa-2a
305053|NCT01641094|Protease Inhibitors|protease inhibitors
305054|NCT01641094|Telaprevir|telaprevir
305055|NCT01641068|Memory|memory
305056|NCT01641068|Attention|attention
305057|NCT01641068|Chemo-brain|chemo-brain
305058|NCT01641068|Survivor|survivor
305059|NCT01641068|Treatment|treatment
305060|NCT01641042|Meningococcal vaccines|meningococcal vaccines
305061|NCT01641042|Vaccines, conjugate|vaccines, conjugate
305062|NCT01641042|Neisseria meningitidis|neisseria meningitidis
305063|NCT01641042|Immunocompromised patient|immunocompromised patient
305064|NCT01641016|short cycle therapy|short cycle therapy
305065|NCT01641016|young people|young people
305066|NCT01641016|HIV|hiv
305067|NCT01641003|cancer stem cells|cancer stem cells
305068|NCT01640990|Healthy male volunteers, intravenous infusion, GW328267X, dose escalation,|healthy male volunteers, intravenous infusion, gw328267x, dose escalation,
305069|NCT01640977|Open PLIF|open plif
305070|NCT01640977|MAS PLIF|mas plif
305071|NCT01640977|Lumbar spine|lumbar spine
305072|NCT01640964|Portal hypertension, cirrhosis, TIPSS, MRI, MRA, portal pressure, portal pressure gradient|portal hypertension, cirrhosis, tipss, mri, mra, portal pressure, portal pressure gradient
305073|NCT01640925|nosocomial infection|nosocomial infection
305074|NCT01640925|hospital acquired infection|hospital acquired infection
305075|NCT01640925|chlorhexidine|chlorhexidine
305076|NCT01640925|pneumonia, ventilator-associated|pneumonia, ventilator-associated
305077|NCT01640925|catheter-related infections|catheter-related infections
305078|NCT01640925|urinary tract infections, catheter-related|urinary tract infections, catheter-related
305079|NCT01640925|surgical site infection|surgical site infection
305080|NCT01640912|Scar|scar
305081|NCT01640912|Scar prevention|scar prevention
305082|NCT01640912|Fibrosis|fibrosis
305083|NCT01640899|Orthotic Devices|orthotic devices
305084|NCT01640899|Activities of Daily Living|activities of daily living
305085|NCT01640899|Pain Measurement|pain measurement
305086|NCT01640899|Lower Extremity|lower extremity
305087|NCT01640899|Foot|foot
305088|NCT01640899|Personal Satisfaction|personal satisfaction
305089|NCT01640886|Staphylococcus aureus|staphylococcus aureus
305090|NCT01640886|methicillin resistant|methicillin resistant
305091|NCT01640886|MRSA|mrsa
305092|NCT01640886|MSSA|mssa
305093|NCT01640886|Blood Culture|blood culture
305094|NCT01640886|Diagnostic|diagnostic
305095|NCT01640873|Type 2 Diabetes|type 2 diabetes
305096|NCT01640860|docetaxel|docetaxel
305097|NCT01640860|cisplatin|cisplatin
305098|NCT01640860|combined modality therapy|combined modality therapy
305099|NCT01640847|Painful bone metastases|painful bone metastases
305100|NCT01640847|Bone Cancer|bone cancer
305101|NCT01640847|Bone Cancer Pain|bone cancer pain
305102|NCT01640847|Patients with|patients with
305103|NCT01640821|Health-At-Every-Size intervention|health-at-every-size intervention
305104|NCT01640782|adenocarcinoma of the stomach|adenocarcinoma of the stomach
305105|NCT01640782|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
305106|NCT01640769|Cardiomyopathy|cardiomyopathy
305107|NCT01640769|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
305108|NCT01640756|Glaucoma Implant|glaucoma implant
305109|NCT01640756|Trabeculectomy|trabeculectomy
305110|NCT01640756|POAG|poag
305111|NCT01640743|Kidney transplantation|kidney transplantation
305112|NCT01640743|Regulatory T cells|regulatory t cells
305113|NCT01640743|Tolerance|tolerance
305114|NCT01640743|Tacrolimus|tacrolimus
305116|NCT01640691|pandemic influenza|pandemic influenza
305117|NCT01640691|pandemic influenza vaccine|pandemic influenza vaccine
305118|NCT01640691|Influenza|influenza
305119|NCT01640691|Orthomyxoviruses|orthomyxoviruses
305120|NCT01640691|A/H5N1|a/h5n1
305121|NCT01640665|histologically|histologically
305122|NCT01640665|unresectable|unresectable
305123|NCT01640665|metastatic|metastatic
305124|NCT01640665|Phase 1|phase 1
305125|NCT01640665|Breast Cancer|breast cancer
305126|NCT01640665|GI Tumors|gi tumors
305127|NCT01640665|Sorafenib|sorafenib
305128|NCT01640665|Capecitabine|capecitabine
305129|NCT01640639|left ventricular function|left ventricular function
305130|NCT01640626|Health Education|health education
305131|NCT01640626|Soil-transmitted helminthiasis|soil-transmitted helminthiasis
305132|NCT01640626|Ascaris|ascaris
305133|NCT01640626|Trichuris|trichuris
305134|NCT01640626|Hookworm|hookworm
305135|NCT01640626|Prevention and control|prevention and control
305136|NCT01640613|carotid endarterectomy|carotid endarterectomy
305137|NCT01640613|regional anaesthesia|regional anaesthesia
305138|NCT01640613|ultrasound guided block|ultrasound guided block
305139|NCT01640600|To determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more behavioral problems.|to determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more behavioral problems.
305140|NCT01640600|To determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more cognitive problems.|to determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more cognitive problems.
305141|NCT01640600|To determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have poorer motor development.|to determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have poorer motor development.
305142|NCT01640587|Uncomplicated falciparum infection|uncomplicated falciparum infection
305143|NCT01640587|Mefloquine-artesunate|mefloquine-artesunate
305144|NCT01640587|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
305145|NCT01640574|Vivax|vivax
305146|NCT01640574|Chloroquine|chloroquine
305147|NCT01640574|Primaquine|primaquine
305148|NCT01640574|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
305149|NCT01640561|HIV affected|hiv affected
305150|NCT01640561|Child Neurodevelopment|child neurodevelopment
305151|NCT01640561|Low and Middle Income Country|low and middle income country
305153|NCT01640522|Hepatocellular carcinoma|hepatocellular carcinoma
305154|NCT01640522|Cholangio carcinoma|cholangio carcinoma
305155|NCT01640522|Primary Liver Cancer|primary liver cancer
305156|NCT01640522|Bile Duct CancerPancreatic Cancer|bile duct cancerpancreatic cancer
305157|NCT01640522|Gallbladder Cancer|gallbladder cancer
305158|NCT01640522|Colorectal Carcinoma|colorectal carcinoma
305159|NCT01640522|Other Primary Cancers with Liver Metastases|other primary cancers with liver metastases
305160|NCT01640509|Radiotherapy, Targeted|radiotherapy, targeted
305161|NCT01640496|Ulcerative Colitis|ulcerative colitis
305162|NCT01640496|Inflammatory Bowel disease|inflammatory bowel disease
305164|NCT01640496|Vitamin D|vitamin d
305165|NCT01640470|assistive technology|assistive technology
305166|NCT01640470|environmental modification|environmental modification
305167|NCT01640470|caregiver|caregiver
305168|NCT01640470|client-centred|client-centred
305169|NCT01640457|degenerative disc|degenerative disc
305170|NCT01640457|herniated disc|herniated disc
305171|NCT01640457|sequestrectomy|sequestrectomy
305172|NCT01640457|Autologous Disc Chondrocyte Transplantation|autologous disc chondrocyte transplantation
305173|NCT01640457|nucleotomy|nucleotomy
305174|NCT01640457|safety|safety
305175|NCT01640457|efficacy|efficacy
305176|NCT01640457|treatment|treatment
295837|NCT01683305|NAF|naf
305177|NCT01640457|lumbar spine|lumbar spine
305178|NCT01640457|low back pain|low back pain
305179|NCT01640457|adjacent degenerative disc|adjacent degenerative disc
305180|NCT01640457|black disc|black disc
305181|NCT01640457|NOVOCART|novocart
305182|NCT01640444|colorectal carcinoma|colorectal carcinoma
305183|NCT01640444|BRAF and PIK3K|braf and pik3k
305184|NCT01640444|FOLFIRI -Bevacizumab -Cetuximab|folfiri -bevacizumab -cetuximab
305185|NCT01640444|circulating tumor cells|circulating tumor cells
305186|NCT01640431|lumbar disc herniation|lumbar disc herniation
305187|NCT01640431|clinical trial|clinical trial
305188|NCT01640431|exercise therapy|exercise therapy
305189|NCT01640431|TENS|tens
305190|NCT01640418|pressure ulcer|pressure ulcer
305191|NCT01640418|dressing|dressing
305192|NCT01640418|prevention|prevention
305193|NCT01640418|higher risk patients|higher risk patients
305194|NCT01640405|colorectal cancer|colorectal cancer
305195|NCT01640405|FOLFOX|folfox
305196|NCT01640405|Bevacizumab|bevacizumab
305197|NCT01640405|FOLFOXIRI|folfoxiri
305198|NCT01640405|circulating tumor cell|circulating tumor cell
305199|NCT01640392|Gay men|gay men
305200|NCT01640392|African American males|african american males
305201|NCT01640392|Unprotected anal sex|unprotected anal sex
305202|NCT01640392|HIV risk|hiv risk
305203|NCT01640392|behavioral intervention|behavioral intervention
305204|NCT01640392|group-level intervention|group-level intervention
305205|NCT01640379|Pelvic Inflammatory Disease (PID)|pelvic inflammatory disease (pid)
305206|NCT01640379|Community Health Nursing|community health nursing
305207|NCT01640379|Text Messaging|text messaging
305208|NCT01640379|mHealth|mhealth
305209|NCT01640379|Adolescents|adolescents
305210|NCT01640366|surgical incision|surgical incision
305211|NCT01640366|reduction mammoplasty|reduction mammoplasty
305212|NCT01640366|healing complications|healing complications
305213|NCT01640366|negative pressure wound therapy|negative pressure wound therapy
305214|NCT01640353|si joint|si joint
305215|NCT01640353|si joint pain|si joint pain
305216|NCT01640353|si joint injury|si joint injury
305217|NCT01640353|si joint treatment|si joint treatment
305218|NCT01640353|si joint injections|si joint injections
305219|NCT01640353|si joint inflammation|si joint inflammation
305220|NCT01640353|si joint problems|si joint problems
305221|NCT01640353|si joint symptoms|si joint symptoms
305222|NCT01640353|hypermobile si joint|hypermobile si joint
305223|NCT01640353|si joint arthritis|si joint arthritis
305224|NCT01640353|si joint pain treatment|si joint pain treatment
305225|NCT01640353|inflamed si joint|inflamed si joint
305226|NCT01640353|si joint sclerosis|si joint sclerosis
305227|NCT01640353|locked si joint|locked si joint
305228|NCT01640353|si joint injuries|si joint injuries
305229|NCT01640353|si joint disease|si joint disease
305230|NCT01640353|si joint infection|si joint infection
305231|NCT01640353|sacroiliac joint pelvic pain|sacroiliac joint pelvic pain
305232|NCT01640353|sacroiliac joint arthritis treatment|sacroiliac joint arthritis treatment
305233|NCT01640340|ondansetron|ondansetron
305234|NCT01640340|palonosetron|palonosetron
305235|NCT01640340|emetogenic chemotherapy|emetogenic chemotherapy
305236|NCT01640340|HEC|hec
305237|NCT01640327|Interpandemic influenza|interpandemic influenza
305238|NCT01640327|Adult|adult
305239|NCT01640327|Elderly|elderly
305240|NCT01640327|Safety|safety
305241|NCT01640327|Tolerability|tolerability
305242|NCT01640327|Immunology|immunology
305243|NCT01640314|Influenza|influenza
305244|NCT01640314|Adults|adults
305245|NCT01640314|Elderly|elderly
305246|NCT01640314|Immunology|immunology
305247|NCT01640314|Safety|safety
305248|NCT01640288|COPD|copd
305249|NCT01640288|Pulmonary Function Testing|pulmonary function testing
305250|NCT01640288|MRI|mri
305251|NCT01640288|Normal Lung Function|normal lung function
305252|NCT01640288|Current Smoker|current smoker
305253|NCT01640288|Non Smoker|non smoker
305254|NCT01640288|Ex Smoker|ex smoker
305255|NCT01640275|General Anesthesia|general anesthesia
305256|NCT01640275|Alzheimers Disease|alzheimers disease
305257|NCT01640275|Cognitive decline|cognitive decline
305258|NCT01640262|prostate biopsy|prostate biopsy
305259|NCT01640262|prostate cancer|prostate cancer
305260|NCT01640262|Magnetic Resonance Imaging|magnetic resonance imaging
305261|NCT01640262|Neoplasm Staging|neoplasm staging
305262|NCT01640236|Ocular flare|ocular flare
305263|NCT01640197|Cognitive performance|cognitive performance
305264|NCT01640197|Cerebral blood flow|cerebral blood flow
305265|NCT01640197|Subjective sleep|subjective sleep
305266|NCT01640197|Subjective mood|subjective mood
305267|NCT01640197|Subjective health|subjective health
305268|NCT01640184|hyperparathyroidism|hyperparathyroidism
305269|NCT01640184|vitamin D|vitamin d
305270|NCT01640184|ultrasonic ablation|ultrasonic ablation
305271|NCT01640184|surgery|surgery
305272|NCT01640171|anesthesia|anesthesia
305273|NCT01640171|pain|pain
305274|NCT01640171|intravitreal|intravitreal
305275|NCT01640171|anti-vegf|anti-vegf
305276|NCT01640158|mild Traumatic Brain Injury|mild traumatic brain injury
305277|NCT01640158|Cognitive remediation|cognitive remediation
305278|NCT01640158|computer|computer
305279|NCT01640119|metabolic acidosis|metabolic acidosis
305280|NCT01640119|renal death|renal death
305281|NCT01640106|Language|language
305282|NCT01640106|Fatty acids|fatty acids
305283|NCT01640106|Nutrition|nutrition
305284|NCT01640106|Developmental delay|developmental delay
305285|NCT01640093|Healthy participants|healthy participants
305286|NCT01640093|Bioavailability|bioavailability
305287|NCT01640093|Pharmacokinetics|pharmacokinetics
305288|NCT01640093|Abiraterone acetate|abiraterone acetate
305289|NCT01640093|Abiraterone|abiraterone
305290|NCT01640080|Major depressive disorder|major depressive disorder
305291|NCT01640080|Treatment resistant depression|treatment resistant depression
305292|NCT01640080|Depression|depression
305293|NCT01640080|Esketamine|esketamine
305294|NCT01640067|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
305295|NCT01640067|motor neuron disease|motor neuron disease
305296|NCT01640067|stem cells|stem cells
305297|NCT01640067|safety|safety
305298|NCT01640067|ALS-FRS-Functional scale R and FVC (%) variation|als-frs-functional scale r and fvc (%) variation
305299|NCT01640067|Survival analysis|survival analysis
305300|NCT01640067|Changes in quality of life scales|changes in quality of life scales
305301|NCT01640054|Rheumatoid Arthritis|rheumatoid arthritis
305302|NCT01640015|Blood pressure|blood pressure
305303|NCT01640015|eating episode|eating episode
305304|NCT01640015|eating frequency|eating frequency
305305|NCT01640015|insulin sensitivity|insulin sensitivity
305306|NCT01640002|overactive bladder|overactive bladder
305307|NCT01640002|HTLV-1|htlv-1
305308|NCT01640002|Propantheline|propantheline
305309|NCT01640002|anticholinergic|anticholinergic
305310|NCT01639989|Doppler, Pregnancy|doppler, pregnancy
305311|NCT01639976|Missed abortion, early pregnancy loss.|missed abortion, early pregnancy loss.
305312|NCT01639950|Self-Report|self-report
305313|NCT01639950|Survey Scale|survey scale
305314|NCT01639950|Validate|validate
305315|NCT01639950|Pain Severity|pain severity
305316|NCT01639950|Reliability|reliability
305317|NCT01639937|Cardiac MRI|cardiac mri
305318|NCT01639937|Congestive Heart Failure|congestive heart failure
305319|NCT01639937|Cardiac Fibrosis|cardiac fibrosis
305320|NCT01639937|Late Gadolinium Enhancement|late gadolinium enhancement
305321|NCT01639924|Small Bowel Disease|small bowel disease
305322|NCT01639924|Digestive Disease|digestive disease
305323|NCT01639924|Gastrointestinal Disease|gastrointestinal disease
305324|NCT01639924|Lower GI Disease|lower gi disease
305325|NCT01639911|malignant solid tumor|malignant solid tumor
305326|NCT01639911|advanced non-hematologic|advanced non-hematologic
305327|NCT01639898|POEMS|poems
305328|NCT01639898|VEGF|vegf
305329|NCT01639898|Free light|free light
305330|NCT01639898|lenalidomide|lenalidomide
305331|NCT01639898|dexamethasone|dexamethasone
305332|NCT01639885|p53 overexpression|p53 overexpression
305333|NCT01639885|platinum-resistant|platinum-resistant
305334|NCT01639872|Schizophrenia|schizophrenia
305335|NCT01639872|Cannabis Abuse|cannabis abuse
305336|NCT01639872|Cannabis Dependence|cannabis dependence
305337|NCT01639872|Dual Diagnosis|dual diagnosis
305338|NCT01639872|Clozapine|clozapine
305339|NCT01639872|Risperidone|risperidone
305340|NCT01639859|prostate cancer|prostate cancer
305341|NCT01639859|elastography|elastography
305342|NCT01639859|elasticity|elasticity
305343|NCT01639820|Cervical cancer|cervical cancer
305344|NCT01639820|early stage carcinoma|early stage carcinoma
305345|NCT01639820|FIGO IA1 IA2 IB1 IIA|figo ia1 ia2 ib1 iia
305346|NCT01639820|sentinel lymph node biopsy|sentinel lymph node biopsy
305347|NCT01639820|pelvic lymphadenectomy|pelvic lymphadenectomy
305348|NCT01639820|Surgery of uterine cervical carcinoma|surgery of uterine cervical carcinoma
305349|NCT01639820|medico economic impact|medico economic impact
305350|NCT01639820|quality of life|quality of life
305351|NCT01639807|Open Angle Glaucoma or Ocular hypertension|open angle glaucoma or ocular hypertension
305352|NCT01639794|LUTS (Lower Urinary Tract Symptoms)|luts (lower urinary tract symptoms)
305353|NCT01639794|Overactive Bladder (OAB)Vesitirim|overactive bladder (oab)vesitirim
305354|NCT01639794|Solifenacin|solifenacin
305355|NCT01639794|Anti-muscarinic treatment|anti-muscarinic treatment
305356|NCT01639794|Cholinergic receptor antagonist|cholinergic receptor antagonist
305357|NCT01639794|Storage Symptom improvement|storage symptom improvement
305358|NCT01639781|flavanols|flavanols
305359|NCT01639781|age related cardiovascular effects|age related cardiovascular effects
305360|NCT01639768|Sublingual immunotherapy|sublingual immunotherapy
305361|NCT01639768|Dose range finding|dose range finding
305362|NCT01639768|Dose tolerability|dose tolerability
305363|NCT01639768|Birch pollen|birch pollen
305364|NCT01639768|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
305366|NCT01639768|Immunogenicity|immunogenicity
307335|NCT01630278|ibuprofen|ibuprofen
305367|NCT01639729|pharmacokinetics|pharmacokinetics
305368|NCT01639729|area under curve|area under curve
305369|NCT01639729|time to maximum concentration|time to maximum concentration
305370|NCT01639716|Survey, interleukin status|survey, interleukin status
305371|NCT01639703|CT perfusion|ct perfusion
305372|NCT01639703|Hepatocellular Carcinoma|hepatocellular carcinoma
305374|NCT01639703|Contrast agent|contrast agent
305375|NCT01639690|BUSULFAN|busulfan
305376|NCT01639690|G-CSF|g-csf
305377|NCT01639690|CliniMACS-CD34 Reagent System|clinimacs-cd34 reagent system
305378|NCT01639690|Blood transfusion|blood transfusion
305379|NCT01639690|10-164|10-164
305380|NCT01639690|Autologous CD34+ cells transduced with TNS9.3.55, a lentiviral vector encoding the human β-globin gene|autologous cd34+ cells transduced with tns9.3.55, a lentiviral vector encoding the human β-globin gene
305381|NCT01639677|Obesity|obesity
305382|NCT01639677|weight loss|weight loss
305383|NCT01639677|surgery|surgery
305384|NCT01639677|gastric bypass|gastric bypass
305385|NCT01639677|VBG|vbg
305386|NCT01639651|Physical Therapy|physical therapy
305387|NCT01639651|Glenohumeral Internal Rotation Deficits|glenohumeral internal rotation deficits
305388|NCT01639651|Joint Mobilization|joint mobilization
305389|NCT01639651|Posterior capsule|posterior capsule
305390|NCT01639651|Capsular contracture|capsular contracture
305391|NCT01639638|Recurrent and non-recurrent genital condyloma|recurrent and non-recurrent genital condyloma
305392|NCT01639612|Stem Cell|stem cell
305393|NCT01639612|Grade IV Malignant Glioma|grade iv malignant glioma
305394|NCT01639599|non-smoker|non-smoker
305395|NCT01639599|female|female
305396|NCT01639599|IV PCA|iv pca
305397|NCT01639599|patient-controlled analgesia|patient-controlled analgesia
305398|NCT01639573|Patients with Scleroderma|patients with scleroderma
305399|NCT01639560|smoking|smoking
305400|NCT01639560|tobacco dependence|tobacco dependence
305401|NCT01639560|nicotine dependence|nicotine dependence
305402|NCT01639547|PEGASYS® PLUS RIBAVIRIN|pegasys® plus ribavirin
305403|NCT01639534|Biomarkers of ischemia|biomarkers of ischemia
305404|NCT01639534|Carotid Stenting procedure|carotid stenting procedure
305405|NCT01639534|Levels Xanthine Hypoxanthine and Inosine|levels xanthine hypoxanthine and inosine
305406|NCT01639534|peripheral blood|peripheral blood
305407|NCT01639508|Lung|lung
305408|NCT01639508|XL184 (CABOZANTINIB)|xl184 (cabozantinib)
305409|NCT01639508|KIF5B/RET Positive|kif5b/ret positive
305410|NCT01639508|RET Fusion Positive|ret fusion positive
305411|NCT01639508|12-097|12-097
305412|NCT01639508|Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity|genotypes: ros1 or ntrk fusions or increased met or axl activity
305413|NCT01639495|Drug refractory|drug refractory
305414|NCT01639495|Atrial fibrillation|atrial fibrillation
305415|NCT01639495|Antiarrhythmic drug failure|antiarrhythmic drug failure
305416|NCT01639495|Atrial tachyarrhythmias|atrial tachyarrhythmias
305417|NCT01639469|Parkinson Disease|parkinson disease
305418|NCT01639469|Quality of Life|quality of life
305419|NCT01639469|Exercise Therapy|exercise therapy
305420|NCT01639456|acute myelogenous leukemia|acute myelogenous leukemia
305421|NCT01639443|quality improvement|quality improvement
305422|NCT01639443|Organization and Administration|organization and administration
305423|NCT01639443|Costs and cost analysis|costs and cost analysis
305424|NCT01639443|Patient satisfaction|patient satisfaction
305425|NCT01639443|Health plan implementation|health plan implementation
305426|NCT01639404|Cerebral Palsy|cerebral palsy
305427|NCT01639404|Umbilical Cord Blood|umbilical cord blood
305428|NCT01639404|Rehabilitation|rehabilitation
305429|NCT01639365|Ventricular tachycardia|ventricular tachycardia
305430|NCT01639365|Catheter ablation|catheter ablation
305431|NCT01639365|Tissue contact|tissue contact
305432|NCT01639352|Hepatocellular Carcinoma|hepatocellular carcinoma
305433|NCT01639352|HCC|hcc
305434|NCT01639352|SOM230|som230
305435|NCT01639352|Pasireotide LAR|pasireotide lar
305436|NCT01639339|Antibodies|antibodies
305439|NCT01639339|Glomerulonephritis|glomerulonephritis
305440|NCT01639339|Belimumab|belimumab
305441|NCT01639339|Lupus|lupus
305442|NCT01639339|Nephritis|nephritis
305443|NCT01639339|Kidney Diseases|kidney diseases
305444|NCT01639339|SLE|sle
305445|NCT01639300|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
305446|NCT01639300|Progressive Forms of Multiple Sclerosis|progressive forms of multiple sclerosis
305447|NCT01639300|GNbAC1|gnbac1
305448|NCT01639300|Monoclonal antibody|monoclonal antibody
305449|NCT01639300|Multiple Sclerosis Associated Retrovirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
305451|NCT01639261|bronchiolitis obliterans|bronchiolitis obliterans
305452|NCT01639261|allogeneic stem cell transplantation|allogeneic stem cell transplantation
305453|NCT01639261|interferon gamma|interferon gamma
305454|NCT01639248|Breast Cancer|breast cancer
305455|NCT01639235|Secondhand Smoke|secondhand smoke
305456|NCT01639235|Flight Attendants|flight attendants
305457|NCT01639235|Lung function|lung function
305458|NCT01639235|Cardiac function|cardiac function
305459|NCT01639235|Reproductive health|reproductive health
305460|NCT01639222|Drug therapy|drug therapy
305461|NCT01639222|Increase in calcium urinary excretion and PTH decrease in serum|increase in calcium urinary excretion and pth decrease in serum
305462|NCT01639209|Retinal detachment|retinal detachment
305463|NCT01639209|Pneumatic retinopexy|pneumatic retinopexy
305464|NCT01639209|Vitrectomy|vitrectomy
305465|NCT01639196|Chronic pain|chronic pain
305466|NCT01639196|Psychological adjustment|psychological adjustment
305467|NCT01639196|Writing|writing
305468|NCT01639196|Brief intervention|brief intervention
305469|NCT01639196|Online|online
305470|NCT01639196|Internet interventions|internet interventions
305471|NCT01639183|oral inflammation|oral inflammation
305472|NCT01639183|systemic inflammation|systemic inflammation
305473|NCT01639183|compliance|compliance
305474|NCT01639183|power toothbrushing|power toothbrushing
305475|NCT01639183|nursing home residents|nursing home residents
305476|NCT01639170|Pneumoperitoneum|pneumoperitoneum
305477|NCT01639170|Free air|free air
305478|NCT01639170|Surgery|surgery
305479|NCT01639170|Perforation|perforation
305480|NCT01639170|Radiograph|radiograph
305481|NCT01639144|Infection|infection
305482|NCT01639144|delayed wound healing|delayed wound healing
305483|NCT01639144|platelet-rich plasma|platelet-rich plasma
305484|NCT01639131|Gemcitabine|gemcitabine
305485|NCT01639131|Docetaxel|docetaxel
305486|NCT01639131|Filgrastim|filgrastim
305487|NCT01639131|Pegfilgrastim|pegfilgrastim
305488|NCT01639118|primary ventral hernia repair with mesh|primary ventral hernia repair with mesh
305489|NCT01639118|umbilical hernia repair|umbilical hernia repair
305490|NCT01639118|epigastric hernia repair|epigastric hernia repair
305491|NCT01639118|C-Qur V-patch|c-qur v-patch
305492|NCT01639118|Size tailored repair|size tailored repair
305493|NCT01639118|preperitoneal repair|preperitoneal repair
305494|NCT01639118|abdominal hernia|abdominal hernia
305495|NCT01639118|dual sided mesh|dual sided mesh
305496|NCT01639092|Resistance of Entecavir|resistance of entecavir
305497|NCT01639079|cigarette smoking behavior|cigarette smoking behavior
305498|NCT01639079|smoking cessation|smoking cessation
305499|NCT01639079|Latino smoking cessation|latino smoking cessation
305500|NCT01639066|Resistance of Adefovir|resistance of adefovir
305501|NCT01639053|Breast Augmentation|breast augmentation
305502|NCT01639053|Breast Reconstruction|breast reconstruction
305503|NCT01639053|Breast Revision|breast revision
305504|NCT01639053|Silicone breast implants|silicone breast implants
305505|NCT01639001|Crizotinib|crizotinib
305506|NCT01639001|ALK positive|alk positive
305508|NCT01639001|Anaplastic Lymphoma Kinase|anaplastic lymphoma kinase
305509|NCT01639001|NSCLC|nsclc
305510|NCT01639001|Non-Small Cell Lung Cancer|non-small cell lung cancer
305511|NCT01639001|Frontline|frontline
305512|NCT01639001|1L|1l
305513|NCT01639001|Previously Untreated|previously untreated
305514|NCT01639001|East Asian|east asian
305515|NCT01639001|Non-Squamous|non-squamous
305516|NCT01638962|Exercise Therapy|exercise therapy
305517|NCT01638962|Gait|gait
305518|NCT01638962|Joint load|joint load
305519|NCT01638962|Knee Joint|knee joint
305520|NCT01638962|Middle Aged|middle aged
305521|NCT01638962|Osteoarthritis, Knee/therapy|osteoarthritis, knee/therapy
305522|NCT01638962|Pain Management|pain management
305523|NCT01638949|Alzheimer's disease|alzheimer's disease
305524|NCT01638949|MCI|mci
305525|NCT01638949|genetic|genetic
305526|NCT01638949|AV45-PET|av45-pet
305529|NCT01638923|Heavy Menstrual Bleeding|heavy menstrual bleeding
305530|NCT01638923|Efficacy|efficacy
305531|NCT01638923|Safety|safety
305532|NCT01638923|Oral contraceptive|oral contraceptive
305533|NCT01638923|Estradiol valerate|estradiol valerate
305534|NCT01638923|Dienogest|dienogest
305535|NCT01638910|Efficacy|efficacy
305536|NCT01638910|Safety|safety
305537|NCT01638910|oral contraception|oral contraception
305538|NCT01638910|estradiol valerate|estradiol valerate
305539|NCT01638910|dienogest|dienogest
305540|NCT01638897|ICD|icd
305541|NCT01638897|CRTD|crtd
305542|NCT01638897|DF4|df4
305543|NCT01638884|Prospective Memory|prospective memory
305544|NCT01638884|Healthy Aging|healthy aging
305545|NCT01638884|Alzheimer Disease|alzheimer disease
305546|NCT01638884|Brain Imaging|brain imaging
305547|NCT01638832|NASH; coronary artery disease|nash; coronary artery disease
305548|NCT01638806|Acute Coronary Syndrome|acute coronary syndrome
305549|NCT01638806|Myocardial infarction|myocardial infarction
305550|NCT01638806|Angioplasty|angioplasty
305551|NCT01638806|Prehospital emergency care|prehospital emergency care
305552|NCT01638806|Biological markers|biological markers
305553|NCT01638806|Troponin|troponin
305554|NCT01638806|Point-of-Care systems|point-of-care systems
305555|NCT01638767|In Vitro Fertilization long protocol|in vitro fertilization long protocol
305556|NCT01638767|NuvaRing|nuvaring
305557|NCT01638767|Marvelon|marvelon
305558|NCT01638767|In vitro fertilization|in vitro fertilization
305559|NCT01638715|Rheumatoid Arthritis|rheumatoid arthritis
305560|NCT01638715|Biologic therapies|biologic therapies
305561|NCT01638715|Biomarker|biomarker
305562|NCT01638715|Mode of Action|mode of action
305563|NCT01638702|Catheterisation, Central Venous|catheterisation, central venous
305564|NCT01638702|Catheters, Indwelling|catheters, indwelling
305565|NCT01638689|Mechanism of Action of escitalopram|mechanism of action of escitalopram
305566|NCT01638676|Unresectable melanoma|unresectable melanoma
296237|NCT01681589|TBI|tbi
305567|NCT01638676|Stage IIIC and Stage IV BRAFV600E+ Melanoma|stage iiic and stage iv brafv600e+ melanoma
305568|NCT01638663|Tolvaptan|tolvaptan
305569|NCT01638663|L-NMMA|l-nmma
305570|NCT01638663|Healthy subjects|healthy subjects
305571|NCT01638663|Nephrology|nephrology
305572|NCT01638663|Cardiology|cardiology
305573|NCT01638624|Propofol|propofol
305574|NCT01638624|antioxidant capacity|antioxidant capacity
305575|NCT01638624|total knee arthroplasty|total knee arthroplasty
305576|NCT01638624|Propofol,antioxidant|propofol,antioxidant
305577|NCT01638611|Healthy male volunteers|healthy male volunteers
305578|NCT01638572|Neuroblastoma|neuroblastoma
305579|NCT01638572|B4GALNT3|b4galnt3
305580|NCT01638572|Prognosis|prognosis
305581|NCT01638559|liver transplant|liver transplant
305582|NCT01638559|allograft function|allograft function
305583|NCT01638559|anti-rejection|anti-rejection
305584|NCT01638559|immunosuppression withdrawal|immunosuppression withdrawal
305585|NCT01638520|Immune Therapy|immune therapy
305586|NCT01638520|Interleukin 4|interleukin 4
305587|NCT01638520|monoclonal antibody|monoclonal antibody
305588|NCT01638507|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
305589|NCT01638507|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
305590|NCT01638507|Coronary Artery Disease|coronary artery disease
305591|NCT01638507|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
305592|NCT01638507|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
305593|NCT01638507|STENT THROMBOSIS|stent thrombosis
305594|NCT01638507|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
305595|NCT01638494|25-Hydroxyvitamin D|25-hydroxyvitamin d
305596|NCT01638494|dietary counseling|dietary counseling
305597|NCT01638494|pediatrics|pediatrics
305598|NCT01638494|allergy|allergy
305599|NCT01638494|bone metabolism|bone metabolism
305600|NCT01638468|Pulmonary Embolism|pulmonary embolism
305601|NCT01638468|Acute Pulmonary Embolism|acute pulmonary embolism
305794|NCT01637402|CRPC|crpc
305602|NCT01638468|Sub-massive Pulmonary Embolism|sub-massive pulmonary embolism
305603|NCT01638468|Massive Pulmonary Embolism|massive pulmonary embolism
305604|NCT01638468|Pulmonary Thromboembolism|pulmonary thromboembolism
305605|NCT01638442|Male subjects, healthy|male subjects, healthy
305606|NCT01638403|narcolepsy|narcolepsy
305607|NCT01638403|excessive daytime sleepiness|excessive daytime sleepiness
305608|NCT01638403|cataplexy|cataplexy
305609|NCT01638377|Back on Track|back on track
305610|NCT01638377|convicted drinking drivers|convicted drinking drivers
305611|NCT01638377|naltrexone|naltrexone
305612|NCT01638377|alcohol dependence|alcohol dependence
305613|NCT01638351|Diabetes mellitus|diabetes mellitus
305614|NCT01638351|Resistance exercise|resistance exercise
305615|NCT01638351|Elderly|elderly
305616|NCT01638351|Skeletal muscle dysfunction|skeletal muscle dysfunction
305617|NCT01638351|Metabolomics|metabolomics
305618|NCT01638338|Alcohol|alcohol
305619|NCT01638338|Risky drinking|risky drinking
305620|NCT01638338|Web site|web site
305621|NCT01638338|Primary Care|primary care
305622|NCT01638338|General Practice|general practice
305623|NCT01638338|Local Community|local community
305624|NCT01638338|Mayors|mayors
305625|NCT01638312|HIV, fructose|hiv, fructose
305626|NCT01638299|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
305627|NCT01638299|Artificial Pancreas|artificial pancreas
305628|NCT01638273|Pregabalin, GLARS|pregabalin, glars
305629|NCT01638260|NEAT|neat
305630|NCT01638260|liraglutide|liraglutide
305631|NCT01638260|glycemic control|glycemic control
305632|NCT01638247|Male breast cancer|male breast cancer
305633|NCT01638247|neoadjuvant, adjuvant or metastatic situation|neoadjuvant, adjuvant or metastatic situation
305634|NCT01638247|anti-hormonal therapy|anti-hormonal therapy
305635|NCT01638234|atopic dermatitis|atopic dermatitis
305636|NCT01638234|eczema|eczema
305637|NCT01638182|phylloquinone,|phylloquinone,
305638|NCT01638182|menaquinone-7|menaquinone-7
305639|NCT01638182|vitamin K-status|vitamin k-status
305640|NCT01638182|efficacy|efficacy
305641|NCT01638156|Aortic stenosis|aortic stenosis
305642|NCT01638143|vitamin K2|vitamin k2
305643|NCT01638143|menaquinone-7|menaquinone-7
305644|NCT01638143|bioavailability|bioavailability
305645|NCT01638091|Narrow band imaging|narrow band imaging
305646|NCT01638091|Screening colonoscopy|screening colonoscopy
305647|NCT01638091|Histology|histology
305648|NCT01638078|coronary restenosis|coronary restenosis
305649|NCT01638065|vein identification|vein identification
305650|NCT01638065|vascular access|vascular access
305651|NCT01638052|Tympanomastoid Surgery|tympanomastoid surgery
305652|NCT01638052|Cochlear Implant|cochlear implant
305653|NCT01638052|Mastoidectomy|mastoidectomy
305654|NCT01638052|Cholesteatoma|cholesteatoma
305655|NCT01638052|Pediatrics|pediatrics
305656|NCT01638052|Clonidine|clonidine
305657|NCT01638052|Bupivacaine|bupivacaine
305658|NCT01638052|Greater Auricular Nerve Block|greater auricular nerve block
305659|NCT01638052|Regional Anesthesia|regional anesthesia
305660|NCT01638026|Gnrh agonist|gnrh agonist
305661|NCT01638013|Rheumatoid Arthritis|rheumatoid arthritis
305662|NCT01638013|ASP015K|asp015k
305663|NCT01638000|Vesitrim|vesitrim
305664|NCT01638000|Frequency|frequency
305665|NCT01638000|Urgency|urgency
305666|NCT01638000|Urgency incontinence|urgency incontinence
305667|NCT01638000|Urinary incontinence|urinary incontinence
305668|NCT01638000|Overactive Bladder (OAB)|overactive bladder (oab)
305669|NCT01638000|Micturition|micturition
305670|NCT01638000|Mirabegron|mirabegron
305671|NCT01638000|YM178|ym178
305672|NCT01638000|Vesicare|vesicare
305673|NCT01638000|Solifenacin|solifenacin
305674|NCT01637987|Peripheral intravenous catheter|peripheral intravenous catheter
305675|NCT01637987|Vein visualization|vein visualization
305676|NCT01637987|Transillumination|transillumination
305677|NCT01637987|Near infrared light|near infrared light
305678|NCT01637948|Chinese medicine|chinese medicine
305679|NCT01637948|gingivitis|gingivitis
305680|NCT01637948|cytokine|cytokine
305681|NCT01637948|microbial|microbial
305682|NCT01637935|Drug therapy|drug therapy
305683|NCT01637909|Prehypertension, Hypertension|prehypertension, hypertension
305684|NCT01637883|benzydamine HCl|benzydamine hcl
305685|NCT01637883|endotracheal tube|endotracheal tube
305686|NCT01637883|postoperative sore throat|postoperative sore throat
305687|NCT01637870|Cesarean delivery|cesarean delivery
305688|NCT01637870|Postpartum infection|postpartum infection
305689|NCT01637870|Wound complications|wound complications
305690|NCT01637870|Wound seroma|wound seroma
305691|NCT01637870|Wound separation|wound separation
305692|NCT01637870|Wound infection|wound infection
305693|NCT01637870|Negative pressure|negative pressure
305694|NCT01637857|foof hypersensitivity|foof hypersensitivity
305695|NCT01637857|anal fissures|anal fissures
305696|NCT01637857|ano-rectal manometry|ano-rectal manometry
305697|NCT01637844|Pregnant women|pregnant women
305698|NCT01637844|HBsAg positive|hbsag positive
305699|NCT01637844|HBeAg positive|hbeag positive
305700|NCT01637844|Telbivudine|telbivudine
305701|NCT01637831|Obstructive Sleep Apnea|obstructive sleep apnea
305795|NCT01637402|prostate|prostate
305702|NCT01637831|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
305703|NCT01637818|Inguinal hernia repair|inguinal hernia repair
305704|NCT01637818|long-term follow-up|long-term follow-up
305705|NCT01637818|Surgical technique|surgical technique
305706|NCT01637792|peritoneal dialysis|peritoneal dialysis
305707|NCT01637792|dose|dose
305708|NCT01637792|residual kidney function|residual kidney function
305709|NCT01637792|technique survival|technique survival
305710|NCT01637792|patient survival|patient survival
305711|NCT01637792|peritonitis|peritonitis
305712|NCT01637779|randomized controlled trial|randomized controlled trial
305713|NCT01637779|parent education|parent education
305714|NCT01637779|pain management|pain management
305715|NCT01637779|infant|infant
305716|NCT01637779|immunization|immunization
305717|NCT01637766|Spinal Metastases|spinal metastases
305718|NCT01637766|Spinal Metastatic Disease|spinal metastatic disease
305719|NCT01637766|Cord Compression|cord compression
305720|NCT01637766|Intra-arterial Chemotherapy|intra-arterial chemotherapy
305721|NCT01637766|Spinal Tumors|spinal tumors
305722|NCT01637740|myopia|myopia
305723|NCT01637740|pseudoexfoliation syndrome|pseudoexfoliation syndrome
305724|NCT01637740|optical low coherence reflectometry|optical low coherence reflectometry
305725|NCT01637740|ocular optical components|ocular optical components
305726|NCT01637740|cataract|cataract
305727|NCT01637727|Long term effects of gestational diabetes mellitus in a population of parous women|long term effects of gestational diabetes mellitus in a population of parous women
305728|NCT01637727|Gestational diabetes mellitus- GDM is defined as glucose intolerance diagnosed during pregnancy and not present shortly after birth|gestational diabetes mellitus- gdm is defined as glucose intolerance diagnosed during pregnancy and not present shortly after birth
305729|NCT01637701|benign prostatic hypertrophy|benign prostatic hypertrophy
305730|NCT01637701|bipolar transurethral resection of the prostate|bipolar transurethral resection of the prostate
305731|NCT01637701|plasmakinetic enucleation of the prostate|plasmakinetic enucleation of the prostate
305732|NCT01637688|cow milk allergy|cow milk allergy
305733|NCT01637688|amino acid formula|amino acid formula
305734|NCT01637675|sodium tanshinone IIA sulfonate|sodium tanshinone iia sulfonate
305735|NCT01637675|pulmonary hypertension|pulmonary hypertension
305736|NCT01637649|dysphagia,diaphragm, ultrasonography, inspiration, expiration,|dysphagia,diaphragm, ultrasonography, inspiration, expiration,
305737|NCT01637636|rifampin,|rifampin,
305738|NCT01637636|ketoconazole,|ketoconazole,
305739|NCT01637636|CYP3A4,|cyp3a4,
305740|NCT01637636|tasimelteon,|tasimelteon,
305741|NCT01637636|VEC-162|vec-162
305742|NCT01637636|Pharmacokinetics|pharmacokinetics
305743|NCT01637623|Hypertension|hypertension
305744|NCT01637623|High Blood Pressure|high blood pressure
305745|NCT01637623|Sleep Apnea|sleep apnea
305746|NCT01637623|Obstructive Sleep Apnea|obstructive sleep apnea
305747|NCT01637623|OSA|osa
305748|NCT01637610|placental alpha microglobulin-1|placental alpha microglobulin-1
305749|NCT01637610|AmniSure|amnisure
305750|NCT01637610|preterm|preterm
305751|NCT01637610|rupture of fetal membranes|rupture of fetal membranes
305752|NCT01637597|Non-small cell lung cancer(NSCLC)|non-small cell lung cancer(nsclc)
305753|NCT01637571|GERD|gerd
305754|NCT01637571|NCCP|nccp
305755|NCT01637571|chest pain|chest pain
305756|NCT01637571|reflux|reflux
305757|NCT01637571|GERD related non-cardiac chest pain|gerd related non-cardiac chest pain
305758|NCT01637545|facial bones|facial bones
305759|NCT01637545|Post operative nasea vomiting|post operative nasea vomiting
305760|NCT01637545|fractures|fractures
305761|NCT01637545|reduction|reduction
305762|NCT01637519|kidney stones|kidney stones
305763|NCT01637519|ureteral stones|ureteral stones
305764|NCT01637519|stent|stent
305765|NCT01637506|urine|urine
305766|NCT01637506|stool|stool
305767|NCT01637506|kidney stones|kidney stones
305768|NCT01637493|Pegylation|pegylation
305769|NCT01637493|G-CSF|g-csf
305770|NCT01637493|Pharmacokinetics|pharmacokinetics
305771|NCT01637493|Pharmacodynamics|pharmacodynamics
305772|NCT01637467|critical illness|critical illness
305773|NCT01637467|myopathy|myopathy
305774|NCT01637467|electrical muscle stimulation|electrical muscle stimulation
305775|NCT01637454|noradrenaline terlipressin type 2 HRS|noradrenaline terlipressin type 2 hrs
305776|NCT01637441|bladder prolapse (cystocele)|bladder prolapse (cystocele)
305777|NCT01637441|Pelvic organ prolapse repair|pelvic organ prolapse repair
305778|NCT01637441|coelioscopic|coelioscopic
305779|NCT01637441|prosthetic surgery|prosthetic surgery
305780|NCT01637441|vaginal approach|vaginal approach
305781|NCT01637441|Randomized study|randomized study
305782|NCT01637441|laparoscopic sacropexy|laparoscopic sacropexy
305783|NCT01637441|vaginal mesh surgery|vaginal mesh surgery
305784|NCT01637441|Stage II|stage ii
305785|NCT01637441|Clavien Dindo|clavien dindo
305786|NCT01637415|alcohol withdrawal syndrome|alcohol withdrawal syndrome
305787|NCT01637415|prediction|prediction
305788|NCT01637415|severity|severity
305789|NCT01637415|alcohol use disorder|alcohol use disorder
305790|NCT01637415|complicated alcohol withdrawal|complicated alcohol withdrawal
305791|NCT01637415|alcohol withdrawal seizures|alcohol withdrawal seizures
305792|NCT01637415|delirium tremens|delirium tremens
305793|NCT01637415|PAWSS|pawss
305796|NCT01637402|cancer|cancer
305797|NCT01637376|Lung neoplasms|lung neoplasms
305798|NCT01637376|Non Small cell lung carcinoma|non small cell lung carcinoma
305799|NCT01637376|Non small cell lung cancer|non small cell lung cancer
305800|NCT01637376|Large cell carcinoma|large cell carcinoma
305801|NCT01637376|squamous cell carcinoma|squamous cell carcinoma
305802|NCT01637376|adenocarcinoma|adenocarcinoma
305803|NCT01637363|Psychoeducation|psychoeducation
305804|NCT01637363|Stress|stress
305805|NCT01637363|Sickness absence|sickness absence
305806|NCT01637363|Psychiatric symptoms|psychiatric symptoms
305807|NCT01637363|Locus of control|locus of control
305808|NCT01637363|Self reported health|self reported health
305809|NCT01637324|To assess VCT and linkage into care|to assess vct and linkage into care
305810|NCT01637324|nPEP|npep
305811|NCT01637324|STIs|stis
305812|NCT01637324|anal dysplasia/cancer|anal dysplasia/cancer
305813|NCT01637324|hyperlipidemia|hyperlipidemia
305814|NCT01637324|diabetes|diabetes
305815|NCT01637324|Proportion of first-time MSM clients attending multidisciplinary services who undergo HIV testing|proportion of first-time msm clients attending multidisciplinary services who undergo hiv testing
402034|NCT01233375|human equilibrative nucleoside transporter-1 (hENT1)|human equilibrative nucleoside transporter-1 (hent1)
402035|NCT01233375|CO-1.01|co-1.01
402036|NCT01233375|CO-101|co-101
305816|NCT01637324|Proportion of MSM clients who have repeated HIV testing during the first six months after the first negative HIV test|proportion of msm clients who have repeated hiv testing during the first six months after the first negative hiv test
305817|NCT01637324|Proportion of HIV-positive MSM who receive HIV care within three months after HIV diagnosis or enrolment|proportion of hiv-positive msm who receive hiv care within three months after hiv diagnosis or enrolment
305818|NCT01637324|Proportion of HIV-positive MSM who still remain in HIV care at six months after enrollment|proportion of hiv-positive msm who still remain in hiv care at six months after enrollment
305819|NCT01637311|Peroral endoscopic myotomy|peroral endoscopic myotomy
305820|NCT01637311|Heller myotomy|heller myotomy
305821|NCT01637311|persistent/recurrent achalasia.|persistent/recurrent achalasia.
305822|NCT01637298|Histological HGAIN|histological hgain
305823|NCT01637298|detected biomarkers|detected biomarkers
305824|NCT01637298|MSM population|msm population
305825|NCT01637298|HPV subtypes|hpv subtypes
305826|NCT01637298|AIN study|ain study
305827|NCT01637298|HIV-positive and HIV-negative MSM|hiv-positive and hiv-negative msm
305828|NCT01637298|anal cytology and biomarkers|anal cytology and biomarkers
305829|NCT01637298|likelihood of AIN development at month 12 and yearly thereafter|likelihood of ain development at month 12 and yearly thereafter
305830|NCT01637272|Dumping syndrome|dumping syndrome
305832|NCT01637272|pasireotide LAR|pasireotide lar
305833|NCT01637259|proteinuria|proteinuria
305834|NCT01637259|HIV|hiv
305835|NCT01637233|HIV-1 infection|hiv-1 infection
305836|NCT01637233|neurocognitive function|neurocognitive function
305837|NCT01637233|switch study|switch study
305838|NCT01637220|Anaphylaxis|anaphylaxis
296519|NCT01680445|osteoarthritis, arthritis|osteoarthritis, arthritis
305839|NCT01637220|Neutrophils|neutrophils
305840|NCT01637220|Platelet activating factor|platelet activating factor
305841|NCT01637220|Neutrophil Extracellular Traps (NETs)|neutrophil extracellular traps (nets)
305842|NCT01637168|Disorders of cognitive function|disorders of cognitive function
305843|NCT01637155|Cholecalciferol|cholecalciferol
305844|NCT01637129|Childhood stroke|childhood stroke
305845|NCT01637129|Perinatal stroke|perinatal stroke
305846|NCT01637129|Pediatric stroke|pediatric stroke
305847|NCT01637129|Presumed perinatal stroke|presumed perinatal stroke
305848|NCT01637129|Children who have hemiparesis|children who have hemiparesis
305849|NCT01637103|Cancer|cancer
305850|NCT01637103|Depression|depression
305851|NCT01637103|Anxiety|anxiety
305852|NCT01637103|Fatigue|fatigue
305853|NCT01637103|Sleep|sleep
305854|NCT01637103|Quality of life|quality of life
305855|NCT01637103|Cognitive therapy|cognitive therapy
305856|NCT01637103|Bright light therapy|bright light therapy
305857|NCT01637064|Myositis|myositis
305858|NCT01637064|Acthar treatment|acthar treatment
305859|NCT01637038|ischemia/reperfusion injury|ischemia/reperfusion injury
305860|NCT01637038|remote ischemic postconditioning|remote ischemic postconditioning
305861|NCT01637012|ALEX|alex
305862|NCT01637012|coronary stent|coronary stent
305863|NCT01637012|cobalt-chromium|cobalt-chromium
305864|NCT01637012|sirolimus|sirolimus
305865|NCT01637012|OCT|oct
305866|NCT01636999|Sedara|sedara
305867|NCT01636999|Nitrous Oxide|nitrous oxide
305868|NCT01636999|Butorphanol|butorphanol
305869|NCT01636999|Visual Analog Scale|visual analog scale
305870|NCT01636986|myopia|myopia
305871|NCT01636986|contact lenses|contact lenses
305872|NCT01636986|dry eyes|dry eyes
305873|NCT01636986|comfort|comfort
305874|NCT01636986|replacement|replacement
305875|NCT01636973|Lung cancer|lung cancer
305876|NCT01636947|chemotherapy|chemotherapy
305877|NCT01636947|nausea|nausea
305878|NCT01636947|vomiting|vomiting
305879|NCT01636947|emetogenic|emetogenic
305880|NCT01636947|cancer|cancer
305881|NCT01636947|antiemetics|antiemetics
305882|NCT01636947|tumor|tumor
305883|NCT01636934|Lung Cancer|lung cancer
305884|NCT01636934|Non Small Cell Lung Cancer|non small cell lung cancer
305885|NCT01636934|NSCLC|nsclc
305886|NCT01636934|Symptom Burden|symptom burden
305887|NCT01636934|Chemoradiation|chemoradiation
305888|NCT01636934|CXRT|cxrt
305889|NCT01636934|Minocycline|minocycline
305890|NCT01636934|Dynacin|dynacin
305891|NCT01636934|Minocin|minocin
305892|NCT01636934|Minocin PAC|minocin pac
305893|NCT01636934|Myrac|myrac
305894|NCT01636934|Solodyn|solodyn
305895|NCT01636934|Placebo|placebo
305896|NCT01636934|Sugar Pill|sugar pill
305897|NCT01636934|Questionnaires|questionnaires
305898|NCT01636934|Surveys|surveys
305899|NCT01636921|Non-Small Cell Lung Cancer|non-small cell lung cancer
305900|NCT01636921|Lung Cancer|lung cancer
305901|NCT01636921|NSCLC|nsclc
305902|NCT01636921|Radiation Therapy|radiation therapy
305903|NCT01636921|Sorafenib|sorafenib
305904|NCT01636921|BAY 43-9006|bay 43-9006
305905|NCT01636921|Thoracic Radiation|thoracic radiation
305906|NCT01636895|malaria|malaria
305907|NCT01636895|pregnancy|pregnancy
305908|NCT01636895|prevention|prevention
305909|NCT01636895|treatment|treatment
305910|NCT01636895|molecular markers|molecular markers
305911|NCT01636882|Melanoma|melanoma
305912|NCT01636882|CALM|calm
305913|NCT01636869|bupivacaine level|bupivacaine level
305914|NCT01636869|periarticular block|periarticular block
305915|NCT01636869|total knee arthroplasty|total knee arthroplasty
305916|NCT01636856|oropharyngeal exercises, obstructive sleep apnea, speech therapy, magnetic resonance, PCRIT, negative expiratory pressure, snore|oropharyngeal exercises, obstructive sleep apnea, speech therapy, magnetic resonance, pcrit, negative expiratory pressure, snore
305917|NCT01636830|Toothbrushing|toothbrushing
305918|NCT01636830|gingival recession|gingival recession
305919|NCT01636804|Quicksite|quicksite
305920|NCT01636804|Quickflex|quickflex
305921|NCT01636804|St. Jude Medical|st. jude medical
305922|NCT01636778|Thrombocytopenia|thrombocytopenia
305923|NCT01636778|Hepatitis C, chronic|hepatitis c, chronic
305924|NCT01636739|Intussusceptions|intussusceptions
305925|NCT01636739|Special Drug Use Investigation|special drug use investigation
305926|NCT01636739|Rotavirus|rotavirus
305927|NCT01636726|COPD|copd
305928|NCT01636726|AMI|ami
305929|NCT01636726|Asthma|asthma
305930|NCT01636726|LABAs|labas
305931|NCT01636700|Tramadol infiltration|tramadol infiltration
305932|NCT01636700|Analgesic effect|analgesic effect
305933|NCT01636700|Serum IL-6|serum il-6
305934|NCT01636687|Psoriasis|psoriasis
305935|NCT01636687|Moderate to Severe Plaque-type Psoriasis|moderate to severe plaque-type psoriasis
305936|NCT01636674|positron emission tomography|positron emission tomography
305937|NCT01636674|computed tomography|computed tomography
305938|NCT01636674|fluordeoxyglucose|fluordeoxyglucose
305939|NCT01636674|colon cancer|colon cancer
296621|NCT01680042|VAS|vas
305940|NCT01636674|cancer|cancer
305941|NCT01636674|staging|staging
305942|NCT01636674|imaging|imaging
305943|NCT01636648|Aortic Valve Replacement|aortic valve replacement
305944|NCT01636648|Aortic Valve Bioprosthesis|aortic valve bioprosthesis
305945|NCT01636622|Advanced Cancers|advanced cancers
305946|NCT01636622|Advanced Malignancy|advanced malignancy
308526|NCT01624844|ultrasound|ultrasound
305947|NCT01636622|BRAF Mutation|braf mutation
305948|NCT01636622|Advanced solid tumor|advanced solid tumor
305949|NCT01636622|Lymphoma|lymphoma
305950|NCT01636622|Vemurafenib|vemurafenib
305952|NCT01636622|RO5185426|ro5185426
305953|NCT01636622|Carboplatin|carboplatin
305954|NCT01636622|Paraplatin|paraplatin
305955|NCT01636622|Paclitaxel|paclitaxel
305956|NCT01636622|Taxol|taxol
305957|NCT01636609|Leukemia|leukemia
305958|NCT01636609|Acute Myeloid Leukemia|acute myeloid leukemia
305959|NCT01636609|AML|aml
305960|NCT01636609|Myelodysplastic Syndromes|myelodysplastic syndromes
305961|NCT01636609|MDS|mds
305962|NCT01636609|Relapsed|relapsed
305963|NCT01636609|Refractory|refractory
305964|NCT01636609|Cytarabine|cytarabine
305965|NCT01636609|ARA-C|ara-c
305966|NCT01636609|Cytosar|cytosar
305967|NCT01636609|DepoCyt|depocyt
305968|NCT01636609|Cytosine Arabinosine|cytosine arabinosine
305969|NCT01636609|5-Azacytidine|5-azacytidine
305970|NCT01636609|Azacitidine|azacitidine
305971|NCT01636609|5-aza|5-aza
305972|NCT01636609|Vidaza|vidaza
305973|NCT01636609|5-AZC|5-azc
305974|NCT01636609|AZA-CR|aza-cr
305975|NCT01636609|Ladakamycin|ladakamycin
305976|NCT01636609|NSC-102816|nsc-102816
305977|NCT01636609|Tosedostat|tosedostat
305978|NCT01636596|Alzheimer's Disease|alzheimer's disease
305979|NCT01636596|Mild Cognitive Impairment|mild cognitive impairment
305980|NCT01636596|Insulin|insulin
305981|NCT01636596|Pulsatile|pulsatile
305982|NCT01636583|zinc|zinc
305983|NCT01636583|absorption|absorption
305984|NCT01636583|bio-availability|bio-availability
305985|NCT01636583|aqueous zinc|aqueous zinc
305986|NCT01636583|zinc deficiency|zinc deficiency
305987|NCT01636583|zinc fortification|zinc fortification
305988|NCT01636570|Vitamin D|vitamin d
305989|NCT01636570|Cholecalciferol|cholecalciferol
305990|NCT01636570|Heart Failure|heart failure
305991|NCT01636570|Congestive heart failure|congestive heart failure
305992|NCT01636570|Cardiomyopathy|cardiomyopathy
305993|NCT01636570|Strength|strength
305994|NCT01636570|Parathyroid Hormone|parathyroid hormone
305995|NCT01636570|Calcium|calcium
305996|NCT01636570|Quality of Life|quality of life
305997|NCT01636570|C reactive protein|c reactive protein
305998|NCT01636570|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
305999|NCT01636570|Prognosis|prognosis
306000|NCT01636557|Rheumatoid arthritis|rheumatoid arthritis
306001|NCT01636557|sirukumab|sirukumab
306002|NCT01636557|CNTO 136|cnto 136
306003|NCT01636557|CYP450 enzyme|cyp450 enzyme
306004|NCT01636557|anti-interleukin-6 monoclonal antibody|anti-interleukin-6 monoclonal antibody
306005|NCT01636466|Chronic allograft failure|chronic allograft failure
306006|NCT01636466|Kidney Transplantation|kidney transplantation
306007|NCT01636453|wide-neck|wide-neck
306008|NCT01636453|saccular|saccular
306009|NCT01636453|intracranial aneurysms|intracranial aneurysms
306010|NCT01636453|ICA|ica
306011|NCT01636453|Stent assisted coiling|stent assisted coiling
306012|NCT01636453|Liberty Stent|liberty stent
306013|NCT01636440|Conditioned Pain Modulation|conditioned pain modulation
306014|NCT01636427|myocardial infarction|myocardial infarction
306015|NCT01636427|coronary angiography|coronary angiography
306016|NCT01636427|STEMI|stemi
306017|NCT01636427|NSTEMI|nstemi
306018|NCT01636414|Total joint arthroplasty, blood loss|total joint arthroplasty, blood loss
306019|NCT01636388|Relapsed Hodgkins Lymphoma|relapsed hodgkins lymphoma
306020|NCT01636388|Refractory Hodgkins Lymphoma|refractory hodgkins lymphoma
306021|NCT01636388|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
306022|NCT01636388|Adoptive Immunotherapy|adoptive immunotherapy
306023|NCT01636388|Cellular Therapy|cellular therapy
306024|NCT01636388|Cytotoxic T cell lymphocytes|cytotoxic t cell lymphocytes
306025|NCT01636362|Partial-thickness second degree burns|partial-thickness second degree burns
306026|NCT01636362|Mepitel Ag|mepitel ag
306027|NCT01636362|Silver dressing|silver dressing
306028|NCT01636349|Type 2 diabetes|type 2 diabetes
306029|NCT01636349|hypertension|hypertension
306030|NCT01636349|obesity|obesity
306031|NCT01636349|metabolic syndrome|metabolic syndrome
306032|NCT01636297|Parkinson's disease|parkinson's disease
306033|NCT01636297|Exercise|exercise
306034|NCT01636284|Liver Cancer|liver cancer
306035|NCT01636284|HCC|hcc
306036|NCT01636284|first line HCC|first line hcc
306037|NCT01636284|Pexa-Vec|pexa-vec
306038|NCT01636284|JX-594|jx-594
306039|NCT01636271|CV Risk|cv risk
306040|NCT01636271|Cardiovascular Disease|cardiovascular disease
306041|NCT01636271|Atherosclerosis|atherosclerosis
296707|NCT01679522|single-port|single-port
306042|NCT01636271|Acute coronary syndrome|acute coronary syndrome
306043|NCT01636258|Prediabetes|prediabetes
306044|NCT01636258|Overweight|overweight
306045|NCT01636258|African American|african american
306046|NCT01636258|Women|women
306047|NCT01636258|Cooking|cooking
306048|NCT01636258|Nutrition|nutrition
306049|NCT01636258|Exercise|exercise
306050|NCT01636258|Stress Management|stress management
306051|NCT01636245|71 vaccine|71 vaccine
306052|NCT01636245|HFMD|hfmd
306053|NCT01636245|consistency of three consecutive lots|consistency of three consecutive lots
306054|NCT01636245|immunogenicity|immunogenicity
306055|NCT01636232|Vitamin D|vitamin d
306056|NCT01636232|infection|infection
306057|NCT01636232|disease severity|disease severity
306058|NCT01636232|mortality|mortality
306059|NCT01636232|critically ill|critically ill
306060|NCT01636232|sepsis|sepsis
306061|NCT01636219|Spirometry,|spirometry,
306062|NCT01636219|Cough|cough
306063|NCT01636193|Rotavirus|rotavirus
306064|NCT01636193|Rotarix|rotarix
306065|NCT01636193|Drug Use Investigation|drug use investigation
306066|NCT01636193|Safety|safety
306067|NCT01636180|STEMI|stemi
306068|NCT01636180|NSTEMI|nstemi
306069|NCT01636180|clopidogrel|clopidogrel
306070|NCT01636180|Areplex|areplex
306071|NCT01636180|REL-0609|rel-0609
306072|NCT01636154|fire-heat syndrome|fire-heat syndrome
306073|NCT01636154|blood stasis syndrome|blood stasis syndrome
306074|NCT01636154|method of clearing heat|method of clearing heat
306075|NCT01636154|method of promoting blood circulation|method of promoting blood circulation
306076|NCT01636154|medicinal fractions-based herbal combinations|medicinal fractions-based herbal combinations
306077|NCT01636141|Safety|safety
306078|NCT01636141|Tolerability|tolerability
306079|NCT01636141|Pharmacokinetics|pharmacokinetics
306080|NCT01636141|Dose escalation|dose escalation
306081|NCT01636141|Randomized|randomized
306082|NCT01636141|Healthy volunteers|healthy volunteers
306083|NCT01636141|Topical|topical
306084|NCT01636141|OLT1177|olt1177
306085|NCT01636141|Olatec|olatec
306086|NCT01636141|Pain|pain
306087|NCT01636141|Inflammation|inflammation
306088|NCT01636128|Urinary|urinary
306089|NCT01636128|biomarkers|biomarkers
306090|NCT01636128|DFMO|dfmo
306091|NCT01636128|sulindac|sulindac
306092|NCT01636102|Influenza|influenza
306093|NCT01636102|Adults|adults
306094|NCT01636102|Elderly|elderly
306095|NCT01636102|Immunology|immunology
306096|NCT01636102|Safety|safety
306097|NCT01636089|intensive care unit|intensive care unit
306098|NCT01636076|COPD|copd
306099|NCT01636063|Induced Abortion|induced abortion
306100|NCT01636063|Abortion Techniques|abortion techniques
306101|NCT01636063|Mifepristone|mifepristone
306102|NCT01636063|Misoprostol|misoprostol
306103|NCT01636063|Initial Cervical Dilation|initial cervical dilation
306104|NCT01636050|squat exercise|squat exercise
306105|NCT01636037|schizophrenia|schizophrenia
306106|NCT01636037|negative symptoms|negative symptoms
306107|NCT01636037|deficit syndrome|deficit syndrome
306108|NCT01636037|SANS|sans
306109|NCT01636037|Sinemet|sinemet
306110|NCT01636037|L-dopa|l-dopa
306111|NCT01636037|levodopa|levodopa
306112|NCT01636037|carbidopa|carbidopa
306113|NCT01636037|augmentation|augmentation
306114|NCT01636037|antipsychotics|antipsychotics
306115|NCT01636024|Phase 1,|phase 1,
306116|NCT01636024|healthy volunteers,|healthy volunteers,
306117|NCT01636024|safety,|safety,
306118|NCT01636024|tolerability,|tolerability,
306119|NCT01636024|pharmacokinetics,|pharmacokinetics,
306120|NCT01636024|pharmacodynamics,|pharmacodynamics,
402037|NCT01233375|CO101|co101
306121|NCT01636024|single ascending dose study,|single ascending dose study,
306122|NCT01636024|multiple|multiple
306123|NCT01636011|Parkinson's Disease|parkinson's disease
306124|NCT01636011|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
306125|NCT01636011|Speech|speech
306126|NCT01636011|Pulmonary Function|pulmonary function
306127|NCT01635998|renal sympathetic denervation|renal sympathetic denervation
306128|NCT01635998|renal catheter ablation|renal catheter ablation
306129|NCT01635998|hypertension|hypertension
306130|NCT01635985|Phase I, Healthy male volunteers, pharmacokinetics|phase i, healthy male volunteers, pharmacokinetics
306131|NCT01635972|Isavuconazole|isavuconazole
306132|NCT01635972|Bupropion|bupropion
306133|NCT01635972|Bupropion hydrochloride|bupropion hydrochloride
306134|NCT01635972|Healthy Volunteers|healthy volunteers
306135|NCT01635972|BAL8557|bal8557
306136|NCT01635972|BAL4815|bal4815
306137|NCT01635972|BAL8728|bal8728
306138|NCT01635959|upper gastro-intestinal symptoms, GERD|upper gastro-intestinal symptoms, gerd
306139|NCT01635946|Isavuconazole|isavuconazole
306140|NCT01635946|Atorvastatin|atorvastatin
306141|NCT01635946|Healthy Volunteers|healthy volunteers
306142|NCT01635946|BAL8557|bal8557
306143|NCT01635946|BAL4815|bal4815
306144|NCT01635946|BAL8728|bal8728
306145|NCT01635933|contact lenses|contact lenses
306146|NCT01635933|color contact lenses|color contact lenses
306147|NCT01635933|myopia|myopia
306148|NCT01635920|contact lenses|contact lenses
306149|NCT01635920|color contact lenses|color contact lenses
306150|NCT01635920|myopia|myopia
306151|NCT01635894|female pelvic floor condition|female pelvic floor condition
306152|NCT01635894|pelvic floor training|pelvic floor training
306153|NCT01635894|supervised pelvic floor training|supervised pelvic floor training
306154|NCT01635894|practice nurse|practice nurse
306155|NCT01635894|nurse specialist|nurse specialist
306156|NCT01635842|Patient|patient
306157|NCT01635842|information leaflet|information leaflet
306158|NCT01635842|informed consent|informed consent
306160|NCT01635829|Healthy participants|healthy participants
306161|NCT01635829|Hepatitis C virus|hepatitis c virus
306162|NCT01635829|Telaprevir|telaprevir
306163|NCT01635829|Phenytoin|phenytoin
306164|NCT01635829|Carbamazepine|carbamazepine
306166|NCT01635829|Interaction|interaction
306167|NCT01635816|Immunogenicity|immunogenicity
306168|NCT01635816|SA 14-14-2 JE vaccine|sa 14-14-2 je vaccine
306169|NCT01635816|Bangladesh|bangladesh
306170|NCT01635803|bevacizumab|bevacizumab
306171|NCT01635803|ranibizumab|ranibizumab
306172|NCT01635803|retinal vein occlusions|retinal vein occlusions
306173|NCT01635803|randomized clinical trial|randomized clinical trial
306174|NCT01635803|Macular edema|macular edema
306175|NCT01635790|bevacizumab|bevacizumab
306176|NCT01635790|ranibizumab|ranibizumab
306177|NCT01635790|diabetic macular edema|diabetic macular edema
306178|NCT01635790|randomized clinical trial|randomized clinical trial
306179|NCT01635777|PKDL|pkdl
306180|NCT01635777|miltefosine|miltefosine
306181|NCT01635764|hidradenitis suppurativa|hidradenitis suppurativa
306182|NCT01635764|adalimumab|adalimumab
306183|NCT01635764|open-label|open-label
306185|NCT01635764|acne inversa|acne inversa
306186|NCT01635764|PIONEER (OPEN-LABEL EXTENSION)|pioneer (open-label extension)
306187|NCT01635764|acne|acne
306188|NCT01635764|tumor necrosis factor|tumor necrosis factor
306189|NCT01635764|boil|boil
306190|NCT01635751|Pregabalin|pregabalin
306191|NCT01635751|GLARS|glars
306192|NCT01635738|Probiotics|probiotics
306193|NCT01635738|Lactobacillus paracasei GMNL-133|lactobacillus paracasei gmnl-133
306194|NCT01635738|Lactobacillus fermentum GM-090|lactobacillus fermentum gm-090
306195|NCT01635738|Atopic dermatitis|atopic dermatitis
306196|NCT01635738|Asthma|asthma
306197|NCT01635738|Lactobacillus paracasei|lactobacillus paracasei
306198|NCT01635738|Lactobacillus fermentum|lactobacillus fermentum
306199|NCT01635738|efficacy and safety|efficacy and safety
306200|NCT01635725|colonoscopy|colonoscopy
306201|NCT01635725|bowel cleanliness|bowel cleanliness
306202|NCT01635725|bowel rating scale|bowel rating scale
306203|NCT01635712|Hematological Malignancy|hematological malignancy
306204|NCT01635712|Hsp90|hsp90
306205|NCT01635699|DNA oxidation|dna oxidation
306206|NCT01635699|obstructive sleep apnea|obstructive sleep apnea
306207|NCT01635699|lipid peroxidation|lipid peroxidation
306208|NCT01635699|oxidative stresses|oxidative stresses
306209|NCT01635673|Exercise|exercise
306210|NCT01635673|Latino|latino
306211|NCT01635673|Hispanic|hispanic
306212|NCT01635673|Boys|boys
306213|NCT01635660|Out-of-hospital|out-of-hospital
306214|NCT01635660|airway management|airway management
306215|NCT01635660|intubation|intubation
306216|NCT01635660|video laryngoscope|video laryngoscope
306217|NCT01635634|Fibromyalgia|fibromyalgia
306218|NCT01635634|Cupping|cupping
306219|NCT01635621|Olokizumab|olokizumab
306220|NCT01635621|OKZ|okz
306221|NCT01635621|CDP6038|cdp6038
306222|NCT01635621|Crohn's Disease|crohn's disease
306223|NCT01635621|CDAI|cdai
306224|NCT01635621|IBDQ|ibdq
306225|NCT01635608|Pharmacokinetics|pharmacokinetics
306226|NCT01635608|Talinolol|talinolol
306227|NCT01635608|Amoxicillin|amoxicillin
306228|NCT01635608|Acetaminophen|acetaminophen
306229|NCT01635608|Magnetic Resonance Imaging|magnetic resonance imaging
306230|NCT01635582|Hand exercises|hand exercises
306231|NCT01635582|Hand function|hand function
306232|NCT01635582|Computer based exercises|computer based exercises
306233|NCT01635582|Therapeutic gaming|therapeutic gaming
306234|NCT01635569|Obsessive-compulsive disorder|obsessive-compulsive disorder
306235|NCT01635569|Pediatric|pediatric
306236|NCT01635569|Group-based|group-based
306237|NCT01635569|Cognitive-behavioural therapy|cognitive-behavioural therapy
306238|NCT01635556|borderline personality disorder|borderline personality disorder
306239|NCT01635556|dialectical behavior therapy|dialectical behavior therapy
306240|NCT01635556|psychological treatment|psychological treatment
306241|NCT01635517|Diuretics|diuretics
306242|NCT01635517|Vasopressins|vasopressins
306243|NCT01635517|Sodium|sodium
306244|NCT01635504|HIV lipoatrophy|hiv lipoatrophy
306245|NCT01635504|masseter hypertrophy|masseter hypertrophy
306246|NCT01635504|parotid enlargement|parotid enlargement
306247|NCT01635504|botulinum toxin|botulinum toxin
306248|NCT01635491|Gastrointestinal Motility|gastrointestinal motility
306250|NCT01635426|Aspirin|aspirin
306251|NCT01635426|Clopidogrel|clopidogrel
306252|NCT01635426|Unexplained recurrent pregnancy loss|unexplained recurrent pregnancy loss
306253|NCT01635426|Uterine artery pulsatility index|uterine artery pulsatility index
306254|NCT01635400|Irinotecan|irinotecan
306255|NCT01635400|UGT1A1 Gene Polymorphisms|ugt1a1 gene polymorphisms
306256|NCT01635400|Small Cell Carcinoma of Lung|small cell carcinoma of lung
306257|NCT01635348|gait speed|gait speed
306258|NCT01635348|cognitive processing speed|cognitive processing speed
306259|NCT01635335|HIV prevention|hiv prevention
306260|NCT01635335|adolescents|adolescents
306261|NCT01635335|Latinos|latinos
306262|NCT01635335|Hispanics|hispanics
306264|NCT01635335|health promotion|health promotion
306265|NCT01635335|disease prevention|disease prevention
306266|NCT01635335|family communication|family communication
306267|NCT01635335|parental supervision|parental supervision
306268|NCT01635322|deformity|deformity
306269|NCT01635322|adult|adult
306270|NCT01635322|lumbar|lumbar
306271|NCT01635322|thoraco-lumbar|thoraco-lumbar
306272|NCT01635322|Sagittal vertebral Alignement (SVA)|sagittal vertebral alignement (sva)
306273|NCT01635322|Oswestry Disability Index (ODI)|oswestry disability index (odi)
306274|NCT01635257|pulmonary embolism diagnosis|pulmonary embolism diagnosis
306275|NCT01635257|ultrasound|ultrasound
306276|NCT01635244|Aortic valve prosthesis|aortic valve prosthesis
306277|NCT01635244|Aortic valve hemodynamics|aortic valve hemodynamics
306278|NCT01635244|Prosthesis-patient mismatch|prosthesis-patient mismatch
306279|NCT01635244|Left ventricular diastolic function|left ventricular diastolic function
306280|NCT01635244|Left ventricular remodeling|left ventricular remodeling
306281|NCT01635231|Nephrology|nephrology
306282|NCT01635231|sodium-channels|sodium-channels
306283|NCT01635231|water-channels|water-channels
306284|NCT01635231|BCM|bcm
306285|NCT01635231|central blood pressure|central blood pressure
306286|NCT01635218|Depression|depression
306287|NCT01635218|Perimenopause|perimenopause
306288|NCT01635218|Postmenopause|postmenopause
306289|NCT01635218|Homeopathy|homeopathy
306290|NCT01635205|Paraspinous block|paraspinous block
306291|NCT01635205|Non-responsive chronic pelvic pain|non-responsive chronic pelvic pain
306292|NCT01635192|renin|renin
306293|NCT01635192|angiotensin|angiotensin
306294|NCT01635192|probiotic|probiotic
306295|NCT01635192|glucose absorption|glucose absorption
306296|NCT01635192|intestinal|intestinal
306297|NCT01635179|Videolaryngoscopy|videolaryngoscopy
306298|NCT01635179|Bronchial Aspiration|bronchial aspiration
306299|NCT01635179|Hypoxia|hypoxia
306300|NCT01635166|Arthroplasty|arthroplasty
306301|NCT01635166|Replacement|replacement
306302|NCT01635166|Hip|hip
306303|NCT01635166|Cementless|cementless
306304|NCT01635166|Ceramic on Ceramic|ceramic on ceramic
306305|NCT01635153|HIV|hiv
306306|NCT01635153|Tuberculosis|tuberculosis
306307|NCT01635153|Nutrition|nutrition
306308|NCT01635140|DIPG|dipg
306309|NCT01635140|Hypofractionated Radiotherapy|hypofractionated radiotherapy
306310|NCT01635140|Radiotherapy|radiotherapy
306311|NCT01635140|Median survival|median survival
306312|NCT01635101|Moderate to severe acute pain following surgery or trauma|moderate to severe acute pain following surgery or trauma
306313|NCT01635088|Asthma|asthma
306314|NCT01635088|FEV1 and IOS change after mometasone for asthma|fev1 and ios change after mometasone for asthma
306315|NCT01635075|psychiatric|psychiatric
306316|NCT01635075|comorbidity|comorbidity
306317|NCT01635075|craving|craving
306318|NCT01635075|tobacco|tobacco
306319|NCT01635049|in vitro fertilization|in vitro fertilization
306320|NCT01635049|assisted reproduction techniques|assisted reproduction techniques
306321|NCT01635049|noninvasive imaging of embryos|noninvasive imaging of embryos
402038|NCT01233375|Stage 4|stage 4
306322|NCT01635049|time lapse imaging of embryos|time lapse imaging of embryos
306323|NCT01635049|traditional morphological grading of embryos|traditional morphological grading of embryos
306324|NCT01635049|prediction of blastocysts|prediction of blastocysts
306325|NCT01635049|infertility|infertility
306326|NCT01635049|preimplantation genetic diagnosis|preimplantation genetic diagnosis
306327|NCT01635049|comprehensive chromosome screening|comprehensive chromosome screening
306328|NCT01635036|in vitro fertilization|in vitro fertilization
306329|NCT01635036|assisted reproduction techniques|assisted reproduction techniques
306330|NCT01635036|noninvasive imaging of embryos|noninvasive imaging of embryos
306331|NCT01635036|time lapse imaging of embryos|time lapse imaging of embryos
306699|NCT01633060|breast cancer|breast cancer
306332|NCT01635036|traditional morphological grading of embryos|traditional morphological grading of embryos
306333|NCT01635036|prediction of blastocyst formation|prediction of blastocyst formation
306334|NCT01635036|infertility|infertility
306335|NCT01635036|male factor female factor|male factor female factor
306336|NCT01635036|embryo viability|embryo viability
306337|NCT01635023|Phase I|phase i
306338|NCT01635023|healthy volunteers|healthy volunteers
306339|NCT01635023|AZD6244|azd6244
306340|NCT01635023|pharmacokinetics|pharmacokinetics
306342|NCT01635023|Cmax|cmax
306343|NCT01635023|tmax|tmax
306344|NCT01635023|AUC(0-t)|auc(0-t)
306345|NCT01635010|obstructive sleep apnea|obstructive sleep apnea
306346|NCT01635010|inflammation|inflammation
306347|NCT01635010|oxidative stress|oxidative stress
306348|NCT01635010|arterial stiffness|arterial stiffness
306349|NCT01634997|Screening for Type 2 Diabetes|screening for type 2 diabetes
306350|NCT01634984|expression of CDK5RAP2|expression of cdk5rap2
306351|NCT01634971|Postoperative pancreatic fistula(POPF);|postoperative pancreatic fistula(popf);
306352|NCT01634971|Postpancreatectomy hemorrhage(PPH);|postpancreatectomy hemorrhage(pph);
306353|NCT01634971|Delayed gastric emptying (DGE);|delayed gastric emptying (dge);
306354|NCT01634971|Bile leakage after pancreatic surgery;|bile leakage after pancreatic surgery;
306355|NCT01634971|Anastomotic leakage|anastomotic leakage
306356|NCT01634958|Allergic Rhinitis|allergic rhinitis
306357|NCT01634958|Hayfever|hayfever
306358|NCT01634958|Immunotherapy|immunotherapy
306359|NCT01634958|Dose-Finding-Study|dose-finding-study
306360|NCT01634945|anemia|anemia
306361|NCT01634945|malaria|malaria
306362|NCT01634945|malnutrition|malnutrition
306363|NCT01634945|iron fortification|iron fortification
306364|NCT01634945|intermittent preventive treatment|intermittent preventive treatment
306365|NCT01634945|subsaharan africa|subsaharan africa
306366|NCT01634945|ivory coast|ivory coast
306367|NCT01634945|young children|young children
306368|NCT01634932|Iron deficiency|iron deficiency
306369|NCT01634932|Biofortification|biofortification
306370|NCT01634932|Pearl Millet|pearl millet
306371|NCT01634932|Benin|benin
306372|NCT01634919|Chronic hepatitis C|chronic hepatitis c
306373|NCT01634919|Liver fibrosis|liver fibrosis
306374|NCT01634919|ARFI(Acoustic radiation force impulse)|arfi(acoustic radiation force impulse)
306375|NCT01634906|Apolipoprotein B, erythrocytes, statins|apolipoprotein b, erythrocytes, statins
306376|NCT01634893|Refractory or Relapsed Solid Tumors|refractory or relapsed solid tumors
306377|NCT01634880|Salivary Gland Malignancies|salivary gland malignancies
306378|NCT01634880|Panitumumab|panitumumab
306379|NCT01634880|Postoperative|postoperative
306380|NCT01634880|Radiotherapy|radiotherapy
306381|NCT01634841|walnuts|walnuts
306382|NCT01634841|age related cognitive decline|age related cognitive decline
306383|NCT01634841|age related macular degeneration|age related macular degeneration
306384|NCT01634841|healthy elderly subjects|healthy elderly subjects
306385|NCT01634802|Clinical Decision Support Systems|clinical decision support systems
306386|NCT01634802|Electronic Medical Record|electronic medical record
306387|NCT01634802|Resource constrained countries|resource constrained countries
306388|NCT01634802|HIV|hiv
306389|NCT01634789|bioavailability|bioavailability
306390|NCT01634763|Phase I, open-label, dose escalation, oral LDK378, Japanese patients with tumors characterized by ALK genetic alterations|phase i, open-label, dose escalation, oral ldk378, japanese patients with tumors characterized by alk genetic alterations
306391|NCT01634750|N-Acetyl-D-mannosamine (ManNAc)|n-acetyl-d-mannosamine (mannac)
306392|NCT01634750|HIBM|hibm
306393|NCT01634750|GNE Myopathy|gne myopathy
306394|NCT01634737|shellfish|shellfish
306395|NCT01634737|tropomyosin|tropomyosin
306396|NCT01634737|mites|mites
306397|NCT01634737|food allergy|food allergy
306398|NCT01634724|GnRH agonist withdrawal|gnrh agonist withdrawal
306399|NCT01634724|OHSS|ohss
306400|NCT01634724|E2|e2
306401|NCT01634724|VEGF|vegf
306402|NCT01634711|ACL|acl
306403|NCT01634711|Anterior Cruciate Ligament|anterior cruciate ligament
306404|NCT01634711|Ligament|ligament
306405|NCT01634711|Resorbable polymer|resorbable polymer
306406|NCT01634711|Knee ligament|knee ligament
306407|NCT01634698|chronic liver disease|chronic liver disease
306408|NCT01634698|cirrhosis|cirrhosis
306409|NCT01634698|vitamin A|vitamin a
306410|NCT01634698|RDR test|rdr test
306411|NCT01634698|retinol-binding protein|retinol-binding protein
306412|NCT01634685|Rectal cancer|rectal cancer
306413|NCT01634685|Bavituximab|bavituximab
306414|NCT01634685|Capecitabine|capecitabine
306415|NCT01634685|Radiation Therapy|radiation therapy
306416|NCT01634672|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
306417|NCT01634672|peritoneal dialysis|peritoneal dialysis
306418|NCT01634672|hemodialysis|hemodialysis
306419|NCT01634659|contact lenses|contact lenses
306420|NCT01634659|myopia|myopia
306421|NCT01634646|Observational study|observational study
306422|NCT01634633|Endometrial nerve fibres|endometrial nerve fibres
306423|NCT01634620|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
306424|NCT01634620|Chronic Obstructive Airways Disease|chronic obstructive airways disease
306425|NCT01634620|Chronic Bronchitis|chronic bronchitis
306426|NCT01634620|Chronic Emphysema|chronic emphysema
306427|NCT01634620|Asthma|asthma
306428|NCT01634607|osteopenia|osteopenia
306429|NCT01634607|vitamin D deficiency|vitamin d deficiency
306430|NCT01634607|HIV-infected patients|hiv-infected patients
306431|NCT01634607|bone health|bone health
306432|NCT01634607|Bone mineral density (BMD)|bone mineral density (bmd)
306433|NCT01634607|HIV-uninfected patients|hiv-uninfected patients
306434|NCT01634607|effects of TDF on the patients' bone|effects of tdf on the patients' bone
306435|NCT01634594|Deliberate hypotension, QTc, Tp-e, heart rate variability|deliberate hypotension, qtc, tp-e, heart rate variability
297109|NCT01677936|lipid|lipid
297110|NCT01677936|waist circumference|waist circumference
297111|NCT01677936|BMI|bmi
297112|NCT01677923|weight|weight
297113|NCT01677923|body mass index|body mass index
297114|NCT01677923|lipid profile|lipid profile
306436|NCT01634555|Advanced Malignant Solid Tumors|advanced malignant solid tumors
306438|NCT01634516|Pregnant|pregnant
306439|NCT01634503|3+3 design|3+3 design
306440|NCT01634503|Phase 1|phase 1
306441|NCT01634503|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
306442|NCT01634503|Adult|adult
306443|NCT01634503|Safety|safety
306444|NCT01634503|Dose Finding|dose finding
306445|NCT01634490|cow's milk allergy|cow's milk allergy
306446|NCT01634490|formulas|formulas
306447|NCT01634490|probiotics|probiotics
306448|NCT01634477|morbidity|morbidity
306449|NCT01634477|mortality|mortality
306450|NCT01634477|HIV-infected patients|hiv-infected patients
306451|NCT01634477|prospective cohort study|prospective cohort study
306452|NCT01634477|highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
306453|NCT01634477|opportunistic infections|opportunistic infections
306454|NCT01634477|Non HIV-related illness|non hiv-related illness
306455|NCT01634477|cardiovascular disease (CVD)|cardiovascular disease (cvd)
306456|NCT01634477|HIV negative patients|hiv negative patients
306457|NCT01634477|Thai HIV-infected patients|thai hiv-infected patients
306458|NCT01634451|Sedation|sedation
306459|NCT01634451|Quality|quality
306460|NCT01634438|coronary angiography|coronary angiography
306461|NCT01634425|NSTEMI|nstemi
306462|NCT01634425|Point of Care Biomarkers|point of care biomarkers
306463|NCT01634334|Secondhand smoke|secondhand smoke
306464|NCT01634295|CKD-828|ckd-828
306465|NCT01634295|Hypertension|hypertension
306466|NCT01634295|Stage 2 Hypertension|stage 2 hypertension
306467|NCT01634295|S-Amlodipine|s-amlodipine
306468|NCT01634295|Telmisartan|telmisartan
306469|NCT01634269|Valvular Heart Disease|valvular heart disease
306470|NCT01634269|Severe Aortic Stenosis|severe aortic stenosis
306471|NCT01634269|Aortic Valve Replacement|aortic valve replacement
306472|NCT01634243|SPM 962|spm 962
306473|NCT01634243|rotigotine|rotigotine
306474|NCT01634243|Parkinson's disease|parkinson's disease
306475|NCT01634204|weight reduction|weight reduction
306476|NCT01634204|web-based intervention|web-based intervention
306477|NCT01634204|cost-effective|cost-effective
306478|NCT01634204|overweight|overweight
306479|NCT01634204|obesity|obesity
306480|NCT01634204|cardiovascular risk|cardiovascular risk
306481|NCT01634191|Apremilast|apremilast
306482|NCT01634191|pharmacokinetic|pharmacokinetic
306483|NCT01634191|safety|safety
306484|NCT01634191|Pharmacokinetics and safety in healthy volunteer subjects|pharmacokinetics and safety in healthy volunteer subjects
306485|NCT01634178|Apremilast,|apremilast,
306486|NCT01634178|pharmacokinetic|pharmacokinetic
306487|NCT01634178|safety|safety
306488|NCT01634178|Safety and pharmacokinetics in healthy volunteer subjects|safety and pharmacokinetics in healthy volunteer subjects
306489|NCT01634126|Colon|colon
306490|NCT01634126|Rectal|rectal
306491|NCT01634126|Cancer|cancer
306492|NCT01634126|Screening|screening
306493|NCT01634126|FIT|fit
306494|NCT01634126|Fecal|fecal
306495|NCT01634061|Castration-resistant prostate cancer, abiraterone acetate, BEZ235, BKM120, dose escalation, abiraterone acetate failure|castration-resistant prostate cancer, abiraterone acetate, bez235, bkm120, dose escalation, abiraterone acetate failure
306496|NCT01634048|high protein diet|high protein diet
306497|NCT01634048|meal replacements|meal replacements
306498|NCT01634048|low calorie diet|low calorie diet
306499|NCT01634048|intra hepatocellular lipid|intra hepatocellular lipid
306500|NCT01634035|glycated hemoglobin|glycated hemoglobin
306501|NCT01634035|mean plasma glucose|mean plasma glucose
306502|NCT01634022|Acupuncture|acupuncture
306503|NCT01634022|Antidepressant|antidepressant
306504|NCT01634022|Monotherapy|monotherapy
306505|NCT01634022|Depression|depression
306506|NCT01634022|Alternative treatments|alternative treatments
306507|NCT01634009|Severe acute malnutrition|severe acute malnutrition
306508|NCT01634009|Ready to use therapeutic food|ready to use therapeutic food
306509|NCT01634009|Soy protein|soy protein
306510|NCT01634009|Community based management|community based management
306511|NCT01634009|Efficacy|efficacy
306512|NCT01634009|Management of Children with SAM in Bangladesh|management of children with sam in bangladesh
306513|NCT01633996|Acupuncture|acupuncture
306514|NCT01633996|Antidepressant|antidepressant
306515|NCT01633996|Augmentation|augmentation
306516|NCT01633996|Depression|depression
306517|NCT01633983|Central Serous Chorioretinopathy|central serous chorioretinopathy
306518|NCT01633983|Methotrexate|methotrexate
306519|NCT01633957|anticoagulation|anticoagulation
306520|NCT01633957|bleeding|bleeding
306521|NCT01633957|CYP2C9|cyp2c9
306522|NCT01633957|CYP4F2|cyp4f2
297236|NCT01677221|acne|acne
306523|NCT01633957|VKORC1|vkorc1
306524|NCT01633957|warfarin dosing|warfarin dosing
306525|NCT01633957|Heart Valve Diseases|heart valve diseases
306526|NCT01633957|pharmacogenomics|pharmacogenomics
306527|NCT01633944|CLBP|clbp
306528|NCT01633944|Chronic Low Back Pain|chronic low back pain
306529|NCT01633944|Chronic Pain|chronic pain
306530|NCT01633944|Back Pain|back pain
306531|NCT01633918|intervention|intervention
306532|NCT01633918|health education|health education
306165|NCT01635829|HCV|hcv
306533|NCT01633918|physical activity|physical activity
306534|NCT01633918|sedentary behavior|sedentary behavior
306535|NCT01633918|health promotion|health promotion
306536|NCT01633918|evaluation|evaluation
306537|NCT01633918|RE-AIM|re-aim
306538|NCT01633905|alcohol-dependence|alcohol-dependence
306539|NCT01633905|event-related potentials|event-related potentials
306540|NCT01633905|emotion|emotion
306541|NCT01633905|crossmodal|crossmodal
306542|NCT01633905|peripheral processing|peripheral processing
306543|NCT01633892|Craniomaxillofacial (CMF)|craniomaxillofacial (cmf)
306544|NCT01633892|Battle-injured (BI)|battle-injured (bi)
306545|NCT01633892|Facial Trauma|facial trauma
306546|NCT01633892|Fat Grafts|fat grafts
306547|NCT01633892|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
306548|NCT01633892|Wounded warriors|wounded warriors
306549|NCT01633892|Adipose Tissue|adipose tissue
306645|NCT01633294|antibiotic prophylaxis|antibiotic prophylaxis
306550|NCT01633879|parenting, prevention, HIV/AIDS, adolescents, Latino|parenting, prevention, hiv/aids, adolescents, latino
306551|NCT01633866|Magnetic Resonance Imaging|magnetic resonance imaging
306552|NCT01633853|chronic kidney disease mineral and bone disorder|chronic kidney disease mineral and bone disorder
306553|NCT01633853|vitamin D2|vitamin d2
306554|NCT01633853|parathyroid hormone|parathyroid hormone
306555|NCT01633840|double-blind placebo-controlled food challenges|double-blind placebo-controlled food challenges
306556|NCT01633840|food allergy|food allergy
306557|NCT01633840|food hypersensitivity|food hypersensitivity
306558|NCT01633840|triangle test|triangle test
306559|NCT01633840|validated recipes|validated recipes
306560|NCT01633814|Physiological Processes|physiological processes
306561|NCT01633814|Exercise|exercise
306562|NCT01633814|Hormone replacement therapy|hormone replacement therapy
306563|NCT01633775|Refractory primary open angle glaucoma|refractory primary open angle glaucoma
306564|NCT01633775|trabeculectomy|trabeculectomy
306565|NCT01633775|ahmed valve implant|ahmed valve implant
306566|NCT01633749|Influenza|influenza
306567|NCT01633749|Vaccine|vaccine
306568|NCT01633749|CHMP criteria|chmp criteria
306569|NCT01633736|single blinded|single blinded
306570|NCT01633736|randomised|randomised
306571|NCT01633736|controlled|controlled
306572|NCT01633736|physiotherapy|physiotherapy
306573|NCT01633736|children|children
306574|NCT01633736|cerebral palsy|cerebral palsy
306575|NCT01633710|Ankle brachial pressure index|ankle brachial pressure index
306576|NCT01633710|Colour duplex ultrasound|colour duplex ultrasound
306577|NCT01633710|Diabetes|diabetes
306578|NCT01633710|Photoplethysmography|photoplethysmography
306579|NCT01633697|emphysema|emphysema
306580|NCT01633697|chronic bronchitis|chronic bronchitis
306581|NCT01633684|diabetes mellitus|diabetes mellitus
306582|NCT01633684|bone|bone
306583|NCT01633671|Misadventures to Patients During Surgical and Medical Care|misadventures to patients during surgical and medical care
306584|NCT01633671|Pulmonary Embolism Without Acute Cor Pulmonale|pulmonary embolism without acute cor pulmonale
306585|NCT01633671|Pulmonary Embolism Without Mention of Acute Cor Pulmonale|pulmonary embolism without mention of acute cor pulmonale
306586|NCT01633658|vitamin D|vitamin d
306587|NCT01633632|Smoking cessation|smoking cessation
306588|NCT01633632|Yoga|yoga
306589|NCT01633632|Cognitive behavioral therapy|cognitive behavioral therapy
306590|NCT01633619|Prosthetic Joint Infection|prosthetic joint infection
306591|NCT01633606|severity of illness|severity of illness
306592|NCT01633606|scoring|scoring
306593|NCT01633606|medium care|medium care
306594|NCT01633606|intensive care|intensive care
306595|NCT01633606|staffing|staffing
306596|NCT01633580|ICSI|icsi
306597|NCT01633580|GnRH antagonist|gnrh antagonist
306598|NCT01633580|corifollitropin alfa|corifollitropin alfa
306599|NCT01633567|Smoking Cessation|smoking cessation
306600|NCT01633567|Cigarette Smoking|cigarette smoking
306601|NCT01633567|Tobacco|tobacco
306602|NCT01633567|LGBT|lgbt
306603|NCT01633567|LGBTQ|lgbtq
306604|NCT01633554|ST-2, IL-33, prediction, fibrosis, hepatitis B|st-2, il-33, prediction, fibrosis, hepatitis b
306605|NCT01633528|low dose aspirin endometrial thickness pregnancy rate ICSI IVF embryo transfer|low dose aspirin endometrial thickness pregnancy rate icsi ivf embryo transfer
306606|NCT01633515|Basal cell carcinoma (BCC)|basal cell carcinoma (bcc)
306607|NCT01633515|Cryotherapy|cryotherapy
306608|NCT01633515|Cryosurgery|cryosurgery
306610|NCT01633476|ANCA associated vasculitis|anca associated vasculitis
306611|NCT01633476|CD4+CD28- T-cells|cd4+cd28- t-cells
306612|NCT01633476|Valaciclovir|valaciclovir
380163|NCT01326013|Stool|stool
306613|NCT01633463|EMERGENCY CANCER PAIN, ASSESSMENT, TREATMENT ADEQUACY.|emergency cancer pain, assessment, treatment adequacy.
306614|NCT01633437|tyramine|tyramine
306615|NCT01633437|MAOI|maoi
306616|NCT01633437|cheese effect|cheese effect
306617|NCT01633437|depression|depression
306618|NCT01633398|Heart Failure|heart failure
306619|NCT01633398|HF|hf
306620|NCT01633385|bronchial inflammation|bronchial inflammation
306621|NCT01633385|Bronchiolitis obliterans|bronchiolitis obliterans
306622|NCT01633385|Sputum|sputum
306623|NCT01633385|Blood|blood
306624|NCT01633385|Inflammation|inflammation
306625|NCT01633385|adaptive immune system|adaptive immune system
306626|NCT01633385|innate immune system|innate immune system
306627|NCT01633372|Primary Myelofibrosis|primary myelofibrosis
306629|NCT01633372|Post Polycythemia Vera Fibrosis|post polycythemia vera fibrosis
306630|NCT01633372|PPV-MF|ppv-mf
306631|NCT01633372|Post Essential Thrombocythemia Myelofibrosis|post essential thrombocythemia myelofibrosis
306632|NCT01633372|PET-MF|pet-mf
306633|NCT01633333|Colonoscopy|colonoscopy
306634|NCT01633333|Colorectal cancer|colorectal cancer
306635|NCT01633333|Colorectal adenomas|colorectal adenomas
306636|NCT01633333|Pain|pain
306637|NCT01633320|Analgesia/Nociception index|analgesia/nociception index
306638|NCT01633307|education|education
306639|NCT01633307|intravenous infusion|intravenous infusion
306640|NCT01633294|premature rupture of membranes|premature rupture of membranes
306641|NCT01633294|term pregnancy|term pregnancy
306642|NCT01633294|chorioamnionitis|chorioamnionitis
306643|NCT01633294|endometritis|endometritis
306644|NCT01633294|neonatal sepsis|neonatal sepsis
306646|NCT01633281|peripheral neuropathy|peripheral neuropathy
306647|NCT01633281|acupuncture|acupuncture
306648|NCT01633281|Bortezomib|bortezomib
306649|NCT01633281|Thalidomide|thalidomide
306650|NCT01633268|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
306651|NCT01633268|Traumatic Brain Injury|traumatic brain injury
306652|NCT01633255|Anti-Angiogenic|anti-angiogenic
306653|NCT01633255|Dynamic Contrast Enhanced Magnetic Resonance Imaging|dynamic contrast enhanced magnetic resonance imaging
306654|NCT01633255|PET/CT Imaging Studies|pet/ct imaging studies
306655|NCT01633242|MRI|mri
306656|NCT01633242|Muscular Dystrophy|muscular dystrophy
306657|NCT01633242|Cardiac|cardiac
306658|NCT01633242|Myocardium|myocardium
306659|NCT01633242|Intramyocardial fat|intramyocardial fat
306660|NCT01633229|Immune Suppression|immune suppression
306661|NCT01633229|BMSC|bmsc
306662|NCT01633229|GVHD|gvhd
306663|NCT01633229|Marrow Failure|marrow failure
306664|NCT01633229|Regimen Related Toxicity|regimen related toxicity
306665|NCT01633229|Graft-Versus-Host Disease|graft-versus-host disease
306666|NCT01633216|poliovirus,|poliovirus,
306667|NCT01633216|trivalent oral polio vaccine,|trivalent oral polio vaccine,
306668|NCT01633216|bivalent oral polio vaccine,|bivalent oral polio vaccine,
306669|NCT01633216|monovalent oral polio vaccine|monovalent oral polio vaccine
306670|NCT01633203|gastric cancer|gastric cancer
306671|NCT01633203|combination chemotherapy|combination chemotherapy
306672|NCT01633203|HER-2 gene|her-2 gene
306673|NCT01633203|quality of life|quality of life
306674|NCT01633190|Surveillance|surveillance
306675|NCT01633190|Rotavirus|rotavirus
306676|NCT01633190|Gastroenteritis|gastroenteritis
306677|NCT01633177|vitamin D|vitamin d
306678|NCT01633177|omega-3 fatty acids|omega-3 fatty acids
306679|NCT01633177|Type 2 diabetes|type 2 diabetes
306680|NCT01633177|Oral glucose tolerance test (OGTT)|oral glucose tolerance test (ogtt)
306681|NCT01633177|Insulin sensitivity|insulin sensitivity
306682|NCT01633177|Beta-cell function|beta-cell function
306683|NCT01633164|Spinal Cord Injury|spinal cord injury
306684|NCT01633164|Self-Efficacy|self-efficacy
306685|NCT01633164|Life Satisfaction|life satisfaction
306686|NCT01633164|Community Participation|community participation
306687|NCT01633138|cognitive remediation therapy|cognitive remediation therapy
306688|NCT01633138|substance abuse treatment|substance abuse treatment
306689|NCT01633125|Group music therapy|group music therapy
306690|NCT01633125|prisoners|prisoners
306691|NCT01633125|Anxiety|anxiety
306692|NCT01633125|Depression|depression
306693|NCT01633125|Self-esteem|self-esteem
306694|NCT01633099|decitabine|decitabine
306695|NCT01633099|acute myeloid leukemia|acute myeloid leukemia
306696|NCT01633099|elderly patient|elderly patient
306697|NCT01633060|BKM120|bkm120
306698|NCT01633060|fulvestrant|fulvestrant
306700|NCT01633060|metastatic|metastatic
306701|NCT01633060|locally advanced|locally advanced
306702|NCT01633060|AI treated|ai treated
306703|NCT01633060|mTOR inhibitor|mtor inhibitor
306704|NCT01633060|PI3K|pi3k
306705|NCT01633060|PIK3CA|pik3ca
306706|NCT01633060|PTEN|pten
306707|NCT01633060|HER2-|her2-
306708|NCT01633060|HR+|hr+
306709|NCT01633047|Anterior Cruciate Ligament|anterior cruciate ligament
306710|NCT01633047|Electric Stimulation Therapy|electric stimulation therapy
306711|NCT01633034|intervertebral disc degeneration|intervertebral disc degeneration
306712|NCT01633034|back pain|back pain
297412|NCT01676376|CABG|cabg
306713|NCT01633034|spine surgery|spine surgery
306714|NCT01633021|Family Study|family study
306715|NCT01633021|Social Networks|social networks
306716|NCT01633021|Diabetes|diabetes
306717|NCT01633008|Modified Brief Pain Inventory|modified brief pain inventory
306718|NCT01633008|Quality of Life|quality of life
306719|NCT01633008|Pain-Related Coping|pain-related coping
306720|NCT01633008|Pain-Related Anxiety|pain-related anxiety
306721|NCT01633008|Depression|depression
306722|NCT01632982|opioid abuse|opioid abuse
306723|NCT01632982|substance abuse|substance abuse
306724|NCT01632982|methadone maintenance treatment|methadone maintenance treatment
306725|NCT01632982|mobile technology|mobile technology
306726|NCT01632982|technology-based intervention|technology-based intervention
306727|NCT01632982|behavioral intervention|behavioral intervention
306728|NCT01632982|psychosocial treatment|psychosocial treatment
306729|NCT01632969|12-136|12-136
306730|NCT01632956|Support Groups|support groups
306731|NCT01632956|Breast cancer|breast cancer
306732|NCT01632956|Mandarin speaking|mandarin speaking
306733|NCT01632956|12-105|12-105
306734|NCT01632943|Uncontrolled Hypertension|uncontrolled hypertension
306735|NCT01632930|diagnosis|diagnosis
306736|NCT01632930|prostate cancer|prostate cancer
306737|NCT01632930|urine|urine
306738|NCT01632930|medical economics|medical economics
306739|NCT01632917|Healthy volunteers|healthy volunteers
306740|NCT01632904|Polycythemia Vera|polycythemia vera
306741|NCT01632904|PV|pv
306742|NCT01632878|Secondary prevention post MI|secondary prevention post mi
306743|NCT01632865|occlusion|occlusion
306744|NCT01632865|recanalization|recanalization
306745|NCT01632865|stenting|stenting
306746|NCT01632839|PISQ-R|pisq-r
306747|NCT01632839|new sexuality questionnaire|new sexuality questionnaire
306749|NCT01632826|refractory multiple myeloma|refractory multiple myeloma
306750|NCT01632826|pomalidomide|pomalidomide
306751|NCT01632813|neurocognitive testing|neurocognitive testing
306752|NCT01632813|critical illness|critical illness
306753|NCT01632813|executive function|executive function
306754|NCT01632813|intelligence|intelligence
306755|NCT01632800|Magnetic fields discomfort|magnetic fields discomfort
306756|NCT01632787|Anxiety|anxiety
306757|NCT01632787|Binocular|binocular
306758|NCT01632787|Chronic Headache|chronic headache
306759|NCT01632787|Dizziness|dizziness
306760|NCT01632787|Vertical Heterophoria|vertical heterophoria
306761|NCT01632787|Vision Dysfunction|vision dysfunction
306762|NCT01632761|anemia|anemia
306763|NCT01632761|vitamin D3|vitamin d3
306764|NCT01632761|omega-3 fatty acids|omega-3 fatty acids
306765|NCT01632761|fish oil|fish oil
306766|NCT01632761|primary prevention|primary prevention
306767|NCT01632735|Continuing Care|continuing care
306768|NCT01632735|Youth Substance Abuse|youth substance abuse
306769|NCT01632735|Recovery Support|recovery support
306770|NCT01632735|Mobile Texting|mobile texting
306771|NCT01632722|colorectal cancer, liver metastasis, bevacizumab, perioperative/postoperative chemotherapy|colorectal cancer, liver metastasis, bevacizumab, perioperative/postoperative chemotherapy
306772|NCT01632696|Antibodies, Monoclonal|antibodies, monoclonal
306773|NCT01632696|Biologics|biologics
306774|NCT01632696|F(ab')2|f(ab')2
306775|NCT01632696|Positron-emission tomography (PET)|positron-emission tomography (pet)
306776|NCT01632696|Phosphatidylserine (PS)|phosphatidylserine (ps)
306777|NCT01632696|Solid Tumors|solid tumors
306778|NCT01632696|Tumor Imaging|tumor imaging
306779|NCT01632683|difficult airway|difficult airway
306780|NCT01632683|video laryngoscopy|video laryngoscopy
306781|NCT01632670|music|music
306782|NCT01632670|cardiac catheterization|cardiac catheterization
306783|NCT01632670|endothelial function|endothelial function
306784|NCT01632631|suitable for endovascular exclusion|suitable for endovascular exclusion
306785|NCT01632605|ADPKD|adpkd
306786|NCT01632605|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
306787|NCT01632605|Sirolimus|sirolimus
306788|NCT01632605|Rapamune|rapamune
306789|NCT01632605|Polycystic liver disease|polycystic liver disease
306790|NCT01632605|Rapamycin|rapamycin
306791|NCT01632605|Mammalian target of rapamycin|mammalian target of rapamycin
306792|NCT01632605|m-TOR|m-tor
306793|NCT01632605|m-TOR inhibition|m-tor inhibition
306794|NCT01632553|Observation|observation
402039|NCT01233375|Stage IV|stage iv
306795|NCT01632553|Domestic Violence|domestic violence
306796|NCT01632553|Partner Abuse|partner abuse
306797|NCT01632553|Spousal Abuse|spousal abuse
306798|NCT01632553|Battered Women|battered women
306799|NCT01632553|Abused Women|abused women
306800|NCT01632553|Cortisol|cortisol
306801|NCT01632553|Mental Health|mental health
306802|NCT01632553|Depression|depression
306803|NCT01632553|Anxiety|anxiety
306804|NCT01632553|Posttraumatic Stress Disorders|posttraumatic stress disorders
306805|NCT01632527|Age-Related Macular Degeneration|age-related macular degeneration
306806|NCT01632527|Dry AMD with GA|dry amd with ga
306807|NCT01632527|Geographic Atrophy of Age-Related Macular Degeneration|geographic atrophy of age-related macular degeneration
380395|NCT01324973|Diet|diet
297497|NCT01675921|ACT|act
306808|NCT01632527|Stem Cell Transplantation|stem cell transplantation
306809|NCT01632527|Stem Cell transplant|stem cell transplant
306810|NCT01632527|Stem cells for AMD|stem cells for amd
306811|NCT01632527|Human neural stem cells|human neural stem cells
306812|NCT01632527|multipotent stem cells|multipotent stem cells
306813|NCT01632527|Macular Degeneration|macular degeneration
306814|NCT01632527|Dry AMD|dry amd
306815|NCT01632527|Human central nervous system stemcells|human central nervous system stemcells
306816|NCT01632527|dry age-related macular degeneration|dry age-related macular degeneration
306817|NCT01632514|hypocalcemia|hypocalcemia
306818|NCT01632514|vitamin D deficiency|vitamin d deficiency
306819|NCT01632514|cholecalciferol|cholecalciferol
306820|NCT01632514|thyroidectomy|thyroidectomy
306821|NCT01632488|Irritable Bowel Syndrome|irritable bowel syndrome
306822|NCT01632488|Inflammatory Bowel Disease|inflammatory bowel disease
306823|NCT01632488|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
306824|NCT01632475|Human umbilical cord blood-derived mesenchymal stem cells|human umbilical cord blood-derived mesenchymal stem cells
306825|NCT01632475|Premature infants|premature infants
306826|NCT01632475|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
306827|NCT01632475|Lung injury|lung injury
306828|NCT01632475|Lung diseases|lung diseases
306829|NCT01632475|Hyperplasia|hyperplasia
306830|NCT01632475|Ventilator-induced lung injury|ventilator-induced lung injury
306831|NCT01632475|Respiratory lung diseases|respiratory lung diseases
306832|NCT01632475|Pathologic Processes|pathologic processes
306833|NCT01632475|Infant, Premature, Diseases|infant, premature, diseases
306834|NCT01632475|Infant, Newborn, Diseases|infant, newborn, diseases
306835|NCT01632462|Crohn's disease|crohn's disease
306836|NCT01632462|VSL#3|vsl#3
306837|NCT01632462|probiotics|probiotics
306838|NCT01632462|metabolic profile|metabolic profile
306839|NCT01632449|bioequivalence|bioequivalence
306840|NCT01632436|Hepatic impairment|hepatic impairment
306841|NCT01632436|Metastatic Cancer|metastatic cancer
306842|NCT01632410|autonomic nerve system|autonomic nerve system
306843|NCT01632410|post stroke|post stroke
306844|NCT01632410|focus of study: to describe the autonomic nerve system function post stroke|focus of study: to describe the autonomic nerve system function post stroke
306845|NCT01632410|autonomic nervous system|autonomic nervous system
306848|NCT01632397|Adherence|adherence
306850|NCT01632397|Men having sex with men|men having sex with men
306851|NCT01632384|Smoker|smoker
306852|NCT01632384|Non-Smoker|non-smoker
306853|NCT01632384|Healthy|healthy
306854|NCT01632384|Drug free|drug free
306855|NCT01632384|MRI|mri
306856|NCT01632371|In-stent Restenosis|in-stent restenosis
306857|NCT01632371|Drug Eluting Stent|drug eluting stent
306858|NCT01632371|Paclitaxel Coated Balloon|paclitaxel coated balloon
306859|NCT01632371|Scoring Balloon|scoring balloon
306860|NCT01632371|Cutting Balloon|cutting balloon
306861|NCT01632371|Angiographic follow-up|angiographic follow-up
306862|NCT01632371|Optical coherence tomography (OCT)|optical coherence tomography (oct)
306863|NCT01632358|safety|safety
306864|NCT01632358|tolerability|tolerability
306865|NCT01632358|pharmacokinetics|pharmacokinetics
306866|NCT01632280|Obesity|obesity
306867|NCT01632280|Gastric Banding|gastric banding
306868|NCT01632280|Transcranial Direct Current Stimulation|transcranial direct current stimulation
306869|NCT01632241|Systemic Lupus Erythematosus|systemic lupus erythematosus
306870|NCT01632241|African Continental Ancestry Group|african continental ancestry group
306871|NCT01632241|Autoimmune Disease|autoimmune disease
306872|NCT01632241|Antibodies|antibodies
306873|NCT01632241|Minority Groups|minority groups
306874|NCT01632241|Black Race|black race
306875|NCT01632241|African Americans|african americans
306876|NCT01632241|SLE|sle
306877|NCT01632241|Belimumab|belimumab
306878|NCT01632241|Lupus|lupus
306879|NCT01632215|gabapentine|gabapentine
306880|NCT01632215|postoperative pain|postoperative pain
306881|NCT01632202|submucosal myomas|submucosal myomas
306882|NCT01632202|intrauterine adhesions|intrauterine adhesions
306883|NCT01632202|hysteroscopic myomectomy|hysteroscopic myomectomy
306884|NCT01632202|seprafilm|seprafilm
306885|NCT01632189|Varenicline|varenicline
306886|NCT01632189|PET imaging|pet imaging
306887|NCT01632189|[11C]-(+)-PHNO PET|[11c]-(+)-phno pet
306888|NCT01632189|neuroimaging in smokers|neuroimaging in smokers
306889|NCT01632176|dating abuse|dating abuse
306890|NCT01632176|dating violence|dating violence
306891|NCT01632176|domestic violence|domestic violence
306892|NCT01632176|sexual violence|sexual violence
306893|NCT01632176|sexual assault|sexual assault
306894|NCT01632176|youth violence|youth violence
306895|NCT01632176|underage alcohol use|underage alcohol use
306896|NCT01632176|alcohol use|alcohol use
306897|NCT01632098|psychosocial|psychosocial
306898|NCT01632098|healthcare|healthcare
306899|NCT01632098|co-morbidities|co-morbidities
306900|NCT01632098|extremely obese adolescents|extremely obese adolescents
306901|NCT01632059|ADMA|adma
306902|NCT01632059|DDAH II|ddah ii
306903|NCT01632059|SAPS|saps
306904|NCT01632059|SOFA|sofa
306905|NCT01632059|Sepsis|sepsis
306906|NCT01632059|Procalcitonin|procalcitonin
306907|NCT01632059|ICU|icu
306908|NCT01632059|mortality|mortality
306909|NCT01632059|length of stay|length of stay
306910|NCT01632046|peritoneal dialysis|peritoneal dialysis
306911|NCT01632046|bicarbonate/lactate buffer|bicarbonate/lactate buffer
306912|NCT01632046|peritoneal transport capacity|peritoneal transport capacity
306913|NCT01632046|ultrafiltration|ultrafiltration
306914|NCT01632046|children|children
306915|NCT01632033|Peripheral artery disease|peripheral artery disease
306916|NCT01632033|claudication|claudication
306917|NCT01632033|walking|walking
306918|NCT01632033|questionnaire|questionnaire
306919|NCT01632020|colorectal tumor|colorectal tumor
306920|NCT01632020|colorectal cancer|colorectal cancer
306921|NCT01632020|colorectal carcinoma|colorectal carcinoma
306922|NCT01632020|neoplasms, colorectal|neoplasms, colorectal
306923|NCT01632020|Metformin|metformin
306924|NCT01631994|metoclopramide video capsule endoscopy gastric transit time|metoclopramide video capsule endoscopy gastric transit time
306925|NCT01631955|Acute cystitis|acute cystitis
306927|NCT01631955|Quality of life|quality of life
306928|NCT01631929|Diabetes|diabetes
306929|NCT01631929|Ketoacidosis|ketoacidosis
306930|NCT01631929|Children|children
306931|NCT01631916|community-acquired pneumonia|community-acquired pneumonia
306932|NCT01631916|children|children
306933|NCT01631916|respiratory infections|respiratory infections
306934|NCT01631864|Hypertension, obesity, insulin sensitivity, lipolysis, LCZ696|hypertension, obesity, insulin sensitivity, lipolysis, lcz696
306935|NCT01631851|Autism|autism
306936|NCT01631851|Irritability|irritability
306937|NCT01631851|Disruptive Behavior|disruptive behavior
306938|NCT01631851|Aggression|aggression
306939|NCT01631851|Behavior Therapy|behavior therapy
306940|NCT01631851|Cognitive Behavioral Therapy|cognitive behavioral therapy
306941|NCT01631838|Tocotrienols|tocotrienols
306942|NCT01631838|Platelet aggregation|platelet aggregation
306943|NCT01631838|Metabolic syndrome|metabolic syndrome
306944|NCT01631838|Platelet activation|platelet activation
306945|NCT01631838|Thrombosis|thrombosis
306946|NCT01631825|SPM 962|spm 962
306947|NCT01631825|rotigotine|rotigotine
306948|NCT01631825|Parkinson's disease|parkinson's disease
306949|NCT01631825|concomitant use of L-dopa|concomitant use of l-dopa
306950|NCT01631812|SPM 962|spm 962
306951|NCT01631812|rotigotine|rotigotine
306952|NCT01631812|Parkinson's disease|parkinson's disease
306953|NCT01631812|concomitant use of L-dopa|concomitant use of l-dopa
306954|NCT01631799|epidural anesthesia|epidural anesthesia
306955|NCT01631799|femoral block|femoral block
306956|NCT01631799|patient control analgesia|patient control analgesia
306957|NCT01631786|Ovaries|ovaries
306958|NCT01631786|Imaging|imaging
306959|NCT01631786|Ultrasonography|ultrasonography
306960|NCT01631786|Synchrotron|synchrotron
306961|NCT01631786|Histology|histology
306962|NCT01631773|Aspirin-exacerbated respiratory disease|aspirin-exacerbated respiratory disease
306963|NCT01631773|Nasal polyp|nasal polyp
306964|NCT01631760|Asthma|asthma
306965|NCT01631760|Asthma Exacerbations|asthma exacerbations
306966|NCT01631747|Pregnancy|pregnancy
306967|NCT01631747|Weight gain|weight gain
306968|NCT01631747|Obesity|obesity
306969|NCT01631747|Pregnancy and weight gain|pregnancy and weight gain
306970|NCT01631721|adolescent couple decision-making|adolescent couple decision-making
306971|NCT01631721|parenting practices|parenting practices
306972|NCT01631721|sexual risk behavior|sexual risk behavior
306973|NCT01631708|Hereditary haemochromatosis|hereditary haemochromatosis
306974|NCT01631708|Moderate iron overload|moderate iron overload
306975|NCT01631708|Serum ferritin|serum ferritin
306976|NCT01631708|Treatment|treatment
306977|NCT01631682|Posttraumatic Stress Disorder|posttraumatic stress disorder
306978|NCT01631682|PTSD|ptsd
306979|NCT01631682|Anxiety|anxiety
306980|NCT01631682|Fear of spiders|fear of spiders
306981|NCT01631682|Reconsolidation|reconsolidation
306982|NCT01631682|Reconsolidation blockade|reconsolidation blockade
306983|NCT01631669|Ossification|ossification
306984|NCT01631669|Heterotopic Ossification|heterotopic ossification
306985|NCT01631656|Rosacea, Mild, Moderate, Combination Therapy, Laser, Finacea Gel, Azelaic Acid,|rosacea, mild, moderate, combination therapy, laser, finacea gel, azelaic acid,
306986|NCT01631643|Blood glucose monitor|blood glucose monitor
306987|NCT01631643|Pattern management|pattern management
306988|NCT01631643|Pattern guide|pattern guide
306989|NCT01631643|Education|education
306990|NCT01631630|Alcohol|alcohol
306991|NCT01631630|Alcohol Dependence|alcohol dependence
306992|NCT01631630|Alcohol Use|alcohol use
306993|NCT01631630|Nicotine Dependence|nicotine dependence
306994|NCT01631630|Nicotine|nicotine
306995|NCT01631617|Investigator-Blinded|investigator-blinded
306996|NCT01631617|Skin Biopsy|skin biopsy
306997|NCT01631617|Randomized|randomized
306998|NCT01631617|Antibiotics|antibiotics
306999|NCT01631617|Topical|topical
307000|NCT01631604|risk of falling|risk of falling
307001|NCT01631604|gait patterns|gait patterns
307002|NCT01631604|muscle activity|muscle activity
380650|NCT01323764|NPH|nph
307003|NCT01631604|fall prevention|fall prevention
307004|NCT01631604|motor impairment|motor impairment
307005|NCT01631578|mitochondrial injection|mitochondrial injection
307006|NCT01631565|Palliative Care|palliative care
307007|NCT01631565|Survival|survival
307008|NCT01631565|Quality of life|quality of life
307009|NCT01631552|Colorectal (CRC)|colorectal (crc)
307010|NCT01631552|Gastric adenocarcinoma (GC)|gastric adenocarcinoma (gc)
307011|NCT01631552|Esophageal cancer (EC)|esophageal cancer (ec)
307012|NCT01631552|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
307013|NCT01631552|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
307014|NCT01631552|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
307015|NCT01631552|Ovarian epithelial cancer (OEC)|ovarian epithelial cancer (oec)
307016|NCT01631552|Triple-negative breast cancer (TNBC)|triple-negative breast cancer (tnbc)
307017|NCT01631552|Hormone-refractory prostate cancer (HRPC)|hormone-refractory prostate cancer (hrpc)
307018|NCT01631552|Pancreatic ductal adenocarcinoma (PDC)|pancreatic ductal adenocarcinoma (pdc)
307019|NCT01631552|Head and neck cancers- squamous cell (SCCHN)|head and neck cancers- squamous cell (scchn)
307020|NCT01631552|Renal cell cancer -clear cell (RCC)|renal cell cancer -clear cell (rcc)
307021|NCT01631552|Bladder cancer|bladder cancer
307022|NCT01631552|Endometrial Cancer|endometrial cancer
307023|NCT01631552|Cervical Cancer|cervical cancer
307024|NCT01631552|Breast cancer|breast cancer
307025|NCT01631552|Metastatic non-triple negative breast cancer|metastatic non-triple negative breast cancer
307026|NCT01631552|Glioblastoma multiforme|glioblastoma multiforme
307027|NCT01631552|Follicular thyroid cancer|follicular thyroid cancer
307028|NCT01631539|chemoembolization|chemoembolization
307030|NCT01631539|Irinotecan|irinotecan
307031|NCT01631539|Cetuximab|cetuximab
307032|NCT01631539|5FU/LV|5fu/lv
307033|NCT01631539|KRAS|kras
307034|NCT01631539|metastatic colorectal cancer|metastatic colorectal cancer
307035|NCT01631526|Lung cancer|lung cancer
307036|NCT01631526|vitamin D|vitamin d
307037|NCT01631526|pharmacokinetics|pharmacokinetics
307038|NCT01631513|Chronic Low Back Pain|chronic low back pain
307039|NCT01631513|Osteoarthritis Pain In The Hip or Knee|osteoarthritis pain in the hip or knee
307040|NCT01631513|Oxycodone|oxycodone
307041|NCT01631513|Morphine, Hydrocodone|morphine, hydrocodone
307042|NCT01631513|Tapentadol|tapentadol
307043|NCT01631513|NUCYNTA ER|nucynta er
307044|NCT01631500|Integrative medicine|integrative medicine
307045|NCT01631500|Acupuncture|acupuncture
307046|NCT01631500|Minor mental health problems|minor mental health problems
307047|NCT01631500|Medically unexplained symptoms|medically unexplained symptoms
307048|NCT01631500|Minor mental health problems (e.g. minor depression and anxiety) and Medically unexplained symptoms (e.g. IBS, fibromyalgia, etc)|minor mental health problems (e.g. minor depression and anxiety) and medically unexplained symptoms (e.g. ibs, fibromyalgia, etc)
307049|NCT01631487|Healthy|healthy
307050|NCT01631487|JNJ-39439335|jnj-39439335
307051|NCT01631487|Japanese|japanese
307052|NCT01631487|Caucasian|caucasian
307053|NCT01631487|Male|male
307054|NCT01631474|Intrepid|intrepid
307055|NCT01631474|acne|acne
307056|NCT01631474|antiandrogen|antiandrogen
307057|NCT01631461|pain|pain
307058|NCT01631461|breast feeding|breast feeding
307059|NCT01631461|yeast|yeast
307060|NCT01631461|candida albicance|candida albicance
307061|NCT01631461|staphylococcus aureus|staphylococcus aureus
307062|NCT01631461|Signs and symptoms|signs and symptoms
307063|NCT01631448|Fibrin sealant|fibrin sealant
307064|NCT01631448|renal transplantation|renal transplantation
307065|NCT01631448|surgical complication|surgical complication
307066|NCT01631435|All subjects will have evidence of active symptoms associated with Crohn's disease|all subjects will have evidence of active symptoms associated with crohn's disease
307067|NCT01631409|clinical research|clinical research
307068|NCT01631409|coronary heart disease|coronary heart disease
307069|NCT01631409|cardiac shock wave therapy|cardiac shock wave therapy
307070|NCT01631409|ischemic heart disease|ischemic heart disease
307071|NCT01631409|myocardial revascularization|myocardial revascularization
307072|NCT01631409|observational research|observational research
307073|NCT01631409|prospective research|prospective research
307074|NCT01631396|Morbid obesity|morbid obesity
307075|NCT01631396|Bariatric Surgery|bariatric surgery
307076|NCT01631396|Neuromuscular block reversal|neuromuscular block reversal
307077|NCT01631383|Cocaine Use|cocaine use
307078|NCT01631305|Euthyroid Sick Syndromes|euthyroid sick syndromes
307079|NCT01631305|Thyroxine|thyroxine
307080|NCT01631305|Intensive care|intensive care
307082|NCT01631279|non-small cell lung cancer|non-small cell lung cancer
307083|NCT01631279|non-squamous, non-small cell lung cancer|non-squamous, non-small cell lung cancer
307084|NCT01631279|solid tumors|solid tumors
307085|NCT01631279|lung cancer|lung cancer
307086|NCT01631240|Sodium|sodium
307087|NCT01631240|Potassium|potassium
307088|NCT01631240|Iodine|iodine
307089|NCT01631240|Creatinine|creatinine
402989|NCT01228734|First occurrence of metastatic colorectal cancer in Chinese subjects with RAS wildtype|first occurrence of metastatic colorectal cancer in chinese subjects with ras wildtype
380772|NCT01323374|FMS|fms
297791|NCT01674634|XIAPEX|xiapex
307090|NCT01631214|Osteoporosis, Osteoporosis-postmenopausal, Bone Diseases-Metabolic, Bone Diseases, Musculoskeletal Diseases|osteoporosis, osteoporosis-postmenopausal, bone diseases-metabolic, bone diseases, musculoskeletal diseases
307091|NCT01631201|Chlamydia|chlamydia
307092|NCT01631188|Minimally Invasive Surgery|minimally invasive surgery
307093|NCT01631188|Port Access Surgery|port access surgery
307094|NCT01631188|Heart|heart
307095|NCT01631188|Pacing|pacing
307096|NCT01631188|Wire|wire
307097|NCT01631188|MICS|mics
307098|NCT01631188|Cardiac Bypass|cardiac bypass
307099|NCT01631188|Epicardial pacing|epicardial pacing
307100|NCT01631188|pacing catheter|pacing catheter
307101|NCT01631188|pacing wire|pacing wire
307102|NCT01631188|pacing swan|pacing swan
307103|NCT01631188|pacing pulmonary catheter|pacing pulmonary catheter
307104|NCT01631188|Pulmonary Endovent|pulmonary endovent
307105|NCT01631188|Catheter|catheter
307106|NCT01631188|Aortic Valve Surgery|aortic valve surgery
307107|NCT01631188|Edwards Lifesciences|edwards lifesciences
307108|NCT01631175|sarcoma|sarcoma
307109|NCT01631175|distress|distress
307110|NCT01631175|tumor|tumor
307111|NCT01631175|quality of life|quality of life
307112|NCT01631175|cancer|cancer
307113|NCT01631162|Asthma|asthma
307114|NCT01631162|COPD|copd
307115|NCT01631149|urology|urology
307117|NCT01631149|laparoscopy|laparoscopy
307118|NCT01631149|anesthesia|anesthesia
307119|NCT01631149|rocuronium|rocuronium
307120|NCT01631136|Non Small Cell Lung Cancer|non small cell lung cancer
307121|NCT01631136|IFCT|ifct
307122|NCT01631136|Maintenance|maintenance
307123|NCT01631136|Switch|switch
307124|NCT01631123|Twins|twins
307125|NCT01631123|High carbohydrat diet|high carbohydrat diet
307126|NCT01631123|High fat diet|high fat diet
307127|NCT01631123|Isocaloric|isocaloric
307128|NCT01631123|Nutrigenomics|nutrigenomics
307129|NCT01631110|Influenza|influenza
307130|NCT01631110|Virus|virus
307131|NCT01631110|Vaccination|vaccination
307132|NCT01631110|Inflexal V|inflexal v
307133|NCT01631084|Diabetes|diabetes
307134|NCT01631084|Structured care|structured care
307135|NCT01631071|Influenza|influenza
307136|NCT01631071|Virus|virus
307137|NCT01631071|Vaccination|vaccination
307138|NCT01631071|Virosomal influenza vaccine|virosomal influenza vaccine
307139|NCT01631058|kidney transplantation|kidney transplantation
307140|NCT01631058|chronic renal failure|chronic renal failure
307141|NCT01631058|immunosuppressive therapy|immunosuppressive therapy
307142|NCT01631058|elderly|elderly
307143|NCT01631058|pharmacokinetic|pharmacokinetic
307144|NCT01631058|tacrolimus|tacrolimus
307145|NCT01631058|everolimus|everolimus
307146|NCT01631058|mycophenolate sodium|mycophenolate sodium
307147|NCT01631058|serious adverse events|serious adverse events
307148|NCT01631058|biopsy|biopsy
307149|NCT01631058|Cystatin C|cystatin c
307150|NCT01631058|metabolic effects|metabolic effects
307151|NCT01631058|Left Ventricular Mass (LVM)|left ventricular mass (lvm)
307152|NCT01631058|Left Ventricle Ejection Fraction|left ventricle ejection fraction
307153|NCT01631045|Obesity|obesity
307154|NCT01631032|Allergic rhinitis|allergic rhinitis
307155|NCT01631032|Chinese herbal products|chinese herbal products
307156|NCT01631032|Qi deficiency|qi deficiency
307157|NCT01631019|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
307158|NCT01631019|Pulmonary Rehabilitation|pulmonary rehabilitation
307159|NCT01631019|Mobile phone|mobile phone
307160|NCT01631019|Biomarker|biomarker
307161|NCT01631006|CPAP|cpap
307162|NCT01631006|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
307163|NCT01631006|Blood Pressure|blood pressure
307164|NCT01631006|The focus of the present study is to evaluate the acute hemodynamic effects of CPAP in patients with non-obstructive and obstructive hypertrophic cardiomyopathy|the focus of the present study is to evaluate the acute hemodynamic effects of cpap in patients with non-obstructive and obstructive hypertrophic cardiomyopathy
307165|NCT01630993|umbilical cord milking|umbilical cord milking
307166|NCT01630993|umbilical cord stripping|umbilical cord stripping
307167|NCT01630993|umbilical cord clamping|umbilical cord clamping
307168|NCT01630993|placental transfusion|placental transfusion
307169|NCT01630993|placental residual blood volume|placental residual blood volume
307170|NCT01630980|Systematic review and meta-analysis|systematic review and meta-analysis
307171|NCT01630980|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
307172|NCT01630980|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
307173|NCT01630980|Clinical practice guidelines|clinical practice guidelines
307174|NCT01630980|Clinical trials|clinical trials
307175|NCT01630980|Tree nuts|tree nuts
307176|NCT01630980|Cardiometabolic risk factors|cardiometabolic risk factors
307177|NCT01630980|Triglycerides|triglycerides
307178|NCT01630980|Cholesterol|cholesterol
307179|NCT01630980|Glycemic control|glycemic control
307180|NCT01630980|Insulin resistance|insulin resistance
307181|NCT01630980|Body weight|body weight
307182|NCT01630980|Blood pressure|blood pressure
307183|NCT01630967|castrate resistance|castrate resistance
307184|NCT01630967|PSA progression|psa progression
307185|NCT01630967|LHRH antagonism|lhrh antagonism
307186|NCT01630954|Hydatidiform mole|hydatidiform mole
307187|NCT01630954|Molar pregnancy|molar pregnancy
307188|NCT01630954|H Mole|h mole
307189|NCT01630954|GTN|gtn
307190|NCT01630954|GTD|gtd
307191|NCT01630941|Osteoarthritis of the hip|osteoarthritis of the hip
307192|NCT01630941|Uncemented Total Hip Arthroplasty|uncemented total hip arthroplasty
307193|NCT01630941|DXA|dxa
307194|NCT01630941|BMD|bmd
307195|NCT01630941|PET|pet
307196|NCT01630941|CT|ct
307197|NCT01630941|Biochemical bone markers|biochemical bone markers
307198|NCT01630928|Renal denervation|renal denervation
307199|NCT01630928|Resistant Hypertension|resistant hypertension
307200|NCT01630928|Cardiovascular disease|cardiovascular disease
307201|NCT01630928|Diabetes|diabetes
307202|NCT01630928|Quality of LIfe|quality of life
307203|NCT01630889|Kidney|kidney
307204|NCT01630889|ESRD|esrd
307205|NCT01630889|End Stage Renal Disease|end stage renal disease
307206|NCT01630889|Anemia|anemia
307207|NCT01630889|Oral anemia treatment|oral anemia treatment
307208|NCT01630889|Hemoglobin levels|hemoglobin levels
307209|NCT01630889|Hemodialysis|hemodialysis
307210|NCT01630889|CKD|ckd
307211|NCT01630889|Chronic Kidney Disease|chronic kidney disease
307212|NCT01630889|Peritoneal|peritoneal
307213|NCT01630889|HD|hd
307214|NCT01630889|PD|pd
307215|NCT01630889|Hb|hb
307216|NCT01630889|Erythropoietin|erythropoietin
307217|NCT01630889|Blood count|blood count
307218|NCT01630876|Epiretinal membrane|epiretinal membrane
307219|NCT01630876|triamcinolone acetonide|triamcinolone acetonide
307220|NCT01630863|Central serous chorioretinopathy|central serous chorioretinopathy
307221|NCT01630863|photodynamic therapy|photodynamic therapy
307222|NCT01630863|safe and effective dose|safe and effective dose
307223|NCT01630824|education program|education program
307224|NCT01630824|kidney transplantation|kidney transplantation
307225|NCT01630824|renal transplantation|renal transplantation
307226|NCT01630824|evaluation|evaluation
307227|NCT01630811|Adults|adults
307228|NCT01630798|barrett's esophgus|barrett's esophgus
307229|NCT01630798|High grade dysplasia|high grade dysplasia
307230|NCT01630798|Esophageal adenocarcinoma|esophageal adenocarcinoma
307231|NCT01630772|women with preeclampsia|women with preeclampsia
307232|NCT01630772|physical therapy|physical therapy
307233|NCT01630772|maternal-fetal hemodynamics|maternal-fetal hemodynamics
307234|NCT01630772|perinatal outcomes|perinatal outcomes
307235|NCT01630759|Gestational diabetes|gestational diabetes
307236|NCT01630759|telemonitoring|telemonitoring
307237|NCT01630759|telehealth|telehealth
307238|NCT01630759|feasibility study|feasibility study
307239|NCT01630733|Metastatic|metastatic
307240|NCT01630733|Stage IV|stage iv
307241|NCT01630733|Advanced|advanced
307242|NCT01630733|lung cancer|lung cancer
307243|NCT01630720|ascorbic acid|ascorbic acid
307244|NCT01630720|cholecalciferol|cholecalciferol
307245|NCT01630720|vitamin C|vitamin c
307246|NCT01630720|vitamin D|vitamin d
307247|NCT01630720|hypovitaminosis|hypovitaminosis
307248|NCT01630720|mood|mood
307249|NCT01630720|distress|distress
307250|NCT01630694|Difficult airway management|difficult airway management
307251|NCT01630694|anesthesia|anesthesia
307252|NCT01630694|difficult intubation|difficult intubation
307253|NCT01630629|Lactation|lactation
307254|NCT01630629|Weaning|weaning
307255|NCT01630629|Bone Density|bone density
307256|NCT01630629|Endocrine|endocrine
307257|NCT01630629|Physiological Properties|physiological properties
307258|NCT01630629|Bone Metabolism|bone metabolism
307259|NCT01630590|Prostate Cancer|prostate cancer
307260|NCT01630590|Metastatic Prostate Cancer|metastatic prostate cancer
307261|NCT01630590|Prostate adenocarcinoma|prostate adenocarcinoma
307262|NCT01630590|Androgen-Dependent Prostate Cancer|androgen-dependent prostate cancer
307263|NCT01630590|Cabozantinib|cabozantinib
307264|NCT01630590|XL 184|xl 184
307265|NCT01630590|Androgen Ablation|androgen ablation
307266|NCT01630577|acute circulatory failure|acute circulatory failure
307267|NCT01630577|hemodynamic stability|hemodynamic stability
307268|NCT01630577|hypovolemia|hypovolemia
307269|NCT01630564|Blood And Marrow Transplantation|blood and marrow transplantation
307270|NCT01630564|Leukemia|leukemia
307271|NCT01630564|Lymphoma|lymphoma
307272|NCT01630564|Myeloproliferative Diseases|myeloproliferative diseases
307273|NCT01630564|Relapsed hematological malignancies|relapsed hematological malignancies
707545|NCT00997867|Nerve Block|nerve block
307274|NCT01630564|Post-Transplant Relapsed Patients|post-transplant relapsed patients
307275|NCT01630564|Cord Blood Lymphocyte Infusion|cord blood lymphocyte infusion
307276|NCT01630564|Ex Vivo Expanded Donor Cord Blood T-Lymphocyte Infusion|ex vivo expanded donor cord blood t-lymphocyte infusion
307277|NCT01630551|tears|tears
307278|NCT01630551|dry eyes|dry eyes
307279|NCT01630551|ocular surface disease|ocular surface disease
307280|NCT01630538|Transplantation|transplantation
307281|NCT01630525|Alzheimer's disease|alzheimer's disease
307282|NCT01630525|neurodegenerative signs|neurodegenerative signs
307283|NCT01630499|Cancer|cancer
307284|NCT01630499|Breast cancer|breast cancer
307285|NCT01630499|Breast cancer prevention|breast cancer prevention
307286|NCT01630499|Breast cancer recurrence|breast cancer recurrence
307287|NCT01630499|Weight loss|weight loss
307288|NCT01630499|Weight management|weight management
307289|NCT01630499|Overweight|overweight
307290|NCT01630499|Obesity|obesity
307291|NCT01630486|renal progression|renal progression
307292|NCT01630486|mortality|mortality
307293|NCT01630486|complications|complications
307294|NCT01630486|risk factors|risk factors
307295|NCT01630486|role of biochemical parameters|role of biochemical parameters
307296|NCT01630486|genetic influence|genetic influence
307297|NCT01630473|Tooth crowding|tooth crowding
307298|NCT01630473|Teeth malpositions|teeth malpositions
307299|NCT01630473|corticotomy|corticotomy
307300|NCT01630473|orthodontics|orthodontics
307301|NCT01630473|tooth movement|tooth movement
307302|NCT01630473|periodontal parameters|periodontal parameters
307303|NCT01630460|Craniometaphyseal dysplasia|craniometaphyseal dysplasia
307304|NCT01630460|bone|bone
307305|NCT01630460|hyperostosis|hyperostosis
307306|NCT01630460|osteoblast|osteoblast
307307|NCT01630460|osteoclast|osteoclast
307308|NCT01630447|cherubism|cherubism
307309|NCT01630447|bone|bone
307310|NCT01630447|autoinflammatory disorder|autoinflammatory disorder
307311|NCT01630447|osteoblast|osteoblast
307312|NCT01630447|osteoclast|osteoclast
307313|NCT01630447|mandible|mandible
307314|NCT01630447|maxilla|maxilla
307315|NCT01630421|Aplasia cutis congenita|aplasia cutis congenita
307316|NCT01630421|bone|bone
307317|NCT01630421|osteoblast|osteoblast
307318|NCT01630421|osteoclast|osteoclast
307319|NCT01630421|skin|skin
307320|NCT01630408|Preserved ejection fraction|preserved ejection fraction
307321|NCT01630408|Left ventricular hypertrophy|left ventricular hypertrophy
307322|NCT01630408|Activated vitamin D|activated vitamin d
307323|NCT01630408|Cardiac lusitropic effect|cardiac lusitropic effect
307324|NCT01630408|Hospitalizations|hospitalizations
307325|NCT01630356|Secondhand Smoke|secondhand smoke
307326|NCT01630356|Nicotine|nicotine
307327|NCT01630356|Indoor Air Pollution|indoor air pollution
307328|NCT01630343|Geriatric hip fracture|geriatric hip fracture
307329|NCT01630343|pain management|pain management
307330|NCT01630304|telecommunications|telecommunications
307331|NCT01630304|Africa|africa
307332|NCT01630304|randomized controlled trial|randomized controlled trial
307333|NCT01630278|Prematurity|prematurity
307334|NCT01630278|patent ductus arteriosus|patent ductus arteriosus
307336|NCT01630265|Discharge Instructions|discharge instructions
307337|NCT01630265|Video Discharge Instructions|video discharge instructions
307338|NCT01630265|Video|video
307339|NCT01630265|Emergency Department Discharge Instructions|emergency department discharge instructions
307340|NCT01630265|ED Discharge|ed discharge
307341|NCT01630226|BRCA1|brca1
307342|NCT01630226|pathological complete response|pathological complete response
307343|NCT01630226|neoadjuvant chemotherapy|neoadjuvant chemotherapy
307344|NCT01630213|Vitamin D3|vitamin d3
307345|NCT01630213|Left ventricular mass|left ventricular mass
307346|NCT01630213|Echocardiography|echocardiography
307347|NCT01630213|Left ventricular systolic and diastolic function|left ventricular systolic and diastolic function
307348|NCT01630200|COPD|copd
307349|NCT01630200|comorbidity|comorbidity
307350|NCT01630200|arterial stiffness|arterial stiffness
307351|NCT01630200|roflumilast|roflumilast
307352|NCT01630187|Carbetocin|carbetocin
307353|NCT01630187|Uterotonic drug|uterotonic drug
307354|NCT01630187|elective cesarean section|elective cesarean section
307355|NCT01630174|IMRT,Pemetrexed,Cisplatin , Esophageal Cancer|imrt,pemetrexed,cisplatin , esophageal cancer
307356|NCT01630161|relapse|relapse
307357|NCT01630161|prevention|prevention
307358|NCT01630161|smoking|smoking
307359|NCT01630161|habit|habit
307360|NCT01630161|Forever Free|forever free
307361|NCT01630148|Thromboprophylaxis|thromboprophylaxis
307362|NCT01630148|Bemiparin|bemiparin
307363|NCT01630148|Low Molecular Weight Heparin|low molecular weight heparin
307364|NCT01630148|Major Gynaecological Surgeries|major gynaecological surgeries
307365|NCT01630148|Benign Gynaecological Surgeries|benign gynaecological surgeries
307366|NCT01630122|Trans-thoracic Needle Biopsy (TNB)|trans-thoracic needle biopsy (tnb)
307367|NCT01630122|Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS-TBNA)|endobronchial ultrasound guided transbronchial needle aspiration (ebus-tbna)
307368|NCT01630122|Trans-esophageal Ultrasound Scanning with FNA (EUS-FNA)|trans-esophageal ultrasound scanning with fna (eus-fna)
307369|NCT01630070|Critical limb ischemia|critical limb ischemia
307370|NCT01630070|Rest pain|rest pain
307371|NCT01630070|Minor tissue loss|minor tissue loss
307372|NCT01630070|Below the knee|below the knee
307373|NCT01630031|atrial fibrillation|atrial fibrillation
307374|NCT01630031|paroxysmal|paroxysmal
307375|NCT01630031|contact force|contact force
307376|NCT01630031|radiofrequency|radiofrequency
307377|NCT01630031|catheter ablation|catheter ablation
307378|NCT01630031|pulmonary vein isolation|pulmonary vein isolation
307379|NCT01630031|recurrence|recurrence
298093|NCT01673282|AED|aed
307380|NCT01630031|follow-up|follow-up
307381|NCT01630018|Epithelial Ovarian Cancer|epithelial ovarian cancer
307382|NCT01630018|Belotecan|belotecan
307383|NCT01630018|Topotecan|topotecan
307384|NCT01629992|Vomiting|vomiting
307385|NCT01629992|Nausea|nausea
307386|NCT01629992|Postoperative pain|postoperative pain
307387|NCT01629992|Feeling|feeling
307388|NCT01629966|Generalized Anxiety Disorder|generalized anxiety disorder
307389|NCT01629966|GAD|gad
307390|NCT01629940|X-linked Hypohidrotic Ectodermal Dysplasia|x-linked hypohidrotic ectodermal dysplasia
307391|NCT01629940|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
307392|NCT01629940|XLHED|xlhed
307393|NCT01629940|HED|hed
307394|NCT01629927|X-linked hypohidrotic ectodermal dysplasia|x-linked hypohidrotic ectodermal dysplasia
307395|NCT01629927|Hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
307396|NCT01629927|HED|hed
307397|NCT01629927|XLHED|xlhed
307398|NCT01629914|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
307399|NCT01629914|executive functioning|executive functioning
307400|NCT01629914|mindfulness meditation|mindfulness meditation
307401|NCT01629914|magnetic resonance imaging|magnetic resonance imaging
307402|NCT01629914|healthy|healthy
307403|NCT01629901|Healthy volunteer|healthy volunteer
307404|NCT01629888|Plant sterol|plant sterol
307405|NCT01629888|Hypercholesterolemia|hypercholesterolemia
307406|NCT01629888|dairy|dairy
307407|NCT01629810|Motion platform at appropriate settings.|motion platform at appropriate settings.
307408|NCT01629810|Relief of pain.|relief of pain.
307409|NCT01629810|Improvement in quality of life, cognition, and mood.|improvement in quality of life, cognition, and mood.
307410|NCT01629810|Effects of WBPA on cognition, mood, behavior, and functioning.|effects of wbpa on cognition, mood, behavior, and functioning.
307411|NCT01629810|Dose response effect .|dose response effect .
307412|NCT01629810|Gather data for long-term (2 year) study|gather data for long-term (2 year) study
307413|NCT01629745|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
307414|NCT01629745|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
307415|NCT01629693|contact lenses|contact lenses
307417|NCT01629693|astigmatism|astigmatism
307418|NCT01629680|moxaverine|moxaverine
307419|NCT01629680|ocular blood flow|ocular blood flow
307420|NCT01629654|Poststroke fatigue|poststroke fatigue
307421|NCT01629654|Health promotion|health promotion
307422|NCT01629654|Patient education|patient education
307423|NCT01629641|goniometry|goniometry
307424|NCT01629641|outcome measures|outcome measures
307425|NCT01629641|shoulder assessment|shoulder assessment
307426|NCT01629628|Crohn Disease|crohn disease
307427|NCT01629628|Colitis Granulomatous|colitis granulomatous
307428|NCT01629628|Crohn's Disease|crohn's disease
307429|NCT01629628|Enteritis Regional|enteritis regional
307430|NCT01629628|Ileitis Regional|ileitis regional
307431|NCT01629628|Ileitis Terminal|ileitis terminal
307432|NCT01629628|Ileocolitis|ileocolitis
307433|NCT01629615|breast cancer|breast cancer
307434|NCT01629615|metastatic|metastatic
307435|NCT01629615|triple negative breast cancer|triple negative breast cancer
307436|NCT01629615|BKM120|bkm120
307437|NCT01629615|SOLTI|solti
307438|NCT01629615|PI3K inhibitor|pi3k inhibitor
307439|NCT01629602|defect;|defect;
307440|NCT01629602|dorsal branch of the proper digital nerve;|dorsal branch of the proper digital nerve;
307441|NCT01629602|proper digital nerve;|proper digital nerve;
307442|NCT01629602|vascularized nerve graft|vascularized nerve graft
307443|NCT01629589|Adacel® vaccine|adacel® vaccine
307444|NCT01629589|Tetanus|tetanus
307445|NCT01629589|Diphtheria|diphtheria
307446|NCT01629589|whooping cough|whooping cough
307447|NCT01629589|Pertussis|pertussis
307448|NCT01629589|BOOSTRIX® vaccine|boostrix® vaccine
307449|NCT01629537|Post Traumatic Stress Disorder|post traumatic stress disorder
307450|NCT01629511|Leukemia|leukemia
307451|NCT01629511|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
307452|NCT01629511|CLL|cll
307453|NCT01629511|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
307454|NCT01629511|HCT|hct
307455|NCT01629511|Methotrexate|methotrexate
307456|NCT01629511|Filgrastim|filgrastim
307457|NCT01629511|G-CSF|g-csf
307458|NCT01629511|Neupogen|neupogen
307459|NCT01629511|Tacrolimus|tacrolimus
307460|NCT01629511|Prograf|prograf
307461|NCT01629511|Busulfan|busulfan
307462|NCT01629511|Busulfex|busulfex
307463|NCT01629511|Myleran|myleran
307464|NCT01629511|Clofarabine|clofarabine
307465|NCT01629511|Clofarex|clofarex
307467|NCT01629511|Gemcitabine|gemcitabine
307468|NCT01629511|Gemcitabine Hydrochloride|gemcitabine hydrochloride
307469|NCT01629511|Gemzar|gemzar
307470|NCT01629511|Thymoglobulin|thymoglobulin
307471|NCT01629511|ATG|atg
307472|NCT01629511|Antithymocyte Globulin|antithymocyte globulin
307473|NCT01629498|Lung cancer|lung cancer
307474|NCT01629498|Non-small cell lung cancer|non-small cell lung cancer
307475|NCT01629498|NSCLC|nsclc
402990|NCT01228734|status|status
307476|NCT01629498|Image-guided intensity-modulated scanning beam proton therapy|image-guided intensity-modulated scanning beam proton therapy
307477|NCT01629498|IMPT|impt
307478|NCT01629498|Simultaneous integrated boost|simultaneous integrated boost
307479|NCT01629498|SIB|sib
307480|NCT01629498|Gross tumor volume|gross tumor volume
307481|NCT01629498|GTV|gtv
307482|NCT01629498|Chemotherapy|chemotherapy
307483|NCT01629498|Questionnaire|questionnaire
307484|NCT01629498|Survey|survey
307485|NCT01629485|Mastery Learning|mastery learning
307486|NCT01629485|Surgical Education|surgical education
307487|NCT01629485|Laparoscopic Hernia Repair|laparoscopic hernia repair
307488|NCT01629485|Part vs Whole Task|part vs whole task
307489|NCT01629485|Contextual Interference|contextual interference
307490|NCT01629485|laparoscopy|laparoscopy
307491|NCT01629485|training|training
307492|NCT01629485|curriculum|curriculum
307493|NCT01629472|Gender norms|gender norms
307494|NCT01629472|Financial Autonomy|financial autonomy
307495|NCT01629472|Economic Well-being|economic well-being
307496|NCT01629459|exercise|exercise
307497|NCT01629459|strength|strength
307498|NCT01629459|training|training
307499|NCT01629459|barth syndrome|barth syndrome
307500|NCT01629459|mitochondria|mitochondria
307501|NCT01629459|amino acid|amino acid
307502|NCT01629459|protein|protein
307503|NCT01629446|Phase 1|phase 1
307504|NCT01629446|Normal healthy volunteers|normal healthy volunteers
307505|NCT01629446|Mass Balance|mass balance
307506|NCT01629433|idiopathic detrusor overactivity|idiopathic detrusor overactivity
307507|NCT01629433|neurogenic dysfunction|neurogenic dysfunction
307508|NCT01629433|onabotulinumtoxinA|onabotulinumtoxina
307509|NCT01629420|Gonadotropin-Releasing Hormone (GnRH) antagonist|gonadotropin-releasing hormone (gnrh) antagonist
307510|NCT01629381|knee arthroscopy|knee arthroscopy
307511|NCT01629381|venous thromboembolism|venous thromboembolism
307513|NCT01629355|Auditory Brainstem Response|auditory brainstem response
307514|NCT01629355|ABR|abr
307515|NCT01629355|SD-BERA|sd-bera
307516|NCT01629329|Headache|headache
307517|NCT01629329|prochlorperazine|prochlorperazine
307518|NCT01629329|excedrin migraine|excedrin migraine
307519|NCT01629329|treatment efficacy|treatment efficacy
307520|NCT01629329|pain scores|pain scores
307521|NCT01629316|HIV|hiv
307522|NCT01629316|prisoners|prisoners
307523|NCT01629316|test|test
307524|NCT01629316|treat|treat
307525|NCT01629316|link coordination|link coordination
307526|NCT01629316|retain|retain
307527|NCT01629316|behavioral|behavioral
307528|NCT01629316|intervention|intervention
307529|NCT01629316|text reminders|text reminders
307530|NCT01629316|motivational interviewing|motivational interviewing
308527|NCT01624831|Psychosis|psychosis
307531|NCT01629316|medication adherence|medication adherence
307532|NCT01629303|constipation|constipation
307533|NCT01629303|sacral nerve modulation|sacral nerve modulation
307534|NCT01629277|Closed-loop insulin delivery|closed-loop insulin delivery
307535|NCT01629277|Non-compliant behaviours during adolescence|non-compliant behaviours during adolescence
307536|NCT01629264|Cornea|cornea
307537|NCT01629264|biomechanics|biomechanics
307538|NCT01629264|pregnancy|pregnancy
307539|NCT01629264|keratoconus|keratoconus
307540|NCT01629264|refractive surgery|refractive surgery
307541|NCT01629251|Closed-loop insulin delivery|closed-loop insulin delivery
307542|NCT01629251|Post-prandial hypoglycaemia|post-prandial hypoglycaemia
307543|NCT01629251|Meal insulin dosing|meal insulin dosing
307544|NCT01629238|cardiovascular risk|cardiovascular risk
307545|NCT01629238|dairy enriched product with plant sterols|dairy enriched product with plant sterols
307546|NCT01629238|general practitioners|general practitioners
307547|NCT01629238|adults followed by general practitioners|adults followed by general practitioners
307548|NCT01629225|men and women|men and women
307549|NCT01629225|in southwestern Han Chinese|in southwestern han chinese
307550|NCT01629186|CPR|cpr
307551|NCT01629186|flexible bronchoscope|flexible bronchoscope
307552|NCT01629186|resuscitation|resuscitation
307553|NCT01629186|ventilation|ventilation
307554|NCT01629173|plantar pressure|plantar pressure
307555|NCT01629173|metatarsalgia|metatarsalgia
307556|NCT01629173|insole|insole
307557|NCT01629147|Constipation|constipation
307558|NCT01629108|Normative Data|normative data
307559|NCT01629108|Vestibular|vestibular
307560|NCT01629108|Auditory|auditory
307561|NCT01629108|Healthy Volunteers|healthy volunteers
307562|NCT01629108|Hearing|hearing
307563|NCT01629095|Fatty Liver|fatty liver
307564|NCT01629095|Liver Transplant|liver transplant
307565|NCT01629095|Non-Alcoholic Steato-Hepatitis|non-alcoholic steato-hepatitis
307566|NCT01629095|Steatosis|steatosis
307567|NCT01629095|Cirrhosis|cirrhosis
307568|NCT01629095|Cryptogenic Cirrhosis|cryptogenic cirrhosis
307569|NCT01629095|Liver Failure|liver failure
307570|NCT01629095|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
307571|NCT01629082|Myelodysplastic Syndromes|myelodysplastic syndromes
307572|NCT01629082|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
307573|NCT01629082|Chronic Myelomonocytic Leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
381399|NCT01321034|LPA|lpa
307574|NCT01629069|stress|stress
307575|NCT01629069|mindfulness|mindfulness
307576|NCT01629069|coping|coping
307577|NCT01629056|atrial fibrillation|atrial fibrillation
307578|NCT01629056|ablation|ablation
307579|NCT01629056|contact|contact
307580|NCT01629043|Parkinson's|parkinson's
307581|NCT01629043|Quality of Care|quality of care
307582|NCT01629043|Improvement|improvement
307583|NCT01629043|Mobility|mobility
307584|NCT01629043|Cognition|cognition
307585|NCT01629043|Caregiver burden|caregiver burden
307586|NCT01629043|Center difference|center difference
307587|NCT01629030|sternal wound infection|sternal wound infection
307588|NCT01629030|coronary artery bypass graft|coronary artery bypass graft
307589|NCT01629030|risk factor|risk factor
307590|NCT01629004|colorectal cancer|colorectal cancer
307591|NCT01629004|screening|screening
307592|NCT01629004|fecal occult blood testing|fecal occult blood testing
307593|NCT01629004|mailed invitation|mailed invitation
307594|NCT01628991|Behavioral Intervention Program|behavioral intervention program
307595|NCT01628991|Vaginal Cones|vaginal cones
307596|NCT01628991|Stress Urinary Incontinence|stress urinary incontinence
307597|NCT01628991|treatment|treatment
307598|NCT01628991|Women|women
307599|NCT01628978|depth of endotracheal tube placement|depth of endotracheal tube placement
307600|NCT01628978|endotracheal intubation|endotracheal intubation
307601|NCT01628978|endobronchial intubation|endobronchial intubation
307602|NCT01628965|SPM 962|spm 962
307603|NCT01628965|rotigotine|rotigotine
307604|NCT01628965|Parkinson's disease|parkinson's disease
307605|NCT01628965|monotherapy|monotherapy
307606|NCT01628939|low back pain|low back pain
307607|NCT01628939|facet joint pain|facet joint pain
307609|NCT01628913|Neuroendocrine tumors|neuroendocrine tumors
307610|NCT01628913|PNET|pnet
307611|NCT01628913|BEZ235|bez235
307612|NCT01628913|Everolimus|everolimus
307613|NCT01628900|pyelonephritis|pyelonephritis
307614|NCT01628900|Infection|infection
307615|NCT01628900|Antibiotic treatment|antibiotic treatment
307616|NCT01628887|Breast Cancer|breast cancer
307617|NCT01628874|Lumbar Puncture|lumbar puncture
307618|NCT01628874|J-Tip|j-tip
307619|NCT01628874|Jet injection|jet injection
307620|NCT01628874|Local Analgesia|local analgesia
307621|NCT01628861|occupation|occupation
307622|NCT01628861|work|work
307623|NCT01628861|sitting|sitting
307624|NCT01628861|sedentary behaviour|sedentary behaviour
307625|NCT01628861|office worker|office worker
307626|NCT01628861|adult|adult
307627|NCT01628861|education|education
307628|NCT01628861|point-of-choice prompt|point-of-choice prompt
307629|NCT01628848|SPM 962|spm 962
307630|NCT01628848|rotigotine|rotigotine
307631|NCT01628848|Parkinson's disease|parkinson's disease
307632|NCT01628848|concomitant use of L-dopa|concomitant use of l-dopa
307633|NCT01628835|overweight|overweight
307634|NCT01628835|pregnancy|pregnancy
307635|NCT01628835|diet counselling|diet counselling
307636|NCT01628835|glycemic|glycemic
307637|NCT01628822|Fibromyalgia|fibromyalgia
307638|NCT01628822|Relaxation|relaxation
307639|NCT01628822|Improving the quality of life|improving the quality of life
307640|NCT01628809|MBSR|mbsr
307641|NCT01628809|mindfulness|mindfulness
307642|NCT01628809|stress|stress
307643|NCT01628783|Depression|depression
307644|NCT01628783|emotional processing|emotional processing
307645|NCT01628783|fMRI|fmri
307646|NCT01628783|autobiographic memory|autobiographic memory
307647|NCT01628783|moderator of treatment response|moderator of treatment response
307648|NCT01628783|mediator of treatment response|mediator of treatment response
307649|NCT01628770|iron|iron
307650|NCT01628770|monofer|monofer
307651|NCT01628770|Pakistan|pakistan
307652|NCT01628731|loop diuretics|loop diuretics
307653|NCT01628731|fluid balance|fluid balance
307654|NCT01628731|urine output|urine output
307655|NCT01628731|acute renal dysfunction|acute renal dysfunction
307656|NCT01628718|OEF/OIF|oef/oif
307657|NCT01628718|Veterans|veterans
307658|NCT01628718|Psychotherapy|psychotherapy
307659|NCT01628718|PTSD|ptsd
307660|NCT01628705|Green tea|green tea
307661|NCT01628705|oxLDL|oxldl
307662|NCT01628705|fat mass|fat mass
307663|NCT01628679|provoked|provoked
307664|NCT01628679|vulvar|vulvar
307665|NCT01628679|vestibulodynia|vestibulodynia
307666|NCT01628679|vestibulitis|vestibulitis
307667|NCT01628666|Arrhythmia|arrhythmia
307668|NCT01628666|Device Procedure|device procedure
307669|NCT01628666|Antibiotics|antibiotics
307670|NCT01628666|Infection|infection
307671|NCT01628666|Cluster|cluster
307672|NCT01628653|Mild cognitive impairment|mild cognitive impairment
307673|NCT01628653|Cognitive rehabilitation|cognitive rehabilitation
307674|NCT01628653|Cognitive therapy|cognitive therapy
307675|NCT01628653|Spaced retrieval Training|spaced retrieval training
307676|NCT01628653|Alzheimer's disease|alzheimer's disease
307677|NCT01628653|Memory enhancement|memory enhancement
307678|NCT01628653|U-healthcare|u-healthcare
298428|NCT01671956|IBD|ibd
307679|NCT01628627|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
307680|NCT01628575|periodontally accelerated orthodontics PAO|periodontally accelerated orthodontics pao
307681|NCT01628562|Remifentanil|remifentanil
307682|NCT01628562|Esmolol|esmolol
307683|NCT01628562|Intracranial surgery|intracranial surgery
307684|NCT01628562|Heart rate|heart rate
307685|NCT01628562|Blood pressure|blood pressure
307686|NCT01628549|acne|acne
307687|NCT01628536|Black Cohosh|black cohosh
307688|NCT01628536|Ductal Carcinoma in situ|ductal carcinoma in situ
307689|NCT01628536|Breast Cancer|breast cancer
307690|NCT01628523|Respiratory failure|respiratory failure
307691|NCT01628523|Mechanical ventilation|mechanical ventilation
307692|NCT01628523|Acute lung injury|acute lung injury
307693|NCT01628510|preterm|preterm
307694|NCT01628471|Phase I b : advanced solid malignancy|phase i b : advanced solid malignancy
307695|NCT01628471|Phase II a: stage III b or IV, Non Small Cell Lung Cancer|phase ii a: stage iii b or iv, non small cell lung cancer
307696|NCT01628458|Pancreatic cancer|pancreatic cancer
307697|NCT01628458|locally advanced|locally advanced
307698|NCT01628458|irresectable|irresectable
307699|NCT01628458|Radiofrequency|radiofrequency
307701|NCT01628445|Diabetes|diabetes
307702|NCT01628445|Insulin|insulin
307703|NCT01628419|Health promotion|health promotion
307704|NCT01628419|Intervention|intervention
307705|NCT01628419|Workplace|workplace
307706|NCT01628419|Exercise program|exercise program
307707|NCT01628380|HIPEC|hipec
307708|NCT01628380|Ovarian Cancer|ovarian cancer
307709|NCT01628380|Cytoreductive Surgery|cytoreductive surgery
307710|NCT01628354|Choroidal neovascularization|choroidal neovascularization
307711|NCT01628354|Lucentis|lucentis
307712|NCT01628328|colonic stenting|colonic stenting
307713|NCT01628328|colorectal cancer obstruction|colorectal cancer obstruction
307714|NCT01628328|circulating tumor cell|circulating tumor cell
307715|NCT01628315|Multiple Sclerosis|multiple sclerosis
307716|NCT01628315|ASA|asa
307717|NCT01628315|MRI|mri
307718|NCT01628315|Lesion activity|lesion activity
307719|NCT01628302|Hypertension,plasma renin activity,salt consumption|hypertension,plasma renin activity,salt consumption
307720|NCT01628289|diabetic retinopathy|diabetic retinopathy
307721|NCT01628289|screening|screening
307722|NCT01628289|co-payment|co-payment
307723|NCT01628289|health service|health service
307724|NCT01628276|Multiple Sclerosis|multiple sclerosis
307725|NCT01628276|MRI Scans|mri scans
307726|NCT01628263|PICU|picu
307727|NCT01628263|Follow up|follow up
307728|NCT01628263|PTSD|ptsd
307729|NCT01628224|Task saturation|task saturation
307730|NCT01628211|hyperthermic chemotherapy|hyperthermic chemotherapy
307731|NCT01628211|intraperitoneal chemotherapy|intraperitoneal chemotherapy
307732|NCT01628211|second-look laparoscopy|second-look laparoscopy
307733|NCT01628211|peritoneal carcinosis|peritoneal carcinosis
307734|NCT01628211|mucinous colorectal cancer|mucinous colorectal cancer
307735|NCT01628198|Hypertension|hypertension
307736|NCT01628198|renal denervation|renal denervation
307737|NCT01628198|renal ablation|renal ablation
307738|NCT01628198|uncontrolled high blood pressure|uncontrolled high blood pressure
307739|NCT01628172|renal sympathetic denervation|renal sympathetic denervation
307740|NCT01628172|renal catheter ablation|renal catheter ablation
307741|NCT01628172|hypertension|hypertension
307742|NCT01628146|Presbyopia|presbyopia
307743|NCT01628146|hyperopia|hyperopia
307744|NCT01628146|Supracor|supracor
307745|NCT01628146|contrast sensitivity|contrast sensitivity
307746|NCT01628133|Transfusion|transfusion
307747|NCT01628133|Neonate|neonate
307748|NCT01628133|Infant, Very Low Birth Weight|infant, very low birth weight
307749|NCT01628133|Patent Ductus Arteriosus|patent ductus arteriosus
307750|NCT01628133|Packed Red Blood Cell|packed red blood cell
307751|NCT01628120|Chronic renal failure|chronic renal failure
307752|NCT01628120|Hemodialysis|hemodialysis
307753|NCT01628107|Chronic renal failure|chronic renal failure
307754|NCT01628107|hemodialysis|hemodialysis
307755|NCT01628081|psoriasis|psoriasis
307756|NCT01628081|Alga Dunaliella Bardawil|alga dunaliella bardawil
307757|NCT01628068|Left atrial appendage occlusion|left atrial appendage occlusion
307758|NCT01628068|gastrointestinal bleeding|gastrointestinal bleeding
307759|NCT01628055|IVIg|ivig
307760|NCT01628055|Acute Ischemic Stroke|acute ischemic stroke
307761|NCT01628055|Stroke|stroke
307762|NCT01628055|CVA|cva
307763|NCT01628055|Cerebrovascular Accident|cerebrovascular accident
307764|NCT01628029|Advanced Cancers|advanced cancers
307765|NCT01628029|Metastatic|metastatic
307766|NCT01628029|Locally advanced|locally advanced
307767|NCT01628029|Sleep disturbance|sleep disturbance
307768|NCT01628029|Sleep problems|sleep problems
307769|NCT01628029|Litebook|litebook
307770|NCT01628029|Melatonin|melatonin
307771|NCT01628029|Methylphenidate|methylphenidate
307772|NCT01628029|Methylphenidate hydrochloride|methylphenidate hydrochloride
307773|NCT01628029|Ritalin|ritalin
307774|NCT01628029|Concerta|concerta
307775|NCT01628029|Placebo|placebo
298520|NCT01671540|IPV|ipv
307776|NCT01628029|Supportive counseling|supportive counseling
307777|NCT01628029|Questionnaires|questionnaires
307778|NCT01628029|Study Diaries|study diaries
307779|NCT01628016|depression|depression
307780|NCT01628016|attention|attention
307781|NCT01628016|training|training
307782|NCT01628016|modification|modification
307783|NCT01628003|Traumatic Brain Injury|traumatic brain injury
307784|NCT01628003|long-term outcome|long-term outcome
307785|NCT01628003|Brain Reserves|brain reserves
307786|NCT01628003|Cognitive Reserves|cognitive reserves
307787|NCT01628003|Emotional Reserves|emotional reserves
307788|NCT01628003|Patients 1 year or more after Moderate or Severe Traumatic Brain Injury|patients 1 year or more after moderate or severe traumatic brain injury
307789|NCT01627990|cytotoxic chemotherapy|cytotoxic chemotherapy
307790|NCT01627990|G-CSF|g-csf
307791|NCT01627990|Solid tumour|solid tumour
307792|NCT01627990|Malignant haematological tumour|malignant haematological tumour
307793|NCT01627977|chromovitrectomy|chromovitrectomy
307794|NCT01627977|epiretinal membrane|epiretinal membrane
307795|NCT01627964|Heart Wall Motion Function|heart wall motion function
307796|NCT01627951|Plasmodium falciparum|plasmodium falciparum
307797|NCT01627951|malaria|malaria
307798|NCT01627938|Multiple Sclerosis|multiple sclerosis
307799|NCT01627938|MS|ms
307800|NCT01627938|Mitoxantrone|mitoxantrone
307801|NCT01627938|Dexrazoxane|dexrazoxane
307802|NCT01627938|Cardioxane|cardioxane
307803|NCT01627938|cardiotoxicity|cardiotoxicity
307804|NCT01627938|cardiac toxicity|cardiac toxicity
307805|NCT01627938|cardiotoxic side effects|cardiotoxic side effects
307806|NCT01627938|cardiac MRI|cardiac mri
307807|NCT01627938|cranial MRI|cranial mri
307808|NCT01627938|LVEF|lvef
307809|NCT01627938|neurological outcome|neurological outcome
307810|NCT01627925|nasal positive airway pressure|nasal positive airway pressure
307811|NCT01627925|upper airway obstruction|upper airway obstruction
307812|NCT01627925|mask ventilation|mask ventilation
307813|NCT01627912|wine|wine
307814|NCT01627912|inflammation|inflammation
307815|NCT01627912|oxidative stress|oxidative stress
307816|NCT01627912|randomized control trial|randomized control trial
307817|NCT01627912|postprandial intervention|postprandial intervention
307818|NCT01627912|platelet aggregation|platelet aggregation
307819|NCT01627912|haemostasis|haemostasis
307820|NCT01627912|robola|robola
307821|NCT01627912|cabernet sauvignon|cabernet sauvignon
307822|NCT01627912|alcohol|alcohol
307823|NCT01627912|PAF metabolism|paf metabolism
307824|NCT01627899|Blood glucose monitor|blood glucose monitor
307825|NCT01627899|Pattern management|pattern management
307826|NCT01627899|Pattern guide|pattern guide
307827|NCT01627899|Education|education
307828|NCT01627886|Bioequivalence|bioequivalence
307829|NCT01627886|Ibandronate Sodium|ibandronate sodium
307830|NCT01627886|crossover|crossover
307831|NCT01627873|Major abdominal surgery|major abdominal surgery
307832|NCT01627873|analgesic method|analgesic method
307833|NCT01627873|Fentanyl|fentanyl
307834|NCT01627873|Remifentanyl|remifentanyl
307835|NCT01627873|Postoperative cognitive disorder|postoperative cognitive disorder
307836|NCT01627873|Pro and anti inflammatory cytokines|pro and anti inflammatory cytokines
307837|NCT01627860|Epilepsy|epilepsy
307838|NCT01627860|Topiramate|topiramate
307839|NCT01627860|Neuro-surgical patients|neuro-surgical patients
307840|NCT01627860|Nervous disorder|nervous disorder
307841|NCT01627860|Seizures|seizures
307842|NCT01627847|Bioequivalence|bioequivalence
307843|NCT01627847|Ropinirole Hydrochloride|ropinirole hydrochloride
307844|NCT01627847|crossover|crossover
307845|NCT01627834|Bioequivalence|bioequivalence
307846|NCT01627834|Ropinirole Hydrochloride|ropinirole hydrochloride
307847|NCT01627834|crossover|crossover
307848|NCT01627821|Heart Failure|heart failure
307849|NCT01627808|intraoperative monitoring|intraoperative monitoring
307850|NCT01627808|fluid management|fluid management
307851|NCT01627795|Malignant Mesothelioma|malignant mesothelioma
307852|NCT01627795|Cancer|cancer
307853|NCT01627795|Anti cancer agents|anti cancer agents
307854|NCT01627782|Major depressive disorder|major depressive disorder
307855|NCT01627782|Treatment-resistant depression|treatment-resistant depression
307856|NCT01627782|Ketamine|ketamine
307857|NCT01627769|scars|scars
307858|NCT01627769|blisters|blisters
307859|NCT01627769|second degree burns|second degree burns
307860|NCT01627769|cryosurgery|cryosurgery
307861|NCT01627769|keloid scars|keloid scars
307862|NCT01627769|hypertrophic scars|hypertrophic scars
307863|NCT01627756|Thoracic Surgery|thoracic surgery
307864|NCT01627756|Endotoxins|endotoxins
307865|NCT01627756|Respiration, Artificial|respiration, artificial
307866|NCT01627756|Immune System|immune system
307867|NCT01627743|CDLM|cdlm
307868|NCT01627743|visual scale - physician evaluation|visual scale - physician evaluation
307869|NCT01627743|COPD|copd
307870|NCT01627743|GOLD group C and D|gold group c and d
307871|NCT01627717|maraviroc|maraviroc
307872|NCT01627717|boceprevir|boceprevir
307874|NCT01627717|HCV|hcv
298613|NCT01671176|ISQ|isq
307875|NCT01627717|drug interaction|drug interaction
307876|NCT01627717|pharmacokinetics|pharmacokinetics
307877|NCT01627704|PET/CT,fluoroestradiol (18F)|pet/ct,fluoroestradiol (18f)
307878|NCT01627704|breast cancer|breast cancer
307879|NCT01627704|metastatic|metastatic
307880|NCT01627704|prediction of response|prediction of response
307881|NCT01627704|hormone therapy|hormone therapy
307882|NCT01627678|HIV-1, Vacc-C5|hiv-1, vacc-c5
307883|NCT01627665|dabigatran|dabigatran
307884|NCT01627665|rivaroxaban|rivaroxaban
307885|NCT01627665|PKC|pkc
307886|NCT01627665|PKD|pkd
307887|NCT01627665|p-glycoprotein|p-glycoprotein
307888|NCT01627665|polymorphism|polymorphism
307889|NCT01627652|hypoxia|hypoxia
307890|NCT01627626|xerostomia|xerostomia
307891|NCT01627626|pilocarpine mouthwash|pilocarpine mouthwash
307892|NCT01627626|minor salivary gland secretion|minor salivary gland secretion
307893|NCT01627600|stroke|stroke
307894|NCT01627600|myocardial infarction|myocardial infarction
307895|NCT01627600|cardiovascular health|cardiovascular health
307896|NCT01627600|population study|population study
307897|NCT01627587|preterm labor|preterm labor
307898|NCT01627574|Pregnancy|pregnancy
307899|NCT01627574|STI prevention|sti prevention
307900|NCT01627574|adolescents|adolescents
307901|NCT01627574|probation|probation
307902|NCT01627561|Immune response|immune response
307903|NCT01627561|Human papillomavirus|human papillomavirus
307904|NCT01627561|HPV vaccine|hpv vaccine
307905|NCT01627561|Safety|safety
307906|NCT01627548|PTSD|ptsd
307907|NCT01627548|Couples|couples
307908|NCT01627548|Combat Veteran|combat veteran
307909|NCT01627548|Warfighter|warfighter
307910|NCT01627548|OEF|oef
307911|NCT01627548|OIF|oif
307912|NCT01627548|OND|ond
307913|NCT01627548|Structured Approach Therapy|structured approach therapy
307914|NCT01627548|Trauma|trauma
307915|NCT01627535|Brain Tumor|brain tumor
6059|NCT03252418|ascorbic acid|ascorbic acid
307916|NCT01627509|continuous glucose monitoring system|continuous glucose monitoring system
307917|NCT01627509|hypoglycemia|hypoglycemia
307918|NCT01627509|insulin regimen|insulin regimen
307919|NCT01627509|basal bolus therapy|basal bolus therapy
307920|NCT01627509|modern premixed insulin|modern premixed insulin
307921|NCT01627509|diabetes control|diabetes control
307922|NCT01627496|malnutrition|malnutrition
307923|NCT01627496|elderly care|elderly care
307924|NCT01627496|quality of life|quality of life
307925|NCT01627496|hospital|hospital
307926|NCT01627483|elderly|elderly
307927|NCT01627483|hip fracture|hip fracture
307928|NCT01627483|osteoporosis|osteoporosis
307929|NCT01627483|fall risk|fall risk
307930|NCT01627483|medication review|medication review
307931|NCT01627470|non-invasive arterial pressure|non-invasive arterial pressure
307932|NCT01627470|emergency|emergency
307933|NCT01627470|intensive care|intensive care
307934|NCT01627457|Coronary Artery Disease|coronary artery disease
307935|NCT01627457|Guided Exercise System including ECG Vest with vital signs sensors and PDA|guided exercise system including ecg vest with vital signs sensors and pda
308031|NCT01626937|Acute respiratory failure|acute respiratory failure
307936|NCT01627457|Validation Telemedical Device in regard to accuracy and safety of data|validation telemedical device in regard to accuracy and safety of data
307937|NCT01627457|Homely Rehabilitation|homely rehabilitation
307938|NCT01627457|Practicability and technical problems at home|practicability and technical problems at home
307939|NCT01627444|Acupuncture|acupuncture
307940|NCT01627444|Anxiety|anxiety
307941|NCT01627444|Human Milk|human milk
307942|NCT01627444|Very low birth weight infants|very low birth weight infants
307943|NCT01627444|Mother of very low birth weight infants|mother of very low birth weight infants
307944|NCT01627431|PAD|pad
307945|NCT01627431|Peripheral revascularization|peripheral revascularization
307946|NCT01627431|Antiplatelet therapy|antiplatelet therapy
307947|NCT01627431|Residual platelet activity|residual platelet activity
307948|NCT01627418|COPD|copd
307949|NCT01627418|CORD|cord
307950|NCT01627418|COAD|coad
307951|NCT01627379|nonresectable|nonresectable
307952|NCT01627379|advanced|advanced
307953|NCT01627379|metastatic esophageal squamous cell cancer|metastatic esophageal squamous cell cancer
307954|NCT01627379|Panitumumab|panitumumab
307955|NCT01627353|Hysterectomy|hysterectomy
307956|NCT01627353|Pain Prevention|pain prevention
307957|NCT01627353|Wound Infiltration|wound infiltration
307958|NCT01627340|hepatitis B|hepatitis b
307959|NCT01627340|adults|adults
307960|NCT01627340|Type 2 diabetes mellitus|type 2 diabetes mellitus
307961|NCT01627340|Engerix™-B|engerix™-b
307962|NCT01627327|Cardiovascular event|cardiovascular event
307963|NCT01627327|Cardiovascular disease|cardiovascular disease
308556|NCT01624805|Depo-Medrol|depo-medrol
307964|NCT01627275|Naive T Cell Depletion|naive t cell depletion
307965|NCT01627275|Donor Lymphocyte Infusion|donor lymphocyte infusion
307966|NCT01627275|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
307967|NCT01627262|diverticular disease|diverticular disease
307968|NCT01627262|colonic diverticulosis|colonic diverticulosis
307969|NCT01627262|mesalamine|mesalamine
298709|NCT01670799|Pain|pain
307970|NCT01627262|placebo|placebo
307971|NCT01627262|randomized|randomized
307972|NCT01627249|Diabetic Macular Edema|diabetic macular edema
307973|NCT01627249|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
307974|NCT01627223|Spontaneous Severe Acute Exacerbation of Chronic Hepatitis B|spontaneous severe acute exacerbation of chronic hepatitis b
307975|NCT01627223|Lamivudine (Zeffix®)|lamivudine (zeffix®)
307976|NCT01627223|Entecavir (Baraclude®)|entecavir (baraclude®)
307977|NCT01627210|Diabetes Mellitus|diabetes mellitus
307978|NCT01627197|Effects of Chemotherapy|effects of chemotherapy
307979|NCT01627145|overactive bladder syndrome|overactive bladder syndrome
307980|NCT01627145|derusor overactivity|derusor overactivity
307981|NCT01627145|urodynamic studies|urodynamic studies
307982|NCT01627145|bladder oversensitivity|bladder oversensitivity
307983|NCT01627119|CTGF|ctgf
307984|NCT01627119|Peritoneal metastasis|peritoneal metastasis
307985|NCT01627093|Head and Neck Cancer|head and neck cancer
307986|NCT01627093|Head and Neck Malignancies|head and neck malignancies
307987|NCT01627093|Chart Review|chart review
307988|NCT01627093|Proton Radiation Therapy|proton radiation therapy
307989|NCT01627080|Esophagus|esophagus
307990|NCT01627080|Esophageal Cancer|esophageal cancer
307991|NCT01627080|Radiation therapy|radiation therapy
307993|NCT01627080|Chemotherapy|chemotherapy
307994|NCT01627080|Mid thoracic tumor|mid thoracic tumor
307995|NCT01627080|Distal esophageal tumor|distal esophageal tumor
307996|NCT01627080|Gastroesophageal junction tumor|gastroesophageal junction tumor
307997|NCT01627080|Cardiac biomarkers|cardiac biomarkers
307998|NCT01627067|Breast Cancer|breast cancer
307999|NCT01627067|Hormone Receptor Positive Metastatic Breast Cancer|hormone receptor positive metastatic breast cancer
308000|NCT01627067|Hormone-sensitive|hormone-sensitive
308001|NCT01627067|Postmenopausal|postmenopausal
308002|NCT01627067|Body Mass Index|body mass index
308003|NCT01627067|BMI|bmi
308004|NCT01627067|Everolimus|everolimus
308005|NCT01627067|Afinitor|afinitor
308006|NCT01627067|RAD001|rad001
308007|NCT01627067|Exemestane|exemestane
308008|NCT01627067|Aromasin|aromasin
308009|NCT01627067|Metformin|metformin
308010|NCT01627028|Thai traditional massage|thai traditional massage
308011|NCT01627028|Bone formation|bone formation
308012|NCT01627028|Bone resorption|bone resorption
308013|NCT01627015|Fully formula fed|fully formula fed
308014|NCT01627002|Phase 1|phase 1
308015|NCT01627002|First in Human|first in human
308016|NCT01627002|Healthy Volunteers|healthy volunteers
308017|NCT01627002|Lipopolysaccharide Challenge|lipopolysaccharide challenge
308018|NCT01626976|safety|safety
308019|NCT01626976|tolerability|tolerability
308020|NCT01626976|pharmacokinetics|pharmacokinetics
308021|NCT01626976|oral|oral
308022|NCT01626976|single ascending dose|single ascending dose
308023|NCT01626976|placebo-controlled|placebo-controlled
308024|NCT01626976|healthy subjects|healthy subjects
308025|NCT01626963|single-port access|single-port access
308026|NCT01626963|laparoscopic surgery|laparoscopic surgery
308027|NCT01626963|surgical trauma|surgical trauma
308028|NCT01626950|Breast cancer|breast cancer
308029|NCT01626950|living conditions|living conditions
308030|NCT01626950|social fragility|social fragility
308330|NCT01625650|Medications|medications
308032|NCT01626937|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
308033|NCT01626937|Non invasive ventilation|non invasive ventilation
308034|NCT01626937|Out of hospital|out of hospital
308035|NCT01626924|Perinatal Asphyxia|perinatal asphyxia
308036|NCT01626924|Neonatal encephalopathy|neonatal encephalopathy
308037|NCT01626924|Oxygen shortage at birth|oxygen shortage at birth
308038|NCT01626924|Antenatal asphyxia|antenatal asphyxia
308039|NCT01626924|hypoxia-ischaemia|hypoxia-ischaemia
308040|NCT01626924|birth asphyxia|birth asphyxia
308041|NCT01626924|asphyxia neonatorum|asphyxia neonatorum
308042|NCT01626911|severe acute pancreatitis;|severe acute pancreatitis;
308043|NCT01626911|continuous regional arterial infusion;|continuous regional arterial infusion;
308044|NCT01626911|low molecular weight heparin|low molecular weight heparin
308045|NCT01626885|Schizophrenia|schizophrenia
308046|NCT01626885|Antipsychotic Agents|antipsychotic agents
308047|NCT01626885|Mental Disorder|mental disorder
308048|NCT01626885|Psychotropic Drugs|psychotropic drugs
308049|NCT01626885|Dopamine Agents|dopamine agents
308050|NCT01626885|Central Nervous System Agents|central nervous system agents
308051|NCT01626872|Schizophrenia|schizophrenia
308052|NCT01626872|Antipsychotic Agents|antipsychotic agents
308053|NCT01626872|Mental Disorder|mental disorder
308054|NCT01626872|Psychotropic Drugs|psychotropic drugs
308055|NCT01626872|Dopamine Agents|dopamine agents
308056|NCT01626872|Risperidone|risperidone
308057|NCT01626872|Central Nervous System Agents|central nervous system agents
308557|NCT01624805|Medrol|medrol
308058|NCT01626859|Schizophrenia|schizophrenia
308059|NCT01626859|Antipsychotic Agents|antipsychotic agents
308060|NCT01626859|Mental Disorder|mental disorder
308061|NCT01626859|Psychotropic Drugs|psychotropic drugs
308062|NCT01626859|Dopamine Agents|dopamine agents
382042|NCT01318044|MRI|mri
308063|NCT01626859|Central Nervous System Agents|central nervous system agents
308064|NCT01626846|Neurofibromatosis|neurofibromatosis
308065|NCT01626833|anorexia nervosa|anorexia nervosa
308066|NCT01626833|GH|gh
308067|NCT01626833|Growth velocity|growth velocity
308068|NCT01626820|Immunogenicity|immunogenicity
308069|NCT01626820|Influenza|influenza
308070|NCT01626820|Safety|safety
308071|NCT01626820|Adults|adults
308072|NCT01626820|Fluviral|fluviral
308073|NCT01626807|Safe Routes to School|safe routes to school
308074|NCT01626807|Walking School Bus|walking school bus
308075|NCT01626807|Cluster Randomized Controlled Trial|cluster randomized controlled trial
308076|NCT01626807|Physical Activity|physical activity
308077|NCT01626807|Obesity|obesity
308078|NCT01626807|Overweight|overweight
308079|NCT01626755|Phantom limb pain|phantom limb pain
308080|NCT01626755|Chronic pain|chronic pain
308081|NCT01626755|Amputation|amputation
308082|NCT01626755|Peripheral vascular disease|peripheral vascular disease
308083|NCT01626729|Food Labeling|food labeling
308084|NCT01626677|Umbilical Cord Blood|umbilical cord blood
308085|NCT01626677|Mesenchymal Stem Cells|mesenchymal stem cells
308086|NCT01626677|Cartilage injury|cartilage injury
308087|NCT01626677|Osteoarthritis|osteoarthritis
308088|NCT01626664|Adult T cell Leukemia-Lymphoma (ATL)|adult t cell leukemia-lymphoma (atl)
308089|NCT01626651|Healthy|healthy
308090|NCT01626651|Ketoconazole|ketoconazole
308091|NCT01626651|Ibrutinib|ibrutinib
308092|NCT01626638|Patients with malignant and pre-malignant pharyngo laryngeal tumors|patients with malignant and pre-malignant pharyngo laryngeal tumors
308093|NCT01626625|nonunion|nonunion
308094|NCT01626625|stem cells|stem cells
308095|NCT01626625|autograft|autograft
308096|NCT01626625|hydroxyapatite|hydroxyapatite
308097|NCT01626599|ECG|ecg
308098|NCT01626599|Accelerometer|accelerometer
308099|NCT01626599|Device|device
308100|NCT01626586|Youth|youth
308101|NCT01626586|Family|family
308102|NCT01626586|Group Therapy|group therapy
308103|NCT01626586|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
308104|NCT01626586|Self-Management|self-management
308105|NCT01626573|Rheumatoid Arthritis|rheumatoid arthritis
308106|NCT01626573|RA|ra
308108|NCT01626547|symptomatic anameia|symptomatic anameia
308109|NCT01626508|breast milk|breast milk
308110|NCT01626508|breast-milk bank|breast-milk bank
308111|NCT01626508|plasma profile|plasma profile
308112|NCT01626508|essential fatty acids|essential fatty acids
308113|NCT01626495|Biological: CART19|biological: cart19
308114|NCT01626443|PCOS|pcos
308115|NCT01626443|Metabolic disorders|metabolic disorders
308116|NCT01626443|Ovarian functionality|ovarian functionality
308117|NCT01626443|Myo-inositol|myo-inositol
308118|NCT01626443|D-chiro-inositol|d-chiro-inositol
308119|NCT01626430|Gamma delta TRF|gamma delta trf
308120|NCT01626430|Insulin sensitivity|insulin sensitivity
308121|NCT01626430|Postprandial lipaemia|postprandial lipaemia
308122|NCT01626430|Inflammatory markers|inflammatory markers
308123|NCT01626430|NF-κB|nf-κb
308124|NCT01626417|Stroke|stroke
308125|NCT01626417|Tibion|tibion
308126|NCT01626417|Bionics|bionics
308127|NCT01626417|Rehab|rehab
308128|NCT01626417|Therapy|therapy
308129|NCT01626417|Robotics|robotics
308130|NCT01626417|Intention|intention
308131|NCT01626404|Thoratec Corporation|thoratec corporation
308427|NCT01625260|p53 gene|p53 gene
308132|NCT01626391|Alzheimer's Disease|alzheimer's disease
308133|NCT01626391|TRx0237|trx0237
308134|NCT01626391|Safety Study|safety study
308136|NCT01626378|Behavioral Variant Frontotemporal Dementia|behavioral variant frontotemporal dementia
308137|NCT01626378|bvFTD|bvftd
308138|NCT01626378|Frontotemporal Dementia|frontotemporal dementia
308139|NCT01626365|double-lumen tube|double-lumen tube
308140|NCT01626365|intubation|intubation
308141|NCT01626365|thermosoftening|thermosoftening
308142|NCT01626352|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
308143|NCT01626352|Ofatumumab|ofatumumab
308144|NCT01626352|Bendamustine|bendamustine
308145|NCT01626339|Anti vascular endothelial growth factor|anti vascular endothelial growth factor
308146|NCT01626339|retinal vessels|retinal vessels
308147|NCT01626326|smoking|smoking
308148|NCT01626326|smoking cessation|smoking cessation
308149|NCT01626326|mobile app|mobile app
308150|NCT01626313|Veteran families|veteran families
308151|NCT01626313|OEF|oef
308152|NCT01626313|OIF|oif
308153|NCT01626313|OND|ond
308154|NCT01626313|Resiliency|resiliency
308155|NCT01626313|Psycho educational training|psycho educational training
308156|NCT01626313|Stress|stress
308157|NCT01626313|Military|military
308158|NCT01626287|perineal|perineal
308159|NCT01626287|postpartum|postpartum
308160|NCT01626287|pain|pain
308161|NCT01626287|treatment|treatment
308162|NCT01626287|ice and black tea|ice and black tea
308558|NCT01624805|Solu-Medrol|solu-medrol
308163|NCT01626287|maternal satisfaction|maternal satisfaction
308164|NCT01626274|Polysomnography|polysomnography
308165|NCT01626274|Long term vital signs monitoring|long term vital signs monitoring
308166|NCT01626274|In-ear sensor system|in-ear sensor system
308167|NCT01626274|Photoplethysmographic micro-optic device|photoplethysmographic micro-optic device
308168|NCT01626274|High wearing comfort|high wearing comfort
308169|NCT01626248|Immunological|immunological
308170|NCT01626248|biomarkers|biomarkers
308171|NCT01626248|observational|observational
308172|NCT01626248|RRMS|rrms
308173|NCT01626248|Relapsing|relapsing
308174|NCT01626248|Remitting Multiple Sclerosis|remitting multiple sclerosis
308175|NCT01626235|pain control|pain control
308176|NCT01626235|fractures|fractures
308177|NCT01626235|sprains|sprains
308178|NCT01626235|strains|strains
308179|NCT01626235|dysmenorrhea|dysmenorrhea
308180|NCT01626235|kidney stones|kidney stones
308181|NCT01626235|gouty arthritis|gouty arthritis
308182|NCT01626235|opioids|opioids
308183|NCT01626235|NSDAIDs|nsdaids
308184|NCT01626235|Emergency Department|emergency department
308185|NCT01626235|patient reported outcomes|patient reported outcomes
308186|NCT01626222|Postmenopausal|postmenopausal
308187|NCT01626222|Estrogen Receptor Positive|estrogen receptor positive
308188|NCT01626222|HER2 negative|her2 negative
308189|NCT01626222|Locally Advanced|locally advanced
308190|NCT01626222|Metastatic Breast Cancer|metastatic breast cancer
308191|NCT01626222|Everolimus (RAD001)|everolimus (rad001)
308192|NCT01626222|Exemestane|exemestane
308193|NCT01626209|Breast cancer, NSCLC, SCCHN, esophageal cancer|breast cancer, nsclc, scchn, esophageal cancer
308194|NCT01626183|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
308195|NCT01626183|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
308196|NCT01626144|Exemestane|exemestane
308197|NCT01626144|Metabolism|metabolism
308198|NCT01626144|Metabolizing enzyme genotype|metabolizing enzyme genotype
308199|NCT01626144|Breast cancer|breast cancer
308200|NCT01626131|combat disorders|combat disorders
308201|NCT01626131|exercise therapy|exercise therapy
308202|NCT01626105|Hemophilia A|hemophilia a
308203|NCT01626105|Factor VIII|factor viii
308204|NCT01626105|Inhibitors|inhibitors
308205|NCT01626105|Immunogenicity|immunogenicity
308206|NCT01626105|Pharmacogenetics|pharmacogenetics
308207|NCT01626105|Mutation|mutation
307873|NCT01627717|HIV|hiv
308208|NCT01626105|Nonsynonymous Single Nucleotide Polymorphisms|nonsynonymous single nucleotide polymorphisms
308209|NCT01626105|Class II Human Leukocyte Antigens|class ii human leukocyte antigens
308210|NCT01626092|bone marrow transplantation|bone marrow transplantation
308211|NCT01626092|reduced intensity conditioning|reduced intensity conditioning
308212|NCT01626092|Adrenoleukodystrophy|adrenoleukodystrophy
308213|NCT01626092|Metachromatic Leukodystrophy|metachromatic leukodystrophy
308214|NCT01626092|Globoid Cell Leukodystrophy|globoid cell leukodystrophy
308215|NCT01626092|Wolman's disease|wolman's disease
308216|NCT01626092|GM1 gangliosidosis|gm1 gangliosidosis
308217|NCT01626092|Tay Sachs disease|tay sachs disease
308218|NCT01626092|Sanfilippo syndrome|sanfilippo syndrome
308219|NCT01626092|Sandhoff disease|sandhoff disease
308220|NCT01626092|inherited metabolic|inherited metabolic
308221|NCT01626092|I-cell disease|i-cell disease
308222|NCT01626092|mucolipidosis II|mucolipidosis ii
308223|NCT01626079|Functional Mitral Regurgitation|functional mitral regurgitation
308224|NCT01626079|Mitral Valve Regurgitation|mitral valve regurgitation
308225|NCT01626079|Symptomatic Heart Failure|symptomatic heart failure
308226|NCT01626079|Functional MR|functional mr
308227|NCT01626079|MitraClip|mitraclip
308228|NCT01626079|Mitral Valve Insufficiency|mitral valve insufficiency
308229|NCT01626079|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
308230|NCT01626079|COAPT CAS|coapt cas
308231|NCT01626079|COAPT Continued Access Study|coapt continued access study
308232|NCT01626079|MitraClip NT|mitraclip nt
308233|NCT01626053|psychological|psychological
308234|NCT01626053|intervention|intervention
308235|NCT01626053|stages of change|stages of change
308236|NCT01626053|motivational interviewing|motivational interviewing
308237|NCT01626053|coping skills|coping skills
308239|NCT01626053|psychological testing|psychological testing
308240|NCT01626053|integrated care|integrated care
308241|NCT01626053|behavioral health|behavioral health
308242|NCT01626027|Coronary Heart Disease|coronary heart disease
308243|NCT01626027|Depression|depression
308244|NCT01626027|Health Care Services|health care services
308245|NCT01626014|Stage III ovarian cancer|stage iii ovarian cancer
308246|NCT01626014|Stage IV ovarian cancer|stage iv ovarian cancer
308247|NCT01626014|recurrent ovarian cancer|recurrent ovarian cancer
308248|NCT01626014|primary peritoneal cancer|primary peritoneal cancer
308249|NCT01626014|fallopian tube cancer|fallopian tube cancer
308250|NCT01626001|Esophagus Cancer|esophagus cancer
308251|NCT01626001|Lung Cancer|lung cancer
308252|NCT01626001|4-dimensional computed tomography|4-dimensional computed tomography
308253|NCT01626001|4D CT|4d ct
308254|NCT01625975|Growth modulation|growth modulation
308255|NCT01625975|Eight plate|eight plate
308663|NCT01624311|Poor suck|poor suck
308256|NCT01625975|Leg length discrepancy|leg length discrepancy
308257|NCT01625975|Varus/valgus deformities|varus/valgus deformities
382311|NCT01316874|CIS|cis
308258|NCT01625975|Pediatric|pediatric
308259|NCT01625962|PTSD|ptsd
308260|NCT01625962|mTBI|mtbi
308261|NCT01625962|mild TBI|mild tbi
308262|NCT01625962|extracranial injury|extracranial injury
308263|NCT01625962|ECI|eci
308264|NCT01625962|Brain Indices|brain indices
308265|NCT01625949|myocardial infarction|myocardial infarction
308266|NCT01625936|metastatic|metastatic
308267|NCT01625936|locally advanced|locally advanced
308268|NCT01625936|unresectable|unresectable
308269|NCT01625923|Gastroparesis|gastroparesis
308270|NCT01625923|Idiopathic|idiopathic
308271|NCT01625923|Olanzapine|olanzapine
308272|NCT01625910|Childhood obesity treatment|childhood obesity treatment
308273|NCT01625910|Motivational interviewing|motivational interviewing
308274|NCT01625897|Schizophrenia|schizophrenia
308275|NCT01625897|Antipsychotic Agents|antipsychotic agents
308276|NCT01625897|Mental Disorder|mental disorder
308277|NCT01625897|Psychotropic Drugs|psychotropic drugs
308278|NCT01625897|Dopamine Agents|dopamine agents
308279|NCT01625897|Risperidone|risperidone
308280|NCT01625897|Central Nervous System Agents|central nervous system agents
308281|NCT01625884|Statin|statin
308282|NCT01625884|Hypercholesterolemia|hypercholesterolemia
308283|NCT01625871|malaria|malaria
308284|NCT01625871|vivax|vivax
308285|NCT01625871|artemether/lumefantrine|artemether/lumefantrine
308286|NCT01625871|Sudan|sudan
308287|NCT01625858|LMA Supreme|lma supreme
308288|NCT01625845|Major Depressive Disorder|major depressive disorder
308289|NCT01625845|Depression|depression
308290|NCT01625845|Depressive Symptoms|depressive symptoms
308291|NCT01625845|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
308292|NCT01625845|Coronary Artery Disease (CAD)|coronary artery disease (cad)
308293|NCT01625845|Heart Disease|heart disease
308294|NCT01625845|Endothelial Function|endothelial function
308295|NCT01625845|Inflammation|inflammation
308296|NCT01625832|intermittent coronary sinus occlusion|intermittent coronary sinus occlusion
308297|NCT01625832|collateral flow index|collateral flow index
308298|NCT01625832|collateral circulation|collateral circulation
308299|NCT01625832|coronary artery occlusion|coronary artery occlusion
308300|NCT01625819|Tai Chi|tai chi
308301|NCT01625793|Hepatitis C|hepatitis c
308302|NCT01625793|interferon|interferon
308303|NCT01625793|stress|stress
308304|NCT01625793|social behavior|social behavior
308305|NCT01625767|Nicotine|nicotine
308306|NCT01625767|Smoking|smoking
308307|NCT01625767|Adolescent|adolescent
308308|NCT01625767|Tobacco|tobacco
308309|NCT01625754|Ceramides|ceramides
308310|NCT01625754|Lipids|lipids
308311|NCT01625728|Voice|voice
308312|NCT01625728|aerodynamics|aerodynamics
308313|NCT01625728|acoustics|acoustics
308314|NCT01625715|peanut allergy|peanut allergy
308315|NCT01625702|no-prior chemotherapy|no-prior chemotherapy
308316|NCT01625689|Influenza vaccines|influenza vaccines
308317|NCT01625689|Influenza, Human|influenza, human
308318|NCT01625689|Live Attenuated Influenza Vaccine|live attenuated influenza vaccine
308319|NCT01625676|Aphasia|aphasia
308320|NCT01625676|Rehabilitation of Speech and Language Disorders|rehabilitation of speech and language disorders
308321|NCT01625663|barth syndrome|barth syndrome
308322|NCT01625663|heart failure|heart failure
308323|NCT01625663|mitochondria|mitochondria
308324|NCT01625663|metabolism|metabolism
308325|NCT01625663|amino acid|amino acid
308326|NCT01625650|Rheumatoid Arthritis|rheumatoid arthritis
308327|NCT01625650|Registry|registry
308328|NCT01625650|RA|ra
308329|NCT01625650|Biologic|biologic
308331|NCT01625650|Rheumatology|rheumatology
308332|NCT01625637|Nicotine|nicotine
308333|NCT01625637|Smoking|smoking
308334|NCT01625637|Adolescent|adolescent
308335|NCT01625637|Tobacco|tobacco
308336|NCT01625611|Alcohol|alcohol
308337|NCT01625611|Drinking|drinking
308338|NCT01625611|Drinkers|drinkers
308339|NCT01625611|Alcohol Drinking|alcohol drinking
308340|NCT01625611|Naltrexone|naltrexone
308341|NCT01625611|Alcohol Dependence|alcohol dependence
308342|NCT01625611|Alcohol Abuse|alcohol abuse
308343|NCT01625611|Alcohol-Related Disorders|alcohol-related disorders
308344|NCT01625611|Ethanol|ethanol
308345|NCT01625611|Alcoholism|alcoholism
308346|NCT01625598|Nonproliferative diabetic retinopathy|nonproliferative diabetic retinopathy
308347|NCT01625598|diabetic macular edema|diabetic macular edema
308348|NCT01625598|proliferative diabetic retinopathy|proliferative diabetic retinopathy
308349|NCT01625598|ophthalmologists|ophthalmologists
308350|NCT01625598|dilated eye exam|dilated eye exam
308351|NCT01625585|Push-and-Pull Enteroscopy|push-and-pull enteroscopy
308352|NCT01625585|Single-Balloon-Enteroscopy|single-balloon-enteroscopy
308353|NCT01625572|general anaesthesia|general anaesthesia
308354|NCT01625572|epidural catheter|epidural catheter
308355|NCT01625572|intravenous pain therapy|intravenous pain therapy
707546|NCT00997867|Popliteal|popliteal
308356|NCT01625546|Major Depressive Disorder|major depressive disorder
308357|NCT01625546|Whole Body Hyperthermia|whole body hyperthermia
308358|NCT01625533|Coronary Angiography|coronary angiography
299121|NCT01668901|aspirin|aspirin
308359|NCT01625533|Rotational Coronary Angiography|rotational coronary angiography
308360|NCT01625533|Contrast media|contrast media
308361|NCT01625533|Radiation|radiation
308362|NCT01625520|Progressive metastatic|progressive metastatic
308363|NCT01625520|postoperative persistent|postoperative persistent
308364|NCT01625468|Secondhand smoke exposure|secondhand smoke exposure
308365|NCT01625468|Smoke-free homes|smoke-free homes
308366|NCT01625468|Smoke-free home bans|smoke-free home bans
308367|NCT01625455|Sezary Syndrome|sezary syndrome
308368|NCT01625455|Pruritus|pruritus
308369|NCT01625455|Aprepitant|aprepitant
308370|NCT01625455|Neurokinin-1|neurokinin-1
308371|NCT01625442|Metabolic syndrome|metabolic syndrome
308372|NCT01625442|hypercholesterolemia|hypercholesterolemia
308373|NCT01625442|hypertriglyceridemia|hypertriglyceridemia
308374|NCT01625442|hyperglycemia|hyperglycemia
308375|NCT01625416|Posttraumatic Stress Disorder|posttraumatic stress disorder
308376|NCT01625416|Depression|depression
308377|NCT01625416|Suicide|suicide
308378|NCT01625416|Traumatic Brain Injury|traumatic brain injury
308379|NCT01625416|Alcohol Use|alcohol use
308380|NCT01625416|Drug Use|drug use
308381|NCT01625416|Information Technology|information technology
308382|NCT01625403|Recombinant BNP|recombinant bnp
308383|NCT01625403|Diuretics|diuretics
308384|NCT01625403|Acute decompensated heart failure|acute decompensated heart failure
308385|NCT01625403|Acute renal injury|acute renal injury
308386|NCT01625403|Heart function|heart function
308387|NCT01625403|Renal function|renal function
308388|NCT01625390|hemophilia, haemophilia, inhibitor, FVIIa, Factor VII activated, bypassing|hemophilia, haemophilia, inhibitor, fviia, factor vii activated, bypassing
308389|NCT01625377|Everolimus,|everolimus,
308390|NCT01625377|liver transplantation,|liver transplantation,
308391|NCT01625377|early introduction,|early introduction,
308392|NCT01625377|renal function|renal function
308393|NCT01625364|Health Education|health education
308394|NCT01625364|Health Counseling|health counseling
308395|NCT01625364|Patient Education|patient education
308396|NCT01625338|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
308397|NCT01625338|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
308398|NCT01625338|HCV|hcv
308399|NCT01625338|Sustained Virologic Response|sustained virologic response
308400|NCT01625338|Direct Acting Antiviral|direct acting antiviral
308401|NCT01625338|Combination Therapy|combination therapy
308402|NCT01625338|GS-7977|gs-7977
308403|NCT01625338|Ribavirin|ribavirin
308404|NCT01625338|Open Label|open label
308405|NCT01625325|obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life|obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life
308406|NCT01625299|intestinal permeability|intestinal permeability
308408|NCT01625299|gluten|gluten
308409|NCT01625299|dairy|dairy
308410|NCT01625286|advanced breast cancer,|advanced breast cancer,
308411|NCT01625286|metastatic breast cancer,|metastatic breast cancer,
308412|NCT01625286|ER+ve breast cancer,|er+ve breast cancer,
308413|NCT01625286|Estrogen receptor positive breast cancer,|estrogen receptor positive breast cancer,
308414|NCT01625286|PIK3CA mutated advanced or metastatic breast cancer|pik3ca mutated advanced or metastatic breast cancer
308415|NCT01625286|AKT inhibitor|akt inhibitor
308416|NCT01625273|F19|f19
308417|NCT01625273|Lactobacillus paracasei paracasei|lactobacillus paracasei paracasei
308418|NCT01625260|cancer|cancer
308419|NCT01625260|immunotherapy|immunotherapy
308420|NCT01625260|targeted|targeted
308421|NCT01625260|non-muscle invasive|non-muscle invasive
308422|NCT01625260|interleukin-2|interleukin-2
308423|NCT01625260|antitumor|antitumor
308424|NCT01625260|TCR|tcr
308425|NCT01625260|T-cell receptor|t-cell receptor
308426|NCT01625260|p53|p53
308428|NCT01625260|p53 tumor supressor protein|p53 tumor supressor protein
308429|NCT01625260|urothelial cancer|urothelial cancer
308430|NCT01625260|bladder cancer|bladder cancer
308431|NCT01625260|HLA-A2 positive|hla-a2 positive
308432|NCT01625260|HLA-A*0201/p53 aa264-272|hla-a*0201/p53 aa264-272
308433|NCT01625260|HLA complex|hla complex
308434|NCT01625260|refractory|refractory
308435|NCT01625260|relapsed|relapsed
308436|NCT01625260|BCG|bcg
308437|NCT01625260|multi-focal|multi-focal
308438|NCT01625260|carcinoma in situ|carcinoma in situ
308439|NCT01625260|transitional cell carcinoma|transitional cell carcinoma
308440|NCT01625260|gemcitabine|gemcitabine
308441|NCT01625234|Cancer|cancer
308442|NCT01625234|Tumors|tumors
308443|NCT01625234|ALK|alk
308444|NCT01625234|NSCLC|nsclc
308445|NCT01625234|Advanced Malignancies|advanced malignancies
308446|NCT01625234|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
308447|NCT01625234|Inflammatory Myofibroblastic Tumors|inflammatory myofibroblastic tumors
308448|NCT01625221|FENIX|fenix
308575|NCT01624766|RAD001|rad001
308449|NCT01625182|chronic inflammatory demyelinating polyradiculoneuropathy, CIDP, FTY720, fingolimod.|chronic inflammatory demyelinating polyradiculoneuropathy, cidp, fty720, fingolimod.
308450|NCT01625169|Pharmacokinetics|pharmacokinetics
308451|NCT01625169|HIV|hiv
308452|NCT01625169|Breast milk|breast milk
308453|NCT01625130|sulforaphane|sulforaphane
308454|NCT01625130|ozone|ozone
308455|NCT01625130|airway inflammation|airway inflammation
308456|NCT01625130|broccoli sprouts|broccoli sprouts
308457|NCT01625130|NRF2|nrf2
308458|NCT01625130|controls|controls
308459|NCT01625117|Treatment of ex-combatants|treatment of ex-combatants
308460|NCT01625117|Narrative Exposure Therapy for ex-combatants|narrative exposure therapy for ex-combatants
308461|NCT01625117|Appetitive Aggression|appetitive aggression
308462|NCT01625117|Posttraumatic Stress Disorder|posttraumatic stress disorder
308463|NCT01625104|Myocardial Infarction|myocardial infarction
308464|NCT01625104|Time to Treatment|time to treatment
308465|NCT01625104|Door to Balloon Time|door to balloon time
308466|NCT01625091|HIV|hiv
308467|NCT01625091|women|women
308468|NCT01625091|drinking|drinking
308469|NCT01625091|Naltrexone|naltrexone
308470|NCT01625078|Baska Mask|baska mask
308471|NCT01625078|Supraglottic airway device|supraglottic airway device
308472|NCT01625078|Children|children
308473|NCT01625078|Pediatric|pediatric
308474|NCT01625065|medication compliance|medication compliance
308475|NCT01625065|adherence|adherence
308476|NCT01625065|toxicological analyzes|toxicological analyzes
308477|NCT01625065|GC-MS|gc-ms
308478|NCT01625065|HPLC|hplc
308479|NCT01625065|pain patients|pain patients
308480|NCT01625065|opioid misuse|opioid misuse
308481|NCT01625065|patients with current pain|patients with current pain
308482|NCT01625052|mask size|mask size
308483|NCT01625052|Baska mask|baska mask
308484|NCT01625052|supraglottic airway|supraglottic airway
308485|NCT01625052|airway management|airway management
308486|NCT01625039|Occupational health|occupational health
308487|NCT01625039|cognitive behavioural therapy|cognitive behavioural therapy
308488|NCT01625039|physiotherapy|physiotherapy
308489|NCT01625039|physical activity|physical activity
308490|NCT01625026|Morbidly obesity|morbidly obesity
308491|NCT01625026|Gastric bypass|gastric bypass
308492|NCT01625026|Cholecystolithiasis|cholecystolithiasis
308493|NCT01625013|osteoarthritis|osteoarthritis
308494|NCT01625013|viscosupplementation|viscosupplementation
308495|NCT01625013|Active|active
308496|NCT01625013|Knee|knee
308497|NCT01625013|Synvisc-One|synvisc-one
308498|NCT01625000|Schizophrenia|schizophrenia
308499|NCT01625000|Antipsychotic Agents|antipsychotic agents
308500|NCT01625000|Acute Schizophrenia|acute schizophrenia
308501|NCT01625000|Mental Disorder|mental disorder
308502|NCT01625000|Psychotropic Drugs|psychotropic drugs
308503|NCT01625000|Dopamine Agents|dopamine agents
308505|NCT01625000|Central Nervous System Agents|central nervous system agents
308506|NCT01624987|Treatment of ex-combatants|treatment of ex-combatants
308507|NCT01624987|FORNET for ex-combatants|fornet for ex-combatants
308508|NCT01624987|Appetitive Aggression|appetitive aggression
308509|NCT01624987|Post-traumatic Stress Disorder|post-traumatic stress disorder
308510|NCT01624961|Controlled human malaria infection (CHMI)|controlled human malaria infection (chmi)
308511|NCT01624961|Malaria challenge|malaria challenge
308512|NCT01624961|Plasmodium falciparum|plasmodium falciparum
308513|NCT01624961|PfSPZ Challenge|pfspz challenge
308514|NCT01624948|BK virus|bk virus
308515|NCT01624948|Kidney Transplantation|kidney transplantation
308516|NCT01624948|Immunologic Monitoring|immunologic monitoring
308517|NCT01624935|PTSD|ptsd
308518|NCT01624935|earthquake|earthquake
308519|NCT01624935|disaster|disaster
308520|NCT01624935|global mental health|global mental health
308521|NCT01624935|disaster mental health|disaster mental health
308522|NCT01624935|depression|depression
308523|NCT01624870|Aortic Valve Stenonis|aortic valve stenonis
308524|NCT01624870|Valvular Heart Disease|valvular heart disease
308525|NCT01624870|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
308528|NCT01624831|schizophrenia|schizophrenia
308529|NCT01624831|schizoaffective disorder|schizoaffective disorder
308530|NCT01624831|Bipolar disorder with psychotic features|bipolar disorder with psychotic features
308531|NCT01624831|Major depression with psychotic features|major depression with psychotic features
308532|NCT01624831|Psychosis NOS|psychosis nos
308533|NCT01624831|Social Cognition|social cognition
308534|NCT01624818|coping|coping
308535|NCT01624818|physical activity|physical activity
308536|NCT01624818|psychosocial|psychosocial
308537|NCT01624818|children|children
308538|NCT01624818|heart disease|heart disease
308539|NCT01624818|habilitation|habilitation
308540|NCT01624805|Leukemia|leukemia
308541|NCT01624805|Aplastic Anemia|aplastic anemia
308542|NCT01624805|AA|aa
308543|NCT01624805|Low/Int-1 Risk Myelodysplastic Syndrome|low/int-1 risk myelodysplastic syndrome
308544|NCT01624805|MDS|mds
308545|NCT01624805|hATG|hatg
308546|NCT01624805|Horse Antithymocyte Globulin|horse antithymocyte globulin
308547|NCT01624805|ATG|atg
308548|NCT01624805|Antithymocyte Globulin|antithymocyte globulin
308549|NCT01624805|Thymoglobulin|thymoglobulin
308550|NCT01624805|Cyclosporine|cyclosporine
308551|NCT01624805|Sandimmune|sandimmune
308552|NCT01624805|CYA|cya
308553|NCT01624805|Cyclosporin A|cyclosporin a
308554|NCT01624805|Methylprednisone|methylprednisone
308555|NCT01624805|Methylprednisolone|methylprednisolone
299301|NCT01668069|nausea|nausea
308559|NCT01624805|pegfilgrastim|pegfilgrastim
308560|NCT01624805|Neulasta|neulasta
308561|NCT01624805|PEG-G-CSF|peg-g-csf
308562|NCT01624805|Filgrastim|filgrastim
308563|NCT01624805|C-CSF|c-csf
308564|NCT01624805|Neupogen|neupogen
308565|NCT01624792|Protein metabolism|protein metabolism
308566|NCT01624792|casein protein|casein protein
308567|NCT01624792|EPA|epa
308568|NCT01624792|Fish oil|fish oil
308569|NCT01624779|autologous adipose tissue|autologous adipose tissue
308570|NCT01624766|Advanced Cancers|advanced cancers
308571|NCT01624766|Advanced Malignancies|advanced malignancies
308572|NCT01624766|Metastatic Cancers|metastatic cancers
308573|NCT01624766|Everolimus|everolimus
308574|NCT01624766|Afinitor|afinitor
308576|NCT01624766|Anakinra|anakinra
308577|NCT01624766|Kineret|kineret
308578|NCT01624766|Denosumab|denosumab
308579|NCT01624766|AMG 162|amg 162
308580|NCT01624753|interstitial lung disease|interstitial lung disease
308581|NCT01624753|interstitial pneumonia|interstitial pneumonia
308582|NCT01624753|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
308583|NCT01624727|Coronary heart disease|coronary heart disease
308584|NCT01624727|metabolic syndrome|metabolic syndrome
308585|NCT01624727|CT angiography|ct angiography
308586|NCT01624714|Treatment Refractory|treatment refractory
308587|NCT01624701|Cord blood|cord blood
308588|NCT01624701|unrelated donor|unrelated donor
308589|NCT01624701|allogeneic|allogeneic
308590|NCT01624701|cell dose|cell dose
308591|NCT01624688|Tattoo|tattoo
308592|NCT01624688|Tattoo Removal|tattoo removal
308593|NCT01624675|Autistic disorder in children and adolescents|autistic disorder in children and adolescents
308594|NCT01624675|Risperidone (R064766)|risperidone (r064766)
308595|NCT01624675|Children|children
308596|NCT01624675|Adolescents|adolescents
308597|NCT01624675|Irritability|irritability
308598|NCT01624675|Autistic disorder|autistic disorder
308599|NCT01624649|Attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
308600|NCT01624649|Developmental disorder|developmental disorder
308601|NCT01624649|Atomoxetine|atomoxetine
308602|NCT01624649|Methylphenidate|methylphenidate
308603|NCT01624649|Psychiatric disorder|psychiatric disorder
308604|NCT01624636|AMD|amd
308605|NCT01624636|Age-related Macular Degeneration|age-related macular degeneration
308607|NCT01624636|Neovascular AMD|neovascular amd
308608|NCT01624623|radiation|radiation
308609|NCT01624623|Calypso|calypso
308610|NCT01624623|prostatectomy|prostatectomy
308611|NCT01624610|Irritable bowel syndrome|irritable bowel syndrome
308612|NCT01624610|Diarrhea|diarrhea
308613|NCT01624610|abdominal pain|abdominal pain
308614|NCT01624610|diet|diet
308615|NCT01624610|nutrition|nutrition
308616|NCT01624597|Road traffic safety|road traffic safety
308617|NCT01624584|child|child
308618|NCT01624584|anxiety|anxiety
308619|NCT01624584|CBT|cbt
308620|NCT01624558|malignant hyperthermia|malignant hyperthermia
308621|NCT01624545|chronic subdural hematoma|chronic subdural hematoma
308622|NCT01624545|burr hole trepanation|burr hole trepanation
308623|NCT01624545|radiologic follow-up|radiologic follow-up
308624|NCT01624545|outcome|outcome
308625|NCT01624545|recurrence|recurrence
308626|NCT01624532|Anthrax vaccine|anthrax vaccine
308627|NCT01624519|Arterial Lactate|arterial lactate
308628|NCT01624519|Central Venous Lactate|central venous lactate
308629|NCT01624519|Peripheral Venous Lactate|peripheral venous lactate
308630|NCT01624506|GERD|gerd
308631|NCT01624506|Fundoplication|fundoplication
308632|NCT01624506|Magnetic Sphincter Augmentation|magnetic sphincter augmentation
308633|NCT01624493|Vascular Disrupting Agents|vascular disrupting agents
308634|NCT01624493|BNC105P|bnc105p
308635|NCT01624493|Partially platinum sensitive|partially platinum sensitive
308636|NCT01624480|Pediatric Narcolepsy|pediatric narcolepsy
308637|NCT01624467|Advanced Solid Tumors|advanced solid tumors
308638|NCT01624454|colonoscopy|colonoscopy
308639|NCT01624454|bowel cleansing|bowel cleansing
308640|NCT01624428|Tobacco|tobacco
308641|NCT01624428|Adolescent|adolescent
308642|NCT01624428|Nicotine|nicotine
308643|NCT01624428|Magnetic Resonance Imaging|magnetic resonance imaging
308644|NCT01624428|Varenicline|varenicline
308645|NCT01624389|[18F]AV-45 PET amyloid binding imaging|[18f]av-45 pet amyloid binding imaging
308646|NCT01624389|Alzheimer's disease|alzheimer's disease
308647|NCT01624376|non-invasive management|non-invasive management
308648|NCT01624376|Fistula|fistula
308649|NCT01624376|Crohn's Disease|crohn's disease
308650|NCT01624376|local administration|local administration
308651|NCT01624376|non-invasive|non-invasive
308652|NCT01624363|Pancreatic cysts incidentally found during EUS|pancreatic cysts incidentally found during eus
308653|NCT01624350|Anorectal Fistulas|anorectal fistulas
308654|NCT01624337|Plasmodium falciparum|plasmodium falciparum
308655|NCT01624337|Plasmodium vivax|plasmodium vivax
308656|NCT01624324|aminoglycoside|aminoglycoside
308657|NCT01624324|KIM-1|kim-1
308658|NCT01624324|DPOAE|dpoae
308659|NCT01624324|nephrotoxicity|nephrotoxicity
308660|NCT01624324|ototoxicity|ototoxicity
308661|NCT01624311|High ammonia level|high ammonia level
308662|NCT01624311|Hyperammonemia|hyperammonemia
308664|NCT01624311|Lethargy|lethargy
308665|NCT01624311|Coma|coma
308666|NCT01624311|Encephalopathy|encephalopathy
308667|NCT01624311|Seizures|seizures
308668|NCT01624311|Brain edema|brain edema
308669|NCT01624311|Urea Cycle Disorder|urea cycle disorder
308670|NCT01624311|Ornithine Transcarbamylase Deficiency|ornithine transcarbamylase deficiency
308671|NCT01624311|Carbamoyl Phosphate Synthetase Deficiency|carbamoyl phosphate synthetase deficiency
308672|NCT01624311|Citrullinemia|citrullinemia
308673|NCT01624311|Argininosuccinic Aciduria|argininosuccinic aciduria
308674|NCT01624311|Organic Acidemia|organic acidemia
308675|NCT01624311|Propionic Aciduria|propionic aciduria
308676|NCT01624311|Methylmalonic Aciduria|methylmalonic aciduria
308677|NCT01624311|Isovaleric Aciduria|isovaleric aciduria
308678|NCT01624298|Randomized controlled trial|randomized controlled trial
308679|NCT01624298|Traumatized youth|traumatized youth
308680|NCT01624298|HIV risk|hiv risk
308681|NCT01624272|Physical Therapy|physical therapy
308682|NCT01624272|Respiratory Muscle Training|respiratory muscle training
308683|NCT01624272|Elderly|elderly
308684|NCT01624220|Spinal tumor|spinal tumor
308685|NCT01624220|Tumor of the mid or lower spine|tumor of the mid or lower spine
308686|NCT01624220|Non-small cell lung cancer|non-small cell lung cancer
308687|NCT01624220|Breast cancer|breast cancer
308688|NCT01624220|Prostate cancer|prostate cancer
308689|NCT01624220|Renal cell cancer|renal cell cancer
308690|NCT01624220|Melanoma|melanoma
308691|NCT01624220|Gastrointestinal cancer|gastrointestinal cancer
308692|NCT01624220|Sarcoma|sarcoma
308693|NCT01624220|Thyroid cancer|thyroid cancer
308694|NCT01624220|Head and neck primary cancer|head and neck primary cancer
308695|NCT01624220|Carcinoma of unknown primary|carcinoma of unknown primary
308696|NCT01624220|Fiducial markers|fiducial markers
308697|NCT01624220|Gold seed markers|gold seed markers
308698|NCT01624220|Spinal stereotactic body radiation therapy|spinal stereotactic body radiation therapy
308699|NCT01624220|Spinal SBRT|spinal sbrt
308700|NCT01624220|Stereotactic Radiotherapy|stereotactic radiotherapy
308701|NCT01624207|Atorva|atorva
308702|NCT01624207|generic|generic
308703|NCT01624207|atorvastatin|atorvastatin
308704|NCT01624207|hypercholesterolemia|hypercholesterolemia
308705|NCT01624181|ion mobility spectrometry|ion mobility spectrometry
308706|NCT01624181|hospital-acquired pneumonia|hospital-acquired pneumonia
308707|NCT01624181|microbiological investigation|microbiological investigation
308708|NCT01624181|intensive care|intensive care
308710|NCT01624168|sleep quality|sleep quality
308711|NCT01624168|tai chi chuan|tai chi chuan
308712|NCT01624168|young adults|young adults
308713|NCT01624155|teratogens|teratogens
308714|NCT01624155|contraception|contraception
308715|NCT01624155|electronic medical record|electronic medical record
308716|NCT01624142|Hypercholesterolemia|hypercholesterolemia
308717|NCT01624142|Elevated Cholesterol|elevated cholesterol
308718|NCT01624142|High Cholesterol|high cholesterol
308719|NCT01624142|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
308720|NCT01624142|PCSK9 mutations|pcsk9 mutations
308721|NCT01624142|Severe Familial Hypercholesterolemia|severe familial hypercholesterolemia
308722|NCT01624103|Arm Injuries|arm injuries
308723|NCT01624103|Wounds and Injuries|wounds and injuries
308724|NCT01624103|Lidocaine|lidocaine
308725|NCT01624103|Levobupivacaine|levobupivacaine
308726|NCT01624103|Bupivacaine|bupivacaine
308727|NCT01624103|Anesthetics|anesthetics
308728|NCT01624103|Central Nervous System Depressants|central nervous system depressants
308939|NCT01623063|infertility|infertility
308729|NCT01624103|Physiological Effects of Drugs|physiological effects of drugs
308730|NCT01624090|Cancer Stem Cell|cancer stem cell
308731|NCT01624090|Thoracic Malignancies|thoracic malignancies
308732|NCT01624090|Mythramycin Treatment|mythramycin treatment
308733|NCT01624090|Lung Tumors|lung tumors
308734|NCT01624090|Metastatic Lung Tumors|metastatic lung tumors
308735|NCT01624077|Regulatory T cells|regulatory t cells
308736|NCT01624077|Liver Transplantation|liver transplantation
308737|NCT01624077|Rejection|rejection
308738|NCT01624077|Tolerance|tolerance
308739|NCT01624077|Cell tolerance|cell tolerance
308740|NCT01624077|Survival|survival
308741|NCT01624064|Renal Insufficiency, Chronic|renal insufficiency, chronic
308742|NCT01624064|Uncertain aetiology|uncertain aetiology
308744|NCT01624051|cisplatin based chemotherapy|cisplatin based chemotherapy
308745|NCT01624051|non-small cell lung cancer|non-small cell lung cancer
308746|NCT01624051|lean body mass|lean body mass
308747|NCT01624051|sarcopenia|sarcopenia
308748|NCT01624038|Hydroxyurea|hydroxyurea
308749|NCT01624038|Erythropoitin therapy|erythropoitin therapy
308750|NCT01624038|Thalassemia intermedia|thalassemia intermedia
308751|NCT01624025|AGC, second-line, docetaxel, epirubicin|agc, second-line, docetaxel, epirubicin
308752|NCT01624012|NIV NAVA|niv nava
308753|NCT01624012|non-invasive ventilation|non-invasive ventilation
308754|NCT01623973|hemiparetic|hemiparetic
308755|NCT01623973|cognitive|cognitive
308756|NCT01623973|balance|balance
308757|NCT01623960|severe haemophilia|severe haemophilia
308758|NCT01623960|quality of life|quality of life
308759|NCT01623947|glutamine|glutamine
308760|NCT01623947|cycling performance|cycling performance
308761|NCT01623947|mental function|mental function
308762|NCT01623934|Gestational diabetes|gestational diabetes
308763|NCT01623934|Adiponectin|adiponectin
308764|NCT01623934|Leptin|leptin
308765|NCT01623934|Single Nucleotides Polymorphisms|single nucleotides polymorphisms
308766|NCT01623934|Insulin resistance|insulin resistance
308767|NCT01623921|Lung|lung
308768|NCT01623921|Contusion|contusion
308769|NCT01623921|Injury|injury
308770|NCT01623921|Cyclooxygenase|cyclooxygenase
308771|NCT01623921|Statin|statin
308772|NCT01623908|Breast neoplasms|breast neoplasms
308773|NCT01623908|Zoledronate|zoledronate
308774|NCT01623908|Bone loss|bone loss
308775|NCT01623882|Diabetes Mellitus|diabetes mellitus
308776|NCT01623882|Wounds|wounds
308777|NCT01623882|Ulcers|ulcers
308779|NCT01623843|randomized|randomized
308780|NCT01623843|hip arthroscopy|hip arthroscopy
308781|NCT01623843|lavage|lavage
308782|NCT01623843|osteochondroplasty|osteochondroplasty
308783|NCT01623830|reconsolidation|reconsolidation
308784|NCT01623830|fear of flying|fear of flying
308785|NCT01623830|virtual reality|virtual reality
308786|NCT01623830|virtual reality exposure therapy|virtual reality exposure therapy
308787|NCT01623804|Ultrasound therapy|ultrasound therapy
308788|NCT01623804|Tibiofemoral joint, medial|tibiofemoral joint, medial
308789|NCT01623804|Nonsurgical|nonsurgical
308790|NCT01623791|Pre-eclampsia|pre-eclampsia
308791|NCT01623791|Proteinuria|proteinuria
308792|NCT01623791|Protein - creatinine ratio|protein - creatinine ratio
308793|NCT01623791|Dipstick proteinuria|dipstick proteinuria
308794|NCT01623791|Severity of disease|severity of disease
308795|NCT01623778|HBeAg seroconversion|hbeag seroconversion
308796|NCT01623778|Peginterferon alfa-2a|peginterferon alfa-2a
308797|NCT01623778|chronic hepatitis B(CHB|chronic hepatitis b(chb
308798|NCT01623778|Optimal therapy|optimal therapy
308799|NCT01623778|Response guild treatment(RGT);|response guild treatment(rgt);
308800|NCT01623765|Endobronchial ultrasound, lung cancer|endobronchial ultrasound, lung cancer
308801|NCT01623739|Dental implants|dental implants
308802|NCT01623739|Esthetic score|esthetic score
308803|NCT01623739|Immediate implants|immediate implants
308804|NCT01623739|Early placement|early placement
308805|NCT01623726|Transcranial Direct Current Stimulation|transcranial direct current stimulation
308806|NCT01623726|Schizophrenia|schizophrenia
308807|NCT01623713|schizophrenia|schizophrenia
308808|NCT01623713|iloperidone|iloperidone
308809|NCT01623713|Risperidone|risperidone
308810|NCT01623713|Efficacy|efficacy
308811|NCT01623713|Safety|safety
308812|NCT01623700|clopidogrel|clopidogrel
308813|NCT01623700|aspirin|aspirin
308814|NCT01623700|percutaneous coronary intervention|percutaneous coronary intervention
308815|NCT01623700|coronary stenting|coronary stenting
308816|NCT01623700|antiplatelet|antiplatelet
308817|NCT01623687|total hip arthroplasty|total hip arthroplasty
308818|NCT01623687|bone metabolism|bone metabolism
308819|NCT01623687|mineralisation|mineralisation
308820|NCT01623674|Sleep deprivation in surgeons during night shifts and the effect on performance.|sleep deprivation in surgeons during night shifts and the effect on performance.
308821|NCT01623661|Nephrology|nephrology
308822|NCT01623661|chronic kidney disease|chronic kidney disease
308823|NCT01623661|sodium-channels|sodium-channels
308824|NCT01623661|water-channels|water-channels
308825|NCT01623661|BCM|bcm
308826|NCT01623648|whey protein|whey protein
308827|NCT01623648|hunger|hunger
308828|NCT01623609|Phase 1|phase 1
308829|NCT01623609|Healthy volunteers|healthy volunteers
308830|NCT01623609|Naloxegol|naloxegol
308831|NCT01623609|Bioequivalence|bioequivalence
308832|NCT01623583|lidocaine|lidocaine
308833|NCT01623583|tetracaine|tetracaine
308834|NCT01623583|Renal dialysis|renal dialysis
308835|NCT01623570|Luteinizing Hormone|luteinizing hormone
308836|NCT01623570|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
308837|NCT01623570|Ovulation Induction|ovulation induction
308838|NCT01623570|Chorionic Gonadotropin|chorionic gonadotropin
308839|NCT01623557|Malaria|malaria
308840|NCT01623557|Vaccine|vaccine
308841|NCT01623557|Plasmodium|plasmodium
308842|NCT01623557|falciparum|falciparum
308843|NCT01623544|Asthma|asthma
308844|NCT01623544|Comparative Effectiveness|comparative effectiveness
308845|NCT01623544|Symbicort|symbicort
308846|NCT01623531|Fibrinogen|fibrinogen
308847|NCT01623531|cardiac surgery|cardiac surgery
308848|NCT01623531|high risk|high risk
308849|NCT01623531|cardiopulmonary bypass|cardiopulmonary bypass
308850|NCT01623531|bleeding|bleeding
308851|NCT01623531|blood transfusion|blood transfusion
308852|NCT01623505|Smoking Cessation|smoking cessation
308853|NCT01623505|Psychiatric Illness|psychiatric illness
308854|NCT01623505|Pharmacotherapy|pharmacotherapy
308855|NCT01623492|Eisenmenger|eisenmenger
308856|NCT01623466|PK and Safety|pk and safety
308857|NCT01623453|crohn's disease|crohn's disease
308859|NCT01623453|complex|complex
308860|NCT01623427|pediatric|pediatric
308861|NCT01623427|laparoscopy|laparoscopy
308862|NCT01623427|vacuum|vacuum
308863|NCT01623427|dressing|dressing
308864|NCT01623362|Dentifrices|dentifrices
308865|NCT01623362|Dental Caries|dental caries
308866|NCT01623362|Fluorides|fluorides
308867|NCT01623362|Nails|nails
308868|NCT01623362|pH|ph
308869|NCT01623349|Recurrent|recurrent
308870|NCT01623349|High Grade|high grade
308871|NCT01623349|Serous|serous
308872|NCT01623349|Triple Negative|triple negative
308873|NCT01623336|HEPATITIS|hepatitis
308874|NCT01623336|HEPATITIS C|hepatitis c
308875|NCT01623336|PEGINTERFERON|peginterferon
308876|NCT01623336|BIOEQUIVALENCE|bioequivalence
308877|NCT01623336|TREATMENT|treatment
308878|NCT01623297|Laparoscopy|laparoscopy
308879|NCT01623297|Surgery|surgery
308880|NCT01623297|Acute Phase Reaction|acute phase reaction
308881|NCT01623297|Aged|aged
308882|NCT01623297|Aged 80 and over|aged 80 and over
308883|NCT01623297|Confusion|confusion
308884|NCT01623297|Inflammation|inflammation
308885|NCT01623297|Delirium|delirium
308886|NCT01623284|aphasia|aphasia
308887|NCT01623284|apraxia of speech|apraxia of speech
308888|NCT01623284|language|language
308889|NCT01623271|CRPS I|crps i
308890|NCT01623232|vaccine|vaccine
308891|NCT01623232|influenzavirus A|influenzavirus a
308892|NCT01623232|influenzavirus B|influenzavirus b
308893|NCT01623232|adjuvant|adjuvant
308894|NCT01623219|PTSD|ptsd
308895|NCT01623219|trauma|trauma
308896|NCT01623219|combat trauma|combat trauma
308897|NCT01623219|veterans|veterans
308898|NCT01623219|telemedicine|telemedicine
308899|NCT01623219|prolonged exposure|prolonged exposure
308900|NCT01623193|Cardioplegia|cardioplegia
308901|NCT01623193|Blood transfusion|blood transfusion
308902|NCT01623193|Cardiac function|cardiac function
308903|NCT01623193|Myocardial edema|myocardial edema
308904|NCT01623193|Coronary artery disease|coronary artery disease
308905|NCT01623193|Valve disease|valve disease
308906|NCT01623180|DES|des
308907|NCT01623180|coronary stent|coronary stent
308908|NCT01623180|bare metal stent|bare metal stent
308909|NCT01623180|high bleeding|high bleeding
308910|NCT01623180|MI|mi
308911|NCT01623180|angina|angina
308912|NCT01623167|T-cells|t-cells
308913|NCT01623167|Immunosuppression|immunosuppression
308914|NCT01623167|Hematopoesis|hematopoesis
308915|NCT01623167|Autoimmunity|autoimmunity
308916|NCT01623167|Thrombocytopenia|thrombocytopenia
308917|NCT01623154|Helicobacter pylori|helicobacter pylori
308918|NCT01623141|CRPS|crps
308919|NCT01623141|TPBS|tpbs
308920|NCT01623141|Pressure pain thresholds|pressure pain thresholds
308921|NCT01623141|limb pain of other origin|limb pain of other origin
308922|NCT01623128|Breastfeeding initiation|breastfeeding initiation
308923|NCT01623128|Breastfeeding duration|breastfeeding duration
308924|NCT01623128|WIC|wic
308925|NCT01623128|Video education|video education
308926|NCT01623128|Breastfeeding rates|breastfeeding rates
308927|NCT01623115|PCSK9|pcsk9
308928|NCT01623102|Bevacizumab|bevacizumab
308929|NCT01623102|gemcitabine|gemcitabine
308930|NCT01623102|cisplatin|cisplatin
308931|NCT01623102|EGFR wild-type|egfr wild-type
308932|NCT01623089|severe asthma, phenotype, data|severe asthma, phenotype, data
308933|NCT01623076|Neuromyelitis Optica|neuromyelitis optica
308934|NCT01623076|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
308935|NCT01623076|Transverse Myelitis|transverse myelitis
308936|NCT01623076|Optic Neuritis|optic neuritis
308937|NCT01623076|Biorepository|biorepository
308938|NCT01623063|endometrium|endometrium
308942|NCT01623037|Lipolysis|lipolysis
308943|NCT01623037|Cryolipolysis|cryolipolysis
308944|NCT01623037|Fat Reduction|fat reduction
308945|NCT01623011|Shoulder|shoulder
308946|NCT01623011|Sub-acromial|sub-acromial
308947|NCT01623011|Rotator Cuff|rotator cuff
308948|NCT01623011|Impingement|impingement
308949|NCT01622998|Pharmacotherapy|pharmacotherapy
308950|NCT01622998|Titration|titration
308951|NCT01622998|Smoking Cessation|smoking cessation
308952|NCT01622959|emergency departement|emergency departement
308953|NCT01622959|acute pain|acute pain
308954|NCT01622959|acupuncture|acupuncture
308955|NCT01622959|morphine|morphine
308956|NCT01622946|total hip arthroplasty|total hip arthroplasty
308957|NCT01622946|tranexamic acid|tranexamic acid
308958|NCT01622946|postoperative blood loss|postoperative blood loss
308962|NCT01622920|enamel erosion|enamel erosion
308963|NCT01622920|ultrasound|ultrasound
308964|NCT01622920|reproducibility|reproducibility
308965|NCT01622920|human central incisor|human central incisor
308966|NCT01622920|reliability|reliability
308967|NCT01622907|Catheter ablation, radiofrequency|catheter ablation, radiofrequency
308968|NCT01622907|Epicardially applied radiofrequency ablation|epicardially applied radiofrequency ablation
402991|NCT01228708|Implementation strategy|implementation strategy
308969|NCT01622907|Minimally invasive surgical approach|minimally invasive surgical approach
308970|NCT01622894|Alzheimer genetics|alzheimer genetics
308972|NCT01622855|Secondary prevention|secondary prevention
308973|NCT01622855|Intervention|intervention
308974|NCT01622842|Impedance|impedance
308975|NCT01622842|Electrical|electrical
308976|NCT01622842|Tissue|tissue
308977|NCT01622842|Excitation frequency|excitation frequency
308978|NCT01622842|arterial distension|arterial distension
308979|NCT01622842|distension wave form|distension wave form
308980|NCT01622777|Rosuvastatin|rosuvastatin
308981|NCT01622777|Diabetic polyneuropathy|diabetic polyneuropathy
308982|NCT01622777|Nerve conduction|nerve conduction
308983|NCT01622777|Oxidative stress|oxidative stress
308984|NCT01622777|Nerve growth factor|nerve growth factor
308985|NCT01622764|RO5323441|ro5323441
308986|NCT01622764|bevacizumab|bevacizumab
308987|NCT01622764|PET imaging|pet imaging
308988|NCT01622764|recurrent glioblastoma|recurrent glioblastoma
308989|NCT01622751|REM sleep|rem sleep
308990|NCT01622751|Adiponectin|adiponectin
308991|NCT01622751|Prader-Willi syndrome|prader-willi syndrome
308992|NCT01622725|ventral hernia|ventral hernia
308993|NCT01622712|inguinal hernia|inguinal hernia
308994|NCT01622699|Jaundice|jaundice
308995|NCT01622699|Neonatal Jaundice|neonatal jaundice
308996|NCT01622699|Hyperbilirubinemia|hyperbilirubinemia
308997|NCT01622699|Transcutaneous bilirubin measurement|transcutaneous bilirubin measurement
308998|NCT01622699|Transcutaneous bilirubinometry|transcutaneous bilirubinometry
308999|NCT01622699|jaundice meter|jaundice meter
309000|NCT01622699|Visual assessment of bilirubin|visual assessment of bilirubin
309001|NCT01622699|Newborn|newborn
309002|NCT01622686|Prescription Labels|prescription labels
309003|NCT01622686|Low Health Literacy|low health literacy
309004|NCT01622686|Limited English Proficiency|limited english proficiency
309005|NCT01622686|Spanish|spanish
309006|NCT01622660|URETER|ureter
309007|NCT01622660|URINARY BLADDER|urinary bladder
309008|NCT01622660|renal pelvis|renal pelvis
309009|NCT01622660|GEMCITABINE|gemcitabine
309010|NCT01622660|GW786034 (PAZOPANIB)|gw786034 (pazopanib)
309011|NCT01622660|11-191|11-191
309012|NCT01622647|NCPAP|ncpap
309013|NCT01622634|cardiovascular disease|cardiovascular disease
309014|NCT01622634|diabetes mellitus|diabetes mellitus
309015|NCT01622621|Lung|lung
309016|NCT01622621|Cancer|cancer
309017|NCT01622608|Adolescent vaccination|adolescent vaccination
309018|NCT01622608|Immunization rates|immunization rates
309019|NCT01622608|Informational kiosk|informational kiosk
309020|NCT01622608|Tailored health messaging|tailored health messaging
309021|NCT01622608|Barriers to vaccination|barriers to vaccination
309022|NCT01622608|Attitudes|attitudes
309023|NCT01622608|Intentions|intentions
309024|NCT01622595|Aspergillosis|aspergillosis
309025|NCT01622595|Candidemia|candidemia
309026|NCT01622595|Candidiasis|candidiasis
309027|NCT01622595|C. Difficile|c. difficile
309028|NCT01622595|cytomegalovirus|cytomegalovirus
309029|NCT01622595|respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
309030|NCT01622595|Influenza|influenza
309032|NCT01622582|Multiple Myeloma, Engraftment syndrome|multiple myeloma, engraftment syndrome
309033|NCT01622556|Chronic Myeloid Leukemia|chronic myeloid leukemia
309034|NCT01622556|Acute Myeloid Leukemia|acute myeloid leukemia
309035|NCT01622556|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
309036|NCT01622556|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
309037|NCT01622556|Hodgkin's Disease|hodgkin's disease
309038|NCT01622556|Myelodysplastic Syndromes|myelodysplastic syndromes
309039|NCT01622556|Myeloproliferative Disorder|myeloproliferative disorder
309040|NCT01622504|Intranasal|intranasal
309041|NCT01622504|nasal spray|nasal spray
309042|NCT01622504|opioid|opioid
309043|NCT01622504|overdose|overdose
309044|NCT01622491|H1N1|h1n1
309045|NCT01622491|pandemic|pandemic
309046|NCT01622491|influenza|influenza
309047|NCT01622491|pneumonia|pneumonia
309048|NCT01622491|vaccine|vaccine
309049|NCT01622491|effectiveness|effectiveness
309050|NCT01622491|Manitoba|manitoba
309051|NCT01622491|Canada|canada
309052|NCT01622478|sentinel lymph node biopsy|sentinel lymph node biopsy
309053|NCT01622478|neoadjuvant chemotherapy|neoadjuvant chemotherapy
309054|NCT01622478|breast cancer|breast cancer
309055|NCT01622478|locally advanced breast cancer|locally advanced breast cancer
309056|NCT01622478|positive axillary lymph node|positive axillary lymph node
309057|NCT01622478|negative conversion|negative conversion
309058|NCT01622465|Hip arthroplasty|hip arthroplasty
309059|NCT01622465|Aged|aged
309060|NCT01622465|Rehabilitation|rehabilitation
309061|NCT01622465|Exercise therapy|exercise therapy
309062|NCT01622452|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
309063|NCT01622452|Cognitive decline|cognitive decline
309064|NCT01622452|Valve surgery|valve surgery
309065|NCT01622452|Cardiac surgery|cardiac surgery
309066|NCT01622452|Diffusion Tensor Imaging|diffusion tensor imaging
309067|NCT01622452|Brain Morphometry|brain morphometry
309068|NCT01622452|1H-Magnetic Resonance Spectroscopy|1h-magnetic resonance spectroscopy
309069|NCT01622439|Lymphoma|lymphoma
309070|NCT01622439|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
309071|NCT01622439|Valproate|valproate
309072|NCT01622439|R-CHOP|r-chop
309073|NCT01622439|CD 20|cd 20
309074|NCT01622413|lumbar spine|lumbar spine
309075|NCT01622413|herniated disc|herniated disc
309076|NCT01622413|slipped disc|slipped disc
309077|NCT01622413|disc herniation|disc herniation
309078|NCT01622413|discectomy|discectomy
309079|NCT01622413|nucleotomy|nucleotomy
309080|NCT01622413|disc surgery|disc surgery
309081|NCT01622413|endoscopy|endoscopy
309082|NCT01622413|spine|spine
309083|NCT01622400|Cardiovascular risk, Therapeutic education, General practice|cardiovascular risk, therapeutic education, general practice
309084|NCT01622387|Coronary artery bypass surgery|coronary artery bypass surgery
309085|NCT01622387|Arteries|arteries
309086|NCT01622387|Veins|veins
309087|NCT01622387|Conduits|conduits
309088|NCT01622374|Music|music
309089|NCT01622374|dental anxiety|dental anxiety
309090|NCT01622374|"music for the mind"|"music for the mind"
309091|NCT01622374|mozart|mozart
309092|NCT01622374|iranian traditional music|iranian traditional music
309093|NCT01622361|Neoadjuvant|neoadjuvant
309094|NCT01622361|endocrine therapy|endocrine therapy
309095|NCT01622361|premenopausal|premenopausal
309096|NCT01622361|hormone responsive|hormone responsive
309097|NCT01622361|HER2 negative|her2 negative
309098|NCT01622361|lymph node positive|lymph node positive
309099|NCT01622348|Psoriasis|psoriasis
309100|NCT01622348|Plaque Psoriasis|plaque psoriasis
309101|NCT01622309|Oxidative Stress|oxidative stress
309102|NCT01622309|Obesity|obesity
309103|NCT01622309|Solanum melongena|solanum melongena
309104|NCT01622218|Medical clown|medical clown
309105|NCT01622192|Probing|probing
309106|NCT01622192|manual probe|manual probe
309107|NCT01622192|automated probe|automated probe
309108|NCT01622192|Periodontal disease|periodontal disease
309109|NCT01622179|surgery|surgery
309110|NCT01622179|suture method|suture method
309111|NCT01622179|blood supply|blood supply
309112|NCT01622140|T-SPOT.TB|t-spot.tb
309113|NCT01622140|QuantiFERON-TB Gold In-Tube|quantiferon-tb gold in-tube
309114|NCT01622140|Latent tuberculosis infection|latent tuberculosis infection
309115|NCT01622140|Tuberculin skin test|tuberculin skin test
309116|NCT01622140|Discordance|discordance
309117|NCT01622140|Predictive value|predictive value
309118|NCT01622140|Tuberculosis disease development|tuberculosis disease development
309119|NCT01622114|Obesity|obesity
309120|NCT01622114|Weight reduction|weight reduction
309121|NCT01622114|premenopausal Women|premenopausal women
308743|NCT01624064|ACEI|acei
309122|NCT01622114|Menstrual cycle|menstrual cycle
309123|NCT01622114|quality of life|quality of life
309124|NCT01622114|food cravings|food cravings
309125|NCT01622101|Energy expenditure|energy expenditure
309126|NCT01622101|Appetite|appetite
309127|NCT01622101|Bioactive herbal compounds|bioactive herbal compounds
309128|NCT01622101|blood pressure|blood pressure
309129|NCT01622088|ALS, Motor Neuron Disease, Amyotrophic Lateral Sclerosis|als, motor neuron disease, amyotrophic lateral sclerosis
309130|NCT01622062|Rabies|rabies
309131|NCT01622062|Verorab®|verorab®
309132|NCT01622062|Favirab®|favirab®
309133|NCT01622036|Malnutrition|malnutrition
309134|NCT01622036|pre-cachexia|pre-cachexia
309135|NCT01622036|cancer|cancer
309136|NCT01622036|cachexia|cachexia
309137|NCT01622036|MNA|mna
309138|NCT01622036|weight loss|weight loss
309139|NCT01622023|insemination|insemination
309140|NCT01622023|donor sperm|donor sperm
309141|NCT01622023|natural cycle|natural cycle
309142|NCT01622010|Heart Failure|heart failure
309143|NCT01622010|Patient Education as Topic|patient education as topic
309144|NCT01622010|Physical Therapy Specialty|physical therapy specialty
309145|NCT01621997|peritoneal dialysis|peritoneal dialysis
309146|NCT01621997|retraining|retraining
309147|NCT01621997|peritonitis|peritonitis
309148|NCT01621984|Cerebral palsy|cerebral palsy
309149|NCT01621984|brain injury|brain injury
309150|NCT01621984|spinal cord injuries|spinal cord injuries
309151|NCT01621984|muscular disease|muscular disease
309152|NCT01621971|inhaled milrinone|inhaled milrinone
309153|NCT01621971|pulmonary hypertension|pulmonary hypertension
309154|NCT01621971|mitral regurgitation|mitral regurgitation
309155|NCT01621971|mitral valve surgery|mitral valve surgery
309156|NCT01621958|balance loss|balance loss
309157|NCT01621958|dynamic stability|dynamic stability
309158|NCT01621958|motor learning|motor learning
309159|NCT01621958|plasticity|plasticity
309160|NCT01621945|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
309166|NCT01621906|18F-FLT-PET Imaging|18f-flt-pet imaging
309167|NCT01621906|FLT(3'DEOXY-3'FLUOROTHYMIDINE)|flt(3'deoxy-3'fluorothymidine)
309168|NCT01621906|MR Imaging|mr imaging
309169|NCT01621906|12-039|12-039
309172|NCT01621880|radiation-induced brain necrosis|radiation-induced brain necrosis
309173|NCT01621880|nasopharyngeal carcinoma|nasopharyngeal carcinoma
309174|NCT01621880|Bevacizumab|bevacizumab
309175|NCT01621880|Methylprednisolone|methylprednisolone
309176|NCT01621867|Cystic fibrosis|cystic fibrosis
309177|NCT01621867|Gene therapy|gene therapy
309178|NCT01621867|CFTR gene|cftr gene
309179|NCT01621867|Gene expression|gene expression
309180|NCT01621867|Non-viral|non-viral
309181|NCT01621867|Multi dose|multi dose
309182|NCT01621854|cancer|cancer
309183|NCT01621854|nucleoside analogue|nucleoside analogue
309184|NCT01621854|advanced solid tumours|advanced solid tumours
309185|NCT01621828|pre-operative anxiety|pre-operative anxiety
309186|NCT01621828|multimedia information|multimedia information
309187|NCT01621828|operating theatre|operating theatre
309188|NCT01621815|ADHD|adhd
309189|NCT01621815|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
309190|NCT01621815|Conduct|conduct
309191|NCT01621815|Depression|depression
309192|NCT01621815|Anxiety|anxiety
309194|NCT01621815|Pervasive Developmental Disorders|pervasive developmental disorders
309195|NCT01621802|Safety|safety
309196|NCT01621802|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
309197|NCT01621802|Immunogenicity|immunogenicity
309198|NCT01621789|lutein|lutein
309199|NCT01621789|zeaxanthin|zeaxanthin
309200|NCT01621789|trypan blue|trypan blue
309201|NCT01621789|dye|dye
309202|NCT01621776|post-prandial hyperglycemia|post-prandial hyperglycemia
309203|NCT01621737|oxytocin|oxytocin
309204|NCT01621724|Gene therapy|gene therapy
309205|NCT01621724|WT1 TCR|wt1 tcr
309206|NCT01621724|AML|aml
309207|NCT01621724|CML|cml
309208|NCT01621711|substance abuse|substance abuse
309209|NCT01621711|Substance Dependence|substance dependence
309210|NCT01621711|Substance, addiction|substance, addiction
309211|NCT01621711|Alcohol Abuse|alcohol abuse
309212|NCT01621711|prevention and control|prevention and control
309213|NCT01621711|preventative health services|preventative health services
309214|NCT01621711|patient centered care|patient centered care
309215|NCT01621698|VATS|vats
309216|NCT01621698|Paravertebral blocks.|paravertebral blocks.
309217|NCT01621698|Thoracoscopic surgery.|thoracoscopic surgery.
309218|NCT01621698|Analgesia.|analgesia.
309219|NCT01621685|Capsaicin|capsaicin
309220|NCT01621685|Cough|cough
309221|NCT01621685|Cough reflex|cough reflex
309222|NCT01621685|Inhalation agents|inhalation agents
309223|NCT01621685|Inhalation challenge|inhalation challenge
309224|NCT01621685|TRPV1 receptor|trpv1 receptor
309225|NCT01621672|Revlimid|revlimid
309226|NCT01621672|progression free|progression free
309227|NCT01621672|Lenalidomide|lenalidomide
309228|NCT01621659|multidisciplinary team|multidisciplinary team
309229|NCT01621659|exercise|exercise
309230|NCT01621659|nutrition|nutrition
309231|NCT01621659|cardiology|cardiology
309239|NCT01621607|fMRI|fmri
309240|NCT01621607|Monoamines|monoamines
309241|NCT01621607|Environment|environment
309242|NCT01621607|Genes|genes
309243|NCT01621607|Reward Learning|reward learning
309244|NCT01621594|Cardiac|cardiac
309245|NCT01621594|Computed Tomography|computed tomography
309246|NCT01621594|Radiation Reduction|radiation reduction
309247|NCT01621594|Iterative Reconstruction|iterative reconstruction
309248|NCT01621581|Gene Therapy|gene therapy
309249|NCT01621581|Parkinson's Disease|parkinson's disease
309250|NCT01621581|Convection-Ehanced Delivery|convection-ehanced delivery
309251|NCT01621581|Viral Vector|viral vector
309253|NCT01621568|Anti-Angiogenesis|anti-angiogenesis
309254|NCT01621568|Targeted Agent|targeted agent
309255|NCT01621555|shoulder surgery|shoulder surgery
309256|NCT01621555|Pain sensitivity|pain sensitivity
309257|NCT01621555|Rowe score|rowe score
309258|NCT01621555|Constant Score|constant score
309259|NCT01621555|Surgical Outcome|surgical outcome
309260|NCT01621555|Postoperative pain|postoperative pain
309261|NCT01621542|Cancer|cancer
309262|NCT01621542|Vaccine|vaccine
309263|NCT01621542|Oncology|oncology
309264|NCT01621542|Malignancies|malignancies
309265|NCT01621542|Wilms' Tumor|wilms' tumor
309266|NCT01621542|WT1|wt1
309267|NCT01621542|Ovarian|ovarian
309268|NCT01621542|Glioblastoma [GBM]|glioblastoma [gbm]
309269|NCT01621542|Acute myeloid leukemia [AML]|acute myeloid leukemia [aml]
309270|NCT01621529|Positron-Emission Tomography|positron-emission tomography
309271|NCT01621529|PET Scan|pet scan
309272|NCT01621529|FDG|fdg
309273|NCT01621529|SUV|suv
309274|NCT01621529|Invasive Breast cancer|invasive breast cancer
309275|NCT01621529|Surgery compare|surgery compare
309276|NCT01621529|Tumor measurement|tumor measurement
309277|NCT01621516|Beta-cell function|beta-cell function
309278|NCT01621516|Liver/small bowel transplant|liver/small bowel transplant
309279|NCT01621516|Donor pancreas|donor pancreas
309280|NCT01621516|Diabetes|diabetes
309281|NCT01621516|Long-term immunesuppression|long-term immunesuppression
309282|NCT01621477|Hematologic malignancy|hematologic malignancy
309283|NCT01621477|Hematopoietic cell transplant|hematopoietic cell transplant
309284|NCT01621464|Neuromediated syncope|neuromediated syncope
309285|NCT01621464|Tilt test|tilt test
309286|NCT01621464|Pacemaker|pacemaker
309287|NCT01621464|CLS sensor|cls sensor
309288|NCT01621438|coronary artery|coronary artery
309289|NCT01621438|atherosclerosis|atherosclerosis
309290|NCT01621438|angina pectoris|angina pectoris
309291|NCT01621425|breast cancer|breast cancer
309292|NCT01621425|prostate carcinoma|prostate carcinoma
309293|NCT01621425|docetaxel|docetaxel
309294|NCT01621425|lean body mass|lean body mass
309295|NCT01621425|Body Surface Area|body surface area
309296|NCT01621425|body weight|body weight
309297|NCT01621425|dexascan|dexascan
309298|NCT01621412|Medication Adherence|medication adherence
309299|NCT01621412|HIV infection|hiv infection
309300|NCT01621412|Disclosure|disclosure
309301|NCT01621373|neonatology|neonatology
309302|NCT01621373|intratracheal intubation|intratracheal intubation
309303|NCT01621373|propofol|propofol
309304|NCT01621360|Randomized controlled trial|randomized controlled trial
309305|NCT01621360|Intention to treat|intention to treat
309306|NCT01621347|HIV|hiv
309307|NCT01621347|Pregnancy|pregnancy
309308|NCT01621347|Postpartum|postpartum
309309|NCT01621347|Women|women
309310|NCT01621347|Medication Adherence|medication adherence
309311|NCT01621308|Diabetes Mellitus type 1|diabetes mellitus type 1
309312|NCT01621308|Intraperitoneal insulin administration|intraperitoneal insulin administration
309313|NCT01621308|Subcutaneous insulin administration|subcutaneous insulin administration
309314|NCT01621308|Continuous intraperitoneal insulin infusion|continuous intraperitoneal insulin infusion
309315|NCT01621282|journal club|journal club
309316|NCT01621269|Multiple Sclerosis|multiple sclerosis
309317|NCT01621269|MS|ms
309318|NCT01621269|Fingolimod|fingolimod
309319|NCT01621269|Gilenya|gilenya
309320|NCT01621269|Neutralizing Antibodies|neutralizing antibodies
309321|NCT01621269|NAb|nab
309322|NCT01621243|necuparanib|necuparanib
309323|NCT01621243|gemcitabine|gemcitabine
309324|NCT01621243|heparin|heparin
309325|NCT01621243|low molecular weight heparin|low molecular weight heparin
309326|NCT01621243|nab-Paclitaxel|nab-paclitaxel
309327|NCT01621230|Bupivacaine|bupivacaine
309328|NCT01621230|Fentanyl|fentanyl
309329|NCT01621230|Epidural|epidural
309330|NCT01621230|Second Stage of Labor|second stage of labor
309331|NCT01621230|Randomized Controlled Trial|randomized controlled trial
309332|NCT01621217|Anal cancer|anal cancer
309333|NCT01621217|Locally advanced anal cancer|locally advanced anal cancer
309334|NCT01621217|Cetuximab|cetuximab
309335|NCT01621217|5-fluoruracil|5-fluoruracil
309336|NCT01621217|Mitomycin C|mitomycin c
309337|NCT01621217|Radiotherapy|radiotherapy
309339|NCT01621204|ITP|itp
309340|NCT01621204|Platelets|platelets
309341|NCT01621204|Bleeding|bleeding
309342|NCT01621204|Immune|immune
309343|NCT01621204|Eltrombopag|eltrombopag
309344|NCT01621204|IVIG|ivig
309345|NCT01621165|treatment of bipolar, mania|treatment of bipolar, mania
309346|NCT01621165|double-blind, placebo-controlled study|double-blind, placebo-controlled study
309347|NCT01621165|drug intervention|drug intervention
309348|NCT01621165|add-on study|add-on study
309349|NCT01621165|prazosin|prazosin
309350|NCT01621165|alpha-1 adrenergic antagonist|alpha-1 adrenergic antagonist
309351|NCT01621152|Acute renal failure|acute renal failure
309352|NCT01621152|acute kidney injury|acute kidney injury
309353|NCT01621152|electronic surveillance|electronic surveillance
309355|NCT01621152|sniffer|sniffer
309356|NCT01621152|AKIN|akin
309357|NCT01621152|improvement in the process of care and outcomes|improvement in the process of care and outcomes
309358|NCT01621126|Shoulder instability|shoulder instability
309359|NCT01621126|Latarjet procedure|latarjet procedure
309360|NCT01621126|Nerve injury|nerve injury
309361|NCT01621113|Spinal Cord Injuries|spinal cord injuries
309362|NCT01621113|4-Aminopyridine|4-aminopyridine
309363|NCT01621113|Physical Therapy Modalities|physical therapy modalities
309364|NCT01621113|Randomized Controlled Trial|randomized controlled trial
309365|NCT01621113|Rehabilitation|rehabilitation
309366|NCT01621113|Walking|walking
309367|NCT01621100|Cancer pain|cancer pain
309368|NCT01621100|OROS|oros
309369|NCT01621100|Osmotic release oral system|osmotic release oral system
309370|NCT01621100|Hydromorphone|hydromorphone
309371|NCT01621100|Painkiller|painkiller
309372|NCT01621100|Opioid analgesic|opioid analgesic
309373|NCT01621100|Korean patients|korean patients
309374|NCT01621061|high altitude illness|high altitude illness
309375|NCT01621061|pulmonary hypertension|pulmonary hypertension
309376|NCT01621061|sleep apnea|sleep apnea
309377|NCT01621061|hypoxia|hypoxia
309378|NCT01621048|Head and Neck Neoplasmsr|head and neck neoplasmsr
309379|NCT01621048|Radiotherapy|radiotherapy
309380|NCT01621048|Xerostomia|xerostomia
309381|NCT01621048|Deglutition Disorders|deglutition disorders
309382|NCT01621022|smoking cessation|smoking cessation
309383|NCT01621022|tobacco dependence|tobacco dependence
309384|NCT01621009|smoking cessation medications|smoking cessation medications
309385|NCT01621009|smoking cessation counseling|smoking cessation counseling
309386|NCT01620996|preintervention and postintervention cohort longitudinal prospective study|preintervention and postintervention cohort longitudinal prospective study
309387|NCT01620983|arthroplasty|arthroplasty
309388|NCT01620983|pain|pain
309389|NCT01620970|Transitional Cell Carcinoma|transitional cell carcinoma
309390|NCT01620970|Metastatic disease|metastatic disease
309391|NCT01620970|Bladder tumors, Recurrent|bladder tumors, recurrent
309392|NCT01620970|Angiogenesis|angiogenesis
309393|NCT01620970|PF03446962|pf03446962
309394|NCT01620970|Transforming growth factor beta|transforming growth factor beta
309395|NCT01620970|Activin receptor like kinase 1|activin receptor like kinase 1
309396|NCT01620970|Monoclonal Antibody|monoclonal antibody
309397|NCT01620970|Locally advanced or metastatic disease|locally advanced or metastatic disease
309398|NCT01620970|Failure of one platinum-based chemotherapy|failure of one platinum-based chemotherapy
309399|NCT01620970|Measurable disease|measurable disease
309400|NCT01620957|Default-mode network|default-mode network
309401|NCT01620957|Difussion tensor imaging|difussion tensor imaging
309402|NCT01620957|Cortical thickness|cortical thickness
309403|NCT01620957|Coma|coma
309404|NCT01620957|Vegetative state|vegetative state
309405|NCT01620957|Minimally conscious state|minimally conscious state
309406|NCT01620957|Neural correlate of consciousness|neural correlate of consciousness
309407|NCT01620892|unicondylar knee arthroplasty|unicondylar knee arthroplasty
309408|NCT01620892|partial knee replacement|partial knee replacement
309409|NCT01620866|EMDR|emdr
309410|NCT01620866|bipolar disorder|bipolar disorder
309411|NCT01620866|trauma|trauma
309412|NCT01620866|subsyndromal symptoms|subsyndromal symptoms
309413|NCT01620866|PTSD|ptsd
309414|NCT01620853|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
309415|NCT01620853|ALK probe|alk probe
309416|NCT01620853|FISH|fish
309417|NCT01620853|Chromosomal aberrations|chromosomal aberrations
309418|NCT01620840|oral administration of Lacosamide is not possible or adequate|oral administration of lacosamide is not possible or adequate
309419|NCT01620827|follow up|follow up
309420|NCT01620827|cell phone|cell phone
309421|NCT01620827|hospital landline|hospital landline
309422|NCT01620814|misoprostol|misoprostol
309423|NCT01620814|dinoprostone|dinoprostone
309424|NCT01620814|cervical ripening|cervical ripening
309425|NCT01620814|diagnostic hysteroscopy|diagnostic hysteroscopy
309426|NCT01620801|AAV|aav
309427|NCT01620801|AAV8|aav8
309428|NCT01620801|Adeno-associated virus|adeno-associated virus
309429|NCT01620801|Adeno-associated viral vectors|adeno-associated viral vectors
309430|NCT01620801|Hemophilia|hemophilia
309431|NCT01620801|Hemophilia B|hemophilia b
309432|NCT01620801|Severe hemophilia B|severe hemophilia b
309433|NCT01620801|Factor IX deficiency|factor ix deficiency
309434|NCT01620801|Factor IX|factor ix
309436|NCT01620762|Cat allergy|cat allergy
309437|NCT01620762|Rhinoconjunctivitis|rhinoconjunctivitis
309438|NCT01620749|melanoma metastatic diagnosis|melanoma metastatic diagnosis
309439|NCT01620736|Raltegravir|raltegravir
309440|NCT01620736|HTLV|htlv
309441|NCT01620736|Integrase|integrase
309442|NCT01620723|Breastfeeding|breastfeeding
309443|NCT01620723|Breastfeeding self efficacy|breastfeeding self efficacy
309444|NCT01620710|prostatectomy|prostatectomy
309445|NCT01620658|Occupational Exposure to Radiation|occupational exposure to radiation
309446|NCT01620632|laparoscopy assisted ERCP|laparoscopy assisted ercp
309447|NCT01620632|altered gastric anatomy|altered gastric anatomy
309448|NCT01620619|Shoulder|shoulder
309449|NCT01620619|Bankart|bankart
309450|NCT01620619|Anterior Instability|anterior instability
309451|NCT01620619|Rotator Cuff|rotator cuff
309452|NCT01620606|FAP|fap
309453|NCT01620606|RAP|rap
309454|NCT01620606|Abdominal Pain|abdominal pain
309455|NCT01620606|IBS|ibs
309456|NCT01620593|Prostate Cancer|prostate cancer
309457|NCT01620593|Metformin|metformin
309458|NCT01620593|Castration therapy|castration therapy
309459|NCT01620580|sleep disturbance|sleep disturbance
309460|NCT01620580|tiredness|tiredness
309461|NCT01620580|itching & numbness|itching & numbness
309462|NCT01620567|lutein|lutein
309463|NCT01620567|avocados|avocados
309464|NCT01620567|chickpeas|chickpeas
309465|NCT01620567|potatoes|potatoes
309466|NCT01620567|elderly|elderly
309467|NCT01620554|Sleep disorder|sleep disorder
309468|NCT01620554|Obstructive Sleep Apnoea|obstructive sleep apnoea
309469|NCT01620554|Excessive Daytime Sleepiness|excessive daytime sleepiness
309470|NCT01620528|Gonadotropin-Releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
309471|NCT01620528|Endometriosis associated pain|endometriosis associated pain
309472|NCT01620528|Dysmenorrhea (DYS)|dysmenorrhea (dys)
309473|NCT01620528|Non-Menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
309474|NCT01620528|Elagolix|elagolix
309475|NCT01620515|Prostate|prostate
309476|NCT01620515|Prostate Cancer|prostate cancer
309477|NCT01620515|Localized Prostate Cancer|localized prostate cancer
309478|NCT01620515|T1c Prostate Cancer|t1c prostate cancer
309479|NCT01620515|Focal Therapy|focal therapy
309481|NCT01620411|Active Duty|active duty
309482|NCT01620411|Comprehensive Medical Management|comprehensive medical management
309483|NCT01620411|Spinal Cord Stimulator|spinal cord stimulator
309484|NCT01620411|Veteran|veteran
309485|NCT01620411|sustained|sustained
309486|NCT01620411|military|military
383700|NCT01311622|RA|ra
309487|NCT01620398|cardiovascular diseases|cardiovascular diseases
309488|NCT01620398|secondary prevention|secondary prevention
309489|NCT01620398|diet|diet
309490|NCT01620385|Cochlear implants|cochlear implants
309491|NCT01620359|Breast cancer|breast cancer
309492|NCT01620359|Breast tumor|breast tumor
309493|NCT01620359|stage 1 disease|stage 1 disease
309494|NCT01620359|T1 M0 N0|t1 m0 n0
309495|NCT01620346|advanced maternal age|advanced maternal age
309496|NCT01620346|infertility|infertility
309497|NCT01620346|IMSI|imsi
309498|NCT01620346|ICSI|icsi
309499|NCT01620346|implantation|implantation
309500|NCT01620320|Left main coronary artery|left main coronary artery
309501|NCT01620320|Coronary artery disease|coronary artery disease
309502|NCT01620320|Stress echography|stress echography
309503|NCT01620320|Intrastent stenosis|intrastent stenosis
309504|NCT01620307|H1N1 patients with severe hypoxemia requiring ventilator support|h1n1 patients with severe hypoxemia requiring ventilator support
309505|NCT01620294|surgical site infection|surgical site infection
309506|NCT01620294|elective colorectal surgery|elective colorectal surgery
309507|NCT01620294|level of surgical site infection|level of surgical site infection
309508|NCT01620294|complication of surgical site infection|complication of surgical site infection
309509|NCT01620294|type of changed bandage|type of changed bandage
309510|NCT01620294|frequency of bandage changing|frequency of bandage changing
309511|NCT01620281|Back Pain|back pain
309512|NCT01620268|leflunomide|leflunomide
309513|NCT01620268|orotic acid|orotic acid
309514|NCT01620268|Polyoma BK Viruria|polyoma bk viruria
309515|NCT01620268|Polyoma BK Viremia|polyoma bk viremia
309516|NCT01620268|Polyoma BK Nephropathy|polyoma bk nephropathy
309517|NCT01620268|Renal Allograft Rejection|renal allograft rejection
309518|NCT01620242|recurrent or metastatic head and neck cancer|recurrent or metastatic head and neck cancer
309519|NCT01620242|cabazitaxel|cabazitaxel
309520|NCT01620203|Premature infants|premature infants
309521|NCT01620203|Intracranial hemorrhage|intracranial hemorrhage
309522|NCT01620203|Intraventricular hemorrhage|intraventricular hemorrhage
309523|NCT01620203|Cerebral oxygenation|cerebral oxygenation
309524|NCT01620203|Brain function|brain function
309525|NCT01620203|Cerebral perfusion|cerebral perfusion
309526|NCT01620177|Cannabis|cannabis
309527|NCT01620177|Marijuana|marijuana
309528|NCT01620177|Marihuana|marihuana
309529|NCT01620177|Alcohol|alcohol
309530|NCT01620177|Driving|driving
309531|NCT01620164|three-dimensional vision|three-dimensional vision
309533|NCT01620151|Post-operative pain|post-operative pain
309534|NCT01620151|Wound bleeding requiring exploration|wound bleeding requiring exploration
309535|NCT01620151|PTH|pth
309536|NCT01620151|RLN complication|rln complication
309537|NCT01620151|Hypocalcaemia complication|hypocalcaemia complication
309538|NCT01620138|Non-functioning pituitary adenomas|non-functioning pituitary adenomas
309539|NCT01620138|Prolactinomas|prolactinomas
309540|NCT01620138|Cabergoline|cabergoline
309541|NCT01620138|Pasireotide|pasireotide
309542|NCT01620138|somatostatin receptors|somatostatin receptors
309543|NCT01620138|Dopamine receptors|dopamine receptors
309544|NCT01620125|Lactobacillus|lactobacillus
309545|NCT01620125|Gut microbiota|gut microbiota
309546|NCT01620125|Diabetes mellitus|diabetes mellitus
309547|NCT01620112|brachial plexus|brachial plexus
309548|NCT01620112|lidocaine|lidocaine
309549|NCT01620112|alfa 2 adrenergic receptor clonidine|alfa 2 adrenergic receptor clonidine
309550|NCT01620112|orthopedic procedure|orthopedic procedure
309551|NCT01620099|Asthma|asthma
309552|NCT01620099|Cigarette smoke|cigarette smoke
309553|NCT01620099|Small airways|small airways
309554|NCT01620099|Lung function|lung function
309555|NCT01620099|Asthma control|asthma control
309556|NCT01620086|Schizophrenia|schizophrenia
309557|NCT01620086|Auditory hallucinations (AH)|auditory hallucinations (ah)
309558|NCT01620086|Phantom sound perception|phantom sound perception
309559|NCT01620086|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
309560|NCT01620086|Percent habituation in the P50 amplitude with 250 ms ISI|percent habituation in the p50 amplitude with 250 ms isi
309561|NCT01620073|Male partner|male partner
309562|NCT01620073|HIV counseling and testing|hiv counseling and testing
309563|NCT01620073|Home based|home based
309564|NCT01620073|Pregnancy|pregnancy
309565|NCT01620060|Schizophrenia|schizophrenia
309566|NCT01620060|autism|autism
309567|NCT01620060|bipolar|bipolar
309568|NCT01620060|Lurasidone|lurasidone
309569|NCT01620060|Latuda|latuda
309570|NCT01620047|Regional Anesthesia|regional anesthesia
309571|NCT01620047|Post-operative pain management|post-operative pain management
309572|NCT01620047|Femoral Nerve Block|femoral nerve block
309573|NCT01620047|Total Knee Replacement|total knee replacement
309574|NCT01620021|wearable sensors|wearable sensors
309575|NCT01620021|kinematics|kinematics
309576|NCT01620021|gait|gait
309577|NCT01620008|cord clamping (delayed or immediate)|cord clamping (delayed or immediate)
309578|NCT01620008|Myelin content|myelin content
309579|NCT01620008|Ferritin|ferritin
309580|NCT01619995|urge incontinence|urge incontinence
300280|NCT01663558|MSM|msm
309581|NCT01619956|dental implants|dental implants
309582|NCT01619956|osteotome sinus floor elevation|osteotome sinus floor elevation
309583|NCT01619956|survival rate|survival rate
309584|NCT01619956|sinus grafting|sinus grafting
309585|NCT01619956|bone remodeling|bone remodeling
309587|NCT01619956|radiographic analysis|radiographic analysis
309588|NCT01619943|Minor head injury|minor head injury
309589|NCT01619943|CT scan|ct scan
309590|NCT01619943|Canadian CT Head Rules|canadian ct head rules
309591|NCT01619943|The New Orleans Criteria|the new orleans criteria
309592|NCT01619930|Depression|depression
309593|NCT01619930|Behavioral activation|behavioral activation
309594|NCT01619917|burn|burn
309595|NCT01619917|scar|scar
309596|NCT01619917|laser|laser
309597|NCT01619917|fractional|fractional
309598|NCT01619917|vascular|vascular
309599|NCT01619904|Pancreas Transplantation|pancreas transplantation
309600|NCT01619904|Goal-directed therapy|goal-directed therapy
309601|NCT01619904|Outcomes|outcomes
309602|NCT01619904|Immunometric|immunometric
309603|NCT01619878|plasmodium|plasmodium
309604|NCT01619878|P. falciparum|p. falciparum
309605|NCT01619878|malaria|malaria
309606|NCT01619878|infant|infant
309607|NCT01619878|neonate|neonate
309608|NCT01619865|GA-68|ga-68
309609|NCT01619865|Gallium 68|gallium 68
309610|NCT01619865|GA-68 PET|ga-68 pet
309611|NCT01619852|Surgery|surgery
309612|NCT01619852|Breast|breast
309613|NCT01619852|Pain|pain
309614|NCT01619852|Chronic Pain|chronic pain
309615|NCT01619852|Lidocaine|lidocaine
309616|NCT01619852|Anesthesia|anesthesia
309617|NCT01619852|Gynecologic|gynecologic
309618|NCT01619852|Urologic|urologic
309619|NCT01619839|Nektar|nektar
309620|NCT01619839|NKTR-181|nktr-181
309621|NCT01619826|physical activity|physical activity
309622|NCT01619826|fitness|fitness
309623|NCT01619826|brain health|brain health
309624|NCT01619826|cognition|cognition
309625|NCT01619826|scholastic achievement|scholastic achievement
309626|NCT01619826|preadolescent children|preadolescent children
309627|NCT01619800|Chronotropic Incompetence|chronotropic incompetence
309628|NCT01619800|Pacemaker|pacemaker
309629|NCT01619800|Mount Sinai School of Medicine|mount sinai school of medicine
309630|NCT01619774|Melanoma|melanoma
309631|NCT01619774|Metastatic melanoma|metastatic melanoma
309632|NCT01619774|Refractory or Resistant to BRAF Inhibitor|refractory or resistant to braf inhibitor
309633|NCT01619774|Advanced melanoma|advanced melanoma
309635|NCT01619774|GSK1120212|gsk1120212
309636|NCT01619761|Leukemia|leukemia
309637|NCT01619761|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
309638|NCT01619761|CLL|cll
309639|NCT01619761|Cord blood|cord blood
309640|NCT01619761|CB|cb
309641|NCT01619761|Umbilical cord blood|umbilical cord blood
309642|NCT01619761|UCB|ucb
309643|NCT01619761|Natural killer cells|natural killer cells
309644|NCT01619761|NK|nk
309645|NCT01619761|Graft versus host disease|graft versus host disease
309646|NCT01619761|GVHD|gvhd
309647|NCT01619761|Lenalidomide|lenalidomide
309648|NCT01619761|CC-5013|cc-5013
309649|NCT01619761|Revlimid|revlimid
309650|NCT01619761|Fludarabine|fludarabine
309651|NCT01619761|Fludarabine Phosphate|fludarabine phosphate
309652|NCT01619761|Fludara|fludara
309653|NCT01619761|Melphalan|melphalan
309654|NCT01619761|Alkeran|alkeran
309655|NCT01619761|Rituximab|rituximab
309656|NCT01619761|Rituxan|rituxan
309657|NCT01619735|Kidney Calculi|kidney calculi
309658|NCT01619735|Kidney Stones|kidney stones
309659|NCT01619735|Nephrolithiasis|nephrolithiasis
309660|NCT01619735|Renal Stones|renal stones
309661|NCT01619722|PKU|pku
309662|NCT01619722|Osteoporosis|osteoporosis
309663|NCT01619722|HMP|hmp
309664|NCT01619722|Life quality|life quality
309665|NCT01619722|Neuropsychological|neuropsychological
309666|NCT01619722|Nutritial evaluation|nutritial evaluation
309667|NCT01619722|Phenylketonuria|phenylketonuria
309668|NCT01619722|Hyperphenylalaninemia|hyperphenylalaninemia
309669|NCT01619709|Intracerebral Hemorrhage|intracerebral hemorrhage
309670|NCT01619709|Cerebral Amyloid angiopathy|cerebral amyloid angiopathy
309671|NCT01619709|Amyloid imaging|amyloid imaging
309672|NCT01619709|18F-AV-45|18f-av-45
309673|NCT01619696|chemotherapy|chemotherapy
309674|NCT01619696|rectal adenocarcinoma|rectal adenocarcinoma
309675|NCT01619696|proctectomy|proctectomy
309676|NCT01619696|Fmiso TEP|fmiso tep
309677|NCT01619696|MRI|mri
309678|NCT01619657|Cystic Fibrosis|cystic fibrosis
309679|NCT01619657|Hypertonic Saline|hypertonic saline
309680|NCT01619657|Infant|infant
309681|NCT01619657|Newborn|newborn
309682|NCT01619657|Prevention|prevention
309683|NCT01619644|RTS|rts
309684|NCT01619644|Rubinstein Taybi|rubinstein taybi
309685|NCT01619644|explorative phase 2|explorative phase 2
309686|NCT01619644|clinical approach|clinical approach
309687|NCT01619644|biological approach|biological approach
309688|NCT01619644|motor skills|motor skills
309689|NCT01619631|Depression|depression
309690|NCT01619631|Tai Chi|tai chi
309691|NCT01619631|Alternative medicine|alternative medicine
309692|NCT01619631|Mind body medicine|mind body medicine
309693|NCT01619618|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
309694|NCT01619618|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
309695|NCT01619618|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
309696|NCT01619618|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
309697|NCT01619618|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
309698|NCT01619618|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
309699|NCT01619618|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
309700|NCT01619618|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
309791|NCT01619293|brain|brain
309792|NCT01619293|trauma|trauma
309701|NCT01619618|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
309702|NCT01619618|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
309703|NCT01619618|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
309704|NCT01619618|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
309705|NCT01619618|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
309706|NCT01619618|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
309707|NCT01619618|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
309708|NCT01619618|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
309709|NCT01619618|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
309710|NCT01619618|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
309835|NCT01619189|Limbal deficiency|limbal deficiency
309711|NCT01619618|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
309712|NCT01619618|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
309713|NCT01619618|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
309714|NCT01619618|recurrent salivary gland cancer|recurrent salivary gland cancer
309715|NCT01619618|stage IVA salivary gland cancer|stage iva salivary gland cancer
309716|NCT01619618|stage IVB salivary gland cancer|stage ivb salivary gland cancer
309717|NCT01619618|stage IVC salivary gland cancer|stage ivc salivary gland cancer
309719|NCT01619605|anaphylaxis|anaphylaxis
309720|NCT01619605|shrimp allergy|shrimp allergy
309721|NCT01619592|patients|patients
309722|NCT01619592|adaptable|adaptable
309723|NCT01619592|insulin|insulin
309724|NCT01619592|schemes|schemes
309725|NCT01619579|Fibromyalgia|fibromyalgia
309726|NCT01619579|Pain|pain
309727|NCT01619579|Non-Invasive|non-invasive
309728|NCT01619579|Arthritis|arthritis
309729|NCT01619579|Rheumatoid Disease|rheumatoid disease
309730|NCT01619566|Fibromyalgia|fibromyalgia
309731|NCT01619566|Duloxetine|duloxetine
309732|NCT01619566|Cymbalta|cymbalta
309733|NCT01619566|Pain|pain
309734|NCT01619566|Peripheral Nerve|peripheral nerve
309735|NCT01619566|Biopsy|biopsy
309736|NCT01619566|Predictive|predictive
309737|NCT01619553|keloid|keloid
309738|NCT01619553|fibrosis|fibrosis
309739|NCT01619553|wound healing|wound healing
309740|NCT01619553|scar|scar
309741|NCT01619540|COPD|copd
309742|NCT01619540|Left Ventricular Failure|left ventricular failure
309743|NCT01619540|Valsalva Manoeuver|valsalva manoeuver
309744|NCT01619527|Healthy participants|healthy participants
309745|NCT01619527|Darunavir|darunavir
309746|NCT01619527|Cobicistat|cobicistat
309747|NCT01619527|Bioequivalence|bioequivalence
309748|NCT01619527|Fixed dose combination|fixed dose combination
309749|NCT01619527|Pharmacokinetics|pharmacokinetics
309750|NCT01619527|Human immunodeficiency virus|human immunodeficiency virus
309751|NCT01619527|Protease inhibitor|protease inhibitor
309752|NCT01619488|Lap-Band|lap-band
309753|NCT01619488|morbid obesity|morbid obesity
309754|NCT01619488|adolescents|adolescents
309755|NCT01619475|Living Donor|living donor
309756|NCT01619475|Liver Transplantation|liver transplantation
309757|NCT01619475|Quality of Life|quality of life
309758|NCT01619475|Biosamples|biosamples
309759|NCT01619475|Liver Recipient|liver recipient
309760|NCT01619462|pneumococcal|pneumococcal
309761|NCT01619462|vaccine|vaccine
309762|NCT01619462|papua new guinea|papua new guinea
309763|NCT01619449|Acute Kidney Injury|acute kidney injury
309764|NCT01619449|Continuous Renal Replacement Therapy|continuous renal replacement therapy
309765|NCT01619449|Liver Transplant|liver transplant
309766|NCT01619423|Metastatic colorectal cancer|metastatic colorectal cancer
309767|NCT01619423|stage IV|stage iv
309768|NCT01619423|FOLFOX6|folfox6
309769|NCT01619423|Chemotherapy|chemotherapy
309770|NCT01619423|PledOx|pledox
309771|NCT01619423|Mangafodipir|mangafodipir
309772|NCT01619423|Febrile neutropenia|febrile neutropenia
309773|NCT01619423|Oxidative stress|oxidative stress
309774|NCT01619423|Antioxidant|antioxidant
309775|NCT01619423|neutropenia|neutropenia
309776|NCT01619423|neuropathy|neuropathy
309777|NCT01619397|Condom|condom
309778|NCT01619397|Medical Device|medical device
309779|NCT01619384|posttraumatic stress|posttraumatic stress
309780|NCT01619384|irritable bowel|irritable bowel
309781|NCT01619371|breast pump|breast pump
309782|NCT01619371|engorgement|engorgement
309783|NCT01619371|lactation|lactation
309784|NCT01619332|Healthy volunteers,|healthy volunteers,
309785|NCT01619332|Diabetes|diabetes
309786|NCT01619332|Glucose|glucose
309787|NCT01619332|Pharmacokinetics|pharmacokinetics
309788|NCT01619319|schizophrenia prodrome|schizophrenia prodrome
309789|NCT01619319|clinical high risk of psychosis|clinical high risk of psychosis
309790|NCT01619293|CCT|cct
309793|NCT01619293|injury|injury
309794|NCT01619280|Acute Lung Injury|acute lung injury
309795|NCT01619280|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
309796|NCT01619280|Sodium Nitroprusside|sodium nitroprusside
309797|NCT01619280|adult|adult
309798|NCT01619280|Safety|safety
309799|NCT01619280|Dose Finding|dose finding
309800|NCT01619280|Phase 1|phase 1
309801|NCT01619280|3 + 3 design|3 + 3 design
309802|NCT01619280|Nebulizers and Vaporizers|nebulizers and vaporizers
309803|NCT01619280|High-Frequency Ventilation|high-frequency ventilation
309804|NCT01619280|nitric oxide|nitric oxide
309805|NCT01619280|lung injury|lung injury
309806|NCT01619280|Pulmonary Gas Exchange|pulmonary gas exchange
309807|NCT01619280|Pulmonary Alveoli|pulmonary alveoli
309808|NCT01619267|pacemaker defibrillator infection|pacemaker defibrillator infection
309809|NCT01619254|Intestinal parasitic infections|intestinal parasitic infections
309810|NCT01619254|Anaemia|anaemia
309811|NCT01619254|School-aged children|school-aged children
309812|NCT01619254|Hand washing and nail clipping|hand washing and nail clipping
309813|NCT01619241|lung cancer|lung cancer
309814|NCT01619241|F-18 FLT PET/CT|f-18 flt pet/ct
309815|NCT01619228|premature infant|premature infant
309816|NCT01619228|neonate|neonate
309817|NCT01619228|skin maturation|skin maturation
309818|NCT01619228|stratum corneum maturation|stratum corneum maturation
309819|NCT01619228|ontogeny of neonatal skin maturation|ontogeny of neonatal skin maturation
309820|NCT01619228|sunflower oil|sunflower oil
309821|NCT01619228|effect of Vitamin B3 on premature skin maturation|effect of vitamin b3 on premature skin maturation
309822|NCT01619228|skin acidity|skin acidity
309823|NCT01619228|stratum corneum barrier integrity|stratum corneum barrier integrity
309824|NCT01619228|stratum corneum lipid composition|stratum corneum lipid composition
309825|NCT01619228|stratum corneum biomarkers|stratum corneum biomarkers
309826|NCT01619228|stratum corneum cytokines|stratum corneum cytokines
309827|NCT01619228|stratum corneum structural proteins|stratum corneum structural proteins
309828|NCT01619202|accident prevention|accident prevention
309829|NCT01619202|Adolescent|adolescent
309830|NCT01619202|examination, automobile driver|examination, automobile driver
309831|NCT01619202|Driving simulator|driving simulator
310030|NCT01618513|Treatment|treatment
309832|NCT01619202|Young drivers|young drivers
309833|NCT01619202|Driving education|driving education
309834|NCT01619189|Cell therapy|cell therapy
309836|NCT01619189|Limbal stem cell|limbal stem cell
309837|NCT01619189|Transplantation|transplantation
309838|NCT01619176|Rheumatoid Arthritis|rheumatoid arthritis
309839|NCT01619176|blood|blood
309840|NCT01619176|gut intestinal microbiome|gut intestinal microbiome
309841|NCT01619163|Prednisolone,|prednisolone,
309842|NCT01619163|pain,|pain,
309843|NCT01619163|inflammation,|inflammation,
309844|NCT01619163|mobility|mobility
309845|NCT01619163|Function|function
309847|NCT01619150|osteoarthritis|osteoarthritis
309848|NCT01619150|central sensitization|central sensitization
309849|NCT01619150|mechanical detection|mechanical detection
309850|NCT01619150|pain threshold|pain threshold
309851|NCT01619150|quantitative sensory testing|quantitative sensory testing
309852|NCT01619150|pain biomarkers|pain biomarkers
309853|NCT01619150|COX-2 inhibitors|cox-2 inhibitors
309854|NCT01619150|etoricoxib.|etoricoxib.
309855|NCT01619137|ununion wound|ununion wound
309856|NCT01619137|soap|soap
309857|NCT01619137|irrigation|irrigation
309858|NCT01619137|Povidone-iodine|povidone-iodine
309859|NCT01619137|normal salin|normal salin
309860|NCT01619124|osteonecrosis|osteonecrosis
309861|NCT01619124|children|children
309862|NCT01619124|pediatric|pediatric
309863|NCT01619124|acute lymphoblastic leukaemia|acute lymphoblastic leukaemia
309864|NCT01619124|lymphoblastic lymphoma|lymphoblastic lymphoma
309865|NCT01619111|metastatic breast cancer|metastatic breast cancer
309866|NCT01619111|circulating tumor cells|circulating tumor cells
309867|NCT01619111|lapatinib|lapatinib
309868|NCT01619098|Hospital readmission|hospital readmission
309869|NCT01619098|Care transition|care transition
309870|NCT01619098|Discharge-transfer intervention|discharge-transfer intervention
309871|NCT01619098|Community health worker|community health worker
309872|NCT01619098|Patient Navigatgor|patient navigatgor
309873|NCT01619072|postpartum hemorrhage|postpartum hemorrhage
309874|NCT01619072|treatment|treatment
309875|NCT01619072|misoprostol|misoprostol
309876|NCT01619072|home births|home births
309877|NCT01619046|GreenGene™F, Previously Treated Patients|greengene™f, previously treated patients
309878|NCT01619033|Renal impairment|renal impairment
309879|NCT01619020|Healthy|healthy
309880|NCT01619020|Colon|colon
309881|NCT01619007|Treatment of Venous Thromboembolism|treatment of venous thromboembolism
309882|NCT01619007|Thromboembolism|thromboembolism
309883|NCT01619007|Venous Thromboembolism|venous thromboembolism
309884|NCT01619007|Embolism and Thrombosis|embolism and thrombosis
309885|NCT01619007|Vascular Diseases|vascular diseases
309886|NCT01619007|Cardiovascular Diseases|cardiovascular diseases
309887|NCT01619007|Thrombosis|thrombosis
309888|NCT01618994|Robotic Simulator|robotic simulator
309890|NCT01618994|Robotic Surgeons|robotic surgeons
309891|NCT01618994|Intuitive Surgical|intuitive surgical
309892|NCT01618994|simulation modules|simulation modules
309893|NCT01618994|benchmarks|benchmarks
309894|NCT01618994|Morristown Protocol|morristown protocol
309895|NCT01618994|Study Surgeons|study surgeons
309896|NCT01618994|Control Surgeons|control surgeons
309897|NCT01618994|Expert Surgeons|expert surgeons
309898|NCT01618994|dual-console daVinci system|dual-console davinci system
309899|NCT01618994|blinded skill assessment|blinded skill assessment
309900|NCT01618981|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
309901|NCT01618981|atrial dyssynchrony syndrome|atrial dyssynchrony syndrome
309902|NCT01618981|left atrio-ventricular asynchrony|left atrio-ventricular asynchrony
309903|NCT01618981|pacemaker|pacemaker
309904|NCT01618981|left atrial pacing therapy|left atrial pacing therapy
309905|NCT01618929|Food allergy|food allergy
309906|NCT01618929|Asthma|asthma
309907|NCT01618929|Children|children
309908|NCT01618929|Montelukast|montelukast
309909|NCT01618929|Inflammation|inflammation
309910|NCT01618903|Keppra Levetiracetam intravenous|keppra levetiracetam intravenous
309911|NCT01618903|Oral tablets|oral tablets
309912|NCT01618903|Bioequivalence|bioequivalence
309913|NCT01618903|Pharmacokinetics|pharmacokinetics
309914|NCT01618903|Safety|safety
309915|NCT01618903|Chinese healthy volunteers|chinese healthy volunteers
309586|NCT01619956|RCT|rct
309916|NCT01618890|Prevention|prevention
309917|NCT01618890|Esophageal variceal bleeding|esophageal variceal bleeding
309918|NCT01618890|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
309919|NCT01618890|Betablocker therapy|betablocker therapy
309920|NCT01618877|Keppra Levetiracetam intravenous|keppra levetiracetam intravenous
309921|NCT01618877|Multiple dose|multiple dose
309922|NCT01618877|Safety|safety
309923|NCT01618877|Pharmacokinetics|pharmacokinetics
309924|NCT01618877|Chinese healthy volunteers|chinese healthy volunteers
309925|NCT01618851|prostate cancer|prostate cancer
309926|NCT01618838|prostate cancer|prostate cancer
309927|NCT01618812|Artificial bone graft|artificial bone graft
309928|NCT01618812|Hydroxyapatite|hydroxyapatite
309929|NCT01618812|Children|children
309930|NCT01618812|Osteotomy|osteotomy
310542|NCT01616212|Parenting|parenting
309931|NCT01618812|Pes plano valgus|pes plano valgus
309932|NCT01618812|Flatfeet|flatfeet
309933|NCT01618786|Falls|falls
309934|NCT01618786|Fall injuries|fall injuries
309935|NCT01618786|Bone fracture|bone fracture
309936|NCT01618786|Hip fracture|hip fracture
309937|NCT01618786|Skull fracture|skull fracture
309938|NCT01618786|Wounds|wounds
309939|NCT01618786|Closed head injury|closed head injury
309940|NCT01618786|Traumatic brain injury|traumatic brain injury
309941|NCT01618786|Concussion|concussion
309942|NCT01618786|Spinal cord injury|spinal cord injury
309943|NCT01618786|Trauma|trauma
309944|NCT01618786|Older adults|older adults
309945|NCT01618786|Long-term care|long-term care
309946|NCT01618786|Compliant flooring|compliant flooring
309947|NCT01618786|Safety floors|safety floors
309948|NCT01618786|Balance|balance
309949|NCT01618786|Injury biomechanics|injury biomechanics
309950|NCT01618786|Biomedical engineering|biomedical engineering
309951|NCT01618786|Environmental hazards|environmental hazards
309952|NCT01618786|Environmental interventions|environmental interventions
309953|NCT01618786|Fall prevention|fall prevention
309954|NCT01618786|Gerontology|gerontology
309955|NCT01618773|acne|acne
309956|NCT01618773|Epiduo|epiduo
309957|NCT01618773|adapalene/ benzoyl peroxide|adapalene/ benzoyl peroxide
309958|NCT01618734|Immune Thrombocytopenia|immune thrombocytopenia
309959|NCT01618734|Thrombopoietin receptor agonist|thrombopoietin receptor agonist
309960|NCT01618721|Chronic obstructive lung disease;|chronic obstructive lung disease;
310087|NCT01618292|bowel dysfunction|bowel dysfunction
309961|NCT01618721|Interstitial lung disease;|interstitial lung disease;
309962|NCT01618721|Ultrasound Doppler;|ultrasound doppler;
309963|NCT01618721|Lung disease diagnosis;|lung disease diagnosis;
309964|NCT01618695|Partial-onset Seizures|partial-onset seizures
309965|NCT01618695|partial seizures|partial seizures
309966|NCT01618695|seizure|seizure
309967|NCT01618695|epilepsy|epilepsy
309968|NCT01618682|hand transplant|hand transplant
309969|NCT01618682|hand replant|hand replant
309970|NCT01618669|Coronary Artery Disease (CAD)|coronary artery disease (cad)
309971|NCT01618669|regadenoson|regadenoson
309972|NCT01618669|pharmacologic stress|pharmacologic stress
309973|NCT01618643|Barrett's|barrett's
309974|NCT01618643|High grade dysplasia|high grade dysplasia
309975|NCT01618643|HGD|hgd
309976|NCT01618643|IMC|imc
309977|NCT01618643|Intramucosal cancer|intramucosal cancer
309978|NCT01618643|Acetic acid|acetic acid
309979|NCT01618643|Chromoendoscopy|chromoendoscopy
309980|NCT01618630|burn injury|burn injury
309981|NCT01618630|children|children
309982|NCT01618630|nutrition|nutrition
309983|NCT01618630|lipid metabolism|lipid metabolism
309984|NCT01618630|insulin sensitivity|insulin sensitivity
309985|NCT01618630|amino acids|amino acids
309986|NCT01618630|stable isotopes|stable isotopes
309987|NCT01618617|Constipation|constipation
309988|NCT01618617|Probiotic|probiotic
309989|NCT01618617|Randomized Controlled Trial|randomized controlled trial
309990|NCT01618604|Conditioned Pain Modulation|conditioned pain modulation
309991|NCT01618604|Quantitative Sensory Testing|quantitative sensory testing
309992|NCT01618604|duration|duration
309993|NCT01618604|correlation|correlation
309994|NCT01618591|diarrhea|diarrhea
309995|NCT01618591|travelers' diarrhea|travelers' diarrhea
309996|NCT01618591|watery diarrhea|watery diarrhea
309997|NCT01618591|enteric illness|enteric illness
309998|NCT01618591|dysentery|dysentery
309999|NCT01618591|gastrointestinal|gastrointestinal
310000|NCT01618578|rubber hand illusion|rubber hand illusion
310001|NCT01618578|CRPS|crps
310002|NCT01618578|body image|body image
310003|NCT01618578|body ownership|body ownership
310004|NCT01618565|shoulder dystocia|shoulder dystocia
310005|NCT01618565|training|training
310006|NCT01618565|To assess the effectiveness of hands-on training versus expert demonstration|to assess the effectiveness of hands-on training versus expert demonstration
310007|NCT01618552|Chronic disease|chronic disease
310008|NCT01618552|Cluster randomization|cluster randomization
310009|NCT01618552|Comorbidity|comorbidity
310010|NCT01618552|Depression|depression
310011|NCT01618552|Diabetes|diabetes
310012|NCT01618552|Medical history taking|medical history taking
310013|NCT01618552|Office visits|office visits
310014|NCT01618552|Patient acceptance of health care|patient acceptance of health care
310015|NCT01618552|Patient compliance|patient compliance
310016|NCT01618552|Patient simulation|patient simulation
310017|NCT01618552|Physician patient relations|physician patient relations
310018|NCT01618552|Primary health care|primary health care
310019|NCT01618552|Randomized controlled trials|randomized controlled trials
310020|NCT01618552|Self care|self care
310021|NCT01618552|Self efficacy|self efficacy
310022|NCT01618539|Total intravenous anesthesia, Bispectral Index Score|total intravenous anesthesia, bispectral index score
310023|NCT01618526|Dietary fibers|dietary fibers
310024|NCT01618526|Butyrate|butyrate
310025|NCT01618526|Short Chain Fatty Acids|short chain fatty acids
310026|NCT01618526|Colon|colon
310027|NCT01618526|Metabolic Syndrome|metabolic syndrome
310028|NCT01618513|Acromegaly|acromegaly
310029|NCT01618513|Somatostatin analogs|somatostatin analogs
310031|NCT01618500|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
310032|NCT01618500|Neuropsychological Test|neuropsychological test
310033|NCT01618500|Assessment of cognitive disorders/dementia|assessment of cognitive disorders/dementia
310034|NCT01618500|Neuropsychological assessment|neuropsychological assessment
707547|NCT00997867|Sciatic|sciatic
310035|NCT01618487|tennis elbow|tennis elbow
310036|NCT01618487|lateral epicondylitis|lateral epicondylitis
310037|NCT01618474|gastric cancer|gastric cancer
310038|NCT01618474|adjuvant chemotherapy|adjuvant chemotherapy
310039|NCT01618461|Prescription drug information|prescription drug information
310040|NCT01618461|Medication management|medication management
310041|NCT01618435|Fusion surgery|fusion surgery
310042|NCT01618435|Degenerative olisthesis|degenerative olisthesis
310043|NCT01618435|i-FACTOR|i-factor
310045|NCT01618435|Spinal stenosis|spinal stenosis
310046|NCT01618422|DOTS plus|dots plus
310047|NCT01618422|DOTS|dots
310048|NCT01618422|multidrug resistant tuberculosis (MDR TB)|multidrug resistant tuberculosis (mdr tb)
310049|NCT01618409|PictureRx|picturerx
310050|NCT01618409|Health Literacy|health literacy
310051|NCT01618409|Limited English Proficiency|limited english proficiency
310052|NCT01618409|Latinos|latinos
310053|NCT01618409|Spanish|spanish
310054|NCT01618396|Microcirculation|microcirculation
310055|NCT01618396|Hypnotics and Sedatives,|hypnotics and sedatives,
310056|NCT01618396|Propofol,|propofol,
310057|NCT01618396|Midazolam|midazolam
310058|NCT01618383|Parkinson's disease|parkinson's disease
310059|NCT01618383|gut|gut
310060|NCT01618383|colon|colon
310061|NCT01618383|biopsies|biopsies
310062|NCT01618383|LRRK2|lrrk2
310063|NCT01618370|Radium 223|radium 223
310064|NCT01618370|Alpharadin|alpharadin
310065|NCT01618370|Prostate Cancer|prostate cancer
310066|NCT01618370|Bone metastases|bone metastases
310067|NCT01618370|Castrate resistant prostate cancer|castrate resistant prostate cancer
310068|NCT01618370|Hormone refractory prostate cancer|hormone refractory prostate cancer
310069|NCT01618357|Veliparib|veliparib
310070|NCT01618357|ABT-888|abt-888
310071|NCT01618357|Radiation|radiation
310072|NCT01618357|POPI|popi
310073|NCT01618344|neoplasms|neoplasms
310074|NCT01618344|adolescent|adolescent
310075|NCT01618344|young adult|young adult
310076|NCT01618344|medication adherence|medication adherence
310077|NCT01618331|FSHD|fshd
310078|NCT01618331|Endurance exercise|endurance exercise
310079|NCT01618331|Protein supplementation|protein supplementation
310080|NCT01618331|Placebo RCT|placebo rct
310081|NCT01618318|Asthma|asthma
310082|NCT01618318|Allergy|allergy
310083|NCT01618318|Diagnosis|diagnosis
310084|NCT01618318|Correlation study|correlation study
310085|NCT01618292|pelvic organ prolapse|pelvic organ prolapse
310086|NCT01618292|constipation|constipation
310088|NCT01618292|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
310089|NCT01618292|CRADI-8|cradi-8
310090|NCT01618292|CRAIQ-7|craiq-7
310091|NCT01618292|splinting with defecation|splinting with defecation
310092|NCT01618292|excessive straining|excessive straining
310093|NCT01618292|bowel movements|bowel movements
310094|NCT01618292|fecal incontinence|fecal incontinence
310095|NCT01618292|bowel symptoms|bowel symptoms
310096|NCT01618279|tryptase|tryptase
310097|NCT01618279|coronary|coronary
310098|NCT01618279|stemi|stemi
310099|NCT01618279|nstemi|nstemi
310100|NCT01618253|Transarterial Chemoembolization|transarterial chemoembolization
310101|NCT01618253|TACE|tace
310102|NCT01618253|Sorafenib Tosylate|sorafenib tosylate
310103|NCT01618253|Sorafenib|sorafenib
310104|NCT01618253|Nexavar|nexavar
310105|NCT01618253|External Beam Radiation Therapy|external beam radiation therapy
310106|NCT01618253|Radiation Therapy|radiation therapy
310107|NCT01618253|Radiotherapy|radiotherapy
310108|NCT01618253|Radiation|radiation
310109|NCT01618240|FEES|fees
310110|NCT01618240|PAS|pas
310111|NCT01618240|VPSR|vpsr
310112|NCT01618240|MRC|mrc
310113|NCT01618201|Inflammation|inflammation
310114|NCT01618201|Migraine|migraine
310115|NCT01618201|Headache|headache
310116|NCT01618175|Bronchiolitis, Viral|bronchiolitis, viral
310117|NCT01618175|Home oxygen therapy|home oxygen therapy
310118|NCT01618175|Home Nursing|home nursing
6140|NCT03251807|Functional treatment|functional treatment
310119|NCT01618175|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
310120|NCT01618175|bronchiolitis severity score|bronchiolitis severity score
310121|NCT01618149|osteoarthritis|osteoarthritis
310122|NCT01618149|periprosthetic bone loss|periprosthetic bone loss
310123|NCT01618149|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
310124|NCT01618136|PARP inhibitors|parp inhibitors
310125|NCT01618136|Malignant Solid Tumour|malignant solid tumour
310126|NCT01618136|ovarian cancer|ovarian cancer
310127|NCT01618136|triple negative breast cancer|triple negative breast cancer
310128|NCT01618136|advanced melanoma|advanced melanoma
310129|NCT01618123|Endothelial function|endothelial function
310130|NCT01618123|Coronary disease|coronary disease
310131|NCT01618123|Atherosclerosis|atherosclerosis
310132|NCT01618123|Chest pain|chest pain
310133|NCT01618110|ADHD|adhd
311241|NCT01612988|Ofatumumab|ofatumumab
310134|NCT01618110|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
310136|NCT01618110|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
310137|NCT01618097|Osteoarthritis|osteoarthritis
310138|NCT01618097|Decision Aids|decision aids
310139|NCT01618097|Health Literacy|health literacy
310140|NCT01618084|hipreplacement|hipreplacement
310141|NCT01618084|uncemented|uncemented
310142|NCT01618084|migration|migration
310143|NCT01618084|boneremodeling|boneremodeling
310144|NCT01618071|n-3 PUFA|n-3 pufa
310145|NCT01618071|Endothelial cells|endothelial cells
310146|NCT01618071|Nitric oxide|nitric oxide
310147|NCT01618071|Oxidative stress|oxidative stress
310148|NCT01618071|Blood pressure|blood pressure
310149|NCT01618071|Vasodilation|vasodilation
310150|NCT01618071|Lipemia|lipemia
310151|NCT01618071|Unsaturated dietary fats|unsaturated dietary fats
310152|NCT01618058|HIV Infections|hiv infections
310153|NCT01618058|Anti-HIV Agents|anti-hiv agents
310154|NCT01618058|HIV-1|hiv-1
310155|NCT01618045|Diabetes|diabetes
310156|NCT01618045|FPP|fpp
310157|NCT01618045|fermented papaya preparation|fermented papaya preparation
310158|NCT01618019|n-3 PUFA|n-3 pufa
310159|NCT01618019|rheumatoid arthritis|rheumatoid arthritis
310160|NCT01618019|inflammation|inflammation
310161|NCT01618019|eicosanoids|eicosanoids
310162|NCT01618019|bone turnover markers|bone turnover markers
310163|NCT01617993|in vitro fertilization|in vitro fertilization
310164|NCT01617993|assisted reproduction|assisted reproduction
310165|NCT01617993|noninvasive imaging of embryos|noninvasive imaging of embryos
310166|NCT01617993|time lapse imaging of embryos|time lapse imaging of embryos
310167|NCT01617993|traditional morphological grading of embryos|traditional morphological grading of embryos
310168|NCT01617993|prediction of blastocysts|prediction of blastocysts
310169|NCT01617993|infertility|infertility
310170|NCT01617993|Genital Diseases, Male|genital diseases, male
310171|NCT01617993|Genital Diseases, Female|genital diseases, female
310172|NCT01617980|Hypoxia imaging|hypoxia imaging
310173|NCT01617980|FMISO-PET|fmiso-pet
310174|NCT01617980|functional MRI|functional mri
310175|NCT01617980|Intensity modulated radiation therapy|intensity modulated radiation therapy
310176|NCT01617967|RNAi therapeutic|rnai therapeutic
310177|NCT01617941|non-chronic migraine, migraine prevention|non-chronic migraine, migraine prevention
310178|NCT01617902|Hyperbilirubinemia|hyperbilirubinemia
310179|NCT01617902|cardiac|cardiac
310180|NCT01617902|surgery|surgery
310181|NCT01617902|aorta|aorta
310182|NCT01617902|prognosis|prognosis
310183|NCT01617876|Stomach Neoplasms|stomach neoplasms
310184|NCT01617876|early gastric cancer|early gastric cancer
310185|NCT01617876|magnifying endoscopy|magnifying endoscopy
310186|NCT01617876|narrow band imaging|narrow band imaging
310187|NCT01617876|acetic acid|acetic acid
310188|NCT01617876|indigocarmine|indigocarmine
310189|NCT01617837|Postoperative nausea and vomiting|postoperative nausea and vomiting
310190|NCT01617837|P6 acupressure|p6 acupressure
310191|NCT01617837|Craniotomy.|craniotomy.
310192|NCT01617824|Diabetes|diabetes
310193|NCT01617824|Kidney|kidney
310194|NCT01617824|Inflammation|inflammation
310195|NCT01617824|Metabolism|metabolism
310196|NCT01617772|Non-alcoholic steatohepatitis, Atorvastatin, L-Carnitine|non-alcoholic steatohepatitis, atorvastatin, l-carnitine
310197|NCT01617746|Asthma|asthma
310198|NCT01617746|Endothelin|endothelin
310199|NCT01617746|Airway hyperreactivity|airway hyperreactivity
310200|NCT01617720|mitral|mitral
310201|NCT01617720|valve|valve
310202|NCT01617720|annuloplasty|annuloplasty
310203|NCT01617720|mitral regurgitation|mitral regurgitation
310204|NCT01617707|sedation|sedation
310205|NCT01617707|endoscopy|endoscopy
310206|NCT01617707|midazolam|midazolam
310207|NCT01617707|propofol|propofol
310208|NCT01617707|chronic alcoholics|chronic alcoholics
310209|NCT01617694|dexmedetomidine|dexmedetomidine
310210|NCT01617694|remifentanil|remifentanil
310211|NCT01617694|target-controlled infusion|target-controlled infusion
310212|NCT01617681|Hypertension; CKD; Pediatric|hypertension; ckd; pediatric
310213|NCT01617668|Breast cancer,|breast cancer,
310214|NCT01617668|LCL161,|lcl161,
310215|NCT01617668|paclitaxel,|paclitaxel,
310216|NCT01617668|neoadjuvant,|neoadjuvant,
310217|NCT01617668|triple negative breast cancer|triple negative breast cancer
310218|NCT01617642|Porphyria|porphyria
310219|NCT01617642|Inflammation|inflammation
310220|NCT01617642|Diet|diet
310221|NCT01617642|Iron status|iron status
310222|NCT01617629|Cvac|cvac
310223|NCT01617603|diabetes type 2|diabetes type 2
310224|NCT01617603|insulin resistance|insulin resistance
310225|NCT01617603|glycaemic control|glycaemic control
310226|NCT01617603|Endothelial function|endothelial function
310227|NCT01617603|Cocoa Polyphenols|cocoa polyphenols
310228|NCT01617590|RA|ra
310229|NCT01617590|Leflunomide|leflunomide
310230|NCT01617590|Methotrexate|methotrexate
310231|NCT01617577|G-CSF|g-csf
310232|NCT01617577|granulocyte colony stimulating factor|granulocyte colony stimulating factor
310233|NCT01617577|Filgrastim|filgrastim
310234|NCT01617564|medical abortion|medical abortion
310235|NCT01617564|second trimester|second trimester
310236|NCT01617564|para cervical blockage|para cervical blockage
310237|NCT01617564|pain management|pain management
310238|NCT01617551|Essential hypertension|essential hypertension
310239|NCT01617551|Nitric oxide|nitric oxide
310240|NCT01617551|Renal denervation|renal denervation
310241|NCT01617551|Sodium|sodium
310242|NCT01617551|GFR|gfr
310243|NCT01617538|atherosclerosis|atherosclerosis
310244|NCT01617538|stenosis|stenosis
310245|NCT01617538|statin therapy|statin therapy
310246|NCT01617538|Signs and Symptoms|signs and symptoms
310247|NCT01617538|Circulatory; Change|circulatory; change
310248|NCT01617499|physical activity|physical activity
310249|NCT01617499|pedometer|pedometer
310250|NCT01617499|worksite|worksite
310251|NCT01617499|wellness|wellness
310252|NCT01617499|cardiovascular|cardiovascular
310253|NCT01617499|lifestyle program|lifestyle program
310254|NCT01617460|Autistic Disorder, children and adolescents|autistic disorder, children and adolescents
310255|NCT01617460|aripiprazole|aripiprazole
310256|NCT01617460|Long-term safety study|long-term safety study
310257|NCT01617460|children and adolescents|children and adolescents
310258|NCT01617447|Autistic Disorder, children and adolescents|autistic disorder, children and adolescents
310259|NCT01617447|Aripiprazole|aripiprazole
310260|NCT01617447|Double-blind|double-blind
310261|NCT01617447|Randomized|randomized
310262|NCT01617447|children and adolescents|children and adolescents
310263|NCT01617421|Yoga|yoga
310264|NCT01617421|Arthritis|arthritis
310265|NCT01617408|Theta Burst Stimulation|theta burst stimulation
310266|NCT01617408|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
310267|NCT01617408|Visual Cortex|visual cortex
310268|NCT01617408|Visual Processing|visual processing
310269|NCT01617395|Multiple Sclerosis|multiple sclerosis
310270|NCT01617395|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
310271|NCT01617382|HIPEC|hipec
310272|NCT01617382|Hyperthermic (heated) chemotherapy after debulking|hyperthermic (heated) chemotherapy after debulking
310273|NCT01617356|TMD|tmd
310274|NCT01617356|temporomandibular|temporomandibular
310275|NCT01617356|dextrose|dextrose
310276|NCT01617356|prolotherapy|prolotherapy
310277|NCT01617330|Particulate matter|particulate matter
310278|NCT01617330|Air pollution|air pollution
310279|NCT01617330|Diesel exhaust|diesel exhaust
310280|NCT01617330|Allergic rhinitis|allergic rhinitis
310281|NCT01617317|H1N1 2009|h1n1 2009
310282|NCT01617317|hyperimmune IVIG|hyperimmune ivig
310283|NCT01617317|mortality|mortality
310284|NCT01617317|length of stay|length of stay
310285|NCT01617317|viral load|viral load
310286|NCT01617317|cytokine|cytokine
310287|NCT01617304|advanced glycation end products|advanced glycation end products
310288|NCT01617304|insulin sensitivity|insulin sensitivity
310289|NCT01617304|obesity|obesity
310290|NCT01617304|inflammation|inflammation
310291|NCT01617304|metabolomics|metabolomics
310292|NCT01617304|appetite|appetite
310293|NCT01617304|CVD|cvd
310294|NCT01617291|Pre-hospital hypothermia|pre-hospital hypothermia
310295|NCT01617291|Induced therapeutic hypothermia|induced therapeutic hypothermia
310296|NCT01617291|Cardiac arrest|cardiac arrest
310297|NCT01617278|Colonoscopy|colonoscopy
310298|NCT01617278|I Scan|i scan
310299|NCT01617278|High definition white light|high definition white light
310300|NCT01617278|Adenomas|adenomas
310301|NCT01617265|intensive care|intensive care
310302|NCT01617265|mechanical ventilation|mechanical ventilation
310303|NCT01617265|sedatives|sedatives
310304|NCT01617265|morphinics|morphinics
310305|NCT01617265|oversedation|oversedation
310306|NCT01617265|mortality|mortality
310307|NCT01617265|midazolam|midazolam
310308|NCT01617265|propofol|propofol
310309|NCT01617265|pain|pain
310310|NCT01617265|agitation|agitation
310311|NCT01617252|Cardiac surgery|cardiac surgery
310312|NCT01617252|Acute respiratory failure|acute respiratory failure
310313|NCT01617252|High flow oxygen therapy|high flow oxygen therapy
310314|NCT01617239|Influenza|influenza
310315|NCT01617239|Vaccination|vaccination
310316|NCT01617239|Virosomal influenza vaccine|virosomal influenza vaccine
310317|NCT01617213|Multiple Myeloma|multiple myeloma
310319|NCT01617174|pain assessment|pain assessment
310320|NCT01617174|12-110|12-110
310321|NCT01617161|Low Risk|low risk
310322|NCT01617161|Intermediate Risk|intermediate risk
310323|NCT01617148|Exudative Macular Degeneration|exudative macular degeneration
310324|NCT01617148|Aflibercept|aflibercept
310325|NCT01617135|Parkinson's disease|parkinson's disease
310326|NCT01617135|Motor fluctuations|motor fluctuations
310327|NCT01617135|levodopa|levodopa
310328|NCT01617135|inhaled drugs|inhaled drugs
310329|NCT01617135|"Motor fluctuation (off episodes)"|"motor fluctuation (off episodes)"
310330|NCT01617122|PID|pid
310331|NCT01617122|PIDD|pidd
310332|NCT01617122|antibody deficiency|antibody deficiency
310333|NCT01617122|CVID|cvid
310334|NCT01617122|recurrent infections|recurrent infections
310335|NCT01617109|Vitamin D|vitamin d
310336|NCT01617109|Calcium|calcium
311442|NCT01611974|CMV|cmv
310340|NCT01617109|Bone resorption|bone resorption
310341|NCT01617109|Micronutrients|micronutrients
310342|NCT01617109|Trace Elements|trace elements
310346|NCT01617083|PANS|pans
310347|NCT01617083|PANDAS|pandas
310348|NCT01617083|OCD|ocd
310349|NCT01617083|Tics|tics
310350|NCT01617083|Azithromycin|azithromycin
310351|NCT01617083|Antibiotic Treatment|antibiotic treatment
310352|NCT01617070|Tetrahydrobiopterin|tetrahydrobiopterin
310353|NCT01617070|Kuvan|kuvan
310354|NCT01617070|Phenylketonuria (PKU)|phenylketonuria (pku)
310355|NCT01617070|Large Neutral Amino Acids|large neutral amino acids
310356|NCT01617070|Serotonin|serotonin
310357|NCT01617070|Dopamine|dopamine
310358|NCT01617070|Melatonin|melatonin
310359|NCT01617057|otosclerosis|otosclerosis
310360|NCT01617057|inner ear|inner ear
310361|NCT01617057|tiludronic acid|tiludronic acid
310362|NCT01617044|Iron|iron
310363|NCT01617044|Deficiency|deficiency
310364|NCT01617044|Restless|restless
310365|NCT01617044|Leg|leg
310366|NCT01617031|aspirin|aspirin
310367|NCT01617031|diabetes mellitus|diabetes mellitus
310368|NCT01617031|coronary artery disease|coronary artery disease
310369|NCT01617018|Psoriasis; Biological therapy; Methotrexate; Cyclosporine|psoriasis; biological therapy; methotrexate; cyclosporine
310370|NCT01616979|Off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
310371|NCT01616979|Transesophageal echocardiography|transesophageal echocardiography
310372|NCT01616966|hoarseness|hoarseness
310373|NCT01616966|sore throat|sore throat
310374|NCT01616966|vocal cord injuries|vocal cord injuries
310375|NCT01616953|dental implants|dental implants
310376|NCT01616940|HIV/AIDS|hiv/aids
310377|NCT01616940|Peer support|peer support
310378|NCT01616927|ADPKD|adpkd
310379|NCT01616927|lanreotide|lanreotide
310380|NCT01616927|polycystic kidney|polycystic kidney
310381|NCT01616927|polycystic liver|polycystic liver
310382|NCT01616914|delirium|delirium
310383|NCT01616914|outcome|outcome
310384|NCT01616901|Obese|obese
310385|NCT01616901|Intensive Care|intensive care
310386|NCT01616901|Respiratory weaning|respiratory weaning
310387|NCT01616901|Spontaneous Breathing trial|spontaneous breathing trial
310388|NCT01616901|Work of breathing|work of breathing
310389|NCT01616888|drug eluting balloon with paclitaxel|drug eluting balloon with paclitaxel
310390|NCT01616888|in stent restenosis|in stent restenosis
310391|NCT01616888|femoropopliteal arteries|femoropopliteal arteries
310392|NCT01616888|angioplasty|angioplasty
310393|NCT01616875|Bladder cancer|bladder cancer
310394|NCT01616875|Transitional cell carcinoma|transitional cell carcinoma
310395|NCT01616875|Urothelial cancer|urothelial cancer
310396|NCT01616875|Cisplatin|cisplatin
310397|NCT01616875|Cabazitaxel|cabazitaxel
310398|NCT01616875|Chemotherapy|chemotherapy
310399|NCT01616875|Neo adjuvant chemotherapy|neo adjuvant chemotherapy
310400|NCT01616862|Pseudomonas aeruginosa|pseudomonas aeruginosa
310401|NCT01616862|cystic fibrosis|cystic fibrosis
310402|NCT01616823|Human immunodeficiency virus (HIV) positive women|human immunodeficiency virus (hiv) positive women
310403|NCT01616810|urinary tract|urinary tract
310404|NCT01616784|Adult|adult
310405|NCT01616784|Diabetes Mellitus|diabetes mellitus
310406|NCT01616784|Type 1|type 1
310407|NCT01616784|Humans|humans
310408|NCT01616784|Hypoglycemic Agents|hypoglycemic agents
310409|NCT01616784|Administration and Dosage|administration and dosage
310410|NCT01616784|Insulin|insulin
310411|NCT01616784|Self Care|self care
310412|NCT01616784|Health Education|health education
310413|NCT01616784|Insulin Infusion Systems|insulin infusion systems
310414|NCT01616784|Randomised controlled trial|randomised controlled trial
310415|NCT01616784|Patient Education as Topic|patient education as topic
310416|NCT01616784|Hemoglobin A|hemoglobin a
310417|NCT01616784|Glycosylated|glycosylated
310418|NCT01616771|laryngoscopes|laryngoscopes
310419|NCT01616745|NTM Lung disease|ntm lung disease
310420|NCT01616745|NTM Lung disease patients enrolled in SNUH|ntm lung disease patients enrolled in snuh
310421|NCT01616693|rotavirus|rotavirus
310422|NCT01616693|polio|polio
310423|NCT01616693|zinc supplement|zinc supplement
310424|NCT01616693|probiotic supplement|probiotic supplement
310425|NCT01616693|rotavirus vaccine shedding|rotavirus vaccine shedding
310426|NCT01616667|Controlled Clinical Trial|controlled clinical trial
310427|NCT01616667|Operative Surgical Procedures|operative surgical procedures
310428|NCT01616667|Treatment Outcome|treatment outcome
310429|NCT01616667|Pain Measurement|pain measurement
310430|NCT01616667|Quality of Life|quality of life
310431|NCT01616667|Questionnaires/standards|questionnaires/standards
310432|NCT01616667|Activities of Daily Living|activities of daily living
310433|NCT01616667|Biomechanics|biomechanics
310434|NCT01616667|Gait*|gait*
310435|NCT01616667|Hip Joint/physiology*|hip joint/physiology*
310436|NCT01616667|Hip Joint/surgery*|hip joint/surgery*
312480|NCT01608139|Bay 43-9006|bay 43-9006
310437|NCT01616667|Recovery of Function/physiology|recovery of function/physiology
310438|NCT01616641|rheumatoid arthritis|rheumatoid arthritis
310439|NCT01616641|bite force|bite force
310440|NCT01616641|grip strenght|grip strenght
310441|NCT01616641|oral health|oral health
310442|NCT01616641|quality of life|quality of life
310443|NCT01616628|Incentives|incentives
310444|NCT01616628|Fruit|fruit
310445|NCT01616628|Vegetables|vegetables
310446|NCT01616602|patients|patients
310447|NCT01616602|presenting|presenting
310448|NCT01616602|elective|elective
310449|NCT01616602|colonoscopy.|colonoscopy.
310450|NCT01616589|Fragile X syndrome|fragile x syndrome
310451|NCT01616589|Fragile X full mutation|fragile x full mutation
310452|NCT01616589|Fragile X premutation|fragile x premutation
310453|NCT01616589|Fragile X intermediate|fragile x intermediate
310454|NCT01616589|CGG repeat length|cgg repeat length
310455|NCT01616576|cochlear implant|cochlear implant
310456|NCT01616576|adults|adults
310457|NCT01616576|HiResolution™|hiresolution™
310458|NCT01616576|Fidelity 120™|fidelity 120™
310459|NCT01616576|listening benefits|listening benefits
310460|NCT01616576|noise|noise
310461|NCT01616576|cochlear implant benefit|cochlear implant benefit
310462|NCT01616563|central obesity|central obesity
310463|NCT01616563|abdominal obesity|abdominal obesity
310464|NCT01616563|hypertension|hypertension
310465|NCT01616563|cardiovascular disease|cardiovascular disease
310466|NCT01616563|high cholesterol|high cholesterol
310467|NCT01616563|high triglycerides|high triglycerides
310468|NCT01616563|insulin resistance|insulin resistance
310469|NCT01616563|diabetes mellitus|diabetes mellitus
310470|NCT01616550|analgesia|analgesia
310471|NCT01616550|thoracic surgery|thoracic surgery
310472|NCT01616537|solid tumors|solid tumors
310473|NCT01616537|hematological malignancy|hematological malignancy
310474|NCT01616472|hypertension|hypertension
310475|NCT01616472|avascular necrosis|avascular necrosis
310476|NCT01616472|systemic lupus erythematosus|systemic lupus erythematosus
310477|NCT01616472|osteoporosis|osteoporosis
310478|NCT01616472|Steroid|steroid
310479|NCT01616472|diabetes|diabetes
310480|NCT01616472|cataracts|cataracts
310481|NCT01616459|Streptococcus pneumoniae|streptococcus pneumoniae
310482|NCT01616459|Haemophilus influenzae|haemophilus influenzae
310483|NCT01616459|Pneumococcal vaccine|pneumococcal vaccine
310484|NCT01616459|Infants|infants
310485|NCT01616459|Safety|safety
310486|NCT01616459|Immunogenicity|immunogenicity
310487|NCT01616446|cyclosporin|cyclosporin
310488|NCT01616446|nephrotic syndrome|nephrotic syndrome
310489|NCT01616446|pharmacokinetics|pharmacokinetics
310490|NCT01616446|children|children
310491|NCT01616433|Arthritis|arthritis
310492|NCT01616433|Preventive Behaviors|preventive behaviors
310493|NCT01616420|prevention|prevention
310494|NCT01616420|treatment|treatment
310495|NCT01616420|cost-effectiveness|cost-effectiveness
310496|NCT01616420|assisted partner notification services|assisted partner notification services
310497|NCT01616420|Kenya|kenya
310498|NCT01616420|linkage to HIV care|linkage to hiv care
310499|NCT01616420|case-finding|case-finding
310604|NCT01615822|OZ439|oz439
310500|NCT01616407|Effects of psychostimulants on emotion recognition and empathy|effects of psychostimulants on emotion recognition and empathy
310501|NCT01616355|denture, complete;|denture, complete;
310502|NCT01616355|sodium hypochlorite;|sodium hypochlorite;
310503|NCT01616355|disinfection;|disinfection;
310504|NCT01616355|surface roughness;|surface roughness;
310505|NCT01616355|color stability.|color stability.
310506|NCT01616329|alloimmunization|alloimmunization
310507|NCT01616329|RBC|rbc
310508|NCT01616329|clinicalfactors|clinicalfactors
310509|NCT01616329|Risk|risk
310510|NCT01616303|ovarian|ovarian
310511|NCT01616303|cancer|cancer
310512|NCT01616303|neoplasm|neoplasm
310513|NCT01616303|adenocarcinoma|adenocarcinoma
310514|NCT01616303|CA125|ca125
310515|NCT01616290|peripheral artery disease|peripheral artery disease
310516|NCT01616290|PAD|pad
310517|NCT01616290|claudication|claudication
310518|NCT01616290|angioplasty|angioplasty
310519|NCT01616290|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
310520|NCT01616290|PTA|pta
310521|NCT01616290|superficial femoral artery|superficial femoral artery
310522|NCT01616290|SFA|sfa
310523|NCT01616290|popliteal artery|popliteal artery
310524|NCT01616290|PA|pa
310525|NCT01616290|PRT-201|prt-201
310526|NCT01616290|restenosis|restenosis
310527|NCT01616290|vonapanitase|vonapanitase
310528|NCT01616264|Tuberculosis|tuberculosis
310529|NCT01616264|Pleural Effusion|pleural effusion
310530|NCT01616264|Computed Tomography|computed tomography
310531|NCT01616251|Protein sources|protein sources
310532|NCT01616251|Appetite|appetite
310533|NCT01616251|Dietary fibers|dietary fibers
310534|NCT01616251|Meat|meat
310535|NCT01616251|Egg|egg
310536|NCT01616251|Legumes|legumes
310537|NCT01616225|Infertility|infertility
310538|NCT01616225|Poor Responder|poor responder
310539|NCT01616225|In Vitro Fertilization|in vitro fertilization
310540|NCT01616225|Growth Hormone|growth hormone
310541|NCT01616212|Teens|teens
310543|NCT01616212|Substance Abuse|substance abuse
310544|NCT01616212|Treatment Efficacy|treatment efficacy
310545|NCT01616199|PX-866|px-866
310546|NCT01616199|BRAF-mutant cancers|braf-mutant cancers
310547|NCT01616199|Advanced melanoma|advanced melanoma
310548|NCT01616199|BRAF inhibitor|braf inhibitor
310549|NCT01616199|Vemurafenib|vemurafenib
310550|NCT01616199|Zelboraf|zelboraf
310551|NCT01616199|PI-3K inhibitor|pi-3k inhibitor
310552|NCT01616186|Renal Cell Carcinoma|renal cell carcinoma
310553|NCT01616173|Nerve Block|nerve block
310554|NCT01616173|Anesthesia Recovery Period|anesthesia recovery period
310555|NCT01616160|Nasal polyps|nasal polyps
310556|NCT01616147|Intensive Lifestyle Intervention|intensive lifestyle intervention
310557|NCT01616134|overweight,|overweight,
310558|NCT01616134|ginseng|ginseng
310559|NCT01616108|strabismus|strabismus
310560|NCT01616108|diplopia|diplopia
310561|NCT01616095|Growth hormone deficiency|growth hormone deficiency
310562|NCT01616095|hrGH therapy|hrgh therapy
310563|NCT01616095|metabolic health|metabolic health
310564|NCT01616095|adipose tissue metabolism|adipose tissue metabolism
310565|NCT01616095|adipose tissue inflammation|adipose tissue inflammation
310566|NCT01616095|adipokines|adipokines
310567|NCT01616082|fatty acid oxidation|fatty acid oxidation
310568|NCT01616082|Proton magnetic resonance spectroscopy|proton magnetic resonance spectroscopy
310569|NCT01616069|CABG|cabg
310570|NCT01616069|Echocardiography|echocardiography
310571|NCT01616069|Heart Failure|heart failure
310572|NCT01616069|Heart Function|heart function
310573|NCT01616056|Chronic graft-versus-host disease|chronic graft-versus-host disease
310574|NCT01616056|eye|eye
310575|NCT01616043|scar quality|scar quality
310576|NCT01616030|Hip fractures|hip fractures
310577|NCT01616030|Strength training|strength training
310578|NCT01616017|Cardiac output|cardiac output
310579|NCT01616017|ultrasound dilution|ultrasound dilution
310580|NCT01616017|thermodilution|thermodilution
310581|NCT01615965|prostate cancer|prostate cancer
310582|NCT01615965|lymph node|lymph node
310583|NCT01615965|micrometastasis|micrometastasis
310584|NCT01615952|Supraclavicular Block|supraclavicular block
310585|NCT01615939|Sciatic Nerve Block|sciatic nerve block
310586|NCT01615939|Continuous Nerve Block|continuous nerve block
310587|NCT01615926|dyspnea|dyspnea
310588|NCT01615926|shortness of breath|shortness of breath
310589|NCT01615926|respiratory rate|respiratory rate
310590|NCT01615926|orthopnea|orthopnea
310591|NCT01615913|onychomycosis|onychomycosis
310592|NCT01615913|terbinafine|terbinafine
310593|NCT01615913|ketoconazole|ketoconazole
310594|NCT01615913|transdermal topical therapy|transdermal topical therapy
310595|NCT01615900|Renal graft|renal graft
310596|NCT01615900|Teleconsultation|teleconsultation
310722|NCT01615484|Lung Transplant|lung transplant
310597|NCT01615900|Kidney transplant failure score|kidney transplant failure score
310598|NCT01615848|polycystic Ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
310599|NCT01615848|diet|diet
310600|NCT01615848|mediterranean diet|mediterranean diet
310601|NCT01615848|high protein diet|high protein diet
310602|NCT01615822|Malaria|malaria
310603|NCT01615822|PK|pk
310605|NCT01615822|Mefloquine|mefloquine
310606|NCT01615822|Healthy Volunteers|healthy volunteers
310607|NCT01615809|Invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
310608|NCT01615809|IFI|ifi
310609|NCT01615809|Leukaemia|leukaemia
310610|NCT01615809|Leukemia|leukemia
310611|NCT01615809|Pediatric|pediatric
310612|NCT01615809|Paediatrics|paediatrics
310613|NCT01615809|Amphotericin B|amphotericin b
310614|NCT01615809|Aspergillosis|aspergillosis
310615|NCT01615809|Pulmonary Aspergillosis|pulmonary aspergillosis
310616|NCT01615809|Invasive Aspergillosis|invasive aspergillosis
310617|NCT01615809|Antifungal agents|antifungal agents
310618|NCT01615809|Fungal infections|fungal infections
310619|NCT01615809|Invasive Fungal Infection|invasive fungal infection
310620|NCT01615796|GSK2140944|gsk2140944
310621|NCT01615796|antibiotics|antibiotics
310622|NCT01615796|first time in human|first time in human
310623|NCT01615796|pharmacokinetics|pharmacokinetics
310624|NCT01615796|intravenous|intravenous
310625|NCT01615796|safety|safety
310626|NCT01615796|absolute bioavailability|absolute bioavailability
310627|NCT01615796|Bacterial Type II|bacterial type ii
310628|NCT01615796|tolerability|tolerability
310629|NCT01615796|infection|infection
310632|NCT01615783|Resource utilization|resource utilization
310634|NCT01615757|AML|aml
310635|NCT01615757|Acute Myeloid Leukemia|acute myeloid leukemia
310636|NCT01615757|Cytarabine dose|cytarabine dose
310637|NCT01615757|Ara-c dose|ara-c dose
310638|NCT01615757|Consolidation|consolidation
310639|NCT01615744|calcaneal fractures|calcaneal fractures
310640|NCT01615744|surgical treatment|surgical treatment
310641|NCT01615744|conservative treatment|conservative treatment
310642|NCT01615744|VAS scoring|vas scoring
310643|NCT01615744|SF-36|sf-36
310644|NCT01615744|AOFAS|aofas
310645|NCT01615744|Olerud-Molander score|olerud-molander score
310646|NCT01615744|outcome|outcome
310647|NCT01615731|Mifepristone|mifepristone
310648|NCT01615731|Induced Abortion|induced abortion
310649|NCT01615731|Dilation and Evacuation|dilation and evacuation
310650|NCT01615731|Cervical preparation|cervical preparation
310651|NCT01615731|Osmotic dilators|osmotic dilators
310652|NCT01615718|noninvasive stimulation|noninvasive stimulation
310653|NCT01615718|motor function|motor function
310654|NCT01615718|transcranial stimulation|transcranial stimulation
310655|NCT01615718|transcranial ultrasound|transcranial ultrasound
310656|NCT01615718|brain stimulation|brain stimulation
310657|NCT01615705|Postphlebitic Syndrome|postphlebitic syndrome
310658|NCT01615705|Post-Thrombotic Syndrome|post-thrombotic syndrome
310659|NCT01615705|Biomarkers|biomarkers
310660|NCT01615705|Markers of Inflammation|markers of inflammation
310661|NCT01615705|Genetic Thrombophilia|genetic thrombophilia
310662|NCT01615705|Coagulation Activation|coagulation activation
310663|NCT01615692|Elastic Stockings|elastic stockings
310664|NCT01615692|Stockings, Compression|stockings, compression
310665|NCT01615692|Randomized Controlled Trials|randomized controlled trials
310666|NCT01615692|Quality of Life|quality of life
310667|NCT01615679|Non-interventional study|non-interventional study
310668|NCT01615679|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
310669|NCT01615679|ADHD|adhd
310670|NCT01615666|Alzheimer's disease|alzheimer's disease
310671|NCT01615666|Mild Cognitive Impairment|mild cognitive impairment
310672|NCT01615666|Frontotemporal dementia|frontotemporal dementia
301362|NCT01658137|diet|diet
310673|NCT01615666|fMRI|fmri
310674|NCT01615666|functional neuroimaging|functional neuroimaging
310675|NCT01615666|Memory|memory
310676|NCT01615653|Pancreatic cancer|pancreatic cancer
310677|NCT01615653|Pancreas cancer|pancreas cancer
310678|NCT01615653|Pain|pain
310679|NCT01615653|Celiac Plexus|celiac plexus
310680|NCT01615653|Neurolysis|neurolysis
310681|NCT01615640|Osteosarcoma|osteosarcoma
310682|NCT01615640|Response of chemotherapy|response of chemotherapy
310683|NCT01615640|Dynamic contrast medium examination|dynamic contrast medium examination
310684|NCT01615640|Diffusion-weighted MR imaging|diffusion-weighted mr imaging
310685|NCT01615627|Subcutaneous Treprostinil|subcutaneous treprostinil
310686|NCT01615614|Rilpivirine|rilpivirine
310687|NCT01615614|Rifabutin|rifabutin
310688|NCT01615614|Pharmacokinetics|pharmacokinetics
310689|NCT01615614|Healthy participants|healthy participants
310690|NCT01615601|Human Immunodeficiency Virus|human immunodeficiency virus
310691|NCT01615601|HIV|hiv
310692|NCT01615601|HIV-1|hiv-1
310693|NCT01615601|HIV type 1|hiv type 1
310694|NCT01615601|Darunavir|darunavir
310695|NCT01615601|PREZISTA|prezista
310696|NCT01615601|Etravirine|etravirine
310697|NCT01615601|INTELENCE|intelence
310698|NCT01615601|HIV symptom Distress Module|hiv symptom distress module
310699|NCT01615601|HIV-SDM|hiv-sdm
310700|NCT01615601|Antiretroviral therapy|antiretroviral therapy
310701|NCT01615601|HIV Symptom Index (HSI),|hiv symptom index (hsi),
310702|NCT01615588|manuka honey|manuka honey
310703|NCT01615588|glycaemic index|glycaemic index
310704|NCT01615588|blood glucose control|blood glucose control
310705|NCT01615588|individuals|individuals
310706|NCT01615588|current disease|current disease
311911|NCT01610089|urea|urea
310707|NCT01615588|medication use|medication use
310708|NCT01615562|Polycystic Ovary Syndrome|polycystic ovary syndrome
310709|NCT01615562|PCOS|pcos
310710|NCT01615562|Infertility|infertility
310711|NCT01615549|Cholecystectomy|cholecystectomy
310712|NCT01615549|Virtual reality device|virtual reality device
310713|NCT01615549|Training|training
310714|NCT01615536|chronic rhinosinusitis|chronic rhinosinusitis
310715|NCT01615536|canine fossa trephine|canine fossa trephine
310716|NCT01615536|canine fossa puncture|canine fossa puncture
310717|NCT01615523|Executive functions|executive functions
310718|NCT01615497|cognitive behavior therapy|cognitive behavior therapy
310719|NCT01615497|computer assisted instruction|computer assisted instruction
310720|NCT01615497|alcohol abuse therapy|alcohol abuse therapy
310721|NCT01615497|educational resource design and development|educational resource design and development
310723|NCT01615484|Emphysema|emphysema
310724|NCT01615484|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
310725|NCT01615484|Cystic Fibrosis|cystic fibrosis
310726|NCT01615484|Pulmonary Fibrosis|pulmonary fibrosis
310727|NCT01615484|Bronchiectasis|bronchiectasis
310728|NCT01615484|Sarcoidosis|sarcoidosis
310729|NCT01615484|Pulmonary Hypertension|pulmonary hypertension
310730|NCT01615484|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
310731|NCT01615471|Obesity|obesity
310732|NCT01615471|Lifestyle Intervention|lifestyle intervention
310733|NCT01615471|Group treatment|group treatment
310734|NCT01615471|Internet Intervention|internet intervention
310735|NCT01615458|Care Management|care management
310736|NCT01615458|Implementation|implementation
310737|NCT01615458|Intervention|intervention
310738|NCT01615458|Mood Disorders|mood disorders
310739|NCT01615380|smoking cessation|smoking cessation
310740|NCT01615380|Aerobic Exercise|aerobic exercise
310741|NCT01615380|Women|women
310742|NCT01615380|YMCA|ymca
310743|NCT01615367|Bipolar disorder|bipolar disorder
310744|NCT01615367|Nutrition|nutrition
310745|NCT01615367|Exercise|exercise
310746|NCT01615367|Symptoms|symptoms
310747|NCT01615367|Functioning|functioning
310748|NCT01615341|Kidney transplantation|kidney transplantation
310749|NCT01615341|Subclinical Viral Infection|subclinical viral infection
310750|NCT01615341|Renal Allograft Injury|renal allograft injury
310751|NCT01615328|anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
310752|NCT01615328|bone graft substitute|bone graft substitute
310753|NCT01615328|PEEK cage|peek cage
310754|NCT01615328|hydroxyapatite|hydroxyapatite
310755|NCT01615328|demineralized bone matrix|demineralized bone matrix
310756|NCT01615328|b-tricalcium phosphate|b-tricalcium phosphate
310757|NCT01615328|Bonion|bonion
310758|NCT01615328|Cervios ChronOs|cervios chronos
310759|NCT01615315|aspirin|aspirin
310760|NCT01615315|screening|screening
310761|NCT01615315|microscopic hematuria|microscopic hematuria
310762|NCT01615302|Rectal Fistula|rectal fistula
310763|NCT01615302|Peri-anal Fistula|peri-anal fistula
310764|NCT01615302|Platelet-Rich Plasma|platelet-rich plasma
310765|NCT01615302|Mucosa advancement flap|mucosa advancement flap
310766|NCT01615276|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
310767|NCT01615276|Ageing|ageing
310768|NCT01615276|Protein ingestion|protein ingestion
752609|NCT01173315|micronutrients|micronutrients
310769|NCT01615263|Video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
310770|NCT01615263|One lung ventilation|one lung ventilation
310771|NCT01615263|Bronchial blocker|bronchial blocker
310772|NCT01615263|Lung collapse|lung collapse
310773|NCT01615263|Double lumen tube|double lumen tube
310774|NCT01615224|missed abortion|missed abortion
310775|NCT01615224|miscarriage|miscarriage
310776|NCT01615211|Abortion|abortion
310777|NCT01615211|medical abortion|medical abortion
310778|NCT01615211|termination of pregnancy|termination of pregnancy
310779|NCT01615211|Mifepristone|mifepristone
310780|NCT01615211|misoprostol|misoprostol
310781|NCT01615211|letrozole|letrozole
310782|NCT01615211|trilostane|trilostane
310783|NCT01615211|femara|femara
310784|NCT01615211|Modrenal|modrenal
310785|NCT01615198|Hypertension, blood pressure, LCZ696, dual inhibitor, neprilysin, NEP inhibition, vasopeptidase, ARNi, angiotensin receptor|hypertension, blood pressure, lcz696, dual inhibitor, neprilysin, nep inhibition, vasopeptidase, arni, angiotensin receptor
310786|NCT01615185|schizophrenia|schizophrenia
310787|NCT01615185|amisulpride|amisulpride
310788|NCT01615185|sulpiride|sulpiride
310789|NCT01615185|antipsychotic combination|antipsychotic combination
310790|NCT01615159|Sodium|sodium
310791|NCT01615159|Diet|diet
310792|NCT01615159|Urinary sodium excretion|urinary sodium excretion
310793|NCT01615159|Feeding study|feeding study
310794|NCT01615159|Diet maintenance|diet maintenance
310795|NCT01615146|Myelodysplasia|myelodysplasia
310796|NCT01615146|Leukemia|leukemia
310797|NCT01615146|Thrombocytopenia|thrombocytopenia
310798|NCT01615146|Platelet|platelet
310799|NCT01615146|transfusions|transfusions
310800|NCT01615146|Outpatient|outpatient
310801|NCT01615081|Malt extract|malt extract
310802|NCT01615081|carbohydrate|carbohydrate
310803|NCT01615081|glucose response|glucose response
310804|NCT01615081|insulin response|insulin response
310805|NCT01615081|Appetite|appetite
310806|NCT01615081|Appetite regulating hormones|appetite regulating hormones
310807|NCT01615055|Chemotherapy|chemotherapy
310808|NCT01615055|Cognitive|cognitive
310809|NCT01615055|Prozac|prozac
310810|NCT01615055|Fluoxetine|fluoxetine
310812|NCT01615055|PET|pet
310813|NCT01615042|Acute Leukemia|acute leukemia
310814|NCT01615042|Bone Marrow Transplant|bone marrow transplant
310815|NCT01615042|High Dose Lenalidomide|high dose lenalidomide
310816|NCT01615029|Multiple Myeloma|multiple myeloma
310817|NCT01615029|Daratumumab|daratumumab
310818|NCT01615029|Lenalidomide|lenalidomide
310819|NCT01615029|Dexamethasone|dexamethasone
310820|NCT01615029|Dose-escalation|dose-escalation
310821|NCT01615029|Relapsed multiple myeloma|relapsed multiple myeloma
310822|NCT01615029|Relapsed and refractory multiple myeloma|relapsed and refractory multiple myeloma
310823|NCT01615016|Preterm infant|preterm infant
310824|NCT01615016|Surfactant application|surfactant application
310825|NCT01615016|Respiratory Distress Syndrome|respiratory distress syndrome
310826|NCT01615016|Minimally invasive Surfactant Application|minimally invasive surfactant application
310827|NCT01615016|INSURE (Intubate-Surfactant-Extubate)|insure (intubate-surfactant-extubate)
310828|NCT01615003|MicroRNA|microrna
310829|NCT01615003|coronary heart disease|coronary heart disease
310830|NCT01615003|unstable angina|unstable angina
310831|NCT01615003|blood stasis syndrome|blood stasis syndrome
310832|NCT01615003|Xuesaitong soft capsule|xuesaitong soft capsule
310833|NCT01614977|nontuberculous mycobacteria|nontuberculous mycobacteria
310834|NCT01614977|corticosteroids|corticosteroids
310835|NCT01614977|children|children
310836|NCT01614977|lymphadeniti|lymphadeniti
402040|NCT01233375|Gemcitabine-Refractory|gemcitabine-refractory
402041|NCT01233375|Second-Line Therapy|second-line therapy
310837|NCT01614977|Therapeutic intervention in immunocompetent children with nontuberculous mycobacterial lymphadenitis.|therapeutic intervention in immunocompetent children with nontuberculous mycobacterial lymphadenitis.
310838|NCT01614964|Plasmodium falciparum|plasmodium falciparum
310839|NCT01614964|pharmacokinetics|pharmacokinetics
310840|NCT01614964|antimalarials (antimalarial drugs)|antimalarials (antimalarial drugs)
310841|NCT01614964|chloroquine (chloroquine-resistant)|chloroquine (chloroquine-resistant)
310842|NCT01614964|QT (QTc) interval|qt (qtc) interval
310843|NCT01614938|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
310844|NCT01614938|Locally advanced|locally advanced
310845|NCT01614938|Cetuximab|cetuximab
310846|NCT01614938|Weekly cisplatin chemotherapy|weekly cisplatin chemotherapy
310847|NCT01614938|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
310848|NCT01614886|Rivastigmine, Alzheimer's disease, Transdermal patch|rivastigmine, alzheimer's disease, transdermal patch
310849|NCT01614873|Breathing Pattern|breathing pattern
310850|NCT01614873|Mechanical Ventilation|mechanical ventilation
310851|NCT01614873|Pressure support ventilation|pressure support ventilation
310852|NCT01614873|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
310853|NCT01614860|Aldosterone|aldosterone
310854|NCT01614860|Echocardiography|echocardiography
310855|NCT01614860|Neurohormones|neurohormones
310856|NCT01614847|dry eye|dry eye
310857|NCT01614847|artificial tears|artificial tears
301611|NCT01656993|ASA|asa
310858|NCT01614847|tear osmolarity|tear osmolarity
310859|NCT01614847|residence time|residence time
310860|NCT01614834|urticaria|urticaria
310861|NCT01614834|disease control|disease control
310862|NCT01614834|severity|severity
310863|NCT01614834|test|test
310864|NCT01614821|Relapsed|relapsed
310865|NCT01614821|Refractory|refractory
310866|NCT01614743|Rosacea|rosacea
310868|NCT01614730|Modified Device|modified device
310869|NCT01614717|Hypertrophic Obstructive Cardiomyopathy|hypertrophic obstructive cardiomyopathy
310870|NCT01614717|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
310871|NCT01614704|Breast cancer|breast cancer
310872|NCT01614704|Fertility|fertility
310873|NCT01614678|myopia|myopia
310874|NCT01614665|Transplant|transplant
310875|NCT01614665|Prograf|prograf
310876|NCT01614665|Heart|heart
310877|NCT01614665|Advagraf|advagraf
310878|NCT01614665|Tacrolimus|tacrolimus
310879|NCT01614665|Immunosuppression|immunosuppression
310880|NCT01614665|Kidney|kidney
310881|NCT01614665|Liver|liver
310882|NCT01614665|Pharmacokinetic|pharmacokinetic
310883|NCT01614665|Pediatric|pediatric
310884|NCT01614652|Congestive Heart Failure Due to LV Systolic Dysfunction|congestive heart failure due to lv systolic dysfunction
310885|NCT01614639|Acupuncture|acupuncture
310886|NCT01614639|fMRI|fmri
310887|NCT01614639|CLBP|clbp
310888|NCT01614639|Pain|pain
310889|NCT01614639|Low Back Pain|low back pain
310890|NCT01614639|Back Pain|back pain
310891|NCT01614626|HIV|hiv
310892|NCT01614626|Alcohol Use|alcohol use
310893|NCT01614626|Microbial Translocation|microbial translocation
310894|NCT01614626|Inflammation|inflammation
310895|NCT01614626|Altered Coagulation|altered coagulation
310896|NCT01614626|Russia|russia
310897|NCT01614600|contact lens|contact lens
310898|NCT01614600|dry eye syndrome|dry eye syndrome
310899|NCT01614600|symptomatic|symptomatic
310900|NCT01614600|daily disposable|daily disposable
310901|NCT01614600|myopia|myopia
310902|NCT01614587|pelvic organ prolapse|pelvic organ prolapse
310903|NCT01614587|recurrence of pelvic organ prolapse|recurrence of pelvic organ prolapse
310904|NCT01614587|genetic predisposition|genetic predisposition
310905|NCT01614587|SNP microarray analysis|snp microarray analysis
310906|NCT01614587|pelvic floor|pelvic floor
310907|NCT01614587|genetic factors|genetic factors
310908|NCT01614587|adequate prolapse repair|adequate prolapse repair
310909|NCT01614587|polymorphisms|polymorphisms
310910|NCT01614587|surgical failure|surgical failure
310911|NCT01614587|reoperation|reoperation
310912|NCT01614587|DNA|dna
310913|NCT01614587|buccal swabs|buccal swabs
310914|NCT01614587|TaqMan SNP allelic discriminiation assays|taqman snp allelic discriminiation assays
310915|NCT01614587|duplex real-time PCR|duplex real-time pcr
310916|NCT01614587|genome-wide SNP microarrays|genome-wide snp microarrays
310917|NCT01614587|next-generation sequencing|next-generation sequencing
310918|NCT01614561|Hypercholesterolemia|hypercholesterolemia
310919|NCT01614561|Lipid lowering drugs|lipid lowering drugs
310920|NCT01614561|Cholesterol level in blood|cholesterol level in blood
310921|NCT01614561|Target cholesterol levels guidelines for the management of high blood cholesterol|target cholesterol levels guidelines for the management of high blood cholesterol
310922|NCT01614548|Prostatic Neoplasms|prostatic neoplasms
310923|NCT01614548|Prostate Cancer|prostate cancer
310924|NCT01614548|Disease Management|disease management
310925|NCT01614548|Rural|rural
310926|NCT01614548|Urban|urban
310927|NCT01614522|Metastatic gastro-oesophageal carcinoma|metastatic gastro-oesophageal carcinoma
310928|NCT01614522|Recurrent gastro-oesophageal carcinoma|recurrent gastro-oesophageal carcinoma
310929|NCT01614522|Gastric cancer|gastric cancer
310930|NCT01614522|HER-1|her-1
310931|NCT01614522|HER-2|her-2
310932|NCT01614509|branch retinal vein occlusion|branch retinal vein occlusion
310933|NCT01614509|bevacizumab|bevacizumab
310934|NCT01614509|triamcinolone acetonide|triamcinolone acetonide
310935|NCT01614483|Vitamin A deficiency|vitamin a deficiency
310936|NCT01614483|Biofortification|biofortification
310937|NCT01614483|Cassava|cassava
310938|NCT01614483|B-carotene|b-carotene
310939|NCT01614483|School children|school children
310940|NCT01614483|Kenya|kenya
310941|NCT01614431|renal function|renal function
310942|NCT01614431|before and after N acetyl cysteine|before and after n acetyl cysteine
310943|NCT01614431|Cystinosis patients|cystinosis patients
310944|NCT01614405|PBC|pbc
310945|NCT01614392|Resistance Exercise|resistance exercise
310946|NCT01614392|Physical Activity|physical activity
310947|NCT01614392|Mobility disability|mobility disability
310948|NCT01614392|Physical function|physical function
310949|NCT01614392|Muscle Strength|muscle strength
310950|NCT01614392|Older Adults|older adults
310951|NCT01614392|Mobility-Limited|mobility-limited
310952|NCT01614392|Peak power and strength|peak power and strength
310953|NCT01614366|amlodipine|amlodipine
310954|NCT01614366|DMTA07|dmta07
310955|NCT01614366|hypertension|hypertension
310956|NCT01614353|Multiple Chronic Conditions|multiple chronic conditions
310957|NCT01614353|Older Adults|older adults
310958|NCT01614353|New Prescription|new prescription
310959|NCT01614340|Home care|home care
310960|NCT01614340|Cognitive-Behavioral techniques|cognitive-behavioral techniques
310961|NCT01614340|Physical Therapy|physical therapy
310962|NCT01614340|Pain|pain
310963|NCT01614340|Older Adults|older adults
310964|NCT01614327|Diabetes Type One|diabetes type one
310965|NCT01614327|Diabetes Type Two|diabetes type two
310966|NCT01614327|PreDiabetes|prediabetes
310967|NCT01614327|Retinal Screening|retinal screening
310968|NCT01614327|RiskAnalyzer|riskanalyzer
310969|NCT01614327|Retinal Imaging|retinal imaging
310970|NCT01614327|Algorithm|algorithm
310971|NCT01614327|Diabetic Retinopathy|diabetic retinopathy
310972|NCT01614327|Microaneurysms|microaneurysms
310973|NCT01614327|Neovascularization|neovascularization
310974|NCT01614327|Intraretinal microvascular abnormalities|intraretinal microvascular abnormalities
310975|NCT01614314|Preceptorship, simulation, nursing, catheters|preceptorship, simulation, nursing, catheters
310976|NCT01614301|advanced Melanoma|advanced melanoma
310977|NCT01614288|HTO|hto
310978|NCT01614288|Arthroscopy|arthroscopy
310979|NCT01614288|Quality-of-Life|quality-of-life
310980|NCT01614288|Gait Analysis|gait analysis
310981|NCT01614275|Autism|autism
310982|NCT01614275|Early Intervention|early intervention
310983|NCT01614275|Parent Training|parent training
310984|NCT01614275|EIBI|eibi
310985|NCT01614275|Applied Behavior Analysis|applied behavior analysis
310986|NCT01614249|Omega-3|omega-3
310987|NCT01614249|EPA|epa
310988|NCT01614249|Depression|depression
310989|NCT01614249|HIV infected|hiv infected
310990|NCT01614249|Pregnant women|pregnant women
310991|NCT01614236|pregabalin|pregabalin
310992|NCT01614236|analgesia|analgesia
310993|NCT01614236|postoperative pain|postoperative pain
310994|NCT01614236|orthopedic oncology patients|orthopedic oncology patients
310995|NCT01614223|Plantar fasciitis|plantar fasciitis
310996|NCT01614223|Autologous Conditioned Plasma|autologous conditioned plasma
310997|NCT01614197|Relapse|relapse
310998|NCT01614197|Lymphoblastic|lymphoblastic
310999|NCT01614197|Leukemia|leukemia
311000|NCT01614197|Refractory|refractory
311001|NCT01614197|Temsirolimus|temsirolimus
311002|NCT01614197|Acute|acute
311003|NCT01614197|Childhood|childhood
311004|NCT01614197|Pediatric|pediatric
311005|NCT01614197|ALL|all
311006|NCT01614197|NHL|nhl
311007|NCT01614197|LL|ll
311008|NCT01614197|PTL|ptl
311009|NCT01614171|osteoporosis pseudoglioma|osteoporosis pseudoglioma
311010|NCT01614171|OPPG|oppg
311011|NCT01614171|growth hormone|growth hormone
311012|NCT01614171|osteoporosis|osteoporosis
311013|NCT01614158|N-AION|n-aion
311014|NCT01614158|perimetry|perimetry
311015|NCT01614158|visual field loss|visual field loss
311016|NCT01614158|Mean Defect|mean defect
311017|NCT01614158|Total Loss Volume|total loss volume
311018|NCT01614158|D-BCVA|d-bcva
311019|NCT01614158|RAPD|rapd
753308|NCT01176214|tracheostomy|tracheostomy
311020|NCT01614158|retinal nerve fibre thickness/volume|retinal nerve fibre thickness/volume
311021|NCT01614158|optic nerve head|optic nerve head
311022|NCT01614132|medulloblastoma|medulloblastoma
311023|NCT01614132|CNS|cns
311024|NCT01614132|malignant neoplasm|malignant neoplasm
311025|NCT01614132|NOA|noa
311026|NCT01614132|neuroectodermal tumor|neuroectodermal tumor
311027|NCT01614132|Vincristin|vincristin
311028|NCT01614132|CCNU|ccnu
311029|NCT01614132|Cisplatin|cisplatin
311030|NCT01614119|Cerebral|cerebral
311031|NCT01614119|Oxygenation|oxygenation
311032|NCT01614119|Performance|performance
311033|NCT01614119|Exercise|exercise
311034|NCT01614106|HIV/AIDS|hiv/aids
311035|NCT01614106|Drug Users|drug users
311036|NCT01614106|Crack-Cocaine Use|crack-cocaine use
311037|NCT01614106|HIV Primary Care|hiv primary care
311038|NCT01614093|Schizophrenia|schizophrenia
311039|NCT01614093|Appetite|appetite
311040|NCT01614093|Oxytocin|oxytocin
311041|NCT01614080|Stroke|stroke
312481|NCT01608139|Vorinostat|vorinostat
311042|NCT01614080|Ischemic stroke|ischemic stroke
311043|NCT01614080|thrombolysis|thrombolysis
311044|NCT01614080|toxicity of t-PA|toxicity of t-pa
311046|NCT01614067|Infertility|infertility
311047|NCT01614067|IVF|ivf
311048|NCT01614067|ART|art
311049|NCT01614067|GnRHa|gnrha
311050|NCT01614067|GnRH Antagonist Protocol|gnrh antagonist protocol
311051|NCT01614067|Ganirelix|ganirelix
311052|NCT01614054|Smoking cessation|smoking cessation
311053|NCT01614054|Nicotine replacement therapy|nicotine replacement therapy
311054|NCT01614054|NRT|nrt
311055|NCT01614054|Inpatient|inpatient
311056|NCT01614054|General Medicine|general medicine
311057|NCT01614041|Generalized Anxiety Disorder|generalized anxiety disorder
311058|NCT01614015|Recording|recording
311059|NCT01614015|Supervision|supervision
311060|NCT01614015|Observation|observation
311061|NCT01614002|carcinoma|carcinoma
311062|NCT01614002|breast cancer|breast cancer
752610|NCT01173315|nephropathy|nephropathy
311063|NCT01614002|non-small cell lung cancer|non-small cell lung cancer
311064|NCT01614002|prostata cancer|prostata cancer
311065|NCT01614002|adenocarcinoma of the stomach|adenocarcinoma of the stomach
311066|NCT01614002|squamous cell carcinoma of the head and neck region|squamous cell carcinoma of the head and neck region
311067|NCT01614002|ambulant chemotherapy|ambulant chemotherapy
311068|NCT01614002|treatment cycles|treatment cycles
311069|NCT01614002|Docetaxel|docetaxel
311070|NCT01614002|Doce onkovis|doce onkovis
311071|NCT01614002|Quantity of Docetaxel|quantity of docetaxel
311072|NCT01614002|Packaging Sizes|packaging sizes
311073|NCT01613989|Hip arthroplasty|hip arthroplasty
311074|NCT01613989|navigation|navigation
311075|NCT01613976|Myelodysplastic Syndromes|myelodysplastic syndromes
311076|NCT01613976|MDS|mds
311077|NCT01613976|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
311078|NCT01613976|CMML|cmml
311079|NCT01613976|Acute Myeloid Leukemia|acute myeloid leukemia
311080|NCT01613976|AML|aml
311081|NCT01613976|Panobinostat|panobinostat
311082|NCT01613976|LBH589|lbh589
311083|NCT01613976|5-Aza|5-aza
311084|NCT01613976|Azacitidine|azacitidine
311085|NCT01613963|Uveitis|uveitis
311086|NCT01613963|Scleritis|scleritis
311087|NCT01613950|gastric cancer advanced gastric or metastatic gastric cancer PI3K PIK3CA mutation Her2 amplification HSP90 inhibitor PI3K inhibitor PIK3CA amplification|gastric cancer advanced gastric or metastatic gastric cancer pi3k pik3ca mutation her2 amplification hsp90 inhibitor pi3k inhibitor pik3ca amplification
311088|NCT01613937|Latinas|latinas
311089|NCT01613937|Gestational Diabetes|gestational diabetes
311090|NCT01613937|Prevention|prevention
311091|NCT01613911|Epilepsy|epilepsy
311092|NCT01613911|Invasive monitoring|invasive monitoring
311093|NCT01613911|Human sensory perception|human sensory perception
311094|NCT01613898|Cerebrotendinous xanthomatosis (CTX),|cerebrotendinous xanthomatosis (ctx),
311095|NCT01613898|lipoprotein,atherosclerosis,|lipoprotein,atherosclerosis,
311096|NCT01613898|carotid artery intima-media thickness (cIMT).|carotid artery intima-media thickness (cimt).
311097|NCT01613833|Alpha2 macroglobulin|alpha2 macroglobulin
311098|NCT01613833|Osteoarthritis|osteoarthritis
311912|NCT01610076|Code Status|code status
311099|NCT01613833|plasma and synovium|plasma and synovium
311100|NCT01613807|gestational diabetes mellitus|gestational diabetes mellitus
311101|NCT01613807|insulin analogues in pregnancy|insulin analogues in pregnancy
311102|NCT01613794|Deep vein thrombosis|deep vein thrombosis
311103|NCT01613794|Pulmonary embolism|pulmonary embolism
311104|NCT01613794|Rosuvastatin treatment|rosuvastatin treatment
311105|NCT01613794|Pharmacologic actions|pharmacologic actions
311106|NCT01613781|hemifacial spasm|hemifacial spasm
311107|NCT01613781|microvascular decompression|microvascular decompression
311108|NCT01613781|neuromuscular blockade|neuromuscular blockade
311109|NCT01613781|electromyography|electromyography
311110|NCT01613755|Effect Dipyridamole on pharmacokinetics of metformin|effect dipyridamole on pharmacokinetics of metformin
311111|NCT01613729|Dyslipidemia|dyslipidemia
311112|NCT01613729|Rosuvastatin|rosuvastatin
311113|NCT01613729|Efficacy|efficacy
311114|NCT01613729|Safety|safety
311115|NCT01613716|Diabetes|diabetes
311116|NCT01613716|Macular Edema|macular edema
311117|NCT01613716|Epiretinal Membrane|epiretinal membrane
311119|NCT01613703|ONO-2952|ono-2952
311120|NCT01613703|Healthy adult subjects|healthy adult subjects
311121|NCT01613703|single doe|single doe
311122|NCT01613703|PET study|pet study
311123|NCT01613703|Safety|safety
311124|NCT01613703|Tolerability|tolerability
311125|NCT01613690|Renal impairment|renal impairment
311126|NCT01613690|NVA237|nva237
311127|NCT01613690|Pharmacokinetics|pharmacokinetics
311128|NCT01613677|advanced cervical cancer, BKM 120, progression free survival|advanced cervical cancer, bkm 120, progression free survival
311129|NCT01613664|obesity|obesity
311130|NCT01613664|surgical management|surgical management
311131|NCT01613664|sleeve gastrectomy|sleeve gastrectomy
311132|NCT01613638|congenital malformation|congenital malformation
311133|NCT01613638|pollutants|pollutants
311134|NCT01613586|Interstitial Cystitis|interstitial cystitis
311135|NCT01613586|Bladder Pain Syndrome|bladder pain syndrome
311136|NCT01613586|Painful Bladder Syndrome|painful bladder syndrome
311137|NCT01613586|ASP3652|asp3652
311138|NCT01613573|pegylated Somatropin|pegylated somatropin
311139|NCT01613573|PEG-GH|peg-gh
311140|NCT01613573|Phase 1 study|phase 1 study
311141|NCT01613573|Pharmacokinetics|pharmacokinetics
311142|NCT01613534|chronic radiation proctopathy|chronic radiation proctopathy
311143|NCT01613534|argon plasma coagulation|argon plasma coagulation
311144|NCT01613534|sucralfate|sucralfate
311145|NCT01613521|DCE-MRI|dce-mri
311146|NCT01613521|18F-FMISO PET|18f-fmiso pet
311147|NCT01613521|11-174|11-174
311148|NCT01613495|obesity|obesity
311149|NCT01613469|fluorouracil|fluorouracil
311150|NCT01613469|leucovorin|leucovorin
311151|NCT01613469|radiotherapy|radiotherapy
311152|NCT01613469|neoadjuvant therapy|neoadjuvant therapy
311153|NCT01613443|Dabigatran, Rivaroxaban, Point of Care-testing|dabigatran, rivaroxaban, point of care-testing
311154|NCT01613417|Have confirmed or are highly suspected of brain disease|have confirmed or are highly suspected of brain disease
311155|NCT01613404|Chronic kidney disease|chronic kidney disease
311156|NCT01613404|Hemodialysis|hemodialysis
311157|NCT01613404|Eprex|eprex
311158|NCT01613404|Aranesp|aranesp
311160|NCT01613404|Anemia|anemia
311161|NCT01613391|Visfatin|visfatin
311162|NCT01613391|Resistin|resistin
311163|NCT01613391|Apelin|apelin
311164|NCT01613391|roux-en-y gastric bypass|roux-en-y gastric bypass
311165|NCT01613391|laparoscopic adjustable gastric banding|laparoscopic adjustable gastric banding
311166|NCT01613391|morbid obesity|morbid obesity
311167|NCT01613352|Early breast cancer surgery|early breast cancer surgery
311168|NCT01613352|Psychosocial wellbeing|psychosocial wellbeing
311169|NCT01613352|Ambulatory surgery|ambulatory surgery
311170|NCT01613339|stroke|stroke
311171|NCT01613339|postural control|postural control
311172|NCT01613339|body awareness therapy|body awareness therapy
311173|NCT01613326|COPD|copd
311174|NCT01613313|Lipoma|lipoma
311175|NCT01613313|Fatty Tumor|fatty tumor
311176|NCT01613300|hodgkin|hodgkin
311177|NCT01613300|disease|disease
311178|NCT01613300|ofatumumab|ofatumumab
311179|NCT01613287|Pulmonary Hypertension|pulmonary hypertension
311180|NCT01613287|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
311181|NCT01613287|TheraSorb|therasorb
311182|NCT01613287|immunoadsorption|immunoadsorption
311183|NCT01613274|colon resection|colon resection
311184|NCT01613261|TAK-733,|tak-733,
311185|NCT01613261|alisertib,|alisertib,
311186|NCT01613261|MLN8237,|mln8237,
311187|NCT01613261|Oral MEK Inhibitor,|oral mek inhibitor,
311188|NCT01613261|Oral Aurora A Kinase Inhibitor|oral aurora a kinase inhibitor
311189|NCT01613235|subarachnoid hemorrhage|subarachnoid hemorrhage
311190|NCT01613235|ischemia|ischemia
311191|NCT01613235|vasospasm|vasospasm
311192|NCT01613235|CT|ct
311193|NCT01613235|perfusion|perfusion
311194|NCT01613235|induced hypertension|induced hypertension
311195|NCT01613235|delayed cerebral ischemia|delayed cerebral ischemia
311196|NCT01613209|Hypertension|hypertension
311197|NCT01613209|ABPM|abpm
311198|NCT01613209|office blood pressure|office blood pressure
311199|NCT01613209|olmesartan|olmesartan
311200|NCT01613209|amlodipine|amlodipine
311201|NCT01613209|fixed combination|fixed combination
311202|NCT01613209|time of intake|time of intake
311203|NCT01613196|Extrapulmonary tuberculosis|extrapulmonary tuberculosis
311204|NCT01613196|FDG-TEP|fdg-tep
311205|NCT01613196|cohorts|cohorts
311206|NCT01613170|Overactive Bladder|overactive bladder
311207|NCT01613170|Vaginal Estrogen|vaginal estrogen
311208|NCT01613170|Anticholinergics|anticholinergics
311209|NCT01613170|Antimuscarinics|antimuscarinics
311210|NCT01613157|pharmacokinetics|pharmacokinetics
311211|NCT01613157|HIV infected women|hiv infected women
311212|NCT01613118|Primary FSGS|primary fsgs
311213|NCT01613118|Nephrotic syndrome|nephrotic syndrome
311214|NCT01613118|Steroid Resistant|steroid resistant
311215|NCT01613105|Diabetes Mellitus|diabetes mellitus
311216|NCT01613105|Type-2|type-2
311217|NCT01613105|Acarbose|acarbose
311218|NCT01613105|Drug Therapy|drug therapy
311219|NCT01613105|Combination|combination
311220|NCT01613092|Arrhythmia|arrhythmia
311221|NCT01613092|Device Procedure|device procedure
311222|NCT01613092|High risk patients|high risk patients
311223|NCT01613092|Antibiotics|antibiotics
311224|NCT01613092|Infection|infection
311226|NCT01613079|Rheumatoid Arthritis|rheumatoid arthritis
311227|NCT01613079|Methotrexate|methotrexate
311228|NCT01613079|Tripterygium|tripterygium
311229|NCT01613066|Haematological malignancies|haematological malignancies
311230|NCT01613066|Allogeneic Cord Blood transplantation|allogeneic cord blood transplantation
311231|NCT01613066|Intrabone|intrabone
311232|NCT01613053|Gastrointestinal Stromal Tumor, GIST|gastrointestinal stromal tumor, gist
311233|NCT01613014|Alcohol|alcohol
311234|NCT01613014|Alcohol Dependence|alcohol dependence
311235|NCT01613014|Alcohol Abuse|alcohol abuse
311236|NCT01613014|Alcohol Use Disorders|alcohol use disorders
311237|NCT01613014|Alcoholism|alcoholism
311238|NCT01612988|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
311239|NCT01612988|relapse|relapse
311240|NCT01612988|Bendamustine|bendamustine
311242|NCT01612988|Méthylprednisolone|méthylprednisolone
311243|NCT01612975|Chest tubes|chest tubes
311244|NCT01612975|Length of stay|length of stay
311245|NCT01612975|Pleural effusion|pleural effusion
311246|NCT01612975|Lung resection|lung resection
311247|NCT01612975|Post-operative|post-operative
311248|NCT01612975|Lung cancer|lung cancer
311249|NCT01612949|endotracheal intubation|endotracheal intubation
311250|NCT01612949|facial structure|facial structure
311251|NCT01612949|Mallampati score|mallampati score
311252|NCT01612949|computerized facial analysis|computerized facial analysis
311253|NCT01612936|Asthma|asthma
311254|NCT01612936|Allergic|allergic
311255|NCT01612936|Inflammation|inflammation
311256|NCT01612936|Constriction|constriction
311257|NCT01612936|Airway|airway
311258|NCT01612936|Challenge|challenge
311259|NCT01612936|Chemokines|chemokines
311260|NCT01612923|abortion|abortion
311261|NCT01612923|medical abortion|medical abortion
311262|NCT01612910|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
311263|NCT01612910|HER2-negative breast cancer|her2-negative breast cancer
311264|NCT01612910|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
311265|NCT01612910|recurrent breast cancer|recurrent breast cancer
311266|NCT01612910|stage II breast cancer|stage ii breast cancer
311267|NCT01612910|stage IIIA breast cancer|stage iiia breast cancer
311268|NCT01612910|stage IIIB breast cancer|stage iiib breast cancer
311269|NCT01612910|stage IIIC breast cancer|stage iiic breast cancer
311270|NCT01612910|triple-negative breast cancer|triple-negative breast cancer
311271|NCT01612897|autism|autism
311272|NCT01612897|well child care|well child care
311273|NCT01612897|screening|screening
311274|NCT01612897|computer|computer
311275|NCT01612897|reminders|reminders
311276|NCT01612871|Breast cancer,|breast cancer,
311277|NCT01612871|hormonotherapy,|hormonotherapy,
311278|NCT01612871|miRNAs,|mirnas,
311279|NCT01612871|biomarkers|biomarkers
311280|NCT01612871|hormone therapy|hormone therapy
311281|NCT01612858|Lipodystrophy|lipodystrophy
311282|NCT01612858|Insulin resistance|insulin resistance
311283|NCT01612858|HIV infection|hiv infection
311284|NCT01612845|rotator cuff|rotator cuff
311285|NCT01612845|shoulder|shoulder
311286|NCT01612845|platelet rich plasma|platelet rich plasma
311287|NCT01612845|fibrin|fibrin
311288|NCT01612793|COPD|copd
311289|NCT01612780|Sinusitis|sinusitis
311290|NCT01612780|Sinus balloon dilation patients|sinus balloon dilation patients
311291|NCT01612767|de novo coronary lesions|de novo coronary lesions
311292|NCT01612767|restenotic coronary lesions|restenotic coronary lesions
311293|NCT01612767|coronary arteries|coronary arteries
311294|NCT01612754|Reduction of noise pollution|reduction of noise pollution
311295|NCT01612754|Specifically enforced workplace rules|specifically enforced workplace rules
311296|NCT01612754|Stress|stress
311297|NCT01612754|Sound Ears (TM)|sound ears (tm)
311298|NCT01612754|Error|error
311299|NCT01612741|Diabetes Mellitus, Type-2|diabetes mellitus, type-2
311300|NCT01612741|Acarbose|acarbose
311301|NCT01612741|Drug Therapy|drug therapy
311302|NCT01612741|Combination|combination
311303|NCT01612728|Aromatase Inhibitors|aromatase inhibitors
311304|NCT01612715|Asthma, allergen challenge, T cells, Fel d 1.|asthma, allergen challenge, t cells, fel d 1.
311305|NCT01612702|postoperative nausea and vomiting|postoperative nausea and vomiting
311306|NCT01612702|postoperative pain|postoperative pain
311307|NCT01612689|Accelerometer|accelerometer
311308|NCT01612689|EMU|emu
311309|NCT01612689|Ambulatory|ambulatory
311310|NCT01612689|ECG|ecg
311311|NCT01612689|Heart rate|heart rate
311312|NCT01612663|Knee pain|knee pain
311313|NCT01612663|Acupuncture|acupuncture
311314|NCT01612663|Sham acupuncture|sham acupuncture
311315|NCT01612650|breast cancer|breast cancer
311316|NCT01612650|surveillance|surveillance
311317|NCT01612650|diagnosis|diagnosis
311318|NCT01612650|2D mammography|2d mammography
311319|NCT01612650|3D mammography|3d mammography
311320|NCT01612637|Pelvic organ prolapse|pelvic organ prolapse
311321|NCT01612637|Pelvic floor muscle training|pelvic floor muscle training
311322|NCT01612637|Prolapse symptoms|prolapse symptoms
311323|NCT01612637|Pelvic organ prolapse quantification system|pelvic organ prolapse quantification system
311324|NCT01612637|Ultrasonography|ultrasonography
311325|NCT01612637|Predictors|predictors
311326|NCT01612520|type 2 Diabetes Mellitus|type 2 diabetes mellitus
311327|NCT01612520|telenursing|telenursing
311329|NCT01612520|economic analysis|economic analysis
311330|NCT01612507|Phase 1|phase 1
311331|NCT01612507|healthy volunteers|healthy volunteers
311332|NCT01612507|Parallel Group Study|parallel group study
311333|NCT01612507|ceftaroline fosamil different doses|ceftaroline fosamil different doses
311334|NCT01612507|safety|safety
311335|NCT01612507|Cmax|cmax
311336|NCT01612507|tmax|tmax
311337|NCT01612507|AUC|auc
311338|NCT01612481|soft tissue sarcoma|soft tissue sarcoma
311339|NCT01612481|lung metastasis|lung metastasis
311340|NCT01612481|surveillance|surveillance
311341|NCT01612468|Diabetes|diabetes
311342|NCT01612468|Liraglutide|liraglutide
311343|NCT01612468|Hypoglycaemia|hypoglycaemia
311344|NCT01612468|Hyperglycaemia|hyperglycaemia
311345|NCT01612468|CIMT|cimt
311346|NCT01612468|PWV|pwv
311347|NCT01612468|Food preference|food preference
311348|NCT01612468|Blood pressure|blood pressure
311349|NCT01612455|HIV|hiv
311350|NCT01612455|drug addiction|drug addiction
311351|NCT01612455|Russia|russia
311352|NCT01612455|case management|case management
311353|NCT01612442|complementary feeding|complementary feeding
311354|NCT01612442|mothers|mothers
311355|NCT01612442|6-24 months children|6-24 months children
311356|NCT01612442|community health volunteers|community health volunteers
311357|NCT01612442|nutrition education|nutrition education
311358|NCT01612442|agricultural education|agricultural education
311359|NCT01612429|Carbamylation|carbamylation
311360|NCT01612429|Albumin|albumin
311361|NCT01612429|Protein structure|protein structure
311362|NCT01612429|Kidney disease|kidney disease
311363|NCT01612416|Ganglion Cell complex, Retinal Nerve Fiber Layer,Glaucoma|ganglion cell complex, retinal nerve fiber layer,glaucoma
311364|NCT01612403|zinc binding protein|zinc binding protein
311365|NCT01612390|postpartum hemorrhage|postpartum hemorrhage
311366|NCT01612377|Moderate to Severe|moderate to severe
311367|NCT01612364|CRPS I|crps i
311368|NCT01612351|Head and neck cancer|head and neck cancer
311369|NCT01612351|Squamous Cell Carcinoma|squamous cell carcinoma
311370|NCT01612351|Phase II|phase ii
311371|NCT01612351|Transoral Surgery|transoral surgery
311372|NCT01612351|Induction Chemotherapy|induction chemotherapy
311373|NCT01612351|Carboplatin|carboplatin
311374|NCT01612351|Paclitaxel|paclitaxel
311375|NCT01612351|Lapatinib|lapatinib
311376|NCT01612338|breast cancer|breast cancer
311377|NCT01612338|young age of onset|young age of onset
311378|NCT01612338|family history|family history
311379|NCT01612338|screening interventions|screening interventions
311380|NCT01612338|family support|family support
311381|NCT01612325|liver tumors|liver tumors
311382|NCT01612312|Non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
311383|NCT01612312|thrombectomy|thrombectomy
311384|NCT01612312|magnetic resonance imaging|magnetic resonance imaging
311385|NCT01612312|microvascular obstruction|microvascular obstruction
311386|NCT01612286|Recombinant human endostatin|recombinant human endostatin
311387|NCT01612286|nasopharyngeal carcinoma|nasopharyngeal carcinoma
311388|NCT01612286|chemotherapy|chemotherapy
311389|NCT01612273|Vasospastic syndrome|vasospastic syndrome
311390|NCT01612273|Vascular dysregulation|vascular dysregulation
311391|NCT01612260|heart failure|heart failure
311392|NCT01612260|ventricular premature complex|ventricular premature complex
311393|NCT01612260|Shensong Yangxin capsule|shensong yangxin capsule
311394|NCT01612247|Breast Cancer|breast cancer
311395|NCT01612247|Neoadjuvant therapy|neoadjuvant therapy
311396|NCT01612234|humans|humans
311397|NCT01612234|lean|lean
311398|NCT01612234|obese|obese
311399|NCT01612234|saturated fat|saturated fat
311400|NCT01612234|monounsaturated fat|monounsaturated fat
311401|NCT01612234|insulin sensitivity|insulin sensitivity
311402|NCT01612234|inflammation|inflammation
311403|NCT01612234|oxidant stress|oxidant stress
312127|NCT01609660|cytokine|cytokine
311404|NCT01612195|anal fistula|anal fistula
311405|NCT01612195|anal continence|anal continence
311406|NCT01612195|health-related quality of life|health-related quality of life
311407|NCT01612182|end-stage renal disease|end-stage renal disease
311408|NCT01612182|renal replacement therapy|renal replacement therapy
311409|NCT01612169|HIV patients|hiv patients
311410|NCT01612169|Hospitalized patients|hospitalized patients
311411|NCT01612169|Substance Users|substance users
311412|NCT01612169|Drug Users|drug users
311413|NCT01612156|Urodynamic testing|urodynamic testing
311414|NCT01612156|pelvic floor examination|pelvic floor examination
311415|NCT01612156|Lidocaine gel|lidocaine gel
311416|NCT01612156|Surgical lubricant|surgical lubricant
311417|NCT01612156|Pain|pain
311418|NCT01612156|Embarrassment|embarrassment
311419|NCT01612117|renal failure|renal failure
311420|NCT01612117|cardiology|cardiology
311421|NCT01612117|contrast-induced nephropathy|contrast-induced nephropathy
311422|NCT01612104|Post Traumatic Stress Disorder|post traumatic stress disorder
311423|NCT01612104|Anxiety symptoms|anxiety symptoms
311424|NCT01612104|Depressive symptoms|depressive symptoms
311425|NCT01612104|Externalizing behavior|externalizing behavior
311426|NCT01612104|Reduced quality of life|reduced quality of life
311427|NCT01612091|Expert System|expert system
311428|NCT01612091|Intensive Care|intensive care
311429|NCT01612091|Telemedicine|telemedicine
311430|NCT01612091|Equipment Design|equipment design
311431|NCT01612065|Office hysteroscopy|office hysteroscopy
311432|NCT01612065|Cervical priming|cervical priming
311433|NCT01612065|Misoprostol|misoprostol
311434|NCT01612052|Vascular Surgery|vascular surgery
311435|NCT01612039|ulcerative colitis|ulcerative colitis
311436|NCT01612013|N-acetylcysteine|n-acetylcysteine
311437|NCT01612013|angiography|angiography
311438|NCT01612013|contrast medium|contrast medium
311439|NCT01612013|contrast-induced nephropathy|contrast-induced nephropathy
311440|NCT01612013|sodium bicarbonate|sodium bicarbonate
311441|NCT01612000|Influenza|influenza
311443|NCT01611974|cytomegalovirus|cytomegalovirus
311444|NCT01611974|resistant|resistant
311445|NCT01611974|refractory|refractory
311446|NCT01611974|transplant|transplant
311447|NCT01611974|treatment|treatment
311448|NCT01611961|Docetaxel|docetaxel
311449|NCT01611961|Lipid Microsphere|lipid microsphere
311450|NCT01611961|Neoplasms|neoplasms
311451|NCT01611961|Antineoplastic Agents|antineoplastic agents
311452|NCT01611961|Pharmacologic Actions|pharmacologic actions
311453|NCT01611961|Therapeutic Uses|therapeutic uses
311454|NCT01611935|trauma|trauma
311455|NCT01611935|shock|shock
311456|NCT01611935|vasopressin|vasopressin
311457|NCT01611935|blood transfusion|blood transfusion
311458|NCT01611922|eye|eye
311459|NCT01611922|eyelid|eyelid
311460|NCT01611922|contact lenses|contact lenses
302182|NCT01654536|PAR|par
311461|NCT01611922|dry eye disease|dry eye disease
311462|NCT01611909|p-menthane-3,8-diol oil extract|p-menthane-3,8-diol oil extract
311463|NCT01611909|topical therapy|topical therapy
311464|NCT01611896|Graves' hyperthyroidism|graves' hyperthyroidism
311465|NCT01611896|Graves' disease|graves' disease
311466|NCT01611896|Selenium|selenium
311467|NCT01611896|Quality of Life|quality of life
311468|NCT01611896|ThyPRO|thypro
311469|NCT01611896|Autoimmunity|autoimmunity
311470|NCT01611870|COPD|copd
311471|NCT01611857|Advanced solid tumors|advanced solid tumors
311472|NCT01611857|First-Line Metastatic GE cancer|first-line metastatic ge cancer
311473|NCT01611857|c-Met Inhibitor|c-met inhibitor
311474|NCT01611857|Tivantinib|tivantinib
311475|NCT01611857|FOLFOX|folfox
311476|NCT01611844|delayed-type hypersensitivity reaction to tuberculin intradermal injection|delayed-type hypersensitivity reaction to tuberculin intradermal injection
311477|NCT01611844|tuberculosis skin test|tuberculosis skin test
311478|NCT01611844|BD micro-needle|bd micro-needle
311479|NCT01611844|medical device|medical device
311480|NCT01611844|spectroscopy|spectroscopy
311481|NCT01611831|fibromyalgia|fibromyalgia
311482|NCT01611831|Acceptation & Commitment Therapy|acceptation & commitment therapy
311483|NCT01611831|randomized controlled trial|randomized controlled trial
311484|NCT01611818|Depression|depression
311485|NCT01611818|Computer-delivered psychotherapy|computer-delivered psychotherapy
311486|NCT01611818|Randomized-controlled trial|randomized-controlled trial
311487|NCT01611792|Stabilization exercise|stabilization exercise
311488|NCT01611792|Strength and conditioning exercise|strength and conditioning exercise
311489|NCT01611792|Physical therapy|physical therapy
311490|NCT01611792|Rehabilitation|rehabilitation
311491|NCT01611779|obstructive sleep apnea|obstructive sleep apnea
311492|NCT01611779|tongue suspension|tongue suspension
311493|NCT01611766|secondary cytoreductive surgery|secondary cytoreductive surgery
311494|NCT01611766|Ovarian Cancer|ovarian cancer
311495|NCT01611766|surgery|surgery
311496|NCT01611766|recurrence|recurrence
311497|NCT01611753|Shock, Septic|shock, septic
311498|NCT01611753|Erythrocyte Transfusion|erythrocyte transfusion
311499|NCT01611753|Ischemia|ischemia
311500|NCT01611740|Preterm infant|preterm infant
311501|NCT01611740|Bacterial infection|bacterial infection
311601|NCT01611285|outcome node|outcome node
312430|NCT01608295|geriatric|geriatric
311502|NCT01611740|Diagnosis of proven or suspected bacterial infection|diagnosis of proven or suspected bacterial infection
311503|NCT01611727|BRCA1|brca1
311504|NCT01611727|survival|survival
311505|NCT01611727|metastatic disease|metastatic disease
311506|NCT01611727|cisplatin|cisplatin
311507|NCT01611714|Racial/ethnic disparities|racial/ethnic disparities
311508|NCT01611714|Imaging|imaging
311509|NCT01611714|Emergency|emergency
311510|NCT01611714|Headache|headache
311511|NCT01611675|Metastatic|metastatic
311512|NCT01611675|Unresectable|unresectable
311513|NCT01611675|Clearly progressive|clearly progressive
311514|NCT01611675|BRAF mutation|braf mutation
311515|NCT01611649|infant formula|infant formula
311516|NCT01611649|dairy lipids|dairy lipids
311517|NCT01611649|omega-3|omega-3
311518|NCT01611636|allergy|allergy
311519|NCT01611636|autoimmune diseases|autoimmune diseases
311520|NCT01611636|rheumatic diseases|rheumatic diseases
311521|NCT01611623|Solid tumor malignancy|solid tumor malignancy
311522|NCT01611623|Hsp90|hsp90
311523|NCT01611610|outcome measures|outcome measures
311524|NCT01611610|spinal muscular atrophy|spinal muscular atrophy
311525|NCT01611597|accelerometry|accelerometry
311526|NCT01611597|neuromuscular disease|neuromuscular disease
311528|NCT01611584|Florescence|florescence
311529|NCT01611584|Lung cancer|lung cancer
311530|NCT01611571|osteoporosis|osteoporosis
311531|NCT01611571|male|male
311532|NCT01611545|Pharmacogenomics|pharmacogenomics
311533|NCT01611545|Pharmacogenetics|pharmacogenetics
311534|NCT01611545|Clopidogrel|clopidogrel
311535|NCT01611545|Plavix|plavix
311536|NCT01611532|Acute pancreatitis|acute pancreatitis
311537|NCT01611532|Intraabdominal pressure|intraabdominal pressure
311538|NCT01611532|Critical illness|critical illness
311539|NCT01611519|urinary bladder|urinary bladder
311540|NCT01611519|urinary catheterization|urinary catheterization
311541|NCT01611519|epidural analgesia|epidural analgesia
311542|NCT01611519|catheters, indwelling|catheters, indwelling
311543|NCT01611493|Dental Implants|dental implants
311544|NCT01611493|Jaw, Edentulous, Partially/rehabilitation|jaw, edentulous, partially/rehabilitation
311545|NCT01611493|Jaw, Edentulous, Partially/surgery|jaw, edentulous, partially/surgery
311546|NCT01611493|randomised Clinical Trials|randomised clinical trials
311547|NCT01611493|Humans|humans
311548|NCT01611467|CC-223|cc-223
311549|NCT01611467|safety|safety
311550|NCT01611467|tolerability|tolerability
311551|NCT01611467|pharmacokinetic|pharmacokinetic
311552|NCT01611467|AME (Absorption, Metabolism, and Excretion)|ame (absorption, metabolism, and excretion)
311553|NCT01611467|FE (Food Effect)|fe (food effect)
311554|NCT01611454|Occupational Exposure to Radiation|occupational exposure to radiation
311555|NCT01611441|Osteoarthritis of the knee|osteoarthritis of the knee
311556|NCT01611441|Biomarkers|biomarkers
311557|NCT01611428|Ipragliflozin|ipragliflozin
311558|NCT01611428|Healthy|healthy
311559|NCT01611428|Absolute Bioavailability|absolute bioavailability
311560|NCT01611428|Pharmacokinetics|pharmacokinetics
311561|NCT01611415|Phase 1|phase 1
311562|NCT01611415|Ipragliflozin|ipragliflozin
311563|NCT01611415|Furosemide|furosemide
311564|NCT01611415|Pharmacokinetics|pharmacokinetics
311565|NCT01611415|Pharmacodynamics|pharmacodynamics
311566|NCT01611402|Tuberculosis|tuberculosis
311567|NCT01611402|HIV Infection|hiv infection
311568|NCT01611402|Transcriptional Signature|transcriptional signature
311569|NCT01611402|IRIS|iris
311570|NCT01611376|impedance cardiography|impedance cardiography
311571|NCT01611376|Flotrac/Vigileo|flotrac/vigileo
311572|NCT01611376|cardiac output|cardiac output
311573|NCT01611363|Ipragliflozin|ipragliflozin
311574|NCT01611363|Phase 1|phase 1
311575|NCT01611363|Healthy|healthy
311576|NCT01611363|Diabetes Mellitus|diabetes mellitus
311577|NCT01611363|Pharmacokinetics|pharmacokinetics
311578|NCT01611363|Pharmacodynamics|pharmacodynamics
311579|NCT01611350|Indoor Air Pollution|indoor air pollution
311580|NCT01611350|Marketing Methods for Increasing Technology Adoption|marketing methods for increasing technology adoption
311581|NCT01611350|Optimal Contracts for Technology Adoption|optimal contracts for technology adoption
311582|NCT01611337|schizophrenia, insight|schizophrenia, insight
311583|NCT01611324|Varicose Veins|varicose veins
311584|NCT01611324|Phlebectomy|phlebectomy
311585|NCT01611324|Local Anesthesia|local anesthesia
311586|NCT01611298|allogeneic stem cell transplant|allogeneic stem cell transplant
311587|NCT01611298|malignant diseases|malignant diseases
311588|NCT01611298|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
311589|NCT01611298|acute myelogenous leukemia|acute myelogenous leukemia
311590|NCT01611298|Chronic myelogenous leukemia|chronic myelogenous leukemia
311591|NCT01611298|myelodysplastic syndrome|myelodysplastic syndrome
311592|NCT01611298|Hodgkin lymphoma|hodgkin lymphoma
311593|NCT01611298|non-Hodgkin lymphoma|non-hodgkin lymphoma
311594|NCT01611298|myeloproliferative disorder|myeloproliferative disorder
311595|NCT01611298|non-malignant disease|non-malignant disease
311596|NCT01611285|UPHOLD|uphold
311597|NCT01611285|robotic surgery|robotic surgery
311598|NCT01611285|decision analysis|decision analysis
311599|NCT01611285|FDA|fda
311600|NCT01611285|decision node|decision node
311602|NCT01611272|Unstable angina|unstable angina
311603|NCT01611259|MALT Lymphoma|malt lymphoma
311604|NCT01611259|Lenalidomide|lenalidomide
311605|NCT01611259|Rituximab|rituximab
311606|NCT01611233|metal on metal|metal on metal
311607|NCT01611233|hip replacement|hip replacement
311609|NCT01611233|DePuy|depuy
311610|NCT01611220|Anorexia Nervosa|anorexia nervosa
311611|NCT01611220|Relapse prevention|relapse prevention
311612|NCT01611220|Cognitive Dissonance|cognitive dissonance
311613|NCT01611220|Inpatient treatment|inpatient treatment
311614|NCT01611220|Cognitive behavior therapy|cognitive behavior therapy
311615|NCT01611207|wound healing impairments,|wound healing impairments,
311616|NCT01611207|negative pressure wound therapy,|negative pressure wound therapy,
311617|NCT01611207|health services research,|health services research,
311618|NCT01611207|germany|germany
311619|NCT01611194|HBO2|hbo2
311620|NCT01611194|HBOT|hbot
311621|NCT01611194|mTBI|mtbi
311622|NCT01611194|Brain injury|brain injury
311623|NCT01611194|PCS|pcs
311624|NCT01611194|PTSD|ptsd
311625|NCT01611194|hyperbaric oxygen|hyperbaric oxygen
402042|NCT01233362|Cholera|cholera
311626|NCT01611181|Iron supplementation|iron supplementation
311627|NCT01611181|Iron deficiency|iron deficiency
311628|NCT01611181|Hip arthroplasty|hip arthroplasty
311629|NCT01611181|Knee arthroplasty|knee arthroplasty
311630|NCT01611142|Monoclonal antibody|monoclonal antibody
311631|NCT01611142|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
311632|NCT01611142|cancer|cancer
311633|NCT01611142|hematologic malignancy|hematologic malignancy
311634|NCT01611129|Disability Evaluation|disability evaluation
311635|NCT01611103|Cognitive Enhancement|cognitive enhancement
311636|NCT01611103|tDCS|tdcs
311637|NCT01611103|stimulation|stimulation
311638|NCT01611103|elderly|elderly
311639|NCT01611103|older adults|older adults
311640|NCT01611090|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
311641|NCT01611090|Small lymphocytic lymphoma|small lymphocytic lymphoma
311642|NCT01611090|Relapsed or refractory chronic lymphocytic leukemia|relapsed or refractory chronic lymphocytic leukemia
312482|NCT01608139|SAHA|saha
311643|NCT01611090|Relapsed or refractory small lymphocytic lymphoma|relapsed or refractory small lymphocytic lymphoma
311644|NCT01611090|Ibrutinib|ibrutinib
311645|NCT01611090|PCI-32765|pci-32765
311646|NCT01611090|JNJ-54179060|jnj-54179060
311647|NCT01611090|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
311648|NCT01611090|Bendamustine|bendamustine
311649|NCT01611090|Rituximab|rituximab
311650|NCT01611064|Hand|hand
311651|NCT01611064|Surgery|surgery
311652|NCT01611064|Tourniquet|tourniquet
311653|NCT01611064|Pain|pain
311654|NCT01611064|Oxygen|oxygen
311655|NCT01611051|breast cancer|breast cancer
311656|NCT01611051|neutropenia|neutropenia
311657|NCT01611051|febrile neutropenia|febrile neutropenia
311658|NCT01611012|Asthma|asthma
311659|NCT01611012|Inflammation|inflammation
311660|NCT01611012|Phenotype|phenotype
311661|NCT01611012|Sputum|sputum
311662|NCT01610986|Fructose|fructose
311663|NCT01610986|Exercise|exercise
311664|NCT01610986|Lactic acid|lactic acid
311665|NCT01610986|Monocarboxylic Acid Transporters|monocarboxylic acid transporters
311666|NCT01610973|Fuch's dystrophy|fuch's dystrophy
311667|NCT01610973|Corneal graft|corneal graft
311668|NCT01610960|Non invasive ventilation|non invasive ventilation
311669|NCT01610960|Helmet|helmet
311670|NCT01610960|NEXT Helmet|next helmet
311671|NCT01610960|Work of breathing|work of breathing
311672|NCT01610960|Intensive care|intensive care
311673|NCT01610947|Spondyloarthritis|spondyloarthritis
311674|NCT01610947|Anti-TNF|anti-tnf
311675|NCT01610947|Adalimumab|adalimumab
311676|NCT01610947|Etanercept|etanercept
311677|NCT01610947|Infliximab|infliximab
311678|NCT01610934|MODY|mody
311679|NCT01610934|Monogenic diabetes|monogenic diabetes
311680|NCT01610934|Non-autoimmune diabetes|non-autoimmune diabetes
311681|NCT01610934|MODY3|mody3
311682|NCT01610921|asthma|asthma
311683|NCT01610921|small airways disease|small airways disease
311684|NCT01610921|inflammation|inflammation
311685|NCT01610921|provocation|provocation
311686|NCT01610921|adenosine|adenosine
311687|NCT01610908|Adolescent|adolescent
311688|NCT01610908|Idiopathic|idiopathic
311689|NCT01610908|Scoliosis|scoliosis
311690|NCT01610908|Schroth|schroth
311691|NCT01610908|Exercises|exercises
311692|NCT01610908|Conservative treatment|conservative treatment
311693|NCT01610895|Colonoscopy|colonoscopy
311694|NCT01610895|low fibre diet|low fibre diet
311695|NCT01610895|clear fluids|clear fluids
311696|NCT01610895|Bowel Preparation|bowel preparation
311697|NCT01610869|Recurrence|recurrence
311698|NCT01610869|Ovarian Neoplasms|ovarian neoplasms
311699|NCT01610869|Ovarian Diseases|ovarian diseases
311700|NCT01610869|Fallopian Tube Neoplasms|fallopian tube neoplasms
311701|NCT01610869|Neoplasms|neoplasms
311702|NCT01610869|Carcinoma|carcinoma
311703|NCT01610869|Neoplasms by site|neoplasms by site
311704|NCT01610856|bowel preparation|bowel preparation
311705|NCT01610856|bowel purgative|bowel purgative
311706|NCT01610856|bowel cleansing|bowel cleansing
311707|NCT01610856|colonoscopy|colonoscopy
311708|NCT01610843|Sarcoidosis|sarcoidosis
311709|NCT01610843|WISE|wise
311710|NCT01610843|Sarcoid Study|sarcoid study
311711|NCT01610843|Worldwide Sarcoidosis Research Study|worldwide sarcoidosis research study
311712|NCT01610830|Purpura, Schoenlein-Henoch|purpura, schoenlein-henoch
311713|NCT01610830|adults|adults
311714|NCT01610830|children|children
311715|NCT01610830|pronostic factors|pronostic factors
311716|NCT01610817|Patient information and active participation|patient information and active participation
311717|NCT01610817|Patient safety|patient safety
311718|NCT01610817|Health education|health education
311719|NCT01610817|Adverse drug event|adverse drug event
311720|NCT01610817|Primary care|primary care
311721|NCT01610817|Antihypertensive drugs|antihypertensive drugs
311722|NCT01610765|HSV|hsv
311723|NCT01610765|pharmacokinetics|pharmacokinetics
311724|NCT01610765|herpes|herpes
311725|NCT01610765|neonates|neonates
311726|NCT01610752|Pregnancy|pregnancy
311727|NCT01610752|Gestational weight gain|gestational weight gain
311728|NCT01610726|colon|colon
311729|NCT01610726|rectum|rectum
311730|NCT01610726|recovery|recovery
311731|NCT01610726|surgery|surgery
311732|NCT01610674|Diabetes mellitus|diabetes mellitus
311733|NCT01610674|Surgery|surgery
311734|NCT01610674|Implementation|implementation
311735|NCT01610674|Quality of care|quality of care
311736|NCT01610674|Quality indicators|quality indicators
311737|NCT01610661|carbohydrate|carbohydrate
311738|NCT01610661|inflammation|inflammation
311739|NCT01610661|glucose homeostasis|glucose homeostasis
311740|NCT01610661|gene expression|gene expression
311742|NCT01610648|metabolic syndrome|metabolic syndrome
311743|NCT01610648|Apnea-hypopnea index|apnea-hypopnea index
311744|NCT01610648|Oxygen desaturation index|oxygen desaturation index
311745|NCT01610635|RCT|rct
311746|NCT01610635|blood donation frequency|blood donation frequency
311747|NCT01610635|quality of life|quality of life
311748|NCT01610635|iron deficiency|iron deficiency
311749|NCT01610622|Cardiac Output|cardiac output
311750|NCT01610622|Blood volumes|blood volumes
311751|NCT01610622|Neonates|neonates
311752|NCT01610609|Statin treatment|statin treatment
311753|NCT01610609|Cardiovascular disease|cardiovascular disease
311754|NCT01610609|High cholesterol|high cholesterol
311755|NCT01610609|Care management|care management
311756|NCT01610596|Psoriasis|psoriasis
311757|NCT01610596|Skin Diseases|skin diseases
311758|NCT01610596|Halobetasol|halobetasol
311759|NCT01610596|Vasoconstrictor Agents|vasoconstrictor agents
752611|NCT01173315|neuropathy|neuropathy
386598|NCT01299883|CVD|cvd
311760|NCT01610596|Therapeutic Uses|therapeutic uses
311761|NCT01610596|Pharmacologic Actions|pharmacologic actions
311762|NCT01610596|Anti-Inflammatory Agents|anti-inflammatory agents
311763|NCT01610596|Physiological Effects of Drugs|physiological effects of drugs
311764|NCT01610583|Genetic Literacy|genetic literacy
311765|NCT01610583|Latino|latino
311766|NCT01610570|Dose Limiting Toxicity|dose limiting toxicity
311767|NCT01610570|Maximum Tolerated Dose|maximum tolerated dose
311768|NCT01610570|Radiographic Response|radiographic response
311769|NCT01610570|Time to Progression|time to progression
311770|NCT01610570|Bone Tumors|bone tumors
311771|NCT01610557|Diabetic Macular Edema|diabetic macular edema
311772|NCT01610557|Ranibizumab|ranibizumab
311773|NCT01610557|Bevacizumab|bevacizumab
311774|NCT01610544|Thymoma|thymoma
311775|NCT01610544|Insulin Growth Factor|insulin growth factor
311776|NCT01610544|Cell Proliferation|cell proliferation
311777|NCT01610544|Non Small Cell Lung Cancer|non small cell lung cancer
311778|NCT01610544|PET/CT Imaging Sessions|pet/ct imaging sessions
311779|NCT01610531|Cohort|cohort
311780|NCT01610531|Melanoma|melanoma
311781|NCT01610531|targeted screening|targeted screening
311782|NCT01610531|risks function|risks function
311783|NCT01610531|cost effectiveness|cost effectiveness
311784|NCT01610518|postprandial blood glucose|postprandial blood glucose
311785|NCT01610518|dietary fiber|dietary fiber
311786|NCT01610518|beta-glucan|beta-glucan
311787|NCT01610505|Knee Osteoarthritis|knee osteoarthritis
311788|NCT01610505|Knee pain|knee pain
311789|NCT01610505|Arthritis|arthritis
311790|NCT01610505|KineSpring|kinespring
311791|NCT01610505|High Tibial Osteotomy|high tibial osteotomy
311792|NCT01610492|IMGN|imgn
311793|NCT01610492|anti-PLA2R antibodies|anti-pla2r antibodies
311794|NCT01610492|pharmacokinetics|pharmacokinetics
311795|NCT01610492|belimumab|belimumab
311796|NCT01610492|Benlysta|benlysta
311797|NCT01610492|Idiopathic Membranous Glomerulonephropathy|idiopathic membranous glomerulonephropathy
311798|NCT01610492|safety|safety
311799|NCT01610492|GSK1550188|gsk1550188
311800|NCT01610492|Lymphostat-B|lymphostat-b
311801|NCT01610492|membrane attack complex|membrane attack complex
311802|NCT01610466|Education|education
311803|NCT01610466|Simulation|simulation
311804|NCT01610466|Technical skills training|technical skills training
311805|NCT01610466|Laparoscopy|laparoscopy
311806|NCT01610466|Bariatric Surgery|bariatric surgery
311807|NCT01610453|prolonged labor|prolonged labor
311808|NCT01610453|cesarean section|cesarean section
311809|NCT01610453|duration of labor|duration of labor
311810|NCT01610440|Duchenne muscular dystrophy|duchenne muscular dystrophy
311811|NCT01610440|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
311812|NCT01610427|CMI|cmi
311813|NCT01610427|HIV|hiv
311814|NCT01610427|Antiretroviral therapy-naïve|antiretroviral therapy-naïve
311815|NCT01610414|Observer-blind|observer-blind
311816|NCT01610414|Efficacy|efficacy
311817|NCT01610414|Immunogenicity|immunogenicity
311818|NCT01610414|Vaccination|vaccination
311819|NCT01610414|Safety|safety
311820|NCT01610414|Adult autologous haematopoietic cell transplant recipients|adult autologous haematopoietic cell transplant recipients
311821|NCT01610414|Herpes Zoster|herpes zoster
311822|NCT01610388|healthy subjects|healthy subjects
311823|NCT01610388|double-blind|double-blind
311824|NCT01610388|FTIH|ftih
311825|NCT01610388|dose-escalation|dose-escalation
311826|NCT01610388|absolute bioavailability|absolute bioavailability
311827|NCT01610388|GSK1322322|gsk1322322
311828|NCT01610388|BAL|bal
311829|NCT01610375|Endometrial cancer|endometrial cancer
311831|NCT01610362|immunoglobulin|immunoglobulin
311832|NCT01610362|dosage|dosage
311833|NCT01610336|EGFR|egfr
311834|NCT01610336|c-MET|c-met
311835|NCT01610336|Lung cancer|lung cancer
311836|NCT01610336|Gefitinib|gefitinib
311837|NCT01610336|Erlotinib|erlotinib
311838|NCT01610323|Pregnancy|pregnancy
311839|NCT01610323|Obesity|obesity
311840|NCT01610323|Physical activity|physical activity
311841|NCT01610323|Cardiorespiratory fitness|cardiorespiratory fitness
311842|NCT01610323|Muscular Fitness|muscular fitness
311843|NCT01610323|Weight gain|weight gain
311844|NCT01610323|Fetal growth|fetal growth
311845|NCT01610310|SC|sc
311846|NCT01610310|PEG|peg
311847|NCT01610310|Inteferon|inteferon
311848|NCT01610310|PK|pk
311849|NCT01610310|Subcutaneous|subcutaneous
311850|NCT01610310|PEGylated|pegylated
311851|NCT01610310|Autoinjector|autoinjector
311852|NCT01610310|Injectable|injectable
311853|NCT01610310|MS|ms
312583|NCT01607762|Olanzapine|olanzapine
311854|NCT01610297|hematopoietic stem cell transplantation, beta-thalassemia major, deferasirox, iron overload|hematopoietic stem cell transplantation, beta-thalassemia major, deferasirox, iron overload
311855|NCT01610284|Breast cancer|breast cancer
311856|NCT01610284|Hormone receptor positive|hormone receptor positive
311857|NCT01610284|HER2-negative|her2-negative
311858|NCT01610284|Metastatic|metastatic
311859|NCT01610284|Locally advanced|locally advanced
311860|NCT01610284|PI3K|pi3k
311861|NCT01610284|Fulvestrant|fulvestrant
311862|NCT01610284|Refractory|refractory
311863|NCT01610284|Aromatase inhibitor|aromatase inhibitor
311864|NCT01610271|Prevention|prevention
311865|NCT01610271|Surgical Site Infection|surgical site infection
311866|NCT01610271|Air Barrier System|air barrier system
311867|NCT01610271|Implant Infection|implant infection
311868|NCT01610258|pregnancy, chorioamnionitis, PPROM, Treg|pregnancy, chorioamnionitis, pprom, treg
311869|NCT01610245|Influenza|influenza
311870|NCT01610232|Infrared LED|infrared led
311871|NCT01610232|Treadmill Training|treadmill training
311872|NCT01610232|Strength Muscle|strength muscle
311873|NCT01610232|Fatigue Muscle|fatigue muscle
311874|NCT01610232|Aerobic Capacity|aerobic capacity
311875|NCT01610232|Cellulite|cellulite
311876|NCT01610232|Osteoporosis|osteoporosis
311877|NCT01610206|recurrent|recurrent
311878|NCT01610206|persistent|persistent
311879|NCT01610193|Pancreatic Stone Protein|pancreatic stone protein
311880|NCT01610193|Abdominal pain|abdominal pain
311881|NCT01610193|Acute appendicitis|acute appendicitis
311882|NCT01610193|Alvarado score|alvarado score
311883|NCT01610193|Appendectomy|appendectomy
311884|NCT01610193|Sensitivity and specificity|sensitivity and specificity
311885|NCT01610180|Eltrombopag|eltrombopag
311886|NCT01610180|ITP|itp
311887|NCT01610180|LPD|lpd
311888|NCT01610180|leukemia|leukemia
311889|NCT01610180|Immune ThrombocytoPenia|immune thrombocytopenia
311890|NCT01610154|glucagon|glucagon
311891|NCT01610154|dipeptidyl peptidase-4 inhibitor|dipeptidyl peptidase-4 inhibitor
311892|NCT01610141|warfarin metabolism|warfarin metabolism
311893|NCT01610141|pharmacogenetics|pharmacogenetics
311894|NCT01610141|CYP2C9|cyp2c9
311895|NCT01610141|genotyping|genotyping
311896|NCT01610141|VKORC1|vkorc1
311897|NCT01610141|CYP4F2|cyp4f2
311898|NCT01610141|anticoagulation|anticoagulation
311899|NCT01610141|atrial fibrillation|atrial fibrillation
311900|NCT01610141|deep vein thrombosis|deep vein thrombosis
311901|NCT01610141|pulmonary embolism|pulmonary embolism
311902|NCT01610141|Artificial Heart Valve|artificial heart valve
311903|NCT01610128|urticaria, patient reported outcome|urticaria, patient reported outcome
311904|NCT01610115|Pregnancy|pregnancy
311905|NCT01610102|clinical follow-up|clinical follow-up
311906|NCT01610102|up to 7 years|up to 7 years
311907|NCT01610102|all patients enrolled in the main study|all patients enrolled in the main study
311908|NCT01610089|citrullinemia|citrullinemia
311909|NCT01610089|argininosuccinate synthetase deficiency|argininosuccinate synthetase deficiency
311910|NCT01610089|nitric oxide|nitric oxide
311913|NCT01610076|Do not resuscitate (DNR)|do not resuscitate (dnr)
311914|NCT01610076|Do not intubate (DNI)|do not intubate (dni)
311915|NCT01610076|CPR|cpr
311916|NCT01610076|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
311917|NCT01610076|video|video
311918|NCT01610076|advanced directives|advanced directives
311919|NCT01610063|Algorithm|algorithm
311920|NCT01610063|Depression|depression
311921|NCT01610063|Assurex|assurex
311922|NCT01610063|GeneSight|genesight
311923|NCT01610050|castration-resistant prostate cancer, advanced breast cancer|castration-resistant prostate cancer, advanced breast cancer
311924|NCT01610037|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
311925|NCT01610037|COPD|copd
311926|NCT01610037|QVA149|qva149
311927|NCT01610037|QAB149|qab149
311928|NCT01610037|NVA237|nva237
311929|NCT01610037|Indacaterol maleate|indacaterol maleate
311930|NCT01610037|Glycopyronnium bromide|glycopyronnium bromide
753309|NCT01176214|sedation|sedation
311931|NCT01610011|Schizophrenia|schizophrenia
311932|NCT01610011|Psychotic Disorders|psychotic disorders
311933|NCT01610011|N-methyl-D-aspartate receptor|n-methyl-d-aspartate receptor
311934|NCT01610011|Glycine augmentation|glycine augmentation
311935|NCT01610011|Glycine|glycine
311936|NCT01610011|Glycine Pharmacodynamics|glycine pharmacodynamics
311937|NCT01610011|Glycine Bioavailability|glycine bioavailability
311938|NCT01610011|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
311939|NCT01610011|Glycine Decarboxylase|glycine decarboxylase
311940|NCT01610011|Glycine Decarboxylase Mutation|glycine decarboxylase mutation
311941|NCT01609998|Influenza A (H1)|influenza a (h1)
311942|NCT01609998|Influenza A (H3)|influenza a (h3)
311943|NCT01609998|Influenza B|influenza b
311944|NCT01609998|DNA Vaccine|dna vaccine
311945|NCT01609998|Trivalent Inactivated Vaccine (TIV)|trivalent inactivated vaccine (tiv)
311946|NCT01609998|Healthy Adolescents|healthy adolescents
311947|NCT01609998|Healthy Children|healthy children
311948|NCT01609985|Cardiac Resynchronization Therapy Defibrillator (CRT-D) Devices|cardiac resynchronization therapy defibrillator (crt-d) devices
311949|NCT01609972|Back pain|back pain
312886|NCT01606306|Montelukast|montelukast
311950|NCT01609972|Spinal Cord Stimulation|spinal cord stimulation
311951|NCT01609959|Hypertension|hypertension
311952|NCT01609959|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
311953|NCT01609959|Azilsartan|azilsartan
311954|NCT01609959|Valsartan|valsartan
302661|NCT01652248|cardiac resynchronization therapy|cardiac resynchronization therapy
302662|NCT01652235|Abdominal aortic aneurysm|abdominal aortic aneurysm
302663|NCT01652235|Endovascular|endovascular
302664|NCT01652235|Fenestration|fenestration
302665|NCT01652235|Juxtarenal|juxtarenal
311955|NCT01609946|presenting for FNAB or surgery|presenting for fnab or surgery
311956|NCT01609933|Hepatitis C|hepatitis c
311957|NCT01609933|Hepatitis C Genotype 1|hepatitis c genotype 1
311958|NCT01609933|Chronic Hepatitis C|chronic hepatitis c
311959|NCT01609933|HCV|hcv
311960|NCT01609920|MRI|mri
311961|NCT01609920|lymph node metastases|lymph node metastases
311962|NCT01609920|breast cancer|breast cancer
311963|NCT01609920|gadofosveset|gadofosveset
311964|NCT01609907|Drug interaction|drug interaction
311965|NCT01609907|YH14700|yh14700
311966|NCT01609907|Rosuvastatin|rosuvastatin
311967|NCT01609907|Valsartan|valsartan
311968|NCT01609907|Yuhan|yuhan
311969|NCT01609894|Postnatal development|postnatal development
311970|NCT01609894|Breast milk fortification|breast milk fortification
311971|NCT01609894|Composition of breast milk|composition of breast milk
311972|NCT01609881|Inflammation|inflammation
311973|NCT01609868|premature infant feeding protein|premature infant feeding protein
311974|NCT01609855|Adenoma Detection Rate|adenoma detection rate
311975|NCT01609855|Anti-spasmotic drug|anti-spasmotic drug
311976|NCT01609842|Acute Coronary Syndrome|acute coronary syndrome
311977|NCT01609842|adherence|adherence
311978|NCT01609816|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
311979|NCT01609816|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
311980|NCT01609816|anaplastic large cell lymphoma|anaplastic large cell lymphoma
311981|NCT01609816|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
311982|NCT01609816|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
311983|NCT01609816|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
311984|NCT01609816|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
311985|NCT01609816|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
311986|NCT01609816|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
311987|NCT01609816|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
311988|NCT01609816|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
311989|NCT01609816|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
311990|NCT01609816|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
311991|NCT01609816|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
312128|NCT01609660|short chain fatty acids|short chain fatty acids
311992|NCT01609816|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
311993|NCT01609816|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
311994|NCT01609816|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
311995|NCT01609816|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
311996|NCT01609816|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
311997|NCT01609816|intraocular lymphoma|intraocular lymphoma
311998|NCT01609816|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
311999|NCT01609816|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
312000|NCT01609816|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
312001|NCT01609816|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
312002|NCT01609816|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
312003|NCT01609816|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
402043|NCT01233362|Vaccine|vaccine
312004|NCT01609816|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
312005|NCT01609816|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
312006|NCT01609816|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
312007|NCT01609816|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
312008|NCT01609816|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
312009|NCT01609816|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
312010|NCT01609816|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
312011|NCT01609816|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
312012|NCT01609816|peripheral T-cell lymphoma|peripheral t-cell lymphoma
312013|NCT01609816|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
752612|NCT01173328|exercise tolerance|exercise tolerance
312014|NCT01609816|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
312015|NCT01609816|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
312016|NCT01609816|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
312017|NCT01609816|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
312018|NCT01609816|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
312019|NCT01609816|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
312020|NCT01609816|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
312021|NCT01609816|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
312022|NCT01609816|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
312023|NCT01609816|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
312024|NCT01609816|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
312025|NCT01609816|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
312026|NCT01609816|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
312027|NCT01609816|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
312028|NCT01609816|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
312029|NCT01609816|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
312030|NCT01609816|refractory hairy cell leukemia|refractory hairy cell leukemia
312031|NCT01609816|refractory multiple myeloma|refractory multiple myeloma
312032|NCT01609816|small intestine lymphoma|small intestine lymphoma
312033|NCT01609816|splenic marginal zone lymphoma|splenic marginal zone lymphoma
312034|NCT01609816|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
312035|NCT01609816|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
312036|NCT01609816|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
312037|NCT01609816|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
312038|NCT01609816|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
312039|NCT01609816|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
312040|NCT01609816|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
312041|NCT01609816|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
312042|NCT01609816|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
312043|NCT01609816|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
312044|NCT01609816|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
312045|NCT01609816|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
312046|NCT01609816|stage I mantle cell lymphoma|stage i mantle cell lymphoma
312047|NCT01609816|stage I marginal zone lymphoma|stage i marginal zone lymphoma
312048|NCT01609816|stage I multiple myeloma|stage i multiple myeloma
312049|NCT01609816|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
312050|NCT01609816|stage IA mycosis fungoides/Sezary syndrome|stage ia mycosis fungoides/sezary syndrome
312051|NCT01609816|stage IB mycosis fungoides/Sezary syndrome|stage ib mycosis fungoides/sezary syndrome
312052|NCT01609816|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
312053|NCT01609816|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
312054|NCT01609816|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
312055|NCT01609816|stage II multiple myeloma|stage ii multiple myeloma
312056|NCT01609816|stage IIA mycosis fungoides/Sezary syndrome|stage iia mycosis fungoides/sezary syndrome
312057|NCT01609816|stage IIB mycosis fungoides/Sezary syndrome|stage iib mycosis fungoides/sezary syndrome
312058|NCT01609816|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
312059|NCT01609816|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
312060|NCT01609816|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
312061|NCT01609816|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
312062|NCT01609816|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
312063|NCT01609816|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
312064|NCT01609816|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
312065|NCT01609816|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
402044|NCT01233362|Kolkata|kolkata
312066|NCT01609816|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
312067|NCT01609816|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
312068|NCT01609816|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
312069|NCT01609816|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
312070|NCT01609816|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
312071|NCT01609816|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
312072|NCT01609816|stage III multiple myeloma|stage iii multiple myeloma
312073|NCT01609816|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
312074|NCT01609816|stage IIIA mycosis fungoides/Sezary syndrome|stage iiia mycosis fungoides/sezary syndrome
312075|NCT01609816|stage IIIB mycosis fungoides/Sezary syndrome|stage iiib mycosis fungoides/sezary syndrome
312076|NCT01609816|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
312077|NCT01609816|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
312078|NCT01609816|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
312079|NCT01609816|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
312080|NCT01609816|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
312081|NCT01609816|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
312082|NCT01609816|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
312083|NCT01609816|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
312084|NCT01609816|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
312280|NCT01608854|postoperative spinal drains|postoperative spinal drains
312085|NCT01609816|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
312086|NCT01609816|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
312087|NCT01609816|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
312088|NCT01609816|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
312089|NCT01609816|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
312090|NCT01609816|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
312091|NCT01609816|stage IVA mycosis fungoides/Sezary syndrome|stage iva mycosis fungoides/sezary syndrome
312092|NCT01609816|stage IVB mycosis fungoides/Sezary syndrome|stage ivb mycosis fungoides/sezary syndrome
312093|NCT01609816|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
312094|NCT01609816|testicular lymphoma|testicular lymphoma
312095|NCT01609816|Waldenström macroglobulinemia|waldenström macroglobulinemia
312096|NCT01609751|probiotic|probiotic
312097|NCT01609751|lactobacillus|lactobacillus
312098|NCT01609751|colonic diseases|colonic diseases
312099|NCT01609751|dietary fibre|dietary fibre
312100|NCT01609738|Cardiac pacing|cardiac pacing
312101|NCT01609738|Left ventricular septal pacing|left ventricular septal pacing
312102|NCT01609738|Feasibility and safety|feasibility and safety
312103|NCT01609738|Lead stability|lead stability
312104|NCT01609738|Hemodynamics|hemodynamics
312105|NCT01609738|Left ventricular dyssynchrony|left ventricular dyssynchrony
312106|NCT01609738|Pacing for heart failure|pacing for heart failure
312107|NCT01609738|Cardiac resynchronization therapy|cardiac resynchronization therapy
312108|NCT01609725|Coronary artery disease|coronary artery disease
312109|NCT01609725|C reactive protein|c reactive protein
312110|NCT01609725|Periodontitis|periodontitis
312111|NCT01609725|Periodontal therapy|periodontal therapy
312112|NCT01609725|Flow-mediated dilation|flow-mediated dilation
312113|NCT01609712|Improvement of lung function (FEV1, PEF)|improvement of lung function (fev1, pef)
312114|NCT01609712|Visual Analog Scale|visual analog scale
312115|NCT01609712|Oswestry Disability Index|oswestry disability index
312116|NCT01609712|Radiographs pre and post Op|radiographs pre and post op
312117|NCT01609699|body circumference|body circumference
312118|NCT01609699|Non-Invasive Reduction|non-invasive reduction
312119|NCT01609686|cardiac surgery|cardiac surgery
312120|NCT01609686|renal dysfunction|renal dysfunction
312121|NCT01609686|pharmacokinetics|pharmacokinetics
312122|NCT01609686|tranexamic acid|tranexamic acid
312123|NCT01609673|Immunosuppression|immunosuppression
312124|NCT01609673|Chronic Kidney Disease|chronic kidney disease
312125|NCT01609673|Renal Transplant|renal transplant
312126|NCT01609660|probiotics|probiotics
312129|NCT01609660|complications|complications
312130|NCT01609660|colorectal surgery|colorectal surgery
312131|NCT01609647|High plate reactivity unit after loading dose of clopidogrel|high plate reactivity unit after loading dose of clopidogrel
312133|NCT01609634|Term infants|term infants
312134|NCT01609634|Growth|growth
312135|NCT01609634|Body composition|body composition
312136|NCT01609595|Thalassemia|thalassemia
312137|NCT01609595|Anemia|anemia
312138|NCT01609595|Fetal hemoglobin|fetal hemoglobin
312139|NCT01609582|Drug therapy|drug therapy
312140|NCT01609556|FOLR solid tumors|folr solid tumors
312141|NCT01609530|verruca|verruca
312142|NCT01609530|vulgaris|vulgaris
312143|NCT01609530|hands|hands
312144|NCT01609530|feet|feet
312145|NCT01609530|Nd:YAG|nd:yag
312146|NCT01609530|laser|laser
312147|NCT01609530|cryotherapy|cryotherapy
312148|NCT01609517|Spinal anesthesia|spinal anesthesia
312149|NCT01609517|determinant|determinant
312150|NCT01609517|duration|duration
312151|NCT01609504|Rectal cancer|rectal cancer
312152|NCT01609504|Radiochemotherapy|radiochemotherapy
312153|NCT01609504|Transanal Endoscopic Microsurgery|transanal endoscopic microsurgery
312154|NCT01609504|Laparoscopic Resection|laparoscopic resection
312155|NCT01609478|asthma|asthma
312156|NCT01609465|CAD|cad
312157|NCT01609465|stable angina|stable angina
312158|NCT01609465|STEMI|stemi
312159|NCT01609465|NSTEMI|nstemi
312160|NCT01609465|CVD|cvd
312161|NCT01609465|secondary prevention|secondary prevention
312162|NCT01609452|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
312163|NCT01609452|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
387186|NCT01297231|10-217|10-217
312164|NCT01609452|Chronic ITP|chronic itp
312165|NCT01609439|Permanent|permanent
312166|NCT01609439|temporary|temporary
312167|NCT01609439|hypocalcemia|hypocalcemia
312168|NCT01609426|Proteinuria|proteinuria
312169|NCT01609426|idiopathic|idiopathic
312170|NCT01609426|nephrotic syndrome|nephrotic syndrome
312171|NCT01609426|herpesvirus|herpesvirus
312172|NCT01609426|epidemiology|epidemiology
312173|NCT01609426|immune response|immune response
312174|NCT01609426|interferon|interferon
312175|NCT01609426|steroid dependency|steroid dependency
312176|NCT01609426|nephrotic disease: Idiopathic nephrotic syndrome|nephrotic disease: idiopathic nephrotic syndrome
312177|NCT01609387|Vitamine|vitamine
312178|NCT01609387|mineral|mineral
312179|NCT01609387|obese patients|obese patients
312478|NCT01608139|Sorafenib|sorafenib
312180|NCT01609387|Vitamine en mineral shortage in obese patients|vitamine en mineral shortage in obese patients
312181|NCT01609374|Spinal Kinetics|spinal kinetics
312182|NCT01609374|artificial cervical disc|artificial cervical disc
312183|NCT01609374|cervical radiculopathy|cervical radiculopathy
312185|NCT01609374|neck pain|neck pain
312186|NCT01609374|cervical spine|cervical spine
312187|NCT01609374|degenerative disc disease|degenerative disc disease
312188|NCT01609361|Rehabilitation program|rehabilitation program
312189|NCT01609361|Fast track surgery|fast track surgery
312190|NCT01609361|Laparoscopic colorectal resection|laparoscopic colorectal resection
312191|NCT01609361|Colorectal cancer|colorectal cancer
312192|NCT01609361|Morbidity|morbidity
312193|NCT01609348|Depression|depression
312194|NCT01609348|Alzheimer's Disease|alzheimer's disease
312195|NCT01609322|fear of falling|fear of falling
312196|NCT01609322|agoraphobia|agoraphobia
312197|NCT01609309|Stomach Neoplasms|stomach neoplasms
312198|NCT01609309|Laparoscopy|laparoscopy
312199|NCT01609296|Peripheral Arterial Disease|peripheral arterial disease
312200|NCT01609296|Drug coated balloon|drug coated balloon
312201|NCT01609296|Superficial Femoral Artery|superficial femoral artery
312202|NCT01609296|Popliteal Femoral Artery|popliteal femoral artery
312203|NCT01609296|Atherosclerosis|atherosclerosis
312204|NCT01609244|Sleep apnea|sleep apnea
312205|NCT01609244|central sleep apnea|central sleep apnea
312206|NCT01609244|bilevel|bilevel
312207|NCT01609244|servoventilation|servoventilation
312208|NCT01609244|CPAP|cpap
312209|NCT01609192|sickle-cell anemia|sickle-cell anemia
312210|NCT01609192|spermatogenesis|spermatogenesis
312211|NCT01609192|hydroxyurea|hydroxyurea
312212|NCT01609166|Hand-foot Syndrome|hand-foot syndrome
312213|NCT01609166|capecitabine|capecitabine
312214|NCT01609166|allopurinol|allopurinol
312215|NCT01609153|schizophrenia|schizophrenia
312216|NCT01609153|amisulpride|amisulpride
312217|NCT01609153|olanzapine|olanzapine
312218|NCT01609153|polypharmacy|polypharmacy
312219|NCT01609140|Hyperlipidemia|hyperlipidemia
312220|NCT01609140|Dyslipidemia|dyslipidemia
312221|NCT01609114|phenomena and mechanism of RT-PK|phenomena and mechanism of rt-pk
312222|NCT01609114|fact for different anticancer drugs|fact for different anticancer drugs
312223|NCT01609114|different part in human|different part in human
312224|NCT01609101|Videolaryngoscopy|videolaryngoscopy
312225|NCT01609101|Palatopharyngeal distance|palatopharyngeal distance
312226|NCT01609101|Trauma|trauma
312227|NCT01609088|endothelium|endothelium
312228|NCT01609088|diabetes mellitus|diabetes mellitus
312229|NCT01609088|oxidative stress|oxidative stress
312230|NCT01609062|Mucopolysaccharidosis IVA Type A|mucopolysaccharidosis iva type a
312231|NCT01609062|MPS IVA Type A|mps iva type a
312232|NCT01609062|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
312233|NCT01609062|MPS IVA|mps iva
312234|NCT01609062|Morquio A Syndrome|morquio a syndrome
312235|NCT01609062|Lysosomal Storage Disorder|lysosomal storage disorder
312236|NCT01609062|LSD|lsd
312237|NCT01609062|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
312238|NCT01609062|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
312239|NCT01609062|sulfatase|sulfatase
312240|NCT01609062|galactose-6-sulfatase|galactose-6-sulfatase
312241|NCT01609062|GALNS|galns
312242|NCT01609062|enzyme replacement therapy|enzyme replacement therapy
312243|NCT01609062|ERT|ert
312244|NCT01609062|MOR-008|mor-008
312245|NCT01609062|CPET|cpet
312246|NCT01609062|MST|mst
312247|NCT01609062|muscle strength test|muscle strength test
312248|NCT01609062|physiological effect|physiological effect
312249|NCT01608984|remote ischemic preconditioning|remote ischemic preconditioning
312250|NCT01608984|coronary artery bypass grafting|coronary artery bypass grafting
312251|NCT01608984|myocardial injury|myocardial injury
312252|NCT01608971|Protamine|protamine
312253|NCT01608971|heparin level|heparin level
312254|NCT01608971|haemostasis|haemostasis
312255|NCT01608971|thromboelastometry|thromboelastometry
312256|NCT01608971|cardiac surgery|cardiac surgery
312257|NCT01608971|Patients undergoing cardiac surgery|patients undergoing cardiac surgery
312258|NCT01608958|Postpartum hemorrhage|postpartum hemorrhage
312259|NCT01608958|Oxytocin|oxytocin
312260|NCT01608958|Third stage of labor|third stage of labor
312261|NCT01608958|Hemoglobin|hemoglobin
312262|NCT01608958|Prevention|prevention
312263|NCT01608958|Intravenous|intravenous
312264|NCT01608958|Intramuscular|intramuscular
312265|NCT01608945|steroid|steroid
312266|NCT01608945|liver function|liver function
312267|NCT01608945|prognosis|prognosis
312268|NCT01608906|venous thrombosis|venous thrombosis
312269|NCT01608906|heparin|heparin
312270|NCT01608906|pulmonary embolism|pulmonary embolism
312271|NCT01608906|ICU|icu
312272|NCT01608867|Phase 1|phase 1
312273|NCT01608867|dose escalation|dose escalation
312274|NCT01608867|histologically confirmed|histologically confirmed
312275|NCT01608867|malignancy|malignancy
312276|NCT01608867|metastatic|metastatic
312277|NCT01608854|surgical site infection|surgical site infection
312278|NCT01608854|spinal surgery|spinal surgery
312279|NCT01608854|prophylactic antibiotics|prophylactic antibiotics
312281|NCT01608815|Salmonella infections|salmonella infections
312282|NCT01608815|Typhoid fever|typhoid fever
312283|NCT01608815|Bacterial infections|bacterial infections
312284|NCT01608815|Typhoid vaccine|typhoid vaccine
312285|NCT01608802|HIV|hiv
312286|NCT01608802|Antiretroviral therapy|antiretroviral therapy
312287|NCT01608802|Palliative care|palliative care
312288|NCT01608802|Pain|pain
312289|NCT01608789|Male sling|male sling
312290|NCT01608789|Stress Urinary Incontinence|stress urinary incontinence
312291|NCT01608789|Urination Disorders|urination disorders
312292|NCT01608789|Urologic Diseases|urologic diseases
312293|NCT01608724|Type 2 DM|type 2 dm
312294|NCT01608711|Gemcitabine|gemcitabine
312295|NCT01608711|ASP6182|asp6182
312296|NCT01608711|AGS-1C4D4|ags-1c4d4
312297|NCT01608711|Pancreatic Cancer|pancreatic cancer
312298|NCT01608698|chlormadinone acetate|chlormadinone acetate
312299|NCT01608698|drospirenone|drospirenone
312300|NCT01608698|contraceptive pills|contraceptive pills
312301|NCT01608685|Tuberculosis|tuberculosis
312302|NCT01608685|Latent tuberculosis infection|latent tuberculosis infection
312303|NCT01608685|Immunosuppression|immunosuppression
312304|NCT01608685|Renal transplant recipient|renal transplant recipient
312305|NCT01608646|S-1|s-1
312306|NCT01608646|Oxaliplatin|oxaliplatin
312307|NCT01608646|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
312308|NCT01608620|Systematic review and meta-analysis|systematic review and meta-analysis
312309|NCT01608620|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
312310|NCT01608620|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
312311|NCT01608620|Clinical practice guidelines|clinical practice guidelines
312312|NCT01608620|Clinical trials|clinical trials
312313|NCT01608620|Dietary sugars|dietary sugars
312314|NCT01608620|Fructose|fructose
312315|NCT01608620|High fructose corn syrup|high fructose corn syrup
312316|NCT01608620|Fruit|fruit
312317|NCT01608620|Isocaloric|isocaloric
312318|NCT01608620|Hypercaloric|hypercaloric
312319|NCT01608620|Cardiometabolic risk factors|cardiometabolic risk factors
312320|NCT01608620|Triglycerides|triglycerides
312321|NCT01608620|Cholesterol|cholesterol
312322|NCT01608620|Glycemic control|glycemic control
312323|NCT01608620|Insulin resistance|insulin resistance
312324|NCT01608620|Body weight|body weight
312325|NCT01608620|Uric acid|uric acid
312326|NCT01608620|Blood pressure|blood pressure
312327|NCT01608607|Systematic review and meta-analysis|systematic review and meta-analysis
312328|NCT01608607|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
312329|NCT01608607|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
312330|NCT01608607|Clinical practice guidelines|clinical practice guidelines
312331|NCT01608607|Clinical trials|clinical trials
312332|NCT01608607|Dietary sugars|dietary sugars
312333|NCT01608607|Fructose|fructose
312334|NCT01608607|High fructose corn syrup|high fructose corn syrup
312335|NCT01608607|sucrose|sucrose
312336|NCT01608607|Isocaloric|isocaloric
312337|NCT01608607|Hypercaloric|hypercaloric
312338|NCT01608607|Glycemic control|glycemic control
312339|NCT01608607|Insulin resistance|insulin resistance
312340|NCT01608607|Body weight|body weight
312341|NCT01608607|body mass index|body mass index
312342|NCT01608607|waist circumference|waist circumference
312343|NCT01608581|prevention|prevention
312344|NCT01608581|burn|burn
312345|NCT01608581|adult|adult
312346|NCT01608581|health promotion|health promotion
312347|NCT01608581|evaluation|evaluation
312348|NCT01608581|media|media
312349|NCT01608568|Sutures|sutures
312350|NCT01608568|Pelvic Organ Prolapse|pelvic organ prolapse
312351|NCT01608568|Sacrocolpopexy|sacrocolpopexy
312352|NCT01608568|Robotic Assisted Laparoscopy|robotic assisted laparoscopy
312353|NCT01608555|cystic fibrosis|cystic fibrosis
312354|NCT01608555|bacterial load|bacterial load
312355|NCT01608555|inhaled tobramycin|inhaled tobramycin
312356|NCT01608542|fostamatinib|fostamatinib
312358|NCT01608542|Japanese Healthy volunteers|japanese healthy volunteers
312359|NCT01608542|Phase 1|phase 1
312360|NCT01608542|Single and Multiple Dose Study|single and multiple dose study
312361|NCT01608529|Restriction device ventilatory nasal flow|restriction device ventilatory nasal flow
312362|NCT01608529|oronasal breathing|oronasal breathing
312363|NCT01608529|nasal breathing.|nasal breathing.
312364|NCT01608516|PET/CT|pet/ct
312365|NCT01608516|68Ga-NODAGA-RGD|68ga-nodaga-rgd
312366|NCT01608516|18F-FDG|18f-fdg
312367|NCT01608516|MRI|mri
312368|NCT01608516|US ultrasound|us ultrasound
312369|NCT01608516|inflammatory atheromatous plaque|inflammatory atheromatous plaque
312370|NCT01608516|endarterectomy|endarterectomy
312371|NCT01608503|subclavian vein|subclavian vein
312372|NCT01608503|ultrasound|ultrasound
312373|NCT01608503|distance between the subclavian vein and the lung|distance between the subclavian vein and the lung
312374|NCT01608490|COPD|copd
312375|NCT01608490|RePneu|repneu
312376|NCT01608477|Heart transplantation|heart transplantation
312377|NCT01608477|Medication adherence|medication adherence
312378|NCT01608477|Behavior system factor|behavior system factor
312379|NCT01608464|Randomized trial,|randomized trial,
312479|NCT01608139|Nexavar|nexavar
312380|NCT01608464|Pre-operative chemo-RT with CDDP and 5-FU|pre-operative chemo-rt with cddp and 5-fu
312381|NCT01608464|Multicenter study|multicenter study
312382|NCT01608438|Body-machine interface|body-machine interface
312383|NCT01608438|Customization|customization
312384|NCT01608438|Upper-body motion|upper-body motion
312385|NCT01608438|Motor learning|motor learning
312386|NCT01608438|Assistive Devices|assistive devices
312387|NCT01608438|Wheelchair|wheelchair
312388|NCT01608438|Computer keyboard|computer keyboard
312389|NCT01608425|diabetic foot ulcer|diabetic foot ulcer
312390|NCT01608425|ulcer monitoring|ulcer monitoring
312391|NCT01608425|telemedicine consultations|telemedicine consultations
312392|NCT01608425|cross-sectoral collaboration|cross-sectoral collaboration
312393|NCT01608412|renal transplantation|renal transplantation
312394|NCT01608412|everolimus|everolimus
312395|NCT01608412|tacrolimus|tacrolimus
312396|NCT01608412|molecular evaluation|molecular evaluation
312397|NCT01608399|major depressive disorder|major depressive disorder
312398|NCT01608399|psychotherapy|psychotherapy
312399|NCT01608399|metacognitive therapy|metacognitive therapy
312400|NCT01608386|Anterior approach|anterior approach
312401|NCT01608386|infrahepatic inferior vena cava clamping|infrahepatic inferior vena cava clamping
312402|NCT01608386|hepatic resection|hepatic resection
312403|NCT01608373|Pain|pain
312404|NCT01608373|Lidocaine|lidocaine
312405|NCT01608373|Intravenous|intravenous
312406|NCT01608373|Intraperitoneum|intraperitoneum
312407|NCT01608373|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
312408|NCT01608360|Pain|pain
312409|NCT01608360|Lidocaine|lidocaine
312410|NCT01608360|Intravenous|intravenous
312411|NCT01608360|Thyroidectomy|thyroidectomy
312412|NCT01608347|LMWH|lmwh
312413|NCT01608347|enoxaparin|enoxaparin
312414|NCT01608347|recurrent miscarriage|recurrent miscarriage
312415|NCT01608347|continuing fetal viability beyond 20 weeks gestation|continuing fetal viability beyond 20 weeks gestation
312416|NCT01608321|Chronic Pain|chronic pain
312417|NCT01608321|Gulf War Illness|gulf war illness
312418|NCT01608321|Gulf War Syndrome|gulf war syndrome
312419|NCT01608321|Fibromyalgia|fibromyalgia
312420|NCT01608321|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
312421|NCT01608321|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
312422|NCT01608321|Veterans|veterans
312423|NCT01608308|Chronic Sinusitis|chronic sinusitis
312424|NCT01608308|Pain Relief|pain relief
312425|NCT01608308|Post-Operative Opioid Requirement|post-operative opioid requirement
312426|NCT01608308|IV Acetaminophen|iv acetaminophen
312427|NCT01608308|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
312428|NCT01608308|FESS|fess
312429|NCT01608295|depressed|depressed
312431|NCT01608295|older adults|older adults
312432|NCT01608295|antidepressants|antidepressants
312433|NCT01608295|depression|depression
312434|NCT01608295|anxious|anxious
312435|NCT01608295|major depressive disorder|major depressive disorder
312436|NCT01608295|MDD|mdd
312437|NCT01608282|Osteoarthritis|osteoarthritis
312438|NCT01608282|Arthritis|arthritis
312439|NCT01608282|Knee|knee
312440|NCT01608282|Exercise|exercise
312441|NCT01608282|Physical Activity|physical activity
312442|NCT01608282|Web-based|web-based
402045|NCT01233362|West Bengal|west bengal
312443|NCT01608256|mild cognitive impairment|mild cognitive impairment
312444|NCT01608256|Automobile Driving|automobile driving
312445|NCT01608256|cognitive aspects|cognitive aspects
312446|NCT01608217|Behavioural disturbances|behavioural disturbances
312447|NCT01608217|Pain|pain
312448|NCT01608217|Dementia|dementia
312449|NCT01608217|Alzheimer's dementia|alzheimer's dementia
312451|NCT01608217|THC|thc
312452|NCT01608217|Cannabis|cannabis
312453|NCT01608204|Pharmacokinetics|pharmacokinetics
312454|NCT01608204|Busulfan|busulfan
312455|NCT01608204|Polymorphism|polymorphism
312456|NCT01608204|GST|gst
312457|NCT01608204|MDR-1(p-Glycoprotein)|mdr-1(p-glycoprotein)
312458|NCT01608204|Acute Myeloid Leukemia adult patients|acute myeloid leukemia adult patients
312459|NCT01608178|Pediatric Neurotransmitter Disorders|pediatric neurotransmitter disorders
312460|NCT01608178|Succinic Semialdehyde Dehydrogenase|succinic semialdehyde dehydrogenase
312461|NCT01608178|GABA|gaba
312462|NCT01608178|Epilepsy|epilepsy
312463|NCT01608165|Small renal cancer mass|small renal cancer mass
312464|NCT01608152|Leukemia|leukemia
312465|NCT01608152|Lymphoma|lymphoma
312466|NCT01608152|Game mechanics|game mechanics
312467|NCT01608152|Stem cell transplant survivors|stem cell transplant survivors
312468|NCT01608152|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
312469|NCT01608152|HSCT|hsct
312470|NCT01608152|Internet-based|internet-based
312471|NCT01608152|Interactive and personalized intervention|interactive and personalized intervention
312472|NCT01608152|Questionnaires|questionnaires
312473|NCT01608152|Focus groups|focus groups
312474|NCT01608152|Interviews|interviews
312475|NCT01608139|Advanced Cancers|advanced cancers
312476|NCT01608139|Advanced Solid Tumors|advanced solid tumors
312477|NCT01608139|Curcumin|curcumin
312483|NCT01608139|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
312484|NCT01608139|MSK-390|msk-390
312485|NCT01608139|Zolinza|zolinza
312486|NCT01608126|Ultrasound|ultrasound
312487|NCT01608126|Cervical Plexus|cervical plexus
312488|NCT01608126|Anesthesia, Conduction|anesthesia, conduction
312489|NCT01608126|Surgical Procedures, Elective|surgical procedures, elective
312490|NCT01608126|Atherectomy|atherectomy
312491|NCT01608113|neovascular AMD|neovascular amd
312492|NCT01608113|Optical coherence tomography|optical coherence tomography
312493|NCT01608113|reading acuity|reading acuity
312494|NCT01608113|contrast sensitivity|contrast sensitivity
312495|NCT01608074|BRCA1|brca1
312496|NCT01608074|BRCA2|brca2
312497|NCT01608074|Prophylactic surgery|prophylactic surgery
312498|NCT01608074|Salpingectomy|salpingectomy
312499|NCT01608074|Fimbriectomy|fimbriectomy
312500|NCT01608061|Mild probable Alzheimer's Disease|mild probable alzheimer's disease
312501|NCT01608048|In-vitro Fertilization|in-vitro fertilization
312502|NCT01608048|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
312503|NCT01608035|sciatic catheter|sciatic catheter
312504|NCT01608035|stump catheter|stump catheter
312505|NCT01608035|below knee amputation|below knee amputation
312506|NCT01608009|platinum resistant|platinum resistant
312507|NCT01608009|ovarian cancer|ovarian cancer
312508|NCT01607996|Epidural anesthesia|epidural anesthesia
312509|NCT01607996|pancreatic perfusion|pancreatic perfusion
312510|NCT01607996|pancreatic necrosectomy|pancreatic necrosectomy
312511|NCT01607983|nitric oxide|nitric oxide
312512|NCT01607983|ventricular-arterial coupling|ventricular-arterial coupling
312513|NCT01607983|congenital heart disease|congenital heart disease
312514|NCT01607970|Oxytocin|oxytocin
312515|NCT01607970|Startle|startle
312516|NCT01607970|moral dilemma|moral dilemma
312517|NCT01607970|oxytocin receptor gene|oxytocin receptor gene
312518|NCT01607957|Refractory, metastatic colorectal cancer|refractory, metastatic colorectal cancer
312519|NCT01607931|Exercise|exercise
312520|NCT01607931|Physical activity|physical activity
312521|NCT01607931|Type 2 diabetes|type 2 diabetes
312522|NCT01607931|Obesity|obesity
312523|NCT01607931|Incretin effect|incretin effect
312524|NCT01607931|GLP-1|glp-1
312525|NCT01607931|GIP|gip
312526|NCT01607931|Insulin secretion|insulin secretion
312527|NCT01607931|Glucagon|glucagon
312528|NCT01607931|Beta-cell function|beta-cell function
312529|NCT01607931|Disposition Index|disposition index
312530|NCT01607918|H pylori, eradication|h pylori, eradication
312531|NCT01607905|Selinexor|selinexor
312532|NCT01607905|KPT-330|kpt-330
312533|NCT01607905|Squamous Cell Carcinoma|squamous cell carcinoma
312534|NCT01607905|Glioblastoma multiforme|glioblastoma multiforme
312535|NCT01607905|Adenocarcinoma|adenocarcinoma
312536|NCT01607905|Melanoma|melanoma
312537|NCT01607892|Selinexor|selinexor
312538|NCT01607892|KPT-330|kpt-330
312539|NCT01607892|Multiple Myeloma|multiple myeloma
312540|NCT01607892|non-Hodgkin Lymphoma|non-hodgkin lymphoma
312541|NCT01607892|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
312542|NCT01607892|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
312543|NCT01607892|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
402046|NCT01233362|India|india
312544|NCT01607892|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
312545|NCT01607892|Chronic Myelocytic Leukemia|chronic myelocytic leukemia
312546|NCT01607892|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
312547|NCT01607879|Prostate Cancer|prostate cancer
312548|NCT01607879|Men|men
312549|NCT01607879|Androgen Deprivation Therapy|androgen deprivation therapy
312550|NCT01607879|Elderly|elderly
312551|NCT01607879|Geriatric|geriatric
312552|NCT01607879|Nutritional supplementation|nutritional supplementation
312553|NCT01607840|Schizophrenia|schizophrenia
312554|NCT01607840|Cognitive Improvement|cognitive improvement
312555|NCT01607840|tDCS|tdcs
312556|NCT01607840|stimulation|stimulation
312557|NCT01607827|polypectomy|polypectomy
312558|NCT01607827|colonoscopy|colonoscopy
312559|NCT01607827|polyp miss rate|polyp miss rate
312560|NCT01607827|surveillance|surveillance
312561|NCT01607827|colorectal cancer|colorectal cancer
312562|NCT01607814|cirrhosis|cirrhosis
312563|NCT01607814|oxidative stress|oxidative stress
312564|NCT01607814|NADPH oxidase|nadph oxidase
312565|NCT01607814|isoprostanes|isoprostanes
312566|NCT01607814|PUFA balance|pufa balance
312567|NCT01607814|platelet activation|platelet activation
312568|NCT01607814|coagulation abnormalities|coagulation abnormalities
312569|NCT01607801|umbilical hernia repair|umbilical hernia repair
312570|NCT01607801|recurrence|recurrence
312571|NCT01607801|choice of suture|choice of suture
312572|NCT01607801|mesh|mesh
312573|NCT01607801|mesh/non-mesh|mesh/non-mesh
312574|NCT01607788|Selection criteria|selection criteria
312575|NCT01607788|Liver transplantation|liver transplantation
312576|NCT01607788|Hepatocellular carcinoma|hepatocellular carcinoma
312577|NCT01607762|Healthy|healthy
312578|NCT01607762|Antipsychotics|antipsychotics
312579|NCT01607762|Aripiprazole|aripiprazole
312580|NCT01607762|Paliperidone|paliperidone
312581|NCT01607762|Risperidone|risperidone
312582|NCT01607762|Quetiapine|quetiapine
312584|NCT01607749|Asthma Control|asthma control
312585|NCT01607749|Quality of life|quality of life
312586|NCT01607749|Children|children
312587|NCT01607749|Asthma education|asthma education
312588|NCT01607736|falls|falls
312589|NCT01607736|walking|walking
312590|NCT01607736|healthy older individuals|healthy older individuals
312591|NCT01607736|virtual gait training|virtual gait training
312592|NCT01607723|Sleep pattern|sleep pattern
312593|NCT01607723|Mechanical ventilation|mechanical ventilation
312594|NCT01607723|weaning|weaning
312595|NCT01607723|Intensive Care|intensive care
312596|NCT01607723|NAVA (Neurally Adjusted Ventilatory Assist)|nava (neurally adjusted ventilatory assist)
312597|NCT01607723|PAV+ (Proportional Assist Ventilation Plus)|pav+ (proportional assist ventilation plus)
312598|NCT01607710|fMRI|fmri
312599|NCT01607710|Generalized Anxiety Disorder|generalized anxiety disorder
312600|NCT01607697|Parkinson's Disease|parkinson's disease
312601|NCT01607671|Ischemic|ischemic
312602|NCT01607671|Optic Neuropathy|optic neuropathy
312603|NCT01607671|Non-Arteritic Anterior Ischemic Optic Neuropathy|non-arteritic anterior ischemic optic neuropathy
312604|NCT01607671|NAION|naion
312605|NCT01607671|Ischemic Optic Neuropathy|ischemic optic neuropathy
312606|NCT01607671|Intraocular Pressure|intraocular pressure
312607|NCT01607658|Testosterone|testosterone
312608|NCT01607632|posttraumatic stress|posttraumatic stress
312609|NCT01607632|depression|depression
312610|NCT01607619|CRP|crp
312611|NCT01606566|Recurrent|recurrent
312612|NCT01606566|Head and Neck|head and neck
312613|NCT01606566|Neoplasms|neoplasms
312614|NCT01606566|Squamous Cell Carcinoma|squamous cell carcinoma
312615|NCT01606566|Amphinex|amphinex
312616|NCT01606566|Cancer|cancer
312617|NCT01606566|Photodynamic therapy|photodynamic therapy
312618|NCT01606566|Chemotherapy|chemotherapy
312619|NCT01606566|Bleomycin|bleomycin
312620|NCT01606553|chronic heart failure|chronic heart failure
312621|NCT01606553|respiratory muscle weakness|respiratory muscle weakness
312622|NCT01606553|inspiratory muscle training|inspiratory muscle training
312623|NCT01606540|Colles fracture|colles fracture
312624|NCT01606540|Non-steroid antiinflammatory drugs|non-steroid antiinflammatory drugs
312625|NCT01606540|Bone healing|bone healing
312626|NCT01606527|Spectrum of Altitude-associated acute mountain sickness|spectrum of altitude-associated acute mountain sickness
312627|NCT01606527|hypoxia|hypoxia
312628|NCT01606527|high altitude headache|high altitude headache
312629|NCT01606527|high altitude cerebral edemat is.....|high altitude cerebral edemat is.....
312630|NCT01607593|Retrospective|retrospective
312631|NCT01607593|Sertraline|sertraline
312632|NCT01607593|Posttraumatic stress disorder|posttraumatic stress disorder
312633|NCT01607554|Lung|lung
312634|NCT01607554|non small cell|non small cell
312635|NCT01607554|NSCLC|nsclc
312636|NCT01607554|Irinotecan|irinotecan
312637|NCT01607541|HIV/AIDS|hiv/aids
312638|NCT01607541|vulnerable populations|vulnerable populations
312639|NCT01607541|heterosexuals at high risk|heterosexuals at high risk
312640|NCT01607541|peer-driven intervention|peer-driven intervention
312641|NCT01607541|tailored intervention|tailored intervention
312642|NCT01607541|African-American|african-american
312643|NCT01607541|Latino/Hispanic|latino/hispanic
312644|NCT01607541|Seek, test, treat, and retain (STTR)|seek, test, treat, and retain (sttr)
312645|NCT01607515|Pulmonary hypertension|pulmonary hypertension
312646|NCT01607515|Cardiac index|cardiac index
312647|NCT01607515|impedance cardiography|impedance cardiography
312648|NCT01607502|Pulmonary hypertension|pulmonary hypertension
312649|NCT01607502|database|database
312650|NCT01607502|biomarker|biomarker
312651|NCT01607489|Early diagnosis of pulmonary arterial hypertension|early diagnosis of pulmonary arterial hypertension
312652|NCT01607489|dynamic dual-energy computed tomography|dynamic dual-energy computed tomography
312654|NCT01607463|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
312655|NCT01607450|Type 2 diabetes mellitus|type 2 diabetes mellitus
303471|NCT01648504|Ipad|ipad
312656|NCT01607450|lean healthy control|lean healthy control
312657|NCT01607424|cognitive rehabilitation|cognitive rehabilitation
312658|NCT01607424|schizophrenia|schizophrenia
312659|NCT01607398|Japan|japan
312660|NCT01607398|COPD|copd
312661|NCT01607398|CAT|cat
312662|NCT01607398|placebo|placebo
312663|NCT01607398|serum|serum
312664|NCT01607398|Adoair250|adoair250
312665|NCT01607398|anti-inflammatory|anti-inflammatory
312666|NCT01607398|sputum|sputum
312667|NCT01607385|pharmacokinetic|pharmacokinetic
312668|NCT01607385|intestinal bile acid transporter inhibitor|intestinal bile acid transporter inhibitor
312669|NCT01607385|GSK2330672|gsk2330672
312670|NCT01607385|pharmacodynamic|pharmacodynamic
312671|NCT01607385|GSK1614235|gsk1614235
312672|NCT01607385|dose escalation|dose escalation
312673|NCT01607372|TLR7 agonist, Respiratory Allergies, Allergic Rhinitis, Mild Allergic Asthma, Repeat Dose Safety, Reduction of Allergic Reactivity|tlr7 agonist, respiratory allergies, allergic rhinitis, mild allergic asthma, repeat dose safety, reduction of allergic reactivity
312674|NCT01607359|atrial fibrillation|atrial fibrillation
312675|NCT01607359|catheter ablation|catheter ablation
312676|NCT01607359|dabigatran|dabigatran
312677|NCT01607359|warfarin|warfarin
312678|NCT01607359|oral anticoagulation|oral anticoagulation
312679|NCT01607346|Urinary Retention|urinary retention
312680|NCT01607333|Antiepileptics|antiepileptics
312681|NCT01607333|suicidality|suicidality
312682|NCT01607320|PCOS|pcos
312683|NCT01607320|Infertility|infertility
312684|NCT01607320|Anovulation|anovulation
312685|NCT01607307|daikenchuto|daikenchuto
312686|NCT01607307|postoperative ileus|postoperative ileus
312687|NCT01607307|pancreaticoduodenectomy|pancreaticoduodenectomy
312688|NCT01607281|anatomical landmark|anatomical landmark
312689|NCT01607281|internal jugular vein canulation|internal jugular vein canulation
312690|NCT01607268|autonomic failure|autonomic failure
312691|NCT01607268|mangenetic resonance|mangenetic resonance
312692|NCT01607268|neurochemistry|neurochemistry
312693|NCT01607268|neurotransmitter|neurotransmitter
312694|NCT01607268|glutamate|glutamate
312695|NCT01607255|adenoma detection|adenoma detection
312696|NCT01607255|screening colonoscopy|screening colonoscopy
312697|NCT01607255|water exchange method|water exchange method
312698|NCT01607255|chromoendoscopy|chromoendoscopy
312699|NCT01607242|total thyroidectomy|total thyroidectomy
312700|NCT01607242|voice handicap index|voice handicap index
312701|NCT01607242|swallowing disorders|swallowing disorders
312702|NCT01607242|thyroid surgery|thyroid surgery
312703|NCT01607242|voice disorders|voice disorders
312704|NCT01607229|multi-frequency|multi-frequency
312705|NCT01607229|bioelectrical impedance|bioelectrical impedance
312706|NCT01607229|body composition|body composition
312707|NCT01607229|hydration|hydration
312708|NCT01607216|Prematurity|prematurity
312709|NCT01607216|Respiratory Illness|respiratory illness
312710|NCT01607216|Lung Function|lung function
312711|NCT01607216|Lung Disease|lung disease
312712|NCT01607203|ovarian hyper stimulation syndrome (OHSS)|ovarian hyper stimulation syndrome (ohss)
312713|NCT01607203|metaphase II oocytes (MII)|metaphase ii oocytes (mii)
312714|NCT01607203|good quality embryo's|good quality embryo's
312715|NCT01607203|implantation|implantation
312716|NCT01607203|pregnancy|pregnancy
312717|NCT01607190|type 2 diabetes mellitus|type 2 diabetes mellitus
312718|NCT01607190|nonproliferative diabetic retinopathy|nonproliferative diabetic retinopathy
312719|NCT01607164|Mood management|mood management
312720|NCT01607164|self-help|self-help
312721|NCT01607164|depression|depression
312722|NCT01607164|prevention|prevention
312723|NCT01607164|cognitive behavioral|cognitive behavioral
312724|NCT01607151|hypothermia|hypothermia
312725|NCT01607151|normothermia|normothermia
312726|NCT01607151|hyperthermia|hyperthermia
312727|NCT01607138|laryngectomy|laryngectomy
312728|NCT01607138|swallowing disturbances|swallowing disturbances
312729|NCT01607138|speech disturbances|speech disturbances
313132|NCT01605123|children|children
312730|NCT01607138|speech intelligibility|speech intelligibility
312731|NCT01607138|voice prothesis|voice prothesis
312732|NCT01607112|Influenza|influenza
312733|NCT01607112|Healthy|healthy
312734|NCT01607112|Immunogenicity|immunogenicity
312735|NCT01607112|Elderly|elderly
312736|NCT01607112|Safety|safety
312737|NCT01607112|Adults|adults
312738|NCT01607099|colonoscopy|colonoscopy
312739|NCT01607099|bowel cleansing|bowel cleansing
312740|NCT01607099|bowel cleanness|bowel cleanness
312741|NCT01607099|efficiency|efficiency
312742|NCT01607099|compatibility|compatibility
312743|NCT01607086|Lamotrigine|lamotrigine
312744|NCT01607086|placebo|placebo
312745|NCT01607086|properties|properties
312746|NCT01607086|characteristics|characteristics
312747|NCT01607073|Dravet|dravet
312748|NCT01607073|seizures|seizures
312749|NCT01607073|verapamil|verapamil
312750|NCT01607060|Critically ill patients|critically ill patients
312751|NCT01607060|intestinal failure|intestinal failure
312752|NCT01607047|leptospirosis|leptospirosis
312753|NCT01607047|qPCR|qpcr
312754|NCT01607047|cohort|cohort
303574|NCT01647971|Rituxan|rituxan
312755|NCT01607047|french west indies|french west indies
312756|NCT01607047|blood sample collection|blood sample collection
312757|NCT01607047|pronostic|pronostic
312758|NCT01607047|diagnosis|diagnosis
312759|NCT01607021|Chronic hepatitis C|chronic hepatitis c
312760|NCT01607021|interleukin 28|interleukin 28
312761|NCT01607021|Children|children
312762|NCT01606995|Stroke|stroke
312763|NCT01606995|Embolism|embolism
312764|NCT01606995|Atrial fibrillation|atrial fibrillation
312765|NCT01606982|prostate|prostate
312766|NCT01606982|MDV3100|mdv3100
312767|NCT01606982|cancer|cancer
312768|NCT01606969|Dexmedetomidine|dexmedetomidine
312769|NCT01606969|epinephrine|epinephrine
312770|NCT01606969|lidocaine|lidocaine
312771|NCT01606969|scalp infiltration|scalp infiltration
312772|NCT01606969|craniotomy|craniotomy
312773|NCT01606943|Aortic dissection|aortic dissection
312774|NCT01606943|Risk factor|risk factor
312775|NCT01606943|Feature|feature
312776|NCT01606943|Management|management
312777|NCT01606943|Outcome|outcome
312778|NCT01606930|Patient Satisfaction|patient satisfaction
312779|NCT01606930|Patient Doctor Communication|patient doctor communication
312780|NCT01606930|Shared Decision Making|shared decision making
312781|NCT01606930|Patient Activation|patient activation
312887|NCT01606306|Preschool-age|preschool-age
312782|NCT01606891|preschooler obesity prevention|preschooler obesity prevention
312783|NCT01606891|community home visiting parents|community home visiting parents
312784|NCT01606891|preschooler excess BMI gain|preschooler excess bmi gain
312785|NCT01606891|multi-setting/component intervention|multi-setting/component intervention
312786|NCT01606852|sedation|sedation
312787|NCT01606852|mechanical ventilation|mechanical ventilation
312788|NCT01606852|anxiety|anxiety
312789|NCT01606852|respiratory failure|respiratory failure
312790|NCT01606826|Severe|severe
312791|NCT01606787|Kidney|kidney
312792|NCT01606787|MANNITOL|mannitol
312793|NCT01606787|PLACEBO|placebo
312794|NCT01606787|Partial Nephrectomy|partial nephrectomy
312795|NCT01606787|12-079|12-079
312796|NCT01606761|Arthritis, Rheumatoid|arthritis, rheumatoid
312797|NCT01606761|Active rheumatoid arthritis despite anti-TNF-alpha therapy|active rheumatoid arthritis despite anti-tnf-alpha therapy
312798|NCT01606761|Sirukumab|sirukumab
312799|NCT01606761|Human Anti-IL-6 monoclonal antibody|human anti-il-6 monoclonal antibody
312800|NCT01606748|Advanced Malignant Solid Tumors|advanced malignant solid tumors
312801|NCT01606748|Solid Cancers|solid cancers
312802|NCT01606748|Non-small Cell Lung Cancer|non-small cell lung cancer
312803|NCT01606748|NSCLC|nsclc
312804|NCT01606748|Breast Cancer|breast cancer
312805|NCT01606735|cataract surgery|cataract surgery
312806|NCT01606735|ocular inflammation|ocular inflammation
312807|NCT01606722|Antiretroviral therapy|antiretroviral therapy
312808|NCT01606722|Boosted-Darunavir monotherapy|boosted-darunavir monotherapy
312809|NCT01606722|Resistance|resistance
312810|NCT01606722|Proviral DNA-HIV|proviral dna-hiv
312811|NCT01606709|GnRHa trigger|gnrha trigger
312812|NCT01606709|endometrial gene profile|endometrial gene profile
312813|NCT01606709|quality of life|quality of life
312814|NCT01606696|CAD|cad
312815|NCT01606696|cardiac rehabilitation|cardiac rehabilitation
312816|NCT01606696|fitness|fitness
312817|NCT01606683|Acidified milk|acidified milk
312818|NCT01606683|Beta-palmitate|beta-palmitate
312819|NCT01606683|Bifidobacteria|bifidobacteria
312820|NCT01606683|Breastfeeding|breastfeeding
312821|NCT01606683|Infant formula|infant formula
312822|NCT01606683|Galacto-oligosaccharides|galacto-oligosaccharides
312823|NCT01606683|Growth|growth
312824|NCT01606683|Infants|infants
312825|NCT01606683|Metabolomics|metabolomics
312826|NCT01606683|Prebiotics|prebiotics
312827|NCT01606670|Rotigotine|rotigotine
312828|NCT01606670|Neupro®|neupro®
312829|NCT01606657|I&D|i&d
312830|NCT01606657|Abscess|abscess
312831|NCT01606657|Irrigation|irrigation
312832|NCT01606657|Cutaneous Abscess|cutaneous abscess
312833|NCT01606644|radiation sequelae|radiation sequelae
312834|NCT01606644|hyperbaric oxygen|hyperbaric oxygen
312835|NCT01606631|severe sepsis|severe sepsis
312836|NCT01606631|toxic shock|toxic shock
312837|NCT01606618|Self-esteem|self-esteem
312838|NCT01606618|Spina Bifida|spina bifida
312839|NCT01606618|Spinal cord injury|spinal cord injury
312840|NCT01606605|Lymphoma|lymphoma
312841|NCT01606605|Prognosis|prognosis
312842|NCT01606605|Relapse|relapse
312843|NCT01606605|Gene|gene
312844|NCT01606605|microRNA|microrna
312845|NCT01606579|Leukemia|leukemia
312846|NCT01606579|acute myeloid leukemia|acute myeloid leukemia
312847|NCT01606579|AML|aml
312848|NCT01606579|chronic myeloid leukemia|chronic myeloid leukemia
312849|NCT01606579|CML|cml
312850|NCT01606579|MDS|mds
312851|NCT01606579|myelodysplastic syndrome|myelodysplastic syndrome
312852|NCT01606579|myeloproliferative neoplasia|myeloproliferative neoplasia
312853|NCT01606579|MPN|mpn
312854|NCT01606488|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
312855|NCT01606488|Postoperative Cognitive Decline|postoperative cognitive decline
312856|NCT01606488|POCD|pocd
312857|NCT01606488|Alzheimer's disease|alzheimer's disease
312858|NCT01606488|Florbetapir F 18 (18F-AV-45)|florbetapir f 18 (18f-av-45)
312859|NCT01606475|Islet transplant|islet transplant
312860|NCT01606475|Diabetes Mellitus|diabetes mellitus
312861|NCT01606475|Hypoglycemia|hypoglycemia
312862|NCT01606462|oxytocin|oxytocin
312863|NCT01606462|social cognition|social cognition
312864|NCT01606462|fMRI|fmri
312865|NCT01606462|oxytocin receptor gene|oxytocin receptor gene
312866|NCT01606449|Gastroesophageal reflux diseases|gastroesophageal reflux diseases
312867|NCT01606449|Hiatal Hernia|hiatal hernia
312868|NCT01606449|Paraesophageal Hernia|paraesophageal hernia
312869|NCT01606358|Ovarian Cancer|ovarian cancer
312870|NCT01606358|Patient with ovarian cancer|patient with ovarian cancer
312871|NCT01606345|Upper Tract Urothelial Carcinoma|upper tract urothelial carcinoma
312872|NCT01606345|UTUC|utuc
312873|NCT01606345|Kidney|kidney
312874|NCT01606345|Cancer|cancer
312875|NCT01606345|Renal|renal
312876|NCT01606319|Asthma|asthma
312877|NCT01606319|Wheezing|wheezing
312878|NCT01606319|Ibuprofen|ibuprofen
312879|NCT01606319|Acetaminophen|acetaminophen
312880|NCT01606319|exacerbations|exacerbations
312881|NCT01606319|pain|pain
312882|NCT01606319|fever|fever
312883|NCT01606306|Asthma|asthma
312884|NCT01606306|Wheezing|wheezing
312885|NCT01606306|Fluticasone|fluticasone
312888|NCT01606293|Small cell carcinomas of the cervix|small cell carcinomas of the cervix
312889|NCT01606293|Large cell carcinomas of the cervix|large cell carcinomas of the cervix
312890|NCT01606293|Online surveys|online surveys
312891|NCT01606293|Electronic surveys|electronic surveys
312892|NCT01606293|Questionnaires|questionnaires
312893|NCT01606293|Facebook|facebook
312894|NCT01606293|Social networking support groups|social networking support groups
312895|NCT01606280|Amyloidosis|amyloidosis
312896|NCT01606267|Integrated Community Case Management|integrated community case management
312897|NCT01606267|Pneumonia|pneumonia
312898|NCT01606267|Ethiopia|ethiopia
312899|NCT01606254|Schizophrenia|schizophrenia
312900|NCT01606254|Paliperidone Palmitate|paliperidone palmitate
312902|NCT01606228|Schizophrenia|schizophrenia
312903|NCT01606228|Paliperidone ER|paliperidone er
312904|NCT01606228|Treatment naive patients|treatment naive patients
312905|NCT01606228|Newly diagnosed patients|newly diagnosed patients
312906|NCT01606215|multiple sclerosis|multiple sclerosis
312907|NCT01606215|mesenchymal stem cells|mesenchymal stem cells
312908|NCT01606215|bone marrow|bone marrow
312909|NCT01606215|rapidly evolving|rapidly evolving
312910|NCT01606150|neonate|neonate
312911|NCT01606150|late preterm|late preterm
312912|NCT01606150|lumbar puncture|lumbar puncture
312913|NCT01606150|analgesia|analgesia
312914|NCT01606150|pain|pain
312915|NCT01606150|lidocaine|lidocaine
312916|NCT01606098|Surgery|surgery
312917|NCT01606098|Chemotherapy|chemotherapy
312918|NCT01606085|Diabetes|diabetes
312919|NCT01606085|Heart Failure|heart failure
312920|NCT01606085|Quality of Life|quality of life
312921|NCT01606085|Self Care|self care
312922|NCT01606072|DDAVP|ddavp
312923|NCT01606033|stress|stress
312924|NCT01606033|Life quality|life quality
312925|NCT01606033|adjustment strategy|adjustment strategy
312926|NCT01606033|receiving an antitumor treatment|receiving an antitumor treatment
312927|NCT01606033|within a clinical trial (case)|within a clinical trial (case)
312928|NCT01606033|according to a standard treatment (control)|according to a standard treatment (control)
312929|NCT01606020|effects of sleep deprivation|effects of sleep deprivation
312930|NCT01606020|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
312931|NCT01606020|male, healthy volunteers|male, healthy volunteers
312932|NCT01605981|Nilotinib|nilotinib
312933|NCT01605981|CML patients|cml patients
312934|NCT01605981|accelerated phase|accelerated phase
312935|NCT01605968|Obstetrics|obstetrics
312936|NCT01605968|Gynecology|gynecology
312937|NCT01605968|Wound healing|wound healing
312938|NCT01605955|SPO2|spo2
313133|NCT01605123|obesity|obesity
312939|NCT01605929|Anesthetics, local/administration & dosage|anesthetics, local/administration & dosage
312940|NCT01605929|Brachial Plexus/ultrasonography|brachial plexus/ultrasonography
312941|NCT01605929|Humans|humans
312942|NCT01605929|Nerve Block/methods|nerve block/methods
312943|NCT01605929|Upper Extremity/surgery|upper extremity/surgery
312944|NCT01605929|Catheters, Indwelling|catheters, indwelling
312945|NCT01605929|Anesthesia, Conduction/methods|anesthesia, conduction/methods
312946|NCT01605929|Analgesia/methods|analgesia/methods
312947|NCT01605929|Nerve Block/adverse effects|nerve block/adverse effects
312948|NCT01605916|Cancer,|cancer,
312949|NCT01605916|Tumour,|tumour,
312950|NCT01605916|Metastatic,|metastatic,
312951|NCT01605916|Lung cancer,|lung cancer,
312952|NCT01605916|Non-Small Cell Lung Cancer|non-small cell lung cancer
312953|NCT01605903|Tonsillectomy|tonsillectomy
312954|NCT01605903|adenoidectomy|adenoidectomy
312955|NCT01605903|bleeding|bleeding
312956|NCT01605903|bleeding rates|bleeding rates
303801|NCT01646502|Esp|esp
312957|NCT01605903|Tonsillectomy with and without adenoidectomy|tonsillectomy with and without adenoidectomy
312958|NCT01605890|HIV-2|hiv-2
312959|NCT01605877|Cataracts|cataracts
312960|NCT01605877|Intraocular lens|intraocular lens
312961|NCT01605877|Multifocal|multifocal
312962|NCT01605877|Presbyopia|presbyopia
312963|NCT01605864|pneumonia|pneumonia
312964|NCT01605864|community acquired bacterial pneumonia|community acquired bacterial pneumonia
312965|NCT01605864|CAP|cap
312966|NCT01605864|CABP|cabp
312967|NCT01605864|bacterial pneumonia|bacterial pneumonia
312968|NCT01605851|PFO|pfo
312969|NCT01605851|closure|closure
312970|NCT01605838|TBI|tbi
312971|NCT01605812|IOL;|iol;
312972|NCT01605812|capsule；|capsule；
312973|NCT01605812|PCO;|pco;
312974|NCT01605812|OCT|oct
312975|NCT01605799|PTSD|ptsd
312976|NCT01605799|Mental Health|mental health
312977|NCT01605799|War|war
312978|NCT01605799|Veterans|veterans
312979|NCT01605786|Malaria|malaria
312980|NCT01605786|Plasmodium falciparum|plasmodium falciparum
312981|NCT01605786|vaccine|vaccine
312982|NCT01605786|ADCI|adci
312983|NCT01605786|sporozoite challenge|sporozoite challenge
312984|NCT01605786|pre-erythrocytic|pre-erythrocytic
312985|NCT01605786|erythrocytic|erythrocytic
312986|NCT01605760|immunotherapy|immunotherapy
312987|NCT01605760|elderly|elderly
312988|NCT01605734|hepatocellular carcinoma|hepatocellular carcinoma
312989|NCT01605734|transarterial chemoembolization|transarterial chemoembolization
312990|NCT01605734|sorafenib|sorafenib
312991|NCT01605721|Everolimus|everolimus
312992|NCT01605721|XIENCE PRIME|xience prime
312993|NCT01605721|Drug eluting stent|drug eluting stent
312994|NCT01605708|Itching|itching
312995|NCT01605695|reference range|reference range
312996|NCT01605695|plasma|plasma
312997|NCT01605695|inducible nitric oxide synthase|inducible nitric oxide synthase
312998|NCT01605695|iNOS|inos
312999|NCT01605695|healthy adults|healthy adults
313000|NCT01605682|effect of different berry doses on mood and cognition|effect of different berry doses on mood and cognition
313001|NCT01605682|adults|adults
313002|NCT01605669|Auscultation|auscultation
313003|NCT01605669|Aortic stenosis|aortic stenosis
313004|NCT01605669|computer assisted auscultation|computer assisted auscultation
313005|NCT01605669|Aortic Stenosis Acceleration Index|aortic stenosis acceleration index
313006|NCT01605656|Cancer Prevention|cancer prevention
313007|NCT01605656|Cervix|cervix
313008|NCT01605656|Questionnaires|questionnaires
313009|NCT01605656|Focus groups|focus groups
313010|NCT01605656|Surveys|surveys
313011|NCT01605656|Interviews|interviews
313012|NCT01605643|cancer|cancer
313013|NCT01605643|tobacco use|tobacco use
313014|NCT01605643|pregnancy|pregnancy
313015|NCT01605604|mindfulness EQ adolescents|mindfulness eq adolescents
313016|NCT01605591|left-side double lumen bronchial tube|left-side double lumen bronchial tube
313017|NCT01605591|bending type|bending type
313018|NCT01605591|GlideScope videolaryngoscope|glidescope videolaryngoscope
313019|NCT01605552|Depression|depression
313020|NCT01605552|Depressive Symptoms|depressive symptoms
313021|NCT01605552|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
313022|NCT01605552|Coronary Artery Disease (CAD)|coronary artery disease (cad)
313023|NCT01605552|Heart Disease|heart disease
313024|NCT01605513|recombinant interferon, tolerated, effective|recombinant interferon, tolerated, effective
313025|NCT01605500|ICD|icd
313026|NCT01605474|foley catheter|foley catheter
313027|NCT01605474|foley bulb|foley bulb
313028|NCT01605474|induction of labor|induction of labor
313029|NCT01605474|labor|labor
313030|NCT01605448|Mild Cognitive Impairment|mild cognitive impairment
313031|NCT01605448|Alzheimer's disease|alzheimer's disease
313032|NCT01605448|Meditation|meditation
313033|NCT01605448|Default Mode Network|default mode network
313034|NCT01605422|Systematic review and meta-analysis|systematic review and meta-analysis
313035|NCT01605422|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
313036|NCT01605422|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
313037|NCT01605422|Clinical practice guidelines|clinical practice guidelines
313038|NCT01605422|Clinical trials|clinical trials
313039|NCT01605422|Dietary pulses|dietary pulses
313040|NCT01605422|legumes|legumes
313041|NCT01605422|Beans, peas, chickpeas, lentils|beans, peas, chickpeas, lentils
313042|NCT01605422|glycemic index|glycemic index
313043|NCT01605422|postprandial glycemia|postprandial glycemia
313044|NCT01605422|insulin resistance|insulin resistance
313045|NCT01605422|body weight|body weight
313046|NCT01605422|appetite|appetite
313047|NCT01605422|food intake regulation|food intake regulation
313048|NCT01605422|satiety|satiety
313049|NCT01605422|satiation|satiation
313050|NCT01605409|Refractory cardiac arrest|refractory cardiac arrest
313051|NCT01605409|Emergency cardiopulmonary bypass|emergency cardiopulmonary bypass
313052|NCT01605409|Extracorporeal life support in cardiac arrest|extracorporeal life support in cardiac arrest
313053|NCT01605383|Avascular Necrosis of Femur Head|avascular necrosis of femur head
303871|NCT01646333|Memory|memory
313054|NCT01605383|Osteonecrosis of the hip|osteonecrosis of the hip
313055|NCT01605383|Osteonecrosis of the femoral head|osteonecrosis of the femoral head
313056|NCT01605383|Mesenchymal Stem Cells|mesenchymal stem cells
313057|NCT01605383|Bone marrow|bone marrow
313058|NCT01605383|Tissue engineering|tissue engineering
313059|NCT01605383|Bone Diseases|bone diseases
313060|NCT01605383|Musculoskeletal Diseases|musculoskeletal diseases
313061|NCT01605370|Hypertension, Left Ventricular Mass|hypertension, left ventricular mass
313062|NCT01605357|Brain Injuries|brain injuries
313063|NCT01605357|Hematoma, subdural|hematoma, subdural
313064|NCT01605357|Decompressive Craniectomy|decompressive craniectomy
313065|NCT01605357|Saline solution, hypertonic|saline solution, hypertonic
313066|NCT01605357|Hypernatremia|hypernatremia
313067|NCT01605357|Intracranial hemorrhages|intracranial hemorrhages
313068|NCT01605357|Head Injuries, closed|head injuries, closed
313069|NCT01605357|Intracranial pressure|intracranial pressure
313070|NCT01605357|Brain edema|brain edema
313071|NCT01605357|Critical care|critical care
313072|NCT01605357|Brain Diseases|brain diseases
313073|NCT01605357|Central Nervous System Diseases|central nervous system diseases
313074|NCT01605357|Nervous System Diseases|nervous system diseases
313075|NCT01605357|Wounds and Injuries|wounds and injuries
313076|NCT01605357|Physiological Effects of Drugs|physiological effects of drugs
313077|NCT01605357|Pharmacologic Actions|pharmacologic actions
313078|NCT01605344|Advanced colon cancer|advanced colon cancer
313079|NCT01605344|Advanced rectal cancer|advanced rectal cancer
313080|NCT01605344|Metastatic colon cancer|metastatic colon cancer
313081|NCT01605344|Metastatic rectal cancer|metastatic rectal cancer
313082|NCT01605344|Lipitor|lipitor
313083|NCT01605344|Atorvastatin|atorvastatin
313084|NCT01605344|FOLFIRI|folfiri
313085|NCT01605331|Adults|adults
313086|NCT01605331|GH deficiency|gh deficiency
313087|NCT01605318|metastatic colorectal cancer|metastatic colorectal cancer
313088|NCT01605318|colon cancer|colon cancer
313089|NCT01605318|rectal cancer|rectal cancer
313090|NCT01605318|previously treated|previously treated
313091|NCT01605292|Transradial catheterization|transradial catheterization
313092|NCT01605292|Ultrasound|ultrasound
313093|NCT01605292|Radial artery|radial artery
313094|NCT01605279|Low superior vena cava flow|low superior vena cava flow
313095|NCT01605279|Functional echocardiography|functional echocardiography
313096|NCT01605266|pediatric|pediatric
313097|NCT01605266|kidney disease|kidney disease
313098|NCT01605266|minimal change disease|minimal change disease
313099|NCT01605266|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
313100|NCT01605266|nephrotic syndrome|nephrotic syndrome
313101|NCT01605253|Post-traumatic stress disorder|post-traumatic stress disorder
313102|NCT01605253|sleep disturbance|sleep disturbance
313103|NCT01605253|insomnia|insomnia
313104|NCT01605253|cytokines|cytokines
313105|NCT01605253|anxiety|anxiety
313106|NCT01605253|traumatic event|traumatic event
313107|NCT01605253|memory|memory
313108|NCT01605240|Fracture pain|fracture pain
313109|NCT01605240|Fracture reduction|fracture reduction
313110|NCT01605240|Analgesia|analgesia
313111|NCT01605240|Acetaminophen|acetaminophen
313112|NCT01605240|Ibuprofen|ibuprofen
313113|NCT01605240|Codeine|codeine
313114|NCT01605240|Pediatric|pediatric
313115|NCT01605240|Fracture Pain Analgesia in Pediatric population|fracture pain analgesia in pediatric population
313116|NCT01605227|prostate cancer|prostate cancer
313117|NCT01605227|castration resistant prostate cancer|castration resistant prostate cancer
313118|NCT01605227|bone pain|bone pain
313119|NCT01605227|CRPC|crpc
313120|NCT01605214|Extravascular Lung Water|extravascular lung water
313121|NCT01605214|Transpulmonary Thermodilution|transpulmonary thermodilution
313122|NCT01605214|Primary Graft Dysfunction|primary graft dysfunction
313123|NCT01605214|Ischemia Reperfusion Injury|ischemia reperfusion injury
313124|NCT01605201|Chondral lesions in the knee after traumatic injury|chondral lesions in the knee after traumatic injury
313125|NCT01605175|Inflammatory Bowel Disease|inflammatory bowel disease
313126|NCT01605175|Predictors Mucosal Healing|predictors mucosal healing
313127|NCT01605149|Diabetes|diabetes
313128|NCT01605136|Erythropoietic Protoporphyria|erythropoietic protoporphyria
313129|NCT01605136|EPP|epp
313130|NCT01605136|Afamelanotide|afamelanotide
313131|NCT01605123|endothelial function|endothelial function
313134|NCT01605123|cardiovascular dysfunction|cardiovascular dysfunction
313135|NCT01605123|carotid intima media thickness|carotid intima media thickness
313136|NCT01605123|blood pressure|blood pressure
313137|NCT01605123|oral glucose tolerance test|oral glucose tolerance test
313138|NCT01605110|blepharoplasty|blepharoplasty
313139|NCT01605110|hyperbaric|hyperbaric
313141|NCT01605110|ecchymosis|ecchymosis
313142|NCT01605110|edema|edema
313143|NCT01605110|wound|wound
313144|NCT01605110|healing|healing
313145|NCT01605097|prostate neoplasms|prostate neoplasms
313146|NCT01605097|interstitial radiation|interstitial radiation
313147|NCT01605097|High dose rate prostate brachytherapy|high dose rate prostate brachytherapy
313148|NCT01605097|dose escalation|dose escalation
313149|NCT01605071|menopause|menopause
313150|NCT01605071|estrogen|estrogen
313151|NCT01605071|insulin sensitivity|insulin sensitivity
313152|NCT01605071|estrogen receptors|estrogen receptors
313153|NCT01605045|Cardiac catheterization|cardiac catheterization
313154|NCT01605045|Radiation|radiation
313155|NCT01605019|Ventricular Assist Devices|ventricular assist devices
313156|NCT01605019|Heart assist pumps|heart assist pumps
313158|NCT01605019|sealant agents|sealant agents
313159|NCT01605006|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
313160|NCT01605006|ALS|als
313161|NCT01605006|motor neuron disease|motor neuron disease
313162|NCT01605006|diaphragm|diaphragm
313163|NCT01605006|diaphragm pacing|diaphragm pacing
313164|NCT01605006|diaphragmatic pacing|diaphragmatic pacing
313165|NCT01605006|phrenic pacing|phrenic pacing
313166|NCT01605006|phrenic nerve|phrenic nerve
313167|NCT01605006|phrenic nerve stimulation|phrenic nerve stimulation
313168|NCT01605006|NeuRx DPS|neurx dps
313169|NCT01605006|DPS|dps
313170|NCT01605006|chronic hypoventilation|chronic hypoventilation
313171|NCT01605006|respiration|respiration
313172|NCT01605006|ventilation|ventilation
313173|NCT01605006|breathing|breathing
313174|NCT01605006|Humanitarian Device Exemption|humanitarian device exemption
313175|NCT01605006|HDE|hde
313176|NCT01605006|post-approval study|post-approval study
313177|NCT01604993|Dietary Nitrates|dietary nitrates
313178|NCT01604993|Arterial Stiffness|arterial stiffness
313179|NCT01604993|Vascular|vascular
313180|NCT01604993|Blood pressure|blood pressure
313181|NCT01604954|Food labeling|food labeling
313182|NCT01604928|Overactive Bladder|overactive bladder
313183|NCT01604928|YM178|ym178
313184|NCT01604928|Mirabegron|mirabegron
313185|NCT01604928|Frequency|frequency
313186|NCT01604928|Urinary urge incontinence|urinary urge incontinence
313187|NCT01604928|Urgency|urgency
313188|NCT01604928|Urinary incontinence|urinary incontinence
313189|NCT01604928|Micturition|micturition
313190|NCT01604902|Psoriasis mRNA and miRNA|psoriasis mrna and mirna
313191|NCT01604889|Melanoma, Skin Cancer, Oncology|melanoma, skin cancer, oncology
313192|NCT01604876|Parkinson's disease|parkinson's disease
313193|NCT01604876|depression|depression
313194|NCT01604876|light therapy|light therapy
313195|NCT01604876|sleeping problems|sleeping problems
313196|NCT01604863|Solid Tumors|solid tumors
313197|NCT01604863|Cancer|cancer
313198|NCT01604863|Lung Cancer|lung cancer
313199|NCT01604863|Prostate Cancer|prostate cancer
313200|NCT01604863|Mesothelioma|mesothelioma
313201|NCT01604863|Small Cell lung Cancer|small cell lung cancer
313202|NCT01604850|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
313203|NCT01604850|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
313204|NCT01604850|HCV|hcv
313205|NCT01604850|Sustained Virologic Response|sustained virologic response
313206|NCT01604850|Direct Acting Antiviral|direct acting antiviral
313207|NCT01604850|Combination Therapy|combination therapy
313208|NCT01604850|Treatment Experienced|treatment experienced
313209|NCT01604850|GS-7977|gs-7977
313210|NCT01604850|Ribavirin|ribavirin
313211|NCT01604837|superior hypogastric plexus block|superior hypogastric plexus block
313212|NCT01604837|pelvic malignancy|pelvic malignancy
313213|NCT01604837|chronic pelvic pain|chronic pelvic pain
313214|NCT01604798|proteomics|proteomics
313215|NCT01604798|serum peptides|serum peptides
313216|NCT01604798|colorectal cancer|colorectal cancer
313217|NCT01604798|MALDI-TOF MS|maldi-tof ms
313218|NCT01604785|Migraine Headache|migraine headache
313219|NCT01604785|Pediatric|pediatric
313220|NCT01604759|Mouth Neoplasms|mouth neoplasms
313221|NCT01604759|Mouth Diseases|mouth diseases
313222|NCT01604733|Multi-Center Survey|multi-center survey
313223|NCT01604733|patients currently on lipid-lowering pharmacological treatment|patients currently on lipid-lowering pharmacological treatment
313224|NCT01604733|level of Control of Hypercholesterolemia in Egypt|level of control of hypercholesterolemia in egypt
313225|NCT01604720|sample size|sample size
313226|NCT01604720|liver disease|liver disease
313227|NCT01604707|stress|stress
313228|NCT01604707|anxiety|anxiety
313229|NCT01604707|depression|depression
313230|NCT01604707|quality of life|quality of life
313231|NCT01604694|Abdominoplasty|abdominoplasty
313232|NCT01604694|Transversus Abdominis Plane (TAP) Block|transversus abdominis plane (tap) block
313233|NCT01604694|levobupivacaine|levobupivacaine
313234|NCT01604694|Placebo|placebo
313235|NCT01604681|Linseed Oil|linseed oil
313648|NCT01602887|PF-05089326|pf-05089326
313236|NCT01604681|Oxidative Stress|oxidative stress
313237|NCT01604681|Polymorphism, Genetic|polymorphism, genetic
313238|NCT01604681|Cardiovascular Diseases|cardiovascular diseases
313239|NCT01604655|Chest pain|chest pain
313240|NCT01604655|shortness of breath|shortness of breath
313241|NCT01604655|suspected acute coronary syndrome|suspected acute coronary syndrome
313242|NCT01604655|stress testing|stress testing
313243|NCT01604655|coronary computed tomography angiography|coronary computed tomography angiography
313244|NCT01604629|Spondylarthropathies|spondylarthropathies
313245|NCT01604629|Persistent clinical remission with anti-TNF therapy|persistent clinical remission with anti-tnf therapy
313246|NCT01604629|Standardized protocol for dose reduction anti-TNF therapy|standardized protocol for dose reduction anti-tnf therapy
313247|NCT01604590|Glioblastoma|glioblastoma
313248|NCT01604590|Imaging Biomarkers|imaging biomarkers
313249|NCT01604590|Bevacizumab|bevacizumab
313251|NCT01604577|health literacy|health literacy
313252|NCT01604577|health numeracy|health numeracy
313253|NCT01604564|Registry|registry
313254|NCT01604564|Colitis Ulcerosa (CU)|colitis ulcerosa (cu)
313255|NCT01604564|Familial Adenomatous Polyposis(FAP)|familial adenomatous polyposis(fap)
313256|NCT01604564|IPAA|ipaa
313257|NCT01604512|Brain tumor|brain tumor
313258|NCT01604512|MRI Perfusion|mri perfusion
313259|NCT01604512|FDG PET/CT|fdg pet/ct
313260|NCT01604512|12-067|12-067
313261|NCT01604499|Healthy eating|healthy eating
313262|NCT01604499|Incentives|incentives
313263|NCT01604499|Feedback|feedback
313264|NCT01604486|Myocardial infarction|myocardial infarction
313265|NCT01604486|Ischaemic preconditioning|ischaemic preconditioning
313266|NCT01604486|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
313267|NCT01604486|General Practice Research Database|general practice research database
313268|NCT01604486|Hospital Episode Statistics|hospital episode statistics
313269|NCT01604486|Office for National Statistics|office for national statistics
313270|NCT01604473|Chronic Kidney Disease|chronic kidney disease
313271|NCT01604473|CKD|ckd
313272|NCT01604473|ESRD|esrd
313273|NCT01604473|AV Fistula|av fistula
313274|NCT01604473|Arterio-venous fistula|arterio-venous fistula
313275|NCT01604473|hemodialysis|hemodialysis
313276|NCT01604460|Hypothermia|hypothermia
313277|NCT01604460|Newborn|newborn
313278|NCT01604460|Plastic bag|plastic bag
313279|NCT01604460|Resuscitation|resuscitation
313280|NCT01604447|Hypothermia|hypothermia
313281|NCT01604447|Newborn|newborn
313282|NCT01604447|Incubator|incubator
313283|NCT01604447|Plastic bag|plastic bag
313284|NCT01604447|Normothermia|normothermia
313285|NCT01604434|Hypothermia|hypothermia
313286|NCT01604434|Low birth Weight|low birth weight
313287|NCT01604434|Newborn|newborn
313288|NCT01604434|Incubator|incubator
313289|NCT01604434|Plastic bag|plastic bag
313290|NCT01604421|Hypothermia|hypothermia
313291|NCT01604421|Low birth weight|low birth weight
313292|NCT01604421|Newborn|newborn
313293|NCT01604421|Plastic bag|plastic bag
313294|NCT01604421|Thermoregulation|thermoregulation
313295|NCT01604395|GHD|ghd
313296|NCT01604395|TS|ts
313297|NCT01604395|CRF|crf
313298|NCT01604395|SGA|sga
313299|NCT01604395|ISS|iss
313300|NCT01604382|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
313301|NCT01604369|Atrial flutter|atrial flutter
313302|NCT01604369|Cryoablation|cryoablation
313303|NCT01604369|Cavotricuspid isthmus|cavotricuspid isthmus
313304|NCT01604369|Visual analogue scale|visual analogue scale
313305|NCT01604356|retinitis pigmentosa|retinitis pigmentosa
313306|NCT01604343|Active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy|active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy
313307|NCT01604343|Sirukumab|sirukumab
313308|NCT01604343|Human Anti-IL-6 monoclonal antibody|human anti-il-6 monoclonal antibody
313309|NCT01604330|High dose baclofen|high dose baclofen
313310|NCT01604330|Alcoholism|alcoholism
313311|NCT01604330|Abstinence|abstinence
313312|NCT01604330|Low risk consumption|low risk consumption
313313|NCT01604330|Craving|craving
313314|NCT01604317|Hypothermia|hypothermia
313315|NCT01604317|Low birth Weight|low birth weight
313316|NCT01604317|Newborn|newborn
313317|NCT01604317|Resuscitation|resuscitation
313318|NCT01604317|Plastic bag|plastic bag
313319|NCT01604304|stone|stone
313320|NCT01604304|calculi|calculi
313321|NCT01604304|kidney|kidney
313322|NCT01604304|renal treatment|renal treatment
313323|NCT01604304|flexible ureteroscopy|flexible ureteroscopy
313324|NCT01604304|extracoporeal shockwave lithotripsy|extracoporeal shockwave lithotripsy
313325|NCT01604304|retrograde intra renal surgery|retrograde intra renal surgery
313326|NCT01604278|Indacaterol|indacaterol
313327|NCT01604278|Glycopyrronium Bromide|glycopyrronium bromide
313328|NCT01604278|COPD|copd
313329|NCT01604278|bronchodilation|bronchodilation
313330|NCT01604239|Osteoarthritis|osteoarthritis
313331|NCT01604239|Shinbaro|shinbaro
313332|NCT01604239|Herbal drug|herbal drug
313333|NCT01604226|total intravenous anesthesia|total intravenous anesthesia
313334|NCT01604226|Bispectral index monitoring|bispectral index monitoring
313335|NCT01604226|propofol|propofol
313336|NCT01604226|remifentanil|remifentanil
313337|NCT01604213|Type 2 diabetes mellitus|type 2 diabetes mellitus
313338|NCT01604213|vildagliptin|vildagliptin
313339|NCT01604213|metformin|metformin
313340|NCT01604213|atherosclerosis|atherosclerosis
313341|NCT01604213|inflammation|inflammation
313342|NCT01604213|interleukin-6|interleukin-6
313344|NCT01604213|atherothrombosis|atherothrombosis
313345|NCT01604213|adiponectin|adiponectin
313346|NCT01604213|MMP-9|mmp-9
313347|NCT01604213|hs-CRP|hs-crp
313348|NCT01604200|hypertension|hypertension
313349|NCT01604200|dentistry|dentistry
313350|NCT01604200|blood pressure|blood pressure
313351|NCT01604200|measurement|measurement
313352|NCT01604200|screening|screening
313353|NCT01604200|qualitative research|qualitative research
313354|NCT01604187|sublingual fentanyl|sublingual fentanyl
313355|NCT01604187|pain in coloscopy|pain in coloscopy
6141|NCT03251781|Minimal Clinically Important Difference|minimal clinically important difference
6142|NCT03251781|Exercise Test|exercise test
313356|NCT01604187|The efficacy and safety of fentanyl transmucosal tablet to placebo in patients having colonoscopy.|the efficacy and safety of fentanyl transmucosal tablet to placebo in patients having colonoscopy.
313357|NCT01604174|knee|knee
313358|NCT01604174|osteoarthritis|osteoarthritis
313359|NCT01604174|arthroplasty|arthroplasty
313360|NCT01604174|rehabilitation|rehabilitation
313361|NCT01604148|Holmium Laser Enucleation of Prostate|holmium laser enucleation of prostate
313362|NCT01604135|Collagen crosslinking|collagen crosslinking
313363|NCT01604135|Keratoconus|keratoconus
313364|NCT01604122|Survey|survey
313365|NCT01604122|burden of illness|burden of illness
313366|NCT01604122|caregivers|caregivers
313367|NCT01604122|TTR-FAP|ttr-fap
313368|NCT01604122|TTR-CM|ttr-cm
313369|NCT01604122|familial amyloid polyneuropathy|familial amyloid polyneuropathy
313370|NCT01604122|observational|observational
313371|NCT01604122|transthyretin familial amyloidosis|transthyretin familial amyloidosis
313372|NCT01604109|Caries detection/diagnosis/prevention|caries detection/diagnosis/prevention
313373|NCT01604109|Preventive Dentistry|preventive dentistry
313374|NCT01604109|Casien Phosphopeptide|casien phosphopeptide
313375|NCT01604109|Remineralization|remineralization
313376|NCT01604109|Clinical trial|clinical trial
313377|NCT01604096|Information|information
313378|NCT01604096|campaign|campaign
313379|NCT01604096|antibiotics|antibiotics
313380|NCT01604096|bacterial resistance|bacterial resistance
313381|NCT01604096|primary care|primary care
313382|NCT01604083|transfusion|transfusion
313383|NCT01604083|packed red blood cells (PRBC)|packed red blood cells (prbc)
313384|NCT01604083|Transfusion Practice|transfusion practice
313385|NCT01604083|Transfusion habits|transfusion habits
313386|NCT01604083|Outcome|outcome
313387|NCT01604083|elective surgery|elective surgery
313388|NCT01604083|ETPOS|etpos
313389|NCT01604083|ESA|esa
313390|NCT01604083|European Society of Anaesthesiology|european society of anaesthesiology
313391|NCT01604070|Hammertoe deformity|hammertoe deformity
313392|NCT01604070|podiatry|podiatry
313393|NCT01604031|B-CLL|b-cll
313394|NCT01604031|vaccine|vaccine
313395|NCT01604031|Lenalidomide|lenalidomide
313396|NCT01604031|CTL|ctl
313397|NCT01604018|Cat Allergy|cat allergy
313398|NCT01604018|Rhinoconjunctivitis|rhinoconjunctivitis
313399|NCT01604005|Mesothelioma|mesothelioma
313400|NCT01604005|radiotherapy|radiotherapy
313401|NCT01604005|prophylactic irradiation of tracts|prophylactic irradiation of tracts
313402|NCT01603992|Cannabis|cannabis
313403|NCT01603992|Craving|craving
313404|NCT01603992|Questionnaire|questionnaire
313405|NCT01603992|Non-Treatment|non-treatment
313406|NCT01603992|Drug Use|drug use
313407|NCT01603979|AV203|av203
313408|NCT01603979|Solid Tumors|solid tumors
313409|NCT01603979|ERBB3|erbb3
313410|NCT01603979|Monoclonal Antibody|monoclonal antibody
313411|NCT01603979|HER3|her3
313412|NCT01603966|platelet|platelet
313413|NCT01603966|aggregation|aggregation
313414|NCT01603966|aspirin|aspirin
313415|NCT01603966|inhibition|inhibition
313416|NCT01603966|reactivity|reactivity
313417|NCT01603940|Hypertension|hypertension
313418|NCT01603940|Diabetes Mellitus|diabetes mellitus
313419|NCT01603940|Vascular stiffness|vascular stiffness
313420|NCT01603940|Endothelial function|endothelial function
313421|NCT01603914|burns, catheter related bacteremia,|burns, catheter related bacteremia,
313422|NCT01603914|infection, central venous catheter,|infection, central venous catheter,
313423|NCT01603914|catheter-related bloodstream, adult critically ill patients|catheter-related bloodstream, adult critically ill patients
313424|NCT01603888|children with heart disease|children with heart disease
313425|NCT01603888|infants|infants
313426|NCT01603888|healthy newborns|healthy newborns
313427|NCT01603875|CPRV|cprv
313428|NCT01603875|SPEEDA|speeda
313429|NCT01603875|intradermal|intradermal
313430|NCT01603875|pre-exposure|pre-exposure
313431|NCT01603875|booster|booster
313432|NCT01603849|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
313433|NCT01603849|Lung Cancer|lung cancer
313434|NCT01603849|Non Small Cell Lung Cancer|non small cell lung cancer
313435|NCT01603849|Carcinoembryonic Antigen|carcinoembryonic antigen
313747|NCT01602380|neoplasm|neoplasm
313436|NCT01603836|Lumbar spine|lumbar spine
313437|NCT01603836|Posterolateral fusion|posterolateral fusion
313438|NCT01603836|Allograft|allograft
313439|NCT01603836|Bone marrow concentrate|bone marrow concentrate
313440|NCT01603836|Mesenchymal stem cells|mesenchymal stem cells
313441|NCT01603836|Fusion rate|fusion rate
313442|NCT01603823|vitrectomy|vitrectomy
313443|NCT01603823|cataract|cataract
388819|NCT01290744|ENL|enl
313444|NCT01603823|macular edema|macular edema
313445|NCT01603810|Basal cell carcinoma|basal cell carcinoma
313446|NCT01603810|Optical Coherence Tomography|optical coherence tomography
313447|NCT01603797|internetdelivered CBT|internetdelivered cbt
313448|NCT01603797|chronic pain|chronic pain
313449|NCT01603797|acceptance and commitment therapy|acceptance and commitment therapy
313450|NCT01603797|mindfulness|mindfulness
313451|NCT01603797|guided self help|guided self help
313452|NCT01603784|exercise|exercise
313453|NCT01603784|cognition|cognition
313454|NCT01603784|memory|memory
313455|NCT01603784|adult|adult
313456|NCT01603771|Adult|adult
313457|NCT01603771|Exercise|exercise
313458|NCT01603771|Cognition|cognition
313460|NCT01603758|Cholesterol|cholesterol
313461|NCT01603758|Spectrometry, mass|spectrometry, mass
313462|NCT01603758|Deuterium|deuterium
313463|NCT01603758|Kinetics|kinetics
313464|NCT01603758|Cholesterol absorption|cholesterol absorption
313465|NCT01603758|Coronary Heart Disease|coronary heart disease
313466|NCT01603745|PCOS|pcos
313467|NCT01603732|Strep exposure and heart defects|strep exposure and heart defects
313468|NCT01603719|infant formula|infant formula
313469|NCT01603719|prebiotics|prebiotics
313470|NCT01603719|beta-palmitate|beta-palmitate
313471|NCT01603719|stool flora|stool flora
313472|NCT01603719|bifidogenic|bifidogenic
313473|NCT01603706|Heart failure|heart failure
313474|NCT01603706|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
313476|NCT01603706|Radial strain echocardiography|radial strain echocardiography
313477|NCT01603706|Ischemic cardiomyopathy|ischemic cardiomyopathy
313478|NCT01603693|Guided bone regeneration|guided bone regeneration
313479|NCT01603693|Bio Oss|bio oss
313480|NCT01603693|BondBone|bondbone
313481|NCT01603693|computerized tomography|computerized tomography
313482|NCT01603693|histological examination|histological examination
313483|NCT01603680|Ultrasonography|ultrasonography
313484|NCT01603680|Block nerve|block nerve
313485|NCT01603680|Anaesthesia|anaesthesia
313486|NCT01603680|Carpal tunnel syndrome|carpal tunnel syndrome
313487|NCT01603654|Colon preparation|colon preparation
313488|NCT01603654|Colonoscopy|colonoscopy
313489|NCT01603654|Polyethylene glycol|polyethylene glycol
313490|NCT01603654|Sodium Picosulphate|sodium picosulphate
313491|NCT01603589|coronary artery disease|coronary artery disease
313492|NCT01603589|coronary artery bypass grafting|coronary artery bypass grafting
313493|NCT01603589|cardiopulmonary bypass|cardiopulmonary bypass
313494|NCT01603589|minimal extracorporeal circulation|minimal extracorporeal circulation
313495|NCT01603563|Stepped Care|stepped care
313496|NCT01603563|Trauma-Focused Cognitive Behavioral Therapy|trauma-focused cognitive behavioral therapy
313497|NCT01603563|Preschool children|preschool children
313498|NCT01603550|energy restriction|energy restriction
313499|NCT01603550|sleep deprivation|sleep deprivation
313500|NCT01603550|cognitive performance|cognitive performance
313501|NCT01603550|brain function|brain function
313502|NCT01603537|Traumatic injuries|traumatic injuries
313503|NCT01603537|Prehospital Trauma Life Support|prehospital trauma life support
313504|NCT01603537|Traffic accidents|traffic accidents
313505|NCT01603524|Ottawa Model for Smoking Cessation|ottawa model for smoking cessation
313506|NCT01603524|Primary Care|primary care
313507|NCT01603511|rewarming|rewarming
313508|NCT01603511|core cooling|core cooling
313509|NCT01603511|afterdrop|afterdrop
313510|NCT01603511|pre-hospital treatment|pre-hospital treatment
313511|NCT01603511|hypothermia|hypothermia
313512|NCT01603498|pain measurement,|pain measurement,
313513|NCT01603498|edema,|edema,
313514|NCT01603498|trismus|trismus
313515|NCT01603485|Bioavailability|bioavailability
313516|NCT01603485|Pharmacokinetics|pharmacokinetics
313517|NCT01603485|Lersivirine|lersivirine
313518|NCT01603485|Modified-release|modified-release
313519|NCT01603472|pediatric|pediatric
313520|NCT01603472|parenteral nutrition|parenteral nutrition
313521|NCT01603472|bone disease|bone disease
313522|NCT01603472|long-term PN|long-term pn
313523|NCT01603446|pediatric|pediatric
313524|NCT01603446|MELAS|melas
313525|NCT01603446|mechanism of action of L-arginine|mechanism of action of l-arginine
313526|NCT01603420|prostate|prostate
313527|NCT01603420|cancer|cancer
313528|NCT01603420|radiation|radiation
313529|NCT01603420|proton|proton
313530|NCT01603420|chemotherapy|chemotherapy
313531|NCT01603420|high risk|high risk
313532|NCT01603407|prednisone|prednisone
313533|NCT01603407|deflazacort|deflazacort
313534|NCT01603407|muscular dystrophy|muscular dystrophy
313535|NCT01603407|neuromuscular disease|neuromuscular disease
313536|NCT01603407|multi-center|multi-center
313537|NCT01603368|Probiotics|probiotics
313748|NCT01602380|metastatic|metastatic
313538|NCT01603368|Lactobacillus reuteri|lactobacillus reuteri
313539|NCT01603368|Prematures|prematures
313540|NCT01603368|Enteral feeding|enteral feeding
313541|NCT01603368|Motility|motility
313542|NCT01603368|Necrotizing enterocolitis|necrotizing enterocolitis
313543|NCT01603368|Sepsis|sepsis
313544|NCT01603368|Weight|weight
313545|NCT01603355|JIA|jia
313546|NCT01603329|medication adherence|medication adherence
313547|NCT01603329|diabetes|diabetes
313548|NCT01603329|hypertension|hypertension
313549|NCT01603329|cholesterol|cholesterol
313550|NCT01603329|statins|statins
313551|NCT01603316|Food pantry|food pantry
313552|NCT01603316|Food voucher|food voucher
313553|NCT01603316|Grocery delivery|grocery delivery
313554|NCT01603316|12-099|12-099
313555|NCT01603303|Breast Cancer|breast cancer
313556|NCT01603303|Localized breast cancer|localized breast cancer
313557|NCT01603303|Postmenopausal women|postmenopausal women
313558|NCT01603303|Aromatase inhibitor|aromatase inhibitor
313559|NCT01603303|AI|ai
313560|NCT01603303|Questionnaires|questionnaires
313562|NCT01603303|Luvena|luvena
313563|NCT01603303|Internet based website|internet based website
313564|NCT01603303|Phone counseling|phone counseling
313565|NCT01603303|Water-based vaginal lubricant|water-based vaginal lubricant
313566|NCT01603303|Hyalo-Gyn|hyalo-gyn
313567|NCT01603290|Acute leukemia,|acute leukemia,
313568|NCT01603290|Chemotherapy,|chemotherapy,
313569|NCT01603290|Cancer-Related Fatigue,|cancer-related fatigue,
313570|NCT01603290|Physical Fitness|physical fitness
313571|NCT01603277|Asthma|asthma
313572|NCT01603277|GM-CSF|gm-csf
313573|NCT01603277|Moderate-to-Severe Asthma|moderate-to-severe asthma
313574|NCT01603264|Bioequivalence|bioequivalence
313575|NCT01603264|Biosimilarity|biosimilarity
313576|NCT01603264|Similarity|similarity
313577|NCT01603264|PK|pk
313578|NCT01603264|Phase I|phase i
313579|NCT01603264|Trastuzumab|trastuzumab
313580|NCT01603264|Healthy Male Volunteers|healthy male volunteers
313581|NCT01603264|Single-dose|single-dose
313582|NCT01603264|HER-2|her-2
313583|NCT01603264|Oncology|oncology
313584|NCT01603251|transmission|transmission
313585|NCT01603251|anopheles|anopheles
313586|NCT01603225|Autism|autism
313587|NCT01603225|tDCS|tdcs
313588|NCT01603212|Melanoma|melanoma
313589|NCT01603212|Metastatic melanoma|metastatic melanoma
313590|NCT01603212|Advanced melanoma|advanced melanoma
313591|NCT01603212|Vemurafenib|vemurafenib
313592|NCT01603212|PLX4032|plx4032
313593|NCT01603212|RO5185426|ro5185426
313594|NCT01603212|IL-2|il-2
313595|NCT01603212|Interleukin-2|interleukin-2
313596|NCT01603212|Aldesleukin|aldesleukin
313597|NCT01603212|Proleukin|proleukin
313598|NCT01603212|Interferon Alfa-2b|interferon alfa-2b
313599|NCT01603212|Intron A|intron a
313600|NCT01603160|Sickle Cell Disease|sickle cell disease
313601|NCT01603160|Emergency Department|emergency department
313602|NCT01603160|Quality Improvement|quality improvement
313603|NCT01603147|methamphetamine|methamphetamine
313604|NCT01603147|monoclonal antibody|monoclonal antibody
313605|NCT01603121|lisofylline|lisofylline
313606|NCT01603108|Liver Transplant Recipient|liver transplant recipient
313607|NCT01603108|Recurrent Fibrosis|recurrent fibrosis
313608|NCT01603095|Achondroplasia|achondroplasia
313609|NCT01603095|dwarfism|dwarfism
313610|NCT01603069|Parkinson's disease|parkinson's disease
313611|NCT01603069|Safety|safety
313612|NCT01603069|Tolerability|tolerability
313613|NCT01603056|House dust mite induced allergic rhinitis.|house dust mite induced allergic rhinitis.
313614|NCT01603043|Geographic Atrophy|geographic atrophy
313615|NCT01603043|Age-Related Macular Degeneration|age-related macular degeneration
313616|NCT01603043|Intravitreal injection|intravitreal injection
313617|NCT01603030|Moxifloxacin|moxifloxacin
313618|NCT01603030|Prednisolone|prednisolone
313619|NCT01603030|LASIK|lasik
313620|NCT01603017|Magnetic Resonance Therapy|magnetic resonance therapy
313621|NCT01603017|Osteoarthrosis|osteoarthrosis
313622|NCT01603017|Osteoarthritis|osteoarthritis
313623|NCT01603004|MRI|mri
313624|NCT01603004|CT|ct
313625|NCT01603004|12-058|12-058
313626|NCT01602991|Obesity|obesity
313627|NCT01602991|Endoscopy|endoscopy
313628|NCT01602991|Nasopharyngoesophagogastroscopy|nasopharyngoesophagogastroscopy
313629|NCT01602991|Bariatric Surgery|bariatric surgery
313630|NCT01602991|Gastric Bypass Surgery|gastric bypass surgery
313631|NCT01602965|obesity|obesity
313632|NCT01602965|counselling|counselling
313633|NCT01602965|weight loss|weight loss
313634|NCT01602952|Radotinib|radotinib
313635|NCT01602952|CML-CP, AP|cml-cp, ap
313636|NCT01602939|Mast cell|mast cell
313637|NCT01602939|Mastocytosis|mastocytosis
313638|NCT01602939|Mast cell disease|mast cell disease
313639|NCT01602926|hallux valgus|hallux valgus
313640|NCT01602913|Pravastatin|pravastatin
313641|NCT01602913|Adverse Events|adverse events
313642|NCT01602913|Type II Diabetes Mellitus|type ii diabetes mellitus
313643|NCT01602913|Incidence|incidence
313644|NCT01602913|Paroxetine|paroxetine
313646|NCT01602887|PK|pk
313647|NCT01602887|PD-0332991|pd-0332991
313649|NCT01602887|Breast Cancer|breast cancer
313650|NCT01602874|children|children
313651|NCT01602874|pediatry|pediatry
313652|NCT01602874|pneumonia|pneumonia
313653|NCT01602874|intra-abdominal|intra-abdominal
313654|NCT01602874|infection|infection
313655|NCT01602861|Fibrosis|fibrosis
313656|NCT01602861|calcineurin inhibitor|calcineurin inhibitor
313657|NCT01602861|kidney transplant|kidney transplant
313658|NCT01602861|chronic rejection|chronic rejection
313659|NCT01602848|Medicaid|medicaid
313660|NCT01602848|frequent users|frequent users
313661|NCT01602848|heavy users|heavy users
313662|NCT01602848|high risk|high risk
313663|NCT01602848|high cost|high cost
313664|NCT01602848|intervention to improve care and reduce Medicaid expenditures|intervention to improve care and reduce medicaid expenditures
313665|NCT01602835|Alport syndrome|alport syndrome
313666|NCT01602835|proteinuria|proteinuria
313667|NCT01602835|glomerular disease|glomerular disease
313668|NCT01602835|hereditary nephropathy|hereditary nephropathy
313669|NCT01602835|nephropathy|nephropathy
313670|NCT01602822|HIV Prevention|hiv prevention
313671|NCT01602822|NPEP|npep
313672|NCT01602822|PEP|pep
313673|NCT01602809|Perfusion|perfusion
313674|NCT01602809|Microvessels|microvessels
313675|NCT01602809|Ultrasound|ultrasound
313676|NCT01602809|Sickle Cell Disease|sickle cell disease
313677|NCT01602783|Radical Prostatectomy|radical prostatectomy
313678|NCT01602770|Oral contraceptives|oral contraceptives
313679|NCT01602770|Adverse events|adverse events
313680|NCT01602770|Safety profile|safety profile
313681|NCT01602770|Contraceptive Agents|contraceptive agents
313682|NCT01602744|STOPP screening tool|stopp screening tool
313683|NCT01602744|START screening tool|start screening tool
313684|NCT01602744|MIP-medication inappropriate prescription|mip-medication inappropriate prescription
313685|NCT01602744|PIM-Potentially inappropriate medication|pim-potentially inappropriate medication
313686|NCT01602731|medication adherence|medication adherence
313687|NCT01602718|physical activity|physical activity
313688|NCT01602718|physical performance|physical performance
313689|NCT01602718|ESRD|esrd
313690|NCT01602718|home dialysis|home dialysis
313691|NCT01602705|Feedback (NOT MESH)|feedback (not mesh)
313692|NCT01602705|Medication errors|medication errors
313693|NCT01602705|Medication review|medication review
313694|NCT01602705|Inappropriate medication|inappropriate medication
313695|NCT01602705|Randomised controlled trial|randomised controlled trial
313696|NCT01602705|Primary Health Care|primary health care
313697|NCT01602705|Family Practice|family practice
313698|NCT01602692|Pain, postoperative|pain, postoperative
313699|NCT01602692|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
313700|NCT01602692|Patient Readmission|patient readmission
313701|NCT01602692|Time to Discharge|time to discharge
313702|NCT01602640|sedation|sedation
313703|NCT01602640|critical care|critical care
313704|NCT01602640|morphine|morphine
313705|NCT01602640|fentanyl|fentanyl
313706|NCT01602640|analgesic based sedation|analgesic based sedation
313707|NCT01602601|Hunter syndrome, immunogenicity, antibodies|hunter syndrome, immunogenicity, antibodies
313708|NCT01602575|IBS, FMRI, MBSR|ibs, fmri, mbsr
313709|NCT01602562|Herpes simplex infection|herpes simplex infection
313710|NCT01602562|valaciclovir|valaciclovir
313711|NCT01602562|herpes simplex virus|herpes simplex virus
313712|NCT01602562|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
313713|NCT01602536|twitter|twitter
313714|NCT01602536|quit smoking|quit smoking
313715|NCT01602536|smoking cessation|smoking cessation
313716|NCT01602536|social media|social media
313717|NCT01602536|peer support|peer support
313718|NCT01602523|Emphysema|emphysema
313719|NCT01602523|COPD|copd
313720|NCT01602523|Sleep|sleep
313721|NCT01602497|Borderline personality disorder|borderline personality disorder
313722|NCT01602497|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
313723|NCT01602471|Endarterectomy|endarterectomy
313724|NCT01602471|K5-C200|k5-c200
313725|NCT01602471|RGD-K5|rgd-k5
313726|NCT01602471|angiogenesis|angiogenesis
313727|NCT01602471|Carotid CT Angiogram|carotid ct angiogram
313728|NCT01602458|Preventative Scar Management|preventative scar management
313729|NCT01602458|Skin Grafts|skin grafts
313730|NCT01602458|Silicone Therapy|silicone therapy
313731|NCT01602458|Silicone Pressure Garment Therapy|silicone pressure garment therapy
313732|NCT01602445|Venous Thrombosis|venous thrombosis
313733|NCT01602445|Coagulation factors|coagulation factors
313734|NCT01602445|Cancer|cancer
313735|NCT01602445|Blood|blood
313736|NCT01602432|Venous Thrombosis|venous thrombosis
313737|NCT01602432|Cancer|cancer
313738|NCT01602432|Coagulation factors|coagulation factors
313739|NCT01602432|Blood|blood
313740|NCT01602406|Advanced HER2-positive Breast cancer or Gastric cancer|advanced her2-positive breast cancer or gastric cancer
313741|NCT01602380|hormone receptor positive breast cancer|hormone receptor positive breast cancer
313742|NCT01602380|endocrine|endocrine
313743|NCT01602380|no hormone therapy|no hormone therapy
313744|NCT01602380|hormone|hormone
313745|NCT01602380|breast|breast
313746|NCT01602380|cancer|cancer
313749|NCT01602380|tumour|tumour
313750|NCT01602354|Endotoxin Activity Assay|endotoxin activity assay
313751|NCT01602354|Gram negative|gram negative
313752|NCT01602354|Septic Shock|septic shock
313754|NCT01602341|atopic dermatitis|atopic dermatitis
313755|NCT01602328|Acute Kidney Injury|acute kidney injury
313756|NCT01602328|Acute renal failure|acute renal failure
313757|NCT01602328|Human mesenchymal stem cells|human mesenchymal stem cells
313758|NCT01602328|Allogeneic stem cells|allogeneic stem cells
313759|NCT01602315|BYL719|byl719
313760|NCT01602315|PI3K inhibitor|pi3k inhibitor
313761|NCT01602315|PIK3CA|pik3ca
313762|NCT01602315|cetuximab|cetuximab
313763|NCT01602315|EGFR|egfr
313764|NCT01602315|HNSCC|hnscc
313765|NCT01602315|RM HNSCC|rm hnscc
313766|NCT01602315|platinum-based chemotherapy|platinum-based chemotherapy
753310|NCT01176214|weaning|weaning
313767|NCT01602315|(RM HNSCC) patients|(rm hnscc) patients
313768|NCT01602315|resistant or ineligible/intolerant to platinum-based chemotherapy|resistant or ineligible/intolerant to platinum-based chemotherapy
313769|NCT01602315|swallowing dysfunction|swallowing dysfunction
313770|NCT01602315|G-tube|g-tube
313771|NCT01602302|rheumatoid arthritis|rheumatoid arthritis
313772|NCT01602302|ultrasound|ultrasound
313773|NCT01602302|remission|remission
313774|NCT01602302|biological DMARD|biological dmard
313775|NCT01602276|Parkinson's disease|parkinson's disease
313776|NCT01602276|Lewy body dementia|lewy body dementia
313777|NCT01602276|Korsakoff's syndrome|korsakoff's syndrome
313778|NCT01602276|Subcortical Dementia|subcortical dementia
313779|NCT01602276|Huntington's Disease|huntington's disease
313780|NCT01602263|Normal cognitive function|normal cognitive function
313781|NCT01602263|Aphasia|aphasia
313782|NCT01602263|Autism|autism
313783|NCT01602263|Schizophrenia|schizophrenia
313784|NCT01602250|Anesthetics, local|anesthetics, local
313785|NCT01602250|Toxicity|toxicity
313786|NCT01602250|Adverse effects|adverse effects
313787|NCT01602211|stem cell transplant|stem cell transplant
313788|NCT01602211|cancer survivors|cancer survivors
313789|NCT01602211|internet|internet
313790|NCT01602211|social media|social media
313791|NCT01602211|distress|distress
313792|NCT01602211|health care adherence|health care adherence
313793|NCT01602185|NMDA (N-Methyl-D-Aspartate) antagonists|nmda (n-methyl-d-aspartate) antagonists
313794|NCT01602185|ketamine|ketamine
313795|NCT01602185|memantine|memantine
314191|NCT01600586|NICU|nicu
313796|NCT01602185|dextromethorphan|dextromethorphan
313797|NCT01602185|Neuropathic pain|neuropathic pain
313798|NCT01602172|alcohol consumption|alcohol consumption
313799|NCT01602172|inpatients|inpatients
313800|NCT01602172|risk reduction behavior|risk reduction behavior
313801|NCT01602172|counseling|counseling
313802|NCT01602172|nurses|nurses
313803|NCT01602172|brief intervention|brief intervention
313804|NCT01602159|Claudication|claudication
313805|NCT01602159|SFA|sfa
313806|NCT01602159|Open Bypass|open bypass
313807|NCT01602159|Angioplasty|angioplasty
313808|NCT01602159|Stenting|stenting
313809|NCT01602146|ultramarathon central fatigue,|ultramarathon central fatigue,
313810|NCT01602133|venous puncture|venous puncture
313811|NCT01602133|seldinger technique|seldinger technique
313812|NCT01602133|ultrasound guidance|ultrasound guidance
313813|NCT01602107|Stress|stress
313814|NCT01602107|Urinary|urinary
313815|NCT01602107|Incontinence|incontinence
313816|NCT01602107|Pelvic|pelvic
313817|NCT01602107|Physiotherapy|physiotherapy
313818|NCT01602094|measles|measles
313819|NCT01602094|antibody|antibody
313820|NCT01602094|prevalence|prevalence
313821|NCT01602094|predictors|predictors
313822|NCT01602094|Donor of National Blood Centre, The Thai Red Cross Society who age 18-30 years old|donor of national blood centre, the thai red cross society who age 18-30 years old
313823|NCT01602094|Measles antibody levels|measles antibody levels
313824|NCT01602094|Predictors of adequate measles antibody levels and inadequate measles antibody levels|predictors of adequate measles antibody levels and inadequate measles antibody levels
313825|NCT01602081|Anal fistula|anal fistula
313826|NCT01602081|Ligation of the intersphincteric fistula tract|ligation of the intersphincteric fistula tract
313827|NCT01602081|LIFT|lift
313828|NCT01602081|Tissue graft|tissue graft
313829|NCT01602068|Iontophoresis|iontophoresis
313830|NCT01602068|Cataract Surgery|cataract surgery
313831|NCT01602068|Ophthalmology|ophthalmology
313832|NCT01602042|essential tremor|essential tremor
313833|NCT01602042|motion sensors|motion sensors
313834|NCT01602042|tremor|tremor
313835|NCT01602029|Anti inflammatory|anti inflammatory
313836|NCT01602029|Schizophrenia|schizophrenia
313837|NCT01602029|Simvastatin|simvastatin
313838|NCT01602029|Ondansetron|ondansetron
313839|NCT01602016|ASD|asd
313840|NCT01602016|PDD-NOS|pdd-nos
313841|NCT01601977|COPD|copd
313842|NCT01601977|Respiratory failure|respiratory failure
313843|NCT01601977|NIV|niv
313844|NCT01601977|OSA|osa
313845|NCT01601964|VEGF, ectopic pregnancy.|vegf, ectopic pregnancy.
313846|NCT01601951|Osteoarthritis|osteoarthritis
313847|NCT01601951|Stem Cell Injections|stem cell injections
313848|NCT01601951|Bone Marrow|bone marrow
313849|NCT01601951|Autologous|autologous
313850|NCT01601938|Sepsis|sepsis
313851|NCT01601938|Shock, Septic|shock, septic
313852|NCT01601938|Selenium|selenium
313853|NCT01601938|Survival|survival
313854|NCT01601912|Whiplash Injuries|whiplash injuries
313855|NCT01601912|Chronic Pain|chronic pain
313856|NCT01601912|Exercise|exercise
313857|NCT01601912|Cognition|cognition
313858|NCT01601899|trial|trial
313859|NCT01601899|stavudine|stavudine
313860|NCT01601899|tenofovir|tenofovir
313861|NCT01601899|mitochondria|mitochondria
313862|NCT01601899|insulin resistance|insulin resistance
313863|NCT01601899|lipids|lipids
313864|NCT01601899|HOMA|homa
313865|NCT01601886|Intubation, Intratracheal|intubation, intratracheal
313866|NCT01601886|Continuous Positive Airway Pressure|continuous positive airway pressure
753311|NCT01176227|bloating|bloating
313867|NCT01601886|Historical Cohort Studies|historical cohort studies
313868|NCT01601886|Clinical Trial|clinical trial
313869|NCT01601873|Arteriovenous graft|arteriovenous graft
313870|NCT01601873|Propaten|propaten
313871|NCT01601873|Heparin-bonded|heparin-bonded
313872|NCT01601873|hemodialysis vascular access|hemodialysis vascular access
313873|NCT01601873|Surgical|surgical
313874|NCT01601873|Arteriovenous Shunt|arteriovenous shunt
313875|NCT01601860|Labor|labor
313876|NCT01601860|vaginal delivery|vaginal delivery
313877|NCT01601860|pain|pain
313878|NCT01601834|Phase 1|phase 1
313879|NCT01601834|Single Dose|single dose
313880|NCT01601834|Pharmacokinetics|pharmacokinetics
313881|NCT01601834|Safety|safety
313882|NCT01601834|Toleration|toleration
313883|NCT01601795|Cardioprotection|cardioprotection
313884|NCT01601769|Cervical preinvasive disease|cervical preinvasive disease
313885|NCT01601769|Colposcopy|colposcopy
313886|NCT01601769|Exocolposcopy|exocolposcopy
313887|NCT01601769|Leep|leep
313888|NCT01601756|revision knee arthroplasty|revision knee arthroplasty
313889|NCT01601756|navigation|navigation
313890|NCT01601756|joint line|joint line
313891|NCT01601743|Cocaine|cocaine
313892|NCT01601743|Exercise|exercise
313893|NCT01601730|Cocaine|cocaine
313894|NCT01601730|Modafinil|modafinil
313895|NCT01601730|Escitalopram|escitalopram
313896|NCT01601717|RTI-336|rti-336
313897|NCT01601717|Methamphetamine|methamphetamine
313898|NCT01601704|Body Weight|body weight
313899|NCT01601704|Bupropion|bupropion
313900|NCT01601704|Cardiovascular Diseases|cardiovascular diseases
314393|NCT01599754|axitinib|axitinib
313901|NCT01601704|Diabetes Mellitus|diabetes mellitus
313902|NCT01601704|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
313903|NCT01601704|Endocrine System Diseases|endocrine system diseases
313904|NCT01601704|Glucose Metabolism Disorders|glucose metabolism disorders
313905|NCT01601704|Heart Diseases|heart diseases
313906|NCT01601704|Metabolic Diseases|metabolic diseases
313907|NCT01601704|Narcotic Antagonists|narcotic antagonists
313908|NCT01601704|Naltrexone|naltrexone
313909|NCT01601704|Nutrition Disorders|nutrition disorders
313910|NCT01601704|Obesity|obesity
313911|NCT01601704|Overnutrition|overnutrition
313912|NCT01601704|Overweight|overweight
313913|NCT01601691|prostate cancer|prostate cancer
313914|NCT01601691|brachytherapy|brachytherapy
313915|NCT01601691|spacer|spacer
313916|NCT01601691|side effect|side effect
313917|NCT01601678|Achalasia|achalasia
313918|NCT01601678|Heller Myotomy|heller myotomy
313919|NCT01601678|Dysphagia|dysphagia
313920|NCT01601678|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
313921|NCT01601665|Intraocular lens|intraocular lens
313922|NCT01601665|Cataracts|cataracts
313923|NCT01601665|Astigmatism|astigmatism
313924|NCT01601665|Toric|toric
313925|NCT01601652|cholestasis|cholestasis
313926|NCT01601652|PNAC|pnac
313927|NCT01601652|Parenteral Nutrition Associated Cholestasis|parenteral nutrition associated cholestasis
313928|NCT01601652|PNALD|pnald
313929|NCT01601652|Parenteral Nutrition Associated Liver Disease|parenteral nutrition associated liver disease
313930|NCT01601639|Gastric Antral Vascular Ectasia|gastric antral vascular ectasia
313931|NCT01601639|Argon plasma Coagulation|argon plasma coagulation
313932|NCT01601639|Endoscopic Band Ligation|endoscopic band ligation
313933|NCT01601639|GAVE|gave
313934|NCT01601587|Introductory Seminar|introductory seminar
313935|NCT01601587|Waiting list|waiting list
313936|NCT01601587|Community Mental Health Centre|community mental health centre
313937|NCT01601574|Type 2 diabetes|type 2 diabetes
313938|NCT01601574|HbA1c|hba1c
313939|NCT01601574|Overweight|overweight
313940|NCT01601574|Obesity|obesity
313941|NCT01601561|Insulin|insulin
313952|NCT01601418|gastrin receptor antagonist|gastrin receptor antagonist
313954|NCT01601418|gastric acid|gastric acid
313955|NCT01601418|healthy subjects|healthy subjects
313956|NCT01601405|YF476|yf476
313957|NCT01601405|gastrin receptor antagonist|gastrin receptor antagonist
313958|NCT01601405|gastrin|gastrin
313959|NCT01601405|gastric aspiration|gastric aspiration
313960|NCT01601405|healthy subjects|healthy subjects
313961|NCT01601392|Ischemic stroke|ischemic stroke
313962|NCT01601392|direct current stimulation|direct current stimulation
313963|NCT01601392|motor threshold|motor threshold
313964|NCT01601392|National institutes of Health Stroke Scale|national institutes of health stroke scale
313965|NCT01601392|Barthel index scale|barthel index scale
313966|NCT01601392|Measurement of motor power improvement|measurement of motor power improvement
313967|NCT01601379|Observational|observational
313968|NCT01601379|GERD|gerd
313969|NCT01601379|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
313970|NCT01601379|Gastro-oesophageal Reflux|gastro-oesophageal reflux
313971|NCT01601379|Heartburn|heartburn
313972|NCT01601366|Adenomyosis|adenomyosis
313973|NCT01601366|Intrauterine levonorgestrel|intrauterine levonorgestrel
313974|NCT01601366|Dysmenorrhea|dysmenorrhea
313975|NCT01601366|Oral contraceptives|oral contraceptives
313976|NCT01601366|Uterus|uterus
313977|NCT01601353|Erectile Dysfunction|erectile dysfunction
313978|NCT01601327|hypogonadism|hypogonadism
313979|NCT01601327|treatment|treatment
313980|NCT01601327|testis volume|testis volume
313996|NCT01601288|obstructive lung disease|obstructive lung disease
313997|NCT01601288|restrictive lung disease|restrictive lung disease
313998|NCT01601288|cough|cough
313999|NCT01601288|dyspnea|dyspnea
314000|NCT01601275|tuberculosis|tuberculosis
314002|NCT01601262|LI-ESWT|li-eswt
314003|NCT01601249|IVF, embryo selection, polarized light|ivf, embryo selection, polarized light
314004|NCT01601236|H.P. Acthar Gel|h.p. acthar gel
314005|NCT01601236|Acthar|acthar
314006|NCT01601236|diabetic nephropathy|diabetic nephropathy
314007|NCT01601236|proteinuria|proteinuria
314008|NCT01601236|nephrotic syndrome|nephrotic syndrome
314009|NCT01601223|Ventilatory Management|ventilatory management
314010|NCT01601223|Mechanical Ventilation|mechanical ventilation
314011|NCT01601223|Post Operative pulmonary complications|post operative pulmonary complications
314012|NCT01601223|Intra-operative complications|intra-operative complications
314013|NCT01601223|General Anesthesia|general anesthesia
314014|NCT01601223|Surgery|surgery
314015|NCT01601223|LAS VEGAS|las vegas
314016|NCT01601223|ESA (European Society of Anaesthesiology)|esa (european society of anaesthesiology)
314017|NCT01601223|European Society of Anaesthesiology|european society of anaesthesiology
314018|NCT01601197|immunization|immunization
314019|NCT01601197|pain management|pain management
314020|NCT01601197|infants|infants
314021|NCT01601197|tactile stimulation|tactile stimulation
314022|NCT01601184|medulloblastoma|medulloblastoma
314023|NCT01601184|sonic hedgehog pathway|sonic hedgehog pathway
314024|NCT01601184|vismodegib|vismodegib
314025|NCT01601171|GnRH deficiency|gnrh deficiency
314026|NCT01601171|hypogonadism|hypogonadism
314027|NCT01601171|anosmia|anosmia
314028|NCT01601171|infertility|infertility
314029|NCT01601171|cleft lip|cleft lip
314030|NCT01601171|cleft palate|cleft palate
314031|NCT01601171|cryptorchidism|cryptorchidism
314032|NCT01601171|microphallus|microphallus
314033|NCT01601158|Global developmental delay|global developmental delay
314034|NCT01601158|Umbilical cord blood|umbilical cord blood
314035|NCT01601158|Rehabilitation|rehabilitation
314036|NCT01601145|Lactobacillus Brevis CD2|lactobacillus brevis cd2
314037|NCT01601145|schoolchildren|schoolchildren
314038|NCT01601145|dental caries|dental caries
314039|NCT01601145|Gingivatis|gingivatis
314040|NCT01601132|pharmacokinetics|pharmacokinetics
314041|NCT01601132|colchicine|colchicine
314042|NCT01601132|theophylline|theophylline
314043|NCT01601119|Multiple Sclerosis|multiple sclerosis
314044|NCT01601119|Patient reported outcome|patient reported outcome
314045|NCT01601119|Patient reported experience|patient reported experience
314046|NCT01601106|Atherosclerosis, inflammation|atherosclerosis, inflammation
314047|NCT01601093|Respiratory and urinary tract infections|respiratory and urinary tract infections
314048|NCT01601093|Ceftazidime and Sulbactam Sodium for Injection (2:1)|ceftazidime and sulbactam sodium for injection (2:1)
314049|NCT01601093|Phase Ⅱ|phase ⅱ
314050|NCT01601080|Adherence|adherence
314051|NCT01601080|Multiple Sclerosis|multiple sclerosis
314052|NCT01601067|posttraumatic stress disorder|posttraumatic stress disorder
314053|NCT01601067|psychotherapy|psychotherapy
314054|NCT01601067|alcoholism|alcoholism
314055|NCT01601054|spine|spine
314056|NCT01601054|deformity|deformity
314057|NCT01601054|instrumentation|instrumentation
314058|NCT01601054|ALIF|alif
314059|NCT01601041|Urinary Tract Infection|urinary tract infection
314060|NCT01601041|Bacteriuria|bacteriuria
314061|NCT01601041|Pyuria|pyuria
314062|NCT01601041|Prostatitis|prostatitis
314063|NCT01601041|Intermittent Catheterization|intermittent catheterization
314064|NCT01601041|Spinal Cord Injuries|spinal cord injuries
314065|NCT01601041|Residual Urine|residual urine
314066|NCT01601028|Autoimmune Diseases|autoimmune diseases
314067|NCT01601028|Sjogren's Syndrome|sjogren's syndrome
314068|NCT01601028|Hydroxychloroquine|hydroxychloroquine
314069|NCT01601015|Tension-type headache, Effectiveness, Manual therapy|tension-type headache, effectiveness, manual therapy
314070|NCT01601002|Mirtazapine|mirtazapine
314071|NCT01600989|shock septic|shock septic
314072|NCT01600989|monocytes|monocytes
314073|NCT01600989|lymphocytes|lymphocytes
314074|NCT01600989|mitochondria|mitochondria
314075|NCT01600989|interleukins|interleukins
314076|NCT01600989|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
314077|NCT01600989|Hypoxia-Inducible Factor 1, alpha Subunit|hypoxia-inducible factor 1, alpha subunit
314078|NCT01600976|Hepatic impairment|hepatic impairment
314079|NCT01600976|Hepatitis C|hepatitis c
314080|NCT01600976|Telaprevir|telaprevir
314081|NCT01600976|VX-950|vx-950
314082|NCT01600976|Pharmacokinetics|pharmacokinetics
314083|NCT01600976|Safety|safety
314084|NCT01600976|Unbound plasma concentrations|unbound plasma concentrations
314085|NCT01600976|Child-Pugh score|child-pugh score
314086|NCT01600963|Multi-drug resistant tuberculosis|multi-drug resistant tuberculosis
314087|NCT01600963|Pre-extensively drug resistant tuberculosis|pre-extensively drug resistant tuberculosis
314088|NCT01600963|TMC207|tmc207
314089|NCT01600963|Background regimen|background regimen
314090|NCT01600937|diabetes mellitus|diabetes mellitus
314091|NCT01600937|diabetes education|diabetes education
314092|NCT01600937|behavioral therapy|behavioral therapy
314093|NCT01600937|behavior modification|behavior modification
314094|NCT01600937|physical activity|physical activity
314095|NCT01600937|supervised exercise|supervised exercise
314096|NCT01600937|physical fitness|physical fitness
314097|NCT01600937|HbA1c|hba1c
314098|NCT01600937|modifiable cardiovascular risk factors|modifiable cardiovascular risk factors
314099|NCT01600937|quality of life|quality of life
314100|NCT01600924|diabetes mellitus|diabetes mellitus
314101|NCT01600924|muscle strength|muscle strength
314102|NCT01600924|bone strength|bone strength
314103|NCT01600924|cardiovascular risk factors|cardiovascular risk factors
314104|NCT01600924|diabetic complications|diabetic complications
314105|NCT01600911|metabolomics|metabolomics
314106|NCT01600911|nutri-metabolomics|nutri-metabolomics
314107|NCT01600911|plant food|plant food
314108|NCT01600911|blood pressure|blood pressure
314109|NCT01600898|Asymptomatic carriers of a BMPR2 mutation|asymptomatic carriers of a bmpr2 mutation
314110|NCT01600898|follow up study|follow up study
314111|NCT01600885|Guanfacine|guanfacine
314112|NCT01600885|Ketamine|ketamine
314113|NCT01600885|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
314114|NCT01600885|Prefrontal Cortex Activity|prefrontal cortex activity
314115|NCT01600885|Receptors, N-Methyl-D-Aspartate|receptors, n-methyl-d-aspartate
314116|NCT01600885|Receptors, Adrenergic, alpha-2|receptors, adrenergic, alpha-2
314117|NCT01600885|Memory, Short-Term|memory, short-term
314118|NCT01600885|Schizophrenia|schizophrenia
314119|NCT01600872|EDCs|edcs
314120|NCT01600872|PCOS|pcos
314122|NCT01600872|TOS|tos
314123|NCT01600872|ROS|ros
314124|NCT01600872|Oxidative Stress, Endocrine-Disrupting Chemicals, Polycystic Ovary syndrome|oxidative stress, endocrine-disrupting chemicals, polycystic ovary syndrome
314125|NCT01600846|Pharmacogenetic testing|pharmacogenetic testing
314126|NCT01600846|pharmacokinetics|pharmacokinetics
314127|NCT01600846|Pharmacogenomics|pharmacogenomics
314128|NCT01600846|genetics|genetics
314129|NCT01600846|pharmacy|pharmacy
314130|NCT01600846|drug response|drug response
314131|NCT01600833|PCOS|pcos
314132|NCT01600833|Ferritin|ferritin
314133|NCT01600833|Homocysteine|homocysteine
314134|NCT01600833|Insulin Resistance|insulin resistance
314135|NCT01600833|Metabolic Syndrome|metabolic syndrome
314136|NCT01600820|Plant sterol|plant sterol
314137|NCT01600820|Hypercholesterolemia|hypercholesterolemia
314138|NCT01600820|diet|diet
314139|NCT01600820|dairy|dairy
314140|NCT01600820|LDL-C|ldl-c
314141|NCT01600820|Mildly hypercholesterolemic subjects|mildly hypercholesterolemic subjects
314142|NCT01600807|Metastatic|metastatic
314143|NCT01600807|Pancreas|pancreas
314144|NCT01600807|Cancer|cancer
314145|NCT01600807|Adenocarcinoma|adenocarcinoma
314146|NCT01600794|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
314147|NCT01600794|androgens|androgens
314148|NCT01600794|ovary function|ovary function
314149|NCT01600794|This study include the patients who are evaluated by the doctors and are sure to process the In Vitro Fertilization cycle.|this study include the patients who are evaluated by the doctors and are sure to process the in vitro fertilization cycle.
314150|NCT01600781|Improve the nutritional status|improve the nutritional status
314152|NCT01600781|children|children
314153|NCT01600781|enhance immune response|enhance immune response
314154|NCT01600781|induction chemotherapy|induction chemotherapy
314155|NCT01600781|fewer side effects|fewer side effects
314156|NCT01600768|focus of study|focus of study
314157|NCT01600755|Cell Therapy|cell therapy
314158|NCT01600755|Autologous Cell Transplantation|autologous cell transplantation
314159|NCT01600755|Muscle-derived Cell|muscle-derived cell
314160|NCT01600755|Anal Incontinence|anal incontinence
314161|NCT01600755|Rectal Diseases|rectal diseases
314162|NCT01600755|Intestinal Diseases|intestinal diseases
314163|NCT01600755|Gastrointestinal Diseases|gastrointestinal diseases
314164|NCT01600755|Urinary Incontinence|urinary incontinence
314165|NCT01600703|Intestinal lipoprotein|intestinal lipoprotein
314166|NCT01600703|Apolipoprotein B48 and apolipoprotein B100|apolipoprotein b48 and apolipoprotein b100
314167|NCT01600703|Pancreatic clamp|pancreatic clamp
314168|NCT01600703|DPPIV inhibitor|dppiv inhibitor
314169|NCT01600690|Stem cells|stem cells
314170|NCT01600690|Regeneration|regeneration
314171|NCT01600690|Inflammation|inflammation
304973|NCT01641406|Neoadjuvant and Oncotype|neoadjuvant and oncotype
314172|NCT01600677|Experimental; Computerized medication delivery unit|experimental; computerized medication delivery unit
314173|NCT01600664|Type 1 diabetes|type 1 diabetes
314174|NCT01600664|"My Diabetic friend"|"my diabetic friend"
314175|NCT01600664|interactive computer game|interactive computer game
314176|NCT01600651|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
314177|NCT01600651|Soluble RAGE (sRAGE)|soluble rage (srage)
314178|NCT01600651|Recruitment Maneuver|recruitment maneuver
314179|NCT01600651|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
314180|NCT01600651|Alveolar epithelium|alveolar epithelium
314181|NCT01600651|Electrical Impedance Tomography|electrical impedance tomography
314182|NCT01600651|Mechanical ventilation|mechanical ventilation
314183|NCT01600651|Intensive Care Unit (ICU)|intensive care unit (icu)
314184|NCT01600638|Lipolysis|lipolysis
314185|NCT01600638|Cryolipolysis|cryolipolysis
314186|NCT01600638|Fat Reduction|fat reduction
314187|NCT01600625|meibomian gland dysfunction|meibomian gland dysfunction
314188|NCT01600625|inflammatory tear cytokine|inflammatory tear cytokine
314189|NCT01600625|minocycline|minocycline
314190|NCT01600612|postpartum hemorrhage, oxytocin, carbetocin, misopristol|postpartum hemorrhage, oxytocin, carbetocin, misopristol
314192|NCT01600586|Music therapy|music therapy
314193|NCT01600586|Premature infant|premature infant
314194|NCT01600586|Oral feeds|oral feeds
314195|NCT01600586|Non-Nutritive Sucking|non-nutritive sucking
314196|NCT01600586|Suck rate|suck rate
314197|NCT01600586|Suck efficiency|suck efficiency
314198|NCT01600586|Contingent music|contingent music
314199|NCT01600586|Mother's voice|mother's voice
314200|NCT01600573|ovarian cancer|ovarian cancer
314201|NCT01600534|gestational diabetes|gestational diabetes
314202|NCT01600508|stoma care|stoma care
314203|NCT01600508|videoconference|videoconference
314205|NCT01600508|quality of life|quality of life
314206|NCT01600495|pain|pain
314207|NCT01600495|electric stimulation|electric stimulation
314208|NCT01600495|nervous|nervous
314209|NCT01600495|transcutaneous|transcutaneous
314210|NCT01600495|humanized childbirth|humanized childbirth
314211|NCT01600482|Hemostasis.|hemostasis.
314337|NCT01599949|Bortezomib|bortezomib
314212|NCT01600482|Percutaneous coronary interventions.|percutaneous coronary interventions.
314213|NCT01600482|Closure Device|closure device
314214|NCT01600469|Alzheimer's disease|alzheimer's disease
314215|NCT01600469|mild cognitive impairment|mild cognitive impairment
314216|NCT01600469|NMDA|nmda
314217|NCT01600456|PTSD|ptsd
314218|NCT01600456|Antidepressants|antidepressants
314219|NCT01600456|Cognitive behavior therapy|cognitive behavior therapy
314220|NCT01600430|Vitamin D|vitamin d
314221|NCT01600430|Newborn|newborn
314222|NCT01600430|Preterm|preterm
314223|NCT01600430|Supplementation|supplementation
314224|NCT01600430|Respiratory|respiratory
314225|NCT01600417|low back pain|low back pain
314226|NCT01600417|spine|spine
314227|NCT01600417|lumbar spine|lumbar spine
314228|NCT01600417|lumbar instability|lumbar instability
314229|NCT01600417|radiology|radiology
314230|NCT01600417|functional radiology|functional radiology
314231|NCT01600404|Mild Cognitive Impairment|mild cognitive impairment
314232|NCT01600404|Muscarinic Antagonists|muscarinic antagonists
314233|NCT01600404|Spinal Cord Injuries|spinal cord injuries
314234|NCT01600404|Urinary Bladder, Neurogenic|urinary bladder, neurogenic
314235|NCT01600404|Urinary Bladder, Overactive|urinary bladder, overactive
314236|NCT01600404|Overactive Detrusor|overactive detrusor
314237|NCT01600391|Stroke|stroke
314238|NCT01600391|Visual cues|visual cues
314239|NCT01600391|Gait rehabilitation|gait rehabilitation
314240|NCT01600391|Walking adaptability|walking adaptability
314241|NCT01600391|Turning|turning
314242|NCT01600391|Overground walking|overground walking
314243|NCT01600391|Treadmill training|treadmill training
314244|NCT01600378|diffuse parenchymal lung disease|diffuse parenchymal lung disease
314245|NCT01600378|interstitial lung disease|interstitial lung disease
314246|NCT01600378|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
314247|NCT01600365|Conjunctivitis|conjunctivitis
314248|NCT01600365|adenovirus.|adenovirus.
314249|NCT01600352|interstitial lung disease|interstitial lung disease
314250|NCT01600352|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
314251|NCT01600313|rice bran oil|rice bran oil
314252|NCT01600313|diet|diet
314253|NCT01600313|cardiovascular disease|cardiovascular disease
314254|NCT01600313|low density lipoprotein|low density lipoprotein
314255|NCT01600313|total cholesterol|total cholesterol
314256|NCT01600300|Age-related macular degeneration|age-related macular degeneration
314257|NCT01600300|electrical stimulation|electrical stimulation
314258|NCT01600300|randomized|randomized
314259|NCT01600300|double blind|double blind
314260|NCT01600287|bispectral index|bispectral index
314261|NCT01600287|propofol|propofol
314262|NCT01600287|paediatric cardiac surgery|paediatric cardiac surgery
314263|NCT01600287|closed loop anaesthesia delivery system|closed loop anaesthesia delivery system
304968|NCT01641419|Ropivacaine|ropivacaine
304969|NCT01641419|sciatic block|sciatic block
304970|NCT01641419|dexamethasone|dexamethasone
304971|NCT01641406|NAC Protocol|nac protocol
314264|NCT01600261|without eye disease|without eye disease
314265|NCT01600248|Chronic Pain|chronic pain
314266|NCT01600248|Military|military
314267|NCT01600248|Veteran|veteran
314268|NCT01600248|Online|online
314269|NCT01600248|Acceptance|acceptance
314270|NCT01600235|Stroke, ischemic|stroke, ischemic
314271|NCT01600235|Progression|progression
314272|NCT01600235|Induced-hypertension|induced-hypertension
314273|NCT01600235|Phenylephrine|phenylephrine
314274|NCT01600209|Cancer|cancer
314275|NCT01600209|Colorectal Cancer|colorectal cancer
314276|NCT01600209|Neoplasm|neoplasm
314277|NCT01600209|Colorectal Neoplasm|colorectal neoplasm
314278|NCT01600209|Intestinal Neoplasms|intestinal neoplasms
314279|NCT01600209|Gastrointestinal Neoplasms|gastrointestinal neoplasms
314280|NCT01600209|Digestive System Neoplasms|digestive system neoplasms
314281|NCT01600209|Neoplasms by Site|neoplasms by site
314282|NCT01600209|Neoplasms|neoplasms
314283|NCT01600209|Digestive System Diseases|digestive system diseases
314284|NCT01600209|Gastrointestinal Diseases|gastrointestinal diseases
314285|NCT01600209|Colonic Diseases|colonic diseases
314286|NCT01600209|Intestinal Diseases|intestinal diseases
314287|NCT01600209|Rectal Diseases|rectal diseases
314288|NCT01600196|Hepatectomy|hepatectomy
314289|NCT01600196|Thrombectomy|thrombectomy
314290|NCT01600196|Hepatocellular carcinoma|hepatocellular carcinoma
314291|NCT01600196|Portal vein tumor thrombus|portal vein tumor thrombus
314293|NCT01600183|metatarsus|metatarsus
314294|NCT01600183|Metatarsus Adductus, also known as Metatarsus Varus|metatarsus adductus, also known as metatarsus varus
314295|NCT01600170|HIV|hiv
314296|NCT01600170|monocytes|monocytes
314297|NCT01600170|CD16+|cd16+
314298|NCT01600170|statins|statins
314299|NCT01600170|mcp1|mcp1
314300|NCT01600170|inflammation|inflammation
314301|NCT01600144|data mammography|data mammography
314302|NCT01600118|tooth mobility|tooth mobility
314303|NCT01600118|periodontal status|periodontal status
314304|NCT01600118|irregularity index|irregularity index
314305|NCT01600118|pulpal blood flow|pulpal blood flow
314306|NCT01600105|liver fibrosis|liver fibrosis
314307|NCT01600105|liver cirrhosis|liver cirrhosis
314308|NCT01600105|chronic hepatitis|chronic hepatitis
314309|NCT01600105|magnetic resonance imaging|magnetic resonance imaging
314310|NCT01600079|Varicella-zoster vaccine|varicella-zoster vaccine
314311|NCT01600079|herpes zoster|herpes zoster
314312|NCT01600079|shingles|shingles
314313|NCT01600079|Varicella-zoster virus|varicella-zoster virus
314314|NCT01600079|postherpetic neuralgia|postherpetic neuralgia
314315|NCT01600079|Herpesviridae Infections|herpesviridae infections
314316|NCT01600079|DNA Virus Infections|dna virus infections
314317|NCT01600079|Virus Diseases|virus diseases
314318|NCT01600053|Chronic|chronic
314319|NCT01600053|Lymphocytic|lymphocytic
314320|NCT01600053|Leukemia|leukemia
314321|NCT01600040|metastatic|metastatic
314322|NCT01600027|Fascia iliaca block|fascia iliaca block
314323|NCT01600027|dexmetomidine|dexmetomidine
314324|NCT01600027|fracture femur|fracture femur
314325|NCT01600027|α2 agonist|α2 agonist
314326|NCT01600001|Chronic Idiopathic Constipation (CIC)|chronic idiopathic constipation (cic)
314327|NCT01600001|Constipation|constipation
314328|NCT01600001|Functional gastrointestinal disorders|functional gastrointestinal disorders
314329|NCT01599975|HAND|hand
314330|NCT01599975|HIV Associated Neurocognitive Disorder|hiv associated neurocognitive disorder
314331|NCT01599975|Methylphenidate|methylphenidate
314332|NCT01599975|HIV Dementia|hiv dementia
314333|NCT01599949|Mantle cell lymphoma|mantle cell lymphoma
314334|NCT01599949|Ibrutinib|ibrutinib
314335|NCT01599949|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
314336|NCT01599949|Rituximab|rituximab
314338|NCT01599936|scorpion sting|scorpion sting
314339|NCT01599936|envenomation|envenomation
314340|NCT01599936|Anascorp|anascorp
314341|NCT01599923|scorpion|scorpion
314342|NCT01599923|envenomation|envenomation
314343|NCT01599923|Alacramyn|alacramyn
314344|NCT01599910|Scribes|scribes
314345|NCT01599910|Physician Productivity|physician productivity
314346|NCT01599910|Electronic Documentation|electronic documentation
314347|NCT01599897|Tuberculosis|tuberculosis
314349|NCT01599897|Pulmonary|pulmonary
314350|NCT01599897|Vaccine|vaccine
314351|NCT01599884|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
314352|NCT01599884|Chronic bronchitis|chronic bronchitis
314353|NCT01599884|N-acetylcysteine|n-acetylcysteine
314354|NCT01599871|COPD|copd
314355|NCT01599858|YF476|yf476
314356|NCT01599858|gastrin receptor antagonist|gastrin receptor antagonist
314357|NCT01599858|gastric pH|gastric ph
314358|NCT01599858|healthy subjects|healthy subjects
314359|NCT01599858|omeprazole|omeprazole
314360|NCT01599845|Lung|lung
314361|NCT01599845|Alveoli|alveoli
314362|NCT01599845|Nanoparticles|nanoparticles
314363|NCT01599845|Particulate matter|particulate matter
314364|NCT01599845|Exhaled breath condensate|exhaled breath condensate
314365|NCT01599845|Induced sputum|induced sputum
314366|NCT01599845|Forced expiratory volume|forced expiratory volume
314367|NCT01599845|Force vital capacity|force vital capacity
314368|NCT01599806|Ceftazidime, Avibactam, Doripenem, Ciprofloxacin, sulfamethoxazole/trimethoprim, Anti-Infective Agents, Complicated Urinary Tract Infection,Acute Pyelonephritis|ceftazidime, avibactam, doripenem, ciprofloxacin, sulfamethoxazole/trimethoprim, anti-infective agents, complicated urinary tract infection,acute pyelonephritis
314369|NCT01599793|castrate resistant prostate cancer|castrate resistant prostate cancer
314370|NCT01599793|CRPC|crpc
314371|NCT01599793|cabozantinib|cabozantinib
314372|NCT01599793|XL184|xl184
314373|NCT01599780|preterm|preterm
314374|NCT01599780|premature|premature
314375|NCT01599780|prematurity|prematurity
314376|NCT01599780|children|children
314377|NCT01599780|child|child
314378|NCT01599780|kid|kid
314379|NCT01599780|toddler|toddler
314380|NCT01599780|infant|infant
314381|NCT01599780|baby|baby
314382|NCT01599780|language|language
314383|NCT01599780|development|development
314384|NCT01599780|skills|skills
314385|NCT01599780|listening|listening
314386|NCT01599780|talking|talking
314387|NCT01599780|communication|communication
314388|NCT01599780|speech|speech
314389|NCT01599780|processing|processing
314390|NCT01599767|transcranial stimulation|transcranial stimulation
314391|NCT01599767|direct current|direct current
314392|NCT01599754|renal cell carcinoma|renal cell carcinoma
314394|NCT01599754|tyrosine kinase inhibitor|tyrosine kinase inhibitor
314395|NCT01599741|X-rays|x-rays
314396|NCT01599741|Endovascular angiography|endovascular angiography
314397|NCT01599741|Image processing|image processing
314398|NCT01599728|Urocortin 2|urocortin 2
314399|NCT01599728|Urocortin 3|urocortin 3
314400|NCT01599728|Forearm venous occlusion plethysmography|forearm venous occlusion plethysmography
314401|NCT01599728|Heart failure|heart failure
314402|NCT01599728|Endothelium|endothelium
314403|NCT01599728|Substance P|substance p
314404|NCT01599715|Urinary Incontinence|urinary incontinence
314405|NCT01599715|Weak bladder|weak bladder
314406|NCT01599715|Frequent urination|frequent urination
314407|NCT01599715|Overactive bladder|overactive bladder
314408|NCT01599715|Urine leakage|urine leakage
314409|NCT01599715|Stress incontinence|stress incontinence
314410|NCT01599715|Urge Incontinence|urge incontinence
314411|NCT01599715|Pelvic Floor weakness|pelvic floor weakness
314412|NCT01599715|Pelvic Floor Muscle Exercises|pelvic floor muscle exercises
314413|NCT01599715|Kegel exercises|kegel exercises
314414|NCT01599715|Self-Care|self-care
314415|NCT01599702|IBD|ibd
314416|NCT01599702|IDA|ida
314417|NCT01599702|Subjects|subjects
314418|NCT01599702|diagnosis|diagnosis
314419|NCT01599689|Delirium|delirium
314420|NCT01599689|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
314421|NCT01599689|Confusion|confusion
314422|NCT01599689|Neurobehavioral Manifestations|neurobehavioral manifestations
314423|NCT01599689|Neurologic Manifestations|neurologic manifestations
314424|NCT01599689|Nervous System Diseases|nervous system diseases
314425|NCT01599689|Signs and Symptoms|signs and symptoms
314426|NCT01599689|Mental Disorders|mental disorders
314427|NCT01599689|Cardiac Surgery|cardiac surgery
314428|NCT01599689|Mirrors|mirrors
314429|NCT01599676|Citrulline|citrulline
314430|NCT01599676|protein-energy malnutrition|protein-energy malnutrition
314431|NCT01599676|amino acids|amino acids
314432|NCT01599676|muscle strength|muscle strength
314433|NCT01599676|resistance training|resistance training
314434|NCT01599663|Pain management|pain management
314435|NCT01599663|Pain assessment|pain assessment
314436|NCT01599663|Intensive care unit|intensive care unit
314437|NCT01599663|Adult|adult
314438|NCT01599650|Macular Edema, Branch Retinal Vein Occlusion, visual impairment|macular edema, branch retinal vein occlusion, visual impairment
314439|NCT01599637|Chronic idiopathic urticaria|chronic idiopathic urticaria
314440|NCT01599637|CIU|ciu
314441|NCT01599637|Xolair|xolair
314442|NCT01599637|IGE025|ige025
314443|NCT01599637|FcεRI|fcεri
314444|NCT01599637|IgE|ige
314445|NCT01599624|Resilience|resilience
314446|NCT01599624|Perceived stress|perceived stress
314447|NCT01599624|PTSD symptoms|ptsd symptoms
314448|NCT01599624|Depression|depression
314449|NCT01599624|Anxiety|anxiety
314450|NCT01599624|Sleep quality|sleep quality
314451|NCT01599624|United States Navy service members|united states navy service members
314452|NCT01599611|Neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
314453|NCT01599611|Follow-up|follow-up
314454|NCT01599611|Motor development|motor development
314455|NCT01599611|Hearing|hearing
305152|NCT01640535|PAR|par
314456|NCT01599611|Executive function|executive function
314457|NCT01599598|perceived stress|perceived stress
314458|NCT01599598|depression|depression
314459|NCT01599598|anxiety|anxiety
314460|NCT01599598|posttraumatic stress disorder|posttraumatic stress disorder
314461|NCT01599598|military|military
314462|NCT01599598|school|school
314463|NCT01599598|training environment|training environment
314464|NCT01599598|heart rate variability|heart rate variability
314465|NCT01599598|progressive muscle relaxation|progressive muscle relaxation
314466|NCT01599598|psychophysiological coherence|psychophysiological coherence
314467|NCT01599598|coherence advantage|coherence advantage
315562|NCT01595178|adults|adults
314468|NCT01599598|stress reduction|stress reduction
314469|NCT01599598|stress regulation|stress regulation
314470|NCT01599598|independent duty corpsmen|independent duty corpsmen
314471|NCT01599585|Depression|depression
314472|NCT01599585|Behavioral Activation|behavioral activation
314473|NCT01599585|Tele-medicine|tele-medicine
314474|NCT01599572|zinc supplementation|zinc supplementation
314475|NCT01599572|serum zinc concentration|serum zinc concentration
314476|NCT01599572|lymphocyte proliferation|lymphocyte proliferation
314477|NCT01599559|previously|previously
314478|NCT01599559|untreated|untreated
314479|NCT01599546|Preterm|preterm
314480|NCT01599546|Full term|full term
314481|NCT01599546|Reading|reading
314482|NCT01599546|Dyslexia|dyslexia
314483|NCT01599546|Brain|brain
314484|NCT01599546|Diffusion tensor imaging|diffusion tensor imaging
314485|NCT01599520|cancer|cancer
314486|NCT01599520|stress|stress
314487|NCT01599520|stress management|stress management
314488|NCT01599520|Latinas|latinas
314489|NCT01599520|Hispanics|hispanics
314490|NCT01599507|Anemia|anemia
314491|NCT01599507|Renal|renal
314492|NCT01599481|Common mental illness|common mental illness
314493|NCT01599481|Supported Employment|supported employment
314494|NCT01599481|Anxiety|anxiety
314495|NCT01599481|Depression|depression
314496|NCT01599481|Sickness absence|sickness absence
314497|NCT01599468|post partum hemorrhage|post partum hemorrhage
314498|NCT01599468|transfusion|transfusion
314499|NCT01599468|tranexamic acid|tranexamic acid
314500|NCT01599455|pediatric spinal cord injury|pediatric spinal cord injury
314501|NCT01599455|blood pressure|blood pressure
314502|NCT01599455|heart rate|heart rate
314503|NCT01599455|baseline|baseline
314504|NCT01599429|AML / LMA|aml / lma
314505|NCT01599416|Oral Probiotics|oral probiotics
314506|NCT01599416|HPV DNA Index Test|hpv dna index test
314507|NCT01599416|Vaginal infection|vaginal infection
314508|NCT01599403|Rib Fracture|rib fracture
314509|NCT01599403|Intercostal Nerve Block|intercostal nerve block
314510|NCT01599403|Paravertebral Nerve Block|paravertebral nerve block
314511|NCT01599390|United States|united states
314512|NCT01599390|Burden of Disease|burden of disease
314513|NCT01599390|Influenza|influenza
314514|NCT01599364|HIV infection|hiv infection
314515|NCT01599364|Atazanavir|atazanavir
314516|NCT01599364|Lamivudine|lamivudine
314517|NCT01599364|Ritonavir|ritonavir
314518|NCT01599364|virological suppression|virological suppression
314519|NCT01599364|non-inferiority|non-inferiority
314520|NCT01599364|Combined antiretroviral therapy|combined antiretroviral therapy
314521|NCT01599351|Radiation exposure|radiation exposure
314522|NCT01599351|ERCP|ercp
314523|NCT01599338|Liraglutide|liraglutide
314524|NCT01599338|GLP-1 analogue|glp-1 analogue
314525|NCT01599338|Food preference|food preference
314526|NCT01599338|Gustative perception|gustative perception
314527|NCT01599338|Liking|liking
314528|NCT01599338|wanting|wanting
314529|NCT01599338|T2DM|t2dm
314530|NCT01599338|body mass composition|body mass composition
314531|NCT01599338|leptin|leptin
314532|NCT01599338|ghrelin|ghrelin
314533|NCT01599312|Videolaryngoscopy|videolaryngoscopy
314534|NCT01599312|Forces|forces
314535|NCT01599312|Teeth|teeth
314536|NCT01599299|ultrasound|ultrasound
314537|NCT01599299|left and right jugular vein|left and right jugular vein
314538|NCT01599299|comparison|comparison
314539|NCT01599286|Hyperammonia|hyperammonia
314540|NCT01599286|propionic acidemia (PA)|propionic acidemia (pa)
314541|NCT01599286|methylmalonic acidemia (MMA)|methylmalonic acidemia (mma)
314542|NCT01599286|late-onset CPS1 deficiency (CPSD)|late-onset cps1 deficiency (cpsd)
314543|NCT01599286|late-onset Ornithine transcarbamylase deficiency (OTCD)|late-onset ornithine transcarbamylase deficiency (otcd)
314544|NCT01599286|Carbaglu|carbaglu
314545|NCT01599273|thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
314546|NCT01599273|triamcinolone|triamcinolone
314547|NCT01599273|retraction|retraction
314548|NCT01599273|swelling|swelling
314549|NCT01599247|Suicide|suicide
314550|NCT01599247|Optimism|optimism
314551|NCT01599247|Hopelessness|hopelessness
314552|NCT01599221|Femoral fractures|femoral fractures
314553|NCT01599221|Nail|nail
314554|NCT01599221|Implant|implant
314555|NCT01599221|Elderly|elderly
314556|NCT01599221|Orthopaedics|orthopaedics
314557|NCT01599195|carotid stenosis|carotid stenosis
314558|NCT01599195|femoral artery ischemia|femoral artery ischemia
314559|NCT01599195|carotid bruit asymptomatic|carotid bruit asymptomatic
314560|NCT01599195|carotid murmur|carotid murmur
314561|NCT01599169|Burnout syndrome|burnout syndrome
314562|NCT01599169|Depression work-related|depression work-related
314563|NCT01599169|Food supplement|food supplement
314564|NCT01599156|Chronic constipation|chronic constipation
314565|NCT01599156|Reflexology|reflexology
314566|NCT01599156|Complementary medicine|complementary medicine
314567|NCT01599143|Mindfulness|mindfulness
314568|NCT01599143|Pain Disorder (Chronic physical or mental health complaints:|pain disorder (chronic physical or mental health complaints:
314569|NCT01599143|Fibromyalgia; Migraines; Back Pain; etc)|fibromyalgia; migraines; back pain; etc)
314570|NCT01599143|Anxiety Disorder/Anxiety State|anxiety disorder/anxiety state
314571|NCT01599130|Hepatitis B|hepatitis b
314572|NCT01599130|sequential peg-interferon-2a to entecavir|sequential peg-interferon-2a to entecavir
314573|NCT01599117|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
314574|NCT01599117|Diastolic Heart Failure|diastolic heart failure
314575|NCT01599117|Exercise Capacity|exercise capacity
314576|NCT01599117|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
314577|NCT01599117|Udenafil (Zydena)|udenafil (zydena)
314578|NCT01599117|Phosphodiesterase Type 5 Inhibitors|phosphodiesterase type 5 inhibitors
314579|NCT01599104|Essential hypertension|essential hypertension
314580|NCT01599104|LCZ696|lcz696
314581|NCT01599091|Fibroblasts|fibroblasts
314582|NCT01599091|Periodontal ligament|periodontal ligament
314583|NCT01599091|Gingiva|gingiva
314584|NCT01599091|Porphyromonas gingivalis|porphyromonas gingivalis
314585|NCT01599091|Chronic periodontitis|chronic periodontitis
6241|NCT03251014|Yellowstripe scad|yellowstripe scad
6242|NCT03251014|Salmon|salmon
314586|NCT01599091|( patients undergoing tooth extraction will be asked permission to use extracted tooth and gingiva for periodontal disease basic research)|( patients undergoing tooth extraction will be asked permission to use extracted tooth and gingiva for periodontal disease basic research)
314588|NCT01599078|Angioplasty|angioplasty
314589|NCT01599078|Stent|stent
314590|NCT01599078|Atherectomy|atherectomy
314785|NCT01598272|Red Orange|red orange
314591|NCT01599078|Femoral Artery|femoral artery
314592|NCT01599078|Popliteal Artery|popliteal artery
314593|NCT01599078|Paclitaxel|paclitaxel
314595|NCT01599065|internal cardioverter defibrillator|internal cardioverter defibrillator
314596|NCT01599065|electrocautery|electrocautery
314597|NCT01599052|Social Cognition|social cognition
314598|NCT01599052|Theory of Mind|theory of mind
314599|NCT01599052|Emotion Recognition|emotion recognition
314600|NCT01599052|Social competence|social competence
314601|NCT01599052|Brain Tumour|brain tumour
314602|NCT01599039|early diagnostics|early diagnostics
314603|NCT01599039|lymphedema|lymphedema
314604|NCT01599039|breast cancer|breast cancer
314605|NCT01599039|breast cancer related lymphedema|breast cancer related lymphedema
314606|NCT01599039|measuring methods|measuring methods
314607|NCT01599039|inverse water volumetry|inverse water volumetry
314608|NCT01599039|prevention|prevention
314609|NCT01599026|cardiology|cardiology
314610|NCT01599026|fetus of diabetic mother|fetus of diabetic mother
314611|NCT01599013|urothelial carcinoma|urothelial carcinoma
314612|NCT01599013|bladder cancer|bladder cancer
314613|NCT01599013|vinflunine|vinflunine
314614|NCT01599013|transitional cell carcinoma|transitional cell carcinoma
314615|NCT01599013|advanced or metastatic|advanced or metastatic
314616|NCT01599013|unfit|unfit
314617|NCT01599013|ineligible to cisplatin|ineligible to cisplatin
314618|NCT01599013|renal impairment|renal impairment
314619|NCT01599013|renal insufficiency|renal insufficiency
314620|NCT01599013|urologic neoplasms|urologic neoplasms
314621|NCT01599013|urogenital neoplasm|urogenital neoplasm
314622|NCT01599013|urinary neoplasms|urinary neoplasms
314623|NCT01599013|cisplatin|cisplatin
314624|NCT01599013|tubulin inhibitors|tubulin inhibitors
314625|NCT01599000|malaria|malaria
314626|NCT01599000|Plasmodium|plasmodium
314627|NCT01599000|Papua New Guinea|papua new guinea
314628|NCT01599000|artemether/lumefantrine|artemether/lumefantrine
314629|NCT01598987|Paediatric liver transplantation|paediatric liver transplantation
314630|NCT01598987|Everolimus|everolimus
314631|NCT01598987|Reduced calcineurin inhibitor|reduced calcineurin inhibitor
314632|NCT01598987|Cyclosporine, tacrolimus|cyclosporine, tacrolimus
314633|NCT01598987|Renal function|renal function
314634|NCT01598987|Composite efficacy endpoint (treated biopsy proven acute rejection death, graft loss)|composite efficacy endpoint (treated biopsy proven acute rejection death, graft loss)
314635|NCT01598987|Liver transplant|liver transplant
314636|NCT01598974|Lower Back Pain|lower back pain
314637|NCT01598974|Acupuncture|acupuncture
314638|NCT01598948|hypercholesterolemia|hypercholesterolemia
314639|NCT01598948|apheresis|apheresis
314640|NCT01598948|coronary heart disease|coronary heart disease
314641|NCT01598948|cerebrovascular disease|cerebrovascular disease
314642|NCT01598948|peripheral arterial disease|peripheral arterial disease
314643|NCT01598922|Depression|depression
305373|NCT01639703|Xenetix|xenetix
314644|NCT01598922|Internet Cognitive Behavioral Therapy|internet cognitive behavioral therapy
314645|NCT01598922|fMRI|fmri
314646|NCT01598922|Neuroimaging|neuroimaging
314647|NCT01598909|blepharoplasty|blepharoplasty
314648|NCT01598909|arnica|arnica
314649|NCT01598909|homeopathy|homeopathy
314650|NCT01598896|Cannabis Dependence|cannabis dependence
314651|NCT01598896|Marijuana Dependence|marijuana dependence
314652|NCT01598896|Cannabis Use Disorders|cannabis use disorders
314653|NCT01598896|Cannabis Withdrawal|cannabis withdrawal
314654|NCT01598896|Dronabinol|dronabinol
314655|NCT01598896|Clonidine|clonidine
314656|NCT01598896|Schizophrenia|schizophrenia
314657|NCT01598870|Spontaneous bacterial peritonitis.|spontaneous bacterial peritonitis.
314658|NCT01598857|granulomatosis with polyangiitis|granulomatosis with polyangiitis
314659|NCT01598857|microscopic polyangiitis|microscopic polyangiitis
314660|NCT01598857|anti-neutrophil cytoplasmic antibodies|anti-neutrophil cytoplasmic antibodies
314661|NCT01598857|ANCA-associated vasculitis|anca-associated vasculitis
314662|NCT01598857|Wegener Granulomatosis|wegener granulomatosis
314663|NCT01598831|sepsis|sepsis
314664|NCT01598818|Vision Nearsighted|vision nearsighted
314665|NCT01598818|Vision Farsighted|vision farsighted
314666|NCT01598805|venous thromboembolism/prevention & control|venous thromboembolism/prevention & control
314667|NCT01598779|genital warts|genital warts
314668|NCT01598779|HPV types|hpv types
314669|NCT01598779|Sexually Transmitted Diseases|sexually transmitted diseases
314670|NCT01598779|Skin Diseases, Viral|skin diseases, viral
314671|NCT01598779|Tumor Virus Infections|tumor virus infections
314672|NCT01598779|Skin Diseases, Infectious|skin diseases, infectious
314673|NCT01598779|Skin Diseases|skin diseases
314674|NCT01598779|Papillomavirus Infections|papillomavirus infections
314675|NCT01598779|DNA Virus Infections|dna virus infections
314676|NCT01598779|Virus Diseases|virus diseases
314677|NCT01598779|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
314678|NCT01598727|parathyroid surgery|parathyroid surgery
314679|NCT01598701|Acetaminophen|acetaminophen
314680|NCT01598701|Intravenous Acetaminophen|intravenous acetaminophen
314681|NCT01598701|Opioid Requirement|opioid requirement
314682|NCT01598701|Pain|pain
314683|NCT01598701|Post-Operative Pain|post-operative pain
314684|NCT01598701|Craniotomy|craniotomy
314685|NCT01598701|Post-Craniotomy Pain|post-craniotomy pain
314686|NCT01598688|Bone marrow transplantation|bone marrow transplantation
314687|NCT01598688|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
314688|NCT01598688|Medication management|medication management
314689|NCT01598688|Nursing care|nursing care
314690|NCT01598675|stroke|stroke
314691|NCT01598675|Gait|gait
314692|NCT01598675|walking|walking
314693|NCT01598662|IUD placement|iud placement
314694|NCT01598662|contraception|contraception
314695|NCT01598662|postpartum|postpartum
314696|NCT01598662|intrauterine device|intrauterine device
314697|NCT01598662|expulsion|expulsion
314698|NCT01598649|Dietary protein|dietary protein
314699|NCT01598649|Lupin protein|lupin protein
314700|NCT01598649|Cholesterol metabolism|cholesterol metabolism
314701|NCT01598649|Protein metabolism|protein metabolism
314702|NCT01598649|Hypercholesterolemia|hypercholesterolemia
314703|NCT01598649|Protein-enriched foods|protein-enriched foods
314704|NCT01598584|Mirtazapine|mirtazapine
314705|NCT01598584|gemcitabine|gemcitabine
314706|NCT01598584|placebo|placebo
314707|NCT01598584|RCT|rct
314708|NCT01598584|pancreatic cancer|pancreatic cancer
314709|NCT01598571|Phase 1|phase 1
314710|NCT01598571|Healthy male volunteers|healthy male volunteers
314711|NCT01598571|pharmacokinetics|pharmacokinetics
314712|NCT01598571|fostamatinib|fostamatinib
314713|NCT01598571|Bioavailability|bioavailability
314714|NCT01598571|R406 plasma AUC and Cmax|r406 plasma auc and cmax
314715|NCT01598571|R406 plasma AUC0-t|r406 plasma auc0-t
314716|NCT01598571|t1/2λz|t1/2λz
314717|NCT01598571|tmax|tmax
314718|NCT01598532|mild traumatic brain injury|mild traumatic brain injury
314719|NCT01598532|mild TBI|mild tbi
314720|NCT01598532|mTBI|mtbi
314721|NCT01598519|school-based|school-based
314722|NCT01598519|adolescent suicide|adolescent suicide
314723|NCT01598519|intervention|intervention
314724|NCT01598519|screening|screening
314725|NCT01598493|Burns|burns
314726|NCT01598493|Wound Healing|wound healing
314727|NCT01598480|Burns|burns
314728|NCT01598480|Wound Healing|wound healing
314729|NCT01598467|pelvic organ prolapse|pelvic organ prolapse
314731|NCT01598467|sacrocolpopexy|sacrocolpopexy
314732|NCT01598467|sacrohysteropexy|sacrohysteropexy
314733|NCT01598467|promontofixation|promontofixation
314734|NCT01598467|colpopexy|colpopexy
314735|NCT01598467|robotic surgery|robotic surgery
314736|NCT01598467|surgical complications|surgical complications
314737|NCT01598467|mesh|mesh
314738|NCT01598467|prolapse repair|prolapse repair
314739|NCT01598441|pulmonary hypertension, pulmonary hypertensive crisis|pulmonary hypertension, pulmonary hypertensive crisis
314740|NCT01598428|age related cataract|age related cataract
305437|NCT01639339|Systemic Lupus Erythematosus|systemic lupus erythematosus
305438|NCT01639339|Autoimmune Disease|autoimmune disease
314741|NCT01598428|phacoemulsification|phacoemulsification
314742|NCT01598428|anterior capsule polishing|anterior capsule polishing
314743|NCT01598428|optical coherence tomography|optical coherence tomography
314744|NCT01598428|anterior chamber depth|anterior chamber depth
314745|NCT01598402|LAHNC|lahnc
314746|NCT01598402|Locally Advanced Head and Neck Cancer|locally advanced head and neck cancer
314747|NCT01598376|entropion|entropion
314748|NCT01598376|suture|suture
314749|NCT01598376|granuloma|granuloma
314750|NCT01598376|tissue reaction|tissue reaction
314751|NCT01598350|Gait|gait
314752|NCT01598350|Orthoses|orthoses
314753|NCT01598350|Down syndrome|down syndrome
314754|NCT01598324|magnetic resonance imaging|magnetic resonance imaging
314755|NCT01598324|magnetic resonance spectroscopy|magnetic resonance spectroscopy
314756|NCT01598324|depression|depression
314757|NCT01598324|escitalopram|escitalopram
314758|NCT01598324|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
314759|NCT01598324|treatment-resistant depression|treatment-resistant depression
314760|NCT01598324|ziprasidone|ziprasidone
314761|NCT01598311|CDAD|cdad
314762|NCT01598311|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
314763|NCT01598311|CDI|cdi
314764|NCT01598311|Clostridium difficile Infection|clostridium difficile infection
314765|NCT01598311|Diarrhea|diarrhea
314766|NCT01598298|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
314767|NCT01598298|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
314768|NCT01598298|stage IA breast cancer|stage ia breast cancer
314769|NCT01598298|stage IB breast cancer|stage ib breast cancer
314770|NCT01598298|stage II breast cancer|stage ii breast cancer
314771|NCT01598298|stage IIIA breast cancer|stage iiia breast cancer
314772|NCT01598298|stage IIIB breast cancer|stage iiib breast cancer
314773|NCT01598298|stage IIIC breast cancer|stage iiic breast cancer
314774|NCT01598298|pain|pain
314775|NCT01598298|musculoskeletal complications|musculoskeletal complications
314777|NCT01598285|GWAS|gwas
314778|NCT01598285|microRNA|microrna
314779|NCT01598285|miRNA|mirna
314780|NCT01598285|Bevacizumab Response Predictors|bevacizumab response predictors
314781|NCT01598285|Metastatic Breast Cancer|metastatic breast cancer
314782|NCT01598272|Ginseng|ginseng
314783|NCT01598272|Cordyceps|cordyceps
314784|NCT01598272|Pomegranate|pomegranate
314790|NCT01598220|schizophrenia|schizophrenia
314791|NCT01598220|cognitive remediation therapy|cognitive remediation therapy
314792|NCT01598220|cognition|cognition
314793|NCT01598220|quality of life|quality of life
314794|NCT01598194|solid pancreatic mass lesions|solid pancreatic mass lesions
314795|NCT01598194|22-gauge core biopsy needle|22-gauge core biopsy needle
314796|NCT01598194|reverse bevel design|reverse bevel design
314797|NCT01598194|endoscopic ultrasound|endoscopic ultrasound
314798|NCT01598194|EUS|eus
314799|NCT01598194|guided|guided
314800|NCT01598194|fine needle aspiration|fine needle aspiration
314801|NCT01598194|FNA|fna
314802|NCT01598168|rivaroxaban|rivaroxaban
314803|NCT01598168|treatment|treatment
314804|NCT01598168|venous thromboembolism|venous thromboembolism
314805|NCT01598168|arterial thromboembolism|arterial thromboembolism
314806|NCT01598168|thrombocytopenia|thrombocytopenia
314807|NCT01598155|dental biofilm|dental biofilm
314808|NCT01598155|periodontitis|periodontitis
314809|NCT01598155|maintenance|maintenance
314810|NCT01598155|randomized clinical trial|randomized clinical trial
314811|NCT01598155|biomarkers|biomarkers
314812|NCT01598155|bacterias|bacterias
314813|NCT01598155|gingival crevicular fluid|gingival crevicular fluid
707548|NCT00997867|Femoral|femoral
314814|NCT01598142|Endoscopic retrograde cholangiopancreatography (ERCP)|endoscopic retrograde cholangiopancreatography (ercp)
314815|NCT01598142|Guidewires|guidewires
314816|NCT01598142|Cannulation|cannulation
314817|NCT01598142|Single-operator|single-operator
314818|NCT01598142|C-Hook|c-hook
314819|NCT01598129|Phase I|phase i
314820|NCT01598129|Dose escalation|dose escalation
314821|NCT01598129|oncolytic virus|oncolytic virus
314822|NCT01598103|Neurogenic detrusor overactivity|neurogenic detrusor overactivity
314823|NCT01598103|spinal cord lesions|spinal cord lesions
314824|NCT01598103|spinal cord injury|spinal cord injury
314825|NCT01598077|Breast cancer, gastric cancer, squamous cell carcinoma of head and neck, esophageal squamous cell carcinoma|breast cancer, gastric cancer, squamous cell carcinoma of head and neck, esophageal squamous cell carcinoma
314826|NCT01598077|Breast cancer|breast cancer
314827|NCT01598077|Gastric cancer|gastric cancer
314828|NCT01598077|Squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
314829|NCT01598077|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
314830|NCT01598051|Xarelto|xarelto
314831|NCT01598051|SPAF|spaf
314832|NCT01598051|QOL|qol
314833|NCT01598038|cancer|cancer
314834|NCT01598038|renal|renal
314835|NCT01598038|Afinitor|afinitor
314836|NCT01598038|pharmacokinetics|pharmacokinetics
314837|NCT01598025|ANTITHYMOCYTE GLOBULIN:ATG|antithymocyte globulin:atg
314838|NCT01598025|FLUDARABINE|fludarabine
314839|NCT01598025|THI0TEPA|thi0tepa
314840|NCT01598025|CliniMACS-CD34 Reagent System|clinimacs-cd34 reagent system
314841|NCT01598025|12-053|12-053
314842|NCT01598012|Ayurved Siriraj Prasaplai|ayurved siriraj prasaplai
314843|NCT01598012|primary dysmenorrhea|primary dysmenorrhea
314844|NCT01597986|isavuconazole|isavuconazole
314845|NCT01597986|ethinyl estradiol|ethinyl estradiol
314846|NCT01597986|norethindrone|norethindrone
314847|NCT01597986|contraceptive|contraceptive
314848|NCT01597986|Healthy Volunteers|healthy volunteers
314849|NCT01597986|BAL8557|bal8557
314850|NCT01597986|BAL4815|bal4815
314851|NCT01597934|Chronic hepatitis B|chronic hepatitis b
314852|NCT01597934|Partial virologic response|partial virologic response
314853|NCT01597934|YMDD mutation|ymdd mutation
314854|NCT01597921|Breast conserving surgery|breast conserving surgery
314855|NCT01597921|Radiation dermatitis|radiation dermatitis
314856|NCT01597908|BRAF inhibitor|braf inhibitor
314857|NCT01597908|Metastatic Melanoma|metastatic melanoma
314858|NCT01597908|Cancer|cancer
314859|NCT01597908|MEK inhibitor|mek inhibitor
314860|NCT01597895|maraviroc|maraviroc
314861|NCT01597895|boceprevir|boceprevir
314862|NCT01597895|telaprevir|telaprevir
314863|NCT01597895|drug interaction|drug interaction
314864|NCT01597895|pharmacokinetics|pharmacokinetics
314865|NCT01597895|HIV|hiv
314866|NCT01597882|case management|case management
314867|NCT01597882|long term conditions|long term conditions
314868|NCT01597882|aged sixty five and over|aged sixty five and over
314869|NCT01597843|education|education
314870|NCT01597843|self care|self care
314871|NCT01597843|peer group|peer group
314872|NCT01597843|Computers|computers
314873|NCT01597843|Attitude to computers|attitude to computers
314874|NCT01597830|knee|knee
314875|NCT01597830|osteoarthritis|osteoarthritis
314876|NCT01597830|loading|loading
314877|NCT01597817|Atopic dermatitis|atopic dermatitis
314878|NCT01597817|Eczema|eczema
314879|NCT01597817|Textiles|textiles
314880|NCT01597791|Urinary Retention|urinary retention
314881|NCT01597791|Urinary Catheter|urinary catheter
314882|NCT01597791|Bacteriuria|bacteriuria
314889|NCT01597765|Oxidative stress|oxidative stress
314890|NCT01597765|antioxidant cocktail|antioxidant cocktail
314891|NCT01597752|Immunotherapy|immunotherapy
314892|NCT01597752|Skin prick test|skin prick test
314893|NCT01597752|Standardization|standardization
314894|NCT01597752|Blomia tropicalis|blomia tropicalis
314895|NCT01597739|Active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy|active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy
314896|NCT01597739|Disease-modifying antirheumatic drugs|disease-modifying antirheumatic drugs
314897|NCT01597726|Abortion, Induced|abortion, induced
314898|NCT01597726|Laminaria|laminaria
314899|NCT01597726|Misoprostol|misoprostol
314900|NCT01597726|Pregnancy Trimester, Second|pregnancy trimester, second
314901|NCT01597687|pertussis infection|pertussis infection
314902|NCT01597687|Prevalence|prevalence
314903|NCT01597687|health economic burden|health economic burden
314904|NCT01597687|prolonged cough|prolonged cough
314906|NCT01597674|gastrin receptor antagonist|gastrin receptor antagonist
314907|NCT01597674|gastric pH|gastric ph
314908|NCT01597674|gastrin|gastrin
314909|NCT01597674|healthy subjects|healthy subjects
314910|NCT01597661|first trimester|first trimester
314911|NCT01597661|left outflow tract obstruction|left outflow tract obstruction
314912|NCT01597661|Bupropion|bupropion
314913|NCT01597661|cardiovascular malformation|cardiovascular malformation
314914|NCT01597661|antidepressants|antidepressants
314915|NCT01597661|pregnancy|pregnancy
314916|NCT01597661|cardiovascular defect|cardiovascular defect
314917|NCT01597661|congenital malformation|congenital malformation
314918|NCT01597648|Combivir™, HIV, bioequivalence, Combined Formulated Tablet, Combined Formulated Tablet, HIV, bioequivalence, Combivir, Selzentry™, Celsentri™, lamivudine, zidov|combivir™, hiv, bioequivalence, combined formulated tablet, combined formulated tablet, hiv, bioequivalence, combivir, selzentry™, celsentri™, lamivudine, zidov
314919|NCT01597635|rhACE2|rhace2
314920|NCT01597635|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
314921|NCT01597635|Acute Lung Injury|acute lung injury
314922|NCT01597635|GSK2586881|gsk2586881
314923|NCT01597635|critical care|critical care
314924|NCT01597622|SELENA|selena
314925|NCT01597622|belimumab|belimumab
314926|NCT01597622|Lupus|lupus
314927|NCT01597622|systemic lupus erythematosus|systemic lupus erythematosus
314929|NCT01597622|BLys|blys
314930|NCT01597622|SLE Flare Index|sle flare index
314931|NCT01597622|continuation|continuation
314932|NCT01597622|phase III|phase iii
314933|NCT01597622|BILAG|bilag
314934|NCT01597622|extension|extension
314935|NCT01597622|efficacy|efficacy
314936|NCT01597622|SRI|sri
314937|NCT01597622|B cell|b cell
314938|NCT01597622|SLEDAI|sledai
314939|NCT01597622|safety|safety
314940|NCT01597622|Asia|asia
314941|NCT01597622|B lymphocyte|b lymphocyte
314942|NCT01597557|Atrial Fibrillation|atrial fibrillation
314943|NCT01597557|Electrical Cardioversion|electrical cardioversion
314944|NCT01597557|Magnesium Sulfate|magnesium sulfate
314945|NCT01597544|Voiding dysfunction|voiding dysfunction
314946|NCT01597544|bladder catheter|bladder catheter
314947|NCT01597544|prolapse surgery|prolapse surgery
314948|NCT01597544|patient satisfaction|patient satisfaction
314949|NCT01597531|Liraglutide|liraglutide
314950|NCT01597531|Orlistat|orlistat
314951|NCT01597518|Riluzole|riluzole
314952|NCT01597518|spinal cord injury|spinal cord injury
314953|NCT01597518|treatment|treatment
314954|NCT01597505|CDAD|cdad
314955|NCT01597505|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
314956|NCT01597505|CDI|cdi
314957|NCT01597505|Clostridium difficile Infection|clostridium difficile infection
314958|NCT01597505|Diarrhea|diarrhea
314959|NCT01597492|Antibodies|antibodies
314960|NCT01597492|Vaccines|vaccines
314961|NCT01597492|SLE|sle
314962|NCT01597492|Immune System Diseases|immune system diseases
314963|NCT01597492|Biological Therapy|biological therapy
314964|NCT01597492|Autoimmune Diseases|autoimmune diseases
314965|NCT01597492|Pneumococcal Vaccines|pneumococcal vaccines
314966|NCT01597492|Lupus|lupus
314967|NCT01597492|Immunoglobulins|immunoglobulins
314968|NCT01597492|Vaccination|vaccination
314969|NCT01597492|Belimumab|belimumab
314970|NCT01597492|Biological Agents|biological agents
314971|NCT01597492|Immunization|immunization
314972|NCT01597479|Ultrasound guided distal peripheral nerve blocks|ultrasound guided distal peripheral nerve blocks
314973|NCT01597453|Young ischemic stroke|young ischemic stroke
314974|NCT01597453|Families|families
314975|NCT01597453|Long-term follow-up|long-term follow-up
314976|NCT01597440|Propionic acidemia (PA)|propionic acidemia (pa)
314977|NCT01597440|Methylmalonic acidemia (MMA)|methylmalonic acidemia (mma)
314978|NCT01597440|Carbaglu NCG|carbaglu ncg
314979|NCT01597440|Hyperammonia|hyperammonia
314980|NCT01597427|Clonidine|clonidine
314981|NCT01597427|Hypertension Pulmonary|hypertension pulmonary
314982|NCT01597427|Cardiac Surgical Procedures|cardiac surgical procedures
314983|NCT01597401|Antisickling Agents|antisickling agents
314594|NCT01599065|ICD|icd
314984|NCT01597388|Estrogen receptor positive|estrogen receptor positive
314985|NCT01597388|Advanced metastatic breast cancer|advanced metastatic breast cancer
314986|NCT01597388|Estrogen receptor positive advanced metastatic breast cancer|estrogen receptor positive advanced metastatic breast cancer
314987|NCT01597375|Aspirin|aspirin
314988|NCT01597375|Prasugrel|prasugrel
314989|NCT01597375|Asthma|asthma
314990|NCT01597375|AERD|aerd
314991|NCT01597375|Aspirin challenge|aspirin challenge
314992|NCT01597375|Aspirin desensitization|aspirin desensitization
314993|NCT01597375|Aspirin induced asthma|aspirin induced asthma
314994|NCT01597362|laparoscopy|laparoscopy
314995|NCT01597362|trocars|trocars
314996|NCT01597362|veress|veress
314997|NCT01597362|open|open
314998|NCT01597362|direct|direct
314999|NCT01597336|abscess|abscess
315000|NCT01597336|tPA|tpa
315001|NCT01597323|Wrinkle Reduction|wrinkle reduction
315002|NCT01597323|Skin Resurfacing|skin resurfacing
315003|NCT01597323|Skin Texture Improvement|skin texture improvement
315004|NCT01597284|Oral therapies|oral therapies
315005|NCT01597284|Cancer|cancer
315006|NCT01597284|cognitive function|cognitive function
315007|NCT01597284|compliance|compliance
315008|NCT01597258|Safety|safety
315009|NCT01597258|All cases surveillance in Japan|all cases surveillance in japan
315010|NCT01597258|ALK-positive unresectable advanced and/or recurrent non-small cell lung cancer|alk-positive unresectable advanced and/or recurrent non-small cell lung cancer
315011|NCT01597232|Transfusion trigger|transfusion trigger
315012|NCT01597232|Hemoglobin level|hemoglobin level
707642|NCT00998192|carboplatin|carboplatin
315013|NCT01597219|Haploidentical transplant|haploidentical transplant
315014|NCT01597219|Haematological malignancy|haematological malignancy
315015|NCT01597219|Myeloablative|myeloablative
315016|NCT01597219|Reduced intensity|reduced intensity
315017|NCT01597206|randomized controlled trial|randomized controlled trial
315018|NCT01597206|intervention|intervention
315019|NCT01597206|posterior reduced dental arch|posterior reduced dental arch
315020|NCT01597206|patient satisfaction|patient satisfaction
315021|NCT01597206|sequential sampling|sequential sampling
315022|NCT01597193|enzalutamide|enzalutamide
315024|NCT01597193|breast cancer|breast cancer
315025|NCT01597180|contraception|contraception
315026|NCT01597180|HIV|hiv
315027|NCT01597180|pharmacokinetics|pharmacokinetics
315028|NCT01597180|pharmacodynamics|pharmacodynamics
315029|NCT01597167|mild moderate treatment-resistant depression|mild moderate treatment-resistant depression
315030|NCT01597167|magnesium sulfate|magnesium sulfate
315031|NCT01597154|Adolescent|adolescent
315032|NCT01597154|Type 2 Diabetes|type 2 diabetes
315033|NCT01597154|Peer mentorship|peer mentorship
315034|NCT01597141|Prodromal|prodromal
315035|NCT01597141|Schizophrenia|schizophrenia
315036|NCT01597141|Psychosis|psychosis
315037|NCT01597141|Family psychoeducation|family psychoeducation
315038|NCT01597141|Assertive community treatment|assertive community treatment
315039|NCT01597141|Supported employment|supported employment
315040|NCT01597141|Supported education|supported education
315041|NCT01597128|Hernia|hernia
315042|NCT01597128|human tissue|human tissue
315043|NCT01597128|mesh|mesh
315044|NCT01597115|duplex study|duplex study
315045|NCT01597115|hemodialysis access|hemodialysis access
315046|NCT01597115|maturation rate|maturation rate
315047|NCT01597115|endovascular intervention|endovascular intervention
315048|NCT01597102|encephalopathy, hepatic|encephalopathy, hepatic
315049|NCT01597102|autoregulation, cerebrovascular|autoregulation, cerebrovascular
315050|NCT01597102|liver failure|liver failure
315051|NCT01597102|liver transplantation|liver transplantation
315052|NCT01597089|Specificity|specificity
315053|NCT01597089|Bronchoalveolar Lavage|bronchoalveolar lavage
315054|NCT01597089|Film Array Assay|film array assay
315055|NCT01597089|Nasopharyngeal Swab|nasopharyngeal swab
315056|NCT01597089|Sensitivity|sensitivity
315057|NCT01597076|Morinda citrifolia|morinda citrifolia
315058|NCT01597076|noni|noni
315059|NCT01597076|advanced glycation end products|advanced glycation end products
315060|NCT01597076|oxidative stress|oxidative stress
315061|NCT01597076|quality of life|quality of life
315062|NCT01597076|metabolic syndrome|metabolic syndrome
315063|NCT01597076|safety|safety
315064|NCT01597050|Discoid Lupus Erythematosus|discoid lupus erythematosus
315065|NCT01597050|Systemic Lupus Erythematosus|systemic lupus erythematosus
315066|NCT01597037|Aphasia|aphasia
315067|NCT01597037|Speech Rehabilitation|speech rehabilitation
315068|NCT01597024|appetite|appetite
315069|NCT01597024|food|food
315070|NCT01597024|gut|gut
315071|NCT01597024|brain|brain
315072|NCT01597024|satiety|satiety
315073|NCT01597024|hunger|hunger
315074|NCT01597024|gut hormones|gut hormones
315075|NCT01597011|Hernia, Inguinal|hernia, inguinal
315076|NCT01597011|Hernia repair|hernia repair
315077|NCT01597011|Fibrin Tissue Adhesive|fibrin tissue adhesive
315078|NCT01597011|Tisseel|tisseel
315079|NCT01597011|Tissucol|tissucol
315080|NCT01597011|Recurrence|recurrence
315081|NCT01597011|Chronic Pain|chronic pain
315082|NCT01597011|Dysejaculation|dysejaculation
315083|NCT01596998|anesthesia, conduction|anesthesia, conduction
315087|NCT01596985|Endometrioma|endometrioma
315088|NCT01596985|Endometriosis|endometriosis
315089|NCT01596985|Cystectomy|cystectomy
315090|NCT01596985|Ablation|ablation
315091|NCT01596985|Plasma energy|plasma energy
315092|NCT01596959|atrial flutter|atrial flutter
315093|NCT01596959|ablation|ablation
315094|NCT01596959|irrigation|irrigation
315096|NCT01596959|ECI|eci
315097|NCT01596946|contact tracing|contact tracing
315098|NCT01596946|home sampling|home sampling
315099|NCT01596946|cluster randomisation|cluster randomisation
315100|NCT01596933|head and neck cancer|head and neck cancer
315101|NCT01596933|omega-3 fatty acid supplementation|omega-3 fatty acid supplementation
315102|NCT01596933|echium oil|echium oil
315103|NCT01596933|weight loss|weight loss
315104|NCT01596933|cancer cachexia|cancer cachexia
315105|NCT01596933|body composition|body composition
315106|NCT01596933|biomarker|biomarker
315107|NCT01596933|quality of life|quality of life
315108|NCT01596920|Chronic DFUs|chronic dfus
315109|NCT01596920|Diabetic Foot Ulcers|diabetic foot ulcers
315110|NCT01596907|resting energy expenditure|resting energy expenditure
315111|NCT01596907|fat free mass|fat free mass
315112|NCT01596907|lean body mass|lean body mass
315113|NCT01596907|bariatric surgery|bariatric surgery
315114|NCT01596907|morbid obesity|morbid obesity
315115|NCT01596907|ephedrine|ephedrine
315116|NCT01596907|caffeine|caffeine
315117|NCT01596907|Low metabolic rate|low metabolic rate
315118|NCT01596907|Low lean body mass|low lean body mass
315119|NCT01596907|Weight loss rate|weight loss rate
315120|NCT01596894|Pediatric|pediatric
315121|NCT01596894|Crohn's disease|crohn's disease
315122|NCT01596894|Azithromycin|azithromycin
315123|NCT01596894|Metronidazole|metronidazole
315124|NCT01596894|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
315125|NCT01596881|Multiple sclerosis|multiple sclerosis
315126|NCT01596881|Blood flow|blood flow
315127|NCT01596881|Optical Coherence Tomography|optical coherence tomography
315128|NCT01596881|Imaging|imaging
315129|NCT01596868|Advanced Nasopharyngeal Carcinoma|advanced nasopharyngeal carcinoma
315130|NCT01596868|treatment|treatment
315131|NCT01596868|Northwest China|northwest china
315132|NCT01596855|Anemia|anemia
315133|NCT01596855|Renal|renal
315134|NCT01596842|Omega-3 fatty acid|omega-3 fatty acid
315135|NCT01596842|vitamin D|vitamin d
315136|NCT01596842|ergocalciferol|ergocalciferol
315137|NCT01596842|hemodialysis|hemodialysis
315138|NCT01596829|antibiotic|antibiotic
315139|NCT01596829|probiotic|probiotic
315140|NCT01596829|antibiotic-associated diarrhoea|antibiotic-associated diarrhoea
315141|NCT01596829|faecal microbiota|faecal microbiota
315142|NCT01596816|prostate cancer|prostate cancer
305831|NCT01637272|SOM230|som230
315143|NCT01596803|FSHD|fshd
315144|NCT01596803|Antioxidants|antioxidants
315145|NCT01596803|Oxidative stress|oxidative stress
315146|NCT01596803|Muscle function|muscle function
315147|NCT01596803|Quality of life|quality of life
315148|NCT01596803|Activity|activity
315149|NCT01596803|(FSHD;4q35)|(fshd;4q35)
315150|NCT01596790|Bevacizumab|bevacizumab
315151|NCT01596790|Circulating tumor cells|circulating tumor cells
315152|NCT01596790|Treatment efficiency|treatment efficiency
315153|NCT01596777|Loperamide-induced obstipation|loperamide-induced obstipation
315154|NCT01596777|Methylnaltrexone|methylnaltrexone
315155|NCT01596777|oro-cecal transit time|oro-cecal transit time
315156|NCT01596777|whole gut transit time|whole gut transit time
315157|NCT01596777|Pharmacokinetics|pharmacokinetics
315158|NCT01596764|whole-gut transit time|whole-gut transit time
315159|NCT01596764|oro-cecal transit time|oro-cecal transit time
315160|NCT01596764|colon transit time|colon transit time
315161|NCT01596764|loperamide-induced obstipation|loperamide-induced obstipation
315162|NCT01596764|pharmacokinetics|pharmacokinetics
315163|NCT01596764|Methylnaltrexone|methylnaltrexone
315164|NCT01596764|Naloxone|naloxone
315165|NCT01596751|metastatic|metastatic
315166|NCT01596751|breast|breast
315167|NCT01596751|cancer|cancer
315168|NCT01596751|triple|triple
315169|NCT01596751|negative|negative
315170|NCT01596751|PLX|plx
315171|NCT01596751|Eribulin|eribulin
315172|NCT01596738|Coronary Artery Disease|coronary artery disease
315173|NCT01596738|Coronary Artery Bypass Graft|coronary artery bypass graft
315174|NCT01596738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
315175|NCT01596738|Tranexamic Acid|tranexamic acid
315176|NCT01596712|Allergy,|allergy,
315177|NCT01596712|Asthma,|asthma,
315178|NCT01596712|Atopic dermatitis,|atopic dermatitis,
315179|NCT01596712|Japanese,|japanese,
315180|NCT01596712|QGE031,|qge031,
315181|NCT01596712|IgE|ige
315182|NCT01596699|conditioning|conditioning
315183|NCT01596699|allogeneic|allogeneic
315184|NCT01596699|hematopoietic|hematopoietic
315187|NCT01596699|HCT|hct
315188|NCT01596660|Tap block|tap block
315189|NCT01596660|laparoscopic hysterectomy|laparoscopic hysterectomy
315190|NCT01596660|pain|pain
315191|NCT01596647|cancer, tumors, phase I, drug-drug interaction, pharmacokinetic, probe drug, caffeine, diclofenac, omeprazole, midazolam, CYP1A2, CYP2C9, CYP2C19, CYP3A4|cancer, tumors, phase i, drug-drug interaction, pharmacokinetic, probe drug, caffeine, diclofenac, omeprazole, midazolam, cyp1a2, cyp2c9, cyp2c19, cyp3a4
315192|NCT01596621|Bendamustine hydrochloride|bendamustine hydrochloride
315193|NCT01596621|CEP-18083|cep-18083
315194|NCT01596621|Treanda®|treanda®
315195|NCT01596621|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
315196|NCT01596608|Magnetic seizure therapy|magnetic seizure therapy
315197|NCT01596608|Treatment resistance|treatment resistance
315198|NCT01596608|Open-label trial|open-label trial
315199|NCT01596608|Treatment resistant depression|treatment resistant depression
315200|NCT01596608|Treatment resistant schizophrenia|treatment resistant schizophrenia
315201|NCT01596608|Treatment resistant obsessive-compulsive disorder|treatment resistant obsessive-compulsive disorder
315202|NCT01596595|ICD|icd
315203|NCT01596595|CRT-D|crt-d
315204|NCT01596595|Defibrillation lead|defibrillation lead
315205|NCT01596582|Colorectal cancer screening|colorectal cancer screening
315206|NCT01596582|Shared decision-making|shared decision-making
315207|NCT01596582|Patient preferences|patient preferences
315208|NCT01596582|Risk assessment|risk assessment
315209|NCT01596582|Advanced colorectal neoplasia|advanced colorectal neoplasia
707643|NCT00998192|paclitaxel|paclitaxel
315210|NCT01596569|Blast Traumatic Brain Injury|blast traumatic brain injury
315211|NCT01596569|Cognitive Rehabilitation|cognitive rehabilitation
315212|NCT01596569|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
315213|NCT01596569|Combined Treatment|combined treatment
315214|NCT01596556|smoking|smoking
315215|NCT01596556|exercise|exercise
315216|NCT01596556|heat tolerance|heat tolerance
315217|NCT01596556|heat stroke|heat stroke
315218|NCT01596543|sleep|sleep
315219|NCT01596543|HTT|htt
315220|NCT01596543|heat illness|heat illness
315221|NCT01596530|Breast Neoplasm|breast neoplasm
315222|NCT01596530|Breast Cancer|breast cancer
315223|NCT01596530|Breast Tumour|breast tumour
315224|NCT01596530|Cancer of Breast|cancer of breast
315225|NCT01596530|Cancer of the Breast|cancer of the breast
315226|NCT01596491|peripheral nerve injury|peripheral nerve injury
315227|NCT01596491|postherpetic neuralgia|postherpetic neuralgia
315228|NCT01596491|PNI|pni
315229|NCT01596491|PHN|phn
315230|NCT01596491|Capsaicin|capsaicin
315231|NCT01596491|QST|qst
315232|NCT01596491|quantitative sensory testing|quantitative sensory testing
315233|NCT01596491|sensory profile|sensory profile
315234|NCT01596491|neuropathic pain|neuropathic pain
315235|NCT01596478|Gambling|gambling
315236|NCT01596478|Pathological Gambling|pathological gambling
315237|NCT01596439|Healthy women|healthy women
315238|NCT01596439|consisting of a friend or relative of the patient|consisting of a friend or relative of the patient
391075|NCT01280682|age|age
315239|NCT01596426|CINV|cinv
315240|NCT01596413|CINV|cinv
315241|NCT01596400|CINV|cinv
315242|NCT01596387|anaesthetics iv|anaesthetics iv
315243|NCT01596387|propofol|propofol
315244|NCT01596387|pharmacokinetics|pharmacokinetics
315245|NCT01596387|pharmacodynamic|pharmacodynamic
315246|NCT01596348|Exercise|exercise
315247|NCT01596348|Barriers|barriers
315248|NCT01596348|Benefits|benefits
315249|NCT01596348|Preferences|preferences
315250|NCT01596348|Stages of change|stages of change
315251|NCT01596335|Infliximab|infliximab
315252|NCT01596335|REMICADE|remicade
315253|NCT01596335|TA-650|ta-650
315254|NCT01596335|intravenous immunoglobulin|intravenous immunoglobulin
315255|NCT01596335|Kawasaki disease|kawasaki disease
315256|NCT01596335|IVIG|ivig
315257|NCT01596322|HIV/AIDS in resource limited setting|hiv/aids in resource limited setting
315258|NCT01596322|HIV treatment outcomes in resource limited setting|hiv treatment outcomes in resource limited setting
315259|NCT01596322|Adherence to HIV treatment in resource limited setting|adherence to hiv treatment in resource limited setting
315260|NCT01596322|ART resistance in resource limited setting|art resistance in resource limited setting
315261|NCT01596309|cardiovascular risk|cardiovascular risk
315262|NCT01596309|Elderly population|elderly population
315263|NCT01596309|cocoa extract|cocoa extract
315264|NCT01596309|overweight and obesity|overweight and obesity
315265|NCT01596309|Glycemic profile|glycemic profile
315266|NCT01596309|lipid profile|lipid profile
315267|NCT01596309|antioxidant status|antioxidant status
315268|NCT01596309|inflammatory state|inflammatory state
315269|NCT01596309|Cardiovascular Risk factors in elder population|cardiovascular risk factors in elder population
315270|NCT01596296|labor induction|labor induction
315271|NCT01596296|transcervical foley catheter|transcervical foley catheter
315272|NCT01596296|dinoprostone|dinoprostone
315273|NCT01596296|parous women|parous women
315274|NCT01596283|Perioperative Fluid Management|perioperative fluid management
315275|NCT01596283|liver resection|liver resection
315276|NCT01596283|12-056|12-056
315277|NCT01596257|CliniMACS-CD34 Reagent System|clinimacs-cd34 reagent system
315278|NCT01596257|Acute Leukemia|acute leukemia
315279|NCT01596257|Myelodysplastic syndrome|myelodysplastic syndrome
315280|NCT01596257|Non Hodgkins Lymphoma|non hodgkins lymphoma
315281|NCT01596257|Hodgkins Disease|hodgkins disease
315282|NCT01596257|Multiple Myeloma|multiple myeloma
315283|NCT01596257|12-016|12-016
315284|NCT01596244|Diabetes Mellitus, Type II|diabetes mellitus, type ii
315285|NCT01596244|Disease management|disease management
315286|NCT01596244|Chronic disease|chronic disease
315287|NCT01596244|Prevention and control|prevention and control
315288|NCT01596244|Education|education
315289|NCT01596231|Alcohol consumption|alcohol consumption
315290|NCT01596231|Kudzu extract|kudzu extract
315291|NCT01596218|Steroid Refractory|steroid refractory
315292|NCT01596218|Acute|acute
315293|NCT01596205|cognitive therapy|cognitive therapy
315294|NCT01596192|allogeneic transplantation, GVHD|allogeneic transplantation, gvhd
315295|NCT01596192|Patients with acute GVHD after allogeneic hematopoietic cell transplantation|patients with acute gvhd after allogeneic hematopoietic cell transplantation
315296|NCT01596179|treatment adherence|treatment adherence
315297|NCT01596179|fatigue|fatigue
315298|NCT01596179|symptom management|symptom management
315299|NCT01596166|migraine|migraine
315300|NCT01596166|pediatric|pediatric
315301|NCT01596166|childhood|childhood
315302|NCT01596166|emergency department|emergency department
315303|NCT01596166|ketorolac|ketorolac
315304|NCT01596166|metoclopramide|metoclopramide
315305|NCT01596166|intravenous|intravenous
315306|NCT01596140|Vemurafenib|vemurafenib
315307|NCT01596140|Everolimus|everolimus
315308|NCT01596140|Afinitor|afinitor
315309|NCT01596140|RAD001|rad001
315310|NCT01596140|temsirolimus|temsirolimus
315311|NCT01596140|BRAF gene mutation|braf gene mutation
315312|NCT01596140|solid tumor|solid tumor
315313|NCT01596140|relapsed BRAF mutation positive malignant melanoma|relapsed braf mutation positive malignant melanoma
315314|NCT01596140|refractory BRAF mutation positive malignant melanoma|refractory braf mutation positive malignant melanoma
315315|NCT01596127|relapsed CD20+ lymphoid malignancies|relapsed cd20+ lymphoid malignancies
315316|NCT01596127|refractory CD20+ lymphoid malignancies|refractory cd20+ lymphoid malignancies
315317|NCT01596127|Rituximab|rituximab
315318|NCT01596127|Intrathecal Rituximab|intrathecal rituximab
315319|NCT01596127|CNS|cns
315320|NCT01596127|Leptomeningeal disease|leptomeningeal disease
315321|NCT01596127|LMD|lmd
315322|NCT01596127|central nervous system disease|central nervous system disease
315323|NCT01596127|Relapsed lymphoid malignancies|relapsed lymphoid malignancies
315324|NCT01596127|refractory lymphoid malignancies|refractory lymphoid malignancies
315325|NCT01596127|CNS leukemia|cns leukemia
315326|NCT01596127|intrathecal chemotherapy|intrathecal chemotherapy
315327|NCT01596127|cerebrospinal fluid|cerebrospinal fluid
315328|NCT01596127|CSF|csf
315329|NCT01596127|lumbar puncture|lumbar puncture
315330|NCT01596127|LP|lp
315331|NCT01596114|TKI|tki
315332|NCT01596114|CML|cml
315333|NCT01596114|Stopping|stopping
315334|NCT01596114|chronic phase|chronic phase
315335|NCT01596114|in remission|in remission
315336|NCT01596088|Extravasation|extravasation
315337|NCT01596088|Anthracyclines|anthracyclines
315338|NCT01596075|Cannabidiol|cannabidiol
315339|NCT01596075|GVHD|gvhd
315340|NCT01596075|Allogeneic transplantation|allogeneic transplantation
315341|NCT01596062|Basiliximab|basiliximab
315342|NCT01596062|renal transplantation|renal transplantation
315343|NCT01596062|CNI-free|cni-free
315344|NCT01596062|everolimus|everolimus
315345|NCT01596036|cardiac rehabilitation|cardiac rehabilitation
315346|NCT01596036|referral|referral
315347|NCT01596036|enrollment|enrollment
315348|NCT01596036|timing|timing
315349|NCT01596023|COPD|copd
315350|NCT01595997|safety tolerability and immunogenicity of two different doses of DLX105 applied intra-dermally into psoriatic lesion of mild-to-moderate psoriatic patients|safety tolerability and immunogenicity of two different doses of dlx105 applied intra-dermally into psoriatic lesion of mild-to-moderate psoriatic patients
315351|NCT01595984|kidney|kidney
315352|NCT01595984|transplantation|transplantation
315353|NCT01595984|graft|graft
315354|NCT01595984|creatinin|creatinin
315355|NCT01595971|Asthma|asthma
315356|NCT01595971|Continuing education|continuing education
315357|NCT01595971|Primary health care|primary health care
315358|NCT01595958|Cardiac arrest|cardiac arrest
315359|NCT01595958|heart arrest|heart arrest
315360|NCT01595958|cyclosporine A|cyclosporine a
315361|NCT01595958|post cardiac arrest syndrome|post cardiac arrest syndrome
315362|NCT01595958|protective agent|protective agent
315363|NCT01595958|multiple organ failure|multiple organ failure
315364|NCT01595958|mitochondrial permeability transition pore|mitochondrial permeability transition pore
315365|NCT01595958|mitochondria|mitochondria
315366|NCT01595958|cardio-pulmonary resuscitation|cardio-pulmonary resuscitation
315367|NCT01595958|cardioprotection|cardioprotection
315368|NCT01595958|ischemia reperfusion|ischemia reperfusion
315369|NCT01595958|postconditioning|postconditioning
315370|NCT01595945|Caloric restriction|caloric restriction
315371|NCT01595945|Obesity|obesity
315373|NCT01595945|Resting metabolic rate|resting metabolic rate
315374|NCT01595932|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
315375|NCT01595932|bloating|bloating
315376|NCT01595932|abdominal distension|abdominal distension
315377|NCT01595932|flatulence|flatulence
315378|NCT01595932|α-Galactosidase|α-galactosidase
315379|NCT01595906|Helmet|helmet
315380|NCT01595906|Heat Tolerance Test|heat tolerance test
315381|NCT01595906|ventilation System|ventilation system
315382|NCT01595893|Polymorphic light eruption|polymorphic light eruption
315383|NCT01595893|Vitamin D3|vitamin d3
315384|NCT01595893|Photo provocation|photo provocation
315385|NCT01595893|Immune function|immune function
315386|NCT01595867|abuse liability|abuse liability
315387|NCT01595867|abuse potential|abuse potential
315388|NCT01595867|morphine|morphine
315389|NCT01595867|intranasal administration|intranasal administration
315390|NCT01595867|snorting|snorting
315391|NCT01595867|opioid abuse|opioid abuse
315392|NCT01595867|pharmacodynamic|pharmacodynamic
315393|NCT01595867|recreational drug use|recreational drug use
315394|NCT01595841|hemodialysis|hemodialysis
315395|NCT01595841|stenosis|stenosis
315396|NCT01595841|angioplasty|angioplasty
315397|NCT01595841|sirolimus|sirolimus
315398|NCT01595815|Fertilization failure, calcium ionophore, SrCl2|fertilization failure, calcium ionophore, srcl2
315399|NCT01595802|Cerebral vasospasm|cerebral vasospasm
315400|NCT01595789|Coronary Artery Disease|coronary artery disease
315401|NCT01595789|Diabetes Mellitus|diabetes mellitus
315402|NCT01595789|Left ventricular ejection fraction|left ventricular ejection fraction
315403|NCT01595789|Beta-cell function|beta-cell function
315404|NCT01595776|CLI, PAD, Buerger disease|cli, pad, buerger disease
315405|NCT01595763|Deep vein thrombosis|deep vein thrombosis
315406|NCT01595763|Primary care|primary care
315407|NCT01595763|Diagnosis|diagnosis
315408|NCT01595763|Clinical model|clinical model
315409|NCT01595750|Post-bronchodilator FEV1<70% reference|post-bronchodilator fev1<70% reference
315410|NCT01595750|Chronic bronchitis|chronic bronchitis
315411|NCT01595750|Presence of estavlished CVD,|presence of estavlished cvd,
315412|NCT01595750|CVD equivalent or diabetes mellitus|cvd equivalent or diabetes mellitus
315413|NCT01595724|Non-interventional study|non-interventional study
315414|NCT01595724|Endometriosis,|endometriosis,
315415|NCT01595724|Quality of life|quality of life
315416|NCT01595698|Physical exercise|physical exercise
315418|NCT01595698|Schizophrenia|schizophrenia
315419|NCT01595698|neuroplasticity|neuroplasticity
315420|NCT01595685|HBeAg-positive|hbeag-positive
315421|NCT01595672|severe acute pancreatitis|severe acute pancreatitis
315422|NCT01595672|organ failure|organ failure
315423|NCT01595672|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
315424|NCT01595672|systemic complications|systemic complications
315425|NCT01595672|continuous veno-venous hemofiltration|continuous veno-venous hemofiltration
315426|NCT01595672|blood purification|blood purification
306184|NCT01635764|HS|hs
315427|NCT01595672|continuous renal replacement therapy|continuous renal replacement therapy
315428|NCT01595659|Risk|risk
315429|NCT01595659|Young drivers|young drivers
315430|NCT01595659|Alcohol|alcohol
315431|NCT01595659|Passengers|passengers
315432|NCT01595659|Gender|gender
315433|NCT01595646|Memory|memory
315434|NCT01595646|Intranasal insulin|intranasal insulin
315435|NCT01595646|Alzheimer's disease|alzheimer's disease
315436|NCT01595646|Mild Cognitive Impairment|mild cognitive impairment
315437|NCT01595633|nucleoside analogue|nucleoside analogue
315438|NCT01595633|adefovir|adefovir
315439|NCT01595633|tenofovir|tenofovir
315440|NCT01595633|hepatitis B|hepatitis b
315441|NCT01595620|Cannabis|cannabis
315442|NCT01595620|THC|thc
315443|NCT01595620|Pain|pain
315444|NCT01595594|Periodontal Diseases|periodontal diseases
315445|NCT01595594|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
315446|NCT01595594|hemoglobin A1c protein|hemoglobin a1c protein
315447|NCT01595581|Testosterone|testosterone
315448|NCT01595581|ACL Reconstruction|acl reconstruction
315449|NCT01595581|Clinical outcomes|clinical outcomes
315450|NCT01595581|Lean mass|lean mass
315451|NCT01595581|Strength|strength
315452|NCT01595581|Muscle atrophy|muscle atrophy
315453|NCT01595568|Adolescents|adolescents
315454|NCT01595568|Dual Diagnosis|dual diagnosis
315455|NCT01595568|Mental Disorders|mental disorders
315456|NCT01595568|Substance Use Problems|substance use problems
315457|NCT01595568|Prevention|prevention
315458|NCT01595555|stress|stress
315459|NCT01595555|relaxation|relaxation
315460|NCT01595555|mindfulness|mindfulness
315461|NCT01595555|web-based|web-based
315462|NCT01595555|online|online
315463|NCT01595555|social media|social media
315464|NCT01595555|discussion board|discussion board
315465|NCT01595529|Urinary tract infection|urinary tract infection
315466|NCT01595529|Antibiotic resistance|antibiotic resistance
315467|NCT01595529|Short course antibiotics|short course antibiotics
315468|NCT01595529|Pediatrics|pediatrics
315469|NCT01595529|Controlled clinical trial|controlled clinical trial
315470|NCT01595529|Anti Infective Agents|anti infective agents
315471|NCT01595529|Trimethoprim Sulfamethoxazole Combination|trimethoprim sulfamethoxazole combination
315472|NCT01595529|Cefixime|cefixime
315473|NCT01595529|Cephalexin|cephalexin
315474|NCT01595529|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
315475|NCT01595529|Trimethoprim|trimethoprim
315476|NCT01595529|Sulfamethoxazole|sulfamethoxazole
315477|NCT01595503|Schizophrenia, auditory hallucination|schizophrenia, auditory hallucination
315478|NCT01595451|Acupuncture|acupuncture
315479|NCT01595451|Back Pain|back pain
315480|NCT01595451|Lower Back Pain|lower back pain
315481|NCT01595451|Brigham and Women's Hospital|brigham and women's hospital
315482|NCT01595451|Massachusetts General Hospital|massachusetts general hospital
315483|NCT01595451|Effects of Acupuncture|effects of acupuncture
315484|NCT01595438|Ceftazidime, Avibactam, Doripenem, Ciprofloxacin, sulfamethoxazole/trimethoprim, Anti-Infective Agents, Complicated Urinary Tract Infection,Acute Pyelonephritis|ceftazidime, avibactam, doripenem, ciprofloxacin, sulfamethoxazole/trimethoprim, anti-infective agents, complicated urinary tract infection,acute pyelonephritis
315485|NCT01595425|Bioequivalence,|bioequivalence,
315486|NCT01595425|pharmacokinetics,|pharmacokinetics,
315487|NCT01595425|safety,|safety,
315488|NCT01595425|esomeprazole,|esomeprazole,
315489|NCT01595425|Japanese,|japanese,
315490|NCT01595425|healthy subject,|healthy subject,
315491|NCT01595425|homo-EM|homo-em
315492|NCT01595412|Laparoscopic surgery|laparoscopic surgery
315493|NCT01595412|Colorectal Surgery|colorectal surgery
315494|NCT01595412|Quality of Life|quality of life
315495|NCT01595412|Rectal Prolapse|rectal prolapse
315496|NCT01595412|Anorectal Physiology|anorectal physiology
315497|NCT01595399|bradycardia|bradycardia
315498|NCT01595399|hypoxemia|hypoxemia
315499|NCT01595399|intubation|intubation
315500|NCT01595399|premedication|premedication
315502|NCT01595373|Microdialysis|microdialysis
315503|NCT01595373|Controls|controls
315504|NCT01595373|Metabolic effects of ghrelin|metabolic effects of ghrelin
315505|NCT01595360|TT-173|tt-173
315506|NCT01595360|Topical Hemostatics|topical hemostatics
315507|NCT01595360|Hemostasis|hemostasis
315508|NCT01595347|Pressure Ulcer|pressure ulcer
315509|NCT01595347|Primary Prevention|primary prevention
315510|NCT01595347|Fatty Acids|fatty acids
315511|NCT01595347|Vegetable Fats|vegetable fats
315512|NCT01595347|Olive oil|olive oil
315513|NCT01595347|"Pressure Ulcer[prevention and control][Mesh]"|"pressure ulcer[prevention and control][mesh]"
315514|NCT01595334|IVF-ET|ivf-et
315515|NCT01595334|ICSI|icsi
315516|NCT01595334|Gonadotrophins|gonadotrophins
315517|NCT01595334|rFSH|rfsh
315518|NCT01595334|rLH|rlh
315519|NCT01595334|Cetrorelix|cetrorelix
315520|NCT01595334|Leuprolide acetate|leuprolide acetate
315521|NCT01595321|Adjuvant therapy|adjuvant therapy
315522|NCT01595321|Immunotherapy|immunotherapy
315523|NCT01595321|Cytoxan|cytoxan
315524|NCT01595321|Cyclophosphamide|cyclophosphamide
315525|NCT01595321|Pancreatic Vaccine|pancreatic vaccine
315526|NCT01595321|Stereotactic radiation therapy|stereotactic radiation therapy
315527|NCT01595321|SBRT|sbrt
315528|NCT01595321|FOLFIRINOX|folfirinox
315529|NCT01595308|Male infertility|male infertility
315530|NCT01595295|CMML|cmml
315531|NCT01595295|MDS|mds
315532|NCT01595295|AML|aml
315533|NCT01595295|registry|registry
315534|NCT01595295|Vidaza|vidaza
315535|NCT01595282|pain|pain
315536|NCT01595282|suction curettage|suction curettage
315537|NCT01595269|Diabetes|diabetes
315538|NCT01595269|eHealth|ehealth
315539|NCT01595269|Type 2 Diabetes|type 2 diabetes
315540|NCT01595269|Education|education
315541|NCT01595269|Calgary Health Region|calgary health region
315542|NCT01595256|colorectal cancer,fatigue,6-minute walking test|colorectal cancer,fatigue,6-minute walking test
315543|NCT01595243|hepatocellular carcinoma|hepatocellular carcinoma
315544|NCT01595243|Needs|needs
315545|NCT01595243|Telephone consultation|telephone consultation
315546|NCT01595230|Internal Hernias|internal hernias
315547|NCT01595230|Clips|clips
315548|NCT01595230|Gastric Bypass|gastric bypass
315549|NCT01595230|Avoid|avoid
315550|NCT01595217|Biliary Tract Neoplasm|biliary tract neoplasm
315551|NCT01595217|Cholangiocarcinoma|cholangiocarcinoma
315552|NCT01595217|Diffusion magnetic resonance imaging|diffusion magnetic resonance imaging
315553|NCT01595217|Magnetic resonance imaging|magnetic resonance imaging
315554|NCT01595217|Magnetic resonance Cholangiopancreatography|magnetic resonance cholangiopancreatography
315555|NCT01595204|Cancer of Ovary, laparoscopy, operability , score.|cancer of ovary, laparoscopy, operability , score.
315556|NCT01595178|smoking|smoking
315557|NCT01595178|drinking|drinking
315558|NCT01595178|SBIRT|sbirt
315559|NCT01595178|BNI|bni
315560|NCT01595178|counseling intervention|counseling intervention
315561|NCT01595178|emergency department|emergency department
315563|NCT01595165|laparoscopic cholecystectomy|laparoscopic cholecystectomy
315564|NCT01595165|ultrasound|ultrasound
315565|NCT01595165|transversus abdominis plane block|transversus abdominis plane block
315566|NCT01595152|Urgency, urgency incontinence,USIQ|urgency, urgency incontinence,usiq
315567|NCT01595100|Waist circumference|waist circumference
315568|NCT01595100|Visceral adipose tissue|visceral adipose tissue
315569|NCT01595100|Intra-abdominal fat|intra-abdominal fat
315570|NCT01595100|Pediatrics|pediatrics
315571|NCT01595087|CRPC|crpc
315572|NCT01595035|Day surgery|day surgery
315573|NCT01595035|Orthopedic surgery|orthopedic surgery
315867|NCT01593930|Lidocaine|lidocaine
315574|NCT01595035|Breast reconstruction surgery|breast reconstruction surgery
315575|NCT01594996|Seroquel XR|seroquel xr
315576|NCT01594996|Quetiapine XR|quetiapine xr
315577|NCT01594996|Drug utilization|drug utilization
315578|NCT01594996|Major depressive disorder (MDD)|major depressive disorder (mdd)
315579|NCT01594983|hypertriglyceridemia|hypertriglyceridemia
315580|NCT01594983|Non familial Chylocmicronemia Syndrome (non-FCS)|non familial chylocmicronemia syndrome (non-fcs)
315581|NCT01594957|LCQ908,|lcq908,
315582|NCT01594957|Hepatic Impairment,|hepatic impairment,
315583|NCT01594957|Pharmacokinetics|pharmacokinetics
315584|NCT01594931|malaria|malaria
315585|NCT01594931|antimalarial|antimalarial
315586|NCT01594931|artemisinin based combination therapy|artemisinin based combination therapy
315587|NCT01594918|metastatic|metastatic
315588|NCT01594918|CRPC|crpc
315589|NCT01594918|prostate|prostate
315590|NCT01594918|CAMP|camp
315591|NCT01594905|To explore|to explore
315592|NCT01594905|adequate management|adequate management
315593|NCT01594905|CHB|chb
315594|NCT01594905|Multidrug resistance|multidrug resistance
315595|NCT01594892|Spinal metastases|spinal metastases
315596|NCT01594892|Vertebral metastases|vertebral metastases
315597|NCT01594892|Radiosurgery|radiosurgery
315598|NCT01594892|Radiotherapy|radiotherapy
315599|NCT01594892|Stereotactic body radiotherapy|stereotactic body radiotherapy
315600|NCT01594892|Pain|pain
315601|NCT01594879|Endometrial cancer|endometrial cancer
315602|NCT01594879|LNG-IUS|lng-ius
315603|NCT01594879|oral MPA|oral mpa
315604|NCT01594866|Major depressive disorder, remission, escitalopram|major depressive disorder, remission, escitalopram
315605|NCT01594853|exercise|exercise
315606|NCT01594853|women|women
315607|NCT01594853|training|training
315608|NCT01594853|rehabilitation|rehabilitation
315609|NCT01594853|leukodystrophy|leukodystrophy
315610|NCT01594840|language development|language development
315611|NCT01594840|parental interaction|parental interaction
315612|NCT01594827|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
315613|NCT01594827|Vancomycin|vancomycin
315614|NCT01594814|AVNRT|avnrt
315615|NCT01594814|AVRT|avrt
315616|NCT01594814|WPW|wpw
315617|NCT01594801|DM|dm
315618|NCT01594801|insulin|insulin
315619|NCT01594801|injections|injections
315620|NCT01594762|Diabetic Foot Ulcer Infection|diabetic foot ulcer infection
315621|NCT01594749|NK-1 Receptor Antagonist, CINV, Emesis, MEC|nk-1 receptor antagonist, cinv, emesis, mec
315622|NCT01594684|restenosis|restenosis
315623|NCT01594684|stent|stent
315624|NCT01594684|drug eltuing balloon|drug eltuing balloon
315625|NCT01594684|peripheral arterial disease|peripheral arterial disease
315626|NCT01594671|primary knee arthroplasty|primary knee arthroplasty
315627|NCT01594671|tranexamic acid|tranexamic acid
315628|NCT01594671|topical|topical
315629|NCT01594658|Ultrasound-guided foam sclerotherapy; chronic venous ulcers|ultrasound-guided foam sclerotherapy; chronic venous ulcers
315630|NCT01594632|AE adverse event|ae adverse event
315631|NCT01594632|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
315632|NCT01594632|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
315633|NCT01594632|ART antiretroviral therapy|art antiretroviral therapy
315634|NCT01594632|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
315635|NCT01594632|DCF data collection forms|dcf data collection forms
315636|NCT01594632|DMC Data Monitoring Committee|dmc data monitoring committee
315637|NCT01594632|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
315638|NCT01594632|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
315639|NCT01594632|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
315640|NCT01594632|ICH International Conference of Harmonization|ich international conference of harmonization
315641|NCT01594632|IND Investigational New Drug Application|ind investigational new drug application
315642|NCT01594632|IRB Institutional Review Board|irb institutional review board
315643|NCT01594632|IU International units|iu international units
315644|NCT01594632|mg milligram(s)|mg milligram(s)
315645|NCT01594632|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
315646|NCT01594632|PCR polymerase chain reaction|pcr polymerase chain reaction
315647|NCT01594632|SAE serious adverse event|sae serious adverse event
315648|NCT01594632|µg microgram|µg microgram
315649|NCT01594632|ULN upper limit of the normal range|uln upper limit of the normal range
315650|NCT01594632|WB Western Blot|wb western blot
315651|NCT01594619|Phase 1|phase 1
315652|NCT01594619|Healthy male and female volunteers|healthy male and female volunteers
315653|NCT01594619|Drug-drug interaction|drug-drug interaction
315654|NCT01594619|Pharmacokinetics|pharmacokinetics
315655|NCT01594619|Naloxegol|naloxegol
315656|NCT01594606|Animal-assisted intervention|animal-assisted intervention
315657|NCT01594606|adjudicated adolescents|adjudicated adolescents
315658|NCT01594606|empathy|empathy
315659|NCT01594593|prostate cancer|prostate cancer
315660|NCT01594593|behavioral|behavioral
315661|NCT01594593|acceptance and commitment therapy|acceptance and commitment therapy
315662|NCT01594593|distress|distress
315663|NCT01594567|Systematic review and meta-analysis|systematic review and meta-analysis
315664|NCT01594567|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
316064|NCT01593059|NSTEMI|nstemi
315665|NCT01594567|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
315666|NCT01594567|Clinical practice guidelines|clinical practice guidelines
315667|NCT01594567|Clinical trials|clinical trials
315668|NCT01594567|Dietary pulses|dietary pulses
315669|NCT01594567|legumes|legumes
315670|NCT01594567|Beans, peas, chickpeas, lentils|beans, peas, chickpeas, lentils
315671|NCT01594567|Cardiometabolic risk factors|cardiometabolic risk factors
315672|NCT01594567|Triglycerides|triglycerides
315673|NCT01594567|Cholesterol|cholesterol
315674|NCT01594567|Glycemic control|glycemic control
315675|NCT01594567|Insulin resistance|insulin resistance
315676|NCT01594567|Body weight|body weight
315677|NCT01594567|Uric acid|uric acid
315678|NCT01594567|Blood pressure|blood pressure
315679|NCT01594554|HCV viral genotypes|hcv viral genotypes
315680|NCT01594554|host genotypes|host genotypes
315681|NCT01594554|IL28B|il28b
315682|NCT01594554|Outcome|outcome
315683|NCT01594554|Follow-Up|follow-up
315684|NCT01594554|ITPA|itpa
315686|NCT01594554|China|china
315687|NCT01594541|hyperhomocysteinemia|hyperhomocysteinemia
315688|NCT01594541|dementia|dementia
315689|NCT01594541|depression|depression
315690|NCT01594541|vitamin B12|vitamin b12
315691|NCT01594541|mild cognitive impairment|mild cognitive impairment
315692|NCT01594541|alzheimer's|alzheimer's
315693|NCT01594528|schizophrenia|schizophrenia
315694|NCT01594528|major depression|major depression
315695|NCT01594528|pain|pain
315696|NCT01594528|behavior|behavior
315697|NCT01594502|prostate cancer|prostate cancer
315698|NCT01594502|dutasteride|dutasteride
315699|NCT01594476|Postpartum|postpartum
315700|NCT01594476|Contraception|contraception
315701|NCT01594476|Intrauterine device|intrauterine device
315702|NCT01594476|Intrauterine system|intrauterine system
315703|NCT01594476|Mirena|mirena
315704|NCT01594476|Paragard|paragard
315705|NCT01594476|Uterine involution|uterine involution
315706|NCT01594463|Intrauterine growth restriction|intrauterine growth restriction
315707|NCT01594463|Screening|screening
315708|NCT01594463|Ultrasound|ultrasound
315709|NCT01594463|Perinatal morbidity|perinatal morbidity
315710|NCT01594463|Maternal complications|maternal complications
315711|NCT01594450|incisional ventral hernia|incisional ventral hernia
315712|NCT01594450|infected field|infected field
315713|NCT01594450|biological mesh|biological mesh
315714|NCT01594437|Cytomegalovirus|cytomegalovirus
391705|NCT01277952|DBS|dbs
315715|NCT01594437|Monoclonal antibody|monoclonal antibody
315716|NCT01594424|Donor-Specific Anti-HLA Antibodies|donor-specific anti-hla antibodies
315717|NCT01594424|Kidney Transplantation|kidney transplantation
315718|NCT01594411|Coronary Artery Disease|coronary artery disease
315719|NCT01594411|Chest Pain|chest pain
315720|NCT01594411|Diagnosis of cardiovascular disease|diagnosis of cardiovascular disease
315721|NCT01594398|carcinoma,non small cell lung|carcinoma,non small cell lung
315722|NCT01594398|lung diseases|lung diseases
315723|NCT01594398|lung neoplasms|lung neoplasms
315724|NCT01594398|Respiratory|respiratory
315725|NCT01594398|Carcinoma, Bronchogenic|carcinoma, bronchogenic
315726|NCT01594398|Bronchial Neoplasms|bronchial neoplasms
315727|NCT01594398|Respiratory Tract Neoplasms|respiratory tract neoplasms
315728|NCT01594398|Thoracic Neoplasms|thoracic neoplasms
315729|NCT01594398|Neoplasms by Site|neoplasms by site
315730|NCT01594398|Respiratory Tract Diseases|respiratory tract diseases
315731|NCT01594398|Erlotinib|erlotinib
315732|NCT01594398|Protein Kinase Inhibitors|protein kinase inhibitors
315733|NCT01594398|Breast Neoplasms|breast neoplasms
315734|NCT01594398|Neoplasms|neoplasms
315735|NCT01594398|Breast Diseases|breast diseases
315736|NCT01594398|Exemestane|exemestane
315737|NCT01594398|Aromatase Inhibitors|aromatase inhibitors
315738|NCT01594385|Open Abdomen|open abdomen
315739|NCT01594385|Damage Control|damage control
315740|NCT01594385|Trauma|trauma
315741|NCT01594385|Wound healing|wound healing
315742|NCT01594385|Gun shot wounds|gun shot wounds
315743|NCT01594385|Stab wounds|stab wounds
315744|NCT01594385|Automobile accidents|automobile accidents
315745|NCT01594385|Wounds and Injury|wounds and injury
315746|NCT01594372|Uterine Prolapse|uterine prolapse
315747|NCT01594372|Laparoscopy|laparoscopy
315748|NCT01594372|Hysterectomy, vaginal|hysterectomy, vaginal
315749|NCT01594359|Ferritin|ferritin
315750|NCT01594346|Vitamin E|vitamin e
315751|NCT01594346|alpha-tocopherol|alpha-tocopherol
315752|NCT01594346|cognitive decline|cognitive decline
315753|NCT01594346|Down syndrome|down syndrome
315754|NCT01594346|Aging|aging
315755|NCT01594346|Dementia|dementia
315756|NCT01594333|Myocardial Infarction|myocardial infarction
315757|NCT01594333|Stroke|stroke
315758|NCT01594333|Cardiovascular death|cardiovascular death
315759|NCT01594333|Type 2 Diabetes|type 2 diabetes
315760|NCT01594333|Metabolic Syndrome|metabolic syndrome
315761|NCT01594333|Cardiovascular Inflammation|cardiovascular inflammation
315762|NCT01594333|Atherothrombosis|atherothrombosis
315764|NCT01594294|CLEAR CARE®|clear care®
315765|NCT01594294|AOSEPT® Plus|aosept® plus
315766|NCT01594294|ReNu MultiPlus®|renu multiplus®
316065|NCT01593059|Ischemia|ischemia
315767|NCT01594294|silicone hydrogel|silicone hydrogel
315768|NCT01594294|hydrogel|hydrogel
315769|NCT01594294|ACUVUE® 2®|acuvue® 2®
315770|NCT01594294|AIR OPTIX® AQUA|air optix® aqua
315771|NCT01594294|eyelid response|eyelid response
315772|NCT01594294|wettability|wettability
315773|NCT01594294|contamination|contamination
315774|NCT01594294|contact lenses|contact lenses
315775|NCT01594281|Panretinal photocoagulation|panretinal photocoagulation
315776|NCT01594281|Ranibizumab|ranibizumab
315777|NCT01594268|kidney transplant|kidney transplant
315778|NCT01594268|Certican|certican
315779|NCT01594255|Healthy volunteer|healthy volunteer
315780|NCT01594255|QT intervals|qt intervals
315782|NCT01594255|QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs|qt/qtc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs
315783|NCT01594242|multiple myeloma|multiple myeloma
315784|NCT01594242|bortezomib|bortezomib
315803|NCT01594177|GBG Forschungs GmbH|gbg forschungs gmbh
315805|NCT01594177|neo-adjuvant|neo-adjuvant
315806|NCT01594177|HER-2 positive breast cancer|her-2 positive breast cancer
315807|NCT01594177|BIBW 2992|bibw 2992
315808|NCT01594177|1200.159|1200.159
315809|NCT01594164|High Resolution Computed Tomography|high resolution computed tomography
315810|NCT01594164|Cone Beam Computed Tomography|cone beam computed tomography
315811|NCT01594164|upper airway|upper airway
315812|NCT01594164|geometry|geometry
315813|NCT01594151|asthma|asthma
315814|NCT01594151|controlled|controlled
315815|NCT01594151|Cone Beam Computed Tomography|cone beam computed tomography
315816|NCT01594151|upper airway|upper airway
315817|NCT01594151|paediatric|paediatric
315818|NCT01594112|Remote monitoring|remote monitoring
315819|NCT01594112|Home monitoring|home monitoring
315820|NCT01594112|Defibrillators, Implantable cardioverter-defibrillator|defibrillators, implantable cardioverter-defibrillator
315821|NCT01594112|Shock|shock
315822|NCT01594112|Inappropriate diagnoses and Therapies|inappropriate diagnoses and therapies
315823|NCT01594112|Corrective actions|corrective actions
315824|NCT01594112|ID recurrences|id recurrences
315825|NCT01594112|Medical reaction time|medical reaction time
315826|NCT01594099|cervical cancer|cervical cancer
315827|NCT01594099|elderly women|elderly women
315828|NCT01594099|concurrent chemotherapy|concurrent chemotherapy
315829|NCT01594086|green tea|green tea
315830|NCT01594086|aging|aging
315831|NCT01594086|atherosclerosis|atherosclerosis
315832|NCT01594086|homocysteine|homocysteine
315833|NCT01594086|cognitive impairment|cognitive impairment
315834|NCT01594073|implantable defibrillator|implantable defibrillator
315835|NCT01594073|ventricular arrhythmias|ventricular arrhythmias
315836|NCT01594073|cardiac death|cardiac death
315837|NCT01594047|hyperalgesia|hyperalgesia
315838|NCT01594047|Patient controlled analgesia|patient controlled analgesia
315839|NCT01594047|morphine|morphine
315840|NCT01594047|methadone|methadone
315841|NCT01594047|ketamine|ketamine
315842|NCT01594021|propofol|propofol
315843|NCT01594021|anesthesia, induction|anesthesia, induction
315844|NCT01594021|hypotension|hypotension
315845|NCT01594021|cardiac output|cardiac output
315846|NCT01594008|Toll like receptors|toll like receptors
315847|NCT01594008|Inflammation|inflammation
315848|NCT01594008|Anthocyanins|anthocyanins
315849|NCT01594008|Blueberries|blueberries
315850|NCT01593995|Erlotinib|erlotinib
315851|NCT01593995|Skin side effect|skin side effect
315852|NCT01593995|EGF ointment|egf ointment
315853|NCT01593982|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
315854|NCT01593982|Cocaine Dependence|cocaine dependence
315855|NCT01593982|Cocaine Addicts|cocaine addicts
315856|NCT01593982|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
315857|NCT01593982|Cognitive Function|cognitive function
315858|NCT01593969|Essential Fatty Acid|essential fatty acid
315859|NCT01593969|Seed oil|seed oil
315860|NCT01593969|Fish oil|fish oil
315861|NCT01593969|Dietary deficiency|dietary deficiency
315862|NCT01593943|contraception|contraception
315863|NCT01593943|india|india
315864|NCT01593943|rural|rural
315865|NCT01593930|Pulp Anesthesia|pulp anesthesia
315866|NCT01593930|Articaine|articaine
315868|NCT01593917|Aortic valve|aortic valve
315869|NCT01593917|Heart valve|heart valve
315870|NCT01593917|Tissue valve|tissue valve
315871|NCT01593917|Bioprosthesis|bioprosthesis
315872|NCT01593904|CCSVI, Flow, Perfusion in MS|ccsvi, flow, perfusion in ms
315873|NCT01593891|IVUS, CCSVI|ivus, ccsvi
316174|NCT01592760|i-gel|i-gel
315874|NCT01593865|Coronary Artery Bypass Grafting|coronary artery bypass grafting
315875|NCT01593865|Mammary Artery Grafts|mammary artery grafts
315876|NCT01593865|Bilateral Mammary Artery Grafting|bilateral mammary artery grafting
315877|NCT01593865|Clinical Outcomes|clinical outcomes
315878|NCT01593852|X-rays|x-rays
315879|NCT01593852|Cardiac Electrophysiology|cardiac electrophysiology
315880|NCT01593852|Image Processing, Computer-Assisted|image processing, computer-assisted
315881|NCT01593852|Catheter Ablation|catheter ablation
315882|NCT01593813|Pronator quadratus|pronator quadratus
315883|NCT01593813|distal radius fracture|distal radius fracture
315884|NCT01593813|volar plating|volar plating
315885|NCT01593800|Probiotics|probiotics
315886|NCT01593800|Lactose|lactose
315887|NCT01593787|Hypertension|hypertension
315888|NCT01593787|Renal dysfunction|renal dysfunction
315889|NCT01593787|LCZ696|lcz696
315890|NCT01593774|Melatonin|melatonin
315891|NCT01593774|Olanzapine|olanzapine
315892|NCT01593774|Metabolic side effects|metabolic side effects
315893|NCT01593774|Psychosis|psychosis
315894|NCT01593774|Hyperlipidemia|hyperlipidemia
315895|NCT01593774|Hyperglycemia|hyperglycemia
315896|NCT01593774|Weight gain|weight gain
315897|NCT01593774|Diabetes|diabetes
315898|NCT01593761|cABSSSI|cabsssi
315899|NCT01593761|MRSA|mrsa
315900|NCT01593748|Sarcoma|sarcoma
315901|NCT01593748|Soft Tissue Sarcoma|soft tissue sarcoma
315902|NCT01593722|Loa loa|loa loa
315903|NCT01593722|Immune Response|immune response
315904|NCT01593722|Therapy|therapy
315905|NCT01593709|Healthy Volunteers|healthy volunteers
315906|NCT01593696|CD 19 Expressing B Cells|cd 19 expressing b cells
315907|NCT01593696|B Cell Lymphoma|b cell lymphoma
315908|NCT01593696|ALL|all
315909|NCT01593696|Anti-CD19 Chimeric Antigen Receptor|anti-cd19 chimeric antigen receptor
315910|NCT01593696|Adoptive Immunotherapy|adoptive immunotherapy
315911|NCT01593683|Oncology service|oncology service
315912|NCT01593683|Nursing staff|nursing staff
315913|NCT01593683|Psychosocial intervention|psychosocial intervention
315914|NCT01593683|Coping skills|coping skills
315915|NCT01593670|high risk myelodysplastic syndrome|high risk myelodysplastic syndrome
315916|NCT01593670|natural killer cells|natural killer cells
315917|NCT01593644|Dipyridamole/adenosine combination given intravenously|dipyridamole/adenosine combination given intravenously
315918|NCT01593644|slow bolus and low doses|slow bolus and low doses
315919|NCT01593644|coronary flow reserve assessment|coronary flow reserve assessment
315920|NCT01593644|transthoracic echodoppler|transthoracic echodoppler
315921|NCT01593644|Patients|patients
315922|NCT01593644|stable|stable
315923|NCT01593631|lactose malabsorption|lactose malabsorption
315924|NCT01593631|lactose intolerance|lactose intolerance
315925|NCT01593631|lactose digestion|lactose digestion
315926|NCT01593631|lactose maldigestion|lactose maldigestion
315927|NCT01593631|acid lactase|acid lactase
315928|NCT01593631|yoghurt bacteria|yoghurt bacteria
391928|NCT01277068|TRL|trl
315929|NCT01593618|cancer survivor|cancer survivor
315930|NCT01593605|Impaired glucose tolerance, pre-diabetes,glycemic control,|impaired glucose tolerance, pre-diabetes,glycemic control,
315931|NCT01593605|supplements|supplements
315932|NCT01593592|Helicobacter pylori|helicobacter pylori
315933|NCT01593592|Lactobacillus reuteri|lactobacillus reuteri
315934|NCT01593592|dyspeptic patients|dyspeptic patients
315935|NCT01593592|eradication|eradication
315936|NCT01593579|melanoma|melanoma
315937|NCT01593579|autonomic failure|autonomic failure
315938|NCT01593579|hypotension|hypotension
315939|NCT01593579|akt therapy|akt therapy
315940|NCT01593566|femoral nerve block|femoral nerve block
315941|NCT01593553|Screening|screening
315942|NCT01593553|Stroke prevention|stroke prevention
315943|NCT01593553|Cost effectiveness|cost effectiveness
315944|NCT01593527|Frequent flares|frequent flares
315945|NCT01593527|Frequent attacks|frequent attacks
315946|NCT01593527|gout|gout
315947|NCT01593527|gouty arthritis|gouty arthritis
315948|NCT01593527|Chronic kidney disease|chronic kidney disease
315949|NCT01593527|renal impairment|renal impairment
315950|NCT01593527|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
315951|NCT01593527|anti-inflammatory therapy|anti-inflammatory therapy
315952|NCT01593514|Vaccines|vaccines
315953|NCT01593514|Meningitis|meningitis
315954|NCT01593514|Meningococcal|meningococcal
315955|NCT01593501|vitamin D|vitamin d
315956|NCT01593501|cholecalciferol|cholecalciferol
315957|NCT01593501|bone mineral density|bone mineral density
315958|NCT01593501|Magnesium deficiency|magnesium deficiency
315959|NCT01593501|Calcium metabolism disorders|calcium metabolism disorders
315960|NCT01593488|recurrent|recurrent
315961|NCT01593488|CNS disease|cns disease
315962|NCT01593488|intrathecal therapy|intrathecal therapy
315963|NCT01593436|insomnia,menopause, polysomnography, mindfulness|insomnia,menopause, polysomnography, mindfulness
315964|NCT01593410|Efficacy/Safety|efficacy/safety
316066|NCT01593059|Angina|angina
315965|NCT01593410|Lenalidomide and Low-Dose Dexamethasone|lenalidomide and low-dose dexamethasone
315966|NCT01593410|Chinese Subjects|chinese subjects
315967|NCT01593410|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
315968|NCT01593397|Obesity|obesity
315969|NCT01593397|Insulin Resistance|insulin resistance
315970|NCT01593384|Breast Cancer|breast cancer
315971|NCT01593384|Digital Breast Tomosynthesis (DBT)|digital breast tomosynthesis (dbt)
315972|NCT01593384|Digital Mammography (DM)|digital mammography (dm)
315973|NCT01593371|Adipokines|adipokines
315974|NCT01593371|leptin|leptin
315975|NCT01593371|chemerin|chemerin
315976|NCT01593371|omentin|omentin
315977|NCT01593371|metformin|metformin
315978|NCT01593371|type 2 diabetes mellitus|type 2 diabetes mellitus
315979|NCT01593358|CCSVI|ccsvi
315980|NCT01593345|Elderly|elderly
315981|NCT01593345|mobility limitations|mobility limitations
315982|NCT01593345|self-management|self-management
315983|NCT01593345|exercise|exercise
315984|NCT01593332|Rituximab|rituximab
315985|NCT01593332|Rheumatoid arthritis|rheumatoid arthritis
315986|NCT01593332|Biologics|biologics
315987|NCT01593332|Anti-tumour necrosis factor|anti-tumour necrosis factor
315988|NCT01593332|Disease-modifying anti-rheumatic drugs|disease-modifying anti-rheumatic drugs
315989|NCT01593332|DAS28|das28
315990|NCT01593332|European League Against Rheumatism response|european league against rheumatism response
315991|NCT01593293|Elderly patients|elderly patients
315992|NCT01593293|Non-squamous Non-small Cell Lung Cancer|non-squamous non-small cell lung cancer
315993|NCT01593293|Pemetrexed|pemetrexed
315994|NCT01593293|Carboplatin|carboplatin
315995|NCT01593280|anesthesia|anesthesia
315996|NCT01593280|regional anesthetic techniques: transversus abdominis plane block,|regional anesthetic techniques: transversus abdominis plane block,
315997|NCT01593280|pain, postoperative|pain, postoperative
315998|NCT01593280|surgery, cesarean section|surgery, cesarean section
315999|NCT01593280|quality of recovery|quality of recovery
316000|NCT01593267|intracranial aneurysm|intracranial aneurysm
316001|NCT01593267|subarachnoid hemorrhage|subarachnoid hemorrhage
316002|NCT01593267|randomized trial|randomized trial
316003|NCT01593267|coil embolization|coil embolization
316004|NCT01593267|clip occlusion|clip occlusion
316005|NCT01593267|vascular disorders|vascular disorders
316006|NCT01593241|Seminoma IIA/B|seminoma iia/b
316007|NCT01593241|Carboplatin|carboplatin
316009|NCT01593215|genetics|genetics
316010|NCT01593215|type 2 diabetes|type 2 diabetes
316011|NCT01593215|insulin secretion|insulin secretion
316012|NCT01593189|developmental disabilities|developmental disabilities
316013|NCT01593189|school readiness|school readiness
316014|NCT01593189|literacy|literacy
316015|NCT01593189|social emotional skills|social emotional skills
316016|NCT01593189|self regulation|self regulation
316017|NCT01593189|caregiver involvement|caregiver involvement
316018|NCT01593176|Femur|femur
316019|NCT01593176|Fracture|fracture
316020|NCT01593176|Radiostereometric Analysis|radiostereometric analysis
316021|NCT01593163|Functional echocardiography|functional echocardiography
316022|NCT01593163|power Doppler cranial ultrasonography|power doppler cranial ultrasonography
316023|NCT01593163|N-terminal probrain natriuretic peptide|n-terminal probrain natriuretic peptide
316024|NCT01593163|Patent ductus arteriosus|patent ductus arteriosus
316025|NCT01593150|Atrial Fibrillation|atrial fibrillation
316026|NCT01593150|TEE|tee
316027|NCT01593150|Early versus late DC cardioversion.|early versus late dc cardioversion.
316028|NCT01593124|Vaginal innate immune and inflammatory responses|vaginal innate immune and inflammatory responses
316029|NCT01593111|Allergies|allergies
316030|NCT01593111|Asthma|asthma
316031|NCT01593111|Environmental|environmental
316032|NCT01593111|NYC|nyc
316033|NCT01593111|Manhattan|manhattan
316034|NCT01593111|Harlem|harlem
316035|NCT01593111|Bronx|bronx
316036|NCT01593111|Brooklyn|brooklyn
316037|NCT01593111|Breathing|breathing
316038|NCT01593111|eNO|eno
316039|NCT01593111|IgE|ige
316040|NCT01593111|Allergens|allergens
316041|NCT01593111|Cockroach|cockroach
316042|NCT01593111|Dust mites|dust mites
316043|NCT01593111|Pets|pets
316044|NCT01593098|siblings|siblings
316045|NCT01593098|advanced neoplasm|advanced neoplasm
316046|NCT01593098|mRNA|mrna
316047|NCT01593098|TaqMan microRNA expression assays|taqman microrna expression assays
316048|NCT01593085|palliative cares|palliative cares
316049|NCT01593085|cancer|cancer
316050|NCT01593085|suicide risk|suicide risk
316051|NCT01593072|Multiple Ascending Dose (MAD)|multiple ascending dose (mad)
316052|NCT01593072|Ebola Virus|ebola virus
316053|NCT01593072|Post Exposure Prophylaxis|post exposure prophylaxis
316054|NCT01593072|EHF|ehf
316055|NCT01593059|International|international
316056|NCT01593059|Multicenter|multicenter
316057|NCT01593059|Observational registry|observational registry
316058|NCT01593059|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
316059|NCT01593059|Stenting|stenting
316060|NCT01593059|Treatment of Coronary Artery Disease|treatment of coronary artery disease
316061|NCT01593059|Coronary revascularization|coronary revascularization
316062|NCT01593059|Percutaneous Coronary Intervention|percutaneous coronary intervention
316063|NCT01593059|STEMI|stemi
316067|NCT01593059|Subgroups|subgroups
316068|NCT01593059|Acute Myocardial Infarction|acute myocardial infarction
316069|NCT01593059|Diabetes|diabetes
316070|NCT01593059|Small Vessels|small vessels
317081|NCT01588522|alopecia|alopecia
316071|NCT01593059|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
316072|NCT01593046|GSK1265744 LAP|gsk1265744 lap
316073|NCT01593046|integrase inhibitor|integrase inhibitor
316074|NCT01593046|healthy subjects|healthy subjects
316075|NCT01593046|TMC278 LA|tmc278 la
316076|NCT01593046|GSK1265744LAP|gsk1265744lap
316077|NCT01593046|long acting retroviral|long acting retroviral
316078|NCT01593046|HIV-1 infection|hiv-1 infection
316080|NCT01593020|Early Stage Breast Cancer Not Overexpressing HER-2|early stage breast cancer not overexpressing her-2
316081|NCT01593020|Primary invasive adenocarcinoma of the breast|primary invasive adenocarcinoma of the breast
316082|NCT01593020|Paclitaxel|paclitaxel
316084|NCT01593020|Eribulin|eribulin
316085|NCT01593020|E7389|e7389
316086|NCT01593020|5-Fluorouracil|5-fluorouracil
316087|NCT01593020|5-FU|5-fu
316088|NCT01593020|Adrucil|adrucil
316089|NCT01593020|Efudex|efudex
316090|NCT01593020|Epirubicin|epirubicin
316091|NCT01593020|Ellence|ellence
316092|NCT01593020|Cyclophosphamide|cyclophosphamide
316093|NCT01593020|Cytoxan|cytoxan
316094|NCT01593020|Neosar|neosar
316095|NCT01593020|Doxorubicin|doxorubicin
316096|NCT01593020|Doxorubicin hydrochloride|doxorubicin hydrochloride
316097|NCT01593020|Adriamycin PFS|adriamycin pfs
316098|NCT01593020|Adriamycin RDF|adriamycin rdf
316099|NCT01593020|Adriamycin|adriamycin
316100|NCT01593020|Rubex|rubex
316101|NCT01593007|Heart failure|heart failure
316102|NCT01593007|respiratory muscles|respiratory muscles
316103|NCT01593007|optoelectronic plethysmography|optoelectronic plethysmography
316105|NCT01592994|condom use|condom use
316106|NCT01592994|India|india
316107|NCT01592994|women|women
316108|NCT01592981|Waldenstrom's macroglobulinaemia|waldenstrom's macroglobulinaemia
316109|NCT01592981|bortezomib|bortezomib
316110|NCT01592981|cyclophosphamide|cyclophosphamide
316111|NCT01592981|rituximab|rituximab
316112|NCT01592968|Brain Neoplasms|brain neoplasms
316113|NCT01592968|Non-melanoma brain metastases|non-melanoma brain metastases
316114|NCT01592968|Stereotactic radiosurgery|stereotactic radiosurgery
316115|NCT01592968|SRS|srs
316116|NCT01592968|Whole brain radiation therapy|whole brain radiation therapy
316117|NCT01592968|WBRT|wbrt
316118|NCT01592955|Glaucoma|glaucoma
316119|NCT01592955|Cyclocoagulation|cyclocoagulation
316120|NCT01592955|HIFU High Intensity Focused Ultrasound|hifu high intensity focused ultrasound
316121|NCT01592942|inguinal hernia|inguinal hernia
316122|NCT01592942|mesh fixation|mesh fixation
316123|NCT01592942|glue|glue
316124|NCT01592942|Lichtenstein|lichtenstein
316125|NCT01592929|Functional Respiratory Imaging|functional respiratory imaging
316126|NCT01592929|Magnetic Resonance Imaging|magnetic resonance imaging
316127|NCT01592929|MRI|mri
316128|NCT01592929|Pharyngometry|pharyngometry
392258|NCT01275625|hiv|hiv
316129|NCT01592929|Upper Airway|upper airway
316130|NCT01592929|Mouthpiece of Inhaler|mouthpiece of inhaler
316131|NCT01592929|Cone Beam Computed Tomography|cone beam computed tomography
316132|NCT01592929|CBCT|cbct
316133|NCT01592929|Computed Tomography|computed tomography
316134|NCT01592929|CT|ct
316135|NCT01592916|Fibromyalgia|fibromyalgia
316136|NCT01592916|Pain|pain
316137|NCT01592916|Women|women
316138|NCT01592916|Exercise|exercise
316139|NCT01592916|IGF1|igf1
316140|NCT01592903|Uterine fibroids|uterine fibroids
316141|NCT01592903|somatic stem cell|somatic stem cell
316142|NCT01592903|Side Population|side population
316143|NCT01592877|UWB|uwb
316144|NCT01592877|non-contact|non-contact
316145|NCT01592877|patient monitor|patient monitor
316146|NCT01592838|Belgium|belgium
316147|NCT01592838|Quality of hospital care|quality of hospital care
316148|NCT01592838|Rotavirus vaccination|rotavirus vaccination
316149|NCT01592825|Breast Cancer|breast cancer
316150|NCT01592825|Prognostic factor|prognostic factor
316151|NCT01592825|uPA/PA-1|upa/pa-1
316152|NCT01592825|cohort|cohort
316153|NCT01592799|Influenza|influenza
316154|NCT01592799|Children|children
316155|NCT01592799|Hospitalizations|hospitalizations
316156|NCT01592799|Spain|spain
316157|NCT01592799|Burden|burden
316158|NCT01592786|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
316159|NCT01592786|Autism|autism
316160|NCT01592786|Autistic Disorder|autistic disorder
316161|NCT01592786|Asperger's Disorder|asperger's disorder
316162|NCT01592786|Asperger's|asperger's
316163|NCT01592786|Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|pervasive developmental disorder not otherwise specified (pdd-nos)
316164|NCT01592786|Memantine|memantine
316165|NCT01592786|Pediatric Disorder|pediatric disorder
316166|NCT01592773|Autistic Disorder|autistic disorder
316167|NCT01592773|Asperger's Disorder|asperger's disorder
316168|NCT01592773|Asperger's|asperger's
316169|NCT01592773|Pediatric Autism|pediatric autism
316265|NCT01592409|residual effects of cannabis|residual effects of cannabis
316170|NCT01592773|Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|pervasive developmental disorder not otherwise specified (pdd-nos)
316171|NCT01592773|Pervasive Child Development Disorder|pervasive child development disorder
316172|NCT01592760|air-Q SP|air-q sp
316173|NCT01592760|air-Q|air-q
316175|NCT01592760|supraglottic airway device|supraglottic airway device
316176|NCT01592760|laryngeal mask airway|laryngeal mask airway
316177|NCT01592747|Asperger's|asperger's
316178|NCT01592747|Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|pervasive developmental disorder not otherwise specified (pdd-nos)
316179|NCT01592747|Memantine|memantine
316180|NCT01592747|Pervasive Child Development Disorder|pervasive child development disorder
316181|NCT01592747|Pediatric Disorder|pediatric disorder
316182|NCT01592747|Randomized Controlled Trial|randomized controlled trial
316183|NCT01592734|chronic constipation|chronic constipation
316184|NCT01592734|faecal impaction|faecal impaction
316185|NCT01592734|PEG-only laxative|peg-only laxative
316186|NCT01592721|Carcinoma|carcinoma
316187|NCT01592721|Squamous cell carcinoma|squamous cell carcinoma
316188|NCT01592721|Head and neck neoplasms|head and neck neoplasms
316189|NCT01592721|Cetuximab|cetuximab
316190|NCT01592708|orthognathic surgery|orthognathic surgery
316191|NCT01592708|maxillary osteotomy|maxillary osteotomy
316192|NCT01592708|post operative nausea vomiting|post operative nausea vomiting
316193|NCT01592708|post discharge nausea vomiting|post discharge nausea vomiting
316194|NCT01592708|anesthesia|anesthesia
316195|NCT01592695|Nicotine dependence|nicotine dependence
316196|NCT01592695|Smoking cessation|smoking cessation
316197|NCT01592695|Telehealth|telehealth
316198|NCT01592695|Alcohol use|alcohol use
316199|NCT01592695|Depression|depression
316200|NCT01592695|Body weight|body weight
316201|NCT01592682|tobacco|tobacco
316202|NCT01592682|secondhand smoke|secondhand smoke
316203|NCT01592682|Chinese|chinese
316204|NCT01592682|NNAL|nnal
316205|NCT01592669|Passive leg raising, blood pressure, heart rate|passive leg raising, blood pressure, heart rate
316206|NCT01592656|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
316207|NCT01592656|GOLD stages II, III and IV|gold stages ii, iii and iv
316208|NCT01592656|Computed Tomography scan|computed tomography scan
316209|NCT01592656|Functional Respiratory Imaging|functional respiratory imaging
316210|NCT01592656|Non-Invasive Ventilation|non-invasive ventilation
316211|NCT01592656|Arterial Blood Gas|arterial blood gas
316212|NCT01592656|Hypercapnic|hypercapnic
316213|NCT01592656|Health Related Quality of Life|health related quality of life
316214|NCT01592656|Lung compliance|lung compliance
316215|NCT01592643|Corneal shield|corneal shield
316217|NCT01592643|Myopia|myopia
316218|NCT01592643|Pain|pain
316219|NCT01592643|Vision|vision
316220|NCT01592617|cancer vaccine|cancer vaccine
316221|NCT01592617|HLA-A*24:02|hla-a*24:02
316222|NCT01592617|lung cancer|lung cancer
316223|NCT01592617|CTL|ctl
316224|NCT01592604|fracture|fracture
316225|NCT01592604|fifth metatarsal|fifth metatarsal
316226|NCT01592604|functioanl outcome|functioanl outcome
316227|NCT01592578|gastroesophgeal variceal bleeding|gastroesophgeal variceal bleeding
316228|NCT01592578|liver cirrhosis|liver cirrhosis
316229|NCT01592578|portal hypertension|portal hypertension
316230|NCT01592552|Alzheimer's Disease|alzheimer's disease
316231|NCT01592552|Multiple Sclerosis|multiple sclerosis
316232|NCT01592552|Parkinson's Disease|parkinson's disease
316233|NCT01592552|Huntington's Disease|huntington's disease
316234|NCT01592552|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
316235|NCT01592539|Type 1 Diabetes|type 1 diabetes
316236|NCT01592539|Bone|bone
316237|NCT01592526|Systemic inflammatory response.|systemic inflammatory response.
316238|NCT01592526|Autonomic nervous regulation.|autonomic nervous regulation.
316239|NCT01592526|Cholinergic antiinflammatory pathway|cholinergic antiinflammatory pathway
316240|NCT01592500|GHD|ghd
316241|NCT01592500|r-hGH|r-hgh
316242|NCT01592500|Long-acting|long-acting
316243|NCT01592474|Multiple Sclerosis|multiple sclerosis
316244|NCT01592474|Avonex|avonex
316245|NCT01592474|Brain atrophy|brain atrophy
316246|NCT01592474|MRI|mri
316247|NCT01592474|Interferon-beta 1a|interferon-beta 1a
316248|NCT01592474|IFN Beta 1-a|ifn beta 1-a
316249|NCT01592474|Clinically isolated syndrome|clinically isolated syndrome
316250|NCT01592474|CIS|cis
316251|NCT01592461|Substance abuse treatment outcomes|substance abuse treatment outcomes
316252|NCT01592461|Opioid dependence|opioid dependence
316253|NCT01592461|Suboxone|suboxone
316254|NCT01592461|Methadone|methadone
316255|NCT01592448|Acetaminophen|acetaminophen
316256|NCT01592448|Patient Safety|patient safety
316257|NCT01592448|Health Literacy|health literacy
316258|NCT01592422|Small cell lung cancer|small cell lung cancer
316259|NCT01592422|Maintenance therapy|maintenance therapy
316260|NCT01592422|Immunotherapy|immunotherapy
316261|NCT01592422|Autologous cytokine-induced killer cell|autologous cytokine-induced killer cell
316262|NCT01592409|cannabis impaired driving|cannabis impaired driving
316263|NCT01592409|driving simulation|driving simulation
316264|NCT01592409|acute psychopharmacologic effects of cannabis|acute psychopharmacologic effects of cannabis
316266|NCT01592409|young drivers|young drivers
316267|NCT01592396|Tralokinumab|tralokinumab
316268|NCT01592396|CAT-354|cat-354
316269|NCT01592396|Asthma|asthma
316270|NCT01592357|cardiac rehabilitation|cardiac rehabilitation
316271|NCT01592357|gait speed|gait speed
316272|NCT01592357|mind body exercise|mind body exercise
316273|NCT01592357|tai chi|tai chi
316274|NCT01592357|cardiac disease|cardiac disease
316275|NCT01592357|frail elderly|frail elderly
316276|NCT01592344|Chronic pain|chronic pain
316277|NCT01592344|peripheral nerve|peripheral nerve
316278|NCT01592344|neuralgia|neuralgia
316279|NCT01592344|somatosensory nervous system|somatosensory nervous system
316280|NCT01592266|FLT|flt
316281|NCT01592266|PET|pet
316282|NCT01592266|bone marrow|bone marrow
316283|NCT01592266|AML|aml
316284|NCT01592240|PF-04950615|pf-04950615
316285|NCT01592240|RN316|rn316
316286|NCT01592227|healthy volunteer|healthy volunteer
316287|NCT01592227|pharmacokinetics|pharmacokinetics
316288|NCT01592227|paracetamol|paracetamol
316289|NCT01592214|Staphylococcus aureus, nasal decolonization, XF-73, gel formulation|staphylococcus aureus, nasal decolonization, xf-73, gel formulation
316290|NCT01592201|Schizophrenia|schizophrenia
316291|NCT01592201|Paliperidone ER|paliperidone er
316292|NCT01592201|Antipsychotics|antipsychotics
316293|NCT01592201|Mental disorder|mental disorder
316294|NCT01592201|Comparative study|comparative study
316295|NCT01592188|meditation, inflammation, children, attention|meditation, inflammation, children, attention
316296|NCT01592149|Appetite|appetite
316297|NCT01592136|Ponatinib|ponatinib
316298|NCT01592136|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
316299|NCT01592123|anxiety|anxiety
316300|NCT01592123|septal surgery|septal surgery
316301|NCT01592123|septum deviation|septum deviation
316302|NCT01592123|sleep|sleep
316303|NCT01592110|Schizophrenia|schizophrenia
316304|NCT01592097|Multiple Sclerosis|multiple sclerosis
316305|NCT01592097|MS|ms
316306|NCT01592097|Autoimmune|autoimmune
316307|NCT01592084|lipid lowering therapy|lipid lowering therapy
316308|NCT01592084|survival|survival
316309|NCT01592084|ALSFRS|alsfrs
316310|NCT01592084|age|age
316311|NCT01592084|BMI|bmi
316312|NCT01592084|weight|weight
316313|NCT01592071|food sensitivity|food sensitivity
316314|NCT01592071|IgG|igg
316315|NCT01592071|obesity|obesity
316316|NCT01592071|overweight|overweight
316317|NCT01592071|body composition|body composition
316318|NCT01592071|reactive foods|reactive foods
316319|NCT01592058|weight change|weight change
316320|NCT01592058|contraception|contraception
316321|NCT01592058|birth control|birth control
316322|NCT01592058|progestin|progestin
316323|NCT01592058|progestin only|progestin only
316324|NCT01592058|weight gain|weight gain
316325|NCT01592058|depo|depo
316326|NCT01592058|Depo Provera|depo provera
316327|NCT01592058|DMPA|dmpa
316328|NCT01592058|IUD|iud
392425|NCT01275014|TMJ|tmj
316329|NCT01592058|IUC|iuc
316330|NCT01592058|Mirena|mirena
316331|NCT01592058|Paragard|paragard
316332|NCT01592058|Implanon|implanon
316333|NCT01592058|implant|implant
316334|NCT01592032|Antibiotic-lock technique.|antibiotic-lock technique.
316335|NCT01592032|In vivo antimicrobial concentration.|in vivo antimicrobial concentration.
316336|NCT01592032|Antimicrobial bioactivity.|antimicrobial bioactivity.
316337|NCT01592006|hepatitis C virus|hepatitis c virus
316338|NCT01592006|liver transplant recipient|liver transplant recipient
316339|NCT01591993|Sensitive skin|sensitive skin
316340|NCT01591993|Lactic acid test|lactic acid test
316341|NCT01591993|Transepidermal water loss|transepidermal water loss
316342|NCT01591993|Colorimetry|colorimetry
316343|NCT01591993|Capacitance|capacitance
316344|NCT01591980|post-craniotomy pain|post-craniotomy pain
316345|NCT01591980|pregabalin|pregabalin
316346|NCT01591980|chronic post-craniotomy headache|chronic post-craniotomy headache
316347|NCT01591980|Craniotomy|craniotomy
316348|NCT01591967|Chiropractic|chiropractic
316349|NCT01591967|Blood pressure|blood pressure
316350|NCT01591967|Pulse Rate|pulse rate
316351|NCT01591967|Thoracic|thoracic
316352|NCT01591941|ACL, Knee , Injury,|acl, knee , injury,
316353|NCT01591928|Pediatrics|pediatrics
316354|NCT01591928|Congenital heart disease|congenital heart disease
316355|NCT01591928|Heterotaxy syndrome|heterotaxy syndrome
316356|NCT01591928|Intestinal malrotation|intestinal malrotation
316357|NCT01591915|Breast cancer, Mindfulness Based Stress Reduction, RCT, mood, cooping, health related quality of life|breast cancer, mindfulness based stress reduction, rct, mood, cooping, health related quality of life
316358|NCT01591876|exercise|exercise
316359|NCT01591876|kidney disease|kidney disease
316360|NCT01591876|vascular function|vascular function
316361|NCT01591876|haemodialysis|haemodialysis
316362|NCT01591863|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
316363|NCT01591863|CDAD|cdad
316364|NCT01591863|Pediatric|pediatric
316365|NCT01591798|Rectal cancer|rectal cancer
316366|NCT01591798|Robotic surgery|robotic surgery
316367|NCT01591798|Laparoscopic surgery|laparoscopic surgery
316368|NCT01591785|Hand|hand
316369|NCT01591785|Foot|foot
316370|NCT01591785|Eczema|eczema
316371|NCT01591785|Atopic Dermatitis|atopic dermatitis
316372|NCT01591772|FALLOPIAN TUBE|fallopian tube
316373|NCT01591772|OVARY|ovary
316374|NCT01591772|PERITONEUM|peritoneum
316375|NCT01591772|Quality of Life|quality of life
316376|NCT01591772|structural MRI|structural mri
316377|NCT01591772|functional MRI|functional mri
316378|NCT01591772|neuropsychological assessment|neuropsychological assessment
316379|NCT01591772|12-075|12-075
316380|NCT01591759|citicoline|citicoline
316381|NCT01591759|cognitive function|cognitive function
316382|NCT01591759|function magnetic resonance imaging|function magnetic resonance imaging
316383|NCT01591759|magnetic resonance spectroscopy|magnetic resonance spectroscopy
316384|NCT01591759|diffusion tensor imaging|diffusion tensor imaging
316386|NCT01591746|Mammaplasty|mammaplasty
316387|NCT01591746|Breast reconstruction|breast reconstruction
316388|NCT01591746|Tissue expansion|tissue expansion
316389|NCT01591746|Botulinum toxins, Type A|botulinum toxins, type a
316390|NCT01591746|Quality of Life|quality of life
316391|NCT01591746|Acellular dermal matrix|acellular dermal matrix
316392|NCT01591733|Borderline resectable|borderline resectable
316393|NCT01591707|autism spectrum disorders|autism spectrum disorders
316394|NCT01591707|school|school
316395|NCT01591707|language|language
316396|NCT01591707|social|social
316397|NCT01591694|child trauma|child trauma
316398|NCT01591694|maltreatment|maltreatment
316399|NCT01591694|physical abuse|physical abuse
316400|NCT01591694|sexual abuse|sexual abuse
316401|NCT01591694|emotional abuse|emotional abuse
316402|NCT01591694|abandonment|abandonment
316403|NCT01591694|domestic violence|domestic violence
316404|NCT01591694|community violence|community violence
316405|NCT01591681|Type 1 Diabetes|type 1 diabetes
316406|NCT01591681|Hypoglycemia|hypoglycemia
316407|NCT01591681|Continuous Glucose Monitoring|continuous glucose monitoring
316408|NCT01591681|Pump Suspension|pump suspension
316409|NCT01591668|Hepatitis|hepatitis
316410|NCT01591668|Hepatitis C|hepatitis c
316411|NCT01591668|Chronic HCV|chronic hcv
316412|NCT01591668|HCV|hcv
316413|NCT01591668|Treatment Naive|treatment naive
316414|NCT01591668|Gilead|gilead
316415|NCT01591668|GS-9620|gs-9620
316416|NCT01591642|physical activity|physical activity
316417|NCT01591642|functional fitness|functional fitness
316418|NCT01591642|quality of life|quality of life
316419|NCT01591629|Cannabis|cannabis
316420|NCT01591629|Marijuana|marijuana
316421|NCT01591629|Naloxone|naloxone
316422|NCT01591629|THC|thc
316423|NCT01591629|Psychotic Disorders|psychotic disorders
316424|NCT01591590|Colorectal Cancer|colorectal cancer
316425|NCT01591590|Cancer|cancer
316426|NCT01591590|Colon Cancer|colon cancer
316427|NCT01591590|Rectal Cancer|rectal cancer
316428|NCT01591590|PET|pet
307081|NCT01631279|NSCLC|nsclc
316429|NCT01591590|PET-CT|pet-ct
316430|NCT01591590|MRI|mri
316431|NCT01591590|Diffusion MRI|diffusion mri
316432|NCT01591590|Apparent Diffusion Coefficient|apparent diffusion coefficient
316433|NCT01591590|ADC|adc
316434|NCT01591590|Metabolic Progression Index|metabolic progression index
316435|NCT01591564|interpersonal psychotherapy|interpersonal psychotherapy
316436|NCT01591564|severe mood dysregulation|severe mood dysregulation
316437|NCT01591538|Prevalence|prevalence
316438|NCT01591538|MDRGNB|mdrgnb
316439|NCT01591538|Acquisition|acquisition
316440|NCT01591538|Middle stay|middle stay
316441|NCT01591538|Endemic area|endemic area
316442|NCT01591525|Type II Diabetes|type ii diabetes
316443|NCT01591525|Minorities|minorities
316444|NCT01591525|Diabetes Mellitus|diabetes mellitus
316445|NCT01591525|Community based screening|community based screening
316446|NCT01591512|Small Cell Lung Cancer|small cell lung cancer
316447|NCT01591512|SCLC|sclc
316448|NCT01591512|Lung Cancer|lung cancer
316449|NCT01591512|Subjects diagnosed with SCLC who will undergo treatment|subjects diagnosed with sclc who will undergo treatment
316450|NCT01591486|Helicobacter pylori (Hp)|helicobacter pylori (hp)
316451|NCT01591486|ASA users|asa users
316452|NCT01591486|peptic ulcer bleeding|peptic ulcer bleeding
316453|NCT01591486|cohorts|cohorts
316454|NCT01591473|Influenza|influenza
316455|NCT01591473|Ampligen|ampligen
316456|NCT01591473|Poly I:Poly C12U|poly i:poly c12u
316457|NCT01591473|Rintatolimod|rintatolimod
316458|NCT01591473|FluMist|flumist
316459|NCT01591408|EEG biofeedback|eeg biofeedback
316460|NCT01591408|neurofeedback|neurofeedback
316461|NCT01591408|therapy|therapy
316462|NCT01591408|adjunct|adjunct
316463|NCT01591395|inguinal hernia|inguinal hernia
316464|NCT01591395|laparoscopy|laparoscopy
316465|NCT01591395|laparoendoscopic single-site surgery|laparoendoscopic single-site surgery
316466|NCT01591382|Ketamine|ketamine
316467|NCT01591382|Postoperative pain|postoperative pain
316468|NCT01591382|Opioid dependent patients|opioid dependent patients
316469|NCT01591382|Acute pain control|acute pain control
316470|NCT01591356|Advanced Cancers|advanced cancers
316471|NCT01591356|Advanced solid tumors|advanced solid tumors
316472|NCT01591356|siRNA/EphA2|sirna/epha2
316473|NCT01591343|Specific immunotherapy|specific immunotherapy
316474|NCT01591343|Allergic rhinitis|allergic rhinitis
316475|NCT01591343|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
316476|NCT01591343|Asthma|asthma
316477|NCT01591304|Ulthera® System|ulthera® system
316478|NCT01591304|Ultherapy™ Treatment|ultherapy™ treatment
316479|NCT01591304|Ulthera, Inc.|ulthera, inc.
316480|NCT01591291|alcohol dependence|alcohol dependence
316481|NCT01591291|alcohol addiction|alcohol addiction
316482|NCT01591265|Compensatory dental extraction|compensatory dental extraction
316483|NCT01591265|Children 7-11 years old|children 7-11 years old
316484|NCT01591252|HIV|hiv
316485|NCT01591252|Bone mineral density|bone mineral density
316486|NCT01591252|bone turnover|bone turnover
316488|NCT01591252|inflammation|inflammation
316489|NCT01591239|Adolescent|adolescent
316490|NCT01591239|Parent|parent
316491|NCT01591239|Substance Abuse|substance abuse
316492|NCT01591239|Parent Training|parent training
316493|NCT01591239|Addiction|addiction
316494|NCT01591239|Family Intervention|family intervention
316495|NCT01591239|Brief Intervention|brief intervention
316496|NCT01591239|Home Intervention|home intervention
316497|NCT01591226|caffeine|caffeine
316498|NCT01591226|sodium citrate|sodium citrate
316499|NCT01591226|exercise performance|exercise performance
316500|NCT01591226|wheelchair athletes|wheelchair athletes
316501|NCT01591226|1500m|1500m
316502|NCT01591213|Cancer education|cancer education
316503|NCT01591213|Prevention education|prevention education
316504|NCT01591213|Volunteers|volunteers
316505|NCT01591200|Alcoholic|alcoholic
316506|NCT01591200|Liver|liver
316507|NCT01591200|Cirrhosis|cirrhosis
316508|NCT01591200|Stem|stem
316509|NCT01591200|Cells|cells
316510|NCT01591187|Text messaging|text messaging
316511|NCT01591187|Secondhand smoke exposure|secondhand smoke exposure
316512|NCT01591174|Functional Dyspepsia|functional dyspepsia
316513|NCT01591174|Postprandial Distress Syndrome|postprandial distress syndrome
316514|NCT01591174|ghrelin|ghrelin
316515|NCT01591174|C-13 acetate|c-13 acetate
316516|NCT01591148|Pharmacokinetics|pharmacokinetics
316517|NCT01591148|Pharmacodynamics|pharmacodynamics
316518|NCT01591135|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
316519|NCT01591135|chemoradiotherapy|chemoradiotherapy
316520|NCT01591122|Prostate cancer|prostate cancer
316521|NCT01591122|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
316522|NCT01591122|Abiraterone acetate|abiraterone acetate
316523|NCT01591122|Prednisone|prednisone
316524|NCT01591122|Zytiga|zytiga
316525|NCT01591096|Stroke|stroke
316526|NCT01591096|Childhood|childhood
316527|NCT01591096|Thrombolysis|thrombolysis
402992|NCT01228708|Chronic disease management programme|chronic disease management programme
316528|NCT01591083|Peptic ulcer rebleeding, double dose of esomeprazole|peptic ulcer rebleeding, double dose of esomeprazole
316529|NCT01591070|Facial seborrhoeic dermatitis, tacrolimus|facial seborrhoeic dermatitis, tacrolimus
316530|NCT01591057|fruit|fruit
316531|NCT01591057|vegetables|vegetables
316532|NCT01591057|biomarkers|biomarkers
316533|NCT01591057|randomised controlled feeding study|randomised controlled feeding study
316534|NCT01591057|Fruit and vegetable intake biomarkers in healthy adults|fruit and vegetable intake biomarkers in healthy adults
316535|NCT01591031|laryngeal injuries|laryngeal injuries
316536|NCT01591031|vocal cord injuries|vocal cord injuries
316537|NCT01591031|hoarseness|hoarseness
316538|NCT01591031|sore throat|sore throat
316539|NCT01591018|sonolysis, brain infarction, prevention, cardiac surgery|sonolysis, brain infarction, prevention, cardiac surgery
316540|NCT01591005|sonolysis|sonolysis
316541|NCT01591005|carotid|carotid
316542|NCT01591005|endarterectomy|endarterectomy
316543|NCT01591005|stenting|stenting
316544|NCT01590992|Somatoform disorder|somatoform disorder
316545|NCT01590992|Functional Somatic Syndrome|functional somatic syndrome
316546|NCT01590992|Functional Somatic Symptoms|functional somatic symptoms
316547|NCT01590992|Somatic Symptom Disorder|somatic symptom disorder
316548|NCT01590992|globus sensation|globus sensation
316549|NCT01590992|globus pharynges|globus pharynges
316550|NCT01590992|globus hystericus|globus hystericus
316551|NCT01590979|Atrial Fibrillation New Onset|atrial fibrillation new onset
316552|NCT01590979|Ranolazine|ranolazine
316553|NCT01590979|CABG|cabg
316554|NCT01590979|valve repair/replacement|valve repair/replacement
316555|NCT01590979|Cardiac Surgery|cardiac surgery
316556|NCT01590966|spondyloarthritis|spondyloarthritis
316557|NCT01590966|Rheumatoid arthritis|rheumatoid arthritis
316558|NCT01590927|pelvic floor|pelvic floor
316559|NCT01590927|ultrasonography|ultrasonography
316560|NCT01590914|Roux-en-Y Bariatric surgery,|roux-en-y bariatric surgery,
316561|NCT01590914|Gastric banding,|gastric banding,
316562|NCT01590914|fMRI,|fmri,
316563|NCT01590914|food cues|food cues
316564|NCT01590901|Pharmacokinetics|pharmacokinetics
316565|NCT01590901|Probucol|probucol
316566|NCT01590901|healthy male subjects|healthy male subjects
316567|NCT01590875|atrial fibrillation|atrial fibrillation
316568|NCT01590875|ablation|ablation
316569|NCT01590875|pulmonary veins|pulmonary veins
316570|NCT01590875|adenosine|adenosine
316571|NCT01590862|Obesessive Compulsive Disorder|obesessive compulsive disorder
316572|NCT01590862|Major Depressive Disorder|major depressive disorder
316573|NCT01590862|Deep Brain Stimulation|deep brain stimulation
316574|NCT01590849|contraceptive agents|contraceptive agents
316575|NCT01590849|autonomic nervous system|autonomic nervous system
316576|NCT01590849|blood pressure|blood pressure
316577|NCT01590849|risk|risk
316578|NCT01590823|pharmacokinetics|pharmacokinetics
316579|NCT01590784|Depression|depression
316580|NCT01590784|Schizophrenia|schizophrenia
316581|NCT01590758|Diabetic Foot Ulcer Infection|diabetic foot ulcer infection
316582|NCT01590745|Ultrasound therapy|ultrasound therapy
316583|NCT01590745|Nerve Conduction studies|nerve conduction studies
316584|NCT01590745|Boston and Levine Questionnaire|boston and levine questionnaire
316585|NCT01590745|Neutral Angle Wrist Splint|neutral angle wrist splint
316586|NCT01590745|Canterbury CTS scale|canterbury cts scale
316588|NCT01590732|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
316589|NCT01590732|PTCL|ptcl
316590|NCT01590732|Relapsed or refractory T-Cell Lymphoma|relapsed or refractory t-cell lymphoma
316591|NCT01590732|TCL|tcl
316592|NCT01590732|Peripheral TCL-NOS|peripheral tcl-nos
316593|NCT01590732|Angioimmunoblastic TCL|angioimmunoblastic tcl
316594|NCT01590732|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
316595|NCT01590732|Hepatosplenic TCL|hepatosplenic tcl
316596|NCT01590732|Enteropathy-associated TCL|enteropathy-associated tcl
316597|NCT01590732|Romidepsin|romidepsin
316598|NCT01590732|Istodax|istodax
316599|NCT01590732|Depsipeptide|depsipeptide
316600|NCT01590732|FK228|fk228
316601|NCT01590732|Etoposide|etoposide
316602|NCT01590732|VePesid|vepesid
316603|NCT01590732|Carboplatin|carboplatin
316604|NCT01590732|Paraplatin|paraplatin
316605|NCT01590732|Mesna|mesna
316606|NCT01590732|Mesnex|mesnex
316607|NCT01590706|Genotype-Phenotype Association|genotype-phenotype association
316608|NCT01590706|Aged|aged
316609|NCT01590706|Middle Aged|middle aged
316610|NCT01590706|Mild Cognitive Impairment|mild cognitive impairment
316611|NCT01590706|Heart Rate Control|heart rate control
316612|NCT01590706|Biomarkers|biomarkers
316613|NCT01590693|Gait|gait
316614|NCT01590667|Fat excretion|fat excretion
316615|NCT01590654|Hepatitis|hepatitis
316616|NCT01590654|Hepatitis B|hepatitis b
316617|NCT01590654|Hepatitis B Virus|hepatitis b virus
316618|NCT01590654|HBV|hbv
316619|NCT01590654|GS-9620|gs-9620
316620|NCT01590654|Toll-like receptor (TLR)-7 Agonist|toll-like receptor (tlr)-7 agonist
316621|NCT01590641|Hepatitis|hepatitis
316622|NCT01590641|Hepatitis B|hepatitis b
316623|NCT01590641|Hepatitis B Virus|hepatitis b virus
316624|NCT01590641|HBV|hbv
316625|NCT01590641|GS-9620|gs-9620
316626|NCT01590641|Toll-like receptor (TLR)-7 Agonist|toll-like receptor (tlr)-7 agonist
316627|NCT01590628|Sickle Cell Disease & Thalassemia|sickle cell disease & thalassemia
316628|NCT01590628|Genetic disorder|genetic disorder
316629|NCT01590615|Hepatitis|hepatitis
316630|NCT01590615|Hepatitis B|hepatitis b
316631|NCT01590615|HBV|hbv
316632|NCT01590615|OLT|olt
316633|NCT01590615|MELD|meld
316634|NCT01590615|Renal Safety|renal safety
316635|NCT01590615|Liver Transplant|liver transplant
316636|NCT01590602|Huntington's Disease|huntington's disease
316637|NCT01590602|European Huntington's Disease Network|european huntington's disease network
316638|NCT01590602|Juvenile HD|juvenile hd
316639|NCT01590602|EHDN|ehdn
316640|NCT01590602|REGISTRY|registry
316641|NCT01590589|Huntington Disease|huntington disease
316642|NCT01590589|European HD Network|european hd network
316643|NCT01590589|Cohort|cohort
316644|NCT01590589|REGISTRY|registry
316645|NCT01590589|EHDN|ehdn
316646|NCT01590576|women|women
316647|NCT01590550|Pediatric hemodialysis|pediatric hemodialysis
316648|NCT01590550|Anticoagulation|anticoagulation
316649|NCT01590537|non-interventional|non-interventional
316650|NCT01590537|Mirena|mirena
316651|NCT01590537|Contraception|contraception
316652|NCT01590537|Russian Federation|russian federation
316653|NCT01590524|Parent|parent
316654|NCT01590524|childhood cancer|childhood cancer
316655|NCT01590524|Complementary and Alternative|complementary and alternative
316656|NCT01590511|mini fluid challenge|mini fluid challenge
316657|NCT01590511|subaortic velocity time integral|subaortic velocity time integral
316658|NCT01590498|Adenocarcinoma|adenocarcinoma
316659|NCT01590498|Prostatic Neoplasms|prostatic neoplasms
316660|NCT01590498|Carcinoma|carcinoma
316661|NCT01590498|Prostatic Diseases|prostatic diseases
316662|NCT01590485|pain|pain
316663|NCT01590485|root canal therapy|root canal therapy
316664|NCT01590472|Genetics of Mesothelioma|genetics of mesothelioma
316665|NCT01590472|Mesothelioma Consortium|mesothelioma consortium
316666|NCT01590472|GWAS|gwas
316667|NCT01590472|Asbestos|asbestos
316668|NCT01590446|Achondroplasia|achondroplasia
316669|NCT01590433|Obesity|obesity
316670|NCT01590433|Overweight|overweight
316671|NCT01590433|Exenatide|exenatide
316672|NCT01590433|Diet|diet
316673|NCT01590433|Women|women
316674|NCT01590420|OSA|osa
316675|NCT01590420|Sleep|sleep
316676|NCT01590420|CPAP|cpap
316677|NCT01590420|Cost|cost
316678|NCT01590394|obstruction|obstruction
316679|NCT01590394|bile duct|bile duct
316680|NCT01590394|malignant|malignant
316681|NCT01590342|Pulmonary embolism|pulmonary embolism
316682|NCT01590342|Right ventricular dysfunction|right ventricular dysfunction
316683|NCT01590342|Prognosis|prognosis
316684|NCT01590342|Inflammation|inflammation
316685|NCT01590329|Skin surgery|skin surgery
316686|NCT01590329|Micrografting|micrografting
316687|NCT01590329|Hypo-pigmentation|hypo-pigmentation
316688|NCT01590316|Brain Injuries|brain injuries
316689|NCT01590316|Infant, Premature|infant, premature
316690|NCT01590316|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
316691|NCT01590316|Randomized Controlled Trial|randomized controlled trial
316693|NCT01590264|tinnitus|tinnitus
316694|NCT01590264|bimodal stimulation|bimodal stimulation
316695|NCT01590264|rTMS|rtms
316696|NCT01590264|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
316697|NCT01590251|Pain|pain
316698|NCT01590251|Addiction|addiction
316699|NCT01590251|Buprenorphine|buprenorphine
316700|NCT01590251|Counseling|counseling
316701|NCT01590251|Methadone|methadone
316702|NCT01590251|Yoga|yoga
316703|NCT01590238|alopecia|alopecia
316704|NCT01590186|Pain|pain
316705|NCT01590186|Front foot|front foot
316706|NCT01590186|Flat foot|flat foot
316707|NCT01590186|Metatarsalgia|metatarsalgia
316708|NCT01590173|Low molecular weight heparin|low molecular weight heparin
316709|NCT01590173|Prednisolone|prednisolone
316710|NCT01590173|Glucocorticoids|glucocorticoids
316711|NCT01590173|Recurrent implantation failure|recurrent implantation failure
316712|NCT01590173|Pregnancy rate|pregnancy rate
316713|NCT01590134|volunteers|volunteers
316714|NCT01590134|Pilot study|pilot study
316715|NCT01590134|There are no pre registration evaluations.|there are no pre registration evaluations.
316837|NCT01589757|"dietary intervention"|"dietary intervention"
316716|NCT01590134|Inclusion criteria: to be a healthy, consenting volunteer not currently receiving iron supplements.|inclusion criteria: to be a healthy, consenting volunteer not currently receiving iron supplements.
316717|NCT01590134|Exclusion criteria: 1) Needle phobia; 2) Currently receiving iron supplements; 3) Unable to provide informed consent|exclusion criteria: 1) needle phobia; 2) currently receiving iron supplements; 3) unable to provide informed consent
316718|NCT01590121|Previous flight by aeroplane|previous flight by aeroplane
316719|NCT01590108|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
316720|NCT01590108|IPAH|ipah
316721|NCT01590108|Apelin|apelin
316722|NCT01590108|APJ receptor|apj receptor
316723|NCT01590095|Chlorine water treatment|chlorine water treatment
316724|NCT01590095|Point-of-use water treatment|point-of-use water treatment
316725|NCT01590095|Household water treatment with safe storage|household water treatment with safe storage
316726|NCT01590095|Hand washing with soap|hand washing with soap
316727|NCT01590095|Hand hygiene|hand hygiene
316728|NCT01590095|Latrines|latrines
316729|NCT01590095|Child potties|child potties
316730|NCT01590095|Point-of-use fortification|point-of-use fortification
316731|NCT01590095|Lipid-based nutrient supplement|lipid-based nutrient supplement
316732|NCT01590095|Environmental enteropathy|environmental enteropathy
316733|NCT01590095|Tropical enteropathy|tropical enteropathy
316734|NCT01590095|Gut function|gut function
316735|NCT01590095|Intestinal parasitic infection|intestinal parasitic infection
316736|NCT01590095|Soil transmitted helminths|soil transmitted helminths
316737|NCT01590095|Intestinal protozoans|intestinal protozoans
316738|NCT01590095|Antibody response|antibody response
316739|NCT01590095|Water|water
316740|NCT01590095|Sanitation|sanitation
316741|NCT01590095|Hand washing|hand washing
316742|NCT01590095|Breast Feeding|breast feeding
316743|NCT01590095|Complementary Feeding|complementary feeding
316744|NCT01590095|Micronutrients|micronutrients
316745|NCT01590095|Malnutrition|malnutrition
316746|NCT01590095|Nutrition Disorders|nutrition disorders
316747|NCT01590095|Diarrhea|diarrhea
316748|NCT01590095|Child Development|child development
316749|NCT01590082|Melanoma|melanoma
316750|NCT01590082|Metastatic Melanoma|metastatic melanoma
316751|NCT01590082|Advanced melanoma|advanced melanoma
316752|NCT01590082|Doxycycline|doxycycline
316753|NCT01590082|Ipilimumab|ipilimumab
316754|NCT01590082|Yervoy|yervoy
316755|NCT01590082|MDX010|mdx010
316756|NCT01590082|BMS-734016|bms-734016
316757|NCT01590082|Temozolomide|temozolomide
316758|NCT01590082|Temodar|temodar
316759|NCT01590069|Sarcoma|sarcoma
316760|NCT01590069|Solid Tumors|solid tumors
316761|NCT01590069|Pulmonary Metastases|pulmonary metastases
316762|NCT01590069|Lung metastases|lung metastases
316763|NCT01590069|Osteosarcomas|osteosarcomas
316764|NCT01590069|Ewing sarcoma|ewing sarcoma
316765|NCT01590069|IL-2|il-2
316766|NCT01590069|Interleukin-2|interleukin-2
316767|NCT01590069|Aldesleukin|aldesleukin
316768|NCT01590069|Proleukin|proleukin
316769|NCT01590069|Aerosol IL-2|aerosol il-2
316770|NCT01590069|Spirometry|spirometry
316771|NCT01590069|Nebulizer|nebulizer
316772|NCT01590069|Pulse oximeter|pulse oximeter
316773|NCT01590056|Mapping limbic areas of the STN|mapping limbic areas of the stn
317267|NCT01587521|Prevalence|prevalence
316774|NCT01590056|neuronal responses to stimuli during surgery|neuronal responses to stimuli during surgery
316775|NCT01590017|stage IB cervical cancer|stage ib cervical cancer
316776|NCT01590017|stage IIA cervical cancer|stage iia cervical cancer
316777|NCT01590017|stage IIB cervical cancer|stage iib cervical cancer
316778|NCT01590017|stage III cervical cancer|stage iii cervical cancer
316779|NCT01590017|stage IVA cervical cancer|stage iva cervical cancer
316780|NCT01590017|cervical adenocarcinoma|cervical adenocarcinoma
316781|NCT01590017|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
316782|NCT01590017|cervical squamous cell carcinoma|cervical squamous cell carcinoma
316783|NCT01590017|HIV infection|hiv infection
316784|NCT01590004|LumbarCool system|lumbarcool system
316785|NCT01590004|Cooled radiofrequency medial ablation|cooled radiofrequency medial ablation
316786|NCT01590004|Cooled-RF neurotomy|cooled-rf neurotomy
316787|NCT01589991|toothpastes|toothpastes
316788|NCT01589991|bioavailability|bioavailability
316789|NCT01589991|sodium fluoride|sodium fluoride
316790|NCT01589991|monofluorphosphate|monofluorphosphate
316791|NCT01589991|low-fluoride|low-fluoride
316792|NCT01589978|drug-eluting stent|drug-eluting stent
316794|NCT01589978|atherosclerosis|atherosclerosis
316795|NCT01589978|everolimus|everolimus
316796|NCT01589965|HIV/AIDS|hiv/aids
316798|NCT01589965|Lottery|lottery
316799|NCT01589952|Pegalyted interferon|pegalyted interferon
316800|NCT01589952|Entecavir|entecavir
316801|NCT01589939|Reduced Planning Target Volume|reduced planning target volume
316802|NCT01589939|radiation therapy|radiation therapy
316803|NCT01589939|Calypso|calypso
316804|NCT01589913|Implantable Cardioverter Defibrillators|implantable cardioverter defibrillators
316805|NCT01589913|Heart Failure|heart failure
316806|NCT01589913|Anxiety|anxiety
316807|NCT01589913|Depression|depression
316808|NCT01589913|Quality of Life|quality of life
316809|NCT01589913|Remote Care|remote care
316810|NCT01589913|Prevention|prevention
316811|NCT01589900|colorectal cancer|colorectal cancer
316812|NCT01589900|invasion|invasion
316813|NCT01589900|metastasis|metastasis
316815|NCT01589874|hepcidin|hepcidin
316816|NCT01589874|anemia|anemia
316817|NCT01589874|acute inflammation|acute inflammation
316818|NCT01589874|IL-6|il-6
316819|NCT01589874|cytokines|cytokines
316820|NCT01589848|vWD|vwd
316821|NCT01589809|Congenital, familial and genetic disorders|congenital, familial and genetic disorders
316822|NCT01589809|Nervous System Diseases|nervous system diseases
316823|NCT01589796|anesthesia|anesthesia
402993|NCT01228708|COPD|copd
402994|NCT01228695|steroids|steroids
307466|NCT01629511|Clolar|clolar
316824|NCT01589796|regional anesthetic techniques: transversus abdominis plane block, ilioinguinal nerve block, iliohypogastric nerve block|regional anesthetic techniques: transversus abdominis plane block, ilioinguinal nerve block, iliohypogastric nerve block
316825|NCT01589796|surgery, inguinal herniorrhaphy|surgery, inguinal herniorrhaphy
316826|NCT01589796|pain, postoperative|pain, postoperative
316827|NCT01589796|surgery, inguinal hernia repair|surgery, inguinal hernia repair
316828|NCT01589783|Pregnancy|pregnancy
316829|NCT01589783|Vitamin D|vitamin d
316830|NCT01589770|rheumatoid arthritis|rheumatoid arthritis
316831|NCT01589770|inflammation|inflammation
316832|NCT01589757|"glycaemic index"|"glycaemic index"
316833|NCT01589757|"glycemic index"|"glycemic index"
316834|NCT01589757|hyperglycaemia|hyperglycaemia
316835|NCT01589757|hyperglycemia|hyperglycemia
316836|NCT01589757|pregnancy|pregnancy
316838|NCT01589757|"education evaluation"|"education evaluation"
316839|NCT01589757|antioxidant|antioxidant
316840|NCT01589757|"Impaired Glucose Tolerance of Pregnancy"|"impaired glucose tolerance of pregnancy"
316841|NCT01589757|"Gestational Diabetes Mellitus"|"gestational diabetes mellitus"
316842|NCT01589757|"Breast Milk"|"breast milk"
316843|NCT01589744|medical device|medical device
316844|NCT01589731|Allergenicity|allergenicity
316845|NCT01589731|Cow's milk allergy|cow's milk allergy
316846|NCT01589731|Leukocyte adherence inhibition test|leukocyte adherence inhibition test
316847|NCT01589731|Polymerization|polymerization
316848|NCT01589718|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
316849|NCT01589718|Tractional Retinal Detachment|tractional retinal detachment
316850|NCT01589718|Vitreous Hemorrhage|vitreous hemorrhage
316851|NCT01589705|Uric acid|uric acid
316852|NCT01589705|polycystic kidney disease|polycystic kidney disease
316853|NCT01589692|WRIST|wrist
316854|NCT01589692|Distal Radius Fracture|distal radius fracture
316855|NCT01589692|DRF|drf
316856|NCT01589692|elderly|elderly
316857|NCT01589692|internal fixation|internal fixation
316858|NCT01589692|VLPS|vlps
316859|NCT01589692|External Fixation|external fixation
316860|NCT01589692|Multi center randomized trial|multi center randomized trial
316861|NCT01589666|Entegrion|entegrion
316862|NCT01589666|Spray-dried Solvent/Detergent Plasma|spray-dried solvent/detergent plasma
316863|NCT01589666|Fresh Frozen Plasma|fresh frozen plasma
316864|NCT01589666|Transfusion|transfusion
316865|NCT01589666|Resuscitation|resuscitation
316866|NCT01589666|Hemorrhage|hemorrhage
316867|NCT01589666|Coagulopathy|coagulopathy
316868|NCT01589627|distal radius fracture|distal radius fracture
316869|NCT01589627|wrist contracture|wrist contracture
316870|NCT01589627|dynasplint|dynasplint
316871|NCT01589601|Congestive Heart Failure|congestive heart failure
316872|NCT01589601|Heart Failure|heart failure
316873|NCT01589601|Palliative Care|palliative care
316874|NCT01589601|Palliative Medicine|palliative medicine
707745|NCT00998634|Lithium|lithium
316875|NCT01589588|acute treatment|acute treatment
316876|NCT01589575|Intensive Care Unit|intensive care unit
316877|NCT01589549|Acute graft versus host disease|acute graft versus host disease
316878|NCT01589549|Bone marrow transplantation|bone marrow transplantation
316879|NCT01589549|Mesenchymal stromal cells|mesenchymal stromal cells
316880|NCT01589536|psychocardiological|psychocardiological
316881|NCT01589536|interval intervention|interval intervention
316882|NCT01589536|disability pension|disability pension
316883|NCT01589536|risk profile|risk profile
316884|NCT01589536|mental comorbidity|mental comorbidity
316885|NCT01589484|Tomography|tomography
316886|NCT01589484|Urinary Lithiasis|urinary lithiasis
316887|NCT01589484|Kidney Calculi|kidney calculi
316888|NCT01589471|Low anterior resection syndrome|low anterior resection syndrome
316889|NCT01589471|Botulinum toxin A|botulinum toxin a
316890|NCT01589471|Quality of life|quality of life
316891|NCT01589471|Incontinence|incontinence
316892|NCT01589471|Rectal cancer|rectal cancer
316893|NCT01589471|Anorectal manometry|anorectal manometry
316894|NCT01589458|toothpastes|toothpastes
316896|NCT01589458|dental caries|dental caries
316897|NCT01589458|fluoride|fluoride
316898|NCT01589445|Bangladesh|bangladesh
316899|NCT01589445|T2DM|t2dm
316900|NCT01589445|Pioglitazone|pioglitazone
316901|NCT01589445|Metformin|metformin
316902|NCT01589445|Insulin secretion and Sensitivity|insulin secretion and sensitivity
316903|NCT01589432|Diabetic peripheral neuropathy|diabetic peripheral neuropathy
316905|NCT01589419|radiation|radiation
316906|NCT01589419|veliparib|veliparib
316907|NCT01589419|locally advanced rectal cancer|locally advanced rectal cancer
316908|NCT01589419|ABT-888|abt-888
316909|NCT01589419|capecitabine|capecitabine
316910|NCT01589419|MTD|mtd
316911|NCT01589419|PARP|parp
316912|NCT01589406|Gynaecological Cancer|gynaecological cancer
316913|NCT01589406|Quality of Life|quality of life
316914|NCT01589406|Sexuality|sexuality
316915|NCT01589393|Trauma|trauma
316916|NCT01589393|Thromboprophylaxis|thromboprophylaxis
316917|NCT01589393|Intracranial haemorrhage|intracranial haemorrhage
316918|NCT01589393|Deep vein Thrombosis|deep vein thrombosis
393145|NCT01272349|air|air
316919|NCT01589380|Aortic stenosis|aortic stenosis
316920|NCT01589380|Exercise performance|exercise performance
316921|NCT01589380|cardiopulmonary exercise test|cardiopulmonary exercise test
316922|NCT01589380|fimasartan|fimasartan
316923|NCT01589367|neoadjuvant endocrine therapy|neoadjuvant endocrine therapy
316924|NCT01589367|metformin|metformin
316925|NCT01589367|postmenopausal breast cancer|postmenopausal breast cancer
316926|NCT01589328|pancreatic cancer|pancreatic cancer
316927|NCT01589328|biliary tract cancer|biliary tract cancer
316928|NCT01589328|cancer pain|cancer pain
316929|NCT01589328|depression|depression
316930|NCT01589315|ECT|ect
316931|NCT01589315|FEAST|feast
316932|NCT01589315|brain stimulation|brain stimulation
316933|NCT01589315|depression|depression
316934|NCT01589302|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
316935|NCT01589302|CLL|cll
316936|NCT01589302|SLL|sll
316937|NCT01589302|B-PLL|b-pll
316938|NCT01589289|Diagnostic research|diagnostic research
316939|NCT01589289|Rapid diagnostic tests|rapid diagnostic tests
316940|NCT01589289|Neurological disorders|neurological disorders
316941|NCT01589289|Neglected Tropical Diseases|neglected tropical diseases
316942|NCT01589289|Developing countries|developing countries
316943|NCT01589263|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
316944|NCT01589263|Lower Urinary Track Symptoms|lower urinary track symptoms
316945|NCT01589263|BPH|bph
316946|NCT01589263|LUTS|luts
316947|NCT01589237|Familial Chylomicronemia Syndrome (FCS) (HLP type I)|familial chylomicronemia syndrome (fcs) (hlp type i)
316948|NCT01589237|LCQ908|lcq908
316949|NCT01589211|smoking|smoking
316950|NCT01589211|cessation|cessation
316951|NCT01589211|intervention|intervention
316952|NCT01589211|brief|brief
316953|NCT01589198|Asthma|asthma
316954|NCT01589185|Pneumonia|pneumonia
316955|NCT01589185|Monoclonal antibody|monoclonal antibody
316956|NCT01589185|Staphylococcus aureus|staphylococcus aureus
316957|NCT01589146|colon-rectal cancer|colon-rectal cancer
316958|NCT01589146|heparin|heparin
316959|NCT01589146|prophylaxis|prophylaxis
316960|NCT01589146|laparoscopy|laparoscopy
316961|NCT01589133|Irregular antibody screening|irregular antibody screening
316962|NCT01589120|CHF|chf
316963|NCT01589120|video decision aid|video decision aid
316964|NCT01589094|CISPLATIN|cisplatin
316965|NCT01589094|GEMCITABINE|gemcitabine
316966|NCT01589094|GM-CSF|gm-csf
316967|NCT01589094|radical cystectomy|radical cystectomy
316968|NCT01589094|12-071|12-071
316969|NCT01589003|low GI milk mood behaviour cognitive function children|low gi milk mood behaviour cognitive function children
316970|NCT01588964|HIPEC|hipec
316971|NCT01588964|ovarian cancer|ovarian cancer
316972|NCT01588964|recurrence|recurrence
316973|NCT01588938|radiation therapy|radiation therapy
316974|NCT01588938|Calypso|calypso
316975|NCT01588925|Cochlear implantation|cochlear implantation
316976|NCT01588925|Dexamethasone|dexamethasone
316977|NCT01588925|Acid, Hyaluronic|acid, hyaluronic
316978|NCT01588912|chronic hepatitis B|chronic hepatitis b
316979|NCT01588912|HBeAg positive|hbeag positive
316980|NCT01588912|telbivudine|telbivudine
316981|NCT01588912|tenofovir|tenofovir
316982|NCT01588912|entecavir|entecavir
316984|NCT01588899|Uterine Leiomyomas|uterine leiomyomas
316985|NCT01588899|Fibroids|fibroids
316986|NCT01588899|HIFU|hifu
316987|NCT01588899|Ablation|ablation
316988|NCT01588899|High Intensity Focused Ultrasound|high intensity focused ultrasound
316989|NCT01588886|Proton pump inhibitors|proton pump inhibitors
316990|NCT01588886|Pneumonia|pneumonia
316991|NCT01588886|Retrospective cohort study|retrospective cohort study
316992|NCT01588873|Oral contraceptive pill|oral contraceptive pill
316993|NCT01588873|Hormonal contraceptive ring|hormonal contraceptive ring
316994|NCT01588873|Polycystic ovary syndrome|polycystic ovary syndrome
316995|NCT01588847|perioperative immunoediting|perioperative immunoediting
316996|NCT01588847|potential predictive biomarkers|potential predictive biomarkers
316997|NCT01588847|lymph node dissection|lymph node dissection
316998|NCT01588821|Metastatic|metastatic
316999|NCT01588821|Refractory|refractory
317000|NCT01588821|Relapsed|relapsed
317001|NCT01588808|Immobilization|immobilization
317002|NCT01588808|Protein supplementation|protein supplementation
317003|NCT01588795|Diabetic nephropathy|diabetic nephropathy
317004|NCT01588795|renal denervation|renal denervation
317005|NCT01588795|nephroprotection|nephroprotection
317006|NCT01588795|Renal failure|renal failure
317007|NCT01588795|Renal injury|renal injury
317008|NCT01588795|End stage renal disease|end stage renal disease
317009|NCT01588782|Healthy volunteers|healthy volunteers
317010|NCT01588782|Pharmacology|pharmacology
317011|NCT01588782|Pharmacokinetics|pharmacokinetics
317012|NCT01588782|Pharmacodynamics|pharmacodynamics
317013|NCT01588782|Drug-drug interactions|drug-drug interactions
317014|NCT01588782|CYP3A4|cyp3a4
317015|NCT01588782|Abiraterone acetate|abiraterone acetate
317016|NCT01588782|JNJ-589485|jnj-589485
317017|NCT01588782|JNJ-212082|jnj-212082
317018|NCT01588782|Ketoconazole|ketoconazole
307700|NCT01628458|RFA|rfa
317019|NCT01588769|Glioblastoma Multiforme|glioblastoma multiforme
317020|NCT01588769|Brain cancer|brain cancer
317021|NCT01588769|Immunotherapy|immunotherapy
317022|NCT01588769|Cell based therapy|cell based therapy
317023|NCT01588769|Autologous cell based therapy|autologous cell based therapy
317024|NCT01588769|Adoptive immunotherapy|adoptive immunotherapy
317025|NCT01588769|Cytotoxic T cells|cytotoxic t cells
317026|NCT01588769|Natural Killer cells|natural killer cells
317027|NCT01588756|Chronic kidney disease|chronic kidney disease
317028|NCT01588756|GFR|gfr
317029|NCT01588756|Inulin|inulin
317030|NCT01588756|51Cr-EDTA|51cr-edta
317031|NCT01588756|ASDKP-NH2|asdkp-nh2
317032|NCT01588756|Healthy male 18-35 yrs old, non smokers, non allergic|healthy male 18-35 yrs old, non smokers, non allergic
317033|NCT01588756|Or Male/female 18-80 yrs old with chronic Kidney disease|or male/female 18-80 yrs old with chronic kidney disease
317034|NCT01588730|PF|pf
317035|NCT01588730|Dynasplint|dynasplint
317036|NCT01588730|ADFD|adfd
317037|NCT01588730|AFD|afd
317038|NCT01588730|Plantar Fasciitis|plantar fasciitis
317039|NCT01588730|plantar Fasciopathy|plantar fasciopathy
317040|NCT01588717|Hyperhydrosis|hyperhydrosis
317041|NCT01588717|Excessive Sweating|excessive sweating
317042|NCT01588717|Sweating|sweating
317043|NCT01588717|Depression|depression
317044|NCT01588717|Antidepressant|antidepressant
317045|NCT01588704|lung cancer|lung cancer
317046|NCT01588704|lung adenocarcinoma|lung adenocarcinoma
317047|NCT01588704|bevacizumab|bevacizumab
317048|NCT01588704|adjuvant chemotherapy|adjuvant chemotherapy
317049|NCT01588704|surgical resection rate|surgical resection rate
317050|NCT01588704|safety|safety
317051|NCT01588704|feasibility|feasibility
317052|NCT01588691|Traumatic Brain Injury|traumatic brain injury
317053|NCT01588678|endometrial|endometrial
317054|NCT01588678|prostate|prostate
317055|NCT01588678|breast|breast
317056|NCT01588678|gastric|gastric
317057|NCT01588678|cervical|cervical
317058|NCT01588678|ovarian|ovarian
317059|NCT01588678|neuroendocrine cancers|neuroendocrine cancers
317060|NCT01588678|soft-tissue sarcoma|soft-tissue sarcoma
317061|NCT01588678|squamous cell NSCLC|squamous cell nsclc
317062|NCT01588678|renal cell carcinoma|renal cell carcinoma
317063|NCT01588678|non-Hodgkin lymphoma|non-hodgkin lymphoma
317064|NCT01588665|pregnancy|pregnancy
317065|NCT01588665|stable isotopes|stable isotopes
317066|NCT01588665|red blood cell catabolism|red blood cell catabolism
317067|NCT01588639|Recombinant human insulin|recombinant human insulin
317068|NCT01588639|T2DM|t2dm
317069|NCT01588639|Safety|safety
317070|NCT01588639|Efficacy|efficacy
317071|NCT01588626|Healthy volunteer|healthy volunteer
317072|NCT01588626|Japanese males|japanese males
317073|NCT01588626|PK study|pk study
317074|NCT01588600|food intake, satiety, fiber|food intake, satiety, fiber
317075|NCT01588548|Advanced solid malignancies|advanced solid malignancies
317076|NCT01588548|Malignant lymphoma|malignant lymphoma
317077|NCT01588535|pain|pain
317078|NCT01588535|pain measurement|pain measurement
317079|NCT01588535|ear, middle|ear, middle
317080|NCT01588535|otitis media|otitis media
317082|NCT01588509|AMG 785, bone mineral density, alendronate|amg 785, bone mineral density, alendronate
317083|NCT01588496|hypercholesterolemia|hypercholesterolemia
317084|NCT01588496|familial hypercholesterolemia|familial hypercholesterolemia
317085|NCT01588496|homozygous familial hypercholesterolemia|homozygous familial hypercholesterolemia
317086|NCT01588470|diastolic function|diastolic function
317087|NCT01588470|intramyocellular fat|intramyocellular fat
317088|NCT01588470|mitochondria|mitochondria
317089|NCT01588470|pioglitazone|pioglitazone
317090|NCT01588444|tooth extraction|tooth extraction
317091|NCT01588444|bone grafting|bone grafting
317092|NCT01588431|Locally advanced head and neck cancer|locally advanced head and neck cancer
317093|NCT01588431|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
317094|NCT01588418|Impaired glucose tolerance (IGT)|impaired glucose tolerance (igt)
317095|NCT01588418|Diabetes|diabetes
317096|NCT01588405|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
317097|NCT01588405|UT-15C SR|ut-15c sr
317098|NCT01588405|PAH|pah
317099|NCT01588392|Physical activity|physical activity
317100|NCT01588392|preschoolers|preschoolers
317101|NCT01588353|AK160, collagenase clostridium histolyticum|ak160, collagenase clostridium histolyticum
317102|NCT01588314|Fabry disease|fabry disease
317103|NCT01588314|neuropathic pain|neuropathic pain
317104|NCT01588314|gabapentin|gabapentin
317105|NCT01588301|Cervical Cancer Screening|cervical cancer screening
317106|NCT01588301|Human Papillomavirus (HPV)|human papillomavirus (hpv)
317107|NCT01588301|Self-collected vaginal sample|self-collected vaginal sample
317108|NCT01588301|Cervical Smear|cervical smear
317109|NCT01588288|Diagnosis|diagnosis
317110|NCT01588288|Galectin 3|galectin 3
317111|NCT01588288|Puncture|puncture
317112|NCT01588288|Goiter, nodular|goiter, nodular
317113|NCT01588288|Surgery|surgery
317114|NCT01588275|cost-effectiveness|cost-effectiveness
317115|NCT01588275|effectiveness|effectiveness
317116|NCT01588275|treatment|treatment
317117|NCT01588275|CPAP|cpap
317118|NCT01588275|MRA|mra
317119|NCT01588275|compliance|compliance
317120|NCT01588210|caries|caries
317121|NCT01588210|sealant|sealant
317122|NCT01588210|fluoride|fluoride
317123|NCT01588210|prevention|prevention
317124|NCT01588210|community dentistry|community dentistry
317125|NCT01588197|Pain|pain
317126|NCT01588197|fMRI|fmri
317127|NCT01588197|real time|real time
317128|NCT01588171|Deep vein thrombosis|deep vein thrombosis
317129|NCT01588171|Pulmonary embolism|pulmonary embolism
317130|NCT01588171|Low molecular weight heparin|low molecular weight heparin
317131|NCT01588171|Enoxaparin|enoxaparin
317132|NCT01588171|Bemiparin|bemiparin
317133|NCT01588158|carpal tunnel syndrome|carpal tunnel syndrome
317134|NCT01588158|Tylenol|tylenol
317135|NCT01588158|Vicodin|vicodin
317136|NCT01588158|pain|pain
317137|NCT01588145|NSCLC|nsclc
317138|NCT01588145|HM61713|hm61713
317139|NCT01588145|EGFR-TKI|egfr-tki
317140|NCT01588145|Phase II|phase ii
317141|NCT01588145|olmutinib|olmutinib
317142|NCT01588041|Microscope mounted SDOCT|microscope mounted sdoct
317143|NCT01587976|Health related quality of life|health related quality of life
317144|NCT01587976|Colorectal liver metastasis|colorectal liver metastasis
317145|NCT01587976|surveillance|surveillance
317146|NCT01587963|hypovolemic or septic|hypovolemic or septic
317147|NCT01587950|dentinal sensitivity|dentinal sensitivity
317148|NCT01587950|potassium nitrate|potassium nitrate
317149|NCT01587950|dental pain|dental pain
317150|NCT01587937|Antibiotic stewardship.|antibiotic stewardship.
317151|NCT01587937|Clostridium difficile infection.|clostridium difficile infection.
317152|NCT01587937|Antibiotic resistance.|antibiotic resistance.
317153|NCT01587924|Renal Impairment|renal impairment
317154|NCT01587924|Anemia|anemia
317155|NCT01587924|pharmacokinetics|pharmacokinetics
317156|NCT01587924|hemodialysis|hemodialysis
317157|NCT01587924|Chronic kidney disease|chronic kidney disease
317158|NCT01587924|GSK1278863|gsk1278863
317159|NCT01587924|hemoglobin|hemoglobin
317160|NCT01587924|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
317161|NCT01587924|recombinant human erythropoietin|recombinant human erythropoietin
317162|NCT01587924|erythropoiesis stimulating agents|erythropoiesis stimulating agents
317163|NCT01587924|Dialysis, Renal|dialysis, renal
317164|NCT01587911|Satiety|satiety
317165|NCT01587911|Food intake regulation|food intake regulation
317166|NCT01587911|Appetite regulation|appetite regulation
317167|NCT01587911|Dairy Protein|dairy protein
317168|NCT01587898|Anemia|anemia
317169|NCT01587898|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
317170|NCT01587898|Hemoglobin|hemoglobin
317171|NCT01587898|Chronic kidney disease|chronic kidney disease
317172|NCT01587898|pharmacokinetics|pharmacokinetics
317268|NCT01587521|Quality of life|quality of life
317173|NCT01587898|recombinant human erythropoietin|recombinant human erythropoietin
317174|NCT01587898|GSK1278863|gsk1278863
317175|NCT01587885|Frequent Heartburn|frequent heartburn
317176|NCT01587885|Omeprazole|omeprazole
317177|NCT01587885|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination
317178|NCT01587885|Gastrointestinal Agents|gastrointestinal agents
317179|NCT01587885|Therapeutic Uses|therapeutic uses
317180|NCT01587885|Pharmacologic Actions|pharmacologic actions
317181|NCT01587885|Enzyme Inhibitors|enzyme inhibitors
317182|NCT01587885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
317183|NCT01587885|Proton Pump Inhibitors|proton pump inhibitors
317184|NCT01587872|Colonoscopy|colonoscopy
317185|NCT01587872|Colorectal cancer|colorectal cancer
317186|NCT01587872|Screening colonoscopy|screening colonoscopy
317187|NCT01587859|esophagus|esophagus
317188|NCT01587859|gastro-esophageal reflux disease|gastro-esophageal reflux disease
317189|NCT01587859|type II-IV hiatal hernia|type ii-iv hiatal hernia
317190|NCT01587859|esophageal surgery|esophageal surgery
317191|NCT01587859|minimally invasive surgery|minimally invasive surgery
317192|NCT01587846|abdominal pain, constipation, Lactobacillus reuteri|abdominal pain, constipation, lactobacillus reuteri
317193|NCT01587833|Benzodiazepines|benzodiazepines
317194|NCT01587833|hip/femur fracture|hip/femur fracture
317195|NCT01587820|cisplatin|cisplatin
317197|NCT01587820|intra-arterial chemotherapy|intra-arterial chemotherapy
317198|NCT01587820|head and neck cancer|head and neck cancer
317199|NCT01587807|Infection, Quality of Life, lung injury|infection, quality of life, lung injury
317200|NCT01587794|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
317201|NCT01587794|thickness of retinal layer|thickness of retinal layer
317202|NCT01587794|outer nuclear layer|outer nuclear layer
317203|NCT01587794|photoreceptor layer|photoreceptor layer
317204|NCT01587781|Pharmacokinetics of enoxaparin|pharmacokinetics of enoxaparin
317205|NCT01587768|Acute liver injury|acute liver injury
317206|NCT01587768|antibiotics|antibiotics
317207|NCT01587742|Calcium channel blockers|calcium channel blockers
317208|NCT01587742|cancer|cancer
317209|NCT01587729|Hip/femur fracture|hip/femur fracture
317210|NCT01587729|antidepressants|antidepressants
317339|NCT01587027|High Altitude Sickness|high altitude sickness
317340|NCT01587001|Sarcoidosis|sarcoidosis
317211|NCT01587716|Safety and tolerability, pharmacokinetics, cough, voltage gated sodium channels (VGSC), anaesthesia|safety and tolerability, pharmacokinetics, cough, voltage gated sodium channels (vgsc), anaesthesia
317212|NCT01587703|BRD3|brd3
317213|NCT01587703|GSK525762|gsk525762
317214|NCT01587703|NUT Midline Carcinoma|nut midline carcinoma
317215|NCT01587703|MYCN-amplified Solid Tumor|mycn-amplified solid tumor
317216|NCT01587703|BRD4|brd4
317217|NCT01587703|BET inhibitor|bet inhibitor
317218|NCT01587703|bromodomains|bromodomains
317220|NCT01587703|Colorectal C ancer|colorectal c ancer
317221|NCT01587703|Small Cell Lung Cancer|small cell lung cancer
317222|NCT01587703|Multiple Myeloma|multiple myeloma
317223|NCT01587703|Neuroblastoma|neuroblastoma
317224|NCT01587703|Oncology|oncology
317225|NCT01587677|Tuberculosis|tuberculosis
317226|NCT01587664|Swallowing disorders|swallowing disorders
317227|NCT01587664|Aspiration|aspiration
317228|NCT01587651|CAD|cad
317229|NCT01587651|prasugrel|prasugrel
317230|NCT01587651|ticagrelor|ticagrelor
317231|NCT01587651|antiplatelet|antiplatelet
317232|NCT01587651|thienopyridine|thienopyridine
317233|NCT01587651|P2Y12 Inhibitors|p2y12 inhibitors
317234|NCT01587638|new-onset diabetes|new-onset diabetes
317235|NCT01587638|carvedilol|carvedilol
317236|NCT01587638|claims analysis|claims analysis
317237|NCT01587638|beta-blocker|beta-blocker
317238|NCT01587638|Diabetes Mellitus|diabetes mellitus
317239|NCT01587625|Delayed labour|delayed labour
317240|NCT01587625|dystocia|dystocia
317241|NCT01587625|oxytocin augmentation|oxytocin augmentation
317242|NCT01587625|primiparous women|primiparous women
317243|NCT01587625|childbirth|childbirth
317244|NCT01587625|childbirth experience|childbirth experience
317245|NCT01587625|progress|progress
317246|NCT01587612|Pain|pain
317247|NCT01587612|Foot|foot
317248|NCT01587599|pharmaceutical care|pharmaceutical care
317249|NCT01587599|drug-related problems|drug-related problems
317250|NCT01587599|elderly|elderly
317251|NCT01587599|Pharmaceutical care of elderly patients with diabetes|pharmaceutical care of elderly patients with diabetes
317252|NCT01587586|Hepatitis C, Chronic|hepatitis c, chronic
317253|NCT01587586|Interferon-alpha|interferon-alpha
317254|NCT01587586|Hepatitis C Virus|hepatitis c virus
317255|NCT01587573|salivary biomarkers|salivary biomarkers
317256|NCT01587560|Shoulder|shoulder
317257|NCT01587560|Arthroplasty|arthroplasty
317258|NCT01587560|Pyrocarbon|pyrocarbon
317259|NCT01587560|Randomized controlled trial|randomized controlled trial
317260|NCT01587560|Shoulder resurfacing|shoulder resurfacing
317261|NCT01587547|ART|art
317262|NCT01587547|IVF|ivf
317263|NCT01587547|ICSI|icsi
317264|NCT01587547|embryo selection|embryo selection
708729|NCT00992121|bevacizumab|bevacizumab
317265|NCT01587534|Unresectable Pancreatic cancer|unresectable pancreatic cancer
317266|NCT01587521|Metabolic syndrome|metabolic syndrome
317269|NCT01587521|Depression|depression
317270|NCT01587521|Antipsychotics|antipsychotics
317271|NCT01587482|Superficial femoral artery|superficial femoral artery
317272|NCT01587482|endovascular|endovascular
317273|NCT01587482|Drug eluting balloon|drug eluting balloon
317274|NCT01587482|Paclitaxel|paclitaxel
316895|NCT01589458|saliva|saliva
317275|NCT01587456|Osteoporosis|osteoporosis
317276|NCT01587430|acute myeloid leukemia|acute myeloid leukemia
317277|NCT01587430|anthracyclines|anthracyclines
317278|NCT01587430|high dose cytarabine|high dose cytarabine
317279|NCT01587430|maintenance|maintenance
317280|NCT01587404|Atrial Fibrillation|atrial fibrillation
317281|NCT01587404|Electrogram|electrogram
317282|NCT01587404|Ablation|ablation
317283|NCT01587404|Contact Force|contact force
317284|NCT01587378|miscarriage|miscarriage
317285|NCT01587378|preterm birth|preterm birth
317286|NCT01587378|prevention|prevention
317287|NCT01587326|cytokine, depression, escitalopram|cytokine, depression, escitalopram
317288|NCT01587313|hydralazine|hydralazine
317289|NCT01587313|isosorbide|isosorbide
317290|NCT01587313|bidil|bidil
317291|NCT01587313|volunteers|volunteers
317292|NCT01587313|pharmacokinetic profile|pharmacokinetic profile
317293|NCT01587287|Anterior corneal power|anterior corneal power
317294|NCT01587287|Placido topographer|placido topographer
317295|NCT01587287|Scheimpﬂug|scheimpﬂug
317296|NCT01587287|Precision|precision
317297|NCT01587287|Agreement|agreement
317298|NCT01587274|low back pain|low back pain
317299|NCT01587261|Burns|burns
317300|NCT01587261|Vitamin C|vitamin c
317301|NCT01587261|Thermal Injury|thermal injury
317302|NCT01587261|Fluid Resuscitation|fluid resuscitation
317303|NCT01587248|Breast cancer,|breast cancer,
317304|NCT01587248|Harmonic scalpel,|harmonic scalpel,
317305|NCT01587248|Electrocautery,|electrocautery,
317306|NCT01587248|Modified Radical Mastectomy,|modified radical mastectomy,
317307|NCT01587248|Randomized Controlled Trial|randomized controlled trial
317308|NCT01587209|decompression|decompression
317309|NCT01587209|intravascular bubbles|intravascular bubbles
317310|NCT01587209|neutrophil activation|neutrophil activation
317311|NCT01587196|prescription opiates/medications|prescription opiates/medications
317312|NCT01587196|vivitrol|vivitrol
317313|NCT01587196|brain imaging|brain imaging
317314|NCT01587183|Running|running
317315|NCT01587183|Blood pressure|blood pressure
317316|NCT01587170|spasticity|spasticity
317317|NCT01587170|spinal cord injury|spinal cord injury
317318|NCT01587170|zolmitriptan|zolmitriptan
317320|NCT01587131|Universal Influenza|universal influenza
317321|NCT01587131|Intradermal DNA-Based Vaccine|intradermal dna-based vaccine
317322|NCT01587131|Senior|senior
317323|NCT01587131|Electroporation|electroporation
317324|NCT01587131|H1|h1
317325|NCT01587131|Influenza|influenza
317326|NCT01587131|FVH1|fvh1
317327|NCT01587118|PTSD|ptsd
317328|NCT01587118|Posttraumatic Stress Disorder|posttraumatic stress disorder
317329|NCT01587118|Asenapine|asenapine
317330|NCT01587118|Adjunctive|adjunctive
317331|NCT01587118|antidepressant|antidepressant
317332|NCT01587118|neuroleptic|neuroleptic
317333|NCT01587092|walking|walking
317334|NCT01587092|physical activity|physical activity
317335|NCT01587092|sedentary behavior|sedentary behavior
317336|NCT01587092|workplace|workplace
317337|NCT01587079|COPD|copd
317338|NCT01587027|Altitude Sickness|altitude sickness
317341|NCT01587001|oxidative stress|oxidative stress
317342|NCT01587001|anti-oxidant|anti-oxidant
317343|NCT01586988|HIV|hiv
317344|NCT01586988|Parenting|parenting
317345|NCT01586988|self-care|self-care
317346|NCT01586988|disclosure|disclosure
317347|NCT01586988|medication adherence|medication adherence
317348|NCT01586988|mother|mother
317349|NCT01586988|child|child
317350|NCT01586988|adolescent|adolescent
317351|NCT01586962|paracetamol|paracetamol
317352|NCT01586962|pseudoephedrine|pseudoephedrine
317353|NCT01586962|syrup|syrup
317354|NCT01586962|upper respiratory tract infection|upper respiratory tract infection
317355|NCT01586949|well-being|well-being
317356|NCT01586949|web-based intervention|web-based intervention
317357|NCT01586949|social networks|social networks
317358|NCT01586923|Anemia|anemia
317359|NCT01586923|Transfusion|transfusion
317360|NCT01586923|RBC storage age|rbc storage age
317361|NCT01586923|Tissue oxygenation|tissue oxygenation
317362|NCT01586923|Malaria|malaria
317363|NCT01586897|health information technology|health information technology
317364|NCT01586897|primary care|primary care
317365|NCT01586897|visit-independent|visit-independent
317366|NCT01586897|medication monitoring|medication monitoring
317367|NCT01586884|LV Pacing|lv pacing
317368|NCT01586884|LV Lead Placement|lv lead placement
317369|NCT01586884|LV Pacing Site|lv pacing site
317370|NCT01586884|CRT Device Placement|crt device placement
317371|NCT01586871|MPS I|mps i
317372|NCT01586871|MPS II|mps ii
317373|NCT01586871|MPS VI|mps vi
317374|NCT01586871|Mucopolysaccharidoses|mucopolysaccharidoses
317375|NCT01586858|Vasculitis|vasculitis
317376|NCT01586858|ANCA|anca
317377|NCT01586858|Rituximab|rituximab
317378|NCT01586858|Small vessel vasculitis|small vessel vasculitis
317379|NCT01586845|Randomized Controlled Trials|randomized controlled trials
317380|NCT01586845|Immunosuppression|immunosuppression
317381|NCT01586845|Adult|adult
317382|NCT01586845|Kidney Transplantation|kidney transplantation
317383|NCT01586845|Treatment Outcome|treatment outcome
317384|NCT01586832|Hospital Supplies|hospital supplies
317385|NCT01586832|Stocking of Supplies|stocking of supplies
317386|NCT01586806|Dexamethasone|dexamethasone
317387|NCT01586806|Glucocorticoids|glucocorticoids
317388|NCT01586806|Physiological Effects of Drugs|physiological effects of drugs
317389|NCT01586806|Therapeutic Uses|therapeutic uses
317390|NCT01586806|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
317391|NCT01586806|Regional Anesthesia, nerve block|regional anesthesia, nerve block
317392|NCT01586806|Ultrasonic Imaging|ultrasonic imaging
317393|NCT01586806|Post-Operative Complications: muscle weakness, pain, nausea and vomiting|post-operative complications: muscle weakness, pain, nausea and vomiting
317394|NCT01586806|Dexamethasone (as local anesthetic additive)|dexamethasone (as local anesthetic additive)
317395|NCT01586793|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
317396|NCT01586793|Bipolar depression|bipolar depression
317397|NCT01586793|Randomized trial|randomized trial
317398|NCT01586793|rTMS|rtms
317399|NCT01586793|Neuromodulation|neuromodulation
317400|NCT01586780|Whey protein|whey protein
317401|NCT01586780|Soy protein|soy protein
317402|NCT01586780|Insulinogenic amino acids|insulinogenic amino acids
317403|NCT01586780|Incretins|incretins
317404|NCT01586780|Glycaemia|glycaemia
317405|NCT01586780|Insulinaemia|insulinaemia
317406|NCT01586767|Nasal cavity|nasal cavity
317407|NCT01586767|Salivary gland tumors|salivary gland tumors
317408|NCT01586767|Hard palate|hard palate
317409|NCT01586767|Sinus|sinus
317410|NCT01586767|Soft Palate|soft palate
317411|NCT01586767|Lacrimal Apparatus|lacrimal apparatus
317412|NCT01586754|metabolic syndrome|metabolic syndrome
317413|NCT01586754|obesity|obesity
317414|NCT01586754|endothelial damage|endothelial damage
317415|NCT01586754|homocysteine|homocysteine
317416|NCT01586754|microalbumin|microalbumin
317417|NCT01586754|carotis intima-media thickness|carotis intima-media thickness
317418|NCT01586728|Cystic fibrosis|cystic fibrosis
317419|NCT01586728|oxygen therapy|oxygen therapy
317420|NCT01586728|sleep|sleep
317421|NCT01586715|Extremely complex perianal fistula|extremely complex perianal fistula
317422|NCT01586715|Adipose Derived Stem Cells|adipose derived stem cells
317423|NCT01586702|Stroke, TIA, secondary prevention, support program, multifactorial intervention|stroke, tia, secondary prevention, support program, multifactorial intervention
317424|NCT01586689|Oxford House|oxford house
317425|NCT01586689|recovery|recovery
317426|NCT01586689|substance abuse|substance abuse
317427|NCT01586689|alcohol abuse|alcohol abuse
317428|NCT01586689|addiction|addiction
317429|NCT01586676|supervision|supervision
317430|NCT01586676|motivational interviewing|motivational interviewing
317431|NCT01586676|substance abuse|substance abuse
317432|NCT01586676|dissemination|dissemination
317433|NCT01586663|Diffuse Systemic Sclerosis|diffuse systemic sclerosis
317434|NCT01586663|Hand|hand
317435|NCT01586663|Range of motion|range of motion
317436|NCT01586663|Splint|splint
317437|NCT01586650|ankylosing spondylitis|ankylosing spondylitis
317438|NCT01586650|aerobic exercise|aerobic exercise
317439|NCT01586637|Fibromyalgia|fibromyalgia
317440|NCT01586637|Art Therapy|art therapy
317441|NCT01586637|Pain|pain
317442|NCT01586637|Quality of life|quality of life
317443|NCT01586637|Body Image|body image
317444|NCT01586624|Phase I|phase i
317445|NCT01586624|Drug evaluation|drug evaluation
317446|NCT01586624|Oncology|oncology
317447|NCT01586624|Vandetanib|vandetanib
317448|NCT01586624|Selumetinib|selumetinib
317449|NCT01586624|Dose escalation|dose escalation
317450|NCT01586624|Clinical trial|clinical trial
317451|NCT01586624|Vascular Endothelial Growth Factor(VEGFR) inhibitor|vascular endothelial growth factor(vegfr) inhibitor
317452|NCT01586624|Epidermal Growth Factor Receptor(EGFR)inhibitor|epidermal growth factor receptor(egfr)inhibitor
317453|NCT01586624|Mitogen Activated Kinase (MEK) inhibitor|mitogen activated kinase (mek) inhibitor
317454|NCT01586624|Non small cell lung cancer|non small cell lung cancer
317455|NCT01586598|Mandibular Nerve|mandibular nerve
317456|NCT01586598|Orthognathic Surgery|orthognathic surgery
317457|NCT01586598|Sagittal Split Osteotomy|sagittal split osteotomy
317458|NCT01586598|Sensory Retraining|sensory retraining
317459|NCT01586572|Polio virus type 1,2,3|polio virus type 1,2,3
317460|NCT01586572|Poliovaccine-Oral|poliovaccine-oral
317461|NCT01586572|Poliovaccine|poliovaccine
317462|NCT01586572|Trivalent Oral Polio vaccine|trivalent oral polio vaccine
317463|NCT01586572|Monovalent oral polio vaccine|monovalent oral polio vaccine
317464|NCT01586572|Bivalent Oral polio vaccine|bivalent oral polio vaccine
317465|NCT01586546|Mind-body|mind-body
317466|NCT01586546|Psychosocial|psychosocial
317467|NCT01586546|Meditation|meditation
317468|NCT01586546|Breathing Exercises|breathing exercises
317469|NCT01586546|Guided Imagery|guided imagery
317470|NCT01586546|Visualization|visualization
317471|NCT01586533|ulcerative colitis|ulcerative colitis
317472|NCT01586533|UC|uc
317473|NCT01586533|left-sided ulcerative colitis|left-sided ulcerative colitis
317474|NCT01586533|distal ulcerative colitis|distal ulcerative colitis
317475|NCT01586533|Zoenasa|zoenasa
317476|NCT01586533|mesalamine|mesalamine
317477|NCT01586533|mesalazine|mesalazine
317478|NCT01586533|5-ASA|5-asa
317480|NCT01586533|N-acetylcysteine|n-acetylcysteine
317481|NCT01586533|acetylcysteine|acetylcysteine
317482|NCT01586533|NAC|nac
317483|NCT01586533|enema|enema
317484|NCT01586533|rectal gel|rectal gel
317485|NCT01586520|thyroid cancer, papillary, follicular, proteomics, genetic markers|thyroid cancer, papillary, follicular, proteomics, genetic markers
317486|NCT01586507|Pain|pain
317487|NCT01586507|ULTRAM ER|ultram er
317488|NCT01586507|Tramadol hydrochloride|tramadol hydrochloride
317489|NCT01586507|Adolescents|adolescents
317490|NCT01586494|Pain|pain
317491|NCT01586494|ULTRAM ER|ultram er
317492|NCT01586494|Tramadol hydrochloride|tramadol hydrochloride
317493|NCT01586494|Children|children
317494|NCT01586481|Diabetic foot ulcer|diabetic foot ulcer
317495|NCT01586481|Off loading|off loading
317496|NCT01586481|Compliance|compliance
317497|NCT01586481|Healing duration|healing duration
317498|NCT01586481|Amputation rate|amputation rate
317499|NCT01586455|umbilical cord blood|umbilical cord blood
317500|NCT01586455|stem cell transplantation|stem cell transplantation
317501|NCT01586455|placental stem cell|placental stem cell
317502|NCT01586455|inborn errors of metabolism|inborn errors of metabolism
317503|NCT01586455|marrow failure|marrow failure
317504|NCT01586455|Severe Combined Immunodeficiency Disease|severe combined immunodeficiency disease
317505|NCT01586455|AML|aml
317506|NCT01586455|ALL|all
317507|NCT01586455|MDS|mds
317508|NCT01586429|comparing the analgesic efficacy of ultrasound-guided nerve block catheter compared with epidural analgesia|comparing the analgesic efficacy of ultrasound-guided nerve block catheter compared with epidural analgesia
317509|NCT01586416|Colonic neoplasms|colonic neoplasms
317510|NCT01586416|Older adults|older adults
317511|NCT01586416|Psychosocial Intervention|psychosocial intervention
317512|NCT01586416|Chemotherapy adherence|chemotherapy adherence
317513|NCT01586403|Melanoma|melanoma
317514|NCT01586403|Gene Therapy|gene therapy
317515|NCT01586403|Adoptive T-Cell Transfer|adoptive t-cell transfer
317516|NCT01586403|IL-2|il-2
317517|NCT01586390|Ankle Sprain|ankle sprain
317518|NCT01586390|Ankle Distortion|ankle distortion
317519|NCT01586390|Functional treatment|functional treatment
317520|NCT01586390|Brace treatment|brace treatment
317521|NCT01586377|Complex regional pain syndrome|complex regional pain syndrome
317522|NCT01586377|Near Infrared Spectroscopy|near infrared spectroscopy
317523|NCT01586377|Vascular Occlusion Test|vascular occlusion test
317524|NCT01586364|Menopausal symptoms|menopausal symptoms
317525|NCT01586364|Vulvar and vaginal atrophy in menopausal women|vulvar and vaginal atrophy in menopausal women
317526|NCT01586364|Vaginal atrophy|vaginal atrophy
317527|NCT01586364|Urogenital atrophy|urogenital atrophy
317528|NCT01586351|Rotator cuff tears|rotator cuff tears
317529|NCT01586351|ACP|acp
317530|NCT01586351|DX Reinforcement Matrix|dx reinforcement matrix
317531|NCT01586325|Chronic hepatitis C infection|chronic hepatitis c infection
317532|NCT01586325|Asian genotype 1 chronic hepatitis C infection|asian genotype 1 chronic hepatitis c infection
317533|NCT01586325|JNJ-47910382|jnj-47910382
317534|NCT01586325|Non-structural protein 5A (NS5A) inhibitor|non-structural protein 5a (ns5a) inhibitor
317535|NCT01586312|Knee degenerative disease|knee degenerative disease
317536|NCT01586312|osteoarthritis|osteoarthritis
317537|NCT01586312|gonarthrosis|gonarthrosis
317538|NCT01586312|stem cell|stem cell
317539|NCT01586312|cellular therapy|cellular therapy
317540|NCT01586312|regenerative therapy|regenerative therapy
317541|NCT01586312|Mesenchymal stem cells|mesenchymal stem cells
317542|NCT01586312|Bone marrow|bone marrow
317543|NCT01586312|musculoskeletal Diseases|musculoskeletal diseases
317544|NCT01586312|Mesenchymal Stromal Cells (allogenic)|mesenchymal stromal cells (allogenic)
317545|NCT01586299|pleuropneumonia children|pleuropneumonia children
317546|NCT01586299|non steroidal anti inflammatory drugs|non steroidal anti inflammatory drugs
317547|NCT01586299|pleural effusion|pleural effusion
317548|NCT01586299|severe pneumonia|severe pneumonia
317549|NCT01586286|Levator Myalgia|levator myalgia
317550|NCT01586286|Pelvic Pain|pelvic pain
317551|NCT01586286|Vaginismus|vaginismus
317552|NCT01586286|Myofascial pain syndromes|myofascial pain syndromes
317553|NCT01586260|Neuroblastoma in remission|neuroblastoma in remission
317554|NCT01586260|Relapsed Neuroblastoma|relapsed neuroblastoma
317555|NCT01586260|Refractory Neuroblastoma|refractory neuroblastoma
317556|NCT01586234|Fuchs' endothelial dystrophy|fuchs' endothelial dystrophy
317557|NCT01586234|DSAEK|dsaek
402047|NCT01233362|Immunogenicity|immunogenicity
708829|NCT00992589|PPI|ppi
317558|NCT01586234|Descemet's stripping automated endothelial keratoplasty|descemet's stripping automated endothelial keratoplasty
317559|NCT01586221|Rehabilitation|rehabilitation
317561|NCT01586221|Grasp|grasp
317562|NCT01586221|Strength|strength
317563|NCT01586221|Brain Function|brain function
317564|NCT01586221|Physiopathology|physiopathology
317565|NCT01586221|Functional Laterality|functional laterality
317566|NCT01586221|Psychomotor Performance|psychomotor performance
317567|NCT01586221|Biomechanis|biomechanis
317568|NCT01586221|Touch|touch
317569|NCT01586221|Music Therapy|music therapy
317570|NCT01586221|Weight-Bearing|weight-bearing
317571|NCT01586208|refractory status epilepticus|refractory status epilepticus
317572|NCT01586208|valproic acid|valproic acid
317573|NCT01586208|phenytoin|phenytoin
317574|NCT01586208|benzodiazepines|benzodiazepines
317575|NCT01586208|Valproic acid initial dosage in status treatment|valproic acid initial dosage in status treatment
317576|NCT01586182|poor prognosis|poor prognosis
317577|NCT01586169|Albendazole|albendazole
317578|NCT01586169|Ivermectin|ivermectin
317579|NCT01586169|Azithromycin|azithromycin
317580|NCT01586169|Lymphatic filariasis|lymphatic filariasis
317581|NCT01586169|Trachoma|trachoma
317582|NCT01586169|Safety|safety
317583|NCT01586143|Paracetamol by permucosal route,|paracetamol by permucosal route,
317584|NCT01586143|Paracetamol by intraveinous route,|paracetamol by intraveinous route,
317585|NCT01586143|Pain.|pain.
317712|NCT01585558|Vaginal atrophy|vaginal atrophy
317586|NCT01586143|Patient with minor trauma of lower limb and/or superior limb (sprains, muscle contusions, …).|patient with minor trauma of lower limb and/or superior limb (sprains, muscle contusions, …).
317587|NCT01586130|Knee Osteoarthritis|knee osteoarthritis
317588|NCT01586130|Exercise|exercise
317589|NCT01586130|Isokinetic|isokinetic
317590|NCT01586130|Muscle strength|muscle strength
317591|NCT01586130|Rehabilitation|rehabilitation
317592|NCT01586117|rectal cancer|rectal cancer
317593|NCT01586117|amifostine|amifostine
317594|NCT01586117|pre-operative chemo-radiation|pre-operative chemo-radiation
317595|NCT01586065|type 1 diabetes|type 1 diabetes
317596|NCT01586065|adolescents|adolescents
317597|NCT01586065|poor control|poor control
317598|NCT01586065|CGM|cgm
317599|NCT01586052|Cerebral Palsy|cerebral palsy
317600|NCT01586052|Erythropoietin|erythropoietin
317601|NCT01586052|Rehabilitation|rehabilitation
317602|NCT01586039|Melatonin|melatonin
317603|NCT01586039|Sleep|sleep
317604|NCT01586039|Light|light
317605|NCT01586039|Alertness|alertness
317606|NCT01586039|Circadian Rhythms|circadian rhythms
317607|NCT01586026|Ports|ports
317608|NCT01586026|Catheters|catheters
317609|NCT01586026|Distal Valved Catheters|distal valved catheters
317610|NCT01586026|Maintenance Flush|maintenance flush
317611|NCT01586026|subjects|subjects
317612|NCT01586026|routine maintenance flushes|routine maintenance flushes
317613|NCT01586013|propofol|propofol
317614|NCT01586013|pharmacodynamic|pharmacodynamic
317615|NCT01586013|age|age
317616|NCT01586013|ke0|ke0
317617|NCT01586000|vaginal ring|vaginal ring
317618|NCT01585974|Renal Cell Carcinoma|renal cell carcinoma
317619|NCT01585974|TKI|tki
317620|NCT01585974|Turkey|turkey
317621|NCT01585974|Observational|observational
317622|NCT01585961|Symptomatic paroxysmal|symptomatic paroxysmal
317623|NCT01585961|Atrial fibrillation|atrial fibrillation
317624|NCT01585961|Observational|observational
317625|NCT01585961|Acute procedural outcomes|acute procedural outcomes
317626|NCT01585961|Ablation|ablation
317627|NCT01585961|Drug refractory|drug refractory
317628|NCT01585961|Arrhythmia Recurrent|arrhythmia recurrent
317629|NCT01585961|Symptomatic|symptomatic
317630|NCT01585935|Infant, Extremely Low Birth Weight|infant, extremely low birth weight
317631|NCT01585935|Parenteral Nutrition|parenteral nutrition
317632|NCT01585935|Fish Oils|fish oils
317633|NCT01585935|Cholestasis|cholestasis
317634|NCT01585935|Psychomotor Disorders, Developmental|psychomotor disorders, developmental
317635|NCT01585922|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
317636|NCT01585896|Hoarding|hoarding
317637|NCT01585896|Compulsive Hoarding|compulsive hoarding
317638|NCT01585896|Self-Help|self-help
317639|NCT01585883|Lung cancer|lung cancer
317640|NCT01585883|Breathlessness|breathlessness
317641|NCT01585883|Self-management|self-management
317642|NCT01585870|Safety|safety
317643|NCT01585870|Tolerability|tolerability
317644|NCT01585870|Pharmacokinetics|pharmacokinetics
317645|NCT01585870|Clinical benefit|clinical benefit
317646|NCT01585870|Sorafenib|sorafenib
317647|NCT01585870|Eribulin|eribulin
317648|NCT01585870|advanced metastatic solid tumors|advanced metastatic solid tumors
317649|NCT01585844|sleep apnea|sleep apnea
317650|NCT01585844|pregnancy|pregnancy
317651|NCT01585844|obesity|obesity
317652|NCT01585831|Klinefelter syndrome|klinefelter syndrome
317653|NCT01585831|XXY syndrome|xxy syndrome
317654|NCT01585831|Sex Chromosome Abnormality|sex chromosome abnormality
317655|NCT01585831|Testosterone replacement therapy|testosterone replacement therapy
317656|NCT01585818|Glycemic Index|glycemic index
317657|NCT01585818|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
317658|NCT01585818|Diet|diet
317659|NCT01585818|Glucose Variability|glucose variability
317660|NCT01585818|Metabolic Response|metabolic response
317661|NCT01585818|Glucose Response|glucose response
317662|NCT01585766|MAb, B cell, depletion, RMS|mab, b cell, depletion, rms
317663|NCT01585753|cardiovascular function|cardiovascular function
317664|NCT01585753|maraviroc|maraviroc
317768|NCT01585350|melanoma|melanoma
317666|NCT01585740|Neonatal acidosis|neonatal acidosis
317667|NCT01585740|Neonatal hyperchloraemia|neonatal hyperchloraemia
317668|NCT01585740|Base excess|base excess
317669|NCT01585740|Metabolic acidosis|metabolic acidosis
317670|NCT01585740|Caesarean section|caesarean section
317671|NCT01585740|Normal saline|normal saline
317779|NCT01585298|Gilenya|gilenya
317672|NCT01585740|Ringer's Lactate|ringer's lactate
317673|NCT01585740|Postoperative morbidity|postoperative morbidity
317674|NCT01585727|Rectal cancer|rectal cancer
317675|NCT01585727|total mesorectal excision|total mesorectal excision
317676|NCT01585727|pelvic autonomic nerve preservation|pelvic autonomic nerve preservation
317677|NCT01585727|neurostimulation|neurostimulation
317678|NCT01585727|urogenital function|urogenital function
317679|NCT01585727|quality of life|quality of life
317680|NCT01585701|Phase I|phase i
317681|NCT01585701|Oncology|oncology
317682|NCT01585701|AGC Kinase inhibitor|agc kinase inhibitor
317683|NCT01585701|Protein Kinase inhibitor|protein kinase inhibitor
317684|NCT01585701|Clinical Trial|clinical trial
317685|NCT01585701|Multiple protein kinases|multiple protein kinases
317686|NCT01585688|NHL|nhl
317687|NCT01585688|CLL|cll
317689|NCT01585662|EUS|eus
317690|NCT01585662|pancreatic pseudocyst|pancreatic pseudocyst
317691|NCT01585662|drainage|drainage
317692|NCT01585636|SQ109|sq109
317693|NCT01585636|Tuberculosis|tuberculosis
317694|NCT01585610|smoking|smoking
317695|NCT01585610|smoking cessation|smoking cessation
317696|NCT01585610|disabled persons|disabled persons
317697|NCT01585610|behavioral research|behavioral research
317698|NCT01585597|Ischemic Stoke|ischemic stoke
317699|NCT01585597|Endovascular Reperfusion|endovascular reperfusion
317700|NCT01585597|Reperfusion Injury|reperfusion injury
317701|NCT01585597|Mild hypothermia|mild hypothermia
317702|NCT01585584|Boceprevir|boceprevir
317703|NCT01585584|Hepatitis C Genotype 3|hepatitis c genotype 3
317704|NCT01585571|Balance|balance
317705|NCT01585571|Posture|posture
317706|NCT01585571|Virtual Environment|virtual environment
317707|NCT01585571|Cerebral Palsy|cerebral palsy
317708|NCT01585571|Adults|adults
317709|NCT01585558|Menopausal symptoms|menopausal symptoms
317710|NCT01585558|Urogenital atrophy|urogenital atrophy
317711|NCT01585558|Vulvar and vaginal atrophy in menopausal women|vulvar and vaginal atrophy in menopausal women
317713|NCT01585545|CT|ct
317714|NCT01585545|PET CT|pet ct
317715|NCT01585545|MRI|mri
317716|NCT01585545|cancer genomics|cancer genomics
317717|NCT01585545|Radiomics|radiomics
317718|NCT01585545|Radiogenomics|radiogenomics
317719|NCT01585532|Tuberculosis|tuberculosis
317720|NCT01585532|Urine|urine
317721|NCT01585532|Nucleic acid|nucleic acid
317722|NCT01585532|Alere|alere
317723|NCT01585532|Borstel|borstel
317724|NCT01585519|High Epicatechin Apples|high epicatechin apples
317725|NCT01585519|Low Epicatechin Apples|low epicatechin apples
317726|NCT01585519|Apple Extract|apple extract
317727|NCT01585519|Apple Granules|apple granules
317728|NCT01585519|Blood Pressure|blood pressure
317729|NCT01585519|Cholesterol|cholesterol
317730|NCT01585493|Lifestyle|lifestyle
317731|NCT01585493|Smoking|smoking
317732|NCT01585493|Dietary|dietary
317733|NCT01585493|Exercise|exercise
317734|NCT01585480|Obesity|obesity
317735|NCT01585480|Weight Gain Prevention|weight gain prevention
317736|NCT01585480|Workplace|workplace
317737|NCT01585480|Intervention|intervention
317738|NCT01585480|Diet|diet
317739|NCT01585480|Exercise|exercise
317740|NCT01585467|Anterior Shoulder Dislocation|anterior shoulder dislocation
317741|NCT01585467|Shoulder Dislocation|shoulder dislocation
317742|NCT01585467|Shoulder Pain|shoulder pain
317743|NCT01585467|Shoulder Deformity|shoulder deformity
317744|NCT01585454|Pregnancy|pregnancy
317745|NCT01585454|Diabetes Mellitus|diabetes mellitus
317746|NCT01585454|Weight Gain|weight gain
317747|NCT01585454|Diabetes|diabetes
317748|NCT01585441|Finasteride|finasteride
317749|NCT01585441|Central Serous Chorioretinopathy|central serous chorioretinopathy
317750|NCT01585428|Immunotherapy|immunotherapy
317751|NCT01585428|HPV-Associated Cancers|hpv-associated cancers
317752|NCT01585428|Cervical Cancer|cervical cancer
317753|NCT01585428|Oropharyngeal Cancer|oropharyngeal cancer
317754|NCT01585428|HPV Infection|hpv infection
317755|NCT01585415|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
317756|NCT01585415|Immunotherapy|immunotherapy
317757|NCT01585415|Adoptive Cell Therapy|adoptive cell therapy
317758|NCT01585415|B Raf Inhibitor|b raf inhibitor
317759|NCT01585402|NT5E|nt5e
317760|NCT01585402|Biphosphonates|biphosphonates
317761|NCT01585402|Vascular Calcifications|vascular calcifications
317762|NCT01585402|Joint Capsule Calcifications|joint capsule calcifications
317763|NCT01585402|Inherited Disease|inherited disease
317764|NCT01585389|adult brain tumor|adult brain tumor
317765|NCT01585389|childhood brain tumor|childhood brain tumor
317766|NCT01585376|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
317767|NCT01585376|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
317769|NCT01585350|peptide vaccine|peptide vaccine
317770|NCT01585350|polyICLC|polyiclc
317771|NCT01585350|lipopolysaccharide (LPS)|lipopolysaccharide (lps)
317772|NCT01585350|immunotherapy|immunotherapy
317773|NCT01585311|Subarachnoid Hemorrhage (SAH)|subarachnoid hemorrhage (sah)
317774|NCT01585311|tachycardia|tachycardia
317775|NCT01585311|Outcome|outcome
317776|NCT01585298|Multiple Sclerosis|multiple sclerosis
317778|NCT01585298|Fingolimod|fingolimod
317780|NCT01585298|ECG|ecg
317781|NCT01585298|Bradyarrythmia|bradyarrythmia
317782|NCT01585298|conduction abnormalities|conduction abnormalities
317783|NCT01585298|first dose observation|first dose observation
317784|NCT01585285|Coronary artery bypass grafting|coronary artery bypass grafting
317785|NCT01585285|Left internal mammary artery|left internal mammary artery
317786|NCT01585285|Composite grafting|composite grafting
317787|NCT01585285|Multislice Spiral Computed Tomography Scanner|multislice spiral computed tomography scanner
317788|NCT01585285|Graft patency assessment|graft patency assessment
317789|NCT01585272|Alzheimer's dementia, AD|alzheimer's dementia, ad
317790|NCT01585259|anti-platelet;|anti-platelet;
317791|NCT01585259|safety;|safety;
317792|NCT01585259|efficacy|efficacy
317793|NCT01585246|Prostate Cancer|prostate cancer
317794|NCT01585246|Radiation Therapy|radiation therapy
317795|NCT01585246|Quality of Life|quality of life
317796|NCT01585246|Symptom Management|symptom management
317797|NCT01585233|Moderate Psoriasis|moderate psoriasis
317798|NCT01585233|Severe Psoriasis|severe psoriasis
317799|NCT01585233|Skin disease|skin disease
317800|NCT01585233|ASKP1240|askp1240
317801|NCT01585233|CD40 antigen|cd40 antigen
317802|NCT01585233|Anti-CD40 monoclonal antibody|anti-cd40 monoclonal antibody
317803|NCT01585220|WSRS|wsrs
317804|NCT01585220|GAIS|gais
317805|NCT01585220|HA filler|ha filler
317806|NCT01585220|filler|filler
317807|NCT01585207|Tourette's Disorder|tourette's disorder
317808|NCT01585207|vigabatrin|vigabatrin
317809|NCT01585194|Melanoma|melanoma
317810|NCT01585194|History of Uveal Melanoma|history of uveal melanoma
317811|NCT01585194|Metastatic|metastatic
317812|NCT01585194|Ipilimumab|ipilimumab
317813|NCT01585194|Yervoy|yervoy
317814|NCT01585194|BMS-734016|bms-734016
317815|NCT01585194|MDX010|mdx010
317816|NCT01585194|Nivolumab|nivolumab
317817|NCT01585194|BMS-936558|bms-936558
317818|NCT01585194|Opdivo|opdivo
317819|NCT01585181|Vaccine, Bacterial disease condition, Cholera|vaccine, bacterial disease condition, cholera
317820|NCT01585168|Reward Circuitry|reward circuitry
317821|NCT01585168|Impulsivity|impulsivity
317822|NCT01585168|Family History of Alcoholism|family history of alcoholism
317823|NCT01585168|NMDA/DA Interactions|nmda/da interactions
317824|NCT01585155|Infliximab|infliximab
317825|NCT01585155|REMICADE|remicade
317826|NCT01585155|TA-650|ta-650
317827|NCT01585090|Ankle positions|ankle positions
317828|NCT01585090|pelvic floor muscles strength|pelvic floor muscles strength
317829|NCT01585090|relaxation of pelvic floor muscles syndrome|relaxation of pelvic floor muscles syndrome
317830|NCT01585090|doing strengthening exercises of pelvic floor muscles|doing strengthening exercises of pelvic floor muscles
317831|NCT01585077|Plasmodium vivax|plasmodium vivax
317832|NCT01585077|Malaria|malaria
317833|NCT01585077|Challenge|challenge
317834|NCT01585077|Anopheles albimanus|anopheles albimanus
317835|NCT01585064|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
317836|NCT01585064|Anti-TNF therapy|anti-tnf therapy
317837|NCT01585064|Adalimumab|adalimumab
317838|NCT01585064|Disease activity|disease activity
317839|NCT01585064|Treating to target|treating to target
317840|NCT01585051|vitamin D|vitamin d
317841|NCT01585051|blood pressure|blood pressure
317842|NCT01585051|typ 2 diabetes mellitus|typ 2 diabetes mellitus
317843|NCT01585051|blood glucose|blood glucose
317844|NCT01585051|HbA1c|hba1c
317845|NCT01585038|endothelium|endothelium
317846|NCT01585038|inflammation|inflammation
317847|NCT01585038|oxidative stress|oxidative stress
317848|NCT01585038|HIV-1|hiv-1
317849|NCT01585025|Primary bile acid malabsorption|primary bile acid malabsorption
317850|NCT01585025|Secondary bile acid malabsorption|secondary bile acid malabsorption
317851|NCT01585025|Chronic diarrhoea|chronic diarrhoea
317852|NCT01585025|Obeticholic acid|obeticholic acid
317853|NCT01585025|SeHCAT|sehcat
317854|NCT01585025|FXR|fxr
317855|NCT01585025|FGF19|fgf19
317856|NCT01585012|Cervical cap insemination|cervical cap insemination
317857|NCT01585012|Collection condom|collection condom
709743|NCT01003132|Values|values
317858|NCT01585012|Instructions for Use|instructions for use
317859|NCT01585012|Safety during intercourse|safety during intercourse
317860|NCT01585012|Acceptability of the cervical cap with condom sheath|acceptability of the cervical cap with condom sheath
317861|NCT01585012|slip|slip
317862|NCT01585012|break|break
317863|NCT01585012|ease of conversion|ease of conversion
317864|NCT01585012|adequate sample collection|adequate sample collection
317865|NCT01584947|Oral pain|oral pain
317866|NCT01584947|Local anesthetic|local anesthetic
317867|NCT01584947|Bupivacaine hydrochloride|bupivacaine hydrochloride
317868|NCT01584934|fatigue|fatigue
317869|NCT01584934|sleep quality|sleep quality
317870|NCT01584934|Chronic, disabling, unexplained fatigue with at least 4 minor criteria for CFS, according to the 1994 Fukuda case definition|chronic, disabling, unexplained fatigue with at least 4 minor criteria for cfs, according to the 1994 fukuda case definition
317871|NCT01584921|Erythropoietin|erythropoietin
317872|NCT01584921|Glomerular filtration rate|glomerular filtration rate
317873|NCT01584921|Tubular reabsorption|tubular reabsorption
317874|NCT01584921|Renal function|renal function
318170|NCT01582763|Prognosis|prognosis
317875|NCT01584921|Renal perfusion|renal perfusion
317876|NCT01584908|kidney transplant recipients|kidney transplant recipients
317877|NCT01584882|Clinical decision support (CDS)|clinical decision support (cds)
317878|NCT01584882|Tobacco|tobacco
317879|NCT01584882|Behavioral|behavioral
317880|NCT01584882|Dental hygienist|dental hygienist
317881|NCT01584882|Dentist|dentist
317882|NCT01584882|Smoking|smoking
317883|NCT01584882|Electronic health record|electronic health record
317884|NCT01584869|GI-bleeding|gi-bleeding
317885|NCT01584869|capsule endoscopy|capsule endoscopy
317886|NCT01584843|Neuromuscular Agents|neuromuscular agents
317887|NCT01584843|Strabismus|strabismus
317888|NCT01584843|Botulinum Toxin Type A|botulinum toxin type a
317889|NCT01584830|Regorafenib|regorafenib
317890|NCT01584830|Colorectal|colorectal
317891|NCT01584830|Metastatic|metastatic
317892|NCT01584817|colonoscopy|colonoscopy
317893|NCT01584817|bowel preparation|bowel preparation
317894|NCT01584817|education|education
317895|NCT01584804|Su Huang antitussive capsule|su huang antitussive capsule
317896|NCT01584804|Cough variant asthma|cough variant asthma
317897|NCT01584804|Placebo|placebo
317898|NCT01584791|CAD|cad
317899|NCT01584791|PCI|pci
317900|NCT01584791|Percutaneous Coronary Intervention|percutaneous coronary intervention
317901|NCT01584778|Behçet's disease|behçet's disease
317902|NCT01584778|Eosinophil cationic protein|eosinophil cationic protein
317903|NCT01584778|Eosinophils|eosinophils
317904|NCT01584765|liver injury|liver injury
317905|NCT01584765|Rechallenge|rechallenge
317906|NCT01584765|Kaiser Permanente California|kaiser permanente california
317907|NCT01584739|Safety|safety
317908|NCT01584739|tolerability|tolerability
317909|NCT01584739|healthy|healthy
317910|NCT01584739|COPD (chronic obstructive pulmonary disease)|copd (chronic obstructive pulmonary disease)
317911|NCT01584739|pharmacokinetic|pharmacokinetic
317912|NCT01584739|pharmacodynamic|pharmacodynamic
317913|NCT01584739|inhaled|inhaled
317914|NCT01584726|magnesium|magnesium
317915|NCT01584726|nebulization|nebulization
317916|NCT01584726|asthma|asthma
317917|NCT01584726|sulfate|sulfate
317918|NCT01584726|children|children
317919|NCT01584726|pediatric|pediatric
317920|NCT01584713|Enterocutaneous fistula|enterocutaneous fistula
317921|NCT01584713|Adipose Derived Stem Cells|adipose derived stem cells
317922|NCT01584700|NYHA class III or IV|nyha class iii or iv
317923|NCT01584700|Maximal medical therapy|maximal medical therapy
317924|NCT01584700|Not eligible for CRT|not eligible for crt
317925|NCT01584687|asthma|asthma
317926|NCT01584687|difficult-to-control asthma|difficult-to-control asthma
317927|NCT01584687|mRNA expression|mrna expression
317928|NCT01584687|biomarker|biomarker
317929|NCT01584687|real time PCR|real time pcr
317930|NCT01584687|ACT|act
317931|NCT01584687|ACQ|acq
317932|NCT01584648|Randomized study|randomized study
317933|NCT01584648|combination therapy|combination therapy
317934|NCT01584648|BRAF inhibitor|braf inhibitor
317935|NCT01584648|GSK1120212|gsk1120212
317936|NCT01584648|BRAF V600E/K mutation-positive cutaneous melanoma|braf v600e/k mutation-positive cutaneous melanoma
317937|NCT01584648|trametinib|trametinib
317938|NCT01584648|GSK2118436|gsk2118436
317939|NCT01584648|MEK inhibitor|mek inhibitor
317940|NCT01584648|Phase III|phase iii
317941|NCT01584648|dabrafenib|dabrafenib
317942|NCT01584635|Less invasive treatment for Achalasia|less invasive treatment for achalasia
317943|NCT01584609|ischemic stroke|ischemic stroke
317944|NCT01584609|large vessel occlusion|large vessel occlusion
317945|NCT01584609|mechanical thrombectomy|mechanical thrombectomy
317946|NCT01584609|revascularization|revascularization
317947|NCT01584609|Penumbra System|penumbra system
317948|NCT01584609|Separator 3D|separator 3d
317949|NCT01584596|physical activity|physical activity
317950|NCT01584596|dietary|dietary
317951|NCT01584596|adults|adults
317952|NCT01584596|pedometer|pedometer
317953|NCT01584596|education|education
317954|NCT01584583|BP|bp
317955|NCT01584570|dexmedetomidine|dexmedetomidine
317956|NCT01584570|heart rate variability|heart rate variability
317957|NCT01584570|QTc interval|qtc interval
317958|NCT01584544|rectal neoplasms|rectal neoplasms
317959|NCT01584544|aged|aged
317960|NCT01584544|chemoradiotherapy|chemoradiotherapy
317961|NCT01584544|clinical trials, phase I|clinical trials, phase i
317962|NCT01584544|capecitabine|capecitabine
317963|NCT01584531|rigosertib sodium|rigosertib sodium
317964|NCT01584531|rigosertib|rigosertib
317965|NCT01584531|ON 01910.Na|on 01910.na
317966|NCT01584531|oral rigosertib|oral rigosertib
317967|NCT01584505|COPD|copd
317968|NCT01584479|periodontitis|periodontitis
317969|NCT01584466|Schizophrenia|schizophrenia
317970|NCT01584466|Substance Abuse|substance abuse
317971|NCT01584427|Dietary fibers|dietary fibers
317972|NCT01584427|Resistent Starch|resistent starch
317973|NCT01584427|Arabinoxylans|arabinoxylans
317974|NCT01584427|Postprandial lipaemia|postprandial lipaemia
317975|NCT01584427|Insulin sensitivity|insulin sensitivity
317977|NCT01584427|Gene expression|gene expression
317978|NCT01584427|Metabolic rate|metabolic rate
317979|NCT01584427|Blood pressure|blood pressure
317980|NCT01584414|Zetiq CellDetect ® stain|zetiq celldetect ® stain
317981|NCT01584414|distinct red/purple color to the cytoplasm of neoplastic|distinct red/purple color to the cytoplasm of neoplastic
317982|NCT01584414|distinguishes green/blue stained non-neoplastic cells and tissues|distinguishes green/blue stained non-neoplastic cells and tissues
317983|NCT01584401|Body temperature|body temperature
317984|NCT01584401|Thermometers|thermometers
317985|NCT01584401|Non invasive|non invasive
317986|NCT01584401|Medisim's non invasive thermometers|medisim's non invasive thermometers
317987|NCT01584388|Type 1 autoimmune pancreatitis|type 1 autoimmune pancreatitis
317988|NCT01584388|IgG4-related sclerosing cholangitis|igg4-related sclerosing cholangitis
317989|NCT01584388|Chronic sclerosing sialadenitis|chronic sclerosing sialadenitis
317990|NCT01584388|Lacrimal glands|lacrimal glands
317991|NCT01584388|Orbital pseudotumor|orbital pseudotumor
317992|NCT01584388|IgG4-related tubulointerstitial nephritis|igg4-related tubulointerstitial nephritis
317993|NCT01584388|Lymphadenopathy|lymphadenopathy
317994|NCT01584388|Pachymeningitis|pachymeningitis
317995|NCT01584388|Aorta|aorta
317996|NCT01584388|Peri-aortitis|peri-aortitis
317997|NCT01584388|Retroperitoneal fibrosis|retroperitoneal fibrosis
317998|NCT01584388|Riedel's thyroiditis|riedel's thyroiditis
317999|NCT01584375|Intraventricular hemorrhage|intraventricular hemorrhage
318000|NCT01584375|Preterm infant|preterm infant
318001|NCT01584375|Midline head position|midline head position
318002|NCT01584375|Lateral head Position|lateral head position
318003|NCT01584362|Taenia solium|taenia solium
318004|NCT01584362|neurocysticercosis|neurocysticercosis
318005|NCT01584362|oxfendazole|oxfendazole
318006|NCT01584362|clinical trial, phase 1|clinical trial, phase 1
318007|NCT01584362|safety|safety
318008|NCT01584362|pharmacokinetics|pharmacokinetics
318009|NCT01584336|Gastric cancer, laparoscopy-assisted total gastrectomy|gastric cancer, laparoscopy-assisted total gastrectomy
318010|NCT01584323|Preterm premature rupture of membranes|preterm premature rupture of membranes
318011|NCT01584323|pomgranate|pomgranate
318012|NCT01584323|oxidative stress|oxidative stress
318013|NCT01584323|pregnant women with Preterm premature rupture of membranes|pregnant women with preterm premature rupture of membranes
318014|NCT01584310|Nutritional assessment|nutritional assessment
318015|NCT01584310|children|children
318016|NCT01584310|malnutrition|malnutrition
318017|NCT01584297|Granulosa Cell Tumour|granulosa cell tumour
318018|NCT01584284|Genelux|genelux
318019|NCT01584284|Genelux Corporation|genelux corporation
318020|NCT01584284|GL-ONC1|gl-onc1
318021|NCT01584284|Vaccinia|vaccinia
318022|NCT01584284|Vaccinia Virus|vaccinia virus
318023|NCT01584284|Oncolytic virus|oncolytic virus
318024|NCT01584284|Oncolytic Virotherapy|oncolytic virotherapy
318025|NCT01584284|Head and Neck Cancer|head and neck cancer
318026|NCT01584284|Squamous Cell Carcinoma|squamous cell carcinoma
318027|NCT01584271|AOE|aoe
318028|NCT01584271|Ear Comfort|ear comfort
318029|NCT01584271|Dex Otic|dex otic
318030|NCT01584271|Otidin|otidin
318031|NCT01584258|Prostate cancer|prostate cancer
318032|NCT01584258|Prostate adenocarcinoma|prostate adenocarcinoma
318033|NCT01584258|Early stage prostate cancer|early stage prostate cancer
318034|NCT01584258|Organ-confined prostate cancer|organ-confined prostate cancer
318035|NCT01584258|Low-risk prostate cancer|low-risk prostate cancer
318036|NCT01584258|Intermediate-risk prostate cancer|intermediate-risk prostate cancer
318037|NCT01584232|Glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
318038|NCT01584206|Sitosterolemia|sitosterolemia
318039|NCT01584206|Ezetimibe|ezetimibe
318040|NCT01584206|Plant sterol|plant sterol
318041|NCT01584206|Cholesterol|cholesterol
318042|NCT01584193|central venous access port|central venous access port
318043|NCT01584193|ultrasound-guided venous puncture|ultrasound-guided venous puncture
318044|NCT01584193|suclavian vein|suclavian vein
318045|NCT01584193|cephalic vein|cephalic vein
318046|NCT01584180|hypothermia|hypothermia
318047|NCT01584180|induction of hypothermia|induction of hypothermia
318048|NCT01584180|cold infusion|cold infusion
318049|NCT01584180|local neck cooling|local neck cooling
318050|NCT01584180|external cooling|external cooling
318051|NCT01584180|surface cooling|surface cooling
318052|NCT01584180|non invasive cooling|non invasive cooling
318053|NCT01584180|stroke|stroke
318054|NCT01584180|intracranial hemorrhage|intracranial hemorrhage
318055|NCT01584180|cerebrovascular disease|cerebrovascular disease
318056|NCT01584180|neuro intensive care|neuro intensive care
318057|NCT01584167|hypothermia|hypothermia
318058|NCT01584167|induction of hypothermia|induction of hypothermia
318059|NCT01584167|cold infusion|cold infusion
318060|NCT01584167|whole-body cooling|whole-body cooling
318061|NCT01584167|external cooling|external cooling
318062|NCT01584167|surface cooling|surface cooling
318063|NCT01584167|non invasive cooling|non invasive cooling
318064|NCT01584167|stroke|stroke
318065|NCT01584167|intracranial hemorrhage|intracranial hemorrhage
318066|NCT01584167|cerebrovascular disease|cerebrovascular disease
318067|NCT01584167|neuro intensive care|neuro intensive care
318068|NCT01584141|Leukemia|leukemia
318069|NCT01584141|Lymphoma|lymphoma
318070|NCT01584141|Occupational Epidemiology|occupational epidemiology
318071|NCT01584141|Molecular Epidemiology|molecular epidemiology
318072|NCT01584141|Genetic Polymorphisms|genetic polymorphisms
318073|NCT01584115|Cancer.|cancer.
318074|NCT01584115|Melanoma.|melanoma.
318075|NCT01584115|Ovarian cancer.|ovarian cancer.
318076|NCT01584115|Lung cancer.|lung cancer.
318077|NCT01584115|NY-ESO-1.|ny-eso-1.
318078|NCT01584115|MPLA (monophosphoryl lipid A).|mpla (monophosphoryl lipid a).
318079|NCT01584115|Tumor antigen.|tumor antigen.
318080|NCT01584115|Bordetella pertussis.|bordetella pertussis.
318081|NCT01584102|Randomized controlled trial|randomized controlled trial
318082|NCT01584102|obesity|obesity
318083|NCT01584102|community-based participatory research|community-based participatory research
318084|NCT01584102|minority health|minority health
318085|NCT01584102|rural health|rural health
318086|NCT01584102|health promotion|health promotion
318087|NCT01584076|Amblyopia|amblyopia
318088|NCT01584076|Donepezil|donepezil
318089|NCT01584063|Mexican Americans|mexican americans
318090|NCT01584063|Pregnancy|pregnancy
318091|NCT01584063|Diabetes Mellitus Type 2|diabetes mellitus type 2
318092|NCT01584063|Prevention|prevention
318093|NCT01584063|Community health workers|community health workers
752613|NCT01173328|dynamic hyperinflation|dynamic hyperinflation
308778|NCT01623843|FAI|fai
318094|NCT01584063|Community based participatory research|community based participatory research
318095|NCT01584063|Behavioral Intervention|behavioral intervention
318096|NCT01584063|Lifestyle Intervention|lifestyle intervention
318097|NCT01584037|Adenovirus|adenovirus
318098|NCT01584037|Adenovirus Type 4|adenovirus type 4
318099|NCT01584037|Adenovirus Type 7|adenovirus type 7
318100|NCT01584037|Adenovirus Type 4 and Type 7 Vaccine, Live, Oral|adenovirus type 4 and type 7 vaccine, live, oral
318101|NCT01584024|Dental caries|dental caries
318102|NCT01584024|Proximal surfaces|proximal surfaces
318103|NCT01584024|Posterior teeth|posterior teeth
318104|NCT01584024|Carious lesions|carious lesions
318105|NCT01584024|Tooth diseases|tooth diseases
318106|NCT01584024|Preventive therapy|preventive therapy
318107|NCT01584011|Taste|taste
318108|NCT01584011|Chorda tympani nerve|chorda tympani nerve
318109|NCT01583998|Major Depressive Disorder|major depressive disorder
318110|NCT01583998|MDD|mdd
318111|NCT01583998|Depression|depression
318112|NCT01583998|Measurement Based Care|measurement based care
318113|NCT01583998|MBC|mbc
318114|NCT01583998|electronic health records|electronic health records
318115|NCT01583998|EHR|ehr
318116|NCT01583998|electronic medical records|electronic medical records
318117|NCT01583998|EMR|emr
318118|NCT01583985|opioid analgesics|opioid analgesics
318119|NCT01583985|chronic pain|chronic pain
318120|NCT01583985|musculoskeletal pain|musculoskeletal pain
318121|NCT01583972|Vitamin A deficiency|vitamin a deficiency
318122|NCT01583972|Vitamin A|vitamin a
318123|NCT01583972|retinyl palmitate|retinyl palmitate
318124|NCT01583972|malnutrition|malnutrition
318125|NCT01583972|vaccine|vaccine
318126|NCT01583972|vaccination|vaccination
318127|NCT01583972|BCG|bcg
318128|NCT01583972|tuberculosis|tuberculosis
318129|NCT01583972|polio virus|polio virus
318130|NCT01583972|tetanus toxoid|tetanus toxoid
318131|NCT01583972|hepatitis B virus|hepatitis b virus
318132|NCT01583972|thymus|thymus
318133|NCT01583972|T lymphocyte|t lymphocyte
318134|NCT01583972|B lymphocyte|b lymphocyte
318135|NCT01583972|antibody|antibody
318136|NCT01583972|bacterial translocation|bacterial translocation
318137|NCT01583972|T-cell receptor excision circle|t-cell receptor excision circle
318138|NCT01583959|rheumatoid arthritis|rheumatoid arthritis
318139|NCT01583959|folic acid|folic acid
318140|NCT01583959|methotrexate|methotrexate
318141|NCT01583946|subjective well-being|subjective well-being
318142|NCT01583946|life transitions|life transitions
318143|NCT01583946|health-related quality of life|health-related quality of life
318144|NCT01583946|health|health
709744|NCT01003145|Influenza|influenza
318145|NCT01583946|healthcare costs|healthcare costs
318146|NCT01583933|Dental stability|dental stability
318147|NCT01583933|Occlusal stability|occlusal stability
318148|NCT01583933|Retainers|retainers
318149|NCT01583920|prostatic neoplasms|prostatic neoplasms
318150|NCT01583920|brachytherapy|brachytherapy
318151|NCT01583920|salvage therapy|salvage therapy
318152|NCT01583920|recurrent prostate cancer|recurrent prostate cancer
318153|NCT01583907|cow's milk allergy|cow's milk allergy
318154|NCT01583881|Patients with diastolic heart failure and hypertension|patients with diastolic heart failure and hypertension
318155|NCT01582815|Major Depressive Disorder|major depressive disorder
318156|NCT01582815|Depression|depression
318157|NCT01582815|Anxiety symptoms|anxiety symptoms
318158|NCT01582815|JNJ-40411813|jnj-40411813
318159|NCT01582763|Guillain-Barré syndrome|guillain-barré syndrome
318160|NCT01582763|Polyneuropathy|polyneuropathy
318161|NCT01582763|Autoimmune Diseases|autoimmune diseases
318162|NCT01582763|Immune System Diseases|immune system diseases
318163|NCT01582763|Neuromuscular Diseases|neuromuscular diseases
318165|NCT01582763|Quality of life|quality of life
318166|NCT01582763|Disability|disability
318167|NCT01582763|Prognostic Determinants|prognostic determinants
318168|NCT01582763|Treatment|treatment
318169|NCT01582763|Immunoglobulins|immunoglobulins
318171|NCT01582763|Infections|infections
318172|NCT01582763|Anti-ganglioside antibodies|anti-ganglioside antibodies
318173|NCT01582763|Genetic polymorphisms|genetic polymorphisms
318174|NCT01582763|Electrophysiology|electrophysiology
318175|NCT01582763|Cerebrospinal Fluid|cerebrospinal fluid
318176|NCT01582763|Serum|serum
318177|NCT01582750|endoscopic ultrasound|endoscopic ultrasound
318178|NCT01582750|pre-operative concurrent chemoradiotherapy|pre-operative concurrent chemoradiotherapy
318179|NCT01583855|Remote catheter ablation|remote catheter ablation
318180|NCT01583855|Atrial fibrillation|atrial fibrillation
318181|NCT01583842|neuroblastoma|neuroblastoma
318182|NCT01583842|imaging|imaging
318183|NCT01583842|124I-MIBG|124i-mibg
318184|NCT01583842|131I-MIBG|131i-mibg
318185|NCT01583842|PET/CT|pet/ct
318186|NCT01583829|ADHD|adhd
318187|NCT01583829|neurofeedback|neurofeedback
318188|NCT01583829|biofeedback|biofeedback
318189|NCT01583829|computer attention training|computer attention training
318190|NCT01583816|Actinic Keratosis|actinic keratosis
308858|NCT01623453|fistula|fistula
318191|NCT01583816|Resiquimod|resiquimod
318192|NCT01583790|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
318193|NCT01583790|Bariatric surgery|bariatric surgery
318194|NCT01583790|Morbid Obesity|morbid obesity
318195|NCT01583777|Belinostat|belinostat
318196|NCT01583751|pilonidal sinus|pilonidal sinus
318197|NCT01583751|new technique|new technique
318198|NCT01583751|videoendoscopic|videoendoscopic
318199|NCT01583725|Obesity|obesity
318200|NCT01583725|Bariatric surgery|bariatric surgery
318201|NCT01583725|Weight loss|weight loss
318202|NCT01583725|fMRI|fmri
318203|NCT01583725|gut peptides|gut peptides
318204|NCT01583712|Confocal laser endomicroscopy|confocal laser endomicroscopy
318205|NCT01583712|Small bowel imaging|small bowel imaging
318206|NCT01583712|Graft-versus-host disease|graft-versus-host disease
318207|NCT01583712|HSCT|hsct
318208|NCT01583699|MALT-lymphoma|malt-lymphoma
318209|NCT01583699|Confocal laser endomicroscopy|confocal laser endomicroscopy
318210|NCT01583699|Gastrointestinal endoscopy|gastrointestinal endoscopy
318211|NCT01583686|Metastatic Cancer|metastatic cancer
318212|NCT01583686|Immunotherapy|immunotherapy
318213|NCT01583686|Gene Therapy|gene therapy
318214|NCT01583686|Mesothelioma|mesothelioma
318215|NCT01583686|Pancreatic Cancer|pancreatic cancer
318216|NCT01583660|NSAIDs|nsaids
318217|NCT01583660|Anti-inflammatory|anti-inflammatory
318218|NCT01583660|elderly hip fracture|elderly hip fracture
318219|NCT01583660|mortality|mortality
318220|NCT01583608|Drug eluting stent|drug eluting stent
318221|NCT01583608|Bioabsorbable|bioabsorbable
318222|NCT01583608|Bioresorbable|bioresorbable
318223|NCT01583608|Coronary Stent|coronary stent
318224|NCT01583608|Scaffold|scaffold
318225|NCT01583608|Stents|stents
318226|NCT01583608|Angioplasty|angioplasty
318227|NCT01583608|Coronary Artery Disease|coronary artery disease
318228|NCT01583608|Stentthrombosis|stentthrombosis
318229|NCT01583595|Chronic Lung Disease|chronic lung disease
318230|NCT01583595|Exercise|exercise
318231|NCT01583595|Self-efficacy|self-efficacy
318232|NCT01583582|randomized double-blind placebo-controlled study|randomized double-blind placebo-controlled study
318233|NCT01583582|peptide concentrate|peptide concentrate
318234|NCT01583582|Coldwater Shrimp|coldwater shrimp
318235|NCT01583582|antihypertensive effect|antihypertensive effect
318236|NCT01583582|mild hypertension|mild hypertension
318237|NCT01583582|moderate hypertension|moderate hypertension
318238|NCT01583582|blood pressure|blood pressure
318239|NCT01583569|Complex Dynamic Systems|complex dynamic systems
318240|NCT01583569|Biomarkers|biomarkers
318241|NCT01583569|Mood Disorders|mood disorders
318242|NCT01583556|Adult|adult
318243|NCT01583556|English speaking|english speaking
318244|NCT01583556|Fractures|fractures
318245|NCT01583556|Excellent prognosis|excellent prognosis
318246|NCT01583556|Upper Extremity|upper extremity
318247|NCT01583543|Recurrent|recurrent
318248|NCT01583543|Metastatic|metastatic
318249|NCT01583530|Belimumab|belimumab
318250|NCT01583530|Injections, Subcutaneous|injections, subcutaneous
318251|NCT01583530|Drug Administration Routes|drug administration routes
318252|NCT01583530|Injections|injections
318253|NCT01583530|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
318255|NCT01583530|SLE|sle
318256|NCT01583530|Systemic Lupus Erythematosus|systemic lupus erythematosus
318257|NCT01583530|Antibodies|antibodies
318258|NCT01583530|Autoimmune Disease|autoimmune disease
318259|NCT01583530|Biological Therapy|biological therapy
318260|NCT01583530|Immune System Diseases|immune system diseases
318261|NCT01583530|Pharmacokinetics|pharmacokinetics
318262|NCT01583530|Biological Availability|biological availability
318263|NCT01583517|Acute pancreatitis|acute pancreatitis
318264|NCT01583517|ERCP|ercp
318265|NCT01583517|Sphincterotomy|sphincterotomy
318266|NCT01583517|Manometry|manometry
318267|NCT01583517|Sphincter of Oddi dysfunction|sphincter of oddi dysfunction
318268|NCT01583504|Achilles|achilles
318269|NCT01583504|Tendinopathy|tendinopathy
318270|NCT01583504|Tendonitis|tendonitis
318271|NCT01583504|Injection|injection
318371|NCT01583192|infection|infection
318272|NCT01583491|platelet rich fibrin|platelet rich fibrin
318273|NCT01583491|mandibular third molar|mandibular third molar
318274|NCT01583491|periodontal problem|periodontal problem
318275|NCT01583478|incobotulinumtoxinA|incobotulinumtoxina
318276|NCT01583478|wrinkles|wrinkles
318277|NCT01583478|glabellar|glabellar
318278|NCT01583478|rhytids|rhytids
318279|NCT01583478|frown|frown
318280|NCT01583478|lines|lines
318281|NCT01583465|randomized controlled trial|randomized controlled trial
318282|NCT01583465|Blood loss, surgical|blood loss, surgical
318283|NCT01583465|Blood loss, postoperative|blood loss, postoperative
318284|NCT01583465|Wound healing|wound healing
318285|NCT01583452|Post operative ileus|post operative ileus
318286|NCT01583452|Gastrointestinal surgery|gastrointestinal surgery
318287|NCT01583452|Chewing gum|chewing gum
318288|NCT01583439|HIV Infections|hiv infections
318289|NCT01583439|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
394912|NCT01263782|NSCLL|nscll
318290|NCT01583439|Anti-HIV Agents|anti-hiv agents
318291|NCT01583439|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
318292|NCT01583439|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
318293|NCT01583439|Immune System Diseases|immune system diseases
318294|NCT01583439|Anti-Retroviral Agents|anti-retroviral agents
318295|NCT01583439|Antiviral Agents|antiviral agents
318296|NCT01583426|GeparSepto|geparsepto
318297|NCT01583426|GBG 69|gbg 69
318298|NCT01583426|GBG|gbg
318299|NCT01583426|German Breast Group|german breast group
318300|NCT01583426|neo-adjuvant|neo-adjuvant
318301|NCT01583426|GBG Forschungs GmbH|gbg forschungs gmbh
318302|NCT01583426|Tubular breast cancer stage II|tubular breast cancer stage ii
318303|NCT01583426|Mucinous breast cancer stage II|mucinous breast cancer stage ii
318304|NCT01583426|Invasive ductal breast cancer|invasive ductal breast cancer
318305|NCT01583426|Tubular breast cancer stage III|tubular breast cancer stage iii
318306|NCT01583426|HER-2 positive breast cancer|her-2 positive breast cancer
318307|NCT01583426|Inflammatory breast cancer|inflammatory breast cancer
318308|NCT01583413|Ventilator-associated pneumonia|ventilator-associated pneumonia
318309|NCT01583400|Depressive Disorder, Major|depressive disorder, major
318310|NCT01583400|Depressive Disorder, Minor|depressive disorder, minor
318311|NCT01583400|Dysthymic Disorder|dysthymic disorder
318312|NCT01583387|healthy adults|healthy adults
318313|NCT01583387|urinary adducts|urinary adducts
318314|NCT01583387|water intake|water intake
318315|NCT01583374|spondylitis|spondylitis
318316|NCT01583374|spondyloarthritis|spondyloarthritis
318317|NCT01583374|Spondyloarthropathy|spondyloarthropathy
318318|NCT01583374|Oral preparation|oral preparation
318319|NCT01583361|two arms|two arms
318320|NCT01583361|D2 lymphadenectomy|d2 lymphadenectomy
318321|NCT01583361|chemotherapy before and after surgery|chemotherapy before and after surgery
318322|NCT01583361|disease free survival|disease free survival
318323|NCT01583348|transvaginal|transvaginal
318324|NCT01583348|NOTES|notes
318325|NCT01583348|cholecystectomy|cholecystectomy
318326|NCT01583348|cholangiography|cholangiography
318327|NCT01583348|symptomatic gallstone disease|symptomatic gallstone disease
318328|NCT01583335|Overweight|overweight
318329|NCT01583335|Obesity|obesity
318330|NCT01583335|Predisposition|predisposition
318331|NCT01583335|Prevention|prevention
318332|NCT01583335|Diet|diet
318333|NCT01583335|Physical activity|physical activity
318334|NCT01583335|Sleep|sleep
318335|NCT01583335|Family stress|family stress
318336|NCT01583322|ovarian cancer|ovarian cancer
318337|NCT01583322|debulking surgery|debulking surgery
318338|NCT01583322|interval debulking|interval debulking
318339|NCT01583322|vargatef|vargatef
318340|NCT01583322|nintedanib|nintedanib
318341|NCT01583322|maintenance|maintenance
318342|NCT01583322|first line|first line
318343|NCT01583322|paclitaxel|paclitaxel
318344|NCT01583322|carboplatin|carboplatin
318345|NCT01583309|blood pressure|blood pressure
318346|NCT01583309|cardiovascular instability|cardiovascular instability
318347|NCT01583309|symptomatic hypotension|symptomatic hypotension
318348|NCT01583309|online hemofiltration|online hemofiltration
318349|NCT01583309|online hemodiafiltration|online hemodiafiltration
318350|NCT01583283|Multiple Myeloma|multiple myeloma
318351|NCT01583283|Relapsed|relapsed
318352|NCT01583283|Refractory|refractory
318353|NCT01583283|Histone deacetylase inhibitors|histone deacetylase inhibitors
318354|NCT01583283|Lenalidomide|lenalidomide
318355|NCT01583283|Revlimid|revlimid
318356|NCT01583283|Dexamethasone|dexamethasone
318357|NCT01583270|Arabinxylan|arabinxylan
318358|NCT01583270|Rye kernels|rye kernels
318359|NCT01583270|whole grain|whole grain
318360|NCT01583270|Dietary fibre|dietary fibre
318361|NCT01583270|Metabolic syndrome|metabolic syndrome
318570|NCT01582191|Everolimus|everolimus
318362|NCT01583270|Glycemic response|glycemic response
318363|NCT01583270|Colon fermentation|colon fermentation
318364|NCT01583270|Second meal effekt|second meal effekt
318365|NCT01583270|Satiety|satiety
318366|NCT01583218|Phase III|phase iii
318368|NCT01583205|Coping Effectiveness Training|coping effectiveness training
318369|NCT01583205|Distress|distress
318370|NCT01583205|Care Giver|care giver
318372|NCT01583192|skin preparation|skin preparation
318373|NCT01583192|fore-foot surgery|fore-foot surgery
318374|NCT01583192|chloride-hexidine|chloride-hexidine
318375|NCT01583192|povidine-jodine|povidine-jodine
318376|NCT01583192|alcohol|alcohol
318377|NCT01583179|nerve block|nerve block
318378|NCT01583179|outpatient surgery|outpatient surgery
318379|NCT01583140|physical activity|physical activity
318380|NCT01583140|Latinas|latinas
318381|NCT01583127|Problem Behavior|problem behavior
318382|NCT01583114|dilated cardiomyopathy|dilated cardiomyopathy
318383|NCT01583114|heart failure|heart failure
318384|NCT01583114|genetics|genetics
318385|NCT01583114|mutation carrier|mutation carrier
318386|NCT01583114|ACE treatment|ace treatment
318387|NCT01583114|preclinical|preclinical
318388|NCT01583088|Amyotrophic lateral sclerosis,|amyotrophic lateral sclerosis,
318389|NCT01583088|Diaphragm|diaphragm
318390|NCT01583088|Mechanical ventilation|mechanical ventilation
318391|NCT01583088|Phrenic nerve stimulation|phrenic nerve stimulation
318392|NCT01583088|Respiratory insufficiency|respiratory insufficiency
318393|NCT01583062|Surgical Wound Infection|surgical wound infection
318394|NCT01583062|Facial Injuries|facial injuries
318395|NCT01583062|Orbital Fractures|orbital fractures
318396|NCT01583062|Zygomatic Fractures|zygomatic fractures
318397|NCT01583062|Mandibular Fractures|mandibular fractures
318398|NCT01583062|Jaw Injuries|jaw injuries
318399|NCT01583023|bipolar disorder|bipolar disorder
318400|NCT01583023|repetitive transcranial magnetic stimulation (rtms)|repetitive transcranial magnetic stimulation (rtms)
318401|NCT01583023|bupropion|bupropion
318402|NCT01583023|lithium a/o Epival|lithium a/o epival
318403|NCT01583010|ultrasound guided regional anaesthesia needle visualization|ultrasound guided regional anaesthesia needle visualization
318404|NCT01582997|BRAF|braf
318405|NCT01582997|Advance solid tumors|advance solid tumors
318406|NCT01582984|consent|consent
318407|NCT01582984|Patient Understanding|patient understanding
318408|NCT01582984|Knee Arthroplasty|knee arthroplasty
318409|NCT01582971|Breast Cancer|breast cancer
318410|NCT01582971|Reflexology|reflexology
318411|NCT01582971|Complementary|complementary
318412|NCT01582958|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
318413|NCT01582958|Pulmonary Function Tests|pulmonary function tests
318414|NCT01582958|Biochemical Alterations|biochemical alterations
318415|NCT01582945|Treatment resistant|treatment resistant
318416|NCT01582945|suicidal ideation|suicidal ideation
318417|NCT01582945|major depressive disorder|major depressive disorder
318418|NCT01582932|plaque psoriasis|plaque psoriasis
318419|NCT01582932|pediatric|pediatric
318420|NCT01582932|mild|mild
318421|NCT01582932|moderate|moderate
318422|NCT01582919|dementia|dementia
318423|NCT01582919|Alzheimer's Disease|alzheimer's disease
318424|NCT01582919|diagnostic|diagnostic
318425|NCT01582919|biomarkers|biomarkers
318426|NCT01582919|neuroimaging|neuroimaging
318427|NCT01582919|PET|pet
318428|NCT01582919|MRI|mri
318429|NCT01582919|mild cognitive impairment|mild cognitive impairment
318430|NCT01582893|inflammation|inflammation
318431|NCT01582893|dialysis|dialysis
318432|NCT01582880|Keratoprosthesis|keratoprosthesis
318433|NCT01582880|sterile cornea ulcer|sterile cornea ulcer
318434|NCT01582867|Hemodiafiltration|hemodiafiltration
318435|NCT01582867|Hemodialysis|hemodialysis
318436|NCT01582867|Sodium|sodium
318437|NCT01582867|Artis|artis
318438|NCT01582867|renal failure|renal failure
318439|NCT01582854|Post-Stroke Cognitive Impairment (PSCI)|post-stroke cognitive impairment (psci)
318440|NCT01582854|Stroke|stroke
318441|NCT01582854|Actovegin|actovegin
318442|NCT01582854|Cognition disorders|cognition disorders
318443|NCT01582841|Colon Cancer|colon cancer
318444|NCT01582841|Lynch Syndrome|lynch syndrome
318445|NCT01582841|Genetic Screening|genetic screening
318447|NCT01582828|fibrillation|fibrillation
318448|NCT01582828|pvi|pvi
318449|NCT01582828|vats|vats
318450|NCT01582828|ablation|ablation
318451|NCT01582828|hybrid|hybrid
318452|NCT01582737|Xarelto|xarelto
318453|NCT01582737|SPAF|spaf
318454|NCT01582724|Menstrual pain|menstrual pain
318455|NCT01582724|Primary dysmenorrhea|primary dysmenorrhea
318456|NCT01582724|Self-care acupressure|self-care acupressure
318457|NCT01582711|LTBI|ltbi
318458|NCT01582711|LTB|ltb
318459|NCT01582711|Latent TB|latent tb
318460|NCT01582711|TB infection|tb infection
318461|NCT01582685|Breast Cancer|breast cancer
318462|NCT01582685|Obesity|obesity
318463|NCT01582685|Exercise|exercise
318464|NCT01582685|Angiogenesis|angiogenesis
318465|NCT01582672|RCC|rcc
318466|NCT01582672|Kidney Cancer|kidney cancer
318467|NCT01582659|constipation|constipation
318468|NCT01582659|children|children
318469|NCT01582659|outpatient|outpatient
318470|NCT01582633|vaccine|vaccine
318471|NCT01582633|influenza|influenza
318472|NCT01582633|needle free jet injector|needle free jet injector
318473|NCT01582633|Intradermal|intradermal
318474|NCT01582633|sparing dose|sparing dose
318475|NCT01582620|Cerebrovascular disorders|cerebrovascular disorders
318476|NCT01582620|Telemedicine|telemedicine
318477|NCT01582620|remote consultation|remote consultation
318479|NCT01582620|thrombolysis therapy|thrombolysis therapy
318480|NCT01582620|plasminogen activators|plasminogen activators
318481|NCT01582620|stroke care|stroke care
318482|NCT01582620|stroke management|stroke management
318483|NCT01582594|1000 residual serum/plasma samples|1000 residual serum/plasma samples
318484|NCT01582594|anti-HCV seronegative or seropositive|anti-hcv seronegative or seropositive
318485|NCT01582581|mental health|mental health
318486|NCT01582581|depression|depression
318487|NCT01582581|behavioral health|behavioral health
318488|NCT01582581|cognitive behavioral therapy|cognitive behavioral therapy
318489|NCT01582581|CBT|cbt
752614|NCT01173328|respiratory mechanics|respiratory mechanics
309161|NCT01621945|Serum bactericidal activity|serum bactericidal activity
309162|NCT01621945|OMV vaccine|omv vaccine
309163|NCT01621932|Anterior approach|anterior approach
309164|NCT01621906|Breast|breast
309165|NCT01621906|brain metastases|brain metastases
309193|NCT01621815|PDD|pdd
318490|NCT01582581|computer-assisted psychotherapy|computer-assisted psychotherapy
318491|NCT01582555|mucolysis|mucolysis
318492|NCT01582555|QOL|qol
318493|NCT01582555|endoscopy|endoscopy
318494|NCT01582555|sinus surgery|sinus surgery
318495|NCT01582529|Developmental Outcomes|developmental outcomes
318496|NCT01582529|Psychosocial Outcomes|psychosocial outcomes
318497|NCT01582529|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
318498|NCT01582529|Congenital Heart Disease|congenital heart disease
318499|NCT01582516|brain tumor|brain tumor
318500|NCT01582516|virotherapy|virotherapy
318501|NCT01582516|glioblastoma|glioblastoma
318502|NCT01582516|replication competent adenovirus|replication competent adenovirus
318503|NCT01582490|Mammoplasty|mammoplasty
318504|NCT01582490|Postoperative pain|postoperative pain
318505|NCT01582490|Analgesia|analgesia
318506|NCT01582477|TAP, robot-assisted prostatectomy|tap, robot-assisted prostatectomy
318507|NCT01582464|Protective Headwear|protective headwear
318508|NCT01582464|Social Marketing|social marketing
318509|NCT01582464|Theory of Planned Behavior|theory of planned behavior
318510|NCT01582425|isavuconazole|isavuconazole
318511|NCT01582425|methadone|methadone
318512|NCT01582425|Healthy Volunteers|healthy volunteers
318513|NCT01582425|BAL8557|bal8557
318514|NCT01582412|Isavuconazole|isavuconazole
318515|NCT01582412|Digoxin|digoxin
318516|NCT01582412|Healthy Volunteers|healthy volunteers
318517|NCT01582412|BAL8557|bal8557
318518|NCT01582399|Healthy Volunteers|healthy volunteers
318519|NCT01582399|CD40 receptor occupancy|cd40 receptor occupancy
318520|NCT01582399|Co-stimulation blockade|co-stimulation blockade
318521|NCT01582399|CD40 antigen|cd40 antigen
318522|NCT01582399|Anti-CD40|anti-cd40
318523|NCT01582399|ASKP1240|askp1240
318524|NCT01582360|critical illness|critical illness
318525|NCT01582360|pharmacokinetics|pharmacokinetics
318526|NCT01582360|CRRT|crrt
318527|NCT01582360|CVVH|cvvh
318528|NCT01582360|CVVHD|cvvhd
318529|NCT01582360|CVVHDF|cvvhdf
318530|NCT01582360|antiinfectives|antiinfectives
318531|NCT01582360|antibiotics|antibiotics
318532|NCT01582360|minimum inhibitory concentration|minimum inhibitory concentration
318533|NCT01582360|bacterial killing|bacterial killing
318534|NCT01582360|pharmacodynamics|pharmacodynamics
318535|NCT01582360|PK/PD index|pk/pd index
318536|NCT01582347|Opioid dependence|opioid dependence
318537|NCT01582334|Growth disorders|growth disorders
318538|NCT01582334|Saizen|saizen
318539|NCT01582334|Easypod|easypod
318540|NCT01582334|Growth hormone|growth hormone
318541|NCT01582334|Pediatric subject|pediatric subject
318542|NCT01582321|vascular ultrasound|vascular ultrasound
318543|NCT01582321|flow cytometry|flow cytometry
318544|NCT01582321|platelet aggregation|platelet aggregation
318545|NCT01582295|Bone disease|bone disease
318546|NCT01582282|Type II NIDDM|type ii niddm
318547|NCT01582243|Diabetes Mellitus, type 2|diabetes mellitus, type 2
318548|NCT01582243|vildagliptin|vildagliptin
318549|NCT01582230|Type 2 diabetes mellitus|type 2 diabetes mellitus
318550|NCT01582230|Vildagliptin|vildagliptin
318551|NCT01582217|Bleeding|bleeding
318552|NCT01582217|Risk Score|risk score
318553|NCT01582217|Outcomes|outcomes
318554|NCT01582217|Prasugrel|prasugrel
318555|NCT01582204|clear cell carcinoma|clear cell carcinoma
318556|NCT01582204|Kidney|kidney
318557|NCT01582204|MAB-124I-CG250|mab-124i-cg250
318558|NCT01582204|PET scan|pet scan
318559|NCT01582204|CT scan|ct scan
318560|NCT01582204|sunitinib|sunitinib
318561|NCT01582204|pazopanib|pazopanib
318562|NCT01582204|11-134|11-134
318563|NCT01582191|Advanced Cancers|advanced cancers
318564|NCT01582191|Advanced solid cancer|advanced solid cancer
318565|NCT01582191|Metastatic cancer|metastatic cancer
318566|NCT01582191|Vandetanib|vandetanib
318567|NCT01582191|ZD 6474|zd 6474
318568|NCT01582191|Zactima|zactima
318569|NCT01582191|Caprelsa|caprelsa
318571|NCT01582191|Afinitor|afinitor
318572|NCT01582191|RAD001|rad001
318573|NCT01582191|Multi-kinase Inhibitor|multi-kinase inhibitor
318574|NCT01582178|colonoscopy|colonoscopy
318575|NCT01582178|warm water immersion|warm water immersion
318576|NCT01582178|cool water immersion|cool water immersion
318577|NCT01582152|Brain Neoplasms|brain neoplasms
318578|NCT01582152|Central Nervous System Neoplasms|central nervous system neoplasms
318579|NCT01582152|Recurrent Glioblastoma|recurrent glioblastoma
318580|NCT01582152|Glioblastoma multiforme|glioblastoma multiforme
318581|NCT01582152|GBM|gbm
318582|NCT01582152|Gliosarcoma|gliosarcoma
318583|NCT01582152|TPI287|tpi287
318584|NCT01582152|Bevacizumab|bevacizumab
318585|NCT01582152|Avastin|avastin
318586|NCT01582152|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
318587|NCT01582152|rhuMAb-VEGF|rhumab-vegf
318588|NCT01582139|Artificial Pancreas Project|artificial pancreas project
318589|NCT01582139|AP Platform|ap platform
318590|NCT01582139|Insulin Pump|insulin pump
318591|NCT01582139|Continuous Glucose Monitor|continuous glucose monitor
318592|NCT01582139|Closed-Loop Control|closed-loop control
318593|NCT01582139|Control-to-Range|control-to-range
318594|NCT01582126|multiple sclerosis|multiple sclerosis
318595|NCT01582126|physical therapy|physical therapy
318596|NCT01582126|postural control|postural control
318597|NCT01582087|acute hepatic failure|acute hepatic failure
318598|NCT01582087|chronic hepatic failure|chronic hepatic failure
318599|NCT01582087|coma|coma
318600|NCT01582074|Ultrasound Tomography|ultrasound tomography
318601|NCT01582074|Tamoxifen|tamoxifen
318602|NCT01582074|Breast Cancer|breast cancer
318603|NCT01582074|Estrogen Receptor Positive|estrogen receptor positive
318604|NCT01582074|Breast Density|breast density
318605|NCT01582061|Cushing's disease|cushing's disease
318606|NCT01582061|Hormone disorder|hormone disorder
318607|NCT01582061|Cortisol|cortisol
318608|NCT01582061|Adrenocorticotropic hormone|adrenocorticotropic hormone
318609|NCT01582061|Pituitary tumor|pituitary tumor
318610|NCT01582035|Hepatitis C|hepatitis c
318611|NCT01582035|TMC647055HPC1005|tmc647055hpc1005
318612|NCT01582035|TMC647055|tmc647055
318613|NCT01582035|telaprevir|telaprevir
318614|NCT01581996|Chronic renal failure|chronic renal failure
318615|NCT01581996|End-stage renal disease|end-stage renal disease
318616|NCT01581996|Chronic peritoneal dialysis|chronic peritoneal dialysis
318617|NCT01581996|Serum phosphorus|serum phosphorus
318618|NCT01581996|Hyperphosphatemia|hyperphosphatemia
318619|NCT01581996|Phosphate binders|phosphate binders
318620|NCT01581996|Phosphate|phosphate
318621|NCT01581970|head and neck cancer|head and neck cancer
318622|NCT01581970|metastatic squamous cell cancer|metastatic squamous cell cancer
318623|NCT01581957|Enteral nutrition, critically ill patients|enteral nutrition, critically ill patients
318624|NCT01581944|myomectomy|myomectomy
318625|NCT01581944|GnRH|gnrh
318626|NCT01581944|blood loss|blood loss
318627|NCT01581905|Hysterectomy|hysterectomy
318628|NCT01581905|Laparoscopy|laparoscopy
318629|NCT01581905|Robotics|robotics
318630|NCT01581892|bone nonunion|bone nonunion
318631|NCT01581892|bone marrow|bone marrow
318632|NCT01581892|mononuclear|mononuclear
318633|NCT01581892|fracture|fracture
318634|NCT01581879|Bioequivalence|bioequivalence
318635|NCT01581879|Ziprasidone hydrochloride|ziprasidone hydrochloride
318636|NCT01581879|crossover|crossover
318637|NCT01581866|Bioequivalence|bioequivalence
318638|NCT01581866|Ziprasidone hydrochloride|ziprasidone hydrochloride
318639|NCT01581866|crossover|crossover
318640|NCT01581853|HIV|hiv
318641|NCT01581853|AIDS|aids
318642|NCT01581853|MONOTHERAPY|monotherapy
318643|NCT01581853|PILOT|pilot
318644|NCT01581853|LOPINAVIR/RITONAVIR|lopinavir/ritonavir
318645|NCT01581840|anus|anus
318646|NCT01581840|carcinoma|carcinoma
318647|NCT01581840|panitumumab|panitumumab
318648|NCT01581840|mitomycine|mitomycine
318650|NCT01581840|radiotherapy|radiotherapy
318651|NCT01581827|Heart Failure|heart failure
318652|NCT01581827|BNP|bnp
318653|NCT01581827|NT-proBNP|nt-probnp
318654|NCT01581814|PCOS|pcos
318655|NCT01581801|gastric bypass|gastric bypass
318656|NCT01581801|sleeve gastrectomy|sleeve gastrectomy
318657|NCT01581801|reactive hypoglycemia|reactive hypoglycemia
318658|NCT01581788|Bioequivalence|bioequivalence
318659|NCT01581788|Divalproex Sodium|divalproex sodium
318660|NCT01581788|Crossover|crossover
318661|NCT01581775|Bioequivalence|bioequivalence
318662|NCT01581775|Divalproex Sodium|divalproex sodium
318663|NCT01581775|Crossover|crossover
318664|NCT01581762|EUS, FNA|eus, fna
318665|NCT01581749|low risk prostate cancer|low risk prostate cancer
318666|NCT01581749|intermediate risk prostate cancer|intermediate risk prostate cancer
318667|NCT01581749|stereotactic radiosurgery|stereotactic radiosurgery
318668|NCT01581736|insulin resistance|insulin resistance
318669|NCT01581736|mitochondria|mitochondria
318670|NCT01581723|urinary bladder tumor|urinary bladder tumor
318671|NCT01581723|monopolar TURBT|monopolar turbt
318672|NCT01581723|bipolar TURBT|bipolar turbt
318673|NCT01581710|Leukotriene Antagonists|leukotriene antagonists
318674|NCT01581710|Bronchial Hyperreactivity|bronchial hyperreactivity
318675|NCT01581697|oat|oat
318676|NCT01581697|cholesterol|cholesterol
318677|NCT01581697|children|children
318678|NCT01581697|adolescent|adolescent
6243|NCT03251014|Healthy overweight subjects|healthy overweight subjects
318679|NCT01581697|Level reduction of ceric cholesterol|level reduction of ceric cholesterol
318680|NCT01581645|Parkinson's disease|parkinson's disease
318681|NCT01581645|Parkinsonism|parkinsonism
318682|NCT01581645|Gait problems|gait problems
318683|NCT01581645|Freezing gait|freezing gait
318684|NCT01581632|atherosclerosis|atherosclerosis
318685|NCT01581632|endothelial dysfunction|endothelial dysfunction
318686|NCT01581632|coronary vasospasm|coronary vasospasm
318687|NCT01581619|Early Invasive N0|early invasive n0
318688|NCT01581619|Non-Invasive|non-invasive
318689|NCT01581606|Age Related Macular Degeneration|age related macular degeneration
318690|NCT01581606|Teleophthalmology|teleophthalmology
318691|NCT01581606|Screening|screening
318692|NCT01581606|Diagnosis|diagnosis
318693|NCT01581606|Timing|timing
318694|NCT01581606|Treatment|treatment
318695|NCT01581593|Primary Immunodeficiency|primary immunodeficiency
318697|NCT01581593|Agammaglobulinemia|agammaglobulinemia
318698|NCT01581593|Hypogammaglobulinemia|hypogammaglobulinemia
318699|NCT01581593|Antibody deficiency|antibody deficiency
318700|NCT01581580|Parkinson's Disease|parkinson's disease
318701|NCT01581580|Deep Brain Stimulation|deep brain stimulation
318702|NCT01581580|Neurophysiology|neurophysiology
318703|NCT01581580|Movement Disorder|movement disorder
318704|NCT01581580|Essential Tremor|essential tremor
318705|NCT01581580|Parkinson Disease|parkinson disease
318706|NCT01581567|Storage|storage
318707|NCT01581567|Repository|repository
318708|NCT01581567|Samples|samples
318709|NCT01581567|Data|data
318710|NCT01581554|Hepatitis B|hepatitis b
318711|NCT01581554|Treatment|treatment
318712|NCT01581554|Nucleoside/Nucleotide Analogue|nucleoside/nucleotide analogue
318713|NCT01581541|Targeted Therapy|targeted therapy
318714|NCT01581541|Solid Tumors|solid tumors
318715|NCT01581541|Lymphoma|lymphoma
318716|NCT01581541|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
318717|NCT01581541|Solid Tumor|solid tumor
318718|NCT01581528|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
318719|NCT01581528|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
318720|NCT01581528|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
318721|NCT01581528|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
318722|NCT01581502|Anticoagulation|anticoagulation
318723|NCT01581502|Recurrent stroke|recurrent stroke
318724|NCT01581502|Bleeding|bleeding
318725|NCT01581489|Cord clamping|cord clamping
318726|NCT01581489|iron deficiency|iron deficiency
318727|NCT01581489|Neurodevelopment|neurodevelopment
318728|NCT01581476|Adolescence|adolescence
318729|NCT01581463|pharmacokinetics of oral T3|pharmacokinetics of oral t3
318730|NCT01581450|Hyperalgesia and pain|hyperalgesia and pain
318731|NCT01581437|atrial fibrillation|atrial fibrillation
318732|NCT01581437|cardiac ablation|cardiac ablation
318733|NCT01581424|Fabry disease|fabry disease
318734|NCT01581424|kidney function|kidney function
318735|NCT01581424|kidney structure morphometry|kidney structure morphometry
318736|NCT01581424|Fabry kidney disease|fabry kidney disease
318737|NCT01581424|Podocytes|podocytes
318738|NCT01581411|central retinal vein occlusion|central retinal vein occlusion
318739|NCT01581411|macular edema|macular edema
318740|NCT01581411|vision loss|vision loss
318741|NCT01581411|rtelative afferent papillary defect|rtelative afferent papillary defect
318742|NCT01581398|Peginterferon|peginterferon
318743|NCT01581398|Pegasys|pegasys
318744|NCT01581398|Sustained virus response|sustained virus response
318746|NCT01581385|atherosclerosis|atherosclerosis
318747|NCT01581385|carotid artery|carotid artery
318748|NCT01581385|carotid endarterectomy|carotid endarterectomy
318749|NCT01581359|Endometriosis|endometriosis
318750|NCT01581359|GnRH treatment|gnrh treatment
318751|NCT01581359|Infertility|infertility
318752|NCT01581359|IVF|ivf
318753|NCT01581346|NSCLC|nsclc
318754|NCT01581346|exercise intervention|exercise intervention
318755|NCT01581346|quality of life|quality of life
318756|NCT01581333|febrile neutropenia|febrile neutropenia
318757|NCT01581333|antimicrobial treatment|antimicrobial treatment
318758|NCT01581333|procalcitonin|procalcitonin
318759|NCT01581307|liver|liver
318760|NCT01581307|pancreas|pancreas
318761|NCT01581307|chemotherapy|chemotherapy
318762|NCT01581307|radiotherapy|radiotherapy
318763|NCT01581294|Rheumatoid arthritis|rheumatoid arthritis
318764|NCT01581294|Psoriatic arthritis|psoriatic arthritis
318765|NCT01581294|Ankylosing spondylitis|ankylosing spondylitis
318766|NCT01581294|Spondyloarthritis|spondyloarthritis
318767|NCT01581281|Pediatric|pediatric
318768|NCT01581281|Children|children
318769|NCT01581281|Adolescent|adolescent
318770|NCT01581281|Headache|headache
318771|NCT01581281|Migraine|migraine
318772|NCT01581255|acute respiratory distress syndrome|acute respiratory distress syndrome
318773|NCT01581255|high frequency oscillation ventilation|high frequency oscillation ventilation
318774|NCT01581255|ventilator-induced lung injury|ventilator-induced lung injury
318775|NCT01581255|biomarkers|biomarkers
318776|NCT01581242|Clevudine and Adefovir dipivoxil|clevudine and adefovir dipivoxil
318777|NCT01581242|pharmacokinetic drug drug interaction|pharmacokinetic drug drug interaction
318778|NCT01581242|oral administration|oral administration
318779|NCT01581242|male subjects|male subjects
318780|NCT01581229|ALI;noninvasive positive pressure ventilation|ali;noninvasive positive pressure ventilation
318781|NCT01581216|Fatigue|fatigue
318782|NCT01581216|Palliative Care|palliative care
318783|NCT01581216|Exercise|exercise
318784|NCT01581190|Bananas|bananas
318785|NCT01581190|Exercise|exercise
318786|NCT01581190|Metabolomics|metabolomics
318787|NCT01581190|Oxidative stress|oxidative stress
318788|NCT01581190|Inflammation|inflammation
318789|NCT01581190|Immune function|immune function
318790|NCT01581177|asthma|asthma
318791|NCT01581177|mild-to-moderate persistent asthma|mild-to-moderate persistent asthma
318792|NCT01581177|mild asthma|mild asthma
318793|NCT01581177|moderate asthma|moderate asthma
318794|NCT01581177|persistent asthma|persistent asthma
318795|NCT01581164|blood|blood
318796|NCT01581164|hematopoietic|hematopoietic
318797|NCT01581164|stem|stem
318798|NCT01581164|cell|cell
318799|NCT01581164|transplant|transplant
318800|NCT01581164|vaccine|vaccine
318801|NCT01581164|vaccination|vaccination
318802|NCT01581164|recovery|recovery
318803|NCT01581164|immune|immune
318804|NCT01581164|system|system
318805|NCT01581151|retinal vein occlusion|retinal vein occlusion
318806|NCT01581151|ozurdex|ozurdex
318807|NCT01581151|lucentis|lucentis
318808|NCT01581151|BCVA|bcva
318809|NCT01581151|foveal thickness|foveal thickness
318810|NCT01581125|Inpatients|inpatients
318811|NCT01581125|Health Normalcy|health normalcy
318812|NCT01581125|circadian rhythm|circadian rhythm
318813|NCT01581099|Atherosclerosis|atherosclerosis
318814|NCT01581099|Cardiovascular risk factors|cardiovascular risk factors
318815|NCT01581099|Calorie restriction|calorie restriction
318816|NCT01581099|Bariatric Surgery|bariatric surgery
318817|NCT01581086|HIV|hiv
318818|NCT01581086|COPD|copd
318819|NCT01581086|Pulmonary disease|pulmonary disease
318820|NCT01581073|renal anemia|renal anemia
318821|NCT01581073|erythropoiesis stimulating agent|erythropoiesis stimulating agent
318822|NCT01581073|hemoglobin|hemoglobin
318823|NCT01581073|non-diabetes|non-diabetes
318824|NCT01581073|CKD|ckd
318825|NCT01581073|Chronic Kidney Disease patients without diabetes|chronic kidney disease patients without diabetes
318826|NCT01581047|amoxicillin|amoxicillin
318827|NCT01581047|clavulanic acid|clavulanic acid
318828|NCT01581047|cefuroxime|cefuroxime
318829|NCT01581047|Patients in the intensive care unit, with an infection which requires amoxicillin/clavulanic acid or cefuroxime|patients in the intensive care unit, with an infection which requires amoxicillin/clavulanic acid or cefuroxime
318830|NCT01581034|endothelial function|endothelial function
318831|NCT01581034|biomarkers|biomarkers
318832|NCT01581034|autonomic nervous system|autonomic nervous system
318833|NCT01581034|coronary artery disease|coronary artery disease
318834|NCT01581021|randomized|randomized
318835|NCT01581021|controlled|controlled
318836|NCT01581021|hooks|hooks
318837|NCT01581021|screws|screws
318838|NCT01581008|palliative care|palliative care
318839|NCT01581008|heart failure|heart failure
318840|NCT01581008|delivery of health care|delivery of health care
318841|NCT01580995|Chronic hepatitis C infection|chronic hepatitis c infection
318842|NCT01580982|Oncogenes|oncogenes
318843|NCT01580982|Lung and Other Thoracic Cancers|lung and other thoracic cancers
318844|NCT01580969|glioma|glioma
318845|NCT01580956|Acute respiratory failure|acute respiratory failure
318846|NCT01580956|Critical illness|critical illness
318847|NCT01580956|Mechanical ventilation|mechanical ventilation
318848|NCT01580956|Ventilation weaning|ventilation weaning
318849|NCT01580956|Intensive Care Unit|intensive care unit
318850|NCT01580956|Variable (NOISY) PSV|variable (noisy) psv
318851|NCT01580956|PSV|psv
318852|NCT01580943|Chlorhexidine|chlorhexidine
318853|NCT01580943|Cetyl pyridinium chloride|cetyl pyridinium chloride
318854|NCT01580943|Mouth rinse|mouth rinse
318855|NCT01580943|Antiplaque Efficacy|antiplaque efficacy
318856|NCT01580943|Self Efficacy|self efficacy
318857|NCT01580943|Taste Sweet|taste sweet
318858|NCT01580943|Side Effects|side effects
318859|NCT01580930|physical inactivity|physical inactivity
318860|NCT01580930|exercise training|exercise training
318861|NCT01580930|sedentary time|sedentary time
318862|NCT01580930|habitual physical activity|habitual physical activity
318863|NCT01580917|laser doppler anemometry|laser doppler anemometry
318864|NCT01580917|dynamic testing of tissue mechanical property|dynamic testing of tissue mechanical property
318865|NCT01580917|diabetic foot complications|diabetic foot complications
318866|NCT01580917|ulcer genesis|ulcer genesis
318867|NCT01580904|Pharmaceutical Care|pharmaceutical care
318868|NCT01580904|Diabetics patients|diabetics patients
318869|NCT01580904|Clinical trial|clinical trial
318870|NCT01580891|Naftifine HCl Cream 1%|naftifine hcl cream 1%
318871|NCT01580891|Naftin® (Naftifine HCl) Cream 1%|naftin® (naftifine hcl) cream 1%
318872|NCT01580891|Tinea Pedis|tinea pedis
318873|NCT01580891|Efficacy and safety|efficacy and safety
318874|NCT01580878|Butenafine Hydrochloride Cream, 1%|butenafine hydrochloride cream, 1%
6245|NCT03251001|gingiva|gingiva
318875|NCT01580878|Lotrimin Ultra® Cream, 1%|lotrimin ultra® cream, 1%
318876|NCT01580878|Interdigital Tinea Pedis|interdigital tinea pedis
318877|NCT01580878|Safety and Bioequivalence|safety and bioequivalence
318878|NCT01580865|Lupus nephritis|lupus nephritis
318879|NCT01580865|Tacrolimus|tacrolimus
318880|NCT01580865|Mycophenolate mofetil|mycophenolate mofetil
318881|NCT01580865|Complete remission|complete remission
318882|NCT01580839|ischemic stroke|ischemic stroke
318883|NCT01580839|ischemic penumbra|ischemic penumbra
318884|NCT01580839|magnetic resonance imaging|magnetic resonance imaging
318886|NCT01580839|diffusion imaging|diffusion imaging
318887|NCT01580839|DWI|dwi
318888|NCT01580839|perfusion imaging|perfusion imaging
318889|NCT01580839|PWI|pwi
318890|NCT01580839|thrombolysis|thrombolysis
318891|NCT01580839|alteplase|alteplase
318892|NCT01580839|tPA|tpa
318893|NCT01580839|EPITHET|epithet
318894|NCT01580826|pasteurization|pasteurization
318895|NCT01580826|human milk|human milk
318896|NCT01580826|very low birth weight infants|very low birth weight infants
318897|NCT01580813|diabetes|diabetes
318898|NCT01580813|exercise|exercise
318899|NCT01580813|cardiovascular|cardiovascular
318900|NCT01580813|heart|heart
318901|NCT01580813|insulin sensitivity|insulin sensitivity
318902|NCT01580787|Parkinson´s disease|parkinson´s disease
318903|NCT01580787|Postural Balance|postural balance
318904|NCT01580787|virtual reality|virtual reality
318905|NCT01580735|NSCLC|nsclc
318906|NCT01580735|c-MET|c-met
318907|NCT01580735|EGFR mutation-positive|egfr mutation-positive
318908|NCT01580735|gefitinib|gefitinib
318909|NCT01580735|erlotinib|erlotinib
318910|NCT01580735|EGFR-TKI resistance|egfr-tki resistance
318911|NCT01580722|Anterior Cruciate Ligament,Early,Delay,Reconstruction|anterior cruciate ligament,early,delay,reconstruction
318912|NCT01580709|stricture|stricture
318913|NCT01580709|cholangiocarcinoma|cholangiocarcinoma
318914|NCT01580709|pancreatic adenocarcinoma|pancreatic adenocarcinoma
318915|NCT01580709|bile duct|bile duct
318916|NCT01580709|ERCP|ercp
318917|NCT01580696|Folate binding protein|folate binding protein
318918|NCT01580696|E39 vaccine|e39 vaccine
318919|NCT01580696|Stage I-IV ovarian cancer|stage i-iv ovarian cancer
318920|NCT01580696|Stage I-IV endometrial cancer|stage i-iv endometrial cancer
318921|NCT01580683|Atrial Fibrillation|atrial fibrillation
318922|NCT01580683|Ascorbic Acid|ascorbic acid
318923|NCT01580683|Thoracic Surgery|thoracic surgery
318924|NCT01580683|Cardiac Arrhythmias|cardiac arrhythmias
318925|NCT01580683|Cardiac Surgery|cardiac surgery
318926|NCT01580683|Vitamin C|vitamin c
318927|NCT01580683|Postoperative Complications|postoperative complications
318928|NCT01580683|Antioxidants|antioxidants
318929|NCT01580683|Inflammation|inflammation
318930|NCT01580670|Infliximab|infliximab
318931|NCT01580670|REMICADE|remicade
318932|NCT01580670|TA-650|ta-650
318933|NCT01580670|pediatric Crohn's disease|pediatric crohn's disease
318934|NCT01580657|HIV|hiv
318935|NCT01580657|Prevention|prevention
318936|NCT01580657|Methods|methods
318937|NCT01580657|Assessment reactivity|assessment reactivity
318938|NCT01580657|South Africa|south africa
318939|NCT01580657|Youth|youth
318940|NCT01580631|Narrow band imaging|narrow band imaging
318941|NCT01580631|Barrett's esophagus|barrett's esophagus
318942|NCT01580631|Gastroesophageal reflux disease|gastroesophageal reflux disease
318943|NCT01580618|pleural effusion|pleural effusion
318944|NCT01580618|malignancy|malignancy
318945|NCT01580618|loculated|loculated
318946|NCT01580579|Radiation pneumonitis|radiation pneumonitis
318947|NCT01580579|locally advanced lung cancer|locally advanced lung cancer
318948|NCT01580579|Respiratory function tests|respiratory function tests
318949|NCT01580566|Myocardial Infarction (MI)|myocardial infarction (mi)
318950|NCT01580566|Kidney function|kidney function
318951|NCT01580566|bio-markers|bio-markers
318952|NCT01580553|Heart failure|heart failure
318953|NCT01580553|L-carnitine|l-carnitine
318954|NCT01580553|injection|injection
318955|NCT01580553|safety|safety
318956|NCT01580553|efficacy|efficacy
318957|NCT01580527|postoperative artificial nutrition|postoperative artificial nutrition
318958|NCT01580527|parenteral nutrition|parenteral nutrition
318959|NCT01580527|enteral nutrition|enteral nutrition
318960|NCT01580527|postoperative complications|postoperative complications
318961|NCT01580527|cephalic pancreatoduodenectomy|cephalic pancreatoduodenectomy
318962|NCT01580514|myocardial infarction|myocardial infarction
318963|NCT01580514|percutaneous coronary intervention|percutaneous coronary intervention
318964|NCT01580514|exenatide|exenatide
318965|NCT01580514|reperfusion injury|reperfusion injury
318966|NCT01580514|cardiac magnetic resonance|cardiac magnetic resonance
318967|NCT01580475|glycemic control,|glycemic control,
318968|NCT01580475|exercise training,|exercise training,
318969|NCT01580475|detraining,|detraining,
318970|NCT01580475|retraining,|retraining,
318971|NCT01580475|body composition,|body composition,
318972|NCT01580475|strength and fitness|strength and fitness
318973|NCT01580462|continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
318974|NCT01580462|children|children
318975|NCT01580462|adolescent|adolescent
318976|NCT01580436|Tricuspid Valve Insufficiency|tricuspid valve insufficiency
318977|NCT01580436|Cardiac Valve Annuloplasty|cardiac valve annuloplasty
318978|NCT01580436|Outcome Assessment (Health Care)|outcome assessment (health care)
318979|NCT01580423|dyspnea|dyspnea
318980|NCT01580397|Pancreatic cancer|pancreatic cancer
318981|NCT01580397|INNO-206|inno-206
318982|NCT01580397|Doxorubicin-EMCH|doxorubicin-emch
318983|NCT01580358|cancer|cancer
318984|NCT01580358|radiotherapy|radiotherapy
318985|NCT01580358|chemotherapy|chemotherapy
318986|NCT01580358|Traditional Chinese Medicine|traditional chinese medicine
318987|NCT01580358|Safety|safety
318988|NCT01580345|DHA|dha
318989|NCT01580345|Omega 3 fatty acid|omega 3 fatty acid
318990|NCT01580345|Decosa hexaenoic acid|decosa hexaenoic acid
318991|NCT01580345|Pregnancy|pregnancy
318992|NCT01580345|Newborn outcome|newborn outcome
318993|NCT01580345|Supplementation|supplementation
318994|NCT01580345|Birth size|birth size
318995|NCT01580345|gestational age|gestational age
318996|NCT01580345|India|india
318997|NCT01580345|Randomized controlled trial|randomized controlled trial
318998|NCT01580345|RCT|rct
318999|NCT01580332|biomarkers|biomarkers
319000|NCT01580332|lung cancer|lung cancer
319001|NCT01580332|solitary pulmonary nodules|solitary pulmonary nodules
319002|NCT01580332|SPN|spn
319003|NCT01580332|breath analysis|breath analysis
319004|NCT01580332|VOC|voc
319005|NCT01580332|volatile organic compounds|volatile organic compounds
319006|NCT01580332|sputum|sputum
319007|NCT01580332|auto-antibodies|auto-antibodies
319008|NCT01580319|obesity|obesity
319009|NCT01580319|cholesterol|cholesterol
319010|NCT01580319|cholesterol, LDL|cholesterol, ldl
319011|NCT01580319|cholesterol, HDL|cholesterol, hdl
319012|NCT01580319|blood glucose|blood glucose
319013|NCT01580319|Triglyceride|triglyceride
319014|NCT01580319|C-Reactive Protein - hs|c-reactive protein - hs
319015|NCT01580319|blood pressure|blood pressure
319016|NCT01580319|physical activity|physical activity
319017|NCT01580319|Sedentary Lifestyle|sedentary lifestyle
319018|NCT01580293|Hemophilia A, factor VIII, prophylaxis|hemophilia a, factor viii, prophylaxis
319019|NCT01580280|Cervicogenic|cervicogenic
319020|NCT01580280|Headache|headache
319021|NCT01580280|Neck Pain|neck pain
319022|NCT01580280|Manipulation|manipulation
319023|NCT01580280|Mobilization|mobilization
319024|NCT01580280|Exercise|exercise
319025|NCT01580267|Anemia in trauma|anemia in trauma
319026|NCT01580254|Latanoprost|latanoprost
319027|NCT01580254|IOP|iop
319028|NCT01580215|Valves|valves
319029|NCT01580215|Endobronchial|endobronchial
319030|NCT01580215|Endoscopic lung volume reduction|endoscopic lung volume reduction
319031|NCT01580215|Pulmonx|pulmonx
319032|NCT01580215|Zephyr|zephyr
319033|NCT01580215|Chartis|chartis
319034|NCT01580215|Emphysema|emphysema
319035|NCT01580215|COPD|copd
319036|NCT01580202|malignancy|malignancy
319037|NCT01580202|hepatitis B|hepatitis b
319038|NCT01580202|lamivudine|lamivudine
319039|NCT01580202|entecavir|entecavir
319040|NCT01580202|prophylaxis|prophylaxis
319041|NCT01580189|Lean tissue|lean tissue
319042|NCT01580189|Strength condition|strength condition
319043|NCT01580189|Protein|protein
319044|NCT01580189|Amino Acid|amino acid
319045|NCT01580163|the opioid dependence in rehabilitation phase|the opioid dependence in rehabilitation phase
319046|NCT01580163|community|community
319047|NCT01580150|Berries|berries
319048|NCT01580150|Starch|starch
319049|NCT01580150|Sucrose|sucrose
319050|NCT01580150|Glucose|glucose
319051|NCT01580150|Insulin|insulin
319052|NCT01580150|Postprandial|postprandial
319053|NCT01580137|acute respiratory tract infection|acute respiratory tract infection
319054|NCT01580137|common cold|common cold
319055|NCT01580137|acute bacterial rhinosinusitis|acute bacterial rhinosinusitis
319056|NCT01580137|adult|adult
319057|NCT01580137|conscript|conscript
319058|NCT01580111|Blood|blood
319059|NCT01580111|Storage|storage
319060|NCT01580111|Age|age
319061|NCT01580111|Transfusion|transfusion
319062|NCT01580111|Lactic acidosis|lactic acidosis
319063|NCT01580085|Sleep disordered breathing|sleep disordered breathing
319064|NCT01580085|gender|gender
319065|NCT01580085|hypercoagulability|hypercoagulability
319066|NCT01580046|Chronic Kidney Disease|chronic kidney disease
319067|NCT01580046|Coronary Angiography|coronary angiography
319068|NCT01580046|Contrast Media|contrast media
319069|NCT01580046|Percutaneous Coronary Intervention|percutaneous coronary intervention
319070|NCT01580046|Serum Creatinine|serum creatinine
319071|NCT01580046|Glomerular Filtration Rate|glomerular filtration rate
319072|NCT01580046|Iodixanol|iodixanol
319073|NCT01580046|Iopromide|iopromide
319074|NCT01580033|immunogenicity|immunogenicity
319075|NCT01580033|safety|safety
319076|NCT01580033|group A, C polysaccharide meningitis|group a, c polysaccharide meningitis
319077|NCT01580033|type b haemophilus Influenza|type b haemophilus influenza
319273|NCT01579266|Dystonia|dystonia
319078|NCT01580020|Macular Degeneration|macular degeneration
319079|NCT01580020|Macular Edema|macular edema
319080|NCT01580020|Retinal Vein Occlusion|retinal vein occlusion
319081|NCT01580020|Choroidal Neovascularization|choroidal neovascularization
319082|NCT01580020|Signs and Symptoms|signs and symptoms
319083|NCT01580020|Retinal Degeneration|retinal degeneration
319084|NCT01580020|Retinal Diseases|retinal diseases
319085|NCT01580020|Eye Diseases|eye diseases
319086|NCT01580020|Venous Thrombosis Sensation Disorders|venous thrombosis sensation disorders
319087|NCT01580020|Dexamethasone acetate|dexamethasone acetate
319088|NCT01580020|Dexamethasone|dexamethasone
319089|NCT01580020|Dexamethasone 21-phosphate|dexamethasone 21-phosphate
319090|NCT01580020|BB 1101|bb 1101
319091|NCT01580020|Anti-Inflammatory Agents|anti-inflammatory agents
319092|NCT01580020|Therapeutic Uses|therapeutic uses
319093|NCT01580020|Vision, Low|vision, low
319094|NCT01580020|Signs|signs
319095|NCT01580020|Vision Disorders|vision disorders
319096|NCT01580007|tuberculosis|tuberculosis
319097|NCT01580007|phenylbutyrate|phenylbutyrate
319098|NCT01580007|vitamin D|vitamin d
319099|NCT01580007|cathelicidin|cathelicidin
319100|NCT01580007|antimicrobial peptide|antimicrobial peptide
319101|NCT01580007|in adults|in adults
319102|NCT01579994|adenocarcinoma|adenocarcinoma
319103|NCT01579994|Lung|lung
319104|NCT01579994|Metastatic|metastatic
319105|NCT01579994|Crizotinib|crizotinib
319106|NCT01579994|Ganetespib|ganetespib
319107|NCT01579994|STA-9090|sta-9090
319108|NCT01579994|ALK Positive Lung Cancers|alk positive lung cancers
319109|NCT01579994|12-015|12-015
319110|NCT01579981|RYGB|rygb
319111|NCT01579981|Bariatric Surgery|bariatric surgery
319112|NCT01579981|Glucagon-like-peptide 1|glucagon-like-peptide 1
319114|NCT01579942|Biomarker|biomarker
319115|NCT01579942|Major Depressive Disorder|major depressive disorder
319116|NCT01579942|Healthy Control|healthy control
319117|NCT01579929|Extensive Stage Small Cell Lung Cancer (ES-SCLC)|extensive stage small cell lung cancer (es-sclc)
319118|NCT01579929|CISPLATIN|cisplatin
319119|NCT01579929|ETOPOSIDE (VP-16)|etoposide (vp-16)
319120|NCT01579929|LDE-225|lde-225
319121|NCT01579929|STAR|star
319122|NCT01579929|Symptom Tracking and Reporting for Patients|symptom tracking and reporting for patients
319123|NCT01579929|11-206|11-206
319124|NCT01579916|Trivalent, Influenza, FluMist, Vaccine, Prevention|trivalent, influenza, flumist, vaccine, prevention
319125|NCT01579903|Hemophilia A|hemophilia a
319126|NCT01579903|moroctocog alfa (AF-CC)|moroctocog alfa (af-cc)
319127|NCT01579903|ReFacto AF|refacto af
319128|NCT01579903|dual-chamber syringe|dual-chamber syringe
319129|NCT01579903|bioavailability|bioavailability
319130|NCT01579877|Xerostomia|xerostomia
319131|NCT01579877|Yukmijihwang-tang|yukmijihwang-tang
319132|NCT01579877|Yin-Deficiency|yin-deficiency
319133|NCT01579877|Visual analogue scale|visual analogue scale
319134|NCT01579877|Dry mouth symptom questionnaire|dry mouth symptom questionnaire
319135|NCT01579812|Ovarian, Fallopian Tube, and Primary Peritoneal Cancer|ovarian, fallopian tube, and primary peritoneal cancer
319136|NCT01579786|post operative pain|post operative pain
319137|NCT01579786|acupuncture|acupuncture
319138|NCT01579760|radiation|radiation
319139|NCT01579760|retinopathy|retinopathy
319140|NCT01579760|macular edema|macular edema
319141|NCT01579760|anti-VEGF|anti-vegf
319142|NCT01579760|VEGF-Trap|vegf-trap
319143|NCT01579760|aflibercept|aflibercept
319144|NCT01579747|nerve stimulation|nerve stimulation
319145|NCT01579747|ultrasound|ultrasound
319146|NCT01579747|sciatic nerve block|sciatic nerve block
319147|NCT01579747|popliteal block|popliteal block
319148|NCT01579747|obese|obese
319149|NCT01579734|breast cancer chemoprevention postmenopause|breast cancer chemoprevention postmenopause
319150|NCT01579708|Diet|diet
319151|NCT01579708|Physical activity|physical activity
319152|NCT01579708|Knowledge|knowledge
319153|NCT01579708|Attitudes|attitudes
319154|NCT01579708|Habits|habits
319155|NCT01579708|Lifestyle|lifestyle
319156|NCT01579708|School-based|school-based
319157|NCT01579695|HIV with lipohypertrophy|hiv with lipohypertrophy
319158|NCT01579682|Eating Disorder|eating disorder
319159|NCT01579682|Anorexia Nervosa|anorexia nervosa
319160|NCT01579682|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
319161|NCT01579682|Maudsley|maudsley
319162|NCT01579682|Family-Based Therapy|family-based therapy
319164|NCT01579682|Family Therapy|family therapy
319165|NCT01579669|Autism Spectrum Disorder|autism spectrum disorder
319166|NCT01579669|Primary Care Services|primary care services
319167|NCT01579669|Patient-Provider Communication|patient-provider communication
319168|NCT01579669|Adults|adults
319169|NCT01579643|cornea|cornea
319170|NCT01579643|opacity|opacity
319171|NCT01579643|congenital|congenital
319172|NCT01579630|NSCLC|nsclc
319173|NCT01579630|Nonsquamous|nonsquamous
319174|NCT01579630|Maintenance therapy|maintenance therapy
319175|NCT01579617|pregnancy|pregnancy
319176|NCT01579617|STI|sti
319177|NCT01579617|STD|std
319178|NCT01579604|Loss of upper extremities functions|loss of upper extremities functions
319179|NCT01579604|Nerve transfer|nerve transfer
6336|NCT03250377|Brivaracetam|brivaracetam
6434|NCT03249935|Youth|youth
6529|NCT03249415|Paracrine factors|paracrine factors
752615|NCT01173354|COPD|copd
396018|NCT01259921|PTSD|ptsd
309846|NCT01619150|knee|knee
319180|NCT01579578|Metastatic Gastric Cancer who progress following First Line Therapy and are Ineligible for Treatment with trastuzumab by HER2 Status|metastatic gastric cancer who progress following first line therapy and are ineligible for treatment with trastuzumab by her2 status
319182|NCT01579565|lens replacement|lens replacement
319183|NCT01579552|Questionnaires|questionnaires
319184|NCT01579552|telephone counseling session|telephone counseling session
319185|NCT01579552|10-104|10-104
319186|NCT01579552|Childhood Cancer Survivor Women Post Chest Radiation|childhood cancer survivor women post chest radiation
319187|NCT01579539|Methylprednisolone|methylprednisolone
319188|NCT01579539|Dry Eye Syndrome|dry eye syndrome
319189|NCT01579539|Tear Film|tear film
319190|NCT01579539|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
319191|NCT01579526|Safety and Pharmacokinetics of FP01 in Healthy Volunteers|safety and pharmacokinetics of fp01 in healthy volunteers
319192|NCT01579513|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
319193|NCT01579513|System Inflammatory Response|system inflammatory response
319194|NCT01579513|inflammation|inflammation
319195|NCT01579513|Methylprednisolone|methylprednisolone
319196|NCT01579513|Neonates|neonates
319197|NCT01579513|Steroid|steroid
319198|NCT01579513|Cardiac Surgical Procedures|cardiac surgical procedures
319199|NCT01579513|Children|children
319200|NCT01579513|Infants|infants
319201|NCT01579513|Pediatrics|pediatrics
319202|NCT01579513|Glucocorticoid|glucocorticoid
319203|NCT01579513|Heart Disease|heart disease
319204|NCT01579513|Heart Defects, Congenital|heart defects, congenital
319205|NCT01579513|Cardiovascular Diseases|cardiovascular diseases
319206|NCT01579513|Cardiovascular Abnormalities|cardiovascular abnormalities
319207|NCT01579513|Corticosteroid|corticosteroid
319208|NCT01579513|methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate
319209|NCT01579513|Hormones|hormones
319210|NCT01579513|Physiological Effects of Drugs|physiological effects of drugs
319211|NCT01579513|Randomized Clinical Trial|randomized clinical trial
319212|NCT01579487|Lipolysis|lipolysis
319213|NCT01579487|Cryolipolysis|cryolipolysis
319214|NCT01579487|Fat Reduction|fat reduction
319215|NCT01579461|Pharmacokinetics|pharmacokinetics
319216|NCT01579461|mirabegron|mirabegron
319217|NCT01579461|hepatic impairment|hepatic impairment
319218|NCT01579461|Phase 1|phase 1
319219|NCT01579448|killed oral cholera vaccine|killed oral cholera vaccine
319220|NCT01579448|boosting vaccine regimen|boosting vaccine regimen
319221|NCT01579448|safety and immunogenicity|safety and immunogenicity
319222|NCT01579435|essential tremor|essential tremor
319223|NCT01579435|primary motor cortex|primary motor cortex
319224|NCT01579435|cerebellum|cerebellum
319225|NCT01579435|transcranial direct current stimulation|transcranial direct current stimulation
319226|NCT01579435|electrophysiology|electrophysiology
319227|NCT01579422|schizophrenia|schizophrenia
319228|NCT01579422|treatment|treatment
319229|NCT01579422|social cognition|social cognition
319230|NCT01579409|Nutrition|nutrition
319231|NCT01579409|Arterial stiffness|arterial stiffness
319232|NCT01579409|Endothelial dysfunction|endothelial dysfunction
319233|NCT01579409|Microcirculation|microcirculation
319234|NCT01579409|Cardiac autonomic system.|cardiac autonomic system.
319236|NCT01579396|high cut-off|high cut-off
319237|NCT01579396|Thoracic Surgery|thoracic surgery
319238|NCT01579396|Renal Replacement Therapy|renal replacement therapy
319239|NCT01579383|Migraine Disorders|migraine disorders
319240|NCT01579383|Phase 1|phase 1
319241|NCT01579383|ALD403|ald403
319242|NCT01579370|healthcare associated infections|healthcare associated infections
319243|NCT01579370|multidrug resistant organisms|multidrug resistant organisms
319244|NCT01579370|methicillin resistant staphylococcus aureus|methicillin resistant staphylococcus aureus
319245|NCT01579370|vancomycin resistant enterococcus|vancomycin resistant enterococcus
319246|NCT01579370|clostridium difficile|clostridium difficile
319247|NCT01579370|acinetobacter|acinetobacter
319248|NCT01579357|colorectal carcinoma|colorectal carcinoma
319249|NCT01579357|K-ras wild type|k-ras wild type
319250|NCT01579357|Capecitabine|capecitabine
319251|NCT01579357|Cetuximab|cetuximab
319252|NCT01579357|Oxaliplatin|oxaliplatin
319253|NCT01579357|Pharmacokinetics|pharmacokinetics
319254|NCT01579357|exclude a possible influence of CETUX|exclude a possible influence of cetux
319255|NCT01579357|plasma disposition|plasma disposition
319256|NCT01579357|metabolic activation|metabolic activation
319257|NCT01579357|CCB|ccb
319258|NCT01579357|OxPt|oxpt
319259|NCT01579344|Iodine Radioisotopes|iodine radioisotopes
319260|NCT01579344|Nasolacrimal Duct|nasolacrimal duct
319261|NCT01579344|radiation effects|radiation effects
319262|NCT01579331|IOP|iop
319263|NCT01579331|Tonometry|tonometry
319264|NCT01579331|Pascal|pascal
319265|NCT01579331|Goldmann|goldmann
319266|NCT01579331|DCT|dct
319267|NCT01579331|Dynamic Contour|dynamic contour
319268|NCT01579279|Diabetic neuropathic pain|diabetic neuropathic pain
319269|NCT01579279|Active controlled phase 2 study|active controlled phase 2 study
319270|NCT01579266|Writer's Cramp|writer's cramp
319271|NCT01579266|Focal Hand Dystonia|focal hand dystonia
318885|NCT01580839|MRI|mri
319272|NCT01579266|Writer Cramp|writer cramp
319274|NCT01579253|Recurrent glioblastoma|recurrent glioblastoma
319275|NCT01579253|Radiotherapy|radiotherapy
319276|NCT01579253|PET-MRI|pet-mri
319277|NCT01579253|FET-PET|fet-pet
319278|NCT01579240|physical activity|physical activity
319279|NCT01579240|older adults|older adults
319280|NCT01579240|Internet|internet
319281|NCT01579240|sedentary|sedentary
319282|NCT01579240|multi-week|multi-week
319283|NCT01579240|internet intervention|internet intervention
319284|NCT01579227|Healthy participants|healthy participants
319285|NCT01579214|HIV|hiv
319286|NCT01579214|Africa south of the sahara|africa south of the sahara
319287|NCT01579214|Knowledge of results|knowledge of results
319288|NCT01579214|Communication barriers|communication barriers
319289|NCT01579214|Cellular Phones|cellular phones
319290|NCT01579201|Postpartum Hemorrhage|postpartum hemorrhage
319291|NCT01579201|Uterine Atony|uterine atony
319292|NCT01579201|Obstetric Anesthesia|obstetric anesthesia
319293|NCT01579201|Cesarean Section|cesarean section
319294|NCT01579201|Carbetocin|carbetocin
319295|NCT01579188|NSCLC|nsclc
319296|NCT01579162|Hepatitis|hepatitis
319297|NCT01579162|Fatty Liver|fatty liver
319298|NCT01579123|Laser atherectomy|laser atherectomy
319299|NCT01579123|Critical Limb Ischemia|critical limb ischemia
319300|NCT01579123|Angioplasty|angioplasty
319301|NCT01579110|autoimmune hemolytic anemia|autoimmune hemolytic anemia
319302|NCT01579110|hemolytic anemia|hemolytic anemia
319303|NCT01579110|Levamisole|levamisole
319304|NCT01579110|Treatment of autoimmune hemolytic anemia|treatment of autoimmune hemolytic anemia
319305|NCT01579110|warm antibody dependant autoimmune hemolytic anemia|warm antibody dependant autoimmune hemolytic anemia
319306|NCT01579097|(PN) Parenteral nutrition|(pn) parenteral nutrition
319307|NCT01579097|oral/enteral not possible|oral/enteral not possible
319308|NCT01579058|aortic stenosis|aortic stenosis
319309|NCT01579058|beta-blocker|beta-blocker
319310|NCT01579032|CKD,|ckd,
319311|NCT01578980|Artificial Pancreas|artificial pancreas
319312|NCT01578980|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
319313|NCT01578980|Control-to-Range|control-to-range
319314|NCT01578980|Closed-Loop Control|closed-loop control
319315|NCT01578980|Continuous Glucose Monitor|continuous glucose monitor
319316|NCT01578967|Hodgkin's lymphoma|hodgkin's lymphoma
319317|NCT01578967|Hodgkin lymphoma|hodgkin lymphoma
319318|NCT01578954|Leukemia|leukemia
319319|NCT01578954|Acute Myeloid Leukemia|acute myeloid leukemia
319320|NCT01578941|menstrual migraine|menstrual migraine
319321|NCT01578941|migraine|migraine
319322|NCT01578941|treximet|treximet
319323|NCT01578928|renal, impairment, endstage renal disease|renal, impairment, endstage renal disease
319324|NCT01578928|renal|renal
319325|NCT01578928|impairment|impairment
319326|NCT01578928|endstage renal disease|endstage renal disease
319327|NCT01578902|Prostatic Neoplasms|prostatic neoplasms
319328|NCT01578902|Radiotherapy|radiotherapy
319329|NCT01578902|Hypofractionation|hypofractionation
319330|NCT01578902|Low Risk Prostate Cancer|low risk prostate cancer
319331|NCT01578876|coronary artery disease|coronary artery disease
319332|NCT01578876|angina pectoris|angina pectoris
319333|NCT01578876|myocardial ischemia|myocardial ischemia
319334|NCT01578876|cardiac shock wave therapy|cardiac shock wave therapy
319335|NCT01578863|Childhood obesity|childhood obesity
319336|NCT01578863|Adolescence|adolescence
319337|NCT01578863|Predictors|predictors
319338|NCT01578863|Success|success
319339|NCT01578863|Intervention program|intervention program
319340|NCT01578850|rheumatoid arthritis|rheumatoid arthritis
319341|NCT01578850|etanercept|etanercept
319342|NCT01578850|methotrexate|methotrexate
319343|NCT01578850|DMARDs|dmards
319344|NCT01578824|Rickets|rickets
319345|NCT01578824|Vitamin D|vitamin d
319346|NCT01578824|airway hyperreactivity|airway hyperreactivity
319347|NCT01578824|Exhaled breath condensate|exhaled breath condensate
319348|NCT01578772|HIV|hiv
319349|NCT01578772|Flow-mediated dialation (FMD)|flow-mediated dialation (fmd)
319350|NCT01578772|Telmisartan|telmisartan
319351|NCT01578772|Cardiovascular disease (CVD)|cardiovascular disease (cvd)
319352|NCT01578772|HIV+ men and women age > 50 at risk for heart disease|hiv+ men and women age > 50 at risk for heart disease
319353|NCT01578759|ovarian function tests|ovarian function tests
319354|NCT01578746|Coxarthrosis|coxarthrosis
319355|NCT01578746|Hip arthroplasty|hip arthroplasty
319356|NCT01578746|Anterior approach|anterior approach
319357|NCT01578746|Direct lateral approach|direct lateral approach
319358|NCT01578746|Hardinge approach|hardinge approach
319359|NCT01578746|Smith-Petersen approach|smith-petersen approach
319360|NCT01578746|Osteoarthrosis|osteoarthrosis
319361|NCT01578733|protein requirement|protein requirement
319362|NCT01578733|female elderly|female elderly
319363|NCT01578733|healthy female subject's protein requirements|healthy female subject's protein requirements
319364|NCT01578707|Chronic|chronic
319365|NCT01578707|SLL|sll
319366|NCT01578707|CLL|cll
310044|NCT01618435|ODI|odi
319367|NCT01578707|Ofatumumab|ofatumumab
319368|NCT01578707|ibrutinib|ibrutinib
319369|NCT01578707|RESONATE|resonate
319370|NCT01578707|Phase III|phase iii
319371|NCT01578707|Leukemia|leukemia
319372|NCT01578707|Lymphoma|lymphoma
319373|NCT01578681|bronchiectasis|bronchiectasis
319374|NCT01578681|respiratory therapy|respiratory therapy
319375|NCT01578681|airway clearance|airway clearance
319376|NCT01578668|lung adenocarcinoma|lung adenocarcinoma
319377|NCT01578668|brain metastases|brain metastases
319378|NCT01578668|erlotinib|erlotinib
319379|NCT01578668|pemetrexed|pemetrexed
319380|NCT01578655|custirsen sodium|custirsen sodium
319381|NCT01578655|prostate cancer|prostate cancer
319382|NCT01578655|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
319383|NCT01578655|overall survival|overall survival
319384|NCT01578642|GERD|gerd
319385|NCT01578642|LES Pressure|les pressure
319386|NCT01578642|Electrical Stimulation|electrical stimulation
319387|NCT01578629|stroke|stroke
319388|NCT01578629|ischemia|ischemia
319390|NCT01578616|Coronary artery disease|coronary artery disease
319391|NCT01578616|Endothelial function|endothelial function
319392|NCT01578616|Optical coherence tomography|optical coherence tomography
319393|NCT01578616|Thin cap fibroatheroma|thin cap fibroatheroma
319394|NCT01578603|prevention & control|prevention & control
319395|NCT01578603|Xylitol|xylitol
319396|NCT01578603|casein phosphopeptide amorphous calcium phosphate complex|casein phosphopeptide amorphous calcium phosphate complex
319397|NCT01578603|Streptococcus mutans|streptococcus mutans
319398|NCT01578603|saliva|saliva
319399|NCT01578603|dental plaque|dental plaque
319400|NCT01578603|gingivitis|gingivitis
319401|NCT01578577|Medication Therapy Management|medication therapy management
319402|NCT01578577|Hypertension|hypertension
319403|NCT01578577|Health Literacy|health literacy
319404|NCT01578577|Medication Reconciliation|medication reconciliation
319405|NCT01578577|Medication Adherence|medication adherence
319406|NCT01578564|Cancer|cancer
319407|NCT01578564|Ovarian Cancer|ovarian cancer
319408|NCT01578564|TRPV6 Calcium channel|trpv6 calcium channel
319409|NCT01578551|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
319410|NCT01578551|Lung adenocarcinoma|lung adenocarcinoma
319411|NCT01578538|hernia, abdominal, strangulation, emergency, wall|hernia, abdominal, strangulation, emergency, wall
319412|NCT01578525|medication safety|medication safety
319413|NCT01578525|elderly|elderly
319414|NCT01578525|pharmaceutical care|pharmaceutical care
319415|NCT01578525|hospital readmission|hospital readmission
319416|NCT01578525|drug-related readmission|drug-related readmission
319417|NCT01578525|Health Services for the Aged|health services for the aged
319418|NCT01578499|brentuximab vedotin|brentuximab vedotin
319419|NCT01578499|ALCANZA|alcanza
319420|NCT01578486|Schizophrenia|schizophrenia
319421|NCT01578486|Cognition|cognition
319422|NCT01578486|Metabolism|metabolism
319423|NCT01578486|Antipsychotics|antipsychotics
319424|NCT01578486|Psychopathology|psychopathology
319425|NCT01578473|low testosterone|low testosterone
319426|NCT01578473|penile curvature|penile curvature
319427|NCT01578460|Pregnancy|pregnancy
319428|NCT01578460|Gestational Diabetes|gestational diabetes
319429|NCT01578460|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
319430|NCT01578460|Continuous Glucose Monitor|continuous glucose monitor
319431|NCT01578460|Glucose|glucose
319432|NCT01578447|injectable contraception|injectable contraception
319433|NCT01578447|acceptability|acceptability
319434|NCT01578447|intramuscular|intramuscular
319435|NCT01578447|subcutaneous|subcutaneous
319436|NCT01578434|Nutritional Rickets|nutritional rickets
319437|NCT01578434|Calcium|calcium
319438|NCT01578434|Vitamin D|vitamin d
319439|NCT01578408|Femoral neck fractures|femoral neck fractures
319440|NCT01578408|Uncemented|uncemented
319441|NCT01578408|Hydroxyapatite|hydroxyapatite
319442|NCT01578408|Coated|coated
319443|NCT01578408|Femoral|femoral
319444|NCT01578408|Stems|stems
319445|NCT01578408|Hip fractures|hip fractures
319446|NCT01578408|THA|tha
319447|NCT01578408|THR|thr
319448|NCT01578408|Cemented|cemented
319449|NCT01578408|Fat embolism|fat embolism
319450|NCT01578408|Cognition|cognition
319451|NCT01578408|Inflammatory response|inflammatory response
319452|NCT01578408|Mobilization|mobilization
319453|NCT01578382|Martorell hypertensive ischemic leg ulcer|martorell hypertensive ischemic leg ulcer
319454|NCT01578382|Calciphylaxis (calcific uremic arteriolopathy)|calciphylaxis (calcific uremic arteriolopathy)
319455|NCT01578382|Ischemic subcutaneous arteriolosclerosis|ischemic subcutaneous arteriolosclerosis
319456|NCT01578382|Hypertension|hypertension
319457|NCT01578382|Diabetes|diabetes
319458|NCT01578382|Medial calcinosis|medial calcinosis
319459|NCT01578382|Wound healing|wound healing
319460|NCT01578369|Urinary incontinence|urinary incontinence
319461|NCT01578369|Pregnancy|pregnancy
319462|NCT01578369|Pelvic floor muscle training|pelvic floor muscle training
319463|NCT01578356|Prostate cancer|prostate cancer
319464|NCT01578343|fludarabine|fludarabine
319465|NCT01578343|mitoxantrone|mitoxantrone
319466|NCT01578343|dexamethasone|dexamethasone
319467|NCT01578343|relapsed or refractory mantle cell lymphoma|relapsed or refractory mantle cell lymphoma
319468|NCT01578343|FND regimen|fnd regimen
319469|NCT01578343|vorinostat|vorinostat
319470|NCT01578343|autologous stem cell transplantation|autologous stem cell transplantation
319471|NCT01578330|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
319472|NCT01578330|Fingolimod|fingolimod
319473|NCT01578330|FTY720|fty720
319474|NCT01578317|H5N1 Vaccine|h5n1 vaccine
319475|NCT01578317|H5N1 Immunization|h5n1 immunization
319476|NCT01578317|MF59 Adjuvant|mf59 adjuvant
319477|NCT01578317|Biologic Sample Collection|biologic sample collection
319478|NCT01578317|Laboratory Research Specimens|laboratory research specimens
319479|NCT01578317|Healthy Volunteer|healthy volunteer
319481|NCT01578304|Overactive bladder|overactive bladder
319482|NCT01578291|Play therapy|play therapy
319483|NCT01578291|Urinary tract infections|urinary tract infections
319484|NCT01578291|Children|children
319485|NCT01578291|Vesicoureteral reflux|vesicoureteral reflux
319486|NCT01578239|Neuroendocrine tumour|neuroendocrine tumour
319487|NCT01578239|177Lu-Dota0-Tyr3-octreotate|177lu-dota0-tyr3-octreotate
319488|NCT01578226|Cirrhosis|cirrhosis
319489|NCT01578226|Ascites|ascites
319490|NCT01578226|Decompensation|decompensation
319491|NCT01578226|Bacterial infection|bacterial infection
319492|NCT01578226|Sepsis|sepsis
319493|NCT01578226|Procalcitonin|procalcitonin
319494|NCT01578226|PCT|pct
319495|NCT01578200|CKD-MBD|ckd-mbd
319496|NCT01578200|phosphate-binder|phosphate-binder
319497|NCT01578200|vascular calcification|vascular calcification
319498|NCT01578200|mortality|mortality
319499|NCT01578200|dialysis|dialysis
319500|NCT01578200|Hemodialysis patients with hyperphosphatemia|hemodialysis patients with hyperphosphatemia
319501|NCT01578187|hair reduction|hair reduction
319502|NCT01578187|hair removal|hair removal
319503|NCT01578187|hair clearance|hair clearance
319504|NCT01578148|Cervical pain|cervical pain
319505|NCT01578148|Cervicalgia,|cervicalgia,
319506|NCT01578148|Cervicodynia|cervicodynia
319507|NCT01578148|Neck ache|neck ache
319508|NCT01578148|Neckache|neckache
319509|NCT01578148|Shoulder pain|shoulder pain
319510|NCT01578148|Shoulder impingement syndrome|shoulder impingement syndrome
319511|NCT01578122|post-thrombotic syndrome|post-thrombotic syndrome
319512|NCT01578122|prevention|prevention
319513|NCT01578122|deep vein thrombosis|deep vein thrombosis
319514|NCT01578122|elastic compression stockings|elastic compression stockings
319515|NCT01578122|compliance|compliance
319516|NCT01578122|quality of life|quality of life
319517|NCT01578096|Type 2 Diabetes|type 2 diabetes
319518|NCT01578083|Chemotherapy|chemotherapy
319519|NCT01578083|Breast Cancer|breast cancer
319520|NCT01578083|Cognitive Impairment|cognitive impairment
319521|NCT01578083|Chemo brain|chemo brain
319522|NCT01578070|Other and Unspecified Vaccines and Biological Substances Causing Adverse Effects in Therapeutic Use|other and unspecified vaccines and biological substances causing adverse effects in therapeutic use
319523|NCT01578057|alcohol|alcohol
319524|NCT01578044|Anti-coagulation|anti-coagulation
319525|NCT01578031|Sleep Apnea|sleep apnea
319526|NCT01578031|Obesity|obesity
319527|NCT01578018|lung cancer|lung cancer
319528|NCT01578018|smoking|smoking
319529|NCT01578005|acute coronary syndrome|acute coronary syndrome
319530|NCT01578005|IVUS|ivus
319531|NCT01578005|atherosclerotic plaque|atherosclerotic plaque
319532|NCT01577992|subjective pain|subjective pain
319533|NCT01577992|Multiple System Atrophy|multiple system atrophy
319534|NCT01577979|Vaccination|vaccination
319535|NCT01577979|Medical Home|medical home
319536|NCT01577979|Adolescents|adolescents
319537|NCT01577966|Patients with brain tumors associated with seizures|patients with brain tumors associated with seizures
319538|NCT01577953|Antisense oligonucleotide|antisense oligonucleotide
319539|NCT01577953|Asthma|asthma
319540|NCT01577953|Patients with asthma|patients with asthma
319541|NCT01577953|Phase 1b|phase 1b
319542|NCT01577953|Transcription factor GATA-3|transcription factor gata-3
319543|NCT01577953|Oral inhalation|oral inhalation
319544|NCT01577940|Transversus abdominis plane block|transversus abdominis plane block
319545|NCT01577940|postoperative pain|postoperative pain
319546|NCT01577940|Postoperative pain management|postoperative pain management
319547|NCT01577927|weaning|weaning
319548|NCT01577927|severe chronic diseases|severe chronic diseases
319549|NCT01577927|UTIR|utir
319550|NCT01577901|Pregnancy|pregnancy
319551|NCT01577862|ACINETOBACTER BAUMANNII|acinetobacter baumannii
319552|NCT01577862|COLISTIN|colistin
319553|NCT01577862|RIFAMPICIN|rifampicin
319554|NCT01577862|THERAPY|therapy
319555|NCT01577862|RESISTANCE|resistance
319556|NCT01577836|Radical prostatectomie|radical prostatectomie
319557|NCT01577836|Robotic assistance|robotic assistance
319558|NCT01577836|Laparotomy|laparotomy
319559|NCT01577810|NIRS|nirs
319560|NCT01577810|near infrared spectroscopy|near infrared spectroscopy
319561|NCT01577810|heart failure|heart failure
319562|NCT01577810|cardiac output|cardiac output
319563|NCT01577810|outpatient|outpatient
319564|NCT01577810|pediatric|pediatric
319565|NCT01577797|Methamphetamine|methamphetamine
319566|NCT01577797|Drug Abuse|drug abuse
319567|NCT01577797|Substance Abuse|substance abuse
319568|NCT01577797|Amphetamine|amphetamine
319569|NCT01577797|Dependence|dependence
319570|NCT01577797|Addiction|addiction
320828|NCT01572727|BKM120|bkm120
319572|NCT01577797|Cognitive Behavioral Therapy|cognitive behavioral therapy
319573|NCT01577797|Text Messaging|text messaging
319574|NCT01577784|Advanced renal cell carcinoma|advanced renal cell carcinoma
319575|NCT01577784|second-line treatment with pazopanib|second-line treatment with pazopanib
319576|NCT01577784|first line of treatment with a Tyrosine Kinase Inhibitor|first line of treatment with a tyrosine kinase inhibitor
319577|NCT01577771|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
319578|NCT01577771|Immunogenicity|immunogenicity
319579|NCT01577771|Reactogenicity|reactogenicity
319580|NCT01577758|Phase 1,|phase 1,
319581|NCT01577758|Advanced gastrointestinal malignancies,|advanced gastrointestinal malignancies,
319582|NCT01577758|MLN0264,|mln0264,
319583|NCT01577758|Guanylyl Cyclase C(GCC),|guanylyl cyclase c(gcc),
319584|NCT01577758|Antibody Drug Conjugate(ADC)|antibody drug conjugate(adc)
319585|NCT01577745|Cancer|cancer
319586|NCT01577732|booster|booster
319587|NCT01577732|Infanrix-IPV+HibTM|infanrix-ipv+hibtm
319588|NCT01577732|DTPa-IPV/Hib|dtpa-ipv/hib
319589|NCT01577732|Vietnamese toddlers|vietnamese toddlers
319590|NCT01577719|Cardiovascular|cardiovascular
319591|NCT01577719|Prevention|prevention
319592|NCT01577719|Ethnicity|ethnicity
319593|NCT01577719|Culture|culture
319594|NCT01577719|Internet|internet
319595|NCT01577719|Text Message|text message
319596|NCT01577706|GABA|gaba
319597|NCT01577706|glutamate|glutamate
319598|NCT01577706|glutamine|glutamine
319599|NCT01577706|spectroscopy|spectroscopy
319600|NCT01577706|brain|brain
319601|NCT01577706|imaging|imaging
319602|NCT01577706|alprazolam|alprazolam
319603|NCT01577706|dextroamphetamine|dextroamphetamine
319604|NCT01577706|placebo|placebo
319605|NCT01577693|dutasteride|dutasteride
319606|NCT01577693|cross over study|cross over study
319607|NCT01577693|bioavailability|bioavailability
319608|NCT01577680|healthy subjects|healthy subjects
319609|NCT01577680|pharmacokinetics|pharmacokinetics
319610|NCT01577680|vilanterol|vilanterol
319611|NCT01577680|tolerability|tolerability
319612|NCT01577680|safety|safety
319613|NCT01577680|hepatic impairment|hepatic impairment
319614|NCT01577680|GW642444|gw642444
319615|NCT01577680|GSK573719|gsk573719
319616|NCT01577667|automation|automation
319617|NCT01577667|closed loop|closed loop
319618|NCT01577667|oxygenation|oxygenation
319619|NCT01577667|ventilation|ventilation
319620|NCT01577654|adenocarcinoma|adenocarcinoma
319621|NCT01577654|squamous|squamous
319622|NCT01577654|adenosquamous|adenosquamous
319623|NCT01577654|adenocarcinoma with other NSCLC variants|adenocarcinoma with other nsclc variants
319624|NCT01577654|EC145|ec145
319625|NCT01577654|EC20|ec20
319626|NCT01577654|Vintafolide|vintafolide
319627|NCT01577654|Etarfolatide|etarfolatide
319628|NCT01577628|Dermatitis|dermatitis
319629|NCT01577628|Eczema|eczema
319630|NCT01577628|Skin diseases|skin diseases
319631|NCT01577628|Skin barrier|skin barrier
319632|NCT01577628|Prevention|prevention
319633|NCT01577628|Infant|infant
319634|NCT01577628|Moisturizer|moisturizer
319635|NCT01577628|Emollient|emollient
319636|NCT01577628|Asthma|asthma
319637|NCT01577628|Food allergy|food allergy
319638|NCT01577628|Allergic rhinitis|allergic rhinitis
319639|NCT01577615|Preterm Infant|preterm infant
319640|NCT01577615|Neurobehavioral|neurobehavioral
319641|NCT01577615|Development|development
319642|NCT01577602|Medication reconciliation|medication reconciliation
319643|NCT01577602|Self report|self report
319644|NCT01577602|Electronic medical record medication list|electronic medical record medication list
319645|NCT01577589|Phase 1|phase 1
319646|NCT01577589|healthy volunteers|healthy volunteers
319647|NCT01577589|cross-over study|cross-over study
319648|NCT01577589|ceftaroline fosamil|ceftaroline fosamil
319649|NCT01577589|various infusion volumes|various infusion volumes
319650|NCT01577589|local tolerability|local tolerability
319651|NCT01577589|Cmax|cmax
319652|NCT01577589|tmax|tmax
319653|NCT01577589|AUC|auc
319654|NCT01577576|Athletes|athletes
319655|NCT01577576|Sedentary volunteers|sedentary volunteers
319656|NCT01577563|osteoarthritis (OA)|osteoarthritis (oa)
319657|NCT01577563|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
319658|NCT01577563|ankylosing spondylitis (AS)|ankylosing spondylitis (as)
319659|NCT01577563|gastrointestinal risk factors|gastrointestinal risk factors
319660|NCT01577563|NSAIDs|nsaids
319661|NCT01577550|ABBV-066|abbv-066
319662|NCT01577550|BI 655066|bi 655066
319663|NCT01577550|risankizumab|risankizumab
319664|NCT01577537|SPL7013|spl7013
319665|NCT01577537|VivaGel|vivagel
319666|NCT01577537|bacterial vaginosis|bacterial vaginosis
319667|NCT01577537|BV|bv
319668|NCT01577511|invasive potential|invasive potential
319669|NCT01577511|molecular characterisation of circulating cells|molecular characterisation of circulating cells
319670|NCT01577498|Skeletal age|skeletal age
319671|NCT01577498|Chronological age|chronological age
319672|NCT01577498|Adolescent|adolescent
319673|NCT01577472|female infertility|female infertility
319674|NCT01577472|poor ovarian response|poor ovarian response
319876|NCT01576666|Advanced solid tumors|advanced solid tumors
319675|NCT01577472|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
319677|NCT01577472|Antagonist protocol|antagonist protocol
319678|NCT01577446|CRT|crt
319679|NCT01577446|heart failure|heart failure
319680|NCT01577446|narrow QRS|narrow qrs
319681|NCT01577446|dyssynchrony|dyssynchrony
319682|NCT01577433|HeartMate II|heartmate ii
319683|NCT01577433|heart-assist device|heart-assist device
319684|NCT01577433|left ventricular assist device|left ventricular assist device
319685|NCT01577433|driveline infection|driveline infection
319686|NCT01577433|LVAD|lvad
319687|NCT01577433|HMII LVAS driveline|hmii lvas driveline
319688|NCT01577433|silicone portion|silicone portion
319689|NCT01577433|Thoratec Corporation|thoratec corporation
319690|NCT01577420|Reflexology|reflexology
319691|NCT01577420|Breast Cancer|breast cancer
319692|NCT01577420|Complementary|complementary
319693|NCT01577407|Dyspnea|dyspnea
319694|NCT01577407|Pain|pain
319695|NCT01577394|Alzheimer disease|alzheimer disease
319696|NCT01577394|Lewy Body Disease|lewy body disease
319697|NCT01577394|Cognitive Disorders|cognitive disorders
319698|NCT01577394|Neurodegenerative Diseases|neurodegenerative diseases
319699|NCT01577394|Differential diagnosis|differential diagnosis
319700|NCT01577394|Eye movement|eye movement
319701|NCT01577381|Phase 2|phase 2
319702|NCT01577381|Advanced Dry Age-Related Macular Degeneration|advanced dry age-related macular degeneration
319703|NCT01577381|Geographic Atrophy|geographic atrophy
319704|NCT01577381|RN6G|rn6g
319705|NCT01577368|Pseudomonas|pseudomonas
319706|NCT01577368|Piperacillin|piperacillin
319707|NCT01577368|Beta-lactams|beta-lactams
319708|NCT01577368|Continuous infusion|continuous infusion
319709|NCT01577368|Intermittent infusion|intermittent infusion
319710|NCT01577368|Pharmacokinetics|pharmacokinetics
319711|NCT01577329|meditation|meditation
319712|NCT01577329|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
319713|NCT01577329|Mindfulness|mindfulness
319714|NCT01577329|Anxiety|anxiety
319715|NCT01577329|Breathing Patterns|breathing patterns
319716|NCT01577316|vaccination|vaccination
319717|NCT01577316|Influenza|influenza
319718|NCT01577316|Immunogenicity|immunogenicity
319719|NCT01577316|Safety|safety
319720|NCT01577303|social phobia|social phobia
319721|NCT01577303|social anxiety|social anxiety
319722|NCT01577303|cognitive bias modification|cognitive bias modification
319723|NCT01577290|Anxiety|anxiety
319724|NCT01577290|Depression|depression
319725|NCT01577290|Insomnia|insomnia
319726|NCT01577290|Mindfulness|mindfulness
319727|NCT01577290|Internet|internet
319728|NCT01577277|Metabolic Syndrome X|metabolic syndrome x
319729|NCT01577277|Fatty Acids, Omega-3|fatty acids, omega-3
319730|NCT01577277|Learning|learning
319731|NCT01577277|Attention|attention
319732|NCT01577277|Nutritional Status|nutritional status
319733|NCT01577277|Nutrition Assessments|nutrition assessments
319734|NCT01577277|Body Weight|body weight
319735|NCT01577277|Physical Activity|physical activity
319736|NCT01577277|Sleep|sleep
319737|NCT01577277|Child Nutrition Sciences|child nutrition sciences
709745|NCT01003145|vaccine|vaccine
319738|NCT01577264|Certolizumab Pegol|certolizumab pegol
319739|NCT01577264|Cimzia|cimzia
319740|NCT01577238|SPL7013|spl7013
319741|NCT01577238|VivaGel|vivagel
319742|NCT01577238|bacterial vaginosis|bacterial vaginosis
319743|NCT01577238|BV|bv
319744|NCT01577225|Clean surgery|clean surgery
319745|NCT01577212|stage III NSCLC|stage iii nsclc
319746|NCT01577212|(chemo)radiotherapy|(chemo)radiotherapy
319747|NCT01577212|individualized dose-escalation|individualized dose-escalation
319748|NCT01577199|IVF|ivf
319749|NCT01577199|poor responder|poor responder
319750|NCT01577199|low ovarian reserve|low ovarian reserve
319751|NCT01577199|ART|art
319752|NCT01577199|ovarian stimulation|ovarian stimulation
319753|NCT01577199|IVF protocols|ivf protocols
319754|NCT01577186|Schizophrenia|schizophrenia
319755|NCT01577186|Paliperidone Extended Release|paliperidone extended release
319756|NCT01577160|Schizophrenia|schizophrenia
319757|NCT01577160|Paliperidone Extended Release (ER)|paliperidone extended release (er)
319758|NCT01577147|pregnancy|pregnancy
319759|NCT01577134|multimorbidity|multimorbidity
319760|NCT01577134|autonomy|autonomy
319761|NCT01577134|older adults|older adults
319762|NCT01577134|physical activity|physical activity
319763|NCT01577134|intervention|intervention
319764|NCT01577134|behavior change|behavior change
319765|NCT01577121|Preterm labor|preterm labor
319766|NCT01577108|31-32 Weeks of Gestation Completed|31-32 weeks of gestation completed
396805|NCT01256203|PDT|pdt
319767|NCT01577108|Group B Streptococcal Infection|group b streptococcal infection
319768|NCT01577108|Streptococcus Group B Infection of the Infant|streptococcus group b infection of the infant
319769|NCT01577095|electroacupuncture|electroacupuncture
319770|NCT01577095|rosiglitazone|rosiglitazone
319771|NCT01577095|plasma glucose|plasma glucose
319772|NCT01577095|insulin resistance|insulin resistance
319773|NCT01577095|free fatty acid|free fatty acid
319774|NCT01577082|Adults, not adequately controlled, pre-dose morning PEF|adults, not adequately controlled, pre-dose morning pef
319775|NCT01577069|Hepatitis C|hepatitis c
320246|NCT01575184|infants|infants
319776|NCT01577069|Direct Antiviral agent (DAA)|direct antiviral agent (daa)
319777|NCT01577069|Ultra-deep pyrosequencing|ultra-deep pyrosequencing
319778|NCT01577069|Single polynucleotide polymorphisms|single polynucleotide polymorphisms
319779|NCT01577069|Treatment-resistant mutants|treatment-resistant mutants
319780|NCT01577069|Hepatitis C Virus Protease Inhibitor|hepatitis c virus protease inhibitor
319781|NCT01577056|Familial hypercholesterolaemia|familial hypercholesterolaemia
319782|NCT01577056|Postprandial dyslipidaemia|postprandial dyslipidaemia
319783|NCT01577056|Fish oil treatment|fish oil treatment
319784|NCT01577056|Cardiovascular disease|cardiovascular disease
319785|NCT01577043|acute diarrhea|acute diarrhea
319786|NCT01577043|Racecadotril|racecadotril
319787|NCT01577043|children|children
319788|NCT01577017|ovulation induction, clomiphene citrate, letrozole|ovulation induction, clomiphene citrate, letrozole
319789|NCT01576978|LUMBAR BACK pain|lumbar back pain
319790|NCT01576978|PELVIC PAIN|pelvic pain
319791|NCT01576978|PREGNANCY|pregnancy
319792|NCT01576978|HATHA YOGA|hatha yoga
319793|NCT01576965|Laparoscopic hysterectomy,laparoscopic sacrocolpopexy,bowel prep|laparoscopic hysterectomy,laparoscopic sacrocolpopexy,bowel prep
319794|NCT01576926|Sleep apnea, obstructive|sleep apnea, obstructive
319795|NCT01576926|Deglutition Disorders|deglutition disorders
319796|NCT01576913|exercise testing|exercise testing
319797|NCT01576913|music|music
319798|NCT01576913|VO2 max|vo2 max
319799|NCT01576900|behavior therapy|behavior therapy
319800|NCT01576900|nocturia|nocturia
319801|NCT01576900|polyuria|polyuria
319802|NCT01576874|nicotine dependence|nicotine dependence
319803|NCT01576874|hormones|hormones
319804|NCT01576848|muscle metabolism|muscle metabolism
319805|NCT01576848|intrinsically labeled protein|intrinsically labeled protein
319806|NCT01576848|protein synthesis|protein synthesis
319807|NCT01576848|insulin|insulin
319808|NCT01576848|perfusion|perfusion
319809|NCT01576835|Non-contrast|non-contrast
319810|NCT01576822|Detoxification|detoxification
319811|NCT01576822|Sauna|sauna
319812|NCT01576809|Paracetamol|paracetamol
319813|NCT01576809|acetaminophen|acetaminophen
319814|NCT01576809|phenylephrine|phenylephrine
319815|NCT01576809|guaifenesin|guaifenesin
319816|NCT01576809|syrup|syrup
319817|NCT01576809|URTI|urti
319818|NCT01576809|productive cough|productive cough
319819|NCT01576796|Radiotherapy|radiotherapy
319820|NCT01576796|Fmiso|fmiso
319821|NCT01576796|FDG PETSCAN|fdg petscan
319822|NCT01576796|FMISO PETSCAN|fmiso petscan
319823|NCT01576796|complement dose|complement dose
319824|NCT01576796|lung cancer|lung cancer
319825|NCT01576796|NSCLC|nsclc
319826|NCT01576796|hypoxic lesion|hypoxic lesion
319827|NCT01576770|propofol|propofol
319828|NCT01576770|Pain|pain
319829|NCT01576770|Synera Patch|synera patch
319830|NCT01576770|Gebauer's Ethyl Chloride topical anesthetic|gebauer's ethyl chloride topical anesthetic
319831|NCT01576757|Stem cell therapy|stem cell therapy
319832|NCT01576744|HE4|he4
319833|NCT01576744|IVF|ivf
319834|NCT01576744|Biomarker|biomarker
710139|NCT00991302|HAART|haart
319835|NCT01576744|Ovarian cancer|ovarian cancer
319836|NCT01576744|Infertility|infertility
319837|NCT01576731|HIV Infection|hiv infection
319838|NCT01576731|Postexposure prophylaxis|postexposure prophylaxis
319839|NCT01576718|Dose ranging|dose ranging
319840|NCT01576718|Fluticasone Propionate|fluticasone propionate
319841|NCT01576718|Dry Powder Inhaler (DPI)|dry powder inhaler (dpi)
319842|NCT01576718|High Dose ICS|high dose ics
319843|NCT01576718|Asthma|asthma
319844|NCT01576705|Down syndrome|down syndrome
319845|NCT01576705|Young children|young children
319846|NCT01576705|Psychomotor development|psychomotor development
319847|NCT01576705|Thyroid hormone|thyroid hormone
319848|NCT01576705|Folinic acid|folinic acid
319849|NCT01576705|Psychometric tests|psychometric tests
319850|NCT01576705|GMDS|gmds
319851|NCT01576705|Griffiths|griffiths
319852|NCT01576705|Genetic factors|genetic factors
319853|NCT01576705|Biochemical factors|biochemical factors
319854|NCT01576692|recurrent neuroblastoma|recurrent neuroblastoma
319855|NCT01576692|refractory neuroblastoma|refractory neuroblastoma
319856|NCT01576692|natural killer cells|natural killer cells
319857|NCT01576679|intra-abdominal|intra-abdominal
319858|NCT01576679|abscess|abscess
319859|NCT01576679|tPA|tpa
319860|NCT01576679|alteplase|alteplase
319861|NCT01576679|cathflo|cathflo
319862|NCT01576666|Dose escalation|dose escalation
319863|NCT01576666|Maximum Tolerated Dose|maximum tolerated dose
319864|NCT01576666|MTD|mtd
319865|NCT01576666|Safety Expansion|safety expansion
319866|NCT01576666|Safety|safety
319867|NCT01576666|Preliminary Efficacy|preliminary efficacy
319868|NCT01576666|Objective Response Rate|objective response rate
319869|NCT01576666|Early progression rate|early progression rate
319870|NCT01576666|PI3K activation|pi3k activation
319871|NCT01576666|Combination Treatment|combination treatment
319872|NCT01576666|Hedgehog Signaling Pathway|hedgehog signaling pathway
319873|NCT01576666|Smoothened inhibitor|smoothened inhibitor
319874|NCT01576666|Phosphoinositide-3' kinase|phosphoinositide-3' kinase
319875|NCT01576666|Phosphatase signaling pathway|phosphatase signaling pathway
320336|NCT01574976|ADHD|adhd
319877|NCT01576666|metastatic breast cancer|metastatic breast cancer
319878|NCT01576666|advanced pancreatic adenocarcinoma|advanced pancreatic adenocarcinoma
319879|NCT01576666|metastatic colorectal cancer|metastatic colorectal cancer
319880|NCT01576666|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
319881|NCT01576666|gastric cancer|gastric cancer
319882|NCT01576666|gastroesophageal junction cancer|gastroesophageal junction cancer
319883|NCT01576666|triple negative metastatic breast cancer|triple negative metastatic breast cancer
319884|NCT01576666|hormone receptor positive (ER+/PR+, and Her2-) metastatic breast cancer|hormone receptor positive (er+/pr+, and her2-) metastatic breast cancer
319885|NCT01576653|IFI|ifi
319886|NCT01576640|Nicotine Dependence|nicotine dependence
319887|NCT01576640|Smoking Cessation|smoking cessation
319888|NCT01576640|Relapse Prevention|relapse prevention
319889|NCT01576640|Cognitive Behavioral Therapy|cognitive behavioral therapy
319890|NCT01576640|Schizophrenia|schizophrenia
319891|NCT01576614|Comparing telephone VS RTP in SICU rounding practices|comparing telephone vs rtp in sicu rounding practices
319892|NCT01576601|pediatrics|pediatrics
319893|NCT01576601|acute pain|acute pain
319894|NCT01576601|neurosurgery|neurosurgery
319895|NCT01576601|Pediatric patients (0-18)|pediatric patients (0-18)
319896|NCT01576601|postoperative management|postoperative management
319897|NCT01576588|Chronic lymphocytic leukemia, relapsed, elderly or unfit patients, methylprednisolone, rituximab|chronic lymphocytic leukemia, relapsed, elderly or unfit patients, methylprednisolone, rituximab
319898|NCT01576575|to determine how people absorb and break down (metabolize) and eliminate buprenorphine and if CYP3A is involved.|to determine how people absorb and break down (metabolize) and eliminate buprenorphine and if cyp3a is involved.
319899|NCT01576562|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
319900|NCT01576562|Ventricular Assist Device|ventricular assist device
319901|NCT01576536|Myocardial infarction|myocardial infarction
319902|NCT01576536|Platelet aggregation|platelet aggregation
319903|NCT01576536|cold pressor test|cold pressor test
319904|NCT01576536|Genetics|genetics
319905|NCT01576497|EUS, EUS-FNA, Pancreatic masses|eus, eus-fna, pancreatic masses
319906|NCT01576471|T. suis ova|t. suis ova
319907|NCT01576471|Trichuris suis ova|trichuris suis ova
319908|NCT01576471|Inflammatory Bowel Disease|inflammatory bowel disease
319909|NCT01576471|TRUST-I|trust-i
319910|NCT01576471|TRUSTI|trusti
319911|NCT01576471|TRUST-1|trust-1
319912|NCT01576471|TRUST1|trust1
319913|NCT01576458|ursodeoxycholic acid|ursodeoxycholic acid
319914|NCT01576458|intrahepatic cholestasis|intrahepatic cholestasis
319915|NCT01576458|pregnancy|pregnancy
319916|NCT01576445|Total Knee Arthroplasty|total knee arthroplasty
319917|NCT01576445|function|function
319918|NCT01576432|Pain|pain
319919|NCT01576432|Breastfeeding|breastfeeding
319920|NCT01576432|Heel prick|heel prick
319921|NCT01576432|Sucrose|sucrose
319922|NCT01576432|Skin-to-skin contact|skin-to-skin contact
319923|NCT01576432|Newborn|newborn
319924|NCT01576419|PG201|pg201
319925|NCT01576419|Non-inferiority|non-inferiority
319926|NCT01576419|100mm pain VAS|100mm pain vas
319927|NCT01576406|crizotinib|crizotinib
319928|NCT01576406|xalkori|xalkori
319929|NCT01576406|PF-02341066|pf-02341066
319930|NCT01576406|hepatic impairment|hepatic impairment
319931|NCT01576406|pharmacokinetics|pharmacokinetics
319932|NCT01576406|advanced cancer|advanced cancer
319933|NCT01576393|substance abuse|substance abuse
319934|NCT01576393|treatment|treatment
319935|NCT01576393|families|families
319936|NCT01576380|Solid tumors|solid tumors
319937|NCT01576380|Advanced scirrhous gastric carcinoma|advanced scirrhous gastric carcinoma
319938|NCT01576380|Gastric Cancer|gastric cancer
319939|NCT01576380|Second-line or third-line treatment|second-line or third-line treatment
319940|NCT01576380|VEGF|vegf
319941|NCT01576380|FGFR|fgfr
319942|NCT01576380|Neoplasms|neoplasms
319943|NCT01576380|Gastric Neoplasms|gastric neoplasms
319944|NCT01576380|Cancer|cancer
319945|NCT01576380|Carcinoma|carcinoma
319946|NCT01576380|Gastric Diseases|gastric diseases
319947|NCT01576380|Female Genital Diseases|female genital diseases
319948|NCT01576380|Tumors|tumors
319949|NCT01576380|Oral Administration|oral administration
319950|NCT01576380|Capsules|capsules
319951|NCT01576380|TKI258|tki258
319952|NCT01576380|TKI-258|tki-258
319953|NCT01576380|TKI 258|tki 258
319954|NCT01576367|Cryopyrin-associated periodic syndromes (CAPS)|cryopyrin-associated periodic syndromes (caps)
319955|NCT01576367|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
319956|NCT01576367|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
319957|NCT01576367|Neonatal Onset Multisystem Inflammatory Disease (NOMID)|neonatal onset multisystem inflammatory disease (nomid)
319958|NCT01576367|children, systemic autoinflammatory disease|children, systemic autoinflammatory disease
319959|NCT01576367|CIAS-1 gene|cias-1 gene
319960|NCT01576367|NALP-3|nalp-3
319961|NCT01576367|NLRP3|nlrp3
319962|NCT01576367|ACZ885|acz885
319963|NCT01576367|canakinumab|canakinumab
319964|NCT01576367|human monoclonal anti-human interleukin-1 antibody|human monoclonal anti-human interleukin-1 antibody
319965|NCT01576367|autosomal dominant|autosomal dominant
319966|NCT01576367|familial autoinflammatory syndrome|familial autoinflammatory syndrome
320538|NCT01574092|Brain tumor|brain tumor
319967|NCT01576367|childhood immunizations vaccinations|childhood immunizations vaccinations
319968|NCT01576354|Multiple Sclerosis|multiple sclerosis
319969|NCT01576354|walking function|walking function
319970|NCT01576354|fampridine|fampridine
319971|NCT01576341|Epoetin alfa, ESA, HX575, CKD|epoetin alfa, esa, hx575, ckd
319972|NCT01576315|cystic fibrosis|cystic fibrosis
319973|NCT01576315|Aspergillus|aspergillus
319974|NCT01576315|itraconazole|itraconazole
319975|NCT01576315|voriconazole|voriconazole
319976|NCT01576302|Rumination|rumination
319977|NCT01576289|Esophagus|esophagus
319978|NCT01576289|Gastroesophageal reflux|gastroesophageal reflux
319979|NCT01576289|Reflux esophagitis|reflux esophagitis
319980|NCT01576289|Barrett's esophagus|barrett's esophagus
319981|NCT01576289|Stomach|stomach
319982|NCT01576289|Intestinal metaplasia stomach|intestinal metaplasia stomach
319983|NCT01576289|Helicobacter pylori infection|helicobacter pylori infection
319984|NCT01576289|Proton pump inhibitor|proton pump inhibitor
319985|NCT01576289|Duodenum|duodenum
319986|NCT01576289|Duodenal bulb|duodenal bulb
319987|NCT01576289|Celiac disease diagnosis|celiac disease diagnosis
319988|NCT01576263|Anaesthesia|anaesthesia
319989|NCT01576263|Infiltration|infiltration
319990|NCT01576263|Blood transfusion|blood transfusion
319991|NCT01576263|Autologous|autologous
319992|NCT01576263|Arthroplasty|arthroplasty
319993|NCT01576263|Replacement|replacement
319994|NCT01576263|Ropivacaine|ropivacaine
319995|NCT01576237|hemovigilance|hemovigilance
319996|NCT01576237|hemapheresis|hemapheresis
319997|NCT01576237|donor vigilance|donor vigilance
319998|NCT01576237|plasmapheresis|plasmapheresis
319999|NCT01576237|platelet apheresis|platelet apheresis
320000|NCT01576237|leukapheresis|leukapheresis
320001|NCT01576237|stem cell apheresis|stem cell apheresis
320002|NCT01576237|granulocyte apheresis|granulocyte apheresis
320003|NCT01576237|monocyte apheresis|monocyte apheresis
320004|NCT01576237|red cell apheresis|red cell apheresis
320005|NCT01576224|Volar locking plate osteosynthesis|volar locking plate osteosynthesis
320006|NCT01576224|Early mobilization|early mobilization
320007|NCT01576224|DASH|dash
320008|NCT01576211|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
320009|NCT01576198|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
320010|NCT01576159|Biochemical Marker|biochemical marker
320011|NCT01576159|Fitness Exercises|fitness exercises
320012|NCT01576159|Impact|impact
320013|NCT01576159|Articular Cartilage|articular cartilage
320014|NCT01576146|Clinical Trial, Phase 2|clinical trial, phase 2
320015|NCT01576146|Renal Dialysis|renal dialysis
320016|NCT01576146|Secondary Hyperparathyroidism|secondary hyperparathyroidism
320017|NCT01576146|Chronic kidney disease-mineral and bone disorder|chronic kidney disease-mineral and bone disorder
710333|NCT00997399|PK & safety|pk & safety
320018|NCT01576146|Parathyroid hormone|parathyroid hormone
320019|NCT01576133|Quality of Life|quality of life
320020|NCT01576120|Known, active Crohn's disease|known, active crohn's disease
320021|NCT01576120|Iieocolonic or colonic involvement|iieocolonic or colonic involvement
320022|NCT01576120|proven patency of the GI tract|proven patency of the gi tract
320023|NCT01576107|Different cancer entities|different cancer entities
320024|NCT01576094|congenital heart disease|congenital heart disease
320025|NCT01576081|bone density|bone density
320026|NCT01576081|weight bearing|weight bearing
320027|NCT01576081|muscle atrophy|muscle atrophy
320028|NCT01576081|vascular degeneration|vascular degeneration
320029|NCT01576081|gravitational loading|gravitational loading
320030|NCT01576081|muscular unloading|muscular unloading
320031|NCT01576068|COPD|copd
320032|NCT01576068|Pharmacy|pharmacy
320033|NCT01576068|Spirometry|spirometry
320034|NCT01576068|Case finding|case finding
320035|NCT01576055|Peripheral Arterial Disease|peripheral arterial disease
320036|NCT01576055|Superficial Femoral Artery|superficial femoral artery
320037|NCT01576055|Proximal Popliteal Artery|proximal popliteal artery
320038|NCT01576055|PAD|pad
320039|NCT01576055|SFA|sfa
320040|NCT01576055|PPA|ppa
320041|NCT01576055|Stent|stent
320042|NCT01576055|Gore|gore
320043|NCT01576055|Bare Metal Stent|bare metal stent
320044|NCT01576055|LifeStent|lifestent
320045|NCT01576055|atherosclerosis|atherosclerosis
320046|NCT01576055|Heparin|heparin
320047|NCT01576055|claudication|claudication
320048|NCT01576055|leg pain|leg pain
320049|NCT01576042|Ischemic heart disease|ischemic heart disease
320050|NCT01576042|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
320051|NCT01576042|Ventricular Tachycardia|ventricular tachycardia
320052|NCT01576042|Patient with Implantable Cardioverter Defibrillator (ICD)|patient with implantable cardioverter defibrillator (icd)
320053|NCT01576016|bradycardia|bradycardia
320054|NCT01576016|MRI scans|mri scans
320055|NCT01576003|Short Bowel Syndrome|short bowel syndrome
320056|NCT01576003|Necrotizing Entercolitis (NEC)|necrotizing entercolitis (nec)
320057|NCT01576003|Atresia|atresia
320058|NCT01576003|Parenteral Nutrition|parenteral nutrition
320059|NCT01576003|Biological Markers|biological markers
320060|NCT01576003|Growth|growth
320061|NCT01575990|Colon cancer screening|colon cancer screening
320154|NCT01575678|activity|activity
320062|NCT01575990|Decision support interventions|decision support interventions
320063|NCT01575990|Health status|health status
320064|NCT01575990|Patient-centered care|patient-centered care
320065|NCT01575990|Age|age
320066|NCT01575990|Randomized controlled trial|randomized controlled trial
320067|NCT01575990|Double blind|double blind
320068|NCT01575990|UNC|unc
320069|NCT01575938|HIV infection|hiv infection
320070|NCT01575925|Pomalidomide for multiple myeloma|pomalidomide for multiple myeloma
320071|NCT01575925|renal impairment|renal impairment
320072|NCT01575925|multiple myeloma patients with renal impairment|multiple myeloma patients with renal impairment
320073|NCT01575925|Pomalidomide for patients with renal impairment due to multiple myeloma|pomalidomide for patients with renal impairment due to multiple myeloma
320074|NCT01575925|Pomalidomide|pomalidomide
320075|NCT01575925|dexamethasone|dexamethasone
320076|NCT01575925|RRMM|rrmm
320077|NCT01575925|impaired renal function in multiple myeloma|impaired renal function in multiple myeloma
320078|NCT01575925|hemodialysis|hemodialysis
320079|NCT01575925|dialysis|dialysis
320080|NCT01575925|POM|pom
320081|NCT01575925|Pomalyst|pomalyst
320082|NCT01575925|MM|mm
320083|NCT01575925|severe renal impairment|severe renal impairment
320084|NCT01575925|CrCl ≤ 30 mL/min|crcl ≤ 30 ml/min
320085|NCT01575925|Creatinine less than 30|creatinine less than 30
320086|NCT01575925|clinical trial in subjects with multiple myeloma with renal impairement|clinical trial in subjects with multiple myeloma with renal impairement
320087|NCT01575912|Schizophrenia|schizophrenia
320088|NCT01575912|Major depression|major depression
320089|NCT01575912|Pain|pain
320090|NCT01575912|Past pain experience|past pain experience
320091|NCT01575899|Helicobacter pylori|helicobacter pylori
320092|NCT01575899|Levofloxacin|levofloxacin
320093|NCT01575899|Amoxicillin/clavulanate|amoxicillin/clavulanate
320094|NCT01575899|Rabeprazole|rabeprazole
320095|NCT01575899|Eastern Taiwan|eastern taiwan
320096|NCT01575886|clinician patient communication|clinician patient communication
320097|NCT01575886|smoking cessation|smoking cessation
320098|NCT01575886|weight management|weight management
320099|NCT01575886|primary care|primary care
320100|NCT01575886|health behavior change advice|health behavior change advice
320101|NCT01575873|GIOP, Glucocorticoid, osteporosis, denosumab, BMD, Bone Mineral Density|giop, glucocorticoid, osteporosis, denosumab, bmd, bone mineral density
320102|NCT01575860|biopsy-proven diagnosis|biopsy-proven diagnosis
320103|NCT01575860|completed at least 2 cycles of salvage chemotherapy|completed at least 2 cycles of salvage chemotherapy
320104|NCT01575860|showing PET positive residual lesions|showing pet positive residual lesions
320105|NCT01575847|Acetaminophen|acetaminophen
320106|NCT01575847|Acetaminophen Toxicity|acetaminophen toxicity
402048|NCT01233362|Vaccination Schedules|vaccination schedules
402049|NCT01233349|overweight|overweight
320107|NCT01575834|Osteoporosis, Osteoporosis-Postmenopausal, Bone Diseases-Metabolic, Bone Diseases, Musculoskeletal Diseases|osteoporosis, osteoporosis-postmenopausal, bone diseases-metabolic, bone diseases, musculoskeletal diseases
320108|NCT01575821|children, cough, honey|children, cough, honey
320109|NCT01575808|Symptomatic PAD|symptomatic pad
320110|NCT01575808|stenosed or occluded lesions|stenosed or occluded lesions
320111|NCT01575808|totaling at least 10 cm in length|totaling at least 10 cm in length
320112|NCT01575808|Rutherford scores 2-5|rutherford scores 2-5
320113|NCT01575795|Ticagrelor|ticagrelor
320114|NCT01575795|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
320115|NCT01575795|Platelet reactivity|platelet reactivity
320116|NCT01575782|small cell lung cancer|small cell lung cancer
320117|NCT01575782|stage I-III|stage i-iii
320118|NCT01575782|chloroquine|chloroquine
320119|NCT01575782|Phase I|phase i
320120|NCT01575730|Peritoneal carcinomatosis from colorectal or appendiceal origin|peritoneal carcinomatosis from colorectal or appendiceal origin
320121|NCT01575717|Vitamin D|vitamin d
320122|NCT01575717|hepatocellular carcinoma|hepatocellular carcinoma
320123|NCT01575717|liver neoplasms|liver neoplasms
320124|NCT01575717|liver transplantation|liver transplantation
320125|NCT01575704|Exercise|exercise
320126|NCT01575704|Hematopoetic cell transplantation|hematopoetic cell transplantation
320127|NCT01575704|Children|children
320128|NCT01575691|Combination Chemotherapy|combination chemotherapy
320130|NCT01575691|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
320131|NCT01575691|AML|aml
320132|NCT01575691|Acute myelogenous leukemia|acute myelogenous leukemia
320133|NCT01575691|valproic acid|valproic acid
320134|NCT01575691|VPA|vpa
320135|NCT01575691|Depakene|depakene
320136|NCT01575691|5-azacytidine|5-azacytidine
320137|NCT01575691|5-aza|5-aza
320138|NCT01575691|Azacitidine|azacitidine
320139|NCT01575691|5-AZC|5-azc
320140|NCT01575691|Vidaza|vidaza
320141|NCT01575691|AZA-CR|aza-cr
320142|NCT01575691|Ladakamycin|ladakamycin
320143|NCT01575691|NSC-102816|nsc-102816
320144|NCT01575691|All-trans retinoic acid|all-trans retinoic acid
320145|NCT01575691|ATRA|atra
320146|NCT01575691|Tretinoin|tretinoin
320148|NCT01575678|enuresis|enuresis
320149|NCT01575678|melatonin|melatonin
320150|NCT01575678|circadian rhythm|circadian rhythm
320151|NCT01575678|children|children
320152|NCT01575678|blood pressure|blood pressure
320153|NCT01575678|urine production|urine production
320155|NCT01575678|sleep|sleep
320156|NCT01575665|Hyperventilation|hyperventilation
320157|NCT01575665|Chronic Idiopathic Hyperventilation|chronic idiopathic hyperventilation
320158|NCT01575665|Dysfunctional Breathing|dysfunctional breathing
320159|NCT01575665|Respiratory Alkalosis|respiratory alkalosis
320160|NCT01575665|Respiratory Acidosis|respiratory acidosis
320161|NCT01575652|peritoneal dialysis|peritoneal dialysis
320162|NCT01575652|protein losses|protein losses
320163|NCT01575613|malaria|malaria
320164|NCT01575613|heterogeneity|heterogeneity
320165|NCT01575613|transmission|transmission
320166|NCT01575613|elimination|elimination
320167|NCT01575587|Pharmacology|pharmacology
320168|NCT01575587|Pharmacokinetics|pharmacokinetics
320169|NCT01575587|Pharmacodynamics|pharmacodynamics
320170|NCT01575587|Abiraterone acetate|abiraterone acetate
320171|NCT01575587|Food intake|food intake
320172|NCT01575587|Caucasion|caucasion
320173|NCT01575587|Japanese|japanese
320174|NCT01575587|Healthy|healthy
320175|NCT01575561|Lurasidone|lurasidone
320176|NCT01575561|Latuda|latuda
320177|NCT01575561|Bipolar Disorder|bipolar disorder
320178|NCT01575535|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
320179|NCT01575535|adult acute basophilic leukemia|adult acute basophilic leukemia
320180|NCT01575535|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
320181|NCT01575535|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
320182|NCT01575535|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
320183|NCT01575535|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
320184|NCT01575535|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
320185|NCT01575535|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
320186|NCT01575535|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
320187|NCT01575535|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
320188|NCT01575535|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
320189|NCT01575535|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
320190|NCT01575535|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
320191|NCT01575535|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
320192|NCT01575535|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
320193|NCT01575535|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
402050|NCT01233349|obesity|obesity
320194|NCT01575535|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
320195|NCT01575496|Tinnitus|tinnitus
320196|NCT01575496|Transcranial direct current stimulation|transcranial direct current stimulation
320197|NCT01575496|Transcranial magnetic stimulation|transcranial magnetic stimulation
320198|NCT01575470|Traumatic Brain Injury|traumatic brain injury
320199|NCT01575470|TBI|tbi
320200|NCT01575470|stem cells|stem cells
320201|NCT01575457|Adolescent Violence Prevention|adolescent violence prevention
320202|NCT01575444|Pap test|pap test
320203|NCT01575444|HPV testing|hpv testing
320204|NCT01575444|cervical cancer|cervical cancer
320205|NCT01575431|coronary artery disease|coronary artery disease
320206|NCT01575431|endothelial progenitor cells|endothelial progenitor cells
320207|NCT01575392|creatinine|creatinine
320208|NCT01575392|chronic kidney disease|chronic kidney disease
320209|NCT01575392|creatinine clearance|creatinine clearance
320210|NCT01575392|estimated glomerular filtration rate|estimated glomerular filtration rate
320211|NCT01575379|allopurinol|allopurinol
320212|NCT01575379|uric acid|uric acid
320213|NCT01575379|diabetes|diabetes
320214|NCT01575379|nephropathy|nephropathy
320215|NCT01575340|inflammatory markers|inflammatory markers
320216|NCT01575340|colorectal cancer|colorectal cancer
320217|NCT01575340|cytokines|cytokines
320218|NCT01575340|fish oil|fish oil
320219|NCT01575314|stapling device|stapling device
320220|NCT01575314|lobectomy|lobectomy
397379|NCT01253733|SMS|sms
320221|NCT01575314|cost utility|cost utility
320222|NCT01575301|GLP-1R agonist|glp-1r agonist
320223|NCT01575301|biomarker|biomarker
320224|NCT01575288|arterial function|arterial function
320225|NCT01575288|cardiovascular|cardiovascular
320226|NCT01575288|aging|aging
320227|NCT01575288|endothelial function|endothelial function
320228|NCT01575288|arterial stiffness|arterial stiffness
320229|NCT01575288|vascular function|vascular function
320230|NCT01575288|Trehalose|trehalose
320231|NCT01575262|behaviour change|behaviour change
320232|NCT01575262|incentives|incentives
320233|NCT01575262|nudging|nudging
320234|NCT01575262|physical activity|physical activity
320235|NCT01575262|self-monitoring|self-monitoring
320236|NCT01575249|progression|progression
320237|NCT01575249|moderate aortic stenosis|moderate aortic stenosis
320238|NCT01575249|asymptomatic|asymptomatic
320239|NCT01575249|symptomatic|symptomatic
320240|NCT01575223|saline irrigation|saline irrigation
320241|NCT01575223|chronic rhinosinusitis|chronic rhinosinusitis
320242|NCT01575223|endoscopic sinus surgery|endoscopic sinus surgery
320332|NCT01575002|direct current stimulation|direct current stimulation
320243|NCT01575223|high volume saline irrigation|high volume saline irrigation
320244|NCT01575184|internal jugular vein cannulation|internal jugular vein cannulation
320245|NCT01575184|common carotid artery|common carotid artery
320247|NCT01575132|Parkinson's Disease|parkinson's disease
320248|NCT01575132|Stimulation, Deep Brain|stimulation, deep brain
320249|NCT01575132|Study, Follow-Up|study, follow-up
320250|NCT01575132|Adverse Effects|adverse effects
320251|NCT01575119|Cigarette smoker|cigarette smoker
320252|NCT01575119|Elective surgery|elective surgery
320253|NCT01575093|Healthy volunteers|healthy volunteers
320254|NCT01574040|Lifestyle|lifestyle
320255|NCT01574040|Lifestyle modification|lifestyle modification
320256|NCT01574040|Behavior|behavior
320257|NCT01574040|Primary prevention|primary prevention
320258|NCT01574040|Healthy staff and visitors of an Academic Hospital|healthy staff and visitors of an academic hospital
320259|NCT01574027|Assess the efficacy of vitamin D for preventing colorectal cancer and identifying the populations likely (or unlikely) to benefit from vitamin D-based therapy.|assess the efficacy of vitamin d for preventing colorectal cancer and identifying the populations likely (or unlikely) to benefit from vitamin d-based therapy.
320260|NCT01574027|Evaluate the ability of Vitamin D3 (cholecalciferol) to reduce ACF's in humans.|evaluate the ability of vitamin d3 (cholecalciferol) to reduce acf's in humans.
320261|NCT01574014|Anxiety Disorder|anxiety disorder
320262|NCT01574014|Phobic Disorders|phobic disorders
320263|NCT01574001|ischemic stroke|ischemic stroke
320264|NCT01574001|smoking cessation|smoking cessation
320265|NCT01574001|antismoking interventions|antismoking interventions
320266|NCT01573988|Nutrition|nutrition
320267|NCT01573988|Eating frequency|eating frequency
320268|NCT01573988|Food intake|food intake
320269|NCT01573988|Eating behavior|eating behavior
320270|NCT01573988|Satiety|satiety
320271|NCT01573988|Ghrelin|ghrelin
320272|NCT01573975|Helicobacter pylori|helicobacter pylori
320273|NCT01573975|antibiotic resistance|antibiotic resistance
320274|NCT01573975|sequential therapy|sequential therapy
320275|NCT01573975|Taiwan|taiwan
320276|NCT01573962|Kidney Renal|kidney renal
320277|NCT01573949|Heart Failure|heart failure
320278|NCT01573949|Diabetes|diabetes
320279|NCT01573949|Pre-diabetes|pre-diabetes
320280|NCT01573949|Early type II diabetes|early type ii diabetes
320281|NCT01573949|Metformin|metformin
320282|NCT01573949|Pharmacotherapy with metformin for prevention of DM in HF patients with pre-diabetes (pre-DM) and glycemic control in HF patients with early type II DM|pharmacotherapy with metformin for prevention of dm in hf patients with pre-diabetes (pre-dm) and glycemic control in hf patients with early type ii dm
320283|NCT01573936|acquired brain injury|acquired brain injury
320284|NCT01573936|health-related quality of life|health-related quality of life
320285|NCT01573936|poliomyelitis survivor|poliomyelitis survivor
320286|NCT01573936|rehabilitation|rehabilitation
320287|NCT01573936|spinal cord injury|spinal cord injury
320288|NCT01573936|completed the WHOQOL-BREF|completed the whoqol-bref
320289|NCT01573923|Umbilical Mesenchymal Stem Cells; Liver cirrhosis|umbilical mesenchymal stem cells; liver cirrhosis
320290|NCT01573910|Bacterial conjunctivitis|bacterial conjunctivitis
320291|NCT01573910|Anti-infective|anti-infective
320292|NCT01573910|Antibiotics|antibiotics
320293|NCT01573897|Diabetes|diabetes
320294|NCT01573897|Sleep apnea|sleep apnea
320295|NCT01573897|Diabetic foot|diabetic foot
320296|NCT01573897|microcirculation|microcirculation
320297|NCT01573858|Infertility|infertility
320298|NCT01573858|Polycystic Ovary Syndrome|polycystic ovary syndrome
320299|NCT01573858|Clomiphene citrate|clomiphene citrate
320300|NCT01573858|Acupuncture|acupuncture
320301|NCT01573845|child|child
320302|NCT01573845|communication|communication
320303|NCT01573845|diet|diet
320304|NCT01573845|food|food
320305|NCT01573845|health communication|health communication
320306|NCT01573845|nutrition|nutrition
320307|NCT01573845|parents|parents
320308|NCT01573845|primary schools|primary schools
320309|NCT01573845|school age population|school age population
311045|NCT01614067|DOR|dor
320310|NCT01573845|school health|school health
320312|NCT01575041|sodium|sodium
320313|NCT01575041|salt|salt
320314|NCT01575041|potassium|potassium
320315|NCT01575041|blood pressure|blood pressure
320316|NCT01575041|flow-mediated dilatation|flow-mediated dilatation
320317|NCT01575041|endothelial function|endothelial function
320318|NCT01575041|renal function|renal function
320319|NCT01575041|controlled feeding study|controlled feeding study
320320|NCT01575041|dietary intervention|dietary intervention
320321|NCT01575028|Transversus abdominis plane block|transversus abdominis plane block
320322|NCT01575028|TAP block|tap block
320323|NCT01575028|Local anesthetic infiltration|local anesthetic infiltration
320324|NCT01575028|Appendectomy|appendectomy
320325|NCT01575028|Laparoscopic appendectomy|laparoscopic appendectomy
320326|NCT01575015|Liver transplantation (E04.210.650)|liver transplantation (e04.210.650)
753312|NCT01176227|constipation|constipation
320327|NCT01575015|Renal replacement therapy (E05.196.353)|renal replacement therapy (e05.196.353)
320328|NCT01575015|Intra-operative period (E04.614.374)|intra-operative period (e04.614.374)
320329|NCT01575015|Safety (N06.850.135.060.075)|safety (n06.850.135.060.075)
320330|NCT01575015|Efficacy|efficacy
320331|NCT01575002|transcranial stimulation|transcranial stimulation
320333|NCT01574989|direct current stimulation|direct current stimulation
320334|NCT01574989|magnetic stimulation|magnetic stimulation
320335|NCT01574989|transcranial stimulation|transcranial stimulation
320337|NCT01574976|probabilistic|probabilistic
320338|NCT01574976|choice|choice
320339|NCT01574976|feedback|feedback
320340|NCT01574976|practice|practice
320341|NCT01574963|Coronary artery disease|coronary artery disease
320342|NCT01574963|OPG|opg
320343|NCT01574963|RANKL|rankl
320344|NCT01574963|bone disease|bone disease
320345|NCT01574950|Delirium|delirium
320346|NCT01574937|Castration Resistant|castration resistant
320347|NCT01574937|Post Chemotherapy|post chemotherapy
320348|NCT01574924|Personality change|personality change
320349|NCT01574924|Perfectionism|perfectionism
320350|NCT01574924|Coping|coping
320351|NCT01574924|Medical Specialty|medical specialty
320352|NCT01574924|Medical Residency|medical residency
320353|NCT01574911|volumetry 3D|volumetry 3d
320354|NCT01574911|Displacement of water|displacement of water
320355|NCT01574911|lymphoedema|lymphoedema
320356|NCT01574911|Venous chronic insufficiency|venous chronic insufficiency
320357|NCT01574898|Smoking cessation|smoking cessation
320358|NCT01574898|Nicotine|nicotine
320359|NCT01574898|Tobacco Use Disorder|tobacco use disorder
320360|NCT01574898|Central Nervous System Agents|central nervous system agents
320361|NCT01574885|sleep apnea|sleep apnea
320362|NCT01574885|adenotonsillar hypertrophy|adenotonsillar hypertrophy
320363|NCT01574885|salt|salt
320364|NCT01574885|sodium chloride|sodium chloride
320365|NCT01574872|psoriasis|psoriasis
320366|NCT01574872|salt|salt
320367|NCT01574872|sodium chloride|sodium chloride
320368|NCT01574859|central hypothyroidism|central hypothyroidism
320369|NCT01574859|hypopituitarism|hypopituitarism
320370|NCT01574859|levothyroxine replacement|levothyroxine replacement
320371|NCT01574859|lipids|lipids
320372|NCT01574859|body composition|body composition
320373|NCT01574820|prediabetes|prediabetes
320374|NCT01574820|coronary artery disease|coronary artery disease
320375|NCT01574820|insulin resistance|insulin resistance
320376|NCT01574820|glucose intolerance|glucose intolerance
320377|NCT01574807|mepivacaine|mepivacaine
320378|NCT01574807|lidocaine|lidocaine
320379|NCT01574807|inferior alveolar nerve block|inferior alveolar nerve block
320380|NCT01574807|pulpal anesthesia|pulpal anesthesia
320381|NCT01574807|pain of injection|pain of injection
320382|NCT01574807|mepivacaine/lidocaine|mepivacaine/lidocaine
320383|NCT01574807|lidocaine/lidocaine|lidocaine/lidocaine
320384|NCT01574781|Down syndrome|down syndrome
320385|NCT01574781|Trisomy 13|trisomy 13
320386|NCT01574781|Trisomy 18|trisomy 18
320387|NCT01574781|Microdeletions|microdeletions
320388|NCT01574781|Pregnancy|pregnancy
320389|NCT01574781|Non-invasive|non-invasive
320390|NCT01574755|gastric inlet patches|gastric inlet patches
320391|NCT01574755|argon plasma coagulation|argon plasma coagulation
320392|NCT01574755|globus sensations|globus sensations
320393|NCT01574729|p53 gene therapy|p53 gene therapy
320394|NCT01574729|non-small cell lung cancer|non-small cell lung cancer
320395|NCT01574729|post-surgery|post-surgery
320396|NCT01574729|chemotherapy|chemotherapy
320397|NCT01574703|smoking cessation|smoking cessation
320398|NCT01574703|psychiatric disease|psychiatric disease
320399|NCT01574703|cardiovascular events|cardiovascular events
320400|NCT01574690|central venous pressure|central venous pressure
320401|NCT01574690|right heart catheter (RHC)|right heart catheter (rhc)
320402|NCT01574690|non-invasive monitor|non-invasive monitor
320403|NCT01574690|physical exam of jugular venous pressure|physical exam of jugular venous pressure
320404|NCT01574690|heart failure (HF)|heart failure (hf)
311159|NCT01613404|ESA|esa
320405|NCT01574677|Colorectal cancer|colorectal cancer
320406|NCT01574677|fecal immunochemical test|fecal immunochemical test
320407|NCT01574677|Septin 9|septin 9
320408|NCT01574677|screening|screening
320409|NCT01574651|QVA149|qva149
320410|NCT01574651|Health related quality of life|health related quality of life
320411|NCT01574651|Formoterol|formoterol
320412|NCT01574651|Tiotropium|tiotropium
320413|NCT01574651|COPD|copd
320414|NCT01574612|Xerese|xerese
320415|NCT01574612|acyclovir hydrocortisone cream|acyclovir hydrocortisone cream
320416|NCT01574612|herpes labialis|herpes labialis
320417|NCT01574612|pediatric|pediatric
320418|NCT01574599|Stroke|stroke
320419|NCT01574599|weakness|weakness
320420|NCT01574599|rehabilitation|rehabilitation
320421|NCT01574599|chronic stroke|chronic stroke
320422|NCT01574586|True Bifurcation stenosis|true bifurcation stenosis
320423|NCT01574573|Obesity|obesity
320424|NCT01574573|GERD|gerd
320425|NCT01574573|Weight loss|weight loss
320426|NCT01574560|smoke-free|smoke-free
320427|NCT01574560|tobacco exposure|tobacco exposure
320428|NCT01574560|biomarker feedback|biomarker feedback
320429|NCT01574560|nicotine|nicotine
320430|NCT01574560|cotinine|cotinine
320431|NCT01574560|secondhand smoke|secondhand smoke
320432|NCT01574547|Cat Scratch Colon.|cat scratch colon.
320433|NCT01574547|Mucosal tears.|mucosal tears.
320434|NCT01574547|Mucosal erosion.|mucosal erosion.
320435|NCT01574547|Colonoscopy.|colonoscopy.
320436|NCT01574508|efficacy|efficacy
320437|NCT01574508|safety|safety
320438|NCT01574508|intensive insulin therapy|intensive insulin therapy
320439|NCT01574495|stroke|stroke
320440|NCT01574495|error augmentation|error augmentation
320441|NCT01574495|arm recovery|arm recovery
320442|NCT01574495|massed practice|massed practice
320443|NCT01574482|Plant sterol - Hypercholesterolemia - diet - dairy|plant sterol - hypercholesterolemia - diet - dairy
320444|NCT01574469|Plant sterol - Cholesterol absorption - diet - dairy - LDL|plant sterol - cholesterol absorption - diet - dairy - ldl
320445|NCT01574443|Epilepsy|epilepsy
320446|NCT01574417|Plant stanols|plant stanols
320447|NCT01574417|Gene expression profile|gene expression profile
320448|NCT01574417|Microbiota|microbiota
320449|NCT01574404|PGS,PGD, IVF, Polar Body Biopsy, FISH, Microarray analysis|pgs,pgd, ivf, polar body biopsy, fish, microarray analysis
320450|NCT01574378|Abdominoplasty|abdominoplasty
320451|NCT01574365|CKD patients with type 2 diabetes|ckd patients with type 2 diabetes
320452|NCT01574352|Children|children
320453|NCT01574352|Overweight|overweight
320454|NCT01574352|Obesity|obesity
320455|NCT01574352|BMI|bmi
320456|NCT01574352|Physical activity|physical activity
320457|NCT01574352|Cognitive function|cognitive function
320458|NCT01574352|Intervention study|intervention study
320459|NCT01574352|Randomized controlled trial|randomized controlled trial
320460|NCT01574352|Day camp|day camp
320461|NCT01574352|Risk factors|risk factors
320462|NCT01574339|GERD|gerd
320463|NCT01574339|LES Pressure|les pressure
320464|NCT01574339|Electrical Stimulation|electrical stimulation
320465|NCT01574326|Chronic Kidney Disease|chronic kidney disease
320466|NCT01574326|Pediatric|pediatric
320467|NCT01574326|Sevelamer Carbonate|sevelamer carbonate
320468|NCT01574326|Hyperphosphatemia|hyperphosphatemia
320469|NCT01574313|stellate ganglion block.|stellate ganglion block.
320470|NCT01574313|Meniere's disease.|meniere's disease.
320471|NCT01574313|electrocochleography.|electrocochleography.
320472|NCT01574313|vertigo.|vertigo.
320473|NCT01574313|hearing impairment.|hearing impairment.
320474|NCT01574300|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
320475|NCT01574300|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
320476|NCT01574300|M1A or B NSCLC|m1a or b nsclc
320477|NCT01574261|Polycystic Ovary Syndrome|polycystic ovary syndrome
320478|NCT01574261|Cardiovascular risk|cardiovascular risk
320479|NCT01574261|Metabolic Syndrome|metabolic syndrome
320480|NCT01574248|ACE inhibitor|ace inhibitor
320481|NCT01574248|Angioedema|angioedema
320482|NCT01574248|Bradykinin|bradykinin
320483|NCT01574248|Swelling|swelling
320484|NCT01574222|Stages IIIB, IV, and recurrent NSCLC|stages iiib, iv, and recurrent nsclc
320485|NCT01574222|Carcinoma, Non-small cell lung|carcinoma, non-small cell lung
320486|NCT01574222|Lung Neoplasms|lung neoplasms
320487|NCT01574222|Carcinoma, Bronchogenic|carcinoma, bronchogenic
320488|NCT01574222|Thoracic Neoplasms|thoracic neoplasms
320489|NCT01574222|Neoplasms by Site|neoplasms by site
320490|NCT01574222|Neoplasms|neoplasms
320491|NCT01574222|Lung Diseases|lung diseases
320492|NCT01574209|Celiac disease|celiac disease
320493|NCT01574209|IBS|ibs
320494|NCT01574209|Intestinal barrier|intestinal barrier
320495|NCT01574209|Intestinal permeability|intestinal permeability
320496|NCT01574209|GI peptides|gi peptides
320497|NCT01574196|Childhood cancer|childhood cancer
320498|NCT01574196|Cancer|cancer
320499|NCT01574196|Sequels|sequels
320500|NCT01574196|Complications|complications
320501|NCT01574196|Chemotherapy|chemotherapy
320502|NCT01574196|Radiotherapy|radiotherapy
320503|NCT01574196|Surgery|surgery
320504|NCT01574196|Autonomic nervous system|autonomic nervous system
320505|NCT01574196|Parasympathetic Nervous System|parasympathetic nervous system
320506|NCT01574196|Sympathetic Nervous System|sympathetic nervous system
320507|NCT01574183|Marijuana|marijuana
320508|NCT01574183|Vilazodone|vilazodone
320509|NCT01574183|Contingency management|contingency management
320510|NCT01574183|Motivational enhancement therapy|motivational enhancement therapy
320511|NCT01574170|Breast cancer,|breast cancer,
320512|NCT01574170|Third line metastatic|third line metastatic
320513|NCT01574170|Chemotherapy,|chemotherapy,
320514|NCT01574170|Overall survival,|overall survival,
320515|NCT01574170|Quality of life.|quality of life.
320516|NCT01574144|Heart Failure|heart failure
320517|NCT01574131|Burn|burn
320518|NCT01574131|Fenofibrate|fenofibrate
320519|NCT01574131|PPAR alpha agonist|ppar alpha agonist
320520|NCT01574131|insulin sensitivity|insulin sensitivity
320521|NCT01574131|mitochondrial|mitochondrial
320522|NCT01574118|PTSD|ptsd
320523|NCT01574118|Posttraumatic Stress Disorder|posttraumatic stress disorder
320524|NCT01574118|Exposure Therapy|exposure therapy
320525|NCT01574118|Prolonged Exposure|prolonged exposure
320526|NCT01574118|Fear Memory Retrieval|fear memory retrieval
320527|NCT01574118|Compound extinction|compound extinction
320528|NCT01574118|Deepened extinction|deepened extinction
320529|NCT01574118|Psychotherapy|psychotherapy
320530|NCT01574105|Heparin Dose|heparin dose
320531|NCT01574105|Heparin Resistance|heparin resistance
320532|NCT01574105|Chest Tube Losses|chest tube losses
320533|NCT01574105|Transfusion Events|transfusion events
320534|NCT01574092|Pediatric|pediatric
320535|NCT01574092|Pediatrics|pediatrics
320536|NCT01574092|Gliomas|gliomas
320537|NCT01574092|Glioma|glioma
320539|NCT01574092|Brain cancer|brain cancer
320540|NCT01574092|Cisplatin|cisplatin
320541|NCT01574092|Cisplatino|cisplatino
320542|NCT01574092|Irinotecan|irinotecan
320543|NCT01574092|Brain stem tumor|brain stem tumor
320544|NCT01574092|Brainstem gliomas|brainstem gliomas
320545|NCT01574092|Intrinsic brain stem tumor|intrinsic brain stem tumor
320546|NCT01574092|PAEDIATRIC HIGH GRADE GLIOMA|paediatric high grade glioma
320547|NCT01574092|Childhood brain stem glioma|childhood brain stem glioma
320548|NCT01574066|Community-acquired pneumonia|community-acquired pneumonia
320549|NCT01574066|Diagnosis|diagnosis
320550|NCT01574066|Emergency medicine|emergency medicine
320551|NCT01574066|Chest CT-scan|chest ct-scan
320552|NCT01574053|Huntington's Disease|huntington's disease
320553|NCT01574053|Huntington Disease|huntington disease
320554|NCT01574053|Juvenile Huntington's Disease|juvenile huntington's disease
320555|NCT01574053|Registry|registry
320556|NCT01574053|Cohort|cohort
320557|NCT01574053|CHDI|chdi
320558|NCT01573819|repeat dose|repeat dose
320559|NCT01573819|PDE4|pde4
320560|NCT01573819|healthy volunteers|healthy volunteers
320561|NCT01573819|GSK356278|gsk356278
320562|NCT01573806|sepsis|sepsis
320563|NCT01573806|septic shock|septic shock
320564|NCT01573806|children|children
320565|NCT01573806|incretins|incretins
320566|NCT01573806|exenatide|exenatide
320567|NCT01573806|pharmacokinetics|pharmacokinetics
320568|NCT01573806|pharmacodynamics|pharmacodynamics
320569|NCT01573806|glucose homeostasis|glucose homeostasis
320570|NCT01573806|inflammation|inflammation
320571|NCT01573806|cytokines|cytokines
320572|NCT01573806|health-related quality of life|health-related quality of life
320573|NCT01573806|functional status|functional status
320574|NCT01573754|Porphyria, rare disease, orphan disease, iron metabolism|porphyria, rare disease, orphan disease, iron metabolism
320575|NCT01573741|depressive ketamine antidepressant|depressive ketamine antidepressant
320576|NCT01573728|Depression|depression
320577|NCT01573728|Biomarkers|biomarkers
320578|NCT01573728|Exercise|exercise
320579|NCT01573702|Non small cell lung cancer|non small cell lung cancer
320580|NCT01573702|EGFR mutant|egfr mutant
320581|NCT01573702|Phase II|phase ii
320582|NCT01573702|erlotinib|erlotinib
320583|NCT01573702|tarceva|tarceva
320584|NCT01573702|cyberknife|cyberknife
320585|NCT01573702|Lineberger|lineberger
320586|NCT01573689|bereaved children, mutual aid group, death, group intervention.|bereaved children, mutual aid group, death, group intervention.
320587|NCT01573676|bariatric surgery|bariatric surgery
320588|NCT01573676|sleep apnea|sleep apnea
320589|NCT01573676|overweight|overweight
320590|NCT01573663|Ambroxol|ambroxol
320591|NCT01573663|Levodropropizine|levodropropizine
320592|NCT01573663|Drug-drug interaction|drug-drug interaction
320593|NCT01573637|schizophrenia|schizophrenia
320594|NCT01573637|negative schizophrenia|negative schizophrenia
320595|NCT01573637|schizophrenia in post-menopausal women|schizophrenia in post-menopausal women
320596|NCT01573637|schizophrenia in women|schizophrenia in women
320597|NCT01573637|ralixifene|ralixifene
320598|NCT01573637|raloxifen|raloxifen
320599|NCT01573637|raloxifeno|raloxifeno
320600|NCT01573637|negative symptoms of schizophrenia|negative symptoms of schizophrenia
752616|NCT01173354|Protein metabolism|protein metabolism
397961|NCT01251003|TBI|tbi
320601|NCT01573637|negative symptoms in schizophrenia|negative symptoms in schizophrenia
320602|NCT01573637|schizophrenia symptoms|schizophrenia symptoms
320603|NCT01573637|negative symptoms of psychosis|negative symptoms of psychosis
320604|NCT01573624|Fluticasone Furoate|fluticasone furoate
320605|NCT01573624|Vilanterol|vilanterol
320606|NCT01573624|Adults|adults
320607|NCT01573624|GSK573719|gsk573719
320608|NCT01573624|Asthma|asthma
320609|NCT01573611|mild cognitive impairment|mild cognitive impairment
320610|NCT01573611|dementia|dementia
320611|NCT01573611|positron emission tomography (PET)|positron emission tomography (pet)
320612|NCT01573611|F-18 Fluorodeoxyglucose (FDG)|f-18 fluorodeoxyglucose (fdg)
320613|NCT01573611|cerebral metabolism|cerebral metabolism
320614|NCT01573611|dietary supplement|dietary supplement
320615|NCT01573598|Major Depressive Disorder|major depressive disorder
320616|NCT01573598|Depression|depression
320617|NCT01573585|Physical Therapy|physical therapy
320618|NCT01573585|Exercise therapy|exercise therapy
320619|NCT01573559|Ambulatory adults with no apparent health conditions|ambulatory adults with no apparent health conditions
320620|NCT01573533|Treatment Resistant Idiopathic FSGS|treatment resistant idiopathic fsgs
320621|NCT01573533|Glomerulosclerosis|glomerulosclerosis
320622|NCT01573533|Proteinuria|proteinuria
320623|NCT01573533|Rituximab|rituximab
320624|NCT01573520|compliance|compliance
320625|NCT01573520|dialysis|dialysis
320626|NCT01573520|hyperparathyroidism|hyperparathyroidism
320627|NCT01573507|traumatic brain injury|traumatic brain injury
320628|NCT01573507|lactate|lactate
320629|NCT01573507|brain metabolism|brain metabolism
320630|NCT01573507|cerebral microdialysis|cerebral microdialysis
320631|NCT01573507|subarachnoid hemorrhage|subarachnoid hemorrhage
320632|NCT01573507|transcranial doppler|transcranial doppler
320633|NCT01573494|Cancer|cancer
320634|NCT01573494|Melanoma|melanoma
320635|NCT01573494|Circulating Tumor Cells|circulating tumor cells
320636|NCT01573481|WEANING|weaning
320637|NCT01573481|PRESSURE CONTROLLED CONTINOUS VENTILATION|pressure controlled continous ventilation
320638|NCT01573481|PRESSURE VENTILATION SUPPORT|pressure ventilation support
320639|NCT01573481|SLEEP|sleep
320640|NCT01573481|POLYGRAPHIC RECORD|polygraphic record
320641|NCT01573442|hot flashes|hot flashes
320642|NCT01573442|musculoskeletal complications|musculoskeletal complications
320643|NCT01573442|sexual dysfunction|sexual dysfunction
320644|NCT01573442|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
320645|NCT01573442|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
320646|NCT01573442|arthralgia|arthralgia
320647|NCT01573442|stage IA breast cancer|stage ia breast cancer
320648|NCT01573442|stage IB breast cancer|stage ib breast cancer
320649|NCT01573442|stage II breast cancer|stage ii breast cancer
320650|NCT01573442|stage IIIA breast cancer|stage iiia breast cancer
320651|NCT01573442|stage IIIB breast cancer|stage iiib breast cancer
320652|NCT01573442|stage IIIC breast cancer|stage iiic breast cancer
320653|NCT01573429|Biologic Sample Collection|biologic sample collection
320654|NCT01573429|Metabolism|metabolism
320655|NCT01573429|Healthy Volunteer|healthy volunteer
320657|NCT01573416|Alcohol|alcohol
320658|NCT01573416|Abuse|abuse
320659|NCT01573416|Drugs|drugs
320660|NCT01573416|Brief intervention|brief intervention
320661|NCT01573416|ASSIST|assist
320662|NCT01573403|Proton pump inhibitor (PPI)|proton pump inhibitor (ppi)
320663|NCT01573403|DLBS2411|dlbs2411
320664|NCT01573403|gastric pH|gastric ph
320665|NCT01573390|Non-invasive|non-invasive
320666|NCT01573390|tissue-oxygenation|tissue-oxygenation
320667|NCT01573390|hyperspectral|hyperspectral
320668|NCT01573390|CWC imaging system|cwc imaging system
320669|NCT01573377|polycystic ovary syndrome|polycystic ovary syndrome
320670|NCT01573377|insulin resistance|insulin resistance
320671|NCT01573364|Distal Airways|distal airways
320672|NCT01573364|Hyperinflation|hyperinflation
320673|NCT01573364|Reversibility|reversibility
320674|NCT01573338|Cyclin dependent kinases|cyclin dependent kinases
320675|NCT01573338|Drug therapy, combination|drug therapy, combination
320676|NCT01573338|Small cell lung carcinoma|small cell lung carcinoma
320677|NCT01573338|Etoposide|etoposide
320678|NCT01573338|Cisplatin|cisplatin
320679|NCT01573338|Carboplatin|carboplatin
320680|NCT01573325|Cirrhosis of the liver|cirrhosis of the liver
320681|NCT01573325|Pre-liver transplant Candidate|pre-liver transplant candidate
320682|NCT01573325|Depression|depression
320683|NCT01573325|Poor social support|poor social support
320684|NCT01573325|Liver disease symptoms|liver disease symptoms
320685|NCT01573325|Health releated quality of life|health releated quality of life
320686|NCT01573312|influenza, vaccine, H5N1, monovalent, adjuvant, ASO3|influenza, vaccine, h5n1, monovalent, adjuvant, aso3
320687|NCT01573299|Cerebral Infarction, Mobilization, Recovery|cerebral infarction, mobilization, recovery
320688|NCT01573286|Infant Nutrition Disorders|infant nutrition disorders
320689|NCT01573286|Childhood nutrition disorders|childhood nutrition disorders
320690|NCT01573286|malnutrition|malnutrition
320691|NCT01573286|post surgical syndromes|post surgical syndromes
320692|NCT01573286|necrotising enterocolitis|necrotising enterocolitis
320693|NCT01573286|intestinal atresia|intestinal atresia
320694|NCT01573286|gastroschisis|gastroschisis
320695|NCT01573273|cocaine|cocaine
320696|NCT01573273|substance abuse|substance abuse
320697|NCT01573273|drug abuse|drug abuse
320698|NCT01573273|cocaine dependence|cocaine dependence
320699|NCT01573273|drug addiction|drug addiction
320700|NCT01573260|Parkinson's Disease|parkinson's disease
320701|NCT01573260|Tango|tango
320702|NCT01573247|Acute myeloid leukemia|acute myeloid leukemia
320703|NCT01573247|Refractory Acute myeloid leukemia|refractory acute myeloid leukemia
320704|NCT01573247|FLT3 inhibitor|flt3 inhibitor
320705|NCT01573247|kinase inhibitor|kinase inhibitor
320706|NCT01573234|MySkin patch|myskin patch
320707|NCT01573234|Hydrogel bandage|hydrogel bandage
320708|NCT01573234|Occlusive dressing|occlusive dressing
320709|NCT01573208|Knee osteoarthritis|knee osteoarthritis
320710|NCT01573195|deescalation|deescalation
320711|NCT01573195|best practice alert|best practice alert
320712|NCT01573195|antimicrobial stewardship|antimicrobial stewardship
320713|NCT01573182|Zostavax|zostavax
320714|NCT01573182|Herpes Zoster|herpes zoster
320715|NCT01573182|VZV vaccination|vzv vaccination
320716|NCT01573182|Allogeneic haemopoietic stem cell transplantation|allogeneic haemopoietic stem cell transplantation
320717|NCT01573169|hemorrhagic stroke|hemorrhagic stroke
320718|NCT01573169|venous thromboembolism|venous thromboembolism
320719|NCT01573169|prevention|prevention
320720|NCT01573156|renal cancer|renal cancer
320721|NCT01573156|photodynamic therapy|photodynamic therapy
320722|NCT01573156|wst 11|wst 11
320723|NCT01573143|Surgical Procedures, Cardiac|surgical procedures, cardiac
320724|NCT01573143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
320819|NCT01572779|vimove|vimove
320725|NCT01573143|Rosuvastatin|rosuvastatin
320726|NCT01573143|Post operative atrial fibrillation|post operative atrial fibrillation
320727|NCT01573130|Depression|depression
320728|NCT01573130|Physical exercise|physical exercise
320729|NCT01573130|Internet|internet
320730|NCT01573117|hypothermia|hypothermia
320731|NCT01573117|induction of hypothermia|induction of hypothermia
320732|NCT01573117|cold infusion|cold infusion
320733|NCT01573117|nasopharyngeal cooling|nasopharyngeal cooling
320734|NCT01573117|stroke|stroke
320735|NCT01573117|intracranial hemorrhage|intracranial hemorrhage
320736|NCT01573117|cerebrovascular disease|cerebrovascular disease
320737|NCT01573117|neuro intensive care|neuro intensive care
320738|NCT01573104|Diagnosis|diagnosis
320739|NCT01573104|Acute Kidney Injury|acute kidney injury
320740|NCT01573091|Cardiac resynchronization therapy|cardiac resynchronization therapy
320741|NCT01573091|Heart failure|heart failure
320742|NCT01573078|Crohn's disease|crohn's disease
320743|NCT01573078|IBS|ibs
320744|NCT01573078|Dissociation|dissociation
320745|NCT01573078|Emotional processing|emotional processing
320746|NCT01573065|alcohol consumption|alcohol consumption
320747|NCT01573065|sexual risk behaviors|sexual risk behaviors
320748|NCT01573065|young, unhealthy drinkers|young, unhealthy drinkers
320749|NCT01573039|Kidney transplantation|kidney transplantation
320750|NCT01573039|PCR quantitative|pcr quantitative
320751|NCT01573039|cytomegalovirus|cytomegalovirus
320752|NCT01573039|antigenemia|antigenemia
320753|NCT01573026|Dental Implants|dental implants
320754|NCT01573026|Dental Implantation|dental implantation
320755|NCT01573026|Osseointegration|osseointegration
320756|NCT01573013|iron deficiency|iron deficiency
320757|NCT01573013|Lead poisoning|lead poisoning
320758|NCT01573013|cognitive development|cognitive development
320759|NCT01573013|motor activity|motor activity
320760|NCT01573000|Bexxar|bexxar
320761|NCT01573000|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
320762|NCT01573000|Tositumomab|tositumomab
320763|NCT01573000|Anti-B1 Antibody|anti-b1 antibody
320764|NCT01573000|Radioimmunotherapy|radioimmunotherapy
320765|NCT01573000|Iodine I-131|iodine i-131
320766|NCT01573000|Iodine-131|iodine-131
320767|NCT01572987|Barrett's Esophagus|barrett's esophagus
320768|NCT01572987|Esophageal neoplasms|esophageal neoplasms
320769|NCT01572987|Radiofrequency ablation|radiofrequency ablation
320770|NCT01572987|Endoscopic mucosal resection|endoscopic mucosal resection
320771|NCT01572974|Barrett's esophagus|barrett's esophagus
320772|NCT01572974|Gastroesophageal reflux disease|gastroesophageal reflux disease
320773|NCT01572974|Quality of life|quality of life
320774|NCT01572961|Laser Doppler flowmetry, skin, microcirculation|laser doppler flowmetry, skin, microcirculation
320775|NCT01572935|childhood obesity prevalence|childhood obesity prevalence
320776|NCT01572922|Sickle cell disease|sickle cell disease
320777|NCT01572922|Thalassemia|thalassemia
320778|NCT01572922|Hemochromatosis|hemochromatosis
320779|NCT01572922|Cancer|cancer
320780|NCT01572909|Myocardial Reperfusion|myocardial reperfusion
320781|NCT01572909|Primary PCI|primary pci
320782|NCT01572909|Stenting for ST-segment Elevation Myocardial Infarction|stenting for st-segment elevation myocardial infarction
320783|NCT01572896|adoloescent|adoloescent
320784|NCT01572896|internet self-management|internet self-management
320785|NCT01572896|managing JIA|managing jia
398136|NCT01250171|Dry eye|dry eye
320786|NCT01572883|adjuvant treatment with Radiotherapy and trastuzumab|adjuvant treatment with radiotherapy and trastuzumab
320787|NCT01572870|Chit1|chit1
320788|NCT01572870|Cystic Fibrosis|cystic fibrosis
320789|NCT01572870|Allergic Bronchopulmonary Aspergillosis (ABPA)|allergic bronchopulmonary aspergillosis (abpa)
320790|NCT01572870|Aspergillus|aspergillus
320791|NCT01572857|multiple myeloma|multiple myeloma
320792|NCT01572857|Proteinuria|proteinuria
320793|NCT01572857|Albuminuria|albuminuria
320794|NCT01572857|Urinary FLC|urinary flc
320795|NCT01572857|Urine creatinine|urine creatinine
320796|NCT01572844|Dermatomyositis|dermatomyositis
320797|NCT01572844|Superficial calcinosis|superficial calcinosis
320798|NCT01572844|Fractional carbon dioxide laser|fractional carbon dioxide laser
320799|NCT01572844|Sodium thiosulfate|sodium thiosulfate
320800|NCT01572831|antibiotic cessation rules|antibiotic cessation rules
320801|NCT01572831|procalcitonin|procalcitonin
320802|NCT01572831|infection|infection
320803|NCT01572831|critical care|critical care
320804|NCT01572818|Phlebotomy|phlebotomy
320805|NCT01572818|Insulin Resistance|insulin resistance
320806|NCT01572818|Iron Overload|iron overload
320807|NCT01572805|Post partum haemorrhage|post partum haemorrhage
320808|NCT01572805|Cesarean|cesarean
320809|NCT01572805|Pain|pain
320810|NCT01572792|COPD|copd
320811|NCT01572792|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
320812|NCT01572792|Chronic Bronchitis|chronic bronchitis
320813|NCT01572792|Emphysema|emphysema
320814|NCT01572792|Airflow Obstruction, Chronic|airflow obstruction, chronic
753313|NCT01176227|diarrhea|diarrhea
320815|NCT01572792|Chronic Airflow Obstruction|chronic airflow obstruction
320816|NCT01572792|Chronic Obstructive Airway Disease|chronic obstructive airway disease
320817|NCT01572792|Chronic Obstructive Lung Disease|chronic obstructive lung disease
320818|NCT01572779|dorsavi|dorsavi
320820|NCT01572779|biofeedback|biofeedback
320821|NCT01572779|objective movement data|objective movement data
320822|NCT01572779|back pain|back pain
320823|NCT01572766|Osteoporosis|osteoporosis
320824|NCT01572766|Pharmacist|pharmacist
320825|NCT01572766|Behavior Change|behavior change
320826|NCT01572766|FRAX|frax
320827|NCT01572766|Osteopenia|osteopenia
320836|NCT01572714|Exercise|exercise
320837|NCT01572714|Self Care|self care
320838|NCT01572714|Fatigue|fatigue
320839|NCT01572675|Pharmacoepidemiological|pharmacoepidemiological
320840|NCT01572675|Longitudinal|longitudinal
320841|NCT01572675|Observational|observational
320842|NCT01572662|Leukemia|leukemia
320843|NCT01572662|Acute myeloid leukemia|acute myeloid leukemia
320844|NCT01572662|Acute lymphocytic leukemia|acute lymphocytic leukemia
320845|NCT01572662|Chronic myeloid leukemia|chronic myeloid leukemia
320846|NCT01572662|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
320847|NCT01572662|Myeloproliferative Diseases|myeloproliferative diseases
320848|NCT01572662|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
320849|NCT01572662|Hodgkins lymphoma|hodgkins lymphoma
320850|NCT01572662|Multiple myeloma|multiple myeloma
320851|NCT01572662|Myelodysplastic syndrome|myelodysplastic syndrome
320852|NCT01572662|MDS|mds
320853|NCT01572662|Fludarabine monophosphate|fludarabine monophosphate
320854|NCT01572662|Fludarabine phosphate|fludarabine phosphate
320855|NCT01572662|Fludara|fludara
320856|NCT01572662|Busulfan|busulfan
320857|NCT01572662|Busulfex|busulfex
320858|NCT01572662|Myleran|myleran
320859|NCT01572662|Tacrolimus|tacrolimus
320860|NCT01572662|Prograf|prograf
320861|NCT01572662|Methotrexate|methotrexate
320862|NCT01572662|G-CSF|g-csf
320863|NCT01572662|Filgrastim|filgrastim
320864|NCT01572662|Neupogen|neupogen
320865|NCT01572662|Stem cell transplant|stem cell transplant
320866|NCT01572662|Allogeneic Transplantation|allogeneic transplantation
320867|NCT01572636|Hurler Syndrome|hurler syndrome
320868|NCT01572623|Therapeutic strategies for carotid artery stenting|therapeutic strategies for carotid artery stenting
320869|NCT01572610|CKD patients with type 2 diabetes|ckd patients with type 2 diabetes
320870|NCT01572597|Helicobacter pylori|helicobacter pylori
320871|NCT01572597|antibiotic resistance|antibiotic resistance
320872|NCT01572597|N-acetylcystein|n-acetylcystein
320874|NCT01572597|second-line eradication treatment|second-line eradication treatment
320875|NCT01572584|Pneumothorax|pneumothorax
320876|NCT01572584|Lung ultrasound|lung ultrasound
320877|NCT01572584|Chest sonography|chest sonography
320878|NCT01572571|Emergency ultrasound|emergency ultrasound
320879|NCT01572571|Focused ultrasound|focused ultrasound
320880|NCT01572571|Point-of-care ultrasound|point-of-care ultrasound
320881|NCT01572571|Undifferentiated hypotension|undifferentiated hypotension
320882|NCT01572558|Appendectomy|appendectomy
320883|NCT01572558|Nonsurgical treatment with antibiotics|nonsurgical treatment with antibiotics
320884|NCT01572545|bone turnover|bone turnover
320885|NCT01572545|denosumab|denosumab
320886|NCT01572545|postmenopausal osteoporosis|postmenopausal osteoporosis
320887|NCT01572545|sclerostin|sclerostin
320888|NCT01572545|zolendronic acid|zolendronic acid
320889|NCT01572532|Adverse Perinatal Outcomes|adverse perinatal outcomes
320890|NCT01572532|Treatment of abnormal vaginal flora|treatment of abnormal vaginal flora
320891|NCT01572519|Relapsed Hodgkin lymphoma|relapsed hodgkin lymphoma
320892|NCT01572519|Refractory Hodgkin lymphoma|refractory hodgkin lymphoma
320893|NCT01572519|JNJ-40346527|jnj-40346527
320894|NCT01572519|Dose-escalation|dose-escalation
320895|NCT01572519|Pharmacokinetics|pharmacokinetics
320896|NCT01572506|Anemia|anemia
320897|NCT01572506|Elderly|elderly
320898|NCT01572506|Mechanisms|mechanisms
320899|NCT01572506|Red Cell Survival|red cell survival
320900|NCT01572493|Pharmacokinetics of lL-15|pharmacokinetics of ll-15
320901|NCT01572493|Cytokine Therapy|cytokine therapy
320902|NCT01572493|Effects of rhlL-15 on T-cells and NK cells|effects of rhll-15 on t-cells and nk cells
320903|NCT01572493|Immunotherapy|immunotherapy
320910|NCT01572467|Leydig cell tumor|leydig cell tumor
320911|NCT01572467|ovarian stromal cancer|ovarian stromal cancer
320912|NCT01572467|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
320913|NCT01572467|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
320914|NCT01572454|coronary artery bypass graft|coronary artery bypass graft
320915|NCT01572454|hypokalemia|hypokalemia
320916|NCT01572454|cardiac arrhythmia|cardiac arrhythmia
320917|NCT01572454|dexmedetomidine|dexmedetomidine
320918|NCT01572454|remifentanil|remifentanil
320919|NCT01572428|Proximal Colon Cancer|proximal colon cancer
320920|NCT01572428|Serrated Colon Lesions|serrated colon lesions
320921|NCT01572428|Narrow Band Imaging|narrow band imaging
320922|NCT01572415|Screening for Type 2 diabetes|screening for type 2 diabetes
320923|NCT01572402|Diet|diet
320924|NCT01572402|Gastrointestinal peptides|gastrointestinal peptides
320925|NCT01572402|Insulin secretion|insulin secretion
320926|NCT01572402|Oxidative stress|oxidative stress
320927|NCT01572402|Plasma lipids|plasma lipids
320928|NCT01572402|Postprandial|postprandial
320929|NCT01572402|Type 2 diabetes|type 2 diabetes
320930|NCT01572389|Diabetes Mellitus|diabetes mellitus
320931|NCT01572389|Depression|depression
320932|NCT01572389|Affective Symptoms|affective symptoms
320933|NCT01572389|Self Care|self care
320934|NCT01572389|Telemedicine|telemedicine
320935|NCT01572389|Psychotherapy|psychotherapy
320936|NCT01572376|Pressure ulcers|pressure ulcers
320937|NCT01572376|Chronic wounds|chronic wounds
320938|NCT01572376|Spinal cord injury patients|spinal cord injury patients
320939|NCT01572376|Bone marrow|bone marrow
320940|NCT01572376|Mononuclear|mononuclear
320941|NCT01572376|Debridement|debridement
320942|NCT01572363|Fontan|fontan
320943|NCT01572363|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
320944|NCT01572363|Sildenafil|sildenafil
320945|NCT01572337|NIV|niv
320946|NCT01572337|acute respiratory failure|acute respiratory failure
320947|NCT01572337|hypoxia|hypoxia
320948|NCT01572337|hypercapnia|hypercapnia
320949|NCT01572337|non-invasive ventilation|non-invasive ventilation
320950|NCT01572337|hospital ward|hospital ward
320951|NCT01572324|Cholangiocarcinoma|cholangiocarcinoma
320952|NCT01572324|gallbladder cancer|gallbladder cancer
320953|NCT01572324|Infusions|infusions
320954|NCT01572324|Intra-Arterial|intra-arterial
320955|NCT01572311|Aerobic exercise|aerobic exercise
320956|NCT01572311|Cognition|cognition
320957|NCT01572311|Dual Task|dual task
320958|NCT01572311|Gait Training|gait training
320959|NCT01572311|Group-based exercise|group-based exercise
320960|NCT01572311|Older adults|older adults
320961|NCT01572285|Hemiplegic|hemiplegic
320962|NCT01572285|Shoulder Pain|shoulder pain
320963|NCT01572285|Transforaminal|transforaminal
320964|NCT01572285|Treatment|treatment
320965|NCT01572285|Interventional|interventional
320966|NCT01572272|Distal Capnography|distal capnography
320967|NCT01572272|CO2|co2
320968|NCT01572272|neonates|neonates
320969|NCT01572272|conventional ventilation|conventional ventilation
320970|NCT01572246|electrosurgery|electrosurgery
320971|NCT01572246|Cardiac surgical procedures|cardiac surgical procedures
320972|NCT01572246|Surgical procedures, operative|surgical procedures, operative
320973|NCT01572246|Defibrillators|defibrillators
320974|NCT01572233|Fatigue,Physical Activity,Hepatitis C Virus Infection|fatigue,physical activity,hepatitis c virus infection
320975|NCT01572220|Hospitalized patients|hospitalized patients
320976|NCT01572207|Multiple Sclerosis|multiple sclerosis
320977|NCT01572207|Exercise|exercise
320978|NCT01572207|Physical activity|physical activity
320979|NCT01572207|Quality of life|quality of life
320981|NCT01572168|Fatigue|fatigue
320982|NCT01572142|Parkinson disease|parkinson disease
320983|NCT01572142|smell|smell
320984|NCT01572142|cognitive|cognitive
320985|NCT01572116|sufentanil|sufentanil
320986|NCT01572116|irreversible pulpitis|irreversible pulpitis
320987|NCT01572116|intra ligament injection|intra ligament injection
320988|NCT01572090|Body mass index|body mass index
320989|NCT01572090|Body fat|body fat
320990|NCT01572090|Obesity|obesity
320991|NCT01572090|Bariatric surgery|bariatric surgery
320992|NCT01572090|Conventional dietary treatment|conventional dietary treatment
311741|NCT01610648|OSA|osa
320993|NCT01572090|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
320994|NCT01572090|Cardiometabolic risk factors|cardiometabolic risk factors
320995|NCT01572090|Inflammation|inflammation
320996|NCT01572090|Adipokines|adipokines
320997|NCT01572090|Gastrointestinal hormones|gastrointestinal hormones
320998|NCT01572090|Comorbidity improvement|comorbidity improvement
320999|NCT01572090|Energy intake|energy intake
321000|NCT01572090|Energy expenditure|energy expenditure
321001|NCT01572090|Physical activity|physical activity
321002|NCT01572064|MRI|mri
321003|NCT01572064|liver biopsy|liver biopsy
321004|NCT01572064|serological markers|serological markers
321005|NCT01572051|osteoarthritis|osteoarthritis
321006|NCT01572051|knee osteoarthritis|knee osteoarthritis
321007|NCT01572051|education|education
321008|NCT01572012|Pharmacokinetics|pharmacokinetics
321009|NCT01572012|Safety|safety
321010|NCT01572012|Healthy Volunteers|healthy volunteers
321011|NCT01572012|tolerability|tolerability
321012|NCT01571999|pharmacokinetics|pharmacokinetics
321013|NCT01571999|GW642444|gw642444
321014|NCT01571999|GSK573719|gsk573719
321015|NCT01571999|vilanterol|vilanterol
321016|NCT01571999|renal impairment|renal impairment
321017|NCT01571999|safety|safety
321018|NCT01571999|COPD|copd
321019|NCT01571986|NIV|niv
321020|NCT01571986|acute respiratory failure|acute respiratory failure
321021|NCT01571986|hypoxia|hypoxia
321022|NCT01571986|hypercapnia|hypercapnia
321023|NCT01571986|non-invasive ventilation|non-invasive ventilation
321024|NCT01571986|hospital ward|hospital ward
321025|NCT01571973|pharmaceutical care|pharmaceutical care
321026|NCT01571973|depression|depression
321027|NCT01571973|compliance|compliance
321028|NCT01571973|pharmacist's intervention|pharmacist's intervention
321029|NCT01571973|Dáder|dáder
321030|NCT01571947|Insulinaemia|insulinaemia
321031|NCT01571947|inflammatory markers|inflammatory markers
321032|NCT01571947|gastrointestinal peptides|gastrointestinal peptides
321033|NCT01571947|SFA|sfa
321034|NCT01571947|dietary fats|dietary fats
321035|NCT01571947|carbohydrate|carbohydrate
321036|NCT01571947|insulin sensitivity|insulin sensitivity
321037|NCT01571934|Hemophilia A|hemophilia a
321038|NCT01571908|rocuronium|rocuronium
321039|NCT01571908|succinylcholine|succinylcholine
321040|NCT01571908|magnesiumsulphate|magnesiumsulphate
321041|NCT01571908|intubation conditions|intubation conditions
321042|NCT01571895|Autoimmune inflammatory blistering disorder|autoimmune inflammatory blistering disorder
321043|NCT01571882|Plant sterol - Policosanols - Hypercholesterolemia - Dairy|plant sterol - policosanols - hypercholesterolemia - dairy
321044|NCT01571869|Plant sterol - hypercholesterolemia - dairy - meal|plant sterol - hypercholesterolemia - dairy - meal
321045|NCT01571856|Acute Diarrhea|acute diarrhea
321046|NCT01571856|Zinc|zinc
321047|NCT01571856|Children|children
321048|NCT01571843|Hyperparathyroidism, Primary|hyperparathyroidism, primary
321049|NCT01571843|Bone Diseases, Metabolic|bone diseases, metabolic
321050|NCT01571843|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
321051|NCT01571843|Bone Loss, Postmenopausal|bone loss, postmenopausal
321052|NCT01571830|food allergy|food allergy
321053|NCT01571830|nutrient intake|nutrient intake
321054|NCT01571830|growth|growth
321055|NCT01571817|Insulin Dependent|insulin dependent
321056|NCT01571804|Anesthesia|anesthesia
321057|NCT01571804|pregabalin|pregabalin
321058|NCT01571804|sevoflurane|sevoflurane
321059|NCT01571804|laparoscopic cholecystectomy|laparoscopic cholecystectomy
321060|NCT01571791|Ketorolac|ketorolac
321061|NCT01571791|lidocaine|lidocaine
321062|NCT01571791|valvular hear diseases|valvular hear diseases
321063|NCT01571791|cesarean section|cesarean section
321064|NCT01571778|Hand Hygiene|hand hygiene
321065|NCT01571778|Non-sterile Glove Use|non-sterile glove use
321066|NCT01571765|maternal|maternal
321067|NCT01571765|newborn|newborn
321068|NCT01571765|child|child
321069|NCT01571752|Drug Abuse/Dependence|drug abuse/dependence
321070|NCT01571752|Drug Abuse|drug abuse
321071|NCT01571752|Drug Dependence|drug dependence
321072|NCT01571739|Biomarker|biomarker
321073|NCT01571739|Latent Tuberculosis|latent tuberculosis
321075|NCT01571739|Isoniazid|isoniazid
321076|NCT01571739|TB Lymphadenopathy|tb lymphadenopathy
321077|NCT01571739|Tuberculosis|tuberculosis
321078|NCT01571739|TB|tb
321079|NCT01571726|(18)-Fluciclatide PET/CT|(18)-fluciclatide pet/ct
321080|NCT01571726|Serum M-Protein|serum m-protein
321081|NCT01571726|Percentage of Plasma Cells in the Bone Marrow|percentage of plasma cells in the bone marrow
321082|NCT01571726|Ratio of Normal/Abnormal Percentage of Plasma Cells in the Bone Marrow|ratio of normal/abnormal percentage of plasma cells in the bone marrow
321083|NCT01571726|Multiple Myeloma|multiple myeloma
321084|NCT01571700|Mechanical Dysynchrony|mechanical dysynchrony
321085|NCT01571700|Electrical Dysynchrony|electrical dysynchrony
321086|NCT01571687|expedition|expedition
321087|NCT01571687|hypoxia|hypoxia
321088|NCT01571687|blood coagulation disorders|blood coagulation disorders
321089|NCT01571687|cell-derived microparticles|cell-derived microparticles
311830|NCT01610362|rabies|rabies
321090|NCT01571687|oxidative stress|oxidative stress
321091|NCT01571687|N-Acetylcystein|n-acetylcystein
321092|NCT01571687|vitamins|vitamins
321093|NCT01571674|Cervical|cervical
321094|NCT01571674|Clinical Prediction Rule|clinical prediction rule
321095|NCT01571674|Exercise|exercise
321096|NCT01571674|Manipulation|manipulation
321097|NCT01571674|Manual therapy|manual therapy
321098|NCT01571674|Mobilization|mobilization
321099|NCT01571674|Physical Therapy|physical therapy
321100|NCT01571674|Prognosis|prognosis
321101|NCT01571674|Shoulder pain|shoulder pain
321102|NCT01571674|Thoracic|thoracic
321103|NCT01571661|KGT-1142|kgt-1142
321104|NCT01571661|safety|safety
321105|NCT01571661|pharmacokinetics|pharmacokinetics
321106|NCT01571661|single-dose escalation|single-dose escalation
321107|NCT01571661|tolerability|tolerability
321108|NCT01571635|Beta-Thalassaemia|beta-thalassaemia
321109|NCT01571622|Whey protein|whey protein
321110|NCT01571622|type 2 diabetes|type 2 diabetes
321111|NCT01571596|XLH|xlh
321112|NCT01571583|Chronic HCV infection|chronic hcv infection
321113|NCT01571583|Genotype 1 chronic HCV|genotype 1 chronic hcv
321114|NCT01571583|Liver transplantation|liver transplantation
321115|NCT01571583|Hepatitis C|hepatitis c
321116|NCT01571583|Hep C|hep c
321117|NCT01571583|HCV|hcv
321118|NCT01571583|Telaprevir|telaprevir
321119|NCT01571583|Pegylated-Interferon-alfa-2a|pegylated-interferon-alfa-2a
321120|NCT01571583|Ribavirin|ribavirin
321121|NCT01571570|Healthy volunteers|healthy volunteers
321122|NCT01571570|Food effect|food effect
321123|NCT01571570|Capsule|capsule
321124|NCT01571570|Formulations|formulations
321125|NCT01571570|Liquid formulation|liquid formulation
321126|NCT01571570|Concept K|concept k
321127|NCT01571570|Concept L|concept l
321128|NCT01571570|Oral suspension|oral suspension
321133|NCT01571518|G-CSF|g-csf
321134|NCT01571518|neutropenia|neutropenia
321143|NCT01571492|Lumbar Plexus Catheters|lumbar plexus catheters
321144|NCT01571492|L2 Paravertebral Catheters|l2 paravertebral catheters
321145|NCT01571479|laparoscopic cholecystectomy|laparoscopic cholecystectomy
321253|NCT01571050|fluoride|fluoride
321147|NCT01571466|HIV Seronegativity|hiv seronegativity
321148|NCT01571466|HIV Preventive Vaccine|hiv preventive vaccine
321149|NCT01571453|MDD|mdd
321150|NCT01571440|Bone|bone
321151|NCT01571440|adolescents|adolescents
321152|NCT01571440|fiber|fiber
321153|NCT01571440|healthy|healthy
321154|NCT01571440|boys|boys
321155|NCT01571440|girls|girls
321156|NCT01571440|camp|camp
321157|NCT01571440|calcium|calcium
321158|NCT01571427|Behavioral intervention|behavioral intervention
321159|NCT01571427|Social engagement|social engagement
321160|NCT01571427|Conversational engagement|conversational engagement
321161|NCT01571427|Social network|social network
321162|NCT01571427|Cognitive Reserve|cognitive reserve
321163|NCT01571427|Alzheimer's disease|alzheimer's disease
321164|NCT01571401|Kidney cancer survivors|kidney cancer survivors
321165|NCT01571401|Randomized Controlled Trial|randomized controlled trial
321166|NCT01571401|Physical Activity|physical activity
321167|NCT01571401|Theory of Planned Behaviour|theory of planned behaviour
321168|NCT01571401|Quality of life|quality of life
321169|NCT01571388|dacomitinib|dacomitinib
321170|NCT01571388|PF-00299804|pf-00299804
321171|NCT01571388|hepatic impairment|hepatic impairment
321172|NCT01571388|pharmacokinetics|pharmacokinetics
321173|NCT01571375|Traumatic Brain Injury|traumatic brain injury
321174|NCT01571375|HEMS|hems
321175|NCT01571375|Out-of-hospital|out-of-hospital
321176|NCT01571375|Finland|finland
321177|NCT01571362|oxycodone|oxycodone
321178|NCT01571362|naltrexone|naltrexone
321179|NCT01571362|chronic pain|chronic pain
321180|NCT01571362|low back pain|low back pain
321181|NCT01571349|rebalanced hemostasis|rebalanced hemostasis
321182|NCT01571349|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
321183|NCT01571349|coagulation status|coagulation status
321184|NCT01571323|post partum haemorrhage at cesarean section|post partum haemorrhage at cesarean section
321185|NCT01571297|Diabetes Mellitus|diabetes mellitus
321186|NCT01571297|Delayed Gastric Emptying|delayed gastric emptying
321187|NCT01571297|Gastroparesis|gastroparesis
321188|NCT01571297|Gastrointestinal Motility Disorder|gastrointestinal motility disorder
321189|NCT01571271|biliary|biliary
321190|NCT01571271|lithotripsy|lithotripsy
321191|NCT01571271|gall stones|gall stones
321192|NCT01571271|bile duct|bile duct
321193|NCT01571271|Biliary stones|biliary stones
321194|NCT01571258|SMS|sms
321195|NCT01571258|Obesity|obesity
321196|NCT01571258|Text Messaging|text messaging
321197|NCT01571258|Intervention|intervention
321198|NCT01571258|Mobile Phone|mobile phone
321199|NCT01571245|Heart rate variability|heart rate variability
321200|NCT01571245|Attentional Bias|attentional bias
321201|NCT01571232|Macular Edema|macular edema
321202|NCT01571232|DME|dme
321203|NCT01571232|PDR|pdr
321204|NCT01571232|NPDR|npdr
321205|NCT01571232|Ozurdex|ozurdex
321206|NCT01571232|Dexamethasone|dexamethasone
321207|NCT01571232|Avastin|avastin
321208|NCT01571232|Bevacizumab|bevacizumab
321209|NCT01571219|RA|ra
321210|NCT01571219|Biosimilar|biosimilar
321211|NCT01571206|AS|as
321212|NCT01571206|Biosimilar|biosimilar
321213|NCT01571180|Obesity|obesity
321214|NCT01571180|Gastric bypass|gastric bypass
321215|NCT01571180|Medication|medication
321216|NCT01571180|Medication counseling|medication counseling
321217|NCT01571180|Dietary pattern|dietary pattern
321218|NCT01571180|Follow-up of patients|follow-up of patients
321219|NCT01571167|Methamphetamine|methamphetamine
321220|NCT01571167|Chantix|chantix
321221|NCT01571167|Varenicline|varenicline
321222|NCT01571141|HPV|hpv
321223|NCT01571141|polyhexamethylene biguanide|polyhexamethylene biguanide
321224|NCT01571141|intraepithelial lesions|intraepithelial lesions
321225|NCT01571141|regression rate|regression rate
321226|NCT01571128|HIV|hiv
321227|NCT01571128|Prevention & Control|prevention & control
321228|NCT01571128|Intervention Studies|intervention studies
321229|NCT01571128|Adolescent|adolescent
321230|NCT01571128|Gender|gender
321231|NCT01571128|Combination prevention|combination prevention
321232|NCT01571128|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
321233|NCT01571128|Cash Transfer|cash transfer
321234|NCT01571128|Medical Male Circumcision|medical male circumcision
321235|NCT01571128|HIV Testing|hiv testing
321236|NCT01571128|Mobile Health|mobile health
321237|NCT01571115|insomnia|insomnia
321238|NCT01571115|resistance physical exercise|resistance physical exercise
321239|NCT01571115|stretching|stretching
321240|NCT01571089|Dialectical behavior therapy|dialectical behavior therapy
321241|NCT01571089|cognitive behavioral therapy|cognitive behavioral therapy
321242|NCT01571089|emotion regulation|emotion regulation
321243|NCT01571089|emotion dysregulation|emotion dysregulation
321244|NCT01571089|anxiety disorders|anxiety disorders
321245|NCT01571089|skills training|skills training
321246|NCT01571076|PGS|pgs
321247|NCT01571076|CGH|cgh
321248|NCT01571076|Aneuploidy|aneuploidy
321249|NCT01571076|Advanced maternal age|advanced maternal age
321250|NCT01571076|Male factor|male factor
321251|NCT01571050|toothpastes|toothpastes
321252|NCT01571050|dental fluorosis|dental fluorosis
321254|NCT01571050|bioavailability|bioavailability
321255|NCT01571037|mechanical circulatory assist device|mechanical circulatory assist device
321256|NCT01571024|FOLFOX6|folfox6
321257|NCT01571024|BKM120|bkm120
321258|NCT01571024|Advanced Solid Tumors|advanced solid tumors
321259|NCT01571024|Metastatic|metastatic
321260|NCT01571024|Colorectal Cancer|colorectal cancer
321261|NCT01571024|Pancreatic Cancer|pancreatic cancer
321262|NCT01571011|Adolescent|adolescent
321263|NCT01571011|Randomized Trial|randomized trial
321264|NCT01571011|Internet|internet
321265|NCT01571011|Depressive Disorder|depressive disorder
321266|NCT01571011|Primary Care|primary care
321267|NCT01571011|Prevention|prevention
321268|NCT01570985|shoulder capsulitis|shoulder capsulitis
321269|NCT01570985|frozen shoulder|frozen shoulder
321270|NCT01570985|adhesive capsulitis|adhesive capsulitis
321271|NCT01570985|distension|distension
321272|NCT01570985|corticosteroid injection|corticosteroid injection
321273|NCT01570985|intraarticular injection|intraarticular injection
321274|NCT01570972|schizophrenia|schizophrenia
321275|NCT01570972|schizoaffective disorder|schizoaffective disorder
321276|NCT01570972|bipolar disorder with psychotic features|bipolar disorder with psychotic features
321277|NCT01570972|major depression with psychotic features|major depression with psychotic features
321278|NCT01570972|recent-onset psychosis|recent-onset psychosis
321279|NCT01570972|first-episode psychosis|first-episode psychosis
321280|NCT01570972|cognitive behavioral therapy|cognitive behavioral therapy
321281|NCT01570972|multifamily group psychoeducation|multifamily group psychoeducation
402051|NCT01233349|weight loss|weight loss
321282|NCT01570946|Lifestyle changes to prevent type 2 diabetes|lifestyle changes to prevent type 2 diabetes
321283|NCT01570933|cardio-pulmonary bypass|cardio-pulmonary bypass
321284|NCT01570920|Activity limitations|activity limitations
321285|NCT01570920|restriction of participation|restriction of participation
321286|NCT01570920|chronic stroke survival|chronic stroke survival
321287|NCT01570920|physical activity|physical activity
321288|NCT01570920|walking|walking
321289|NCT01570881|postoperative delirium|postoperative delirium
321290|NCT01570881|melatonin|melatonin
321291|NCT01570881|sevoflurane|sevoflurane
321292|NCT01570868|Leukemia|leukemia
321293|NCT01570868|Chronic Myeloid Leukemia|chronic myeloid leukemia
321294|NCT01570868|CML|cml
321295|NCT01570868|Chronic Phase|chronic phase
321296|NCT01570868|Cytogenetic response|cytogenetic response
321297|NCT01570868|CCyR|ccyr
321298|NCT01570868|Major molecular response|major molecular response
321299|NCT01570868|MMR|mmr
321300|NCT01570868|Complete molecular response|complete molecular response
321301|NCT01570868|CMR|cmr
321302|NCT01570868|Ponatinib|ponatinib
321303|NCT01570868|AP24534|ap24534
321304|NCT01570855|Lung cancer|lung cancer
321305|NCT01570855|chemosensitivity|chemosensitivity
321306|NCT01570842|Gastroesophageal reflux disease|gastroesophageal reflux disease
321307|NCT01570842|GERD|gerd
321308|NCT01570842|Barrett's esophagus|barrett's esophagus
321309|NCT01570816|spinal cord injury|spinal cord injury
321310|NCT01570816|partial paralysis|partial paralysis
321311|NCT01570816|gait correction|gait correction
321312|NCT01570816|functional electrical stimulation|functional electrical stimulation
321313|NCT01570816|paraplegia|paraplegia
321314|NCT01570816|tetraplegia|tetraplegia
321315|NCT01570803|peripheral arterial disease,|peripheral arterial disease,
321316|NCT01570803|atherosclerosis,|atherosclerosis,
321317|NCT01570803|nitinol,|nitinol,
321318|NCT01570803|stents|stents
321319|NCT01570777|Resistant hypertension|resistant hypertension
321320|NCT01570777|Renal denervation|renal denervation
321321|NCT01570777|Standardized medication regimen|standardized medication regimen
321322|NCT01570777|Endovascular|endovascular
321323|NCT01570777|Primary hypertension|primary hypertension
321324|NCT01570777|Cardiovascular diseases|cardiovascular diseases
321325|NCT01570777|Vascular diseases|vascular diseases
321326|NCT01570764|Systemic sclerosis|systemic sclerosis
321327|NCT01570764|Interstitial lung disease|interstitial lung disease
321328|NCT01570764|Worsening|worsening
321329|NCT01570764|Cyclophosphamide|cyclophosphamide
321330|NCT01570764|Intravenous|intravenous
321331|NCT01570738|sleep disorders|sleep disorders
321332|NCT01570738|sleep apnea|sleep apnea
321333|NCT01570738|ambulatory device|ambulatory device
321334|NCT01570738|polysomnography|polysomnography
321335|NCT01570738|WatchPAT|watchpat
321336|NCT01570725|Immersive virtual reality|immersive virtual reality
321337|NCT01570725|e-health|e-health
321338|NCT01570725|surgery|surgery
321339|NCT01570725|anxiety|anxiety
321340|NCT01570725|relaxation|relaxation
321341|NCT01570725|Patients who undergo ambulatory surgical operations|patients who undergo ambulatory surgical operations
321342|NCT01570699|Cross-sectional observational study|cross-sectional observational study
321343|NCT01570699|COMT polymorphism|comt polymorphism
321344|NCT01570699|Opiate-users|opiate-users
321345|NCT01570699|Opiate dependence|opiate dependence
321346|NCT01570686|Food effect, hypertension, aliskiren|food effect, hypertension, aliskiren
321347|NCT01570673|quality of life|quality of life
321348|NCT01570673|urinary bladder|urinary bladder
321349|NCT01570673|symptoms|symptoms
321350|NCT01570673|children|children
321351|NCT01570634|Clostridium difficile|clostridium difficile
321352|NCT01570634|infection|infection
321353|NCT01570634|diarrhea|diarrhea
321354|NCT01570634|cramping|cramping
321355|NCT01570621|achalasia|achalasia
321356|NCT01570621|peroral endoscopic myotomy|peroral endoscopic myotomy
321357|NCT01570621|LES pressure|les pressure
321358|NCT01570621|postoperative complication|postoperative complication
321359|NCT01570621|symptom relief|symptom relief
321360|NCT01570621|esophageal barium|esophageal barium
321361|NCT01570608|Ranibizumab|ranibizumab
321362|NCT01570608|Bevacizumab|bevacizumab
321363|NCT01570608|Verteporfin|verteporfin
321364|NCT01570608|age-related macular degeneration|age-related macular degeneration
321365|NCT01570595|Tobacco Use Cessation|tobacco use cessation
321366|NCT01570595|Tobacco Cessation|tobacco cessation
321367|NCT01570595|Tobacco Use Disorder|tobacco use disorder
321368|NCT01570595|Tobacco Dependence|tobacco dependence
321369|NCT01570595|Tobacco-Use Disorder|tobacco-use disorder
321370|NCT01570595|Virus, Human Immunodeficiency|virus, human immunodeficiency
321371|NCT01570582|recurrent ovarian|recurrent ovarian
321372|NCT01570582|ECG|ecg
321373|NCT01570582|GOG performance|gog performance
321374|NCT01570582|Hematologic g|hematologic g
321375|NCT01570582|Blood chemistry and urinalysis h|blood chemistry and urinalysis h
321376|NCT01570569|Volunteers|volunteers
321377|NCT01570556|Hemodialysis|hemodialysis
321378|NCT01570556|Inflammation|inflammation
321379|NCT01570556|Bacteriuria|bacteriuria
321380|NCT01570556|Interleukin 6|interleukin 6
321381|NCT01570556|C reactive protein|c reactive protein
321382|NCT01570543|implants|implants
321383|NCT01570543|knee implants|knee implants
321384|NCT01570543|hip implants|hip implants
321385|NCT01570543|metallic implants|metallic implants
321386|NCT01570504|Strongyloidiasis|strongyloidiasis
321387|NCT01570504|Strongyloides stercoralis|strongyloides stercoralis
321388|NCT01570504|Ivermectin|ivermectin
321389|NCT01570465|AML|aml
321390|NCT01570465|adult|adult
321391|NCT01570465|AML1310 GIMEMA study|aml1310 gimema study
321392|NCT01570452|matrilysin|matrilysin
321393|NCT01570452|MMP-7|mmp-7
321394|NCT01570452|colorectal cancer|colorectal cancer
321395|NCT01570452|adenoma|adenoma
321396|NCT01570452|lymph nodes|lymph nodes
321397|NCT01570426|Bipolar disorder|bipolar disorder
321398|NCT01570426|Mood disorders|mood disorders
321399|NCT01570426|ADHD|adhd
321400|NCT01570426|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
321401|NCT01570426|Attention Deficit Disorder without Hyperactivity|attention deficit disorder without hyperactivity
321402|NCT01570426|Anxiety disorders|anxiety disorders
321403|NCT01570426|Generalized anxiety disorder|generalized anxiety disorder
321404|NCT01570426|Magnetic resonance imaging|magnetic resonance imaging
321405|NCT01570426|Mental disorders|mental disorders
321406|NCT01570426|Mental disorders diagnosed in childhood|mental disorders diagnosed in childhood
321407|NCT01570426|affective neuroscience|affective neuroscience
321408|NCT01570426|emotion|emotion
321409|NCT01570426|MRI|mri
321410|NCT01570426|fMRI|fmri
321411|NCT01570426|neurocognitive tasks|neurocognitive tasks
321412|NCT01570426|imaging|imaging
321413|NCT01570426|Healthy controls|healthy controls
321414|NCT01570426|typical development|typical development
321415|NCT01570400|social phobia|social phobia
321416|NCT01570400|social anxiety|social anxiety
321417|NCT01570400|cognitive bias modification|cognitive bias modification
321418|NCT01570374|Cognitive behavioral therapy|cognitive behavioral therapy
321419|NCT01570374|Internet|internet
321420|NCT01570374|Anxiety|anxiety
321421|NCT01570374|Generalized anxiety disorder|generalized anxiety disorder
321422|NCT01570361|Atrial Fibrillation|atrial fibrillation
321423|NCT01570361|Arrhythmias, Cardiac|arrhythmias, cardiac
321424|NCT01570361|Heart Diseases|heart diseases
321425|NCT01570361|Cardiovascular Diseases|cardiovascular diseases
321426|NCT01570361|Pathologic Processes|pathologic processes
321427|NCT01570348|Crohn's Disease|crohn's disease
321428|NCT01570348|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
321429|NCT01570348|Hematopoietic cell transplantation|hematopoietic cell transplantation
321430|NCT01570335|SBAR,|sbar,
321431|NCT01570335|SAQ,|saq,
321432|NCT01570335|Team Resource Management|team resource management
321436|NCT01570309|coronary artery disease|coronary artery disease
321437|NCT01570309|ergocalciferol|ergocalciferol
321438|NCT01570309|endothelial function|endothelial function
321439|NCT01570309|adhesion molecules|adhesion molecules
321440|NCT01570309|inflammation|inflammation
321441|NCT01570309|IL-12|il-12
321442|NCT01570309|interferon-gamma|interferon-gamma
321443|NCT01570309|CXCL-10|cxcl-10
321444|NCT01570309|reactive hyperemia peripheral arterial tonometry|reactive hyperemia peripheral arterial tonometry
321445|NCT01570309|endothelial dysfunction|endothelial dysfunction
321446|NCT01570309|cytokines|cytokines
321447|NCT01570309|chemokines|chemokines
321448|NCT01570296|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
321449|NCT01570296|tumors harbor molecular|tumors harbor molecular
321450|NCT01570296|alterations of PI3K pathway|alterations of pi3k pathway
321451|NCT01570296|known to overexpress EGFR|known to overexpress egfr
321452|NCT01570283|post allogeneic hematopoietic stem cell transplant|post allogeneic hematopoietic stem cell transplant
321453|NCT01570283|cytotoxic T lymphocytes|cytotoxic t lymphocytes
321454|NCT01570283|Cytomegalovirus|cytomegalovirus
321456|NCT01570283|adenovirus|adenovirus
321457|NCT01570283|Epstein-Barr virus|epstein-barr virus
321458|NCT01570283|EBV|ebv
321459|NCT01570283|Human polyomavirus type I|human polyomavirus type i
321460|NCT01570283|BK virus|bk virus
321461|NCT01570283|Human herpesvirus 6|human herpesvirus 6
321462|NCT01570283|HHV6|hhv6
321463|NCT01570270|Hypercholesterolemia|hypercholesterolemia
321464|NCT01570270|Endocannabinoids|endocannabinoids
321465|NCT01570257|normal pressure hydrocephalus|normal pressure hydrocephalus
321466|NCT01570257|ventriculoperitoneal shunt|ventriculoperitoneal shunt
321467|NCT01570257|overdrainage|overdrainage
321468|NCT01570257|subdural effusion|subdural effusion
321469|NCT01570231|remote ischemic preconditioning|remote ischemic preconditioning
321470|NCT01570231|octogenarian|octogenarian
321471|NCT01570231|intracranial arterial stenosis|intracranial arterial stenosis
321472|NCT01570231|stroke recurrence|stroke recurrence
321473|NCT01570218|breast cancer|breast cancer
321474|NCT01570218|gynecological cancer|gynecological cancer
321475|NCT01570218|radiotherapy|radiotherapy
321476|NCT01570218|fatigue|fatigue
321477|NCT01570218|musicotherapy|musicotherapy
321478|NCT01570192|gram negative pathogens|gram negative pathogens
321479|NCT01570192|Pseudomonas aeruginosa|pseudomonas aeruginosa
321480|NCT01570192|Acinetobacter|acinetobacter
321481|NCT01570192|HCAP|hcap
321482|NCT01570192|VABP|vabp
321483|NCT01570192|HABP|habp
321484|NCT01570179|bariatric surgery|bariatric surgery
321485|NCT01570179|residual paralysis|residual paralysis
321486|NCT01570179|surgical conditions|surgical conditions
321487|NCT01570166|Hepatocellular Carcinoma|hepatocellular carcinoma
321488|NCT01570166|RFA|rfa
321489|NCT01570166|HR|hr
321490|NCT01570127|Individualized Acupuncture|individualized acupuncture
321491|NCT01570127|Standardized Acupuncture|standardized acupuncture
321492|NCT01570127|Low Back Pain|low back pain
321493|NCT01570127|Randomized Controlled Trial|randomized controlled trial
321494|NCT01570114|Covered metallic stent|covered metallic stent
321495|NCT01570114|colon|colon
321496|NCT01570114|benign stricture|benign stricture
321497|NCT01570075|Hepatocellular Carcinoma|hepatocellular carcinoma
321498|NCT01570075|RFA|rfa
321499|NCT01570075|HR|hr
321500|NCT01570062|Inflammation|inflammation
321501|NCT01570062|Pathologic Processes|pathologic processes
321502|NCT01570049|Single arm|single arm
321503|NCT01570049|Open label|open label
321504|NCT01570049|Bendamustine HCl|bendamustine hcl
321505|NCT01570049|Non-hodgkin's lymphoma|non-hodgkin's lymphoma
321506|NCT01570036|stage I breast cancer|stage i breast cancer
321507|NCT01570036|stage II breast cancer|stage ii breast cancer
321508|NCT01570036|stage IIIA breast cancer|stage iiia breast cancer
321509|NCT01570036|stage IIIB breast cancer|stage iiib breast cancer
321510|NCT01570036|stage IIIC breast cancer|stage iiic breast cancer
321511|NCT01570036|male breast cancer|male breast cancer
321512|NCT01570023|Deglutition|deglutition
321513|NCT01570023|Exercise|exercise
321514|NCT01569997|Dementia|dementia
321515|NCT01569997|emergency hospitalization|emergency hospitalization
321516|NCT01569997|nursing home|nursing home
321517|NCT01569997|multidisciplinary meeting|multidisciplinary meeting
321518|NCT01569997|cognitive decline|cognitive decline
321519|NCT01569997|disability|disability
321520|NCT01569997|residents|residents
321521|NCT01569997|facilities|facilities
321522|NCT01569997|long term care unit|long term care unit
321523|NCT01569997|health policy|health policy
321524|NCT01569997|general practitioner|general practitioner
321525|NCT01569997|prevention|prevention
321526|NCT01569984|Colorectal|colorectal
321527|NCT01569971|Transition Program|transition program
321528|NCT01569971|Perspectives|perspectives
321529|NCT01569932|chemobrain, chemotherapy, cognitive impairments, fcMRI, neurocognitive Assessments|chemobrain, chemotherapy, cognitive impairments, fcmri, neurocognitive assessments
321530|NCT01569919|Phase II|phase ii
321531|NCT01569919|Single arm|single arm
321532|NCT01569919|Vaccine|vaccine
321533|NCT01569906|Atopic Dermatitis|atopic dermatitis
321534|NCT01569893|Telemonitoring|telemonitoring
321535|NCT01569893|Telemedicine|telemedicine
321536|NCT01569893|Diabetes mellitus|diabetes mellitus
321537|NCT01569880|Blood gas response|blood gas response
321538|NCT01569880|Exercise|exercise
321539|NCT01569880|Gas exchange|gas exchange
321540|NCT01569880|Hypoxia altitude simulation test|hypoxia altitude simulation test
321541|NCT01569880|Pulmonary function|pulmonary function
321542|NCT01569828|LCZ696|lcz696
321543|NCT01569828|pharmacokinetics|pharmacokinetics
321544|NCT01569815|Renal Impairment,|renal impairment,
321545|NCT01569815|LCZ696|lcz696
321546|NCT01569802|breast cancer screening|breast cancer screening
321547|NCT01569802|tomosynthesis|tomosynthesis
321548|NCT01569802|FFDM|ffdm
321549|NCT01569789|cytokines|cytokines
321550|NCT01569789|inflammation|inflammation
321551|NCT01569789|vagus nerve|vagus nerve
321552|NCT01569789|TNF|tnf
321553|NCT01569776|Cow milk allergy|cow milk allergy
321554|NCT01569776|CMA|cma
321555|NCT01569763|endometrial ablation|endometrial ablation
321556|NCT01569750|CD20-positive B-cell non-Hodgkin lymphoma|cd20-positive b-cell non-hodgkin lymphoma
321557|NCT01569750|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
321558|NCT01569750|Mantle cell lymphoma|mantle cell lymphoma
321559|NCT01569750|Follicular lymphoma|follicular lymphoma
321560|NCT01569750|Ibrutinib|ibrutinib
321561|NCT01569750|R-CHOP|r-chop
321562|NCT01569750|Rituximab|rituximab
321563|NCT01569750|Cyclophosphamide|cyclophosphamide
321564|NCT01569750|Doxorubicin|doxorubicin
321565|NCT01569750|Vincristine|vincristine
321566|NCT01569750|Prednisone|prednisone
321567|NCT01569737|ella|ella
321568|NCT01569737|ulipristal acetate|ulipristal acetate
321569|NCT01569737|pregnancy|pregnancy
321570|NCT01569737|emergency contraception|emergency contraception
321571|NCT01569724|hypertriglyceridemia|hypertriglyceridemia
321572|NCT01569724|bexarotene|bexarotene
321573|NCT01569711|chronic and resistant major depressive disorder|chronic and resistant major depressive disorder
321574|NCT01569711|deep brain stimulation|deep brain stimulation
321575|NCT01569698|pediatric|pediatric
321576|NCT01569698|acute renal failure|acute renal failure
321577|NCT01569698|acute extra renal replacement therapy|acute extra renal replacement therapy
321578|NCT01569698|Intermittent Hemodialysis|intermittent hemodialysis
321579|NCT01569698|Continuous Renal Replacement Therapies|continuous renal replacement therapies
321580|NCT01569698|Peritoneal Dialysis|peritoneal dialysis
321581|NCT01569685|PTSD|ptsd
321582|NCT01569685|Traumatic Stress|traumatic stress
321583|NCT01569685|Depressions|depressions
321584|NCT01569685|Refugees|refugees
321585|NCT01569672|Navigator|navigator
321586|NCT01569659|Schizophrenia|schizophrenia
321587|NCT01569659|Refractory|refractory
321588|NCT01569659|Treatment resistant|treatment resistant
321589|NCT01569659|Lurasidone|lurasidone
321590|NCT01569646|monocytes|monocytes
321591|NCT01569646|culprit vessels|culprit vessels
321592|NCT01569620|Colorectal Cancer Screening|colorectal cancer screening
321593|NCT01569620|CRC|crc
321594|NCT01569620|Screening Colonoscopy|screening colonoscopy
321595|NCT01569620|Hispanics|hispanics
321596|NCT01569620|Latinos|latinos
321597|NCT01569607|Neurophysiology|neurophysiology
321598|NCT01569607|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
321599|NCT01569607|Neurology|neurology
321600|NCT01569607|Stroke|stroke
752617|NCT01173354|Essential amino acid intake|essential amino acid intake
321601|NCT01569607|Physical Medicine and Rehabilitation|physical medicine and rehabilitation
321602|NCT01569581|Human Enterovirus 71 (EV71)|human enterovirus 71 (ev71)
321603|NCT01569581|Hand, Foot and Mouth Disease (HFMD)|hand, foot and mouth disease (hfmd)
321604|NCT01569581|Inactivated Vaccine|inactivated vaccine
321605|NCT01569581|Human Diploid cell (KMB17)|human diploid cell (kmb17)
321606|NCT01569581|Adverse reactions associated with vaccine|adverse reactions associated with vaccine
321607|NCT01569581|Efficacy|efficacy
321608|NCT01569568|Neuroimaging|neuroimaging
321609|NCT01569568|MRI|mri
321610|NCT01569568|Urea cycle|urea cycle
321611|NCT01569568|hyperammonemia|hyperammonemia
321612|NCT01569568|cognitive function|cognitive function
321613|NCT01569568|ornithine transcarbamylase deficiency|ornithine transcarbamylase deficiency
321614|NCT01569516|Alzheimer's Disease|alzheimer's disease
321615|NCT01569516|Octohydroaminoacridine Succinate|octohydroaminoacridine succinate
321616|NCT01569503|Crohn's Disease|crohn's disease
321617|NCT01569503|VNS|vns
321618|NCT01569503|vagus nerve stimulation|vagus nerve stimulation
321619|NCT01569503|inflammation|inflammation
321620|NCT01569503|Inflammatory bowel diseases|inflammatory bowel diseases
321621|NCT01569503|TNF|tnf
321622|NCT01569464|Rotigotine|rotigotine
321623|NCT01569464|Restless Legs Syndrome|restless legs syndrome
321624|NCT01569464|Neupro®|neupro®
321625|NCT01569451|Multiple Sclerosis|multiple sclerosis
321626|NCT01569451|Glatiramer Acetate|glatiramer acetate
321627|NCT01569451|Rituximab|rituximab
321628|NCT01569451|Relapsing forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
321629|NCT01569451|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
321630|NCT01569425|PCOS|pcos
321631|NCT01569399|Alcohol dependance|alcohol dependance
321632|NCT01569399|rTMS|rtms
321633|NCT01569399|craving|craving
321634|NCT01569399|alcohol consumption|alcohol consumption
321635|NCT01569386|pulse wave velocity|pulse wave velocity
321636|NCT01569386|low intensity physical activity|low intensity physical activity
321637|NCT01569386|hemiplegia|hemiplegia
321638|NCT01569373|Allogeneic stem cell transplant|allogeneic stem cell transplant
321639|NCT01569373|Graft versus Host Disease|graft versus host disease
321640|NCT01569373|GVHD|gvhd
321641|NCT01569360|Spinal cord injury|spinal cord injury
321642|NCT01569360|Tetraplegia|tetraplegia
321643|NCT01569360|Paraplegia|paraplegia
321644|NCT01569360|Respiratory function|respiratory function
321645|NCT01569360|Corset|corset
321646|NCT01569347|Cocaine|cocaine
321647|NCT01569347|Cocaine-induced psychosis|cocaine-induced psychosis
321648|NCT01569347|Genetic|genetic
321649|NCT01569347|Clinical|clinical
321650|NCT01569347|Biological|biological
321651|NCT01569334|identify early non invasive markers that index the endothelial lesion/ regeneration potential in association with CAV in heart transplanted recipients (HTR)|identify early non invasive markers that index the endothelial lesion/ regeneration potential in association with cav in heart transplanted recipients (htr)
321652|NCT01569308|Cardiac output|cardiac output
321653|NCT01569308|Pulse pressure variation|pulse pressure variation
321654|NCT01569308|Fluid responsiveness|fluid responsiveness
321655|NCT01569308|Low tidal volume|low tidal volume
321656|NCT01569295|Zydelig|zydelig
321657|NCT01569295|CLL|cll
321658|NCT01569295|CAL 101|cal 101
321659|NCT01569295|CAL-101|cal-101
321660|NCT01569295|GS 1101|gs 1101
321661|NCT01569295|GS-1101|gs-1101
321662|NCT01569295|PI3K|pi3k
321663|NCT01569295|Rituxan|rituxan
321664|NCT01569295|Rituximab|rituximab
321665|NCT01569295|Bendamustine|bendamustine
321666|NCT01569295|Leukemia|leukemia
321667|NCT01569295|idelalisib|idelalisib
321668|NCT01569282|Surgical bypass|surgical bypass
321669|NCT01569282|Hepaticojejunostomy|hepaticojejunostomy
321670|NCT01569282|Gastrojejunostomy|gastrojejunostomy
321671|NCT01569282|Biliary stent|biliary stent
321672|NCT01569282|Enteral stent|enteral stent
321673|NCT01569269|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
321675|NCT01569269|psychological distress|psychological distress
321676|NCT01569269|mindfulness|mindfulness
321677|NCT01569269|complementary and alternative|complementary and alternative
321678|NCT01569243|Diabetes mellitus|diabetes mellitus
321679|NCT01569243|Text messaging|text messaging
321680|NCT01569243|Physical activity|physical activity
321681|NCT01569230|Knee osteoarthritis|knee osteoarthritis
321682|NCT01569230|acupuncture|acupuncture
321683|NCT01569230|sham acupuncture|sham acupuncture
321684|NCT01569217|Diaphragm|diaphragm
321685|NCT01569217|Abdomen|abdomen
321686|NCT01569217|Breathing pattern|breathing pattern
321687|NCT01569217|dyspnea|dyspnea
321688|NCT01569191|Ocular allergy|ocular allergy
321689|NCT01569191|Tear supplement|tear supplement
321690|NCT01569191|Cold compress|cold compress
321691|NCT01569178|stem cells|stem cells
321692|NCT01569178|acute myocardial infarction|acute myocardial infarction
321693|NCT01569178|heart failure|heart failure
321694|NCT01569178|heart attack|heart attack
321695|NCT01569178|bone marrow|bone marrow
321696|NCT01569178|intracoronary reinfusion|intracoronary reinfusion
321697|NCT01569178|bone marrow derived mononuclear cells|bone marrow derived mononuclear cells
321698|NCT01569178|Left ventricular function improvement|left ventricular function improvement
321699|NCT01569178|mortality|mortality
321700|NCT01569165|Acidogenicity|acidogenicity
321701|NCT01569165|Acidulated phosphate fluoride|acidulated phosphate fluoride
321702|NCT01569165|dental plaque|dental plaque
321703|NCT01569165|water rinsing|water rinsing
321704|NCT01569139|Validation|validation
321705|NCT01569139|Concordance|concordance
321706|NCT01569139|Myocardial infarction|myocardial infarction
321707|NCT01569139|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
321708|NCT01569139|General Practice Research Database|general practice research database
321709|NCT01569139|Hospital Episode Statistics|hospital episode statistics
321710|NCT01569139|ONS mortality|ons mortality
321711|NCT01569113|ella|ella
321712|NCT01569113|ellaOne|ellaone
321713|NCT01569113|quickstart|quickstart
321714|NCT01569113|contraception|contraception
321715|NCT01569113|combined oral pill|combined oral pill
321716|NCT01569113|microgynon|microgynon
321717|NCT01569087|empegfilgrastim|empegfilgrastim
321718|NCT01569087|pegylated filgrastim|pegylated filgrastim
321719|NCT01569087|neutropenia|neutropenia
321720|NCT01569087|febrile neutropenia|febrile neutropenia
321721|NCT01569087|chemotherapy-associated neutropenia|chemotherapy-associated neutropenia
321722|NCT01569087|breast cancer|breast cancer
321723|NCT01569087|docetaxel|docetaxel
321724|NCT01569087|doxorubicin|doxorubicin
321725|NCT01569074|Rheumatoid Arthritis|rheumatoid arthritis
321831|NCT01568671|Healthy|healthy
321726|NCT01569061|overactive bladder|overactive bladder
321727|NCT01569061|laser therapy|laser therapy
321728|NCT01569061|urinary incontinence|urinary incontinence
321729|NCT01569061|urinary urgency|urinary urgency
321730|NCT01569035|oligohudramnios|oligohudramnios
321731|NCT01569035|oral anti coagulant|oral anti coagulant
321732|NCT01569035|Dopplar ultrasound|dopplar ultrasound
321733|NCT01569022|post traumatic stress disorder|post traumatic stress disorder
321734|NCT01569022|continuous positive airway pressure|continuous positive airway pressure
321735|NCT01569022|oral appliance|oral appliance
321736|NCT01569009|Bronchiectasis|bronchiectasis
321737|NCT01569009|Physical activity|physical activity
321738|NCT01569009|Activity monitor|activity monitor
321739|NCT01569009|Pedometer|pedometer
321740|NCT01568996|atypical nevi|atypical nevi
321741|NCT01568996|melanoma|melanoma
321742|NCT01568996|sulforaphane|sulforaphane
321743|NCT01568996|broccoli|broccoli
321744|NCT01568996|lesions|lesions
321745|NCT01568996|STAT1|stat1
321746|NCT01568996|STAT3|stat3
321747|NCT01568970|rehabilitation|rehabilitation
321748|NCT01568970|return to work|return to work
321749|NCT01568970|sick leave|sick leave
321750|NCT01568957|Gait|gait
321751|NCT01568957|Dual-task|dual-task
321752|NCT01568957|Obstacle avoidance|obstacle avoidance
321753|NCT01568957|Attention allocation|attention allocation
321754|NCT01568944|periodontal|periodontal
321755|NCT01568944|disease|disease
321756|NCT01568944|dendritic|dendritic
321757|NCT01568944|cells|cells
321758|NCT01568944|antibiotics|antibiotics
321759|NCT01568931|thrombectomy|thrombectomy
321760|NCT01568905|smoker|smoker
321761|NCT01568905|smoking|smoking
321762|NCT01568905|nicotine levels|nicotine levels
321763|NCT01568905|tobacco|tobacco
321764|NCT01568905|nicotine|nicotine
321765|NCT01568892|ART-experienced|art-experienced
321766|NCT01568892|GSK1349572|gsk1349572
321767|NCT01568892|Integrase inhibitor resistance|integrase inhibitor resistance
321768|NCT01568892|Dolutegravir|dolutegravir
321769|NCT01568879|Recurrent gout|recurrent gout
321770|NCT01568879|Tophaceous gout|tophaceous gout
321771|NCT01568879|Gout flares|gout flares
321772|NCT01568879|Arthritis|arthritis
321773|NCT01568879|Joint Diseases|joint diseases
321774|NCT01568879|Rheumatic Diseases|rheumatic diseases
321775|NCT01568866|multiple myeloma|multiple myeloma
321776|NCT01568866|relapsed multiple myeloma|relapsed multiple myeloma
321777|NCT01568840|Physical Therapy Modalities|physical therapy modalities
321778|NCT01568840|Posture|posture
321779|NCT01568840|Muscle Stretching Exercises|muscle stretching exercises
321780|NCT01568840|Dyskinesias|dyskinesias
321781|NCT01568840|Neck pain|neck pain
321782|NCT01568814|colonoscopy|colonoscopy
321783|NCT01568814|bowel preparation|bowel preparation
321784|NCT01568814|polyethylene glycol|polyethylene glycol
321785|NCT01568814|low residue meal|low residue meal
321786|NCT01568801|Integrated Services|integrated services
321787|NCT01568801|Health Services for the Elderly|health services for the elderly
321788|NCT01568801|Community Services|community services
321789|NCT01568788|Respiratory Tract Infections; Orthomyxoviridae Infections|respiratory tract infections; orthomyxoviridae infections
321790|NCT01568775|End Stage Renal Disease|end stage renal disease
321791|NCT01568775|Dialysis|dialysis
321792|NCT01568775|aliskiren|aliskiren
321793|NCT01568775|SPP100A|spp100a
321794|NCT01568762|Asthma|asthma
321795|NCT01568762|VAK694|vak694
321796|NCT01568762|QAX576|qax576
321797|NCT01568762|QBX258|qbx258
321798|NCT01568762|pharmacokinetics|pharmacokinetics
321800|NCT01568749|Analgesia|analgesia
321801|NCT01568749|Paracetamol|paracetamol
321802|NCT01568736|Hyper IgD Syndrome (HIDS)|hyper igd syndrome (hids)
321803|NCT01568736|Mevalonate Kinase Deficiency (MKD)|mevalonate kinase deficiency (mkd)
321804|NCT01568723|Barrett's esophagus|barrett's esophagus
321805|NCT01568723|high grade dysplasia|high grade dysplasia
321806|NCT01568723|ablation|ablation
321807|NCT01568723|radiofrequency ablation|radiofrequency ablation
321808|NCT01568723|esophageal cancer|esophageal cancer
321809|NCT01568710|Blood Flow|blood flow
321810|NCT01568710|Endothelium|endothelium
321811|NCT01568710|Nitric Oxide|nitric oxide
321812|NCT01568710|Oximetry|oximetry
321813|NCT01568710|Laser Doppler|laser doppler
321814|NCT01568710|Sickle Cell Disease|sickle cell disease
321815|NCT01568697|Oral Microbiome|oral microbiome
321816|NCT01568697|Periodontitis|periodontitis
321817|NCT01568697|Oral Mucosal Immunity|oral mucosal immunity
321818|NCT01568697|Oral Infection|oral infection
321819|NCT01568697|Immune Disorder|immune disorder
321820|NCT01568697|Periodontal Disease|periodontal disease
321821|NCT01568697|Gum Disease|gum disease
321822|NCT01568697|Healthy Volunteer|healthy volunteer
321824|NCT01568684|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
321825|NCT01568684|Depression|depression
321826|NCT01568684|Depression Treatment|depression treatment
321827|NCT01568684|Major Depression|major depression
321828|NCT01568684|Unipolar Depression|unipolar depression
321829|NCT01568671|Adult|adult
321830|NCT01568671|Body Fat Distribution|body fat distribution
321455|NCT01570283|CMV|cmv
321832|NCT01568671|Metabolic Rate|metabolic rate
321833|NCT01568671|Thermophysiology|thermophysiology
321834|NCT01568671|Brown Fat|brown fat
321835|NCT01568671|Healthy Volunteer|healthy volunteer
321837|NCT01568658|Hereditary Myopathies|hereditary myopathies
321838|NCT01568658|Neuropathology|neuropathology
321839|NCT01568658|Muscular Dystrophy|muscular dystrophy
321840|NCT01568658|Inherited Neuromuscular Condition|inherited neuromuscular condition
321841|NCT01568658|Inherited Neuropathy|inherited neuropathy
321842|NCT01568658|Inherited Myopathy|inherited myopathy
321843|NCT01568658|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
321844|NCT01568658|Healthy Volunteer|healthy volunteer
321845|NCT01568658|HV|hv
321846|NCT01568645|Sickle Cell Anemia|sickle cell anemia
321847|NCT01568645|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
321848|NCT01568645|Platelet Derived Growth Factor|platelet derived growth factor
321849|NCT01568645|Beta Adrenergic Receptor Blocker|beta adrenergic receptor blocker
321850|NCT01568645|Pulmonary Vascular Disease|pulmonary vascular disease
321851|NCT01568645|Sickle Cell Disease|sickle cell disease
321852|NCT01568645|Pulmonary Hypertension|pulmonary hypertension
321853|NCT01568632|Dose Limiting Toxicity|dose limiting toxicity
321854|NCT01568632|Maximum Tolerated Dose|maximum tolerated dose
321855|NCT01568632|Telomerase Inhibitor|telomerase inhibitor
321856|NCT01568632|Safety|safety
321857|NCT01568632|Solid Tumor|solid tumor
321858|NCT01568632|Lymphoma|lymphoma
321859|NCT01568619|cardiopulmonary exercise test|cardiopulmonary exercise test
321860|NCT01568619|cardiac output|cardiac output
321861|NCT01568606|Heart Failure|heart failure
321862|NCT01568606|Obesity|obesity
321863|NCT01568606|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
321864|NCT01568580|Hemophilia A|hemophilia a
321865|NCT01568580|Factor VIII|factor viii
321866|NCT01568580|Recombinant|recombinant
321867|NCT01568567|safety|safety
321868|NCT01568567|tolerance|tolerance
321869|NCT01568567|lactobacillus Reuteri|lactobacillus reuteri
321870|NCT01568541|children|children
321871|NCT01568541|dentifrice|dentifrice
321872|NCT01568541|fluoride|fluoride
321873|NCT01568541|dental fluorosis|dental fluorosis
321874|NCT01568515|HPV vaccine|hpv vaccine
321875|NCT01568515|Vaccine adherence|vaccine adherence
321876|NCT01568515|Vaccine utilization|vaccine utilization
321877|NCT01568515|Electronic Messaging|electronic messaging
321878|NCT01568502|dobutamine stress|dobutamine stress
321879|NCT01568502|inducible ischemia|inducible ischemia
321881|NCT01568476|Regional anesthesia|regional anesthesia
321882|NCT01568476|Sciatic nerve block|sciatic nerve block
321883|NCT01568476|foot surgery|foot surgery
321884|NCT01568476|ankle surgery|ankle surgery
321885|NCT01568476|Interneural local anesthetic|interneural local anesthetic
321886|NCT01568463|Inter-scalene Block|inter-scalene block
321887|NCT01568463|Regional Anesthesia|regional anesthesia
321888|NCT01568463|shoulder surgeries|shoulder surgeries
321889|NCT01568450|Oxycodone, controlled release formulation|oxycodone, controlled release formulation
321890|NCT01568437|Laparoscopic gastric-bypass surgery|laparoscopic gastric-bypass surgery
321891|NCT01568437|TAP block|tap block
321892|NCT01568424|Heart Failure|heart failure
321893|NCT01568424|Right Ventricular Failure|right ventricular failure
321894|NCT01568424|Levitronix|levitronix
321895|NCT01568424|Thoratec Corporation|thoratec corporation
321896|NCT01568411|None - normal volunteers|none - normal volunteers
321897|NCT01568398|Gastric or duodenal ulcer|gastric or duodenal ulcer
321898|NCT01568385|Gastric or duodenal ulcer|gastric or duodenal ulcer
321899|NCT01568372|pediatric|pediatric
321900|NCT01568372|tonsillectomy|tonsillectomy
321901|NCT01568372|pain management|pain management
321902|NCT01568372|nurse follow-up|nurse follow-up
321903|NCT01568346|Newly diagnosed|newly diagnosed
321904|NCT01568346|Early stage|early stage
321905|NCT01568333|Decitabine|decitabine
321906|NCT01568333|Immune thrombocytopenia|immune thrombocytopenia
321907|NCT01568320|Aorta|aorta
321908|NCT01568320|Thoracic|thoracic
321909|NCT01568320|Aortic dissection|aortic dissection
321910|NCT01568320|Rupture|rupture
321911|NCT01568320|Type B|type b
321912|NCT01568320|DeBakey type III|debakey type iii
321913|NCT01568320|Endovascular|endovascular
321914|NCT01568307|Major depressive disorder|major depressive disorder
321915|NCT01568307|Serotonin transporter|serotonin transporter
321916|NCT01568307|Sympathetic nervous system activation|sympathetic nervous system activation
321917|NCT01568307|Cardiovascular risk factors|cardiovascular risk factors
321918|NCT01568307|Serotonin re-uptake inhibitor|serotonin re-uptake inhibitor
321919|NCT01568281|Bioequivalence|bioequivalence
321920|NCT01568281|pharmacokinetics|pharmacokinetics
321921|NCT01568281|safety|safety
321922|NCT01568281|anastrozole|anastrozole
321923|NCT01568281|Arimidex|arimidex
321924|NCT01568281|Japanese|japanese
321925|NCT01568281|healthy subject|healthy subject
321926|NCT01568268|palonosetron|palonosetron
321927|NCT01568268|postoperative nausea and vomiting|postoperative nausea and vomiting
321928|NCT01568255|myopathic symptoms|myopathic symptoms
321929|NCT01568242|Cataract|cataract
321930|NCT01568242|Phacoemulsification|phacoemulsification
321931|NCT01568242|Temperature|temperature
321932|NCT01568242|Vitreous|vitreous
321933|NCT01568229|schizophrenia negative symptoms|schizophrenia negative symptoms
321934|NCT01568216|schizophrenia negative symptoms|schizophrenia negative symptoms
321935|NCT01568203|single dose, safety, healthy subjects, schizoaffective disorder, AMG 579|single dose, safety, healthy subjects, schizoaffective disorder, amg 579
321936|NCT01568190|House dust mites sensitisation|house dust mites sensitisation
321938|NCT01568164|Epicardial Catheter-based Restoration|epicardial catheter-based restoration
321939|NCT01568164|Surgical/Left Ventricular Reconstruction|surgical/left ventricular reconstruction
321940|NCT01568164|Ventricular Remodeling|ventricular remodeling
321941|NCT01568164|Dor|dor
321942|NCT01568151|Colorectal Cancer|colorectal cancer
321943|NCT01568151|Screening|screening
321944|NCT01568151|Education|education
321945|NCT01568151|Testing|testing
321946|NCT01568138|Ventricular Remodeling|ventricular remodeling
321947|NCT01568112|BG00012|bg00012
321948|NCT01568112|gastrointestinal events|gastrointestinal events
321949|NCT01568112|flushing events|flushing events
321950|NCT01568112|dose titration|dose titration
321951|NCT01568112|pre-medication|pre-medication
321952|NCT01568112|aspirin|aspirin
321953|NCT01568073|Parkinson|parkinson
321954|NCT01568073|PD|pd
321955|NCT01568073|Wearing-off|wearing-off
321956|NCT01568073|Levodopa/DDCI|levodopa/ddci
321957|NCT01568060|Safety|safety
321958|NCT01568060|Infanrix-IPV|infanrix-ipv
321959|NCT01568060|Post-marketing surveillance|post-marketing surveillance
321960|NCT01568060|Diphtheria, tetanus, pertussis and poliomyelitis|diphtheria, tetanus, pertussis and poliomyelitis
321961|NCT01568047|Parkinson Disease|parkinson disease
321962|NCT01568047|BIA 9-1067|bia 9-1067
321963|NCT01568034|Parkinson's Disease|parkinson's disease
321964|NCT01568034|BIA 9-1067|bia 9-1067
321965|NCT01567995|eczematous|eczematous
321966|NCT01567995|dermatitis|dermatitis
321967|NCT01567982|tDCS|tdcs
321968|NCT01567982|brain stimulation|brain stimulation
321969|NCT01567982|addiction|addiction
321970|NCT01567982|substance dependence|substance dependence
321971|NCT01567982|craving|craving
321972|NCT01567982|cognition|cognition
321973|NCT01567969|mental health services|mental health services
321974|NCT01567969|child behavior disorders|child behavior disorders
321975|NCT01567969|child psychiatry|child psychiatry
321976|NCT01567956|Ulcerative colitis|ulcerative colitis
321977|NCT01567943|alcohol abuse|alcohol abuse
321978|NCT01567943|drug abuse|drug abuse
321979|NCT01567943|schizophrenia|schizophrenia
321980|NCT01567943|bipolar disorder|bipolar disorder
321981|NCT01567943|major depressive disorder|major depressive disorder
321982|NCT01567943|contingency management|contingency management
321983|NCT01567943|psychosocial treatment|psychosocial treatment
321984|NCT01567930|Temsirolimus|temsirolimus
321985|NCT01567930|HCC|hcc
321986|NCT01567930|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
321987|NCT01567917|Venous thromboembolism|venous thromboembolism
321988|NCT01567917|Colorectal cancer|colorectal cancer
321989|NCT01567917|Postoperative period|postoperative period
321990|NCT01567917|detected on 5th~14th days after surgery (by doppler US) or the follow-up period of postoperative 1 month|detected on 5th~14th days after surgery (by doppler us) or the follow-up period of postoperative 1 month
321991|NCT01567904|thrombosis|thrombosis
321992|NCT01567904|Central Venous Line|central venous line
321993|NCT01567904|CVL|cvl
321994|NCT01567891|Ovarian Cancer|ovarian cancer
321995|NCT01567891|Cell Therapy|cell therapy
312653|NCT01607463|pain|pain
321996|NCT01567891|T Cell Therapy|t cell therapy
321997|NCT01567891|NY-ESO-1|ny-eso-1
321998|NCT01567891|Immuno-oncology|immuno-oncology
321999|NCT01567891|Metastatic|metastatic
322000|NCT01567891|Previously treated|previously treated
322001|NCT01567891|T Cell Receptor|t cell receptor
322002|NCT01567878|ultrasound|ultrasound
322003|NCT01567878|MASEI index|masei index
322004|NCT01567878|clinical and ultrasound correlation|clinical and ultrasound correlation
322005|NCT01567878|enthesis ultrasound|enthesis ultrasound
322006|NCT01567878|articular ultrasound|articular ultrasound
322007|NCT01567878|ankylosing spondylitis ultrasound|ankylosing spondylitis ultrasound
322008|NCT01567878|radiographic and ultrasound correlation|radiographic and ultrasound correlation
322009|NCT01567852|orientation|orientation
322010|NCT01567852|post-anesthesia recovery|post-anesthesia recovery
322011|NCT01567852|electroconvulsive therapy|electroconvulsive therapy
322012|NCT01567839|degree of pulpal anesthesia obtained|degree of pulpal anesthesia obtained
322013|NCT01567839|primary infiltration in the lower first molar|primary infiltration in the lower first molar
322014|NCT01567826|YELLO|yello
322015|NCT01567826|Atorvastatin|atorvastatin
322016|NCT01567826|Simvastatin|simvastatin
322017|NCT01567826|Rosuvastatin|rosuvastatin
322018|NCT01567826|lipid therapy|lipid therapy
322019|NCT01567826|Statin therapy|statin therapy
322020|NCT01567826|Coronary artery disease|coronary artery disease
322021|NCT01567826|CHD|chd
322022|NCT01567813|Warts|warts
322023|NCT01567813|Papillomavirus infections|papillomavirus infections
322024|NCT01567813|DNA virus infections|dna virus infections
322025|NCT01567813|Virus diseases|virus diseases
322026|NCT01567813|Skin diseases, viral|skin diseases, viral
322027|NCT01567813|Tumor virus infections|tumor virus infections
322028|NCT01567813|Skin diseases, infectious|skin diseases, infectious
322030|NCT01567800|Procedure/Surgery: 18F-Fluoroazomycin Arabinoside (18F-FAZA)|procedure/surgery: 18f-fluoroazomycin arabinoside (18f-faza)
322031|NCT01567787|Proton Radiation Therapy|proton radiation therapy
322032|NCT01567787|Spinal tumors|spinal tumors
322033|NCT01567787|Neurofibroma(NF1)|neurofibroma(nf1)
322034|NCT01567787|Malignant peripheral nerve sheath tumor(MPNST)|malignant peripheral nerve sheath tumor(mpnst)
322035|NCT01567774|Coronary artery disease|coronary artery disease
322036|NCT01567774|dual antiplatelet therapy|dual antiplatelet therapy
322037|NCT01567774|atorvastatin|atorvastatin
322038|NCT01567774|rosuvastatin|rosuvastatin
322039|NCT01567761|IOP|iop
322040|NCT01567748|CABG|cabg
322041|NCT01567748|Coronary Artery Bypass|coronary artery bypass
322042|NCT01567748|Central Aortic Pressure|central aortic pressure
322043|NCT01567748|Peripheral Arterial Waveform|peripheral arterial waveform
322044|NCT01567735|Hepatitis C|hepatitis c
322045|NCT01567735|TMC435HPC3011|tmc435hpc3011
322046|NCT01567735|TMC435|tmc435
322047|NCT01567722|HIV infection|hiv infection
322048|NCT01567722|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
322049|NCT01567722|anal cancer|anal cancer
322050|NCT01567722|cervical cancer|cervical cancer
322051|NCT01567722|non-small cell lung cancer|non-small cell lung cancer
322052|NCT01567722|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
322053|NCT01567696|Revision,|revision,
322054|NCT01567683|Safety and Tolerability of Limtop and vehicle|safety and tolerability of limtop and vehicle
322055|NCT01567683|of Limtop and vehicle|of limtop and vehicle
322056|NCT01567657|Sedation in TEE|sedation in tee
322057|NCT01567657|Blood pressure drop during TEE|blood pressure drop during tee
322058|NCT01567657|Safety of sedation in TEE|safety of sedation in tee
402052|NCT01233349|body fat|body fat
322059|NCT01567644|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
322060|NCT01567644|Myocardial Ischemia|myocardial ischemia
322061|NCT01567644|Refractory Angina|refractory angina
322062|NCT01567631|Classical Procedure|classical procedure
322063|NCT01567631|Intrahepatic Glisson's Approach|intrahepatic glisson's approach
322064|NCT01567631|laparoscopic hepatectomy|laparoscopic hepatectomy
322065|NCT01567631|Minimal invasive surgery|minimal invasive surgery
322066|NCT01567631|Endoscopic stapling devices|endoscopic stapling devices
322067|NCT01567618|Docetaxel|docetaxel
322068|NCT01567618|Fluorouracil|fluorouracil
322069|NCT01567618|First line therapy|first line therapy
322070|NCT01567618|Gastric cancer|gastric cancer
322071|NCT01567605|spinal cord injury|spinal cord injury
322072|NCT01567605|autonomic dysreflexia|autonomic dysreflexia
322073|NCT01567605|blood pressure|blood pressure
322074|NCT01567605|bowel care management|bowel care management
322075|NCT01567605|defecation|defecation
322076|NCT01567592|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
322077|NCT01567592|Myocardial Ischemia|myocardial ischemia
322078|NCT01567592|Refractory Angina|refractory angina
322079|NCT01567579|congenital heart defects|congenital heart defects
322080|NCT01567566|home based daily exercise program|home based daily exercise program
322081|NCT01567566|local lumbopelvic stabilizer muscles|local lumbopelvic stabilizer muscles
322082|NCT01567566|hip stabilizer muscles|hip stabilizer muscles
322083|NCT01567566|real time ultrasound imaging|real time ultrasound imaging
322084|NCT01567553|inflammatory disease of the central nervous system|inflammatory disease of the central nervous system
322085|NCT01567553|early clinical deficit|early clinical deficit
322086|NCT01567553|multiple sclerosis (MS)|multiple sclerosis (ms)
322087|NCT01567540|Chronic Hepatitis C|chronic hepatitis c
322088|NCT01567540|Interferon protein 10|interferon protein 10
322089|NCT01567540|Chemokine gradients|chemokine gradients
322090|NCT01567540|Sitagliptin|sitagliptin
322091|NCT01567527|Aripiprazole|aripiprazole
322092|NCT01567527|Intramuscular (IM) Depot|intramuscular (im) depot
322093|NCT01567527|Bipolar|bipolar
322094|NCT01567514|Deep occlusal caries restored with resin composite|deep occlusal caries restored with resin composite
322095|NCT01567514|on Pit and Fissure Surface Penetrating Into Dentin|on pit and fissure surface penetrating into dentin
322096|NCT01567488|Advanced|advanced
322097|NCT01567488|Non functioning|non functioning
322098|NCT01567488|Well differentiated|well differentiated
322099|NCT01567462|bladder cancer|bladder cancer
322100|NCT01567462|transurethral resection of bladder tumors|transurethral resection of bladder tumors
322101|NCT01567423|Malaria|malaria
322102|NCT01567423|Plasmodium falciparum|plasmodium falciparum
322103|NCT01567423|Children|children
322104|NCT01567423|Efficacy|efficacy
322105|NCT01567423|Uncomplicated malaria|uncomplicated malaria
322106|NCT01567410|e-learning|e-learning
322107|NCT01567410|education|education
322108|NCT01567384|cancer|cancer
322109|NCT01567384|neoplasms|neoplasms
322110|NCT01567384|tumors|tumors
322111|NCT01567345|Pain|pain
322112|NCT01567345|cancer|cancer
322113|NCT01567345|Intrathecal|intrathecal
322114|NCT01567345|analgesia|analgesia
322115|NCT01567345|Morphine|morphine
321823|NCT01568697|HV|hv
322116|NCT01567345|Implantable pump|implantable pump
322117|NCT01567319|Sensitization|sensitization
322118|NCT01567319|Skin Prick Test|skin prick test
322119|NCT01567319|Standardization|standardization
322120|NCT01567319|sources of: D. glomerata, L. perenne, S. cereale and O. europaea|sources of: d. glomerata, l. perenne, s. cereale and o. europaea
322122|NCT01567306|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
322123|NCT01567306|Subcutaneous Immunotherapy|subcutaneous immunotherapy
322124|NCT01567306|Phleum pratense pollen extract|phleum pratense pollen extract
322125|NCT01567267|Evidence-based Medicine|evidence-based medicine
322126|NCT01567267|Good Scientific Practice|good scientific practice
322127|NCT01567267|Problem-based Learning|problem-based learning
322128|NCT01567267|Critical health literacy|critical health literacy
322129|NCT01567267|Educational intervention|educational intervention
322130|NCT01567254|guided imaginary|guided imaginary
322131|NCT01567241|clinical hypnosis|clinical hypnosis
322132|NCT01567241|relaxation music|relaxation music
322133|NCT01567241|reproduction techniques|reproduction techniques
322134|NCT01567241|insemination|insemination
322135|NCT01567241|embryo transfer|embryo transfer
322136|NCT01567241|pregnancy rate|pregnancy rate
322137|NCT01567228|obesity|obesity
322138|NCT01567228|overweight|overweight
322139|NCT01567228|dental caries|dental caries
322140|NCT01567228|school problems|school problems
322141|NCT01567228|school failure|school failure
322142|NCT01567228|child BMI > 85th percentile|child bmi > 85th percentile
322143|NCT01567228|Needing dental preventive services|needing dental preventive services
322144|NCT01567228|Needing academic support for school problems|needing academic support for school problems
322145|NCT01567215|granuloma umbilical|granuloma umbilical
322146|NCT01567202|Brain tumor|brain tumor
322147|NCT01567202|Glioma|glioma
322148|NCT01567202|Glioblastoma|glioblastoma
322149|NCT01567202|Tumor stem cells|tumor stem cells
322150|NCT01567202|Immunotherapy|immunotherapy
322151|NCT01567202|Vaccine|vaccine
322152|NCT01567189|Exercise therapy|exercise therapy
322153|NCT01567189|cost effectiveness|cost effectiveness
322154|NCT01567189|cardiac rehabilitation|cardiac rehabilitation
322155|NCT01567189|home-based exercise|home-based exercise
322156|NCT01567176|Sirtuins|sirtuins
322157|NCT01567176|Aging|aging
322158|NCT01567176|Metabolic disease|metabolic disease
322159|NCT01567163|Advanced Malignant Solid Tumors|advanced malignant solid tumors
322160|NCT01567124|Schizophrenia|schizophrenia
322161|NCT01567124|Moxonidine|moxonidine
322162|NCT01567124|Sympathetic nervous system activation|sympathetic nervous system activation
322163|NCT01567124|Cardiometabolic side effects of antipsychotics|cardiometabolic side effects of antipsychotics
322164|NCT01567111|Primary aldosteronism|primary aldosteronism
322165|NCT01567111|Aldosterone producing adenoma|aldosterone producing adenoma
322166|NCT01567111|Bilateral adrenal hyperplasia|bilateral adrenal hyperplasia
322167|NCT01567111|Metomidate-Positron emission tomography|metomidate-positron emission tomography
322168|NCT01567072|NSAID|nsaid
322169|NCT01567072|bone fracture|bone fracture
322170|NCT01567072|heal|heal
322171|NCT01567033|Diabetes|diabetes
322172|NCT01567033|Obesity|obesity
322173|NCT01567033|Home visiting|home visiting
322174|NCT01567020|Central Auditory Processing|central auditory processing
322175|NCT01567020|Traumatic Brain Injury|traumatic brain injury
322176|NCT01567020|Hearing Loss|hearing loss
322177|NCT01567007|pedometer|pedometer
322178|NCT01567007|physical activity|physical activity
322179|NCT01567007|workplace|workplace
322180|NCT01566994|smoking cessation|smoking cessation
322181|NCT01566981|Diabetes mellitus tip II|diabetes mellitus tip ii
322182|NCT01566981|eHealth solution|ehealth solution
322183|NCT01566981|Health Information Technology|health information technology
322184|NCT01566981|quality of life|quality of life
322185|NCT01566981|family medicine|family medicine
322186|NCT01566981|satisfaction with e-health care|satisfaction with e-health care
322187|NCT01566981|primary care|primary care
322188|NCT01566968|COPD|copd
322189|NCT01566968|Asthma|asthma
322190|NCT01566968|Healthy volunteers|healthy volunteers
322191|NCT01566968|Chronic cough|chronic cough
322192|NCT01566968|Smokers|smokers
322193|NCT01566968|Cough challenge|cough challenge
322194|NCT01566968|Cough challenge testing.|cough challenge testing.
322195|NCT01566955|transgastric|transgastric
322196|NCT01566955|NOTES|notes
322197|NCT01566955|Gastrotomy|gastrotomy
322198|NCT01566955|BRCA 1/2|brca 1/2
322199|NCT01566942|FOLFIRI|folfiri
322200|NCT01566942|FOLFOX|folfox
322201|NCT01566942|adjuvant chemotherapy|adjuvant chemotherapy
322202|NCT01566942|advanced colorectal cancer|advanced colorectal cancer
322203|NCT01566929|Obesity|obesity
322204|NCT01566929|In vitro fertilization|in vitro fertilization
322205|NCT01566929|Low calorie diet (LCD)|low calorie diet (lcd)
322206|NCT01566929|Obstetric outcome|obstetric outcome
322207|NCT01566929|Weight reduction|weight reduction
322208|NCT01566903|arterial stenosis|arterial stenosis
322209|NCT01566903|arteriovenous malformations|arteriovenous malformations
322210|NCT01566903|Post-treatment follow-up|post-treatment follow-up
321836|NCT01568671|HV|hv
322211|NCT01566890|sickle cell|sickle cell
322212|NCT01566890|sickle cell crisis|sickle cell crisis
322213|NCT01566890|sickle cell pain crisis|sickle cell pain crisis
322214|NCT01566890|vaso-occlusive crisis|vaso-occlusive crisis
322215|NCT01566890|vaso-occlusion|vaso-occlusion
322216|NCT01566890|sickle cell anemia|sickle cell anemia
322217|NCT01566890|sickle cell disease|sickle cell disease
322218|NCT01566890|genetic diseases|genetic diseases
322219|NCT01566890|adenosine 2A Receptor Agonists|adenosine 2a receptor agonists
322220|NCT01566890|Lexiscan|lexiscan
322221|NCT01566890|Regadenoson|regadenoson
322222|NCT01566890|contrast-enhanced ultrasound|contrast-enhanced ultrasound
322223|NCT01566890|Hydroxyurea|hydroxyurea
322224|NCT01566877|Multiple Ascending Dose (MAD)|multiple ascending dose (mad)
322225|NCT01566877|Marburg Virus|marburg virus
322226|NCT01566877|Post Exposure Prophylaxis|post exposure prophylaxis
322227|NCT01566864|hypertension|hypertension
322228|NCT01566864|disparities|disparities
322229|NCT01566864|care management|care management
322230|NCT01566864|provider education|provider education
322231|NCT01566864|audit and feedback|audit and feedback
322233|NCT01566864|African Americans|african americans
322234|NCT01566864|organizational change|organizational change
322235|NCT01566864|implementation research|implementation research
322236|NCT01566838|Visual analog pain score|visual analog pain score
322237|NCT01566838|Length of stay|length of stay
322238|NCT01566838|Hospital Cost|hospital cost
322239|NCT01566838|Subpleural pain catheter|subpleural pain catheter
322240|NCT01566838|Bupivacaine|bupivacaine
322241|NCT01566825|amitriptyline|amitriptyline
322242|NCT01566825|sleep dependent memory consolidation|sleep dependent memory consolidation
322243|NCT01566812|Breast Feeding|breast feeding
322244|NCT01566812|Cardiovascular Risk|cardiovascular risk
322245|NCT01566799|Locally advanced breast cancer|locally advanced breast cancer
322246|NCT01566799|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
322247|NCT01566799|Metformin|metformin
322248|NCT01566799|Pathologic Complete Response|pathologic complete response
322249|NCT01566773|COPD|copd
322250|NCT01566760|food effect|food effect
322251|NCT01566760|bioavailability|bioavailability
322252|NCT01566760|pharmacokinetics|pharmacokinetics
322253|NCT01566760|fesoterodine|fesoterodine
322254|NCT01566760|5-hydroxymethyl tolterodine|5-hydroxymethyl tolterodine
322255|NCT01566760|treatment of overactive bladder|treatment of overactive bladder
322256|NCT01566734|Surgical Wound Infection|surgical wound infection
322257|NCT01566734|cefazolin|cefazolin
322258|NCT01566734|Cesarean Section|cesarean section
322259|NCT01566708|Acute Tinnitus|acute tinnitus
322260|NCT01566708|Recent Onset Tinnitus|recent onset tinnitus
322261|NCT01566708|Music Therapy|music therapy
322262|NCT01566708|fMRI|fmri
322263|NCT01566708|Therapy Evaluation|therapy evaluation
322264|NCT01566682|Lung Lesion|lung lesion
322265|NCT01566682|Lung Mass|lung mass
322266|NCT01566682|Lung Nodule|lung nodule
322267|NCT01566682|Lung Cancer|lung cancer
322268|NCT01566682|Low-Dose CT|low-dose ct
322269|NCT01566682|CT|ct
322270|NCT01566682|Diagnostic|diagnostic
322271|NCT01566682|Evaluation|evaluation
322272|NCT01566682|Bioconductance|bioconductance
322273|NCT01566682|ProLung|prolung
322274|NCT01566669|Cyclooxygenase inhibitors|cyclooxygenase inhibitors
322275|NCT01566669|Morphine|morphine
322276|NCT01566669|Analgesia|analgesia
322277|NCT01566669|patient-controlled|patient-controlled
322278|NCT01566669|Gynecologic surgical procedures|gynecologic surgical procedures
322279|NCT01566656|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
322280|NCT01566656|Non-myeloablative preparative regimen|non-myeloablative preparative regimen
322281|NCT01566656|Total lymphoid irradiation|total lymphoid irradiation
322282|NCT01566656|Anti-thymocyte globulin|anti-thymocyte globulin
322283|NCT01566656|Lymphoid malignancies|lymphoid malignancies
322284|NCT01566643|Helicobacter pylori|helicobacter pylori
322285|NCT01566643|antibiotic resistance|antibiotic resistance
322286|NCT01566643|sequential-concomitant hybrid therapy|sequential-concomitant hybrid therapy
322287|NCT01566630|human recombinant RLX030|human recombinant rlx030
322288|NCT01566630|Pre-eclampsia|pre-eclampsia
322289|NCT01566630|hemodynamics|hemodynamics
322290|NCT01566630|Pharmacokinetics|pharmacokinetics
322291|NCT01566604|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
322292|NCT01566604|NVA237|nva237
322293|NCT01566591|Bipolar Depression|bipolar depression
322294|NCT01566552|AMBISOME|ambisome
322295|NCT01566552|VISCERAL LEISHMANIASIS|visceral leishmaniasis
322296|NCT01566552|SINGLE DOSE|single dose
322297|NCT01566539|Social cooperation|social cooperation
322298|NCT01566539|Oxytocin|oxytocin
322299|NCT01566539|Vasopressin|vasopressin
322300|NCT01566539|Prisoner's Dilemma game|prisoner's dilemma game
322301|NCT01566539|Empathy|empathy
322302|NCT01566539|fMRI|fmri
322303|NCT01566513|Peer Support|peer support
322304|NCT01566513|Cost Effectiveness|cost effectiveness
322305|NCT01566513|Reducing Hospital use|reducing hospital use
322306|NCT01566513|Serious Mental Illness|serious mental illness
322307|NCT01566500|Epilepsy|epilepsy
322308|NCT01566500|Medication Adherence|medication adherence
322309|NCT01566487|Bioequivalence|bioequivalence
322310|NCT01566487|Quetiapine fumarate|quetiapine fumarate
322311|NCT01566487|crossover|crossover
322312|NCT01566461|Drug-Coated Angioplasty Balloon|drug-coated angioplasty balloon
322313|NCT01566461|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
322314|NCT01566461|Peripheral Artery Disease|peripheral artery disease
322315|NCT01566461|Experimental|experimental
322316|NCT01566461|Percutaneous Transluminal Angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
322317|NCT01566448|Ketamine|ketamine
322318|NCT01566448|Mucositis|mucositis
322319|NCT01566448|Oral ketamine rinse|oral ketamine rinse
322320|NCT01566409|Constipation|constipation
322321|NCT01566409|Maintenance treatment|maintenance treatment
322322|NCT01566409|Ultrasound of rectum|ultrasound of rectum
322323|NCT01566396|Fractional,|fractional,
322325|NCT01566396|Wrinkles|wrinkles
322326|NCT01566396|Safety|safety
322327|NCT01566396|Efficacy|efficacy
322328|NCT01566396|treatment|treatment
322329|NCT01566370|alcoholism|alcoholism
322330|NCT01566370|alcohol use disorder|alcohol use disorder
322331|NCT01566370|alcohol dependence|alcohol dependence
322332|NCT01566370|alcohol abuse|alcohol abuse
322333|NCT01566370|bipolar|bipolar
322334|NCT01566370|anticonvulsant|anticonvulsant
322335|NCT01566370|zonisamide|zonisamide
322737|NCT01564797|Hispanic|hispanic
322336|NCT01566357|dental erosion|dental erosion
322337|NCT01566357|enamel|enamel
322338|NCT01566357|dentin|dentin
322339|NCT01566344|Premature Ventricular Complex|premature ventricular complex
322340|NCT01566344|Cardiomyopathy|cardiomyopathy
322341|NCT01566344|Left ventricular dysfunction|left ventricular dysfunction
322342|NCT01566344|Catheter Ablation|catheter ablation
710432|NCT01004731|gemcitabine|gemcitabine
322343|NCT01566344|Anti-Arrhythmic Agents|anti-arrhythmic agents
322344|NCT01566344|Randomized Clinical Trial|randomized clinical trial
322345|NCT01566331|Safe Delivery|safe delivery
322346|NCT01566331|reduction of pain|reduction of pain
322347|NCT01566331|reduction stage of labor|reduction stage of labor
322348|NCT01566318|Depression|depression
322349|NCT01566318|Anxiety|anxiety
322350|NCT01566318|Geriatric mental health|geriatric mental health
322351|NCT01566279|solid tumors|solid tumors
322352|NCT01566279|all comers|all comers
322353|NCT01566279|everolimus|everolimus
322354|NCT01566279|biomarker|biomarker
322355|NCT01566279|next generation sequencing|next generation sequencing
322356|NCT01566266|gut flora|gut flora
322357|NCT01566266|antibiotics|antibiotics
322358|NCT01566266|lipid metabolism|lipid metabolism
322359|NCT01566266|LDL cholesterol|ldl cholesterol
322360|NCT01566253|planned caesarian section, analgesic, PCOA|planned caesarian section, analgesic, pcoa
322361|NCT01566240|cervical cancer|cervical cancer
322362|NCT01566240|Chemotherapy|chemotherapy
322363|NCT01566240|Paclitaxel|paclitaxel
322364|NCT01566240|Carboplatin|carboplatin
322365|NCT01566240|Cisplatin|cisplatin
322366|NCT01566240|Radiotherapy|radiotherapy
322367|NCT01566240|Chemoradiation|chemoradiation
322368|NCT01566240|Brachytherapy|brachytherapy
322369|NCT01566240|Stage IB2 Cervical Cancer|stage ib2 cervical cancer
322370|NCT01566240|Stage IIA Cervical Cancer|stage iia cervical cancer
322371|NCT01566240|Stage IIB Cervical Cancer|stage iib cervical cancer
322372|NCT01566240|Stage IIIB Cervical Cancer|stage iiib cervical cancer
322373|NCT01566240|Stage IVA Cervical Cancer|stage iva cervical cancer
322374|NCT01566227|overdenture|overdenture
322375|NCT01566227|implant|implant
322376|NCT01566227|edentulism|edentulism
322377|NCT01566214|coronary heart disease (CHD)|coronary heart disease (chd)
322378|NCT01566214|myocardial infarction (MI)|myocardial infarction (mi)
322379|NCT01566214|acute coronary syndromes (ACS)|acute coronary syndromes (acs)
322380|NCT01566201|Arterial stiffness|arterial stiffness
322381|NCT01566201|Endothelial function|endothelial function
322382|NCT01566201|Left ventricular function|left ventricular function
322383|NCT01566201|Apoptosis|apoptosis
322384|NCT01566201|Nitrooxidative stress|nitrooxidative stress
322385|NCT01566175|Neovasc Reducer|neovasc reducer
322386|NCT01566175|Coronary Sinus|coronary sinus
322387|NCT01566175|Refractory Angina Pectoris|refractory angina pectoris
322388|NCT01566175|angina class 3-4|angina class 3-4
322389|NCT01566162|Lurasidone|lurasidone
322390|NCT01566162|Latuda|latuda
322391|NCT01566162|Schizophrenia|schizophrenia
322392|NCT01566136|hip fracture patients|hip fracture patients
322393|NCT01566136|cognitive impairment|cognitive impairment
322394|NCT01566136|rehabilitation model of care|rehabilitation model of care
322395|NCT01566123|retroperitoneal soft tissue sarcoma|retroperitoneal soft tissue sarcoma
322396|NCT01566123|IMRT|imrt
322397|NCT01566123|IORT|iort
322398|NCT01566110|pediatric|pediatric
322399|NCT01566110|dietary treatment|dietary treatment
322400|NCT01566110|celiac disease|celiac disease
322401|NCT01566110|T1D|t1d
322402|NCT01566097|Cluster randomized trial|cluster randomized trial
322403|NCT01566097|Decision aids|decision aids
322404|NCT01566097|Culturally-appropriate decision aids|culturally-appropriate decision aids
322405|NCT01566058|Post partum|post partum
322406|NCT01566058|mother-child relationships|mother-child relationships
322407|NCT01566045|Prostate Cancer|prostate cancer
322408|NCT01566045|Biopsy|biopsy
322409|NCT01566032|pulmonary air leak|pulmonary air leak
322410|NCT01566032|Thopaz|thopaz
322411|NCT01566032|analog|analog
322412|NCT01566032|digital|digital
322413|NCT01566006|Mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
322414|NCT01566006|Diabetic Nephropathy|diabetic nephropathy
322415|NCT01566006|proteinuria|proteinuria
322416|NCT01566006|Diabetic Nephropathy in Chronic Kidney Disease patients stages 2-4|diabetic nephropathy in chronic kidney disease patients stages 2-4
322417|NCT01565980|Lung cancer|lung cancer
322418|NCT01565980|mindfulness therapy|mindfulness therapy
322419|NCT01565980|active treatment (radiation and/or chemotherapy)|active treatment (radiation and/or chemotherapy)
322420|NCT01565967|AutoLog|autolog
322421|NCT01565967|Post market release|post market release
322422|NCT01565967|Non-interventional|non-interventional
322423|NCT01565954|Sickle Cell Disease|sickle cell disease
322424|NCT01565954|Respiration Disorders|respiration disorders
322425|NCT01565954|Polysomnography|polysomnography
322426|NCT01565941|Cardiovascular|cardiovascular
322427|NCT01565941|Respiratory|respiratory
322428|NCT01565941|Failure|failure
322429|NCT01565941|Heart|heart
322430|NCT01565941|Lung|lung
322431|NCT01565941|Continuous glucose monitoring|continuous glucose monitoring
322432|NCT01565941|Tight glycemic control|tight glycemic control
322433|NCT01565941|Subcutaneous|subcutaneous
322434|NCT01565941|Insulin|insulin
322435|NCT01565941|Algorithm|algorithm
322436|NCT01565928|Prostate cancer|prostate cancer
322437|NCT01565928|docetaxel|docetaxel
322438|NCT01565928|MDV3100|mdv3100
322439|NCT01565928|enzalutamide|enzalutamide
322440|NCT01565928|Xtandi|xtandi
322441|NCT01565902|BAF312|baf312
322442|NCT01565902|Pharmacokinetics|pharmacokinetics
322443|NCT01565902|Hepatic impairment|hepatic impairment
322444|NCT01565876|weight bearing|weight bearing
322445|NCT01565876|physiological load|physiological load
322446|NCT01565863|Perceived Disability|perceived disability
322447|NCT01565863|Mental Wellness|mental wellness
322448|NCT01565863|Employment|employment
322449|NCT01565863|Social Integration and Engagement|social integration and engagement
322450|NCT01565863|Goal Achievement|goal achievement
322451|NCT01565850|HIV-1|hiv-1
322452|NCT01565850|HIV|hiv
322453|NCT01565850|Treatment-Naive|treatment-naive
322454|NCT01565837|Melanoma|melanoma
322455|NCT01565837|Malignant Melanoma|malignant melanoma
322456|NCT01565837|Metastatic|metastatic
322457|NCT01565837|Oligometastatic|oligometastatic
322458|NCT01565837|Radiosurgery|radiosurgery
322459|NCT01565837|Radiosurgery, Stereotactic|radiosurgery, stereotactic
322460|NCT01565837|Stereotactic Radiosurgery|stereotactic radiosurgery
322461|NCT01565837|Ipilimumab|ipilimumab
322462|NCT01565837|Yervoy|yervoy
322463|NCT01565837|MDX-010|mdx-010
322464|NCT01565837|Circulating Tumor Cells|circulating tumor cells
322465|NCT01565811|colon neoplasm, rectal neoplasm, liver metastasis|colon neoplasm, rectal neoplasm, liver metastasis
322466|NCT01565798|healthcare-acquired infections|healthcare-acquired infections
322467|NCT01565798|colonization|colonization
322468|NCT01565798|copper-alloy surfaces|copper-alloy surfaces
322469|NCT01565785|Child parent home self-management|child parent home self-management
322470|NCT01565772|Lung cancer|lung cancer
313140|NCT01605110|oxygen|oxygen
322471|NCT01565772|Stage III|stage iii
322472|NCT01565759|Gene expression|gene expression
322473|NCT01565759|Lithium|lithium
322474|NCT01565759|Healthy volunteers|healthy volunteers
322475|NCT01565759|Lymphoblastoid cell lines|lymphoblastoid cell lines
322476|NCT01565746|BAY88-8223|bay88-8223
322477|NCT01565746|radium-223 dichloride|radium-223 dichloride
322478|NCT01565746|prostate cancer|prostate cancer
322479|NCT01565720|Isavuconazole|isavuconazole
322480|NCT01565720|Healthy Volunteers|healthy volunteers
322481|NCT01565720|BAL8557|bal8557
322482|NCT01565707|Pediatric|pediatric
322483|NCT01565707|Solifenacin succinate suspension|solifenacin succinate suspension
322484|NCT01565707|Phase 3|phase 3
322485|NCT01565707|Pharmacokinetics|pharmacokinetics
322486|NCT01565707|Overactive bladder (OAB)|overactive bladder (oab)
322487|NCT01565694|Cognitive Function|cognitive function
322488|NCT01565694|Phase 3|phase 3
322489|NCT01565694|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
322490|NCT01565694|Pharmacokinetics|pharmacokinetics
322491|NCT01565694|Ocular Accommodation|ocular accommodation
322492|NCT01565694|Urodynamics|urodynamics
322493|NCT01565681|Healthy Volunteers|healthy volunteers
322494|NCT01565681|B cell CD40 receptor occupancy|b cell cd40 receptor occupancy
322495|NCT01565681|anti-CD40 monoclonal antibody|anti-cd40 monoclonal antibody
322496|NCT01565668|FLT3-ITD positive Acute Myeloid Leukemia (AML)|flt3-itd positive acute myeloid leukemia (aml)
322497|NCT01565668|AC220|ac220
322498|NCT01565668|Relapse|relapse
322499|NCT01565668|Refractory|refractory
322500|NCT01565655|Rheumatoid Arthritis|rheumatoid arthritis
322501|NCT01565655|ASP015K|asp015k
322502|NCT01565642|Dementia, decision making|dementia, decision making
322503|NCT01565629|Autism|autism
322504|NCT01565629|Asperger's Syndrome|asperger's syndrome
322505|NCT01565629|Treatment|treatment
322506|NCT01565629|Cognitive-behavioral therapy|cognitive-behavioral therapy
322507|NCT01565629|Anxiety|anxiety
322509|NCT01565629|Therapy|therapy
322510|NCT01565616|Severe Sickle Cell Disease|severe sickle cell disease
322718|NCT01564927|BP HR HRV|bp hr hrv
322511|NCT01565616|Hematopoietic cell transplantation (HCT)|hematopoietic cell transplantation (hct)
322512|NCT01565616|Hematopoietic Stem Cell Therapy|hematopoietic stem cell therapy
322513|NCT01565616|Bone Marrow Transplant|bone marrow transplant
322514|NCT01565616|Hematologic Diseases|hematologic diseases
322515|NCT01565616|Genetic Diseases|genetic diseases
322516|NCT01565616|Anemia|anemia
322517|NCT01565616|Hemolytic|hemolytic
322518|NCT01565616|Congenital|congenital
322519|NCT01565616|Human Leukocyte Antigen|human leukocyte antigen
322520|NCT01565616|HLA|hla
322521|NCT01565603|Hypoxia|hypoxia
322522|NCT01565603|Exercise|exercise
322523|NCT01565603|Sleep|sleep
322524|NCT01565603|Brain|brain
322525|NCT01565603|Neuromuscular function|neuromuscular function
322526|NCT01565603|Heart|heart
322527|NCT01565590|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
322528|NCT01565590|dexmedetomidine|dexmedetomidine
322529|NCT01565590|cytokines|cytokines
322530|NCT01565577|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
322531|NCT01565577|Serum bactericidal activity|serum bactericidal activity
322532|NCT01565577|Menbvac|menbvac
322533|NCT01565564|Gestational diabetes mellitus|gestational diabetes mellitus
322534|NCT01565564|intervention|intervention
322535|NCT01565564|shared care|shared care
322536|NCT01565564|pregnancy outcome|pregnancy outcome
322537|NCT01565564|macrosomia|macrosomia
322538|NCT01565564|pregnancy-induced hypertension|pregnancy-induced hypertension
322539|NCT01565551|Traumatic Brain Injury|traumatic brain injury
322540|NCT01565551|Common Data Elements|common data elements
322541|NCT01565551|Prognostic Models|prognostic models
322542|NCT01565551|Neuroimaging|neuroimaging
322543|NCT01565551|Biomarkers|biomarkers
322544|NCT01565551|Genetic Variants|genetic variants
322545|NCT01565551|Concussion|concussion
322546|NCT01565551|Psychological Health|psychological health
322547|NCT01565538|Cancer|cancer
322548|NCT01565538|Non-small-cell lung cancer|non-small-cell lung cancer
322549|NCT01565538|Adenocarcinoma|adenocarcinoma
322550|NCT01565538|EGFR gene mutation|egfr gene mutation
322551|NCT01565538|Chemotherapy|chemotherapy
322552|NCT01565538|Pemetrexed|pemetrexed
322553|NCT01565538|Erlotinib|erlotinib
322554|NCT01565525|well child visit|well child visit
322555|NCT01565525|anticipatory guidance|anticipatory guidance
322556|NCT01565525|obesity prevention|obesity prevention
322557|NCT01565525|infant feeding|infant feeding
322558|NCT01565512|randomized trial|randomized trial
322559|NCT01565512|robotic prostatectomy|robotic prostatectomy
322560|NCT01565512|prostate cancer|prostate cancer
322561|NCT01565512|foley catheter discomfort|foley catheter discomfort
322562|NCT01565499|Neoadjuvant nab-paclitaxel luminal breast cancer|neoadjuvant nab-paclitaxel luminal breast cancer
322563|NCT01565486|operation time|operation time
322564|NCT01565486|complication rate|complication rate
322565|NCT01565486|costs|costs
322566|NCT01565486|admission time|admission time
322567|NCT01565486|RFS|rfs
400373|NCT01240161|FLT|flt
313250|NCT01604590|MRI|mri
322568|NCT01565486|OS|os
322569|NCT01565473|non-motor symptoms|non-motor symptoms
322570|NCT01565460|pancreas|pancreas
322571|NCT01565460|biliary|biliary
322572|NCT01565460|stricture|stricture
322573|NCT01563510|Hepatolithiasis|hepatolithiasis
322574|NCT01563510|Minimal invasive surgery|minimal invasive surgery
322575|NCT01563510|Laparoscopic hepatectomy|laparoscopic hepatectomy
322576|NCT01563510|Choledochoscope|choledochoscope
322577|NCT01563484|Primary Hepatocellular Carcinoma(HCC)|primary hepatocellular carcinoma(hcc)
322578|NCT01563484|Transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
322579|NCT01563484|Liver function|liver function
322580|NCT01563484|Renal function|renal function
322581|NCT01563432|crossover|crossover
322582|NCT01563432|pharmacokinetic|pharmacokinetic
322583|NCT01563432|hyperuricemia|hyperuricemia
322584|NCT01563432|gout|gout
322585|NCT01563419|Insulin|insulin
322586|NCT01563419|Diabetes|diabetes
322587|NCT01563419|Low vision|low vision
322588|NCT01563406|Needleless connectors|needleless connectors
322589|NCT01563406|catheter hubs|catheter hubs
322590|NCT01563393|tool for nutritional evaluation|tool for nutritional evaluation
322591|NCT01563393|children|children
322592|NCT01563393|malnutrition|malnutrition
322593|NCT01563380|total knee arthroplasty|total knee arthroplasty
322594|NCT01563380|osteoarthritis|osteoarthritis
322595|NCT01563380|autologous Platelet rich plasma|autologous platelet rich plasma
322596|NCT01563380|complications|complications
322597|NCT01563380|blood loss|blood loss
322598|NCT01563380|Pain|pain
322599|NCT01563380|functional outcome|functional outcome
322600|NCT01563367|Anaemia|anaemia
322601|NCT01563367|Cardiac surgery|cardiac surgery
322602|NCT01565421|Cancer|cancer
322603|NCT01565421|Neoplasms|neoplasms
322604|NCT01565421|Solid Tumor|solid tumor
322605|NCT01565421|Ovarian Cancer|ovarian cancer
322606|NCT01565421|Solid Malignancies|solid malignancies
322607|NCT01565395|ALS|als
322608|NCT01565395|PD|pd
322609|NCT01565382|Amyloid imaging|amyloid imaging
322610|NCT01565382|Positron Emission Tomography|positron emission tomography
322611|NCT01565382|18F-AV-45|18f-av-45
322612|NCT01565382|florbetapir F 18|florbetapir f 18
322613|NCT01565382|Diagnostic imaging|diagnostic imaging
322614|NCT01565369|Amyloid imaging|amyloid imaging
322615|NCT01565369|Positron Emission Tomography|positron emission tomography
322616|NCT01565369|18F-AV-45|18f-av-45
322617|NCT01565369|florbetapir F 18|florbetapir f 18
322618|NCT01565369|Diagnostic imaging|diagnostic imaging
322619|NCT01565356|Amyloid imaging|amyloid imaging
322620|NCT01565356|Positron Emission Tomography|positron emission tomography
322621|NCT01565356|18F-AV-45|18f-av-45
322622|NCT01565356|florbetapir F 18|florbetapir f 18
322623|NCT01565356|Diagnostic imaging|diagnostic imaging
322624|NCT01565343|Amyloid imaging|amyloid imaging
322625|NCT01565343|Positron Emission Tomography|positron emission tomography
322626|NCT01565343|18F-AV-45|18f-av-45
322627|NCT01565343|florbetapir F 18|florbetapir f 18
322628|NCT01565343|Diagnostic imaging|diagnostic imaging
322629|NCT01565330|Amyloid imaging|amyloid imaging
322630|NCT01565330|Positron Emission Tomography|positron emission tomography
322631|NCT01565330|18F-AV-45|18f-av-45
322632|NCT01565330|florbetapir F 18|florbetapir f 18
322633|NCT01565330|Diagnostic imaging|diagnostic imaging
322634|NCT01565304|Teen pregnancy|teen pregnancy
322635|NCT01565304|Sexually transmitted infections|sexually transmitted infections
322636|NCT01565304|Sexual risk behaviors|sexual risk behaviors
322637|NCT01565291|Amyloid imaging|amyloid imaging
402053|NCT01233349|waist circumference|waist circumference
322638|NCT01565291|Positron Emission Tomography|positron emission tomography
322639|NCT01565291|18F-AV-45|18f-av-45
322640|NCT01565291|florbetapir F 18|florbetapir f 18
322641|NCT01565291|Diagnostic imaging|diagnostic imaging
322642|NCT01565278|Parenteral nutrition|parenteral nutrition
322643|NCT01565278|fish oil|fish oil
322644|NCT01565278|liver disease|liver disease
322645|NCT01565278|Omegaven|omegaven
322646|NCT01565278|hepatic|hepatic
322647|NCT01565278|liver biopsy|liver biopsy
322648|NCT01565278|bilirubin|bilirubin
322649|NCT01565265|ovarian hyperstimulation|ovarian hyperstimulation
322650|NCT01565265|GnRH antagonist|gnrh antagonist
322651|NCT01565265|GnRH agonist|gnrh agonist
322652|NCT01565265|assisted reproduction|assisted reproduction
322653|NCT01565265|FSH|fsh
322654|NCT01565265|LH|lh
322655|NCT01565252|Egg,Omega 3, Omega 6|egg,omega 3, omega 6
322656|NCT01565239|Warfarin|warfarin
322657|NCT01565239|Monitoring|monitoring
322658|NCT01565239|prothrombin time|prothrombin time
322659|NCT01565239|Fiix prothrombin time|fiix prothrombin time
322660|NCT01565239|international normalized ratio (INR)|international normalized ratio (inr)
322661|NCT01565239|new test|new test
322662|NCT01565226|Capnography|capnography
322663|NCT01565226|CO2|co2
322664|NCT01565226|neonates|neonates
752618|NCT01173367|Fever|fever
752619|NCT01173367|ICU|icu
400482|NCT01239693|LNS|lns
313343|NCT01604213|TNF|tnf
322665|NCT01565226|High Frequency ventilation (HFV)|high frequency ventilation (hfv)
322666|NCT01565213|primary health care,common mental disorders,|primary health care,common mental disorders,
322667|NCT01565213|group therapy|group therapy
322668|NCT01565200|HER2|her2
322669|NCT01565200|Metastatic Breast Cancer|metastatic breast cancer
322670|NCT01565187|Hand Transplantation|hand transplantation
322671|NCT01565174|cannabis|cannabis
322672|NCT01565174|THC|thc
322673|NCT01565174|COMT|comt
322674|NCT01565174|psychosis|psychosis
322675|NCT01565174|D2|d2
322676|NCT01565161|Obesity|obesity
322677|NCT01565161|Overweight|overweight
322678|NCT01565148|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
322679|NCT01565109|NESC|nesc
322680|NCT01565109|NEOADJUVANT|neoadjuvant
322681|NCT01565109|GASTRIC|gastric
322682|NCT01565070|Osteoarthritis|osteoarthritis
322683|NCT01565070|Pain|pain
322684|NCT01565070|Quality of life|quality of life
322685|NCT01565057|emulsion|emulsion
322686|NCT01565057|emptying|emptying
322687|NCT01565057|protein|protein
322688|NCT01565057|layering|layering
322689|NCT01565044|Stroke|stroke
322690|NCT01565044|hemiplegia|hemiplegia
322691|NCT01565044|automatic pilot|automatic pilot
322692|NCT01565044|upper-limb rehabilitation|upper-limb rehabilitation
322693|NCT01565031|Asthma|asthma
322694|NCT01565018|Rotigotine|rotigotine
322695|NCT01565018|Neupro®|neupro®
322696|NCT01565018|Transdermal Patch|transdermal patch
322697|NCT01565018|Bioequivalence|bioequivalence
322698|NCT01565005|MCPH|mcph
322699|NCT01565005|FANCONI ANEMIA|fanconi anemia
322700|NCT01564992|Parkinson's disease|parkinson's disease
322701|NCT01564992|Pharmacogenetics|pharmacogenetics
322702|NCT01564992|Genetics|genetics
322703|NCT01564979|botulinum toxin|botulinum toxin
322704|NCT01564979|facial nerve|facial nerve
322705|NCT01564979|hemifacial spasm|hemifacial spasm
322706|NCT01564979|tears|tears
322707|NCT01564966|transplantation|transplantation
322708|NCT01564966|inflammation|inflammation
322709|NCT01564966|endothelial dysfunction|endothelial dysfunction
322710|NCT01564953|vitamin D|vitamin d
322711|NCT01564953|calcium|calcium
322712|NCT01564953|magnesium|magnesium
322713|NCT01564953|COPD|copd
322714|NCT01564953|QoL|qol
322715|NCT01564940|Cervical cap insemination|cervical cap insemination
322716|NCT01564940|Usability Study|usability study
322717|NCT01564927|deqi electroacupuncture|deqi electroacupuncture
322719|NCT01564875|Simvast CR|simvast cr
322720|NCT01564875|Zocor|zocor
322721|NCT01564862|Drug Therapy|drug therapy
322722|NCT01564849|Pomegranate fruit extract|pomegranate fruit extract
322723|NCT01564849|Sinusitis|sinusitis
322724|NCT01564849|rhinitis|rhinitis
322725|NCT01564849|nasal polyps|nasal polyps
322726|NCT01564823|Crohn´s disease|crohn´s disease
322727|NCT01564823|Metronidazole|metronidazole
322728|NCT01564823|Azathioprine|azathioprine
322729|NCT01564823|Adalimumab|adalimumab
322730|NCT01564823|post-chirurgic recurrence|post-chirurgic recurrence
322731|NCT01564810|liver metastasis|liver metastasis
322732|NCT01564810|colorectal cancer|colorectal cancer
322733|NCT01564810|cetuximab|cetuximab
322734|NCT01564810|chemotherapy|chemotherapy
322735|NCT01564797|Diabetes|diabetes
322736|NCT01564797|haemoglobin A1C|haemoglobin a1c
322738|NCT01564797|Behavioural Intervention|behavioural intervention
322739|NCT01564771|Pneumococcal serotypes|pneumococcal serotypes
322740|NCT01564771|Community Acquired Pneumonia (CAP)|community acquired pneumonia (cap)
322741|NCT01564758|non-interventional|non-interventional
322742|NCT01564758|non-comparative|non-comparative
322743|NCT01564758|open-label study|open-label study
322744|NCT01564758|safety|safety
322745|NCT01564758|Linezolid|linezolid
322746|NCT01564758|gram positive infections|gram positive infections
322747|NCT01564758|Filipino|filipino
322748|NCT01564732|morbid obesity|morbid obesity
322749|NCT01564732|gastric band|gastric band
322750|NCT01564719|clergy|clergy
322751|NCT01564719|weight loss|weight loss
322752|NCT01564719|holistic|holistic
322753|NCT01564719|stress|stress
322754|NCT01564719|spiritual|spiritual
322755|NCT01564706|Amyloid imaging|amyloid imaging
322756|NCT01564706|Positron Emission Tomography|positron emission tomography
322757|NCT01564706|18F-AV-45|18f-av-45
322758|NCT01564706|florbetapir F 18|florbetapir f 18
322759|NCT01564706|Diagnostic imaging|diagnostic imaging
322760|NCT01564693|anorexia|anorexia
322761|NCT01564693|cancer|cancer
322762|NCT01564693|hypothalamus|hypothalamus
322763|NCT01564693|inflammation|inflammation
322764|NCT01564680|Lower abdominal surgery|lower abdominal surgery
322765|NCT01564680|Paracetamol|paracetamol
322766|NCT01564680|Lornoxicam|lornoxicam
322767|NCT01564680|Morphine|morphine
322768|NCT01564667|PTSD|ptsd
322769|NCT01564667|Posttraumatic Stress|posttraumatic stress
313459|NCT01603771|MRI|mri
322770|NCT01564667|Post Traumatic Stress|post traumatic stress
322771|NCT01564667|Attention Bias|attention bias
322772|NCT01564667|Threat Bias|threat bias
322773|NCT01564667|Combat|combat
322774|NCT01564667|Warzone|warzone
322775|NCT01564641|knee|knee
322776|NCT01564641|osteoarthritis|osteoarthritis
322777|NCT01564641|bicompartmental|bicompartmental
322778|NCT01564641|arthroplasty|arthroplasty
322779|NCT01564641|joint diseases|joint diseases
322780|NCT01564628|CAD|cad
322781|NCT01564615|Catheter related bloodstream infection|catheter related bloodstream infection
322782|NCT01564615|Umbilical venous catheter|umbilical venous catheter
322783|NCT01564615|Silver|silver
322784|NCT01564615|Preterm infants|preterm infants
322785|NCT01564602|2-channel single port laparoscopy|2-channel single port laparoscopy
322786|NCT01564602|multiple-channel port laparoscopy|multiple-channel port laparoscopy
322787|NCT01563354|neuroendocrine carcinoma; lung; thymus; pasireotide LAR; everolimus|neuroendocrine carcinoma; lung; thymus; pasireotide lar; everolimus
322788|NCT01563328|Dolutegravir, GSK1349572, DTG, BCV, TVR, drug interaction|dolutegravir, gsk1349572, dtg, bcv, tvr, drug interaction
322789|NCT01563315|Community-Acquired Infections|community-acquired infections
322790|NCT01563315|Pneumonia/microbiology|pneumonia/microbiology
322791|NCT01563315|Pneumonia/diagnosis|pneumonia/diagnosis
322792|NCT01563315|Prognosis|prognosis
322793|NCT01563315|Prospective Studies|prospective studies
322794|NCT01563302|Advanced Cancers|advanced cancers
322795|NCT01563302|DLBCL|dlbcl
322796|NCT01563302|Advanced Lymphoma|advanced lymphoma
322797|NCT01563276|Progressive Supranuclear Palsy|progressive supranuclear palsy
322798|NCT01563276|PSP|psp
322799|NCT01563276|Falls|falls
322800|NCT01563276|Gait|gait
322801|NCT01563276|Balance|balance
322802|NCT01563276|Parkinson's Disease|parkinson's disease
322803|NCT01563276|PD|pd
322804|NCT01563263|IC43|ic43
322805|NCT01563263|Pseudomonas Aeruginosa|pseudomonas aeruginosa
322806|NCT01563263|mechanically ventilated ICU patients|mechanically ventilated icu patients
322807|NCT01563263|ICU patients|icu patients
322808|NCT01563250|Acute Coronary Syndrome|acute coronary syndrome
322809|NCT01563250|Cardiac Biomarkers|cardiac biomarkers
322810|NCT01563250|point of care testing|point of care testing
322811|NCT01564576|Laparoscopic surgery|laparoscopic surgery
322812|NCT01564576|Anesthesiology|anesthesiology
322813|NCT01564576|Neuromuscular blockade|neuromuscular blockade
322814|NCT01564550|Type 2 diabetes|type 2 diabetes
322815|NCT01564550|Very-low-density-lipoprotein(VLDL)|very-low-density-lipoprotein(vldl)
322816|NCT01564550|VLDL1|vldl1
322817|NCT01564550|VLDL2|vldl2
322818|NCT01564550|hyperinsulinemia|hyperinsulinemia
322819|NCT01564550|diet|diet
323220|NCT01562301|NSCLC|nsclc
322820|NCT01564537|Drug therapy|drug therapy
322821|NCT01564524|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
322822|NCT01564524|Facial Trauma|facial trauma
322823|NCT01564524|Fat Grafts|fat grafts
322824|NCT01564524|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
322825|NCT01564524|Wounded warriors|wounded warriors
322826|NCT01564511|Multiple Sclerosis|multiple sclerosis
322827|NCT01564511|Robotic Rahabilitation|robotic rahabilitation
322828|NCT01564511|Fatigue|fatigue
322829|NCT01564511|Gait disorder|gait disorder
322830|NCT01564498|anthocyanins|anthocyanins
322831|NCT01564498|antioxidant|antioxidant
322832|NCT01564498|polyphenols|polyphenols
322833|NCT01564498|bioavailability|bioavailability
322834|NCT01564498|cholesterol|cholesterol
322835|NCT01564498|insulin sensitivity|insulin sensitivity
322836|NCT01564498|glucose tolerance|glucose tolerance
322837|NCT01564498|atherosclerosis|atherosclerosis
322838|NCT01564498|metabolic syndrome|metabolic syndrome
322839|NCT01564446|medication|medication
322840|NCT01564446|discharge|discharge
322841|NCT01564446|adherence|adherence
322842|NCT01564446|compliance|compliance
322843|NCT01564446|secure message|secure message
322844|NCT01564433|robotics|robotics
322845|NCT01564433|rehabilitation|rehabilitation
322846|NCT01564433|gait|gait
322847|NCT01564433|cerebral palsy|cerebral palsy
322848|NCT01564420|pharmacokinetic/pharmacodynamic modeling|pharmacokinetic/pharmacodynamic modeling
322849|NCT01564420|intrathecal morphine|intrathecal morphine
322850|NCT01564420|postoperative analgesia|postoperative analgesia
322851|NCT01564420|patient-controlled analgesia device|patient-controlled analgesia device
322852|NCT01564407|ICX‐RHY‐013|icx‐rhy‐013
322853|NCT01564407|Restrictive scar contracture|restrictive scar contracture
322854|NCT01564407|Restrictive hypertrophic scar|restrictive hypertrophic scar
322855|NCT01564407|Burn Scar|burn scar
322856|NCT01564407|Burn Scar contractures|burn scar contractures
322857|NCT01564407|Scar|scar
322858|NCT01564394|qigong|qigong
322859|NCT01564394|mindfulness meditation|mindfulness meditation
322860|NCT01564394|fatigue|fatigue
322861|NCT01564394|prostate cancer|prostate cancer
322862|NCT01564381|Cardiovascular disease|cardiovascular disease
322863|NCT01564368|stage II breast cancer|stage ii breast cancer
322864|NCT01564368|stage IIIA breast cancer|stage iiia breast cancer
322865|NCT01564368|stage IIIB breast cancer|stage iiib breast cancer
322866|NCT01564368|stage IIIC breast cancer|stage iiic breast cancer
322867|NCT01564368|stage IV breast cancer|stage iv breast cancer
322868|NCT01564368|HER2-negative breast cancer|her2-negative breast cancer
322869|NCT01564368|HER2-positive breast cancer|her2-positive breast cancer
322870|NCT01564342|wound irrigation|wound irrigation
322871|NCT01564342|tap water irrigation|tap water irrigation
322872|NCT01564342|wound infection|wound infection
322873|NCT01564342|wound irrigation solution|wound irrigation solution
322874|NCT01564329|endostar|endostar
322875|NCT01564329|CT Perfusion|ct perfusion
322876|NCT01564329|Advanced Primary Lung Adenocarcinoma|advanced primary lung adenocarcinoma
322877|NCT01564303|Carnitine|carnitine
322878|NCT01564303|Phosphodiesterase type 5 (PDE5) inhibitor|phosphodiesterase type 5 (pde5) inhibitor
322879|NCT01564303|Contrast Media-induced Nephropathy (CMN)|contrast media-induced nephropathy (cmn)
322880|NCT01564290|acute diarrhea|acute diarrhea
322881|NCT01564290|probiotics|probiotics
322882|NCT01564290|children|children
322883|NCT01564264|Uterine Neoplasms|uterine neoplasms
322884|NCT01564264|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
322885|NCT01564238|calcium retention|calcium retention
322886|NCT01564238|sodium retention|sodium retention
322887|NCT01564225|XLHED|xlhed
322888|NCT01564212|heat loss|heat loss
322889|NCT01564212|laminar airflow|laminar airflow
322890|NCT01564212|operating rooms|operating rooms
322891|NCT01564160|Fish Oil|fish oil
322893|NCT01564160|DHA|dha
322894|NCT01564160|Omega-Score|omega-score
322895|NCT01564160|Omega-3 Fatty Acids|omega-3 fatty acids
322896|NCT01564160|Green-Lipped Mussel|green-lipped mussel
322897|NCT01564160|Omega-score < 5.2%|omega-score < 5.2%
322898|NCT01564147|Therapeutic Education, Rheumatoid Arthritis|therapeutic education, rheumatoid arthritis
322899|NCT01564134|response vaccination|response vaccination
322900|NCT01564108|Intravitreal Ranibizumab|intravitreal ranibizumab
322901|NCT01564108|Non-infectious uveitis|non-infectious uveitis
322902|NCT01564108|Refractory Cystoid Macular Oedema|refractory cystoid macular oedema
322903|NCT01564108|Lucentis|lucentis
322904|NCT01564108|LIMO|limo
322905|NCT01564095|Liver transplantation|liver transplantation
322906|NCT01564095|EDC|edc
322907|NCT01564095|IRI|iri
322908|NCT01564095|graft survival|graft survival
322909|NCT01564095|graft function|graft function
322910|NCT01564095|graft preconditioning|graft preconditioning
322911|NCT01564095|Tacrolimus rinse|tacrolimus rinse
322912|NCT01564095|randomised multicenter trial|randomised multicenter trial
322913|NCT01564082|endotracheal intubation|endotracheal intubation
322914|NCT01564082|GlideScope|glidescope
322915|NCT01564069|Chronic pain|chronic pain
322916|NCT01564069|Intrathecal pain management|intrathecal pain management
323416|NCT01561469|Vancomycin|vancomycin
322917|NCT01564056|Adjuvant systemic treatment|adjuvant systemic treatment
322918|NCT01564056|Breast cancer|breast cancer
322919|NCT01564056|Elderly patients|elderly patients
322920|NCT01564030|Pregnancy|pregnancy
322921|NCT01564030|Respiratory aspiration|respiratory aspiration
322922|NCT01564030|Gastric contents|gastric contents
322923|NCT01564030|Ultrasound|ultrasound
322924|NCT01564017|Allergy|allergy
322925|NCT01564017|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
322926|NCT01564017|Immunotherapy|immunotherapy
322927|NCT01564017|D. pteronyssinus|d. pteronyssinus
322928|NCT01564017|house dust allergy|house dust allergy
322929|NCT01564004|breech presentation at term|breech presentation at term
322930|NCT01564004|pregnancy|pregnancy
322931|NCT01564004|external cephalic version (ECV)|external cephalic version (ecv)
322932|NCT01564004|clinical hypnosis|clinical hypnosis
323525|NCT01561053|AB peptide|ab peptide
322933|NCT01564004|neuro-linguistic programming (NLP)|neuro-linguistic programming (nlp)
322934|NCT01563991|surgery|surgery
322935|NCT01563991|fluid|fluid
322936|NCT01563991|morbidity|morbidity
322937|NCT01563978|Rheumatoid Arthritis|rheumatoid arthritis
322938|NCT01563965|Preoperative fasting|preoperative fasting
322939|NCT01563965|Acute phase proteins|acute phase proteins
322940|NCT01563965|Carbohydrates|carbohydrates
322941|NCT01563965|Protein hydrolizate|protein hydrolizate
322942|NCT01563965|Inflammatory response|inflammatory response
322943|NCT01563965|Surgery|surgery
322944|NCT01563939|Labour analgesia|labour analgesia
322945|NCT01563939|Pregnancy|pregnancy
322946|NCT01563939|IVPCA|ivpca
322947|NCT01563913|Parkinsons disease|parkinsons disease
322948|NCT01563913|supplement|supplement
322949|NCT01563913|DHA|dha
322950|NCT01563913|dyskinesia|dyskinesia
322951|NCT01563913|abnormal movements|abnormal movements
322952|NCT01563900|fatigue|fatigue
322953|NCT01563900|multiple sclerosis|multiple sclerosis
322954|NCT01563900|sleep apnea|sleep apnea
322955|NCT01563900|CPAP|cpap
322956|NCT01563887|Type 1 Diabetes|type 1 diabetes
322957|NCT01563887|Hypoglycemia|hypoglycemia
322958|NCT01563887|Driving|driving
322959|NCT01563887|Driving safety|driving safety
322960|NCT01563887|Internet|internet
322961|NCT01563887|Web|web
322962|NCT01563887|Treatment|treatment
313645|NCT01602887|BA/BE|ba/be
322963|NCT01563887|Intervention|intervention
322964|NCT01563874|Antibodies|antibodies
322965|NCT01563874|Reverse Phase Microarrays|reverse phase microarrays
322966|NCT01563874|Epigenetics|epigenetics
322967|NCT01563874|Acetylation|acetylation
322968|NCT01563874|Methylation|methylation
322969|NCT01563874|Lymphoma|lymphoma
322970|NCT01563861|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
322971|NCT01563861|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
322972|NCT01563861|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
322973|NCT01563861|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
322974|NCT01563835|Termination of pregnancy|termination of pregnancy
322975|NCT01563835|Epidural|epidural
322976|NCT01563835|IV PCA|iv pca
322977|NCT01563822|Follicular Fluid|follicular fluid
322978|NCT01563822|uterine cavity|uterine cavity
322979|NCT01563822|Implantation rates|implantation rates
322980|NCT01563822|ICSI|icsi
322981|NCT01563796|bladder cancer|bladder cancer
322982|NCT01563796|TCC|tcc
322983|NCT01563796|urine|urine
322984|NCT01563796|protein ELISA|protein elisa
322985|NCT01563783|Fibroids|fibroids
322986|NCT01563783|Myomas|myomas
322987|NCT01563783|leiomyomata|leiomyomata
322988|NCT01563783|menorrhagia|menorrhagia
322989|NCT01563783|Acessa Procedure|acessa procedure
322990|NCT01563783|Radiofrequency Ablation|radiofrequency ablation
322991|NCT01563783|RFA|rfa
322992|NCT01563770|Hyperlipidemia|hyperlipidemia
322993|NCT01563770|Hypertension|hypertension
322994|NCT01563770|Vasodilation|vasodilation
322995|NCT01563770|Oxidative stress|oxidative stress
322996|NCT01563770|Inflammation|inflammation
322997|NCT01563770|Hemostasis|hemostasis
322998|NCT01563770|Hemorheology|hemorheology
322999|NCT01563770|Cardiovascular diseases|cardiovascular diseases
323000|NCT01563770|Cardiovascular agents|cardiovascular agents
323001|NCT01563770|Salvia miltiorrhiza|salvia miltiorrhiza
323002|NCT01563770|Danshen|danshen
323003|NCT01563770|Danshen root extract|danshen root extract
323004|NCT01563770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
323005|NCT01563770|Therapeutic Uses|therapeutic uses
323006|NCT01563744|colonoscopy|colonoscopy
323007|NCT01563744|bowel preparation|bowel preparation
323008|NCT01563744|tolerability|tolerability
323009|NCT01563744|EGD-assisted|egd-assisted
323010|NCT01563731|Blood pressure medicines|blood pressure medicines
323011|NCT01563731|Lipid lowering medicines|lipid lowering medicines
323012|NCT01563731|Hypertension|hypertension
323013|NCT01563731|Stroke|stroke
323014|NCT01563731|Dementia|dementia
323015|NCT01563731|Heart attack|heart attack
323016|NCT01563731|Heart failure|heart failure
323017|NCT01563705|Neuromuscular Disorders|neuromuscular disorders
323018|NCT01563705|GSD III|gsd iii
323019|NCT01563705|glycogen storage disease|glycogen storage disease
323020|NCT01563692|RSV|rsv
323021|NCT01563692|Immune response|immune response
323022|NCT01563679|cancer|cancer
323023|NCT01563679|locoregional therapies|locoregional therapies
323024|NCT01563679|RFA|rfa
323025|NCT01563679|Cryoablation|cryoablation
323026|NCT01563679|Microwave ablation|microwave ablation
323027|NCT01563679|chemical ablation|chemical ablation
323028|NCT01563679|Irreversible electroporation|irreversible electroporation
323029|NCT01563653|predicting surgical success|predicting surgical success
323030|NCT01563653|simple diagnostic test device|simple diagnostic test device
323031|NCT01563640|dengue|dengue
323032|NCT01563588|breast cancer|breast cancer
323033|NCT01563588|chemotherapy|chemotherapy
323034|NCT01563588|first line treatment|first line treatment
323035|NCT01563588|treatments include a chemotherapy|treatments include a chemotherapy
323036|NCT01563588|last treatment not performed more than 9 months earlier|last treatment not performed more than 9 months earlier
323037|NCT01563575|Recognition Process|recognition process
323038|NCT01563575|Health Promotion|health promotion
323039|NCT01563575|HPH|hph
323040|NCT01563575|WHO|who
323041|NCT01563575|Hospitals|hospitals
323042|NCT01563575|Health Services|health services
323043|NCT01563575|Health Gain|health gain
323044|NCT01563575|Service Delivery|service delivery
323045|NCT01563575|Quality Management|quality management
323046|NCT01563536|Hepatitis C,Genotype 1|hepatitis c,genotype 1
323047|NCT01563224|GABA-B|gaba-b
323048|NCT01563211|breast cancer therapy|breast cancer therapy
323049|NCT01563211|toxicity|toxicity
323050|NCT01563211|side effect profile|side effect profile
323051|NCT01563198|MRI departments and facilities|mri departments and facilities
323052|NCT01563198|Noncompletion of MRI|noncompletion of mri
323053|NCT01563185|JIA|jia
323054|NCT01563185|ibuprofen|ibuprofen
323055|NCT01563185|famotidine|famotidine
323056|NCT01563185|pediatrics|pediatrics
323057|NCT01563185|for > 1 month|for > 1 month
323058|NCT01563159|Belgium|belgium
323059|NCT01563159|hospitals|hospitals
323060|NCT01563159|Rotavirus|rotavirus
313753|NCT01602354|EAA|eaa
323061|NCT01563146|Rotavirus|rotavirus
323062|NCT01563146|hospitals|hospitals
323063|NCT01563146|Belgium|belgium
323064|NCT01563133|endomicroscopy|endomicroscopy
323065|NCT01563133|needle-based|needle-based
323066|NCT01563133|pancreatic|pancreatic
323067|NCT01563133|cyst|cyst
323068|NCT01563133|mass|mass
323069|NCT01563133|EUSFNA|eusfna
323070|NCT01563107|Orthostatic Intolerance|orthostatic intolerance
323071|NCT01563107|Tachycardia|tachycardia
323072|NCT01563107|Orthostatic Hypotension|orthostatic hypotension
323073|NCT01563107|Sodium|sodium
323074|NCT01563094|Bone Density|bone density
323075|NCT01563094|Lactation|lactation
323076|NCT01563094|Bone Turnover Markers|bone turnover markers
323077|NCT01563081|Allergic rhinitis|allergic rhinitis
323078|NCT01563081|Pediatric|pediatric
323079|NCT01563081|Pruritus|pruritus
323080|NCT01563081|Levocetirizine|levocetirizine
323081|NCT01563068|plaque psoriasis|plaque psoriasis
323082|NCT01563068|pediatric|pediatric
323083|NCT01563068|adolescent|adolescent
323084|NCT01563042|immunogenicity|immunogenicity
323085|NCT01563042|GSK2434735|gsk2434735
323086|NCT01563042|pharmacokinetics (PK)|pharmacokinetics (pk)
323087|NCT01563042|PK|pk
323088|NCT01563042|biospecific antibody|biospecific antibody
323089|NCT01563016|schizophrenia|schizophrenia
323090|NCT01563016|Psychotic Disorders|psychotic disorders
323091|NCT01563016|Psychoses|psychoses
323092|NCT01563003|Autism|autism
323093|NCT01563003|Asperger's Syndrome|asperger's syndrome
323094|NCT01563003|Pervasive Developmental Disorder Not Otherwise Specified|pervasive developmental disorder not otherwise specified
323095|NCT01563003|Treatment|treatment
323096|NCT01563003|Cognitive-behavioral therapy|cognitive-behavioral therapy
323097|NCT01563003|Anxiety|anxiety
323098|NCT01563003|Children|children
323099|NCT01563003|Therapy|therapy
323100|NCT01562951|Crohn's disease|crohn's disease
323101|NCT01562951|mucosal inflammation|mucosal inflammation
323102|NCT01562951|lesions|lesions
323103|NCT01562938|Respiratory Syncytial Virus|respiratory syncytial virus
323104|NCT01562912|radiofrequency|radiofrequency
323105|NCT01562912|ablation|ablation
323106|NCT01562912|atrial fibrillation|atrial fibrillation
323107|NCT01562912|PVAC|pvac
323108|NCT01562899|MEK162|mek162
323109|NCT01562899|AMG 479|amg 479
323110|NCT01562899|Ganitumab|ganitumab
323111|NCT01562899|colorectal adenocarcinoma|colorectal adenocarcinoma
323112|NCT01562899|pancreatic adenocarcinoma|pancreatic adenocarcinoma
323113|NCT01562899|melanoma|melanoma
323114|NCT01562899|KRAS|kras
323115|NCT01562899|BRAF|braf
323116|NCT01562886|Rilpivirine CSF pharmacokinetics|rilpivirine csf pharmacokinetics
323117|NCT01562873|pSTAT3+|pstat3+
323118|NCT01562860|median nerve|median nerve
323119|NCT01562860|carpal tunnel syndrome|carpal tunnel syndrome
323120|NCT01562860|Pronator Teres Release|pronator teres release
323121|NCT01562782|Elevated triglycerides|elevated triglycerides
323122|NCT01562782|Diabetes Mellitus|diabetes mellitus
323123|NCT01562782|Dyslipidemia|dyslipidemia
323124|NCT01562782|Lipid Metabolic Disorders|lipid metabolic disorders
323125|NCT01562782|Body Weight|body weight
323126|NCT01562730|Coronary Artery Disease|coronary artery disease
323127|NCT01562730|Myocardial Ischemia|myocardial ischemia
323128|NCT01562730|Coronary Disease|coronary disease
323129|NCT01562730|Heart Diseases|heart diseases
323130|NCT01562730|Cardiovascular Diseases|cardiovascular diseases
323131|NCT01562730|Arteriosclerosis|arteriosclerosis
323132|NCT01562730|Arterial Occlusive Diseases|arterial occlusive diseases
323133|NCT01562730|Vascular Diseases|vascular diseases
323135|NCT01562730|12 leads ECG|12 leads ecg
323136|NCT01562704|mechanism of action of paracetamol in the brain structures|mechanism of action of paracetamol in the brain structures
323137|NCT01562691|nasal packing|nasal packing
323526|NCT01561053|Albumin|albumin
323138|NCT01562691|nasal airway|nasal airway
323139|NCT01562691|septoplasty|septoplasty
323140|NCT01562691|oxygen saturation|oxygen saturation
323141|NCT01562691|postoperative pain|postoperative pain
323142|NCT01562678|fMRI|fmri
323143|NCT01562678|Liraglutide|liraglutide
323144|NCT01562678|diabetes|diabetes
323145|NCT01562678|GLP-1|glp-1
323146|NCT01562665|All patients with NSCLC attending participating hospitals|all patients with nsclc attending participating hospitals
323147|NCT01562639|maintenance therapy,|maintenance therapy,
323148|NCT01562639|repeatedly recurring,|repeatedly recurring,
323149|NCT01562639|relapsing reflux oesophagitis,|relapsing reflux oesophagitis,
323150|NCT01562639|Nexium|nexium
323151|NCT01562613|Stroke|stroke
323152|NCT01562613|Hypertension|hypertension
323153|NCT01562600|NSAIDs|nsaids
323154|NCT01562600|Gastric ulcer or duodenal ulcer|gastric ulcer or duodenal ulcer
323155|NCT01562600|Nexium|nexium
323156|NCT01562548|upper back/neck/shoulder muscle spasm|upper back/neck/shoulder muscle spasm
323157|NCT01562535|pulled elbow|pulled elbow
323158|NCT01562535|nursemaid elbow|nursemaid elbow
323159|NCT01562509|Non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
323160|NCT01562509|Quality of health care|quality of health care
323161|NCT01562509|Oncology Service Hospital|oncology service hospital
323162|NCT01562509|Patient-centredness|patient-centredness
323163|NCT01562509|PROMs|proms
323164|NCT01562496|Parkinson's disease|parkinson's disease
323165|NCT01562496|Neuroprotective|neuroprotective
323166|NCT01562496|Intensive exercise|intensive exercise
323167|NCT01562483|postsurgical pain|postsurgical pain
323168|NCT01562483|abdominal pain|abdominal pain
323169|NCT01562483|visceral pain|visceral pain
323170|NCT01562483|chronic pain|chronic pain
323171|NCT01562470|cellulite|cellulite
323172|NCT01562470|reduction|reduction
323173|NCT01562470|cream|cream
323174|NCT01562470|thighs|thighs
323175|NCT01562470|women|women
323176|NCT01562444|Long term immunogenicity study|long term immunogenicity study
323177|NCT01562418|Ergonomics|ergonomics
323178|NCT01562418|musculoskeletal symptoms|musculoskeletal symptoms
323179|NCT01562418|kinematics|kinematics
323180|NCT01562405|Relapsed|relapsed
323181|NCT01562405|Refractory|refractory
323182|NCT01562392|dietary prevention|dietary prevention
323183|NCT01562392|cognitive performance|cognitive performance
323184|NCT01562392|metabolic syndrome|metabolic syndrome
323185|NCT01562392|colonic fermentation|colonic fermentation
323186|NCT01562392|sub clinical inflammation|sub clinical inflammation
323187|NCT01562392|cognition and metabolism|cognition and metabolism
323188|NCT01562379|complementary food supplements|complementary food supplements
323189|NCT01562379|stunting|stunting
323190|NCT01562379|wasting|wasting
323191|NCT01562379|growth|growth
323192|NCT01562379|Bangladesh|bangladesh
323193|NCT01562379|infant feeding|infant feeding
323194|NCT01562366|Iliotibial Band Release|iliotibial band release
323195|NCT01562366|Trochanteric Bursectomy|trochanteric bursectomy
323196|NCT01562366|Micro debridement|micro debridement
323197|NCT01562353|Opioid Dependence|opioid dependence
323198|NCT01562353|Opioids for the treatment of pain|opioids for the treatment of pain
323199|NCT01562340|Hemodialysis|hemodialysis
323200|NCT01562340|End stage renal disease|end stage renal disease
323201|NCT01562340|Oxidative stress|oxidative stress
323202|NCT01562340|Inflammation|inflammation
323203|NCT01562340|Endothelial dysfunction|endothelial dysfunction
323204|NCT01562340|Cardiovascular disease|cardiovascular disease
323205|NCT01562340|Antioxidants|antioxidants
323206|NCT01562340|Flavonoids|flavonoids
323207|NCT01562314|Mild to Moderate Ulcerative Colitis|mild to moderate ulcerative colitis
323208|NCT01562301|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
323209|NCT01562301|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
323210|NCT01562301|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
323211|NCT01562301|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
323212|NCT01562301|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
323213|NCT01562301|carboplatin|carboplatin
323214|NCT01562301|Paraplatin|paraplatin
323215|NCT01562301|docetaxel|docetaxel
323216|NCT01562301|Taxotere|taxotere
323217|NCT01562301|Anvirzel|anvirzel
323218|NCT01562301|nerium oleander|nerium oleander
323219|NCT01562301|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
323221|NCT01562288|HER2-positive breast cancer|her2-positive breast cancer
323222|NCT01562288|HER2-negative breast cancer|her2-negative breast cancer
323223|NCT01562288|stage IA breast cancer|stage ia breast cancer
323224|NCT01562288|stage IB breast cancer|stage ib breast cancer
323225|NCT01562288|stage II breast cancer|stage ii breast cancer
323226|NCT01562288|stage IIIA breast cancer|stage iiia breast cancer
323227|NCT01562275|GDC0973|gdc0973
323229|NCT01562275|MEK inhibitor|mek inhibitor
323230|NCT01562275|GDC0068|gdc0068
323232|NCT01562275|Akt inhibitor|akt inhibitor
323233|NCT01562262|Apnea|apnea
323234|NCT01562262|PVT|pvt
323235|NCT01562262|Reaction Time|reaction time
323236|NCT01562249|clinical evaluation|clinical evaluation
323237|NCT01562249|controlled clinical trial|controlled clinical trial
323936|NCT01559415|Adipocytes|adipocytes
323238|NCT01562249|electromyography|electromyography
323239|NCT01562249|exercise program|exercise program
323240|NCT01562249|motor control|motor control
323241|NCT01562223|stage IIA prostate cancer|stage iia prostate cancer
323242|NCT01562223|stage IIB prostate cancer|stage iib prostate cancer
323243|NCT01562223|stage III prostate cancer|stage iii prostate cancer
323244|NCT01562223|stage IV prostate cancer|stage iv prostate cancer
323245|NCT01562223|adenocarcinoma of the prostate|adenocarcinoma of the prostate
323246|NCT01562210|NSCLC|nsclc
323247|NCT01562210|Olaparib|olaparib
323248|NCT01562210|CCRT|ccrt
323249|NCT01562197|axitinib|axitinib
323250|NCT01562197|glioblastoma|glioblastoma
323251|NCT01562197|recurrent|recurrent
323252|NCT01562171|Overweight|overweight
323253|NCT01562171|Obese|obese
323254|NCT01562171|Obesity|obesity
323255|NCT01562171|Cholesterol|cholesterol
323256|NCT01562171|Hypercholesterolemia|hypercholesterolemia
323257|NCT01562171|LDL-Cholesterol|ldl-cholesterol
402995|NCT01228695|patients treated with systemic steroids|patients treated with systemic steroids
402996|NCT01228682|Sodium|sodium
402997|NCT01228682|SIADH|siadh
313942|NCT01601561|Protein metabolism|protein metabolism
313943|NCT01601561|Stress response|stress response
313944|NCT01601483|AMD|amd
313945|NCT01601483|Dry AMD|dry amd
313946|NCT01601483|Nonexudative AMD|nonexudative amd
313947|NCT01601483|MC-1101|mc-1101
313948|NCT01601470|LCZ696, sildenafil, pharmacokinetics, mild to moderate hypertension|lcz696, sildenafil, pharmacokinetics, mild to moderate hypertension
313949|NCT01601444|To assess pleural effusion by measuring internal thoracic impedance|to assess pleural effusion by measuring internal thoracic impedance
313950|NCT01601431|Screening colonoscopy|screening colonoscopy
313951|NCT01601418|YF476|yf476
313953|NCT01601418|pentagastrin|pentagastrin
323258|NCT01562145|Rotator cuff tear, matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, partial-thickness tear, full-thickness tear, plasma.|rotator cuff tear, matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, partial-thickness tear, full-thickness tear, plasma.
323259|NCT01562132|cryptococcus|cryptococcus
323260|NCT01562132|HIV|hiv
323261|NCT01562119|Burns|burns
323262|NCT01562119|Wound repair|wound repair
323263|NCT01562119|Skin substitutes|skin substitutes
323264|NCT01562106|Cancer of Endometrium|cancer of endometrium
323265|NCT01562106|Cancer of the Endometrium|cancer of the endometrium
323266|NCT01562106|Carcinoma of Endometrium|carcinoma of endometrium
323267|NCT01562106|Endometrial Carcinoma|endometrial carcinoma
323268|NCT01562106|Endometrium Cancer|endometrium cancer
323269|NCT01562106|Neoplasms, Endometrial|neoplasms, endometrial
323270|NCT01562093|Adrenal Cortex Hormones|adrenal cortex hormones
323271|NCT01562093|Spirometry|spirometry
323272|NCT01562093|Administration, Intranasal|administration, intranasal
323273|NCT01562093|Nasal blockage|nasal blockage
323274|NCT01562093|Nasal sprays|nasal sprays
323275|NCT01562080|hyperlipidemia|hyperlipidemia
323276|NCT01562080|metabolic syndrome|metabolic syndrome
323277|NCT01562080|yeast red|yeast red
323278|NCT01562080|berberine|berberine
323279|NCT01562080|policosanol|policosanol
323280|NCT01562080|astaxanthin|astaxanthin
323281|NCT01562067|Cervical tumors,vascular changes,Sonographic characteristics|cervical tumors,vascular changes,sonographic characteristics
323282|NCT01562041|Cardiovascular disease|cardiovascular disease
323283|NCT01562041|Exercise Treadmill Test|exercise treadmill test
323284|NCT01562041|Ranolazine|ranolazine
323285|NCT01562041|Angina|angina
323286|NCT01562041|Myocardial ischemia|myocardial ischemia
323287|NCT01562028|non small cell lung cancer|non small cell lung cancer
323288|NCT01562028|advanced|advanced
323289|NCT01562028|non-squamous|non-squamous
323290|NCT01562028|EGFR|egfr
323291|NCT01562028|mutations|mutations
323292|NCT01562002|limbus|limbus
323293|NCT01562002|cornea|cornea
323294|NCT01562002|insufficiency syndrome|insufficiency syndrome
323295|NCT01562002|stem cell transplant|stem cell transplant
323296|NCT01561963|Apremilast|apremilast
323297|NCT01561963|drug interaction|drug interaction
323298|NCT01561963|pharmacokinetics|pharmacokinetics
323299|NCT01561911|Clinical Trial|clinical trial
323300|NCT01561911|Phase I|phase i
323301|NCT01561911|Antibodies|antibodies
323302|NCT01561911|Monoclonal|monoclonal
323303|NCT01561898|Schizophrenia|schizophrenia
323304|NCT01561898|JNS007ER|jns007er
323305|NCT01561898|Paliperidone extended-release|paliperidone extended-release
323306|NCT01561885|Clinical Pathways|clinical pathways
323307|NCT01561885|Length of Stay|length of stay
323308|NCT01561885|Patient-Centered Care|patient-centered care
323309|NCT01561885|Pragmatic Randomized Controlled Trial|pragmatic randomized controlled trial
323310|NCT01561859|Early Course Schizophrenia|early course schizophrenia
323311|NCT01561859|Cognitive Enhancement Therapy|cognitive enhancement therapy
323312|NCT01561859|Enriched Supportive Therapy|enriched supportive therapy
323313|NCT01561846|Conjugated Linoleic Acid|conjugated linoleic acid
323314|NCT01561846|LDL-cholesterol|ldl-cholesterol
323315|NCT01561846|Endocannabinoids|endocannabinoids
323316|NCT01561833|relapsed or refractory T cell lymphoma|relapsed or refractory t cell lymphoma
323317|NCT01561820|mild cognitive impairment|mild cognitive impairment
324331|NCT01557920|hypercapnia|hypercapnia
323318|NCT01561820|cognitive disorders|cognitive disorders
323319|NCT01561820|exercise|exercise
323320|NCT01561794|Ciprofloxacin|ciprofloxacin
323321|NCT01561794|Bacterial pneumonia|bacterial pneumonia
323322|NCT01561794|Community Acquired Pneumonia (CAP)|community acquired pneumonia (cap)
323323|NCT01561794|Hospital Acquired Pneumonia (HAP)|hospital acquired pneumonia (hap)
323324|NCT01561794|Secondary infection of chronic respiratory disease|secondary infection of chronic respiratory disease
314121|NCT01600872|TAS|tas
323325|NCT01561794|400 mg BID/TID|400 mg bid/tid
323326|NCT01561781|Phase 1|phase 1
323327|NCT01561781|healthy volunteers|healthy volunteers
323328|NCT01561781|pharmacokinetics|pharmacokinetics
323329|NCT01561781|vandetanib|vandetanib
323330|NCT01561781|digoxin|digoxin
323331|NCT01561755|HIV associated myelopathy|hiv associated myelopathy
323332|NCT01561742|minocycline, augmentation, schizophrenia|minocycline, augmentation, schizophrenia
323333|NCT01561729|nasogastric tube|nasogastric tube
323334|NCT01561729|orogastric tube|orogastric tube
323335|NCT01561729|RightSpot pH Indicator|rightspot ph indicator
323336|NCT01561729|suction tube|suction tube
323337|NCT01561729|RightBio Metrics|rightbio metrics
323338|NCT01561729|RightLevel|rightlevel
323339|NCT01561729|RightSpot Infant|rightspot infant
323340|NCT01561729|NG Tube|ng tube
323342|NCT01561729|Gastric Acidity|gastric acidity
323343|NCT01561716|video games|video games
323344|NCT01561716|energy expenditure|energy expenditure
323345|NCT01561716|physical activity|physical activity
323346|NCT01561716|exercise physiology|exercise physiology
323347|NCT01561703|Healthcare utilization|healthcare utilization
323348|NCT01561703|Tonsillectomy|tonsillectomy
323349|NCT01561703|Adenoidectomy/Tonsillectomy|adenoidectomy/tonsillectomy
323350|NCT01561703|Antibiotics|antibiotics
323351|NCT01561677|obstructive sleep apnea|obstructive sleep apnea
323352|NCT01561677|syndrome survival|syndrome survival
323353|NCT01561677|ischemic stroke|ischemic stroke
323354|NCT01561677|continuous positive airway pressure|continuous positive airway pressure
323355|NCT01561677|handicap|handicap
323356|NCT01561664|obesity|obesity
323357|NCT01561664|insulin resistance|insulin resistance
323358|NCT01561651|cardiac surgery|cardiac surgery
323359|NCT01561651|left atrial appendage|left atrial appendage
323360|NCT01561651|atrial fibrillation|atrial fibrillation
323361|NCT01561651|stroke|stroke
323362|NCT01561651|non-CNS systemic embolism|non-cns systemic embolism
323363|NCT01561638|Pulsed|pulsed
323364|NCT01561638|radiofrequency|radiofrequency
323365|NCT01561638|single-dose|single-dose
323366|NCT01561638|shoulder pain|shoulder pain
323367|NCT01561638|Pain lasts more than one month|pain lasts more than one month
323368|NCT01561638|patients referred to the pain clinic from the shoulder clinic|patients referred to the pain clinic from the shoulder clinic
323369|NCT01561638|Failed all conservative therapies available|failed all conservative therapies available
323370|NCT01561625|COPD|copd
323371|NCT01561625|exercise training|exercise training
323372|NCT01561612|Breastfeeding|breastfeeding
323373|NCT01561612|Child Health|child health
323374|NCT01561612|Obesity|obesity
323375|NCT01561612|Blood Pressure|blood pressure
323376|NCT01561612|Asthma|asthma
323377|NCT01561612|Cognitive Development|cognitive development
323378|NCT01561612|Behavior|behavior
323379|NCT01561612|Eczema|eczema
323380|NCT01561612|Lung Function|lung function
323381|NCT01561612|Spirometry|spirometry
323382|NCT01561599|hepatocyte growth factor mimetic|hepatocyte growth factor mimetic
323383|NCT01561599|hepatocyte growth factor(HGF)|hepatocyte growth factor(hgf)
323384|NCT01561599|Delayed Graft Function (DGF)|delayed graft function (dgf)
323385|NCT01561599|Kidney transplantation|kidney transplantation
323386|NCT01561586|Cervical cancer|cervical cancer
323387|NCT01561586|Concurrent chemoradiation|concurrent chemoradiation
323388|NCT01561586|Cisplatin|cisplatin
323389|NCT01561573|Point of Care Ultrasound|point of care ultrasound
323390|NCT01561573|Emergency Ultrasound|emergency ultrasound
323391|NCT01561573|Colles Fracture|colles fracture
323392|NCT01561573|Fracture Reduction|fracture reduction
323393|NCT01561573|Bedside Ultrasound|bedside ultrasound
323394|NCT01561560|DAILIES TOTAL1|dailies total1
323395|NCT01561560|contact lenses|contact lenses
323396|NCT01561560|myopia|myopia
323397|NCT01561547|pain|pain
323398|NCT01561547|preterm neonate|preterm neonate
323399|NCT01561547|sucrose|sucrose
323400|NCT01561547|kangaroo mother care|kangaroo mother care
323401|NCT01561534|fibula flap|fibula flap
323402|NCT01561534|oral implants|oral implants
323403|NCT01561534|computer-guided|computer-guided
323404|NCT01561508|diabetes mellitus|diabetes mellitus
323405|NCT01561508|children|children
323406|NCT01561495|scheduled to receive RT either pre- or postoperatively|scheduled to receive rt either pre- or postoperatively
323407|NCT01561482|Prostate carcinoma|prostate carcinoma
323408|NCT01561482|Prostate cancer|prostate cancer
323409|NCT01561482|Prostate Specific Antigen|prostate specific antigen
323410|NCT01561482|PSA|psa
323411|NCT01561482|Metformin|metformin
323412|NCT01561482|Simvastatin|simvastatin
323413|NCT01561482|Radiation therapy|radiation therapy
323414|NCT01561482|Prostatectomy|prostatectomy
323415|NCT01561469|Linezolid|linezolid
323417|NCT01561469|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
323418|NCT01561469|Respiratory Tract Infections|respiratory tract infections
323419|NCT01561456|non-small-cell lung cancer|non-small-cell lung cancer
323420|NCT01561456|squamous cell carcinoma|squamous cell carcinoma
323421|NCT01561456|adenocarcinoma of the lung|adenocarcinoma of the lung
401518|NCT01235598|CZP|czp
314151|NCT01600781|QOL|qol
323422|NCT01561456|IGF-1 inhibitor|igf-1 inhibitor
323423|NCT01561456|docetaxel|docetaxel
323424|NCT01561456|AXL1717|axl1717
323425|NCT01561456|NSCLC|nsclc
323426|NCT01561456|SCC|scc
323427|NCT01561456|AC|ac
323428|NCT01561443|Breast cancer,|breast cancer,
323429|NCT01561443|hormone positive,|hormone positive,
323430|NCT01561430|beta-secretase inhibitor|beta-secretase inhibitor
323431|NCT01561326|cervical cancer|cervical cancer
323432|NCT01561326|follow-up|follow-up
323433|NCT01561326|Pap test|pap test
323434|NCT01561326|Medical management|medical management
323435|NCT01561326|Colposcopy|colposcopy
323436|NCT01561313|On label Humira users|on label humira users
323437|NCT01561313|Pain|pain
323438|NCT01561313|Rheumatoid Arthritis,|rheumatoid arthritis,
323439|NCT01561300|Black tea|black tea
323440|NCT01561300|Flow Mediated Dilation|flow mediated dilation
323441|NCT01561300|Vascular function|vascular function
323442|NCT01561300|India|india
323443|NCT01561261|fasciotomy|fasciotomy
323444|NCT01561261|ACS|acs
323445|NCT01561248|EHEC|ehec
323446|NCT01561248|O104:H4|o104:h4
323447|NCT01561248|German|german
323448|NCT01561248|outbreak|outbreak
323449|NCT01561248|polyethylene glycol|polyethylene glycol
323450|NCT01561248|Bowel lavage|bowel lavage
323451|NCT01561235|Protein|protein
323452|NCT01561235|Appetite|appetite
323453|NCT01561235|Satiety|satiety
323454|NCT01561235|Energi intake|energi intake
323455|NCT01561235|Appetite regulating hormones|appetite regulating hormones
323456|NCT01561235|Dose-response|dose-response
323457|NCT01561222|calcitrol|calcitrol
323458|NCT01561222|Bone mineral density|bone mineral density
323459|NCT01561222|Osteoprotegin|osteoprotegin
323460|NCT01561222|Vascular calcification|vascular calcification
323461|NCT01561209|amitryptiline|amitryptiline
323462|NCT01561209|Chronic pain|chronic pain
323463|NCT01561209|Neck pain|neck pain
323464|NCT01561196|arteria cannulation|arteria cannulation
323465|NCT01561196|Ultrasound|ultrasound
323466|NCT01561196|pain|pain
323467|NCT01561196|complications|complications
323468|NCT01561183|Vital pulp therapy|vital pulp therapy
323469|NCT01561183|Pulp cap|pulp cap
323470|NCT01561183|pulpotomy|pulpotomy
323471|NCT01561183|calcium enriched mixture|calcium enriched mixture
323472|NCT01561183|CEM cement|cem cement
323473|NCT01561183|Endodontic|endodontic
323474|NCT01561170|Electromagnetic|electromagnetic
323475|NCT01561170|Field therapy|field therapy
323476|NCT01561170|Chronically venous ulcer|chronically venous ulcer
323477|NCT01561170|Venous insufficiens|venous insufficiens
323478|NCT01561157|porphyria|porphyria
323479|NCT01561157|acute intermittent|acute intermittent
323480|NCT01561157|coproporphyria|coproporphyria
323481|NCT01561157|variegate|variegate
323482|NCT01561157|erythropoietic|erythropoietic
323483|NCT01561157|protoporphyria|protoporphyria
323484|NCT01561157|hepatoerythropoietic|hepatoerythropoietic
323485|NCT01561157|cutanea tarda|cutanea tarda
323486|NCT01561157|AIP|aip
323487|NCT01561157|HCP|hcp
323488|NCT01561157|VP|vp
323489|NCT01561157|ADP|adp
323490|NCT01561157|ALAD|alad
323491|NCT01561157|PCT|pct
323492|NCT01561157|HEP|hep
323493|NCT01561157|CEP|cep
323494|NCT01561157|EPP|epp
323495|NCT01561157|XLP|xlp
323496|NCT01561144|Defibrillators, Implantable|defibrillators, implantable
323497|NCT01561144|Cardiac arrhythmias|cardiac arrhythmias
323498|NCT01561144|Heart Disease|heart disease
323499|NCT01561131|Obesity|obesity
323500|NCT01561131|Protein intake|protein intake
323501|NCT01561131|Calcium intake|calcium intake
323502|NCT01561131|Weight loss|weight loss
323503|NCT01561131|Weight maintenance|weight maintenance
323504|NCT01561131|Blood lipid profile|blood lipid profile
323505|NCT01561131|Diet induced thermogenesis|diet induced thermogenesis
323506|NCT01561118|hemodialysis|hemodialysis
323507|NCT01561118|dialysis efficacy|dialysis efficacy
323508|NCT01561118|cardiorespiratory capacity|cardiorespiratory capacity
323509|NCT01561118|exercise capacity|exercise capacity
323510|NCT01561118|children and adolescents|children and adolescents
323511|NCT01561092|Stroke|stroke
323512|NCT01561092|RCT|rct
323513|NCT01561092|SSRI|ssri
323514|NCT01561092|Outcome|outcome
323515|NCT01561079|Buprenorphine|buprenorphine
323516|NCT01561079|Methadone|methadone
323517|NCT01561079|Fetal neurobehavior|fetal neurobehavior
323518|NCT01561079|Infant neurobehavior|infant neurobehavior
323519|NCT01561066|Fibrin glue|fibrin glue
323520|NCT01561066|Platelet|platelet
323521|NCT01561066|Autologous derivation|autologous derivation
323522|NCT01561066|Prospective randomized trial|prospective randomized trial
323524|NCT01561053|Alzheimer's disease|alzheimer's disease
323527|NCT01561053|Intravenous immune globulin|intravenous immune globulin
323528|NCT01561053|IGIV|igiv
323529|NCT01561040|Dry Eye syndrome|dry eye syndrome
323530|NCT01561040|tear film deficiency|tear film deficiency
323531|NCT01561040|Essential Fatty Acid nutritional supplements|essential fatty acid nutritional supplements
323532|NCT01561040|Omega three supplements|omega three supplements
323533|NCT01560988|Asthma|asthma
323534|NCT01560988|Borage|borage
323535|NCT01560988|Echium|echium
323536|NCT01560988|Botanical|botanical
323537|NCT01560949|Pancreatic Cancer|pancreatic cancer
323538|NCT01560949|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
402054|NCT01233349|satiety|satiety
323539|NCT01560949|High Risk Resectable|high risk resectable
323540|NCT01560949|Borderline Resectable|borderline resectable
323541|NCT01560949|Chemotherapy|chemotherapy
323542|NCT01560949|Chemoradiation therapy|chemoradiation therapy
323543|NCT01560949|Oxaliplatin|oxaliplatin
323544|NCT01560949|Eloxatin|eloxatin
323545|NCT01560949|Irinotecan|irinotecan
323546|NCT01560949|CPT-11|cpt-11
323547|NCT01560949|Camptosar|camptosar
323548|NCT01560949|5-FU|5-fu
323549|NCT01560949|5-Fluorouracil|5-fluorouracil
323550|NCT01560949|Adrucil|adrucil
323551|NCT01560949|Efudex|efudex
323552|NCT01560949|Gemcitabine|gemcitabine
323553|NCT01560949|Gemcitabine Hydrochloride|gemcitabine hydrochloride
323554|NCT01560949|Gemzar|gemzar
323555|NCT01560949|Radiation Therapy|radiation therapy
323556|NCT01560949|XRT|xrt
323557|NCT01560949|RT|rt
323558|NCT01560949|External Beam Radiation Therapy|external beam radiation therapy
323559|NCT01560936|bacterial contamination|bacterial contamination
323560|NCT01560923|hormone refractory prostate cancer|hormone refractory prostate cancer
323561|NCT01560910|with or without GERD symptoms|with or without gerd symptoms
323562|NCT01560910|presenting to gastrointestinal clinic of Maharaj Nakorn Chiangmai Hospital|presenting to gastrointestinal clinic of maharaj nakorn chiangmai hospital
323563|NCT01560910|November 2009 to November 2010|november 2009 to november 2010
323564|NCT01560910|GERD|gerd
323565|NCT01560910|NERD|nerd
323566|NCT01560871|Heart failure|heart failure
323567|NCT01560871|inspiratory muscle training|inspiratory muscle training
323568|NCT01560871|physical activity|physical activity
323569|NCT01560845|autologous bone marrow stem cells|autologous bone marrow stem cells
323570|NCT01560845|portal hypertension|portal hypertension
323571|NCT01560845|surgery|surgery
323572|NCT01560845|liver cirrhosis|liver cirrhosis
323573|NCT01560819|ulcerative colitis, gut microbial transplantation|ulcerative colitis, gut microbial transplantation
323574|NCT01560806|hypertension|hypertension
323575|NCT01560806|cardiovascular risk factor|cardiovascular risk factor
323576|NCT01560806|lifestyle|lifestyle
323577|NCT01560793|Influenza|influenza
323578|NCT01560793|Vaccines|vaccines
323579|NCT01560793|H5N1|h5n1
323580|NCT01560780|Coronary Artery Bypass|coronary artery bypass
323581|NCT01560780|thrombosis|thrombosis
323582|NCT01560780|prasugrel|prasugrel
323583|NCT01560767|Pain relief|pain relief
323584|NCT01560767|Arthroplasty|arthroplasty
323585|NCT01560767|periarticular knee infiltration|periarticular knee infiltration
323586|NCT01560754|Randomized|randomized
323587|NCT01560754|Placebo-controlled|placebo-controlled
323588|NCT01560754|Double-blind|double-blind
323589|NCT01560754|Multi-center|multi-center
323590|NCT01560754|Disease-modifying potential|disease-modifying potential
323591|NCT01560754|transdermal nicotine|transdermal nicotine
323592|NCT01560741|Chronic respiratory failure|chronic respiratory failure
323593|NCT01560741|Noninvasive Mechanical Ventilation|noninvasive mechanical ventilation
323594|NCT01560741|Home-care|home-care
323595|NCT01560741|Telemedicine|telemedicine
323596|NCT01560741|COPD|copd
323597|NCT01560728|Post Traumatic Stress Disorder|post traumatic stress disorder
323598|NCT01560728|Major Depressive Disorder|major depressive disorder
323599|NCT01560728|Dysthymia|dysthymia
323600|NCT01560728|Generalized Anxiety Disorder|generalized anxiety disorder
323601|NCT01560728|Social Phobia|social phobia
323602|NCT01560728|Panic Disorder|panic disorder
323603|NCT01560715|Retinitis pigmentosa|retinitis pigmentosa
323604|NCT01560715|stem cell|stem cell
323605|NCT01560715|bone marrow|bone marrow
323606|NCT01560715|retinal dysprophy|retinal dysprophy
323607|NCT01560702|autologous blood|autologous blood
323608|NCT01560702|epinephrine|epinephrine
323609|NCT01560702|endoscopy|endoscopy
323610|NCT01560702|ulcer|ulcer
323611|NCT01560702|hemostasis|hemostasis
323612|NCT01560689|bone marrow transplantation|bone marrow transplantation
323613|NCT01560689|obstructive lung disease|obstructive lung disease
323614|NCT01560689|bronchodilators|bronchodilators
323615|NCT01560689|inhaled steroids|inhaled steroids
323616|NCT01560689|late-onset pulmonary complication|late-onset pulmonary complication
323617|NCT01560676|Internet|internet
323618|NCT01560676|School based|school based
323619|NCT01560676|Obesity Prevention Program|obesity prevention program
323620|NCT01560676|Adolescents|adolescents
323621|NCT01560663|Breast Cancer|breast cancer
323622|NCT01560663|Neoadjuvant therapy|neoadjuvant therapy
323623|NCT01560663|Triple negative|triple negative
323624|NCT01560663|predictor of response|predictor of response
323625|NCT01560663|predictor of resistance|predictor of resistance
401843|NCT01234155|GIP|gip
314348|NCT01599897|TB|tb
323626|NCT01560663|Continuous Renal Replacement Therapy|continuous renal replacement therapy
323628|NCT01560650|cardiac surgery associated acute kidney injury|cardiac surgery associated acute kidney injury
323629|NCT01560650|Intensity|intensity
323630|NCT01560637|PAH|pah
323631|NCT01560637|PH|ph
323632|NCT01560637|FREEDOM|freedom
323633|NCT01560637|6 minute walk test|6 minute walk test
323634|NCT01560637|treprostinil|treprostinil
323635|NCT01560637|open label|open label
323636|NCT01560624|PAH|pah
323637|NCT01560624|PH|ph
323638|NCT01560624|Clinical Worsening|clinical worsening
323639|NCT01560624|Freedom|freedom
323640|NCT01560624|Freedom-Ev|freedom-ev
323641|NCT01560624|Treprostinil|treprostinil
323642|NCT01560624|UT-15C|ut-15c
323643|NCT01560624|6 Minute walk test|6 minute walk test
323644|NCT01560598|GERD|gerd
323645|NCT01560598|reflux esophagitis|reflux esophagitis
323646|NCT01560598|adipokine|adipokine
323647|NCT01560598|especially|especially
323648|NCT01560598|endoscopically proven|endoscopically proven
323649|NCT01560585|Isotretinoin|isotretinoin
323650|NCT01560585|Alzheimer's disease|alzheimer's disease
323651|NCT01560585|Dementia|dementia
323652|NCT01560585|Retinoid|retinoid
323653|NCT01560572|kidney transplantation|kidney transplantation
323654|NCT01560572|immunosuppression|immunosuppression
323655|NCT01560572|steroids|steroids
323656|NCT01560572|tacrolimus OD|tacrolimus od
323657|NCT01560559|Primary esophageal achalasia|primary esophageal achalasia
323658|NCT01560559|endoscopic myotomy|endoscopic myotomy
323659|NCT01560559|high resolution manometry|high resolution manometry
323660|NCT01560520|acute ischemic stroke|acute ischemic stroke
323661|NCT01560520|accelerometer|accelerometer
323662|NCT01560481|metformin glycinate|metformin glycinate
323663|NCT01560481|pharmacokinetics|pharmacokinetics
323664|NCT01560481|pharmacodynamics|pharmacodynamics
323665|NCT01560468|Hepatitis C Virus Infection|hepatitis c virus infection
323666|NCT01560468|Liver Transplantation|liver transplantation
323667|NCT01560455|stent|stent
323668|NCT01560455|bifurcation|bifurcation
323669|NCT01560455|coronary|coronary
323670|NCT01560442|Analgesics, opioids|analgesics, opioids
323671|NCT01560442|Opiate substitution treatment|opiate substitution treatment
323672|NCT01560442|Methadone|methadone
323673|NCT01560442|Buprenorphine|buprenorphine
323674|NCT01560442|Hyperalgesia|hyperalgesia
323675|NCT01560442|Pupil|pupil
323676|NCT01560442|Pain|pain
323677|NCT01560442|Psychophysics|psychophysics
323678|NCT01560442|previous illicit drug intake, under a substitution program|previous illicit drug intake, under a substitution program
323679|NCT01560429|anesthesia and analgesia|anesthesia and analgesia
323680|NCT01560429|Epidural Anesthesia|epidural anesthesia
323681|NCT01560429|administration schedules, drug|administration schedules, drug
323682|NCT01560416|Metastatic|metastatic
323683|NCT01560416|HR positive|hr positive
323684|NCT01560416|ER positive|er positive
323685|NCT01560403|Short bowel syndrome|short bowel syndrome
323686|NCT01560403|Parenteral nutrition|parenteral nutrition
323687|NCT01560403|PN|pn
323688|NCT01560403|HPN|hpn
323689|NCT01560403|TPN|tpn
323690|NCT01560403|SBS|sbs
323691|NCT01560390|Sedation|sedation
323692|NCT01560390|ICU|icu
323693|NCT01560390|Ketamine|ketamine
323694|NCT01560390|Confusion|confusion
323695|NCT01560390|Hyperalgesia|hyperalgesia
323696|NCT01560377|Laparoscopic low anterior colon resection|laparoscopic low anterior colon resection
323697|NCT01560377|Laparoscopic left colectomy|laparoscopic left colectomy
323698|NCT01560377|Colectomy|colectomy
323699|NCT01560377|Rectal cancer|rectal cancer
323700|NCT01560377|Colon cancer|colon cancer
323701|NCT01560377|Crohn's Disease|crohn's disease
323702|NCT01560377|Polyp|polyp
323703|NCT01560377|Procidentia|procidentia
323704|NCT01560377|Diverticulitis|diverticulitis
323705|NCT01560364|Renal replacement therapy|renal replacement therapy
323706|NCT01560364|Hemofilter clotting|hemofilter clotting
323707|NCT01560364|Clotting risk factor|clotting risk factor
323708|NCT01560364|Hemofilter clotting prevention|hemofilter clotting prevention
323709|NCT01560351|Pathological gambling|pathological gambling
323710|NCT01560351|craving|craving
323711|NCT01560351|repeated Transcranial Magnetic Stimulation|repeated transcranial magnetic stimulation
323712|NCT01560351|craving cues|craving cues
323713|NCT01560338|Pharmacokinetics|pharmacokinetics
323714|NCT01560338|Midazolam|midazolam
323715|NCT01560338|Morphine|morphine
323716|NCT01560338|Cardiac Arrest|cardiac arrest
323717|NCT01560338|Hypothermia|hypothermia
323718|NCT01560325|Solid Tumor, Tubulin inhibitor|solid tumor, tubulin inhibitor
323719|NCT01560312|Renal denervation|renal denervation
323720|NCT01560312|Resistant hypertension|resistant hypertension
323721|NCT01560312|Spironolactone|spironolactone
323722|NCT01560312|Long-term Outcome|long-term outcome
323723|NCT01560299|hyperthyroidism|hyperthyroidism
323724|NCT01560299|radio-iodine|radio-iodine
323726|NCT01560299|methimazole|methimazole
401871|NCT01234012|sarcoma|sarcoma
324836|NCT01555892|LMP|lmp
323727|NCT01560299|graves disease|graves disease
323728|NCT01560286|PKU|pku
323729|NCT01560286|Injections|injections
323730|NCT01560286|PEG-PAL|peg-pal
323731|NCT01560286|PAL|pal
323732|NCT01560247|Stroke|stroke
323733|NCT01560247|Ischemic Stroke|ischemic stroke
323734|NCT01560247|Revascularization|revascularization
323735|NCT01560247|Mechanical thrombectomy|mechanical thrombectomy
323736|NCT01560247|Neurothrombectomy|neurothrombectomy
323737|NCT01560234|Safety|safety
323738|NCT01560234|tolerability|tolerability
323739|NCT01560234|healthy|healthy
323740|NCT01560234|pharmacokinetic|pharmacokinetic
323741|NCT01560234|pharmacodynamic|pharmacodynamic
323742|NCT01560234|inhaled|inhaled
323743|NCT01560208|infectious keratitis|infectious keratitis
323744|NCT01560208|infective keratitis|infective keratitis
323745|NCT01560208|prospective multicentre study|prospective multicentre study
323746|NCT01560208|Asia|asia
323747|NCT01560195|neutropenia|neutropenia
323748|NCT01560195|febrile neutropenia|febrile neutropenia
323749|NCT01560195|chemotherapy|chemotherapy
323750|NCT01560182|Lentiviral vector|lentiviral vector
323751|NCT01560182|Metachromatic Leukodystrophy|metachromatic leukodystrophy
323752|NCT01560182|Gene Therapy|gene therapy
323753|NCT01560169|Celiac Disease|celiac disease
323754|NCT01560169|Coeliac Disease|coeliac disease
323755|NCT01560169|Celiac Sprue|celiac sprue
323756|NCT01560169|Keilakia Disease|keilakia disease
323757|NCT01560117|AGMT|agmt
323758|NCT01560117|NHL|nhl
323759|NCT01560104|Randomized|randomized
323760|NCT01560104|metastatic|metastatic
323761|NCT01560104|ABT-888|abt-888
323762|NCT01560104|paclitaxel|paclitaxel
323763|NCT01560104|non-small cell lung cancer|non-small cell lung cancer
323764|NCT01560104|PARP|parp
323765|NCT01560104|veliparib|veliparib
323766|NCT01560104|progression free survival|progression free survival
323767|NCT01560104|carboplatin|carboplatin
323768|NCT01560091|clearance rate|clearance rate
323769|NCT01560078|Tuberculosis|tuberculosis
323770|NCT01560078|Pleural effusion|pleural effusion
323771|NCT01560078|Category 3|category 3
323772|NCT01560052|end stage kidney disease|end stage kidney disease
323773|NCT01560052|IgA nephropathy|iga nephropathy
323774|NCT01560039|Neuropathic pain|neuropathic pain
323775|NCT01560039|neurostimulation|neurostimulation
323776|NCT01560026|ovarian preservation|ovarian preservation
323777|NCT01560013|Alcohol|alcohol
323778|NCT01560013|naltrexone|naltrexone
323779|NCT01560013|cue reactivity|cue reactivity
323780|NCT01560013|PET|pet
323781|NCT01560000|The focus of this study is to determine satiety|the focus of this study is to determine satiety
323782|NCT01559987|plaque removal methods|plaque removal methods
323783|NCT01559987|oral hygiene devices|oral hygiene devices
323784|NCT01559974|Peripheral arterial disease|peripheral arterial disease
323785|NCT01559974|PAOD|paod
323786|NCT01559974|Vitamin D|vitamin d
323787|NCT01559974|Walking impairment|walking impairment
323788|NCT01559961|bladder|bladder
323789|NCT01559961|cystitis|cystitis
323790|NCT01559961|frequency|frequency
323791|NCT01559961|nocturia|nocturia
323792|NCT01559961|pain|pain
323793|NCT01559961|urgency|urgency
323794|NCT01559948|Low back pain|low back pain
323795|NCT01559948|Sacroiliac joint pain|sacroiliac joint pain
323796|NCT01559948|Lumbopelvic stabilization program|lumbopelvic stabilization program
323797|NCT01559948|Pelvic compression belt|pelvic compression belt
323798|NCT01559948|Deep abdominal muscles|deep abdominal muscles
323799|NCT01559935|Multiple Myeloma|multiple myeloma
323800|NCT01559922|Acne|acne
323801|NCT01559909|Lower limb loss|lower limb loss
323802|NCT01559909|Leg amputation|leg amputation
323803|NCT01559909|walking study|walking study
323804|NCT01559909|socket technology|socket technology
323805|NCT01559896|egg protein hydrolysate|egg protein hydrolysate
323806|NCT01559883|cancer|cancer
323807|NCT01559883|thrombosis|thrombosis
323808|NCT01559883|pulmonary embolism|pulmonary embolism
323809|NCT01559883|anticoagulation|anticoagulation
323810|NCT01559883|low molecular weight heparin|low molecular weight heparin
323811|NCT01559870|cardiac surgery|cardiac surgery
323812|NCT01559870|cytokine|cytokine
323813|NCT01559870|clinical scoring system|clinical scoring system
323814|NCT01559870|risk factor|risk factor
323815|NCT01559857|Depression|depression
323816|NCT01559857|Insulin resistance|insulin resistance
323817|NCT01559857|Mood disorder|mood disorder
323818|NCT01559844|Hepatitis|hepatitis
323819|NCT01559844|Chronic|chronic
323820|NCT01559844|hepatocellular carcinoma|hepatocellular carcinoma
323821|NCT01559844|HCC|hcc
323822|NCT01559844|transplant|transplant
323823|NCT01559831|Japanese Encephalitis|japanese encephalitis
323824|NCT01559831|IXIARO|ixiaro
323825|NCT01559831|Japanese Encephalitis Vaccine|japanese encephalitis vaccine
323826|NCT01559805|HIV|hiv
323827|NCT01559805|Viral Load|viral load
323828|NCT01559805|Risk|risk
323829|NCT01559805|Patient Compliance|patient compliance
323830|NCT01559805|Homosexuality, Male|homosexuality, male
323831|NCT01559805|Anti-Retroviral Agents|anti-retroviral agents
323832|NCT01559779|Obesity|obesity
323833|NCT01559779|Roux-en-Y gastric bypass|roux-en-y gastric bypass
323834|NCT01559779|Incretin hormones|incretin hormones
323835|NCT01559779|Beta cell function|beta cell function
323836|NCT01559766|Vitamin A|vitamin a
323837|NCT01559766|Dietary requirement|dietary requirement
323838|NCT01559766|Dietary records|dietary records
323839|NCT01559766|Deuterated retinol dilution technique|deuterated retinol dilution technique
323840|NCT01559766|Chinese children|chinese children
323841|NCT01559766|Dietary intake of vitamin A|dietary intake of vitamin a
323842|NCT01559766|Vitamin A liver reserves|vitamin a liver reserves
323843|NCT01559753|Antibiotic|antibiotic
323844|NCT01559753|treatment|treatment
323845|NCT01559753|ventilator associated pneumonia|ventilator associated pneumonia
323846|NCT01559753|duration|duration
323847|NCT01559740|regional anesthesia|regional anesthesia
323848|NCT01559740|children|children
323849|NCT01559740|postoperative pain relief|postoperative pain relief
323850|NCT01559727|heart failure|heart failure
323851|NCT01559727|diuresis|diuresis
323852|NCT01559727|prednisone|prednisone
323853|NCT01559714|Troponin|troponin
323854|NCT01559714|Exercise|exercise
323856|NCT01559701|Safety|safety
323857|NCT01559701|PF-00345439|pf-00345439
323858|NCT01559701|Remoxy|remoxy
323859|NCT01559701|PTI-821|pti-821
323860|NCT01559675|Corticosteroids|corticosteroids
323861|NCT01559675|perioperative|perioperative
323862|NCT01559675|colorectal surgery|colorectal surgery
323863|NCT01559662|chewing gum|chewing gum
323864|NCT01559662|ileus|ileus
323865|NCT01559662|gastrointestinal function|gastrointestinal function
323866|NCT01559662|colorectal surgery|colorectal surgery
323867|NCT01559662|abdominal surgery|abdominal surgery
323868|NCT01559649|Stroke|stroke
323869|NCT01559649|Deglutition|deglutition
323870|NCT01559649|Deglutition Disorders|deglutition disorders
323871|NCT01559649|Nurse Screening|nurse screening
323872|NCT01559636|seroconversion|seroconversion
323873|NCT01559636|oral polio vaccine|oral polio vaccine
323874|NCT01559636|OPV|opv
323875|NCT01559636|poliomyelitis|poliomyelitis
323876|NCT01559636|diarrhea|diarrhea
323877|NCT01559636|seroimmunity|seroimmunity
323878|NCT01559610|cardiac surgery|cardiac surgery
323879|NCT01559610|orientation|orientation
323880|NCT01559610|nursing|nursing
323881|NCT01559597|controlled temperature chain|controlled temperature chain
323882|NCT01559597|outside the cold chain|outside the cold chain
323883|NCT01559597|vaccination|vaccination
323884|NCT01559597|prevention of mother to child transmission|prevention of mother to child transmission
323885|NCT01559584|Alopecia|alopecia
323886|NCT01559584|Areata|areata
323887|NCT01559584|Phototherapy|phototherapy
323888|NCT01559584|Phototoxic|phototoxic
323889|NCT01559584|Ultraviolet A|ultraviolet a
323890|NCT01559584|Randomized controlled trial|randomized controlled trial
323891|NCT01559584|Interferon gamma|interferon gamma
323892|NCT01559584|Transforming growth factor beta-1|transforming growth factor beta-1
323893|NCT01559584|Insulin like growth factor-1|insulin like growth factor-1
323894|NCT01559571|Retinopathy of Prematurity|retinopathy of prematurity
323895|NCT01559545|Clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
323896|NCT01559545|Metronidazole|metronidazole
323897|NCT01559545|CDAD|cdad
323898|NCT01559532|Deep vein thrombosis|deep vein thrombosis
323899|NCT01559532|Thromboembolism|thromboembolism
323900|NCT01559532|Tourniquet|tourniquet
323901|NCT01559532|Knee prosthesis.|knee prosthesis.
323902|NCT01559519|TIPS|tips
323903|NCT01559519|albumin|albumin
323904|NCT01559519|hepatic encephalopathy|hepatic encephalopathy
323905|NCT01559519|hyponatremia|hyponatremia
323906|NCT01559519|hypovolemia|hypovolemia
323907|NCT01559519|cirrhosis|cirrhosis
323908|NCT01559506|CFU|cfu
323909|NCT01559506|surgery site|surgery site
323910|NCT01559493|atherosclerotic lesion assessment|atherosclerotic lesion assessment
323911|NCT01559480|Endometriosis|endometriosis
323912|NCT01559480|Desogestrel|desogestrel
323913|NCT01559480|Placebo|placebo
323914|NCT01559467|Myocardial infarction|myocardial infarction
323915|NCT01559467|Randomized Controlled Trial|randomized controlled trial
323916|NCT01559467|Magnetic Resonance Imaging|magnetic resonance imaging
323917|NCT01559467|Coronary Angiography|coronary angiography
323918|NCT01559467|Tomography, X-Ray Computed|tomography, x-ray computed
323919|NCT01559467|Mortality|mortality
323920|NCT01559467|Complications|complications
323921|NCT01559467|Quality of Life|quality of life
323922|NCT01559467|Cost-Benefit Analysis|cost-benefit analysis
323923|NCT01559454|chronic pain|chronic pain
323924|NCT01559454|opioid dependence|opioid dependence
323925|NCT01559454|methadone|methadone
323926|NCT01559454|buprenorphine|buprenorphine
323927|NCT01559454|substance use disorder|substance use disorder
323928|NCT01559441|beetroot juice|beetroot juice
323929|NCT01559441|nitrate|nitrate
323930|NCT01559441|vascular activity|vascular activity
323931|NCT01559441|postprandial state|postprandial state
323932|NCT01559428|Plant sterols|plant sterols
323933|NCT01559428|Plant stanols|plant stanols
323934|NCT01559428|Oxyphytosterols|oxyphytosterols
323935|NCT01559428|Cardiovascular Disease|cardiovascular disease
323937|NCT01559389|Urge Urinary Incontinence|urge urinary incontinence
323938|NCT01559389|Vesicare|vesicare
323939|NCT01559389|Urinary Incontinence|urinary incontinence
323940|NCT01559389|Sexual function|sexual function
323941|NCT01559350|OPCAB|opcab
323942|NCT01559337|defect|defect
323943|NCT01559337|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
323944|NCT01559337|proper digital nerve|proper digital nerve
402055|NCT01233336|ACS,|acs,
323945|NCT01559337|nerve transfer|nerve transfer
323946|NCT01559337|finger sensory reconstruction|finger sensory reconstruction
323947|NCT01559311|Bradycardia|bradycardia
323948|NCT01559298|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
323949|NCT01559298|Antithrombotic treatment|antithrombotic treatment
323950|NCT01559298|Clopidogrel|clopidogrel
323952|NCT01559298|Myocardial Infarction|myocardial infarction
323953|NCT01559298|Ischemic stroke|ischemic stroke
323954|NCT01559298|Major bleeding|major bleeding
323955|NCT01559285|epidural, local, ropivacaine|epidural, local, ropivacaine
323956|NCT01559285|epidural administration|epidural administration
323957|NCT01559285|stroke volume variability|stroke volume variability
323958|NCT01559272|Schizophrenia|schizophrenia
323959|NCT01559272|Paliperidone palmitate|paliperidone palmitate
323960|NCT01559272|R092670|r092670
323961|NCT01559272|Paliperidone|paliperidone
323962|NCT01559272|3-month formulation|3-month formulation
323963|NCT01559272|Pharmacokinetics|pharmacokinetics
323964|NCT01559259|ibuprofen|ibuprofen
323965|NCT01559259|acetaminophen|acetaminophen
323966|NCT01559259|pain|pain
323967|NCT01559259|molar extraction|molar extraction
323968|NCT01559246|Cardiac Arrhythmia Monitoring|cardiac arrhythmia monitoring
323969|NCT01559246|Holter Monitoring|holter monitoring
323970|NCT01559246|Continuous ECG monitoring|continuous ecg monitoring
323971|NCT01559246|Event monitoring|event monitoring
323972|NCT01559246|Observational|observational
323973|NCT01559207|nucleosome|nucleosome
323974|NCT01559207|plasma nucleosome concentrations|plasma nucleosome concentrations
323975|NCT01559207|free DNA|free dna
323976|NCT01559207|plasma free DNA concentrations|plasma free dna concentrations
323977|NCT01559181|Offspring of mothers with type 1 diabetes|offspring of mothers with type 1 diabetes
323978|NCT01559181|Pregnancy and programing|pregnancy and programing
323979|NCT01559181|Intrauterine hyperglycaemia|intrauterine hyperglycaemia
323980|NCT01559181|Study focuses on offspring of mothers with type 1 diabetes|study focuses on offspring of mothers with type 1 diabetes
323981|NCT01559155|proteasomes|proteasomes
323982|NCT01559155|proteasome concentration|proteasome concentration
323983|NCT01559155|disease activity|disease activity
323984|NCT01559155|proteolytic activity|proteolytic activity
323985|NCT01559155|autoantibodies|autoantibodies
323986|NCT01559155|proteasome autoantibody|proteasome autoantibody
323987|NCT01559142|Crohn Disease|crohn disease
323988|NCT01559142|infliximab|infliximab
323989|NCT01559142|azathioprine|azathioprine
323990|NCT01559103|Rheumatoid Arthritis|rheumatoid arthritis
323991|NCT01559103|Phase I|phase i
323992|NCT01559103|Biologic|biologic
323993|NCT01559090|Japan|japan
323994|NCT01559090|Phase2|phase2
323995|NCT01559090|Safety|safety
323996|NCT01559090|Tolerability|tolerability
323997|NCT01559090|Systemic Lupus Erythematosus|systemic lupus erythematosus
323998|NCT01559090|SLE, MEDI-546|sle, medi-546
323999|NCT01559077|ATTR|attr
324000|NCT01559051|COPD|copd
324001|NCT01559051|Pulmonary|pulmonary
324002|NCT01559051|Lungs|lungs
324003|NCT01559038|Assessing Effectiveness in Psoriatic Arthritis|assessing effectiveness in psoriatic arthritis
324004|NCT01559025|Type 1 diabetes|type 1 diabetes
324005|NCT01559025|Vildagliptin|vildagliptin
324006|NCT01559025|Galvus|galvus
324007|NCT01559012|Hyperemesis Gravidarum|hyperemesis gravidarum
324008|NCT01559012|treatment|treatment
324009|NCT01559012|transdermal clonidine|transdermal clonidine
324010|NCT01558986|Antibiotic prophylaxis|antibiotic prophylaxis
324011|NCT01558986|surgical site infection|surgical site infection
324012|NCT01558986|modified radical mastectomy|modified radical mastectomy
324013|NCT01558986|Prevention of surgical site infection (SSI) in patients undergoing MRM for breast cancer|prevention of surgical site infection (ssi) in patients undergoing mrm for breast cancer
324014|NCT01558960|Retinoblastoma|retinoblastoma
324015|NCT01558947|gastric cancer|gastric cancer
324016|NCT01558947|Peri-operative chemotherapy|peri-operative chemotherapy
324017|NCT01558934|lofexidine|lofexidine
324018|NCT01558934|methadone|methadone
324019|NCT01558934|interaction|interaction
324020|NCT01558934|pharmacodynamic|pharmacodynamic
324021|NCT01558934|ECG|ecg
324022|NCT01558934|QTc|qtc
324023|NCT01558921|rectal cancer|rectal cancer
324024|NCT01558921|radiotherapy|radiotherapy
324025|NCT01558921|chemotherapy|chemotherapy
324026|NCT01558921|5x5|5x5
324027|NCT01558921|capecitbine|capecitbine
324028|NCT01558921|oxaliplatin|oxaliplatin
324029|NCT01558921|CAPOX|capox
324030|NCT01558921|FOLFOX|folfox
324031|NCT01558921|folinic acid|folinic acid
324032|NCT01558921|fluorouracil|fluorouracil
324033|NCT01558908|critical limb ischemia|critical limb ischemia
324034|NCT01558895|Infrared ray heat treatment|infrared ray heat treatment
324035|NCT01558895|liver cirrhosis|liver cirrhosis
324036|NCT01558895|refractory ascites|refractory ascites
324037|NCT01558882|Essure|essure
324038|NCT01558882|Change in uterine cytokines|change in uterine cytokines
324039|NCT01558882|Change in uterine natural killer cells|change in uterine natural killer cells
324040|NCT01558882|cytokine|cytokine
324041|NCT01558882|natural killer cell|natural killer cell
324042|NCT01558856|refractory overactive bladder|refractory overactive bladder
324043|NCT01558856|neuromodulation|neuromodulation
324044|NCT01558856|sacral nerves|sacral nerves
324045|NCT01558843|Sodium Management|sodium management
324046|NCT01558843|Neurointensive Care|neurointensive care
324047|NCT01558843|Hyponatremia|hyponatremia
324048|NCT01558830|amiodarone|amiodarone
324049|NCT01558830|ranolazine|ranolazine
324051|NCT01558830|arrhythmia|arrhythmia
324052|NCT01558817|CPR|cpr
324053|NCT01558817|Palliative|palliative
324054|NCT01558817|Outcome|outcome
324055|NCT01558804|Streptococcus pyogenes|streptococcus pyogenes
324056|NCT01558804|Streptococcus|streptococcus
324057|NCT01558791|PTSD|ptsd
324058|NCT01558791|patient education handout|patient education handout
324059|NCT01558765|Rehabilitation|rehabilitation
324060|NCT01558765|Integrated rehabilitation programme|integrated rehabilitation programme
324061|NCT01558765|Exercise training|exercise training
324062|NCT01558765|Psycho-educational care|psycho-educational care
324063|NCT01558752|Total hip replacement|total hip replacement
324064|NCT01558752|Bone mineral density (BMD)|bone mineral density (bmd)
324065|NCT01558739|Ruxolitinib|ruxolitinib
324066|NCT01558739|INC424|inc424
324067|NCT01558739|myelofibrosis|myelofibrosis
324068|NCT01558739|PMF|pmf
324069|NCT01558739|post polycythemia myelofibrosis|post polycythemia myelofibrosis
324070|NCT01558739|PPV MF|ppv mf
324071|NCT01558739|post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
324072|NCT01558739|PET-MF|pet-mf
324073|NCT01558739|Primary Myelofibrosis|primary myelofibrosis
324074|NCT01558739|Polycythemia|polycythemia
324075|NCT01558739|Thrombocythemia|thrombocythemia
324076|NCT01558739|Essential Thrombocytosis|essential thrombocytosis
324077|NCT01558739|myeloproliferative Disorders|myeloproliferative disorders
324078|NCT01558739|Bone Marrow Diseases|bone marrow diseases
324079|NCT01558739|Haematologic Diseases|haematologic diseases
324080|NCT01558739|Blood Coagulation Disorders|blood coagulation disorders
324081|NCT01558739|Blood Platelet Disorders|blood platelet disorders
324082|NCT01558739|Haemorrhagic Disorders|haemorrhagic disorders
324083|NCT01558726|Case Management|case management
324084|NCT01558726|Crack abuse/dependents|crack abuse/dependents
324085|NCT01558726|Evaluation|evaluation
324086|NCT01558726|Inpatient|inpatient
324087|NCT01558726|ASI|asi
324088|NCT01558726|Treatment retention|treatment retention
324089|NCT01558726|Abstinence|abstinence
324090|NCT01558713|parturient|parturient
324091|NCT01558700|osteoarthritis|osteoarthritis
324092|NCT01558700|pain|pain
324093|NCT01558700|brain|brain
324094|NCT01558700|gray matter|gray matter
324095|NCT01558687|Oncology|oncology
324096|NCT01558687|newly diagnosed inoperable glioblastoma|newly diagnosed inoperable glioblastoma
324097|NCT01558687|temolozomide|temolozomide
324098|NCT01558687|radiotherapy|radiotherapy
324099|NCT01558687|dynamic MRI|dynamic mri
324100|NCT01558687|Positron emission tomography|positron emission tomography
324101|NCT01558687|[18]FET tracer|[18]fet tracer
324102|NCT01558687|cilengitide|cilengitide
324103|NCT01558687|World Health Organization [WHO] Grade IV|world health organization [who] grade iv
324104|NCT01558661|axitinib (AG-013736)|axitinib (ag-013736)
324105|NCT01558661|recurrent|recurrent
324106|NCT01558661|metastatic|metastatic
324107|NCT01558661|12-004|12-004
324108|NCT01558648|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
324109|NCT01558648|Open Esophagectomy|open esophagectomy
324110|NCT01558648|Quality of Life|quality of life
324111|NCT01558648|12-003|12-003
324112|NCT01558635|Atrial Fibrillation|atrial fibrillation
324113|NCT01558635|Surgical ablation|surgical ablation
324114|NCT01558635|Maze procedure|maze procedure
324115|NCT01558635|AF|af
324116|NCT01558622|postoperative analgesia|postoperative analgesia
324117|NCT01558622|dexketoprofen trometamol|dexketoprofen trometamol
324118|NCT01558622|tramadol hydrochloride|tramadol hydrochloride
324119|NCT01558622|pethidine|pethidine
324120|NCT01558622|laparoscopic Nissen fundoplication|laparoscopic nissen fundoplication
324121|NCT01555697|Schizophrenia|schizophrenia
324122|NCT01555697|prepulse inhibition|prepulse inhibition
324123|NCT01555697|neurocognition|neurocognition
324124|NCT01555697|working memory|working memory
324125|NCT01555697|memantine|memantine
324126|NCT01555697|MATRICS Consensus Cognitive Battery|matrics consensus cognitive battery
324127|NCT01555684|MS|ms
324128|NCT01555684|CCSVI|ccsvi
324129|NCT01555671|labor,|labor,
324130|NCT01555671|meperidine,|meperidine,
324131|NCT01555671|active phase,|active phase,
324132|NCT01555671|duration of labor|duration of labor
324133|NCT01555658|Long Lesions|long lesions
324134|NCT01555658|Stent Implantation|stent implantation
324135|NCT01555645|Breast cancer|breast cancer
324136|NCT01555645|Stress management|stress management
324137|NCT01555645|Stepped care|stepped care
324138|NCT01555645|Randomized|randomized
324139|NCT01555619|Left heart pacing lead|left heart pacing lead
402056|NCT01233336|HGF,|hgf,
324140|NCT01555619|Cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
324141|NCT01555619|Heart Failure|heart failure
324142|NCT01555619|Quadripolar pacing|quadripolar pacing
324143|NCT01555606|Psoriasis|psoriasis
324144|NCT01555606|Patient-reported outcome|patient-reported outcome
324145|NCT01555606|Quality of Life|quality of life
324146|NCT01555593|COPD|copd
324147|NCT01555593|FeNO|feno
324148|NCT01555593|Bronchial inflammation|bronchial inflammation
324149|NCT01555593|Small airways|small airways
324150|NCT01555593|Decubitus|decubitus
324151|NCT01555580|myasthenia gravis|myasthenia gravis
324152|NCT01555580|autoimmune|autoimmune
324153|NCT01555580|GM-CSF|gm-csf
324155|NCT01555567|muscle|muscle
324156|NCT01555567|quadriceps|quadriceps
324157|NCT01555567|strength|strength
324158|NCT01555554|Post-traumatic stress disorder|post-traumatic stress disorder
324159|NCT01555554|Propranolol|propranolol
324160|NCT01555554|surgery|surgery
324161|NCT01555554|anesthesia|anesthesia
324162|NCT01555541|relapsed|relapsed
324163|NCT01555541|refractory|refractory
324164|NCT01555541|DLBCL|dlbcl
324165|NCT01555541|lymphoma|lymphoma
324166|NCT01555541|B-cell|b-cell
324167|NCT01555541|diffuse|diffuse
324168|NCT01555528|Growth disorders|growth disorders
324169|NCT01555528|Saizen|saizen
324170|NCT01555528|Easypod|easypod
324171|NCT01555528|Growth hormone|growth hormone
324172|NCT01555528|Pediatric subject|pediatric subject
324173|NCT01555489|Pancreatic Neoplasms|pancreatic neoplasms
324174|NCT01555489|Pancreatic Cancer cells|pancreatic cancer cells
324175|NCT01555489|Digestive System Neoplasms|digestive system neoplasms
324176|NCT01555489|Neoplasms by Site|neoplasms by site
324177|NCT01555489|Neoplasms|neoplasms
324178|NCT01555489|Endocrine Gland Neoplasms|endocrine gland neoplasms
324179|NCT01555489|Digestive System Diseases|digestive system diseases
324180|NCT01555489|Pancreatic Diseases|pancreatic diseases
324181|NCT01555489|Endocrine System Diseases|endocrine system diseases
324182|NCT01555489|Ascorbic Acid|ascorbic acid
324183|NCT01555489|Gemcitabine Vitamins|gemcitabine vitamins
324184|NCT01555489|Vitamin C|vitamin c
324185|NCT01555489|Antioxidants|antioxidants
324186|NCT01555489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
324187|NCT01555489|Pharmacologic Actions|pharmacologic actions
324188|NCT01555489|Protective Agents|protective agents
324189|NCT01555489|Physiological Effects of Drugs|physiological effects of drugs
324190|NCT01555489|Micronutrients|micronutrients
324191|NCT01555489|Growth Substances|growth substances
324192|NCT01555489|Erlotinib|erlotinib
324193|NCT01555489|Integrative Medicine|integrative medicine
324194|NCT01555489|Alternative Medicine|alternative medicine
324195|NCT01555489|Complementary Medicine|complementary medicine
324196|NCT01558583|Colon|colon
324197|NCT01558583|Prostate|prostate
324198|NCT01558583|Cancer|cancer
324199|NCT01558544|Ovarian tissue cryopreservation|ovarian tissue cryopreservation
324200|NCT01558544|Ovarian tissue transplantation|ovarian tissue transplantation
324201|NCT01558544|Fertility preservation|fertility preservation
324202|NCT01558544|Risk of premature ovarian failure|risk of premature ovarian failure
324203|NCT01558531|peripheral arterial disease|peripheral arterial disease
324204|NCT01558531|drug-eluting balloon|drug-eluting balloon
324205|NCT01558531|restenosis|restenosis
324206|NCT01558518|Handheld echocardiography|handheld echocardiography
324207|NCT01558518|V-scan|v-scan
324208|NCT01558518|Handheld ultrasound|handheld ultrasound
324209|NCT01558518|Portable ultrasound|portable ultrasound
324210|NCT01558505|critical limb ischemia|critical limb ischemia
324211|NCT01558505|drug-eluting balloon|drug-eluting balloon
324212|NCT01558505|restenosis|restenosis
324213|NCT01558492|Metastatic Castrate Resistant Prostate Cancer|metastatic castrate resistant prostate cancer
324214|NCT01558492|CRPC|crpc
324215|NCT01558479|Parkinson's Disease|parkinson's disease
324216|NCT01558479|Genetics|genetics
324217|NCT01558479|Family Research|family research
324218|NCT01558479|Hereditary Neurodegenerative Diseases|hereditary neurodegenerative diseases
324219|NCT01558466|newborn|newborn
324221|NCT01558466|Sildenafil|sildenafil
324222|NCT01558466|PPHN|pphn
324223|NCT01558440|Nutrition rehabilitation|nutrition rehabilitation
324224|NCT01558440|severe malnutrition|severe malnutrition
324225|NCT01558440|infant formula|infant formula
324226|NCT01558440|F-100|f-100
324227|NCT01558414|Cholecystectomy|cholecystectomy
324228|NCT01558414|Minimally invasive surgery|minimally invasive surgery
402483|NCT01231113|Ghana|ghana
324229|NCT01558414|Laparoscopic surgery|laparoscopic surgery
324230|NCT01558414|Single incision surgery|single incision surgery
324231|NCT01558401|physical activity|physical activity
324232|NCT01558401|elderly|elderly
324233|NCT01558401|women|women
324234|NCT01558401|efficiency|efficiency
324235|NCT01558362|myocardial perfusion imaging|myocardial perfusion imaging
324236|NCT01558362|single photon emission tomography|single photon emission tomography
324237|NCT01558362|Coronary artery disease|coronary artery disease
324238|NCT01558362|gamma camera imaging|gamma camera imaging
324239|NCT01558362|Phase 1 clinical trial|phase 1 clinical trial
324240|NCT01558362|cyclotron|cyclotron
324241|NCT01558349|Epispot|epispot
324242|NCT01558349|CellSearch|cellsearch
324243|NCT01558349|Circulating melanoma cells|circulating melanoma cells
324244|NCT01558349|circulating cells|circulating cells
324245|NCT01558336|Schistosoma haematobium|schistosoma haematobium
324246|NCT01558336|schoolchildren|schoolchildren
324247|NCT01558336|Central Sudan|central sudan
324248|NCT01558336|Praziquantel|praziquantel
324249|NCT01558323|LCQ908, Renal Impairment, Pharmacokinetics|lcq908, renal impairment, pharmacokinetics
324250|NCT01558284|Irritable bowel syndrome|irritable bowel syndrome
324251|NCT01558284|Neu-P11|neu-p11
324252|NCT01558284|Melatonin|melatonin
324253|NCT01558284|D-IBS|d-ibs
324254|NCT01558271|GLP-1|glp-1
324255|NCT01558245|ischemic stroke; in-stent restenosis; tissue kallikrein;|ischemic stroke; in-stent restenosis; tissue kallikrein;
324256|NCT01558245|the middle cerebral artery; atherosclerotic stenosis|the middle cerebral artery; atherosclerotic stenosis
324257|NCT01558232|Stroke|stroke
324258|NCT01558232|Tibion|tibion
324259|NCT01558232|Bionics|bionics
324260|NCT01558232|Rehab|rehab
324261|NCT01558232|Therapy|therapy
324262|NCT01558232|Robotics|robotics
324263|NCT01558232|Intention|intention
324264|NCT01558219|Metastatic prostate cancer|metastatic prostate cancer
324266|NCT01558206|Emergency bedside ultrasonography|emergency bedside ultrasonography
324267|NCT01558206|pulmonary CT Angiography|pulmonary ct angiography
324268|NCT01558206|Pulmonary Wedge infarction|pulmonary wedge infarction
324269|NCT01558206|Pulmonary Thromboembolism|pulmonary thromboembolism
324270|NCT01558193|Aggression DHA|aggression dha
324271|NCT01558193|Docosahexaenoic acid|docosahexaenoic acid
324272|NCT01558193|Impulsivity|impulsivity
324273|NCT01558193|Minerals|minerals
324274|NCT01558193|Vitamins|vitamins
324275|NCT01558167|Dose limiting toxicity of Lenalidomide|dose limiting toxicity of lenalidomide
324276|NCT01558167|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
324277|NCT01558154|depression|depression
324278|NCT01558154|Chinese herb|chinese herb
324279|NCT01558154|acupuncture|acupuncture
324280|NCT01558154|Psychotherapy|psychotherapy
324281|NCT01558154|Transcranial magnetic stimulation|transcranial magnetic stimulation
324282|NCT01558141|IVF stimulation.|ivf stimulation.
324283|NCT01558141|Poor responders.|poor responders.
324284|NCT01558141|IVF patients with poor response to stimulation|ivf patients with poor response to stimulation
324285|NCT01558115|Columbia University|columbia university
324286|NCT01558115|Primary hyperparathyroidism|primary hyperparathyroidism
324287|NCT01558115|Low bone density|low bone density
324288|NCT01558115|Denosumab|denosumab
324289|NCT01558115|Prolia|prolia
324290|NCT01558102|brain aneurysm PED Pipeline|brain aneurysm ped pipeline
324291|NCT01558076|Sickle cell anemia|sickle cell anemia
324292|NCT01558076|exercise testing|exercise testing
324293|NCT01558076|cardiopulmonary disease|cardiopulmonary disease
324294|NCT01558063|Ketamine|ketamine
324295|NCT01558063|Major Depressive Disorder|major depressive disorder
324296|NCT01558063|Treatment|treatment
324297|NCT01558063|Depression|depression
324298|NCT01558037|transplant|transplant
324299|NCT01558037|solid organ transplant|solid organ transplant
324300|NCT01558037|kidney transplant|kidney transplant
324301|NCT01558037|liver transplant|liver transplant
324302|NCT01558037|pancreas transplant|pancreas transplant
324303|NCT01558037|heart transplant|heart transplant
324304|NCT01558037|CMV|cmv
324305|NCT01558037|Cytomegalovirus|cytomegalovirus
324306|NCT01558024|compression stockings|compression stockings
324307|NCT01558024|physiopathology|physiopathology
324308|NCT01558011|gastric adenocarcinoma|gastric adenocarcinoma
324309|NCT01558011|Capecitabine and oxaliplatin (XELOX)|capecitabine and oxaliplatin (xelox)
324310|NCT01558011|Docetaxel and capecitabine (TX)|docetaxel and capecitabine (tx)
324311|NCT01558011|Using genetic polymorphisms|using genetic polymorphisms
324312|NCT01558011|drug metabolism and immunohistochemical stain|drug metabolism and immunohistochemical stain
324313|NCT01558011|predict the efficacy|predict the efficacy
324314|NCT01557998|Test and linkage to care|test and linkage to care
324315|NCT01557998|Injecting drug user (IDU)|injecting drug user (idu)
324316|NCT01557998|Prevention with positives|prevention with positives
324317|NCT01557998|ART adherence|art adherence
324318|NCT01557998|point of care CD4 counts|point of care cd4 counts
324319|NCT01557998|Peer case management|peer case management
324320|NCT01557998|Conditional cash transfer|conditional cash transfer
315023|NCT01597193|MDV3100|mdv3100
324321|NCT01557985|children|children
324322|NCT01557985|regional anesthesia|regional anesthesia
753314|NCT01176227|gas|gas
324323|NCT01557985|postoperative pain management|postoperative pain management
324324|NCT01557985|local anesthetic solution|local anesthetic solution
324325|NCT01557985|toxicity|toxicity
324326|NCT01557933|ECT|ect
324327|NCT01557933|Bipolar Disorder|bipolar disorder
324328|NCT01557920|apnea|apnea
324329|NCT01557920|airway collapsibility|airway collapsibility
324330|NCT01557920|healthy|healthy
324332|NCT01557920|general anesthesia|general anesthesia
710433|NCT01004731|carboplatin|carboplatin
324333|NCT01557920|breathing-swallow coordination|breathing-swallow coordination
324334|NCT01557920|aspiration|aspiration
324335|NCT01557907|Diabetes|diabetes
324336|NCT01557907|Diabetes Mellitus|diabetes mellitus
324337|NCT01557907|Type 1 diabetes|type 1 diabetes
324338|NCT01557907|Insulin Pump users|insulin pump users
324339|NCT01557907|Intradermal insulin|intradermal insulin
324340|NCT01557894|Social anxiety disorders|social anxiety disorders
324341|NCT01557894|Social phobia|social phobia
324342|NCT01557894|Anxiety sensitivity|anxiety sensitivity
324343|NCT01557894|Irrational thinking|irrational thinking
324344|NCT01557894|Guided self-help|guided self-help
324345|NCT01557894|Internet-delivered treatment|internet-delivered treatment
324346|NCT01557842|Ischemic|ischemic
324347|NCT01557842|Ventricular Tachycardia|ventricular tachycardia
324475|NCT01557426|skin|skin
324348|NCT01557842|Implantable Cardioverter Defibrillators|implantable cardioverter defibrillators
324349|NCT01557842|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
324350|NCT01557842|Ablation|ablation
324351|NCT01557842|Electrophysiology|electrophysiology
324352|NCT01557829|spondylolisthesis|spondylolisthesis
324353|NCT01557829|disc degeneration|disc degeneration
324354|NCT01557829|lumbar interbody fusion|lumbar interbody fusion
324355|NCT01557829|randomized controlled trial|randomized controlled trial
324356|NCT01557829|ceramic interbody spacer|ceramic interbody spacer
324357|NCT01557816|osteoarthritis|osteoarthritis
324358|NCT01557816|knee|knee
324359|NCT01557816|Naproxen|naproxen
324360|NCT01557803|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
324361|NCT01557803|Biomarkers|biomarkers
324362|NCT01557803|HIV|hiv
324363|NCT01557803|ART|art
324364|NCT01557803|predictive factors|predictive factors
324365|NCT01557803|epidemiological pattern|epidemiological pattern
324366|NCT01557803|Gabon|gabon
324367|NCT01557790|Adult male|adult male
324368|NCT01557790|18 years or older|18 years or older
324369|NCT01557790|clinical diagnosis|clinical diagnosis
324370|NCT01557751|Total knee arthroplasty|total knee arthroplasty
324371|NCT01557751|Total knee replacement|total knee replacement
324372|NCT01557751|Genetics of pain|genetics of pain
324373|NCT01557738|Exercise|exercise
324374|NCT01557738|Blood Flow|blood flow
324375|NCT01557738|Nitric Oxide|nitric oxide
324376|NCT01557738|Aging|aging
324377|NCT01557738|Antioxidant|antioxidant
324378|NCT01557738|Flavanol|flavanol
324379|NCT01557738|Young (18-30 yrs)|young (18-30 yrs)
324380|NCT01557738|Aging (60 - 80 yrs)|aging (60 - 80 yrs)
324381|NCT01557725|Knee Replacement, Total|knee replacement, total
324382|NCT01557725|Hip Replacement, Total|hip replacement, total
324383|NCT01557725|Thromboembolism, Venous|thromboembolism, venous
324384|NCT01557725|prophylaxis|prophylaxis
324385|NCT01557725|Enhanced recovery|enhanced recovery
324386|NCT01557686|Cancer Related fatigue|cancer related fatigue
324387|NCT01557686|Quality of Life|quality of life
324388|NCT01557686|Psychosocial Intervention|psychosocial intervention
324389|NCT01557686|Rehabilitation|rehabilitation
324390|NCT01557686|Physical Fitness|physical fitness
324391|NCT01557686|Physical Activity|physical activity
324392|NCT01557686|Exercise Therapy|exercise therapy
324393|NCT01557686|Exercise|exercise
324394|NCT01557686|Hematologic|hematologic
324395|NCT01557686|Hematological|hematological
324396|NCT01557686|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
324397|NCT01557686|Acute Myeloid Leukemia|acute myeloid leukemia
324398|NCT01557686|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
324399|NCT01557686|Acute Leukemia|acute leukemia
324400|NCT01557673|Nasogastric|nasogastric
324401|NCT01557673|Small bowel water|small bowel water
324402|NCT01557673|Diarrhoea|diarrhoea
324403|NCT01557673|Mesenteric blood flow|mesenteric blood flow
324404|NCT01557673|Enteral feeding|enteral feeding
324405|NCT01555476|Pharmacokinetics|pharmacokinetics
324406|NCT01555463|Rosacea|rosacea
324407|NCT01555450|Colorectal cancer screening|colorectal cancer screening
324408|NCT01555450|Social inequalities|social inequalities
324409|NCT01555450|Patient Navigator|patient navigator
324410|NCT01555437|capsule endoscopy scoring index|capsule endoscopy scoring index
324411|NCT01555437|Harvey-Bradshaw index|harvey-bradshaw index
324412|NCT01555437|C-reactive protein|c-reactive protein
324413|NCT01555437|serum albumin|serum albumin
324414|NCT01555437|hemoglobin|hemoglobin
324415|NCT01555424|25-hydroxyvitamin D|25-hydroxyvitamin d
324416|NCT01555424|Institutionalized seniors|institutionalized seniors
324417|NCT01555424|SF-36 survey|sf-36 survey
324418|NCT01555424|Winter|winter
324419|NCT01555411|Cardiovascular epidemiology|cardiovascular epidemiology
753315|NCT01176227|mucous|mucous
324420|NCT01555411|Prospective, observational cohort study|prospective, observational cohort study
324421|NCT01555411|Biomarkers|biomarkers
324422|NCT01555411|Cardio- and cerebrovascular imaging|cardio- and cerebrovascular imaging
324423|NCT01555398|Fenofibric acid|fenofibric acid
324425|NCT01555398|food effect|food effect
324426|NCT01557621|Immunization reminder/recall|immunization reminder/recall
710434|NCT01004731|NSCLC|nsclc
324837|NCT01555892|BARF1|barf1
324427|NCT01557621|Reminder/Recall systems|reminder/recall systems
324428|NCT01557621|Population based Recall|population based recall
324429|NCT01557621|Practice based Recall|practice based recall
324431|NCT01557608|chemotherapy|chemotherapy
324432|NCT01557608|photon stimulation|photon stimulation
324433|NCT01557608|neuropathy|neuropathy
324434|NCT01557608|pain|pain
324435|NCT01557582|IPAH|ipah
324436|NCT01557582|HPAH|hpah
324437|NCT01557582|APAH CTD|apah ctd
324438|NCT01557582|APAH HIV|apah hiv
324439|NCT01557582|APAH PoPH|apah poph
324440|NCT01557582|APAH Drugs/Toxins|apah drugs/toxins
324441|NCT01557582|APAH CHD repaired|apah chd repaired
324442|NCT01557582|APAH CHD unrepaired|apah chd unrepaired
324443|NCT01557569|methamphetamine|methamphetamine
324444|NCT01557569|addiction|addiction
324445|NCT01557569|relapse|relapse
324446|NCT01557569|atomoxetine|atomoxetine
324447|NCT01557556|CRH Antagonist|crh antagonist
324448|NCT01557556|Nicotine|nicotine
324449|NCT01557556|Nicotine Dependence|nicotine dependence
324450|NCT01557556|Smoking|smoking
324451|NCT01557556|Stress|stress
324452|NCT01557543|Coronary Artery Bypass Grafting|coronary artery bypass grafting
324453|NCT01557543|Coronary Artery Disease|coronary artery disease
324454|NCT01557543|Transmyocardial Revascularization|transmyocardial revascularization
324455|NCT01557543|Bone Marrow Stromal Cells|bone marrow stromal cells
324456|NCT01557517|cGVHD|cgvhd
324457|NCT01557517|Oral cGVHD|oral cgvhd
324458|NCT01557517|Topical|topical
324459|NCT01557517|Oral Rinse|oral rinse
324460|NCT01557517|Clobetasol|clobetasol
324461|NCT01557517|Oral Graft-Versus-Host Disease|oral graft-versus-host disease
324462|NCT01557517|GVHD|gvhd
324463|NCT01557491|Alopecia|alopecia
324464|NCT01557491|Coronal Incision|coronal incision
324465|NCT01557491|Scar Quality|scar quality
324466|NCT01557478|breast cancer|breast cancer
324467|NCT01557478|melatonin|melatonin
324468|NCT01557478|adjuvant therapy|adjuvant therapy
324469|NCT01557478|quality of life|quality of life
324470|NCT01557478|pain|pain
324471|NCT01557478|sleep|sleep
324472|NCT01557478|survival|survival
324473|NCT01557478|adverse events|adverse events
324474|NCT01557452|JIA|jia
324476|NCT01557426|soft tissue|soft tissue
324477|NCT01557426|infection|infection
324478|NCT01557426|cellulitis|cellulitis
324479|NCT01557426|abscess|abscess
324480|NCT01557413|Humerus|humerus
324481|NCT01557413|fracture|fracture
324482|NCT01557413|nail|nail
324483|NCT01557413|plate|plate
324484|NCT01557413|tuberosity|tuberosity
324485|NCT01557400|Duchenne muscular dystrophy|duchenne muscular dystrophy
324486|NCT01557400|Becker muscular dystrophy|becker muscular dystrophy
324487|NCT01557400|Nonsense mutation|nonsense mutation
324488|NCT01557400|Premature stop codon|premature stop codon
324490|NCT01557400|BMD|bmd
324491|NCT01557400|nmDBMD|nmdbmd
324492|NCT01557400|DBMD|dbmd
324493|NCT01557400|Ataluren|ataluren
324494|NCT01557400|PTC124|ptc124
324495|NCT01557387|Pseudopolyp|pseudopolyp
324496|NCT01557387|Inflammatory bowel disease|inflammatory bowel disease
324497|NCT01557374|Rheumatoid arthritis|rheumatoid arthritis
324498|NCT01557374|Disease activity|disease activity
324499|NCT01557374|Remission|remission
324500|NCT01557374|Lowest Effective DOse|lowest effective dose
324501|NCT01557374|Abatacept Tocilizumab|abatacept tocilizumab
324502|NCT01557374|ACR-EULAR 2010|acr-eular 2010
324503|NCT01557361|renal replacement therapy|renal replacement therapy
324504|NCT01557361|dialysis|dialysis
324505|NCT01557361|acute kidney injury|acute kidney injury
324506|NCT01557361|hemodialysis|hemodialysis
324507|NCT01557361|critical illness|critical illness
324508|NCT01557335|To evaluate adenosine diphosphate (ADP)-induced platelet aggregation|to evaluate adenosine diphosphate (adp)-induced platelet aggregation
324509|NCT01557309|traumatic rotator cuff tear|traumatic rotator cuff tear
324510|NCT01557309|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
324511|NCT01557309|age|age
324512|NCT01557309|early rotator cuff repair|early rotator cuff repair
324513|NCT01557296|Diet|diet
324514|NCT01557296|Dietary treatment|dietary treatment
324515|NCT01557296|Particle size|particle size
324516|NCT01557296|Gastroparesis|gastroparesis
324517|NCT01557296|Diabetes Mellitus|diabetes mellitus
324518|NCT01557257|single- and multiple-dose pharmacokinetics|single- and multiple-dose pharmacokinetics
324519|NCT01557257|ALO-02|alo-02
324520|NCT01557257|OxyContin|oxycontin
324521|NCT01557244|neurogenic detrusor overactivity|neurogenic detrusor overactivity
324522|NCT01557244|neurogenic bladder|neurogenic bladder
324523|NCT01557244|neuropathic bladder|neuropathic bladder
324524|NCT01557244|neurologic disease|neurologic disease
324525|NCT01557244|fesoterodine|fesoterodine
324527|NCT01557231|osteoarthritis|osteoarthritis
324528|NCT01557231|pain|pain
324529|NCT01557231|variability|variability
324530|NCT01557231|activity|activity
324531|NCT01557231|treatment|treatment
324532|NCT01557218|Dietary variety|dietary variety
324533|NCT01557218|Vegetable intake|vegetable intake
324534|NCT01557218|Fruit intake|fruit intake
324838|NCT01555892|EBNA1|ebna1
324535|NCT01557205|optical coherence tomography|optical coherence tomography
324536|NCT01557205|cell imaging|cell imaging
324537|NCT01557192|Depression|depression
324538|NCT01557192|Bipolar Depression|bipolar depression
324539|NCT01557192|LFMS|lfms
324540|NCT01557192|Electromagnetic Stimulation|electromagnetic stimulation
324542|NCT01557153|Late-life Unremitted Depression|late-life unremitted depression
324543|NCT01557140|Chagas cardiomyopathy,|chagas cardiomyopathy,
324544|NCT01557140|Renin-angiotensin system,|renin-angiotensin system,
324545|NCT01557140|Beta-blockers,|beta-blockers,
324546|NCT01557140|Enalapril,|enalapril,
324547|NCT01557140|Carvedilol,|carvedilol,
324548|NCT01557140|Renin-angiotensin system inhibitors,|renin-angiotensin system inhibitors,
324549|NCT01557140|Brain natriuretic peptide level,|brain natriuretic peptide level,
324550|NCT01557140|Left ventricular ejection fraction,|left ventricular ejection fraction,
324551|NCT01557140|Chemokines|chemokines
324552|NCT01557127|Renal cell carcinoma,|renal cell carcinoma,
324553|NCT01557127|Sorafenib|sorafenib
324554|NCT01557127|Dosing|dosing
324555|NCT01557114|unresectable Stage III or stage IV advanced malignant melanoma|unresectable stage iii or stage iv advanced malignant melanoma
324556|NCT01557088|coronary artery disease|coronary artery disease
324557|NCT01557088|coronary artery spasm|coronary artery spasm
324558|NCT01557088|small vessel coronary artery disease|small vessel coronary artery disease
324559|NCT01557075|High dose statin|high dose statin
324560|NCT01557062|Fibromyalgia|fibromyalgia
324561|NCT01557062|Hydrotherapy|hydrotherapy
324562|NCT01557062|Sleep|sleep
324563|NCT01557062|Pain|pain
324564|NCT01557062|Body Temperature|body temperature
324565|NCT01557049|chronic low back pain|chronic low back pain
324566|NCT01557049|Postural global reeducation|postural global reeducation
324567|NCT01557049|randomized|randomized
324568|NCT01557049|physical rehabilitation|physical rehabilitation
324569|NCT01557036|Brain Aneurysm|brain aneurysm
324570|NCT01556997|Hypertension|hypertension
324571|NCT01556997|Essential Hypertension|essential hypertension
324572|NCT01556984|diabetic foot|diabetic foot
324573|NCT01556984|digital subtraction angiography|digital subtraction angiography
324574|NCT01556984|endothelial function|endothelial function
324575|NCT01556984|Patients with diabetes|patients with diabetes
324576|NCT01556984|Age 40 to 70 years old|age 40 to 70 years old
324577|NCT01556984|Endothelial function are determined|endothelial function are determined
324578|NCT01556945|P. falciparum|p. falciparum
324579|NCT01556945|vaccine|vaccine
324580|NCT01556945|healthy volunteers|healthy volunteers
324581|NCT01556919|GERD|gerd
324582|NCT01556919|Esophagitis|esophagitis
324583|NCT01556893|Flap Creation|flap creation
324584|NCT01556893|Femtosecond Laser|femtosecond laser
324585|NCT01556893|corneal flap prior to LASIK procedure|corneal flap prior to lasik procedure
324586|NCT01556880|Drivers|drivers
324587|NCT01556880|Chinese|chinese
324588|NCT01556880|Short Message Service|short message service
324589|NCT01556880|Cellular Phone|cellular phone
324590|NCT01556867|Umbilical cord care|umbilical cord care
324591|NCT01556867|dry cord care|dry cord care
324592|NCT01556867|antiseptic|antiseptic
324593|NCT01556867|Omphalitis|omphalitis
324594|NCT01556867|umbilical cord drop|umbilical cord drop
324595|NCT01556867|hospitalized in maternity hospital|hospitalized in maternity hospital
324596|NCT01556854|ginkgo leaves|ginkgo leaves
324597|NCT01556854|butylphthalide|butylphthalide
324598|NCT01556854|edaravone|edaravone
324599|NCT01556854|citicoline|citicoline
324600|NCT01556854|cerebrolysin|cerebrolysin
324601|NCT01556854|piracetam|piracetam
324602|NCT01556854|Neuroprotectants|neuroprotectants
324603|NCT01556841|Randomised|randomised
324604|NCT01556841|Controlled|controlled
324605|NCT01556841|Trovax|trovax
324606|NCT01556841|MVA-5T4|mva-5t4
324608|NCT01556841|Immunotherapy|immunotherapy
324609|NCT01556841|Relapsed|relapsed
324610|NCT01556841|Asymptomatic|asymptomatic
324611|NCT01556841|Epithelial|epithelial
324612|NCT01556841|Ovarian|ovarian
324613|NCT01556841|Fallopian|fallopian
324614|NCT01556841|Peritoneal|peritoneal
324615|NCT01556815|Hepatocellular Carcinoma|hepatocellular carcinoma
324616|NCT01556815|Sorafenib|sorafenib
324617|NCT01556815|Transarterial Chemoembolization|transarterial chemoembolization
324618|NCT01556815|HBV|hbv
324619|NCT01556802|stroke|stroke
324620|NCT01556802|sequelaes|sequelaes
324621|NCT01556802|minocicline|minocicline
324622|NCT01556789|ONT-10|ont-10
324623|NCT01556789|MUC1|muc1
324624|NCT01556789|Vaccine|vaccine
324625|NCT01556789|Phase 1|phase 1
324626|NCT01556789|Solid Tumors|solid tumors
324627|NCT01556789|Dose escalation|dose escalation
324628|NCT01556776|CLL|cll
324629|NCT01556776|High Risk|high risk
324630|NCT01556776|Maintenance|maintenance
324631|NCT01556763|Schizophrenia|schizophrenia
324632|NCT01556763|Schizoaffective|schizoaffective
324633|NCT01556763|CNS|cns
324634|NCT01555385|Mental workload|mental workload
324635|NCT01555385|Multitasking|multitasking
324636|NCT01555385|Protein|protein
324637|NCT01555385|Tryptophan|tryptophan
324638|NCT01555372|unstable distal clavicular fractures (Neer 2b)|unstable distal clavicular fractures (neer 2b)
324639|NCT01555372|Study Protocol|study protocol
324640|NCT01555372|Fracture Fixation|fracture fixation
324641|NCT01555346|Down syndrome|down syndrome
324642|NCT01555346|fetal aneuploidy|fetal aneuploidy
324643|NCT01555346|trisomy|trisomy
324644|NCT01555346|noninvasive prenatal test|noninvasive prenatal test
324645|NCT01556737|isoflavone|isoflavone
324646|NCT01556737|supplement|supplement
324647|NCT01556737|daidzein|daidzein
324648|NCT01556737|genistein|genistein
324649|NCT01556737|gene expression|gene expression
324650|NCT01556724|Peripheral nerve blocks|peripheral nerve blocks
324651|NCT01556724|Ropivacaine concentrations in lumbar plexus catheters|ropivacaine concentrations in lumbar plexus catheters
324652|NCT01556724|Postoperative pain|postoperative pain
324653|NCT01556724|Total hip replacement|total hip replacement
324654|NCT01556711|Head Injury|head injury
324655|NCT01556711|Head Trauma|head trauma
324656|NCT01556711|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
324657|NCT01556711|Emergency Department|emergency department
324658|NCT01556698|Acne Vulgaris|acne vulgaris
324659|NCT01556698|Acne|acne
324660|NCT01556672|small bowel lesions|small bowel lesions
324661|NCT01556672|Crohn's Disease|crohn's disease
324662|NCT01556672|Plaque psoriasis|plaque psoriasis
324663|NCT01556672|adalimumab|adalimumab
324664|NCT01556672|capsule endoscopy|capsule endoscopy
324665|NCT01556659|Left ventricular thrombus|left ventricular thrombus
324666|NCT01556659|Acute myocardial infarction|acute myocardial infarction
324667|NCT01556659|Anticoagulation|anticoagulation
324668|NCT01556646|Cirrhosis|cirrhosis
324669|NCT01556646|Hepatic Encephalopathy|hepatic encephalopathy
324670|NCT01556646|Hyponatremia|hyponatremia
324671|NCT01556646|Brain MRI|brain mri
324672|NCT01556646|Health-related quality of life|health-related quality of life
324673|NCT01556646|cognitive function|cognitive function
324674|NCT01556620|PtiO2|ptio2
324675|NCT01556620|NIRS|nirs
324676|NCT01556607|Respiratory Syncytial Virus Infection|respiratory syncytial virus infection
324677|NCT01556607|RSV|rsv
324678|NCT01556594|Hypoglycemia|hypoglycemia
324679|NCT01556594|Diabetes mellitus|diabetes mellitus
324680|NCT01556581|back pain|back pain
324681|NCT01556581|primary care|primary care
324682|NCT01556581|physical therapy|physical therapy
324683|NCT01556568|Noonan Syndrome, hypertrophic cardiomyopathy.|noonan syndrome, hypertrophic cardiomyopathy.
324684|NCT01556555|Sclerosing cholangitis|sclerosing cholangitis
324685|NCT01556555|Spyglass|spyglass
324686|NCT01556555|Endoscopic retrograde cholangiopancreaticography|endoscopic retrograde cholangiopancreaticography
324687|NCT01556542|peripheral arterial disease|peripheral arterial disease
324688|NCT01556542|drug-eluting balloon|drug-eluting balloon
324689|NCT01556542|restenosis|restenosis
324690|NCT01556477|MDS|mds
324691|NCT01556477|AML|aml
324692|NCT01556477|Azacitidine|azacitidine
324693|NCT01556477|Lenalidomide|lenalidomide
324694|NCT01556477|del5q|del5q
324695|NCT01556464|Obstructive sleep apnea|obstructive sleep apnea
324696|NCT01556464|CPAP|cpap
324697|NCT01556412|endoscopic ultrasound|endoscopic ultrasound
324698|NCT01556412|primary sclerosing cholangitis|primary sclerosing cholangitis
324699|NCT01556412|EUS|eus
324700|NCT01556412|cholestatic hepatopathy|cholestatic hepatopathy
324701|NCT01556399|Duodenal adenoma|duodenal adenoma
324702|NCT01556399|Ampullary adenoma|ampullary adenoma
324703|NCT01556386|acute lymphoblastic leukemia|acute lymphoblastic leukemia
324704|NCT01556386|single nucleotide polymorphism|single nucleotide polymorphism
324705|NCT01556373|acute systemic inflammation|acute systemic inflammation
324706|NCT01556373|arterial stiffness|arterial stiffness
324707|NCT01556373|Carotid-femoral pulse wave velocity|carotid-femoral pulse wave velocity
324708|NCT01556360|genetic hemochromatosis|genetic hemochromatosis
324709|NCT01556360|Iron overload|iron overload
324710|NCT01556360|C282 homozygosity|c282 homozygosity
324711|NCT01556347|alloantibody|alloantibody
324712|NCT01556347|immunologic|immunologic
324713|NCT01556347|memory|memory
324714|NCT01556347|heart|heart
324715|NCT01556347|transplant|transplant
324716|NCT01556347|desensitization|desensitization
324717|NCT01556334|premature ruptured membranes|premature ruptured membranes
324718|NCT01556334|azithromycin|azithromycin
324719|NCT01556334|erythromycin|erythromycin
324720|NCT01556334|latency|latency
324721|NCT01556334|antibiotics|antibiotics
315417|NCT01595698|IGF-1|igf-1
324722|NCT01556321|Obesity|obesity
324723|NCT01556321|Body weight|body weight
324724|NCT01556321|Gut flora|gut flora
324725|NCT01556321|Fat absorption|fat absorption
324726|NCT01556308|Dowling Meara|dowling meara
324727|NCT01556308|Epidermolysis bullosa|epidermolysis bullosa
324728|NCT01556308|inflammation|inflammation
324729|NCT01556295|Nurses|nurses
324731|NCT01556295|Gesture behavior|gesture behavior
324732|NCT01556295|Knowlegde|knowlegde
324733|NCT01556282|Hepatocellular Carcinoma|hepatocellular carcinoma
711301|NCT01001377|Panitumumab|panitumumab
324734|NCT01556282|portal vein thrombosis|portal vein thrombosis
324735|NCT01556282|HCC|hcc
324736|NCT01556243|stage IA breast cancer|stage ia breast cancer
324737|NCT01556243|stage IB breast cancer|stage ib breast cancer
324738|NCT01556243|stage II breast cancer|stage ii breast cancer
324841|NCT01555879|Data warehouse|data warehouse
324739|NCT01556243|ductal breast carcinoma in situ|ductal breast carcinoma in situ
324740|NCT01556243|lobular breast carcinoma in situ|lobular breast carcinoma in situ
324741|NCT01556230|pituitary gland|pituitary gland
324742|NCT01556230|pituitary adenoma|pituitary adenoma
324743|NCT01556230|pituitary tumor|pituitary tumor
324744|NCT01556230|hypophysis|hypophysis
324745|NCT01556230|endocrine|endocrine
324746|NCT01556230|neuroendocrine|neuroendocrine
324747|NCT01556230|hormone|hormone
324748|NCT01556217|Healthy volunteers|healthy volunteers
324749|NCT01556217|JNJ-39393406-aaa|jnj-39393406-aaa
324750|NCT01556217|Pharmacokinetics|pharmacokinetics
324751|NCT01556217|Central brain penetrance|central brain penetrance
324752|NCT01556217|Cerebral spinal fluid|cerebral spinal fluid
324753|NCT01556204|Endometriosis|endometriosis
324754|NCT01556191|lung cancer|lung cancer
324755|NCT01556191|women|women
324756|NCT01556178|Hydrocephalus|hydrocephalus
324757|NCT01556178|Survivin|survivin
324758|NCT01556178|miRNA|mirna
324759|NCT01556165|Rasagiline|rasagiline
324760|NCT01556165|Azilect|azilect
324761|NCT01556165|Parkinson´s Disease|parkinson´s disease
324762|NCT01556165|Motor fluctuations|motor fluctuations
324763|NCT01556139|Endurance|endurance
324764|NCT01556139|exercise training|exercise training
324765|NCT01556139|6-min walking test|6-min walking test
324766|NCT01556126|Coronary artery disease|coronary artery disease
324767|NCT01556126|Drug Eluting Stent|drug eluting stent
324768|NCT01556126|All comers patients|all comers patients
324769|NCT01556113|fatty liver|fatty liver
324770|NCT01556113|hypertriglyceridemia|hypertriglyceridemia
324771|NCT01556113|elevated liver enzymes|elevated liver enzymes
324772|NCT01556100|18F-DTBZ AV-133 imaging|18f-dtbz av-133 imaging
324773|NCT01556087|opioids|opioids
324774|NCT01556087|distress tolerance|distress tolerance
324775|NCT01556087|buprenorphine|buprenorphine
324776|NCT01556074|Post traumatic stress disorder|post traumatic stress disorder
324777|NCT01556074|PTSD|ptsd
324778|NCT01556074|Insomnia|insomnia
324779|NCT01556074|Sleep|sleep
324780|NCT01556074|Yoga|yoga
324781|NCT01556074|Meditation|meditation
324782|NCT01556074|Mental Health|mental health
324783|NCT01556074|Sleep Quality|sleep quality
324784|NCT01556074|Actigraphy|actigraphy
324785|NCT01556074|Sleep Diaries|sleep diaries
324786|NCT01556074|Autonomic|autonomic
324787|NCT01556074|Social Health|social health
324788|NCT01556074|Interoception|interoception
324789|NCT01556074|Attention Regulation|attention regulation
324790|NCT01556074|Emotion Regulation|emotion regulation
324791|NCT01556061|Laryngoscopy|laryngoscopy
324792|NCT01556061|Airway Management|airway management
324793|NCT01556061|Intubation|intubation
324794|NCT01556048|Behavior therapy|behavior therapy
324795|NCT01556048|Bereavement|bereavement
324796|NCT01556048|Complicated grief|complicated grief
324797|NCT01556048|Depression|depression
324798|NCT01556048|Posttraumatic Stress Disorder|posttraumatic stress disorder
324799|NCT01556035|oncodermatology|oncodermatology
324800|NCT01556035|hematology|hematology
324801|NCT01556035|cutaneous B cell lymphoma|cutaneous b cell lymphoma
324802|NCT01556035|lenalidomide|lenalidomide
324803|NCT01556022|Ischemic heart disease|ischemic heart disease
324804|NCT01556022|Coronary artery disease|coronary artery disease
324805|NCT01556022|Chronic heart failure|chronic heart failure
324806|NCT01556022|Cardiovascular disease|cardiovascular disease
324807|NCT01556022|Adult stem cells|adult stem cells
324808|NCT01556022|Adipose derived regenerative cells|adipose derived regenerative cells
324809|NCT01556009|Basal Cell Carcinoma|basal cell carcinoma
324810|NCT01556009|Photodynamic Therapy|photodynamic therapy
324811|NCT01555996|older|older
324812|NCT01555996|delirium|delirium
324813|NCT01555996|cognitive status|cognitive status
324814|NCT01555996|occupational therapy|occupational therapy
324815|NCT01555996|critically ill patients|critically ill patients
324816|NCT01555983|cannabis|cannabis
324817|NCT01555983|central neuropathic pain|central neuropathic pain
324818|NCT01555983|analgesia|analgesia
324819|NCT01555970|Obsessive-compulsive disorder|obsessive-compulsive disorder
315501|NCT01595373|Ghrelin|ghrelin
324820|NCT01555970|Treatment|treatment
324821|NCT01555970|Glutamate|glutamate
324822|NCT01555970|N-Acetylcysteine|n-acetylcysteine
324823|NCT01555918|Pharmacokinetics|pharmacokinetics
324824|NCT01555918|Healthy volunteers|healthy volunteers
324825|NCT01555918|Isavuconazole|isavuconazole
324826|NCT01555918|BAL4815|bal4815
324827|NCT01555918|BAL8728|bal8728
324828|NCT01555918|BAL8557|bal8557
324829|NCT01555905|Respiratory Muscle Strength|respiratory muscle strength
324830|NCT01555892|EBV|ebv
324831|NCT01555892|Hodgkin's Lymphoma|hodgkin's lymphoma
711302|NCT01001377|Vectibix|vectibix
324832|NCT01555892|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
324833|NCT01555892|Lymphoma Relapse|lymphoma relapse
324834|NCT01555892|Autologous or Syngeneic Stem Cell Transplant|autologous or syngeneic stem cell transplant
324835|NCT01555892|T/NK-lymphoproliferative disease|t/nk-lymphoproliferative disease
324839|NCT01555879|Retrospective|retrospective
324840|NCT01555879|Database|database
324842|NCT01555879|Data mining|data mining
324843|NCT01555879|Collaborative effectiveness|collaborative effectiveness
324844|NCT01555879|Comparative effectiveness|comparative effectiveness
324845|NCT01555879|Outcome based medicine|outcome based medicine
324846|NCT01555879|Evidence based medicine|evidence based medicine
324847|NCT01555866|isavuconazole|isavuconazole
324848|NCT01555866|BAL4815|bal4815
324849|NCT01555866|BAL8557|bal8557
324850|NCT01555866|BAL8728|bal8728
324851|NCT01555840|Magnetically guided capsule endoscopy (MGCE)|magnetically guided capsule endoscopy (mgce)
324852|NCT01555840|Gastroscopy|gastroscopy
324853|NCT01555827|Retina|retina
324854|NCT01555827|ALzheimer's disease|alzheimer's disease
324855|NCT01555827|neurodegenerative signs|neurodegenerative signs
324856|NCT01555814|dopamine|dopamine
324857|NCT01555814|first episode|first episode
324858|NCT01555814|reward|reward
324859|NCT01555814|cognition|cognition
324860|NCT01555814|MRI|mri
324861|NCT01555814|fMRI|fmri
324862|NCT01555814|PPI|ppi
324863|NCT01555814|P300|p300
324864|NCT01555814|P50 gating|p50 gating
324865|NCT01555814|endophenotypes|endophenotypes
324866|NCT01555801|esophageal cancer|esophageal cancer
324867|NCT01555801|early cancer|early cancer
324868|NCT01555801|ultrasonography (EUS)|ultrasonography (eus)
324869|NCT01555801|stage|stage
324870|NCT01555788|type 1 diabetes,|type 1 diabetes,
324871|NCT01555788|diaport,|diaport,
324872|NCT01555788|artificial pancreas,|artificial pancreas,
324873|NCT01555788|zone mpc algorithm,|zone mpc algorithm,
324874|NCT01555788|ap system,|ap system,
324875|NCT01555788|intraperitoneal insulin|intraperitoneal insulin
324876|NCT01555775|exercise-induced muscle damage|exercise-induced muscle damage
324877|NCT01555775|nutritional recovery|nutritional recovery
324878|NCT01555775|nutritional supplement|nutritional supplement
324879|NCT01555775|natural food|natural food
324880|NCT01555736|allergic rhinitis|allergic rhinitis
324881|NCT01555736|perennial immunotherapy|perennial immunotherapy
324882|NCT01555736|preseasonal immunotherapy|preseasonal immunotherapy
324883|NCT01555307|total hip arthroplasty|total hip arthroplasty
324884|NCT01555307|total knee arthroplasty|total knee arthroplasty
324885|NCT01555307|balance exercises|balance exercises
324886|NCT01555307|force plate|force plate
324887|NCT01555307|berg balance scale|berg balance scale
324888|NCT01555307|timed up and go test|timed up and go test
324889|NCT01555294|(subclinical)atherosclerosis|(subclinical)atherosclerosis
324890|NCT01555294|non-invasive measurements|non-invasive measurements
324891|NCT01555294|intima-media thickness|intima-media thickness
324892|NCT01555294|flow-mediated dilation|flow-mediated dilation
324893|NCT01555294|pulse wave velocity and analysis|pulse wave velocity and analysis
324894|NCT01555294|fatal and non-fatal cardiovascular events|fatal and non-fatal cardiovascular events
324895|NCT01555294|ankle-brachial index (at rest and after exercise)|ankle-brachial index (at rest and after exercise)
324896|NCT01555294|general population|general population
324897|NCT01555294|Familial Combined Hyperlipidemia|familial combined hyperlipidemia
324898|NCT01555281|Multiple Myeloma|multiple myeloma
324899|NCT01555281|Kahler Disease|kahler disease
324900|NCT01555281|Lenalidomide|lenalidomide
324901|NCT01555281|Revlimid|revlimid
324902|NCT01555281|Nelfinavir|nelfinavir
324903|NCT01555281|Viracept|viracept
324904|NCT01555281|Dexamethasone|dexamethasone
324905|NCT01555255|malaria|malaria
324906|NCT01555255|pregnancy|pregnancy
324907|NCT01555255|placental malaria|placental malaria
324908|NCT01555255|malaria in pregnancy|malaria in pregnancy
324909|NCT01555255|birth weight|birth weight
324910|NCT01555255|anemia|anemia
324911|NCT01555242|Advanced Cancer|advanced cancer
324912|NCT01555242|Lymphoma|lymphoma
324913|NCT01555242|Refractory|refractory
324914|NCT01555229|Secretion drainage|secretion drainage
324915|NCT01555229|Ventilator-associated pneumonia|ventilator-associated pneumonia
324916|NCT01555229|Tracheal fibroscopy|tracheal fibroscopy
324917|NCT01555216|Forefoot surgery|forefoot surgery
324918|NCT01555190|myo-inositol|myo-inositol
324919|NCT01555190|folic acid|folic acid
324920|NCT01555177|Peri-operative myocardial infarction|peri-operative myocardial infarction
324921|NCT01555177|Non-ST elevation myocardial infarction|non-st elevation myocardial infarction
324922|NCT01555177|Optical coherence tomography|optical coherence tomography
324923|NCT01555151|Asthma|asthma
324924|NCT01555138|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
324925|NCT01555138|Indacaterol|indacaterol
753316|NCT01176227|cramping|cramping
324926|NCT01555138|Salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
324927|NCT01555125|Psoriasis|psoriasis
324928|NCT01555099|COPD, FEV1, AZD5423|copd, fev1, azd5423
324929|NCT01555086|Lymphadenectomy|lymphadenectomy
324930|NCT01555086|Prostate cancer|prostate cancer
324931|NCT01555060|hemoglobin recovery|hemoglobin recovery
324932|NCT01555060|iron recovery|iron recovery
324933|NCT01555060|iron supplements|iron supplements
324934|NCT01555034|obesity|obesity
324935|NCT01555034|movement therapy|movement therapy
324936|NCT01555034|exercise|exercise
324937|NCT01555034|behaviour|behaviour
324938|NCT01554995|LCB01-0371|lcb01-0371
324939|NCT01554982|Participation Limited|participation limited
324940|NCT01554982|Long Term|long term
324941|NCT01554982|Safety Extension|safety extension
324942|NCT01554956|Plasminogen Deficiency|plasminogen deficiency
324943|NCT01554956|Ligneous Conjunctivitis|ligneous conjunctivitis
324944|NCT01554956|Plasminogen|plasminogen
324945|NCT01554956|Ligneous Conjunctivitis in Plasminogen Deficient Patients|ligneous conjunctivitis in plasminogen deficient patients
324946|NCT01554943|CMF|cmf
324947|NCT01554943|HEC|hec
324948|NCT01554943|EC|ec
324949|NCT01554943|node positive|node positive
324950|NCT01554943|breast cancer|breast cancer
324951|NCT01554930|HFMD|hfmd
324952|NCT01554930|Traditional Chinese Medicine|traditional chinese medicine
324953|NCT01554930|Xiyanping|xiyanping
324954|NCT01554917|Rheumatoid Arthritis|rheumatoid arthritis
324955|NCT01554917|Iguratimod|iguratimod
324956|NCT01554904|Sleep Study|sleep study
324957|NCT01554904|Snoring|snoring
324958|NCT01554904|Sleep Apnea|sleep apnea
324959|NCT01554904|Muscle Laxity|muscle laxity
324960|NCT01554904|Oral Appliance|oral appliance
324961|NCT01554904|Facial Muscles|facial muscles
324962|NCT01554904|Neck Muscles|neck muscles
324963|NCT01554904|Upper Airway|upper airway
324964|NCT01554904|Muscle Strength|muscle strength
324965|NCT01554904|Dynamic Resistance|dynamic resistance
324966|NCT01554904|Oral Exercise|oral exercise
324967|NCT01554904|Facial Toning|facial toning
324968|NCT01554904|Facial Muscle Strength|facial muscle strength
324969|NCT01554904|Strap Muscles of the Neck|strap muscles of the neck
324970|NCT01554904|Apnea-Hypopnea|apnea-hypopnea
324971|NCT01554891|brain injuries, traumatic|brain injuries, traumatic
324972|NCT01554891|military personnel|military personnel
324973|NCT01554891|classification|classification
324974|NCT01554891|diagnosis|diagnosis
324975|NCT01554891|instrumentation|instrumentation
324976|NCT01554878|osteochondral defect of the knee|osteochondral defect of the knee
324977|NCT01554865|obesity|obesity
324978|NCT01554865|men|men
324979|NCT01554865|sexual function|sexual function
324980|NCT01554865|urinary tract symptoms|urinary tract symptoms
324981|NCT01554865|endothelial function|endothelial function
324982|NCT01554865|inflammation|inflammation
324983|NCT01554865|quality of life|quality of life
324984|NCT01554852|myeloma|myeloma
324985|NCT01554852|lenalidomide|lenalidomide
324986|NCT01554852|Revlimid|revlimid
324987|NCT01554852|cyclophosphamide|cyclophosphamide
324988|NCT01554852|dexamethasone|dexamethasone
324989|NCT01554852|bortezomib|bortezomib
324990|NCT01554852|Velcade|velcade
324991|NCT01554852|vorinostat|vorinostat
324992|NCT01554852|Zolinza|zolinza
324993|NCT01554852|stem cell|stem cell
324994|NCT01554852|carfilzomib|carfilzomib
324995|NCT01554852|Kyprolis|kyprolis
324996|NCT01554826|Pediatric influenza vaccine|pediatric influenza vaccine
324997|NCT01554813|Influenza Vaccine, Vaccination,|influenza vaccine, vaccination,
324998|NCT01554800|Lecithin Cholesterol Acyl Transferase|lecithin cholesterol acyl transferase
324999|NCT01554800|LCAT|lcat
325000|NCT01554800|rhLCAT|rhlcat
325001|NCT01554800|Enzyme replacement therapy|enzyme replacement therapy
325002|NCT01554800|High-Density Lipoprotein (HDL)|high-density lipoprotein (hdl)
325003|NCT01554800|Cholesterol|cholesterol
325004|NCT01554800|Cholesterol ester|cholesterol ester
325005|NCT01554800|LCAT Deficiency|lcat deficiency
325006|NCT01554787|After stroke with fatigue|after stroke with fatigue
325007|NCT01554774|COPD|copd
325008|NCT01554774|PVR|pvr
325009|NCT01554761|astigmatism|astigmatism
325010|NCT01554761|pseudophakia|pseudophakia
325011|NCT01554748|total joint arthroplasty|total joint arthroplasty
325012|NCT01554748|thumb|thumb
325013|NCT01554748|trapeziometacarpal joint|trapeziometacarpal joint
325014|NCT01554748|osteoarthritis|osteoarthritis
325015|NCT01554735|obesity|obesity
325016|NCT01554735|men|men
325017|NCT01554735|sexual function|sexual function
325018|NCT01554735|urinary tract symptoms|urinary tract symptoms
315685|NCT01594554|RNA|rna
325019|NCT01554735|endothelial function|endothelial function
325020|NCT01554735|inflammation|inflammation
325021|NCT01554735|quality of life|quality of life
325022|NCT01554722|Ultrasound guidance|ultrasound guidance
325023|NCT01554722|Femoral nerve block|femoral nerve block
325024|NCT01554722|Needle placement|needle placement
325025|NCT01554722|Intraneural needle insertion|intraneural needle insertion
325026|NCT01554709|bypass|bypass
325027|NCT01554709|cannula|cannula
325028|NCT01554696|Rheumatoid Arthritis|rheumatoid arthritis
325029|NCT01554696|ASP015K|asp015k
325030|NCT01554683|Alzheimer's Disease|alzheimer's disease
325032|NCT01554683|Memory|memory
325033|NCT01554683|Executive|executive
325034|NCT01554670|Arthroscopic subacromial decompression|arthroscopic subacromial decompression
325035|NCT01554670|Bipolar radiofrequency|bipolar radiofrequency
325036|NCT01554670|Tendon debridement|tendon debridement
325037|NCT01554670|Shoulder surgery|shoulder surgery
325038|NCT01554657|Pneumonia, Bacterial|pneumonia, bacterial
325039|NCT01554644|Cleansing|cleansing
325040|NCT01554644|Chronic Leg Ulcers|chronic leg ulcers
325041|NCT01554644|Diabetic Patients|diabetic patients
325042|NCT01554631|Bioequivalence|bioequivalence
325043|NCT01554631|Acarbose|acarbose
325045|NCT01554618|exenatide|exenatide
325046|NCT01554618|type 2 diabetes|type 2 diabetes
325047|NCT01554618|GLP-1 receptor agonist|glp-1 receptor agonist
325048|NCT01554592|Heart Failure|heart failure
325049|NCT01554592|Statin withdrawal|statin withdrawal
325050|NCT01554566|honey|honey
325051|NCT01554566|diabetes|diabetes
325052|NCT01554566|lipids|lipids
325053|NCT01554566|c-peptide|c-peptide
325054|NCT01554553|Sleeve gastrectomy|sleeve gastrectomy
325055|NCT01554553|Posterior crural repair|posterior crural repair
325056|NCT01554540|Treprostinil|treprostinil
325057|NCT01554540|Scleroderma|scleroderma
325058|NCT01554540|Iontophoresis|iontophoresis
325059|NCT01554527|polysomnography|polysomnography
325060|NCT01554527|child|child
325061|NCT01554527|continuous positive airway pressure|continuous positive airway pressure
325062|NCT01554527|tonsillectomy|tonsillectomy
325063|NCT01554527|neuropsychological tests|neuropsychological tests
325064|NCT01554527|cognition|cognition
325065|NCT01554527|sleepiness|sleepiness
325066|NCT01554527|behavior|behavior
325067|NCT01554514|ADAMTS13|adamts13
325068|NCT01554514|Rituximab|rituximab
325069|NCT01554514|Thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
325070|NCT01554514|TTP|ttp
325071|NCT01554514|Plasma exchange|plasma exchange
325072|NCT01554501|stress|stress
325073|NCT01554501|self-control|self-control
325074|NCT01554501|emotion regulation|emotion regulation
325075|NCT01554501|health|health
325076|NCT01554488|asthma|asthma
325077|NCT01554488|COPD|copd
325078|NCT01554488|sleep apnea, obstructive|sleep apnea, obstructive
325079|NCT01554475|herbal drugs|herbal drugs
325080|NCT01554475|dietary supplements|dietary supplements
325081|NCT01554475|drug interactions|drug interactions
325082|NCT01554462|Attention|attention
325083|NCT01554462|Cognitive control|cognitive control
325084|NCT01554462|ADHD|adhd
325085|NCT01554462|Healthy|healthy
325086|NCT01554462|EPA|epa
325087|NCT01554462|Eicosapentaenoic acid|eicosapentaenoic acid
325088|NCT01554462|DHA|dha
325089|NCT01554462|Docosahexaenoic acid|docosahexaenoic acid
325090|NCT01554462|PUFA|pufa
325091|NCT01554462|Omega-3|omega-3
325092|NCT01554449|Stroke|stroke
325093|NCT01554449|Upper arm|upper arm
325094|NCT01554449|Rehabilitation|rehabilitation
325095|NCT01554449|Motor function|motor function
325096|NCT01554449|Video games|video games
325097|NCT01554449|Virtual reality|virtual reality
325098|NCT01554449|Occupational Therapy|occupational therapy
325099|NCT01554449|Functional MRI|functional mri
325100|NCT01554436|Smoking|smoking
325101|NCT01554436|Neuropsychology|neuropsychology
325102|NCT01554436|Abstinence|abstinence
325103|NCT01554436|Prognosis|prognosis
325104|NCT01554436|Nicotine Dependence, Cigarettes, with Other Nicotine-induced Disorders|nicotine dependence, cigarettes, with other nicotine-induced disorders
325105|NCT01554423|HIV Prevention Intervention|hiv prevention intervention
325106|NCT01554410|Cervical|cervical
325107|NCT01554410|Carcinoma|carcinoma
325108|NCT01554410|Gemcitabine|gemcitabine
325109|NCT01554410|Gemzar|gemzar
325110|NCT01554410|Cisplatin|cisplatin
325111|NCT01554410|IMRT|imrt
325112|NCT01554410|Radiation|radiation
325113|NCT01554410|External Beam|external beam
325114|NCT01554410|Brachytherapy|brachytherapy
325115|NCT01554397|Cervical|cervical
325116|NCT01554397|Carcinoma|carcinoma
325117|NCT01554397|Cisplatin|cisplatin
325119|NCT01554397|Radiation|radiation
325120|NCT01554397|INTERTECC|intertecc
325121|NCT01554397|International|international
325122|NCT01554397|External Beam|external beam
325123|NCT01554397|Brachytherapy|brachytherapy
325124|NCT01554397|LDR|ldr
325125|NCT01554397|HDR|hdr
325126|NCT01554397|IGRT|igrt
325127|NCT01554397|CBCT|cbct
315785|NCT01594242|proteasome inhibitor|proteasome inhibitor
315795|NCT01594216|Postmenopausal female|postmenopausal female
315796|NCT01594203|Soft Tissue Sarcoma|soft tissue sarcoma
315797|NCT01594203|Pazopanib|pazopanib
315798|NCT01594203|F18-FDG PET/CT|f18-fdg pet/ct
315799|NCT01594177|DAFNE|dafne
315800|NCT01594177|GBG 70|gbg 70
315801|NCT01594177|GBG|gbg
315802|NCT01594177|German Breast Group|german breast group
315804|NCT01594177|Afatinib|afatinib
325128|NCT01554384|Tuberculosis|tuberculosis
325129|NCT01554384|diagnosis|diagnosis
325130|NCT01554384|Xpert MTB/RIF|xpert mtb/rif
325131|NCT01554384|point-of-treatment|point-of-treatment
325132|NCT01554384|randomized controlled trial|randomized controlled trial
325133|NCT01554371|Solid tumor|solid tumor
325134|NCT01554371|Metastatic breast cancer|metastatic breast cancer
325135|NCT01554371|Unresectable or metastatic carcinoma|unresectable or metastatic carcinoma
325136|NCT01554371|Neuropathy|neuropathy
325137|NCT01554371|Eribulin|eribulin
325138|NCT01554371|Cyclophosphamide|cyclophosphamide
325139|NCT01554358|Gestational diabetes mellitus|gestational diabetes mellitus
325140|NCT01554358|Lifestyle intervention|lifestyle intervention
325141|NCT01554332|Motor Cortex Stimulation|motor cortex stimulation
325142|NCT01554332|Neuropathic pain|neuropathic pain
325143|NCT01554319|Antisense oligonucleotide|antisense oligonucleotide
325144|NCT01554319|Asthma|asthma
325145|NCT01554319|Healthy subjects|healthy subjects
325146|NCT01554319|Phase 1|phase 1
325147|NCT01554319|Transcription factor GATA-3|transcription factor gata-3
325148|NCT01554319|Oral inhalation|oral inhalation
325149|NCT01554280|Stricture|stricture
325150|NCT01554280|Dysphagia|dysphagia
325151|NCT01554267|Mastectomy skin flap necrosis|mastectomy skin flap necrosis
325152|NCT01554267|Breast reconstruction|breast reconstruction
325153|NCT01554267|Indocyanine Green Dye|indocyanine green dye
325154|NCT01554254|Cord blood transplant|cord blood transplant
325155|NCT01554254|hematological malignancy|hematological malignancy
325156|NCT01554254|inherited metabolic disease|inherited metabolic disease
325157|NCT01554254|Mucositis|mucositis
325158|NCT01554254|Neutrophil engraftment|neutrophil engraftment
325159|NCT01554254|Platelet recovery|platelet recovery
325160|NCT01554254|Immune reconstitution|immune reconstitution
325161|NCT01554241|vitamin D3|vitamin d3
325162|NCT01554241|D3|d3
325163|NCT01554241|cholecalciferol|cholecalciferol
325164|NCT01554241|25-OH vitamin D|25-oh vitamin d
325165|NCT01554241|elderly|elderly
325166|NCT01554241|nursing home resident|nursing home resident
325167|NCT01554215|parenting|parenting
325168|NCT01554215|child behavior|child behavior
325169|NCT01554215|attachment|attachment
325170|NCT01554202|Alzheimer's disease|alzheimer's disease
325171|NCT01554202|MCI|mci
325172|NCT01554202|genetic|genetic
325173|NCT01554202|AV45-PET|av45-pet
325174|NCT01554176|Current depressive episode|current depressive episode
325175|NCT01554176|moderate to severe|moderate to severe
325176|NCT01554163|Osteoarthritis|osteoarthritis
325177|NCT01554163|Celecoxib|celecoxib
325178|NCT01554163|Etoricoxib|etoricoxib
325179|NCT01554150|Primary Health Care|primary health care
325180|NCT01554150|Mental Health|mental health
325181|NCT01554150|Cognitive Therapy|cognitive therapy
325182|NCT01554124|Meningitis|meningitis
325183|NCT01554124|Neonates|neonates
325184|NCT01554124|Meropenem|meropenem
325185|NCT01554111|Bowel Evacuants|bowel evacuants
325186|NCT01554111|Purgatives|purgatives
325187|NCT01554098|Polyp detection|polyp detection
325188|NCT01554098|Supine|supine
325189|NCT01554098|Colonoscope withdrawal|colonoscope withdrawal
325190|NCT01554098|Patient position|patient position
325191|NCT01554098|Dynamic position change|dynamic position change
325192|NCT01554072|home-based|home-based
325193|NCT01554072|pulmonary rehabilitation|pulmonary rehabilitation
325194|NCT01554072|COPD|copd
325195|NCT01554059|Rectal cancer|rectal cancer
325196|NCT01554059|Adenocarcinoma|adenocarcinoma
325197|NCT01554059|Bevacizumab|bevacizumab
325198|NCT01554059|Chemoradiation|chemoradiation
325199|NCT01554046|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
325200|NCT01554046|Methylphenidate- RITALIN IR (Immediate Release)|methylphenidate- ritalin ir (immediate release)
325201|NCT01554033|European Huntington's Disease Network|european huntington's disease network
325202|NCT01554033|Huntington patients in KOREA|huntington patients in korea
325203|NCT01554020|Blood glucose|blood glucose
325204|NCT01554020|Insulin sensitivity|insulin sensitivity
325205|NCT01554020|Oral glucose tolerance|oral glucose tolerance
325206|NCT01554007|Crohn's disease|crohn's disease
325207|NCT01553981|Interstitial lung disease|interstitial lung disease
325208|NCT01553981|Scleroderma|scleroderma
325209|NCT01553955|PRP,|prp,
325210|NCT01553955|Platelet|platelet
325211|NCT01553955|Manual|manual
325212|NCT01553942|NSCLC|nsclc
325213|NCT01553929|MCI|mci
325214|NCT01553903|Hormonal therapy|hormonal therapy
325215|NCT01553903|Breast Cancer|breast cancer
325216|NCT01553903|AEBS|aebs
325217|NCT01553903|Oxysterols|oxysterols
325218|NCT01553890|SSc= scleroderma|ssc= scleroderma
325219|NCT01553890|ICF+ informed consent form|icf+ informed consent form
325220|NCT01553890|age 18 to 85|age 18 to 85
325221|NCT01553890|healthy|healthy
325222|NCT01553838|prostate biopsy|prostate biopsy
325223|NCT01553838|MRI guided biopsy|mri guided biopsy
325224|NCT01553838|TRUS guided biopsy|trus guided biopsy
325225|NCT01553812|forced oscillation technique|forced oscillation technique
325226|NCT01553812|COPD|copd
325227|NCT01553812|elderly|elderly
325228|NCT01553812|airway resistance|airway resistance
325229|NCT01553812|airtrapping|airtrapping
325230|NCT01553786|T-cell lymphoma|t-cell lymphoma
325231|NCT01553786|CHOp|chop
325232|NCT01553786|lenalidomide|lenalidomide
325233|NCT01553773|Hyaluroic acid|hyaluroic acid
325234|NCT01553773|Estradiol|estradiol
325235|NCT01553773|Isoflavone|isoflavone
325236|NCT01553773|Skin|skin
325237|NCT01553773|Postmenopause|postmenopause
325238|NCT01553760|Cataract|cataract
325239|NCT01553760|TRI-MICS|tri-mics
325240|NCT01553760|ACM|acm
325241|NCT01553760|MICS|mics
325242|NCT01553760|phacoemulsification|phacoemulsification
325243|NCT01553747|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
325538|NCT01552577|Concussion|concussion
325244|NCT01553747|Irritable bowel syndrome|irritable bowel syndrome
325245|NCT01553747|Diarrhea predominant irritable bowel syndrome|diarrhea predominant irritable bowel syndrome
325246|NCT01553747|Colonic diseases|colonic diseases
325247|NCT01553747|Colonic diseases, functional|colonic diseases, functional
325248|NCT01553747|Digestive system disease|digestive system disease
325249|NCT01553747|Gastrointestinal disease|gastrointestinal disease
325250|NCT01553747|Intestinal disease|intestinal disease
325251|NCT01553747|Colonic pseudo-obstruction|colonic pseudo-obstruction
325252|NCT01553747|Diarrhea|diarrhea
325350|NCT01553435|analgesia|analgesia
325253|NCT01553747|Signs and symptoms, Digestive|signs and symptoms, digestive
325254|NCT01553734|QT prolongation|qt prolongation
325255|NCT01553734|Azithromycin|azithromycin
325256|NCT01553734|macrolide|macrolide
325257|NCT01553734|pneumonia|pneumonia
325258|NCT01553734|ECG changes|ecg changes
325259|NCT01553708|Wound healing|wound healing
325260|NCT01553708|Epithelialization|epithelialization
325262|NCT01553695|Touble|touble
325263|NCT01553695|deficit|deficit
325264|NCT01553695|attention|attention
325265|NCT01553695|hyperactivity|hyperactivity
325266|NCT01553695|Touble deficit attention with hyperactivity|touble deficit attention with hyperactivity
325268|NCT01553682|STDs|stds
325269|NCT01553682|African American Females|african american females
325270|NCT01553682|Alcohol|alcohol
325271|NCT01553656|Advanced cancer|advanced cancer
325272|NCT01553656|Metastatic|metastatic
325273|NCT01553656|NSCLC|nsclc
325274|NCT01553643|Huang-Chi-Wu-Wu-Tang|huang-chi-wu-wu-tang
325275|NCT01553643|Intracranial arterial prominent stenosis|intracranial arterial prominent stenosis
325276|NCT01553630|Fractures|fractures
325277|NCT01553630|distal femur fractures|distal femur fractures
325278|NCT01553630|distal tibial fracures|distal tibial fracures
325279|NCT01553604|breast prosthesis implantation|breast prosthesis implantation
325280|NCT01553604|bandages|bandages
325281|NCT01553604|skin colonization|skin colonization
325282|NCT01553604|surgical site infection|surgical site infection
325283|NCT01553604|augmentation mammaplasty|augmentation mammaplasty
325284|NCT01553604|dressing wear time|dressing wear time
325285|NCT01553591|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
325286|NCT01553591|Irritable bowel syndrome|irritable bowel syndrome
325287|NCT01553591|Diarrhea Predominant Irritable Bowel Syndrome|diarrhea predominant irritable bowel syndrome
325288|NCT01553591|Colonic diseases|colonic diseases
325289|NCT01553591|Colonic diseases, functional|colonic diseases, functional
325290|NCT01553591|Digestive system disease|digestive system disease
325291|NCT01553591|Gastrointestinal disease|gastrointestinal disease
325292|NCT01553591|Intestinal disease|intestinal disease
325293|NCT01553591|Colonic pseudo-obstruction|colonic pseudo-obstruction
325294|NCT01553591|Diarrhea|diarrhea
325295|NCT01553591|Signs and symptoms, Digestive|signs and symptoms, digestive
325296|NCT01553565|10 mm in diameter|10 mm in diameter
325297|NCT01553565|antithrombotic agents|antithrombotic agents
325298|NCT01553552|Schistosoma haematobium|schistosoma haematobium
325299|NCT01553552|schistosoma mansoni|schistosoma mansoni
325300|NCT01553552|Anemia|anemia
325301|NCT01553552|Underweight|underweight
325302|NCT01553552|stunting|stunting
325303|NCT01553552|Blastocystis|blastocystis
325304|NCT01553526|International|international
325305|NCT01553526|Multicenter|multicenter
325306|NCT01553526|Observational registry|observational registry
325307|NCT01553526|All-comers open label registry|all-comers open label registry
325308|NCT01553526|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
325309|NCT01553526|Stenting|stenting
325310|NCT01553526|Treatment of Coronary Artery Disease|treatment of coronary artery disease
325311|NCT01553526|Coronary revascularization|coronary revascularization
325312|NCT01553526|Percutaneous Coronary Intervention|percutaneous coronary intervention
325313|NCT01553526|STEMI|stemi
325314|NCT01553526|NSTEMI|nstemi
325315|NCT01553526|Ischemia|ischemia
325316|NCT01553526|Angina|angina
325317|NCT01553526|Subgroups|subgroups
325318|NCT01553526|Acute Myocardial Infarction|acute myocardial infarction
325319|NCT01553526|Diabetes|diabetes
325320|NCT01553526|Small Vessels|small vessels
325321|NCT01553526|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
325322|NCT01553513|PET|pet
325323|NCT01553513|Coronary Artery Disease|coronary artery disease
325324|NCT01553513|Inflammation|inflammation
325325|NCT01553513|Plaque|plaque
325326|NCT01553513|Atherosclerosis|atherosclerosis
325327|NCT01553500|NAFLD|nafld
325328|NCT01553500|insulin resistance|insulin resistance
325329|NCT01553500|children|children
325330|NCT01553487|vibration|vibration
325331|NCT01553487|muscle strength|muscle strength
325332|NCT01553487|bone loss|bone loss
325333|NCT01553487|immobilization|immobilization
325334|NCT01553487|fracture|fracture
325335|NCT01553474|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
325336|NCT01553474|Eye Diseases|eye diseases
325337|NCT01553461|Transplant|transplant
325338|NCT01553461|Umbilical Cord Blood|umbilical cord blood
325340|NCT01553461|Graft Versus Host Disease|graft versus host disease
325341|NCT01553448|disseminated neuroblastoma|disseminated neuroblastoma
325342|NCT01553448|hereditary neuroblastoma|hereditary neuroblastoma
325343|NCT01553448|localized resectable neuroblastoma|localized resectable neuroblastoma
325344|NCT01553448|localized unresectable neuroblastoma|localized unresectable neuroblastoma
325345|NCT01553448|stage 4S neuroblastoma|stage 4s neuroblastoma
325346|NCT01553435|Dextromethorphan|dextromethorphan
325347|NCT01553435|Morphine|morphine
325348|NCT01553435|Fentanyl|fentanyl
325349|NCT01553435|Opioid|opioid
325351|NCT01553435|Efficacy|efficacy
325352|NCT01553422|Intrabdominal Pressure|intrabdominal pressure
325353|NCT01553422|Emergency Bedside Ultrasonography|emergency bedside ultrasonography
325354|NCT01553422|Abdominal Compartment Syndrome|abdominal compartment syndrome
325355|NCT01553409|Hypertension|hypertension
325356|NCT01553409|Ferritin|ferritin
325357|NCT01553409|Phlebotomy|phlebotomy
325358|NCT01553409|Blood donation|blood donation
325360|NCT01553357|Plasma cell leukemia|plasma cell leukemia
325361|NCT01553357|Lenalidomide|lenalidomide
325362|NCT01553357|Dexamethasone|dexamethasone
325363|NCT01553357|Multiple myeloma|multiple myeloma
325364|NCT01553357|Bortezomib|bortezomib
325365|NCT01553357|Stem cell transplantation|stem cell transplantation
325366|NCT01553344|sclerostin|sclerostin
325367|NCT01553344|osteomalacia|osteomalacia
325368|NCT01553344|vitamin D deficiency|vitamin d deficiency
325369|NCT01553331|laparoscopic cholecystectomy|laparoscopic cholecystectomy
325370|NCT01553318|Fibromyalgia|fibromyalgia
325371|NCT01553318|FMS|fms
325372|NCT01553305|exercise programme|exercise programme
325373|NCT01553292|Respiratory distress syndrome|respiratory distress syndrome
325374|NCT01553292|Preterm infants|preterm infants
325375|NCT01553292|Vascular catheter|vascular catheter
325376|NCT01553292|Surfactant|surfactant
325377|NCT01553292|CPAP|cpap
325378|NCT01553292|ECALMIST|ecalmist
325379|NCT01553266|Diabetes Mellitus|diabetes mellitus
325380|NCT01553266|diabetes care|diabetes care
325381|NCT01553266|diabetes self-management education|diabetes self-management education
325382|NCT01553266|primary care physicians|primary care physicians
325383|NCT01553266|interprofessional collaboration|interprofessional collaboration
325384|NCT01553266|diabetes education programs|diabetes education programs
325385|NCT01553266|qualitative|qualitative
325386|NCT01553266|quantitative|quantitative
325387|NCT01553266|implementation|implementation
325388|NCT01553266|evaluation|evaluation
325389|NCT01553266|health services|health services
325390|NCT01553266|coordinated care|coordinated care
325391|NCT01553266|integrated care|integrated care
325392|NCT01553266|patient care processes|patient care processes
325393|NCT01553253|Postcholecystectomy Pain|postcholecystectomy pain
325394|NCT01553253|Chronic Postoperative Pain|chronic postoperative pain
325395|NCT01553253|Visceral Pain|visceral pain
325396|NCT01553253|Referred pain|referred pain
325397|NCT01553253|Somatic pain|somatic pain
325398|NCT01553253|Quantitative Sensory Testing|quantitative sensory testing
325399|NCT01553240|TMS|tms
325400|NCT01553240|functional MRI|functional mri
325401|NCT01553240|Supplementary motor cortex|supplementary motor cortex
325402|NCT01553240|Right Temporoparietal junction( RTPJ)|right temporoparietal junction( rtpj)
325403|NCT01553227|OSAHS: Obstructive Sleep Apnea hypopnea Syndrome|osahs: obstructive sleep apnea hypopnea syndrome
325404|NCT01553227|OHS: Obesity Hypoventilation Syndrome|ohs: obesity hypoventilation syndrome
325405|NCT01553227|Auto-trilevel ventilation|auto-trilevel ventilation
325406|NCT01553227|BiPAP ventilation|bipap ventilation
325407|NCT01553214|Healthy Volunteers|healthy volunteers
325408|NCT01553214|Granulocyte Transfusion|granulocyte transfusion
325409|NCT01553214|Granulocytapheresis|granulocytapheresis
325410|NCT01553214|Leukapheresis|leukapheresis
325411|NCT01553214|Cytokine Stimulation|cytokine stimulation
325412|NCT01553214|Healthy Volunteer|healthy volunteer
325413|NCT01553214|HV|hv
325414|NCT01553201|Quality of Life|quality of life
325415|NCT01553201|Endometriosis|endometriosis
325416|NCT01553201|Botulinum Toxin A|botulinum toxin a
325417|NCT01553201|Pelvic Pain Spasm|pelvic pain spasm
325418|NCT01553201|Chronic Pelvic Pain|chronic pelvic pain
325419|NCT01553188|Anti-Angiogenesis|anti-angiogenesis
325420|NCT01553188|Ang 1|ang 1
325421|NCT01553188|Ang 2|ang 2
325422|NCT01553188|Peptide-Fc fusion protein|peptide-fc fusion protein
325423|NCT01553188|Small Molecule|small molecule
325424|NCT01553175|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
325425|NCT01553175|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
325426|NCT01553162|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
325427|NCT01553162|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
325428|NCT01553136|alcohol-related disorders|alcohol-related disorders
325429|NCT01553136|Cholinergic Drugs|cholinergic drugs
325430|NCT01553136|varenicline|varenicline
325431|NCT01553136|Chantix|chantix
325432|NCT01553123|Leiomyomas|leiomyomas
325433|NCT01553110|Cold|cold
325434|NCT01553110|Acute Rhinosinusitis|acute rhinosinusitis
325435|NCT01553110|Allergic Rhinitis|allergic rhinitis
325436|NCT01553097|Breast Cancer|breast cancer
325437|NCT01553097|Neurocognitive Impairment|neurocognitive impairment
325438|NCT01553097|Quality of Life|quality of life
325439|NCT01553097|Cytokines|cytokines
325440|NCT01553084|Smoking Cessation|smoking cessation
325441|NCT01553084|Smoking|smoking
325442|NCT01553084|Nicotine|nicotine
325443|NCT01553071|Malignancy, Relapsed|malignancy, relapsed
325444|NCT01553071|Chemotherapy, Intravenous|chemotherapy, intravenous
325445|NCT01553058|Psoriasis|psoriasis
325446|NCT01553058|Cardiovascular Disease|cardiovascular disease
325447|NCT01553058|FDG/PET-CT|fdg/pet-ct
325448|NCT01553058|NB-UVB Phototherapy|nb-uvb phototherapy
325449|NCT01553058|Vascular Inflammation|vascular inflammation
325450|NCT01553058|Lipid Biomarkers|lipid biomarkers
325451|NCT01553045|symptom burden|symptom burden
325452|NCT01553045|atrial fibrillation|atrial fibrillation
325453|NCT01553045|biomarkers|biomarkers
325454|NCT01553045|intracardiac pressures|intracardiac pressures
325455|NCT01553032|Immuno-(Chemo-)and Radiotherapy|immuno-(chemo-)and radiotherapy
325456|NCT01553032|Erbitux®|erbitux®
325457|NCT01553032|Skin changes in Head and neck cancer|skin changes in head and neck cancer
325458|NCT01553019|Proton radiation|proton radiation
325459|NCT01553019|Chemotherapy|chemotherapy
325460|NCT01553019|Pancreatic cancer|pancreatic cancer
325461|NCT01553019|Postoperative|postoperative
325462|NCT01553006|rhinosinusitis|rhinosinusitis
325463|NCT01553006|cefditoren pivoxil|cefditoren pivoxil
325464|NCT01552993|prematurity|prematurity
325465|NCT01552993|retinopathy|retinopathy
325466|NCT01552993|pain|pain
325467|NCT01552993|acetaminophen|acetaminophen
325468|NCT01552980|Gastric cancer|gastric cancer
325469|NCT01552980|Adenocarcinoma|adenocarcinoma
325470|NCT01552980|SOX|sox
325471|NCT01552967|Colorectal cancer|colorectal cancer
325472|NCT01552967|Adenocarcinoma|adenocarcinoma
325473|NCT01552967|XELOX|xelox
325474|NCT01552954|hypertension|hypertension
325475|NCT01552954|Chronic kidney disease|chronic kidney disease
325476|NCT01552954|albuminuria|albuminuria
325477|NCT01552954|low salt diet|low salt diet
325478|NCT01552954|Angiotensin II receptor blocker|angiotensin ii receptor blocker
325479|NCT01552941|Vagus Nerve|vagus nerve
325480|NCT01552941|Vagal Nerve Stimulation|vagal nerve stimulation
325481|NCT01552941|Rheumatoid Arthritis|rheumatoid arthritis
325482|NCT01552941|Implantable Medical Device|implantable medical device
325483|NCT01552915|ADHD|adhd
325484|NCT01552902|ADHD|adhd
325485|NCT01552863|pharmacokinetics|pharmacokinetics
325486|NCT01552863|bioavailability|bioavailability
325487|NCT01552863|oxycodone.|oxycodone.
325488|NCT01552850|pharmacokinetics|pharmacokinetics
325489|NCT01552850|relative bioavailability|relative bioavailability
325490|NCT01552850|oxycodone|oxycodone
325491|NCT01552837|Diffusion Tensor Imaging,|diffusion tensor imaging,
325492|NCT01552837|quetiapine|quetiapine
325493|NCT01552837|Bipolar Disorder|bipolar disorder
325494|NCT01552837|hippocampus|hippocampus
325495|NCT01552837|Volume Brain Morphometry|volume brain morphometry
325496|NCT01552837|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
325497|NCT01552837|effect of quetiapine on hippocampal neurogenesis|effect of quetiapine on hippocampal neurogenesis
325498|NCT01552824|LUTO|luto
325499|NCT01552824|posterior urethral valves|posterior urethral valves
325500|NCT01552824|urethral atresia|urethral atresia
325501|NCT01552772|Safety|safety
325502|NCT01552772|Tolerability|tolerability
325503|NCT01552772|Schizophrenia|schizophrenia
325504|NCT01552772|Aripiprazole|aripiprazole
325505|NCT01552759|Appetite Hormones|appetite hormones
325506|NCT01552759|Binge Eating Disorder|binge eating disorder
325507|NCT01552759|Obesity|obesity
325508|NCT01552759|Cortisol|cortisol
325509|NCT01552759|Stress|stress
325510|NCT01552746|Postoperative shoulder pain|postoperative shoulder pain
325511|NCT01552746|Persisting postoperative pain|persisting postoperative pain
325512|NCT01552720|aorta|aorta
325513|NCT01552720|dissection|dissection
325514|NCT01552720|feature|feature
325515|NCT01552707|Spondylolisthesis|spondylolisthesis
325516|NCT01552707|Degenerative discopathy|degenerative discopathy
325517|NCT01552707|Mesenchymal Stem Cells|mesenchymal stem cells
325518|NCT01552707|Bone marrow|bone marrow
325519|NCT01552707|Tissue engineering|tissue engineering
325520|NCT01552707|Spinal fusion|spinal fusion
325521|NCT01552694|cardiometabolic complications|cardiometabolic complications
325522|NCT01552681|baminercept treatment|baminercept treatment
325523|NCT01552668|Clostridium difficile infection|clostridium difficile infection
325524|NCT01552668|fidaxomicin|fidaxomicin
325525|NCT01552655|Dual-time PET/CT|dual-time pet/ct
325526|NCT01552655|Breast cancer recurrence|breast cancer recurrence
325527|NCT01552655|Bone scintigraphy|bone scintigraphy
325528|NCT01552655|CT thorax upper abdomen|ct thorax upper abdomen
325529|NCT01552642|Comprehensive Health Enhancement Support System (CHESS)|comprehensive health enhancement support system (chess)
325530|NCT01552629|Atopic dermatitis|atopic dermatitis
325531|NCT01552629|Atopic eczema|atopic eczema
325532|NCT01552629|Skin Diseases|skin diseases
325534|NCT01552603|glucose sensors|glucose sensors
325535|NCT01552603|artificial pancreas|artificial pancreas
325536|NCT01552603|Diabetes Mellitus|diabetes mellitus
325537|NCT01552577|Post-Concussion Syndrome|post-concussion syndrome
325539|NCT01552577|Brain Injury|brain injury
325540|NCT01552577|TBI|tbi
325541|NCT01552577|Military Personnel|military personnel
325542|NCT01552577|Eye-tracking|eye-tracking
325543|NCT01552577|Neurocognitive Function|neurocognitive function
325544|NCT01552577|Assessment|assessment
325545|NCT01552551|Falls|falls
325546|NCT01552551|exercise|exercise
325547|NCT01552551|safety|safety
325548|NCT01552551|injury|injury
325549|NCT01552551|Older adults|older adults
325550|NCT01552538|Rheumatoid Arthritis|rheumatoid arthritis
325551|NCT01552538|Vagus Nerve|vagus nerve
325552|NCT01552538|Vagal Nerve Stimulation|vagal nerve stimulation
325553|NCT01552525|acute kidney injury|acute kidney injury
325554|NCT01552525|asymmetric dimethylarginine|asymmetric dimethylarginine
325555|NCT01552525|symmetric dimethylarginine|symmetric dimethylarginine
325556|NCT01552525|l-arginine|l-arginine
325557|NCT01552525|arterial stiffness|arterial stiffness
325558|NCT01552525|augmentation index|augmentation index
325559|NCT01552525|pulse wave velocity|pulse wave velocity
325560|NCT01552512|Stunting|stunting
325561|NCT01552512|Hidden Hunger|hidden hunger
325562|NCT01552512|Diarrhea|diarrhea
325563|NCT01552512|Vitamin A Deficiency|vitamin a deficiency
325564|NCT01552486|chiropractic|chiropractic
325565|NCT01552486|manipulation|manipulation
325566|NCT01552486|radiculopathy|radiculopathy
325567|NCT01552486|sciatica|sciatica
325568|NCT01552486|lumbar|lumbar
325569|NCT01552486|disc|disc
325570|NCT01552486|herniation|herniation
325571|NCT01552486|protrusion|protrusion
325572|NCT01552473|TBI|tbi
325573|NCT01552473|Traumatic Brain Injury|traumatic brain injury
325574|NCT01552473|combat related injury|combat related injury
325575|NCT01552473|blast injury|blast injury
325576|NCT01552473|concussion|concussion
325577|NCT01552473|sleep problems|sleep problems
325578|NCT01552473|attention problems|attention problems
325579|NCT01552473|memory problems|memory problems
325580|NCT01552473|headaches|headaches
325581|NCT01552473|dizziness|dizziness
325582|NCT01552473|OEF|oef
325583|NCT01552473|OIF|oif
325584|NCT01552473|Veterans|veterans
325585|NCT01552473|Civilian|civilian
325586|NCT01552460|Autism Spectrum Disorders|autism spectrum disorders
325587|NCT01552460|Brain Imaging|brain imaging
325588|NCT01552460|Genetics|genetics
325589|NCT01552434|Advanced Cancers|advanced cancers
325590|NCT01552434|Advanced Malignancy|advanced malignancy
325591|NCT01552434|Metastatic cancer|metastatic cancer
325592|NCT01552434|Temsirolimus|temsirolimus
325593|NCT01552434|CCI-779|cci-779
325594|NCT01552434|Torisel|torisel
325595|NCT01552434|Bevacizumab|bevacizumab
325596|NCT01552434|Avastin|avastin
325597|NCT01552434|rhuMAb-VEGF|rhumab-vegf
325598|NCT01552434|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
325599|NCT01552434|Cetuximab|cetuximab
325600|NCT01552434|C225|c225
325601|NCT01552434|Erbitux|erbitux
325602|NCT01552434|IMC-C225|imc-c225
325603|NCT01552434|Valproic Acid|valproic acid
325604|NCT01552434|Depakene|depakene
325605|NCT01552421|Cholecystectomy|cholecystectomy
402998|NCT01228682|Hyponatremia|hyponatremia
325606|NCT01552421|Natural Orifice Transluminal Endoscopic Surgery|natural orifice transluminal endoscopic surgery
325607|NCT01552421|Transvaginal cholecystectomy|transvaginal cholecystectomy
325608|NCT01552421|Postoperative outcome|postoperative outcome
325609|NCT01552408|Non Proliferative Diabetic Retinopathy|non proliferative diabetic retinopathy
325610|NCT01552408|Diabetic Retinopathy|diabetic retinopathy
325611|NCT01552408|Macular Edema|macular edema
325612|NCT01552408|Background Diabetic Retinopathy|background diabetic retinopathy
325613|NCT01552408|Pre Proliferative Diabetic Retinopathy|pre proliferative diabetic retinopathy
325614|NCT01552382|vitamin D|vitamin d
325615|NCT01552382|25-hydroxyvitamin D|25-hydroxyvitamin d
325616|NCT01552382|MACCE|macce
325617|NCT01552382|mortality|mortality
325618|NCT01552382|cardiac|cardiac
325619|NCT01552382|cerebrovascular|cerebrovascular
325620|NCT01552369|liver transplantation|liver transplantation
325621|NCT01552369|CMV disease|cmv disease
325622|NCT01552369|valgancyclovir|valgancyclovir
325623|NCT01552369|prophylaxis|prophylaxis
325624|NCT01552369|preemptive therapy|preemptive therapy
325625|NCT01552330|Primaquine|primaquine
325626|NCT01552330|Pyronaridine-artesunate|pyronaridine-artesunate
325627|NCT01552317|chronic kidney disease|chronic kidney disease
325628|NCT01552304|Obstructive sleep apnea|obstructive sleep apnea
325629|NCT01552304|Oxygen therapy|oxygen therapy
325630|NCT01552304|Surgery|surgery
325631|NCT01552304|Anesthesia|anesthesia
325632|NCT01552291|Malnourishment|malnourishment
325633|NCT01552291|Gastrointestinal tumors|gastrointestinal tumors
325634|NCT01552291|Immunocompetence|immunocompetence
711409|NCT01007201|Influenza|influenza
325635|NCT01552265|Mild Cognitive Impairment|mild cognitive impairment
325636|NCT01552265|Alzheimer's Disease|alzheimer's disease
325637|NCT01552252|POs-Ca|pos-ca
325638|NCT01552252|calcium additives|calcium additives
325639|NCT01552252|drink|drink
325640|NCT01552239|Soft tissue sarcoma|soft tissue sarcoma
325735|NCT01551771|CCR3 antagonist|ccr3 antagonist
325641|NCT01552239|Intensity-Modulated Radiation Therapy (IMRT)|intensity-modulated radiation therapy (imrt)
325642|NCT01552239|Tomotherapy|tomotherapy
325643|NCT01552239|Safety Margins|safety margins
325644|NCT01552239|Image-guided Radiation Therapy|image-guided radiation therapy
325645|NCT01552239|Brachytherapy|brachytherapy
325646|NCT01552239|interstitial|interstitial
325647|NCT01552200|Colorectal Cancer|colorectal cancer
325648|NCT01552200|Polyp|polyp
325649|NCT01552200|Adenoma|adenoma
325650|NCT01552200|Detection Rate|detection rate
325651|NCT01552200|Colonoscopy|colonoscopy
325652|NCT01552200|NaviAid™ G-Eye procedure|naviaid™ g-eye procedure
325653|NCT01552200|NaviAid™ G-Eye system|naviaid™ g-eye system
325654|NCT01552200|G-Eye procedure|g-eye procedure
325655|NCT01552200|G-Eye system|g-eye system
325656|NCT01552187|cardiac surgery|cardiac surgery
325657|NCT01552187|post-pericardiotomy syndrome|post-pericardiotomy syndrome
325658|NCT01552187|atrial fibrillation|atrial fibrillation
325659|NCT01552187|pericardial effusion|pericardial effusion
325660|NCT01552187|pleural effusion|pleural effusion
325661|NCT01552187|prevention|prevention
325662|NCT01552187|colchicine|colchicine
325664|NCT01552174|ocular surface pathologies|ocular surface pathologies
325665|NCT01552161|Angiography|angiography
325666|NCT01552161|Atherosclerosis|atherosclerosis
325667|NCT01552161|Asthma|asthma
325668|NCT01552161|Tryptase|tryptase
325669|NCT01552161|Eosinophil cationic protein|eosinophil cationic protein
325670|NCT01552135|titanium dioxide|titanium dioxide
325671|NCT01552135|nanoparticles|nanoparticles
325672|NCT01552135|skin|skin
325673|NCT01552135|penetrate|penetrate
325674|NCT01552109|symptomatic stable angina|symptomatic stable angina
325675|NCT01552109|subjects with symptomatic stable angina visiting non-interventional consulting physicians for treatment and meets the inclusion/exclusion criteria|subjects with symptomatic stable angina visiting non-interventional consulting physicians for treatment and meets the inclusion/exclusion criteria
325676|NCT01552096|Anaesthesia|anaesthesia
325677|NCT01552096|tonsillectomy|tonsillectomy
325678|NCT01552096|inflammatory response|inflammatory response
325679|NCT01552096|stress response|stress response
325680|NCT01552096|tramadol|tramadol
325681|NCT01552096|lidocaine|lidocaine
325682|NCT01552083|sleep apnea|sleep apnea
325683|NCT01552083|screening|screening
325684|NCT01552083|community pharmacy|community pharmacy
325685|NCT01552044|retina|retina
325686|NCT01552031|COPD exacerbations|copd exacerbations
325687|NCT01552031|FOT variability|fot variability
325688|NCT01551992|Sutures|sutures
325689|NCT01551992|Pelvic Organ Prolapse|pelvic organ prolapse
325690|NCT01551992|Sacrocolpopexy|sacrocolpopexy
325691|NCT01551992|Laparoscopy|laparoscopy
325692|NCT01551979|Schizophrenia|schizophrenia
325693|NCT01551979|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
325694|NCT01551966|Esophageal varices|esophageal varices
325695|NCT01551966|Portal hypertension in children|portal hypertension in children
325696|NCT01551966|Wireless capsule endoscopy|wireless capsule endoscopy
325697|NCT01551953|chronic bronchitis|chronic bronchitis
325698|NCT01551953|emphysema|emphysema
325699|NCT01551953|pulmonary|pulmonary
325700|NCT01551953|COPD|copd
325701|NCT01551940|Sialorrhea|sialorrhea
325702|NCT01551940|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
325703|NCT01551940|Botulinum toxin|botulinum toxin
325704|NCT01551927|expectations|expectations
325705|NCT01551914|Ultrasonic scissors|ultrasonic scissors
325706|NCT01551914|thyroidectomy|thyroidectomy
325707|NCT01551901|Back pain|back pain
325708|NCT01551901|Spinal fusion|spinal fusion
325709|NCT01551901|Degenerative disc disease (DDD)|degenerative disc disease (ddd)
325710|NCT01551901|Lower back pain|lower back pain
325711|NCT01551901|Fusion|fusion
325712|NCT01551888|COPD|copd
325713|NCT01551888|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
325714|NCT01551888|Chronic Bronchitis|chronic bronchitis
325715|NCT01551888|Emphysema|emphysema
325716|NCT01551888|Airflow Obstruction, Chronic|airflow obstruction, chronic
325717|NCT01551888|Chronic Airflow Obstruction|chronic airflow obstruction
325718|NCT01551888|Chronic Obstructive Airway Disease|chronic obstructive airway disease
325719|NCT01551888|Chronic Obstructive Lung Disease|chronic obstructive lung disease
325720|NCT01551875|CIMT|cimt
325721|NCT01551875|cardiovascular disease|cardiovascular disease
325722|NCT01551875|correlation with cardiovascular Risk factors|correlation with cardiovascular risk factors
325723|NCT01551862|lower body lift|lower body lift
325724|NCT01551862|body contouring surgery|body contouring surgery
325725|NCT01551862|massive weight loss|massive weight loss
325726|NCT01551836|pharmacokinetics|pharmacokinetics
325727|NCT01551836|paracetamol|paracetamol
325728|NCT01551823|Influenza Virus Vaccine (Split Virion, Inactivated)|influenza virus vaccine (split virion, inactivated)
325729|NCT01551823|Influenza|influenza
325730|NCT01551810|Influenza Virus Vaccine (Split Virion, Inactivated)|influenza virus vaccine (split virion, inactivated)
325731|NCT01551810|Influenza|influenza
325732|NCT01551784|Statin treatment|statin treatment
325733|NCT01551784|Cardiovascular disease|cardiovascular disease
325734|NCT01551784|Statin treatment induced HDL changes and the effect on cardiovascular disease|statin treatment induced hdl changes and the effect on cardiovascular disease
325736|NCT01551758|Exacerbation|exacerbation
325738|NCT01551758|COPD|copd
325739|NCT01551758|Respiratory|respiratory
325740|NCT01551745|Papillary Serous Ovarian Cancer|papillary serous ovarian cancer
325741|NCT01551745|Endometrioid Ovarian Cancer|endometrioid ovarian cancer
325742|NCT01551745|Epithelial Ovarian Cancer|epithelial ovarian cancer
325743|NCT01551732|Anger|anger
325744|NCT01551732|Aggression|aggression
325745|NCT01551732|Biofeedback|biofeedback
325746|NCT01551732|Videogame|videogame
325747|NCT01551719|Bacterial infection of skin or soft tissues|bacterial infection of skin or soft tissues
325748|NCT01551706|Total antioxidant capacity|total antioxidant capacity
325749|NCT01551706|SOD|sod
325750|NCT01551706|8-OHdG|8-ohdg
325751|NCT01551706|8-isoprostane|8-isoprostane
325752|NCT01551706|oxLDL|oxldl
325753|NCT01551693|Stage III|stage iii
325754|NCT01551693|Stage IV|stage iv
325755|NCT01551693|Unresectable|unresectable
325756|NCT01551693|Metastatic|metastatic
325757|NCT01551667|S. aureus|s. aureus
325758|NCT01551654|Pain|pain
325759|NCT01551654|Colonoscopy|colonoscopy
325760|NCT01551654|TENS|tens
325761|NCT01551654|Acupuncture|acupuncture
325762|NCT01551641|Esophageal Cancer|esophageal cancer
325763|NCT01551641|Chemoradiotherapy|chemoradiotherapy
325764|NCT01551641|VEGF|vegf
325765|NCT01551641|Thalidomide|thalidomide
325766|NCT01551615|Phase 1|phase 1
325767|NCT01551615|healthy volunteers|healthy volunteers
325768|NCT01551615|pharmacokinetics|pharmacokinetics
325769|NCT01551615|vandetanib|vandetanib
325770|NCT01551615|metformin|metformin
325771|NCT01551615|AUC(0-t)|auc(0-t)
325772|NCT01551615|t1/2|t1/2
325773|NCT01551615|tmax|tmax
325774|NCT01551615|CL/F|cl/f
325775|NCT01551615|Vz/F|vz/f
325776|NCT01551615|Cmax|cmax
325777|NCT01551602|AK159|ak159
325778|NCT01551602|teriparatide acetate|teriparatide acetate
325779|NCT01551589|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
325780|NCT01551589|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
325781|NCT01551589|Clinical target volume|clinical target volume
325782|NCT01551589|Safety|safety
325783|NCT01551589|Prognosis|prognosis
325784|NCT01551550|Glaucoma Drainage Device, Tube Exposure, Amniotic Membrane|glaucoma drainage device, tube exposure, amniotic membrane
325785|NCT01551537|Healthy females|healthy females
325786|NCT01551537|Post-marketing surveillance (PMS)|post-marketing surveillance (pms)
325787|NCT01551537|Human papillomavirus vaccine|human papillomavirus vaccine
325788|NCT01551537|Sri Lanka|sri lanka
325789|NCT01551537|Cervarix|cervarix
325790|NCT01551524|Leukemia|leukemia
325791|NCT01551524|Lymphoma|lymphoma
325792|NCT01551524|C240588.448|c240588.448
325793|NCT01551524|C115.378.400|c115.378.400
325794|NCT01551511|chronic pancreatitis|chronic pancreatitis
325795|NCT01551511|abdominal pain|abdominal pain
325796|NCT01551511|visceral pain|visceral pain
325797|NCT01551511|chronic pain|chronic pain
325798|NCT01551498|Hashimoto Disease|hashimoto disease
404474|NCT01221753|HPV|hpv
325799|NCT01551498|Thyroiditis|thyroiditis
325800|NCT01551459|Uveal|uveal
325801|NCT01551459|Melanoma|melanoma
325802|NCT01551459|Metastatic|metastatic
325803|NCT01551459|Sunitinib|sunitinib
325804|NCT01551433|esophagectomy|esophagectomy
325805|NCT01551433|ESOPHAGUS|esophagus
325806|NCT01551433|Wipox instrument|wipox instrument
325807|NCT01551433|Tissue Oxygenation|tissue oxygenation
325808|NCT01551433|Anastomotic Leak|anastomotic leak
325809|NCT01551433|11-192|11-192
325810|NCT01551420|Amputation|amputation
325811|NCT01551420|Prosthetic Design|prosthetic design
325812|NCT01551420|Upper Extremity|upper extremity
325813|NCT01551407|Hexvix|hexvix
325814|NCT01551407|bladder cancer|bladder cancer
325815|NCT01551407|cystoscopy|cystoscopy
325816|NCT01551407|Patients with known or suspicion of bladder cancer|patients with known or suspicion of bladder cancer
325817|NCT01551394|sepsis|sepsis
325818|NCT01551394|neonates|neonates
325819|NCT01551394|meropenem|meropenem
325820|NCT01551381|Safety|safety
325821|NCT01551381|Tolerability|tolerability
325822|NCT01551381|Pharmacokinetics|pharmacokinetics
325823|NCT01551381|Pharmacodynamics|pharmacodynamics
325824|NCT01551368|male factor|male factor
325825|NCT01551368|intrauterine insemination|intrauterine insemination
325826|NCT01551368|LH surge|lh surge
325827|NCT01551368|controlled ovarian stimulation|controlled ovarian stimulation
325828|NCT01551368|clomiphene citrate|clomiphene citrate
325829|NCT01551368|letrozole|letrozole
325830|NCT01551368|human menopausal gonadotropins|human menopausal gonadotropins
325831|NCT01551355|behavioral modification|behavioral modification
325832|NCT01551355|health communication|health communication
325833|NCT01551355|prevention|prevention
325834|NCT01551342|bladder cancer|bladder cancer
325835|NCT01551342|Transitional cell carcinoma (TCC)|transitional cell carcinoma (tcc)
325836|NCT01551329|depression|depression
325837|NCT01551329|alcohol|alcohol
325838|NCT01551329|comorbidity|comorbidity
325839|NCT01551329|ketamine|ketamine
325840|NCT01551329|glutamate|glutamate
325841|NCT01551329|NMDA|nmda
325842|NCT01551316|safety|safety
325843|NCT01551316|pharmacokinetics|pharmacokinetics
325844|NCT01551316|spirometry|spirometry
325845|NCT01551290|Ulcerative colitis|ulcerative colitis
325846|NCT01551290|UC|uc
325847|NCT01551290|Remicade|remicade
325848|NCT01551290|Infliximab|infliximab
325849|NCT01551290|Chinese patients|chinese patients
325850|NCT01551290|Mayo score|mayo score
325851|NCT01551290|Mucosal healing|mucosal healing
325852|NCT01551290|Rectal bleeding|rectal bleeding
325853|NCT01551290|Inflammatory bowel disease|inflammatory bowel disease
325854|NCT01551290|IBD|ibd
325855|NCT01551238|Energy expenditure|energy expenditure
325856|NCT01551238|Sleep|sleep
325857|NCT01551238|Protein|protein
325858|NCT01551238|Carbohydrate|carbohydrate
325859|NCT01551225|Randomized controlled trial|randomized controlled trial
325860|NCT01551225|Escitalopram|escitalopram
325861|NCT01551225|Irritable bowel syndrome|irritable bowel syndrome
325862|NCT01551225|Panic disorder|panic disorder
325863|NCT01551212|Liver transplantation|liver transplantation
325864|NCT01551212|everolimus|everolimus
325865|NCT01551212|kidney function|kidney function
325866|NCT01551186|Probiotics|probiotics
325867|NCT01551173|Dyslipidemias|dyslipidemias
325868|NCT01551173|Fluvastatin sodium|fluvastatin sodium
325869|NCT01551173|Chinese|chinese
325870|NCT01551160|Non-technical skills|non-technical skills
325871|NCT01551160|Crisis resource management|crisis resource management
325872|NCT01551160|Medical Emergency Team|medical emergency team
325873|NCT01551160|Rapid Response Team|rapid response team
325874|NCT01551147|asthma|asthma
325875|NCT01551147|ONO-6950|ono-6950
325876|NCT01551147|asthma in adult patients|asthma in adult patients
325877|NCT01551134|Gastroesophageal Reflux|gastroesophageal reflux
325878|NCT01551134|Fundoplication|fundoplication
325879|NCT01551134|Randomized Controlled Trial|randomized controlled trial
325880|NCT01551134|General Surgery|general surgery
325881|NCT01551134|Child|child
325882|NCT01551134|Laparoscopy|laparoscopy
325883|NCT01551108|Children|children
325884|NCT01551108|physical activity|physical activity
325885|NCT01551095|PEGJ|pegj
325886|NCT01551095|PEG-J|peg-j
325887|NCT01551095|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
325888|NCT01551095|feeding tube|feeding tube
325889|NCT01551095|gastroparesis|gastroparesis
325890|NCT01551095|acute pancreatitis|acute pancreatitis
325891|NCT01551095|stroke|stroke
325892|NCT01551095|respiratory failure|respiratory failure
325893|NCT01551095|GERD|gerd
325894|NCT01551095|balloon|balloon
325895|NCT01551095|self-propelled|self-propelled
325896|NCT01551043|adult patients|adult patients
325897|NCT01551043|aged 18|aged 18
325898|NCT01551043|CD19+ ALL relapsed|cd19+ all relapsed
325899|NCT01551043|after allogeneic SCT|after allogeneic sct
325900|NCT01551030|KIDNEY|kidney
325901|NCT01551030|URETER|ureter
325902|NCT01551030|URINARY BLADDER|urinary bladder
325903|NCT01551030|Buparlisib|buparlisib
325904|NCT01551030|11-060|11-060
325905|NCT01551017|total knee endoprostheses|total knee endoprostheses
325906|NCT01551017|swelling|swelling
325907|NCT01551017|mobilisation|mobilisation
325908|NCT01551004|C. difficile, Clostridium difficile, C. diff, CRS3123|c. difficile, clostridium difficile, c. diff, crs3123
325909|NCT01550965|Quality of Life|quality of life
325910|NCT01550965|Costs of Ulcerative Colitis|costs of ulcerative colitis
325911|NCT01550965|Health Care Utilization|health care utilization
325912|NCT01550939|Biometry of the Eye|biometry of the eye
325913|NCT01550939|Intraocular Lens Implantation|intraocular lens implantation
325914|NCT01550939|IOL|iol
325915|NCT01550926|orlistat|orlistat
325916|NCT01550926|overweight|overweight
325917|NCT01550926|bioequivalence|bioequivalence
325918|NCT01550913|Substance use|substance use
325919|NCT01550913|perinatal depression|perinatal depression
325920|NCT01550913|pregnant|pregnant
325921|NCT01550900|Colorectum|colorectum
325922|NCT01550900|Metachronous ctalColonic Neoplastic Polyps|metachronous ctalcolonic neoplastic polyps
325923|NCT01550900|Chemoprevention|chemoprevention
325924|NCT01550900|Colonic adenoma(s)|colonic adenoma(s)
325925|NCT01550900|Pre-cancerous tumor(s) on the colon|pre-cancerous tumor(s) on the colon
325926|NCT01550900|Metformin ER|metformin er
325927|NCT01550900|Extended Release|extended release
325928|NCT01550900|Placebo|placebo
325929|NCT01550900|Sugar pill|sugar pill
325930|NCT01550874|Physical Activity|physical activity
325931|NCT01550874|Epilepsy|epilepsy
325932|NCT01550874|Children|children
325933|NCT01550861|infertility|infertility
711410|NCT01007201|H1N1|h1n1
325934|NCT01550861|in vitro maturation (IVM)|in vitro maturation (ivm)
325935|NCT01550861|in vitro fertilization (IVF)|in vitro fertilization (ivf)
325936|NCT01550861|natural cycle|natural cycle
325937|NCT01550835|Symptomatic carotid artery stenosis|symptomatic carotid artery stenosis
325938|NCT01550822|stroke, lifestyle habits|stroke, lifestyle habits
325939|NCT01550809|T1DM|t1dm
325940|NCT01550809|CSII|csii
325942|NCT01550809|postprandial control|postprandial control
325943|NCT01550809|glycemic variability|glycemic variability
326135|NCT01550120|sensitivity|sensitivity
326136|NCT01550120|human|human
325944|NCT01550809|Prandial insulin dosing in Type 1 diabetes treated with continuous subcutaneous insulin infusion|prandial insulin dosing in type 1 diabetes treated with continuous subcutaneous insulin infusion
325945|NCT01550796|Tinnitus|tinnitus
325946|NCT01550796|Brain Fitness Program|brain fitness program
325947|NCT01550796|Posit Science|posit science
325948|NCT01550796|D-cycloserine|d-cycloserine
325949|NCT01550796|Cognitive Training|cognitive training
325950|NCT01550783|Cervical cancer|cervical cancer
326047|NCT01550510|Topoisomerase I Inhibitors|topoisomerase i inhibitors
325951|NCT01550783|Atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
325952|NCT01550783|Stage 0 cervical cancer|stage 0 cervical cancer
325953|NCT01550783|Cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
325954|NCT01550783|Cervical|cervical
325955|NCT01550783|intraepithelial neoplasia grade 2|intraepithelial neoplasia grade 2
325956|NCT01550783|Cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
325957|NCT01550783|Human papillomavirus|human papillomavirus
325958|NCT01550783|HPV|hpv
325959|NCT01550744|Psoriasis|psoriasis
325960|NCT01550744|Ustekinumab|ustekinumab
325961|NCT01550744|STELARA|stelara
325962|NCT01550744|Skin disease|skin disease
325963|NCT01550744|Monoclonal|monoclonal
325964|NCT01550731|advance care planning|advance care planning
325965|NCT01550731|health communication|health communication
325966|NCT01550731|aging|aging
325967|NCT01550718|Aerobic Exercise|aerobic exercise
325968|NCT01550718|Alzheimer's Disease|alzheimer's disease
325969|NCT01550718|Burden and Stress|burden and stress
325970|NCT01550718|Caregiving Issues|caregiving issues
325971|NCT01550718|Quality of Life|quality of life
325972|NCT01550718|Early Stage Memory Loss|early stage memory loss
325973|NCT01550705|Protoporphyria|protoporphyria
325974|NCT01550705|Porphyria|porphyria
325975|NCT01550705|Porphyrins|porphyrins
325976|NCT01550666|negative symptoms|negative symptoms
325977|NCT01550653|Memory|memory
325978|NCT01550653|GLP-1|glp-1
325979|NCT01550653|Liraglutide|liraglutide
325980|NCT01550653|energy output|energy output
325981|NCT01550653|Memory facilitation|memory facilitation
325982|NCT01550653|GLP-1 analogue|glp-1 analogue
325983|NCT01550640|remifentanil|remifentanil
325984|NCT01550640|Caesarean operation|caesarean operation
325985|NCT01550640|general anaesthesia|general anaesthesia
325986|NCT01550640|hypertension|hypertension
325987|NCT01550640|newborn's adaptation|newborn's adaptation
325988|NCT01550640|pharmacogenetics|pharmacogenetics
325989|NCT01550627|preterm infants < 32 weeks of gestation|preterm infants < 32 weeks of gestation
325990|NCT01550614|Angina Pectoris|angina pectoris
325991|NCT01550614|Myocardial Ischemia|myocardial ischemia
325992|NCT01550614|Chest Pain|chest pain
325993|NCT01550614|Coronary Artery Disease|coronary artery disease
325994|NCT01550614|Heart Diseases|heart diseases
325995|NCT01550614|Cardiovascular Diseases|cardiovascular diseases
325996|NCT01550614|Myocardial Perfusion|myocardial perfusion
404707|NCT01220817|psa|psa
325997|NCT01550614|Reversible Perfusion Defect Size|reversible perfusion defect size
325998|NCT01550614|SPECT-MIBI|spect-mibi
325999|NCT01550614|Anti-Anginal Medication|anti-anginal medication
326000|NCT01550614|Quality of Life|quality of life
326001|NCT01550601|morbid obesity|morbid obesity
326002|NCT01550601|gastrectomy|gastrectomy
326003|NCT01550601|gastrinaemia|gastrinaemia
326004|NCT01550601|comorbidity|comorbidity
326005|NCT01550601|gastric antrum|gastric antrum
326006|NCT01550588|PFO|pfo
326007|NCT01550588|Stroke|stroke
326008|NCT01550549|Amyloid imaging|amyloid imaging
326009|NCT01550549|Positron Emission Tomography|positron emission tomography
326010|NCT01550549|18F-AV-45|18f-av-45
326011|NCT01550549|florbetapir F 18|florbetapir f 18
326012|NCT01550549|Diagnostic imaging|diagnostic imaging
326013|NCT01550536|basal metabolic rate|basal metabolic rate
326014|NCT01550536|resting energy expenditure|resting energy expenditure
326015|NCT01550536|menopause|menopause
326016|NCT01550536|physical activity|physical activity
326017|NCT01550536|metabolic syndrome|metabolic syndrome
326018|NCT01550523|Brain Tumor|brain tumor
326019|NCT01550510|Stage IV Colorectal cancer|stage iv colorectal cancer
326020|NCT01550510|Colorectal Neoplasms|colorectal neoplasms
326021|NCT01550510|Intestinal Neoplasms|intestinal neoplasms
326022|NCT01550510|Gastrointestinal Neoplasms|gastrointestinal neoplasms
326023|NCT01550510|Digestive System Neoplasms|digestive system neoplasms
326024|NCT01550510|Neoplasms by Site|neoplasms by site
326025|NCT01550510|Neoplasms|neoplasms
326026|NCT01550510|Digestive System Diseases|digestive system diseases
711411|NCT01007201|vaccine|vaccine
326027|NCT01550510|Gastrointestinal Diseases|gastrointestinal diseases
326028|NCT01550510|Colonic Diseases|colonic diseases
326029|NCT01550510|Intestinal Diseases|intestinal diseases
326030|NCT01550510|Rectal Diseases|rectal diseases
326031|NCT01550510|Ascorbic Acid|ascorbic acid
326032|NCT01550510|Vitamins|vitamins
326033|NCT01550510|Irinotecan|irinotecan
326034|NCT01550510|Integrative Medicine|integrative medicine
326035|NCT01550510|Complementary Medicine|complementary medicine
326036|NCT01550510|Alternative Medicine Antioxidants|alternative medicine antioxidants
326037|NCT01550510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
326038|NCT01550510|Pharmacologic Actions|pharmacologic actions
326039|NCT01550510|Protective Agents|protective agents
326040|NCT01550510|Physiological Effects of Drugs|physiological effects of drugs
326041|NCT01550510|Micronutrients|micronutrients
326042|NCT01550510|Growth Substances|growth substances
326043|NCT01550510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
326044|NCT01550510|Antineoplastic Agents|antineoplastic agents
326045|NCT01550510|Therapeutic Uses|therapeutic uses
326046|NCT01550510|Radiation-Sensitizing Agents|radiation-sensitizing agents
326048|NCT01550510|Topoisomerase Inhibitors|topoisomerase inhibitors
326049|NCT01550510|Enzyme Inhibitors|enzyme inhibitors
326050|NCT01550497|back pain|back pain
326051|NCT01550497|scoliosis|scoliosis
326052|NCT01550497|home exercise program|home exercise program
326053|NCT01550471|Mild asthma and allergic rhinitis|mild asthma and allergic rhinitis
326054|NCT01550458|Clinical Trial, Phase I|clinical trial, phase i
326055|NCT01550458|Human Volunteers|human volunteers
326056|NCT01550458|Healthy Volunteers|healthy volunteers
326057|NCT01550458|mibefradil|mibefradil
326058|NCT01550458|Posicor®|posicor®
326059|NCT01550445|Steroid withdrawal, Kidney transplantation|steroid withdrawal, kidney transplantation
326060|NCT01550419|Ventilator-associated pneumonia|ventilator-associated pneumonia
326061|NCT01550419|Ischemic stroke|ischemic stroke
326062|NCT01550419|Atorvastatin|atorvastatin
326063|NCT01550419|Morbidity|morbidity
326064|NCT01550419|Mortality|mortality
326065|NCT01550406|Pancreatic fistula|pancreatic fistula
326066|NCT01550406|distal Pancreatectomy|distal pancreatectomy
326067|NCT01550393|stage II Wilms tumor|stage ii wilms tumor
326068|NCT01550393|stage III Wilms tumor|stage iii wilms tumor
326069|NCT01550393|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
326070|NCT01550380|Endometrial cancer|endometrial cancer
326072|NCT01550341|AIDS|aids
326073|NCT01550341|Opiate Addiction|opiate addiction
326074|NCT01550341|Drug Dependence|drug dependence
326075|NCT01550341|Buprenorphine|buprenorphine
326076|NCT01550328|Screening for Type 2 diabetes|screening for type 2 diabetes
326077|NCT01550315|POTS|pots
326078|NCT01550315|endothelial function|endothelial function
326079|NCT01550315|high salt vs low salt diet|high salt vs low salt diet
326080|NCT01550315|PAT protocol|pat protocol
326081|NCT01550315|Calf blood flow|calf blood flow
326082|NCT01550315|forearm mediated dilation|forearm mediated dilation
326083|NCT01550302|Superficial Cervical Plexus Block|superficial cervical plexus block
326084|NCT01550302|Thoracic Surgery|thoracic surgery
326085|NCT01550302|Thoracotomy|thoracotomy
326086|NCT01550302|Video-Assisted Thoracoscopic Surgery|video-assisted thoracoscopic surgery
326087|NCT01550289|Dengue Fever|dengue fever
326088|NCT01550289|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
326089|NCT01550289|CYD Dengue Vaccine|cyd dengue vaccine
326090|NCT01550289|Dengue Virus|dengue virus
326091|NCT01550289|Flavivirus|flavivirus
326092|NCT01550276|Effectiveness|effectiveness
326093|NCT01550276|Tension-type headache|tension-type headache
326094|NCT01550276|Manual therapy|manual therapy
326095|NCT01550263|Hip Preservation|hip preservation
326096|NCT01550263|Hip Arthroscopy|hip arthroscopy
326097|NCT01550263|Hip Pain|hip pain
326098|NCT01550263|Psychological distress|psychological distress
326099|NCT01550250|Breast cancer|breast cancer
326100|NCT01550250|Arm lymphedema|arm lymphedema
326101|NCT01550250|Compression therapy|compression therapy
326102|NCT01550237|radiotherapy, image-guided|radiotherapy, image-guided
326103|NCT01550237|adverse effects|adverse effects
326104|NCT01550237|position verification|position verification
326105|NCT01550237|safety margins|safety margins
326106|NCT01550198|newborn|newborn
326107|NCT01550198|shock|shock
326108|NCT01550198|hemodynamics|hemodynamics
326109|NCT01550198|cardiac output|cardiac output
326110|NCT01550198|blood pressure|blood pressure
326111|NCT01550172|dementia caregivers|dementia caregivers
326112|NCT01550172|caregivers|caregivers
326113|NCT01550172|Alzheimer's caregivers|alzheimer's caregivers
326114|NCT01550172|caregiver sleep|caregiver sleep
326115|NCT01550172|heart disease risk|heart disease risk
326116|NCT01550172|dementia|dementia
326117|NCT01550172|Alzheimer's Disease|alzheimer's disease
326118|NCT01550159|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
326119|NCT01550159|Cardiac Surgery|cardiac surgery
326120|NCT01550159|General Anesthesia|general anesthesia
711506|NCT01013493|myopia|myopia
326121|NCT01550159|Neuropsychological Tests|neuropsychological tests
326122|NCT01550146|Fractured neck of femur|fractured neck of femur
326123|NCT01550146|Dexamethasone|dexamethasone
326124|NCT01550133|Peptides|peptides
326125|NCT01550133|Hormones|hormones
326126|NCT01550133|Appetite|appetite
326127|NCT01550133|Humans|humans
326128|NCT01550133|Obese|obese
326129|NCT01550133|Beverage|beverage
326130|NCT01550133|Solid food|solid food
326131|NCT01550133|cephalic phase|cephalic phase
326132|NCT01550120|taste|taste
326133|NCT01550120|fat|fat
326134|NCT01550120|threshold|threshold
326137|NCT01550107|Sarcopenia|sarcopenia
326138|NCT01550107|Allopurinol|allopurinol
326139|NCT01550107|Xanthine Oxidase|xanthine oxidase
326140|NCT01550107|MR Spectroscopy|mr spectroscopy
326141|NCT01550094|obese|obese
326142|NCT01550094|regional anesthesia|regional anesthesia
326143|NCT01550094|anesthesia|anesthesia
326144|NCT01550094|anesthesiology|anesthesiology
326145|NCT01550094|surgery|surgery
326146|NCT01550094|foot|foot
326147|NCT01550094|foot surgery|foot surgery
326148|NCT01550094|ankle|ankle
326149|NCT01550094|ankle surgery|ankle surgery
326150|NCT01550094|orthopedics|orthopedics
326151|NCT01550094|orthopedic surgery|orthopedic surgery
326152|NCT01550094|sports medicine|sports medicine
326153|NCT01550094|sports medicine surgery|sports medicine surgery
326154|NCT01550094|Ochsner Hospital|ochsner hospital
326155|NCT01550094|Ochsner Clinic|ochsner clinic
326156|NCT01550094|New Orleans|new orleans
326157|NCT01550094|Louisiana|louisiana
326158|NCT01550094|Jefferson|jefferson
326160|NCT01550081|exercise intensity|exercise intensity
326161|NCT01550081|aerobic interval training|aerobic interval training
326162|NCT01550081|cardiac rehabilitation|cardiac rehabilitation
326163|NCT01550081|group exercise|group exercise
326164|NCT01550068|Rheumatic Heart Disease|rheumatic heart disease
326165|NCT01550055|KRAS wild-type|kras wild-type
326166|NCT01550055|Metastatic Colorectal Cancer|metastatic colorectal cancer
326167|NCT01550055|CMAB009 Plus Irinotecan|cmab009 plus irinotecan
326168|NCT01550055|Phase II/III|phase ii/iii
326169|NCT01550029|Smoking|smoking
326170|NCT01550029|Tobacco|tobacco
326171|NCT01550029|Nicotine|nicotine
326172|NCT01550029|Bipolar|bipolar
326173|NCT01550016|dengue warning signs|dengue warning signs
326174|NCT01550016|latin america|latin america
326175|NCT01550016|south east asia|south east asia
326176|NCT01550016|other febrile illnesses|other febrile illnesses
326177|NCT01550016|dengue classification|dengue classification
326178|NCT01550003|Cimzia|cimzia
326179|NCT01550003|JIA|jia
326180|NCT01550003|Polyarticular|polyarticular
326181|NCT01550003|Oligoarticular|oligoarticular
326182|NCT01550003|Enthesitis-related-Arthritis|enthesitis-related-arthritis
326183|NCT01550003|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
326184|NCT01550003|Juvenile Psoriatic Arthritis|juvenile psoriatic arthritis
326185|NCT01550003|Certolizumab Pegol|certolizumab pegol
326186|NCT01550003|PASCAL|pascal
326187|NCT01550003|CDP870|cdp870
326188|NCT01549977|Drug Therapy|drug therapy
326189|NCT01549964|Drug Therapy|drug therapy
326190|NCT01549951|Metastatic castrate resistant prostate cancer, mCRPC, orteronel, TAK-700, Phase 2, QT, QTc|metastatic castrate resistant prostate cancer, mcrpc, orteronel, tak-700, phase 2, qt, qtc
326191|NCT01549938|Vitamin D|vitamin d
405020|NCT01219595|UTI|uti
326192|NCT01549938|Cholecalciferol|cholecalciferol
326193|NCT01549938|Respiratory tract infection|respiratory tract infection
326194|NCT01549912|Rotator Cuff Tears|rotator cuff tears
326195|NCT01549912|Dislocation|dislocation
326196|NCT01549912|Shoulder Dislocation|shoulder dislocation
326197|NCT01549899|Insomnia|insomnia
326198|NCT01549899|Cognitive|cognitive
326199|NCT01549899|Behavioral|behavioral
326200|NCT01549899|Therapy|therapy
326201|NCT01549899|Internet|internet
326202|NCT01549899|Depression|depression
326203|NCT01549899|Substance Use|substance use
326204|NCT01549899|Post-Tramatic Stress Disorder|post-tramatic stress disorder
326205|NCT01549886|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
326206|NCT01549886|Zevalin|zevalin
326207|NCT01549886|Motexafin Gadolinium|motexafin gadolinium
326208|NCT01549860|Venous Insufficiency|venous insufficiency
326209|NCT01549860|Reflux|reflux
326210|NCT01549860|Lower Extremity Ulcer|lower extremity ulcer
326211|NCT01549847|Postpoliomyelitis Syndrome|postpoliomyelitis syndrome
326212|NCT01549847|Piracetam|piracetam
326213|NCT01549847|L-Carnitine|l-carnitine
326214|NCT01549808|ADL|adl
326215|NCT01549808|activities of daily living|activities of daily living
326216|NCT01549808|level of function|level of function
326217|NCT01549795|Liver transplantation|liver transplantation
326218|NCT01549795|Neoadjuvant radio- chemo-therapy|neoadjuvant radio- chemo-therapy
326219|NCT01549782|Prebiotics|prebiotics
326220|NCT01549782|Microbiota|microbiota
326221|NCT01549782|Radiotherapy|radiotherapy
326222|NCT01549782|Gynaecological Cancer|gynaecological cancer
326223|NCT01549756|stage 4 stomach cancer|stage 4 stomach cancer
326224|NCT01549756|stage 4 gastric cancer|stage 4 gastric cancer
326225|NCT01549717|Early warning score|early warning score
326226|NCT01549717|Physiological score|physiological score
326227|NCT01549717|Track and trigger score|track and trigger score
326228|NCT01549717|Scoring system|scoring system
326229|NCT01549717|Physiological model|physiological model
326230|NCT01549717|Monitoring|monitoring
326231|NCT01549717|Patient monitoring|patient monitoring
326232|NCT01549717|Wireless monitoring|wireless monitoring
326233|NCT01549717|Wearable monitor|wearable monitor
326234|NCT01549704|Total knee arthroplasty|total knee arthroplasty
326235|NCT01549704|Adductor canal blockade (ACB)|adductor canal blockade (acb)
326236|NCT01549704|High pain responders|high pain responders
326237|NCT01549704|US-guided nerve block|us-guided nerve block
326238|NCT01549691|Premedication|premedication
326239|NCT01549691|Benzodiazepine|benzodiazepine
326240|NCT01549691|Anti-anxiety agents|anti-anxiety agents
326242|NCT01549691|Surgery|surgery
326243|NCT01549691|Adult|adult
326244|NCT01549691|Human|human
326245|NCT01549678|Plantar fasciitis|plantar fasciitis
326246|NCT01549678|foot pain|foot pain
326247|NCT01549678|insoles|insoles
326248|NCT01549678|foot function|foot function
326249|NCT01549678|electronic baropodometer|electronic baropodometer
326250|NCT01549678|plantar pressure|plantar pressure
326251|NCT01549678|gait analysis|gait analysis
326252|NCT01549665|Graft-Versus-Host Disease|graft-versus-host disease
326254|NCT01549665|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
326255|NCT01549665|Stem Cell Transplantation|stem cell transplantation
326256|NCT01549665|Allogeneic hematopoietic transplant|allogeneic hematopoietic transplant
326257|NCT01549665|Mesenchymal Stem Cells|mesenchymal stem cells
326258|NCT01549665|Unrelated Donors|unrelated donors
326259|NCT01549665|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
326260|NCT01549639|Propofol|propofol
326261|NCT01549639|Target controlled infusion|target controlled infusion
326262|NCT01549639|General anaesthesia|general anaesthesia
326263|NCT01549626|Flaxseed|flaxseed
326264|NCT01549626|Women|women
326265|NCT01549626|Obesity|obesity
326266|NCT01549626|No smokers|no smokers
326267|NCT01549574|crizotinib|crizotinib
326268|NCT01549574|pharmacokinetics|pharmacokinetics
326269|NCT01549574|esomeprazole|esomeprazole
326270|NCT01549574|proton pump inhibitor|proton pump inhibitor
326271|NCT01549574|drug drug interaction|drug drug interaction
326272|NCT01549574|healthy volunteers|healthy volunteers
326273|NCT01549561|behavior problems|behavior problems
326274|NCT01549561|foster care|foster care
326275|NCT01549561|parent training|parent training
326276|NCT01549561|youth skills training|youth skills training
326277|NCT01549548|CML|cml
326278|NCT01549522|patients or caregivers|patients or caregivers
326279|NCT01549522|for caregivers, loved one must still be living|for caregivers, loved one must still be living
326280|NCT01549496|HCV|hcv
326281|NCT01549496|pharmacokinetics|pharmacokinetics
326282|NCT01549496|boceprevir|boceprevir
326283|NCT01549496|hypertension|hypertension
326284|NCT01549496|amlodipine|amlodipine
326285|NCT01549496|diltiazem|diltiazem
326286|NCT01549483|asthma|asthma
326287|NCT01549483|airway hyperresponsiveness|airway hyperresponsiveness
326288|NCT01549483|asymptomatic airway hyperresponsiveness|asymptomatic airway hyperresponsiveness
326289|NCT01549483|small airways|small airways
326290|NCT01549457|latent tuberculosis|latent tuberculosis
326291|NCT01549457|text message interventions|text message interventions
326292|NCT01549457|medication adherence|medication adherence
326293|NCT01549444|renin|renin
326294|NCT01549444|aldosterone|aldosterone
326295|NCT01549444|neonate|neonate
326296|NCT01549431|Multiple Myeloma|multiple myeloma
326297|NCT01549418|Gastrointestinal bleeding|gastrointestinal bleeding
326298|NCT01549418|Lower gastrointestinal bleeding (LGIB)|lower gastrointestinal bleeding (lgib)
326299|NCT01549418|Polypectomy|polypectomy
326300|NCT01549418|Large colorectal polyps|large colorectal polyps
326301|NCT01549418|ASA|asa
326302|NCT01549418|Aspirin|aspirin
326303|NCT01549418|Acetylsalicylic acid|acetylsalicylic acid
326304|NCT01549418|Colorectal Neoplasms|colorectal neoplasms
326305|NCT01549418|Intestinal Neoplasms|intestinal neoplasms
326306|NCT01549418|Gastrointestinal Neoplasms|gastrointestinal neoplasms
326307|NCT01549418|Digestive System Neoplasms|digestive system neoplasms
326308|NCT01549418|Neoplasms by Site|neoplasms by site
326309|NCT01549418|Neoplasms|neoplasms
326310|NCT01549418|Digestive System Diseases|digestive system diseases
326311|NCT01549418|Gastrointestinal Diseases|gastrointestinal diseases
326312|NCT01549418|Colonic Diseases|colonic diseases
326313|NCT01549418|Intestinal Diseases|intestinal diseases
326314|NCT01549418|Rectal Diseases|rectal diseases
326315|NCT01549405|percutanous nephrolitotomy,intercostal nerve block, Ultrasound|percutanous nephrolitotomy,intercostal nerve block, ultrasound
326316|NCT01549392|dynamic enhanced ct scan|dynamic enhanced ct scan
326317|NCT01549392|mri spectroscopy|mri spectroscopy
326318|NCT01549392|recurrent gliomas|recurrent gliomas
326319|NCT01549379|Head and neck cancer|head and neck cancer
326320|NCT01549379|Radiation|radiation
711612|NCT01013948|Bronchitis|bronchitis
326321|NCT01549379|Chemotherapy|chemotherapy
326322|NCT01549379|Surgery|surgery
326323|NCT01549379|Dynamic contrast enhanced computed tomography|dynamic contrast enhanced computed tomography
326324|NCT01549340|Rhinitis|rhinitis
326325|NCT01549340|Allergen immunotherapy|allergen immunotherapy
326326|NCT01549327|Virtual Patient Navigation|virtual patient navigation
326327|NCT01549327|Randomized Clinical Trial|randomized clinical trial
326328|NCT01549327|Empowerment|empowerment
326329|NCT01549327|Cost-Effectiveness|cost-effectiveness
326330|NCT01549327|Cancer Information Preferences|cancer information preferences
326331|NCT01549314|Cystic fibrosis related bone disease|cystic fibrosis related bone disease
326332|NCT01549314|Cystic fibrosis|cystic fibrosis
326333|NCT01549314|Ivacaftor|ivacaftor
326334|NCT01549249|cone outer segment tips line|cone outer segment tips line
326335|NCT01549249|inner segment/outer segment junction line|inner segment/outer segment junction line
326336|NCT01549249|optical coherence tomography|optical coherence tomography
326337|NCT01549249|epiretinal membrane|epiretinal membrane
326338|NCT01549236|Chagas Disease|chagas disease
326339|NCT01549236|Trypanosoma Cruzi|trypanosoma cruzi
326340|NCT01549236|T.Cruzi|t.cruzi
326341|NCT01549223|Uterine Atony|uterine atony
326342|NCT01549223|Hypotension|hypotension
326343|NCT01549223|Cesarean Delivery|cesarean delivery
326344|NCT01549223|Hemorrhage|hemorrhage
326345|NCT01549223|Phenylephrine|phenylephrine
326346|NCT01549223|Ephedrine|ephedrine
326347|NCT01549210|gout|gout
326348|NCT01549210|gouty arthritis|gouty arthritis
326349|NCT01549197|PTSD|ptsd
326350|NCT01549184|secondary ITP|secondary itp
326351|NCT01549184|hydroxychloroquine|hydroxychloroquine
326352|NCT01549184|Systemic Lupus Erythematosus|systemic lupus erythematosus
326353|NCT01549171|Human ART|human art
326354|NCT01549171|Prostacyclin|prostacyclin
326355|NCT01549171|Iloprost|iloprost
326356|NCT01549171|Pregnancy|pregnancy
326357|NCT01549158|loop diuretics|loop diuretics
326358|NCT01549158|torasemide prolonged release|torasemide prolonged release
326359|NCT01549158|torasemide immediate release|torasemide immediate release
326360|NCT01549158|Sutril Neo|sutril neo
326361|NCT01549158|pharmacodynamic profile of Torasemide-PR|pharmacodynamic profile of torasemide-pr
326362|NCT01549145|Severe|severe
326363|NCT01549145|Ongoing|ongoing
326364|NCT01549145|Unilateral|unilateral
326365|NCT01549145|present for more than 6 months|present for more than 6 months
326366|NCT01549132|Clinically significant macular oedema|clinically significant macular oedema
326367|NCT01549132|Retinal Oximetry|retinal oximetry
326368|NCT01549132|Spectral imaging|spectral imaging
326369|NCT01549132|Retinal Laser therapy|retinal laser therapy
326370|NCT01549132|Intravitreal Anti-VEGF Injection therapy|intravitreal anti-vegf injection therapy
326371|NCT01549119|HIV-1|hiv-1
326372|NCT01549119|HIV|hiv
326373|NCT01549119|immunotherapy|immunotherapy
326374|NCT01549119|active immunotherapy|active immunotherapy
326375|NCT01549119|vaccine|vaccine
326376|NCT01549119|virulence|virulence
326377|NCT01549119|innate immunity|innate immunity
326378|NCT01549119|NK cells|nk cells
326379|NCT01549093|Non-small cell lung cancer|non-small cell lung cancer
326380|NCT01549093|Endostar|endostar
326381|NCT01549093|Continued Pumping into|continued pumping into
326382|NCT01549093|Gemcitabine|gemcitabine
326383|NCT01549093|Carboplatin|carboplatin
402999|NCT01228682|Vasopressin|vasopressin
326384|NCT01549080|traditional chinese medicine and thalassemia|traditional chinese medicine and thalassemia
326385|NCT01549067|Advanced|advanced
326386|NCT01549067|Colorectal Cancer|colorectal cancer
326387|NCT01549067|Targeted chemotherapy|targeted chemotherapy
326388|NCT01549067|Surgery|surgery
326389|NCT01549067|Radiotherapy|radiotherapy
326390|NCT01549041|schizophrenia|schizophrenia
326391|NCT01549041|asenapine|asenapine
326392|NCT01549041|Once daily|once daily
326393|NCT01549041|twice daily|twice daily
326394|NCT01549015|Urea Cycle Defects|urea cycle defects
326395|NCT01549015|CPSD|cpsd
326396|NCT01549015|OTCD|otcd
326397|NCT01549015|ASSD|assd
326398|NCT01549015|ASLD|asld
326399|NCT01549002|Abscess|abscess
326400|NCT01549002|Pain|pain
326401|NCT01549002|Administration intranasal|administration intranasal
326402|NCT01549002|Infusions intravenous|infusions intravenous
326403|NCT01548989|linguistic validation of a new questionnaire|linguistic validation of a new questionnaire
326404|NCT01548976|linguistic validation of the PISQ-R questionnaire|linguistic validation of the pisq-r questionnaire
326405|NCT01548963|Tight glycemia control|tight glycemia control
326406|NCT01548963|Model Predictive Control algorithm|model predictive control algorithm
326407|NCT01548963|Cardiac surgery patients|cardiac surgery patients
326408|NCT01548950|Congenital heart disease|congenital heart disease
326409|NCT01548950|Pulmonary arterial hypertension|pulmonary arterial hypertension
326410|NCT01548950|Sildenafil|sildenafil
326411|NCT01548950|Bosentan|bosentan
326412|NCT01548950|Pediatric cardiac surgery|pediatric cardiac surgery
326413|NCT01548937|I-123 ADAM Serotonin transporter imaging|i-123 adam serotonin transporter imaging
402057|NCT01233336|myocardial infarction|myocardial infarction
586556|NCT00516698|stage I breast cancer|stage i breast cancer
326414|NCT01548924|Patients with malignant solid tumors of any histologically confirmed, not susceptible of cure, which have received the standard treatment available|patients with malignant solid tumors of any histologically confirmed, not susceptible of cure, which have received the standard treatment available
326415|NCT01548872|HTk solution|htk solution
326416|NCT01548872|Cardioplegia|cardioplegia
326417|NCT01548872|myocardial protection|myocardial protection
326418|NCT01548872|pediatric cardiac surgery|pediatric cardiac surgery
326419|NCT01548859|Myocardial protection|myocardial protection
326420|NCT01548859|Myocardial injury|myocardial injury
326421|NCT01548859|Anaesthetic preconditioning|anaesthetic preconditioning
326422|NCT01548859|Pediatric cardiac surgery|pediatric cardiac surgery
326423|NCT01548859|Troponin I|troponin i
326424|NCT01548859|Sevoflurane|sevoflurane
326425|NCT01548859|Midazolam|midazolam
326426|NCT01548846|tomotherapy|tomotherapy
326427|NCT01548846|xerostomy|xerostomy
326428|NCT01548846|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
326430|NCT01548833|Contact Lenses|contact lenses
326431|NCT01548820|Hepatitis B virus|hepatitis b virus
326432|NCT01548820|Lamivudine|lamivudine
326433|NCT01548820|Resistance to treatment|resistance to treatment
326434|NCT01548794|spinal anesthesia|spinal anesthesia
326435|NCT01548794|bupivacaine|bupivacaine
326436|NCT01548794|lidocaine|lidocaine
326437|NCT01548794|local infiltration anesthesia|local infiltration anesthesia
326438|NCT01548794|recovery|recovery
326439|NCT01548794|duration of anesthesia|duration of anesthesia
326440|NCT01548794|outpatient herniorrhaphy|outpatient herniorrhaphy
326441|NCT01548781|arm|arm
326442|NCT01548781|strength|strength
326443|NCT01548781|coordination|coordination
326444|NCT01548781|physical therapy|physical therapy
326445|NCT01548781|robotics|robotics
326446|NCT01548781|stroke|stroke
326447|NCT01548781|synergy|synergy
326448|NCT01548768|Rheumatoid Arthritis|rheumatoid arthritis
326449|NCT01548768|Cardiovascular disease|cardiovascular disease
326450|NCT01548768|Myocardium|myocardium
326451|NCT01548768|TNF-alpha inhibitors|tnf-alpha inhibitors
326452|NCT01548768|ESCAPE|escape
326453|NCT01548768|Co-morbidities|co-morbidities
326454|NCT01548768|RHYTHM|rhythm
326455|NCT01548755|Home monitoring|home monitoring
326456|NCT01548755|cardiomessenger|cardiomessenger
326457|NCT01548755|ICD|icd
326458|NCT01548742|Meditation|meditation
326459|NCT01548729|Cystic Fibrosis|cystic fibrosis
326460|NCT01548729|Diabetes Related Cystic Fibrosis|diabetes related cystic fibrosis
326461|NCT01548729|Lung transplantation|lung transplantation
326462|NCT01548729|Pancreatic islets|pancreatic islets
326463|NCT01548716|Pruritis in hemodialysis patients|pruritis in hemodialysis patients
326464|NCT01548716|25-Vitamin D in chronic kidney disease|25-vitamin d in chronic kidney disease
326465|NCT01548703|metabotropic glutamate receptors 2 and 3|metabotropic glutamate receptors 2 and 3
326466|NCT01548703|antagonist|antagonist
326467|NCT01548703|mGluR|mglur
326468|NCT01548703|ketamine|ketamine
326469|NCT01548703|BDNF|bdnf
326470|NCT01548703|Depression|depression
326471|NCT01548703|Major Depressive Disorder|major depressive disorder
326472|NCT01548703|Treatment Resistant Depression|treatment resistant depression
326473|NCT01548703|Mood Disorder|mood disorder
326474|NCT01548703|Phase 1 safety, tolerability and pharmacokinetics study|phase 1 safety, tolerability and pharmacokinetics study
326475|NCT01548690|ornithine|ornithine
326476|NCT01548690|phenylacetate|phenylacetate
326477|NCT01548690|acetaminophen toxicity|acetaminophen toxicity
326478|NCT01548690|acute liver failure|acute liver failure
326479|NCT01548690|hepatitis B|hepatitis b
326480|NCT01548690|autoimmune hepatitis|autoimmune hepatitis
326481|NCT01548690|drug-induced liver injury|drug-induced liver injury
326482|NCT01548677|Circulating Tumour Cells|circulating tumour cells
326483|NCT01548677|HER2 negative primary breast cancer|her2 negative primary breast cancer
326484|NCT01548677|HER2 positive CTC|her2 positive ctc
326485|NCT01548677|Trastuzumab|trastuzumab
326486|NCT01548664|Total knee replacement|total knee replacement
326487|NCT01548664|Outpatient|outpatient
326488|NCT01548664|Randomized controlled trial|randomized controlled trial
326489|NCT01548664|Video games|video games
326490|NCT01548638|Tobacco|tobacco
326491|NCT01548638|Smoking|smoking
326492|NCT01548638|Galantamine|galantamine
326493|NCT01548625|risk of cardiovascular events|risk of cardiovascular events
326494|NCT01548612|Schizophrenia|schizophrenia
326495|NCT01548612|Nitric oxide|nitric oxide
326496|NCT01548612|Sodium nitroprusside|sodium nitroprusside
326497|NCT01548599|HIV|hiv
326498|NCT01548599|Malnutrition|malnutrition
326499|NCT01548599|Food Security|food security
326500|NCT01548599|Kenya|kenya
326501|NCT01548586|tDCS|tdcs
326502|NCT01548586|Diaphragm|diaphragm
326503|NCT01548586|Cortical Excitability|cortical excitability
326504|NCT01548586|MEPs|meps
326505|NCT01548586|TMS|tms
326506|NCT01548573|multiple myeloma|multiple myeloma
326507|NCT01548573|POEMS (Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes)|poems (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes)
326508|NCT01548573|amyloidosis|amyloidosis
326509|NCT01548573|bone marrow transplant|bone marrow transplant
326510|NCT01548573|autologous|autologous
326511|NCT01548560|HIV Infections|hiv infections
326512|NCT01548560|Anti-HIV agents|anti-hiv agents
326513|NCT01548560|HIV-1|hiv-1
326514|NCT01548547|intravenous line|intravenous line
326515|NCT01548547|simulation education|simulation education
326516|NCT01548534|Metastatic Breast Cancer|metastatic breast cancer
326517|NCT01548534|First-Line chemotherapy|first-line chemotherapy
326159|NCT01550094|Soberon|soberon
326518|NCT01548534|Taxane or Anthracycline|taxane or anthracycline
326520|NCT01548534|PUFA|pufa
326521|NCT01548534|Dietary supplementation|dietary supplementation
326522|NCT01548534|First-Line Taxane or Anthracycline based chemotherapy|first-line taxane or anthracycline based chemotherapy
326523|NCT01548521|Prader-Willi, neonates, poor suckling|prader-willi, neonates, poor suckling
326623|NCT01548040|strength|strength
326524|NCT01548508|Advanced Chronic Heart Failure, physical therapy, Exercise|advanced chronic heart failure, physical therapy, exercise
326525|NCT01548495|MDS|mds
326526|NCT01548495|Autoantibodies|autoantibodies
326527|NCT01548495|Erythropoietin|erythropoietin
326528|NCT01548495|Autoantibodies in MDS patients treated with EPO|autoantibodies in mds patients treated with epo
326529|NCT01548469|Mild periodontitis|mild periodontitis
326530|NCT01548469|Bio Mineral toothpaste|bio mineral toothpaste
326531|NCT01548469|Geumjin Thermal Water|geumjin thermal water
326532|NCT01548456|femur fracture|femur fracture
326533|NCT01548456|internal fixation|internal fixation
326534|NCT01548456|intramedullary nailing|intramedullary nailing
326535|NCT01548443|Wound Healing|wound healing
326536|NCT01548443|hydrocolloid|hydrocolloid
326537|NCT01548443|Wound Dressing|wound dressing
326538|NCT01548443|Medifoam H|medifoam h
326539|NCT01548443|Duoderm THIN|duoderm thin
326540|NCT01548443|Mild Acute Trauma|mild acute trauma
326541|NCT01548417|Alcohol|alcohol
326542|NCT01548417|Relapse|relapse
326543|NCT01548378|HGF|hgf
326544|NCT01548378|Gene|gene
326545|NCT01548378|Critical Limb Ischemia|critical limb ischemia
326546|NCT01548365|Nursing Services|nursing services
326547|NCT01548365|Catheterization, Central Venous|catheterization, central venous
326548|NCT01548365|Catheters Indwelling|catheters indwelling
326549|NCT01548365|Catheterization, Peripheral|catheterization, peripheral
326550|NCT01548352|Syncope|syncope
326551|NCT01548352|Unconsciousness|unconsciousness
326552|NCT01548352|Syncope, vasovagal, neurally-mediated|syncope, vasovagal, neurally-mediated
326553|NCT01548352|Syncope, cardiogenic|syncope, cardiogenic
326554|NCT01548352|Cardiac arrhythmia|cardiac arrhythmia
326555|NCT01548352|Sudden cardiac death|sudden cardiac death
326556|NCT01548352|Syncopal episode|syncopal episode
326557|NCT01548326|Vaccination Failure|vaccination failure
326558|NCT01548326|Nonresponder|nonresponder
326559|NCT01548326|Hepatitis B virus|hepatitis b virus
326560|NCT01548326|Atorvastatin|atorvastatin
326561|NCT01548326|Immunization against viral Hepatitis|immunization against viral hepatitis
326562|NCT01548313|human milk|human milk
326563|NCT01548313|nutrition|nutrition
326564|NCT01548313|breastfed child|breastfed child
326565|NCT01548313|microbiota|microbiota
326566|NCT01548313|fatty acids|fatty acids
326567|NCT01548313|intestinal microbiota|intestinal microbiota
326568|NCT01548313|probiotics|probiotics
326569|NCT01548300|cardiometabolic disease|cardiometabolic disease
317319|NCT01587144|GBM|gbm
326570|NCT01548287|Mild Cognitive Impairment|mild cognitive impairment
326571|NCT01548287|Mild Alzheimer's disease|mild alzheimer's disease
326572|NCT01548287|Safety|safety
326573|NCT01548287|Tolerability|tolerability
326574|NCT01548274|endothelial progenitor cells|endothelial progenitor cells
326575|NCT01548261|obtain the oral mucosal tissue from healthy donors|obtain the oral mucosal tissue from healthy donors
326576|NCT01548222|type 2 diabetes|type 2 diabetes
326577|NCT01548222|continuous glucose|continuous glucose
326578|NCT01548222|basal insulin|basal insulin
326579|NCT01548196|nephrolithotomy|nephrolithotomy
326580|NCT01548170|Pharmacokinetic|pharmacokinetic
326581|NCT01548170|Sunitinib|sunitinib
326582|NCT01548170|Ketoconazol|ketoconazol
326583|NCT01548170|interaction, Phase I|interaction, phase i
326584|NCT01548157|HCP1007|hcp1007
326585|NCT01548157|Rosuvastatin|rosuvastatin
326586|NCT01548157|Omega-3|omega-3
326587|NCT01548144|Advanced Cancers|advanced cancers
326588|NCT01548144|Advanced Malignancies|advanced malignancies
326589|NCT01548144|Crizotinib|crizotinib
326590|NCT01548144|PF-02341066|pf-02341066
326591|NCT01548144|Pazopanib|pazopanib
326592|NCT01548144|Gw786034|gw786034
326593|NCT01548144|Pemetrexed|pemetrexed
326594|NCT01548144|LY231514|ly231514
326595|NCT01548144|Alimta|alimta
326596|NCT01548144|MTA|mta
326597|NCT01548144|Multitargeted Antifolate|multitargeted antifolate
326598|NCT01548144|NSC-698037|nsc-698037
326599|NCT01548131|fear of childbirth|fear of childbirth
326600|NCT01548131|delivery mode|delivery mode
326601|NCT01548131|delivery satisfaction|delivery satisfaction
326602|NCT01548118|Human papillomavirus|human papillomavirus
326603|NCT01548118|vaccine|vaccine
326604|NCT01548118|cervical infection|cervical infection
711613|NCT01013948|COPD|copd
326605|NCT01548118|cervical cancer|cervical cancer
326606|NCT01548105|Pelvic organ prolapse|pelvic organ prolapse
326607|NCT01548105|smoking and collagen metabolism|smoking and collagen metabolism
326608|NCT01548092|Recto-vaginal fistula|recto-vaginal fistula
326609|NCT01548092|Adipose Derived Stem Cells|adipose derived stem cells
326610|NCT01548079|ursodeoxycholic acid|ursodeoxycholic acid
326611|NCT01548079|fatty liver disease|fatty liver disease
326612|NCT01548079|morbid obesity|morbid obesity
326613|NCT01548079|bariatric surgery|bariatric surgery
326614|NCT01548079|NAFLD|nafld
326615|NCT01548053|Primary care|primary care
326616|NCT01548053|Dementia|dementia
326617|NCT01548053|Knowledge translation|knowledge translation
326618|NCT01548053|Quality of care|quality of care
326619|NCT01548053|Qualitative methods|qualitative methods
326620|NCT01548053|Alzheimer's disease|alzheimer's disease
326622|NCT01548040|Muscle|muscle
326624|NCT01548040|TKA|tka
326625|NCT01548040|Focus to show shorter muscle recovery after Knee operation|focus to show shorter muscle recovery after knee operation
326626|NCT01548027|TAP block|tap block
326627|NCT01548027|postoperative analgesia|postoperative analgesia
326628|NCT01548014|Crohn's disease|crohn's disease
326629|NCT01548014|VSL #3|vsl #3
326630|NCT01548014|infliximab|infliximab
326631|NCT01548001|Rheumatoid Arthritis|rheumatoid arthritis
326632|NCT01548001|Iguratimod|iguratimod
326633|NCT01548001|Methotrexate|methotrexate
326634|NCT01547988|Aging|aging
326635|NCT01547988|Falls|falls
326636|NCT01547988|Balance Control|balance control
326637|NCT01547988|Voluntary Step Execution Test|voluntary step execution test
326638|NCT01547988|Dual-Task|dual-task
326639|NCT01547988|Self-reported function|self-reported function
326640|NCT01547975|surgical outcomes after corneal transplantation|surgical outcomes after corneal transplantation
326641|NCT01547975|Retrospective analysis|retrospective analysis
326642|NCT01547975|corneal transplantation|corneal transplantation
326643|NCT01547949|pain|pain
326644|NCT01547949|inflammation|inflammation
326645|NCT01547949|muscle damage|muscle damage
326646|NCT01547923|Colorectal Cancer|colorectal cancer
326647|NCT01547923|DihydroPyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
326648|NCT01547923|Lethal toxicity|lethal toxicity
326649|NCT01547923|Fluoropyrimidine|fluoropyrimidine
326650|NCT01547910|fatty liver|fatty liver
326651|NCT01547910|hepatitis|hepatitis
326652|NCT01547910|insulin resistance|insulin resistance
326653|NCT01547910|unsaturated fatty acids|unsaturated fatty acids
326654|NCT01547910|NAFLD, children|nafld, children
326655|NCT01547884|Immune Responses|immune responses
326656|NCT01547884|Mycobacterial Antigens|mycobacterial antigens
326657|NCT01547884|Tissue-invasive Helminth Parasites|tissue-invasive helminth parasites
326658|NCT01547871|Natural History Study|natural history study
326659|NCT01547871|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
326660|NCT01547871|Natural History|natural history
326661|NCT01547858|Hematotoxicity|hematotoxicity
326662|NCT01547858|Formaldehyde|formaldehyde
326663|NCT01547858|Cross-Sectional Study|cross-sectional study
326664|NCT01547858|Occupational Exposure|occupational exposure
326665|NCT01547845|Disparities|disparities
326666|NCT01547845|Patient Reported Outcomes|patient reported outcomes
326667|NCT01547845|Symptoms|symptoms
326668|NCT01547845|Symptom Surveillance|symptom surveillance
326669|NCT01547832|Cholesterol|cholesterol
326670|NCT01547832|Early Onset Parkinson's Disease|early onset parkinson's disease
326671|NCT01547832|Fat Metabolism|fat metabolism
326672|NCT01547832|Insulin Resistance|insulin resistance
326673|NCT01547832|PARK2 Mutations|park2 mutations
326674|NCT01547819|TBI|tbi
326675|NCT01547819|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
326676|NCT01547819|PTSD|ptsd
326677|NCT01547819|PET Imaging|pet imaging
326678|NCT01547819|11C-Flumazenil|11c-flumazenil
326679|NCT01547806|Autologous Hematopoietic Cell Transplantation|autologous hematopoietic cell transplantation
326680|NCT01547806|Plasma Cell Myeloma|plasma cell myeloma
326681|NCT01547806|Mobilization|mobilization
326682|NCT01547806|Apheresis|apheresis
326683|NCT01547806|Plerixafor|plerixafor
326684|NCT01547793|Hemolytic Severity|hemolytic severity
326685|NCT01547793|Erythrocyte|erythrocyte
326686|NCT01547793|Sickle Cell Disease|sickle cell disease
326687|NCT01547793|SD|sd
326688|NCT01547780|MRI|mri
326689|NCT01547780|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
326690|NCT01547780|Inflammation|inflammation
326691|NCT01547780|Microglial Activation|microglial activation
326692|NCT01547780|Traumatic Brain Injury|traumatic brain injury
326693|NCT01547780|TBI|tbi
326694|NCT01547767|Metabolism|metabolism
326695|NCT01547767|Muscle|muscle
326696|NCT01547767|Mutation|mutation
326697|NCT01547767|ISCU Myopathy|iscu myopathy
326698|NCT01547767|Myopathy|myopathy
326699|NCT01547754|Neuroinflammation|neuroinflammation
326700|NCT01547754|HIV|hiv
326701|NCT01547754|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
326702|NCT01547754|Mild Neurocognitive Disorder|mild neurocognitive disorder
711804|NCT01014767|Etoposide|etoposide
326703|NCT01547754|P-Glycoprotein|p-glycoprotein
326704|NCT01547754|Mild Cognitive Disorder|mild cognitive disorder
326705|NCT01547754|Healthy Volunteer|healthy volunteer
326707|NCT01547741|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
326708|NCT01547741|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
326709|NCT01547741|HER2-negative breast cancer|her2-negative breast cancer
326710|NCT01547741|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
326711|NCT01547741|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
326712|NCT01547741|stage IA breast cancer|stage ia breast cancer
326713|NCT01547741|stage IB breast cancer|stage ib breast cancer
326714|NCT01547741|stage II breast cancer|stage ii breast cancer
326715|NCT01547741|stage IIIA breast cancer|stage iiia breast cancer
326716|NCT01547741|stage IIIC breast cancer|stage iiic breast cancer
326717|NCT01547728|antithrombin|antithrombin
326718|NCT01547728|Heparin Resistant|heparin resistant
326719|NCT01547728|Cardiac Surgery|cardiac surgery
326720|NCT01547715|Meningococcal,|meningococcal,
326721|NCT01547715|ACWY,|acwy,
326722|NCT01547715|bacterial meningitis,|bacterial meningitis,
326723|NCT01547715|conjugate vaccine,|conjugate vaccine,
326724|NCT01547715|healthy, children,|healthy, children,
326725|NCT01547715|adolescents,|adolescents,
326726|NCT01547715|adults,|adults,
326727|NCT01547715|India|india
326728|NCT01547702|ADHD|adhd
326729|NCT01547702|attention|attention
326730|NCT01547702|inattention|inattention
326731|NCT01547702|hyperactivity|hyperactivity
326732|NCT01547702|classroom intervention|classroom intervention
326733|NCT01547702|teacher education|teacher education
326734|NCT01547702|web-based intervention|web-based intervention
326735|NCT01547663|pain scale|pain scale
326736|NCT01547663|craniotomy|craniotomy
326737|NCT01547637|Obturator nerve block|obturator nerve block
326738|NCT01547637|Regional anesthesia|regional anesthesia
326739|NCT01547637|TURBT|turbt
326740|NCT01547624|Neck|neck
326742|NCT01547624|Muscles|muscles
326743|NCT01547624|Activity|activity
326744|NCT01547624|Coordination|coordination
326745|NCT01547611|Rehabilitation|rehabilitation
326746|NCT01547611|Cervical Spine|cervical spine
326747|NCT01547611|Radiculopathy|radiculopathy
326748|NCT01547611|Disc|disc
326749|NCT01547611|Surgery|surgery
326750|NCT01547585|Cholesterol|cholesterol
326751|NCT01547585|Cardiovascular disease|cardiovascular disease
326752|NCT01547585|Soy|soy
326753|NCT01547585|Dose-response|dose-response
326754|NCT01547572|Video education|video education
326755|NCT01547572|Enhanced recovery|enhanced recovery
326756|NCT01547572|Reducing hospital stay|reducing hospital stay
326757|NCT01547572|Improving patient satisfaction|improving patient satisfaction
326758|NCT01547533|Chagas disease|chagas disease
326759|NCT01547533|lactation|lactation
326760|NCT01547533|breastmilk|breastmilk
326761|NCT01547533|postpartum period|postpartum period
326762|NCT01547533|infants|infants
326763|NCT01547533|pediatric clinical pharmacology|pediatric clinical pharmacology
326764|NCT01547533|developmental clinical pharmacology|developmental clinical pharmacology
326765|NCT01547533|parasitology|parasitology
326766|NCT01547533|trypanosoma cruzi|trypanosoma cruzi
326767|NCT01547520|meperidine|meperidine
326768|NCT01547520|esophagogastroduodenoscopy|esophagogastroduodenoscopy
326769|NCT01547520|unsedated|unsedated
326770|NCT01547520|minimal sedation|minimal sedation
326771|NCT01547507|hemodynamics|hemodynamics
326772|NCT01547507|respiratory|respiratory
326773|NCT01547494|Migraines|migraines
326774|NCT01547494|Diet, Vegetarian|diet, vegetarian
326775|NCT01547494|Diet, Fat-Restricted|diet, fat-restricted
326776|NCT01547494|Pain|pain
326777|NCT01547468|hip fracture|hip fracture
326778|NCT01547468|elderly|elderly
326779|NCT01547468|delirium|delirium
326780|NCT01547468|broken hip|broken hip
326781|NCT01547468|hip|hip
326782|NCT01547468|surgery|surgery
326783|NCT01547468|orthopedic|orthopedic
326784|NCT01547468|orthopedic surgery|orthopedic surgery
326785|NCT01547468|pain|pain
326786|NCT01547468|anesthesia|anesthesia
326787|NCT01547468|Ochsner Clinic|ochsner clinic
326788|NCT01547468|Ochsner Hospital|ochsner hospital
326789|NCT01547468|Leslie Thomas MD|leslie thomas md
326790|NCT01547468|New Orleans|new orleans
326791|NCT01547468|Louisiana|louisiana
326792|NCT01547455|Statin|statin
326793|NCT01547455|kidney function|kidney function
326794|NCT01547455|antiinflammatory effect|antiinflammatory effect
326795|NCT01547442|aphakia|aphakia
326796|NCT01547442|secondary intraocular lens|secondary intraocular lens
326797|NCT01547442|congenital cataract|congenital cataract
326798|NCT01547442|marfan syndrome|marfan syndrome
326799|NCT01547442|pediatric cataract|pediatric cataract
326800|NCT01547442|ectopia lentis|ectopia lentis
326801|NCT01547442|subluxated lens|subluxated lens
326802|NCT01547429|aphakia|aphakia
326803|NCT01547429|secondary intraocular lens|secondary intraocular lens
326804|NCT01547416|Diaphragmatic dysfunction|diaphragmatic dysfunction
326805|NCT01547416|General anesthesia|general anesthesia
326806|NCT01547416|Epidural Anesthesia|epidural anesthesia
326807|NCT01547403|Screening for Type 2 Diabetes|screening for type 2 diabetes
326808|NCT01547390|preeclampsia|preeclampsia
326810|NCT01547377|atherosclerosis|atherosclerosis
326811|NCT01547377|zinc and selenium status|zinc and selenium status
326812|NCT01547377|rosuvastatin|rosuvastatin
326813|NCT01547377|oxidative stress biomarkers|oxidative stress biomarkers
326814|NCT01547377|inflammation biomarkers|inflammation biomarkers
326815|NCT01547364|Caudal|caudal
326816|NCT01547364|Epidural|epidural
326817|NCT01547364|Dextrose|dextrose
326818|NCT01547364|Analgesia|analgesia
326819|NCT01547364|TRVP1|trvp1
326820|NCT01547351|Relapse in multiple sclerosis|relapse in multiple sclerosis
326821|NCT01547351|Psychometric properties of the patient self-report questionnaire|psychometric properties of the patient self-report questionnaire
326822|NCT01547351|Evaluation of ARMS questionnaire|evaluation of arms questionnaire
326823|NCT01547338|Breast|breast
326824|NCT01547338|Reconstruction|reconstruction
326825|NCT01547299|prostate cancer|prostate cancer
327279|NCT01545492|measurement|measurement
326826|NCT01547299|prostatectomy|prostatectomy
326827|NCT01547299|neoadjuvant|neoadjuvant
326828|NCT01547286|Asthma|asthma
326829|NCT01547286|Allergen Challenge|allergen challenge
326830|NCT01547286|Cat allergen|cat allergen
326831|NCT01547286|Dust mite allergen|dust mite allergen
326832|NCT01547286|Airway Hyper-responsiveness|airway hyper-responsiveness
326833|NCT01547286|Positron Emission Tomography - Computed Tomography|positron emission tomography - computed tomography
326834|NCT01547286|Nitrogen isotopes|nitrogen isotopes
326835|NCT01547286|Blood flow|blood flow
326836|NCT01547247|colonoscopy|colonoscopy
326837|NCT01547247|cap-assisted colonoscopy|cap-assisted colonoscopy
326838|NCT01547247|water immersion colonoscopy|water immersion colonoscopy
326839|NCT01547234|Multiple Sclerosis|multiple sclerosis
326840|NCT01547234|ambulation|ambulation
326841|NCT01547234|manual function|manual function
326842|NCT01547234|Fampridine|fampridine
326843|NCT01547221|otomycosis|otomycosis
326844|NCT01547221|3% boric acid|3% boric acid
326845|NCT01547221|1% clotrimazole ear drop|1% clotrimazole ear drop
326846|NCT01547208|ICD shocks|icd shocks
326847|NCT01547208|Ventricular tachycardias ablation|ventricular tachycardias ablation
326848|NCT01547208|Timing of ablation|timing of ablation
326849|NCT01547208|Electrical storm|electrical storm
326850|NCT01547208|Arrhythmic storm|arrhythmic storm
326851|NCT01547195|fibromyalgia|fibromyalgia
326852|NCT01547195|swimming|swimming
326853|NCT01547169|memory|memory
326854|NCT01547169|intranasal insulin|intranasal insulin
326855|NCT01547169|Alzheimer's disease|alzheimer's disease
326856|NCT01547156|patient decision support|patient decision support
326857|NCT01547156|telemonitoring|telemonitoring
326858|NCT01547156|self-management|self-management
326859|NCT01547156|remote patient monitoring|remote patient monitoring
326860|NCT01547156|active assistance technology|active assistance technology
326861|NCT01547156|selfcare|selfcare
326862|NCT01547143|Secondary hemophagocytic lymphohistiocytosis of adults|secondary hemophagocytic lymphohistiocytosis of adults
326863|NCT01547130|Colonoscopy|colonoscopy
326864|NCT01547130|Yoga|yoga
326865|NCT01547130|Complementary and alternative medicine|complementary and alternative medicine
317560|NCT01586221|Fingers|fingers
326866|NCT01547130|Bowel cleansing|bowel cleansing
326867|NCT01547130|Large bowel preparation|large bowel preparation
326868|NCT01547130|Cancer screening|cancer screening
326869|NCT01547130|Colorectal cancer|colorectal cancer
326870|NCT01547117|POTS|pots
326871|NCT01547117|Orthostatic Intolerance|orthostatic intolerance
326872|NCT01547117|Orthostatic Tachycardia|orthostatic tachycardia
326873|NCT01547091|Mesenchymal Stem Cells|mesenchymal stem cells
326874|NCT01547091|Rheumatoid Arthritis|rheumatoid arthritis
326875|NCT01547065|TEE and renal resistive index|tee and renal resistive index
326876|NCT01547052|DBT, child, emotion regulation, behavior problems, residential care|dbt, child, emotion regulation, behavior problems, residential care
326877|NCT01547039|Carotid endarterectomy|carotid endarterectomy
326878|NCT01547039|Transcranial doppler|transcranial doppler
326879|NCT01547039|Micro embolic signals|micro embolic signals
326880|NCT01547039|Platelets|platelets
326881|NCT01547039|Aspirin|aspirin
326882|NCT01547026|schizophrenia|schizophrenia
326883|NCT01547026|exercise|exercise
326884|NCT01547026|sport|sport
326885|NCT01547026|weight control|weight control
326886|NCT01547026|fitness|fitness
326887|NCT01547000|Tourette Syndrome|tourette syndrome
326888|NCT01547000|Tourette Disorder|tourette disorder
326889|NCT01547000|Tics|tics
326890|NCT01547000|Motor tics|motor tics
326891|NCT01547000|Vocal tics|vocal tics
326892|NCT01547000|Intuniv|intuniv
326893|NCT01547000|Guanfacine|guanfacine
326894|NCT01547000|Medication|medication
326895|NCT01547000|Drug|drug
326896|NCT01547000|Placebo|placebo
326897|NCT01547000|Child|child
326898|NCT01547000|Children|children
326899|NCT01547000|Adolescent|adolescent
326900|NCT01546987|adenocarcinoma of the prostate|adenocarcinoma of the prostate
326901|NCT01546987|stage I prostate cancer|stage i prostate cancer
326902|NCT01546987|stage IIA prostate cancer|stage iia prostate cancer
326903|NCT01546987|stage IIB prostate cancer|stage iib prostate cancer
326904|NCT01546987|stage III prostate cancer|stage iii prostate cancer
326905|NCT01546987|stage IV prostate cancer|stage iv prostate cancer
326906|NCT01546974|Mechanical Ventilation|mechanical ventilation
326907|NCT01546974|Humidification system|humidification system
326908|NCT01546974|Patients submitted to mechanical ventilation for at least 48 hours|patients submitted to mechanical ventilation for at least 48 hours
326909|NCT01546961|Chloroquine|chloroquine
326910|NCT01546961|Uncomplicated vivax malaria|uncomplicated vivax malaria
326911|NCT01546948|Methadone|methadone
326912|NCT01546948|Hydromorphone|hydromorphone
326913|NCT01546948|Hepatobiliary surgery|hepatobiliary surgery
326914|NCT01546948|Postoperative pain|postoperative pain
326915|NCT01546935|Influenza|influenza
326916|NCT01546935|Oseltamivir|oseltamivir
326917|NCT01546935|Lower tract respiratory infection|lower tract respiratory infection
326918|NCT01546922|Hydrocortisone|hydrocortisone
326919|NCT01546922|Cognition|cognition
326920|NCT01546922|Adrenal insufficiency|adrenal insufficiency
326921|NCT01546922|Quality of Life|quality of life
326922|NCT01546922|Common Somatic Complaints|common somatic complaints
326923|NCT01546922|Cardiovascular/Metabolic Profile|cardiovascular/metabolic profile
326924|NCT01546922|Somatosensation|somatosensation
326925|NCT01546883|Atrial fibrillation|atrial fibrillation
326926|NCT01546883|MRI|mri
326927|NCT01546857|orthopedic pain|orthopedic pain
326928|NCT01546844|SMS|sms
326929|NCT01546844|text|text
326930|NCT01546844|text messages|text messages
326931|NCT01546844|text messaging|text messaging
326932|NCT01546844|diabetes|diabetes
326933|NCT01546844|diabetes mellitus|diabetes mellitus
326934|NCT01546844|type II diabetes|type ii diabetes
327702|NCT01543763|progression|progression
326935|NCT01546844|type II diabetes mellitus|type ii diabetes mellitus
326936|NCT01546844|type 2 diabetes|type 2 diabetes
326937|NCT01546844|type 2 diabetes mellitus|type 2 diabetes mellitus
326938|NCT01546844|Beacon|beacon
326939|NCT01546818|HIV|hiv
326940|NCT01546818|Vaccine|vaccine
326941|NCT01546818|HIV-1 infections|hiv-1 infections
326942|NCT01546805|Blepharospasm|blepharospasm
326943|NCT01546805|Hemifacial spasm|hemifacial spasm
326944|NCT01546805|Botox|botox
326945|NCT01546805|Zinc|zinc
326946|NCT01546792|exercise|exercise
326947|NCT01546792|diet|diet
326948|NCT01546792|lifestyle|lifestyle
326949|NCT01546792|sleep apnoea|sleep apnoea
326950|NCT01546792|obesity|obesity
326951|NCT01546766|Diabetes|diabetes
326952|NCT01546766|Pupillary response|pupillary response
326953|NCT01546766|Retinal disorders|retinal disorders
326954|NCT01546766|Midperipheral ischemia|midperipheral ischemia
326955|NCT01546766|Fundus photography|fundus photography
326956|NCT01546766|Optical coherence tomography|optical coherence tomography
326957|NCT01546753|Walnut hypersensitivity|walnut hypersensitivity
326958|NCT01546753|Tree nut hypersensitivity|tree nut hypersensitivity
326959|NCT01546753|Oral immunotherapy|oral immunotherapy
326960|NCT01546753|Food allergy|food allergy
326961|NCT01546753|Walnut allergy|walnut allergy
326962|NCT01546753|tree nut allergy|tree nut allergy
326963|NCT01546740|Glaucoma, Compliance, Prevalence|glaucoma, compliance, prevalence
326964|NCT01546727|Preschoolers|preschoolers
326965|NCT01546727|Obesity|obesity
326966|NCT01546727|Behavioral Treatment|behavioral treatment
326967|NCT01546675|Amputation|amputation
326968|NCT01546675|Prosthesis Design|prosthesis design
326969|NCT01546675|Biomechanics|biomechanics
326970|NCT01546662|Rhinitis|rhinitis
326971|NCT01546636|Cerebral desaturation events|cerebral desaturation events
326972|NCT01546636|Cerebral oximetry|cerebral oximetry
326973|NCT01546636|Beach chair position|beach chair position
326974|NCT01546610|Rheumatoid foot|rheumatoid foot
326975|NCT01546610|foot pain|foot pain
326976|NCT01546610|insoles|insoles
326977|NCT01546610|foot function|foot function
326978|NCT01546610|electronic baropodometer|electronic baropodometer
326979|NCT01546610|plantar pressure|plantar pressure
326980|NCT01546610|gait analysis|gait analysis
326981|NCT01546597|Metformin|metformin
326982|NCT01546597|Ranolazine|ranolazine
326983|NCT01546597|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
326984|NCT01546558|Metformin|metformin
326985|NCT01546558|Ranolazine|ranolazine
326986|NCT01546558|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
326987|NCT01546532|Heart failure|heart failure
326988|NCT01546532|RLX030|rlx030
326989|NCT01546532|hemodynamics|hemodynamics
326990|NCT01546532|cardiovascular diseases|cardiovascular diseases
326991|NCT01546480|Chronic postoperative pain|chronic postoperative pain
326992|NCT01546480|Postcholecystectomy pain|postcholecystectomy pain
326993|NCT01546480|Inflammation|inflammation
326994|NCT01546480|Interleukines|interleukines
326995|NCT01546467|Schizophrenia|schizophrenia
326996|NCT01546467|Schizoaffective disorder|schizoaffective disorder
326997|NCT01546467|Psychosis|psychosis
326998|NCT01546467|Early phase|early phase
326999|NCT01546467|Cognitive remediation|cognitive remediation
327000|NCT01546467|Functional outcome|functional outcome
327001|NCT01546454|Premenopausal women|premenopausal women
327002|NCT01546454|coronary heart disease|coronary heart disease
327003|NCT01546454|menstrual cycle|menstrual cycle
327004|NCT01546454|lipids|lipids
327005|NCT01546441|primary care|primary care
327006|NCT01546441|aging|aging
327007|NCT01546441|interprofessional care|interprofessional care
327008|NCT01546441|multimorbidity|multimorbidity
327009|NCT01546428|c-MET|c-met
327010|NCT01546428|Advanced solid tumor|advanced solid tumor
327011|NCT01546415|Phase 4|phase 4
327012|NCT01546415|Desferasirox|desferasirox
327013|NCT01546415|Iron Overload|iron overload
327014|NCT01546415|Aplastic Anemia|aplastic anemia
327015|NCT01546389|Malaria, vaccine, PfSPZ, challenge|malaria, vaccine, pfspz, challenge
327016|NCT01546350|infertility, recurrent pregnancy loss, miscarriage|infertility, recurrent pregnancy loss, miscarriage
327017|NCT01546337|anemia|anemia
327018|NCT01546337|non-myeloid haemopathy|non-myeloid haemopathy
327019|NCT01546337|myelodysplastic syndrome|myelodysplastic syndrome
327020|NCT01546337|Erythropoiesis stimulating agents|erythropoiesis stimulating agents
327021|NCT01546337|predictive markers|predictive markers
327280|NCT01545492|genetics|genetics
327022|NCT01546324|Maternal Blood|maternal blood
327023|NCT01546324|PGD|pgd
327024|NCT01546324|PGS|pgs
327025|NCT01546324|Natera|natera
327026|NCT01546324|Gene Security Network|gene security network
327027|NCT01546324|Non-invasive prenatal diagnosis|non-invasive prenatal diagnosis
327028|NCT01546311|prosthetic socket|prosthetic socket
327029|NCT01546311|residual limb volume fluctuation|residual limb volume fluctuation
327030|NCT01546311|instantaneous bladder|instantaneous bladder
327031|NCT01546298|Contact Dermatitis|contact dermatitis
327126|NCT01545882|hormone-resistant|hormone-resistant
327127|NCT01545882|degarelix|degarelix
327128|NCT01545882|firmagon|firmagon
327129|NCT01545882|anti-androgens|anti-androgens
327032|NCT01546285|The focus of this study is to demonstrate that DINAMAP® SuperSTATTM NIBP algorithm has been implemented correctly without performance losses to the B40 monitor|the focus of this study is to demonstrate that dinamap® superstattm nibp algorithm has been implemented correctly without performance losses to the b40 monitor
327033|NCT01546272|Subcutaneous resorbable sutures|subcutaneous resorbable sutures
327034|NCT01546272|Tolerance / effectiveness of subcutaneous suture|tolerance / effectiveness of subcutaneous suture
327035|NCT01546272|Reduced operative time and anesthesia time|reduced operative time and anesthesia time
327036|NCT01546272|Medico-economic evaluation|medico-economic evaluation
327037|NCT01546272|Accidental exposure to blood|accidental exposure to blood
327038|NCT01546259|colonoscopy|colonoscopy
327039|NCT01546259|water|water
327040|NCT01546259|female|female
327041|NCT01546259|BMI|bmi
327042|NCT01546259|unsedated|unsedated
327043|NCT01546259|low BMI female patients|low bmi female patients
327044|NCT01546259|Intubation|intubation
327045|NCT01546246|colonoscopy|colonoscopy
327046|NCT01546246|water|water
327047|NCT01546246|incomplete|incomplete
327048|NCT01546246|failed|failed
327049|NCT01546246|unsedated|unsedated
327050|NCT01546233|Lung cancer|lung cancer
327051|NCT01546233|Chemotherapy|chemotherapy
327052|NCT01546233|Multidisciplinary self care programme|multidisciplinary self care programme
327053|NCT01546233|Fatigue|fatigue
406115|NCT01213810|HIV|hiv
327054|NCT01546220|colonoscopy|colonoscopy
327055|NCT01546220|elder patient|elder patient
327056|NCT01546220|water|water
327057|NCT01546220|unsedated|unsedated
327058|NCT01546207|ventricular tachycardia|ventricular tachycardia
327059|NCT01546207|catheter ablation|catheter ablation
327060|NCT01546207|VT|vt
327061|NCT01546194|Informed consent|informed consent
327062|NCT01546194|Perioperative period|perioperative period
327063|NCT01546194|Morning of surgery|morning of surgery
327064|NCT01546194|Anesthesiology|anesthesiology
327065|NCT01546181|photoreceptors|photoreceptors
327066|NCT01546181|retinal pigment epithelium|retinal pigment epithelium
327067|NCT01546181|adaptive optics|adaptive optics
327068|NCT01546168|Atrial Fibrillation ablation|atrial fibrillation ablation
327069|NCT01546168|Esophageal Deviation|esophageal deviation
327070|NCT01546168|AF|af
327071|NCT01546116|adefovir|adefovir
327072|NCT01546116|lamivudine|lamivudine
327073|NCT01546116|entecavir resistance|entecavir resistance
327074|NCT01546103|Vitamin D deficiency|vitamin d deficiency
327075|NCT01546090|Alprazolam|alprazolam
327076|NCT01546090|benzodiazepines|benzodiazepines
327077|NCT01546090|Inferior alveolar nerve block|inferior alveolar nerve block
327078|NCT01546090|irreversible pulpitis|irreversible pulpitis
327079|NCT01546090|local anesthesia|local anesthesia
327080|NCT01546064|Bile duct anastomosis|bile duct anastomosis
327081|NCT01546064|Biliary complications|biliary complications
327082|NCT01546051|metabotropic glutamate receptors 2 and 3|metabotropic glutamate receptors 2 and 3
327083|NCT01546051|antagonist|antagonist
327084|NCT01546051|mGluR|mglur
327085|NCT01546051|ketamine|ketamine
327086|NCT01546051|BDNF|bdnf
327087|NCT01546051|Depression|depression
711805|NCT01014767|Carboplatin|carboplatin
327088|NCT01546051|Major Depressive Disorder|major depressive disorder
327089|NCT01546051|Mood Disorder|mood disorder
327090|NCT01546051|Treatment Resistant Depression|treatment resistant depression
327091|NCT01546051|Phase 1 safety, tolerability and pharmacokinetics study|phase 1 safety, tolerability and pharmacokinetics study
327092|NCT01546038|Hedgehog Inhibitor|hedgehog inhibitor
327093|NCT01546038|Acute Myeloid Leukemia|acute myeloid leukemia
327094|NCT01546038|Myelodysplastic syndrome|myelodysplastic syndrome
327095|NCT01546038|Intensive chemotherapy|intensive chemotherapy
327096|NCT01546038|LDAC|ldac
327097|NCT01545999|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
327098|NCT01545999|Dorsolateral Prefrontal Cortex (DLPFC)|dorsolateral prefrontal cortex (dlpfc)
327099|NCT01545999|Schizophrenia|schizophrenia
327100|NCT01545999|Working Memory|working memory
327101|NCT01545999|Paired Associative Stimulation (PAS)|paired associative stimulation (pas)
327102|NCT01545999|Electroencephalography (EEG)|electroencephalography (eeg)
327103|NCT01545999|Cognition|cognition
327104|NCT01545986|Joint Replacement|joint replacement
327105|NCT01545986|Exercise|exercise
327106|NCT01545986|Power training|power training
327107|NCT01545947|Neoplasms|neoplasms
327108|NCT01545947|Pulmonary|pulmonary
327109|NCT01545947|Lung Cancer|lung cancer
327110|NCT01545947|Cancer of the Lung|cancer of the lung
327111|NCT01545947|Stage IIIB Non-Small Cell Lung Cancer|stage iiib non-small cell lung cancer
327112|NCT01545947|IV Non-Small Cell Lung Cancer|iv non-small cell lung cancer
327113|NCT01545947|Non-Small Cell Lung Cancer|non-small cell lung cancer
327114|NCT01545934|Overweight|overweight
327115|NCT01545934|Obese|obese
327116|NCT01545934|Pregnancy|pregnancy
327117|NCT01545934|Weight Gain|weight gain
327118|NCT01545921|Quality Of Life|quality of life
327119|NCT01545921|Cancer|cancer
327120|NCT01545921|End of life|end of life
327121|NCT01545921|palliative setting|palliative setting
327122|NCT01545908|Fecal transplant|fecal transplant
327123|NCT01545908|induction of remission|induction of remission
327124|NCT01545908|active ulcerative colitis|active ulcerative colitis
327125|NCT01545882|prostate|prostate
327130|NCT01545882|total androgen blockade|total androgen blockade
327131|NCT01545882|injection|injection
327132|NCT01545869|carbon dioxide laser|carbon dioxide laser
327133|NCT01545869|fractional resurfacing|fractional resurfacing
327134|NCT01545869|freckles|freckles
327135|NCT01545869|melanosis|melanosis
327136|NCT01545856|Parkinson's Disease|parkinson's disease
327137|NCT01545856|cardiovascular events|cardiovascular events
327138|NCT01545856|Levodopa|levodopa
327139|NCT01545843|depression|depression
327140|NCT01545843|sleep|sleep
327141|NCT01545843|treatment|treatment
327142|NCT01545830|Metabolic syndrome|metabolic syndrome
327143|NCT01545830|Insulin resistance|insulin resistance
327144|NCT01545830|Vitamin D deficiency|vitamin d deficiency
327145|NCT01545817|Renal cell carcinoma|renal cell carcinoma
327146|NCT01545817|GW786034|gw786034
327147|NCT01545817|Everolimus|everolimus
327148|NCT01545817|Pazopanib|pazopanib
327149|NCT01545804|Hepatocellular carcinoma|hepatocellular carcinoma
327150|NCT01545778|Substance abuse detection|substance abuse detection
327151|NCT01545778|Opioids abuse|opioids abuse
403000|NCT01228682|Salt|salt
327152|NCT01545778|Tapentadol immediate-release (IR)|tapentadol immediate-release (ir)
327153|NCT01545778|Oxycodone immediate-release (IR)|oxycodone immediate-release (ir)
327154|NCT01545765|Healthy volunteers|healthy volunteers
327155|NCT01545752|elearning|elearning
327156|NCT01545752|CD-based education|cd-based education
327157|NCT01545739|Pacemaker therapy|pacemaker therapy
327158|NCT01545739|Cardiac resynchronisation therapy (CRT)|cardiac resynchronisation therapy (crt)
327159|NCT01545726|Asthma|asthma
327160|NCT01545726|Sputum eosinophilia|sputum eosinophilia
327161|NCT01545726|CRTH2 receptor|crth2 receptor
327162|NCT01545726|PGD2 antagonist|pgd2 antagonist
327163|NCT01545713|renal|renal
327164|NCT01545713|kidney|kidney
327165|NCT01545713|transplant|transplant
327166|NCT01545713|living donor|living donor
327167|NCT01545700|dexamethasone|dexamethasone
327168|NCT01545700|hyperglycemia|hyperglycemia
327169|NCT01545700|gynecologic surgery|gynecologic surgery
327170|NCT01545687|pain|pain
327171|NCT01545687|oral complications of radiation therapy|oral complications of radiation therapy
327172|NCT01545687|weight changes|weight changes
327173|NCT01545687|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
327174|NCT01545687|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
327175|NCT01545687|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
327176|NCT01545687|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
327177|NCT01545687|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
327178|NCT01545687|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
327179|NCT01545687|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
327180|NCT01545687|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
711806|NCT01014767|Vincristine|vincristine
327181|NCT01545687|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
327182|NCT01545687|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
327183|NCT01545687|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
327184|NCT01545687|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
327185|NCT01545687|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
327186|NCT01545687|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
327187|NCT01545687|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
327188|NCT01545687|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
327189|NCT01545687|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
327190|NCT01545687|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
751923|NCT01171248|nocturnal blood pressure dip|nocturnal blood pressure dip
327191|NCT01545687|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
327192|NCT01545687|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
327193|NCT01545687|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
327194|NCT01545687|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
327195|NCT01545687|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
327196|NCT01545687|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
327197|NCT01545687|stage IVA verrucous carcinoma of the larynx|stage iva verrucous carcinoma of the larynx
327198|NCT01545687|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
327199|NCT01545687|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
327200|NCT01545687|stage IVB verrucous carcinoma of the larynx|stage ivb verrucous carcinoma of the larynx
327201|NCT01545687|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
327202|NCT01545687|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
327203|NCT01545687|stage IVC verrucous carcinoma of the larynx|stage ivc verrucous carcinoma of the larynx
327204|NCT01545687|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
327205|NCT01545687|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
327206|NCT01545687|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
327207|NCT01545687|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
327208|NCT01545687|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
327209|NCT01545687|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
327210|NCT01545687|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
327211|NCT01545687|stage IVA verrucous carcinoma of the oral cavity|stage iva verrucous carcinoma of the oral cavity
327212|NCT01545687|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
403001|NCT01228682|Water|water
403002|NCT01228656|Psoriasis|psoriasis
327213|NCT01545687|stage IVB verrucous carcinoma of the oral cavity|stage ivb verrucous carcinoma of the oral cavity
327214|NCT01545687|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
327215|NCT01545687|stage IVC verrucous carcinoma of the oral cavity|stage ivc verrucous carcinoma of the oral cavity
327216|NCT01545687|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
327217|NCT01545687|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
327218|NCT01545674|Aneuploidy|aneuploidy
327219|NCT01545674|Non-invasive Prenatal Diagnosis|non-invasive prenatal diagnosis
327220|NCT01545674|Prenatal Blood Test|prenatal blood test
327221|NCT01545674|Prenatal Aneuploidy Screening|prenatal aneuploidy screening
327222|NCT01545674|Trisomy 13|trisomy 13
327223|NCT01545674|Trisomy 18|trisomy 18
327224|NCT01545674|Trisomy 21|trisomy 21
327226|NCT01545674|Down Syndrome|down syndrome
327227|NCT01545674|Turner Syndrome|turner syndrome
327228|NCT01545674|Edwards Syndrome|edwards syndrome
327229|NCT01545661|Tuberculosis|tuberculosis
327230|NCT01545661|diagnosis|diagnosis
327231|NCT01545661|sputum induction|sputum induction
327232|NCT01545661|primary care|primary care
327233|NCT01545648|breast|breast
327234|NCT01545648|cancer|cancer
327235|NCT01545648|early|early
327236|NCT01545648|DTC|dtc
327237|NCT01545648|disseminated|disseminated
327238|NCT01545648|tumor|tumor
327239|NCT01545648|cells|cells
327240|NCT01545635|Major trauma|major trauma
327241|NCT01545635|Injury Severity Score|injury severity score
327242|NCT01545635|ISS > 15|iss > 15
327243|NCT01545635|clinical signs|clinical signs
327244|NCT01545635|risk of blood loss|risk of blood loss
327245|NCT01545635|coagulopathy|coagulopathy
327246|NCT01545635|rotational thrombelastometry|rotational thrombelastometry
327247|NCT01545635|ROTEM|rotem
327248|NCT01545609|Text messaging|text messaging
327249|NCT01545609|birth control|birth control
327250|NCT01545609|adolescents|adolescents
327251|NCT01545596|Intraoperative Monitoring|intraoperative monitoring
327252|NCT01545596|Decision Support Systems|decision support systems
327253|NCT01545596|anesthesia outcomes|anesthesia outcomes
327254|NCT01545557|Volume loss|volume loss
327255|NCT01545544|B-Cell Non Hodgkin Lymphomas|b-cell non hodgkin lymphomas
327256|NCT01545544|Hepatitis C|hepatitis c
327257|NCT01545531|glomerular filtration rate|glomerular filtration rate
327258|NCT01545531|iohexol|iohexol
327259|NCT01545531|hematopoietic cell transplant|hematopoietic cell transplant
327260|NCT01545531|kidney function|kidney function
327261|NCT01545531|gold standard measure|gold standard measure
327262|NCT01545531|cystatin C.|cystatin c.
327263|NCT01545518|Refractory epilepsy|refractory epilepsy
327264|NCT01545518|Cryptogenic epilepsy|cryptogenic epilepsy
327265|NCT01545518|Autoimmune disorders|autoimmune disorders
327266|NCT01545518|IVIG|ivig
327267|NCT01545518|Immunomodulatory therapy|immunomodulatory therapy
327268|NCT01545518|Autoantibodies|autoantibodies
327269|NCT01545492|CHIPS|chips
327271|NCT01545492|reprogramming|reprogramming
327272|NCT01545492|developmental|developmental
327273|NCT01545492|blood|blood
327274|NCT01545492|pressure|pressure
327275|NCT01545492|randomised|randomised
327276|NCT01545492|randomized|randomized
327277|NCT01545492|hypertension|hypertension
327278|NCT01545492|anthropometry|anthropometry
327281|NCT01545492|epigenetics|epigenetics
327282|NCT01545492|methylation|methylation
327283|NCT01545492|cortisol|cortisol
327284|NCT01545492|stress|stress
327285|NCT01545492|DNA|dna
327286|NCT01545492|growth|growth
327287|NCT01545492|weight|weight
327288|NCT01545492|length|length
327289|NCT01545492|height|height
327290|NCT01545479|ECA|eca
327291|NCT01545479|BOLD-MRI|bold-mri
327292|NCT01545479|kidney|kidney
327293|NCT01545466|Migraines|migraines
327294|NCT01545466|Behavioral|behavioral
327295|NCT01545466|Complementary and Alternative Medicine|complementary and alternative medicine
327296|NCT01545466|Mindfulness Meditation|mindfulness meditation
327297|NCT01545466|Mindfulness Based Stress Reduction|mindfulness based stress reduction
327298|NCT01545427|Scleroderma|scleroderma
327701|NCT01543763|sarcoma|sarcoma
327299|NCT01545427|Randomized controled trial|randomized controled trial
327300|NCT01545427|Pilot study|pilot study
327301|NCT01545427|Gleevec (imatinib)|gleevec (imatinib)
327302|NCT01545427|Biomarkers|biomarkers
327303|NCT01545414|Self-help treatment|self-help treatment
327304|NCT01545414|Internet treatment|internet treatment
327305|NCT01545414|Cognitive Behavioral Therapy|cognitive behavioral therapy
327306|NCT01545414|Internet-based Cognitive Behavioral Therapy|internet-based cognitive behavioral therapy
327307|NCT01545401|chronic disease management|chronic disease management
327308|NCT01545401|Chronic Care Model|chronic care model
327309|NCT01545401|multifaceted intervention|multifaceted intervention
327310|NCT01545401|primary care|primary care
327311|NCT01545401|type 2 diabetes mellitus|type 2 diabetes mellitus
406440|NCT01213238|HAI|hai
327312|NCT01545401|hypertension|hypertension
327313|NCT01545375|nasopharyngeal carriage|nasopharyngeal carriage
327314|NCT01545375|safety|safety
327315|NCT01545375|immunogenicity|immunogenicity
327316|NCT01545375|US|us
327317|NCT01545375|Pneumococcal vaccine|pneumococcal vaccine
327318|NCT01545375|efficacy|efficacy
327319|NCT01545375|Streptococcus pneumoniae|streptococcus pneumoniae
327320|NCT01545375|infants|infants
327321|NCT01545349|LGG|lgg
327322|NCT01545349|Immune response|immune response
327323|NCT01545349|Influenza vaccine|influenza vaccine
327324|NCT01545349|Elderly|elderly
327325|NCT01545349|Healthy|healthy
327326|NCT01545349|Microbiome|microbiome
327327|NCT01545323|Netherton syndrome|netherton syndrome
327328|NCT01545323|Gene therapy|gene therapy
327329|NCT01545323|SPINK5|spink5
327330|NCT01545297|dexmedetomidine|dexmedetomidine
327331|NCT01545297|conscious sedation|conscious sedation
327332|NCT01545297|awake craniotomy|awake craniotomy
327333|NCT01545297|brain mapping|brain mapping
327334|NCT01545284|chronic hand dermatitis|chronic hand dermatitis
327335|NCT01545284|acitretin|acitretin
327336|NCT01545284|PGA|pga
327337|NCT01545271|Xenon|xenon
327338|NCT01545271|Hypothermia|hypothermia
327339|NCT01545271|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
327340|NCT01545271|Newborn|newborn
327341|NCT01545271|Term|term
327342|NCT01545271|Neuroprotection|neuroprotection
327343|NCT01545271|Cooling|cooling
327344|NCT01545271|HIE|hie
327345|NCT01545245|atopic asthma|atopic asthma
327346|NCT01545245|recurrent wheezing|recurrent wheezing
327347|NCT01545245|preterm infants|preterm infants
327348|NCT01545245|palivizumab|palivizumab
327349|NCT01545245|respiratory syncytial virus|respiratory syncytial virus
327351|NCT01545232|Massive Transfusion|massive transfusion
327352|NCT01545232|Trauma|trauma
327353|NCT01545232|Coagulopathy|coagulopathy
327354|NCT01545232|Trauma Induced Coagulopathy|trauma induced coagulopathy
327355|NCT01545232|Plasma|plasma
327356|NCT01545232|Platelets|platelets
327357|NCT01545232|Red Blood Cells|red blood cells
327358|NCT01545232|Mortality|mortality
327359|NCT01545232|Wounds and Injuries|wounds and injuries
327360|NCT01545232|Shock, Hemorrhagic|shock, hemorrhagic
327361|NCT01545232|Shock|shock
327362|NCT01545232|Pathologic Processes|pathologic processes
327363|NCT01545232|Hemorrhage|hemorrhage
327364|NCT01545232|Hemostatics|hemostatics
327365|NCT01545232|Coagulation|coagulation
327366|NCT01545232|Transfusion-related acute lung injury (TRALI)|transfusion-related acute lung injury (trali)
327367|NCT01545232|Inflammation|inflammation
327368|NCT01545193|Elderly|elderly
327369|NCT01545193|Residual neuromuscular blockade|residual neuromuscular blockade
327370|NCT01545180|Observatory|observatory
327371|NCT01545180|Heart failure|heart failure
327372|NCT01545180|Post-capillary pulmonary hypertension|post-capillary pulmonary hypertension
327373|NCT01545180|HTPcap|htpcap
327374|NCT01545167|pancreatits|pancreatits
327375|NCT01545141|metastatic|metastatic
327376|NCT01545141|recurrent|recurrent
327377|NCT01545141|peritoneal metastasis|peritoneal metastasis
327378|NCT01545141|cytoreductive surgery|cytoreductive surgery
327379|NCT01545141|hyperthermic intraperitoneal chemoperfusion|hyperthermic intraperitoneal chemoperfusion
327381|NCT01545141|hepatic metastasis|hepatic metastasis
327382|NCT01545141|extrahepatic metastasis|extrahepatic metastasis
327383|NCT01545141|vaccine|vaccine
327384|NCT01544153|Web based behavioral intervention|web based behavioral intervention
327385|NCT01544153|Adherence|adherence
327386|NCT01544153|Smoking cessation|smoking cessation
327387|NCT01544153|Social network|social network
327388|NCT01544153|Nicotine replacement therapy|nicotine replacement therapy
327389|NCT01544153|Social support|social support
327390|NCT01544140|Phase 1|phase 1
327391|NCT01544140|healthy volunteers|healthy volunteers
327392|NCT01544140|pharmacokinetics|pharmacokinetics
327393|NCT01544140|vandetanib|vandetanib
327394|NCT01544140|midazolam|midazolam
327395|NCT01544127|Veterans|veterans
327396|NCT01544127|Motivational Interviewing|motivational interviewing
327397|NCT01544127|Inpatients|inpatients
327398|NCT01544127|Suicide, Attempted|suicide, attempted
327399|NCT01544101|Rheumatoid Arthritis|rheumatoid arthritis
327400|NCT01544101|Diet, Vegetarian|diet, vegetarian
327401|NCT01544101|Diet, Fat-Restricted|diet, fat-restricted
327402|NCT01544101|Pain|pain
327411|NCT01544062|Patient Satisfaction|patient satisfaction
327412|NCT01544049|fallopian tube removal|fallopian tube removal
327413|NCT01544049|salpingectomy|salpingectomy
327414|NCT01544049|ovarian cancer prevention|ovarian cancer prevention
327415|NCT01544036|AKI|aki
327416|NCT01544036|contrast nephropathy|contrast nephropathy
327417|NCT01544036|renal blood flow|renal blood flow
327418|NCT01544023|breast reconstruction|breast reconstruction
327419|NCT01544023|mesh|mesh
327420|NCT01544023|implant reconstruction|implant reconstruction
327421|NCT01544023|acellular dermal matrix|acellular dermal matrix
327422|NCT01544023|titanized polypropylene mesh|titanized polypropylene mesh
327423|NCT01544023|TiLOOP Bra|tiloop bra
327424|NCT01544023|TiLOOP|tiloop
327425|NCT01544023|implant based breast reconstruction|implant based breast reconstruction
327426|NCT01544010|Transtheoretical Model|transtheoretical model
327427|NCT01544010|Tailored Print Intervention|tailored print intervention
327428|NCT01544010|Population-based|population-based
327429|NCT01544010|Behavioral Intervention|behavioral intervention
327430|NCT01543984|health care workers|health care workers
327431|NCT01543984|tailored physical activity|tailored physical activity
327432|NCT01543984|prevention|prevention
327433|NCT01543984|spine|spine
327434|NCT01543984|upper body|upper body
327435|NCT01543984|pain related to Spine or Upper body|pain related to spine or upper body
327436|NCT01543971|Peripheral blood stem cell mobilization|peripheral blood stem cell mobilization
327437|NCT01543971|CD34+ count|cd34+ count
327438|NCT01543945|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
327439|NCT01543945|Ambulatory|ambulatory
327440|NCT01543945|Gynecologic laparoscopy|gynecologic laparoscopy
327441|NCT01543945|Incidence of postoperative nausea and vomiting.|incidence of postoperative nausea and vomiting.
327442|NCT01543932|antiplatelet effect|antiplatelet effect
327443|NCT01543932|prasugrel|prasugrel
327444|NCT01543932|clopidogrel|clopidogrel
327445|NCT01543932|stable angina|stable angina
327446|NCT01543893|neck pain|neck pain
327447|NCT01543893|shoulder pain|shoulder pain
327448|NCT01543893|resistance training|resistance training
327449|NCT01545128|COPD|copd
327450|NCT01545128|Pulmonary rehabilitation|pulmonary rehabilitation
327451|NCT01545115|Children|children
327452|NCT01545115|Immunity|immunity
327453|NCT01545115|Sub-Saharan|sub-saharan
327454|NCT01545115|Pertussis|pertussis
327455|NCT01545115|Malaria|malaria
327456|NCT01545115|Nutrition|nutrition
327457|NCT01545115|antibodies|antibodies
327458|NCT01545011|Inspiratory muscle training|inspiratory muscle training
327459|NCT01545011|COPD|copd
327460|NCT01545011|Conventional respiratory rehabilitation|conventional respiratory rehabilitation
327461|NCT01545011|Dyspnea scale|dyspnea scale
327462|NCT01544985|pediatrics|pediatrics
327463|NCT01544985|emergency medicine|emergency medicine
327464|NCT01544985|pain|pain
327465|NCT01544985|bladder catheterization|bladder catheterization
327466|NCT01544972|Patent Ductus Arteriosus|patent ductus arteriosus
327467|NCT01544972|Paracetamol|paracetamol
327468|NCT01544972|Ibuprofen|ibuprofen
327469|NCT01544972|Serum levels|serum levels
327470|NCT01544972|Preterm infant|preterm infant
327471|NCT01544959|Narcotic|narcotic
327472|NCT01544959|Opioid|opioid
327473|NCT01544959|betablocking drug|betablocking drug
327474|NCT01544959|postoperative pain|postoperative pain
327475|NCT01544959|postoperative nausea and vomiting|postoperative nausea and vomiting
327476|NCT01544959|breast cancer|breast cancer
327477|NCT01544959|hyperalgesia|hyperalgesia
327478|NCT01544959|cancer recurrence|cancer recurrence
327479|NCT01544959|anesthesia|anesthesia
327480|NCT01544959|mastectomy|mastectomy
327481|NCT01544959|chronic postsurgical pain syndrome|chronic postsurgical pain syndrome
327482|NCT01544959|acute postoperative pain|acute postoperative pain
327483|NCT01544959|postmastectomy pain syndrome|postmastectomy pain syndrome
327485|NCT01544959|ambulatory surgery|ambulatory surgery
327486|NCT01544946|pediatrics|pediatrics
327487|NCT01544946|emergency medicine|emergency medicine
327488|NCT01544946|pain|pain
327489|NCT01544946|nasopharyngeal aspiration|nasopharyngeal aspiration
327490|NCT01544933|spinal fractures|spinal fractures
327491|NCT01544933|Thoracic vertebrae|thoracic vertebrae
327492|NCT01544933|spinal canal|spinal canal
327493|NCT01544933|kyphosis|kyphosis
327494|NCT01544907|Drug Eluting Balloon|drug eluting balloon
327495|NCT01544907|Arteriovenous fistula or graft stenosis|arteriovenous fistula or graft stenosis
327496|NCT01544894|Postmenopausal osteoporosis|postmenopausal osteoporosis
327497|NCT01544894|Compliance|compliance
327498|NCT01544894|Bone mineral density|bone mineral density
327499|NCT01544894|Bonemarkers|bonemarkers
327500|NCT01544881|Pharmacokinetics|pharmacokinetics
327501|NCT01544881|Pharmacodynamics|pharmacodynamics
327502|NCT01544881|Hyperglycemia|hyperglycemia
327503|NCT01544881|Insulin|insulin
327504|NCT01544868|Total Energy Expenditure|total energy expenditure
327505|NCT01544868|Protein Balance|protein balance
327506|NCT01544868|Burns|burns
327507|NCT01544855|Health young participants|health young participants
327508|NCT01544842|Oral lichen planus|oral lichen planus
327509|NCT01544842|Tacrolimus ointment|tacrolimus ointment
327510|NCT01544842|Triamcinolone paste|triamcinolone paste
327511|NCT01544829|theobromine|theobromine
327512|NCT01544829|heart rate|heart rate
327513|NCT01544829|blood lipids|blood lipids
327514|NCT01544803|Randomized Controlled Trial|randomized controlled trial
327515|NCT01544803|Alcohol|alcohol
327516|NCT01544803|Internet|internet
327517|NCT01544803|Screening|screening
327518|NCT01544803|Brief intervention|brief intervention
327519|NCT01544803|Personalized feedback|personalized feedback
327520|NCT01544790|Esophageal carcinoma|esophageal carcinoma
327521|NCT01544790|Esophageal cancer|esophageal cancer
318254|NCT01583530|Lupus|lupus
327522|NCT01544790|Robotic surgery|robotic surgery
327523|NCT01544790|Esophagectomy|esophagectomy
327524|NCT01544790|Minimally invasive|minimally invasive
327525|NCT01544777|Aphakia|aphakia
327526|NCT01544777|Cataract|cataract
327527|NCT01544764|Diphtheria-Tetanus-Pertussis Vaccine|diphtheria-tetanus-pertussis vaccine
327528|NCT01544764|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
327529|NCT01544764|Meningococcal Vaccines|meningococcal vaccines
327530|NCT01544764|Hepatitis B Vaccines|hepatitis b vaccines
327531|NCT01544764|Chickenpox Vaccine|chickenpox vaccine
327532|NCT01544764|Papillomavirus Vaccines|papillomavirus vaccines
327533|NCT01544751|NAFLD|nafld
327534|NCT01544751|metformin|metformin
327535|NCT01544751|atorvastatin|atorvastatin
327536|NCT01544751|metabolic syndrome|metabolic syndrome
327537|NCT01544738|Parkinson Disease|parkinson disease
327538|NCT01544738|sensory stimulation|sensory stimulation
327539|NCT01544738|Bradykinesia|bradykinesia
327540|NCT01544725|Procedural sedation|procedural sedation
327541|NCT01544725|Ketamine-propofol|ketamine-propofol
327542|NCT01544725|Ketamine|ketamine
327543|NCT01544712|osteonecrosis|osteonecrosis
327544|NCT01544712|cell-based therapy|cell-based therapy
327545|NCT01544712|bone marrow|bone marrow
327546|NCT01544712|mesenchymal stem cell|mesenchymal stem cell
327547|NCT01544712|hip|hip
327548|NCT01544712|core decompression|core decompression
327549|NCT01544699|stroke|stroke
327550|NCT01544686|neutropenia|neutropenia
327551|NCT01544686|cancer|cancer
327552|NCT01544686|fever|fever
327553|NCT01544686|central venous catheter|central venous catheter
327554|NCT01544686|infection|infection
327555|NCT01544660|spine and hip scan|spine and hip scan
327556|NCT01544660|BMD|bmd
327557|NCT01544647|Knee osteoarthritis|knee osteoarthritis
327558|NCT01544647|spa therapy|spa therapy
327559|NCT01544647|spa modalities|spa modalities
327560|NCT01544634|Asthma|asthma
327561|NCT01544634|Propranolol|propranolol
327562|NCT01544634|Inhaled corticosteroids|inhaled corticosteroids
327563|NCT01544634|Steroid sparing agent|steroid sparing agent
327564|NCT01544634|Airway hyper-responsiveness|airway hyper-responsiveness
327565|NCT01544621|Real life smoking cessation. NON-drug NON-intervention study|real life smoking cessation. non-drug non-intervention study
327566|NCT01544608|Acute psychotic episode of Schizophrenia|acute psychotic episode of schizophrenia
327567|NCT01544595|Psoriasis, inflammatory skin disease|psoriasis, inflammatory skin disease
327568|NCT01544595|scaly patches|scaly patches
327569|NCT01544595|secukinumab (AIN457)|secukinumab (ain457)
327570|NCT01544595|Psoriasis Area and Severity Index (PASI)|psoriasis area and severity index (pasi)
327571|NCT01544595|Investigator Global Assessment (IGA) mod 2011|investigator global assessment (iga) mod 2011
327572|NCT01544582|Pegylated Interferon|pegylated interferon
327573|NCT01544582|boceprevir|boceprevir
327574|NCT01544582|telaprevir|telaprevir
327575|NCT01544569|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
327576|NCT01544556|abdominoplasty|abdominoplasty
327577|NCT01544543|COPD|copd
327578|NCT01544530|Brain-death|brain-death
327579|NCT01544530|organ donation|organ donation
327580|NCT01544517|Helicobacter pylori|helicobacter pylori
327581|NCT01544517|Concomitant therapy|concomitant therapy
327582|NCT01544517|Sequential therapy|sequential therapy
327583|NCT01544517|levofloxacin|levofloxacin
327584|NCT01544504|Radiodermatitis|radiodermatitis
327585|NCT01544504|Prevention|prevention
327586|NCT01544504|Radiotherapy|radiotherapy
327587|NCT01544504|Breast|breast
327588|NCT01544504|Radiation Dermatitis|radiation dermatitis
327589|NCT01544491|Paediatric kidney transplantation|paediatric kidney transplantation
327590|NCT01544491|Early MMF to everolimus conversion|early mmf to everolimus conversion
327591|NCT01544491|Composite efficacy (biopsy-proven acute rejection, graft loss or death)|composite efficacy (biopsy-proven acute rejection, graft loss or death)
327592|NCT01544491|Renal function|renal function
327593|NCT01544465|Parkinson's disease|parkinson's disease
327594|NCT01544465|Sleep Quality|sleep quality
327595|NCT01544465|Daytime sleepiness|daytime sleepiness
327596|NCT01544465|physical therapy|physical therapy
327597|NCT01544465|exercise|exercise
327598|NCT01544452|MR|mr
327600|NCT01544452|ultrasonography|ultrasonography
327601|NCT01544452|MR colonography|mr colonography
327602|NCT01544452|MR rectum|mr rectum
327603|NCT01544452|MR liver|mr liver
327604|NCT01544439|Temporomandibular joint disorders|temporomandibular joint disorders
327605|NCT01544439|Stress psychological|stress psychological
327606|NCT01544439|Depression|depression
327607|NCT01544439|Quality of Life|quality of life
327608|NCT01544426|Office hysteroscopy,|office hysteroscopy,
327609|NCT01544426|intrauterine insemination|intrauterine insemination
327610|NCT01544426|endometrial scrap|endometrial scrap
327611|NCT01544413|laparoscopic sentinel lymph node biopsy|laparoscopic sentinel lymph node biopsy
327612|NCT01544413|quality control study|quality control study
327613|NCT01544413|early gastric cancer|early gastric cancer
327614|NCT01544400|reverse anorexia,|reverse anorexia,
327615|NCT01544400|anorexia athletics|anorexia athletics
327616|NCT01544387|Preterm Premature Rupture Of Membranes|preterm premature rupture of membranes
327617|NCT01544387|PPROM|pprom
327618|NCT01544387|Pregnancy|pregnancy
327619|NCT01544387|Bed rest.|bed rest.
327620|NCT01544374|Breast Cancer|breast cancer
327621|NCT01544374|Treatment Disparities|treatment disparities
327622|NCT01544374|Tracking and Feedback|tracking and feedback
327623|NCT01544374|Registry|registry
327624|NCT01544374|Cancer Therapy Disparities|cancer therapy disparities
327625|NCT01544374|Adjuvant Treatment|adjuvant treatment
327626|NCT01544374|Racial Disparities|racial disparities
327627|NCT01544374|Underuse of Adjuvant Treatment|underuse of adjuvant treatment
327628|NCT01544361|Healthy subjects|healthy subjects
327629|NCT01544361|MEDI7814|medi7814
327630|NCT01544361|FTiH|ftih
327631|NCT01544348|Allergic|allergic
327632|NCT01544348|Atopic Dermatitis|atopic dermatitis
327633|NCT01544348|MEDI4212|medi4212
327634|NCT01544322|solid tumors|solid tumors
327635|NCT01544322|recurrent|recurrent
327636|NCT01544322|advanced|advanced
327637|NCT01544322|metastatic|metastatic
327638|NCT01544322|refractory|refractory
327639|NCT01544283|Shoulder Pain|shoulder pain
327640|NCT01544283|Shoulder Impingement Syndrome|shoulder impingement syndrome
327641|NCT01544270|milk protein|milk protein
327642|NCT01544270|probiotics|probiotics
327643|NCT01544270|stress|stress
327644|NCT01544270|cortisol|cortisol
327645|NCT01544270|heart beat|heart beat
327646|NCT01544257|Osteopathic manipulative treatment|osteopathic manipulative treatment
327647|NCT01544257|alternative medicine|alternative medicine
327648|NCT01544257|complementary medicine|complementary medicine
327649|NCT01544257|neonatology|neonatology
327650|NCT01544257|neonatal care|neonatal care
327651|NCT01544257|prematurity|prematurity
327652|NCT01544257|allied health care|allied health care
327653|NCT01544244|comparison of physical therapy strategies|comparison of physical therapy strategies
327654|NCT01544231|Neutrophil Gelatinase Associated Lipocalin|neutrophil gelatinase associated lipocalin
327655|NCT01544231|predicting acute kidney failure|predicting acute kidney failure
327656|NCT01544231|emergency room|emergency room
327657|NCT01544218|Alcohol related disorders|alcohol related disorders
327658|NCT01544192|Antioxidant|antioxidant
327659|NCT01544192|α−tocopherol|α−tocopherol
327660|NCT01544192|Vitamin E|vitamin e
327661|NCT01544192|Gingko Biloba|gingko biloba
327662|NCT01544192|Glaucoma|glaucoma
327663|NCT01544192|Neuroprotection|neuroprotection
327664|NCT01544192|Retina|retina
327665|NCT01544179|Non Small Cell Lung Cancer|non small cell lung cancer
327666|NCT01544179|Gefitinib|gefitinib
327667|NCT01544179|Pemetrexed|pemetrexed
327668|NCT01544179|Treatment Beyond Progression|treatment beyond progression
327669|NCT01544166|Gadolinium, Pediatrics, MRI, contrast|gadolinium, pediatrics, mri, contrast
327670|NCT01543854|Heart failure|heart failure
327671|NCT01543854|RLX030|rlx030
327672|NCT01543854|Hemodynamics|hemodynamics
327673|NCT01543854|Cardiovascular Diseases|cardiovascular diseases
327674|NCT01543841|advanced cancer|advanced cancer
327675|NCT01543841|healthy|healthy
327676|NCT01543841|blood sample|blood sample
327677|NCT01543841|TEM|tem
327678|NCT01543841|TIE-2 expressing monocytes|tie-2 expressing monocytes
327679|NCT01543841|ANG1|ang1
327685|NCT01543828|patient perception|patient perception
327686|NCT01543815|Psychological Distress|psychological distress
327687|NCT01543815|Depression|depression
327688|NCT01543815|Anxiety|anxiety
327689|NCT01543815|Well-Being Therapy|well-being therapy
327690|NCT01543815|Heart Failure|heart failure
327691|NCT01543815|Quality of Life|quality of life
327692|NCT01543815|Adherence|adherence
327693|NCT01543802|soft-tissue sarcoma|soft-tissue sarcoma
327694|NCT01543802|pazopanib|pazopanib
327695|NCT01543802|antiangiogenetic treatment|antiangiogenetic treatment
327696|NCT01543802|endothelial progenitor cells|endothelial progenitor cells
327697|NCT01543802|preoperative therapy|preoperative therapy
327698|NCT01543789|Umbilical Hernia|umbilical hernia
327699|NCT01543763|metastatic|metastatic
327700|NCT01543763|solid|solid
327703|NCT01543750|episodic ataxia|episodic ataxia
327704|NCT01543750|CACNA1A mutations|cacna1a mutations
327705|NCT01543711|Breast cancer|breast cancer
327706|NCT01543711|persistent pain|persistent pain
327707|NCT01543711|neuropathic pain|neuropathic pain
327708|NCT01543711|lymphedema|lymphedema
327709|NCT01543698|Advanced solid tumor,|advanced solid tumor,
327710|NCT01543698|BRAF V600 mutation|braf v600 mutation
327711|NCT01543672|lung|lung
327712|NCT01543672|SBRT|sbrt
327714|NCT01543672|toxicity|toxicity
327715|NCT01543659|89Zr-DFO-huJ591|89zr-dfo-huj591
327716|NCT01543659|prostate|prostate
327717|NCT01543659|Pet scan|pet scan
327718|NCT01543659|11-126|11-126
327719|NCT01543646|Hepatology|hepatology
327720|NCT01543646|Liver Cirrhosis|liver cirrhosis
327721|NCT01543646|Fatty Liver|fatty liver
327722|NCT01543620|kidney safety|kidney safety
327723|NCT01543620|biomarkers|biomarkers
327724|NCT01543620|serum creatinine|serum creatinine
327725|NCT01543620|BUN|bun
318446|NCT01582828|atrial|atrial
327726|NCT01543620|cystic fibrosis|cystic fibrosis
327727|NCT01543620|head and neck cancer|head and neck cancer
327728|NCT01543620|renal injury|renal injury
327729|NCT01543620|drug induced acute kidney injury|drug induced acute kidney injury
327730|NCT01543620|aminoglycoside|aminoglycoside
327731|NCT01543620|cisplatin|cisplatin
327732|NCT01543620|nephrotoxicity|nephrotoxicity
327733|NCT01543620|biomarker qualification|biomarker qualification
327734|NCT01543607|Bile duct|bile duct
327735|NCT01543607|Cholangiocarcinoma|cholangiocarcinoma
327736|NCT01543607|Bile duct stenosis|bile duct stenosis
327737|NCT01543607|Malignant bile duct obstruction|malignant bile duct obstruction
327738|NCT01543607|Malignant bile duct stricture|malignant bile duct stricture
327739|NCT01543607|Radiofrequency ablation|radiofrequency ablation
327741|NCT01543607|Endoscopic RFA catheter|endoscopic rfa catheter
327742|NCT01543607|EndoHPB|endohpb
327743|NCT01543594|Rheumatoid arthritis|rheumatoid arthritis
327744|NCT01543594|Seronegative polyarthritis|seronegative polyarthritis
327745|NCT01543594|Biologic drugs|biologic drugs
327746|NCT01543594|Safety efficacy biologics polyarthritis|safety efficacy biologics polyarthritis
327747|NCT01543581|Basal Cell Carcinoma|basal cell carcinoma
327748|NCT01543581|Treatment of Skin Cancer|treatment of skin cancer
327749|NCT01543568|Age related Macular Degeneration|age related macular degeneration
327750|NCT01543568|Recalcitrant Age Related Macular Degeneration|recalcitrant age related macular degeneration
327751|NCT01543555|myocardial infarction|myocardial infarction
327752|NCT01543555|statin|statin
327753|NCT01543555|perioperative care|perioperative care
327754|NCT01543555|peripheral vascular diseases|peripheral vascular diseases
327755|NCT01543555|anesthesiology|anesthesiology
327756|NCT01543542|1-3 brain metastases from any primary cancer|1-3 brain metastases from any primary cancer
327757|NCT01543516|Asthma|asthma
327758|NCT01543516|Sputum|sputum
327759|NCT01543516|Blood|blood
327760|NCT01543516|Inflammation|inflammation
327761|NCT01543516|adaptive immune system|adaptive immune system
327762|NCT01543516|innate immune system|innate immune system
327763|NCT01543464|Indeolamine 2,3 dioxygenase|indeolamine 2,3 dioxygenase
327764|NCT01543464|Survivin|survivin
327765|NCT01543464|Montanide|montanide
327766|NCT01543464|Imiquimod|imiquimod
327767|NCT01543464|GMCSF|gmcsf
327768|NCT01543438|ED utilization|ed utilization
327769|NCT01543438|video education|video education
327770|NCT01543438|mobile health|mobile health
327771|NCT01543438|streaming media|streaming media
327772|NCT01543438|underserved populations|underserved populations
327773|NCT01543425|Neuropathic Pain|neuropathic pain
327774|NCT01543425|Adenocorticotrophic axis|adenocorticotrophic axis
327775|NCT01543425|Psychological state|psychological state
327776|NCT01543412|FOLFIRI|folfiri
327777|NCT01543412|Metastases|metastases
327778|NCT01543412|pancreatic adenocarcinoma|pancreatic adenocarcinoma
327779|NCT01543412|locally advanced or metastatic pancreatic adenocarcinoma|locally advanced or metastatic pancreatic adenocarcinoma
327780|NCT01543399|Tibolone|tibolone
327781|NCT01543399|climacteric|climacteric
327782|NCT01543399|Doppler|doppler
327783|NCT01543399|hormone replacement therapy|hormone replacement therapy
327784|NCT01543386|Polyphenol|polyphenol
327785|NCT01543386|Curcumin|curcumin
327786|NCT01543386|Endothelium, vascular|endothelium, vascular
327787|NCT01543386|Endothelium-dependant relaxing factor|endothelium-dependant relaxing factor
327788|NCT01543386|Smoking|smoking
327789|NCT01543386|Transcriptome|transcriptome
327790|NCT01543373|Coronary artery disease|coronary artery disease
327791|NCT01543373|Optical Coherence Tomography|optical coherence tomography
327792|NCT01543373|Tissue coverage|tissue coverage
327794|NCT01543360|axillary vein|axillary vein
327795|NCT01543360|sub clavian vein|sub clavian vein
327796|NCT01543360|comparison of strategies|comparison of strategies
327797|NCT01543347|UTI|uti
327798|NCT01543347|ESBL|esbl
327799|NCT01543347|AmpC Enterobacteriaceae|ampc enterobacteriaceae
327800|NCT01543334|intensive care|intensive care
327801|NCT01543334|antibiotic levels in blood samples|antibiotic levels in blood samples
327802|NCT01543321|tetrabenazine|tetrabenazine
327803|NCT01543321|movement disorders|movement disorders
327804|NCT01543321|tardive disorders|tardive disorders
327805|NCT01543295|Non-Treponemal|non-treponemal
327806|NCT01543295|Treponemal|treponemal
327807|NCT01543282|endoscopic ultrasonography|endoscopic ultrasonography
327808|NCT01543282|fine needle aspiration cytology|fine needle aspiration cytology
327809|NCT01543282|22 gauge|22 gauge
327810|NCT01543282|25 gauge|25 gauge
327811|NCT01543269|Obesity|obesity
327812|NCT01543269|Lipid disorders|lipid disorders
327813|NCT01543256|benign biliary strictures secondary to chronic pancreatitis|benign biliary strictures secondary to chronic pancreatitis
327814|NCT01543243|postural balance|postural balance
327815|NCT01543243|strength|strength
327816|NCT01543230|Non-Inflammatory Degenerative Joint Disease|non-inflammatory degenerative joint disease
327817|NCT01543217|COPD|copd
327818|NCT01543204|plaque psoriasis|plaque psoriasis
327819|NCT01543204|etanercept|etanercept
407077|NCT01210846|QTc|qtc
327820|NCT01543204|adalimumab|adalimumab
327821|NCT01543191|Lung Diseases|lung diseases
327822|NCT01543191|Respiratory Tract Diseases|respiratory tract diseases
327823|NCT01543191|Fibrosis|fibrosis
327824|NCT01543178|IBS|ibs
327825|NCT01543178|IBS-D|ibs-d
327826|NCT01543178|IBS with diarrhea|ibs with diarrhea
327827|NCT01543178|Diarrhea|diarrhea
327828|NCT01543178|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
327829|NCT01543165|Renal colic|renal colic
327830|NCT01543165|Analgesia|analgesia
327831|NCT01543165|Nefopam|nefopam
327832|NCT01543165|Ketorolac|ketorolac
327833|NCT01543152|HIV|hiv
327834|NCT01543152|autologous cell therapy|autologous cell therapy
327835|NCT01543152|cyclophosphamide|cyclophosphamide
327836|NCT01543113|melanoma|melanoma
327837|NCT01543113|white-caucasian population|white-caucasian population
327838|NCT01543100|MGUS|mgus
327839|NCT01543074|HDAC|hdac
327840|NCT01543074|histone acetylation|histone acetylation
327841|NCT01543074|broccoli sprout extract|broccoli sprout extract
327842|NCT01543074|garlic oil|garlic oil
327843|NCT01543074|PBMCs|pbmcs
327844|NCT01543048|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
327845|NCT01543048|Virological tests|virological tests
327846|NCT01543048|CIN3|cin3
327847|NCT01543048|Cervical cancer|cervical cancer
327848|NCT01543048|Conization|conization
327849|NCT01543048|within women treated by conization for a CIN3|within women treated by conization for a cin3
327850|NCT01543035|HIV infection|hiv infection
327851|NCT01543035|lipid lowering drugs|lipid lowering drugs
327852|NCT01543035|etravirine|etravirine
327853|NCT01543035|patient|patient
327854|NCT01543035|statin treatment|statin treatment
327855|NCT01543035|EFV or boosted PI antiretroviral treatment|efv or boosted pi antiretroviral treatment
327856|NCT01543009|child|child
327857|NCT01543009|venipuncture|venipuncture
327858|NCT01543009|pain|pain
327859|NCT01542983|breast cancer|breast cancer
327860|NCT01542983|bright light|bright light
327861|NCT01542983|insomnia|insomnia
327862|NCT01542983|fatigue|fatigue
327863|NCT01542970|intervention|intervention
327864|NCT01542970|lactobacillus reuteri|lactobacillus reuteri
327865|NCT01542970|omega-3 fatty acids|omega-3 fatty acids
327866|NCT01542970|pregnancy|pregnancy
327867|NCT01542970|lactation|lactation
327868|NCT01542970|allergic symptoms|allergic symptoms
327869|NCT01542970|IgE associated disease|ige associated disease
327870|NCT01542970|gastrointestinal function|gastrointestinal function
327871|NCT01542957|Major Depressive Disorder|major depressive disorder
327872|NCT01542957|Dysthymic Disorder|dysthymic disorder
327873|NCT01542957|Depression|depression
327874|NCT01542957|Cognitive Behavior Therapy|cognitive behavior therapy
327875|NCT01542957|Personal Construct Theory|personal construct theory
327876|NCT01542957|Repertory Grid Technique|repertory grid technique
327877|NCT01542957|Cognitive Conflicts|cognitive conflicts
327878|NCT01542957|Personal dilemmas|personal dilemmas
327879|NCT01542944|Acute myeloid leukemia|acute myeloid leukemia
327880|NCT01542944|Myelodysplastic syndrome|myelodysplastic syndrome
327881|NCT01542944|Stem Cell Mobilization|stem cell mobilization
327882|NCT01542944|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
327883|NCT01542931|Oral squamous cell carcinoma|oral squamous cell carcinoma
327884|NCT01542931|Induction chemotherapy|induction chemotherapy
327885|NCT01542931|Surgery|surgery
327886|NCT01542931|Radiotherapy|radiotherapy
327887|NCT01542918|Recurrent|recurrent
327888|NCT01542918|Refractory|refractory
327890|NCT01542918|Intraocular|intraocular
327891|NCT01542918|Lymphoma|lymphoma
327892|NCT01542892|Sarcopenia|sarcopenia
327893|NCT01542892|Nutrition|nutrition
327894|NCT01542892|Vitamin D|vitamin d
327895|NCT01542892|Exercise|exercise
327896|NCT01542866|ranibizumab|ranibizumab
327897|NCT01542866|Age related Macular Degeneration|age related macular degeneration
327899|NCT01542866|Health Management Tool|health management tool
327900|NCT01542866|HMT|hmt
327901|NCT01542866|Best Corrected Visual Acuity|best corrected visual acuity
327902|NCT01542866|Investigator's Clinical Judgement of Change|investigator's clinical judgement of change
328888|NCT01538485|GUT|gut
327903|NCT01542866|Choroidal Neovascularization|choroidal neovascularization
327904|NCT01542866|Central Retinal Subfield Thickness|central retinal subfield thickness
327905|NCT01542866|visual function self test|visual function self test
327907|NCT01542840|orthopedic surgery|orthopedic surgery
327908|NCT01542840|foot surgery|foot surgery
327909|NCT01542840|leg surgery|leg surgery
327910|NCT01542840|ankle surgery|ankle surgery
327911|NCT01542840|leg|leg
327912|NCT01542840|foot|foot
327913|NCT01542840|ankle|ankle
327914|NCT01542840|anesthesia|anesthesia
327915|NCT01542840|local anesthesia|local anesthesia
327916|NCT01542840|regional anesthesia|regional anesthesia
327917|NCT01542840|Ochsner Clinic|ochsner clinic
327918|NCT01542840|Ochsner Hospital|ochsner hospital
327919|NCT01542840|New Orleans|new orleans
327920|NCT01542840|Louisiana|louisiana
318649|NCT01581840|5Fu|5fu
327921|NCT01542840|Kristie Osteen, MD|kristie osteen, md
327922|NCT01542827|neck pain|neck pain
327923|NCT01542827|menthol|menthol
327924|NCT01542814|Screening Mammogram|screening mammogram
327925|NCT01542814|Diagnostic Mammogram|diagnostic mammogram
327926|NCT01542814|Benign|benign
327927|NCT01542814|Malignant|malignant
327928|NCT01542814|BI-RADS Categories|bi-rads categories
327929|NCT01542801|Effect of Preventive Antibiotics|effect of preventive antibiotics
327930|NCT01542788|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
327931|NCT01542788|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
327932|NCT01542788|HCV|hcv
327933|NCT01542788|Sustained Virologic Response|sustained virologic response
327934|NCT01542788|Direct Acting Antiviral|direct acting antiviral
327935|NCT01542788|Combination Therapy|combination therapy
327936|NCT01542788|Interferon intolerant|interferon intolerant
327937|NCT01542788|Interferon ineligible|interferon ineligible
327938|NCT01542788|GS-7977|gs-7977
327939|NCT01542788|Ribavirin|ribavirin
327940|NCT01542762|Deep venous thrombosis|deep venous thrombosis
327941|NCT01542762|Pulmonary Embolism|pulmonary embolism
327942|NCT01542762|Lower leg Cast immobilization|lower leg cast immobilization
327943|NCT01542749|BVA-100 Blood volume analyzer|bva-100 blood volume analyzer
327944|NCT01542749|Human serum albumin labeled with Iodine 131|human serum albumin labeled with iodine 131
327945|NCT01542723|Deep venous thrombosis|deep venous thrombosis
327946|NCT01542723|Pulmonary Embolism|pulmonary embolism
327947|NCT01542723|Arthroscopy of the knee|arthroscopy of the knee
327948|NCT01542697|magnesium sulpahate|magnesium sulpahate
327949|NCT01542697|postoperative analgesia|postoperative analgesia
327950|NCT01542684|Leukemia|leukemia
327951|NCT01542684|Myelodysplastic Syndrome|myelodysplastic syndrome
327952|NCT01542684|MDS|mds
327953|NCT01542684|Azacytidine|azacytidine
327954|NCT01542684|5-Azacytidine|5-azacytidine
327955|NCT01542684|5-AZA|5-aza
327956|NCT01542684|Vidaza|vidaza
327957|NCT01542684|5-AZC|5-azc
327958|NCT01542684|Aza-CR|aza-cr
327959|NCT01542684|Ladakamycin|ladakamycin
327960|NCT01542684|NSC-102816|nsc-102816
327961|NCT01542684|GM-CSF|gm-csf
327962|NCT01542684|Sargramostim|sargramostim
327963|NCT01542684|Leukine|leukine
327964|NCT01542671|lifestyle change|lifestyle change
327965|NCT01542671|obesity treatment|obesity treatment
327966|NCT01542671|physical activity|physical activity
327967|NCT01542671|primary care|primary care
327968|NCT01542671|quality of life|quality of life
327969|NCT01542645|Fentanyl|fentanyl
327970|NCT01542645|Methadone|methadone
327971|NCT01542645|Thoracic Surgery|thoracic surgery
327972|NCT01542632|safety and immunogenicity of dengue vaccine|safety and immunogenicity of dengue vaccine
327973|NCT01542606|PH|ph
327974|NCT01542606|SCREENING|screening
327975|NCT01542606|EARLY WARNING|early warning
327976|NCT01542606|VAGINAL HEALTH|vaginal health
327977|NCT01542606|VAGINAL SECRETION|vaginal secretion
327978|NCT01542606|VAGINAL PH|vaginal ph
327979|NCT01542580|Revision surgery|revision surgery
327980|NCT01542567|Diclofenac|diclofenac
327982|NCT01542567|BLADDER IRRIGATIONS|bladder irrigations
327983|NCT01542554|Diabetes mellitus|diabetes mellitus
327984|NCT01542554|Chinese|chinese
327985|NCT01542554|Glycaemic index|glycaemic index
327986|NCT01542528|ADHD|adhd
327987|NCT01542528|Executive function|executive function
327988|NCT01542528|Inhibitory control|inhibitory control
327989|NCT01542528|Computer games|computer games
327990|NCT01542528|Sports activities|sports activities
327991|NCT01542528|Good Behavior Game|good behavior game
327992|NCT01542515|Allograft|allograft
327993|NCT01542515|Arthroplasty|arthroplasty
327994|NCT01542515|Basal Joint|basal joint
327995|NCT01542515|carpometacarpal joint|carpometacarpal joint
327996|NCT01542515|Thumb|thumb
327997|NCT01542515|meniscus|meniscus
327998|NCT01542515|osteoarthritis|osteoarthritis
327999|NCT01542515|Patients with Stages I - III arthritis of the the thumb carpometacarpal joint|patients with stages i - iii arthritis of the the thumb carpometacarpal joint
328000|NCT01542502|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
328191|NCT01541618|MS|ms
328001|NCT01542502|Diastolic heart failure|diastolic heart failure
328002|NCT01542502|Aerobic exercise performance|aerobic exercise performance
328003|NCT01542437|Non-Small Cell Lung Cancer|non-small cell lung cancer
328004|NCT01542398|community-based|community-based
328005|NCT01542398|war-affected|war-affected
328006|NCT01542398|psychosocial support|psychosocial support
328007|NCT01542398|family-focused|family-focused
328008|NCT01542398|psychological distress|psychological distress
328009|NCT01542398|adolescents|adolescents
328010|NCT01542398|Democratic Republic of Congo|democratic republic of congo
328011|NCT01542398|family functioning|family functioning
328012|NCT01542398|community functioning|community functioning
328013|NCT01542398|daily functioning|daily functioning
328014|NCT01542385|Delayed stenting|delayed stenting
328015|NCT01542385|Deferred stenting|deferred stenting
328016|NCT01542385|Late stenting|late stenting
328017|NCT01542385|postponed stenting|postponed stenting
328018|NCT01542385|Thrombectomy|thrombectomy
328019|NCT01542385|Percutaneous coronary intervention|percutaneous coronary intervention
328021|NCT01542385|Angioplasty|angioplasty
328022|NCT01542385|STEMI|stemi
328023|NCT01542385|acute myocardial infarction|acute myocardial infarction
328024|NCT01542372|PTSD|ptsd
328025|NCT01542372|Cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
328026|NCT01542372|Medication augmentation|medication augmentation
328027|NCT01542372|Treatment-resistant PTSD|treatment-resistant ptsd
328028|NCT01542372|Cambodian refugees|cambodian refugees
328029|NCT01542372|Culturally sensitive treatment|culturally sensitive treatment
328030|NCT01542359|Yoga, Hypertension|yoga, hypertension
328031|NCT01542359|Blood Pressure|blood pressure
328032|NCT01542359|Autonomic Nervous system|autonomic nervous system
328033|NCT01542346|Wound closure|wound closure
328034|NCT01542346|cosmetic outcome|cosmetic outcome
328035|NCT01542333|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
328036|NCT01542333|stage I Wilms tumor|stage i wilms tumor
328037|NCT01542333|stage II Wilms tumor|stage ii wilms tumor
328038|NCT01542333|stage III Wilms tumor|stage iii wilms tumor
328039|NCT01542333|stage IV Wilms tumor|stage iv wilms tumor
328040|NCT01542333|stage V Wilms tumor|stage v wilms tumor
328041|NCT01542320|probiotic|probiotic
328042|NCT01542320|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
328043|NCT01542320|healthy infants|healthy infants
328044|NCT01542307|migraine|migraine
328045|NCT01542307|oxygen therapy|oxygen therapy
328046|NCT01542294|gastric cancer|gastric cancer
328047|NCT01542294|S-1|s-1
328048|NCT01542294|oxaliplatin|oxaliplatin
328049|NCT01542294|adjuvant chemotherapy|adjuvant chemotherapy
328050|NCT01542281|liver resection|liver resection
328051|NCT01542281|hepatectomy|hepatectomy
328052|NCT01542281|pre-habilitation|pre-habilitation
328053|NCT01542268|pentoxifylline|pentoxifylline
711914|NCT01015183|Mucositis|mucositis
328054|NCT01542268|tight junction signalling|tight junction signalling
328055|NCT01542268|intestinal epithelial barrier|intestinal epithelial barrier
328056|NCT01542268|irritable bowel syndrome|irritable bowel syndrome
328057|NCT01542255|Metronomic Therapy|metronomic therapy
328058|NCT01542255|Metastatic Melanoma|metastatic melanoma
328059|NCT01542255|Vinblastine|vinblastine
328060|NCT01542255|Cyclophosphamide|cyclophosphamide
328061|NCT01542255|Dacarbazine|dacarbazine
328062|NCT01542242|Diabetes Mellitus Type 2|diabetes mellitus type 2
328063|NCT01542242|Prader Willi Syndrome|prader willi syndrome
328064|NCT01542229|Post Traumatic Stress Disorder|post traumatic stress disorder
328065|NCT01542229|Severe Mental Illness|severe mental illness
328066|NCT01542203|doxorubicin|doxorubicin
328067|NCT01542203|cyclophosphamide|cyclophosphamide
328068|NCT01542203|Breast Cancer|breast cancer
328069|NCT01542203|BMI|bmi
328070|NCT01542190|cataract surgery|cataract surgery
328071|NCT01542190|cystoid macular edema|cystoid macular edema
328072|NCT01542190|angiography|angiography
328073|NCT01542177|hypoxia|hypoxia
328074|NCT01542177|pancreas|pancreas
328075|NCT01542177|cancer|cancer
328076|NCT01542177|pancreatic cancer|pancreatic cancer
328077|NCT01542177|18F-FAZA|18f-faza
328078|NCT01542177|18F-Fluoroazomycin Arabinoside|18f-fluoroazomycin arabinoside
327713|NCT01543672|MLD|mld
328079|NCT01542177|Positron Emission Tomography|positron emission tomography
328080|NCT01542177|PET|pet
328081|NCT01542164|Calcium intake|calcium intake
328082|NCT01542164|Fat excretion|fat excretion
328083|NCT01542164|Energy excretion|energy excretion
328084|NCT01542164|Gut micro flora|gut micro flora
328085|NCT01542151|Labor, induced|labor, induced
328086|NCT01542151|Sleep|sleep
328087|NCT01542151|Fatigue|fatigue
328088|NCT01542151|Patient satisfaction|patient satisfaction
328089|NCT01542151|Circadian rhythm|circadian rhythm
328090|NCT01542138|Inflammatory hyperpigmentation, axillar pigmentation|inflammatory hyperpigmentation, axillar pigmentation
328091|NCT01542125|Patients aged 3 to 16 years presenting for|patients aged 3 to 16 years presenting for
328092|NCT01542125|removal of smooth percutaneous interosseus pins|removal of smooth percutaneous interosseus pins
328093|NCT01542125|after orthopeadic surgery|after orthopeadic surgery
328094|NCT01542112|Patient-Centered Care|patient-centered care
328095|NCT01542112|Patient Satisfaction|patient satisfaction
328096|NCT01542112|Interventional study|interventional study
328097|NCT01542112|Patient Expectations|patient expectations
328098|NCT01542112|Hospitalization|hospitalization
328889|NCT01538472|Lymphoma|lymphoma
328099|NCT01542086|intermediate pre-test|intermediate pre-test
328100|NCT01542086|probability of significant coronary heart disease|probability of significant coronary heart disease
328101|NCT01542073|myocardial infarction|myocardial infarction
328102|NCT01542073|angiogenesis|angiogenesis
328103|NCT01542073|integrin receptor imaging|integrin receptor imaging
328104|NCT01542073|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
328105|NCT01542047|Metastatic|metastatic
328106|NCT01542047|Solid tumors|solid tumors
328107|NCT01542047|carboplatin|carboplatin
328108|NCT01542047|Paraplatin|paraplatin
328109|NCT01542047|Pazopanib|pazopanib
328110|NCT01542047|Votrient|votrient
328111|NCT01542047|Alkylating agent|alkylating agent
328112|NCT01542047|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
328113|NCT01542047|Metastatic disease|metastatic disease
328114|NCT01542021|prostate|prostate
328115|NCT01542021|Degarelix|degarelix
328116|NCT01542021|injections|injections
328117|NCT01542021|radical prostatectomy|radical prostatectomy
328118|NCT01542021|11-182|11-182
328119|NCT01541995|contrast medium enhanced post mortem CT|contrast medium enhanced post mortem ct
328120|NCT01541995|virtual autopsy|virtual autopsy
328121|NCT01541995|To evaluate the value of contrast medium enhanced post-mortem CT in virtual autopsy focussing on thromboembolic and vascular conditions|to evaluate the value of contrast medium enhanced post-mortem ct in virtual autopsy focussing on thromboembolic and vascular conditions
328122|NCT01541969|Ear|ear
328123|NCT01541969|Hearing|hearing
328124|NCT01541956|type 2 diabetes;|type 2 diabetes;
328125|NCT01541956|vildagliptin;|vildagliptin;
328126|NCT01541956|metformin;|metformin;
328127|NCT01541943|Atorvastatin|atorvastatin
328128|NCT01541943|Losartan|losartan
328129|NCT01541943|Essential Hypertension|essential hypertension
328130|NCT01541943|Hyperlipidemia|hyperlipidemia
328131|NCT01541904|Ocular Allergy.|ocular allergy.
328132|NCT01541904|Seasonal Allergic Conjunctivitis|seasonal allergic conjunctivitis
328133|NCT01541904|Perennial Allergic Conjunctivitis|perennial allergic conjunctivitis
328134|NCT01541904|Conjunctivitis, Allergic|conjunctivitis, allergic
328135|NCT01541904|Ocular Antihistamines.|ocular antihistamines.
328136|NCT01541891|PRO-148|pro-148
328137|NCT01541891|Dry eye syndrome|dry eye syndrome
328138|NCT01541865|hypertension, renal denervation, uncontrolled hypertension, medication resistant hypertension|hypertension, renal denervation, uncontrolled hypertension, medication resistant hypertension
328139|NCT01541852|Vascular Inflammation|vascular inflammation
328140|NCT01541852|FDG PET-CT|fdg pet-ct
328141|NCT01541852|COPD|copd
328142|NCT01541852|Atherosclerosis|atherosclerosis
712016|NCT01015547|infliximab|infliximab
328143|NCT01541852|p38 MAP kinase inhibitor|p38 map kinase inhibitor
328144|NCT01541839|Nasal septum|nasal septum
328145|NCT01541839|Nasal surgical procedures|nasal surgical procedures
328146|NCT01541826|aronia|aronia
328147|NCT01541826|LDL cholesterol|ldl cholesterol
328148|NCT01541826|polyphenols|polyphenols
328149|NCT01541826|bioavailability|bioavailability
328150|NCT01541826|oxidative stress|oxidative stress
328151|NCT01541813|Rare iron overload|rare iron overload
328152|NCT01541813|hepcidin|hepcidin
328153|NCT01541774|Atherectomy|atherectomy
328154|NCT01541774|Atherosclerosis|atherosclerosis
328155|NCT01541774|Peripheral artery disease|peripheral artery disease
328156|NCT01541761|Obesity|obesity
328157|NCT01541761|Child|child
328158|NCT01541761|Hispanic|hispanic
328159|NCT01541761|Prevention|prevention
328160|NCT01541761|Nutrition|nutrition
328161|NCT01541761|Parenting|parenting
328162|NCT01541735|Diabetes|diabetes
328163|NCT01541735|Insulin|insulin
328164|NCT01541735|Pantoprazole|pantoprazole
328165|NCT01541722|Urea cycle disorders|urea cycle disorders
328166|NCT01541709|This is a single-center|this is a single-center
328167|NCT01541709|prospective|prospective
328168|NCT01541709|single-arm|single-arm
328169|NCT01541709|open-label phase II study|open-label phase ii study
328170|NCT01541696|zinc|zinc
328171|NCT01541696|zn|zn
328172|NCT01541696|EZP (exchangeable zinc pools)multivitamin MN|ezp (exchangeable zinc pools)multivitamin mn
328174|NCT01541683|bowel cleansing|bowel cleansing
328175|NCT01541683|Mentholyptus drops|mentholyptus drops
328176|NCT01541683|Palatability|palatability
328177|NCT01541657|Ankle Instability|ankle instability
328178|NCT01541657|Sensorimotor Control|sensorimotor control
328179|NCT01541657|Sensory|sensory
328180|NCT01541657|Postural Control|postural control
328181|NCT01541657|Balance|balance
328182|NCT01541657|Gait|gait
328183|NCT01541644|Acupuncture Therapy|acupuncture therapy
328184|NCT01541644|bortezomib-induced peripheral neuropathy|bortezomib-induced peripheral neuropathy
328185|NCT01541631|Human Immunodeficiency Virus-1|human immunodeficiency virus-1
328186|NCT01541631|Schistosoma mansoni|schistosoma mansoni
328187|NCT01541631|Anemia|anemia
328188|NCT01541631|Immune response|immune response
328189|NCT01541631|Opportunistic infections|opportunistic infections
328190|NCT01541631|Tanzania|tanzania
328192|NCT01541618|RRMS|rrms
328193|NCT01541618|RR Multiple Sclerosis|rr multiple sclerosis
328194|NCT01541592|Insulin resistance|insulin resistance
328195|NCT01541592|Endothelial dysfunction|endothelial dysfunction
328196|NCT01541592|saturated fat|saturated fat
328197|NCT01541592|monounsaturated fat|monounsaturated fat
328198|NCT01541592|polyunsaturated fat|polyunsaturated fat
328199|NCT01541579|Perianal fistulising Crohn's disease.|perianal fistulising crohn's disease.
328200|NCT01541566|arterial hypertension|arterial hypertension
328201|NCT01541566|metabolic syndrome|metabolic syndrome
328202|NCT01541566|home blood pressure|home blood pressure
328203|NCT01541566|ambulatory blood pressure|ambulatory blood pressure
328204|NCT01541566|office blood pressure|office blood pressure
328205|NCT01541566|telemedicine|telemedicine
328206|NCT01541527|non neutralizing antibody|non neutralizing antibody
328207|NCT01541527|Epitopic profile|epitopic profile
328208|NCT01541527|Clinical relevance|clinical relevance
328209|NCT01541501|Central Corneal Thickness|central corneal thickness
328210|NCT01541501|Pachymetry|pachymetry
328211|NCT01541462|mechanical ventilation|mechanical ventilation
328212|NCT01541462|weaning|weaning
328213|NCT01541462|pressure support|pressure support
328214|NCT01541462|spontaneous breathing|spontaneous breathing
328215|NCT01541462|Long-term acute care facility|long-term acute care facility
328216|NCT01541462|mortality|mortality
328217|NCT01541449|AMD|amd
328218|NCT01541449|PLAQUENIL|plaquenil
328219|NCT01541449|CNV|cnv
328220|NCT01541436|Remote Ischemic Preconditioning|remote ischemic preconditioning
328221|NCT01541436|Nociception|nociception
328222|NCT01541436|Central Sensitization|central sensitization
328223|NCT01541436|Peripheral Sensitization|peripheral sensitization
328224|NCT01541397|Hyperphenylalaninemia|hyperphenylalaninemia
328225|NCT01541397|Phenylketonuria|phenylketonuria
328226|NCT01541397|Adults|adults
328227|NCT01541397|Bone Mineral Density|bone mineral density
328228|NCT01541384|Kidney transplant|kidney transplant
328229|NCT01541384|Adherence|adherence
328230|NCT01541384|Electronic pill bottles|electronic pill bottles
328231|NCT01541371|Schizophrenia|schizophrenia
328232|NCT01541371|Paliperidone extended-release tablets|paliperidone extended-release tablets
328233|NCT01541332|relapsed refractory|relapsed refractory
328234|NCT01541332|multiple myeloma|multiple myeloma
328235|NCT01541332|pomalidomide|pomalidomide
328236|NCT01541332|Doxil|doxil
328237|NCT01541332|dexamethasone|dexamethasone
328238|NCT01541332|Oncotherapeutics|oncotherapeutics
328239|NCT01541319|Cardiac Surgery|cardiac surgery
328240|NCT01541319|Erythrocyte Transfusion|erythrocyte transfusion
328241|NCT01541306|C-type natriuretic peptide|c-type natriuretic peptide
328242|NCT01541306|dwarfism|dwarfism
328243|NCT01541306|growth|growth
328244|NCT01541306|achondroplasia|achondroplasia
328245|NCT01541306|hypochondroplasia|hypochondroplasia
328246|NCT01541306|biomarker|biomarker
328247|NCT01541293|Abortion, Induced|abortion, induced
328248|NCT01541293|Laminaria|laminaria
328249|NCT01541293|Pain management|pain management
328250|NCT01541293|Cervical preparation|cervical preparation
328251|NCT01541293|Dilation and Evacuation|dilation and evacuation
328252|NCT01541280|Allogreffe, LAM , MDS|allogreffe, lam , mds
328253|NCT01541280|Azacitidine (VidazaÒ)|azacitidine (vidazaò)
328254|NCT01541280|Injection de lymphocytes de donneur (DLI)|injection de lymphocytes de donneur (dli)
328255|NCT01541267|aliskiren|aliskiren
328256|NCT01541267|eplerenon|eplerenon
328257|NCT01541267|telmisartan|telmisartan
328258|NCT01541267|direct renin inhibitor|direct renin inhibitor
328259|NCT01541267|ACE inhibitor|ace inhibitor
328260|NCT01541267|mineralocorticoid inhibitor|mineralocorticoid inhibitor
328261|NCT01541267|proteinuria|proteinuria
328262|NCT01541267|chronic kidney diseases|chronic kidney diseases
328263|NCT01541267|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
328264|NCT01541254|intracranial aneurysm|intracranial aneurysm
328265|NCT01541254|wide-neck|wide-neck
328266|NCT01541254|saccular|saccular
328267|NCT01541254|endovascular treatment|endovascular treatment
328268|NCT01541254|coil embolization|coil embolization
328269|NCT01541254|stent|stent
328270|NCT01541254|bare platinum|bare platinum
328271|NCT01541241|Intrauterine contraceptive device (IUD) is one of the most frequently used methods of birth control around the world|intrauterine contraceptive device (iud) is one of the most frequently used methods of birth control around the world
328272|NCT01541241|Uterine Hemodynamic changes|uterine hemodynamic changes
328273|NCT01541228|actinic keratosis|actinic keratosis
328274|NCT01541228|photodynamic therapy|photodynamic therapy
328275|NCT01541228|5-aminolevulinic acid|5-aminolevulinic acid
328276|NCT01541202|chronic heart failure|chronic heart failure
328277|NCT01541202|neuregulin|neuregulin
328278|NCT01541202|mortality|mortality
328279|NCT01541189|hypertension|hypertension
328280|NCT01541189|valsartan|valsartan
328281|NCT01541176|Corticotherapy|corticotherapy
328282|NCT01541176|Fibrosis|fibrosis
328283|NCT01541176|Numerical reading|numerical reading
328284|NCT01541176|18-70 years|18-70 years
328285|NCT01541176|first renal transplant was lost due to rejection|first renal transplant was lost due to rejection
328286|NCT01541176|first or second renal transplant|first or second renal transplant
328287|NCT01541163|Ischemia|ischemia
328288|NCT01541163|Brain Infarction|brain infarction
328289|NCT01541163|Acute Stroke|acute stroke
328290|NCT01541163|Heart Diseases|heart diseases
328291|NCT01541163|Myocardial Infarction|myocardial infarction
328292|NCT01541150|Pedophilia|pedophilia
328293|NCT01541150|Impaired Decision making|impaired decision making
328294|NCT01541150|Insight|insight
328295|NCT01541150|Cognitive Distorsions|cognitive distorsions
328296|NCT01541150|Impulsiveness|impulsiveness
328297|NCT01541137|thoracotomy|thoracotomy
328298|NCT01541137|pain|pain
328299|NCT01541137|NSAID|nsaid
328300|NCT01541137|PCA|pca
328301|NCT01541137|TEA|tea
328302|NCT01541137|chronic|chronic
328303|NCT01541124|cancer pain|cancer pain
328304|NCT01541124|analgesia|analgesia
328305|NCT01541124|morphine|morphine
328306|NCT01541111|Cancer pain|cancer pain
328307|NCT01541111|Magnesiun|magnesiun
328308|NCT01541085|Human Immunodeficiency Virus; HIV; Highly Active Antiretroviral Therapy; HAART; Darunavir; Ritonavir; Efavirenz; Kinetics; Immunological Recovery|human immunodeficiency virus; hiv; highly active antiretroviral therapy; haart; darunavir; ritonavir; efavirenz; kinetics; immunological recovery
328309|NCT01541072|Lymphoma, B-cell|lymphoma, b-cell
328310|NCT01541072|Lymphocyte reconstitution|lymphocyte reconstitution
328311|NCT01541072|Lymphocyte subsets|lymphocyte subsets
328312|NCT01541072|Peripheral stem cell transplantation|peripheral stem cell transplantation
328313|NCT01541072|Induction chemotherapy|induction chemotherapy
328314|NCT01541072|growth factor|growth factor
328315|NCT01541072|Granulocyte Colony-stimulating factor|granulocyte colony-stimulating factor
328316|NCT01541072|Pegfilgrastim|pegfilgrastim
328317|NCT01541072|Filgrastim|filgrastim
328318|NCT01541059|Third molar extraction|third molar extraction
328319|NCT01541059|local anesthesia|local anesthesia
328320|NCT01541059|ropivacaine|ropivacaine
328321|NCT01541046|pediatric|pediatric
328322|NCT01541046|infantile colic|infantile colic
328323|NCT01541046|probiotic treatment|probiotic treatment
328324|NCT01541033|autism|autism
328325|NCT01541033|children|children
328326|NCT01541007|Prostate Cancer|prostate cancer
328327|NCT01541007|Metastatic|metastatic
328328|NCT01541007|Castration Resistant|castration resistant
328329|NCT01540994|Neoplasms|neoplasms
328330|NCT01540994|Urogenital neoplasm|urogenital neoplasm
328331|NCT01540994|Genital neoplasms, male|genital neoplasms, male
328332|NCT01540955|Reduce Cognitive Complaints|reduce cognitive complaints
328333|NCT01540955|improve cognitive function|improve cognitive function
586557|NCT00516698|stage II breast cancer|stage ii breast cancer
328334|NCT01540955|post-treatment breast cancer patients|post-treatment breast cancer patients
328335|NCT01540942|Crohn's disease|crohn's disease
328336|NCT01540942|Nutrition|nutrition
328337|NCT01540942|Bowel resection|bowel resection
328338|NCT01540942|Postoperative recurrence|postoperative recurrence
328339|NCT01540942|complication|complication
328340|NCT01540942|Active disease|active disease
328341|NCT01540929|Smallpox|smallpox
328342|NCT01540929|ACAM2000®|acam2000®
328343|NCT01540929|Smallpox vaccine|smallpox vaccine
328344|NCT01540916|acid-base equilibrium|acid-base equilibrium
328345|NCT01540916|renal system|renal system
328346|NCT01540916|urinary electrolytes|urinary electrolytes
328347|NCT01540903|Malaria Challenge|malaria challenge
328348|NCT01540903|Plasmodium falciparum|plasmodium falciparum
328349|NCT01540903|PfSPZ Challenge|pfspz challenge
328350|NCT01540903|Controlled|controlled
328351|NCT01540903|human|human
328352|NCT01540903|malaria infection|malaria infection
328353|NCT01540864|Obesity|obesity
328354|NCT01540864|Overweight|overweight
328355|NCT01540864|Body Mass Index|body mass index
328356|NCT01540851|Osteoarthritis|osteoarthritis
328357|NCT01540851|Total Knee Replacement|total knee replacement
328358|NCT01540851|total Knee Arthroplasty|total knee arthroplasty
328359|NCT01540851|Post operative recovery, TKA|post operative recovery, tka
328360|NCT01540851|Post-operative recovery TKR|post-operative recovery tkr
328361|NCT01540851|Care Navigator|care navigator
328362|NCT01540838|Bacterial meningitis|bacterial meningitis
328363|NCT01540838|infusion|infusion
328364|NCT01540838|bolus|bolus
328365|NCT01540838|paracetamol|paracetamol
328366|NCT01540812|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
328367|NCT01540799|Migraine|migraine
328368|NCT01540799|High disability migraine|high disability migraine
328369|NCT01540799|Sphenopalatine ganglion|sphenopalatine ganglion
328370|NCT01540799|Neuromodulation|neuromodulation
328371|NCT01540799|Neurostimulation|neurostimulation
328372|NCT01540799|Autonomic nervous system|autonomic nervous system
328374|NCT01540786|High Resolution Urodynamics|high resolution urodynamics
328375|NCT01540773|growth hormone|growth hormone
328376|NCT01540747|intrafollicular melatonin|intrafollicular melatonin
328377|NCT01540747|PCOS|pcos
328378|NCT01540747|embryos quality|embryos quality
328379|NCT01540747|oocytes quality|oocytes quality
328380|NCT01540734|paracetamol|paracetamol
328381|NCT01540734|pharmacokinetic|pharmacokinetic
328382|NCT01540721|paracetamol|paracetamol
328383|NCT01540721|pharmacokinetics|pharmacokinetics
328384|NCT01540708|Asthma|asthma
328385|NCT01540708|Respiratory|respiratory
328386|NCT01540708|COPD|copd
328387|NCT01540695|Any patient with a routine basal cell or squamous cell carcinoma|any patient with a routine basal cell or squamous cell carcinoma
328483|NCT01540201|one lung ventilation|one lung ventilation
328388|NCT01540695|of the skin diagnosed on frozen histology during a Mohs procedure|of the skin diagnosed on frozen histology during a mohs procedure
328389|NCT01540682|Male and female patients with HNSCC of the oral cavity, oropharynx, hypopharynx, larynx,|male and female patients with hnscc of the oral cavity, oropharynx, hypopharynx, larynx,
403003|NCT01228643|Pancreatic enzymes.|pancreatic enzymes.
319163|NCT01579682|FBT|fbt
328390|NCT01540682|nasopharynx or paranasal sinuses that is considered appropriate|nasopharynx or paranasal sinuses that is considered appropriate
328391|NCT01540682|for definitive cetuximab-based radiation therapy.|for definitive cetuximab-based radiation therapy.
328392|NCT01540669|constipation|constipation
328393|NCT01540669|functional constipation|functional constipation
328394|NCT01540669|polydextrose|polydextrose
328395|NCT01540669|whole gut transit time|whole gut transit time
328396|NCT01540656|Stress incontinence|stress incontinence
328397|NCT01540656|Incontinence|incontinence
328398|NCT01540656|prostate cancer|prostate cancer
328399|NCT01540656|Radical Prostatectomy vibration|radical prostatectomy vibration
328400|NCT01540656|nerve stimulation|nerve stimulation
328401|NCT01540643|abdominal aortic aneurysm|abdominal aortic aneurysm
328402|NCT01540643|iliac leg graft|iliac leg graft
328403|NCT01540617|Low back pain|low back pain
328404|NCT01540617|Proprioception|proprioception
328405|NCT01540617|Postural control|postural control
328406|NCT01540617|Spine|spine
328407|NCT01540617|Variability|variability
328408|NCT01540617|MRI|mri
328409|NCT01540617|Vibration|vibration
328410|NCT01540617|Brain|brain
328411|NCT01540604|DMD|dmd
328412|NCT01540604|BMD|bmd
328413|NCT01540604|symptomatic carriers|symptomatic carriers
328414|NCT01540591|repeated implantation failure|repeated implantation failure
328415|NCT01540591|intralipid|intralipid
328416|NCT01540552|lung cancer|lung cancer
328417|NCT01540552|precancerous condition|precancerous condition
328418|NCT01540552|lung nodules|lung nodules
328419|NCT01540552|CT Scan|ct scan
328420|NCT01540500|Pharmacokinetics|pharmacokinetics
328421|NCT01540500|Drug Interaction|drug interaction
328422|NCT01540474|Interference of malaria infection|interference of malaria infection
328423|NCT01540461|HCC|hcc
328424|NCT01540435|Colorectal cancer|colorectal cancer
328425|NCT01540435|Liver metastases|liver metastases
328426|NCT01540435|Perioperative treatment|perioperative treatment
712268|NCT01016067|Fixation|fixation
328427|NCT01540435|Liver resection|liver resection
328428|NCT01540422|vein grafts|vein grafts
328429|NCT01540422|coronary bypass|coronary bypass
328430|NCT01540422|endoscopic harvest|endoscopic harvest
328431|NCT01540422|endoscopic vein harvest|endoscopic vein harvest
328432|NCT01540409|DMD, Duchenne, Eteplirsen, dystrophy, dystrophin, exon 51|dmd, duchenne, eteplirsen, dystrophy, dystrophin, exon 51
328433|NCT01540396|Gestational Diabetes|gestational diabetes
328434|NCT01540383|Communication|communication
328435|NCT01540383|Language|language
328436|NCT01540383|Treatment|treatment
328437|NCT01540383|Intervention|intervention
328438|NCT01540383|Therapy|therapy
328439|NCT01540383|Efficacy|efficacy
328440|NCT01540383|Maintenance|maintenance
328441|NCT01540383|Recovery|recovery
328442|NCT01540383|Outcome|outcome
328443|NCT01540383|Rehabilitation|rehabilitation
328444|NCT01540383|Treatment Intensity|treatment intensity
328445|NCT01540383|Language Impairment|language impairment
328446|NCT01540383|Intensive Language Therapy|intensive language therapy
328447|NCT01540383|Functional Communication|functional communication
328448|NCT01540383|Functional Improvement|functional improvement
328449|NCT01540383|Evidence-Based Intervention|evidence-based intervention
328450|NCT01540383|High-Frequency|high-frequency
328451|NCT01540357|mindfulness-based therapy|mindfulness-based therapy
328452|NCT01540357|chronic tinnitus;|chronic tinnitus;
328453|NCT01540344|peritoneal carcinomatosis|peritoneal carcinomatosis
328454|NCT01540344|cytoreductive surgery|cytoreductive surgery
328455|NCT01540344|HIPEC|hipec
328456|NCT01540344|colorectal cancer|colorectal cancer
328457|NCT01540318|ultrasonography|ultrasonography
328458|NCT01540318|Abdominal Injuries|abdominal injuries
328459|NCT01540318|Trauma|trauma
328460|NCT01540305|Obsessive Compulsive Disorder|obsessive compulsive disorder
328461|NCT01540305|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
328462|NCT01540305|Treatment|treatment
328463|NCT01540292|Crohn's disease|crohn's disease
328464|NCT01540292|Mesenchymal Stem Cell|mesenchymal stem cell
328465|NCT01540292|Cell therapy|cell therapy
328466|NCT01540292|Allogeneic|allogeneic
328467|NCT01540292|Inflammatory disorders|inflammatory disorders
328468|NCT01540292|Autoimmune disorders|autoimmune disorders
328469|NCT01540266|physician-patient communication|physician-patient communication
328470|NCT01540266|information structuring|information structuring
328471|NCT01540266|emergency department|emergency department
328472|NCT01540240|HIV treatment|hiv treatment
328473|NCT01540240|zidovudine|zidovudine
328474|NCT01540240|dose reduction|dose reduction
328475|NCT01540240|anaemia|anaemia
328674|NCT01539291|idelalisib|idelalisib
328476|NCT01540240|safety and efficacy comparison|safety and efficacy comparison
328477|NCT01540227|Syphilis|syphilis
328478|NCT01540227|Penicillin|penicillin
328479|NCT01540214|Urinary Bladder, Overactive|urinary bladder, overactive
328480|NCT01540214|Pelvic Organ Prolapse|pelvic organ prolapse
328481|NCT01540214|Gynecologic Surgical Procedures|gynecologic surgical procedures
328482|NCT01540214|Urodynamics|urodynamics
328484|NCT01540201|gas exchange|gas exchange
328485|NCT01540201|inverse-ratio ventilation|inverse-ratio ventilation
328486|NCT01540188|Drug user|drug user
328487|NCT01540188|Family member|family member
328488|NCT01540188|Intervention|intervention
328489|NCT01540188|Community|community
328490|NCT01540188|Support|support
328491|NCT01540175|Autologous stem cell transplant|autologous stem cell transplant
328492|NCT01540175|Immune reconstitution|immune reconstitution
328493|NCT01540162|preterm newborn|preterm newborn
328494|NCT01540162|neonatology|neonatology
328495|NCT01540162|EcN|ecn
328496|NCT01540162|Nissle|nissle
328497|NCT01540162|Mutaflor|mutaflor
328498|NCT01540162|prophylaxis|prophylaxis
328499|NCT01540162|infection|infection
328500|NCT01540110|Locally Advanced or Node Positive Primary Breast Cancer|locally advanced or node positive primary breast cancer
328501|NCT01540084|Cocktail sedation|cocktail sedation
328502|NCT01540084|ERCP|ercp
328503|NCT01540071|Hormone refractory prostate cancer|hormone refractory prostate cancer
328504|NCT01540071|HRPC|hrpc
328505|NCT01540071|Androgen independent prostate cancer|androgen independent prostate cancer
328506|NCT01540071|CRPC|crpc
328507|NCT01540071|Castration and Taxane Resistant Prostate Cancer|castration and taxane resistant prostate cancer
328508|NCT01540045|Non-Small Cell Lung Cancer|non-small cell lung cancer
328509|NCT01540045|Dysgeusia|dysgeusia
328510|NCT01540045|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
328511|NCT01540045|Paclitaxel|paclitaxel
328512|NCT01540045|Cisplatin|cisplatin
328513|NCT01540019|anorexia|anorexia
328514|NCT01540019|Paullinia cupana|paullinia cupana
328515|NCT01540019|loss of weight|loss of weight
328516|NCT01539993|Hepatocellular carcinoma|hepatocellular carcinoma
328517|NCT01539993|Liver metastases|liver metastases
328518|NCT01539993|Cholangiocarcinoma|cholangiocarcinoma
328519|NCT01539993|Percutaneous treatments|percutaneous treatments
328520|NCT01539993|RFA|rfa
328521|NCT01539993|TACE|tace
328522|NCT01539993|DEB|deb
328523|NCT01539980|Sericin scaffold|sericin scaffold
328524|NCT01539980|Wound healing|wound healing
328525|NCT01539980|Skin graft donor|skin graft donor
328526|NCT01539967|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
328527|NCT01539967|Obesity follow-up|obesity follow-up
328528|NCT01539954|Alcohol related disorders|alcohol related disorders
328529|NCT01539941|Co-occurring adolescent substance use and ADHD|co-occurring adolescent substance use and adhd
328530|NCT01539928|Dual time PET/CT|dual time pet/ct
328531|NCT01539928|glucose-6-phosphatase|glucose-6-phosphatase
328532|NCT01539915|Psoriasis|psoriasis
328533|NCT01539915|Stable plaque psoriasis|stable plaque psoriasis
328534|NCT01539915|lesions|lesions
328535|NCT01539915|TNF-alpha|tnf-alpha
328536|NCT01539915|BCT194|bct194
328537|NCT01539902|MSC for the treatment of Lupus Nephritis|msc for the treatment of lupus nephritis
328538|NCT01539876|locally advanced breast cancer patients|locally advanced breast cancer patients
328539|NCT01539850|obesity|obesity
328540|NCT01539850|gastric stimulation|gastric stimulation
328541|NCT01539850|morbid obesity|morbid obesity
328542|NCT01539837|Parkinson's disease|parkinson's disease
328543|NCT01539837|Brain Iron|brain iron
328544|NCT01539837|Iron chelation|iron chelation
328545|NCT01539837|Oxidative stress|oxidative stress
328546|NCT01539811|Foot Infections|foot infections
328547|NCT01539811|Diabetes|diabetes
328548|NCT01539811|Antibiotic|antibiotic
328549|NCT01539798|Saline solution|saline solution
328550|NCT01539798|Sodium Chloride|sodium chloride
328551|NCT01539798|Hypoalbuminemia|hypoalbuminemia
328552|NCT01539798|Weight Gain|weight gain
328553|NCT01539785|HIPEC|hipec
328554|NCT01539785|Hyperthermic|hyperthermic
328555|NCT01539785|ovarian cancer|ovarian cancer
328556|NCT01539785|recurrence|recurrence
328557|NCT01539759|Postpartum Contraception|postpartum contraception
328558|NCT01539759|Intrauterine Devices|intrauterine devices
328559|NCT01539746|Aortic stenosis|aortic stenosis
328560|NCT01539746|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
328561|NCT01539746|TAVI|tavi
328562|NCT01539746|Predilation|predilation
328563|NCT01539746|Balloon valvuloplasty|balloon valvuloplasty
328564|NCT01539746|BAV|bav
328565|NCT01539746|CoreValve|corevalve
328566|NCT01539720|emergency contraception|emergency contraception
328567|NCT01539720|Ella|ella
328568|NCT01539720|Mirena IUD|mirena iud
328569|NCT01539720|post-coital contraception|post-coital contraception
328570|NCT01539720|Liletta IUD|liletta iud
328571|NCT01539707|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
328572|NCT01539707|Solifenacin succinate suspension|solifenacin succinate suspension
328573|NCT01539707|Pharmacokinetics|pharmacokinetics
328574|NCT01539707|Phase 1|phase 1
328575|NCT01539681|Hepatocellular Carcinoma|hepatocellular carcinoma
328576|NCT01539681|Cancer, Liver|cancer, liver
328577|NCT01539681|Sorafenib|sorafenib
328578|NCT01539681|Nexavar|nexavar
328579|NCT01539668|Cervical Cancer|cervical cancer
328580|NCT01539668|HPV|hpv
328581|NCT01539668|Secondary prevention|secondary prevention
328582|NCT01539655|Phase 1|phase 1
328583|NCT01539655|healthy volunteers|healthy volunteers
328584|NCT01539655|pharmacokinetics|pharmacokinetics
328585|NCT01539655|vandetanib|vandetanib
328586|NCT01539655|omeprazole|omeprazole
328587|NCT01539655|ranitidine|ranitidine
328588|NCT01539642|In patient, post operative pain|in patient, post operative pain
328589|NCT01539642|Adult post-operative inpatients who are expected to require parenteral opioid analgesia for at least 48 hours after open abdominal surgery|adult post-operative inpatients who are expected to require parenteral opioid analgesia for at least 48 hours after open abdominal surgery
328590|NCT01539629|Heart failure|heart failure
328591|NCT01539629|Autothreshold|autothreshold
328592|NCT01539629|Pacing|pacing
328593|NCT01539629|CRT-D recipients|crt-d recipients
328594|NCT01539629|Left Ventricular evoked response signals|left ventricular evoked response signals
328595|NCT01539616|Hypertriglyceridemia|hypertriglyceridemia
328596|NCT01539616|Dyslipidemia|dyslipidemia
328597|NCT01539603|drug eluting balloon|drug eluting balloon
328598|NCT01539603|bare metal stent|bare metal stent
328599|NCT01539603|drug eluting stent|drug eluting stent
328600|NCT01539603|coronary artery disease|coronary artery disease
328601|NCT01539590|hepatocyte growth factor mimetic|hepatocyte growth factor mimetic
328602|NCT01539590|hepatocyte growth factor(HGF)|hepatocyte growth factor(hgf)
328603|NCT01539590|Myocardial Infarction|myocardial infarction
328604|NCT01539590|Acute ST Segment Elevation Myocardial Infarction (STEMI)|acute st segment elevation myocardial infarction (stemi)
328605|NCT01539590|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
328606|NCT01539538|Adult post-operative inpatients who|adult post-operative inpatients who
328607|NCT01539538|are expected to require parenteral|are expected to require parenteral
328608|NCT01539538|opioid analgesia for at least 48|opioid analgesia for at least 48
328609|NCT01539538|hours after open abdominal surgery|hours after open abdominal surgery
328610|NCT01539538|or hip/knee replacement surgery|or hip/knee replacement surgery
328611|NCT01539512|CLL|cll
328612|NCT01539512|CAL-101|cal-101
328613|NCT01539512|GS 1101|gs 1101
328614|NCT01539512|PI3K|pi3k
328615|NCT01539512|GS-US-312-0117|gs-us-312-0117
328616|NCT01539512|idelalisib|idelalisib
328617|NCT01539460|Axillary osmidrosis|axillary osmidrosis
328618|NCT01539460|liposuction|liposuction
328619|NCT01539460|minimally invasive surgery|minimally invasive surgery
328620|NCT01539447|Hip arthroscopy|hip arthroscopy
328621|NCT01539447|Femoroacetabular impingement|femoroacetabular impingement
328622|NCT01539447|Heterotopic ossification|heterotopic ossification
328623|NCT01539447|Heterotopic bone formation|heterotopic bone formation
328624|NCT01539434|COPD|copd
328625|NCT01539434|Behavioral intervention|behavioral intervention
328626|NCT01539434|Physical capacity|physical capacity
328627|NCT01539434|Physical activity|physical activity
328628|NCT01539421|COPD|copd
328629|NCT01539421|exercise endurance|exercise endurance
328630|NCT01539395|Relapsing Remitting|relapsing remitting
328631|NCT01539395|MS|ms
328632|NCT01539382|cardiac surgery|cardiac surgery
328633|NCT01539382|neurocognitive assessment|neurocognitive assessment
328634|NCT01539382|neurocognitive function|neurocognitive function
328635|NCT01539369|dietary intervention|dietary intervention
328636|NCT01539369|dietary fibre|dietary fibre
328637|NCT01539369|weight loss|weight loss
328638|NCT01539369|weight maintenance|weight maintenance
328639|NCT01539356|Hepcidin|hepcidin
328640|NCT01539356|Preterm Infants|preterm infants
328641|NCT01539356|Anemia|anemia
328642|NCT01539356|Sepsis|sepsis
328643|NCT01539356|Ferritin|ferritin
328644|NCT01539343|Infection|infection
328645|NCT01539343|Catheter-related bloodstream infection|catheter-related bloodstream infection
328646|NCT01539343|CRBSI|crbsi
328647|NCT01539343|Antimicrobial Lock Therapy|antimicrobial lock therapy
328648|NCT01539343|ALT|alt
328649|NCT01539343|Central Line Associated Bloodstream Infection|central line associated bloodstream infection
328651|NCT01539343|Central Venous Catheter|central venous catheter
328652|NCT01539343|CVC|cvc
328653|NCT01539343|Quantitative blood cultures|quantitative blood cultures
328654|NCT01539343|QBC|qbc
328655|NCT01539330|voriconazole|voriconazole
328656|NCT01539330|microdialysis|microdialysis
328657|NCT01539330|sequence therapy|sequence therapy
328658|NCT01539330|pharmacokinetics|pharmacokinetics
328659|NCT01539330|Target Site Pharmacokinetics|target site pharmacokinetics
328660|NCT01539317|Vulvodynia|vulvodynia
328661|NCT01539317|Dyspareunia|dyspareunia
328662|NCT01539317|Breast Cancer|breast cancer
328663|NCT01539317|Menopause|menopause
328664|NCT01539317|Vaginal dryness|vaginal dryness
328665|NCT01539317|Painful intercourse|painful intercourse
328666|NCT01539291|CLL|cll
328667|NCT01539291|CAL-101|cal-101
328668|NCT01539291|CAL 101|cal 101
328669|NCT01539291|GS-1101|gs-1101
328670|NCT01539291|GS 1101|gs 1101
328671|NCT01539291|PI3K|pi3k
328672|NCT01539291|Leukemia|leukemia
328673|NCT01539291|GS-US-312-0116|gs-us-312-0116
328675|NCT01539278|Sleep Apnea, Obstructive|sleep apnea, obstructive
328676|NCT01539278|Child|child
328677|NCT01539278|Tonsillectomy|tonsillectomy
328678|NCT01539278|Adenoidectomy|adenoidectomy
328679|NCT01539265|urinary calculus|urinary calculus
328680|NCT01539265|ureteral stones|ureteral stones
328681|NCT01539265|medical expulsive therapy|medical expulsive therapy
328682|NCT01539252|hemodialysis|hemodialysis
328683|NCT01539252|adequacy|adequacy
328684|NCT01539252|phosphate clearance|phosphate clearance
328685|NCT01539252|double dialyzer|double dialyzer
328686|NCT01539252|two dialyzers in parallel|two dialyzers in parallel
328687|NCT01539239|Glaucoma|glaucoma
328688|NCT01539239|POAG|poag
328689|NCT01539239|Cataract|cataract
328690|NCT01539226|HIV Infections|hiv infections
328691|NCT01539226|Anti-HIV agents|anti-hiv agents
328692|NCT01539226|HIV-1|hiv-1
328693|NCT01539213|Psoriasis|psoriasis
328694|NCT01539213|interstitial fluid|interstitial fluid
328695|NCT01539213|open flow microperfusion|open flow microperfusion
328696|NCT01539213|IL-17|il-17
328697|NCT01539213|inflammatory skin disease|inflammatory skin disease
328698|NCT01539213|scaly patches|scaly patches
328699|NCT01539213|Healthy volunteers and psoriasis patients|healthy volunteers and psoriasis patients
328700|NCT01539187|uterine fibroid RF ablation|uterine fibroid rf ablation
328701|NCT01539187|intrauterine ultrasound|intrauterine ultrasound
328702|NCT01539187|VizAblate|vizablate
328703|NCT01539161|Chagas Disease|chagas disease
328704|NCT01539161|Chagasic|chagasic
328705|NCT01539161|Reveal XT|reveal xt
328706|NCT01539161|Implantable Cardiac Monitor|implantable cardiac monitor
328707|NCT01539161|ICM|icm
328708|NCT01539148|Quality of Life|quality of life
328709|NCT01539148|Qol|qol
328710|NCT01539148|Questionnaire|questionnaire
328711|NCT01539148|Survey|survey
328712|NCT01539148|Insulin Potentiation Targeted Low Dose Chemotherapy|insulin potentiation targeted low dose chemotherapy
328713|NCT01539148|IPTLD|iptld
328714|NCT01539148|Nutritional Therapy|nutritional therapy
328715|NCT01539148|Chemotherapy|chemotherapy
328716|NCT01539148|Cancer Treatment|cancer treatment
328717|NCT01539148|Kotsanis Institute|kotsanis institute
328718|NCT01539148|The Best Answer for Cancer Foundation|the best answer for cancer foundation
328719|NCT01539148|Liberty IRB|liberty irb
328720|NCT01539148|Texas|texas
328721|NCT01539135|Aspiration, Respiratory|aspiration, respiratory
328722|NCT01539122|osteoarthritis|osteoarthritis
328723|NCT01539122|shoulder replacement|shoulder replacement
328724|NCT01539109|Incomplete Spinal Cord Injury|incomplete spinal cord injury
328725|NCT01539109|Quadriplegia|quadriplegia
328726|NCT01539109|Tetraplegia|tetraplegia
328728|NCT01539109|Spinal Cord Disease|spinal cord disease
328729|NCT01539109|Spinal Cord Injury|spinal cord injury
328730|NCT01539109|iSCI|isci
328731|NCT01539109|Transcranial Direct Current Stimulation|transcranial direct current stimulation
328732|NCT01539109|tDCS|tdcs
328733|NCT01539109|SCI recovery|sci recovery
328734|NCT01539109|brain stimulation|brain stimulation
328735|NCT01539109|rehabilitation|rehabilitation
328736|NCT01539096|Stroke|stroke
328737|NCT01539096|Rehabilitation|rehabilitation
328738|NCT01539096|Paresis|paresis
328739|NCT01539096|Paralysis|paralysis
328740|NCT01539096|Recovery|recovery
328741|NCT01539096|tDCS|tdcs
328742|NCT01539096|Transcranial Direct Current Stimulation|transcranial direct current stimulation
328743|NCT01539096|CIMT|cimt
328744|NCT01539096|Constraint Induced Movement Therapy|constraint induced movement therapy
328745|NCT01539096|Stroke therapy|stroke therapy
328746|NCT01539096|MRI|mri
328747|NCT01539096|Hand|hand
328748|NCT01539096|CVA|cva
328749|NCT01539096|Cerebrovascular accident|cerebrovascular accident
328750|NCT01539083|Multiple Myeloma|multiple myeloma
328751|NCT01539083|Bortezomib|bortezomib
328752|NCT01539083|VELCADE|velcade
328753|NCT01539083|Consolidation therapy|consolidation therapy
328754|NCT01539083|Subcutaneous|subcutaneous
328755|NCT01539083|Thalidomide|thalidomide
328756|NCT01539083|Prednisolone|prednisolone
328757|NCT01539083|Autologous stem cell transplant (ASCT)|autologous stem cell transplant (asct)
328758|NCT01539083|VELCADE, cyclophosphamide, dexamethasone (VCD) induction therapy|velcade, cyclophosphamide, dexamethasone (vcd) induction therapy
328759|NCT01539070|Nutritional intervention|nutritional intervention
328760|NCT01539070|Childhood obesity|childhood obesity
328761|NCT01539070|Physical activity|physical activity
328762|NCT01539070|Feeding practices|feeding practices
328764|NCT01539057|Surgery|surgery
328765|NCT01539057|hemostasis|hemostasis
328766|NCT01539057|coagulation|coagulation
328767|NCT01539057|Fibrinogen|fibrinogen
328768|NCT01539044|reversal|reversal
328769|NCT01539044|muscle relaxant|muscle relaxant
328770|NCT01539044|sugammadex|sugammadex
328771|NCT01539031|Alzheimer Disease|alzheimer disease
328772|NCT01539031|Dementia|dementia
328773|NCT01539031|Delirium|delirium
328774|NCT01539031|Amnestic|amnestic
328775|NCT01539031|Cognitive Disorders|cognitive disorders
328776|NCT01539031|Donepezil|donepezil
328777|NCT01539031|Brain Diseases|brain diseases
328778|NCT01539031|Central Nervous System Diseases|central nervous system diseases
328779|NCT01539031|Nervous System Diseases|nervous system diseases
328780|NCT01539031|Tauopathies|tauopathies
328781|NCT01539031|Neurodegenerative Diseases|neurodegenerative diseases
328782|NCT01539031|Mental Disorders|mental disorders
328783|NCT01539031|Cholinesterase Inhibitors|cholinesterase inhibitors
328784|NCT01539031|Enzy|enzy
328785|NCT01539005|Recurrence|recurrence
328786|NCT01539005|Tuberculosis|tuberculosis
328787|NCT01538992|renal denervation|renal denervation
328788|NCT01538992|heart failure|heart failure
328789|NCT01538979|Grass pollen allergy|grass pollen allergy
328790|NCT01538979|Immunotherapy|immunotherapy
328791|NCT01538979|Recombinant vaccine|recombinant vaccine
328792|NCT01538979|Rhinitis, allergic, seasonal|rhinitis, allergic, seasonal
328793|NCT01538966|acromegaly|acromegaly
328794|NCT01538966|pituitary|pituitary
328795|NCT01538966|pegvisomant|pegvisomant
328796|NCT01538966|somavert|somavert
328797|NCT01538966|lanreotide|lanreotide
328798|NCT01538966|octreotide|octreotide
328799|NCT01538953|diarrhea|diarrhea
328800|NCT01538953|handwashing|handwashing
328801|NCT01538953|point-of-use water treatment|point-of-use water treatment
328802|NCT01538953|diarrhea longitudinal prevalence|diarrhea longitudinal prevalence
328803|NCT01538940|Influenza|influenza
328804|NCT01538940|Vaccine|vaccine
328805|NCT01538940|Thailand|thailand
328806|NCT01538927|fibrin sealant|fibrin sealant
328807|NCT01538927|tissue adhesive|tissue adhesive
328808|NCT01538927|wound healing|wound healing
328809|NCT01538927|interleukin 1 beta|interleukin 1 beta
328810|NCT01538927|interleukin 8|interleukin 8
328811|NCT01538901|actinic keratoses|actinic keratoses
328812|NCT01538901|organ transplant recipients|organ transplant recipients
328813|NCT01538901|photodynamic therapy|photodynamic therapy
328814|NCT01538901|imiquimod|imiquimod
328815|NCT01538888|WHOLE BODY VIBRATION|whole body vibration
328816|NCT01538888|AGED|aged
328817|NCT01538888|VO2|vo2
328818|NCT01538888|muscle strength|muscle strength
328819|NCT01538875|Hypertension, pregnancy induced|hypertension, pregnancy induced
328820|NCT01538875|Hydralazine|hydralazine
328821|NCT01538875|Labetalol|labetalol
328822|NCT01538823|Surgery, Renal Cell Cancer|surgery, renal cell cancer
328823|NCT01538810|CT imaging|ct imaging
328824|NCT01538797|YF476|yf476
328825|NCT01538797|gastrin receptor antagonist|gastrin receptor antagonist
328826|NCT01538797|gastric pH|gastric ph
328827|NCT01538797|healthy subjects|healthy subjects
328828|NCT01538797|ranitidine|ranitidine
328829|NCT01538784|YF476|yf476
328830|NCT01538784|gastrin receptor antagonist|gastrin receptor antagonist
328831|NCT01538784|gastric pH|gastric ph
328832|NCT01538784|healthy subjects|healthy subjects
328833|NCT01538771|Myocardial infarction|myocardial infarction
328834|NCT01538771|Erythropoietin|erythropoietin
328835|NCT01538771|Myocardial reperfusion injury|myocardial reperfusion injury
328836|NCT01538758|calcifying tendinitis|calcifying tendinitis
328837|NCT01538758|rotator cuff|rotator cuff
328838|NCT01538745|Pain|pain
328839|NCT01538745|Emergency Department|emergency department
328840|NCT01538745|Morphine|morphine
328841|NCT01538745|Ketamine|ketamine
328842|NCT01538706|Hospital-based home care|hospital-based home care
328843|NCT01538706|Pediatric oncology|pediatric oncology
328844|NCT01538693|BDNF|bdnf
328845|NCT01538693|serotonin|serotonin
328846|NCT01538693|high-intensity|high-intensity
328847|NCT01538693|exercise|exercise
328848|NCT01538667|Lung|lung
328849|NCT01538667|Scintigraphy|scintigraphy
328850|NCT01538667|Pharmacokinetics|pharmacokinetics
328851|NCT01538667|Inhalation|inhalation
328852|NCT01538667|Ciprofloxacin|ciprofloxacin
328853|NCT01538654|obesity|obesity
328854|NCT01538654|PSMF ( protein sparing modified fast)|psmf ( protein sparing modified fast)
328855|NCT01538654|Enteral nutrition|enteral nutrition
328857|NCT01538654|VLCD ( very low calorie diet)|vlcd ( very low calorie diet)
328858|NCT01538654|Pulmonary function tests|pulmonary function tests
328859|NCT01538654|body composition|body composition
328860|NCT01538654|FFM ( fat free mass)|ffm ( fat free mass)
328861|NCT01538654|Body fat|body fat
328862|NCT01538654|Handgripstregth|handgripstregth
328863|NCT01538628|Prostate cancer|prostate cancer
328864|NCT01538628|Spacer|spacer
328865|NCT01538615|Family meals|family meals
328866|NCT01538615|Home food environment|home food environment
328867|NCT01538615|Electronic media|electronic media
328868|NCT01538602|PCOS|pcos
328869|NCT01538602|cardiovascular disorders|cardiovascular disorders
328870|NCT01538563|ON 01910.Na|on 01910.na
328871|NCT01538563|rigosertib sodium|rigosertib sodium
328872|NCT01538563|rogosertib|rogosertib
328873|NCT01538550|cancer|cancer
328874|NCT01538550|colon|colon
328875|NCT01538550|rectum|rectum
328876|NCT01538550|adenoma|adenoma
328877|NCT01538550|screening|screening
328878|NCT01538550|iFOBT|ifobt
328879|NCT01538550|flexible sigmoidoscopy|flexible sigmoidoscopy
328880|NCT01538550|randomized trial|randomized trial
328881|NCT01538537|ON 01910.Na|on 01910.na
328882|NCT01538537|rigosertib Sodium|rigosertib sodium
328883|NCT01538537|rigosertib|rigosertib
328884|NCT01538498|PCI|pci
328885|NCT01538498|Ovarian cancer|ovarian cancer
328886|NCT01538485|Vitamin D|vitamin d
328887|NCT01538485|regulatory T cells|regulatory t cells
328890|NCT01538472|Relapse B-cell CD20+ non-Hodgkin's lymphoma|relapse b-cell cd20+ non-hodgkin's lymphoma
328891|NCT01538472|High-dose BEAM chemotherapy|high-dose beam chemotherapy
328892|NCT01538472|Y Zevalin|y zevalin
328893|NCT01538472|In Zevalin|in zevalin
328894|NCT01538472|Rituxan|rituxan
328895|NCT01538472|Rituximab|rituximab
328896|NCT01538472|BCNU|bcnu
328897|NCT01538472|1,3-bis(2-chloroethyl)-1-nitrosourea bis-chloronitrosourea|1,3-bis(2-chloroethyl)-1-nitrosourea bis-chloronitrosourea
328898|NCT01538472|Carmustine|carmustine
328899|NCT01538472|BiCNU|bicnu
328900|NCT01538472|VP-16|vp-16
328901|NCT01538472|Ara-C|ara-c
328902|NCT01538472|Cytarabine|cytarabine
328903|NCT01538472|Cytosar|cytosar
328904|NCT01538472|DepoCyt|depocyt
328905|NCT01538472|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
328906|NCT01538472|Melphalan|melphalan
328907|NCT01538472|Alkeran|alkeran
328908|NCT01538472|G-CSF|g-csf
328909|NCT01538472|Filgrastim|filgrastim
328910|NCT01538472|Neupogen|neupogen
328911|NCT01538472|Stem cell infusion|stem cell infusion
328912|NCT01538472|Autologous stem cell transplantation|autologous stem cell transplantation
328913|NCT01538459|Blood Glucose|blood glucose
328914|NCT01538459|Bupivacaine|bupivacaine
328915|NCT01538459|Interscalene Nerve Block|interscalene nerve block
328916|NCT01538459|Regional Anesthesia|regional anesthesia
328917|NCT01538459|Pain Blockade|pain blockade
328918|NCT01538459|Arthroscopic Surgery|arthroscopic surgery
328919|NCT01538459|Arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
328920|NCT01538459|Dexamethasone|dexamethasone
328921|NCT01538459|Anti-Inflammatory Agents|anti-inflammatory agents
328922|NCT01538459|Therapeutic Uses|therapeutic uses
328923|NCT01538459|Physiological Effects of Drugs|physiological effects of drugs
328924|NCT01538459|Glucocorticoids|glucocorticoids
328925|NCT01538459|Anesthetics, Local|anesthetics, local
328926|NCT01538459|Anesthetics|anesthetics
328927|NCT01538459|Sensory System Agents|sensory system agents
328928|NCT01538459|Adjuvants, Anesthesia|adjuvants, anesthesia
328929|NCT01538459|Anesthesiology|anesthesiology
328930|NCT01538459|Injections|injections
328931|NCT01538459|Adult|adult
328932|NCT01538459|Analgesia/methods|analgesia/methods
328933|NCT01538459|Brachial Plexus/drug effects|brachial plexus/drug effects
328934|NCT01538459|Brachial Plexus/surgery|brachial plexus/surgery
328935|NCT01538459|Brachial Plexus/ultrasonography|brachial plexus/ultrasonography
328936|NCT01538459|Bupivacaine/administration & dosage|bupivacaine/administration & dosage
328937|NCT01538459|Dexamethasone/administration & dosage|dexamethasone/administration & dosage
328938|NCT01538459|Drug Therapy, Combination|drug therapy, combination
328939|NCT01538459|Female|female
328940|NCT01538459|Humans|humans
328941|NCT01538459|Male|male
328942|NCT01538459|Nerve Block/methods|nerve block/methods
328943|NCT01538459|Pain, Postoperative/etiology|pain, postoperative/etiology
328944|NCT01538459|Pain, Postoperative/prevention & control|pain, postoperative/prevention & control
328945|NCT01538459|Prospective Studies|prospective studies
328946|NCT01538459|Time Factors|time factors
328947|NCT01538446|Elderly|elderly
328948|NCT01538446|Acute coronary syndrome|acute coronary syndrome
328949|NCT01538446|Percutaneous coronary intervention|percutaneous coronary intervention
328950|NCT01538446|Prasugrel|prasugrel
328951|NCT01538446|Platelet function test|platelet function test
328952|NCT01538433|diagnosis|diagnosis
328953|NCT01538433|IgA nephropathy|iga nephropathy
328954|NCT01538420|Safety|safety
328955|NCT01538420|Tolerability|tolerability
328956|NCT01538420|Pharmacokinetics|pharmacokinetics
328957|NCT01538420|Pharmacodynamics|pharmacodynamics
328959|NCT01538407|Biomechanics|biomechanics
328960|NCT01538407|Quadriceps|quadriceps
328961|NCT01538407|Gait|gait
328962|NCT01538394|smoking cessation|smoking cessation
328963|NCT01538394|abstinence|abstinence
328964|NCT01538394|clinical trial|clinical trial
328965|NCT01538394|varenicline|varenicline
328966|NCT01538394|nicotine|nicotine
328967|NCT01538381|Neoadjuvant targeted therapy|neoadjuvant targeted therapy
328968|NCT01538381|Preoperative targeted therapy|preoperative targeted therapy
328969|NCT01538381|Afatinib|afatinib
328970|NCT01538368|MRCP|mrcp
328972|NCT01538368|EUS|eus
328973|NCT01538368|Image interpretation|image interpretation
328974|NCT01538368|MRCP findings|mrcp findings
328975|NCT01538368|endoscopic intervention(s)|endoscopic intervention(s)
328976|NCT01538355|multiple sclerosis|multiple sclerosis
328977|NCT01538355|diet|diet
328978|NCT01538355|prolonged fasting|prolonged fasting
328979|NCT01538355|caloric restriction|caloric restriction
328980|NCT01538355|ketogenic low glycemic load treatment|ketogenic low glycemic load treatment
328981|NCT01538355|health related quality of life|health related quality of life
328982|NCT01538355|ketogenic diet|ketogenic diet
328983|NCT01538355|neurodegeneration|neurodegeneration
328984|NCT01538355|neuroinflammation|neuroinflammation
328985|NCT01538329|Dyskinesia|dyskinesia
328986|NCT01538329|L-DOPA|l-dopa
329082|NCT01537848|EUS|eus
328987|NCT01538329|Early introduced treatment|early introduced treatment
328988|NCT01538329|Amantadine|amantadine
328989|NCT01538316|Prostate cancer|prostate cancer
328990|NCT01538316|dietary supplements|dietary supplements
328991|NCT01538316|quercetin|quercetin
328992|NCT01538316|genistein|genistein
328993|NCT01538316|prostate-specific antigen|prostate-specific antigen
328994|NCT01538316|oxidative Status|oxidative status
328995|NCT01538303|STEMI|stemi
328996|NCT01538303|absolute flow|absolute flow
328997|NCT01538303|microvascular resistance|microvascular resistance
328998|NCT01538290|Calibration|calibration
328999|NCT01538290|Validation|validation
329000|NCT01538290|Transfer function|transfer function
329001|NCT01538290|SphygmoCor|sphygmocor
329002|NCT01538290|Arteriograph|arteriograph
329003|NCT01538277|contact force catheter|contact force catheter
329004|NCT01538277|loop recorder|loop recorder
329005|NCT01538251|ulcerative colitis|ulcerative colitis
329006|NCT01538251|propionyl-l-carnitine|propionyl-l-carnitine
329007|NCT01538225|Spasticity|spasticity
329008|NCT01538212|Alzheimer's disease|alzheimer's disease
329009|NCT01538212|retrospective|retrospective
329010|NCT01538212|Axona|axona
329011|NCT01538199|Device study|device study
329012|NCT01538199|Depression|depression
329013|NCT01538199|Major Depression|major depression
329014|NCT01538199|Major Depressive Disorder|major depressive disorder
329015|NCT01538199|MDD|mdd
329016|NCT01538199|Device for depression|device for depression
329017|NCT01538199|Alternatives to medication for depression|alternatives to medication for depression
329018|NCT01538199|Massachusetts General Hospital|massachusetts general hospital
329019|NCT01538199|Boston|boston
329020|NCT01538186|Coronary intervention|coronary intervention
329021|NCT01538186|PCI of the side branch|pci of the side branch
329022|NCT01538173|surgical side infection|surgical side infection
329023|NCT01538173|breast reduction|breast reduction
329024|NCT01538173|reduction mammaplasty|reduction mammaplasty
329025|NCT01538173|prospective trial|prospective trial
329026|NCT01538173|microcirculation|microcirculation
329027|NCT01538173|breast surgery|breast surgery
329028|NCT01538160|recombinant factor VIIa|recombinant factor viia
329029|NCT01538160|factor XI deficiency|factor xi deficiency
329030|NCT01538147|Restless Leg Syndrome|restless leg syndrome
329031|NCT01538147|Severe Preeclampsia|severe preeclampsia
329032|NCT01538134|Antibodies, anticardiolipin|antibodies, anticardiolipin
329033|NCT01538134|Antibodies, B2 Glycoprotein I|antibodies, b2 glycoprotein i
329034|NCT01538134|Lupus Anticoagulant|lupus anticoagulant
329035|NCT01538134|Fetal Growth Restriction|fetal growth restriction
329036|NCT01538121|Antibodies, anticardiolipin|antibodies, anticardiolipin
329037|NCT01538121|Antibodies, B2 Glycoprotein I|antibodies, b2 glycoprotein i
329038|NCT01538121|Lupus Anticoagulant|lupus anticoagulant
329039|NCT01538121|Severe Preeclampsia|severe preeclampsia
329040|NCT01538082|Anxiety disorders|anxiety disorders
329041|NCT01538082|Depressive disorders|depressive disorders
329042|NCT01538082|Metabolic syndrome|metabolic syndrome
329043|NCT01538082|Stress disorders|stress disorders
329044|NCT01538082|Primary care|primary care
329045|NCT01538069|Heart failure|heart failure
329046|NCT01538069|Sleep apnea syndromes|sleep apnea syndromes
329047|NCT01538069|Exercise|exercise
329048|NCT01538069|Continuous Positive Airway Pressure|continuous positive airway pressure
329049|NCT01538056|AAA|aaa
329050|NCT01538043|Cost-effectiveness analysis|cost-effectiveness analysis
329051|NCT01538043|Cost-utility analysis|cost-utility analysis
329052|NCT01538043|Osteoarthritis|osteoarthritis
329053|NCT01538043|Spa therapy|spa therapy
329054|NCT01538043|Randomized clinical trial|randomized clinical trial
329055|NCT01538043|Mechanisms of action|mechanisms of action
329056|NCT01538030|Fetal membranes, premature rupture|fetal membranes, premature rupture
329057|NCT01538030|Cesarean section|cesarean section
329058|NCT01538030|Perinatal mortality|perinatal mortality
329059|NCT01538030|Neonatal sepsis|neonatal sepsis
329060|NCT01538030|Amniotic Fluid Volume|amniotic fluid volume
329061|NCT01538004|Blood pressure determination|blood pressure determination
329062|NCT01538004|Primary health care|primary health care
329063|NCT01538004|Office visits|office visits
329064|NCT01538004|Reproducibility of results|reproducibility of results
329065|NCT01537991|radiotherapy|radiotherapy
329066|NCT01537991|non small cell lung cancer|non small cell lung cancer
329067|NCT01537991|isotoxic|isotoxic
329068|NCT01537978|spinal cord injury, video gaming, functional improvement|spinal cord injury, video gaming, functional improvement
329069|NCT01537965|hepatitis|hepatitis
329070|NCT01537965|fibrosis|fibrosis
329071|NCT01537965|elastography|elastography
329072|NCT01537952|facial paralysis, facial nerve, borreliosis, Bell's palsy|facial paralysis, facial nerve, borreliosis, bell's palsy
329073|NCT01537939|Physical Activity|physical activity
329074|NCT01537939|Walking|walking
329075|NCT01537939|Pedometer|pedometer
329076|NCT01537939|Body Composition|body composition
329077|NCT01537939|Aerobic Fitness|aerobic fitness
329078|NCT01537926|HALT|halt
329079|NCT01537926|HCM|hcm
329080|NCT01537874|Secondhand smoke|secondhand smoke
408675|NCT01203917|safety|safety
329081|NCT01537874|Pediatric disease|pediatric disease
329083|NCT01537848|Endoscopic ultrasound|endoscopic ultrasound
329084|NCT01537848|abdominal collection|abdominal collection
329085|NCT01537848|post-operative|post-operative
329086|NCT01537848|post-surgical|post-surgical
329087|NCT01537835|healthcare|healthcare
329088|NCT01537835|worker|worker
329089|NCT01537835|uniforms|uniforms
329090|NCT01537835|bacterial|bacterial
329091|NCT01537835|contamination|contamination
329092|NCT01537822|intrauterine polyps|intrauterine polyps
329093|NCT01537822|myomas|myomas
329094|NCT01537822|residual placental tissue|residual placental tissue
329095|NCT01537809|Vitamin D|vitamin d
329096|NCT01537809|Vitamin D Deficiency|vitamin d deficiency
329097|NCT01537809|Avitaminosis|avitaminosis
329098|NCT01537809|Deficiency Diseases|deficiency diseases
329099|NCT01537809|Blood lipids|blood lipids
329100|NCT01537796|Obesity|obesity
329101|NCT01537796|Exercise|exercise
329102|NCT01537783|abscess|abscess
329103|NCT01537770|Vertebroplasty|vertebroplasty
329104|NCT01537770|Low energy osteoporotic vertebral fractures|low energy osteoporotic vertebral fractures
329105|NCT01537770|of the thoracic and/or lumbar spine|of the thoracic and/or lumbar spine
329106|NCT01537744|expansion cohort|expansion cohort
329107|NCT01537705|Medical food|medical food
329108|NCT01537705|Neuropathy|neuropathy
329109|NCT01537705|Diabetes|diabetes
329110|NCT01537705|Neuropathic Pain|neuropathic pain
329111|NCT01537679|Caregiver|caregiver
329112|NCT01537679|meditation|meditation
329113|NCT01537679|relaxation|relaxation
329114|NCT01537679|stress|stress
329115|NCT01537627|Motor activity|motor activity
329116|NCT01537627|Exercise|exercise
329117|NCT01537627|Rehabilitation|rehabilitation
329118|NCT01537601|Posterior urethral valves|posterior urethral valves
329119|NCT01537601|Febrile urinary tract infection|febrile urinary tract infection
329120|NCT01537601|Circumcision|circumcision
712269|NCT01016067|Internal|internal
329121|NCT01537601|Antibioprophylaxis|antibioprophylaxis
329122|NCT01537601|Impact on family|impact on family
329123|NCT01537588|anterior cruciate ligament|anterior cruciate ligament
329124|NCT01537588|hamstring|hamstring
329125|NCT01537588|semitendinosus|semitendinosus
329126|NCT01537588|gracilis|gracilis
329128|NCT01537562|Copper IUD|copper iud
329129|NCT01537562|LNG-IUS|lng-ius
329130|NCT01537562|intrauterine contraception|intrauterine contraception
329131|NCT01537562|medical abortion|medical abortion
329132|NCT01537562|postabortion contraception|postabortion contraception
329133|NCT01537549|Progressive supranuclear palsy|progressive supranuclear palsy
329134|NCT01537549|alpha-lipoic acid|alpha-lipoic acid
329135|NCT01537549|L-acetyl carnitine|l-acetyl carnitine
329136|NCT01537549|antioxidant|antioxidant
329137|NCT01537549|magnetic resonance spectroscopy|magnetic resonance spectroscopy
329138|NCT01537549|neurodegeneration|neurodegeneration
329139|NCT01537549|glutathione|glutathione
329140|NCT01537536|Breast cancer|breast cancer
329141|NCT01537536|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
329142|NCT01537536|EndoTAG-1|endotag-1
329143|NCT01537523|physical|physical
329144|NCT01537523|psychological|psychological
329145|NCT01537523|fracture hip|fracture hip
329146|NCT01537497|Phase 1|phase 1
329147|NCT01537497|Single Doses|single doses
329148|NCT01537497|Pharmacodynamics|pharmacodynamics
329149|NCT01537497|Healthy Volunteers|healthy volunteers
329150|NCT01537484|massage|massage
329151|NCT01537484|osteoarthritis|osteoarthritis
329152|NCT01537484|light touch|light touch
329153|NCT01537484|Swedish|swedish
329154|NCT01537471|PPI|ppi
329155|NCT01537471|Meclizine|meclizine
329156|NCT01537471|Startle|startle
329157|NCT01537471|Sensory processing|sensory processing
329158|NCT01537471|antihistamines|antihistamines
329159|NCT01537445|Diabetes Mellitus|diabetes mellitus
329160|NCT01537445|Pancreas|pancreas
329161|NCT01537445|Renal failure|renal failure
329162|NCT01537445|Transplantation|transplantation
329163|NCT01537432|Psoriasis, Plaque-type psoriasis|psoriasis, plaque-type psoriasis
329164|NCT01537432|Plaque|plaque
329165|NCT01537432|Secukinumab|secukinumab
329166|NCT01537432|AIN457A|ain457a
329167|NCT01537432|PASI|pasi
329168|NCT01537432|DLQI|dlqi
329169|NCT01537432|IGA|iga
329170|NCT01537419|Suicide|suicide
329171|NCT01537419|Depression|depression
329172|NCT01537419|Family Relationships|family relationships
329173|NCT01537406|BREAST IRRADIATION USING INTENSITY MODULATED RADIATION THERAPY|breast irradiation using intensity modulated radiation therapy
329174|NCT01537393|cornea|cornea
329175|NCT01537393|transplant|transplant
329176|NCT01537393|preservation|preservation
329177|NCT01537393|endothelial keratoplasty|endothelial keratoplasty
329178|NCT01537367|Human immunodeficiency virus|human immunodeficiency virus
329179|NCT01537367|HIV primary care|hiv primary care
329180|NCT01537328|Total knee arthroplasty|total knee arthroplasty
329181|NCT01537328|quadriceps|quadriceps
329182|NCT01537328|muscle|muscle
329183|NCT01537328|arthroplasty|arthroplasty
329184|NCT01537328|joint diseases|joint diseases
329185|NCT01537328|musculoskeletal diseases|musculoskeletal diseases
329186|NCT01537315|Kidney Failure, Chronic|kidney failure, chronic
329187|NCT01537315|Cardiovascular Disease|cardiovascular disease
329188|NCT01537315|Arteriosclerosis|arteriosclerosis
329189|NCT01537302|Chronic Total Occlusion|chronic total occlusion
329190|NCT01537302|Optimal Coherence Tomography|optimal coherence tomography
329191|NCT01537302|Lumivascular|lumivascular
329192|NCT01537289|Trauma|trauma
329193|NCT01537289|Pneumothorax|pneumothorax
329194|NCT01537276|hysterosalpingography|hysterosalpingography
329195|NCT01537276|Fluoroscopy|fluoroscopy
329196|NCT01537276|diagnostic accuracy|diagnostic accuracy
329197|NCT01537263|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
329198|NCT01537263|SAB|sab
329199|NCT01537263|SAH|sah
329200|NCT01537263|Ultrasound|ultrasound
329201|NCT01537263|Perfusion imaging|perfusion imaging
329202|NCT01537250|CAP|cap
329203|NCT01537237|Atrial Fibrillation|atrial fibrillation
329204|NCT01537237|Catheter-based ablation|catheter-based ablation
329205|NCT01537237|Pulmonary vein isolation|pulmonary vein isolation
329206|NCT01537237|Electro-anatomical mapping|electro-anatomical mapping
329207|NCT01537237|Rotational angiography|rotational angiography
329208|NCT01537224|Electrophysiology|electrophysiology
329209|NCT01537224|Subthalamic nucleus|subthalamic nucleus
329210|NCT01537224|Parkinson|parkinson
329211|NCT01537211|Dysvascular|dysvascular
329212|NCT01537211|amputation|amputation
329213|NCT01537211|above knee|above knee
329214|NCT01537211|ambulation|ambulation
329215|NCT01537198|Postmarketing Drug Surveillance|postmarketing drug surveillance
329216|NCT01537172|ONO-4053 healthy subjects|ono-4053 healthy subjects
329217|NCT01537172|3 part adaptive design|3 part adaptive design
329218|NCT01537159|AML|aml
329219|NCT01537146|unicompartmental|unicompartmental
329220|NCT01537146|osteoarthritis|osteoarthritis
329221|NCT01537146|varus|varus
329222|NCT01537146|malalignment|malalignment
329223|NCT01537146|opening wedge|opening wedge
329224|NCT01537146|HTO|hto
329225|NCT01537146|high|high
329226|NCT01537146|tibia|tibia
329227|NCT01537146|osteotomy|osteotomy
329228|NCT01537094|low vitamin c|low vitamin c
329229|NCT01537094|reduced growth hormone secretion|reduced growth hormone secretion
329230|NCT01537068|Dysthymic disorder|dysthymic disorder
329231|NCT01537068|Dysthymia|dysthymia
329232|NCT01537068|Chronic non-major depression|chronic non-major depression
329233|NCT01537068|Non-major chronic depression|non-major chronic depression
329234|NCT01537068|Chronic depressive disorder|chronic depressive disorder
329235|NCT01537068|Antidepressant treatment|antidepressant treatment
329236|NCT01537055|H pylori eradication|h pylori eradication
329237|NCT01537042|Rotigotine|rotigotine
329238|NCT01537042|Neupro|neupro
329239|NCT01537042|Restless Legs Syndrome|restless legs syndrome
329240|NCT01537042|RLS|rls
329241|NCT01537042|End-Stage Renal Disease|end-stage renal disease
329242|NCT01537029|Breast cancer|breast cancer
329243|NCT01537029|Pharmacokinetics|pharmacokinetics
329244|NCT01537029|Obesity|obesity
329245|NCT01537029|Doxorubicin|doxorubicin
329246|NCT01537029|Cyclophosphamide|cyclophosphamide
329247|NCT01537029|Weight|weight
329248|NCT01536977|quality of life|quality of life
329249|NCT01536925|Behavioral Economics|behavioral economics
329250|NCT01536925|Drug self administration|drug self administration
329251|NCT01536925|Opioid|opioid
329252|NCT01536912|HIV positive|hiv positive
329253|NCT01536899|HIV positive|hiv positive
329254|NCT01536899|Medical Marijuana|medical marijuana
329255|NCT01536873|treatment experienced patients|treatment experienced patients
329256|NCT01536873|Integrase resistance|integrase resistance
329257|NCT01536821|Parkinson disease|parkinson disease
329258|NCT01536821|Parkinson's Disease|parkinson's disease
329259|NCT01536821|PD|pd
329260|NCT01536821|LRRK2|lrrk2
329261|NCT01536821|genetics|genetics
329262|NCT01536821|genes|genes
329263|NCT01536808|Diabetes mellitus|diabetes mellitus
329264|NCT01536808|accelerated aging|accelerated aging
329265|NCT01536808|cellular senescence|cellular senescence
329266|NCT01536808|diabetic cardiomyopathy|diabetic cardiomyopathy
329267|NCT01536808|strain imaging|strain imaging
329268|NCT01536808|strain rate imaging,|strain rate imaging,
329269|NCT01536808|echocardiography|echocardiography
329270|NCT01536795|Ointment to treat leishmania skin lesions|ointment to treat leishmania skin lesions
329271|NCT01536782|head and neck cancer|head and neck cancer
329272|NCT01536782|chemoradiation therapy|chemoradiation therapy
329273|NCT01536782|bolus feeding|bolus feeding
329274|NCT01536782|gravity feeding|gravity feeding
329275|NCT01536782|pump feeding|pump feeding
329276|NCT01536782|optimal enteral feeding method|optimal enteral feeding method
329277|NCT01536782|To determine the optimal tube feeding method by analyzing percent weigtht loss.|to determine the optimal tube feeding method by analyzing percent weigtht loss.
329278|NCT01536782|To determine the optimal tube feeding method by analyzing tolerance of enteral feeds.|to determine the optimal tube feeding method by analyzing tolerance of enteral feeds.
329279|NCT01536782|To determine the optimal tube feeding method by analyzing percent met of estimated calories and protein.|to determine the optimal tube feeding method by analyzing percent met of estimated calories and protein.
329280|NCT01536769|Metagenomic analysis|metagenomic analysis
329281|NCT01536769|Microbiota|microbiota
329282|NCT01536756|Depressive disorder|depressive disorder
329283|NCT01536756|exercise|exercise
329284|NCT01536756|pain|pain
329285|NCT01536756|physical|physical
329286|NCT01536756|psychological|psychological
329287|NCT01536756|Chinese|chinese
329288|NCT01536756|mild to severe depressive disorders|mild to severe depressive disorders
329289|NCT01536717|atrial septal defect|atrial septal defect
329290|NCT01536717|mitral valve annuloplasty|mitral valve annuloplasty
329291|NCT01536717|aortic valve annuloplasty|aortic valve annuloplasty
329292|NCT01536717|open heart surgery|open heart surgery
329293|NCT01536717|oxycodone consumption|oxycodone consumption
329294|NCT01536717|articain|articain
329295|NCT01536717|bupivacaine|bupivacaine
329296|NCT01536717|pain after sternotomy|pain after sternotomy
329297|NCT01536717|postoperative pain|postoperative pain
329298|NCT01536717|wound infusion|wound infusion
329299|NCT01536704|nicotine lozenge|nicotine lozenge
329300|NCT01536704|nicotine|nicotine
329301|NCT01536704|nicotine replacement therapy|nicotine replacement therapy
329302|NCT01536691|ramosetron|ramosetron
329303|NCT01536691|ondansetron|ondansetron
329304|NCT01536691|aprepitant|aprepitant
329305|NCT01536691|chemotherapy induced nausea & vomiting|chemotherapy induced nausea & vomiting
329306|NCT01536587|influence of bronchodilatation with salmeterol on the autonomic nervous systems in COPD patients will be measured using MSNA.|influence of bronchodilatation with salmeterol on the autonomic nervous systems in copd patients will be measured using msna.
329307|NCT01536587|Relation of COPD and sympathetic nerve activity is to be evaluated,|relation of copd and sympathetic nerve activity is to be evaluated,
329308|NCT01536561|Tositumomab and/or Iodine I 131 Tositumomab|tositumomab and/or iodine i 131 tositumomab
329309|NCT01536561|B-cell non-Hodgkin's lymphoma|b-cell non-hodgkin's lymphoma
329310|NCT01536561|Dose-limiting toxicity|dose-limiting toxicity
329311|NCT01536561|Bexxar|bexxar
329312|NCT01536548|hemodialysis|hemodialysis
329313|NCT01536548|cannulation|cannulation
329314|NCT01536548|AV-fistula|av-fistula
329315|NCT01536548|buttonhole technique|buttonhole technique
329316|NCT01536535|Ulcerative Colitis|ulcerative colitis
329317|NCT01536535|mesalamine|mesalamine
329318|NCT01536535|corticosteroids|corticosteroids
329319|NCT01536535|PROTECT|protect
329320|NCT01536522|Asthma|asthma
329321|NCT01536522|Allergic Asthma|allergic asthma
329322|NCT01536522|Non-allergic Asthma|non-allergic asthma
329323|NCT01536496|trauma|trauma
329324|NCT01536496|hemorrhagic shock|hemorrhagic shock
329325|NCT01536496|thrombelastography|thrombelastography
329326|NCT01536496|coagulopathy|coagulopathy
329327|NCT01536496|transfusion|transfusion
329328|NCT01536496|resuscitation|resuscitation
329329|NCT01536483|Butyrate|butyrate
329330|NCT01536483|Preterms|preterms
329331|NCT01536483|Very Low Birth Weight (<1250g)|very low birth weight (<1250g)
329332|NCT01536483|Rectocolonic enemas|rectocolonic enemas
329333|NCT01536483|Digestive maturation|digestive maturation
329334|NCT01536483|Parenteral nutrition weaning|parenteral nutrition weaning
329335|NCT01536483|ECUN|ecun
329336|NCT01536483|Whole gut transit time|whole gut transit time
329337|NCT01536470|Intraoperative hemodynamic|intraoperative hemodynamic
329338|NCT01536470|Arterial pressure|arterial pressure
329339|NCT01536470|Postoperative complications|postoperative complications
329340|NCT01536470|Intraoperative fluids|intraoperative fluids
329341|NCT01536470|Noradrenaline|noradrenaline
329342|NCT01536457|asthma|asthma
329343|NCT01536457|children|children
329344|NCT01536457|gastroesophageal reflux|gastroesophageal reflux
329345|NCT01536457|retrospective|retrospective
329346|NCT01536457|data analysis|data analysis
329347|NCT01536444|Mohs surgery|mohs surgery
329348|NCT01536444|Excisional skin surgery|excisional skin surgery
329349|NCT01536444|Micrografting|micrografting
329350|NCT01536431|Diabetes|diabetes
329351|NCT01536418|Crohn's disease, chemokine receptor 9 antagonist, Crohn's Disease Activity Index|crohn's disease, chemokine receptor 9 antagonist, crohn's disease activity index
329352|NCT01536418|active treatment|active treatment
329353|NCT01536392|Cancer of the Cervix|cancer of the cervix
329354|NCT01536392|Anti-emetic therapy|anti-emetic therapy
329355|NCT01536392|Granisetron|granisetron
329356|NCT01536392|Transdermal patch|transdermal patch
329357|NCT01536392|Ondansetron|ondansetron
329358|NCT01536392|Zofran|zofran
329359|NCT01536392|Questionnaires|questionnaires
329360|NCT01536392|Surveys|surveys
329361|NCT01536392|Study Drug Diary|study drug diary
329362|NCT01536379|Infection|infection
329363|NCT01536379|Quality of Life|quality of life
329364|NCT01536366|Parkinson Disease|parkinson disease
329365|NCT01536366|BIA 9-1067|bia 9-1067
329366|NCT01536340|post discharge adverse events|post discharge adverse events
329367|NCT01536340|discontinuities in care|discontinuities in care
329368|NCT01536340|medical injury|medical injury
329369|NCT01536327|Metachromatic Leukodystrophy|metachromatic leukodystrophy
329370|NCT01536327|Demyelinating Diseases|demyelinating diseases
329371|NCT01536314|Pre-emptive administration|pre-emptive administration
329372|NCT01536314|Post-operative administration|post-operative administration
329373|NCT01536314|Prophylaxis|prophylaxis
329374|NCT01536314|Memantine|memantine
329375|NCT01536314|Post-mastectomy/tumorectomy|post-mastectomy/tumorectomy
329376|NCT01536314|Neuropathic pain|neuropathic pain
329377|NCT01536301|oxycodone|oxycodone
329378|NCT01536301|morphine|morphine
329379|NCT01536301|hip replacement|hip replacement
329380|NCT01536301|analgesia|analgesia
329381|NCT01536301|post operative analgesia|post operative analgesia
329382|NCT01536288|acute mountain sickness|acute mountain sickness
329383|NCT01536288|AMS|ams
329384|NCT01536288|Rhodiola Crenulata|rhodiola crenulata
329385|NCT01536288|mountaineering|mountaineering
329386|NCT01536288|pulse oximetry|pulse oximetry
329387|NCT01536288|oxygen saturation|oxygen saturation
329388|NCT01536275|critical illness|critical illness
329389|NCT01536275|children|children
329390|NCT01536275|nutrition|nutrition
329391|NCT01536275|metabolism|metabolism
329392|NCT01536236|Diabetes|diabetes
329393|NCT01536236|Polyneuropathy|polyneuropathy
329394|NCT01536236|Spinal cord stimulation|spinal cord stimulation
329395|NCT01536223|Nasopharyngeal Carcinoma (NPC)|nasopharyngeal carcinoma (npc)
329396|NCT01536223|cisplatin and 5-fluorouracil (PF)|cisplatin and 5-fluorouracil (pf)
329397|NCT01536223|docetaxel,cisplatin and 5-fluorouracil(TPF)|docetaxel,cisplatin and 5-fluorouracil(tpf)
329398|NCT01536223|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
329399|NCT01536223|intensity modulated radiotherapy(IMRT)|intensity modulated radiotherapy(imrt)
329400|NCT01536210|ADHD(attention Deficit Hyperactivity Disorder)|adhd(attention deficit hyperactivity disorder)
329401|NCT01536197|obesity|obesity
329402|NCT01536197|gastric bypass|gastric bypass
329403|NCT01536197|gastric banding|gastric banding
329404|NCT01536197|weight loss|weight loss
329405|NCT01536197|taste perception|taste perception
712270|NCT01016080|glutathione|glutathione
329406|NCT01536184|Fetal Alcohol Spectrum Disorder|fetal alcohol spectrum disorder
329407|NCT01536184|FASD|fasd
329408|NCT01536171|runners|runners
329409|NCT01536171|mid-foot strike|mid-foot strike
329410|NCT01536171|fore foot strike|fore foot strike
329411|NCT01536171|metabolic costs|metabolic costs
329412|NCT01536171|trained runners (men,women) with a FM strike|trained runners (men,women) with a fm strike
329413|NCT01536171|shod running|shod running
329414|NCT01536171|barefoot running|barefoot running
329415|NCT01536158|Patent Ductus Arteriosus|patent ductus arteriosus
329416|NCT01536158|Paracetamol|paracetamol
329417|NCT01536158|Ibuprofen|ibuprofen
329418|NCT01536158|Preterm infant|preterm infant
329419|NCT01536145|IGF-1R inhibitor|igf-1r inhibitor
329420|NCT01536145|CP-751871|cp-751871
329421|NCT01536145|multiple myeloma|multiple myeloma
329422|NCT01536132|Levosimendan|levosimendan
329423|NCT01536132|chronic heart failure|chronic heart failure
329424|NCT01536132|inotropic drug|inotropic drug
329425|NCT01536119|Breastfeeding|breastfeeding
329426|NCT01536119|Coparenting|coparenting
329427|NCT01536119|Infant feeding|infant feeding
329428|NCT01536119|Fathers' support|fathers' support
329429|NCT01536119|Breastfeeding support|breastfeeding support
329430|NCT01536119|Breastfeeding support intervention|breastfeeding support intervention
329431|NCT01536119|clinical trial|clinical trial
329432|NCT01536106|Cell therapy, Bone marrow stem cells, cardiac cell therapy|cell therapy, bone marrow stem cells, cardiac cell therapy
329433|NCT01536041|asthma|asthma
329434|NCT01536041|Adult|adult
329435|NCT01536015|Rotigotine|rotigotine
329436|NCT01536015|Neupro®|neupro®
329437|NCT01536015|Levodopa|levodopa
329438|NCT01536015|Gastrointestinal Dysfunction|gastrointestinal dysfunction
329439|NCT01536002|Bariatric surgery|bariatric surgery
329440|NCT01536002|Anesthetics, intravenous|anesthetics, intravenous
329441|NCT01536002|Propofol|propofol
329442|NCT01536002|Pharmacokinetics|pharmacokinetics
329443|NCT01535989|B-cell Non Hodgkin's Lymphomas|b-cell non hodgkin's lymphomas
329444|NCT01535989|CD22 positive|cd22 positive
329445|NCT01535950|Age-related macular degeneration|age-related macular degeneration
329446|NCT01535950|intravitreal, neovascular|intravitreal, neovascular
329447|NCT01535950|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
329449|NCT01535950|Age-related|age-related
329450|NCT01535950|Macular degeneration|macular degeneration
329451|NCT01535950|Intravitreal|intravitreal
329452|NCT01535950|Neovascular|neovascular
329453|NCT01535924|Hodgkin's Lymphoma|hodgkin's lymphoma
329454|NCT01535924|relapsed|relapsed
329455|NCT01535924|refractory|refractory
329456|NCT01535911|ketogenic diet|ketogenic diet
329457|NCT01535911|brain tumors|brain tumors
329458|NCT01535898|MRI|mri
329459|NCT01535898|MR imaging Pulse Sequence|mr imaging pulse sequence
329460|NCT01535898|High Resolution Diffusion-weighted|high resolution diffusion-weighted
329461|NCT01535898|Questionnaire|questionnaire
329462|NCT01535898|12-033|12-033
329463|NCT01535885|Cytoxic T Lymphocytes(CTL)|cytoxic t lymphocytes(ctl)
329464|NCT01535885|T-cell Depleted|t-cell depleted
329465|NCT01535885|Allogeneic Transplant|allogeneic transplant
329466|NCT01535885|Epstein Barr Virus|epstein barr virus
329467|NCT01535885|Adenovirus|adenovirus
329468|NCT01535885|Cytomegalovirus|cytomegalovirus
329469|NCT01535885|Hematopoietic progenitor cell transplantation|hematopoietic progenitor cell transplantation
329470|NCT01535846|taste|taste
329471|NCT01535846|mindful eating|mindful eating
329472|NCT01535846|intuitive eating|intuitive eating
329473|NCT01535846|attitude|attitude
329474|NCT01535846|behavior|behavior
329475|NCT01535833|robotic sacral colpopexy|robotic sacral colpopexy
329476|NCT01535833|Learning curve|learning curve
329477|NCT01535833|Pelvic Organ Prolapse|pelvic organ prolapse
329478|NCT01535833|Robotic Surgery|robotic surgery
329479|NCT01535820|Healthy volunteers|healthy volunteers
329480|NCT01535820|ORTHO EVRA|ortho evra
329481|NCT01535820|Contraceptive hormones|contraceptive hormones
329482|NCT01535820|Transdermal patch|transdermal patch
329483|NCT01535820|Progestin norelgestromin (NGMN)|progestin norelgestromin (ngmn)
329484|NCT01535820|Estrogen ethinyl estradiol (EE)|estrogen ethinyl estradiol (ee)
329485|NCT01535820|JNJ-93964|jnj-93964
329486|NCT01535820|JNJ-622206|jnj-622206
329487|NCT01535807|Atrial Fibrillation|atrial fibrillation
329488|NCT01535807|Cardiac surgery|cardiac surgery
329489|NCT01535807|Coronary Artery Bypass Graft|coronary artery bypass graft
329490|NCT01535807|CorMatrix extra cellular matrix|cormatrix extra cellular matrix
329491|NCT01535807|Heart surgery|heart surgery
329492|NCT01535807|Inflammatory Biomarkers|inflammatory biomarkers
329493|NCT01535807|Myocardial Infarction|myocardial infarction
329494|NCT01535807|identify proteomic inflammatory biomarkers|identify proteomic inflammatory biomarkers
329495|NCT01535794|HPV vaccine|hpv vaccine
329496|NCT01535794|acceptability|acceptability
329497|NCT01535794|males|males
329498|NCT01535794|men who have sex with men|men who have sex with men
329499|NCT01535781|pertrochanteric fracture|pertrochanteric fracture
329505|NCT01535755|noninvasive mechanical ventilation|noninvasive mechanical ventilation
329506|NCT01535755|ventilator weaning|ventilator weaning
329507|NCT01535742|laryngeal mask airway|laryngeal mask airway
329508|NCT01535742|children|children
329509|NCT01535742|tracheal intubation|tracheal intubation
329510|NCT01535742|fiberoptic bronchoscopy|fiberoptic bronchoscopy
329512|NCT01535690|Clinical trial|clinical trial
329513|NCT01535690|Non-surgical periodontal therapy|non-surgical periodontal therapy
329514|NCT01535690|Periodontitis|periodontitis
329515|NCT01535690|bleeding on probing and radiographic bone loss|bleeding on probing and radiographic bone loss
329516|NCT01535690|minimum of 2 teeth with probing depth (PD) ≥ 7 mm and|minimum of 2 teeth with probing depth (pd) ≥ 7 mm and
329517|NCT01535690|2 other teeth with PD ≥ 5 mm|2 other teeth with pd ≥ 5 mm
329518|NCT01535690|mininum 16 teeth in both jaws|mininum 16 teeth in both jaws
329519|NCT01535677|Phase 1|phase 1
329520|NCT01535677|healthy volunteers|healthy volunteers
329521|NCT01535677|cross-over study|cross-over study
329522|NCT01535677|Bioavailability|bioavailability
329523|NCT01535677|Bioequivalence|bioequivalence
329524|NCT01535677|Cmax|cmax
329525|NCT01535677|tmax|tmax
329526|NCT01535677|AUC|auc
329527|NCT01535677|AUC(0-t)|auc(0-t)
329528|NCT01535677|λz|λz
329529|NCT01535677|tlast|tlast
329530|NCT01535664|Multiple Sclerosis|multiple sclerosis
329531|NCT01535664|MS|ms
329532|NCT01535625|Coronary artery disease|coronary artery disease
329533|NCT01535625|Atherosclerosis|atherosclerosis
329534|NCT01535625|CAD|cad
329535|NCT01535599|Acute Otitis Externa|acute otitis externa
329536|NCT01535586|CPAP|cpap
329537|NCT01535586|MAD|mad
329538|NCT01535586|sleep apnea|sleep apnea
329539|NCT01535586|PTSD|ptsd
329540|NCT01535573|Cocaine|cocaine
329541|NCT01535573|citalopram|citalopram
329542|NCT01535573|treatment|treatment
329543|NCT01535573|serotonin|serotonin
329544|NCT01535560|Acute otitis externa|acute otitis externa
329545|NCT01535547|isavuconazole|isavuconazole
329546|NCT01535547|tacrolimus|tacrolimus
329547|NCT01535547|Healthy Volunteers|healthy volunteers
329548|NCT01535547|BAL8557|bal8557
329549|NCT01535534|sepsis|sepsis
329550|NCT01535534|inflammation|inflammation
329551|NCT01535534|diagnosis|diagnosis
329552|NCT01535534|prognosis|prognosis
329553|NCT01535534|survival|survival
329554|NCT01535534|mortality|mortality
329555|NCT01535495|beta-antagonist|beta-antagonist
329556|NCT01535495|propranolol|propranolol
329557|NCT01535495|diabetic retinopathy|diabetic retinopathy
329558|NCT01535495|diabetes|diabetes
329559|NCT01535495|angiogenesis|angiogenesis
329560|NCT01535495|neovascularization|neovascularization
329561|NCT01535482|Cognitive therapy|cognitive therapy
329562|NCT01535482|Suicide|suicide
329563|NCT01535482|Older men|older men
329564|NCT01535482|suicide ideation|suicide ideation
329565|NCT01535469|cryptococcal meningitis|cryptococcal meningitis
329566|NCT01535469|hiv|hiv
329567|NCT01535469|aids|aids
329568|NCT01535469|implementation science|implementation science
329569|NCT01535469|stepped wedge design|stepped wedge design
329570|NCT01535469|retention-in-care|retention-in-care
320311|NCT01575067|BP|bp
329571|NCT01535456|MDS|mds
329572|NCT01535456|AML|aml
329573|NCT01535456|5 azacitidine|5 azacitidine
329574|NCT01535456|FLT PET|flt pet
329575|NCT01535443|PRO-155|pro-155
329576|NCT01535443|Ocular NSAIDs|ocular nsaids
329577|NCT01535443|Safety and tolerability|safety and tolerability
329578|NCT01535443|Ocular Inflammation|ocular inflammation
329579|NCT01535443|Ocular Paint|ocular paint
329580|NCT01535430|brain mapping|brain mapping
329581|NCT01535430|brain tumor|brain tumor
329582|NCT01535417|Osteoarthritis|osteoarthritis
329588|NCT01535365|muscular sprain|muscular sprain
329589|NCT01535365|acute back pain|acute back pain
329590|NCT01535365|acute neck pain|acute neck pain
329591|NCT01535365|heat treatment|heat treatment
329592|NCT01535365|cold treatment|cold treatment
329593|NCT01535339|mild Traumatic Brain Injury|mild traumatic brain injury
329594|NCT01535339|mTBI|mtbi
329595|NCT01535339|Concussion|concussion
329596|NCT01535326|colonoscopy|colonoscopy
329597|NCT01535300|Ultrasound|ultrasound
329598|NCT01535300|Minimal transverse tracheal diameter|minimal transverse tracheal diameter
329599|NCT01535300|Endotracheal tube size|endotracheal tube size
329600|NCT01535300|Paediatric age-based formulas|paediatric age-based formulas
329601|NCT01535300|Sonographic measurement of the trachea|sonographic measurement of the trachea
329602|NCT01535287|Dexmedetomidine|dexmedetomidine
329603|NCT01535287|Emergence Agitation|emergence agitation
329604|NCT01535287|Myringotomy|myringotomy
329605|NCT01535287|Children|children
329606|NCT01535287|General Anesthesia|general anesthesia
329607|NCT01535274|Cerebral oxygenation|cerebral oxygenation
329608|NCT01535274|Beach chair position|beach chair position
329609|NCT01535274|General anesthetic technique|general anesthetic technique
329610|NCT01535274|Inspired oxygen fraction|inspired oxygen fraction
329611|NCT01535274|End tidal carbon dioxide|end tidal carbon dioxide
329612|NCT01535261|Ophthalmology|ophthalmology
329613|NCT01535261|Ranibizumab|ranibizumab
329614|NCT01535261|Central Retinal Vein Occlusion|central retinal vein occlusion
329616|NCT01535248|Transthoracic Echocardiography|transthoracic echocardiography
329617|NCT01535248|Air Embolus|air embolus
329618|NCT01535248|ERCP associated air embolus|ercp associated air embolus
329619|NCT01535235|HIV|hiv
329620|NCT01535235|Lymphoid fibrosis|lymphoid fibrosis
329621|NCT01535222|cardiac surgery|cardiac surgery
329622|NCT01535222|coronary artery bypass graft|coronary artery bypass graft
329623|NCT01535222|cardiopulmonary bypass|cardiopulmonary bypass
329624|NCT01535222|haemostasis modulator|haemostasis modulator
329625|NCT01535222|blood loss|blood loss
329626|NCT01535222|direct inhibitor of plasmin and plasma kallikrein|direct inhibitor of plasmin and plasma kallikrein
329627|NCT01535222|CABG|cabg
329628|NCT01535222|CPB|cpb
329629|NCT01535209|Stereotactic radiotherapy|stereotactic radiotherapy
329630|NCT01535209|Whole-brain radiotherapy|whole-brain radiotherapy
329631|NCT01535209|Resection cavity|resection cavity
329632|NCT01535196|vitamin D|vitamin d
329633|NCT01535196|heart failure|heart failure
329634|NCT01535183|irinotecan|irinotecan
329635|NCT01535183|brain tumor|brain tumor
329636|NCT01535183|pediatrics|pediatrics
329637|NCT01535183|salvage therapy|salvage therapy
329638|NCT01535183|chemotherapy|chemotherapy
329639|NCT01535170|lactoferrin|lactoferrin
329640|NCT01535170|selective decontamination of digestive tract|selective decontamination of digestive tract
329641|NCT01535170|antimicrobial activity|antimicrobial activity
329642|NCT01535170|prolonged mechanical ventilation|prolonged mechanical ventilation
329643|NCT01535170|respiratory care center|respiratory care center
329644|NCT01535157|Chemotherapy|chemotherapy
329645|NCT01535131|otitis media|otitis media
329646|NCT01535131|cleft palate|cleft palate
329647|NCT01535118|Allergies|allergies
329648|NCT01535118|Immunotherapy|immunotherapy
329649|NCT01535092|HCV recurrence|hcv recurrence
329650|NCT01535092|HCV reinfection|hcv reinfection
329651|NCT01535092|Liver transplantation|liver transplantation
329652|NCT01535092|Legalon SIL|legalon sil
329653|NCT01535092|silibinin|silibinin
329654|NCT01535092|viral load|viral load
329655|NCT01535079|sore throat pain|sore throat pain
329656|NCT01535079|tonsillopharyngitis|tonsillopharyngitis
329657|NCT01535079|upper respiratory tract infection|upper respiratory tract infection
329658|NCT01535066|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
329659|NCT01535066|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
329660|NCT01535066|stage IA breast cancer|stage ia breast cancer
329661|NCT01535066|stage IB breast cancer|stage ib breast cancer
329662|NCT01535066|stage II breast cancer|stage ii breast cancer
329663|NCT01535066|stage IIIA breast cancer|stage iiia breast cancer
329664|NCT01535066|stage IIIB breast cancer|stage iiib breast cancer
329665|NCT01535066|stage IIIC breast cancer|stage iiic breast cancer
329666|NCT01535066|pain|pain
329667|NCT01535040|cancer survivor|cancer survivor
329668|NCT01535040|stage I non-small cell lung cancer|stage i non-small cell lung cancer
329669|NCT01535040|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
329670|NCT01535040|tobacco use disorder|tobacco use disorder
329671|NCT01535040|stage IA breast cancer|stage ia breast cancer
329672|NCT01535040|stage IB breast cancer|stage ib breast cancer
329673|NCT01535040|stage II breast cancer|stage ii breast cancer
329773|NCT01534663|Glutamine|glutamine
329674|NCT01535040|stage IIIA breast cancer|stage iiia breast cancer
329675|NCT01535040|stage IIIB breast cancer|stage iiib breast cancer
329676|NCT01535040|stage IIIC breast cancer|stage iiic breast cancer
329677|NCT01535040|stage I prostate cancer|stage i prostate cancer
329678|NCT01535040|stage IIA prostate cancer|stage iia prostate cancer
329679|NCT01535040|stage IIB prostate cancer|stage iib prostate cancer
329680|NCT01535040|stage III prostate cancer|stage iii prostate cancer
329681|NCT01535040|stage I colon cancer|stage i colon cancer
329682|NCT01535040|stage IIA colon cancer|stage iia colon cancer
329683|NCT01535040|stage IIB colon cancer|stage iib colon cancer
329684|NCT01535040|stage IIC colon cancer|stage iic colon cancer
329685|NCT01535040|stage IIIA colon cancer|stage iiia colon cancer
329686|NCT01535040|stage IIIB colon cancer|stage iiib colon cancer
329687|NCT01535040|stage IIIC colon cancer|stage iiic colon cancer
329688|NCT01535040|stage I rectal cancer|stage i rectal cancer
329689|NCT01535040|stage IIA rectal cancer|stage iia rectal cancer
329690|NCT01535040|stage IIB rectal cancer|stage iib rectal cancer
329691|NCT01535040|stage IIC rectal cancer|stage iic rectal cancer
329692|NCT01535040|stage IIIA rectal cancer|stage iiia rectal cancer
329693|NCT01535040|stage IIIB rectal cancer|stage iiib rectal cancer
329694|NCT01535040|stage IIIC rectal cancer|stage iiic rectal cancer
329695|NCT01535027|teriparatide|teriparatide
329696|NCT01535027|alendronate|alendronate
329697|NCT01535027|raloxifene|raloxifene
329698|NCT01535027|bone mineral density|bone mineral density
329699|NCT01535001|Osteoarthritis, Knee|osteoarthritis, knee
329700|NCT01535001|Treatment Outcome|treatment outcome
329701|NCT01535001|Time Factors|time factors
329702|NCT01535001|Rehabilitation|rehabilitation
329703|NCT01535001|Combined Modality Therapy|combined modality therapy
329704|NCT01535001|Middle Aged|middle aged
329705|NCT01535001|Aged|aged
329706|NCT01535001|Aged, 80 and over|aged, 80 and over
329707|NCT01535001|Male|male
329708|NCT01535001|Female|female
329709|NCT01535001|Humans|humans
329710|NCT01535001|Analysis of Variance|analysis of variance
329711|NCT01534975|cardiac CT|cardiac ct
329712|NCT01534975|enhancement|enhancement
329713|NCT01534975|contrast|contrast
329714|NCT01534975|safety|safety
329715|NCT01534975|image quality|image quality
329716|NCT01534962|Atrial Fibrillation|atrial fibrillation
329717|NCT01534962|Ranolazine|ranolazine
329718|NCT01534962|Arrhythmias, Cardiac|arrhythmias, cardiac
329719|NCT01534962|Antiarrhythmic Agents|antiarrhythmic agents
329720|NCT01534962|Cardiac Electroversion|cardiac electroversion
329721|NCT01534962|Ranexa|ranexa
329722|NCT01534949|DLBCL, Biosimilar|dlbcl, biosimilar
329723|NCT01534936|schizophrenia|schizophrenia
329724|NCT01534936|atypical antipsychotics|atypical antipsychotics
329725|NCT01534936|depressive symptoms|depressive symptoms
329726|NCT01534923|Doctor-Patient Communication|doctor-patient communication
329727|NCT01534923|questionnaire|questionnaire
329728|NCT01534923|survey|survey
329729|NCT01534923|12-017|12-017
329730|NCT01534910|garlic|garlic
329731|NCT01534910|ct angiography|ct angiography
329732|NCT01534910|atherosclerosis|atherosclerosis
329733|NCT01534910|carotid IMT|carotid imt
329734|NCT01534897|thyroid cancer|thyroid cancer
329735|NCT01534897|Tall cell PTC|tall cell ptc
329736|NCT01534897|Poorly differentiated thyroid carcinoma|poorly differentiated thyroid carcinoma
329737|NCT01534897|metastatic|metastatic
329738|NCT01534884|RA, Biosimilar|ra, biosimilar
329739|NCT01534871|Cardiac rehabilitation|cardiac rehabilitation
329740|NCT01534871|Exercise|exercise
329741|NCT01534871|Systemic inflammation|systemic inflammation
329742|NCT01534871|Cardiovascular disease risk|cardiovascular disease risk
329743|NCT01534858|polyhexanide, polihexanide, PHMB, Prontosan, burns, wounds|polyhexanide, polihexanide, phmb, prontosan, burns, wounds
329744|NCT01534832|surgical smoke|surgical smoke
329745|NCT01534832|laparoscopic surgery|laparoscopic surgery
329746|NCT01534832|impaired vision|impaired vision
329747|NCT01534819|Abdominal aortic aneurysm|abdominal aortic aneurysm
329748|NCT01534819|AAA|aaa
329749|NCT01534819|Endograft|endograft
329750|NCT01534819|interventional treatment of AAA|interventional treatment of aaa
329751|NCT01534806|Migraine|migraine
329752|NCT01534793|Quality assessment|quality assessment
329753|NCT01534793|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
329754|NCT01534793|Enucleation of the prostate|enucleation of the prostate
329755|NCT01534793|LUMENIS|lumenis
329756|NCT01534793|Laser|laser
329757|NCT01534793|Learning Curve|learning curve
329758|NCT01534728|Hepatitis C|hepatitis c
329759|NCT01534728|CD8 epitopes|cd8 epitopes
329760|NCT01534702|Acute Myeloid Leukemia|acute myeloid leukemia
329761|NCT01534702|chemotherapy|chemotherapy
329762|NCT01534702|clofarabine|clofarabine
329763|NCT01534676|iron|iron
329764|NCT01534676|transfusion|transfusion
329765|NCT01534676|red blood cells|red blood cells
329766|NCT01534676|sickle cell disease|sickle cell disease
329767|NCT01534676|thalassemia|thalassemia
329768|NCT01534676|blood donors|blood donors
329769|NCT01534663|Heart Failure|heart failure
329770|NCT01534663|Skeletal Muscle Function|skeletal muscle function
329771|NCT01534663|Metabolism|metabolism
329772|NCT01534663|Inflammation|inflammation
329774|NCT01534663|Fish oil|fish oil
329775|NCT01534663|Muscle Function|muscle function
329776|NCT01534650|motion sensors|motion sensors
329777|NCT01534650|tremor|tremor
329778|NCT01534650|bradykinesia|bradykinesia
329779|NCT01534650|gait|gait
329780|NCT01534650|balance|balance
329781|NCT01534650|dyskinesia|dyskinesia
329782|NCT01534624|Induced Pluripotent Stem Cell (iPS) Cell Lines|induced pluripotent stem cell (ips) cell lines
329783|NCT01534624|Addiction|addiction
329784|NCT01534624|Addiction-Associated Human Gene Variants|addiction-associated human gene variants
329785|NCT01534624|Dopamine Transporter|dopamine transporter
329786|NCT01534598|DNA Methylation|dna methylation
329787|NCT01534598|Advanced Cancer|advanced cancer
329788|NCT01534598|Methyltransferase Inhibitor|methyltransferase inhibitor
329789|NCT01534598|Epigenetics|epigenetics
329790|NCT01534598|Gene Re-Expression|gene re-expression
329791|NCT01534598|Cancer|cancer
329792|NCT01534598|Solid Tumor|solid tumor
329793|NCT01534585|nasopharyngeal carcinoma(NPC)|nasopharyngeal carcinoma(npc)
329794|NCT01534585|Icotinib|icotinib
329795|NCT01534585|Intensity Modulation Radiation Therapy(IMRT)|intensity modulation radiation therapy(imrt)
329796|NCT01534546|neoadjuvant chemotherapy|neoadjuvant chemotherapy
329797|NCT01534546|adjuvant chemotherapy|adjuvant chemotherapy
329799|NCT01534546|OS|os
329800|NCT01534546|safety|safety
329801|NCT01534546|resectable locally advanced gastric carcinoma|resectable locally advanced gastric carcinoma
329802|NCT01534546|potentially resectable locally advanced gastric carcinoma|potentially resectable locally advanced gastric carcinoma
329803|NCT01534533|early atherosclerosis|early atherosclerosis
329804|NCT01534533|serum lutein|serum lutein
329805|NCT01534533|serum lycopene|serum lycopene
329806|NCT01534533|intima-media thickness|intima-media thickness
329807|NCT01534533|arterial stiffness|arterial stiffness
329808|NCT01534533|combined effect|combined effect
329809|NCT01534520|Intrauterine Device|intrauterine device
329810|NCT01534520|Pain|pain
329811|NCT01534520|Lidocaine|lidocaine
329812|NCT01534494|alcohol dependence|alcohol dependence
329813|NCT01534494|psilocybin|psilocybin
329814|NCT01534494|clinical trial|clinical trial
329815|NCT01534494|motivational enhancement therapy|motivational enhancement therapy
329816|NCT01534481|NICHD Neonatal Research Network|nichd neonatal research network
329817|NCT01534481|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
329818|NCT01534481|Prematurity|prematurity
329819|NCT01534481|Neurodevelopmental Impairment|neurodevelopmental impairment
329820|NCT01534481|Donor Breast Milk|donor breast milk
329821|NCT01534481|Preterm Formula|preterm formula
329822|NCT01534455|German Breast Group|german breast group
329823|NCT01534455|GBG Forschungs GmbH|gbg forschungs gmbh
329824|NCT01534455|GBG|gbg
329825|NCT01534455|GBG 64|gbg 64
329826|NCT01534455|E-VITA|e-vita
329827|NCT01534455|Breast Cancer|breast cancer
329828|NCT01534455|Metastatic Breast Cancer|metastatic breast cancer
329829|NCT01534455|Eribulin|eribulin
329830|NCT01534455|Lapatinib|lapatinib
329831|NCT01534455|Halaven|halaven
329832|NCT01534455|Tyverb|tyverb
329833|NCT01534429|pain|pain
329834|NCT01534416|Paracervical Block|paracervical block
329835|NCT01534416|Laparoscopic Surgery|laparoscopic surgery
329836|NCT01534416|Postoperative Pain|postoperative pain
329837|NCT01534416|Bupivacaine|bupivacaine
329838|NCT01534416|Hysterectomy|hysterectomy
329839|NCT01534416|Myomectomy|myomectomy
329840|NCT01534416|Randomized Trial|randomized trial
329841|NCT01534403|Lupus|lupus
329842|NCT01534403|Monoclonal antibody|monoclonal antibody
329843|NCT01534403|B-cell immunotherapy|b-cell immunotherapy
329844|NCT01534403|Epratuzumab|epratuzumab
329845|NCT01534390|microparticles|microparticles
329846|NCT01534390|in-line microfilters|in-line microfilters
329847|NCT01534390|systemic inflammation|systemic inflammation
329848|NCT01534390|organ failure|organ failure
329849|NCT01534390|critical illness|critical illness
329850|NCT01534390|adult|adult
329851|NCT01534377|Depression|depression
329852|NCT01534377|Adolescents|adolescents
329853|NCT01534364|acute renal failure|acute renal failure
329854|NCT01534364|acute kidney injury|acute kidney injury
329856|NCT01534364|caloric restriction|caloric restriction
329857|NCT01534364|cardiac surgery|cardiac surgery
329858|NCT01534364|cardiothoracic surgery|cardiothoracic surgery
329859|NCT01534338|Sleep|sleep
329860|NCT01534338|inflammation|inflammation
329861|NCT01534338|mindfulness|mindfulness
329862|NCT01534338|meditation|meditation
329863|NCT01534338|randomized controlled trial|randomized controlled trial
329864|NCT01534312|Glycopeptides|glycopeptides
329865|NCT01534312|Dietary proteins|dietary proteins
329866|NCT01534286|Prescription Medical Food|prescription medical food
329867|NCT01534286|Theramine|theramine
329868|NCT01534286|Knee surgery|knee surgery
329869|NCT01534273|Mild Cognitive Impairment|mild cognitive impairment
329870|NCT01534247|Phase I|phase i
329871|NCT01534247|drug to drug|drug to drug
329872|NCT01534247|CAZ-AVI|caz-avi
329873|NCT01534247|Healthy volunteer|healthy volunteer
329874|NCT01534247|pharmacokinetics|pharmacokinetics
329875|NCT01534247|open label|open label
329876|NCT01534247|metronidazole|metronidazole
329877|NCT01534247|safety|safety
329878|NCT01534234|CRT-D device|crt-d device
329879|NCT01534234|Severe HF (NYHA Class III or ambulatory IV)|severe hf (nyha class iii or ambulatory iv)
329880|NCT01534234|stable, optimal drug regimen|stable, optimal drug regimen
329881|NCT01534234|sinus rhythm|sinus rhythm
329882|NCT01534221|Ischemic Heart Disease|ischemic heart disease
329883|NCT01534182|Relapsing Remitting Multiple Sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
329884|NCT01534182|Fingolimod|fingolimod
329885|NCT01534182|Disease Modifying Therapy (DMT)|disease modifying therapy (dmt)
329886|NCT01534182|TSQM-9|tsqm-9
329887|NCT01534169|Graves' disease|graves' disease
329888|NCT01534169|Dexamethasone|dexamethasone
329889|NCT01534169|Function of regulatory T cells|function of regulatory t cells
329890|NCT01534169|The proportion of Th1 and Th2 cells|the proportion of th1 and th2 cells
329891|NCT01534130|Chronic Fatigue Syndrome|chronic fatigue syndrome
329892|NCT01534130|Sleep Disorder, Adjustment|sleep disorder, adjustment
329893|NCT01534130|Acupuncture|acupuncture
329894|NCT01534104|fMRI|fmri
329895|NCT01534104|DTI|dti
329896|NCT01534104|DSI|dsi
329897|NCT01534104|tractography|tractography
329898|NCT01534104|neurological/physical testing|neurological/physical testing
329899|NCT01534104|Motor and Language Pathways|motor and language pathways
329900|NCT01534104|resting state fMRI|resting state fmri
329901|NCT01534104|12-008|12-008
329902|NCT01534091|overweight|overweight
329903|NCT01534091|obese|obese
329904|NCT01534091|children|children
329905|NCT01534091|exercise|exercise
329906|NCT01534091|physical activity|physical activity
329907|NCT01534091|pedometer|pedometer
329908|NCT01534078|non-bulky|non-bulky
329909|NCT01534078|limited stage|limited stage
329910|NCT01534065|Hernia|hernia
329911|NCT01534065|Intervertebral Disk Displacement|intervertebral disk displacement
329912|NCT01534065|Pathological Conditions, Anatomical|pathological conditions, anatomical
329913|NCT01534065|Spinal Diseases|spinal diseases
329914|NCT01534065|Bone Diseases|bone diseases
329915|NCT01534065|Musculoskeletal Diseases|musculoskeletal diseases
329916|NCT01534052|Prostate Cancer|prostate cancer
329917|NCT01534052|Castration-Resistant Prostate Cancer (CRPC)|castration-resistant prostate cancer (crpc)
329918|NCT01534052|MDV3100|mdv3100
329919|NCT01534052|Androgen receptor signaling inhibitor|androgen receptor signaling inhibitor
329920|NCT01534013|Closed loop insulin delivery|closed loop insulin delivery
329921|NCT01534000|Cardiac CT|cardiac ct
329922|NCT01534000|Ischemic heat disease|ischemic heat disease
329923|NCT01534000|Stress test|stress test
329924|NCT01533987|Male|male
329925|NCT01533987|Overweight|overweight
329926|NCT01533987|Juice Plus|juice plus
329927|NCT01533961|neglected disease|neglected disease
329928|NCT01533961|africa|africa
329929|NCT01533961|new drug|new drug
329930|NCT01533961|oral drug|oral drug
329931|NCT01533961|parasite|parasite
329932|NCT01533896|Obesity prevention|obesity prevention
329933|NCT01533896|Primary care|primary care
329934|NCT01533896|Education|education
329935|NCT01533883|Mitral|mitral
329936|NCT01533883|Valve|valve
329937|NCT01533883|Annuloplasty|annuloplasty
329938|NCT01533883|Transatrial|transatrial
329939|NCT01533883|Transapical|transapical
329940|NCT01533883|Transfemoral|transfemoral
329941|NCT01533883|Mitral valve insufficiency|mitral valve insufficiency
329942|NCT01533870|Phase 1|phase 1
329943|NCT01533870|Healthy male and female volunteers|healthy male and female volunteers
329944|NCT01533870|Drug-drug interaction|drug-drug interaction
329945|NCT01533870|Pharmacokinetics|pharmacokinetics
329946|NCT01533870|NKTR-118|nktr-118
329947|NCT01533870|Bioavailability|bioavailability
329948|NCT01533870|Plasma AUC and Cmax|plasma auc and cmax
329949|NCT01533870|Plasma AUC0-t and t1/2λz and tmax|plasma auc0-t and t1/2λz and tmax
329950|NCT01533857|Black tea|black tea
329951|NCT01533857|phenolic acids|phenolic acids
329952|NCT01533844|CDAD|cdad
329953|NCT01533844|Neonates|neonates
329954|NCT01533844|Clostridium difficile|clostridium difficile
329955|NCT01533818|Fast breathing|fast breathing
329956|NCT01533818|Young infants|young infants
329957|NCT01533818|Management|management
329958|NCT01533818|Amoxicillin|amoxicillin
329959|NCT01533818|Placebo|placebo
329960|NCT01533805|Lumbago|lumbago
329961|NCT01533805|Exercise therapy|exercise therapy
329962|NCT01533805|Spine|spine
329963|NCT01533792|Treatment|treatment
329964|NCT01533792|pregnant women|pregnant women
329965|NCT01533792|periodontitis|periodontitis
329966|NCT01533792|dental scaling|dental scaling
329967|NCT01533792|dental plaque|dental plaque
329968|NCT01533779|children|children
329969|NCT01533779|malignancy|malignancy
329970|NCT01533779|neutrophil|neutrophil
329971|NCT01533779|neutrophil extracellular traps|neutrophil extracellular traps
329972|NCT01533779|superoxide production|superoxide production
329973|NCT01533779|hydrogen peroxide production|hydrogen peroxide production
329974|NCT01533779|chemotaxis|chemotaxis
329975|NCT01533779|myeloperoxidase|myeloperoxidase
329976|NCT01533779|immunosurveillance|immunosurveillance
329977|NCT01533779|cancer cell lines|cancer cell lines
329978|NCT01533753|hot flashes|hot flashes
329979|NCT01533753|prostate cancer|prostate cancer
329980|NCT01533727|Cytokine-Induced Killer Cell|cytokine-induced killer cell
329981|NCT01533727|NSCLC|nsclc
329982|NCT01533727|adjuvant therapy|adjuvant therapy
329983|NCT01533714|Rheumatoid Arthritis|rheumatoid arthritis
329984|NCT01533714|Monoclonal antibody|monoclonal antibody
329985|NCT01533714|Interleukin-6|interleukin-6
329986|NCT01533714|Olokizumab|olokizumab
329987|NCT01533714|CDP6038|cdp6038
329988|NCT01533701|Hypoxia|hypoxia
329989|NCT01533701|Fetal blood sampling|fetal blood sampling
329990|NCT01533701|Lactate|lactate
329992|NCT01533701|base deficit|base deficit
329993|NCT01533701|angiogenic factors|angiogenic factors
329994|NCT01533701|suspected fetal hypoxia|suspected fetal hypoxia
402058|NCT01233336|markers of myocardial injury|markers of myocardial injury
712271|NCT01016080|melanin|melanin
329995|NCT01533675|suture, tensile strength, wound care, saline, hydrogen peroxide, skin closure, wounds, wound healing, wound cleansing, antiseptics|suture, tensile strength, wound care, saline, hydrogen peroxide, skin closure, wounds, wound healing, wound cleansing, antiseptics
329996|NCT01533662|phenylephrine|phenylephrine
329997|NCT01533662|hypotension|hypotension
329998|NCT01533662|spinal anesthesia|spinal anesthesia
329999|NCT01533662|lower limb orthopedic surgery|lower limb orthopedic surgery
330000|NCT01533649|Behavioral intervention|behavioral intervention
330001|NCT01533649|Seizure self-efficacy|seizure self-efficacy
330002|NCT01533649|Psychosocial outcomes|psychosocial outcomes
330003|NCT01533649|Quality of Life in Epilepsy|quality of life in epilepsy
330004|NCT01533636|Cystic Fibrosis, Healthy|cystic fibrosis, healthy
330005|NCT01533610|Post-Traumatic Stress disorder|post-traumatic stress disorder
330006|NCT01533610|Stellate ganglion|stellate ganglion
330007|NCT01533610|cervical plexus|cervical plexus
330008|NCT01533610|local anesthesia|local anesthesia
330009|NCT01533610|anxiety|anxiety
330010|NCT01533597|Overactive bladder|overactive bladder
330011|NCT01533597|Solifenacin succinate|solifenacin succinate
330012|NCT01533597|Tamsulosin|tamsulosin
330013|NCT01533571|Guided Bone Regeneration|guided bone regeneration
330014|NCT01533571|Dental Implant|dental implant
330015|NCT01533571|Alveolar Ridge Augmentation|alveolar ridge augmentation
330016|NCT01533571|Socket graft|socket graft
330017|NCT01533558|caspofungin|caspofungin
330018|NCT01533558|pharmacokinetics|pharmacokinetics
330019|NCT01533558|invasive fungal infection|invasive fungal infection
330020|NCT01533558|candidiasis|candidiasis
330021|NCT01533558|aspergillosis|aspergillosis
330022|NCT01533558|intensive care|intensive care
330023|NCT01533545|Mepivacaine|mepivacaine
330024|NCT01533545|Epinephrine|epinephrine
330025|NCT01533545|Brachial plexus block|brachial plexus block
330026|NCT01533545|Renal insufficiency|renal insufficiency
330027|NCT01533532|Gonadotropin-Releasing Hormone (GnRH) antagonist|gonadotropin-releasing hormone (gnrh) antagonist
330028|NCT01533519|Neuropeptide Y|neuropeptide y
330029|NCT01533519|Intranasal Administration|intranasal administration
330030|NCT01533519|PTSD|ptsd
330031|NCT01533519|Trauma|trauma
330032|NCT01533506|treatment with stiripentol|treatment with stiripentol
330033|NCT01533493|ADHD|adhd
330034|NCT01533493|Executive Function|executive function
330035|NCT01533493|Namenda|namenda
330036|NCT01533493|Concerta|concerta
330037|NCT01533480|Adenovirus|adenovirus
330038|NCT01533480|Conjunctivitis|conjunctivitis
330039|NCT01533480|keratoconjunctivitis|keratoconjunctivitis
330040|NCT01533480|viral shedding|viral shedding
330041|NCT01533480|subepithelial infiltrate|subepithelial infiltrate
330042|NCT01533480|bulbar injection|bulbar injection
330043|NCT01533467|Delivery rupture|delivery rupture
330044|NCT01533467|perineal protection device|perineal protection device
330045|NCT01533467|reduce perineal tears|reduce perineal tears
330046|NCT01533454|Obesity|obesity
330047|NCT01533454|Weight loss|weight loss
330048|NCT01533454|Incentives|incentives
330049|NCT01533454|Motivation|motivation
330050|NCT01533441|anticoagulant therapy|anticoagulant therapy
330051|NCT01533441|INR|inr
330052|NCT01533441|vitamin K2|vitamin k2
330053|NCT01533441|vitamin K antagonist|vitamin k antagonist
330054|NCT01533428|Painful Diabetic Peripheral Neuropathy,|painful diabetic peripheral neuropathy,
330055|NCT01533428|Capsaicin 8% transdermal delivery system|capsaicin 8% transdermal delivery system
330056|NCT01533415|Anxiety|anxiety
330057|NCT01533415|Anxiety Disorders|anxiety disorders
330058|NCT01533402|Cognitive behavior therapy|cognitive behavior therapy
330059|NCT01533402|Internet|internet
330060|NCT01533402|Anxiety disorders|anxiety disorders
330061|NCT01533402|Children|children
330062|NCT01533376|Sturge Weber|sturge weber
330063|NCT01533376|SWS|sws
330064|NCT01533376|Timolol|timolol
330065|NCT01533376|Port wine mark|port wine mark
330066|NCT01533363|Hemorrhoids|hemorrhoids
330067|NCT01533363|Surgery|surgery
330068|NCT01533363|Hemorrhoidopexy|hemorrhoidopexy
330069|NCT01533363|Milligan Morgan|milligan morgan
330070|NCT01533350|Ultrasonography|ultrasonography
330071|NCT01533350|late follicle phase|late follicle phase
330072|NCT01533350|homogeneous endometrium|homogeneous endometrium
330073|NCT01533350|receptivity|receptivity
330074|NCT01533350|biochemical factor|biochemical factor
330075|NCT01533350|ultrastructure|ultrastructure
330076|NCT01533350|endometrial echo pattern|endometrial echo pattern
330077|NCT01533337|dorsal digital free flap|dorsal digital free flap
330078|NCT01533337|dorsal branch of proper digital nerve|dorsal branch of proper digital nerve
330177|NCT01532791|mitochondria|mitochondria
330079|NCT01533337|dorsal branch of proper digital artery|dorsal branch of proper digital artery
330080|NCT01533337|proper digital artery|proper digital artery
330081|NCT01533324|hepatocellular carcinoma|hepatocellular carcinoma
330082|NCT01533324|S-1|s-1
330083|NCT01533324|Leucovorin|leucovorin
330084|NCT01533324|fluorouracil|fluorouracil
330085|NCT01533311|nonpolypoid colorectal neoplasms(NP-CRN)|nonpolypoid colorectal neoplasms(np-crn)
330086|NCT01533311|prevalence|prevalence
330087|NCT01533311|histology|histology
330088|NCT01533285|Major depressive disorder|major depressive disorder
330089|NCT01533285|MDD|mdd
330090|NCT01533285|Psychiatry disorders|psychiatry disorders
330091|NCT01533285|Psychosocial stressor|psychosocial stressor
330092|NCT01533285|Psychosocial stress|psychosocial stress
330093|NCT01533285|Typhoid vaccination|typhoid vaccination
330094|NCT01533285|Typhoid vaccine|typhoid vaccine
330095|NCT01533272|HIV infection|hiv infection
330096|NCT01533272|Postexposure prophylaxis|postexposure prophylaxis
330097|NCT01533259|HIV-1|hiv-1
330099|NCT01533259|Treatment Experienced|treatment experienced
330100|NCT01533233|thoracoscopy|thoracoscopy
330101|NCT01533233|lung cancer|lung cancer
330102|NCT01533233|lobectomy|lobectomy
330103|NCT01533233|epidural anesthesia|epidural anesthesia
330104|NCT01533220|nasal and nasopharyngeal congestion|nasal and nasopharyngeal congestion
330105|NCT01533168|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
330106|NCT01533168|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
330107|NCT01533168|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
330108|NCT01533155|Phase 1|phase 1
330109|NCT01533155|Healthy male and female volunteers|healthy male and female volunteers
330110|NCT01533155|Drug-drug interaction|drug-drug interaction
330111|NCT01533155|Pharmacokinetics|pharmacokinetics
330112|NCT01533155|NKTR-118|nktr-118
330113|NCT01533142|lipids|lipids
330114|NCT01533129|Hypogonadism|hypogonadism
330115|NCT01533129|Endothelial dysfunction|endothelial dysfunction
330116|NCT01533129|Inflammation|inflammation
330117|NCT01533129|Insulin resistance|insulin resistance
330118|NCT01533129|Testosterone replacement therapy|testosterone replacement therapy
330119|NCT01533116|Parkinson Disease|parkinson disease
330120|NCT01533116|BIA 9-1067|bia 9-1067
330121|NCT01533077|Parkinson Disease|parkinson disease
330122|NCT01533077|BIA 9-1067|bia 9-1067
330123|NCT01533051|Chronic hepatitis B|chronic hepatitis b
330124|NCT01533051|Nucleos(t)ide analogue|nucleos(t)ide analogue
330125|NCT01533051|Antiviral treatment|antiviral treatment
330126|NCT01533051|Korea|korea
330127|NCT01533025|anterior cruciate ligament|anterior cruciate ligament
330128|NCT01533025|Achilles|achilles
330129|NCT01533025|free tendon|free tendon
330130|NCT01533025|bone-tendon|bone-tendon
330131|NCT01533025|free tendon Achilles allograft|free tendon achilles allograft
330132|NCT01533025|Achilles allograft with calcaneal bone block on its end|achilles allograft with calcaneal bone block on its end
330133|NCT01532999|Posttraumatic Stress Disorder|posttraumatic stress disorder
330134|NCT01532999|Meditation|meditation
330135|NCT01532999|Present Centered Group Therapy|present centered group therapy
330136|NCT01532999|mindfulness|mindfulness
330137|NCT01532999|MBSR|mbsr
330138|NCT01532999|complementary alternative medicine|complementary alternative medicine
330139|NCT01532986|Quality of Health Care|quality of health care
330140|NCT01532986|Nursing Care Management|nursing care management
330141|NCT01532986|Care Coordination|care coordination
330142|NCT01532986|Randomized Trials|randomized trials
330143|NCT01532960|breast cancer|breast cancer
330144|NCT01532960|peptide vaccine|peptide vaccine
330145|NCT01532960|immunotherapy|immunotherapy
330146|NCT01532934|substance use|substance use
330147|NCT01532934|psychopathy|psychopathy
330148|NCT01532934|motivational enhancement|motivational enhancement
330149|NCT01532934|criminal recidivism|criminal recidivism
330150|NCT01532908|Liver Transplantation|liver transplantation
330152|NCT01532895|Cancer pain|cancer pain
330153|NCT01532895|Hydromorphone|hydromorphone
330154|NCT01532895|Hydromorphone OROS|hydromorphone oros
330155|NCT01532895|Narcotic analgesics|narcotic analgesics
330156|NCT01532895|Opioid-naive|opioid-naive
330157|NCT01532856|multiple myeloma|multiple myeloma
330158|NCT01532856|thalidomide|thalidomide
330159|NCT01532856|comparative|comparative
320873|NCT01572597|biofilm|biofilm
330160|NCT01532856|elderly|elderly
330161|NCT01532843|Hepatitis B|hepatitis b
330162|NCT01532843|sustained response|sustained response
330163|NCT01532843|peginterferon|peginterferon
330164|NCT01532843|nucleos(t)ide analogues|nucleos(t)ide analogues
330165|NCT01532830|vagus nerve stimulation|vagus nerve stimulation
330166|NCT01532830|vagal nerve stimulation|vagal nerve stimulation
330167|NCT01532830|nVNS|nvns
330168|NCT01532830|VNS|vns
330169|NCT01532830|migraine|migraine
330170|NCT01532830|non invasive|non invasive
330171|NCT01532830|gammacore|gammacore
330172|NCT01532804|Unresectable metastases|unresectable metastases
330173|NCT01532791|MELAS|melas
330174|NCT01532791|mitochondrial DNA mutation|mitochondrial dna mutation
330175|NCT01532791|mtDNA mutation|mtdna mutation
330176|NCT01532791|mitochondrial DNA|mitochondrial dna
330178|NCT01532791|m.3243A>G mutation|m.3243a>g mutation
330179|NCT01532765|Internal limiting membrane|internal limiting membrane
330180|NCT01532765|Indocyanine green dye|indocyanine green dye
330181|NCT01532739|Mild Cognitive Impairment|mild cognitive impairment
330182|NCT01532739|Aging|aging
330183|NCT01532739|Memory|memory
330184|NCT01532739|Executive Function|executive function
712272|NCT01016080|whitening|whitening
330185|NCT01532739|Cognitive Intervention|cognitive intervention
330186|NCT01532739|Memory Training|memory training
330187|NCT01532739|Mental Health|mental health
330188|NCT01532726|Partial-Onset Seizures|partial-onset seizures
330189|NCT01532726|Eslicarbazepine Acetate|eslicarbazepine acetate
330190|NCT01532726|ESL|esl
330191|NCT01532726|BIA 2-093|bia 2-093
330192|NCT01532726|BIAL|bial
330193|NCT01532661|TRAUMA|trauma
330194|NCT01532661|HAEMORRHAGIC|haemorrhagic
330195|NCT01532661|rVIIa|rviia
330196|NCT01532661|Complication of Trauma hemorrhage|complication of trauma hemorrhage
330197|NCT01532661|bleeding|bleeding
330198|NCT01532661|rFVIIa administration for hemorrhage after trauma|rfviia administration for hemorrhage after trauma
330199|NCT01532648|Ulcerative Colitis|ulcerative colitis
330200|NCT01532635|hematologic malignancy|hematologic malignancy
330201|NCT01532635|leukemia|leukemia
330202|NCT01532635|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
330203|NCT01532635|ALL|all
330204|NCT01532635|Acute myelogenous leukemia|acute myelogenous leukemia
330205|NCT01532635|AML|aml
330206|NCT01532635|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
330207|NCT01532635|CLL|cll
330208|NCT01532635|lymphoma|lymphoma
330209|NCT01532635|hodgkin's lymphoma|hodgkin's lymphoma
330210|NCT01532635|non-hodgkin's lymphoma|non-hodgkin's lymphoma
330211|NCT01532635|myeloma|myeloma
330212|NCT01532635|allogeneic stem cell transplant|allogeneic stem cell transplant
330213|NCT01532635|TJU 2-step|tju 2-step
330214|NCT01532635|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
330215|NCT01532635|HSCT|hsct
330216|NCT01532635|bone marrow transplant|bone marrow transplant
330217|NCT01532635|Cyclophosphamide|cyclophosphamide
330218|NCT01532635|MMF|mmf
330219|NCT01532635|Mycophenolate Mofetil|mycophenolate mofetil
330220|NCT01532622|Blueberry|blueberry
330221|NCT01532609|Methadone maintenance therapy|methadone maintenance therapy
330222|NCT01532609|Behavioral intervention|behavioral intervention
330223|NCT01532609|Service provider|service provider
330224|NCT01532609|Drug use|drug use
330225|NCT01532570|Behcet's disease|behcet's disease
330226|NCT01532570|intestinal Behcet's disease|intestinal behcet's disease
330227|NCT01532570|neuro-Behcet's disease|neuro-behcet's disease
330228|NCT01532570|vascular Behcet's disease|vascular behcet's disease
330229|NCT01532544|Severe pneumonia|severe pneumonia
330230|NCT01532531|Collateral Meridian Therapy|collateral meridian therapy
330231|NCT01532531|Knee Osteoarthritis|knee osteoarthritis
330232|NCT01532518|Feeding intolerance|feeding intolerance
330233|NCT01532518|Infant|infant
330234|NCT01532518|tachykinin antagonist|tachykinin antagonist
330235|NCT01532518|Infant colic|infant colic
330236|NCT01532518|Nepadutant|nepadutant
330237|NCT01532505|cardiopulmonary bypass|cardiopulmonary bypass
330238|NCT01532505|Postcardiotomy vasodilatory shock|postcardiotomy vasodilatory shock
330239|NCT01532505|Microcirculation|microcirculation
330240|NCT01532505|Catecholamines|catecholamines
330241|NCT01532505|Vasopressin|vasopressin
330242|NCT01532492|Questionnaire|questionnaire
330243|NCT01532492|WORC|worc
330244|NCT01532492|Rotator cuff|rotator cuff
330245|NCT01532492|Reliability|reliability
330246|NCT01532492|Validity|validity
330247|NCT01532492|Responsiveness|responsiveness
330248|NCT01532479|Osteoradionecrosis|osteoradionecrosis
330249|NCT01532479|Xerostomia|xerostomia
330250|NCT01532466|fentanyl-induced coughing, rocuronium|fentanyl-induced coughing, rocuronium
330251|NCT01532401|Blood pressure|blood pressure
330252|NCT01532388|Randomized Controlled Trial|randomized controlled trial
330253|NCT01532388|Alcohol|alcohol
330254|NCT01532388|Drugs|drugs
330255|NCT01532388|Internet|internet
330256|NCT01532388|Screening|screening
330257|NCT01532388|Brief intervention|brief intervention
320980|NCT01572194|CF|cf
330258|NCT01532375|Kochujang,|kochujang,
330259|NCT01532375|visceral fat|visceral fat
330260|NCT01532375|population|population
330261|NCT01532349|chronic kidney disease|chronic kidney disease
330262|NCT01532349|anemia|anemia
330263|NCT01532336|adenovirus|adenovirus
330264|NCT01532336|conjunctivitis|conjunctivitis
330265|NCT01532336|pinkeye|pinkeye
330266|NCT01532323|Oral disorders|oral disorders
330267|NCT01532310|systemic lupus erythematosus|systemic lupus erythematosus
330268|NCT01532310|belimumab|belimumab
330269|NCT01532310|pregnancy|pregnancy
330270|NCT01532297|citrate dialysate|citrate dialysate
330271|NCT01532297|dialysis|dialysis
330272|NCT01532297|calcium|calcium
330273|NCT01532284|aneuploid oocytes|aneuploid oocytes
330274|NCT01532284|ICSI|icsi
330275|NCT01532284|IVF|ivf
330276|NCT01532284|Polar Body Biopsy|polar body biopsy
330277|NCT01532271|mild Traumatic Brain Injury|mild traumatic brain injury
330278|NCT01532271|mTBI|mtbi
330279|NCT01532271|Concussion|concussion
330280|NCT01532258|BMI|bmi
330281|NCT01532258|Weight loss|weight loss
330282|NCT01532258|Nutrition|nutrition
330283|NCT01532258|Diet|diet
330284|NCT01532258|Mediterranean diet|mediterranean diet
330285|NCT01532258|Online program|online program
330286|NCT01532258|web-based program|web-based program
712273|NCT01016080|UV spots|uv spots
330287|NCT01532258|Oxidative stress|oxidative stress
330288|NCT01532258|F2 isoprostanes|f2 isoprostanes
330289|NCT01532232|PLACEBO|placebo
330290|NCT01532232|VARENICLINE (CHANTIX)|varenicline (chantix)
330291|NCT01532232|Self-reported cigarettes smokers|self-reported cigarettes smokers
330292|NCT01532232|Smoking Cessation|smoking cessation
330293|NCT01532232|11-136|11-136
330294|NCT01532206|Remote ischemic preconditioning|remote ischemic preconditioning
330295|NCT01532206|inflammation|inflammation
330296|NCT01532180|Obstructive sleep apnea, neurostimulation, hypoglossal nerve|obstructive sleep apnea, neurostimulation, hypoglossal nerve
330297|NCT01532141|Parkinson Disease|parkinson disease
330298|NCT01532141|BIA 9-1067|bia 9-1067
330299|NCT01532128|Parkinson Disease|parkinson disease
330300|NCT01532128|BIA 9-1067|bia 9-1067
330301|NCT01532115|Parkinson Disease|parkinson disease
330302|NCT01532115|BIA 9-1067|bia 9-1067
330303|NCT01532102|Genital warts|genital warts
330304|NCT01532102|Anogenital warts|anogenital warts
330305|NCT01532102|HPV|hpv
330306|NCT01532102|Human papillomavirus|human papillomavirus
330307|NCT01532102|Antiviral|antiviral
330308|NCT01532076|osteoporosis|osteoporosis
330309|NCT01532076|prox. humeral fracture|prox. humeral fracture
330310|NCT01532076|geriatric trauma|geriatric trauma
330311|NCT01532076|mesenchymal stem cells|mesenchymal stem cells
330312|NCT01532063|Difficult intubation|difficult intubation
330313|NCT01532063|Intensive care units|intensive care units
330314|NCT01532063|Risk factors|risk factors
330315|NCT01532063|Incidence|incidence
330316|NCT01532063|Complications|complications
330317|NCT01532063|Intubation in Intensive Care Unit|intubation in intensive care unit
330318|NCT01532063|More than 2 attempts of intubation|more than 2 attempts of intubation
330319|NCT01532063|Intubation attempts lasting more than 10 minutes|intubation attempts lasting more than 10 minutes
330320|NCT01532050|OSAS|osas
330321|NCT01532050|American Academy of Sleep Medicine Task Force|american academy of sleep medicine task force
330322|NCT01532037|Randomised controlled trial|randomised controlled trial
330323|NCT01532037|Multiple Sclerosis|multiple sclerosis
330324|NCT01532037|Fatigue|fatigue
330325|NCT01532037|Cognitive Behavioural Therapy|cognitive behavioural therapy
330326|NCT01532037|Self Help|self help
330327|NCT01532024|Optical Imaging|optical imaging
330328|NCT01532024|Neutrophil|neutrophil
330329|NCT01532024|Elastase|elastase
330330|NCT01532024|Molecular Imaging|molecular imaging
330331|NCT01532024|Acute Lung Injury|acute lung injury
330332|NCT01532024|ARDS|ards
330333|NCT01532011|Advanced Cancers|advanced cancers
330334|NCT01532011|Solid Tumors|solid tumors
330335|NCT01532011|Erlotinib|erlotinib
330336|NCT01532011|Erlotinib Hydrochloride|erlotinib hydrochloride
330337|NCT01532011|OSI-774|osi-774
330338|NCT01532011|Tarceva|tarceva
330339|NCT01532011|Pralatrexate|pralatrexate
330340|NCT01532011|Folotyn|folotyn
330341|NCT01532011|PDX-010|pdx-010
330342|NCT01531998|Myeloma|myeloma
330343|NCT01531998|Multiple Myeloma|multiple myeloma
330344|NCT01531998|MM|mm
330345|NCT01531998|Newly diagnosed|newly diagnosed
330346|NCT01531998|Lenalidomide|lenalidomide
330347|NCT01531998|CC-5013|cc-5013
330348|NCT01531998|Revlimid|revlimid
330349|NCT01531998|Bortezomib|bortezomib
330350|NCT01531998|Velcade|velcade
330352|NCT01531998|MLN341|mln341
330353|NCT01531998|PS-341|ps-341
330354|NCT01531998|Siltuximab|siltuximab
330355|NCT01531998|CNTO 328|cnto 328
330356|NCT01531998|Anti-IL-6 Antibody|anti-il-6 antibody
330357|NCT01531998|Dexamethasone|dexamethasone
330358|NCT01531998|Decadron|decadron
330359|NCT01531998|M. D. Anderson Symptom Inventory Module|m. d. anderson symptom inventory module
321074|NCT01571739|IGRA|igra
330360|NCT01531998|MDASI-MM|mdasi-mm
330361|NCT01531998|Questionnaires|questionnaires
330362|NCT01531998|Surveys|surveys
330363|NCT01531985|Congenital Heart Disease|congenital heart disease
330364|NCT01531985|Acute Kidney Injury|acute kidney injury
330365|NCT01531985|Cardiopulmonary Bypass|cardiopulmonary bypass
330366|NCT01531985|Biomarkers|biomarkers
330367|NCT01531972|Single-photon Emission Computed Tomography|single-photon emission computed tomography
330368|NCT01531972|Healthy Volunteers|healthy volunteers
330369|NCT01531972|Tomography|tomography
330370|NCT01531959|Midodrine|midodrine
330371|NCT01531959|Hypotension|hypotension
330372|NCT01531959|Intensive care unit|intensive care unit
330373|NCT01531959|IV vasopressors|iv vasopressors
330374|NCT01531959|ICU discharge|icu discharge
330375|NCT01531946|Diffusion Tensor Imaging|diffusion tensor imaging
330376|NCT01531933|Prediabetic|prediabetic
330377|NCT01531933|Primary prevention|primary prevention
330378|NCT01531933|Type 2 diabetes mellitus|type 2 diabetes mellitus
330379|NCT01531907|GLP2|glp2
330380|NCT01531907|Obesity|obesity
330381|NCT01531907|Premenopausal|premenopausal
330382|NCT01531907|Bone|bone
330383|NCT01531907|Formation|formation
330384|NCT01531907|Resorption|resorption
330385|NCT01531894|solid tumor|solid tumor
330386|NCT01531894|GSK2110183|gsk2110183
330387|NCT01531894|hematologic malignancy|hematologic malignancy
712567|NCT01018706|Stent|stent
330388|NCT01531894|AKT inhibitor|akt inhibitor
330389|NCT01531894|cancer|cancer
330390|NCT01531894|safety|safety
330391|NCT01531868|Decision making|decision making
330392|NCT01531868|Carotid stenosis|carotid stenosis
330393|NCT01531855|T1DM, Exercise|t1dm, exercise
330394|NCT01531842|Conjunctival bacterial flora|conjunctival bacterial flora
330395|NCT01531842|prophylactic topical antibiotic|prophylactic topical antibiotic
330396|NCT01531842|injection|injection
330397|NCT01531842|intravitreal injection|intravitreal injection
330398|NCT01531842|bacterial resistance|bacterial resistance
330399|NCT01531842|serial injection|serial injection
330400|NCT01531842|serial intravitreal injections|serial intravitreal injections
330402|NCT01531842|CRVO|crvo
330403|NCT01531842|AMD|amd
330404|NCT01531842|BRVO|brvo
330405|NCT01531829|pulmonary embolism|pulmonary embolism
330406|NCT01531829|right ventricular dysfunction|right ventricular dysfunction
330407|NCT01531829|Thrombolysis|thrombolysis
330408|NCT01531829|Heparin|heparin
330409|NCT01531816|Pediatrics,|pediatrics,
330410|NCT01531816|Critically ill Children|critically ill children
330411|NCT01531816|immobility|immobility
330412|NCT01531790|Endostar|endostar
330413|NCT01531790|Carboplatin|carboplatin
330414|NCT01531790|Pemetrexed|pemetrexed
330415|NCT01531790|NSCLC|nsclc
330416|NCT01531790|Phase I|phase i
330417|NCT01531777|Advanced Colorectal Cancer|advanced colorectal cancer
330418|NCT01531764|Metastatic breast cancer|metastatic breast cancer
330419|NCT01531764|intermediate HER2 expression|intermediate her2 expression
330420|NCT01531764|Afatinib|afatinib
330421|NCT01531751|HCO-HD|hco-hd
330422|NCT01531751|survival|survival
330423|NCT01531751|cardiac biomarkers|cardiac biomarkers
330424|NCT01531751|AL amyloidosis|al amyloidosis
330425|NCT01531751|Light Chain Amyloidosis|light chain amyloidosis
330426|NCT01531738|Taste|taste
330427|NCT01531738|bariatric surgery|bariatric surgery
330428|NCT01531738|food preferences|food preferences
330429|NCT01531738|reward|reward
330430|NCT01531738|progressive ratio task|progressive ratio task
330431|NCT01531725|Stents|stents
330432|NCT01531712|neoadjuvant treatment|neoadjuvant treatment
330433|NCT01531712|borderline resectability|borderline resectability
330434|NCT01531686|intraosseous vascular access|intraosseous vascular access
330435|NCT01531686|CT examination|ct examination
330436|NCT01531634|Borderline Personality Disorder|borderline personality disorder
330437|NCT01531634|Women|women
330438|NCT01531634|Dynamic Cognitive Intervention|dynamic cognitive intervention
330439|NCT01531634|Recovery|recovery
330440|NCT01531634|Hope Scale|hope scale
330441|NCT01531621|metastatic colorectal cancer|metastatic colorectal cancer
330442|NCT01531608|melanoma|melanoma
330443|NCT01531608|imaging|imaging
330444|NCT01531608|sentinel node|sentinel node
330445|NCT01531608|biopsy|biopsy
330446|NCT01531595|metastatic colorectal cancer|metastatic colorectal cancer
330447|NCT01531582|Angelman|angelman
330448|NCT01531582|Minocycline|minocycline
330449|NCT01531582|cognitive|cognitive
330450|NCT01531582|children|children
330451|NCT01531582|tetracycline|tetracycline
330452|NCT01531569|Flaxseed|flaxseed
330453|NCT01531569|Lignans|lignans
330454|NCT01531569|Pharmacokinetics|pharmacokinetics
330455|NCT01531543|Vacuum Assisted Closure (VAC)|vacuum assisted closure (vac)
330456|NCT01531543|Laparostomy|laparostomy
330457|NCT01531543|Severe peritonitis|severe peritonitis
330458|NCT01531530|Shigella|shigella
330459|NCT01531530|Vaccine|vaccine
330460|NCT01531530|Mucosal immunity|mucosal immunity
330461|NCT01531517|Pedyphar|pedyphar
330462|NCT01531517|Ointment|ointment
330463|NCT01531517|Healing|healing
330464|NCT01531517|Diabetic|diabetic
330465|NCT01531517|Foot Ulcer|foot ulcer
330466|NCT01531504|hysterectomies|hysterectomies
330467|NCT01531504|uterine manipulator|uterine manipulator
330468|NCT01531491|Emergence|emergence
330469|NCT01531491|Hypercapnia|hypercapnia
330470|NCT01531491|Hypocapnia|hypocapnia
330471|NCT01531491|Propofol|propofol
330472|NCT01531478|Childhood cancer|childhood cancer
330473|NCT01531478|Cancer|cancer
330474|NCT01531478|Sequels|sequels
330475|NCT01531478|Complications|complications
330476|NCT01531478|Chemotherapy|chemotherapy
330477|NCT01531478|Radiotherapy|radiotherapy
330478|NCT01531478|Surgery|surgery
330479|NCT01531465|Respiratory insufficiency|respiratory insufficiency
330480|NCT01531465|Infants|infants
330481|NCT01531465|High Flow Nasal Cannula (HFNC)|high flow nasal cannula (hfnc)
330482|NCT01531465|Nasal Continuous Positive Airway Pressure (NCPAP)|nasal continuous positive airway pressure (ncpap)
330483|NCT01531452|Stomach Neoplasms|stomach neoplasms
330484|NCT01531452|drug therapy|drug therapy
330485|NCT01531452|oxaliplatin|oxaliplatin
330486|NCT01531452|s1|s1
330487|NCT01531439|Narcotic Antagonists|narcotic antagonists
330488|NCT01531439|Naloxone infusion|naloxone infusion
330489|NCT01531439|Postoperative pruritis|postoperative pruritis
330490|NCT01531439|Patient controlled analgesia|patient controlled analgesia
330491|NCT01531439|Pediatric|pediatric
330492|NCT01531439|Children|children
330493|NCT01531426|resuscitation|resuscitation
330494|NCT01531426|hypothermia|hypothermia
330495|NCT01531426|outcome|outcome
330496|NCT01531387|Phase III|phase iii
330497|NCT01531387|Sickle cell anemia|sickle cell anemia
330498|NCT01531387|Conditional transcranial doppler velocities|conditional transcranial doppler velocities
330499|NCT01531387|Reduce risk of conversion to abnormally high transcranial doppler velocities|reduce risk of conversion to abnormally high transcranial doppler velocities
330500|NCT01531387|Pediatric patients|pediatric patients
330501|NCT01531374|Valvular Heart Disease|valvular heart disease
330502|NCT01531374|Critical Aortic Stenosis|critical aortic stenosis
330503|NCT01531374|Severe Aortic Stenosis|severe aortic stenosis
330504|NCT01531374|Extreme Risk|extreme risk
330505|NCT01531374|High Risk|high risk
330506|NCT01531374|Aortic Valve Replacement|aortic valve replacement
330507|NCT01531361|Advanced Cancers|advanced cancers
330508|NCT01531361|Advanced Malignancies|advanced malignancies
330509|NCT01531361|Metastatic cancers|metastatic cancers
330510|NCT01531361|Vemurafenib|vemurafenib
330511|NCT01531361|PLX4032|plx4032
330512|NCT01531361|R05185426|r05185426
330513|NCT01531361|Sorafenib|sorafenib
330514|NCT01531361|Nexavar|nexavar
330515|NCT01531361|Bay 43-9006|bay 43-9006
330516|NCT01531361|Crizotinib|crizotinib
330517|NCT01531361|PF-02341066|pf-02341066
330518|NCT01531361|Xalkori|xalkori
330519|NCT01531361|Maximum tolerated dose|maximum tolerated dose
330520|NCT01531361|MTD|mtd
330521|NCT01531361|Dose limiting toxicity|dose limiting toxicity
330522|NCT01531361|DLT|dlt
330523|NCT01531348|Retinitis pigmentosa|retinitis pigmentosa
330524|NCT01531348|Bone marrow-derived mesenchymal stem cells|bone marrow-derived mesenchymal stem cells
330525|NCT01531348|Intravitreal injection|intravitreal injection
330526|NCT01531335|adults|adults
330527|NCT01531322|13vPnC|13vpnc
330528|NCT01531322|Healthy subjects|healthy subjects
330529|NCT01531322|China|china
330530|NCT01531309|Liver impairment|liver impairment
330531|NCT01531309|Major Depression Disorder|major depression disorder
330532|NCT01531309|Sublingual tablet|sublingual tablet
330533|NCT01531296|MRI|mri
330534|NCT01531296|Lower Extremity Rotational|lower extremity rotational
330535|NCT01531296|Femoral Version|femoral version
330536|NCT01531296|Tibial Torsion|tibial torsion
330537|NCT01531283|unacylated ghrelin|unacylated ghrelin
330538|NCT01531283|beta cell function|beta cell function
330539|NCT01531231|heart disease|heart disease
330540|NCT01531231|unstable angina|unstable angina
330541|NCT01531231|myocardial infarction|myocardial infarction
330542|NCT01531231|behavioral|behavioral
330543|NCT01531231|cardiovascular|cardiovascular
330544|NCT01531231|emotions|emotions
330545|NCT01531218|Campylobacter|campylobacter
330546|NCT01531218|concisus|concisus
330547|NCT01531218|diarrhea|diarrhea
330548|NCT01531218|fever|fever
330549|NCT01531218|abdominal pain|abdominal pain
330550|NCT01531218|vomiting|vomiting
330551|NCT01531205|recurrent|recurrent
330552|NCT01531205|high risk|high risk
330553|NCT01531192|Lactobacillus reuteri|lactobacillus reuteri
330554|NCT01531192|Nystatin|nystatin
330555|NCT01531192|Very Low Birth Weight Infants|very low birth weight infants
330556|NCT01531192|Candida Colonization|candida colonization
330557|NCT01531166|Chronic hepatitis B|chronic hepatitis b
330558|NCT01531166|pegylated Interferon-alpha 2a|pegylated interferon-alpha 2a
330559|NCT01531166|Korean|korean
330560|NCT01531153|Cocaine use decreases, increases or stays the same|cocaine use decreases, increases or stays the same
330561|NCT01531140|colonoscopy cleansing|colonoscopy cleansing
330562|NCT01531140|PEG|peg
330563|NCT01531140|sennosides|sennosides
330564|NCT01531140|children|children
330565|NCT01531114|Diabetes mellitus|diabetes mellitus
330566|NCT01531114|antiplatelet effect|antiplatelet effect
330567|NCT01531114|prasugrel|prasugrel
330568|NCT01531114|ticagrelor|ticagrelor
330569|NCT01531114|STEMI|stemi
330570|NCT01531114|Insulin|insulin
330571|NCT01531101|Transference work|transference work
330572|NCT01531101|Psychodynamic|psychodynamic
330573|NCT01531101|Depression|depression
330574|NCT01531101|Treatment|treatment
330575|NCT01531101|Adolescent|adolescent
330576|NCT01531088|Nursing Home|nursing home
330577|NCT01531075|HBV, Inflammatory bowel disease, immunosuppressor|hbv, inflammatory bowel disease, immunosuppressor
330578|NCT01531062|nigella sativa|nigella sativa
330579|NCT01531062|dyslipidemia|dyslipidemia
330580|NCT01531062|elderly|elderly
330581|NCT01531049|smoking cessation|smoking cessation
330582|NCT01531049|young adults|young adults
330583|NCT01531049|motivational counselling|motivational counselling
330584|NCT01531049|smoking|smoking
330585|NCT01531049|nicotine replacement therapy|nicotine replacement therapy
330586|NCT01531049|therapy|therapy
330686|NCT01530659|Vision|vision
330687|NCT01530659|Blind|blind
330587|NCT01531023|Extended-Spectrum Beta-lactamase Producing Bacteria|extended-spectrum beta-lactamase producing bacteria
330588|NCT01531010|Neonate|neonate
330589|NCT01531010|Premature|premature
330590|NCT01531010|Pressure limited ventilation|pressure limited ventilation
330591|NCT01531010|Volume ventilation|volume ventilation
330592|NCT01530997|Human Papilloma Virus|human papilloma virus
330593|NCT01530997|Oropharynx|oropharynx
330594|NCT01530997|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
330595|NCT01530997|Squamous Cell Carcinoma|squamous cell carcinoma
330596|NCT01530997|Radiation Therapy|radiation therapy
330597|NCT01530997|Chemotherapy|chemotherapy
330598|NCT01530997|p16|p16
330599|NCT01530984|prostate cancer|prostate cancer
330600|NCT01530984|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
330601|NCT01530984|Chemotherapy-naïve patients|chemotherapy-naïve patients
330602|NCT01530984|Anti-CTLA4 blockade|anti-ctla4 blockade
330603|NCT01530984|systemic GM-CSF|systemic gm-csf
330604|NCT01530984|Ipilimumab|ipilimumab
330605|NCT01530971|oxygen|oxygen
330606|NCT01530971|pregnancy|pregnancy
330607|NCT01530971|caesarean section|caesarean section
330608|NCT01530971|anesthetic techniques|anesthetic techniques
330609|NCT01530958|CKD|ckd
330610|NCT01530958|Automated Telephone Self Management|automated telephone self management
330611|NCT01530958|Registry|registry
330612|NCT01530958|CKD awareness|ckd awareness
330613|NCT01530958|Self efficacy|self efficacy
330614|NCT01530932|sepsis|sepsis
330615|NCT01530932|tissue oxygenation|tissue oxygenation
330616|NCT01530932|tissue perfusion|tissue perfusion
330617|NCT01530932|immune reaction|immune reaction
330618|NCT01530906|Eating disorders|eating disorders
330619|NCT01530906|Bulimia|bulimia
330620|NCT01530906|rTMS|rtms
330621|NCT01530906|Treatment|treatment
330622|NCT01530893|flavonoids|flavonoids
330623|NCT01530893|vascular function|vascular function
330624|NCT01530893|randomised controlled trial|randomised controlled trial
330625|NCT01530893|placebo controlled|placebo controlled
330626|NCT01530880|Fever reduction|fever reduction
330627|NCT01530880|Fever burden|fever burden
330628|NCT01530880|intravenous ibuprofen|intravenous ibuprofen
330629|NCT01530867|Dietary Supplements|dietary supplements
330630|NCT01530867|Physician-patient communication|physician-patient communication
330631|NCT01530867|Qualitative study|qualitative study
330632|NCT01530867|Audio recorded office visits|audio recorded office visits
330633|NCT01530854|sepsis|sepsis
330634|NCT01530854|free fatty acids|free fatty acids
330635|NCT01530854|emergency department|emergency department
330636|NCT01530841|Myotonic dystrophy type 1|myotonic dystrophy type 1
330637|NCT01530841|Home ventilation|home ventilation
330638|NCT01530841|Respiratory insufficiency|respiratory insufficiency
330639|NCT01530841|Neuromuscular|neuromuscular
330640|NCT01530828|Immunoreactive Trypsinogen|immunoreactive trypsinogen
330641|NCT01530828|Nectrotizing Enterocolitis|nectrotizing enterocolitis
330642|NCT01530828|Premature Infants|premature infants
330643|NCT01530828|Serial IRT|serial irt
330644|NCT01530802|laparoscopic myomectomy, leiomyoma, blood loss, uterine artery|laparoscopic myomectomy, leiomyoma, blood loss, uterine artery
330645|NCT01530789|Telemedecine|telemedecine
330646|NCT01530789|Telemedecine nurse|telemedecine nurse
330647|NCT01530789|Delegation of tasks|delegation of tasks
330648|NCT01530789|Type 1 diabetes|type 1 diabetes
330649|NCT01530776|Pregnancy|pregnancy
330650|NCT01530776|Postpartum|postpartum
330651|NCT01530776|Weight Retention|weight retention
330652|NCT01530776|Behavioral|behavioral
330653|NCT01530776|Electronically-mediated|electronically-mediated
330654|NCT01530763|Infections|infections
330655|NCT01530763|Pediatrics|pediatrics
330656|NCT01530763|Teflaro|teflaro
330657|NCT01530763|cephalosporin|cephalosporin
330658|NCT01530750|postoperative atrial fibrillation|postoperative atrial fibrillation
330659|NCT01530750|internal loop recorder|internal loop recorder
330660|NCT01530750|risk factors|risk factors
330661|NCT01530750|coronary artery bypass surgery|coronary artery bypass surgery
330662|NCT01530737|pediatric|pediatric
330663|NCT01530737|Antithrombin|antithrombin
330664|NCT01530737|anticoagulation efficiency|anticoagulation efficiency
330665|NCT01530737|cardiac surgery|cardiac surgery
330666|NCT01530724|abdominal obesity|abdominal obesity
330667|NCT01530698|dendritic cell vaccination|dendritic cell vaccination
330668|NCT01530698|melanoma|melanoma
330669|NCT01530698|toll like receptor ligands|toll like receptor ligands
330670|NCT01530698|mRNA electroporation|mrna electroporation
330671|NCT01530698|vaccines|vaccines
330672|NCT01530685|cinnamon|cinnamon
330673|NCT01530685|chromium|chromium
330674|NCT01530685|prediabete|prediabete
330675|NCT01530685|overweight|overweight
330676|NCT01530672|HIV|hiv
330677|NCT01530672|Syphilis|syphilis
330678|NCT01530672|Combination|combination
330679|NCT01530672|POC|poc
330680|NCT01530672|point-of-care|point-of-care
330681|NCT01530672|MBIO|mbio
330682|NCT01530659|Retinitis pigmentosa|retinitis pigmentosa
330683|NCT01530659|Usher syndrome type 2|usher syndrome type 2
330684|NCT01530659|Usher syndrome type 3|usher syndrome type 3
330685|NCT01530659|Cone photoreceptor|cone photoreceptor
330688|NCT01530646|obesity|obesity
330689|NCT01530646|overweight|overweight
330690|NCT01530646|muscle|muscle
330691|NCT01530646|protein|protein
330692|NCT01530646|muscle protein synthesis|muscle protein synthesis
330693|NCT01530646|muscle protein breakdown|muscle protein breakdown
330694|NCT01530646|whey|whey
330695|NCT01530646|soy|soy
330696|NCT01530646|caloric restriction|caloric restriction
330697|NCT01530620|Antimuscarinics|antimuscarinics
330698|NCT01530620|Neurogenic bladder|neurogenic bladder
330699|NCT01530620|Propiverine|propiverine
330700|NCT01530620|Urodynamics|urodynamics
330701|NCT01530607|Early Stage Breast Cancer|early stage breast cancer
330702|NCT01530607|Reduce Ovarian Failure Following Chemotherapy|reduce ovarian failure following chemotherapy
330703|NCT01530594|Untreated|untreated
330704|NCT01530594|Without intent for immediate autologous stem cell transplant|without intent for immediate autologous stem cell transplant
330705|NCT01530568|Intensive care, TB, tracheal aspirates, Gene Xpert|intensive care, tb, tracheal aspirates, gene xpert
330706|NCT01530542|bioavailability|bioavailability
330707|NCT01530542|food effect|food effect
330708|NCT01530542|oxycodone|oxycodone
330709|NCT01530542|management of acute and chronic moderate to severe pain|management of acute and chronic moderate to severe pain
330710|NCT01530529|PF-05180999|pf-05180999
330711|NCT01530529|safety|safety
330712|NCT01530529|pharmacokinetics|pharmacokinetics
330713|NCT01530529|relative bioavailability|relative bioavailability
330714|NCT01530529|Mental Disorders|mental disorders
330715|NCT01530529|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
330716|NCT01530529|Schizophrenia|schizophrenia
330717|NCT01530516|Malocclusion, Angle Class II|malocclusion, angle class ii
330718|NCT01530503|biliary tract cancer|biliary tract cancer
330719|NCT01530503|advanced disease|advanced disease
330720|NCT01530503|chemotherapy|chemotherapy
330721|NCT01530490|IVF|ivf
330722|NCT01530490|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
330723|NCT01530490|cabergoline|cabergoline
330724|NCT01530490|hydroxyethyl starch|hydroxyethyl starch
330725|NCT01530490|prevention|prevention
330726|NCT01530477|Bone mineral density|bone mineral density
330727|NCT01530477|weight|weight
330728|NCT01530477|body composition|body composition
330729|NCT01530477|DEXA|dexa
330730|NCT01530477|DXA|dxa
330731|NCT01530464|High altitude induced fatigue|high altitude induced fatigue
330732|NCT01530464|High altitude induced pulmonary Hypertension|high altitude induced pulmonary hypertension
330733|NCT01530451|Nocturia|nocturia
330734|NCT01530451|Obstructive sleep Apnoea|obstructive sleep apnoea
330735|NCT01530451|Desmopressin|desmopressin
330736|NCT01530438|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
330737|NCT01530425|pediatric wheelchairs|pediatric wheelchairs
330738|NCT01530425|low-income|low-income
330739|NCT01530425|comparisons|comparisons
330740|NCT01530412|Quality of Life|quality of life
330741|NCT01530412|Free-living activity|free-living activity
330742|NCT01530412|Exacerbation|exacerbation
330743|NCT01530412|Rehabilitation|rehabilitation
330744|NCT01530386|Lacosamide|lacosamide
330745|NCT01530386|Vimpat|vimpat
330746|NCT01530373|hot flashes|hot flashes
330747|NCT01530373|breast cancer|breast cancer
330748|NCT01530373|aromatase inhibitors|aromatase inhibitors
330749|NCT01530373|solifenacin|solifenacin
330750|NCT01530373|clonidine|clonidine
330751|NCT01530373|quality of life|quality of life
330752|NCT01530347|Glucose monitoring|glucose monitoring
330753|NCT01530347|non-invasive glucometer|non-invasive glucometer
330754|NCT01530347|Self glucose monitoring|self glucose monitoring
330755|NCT01530321|cervicogenic headache|cervicogenic headache
330756|NCT01530321|spinal manipulation|spinal manipulation
330757|NCT01530321|chiropractic|chiropractic
330758|NCT01530321|randomized controlled trial|randomized controlled trial
330759|NCT01530321|dose-response|dose-response
330760|NCT01530321|efficacy|efficacy
330761|NCT01530308|Delirium|delirium
330762|NCT01530282|Respiratory Insufficiency [C08.618.846]|respiratory insufficiency [c08.618.846]
330763|NCT01530269|intermediate|intermediate
330765|NCT01530269|risk|risk
330766|NCT01530269|radiation|radiation
330767|NCT01530269|therapy|therapy
330768|NCT01530269|planning|planning
330769|NCT01530269|surgical|surgical
330770|NCT01530269|immunotherapy|immunotherapy
330771|NCT01530269|chemotherapy|chemotherapy
330772|NCT01530269|hormone|hormone
330773|NCT01530256|allograph|allograph
330774|NCT01530256|steroid refractory|steroid refractory
330775|NCT01530230|cesarean section|cesarean section
330776|NCT01530230|electrocardiography|electrocardiography
330777|NCT01530230|heart|heart
330778|NCT01530230|hypotension|hypotension
330779|NCT01530230|ischemia|ischemia
330780|NCT01530230|oxytocin|oxytocin
330781|NCT01530230|preeclampsia|preeclampsia
330782|NCT01530230|regional anesthesia|regional anesthesia
330783|NCT01530230|ECG changes suggestive of myocardial ischemia|ecg changes suggestive of myocardial ischemia
330784|NCT01530217|Analgesics|analgesics
330785|NCT01530217|Ibuprofen|ibuprofen
330786|NCT01530217|Inflammation|inflammation
330787|NCT01530217|Tooth Bleaching|tooth bleaching
330788|NCT01530204|knee arthritis|knee arthritis
330789|NCT01530204|knee osteoarthritis|knee osteoarthritis
330790|NCT01530204|knee pain|knee pain
330791|NCT01530204|cognitive behavioral therapy|cognitive behavioral therapy
330792|NCT01530204|physical therapy|physical therapy
330793|NCT01530204|depression prevention|depression prevention
330794|NCT01530191|depression|depression
330796|NCT01530191|pelvic organ prolapse|pelvic organ prolapse
330797|NCT01530191|POP|pop
330798|NCT01530178|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
330799|NCT01530165|IFG|ifg
330800|NCT01530165|IGTT|igtt
330801|NCT01530152|Truwiev PCD laryngoscope|truwiev pcd laryngoscope
330802|NCT01530152|Macintosh laryngoscope|macintosh laryngoscope
330803|NCT01530126|periodontitis|periodontitis
330804|NCT01530113|Childhood sexual abuse|childhood sexual abuse
330805|NCT01530113|Vaginismus|vaginismus
330806|NCT01530113|Partial vaginismus|partial vaginismus
330807|NCT01530113|Labor dystocia|labor dystocia
330808|NCT01530113|Depression|depression
330809|NCT01530100|Edema|edema
330810|NCT01530100|Pain|pain
330811|NCT01530100|Lower laser therapy|lower laser therapy
330812|NCT01530100|orthognathics surgery|orthognathics surgery
330813|NCT01530087|colostomy|colostomy
330814|NCT01530087|ileostomy|ileostomy
330815|NCT01530087|irritant dermatitis|irritant dermatitis
330816|NCT01530087|two piece barrier|two piece barrier
330817|NCT01530074|Mandibular nerve|mandibular nerve
330818|NCT01530074|Mental nerve|mental nerve
330819|NCT01530074|Mandibular incisive nerve|mandibular incisive nerve
330820|NCT01530074|Local anesthesia|local anesthesia
330821|NCT01530074|None, only healthy subjects will be enrolled in this study|none, only healthy subjects will be enrolled in this study
330822|NCT01530035|cardiac|cardiac
330823|NCT01530035|vascular|vascular
330824|NCT01530035|muscular|muscular
330825|NCT01530035|adaptations|adaptations
330826|NCT01530035|soccer training|soccer training
330827|NCT01530035|strength training|strength training
330828|NCT01530022|Lacosamide|lacosamide
330829|NCT01530022|Vimpat|vimpat
330830|NCT01530022|Cognition|cognition
330831|NCT01530022|Mental Processes|mental processes
330832|NCT01530022|Adverse Effects|adverse effects
330833|NCT01530009|Antroduodenal manometry|antroduodenal manometry
330834|NCT01530009|Child|child
330835|NCT01530009|Adolescent|adolescent
330836|NCT01530009|Amoxicillin|amoxicillin
330837|NCT01530009|Gastrointestinal Motility|gastrointestinal motility
330838|NCT01529957|Volunteers|volunteers
330839|NCT01529918|Diabetes|diabetes
330840|NCT01529918|Self-screening|self-screening
330841|NCT01529918|Web-based technology|web-based technology
330842|NCT01529918|follow-up clinical care|follow-up clinical care
330843|NCT01529918|randomized control trial|randomized control trial
330844|NCT01529905|depression|depression
330845|NCT01529905|mania|mania
330846|NCT01529905|bipolar|bipolar
330847|NCT01529905|outcome|outcome
330848|NCT01529905|cognitive|cognitive
330849|NCT01529879|edentulism|edentulism
330850|NCT01529879|dental implants|dental implants
330851|NCT01529879|clinical study|clinical study
330852|NCT01529879|Nanotite Certain Tapered implant|nanotite certain tapered implant
330853|NCT01529879|randomized|randomized
330854|NCT01529879|crestal bone level|crestal bone level
330855|NCT01529866|clinical study|clinical study
330856|NCT01529866|edentulism|edentulism
330857|NCT01529866|dental implants|dental implants
330858|NCT01529866|Nanotite Certain Tapered implant|nanotite certain tapered implant
330859|NCT01529866|randomized|randomized
330860|NCT01529866|crestal bone level|crestal bone level
330861|NCT01529866|immediate loading|immediate loading
330862|NCT01529814|edentulism|edentulism
410922|NCT01194128|grief|grief
330863|NCT01529814|dental implants|dental implants
330864|NCT01529814|clinical study|clinical study
330865|NCT01529814|Nanotite Certain Tapered implant|nanotite certain tapered implant
330866|NCT01529814|randomized|randomized
330867|NCT01529814|crestal bone level|crestal bone level
330868|NCT01529814|early loading|early loading
330869|NCT01529801|edentulism|edentulism
330870|NCT01529801|dental implants|dental implants
330871|NCT01529801|clinical study|clinical study
330872|NCT01529801|randomized|randomized
330873|NCT01529801|Osseotite Certain Tapered|osseotite certain tapered
330874|NCT01529801|Crestal bone level|crestal bone level
330875|NCT01529788|abobotulinum toxin lateral orbital lines|abobotulinum toxin lateral orbital lines
330876|NCT01529788|BotoxCosmetic|botoxcosmetic
330877|NCT01529788|Dysport|dysport
330878|NCT01529788|onabotulinum toxin|onabotulinum toxin
330879|NCT01529788|wrinkles|wrinkles
330880|NCT01529788|lateral orbital lines|lateral orbital lines
330881|NCT01529775|partial edentulism|partial edentulism
330882|NCT01529775|dental implants|dental implants
330883|NCT01529775|Osseotite Certain Prevail Tapered|osseotite certain prevail tapered
330884|NCT01529775|Osseotite Certain Tapered|osseotite certain tapered
330885|NCT01529775|Crestal bone level|crestal bone level
330886|NCT01529775|randomized|randomized
331088|NCT01529021|vaccination|vaccination
330887|NCT01529775|clinical study|clinical study
330888|NCT01529762|edentulism|edentulism
330889|NCT01529762|dental implants|dental implants
330890|NCT01529762|Osseotite Certain Tapered|osseotite certain tapered
330891|NCT01529762|randomized|randomized
330892|NCT01529762|clinical study|clinical study
330893|NCT01529762|partial edentulism|partial edentulism
330894|NCT01529762|immediate loading|immediate loading
330895|NCT01529762|crestal bone level|crestal bone level
330896|NCT01529736|edentulism|edentulism
330897|NCT01529736|dental implants|dental implants
330898|NCT01529736|early loading|early loading
330899|NCT01529736|crestal bone level|crestal bone level
330900|NCT01529736|high torque insertion|high torque insertion
330901|NCT01529736|low torque insertion|low torque insertion
330902|NCT01529736|randomized|randomized
330903|NCT01529736|Osseotite|osseotite
330904|NCT01529736|clinical study|clinical study
330905|NCT01529723|Stroke|stroke
330906|NCT01529723|Dysphagia screening|dysphagia screening
330907|NCT01529710|Schistosomiasis hematobium|schistosomiasis hematobium
330908|NCT01529710|Schistosomiasis mansoni|schistosomiasis mansoni
330909|NCT01529697|Asthma|asthma
330910|NCT01529697|Inhaler use|inhaler use
330911|NCT01529684|Cancer, solid tumors|cancer, solid tumors
330912|NCT01529684|oncology patients|oncology patients
330913|NCT01529684|OSI-906|osi-906
330914|NCT01529684|mass balance|mass balance
330915|NCT01529684|Absorption, Metabolism, and Excretion of OSI-906|absorption, metabolism, and excretion of osi-906
330916|NCT01529684|Metabolic profile of 906|metabolic profile of 906
330917|NCT01529684|Pharmacokinetics of 14C-OSI-906|pharmacokinetics of 14c-osi-906
330918|NCT01529658|Renal function|renal function
330919|NCT01529658|Renal hypothermia|renal hypothermia
330920|NCT01529658|Nephrology|nephrology
330921|NCT01529658|Nephrectomy|nephrectomy
330922|NCT01529658|Renal tumor|renal tumor
330923|NCT01529658|Urology|urology
330924|NCT01529658|Kidney|kidney
330925|NCT01529645|pertussis|pertussis
330926|NCT01529645|booster vaccine|booster vaccine
330927|NCT01529645|tetanus|tetanus
330928|NCT01529645|diphtheria in adults|diphtheria in adults
330929|NCT01529632|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
330930|NCT01529632|COPD|copd
330931|NCT01529632|QVA149|qva149
330932|NCT01529632|QAB149|qab149
330933|NCT01529632|NVA237|nva237
330934|NCT01529632|indacaterol|indacaterol
330935|NCT01529632|glycopyrronium bromide|glycopyrronium bromide
330936|NCT01529619|Rivastigmine|rivastigmine
330937|NCT01529619|Alzheimer's disease|alzheimer's disease
330938|NCT01529619|Transdermal patch|transdermal patch
330939|NCT01529606|dental restoration|dental restoration
330940|NCT01529606|dental caries|dental caries
330941|NCT01529606|tooth cavity|tooth cavity
330942|NCT01529593|Advanced Cancers|advanced cancers
330943|NCT01529593|Metastatic cancer|metastatic cancer
330944|NCT01529593|Tumor response|tumor response
330945|NCT01529593|Dose limiting toxicity|dose limiting toxicity
330946|NCT01529593|DLT|dlt
330947|NCT01529593|Maximum tolerated dose|maximum tolerated dose
330948|NCT01529593|MTD|mtd
330949|NCT01529593|Temsirolimus|temsirolimus
330950|NCT01529593|CCI-779|cci-779
330951|NCT01529593|Torisel|torisel
330952|NCT01529593|Metformin|metformin
330953|NCT01529580|Autism Spectrum Disorder|autism spectrum disorder
330954|NCT01529580|language|language
330955|NCT01529580|intervention|intervention
330956|NCT01529580|school-age|school-age
330957|NCT01529554|Acute Coronary Syndromes|acute coronary syndromes
330958|NCT01529554|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
330959|NCT01529554|Infarct size|infarct size
330960|NCT01529554|inflammation|inflammation
330961|NCT01529554|everolimus|everolimus
411073|NCT01194232|CF|cf
321674|NCT01569269|cancer|cancer
330962|NCT01529541|CWP-0403|cwp-0403
330963|NCT01529541|Sitagliptin|sitagliptin
330964|NCT01529541|Metformin|metformin
330965|NCT01529541|type 2 DM|type 2 dm
330966|NCT01529528|CWP-0403|cwp-0403
330967|NCT01529528|type 2 DM|type 2 dm
330968|NCT01529528|Efficacy|efficacy
330969|NCT01529528|Safety|safety
330970|NCT01529528|Phase 3|phase 3
330971|NCT01529515|Schizophrenia|schizophrenia
330972|NCT01529515|R092670|r092670
330973|NCT01529515|Paliperidone Palmitate|paliperidone palmitate
330974|NCT01529515|Paliperidone palmitate 3 month formulation (PP3M)|paliperidone palmitate 3 month formulation (pp3m)
330975|NCT01529502|Blood Transfusion, Autologous|blood transfusion, autologous
330976|NCT01529502|Blood Preservation/adverse effects|blood preservation/adverse effects
330977|NCT01529502|Blood Transfusion/adverse effects|blood transfusion/adverse effects
330978|NCT01529502|Endothelium, Vascular/physiopathology|endothelium, vascular/physiopathology
330979|NCT01529502|Hemoglobins|hemoglobins
330980|NCT01529502|Nitric Oxide|nitric oxide
330981|NCT01529502|Pulmonary Hypertension|pulmonary hypertension
330982|NCT01529489|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
330983|NCT01529489|Physical training|physical training
330984|NCT01529489|Oxygen uptake kinetic|oxygen uptake kinetic
330985|NCT01529489|Heart rate kinetic|heart rate kinetic
330986|NCT01529476|Ofloxacin|ofloxacin
330987|NCT01529476|Levofloxacin|levofloxacin
330988|NCT01529476|Ofloxacin hydrochloride|ofloxacin hydrochloride
330989|NCT01529463|Congestive Heart Failure|congestive heart failure
330990|NCT01529450|basal cell carcinoma, sonidegib, smoothened inhibitor, hedgehog|basal cell carcinoma, sonidegib, smoothened inhibitor, hedgehog
330991|NCT01529437|allergy|allergy
330992|NCT01529437|immunology|immunology
330993|NCT01529437|immune tolerance|immune tolerance
330994|NCT01529437|immunotherapy|immunotherapy
330995|NCT01529424|Hypertriglyceridemia|hypertriglyceridemia
330996|NCT01529411|urothelium|urothelium
330997|NCT01529411|transitional|transitional
330998|NCT01529411|carcinoma|carcinoma
330999|NCT01529411|cancer|cancer
331000|NCT01529411|metastatic|metastatic
331001|NCT01529411|tract|tract
331002|NCT01529398|knee osteoarthritis|knee osteoarthritis
331003|NCT01529398|exercise therapy|exercise therapy
331004|NCT01529398|resistance training|resistance training
331005|NCT01529398|proprioception|proprioception
331006|NCT01529385|swollen leg|swollen leg
331007|NCT01529385|diabetes|diabetes
331008|NCT01529385|compression stockings|compression stockings
331009|NCT01529385|edema|edema
331010|NCT01529372|Hypertension|hypertension
331011|NCT01529372|Blood pressure|blood pressure
331012|NCT01529372|Renal denervation|renal denervation
331013|NCT01529359|Irritable Bowel Syndrome|irritable bowel syndrome
331014|NCT01529359|Probiotics|probiotics
331015|NCT01529346|Postoperative dental pain|postoperative dental pain
331016|NCT01529307|Biologic,|biologic,
331017|NCT01529307|solid tumors,|solid tumors,
331018|NCT01529307|Death Receptor 5 agonist,|death receptor 5 agonist,
331019|NCT01529307|caspase-8|caspase-8
331020|NCT01529294|Hepatic impairment|hepatic impairment
331021|NCT01529294|Iloperidone|iloperidone
331022|NCT01529294|ILO522D|ilo522d
331023|NCT01529294|Pharmacokinetics|pharmacokinetics
331024|NCT01529268|Nonalcoholic Fatty Liver Disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
331025|NCT01529268|Cysteamine bitartrate delayed release|cysteamine bitartrate delayed release
331026|NCT01529268|Children|children
331027|NCT01529255|Chronic Hepatitis B|chronic hepatitis b
331028|NCT01529255|Compensated Chronic hepatitis B|compensated chronic hepatitis b
331029|NCT01529216|DIAMOND System|diamond system
331030|NCT01529216|T2DM|t2dm
331031|NCT01529216|Randomized study|randomized study
331032|NCT01529216|Electrical stimulation|electrical stimulation
331033|NCT01529216|Fundus|fundus
331034|NCT01529190|pregabalin|pregabalin
331035|NCT01529190|postoperative pain control|postoperative pain control
331036|NCT01529190|interleukin-6|interleukin-6
331037|NCT01529190|acute pain|acute pain
331038|NCT01529177|Metformin|metformin
331039|NCT01529177|Insulin resistance|insulin resistance
331040|NCT01529177|male infertility|male infertility
331041|NCT01529177|unexplained Oligozspermia|unexplained oligozspermia
331042|NCT01529177|Clomiphene citrate|clomiphene citrate
331043|NCT01529177|Unexplained azoospermia|unexplained azoospermia
331044|NCT01529164|endostatin|endostatin
331045|NCT01529164|chemotherapy|chemotherapy
331046|NCT01529164|antiangiogenesis agent|antiangiogenesis agent
331047|NCT01529164|colorectal cancer|colorectal cancer
331048|NCT01529151|Dizziness|dizziness
331049|NCT01529151|Vertigo|vertigo
331050|NCT01529151|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
331051|NCT01529151|Labyrinthitis|labyrinthitis
331052|NCT01529151|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
331053|NCT01529151|Vestibular Rehabilitation Therapy|vestibular rehabilitation therapy
331054|NCT01529138|Cancer|cancer
331055|NCT01529112|Locally Advanced|locally advanced
331056|NCT01529112|Metastatic Non-Squamous Non-Small Cell Lung Cancer|metastatic non-squamous non-small cell lung cancer
331057|NCT01529099|Osteoarthritis|osteoarthritis
331058|NCT01529099|Knee|knee
331059|NCT01529099|Knee replacement|knee replacement
331060|NCT01529099|Knee implant|knee implant
331061|NCT01529099|Knee arthroplasty|knee arthroplasty
331062|NCT01529099|Unicompartmental|unicompartmental
331063|NCT01529099|Primary|primary
331064|NCT01529099|Partial|partial
331065|NCT01529099|Patellofemoral|patellofemoral
331066|NCT01529099|Medial|medial
331067|NCT01529099|Lateral|lateral
331068|NCT01529099|Bicompartmental|bicompartmental
331069|NCT01529099|Cemented|cemented
331070|NCT01529099|Post-traumatic arthritis of the tibio-femoral and/or patellofemoral articular surfaces|post-traumatic arthritis of the tibio-femoral and/or patellofemoral articular surfaces
331071|NCT01529099|History of Gout or pseudo-gout.|history of gout or pseudo-gout.
331072|NCT01529086|prostate cancer|prostate cancer
331073|NCT01529086|dutasteride|dutasteride
331074|NCT01529086|for cause prostate biopsy|for cause prostate biopsy
331075|NCT01529073|HIV|hiv
331076|NCT01529073|genotype 4 HCV|genotype 4 hcv
331077|NCT01529073|pegylated interferon|pegylated interferon
331078|NCT01529073|ribavirin|ribavirin
331079|NCT01529073|nitazoxanide|nitazoxanide
331080|NCT01529060|phenylbutyrate|phenylbutyrate
331081|NCT01529060|MSUD|msud
331082|NCT01529060|Buphenyl-TM|buphenyl-tm
331083|NCT01529034|Epilepsy|epilepsy
331084|NCT01529034|seizure clusters|seizure clusters
331085|NCT01529034|acute repetitive seizures|acute repetitive seizures
331086|NCT01529034|rescue treatment|rescue treatment
331087|NCT01529021|Pain management|pain management
331089|NCT01529021|immunization|immunization
331090|NCT01529021|pediatric|pediatric
331091|NCT01529021|robotics|robotics
331092|NCT01529021|human-robot interaction|human-robot interaction
331093|NCT01529008|Osteonecrosis|osteonecrosis
331094|NCT01529008|Femoral Head|femoral head
331095|NCT01529008|Hip|hip
331096|NCT01529008|Orthopedics|orthopedics
331097|NCT01529008|Bone|bone
331098|NCT01529008|Musculoskeletal Disorders|musculoskeletal disorders
331099|NCT01528995|fecal incontinence|fecal incontinence
331100|NCT01528995|anal incontinence|anal incontinence
331101|NCT01528995|obstetric sphincter injuries|obstetric sphincter injuries
331102|NCT01528995|OASIS|oasis
331103|NCT01528995|double incontinence|double incontinence
331104|NCT01528995|urinary incontinence|urinary incontinence
331105|NCT01528995|sexual function|sexual function
331106|NCT01528995|sacral nerve modulation|sacral nerve modulation
331107|NCT01528995|sacral nerve stimulation|sacral nerve stimulation
331108|NCT01528995|Interstim|interstim
331109|NCT01528995|anal bulking injections|anal bulking injections
331110|NCT01528995|Permacol|permacol
331111|NCT01528969|oral microbiota|oral microbiota
331112|NCT01528969|mutans streptococci|mutans streptococci
331113|NCT01528969|xylitol|xylitol
331114|NCT01528956|adrenocortical carcinoma|adrenocortical carcinoma
331115|NCT01528943|To evaluate the effect of prostacycline on endothelial integrity during major abdominal surgery|to evaluate the effect of prostacycline on endothelial integrity during major abdominal surgery
331116|NCT01528930|Lung Diseases|lung diseases
331117|NCT01528930|Anti-Infective Agents|anti-infective agents
331118|NCT01528930|Therapeutic Uses|therapeutic uses
331119|NCT01528930|Amikacin|amikacin
331120|NCT01528917|Lysosomal Storage Disease|lysosomal storage disease
331121|NCT01528917|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
331122|NCT01528917|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
331123|NCT01528917|Acid lipase disease|acid lipase disease
331124|NCT01528917|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
331125|NCT01528917|LAL Deficiency|lal deficiency
331126|NCT01528917|LIPA Deficiency|lipa deficiency
331127|NCT01528917|Wolman disease|wolman disease
331128|NCT01528904|pregnancy|pregnancy
331129|NCT01528904|autoimmune thyroid disease|autoimmune thyroid disease
331130|NCT01528904|fetal thyroid hormones|fetal thyroid hormones
331131|NCT01528904|antithyroid antibodies|antithyroid antibodies
331132|NCT01528904|ultrasound parameters|ultrasound parameters
331133|NCT01528891|tonsillectomy|tonsillectomy
331134|NCT01528891|emergence agitation|emergence agitation
331135|NCT01528878|Liver Cancer|liver cancer
331136|NCT01528878|Hepatocellular Carcinoma|hepatocellular carcinoma
331137|NCT01528878|HCC|hcc
331138|NCT01528878|Metastatic Cancer to Liver|metastatic cancer to liver
331139|NCT01528878|Metastatic Colon Cancer|metastatic colon cancer
331140|NCT01528878|Metastatic Colo-rectal Cancer|metastatic colo-rectal cancer
331141|NCT01528878|mCRC|mcrc
331142|NCT01528878|Liver Function|liver function
331143|NCT01528878|Child-Pugh|child-pugh
331144|NCT01528865|virus|virus
331145|NCT01528865|K(HML2)[HERV-K(HML2)]|k(hml2)[herv-k(hml2)]
331146|NCT01528865|Lymphoma|lymphoma
331147|NCT01528865|Human endogenous retrovirus-K(HLM2)[HERV-K(HML2)]|human endogenous retrovirus-k(hlm2)[herv-k(hml2)]
331148|NCT01528852|neonatal Mortality|neonatal mortality
331149|NCT01528852|chlorhexidine cord care|chlorhexidine cord care
331150|NCT01528852|cord infections|cord infections
321880|NCT01568502|CAD|cad
331151|NCT01528852|african settings|african settings
331152|NCT01528852|clinical trials|clinical trials
331153|NCT01528839|Bipolar disorder|bipolar disorder
331154|NCT01528839|Bipolar depression|bipolar depression
331155|NCT01528839|Thyroid abnormality|thyroid abnormality
331156|NCT01528839|mood stabilizer|mood stabilizer
331157|NCT01528839|antidepressants|antidepressants
331158|NCT01528839|currently depressed|currently depressed
331159|NCT01528826|metastatic triple-negative breast cancer|metastatic triple-negative breast cancer
331160|NCT01528826|vinorebine|vinorebine
331161|NCT01528826|oxaliplatin|oxaliplatin
331162|NCT01528813|Erbium-doped yttrium aluminium garnet laser|erbium-doped yttrium aluminium garnet laser
331164|NCT01528813|Amorolfine lacquer|amorolfine lacquer
331165|NCT01528813|Dermatophytes|dermatophytes
331166|NCT01528813|Subungual distal lateral onychomycosis|subungual distal lateral onychomycosis
331167|NCT01528813|Drug delivery|drug delivery
331168|NCT01528800|Vitamin K|vitamin k
331169|NCT01528800|Chronic kidney disease|chronic kidney disease
331170|NCT01528800|vascular calcification|vascular calcification
331171|NCT01528800|hemodialysis|hemodialysis
331172|NCT01528800|coronary artery calcification|coronary artery calcification
331173|NCT01528787|Intraocular pressure|intraocular pressure
331174|NCT01528787|visual field|visual field
331175|NCT01528787|Ocular hypertension or open angle glaucoma|ocular hypertension or open angle glaucoma
331176|NCT01528774|Melanoma|melanoma
331177|NCT01528774|Circulating Tumor Cells|circulating tumor cells
331178|NCT01528774|Prostate cancer|prostate cancer
331179|NCT01528774|Sarcoma|sarcoma
331180|NCT01528774|Renal Cancer|renal cancer
331181|NCT01528774|Pancreatic neuroendocrine cancer|pancreatic neuroendocrine cancer
331381|NCT01527773|COPD|copd
331182|NCT01528774|Other solid tumor|other solid tumor
331183|NCT01528761|physical activity|physical activity
331184|NCT01528761|older adults|older adults
331185|NCT01528761|physical function|physical function
331186|NCT01528761|health-related quality of life|health-related quality of life
331187|NCT01528761|prosocial behavior|prosocial behavior
331188|NCT01528761|social cognitive theory|social cognitive theory
331189|NCT01528722|Emergency laparoscopic cholecystectomy|emergency laparoscopic cholecystectomy
331190|NCT01528722|Pain scores|pain scores
331191|NCT01528722|Intraperitoneal local anaesthesia|intraperitoneal local anaesthesia
331192|NCT01528722|Cholecystitis|cholecystitis
331193|NCT01528709|Statin,|statin,
331194|NCT01528709|CABG,|cabg,
331195|NCT01528709|saphenous vein graft,|saphenous vein graft,
331196|NCT01528709|graft occlusion,|graft occlusion,
331197|NCT01528709|lipids|lipids
331198|NCT01528696|Obesity|obesity
331199|NCT01528696|Cesarean Section|cesarean section
331200|NCT01528696|Wound care|wound care
331201|NCT01528657|Sick Sinus Syndrome|sick sinus syndrome
331202|NCT01528657|Ventricular pacing|ventricular pacing
331203|NCT01528657|Minimal ventricular pacing|minimal ventricular pacing
331204|NCT01528657|Ventricular pacing suppression|ventricular pacing suppression
331205|NCT01528657|Intrinsic rhythm support|intrinsic rhythm support
331206|NCT01528657|Long term AV|long term av
331207|NCT01528644|iron|iron
331208|NCT01528644|fortification|fortification
331209|NCT01528644|alginate|alginate
331210|NCT01528644|iron deficiency|iron deficiency
331211|NCT01528618|Advanced Nasopharyngeal Carcinoma|advanced nasopharyngeal carcinoma
331212|NCT01528618|treatment|treatment
331213|NCT01528605|lutein|lutein
331214|NCT01528605|zeaxanthin|zeaxanthin
331215|NCT01528605|age-related macular degeneration|age-related macular degeneration
331216|NCT01528605|supplementation|supplementation
331217|NCT01528605|macular pigment optical density|macular pigment optical density
331218|NCT01528605|visual function|visual function
331219|NCT01528605|serum concentration|serum concentration
331220|NCT01528579|Whiplash|whiplash
331221|NCT01528579|Rehabilitation|rehabilitation
331222|NCT01528579|Physiotherapy|physiotherapy
331223|NCT01528579|Exercises|exercises
331224|NCT01528566|osteoarthritis, knee|osteoarthritis, knee
331225|NCT01528566|Cognitive impairment|cognitive impairment
331226|NCT01528566|Tai Chi|tai chi
331227|NCT01528553|genu valgus|genu valgus
331228|NCT01528553|lower limb|lower limb
331229|NCT01528553|paediatric|paediatric
331230|NCT01528553|epiphysiodesis|epiphysiodesis
331231|NCT01528540|chronic pancreatitis|chronic pancreatitis
331232|NCT01528540|pregabalin|pregabalin
331233|NCT01528540|antioxidant|antioxidant
331234|NCT01528514|Myocardial infarction|myocardial infarction
331235|NCT01528514|Coronary artery bypass grafting|coronary artery bypass grafting
331236|NCT01528514|Anti-oxidant|anti-oxidant
331237|NCT01528514|Curcuminoids|curcuminoids
331238|NCT01528475|Therapeutic Hypothermia|therapeutic hypothermia
331239|NCT01528475|Cardiac arrest|cardiac arrest
331240|NCT01528462|Stroke|stroke
331241|NCT01528462|Ischemic Attack, Transient|ischemic attack, transient
331242|NCT01528462|Sleep Disorders|sleep disorders
331243|NCT01528462|Sleep Apnea Syndromes|sleep apnea syndromes
331244|NCT01528462|Restless Legs Syndrome|restless legs syndrome
331245|NCT01528462|Chronobiology Disorders|chronobiology disorders
331246|NCT01528449|babesia|babesia
331247|NCT01528449|blood donation|blood donation
331248|NCT01528449|transfusion transmitted babesiosis|transfusion transmitted babesiosis
331249|NCT01528436|Cerebral Palsy|cerebral palsy
331250|NCT01528436|Umbilical Cord Blood|umbilical cord blood
331251|NCT01528436|Rehabilitation|rehabilitation
331252|NCT01528423|XtremeCT|xtremect
331253|NCT01528423|Density|density
331254|NCT01528423|pQCT|pqct
331255|NCT01528423|Turnover|turnover
331256|NCT01528423|Bone|bone
331257|NCT01528423|short-term reproducibility|short-term reproducibility
331258|NCT01528397|defect|defect
331259|NCT01528397|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
331260|NCT01528397|proper digital nerve|proper digital nerve
331261|NCT01528397|second dorsal metacarpal artery|second dorsal metacarpal artery
331262|NCT01528397|pedicled nerve graft.|pedicled nerve graft.
331263|NCT01528384|Arginine|arginine
331264|NCT01528384|Arginine deiminase|arginine deiminase
331265|NCT01528384|Argininosuccinate synthetase|argininosuccinate synthetase
331266|NCT01528384|Phase 1|phase 1
331267|NCT01528384|Pediatric|pediatric
331268|NCT01528384|Failed other treatments|failed other treatments
331269|NCT01528384|Pediatric patients|pediatric patients
331270|NCT01528371|Intravenous sedation|intravenous sedation
331271|NCT01528371|Midazolam|midazolam
331272|NCT01528371|Dental treatment|dental treatment
331273|NCT01528371|White-coat hypertension|white-coat hypertension
331274|NCT01528371|STAI|stai
331275|NCT01528371|Dental patients|dental patients
331276|NCT01528371|Transient hypertension|transient hypertension
331277|NCT01528358|sepsis|sepsis
331278|NCT01528358|tissue oximetry|tissue oximetry
331279|NCT01528358|NIRS|nirs
331280|NCT01528358|VOT|vot
331281|NCT01528345|Breast Cancer|breast cancer
331282|NCT01528345|HER2-, HR+|her2-, hr+
331283|NCT01528345|post-menopausal|post-menopausal
331284|NCT01528345|Locally advanced or metastatic Breast Cancer (HER2-, HR+)|locally advanced or metastatic breast cancer (her2-, hr+)
331285|NCT01528332|Musculoskeletal pain|musculoskeletal pain
331286|NCT01528332|Back pain|back pain
331287|NCT01528332|Chronic pain|chronic pain
331288|NCT01528319|Arthroscopic Bankart repair|arthroscopic bankart repair
331289|NCT01528319|Suture anchor|suture anchor
331290|NCT01528319|Shoulder dislocation|shoulder dislocation
331291|NCT01528306|HP802-247|hp802-247
331292|NCT01528306|EB (epidermolysis bullosa)|eb (epidermolysis bullosa)
331293|NCT01528280|Shift work|shift work
331294|NCT01528280|Hepatitis A vaccination|hepatitis a vaccination
331295|NCT01528280|humoral response|humoral response
331296|NCT01528280|cellular response|cellular response
331297|NCT01528267|Emphysema, lung volume reduction, autologous blood|emphysema, lung volume reduction, autologous blood
331298|NCT01528254|Type 2 Diabetes Mellitus,|type 2 diabetes mellitus,
331299|NCT01528254|Vildagliptin,|vildagliptin,
331300|NCT01528254|Elderly Patients|elderly patients
331301|NCT01528241|ABP688|abp688
331302|NCT01528241|Tracer|tracer
331303|NCT01528241|Depression|depression
331304|NCT01528202|Sleep, circadian cycle, melatonin|sleep, circadian cycle, melatonin
331305|NCT01528189|Insulin, surgery, infection|insulin, surgery, infection
331306|NCT01528176|FGF-23, CKD, Cyp24, 24,25(OH)2D, vitamin D metabolism|fgf-23, ckd, cyp24, 24,25(oh)2d, vitamin d metabolism
331307|NCT01528163|Head and neck|head and neck
331308|NCT01528163|Squamous cell carcinoma|squamous cell carcinoma
331309|NCT01528163|Randomized|randomized
331310|NCT01528163|palliative treatment|palliative treatment
331311|NCT01528098|polyethylene glycol|polyethylene glycol
331312|NCT01528098|bisacodyl|bisacodyl
331313|NCT01528085|Philadelphia chromsome|philadelphia chromsome
331314|NCT01528085|BCR-ABL|bcr-abl
331315|NCT01528085|ALL|all
331316|NCT01528085|acute lymphoblastic leukemia|acute lymphoblastic leukemia
331317|NCT01528085|Nilotinib|nilotinib
331318|NCT01528085|Tasigna|tasigna
331319|NCT01528072|Dynesys Dynamic Stabilization System|dynesys dynamic stabilization system
331320|NCT01528072|Spondylolithesis|spondylolithesis
331321|NCT01528072|pseudoarthrosis|pseudoarthrosis
331322|NCT01528072|neurologic impairment|neurologic impairment
331323|NCT01528072|failed fusion|failed fusion
331324|NCT01528059|Diabetes|diabetes
331325|NCT01528059|Gastric cancer|gastric cancer
331326|NCT01528059|Gastric bypass|gastric bypass
331327|NCT01528046|central nervous system (CNS)|central nervous system (cns)
331328|NCT01528046|malignancy|malignancy
331329|NCT01528046|relapsed|relapsed
331330|NCT01528046|refractory|refractory
331331|NCT01528046|pediatric|pediatric
331332|NCT01528046|recurrent|recurrent
331333|NCT01528033|surgical wound|surgical wound
331334|NCT01528033|wound healing disorder|wound healing disorder
331335|NCT01528033|Wound healing impairment|wound healing impairment
331336|NCT01528033|post surgical wound healing disorder|post surgical wound healing disorder
331337|NCT01528033|abdominal wound healing impairment|abdominal wound healing impairment
331338|NCT01528033|Vacuum Assisted Closure|vacuum assisted closure
331339|NCT01528033|negative pressure wound therapy|negative pressure wound therapy
331340|NCT01528007|Pathological gambling|pathological gambling
411538|NCT01192256|smoking|smoking
331341|NCT01528007|Treatment intervention|treatment intervention
331342|NCT01527994|Aprepitant|aprepitant
331343|NCT01527994|Intravenous heroin dependence|intravenous heroin dependence
331344|NCT01527981|Depression|depression
331345|NCT01527981|Diabetes|diabetes
331346|NCT01527981|Adherence|adherence
331347|NCT01527981|Medication|medication
331348|NCT01527981|Glucose|glucose
331349|NCT01527981|Insulin|insulin
331350|NCT01527955|Kelee|kelee
331351|NCT01527955|Meditation|meditation
331352|NCT01527955|Stress|stress
331353|NCT01527955|Anxiety|anxiety
331354|NCT01527955|Depression|depression
331355|NCT01527955|Brain|brain
331356|NCT01527955|Mind|mind
331357|NCT01527942|Pain Management|pain management
331358|NCT01527903|propofol|propofol
331359|NCT01527903|midazolam|midazolam
331360|NCT01527903|sedation|sedation
331361|NCT01527903|ICU|icu
331362|NCT01527890|intravenous patient-controlled analgesia|intravenous patient-controlled analgesia
331363|NCT01527890|IV PCA|iv pca
331364|NCT01527877|BKM120|bkm120
331365|NCT01527877|head and neck cancer|head and neck cancer
331366|NCT01527877|squamous cell carcinoma|squamous cell carcinoma
331367|NCT01527864|NSCLC|nsclc
331368|NCT01527851|Post-bariatric surgery|post-bariatric surgery
331369|NCT01527851|Excess skin|excess skin
331370|NCT01527851|Physical fitness|physical fitness
331371|NCT01527851|Physical activity|physical activity
331372|NCT01527851|Barriers to physical activity|barriers to physical activity
331373|NCT01527851|Plastic surgery|plastic surgery
331374|NCT01527851|Quality of life|quality of life
331375|NCT01527851|Self-esteem|self-esteem
331376|NCT01527838|Hematologic malignancies|hematologic malignancies
331377|NCT01527799|Sickle cell anemia|sickle cell anemia
331378|NCT01527799|Exercise testing|exercise testing
331379|NCT01527799|Cardiopulmonary disease|cardiopulmonary disease
331380|NCT01527786|Major Depressive Disorder, Postpartum Onset|major depressive disorder, postpartum onset
331382|NCT01527773|Cardiovascular disease|cardiovascular disease
331383|NCT01527773|Phenotypes|phenotypes
331384|NCT01527760|Essential Hypertension|essential hypertension
331385|NCT01527760|Viscum album mother tincture|viscum album mother tincture
331386|NCT01527760|one group pretest post-test study|one group pretest post-test study
331387|NCT01527747|Type 2 Diabetes|type 2 diabetes
331388|NCT01527747|Hypertriglyceridemia|hypertriglyceridemia
331389|NCT01527747|dipeptidyl peptidase-4 (DPP-4)|dipeptidyl peptidase-4 (dpp-4)
331390|NCT01527747|glucagon-like peptide-1 (glp-1)|glucagon-like peptide-1 (glp-1)
331391|NCT01527734|Comparison study|comparison study
331392|NCT01527721|keratoconus|keratoconus
331393|NCT01527721|CxL|cxl
331394|NCT01527721|CxL combined with t-PRK|cxl combined with t-prk
331395|NCT01527695|Phase IIa|phase iia
331396|NCT01527695|AZD3241|azd3241
331397|NCT01527695|microglia activation|microglia activation
331398|NCT01527695|safety|safety
331399|NCT01527695|Pharmacodynamics and pharmacokinetics analyses|pharmacodynamics and pharmacokinetics analyses
331400|NCT01527695|Parkinson patients|parkinson patients
331401|NCT01527682|Intraocular pressure|intraocular pressure
331402|NCT01527682|Latanoprost|latanoprost
331403|NCT01527682|Dorzolamide|dorzolamide
331404|NCT01527669|Red yeast rice|red yeast rice
331405|NCT01527669|lovastatin|lovastatin
331406|NCT01527669|Pharmacokinetics|pharmacokinetics
331407|NCT01527578|Healthy children|healthy children
331408|NCT01527578|Healthy adults|healthy adults
331409|NCT01527578|individuals ages 7-60|individuals ages 7-60
331410|NCT01527526|DMPA|dmpa
331411|NCT01527526|insulin resistance|insulin resistance
331412|NCT01527526|cardiovascular disease|cardiovascular disease
331413|NCT01527526|BMI|bmi
331414|NCT01527526|weight gain|weight gain
331415|NCT01527526|thrombosis|thrombosis
331416|NCT01527513|Partial Epilepsy|partial epilepsy
331417|NCT01527513|eslicarbazepine acetate|eslicarbazepine acetate
331418|NCT01527513|Children|children
331419|NCT01527500|AMD|amd
331420|NCT01527500|Age-related Macular Degeneration|age-related macular degeneration
331421|NCT01527500|geographic atrophy|geographic atrophy
331422|NCT01527500|GA|ga
331423|NCT01527500|Dry AMD|dry amd
331424|NCT01527500|Blindness|blindness
331425|NCT01527500|Drusen|drusen
331426|NCT01527500|GA lesion|ga lesion
331427|NCT01527487|breast cancer|breast cancer
331428|NCT01527487|eribulin|eribulin
331429|NCT01527487|Halaven|halaven
331430|NCT01527487|taxotere|taxotere
331431|NCT01527474|postpartum|postpartum
331432|NCT01527474|postpartum depression|postpartum depression
331433|NCT01527474|PPD|ppd
331434|NCT01527474|escitalopram|escitalopram
331435|NCT01527461|lung neoplasms|lung neoplasms
331436|NCT01527461|dogs|dogs
331437|NCT01527461|sweat|sweat
331438|NCT01527461|smell|smell
331439|NCT01527448|postpartum|postpartum
331440|NCT01527448|postpartum depression|postpartum depression
331441|NCT01527448|PPD|ppd
331442|NCT01527448|quetiapine XR|quetiapine xr
331443|NCT01527448|quetiapine|quetiapine
331444|NCT01527448|seroquel|seroquel
331445|NCT01527448|bipolar|bipolar
411675|NCT01191853|HV|hv
331446|NCT01527448|bipolar disorder|bipolar disorder
331447|NCT01527448|bipolar disorder, type II|bipolar disorder, type ii
331448|NCT01527435|Best corrected visual acuity|best corrected visual acuity
331449|NCT01527435|Slit lamp examination|slit lamp examination
331450|NCT01527435|Ophthalmoscopy with contact lens/indirect ophthalmoscope|ophthalmoscopy with contact lens/indirect ophthalmoscope
331451|NCT01527435|OCT assessment|oct assessment
331452|NCT01527435|Fundus photos, fluorescein angiogram, ICG angiogram|fundus photos, fluorescein angiogram, icg angiogram
331453|NCT01527422|Aggressive Non-Hodgkin's Lymphoma|aggressive non-hodgkin's lymphoma
331454|NCT01527409|Exercise|exercise
331455|NCT01527409|Diet|diet
331456|NCT01527409|Posttraumatic growth|posttraumatic growth
331457|NCT01527396|endometrial cancer|endometrial cancer
331458|NCT01527396|lymph node metastasis|lymph node metastasis
331459|NCT01527396|lymphadenectomy|lymphadenectomy
331460|NCT01527396|risk criteria|risk criteria
331461|NCT01527383|Shingles|shingles
331462|NCT01527357|fibrin sealant|fibrin sealant
331463|NCT01527357|thrombin|thrombin
331464|NCT01527357|fibrinogen|fibrinogen
331465|NCT01527357|hemostasis|hemostasis
331466|NCT01527344|OCT|oct
331467|NCT01527344|IVUS|ivus
331468|NCT01527344|CAV|cav
331469|NCT01527318|NLSDM|nlsdm
331470|NCT01527318|Lipid accumulation|lipid accumulation
331471|NCT01527305|Schizophrenia|schizophrenia
331472|NCT01527305|Antipsychotics|antipsychotics
331473|NCT01527305|Paliperidone Palmitate|paliperidone palmitate
331474|NCT01527305|Paliperidone|paliperidone
331475|NCT01527305|Invega|invega
331476|NCT01527305|Sustenna|sustenna
331477|NCT01527305|Psychotic disorder|psychotic disorder
331478|NCT01527305|Psychosis|psychosis
331479|NCT01527292|Vertebral Metastasis|vertebral metastasis
331480|NCT01527292|pain control|pain control
331481|NCT01527292|VAP|vap
331482|NCT01527292|SRT+VAP|srt+vap
331483|NCT01527279|atrial fibrillation|atrial fibrillation
331484|NCT01527279|paroxysmal|paroxysmal
331485|NCT01527279|cardioversion|cardioversion
331486|NCT01527279|antazoline|antazoline
331487|NCT01527266|carbohydrate|carbohydrate
331488|NCT01527266|performance|performance
331489|NCT01527266|cycling|cycling
331490|NCT01527253|Cardiometabolic risk|cardiometabolic risk
331491|NCT01527253|Metabolic syndrome|metabolic syndrome
331492|NCT01527253|Prebiotics|prebiotics
331493|NCT01527253|Legumes|legumes
331494|NCT01527253|Wholegrain cereal|wholegrain cereal
331495|NCT01527253|Functional diet|functional diet
331496|NCT01527253|Low glycemic index diet|low glycemic index diet
331497|NCT01527240|Volume of cerebral infarction|volume of cerebral infarction
331498|NCT01527240|Stroke|stroke
331499|NCT01527240|CsA|csa
331500|NCT01527240|NIHSS|nihss
331501|NCT01527227|Children of mentally ill|children of mentally ill
331502|NCT01527214|Lung cancer|lung cancer
331503|NCT01527214|early detection|early detection
331504|NCT01527214|CT scan|ct scan
331505|NCT01527214|General Practice|general practice
331506|NCT01527214|Effect of Computed Tomography scans|effect of computed tomography scans
331507|NCT01527214|Clinical medical education|clinical medical education
331508|NCT01527201|Arthroscopy|arthroscopy
331509|NCT01527201|Debridement|debridement
331510|NCT01527188|HDM|hdm
331511|NCT01527188|allergic rhinitis|allergic rhinitis
331512|NCT01527162|Cerebral palsy|cerebral palsy
331513|NCT01527162|orthotics|orthotics
331514|NCT01527162|solid ankle foot orthoses|solid ankle foot orthoses
331515|NCT01527123|GSK2585823, benzoic acid, hippuric acid, acne vulgaris, pharmacokinetics|gsk2585823, benzoic acid, hippuric acid, acne vulgaris, pharmacokinetics
331516|NCT01527110|zanamivir|zanamivir
331517|NCT01527110|Seasonal Influenza|seasonal influenza
331518|NCT01527110|H1N1|h1n1
331519|NCT01527110|intravenous|intravenous
331520|NCT01527110|neuraminidase inhibitor|neuraminidase inhibitor
331521|NCT01527110|Pandemic|pandemic
331522|NCT01527110|Relenza|relenza
331523|NCT01527110|Influenza B virus|influenza b virus
331524|NCT01527110|Influenza A virus|influenza a virus
331525|NCT01527097|Cardiovascular Diseases|cardiovascular diseases
331526|NCT01527097|Pharmacologic Actions|pharmacologic actions
331527|NCT01527097|Endothelial Function|endothelial function
331528|NCT01527097|Dermatology|dermatology
331529|NCT01527097|Inflammatory Disease|inflammatory disease
331530|NCT01527097|Skin Disease|skin disease
331531|NCT01527058|lung cancer|lung cancer
331532|NCT01527058|integrin receptor|integrin receptor
331533|NCT01527058|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
331534|NCT01527058|PET/CT|pet/ct
331535|NCT01527058|efficacy and safety|efficacy and safety
331536|NCT01527032|amyloidosis|amyloidosis
331537|NCT01527032|stem cell transplant|stem cell transplant
331538|NCT01527019|Acute Cystitis|acute cystitis
331539|NCT01526967|ostomy|ostomy
331540|NCT01526967|peristomal skin breakdown|peristomal skin breakdown
331541|NCT01526967|ConvaTec Moldable Skin Barriers|convatec moldable skin barriers
331542|NCT01526928|cancer|cancer
331543|NCT01526928|metastatic|metastatic
331544|NCT01526928|locally advanced|locally advanced
331545|NCT01526928|lung|lung
331546|NCT01526928|non-small cell lung cancer|non-small cell lung cancer
331547|NCT01526928|NSCLC|nsclc
331548|NCT01526928|epidermal growth factor receptor|epidermal growth factor receptor
331549|NCT01526928|EGFR|egfr
331550|NCT01526928|T790M|t790m
331551|NCT01526928|CO-1686|co-1686
331552|NCT01526928|unresectable|unresectable
331553|NCT01526928|recurrent|recurrent
331554|NCT01526928|EGFR-directed therapy|egfr-directed therapy
331555|NCT01526928|irreversible EGFR inhibitor|irreversible egfr inhibitor
331556|NCT01526928|TIGER|tiger
331557|NCT01526928|Rociletinib|rociletinib
331558|NCT01526915|PRF|prf
331559|NCT01526915|PLATELET RICH FIBRIN|platelet rich fibrin
331560|NCT01526915|BISPHOSPHONATES|bisphosphonates
331561|NCT01526902|contact lenses|contact lenses
331562|NCT01526889|Non-infectious uveitis|non-infectious uveitis
331563|NCT01526889|Panuveitis|panuveitis
331564|NCT01526889|Vitreous haze|vitreous haze
331565|NCT01526889|Visual acuity|visual acuity
331566|NCT01526876|Intracranial Pressure|intracranial pressure
331567|NCT01526876|Cerebral Perfusion Pressure|cerebral perfusion pressure
331568|NCT01526876|Clevidipine Butyrate|clevidipine butyrate
331569|NCT01526863|Allergy|allergy
331571|NCT01526850|cGVHD|cgvhd
331572|NCT01526837|Brain tumor|brain tumor
331573|NCT01526837|GBM|gbm
331574|NCT01526837|Brain cancer|brain cancer
331575|NCT01526811|Endurant|endurant
331576|NCT01526811|Stent Graft|stent graft
331577|NCT01526811|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
331578|NCT01526798|End-Stage Renal Disease (ESRD)|end-stage renal disease (esrd)
331579|NCT01526798|chronic Inflammation|chronic inflammation
331580|NCT01526798|EPO Resistance|epo resistance
331581|NCT01526798|ESA Resistance|esa resistance
331582|NCT01526798|high cut-off dialysis|high cut-off dialysis
331583|NCT01526798|hemodialysis|hemodialysis
331584|NCT01526772|Transnasal|transnasal
331585|NCT01526772|Transoral|transoral
331586|NCT01526772|Roux en Y gastric bypass|roux en y gastric bypass
331587|NCT01526772|Upper Endoscopy|upper endoscopy
331589|NCT01526759|dietary fiber|dietary fiber
331590|NCT01526759|energy intake|energy intake
331591|NCT01526759|satiety|satiety
331592|NCT01526759|physicochemical properties|physicochemical properties
331593|NCT01526759|men and women|men and women
331594|NCT01526759|Healthy adults|healthy adults
331595|NCT01526746|End stage renal disease|end stage renal disease
331596|NCT01526746|ESRD|esrd
331597|NCT01526746|kidney disease|kidney disease
331598|NCT01526746|renal impairment|renal impairment
331599|NCT01526746|renal|renal
331600|NCT01526733|Type 1 Diabetes|type 1 diabetes
331601|NCT01526733|Continuous Subcutaneous Insulin Infusion (CSII)|continuous subcutaneous insulin infusion (csii)
331602|NCT01526720|Type 2 diabetes mellitus|type 2 diabetes mellitus
331603|NCT01526720|Beta cell function|beta cell function
331604|NCT01526720|Insulin sensitivity|insulin sensitivity
331605|NCT01526720|Genetics of diabetes|genetics of diabetes
331606|NCT01526707|To identify changes in FKBP51 expression with inhaled steroid treatment in asthma|to identify changes in fkbp51 expression with inhaled steroid treatment in asthma
331607|NCT01526694|relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
331608|NCT01526681|Sensory Nerve|sensory nerve
331609|NCT01526681|Mixed Nerve|mixed nerve
331610|NCT01526681|Motor Nerve|motor nerve
331611|NCT01526668|Benign gynecological disease|benign gynecological disease
331612|NCT01526668|Surgery|surgery
331613|NCT01526668|Postoperative follow-up strategy|postoperative follow-up strategy
331614|NCT01526668|Pain threshold|pain threshold
331615|NCT01526668|Chronic pelvic pain|chronic pelvic pain
331616|NCT01526668|[E04.950.300.399]|[e04.950.300.399]
331617|NCT01526668|[C13.351.500]|[c13.351.500]
331618|NCT01526668|[F02.463.593.710.560]|[f02.463.593.710.560]
331619|NCT01526668|[N02.421.585.722.700]|[n02.421.585.722.700]
331620|NCT01526668|Postoperative Care|postoperative care
331621|NCT01526655|Endometrial cancer|endometrial cancer
331622|NCT01526655|Robot assisted laparoscopy|robot assisted laparoscopy
331623|NCT01526655|Abdominal hysterectomy|abdominal hysterectomy
331624|NCT01526655|Fast track program|fast track program
331625|NCT01526629|ICD|icd
331626|NCT01526629|Remote follow-up|remote follow-up
331627|NCT01526616|PCOS|pcos
331628|NCT01526616|metformin|metformin
331629|NCT01526616|spironolactone|spironolactone
331630|NCT01526616|metabolic syndrome|metabolic syndrome
331631|NCT01526616|hyperandrogenism|hyperandrogenism
331632|NCT01526603|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
331633|NCT01526603|autologous stem cell transplant|autologous stem cell transplant
331634|NCT01526577|phase1|phase1
331635|NCT01526577|healthy subjects|healthy subjects
331636|NCT01526577|antiplatelet agent|antiplatelet agent
331637|NCT01526564|Chemotherapy-induced peripheral neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
331638|NCT01526551|Human Papillomavirus|human papillomavirus
331639|NCT01526525|tramadol|tramadol
331640|NCT01526525|ketamine|ketamine
331641|NCT01526525|parecoxib|parecoxib
331642|NCT01526525|paracetamol|paracetamol
331643|NCT01526525|numerical rating scale (NRS)|numerical rating scale (nrs)
331644|NCT01526525|McGill (SF-MPQ)|mcgill (sf-mpq)
331645|NCT01526525|electronic pressure algometer|electronic pressure algometer
331646|NCT01526525|Spielberger State Trait Anxiety Inventory STAI Y-6 item|spielberger state trait anxiety inventory stai y-6 item
331647|NCT01526512|Metronomic cyclophosphamide|metronomic cyclophosphamide
331648|NCT01526512|Metronomic capecitabine|metronomic capecitabine
331649|NCT01526512|HER2-negative breast cancer|her2-negative breast cancer
331650|NCT01526499|Metronomic cyclophosphamide|metronomic cyclophosphamide
331651|NCT01526499|metastatic breast cancer|metastatic breast cancer
331652|NCT01526499|first line|first line
331653|NCT01526499|docetaxel|docetaxel
331654|NCT01526486|melanoma|melanoma
331656|NCT01526486|inguinal|inguinal
331657|NCT01526486|lymph nodes|lymph nodes
331658|NCT01526486|groin|groin
331659|NCT01526486|lymphadenectomy|lymphadenectomy
331660|NCT01526486|groin dissection|groin dissection
331661|NCT01526486|skin cancer|skin cancer
331662|NCT01526486|penile cancer|penile cancer
331663|NCT01526486|urethral cancer|urethral cancer
331664|NCT01526486|scrotal cancer|scrotal cancer
331665|NCT01526486|Paget's disease|paget's disease
331666|NCT01526473|Alphavirus|alphavirus
331667|NCT01526473|Vaccine|vaccine
331668|NCT01526473|Immunotherapy|immunotherapy
331669|NCT01526473|HER2|her2
331670|NCT01526460|Platelet|platelet
331671|NCT01526460|Atorvastatin|atorvastatin
331672|NCT01526460|Rosuvastatin|rosuvastatin
331673|NCT01526460|Multiplate|multiplate
331674|NCT01526460|reactivity|reactivity
331675|NCT01526447|Neck Pain|neck pain
331676|NCT01526447|Craniosacral Manipulation|craniosacral manipulation
331677|NCT01526447|Complementary Therapies|complementary therapies
331678|NCT01526447|Randomized Controlled Trial|randomized controlled trial
331679|NCT01526447|Sensory Thresholds|sensory thresholds
331680|NCT01526447|Quality of Life|quality of life
331681|NCT01526434|Cimzia|cimzia
331682|NCT01526434|Non-interventional|non-interventional
331683|NCT01526434|Multicenter|multicenter
331684|NCT01526434|Postmarketing|postmarketing
331685|NCT01526434|Local|local
331687|NCT01526421|Antiretroviral therapy, highly active|antiretroviral therapy, highly active
331688|NCT01526408|Meniere's Disease|meniere's disease
331689|NCT01526408|Vertigo|vertigo
331994|NCT01524861|MIBG|mibg
331690|NCT01526408|Hearing loss|hearing loss
331691|NCT01526408|Tinnitus|tinnitus
331692|NCT01526408|Anti-viral|anti-viral
331693|NCT01526408|Famciclovir|famciclovir
331694|NCT01526395|electroconvulsive therapy|electroconvulsive therapy
331695|NCT01526395|ECT|ect
331696|NCT01526395|unmodified|unmodified
331697|NCT01526395|anesthesia|anesthesia
331698|NCT01526395|propofol|propofol
331699|NCT01526382|septic shock|septic shock
331700|NCT01526382|acute respiratory distress syndrome|acute respiratory distress syndrome
331701|NCT01526382|transpulmonary thermodilution technique|transpulmonary thermodilution technique
331702|NCT01526382|mortality|mortality
331703|NCT01526369|HER2-positive metastatic breast cancer.|her2-positive metastatic breast cancer.
331704|NCT01526356|Angiofibroma|angiofibroma
331705|NCT01526356|Tuberous Sclerosis|tuberous sclerosis
331706|NCT01526356|Rapamycin|rapamycin
331707|NCT01526356|Sirolimus|sirolimus
331708|NCT01526356|mTOR|mtor
331709|NCT01526343|Patients|patients
331710|NCT01526330|Degenerative disc disease|degenerative disc disease
331711|NCT01526330|YH14618|yh14618
331712|NCT01526330|Penial 2000|penial 2000
331713|NCT01526330|Penial 2K|penial 2k
331714|NCT01526317|Drug interaction|drug interaction
331715|NCT01526317|Rosuvastatin|rosuvastatin
331716|NCT01526317|Metformin SR|metformin sr
331717|NCT01526317|Pharmacokinetic|pharmacokinetic
331718|NCT01526291|Myopia|myopia
331719|NCT01526291|Hyperopia|hyperopia
331720|NCT01526291|Astigmatism|astigmatism
331721|NCT01526291|Patient-reported outcomes|patient-reported outcomes
331722|NCT01526291|Patient satisfaction|patient satisfaction
331723|NCT01526291|Refractive Error|refractive error
331724|NCT01526291|Emmetropia|emmetropia
331725|NCT01526291|Dry eyes|dry eyes
331726|NCT01526291|glare|glare
331727|NCT01526291|halos|halos
331728|NCT01526291|patient expectations|patient expectations
331729|NCT01526278|alendronate|alendronate
331730|NCT01526278|Maxmarvil®|maxmarvil®
331731|NCT01526265|Smoking Cessation|smoking cessation
331732|NCT01526265|Work-site|work-site
331733|NCT01526265|Incentives|incentives
331734|NCT01526265|Health Behavior|health behavior
331735|NCT01526265|Smoking|smoking
331736|NCT01526252|speckle tracking echocardiography|speckle tracking echocardiography
331737|NCT01526252|database|database
331738|NCT01526239|Colorectal cancer screening|colorectal cancer screening
331739|NCT01526239|colon cancer screening|colon cancer screening
331740|NCT01526239|colonoscopy|colonoscopy
331741|NCT01526226|High flow nasal cannula|high flow nasal cannula
331742|NCT01526226|Discomfort|discomfort
331743|NCT01526200|CLM|clm
331744|NCT01526187|Public Health and Epidemiology|public health and epidemiology
331745|NCT01526187|Bacteriology|bacteriology
331746|NCT01526187|Infectious and Tropical|infectious and tropical
331747|NCT01526174|autoimmune|autoimmune
331748|NCT01526174|hearing loss|hearing loss
331749|NCT01526174|bilateral hearing loss|bilateral hearing loss
331750|NCT01526174|steroid-dependent|steroid-dependent
331751|NCT01526161|Asthma|asthma
331752|NCT01526161|Children|children
331753|NCT01526161|Therapy|therapy
331754|NCT01526161|Fluticasone|fluticasone
331755|NCT01526161|Salmeterol|salmeterol
331756|NCT01526161|Montelukast|montelukast
331757|NCT01526135|National multicentric phase III superiority trial|national multicentric phase iii superiority trial
331758|NCT01526122|Clopidogrel|clopidogrel
331759|NCT01526122|Aspirin|aspirin
331760|NCT01526122|coadministration|coadministration
331761|NCT01526109|elderly|elderly
331763|NCT01526109|functional capacity|functional capacity
331764|NCT01526109|cognitive function|cognitive function
331765|NCT01526109|physical exercise|physical exercise
331766|NCT01526083|Male Healthy Volunteers|male healthy volunteers
331767|NCT01526057|rheumatoid arthritis|rheumatoid arthritis
331768|NCT01526057|rituximab|rituximab
331769|NCT01526057|methotrexate|methotrexate
331770|NCT01526057|anti-TNF|anti-tnf
331771|NCT01526044|hyperglycemia|hyperglycemia
331772|NCT01526044|hypoglycemia|hypoglycemia
331773|NCT01526044|insulin|insulin
331774|NCT01526044|critical illness|critical illness
331775|NCT01526044|intensive insulin therapy|intensive insulin therapy
331776|NCT01526044|continuous glucose monitoring|continuous glucose monitoring
331777|NCT01526044|CGM|cgm
331778|NCT01526044|interstitial fluid glucose|interstitial fluid glucose
331779|NCT01526044|intensive care unit|intensive care unit
331780|NCT01526044|Blood glucose|blood glucose
331781|NCT01526031|frozen shoulder|frozen shoulder
331782|NCT01526031|bee venom acupuncture|bee venom acupuncture
331783|NCT01526018|Intake|intake
331784|NCT01526018|Formula feeding|formula feeding
331785|NCT01525992|Community Pharmacy Services|community pharmacy services
331786|NCT01525992|Pharmacists|pharmacists
331787|NCT01525992|Diabetes Mellitus|diabetes mellitus
331788|NCT01525992|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
331789|NCT01525992|Self Care|self care
331790|NCT01525992|Randomized Controlled Trial|randomized controlled trial
331791|NCT01525979|Stroke rehabilitation|stroke rehabilitation
331792|NCT01525979|Unilateral arm training|unilateral arm training
331793|NCT01525979|Bilateral arm training|bilateral arm training
331794|NCT01525979|Robot-assisted arm training|robot-assisted arm training
331795|NCT01525979|Kinematic analysis|kinematic analysis
331796|NCT01525979|Functional magnetic resonance image|functional magnetic resonance image
331797|NCT01525979|Motor recovery|motor recovery
331798|NCT01525979|Quality of life|quality of life
331799|NCT01525953|esophageal cancer|esophageal cancer
331800|NCT01525953|radiochemotherapy|radiochemotherapy
331801|NCT01525953|prognosis|prognosis
331802|NCT01525940|colon capsule endoscopy|colon capsule endoscopy
331803|NCT01525940|CT-colonography|ct-colonography
331804|NCT01525940|Patients|patients
331805|NCT01525940|incomplete colonoscopy|incomplete colonoscopy
331806|NCT01525927|Oropharyngeal Neoplasms|oropharyngeal neoplasms
331807|NCT01525927|Neoplasms, Oropharyngeal|neoplasms, oropharyngeal
331808|NCT01525927|Oropharynx Neoplasms|oropharynx neoplasms
331809|NCT01525914|prostate cancer|prostate cancer
331810|NCT01525914|PSA kinetics|psa kinetics
331811|NCT01525914|PSA doubling time|psa doubling time
331812|NCT01525914|active surveillance|active surveillance
331813|NCT01525901|SHANK3|shank3
331814|NCT01525901|IGF-1|igf-1
331815|NCT01525901|Autism|autism
331816|NCT01525888|Contrast induced nephropathy|contrast induced nephropathy
331817|NCT01525875|pseudoxanthoma elasticum|pseudoxanthoma elasticum
331818|NCT01525875|calcification|calcification
331819|NCT01525836|Purpura|purpura
331820|NCT01525836|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
331821|NCT01525797|Liver Transplant|liver transplant
331822|NCT01525784|rtCGMS|rtcgms
331823|NCT01525784|glycemic control|glycemic control
331824|NCT01525784|type 1 diabetes mellitus|type 1 diabetes mellitus
331825|NCT01525784|youth|youth
331826|NCT01525771|Advanced Gastric cancer|advanced gastric cancer
331827|NCT01525771|Xeloda (Capecitabine)|xeloda (capecitabine)
331828|NCT01525771|Cisplatin|cisplatin
331829|NCT01525771|Taxotere (Docetaxel)|taxotere (docetaxel)
331830|NCT01525732|Achalasia, Hypertensive LES|achalasia, hypertensive les
331831|NCT01525719|cholangiocarcinoma|cholangiocarcinoma
331832|NCT01525719|RAD001|rad001
331833|NCT01525719|everolimus|everolimus
331834|NCT01525706|Endoscopic Ultrasound|endoscopic ultrasound
331835|NCT01525706|Pancreatic Mucinous Cystic Neoplasm|pancreatic mucinous cystic neoplasm
331836|NCT01525706|Fine Needle Injection|fine needle injection
331837|NCT01525706|Ethanol Ablation|ethanol ablation
331838|NCT01525706|Paclitaxel Ablation|paclitaxel ablation
331839|NCT01525693|diabetes|diabetes
331840|NCT01525693|diabetics|diabetics
331841|NCT01525693|high glucose|high glucose
331842|NCT01525693|Chinese patients|chinese patients
331843|NCT01525680|PTSD|ptsd
331844|NCT01525667|THA|tha
331845|NCT01525667|Muscle injury|muscle injury
331846|NCT01525654|Rheumatoid Arthritis|rheumatoid arthritis
331847|NCT01525654|peer support|peer support
331848|NCT01525654|self-efficacy|self-efficacy
331849|NCT01525654|medication adherence|medication adherence
331850|NCT01525602|advanced, incurable solid tumors|advanced, incurable solid tumors
331851|NCT01525589|Breast cancer|breast cancer
331852|NCT01525589|PM01183|pm01183
331853|NCT01525589|lurbinectedin|lurbinectedin
331854|NCT01525589|Pharma Mar|pharma mar
331855|NCT01525576|booster program|booster program
331856|NCT01525576|internet|internet
331857|NCT01525576|cbt|cbt
331858|NCT01525576|Study the specific effects of adding a booster program|study the specific effects of adding a booster program
331859|NCT01525563|Duphaston Study|duphaston study
331860|NCT01525550|neuroendocrine tumors|neuroendocrine tumors
331861|NCT01525550|adenoma islet cells|adenoma islet cells
331862|NCT01525550|carcinoma islet cells|carcinoma islet cells
331863|NCT01525550|pancreatic neoplasms|pancreatic neoplasms
331864|NCT01525550|angiogenesis inhibitors|angiogenesis inhibitors
331866|NCT01525550|neoplasms|neoplasms
331867|NCT01525550|carcinoma|carcinoma
331868|NCT01525550|adenoma|adenoma
331869|NCT01525537|Anesthesia General|anesthesia general
331870|NCT01525537|Anesthetics Inhalation|anesthetics inhalation
331871|NCT01525537|Diagnostic techniques and procedures|diagnostic techniques and procedures
331872|NCT01525524|tDCS|tdcs
331873|NCT01525524|Major Depression|major depression
331874|NCT01525524|Stroke|stroke
331875|NCT01525498|Pelvic Organ Prolapse|pelvic organ prolapse
331876|NCT01525498|Catheterization|catheterization
713258|NCT01012466|labor|labor
331877|NCT01525498|Urinary tract infection|urinary tract infection
331878|NCT01525498|Urinary retention|urinary retention
331879|NCT01525472|obesity|obesity
331880|NCT01525472|adipose tissue|adipose tissue
331881|NCT01525472|angiogenesis|angiogenesis
331882|NCT01525472|senecence|senecence
331883|NCT01525459|Glioma|glioma
331884|NCT01525459|PBMC subpopulations|pbmc subpopulations
331885|NCT01525459|Gene expression|gene expression
331886|NCT01525459|Metabolomics|metabolomics
331887|NCT01525459|Immunological status|immunological status
331888|NCT01525459|miRNA|mirna
331889|NCT01525459|Proteomics|proteomics
331890|NCT01525446|NSCLC|nsclc
331891|NCT01525446|Lung Cancer|lung cancer
331892|NCT01525394|lymphomas|lymphomas
331893|NCT01525394|Refractory solid tumors|refractory solid tumors
331894|NCT01525368|mild cognitive impairment|mild cognitive impairment
331895|NCT01525368|Alzheimer's disease|alzheimer's disease
331896|NCT01525368|cognitive intervention|cognitive intervention
331897|NCT01525368|cognitive reserve|cognitive reserve
331898|NCT01525355|EUS|eus
331899|NCT01525355|ERCP|ercp
331900|NCT01525355|Intraoperative cholangiogram|intraoperative cholangiogram
331901|NCT01525355|Cholecystectomy|cholecystectomy
331902|NCT01525355|Common Bile Duct Stones|common bile duct stones
331903|NCT01525355|Strictures|strictures
331904|NCT01525355|Stenosis|stenosis
331905|NCT01525355|Duodenum|duodenum
331906|NCT01525355|Dilated Bile duct|dilated bile duct
331907|NCT01525355|Non-filling of the duodenum by contrast|non-filling of the duodenum by contrast
331908|NCT01525329|Actinic Keratosis|actinic keratosis
331909|NCT01525329|Photodynamic Therapy|photodynamic therapy
331910|NCT01525316|Late Onset Neonatal Sepsis|late onset neonatal sepsis
331911|NCT01525316|Neonates|neonates
331912|NCT01525316|Lactoferrin|lactoferrin
331913|NCT01525316|Infections|infections
331914|NCT01525316|Prevention|prevention
331915|NCT01525316|Neurodevelopment|neurodevelopment
331916|NCT01525303|headaches|headaches
331917|NCT01525303|behavioral treatment|behavioral treatment
331918|NCT01525303|physical activity|physical activity
331919|NCT01525290|wake-up stroke|wake-up stroke
331920|NCT01525290|thrombolysis|thrombolysis
331921|NCT01525290|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
331922|NCT01525290|diffusion weighted imaging (DWI)|diffusion weighted imaging (dwi)
331923|NCT01525290|fluid attenuated inversion recovery (FLAIR)|fluid attenuated inversion recovery (flair)
331924|NCT01525264|Mammography|mammography
331925|NCT01525251|primary caregiver|primary caregiver
331926|NCT01525251|neuroblastoma|neuroblastoma
331927|NCT01525251|support group|support group
331928|NCT01525251|posttraumatic stress|posttraumatic stress
331929|NCT01525251|uncertainty|uncertainty
331930|NCT01525199|Non-Small Cell Lung Cancer,|non-small cell lung cancer,
331931|NCT01525199|Epidermal Growth Factor Receptor mutation,|epidermal growth factor receptor mutation,
331932|NCT01525199|Lung cancer,|lung cancer,
331933|NCT01525199|Lung adenocarcinoma|lung adenocarcinoma
331934|NCT01525186|Weight|weight
331935|NCT01525186|Food intakes|food intakes
331936|NCT01525186|Feeding|feeding
331937|NCT01525160|Clot structure|clot structure
331938|NCT01525160|Haemostasis|haemostasis
331939|NCT01525160|Gel point|gel point
331940|NCT01525160|Fractal dimension|fractal dimension
331941|NCT01525160|serum amyloid A|serum amyloid a
331942|NCT01525160|C-reactive protein|c-reactive protein
331943|NCT01525160|vascular cell adhesion molecule-1|vascular cell adhesion molecule-1
331944|NCT01525160|intercellular adhesion molecule-1|intercellular adhesion molecule-1
331945|NCT01525134|Tests, Diagnostic|tests, diagnostic
331946|NCT01525134|Mycobacterium tuberculosis|mycobacterium tuberculosis
331947|NCT01525134|Mycobacterium tuberculosis antigens|mycobacterium tuberculosis antigens
331948|NCT01525134|TB|tb
331949|NCT01525134|Tuberculosis|tuberculosis
331950|NCT01525134|Tuberculosis, Pulmonary|tuberculosis, pulmonary
331951|NCT01525134|Tuberculosis, Miliary|tuberculosis, miliary
331952|NCT01525134|Lipoarabinomannan|lipoarabinomannan
331953|NCT01525121|mechanical ventilation|mechanical ventilation
331954|NCT01525121|chest physiotherapy|chest physiotherapy
331955|NCT01525121|critical care|critical care
331956|NCT01525121|pneumonia|pneumonia
751924|NCT01171248|complications|complications
331957|NCT01525121|Mechanically ventilated patients with pulmonary infection.|mechanically ventilated patients with pulmonary infection.
331958|NCT01525108|Medication adherence|medication adherence
331959|NCT01525108|Blood pressure|blood pressure
331960|NCT01525108|Home-based blood pressure measurement|home-based blood pressure measurement
331961|NCT01525108|Blood Pressure Determination|blood pressure determination
331962|NCT01525108|Blood Pressure Monitors|blood pressure monitors
331963|NCT01525108|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
331964|NCT01525095|Candida|candida
331965|NCT01525095|Diagnostic Assay|diagnostic assay
331966|NCT01525095|Blood culture|blood culture
331967|NCT01525095|Sepsis|sepsis
331968|NCT01525095|T2 Magnetic Relaxation|t2 magnetic relaxation
331969|NCT01525056|rectal cancer|rectal cancer
331970|NCT01525056|imaging|imaging
331971|NCT01525056|PET|pet
331972|NCT01525056|MRI|mri
331973|NCT01525043|Epicondylitis|epicondylitis
331974|NCT01525004|Solid organ transplant|solid organ transplant
331975|NCT01525004|Flu vaccine|flu vaccine
331976|NCT01524965|Locking Plate|locking plate
331977|NCT01524965|Physiotherapy|physiotherapy
331978|NCT01524926|Phase 2|phase 2
331979|NCT01524926|Crizotinib|crizotinib
331980|NCT01524926|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
331981|NCT01524926|Inflammatory myofibroblastic tumor|inflammatory myofibroblastic tumor
331982|NCT01524926|Papillary renal cell carcinoma type 1|papillary renal cell carcinoma type 1
331983|NCT01524926|Alveolar soft part sarcoma|alveolar soft part sarcoma
331984|NCT01524926|Clear cell sarcoma|clear cell sarcoma
331985|NCT01524926|Alveolar rhabdomyosarcoma|alveolar rhabdomyosarcoma
331986|NCT01524874|vitamin d|vitamin d
331987|NCT01524874|cholecalciferol|cholecalciferol
332093|NCT01524510|AHI|ahi
331993|NCT01524861|Sympathetic heart innervation|sympathetic heart innervation
331995|NCT01524861|Alpha-lipoic acid|alpha-lipoic acid
331996|NCT01524861|L-acetyl carnitine|l-acetyl carnitine
331997|NCT01524848|Clinical trial|clinical trial
331998|NCT01524848|Investigational drugs|investigational drugs
331999|NCT01524848|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
332000|NCT01524848|Pazopanib|pazopanib
332001|NCT01524835|Tissue Donors|tissue donors
332002|NCT01524835|Lung|lung
332003|NCT01524835|Transplants|transplants
332004|NCT01524835|Transplantation|transplantation
332010|NCT01524796|Real-life|real-life
332011|NCT01524796|non-interventional|non-interventional
332012|NCT01524796|observational|observational
332013|NCT01524796|peripheral neuropathic pain|peripheral neuropathic pain
332014|NCT01524796|Lyrica|lyrica
332015|NCT01524796|pregabalin|pregabalin
332016|NCT01524783|Neuroendocrine tumor|neuroendocrine tumor
332017|NCT01524783|NET|net
332018|NCT01524783|progressive|progressive
332019|NCT01524783|advanced|advanced
332020|NCT01524783|gastrointestinal|gastrointestinal
332021|NCT01524783|GI or lung origin|gi or lung origin
332022|NCT01524783|nonfunctional|nonfunctional
332023|NCT01524783|everolimus|everolimus
332024|NCT01524783|Advanced NET of GI origin|advanced net of gi origin
332025|NCT01524783|Advanced NET of lung origin|advanced net of lung origin
332026|NCT01524744|oral lichen planus treatment pimecrolimus|oral lichen planus treatment pimecrolimus
332027|NCT01524718|radiation|radiation
332028|NCT01524718|time surgery|time surgery
332029|NCT01524705|Pilot Study|pilot study
332030|NCT01524705|Prospective Randomized Trial|prospective randomized trial
332031|NCT01524705|Comparative Effectiveness|comparative effectiveness
332032|NCT01524705|Glycemic Variability|glycemic variability
332033|NCT01524705|insulin glargine|insulin glargine
332034|NCT01524705|exenatide|exenatide
332035|NCT01524705|basal insulin|basal insulin
332036|NCT01524705|bolus insulin|bolus insulin
332037|NCT01524679|chronic hepatitis B|chronic hepatitis b
332038|NCT01524653|VTE|vte
332039|NCT01524653|DVT|dvt
332040|NCT01524653|Chemo|chemo
332041|NCT01524653|Metastatic|metastatic
332042|NCT01524653|Advanced|advanced
332043|NCT01524653|Systemic therapy|systemic therapy
332044|NCT01524653|statin|statin
332045|NCT01524653|biomarkers|biomarkers
332046|NCT01524640|oral cholera vaccine|oral cholera vaccine
332047|NCT01524640|safety and immunogenicity|safety and immunogenicity
332048|NCT01524640|bridging study|bridging study
332049|NCT01524640|ethiopia|ethiopia
332050|NCT01524627|Smokers|smokers
332051|NCT01524627|fMRI|fmri
332052|NCT01524627|varenicline|varenicline
332053|NCT01524614|continuous positive airway pressure|continuous positive airway pressure
412414|NCT01188681|CLL|cll
332054|NCT01524614|nasal mask|nasal mask
332055|NCT01524614|upper airway obstruction|upper airway obstruction
332056|NCT01524601|Immunosuppression|immunosuppression
332057|NCT01524601|Everolimus|everolimus
332058|NCT01524601|rosuvastatin|rosuvastatin
332059|NCT01524601|fluvastatin|fluvastatin
332060|NCT01524601|Lipid lowering|lipid lowering
332061|NCT01524588|Genotype|genotype
332062|NCT01524588|Phenotype|phenotype
332063|NCT01524588|Genotypic Variation Between Patients|genotypic variation between patients
332064|NCT01524588|Genotypic Phenotypic Relationships|genotypic phenotypic relationships
332065|NCT01524575|pancreatic cancer|pancreatic cancer
332067|NCT01524575|oxaliplatin|oxaliplatin
332068|NCT01524575|gemcitabine|gemcitabine
332069|NCT01524562|Fibrosis|fibrosis
332070|NCT01524562|Cirrhosis|cirrhosis
332071|NCT01524562|Africa|africa
332072|NCT01524562|Schistosomiasis|schistosomiasis
332073|NCT01524562|Aflatoxin|aflatoxin
332074|NCT01524562|Liver Disease|liver disease
332075|NCT01524549|Cardiovascular|cardiovascular
332076|NCT01524549|P450s|p450s
332077|NCT01524549|Flow-Mediated Dilatation|flow-mediated dilatation
332078|NCT01524549|Brachial Artery Ultrasound|brachial artery ultrasound
332079|NCT01524549|Endothelial Cell Function|endothelial cell function
332080|NCT01524549|Healthy Volunteer|healthy volunteer
332081|NCT01524549|HV|hv
332082|NCT01524536|Hypereosinophilia|hypereosinophilia
332083|NCT01524536|Hypereosinophilic Syndrome|hypereosinophilic syndrome
332084|NCT01524536|Corticosteroids|corticosteroids
332085|NCT01524536|Therapy|therapy
332086|NCT01524536|HES|hes
332087|NCT01524523|Gene Expression|gene expression
332088|NCT01524523|Acute Pain|acute pain
332089|NCT01524523|Nitric Oxide|nitric oxide
332090|NCT01524523|Pain|pain
332091|NCT01524523|Bone Marrow|bone marrow
332092|NCT01524510|OSAS|osas
332094|NCT01524510|MRA|mra
332095|NCT01524510|CFD|cfd
332096|NCT01524497|losing interest and feelings of guilt|losing interest and feelings of guilt
332097|NCT01524497|poor concentration|poor concentration
332098|NCT01524497|loss of appetite|loss of appetite
332099|NCT01524497|suicide|suicide
332100|NCT01524484|Data quality|data quality
332101|NCT01524484|Anesthesia|anesthesia
332102|NCT01524484|Quality assurance|quality assurance
332103|NCT01524471|Hypertensive LES|hypertensive les
332104|NCT01524445|Bortezomib|bortezomib
332105|NCT01524445|Velcade|velcade
332106|NCT01524445|multiple myeloma|multiple myeloma
332107|NCT01524445|retrospective study, response rate, medical resource utilization|retrospective study, response rate, medical resource utilization
332108|NCT01524432|Clotrimazole|clotrimazole
332109|NCT01524432|Microcapsules|microcapsules
332110|NCT01524419|spontaneous labor|spontaneous labor
332111|NCT01524419|term|term
332112|NCT01524419|surgical|surgical
332113|NCT01524419|mechanical|mechanical
332114|NCT01524419|fetal or maternal complications|fetal or maternal complications
332115|NCT01524406|Muscle Atrophy|muscle atrophy
332116|NCT01524393|Assisted Reproductive Techniques|assisted reproductive techniques
332117|NCT01524393|Pregnancy|pregnancy
332118|NCT01524393|Pulmonary Embolism|pulmonary embolism
332119|NCT01524393|Venous Thromboembolism|venous thromboembolism
332120|NCT01524380|Schizophrenia|schizophrenia
332121|NCT01524380|clinical trial|clinical trial
332122|NCT01524380|risperidone|risperidone
332123|NCT01524380|ginkgo biloba extract|ginkgo biloba extract
332124|NCT01524380|antioxidant|antioxidant
332125|NCT01524354|depth of anesthesia|depth of anesthesia
332126|NCT01524354|valve surgery|valve surgery
332127|NCT01524341|Acute malaria|acute malaria
332128|NCT01524341|KAE609|kae609
332129|NCT01524328|Complementary and alternative medicine|complementary and alternative medicine
332130|NCT01524328|HRQoL, Inflammatory bowel disease|hrqol, inflammatory bowel disease
332131|NCT01524315|Thiamine|thiamine
332132|NCT01524315|Vitamin B1|vitamin b1
332133|NCT01524315|Thiamine Deficiency|thiamine deficiency
332134|NCT01524315|Thiamine supplementation|thiamine supplementation
332135|NCT01524315|Cardiac surgery|cardiac surgery
332136|NCT01524315|Lactic Acid|lactic acid
332137|NCT01524302|pneumonia|pneumonia
332138|NCT01524302|ceftaroline|ceftaroline
332139|NCT01524302|community-aquired|community-aquired
332140|NCT01524250|Multiple Sclerosis|multiple sclerosis
332141|NCT01524250|relapse|relapse
332142|NCT01524250|demyelination|demyelination
332143|NCT01524250|treatment|treatment
332144|NCT01524250|corticosteroids|corticosteroids
332145|NCT01524224|Metastases|metastases
332146|NCT01524224|Neoplasm|neoplasm
332147|NCT01524224|Advanced Cancer|advanced cancer
332148|NCT01524224|Metastatic Cancer|metastatic cancer
332149|NCT01524211|Aortic Aneurysms|aortic aneurysms
332150|NCT01524185|childhood trauma|childhood trauma
332151|NCT01524185|intergenerational trauma|intergenerational trauma
332152|NCT01524185|child neglect|child neglect
332153|NCT01524185|child maltreatment|child maltreatment
332154|NCT01524185|mental health|mental health
332155|NCT01524172|child trauma exposure|child trauma exposure
332156|NCT01524172|mental health|mental health
332157|NCT01524172|yoga|yoga
332158|NCT01524172|mood regulation|mood regulation
332159|NCT01524172|child maltreatment|child maltreatment
332160|NCT01524159|cardiovascular disease|cardiovascular disease
332161|NCT01524146|Unresectable Cholangiocarcinoma|unresectable cholangiocarcinoma
332162|NCT01524146|Biliary obstruction|biliary obstruction
332163|NCT01524146|Stent obstruction|stent obstruction
332164|NCT01524146|Biliary stricture|biliary stricture
332165|NCT01524146|Photodynamic therapy|photodynamic therapy
332166|NCT01524146|PDT|pdt
332167|NCT01524146|Ablation|ablation
332168|NCT01524133|combat-related PTSD|combat-related ptsd
332169|NCT01524133|Posttraumatic stress disorder|posttraumatic stress disorder
332170|NCT01524133|prolonged exposure therapy|prolonged exposure therapy
332171|NCT01524133|sertraline|sertraline
332172|NCT01524133|military|military
332173|NCT01524133|veterans|veterans
332174|NCT01524133|VA hospital|va hospital
332175|NCT01524133|mental illness|mental illness
332176|NCT01524120|Mucosal healing|mucosal healing
332177|NCT01524107|Prophylaxis Antibiotics|prophylaxis antibiotics
332178|NCT01524107|Maternal Complications|maternal complications
332179|NCT01524107|Neonatal Complications|neonatal complications
332180|NCT01524107|Cord Prolapse|cord prolapse
332181|NCT01524107|Elective Caesarian Section|elective caesarian section
332182|NCT01524107|Maternal Morbidity|maternal morbidity
332183|NCT01524107|Neonatal Morbidity|neonatal morbidity
332184|NCT01524094|colorectal cancer|colorectal cancer
713259|NCT01012466|labor pain|labor pain
332185|NCT01524094|cytoreductive surgery|cytoreductive surgery
332186|NCT01524094|intraperitoneal chemotherapy|intraperitoneal chemotherapy
332187|NCT01524094|systemic chemotherapy|systemic chemotherapy
332188|NCT01524094|Peritoneal Metastatic Disease From the Colon or Rectum|peritoneal metastatic disease from the colon or rectum
332189|NCT01524081|antibiotic prophylaxis|antibiotic prophylaxis
332190|NCT01524081|emergent surgery|emergent surgery
332191|NCT01524081|surgical site infection|surgical site infection
332289|NCT01523639|steatosis|steatosis
332192|NCT01524068|Acute Idiopathic Pulmonary Fibrosis Exacerbations|acute idiopathic pulmonary fibrosis exacerbations
332193|NCT01524068|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
332195|NCT01524042|Satisfaction|satisfaction
332196|NCT01524042|colonoscopy|colonoscopy
332197|NCT01524042|double pants|double pants
332198|NCT01524042|single pants|single pants
332199|NCT01524029|Digital Breast Tomosynthesis|digital breast tomosynthesis
332200|NCT01524029|Digital Mammography|digital mammography
332201|NCT01524029|Breast cancer detection|breast cancer detection
332513|NCT01522612|QLQ-C30|qlq-c30
332202|NCT01524016|Oncogenic osteomalacia|oncogenic osteomalacia
332203|NCT01524016|mesenchymal tumor|mesenchymal tumor
332204|NCT01524016|Somatostatin receptor|somatostatin receptor
332205|NCT01524016|68Ga-DOTATATE|68ga-dotatate
332206|NCT01524016|PET/CT|pet/ct
332207|NCT01524003|community based participatory research|community based participatory research
332208|NCT01523977|ALL|all
332209|NCT01523977|pediatric|pediatric
332210|NCT01523977|relapse|relapse
332211|NCT01523964|DMD|dmd
332212|NCT01523964|EIM|eim
332213|NCT01523964|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
332214|NCT01523964|electrical impedance myography|electrical impedance myography
332215|NCT01523951|topical local anaesthesia|topical local anaesthesia
332216|NCT01523951|cooling|cooling
332217|NCT01523951|capsaicin 8%|capsaicin 8%
332218|NCT01523951|epidermal nerve fiber density|epidermal nerve fiber density
332219|NCT01523951|treatment pain|treatment pain
332220|NCT01523925|Functional electrical therapy|functional electrical therapy
332221|NCT01523925|Bilateral arm training|bilateral arm training
332222|NCT01523925|Constraint induced therapy|constraint induced therapy
332223|NCT01523925|Stroke rehabilitation|stroke rehabilitation
332224|NCT01523925|Clinical evaluation|clinical evaluation
332225|NCT01523925|Kinematic analysis|kinematic analysis
332226|NCT01523912|radiofrequency ablation|radiofrequency ablation
332227|NCT01523912|gastric dysplasia|gastric dysplasia
332228|NCT01523912|gastric neoplasia|gastric neoplasia
332229|NCT01523899|SSTI|ssti
332230|NCT01523899|cutaneous abscess|cutaneous abscess
332231|NCT01523899|boil|boil
332232|NCT01523847|Hodgkin Lymphoma|hodgkin lymphoma
332233|NCT01523847|Cardiopathic|cardiopathic
332234|NCT01523847|elderly|elderly
332235|NCT01523847|Myocet|myocet
332236|NCT01523834|Diffuse Large B-cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
332237|NCT01523834|Panobinostat|panobinostat
332238|NCT01523834|Patients with relapsed/refractory DLBCL.|patients with relapsed/refractory dlbcl.
332239|NCT01523808|pancreatic cancer|pancreatic cancer
332240|NCT01523808|asparaginase|asparaginase
332241|NCT01523795|Energy intake|energy intake
332242|NCT01523795|Video games|video games
332243|NCT01523795|Television|television
332244|NCT01523795|Physical activity|physical activity
332245|NCT01523795|Obesity|obesity
332246|NCT01523782|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
332247|NCT01523782|Elderly patient|elderly patient
332248|NCT01523782|Asparaginase|asparaginase
332249|NCT01523769|prematurity|prematurity
332250|NCT01523769|umbilical cord milking|umbilical cord milking
332251|NCT01523769|delayed cord clamping|delayed cord clamping
332252|NCT01523769|neonatal transfusion|neonatal transfusion
332253|NCT01523730|Schizophrenia|schizophrenia
332254|NCT01523730|Nicotine|nicotine
332255|NCT01523730|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
332256|NCT01523730|Cognition|cognition
332257|NCT01523730|EEG|eeg
332258|NCT01523717|procalcitonin|procalcitonin
332259|NCT01523717|decrease over 72 hours|decrease over 72 hours
332260|NCT01523717|severe sepsis|severe sepsis
332261|NCT01523717|septic shock|septic shock
332262|NCT01523691|Healthy individuals|healthy individuals
332263|NCT01523678|Ovarian Cancer|ovarian cancer
332264|NCT01523678|Endometrial Cancer|endometrial cancer
332270|NCT01523678|Filgrastim|filgrastim
332271|NCT01523678|Ovarian Diseases|ovarian diseases
332272|NCT01523678|Peritoneal Diseases|peritoneal diseases
332273|NCT01523678|Fallopian Tube Diseases|fallopian tube diseases
332274|NCT01523678|Endocrine System Diseases|endocrine system diseases
332275|NCT01523678|Endometrial Diseases|endometrial diseases
332276|NCT01523678|Uterine Cervical Diseases|uterine cervical diseases
332277|NCT01523678|Neoplasms|neoplasms
332278|NCT01523678|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
332279|NCT01523678|Ovarian Neoplasms|ovarian neoplasms
332280|NCT01523678|Peritoneal Neoplasms|peritoneal neoplasms
332281|NCT01523678|Fallopian Tube Neoplasms|fallopian tube neoplasms
332282|NCT01523678|Neoplasms, Endometrial|neoplasms, endometrial
332283|NCT01523678|Cervical Neoplasms|cervical neoplasms
332284|NCT01523678|Genital Neoplasms, Female|genital neoplasms, female
332285|NCT01523678|Urogenital Neoplasms|urogenital neoplasms
332286|NCT01523678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
332287|NCT01523678|Genital Diseases, Female|genital diseases, female
332288|NCT01523639|liver injury|liver injury
332290|NCT01523639|KRAS-Wild-Type|kras-wild-type
332291|NCT01523639|metastatic colorectal cancer|metastatic colorectal cancer
332292|NCT01523639|metformin|metformin
332293|NCT01523639|placebo|placebo
332294|NCT01523639|chemotherapy|chemotherapy
332295|NCT01523626|Trauma|trauma
332296|NCT01523626|Injur*|injur*
332297|NCT01523626|Emergen*|emergen*
332298|NCT01523626|Computed Tomography|computed tomography
332299|NCT01523626|Total body|total body
332300|NCT01523626|TBCT|tbct
332301|NCT01523626|Whole body|whole body
332302|NCT01523626|WBCT|wbct
332303|NCT01523626|Full body|full body
332304|NCT01523626|Pan CT|pan ct
332305|NCT01523613|Dental caries|dental caries
332306|NCT01523613|Proximal surfaces|proximal surfaces
332307|NCT01523613|Posterior teeth|posterior teeth
332308|NCT01523613|Carious lesions|carious lesions
332309|NCT01523613|Tooth diseases|tooth diseases
332310|NCT01523613|Dental restorations|dental restorations
332311|NCT01523613|Glass-ionomer|glass-ionomer
332312|NCT01523600|whole body vibration|whole body vibration
332313|NCT01523600|physical functioning|physical functioning
332314|NCT01523600|falls|falls
332315|NCT01523600|older people|older people
332316|NCT01523600|prevention|prevention
332317|NCT01523574|oxaliplatin|oxaliplatin
332318|NCT01523574|vitamin e|vitamin e
332319|NCT01523574|neuropathy|neuropathy
332320|NCT01523574|peripheral|peripheral
332321|NCT01523574|prophylaxis|prophylaxis
332322|NCT01523561|dance|dance
332323|NCT01523561|intervention|intervention
332324|NCT01523561|adolescent|adolescent
332325|NCT01523561|girls|girls
332326|NCT01523548|Carbon Monoxide|carbon monoxide
332327|NCT01523548|Hypertension, Pulmonary|hypertension, pulmonary
332328|NCT01523522|Fecal incontinence|fecal incontinence
332329|NCT01523522|Myoblast|myoblast
332330|NCT01523522|Surgery|surgery
332331|NCT01523509|Dental Caries|dental caries
332332|NCT01523509|Radiography, Dental|radiography, dental
332333|NCT01523509|Contrast media|contrast media
332334|NCT01523509|Tooth|tooth
332335|NCT01523496|HIV|hiv
332336|NCT01523496|Vitamin D Deficiency|vitamin d deficiency
332337|NCT01523483|preterm birth|preterm birth
332338|NCT01523483|preterm labor|preterm labor
332339|NCT01523483|progesterone|progesterone
332340|NCT01523483|uterine electromyography|uterine electromyography
332341|NCT01523483|cervical length|cervical length
332342|NCT01523470|non-invasive ventilator|non-invasive ventilator
332343|NCT01523457|metastatic pancreatic cancer|metastatic pancreatic cancer
332344|NCT01523457|locally advanced pancreatic cancer|locally advanced pancreatic cancer
332345|NCT01523457|FOLFIRINOX|folfirinox
332346|NCT01523457|phase II|phase ii
332347|NCT01523457|progression free survival|progression free survival
332348|NCT01523444|Adolescents|adolescents
332349|NCT01523444|Screening|screening
332350|NCT01523444|Advice|advice
332351|NCT01523444|Referral|referral
332352|NCT01523431|Colorectal cancer|colorectal cancer
332353|NCT01523431|Irinotecan|irinotecan
332354|NCT01523431|UGT1A1 genotype|ugt1a1 genotype
332355|NCT01523431|Neutropenia|neutropenia
332356|NCT01523431|diarrhea|diarrhea
332357|NCT01523431|response|response
332358|NCT01523431|pharmacokinetic|pharmacokinetic
332359|NCT01523418|Xarelto|xarelto
332360|NCT01523418|Thromboembolism, Venous|thromboembolism, venous
332361|NCT01523418|Orthopedic surgery|orthopedic surgery
332362|NCT01523418|Factor Xa inhibitor|factor xa inhibitor
332363|NCT01523418|Observational study|observational study
331990|NCT01524874|klotho|klotho
332364|NCT01523405|Non Interventional Study, Type II Diabetes Mellitus, Quality of Life|non interventional study, type ii diabetes mellitus, quality of life
332365|NCT01523392|Stable Coronary Artery Disease, CAD|stable coronary artery disease, cad
332366|NCT01523379|Causalgia|causalgia
332367|NCT01523379|CRPS|crps
332368|NCT01523379|complex regional pain syndrome|complex regional pain syndrome
332369|NCT01523379|Dynastat|dynastat
332370|NCT01523379|Parecoxib|parecoxib
332371|NCT01523366|Stable Coronary Artery Disease, CAD|stable coronary artery disease, cad
332372|NCT01523353|Prehabilitation|prehabilitation
332373|NCT01523353|Exercise|exercise
332374|NCT01523353|Colorectal Cancer|colorectal cancer
332375|NCT01523353|Surgery|surgery
332376|NCT01523327|Uric acid|uric acid
332377|NCT01523314|diabetic macular edema|diabetic macular edema
332378|NCT01523314|intravitreal injection|intravitreal injection
332379|NCT01523314|dexamethasone|dexamethasone
332380|NCT01523314|Cyclodextrin|cyclodextrin
332381|NCT01523314|eye drops|eye drops
332382|NCT01523314|bevacizumab|bevacizumab
332383|NCT01523314|macular laser|macular laser
332384|NCT01523301|Rotigotine|rotigotine
332385|NCT01523301|Neupro|neupro
332386|NCT01523301|Depressive Symptom|depressive symptom
332387|NCT01523301|Idiopathic Parkinson's disease|idiopathic parkinson's disease
332388|NCT01523275|mitomycin-C|mitomycin-c
332389|NCT01523275|laryngotracheal stenosis|laryngotracheal stenosis
332390|NCT01523275|subglottic stenosis|subglottic stenosis
332391|NCT01523275|tracheal stenosis|tracheal stenosis
332392|NCT01523275|endoscopic airway surgery|endoscopic airway surgery
332393|NCT01523262|preconditioning|preconditioning
332394|NCT01523262|aortic aneurysm|aortic aneurysm
332395|NCT01523249|3D ultrasonography|3d ultrasonography
332396|NCT01523249|epidural|epidural
332397|NCT01523249|neuraxial anesthesia|neuraxial anesthesia
332398|NCT01523249|neuraxial analgesia|neuraxial analgesia
332399|NCT01523249|pregnant woman|pregnant woman
332400|NCT01523249|parturients|parturients
332401|NCT01523236|Allergic Rhinitis|allergic rhinitis
332402|NCT01523236|Bioequivalence|bioequivalence
332403|NCT01523210|spasticity|spasticity
332404|NCT01523210|Diffusor tensor imaging|diffusor tensor imaging
332405|NCT01523210|distribution|distribution
332406|NCT01523210|botulinum toxin|botulinum toxin
332407|NCT01523210|physiotherapy|physiotherapy
332408|NCT01523197|Obstructive Sleep Apnea hypopnea Syndrome|obstructive sleep apnea hypopnea syndrome
332409|NCT01523197|COPD|copd
332410|NCT01523197|overlap syndrome|overlap syndrome
332411|NCT01523197|Auto-trilevel ventilation|auto-trilevel ventilation
332412|NCT01523197|BiPAP ventilation|bipap ventilation
332413|NCT01523184|Chronic constipation (CC)|chronic constipation (cc)
332414|NCT01523184|Functional Constipation (FC)|functional constipation (fc)
332415|NCT01523184|Gastric Emptying|gastric emptying
332416|NCT01523184|Colon Transit|colon transit
332417|NCT01523184|multiple doses of YKP10811|multiple doses of ykp10811
332418|NCT01523184|gastrointestinal transit|gastrointestinal transit
332419|NCT01523184|colonic transit|colonic transit
332420|NCT01523158|Allergic Rhinitis|allergic rhinitis
332421|NCT01523158|Immunotherapy|immunotherapy
332422|NCT01523145|Atrial fibrillation|atrial fibrillation
332423|NCT01523145|Radio Frequency Ablation|radio frequency ablation
332424|NCT01523145|Rehabilitation|rehabilitation
332425|NCT01523145|Physical capacity|physical capacity
332426|NCT01523145|Quality of life|quality of life
332427|NCT01523145|Integrated rehabilitation|integrated rehabilitation
332428|NCT01523106|Crohn's disease|crohn's disease
332429|NCT01523106|carnitine|carnitine
332430|NCT01523067|Vasomera|vasomera
332431|NCT01523067|PB1046|pb1046
332432|NCT01523067|Hypertension|hypertension
332433|NCT01523054|metoprolol, acute myocardial infarction, pharmacokinetics, pharmacodynamics|metoprolol, acute myocardial infarction, pharmacokinetics, pharmacodynamics
332434|NCT01523015|Adenocarcinoma|adenocarcinoma
332435|NCT01523015|esophago-gastric cancer|esophago-gastric cancer
332436|NCT01523015|chemotherapy|chemotherapy
332437|NCT01523015|chemoradiotherapy|chemoradiotherapy
332438|NCT01523015|surgery|surgery
332439|NCT01522989|Cancer|cancer
332440|NCT01522989|Advanced|advanced
332441|NCT01522989|Refractory|refractory
332442|NCT01522950|hypertension|hypertension
332443|NCT01522950|prevention|prevention
332444|NCT01522950|endothelial function|endothelial function
332445|NCT01522924|tobacco cessation treatment|tobacco cessation treatment
332446|NCT01522924|standardized patients|standardized patients
332447|NCT01522924|dental students|dental students
332448|NCT01522924|tobacco cessation treatment education|tobacco cessation treatment education
332449|NCT01522898|Heart Failure|heart failure
332450|NCT01522898|Atrial Fibrillation|atrial fibrillation
332451|NCT01522885|Chest tube|chest tube
332452|NCT01522885|placement|placement
332453|NCT01522885|mal positioning|mal positioning
332454|NCT01522872|TH-302|th-302
332455|NCT01522872|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
332456|NCT01522872|Bortezomib|bortezomib
332457|NCT01522872|Phase 1/2|phase 1/2
332458|NCT01522872|Hypoxia|hypoxia
332459|NCT01522872|Myeloma|myeloma
332460|NCT01522872|Evofosfamide|evofosfamide
332461|NCT01522872|Pomalidomide|pomalidomide
332462|NCT01522872|Pimonidazole|pimonidazole
332464|NCT01522859|Telehealth|telehealth
332465|NCT01522859|health related quality of life|health related quality of life
332466|NCT01522833|NSLCL|nslcl
332467|NCT01522833|Erlotinib|erlotinib
332468|NCT01522833|Tarceva|tarceva
332469|NCT01522807|Phase 1|phase 1
332470|NCT01522807|Single Doses|single doses
332471|NCT01522807|Biocomparison|biocomparison
332472|NCT01522807|Pharmacokinetics|pharmacokinetics
332473|NCT01522807|Healthy Volunteers|healthy volunteers
332474|NCT01522768|ESOPHAGUS|esophagus
332475|NCT01522768|STOMACH|stomach
332476|NCT01522768|Afatinib|afatinib
332477|NCT01522768|paclitaxel|paclitaxel
332478|NCT01522768|trastuzumab|trastuzumab
332479|NCT01522768|11-166|11-166
332480|NCT01522755|Pacing lead|pacing lead
332481|NCT01522755|implant|implant
332482|NCT01522755|pacemaker|pacemaker
332483|NCT01522742|psoriasis|psoriasis
332484|NCT01522742|cardiovascular disease risk|cardiovascular disease risk
332485|NCT01522742|atherosclerosis|atherosclerosis
332486|NCT01522742|etanercept (enbrel)|etanercept (enbrel)
332487|NCT01522729|Chronic pulmonary obstructive disease|chronic pulmonary obstructive disease
332488|NCT01522729|Muscle dysfunction|muscle dysfunction
332489|NCT01522729|Exercise intolerance|exercise intolerance
332490|NCT01522729|Muscle afferents|muscle afferents
332491|NCT01522729|Ventilation|ventilation
332492|NCT01522703|asthma|asthma
332493|NCT01522703|allergic rhinitis|allergic rhinitis
332494|NCT01522703|dietary interventions|dietary interventions
332495|NCT01522703|mouse allergy|mouse allergy
332496|NCT01522690|Accelerometer|accelerometer
332497|NCT01522690|gait analysis|gait analysis
332498|NCT01522690|Healthy subjects|healthy subjects
332499|NCT01522677|tumor immunology|tumor immunology
332500|NCT01522677|neoadjuvant|neoadjuvant
332501|NCT01522677|colonoscopy|colonoscopy
332502|NCT01522677|photosensitization|photosensitization
332503|NCT01522651|Atrial Fibrillation|atrial fibrillation
332504|NCT01522651|Ranolazine|ranolazine
332505|NCT01522651|Dronedarone|dronedarone
332506|NCT01522651|Dual Chamber Pacemakers|dual chamber pacemakers
332507|NCT01522625|chronic hepatitis B|chronic hepatitis b
332508|NCT01522625|hepatitis B viral DNA|hepatitis b viral dna
332509|NCT01522625|antiviral therapy|antiviral therapy
332510|NCT01522625|Tenofovir|tenofovir
332511|NCT01522612|KRAS Wild Type|kras wild type
332512|NCT01522612|Frail Elderly|frail elderly
332514|NCT01522612|QLQ-ELD14|qlq-eld14
332515|NCT01522612|CGA|cga
332516|NCT01522612|EGFR|egfr
332517|NCT01522612|Cetuximab|cetuximab
332518|NCT01522612|5-FU|5-fu
332519|NCT01522599|ARDS: Acute Respiratory Distress Syndrome|ards: acute respiratory distress syndrome
332520|NCT01522599|LOW FLOW ECCO2-R: EXTRA-CORPOREAL CO2 REMOVAL|low flow ecco2-r: extra-corporeal co2 removal
332521|NCT01522599|VILI: Ventilator Induced Lung Injury|vili: ventilator induced lung injury
332522|NCT01522573|Cholangiocarcinoma|cholangiocarcinoma
332523|NCT01522573|Pancreatic Cancer|pancreatic cancer
332524|NCT01522573|Bile Duct Cancer|bile duct cancer
332525|NCT01522573|Biliary Stricture|biliary stricture
332526|NCT01522573|Biliary obstruction|biliary obstruction
332527|NCT01522573|Stent obstruction|stent obstruction
332528|NCT01522573|Proximal duct stricture|proximal duct stricture
332529|NCT01522573|Distal duct stricture|distal duct stricture
332530|NCT01522573|Ampullary Cancer|ampullary cancer
332531|NCT01522573|Biliary sphincter stenosis|biliary sphincter stenosis
332532|NCT01522573|Impacted stones|impacted stones
332533|NCT01522573|Chronic pancreatitis|chronic pancreatitis
332534|NCT01522573|Peri-ampullary diverticula|peri-ampullary diverticula
332535|NCT01522573|Altered anatomy|altered anatomy
332536|NCT01522573|Endoscopic ultrasound|endoscopic ultrasound
332537|NCT01522573|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
332538|NCT01522573|Multicenter|multicenter
332539|NCT01522560|CA2 and CA3 residents|ca2 and ca3 residents
332540|NCT01522560|Pediatric Anesthesia|pediatric anesthesia
332541|NCT01522547|Pomalidomide|pomalidomide
332542|NCT01522547|Sickle Cell Disease|sickle cell disease
332543|NCT01522547|Fetal Hemoglobin|fetal hemoglobin
332544|NCT01522534|injuries|injuries
332545|NCT01522534|pain|pain
332546|NCT01522534|Block, Nerve|block, nerve
332547|NCT01522534|morphine|morphine
332548|NCT01522534|Prehospital Emergency Care|prehospital emergency care
332549|NCT01522521|AK156|ak156
332550|NCT01522508|Analgesia|analgesia
332551|NCT01522508|Anesthetics|anesthetics
332552|NCT01522508|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
332553|NCT01522482|fatty acids|fatty acids
332554|NCT01522482|cardiovascular disease|cardiovascular disease
332555|NCT01522482|genotype|genotype
332556|NCT01522482|apoE|apoe
332557|NCT01522469|FLT3|flt3
332558|NCT01522469|Crenolanib|crenolanib
332559|NCT01522469|Acute|acute
332560|NCT01522469|myeloid|myeloid
332561|NCT01522469|leukemia|leukemia
332562|NCT01522469|relapsed|relapsed
332563|NCT01522469|refractory|refractory
332564|NCT01522443|prostate cancer|prostate cancer
332565|NCT01522443|castration resistant prostate cancer|castration resistant prostate cancer
332566|NCT01522443|bone pain|bone pain
332567|NCT01522443|CRPC|crpc
332568|NCT01522430|Resistant hypertension|resistant hypertension
332569|NCT01522430|Renal denervation|renal denervation
332570|NCT01522430|Ambulatory blood pressure|ambulatory blood pressure
332571|NCT01522430|Renal function|renal function
332572|NCT01522430|Simplicity catheter|simplicity catheter
332573|NCT01522430|Sham procedure|sham procedure
332574|NCT01522404|Mild Cognitive Impairment|mild cognitive impairment
332575|NCT01522404|Memory Loss|memory loss
332576|NCT01522404|Alzheimer's Disease|alzheimer's disease
332577|NCT01522378|cardiac resynchronization therapy|cardiac resynchronization therapy
332578|NCT01522365|Dental implants|dental implants
332579|NCT01522365|XiVE CAD/CAM bridge|xive cad/cam bridge
332580|NCT01522352|Bioprosthesis,|bioprosthesis,
713348|NCT01012843|Antibiotic|antibiotic
332581|NCT01522352|aortic valve replacement|aortic valve replacement
332582|NCT01522352|Magna Ease|magna ease
332583|NCT01522352|Mitroflow|mitroflow
332584|NCT01522352|Trifecta|trifecta
332585|NCT01522339|NICU|nicu
332586|NCT01522339|MRI|mri
332587|NCT01522339|Neonatal|neonatal
332588|NCT01522339|Safety|safety
332589|NCT01522339|Efficacy|efficacy
332590|NCT01522339|Cincinnati|cincinnati
332591|NCT01522326|Acute Mountain Sickness|acute mountain sickness
332592|NCT01522326|High Altitude Headache|high altitude headache
332593|NCT01522326|Lake Louise AMS Score|lake louise ams score
332594|NCT01522326|Visual Analog Scale|visual analog scale
332595|NCT01522326|Ibuprofen|ibuprofen
332596|NCT01522326|Metoclopramide|metoclopramide
332597|NCT01522326|Nepal|nepal
332598|NCT01522300|Tomosynthesis|tomosynthesis
332599|NCT01522300|breast cancer|breast cancer
332600|NCT01522300|specificity|specificity
332601|NCT01522300|sensitivity|sensitivity
332602|NCT01522300|To assess efficacy of Tomosynthesis by evaluating its sensitivity and specificity in detecting the multicentricity of mammary tumor|to assess efficacy of tomosynthesis by evaluating its sensitivity and specificity in detecting the multicentricity of mammary tumor
332603|NCT01522287|Obsessive Compulsive Disorder|obsessive compulsive disorder
332604|NCT01522287|Computer Assisted Therapy|computer assisted therapy
332605|NCT01522287|Cognitive Behavior Therapy|cognitive behavior therapy
332606|NCT01522287|Cognitive Therapy|cognitive therapy
332607|NCT01522261|Mechanical Bowel Prep|mechanical bowel prep
332608|NCT01522248|influenza vaccine|influenza vaccine
332609|NCT01522248|cytokines|cytokines
332610|NCT01522248|chemokines|chemokines
332611|NCT01522248|symptoms|symptoms
332612|NCT01522235|Autoimmune autonomic neuropathy|autoimmune autonomic neuropathy
332613|NCT01522235|Orthostatic hypotension|orthostatic hypotension
332614|NCT01522235|Dysautonomia|dysautonomia
332615|NCT01522235|Autonomic failure|autonomic failure
332616|NCT01522235|Peripheral autonomic neuropathy|peripheral autonomic neuropathy
332617|NCT01522222|cardiopulmonary bypass surgery|cardiopulmonary bypass surgery
332618|NCT01522222|CABG|cabg
332619|NCT01522222|PEEP|peep
332620|NCT01522209|CRLM|crlm
332621|NCT01522209|Primovist MRI|primovist mri
332622|NCT01522209|CEIOUS|ceious
332623|NCT01522196|SCD|scd
332624|NCT01522183|Atypical Hemolytic-Uremic Syndrome|atypical hemolytic-uremic syndrome
332625|NCT01522183|aHUS|ahus
332626|NCT01522183|Thrombotic Microangiopathy|thrombotic microangiopathy
332627|NCT01522183|TMA|tma
332628|NCT01522170|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
332629|NCT01522170|aHUS|ahus
332630|NCT01522170|Eculizumab|eculizumab
332631|NCT01522157|Diet|diet
332632|NCT01522157|Low-carbohydrate|low-carbohydrate
332633|NCT01522157|Postprandial|postprandial
332634|NCT01522157|Type 2 diabetes mellitus|type 2 diabetes mellitus
332635|NCT01522131|bioresorbable membrane|bioresorbable membrane
332636|NCT01522118|Prostate Cancer|prostate cancer
332637|NCT01522118|High Intensity Focused Ultrasound|high intensity focused ultrasound
332638|NCT01522118|Magnetic Resonance guided Focused Ultrasound|magnetic resonance guided focused ultrasound
332639|NCT01522118|Non-invasive therapy|non-invasive therapy
332640|NCT01522118|Focal Disease|focal disease
332641|NCT01522105|Meningitis|meningitis
332642|NCT01522105|Central Nervous System Infections|central nervous system infections
332643|NCT01522105|Pediatrics|pediatrics
332644|NCT01522105|Daptomycin|daptomycin
332645|NCT01522105|Anti-Bacterial Agents|anti-bacterial agents
332646|NCT01522105|Therapeutic Use|therapeutic use
332647|NCT01522105|Pharmacologic Actions|pharmacologic actions
332648|NCT01522092|Exacerbations|exacerbations
332649|NCT01522079|spinal muscular atrophy|spinal muscular atrophy
332650|NCT01522079|heart rate variability|heart rate variability
332651|NCT01522079|posture|posture
332652|NCT01522079|air stacking|air stacking
332653|NCT01522040|Asthma|asthma
413176|NCT01185457|HRV|hrv
332654|NCT01522040|Magnesium|magnesium
332655|NCT01522040|Adrenergic Receptor|adrenergic receptor
332656|NCT01522014|Joint Replacement|joint replacement
332657|NCT01522014|Health Related Quality of Life|health related quality of life
332658|NCT01522014|Functional Outcomes|functional outcomes
332659|NCT01522014|Revision Rate|revision rate
332660|NCT01522001|Acute Coronary Syndrome|acute coronary syndrome
332661|NCT01522001|Myocardial Ischemia|myocardial ischemia
332662|NCT01522001|Shared Care|shared care
332663|NCT01522001|Rehabilitation|rehabilitation
332664|NCT01522001|Community|community
332665|NCT01522001|Cardiac Rehabilitation|cardiac rehabilitation
332666|NCT01522001|Hospital|hospital
332667|NCT01521988|Atrial flutter|atrial flutter
332668|NCT01521988|Atrial fibrillation|atrial fibrillation
332669|NCT01521988|Catheter ablation|catheter ablation
332670|NCT01521975|HBV DNA|hbv dna
332671|NCT01521975|LdT|ldt
332672|NCT01521975|ADV|adv
332673|NCT01521975|HBeAg negative hepatitis|hbeag negative hepatitis
332674|NCT01521975|CHB|chb
332675|NCT01521949|Prostate Cancer|prostate cancer
332676|NCT01521949|Nutraceutical|nutraceutical
332677|NCT01521949|Acai Juice|acai juice
332678|NCT01521923|Certolizumab Pegol - Cimzia|certolizumab pegol - cimzia
332679|NCT01521923|Rheumatoid Arthritis|rheumatoid arthritis
332680|NCT01521910|survival|survival
332681|NCT01521910|protein restriction|protein restriction
332682|NCT01521910|diabetic nephropathy|diabetic nephropathy
332683|NCT01521910|type 1 diabetes|type 1 diabetes
332684|NCT01521910|GFR|gfr
332685|NCT01521910|ESRD|esrd
332686|NCT01521910|progressive renal disease|progressive renal disease
332687|NCT01521897|Pneumococcal Vaccine|pneumococcal vaccine
332688|NCT01521897|Prevenar|prevenar
332689|NCT01521897|7-valent|7-valent
332690|NCT01521897|Special Use-result surveillance|special use-result surveillance
332691|NCT01521871|Tissue glue|tissue glue
332692|NCT01521871|Cyanoacrylate|cyanoacrylate
332693|NCT01521871|Wound closure|wound closure
332694|NCT01521871|Living donor nephrectomy|living donor nephrectomy
332695|NCT01521871|Surgical wound closure|surgical wound closure
332798|NCT01521364|drug-interaction|drug-interaction
332696|NCT01521845|elective percutaneous coronary intervention|elective percutaneous coronary intervention
332697|NCT01521845|hs-CRP|hs-crp
332698|NCT01521845|CKMB and troponin I|ckmb and troponin i
332699|NCT01521819|AMD|amd
332700|NCT01521819|V-Ped|v-ped
332701|NCT01521819|Vascularized Pigment Epithelial Detachment|vascularized pigment epithelial detachment
332702|NCT01521819|Iray|iray
332703|NCT01521819|radiation|radiation
332704|NCT01521819|retina|retina
332705|NCT01521819|macula|macula
332706|NCT01521819|radiotherapy|radiotherapy
332707|NCT01521806|insulin sensitivity|insulin sensitivity
332708|NCT01521806|resistant starch|resistant starch
332709|NCT01521780|hepatocellular carcinoma|hepatocellular carcinoma
332710|NCT01521780|MRI|mri
332711|NCT01521780|pharmacogenomics|pharmacogenomics
332712|NCT01521780|beta-catenin|beta-catenin
332713|NCT01521767|pharmacokinetics|pharmacokinetics
332714|NCT01521767|relative bioavailability|relative bioavailability
332715|NCT01521767|tolterodine microspheres in powder blend|tolterodine microspheres in powder blend
332716|NCT01521767|Overactive Urinary Bladder|overactive urinary bladder
332717|NCT01521741|Breast Cancer|breast cancer
332718|NCT01521741|Lymphedema|lymphedema
332719|NCT01521741|symptoms|symptoms
332720|NCT01521728|ALS|als
332721|NCT01521728|Exercise|exercise
332722|NCT01521728|Resistance|resistance
332723|NCT01521728|Endurance|endurance
332724|NCT01521702|adenocarcinoma|adenocarcinoma
332725|NCT01521702|pancreatic head|pancreatic head
332726|NCT01521689|MRD negative CR|mrd negative cr
332727|NCT01521676|breast cancer|breast cancer
332728|NCT01521663|Moderate to severe idiopathic RLS|moderate to severe idiopathic rls
332729|NCT01521650|Probiotics|probiotics
332730|NCT01521650|Anaesthesia|anaesthesia
332731|NCT01521650|Intubation|intubation
332732|NCT01521650|Pathogenic bacteria|pathogenic bacteria
332733|NCT01521611|Radioimmunotherapy|radioimmunotherapy
332734|NCT01521611|Transplant|transplant
332735|NCT01521611|BMT|bmt
332736|NCT01521611|yttrium|yttrium
332737|NCT01521611|indium|indium
332738|NCT01521598|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
332739|NCT01521572|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
332740|NCT01521572|bronchial reversibility,|bronchial reversibility,
332741|NCT01521572|bronchodilator,|bronchodilator,
332742|NCT01521572|respiratory impedance,|respiratory impedance,
332743|NCT01521572|forced oscillation technique,|forced oscillation technique,
332744|NCT01521572|plethysmography,|plethysmography,
332745|NCT01521572|spirometry|spirometry
332746|NCT01521572|Diagnostic Techniques, Respiratory System|diagnostic techniques, respiratory system
332747|NCT01521546|Duchenne muscular dystrophy|duchenne muscular dystrophy
332748|NCT01521546|cardiomyopathy|cardiomyopathy
332749|NCT01521546|aldosterone antagonist|aldosterone antagonist
332750|NCT01521533|Relapsed Multiple Myeloma|relapsed multiple myeloma
332751|NCT01521533|NOX-A12|nox-a12
332752|NCT01521533|Velcade|velcade
332753|NCT01521533|Dexamethasone|dexamethasone
332754|NCT01521533|Spiegelmer|spiegelmer
332755|NCT01521533|Chemosensitization|chemosensitization
332756|NCT01521533|Stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
332757|NCT01521533|CXCL12|cxcl12
332758|NCT01521520|type 1 diabetes|type 1 diabetes
332759|NCT01521520|magnetic resonance imaging|magnetic resonance imaging
332760|NCT01521520|insulitis|insulitis
332761|NCT01521520|ferumoxytol|ferumoxytol
332762|NCT01521494|Hemodialysis|hemodialysis
332763|NCT01521494|Hyperphosphatemia|hyperphosphatemia
332764|NCT01521468|Coronary artery disease|coronary artery disease
332765|NCT01521468|Diagnostic accuracy|diagnostic accuracy
332766|NCT01521468|CT coronary angiography|ct coronary angiography
332767|NCT01521468|Positron emission tomography|positron emission tomography
332768|NCT01521468|Single photon emission tomography|single photon emission tomography
332769|NCT01521468|Noninvasive techniques|noninvasive techniques
332770|NCT01521468|Cardiac catheterization|cardiac catheterization
332771|NCT01521468|Fractional flow reserve|fractional flow reserve
332772|NCT01521442|PTSD|ptsd
332773|NCT01521442|Yoga|yoga
332774|NCT01521442|Complementary and Alternative Medicine (CAM)|complementary and alternative medicine (cam)
332775|NCT01521416|Illness|illness
332776|NCT01521416|Influenza|influenza
332777|NCT01521416|Cost|cost
332778|NCT01521416|UK|uk
332779|NCT01521403|Blastocystis hominis|blastocystis hominis
332780|NCT01521403|Metronidazole|metronidazole
332781|NCT01521377|LAMA|lama
332782|NCT01521377|Respiratory|respiratory
332783|NCT01521377|COPD|copd
332784|NCT01521377|Tolerability|tolerability
332785|NCT01521377|Beta-2 Agonist|beta-2 agonist
332786|NCT01521377|Safety|safety
332787|NCT01521377|Pharmacokinetics|pharmacokinetics
332788|NCT01521377|Pharmacodynamics|pharmacodynamics
332789|NCT01521377|LABA|laba
332790|NCT01521377|Muscarinic Receptor Agonist|muscarinic receptor agonist
332791|NCT01521377|Healthy subjects|healthy subjects
332792|NCT01521377|Moxifloxacin|moxifloxacin
332793|NCT01521377|Anticholinergic|anticholinergic
332794|NCT01521377|GW642444|gw642444
332795|NCT01521377|GSK573719|gsk573719
332796|NCT01521377|QTc|qtc
332797|NCT01521364|pharmacokinetic|pharmacokinetic
332799|NCT01521364|linezolid|linezolid
332800|NCT01521364|clarithromycin|clarithromycin
332801|NCT01521364|Mycobacterium tuberculosis|mycobacterium tuberculosis
332802|NCT01521351|microwave radiometry|microwave radiometry
332803|NCT01521351|cardiovascular events|cardiovascular events
332804|NCT01521351|carotid artery disease|carotid artery disease
332805|NCT01521351|stroke|stroke
332806|NCT01521351|myocardial infarction|myocardial infarction
332807|NCT01521338|Cystic Fibrosis|cystic fibrosis
332808|NCT01521338|G551D|g551d
332809|NCT01521338|G551D Mutation|g551d mutation
332810|NCT01521312|Impaired glucose tolerance|impaired glucose tolerance
332811|NCT01521312|Saxagliptin|saxagliptin
332812|NCT01521312|Cardiovascular risk integrators|cardiovascular risk integrators
332813|NCT01521312|Vago-sympathetic activity|vago-sympathetic activity
332814|NCT01521312|Arterial stiffness|arterial stiffness
332815|NCT01521312|Endothelial function|endothelial function
332816|NCT01521299|hydroxyurea|hydroxyurea
332817|NCT01521299|S phase|s phase
332818|NCT01521299|G2 phase|g2 phase
332819|NCT01521299|pharmacokinetics|pharmacokinetics
332820|NCT01521286|Spain|spain
332821|NCT01521286|cost|cost
332822|NCT01521286|complications|complications
332823|NCT01521286|incidence|incidence
332824|NCT01521286|adults|adults
332825|NCT01521286|quality of life|quality of life
332826|NCT01521286|Herpes Zoster|herpes zoster
332827|NCT01521286|Surveillance|surveillance
332828|NCT01521273|beans|beans
332829|NCT01521273|biofortification|biofortification
332830|NCT01521273|phytic acid|phytic acid
332831|NCT01521273|iron|iron
332832|NCT01521273|iron isotopes|iron isotopes
332833|NCT01521273|different phytic acid concentrations|different phytic acid concentrations
332834|NCT01521260|dental implants|dental implants
332835|NCT01521260|microbiology|microbiology
332836|NCT01521260|chlorhexidine|chlorhexidine
332837|NCT01521247|Asthma|asthma
332838|NCT01521247|Transition program|transition program
332839|NCT01521247|Pediatric|pediatric
332840|NCT01521247|Adult|adult
332841|NCT01521208|Out-of-Hospital cardiac arrest (OHCA)|out-of-hospital cardiac arrest (ohca)
332842|NCT01521208|Chest compressions|chest compressions
332843|NCT01521208|LUCAS device|lucas device
332844|NCT01521195|pediatric|pediatric
332845|NCT01521195|ECMO|ecmo
332846|NCT01521195|extracorporeal blood flow|extracorporeal blood flow
332847|NCT01521195|VO2|vo2
332848|NCT01521182|Probiotic - dairy product - influenza vaccination - healthy elderly|probiotic - dairy product - influenza vaccination - healthy elderly
332849|NCT01521169|Plant sterol - Hypercholesterolemia - Diet - Dairy|plant sterol - hypercholesterolemia - diet - dairy
332850|NCT01521156|Plant sterols - Hypercholesterolemia - Diet - Dairy|plant sterols - hypercholesterolemia - diet - dairy
332851|NCT01521143|EOC|eoc
752620|NCT01173367|Acetaminophen|acetaminophen
332852|NCT01521130|Benign Childhood Epilepsy With Centrotemporal Spikes|benign childhood epilepsy with centrotemporal spikes
332853|NCT01521130|Benign Rolandic Epilepsy|benign rolandic epilepsy
332854|NCT01521117|donepezil|donepezil
332855|NCT01521117|parkinson's disease|parkinson's disease
332856|NCT01521117|balance|balance
332857|NCT01521117|cholinesterase inhibitor|cholinesterase inhibitor
332858|NCT01521104|narrow band imaging（NBI）|narrow band imaging（nbi）
332859|NCT01521104|colorectal lesions|colorectal lesions
332860|NCT01521104|predicting histology|predicting histology
332861|NCT01521091|narrow band imaging（NBI）|narrow band imaging（nbi）
332862|NCT01521091|indigo carmine|indigo carmine
332863|NCT01521091|acetic acid|acetic acid
332864|NCT01521091|colorectal lesions|colorectal lesions
332865|NCT01521091|predicting histology|predicting histology
332866|NCT01521065|AMD|amd
332867|NCT01521065|Wet AMD|wet amd
332868|NCT01521039|aGVHD|agvhd
332869|NCT01521039|Acute Graft-versus-Host Disease|acute graft-versus-host disease
332870|NCT01521039|allogeneic stem cell transplantation|allogeneic stem cell transplantation
332871|NCT01521039|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
332872|NCT01521039|MicroRNA Expression|microrna expression
332873|NCT01521000|Breast Cancer|breast cancer
332874|NCT01521000|Lymphedema|lymphedema
332875|NCT01521000|Sentinel Node Biopsy|sentinel node biopsy
332876|NCT01521000|Axillary Dissection|axillary dissection
332877|NCT01520987|Parkinson Disease|parkinson disease
332878|NCT01520987|BIA 9-1067|bia 9-1067
713349|NCT01012843|Anorectal|anorectal
332879|NCT01520961|Partial Hip Arthroplasty|partial hip arthroplasty
332880|NCT01520948|Parkinson disease|parkinson disease
332881|NCT01520948|Incontinence|incontinence
332882|NCT01520935|Office of National Statistics|office of national statistics
332883|NCT01520935|Burden of Disease|burden of disease
332884|NCT01520935|Influenza|influenza
332885|NCT01520935|Hospital Episode Statistics|hospital episode statistics
332886|NCT01520935|General Practitioners Research Database|general practitioners research database
332887|NCT01520922|Relapsed or Refractory Chronic Lymphocytic Leukemia|relapsed or refractory chronic lymphocytic leukemia
332888|NCT01520922|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
332889|NCT01520922|CLL|cll
332890|NCT01520922|Cancer|cancer
332891|NCT01520922|Lymphoid leukemia|lymphoid leukemia
332892|NCT01520922|Lymphoblastic leukemia|lymphoblastic leukemia
332893|NCT01520909|immune thrombocytopenic purpura|immune thrombocytopenic purpura
332894|NCT01520909|pediatrics|pediatrics
332895|NCT01520909|chronic ITP|chronic itp
332896|NCT01520909|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
332897|NCT01520909|eltrombopag|eltrombopag
332898|NCT01520909|Chronic Immune Thrombocytopenia|chronic immune thrombocytopenia
332899|NCT01520909|platelet disorder|platelet disorder
332900|NCT01520909|thrombocytopenia|thrombocytopenia
332901|NCT01520896|Phase 1|phase 1
332902|NCT01520896|Healthy male and female volunteers|healthy male and female volunteers
332903|NCT01520896|Drug-drug interaction|drug-drug interaction
332904|NCT01520896|Pharmacokinetics|pharmacokinetics
332905|NCT01520896|NKTR-118|nktr-118
332906|NCT01520870|Dacomitinib|dacomitinib
332907|NCT01520870|PF-299804|pf-299804
332908|NCT01520870|Glioblastoma, Recurrent|glioblastoma, recurrent
332909|NCT01520870|EGFR|egfr
332910|NCT01520857|Laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
332911|NCT01520857|TAPP|tapp
332912|NCT01520857|Spinal Anesthesia|spinal anesthesia
332913|NCT01520857|General Anesthesia|general anesthesia
332914|NCT01520805|acute myeloid leukemia|acute myeloid leukemia
332915|NCT01520805|myelodysplastic syndrome|myelodysplastic syndrome
332916|NCT01520805|refractory|refractory
332917|NCT01520805|relapsed|relapsed
332918|NCT01520805|hypomethylating agents|hypomethylating agents
332919|NCT01520792|pharmacogenetic of paracetamol|pharmacogenetic of paracetamol
332920|NCT01520792|Pain threshold|pain threshold
332921|NCT01520779|Hepatocellular cacinoma|hepatocellular cacinoma
332922|NCT01520779|Radiofrequancy ablation|radiofrequancy ablation
332923|NCT01520779|Intrahepatic recurrence|intrahepatic recurrence
332924|NCT01520766|glass fiber posts|glass fiber posts
332925|NCT01520766|titanium posts|titanium posts
332926|NCT01520766|postendodontic restoration|postendodontic restoration
332927|NCT01520766|self-adhesive resin cement|self-adhesive resin cement
332928|NCT01520740|Gold Stage III|gold stage iii
332929|NCT01520740|Gold Stage IV|gold stage iv
332930|NCT01520740|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
332931|NCT01520740|COPD|copd
332932|NCT01520740|Lung Volume Reduction Surgery|lung volume reduction surgery
332933|NCT01520740|LVRS|lvrs
332934|NCT01520740|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
332935|NCT01520740|BLVR|blvr
332936|NCT01520740|Upper Lobe Predominant|upper lobe predominant
332937|NCT01520740|ULP|ulp
332938|NCT01520740|Heterogeneous|heterogeneous
332939|NCT01520740|Homogeneous|homogeneous
332940|NCT01520727|BIA 9-1067|bia 9-1067
332941|NCT01520714|Congestive Heart Failure (CHF)|congestive heart failure (chf)
332942|NCT01520714|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
332943|NCT01520714|BiVentricular Implantable Cardioverter Defibrillator (BiVICD)|biventricular implantable cardioverter defibrillator (bivicd)
332944|NCT01520714|Fraction|fraction
332945|NCT01520701|head and neck cancer|head and neck cancer
332946|NCT01520701|Hydrotac®|hydrotac®
332947|NCT01520701|radiodermatitis|radiodermatitis
332948|NCT01520701|algia|algia
332949|NCT01520701|radiotherapy|radiotherapy
332950|NCT01520688|Mild persistent or mild intermittent asthma|mild persistent or mild intermittent asthma
332951|NCT01520675|chronic pancreatitis|chronic pancreatitis
332952|NCT01520675|randomized controlled trial|randomized controlled trial
332953|NCT01520675|endoscopic therapy|endoscopic therapy
332954|NCT01520675|surgery|surgery
332955|NCT01520675|ESWL|eswl
332956|NCT01520662|patient-centered care|patient-centered care
332957|NCT01520662|wellness|wellness
332958|NCT01520662|preventive services|preventive services
332959|NCT01520662|primary care|primary care
332960|NCT01520662|To accomplish Aim 2, we will conduct a nine-month pre-post|to accomplish aim 2, we will conduct a nine-month pre-post
332961|NCT01520662|randomized controlled trial (RCT) in four primary care|randomized controlled trial (rct) in four primary care
332962|NCT01520662|practices. The study will focus on the impact of a patient|practices. the study will focus on the impact of a patient
332963|NCT01520662|Wellness Portal on the quantity and quality of preventive|wellness portal on the quantity and quality of preventive
332964|NCT01520662|care patients receive in primary care practices.|care patients receive in primary care practices.
332965|NCT01520649|Neurogenesis|neurogenesis
332966|NCT01520649|hippocampal stem cells|hippocampal stem cells
332967|NCT01520649|depression|depression
332968|NCT01520649|stroke|stroke
332969|NCT01520636|stroke|stroke
332970|NCT01520636|early rehabilitation|early rehabilitation
332971|NCT01520636|motor recovery|motor recovery
332972|NCT01520636|functional recovery|functional recovery
332973|NCT01520623|Allogeneic haematopoietic stem cell transplantation (HSCT)|allogeneic haematopoietic stem cell transplantation (hsct)
332974|NCT01520623|Myeloablative conditioning for an haematological malignancy|myeloablative conditioning for an haematological malignancy
332975|NCT01520623|Graft-versus-host disease (GvHD)|graft-versus-host disease (gvhd)
332976|NCT01520623|Activation of complement system|activation of complement system
332977|NCT01520623|Gut GVHD|gut gvhd
332978|NCT01520610|Tako-TSUBO Cardiomyopathy|tako-tsubo cardiomyopathy
332979|NCT01520610|Stress Cardiomyopathy|stress cardiomyopathy
332980|NCT01520610|Myocardiopathies|myocardiopathies
332981|NCT01520610|Acute Coronary Syndrome|acute coronary syndrome
332982|NCT01520610|Gene|gene
332983|NCT01520597|Multicentric|multicentric
332984|NCT01520597|National|national
332985|NCT01520597|Prospective on|prospective on
332986|NCT01520597|Listeriosis|listeriosis
332987|NCT01520597|Listeria|listeria
332988|NCT01520571|Computer Assistance|computer assistance
332989|NCT01520571|Total Knee Arthroplasty|total knee arthroplasty
332990|NCT01520571|conventional|conventional
332991|NCT01520558|Acute Myeloid Leukemia|acute myeloid leukemia
332992|NCT01520558|High Risk Relapse|high risk relapse
332993|NCT01520558|Complete Remission|complete remission
332994|NCT01520558|Allogeneic Natural Killer Cells|allogeneic natural killer cells
332995|NCT01520545|Gablofen|gablofen
332996|NCT01520545|baclofen injection|baclofen injection
332997|NCT01520519|Leukemia|leukemia
332998|NCT01520519|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
332999|NCT01520519|CLL|cll
333000|NCT01520519|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
333001|NCT01520519|SLL|sll
333002|NCT01520519|Rituximab|rituximab
333003|NCT01520519|Rituxan|rituxan
333004|NCT01520519|PCI-32765|pci-32765
333005|NCT01520506|Hypertension|hypertension
333006|NCT01520506|Kidney Diseases|kidney diseases
333007|NCT01520506|Kidney Failure, Chronic|kidney failure, chronic
333008|NCT01520506|Vascular Diseases|vascular diseases
333009|NCT01520506|Cardiovascular Diseases|cardiovascular diseases
333010|NCT01520506|Urologic Diseases|urologic diseases
333011|NCT01520506|Renal Insufficiency, Chronic|renal insufficiency, chronic
333012|NCT01520506|Renal Insufficiency|renal insufficiency
333013|NCT01520493|pulmonary arterial hypertension|pulmonary arterial hypertension
333014|NCT01520493|skeletal muscle microcirculation|skeletal muscle microcirculation
333015|NCT01520493|exercise induced blood flow|exercise induced blood flow
333016|NCT01520480|survival after surgery|survival after surgery
333017|NCT01520480|Pathological Subtrochanteric Fractures|pathological subtrochanteric fractures
333018|NCT01520467|SRS|srs
333019|NCT01520467|PWS|pws
333020|NCT01520467|pathological adrenarche|pathological adrenarche
333021|NCT01520467|aromatase inhibitor|aromatase inhibitor
333022|NCT01520467|Children|children
333023|NCT01520454|Leptin resistance|leptin resistance
333024|NCT01520454|Free fatty acids|free fatty acids
333025|NCT01520454|Lipotoxicity|lipotoxicity
333026|NCT01520441|Botulinum Toxin|botulinum toxin
333027|NCT01520441|Prostate Cancer|prostate cancer
333028|NCT01520441|BPH|bph
333029|NCT01520441|LUTS|luts
333030|NCT01520402|Genetic Determinants of Warfarin Dose Variability|genetic determinants of warfarin dose variability
333031|NCT01520389|cancer|cancer
333032|NCT01520389|solid tumors|solid tumors
333033|NCT01520389|oncology|oncology
333034|NCT01520389|Phase I|phase i
333035|NCT01520389|EGFR|egfr
333036|NCT01520389|EGF receptor (ErbB1)|egf receptor (erbb1)
333037|NCT01520389|irinotecan|irinotecan
333038|NCT01520363|Rett syndrome|rett syndrome
333039|NCT01520363|RTT|rtt
333040|NCT01520363|MECP2|mecp2
333041|NCT01520363|dextromethorphan|dextromethorphan
333042|NCT01520363|DM|dm
333043|NCT01520311|Coronary Artery Disease|coronary artery disease
333044|NCT01520311|Myocardial Ischemia|myocardial ischemia
333045|NCT01520311|Coronary Disease|coronary disease
333046|NCT01520311|Heart Diseases|heart diseases
333047|NCT01520311|Cardiovascular Diseases|cardiovascular diseases
333048|NCT01520311|Arteriosclerosis|arteriosclerosis
333049|NCT01520311|Arterial Occlusive Diseases|arterial occlusive diseases
333050|NCT01520311|Vascular Diseases|vascular diseases
333052|NCT01520311|SVG|svg
333053|NCT01520311|eSVS Mesh|esvs mesh
333054|NCT01520311|Bypass Grafting|bypass grafting
333055|NCT01520285|hypertension|hypertension
333056|NCT01520285|Blood pressure decrease|blood pressure decrease
333057|NCT01520285|efficacy|efficacy
333058|NCT01520272|HPV18 Immunogenicity|hpv18 immunogenicity
333059|NCT01520272|HPV16 Immunogenicity|hpv16 immunogenicity
333060|NCT01520272|Bivalent HPV16/18 Vaccine|bivalent hpv16/18 vaccine
333061|NCT01520272|Less than 3 Dosed of the Bivalent HPV Vaccine|less than 3 dosed of the bivalent hpv vaccine
333062|NCT01520272|HP Vaccine|hp vaccine
333063|NCT01520259|Gallbaldder|gallbaldder
333064|NCT01520259|Gallstones|gallstones
333065|NCT01520259|Inflammation|inflammation
333066|NCT01520259|Cholecystectomy|cholecystectomy
333067|NCT01520259|Cancer|cancer
333068|NCT01520259|Gallbaldder Cancer|gallbaldder cancer
333069|NCT01520246|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
333070|NCT01520246|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
333071|NCT01520246|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
333072|NCT01520233|disseminated neuroblastoma|disseminated neuroblastoma
333073|NCT01520233|localized unresectable neuroblastoma|localized unresectable neuroblastoma
333074|NCT01520233|recurrent neuroblastoma|recurrent neuroblastoma
333075|NCT01520233|regional neuroblastoma|regional neuroblastoma
333076|NCT01520233|stage 4S neuroblastoma|stage 4s neuroblastoma
333077|NCT01520194|genital warts|genital warts
333078|NCT01520194|HPV|hpv
333079|NCT01520194|psychosocial burden|psychosocial burden
333080|NCT01520194|economic burden|economic burden
333081|NCT01520194|female genital warts|female genital warts
333082|NCT01520168|Incisional hernia|incisional hernia
333083|NCT01520168|Mesh|mesh
333084|NCT01520168|Surgery|surgery
333085|NCT01520168|Composix Kugel|composix kugel
333086|NCT01520168|IPOM technique|ipom technique
333087|NCT01520155|lupus erythematosus|lupus erythematosus
333088|NCT01520155|cardiovascular risk|cardiovascular risk
333089|NCT01520142|Healthy participants|healthy participants
333090|NCT01520142|Pharmacodynamic|pharmacodynamic
333091|NCT01520142|Pharmacokinetics|pharmacokinetics
333092|NCT01520142|Intravenous Endotoxin-Induced Model|intravenous endotoxin-induced model
333093|NCT01520142|Acute Inflammation|acute inflammation
333094|NCT01520142|JNJ-26528398|jnj-26528398
333095|NCT01520142|Anti-inflammatory|anti-inflammatory
333096|NCT01520129|Bipolar Disorder|bipolar disorder
333097|NCT01520129|Bipolar NOS|bipolar nos
333098|NCT01520129|Bipolar Depression|bipolar depression
333099|NCT01520103|Metastatic breast cancer|metastatic breast cancer
333100|NCT01520103|locally advanced breast cancer|locally advanced breast cancer
333101|NCT01520103|Her2/new negative|her2/new negative
333102|NCT01520103|HER2 negative|her2 negative
333103|NCT01520090|contraception|contraception
333104|NCT01520090|family planning|family planning
333105|NCT01520090|egyptian|egyptian
333106|NCT01520090|knowledge|knowledge
333107|NCT01520077|alopecia areata|alopecia areata
333108|NCT01520077|vytorin|vytorin
333109|NCT01520077|statin|statin
333110|NCT01520077|hair growth|hair growth
333111|NCT01520064|Emphysema|emphysema
333112|NCT01520064|GOLD Stage III|gold stage iii
333113|NCT01520064|GOLD Stage IV|gold stage iv
333114|NCT01520064|AeriSeal System|aeriseal system
333115|NCT01520064|Homogeneous|homogeneous
333116|NCT01520064|Heterogeneous|heterogeneous
333117|NCT01520064|Upper Lobe Predominant|upper lobe predominant
333119|NCT01520064|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
333120|NCT01520064|COPD|copd
333121|NCT01520064|Lung Volume Reduction Surgery|lung volume reduction surgery
333122|NCT01520064|LVRS|lvrs
333123|NCT01520064|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
333124|NCT01520064|BLVR|blvr
333125|NCT01520051|Asthma|asthma
333126|NCT01520051|Viral|viral
333127|NCT01520051|Infection|infection
333128|NCT01520051|Inflammation|inflammation
333129|NCT01520051|Mepolizumab|mepolizumab
333130|NCT01520051|Eosinophilia|eosinophilia
333131|NCT01520025|Radiopharmaceutical|radiopharmaceutical
333132|NCT01520025|18FDG PET|18fdg pet
333133|NCT01520025|CTA|cta
333134|NCT01520025|Multi-modality imaging|multi-modality imaging
333135|NCT01520025|Metabolic Imaging of Ischemia|metabolic imaging of ischemia
333136|NCT01520025|Myocardial blood flow|myocardial blood flow
333137|NCT01520025|Myocardial blood flow reserve|myocardial blood flow reserve
333138|NCT01519999|Shared decision making|shared decision making
333139|NCT01519999|Ambulatory Care|ambulatory care
333140|NCT01519999|Patient-Centered Care|patient-centered care
333141|NCT01519999|Community-wide intervention|community-wide intervention
333142|NCT01519999|Intervention Study|intervention study
333143|NCT01519999|Longitudinal Studies|longitudinal studies
333144|NCT01519986|Vitamin D|vitamin d
333145|NCT01519986|Cholecalciferol|cholecalciferol
333146|NCT01519986|Supplementation|supplementation
333147|NCT01519986|Dietary Supplements|dietary supplements
333148|NCT01519986|Dietary Fats|dietary fats
333149|NCT01519986|25-hydroxyvitamin D|25-hydroxyvitamin d
333150|NCT01519973|Diagnostic imaging|diagnostic imaging
333151|NCT01519973|Single Photon Emission Computed Tomography|single photon emission computed tomography
333152|NCT01519973|Positron emission tomography|positron emission tomography
333153|NCT01519973|Computed tomography|computed tomography
333154|NCT01519973|Attenuation|attenuation
333155|NCT01519973|Resolution|resolution
333156|NCT01519973|Scatter|scatter
333157|NCT01519973|Radiopharmaceutical|radiopharmaceutical
333158|NCT01519934|Ulthera® System|ulthera® system
333159|NCT01519934|Ultherapy™ Treatment|ultherapy™ treatment
333160|NCT01519934|Ulthera, Inc.|ulthera, inc.
333161|NCT01519934|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
333162|NCT01519908|cardiac resynchronization therapy|cardiac resynchronization therapy
333163|NCT01519908|biomarkers|biomarkers
333164|NCT01519908|response|response
333165|NCT01519895|quality of life|quality of life
333166|NCT01519895|anxiety|anxiety
333168|NCT01519895|carers|carers
333169|NCT01519895|colorectal or colon cancer|colorectal or colon cancer
333170|NCT01519882|Rotigotine|rotigotine
333171|NCT01519882|Neupro|neupro
333172|NCT01519882|Polysomnography|polysomnography
333173|NCT01519882|Sleep efficiency|sleep efficiency
333174|NCT01519882|Advanced Idiopathic Parkinson's Disease|advanced idiopathic parkinson's disease
333175|NCT01519882|Sleep Disorder|sleep disorder
333176|NCT01519869|peritoneal|peritoneal
333177|NCT01519869|carcinoma|carcinoma
333178|NCT01519869|ovarian|ovarian
333179|NCT01519869|fallopian tube|fallopian tube
333180|NCT01519869|neoadjuvant chemotherapy|neoadjuvant chemotherapy
333181|NCT01519869|surgical debulking|surgical debulking
333182|NCT01519856|open|open
333183|NCT01519856|non-intervention|non-intervention
333184|NCT01519856|observational|observational
333185|NCT01519843|stroke|stroke
333186|NCT01519830|Anemia, Iron-Deficiency|anemia, iron-deficiency
333187|NCT01519830|Blood Donors|blood donors
333188|NCT01519817|Vaccine Therapy|vaccine therapy
333189|NCT01519817|Dose-Limiting Toxicity|dose-limiting toxicity
333190|NCT01519817|Maximum Tolerated Dose|maximum tolerated dose
333191|NCT01519817|Clinical Response|clinical response
333192|NCT01519817|Immune Response|immune response
333193|NCT01519817|Cancer|cancer
333194|NCT01519817|Solid Tumor|solid tumor
333195|NCT01519791|Certolizumab Pegol - Cimzia|certolizumab pegol - cimzia
333196|NCT01519791|Methotrexate|methotrexate
333197|NCT01519791|Rheumatoid Arthritis|rheumatoid arthritis
333198|NCT01519752|Tinea Pedis|tinea pedis
333199|NCT01519713|Meningitis|meningitis
333200|NCT01519713|Meningococcal Meningitis|meningococcal meningitis
333201|NCT01519713|Meningococcal Infections|meningococcal infections
333202|NCT01519713|Meningococcal conjugate Vaccine|meningococcal conjugate vaccine
333203|NCT01519713|Menactra®|menactra®
333204|NCT01519700|Filgrastim|filgrastim
333205|NCT01519700|G-CSF, neutropenia|g-csf, neutropenia
333206|NCT01519700|supportive care|supportive care
333207|NCT01519700|breast cancer|breast cancer
333208|NCT01519687|hyperuricemia|hyperuricemia
333209|NCT01519687|gout|gout
333210|NCT01519687|levotofisopam|levotofisopam
333211|NCT01519661|Tobramycin Inhalation powder|tobramycin inhalation powder
333212|NCT01519661|Cystic fibrosis|cystic fibrosis
333213|NCT01519661|Lung disease|lung disease
333214|NCT01519661|Anti-bacterial agents|anti-bacterial agents
333215|NCT01519648|Invasive fungal infection|invasive fungal infection
333216|NCT01519648|Acute leukemia (AL)|acute leukemia (al)
333217|NCT01519648|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
333218|NCT01519648|Antifungal stewardship|antifungal stewardship
333219|NCT01519648|Neutropenia|neutropenia
333220|NCT01519648|Hematological malignancies|hematological malignancies
333221|NCT01519635|Kidney oxygenation|kidney oxygenation
333222|NCT01519635|Stage 1 or 2 hypertension|stage 1 or 2 hypertension
333223|NCT01519635|BOLD-IRM|bold-irm
333224|NCT01519622|End of life decisions|end of life decisions
333225|NCT01519622|Perception of illness|perception of illness
333226|NCT01519609|Bowel prep|bowel prep
333227|NCT01519609|Safety|safety
333228|NCT01519609|Efficacy|efficacy
333229|NCT01519583|walking|walking
333230|NCT01519583|physical activity|physical activity
333231|NCT01519583|sedentary behavior|sedentary behavior
333232|NCT01519570|Herpes Zoster vaccine|herpes zoster vaccine
323951|NCT01559298|Aspirin|aspirin
333233|NCT01519570|Electronic patient portal|electronic patient portal
333234|NCT01519570|Electronic medical record|electronic medical record
333235|NCT01519570|Primary care|primary care
333236|NCT01519570|Immunizations|immunizations
333237|NCT01519544|Sleep|sleep
333238|NCT01519544|High Altitude|high altitude
333239|NCT01519544|High-altitude Sleep Disturbance|high-altitude sleep disturbance
333240|NCT01519544|Acute Mountain Sickness|acute mountain sickness
333241|NCT01519544|Difficulty Sleeping at High Altitude|difficulty sleeping at high altitude
333242|NCT01519544|Periodic Breathing|periodic breathing
333243|NCT01519544|Actigraphy|actigraphy
333244|NCT01519544|Acetazolamide|acetazolamide
333245|NCT01519544|Temazepam|temazepam
333246|NCT01519544|Groningen Sleep Quality Questionnaire survey|groningen sleep quality questionnaire survey
333247|NCT01519544|Stanford Sleepiness Scale|stanford sleepiness scale
333248|NCT01519544|Lake Louise Acute Mountain Sickness Score|lake louise acute mountain sickness score
333249|NCT01519518|ST elevation myocardial infarction|st elevation myocardial infarction
333250|NCT01519518|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
333251|NCT01519518|Unfractionated heparin|unfractionated heparin
333252|NCT01519518|Bivalirudin|bivalirudin
333253|NCT01519518|primary angioplasty|primary angioplasty
333254|NCT01519505|Prevention|prevention
333255|NCT01519505|Diabetes mellitus|diabetes mellitus
333256|NCT01519505|Lifestyle changes|lifestyle changes
333257|NCT01519505|Cardiovascular risk|cardiovascular risk
333258|NCT01519505|Cost-effectiveness|cost-effectiveness
333259|NCT01519492|Skin and Subcutaneous Tissue Bacterial Infections|skin and subcutaneous tissue bacterial infections
333260|NCT01519479|Congestive Heart Failure|congestive heart failure
333261|NCT01519479|Heart Failure|heart failure
333262|NCT01519479|Palliative Care|palliative care
333263|NCT01519479|Palliative Medicine|palliative medicine
333264|NCT01519466|Diabetes|diabetes
333265|NCT01519466|SMBG|smbg
333266|NCT01519466|Insulin calculator|insulin calculator
333267|NCT01519453|Asthma|asthma
333268|NCT01519453|Preschool|preschool
333269|NCT01519453|Health Disparities|health disparities
333270|NCT01519453|Implementation|implementation
333271|NCT01519440|unintended extension|unintended extension
333272|NCT01519440|blunt|blunt
333273|NCT01519440|sharp|sharp
333274|NCT01519440|maternal blood loss|maternal blood loss
333275|NCT01519401|PCOS|pcos
333276|NCT01519401|drospirenone ethinylestradiol|drospirenone ethinylestradiol
333277|NCT01519401|androgens|androgens
333278|NCT01519401|metabolism|metabolism
333279|NCT01519388|Neuromuscular disorder|neuromuscular disorder
333280|NCT01519388|Respiratory failure|respiratory failure
333281|NCT01519388|Swallowing|swallowing
333491|NCT01518634|Treatment|treatment
333282|NCT01519388|Mechanical ventilation|mechanical ventilation
333283|NCT01519375|Osteoarthritis|osteoarthritis
333284|NCT01519375|Rheumatoid Arthritis|rheumatoid arthritis
333285|NCT01519375|Ankylosing Spondylitis|ankylosing spondylitis
333286|NCT01519362|Polyacrylamide hydrogel|polyacrylamide hydrogel
333287|NCT01519362|leukocytopenia|leukocytopenia
333288|NCT01519362|migration|migration
333289|NCT01519362|complication|complication
333290|NCT01519362|epicranial aponeurosis|epicranial aponeurosis
333291|NCT01519362|PAAG injection|paag injection
333292|NCT01519349|Becker muscular dystrophy|becker muscular dystrophy
333293|NCT01519349|BMD|bmd
333294|NCT01519349|muscular dystrophy|muscular dystrophy
333295|NCT01519349|inclusion body myositis|inclusion body myositis
333296|NCT01519349|IBM|ibm
333297|NCT01519349|Follistatin|follistatin
333298|NCT01519310|choline metabolism|choline metabolism
333299|NCT01519310|gut flora|gut flora
333300|NCT01519310|phosphatidylcholine|phosphatidylcholine
333301|NCT01519310|lecithin|lecithin
333302|NCT01519297|Preeclampsia|preeclampsia
333303|NCT01519297|Pregnancy Induced Hypertension|pregnancy induced hypertension
333304|NCT01519284|Parkinson Disease|parkinson disease
333305|NCT01519284|BIA 9-1067|bia 9-1067
333306|NCT01519271|Parkinson's Disease|parkinson's disease
333307|NCT01519271|Mild Cognitive Impairment|mild cognitive impairment
333308|NCT01519271|Cognition|cognition
333309|NCT01519271|Memory|memory
333310|NCT01519271|Attention|attention
333311|NCT01519271|Exelon|exelon
333312|NCT01519271|Rivastigmine|rivastigmine
333313|NCT01519258|ARDS|ards
333314|NCT01519245|coronary artery bypass grafting|coronary artery bypass grafting
333315|NCT01519245|tranexamic acid|tranexamic acid
333316|NCT01519245|antifibrinolytic|antifibrinolytic
333317|NCT01519245|administration, topical|administration, topical
333318|NCT01519245|operative blood salvage|operative blood salvage
333319|NCT01519232|hepatocellular carcinoma|hepatocellular carcinoma
333320|NCT01519219|hepatic irradiation|hepatic irradiation
333321|NCT01519219|IC-GREEN|ic-green
333322|NCT01519206|Ulthera® System|ulthera® system
333323|NCT01519206|Ultherapy™ Treatment|ultherapy™ treatment
333324|NCT01519206|Ulthera, Inc.|ulthera, inc.
333325|NCT01519193|Aggressive Behavior|aggressive behavior
333326|NCT01519193|Appetitive Aggression|appetitive aggression
324050|NCT01558830|safety|safety
333327|NCT01519193|Post-Traumatic Stress Disorder|post-traumatic stress disorder
333328|NCT01519180|gastroparesis|gastroparesis
333329|NCT01519180|gastric emptying|gastric emptying
333330|NCT01519180|antro-duodenal manometry|antro-duodenal manometry
333331|NCT01519154|deep sedation|deep sedation
333332|NCT01519154|propofol|propofol
333333|NCT01519154|ketamine|ketamine
333334|NCT01519154|child|child
333335|NCT01519154|preschool child|preschool child
333336|NCT01519154|infant|infant
333337|NCT01519154|recovery and quality of sedation|recovery and quality of sedation
333338|NCT01519141|Human Immunodeficiency Virus|human immunodeficiency virus
333339|NCT01519141|Atherosclerosis|atherosclerosis
333340|NCT01519141|Inflammation|inflammation
333341|NCT01519141|Endothelial Function|endothelial function
333342|NCT01519141|Thrombosis|thrombosis
333343|NCT01519128|Healthy|healthy
333344|NCT01519128|TMC278|tmc278
333345|NCT01519128|TMC278IFD1001|tmc278ifd1001
751925|NCT01171248|ambulatory blood pressure|ambulatory blood pressure
333346|NCT01519128|Human immunodeficiency virus - type 1|human immunodeficiency virus - type 1
333347|NCT01519128|Pharmacokinetics|pharmacokinetics
333348|NCT01519128|Digoxin|digoxin
333349|NCT01519115|deep cervical flexors|deep cervical flexors
333350|NCT01519115|spine stabilization|spine stabilization
333351|NCT01519115|posture|posture
333352|NCT01519115|function|function
333353|NCT01519115|neck pain|neck pain
333354|NCT01519089|chronic|chronic
333355|NCT01519089|severe|severe
333356|NCT01519089|moderate|moderate
333357|NCT01519089|treatment|treatment
333358|NCT01519089|safety|safety
333359|NCT01519089|efficacy|efficacy
333360|NCT01519089|CP-690|cp-690
333361|NCT01519089|550|550
333362|NCT01519089|Plaque psoriasis|plaque psoriasis
333363|NCT01519089|Psoriasis Vulgaris|psoriasis vulgaris
333364|NCT01519089|Psoriatic Arthritis|psoriatic arthritis
333365|NCT01519089|tofacitinib|tofacitinib
333366|NCT01519089|Xeljanz|xeljanz
333367|NCT01519076|stroke|stroke
333368|NCT01519063|Alcohol|alcohol
333369|NCT01519063|Drinking|drinking
333370|NCT01519063|Drinkers|drinkers
333371|NCT01519063|Alcohol Drinking|alcohol drinking
333372|NCT01519063|Memantine|memantine
333373|NCT01519063|Naltrexone|naltrexone
333374|NCT01519063|Alcohol Dependence|alcohol dependence
333375|NCT01519063|Alcohol Abuse|alcohol abuse
333376|NCT01519063|Alcohol-Related Disorders|alcohol-related disorders
333377|NCT01519063|Ethanol|ethanol
333378|NCT01519063|Alcoholism|alcoholism
333379|NCT01519037|calcimimetic agent|calcimimetic agent
333380|NCT01519037|RAAS|raas
333381|NCT01519037|renin|renin
333382|NCT01519037|aldosterone|aldosterone
333383|NCT01519024|hypertrophy|hypertrophy
333384|NCT01519024|breast|breast
333385|NCT01519024|postural balance|postural balance
333386|NCT01519011|Myelodysplastic Syndromes|myelodysplastic syndromes
333387|NCT01519011|MDS|mds
333388|NCT01519011|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
333389|NCT01519011|CMML|cmml
333390|NCT01519011|Acute Myeloid Leukemia|acute myeloid leukemia
333391|NCT01519011|AML|aml
333392|NCT01519011|Vidaza|vidaza
333393|NCT01519011|oral azacitidine|oral azacitidine
333394|NCT01519011|aza|aza
333395|NCT01519011|oral aza|oral aza
333396|NCT01519011|pharmacokinetics|pharmacokinetics
333397|NCT01519011|hematology|hematology
333398|NCT01519011|myeloid disease|myeloid disease
333399|NCT01519011|PK|pk
333400|NCT01518998|Fimasartan|fimasartan
333401|NCT01518998|Amlodipine|amlodipine
333402|NCT01518998|antihypertension|antihypertension
333403|NCT01518972|Alcohol|alcohol
333404|NCT01518972|Abuse|abuse
333405|NCT01518972|Use|use
333406|NCT01518972|Disorder|disorder
333407|NCT01518972|Dependence|dependence
333408|NCT01518972|Symptoms|symptoms
333409|NCT01518972|Alcoholic|alcoholic
333410|NCT01518972|Alcoholism|alcoholism
333411|NCT01518972|Prazosin|prazosin
333412|NCT01518972|Drug|drug
333413|NCT01518972|Medicine|medicine
333414|NCT01518972|Medication|medication
333415|NCT01518972|Treatment|treatment
333416|NCT01518972|Study|study
333417|NCT01518972|Placebo|placebo
333418|NCT01518972|Medical|medical
333419|NCT01518972|Management|management
333420|NCT01518972|Craving|craving
333421|NCT01518972|Consumption|consumption
333422|NCT01518972|Binge|binge
333423|NCT01518972|Drinking|drinking
333424|NCT01518972|Drink|drink
333425|NCT01518972|Heavy|heavy
333426|NCT01518972|PTSD|ptsd
333427|NCT01518972|Trauma|trauma
333428|NCT01518972|Post|post
333429|NCT01518972|Posttraumatic|posttraumatic
333430|NCT01518946|Symptomatic Orthostatic Hypotension|symptomatic orthostatic hypotension
333431|NCT01518933|HCV recurrence|hcv recurrence
333432|NCT01518933|stable liver transplanted patients|stable liver transplanted patients
333433|NCT01518920|Age related sensorineural hearing loss|age related sensorineural hearing loss
333434|NCT01518920|PF-04958242|pf-04958242
333435|NCT01518907|cellulite|cellulite
333436|NCT01518907|Xiaflex|xiaflex
333437|NCT01518894|PF-04958242|pf-04958242
333438|NCT01518894|multiple dose|multiple dose
333439|NCT01518894|Safety|safety
333440|NCT01518894|schizophrenia|schizophrenia
333441|NCT01518842|ischemic retinopathy, stem cell,bone marrow|ischemic retinopathy, stem cell,bone marrow
333442|NCT01518829|hepatocellular carcinom|hepatocellular carcinom
333443|NCT01518829|postablation syndrom|postablation syndrom
333444|NCT01518829|procalcitonin|procalcitonin
333445|NCT01518816|antioxidant preterm labor|antioxidant preterm labor
333446|NCT01518803|Obesity|obesity
333447|NCT01518803|Adolescence|adolescence
333448|NCT01518803|Lipid metabolism|lipid metabolism
333449|NCT01518803|Mediterranean diet|mediterranean diet
333450|NCT01518803|Chylomicron|chylomicron
333451|NCT01518803|Macrophages|macrophages
333452|NCT01518790|PEG 3350|peg 3350
333453|NCT01518790|boston bowel preparation scale|boston bowel preparation scale
333454|NCT01518790|colonoscopy cleanout|colonoscopy cleanout
333455|NCT01518790|bowel preparation|bowel preparation
333456|NCT01518790|miralax|miralax
333118|NCT01520064|ULP|ulp
333458|NCT01518790|cleanout efficacy|cleanout efficacy
333459|NCT01518790|Focus of study is efficacy of PEG 3350 cleanout for improving diagnostic yield of colonoscopy.|focus of study is efficacy of peg 3350 cleanout for improving diagnostic yield of colonoscopy.
333460|NCT01518777|Coronary Artery Disease|coronary artery disease
333461|NCT01518725|Muscle Power|muscle power
333462|NCT01518725|Vitamin D|vitamin d
333463|NCT01518725|Vitamins|vitamins
333464|NCT01518725|Cholecalciferol|cholecalciferol
333465|NCT01518712|Healthy Volunteers|healthy volunteers
333466|NCT01518712|Bioequivalence|bioequivalence
333467|NCT01518712|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
333468|NCT01518712|Metformin IR|metformin ir
333469|NCT01518686|Norm values|norm values
333470|NCT01518686|semi-automated kinetic perimetry|semi-automated kinetic perimetry
333471|NCT01518686|isopters|isopters
333472|NCT01518686|mathematical model|mathematical model
333473|NCT01518686|luminance|luminance
333474|NCT01518686|test-retest reliability|test-retest reliability
333475|NCT01518686|deviation|deviation
333476|NCT01518686|age dependance|age dependance
333477|NCT01518686|different age groups|different age groups
333478|NCT01518686|Healthy subjects|healthy subjects
333479|NCT01518660|Resistance Training|resistance training
333480|NCT01518660|Strength Training|strength training
333481|NCT01518647|Bodily Distress Syndrome|bodily distress syndrome
333482|NCT01518647|Medically unexplained symptoms|medically unexplained symptoms
333483|NCT01518647|Functional somatic symptoms|functional somatic symptoms
333484|NCT01518647|Functional somatic syndromes|functional somatic syndromes
333485|NCT01518647|Treatment|treatment
333486|NCT01518647|Acceptance and Commitment Therapy|acceptance and commitment therapy
333487|NCT01518634|Bodily Distress Syndrome|bodily distress syndrome
333488|NCT01518634|Medically unexplained symptoms|medically unexplained symptoms
333489|NCT01518634|Functional somatic symptoms|functional somatic symptoms
333490|NCT01518634|Functional somatic syndromes|functional somatic syndromes
333492|NCT01518634|Imipramine|imipramine
333493|NCT01518634|Tricyclic antidepressant|tricyclic antidepressant
333494|NCT01518608|Alfentanil|alfentanil
333495|NCT01518608|Tracheal intubation|tracheal intubation
333496|NCT01518608|Rapid sequence induction|rapid sequence induction
333497|NCT01518595|patients|patients
333498|NCT01518582|Cervicobrachial|cervicobrachial
333499|NCT01518582|neuralgia|neuralgia
333500|NCT01518582|symptomatic cervical discopathy|symptomatic cervical discopathy
333501|NCT01518569|ulinastatin|ulinastatin
333502|NCT01518569|systemic inflammation|systemic inflammation
333503|NCT01518569|cardiac surgery|cardiac surgery
333504|NCT01518569|cardiopulmonary bypass|cardiopulmonary bypass
333505|NCT01518556|Idarubicin|idarubicin
333506|NCT01518556|Remission Induction|remission induction
333507|NCT01518556|Maximum Tolerated Dose|maximum tolerated dose
333508|NCT01518556|Survival|survival
333509|NCT01518543|arthrodesis|arthrodesis
333510|NCT01518543|arthrodesis in the following joints:Ankle, 1st MTP, Metatarso - Cuneiform (1st), Navicular - Cuneiform, Talo-Navicular, Calcaneum - Cuboid;|arthrodesis in the following joints:ankle, 1st mtp, metatarso - cuneiform (1st), navicular - cuneiform, talo-navicular, calcaneum - cuboid;
333511|NCT01518530|Chronic Neck Pain, Occiflex, Computerized Mobilization|chronic neck pain, occiflex, computerized mobilization
333512|NCT01518517|acute lymphoblastic leukemia|acute lymphoblastic leukemia
333513|NCT01518517|relapse|relapse
333514|NCT01518517|asparaginase|asparaginase
333515|NCT01518504|Thoracic|thoracic
333516|NCT01518504|Manipulation|manipulation
333517|NCT01518504|Manual Therapy|manual therapy
333518|NCT01518504|Mobilization|mobilization
333519|NCT01518504|Shoulder|shoulder
333520|NCT01518504|Range of Motion|range of motion
333521|NCT01518452|working memory training, computerized|working memory training, computerized
333522|NCT01518452|clinical assessment|clinical assessment
333523|NCT01518452|quantitative EEG|quantitative eeg
333524|NCT01518452|child, preschool|child, preschool
333525|NCT01518439|neuromuscular|neuromuscular
333526|NCT01518439|cough|cough
333527|NCT01518439|restrictive|restrictive
333528|NCT01518426|Brain computer interface|brain computer interface
333529|NCT01518426|EEG recording|eeg recording
333530|NCT01518426|Electrodes|electrodes
333531|NCT01518413|Sora./Irino. combination therapy|sora./irino. combination therapy
333532|NCT01518400|Pediatric Cancer|pediatric cancer
333533|NCT01518400|Cancer Late Effects|cancer late effects
333534|NCT01518400|Cancer Survivor|cancer survivor
333535|NCT01518400|Cancer Survivorship|cancer survivorship
333536|NCT01518387|Hyperphosphatemia in ESRD (End Stage Renal Disease) patients on dialysis|hyperphosphatemia in esrd (end stage renal disease) patients on dialysis
333537|NCT01518374|Male or female subjects at least 18 years of age|male or female subjects at least 18 years of age
333538|NCT01518374|AD|ad
333539|NCT01518374|MCI|mci
333540|NCT01518348|Patch Test|patch test
333541|NCT01518348|Contact Dermatitis|contact dermatitis
333542|NCT01518348|Allergy|allergy
333543|NCT01518348|Children|children
333544|NCT01518348|PREA|prea
333545|NCT01518335|platelet rich plasma|platelet rich plasma
333546|NCT01518335|ankle|ankle
333547|NCT01518335|sprain|sprain
333548|NCT01518335|injection|injection
333549|NCT01518335|Platelet Rich Plasma therapy|platelet rich plasma therapy
333550|NCT01518335|focal, invasive therapy for sprains|focal, invasive therapy for sprains
333551|NCT01518322|Asthma|asthma
333552|NCT01518322|Fractional Exhaled Nitric Oxide|fractional exhaled nitric oxide
333553|NCT01518322|Respiratory Symptoms|respiratory symptoms
333554|NCT01518322|NIOX MINO|niox mino
333555|NCT01518322|Inhaled corticosteroids|inhaled corticosteroids
333556|NCT01518322|Nitric Oxide|nitric oxide
333557|NCT01518296|Pelvic Organ Prolapse Quantification (POPQ)|pelvic organ prolapse quantification (popq)
333558|NCT01518296|POPQ|popq
333559|NCT01518296|Urodynamic test|urodynamic test
333560|NCT01518283|Weekly cabazitaxel.|weekly cabazitaxel.
333561|NCT01518283|Advanced Hormone-refractory prostate Cancer.|advanced hormone-refractory prostate cancer.
333562|NCT01518283|Unfit patients.|unfit patients.
333563|NCT01518244|Primary open angle-glaucoma|primary open angle-glaucoma
333564|NCT01518244|Ocular hypertension|ocular hypertension
333565|NCT01518244|Pigment dispersion glaucoma|pigment dispersion glaucoma
333566|NCT01518231|stroke|stroke
713548|NCT01020110|HUVEC|huvec
333567|NCT01518231|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
333568|NCT01518218|Sickle cell disease|sickle cell disease
333569|NCT01518218|laying-on-of-hands|laying-on-of-hands
333570|NCT01518218|morbidity|morbidity
333571|NCT01518218|mortality|mortality
333572|NCT01518205|diabetic foot ulcers,|diabetic foot ulcers,
333573|NCT01518205|peripheral arterial disease,|peripheral arterial disease,
333574|NCT01518205|heparin-induced extracorporal lipid apheresis.|heparin-induced extracorporal lipid apheresis.
333575|NCT01518205|inflammatory markers|inflammatory markers
333576|NCT01518205|type 2 diabetes|type 2 diabetes
333577|NCT01518205|LDL-cholesterol|ldl-cholesterol
333578|NCT01518192|erythema migrans|erythema migrans
333579|NCT01518192|doxycycline|doxycycline
333580|NCT01518192|cefuroxime axetil|cefuroxime axetil
333581|NCT01518192|post-Lyme disease symptoms|post-lyme disease symptoms
333582|NCT01518192|background symptoms in general population|background symptoms in general population
333583|NCT01518179|Colles' Fracture|colles' fracture
333584|NCT01518179|Compression Bandages|compression bandages
333585|NCT01518179|Occupational therapy|occupational therapy
333586|NCT01518179|Rehabilitation|rehabilitation
333587|NCT01518179|Smith's fracture|smith's fracture
333588|NCT01518153|Blood and Marrow Transplantation|blood and marrow transplantation
333589|NCT01518153|Lymphoma|lymphoma
333590|NCT01518153|Myeloma|myeloma
333591|NCT01518153|Myeloproliferative Diseases|myeloproliferative diseases
333592|NCT01518153|Leukemia|leukemia
333593|NCT01518153|Myelodysplastic syndrome|myelodysplastic syndrome
333594|NCT01518153|MDS|mds
333595|NCT01518153|Hodgkin disease|hodgkin disease
333596|NCT01518153|Multiple myeloma|multiple myeloma
333597|NCT01518153|Fludarabine|fludarabine
333598|NCT01518153|Fludarabine Phosphate|fludarabine phosphate
333599|NCT01518153|Fludara|fludara
333600|NCT01518153|Melphalan|melphalan
333601|NCT01518153|Alkeran|alkeran
333602|NCT01518153|Tacrolimus|tacrolimus
333603|NCT01518153|Prograf|prograf
333604|NCT01518153|Methotrexate|methotrexate
333605|NCT01518153|G-CSF|g-csf
333606|NCT01518153|Filgrastim|filgrastim
333607|NCT01518153|NeupogenTM|neupogentm
333608|NCT01518153|Donor Lymphocyte Infusion|donor lymphocyte infusion
333609|NCT01518153|DLI|dli
333610|NCT01518153|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
333611|NCT01518153|Graft-vs-host disease|graft-vs-host disease
333612|NCT01518153|GvHD|gvhd
333613|NCT01518153|T-lymphocytes|t-lymphocytes
333614|NCT01518153|T-cells|t-cells
333615|NCT01518153|Alemtuzumab|alemtuzumab
333616|NCT01518153|CAMPATH-1H|campath-1h
333617|NCT01518153|Campath|campath
333618|NCT01518140|Advanced Cancers|advanced cancers
333619|NCT01518140|Locally advanced|locally advanced
333620|NCT01518140|Recurrent|recurrent
333621|NCT01518140|Metastatic disease|metastatic disease
333622|NCT01518140|Oxygen Delivery Modalities|oxygen delivery modalities
414403|NCT01180660|Pain|pain
333623|NCT01518140|Shortness of breath|shortness of breath
333624|NCT01518140|Dyspnea|dyspnea
333625|NCT01518140|VapoTherm|vapotherm
333626|NCT01518140|Bilevel positive airway pressure|bilevel positive airway pressure
333627|NCT01518140|BiPAP|bipap
333628|NCT01518140|Non-rebreather mask|non-rebreather mask
333629|NCT01518127|Macular Degeneration|macular degeneration
333630|NCT01518114|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
333631|NCT01518114|Exercise Training|exercise training
333632|NCT01518114|Cardiac Rehabilitation|cardiac rehabilitation
333633|NCT01518114|Heart Failure|heart failure
333634|NCT01518101|patient preference|patient preference
333635|NCT01518101|vildagliptin|vildagliptin
333636|NCT01518101|liraglutide|liraglutide
333637|NCT01518075|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
333638|NCT01518075|Non invasive mechanical ventilation|non invasive mechanical ventilation
333639|NCT01518075|Breathing-swallowing interaction|breathing-swallowing interaction
333640|NCT01518075|Intensive Care Unit|intensive care unit
333641|NCT01518049|Affective Disorders, Psychotic|affective disorders, psychotic
333642|NCT01518049|Psychometrics|psychometrics
333643|NCT01518049|Biological Markers|biological markers
333645|NCT01518023|prediabetes|prediabetes
333646|NCT01518023|fasting blood glucose|fasting blood glucose
333647|NCT01518023|HbA1c|hba1c
333648|NCT01518023|Roux en Y gastric bypass|roux en y gastric bypass
333649|NCT01518023|Cancer gastrectomy|cancer gastrectomy
333650|NCT01518023|Cancer colorectal surgery|cancer colorectal surgery
333651|NCT01518010|Brain injury|brain injury
333652|NCT01518010|Cognitive rehabilitation|cognitive rehabilitation
333653|NCT01518010|Video game|video game
333654|NCT01517997|Drug coated balloons|drug coated balloons
333655|NCT01517997|Drug eluting stents|drug eluting stents
333656|NCT01517984|recipients of living-donor kidney allografts|recipients of living-donor kidney allografts
333657|NCT01517984|antithymocyte globulin (ATG) induction|antithymocyte globulin (atg) induction
333658|NCT01517984|calcineurin inhibitors (CNIs)|calcineurin inhibitors (cnis)
333659|NCT01517984|CNI withdrawal|cni withdrawal
333660|NCT01517971|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
333661|NCT01517971|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
714641|NCT01010464|Laparotomy|laparotomy
333662|NCT01517971|adenocarcinoma of the lung|adenocarcinoma of the lung
333663|NCT01517971|squamous cell lung cancer|squamous cell lung cancer
333664|NCT01517958|Transient tachypnea of the newborn|transient tachypnea of the newborn
333665|NCT01517958|Respiratory Distress Syndrome|respiratory distress syndrome
333666|NCT01517958|Lung Ultrasound|lung ultrasound
333667|NCT01517958|Neonates|neonates
333668|NCT01517945|Survivors|survivors
333669|NCT01517945|Quality of Life|quality of life
333670|NCT01517945|Questionnaire|questionnaire
333671|NCT01517945|11-204|11-204
333672|NCT01517919|peer support|peer support
333673|NCT01517919|peer leader|peer leader
333674|NCT01517919|community health worker|community health worker
333675|NCT01517919|empowerment|empowerment
333676|NCT01517919|self-management|self-management
333677|NCT01517906|eating disorder behaviors|eating disorder behaviors
333678|NCT01517906|well being|well being
333679|NCT01517906|functional health|functional health
333680|NCT01517893|vitiligo|vitiligo
333681|NCT01517893|simvastatin|simvastatin
333682|NCT01517880|Hereditary Inclusion Body Myopathy (HIBM)|hereditary inclusion body myopathy (hibm)
333683|NCT01517880|GNE myopathies|gne myopathies
333684|NCT01517880|distal myopathy with rimmed vacuoles [DMRV]|distal myopathy with rimmed vacuoles [dmrv]
333685|NCT01517880|Nonaka disease|nonaka disease
333686|NCT01517867|preschool children behavior problems|preschool children behavior problems
333687|NCT01517867|child between 2 and 5 years old|child between 2 and 5 years old
333688|NCT01517841|peritoneal dialysis|peritoneal dialysis
333689|NCT01517841|modality choice|modality choice
333690|NCT01517841|kidney disease|kidney disease
333691|NCT01517828|Intubation|intubation
333692|NCT01517828|Delivery room|delivery room
333693|NCT01517828|Sedation|sedation
333694|NCT01517828|Analgesia|analgesia
333695|NCT01517815|Septic shock|septic shock
333696|NCT01517815|overweight|overweight
333697|NCT01517815|critically ill|critically ill
333698|NCT01517815|pharmacokinetic|pharmacokinetic
333699|NCT01517815|doripenem|doripenem
333700|NCT01517815|piperacillin-tazobactam|piperacillin-tazobactam
333701|NCT01517802|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
333702|NCT01517802|Metastatic breast cancer|metastatic breast cancer
333703|NCT01517802|Abiraterone acetate|abiraterone acetate
333704|NCT01517802|Low-dose corticosteroid treatment|low-dose corticosteroid treatment
333705|NCT01517802|Long-term access|long-term access
333706|NCT01517789|Surgery|surgery
333707|NCT01517789|Optic Nerve and Pathway Injury|optic nerve and pathway injury
333708|NCT01517789|visual event-related potential|visual event-related potential
333709|NCT01517776|High grade glioma|high grade glioma
333710|NCT01517776|Glioblastoma multiforme|glioblastoma multiforme
333711|NCT01517776|Anaplastic astrocytoma|anaplastic astrocytoma
333712|NCT01517776|Diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
333713|NCT01517776|Relapse|relapse
333714|NCT01517776|refractory tumour disease|refractory tumour disease
333715|NCT01517776|Relapsed or refractory high grade gliomas and diffuse intrinsic pontine gliomas|relapsed or refractory high grade gliomas and diffuse intrinsic pontine gliomas
333716|NCT01517763|Obstructive Sleep Apnea|obstructive sleep apnea
333717|NCT01517763|Humidification|humidification
333718|NCT01517763|Continuous Positive Airway Pressure|continuous positive airway pressure
333719|NCT01517763|ICON|icon
333720|NCT01517763|ThermoSmart|thermosmart
333721|NCT01517763|SensAwake|sensawake
333722|NCT01517750|Obstructive Sleep Apnea|obstructive sleep apnea
333723|NCT01517750|Humidification|humidification
333724|NCT01517750|Continuous Positive Airway Pressure|continuous positive airway pressure
333725|NCT01517750|ICON|icon
333726|NCT01517750|ThermoSmart|thermosmart
333727|NCT01517724|MM|mm
333728|NCT01517724|HDT|hdt
333729|NCT01517724|ASCT|asct
333730|NCT01517724|consolidation|consolidation
333731|NCT01517724|bortezomib|bortezomib
333732|NCT01517711|pharmacotherapy|pharmacotherapy
333733|NCT01517711|combat disorders|combat disorders
333734|NCT01517685|Eicosapentaenoic acid|eicosapentaenoic acid
333735|NCT01517685|EPA|epa
333736|NCT01517685|Docosahexaenoic acid|docosahexaenoic acid
333738|NCT01517685|Omega 3 fat|omega 3 fat
333739|NCT01517685|alpha-linoleic acid|alpha-linoleic acid
333740|NCT01517685|ALA|ala
333741|NCT01517685|fish oil|fish oil
333742|NCT01517685|flax seed oil|flax seed oil
333743|NCT01517672|PTSD|ptsd
333744|NCT01517672|domestic violence|domestic violence
333745|NCT01517672|intimate partner violence|intimate partner violence
333746|NCT01517672|functional MRI|functional mri
333747|NCT01517672|neuroimaging|neuroimaging
333748|NCT01517659|Lipolysis|lipolysis
333749|NCT01517659|Cryolipolysis|cryolipolysis
333750|NCT01517659|Fat Reduction|fat reduction
333751|NCT01517646|Lipolysis|lipolysis
333752|NCT01517646|Cryolipolysis|cryolipolysis
333753|NCT01517646|Fat Reduction|fat reduction
333754|NCT01517633|Amniotic fluid leakage|amniotic fluid leakage
333755|NCT01517633|Urinary incontinence|urinary incontinence
333756|NCT01517581|Brown adipose tissue|brown adipose tissue
333757|NCT01517542|diet|diet
333758|NCT01517542|DASH|dash
333759|NCT01517542|Stroke|stroke
333760|NCT01517542|Nutritional counseling|nutritional counseling
333761|NCT01517529|Hepatitis C|hepatitis c
333762|NCT01517529|HCV|hcv
333763|NCT01517516|fMRI|fmri
333764|NCT01517516|resting state|resting state
333765|NCT01517516|structural MRI|structural mri
333766|NCT01517516|functional MRI|functional mri
333767|NCT01517477|Open angle|open angle
333768|NCT01517477|Glaucoma|glaucoma
333769|NCT01517477|surgery|surgery
333770|NCT01517477|Glaucoma, Open-Angle|glaucoma, open-angle
333771|NCT01517477|Ocular Hypertension|ocular hypertension
333772|NCT01517477|Eye Diseases|eye diseases
333773|NCT01517464|neoplasm|neoplasm
333774|NCT01517464|bladder cancer|bladder cancer
333775|NCT01517464|advances solid tumors|advances solid tumors
333776|NCT01517438|agitation, desflurane, children|agitation, desflurane, children
333777|NCT01517399|Oncology|oncology
333778|NCT01517399|pharmacokinetics|pharmacokinetics
333779|NCT01517399|PK interaction in advanced solid tumors with our drug and other drugs|pk interaction in advanced solid tumors with our drug and other drugs
334076|NCT01516281|PD|pd
333780|NCT01517386|paravertebral space|paravertebral space
333781|NCT01517386|needle placement|needle placement
333782|NCT01517386|tissue identification|tissue identification
333783|NCT01517386|regional|regional
333784|NCT01517373|T2DM|t2dm
333785|NCT01517373|PF-04937319|pf-04937319
333786|NCT01517373|Phase 2|phase 2
333787|NCT01517360|Schizophrenia|schizophrenia
333788|NCT01517360|Social Cognition|social cognition
333789|NCT01517360|Oxytocin|oxytocin
333790|NCT01517347|IL2|il2
333791|NCT01517347|relapse|relapse
333792|NCT01517347|GVHD|gvhd
333793|NCT01517347|survival|survival
333794|NCT01517347|allogeneic stem cell transplantation|allogeneic stem cell transplantation
333795|NCT01517347|MRD|mrd
333796|NCT01517347|CR|cr
333797|NCT01517308|HCV|hcv
333798|NCT01517308|Hepatitis|hepatitis
333799|NCT01517308|Genotype 2 or 3|genotype 2 or 3
333800|NCT01517308|Pegylated Interferon|pegylated interferon
333801|NCT01517308|Duration|duration
333802|NCT01517295|Pharmacokinetics|pharmacokinetics
333803|NCT01517295|Hydromorphone|hydromorphone
333804|NCT01517295|Hydrocodone|hydrocodone
333805|NCT01517295|APAP|apap
333806|NCT01517269|Parent education|parent education
333807|NCT01517256|Chronic pain|chronic pain
333808|NCT01517256|Primary care|primary care
333809|NCT01517256|Multidisciplinary group therapy|multidisciplinary group therapy
333810|NCT01517256|Embedded mixed-methods study|embedded mixed-methods study
333811|NCT01517243|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
333812|NCT01517243|sunitinib|sunitinib
333813|NCT01517243|alternating|alternating
333814|NCT01517243|temsirolimus|temsirolimus
324541|NCT01557166|OSA|osa
333815|NCT01517230|Cluster-randomised trial|cluster-randomised trial
333816|NCT01517230|Comprehensive mass media campaign|comprehensive mass media campaign
333817|NCT01517230|Rural community radio|rural community radio
333818|NCT01517230|Under-five child mortality|under-five child mortality
333819|NCT01517230|Preventive and curative behaviours|preventive and curative behaviours
333820|NCT01517230|Burkina Faso|burkina faso
333821|NCT01517230|Health care seeking behavior|health care seeking behavior
333822|NCT01517230|Childbirth|childbirth
333823|NCT01517217|girdle|girdle
333824|NCT01517217|laparotomy|laparotomy
333825|NCT01517217|pulmonary function|pulmonary function
333826|NCT01517217|postoperative pain|postoperative pain
333827|NCT01517217|mobilisation|mobilisation
333828|NCT01517204|Trachway(R) intubating stylet|trachway(r) intubating stylet
333829|NCT01517204|Left sided double lumen endobronchial tube|left sided double lumen endobronchial tube
333830|NCT01517204|Efficacy|efficacy
333831|NCT01517204|Intubation complication|intubation complication
333832|NCT01517191|Influenza|influenza
333833|NCT01517191|Respiratory Infection|respiratory infection
333834|NCT01517165|Opioid Dependence|opioid dependence
333835|NCT01517165|Pioglitazone|pioglitazone
333836|NCT01517165|Buprenorphine|buprenorphine
333837|NCT01517152|Symptoms|symptoms
333838|NCT01517152|Patient-Reported Outcomes|patient-reported outcomes
333839|NCT01517152|Linguistic Validation|linguistic validation
333840|NCT01517152|Toxicity|toxicity
333841|NCT01517152|PRO-CTCAE|pro-ctcae
333842|NCT01517152|Adverse Events|adverse events
333843|NCT01517152|Translation|translation
333844|NCT01517152|Questionnaire|questionnaire
333845|NCT01517139|Diet and Nutrition|diet and nutrition
333846|NCT01517139|Pregnancy Folic Acid|pregnancy folic acid
333847|NCT01517139|In Utero Exposure|in utero exposure
333848|NCT01517139|DNA Methylation|dna methylation
333849|NCT01517139|Physical Activity|physical activity
333850|NCT01517126|Youth Suicide|youth suicide
333851|NCT01517126|Suicide Screening|suicide screening
333852|NCT01517126|Developmental Delay|developmental delay
333853|NCT01517126|Intellectual Disability|intellectual disability
333854|NCT01517126|Assessment Instrument|assessment instrument
333855|NCT01517126|Mental Retardation|mental retardation
333856|NCT01517126|Suicidal Thoughts|suicidal thoughts
333857|NCT01517126|Suicidal Behavior|suicidal behavior
333858|NCT01517113|Endothelial Dysfunction|endothelial dysfunction
333859|NCT01517113|Hepatic|hepatic
333860|NCT01517113|Adiposity|adiposity
333861|NCT01517113|Cytokines|cytokines
333862|NCT01517113|Muscle Mass|muscle mass
333863|NCT01517113|Coronary Artery Disease|coronary artery disease
333864|NCT01517113|Aging|aging
333865|NCT01517113|Inflammation|inflammation
333866|NCT01517100|Glucose|glucose
333867|NCT01517100|Insulin Secretion|insulin secretion
333868|NCT01517100|Insulin Action|insulin action
333869|NCT01517100|Endocannabinoids|endocannabinoids
333870|NCT01517100|Insulin|insulin
333871|NCT01517100|Metabolism|metabolism
333872|NCT01517087|Motor Function|motor function
333873|NCT01517087|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
333874|NCT01517087|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
333875|NCT01517087|Diffusion Tensor Imaging|diffusion tensor imaging
333876|NCT01517087|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
333877|NCT01517087|Healthy Volunteer|healthy volunteer
333879|NCT01517074|Sirolimus|sirolimus
333880|NCT01517074|Scleritis|scleritis
333881|NCT01517074|Autoimmune Scleritis|autoimmune scleritis
333882|NCT01517061|Phantom Limb Pain|phantom limb pain
333883|NCT01517061|Genetic Polymorphisms|genetic polymorphisms
333884|NCT01517061|Genetic Susceptibility|genetic susceptibility
333885|NCT01517061|Amputation|amputation
333886|NCT01517048|Body Composition|body composition
333887|NCT01517048|Obesity|obesity
333888|NCT01517048|Overweight|overweight
333889|NCT01517048|Energy Homeostasis|energy homeostasis
333890|NCT01517048|Nociception|nociception
333891|NCT01517048|Prader-Willi Syndrome|prader-willi syndrome
333892|NCT01517048|Genetic Disorder|genetic disorder
333893|NCT01517048|Healthy Volunteer|healthy volunteer
333894|NCT01517048|HV|hv
333895|NCT01517035|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
333896|NCT01517035|Stem Cell Transplant|stem cell transplant
333897|NCT01517035|Transplant|transplant
333898|NCT01517035|Myelodyplastic Syndrome|myelodyplastic syndrome
333899|NCT01517035|MDS|mds
333900|NCT01517035|Leukemia|leukemia
333901|NCT01517022|smoking cessation|smoking cessation
333902|NCT01517022|early sputum smear conversion|early sputum smear conversion
333903|NCT01517009|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
333904|NCT01517009|D1extra-resection|d1extra-resection
333905|NCT01516996|Neoadjuvant|neoadjuvant
333906|NCT01516996|Concurrent Chemoradiotherapy,CCRT|concurrent chemoradiotherapy,ccrt
333907|NCT01516996|Nimotuzumab|nimotuzumab
333908|NCT01516996|Locoregionally Advanced Oropharynx|locoregionally advanced oropharynx
333909|NCT01516996|Hypopharynx cancer|hypopharynx cancer
333910|NCT01516996|Randomized|randomized
333911|NCT01516996|Multicenter|multicenter
333912|NCT01516983|Safety|safety
333913|NCT01516983|EGFR-TKI|egfr-tki
333914|NCT01516983|NSCLC|nsclc
333915|NCT01516983|Icotinib|icotinib
333916|NCT01516983|WBRT|wbrt
333917|NCT01516970|Human Immunodeficiency Virus (HIV) Post exposure prophylaxis|human immunodeficiency virus (hiv) post exposure prophylaxis
333918|NCT01516970|DRV/r|drv/r
333919|NCT01516970|Occupational injury|occupational injury
333920|NCT01516970|Non-occupational exposure|non-occupational exposure
333921|NCT01516970|Prezista|prezista
333922|NCT01516970|Darunavir/r|darunavir/r
333923|NCT01516957|Psoriatic Arthritis|psoriatic arthritis
333924|NCT01516957|IL-17|il-17
333925|NCT01516957|AMG 827|amg 827
333926|NCT01516957|AMG827|amg827
333927|NCT01516957|Musculoskeletal Disease|musculoskeletal disease
333928|NCT01516957|Spondylarthropathy|spondylarthropathy
333929|NCT01516944|Tegafur，Gimeracil and Oteracil Potassium Capsules|tegafur，gimeracil and oteracil potassium capsules
333930|NCT01516944|Capecitabine|capecitabine
333931|NCT01516944|Oxaliplatin|oxaliplatin
333932|NCT01516944|perioperative Chemotherapy|perioperative chemotherapy
333933|NCT01516944|Gastric Cancer|gastric cancer
333934|NCT01516931|repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
333935|NCT01516931|Depression|depression
333936|NCT01516931|Venlafaxine|venlafaxine
333938|NCT01516879|Cholesterol|cholesterol
333939|NCT01516879|High Cholesterol|high cholesterol
333940|NCT01516879|Elevated Cholesterol|elevated cholesterol
333941|NCT01516879|Raised Cholesterol|raised cholesterol
333942|NCT01516866|Androgen receptor-directed therapy|androgen receptor-directed therapy
333943|NCT01516866|NaF PET/CT|naf pet/ct
333944|NCT01516866|antimicrotubule directed chemotherapy|antimicrotubule directed chemotherapy
333945|NCT01516840|acute symptomatic deep vein thrombosis|acute symptomatic deep vein thrombosis
333946|NCT01516827|PTSD|ptsd
333947|NCT01516827|Children and Adolescents|children and adolescents
333948|NCT01516827|Post-Traumatic Stress Disorder in Children and Adolescents|post-traumatic stress disorder in children and adolescents
333949|NCT01516814|acute symptomatic pulmonary embolism|acute symptomatic pulmonary embolism
333950|NCT01516801|Prostate Cancer Screening|prostate cancer screening
333951|NCT01516801|Pragmatic Trial|pragmatic trial
333952|NCT01516801|Health Literacy|health literacy
333953|NCT01516775|preoperative care|preoperative care
333954|NCT01516775|preoperative period|preoperative period
333955|NCT01516775|fasting|fasting
333956|NCT01516762|Radium 223|radium 223
333957|NCT01516762|Alpharadin|alpharadin
333958|NCT01516762|Prostate Cancer|prostate cancer
333959|NCT01516762|Bone metastases|bone metastases
333960|NCT01516762|Castrate resistant prostate cancer|castrate resistant prostate cancer
333961|NCT01516762|Hormone refractory prostate cancer|hormone refractory prostate cancer
333962|NCT01516749|hidradenitis suppurativa|hidradenitis suppurativa
333963|NCT01516749|anakinra|anakinra
333964|NCT01516736|Pegfilgrastim|pegfilgrastim
333965|NCT01516736|G-CSF|g-csf
333966|NCT01516736|neutropenia|neutropenia
333967|NCT01516736|breast cancer|breast cancer
333968|NCT01516736|myelosuppressive chemotherapy|myelosuppressive chemotherapy
333969|NCT01516723|drug-eluting stent|drug-eluting stent
333970|NCT01516723|chronic total occlusion|chronic total occlusion
333971|NCT01516723|hybrid sirolimus-eluting stent|hybrid sirolimus-eluting stent
333972|NCT01516723|everolimus-eluting stent|everolimus-eluting stent
333973|NCT01516710|Open liver resection|open liver resection
333974|NCT01516710|Laparoscopic liver resection|laparoscopic liver resection
333975|NCT01516710|Colorectal cancer liver metastases|colorectal cancer liver metastases
333976|NCT01516697|thoracic electric bioimpedance|thoracic electric bioimpedance
333977|NCT01516697|cardiac output monitoring|cardiac output monitoring
333978|NCT01516697|cesarean section|cesarean section
333979|NCT01516697|spinal anesthesia|spinal anesthesia
333980|NCT01516671|Subarachnoid hemorrhage|subarachnoid hemorrhage
333981|NCT01516671|Cerebral vasospasm|cerebral vasospasm
333982|NCT01516671|Neuroinflammation|neuroinflammation
333983|NCT01516671|Bilateral Bispectral Index|bilateral bispectral index
333984|NCT01516658|intracranial aneurysm|intracranial aneurysm
333985|NCT01516658|endovascular therapy|endovascular therapy
333986|NCT01516658|detachable coil|detachable coil
333987|NCT01516658|recanalization|recanalization
333988|NCT01516645|Squamous cell type tumor|squamous cell type tumor
333989|NCT01516632|Cellular Phone|cellular phone
333990|NCT01516632|Mobile Phone|mobile phone
333991|NCT01516632|Cognitive Behavior Therapy|cognitive behavior therapy
333992|NCT01516632|Technology|technology
333993|NCT01516632|Smoking cessation|smoking cessation
333994|NCT01516632|young adults|young adults
333995|NCT01516619|NHL|nhl
333996|NCT01516619|chemotherapy-induced grade-4 thrombocytopenia|chemotherapy-induced grade-4 thrombocytopenia
333997|NCT01516606|MALT|malt
333998|NCT01516606|refractory|refractory
333999|NCT01516606|relapsed|relapsed
334000|NCT01516606|extranodal|extranodal
334001|NCT01516606|relapsed or refractory extranodal marginal zone lymphoma|relapsed or refractory extranodal marginal zone lymphoma
334002|NCT01516593|HIV|hiv
414901|NCT00000367|Suicide|suicide
334003|NCT01516593|Burkitt's lymphoma|burkitt's lymphoma
334004|NCT01516593|intensive|intensive
334005|NCT01516593|short term|short term
334006|NCT01516593|immuno-chemotherapy|immuno-chemotherapy
334007|NCT01516593|HIV-positive patients with Burkitt's lymphoma|hiv-positive patients with burkitt's lymphoma
334008|NCT01516554|Multiple Sclerosis|multiple sclerosis
334009|NCT01516554|Fatigue|fatigue
334010|NCT01516528|COPD|copd
334011|NCT01516528|exacerbation|exacerbation
334012|NCT01516528|comorbidities|comorbidities
334013|NCT01516528|lung function|lung function
334014|NCT01516528|burden|burden
334015|NCT01516528|chronic bronchitis|chronic bronchitis
334016|NCT01516528|emphysema|emphysema
334017|NCT01516528|prevalence|prevalence
334018|NCT01516528|cardiovascular disease|cardiovascular disease
334019|NCT01516515|Actinic Keratosis|actinic keratosis
334020|NCT01516515|AK|ak
334021|NCT01516502|laser therapy|laser therapy
334022|NCT01516502|myofascial pain syndrome|myofascial pain syndrome
334023|NCT01516502|acupoint|acupoint
334024|NCT01516502|trigger point|trigger point
334025|NCT01516502|range of motion|range of motion
334026|NCT01516489|screening|screening
334027|NCT01516489|colon cancer|colon cancer
334028|NCT01516489|incentives|incentives
334029|NCT01516489|behavioral economics|behavioral economics
334030|NCT01516463|burn|burn
334031|NCT01516463|partial thickness burn|partial thickness burn
334032|NCT01516463|second degree burn|second degree burn
334034|NCT01516463|scar|scar
334035|NCT01516463|Santyl|santyl
334036|NCT01516463|Bacitracin|bacitracin
334037|NCT01516463|outpatient burn center|outpatient burn center
334038|NCT01516463|scar appearance|scar appearance
334039|NCT01516463|Kansas City|kansas city
334040|NCT01516463|University of Kansas Medical Center|university of kansas medical center
334041|NCT01516463|KUMC|kumc
334042|NCT01516450|GSK1550188, belimumab, SLE, healthy, Japanese, pharmacokinetics, safety|gsk1550188, belimumab, sle, healthy, japanese, pharmacokinetics, safety
334043|NCT01516437|Chronic Obstructive Pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
334044|NCT01516424|Blonanserin|blonanserin
334045|NCT01516411|Health Promotion|health promotion
334046|NCT01516411|Physical Activity|physical activity
334047|NCT01516411|Sedentary Time|sedentary time
334048|NCT01516411|Smartphones|smartphones
334049|NCT01516385|spinal cord injury|spinal cord injury
334050|NCT01516385|biomarkers|biomarkers
334051|NCT01516385|rehabilitation|rehabilitation
334052|NCT01516385|functional independence|functional independence
334053|NCT01516385|prognosis|prognosis
334054|NCT01516372|GEn, moxifloxacin, cardiac repolarisation, QT/QTc|gen, moxifloxacin, cardiac repolarisation, qt/qtc
334055|NCT01516346|Heart Failure|heart failure
334056|NCT01516346|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
334057|NCT01516346|Vasodilators|vasodilators
334058|NCT01516346|Isosorbide dinitrate|isosorbide dinitrate
334059|NCT01516346|Hydralazine|hydralazine
334060|NCT01516346|wave reflections|wave reflections
334061|NCT01516346|arterial stiffness|arterial stiffness
334062|NCT01516346|hemodynamics|hemodynamics
334063|NCT01516333|glycemic Index|glycemic index
334064|NCT01516320|Type 2 Diabetes|type 2 diabetes
334065|NCT01516320|Gastric Bypass|gastric bypass
334066|NCT01516320|Laparoscopic Banding|laparoscopic banding
334067|NCT01516320|Vertical Sleeve Gastrectomy|vertical sleeve gastrectomy
334068|NCT01516294|AMD|amd
334069|NCT01516294|PCV|pcv
334070|NCT01516294|Iray|iray
334071|NCT01516294|radiation|radiation
334072|NCT01516294|retina|retina
334073|NCT01516294|macula|macula
334074|NCT01516294|radiotherapy|radiotherapy
334075|NCT01516281|TBI|tbi
334077|NCT01516268|Cesarean Delivery|cesarean delivery
334078|NCT01516268|TAP block|tap block
334079|NCT01516268|sufentanyl|sufentanyl
334080|NCT01516268|Narcotic dosages|narcotic dosages
334081|NCT01516216|previously untreated|previously untreated
334082|NCT01516203|AZD5847,dose-ranging,Mycobacterium tuberculosis,Rifafour,tuberculosis|azd5847,dose-ranging,mycobacterium tuberculosis,rifafour,tuberculosis
334083|NCT01516190|stage I-III breast cancer|stage i-iii breast cancer
334084|NCT01516177|Kidney Transplantation|kidney transplantation
334085|NCT01516177|kidney transplant|kidney transplant
334284|NCT01515319|Food intake|food intake
334086|NCT01516177|renal transplant|renal transplant
334087|NCT01516177|immunosuppression|immunosuppression
334088|NCT01516164|Laryngoscopy|laryngoscopy
334089|NCT01516164|Videolaryngoscopy|videolaryngoscopy
334090|NCT01516164|Ease of Intubation|ease of intubation
334091|NCT01516151|Hypertriglyceridemia|hypertriglyceridemia
334092|NCT01516138|Glucose-insulin-potassium|glucose-insulin-potassium
334093|NCT01516138|Cardiac surgery|cardiac surgery
334094|NCT01516125|healthy adult|healthy adult
334095|NCT01516125|genetic variation|genetic variation
334096|NCT01516125|botanical oils|botanical oils
334097|NCT01516125|polyunsaturated fatty acid|polyunsaturated fatty acid
334098|NCT01516125|fish oil|fish oil
334099|NCT01516125|fat metabolism|fat metabolism
752621|NCT01173367|Inflammatory mediators|inflammatory mediators
752622|NCT01173367|Safety|safety
334100|NCT01516125|Genetic variation of fat metabolism in healthy adults|genetic variation of fat metabolism in healthy adults
334101|NCT01516112|ICD, home monitoring, cardiomessenger, implant|icd, home monitoring, cardiomessenger, implant
334102|NCT01516099|Physical activity counselor|physical activity counselor
334103|NCT01516099|Active and healthy lifestyle|active and healthy lifestyle
334104|NCT01516099|General Practitioner|general practitioner
334105|NCT01516099|Social-cultural Organization|social-cultural organization
334106|NCT01516086|Controlled|controlled
334107|NCT01516086|uncontrolled|uncontrolled
334108|NCT01516073|partially controlled|partially controlled
334109|NCT01516073|uncontrolled|uncontrolled
334110|NCT01516047|Hepatic impairment|hepatic impairment
334111|NCT01516047|Pharmacology|pharmacology
334112|NCT01516047|Pharmacokinetics|pharmacokinetics
334113|NCT01516047|Pharmacodynamics|pharmacodynamics
334114|NCT01516047|Abiraterone acetate suspension|abiraterone acetate suspension
334115|NCT01516047|JNJ-212082|jnj-212082
334116|NCT01516034|Tattoo removal|tattoo removal
334117|NCT01516034|ultrasound|ultrasound
334118|NCT01516021|Fat ingestion|fat ingestion
334119|NCT01516021|hypothalamus|hypothalamus
334120|NCT01516021|insula|insula
334121|NCT01516021|fMRI|fmri
334123|NCT01516008|Hallux Valgus|hallux valgus
334124|NCT01516008|Bunionectomy|bunionectomy
334125|NCT01516008|Bunion|bunion
334126|NCT01516008|Acute pain|acute pain
334127|NCT01516008|Tapentadol|tapentadol
334128|NCT01516008|Tapentadol IR|tapentadol ir
334129|NCT01515995|Magnesium sulfate|magnesium sulfate
334130|NCT01515995|Childhood asthma|childhood asthma
334131|NCT01515995|Emergency department|emergency department
334132|NCT01515982|Alzheimer's disease|alzheimer's disease
334133|NCT01515982|Aerobic exercise|aerobic exercise
334134|NCT01515982|Physical training|physical training
334135|NCT01515982|Cognitive function|cognitive function
334136|NCT01515982|Functional capacity.|functional capacity.
334137|NCT01515956|Mucopolysaccharidosis IVA type A|mucopolysaccharidosis iva type a
334138|NCT01515956|MPS IVA Type A|mps iva type a
334139|NCT01515956|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
334140|NCT01515956|MPS IVA|mps iva
334141|NCT01515956|Morquio A Syndrome|morquio a syndrome
334142|NCT01515956|Lysosomal Storage Disorder|lysosomal storage disorder
334143|NCT01515956|LSD|lsd
334144|NCT01515956|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
334145|NCT01515956|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
334146|NCT01515956|sulfatase|sulfatase
334147|NCT01515956|galactose-6-sulfatase|galactose-6-sulfatase
334148|NCT01515956|GALNS|galns
334149|NCT01515956|enzyme replacement therapy|enzyme replacement therapy
334150|NCT01515956|ERT|ert
334151|NCT01515943|Convergence insufficiency|convergence insufficiency
334152|NCT01515930|Parenting|parenting
334153|NCT01515930|Parental Monitoring|parental monitoring
334154|NCT01515930|Diabetes|diabetes
334155|NCT01515930|Care|care
334156|NCT01515917|Veterans|veterans
334157|NCT01515917|Traumatic Brain Injury|traumatic brain injury
334158|NCT01515917|TBI|tbi
334159|NCT01515917|Substance Abuse|substance abuse
334160|NCT01515917|Substance Dependence|substance dependence
334161|NCT01515917|Veterans with traumatic brain injury (TBI)|veterans with traumatic brain injury (tbi)
334162|NCT01515917|Veterans with substance abuse or dependence|veterans with substance abuse or dependence
334163|NCT01515904|obesity management|obesity management
334164|NCT01515904|adolescents|adolescents
334165|NCT01515904|body mass index|body mass index
334166|NCT01515904|treatment outcomes|treatment outcomes
334167|NCT01515904|program evaluation|program evaluation
334168|NCT01515891|Parkinson Disease|parkinson disease
334169|NCT01515891|BIA 9-1067|bia 9-1067
334170|NCT01515852|stress level|stress level
334171|NCT01515852|stereotactic biopsy|stereotactic biopsy
334172|NCT01515852|brain lesion|brain lesion
334173|NCT01515852|general anesthesia|general anesthesia
334174|NCT01515852|local anesthesia|local anesthesia
334175|NCT01515839|SPECT|spect
334176|NCT01515839|Imaging|imaging
334177|NCT01515839|Football|football
334178|NCT01515839|Traumatic brain injury|traumatic brain injury
334179|NCT01515839|Regional cerebral blood flow|regional cerebral blood flow
334180|NCT01515826|Cataract surgery|cataract surgery
334181|NCT01515826|Topical therapy|topical therapy
334182|NCT01515826|Prevention of inflammation|prevention of inflammation
334183|NCT01515826|Inflammation of infection|inflammation of infection
334184|NCT01515800|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
334185|NCT01515800|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
334186|NCT01515800|stage IA breast cancer|stage ia breast cancer
334187|NCT01515800|stage IB breast cancer|stage ib breast cancer
334188|NCT01515800|stage II breast cancer|stage ii breast cancer
334189|NCT01515800|stage IIIA breast cancer|stage iiia breast cancer
334190|NCT01515787|stage IIA rectal cancer|stage iia rectal cancer
334191|NCT01515787|stage IIIA rectal cancer|stage iiia rectal cancer
334192|NCT01515787|stage IIIB rectal cancer|stage iiib rectal cancer
334193|NCT01515774|Parkinson's disease|parkinson's disease
334194|NCT01515774|Pramipexole|pramipexole
334195|NCT01515722|Medication Persistence|medication persistence
334196|NCT01515722|Compliance|compliance
334197|NCT01515722|Health Education Intervention (HEI)|health education intervention (hei)
334198|NCT01515709|Cohort Studies|cohort studies
334199|NCT01515709|Longitudinal Studies|longitudinal studies
334200|NCT01515696|VLBW infant|vlbw infant
334201|NCT01515696|Meconium|meconium
334202|NCT01515696|Enteral nutrition|enteral nutrition
334203|NCT01515696|Meconium passage|meconium passage
334204|NCT01515683|Nervousness before anesthesia|nervousness before anesthesia
334205|NCT01515670|THA|tha
334206|NCT01515670|TKA|tka
334207|NCT01515670|Fast-track|fast-track
334208|NCT01515670|Enhanced recovery|enhanced recovery
334209|NCT01515670|preoperative co-morbidity|preoperative co-morbidity
334210|NCT01515670|postoperative morbidity|postoperative morbidity
334211|NCT01515670|Arthroplasty|arthroplasty
334212|NCT01515670|Replacement|replacement
334213|NCT01515670|Hip|hip
334214|NCT01515670|Knee|knee
334215|NCT01515670|Morbidity|morbidity
334216|NCT01515644|Healthy infants|healthy infants
334217|NCT01515644|Infant formula|infant formula
334218|NCT01515644|Prebiotics|prebiotics
334219|NCT01515566|Advanced Cancer|advanced cancer
334220|NCT01515566|Dyspnea|dyspnea
334221|NCT01515566|Exercise-induced breakthrough dyspnea|exercise-induced breakthrough dyspnea
334222|NCT01515566|Shortness of breath|shortness of breath
334223|NCT01515566|Fentanyl|fentanyl
334224|NCT01515566|Sublimaze|sublimaze
334225|NCT01515566|Placebo|placebo
334226|NCT01515566|Normal saline|normal saline
334227|NCT01515566|NS|ns
334228|NCT01515566|Questionnaires|questionnaires
334229|NCT01515566|Surveys|surveys
334230|NCT01515566|Walk test|walk test
334231|NCT01515540|chronic back pain|chronic back pain
334232|NCT01515540|placebo|placebo
334233|NCT01515540|fmri|fmri
334234|NCT01515540|brain imaging|brain imaging
334235|NCT01515527|Leukemia|leukemia
334236|NCT01515527|Acute myeloid leukemia|acute myeloid leukemia
334237|NCT01515527|AML|aml
334238|NCT01515527|myelodysplastic syndrome|myelodysplastic syndrome
334239|NCT01515527|MDS|mds
334240|NCT01515527|Cytarabine|cytarabine
334241|NCT01515527|Ara-C|ara-c
334242|NCT01515527|Cytosar|cytosar
334243|NCT01515527|DepoCyt|depocyt
334244|NCT01515527|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
334245|NCT01515527|Decitabine|decitabine
334246|NCT01515527|Dacogen|dacogen
334247|NCT01515527|Cladribine|cladribine
334248|NCT01515527|Leustatin|leustatin
334249|NCT01515527|2-CdA|2-cda
334250|NCT01515514|polyps|polyps
334251|NCT01515514|inflammatory bowel disease|inflammatory bowel disease
334252|NCT01515514|associated neoplasia|associated neoplasia
334253|NCT01515501|Constipation|constipation
334254|NCT01515501|Hirschsprung Disease|hirschsprung disease
334255|NCT01515488|Triage|triage
334256|NCT01515488|Automated|automated
334257|NCT01515488|Admitting|admitting
334258|NCT01515488|Pediatric ED|pediatric ed
334259|NCT01515475|Hyperopia|hyperopia
334260|NCT01515475|Glasses|glasses
334261|NCT01515462|Lentiviral vector|lentiviral vector
334262|NCT01515462|Gene therapy|gene therapy
334263|NCT01515462|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
334264|NCT01515436|Rolandic Epilepsy|rolandic epilepsy
334265|NCT01515436|Benign Childhood Epilepsy with Centrotemporal Spikes (BCECTS)|benign childhood epilepsy with centrotemporal spikes (bcects)
334266|NCT01515436|Epilepsy|epilepsy
334267|NCT01515436|Seizures|seizures
334268|NCT01515436|Music|music
334269|NCT01515436|Mozart|mozart
334270|NCT01515436|Beethoven|beethoven
334271|NCT01515423|Schizophrenia|schizophrenia
334272|NCT01515423|R092670|r092670
334273|NCT01515423|Paliperidone Palmitate|paliperidone palmitate
334274|NCT01515423|Paliperidone palmitate 1 month formulation (PP1M)|paliperidone palmitate 1 month formulation (pp1m)
334680|NCT01513317|MDS|mds
334275|NCT01515423|Paliperidone palmitate 3 month formulation (PP3M)|paliperidone palmitate 3 month formulation (pp3m)
334276|NCT01515410|Parkinson's disease|parkinson's disease
334277|NCT01515410|PD|pd
334278|NCT01515410|stage2/3Parkinson's|stage2/3parkinson's
334279|NCT01515410|Advanced Parkinson's Disease with Motor Fluctuations|advanced parkinson's disease with motor fluctuations
334280|NCT01515345|clopidogrel-nonresponder|clopidogrel-nonresponder
334281|NCT01515345|stent thrombosis|stent thrombosis
334282|NCT01515319|Obesity|obesity
334283|NCT01515319|Peptide YY|peptide yy
334285|NCT01515319|Safety|safety
334286|NCT01515319|Pharmacokinetics|pharmacokinetics
334287|NCT01515306|Advanced Malignant Solid Tumors|advanced malignant solid tumors
334288|NCT01515280|chronic cough|chronic cough
334289|NCT01515267|EF|ef
334290|NCT01515267|EDV|edv
334291|NCT01515267|ESV|esv
334292|NCT01515267|Biplane|biplane
334293|NCT01515267|Echocardiography|echocardiography
334294|NCT01515254|Children|children
334295|NCT01515254|Obesity Prevention|obesity prevention
334296|NCT01515254|Child Overweight|child overweight
334297|NCT01515254|Eating Behavior|eating behavior
334298|NCT01515254|Energy Compensation|energy compensation
334299|NCT01515254|Food Intake|food intake
334300|NCT01515254|Parenting Behavior|parenting behavior
334301|NCT01515241|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
334302|NCT01515241|Familial Hypercholesterolemia|familial hypercholesterolemia
334303|NCT01515241|HDL mimetic|hdl mimetic
334304|NCT01515241|ApoA-1|apoa-1
334305|NCT01515228|requiring drug eluting stents|requiring drug eluting stents
334306|NCT01515215|Major Depression Disorder|major depression disorder
334307|NCT01515215|Treatment Resistance|treatment resistance
334308|NCT01515215|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
334309|NCT01515150|diverticulitis|diverticulitis
334310|NCT01515150|Out-patient management|out-patient management
334311|NCT01515150|Antibiotics|antibiotics
334312|NCT01515137|Head and Neck|head and neck
334313|NCT01515137|Locally Advanced Head and Neck Squamous Cell Carcinoma|locally advanced head and neck squamous cell carcinoma
334314|NCT01515124|Lymphedema|lymphedema
334315|NCT01515124|Strength training intervention|strength training intervention
334316|NCT01515124|Weight loss intervention|weight loss intervention
334317|NCT01515124|Breast cancer recurrence|breast cancer recurrence
334318|NCT01515124|Cost Effectiveness|cost effectiveness
334319|NCT01515111|Non-communicable diseases|non-communicable diseases
334320|NCT01515111|Preventive services|preventive services
334321|NCT01515111|Medical education|medical education
334322|NCT01515111|Guatemala|guatemala
334323|NCT01515072|Remote Ischemic Preconditioning|remote ischemic preconditioning
334324|NCT01515072|Brain death organ donors|brain death organ donors
334325|NCT01515072|Delayed graft function|delayed graft function
334326|NCT01515072|Donor management|donor management
334327|NCT01515072|Pulsatile perfusion|pulsatile perfusion
334329|NCT01515059|diabetes|diabetes
334330|NCT01515059|bariatric surgery|bariatric surgery
334331|NCT01515059|gastric bypass|gastric bypass
334332|NCT01515059|insulin|insulin
334333|NCT01515059|glucose|glucose
334334|NCT01515059|incretins|incretins
334335|NCT01515059|leptin|leptin
334336|NCT01515059|ghrelin|ghrelin
334337|NCT01515046|Vitamins|vitamins
334338|NCT01515046|Complementary medicine|complementary medicine
334339|NCT01515046|Pancreatic cancer|pancreatic cancer
334340|NCT01515046|Ascorbate|ascorbate
334341|NCT01515046|Ascorbic Acid|ascorbic acid
334342|NCT01515046|Antioxidants|antioxidants
334343|NCT01515046|Gemcitabine|gemcitabine
334344|NCT01515046|Pharmacologic actions|pharmacologic actions
334345|NCT01515033|Coronary artery disease|coronary artery disease
334346|NCT01515033|Exercise|exercise
334347|NCT01515033|Ventilatory efficiency|ventilatory efficiency
334348|NCT01515020|bacteremia|bacteremia
334349|NCT01515020|meticillin-resistant Staphylococcus aureus|meticillin-resistant staphylococcus aureus
334350|NCT01515020|nosocomial infection|nosocomial infection
334351|NCT01515020|healthcare-associated infection|healthcare-associated infection
334352|NCT01515020|rapid molecular diagnostic test|rapid molecular diagnostic test
334353|NCT01515007|Bronchiectasis, non-CF, Ciprofloxacin, Liposome|bronchiectasis, non-cf, ciprofloxacin, liposome
334354|NCT01514981|Asthma|asthma
334355|NCT01514942|PCOS|pcos
334356|NCT01514942|Insulin resistance|insulin resistance
334357|NCT01514942|Myo-inositol|myo-inositol
334358|NCT01514942|D-chiro-inositol|d-chiro-inositol
334359|NCT01514929|Thorough QT|thorough qt
334360|NCT01514903|anti erectile dysfunction agent|anti erectile dysfunction agent
334361|NCT01514877|tumors metastatic to brain|tumors metastatic to brain
334362|NCT01514877|non-small cell lung cancer|non-small cell lung cancer
334363|NCT01514877|Icotinib|icotinib
334364|NCT01514851|Hyperphosphatemia in ESRD (End Stage Renal Disease) patients on dialysis|hyperphosphatemia in esrd (end stage renal disease) patients on dialysis
334365|NCT01514838|ASP1941|asp1941
334366|NCT01514838|ipragliflozin|ipragliflozin
334367|NCT01514838|plasma glucose|plasma glucose
334368|NCT01514838|urine glucose|urine glucose
334369|NCT01514825|YM150|ym150
335870|NCT01508325|Heart rate|heart rate
334370|NCT01514825|Plasma concentration|plasma concentration
334371|NCT01514825|darexaban|darexaban
334372|NCT01514825|Healthy elderly subject|healthy elderly subject
334373|NCT01514825|Pharmacokinetics of YM150|pharmacokinetics of ym150
334374|NCT01514812|YM150|ym150
334375|NCT01514812|digoxin|digoxin
334376|NCT01514812|drug-drug interaction|drug-drug interaction
334377|NCT01514812|Plasma concentration|plasma concentration
334378|NCT01514812|darexaban|darexaban
334379|NCT01514812|Pharmacokinetics of digoxin|pharmacokinetics of digoxin
334380|NCT01514799|gastric bypass|gastric bypass
334484|NCT01514344|conjunctiva|conjunctiva
334381|NCT01514799|morbid obesity|morbid obesity
334382|NCT01514799|gut function|gut function
334383|NCT01514799|weight loss|weight loss
334384|NCT01514786|Colorectal Cancer|colorectal cancer
334385|NCT01514786|Screening|screening
334386|NCT01514786|Prevention|prevention
334387|NCT01514773|left ventricular systolic dysfunction|left ventricular systolic dysfunction
334388|NCT01514773|implantable cardioverter defibrillator|implantable cardioverter defibrillator
334389|NCT01514773|systolic heart failure|systolic heart failure
334390|NCT01514773|congestive heart failure|congestive heart failure
334391|NCT01514773|Ischemic cardiomyopathy|ischemic cardiomyopathy
334392|NCT01514773|Nonischemic cardiomyopathy|nonischemic cardiomyopathy
334394|NCT01514773|ICD utilization|icd utilization
334395|NCT01514773|ICD implantation|icd implantation
334396|NCT01514773|defibrillator|defibrillator
334397|NCT01514773|defibrillator therapy|defibrillator therapy
334398|NCT01514773|sudden cardiac death|sudden cardiac death
334399|NCT01514760|Adolescents|adolescents
334400|NCT01514760|Mobile based applications|mobile based applications
334401|NCT01514760|Asthma action plan|asthma action plan
334402|NCT01514760|Self Efficacy|self efficacy
334403|NCT01514734|Primary open-angle glaucoma|primary open-angle glaucoma
334404|NCT01514734|Ocular hypertension|ocular hypertension
334405|NCT01514734|Pigment dispersion glaucoma|pigment dispersion glaucoma
334406|NCT01514721|Open-angle glaucoma|open-angle glaucoma
334407|NCT01514721|Ocular hypertension|ocular hypertension
334408|NCT01514721|Pigment dispersion glaucoma|pigment dispersion glaucoma
334409|NCT01514708|Influenza|influenza
334410|NCT01514708|Vaccination|vaccination
334411|NCT01514708|Vaccine|vaccine
334412|NCT01514708|Pregnancy|pregnancy
334413|NCT01514695|endoscopy|endoscopy
334414|NCT01514695|sedation|sedation
334415|NCT01514695|opioid|opioid
334416|NCT01514695|narcotic|narcotic
334417|NCT01514682|schizophrenia|schizophrenia
334418|NCT01514682|anti-inflammatory|anti-inflammatory
334419|NCT01514682|salsalate|salsalate
334420|NCT01514682|statins|statins
334421|NCT01514682|omega-3-fatty acids|omega-3-fatty acids
334422|NCT01514643|tibial plateau fracture|tibial plateau fracture
334423|NCT01514643|tibial plafond fracture|tibial plafond fracture
334424|NCT01514643|inflammatory cytokine profile|inflammatory cytokine profile
334425|NCT01514643|synovial fluid|synovial fluid
334426|NCT01514643|blood serum|blood serum
334427|NCT01514643|Post-traumatic osteoarthritis (PTOA)|post-traumatic osteoarthritis (ptoa)
334428|NCT01514617|Leiomyoma|leiomyoma
334429|NCT01514617|Diffusion weighted MRI|diffusion weighted mri
334430|NCT01514617|Perfusion MRI|perfusion mri
334431|NCT01514617|Uterine artery embolization|uterine artery embolization
334432|NCT01514617|Volumetric Response|volumetric response
334433|NCT01514617|Women with symptomatic leiomyomas|women with symptomatic leiomyomas
334434|NCT01514604|Anesthesia and analgesia|anesthesia and analgesia
334435|NCT01514604|ultrasonography|ultrasonography
334436|NCT01514604|education|education
334437|NCT01514578|safety|safety
334438|NCT01514578|tolerability|tolerability
334439|NCT01514578|TRV130A|trv130a
334440|NCT01514565|Triple negative Breast Cancer|triple negative breast cancer
334442|NCT01514565|PTEN|pten
334443|NCT01514565|Chemotherapy|chemotherapy
334444|NCT01514565|Neoadjuvant|neoadjuvant
334445|NCT01514552|Functional food|functional food
334446|NCT01514552|Strawberries|strawberries
334447|NCT01514552|Gummies|gummies
334448|NCT01514552|Smoker|smoker
334449|NCT01514552|Nonsmoker|nonsmoker
334450|NCT01514539|Human milk, Ghrelin,PYY and maternal obesity.|human milk, ghrelin,pyy and maternal obesity.
334451|NCT01514526|Adrenocortical carcinoma|adrenocortical carcinoma
334452|NCT01514461|Hyperlipoproteinemia (HLP Type I)|hyperlipoproteinemia (hlp type i)
334453|NCT01514461|Fasting Triglycerides|fasting triglycerides
334454|NCT01514448|Kidney cancer|kidney cancer
334455|NCT01514448|mRCC|mrcc
334456|NCT01514448|metastic renal cell carcinoma|metastic renal cell carcinoma
334457|NCT01514448|everolimus|everolimus
334458|NCT01514448|sunitinib|sunitinib
334459|NCT01514448|pazopanib|pazopanib
334460|NCT01514435|depression|depression
334461|NCT01514435|FDG-PET|fdg-pet
334462|NCT01514435|Electroconvulsive therapy|electroconvulsive therapy
334463|NCT01514435|glucose metabolism|glucose metabolism
334464|NCT01514422|Bipolar disorder|bipolar disorder
334465|NCT01514422|depression|depression
334466|NCT01514422|minocycline|minocycline
334467|NCT01514422|mood disorders|mood disorders
334468|NCT01514422|bipolar depression|bipolar depression
334469|NCT01514409|5-hydroxytryptophan|5-hydroxytryptophan
334470|NCT01514409|Mood|mood
334471|NCT01514409|Emotional Processing|emotional processing
334472|NCT01514409|Emotional Cognition|emotional cognition
334473|NCT01514409|Nutritional Supplement|nutritional supplement
334474|NCT01514409|Low mood|low mood
334475|NCT01514396|Pediatric|pediatric
334476|NCT01514396|Wounds|wounds
334477|NCT01514383|wounds|wounds
334478|NCT01514370|Multiple Sclerosis|multiple sclerosis
334479|NCT01514370|Relapsing|relapsing
334480|NCT01514370|Interferon beta 1a|interferon beta 1a
334481|NCT01514370|Curcumin|curcumin
334482|NCT01514344|OAL|oal
334483|NCT01514344|MALT|malt
334485|NCT01514344|indolent|indolent
334486|NCT01514344|CD20+|cd20+
334487|NCT01514331|Ventilator Induced Lung Injury|ventilator induced lung injury
334488|NCT01514331|Neonatal respiratory distress|neonatal respiratory distress
334489|NCT01514331|Mechanical ventilation|mechanical ventilation
334490|NCT01514279|Overweight|overweight
334491|NCT01514279|Obese|obese
334492|NCT01514279|Over Nutrition|over nutrition
334493|NCT01514279|Nutrition Disorders|nutrition disorders
334494|NCT01514279|Body weight|body weight
752623|NCT01173380|Soy|soy
325267|NCT01553682|HIV|hiv
334495|NCT01514279|Signs and Symptoms|signs and symptoms
334496|NCT01514266|proven diagnosis|proven diagnosis
334497|NCT01514266|COPD|copd
334498|NCT01514266|sputum|sputum
334499|NCT01514253|glucose|glucose
334500|NCT01514253|analgesic|analgesic
334501|NCT01514253|newborns|newborns
334502|NCT01514240|mild to moderate active Crohn's disease|mild to moderate active crohn's disease
334503|NCT01514240|affecting ileum|affecting ileum
334504|NCT01514240|ileocecal region|ileocecal region
334505|NCT01514240|ascending colon|ascending colon
334506|NCT01514240|score of 180-400 on the CDAI|score of 180-400 on the cdai
334507|NCT01514214|ERCP|ercp
334508|NCT01514214|biliary stricture|biliary stricture
334509|NCT01514214|viaduct|viaduct
334510|NCT01514214|cancer|cancer
334511|NCT01514188|sarcoma|sarcoma
334512|NCT01514188|soft-tissue sarcoma|soft-tissue sarcoma
334513|NCT01514188|Metastatic,locally advanced, or unresectable soft tissue sarcoma|metastatic,locally advanced, or unresectable soft tissue sarcoma
334514|NCT01514175|Ketorolac|ketorolac
334515|NCT01514175|Caldolor|caldolor
334516|NCT01514175|Chronic Pelvic Pain|chronic pelvic pain
334517|NCT01514162|Trifecta Valve|trifecta valve
334518|NCT01514149|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
334519|NCT01514149|T2DM|t2dm
334520|NCT01514149|diabetes|diabetes
334521|NCT01514149|ConjuChem|conjuchem
334522|NCT01514149|GLP-1|glp-1
334523|NCT01514149|Glucagon-like peptide-1|glucagon-like peptide-1
334524|NCT01514149|exendin-4|exendin-4
334525|NCT01514149|modified exendin-4|modified exendin-4
334526|NCT01514123|VGX-100|vgx-100
334527|NCT01514123|Bevacizumab|bevacizumab
334528|NCT01514123|VEGF-C|vegf-c
334529|NCT01514123|First-In-Human|first-in-human
334530|NCT01514123|Dose Escalation|dose escalation
334531|NCT01514123|Advanced Solid Tumors|advanced solid tumors
334532|NCT01514123|Angiogenesis Inhibitors|angiogenesis inhibitors
334533|NCT01514123|Angiogenesis Modulating Agents|angiogenesis modulating agents
334534|NCT01514123|Pharmacologic Actions|pharmacologic actions
334535|NCT01514123|Antibodies, Monoclonal|antibodies, monoclonal
334536|NCT01514123|Phase 1|phase 1
334537|NCT01514123|Oncology|oncology
334538|NCT01514123|Advanced malignancy|advanced malignancy
334539|NCT01514097|emergency|emergency
334540|NCT01514097|pediatric|pediatric
334541|NCT01514097|fracture|fracture
334542|NCT01514097|pain|pain
334543|NCT01514084|laceration|laceration
334544|NCT01514084|emergency|emergency
334545|NCT01514084|cosmetic outcomes|cosmetic outcomes
334546|NCT01514084|patient satisfaction|patient satisfaction
334547|NCT01514084|suture|suture
334548|NCT01514071|head injury|head injury
334549|NCT01514071|CT|ct
334550|NCT01514071|emergency|emergency
334551|NCT01514071|radiation|radiation
334552|NCT01514045|Quality of Life|quality of life
334553|NCT01514019|SLCO2B1 genotype|slco2b1 genotype
334554|NCT01514019|effect of apple juice|effect of apple juice
334555|NCT01514006|Primary hip arthroplasty|primary hip arthroplasty
716962|NCT01030445|Icon|icon
334556|NCT01514006|postoperative anemia|postoperative anemia
334557|NCT01514006|functional outcomes|functional outcomes
334558|NCT01513993|CHF|chf
334559|NCT01513993|Telemonitoring|telemonitoring
334560|NCT01513980|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
334561|NCT01513980|Telemonitoring|telemonitoring
334562|NCT01513967|Alzheimer,|alzheimer,
334563|NCT01513967|dementia|dementia
334564|NCT01513954|Infertility|infertility
334565|NCT01513941|Chronic hepatitis C|chronic hepatitis c
334566|NCT01513941|Genotype 1 chronic hepatitis C|genotype 1 chronic hepatitis c
334567|NCT01513941|Treatment experienced with HCV-1/HIV-1 coinfection|treatment experienced with hcv-1/hiv-1 coinfection
334568|NCT01513941|Telaprevir|telaprevir
334569|NCT01513941|Pegylated-Interferon-alfa-2a|pegylated-interferon-alfa-2a
334570|NCT01513941|Ribavirin|ribavirin
334571|NCT01513941|HCV-1/HIV-1 coinfection|hcv-1/hiv-1 coinfection
334572|NCT01513941|Hepatitis C|hepatitis c
334573|NCT01513928|pharmacokinetics|pharmacokinetics
334574|NCT01513928|relative bioavailability|relative bioavailability
334575|NCT01513928|formulation comparison|formulation comparison
334576|NCT01513915|parents|parents
334577|NCT01513915|group cognitive behavioral intervention|group cognitive behavioral intervention
334578|NCT01513915|anxiety disorder|anxiety disorder
334579|NCT01513915|children|children
334580|NCT01513915|FRIENDS program|friends program
334581|NCT01513902|Arthritis|arthritis
334582|NCT01513902|Pediatric|pediatric
334583|NCT01513902|Tofacitinib|tofacitinib
334584|NCT01513902|JIA|jia
334585|NCT01513850|Liver Transplantation|liver transplantation
334586|NCT01513850|HBV|hbv
334587|NCT01513850|HBV Recurrence|hbv recurrence
334588|NCT01513850|HBsAg Positive|hbsag positive
334589|NCT01513824|stress|stress
334590|NCT01513824|biofeed back guided treatment|biofeed back guided treatment
334591|NCT01513824|acupressure|acupressure
334592|NCT01513824|ischemic heart disease|ischemic heart disease
334593|NCT01513811|bowel preparation|bowel preparation
334594|NCT01513811|constipation|constipation
325359|NCT01553383|OSA|osa
334595|NCT01513811|polyethylene glycol|polyethylene glycol
334596|NCT01513811|itopride|itopride
334597|NCT01513798|Diet Therapy|diet therapy
334598|NCT01513798|Exercise Therapy|exercise therapy
334599|NCT01513798|Insulin Resistance|insulin resistance
334600|NCT01513785|H. pylori|h. pylori
334601|NCT01513785|Dual therapy|dual therapy
334602|NCT01513785|Amoxicillin|amoxicillin
334603|NCT01513785|Rabeprazole|rabeprazole
334604|NCT01513759|Fibrinolysis|fibrinolysis
334605|NCT01513759|catheter directed fibrinolysis|catheter directed fibrinolysis
334606|NCT01513759|ultrasound accelerated fibrinolysis|ultrasound accelerated fibrinolysis
334607|NCT01513759|recombinant t-PA|recombinant t-pa
334608|NCT01513759|Activase|activase
334609|NCT01513746|Type 1 Diabetes|type 1 diabetes
334610|NCT01513746|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
334611|NCT01513746|Eating Disorders|eating disorders
334612|NCT01513746|Insulin Omission|insulin omission
334613|NCT01513720|Bioequivalence|bioequivalence
334614|NCT01513720|Lamotrigine|lamotrigine
334615|NCT01513720|crossover|crossover
334616|NCT01513707|kidney transplantation|kidney transplantation
334617|NCT01513707|hemodialysis|hemodialysis
334618|NCT01513707|peritoneal dialysis|peritoneal dialysis
334619|NCT01513694|Mesenchymal Stem Cells|mesenchymal stem cells
334620|NCT01513694|Stem Cells|stem cells
334621|NCT01513694|Intervertebral disc disease|intervertebral disc disease
334622|NCT01513681|Bioequivalence|bioequivalence
334623|NCT01513681|Lamotrigine|lamotrigine
334624|NCT01513681|crossover|crossover
334625|NCT01513655|COPD|copd
334626|NCT01513655|Home NIV|home niv
334627|NCT01513655|NIV|niv
334628|NCT01513642|physiotherapy|physiotherapy
334629|NCT01513642|cardiac surgery|cardiac surgery
334630|NCT01513642|breath Stacking|breath stacking
334631|NCT01513629|Autism spectrum disorders|autism spectrum disorders
334632|NCT01513629|structural connectivity|structural connectivity
334633|NCT01513629|diffusion spectrum imaging|diffusion spectrum imaging
334634|NCT01513629|sibling|sibling
334635|NCT01513629|endophenotype|endophenotype
334636|NCT01513616|COPD|copd
334637|NCT01513616|dyspnea|dyspnea
334638|NCT01513616|exercise|exercise
334639|NCT01513616|measurement|measurement
334640|NCT01513616|respiratory physiology|respiratory physiology
334641|NCT01513577|Lumbar fusion|lumbar fusion
334642|NCT01513577|Pedicular screws|pedicular screws
334643|NCT01513577|Minimal invasive technique|minimal invasive technique
334644|NCT01513577|Randomized controlled trial|randomized controlled trial
334645|NCT01513564|Disc disease|disc disease
334646|NCT01513564|Spondylolisthesis|spondylolisthesis
334647|NCT01513538|Pacemaker programming|pacemaker programming
334648|NCT01513538|Bradyarrhythmia|bradyarrhythmia
334649|NCT01513499|Eating behavior|eating behavior
334650|NCT01513499|Appetite|appetite
334651|NCT01513499|Oxytocin|oxytocin
334652|NCT01513499|Neuropeptide|neuropeptide
334653|NCT01513460|Chronic Obstructive Pulmonary Disease,|chronic obstructive pulmonary disease,
334654|NCT01513460|NVA 237,|nva 237,
334655|NCT01513460|glycopyrronium,|glycopyrronium,
334656|NCT01513460|COPD|copd
716963|NCT01030445|pediatrics|pediatrics
334657|NCT01513447|sterile water injections|sterile water injections
334658|NCT01513447|back labor|back labor
334659|NCT01513421|Infected|infected
334660|NCT01513421|Intra-abdominal|intra-abdominal
334661|NCT01513421|Collection|collection
334662|NCT01513421|Drainage|drainage
334663|NCT01513421|Percutaneous|percutaneous
334664|NCT01513408|breast cancer|breast cancer
334665|NCT01513408|CD8+|cd8+
334666|NCT01513408|Foxp3|foxp3
334667|NCT01513408|neoadjuvant chemotherapy|neoadjuvant chemotherapy
334668|NCT01513395|Cervical assessment|cervical assessment
334669|NCT01513395|Focal myometrial contractions|focal myometrial contractions
334670|NCT01513382|Pilonidal sinus|pilonidal sinus
334671|NCT01513382|Methylene blue|methylene blue
334672|NCT01513382|Histopathology|histopathology
334673|NCT01513382|Surgery|surgery
334674|NCT01513369|Diabetes|diabetes
334675|NCT01513369|iron deficiency|iron deficiency
334676|NCT01513356|breast|breast
334677|NCT01513356|cancer|cancer
334678|NCT01513356|BKM120|bkm120
334679|NCT01513317|Myelodysplastic Syndrome|myelodysplastic syndrome
334681|NCT01513317|Blood and lymphatic diseases|blood and lymphatic diseases
334682|NCT01513317|Siltuximab|siltuximab
334683|NCT01513317|Anemic|anemic
334684|NCT01513265|reduction polypharmacy|reduction polypharmacy
334685|NCT01513265|clinical outcomes|clinical outcomes
334686|NCT01513265|pharmaceutical care|pharmaceutical care
334687|NCT01513265|clinical pharmacy|clinical pharmacy
334688|NCT01513265|geriatrics|geriatrics
334689|NCT01513265|medication review|medication review
334690|NCT01513265|potentially inappropriate drugs|potentially inappropriate drugs
334691|NCT01513252|Cognitive decline|cognitive decline
334692|NCT01513252|prevention|prevention
334693|NCT01513252|omega-3 fatty acids|omega-3 fatty acids
334694|NCT01513252|nutrition exercise|nutrition exercise
334695|NCT01513252|cognitive training|cognitive training
752624|NCT01173380|Equol|equol
334696|NCT01513252|social activities|social activities
334697|NCT01513252|frailty|frailty
334698|NCT01513239|Clostridium difficile|clostridium difficile
334699|NCT01513239|Clostridium difficile infection (CDI)|clostridium difficile infection (cdi)
334700|NCT01513239|recurrent Clostridium difficile|recurrent clostridium difficile
334701|NCT01513239|vancomycin|vancomycin
334702|NCT01513239|metronidazole|metronidazole
334703|NCT01513239|monoclonal antibody|monoclonal antibody
334704|NCT01513226|cycled light|cycled light
334705|NCT01513226|dim light|dim light
334706|NCT01513226|circadian rhythm|circadian rhythm
334707|NCT01513226|actigraphy, sleep|actigraphy, sleep
334708|NCT01513226|premature infant|premature infant
334709|NCT01513213|Arterial cannulation|arterial cannulation
334710|NCT01513213|Blood gas|blood gas
334711|NCT01513213|Carbon dioxide|carbon dioxide
334712|NCT01513213|Arterial blood|arterial blood
334713|NCT01513213|Oxygen|oxygen
334714|NCT01513213|Oxygen fractions|oxygen fractions
334715|NCT01513187|Advanced renal cell carcinoma|advanced renal cell carcinoma
334716|NCT01513187|SOGUG|sogug
334717|NCT01513187|Pazopanib|pazopanib
334718|NCT01513187|Pazopanib in combination with interferon alpha 2A|pazopanib in combination with interferon alpha 2a
334719|NCT01513174|GOAL|goal
334720|NCT01513174|Lung|lung
334721|NCT01513174|Non small cell lung cancer|non small cell lung cancer
334722|NCT01513174|EGFR mutations|egfr mutations
334723|NCT01513161|pruritus|pruritus
334724|NCT01513135|HIV,|hiv,
334725|NCT01513135|HAART-treated|haart-treated
334726|NCT01513135|participants|participants
334727|NCT01513135|Tat protein,|tat protein,
334728|NCT01513135|Therapeutic immunization|therapeutic immunization
334729|NCT01513109|WT1 positive Acute Myeloid Leukemia|wt1 positive acute myeloid leukemia
334730|NCT01513109|Antigen specific cancer immunotherapeutic|antigen specific cancer immunotherapeutic
334731|NCT01513109|Ex vivo regulatory T cell depletion|ex vivo regulatory t cell depletion
751926|NCT01171261|Physical Activity|physical activity
334732|NCT01513109|In vivo regulatory T cell depletion|in vivo regulatory t cell depletion
334734|NCT01513096|bowel preparation|bowel preparation
334735|NCT01513096|PEG|peg
334736|NCT01513096|Prokinetics|prokinetics
334737|NCT01513070|Quick-Acting Heart Reliever|quick-acting heart reliever
334738|NCT01513070|Coronary Artery Stenosis|coronary artery stenosis
334739|NCT01513070|Coronary Heart Disease|coronary heart disease
334740|NCT01513070|Suxiao Jiuxin Pill|suxiao jiuxin pill
334741|NCT01513070|Chinese Herbal Drugs|chinese herbal drugs
334865|NCT01512589|Symptom scores|symptom scores
334742|NCT01513070|Traditional Chinese Medicine|traditional chinese medicine
334743|NCT01513070|Chinese Medicine|chinese medicine
334744|NCT01513070|Angina Pectoris|angina pectoris
334745|NCT01513070|Isosorbide Dinitrate|isosorbide dinitrate
334746|NCT01513070|Myocardial Perfusion Imaging|myocardial perfusion imaging
334747|NCT01513070|Clinical Trial|clinical trial
334748|NCT01513057|bioequivalence|bioequivalence
334749|NCT01513057|Mycophenolate Mofetil|mycophenolate mofetil
334750|NCT01513057|crossover|crossover
334751|NCT01513044|bioequivalence|bioequivalence
334752|NCT01513044|Mycophenolate Mofetil|mycophenolate mofetil
334753|NCT01513044|crossover|crossover
334754|NCT01513031|Atrial fibrillation|atrial fibrillation
334755|NCT01513031|Anti-arrhythmic medication|anti-arrhythmic medication
334756|NCT01513031|Medication adherence|medication adherence
334758|NCT01513018|one lung ventilation|one lung ventilation
334759|NCT01513005|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
334760|NCT01513005|obesity management|obesity management
334761|NCT01512966|Diabetic Macular Edema|diabetic macular edema
334762|NCT01512966|DME|dme
334763|NCT01512966|VEGF Trap-Eye|vegf trap-eye
334764|NCT01512966|best-corrected visual acuity (BCVA)|best-corrected visual acuity (bcva)
334765|NCT01512953|PPI|ppi
334766|NCT01512953|clopidogrel|clopidogrel
334767|NCT01512953|2C19|2c19
334768|NCT01512953|Lansoprazole|lansoprazole
334769|NCT01512940|obesity|obesity
334770|NCT01512940|Laparoscopic Greater Curvature Plication|laparoscopic greater curvature plication
334771|NCT01512940|Percent Excess weight Loss|percent excess weight loss
334772|NCT01512940|comorbidities|comorbidities
334773|NCT01512940|BMI|bmi
334774|NCT01512940|Bariatric Surgery|bariatric surgery
334775|NCT01512927|electronic stethoscope|electronic stethoscope
334776|NCT01512927|arteriovenous fistula|arteriovenous fistula
334777|NCT01512927|hemodialysis,|hemodialysis,
334778|NCT01512914|Gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
334779|NCT01512914|Postoperative pain|postoperative pain
334780|NCT01512914|Nebulization|nebulization
334781|NCT01512914|Ropivacaine|ropivacaine
334782|NCT01512888|SCID|scid
334783|NCT01512888|SCID-X1|scid-x1
334784|NCT01512888|X-linked SCID|x-linked scid
334785|NCT01512888|immunodeficiency|immunodeficiency
334786|NCT01512888|gene therapy|gene therapy
334787|NCT01512875|Helicobacter pylori|helicobacter pylori
334788|NCT01512875|water contamination|water contamination
334789|NCT01512875|Lima, Peru|lima, peru
334790|NCT01512862|Calcitriol|calcitriol
334791|NCT01512862|Off-label|off-label
334792|NCT01512849|TA-7284|ta-7284
334793|NCT01512849|JNJ-28431754|jnj-28431754
334794|NCT01512849|Canagliflozin|canagliflozin
334795|NCT01512849|Renal Impairment|renal impairment
334796|NCT01512849|Sodium Glucose Co-transporter2 (SGLT2) inhibitor|sodium glucose co-transporter2 (sglt2) inhibitor
334797|NCT01512836|COPD|copd
334798|NCT01512836|Case management|case management
334799|NCT01512836|CEA|cea
334800|NCT01512836|Health economy|health economy
334801|NCT01512836|Quality of Life|quality of life
334802|NCT01512823|randomised controlled trial|randomised controlled trial
334803|NCT01512823|educational intervention|educational intervention
334804|NCT01512823|occupational therapy|occupational therapy
334805|NCT01512810|Endometrial|endometrial
334806|NCT01512810|Cancer|cancer
334807|NCT01512810|Intraoperative Consultation|intraoperative consultation
334808|NCT01512797|Januvia|januvia
334809|NCT01512797|Sitagliptin|sitagliptin
334810|NCT01512797|Diabetes|diabetes
334811|NCT01512797|Gastric-Bypass|gastric-bypass
334812|NCT01512784|Quadrivalent Human Papillomavirus Vaccine (HPV) Gardasil|quadrivalent human papillomavirus vaccine (hpv) gardasil
334813|NCT01512784|HIV infection|hiv infection
334814|NCT01512784|Evaluation of quadrivalent HPV vaccine in adolescents and young adults.|evaluation of quadrivalent hpv vaccine in adolescents and young adults.
334815|NCT01512758|East Asian Patients|east asian patients
334816|NCT01512758|Advanced solid tumors|advanced solid tumors
334817|NCT01512758|Lymphomas|lymphomas
334818|NCT01512758|MLN8237|mln8237
334819|NCT01512758|Alisertib|alisertib
334820|NCT01512758|Aurora A Kinase Inhibitor|aurora a kinase inhibitor
334821|NCT01512706|Human Enterovirus 71 (EV71)|human enterovirus 71 (ev71)
334822|NCT01512706|Hand, Foot and Mouth Disease|hand, foot and mouth disease
334823|NCT01512706|Inactivated Vaccine|inactivated vaccine
334824|NCT01512706|Human Diploid cell|human diploid cell
334825|NCT01512706|Safety|safety
334826|NCT01512706|Immunogenicity|immunogenicity
334827|NCT01512706|Adverse reactions associated with vaccine|adverse reactions associated with vaccine
334828|NCT01512680|Functional Insulin Thearpy|functional insulin thearpy
334829|NCT01512680|Carbs counting|carbs counting
334830|NCT01512680|Type 1 diabetes mellitus|type 1 diabetes mellitus
334831|NCT01512680|Insulin pump|insulin pump
334832|NCT01512680|Treatment by external insulin pump|treatment by external insulin pump
334833|NCT01512654|diabetes|diabetes
334834|NCT01512654|diadvisor|diadvisor
334835|NCT01512654|type 1 diabetes|type 1 diabetes
334836|NCT01512654|type 2 diabetes|type 2 diabetes
334837|NCT01512654|glucose prediction|glucose prediction
334838|NCT01512654|cgm prediction|cgm prediction
334839|NCT01512654|algorithm|algorithm
334840|NCT01512654|therapy advices|therapy advices
334841|NCT01512641|children dissociative disorders schizophrenia|children dissociative disorders schizophrenia
334842|NCT01512615|Rehabilitation|rehabilitation
334843|NCT01512615|Exercise training|exercise training
334844|NCT01512615|Psycho-educational care|psycho-educational care
334845|NCT01512602|Borderline Personality Disorder traits|borderline personality disorder traits
334846|NCT01512602|Suicide prevention|suicide prevention
334847|NCT01512602|Self-harm|self-harm
334848|NCT01512602|Dialectical Behavior Therapy|dialectical behavior therapy
334849|NCT01512602|DBT|dbt
334850|NCT01512602|Collaborative Assessment and Management of Suicidology|collaborative assessment and management of suicidology
334851|NCT01512602|CAMS|cams
334852|NCT01512589|Proton Beam Therapy|proton beam therapy
334853|NCT01512589|PBT|pbt
334854|NCT01512589|Intensity-Modulated Radiation Therapy|intensity-modulated radiation therapy
334855|NCT01512589|IMRT|imrt
334856|NCT01512589|Esophageal cancer|esophageal cancer
334857|NCT01512589|Adenocarcinoma|adenocarcinoma
334858|NCT01512589|Squamous cell carcinoma|squamous cell carcinoma
334859|NCT01512589|Cervical esophagus|cervical esophagus
334860|NCT01512589|Thoracic esophagus|thoracic esophagus
334861|NCT01512589|Gastroesophageal junction|gastroesophageal junction
334862|NCT01512589|Cardia of stomach|cardia of stomach
334863|NCT01512589|Questionnaires|questionnaires
334864|NCT01512589|Surveys|surveys
334866|NCT01512589|Quality of life|quality of life
334867|NCT01512589|QOL|qol
334868|NCT01512576|whiplash|whiplash
334869|NCT01512576|chronic pain|chronic pain
334870|NCT01512576|sensitization|sensitization
334871|NCT01512576|treatment|treatment
334872|NCT01512576|acupuncture|acupuncture
334873|NCT01512576|relaxation|relaxation
334874|NCT01512563|paclitaxel|paclitaxel
334875|NCT01512563|drug eluting stent|drug eluting stent
335078|NCT01511848|Iron balance|iron balance
334876|NCT01512550|Radiostereometric Analysis (RSA)|radiostereometric analysis (rsa)
334877|NCT01512550|Total hip arthroplasty (THA)|total hip arthroplasty (tha)
334878|NCT01512550|Hip anatomy|hip anatomy
334879|NCT01512550|Hip biomechanics|hip biomechanics
334880|NCT01512537|Vitamin D|vitamin d
334881|NCT01512537|UVB|uvb
334882|NCT01512537|Vitamin D supplementation|vitamin d supplementation
334883|NCT01512524|Traumatic Brain Injury|traumatic brain injury
334884|NCT01512524|Quality of Life (QoL)|quality of life (qol)
334885|NCT01512524|hypopituitarism,GH|hypopituitarism,gh
334886|NCT01512511|laparoscopic cholecystectomy|laparoscopic cholecystectomy
334887|NCT01512511|pneumoperitoneum|pneumoperitoneum
325663|NCT01552174|MGD|mgd
334888|NCT01512511|nitrous oxide|nitrous oxide
334889|NCT01512511|carbon dioxide|carbon dioxide
334890|NCT01512498|VV GVHD|vv gvhd
334891|NCT01512498|girls|girls
334892|NCT01512498|adolescents|adolescents
334893|NCT01512498|HSCT|hsct
334894|NCT01512485|Bioequivalence|bioequivalence
334895|NCT01512485|Clopidogrel|clopidogrel
334896|NCT01512485|crossover|crossover
334897|NCT01512472|localized prostate cancer|localized prostate cancer
334898|NCT01512472|degarelix|degarelix
334899|NCT01512472|intermittent androgen deprivation therapy|intermittent androgen deprivation therapy
334900|NCT01512459|Bioavailability|bioavailability
334901|NCT01512459|Venlafaxine|venlafaxine
334902|NCT01512459|two way crossover|two way crossover
334903|NCT01512446|Osteoporosis|osteoporosis
334904|NCT01512446|Osteoporotic fractures|osteoporotic fractures
334905|NCT01512446|Bisphosphonate|bisphosphonate
334906|NCT01512446|Pretreatment with bisphosphonates|pretreatment with bisphosphonates
334907|NCT01512433|acupuncture|acupuncture
334908|NCT01512433|methadone|methadone
334909|NCT01512407|Hepatocellular Carcinoma|hepatocellular carcinoma
334910|NCT01512407|Randomised controlled trial|randomised controlled trial
334911|NCT01512407|Transarterial chemoembolisation|transarterial chemoembolisation
334912|NCT01512394|bowel preparation|bowel preparation
334913|NCT01512381|heart failure|heart failure
334914|NCT01512381|CRT|crt
334915|NCT01512381|atrial fibrillation|atrial fibrillation
334916|NCT01512381|AV junction ablation|av junction ablation
334917|NCT01512368|Fibroblast growth factor 21 (FGF21)|fibroblast growth factor 21 (fgf21)
334918|NCT01512368|Exercise|exercise
334919|NCT01512368|Metabolic equivalents (METs)|metabolic equivalents (mets)
334920|NCT01512368|Lipolysis|lipolysis
334921|NCT01512368|Glucose|glucose
334922|NCT01512368|Free fatty acids (FFAs)|free fatty acids (ffas)
334923|NCT01512368|Epinephrine|epinephrine
334924|NCT01512342|pacing|pacing
334925|NCT01512342|activity management|activity management
334926|NCT01512342|relaxation|relaxation
334927|NCT01512342|physiotherapy|physiotherapy
334928|NCT01512342|occupational therapy|occupational therapy
334929|NCT01512342|autonomic nervous system|autonomic nervous system
334930|NCT01512329|neurology|neurology
334931|NCT01512329|physiotherapy|physiotherapy
334932|NCT01512329|physical therapy|physical therapy
334933|NCT01512329|occupational therapy|occupational therapy
334934|NCT01512329|stress management|stress management
334935|NCT01512329|activity management|activity management
334936|NCT01512329|treatment|treatment
334937|NCT01512316|Fear|fear
334938|NCT01512316|Cycloserine|cycloserine
334939|NCT01512316|Conditioning|conditioning
334940|NCT01512316|Functional neuroimaging|functional neuroimaging
334941|NCT01512316|Anxiety disorders|anxiety disorders
334942|NCT01512303|PTSD|ptsd
334943|NCT01512303|Veterans' Health|veterans' health
334944|NCT01512303|Meditation|meditation
334945|NCT01512303|MRI, Functional|mri, functional
334946|NCT01512290|Auditory verbal hallucinations|auditory verbal hallucinations
334947|NCT01512290|Transcranial Magnetic stimulation|transcranial magnetic stimulation
334948|NCT01512290|Theta Burst frequency|theta burst frequency
334949|NCT01512277|vaccines|vaccines
334950|NCT01512277|safety|safety
334951|NCT01512277|drug tolerance|drug tolerance
334952|NCT01512277|immunogenic protein|immunogenic protein
334953|NCT01512277|antibody response|antibody response
334954|NCT01512277|cytokine|cytokine
334955|NCT01512264|Aphasia|aphasia
334956|NCT01512264|Stroke|stroke
334957|NCT01512264|functional Magnetic resonance imaging|functional magnetic resonance imaging
334958|NCT01512264|fMRI|fmri
334959|NCT01512264|Language recovery after stroke|language recovery after stroke
334960|NCT01512264|constraint induced aphasia therapy|constraint induced aphasia therapy
334961|NCT01512264|CIAT|ciat
334962|NCT01512264|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
334963|NCT01512264|rTMS|rtms
334964|NCT01512251|BKM120|bkm120
334965|NCT01512251|BRAF|braf
334966|NCT01512251|Melanoma|melanoma
334967|NCT01512251|PI3K|pi3k
334968|NCT01512238|Medicine adherence|medicine adherence
334969|NCT01512238|Drug substitution|drug substitution
334970|NCT01512238|Herb-drug interaction|herb-drug interaction
334971|NCT01512238|Herbal medicine|herbal medicine
334972|NCT01512238|Dietary supplements|dietary supplements
334973|NCT01512238|Over-the-counter products|over-the-counter products
334974|NCT01512238|On-line prescription records|on-line prescription records
335664|NCT01509365|clopidogrel|clopidogrel
334975|NCT01512238|Personal electronic medicine profile|personal electronic medicine profile
334976|NCT01512238|Intentional non-adherence|intentional non-adherence
334977|NCT01512238|Unintentional non-adherence|unintentional non-adherence
334978|NCT01512225|breastmilk|breastmilk
334979|NCT01512225|domperidone|domperidone
334980|NCT01512225|preterm|preterm
334981|NCT01512212|thyroid|thyroid
334982|NCT01512212|fine|fine
334983|NCT01512212|needle|needle
334984|NCT01512212|aspiration|aspiration
334985|NCT01512212|biopsy|biopsy
334986|NCT01512212|new|new
325737|NCT01551758|Adult|adult
334987|NCT01512212|technique|technique
334988|NCT01512199|U3-1287|u3-1287
334989|NCT01512199|Trastuzumab|trastuzumab
334990|NCT01512199|Paclitaxel|paclitaxel
334991|NCT01512199|newly diagnosed HER-2 positive|newly diagnosed her-2 positive
334992|NCT01512199|breast cancer|breast cancer
334993|NCT01512199|metastatic|metastatic
334994|NCT01512186|Clear cell renal cancer|clear cell renal cancer
334995|NCT01512173|Propranolol gel|propranolol gel
334996|NCT01512173|Hemangioma|hemangioma
334997|NCT01512173|capillary neoplasm|capillary neoplasm
334998|NCT01512173|vascular tissue|vascular tissue
334999|NCT01512173|neoplasm by histologic type|neoplasm by histologic type
335000|NCT01512173|neoplasm|neoplasm
335001|NCT01512173|therapeutic uses|therapeutic uses
335002|NCT01512173|pharmacologic actions|pharmacologic actions
335003|NCT01512173|adrenergic beta-antagonists|adrenergic beta-antagonists
335004|NCT01512173|adrenergic antagonist|adrenergic antagonist
335005|NCT01512173|adrenergics agent|adrenergics agent
335006|NCT01512173|neurotransmitter agent|neurotransmitter agent
335007|NCT01512173|molecular mechanism of pharmacological action|molecular mechanism of pharmacological action
335008|NCT01512173|physiological effects of drugs|physiological effects of drugs
335009|NCT01512160|Post-surgical dental pain|post-surgical dental pain
335010|NCT01512147|SSEP measurements|ssep measurements
335011|NCT01512147|MEP measurements|mep measurements
335012|NCT01512147|Pediatric Patients|pediatric patients
335013|NCT01512147|Neurosurgery|neurosurgery
335014|NCT01512147|General Anesthesia|general anesthesia
335015|NCT01512134|Obesity|obesity
335016|NCT01512134|DBS|dbs
335017|NCT01512082|Pain|pain
335018|NCT01512082|Delayed onset muscle soreness|delayed onset muscle soreness
335019|NCT01512082|Pulsed electromagnetic field|pulsed electromagnetic field
335020|NCT01512082|Marathon|marathon
335021|NCT01512069|randomized controlled trial|randomized controlled trial
335022|NCT01512069|internet|internet
335023|NCT01512069|diet|diet
335024|NCT01512069|exercise|exercise
335025|NCT01512069|health planning|health planning
335026|NCT01512069|the TTM|the ttm
335027|NCT01512056|Influenza vaccine|influenza vaccine
335028|NCT01512056|dialysis|dialysis
335029|NCT01512056|vaccine|vaccine
335030|NCT01512056|Seroprotection|seroprotection
335031|NCT01512056|Seroresponse|seroresponse
335032|NCT01512056|Seroconversion|seroconversion
335033|NCT01512056|Safety of the vaccine|safety of the vaccine
335034|NCT01512043|Breathlessness|breathlessness
335035|NCT01512043|Symptoms|symptoms
335036|NCT01512043|Quality of life|quality of life
335037|NCT01512017|skin lesions or defects|skin lesions or defects
335038|NCT01512004|Overactive Bladder|overactive bladder
335039|NCT01512004|urgent micturition|urgent micturition
335040|NCT01512004|frequent micturition|frequent micturition
335041|NCT01512004|urge urinary incontinence|urge urinary incontinence
335042|NCT01511991|cardiac surgery|cardiac surgery
335043|NCT01511991|sevoflurane|sevoflurane
335044|NCT01511991|tissue Doppler|tissue doppler
335045|NCT01511978|Lambert-Eaton|lambert-eaton
335046|NCT01511978|Eaton-Lambert|eaton-lambert
335047|NCT01511978|myasthenia|myasthenia
335048|NCT01511978|myasthenic|myasthenic
335049|NCT01511978|LEMS|lems
335050|NCT01511978|LES|les
335051|NCT01511978|DAP|dap
335054|NCT01511978|3,4-DAP|3,4-dap
335055|NCT01511952|music therapy|music therapy
335056|NCT01511952|entrainment|entrainment
335057|NCT01511952|premature infants|premature infants
335058|NCT01511952|live music intervention|live music intervention
335059|NCT01511952|parent preferred lullabies|parent preferred lullabies
335060|NCT01511939|Knee pain|knee pain
335061|NCT01511939|Anticoagulant|anticoagulant
335062|NCT01511939|Warfarin|warfarin
335063|NCT01511939|Dabigatran|dabigatran
335064|NCT01511939|Clopidogrel|clopidogrel
335065|NCT01511939|Aspirin|aspirin
335066|NCT01511939|Topical NSAID|topical nsaid
335067|NCT01511939|Osteoarthritis|osteoarthritis
335068|NCT01511926|Vimovo™ treated patients and prescribing patterns|vimovo™ treated patients and prescribing patterns
335069|NCT01511926|Risk of gastrointestinal side effects|risk of gastrointestinal side effects
335071|NCT01511887|Patent Ductus Arteriosus|patent ductus arteriosus
335072|NCT01511887|PDA|pda
335073|NCT01511887|Term newborns|term newborns
335074|NCT01511887|Ibuprofen|ibuprofen
335075|NCT01511874|ELIGARD|eligard
335076|NCT01511874|Prostate cancer|prostate cancer
335077|NCT01511848|Iron chelation|iron chelation
335079|NCT01511848|Secondary iron overload|secondary iron overload
335080|NCT01511848|deferoxamine|deferoxamine
335081|NCT01511848|deferasirox|deferasirox
335082|NCT01511848|Deferiprone|deferiprone
335083|NCT01511848|1- Beta-thalassemia major patients;|1- beta-thalassemia major patients;
335084|NCT01511848|Patients with high iron stores|patients with high iron stores
335085|NCT01511848|Serum ferritin consistently > 2500 mcg/l and or increasing trend over previous 12 months|serum ferritin consistently > 2500 mcg/l and or increasing trend over previous 12 months
335086|NCT01511848|Liver iron >14 mg/g dry weight- by R2 MRI|liver iron >14 mg/g dry weight- by r2 mri
335087|NCT01511848|2- Sickle cell disease|2- sickle cell disease
335088|NCT01511848|3- Other causes of transfusional iron hemosiderosis|3- other causes of transfusional iron hemosiderosis
335089|NCT01511835|diabetes|diabetes
335090|NCT01511835|pregnancy|pregnancy
335091|NCT01511835|myo-inositol|myo-inositol
335092|NCT01511822|PCOS|pcos
335093|NCT01511822|Insulin resistance|insulin resistance
335094|NCT01511822|Hyperandrogenism|hyperandrogenism
335095|NCT01511822|Myo-inositol|myo-inositol
335096|NCT01511809|HIV-1|hiv-1
335097|NCT01511796|stroke|stroke
335098|NCT01511796|upper limb rehabilitation function|upper limb rehabilitation function
335099|NCT01511770|Bioequivalence|bioequivalence
335100|NCT01511770|Fluconazole|fluconazole
335101|NCT01511770|Crossover|crossover
335102|NCT01511757|Bioequivalence|bioequivalence
335103|NCT01511757|Fluconazole|fluconazole
335104|NCT01511757|Crossover|crossover
335105|NCT01511744|Respiratory Tract Infections; Orthomyxoviridae Infections|respiratory tract infections; orthomyxoviridae infections
335106|NCT01511731|Bioequivalence|bioequivalence
335107|NCT01511731|famotidine|famotidine
335108|NCT01511731|Crossover|crossover
335109|NCT01511718|Bioequivalence|bioequivalence
335110|NCT01511718|Ondansetron|ondansetron
335111|NCT01511718|crossover|crossover
335112|NCT01511705|Bioequivalence|bioequivalence
335113|NCT01511705|Ondansetron|ondansetron
335114|NCT01511705|crossover|crossover
335115|NCT01511679|Alcohol abuse|alcohol abuse
335116|NCT01511666|cardiac arrest|cardiac arrest
335117|NCT01511666|mechanical chest compressions|mechanical chest compressions
335118|NCT01511666|intraarrest cooling|intraarrest cooling
335119|NCT01511666|ECLS|ecls
335120|NCT01511653|screening colonoscopy|screening colonoscopy
335121|NCT01511653|colon cancer early detection|colon cancer early detection
335122|NCT01511653|rectal cancer early detection|rectal cancer early detection
335123|NCT01511653|colorectal cancer prevention|colorectal cancer prevention
335124|NCT01511653|biomarker validation|biomarker validation
335125|NCT01511640|marijuana|marijuana
335126|NCT01511640|addiction|addiction
335127|NCT01511640|treatment|treatment
335128|NCT01511640|pharmacotherapy|pharmacotherapy
335129|NCT01511640|cannabinoid|cannabinoid
335130|NCT01511614|fMRI|fmri
335131|NCT01511614|Nicotine Withdrawal|nicotine withdrawal
335132|NCT01511601|Apheresis|apheresis
335133|NCT01511601|Leukocytes|leukocytes
335134|NCT01511601|Plasma|plasma
335135|NCT01511601|Plamodium Falciparum Malaria|plamodium falciparum malaria
335136|NCT01511601|Immunology|immunology
335137|NCT01511588|Kallmann Syndrome|kallmann syndrome
335138|NCT01511588|Delayed Puberty|delayed puberty
335139|NCT01511588|GnRH Deficiency|gnrh deficiency
335140|NCT01511588|Infertility|infertility
335141|NCT01511588|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
335142|NCT01511588|Amenorrhea|amenorrhea
335143|NCT01511588|Hypogonadism|hypogonadism
335144|NCT01511575|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
335145|NCT01511575|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
335146|NCT01511575|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
335147|NCT01511562|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
335148|NCT01511562|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
335149|NCT01511562|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
335150|NCT01511562|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
335151|NCT01511562|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
335152|NCT01511562|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
335153|NCT01511523|Liver|liver
335154|NCT01511523|Fatty|fatty
335155|NCT01511523|Non Alcoholic|non alcoholic
335156|NCT01511523|Vitamin E|vitamin e
335157|NCT01511523|Silymarin|silymarin
335158|NCT01511523|Carnitine|carnitine
335159|NCT01511523|Supplement|supplement
335160|NCT01511523|NAFLD|nafld
335161|NCT01511510|PF-04958242|pf-04958242
335162|NCT01511510|multiple dose|multiple dose
335163|NCT01511510|safety|safety
335164|NCT01511510|schizophrenia|schizophrenia
335165|NCT01511497|Phase 1|phase 1
335166|NCT01511497|PF-04427429|pf-04427429
335167|NCT01511484|fruit|fruit
335168|NCT01511484|vegetables|vegetables
335169|NCT01511484|appearance|appearance
335170|NCT01511484|skin color|skin color
335171|NCT01511484|carotenoids|carotenoids
335172|NCT01511484|diet|diet
335173|NCT01511471|Ticagrelor|ticagrelor
335174|NCT01511471|platelet reactivity|platelet reactivity
335175|NCT01511471|clopidogrel|clopidogrel
335176|NCT01511471|haemodialysis|haemodialysis
335177|NCT01511458|Pregnancy|pregnancy
335178|NCT01511458|Fetal aneuploidy|fetal aneuploidy
335179|NCT01511458|Trisomy 21|trisomy 21
335180|NCT01511458|Down Syndrome|down syndrome
335181|NCT01511458|Prenatal screening|prenatal screening
335182|NCT01511458|Non-invasive prenatal testing|non-invasive prenatal testing
335471|NCT01510236|Depression|depression
335183|NCT01511458|First trimester|first trimester
335184|NCT01511458|Combined screening|combined screening
335185|NCT01511458|Nuchal translucency|nuchal translucency
335186|NCT01511458|PAPP-A|papp-a
335187|NCT01511458|hCG|hcg
335188|NCT01511458|cell free DNA|cell free dna
335189|NCT01511458|cf DNA|cf dna
335190|NCT01511458|DNA|dna
335191|NCT01511458|Performance characteristics of non-invasive first trimester screening|performance characteristics of non-invasive first trimester screening
335192|NCT01511458|Harmony Prenatal Test|harmony prenatal test
335193|NCT01511445|Cervicobrachial pain|cervicobrachial pain
335194|NCT01511445|radicular pain|radicular pain
335195|NCT01511445|arm pain|arm pain
335196|NCT01511445|myelopathy|myelopathy
335197|NCT01511445|radiculitis|radiculitis
335198|NCT01511445|Radiating pain with or without signs of myelopathy.|radiating pain with or without signs of myelopathy.
335199|NCT01511432|Relative bioavailability|relative bioavailability
335200|NCT01511432|telaprevir formulations|telaprevir formulations
335201|NCT01511419|Influenza|influenza
335202|NCT01511419|Vaccine|vaccine
335203|NCT01511419|Pandemic|pandemic
335204|NCT01511419|H7N3|h7n3
335205|NCT01511406|Psychosis|psychosis
335206|NCT01511406|Schizophrenia|schizophrenia
335207|NCT01511406|Cognitive behavioral therapy|cognitive behavioral therapy
335208|NCT01511406|Self esteem|self esteem
335209|NCT01511406|Depression|depression
335210|NCT01511393|GLP1|glp1
335211|NCT01511393|Glucagon like peptide|glucagon like peptide
335212|NCT01511393|liraglutide|liraglutide
335213|NCT01511393|exenatide extended release|exenatide extended release
335214|NCT01511393|albiglutide|albiglutide
335215|NCT01511393|dulaglutide|dulaglutide
335216|NCT01511380|juvenile|juvenile
335217|NCT01511380|randomized trial|randomized trial
335218|NCT01511380|substance abuse|substance abuse
335219|NCT01511380|sexual risk|sexual risk
335220|NCT01511380|contingency management|contingency management
335221|NCT01511367|moderate to severe persistent reversible asthma|moderate to severe persistent reversible asthma
335222|NCT01511354|critically ill children|critically ill children
335223|NCT01511354|ICU|icu
335224|NCT01511354|24hr protein balance|24hr protein balance
335225|NCT01511354|stable isotopes|stable isotopes
335226|NCT01511354|fed state|fed state
335227|NCT01511341|Telenursing|telenursing
335228|NCT01511341|Children|children
335229|NCT01511341|Chronic Illness|chronic illness
335230|NCT01511341|Nursing|nursing
335231|NCT01511328|HPV testing|hpv testing
335232|NCT01511328|Primary screening|primary screening
335233|NCT01511328|Cervical Cancer|cervical cancer
335234|NCT01511315|Moderate to severe psoriasis|moderate to severe psoriasis
335235|NCT01511289|Radotinib|radotinib
335236|NCT01511289|CML-CP|cml-cp
335237|NCT01511289|Chronic Myeloid Leukemia, chronic phase|chronic myeloid leukemia, chronic phase
335238|NCT01511276|Breast cancer|breast cancer
335239|NCT01511276|Sex hormones|sex hormones
335240|NCT01511276|Physical activity|physical activity
335241|NCT01511263|Epigallocatechin gallate|epigallocatechin gallate
335242|NCT01511263|AL amyloidosis|al amyloidosis
335243|NCT01511250|normal healthy adults and children|normal healthy adults and children
335244|NCT01511250|Safety and tolerability|safety and tolerability
335245|NCT01511250|active vaccine|active vaccine
335246|NCT01511250|placebo|placebo
335247|NCT01511250|Dengue virus vaccine|dengue virus vaccine
335248|NCT01511250|Immune response|immune response
335249|NCT01511237|HIV-1 infection|hiv-1 infection
335250|NCT01511237|Prophylaxis|prophylaxis
335251|NCT01511237|Mother-to-child transmission HIV-1|mother-to-child transmission hiv-1
335252|NCT01511237|Thailand|thailand
335253|NCT01511237|Developing Countries|developing countries
335254|NCT01511224|Bloodstream infections|bloodstream infections
335255|NCT01511224|Acinetobacter|acinetobacter
335256|NCT01511224|Drug resistant Acinetobacter baumannii bacteremia|drug resistant acinetobacter baumannii bacteremia
335257|NCT01511211|Dexamethasone|dexamethasone
335258|NCT01511211|lower limb block|lower limb block
335259|NCT01511211|ultrasound guided femoral nerve block|ultrasound guided femoral nerve block
335260|NCT01511211|ultrasound guided obturator nerve block|ultrasound guided obturator nerve block
335261|NCT01511211|ultrasound guided sciatic nerve block|ultrasound guided sciatic nerve block
335262|NCT01511211|ropivacaine|ropivacaine
335263|NCT01511211|total knee arthroplasty|total knee arthroplasty
335264|NCT01511211|Post surgical pain after total knee arthroplasty|post surgical pain after total knee arthroplasty
335265|NCT01511146|oxaliplatin|oxaliplatin
335266|NCT01511146|mitomycin|mitomycin
335267|NCT01511146|gemcitabine|gemcitabine
335268|NCT01511146|intrahepatic|intrahepatic
335269|NCT01511146|liver metastasis|liver metastasis
335270|NCT01511146|response in liver metastasis|response in liver metastasis
335665|NCT01509365|overweight|overweight
335271|NCT01511146|downsized to operation|downsized to operation
335272|NCT01511133|Laboratory evaluations|laboratory evaluations
335273|NCT01511133|infants|infants
335274|NCT01511133|Porcine circovirus type 1 (PCV-1)|porcine circovirus type 1 (pcv-1)
335275|NCT01511133|serologic response|serologic response
335276|NCT01511133|human rotavirus (HRV) vaccine|human rotavirus (hrv) vaccine
335277|NCT01511107|acute otitis media|acute otitis media
335278|NCT01511107|ear infection|ear infection
335279|NCT01511107|antimicrobial therapy|antimicrobial therapy
335280|NCT01511107|antimicrobial resistance|antimicrobial resistance
335281|NCT01511094|ab-interno trabeculectomy,|ab-interno trabeculectomy,
335282|NCT01511094|intraocular pressure,|intraocular pressure,
335283|NCT01511094|open angle glaucoma|open angle glaucoma
335284|NCT01511094|trabeculectomy|trabeculectomy
335285|NCT01511094|Goniocurettage|goniocurettage
335286|NCT01511094|Non-Filtering Surgery|non-filtering surgery
335287|NCT01511081|Non-small-cell lung cancer|non-small-cell lung cancer
335288|NCT01511081|NSCLC|nsclc
335289|NCT01511081|Centrally-located|centrally-located
335290|NCT01511081|Recurrent|recurrent
335291|NCT01511081|Squamous cell carcinoma|squamous cell carcinoma
335292|NCT01511081|Adenocarcinoma|adenocarcinoma
335293|NCT01511081|Large cell carcinoma|large cell carcinoma
335294|NCT01511081|Bronchioloalveolar cell carcinoma|bronchioloalveolar cell carcinoma
335295|NCT01511081|Non-small cell carcinoma not otherwise specified|non-small cell carcinoma not otherwise specified
335296|NCT01511081|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
335297|NCT01511081|SBRT|sbrt
335298|NCT01511081|Stereotactic Body Proton Therapy|stereotactic body proton therapy
335299|NCT01511081|SBPT|sbpt
335300|NCT01511068|PAP|pap
335301|NCT01511055|Ovarian Cancer|ovarian cancer
335302|NCT01511016|lipid kinetics|lipid kinetics
335303|NCT01511016|fat oxidation|fat oxidation
335304|NCT01511003|calcineurin inhibitor|calcineurin inhibitor
335305|NCT01511003|Prograf|prograf
335306|NCT01511003|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
335307|NCT01511003|Tacrolimus|tacrolimus
335308|NCT01510990|Non-small cell lung cancer|non-small cell lung cancer
335309|NCT01510990|Gefitinib|gefitinib
335310|NCT01510990|FDG-PET|fdg-pet
335311|NCT01510977|colonoscopy|colonoscopy
335312|NCT01510977|bowel preparation|bowel preparation
335313|NCT01510964|Breast cancer|breast cancer
335314|NCT01510964|Patient involvement|patient involvement
335315|NCT01510964|Question prompt-sheet|question prompt-sheet
335316|NCT01510964|Doctor-patient communication|doctor-patient communication
335317|NCT01510964|RCT|rct
335318|NCT01510951|AMGEN|amgen
335319|NCT01510951|PSORIASIS|psoriasis
335320|NCT01510951|SAFETY|safety
335321|NCT01510938|Children|children
335322|NCT01510938|Respiratory Tract Infections|respiratory tract infections
335324|NCT01510886|MDD, management, Andalusia, Database, PismaEP|mdd, management, andalusia, database, pismaep
335325|NCT01510873|Health-related quality of life|health-related quality of life
335326|NCT01510873|Fatigue|fatigue
335327|NCT01510873|pITO|pito
335328|NCT01510873|Primary Immune Thrombocytopenic Purpura|primary immune thrombocytopenic purpura
335329|NCT01510834|Computerized Tailored Intervention|computerized tailored intervention
335330|NCT01510834|CTI|cti
335331|NCT01510834|Post Traumatic Stress Disorder|post traumatic stress disorder
335332|NCT01510834|PTSD|ptsd
335333|NCT01510834|Smoking|smoking
335334|NCT01510834|Anxiety|anxiety
335335|NCT01510834|Depression|depression
335336|NCT01510821|endoscopic vein harvest|endoscopic vein harvest
335337|NCT01510821|saphenous vein graft|saphenous vein graft
335338|NCT01510821|endothelial function|endothelial function
586558|NCT00516698|stage IIIA breast cancer|stage iiia breast cancer
335339|NCT01510808|aggressive periodontitis orthodontic stability|aggressive periodontitis orthodontic stability
335340|NCT01510795|Kidney transplantation|kidney transplantation
335341|NCT01510795|Mineralocorticoid receptors|mineralocorticoid receptors
335342|NCT01510795|Spironolactone|spironolactone
335343|NCT01510743|open heart surgery|open heart surgery
335344|NCT01510743|lung surgery|lung surgery
335345|NCT01510743|spine surgery|spine surgery
335346|NCT01510743|hepatobiliary surgery|hepatobiliary surgery
335347|NCT01510730|gastric tumor|gastric tumor
335348|NCT01510730|Helicobacter pylori|helicobacter pylori
335349|NCT01510730|endoscopic resection|endoscopic resection
335350|NCT01510730|metachronous neoplasms|metachronous neoplasms
335351|NCT01510717|Intraocular Lens|intraocular lens
335352|NCT01510717|Monofocal|monofocal
335353|NCT01510717|Multifocal|multifocal
335354|NCT01510691|Oxygenation of the retinal vessels|oxygenation of the retinal vessels
335355|NCT01510691|vitroretinal surgery|vitroretinal surgery
335356|NCT01510678|Diet Quality|diet quality
335357|NCT01510665|Weight gain in pregnancy|weight gain in pregnancy
335358|NCT01510665|Metabolic and Inflammatory markers|metabolic and inflammatory markers
335359|NCT01510652|Cardiac Resynchronization therapy,|cardiac resynchronization therapy,
335360|NCT01510652|Heart Failure,|heart failure,
335361|NCT01510652|Left Ventricular Lead,|left ventricular lead,
335362|NCT01510652|Quadripolar Left ventricular Lead,|quadripolar left ventricular lead,
335363|NCT01510652|Phrenic Nerve Stimulation,|phrenic nerve stimulation,
335364|NCT01510652|Intra and post operative related complications|intra and post operative related complications
335365|NCT01510626|Multiple food allergies|multiple food allergies
335366|NCT01510613|Pomalidomide|pomalidomide
335367|NCT01510613|Dexamethasone|dexamethasone
335368|NCT01510613|treatment|treatment
335369|NCT01510613|AL amyloidosis|al amyloidosis
335370|NCT01510600|stage 4S neuroblastoma|stage 4s neuroblastoma
335371|NCT01510600|localized resectable neuroblastoma|localized resectable neuroblastoma
335472|NCT01510236|Anxiety|anxiety
335372|NCT01510600|localized unresectable neuroblastoma|localized unresectable neuroblastoma
335373|NCT01510600|recurrent neuroblastoma|recurrent neuroblastoma
335374|NCT01510600|regional neuroblastoma|regional neuroblastoma
335375|NCT01510587|obesity|obesity
335376|NCT01510587|prevention|prevention
335377|NCT01510587|preteen|preteen
335378|NCT01510587|nutrition|nutrition
335379|NCT01510587|physical activity|physical activity
335380|NCT01510587|body image|body image
335381|NCT01510587|family dynamics|family dynamics
335382|NCT01510574|postpartum hemorrhage, PPH, misoprostol|postpartum hemorrhage, pph, misoprostol
335383|NCT01510561|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
335384|NCT01510561|pancreatic cancer|pancreatic cancer
335385|NCT01510561|metastatic pancreatic cancer|metastatic pancreatic cancer
335386|NCT01510548|Disc prolapse|disc prolapse
335387|NCT01510548|Pain|pain
335388|NCT01510548|Disability|disability
335389|NCT01510535|Osteoartritis|osteoartritis
335390|NCT01510535|Knee|knee
335391|NCT01510535|LBSA0103|lbsa0103
335392|NCT01510535|Hyruan Plus Inj.|hyruan plus inj.
335393|NCT01510522|Diabetes|diabetes
335394|NCT01510522|Glucophage|glucophage
335395|NCT01510522|Metformin|metformin
335396|NCT01510522|sachets|sachets
335397|NCT01510522|tablets|tablets
335398|NCT01510509|Drug Eluting Stent|drug eluting stent
335399|NCT01510509|Bioactive Bare Metal Stent|bioactive bare metal stent
335400|NCT01510496|Chronic pain|chronic pain
335401|NCT01510496|genetic polymorphisms|genetic polymorphisms
335402|NCT01510496|postoperative pain|postoperative pain
335403|NCT01510483|obesity prevention|obesity prevention
335404|NCT01510483|tobacco prevention|tobacco prevention
335405|NCT01510483|nutrition|nutrition
335406|NCT01510483|physical activity|physical activity
335407|NCT01510483|sedentary activity|sedentary activity
335408|NCT01510483|tobacco use|tobacco use
335409|NCT01510483|tobacco exposure|tobacco exposure
335410|NCT01510483|prevention|prevention
335411|NCT01510483|clinician intervention|clinician intervention
335412|NCT01510483|preteen|preteen
335413|NCT01510483|adolescents|adolescents
335414|NCT01510470|AstraTech Osseospeed Profile Implant|astratech osseospeed profile implant
335415|NCT01510470|Marginal bone level|marginal bone level
335416|NCT01510470|soft tissue|soft tissue
335417|NCT01510470|soft tissue responds|soft tissue responds
335418|NCT01510457|Knee Osteoarthritis|knee osteoarthritis
335419|NCT01510457|Degenerative Joint Disease|degenerative joint disease
335420|NCT01510457|Chronic Pain|chronic pain
335421|NCT01510457|Knee Pain|knee pain
335422|NCT01510418|Hemophilia|hemophilia
335423|NCT01510418|Spouse|spouse
335424|NCT01510418|Significant Other|significant other
335425|NCT01510418|Quality of Life|quality of life
335426|NCT01510405|Subjects undergoing or who have undergone thoracic surgery for presumed lung cancer.|subjects undergoing or who have undergone thoracic surgery for presumed lung cancer.
335427|NCT01510405|The following procedures are allowed: Wedge resection, lobectomy, bilobectomy, segmentectomy and pneumonectomy thoracic surgical operations are permitted.|the following procedures are allowed: wedge resection, lobectomy, bilobectomy, segmentectomy and pneumonectomy thoracic surgical operations are permitted.
335428|NCT01510392|Optical coherence tomography|optical coherence tomography
335429|NCT01510392|Glaucoma|glaucoma
335430|NCT01510392|Macula|macula
335431|NCT01510392|Keratoconus|keratoconus
335432|NCT01510392|Screening|screening
335433|NCT01510379|nausea|nausea
335434|NCT01510379|vomiting|vomiting
335435|NCT01510379|post-operative|post-operative
335436|NCT01510379|foregut surgery|foregut surgery
335437|NCT01510366|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
335438|NCT01510366|Sabin Strains|sabin strains
335439|NCT01510366|poliomyelitis|poliomyelitis
335440|NCT01510340|adherence|adherence
335442|NCT01510340|antiretroviral therapy|antiretroviral therapy
335443|NCT01510340|tailored web intervention|tailored web intervention
335444|NCT01510327|drug-eluting stents|drug-eluting stents
335445|NCT01510327|DES|des
335446|NCT01510327|atherosclerotic|atherosclerotic
335447|NCT01510301|Self-report|self-report
335448|NCT01510301|Self-management|self-management
335449|NCT01510301|Hypertension|hypertension
335450|NCT01510301|Adherence|adherence
335451|NCT01510301|Cell phone|cell phone
335452|NCT01510301|Drug treatment|drug treatment
335453|NCT01510301|Medical Adherence|medical adherence
335454|NCT01510288|GVAX|gvax
335455|NCT01510288|Ipilimumab|ipilimumab
335456|NCT01510288|prostate cancer|prostate cancer
335457|NCT01510275|cardio-thoracic surgery|cardio-thoracic surgery
335458|NCT01510275|patients|patients
335459|NCT01510275|pulmonary volume|pulmonary volume
335460|NCT01510275|respiratory muscle performance|respiratory muscle performance
335461|NCT01510262|Repeat STI patients|repeat sti patients
335462|NCT01510262|HIV|hiv
335463|NCT01510262|Cost effectiveness|cost effectiveness
335464|NCT01510262|Resource scarce|resource scarce
335465|NCT01510262|Urban clinics|urban clinics
335466|NCT01510249|calcaneal spur|calcaneal spur
335467|NCT01510249|shock wave therapy|shock wave therapy
335468|NCT01510249|ultrasound therapy|ultrasound therapy
335469|NCT01510236|Adolescence|adolescence
335470|NCT01510236|Cancer|cancer
335473|NCT01510236|Self-help via internet|self-help via internet
335474|NCT01510223|Fats|fats
335475|NCT01510223|Macronutrients|macronutrients
335476|NCT01510223|appetite|appetite
335477|NCT01510223|gastric emptying|gastric emptying
335478|NCT01510223|Gastrointestinal transit|gastrointestinal transit
335479|NCT01510210|Atrial Fibrillation|atrial fibrillation
335480|NCT01510210|Arrhythmia|arrhythmia
335481|NCT01510210|Rhythm control|rhythm control
335482|NCT01510197|Atrial Fibrillation|atrial fibrillation
335483|NCT01510197|Arrhythmia|arrhythmia
335484|NCT01510197|Rhythm control|rhythm control
335485|NCT01510171|platelet inhibitor|platelet inhibitor
335486|NCT01510171|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
335487|NCT01510171|stent|stent
335488|NCT01510171|prasugrel|prasugrel
335489|NCT01510171|ticagrelor|ticagrelor
335490|NCT01510145|Glaucoma|glaucoma
335491|NCT01510145|Open-angle glaucoma|open-angle glaucoma
335492|NCT01510145|Ocular hypertension|ocular hypertension
335493|NCT01510145|Hypertension|hypertension
335494|NCT01510145|Eye Diseases|eye diseases
335495|NCT01510145|Vascular Diseases|vascular diseases
335496|NCT01510145|Cardiovascular Diseases|cardiovascular diseases
335497|NCT01510145|Travoprost|travoprost
335498|NCT01510145|Antihypertensive Agents|antihypertensive agents
335499|NCT01510145|Cardiovascular Agents|cardiovascular agents
335500|NCT01510145|Therapeutic Uses|therapeutic uses
335501|NCT01510145|Pharmacologic Actions|pharmacologic actions
335503|NCT01510132|OHT|oht
335504|NCT01510093|type 2 diabetes mellitus, endogenous insulin|type 2 diabetes mellitus, endogenous insulin
335505|NCT01510080|Computer-assisted live supervision|computer-assisted live supervision
335506|NCT01510080|"Bug-in-the-eye supervision"|"bug-in-the-eye supervision"
335507|NCT01510080|Delayed video-based supervision|delayed video-based supervision
335508|NCT01510080|Cognitive behavioral therapy supervision|cognitive behavioral therapy supervision
335509|NCT01510067|CLE|cle
335510|NCT01510067|Lupus|lupus
335511|NCT01510067|Lupus Erythematosus|lupus erythematosus
335512|NCT01510054|miRNA in endometrium|mirna in endometrium
335513|NCT01510041|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
335514|NCT01510041|Physical therapy|physical therapy
335515|NCT01510041|Dyspnea|dyspnea
335516|NCT01510041|Inspiratory muscle training|inspiratory muscle training
335517|NCT01510041|Activities of daily living|activities of daily living
335518|NCT01510028|Intrathecal Drug Delivery Device (IDDD)|intrathecal drug delivery device (iddd)
335519|NCT01510028|Recombinant human arylsulfatase A (rhASA)|recombinant human arylsulfatase a (rhasa)
335520|NCT01510028|Metachromatic Leukodystrophy (MLD)|metachromatic leukodystrophy (mld)
335521|NCT01510015|cannabis|cannabis
335522|NCT01510015|psychostimulants|psychostimulants
335523|NCT01510015|psychosis|psychosis
335524|NCT01510002|papillary thyroid cancer|papillary thyroid cancer
335525|NCT01510002|central neck dissection|central neck dissection
335526|NCT01510002|survival|survival
335527|NCT01510002|locoregional control|locoregional control
335528|NCT01510002|morbidity|morbidity
335529|NCT01509989|Adherence|adherence
335530|NCT01509989|Compliance|compliance
335531|NCT01509989|Systemic Lupus Erythematosus|systemic lupus erythematosus
335532|NCT01509989|Hydroxychloroquine|hydroxychloroquine
335533|NCT01509989|Blood monitoring|blood monitoring
335534|NCT01509989|Flares|flares
335535|NCT01509976|Triclosan|triclosan
335536|NCT01509976|Triclocarban|triclocarban
335537|NCT01509976|Microbial flora|microbial flora
335538|NCT01509976|Obesity|obesity
335539|NCT01509963|MSKCC nomogram|mskcc nomogram
335540|NCT01509963|Tenon score|tenon score
335541|NCT01509963|metastatic SN|metastatic sn
335542|NCT01509963|low risk of metastatic non-SN|low risk of metastatic non-sn
335543|NCT01509963|additional ALND|additional alnd
335544|NCT01509937|end stage renal disease|end stage renal disease
335545|NCT01509937|maintenance hemodialysis|maintenance hemodialysis
335546|NCT01509937|dry weight|dry weight
335547|NCT01509937|bioimpedance spectroscopy analysis|bioimpedance spectroscopy analysis
335548|NCT01509937|body composition monitor|body composition monitor
335549|NCT01509937|Fresenius BCM|fresenius bcm
335550|NCT01509937|Ultrafiltration|ultrafiltration
335551|NCT01509924|Walking capacity|walking capacity
335552|NCT01509924|Mental Fatigue|mental fatigue
335553|NCT01509924|Quality of Life|quality of life
335554|NCT01509924|Cognition|cognition
335555|NCT01509924|Motor activity|motor activity
335556|NCT01509924|Exercise|exercise
335557|NCT01509872|Trauma-Focused Cognitive Behavior Therapy|trauma-focused cognitive behavior therapy
335558|NCT01509872|War-affected Children|war-affected children
335559|NCT01509872|Post-traumatic Stress Symptoms|post-traumatic stress symptoms
335560|NCT01509872|Psychosocial Distress|psychosocial distress
335561|NCT01509859|proximal femur nail|proximal femur nail
335563|NCT01509859|intertan|intertan
335564|NCT01509859|weight bearing|weight bearing
335565|NCT01509859|pertrochanteric fracture|pertrochanteric fracture
335566|NCT01509859|femur neck fracture|femur neck fracture
335567|NCT01509846|Shigella|shigella
335568|NCT01509846|vaccine|vaccine
335569|NCT01509846|shigellosis|shigellosis
335570|NCT01509846|dysentery|dysentery
335571|NCT01509846|whole cell|whole cell
335572|NCT01509833|ICSI Ovarian stimulation|icsi ovarian stimulation
335573|NCT01509833|hCG low dose|hcg low dose
335574|NCT01509833|Oocyte maturity|oocyte maturity
335575|NCT01509833|poor respond|poor respond
335576|NCT01509807|Ileostomy reversal|ileostomy reversal
335577|NCT01509794|CME|cme
335578|NCT01509794|Simulation|simulation
335579|NCT01509794|Affective engagement|affective engagement
335580|NCT01509794|Cognitive performance|cognitive performance
335581|NCT01509781|simple mastectomy|simple mastectomy
335582|NCT01509781|modified radical mastectomy|modified radical mastectomy
335583|NCT01509781|wound care|wound care
335584|NCT01509781|suction drain|suction drain
335585|NCT01509781|adaptive suture|adaptive suture
335586|NCT01509768|MPS IIIB|mps iiib
335587|NCT01509729|Knee|knee
335588|NCT01509729|Arthroscopy|arthroscopy
335589|NCT01509729|Lidocaine patch|lidocaine patch
335590|NCT01509729|Pain management after knee arthroscopy|pain management after knee arthroscopy
335591|NCT01509716|Predialysis|predialysis
335592|NCT01509703|COPD|copd
335593|NCT01509703|Nasal High Flow Therapy|nasal high flow therapy
335594|NCT01509703|tracheotomy stent|tracheotomy stent
335595|NCT01509703|tracheotomy|tracheotomy
335596|NCT01509690|Incident|incident
335597|NCT01509690|Hemodialysis|hemodialysis
335598|NCT01509677|Roflumilast|roflumilast
335599|NCT01509677|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
335600|NCT01509677|COPD|copd
335601|NCT01509651|antagonists neuromuscular block|antagonists neuromuscular block
335602|NCT01509651|neuromuscular block, monitoring|neuromuscular block, monitoring
335603|NCT01509651|neuromuscular function|neuromuscular function
335604|NCT01509638|Ileostomy reversal|ileostomy reversal
335605|NCT01509625|Fulvestrant|fulvestrant
335606|NCT01509625|Faslodex|faslodex
335607|NCT01509612|cancer|cancer
335608|NCT01509612|additive homeopathy|additive homeopathy
335609|NCT01509612|patients with advanced malignant tumors|patients with advanced malignant tumors
335610|NCT01509599|Venous disease|venous disease
335611|NCT01509599|Venous disorders|venous disorders
335612|NCT01509599|Venous insufficiency|venous insufficiency
335613|NCT01509599|Venous ulcers|venous ulcers
335614|NCT01509599|Cryotherapy|cryotherapy
335615|NCT01509586|smoking|smoking
335616|NCT01509586|smoking cessation|smoking cessation
335617|NCT01509586|Potentially Reduced Exposure Products (PREPs)|potentially reduced exposure products (preps)
335618|NCT01509573|prevention therapy|prevention therapy
335619|NCT01509573|depressive symptoms|depressive symptoms
335620|NCT01509573|anxiety|anxiety
335621|NCT01509573|parenting|parenting
335622|NCT01509573|family functioning|family functioning
335623|NCT01509573|resilience, psychological|resilience, psychological
335624|NCT01509573|Developing countries|developing countries
335625|NCT01509573|Rwanda|rwanda
335626|NCT01509573|HIV/AIDS|hiv/aids
335627|NCT01509534|pacemaker|pacemaker
335628|NCT01509534|implantable loop recorder|implantable loop recorder
335629|NCT01509534|syncope|syncope
335630|NCT01509521|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
335631|NCT01509521|Fetal heartrate|fetal heartrate
335632|NCT01509521|Ephedrine|ephedrine
335633|NCT01509521|Phenylephrine|phenylephrine
335635|NCT01509508|Prevention|prevention
335636|NCT01509508|Treatment|treatment
335637|NCT01509508|South Africa|south africa
335638|NCT01509495|Heart Failure|heart failure
335639|NCT01509495|HF|hf
335640|NCT01509482|insulin resistance|insulin resistance
335641|NCT01509482|unexplained azoospermia|unexplained azoospermia
335642|NCT01509482|unexplained oligospermia|unexplained oligospermia
335643|NCT01509469|Ileal brake|ileal brake
335644|NCT01509469|Casein|casein
335645|NCT01509469|Sucrose|sucrose
335646|NCT01509469|Ileal infusion|ileal infusion
335647|NCT01509456|bone metabolism|bone metabolism
335648|NCT01509456|potassium bicarbonate|potassium bicarbonate
335649|NCT01509456|alkaline salt|alkaline salt
335650|NCT01509456|acid base balance|acid base balance
335651|NCT01509456|bed rest|bed rest
335652|NCT01509443|Asthma|asthma
335653|NCT01509443|Obesity|obesity
335654|NCT01509443|Breathing exercise|breathing exercise
335655|NCT01509417|pyloric stenosis|pyloric stenosis
335656|NCT01509404|CMV|cmv
335657|NCT01509404|cytomegalovirus|cytomegalovirus
335658|NCT01509404|transplant|transplant
335659|NCT01509378|ICD|icd
335660|NCT01509378|ATP therapy|atp therapy
335661|NCT01509378|Rescue Shock therapy|rescue shock therapy
335662|NCT01509365|cardiovascular disease|cardiovascular disease
335663|NCT01509365|maintenance dose|maintenance dose
335666|NCT01509365|antiplatelet agents|antiplatelet agents
335667|NCT01509352|fundoplication|fundoplication
335668|NCT01509352|gastric reflux|gastric reflux
335669|NCT01509339|Vancomycin|vancomycin
335670|NCT01509339|Inhalation|inhalation
335671|NCT01509339|Nebulization|nebulization
335672|NCT01509339|Pharmacokinetics|pharmacokinetics
335673|NCT01509326|headache|headache
335674|NCT01509326|chiropractic|chiropractic
335675|NCT01509326|manipulation|manipulation
335676|NCT01509326|acupressure|acupressure
335677|NCT01509326|self-care|self-care
335678|NCT01509313|endometrial polyps|endometrial polyps
335679|NCT01509313|uterine polyps|uterine polyps
335680|NCT01509313|morcellator|morcellator
335681|NCT01509313|hysteroscopy|hysteroscopy
335682|NCT01509300|TBI|tbi
335683|NCT01509300|Fludarabine|fludarabine
335684|NCT01509300|CD3 depletion|cd3 depletion
335685|NCT01509300|Children and adolescents|children and adolescents
335686|NCT01509300|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
335687|NCT01509287|Donnai-Barrow Syndrome (DBS)|donnai-barrow syndrome (dbs)
335688|NCT01509287|metabolic testing|metabolic testing
335689|NCT01509287|genes|genes
335690|NCT01509287|genetic|genetic
335691|NCT01509274|Plantar fasciitis|plantar fasciitis
335692|NCT01509274|Plasma|plasma
335693|NCT01509274|PRP|prp
335694|NCT01509274|Heel pain|heel pain
335695|NCT01509261|Erosive Esophagitis|erosive esophagitis
335696|NCT01509261|Ilaprazole|ilaprazole
335697|NCT01509261|GERD|gerd
335698|NCT01509248|Theophylline|theophylline
335699|NCT01509235|cystic fibrosis|cystic fibrosis
335700|NCT01509235|Lung function|lung function
335701|NCT01509235|physical exercise|physical exercise
335702|NCT01509222|Health promotion|health promotion
335703|NCT01509222|Dietary Counseling|dietary counseling
335704|NCT01509209|vasomotor|vasomotor
335705|NCT01509209|pseudoephedrine|pseudoephedrine
335706|NCT01509209|levocetirizine|levocetirizine
335707|NCT01509196|Fenofibric acid|fenofibric acid
335708|NCT01509196|HIP0901|hip0901
335709|NCT01509196|Lipidilsupra|lipidilsupra
335710|NCT01509183|asthma|asthma
335711|NCT01509183|healthcare utilization costs|healthcare utilization costs
335712|NCT01509157|Type 1 diabetes|type 1 diabetes
335713|NCT01509157|Continuous Glucose Monitoring|continuous glucose monitoring
335714|NCT01509157|Nocturnal Hypoglycemia|nocturnal hypoglycemia
335715|NCT01509144|Safety of this HIV vaccine|safety of this hiv vaccine
335716|NCT01509092|traumatic macular hole|traumatic macular hole
335717|NCT01509092|vitrectomy|vitrectomy
335718|NCT01509092|observation|observation
335719|NCT01509066|vegetarian|vegetarian
335720|NCT01509066|vegan|vegan
335721|NCT01509066|low calorie|low calorie
335722|NCT01509066|infertility|infertility
335723|NCT01509066|PCOS|pcos
335725|NCT01509040|Resuscitated from Out-of-Hospital Cardiac Arrest|resuscitated from out-of-hospital cardiac arrest
335726|NCT01509027|hemodialysis|hemodialysis
335727|NCT01509027|hyperphoshatemia|hyperphoshatemia
335728|NCT01509027|compliance|compliance
335729|NCT01509014|Statins|statins
335730|NCT01509014|Adherence|adherence
335731|NCT01509014|Pharmacists|pharmacists
335732|NCT01509001|type 2 diabetes|type 2 diabetes
335733|NCT01509001|metformin|metformin
335734|NCT01509001|glimepiride|glimepiride
335735|NCT01509001|glucose control|glucose control
335736|NCT01509001|vascular reactivity|vascular reactivity
335737|NCT01509001|Adverse Reaction to Other Drugs and Medicines|adverse reaction to other drugs and medicines
335738|NCT01508988|ONO-9054|ono-9054
335739|NCT01508988|adult healthy volunteers|adult healthy volunteers
335740|NCT01508988|single dose|single dose
335741|NCT01508988|phase 1|phase 1
335742|NCT01508975|satiety|satiety
335743|NCT01508975|obesity|obesity
335744|NCT01508975|food intake|food intake
335745|NCT01508962|Disease onset|disease onset
335746|NCT01508962|Disease progression|disease progression
335747|NCT01508884|intradermal|intradermal
335748|NCT01508884|influenza|influenza
335749|NCT01508884|vaccination|vaccination
335750|NCT01508845|vitamin D|vitamin d
335751|NCT01508845|vitamin D absorption|vitamin d absorption
335752|NCT01508845|vitamin D deficiency|vitamin d deficiency
335753|NCT01508819|Patients over 75|patients over 75
335754|NCT01508819|acute pathology|acute pathology
335755|NCT01508819|ICU admission|icu admission
335756|NCT01508793|Sleep|sleep
335757|NCT01508793|Obesity|obesity
335758|NCT01508793|Children|children
335759|NCT01508793|Eating behaviors|eating behaviors
335760|NCT01508793|Activity|activity
335761|NCT01508754|Continuous positive airway pressure|continuous positive airway pressure
335762|NCT01508754|Ambulatory blood pressures|ambulatory blood pressures
335763|NCT01508741|Insomnia|insomnia
335764|NCT01508741|Frequent Nocturnal Awakening|frequent nocturnal awakening
335765|NCT01508741|Irritability|irritability
335766|NCT01508741|Moody|moody
335767|NCT01508741|Moodiness|moodiness
335768|NCT01508741|Coping Ability|coping ability
335769|NCT01508741|Coping Behavior|coping behavior
335770|NCT01508741|Stress|stress
335771|NCT01508741|Feeling Overwhelmed|feeling overwhelmed
335772|NCT01508728|unoperated severe sprain of the knee with partial or total rupture of the anterior|unoperated severe sprain of the knee with partial or total rupture of the anterior
752625|NCT01173380|Metabolic syndrome|metabolic syndrome
335773|NCT01508728|cruciate ligament and medial or lateral collateral ligament|cruciate ligament and medial or lateral collateral ligament
335774|NCT01508715|subacromial|subacromial
335775|NCT01508715|rotator cuff|rotator cuff
335776|NCT01508715|impingement|impingement
335777|NCT01508715|physical therapy|physical therapy
335778|NCT01508715|eccentric exercise|eccentric exercise
335779|NCT01508715|concentric exercise|concentric exercise
335780|NCT01508702|Gout|gout
335781|NCT01508689|Cereal bar|cereal bar
335782|NCT01508689|Calcium-fortified|calcium-fortified
335783|NCT01508689|Calcium intake|calcium intake
335784|NCT01508676|neuropathic pain|neuropathic pain
335785|NCT01508676|postherpetic neuralgia|postherpetic neuralgia
335786|NCT01508676|complex regional pain syndrome|complex regional pain syndrome
335787|NCT01508676|reflex sympathetic dystrophy|reflex sympathetic dystrophy
335788|NCT01508663|Coronary artery disease 75years of age or older|coronary artery disease 75years of age or older
335789|NCT01508650|heart failure|heart failure
335790|NCT01508637|air pollution|air pollution
335791|NCT01508637|vasoconstriction|vasoconstriction
335792|NCT01508637|blood pressure|blood pressure
335793|NCT01508637|diesel exhaust|diesel exhaust
335794|NCT01508624|Randomised controlled trial|randomised controlled trial
335795|NCT01508624|Pain|pain
335796|NCT01508624|Recovery|recovery
335797|NCT01508624|Office based surgery|office based surgery
335798|NCT01508611|dental caries|dental caries
335799|NCT01508611|permanent teeth|permanent teeth
335800|NCT01508611|silver diamine fluoride|silver diamine fluoride
335801|NCT01508611|tooth eruption|tooth eruption
335802|NCT01508598|Pediatric|pediatric
335803|NCT01508598|Obesity|obesity
335804|NCT01508598|Bariatric surgery|bariatric surgery
335805|NCT01508598|Cardiovascular disease|cardiovascular disease
335806|NCT01508585|Bariatric surgery|bariatric surgery
335807|NCT01508585|Cognitive Behavioral Therapy|cognitive behavioral therapy
335808|NCT01508585|Telephone based CBT|telephone based cbt
335809|NCT01508585|Obesity|obesity
335810|NCT01508572|breast cancer|breast cancer
335811|NCT01508572|VEGF|vegf
335812|NCT01508572|optical imaging|optical imaging
335813|NCT01508559|HIV|hiv
335814|NCT01508559|Neurocognitive|neurocognitive
335815|NCT01508546|breast cancer|breast cancer
335816|NCT01508546|axillary dissection|axillary dissection
335817|NCT01508533|Disease burden|disease burden
335818|NCT01508533|Rotavirus gastroenteritis|rotavirus gastroenteritis
335819|NCT01508520|early gastric cancer|early gastric cancer
335820|NCT01508520|stomach neoplasms|stomach neoplasms
335821|NCT01508520|magnifying endoscopy|magnifying endoscopy
335822|NCT01508520|narrow band imaging|narrow band imaging
335824|NCT01508507|Cholera|cholera
335825|NCT01508507|Vaccine|vaccine
335826|NCT01508507|Herd|herd
335827|NCT01508507|Risk|risk
335828|NCT01508507|population|population
335829|NCT01508507|Matched|matched
335830|NCT01508507|Control|control
335831|NCT01508507|Case|case
335832|NCT01508507|Bias|bias
335833|NCT01508494|modification of fMRI maps after galantamine/placebo|modification of fmri maps after galantamine/placebo
335834|NCT01508481|Vitamin D|vitamin d
335835|NCT01508481|Diabetes|diabetes
335836|NCT01508481|pancreas beta cell function|pancreas beta cell function
335837|NCT01508481|insulin resistance|insulin resistance
335838|NCT01508481|Deficiency of Vitamin D3|deficiency of vitamin d3
335839|NCT01508468|Rituximab|rituximab
335840|NCT01508468|membranous nephropathy|membranous nephropathy
717343|NCT01032941|Probiotics|probiotics
335841|NCT01508468|anti-PLA2R antibody|anti-pla2r antibody
335842|NCT01508429|Postpartum hemorrhage|postpartum hemorrhage
335843|NCT01508429|PPH|pph
335844|NCT01508429|misoprostol|misoprostol
335845|NCT01508429|home deliveries|home deliveries
335846|NCT01508416|Multiple Myeloma|multiple myeloma
335847|NCT01508416|Newly diagnosed|newly diagnosed
335848|NCT01508416|Thrombin generation|thrombin generation
335849|NCT01508416|TFPI|tfpi
335850|NCT01508416|Tissue Factor pathway inhibitor|tissue factor pathway inhibitor
335851|NCT01508416|Protein S|protein s
335852|NCT01508416|Thrombosis|thrombosis
335853|NCT01508416|Chemotherapy|chemotherapy
335854|NCT01508390|prostate|prostate
335855|NCT01508377|posttraumatic stress disorder|posttraumatic stress disorder
335856|NCT01508377|internet-based psychotherapy|internet-based psychotherapy
335857|NCT01508377|cognitive restructuring|cognitive restructuring
335858|NCT01508377|exposure|exposure
335859|NCT01508364|renal cell carcinoma, first targeted therapy, observational study|renal cell carcinoma, first targeted therapy, observational study
335860|NCT01508351|Propofol|propofol
335861|NCT01508351|Induction|induction
335862|NCT01508351|Hypotension|hypotension
335863|NCT01508351|General population|general population
335864|NCT01508338|HMB beta-hydroxy-beta-methylbutyrate|hmb beta-hydroxy-beta-methylbutyrate
335865|NCT01508338|ATP (adenosine-triphosphate)|atp (adenosine-triphosphate)
335866|NCT01508338|trained athletes|trained athletes
335867|NCT01508325|Bisoprolol|bisoprolol
335868|NCT01508325|Hypertension|hypertension
335869|NCT01508325|Blood pressure|blood pressure
335871|NCT01508312|CARBOPLATIN|carboplatin
335872|NCT01508312|ETOPOSIDE (VP-16)|etoposide (vp-16)
335873|NCT01508312|IFOSFAMIDE|ifosfamide
335874|NCT01508312|SGN-35 (BRENTUXIMAB VEDOTIN)|sgn-35 (brentuximab vedotin)
335875|NCT01508312|11-142|11-142
335876|NCT01508299|skin test|skin test
335877|NCT01508299|raw food|raw food
335878|NCT01508299|commercial extract|commercial extract
335879|NCT01508286|telaprevir|telaprevir
335880|NCT01508286|hepatitis C|hepatitis c
335881|NCT01508286|early access program|early access program
335882|NCT01508273|Breast Cancer|breast cancer
335883|NCT01508273|Breast Cancer Survivors|breast cancer survivors
335884|NCT01508273|High risk cancer survivors|high risk cancer survivors
335885|NCT01508273|Stage II to IIIC breast cancer|stage ii to iiic breast cancer
335886|NCT01508273|African American|african american
335888|NCT01508273|Hispanic|hispanic
335889|NCT01508273|Non-Hispanic White|non-hispanic white
335890|NCT01508273|Operable invasive breast carcinoma|operable invasive breast carcinoma
335891|NCT01508273|Aerobic and resistance training|aerobic and resistance training
335892|NCT01508273|Pedometer|pedometer
335893|NCT01508273|Telephone Counseling Calls|telephone counseling calls
335894|NCT01508273|Physical activity report|physical activity report
335895|NCT01508273|PAR|par
335896|NCT01508273|Functional Assessment of Cancer Therapy-Breast|functional assessment of cancer therapy-breast
335897|NCT01508273|FACT-B|fact-b
335898|NCT01508273|Health related quality of life|health related quality of life
335899|NCT01508273|HRQOL|hrqol
335900|NCT01508260|Leukemia|leukemia
335901|NCT01508260|Aquapheresis|aquapheresis
335902|NCT01508260|Ultrafiltration|ultrafiltration
335903|NCT01508260|Aquadex pump|aquadex pump
335904|NCT01508260|Severe Fluid Overload|severe fluid overload
335905|NCT01508260|Diuretic therapy|diuretic therapy
335906|NCT01508260|Dyspnea|dyspnea
335907|NCT01508260|Orthopnea|orthopnea
335908|NCT01508260|Paroxysmal nocturnal dyspnea|paroxysmal nocturnal dyspnea
335909|NCT01508260|PND|pnd
335910|NCT01508260|Peripheral edema|peripheral edema
335911|NCT01508260|Rales|rales
335912|NCT01508260|Jugular venous distension|jugular venous distension
335913|NCT01508260|JVD|jvd
335914|NCT01508260|Hypoxia|hypoxia
335915|NCT01508260|Pulmonary edema by chest X-ray|pulmonary edema by chest x-ray
335916|NCT01508260|Furosemide|furosemide
335917|NCT01508260|Lasix|lasix
335918|NCT01508247|efficacy|efficacy
335919|NCT01508247|safety|safety
335920|NCT01508247|inactivated vaccine (Vero Cell) against EV71|inactivated vaccine (vero cell) against ev71
335921|NCT01508247|EV71-associated diseases|ev71-associated diseases
335922|NCT01508221|brain metastasis|brain metastasis
335923|NCT01508208|Hypertension|hypertension
335924|NCT01508208|24 hour urine protein|24 hour urine protein
335925|NCT01508208|Protein/creatinine ratio|protein/creatinine ratio
335926|NCT01508195|Healthy Volunteers|healthy volunteers
335927|NCT01508195|Bioequivalence|bioequivalence
335928|NCT01508195|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
335929|NCT01508195|Metformin IR|metformin ir
335930|NCT01508182|Healthy Volunteers|healthy volunteers
335931|NCT01508182|Bioequivalence|bioequivalence
335932|NCT01508182|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
335933|NCT01508182|Metformin IR|metformin ir
335934|NCT01508169|elderly|elderly
335935|NCT01508169|balance|balance
335936|NCT01508169|insole|insole
335937|NCT01508169|foot orthosis|foot orthosis
335938|NCT01508169|orthotics|orthotics
335939|NCT01508156|Hepatitis C|hepatitis c
335940|NCT01508156|HCV|hcv
335941|NCT01508156|treatment-naive|treatment-naive
335942|NCT01508143|Abortion|abortion
335943|NCT01508143|Pregnancy|pregnancy
335944|NCT01508143|Termination|termination
335945|NCT01508143|Misoprostol|misoprostol
335946|NCT01508117|GBM|gbm
335947|NCT01508117|brain tumor|brain tumor
335948|NCT01508104|solid tumor|solid tumor
335949|NCT01508104|glioblastoma multiforme|glioblastoma multiforme
335950|NCT01508104|GBM|gbm
335951|NCT01508104|brain tumor|brain tumor
335952|NCT01508104|neuroendocrine tumor|neuroendocrine tumor
335953|NCT01508091|Obesity|obesity
335954|NCT01508091|ageing|ageing
335955|NCT01508052|core temperature|core temperature
335956|NCT01508052|sequential compression device|sequential compression device
335957|NCT01508052|total intravenous anesthesia|total intravenous anesthesia
335958|NCT01508039|Intranasal|intranasal
335959|NCT01508039|Chitin Micro-particles|chitin micro-particles
335960|NCT01508039|Immunological Effects|immunological effects
335961|NCT01508039|Nasal mucosa|nasal mucosa
335962|NCT01508039|Cytokines|cytokines
335963|NCT01508039|Immunological Effects from Intranasal Chitin Micro-Particles|immunological effects from intranasal chitin micro-particles
335964|NCT01508026|Stage 1|stage 1
335965|NCT01508026|Stage 2|stage 2
335966|NCT01508026|Hypertension|hypertension
335967|NCT01508013|Melanoma|melanoma
335968|NCT01508013|Basal Cell Carcinoma|basal cell carcinoma
335969|NCT01508013|Squamous Cell Carcinoma|squamous cell carcinoma
335970|NCT01508000|Liver metastases|liver metastases
335971|NCT01508000|Colorectal Cancer|colorectal cancer
335972|NCT01508000|KRAS wild type|kras wild type
335973|NCT01508000|FOLFOX|folfox
326706|NCT01547754|HV|hv
335974|NCT01508000|Bevacizumab|bevacizumab
335975|NCT01508000|Panitumumab|panitumumab
335976|NCT01508000|Randomized|randomized
335977|NCT01508000|Phase II|phase ii
335978|NCT01508000|Perioperative treatment|perioperative treatment
335979|NCT01508000|Adjuvant|adjuvant
335980|NCT01508000|Neo-adjuvant|neo-adjuvant
335981|NCT01508000|Surgery|surgery
335982|NCT01508000|Progression Free Survival|progression free survival
335983|NCT01507987|Externalized Conductors|externalized conductors
335984|NCT01507974|preventive|preventive
335985|NCT01507974|antibiotic treatment|antibiotic treatment
335986|NCT01507974|urinary tract infection|urinary tract infection
335987|NCT01507974|pregnancy|pregnancy
335988|NCT01507974|puerperium|puerperium
335989|NCT01507948|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
335990|NCT01507948|Psychotherapy|psychotherapy
335991|NCT01507948|non-medication treatment|non-medication treatment
335992|NCT01507948|Prolonged Exposure|prolonged exposure
335993|NCT01507948|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
335994|NCT01507948|Anxiety Disorders|anxiety disorders
335995|NCT01507948|emotion|emotion
335996|NCT01507948|emotion regulation|emotion regulation
335997|NCT01507948|functional MRI|functional mri
335998|NCT01507948|Affective Symptoms|affective symptoms
335999|NCT01507935|Healthy infants|healthy infants
336000|NCT01507935|Infant formula|infant formula
336001|NCT01507935|Prebiotics oligosaccharides|prebiotics oligosaccharides
336002|NCT01507935|Colonisation Resistance|colonisation resistance
336003|NCT01507935|Gut Microbiota|gut microbiota
336004|NCT01507922|Fenoverine|fenoverine
336005|NCT01507922|Irritable Bowel Syndrome|irritable bowel syndrome
336006|NCT01507922|Abdominal pain|abdominal pain
336007|NCT01507922|BSS|bss
336008|NCT01507909|EEG|eeg
336009|NCT01507909|related visual|related visual
336010|NCT01507909|and verbal cues|and verbal cues
336011|NCT01507883|Supervision|supervision
336012|NCT01507883|embryos|embryos
336013|NCT01507883|Resulting|resulting
336014|NCT01507870|body mass index|body mass index
336015|NCT01507857|EV71 vaccine|ev71 vaccine
336016|NCT01507857|HFMD|hfmd
336017|NCT01507857|efficacy|efficacy
336018|NCT01507857|EV71 associated disease|ev71 associated disease
336019|NCT01507844|COPD|copd
336020|NCT01507844|CPAP|cpap
336021|NCT01507844|Sham|sham
336022|NCT01507844|FEV1|fev1
336023|NCT01507844|IC|ic
336024|NCT01507844|RV/TLC|rv/tlc
336025|NCT01507818|Arthroscopic Rotator Cuff Repair|arthroscopic rotator cuff repair
336026|NCT01507818|Electromagnetic field treatment|electromagnetic field treatment
336027|NCT01507818|Pulsed Radio Frequency treatment|pulsed radio frequency treatment
336028|NCT01507818|Non-invasive|non-invasive
336029|NCT01507818|Non-thermal|non-thermal
336030|NCT01507805|Electroacupuncture|electroacupuncture
336031|NCT01507805|preconditioning|preconditioning
336032|NCT01507805|Non-cardiac surgery|non-cardiac surgery
336033|NCT01507805|Coronary heart disease|coronary heart disease
336034|NCT01507792|Cough|cough
336035|NCT01507792|Laryngismus|laryngismus
336036|NCT01507792|Bronchial spasm|bronchial spasm
336037|NCT01507792|Deficiency diseases|deficiency diseases
336038|NCT01507766|severe acute pancreatitis|severe acute pancreatitis
336039|NCT01507766|intra-abdominal pressure|intra-abdominal pressure
336040|NCT01507766|enteral nutrition|enteral nutrition
336041|NCT01507753|childhood bipolar disorder|childhood bipolar disorder
336042|NCT01507727|hyponatremia|hyponatremia
336043|NCT01507727|Non-hypovolemic and Non-acute hyponatremia|non-hypovolemic and non-acute hyponatremia
336044|NCT01507727|Tolvaptan|tolvaptan
336045|NCT01507714|Preventive|preventive
336046|NCT01507714|tvt-o|tvt-o
336047|NCT01507714|stress incontinence|stress incontinence
336048|NCT01507701|adolescents|adolescents
336049|NCT01507688|Stroke|stroke
336050|NCT01507675|suicide|suicide
336051|NCT01507675|psychometric properties|psychometric properties
336052|NCT01507675|military|military
336053|NCT01507675|veterans|veterans
336054|NCT01507675|Interpersonal needs questionnaire|interpersonal needs questionnaire
336055|NCT01507675|Acquired capability for suicide|acquired capability for suicide
336056|NCT01507675|mental health|mental health
336057|NCT01507675|Survey of Life Principles|survey of life principles
336058|NCT01507675|Risk assessment|risk assessment
336059|NCT01507662|Bone Density|bone density
336060|NCT01507662|Absorptiometry, Photon|absorptiometry, photon
336061|NCT01507662|Osteoporosis|osteoporosis
336062|NCT01507662|Bone, Diseases, Metabolic|bone, diseases, metabolic
336063|NCT01507662|Patient Education as Topic|patient education as topic
336064|NCT01507662|Fractures, Bone/Prevention and Control|fractures, bone/prevention and control
336065|NCT01507649|postnatal depression|postnatal depression
336066|NCT01507649|quality of life|quality of life
336067|NCT01507636|apraxia|apraxia
336068|NCT01507636|occupational therapy|occupational therapy
336069|NCT01507636|multiple sclerosis|multiple sclerosis
336070|NCT01507636|manual dexterity|manual dexterity
336071|NCT01507623|NAPS|naps
336072|NCT01507623|Hypoxia|hypoxia
326809|NCT01547390|Aspirin|aspirin
336073|NCT01507623|Propofol|propofol
336074|NCT01507623|capnography|capnography
336075|NCT01507623|endoscopy|endoscopy
336076|NCT01507623|Sedation|sedation
336077|NCT01507610|sumatriptan|sumatriptan
336078|NCT01507610|bioavailability|bioavailability
336079|NCT01507597|Glucagon-like peptide-1|glucagon-like peptide-1
336080|NCT01507597|Glucagon|glucagon
336081|NCT01507597|Normal physiology|normal physiology
336082|NCT01507597|T2DM|t2dm
336083|NCT01507597|T1DM|t1dm
336084|NCT01507571|Incurable cancer|incurable cancer
336085|NCT01507571|Palliative care|palliative care
336086|NCT01507571|Dignity Therapy|dignity therapy
336087|NCT01507571|Loss of dignity|loss of dignity
336088|NCT01507571|Patient Dignity Intventory|patient dignity intventory
336089|NCT01507571|Eortc QLQ-C15-PAL|eortc qlq-c15-pal
336090|NCT01507571|Structured Interview for Symptoms and Concerns|structured interview for symptoms and concerns
336091|NCT01507571|Hospital Anxiety and Depression Scale|hospital anxiety and depression scale
336092|NCT01507558|Peripheral Arterial Disease|peripheral arterial disease
336093|NCT01507558|Femoral popliteal lesions|femoral popliteal lesions
336094|NCT01507545|mCRC|mcrc
336095|NCT01507545|chemorefractory metastatic colorectal cancer|chemorefractory metastatic colorectal cancer
336096|NCT01507506|Glioblastoma|glioblastoma
336097|NCT01507506|Radiotherapy|radiotherapy
336098|NCT01507506|Intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
336099|NCT01507506|Magnetic resonance spectroscopic imaging (MRSI)|magnetic resonance spectroscopic imaging (mrsi)
336100|NCT01507493|gene polymorphism|gene polymorphism
336101|NCT01507493|SCN9A|scn9a
336102|NCT01507493|pain perception|pain perception
336103|NCT01507493|postoperative pain|postoperative pain
336104|NCT01507480|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
336105|NCT01507480|Antiangiogenic therapies|antiangiogenic therapies
336106|NCT01507480|Bevacizumab|bevacizumab
336107|NCT01507467|Head and neck carcinoma|head and neck carcinoma
336108|NCT01507467|Accelerated radiotherapy|accelerated radiotherapy
336109|NCT01507467|Hypoxic modification with Nimorazole|hypoxic modification with nimorazole
336110|NCT01507441|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
336111|NCT01507441|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
336112|NCT01507441|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
336113|NCT01507415|Cohort Studies|cohort studies
336114|NCT01507415|Longitudinal Studies|longitudinal studies
336115|NCT01507415|Patient Readmission|patient readmission
336116|NCT01507415|Hospitalization|hospitalization
336117|NCT01507415|Disability Evaluation|disability evaluation
336118|NCT01507376|Ovulation induction|ovulation induction
336119|NCT01507376|urinary|urinary
336120|NCT01507376|hCG|hcg
336121|NCT01507376|recombinant hCG|recombinant hcg
336122|NCT01507350|obesity related glmerulopathy|obesity related glmerulopathy
336123|NCT01507350|51 Cr-EDTA clearance|51 cr-edta clearance
336124|NCT01507350|impaired renal function|impaired renal function
336125|NCT01507350|gastric band|gastric band
336126|NCT01507350|GFR measurement|gfr measurement
336127|NCT01507350|gastric bypass|gastric bypass
336128|NCT01507350|sleeve gastrectomy|sleeve gastrectomy
336129|NCT01507298|Physical activity|physical activity
336130|NCT01507298|Accelerometry|accelerometry
336131|NCT01507298|Oesophageal pH|oesophageal ph
336132|NCT01507298|Capsule endoscopy|capsule endoscopy
336133|NCT01507259|Determine effect on cerebral vasculature|determine effect on cerebral vasculature
336134|NCT01507246|open colectomy|open colectomy
336135|NCT01507233|open colectomy|open colectomy
336136|NCT01507233|colectomy|colectomy
336137|NCT01507220|open colectomy|open colectomy
336138|NCT01507207|Dysphagia|dysphagia
336139|NCT01507207|aspiration|aspiration
336140|NCT01507207|pediatric|pediatric
336141|NCT01507207|injection laryngoplasty|injection laryngoplasty
336142|NCT01507181|suicidal ideation|suicidal ideation
336143|NCT01507181|major depression|major depression
336144|NCT01507181|treatment resistant|treatment resistant
336145|NCT01507181|ketamine|ketamine
336146|NCT01507181|glutamate|glutamate
336147|NCT01507155|Major|major
336148|NCT01507155|Depressive|depressive
336149|NCT01507155|Disorder|disorder
336150|NCT01507155|Depression|depression
336152|NCT01507155|Treatment Resistant|treatment resistant
336153|NCT01507155|Anxiety|anxiety
336154|NCT01507155|GAD|gad
336155|NCT01507142|saliva|saliva
336156|NCT01507142|diagnostics|diagnostics
336157|NCT01507142|HIV|hiv
336158|NCT01507142|AIDS|aids
336159|NCT01507129|dehydration|dehydration
336160|NCT01507129|plasma|plasma
336161|NCT01507129|osmolality|osmolality
336162|NCT01507129|saliva|saliva
336163|NCT01507129|urine|urine
336164|NCT01507129|biomarkers|biomarkers
336165|NCT01507129|hypertonic|hypertonic
336166|NCT01507129|isotonic|isotonic
336167|NCT01507129|hydration|hydration
336168|NCT01507103|Tecemotide (L-BLP25)|tecemotide (l-blp25)
336169|NCT01507103|Cyclophosphamide (CPA)|cyclophosphamide (cpa)
336170|NCT01507103|Mode of action|mode of action
336171|NCT01507103|Neoplasms|neoplasms
336172|NCT01507103|Neoplasms by Site|neoplasms by site
336173|NCT01507103|Carcinomas|carcinomas
336174|NCT01507103|Antineoplastic Agents|antineoplastic agents
336175|NCT01507103|Neoadjuvant|neoadjuvant
336176|NCT01507103|Radiotherapy Pharmacologic Actions|radiotherapy pharmacologic actions
336177|NCT01507103|Immunosuppressive Agents|immunosuppressive agents
336178|NCT01507103|Immunologic Function|immunologic function
336179|NCT01507103|Therapeutic Uses|therapeutic uses
336180|NCT01507103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
336181|NCT01507090|children for whom there is no scale to determine weight|children for whom there is no scale to determine weight
336182|NCT01507077|Obese|obese
336183|NCT01507077|Obesity|obesity
336184|NCT01507077|Overweight|overweight
336185|NCT01507064|hepatocellular carcinoma|hepatocellular carcinoma
336186|NCT01507064|sorafenib|sorafenib
336187|NCT01507064|laser ablation|laser ablation
336188|NCT01507051|Rivaroxaban|rivaroxaban
336189|NCT01507051|Xa-Factors|xa-factors
336190|NCT01507051|Warfarin|warfarin
336191|NCT01507051|Thrombosis|thrombosis
336192|NCT01507051|Embolism|embolism
336193|NCT01507038|Diabetes Mellitus|diabetes mellitus
336194|NCT01507038|YH14617|yh14617
336195|NCT01507038|Exenatide|exenatide
336196|NCT01507038|Yuhan|yuhan
336197|NCT01507025|hinge position|hinge position
336198|NCT01507025|dry eye|dry eye
336199|NCT01507012|Berry phenolics|berry phenolics
336200|NCT01507012|mood|mood
336201|NCT01507012|cognition|cognition
336202|NCT01507012|adults|adults
336203|NCT01506999|Angina Pectoris|angina pectoris
336204|NCT01506999|SNPs|snps
336205|NCT01506999|Genetic|genetic
336206|NCT01506999|Myocardial Infarction|myocardial infarction
336207|NCT01506999|Cardiovascular Risk Factors|cardiovascular risk factors
336208|NCT01506986|Ulcer bleeding|ulcer bleeding
336209|NCT01506986|Aspirin|aspirin
336210|NCT01506986|Helicobacter pylori|helicobacter pylori
336211|NCT01506986|H. pylori|h. pylori
336212|NCT01506986|Hospitalisation for ulcer bleeding|hospitalisation for ulcer bleeding
336213|NCT01506973|histologically or cytologically documented|histologically or cytologically documented
336214|NCT01506947|Hemodialysis|hemodialysis
336215|NCT01506947|Chronic kidney disease|chronic kidney disease
336216|NCT01506947|Secondary hyperparathyroidism,|secondary hyperparathyroidism,
336217|NCT01506921|racemic ketamine|racemic ketamine
336218|NCT01506921|S-ketamine|s-ketamine
336219|NCT01506921|Cerebral blood flow|cerebral blood flow
336220|NCT01506921|Magnetic resonance imaging|magnetic resonance imaging
336221|NCT01506921|arterial spin labeling|arterial spin labeling
336222|NCT01506921|healthy volunteers|healthy volunteers
336223|NCT01506908|craving|craving
336224|NCT01506895|Diabetic Macular Edema|diabetic macular edema
336225|NCT01506856|Epithelial ovarian cancer|epithelial ovarian cancer
336226|NCT01506856|Fallopian tube cancer|fallopian tube cancer
336227|NCT01506856|peritoneal cancer|peritoneal cancer
336228|NCT01506856|intraperitoneal therapy|intraperitoneal therapy
336229|NCT01506856|Carboplatin|carboplatin
336230|NCT01506856|Paclitaxel|paclitaxel
336231|NCT01506843|IgA antibody|iga antibody
336232|NCT01506843|IgE antibody|ige antibody
336233|NCT01506843|IgG1/IgG4 subclasses|igg1/igg4 subclasses
336234|NCT01506843|Mite allergy|mite allergy
336235|NCT01506843|Sublingual immunotherapy|sublingual immunotherapy
336236|NCT01506843|Saliva|saliva
336237|NCT01506830|Adhesives.|adhesives.
336238|NCT01506830|Composites.|composites.
336239|NCT01506830|Noncarious cervical lesions.|noncarious cervical lesions.
336240|NCT01506830|Clinical performance.|clinical performance.
336241|NCT01506830|Treatment|treatment
336242|NCT01506817|fibromyalgia|fibromyalgia
336243|NCT01506817|DCE-MRI|dce-mri
336244|NCT01506817|neurogenic inflammation|neurogenic inflammation
336245|NCT01506817|contrast-enhancement patterns|contrast-enhancement patterns
336246|NCT01506804|Shoulder|shoulder
336247|NCT01506804|Impingement|impingement
336248|NCT01506804|Ultrasound|ultrasound
336249|NCT01506804|injection of glucocorticosteroid|injection of glucocorticosteroid
336250|NCT01506804|exercise|exercise
336251|NCT01506791|Bioequivalence|bioequivalence
336252|NCT01506791|Desloratadine and pseudoephedrine|desloratadine and pseudoephedrine
336253|NCT01506791|crossover|crossover
336254|NCT01506778|Endometrial Sampling Procedure|endometrial sampling procedure
336255|NCT01506778|Likert Scala|likert scala
336257|NCT01506778|Tenaculum|tenaculum
336258|NCT01506778|Visual Analog Pain Scala|visual analog pain scala
336259|NCT01506765|Schizophrenia|schizophrenia
336260|NCT01506765|glutathione|glutathione
336261|NCT01506765|NAC|nac
336262|NCT01506765|Neurological scales|neurological scales
336263|NCT01506765|Magnetic Resonance Spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
336264|NCT01506765|EEG/evoked potentials|eeg/evoked potentials
336265|NCT01506765|fibroblasts|fibroblasts
336266|NCT01506765|patients who receive NAC|patients who receive nac
336267|NCT01506765|patients who receive placebo|patients who receive placebo
336268|NCT01506752|Bioequivalence|bioequivalence
417695|NCT00000976|IgG|igg
336269|NCT01506752|Healthy Subjects|healthy subjects
336270|NCT01506752|Donepezil|donepezil
336271|NCT01506739|Bioequivalence|bioequivalence
336272|NCT01506739|Healthy Subjects|healthy subjects
336273|NCT01506739|Donepezil|donepezil
336274|NCT01506726|anemia|anemia
336275|NCT01506726|unexplained anemia|unexplained anemia
336276|NCT01506726|elderly|elderly
336277|NCT01506726|geriatric|geriatric
336278|NCT01506726|older adults|older adults
336279|NCT01506726|UAE|uae
336280|NCT01506726|over 65|over 65
336281|NCT01506726|salsalate|salsalate
336282|NCT01506726|PACTTE|pactte
336283|NCT01506726|pactee|pactee
336284|NCT01506726|aging|aging
336285|NCT01506726|aged|aged
336286|NCT01506726|old|old
336287|NCT01506726|older|older
336288|NCT01506687|Colorectal cancer screening|colorectal cancer screening
336289|NCT01506687|50 years or older|50 years or older
336290|NCT01506661|Rheumatoid arthritis|rheumatoid arthritis
336291|NCT01506661|vaccination|vaccination
336292|NCT01506661|immune response|immune response
336293|NCT01506661|varicella zoster|varicella zoster
336294|NCT01506609|temozolomide|temozolomide
336295|NCT01506609|Temodar|temodar
336296|NCT01506609|Paclitaxel|paclitaxel
336297|NCT01506609|BRCA1 mutation carrier|brca1 mutation carrier
336298|NCT01506609|Metastatic breast cancer|metastatic breast cancer
336299|NCT01506609|TMZ|tmz
336300|NCT01506609|Recurrent breast cancer|recurrent breast cancer
336301|NCT01506609|Carboplatin|carboplatin
336302|NCT01506609|ABT-888|abt-888
336303|NCT01506609|veliparib|veliparib
336304|NCT01506609|Breast cancer|breast cancer
336305|NCT01506609|Locally recurrent|locally recurrent
336306|NCT01506609|Temodal|temodal
336307|NCT01506609|BRCA2 mutation carrier|brca2 mutation carrier
336308|NCT01506609|PARP|parp
336309|NCT01506596|Liposarcoma|liposarcoma
336310|NCT01506583|cough|cough
336311|NCT01506583|myalgia|myalgia
336312|NCT01506583|nasal obstruction|nasal obstruction
336313|NCT01506583|sore throat|sore throat
336314|NCT01506583|headache|headache
336315|NCT01506583|fatigue|fatigue
336316|NCT01506583|feverishness|feverishness
336317|NCT01506583|Patients who exhibit flu-like symptoms during a flu season, including cough, myalgia, nasal obstruction, sore throat, headache, fatigue, and/or feverishness.|patients who exhibit flu-like symptoms during a flu season, including cough, myalgia, nasal obstruction, sore throat, headache, fatigue, and/or feverishness.
336318|NCT01506557|vitamin D|vitamin d
336319|NCT01506557|vitamin D deficiency|vitamin d deficiency
336320|NCT01506557|breastfeeding|breastfeeding
336321|NCT01506557|body composition|body composition
336322|NCT01506557|bone mineral content|bone mineral content
336323|NCT01506544|HU|hu
336324|NCT01506544|Hydroxyurea|hydroxyurea
336325|NCT01506544|Sickle cell|sickle cell
336326|NCT01506544|Pediatric|pediatric
336327|NCT01506531|gastroschisis|gastroschisis
336328|NCT01506531|silo|silo
336329|NCT01506531|primary closure|primary closure
336330|NCT01506518|Muscular Dystrophy, Duchenne|muscular dystrophy, duchenne
336331|NCT01506518|Ultrasound|ultrasound
336332|NCT01506518|Imaging|imaging
336333|NCT01506518|Acoustic Radiation Force|acoustic radiation force
336334|NCT01506518|Double Push|double push
336335|NCT01506505|Cardiovascular prevention|cardiovascular prevention
336336|NCT01506505|Polypill|polypill
336337|NCT01506505|Combination therapy|combination therapy
336338|NCT01506492|Randomized controlled trial|randomized controlled trial
336339|NCT01506492|Depression|depression
336340|NCT01506492|Cancer|cancer
336341|NCT01506492|Psychotherapy|psychotherapy
336342|NCT01506492|Quality of life|quality of life
336343|NCT01506479|Parkinson Disease|parkinson disease
336344|NCT01506479|Basal Ganglia Disease|basal ganglia disease
336345|NCT01506479|Central Nervous System Diseases|central nervous system diseases
336346|NCT01506479|Nervous System Diseases|nervous system diseases
336347|NCT01506479|Movement Disorders|movement disorders
336348|NCT01506479|Neurodegenerative Diseases|neurodegenerative diseases
336349|NCT01506479|Brain Diseases|brain diseases
336350|NCT01506466|chemotherapy|chemotherapy
336351|NCT01506466|metabolism|metabolism
336352|NCT01506466|weight|weight
336353|NCT01506466|body composition|body composition
336354|NCT01506453|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
336355|NCT01506453|Neuropathy|neuropathy
336356|NCT01506453|Neuropathic Pain|neuropathic pain
336357|NCT01506453|Vincristine|vincristine
336358|NCT01506453|TOTAL XVI Protocol|total xvi protocol
336359|NCT01506427|Newly Diagnosed|newly diagnosed
336360|NCT01506427|Head and Neck Cancer|head and neck cancer
336361|NCT01506427|PET Imaging|pet imaging
336362|NCT01506414|Purpura|purpura
336363|NCT01506414|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
336364|NCT01506401|ARDS|ards
336365|NCT01506401|ventilator-induced lung injury|ventilator-induced lung injury
336366|NCT01506401|lung protective ventilation|lung protective ventilation
336367|NCT01506401|high frequency oscillation|high frequency oscillation
336368|NCT01506388|labour induction|labour induction
336369|NCT01506388|Foley catheter|foley catheter
336370|NCT01506388|misoprostol|misoprostol
336371|NCT01506388|isosorbide mononitrate|isosorbide mononitrate
336372|NCT01506375|seasonal allergic rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
336373|NCT01506375|grass pollen|grass pollen
336374|NCT01506375|allergen specific immunotherapy|allergen specific immunotherapy
336375|NCT01506362|Ulcerative Colitis|ulcerative colitis
336376|NCT01506362|IBD|ibd
336377|NCT01506349|celiac disease|celiac disease
336386|NCT01506323|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
336387|NCT01506323|Veterans Health|veterans health
336388|NCT01506323|Clinical Trials, Randomized|clinical trials, randomized
336389|NCT01506323|Mindfulness|mindfulness
336390|NCT01506323|Spirituality|spirituality
336391|NCT01506323|Meditation|meditation
336392|NCT01506323|Mind-body therapy|mind-body therapy
336393|NCT01506310|gestational diabetes mellitus|gestational diabetes mellitus
336394|NCT01506310|fasting glucose|fasting glucose
336395|NCT01506310|insulin resistance|insulin resistance
336396|NCT01506310|birth-weight|birth-weight
336397|NCT01506310|Glucose values|glucose values
336398|NCT01506310|Insulin concentrations|insulin concentrations
336399|NCT01506310|Cesarean sections|cesarean sections
336400|NCT01506297|obesity|obesity
336401|NCT01506297|satiety|satiety
336402|NCT01506297|body weight management|body weight management
336403|NCT01506284|Forced oscillatory technique|forced oscillatory technique
336404|NCT01506284|Laser interferometry|laser interferometry
336405|NCT01506284|Intravenous anesthesia|intravenous anesthesia
336406|NCT01506284|Mechanical ventilation|mechanical ventilation
336407|NCT01506284|Pressure controlled ventilation|pressure controlled ventilation
336408|NCT01506284|Airways mechanical properties|airways mechanical properties
336409|NCT01506284|Respiratory system reactance|respiratory system reactance
336410|NCT01506284|Oscillatory mechanics|oscillatory mechanics
336411|NCT01506284|Atelectasis|atelectasis
336412|NCT01506271|Complicated Intra-abdominal Infections|complicated intra-abdominal infections
336413|NCT01506258|CD34+|cd34+
336414|NCT01506258|perinatal hypoxia|perinatal hypoxia
336415|NCT01506258|autologous hematopoietic stem cells|autologous hematopoietic stem cells
336416|NCT01506258|cord and placental blood|cord and placental blood
336417|NCT01506258|cerebral palsy|cerebral palsy
336418|NCT01506245|Obesity|obesity
336419|NCT01506245|Children|children
336420|NCT01506245|Behavior|behavior
336421|NCT01506245|Family|family
336422|NCT01506245|Exercise|exercise
336423|NCT01506232|ADHD|adhd
336424|NCT01506232|Pediatric Bipolar Disorder|pediatric bipolar disorder
336425|NCT01506232|Autism|autism
336426|NCT01506232|Autism Spectrum Disorders|autism spectrum disorders
336427|NCT01506232|EEG|eeg
336428|NCT01506232|Brain Flow Analyses|brain flow analyses
336436|NCT01506206|Deep Brain Stimulation|deep brain stimulation
336437|NCT01506206|Impulsivity|impulsivity
336438|NCT01506193|safety|safety
336439|NCT01506193|healthy|healthy
336440|NCT01506193|conjugated|conjugated
336441|NCT01506193|immunogenicity|immunogenicity
336442|NCT01506193|children|children
336443|NCT01506193|MenC vaccine|menc vaccine
336444|NCT01506193|MMRV vaccine|mmrv vaccine
336445|NCT01506180|acute medical care|acute medical care
336446|NCT01506180|comprehensive geriatric assessment|comprehensive geriatric assessment
336447|NCT01506180|Health Services for the Aged|health services for the aged
336448|NCT01506180|Geriatric Assessment|geriatric assessment
336449|NCT01506180|Geriatrics|geriatrics
336450|NCT01506180|Aged|aged
336451|NCT01506154|bursitis/tendonitis and/or subdeltoid bursitis|bursitis/tendonitis and/or subdeltoid bursitis
336452|NCT01506141|MPS II|mps ii
336453|NCT01506141|MPS 2|mps 2
336454|NCT01506141|lysosomal storage disorder|lysosomal storage disorder
336455|NCT01506141|mps symptoms|mps symptoms
336456|NCT01506141|enlarged adenoids|enlarged adenoids
336457|NCT01506141|elaprase|elaprase
336458|NCT01506141|hunter's syndrome|hunter's syndrome
336459|NCT01506141|MPS2|mps2
336460|NCT01506141|hunters disease|hunters disease
718235|NCT01038037|BRAF|braf
336461|NCT01506141|hunter's disease treatment|hunter's disease treatment
336462|NCT01506141|hunter syndrome therapy|hunter syndrome therapy
336463|NCT01506141|iduronate sulfatase|iduronate sulfatase
336464|NCT01506141|mps society|mps society
336465|NCT01506141|MPSII|mpsii
336466|NCT01506141|hunter syndrome treatment|hunter syndrome treatment
336467|NCT01506141|hunter's disease|hunter's disease
336468|NCT01506141|iduronate 2 sulfatase|iduronate 2 sulfatase
336469|NCT01506141|mucopolysaccharides|mucopolysaccharides
336470|NCT01506141|mps diagnosis|mps diagnosis
336471|NCT01506141|chronic ear infection|chronic ear infection
336472|NCT01506141|hunters syndrome|hunters syndrome
336473|NCT01506141|ert treatment|ert treatment
336474|NCT01506141|lysosomal storage disease|lysosomal storage disease
336475|NCT01506141|hunter disease|hunter disease
336476|NCT01506141|enzyme replacement therapy|enzyme replacement therapy
336477|NCT01506141|idursulfase|idursulfase
336478|NCT01506141|hunter's syndrome treatment|hunter's syndrome treatment
336479|NCT01506128|HPV|hpv
336480|NCT01506128|Menstrual blood|menstrual blood
327599|NCT01544452|CT|ct
336481|NCT01506128|HPV detection using menstrual blood|hpv detection using menstrual blood
336482|NCT01506115|Hepatocellular carcinoma|hepatocellular carcinoma
336483|NCT01506115|Obstructive jaundice|obstructive jaundice
336484|NCT01506115|Photodynamic therapy|photodynamic therapy
336485|NCT01506089|IVF|ivf
336486|NCT01506089|infertility|infertility
336487|NCT01506089|PGD|pgd
336488|NCT01506089|embryo|embryo
336489|NCT01506089|temperature|temperature
336490|NCT01506089|incubator|incubator
336491|NCT01506089|CCS|ccs
336492|NCT01506089|culture|culture
336493|NCT01506089|incubator-36 degrees Celsius|incubator-36 degrees celsius
336494|NCT01506089|incubator-37 degrees Celsius|incubator-37 degrees celsius
336495|NCT01506063|Bioequivalence|bioequivalence
336496|NCT01506063|Levocetirizine|levocetirizine
336497|NCT01506063|Crossover|crossover
336498|NCT01506050|Bioequivalence|bioequivalence
336499|NCT01506050|Desloratadine|desloratadine
336500|NCT01506050|crossover|crossover
336501|NCT01506037|Bioequivalence|bioequivalence
336502|NCT01506037|Desloratadine|desloratadine
336503|NCT01506037|crossover|crossover
336504|NCT01506024|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
336505|NCT01506024|Surgical Procedures, Operative|surgical procedures, operative
336506|NCT01506024|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
336507|NCT01505985|Hip fracture|hip fracture
336508|NCT01505985|SPPB|sppb
336509|NCT01505985|Functional recovery|functional recovery
336510|NCT01505972|screening colonoscopy|screening colonoscopy
336511|NCT01505972|attendance|attendance
336512|NCT01505972|response|response
336513|NCT01505972|colorectal cancer|colorectal cancer
336514|NCT01505959|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
336515|NCT01505959|Apnea|apnea
336516|NCT01505959|Sleep Apnea|sleep apnea
336517|NCT01505959|Telemedicine|telemedicine
336518|NCT01505959|CPAP compliance|cpap compliance
336519|NCT01505946|Thrombin|thrombin
336520|NCT01505946|Hemophilia|hemophilia
336521|NCT01505946|Inhibitors|inhibitors
336522|NCT01505946|Immunotolerance|immunotolerance
336523|NCT01505946|Haemostatic|haemostatic
336524|NCT01505946|FVIII|fviii
336525|NCT01505946|Epitopes|epitopes
336526|NCT01505946|Moderately severe Hemophilia A with inhibitor|moderately severe hemophilia a with inhibitor
336527|NCT01505933|upper|upper
336528|NCT01505933|airway|airway
336529|NCT01505933|dimensions|dimensions
336530|NCT01505933|propofol|propofol
336531|NCT01505933|dexmedetomidine|dexmedetomidine
336532|NCT01505907|Pharmacokinetics|pharmacokinetics
336533|NCT01505907|Safety|safety
336534|NCT01505907|Healthy Males|healthy males
336535|NCT01505868|Prostate Cancer|prostate cancer
336536|NCT01505868|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
336537|NCT01505868|mCRPC|mcrpc
336538|NCT01505868|Prior treatment with docetaxel|prior treatment with docetaxel
336539|NCT01505868|Cabazitaxel|cabazitaxel
336540|NCT01505868|Jevtana|jevtana
336541|NCT01505868|Carboplatin|carboplatin
336542|NCT01505868|Paraplatin|paraplatin
336543|NCT01505868|Prednisone|prednisone
336544|NCT01505855|Crohn's disease|crohn's disease
336545|NCT01505855|Pneumococcal vaccination|pneumococcal vaccination
336546|NCT01505842|Ulcerative colitis|ulcerative colitis
336547|NCT01505842|Crohn's disease|crohn's disease
336548|NCT01505842|Chromoendoscopy|chromoendoscopy
336549|NCT01505842|Dysplasia|dysplasia
336550|NCT01505842|Neoplasia|neoplasia
336551|NCT01505842|Inflammatory Bowel Disease|inflammatory bowel disease
336552|NCT01505816|Cataract|cataract
336553|NCT01505816|Vision|vision
336554|NCT01505816|Intraocular lens|intraocular lens
336555|NCT01505816|Multifocal|multifocal
336556|NCT01505816|Toric|toric
336557|NCT01505803|Type 2 diabetes mellitus|type 2 diabetes mellitus
336558|NCT01505803|Dietary supplements|dietary supplements
336559|NCT01505803|Hyperglycemia|hyperglycemia
336560|NCT01505803|Insulin resistance|insulin resistance
336561|NCT01505803|Dyslipidemia|dyslipidemia
336562|NCT01505803|Inflammation|inflammation
336563|NCT01505803|Oxidative stress|oxidative stress
336564|NCT01505803|Zinc|zinc
336565|NCT01505803|Omega 3|omega 3
336566|NCT01505777|irritable bowel syndrome without predominant diarrhea|irritable bowel syndrome without predominant diarrhea
336567|NCT01505777|Probiotics(Medirac) 10/mosapride 10mg|probiotics(medirac) 10/mosapride 10mg
336568|NCT01505777|Probiotics(Medirac) 15/mosapride 10mg|probiotics(medirac) 15/mosapride 10mg
336569|NCT01505777|Probiotics(Medirac) 15/mosapride 15mg|probiotics(medirac) 15/mosapride 15mg
336570|NCT01505777|Probiotics(Medirac) 30/mosapride 15mg|probiotics(medirac) 30/mosapride 15mg
336571|NCT01505777|Probiotics(Medirac) placebo/mosapride placebo|probiotics(medirac) placebo/mosapride placebo
336572|NCT01505764|Cachexia|cachexia
336573|NCT01505751|Outcome of cervical cancer|outcome of cervical cancer
336574|NCT01505725|Nicotine Reinforcement|nicotine reinforcement
336575|NCT01505725|Tobacco Craving|tobacco craving
336576|NCT01505725|Behavior Genetics|behavior genetics
336577|NCT01505725|Smoking|smoking
336578|NCT01505712|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
336579|NCT01505712|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
336580|NCT01505712|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
336581|NCT01505712|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
336582|NCT01505699|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
336583|NCT01505699|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
336584|NCT01505673|Insulin|insulin
336585|NCT01505673|Glucagon-like peptide|glucagon-like peptide
336586|NCT01505673|Liraglutide|liraglutide
336587|NCT01505673|Beta-Cell|beta-cell
336588|NCT01505673|pancreatic steatosis|pancreatic steatosis
336589|NCT01505673|hepatic steatosis|hepatic steatosis
336590|NCT01505660|Adherence|adherence
336591|NCT01505660|Depression|depression
336592|NCT01505660|Care management|care management
336593|NCT01505660|Stepped care|stepped care
336595|NCT01505660|Patient reported outcomes|patient reported outcomes
336596|NCT01505660|Antiretroviral medication adherence|antiretroviral medication adherence
336597|NCT01505621|Aging|aging
336598|NCT01505621|Protein accumulation|protein accumulation
336599|NCT01505621|Protein damage|protein damage
336600|NCT01505569|autologous transplantation|autologous transplantation
336601|NCT01505569|high risk solid tumor|high risk solid tumor
336602|NCT01505569|relapsed solid tumor|relapsed solid tumor
336603|NCT01505478|Sepsis|sepsis
336604|NCT01505478|Clinical Prediction Rule|clinical prediction rule
336605|NCT01505478|Clinical Informatics|clinical informatics
336606|NCT01505478|Machine Learning|machine learning
336607|NCT01505465|Total Knee Replacement|total knee replacement
336608|NCT01505465|Pain|pain
336609|NCT01505465|Confusion|confusion
336610|NCT01505465|Sleep|sleep
336611|NCT01505439|solifenacin|solifenacin
336612|NCT01505439|bladder symptom|bladder symptom
336613|NCT01505426|ASP1941|asp1941
336614|NCT01505426|ipragliflozin|ipragliflozin
336615|NCT01505426|metformin|metformin
336616|NCT01505426|plasma glucose|plasma glucose
336617|NCT01505426|urine glucose|urine glucose
336618|NCT01505413|advanced unresectable or metastatic Pancreatic Cancer|advanced unresectable or metastatic pancreatic cancer
336619|NCT01505400|Molecular profiling|molecular profiling
336620|NCT01505400|Advanced cancer|advanced cancer
336621|NCT01505400|Breast cancer|breast cancer
336622|NCT01505400|Non-small cell lung cancer|non-small cell lung cancer
336623|NCT01505400|Colorectal cancer|colorectal cancer
336624|NCT01505400|Genitourinary cancer|genitourinary cancer
336625|NCT01505400|Pancreatobiliary gastrointestinal cancer|pancreatobiliary gastrointestinal cancer
336626|NCT01505400|Upper aerodigestive tract cancer|upper aerodigestive tract cancer
336627|NCT01505400|Gynecological cancers|gynecological cancers
336628|NCT01505400|Phase I|phase i
336629|NCT01505400|Phase I Clinical Trial Candidates|phase i clinical trial candidates
336630|NCT01505400|melanoma cancer|melanoma cancer
336631|NCT01505400|rare cancer|rare cancer
336632|NCT01505400|unknown primary cancer|unknown primary cancer
336633|NCT01505387|Weight maintenance|weight maintenance
336634|NCT01505387|Overweight|overweight
336635|NCT01505387|Obese|obese
336636|NCT01505387|Weight management|weight management
336637|NCT01505374|Bilateral total knee replacement|bilateral total knee replacement
336645|NCT01505361|intrapartum prophylaxis|intrapartum prophylaxis
336646|NCT01505348|feeding patterns|feeding patterns
336647|NCT01505348|aerobic exercise|aerobic exercise
336648|NCT01505348|osteoclasts|osteoclasts
336649|NCT01505335|alveolar nerve, inferior|alveolar nerve, inferior
336650|NCT01505335|ultrasound|ultrasound
336651|NCT01505335|digital radiography, dental|digital radiography, dental
336652|NCT01505335|nerve injury|nerve injury
336653|NCT01505322|daily activities|daily activities
336654|NCT01505309|Aortic Diseases|aortic diseases
336655|NCT01505309|Vascular Diseases|vascular diseases
718236|NCT01038037|PI3K|pi3k
336656|NCT01505309|Cardiovascular Diseases|cardiovascular diseases
336657|NCT01505309|Treatment Outcome|treatment outcome
336658|NCT01505309|Aorta Dissection|aorta dissection
336659|NCT01505309|Aorta Aneurysm|aorta aneurysm
336660|NCT01505309|Aorta pseudoaneurysm|aorta pseudoaneurysm
336661|NCT01505309|Endovascular aortic repair|endovascular aortic repair
336662|NCT01505296|Catheter ablation|catheter ablation
336663|NCT01505257|Delirium|delirium
336664|NCT01505257|Dementia|dementia
336665|NCT01505257|Confusion Assessment Method|confusion assessment method
336666|NCT01505231|Shock|shock
336667|NCT01505231|norepinephrine|norepinephrine
336668|NCT01505231|vasopressin|vasopressin
336669|NCT01505231|cardiac surgery|cardiac surgery
336670|NCT01505218|Sedation|sedation
336671|NCT01505218|propofol|propofol
336869|NCT01504594|Idiopathic|idiopathic
336672|NCT01505218|patient-controlled|patient-controlled
336673|NCT01505218|safety|safety
336674|NCT01505205|Gist,c-KIT,PDGFRA,DOG1,mutation|gist,c-kit,pdgfra,dog1,mutation
336675|NCT01505192|Those in Labor, Delivery and the Puerperium|those in labor, delivery and the puerperium
336676|NCT01505179|HFPEF|hfpef
336677|NCT01505179|Heart Failure|heart failure
336678|NCT01505179|HF w/ preserved EF|hf w/ preserved ef
336679|NCT01505179|Preserved EF|preserved ef
336680|NCT01505179|Preserved Ejection Fraction|preserved ejection fraction
336681|NCT01505179|Diastolic Dysfunction|diastolic dysfunction
336682|NCT01505166|colorectal carcinoma|colorectal carcinoma
336683|NCT01505166|colon cancer|colon cancer
336684|NCT01505166|liver metastases|liver metastases
336685|NCT01505153|Advanced cancer|advanced cancer
336686|NCT01505153|Metastatic cancer|metastatic cancer
336687|NCT01505153|solid tumors|solid tumors
336688|NCT01505153|Melanoma|melanoma
336689|NCT01505140|Andrology|andrology
336690|NCT01505140|Fertility|fertility
336691|NCT01505140|Reproduction|reproduction
336692|NCT01505140|Diet|diet
336693|NCT01505140|Nutritional Sciences|nutritional sciences
336694|NCT01505140|Fatty Acids|fatty acids
336695|NCT01505140|Antioxidants|antioxidants
336696|NCT01505140|Body weight changes|body weight changes
336697|NCT01505127|Drug Therapy|drug therapy
336698|NCT01505114|HIV Prevention|hiv prevention
336699|NCT01505114|PrEP|prep
336700|NCT01505114|Maraviroc|maraviroc
336701|NCT01505088|Iontophoresis|iontophoresis
337367|NCT01502397|occult HBV|occult hbv
336702|NCT01505088|Non-Infectious Anterior Segment Uveitis|non-infectious anterior segment uveitis
336703|NCT01505088|Ophthalmology|ophthalmology
336704|NCT01505075|prostatic neoplasms|prostatic neoplasms
336705|NCT01505075|radiotherapy|radiotherapy
336706|NCT01505075|hypofractionated|hypofractionated
336707|NCT01505075|high risk prostate cancer|high risk prostate cancer
336708|NCT01505062|Usher Syndrome Retinitis Pigmentosa|usher syndrome retinitis pigmentosa
336709|NCT01505062|Usher Syndrome associated Retinitis Pigmentosa|usher syndrome associated retinitis pigmentosa
336710|NCT01505049|immunology|immunology
336711|NCT01505049|vaccination|vaccination
336712|NCT01505049|human papillomavirus|human papillomavirus
336713|NCT01505036|Diabetes Mellitus|diabetes mellitus
336714|NCT01505036|smart-care|smart-care
336715|NCT01505036|U-health care|u-health care
336716|NCT01505010|Treatment-resistant hypertension|treatment-resistant hypertension
336717|NCT01505010|Renal denervation|renal denervation
336718|NCT01505010|Sympathetic nervous system|sympathetic nervous system
336719|NCT01504997|DaVinci|davinci
336720|NCT01504997|Robot assisted surgery|robot assisted surgery
336721|NCT01504997|Gastrectomy|gastrectomy
336722|NCT01504997|Safety|safety
336723|NCT01504997|Gastric Cancer|gastric cancer
336724|NCT01504984|Evaluation of the pharmacokinetics equivalence|evaluation of the pharmacokinetics equivalence
336725|NCT01504984|Healthy volunteers|healthy volunteers
336378|NCT01506349|gluten|gluten
336726|NCT01504984|Single dose over the period I and II(crossover)|single dose over the period i and ii(crossover)
336727|NCT01504984|Healthy male volunteers|healthy male volunteers
336728|NCT01504971|Gastroesophageal Reflux;|gastroesophageal reflux;
336729|NCT01504971|Endoscopy;|endoscopy;
336730|NCT01504971|Esophageal pH monitoring;|esophageal ph monitoring;
336731|NCT01504971|Narrow band imaging;|narrow band imaging;
336732|NCT01504971|Autofluorescence imaging;|autofluorescence imaging;
336733|NCT01504971|White light imaging;|white light imaging;
336734|NCT01504958|Alzheimer's disease|alzheimer's disease
336735|NCT01504958|Cognitive Training|cognitive training
336736|NCT01504958|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
336737|NCT01504945|chronic coronary artery disease|chronic coronary artery disease
336738|NCT01504932|black raspberry lozenges|black raspberry lozenges
336739|NCT01504932|Appalachian|appalachian
336740|NCT01504932|Oral Cancer|oral cancer
336741|NCT01504919|Psychosocial|psychosocial
336742|NCT01504919|Behavioral intervention|behavioral intervention
336743|NCT01504919|Nicotine patch|nicotine patch
336744|NCT01504919|Latinos|latinos
336745|NCT01504919|Mexican American|mexican american
336746|NCT01504919|Motivation and Problem Solving|motivation and problem solving
336747|NCT01504919|MAPS|maps
336748|NCT01504919|Cancer risk reduction|cancer risk reduction
336749|NCT01504919|Smoking cessation|smoking cessation
336750|NCT01504919|Overweight/obese smokers|overweight/obese smokers
718539|NCT01031069|Gardasil|gardasil
336751|NCT01504919|BMI greater than or equal to 25|bmi greater than or equal to 25
336752|NCT01504919|Wellness program|wellness program
336753|NCT01504919|Questionnaires|questionnaires
336755|NCT01504919|Self-help materials|self-help materials
336756|NCT01504919|Pamphlets|pamphlets
336757|NCT01504906|Phase 1|phase 1
336758|NCT01504906|Healthy male volunteers|healthy male volunteers
336759|NCT01504906|pharmacokinetics|pharmacokinetics
336760|NCT01504906|cyclosporine|cyclosporine
336761|NCT01504906|ticagrelor|ticagrelor
336762|NCT01504906|Bioavailability (plasma AUC, Cmax, plasma AUC0-t, t1/2λz, tmax)|bioavailability (plasma auc, cmax, plasma auc0-t, t1/2λz, tmax)
336763|NCT01504893|ventilation|ventilation
336764|NCT01504893|PEEP|peep
336765|NCT01504893|Acute Lung Injury|acute lung injury
336766|NCT01504893|pneumonectomy|pneumonectomy
336767|NCT01504893|ARDS|ards
336768|NCT01504880|Mitral Regurgitation|mitral regurgitation
336769|NCT01504880|Tricuspid Regurgitation|tricuspid regurgitation
336770|NCT01504880|Vena Contracta|vena contracta
336771|NCT01504867|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
336772|NCT01504867|Acute Lung Injury|acute lung injury
336773|NCT01504867|ARDS|ards
336775|NCT01504867|aspirin|aspirin
336776|NCT01504867|prevention|prevention
336777|NCT01504854|Alzheimer's disease|alzheimer's disease
336778|NCT01504854|Dementia|dementia
336779|NCT01504854|Brain diseases|brain diseases
336780|NCT01504854|Resveratrol|resveratrol
336781|NCT01504854|Memory problems|memory problems
336782|NCT01504854|Mental disorders|mental disorders
336783|NCT01504854|Cognitive disorders|cognitive disorders
336784|NCT01504828|Energy Metabolism|energy metabolism
336785|NCT01504828|Ageing|ageing
336786|NCT01504828|left ventricle|left ventricle
336787|NCT01504828|energetics|energetics
336788|NCT01504828|function|function
336789|NCT01504815|advanced head and neck cancer|advanced head and neck cancer
336790|NCT01504815|adaptive radiotherapy|adaptive radiotherapy
336791|NCT01504815|cisplatinum|cisplatinum
336792|NCT01504802|Growth hormone|growth hormone
336793|NCT01504802|C-type natriuretic peptide|c-type natriuretic peptide
336794|NCT01504802|amino-terminal propeptide of C-type natriuretic peptide|amino-terminal propeptide of c-type natriuretic peptide
336795|NCT01504802|insulin-like growth factor-I|insulin-like growth factor-i
337468|NCT01502059|Treatment|treatment
336796|NCT01504802|bone specific alkaline phosphatase|bone specific alkaline phosphatase
336797|NCT01504802|leptin|leptin
336798|NCT01504802|deoxypyridinoline|deoxypyridinoline
336799|NCT01504802|growth velocity|growth velocity
336800|NCT01504802|pharmacodynamic|pharmacodynamic
336801|NCT01504802|biomarker|biomarker
336802|NCT01504789|Breast Cancer|breast cancer
336803|NCT01504789|Breast Cancer Survivors|breast cancer survivors
336804|NCT01504789|Exercise|exercise
336805|NCT01504789|Hispanic|hispanic
336806|NCT01504789|Mexican-American|mexican-american
336807|NCT01504789|Puerto Rican|puerto rican
336808|NCT01504789|Culturally tailored exercise|culturally tailored exercise
336809|NCT01504789|Fitness tests|fitness tests
336810|NCT01504789|Questionnaires|questionnaires
336811|NCT01504789|Surveys|surveys
336812|NCT01504789|Culturally tailored written material|culturally tailored written material
336813|NCT01504776|MCL|mcl
336814|NCT01504776|Lymphoma|lymphoma
336815|NCT01504776|Panobinostat|panobinostat
336816|NCT01504763|Massage|massage
336817|NCT01504763|Chair massage|chair massage
336818|NCT01504763|Relaxation|relaxation
336819|NCT01504763|Nurses|nurses
336820|NCT01504750|Length of Stay [E02.760.400.480]|length of stay [e02.760.400.480]
336821|NCT01504750|Activities of Daily Living [I03.050]|activities of daily living [i03.050]
336822|NCT01504737|Exercise|exercise
336823|NCT01504737|Physical Activity|physical activity
336824|NCT01504737|Physiotherapy|physiotherapy
336825|NCT01504737|Exercise test|exercise test
336826|NCT01504737|Quality of Life|quality of life
336827|NCT01504737|Aortic Valve Replacement|aortic valve replacement
336828|NCT01504724|central macular thickness|central macular thickness
336829|NCT01504698|Manipulative treatment|manipulative treatment
336830|NCT01504698|Children|children
336831|NCT01504698|Neck pain|neck pain
336832|NCT01504698|Back pain|back pain
336833|NCT01504698|Effect|effect
336834|NCT01504698|Adolescence|adolescence
336835|NCT01504698|Advise|advise
336836|NCT01504698|Exercise|exercise
336837|NCT01504685|Morbid obesity|morbid obesity
336838|NCT01504685|Obesity surgery|obesity surgery
336839|NCT01504685|Gastric bypass|gastric bypass
336840|NCT01504685|Banded gastric bypass|banded gastric bypass
336841|NCT01504672|Drug related problems|drug related problems
336842|NCT01504659|bipolar disorder|bipolar disorder
336843|NCT01504659|treatment resistance|treatment resistance
336844|NCT01504659|depression|depression
336845|NCT01504659|ketamine|ketamine
336846|NCT01504659|intranasal|intranasal
336847|NCT01504659|child|child
336848|NCT01504646|Asthma|asthma
336849|NCT01504646|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
336850|NCT01504646|lipids|lipids
336851|NCT01504646|n-3 PUFA|n-3 pufa
336852|NCT01504646|airway inflammation|airway inflammation
336853|NCT01504646|Bronchoconstriction|bronchoconstriction
336854|NCT01504633|cognitive function|cognitive function
336855|NCT01504633|omega-3 PUFA (DHA)|omega-3 pufa (dha)
336856|NCT01504633|iron|iron
336857|NCT01504633|nutrigenomics|nutrigenomics
336858|NCT01504633|under-two year old children|under-two year old children
336859|NCT01504633|Indonesia|indonesia
336860|NCT01504620|diabetes mellitus|diabetes mellitus
336861|NCT01504620|blood glucose self-assessment|blood glucose self-assessment
336862|NCT01504620|Accuracy|accuracy
336863|NCT01504620|Intra-Assay precision|intra-assay precision
336864|NCT01504620|Hematocrit interference|hematocrit interference
336865|NCT01504607|corneal endothelium|corneal endothelium
336866|NCT01504607|congenital cataract surgery|congenital cataract surgery
336867|NCT01504607|IOL implantation|iol implantation
336868|NCT01504594|Dilated cardiomyopathy|dilated cardiomyopathy
336870|NCT01504594|Bone Marrow|bone marrow
336871|NCT01504594|Stem Cells|stem cells
336872|NCT01504594|CD34 +|cd34 +
336873|NCT01504594|Autologous|autologous
336874|NCT01504555|hypercortisolism, dexamethasone, alcoholism,obesity.|hypercortisolism, dexamethasone, alcoholism,obesity.
336875|NCT01504542|Immunotherapy|immunotherapy
336876|NCT01504529|Rotigotine (Neupro)|rotigotine (neupro)
336877|NCT01504529|Non-Motor Symptoms|non-motor symptoms
336878|NCT01504529|Advanced Parkinson's Disease|advanced parkinson's disease
336879|NCT01504529|Local study|local study
336880|NCT01504529|Spain|spain
336881|NCT01504529|Observational study|observational study
336882|NCT01504529|Non-interventional study|non-interventional study
336883|NCT01504529|Retrospective study|retrospective study
336884|NCT01504529|Post-marketing study|post-marketing study
336885|NCT01504529|Multicenter study|multicenter study
336886|NCT01504516|Bioequivalence|bioequivalence
336887|NCT01504516|Donepezil|donepezil
336888|NCT01504516|crossover|crossover
336889|NCT01504503|Bioequivalence|bioequivalence
336890|NCT01504503|Donepezil|donepezil
336891|NCT01504503|crossover|crossover
336892|NCT01504490|Advanced cancer|advanced cancer
336893|NCT01504477|colorectal cancer|colorectal cancer
336894|NCT01504477|relapsed|relapsed
336895|NCT01504477|refractory|refractory
336896|NCT01504477|Kras wild type|kras wild type
336897|NCT01504464|knee joint osteoarthritis mesenchymal stem cell|knee joint osteoarthritis mesenchymal stem cell
336898|NCT01504451|Atrial fibrillation|atrial fibrillation
336899|NCT01504451|Ablation|ablation
336900|NCT01504451|Implantable loop recorder|implantable loop recorder
336901|NCT01504412|Pain|pain
336902|NCT01504412|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
336903|NCT01504399|Pituitary surgery|pituitary surgery
336904|NCT01504399|Transsphenoidal surgery|transsphenoidal surgery
336905|NCT01504399|Anterior skull base surgery|anterior skull base surgery
336906|NCT01504399|Endoscopic surgery|endoscopic surgery
336907|NCT01504399|Patient survey|patient survey
336908|NCT01504399|Nasal complications|nasal complications
336909|NCT01504373|NAVA|nava
336910|NCT01504373|neurally adjusted ventilatory support|neurally adjusted ventilatory support
336911|NCT01504373|lung injury|lung injury
336912|NCT01504373|ventilation|ventilation
336913|NCT01504373|lung volume distribution|lung volume distribution
336914|NCT01504373|oxygen cost of breathing|oxygen cost of breathing
336915|NCT01504360|sarcoma|sarcoma
336916|NCT01504360|radiation therapy|radiation therapy
336917|NCT01504360|predictive essay|predictive essay
336918|NCT01504321|Polycystic Ovary syndrome|polycystic ovary syndrome
336919|NCT01504321|PCOS|pcos
336920|NCT01504321|sympathetic nervous system|sympathetic nervous system
336921|NCT01504321|moxonidine|moxonidine
336922|NCT01504308|uterine fibroids|uterine fibroids
336923|NCT01504308|uterine leiomyomas|uterine leiomyomas
336924|NCT01504308|magnetic resonance imaging|magnetic resonance imaging
336925|NCT01504308|focused ultrasound|focused ultrasound
336926|NCT01504256|Adenocarcinoma|adenocarcinoma
336927|NCT01504256|Esophagogastric Junction|esophagogastric junction
336928|NCT01504256|Peritoneal Carcinomatosis|peritoneal carcinomatosis
336929|NCT01504256|Catumaxomab|catumaxomab
336930|NCT01504256|AIO-STO-0110|aio-sto-0110
336931|NCT01504243|CD163;|cd163;
336932|NCT01504243|SNPs;|snps;
336933|NCT01504243|prognosis;|prognosis;
336934|NCT01504243|control（normal person）|control（normal person）
336935|NCT01504230|To ascertain the mechanisms for effectively controlling balance in seniors with osteoporosis and to provide a basis for developing fall prevention programs.|to ascertain the mechanisms for effectively controlling balance in seniors with osteoporosis and to provide a basis for developing fall prevention programs.
336936|NCT01504230|To develop biomechanical models that control the entire body's center of mass (CoM) during upright quiet stance in seniors with osteoporosis.|to develop biomechanical models that control the entire body's center of mass (com) during upright quiet stance in seniors with osteoporosis.
336937|NCT01504230|To identify the mechanism to control the entire body's CoM after receiving a balance perturbation in seniors with osteoporosis.|to identify the mechanism to control the entire body's com after receiving a balance perturbation in seniors with osteoporosis.
336938|NCT01504217|Healthy older people over 65 years old|healthy older people over 65 years old
336939|NCT01504204|adherence|adherence
336940|NCT01504204|adapalene|adapalene
336941|NCT01504204|benzoyl peroxide|benzoyl peroxide
336942|NCT01504204|sample|sample
336943|NCT01504204|topical treatment|topical treatment
336944|NCT01504191|myocardial infarction|myocardial infarction
336945|NCT01504191|depression|depression
336946|NCT01504191|anxiety|anxiety
336947|NCT01504191|Internet‐based CBT|internet‐based cbt
336948|NCT01504191|genetic disposition|genetic disposition
336949|NCT01504178|Noradrenergic system and pain in Parkinson's disease|noradrenergic system and pain in parkinson's disease
336950|NCT01504165|Renal impairment|renal impairment
336951|NCT01504165|Pharmacokinetic|pharmacokinetic
336952|NCT01504165|cilengitide|cilengitide
336953|NCT01504165|subjects with mild|subjects with mild
336954|NCT01504165|moderate or severe renal impairment compared to subjects with normal renal function|moderate or severe renal impairment compared to subjects with normal renal function
336955|NCT01504152|International travel|international travel
336956|NCT01504152|cancer patients|cancer patients
336957|NCT01504152|HSCT|hsct
336958|NCT01504152|Quality of Life|quality of life
336959|NCT01504152|questionnaire|questionnaire
336960|NCT01504152|11-176|11-176
336961|NCT01504126|Ovarian Cancer|ovarian cancer
336962|NCT01504126|Primary peritoneal carcinoma|primary peritoneal carcinoma
336963|NCT01504126|Fallopian tube cancer|fallopian tube cancer
336964|NCT01504126|Invasive epithelial ovarian cancer|invasive epithelial ovarian cancer
336965|NCT01504126|Serous adenocarcinoma|serous adenocarcinoma
336966|NCT01504126|Endometrioid adenocarcinoma|endometrioid adenocarcinoma
336967|NCT01504126|Mucinous adenocarcinoma|mucinous adenocarcinoma
336968|NCT01504126|Undifferentiated carcinoma|undifferentiated carcinoma
336969|NCT01504126|Clear cell carcinoma|clear cell carcinoma
336970|NCT01504126|Mixed epithelial carcinoma|mixed epithelial carcinoma
336971|NCT01504126|Adenocarcinoma not otherwise specified|adenocarcinoma not otherwise specified
336972|NCT01504126|Primary Müllerian epithelial adenocarcinoma|primary müllerian epithelial adenocarcinoma
336973|NCT01504126|Propranolol|propranolol
336974|NCT01504126|Beta-blocker|beta-blocker
336975|NCT01504113|Target therapy|target therapy
336976|NCT01504113|Biologics|biologics
336977|NCT01504113|Psoriasis|psoriasis
336978|NCT01504113|Latent virus|latent virus
336979|NCT01504113|Human papillomaviruses|human papillomaviruses
336980|NCT01504113|Cytomegalovirus|cytomegalovirus
336981|NCT01504113|Epstein-Barr virus|epstein-barr virus
336982|NCT01504113|Tumor necrosis factor|tumor necrosis factor
338069|NCT01499667|fingolimod|fingolimod
336983|NCT01504087|patient in critical care|patient in critical care
336984|NCT01504074|Irvine Gass syndrome|irvine gass syndrome
336985|NCT01504074|multimodal imaging|multimodal imaging
336986|NCT01504074|SD-OCT|sd-oct
336987|NCT01504074|CME secondary to cataract surgery|cme secondary to cataract surgery
336988|NCT01504074|in vivo correlation of morphology and function|in vivo correlation of morphology and function
336989|NCT01504061|surgical|surgical
336990|NCT01504061|scars|scars
336991|NCT01504061|Mederma|mederma
336992|NCT01504048|Microscopic colitis|microscopic colitis
336993|NCT01504048|Intestinal Diseases|intestinal diseases
336994|NCT01504048|Inflammatory Bowel Diseases|inflammatory bowel diseases
336995|NCT01504035|Donor site pain|donor site pain
336996|NCT01504035|Iliac crest|iliac crest
336997|NCT01504035|Bone graft|bone graft
336998|NCT01504035|Hemostatic putty|hemostatic putty
336999|NCT01504035|lidocaine|lidocaine
337000|NCT01504035|Donor site pain following harvest of iliac crest bone grafts|donor site pain following harvest of iliac crest bone grafts
337001|NCT01504022|Hypertension|hypertension
337002|NCT01504022|self-monitoring|self-monitoring
337003|NCT01504022|internet|internet
337004|NCT01504022|lifestyle modification|lifestyle modification
337005|NCT01504009|Nervous System Disease|nervous system disease
337006|NCT01504009|Neurodegenerative Disease|neurodegenerative disease
337007|NCT01504009|Motor Neuron Disease|motor neuron disease
337009|NCT01504009|Muscle training|muscle training
337010|NCT01504009|Muscle atrophy|muscle atrophy
337011|NCT01503996|dehydration|dehydration
337012|NCT01503996|risk factor|risk factor
337013|NCT01503996|glaucoma|glaucoma
337014|NCT01503996|Controls|controls
337015|NCT01503983|Gastric Cancer with Metastasis|gastric cancer with metastasis
337016|NCT01503983|HER2-positive|her2-positive
337017|NCT01503970|chondral lesions|chondral lesions
337018|NCT01503970|knee|knee
337019|NCT01503957|Allergic rhinitis|allergic rhinitis
337020|NCT01503957|Allergen|allergen
337021|NCT01503957|Allergy|allergy
337022|NCT01503957|Dustmite|dustmite
337023|NCT01503931|alcohol dependence, functional magnetic resonance imaging, genetics, endophenotypes, dopamine,|alcohol dependence, functional magnetic resonance imaging, genetics, endophenotypes, dopamine,
337024|NCT01503931|glutamate|glutamate
337025|NCT01503918|Critical Illness|critical illness
337026|NCT01503918|Critical Care|critical care
337027|NCT01503918|Valganciclovir|valganciclovir
337028|NCT01503918|Ganciclovir|ganciclovir
337029|NCT01503918|Aciclovir|aciclovir
337030|NCT01503918|Valaciclovir|valaciclovir
337031|NCT01503918|Cytomegalovirus|cytomegalovirus
337032|NCT01503905|breast cancer|breast cancer
337033|NCT01503905|neoadjuvant chemotherapy|neoadjuvant chemotherapy
337034|NCT01503905|amenorrhea|amenorrhea
337035|NCT01503892|Small Fiber Neuropathy|small fiber neuropathy
337036|NCT01503892|Metanx Effect on Small Fiber Neuropathy|metanx effect on small fiber neuropathy
337037|NCT01503892|Metanx Effect on Diabetic Peripheral Neuropathy|metanx effect on diabetic peripheral neuropathy
337038|NCT01503879|general anaesthesia|general anaesthesia
337039|NCT01503879|invasive mechanical ventilation|invasive mechanical ventilation
337040|NCT01503879|DLCO|dlco
337041|NCT01503879|SPB|spb
337042|NCT01503853|Medical Costs|medical costs
337043|NCT01503853|Health Care|health care
337044|NCT01503853|Focus Groups|focus groups
337045|NCT01503827|Whole Brain Radiotherapy|whole brain radiotherapy
337046|NCT01503827|Brain metastases|brain metastases
337047|NCT01503827|Melanoma|melanoma
337048|NCT01503827|Stage IV Metastatic Melanoma|stage iv metastatic melanoma
337049|NCT01503827|Neurocognitive function|neurocognitive function
337050|NCT01503827|Quality of life|quality of life
337051|NCT01503814|hypertension|hypertension
327793|NCT01543373|DES|des
337052|NCT01503814|primary care|primary care
337146|NCT01503294|Temporal artery thermometer|temporal artery thermometer
337053|NCT01503814|cardiovascular disease prevention|cardiovascular disease prevention
337054|NCT01503814|high cardiovascular risk|high cardiovascular risk
337055|NCT01503814|diuretics|diuretics
337056|NCT01503814|aspirin|aspirin
337057|NCT01503814|smoking cessation|smoking cessation
337058|NCT01503814|salt reduction|salt reduction
337059|NCT01503814|Tibet|tibet
337060|NCT01503801|Preterm neonates|preterm neonates
337061|NCT01503801|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
337062|NCT01503801|Chronic lung disease|chronic lung disease
337063|NCT01503801|Inhaled nitric oxide|inhaled nitric oxide
337064|NCT01503801|Respiratory therapy|respiratory therapy
337065|NCT01503775|intracranial|intracranial
337066|NCT01503775|ruptured|ruptured
337067|NCT01503775|non-ruptured|non-ruptured
337068|NCT01503775|aneurysms|aneurysms
337069|NCT01503775|Intracranial ruptured or non-ruptured aneurysms|intracranial ruptured or non-ruptured aneurysms
337070|NCT01503762|Hand Flexor tendon Injuries|hand flexor tendon injuries
337071|NCT01503762|hand Extensor Tendon Injuries|hand extensor tendon injuries
337072|NCT01503762|Hand Joint Dislocations and subluxation|hand joint dislocations and subluxation
337073|NCT01503736|Kidney Diseases|kidney diseases
337074|NCT01503736|Kidney Failure, Chronic|kidney failure, chronic
337075|NCT01503736|Hyperphosphatemia|hyperphosphatemia
337076|NCT01503736|Urologic Diseases|urologic diseases
337077|NCT01503736|Renal Insufficiency, Chronic|renal insufficiency, chronic
337078|NCT01503736|Renal Insufficiency|renal insufficiency
337079|NCT01503736|Phosphorus Metabolism Disorders|phosphorus metabolism disorders
337080|NCT01503710|Proteinuria predict outcome|proteinuria predict outcome
337081|NCT01503710|BNP and NGAL predict outcome|bnp and ngal predict outcome
337082|NCT01503710|Pre-operative GFR and proteinuria|pre-operative gfr and proteinuria
337083|NCT01503697|Breast Cancer|breast cancer
337084|NCT01503697|High Risk|high risk
337085|NCT01503697|Imaging|imaging
337086|NCT01503697|Angiogenesis|angiogenesis
337087|NCT01503684|sepsis|sepsis
337088|NCT01503671|left ventricular diastolic function|left ventricular diastolic function
337089|NCT01503671|inflammation|inflammation
337090|NCT01503671|peritoneal dialysis|peritoneal dialysis
337091|NCT01503671|LV diastolic function changes after statin intervention|lv diastolic function changes after statin intervention
337092|NCT01503658|Clopidogrel,|clopidogrel,
337093|NCT01503658|Aspirin,|aspirin,
337094|NCT01503658|Pharmacogenomics|pharmacogenomics
337095|NCT01503645|kidney diseases|kidney diseases
337096|NCT01503645|drugs, Chinese herbal|drugs, chinese herbal
337097|NCT01503645|aristolochic acid|aristolochic acid
337098|NCT01503645|polymorphism, genetic|polymorphism, genetic
337099|NCT01503619|small cell lung cancer|small cell lung cancer
337100|NCT01503606|preterm premature rupture of membrane|preterm premature rupture of membrane
337101|NCT01503606|antibiotics|antibiotics
337102|NCT01503606|duration|duration
337103|NCT01503606|cefazolin|cefazolin
337104|NCT01503606|clarithromycin|clarithromycin
337105|NCT01503541|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
337106|NCT01503541|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
337107|NCT01503541|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
337108|NCT01503541|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
337109|NCT01503541|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
337110|NCT01503541|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
337111|NCT01503541|adult acute myeloid leukemia|adult acute myeloid leukemia
337112|NCT01503528|arthroplasty|arthroplasty
337113|NCT01503528|wound|wound
337114|NCT01503528|catheter|catheter
337115|NCT01503528|infusion|infusion
337116|NCT01503528|local|local
337117|NCT01503528|anesthesia|anesthesia
337118|NCT01503528|infiltration|infiltration
337119|NCT01503502|Myelogenous Leukemia|myelogenous leukemia
337120|NCT01503502|chronce|chronce
337121|NCT01503502|Philadelphia Chromosome Positive|philadelphia chromosome positive
337122|NCT01503502|Flumatinib|flumatinib
337123|NCT01503489|Switch.|switch.
337124|NCT01503476|gastro esophageal reflux disease|gastro esophageal reflux disease
337125|NCT01503463|Congestive Heart Failure|congestive heart failure
337126|NCT01503463|Telemedicine|telemedicine
337127|NCT01503385|Celecoxib|celecoxib
337128|NCT01503385|phase II|phase ii
337129|NCT01503359|glutamic acid|glutamic acid
337130|NCT01503359|sarcosine|sarcosine
337131|NCT01503359|NMDA|nmda
337132|NCT01503359|schizophrenia|schizophrenia
337133|NCT01503346|Appetite Loss|appetite loss
337134|NCT01503333|exercise|exercise
337135|NCT01503333|adolescent|adolescent
337136|NCT01503333|intervention|intervention
337137|NCT01503333|female|female
337138|NCT01503333|counseling|counseling
337139|NCT01503320|To evaluate|to evaluate
337140|NCT01503320|efficacy|efficacy
327889|NCT01542918|CNS|cns
337141|NCT01503320|enteral glutamine|enteral glutamine
337142|NCT01503307|prenatal chd diagnosis|prenatal chd diagnosis
337143|NCT01503307|postpartum chd diagnosis|postpartum chd diagnosis
337144|NCT01503307|parenting|parenting
337145|NCT01503307|internal working models|internal working models
337147|NCT01503294|Pulmonary artery thermistor|pulmonary artery thermistor
337148|NCT01503281|Children|children
337149|NCT01503281|Physical activity|physical activity
337150|NCT01503281|Home-based treatment|home-based treatment
337151|NCT01503281|Body mass index (z-BMI)|body mass index (z-bmi)
337152|NCT01503281|Percentage body fat|percentage body fat
337153|NCT01503281|Waist circumference|waist circumference
337154|NCT01503268|Atrial fibrillation|atrial fibrillation
337155|NCT01503268|Ablation|ablation
337156|NCT01503268|Percutaneous ablation|percutaneous ablation
337157|NCT01503268|Minimally-invasive thoracoscopic ablation|minimally-invasive thoracoscopic ablation
337158|NCT01503268|Implantable loop recorder|implantable loop recorder
337160|NCT01503255|alcohol|alcohol
337161|NCT01503255|HIV|hiv
337162|NCT01503255|Kenya|kenya
337163|NCT01503255|paraprofessional|paraprofessional
337164|NCT01503216|randomized controlled trial|randomized controlled trial
337165|NCT01503216|vitamin D|vitamin d
337166|NCT01503216|bioavailability|bioavailability
337167|NCT01503203|Older|older
337168|NCT01503203|virtual systems|virtual systems
337169|NCT01503203|low back pain|low back pain
337170|NCT01503203|postural balance|postural balance
337171|NCT01503190|Breast Cancer|breast cancer
337172|NCT01503190|Young Women|young women
338259|NCT01498614|depression|depression
337173|NCT01503190|Pregnancy Associated Breast Cancer|pregnancy associated breast cancer
337174|NCT01503190|Pregnancy|pregnancy
337175|NCT01503190|Premenopausal Breast Cancer|premenopausal breast cancer
337176|NCT01503164|Obstructive sleep apnea|obstructive sleep apnea
337177|NCT01503164|Sleep Apnea|sleep apnea
337178|NCT01503164|Sleep-disordered breathing|sleep-disordered breathing
337179|NCT01503164|Insulin sensitivity|insulin sensitivity
337180|NCT01503164|Glucose tolerance|glucose tolerance
337181|NCT01503164|Type 2 diabetes|type 2 diabetes
337182|NCT01503151|attention bias modification treatment|attention bias modification treatment
337183|NCT01503151|interpretive bias modification|interpretive bias modification
337184|NCT01503151|cognitive bias modification|cognitive bias modification
337185|NCT01503151|attention training|attention training
337186|NCT01503151|social anxiety|social anxiety
337187|NCT01503138|Intimate Partner Violence|intimate partner violence
337188|NCT01503138|Depressive Symptoms|depressive symptoms
337189|NCT01503138|Intervention|intervention
337190|NCT01503138|Randomized Controlled Trial|randomized controlled trial
337191|NCT01503138|Mainland Chinese|mainland chinese
337192|NCT01503138|Immigrants|immigrants
337193|NCT01503138|Women|women
337194|NCT01503125|GAN|gan
337195|NCT01503125|Giant Axonal Neuropathy|giant axonal neuropathy
337196|NCT01503125|Neuromuscular Disease|neuromuscular disease
337197|NCT01503125|Natural History Study|natural history study
337198|NCT01503125|Observational Study|observational study
337199|NCT01503112|Glucagon-Like Peptide 1, DPP4 protein, Therapeutics, Hypoglycemic Agents, C-Peptide, Type 2 Diabetes Mellitus,|glucagon-like peptide 1, dpp4 protein, therapeutics, hypoglycemic agents, c-peptide, type 2 diabetes mellitus,
337200|NCT01503099|ITB|itb
337201|NCT01503099|PTB|ptb
337202|NCT01503099|CD|cd
337203|NCT01503073|stroke|stroke
337204|NCT01503060|pediatrics|pediatrics
337205|NCT01503060|Pain|pain
337206|NCT01503060|Immunization|immunization
337207|NCT01503034|Pregnant women|pregnant women
337208|NCT01503021|Soluble ferric pyrophosphate|soluble ferric pyrophosphate
337209|NCT01503021|Chronic kidney disease|chronic kidney disease
337210|NCT01503021|Chronic hemodialysis|chronic hemodialysis
337211|NCT01503021|Ferric pyrophosphate citrate|ferric pyrophosphate citrate
337212|NCT01502995|Assistive devices|assistive devices
337213|NCT01502995|Freezing of gait|freezing of gait
337214|NCT01502995|Gait disorders|gait disorders
337215|NCT01502995|Gait hesitation|gait hesitation
337216|NCT01502995|Gait ignition failure|gait ignition failure
337217|NCT01502995|Laser light|laser light
337218|NCT01502995|Parkinson's disease|parkinson's disease
337219|NCT01502995|Rolling walker|rolling walker
337220|NCT01502995|Visual Cue|visual cue
337221|NCT01502995|Walker|walker
337222|NCT01502982|DLBCL|dlbcl
337223|NCT01502982|high risk|high risk
337224|NCT01502982|young|young
337225|NCT01502969|diarrhea|diarrhea
337226|NCT01502969|fever|fever
337227|NCT01502969|nausea|nausea
337228|NCT01502969|vomit|vomit
337229|NCT01502969|irritability|irritability
337230|NCT01502956|Refractory Urinary Urge Incontinence|refractory urinary urge incontinence
337231|NCT01502956|Botox A®|botox a®
337232|NCT01502956|Interstim® Device|interstim® device
337233|NCT01502943|Complementary Therapies|complementary therapies
337234|NCT01502943|Traditional Chinese Medicine|traditional chinese medicine
337235|NCT01502943|Quality of life|quality of life
337236|NCT01502943|Seattle angina questionnaire (SAQ)|seattle angina questionnaire (saq)
337237|NCT01502943|SF-12|sf-12
337238|NCT01502943|Measure Your Medical Outcome Profile (MYMOP)|measure your medical outcome profile (mymop)
337239|NCT01502943|Phlegm and blood stasis Syndrome|phlegm and blood stasis syndrome
337240|NCT01502943|Qi deficiency and blood stasis Syndrome|qi deficiency and blood stasis syndrome
337241|NCT01502943|Invigorating Spleen to Remove Phlegm or replenish Qi|invigorating spleen to remove phlegm or replenish qi
337242|NCT01502943|Activating blood and dissolving stasis|activating blood and dissolving stasis
337243|NCT01502943|Traditional Chinese medicine SYndrome Scale (TCMsys)|traditional chinese medicine syndrome scale (tcmsys)
337244|NCT01502943|Patients Report Outcomes(PRO)|patients report outcomes(pro)
337245|NCT01502943|clinical efficacy|clinical efficacy
337246|NCT01502943|evaluative index|evaluative index
337247|NCT01502917|Brain stem glioma|brain stem glioma
337249|NCT01502917|MAB 124I-8H9|mab 124i-8h9
337250|NCT01502917|infusion cannula|infusion cannula
337251|NCT01502917|DIPG|dipg
337252|NCT01502917|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
337253|NCT01502917|11-011|11-011
337254|NCT01502904|SES vs BES|ses vs bes
337255|NCT01502891|Comparative Effectiveness Research|comparative effectiveness research
337256|NCT01502891|Decision Support Techniques|decision support techniques
337257|NCT01502891|Decision Making|decision making
337258|NCT01502878|Nut allergy|nut allergy
337259|NCT01502878|Double-blind placebo-controlled (DBPC) oral nut challenge|double-blind placebo-controlled (dbpc) oral nut challenge
337260|NCT01502878|Nut oral immunotherapy (OIT)|nut oral immunotherapy (oit)
337261|NCT01502878|Nut oral desensitization|nut oral desensitization
337262|NCT01502852|OEF/OIF Veterans|oef/oif veterans
337263|NCT01502852|Traumatic Brain Injury|traumatic brain injury
337264|NCT01502852|Community Mental Health|community mental health
337265|NCT01502826|Childhood obesity|childhood obesity
337266|NCT01502826|Endothelial dysfunction|endothelial dysfunction
337267|NCT01502826|Inflammation|inflammation
337268|NCT01502826|Insulin resistance|insulin resistance
337269|NCT01502813|Neuropsychological testing|neuropsychological testing
337270|NCT01502813|Dietary supplements|dietary supplements
337271|NCT01502800|Metastatic|metastatic
337272|NCT01502800|Unresectable|unresectable
337273|NCT01502800|Recurrent advanced|recurrent advanced
337274|NCT01502787|hypertension|hypertension
337275|NCT01502787|blood pressure|blood pressure
337276|NCT01502787|blood pressure medications|blood pressure medications
337277|NCT01502787|metoprolol|metoprolol
337278|NCT01502787|nebivolol|nebivolol
337279|NCT01502787|handgrip exercise|handgrip exercise
337280|NCT01502787|lower body negative pressure|lower body negative pressure
337281|NCT01502787|angiotensin II|angiotensin ii
337282|NCT01502787|sympathetic nerve activity|sympathetic nerve activity
337283|NCT01502787|flow mediated dilation|flow mediated dilation
337284|NCT01502787|nitric oxide|nitric oxide
337285|NCT01502787|microneurography|microneurography
337286|NCT01502774|STEMI|stemi
337287|NCT01502774|cyclosporine|cyclosporine
337288|NCT01502774|reperfusion injury|reperfusion injury
337289|NCT01502761|stroke|stroke
337290|NCT01502761|Magnesium|magnesium
337291|NCT01502761|endovascular|endovascular
337292|NCT01502748|stroke|stroke
337293|NCT01502748|Magnesium|magnesium
337294|NCT01502748|Endovascular|endovascular
337295|NCT01502735|dengue|dengue
337296|NCT01502735|dengue fever|dengue fever
337297|NCT01502735|monovalent dengue vaccine|monovalent dengue vaccine
337298|NCT01502709|Single blind|single blind
337299|NCT01502709|Randomized|randomized
337300|NCT01502709|Controlled clinical trial|controlled clinical trial
337301|NCT01502696|ulcerated primary cutaneous melanoma|ulcerated primary cutaneous melanoma
337302|NCT01502696|Stage II|stage ii
337303|NCT01502696|PEG IFN alfa-2b|peg ifn alfa-2b
337304|NCT01502696|T(2-4)bN0M0|t(2-4)bn0m0
337305|NCT01502683|Stroke|stroke
337306|NCT01502683|neurocognitive dysfunction|neurocognitive dysfunction
337307|NCT01502683|cerebral embolic events|cerebral embolic events
337308|NCT01502670|Pulmonary nodules|pulmonary nodules
337309|NCT01502657|percutaneous tracheostomy|percutaneous tracheostomy
337310|NCT01502657|ultrasonography|ultrasonography
337311|NCT01502657|echography|echography
337312|NCT01502657|critical care|critical care
337313|NCT01502644|low back pain|low back pain
337314|NCT01502644|opioids|opioids
337315|NCT01502644|mood symptoms|mood symptoms
337316|NCT01502618|Adolescent Medicine Trials Network for HIV/AIDS Interventions|adolescent medicine trials network for hiv/aids interventions
337317|NCT01502618|Human Immunodeficiency Virus|human immunodeficiency virus
337318|NCT01502605|5-ALA|5-ala
337319|NCT01502605|Aminolevulinic Acid|aminolevulinic acid
337320|NCT01502605|Craniotomy|craniotomy
337321|NCT01502605|Brain Tumor|brain tumor
337322|NCT01502605|Surgical Resection|surgical resection
337323|NCT01502605|Neurosurgery|neurosurgery
337324|NCT01502592|MDX-010 (Ipilimumab)|mdx-010 (ipilimumab)
337325|NCT01502592|Cryoablation|cryoablation
337326|NCT01502592|Total mastectomy planned|total mastectomy planned
337327|NCT01502592|11-202|11-202
337328|NCT01502579|IgA nephropathy|iga nephropathy
337329|NCT01502566|educational intervention|educational intervention
337330|NCT01502566|dentals caries|dentals caries
337331|NCT01502566|population|population
337332|NCT01502566|new populational caries prevention strategies.|new populational caries prevention strategies.
337333|NCT01502553|blood pressure|blood pressure
337334|NCT01502553|heart rate|heart rate
337335|NCT01502540|pain|pain
337336|NCT01502540|craniotomy|craniotomy
337337|NCT01502527|Vulvo vaginal atrophy|vulvo vaginal atrophy
337338|NCT01502527|Femarelle|femarelle
337339|NCT01502514|CHF|chf
337340|NCT01502514|ischemia|ischemia
337341|NCT01502514|Heart Failure|heart failure
337342|NCT01502501|CHF|chf
337343|NCT01502501|Heart Failure|heart failure
337344|NCT01502501|Non-Ischemic|non-ischemic
337345|NCT01502501|nonischemic|nonischemic
337346|NCT01502501|nonischemia|nonischemia
337347|NCT01502488|Autistic|autistic
337348|NCT01502488|ASC therapy|asc therapy
337349|NCT01502488|ADSC|adsc
337350|NCT01502475|Complementary Alternative Medicine|complementary alternative medicine
337351|NCT01502475|Veteran|veteran
337352|NCT01502475|Attitudes|attitudes
337353|NCT01502475|Beliefs|beliefs
337354|NCT01502462|Clinical course and prognostic factors in patients with severe isolated TR|clinical course and prognostic factors in patients with severe isolated tr
337355|NCT01502449|telemedicine, telephonic, PTSD|telemedicine, telephonic, ptsd
337356|NCT01502436|posttraumatic stress disorder|posttraumatic stress disorder
337357|NCT01502436|traumatic brain injury|traumatic brain injury
337358|NCT01502436|Suicide Attempt|suicide attempt
337359|NCT01502436|Veterans|veterans
337360|NCT01502423|On label Humira users|on label humira users
337361|NCT01502423|Rheumatoid Arthritis|rheumatoid arthritis
337362|NCT01502423|Pain|pain
337363|NCT01502397|hepatitis B|hepatitis b
337364|NCT01502397|anti-HBc|anti-hbc
337365|NCT01502397|HBsAg|hbsag
337366|NCT01502397|rituximab|rituximab
337368|NCT01502384|healthy 1st degree relatives of pd patients|healthy 1st degree relatives of pd patients
337369|NCT01502371|Asthma|asthma
337370|NCT01502371|Children|children
337371|NCT01502371|Persistent|persistent
337372|NCT01502358|dengue|dengue
337373|NCT01502358|dengue fever|dengue fever
337374|NCT01502358|dengue disease|dengue disease
337375|NCT01502358|tetravalent dengue vaccine|tetravalent dengue vaccine
337376|NCT01502358|Vaxfectin®|vaxfectin®
337377|NCT01502345|HFRS|hfrs
337378|NCT01502332|Mechanical ventilation|mechanical ventilation
337379|NCT01502332|Open lung approach|open lung approach
337380|NCT01502332|Blood gases|blood gases
337381|NCT01502332|Cardiac surgery|cardiac surgery
337382|NCT01502332|Pulmonary complications|pulmonary complications
337383|NCT01502306|Smoking cessation|smoking cessation
337384|NCT01502306|Telephone|telephone
337385|NCT01502306|Self-help|self-help
337386|NCT01502306|Smoking abstinence|smoking abstinence
337387|NCT01502306|Incentives|incentives
337388|NCT01502306|Nicotine-replacement therapy|nicotine-replacement therapy
337389|NCT01502306|Medi-Cal|medi-cal
337390|NCT01502306|Medicaid|medicaid
337391|NCT01502280|extent of resection|extent of resection
337392|NCT01502280|Glioma|glioma
337393|NCT01502280|5-ALA|5-ala
337394|NCT01502280|tumor fluorescence|tumor fluorescence
337395|NCT01502280|confocal microscopy|confocal microscopy
337396|NCT01502267|Waiting list|waiting list
337397|NCT01502267|Deceased donor kidney transplantation|deceased donor kidney transplantation
337398|NCT01502267|Desensitization|desensitization
337399|NCT01502267|anti HLA antibody|anti hla antibody
337400|NCT01502254|Informed consent|informed consent
337401|NCT01502254|Cancer clinical trials|cancer clinical trials
337402|NCT01502254|Patient information|patient information
337403|NCT01502254|Knowledge|knowledge
337404|NCT01502254|Questionnaire|questionnaire
337405|NCT01502254|Patient Eligible for a Phase II or III Cancer Clinical Trial|patient eligible for a phase ii or iii cancer clinical trial
337406|NCT01502254|Scheduled Clinical Visit for Information About a Trial|scheduled clinical visit for information about a trial
337407|NCT01502241|elderly|elderly
337408|NCT01502241|brain tumors|brain tumors
337409|NCT01502241|MGMT|mgmt
337410|NCT01502241|chemotherapy|chemotherapy
337411|NCT01502241|Newly diagnosed|newly diagnosed
337412|NCT01502241|patients > 65 years|patients > 65 years
337413|NCT01502202|lung adenocarcinoma|lung adenocarcinoma
337414|NCT01502202|never smoker|never smoker
337415|NCT01502202|1st line treatment|1st line treatment
337416|NCT01502202|Intercalation administration|intercalation administration
337417|NCT01502202|Gefitinib|gefitinib
337418|NCT01502202|never smokers|never smokers
337419|NCT01502189|patient education as topic|patient education as topic
337420|NCT01502189|representational approach|representational approach
337422|NCT01502189|childhood cancer|childhood cancer
337423|NCT01502189|paediatric oncology|paediatric oncology
337424|NCT01502189|nursing|nursing
337425|NCT01502189|parents of children with cancer|parents of children with cancer
337426|NCT01502189|Stress|stress
337427|NCT01502189|Health Knowledge|health knowledge
337428|NCT01502189|Attitudes|attitudes
337429|NCT01502189|Practice|practice
337430|NCT01502176|atrial fibrillation|atrial fibrillation
337431|NCT01502176|registry|registry
337432|NCT01502163|perioperative hypothermia|perioperative hypothermia
337433|NCT01502163|prewarming|prewarming
337434|NCT01502163|forced air warming|forced air warming
337435|NCT01502163|insulation|insulation
337436|NCT01502150|Pediatric Cancer|pediatric cancer
337437|NCT01502150|Proton Radiation Therapy|proton radiation therapy
337438|NCT01502150|Proton beam radiotherapy|proton beam radiotherapy
337440|NCT01502150|Data Collection|data collection
337441|NCT01502150|Database|database
337442|NCT01502150|Acute and late normal tissue toxicities|acute and late normal tissue toxicities
337443|NCT01502150|Dosimetric data|dosimetric data
337444|NCT01502150|Toxicity data|toxicity data
337445|NCT01502111|decreased level of consciousness|decreased level of consciousness
337446|NCT01502111|hypoxemia|hypoxemia
337447|NCT01502111|ineffective ventilation|ineffective ventilation
337448|NCT01502111|airway obstruction|airway obstruction
337449|NCT01502111|combative or unresponsive|combative or unresponsive
337450|NCT01502111|relief of pain or distress|relief of pain or distress
337451|NCT01502111|cardiopulmonary arrest|cardiopulmonary arrest
337452|NCT01502085|multiple myeloma lenalidomide|multiple myeloma lenalidomide
337453|NCT01502072|Ribavirin|ribavirin
337454|NCT01502072|Ribavirin Aerosol|ribavirin aerosol
337455|NCT01502072|Respiratory Syncytial Virus|respiratory syncytial virus
337456|NCT01502072|RSV|rsv
337457|NCT01502072|upper respiratory tract infection|upper respiratory tract infection
337458|NCT01502072|URI|uri
337459|NCT01502072|Lower respiratory tract Infection|lower respiratory tract infection
337460|NCT01502072|LRI|lri
337461|NCT01502072|pneumonia|pneumonia
337462|NCT01502072|aerosolized ribavirin|aerosolized ribavirin
337463|NCT01502072|HSCT|hsct
337464|NCT01502072|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
337465|NCT01502072|oral ribavirin therapy|oral ribavirin therapy
337466|NCT01502059|Pilates|pilates
337467|NCT01502059|Exercise|exercise
337469|NCT01502059|Low back pain|low back pain
337470|NCT01502059|Pain|pain
337471|NCT01502059|Function|function
337472|NCT01502046|Huntington's disease, cannabinoids|huntington's disease, cannabinoids
337473|NCT01502033|Adolescent Depression|adolescent depression
337474|NCT01502033|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
337475|NCT01502020|actinic keratoses|actinic keratoses
337476|NCT01502020|actinic keratosis|actinic keratosis
337477|NCT01502020|imiquimod, 3.75%|imiquimod, 3.75%
337478|NCT01502020|imiquimod|imiquimod
337479|NCT01502020|Zyclara|zyclara
337605|NCT01501526|dysphagia|dysphagia
337480|NCT01502020|Actinic keratoses of the face or balding scalp|actinic keratoses of the face or balding scalp
337481|NCT01502007|Activity Level|activity level
337482|NCT01502007|Overweight|overweight
337483|NCT01502007|Obesity|obesity
337484|NCT01501994|Activity level|activity level
337485|NCT01501994|Weight|weight
337486|NCT01501994|Body Fat|body fat
337487|NCT01501994|Well Being|well being
337488|NCT01501981|heart failure|heart failure
337489|NCT01501981|MR-proANP|mr-proanp
337490|NCT01501981|MR-proADM|mr-proadm
337491|NCT01501981|decompensation|decompensation
337492|NCT01501981|Copeptin|copeptin
337493|NCT01501981|CT-proET1|ct-proet1
337494|NCT01501981|NT-proBNP|nt-probnp
337495|NCT01501968|Colistin|colistin
337496|NCT01501968|ascorbic acid|ascorbic acid
337497|NCT01501968|renal toxicity|renal toxicity
337498|NCT01501955|Osteoarthritis|osteoarthritis
337499|NCT01501942|Asthma|asthma
337500|NCT01501942|Allergen induced asthma|allergen induced asthma
337501|NCT01501942|ATS Criteria (1)|ats criteria (1)
337502|NCT01501929|hypertension|hypertension
337503|NCT01501929|blood pressure|blood pressure
337504|NCT01501929|blood pressure medications|blood pressure medications
337505|NCT01501929|metoprolol|metoprolol
337506|NCT01501929|nebivolol|nebivolol
337507|NCT01501929|vascular oxidative stress|vascular oxidative stress
337508|NCT01501929|nitric oxide|nitric oxide
337509|NCT01501929|nitric oxide synthase (eNOS)|nitric oxide synthase (enos)
337510|NCT01501929|endothelium|endothelium
337511|NCT01501929|endothelial dysfunction|endothelial dysfunction
337512|NCT01501929|endothelial cell protein expression|endothelial cell protein expression
337513|NCT01501929|microvascular blood flow|microvascular blood flow
337514|NCT01501929|flow mediated dilation|flow mediated dilation
337515|NCT01501929|handgrip exercise|handgrip exercise
337516|NCT01501929|endothelial cell collection|endothelial cell collection
337517|NCT01501929|microbubbles|microbubbles
337518|NCT01501929|Definity|definity
337519|NCT01501890|Threatened Abortion|threatened abortion
337520|NCT01501890|Progesterone|progesterone
337521|NCT01501890|Subchorionic Hematoma|subchorionic hematoma
337522|NCT01501890|Pre-Eclampsia|pre-eclampsia
337523|NCT01501890|Abruptio Placentae|abruptio placentae
337524|NCT01501890|Fetal Growth Retardation|fetal growth retardation
337525|NCT01501890|Premature Birth|premature birth
337527|NCT01501877|Type 2 Diabetes|type 2 diabetes
337528|NCT01501877|Smoking cessation|smoking cessation
337529|NCT01501864|HIV prevention|hiv prevention
337530|NCT01501864|HSV-2|hsv-2
337531|NCT01501864|Schooling|schooling
337532|NCT01501864|Kenya|kenya
337533|NCT01501864|Orphans|orphans
337534|NCT01501864|School support|school support
337535|NCT01501799|acne|acne
337536|NCT01501799|adapalene/benzoyl peroxide|adapalene/benzoyl peroxide
337537|NCT01501799|Epiduo|epiduo
337538|NCT01501799|Mild to severe acne vulgaris|mild to severe acne vulgaris
337539|NCT01501786|children|children
337540|NCT01501786|sedation|sedation
337541|NCT01501786|propofol|propofol
337542|NCT01501786|ketamine|ketamine
337543|NCT01501773|Acute ischemic stroke|acute ischemic stroke
337544|NCT01501747|Placebo effect|placebo effect
337545|NCT01501747|drug half life|drug half life
337546|NCT01501747|pharmacokinetics|pharmacokinetics
337548|NCT01501734|watch-pat|watch-pat
337549|NCT01501734|embletta x|embletta x
337550|NCT01501734|endothelial function|endothelial function
337551|NCT01501721|prevention|prevention
337552|NCT01501721|workers|workers
337553|NCT01501721|clinical trials|clinical trials
337554|NCT01501721|obesity|obesity
337555|NCT01501708|caspofungin|caspofungin
337556|NCT01501708|IFI|ifi
337557|NCT01501708|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
337558|NCT01501695|tic disorder|tic disorder
337559|NCT01501695|pediatric|pediatric
337560|NCT01501682|ventralex|ventralex
337561|NCT01501682|ventral hernia|ventral hernia
337562|NCT01501669|irinotecan|irinotecan
337563|NCT01501669|capecitabine|capecitabine
337564|NCT01501669|metastatic breast cancer|metastatic breast cancer
337565|NCT01501643|Non invasive positive pressure ventilation|non invasive positive pressure ventilation
337566|NCT01501643|Spirometry|spirometry
337567|NCT01501643|Acute chest syndrome|acute chest syndrome
337568|NCT01501643|Sickle cell disease|sickle cell disease
337569|NCT01501643|Vaso-occlusive crisis|vaso-occlusive crisis
337570|NCT01501630|Comparison of imaging modalities|comparison of imaging modalities
337571|NCT01501630|Impact on patient management|impact on patient management
337572|NCT01501630|Optimisation of cost of the diagnostic strategy|optimisation of cost of the diagnostic strategy
337573|NCT01501617|Hair Loss|hair loss
337574|NCT01501617|Androgenetic Alopecia|androgenetic alopecia
337575|NCT01501617|Baldness|baldness
337576|NCT01501617|Male pattern baldness|male pattern baldness
337577|NCT01501617|Male pattern hair loss|male pattern hair loss
337578|NCT01501617|Hair Regrowth|hair regrowth
337579|NCT01501617|Alopecia|alopecia
337580|NCT01501617|Hair growth|hair growth
337581|NCT01501617|Regrow Hair|regrow hair
337582|NCT01501604|PIK3CA mutation|pik3ca mutation
337583|NCT01501604|Advanced solid tumors|advanced solid tumors
337584|NCT01501591|Placebo effect|placebo effect
337585|NCT01501591|placebo drug interaction|placebo drug interaction
337586|NCT01501591|placebo -controlled clinical trials|placebo -controlled clinical trials
337587|NCT01501578|Pulmonary fibrosis|pulmonary fibrosis
337588|NCT01501578|Telomerase mutation|telomerase mutation
337589|NCT01501565|Postoperative pain|postoperative pain
337590|NCT01501565|Transverse abdominal blockade|transverse abdominal blockade
337591|NCT01501565|Efficacy|efficacy
337592|NCT01501565|Safety|safety
337593|NCT01501565|Urology|urology
337594|NCT01501552|Primary health care|primary health care
751927|NCT01171261|Sedentary Behavior|sedentary behavior
337595|NCT01501552|Identification and Brief Intervention Programmes|identification and brief intervention programmes
337596|NCT01501552|Hazardous and harmful alcohol consumption|hazardous and harmful alcohol consumption
337597|NCT01501539|Hypergranulation tissue|hypergranulation tissue
337598|NCT01501539|Gastrostomy tube|gastrostomy tube
337599|NCT01501539|Hydrocolloid dressing|hydrocolloid dressing
337600|NCT01501539|Silver hydrocolloid dressing|silver hydrocolloid dressing
337601|NCT01501539|Gastrostomy tube dislodgement|gastrostomy tube dislodgement
337602|NCT01501539|Wound infection|wound infection
337603|NCT01501539|Peristomal skin breakdown|peristomal skin breakdown
337604|NCT01501526|herpes esophagitis|herpes esophagitis
337606|NCT01501526|vocal fold palsy|vocal fold palsy
337607|NCT01501526|immunocompetent|immunocompetent
337608|NCT01501526|husky voice|husky voice
337609|NCT01501513|colonoscopy|colonoscopy
337610|NCT01501513|bowel preparation|bowel preparation
337611|NCT01501513|endoscopy|endoscopy
337612|NCT01501500|botulinum toxin type A|botulinum toxin type a
337613|NCT01501500|hallux valgus angle|hallux valgus angle
337614|NCT01501500|foot function index|foot function index
337615|NCT01501500|VAS pain scale|vas pain scale
337616|NCT01501487|breast cancer|breast cancer
337617|NCT01501487|neo adjuvant therapy|neo adjuvant therapy
337618|NCT01501474|Confocal|confocal
337619|NCT01501474|malignant biliary stricture|malignant biliary stricture
337620|NCT01501474|Sensitivity, specificity and accuracy of CholangioFlex in malignant biliary stricture diagnosis|sensitivity, specificity and accuracy of cholangioflex in malignant biliary stricture diagnosis
337621|NCT01501474|sensitivity, specificity and accuracy of Fluorescent in situ Hybridization(FISH) in malignant biliary stricture diagnosis|sensitivity, specificity and accuracy of fluorescent in situ hybridization(fish) in malignant biliary stricture diagnosis
337623|NCT01501435|Pharmacokinetics|pharmacokinetics
337624|NCT01501422|postmenopause|postmenopause
337625|NCT01501422|sleep quality|sleep quality
337626|NCT01501422|estrogen|estrogen
337627|NCT01501422|objective sleep quality|objective sleep quality
337628|NCT01501422|actigraph|actigraph
337629|NCT01501409|Sodium lauryl sulfate (SLS)|sodium lauryl sulfate (sls)
337630|NCT01501409|recurrent aphthous stomatitis (RAS)|recurrent aphthous stomatitis (ras)
337631|NCT01501409|dentifrice|dentifrice
337632|NCT01501409|pain|pain
337633|NCT01501370|Myeloma|myeloma
337634|NCT01501370|Biochemical relapse|biochemical relapse
337635|NCT01501357|caries|caries
337636|NCT01501357|primary molars|primary molars
337637|NCT01501357|plaque|plaque
337638|NCT01501357|toothbrushing|toothbrushing
337639|NCT01501344|osteoporosis|osteoporosis
337640|NCT01501344|postmenopausal women|postmenopausal women
337641|NCT01501344|bone remodelling|bone remodelling
337642|NCT01501344|bone turnover markers|bone turnover markers
337643|NCT01501331|Congestive Heart Failure|congestive heart failure
337644|NCT01501331|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
337645|NCT01501331|Internal Cardioverter Defibrillators|internal cardioverter defibrillators
337646|NCT01501318|SBIRT|sbirt
337647|NCT01501318|brief intervention|brief intervention
337648|NCT01501318|alcohol|alcohol
337649|NCT01501318|drug abuse|drug abuse
337650|NCT01501305|influence|influence
337651|NCT01501305|carob powder|carob powder
337652|NCT01501305|probiotics|probiotics
337653|NCT01501305|duration|duration
337654|NCT01501279|pudendal nerve block|pudendal nerve block
337655|NCT01501279|postoperative pain|postoperative pain
337656|NCT01501279|bladder spasm|bladder spasm
337657|NCT01501266|postmenopausal breast cancer|postmenopausal breast cancer
337658|NCT01501266|Faslodex|faslodex
337659|NCT01501266|cohort|cohort
337660|NCT01501253|CKD-828|ckd-828
337661|NCT01501253|Hypertension|hypertension
337662|NCT01501253|Primary Hypertension|primary hypertension
337663|NCT01501253|S-Amlodipine|s-amlodipine
337664|NCT01501253|Telmisartan|telmisartan
337665|NCT01501253|Non-Responder|non-responder
338260|NCT01498614|anxiety|anxiety
337666|NCT01501240|Magnetic resonance image|magnetic resonance image
337667|NCT01501240|gadoxetic acid|gadoxetic acid
337668|NCT01501240|hepatocellular carcinoma|hepatocellular carcinoma
337669|NCT01501240|liver cirrhosis|liver cirrhosis
337670|NCT01501227|ventilator associated pneumonia|ventilator associated pneumonia
337671|NCT01501214|atosiban|atosiban
337672|NCT01501214|in vitro fertilization|in vitro fertilization
337673|NCT01501214|subfertility|subfertility
337674|NCT01501201|Obesity|obesity
337675|NCT01501201|Diabetes|diabetes
337676|NCT01501201|Bariatric Surgery|bariatric surgery
337677|NCT01501188|Chronic Venous Insufficiency|chronic venous insufficiency
337678|NCT01501188|Kinesio Taping|kinesio taping
337679|NCT01501188|Electromyography|electromyography
337680|NCT01501188|Range of ankle motion|range of ankle motion
337681|NCT01501175|superficial vein thrombosis|superficial vein thrombosis
337682|NCT01501175|Saint Etienne region|saint etienne region
337683|NCT01501162|hepatitis, alcohol|hepatitis, alcohol
337684|NCT01501149|NK/T cell lymphoma|nk/t cell lymphoma
337685|NCT01501149|chemotherapy|chemotherapy
337686|NCT01501149|clinical trial|clinical trial
337688|NCT01501149|PFS|pfs
337689|NCT01501149|OS|os
337690|NCT01501136|NK/T cell lymphoma|nk/t cell lymphoma
337691|NCT01501136|chemotherapy|chemotherapy
337692|NCT01501136|clinical trial|clinical trial
337693|NCT01501136|RR|rr
337694|NCT01501136|PFS|pfs
337695|NCT01501136|OS|os
337696|NCT01501123|Time to sedation of agitated patients|time to sedation of agitated patients
337697|NCT01501110|Euthyroid Sick Syndrome|euthyroid sick syndrome
337698|NCT01501110|low T3 syndrome|low t3 syndrome
337699|NCT01501110|deiodases|deiodases
337700|NCT01501110|oxidative stress|oxidative stress
337701|NCT01501110|ischemic heart disease|ischemic heart disease
337702|NCT01501084|functional MRI|functional mri
337703|NCT01501084|Structural MRI|structural mri
337704|NCT01501084|obesity|obesity
337705|NCT01501084|resting state networks|resting state networks
337706|NCT01501071|Laparoscopic Nissen fundoplication|laparoscopic nissen fundoplication
337707|NCT01501071|Esophageal calibration|esophageal calibration
337708|NCT01501071|Postoperative dysphagia|postoperative dysphagia
337709|NCT01501045|TMS|tms
337710|NCT01501045|CPM|cpm
337711|NCT01501045|headache|headache
337712|NCT01501045|migraine|migraine
337713|NCT01501045|EEG|eeg
337714|NCT01501045|psychophysics|psychophysics
337715|NCT01501032|Diabetes Type 1|diabetes type 1
337716|NCT01501032|Artificial Pancreas|artificial pancreas
337717|NCT01501006|Physicians|physicians
337718|NCT01500993|Rectal cancer|rectal cancer
337719|NCT01500993|Chemoradiotherapy|chemoradiotherapy
337720|NCT01500993|Capecitabine|capecitabine
337721|NCT01500993|phase-III trial|phase-iii trial
337722|NCT01500980|malaria|malaria
337723|NCT01500980|challenge|challenge
337724|NCT01500980|P. falciparum|p. falciparum
337725|NCT01500980|prevention|prevention
337726|NCT01500928|Insulin Pump|insulin pump
337727|NCT01500928|Glycemic Control|glycemic control
337728|NCT01500928|Type 1 Diabetes|type 1 diabetes
337729|NCT01500915|AMD|amd
337730|NCT01500915|ranibizumab|ranibizumab
337731|NCT01500915|antiVEGF|antivegf
337732|NCT01500915|regimen of injections|regimen of injections
337733|NCT01500915|anti VEGF regimen|anti vegf regimen
337734|NCT01500915|PRN|prn
337735|NCT01500915|treat and extend|treat and extend
337736|NCT01500902|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
337737|NCT01500902|Percutaneous Intervention (PCI)|percutaneous intervention (pci)
337738|NCT01500902|Coronary Stent (CStent)|coronary stent (cstent)
337739|NCT01500902|Percutaneous Transluminal Coronary Angioplasty (PTCA)|percutaneous transluminal coronary angioplasty (ptca)
337840|NCT01500538|lymphoma|lymphoma
337740|NCT01500902|stent placement|stent placement
337741|NCT01500902|balloon angioplasty|balloon angioplasty
337742|NCT01500889|Anal fissure|anal fissure
337743|NCT01500889|Advancement flap|advancement flap
337744|NCT01500889|Internal sphincterotomy|internal sphincterotomy
337745|NCT01500876|lung cancer|lung cancer
337746|NCT01500863|endometrial receptivity|endometrial receptivity
337747|NCT01500863|gene arrays|gene arrays
337748|NCT01500863|agonist triggering|agonist triggering
337749|NCT01500863|Endometrial gene expression|endometrial gene expression
337750|NCT01500863|OHSS|ohss
337751|NCT01500850|Type 2 Diabetes mellitus|type 2 diabetes mellitus
337752|NCT01500850|NPH insulin|nph insulin
337753|NCT01500850|Insulin Glargine|insulin glargine
337754|NCT01500850|cardiovascular biomarkers|cardiovascular biomarkers
337755|NCT01500850|hsCRP, adiponectin|hscrp, adiponectin
337756|NCT01500850|intact proinsulin|intact proinsulin
337757|NCT01500850|cardiovascular risk|cardiovascular risk
337758|NCT01500837|Staphylococcus aureus|staphylococcus aureus
337759|NCT01500837|osteoarticular infection|osteoarticular infection
337760|NCT01500837|clindamycin|clindamycin
337761|NCT01500837|serum concentration|serum concentration
337762|NCT01500837|orthopedic surgery|orthopedic surgery
337763|NCT01500824|Crizotinib|crizotinib
337764|NCT01500824|ALK|alk
337765|NCT01500824|NSCLC|nsclc
337766|NCT01500824|Non-Small Cell Lung Cancer|non-small cell lung cancer
337767|NCT01500824|Asian|asian
337768|NCT01500811|chondrocyte hip osteoarthritis intra articular injection|chondrocyte hip osteoarthritis intra articular injection
337769|NCT01500772|Hepatitis C|hepatitis c
337770|NCT01500772|PI treatment failure|pi treatment failure
337771|NCT01500759|chronic heart failure|chronic heart failure
337772|NCT01500759|heart failure|heart failure
337773|NCT01500759|hf|hf
337774|NCT01500759|sleep-disordered breathing|sleep-disordered breathing
337775|NCT01500759|sdb|sdb
337776|NCT01500759|nyha|nyha
337777|NCT01500759|lvef|lvef
337778|NCT01500759|cheyne stokes|cheyne stokes
337779|NCT01500759|central sleep apnoea|central sleep apnoea
337780|NCT01500759|sleep apnoea|sleep apnoea
337781|NCT01500746|chronic wound treatment|chronic wound treatment
337782|NCT01500746|pulse lavage|pulse lavage
337783|NCT01500746|serial pulse lavage|serial pulse lavage
337784|NCT01500746|wounds|wounds
337785|NCT01500746|bacterial colonization of wounds|bacterial colonization of wounds
337786|NCT01500733|Treatment|treatment
337787|NCT01500733|CLL (Chronic Lymphocytic Leukemia)|cll (chronic lymphocytic leukemia)
337788|NCT01500733|SLL (Small Lymphocytic Lymphoma)|sll (small lymphocytic lymphoma)
337789|NCT01500733|Leukemia|leukemia
337790|NCT01500733|Lymphocytic Leukemia|lymphocytic leukemia
751928|NCT01171261|Video Games|video games
337791|NCT01500733|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
337792|NCT01500733|CLL|cll
337793|NCT01500733|Small Lymphocytic Leukemia|small lymphocytic leukemia
337794|NCT01500733|SLL|sll
337795|NCT01500668|Botox|botox
337796|NCT01500668|catocholamine|catocholamine
337797|NCT01500668|shock|shock
337798|NCT01500668|vasomotor|vasomotor
337799|NCT01500668|Vasopressin|vasopressin
337800|NCT01500668|botulinum toxin|botulinum toxin
337801|NCT01500655|burn|burn
337802|NCT01500655|skin graft donor site|skin graft donor site
337803|NCT01500655|analgesia for donor site|analgesia for donor site
337804|NCT01500629|Allergic Rhinitis|allergic rhinitis
337805|NCT01500629|Hayfever|hayfever
337806|NCT01500629|Pollen Allergy|pollen allergy
337807|NCT01500616|Chronic Hepatitis C Infection|chronic hepatitis c infection
337808|NCT01500616|Chronic Hepatitis C Co-Infected Patients|chronic hepatitis c co-infected patients
337809|NCT01500616|Hepatitis C|hepatitis c
337810|NCT01500616|Severe Fibrosis|severe fibrosis
337811|NCT01500616|Compensated Cirrhosis|compensated cirrhosis
337812|NCT01500616|VX-950HPC3005|vx-950hpc3005
337813|NCT01500603|post-radical prostatectomy|post-radical prostatectomy
337814|NCT01500603|stress urinary incontinence|stress urinary incontinence
337815|NCT01500603|periurethral Pro-ACT balloons|periurethral pro-act balloons
337816|NCT01500603|AdvanceXP retrourethral male sling|advancexp retrourethral male sling
337817|NCT01500590|Diabetes|diabetes
337818|NCT01500590|hypertensive|hypertensive
337819|NCT01500590|without albuminuria|without albuminuria
337820|NCT01500577|Prevention|prevention
337821|NCT01500577|Breast Cancer|breast cancer
337822|NCT01500577|Proliferation|proliferation
337823|NCT01500577|Breast Cancer Prevention|breast cancer prevention
337824|NCT01500564|Stroke|stroke
337825|NCT01500564|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
337826|NCT01500564|motor function|motor function
337827|NCT01500551|Arthritis|arthritis
337828|NCT01500551|Pediatric|pediatric
337829|NCT01500551|Tofacitinib|tofacitinib
337830|NCT01500551|Long-term|long-term
337831|NCT01500551|JIA|jia
337832|NCT01500551|CP-690,550|cp-690,550
337833|NCT01500551|Xeljanz|xeljanz
337834|NCT01500538|Follicular lymphoma|follicular lymphoma
337835|NCT01500538|Marginal zone lymphoma|marginal zone lymphoma
337836|NCT01500538|Mantle cell lymphoma|mantle cell lymphoma
337837|NCT01500538|thrombocytopenia|thrombocytopenia
337838|NCT01500538|eltrombopag|eltrombopag
337839|NCT01500538|vorinostat|vorinostat
337841|NCT01500525|asthma|asthma
337842|NCT01500525|children|children
337843|NCT01500525|accuracy of bronchodilator response|accuracy of bronchodilator response
337844|NCT01500499|adult acute myeloid leukemia|adult acute myeloid leukemia
337845|NCT01500499|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
337846|NCT01500447|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
337847|NCT01500447|Kallmann Syndrome|kallmann syndrome
337848|NCT01500447|Delayed Puberty|delayed puberty
337849|NCT01500447|Infertility|infertility
337850|NCT01500447|Hypothalamic Amenorrhea|hypothalamic amenorrhea
337851|NCT01500447|Early Puberty|early puberty
337852|NCT01500447|Late Puberty|late puberty
337853|NCT01500447|Hypogonadism|hypogonadism
337854|NCT01500447|Amenorrhea|amenorrhea
337855|NCT01500447|Endocrine Diseases|endocrine diseases
337856|NCT01500434|drug-eluting stents|drug-eluting stents
337858|NCT01500434|atherosclerotic|atherosclerotic
337859|NCT01500421|Hypothermia, Induced|hypothermia, induced
337860|NCT01500395|Aortic Diseases|aortic diseases
337861|NCT01500395|Vascular Diseases|vascular diseases
337862|NCT01500395|Cardiovascular Diseases|cardiovascular diseases
337863|NCT01500395|Treatment Outcome|treatment outcome
337864|NCT01500395|Aorta Dissection|aorta dissection
337865|NCT01500395|Aorta Aneurysm|aorta aneurysm
337866|NCT01500395|Aorta pseudoaneurysm|aorta pseudoaneurysm
337867|NCT01500395|Endovascular aortic repair|endovascular aortic repair
337868|NCT01500395|Hybrid operation|hybrid operation
337869|NCT01500395|Debranching|debranching
337870|NCT01500369|atrial fibrillation|atrial fibrillation
337871|NCT01500369|remote ischemic conditioning|remote ischemic conditioning
337872|NCT01500356|cardiovascular disease|cardiovascular disease
337873|NCT01500356|obesity|obesity
337874|NCT01500356|exercise|exercise
337875|NCT01500343|heart failure|heart failure
337876|NCT01500343|probiotics|probiotics
337877|NCT01500343|Saccharomyces boulardii|saccharomyces boulardii
337878|NCT01500343|cardio-intestinal syndrome|cardio-intestinal syndrome
337879|NCT01500343|gut|gut
337880|NCT01500343|inflammation|inflammation
337881|NCT01500317|tapentadol|tapentadol
337882|NCT01500317|oxycodone|oxycodone
337883|NCT01500317|mu-opiate|mu-opiate
337884|NCT01500317|stomach|stomach
337885|NCT01500317|small intestine|small intestine
337886|NCT01500317|colon|colon
337887|NCT01500317|motility|motility
337888|NCT01500317|nausea|nausea
337889|NCT01500317|constipation|constipation
337890|NCT01500304|Melanoma|melanoma
337891|NCT01500304|Lymph Nodes|lymph nodes
337892|NCT01500304|Lymph Node Dissection|lymph node dissection
337893|NCT01500304|Minimally invasive|minimally invasive
337894|NCT01500291|anesthesia stress|anesthesia stress
337895|NCT01500278|Certolizumab Pegol|certolizumab pegol
337896|NCT01500278|Cimzia|cimzia
337897|NCT01500278|Adalimumab|adalimumab
337898|NCT01500278|Humira|humira
337899|NCT01500278|Rheumatoid Arthritis|rheumatoid arthritis
337900|NCT01500265|hepatitis B virus|hepatitis b virus
337901|NCT01500265|early screening tools|early screening tools
337902|NCT01500265|renal proximal tubular tolerance|renal proximal tubular tolerance
337903|NCT01500252|Total Knee Replacement|total knee replacement
337904|NCT01500252|Patellar Resurfacing|patellar resurfacing
337905|NCT01500252|Health Related Quality of Life|health related quality of life
337906|NCT01500226|Rolapitant|rolapitant
337907|NCT01500226|Nausea|nausea
337908|NCT01500226|Vomiting|vomiting
337909|NCT01500226|CINV|cinv
337910|NCT01500226|Chemotherapy|chemotherapy
337911|NCT01500213|Rolapitant|rolapitant
337912|NCT01500213|Nausea|nausea
337913|NCT01500213|Vomiting|vomiting
337914|NCT01500213|CINV|cinv
337915|NCT01500213|Chemotherapy|chemotherapy
337916|NCT01500187|white spot lesions|white spot lesions
337917|NCT01500187|fixed orthodontic brackets|fixed orthodontic brackets
337918|NCT01500187|fluoride varnish|fluoride varnish
337919|NCT01500187|fluoride gel|fluoride gel
337920|NCT01500174|skin|skin
337921|NCT01500174|decubitus|decubitus
337922|NCT01500174|pressure|pressure
337923|NCT01500174|sore|sore
337924|NCT01500174|spinal cord injury|spinal cord injury
337925|NCT01500161|Leukemia|leukemia
337926|NCT01500161|Lymphoma|lymphoma
337927|NCT01500161|Myeloma|myeloma
337928|NCT01500161|Aplastic Anemia|aplastic anemia
337929|NCT01500161|Myelodysplasia|myelodysplasia
337931|NCT01500161|ALL|all
337932|NCT01500161|CLL|cll
337933|NCT01500161|CML|cml
337934|NCT01500148|Mitral Valve Prolapse|mitral valve prolapse
337935|NCT01500148|Mitral Valve Disease|mitral valve disease
337936|NCT01500148|Mitral Valve Regurgitation|mitral valve regurgitation
337937|NCT01500148|Mitral Valve Insufficiency|mitral valve insufficiency
337938|NCT01500148|Mitral Valve Incompetence|mitral valve incompetence
337939|NCT01500148|Percutaneous Mitral Valve Repair|percutaneous mitral valve repair
337940|NCT01500148|Posterior leaflet prolapse|posterior leaflet prolapse
337941|NCT01500148|Mitral valve degeneration|mitral valve degeneration
337942|NCT01500135|Vascular Surgery|vascular surgery
337943|NCT01500135|Secondary treatment of needle hole bleeding|secondary treatment of needle hole bleeding
337944|NCT01500135|Subjects undergoing vascular surgery and who need supportive treatment in order to control bleeding|subjects undergoing vascular surgery and who need supportive treatment in order to control bleeding
337945|NCT01500109|cleft palate surgery|cleft palate surgery
337946|NCT01500109|post-operative pain management|post-operative pain management
337947|NCT01500109|Acetaminophen|acetaminophen
337948|NCT01500096|Fatigue|fatigue
337949|NCT01500096|HIV/AIDS|hiv/aids
337950|NCT01500096|American ginseng|american ginseng
337951|NCT01500096|Panax quinquefolius|panax quinquefolius
337952|NCT01500096|Fatigue Severity Scale|fatigue severity scale
337953|NCT01500096|CD4 count|cd4 count
337954|NCT01500096|plasma HIV RNA|plasma hiv rna
337955|NCT01500096|cytokines|cytokines
337956|NCT01500096|IL-6|il-6
337957|NCT01500096|sTNFR1|stnfr1
337958|NCT01500096|sTNFR2|stnfr2
337959|NCT01500083|iNHL|inhl
337960|NCT01500083|CLL|cll
337961|NCT01500070|Peripheral Arterial Disease|peripheral arterial disease
337962|NCT01500070|Claudication|claudication
337963|NCT01500070|Drug-Eluting Stent|drug-eluting stent
337964|NCT01500070|BTK|btk
337965|NCT01500070|Everolimus|everolimus
337966|NCT01500070|CLI|cli
337967|NCT01500057|enlarged prostate|enlarged prostate
337968|NCT01500044|Radiculopathy|radiculopathy
337969|NCT01500044|Rehabilitation|rehabilitation
337970|NCT01500044|Mobilization|mobilization
337971|NCT01500044|Exercise|exercise
337972|NCT01500044|Physical Therapy|physical therapy
337973|NCT01500018|Phase I|phase i
337974|NCT01500018|healthy recreational polydrug users|healthy recreational polydrug users
337975|NCT01500018|abuse liability|abuse liability
337976|NCT01500018|TC-5214|tc-5214
337977|NCT01500018|Single dose crossover study to evaluate the abuse potential of TC-5214|single dose crossover study to evaluate the abuse potential of tc-5214
337978|NCT01499992|Shoulder rehabilitation|shoulder rehabilitation
337979|NCT01499992|Rotator cuff tear|rotator cuff tear
337980|NCT01499992|Physiotherapy|physiotherapy
337981|NCT01499992|aqua therapy|aqua therapy
337982|NCT01499992|Therapy dosage|therapy dosage
337983|NCT01499992|adjunctive aquatic physical therapy|adjunctive aquatic physical therapy
337984|NCT01499979|Ischemia-reperfusion injury|ischemia-reperfusion injury
337985|NCT01499979|In situ hypothermic perfusion|in situ hypothermic perfusion
337986|NCT01499979|In situ hypothermic preservation|in situ hypothermic preservation
337987|NCT01499966|Lateral Ankle Sprain|lateral ankle sprain
337988|NCT01499966|Plaster of Paris|plaster of paris
337989|NCT01499966|Tubigrip|tubigrip
337990|NCT01499953|superficial vein thrombosis|superficial vein thrombosis
337991|NCT01499953|thrombosis|thrombosis
337992|NCT01499953|SVT|svt
337993|NCT01499940|peripheral neuropathy|peripheral neuropathy
337994|NCT01499940|vitamin D status|vitamin d status
337995|NCT01499940|oxaliplatin|oxaliplatin
337996|NCT01499927|Early reassessment of intravenous antiinfective therapy|early reassessment of intravenous antiinfective therapy
337997|NCT01499914|vaccination H1N1|vaccination h1n1
337998|NCT01499914|cystic fibrosis|cystic fibrosis
337999|NCT01499901|deafness|deafness
338000|NCT01499901|unilateral implantation|unilateral implantation
338001|NCT01499901|bilateral|bilateral
338002|NCT01499901|auditory perception|auditory perception
338003|NCT01499888|Sickle Cell Disease|sickle cell disease
338004|NCT01499888|Subtype Hgb SS|subtype hgb ss
338005|NCT01499888|Subtype Hgb SC|subtype hgb sc
338006|NCT01499888|Subtype Hgb SB|subtype hgb sb
338007|NCT01499888|Chronic Transfusion Therapy|chronic transfusion therapy
338008|NCT01499888|Prior Stroke|prior stroke
338009|NCT01499888|Allogeneic|allogeneic
338010|NCT01499888|Stem Cell Transplantation|stem cell transplantation
338011|NCT01499888|Alemtuzumab|alemtuzumab
338012|NCT01499888|Sirolimus|sirolimus
338013|NCT01499888|Total Body Irradiation|total body irradiation
338014|NCT01499888|Hydroxyurea Intolerant|hydroxyurea intolerant
338015|NCT01499875|Pharmacokinetic|pharmacokinetic
338016|NCT01499875|Pharmacodynamic|pharmacodynamic
338017|NCT01499875|Phenoxymethylpenicillin|phenoxymethylpenicillin
338018|NCT01499875|Children|children
338019|NCT01499862|Stroke|stroke
338020|NCT01499862|Tibion|tibion
338021|NCT01499862|Bionics|bionics
338022|NCT01499862|Rehab|rehab
338023|NCT01499862|Therapy|therapy
338024|NCT01499862|Robotics|robotics
338025|NCT01499862|Intention|intention
338026|NCT01499849|Rolapitant|rolapitant
338027|NCT01499849|Nausea|nausea
338028|NCT01499849|Vomiting|vomiting
338029|NCT01499849|CINV|cinv
338030|NCT01499849|Chemotherapy|chemotherapy
338031|NCT01499823|Permeability Map|permeability map
338032|NCT01499823|High-Grade Glioma|high-grade glioma
338033|NCT01499810|Hypertension|hypertension
338034|NCT01499810|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
338035|NCT01499810|Renal Artery|renal artery
338036|NCT01499810|Sympathetic Nerve Block|sympathetic nerve block
338037|NCT01499797|frailty|frailty
338038|NCT01499797|frail elders|frail elders
338039|NCT01499797|multicomponent intervention|multicomponent intervention
338040|NCT01499797|overall functioning|overall functioning
338041|NCT01499797|cost-effectiveness|cost-effectiveness
338042|NCT01499797|integrated care|integrated care
338043|NCT01499797|primary care|primary care
338044|NCT01499797|community dwelling|community dwelling
338045|NCT01499745|Idiopathic pulmonary fibrosis (IPF) patients|idiopathic pulmonary fibrosis (ipf) patients
338046|NCT01499732|Premature endothelial dysfunction|premature endothelial dysfunction
338047|NCT01499732|Early Rheumatoid Arthritis|early rheumatoid arthritis
338048|NCT01499732|established rheumatoid arthritis|established rheumatoid arthritis
338049|NCT01499732|Premature endothelial dysfunction in early rheumatoid arthritis|premature endothelial dysfunction in early rheumatoid arthritis
338050|NCT01499732|Premature endothelial dysfunction in established rheumatoid arthritis|premature endothelial dysfunction in established rheumatoid arthritis
338051|NCT01499732|Endothelial function in healthy subjects|endothelial function in healthy subjects
338052|NCT01499719|Sinusitis|sinusitis
338054|NCT01499719|Chronic|chronic
338055|NCT01499719|Sinonasal|sinonasal
338056|NCT01499706|Motivational Interviewing|motivational interviewing
338057|NCT01499706|Telephone|telephone
338059|NCT01499706|AIDS|aids
338060|NCT01499706|Older Adults|older adults
338061|NCT01499693|Proton Pump Inhibitors|proton pump inhibitors
338062|NCT01499693|gastric pH|gastric ph
338063|NCT01499680|Degenerative Lumbar Conditions|degenerative lumbar conditions
338064|NCT01499667|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
338065|NCT01499667|multiple sclerosis (MS)|multiple sclerosis (ms)
338066|NCT01499667|safety|safety
338067|NCT01499667|tolerability|tolerability
338068|NCT01499667|health outcomes|health outcomes
338070|NCT01499667|disease control|disease control
338071|NCT01499667|MRI|mri
338072|NCT01499654|SPECT MPI|spect mpi
338073|NCT01499654|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
338074|NCT01499654|Wide Beam Reconstruction|wide beam reconstruction
338075|NCT01499641|discectomy|discectomy
338076|NCT01499641|methylprednisolone|methylprednisolone
338077|NCT01499641|randomized control trial|randomized control trial
338078|NCT01499615|adverse events|adverse events
338079|NCT01499615|adverse cardiovascular events|adverse cardiovascular events
338080|NCT01499615|early warning|early warning
338081|NCT01499602|Endometrial hyperplasia,|endometrial hyperplasia,
338082|NCT01499602|LNG-IUS,|lng-ius,
338083|NCT01499602|Progestin|progestin
338084|NCT01499589|anesthesia-controlled time|anesthesia-controlled time
338085|NCT01499589|turnover time|turnover time
338086|NCT01499576|Mass Screening|mass screening
338087|NCT01499576|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
338088|NCT01499576|Stomach Neoplasms|stomach neoplasms
338089|NCT01499576|Metaplasia|metaplasia
338090|NCT01499576|Diagnosis|diagnosis
338091|NCT01499576|Acetic acid|acetic acid
338092|NCT01499576|Chromoendoscopy|chromoendoscopy
338093|NCT01499550|transnasal high flow therapy|transnasal high flow therapy
338094|NCT01499550|COPD|copd
338095|NCT01499537|Stenosis of biliary ways|stenosis of biliary ways
338096|NCT01499524|ICP, GDM|icp, gdm
338097|NCT01499511|Hypertension|hypertension
338098|NCT01499511|Mortality|mortality
338099|NCT01499511|Morbidity|morbidity
338100|NCT01499511|Coronary Heart Disease|coronary heart disease
338101|NCT01499511|Stroke|stroke
338102|NCT01499511|Diabetes|diabetes
338103|NCT01499498|Healthy volunteers|healthy volunteers
338104|NCT01499485|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
338105|NCT01499485|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
338106|NCT01499485|Alkalosis|alkalosis
338107|NCT01499485|Respiration, Artificial|respiration, artificial
338108|NCT01499485|Acetazolamide|acetazolamide
338109|NCT01499485|Intensive care|intensive care
338110|NCT01499485|Adult|adult
338111|NCT01499459|liver cirrhosis|liver cirrhosis
338112|NCT01499459|autologous mesenchymal stem cell transplantation|autologous mesenchymal stem cell transplantation
338113|NCT01499342|Stent|stent
338114|NCT01499342|Atherosclerotic occlusive disease|atherosclerotic occlusive disease
338115|NCT01499342|Peripheral arterial disease|peripheral arterial disease
338116|NCT01499342|Superficial femoral artery|superficial femoral artery
338117|NCT01499342|SFA|sfa
338118|NCT01499329|Stent therapy|stent therapy
338119|NCT01499316|Coronary artery disease|coronary artery disease
338120|NCT01499316|Fractional flow reserve|fractional flow reserve
338121|NCT01499303|lymphoma|lymphoma
338122|NCT01499303|DLBCL|dlbcl
338123|NCT01499303|fostamatinib|fostamatinib
338124|NCT01499303|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
338125|NCT01499290|Ceftazidime|ceftazidime
338126|NCT01499290|Meropenem|meropenem
338127|NCT01499290|Metronidazole|metronidazole
338128|NCT01499290|Anti-Bacterial Agents|anti-bacterial agents
338129|NCT01499290|Anti-Infective Agents|anti-infective agents
338130|NCT01499290|Antiprotozoal Agents|antiprotozoal agents
338131|NCT01499290|Antiparasitic Agents|antiparasitic agents
338132|NCT01499290|cIAI, Complicated Intra-Abdominal Infection|ciai, complicated intra-abdominal infection
338133|NCT01499277|complicated skin and soft tissue infections (cSSTI)|complicated skin and soft tissue infections (cssti)
338134|NCT01499277|skin infection|skin infection
338135|NCT01499277|ceftaroline|ceftaroline
338136|NCT01499277|wound infection|wound infection
338137|NCT01499277|cellulitis|cellulitis
338138|NCT01499277|burn infection|burn infection
338139|NCT01499277|bacterial infection|bacterial infection
338140|NCT01499277|vancomycin|vancomycin
338141|NCT01499264|MySkin patch|myskin patch
338142|NCT01499251|glioblastoma|glioblastoma
338143|NCT01499238|Efficacy|efficacy
338144|NCT01499238|safety|safety
338145|NCT01499238|nasal SIMV|nasal simv
338146|NCT01499238|nasal CPAP|nasal cpap
338147|NCT01499238|infants who are >35 gestational week with wet lung|infants who are >35 gestational week with wet lung
338148|NCT01499199|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
338149|NCT01499199|ART-naive|art-naive
338150|NCT01499199|integrase inhibitor|integrase inhibitor
338151|NCT01499199|dolutegravir|dolutegravir
338152|NCT01499199|antiretroviral therapy naive|antiretroviral therapy naive
338153|NCT01499186|Local vibration, elderly, bone, muscle, functionality|local vibration, elderly, bone, muscle, functionality
338154|NCT01499160|endocrine resistant|endocrine resistant
338155|NCT01499160|everolimus|everolimus
338156|NCT01499160|lapatinib|lapatinib
338157|NCT01499160|letrozole|letrozole
338158|NCT01499147|Acute myeloid leukemia|acute myeloid leukemia
338159|NCT01499147|First remission|first remission
338160|NCT01499147|Acute lymphocytic leukemia|acute lymphocytic leukemia
338161|NCT01499147|Acute leukemia|acute leukemia
338162|NCT01499147|Second remission|second remission
338163|NCT01499147|Early relapse|early relapse
338164|NCT01499147|Partial remission|partial remission
338165|NCT01499147|Accelerated phase|accelerated phase
338466|NCT01497821|Open-label|open-label
338166|NCT01499147|Blast-crisis|blast-crisis
338167|NCT01499147|Chronic myelogenous leukemia|chronic myelogenous leukemia
338168|NCT01499147|Chronic phase|chronic phase
338169|NCT01499147|Recurrent malignant lymphoma|recurrent malignant lymphoma
338170|NCT01499147|Refractory malignant lymphoma|refractory malignant lymphoma
338171|NCT01499147|Hodgkin's disease|hodgkin's disease
338172|NCT01499147|Multiple myeloma.|multiple myeloma.
338173|NCT01499147|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
338174|NCT01499147|Myeloproliferative disorder|myeloproliferative disorder
338175|NCT01499147|Polycythemia vera|polycythemia vera
338176|NCT01499147|Myelofibrosis|myelofibrosis
338177|NCT01499147|Severe aplastic anemia|severe aplastic anemia
338178|NCT01499108|type 2 diabetes|type 2 diabetes
338179|NCT01499108|hypertension|hypertension
338180|NCT01499108|liraglutide|liraglutide
338181|NCT01499108|kidney function|kidney function
338182|NCT01499056|osteoarthritis|osteoarthritis
338183|NCT01499056|hip joint|hip joint
338184|NCT01499056|mesenchymal stem cell|mesenchymal stem cell
338185|NCT01499043|CRPC|crpc
338186|NCT01499043|Prostate Cancer|prostate cancer
338187|NCT01499043|Bone metastasis|bone metastasis
751929|NCT01171261|Exergames|exergames
338188|NCT01499043|Advanced Castration-Resistant Prostate Cancer (CRPC)|advanced castration-resistant prostate cancer (crpc)
338189|NCT01499017|Single Ascending Dose Study in healthy subjects|single ascending dose study in healthy subjects
338190|NCT01499004|tofacitinib|tofacitinib
338191|NCT01499004|CP-690|cp-690
338192|NCT01499004|550|550
338193|NCT01499004|relative bioavailability|relative bioavailability
338194|NCT01499004|modified release|modified release
338195|NCT01499004|Phase 1|phase 1
338196|NCT01498991|Incomplete Spinal Cord Injury|incomplete spinal cord injury
338197|NCT01498991|Rehabilitation|rehabilitation
338198|NCT01498991|AMES device|ames device
338199|NCT01498991|Lower Extremity|lower extremity
338200|NCT01498991|Gait|gait
338201|NCT01498991|Paraplegia|paraplegia
338202|NCT01498965|food allergy|food allergy
338203|NCT01498965|eczema|eczema
338204|NCT01498965|Vitamin D status|vitamin d status
338205|NCT01498965|body composition|body composition
338206|NCT01498965|obesity|obesity
338207|NCT01498965|neurodevelopmental and behavioural outcome|neurodevelopmental and behavioural outcome
338208|NCT01498952|HCC, liver cancer, hepatocellular carcinoma, MEDI-573, anti-IGF|hcc, liver cancer, hepatocellular carcinoma, medi-573, anti-igf
338209|NCT01498887|Multiple Sclerosis|multiple sclerosis
338210|NCT01498887|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
338211|NCT01498887|Fingolimod|fingolimod
338212|NCT01498887|Early multiple sclerosis|early multiple sclerosis
338213|NCT01498887|Naive patients|naive patients
338214|NCT01498874|Acne|acne
338215|NCT01498874|Acne Vulgaris|acne vulgaris
338216|NCT01498835|Soft tissue sarcoma|soft tissue sarcoma
338217|NCT01498835|Radiation therapy|radiation therapy
338218|NCT01498835|Sunitinib|sunitinib
338219|NCT01498822|Levetiracetam|levetiracetam
338220|NCT01498822|Oxcarbazepine|oxcarbazepine
338221|NCT01498822|treatment failure|treatment failure
338222|NCT01498822|partial epilepsy|partial epilepsy
338223|NCT01498809|Orthostatic intolerance in people with spinal cord injury|orthostatic intolerance in people with spinal cord injury
338224|NCT01498744|Skin and Soft Tissue Abscess|skin and soft tissue abscess
338225|NCT01498744|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
338226|NCT01498744|Incision and Drainage|incision and drainage
338227|NCT01498744|Clindamycin|clindamycin
338228|NCT01498744|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
338229|NCT01498744|Skin Infection|skin infection
338230|NCT01498731|Copeptin|copeptin
338231|NCT01498731|Troponin|troponin
338232|NCT01498731|Acute Coronary Syndrome|acute coronary syndrome
338233|NCT01498731|Rule-out of acute myocardial infarction|rule-out of acute myocardial infarction
338234|NCT01498731|Emergency Medicine|emergency medicine
338235|NCT01498718|Influenza A (H1N1)|influenza a (h1n1)
338236|NCT01498718|Influenza A (H3N2)|influenza a (h3n2)
338237|NCT01498718|Influenza B|influenza b
338238|NCT01498718|Trivalent Inactivated Vaccine (TIV)|trivalent inactivated vaccine (tiv)
338239|NCT01498718|Healthy Adults|healthy adults
338240|NCT01498705|Intraventricular Hemorrhage|intraventricular hemorrhage
338241|NCT01498705|Intracerebral Hemorrhage|intracerebral hemorrhage
338242|NCT01498705|Cerebrovascular Disorders|cerebrovascular disorders
338243|NCT01498705|Brain Diseases|brain diseases
338244|NCT01498705|Central Nervous System Diseases|central nervous system diseases
338245|NCT01498705|Nervous System Diseases|nervous system diseases
338246|NCT01498705|Vascular Diseases|vascular diseases
338247|NCT01498705|Procalcitonin Level|procalcitonin level
338248|NCT01498692|drug-eluting stents|drug-eluting stents
338249|NCT01498692|DES|des
338250|NCT01498692|atherosclerotic|atherosclerotic
338251|NCT01498640|XIAFLEX|xiaflex
338252|NCT01498640|XIAPEX|xiapex
338253|NCT01498640|Dupuytren's disease|dupuytren's disease
338254|NCT01498640|contracture|contracture
338255|NCT01498627|Autoimmune diseases (AIDs)|autoimmune diseases (aids)
338256|NCT01498627|Cervarix|cervarix
338257|NCT01498627|PGRx information system|pgrx information system
338258|NCT01498614|Diabetes mellitus|diabetes mellitus
338261|NCT01498614|negative self image|negative self image
338262|NCT01498614|alexithymia|alexithymia
338263|NCT01498614|metabolic control|metabolic control
338264|NCT01498614|diabetes complications|diabetes complications
338265|NCT01498601|oral hygiene|oral hygiene
338266|NCT01498601|tracheostomy|tracheostomy
338267|NCT01498601|deglutition disorders|deglutition disorders
338268|NCT01498601|enteral nutrition|enteral nutrition
338269|NCT01498601|brain injury|brain injury
338270|NCT01498601|coma|coma
338271|NCT01498588|Breast Neoplasms|breast neoplasms
338272|NCT01498588|Breast Cancer|breast cancer
338273|NCT01498588|Breast Tumors|breast tumors
338274|NCT01498588|Cancer of the Breast|cancer of the breast
338275|NCT01498588|Neoplasms, Breast|neoplasms, breast
338276|NCT01498588|Tumors, Breast|tumors, breast
338277|NCT01498575|Teen driving|teen driving
338278|NCT01498575|Behind the wheel practice driving|behind the wheel practice driving
338279|NCT01498575|Parent supervision|parent supervision
338280|NCT01498549|Abstinent cocaine users|abstinent cocaine users
338281|NCT01498549|cognitive testing|cognitive testing
338282|NCT01498523|Camel milk|camel milk
338283|NCT01498523|Postprandial glycaemic response|postprandial glycaemic response
338284|NCT01498523|postprandial insulinaemic response|postprandial insulinaemic response
338286|NCT01498510|chronic pain|chronic pain
338287|NCT01498510|cognitive behavior therapy|cognitive behavior therapy
338288|NCT01498510|web-based intervention|web-based intervention
338289|NCT01498484|EBV-specific T-cell lines|ebv-specific t-cell lines
338290|NCT01498484|11-130|11-130
338291|NCT01498458|German Breast Group|german breast group
338292|NCT01498458|GBG Forschungs GmbH|gbg forschungs gmbh
338293|NCT01498458|GBG|gbg
338294|NCT01498458|GBG 62|gbg 62
338295|NCT01498458|PazoX|pazox
338296|NCT01498458|Breast Cancer|breast cancer
338297|NCT01498458|Metastatic Breast Cancer|metastatic breast cancer
338298|NCT01498458|Pazopanib|pazopanib
338299|NCT01498458|Abraxane|abraxane
338300|NCT01498458|Capecitabine|capecitabine
338301|NCT01498458|Xeloda|xeloda
338302|NCT01498445|Leukemia|leukemia
338303|NCT01498445|Chronic myelogenous leukemia|chronic myelogenous leukemia
338304|NCT01498445|Chronic myeloid leukemia|chronic myeloid leukemia
338305|NCT01498445|CML|cml
338306|NCT01498445|Accelerated phase|accelerated phase
338307|NCT01498445|Blastic phase|blastic phase
338308|NCT01498445|Dasatinib|dasatinib
338309|NCT01498445|BMS-354825|bms-354825
338310|NCT01498445|Sprycel|sprycel
338311|NCT01498445|Decitabine|decitabine
338312|NCT01498445|Dacogen|dacogen
338313|NCT01498419|Tuberculosis|tuberculosis
338314|NCT01498419|Serial Sputum Colony Counts|serial sputum colony counts
338315|NCT01498419|Colony Forming Units|colony forming units
338316|NCT01498419|Time to Sputum Culture Positivity|time to sputum culture positivity
338317|NCT01498419|PA824|pa824
338318|NCT01498419|pretomanid|pretomanid
338319|NCT01498406|cutaneous lupus erythematosus|cutaneous lupus erythematosus
338320|NCT01498406|vitamin D|vitamin d
338321|NCT01498406|quality of life|quality of life
338322|NCT01498393|fungal nail|fungal nail
338323|NCT01498380|Dexmedetomidine|dexmedetomidine
338324|NCT01498380|Precedex|precedex
338325|NCT01498380|TIVA|tiva
338326|NCT01498380|Rapid bolus|rapid bolus
338327|NCT01498367|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
338328|NCT01498367|Telemedicine|telemedicine
338329|NCT01498354|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
338330|NCT01498354|Transanal endoscopic operations|transanal endoscopic operations
338331|NCT01498354|Rectal adenomas|rectal adenomas
338332|NCT01498354|Transanal endoscopic surgery|transanal endoscopic surgery
338333|NCT01498354|"Rectal adenocarcinomas in situ"|"rectal adenocarcinomas in situ"
338334|NCT01498341|Hypoparathyroidism|hypoparathyroidism
338335|NCT01498341|Epidemiology|epidemiology
338336|NCT01498341|Prognosis|prognosis
338337|NCT01498341|Symptoms|symptoms
338338|NCT01498328|EGFRvIII|egfrviii
338339|NCT01498328|Glioblastoma|glioblastoma
338340|NCT01498328|Rindopepimut|rindopepimut
338341|NCT01498328|CDX-110|cdx-110
338342|NCT01498328|Small cell|small cell
338343|NCT01498328|Giant cell|giant cell
338344|NCT01498328|Brain Cancer|brain cancer
338345|NCT01498328|Brain Tumor|brain tumor
338346|NCT01498328|Gliosarcoma|gliosarcoma
338347|NCT01498328|oligodendroglial|oligodendroglial
338348|NCT01498328|radiotherapy|radiotherapy
338349|NCT01498328|chemoradiation|chemoradiation
338350|NCT01498328|Tumor|tumor
338351|NCT01498328|Bevacizumab|bevacizumab
338352|NCT01498328|Relapsed|relapsed
338353|NCT01498328|Returned|returned
338354|NCT01498328|Recurrent|recurrent
338355|NCT01498328|EGFR variant III|egfr variant iii
338356|NCT01498302|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
338357|NCT01498289|recurrent esophageal cancer|recurrent esophageal cancer
338358|NCT01498289|stage IV esophageal cancer|stage iv esophageal cancer
338359|NCT01498289|recurrent gastric cancer|recurrent gastric cancer
338360|NCT01498289|stage IV gastric cancer|stage iv gastric cancer
338361|NCT01498289|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
338362|NCT01498289|stage IIIB gastric cancer|stage iiib gastric cancer
338363|NCT01498289|stage IIIC gastric cancer|stage iiic gastric cancer
338364|NCT01498289|stage IIIB esophageal cancer|stage iiib esophageal cancer
338365|NCT01498289|stage IIIC esophageal cancer|stage iiic esophageal cancer
338366|NCT01498289|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
338367|NCT01498289|adenocarcinoma of the stomach|adenocarcinoma of the stomach
338368|NCT01498276|Family History|family history
338369|NCT01498276|Family Health History|family health history
338370|NCT01498276|Disease Risk Assessment|disease risk assessment
338371|NCT01498263|Family Systems|family systems
338372|NCT01498263|Caregiving|caregiving
338373|NCT01498263|Alzheimer Disease|alzheimer disease
338374|NCT01498263|Family History|family history
338375|NCT01498263|Alzheimer's Disease|alzheimer's disease
338376|NCT01498263|AD|ad
338377|NCT01498237|Photoacoustic endoscopy|photoacoustic endoscopy
338378|NCT01498224|Cataract surgery|cataract surgery
338379|NCT01498211|volunteer|volunteer
338380|NCT01498198|Rotator Cuff|rotator cuff
338381|NCT01498198|WCB|wcb
338382|NCT01498172|Non muscle invasive bladder cancer|non muscle invasive bladder cancer
338383|NCT01498159|Diabetes Mellitus|diabetes mellitus
338384|NCT01498159|Pharmacists|pharmacists
338385|NCT01498159|Community Health Aides|community health aides
338386|NCT01498146|cryptogenic stroke|cryptogenic stroke
338387|NCT01498146|atrial fibrillation|atrial fibrillation
338388|NCT01498146|longterm monitoring|longterm monitoring
338389|NCT01498146|loop recorder|loop recorder
338390|NCT01498133|Skin-to-skin contact|skin-to-skin contact
338391|NCT01498133|Decolonization|decolonization
338392|NCT01498133|MRSA|mrsa
338393|NCT01498120|Rotigotine|rotigotine
338394|NCT01498120|Restless Legs Syndrome|restless legs syndrome
338395|NCT01498120|RLS|rls
338396|NCT01498120|Long-term|long-term
338397|NCT01498120|Adolescents|adolescents
338398|NCT01498107|online intervention|online intervention
338399|NCT01498107|computerized CBT|computerized cbt
338400|NCT01498107|e-health|e-health
338401|NCT01498094|Bronchiolitis|bronchiolitis
338402|NCT01498094|High|high
338403|NCT01498094|Flow|flow
338404|NCT01498094|Oxygen|oxygen
338405|NCT01498094|Therapy|therapy
338406|NCT01498094|Nasal|nasal
338407|NCT01498094|Cannulae|cannulae
338408|NCT01498094|Prongs|prongs
338409|NCT01498081|COPD, pulmonary disease|copd, pulmonary disease
329127|NCT01537588|graft|graft
720474|NCT01045564|Avian|avian
338410|NCT01498068|Genotype 1 chronic Hepatitis C|genotype 1 chronic hepatitis c
338411|NCT01498068|VX-950HPC3007|vx-950hpc3007
338412|NCT01498068|VX-950|vx-950
338413|NCT01498068|Hepatitis C|hepatitis c
338414|NCT01498068|Telaprevir|telaprevir
338415|NCT01498068|HCV|hcv
338416|NCT01498055|lung cancer|lung cancer
338417|NCT01498055|CIK cells|cik cells
338418|NCT01498055|therapy|therapy
338419|NCT01498029|Cartilage, Articular|cartilage, articular
338420|NCT01498016|acute leukemia|acute leukemia
338421|NCT01498016|allogeneic stem cell transplantation|allogeneic stem cell transplantation
338422|NCT01498016|busulfan|busulfan
338423|NCT01498003|coronary disease|coronary disease
338424|NCT01498003|stents|stents
338425|NCT01498003|thrombosis|thrombosis
338426|NCT01498003|myocardial infarction|myocardial infarction
338427|NCT01498003|prognosis|prognosis
338428|NCT01497990|Burns|burns
338429|NCT01497990|Ertapenem|ertapenem
338430|NCT01497990|Pharmacokinetics|pharmacokinetics
338431|NCT01497977|phytoestrogens|phytoestrogens
338432|NCT01497977|postmenopause|postmenopause
338433|NCT01497977|serum lipids|serum lipids
339131|NCT01494974|FP8|fp8
338434|NCT01497925|Arginine deiminase|arginine deiminase
338435|NCT01497925|Arginine|arginine
338436|NCT01497925|Solid tumors|solid tumors
338437|NCT01497925|Prostate cancer|prostate cancer
338438|NCT01497925|Phase 1 study|phase 1 study
338439|NCT01497899|HIV-1|hiv-1
338441|NCT01497899|Treatment-Naive|treatment-naive
338442|NCT01497886|Stroke|stroke
338443|NCT01497886|Children|children
338444|NCT01497886|Hip Hop Stroke|hip hop stroke
338445|NCT01497886|New York City|new york city
338446|NCT01497873|Small Cell Lung Cancer|small cell lung cancer
338447|NCT01497873|Belotecan|belotecan
338448|NCT01497873|Topotecan|topotecan
338449|NCT01497860|pediatric|pediatric
338450|NCT01497860|children|children
338451|NCT01497860|glioma|glioma
338452|NCT01497860|low-grade|low-grade
338453|NCT01497860|vinorelbine|vinorelbine
338454|NCT01497860|recurrent|recurrent
338455|NCT01497860|progressive|progressive
338456|NCT01497847|Post-Infectious Irritable Bowel Syndrome|post-infectious irritable bowel syndrome
338457|NCT01497847|PI-IBS|pi-ibs
338458|NCT01497834|Hepatitis C Virus Infection|hepatitis c virus infection
338459|NCT01497821|Amgen|amgen
338460|NCT01497821|Phase 1|phase 1
338461|NCT01497821|First in Human|first in human
338462|NCT01497821|Relapsed / Refractory Renal Cell Carcinoma (RCC)|relapsed / refractory renal cell carcinoma (rcc)
338463|NCT01497821|Kidney Cancer|kidney cancer
338464|NCT01497821|Clinical Trial|clinical trial
338465|NCT01497821|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
338467|NCT01497821|Oncology|oncology
338468|NCT01497808|previously untreated|previously untreated
338469|NCT01497808|previously treated|previously treated
338470|NCT01497808|bone, lung, liver or subcutaneous involvement|bone, lung, liver or subcutaneous involvement
338471|NCT01497808|nodal involvement|nodal involvement
338472|NCT01497808|without evidence of brain involvement|without evidence of brain involvement
338473|NCT01497782|virtual reality, simulator, feedback, laparoscopy, training|virtual reality, simulator, feedback, laparoscopy, training
338474|NCT01497769|vaccine|vaccine
338475|NCT01497769|immunogenicity|immunogenicity
338476|NCT01497743|Scleroderma|scleroderma
338477|NCT01497743|gastrointestinal|gastrointestinal
338478|NCT01497743|bloating|bloating
338479|NCT01497743|reflux|reflux
338480|NCT01497730|Arthroplasty, Replacement, Knee,|arthroplasty, replacement, knee,
338481|NCT01497704|Cancer|cancer
338482|NCT01497704|Tumor|tumor
338483|NCT01497704|Oncology|oncology
338484|NCT01497704|Antiangiogenesis|antiangiogenesis
338485|NCT01497691|Asthma|asthma
338486|NCT01497691|Pediatrics|pediatrics
338487|NCT01497691|BiPAP|bipap
338488|NCT01497691|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
338489|NCT01497678|MTURR|mturr
338490|NCT01497678|ECM|ecm
338491|NCT01497678|Muscle Loss|muscle loss
338492|NCT01497678|Tendon|tendon
338493|NCT01497678|Tendon Repair|tendon repair
338494|NCT01497678|Muscle Repair|muscle repair
338495|NCT01497678|Soft Tissue Repair|soft tissue repair
338496|NCT01497678|Scaffold|scaffold
338497|NCT01497678|Extracellular Matrix|extracellular matrix
338498|NCT01497665|GRN1005|grn1005
338499|NCT01497665|ANG1005|ang1005
338500|NCT01497665|LRP-1|lrp-1
338501|NCT01497665|Targeted Therapy|targeted therapy
338502|NCT01497665|Brain Tumor|brain tumor
338503|NCT01497665|Blood Brain Barrier|blood brain barrier
338504|NCT01497665|Peptide-Drug Conjugate (PDC)|peptide-drug conjugate (pdc)
338505|NCT01497665|Brain Metastases|brain metastases
338506|NCT01497665|Paclitaxel|paclitaxel
338507|NCT01497665|Taxol|taxol
338508|NCT01497665|NSCLC|nsclc
338509|NCT01497665|Non-Small Cell Lung Cancer|non-small cell lung cancer
338510|NCT01497652|Parkinson's Disease|parkinson's disease
338511|NCT01497652|Cognition|cognition
338512|NCT01497652|Rasagiline|rasagiline
338513|NCT01497652|MoCA|moca
338514|NCT01497652|Mild Cognitive Impairment in Parkinson's Disease|mild cognitive impairment in parkinson's disease
338515|NCT01497639|dystonia|dystonia
338516|NCT01497639|pallidal stimulation|pallidal stimulation
338517|NCT01497639|deep brain stimulation|deep brain stimulation
338518|NCT01497639|deep brain stimulation of GPi|deep brain stimulation of gpi
338519|NCT01497639|GPi|gpi
338520|NCT01497639|interleaving stimulation|interleaving stimulation
338521|NCT01497626|Advanced cancer|advanced cancer
338522|NCT01497626|Solid tumor|solid tumor
338523|NCT01497613|Socialization|socialization
338524|NCT01497613|Well-being|well-being
338525|NCT01497613|Quality of Life|quality of life
338526|NCT01497613|Connectivity|connectivity
338527|NCT01497548|Depression|depression
338528|NCT01497548|cancer|cancer
338529|NCT01497548|methylphenidate|methylphenidate
338530|NCT01497548|pharmacotherapy|pharmacotherapy
338531|NCT01497522|Vildagliptin|vildagliptin
338532|NCT01497522|Type 2 diabetes|type 2 diabetes
338533|NCT01497522|HbA1c|hba1c
338534|NCT01497522|Fasting plasma glucose|fasting plasma glucose
338535|NCT01497496|leukemia|leukemia
338536|NCT01497496|lymphoma|lymphoma
338537|NCT01497496|consolidative therapy|consolidative therapy
338538|NCT01497496|combination regimen|combination regimen
338539|NCT01497496|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
338540|NCT01497496|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
338541|NCT01497470|paclitaxel|paclitaxel
338542|NCT01497470|carboplatin|carboplatin
338543|NCT01497470|custirsen|custirsen
338544|NCT01497470|drug-drug interaction|drug-drug interaction
338545|NCT01497470|pharmacokinetics|pharmacokinetics
338546|NCT01497470|cancer|cancer
338547|NCT01497444|recurrent adult primary liver cancer|recurrent adult primary liver cancer
338548|NCT01497444|recurrent renal cell cancer|recurrent renal cell cancer
338549|NCT01497444|advanced adult primary liver cancer|advanced adult primary liver cancer
338550|NCT01497444|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
338551|NCT01497444|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
338552|NCT01497405|Gender-based Violence|gender-based violence
338554|NCT01497405|Randomized Controlled Trial|randomized controlled trial
338555|NCT01497405|Sexually Transmitted Diseases|sexually transmitted diseases
338556|NCT01497405|Substance Abuse Detection|substance abuse detection
338557|NCT01497405|Test, Treat and Retain|test, treat and retain
338558|NCT01497379|Hereditary retinal|hereditary retinal
338559|NCT01497379|degeneration outer|degeneration outer
338560|NCT01497379|retinal layers|retinal layers
338561|NCT01497379|photoreceptor rods cones|photoreceptor rods cones
338562|NCT01497379|Retinitis pigmentosa|retinitis pigmentosa
338563|NCT01497379|blindness|blindness
338564|NCT01497379|reading ability|reading ability
338565|NCT01497379|retina implant|retina implant
338566|NCT01497379|subretinal|subretinal
338567|NCT01497366|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
338568|NCT01497366|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
338569|NCT01497353|Cord clamping|cord clamping
338570|NCT01497353|newborn|newborn
338571|NCT01497353|Skin contact|skin contact
338572|NCT01497353|Placental transfusion|placental transfusion
338573|NCT01497353|Delivery room|delivery room
338574|NCT01497340|Cord clamping|cord clamping
338575|NCT01497340|newborn|newborn
338576|NCT01497340|Placental trasfusion|placental trasfusion
338577|NCT01497340|Delivery room|delivery room
338578|NCT01497327|HEPATITIS C, CHRONIC|hepatitis c, chronic
338579|NCT01497327|HCV|hcv
338580|NCT01497327|hepatic impairment|hepatic impairment
338581|NCT01497314|healthy term infants|healthy term infants
338582|NCT01497314|growth|growth
338583|NCT01497314|infant formula|infant formula
338584|NCT01497301|Diabetes|diabetes
338585|NCT01497301|Group Visit|group visit
338586|NCT01497301|Shared Medical Appointment|shared medical appointment
338587|NCT01497288|Intranasal fentanyl spray|intranasal fentanyl spray
338588|NCT01497288|Population PK|population pk
338589|NCT01497262|Multiple Sclerosis|multiple sclerosis
338590|NCT01497262|Relapsing-Remitting|relapsing-remitting
338591|NCT01497249|Dietary Fiber|dietary fiber
338592|NCT01497249|Blood glucose control|blood glucose control
338593|NCT01497249|Fermentability|fermentability
338594|NCT01497249|Tolerability|tolerability
338595|NCT01497223|Phase II|phase ii
338596|NCT01497223|Double-Blind|double-blind
338597|NCT01497223|Placebo-Controlled|placebo-controlled
338598|NCT01497223|Vulvovaginal Candidiasis|vulvovaginal candidiasis
338599|NCT01497223|Moderate to Severe|moderate to severe
338600|NCT01497223|Acute|acute
338601|NCT01497223|Treatment of Moderate to Severe Vulvovaginal Candidiasis|treatment of moderate to severe vulvovaginal candidiasis
338602|NCT01497197|Reproduction Techniques|reproduction techniques
338603|NCT01497197|Reproductive Medicine|reproductive medicine
338604|NCT01497197|Assisted Reproductive Technics|assisted reproductive technics
338605|NCT01497197|Pregnancy Rate|pregnancy rate
338606|NCT01497197|Ovulation Induction|ovulation induction
338607|NCT01497197|Ovarian Stimulation|ovarian stimulation
420690|NCT00001053|HIV-1|hiv-1
338608|NCT01497197|Oocytes|oocytes
338609|NCT01497197|Implantation|implantation
338610|NCT01497184|Leukemia|leukemia
338611|NCT01497184|Lymphoma|lymphoma
338612|NCT01497184|Allogeneic donor lymphocyte infusion|allogeneic donor lymphocyte infusion
338614|NCT01497184|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
338615|NCT01497184|HSCT|hsct
338616|NCT01497184|Bone marrow transplant|bone marrow transplant
338617|NCT01497184|CD19-specific T cells|cd19-specific t cells
338618|NCT01497184|T cell infusion|t cell infusion
338619|NCT01497184|B-Lineage lymphoid malignancies|b-lineage lymphoid malignancies
338620|NCT01497184|CD19+ lymphoid malignancies|cd19+ lymphoid malignancies
338621|NCT01497184|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
338622|NCT01497184|ALL|all
338623|NCT01497184|Biphenotypic leukemia CD19+ in advanced remission|biphenotypic leukemia cd19+ in advanced remission
338624|NCT01497184|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
338625|NCT01497184|NHL|nhl
338626|NCT01497184|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
338627|NCT01497184|Small lymphocytic lymphoma|small lymphocytic lymphoma
338628|NCT01497184|Follicular lymphoma|follicular lymphoma
338629|NCT01497184|Mantle cell lymphoma with active disease at time of transplant|mantle cell lymphoma with active disease at time of transplant
338630|NCT01497171|Cystocele|cystocele
338631|NCT01497171|Bladder prolapse|bladder prolapse
338632|NCT01497171|Anterior prolapse|anterior prolapse
338633|NCT01497171|Vaginal prolapse|vaginal prolapse
338634|NCT01497171|Uterine prolapse|uterine prolapse
338635|NCT01497171|Urinary incontinence|urinary incontinence
338636|NCT01497158|tobacco cessation|tobacco cessation
338637|NCT01497119|Moderate atopic dermatitis|moderate atopic dermatitis
338638|NCT01497119|JNJ-39758979|jnj-39758979
338639|NCT01497119|Japanese patients|japanese patients
338640|NCT01497106|Insulin resistance|insulin resistance
338641|NCT01497106|Abdominal obesity|abdominal obesity
338642|NCT01497106|Calorie restriction|calorie restriction
338644|NCT01497093|Multiple Myeloma|multiple myeloma
338645|NCT01497093|Relapsed Multiple Myeloma|relapsed multiple myeloma
338646|NCT01497093|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
338647|NCT01497093|Refractory Myeloma|refractory myeloma
338648|NCT01497093|Resistant Multiple Myeloma|resistant multiple myeloma
338649|NCT01497093|Treatment-resistant Multiple Myeloma|treatment-resistant multiple myeloma
338650|NCT01497093|Pomalidomide|pomalidomide
338651|NCT01497093|Lenalidomide-resistant|lenalidomide-resistant
338652|NCT01497080|distal radius fracture|distal radius fracture
338653|NCT01497080|Condition|condition
338654|NCT01497080|risk factors|risk factors
338655|NCT01497080|adverse activity transitions following DRF|adverse activity transitions following drf
338656|NCT01497080|optimal assessment approach|optimal assessment approach
338657|NCT01497054|B type natriuretic peptide|b type natriuretic peptide
338658|NCT01497054|Patent Ductus Arteriosus|patent ductus arteriosus
338659|NCT01497054|Preterm infant|preterm infant
338660|NCT01497028|Co-morbid disease resolution|co-morbid disease resolution
338661|NCT01497002|AML|aml
338662|NCT01496989|HIV|hiv
338663|NCT01496989|AIDS|aids
338664|NCT01496989|HIV vaccine|hiv vaccine
338665|NCT01496989|HIV prevention|hiv prevention
338666|NCT01496976|leukemia|leukemia
338667|NCT01496976|lymphoma|lymphoma
338668|NCT01496976|consolidative therapy|consolidative therapy
338669|NCT01496976|combination regimen|combination regimen
338670|NCT01496976|CLL|cll
338671|NCT01496976|SLL|sll
338672|NCT01496963|Thalassemia|thalassemia
338673|NCT01496963|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
338674|NCT01496950|migraine|migraine
338675|NCT01496924|Dysphagia|dysphagia
338676|NCT01496924|Intensive care units|intensive care units
338677|NCT01496924|Deglutition disorders|deglutition disorders
338678|NCT01496924|Rehabilitation|rehabilitation
338679|NCT01496911|Diving|diving
338680|NCT01496911|Drugs|drugs
338681|NCT01496911|Antihistamines|antihistamines
338682|NCT01496911|Performance|performance
338683|NCT01496898|Microflora|microflora
338685|NCT01496898|Cervical|cervical
338686|NCT01496898|Uterine|uterine
338687|NCT01496898|Inflammation|inflammation
338688|NCT01496898|Cytokine|cytokine
338689|NCT01496898|Intrauterine Device|intrauterine device
338690|NCT01496898|Levonorgestrel|levonorgestrel
338691|NCT01496885|stroke|stroke
338692|NCT01496872|Newborn cranial somatic dysfunction|newborn cranial somatic dysfunction
338693|NCT01496872|Newborn observational study|newborn observational study
338694|NCT01496872|Somatic dysfunction|somatic dysfunction
338695|NCT01496872|Cranial strain pattern|cranial strain pattern
338696|NCT01496872|Osteopathy|osteopathy
338697|NCT01496859|Baska mask|baska mask
338698|NCT01496859|supraglottic airway|supraglottic airway
338699|NCT01496859|airway management|airway management
338700|NCT01496846|Articaine|articaine
338701|NCT01496846|Lidocaine|lidocaine
338702|NCT01496846|Anesthesia, Local|anesthesia, local
338703|NCT01496846|Endodontics|endodontics
338704|NCT01496846|Molar|molar
420844|NCT00001080|HIV-1|hiv-1
338705|NCT01496846|Dental Pulp Diseases|dental pulp diseases
338706|NCT01496833|Aortic Diseases|aortic diseases
338707|NCT01496833|Vascular Diseases|vascular diseases
338708|NCT01496833|Cardiovascular Diseases|cardiovascular diseases
338709|NCT01496833|Treatment Outcome|treatment outcome
338710|NCT01496833|Aorta Dissection|aorta dissection
338711|NCT01496833|Aorta Aneurysm|aorta aneurysm
338712|NCT01496833|Aorta pseudoaneurysm|aorta pseudoaneurysm
338713|NCT01496833|Endovascular aortic repair|endovascular aortic repair
338714|NCT01496807|unresectable|unresectable
338715|NCT01496807|stage 3|stage 3
338716|NCT01496807|stage 4|stage 4
338717|NCT01496807|autoimmune|autoimmune
338718|NCT01496807|antibodies|antibodies
338719|NCT01496781|Endoscopic Hemostasis|endoscopic hemostasis
338720|NCT01496781|metallic hemoclip|metallic hemoclip
338721|NCT01496781|EndoClot Absorbable Polysaccharide Hemostat|endoclot absorbable polysaccharide hemostat
338722|NCT01496781|Colonic Polyps|colonic polyps
338723|NCT01496729|Kidney transplantation|kidney transplantation
338724|NCT01496729|Transversus abdominis plane (TAP) block|transversus abdominis plane (tap) block
338725|NCT01496716|Osteoarthritis|osteoarthritis
338726|NCT01496716|obesity|obesity
338727|NCT01496716|quality of life|quality of life
338728|NCT01496703|reasons for MMF dose reduction|reasons for mmf dose reduction
338729|NCT01496690|Anxiety-comorbidity to schizophrenia|anxiety-comorbidity to schizophrenia
338730|NCT01496690|Double-blinded randomized placebo controlled trial|double-blinded randomized placebo controlled trial
338731|NCT01496690|Pregabalin|pregabalin
338732|NCT01496677|volunteer|volunteer
338733|NCT01496651|Percutaneous coronary intervention|percutaneous coronary intervention
338734|NCT01496651|Coronary artery bypass graft operation|coronary artery bypass graft operation
338735|NCT01496651|Left Main|left main
338736|NCT01496638|PCI|pci
338737|NCT01496638|Bifurcation lesion|bifurcation lesion
338738|NCT01496625|Biological Specimens|biological specimens
338739|NCT01496625|Retinal Disease|retinal disease
338740|NCT01496625|Phenotype|phenotype
338741|NCT01496625|Phenotype-Genotype correlation|phenotype-genotype correlation
338742|NCT01496625|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
338743|NCT01496625|AMD|amd
338744|NCT01496625|Diabetic Retinopathy|diabetic retinopathy
338745|NCT01496625|Healthy Volunteer|healthy volunteer
338746|NCT01496625|HV|hv
338747|NCT01496612|Epilepsy|epilepsy
338748|NCT01496612|Temporal Lobe Epilepsy|temporal lobe epilepsy
338749|NCT01496612|Serotonin 1A Receptor|serotonin 1a receptor
338750|NCT01496612|Seizures|seizures
338751|NCT01496599|Brain Imaging|brain imaging
338752|NCT01496599|Parkinson's Disease|parkinson's disease
338753|NCT01496599|Parkinsonism|parkinsonism
338754|NCT01496599|Parkinson Disease|parkinson disease
338755|NCT01496599|PD|pd
338756|NCT01496599|Healthy Volunteer|healthy volunteer
338757|NCT01496599|HV|hv
338758|NCT01496586|Fatigue|fatigue
338759|NCT01496586|Traumatic Brain Injury|traumatic brain injury
338760|NCT01496586|Motivational Incentive|motivational incentive
338761|NCT01496586|TBI|tbi
338762|NCT01496560|colonoscopy|colonoscopy
338763|NCT01496560|pain|pain
338764|NCT01496560|rectal balloon|rectal balloon
338765|NCT01496547|feasibility, effective and safety|feasibility, effective and safety
338766|NCT01496547|intensive chemotherapy|intensive chemotherapy
338767|NCT01496547|RIC regimen|ric regimen
338768|NCT01496547|refractory or relapse leukemia|refractory or relapse leukemia
338769|NCT01496547|allogeneic stem cell transplantation|allogeneic stem cell transplantation
338770|NCT01496534|advanced solid tumors|advanced solid tumors
338771|NCT01496534|bladder cancer|bladder cancer
338772|NCT01496534|gemcitabine|gemcitabine
338773|NCT01496534|cisplatin|cisplatin
338774|NCT01496534|carboplatin|carboplatin
338775|NCT01496534|solid tumors|solid tumors
338776|NCT01496521|Aspirin|aspirin
338777|NCT01496521|polyphenols|polyphenols
338778|NCT01496521|Chemoprevention|chemoprevention
338779|NCT01496508|high-frequency oscillatory ventilation|high-frequency oscillatory ventilation
338780|NCT01496508|respiratory distress syndrome|respiratory distress syndrome
338782|NCT01496508|neurodevelopment|neurodevelopment
338783|NCT01496508|preterm infants with severe respiratory distress syndrome|preterm infants with severe respiratory distress syndrome
338784|NCT01496482|Dry eye Syndromes|dry eye syndromes
338785|NCT01496469|Drug Therapy|drug therapy
338786|NCT01496456|Dental caries|dental caries
338787|NCT01496456|Proximal surfaces|proximal surfaces
338788|NCT01496456|Posterior teeth|posterior teeth
338789|NCT01496456|Carious lesions|carious lesions
338790|NCT01496456|Tooth diseases|tooth diseases
338791|NCT01496456|Preventive therapy|preventive therapy
338792|NCT01496443|Drug Therapy|drug therapy
338793|NCT01496430|Drug Therapy|drug therapy
338794|NCT01496430|Hypertension and Diabetes|hypertension and diabetes
338795|NCT01496417|Kidney Transplantation|kidney transplantation
338796|NCT01496417|Biopsy|biopsy
338797|NCT01496417|Belatacept|belatacept
338798|NCT01496404|Electrocautery|electrocautery
338799|NCT01496391|imaging|imaging
338800|NCT01496391|renal function|renal function
329500|NCT01535781|tranexamic acid|tranexamic acid
329501|NCT01535781|postoperative blood loss|postoperative blood loss
329502|NCT01535781|blood loss|blood loss
329503|NCT01535781|hidden blood loss|hidden blood loss
329504|NCT01535781|blood transfusions|blood transfusions
329511|NCT01535690|Laser|laser
338801|NCT01496391|I-123 OIH|i-123 oih
338802|NCT01496391|Tc-99m MAG 3|tc-99m mag 3
338803|NCT01496378|Chronic Pain|chronic pain
338804|NCT01496378|Abdominal Pain|abdominal pain
338805|NCT01496378|Headache|headache
338806|NCT01496378|Adolescents|adolescents
338807|NCT01496378|Children|children
338808|NCT01496378|Parents|parents
338809|NCT01496378|Problem-Solving Skills Training|problem-solving skills training
720475|NCT01045564|Safety|safety
338810|NCT01496365|Keywords: pain, diabetes, neuropathy|keywords: pain, diabetes, neuropathy
338811|NCT01496352|Surgical site infection|surgical site infection
338812|NCT01496352|Colorectal surgery|colorectal surgery
338813|NCT01496326|Osteoarthritis|osteoarthritis
338814|NCT01496326|knee pain|knee pain
338815|NCT01496313|medullary thyroid cancer|medullary thyroid cancer
338816|NCT01496313|metastatic|metastatic
338817|NCT01496313|thyroid cancer|thyroid cancer
338818|NCT01496313|carcinoma of the thyroid|carcinoma of the thyroid
338819|NCT01496313|receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
338820|NCT01496313|VEGFR|vegfr
338821|NCT01496313|Unresectable locally advanced thyroid cancer|unresectable locally advanced thyroid cancer
338822|NCT01496300|Navigation OrthoPilot Hip TEP THA|navigation orthopilot hip tep tha
338823|NCT01496261|Clopidogrel|clopidogrel
338824|NCT01496261|Aspirin|aspirin
338825|NCT01496261|Combination|combination
338826|NCT01496261|Pharmacokinetics|pharmacokinetics
338827|NCT01496261|Phase 1|phase 1
338828|NCT01496248|Major depressive disorder|major depressive disorder
338829|NCT01496248|Residual symptoms|residual symptoms
338830|NCT01496248|Korean red ginseng|korean red ginseng
338831|NCT01496222|mild cognitive impairment|mild cognitive impairment
338832|NCT01496222|Montreal Cognitive Assessment test|montreal cognitive assessment test
338833|NCT01496209|Infarction|infarction
338834|NCT01496209|Myocardial Infarction|myocardial infarction
338835|NCT01496209|Ventricular Dysfunction, Left|ventricular dysfunction, left
338836|NCT01496209|Heart Disease|heart disease
338837|NCT01496209|Cardiovascular Disease|cardiovascular disease
338838|NCT01496209|Chronic Ischemia|chronic ischemia
338839|NCT01496196|hemoptisis|hemoptisis
338840|NCT01496196|bleeding|bleeding
338841|NCT01496196|tranexamic acid|tranexamic acid
338842|NCT01496157|Primary Prostate Cancer|primary prostate cancer
338843|NCT01496144|Chronic non specific low back pain|chronic non specific low back pain
338844|NCT01496144|Manual therapy|manual therapy
338845|NCT01496144|Active exercises|active exercises
338846|NCT01496144|Pain|pain
338847|NCT01496144|Disability|disability
338848|NCT01496131|Tecemotide|tecemotide
338849|NCT01496131|Prostate Cancer|prostate cancer
338850|NCT01496131|Goserelin|goserelin
338851|NCT01496131|Cyclophosphamide|cyclophosphamide
338852|NCT01496131|Radiotherapy|radiotherapy
338853|NCT01496118|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
338854|NCT01496118|carfilzomib|carfilzomib
338855|NCT01496118|panobinostat|panobinostat
338856|NCT01496092|Keto Acid|keto acid
338857|NCT01496092|Peritoneal dialysis|peritoneal dialysis
338858|NCT01496092|Insulin resistance|insulin resistance
338859|NCT01496079|Maternal immunization|maternal immunization
338860|NCT01496079|Infant immunization|infant immunization
338861|NCT01496079|Influenza vaccine|influenza vaccine
338862|NCT01496079|Passive transfer of immunity|passive transfer of immunity
338863|NCT01496053|Cytokine levels in blood|cytokine levels in blood
338864|NCT01496053|Calprotectin in feces|calprotectin in feces
338865|NCT01496053|Clinical symptom score.|clinical symptom score.
338866|NCT01496027|cerebral oxygenation|cerebral oxygenation
338867|NCT01496027|NIRS|nirs
338868|NCT01496027|tissue oximeters|tissue oximeters
338869|NCT01496027|near infrared spectroscopy|near infrared spectroscopy
338870|NCT01496027|newborn|newborn
338871|NCT01496014|open fracture wounds|open fracture wounds
338872|NCT01496014|infections|infections
338873|NCT01496014|tibia fractures|tibia fractures
338874|NCT01496014|antibiotic therapies in severe fractures|antibiotic therapies in severe fractures
338875|NCT01496014|All severe open fracture of the tibia bone|all severe open fracture of the tibia bone
338876|NCT01496001|Early unilateral breast cancer|early unilateral breast cancer
338878|NCT01495988|BRAF-mutant|braf-mutant
338879|NCT01495988|Stage IV melanoma|stage iv melanoma
338880|NCT01495988|Vemurafenib|vemurafenib
338881|NCT01495988|Bevacizumab|bevacizumab
338882|NCT01495988|Cobimetinib|cobimetinib
338883|NCT01495975|Diabetes Mellitus|diabetes mellitus
338884|NCT01495975|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
329615|NCT01535248|ERCP|ercp
338885|NCT01495975|Hospitalization|hospitalization
338886|NCT01495975|Patient Discharge|patient discharge
338887|NCT01495962|Damage Control Laparotomy|damage control laparotomy
338888|NCT01495962|Open Abdomen|open abdomen
338889|NCT01495962|Botulinum Toxin A|botulinum toxin a
338890|NCT01495962|Primary Fascial Closure|primary fascial closure
338891|NCT01495949|etomidate|etomidate
338892|NCT01495949|cortisol level|cortisol level
338893|NCT01495949|inotrope|inotrope
338894|NCT01495949|cardiac patients|cardiac patients
338895|NCT01495936|One Lung Ventilation (OLV)|one lung ventilation (olv)
338896|NCT01495936|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
338897|NCT01495936|Positive End Expiratory Pressure (PEEP)|positive end expiratory pressure (peep)
338898|NCT01495936|Lung recruitment maneuver|lung recruitment maneuver
338899|NCT01495936|Hypoxia|hypoxia
338900|NCT01495923|low back pain|low back pain
338901|NCT01495923|radiculopathy|radiculopathy
338902|NCT01495923|injection|injection
338903|NCT01495910|21-hydroxylase deficiency|21-hydroxylase deficiency
338904|NCT01495910|Androstenedione|androstenedione
338905|NCT01495910|Abiraterone acetate|abiraterone acetate
338906|NCT01495910|Pharmacokinetics|pharmacokinetics
338907|NCT01495910|Pharmacodynamics|pharmacodynamics
338908|NCT01495910|Dose-finding|dose-finding
338909|NCT01495897|Dystonia|dystonia
338910|NCT01495897|Cerebellar|cerebellar
338911|NCT01495897|ocular movements|ocular movements
338912|NCT01495897|DYT 11|dyt 11
338913|NCT01495897|sensorimotor integration|sensorimotor integration
338914|NCT01495858|Naproxen sodium|naproxen sodium
338915|NCT01495858|Diphenhydramine|diphenhydramine
338916|NCT01495845|pharmacogenomics|pharmacogenomics
338917|NCT01495845|feasibility|feasibility
338918|NCT01495845|community pharmacy|community pharmacy
338919|NCT01495845|personalized medicine|personalized medicine
338920|NCT01495845|clopidogrel|clopidogrel
338921|NCT01495845|Plavix|plavix
338922|NCT01495832|Adult Obesity|adult obesity
338923|NCT01495832|Cardiometabolic health|cardiometabolic health
338924|NCT01495832|Pulse Foods|pulse foods
338925|NCT01495832|Beans, Peas, Lentils|beans, peas, lentils
338926|NCT01495832|Cognitive Function|cognitive function
338927|NCT01495819|Nicotine|nicotine
338928|NCT01495819|smokers|smokers
338929|NCT01495819|vitals associated with smoking|vitals associated with smoking
338930|NCT01495806|functional dyspepsia|functional dyspepsia
338931|NCT01495806|irritable bowel syndrome|irritable bowel syndrome
338932|NCT01495806|functional abdominal pain|functional abdominal pain
338933|NCT01495793|Rotigotine|rotigotine
338934|NCT01495793|Restless Legs Syndrome|restless legs syndrome
338935|NCT01495793|RLS|rls
338936|NCT01495793|Children|children
338937|NCT01495793|Adolescents|adolescents
338938|NCT01495780|Behavioral|behavioral
338939|NCT01495780|Remote monitoring|remote monitoring
338940|NCT01495767|childhood uveitis|childhood uveitis
338941|NCT01495767|health-related quality of life|health-related quality of life
338942|NCT01495767|gender|gender
338943|NCT01495754|coffee|coffee
338944|NCT01495754|overweight/obese|overweight/obese
338945|NCT01495754|appetite|appetite
338946|NCT01495754|energy intake|energy intake
338947|NCT01495754|inflammation|inflammation
338948|NCT01495754|glucose metabolism|glucose metabolism
338949|NCT01495754|randomized controlled trial|randomized controlled trial
338950|NCT01495741|Mania|mania
338951|NCT01495741|Manic|manic
338952|NCT01495741|Depressive|depressive
338953|NCT01495741|Manic Depressive|manic depressive
338954|NCT01495728|Cervical Radiculopathy|cervical radiculopathy
338955|NCT01495728|Neck Pain|neck pain
338956|NCT01495728|Manipulation|manipulation
338957|NCT01495702|HIV-1|hiv-1
338958|NCT01495702|HIV|hiv
338959|NCT01495702|Treatment Experienced|treatment experienced
338960|NCT01495689|Smoking Cessation|smoking cessation
338961|NCT01495689|respirology Out-patient setting|respirology out-patient setting
338962|NCT01495689|SmartCard|smartcard
338963|NCT01495676|Bladder cancer|bladder cancer
338964|NCT01495676|Organ-conserving strategy|organ-conserving strategy
338965|NCT01495676|Radiochemotherapy|radiochemotherapy
338966|NCT01495676|non metastatic|non metastatic
338967|NCT01495663|refractory|refractory
338968|NCT01495663|relapsed|relapsed
338969|NCT01495663|non-small cell lung cancer|non-small cell lung cancer
338970|NCT01495663|triple-negative breast cancer|triple-negative breast cancer
338971|NCT01495663|soft tissue sarcoma|soft tissue sarcoma
338972|NCT01495663|colorectal cancer|colorectal cancer
338973|NCT01495663|esophageal cancer|esophageal cancer
338974|NCT01495663|prostate cancer|prostate cancer
338975|NCT01495663|ovarian cancer|ovarian cancer
338976|NCT01495650|Comprehensive Adjuvant Care|comprehensive adjuvant care
338977|NCT01495650|Cancer-related fatigue|cancer-related fatigue
338978|NCT01495650|Therapeutic patient education|therapeutic patient education
338979|NCT01495650|Physical Activity|physical activity
338980|NCT01495650|Nutritional counselling|nutritional counselling
338981|NCT01495650|Rehabilitation|rehabilitation
338982|NCT01495637|pediatric|pediatric
338983|NCT01495637|trauma|trauma
338984|NCT01495637|critical|critical
338985|NCT01495637|GM-CSF|gm-csf
338986|NCT01495637|immune|immune
338987|NCT01495624|rotator cuff repair|rotator cuff repair
338988|NCT01495624|capsular shift|capsular shift
338989|NCT01495624|shoulder arthroplasty|shoulder arthroplasty
338990|NCT01495624|subacromial decompression|subacromial decompression
338991|NCT01495624|18 and 75 years|18 and 75 years
338992|NCT01495611|postoperative,|postoperative,
338993|NCT01495611|pediatric|pediatric
338994|NCT01495611|pharmacogenetic|pharmacogenetic
338995|NCT01495611|opioid|opioid
338996|NCT01495611|morphine|morphine
338997|NCT01495611|perioperative|perioperative
338998|NCT01495611|respiratory depression|respiratory depression
338999|NCT01495598|Human Herpesvirus-8/HHV8|human herpesvirus-8/hhv8
339000|NCT01495598|Immune Modulation|immune modulation
339001|NCT01495598|CC-4047|cc-4047
339002|NCT01495598|IMiD|imid
339003|NCT01495598|Kaposi Sarcoma|kaposi sarcoma
339004|NCT01495585|Hepatitis|hepatitis
339005|NCT01495585|Delta|delta
339006|NCT01495585|Treatment|treatment
339007|NCT01495585|Lonafarnib|lonafarnib
339008|NCT01495585|Hepatitis D|hepatitis d
339009|NCT01495572|Malignant Melanoma|malignant melanoma
339010|NCT01495572|Immunotherapy|immunotherapy
339011|NCT01495572|Cell Therapy|cell therapy
339012|NCT01495572|HLA-A2 Positive|hla-a2 positive
339013|NCT01495572|Skin Cancer|skin cancer
339014|NCT01495546|total hip arthroplasty|total hip arthroplasty
339016|NCT01495546|prosthesis type Lepine|prosthesis type lepine
339017|NCT01495520|Arrhythmias|arrhythmias
339018|NCT01495520|palpitations|palpitations
339019|NCT01495494|Nasal Strip|nasal strip
339020|NCT01495481|Supraventricular Tachycardia|supraventricular tachycardia
339022|NCT01495481|Reentrant Tachycardia|reentrant tachycardia
339023|NCT01495481|Dexmedetomidine|dexmedetomidine
339024|NCT01495481|Adenosine|adenosine
339025|NCT01495468|pegylated somatropin|pegylated somatropin
339026|NCT01495468|PEG-rhGH|peg-rhgh
339027|NCT01495468|growth hormone|growth hormone
339028|NCT01495468|Growth Hormone Deficiency|growth hormone deficiency
339029|NCT01495468|phase III study|phase iii study
339030|NCT01495429|catheter related large vein thrombosis|catheter related large vein thrombosis
339031|NCT01495429|upper extremity deep venous thrombosis|upper extremity deep venous thrombosis
339032|NCT01495429|central venous catheters|central venous catheters
339033|NCT01495429|upper extremity catheter related large vein thrombosis|upper extremity catheter related large vein thrombosis
339034|NCT01495403|liver cirrhosis|liver cirrhosis
339035|NCT01495403|muscle cramps|muscle cramps
339036|NCT01495390|Biomarkers|biomarkers
339037|NCT01495390|Biological Markers|biological markers
339038|NCT01495390|Surrogate Markers|surrogate markers
339039|NCT01495390|Clinical Markers|clinical markers
339040|NCT01495390|Plasma|plasma
339041|NCT01495390|Cerebrospinal Fluid|cerebrospinal fluid
339042|NCT01495390|DNA|dna
339043|NCT01495390|Serum|serum
339044|NCT01495390|RNA|rna
339045|NCT01495377|swallowing difficulties|swallowing difficulties
339046|NCT01495377|remifentanil|remifentanil
339047|NCT01495377|pulmonary aspiration|pulmonary aspiration
339048|NCT01495377|scintigraphy|scintigraphy
339049|NCT01495364|STEMI|stemi
339050|NCT01495325|Firefighter|firefighter
339051|NCT01495325|Woodsmoke|woodsmoke
339052|NCT01495325|Vascular function|vascular function
339053|NCT01495325|Air Pollution|air pollution
339054|NCT01495325|Endothelial function|endothelial function
339055|NCT01495325|Thrombosis|thrombosis
339056|NCT01495312|IOP fluctuations|iop fluctuations
339057|NCT01495312|during two 24-hour periods|during two 24-hour periods
339058|NCT01495299|relationship|relationship
339059|NCT01495299|IOP fluctuations|iop fluctuations
339060|NCT01495299|glaucoma|glaucoma
339061|NCT01495299|cataract surgery|cataract surgery
339062|NCT01495299|SENSIMED Triggerfish|sensimed triggerfish
339063|NCT01495286|newborn infant|newborn infant
339064|NCT01495286|acupuncture|acupuncture
339065|NCT01495286|safety|safety
339066|NCT01495286|pain|pain
339067|NCT01495260|XALD|xald
339068|NCT01495260|AMN|amn
339069|NCT01495247|Locally advanced|locally advanced
339070|NCT01495247|metastatic|metastatic
339071|NCT01495247|breast cancer|breast cancer
339072|NCT01495247|HER2 negative|her2 negative
339073|NCT01495247|PI3K pathway|pi3k pathway
339074|NCT01495247|paclitaxel|paclitaxel
339075|NCT01495247|mTOR inhibitor|mtor inhibitor
339076|NCT01495234|Spinal degeneration|spinal degeneration
339077|NCT01495195|Acetylcholine|acetylcholine
339078|NCT01495195|Cholinesterases|cholinesterases
339079|NCT01495195|Cocaine|cocaine
339080|NCT01495195|Self-Administration|self-administration
339081|NCT01495182|Dietary fiber|dietary fiber
339082|NCT01495182|Gastrointestinal toleration|gastrointestinal toleration
339083|NCT01495182|Fecal weight|fecal weight
339084|NCT01495169|Antipsychotic|antipsychotic
339085|NCT01495169|Schizophrenia|schizophrenia
339086|NCT01495169|Bipolar disorder|bipolar disorder
339087|NCT01495169|Iloperidone|iloperidone
329798|NCT01534546|DFS|dfs
339088|NCT01495143|Glucose|glucose
339089|NCT01495143|Lactate pyruvate ratio|lactate pyruvate ratio
339090|NCT01495143|Glycerol|glycerol
339091|NCT01495143|Paraspinal muscle|paraspinal muscle
339092|NCT01495143|Microdialysis|microdialysis
339093|NCT01495117|surgical site infection|surgical site infection
339094|NCT01495117|chlorhexidine gluconate|chlorhexidine gluconate
339095|NCT01495117|povidone iodine|povidone iodine
339096|NCT01495091|coronary artery disease|coronary artery disease
339097|NCT01495091|cardiovascular disease|cardiovascular disease
339098|NCT01495091|exercise stress testing|exercise stress testing
339099|NCT01495091|biomarkers|biomarkers
339100|NCT01495091|NT-pro-BNP|nt-pro-bnp
339101|NCT01495078|telemonitoring|telemonitoring
339102|NCT01495078|heart failure|heart failure
339103|NCT01495065|GSK2251052, healthy volunteer, safety, tolerability, pharmacokinetics, single|gsk2251052, healthy volunteer, safety, tolerability, pharmacokinetics, single
339104|NCT01495052|naked oat (Avena nuda L.)|naked oat (avena nuda l.)
339105|NCT01495052|diabetes mellitus|diabetes mellitus
339106|NCT01495052|RCT|rct
339107|NCT01495026|Healthy male subjects|healthy male subjects
339108|NCT01495026|North-East Asian ancestry|north-east asian ancestry
339109|NCT01495026|Bioequivalence|bioequivalence
339123|NCT01495000|bone mineral density|bone mineral density
339124|NCT01495000|denosumab|denosumab
339125|NCT01494987|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
339126|NCT01494974|Glaucoma|glaucoma
339127|NCT01494974|Pediatric|pediatric
339128|NCT01494974|Ahmed|ahmed
339129|NCT01494974|Congenital|congenital
339130|NCT01494974|FP7|fp7
339132|NCT01494961|Partner HIV testing|partner hiv testing
339133|NCT01494961|Couple HIV counseling|couple hiv counseling
339134|NCT01494961|Couple communication on sexual and reproductive health|couple communication on sexual and reproductive health
339135|NCT01494961|HIV incidence|hiv incidence
339136|NCT01494961|Incidence of pregnancies|incidence of pregnancies
339137|NCT01494961|Disclosure|disclosure
339138|NCT01494961|Condom use|condom use
339139|NCT01494922|Skin scarring|skin scarring
339140|NCT01494922|cicatrix|cicatrix
339141|NCT01494922|hypertrophic scar|hypertrophic scar
339142|NCT01494922|hypertrophic scar prevention|hypertrophic scar prevention
339143|NCT01494909|protein digestion|protein digestion
339144|NCT01494909|fat absorption|fat absorption
339145|NCT01494909|gut function|gut function
339146|NCT01494909|glucose absorption|glucose absorption
339148|NCT01494909|pancreatic intake|pancreatic intake
339149|NCT01494909|feeding|feeding
339150|NCT01494896|Pulmonary Hypertension|pulmonary hypertension
339151|NCT01494896|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
339152|NCT01494896|COPD|copd
339153|NCT01494896|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
339154|NCT01494896|Tyvaso|tyvaso
339155|NCT01494896|Inhaled Treprostinil Sodium|inhaled treprostinil sodium
339156|NCT01494896|Ventilation Perfusion Matching|ventilation perfusion matching
339157|NCT01494896|HO Group 1 Pulmonary Arterial Hypertension|ho group 1 pulmonary arterial hypertension
339158|NCT01494896|Concomitant Chronic Obstructive Pulmonary Disease|concomitant chronic obstructive pulmonary disease
339159|NCT01494883|Mindfulness Based Stress Reduction|mindfulness based stress reduction
339160|NCT01494883|lung cancer|lung cancer
339161|NCT01494883|psychological distress|psychological distress
339162|NCT01494883|caretakers|caretakers
339163|NCT01494870|acute coronary syndrome|acute coronary syndrome
339164|NCT01494870|percutaneous coronary intervention|percutaneous coronary intervention
339165|NCT01494870|left bundle branch block|left bundle branch block
339166|NCT01494857|Ulcerative colitis|ulcerative colitis
339167|NCT01494857|biological treatment|biological treatment
339168|NCT01494857|anti-TNF|anti-tnf
339169|NCT01494844|Patient Monitoring|patient monitoring
339170|NCT01494844|Capnography|capnography
339171|NCT01494844|Human Engineering|human engineering
339172|NCT01494818|Contact lenses|contact lenses
339173|NCT01494818|Contact lens solutions|contact lens solutions
339188|NCT01494779|children|children
339189|NCT01494766|RLS|rls
339190|NCT01494740|H1N1|h1n1
339191|NCT01494740|Vaccine|vaccine
339192|NCT01494740|Immunogenicity|immunogenicity
339193|NCT01494740|Safety|safety
339194|NCT01494740|infants|infants
339195|NCT01494727|Safety|safety
339196|NCT01494727|Pharmacokinetics|pharmacokinetics
339197|NCT01494714|Healthy volunteers|healthy volunteers
339198|NCT01494714|JNJ 10229570-AAA|jnj 10229570-aaa
339199|NCT01494714|Skin irritation|skin irritation
339200|NCT01494714|Skin photo irritation|skin photo irritation
339201|NCT01494701|Spinal Muscular Atrophy|spinal muscular atrophy
339202|NCT01494701|SMA|sma
339203|NCT01494701|SMN|smn
339204|NCT01494701|SMNRx|smnrx
339205|NCT01494701|ISIS-SMNRx|isis-smnrx
339206|NCT01494701|ISIS-SMN Rx|isis-smn rx
339207|NCT01494701|ISIS 396443|isis 396443
339208|NCT01494701|IONIS-SMNRx|ionis-smnrx
339209|NCT01494701|IONIS-SMN Rx|ionis-smn rx
339210|NCT01494701|Spinraza|spinraza
339211|NCT01494675|procalcitonin|procalcitonin
339212|NCT01494675|duration of the antibiotic therapy|duration of the antibiotic therapy
339213|NCT01494675|sepsis|sepsis
339214|NCT01494662|HER2 Positive|her2 positive
339215|NCT01494662|BrCa|brca
339216|NCT01494649|dentinal|dentinal
339217|NCT01494649|hypersensitivity|hypersensitivity
339218|NCT01494636|Capsaicin Challenge|capsaicin challenge
339219|NCT01494636|Pharmacodynamics|pharmacodynamics
339220|NCT01494636|Safety|safety
339221|NCT01494636|Pharmacokinetics|pharmacokinetics
339222|NCT01494636|Oral GSK2339345|oral gsk2339345
339223|NCT01494636|Tolerability|tolerability
339224|NCT01494636|FTIH|ftih
339225|NCT01494636|Chronic Cough|chronic cough
339226|NCT01494623|working memory|working memory
339227|NCT01494623|schizophrenia|schizophrenia
339228|NCT01494623|cognition|cognition
339229|NCT01494623|rTMS|rtms
339230|NCT01494610|safety|safety
339231|NCT01494610|replicated cross-over design|replicated cross-over design
339232|NCT01494610|pharmacodynamics|pharmacodynamics
339233|NCT01494610|Fluticasone propionate/Salmeterol|fluticasone propionate/salmeterol
339234|NCT01494610|capsule-based inhaler|capsule-based inhaler
339235|NCT01494610|COPD|copd
339236|NCT01494610|asthma|asthma
339237|NCT01494610|multi dose dry powder inhaler|multi dose dry powder inhaler
339238|NCT01494610|bioavailability|bioavailability
339239|NCT01494610|pharmacokinetics|pharmacokinetics
339240|NCT01494597|Isavuconazole|isavuconazole
339241|NCT01494597|Cyclosporine|cyclosporine
339242|NCT01494597|Healthy Volunteers|healthy volunteers
339243|NCT01494597|BAL8557|bal8557
339244|NCT01494597|Pharmacokinetics of isavuconazole|pharmacokinetics of isavuconazole
339245|NCT01494597|Pharmacokinetics of cyclosporine|pharmacokinetics of cyclosporine
339246|NCT01494558|Overall survival|overall survival
339247|NCT01494545|DAILIES TOTAL1|dailies total1
339248|NCT01494545|Alcon|alcon
339249|NCT01494545|contact lens|contact lens
339250|NCT01494519|External ring fixation|external ring fixation
339251|NCT01494519|internal fixation|internal fixation
339252|NCT01494519|traumatic tibia fracture|traumatic tibia fracture
339253|NCT01494506|Pancreatic cancer|pancreatic cancer
339254|NCT01494506|MM-398|mm-398
339255|NCT01494506|PEP02|pep02
339256|NCT01494506|Metastatic pancreatic cancer|metastatic pancreatic cancer
339257|NCT01494506|Gemcitabine refractory pancreatic cancer|gemcitabine refractory pancreatic cancer
339258|NCT01494506|Second line pancreatic cancer treatment|second line pancreatic cancer treatment
339259|NCT01494506|Pancreatic cancer post gemcitabine therapy|pancreatic cancer post gemcitabine therapy
339260|NCT01494493|symptomatic degenerative disc disease|symptomatic degenerative disc disease
339262|NCT01494480|stem cell|stem cell
339263|NCT01494467|PPR|ppr
339264|NCT01494454|Lumbar degenerative disc disease|lumbar degenerative disc disease
339265|NCT01494441|lumbar degenerative disc disease|lumbar degenerative disc disease
339266|NCT01494428|symptomatic degenerative disc disease|symptomatic degenerative disc disease
339267|NCT01494415|Squamous Cell Lung Cancer|squamous cell lung cancer
339268|NCT01494415|radiation therapy|radiation therapy
339269|NCT01494415|chemotherapy|chemotherapy
339270|NCT01494402|Healthy volunteer, Japanese males, homo-EM|healthy volunteer, japanese males, homo-em
339271|NCT01494389|CD4+T lymphocyte subsets|cd4+t lymphocyte subsets
339272|NCT01494389|sepsis|sepsis
339273|NCT01494389|immunoparalysis|immunoparalysis
339274|NCT01493323|Psychic pain|psychic pain
339275|NCT01493323|Social exclusion|social exclusion
339276|NCT01493323|Mood disorders|mood disorders
339277|NCT01493323|Suicide, attempted|suicide, attempted
339278|NCT01493323|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
339279|NCT01493323|Genetic|genetic
339280|NCT01493323|Physic pain|physic pain
339281|NCT01493297|Retinyl palmitate, beta-carotene, stable isotopes, radio isotopes|retinyl palmitate, beta-carotene, stable isotopes, radio isotopes
339282|NCT01493284|aortic stenosis|aortic stenosis
339283|NCT01493284|aortic valve stenosis|aortic valve stenosis
339284|NCT01493284|valvular heart disease|valvular heart disease
339285|NCT01493284|aortic valve replacement|aortic valve replacement
339286|NCT01493284|transcatheter aortic valve implantation|transcatheter aortic valve implantation
339287|NCT01493284|TAVI|tavi
339288|NCT01493258|Diabetes|diabetes
339289|NCT01493258|Comparative Effectiveness Research|comparative effectiveness research
339290|NCT01493258|Interactive computer-assisted education|interactive computer-assisted education
339291|NCT01493258|Informatics|informatics
339292|NCT01493245|Chronic Pain|chronic pain
339293|NCT01493245|JNS020QD|jns020qd
339294|NCT01493245|Fentanyl|fentanyl
339295|NCT01493245|Opioid analgesics|opioid analgesics
339296|NCT01493232|Lingualized occlusion|lingualized occlusion
339297|NCT01493232|Complete denture occlusion|complete denture occlusion
339298|NCT01493232|Fully bilateral balanced occlusion|fully bilateral balanced occlusion
339299|NCT01493232|Patient satisfaction of complete denture|patient satisfaction of complete denture
339300|NCT01493219|Glioblastoma|glioblastoma
339301|NCT01493219|Glioblastoma Multiforme|glioblastoma multiforme
339302|NCT01493219|Astrocytoma|astrocytoma
339303|NCT01493219|Gliosarcoma|gliosarcoma
339304|NCT01493219|Glioma WHO grade IV|glioma who grade iv
720768|NCT01050699|fentanyl|fentanyl
339305|NCT01493206|intraoperative radiotherapy|intraoperative radiotherapy
339306|NCT01494350|cutaneous leishmaniasis|cutaneous leishmaniasis
339307|NCT01494350|topical treatment|topical treatment
339309|NCT01494337|LASER|laser
339310|NCT01494337|BPH|bph
339311|NCT01494337|Prostate surgery|prostate surgery
339312|NCT01494337|HOLEP|holep
339313|NCT01494337|Green light PVP|green light pvp
339314|NCT01494324|Liver|liver
339315|NCT01494324|Thermal Ablation|thermal ablation
339316|NCT01494324|Dynamic CT|dynamic ct
339317|NCT01494324|09-122|09-122
339318|NCT01494311|Arterial catheter|arterial catheter
339319|NCT01494311|arterial cannula|arterial cannula
339320|NCT01494311|Rapydan|rapydan
339321|NCT01494311|lidocaine/tetracaine patch|lidocaine/tetracaine patch
339322|NCT01494311|topical anaesthesia|topical anaesthesia
339323|NCT01494298|Type 2 diabetes|type 2 diabetes
339324|NCT01494298|African American|african american
339325|NCT01494298|cholesterol|cholesterol
339326|NCT01494298|lipoprotein|lipoprotein
339327|NCT01494298|apolipoprotein|apolipoprotein
339328|NCT01494285|Acne Vulgaris|acne vulgaris
339330|NCT01494285|Foam|foam
339331|NCT01494272|caudal epidural analgesia|caudal epidural analgesia
339332|NCT01494272|elective circumcision|elective circumcision
339333|NCT01494272|elective inguinal herniorrhaphy|elective inguinal herniorrhaphy
339334|NCT01494259|immediate breast reconstruction|immediate breast reconstruction
339335|NCT01494259|pain control|pain control
339336|NCT01494259|post mastectomy pain control|post mastectomy pain control
339337|NCT01494246|Adult|adult
339338|NCT01494246|computer-assisted instruction|computer-assisted instruction
339339|NCT01494246|electronic mail|electronic mail
339340|NCT01494246|program evaluation|program evaluation
339341|NCT01494246|smoking cessation/methods|smoking cessation/methods
339342|NCT01494246|continued abstinence|continued abstinence
339343|NCT01494220|Bispectral index; anesthesia|bispectral index; anesthesia
339344|NCT01494220|liver transplantation|liver transplantation
339345|NCT01494220|independent factors|independent factors
339346|NCT01494220|outcome|outcome
339347|NCT01494220|Living donor liver transplantation|living donor liver transplantation
339348|NCT01494207|worksite|worksite
339349|NCT01494207|interventions|interventions
339350|NCT01494207|motivational interviewing|motivational interviewing
339351|NCT01494207|physical activity|physical activity
339352|NCT01494194|Mold sensitized|mold sensitized
339353|NCT01494181|obstructive sleep apnea|obstructive sleep apnea
339354|NCT01494181|vascular events|vascular events
339355|NCT01494168|Hypertension|hypertension
339356|NCT01494168|Arterial stiffness|arterial stiffness
339357|NCT01494168|Obesity|obesity
339358|NCT01494168|Bariatric surgery|bariatric surgery
339359|NCT01494155|resectable pancreatic cancer|resectable pancreatic cancer
339360|NCT01494155|pancreaticoduodenectomy|pancreaticoduodenectomy
339361|NCT01494142|Registry|registry
339362|NCT01494142|Atopic Dermatitis|atopic dermatitis
339363|NCT01494142|Eczema Herpeticum|eczema herpeticum
339365|NCT01494142|Staphylococcus aureus|staphylococcus aureus
339366|NCT01494116|Pediatrics|pediatrics
339367|NCT01494116|Fluid|fluid
339368|NCT01494116|Bolus|bolus
339369|NCT01494116|Resuscitation|resuscitation
339370|NCT01494116|Shock|shock
339371|NCT01494103|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
339372|NCT01494103|Myelodysplastic syndrome|myelodysplastic syndrome
339373|NCT01494103|Acute myeloid leukemia|acute myeloid leukemia
339374|NCT01494103|Chronic myelogenous leukemia|chronic myelogenous leukemia
339375|NCT01494103|Non Hodgkin lymphoma|non hodgkin lymphoma
339376|NCT01494103|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
339377|NCT01494103|Familial hemophagocytic lymphohistiocytosis|familial hemophagocytic lymphohistiocytosis
339378|NCT01494103|Hemophagocytic syndrome|hemophagocytic syndrome
339379|NCT01494103|Epstein Barr virus infection|epstein barr virus infection
339380|NCT01494103|X-linked lymphoproliferative disease|x-linked lymphoproliferative disease
339381|NCT01494090|Venous thromboembolism|venous thromboembolism
339382|NCT01494090|Hip fracture|hip fracture
339383|NCT01494090|Cardiovascular events|cardiovascular events
339384|NCT01494090|Statin|statin
339385|NCT01494077|Pancreatic Cyst Fluid|pancreatic cyst fluid
339386|NCT01494077|Dilution|dilution
339387|NCT01494077|Carcinoembryonic Antigen (CEA)|carcinoembryonic antigen (cea)
339388|NCT01494051|fatty acid oxidation disorders|fatty acid oxidation disorders
339389|NCT01494025|Diabetes|diabetes
339390|NCT01494025|Pre-diabetes|pre-diabetes
339391|NCT01494025|Obese|obese
339392|NCT01493999|Clopidogrel|clopidogrel
339393|NCT01493999|prasugrel|prasugrel
339394|NCT01493999|HPR|hpr
339395|NCT01493999|loading dose|loading dose
339396|NCT01493999|maintenance dose|maintenance dose
339397|NCT01493999|stent thrombosis|stent thrombosis
339398|NCT01493999|platelet reactivity|platelet reactivity
339399|NCT01493999|Coronary intervention|coronary intervention
339400|NCT01493999|stent implantation|stent implantation
339401|NCT01493986|Ropivacaine|ropivacaine
339402|NCT01493986|Brachial plexus|brachial plexus
339403|NCT01493973|Erythropoietin|erythropoietin
339405|NCT01493973|Friedreich|friedreich
339406|NCT01493973|Ataxia|ataxia
339407|NCT01493973|Epoetin alfa|epoetin alfa
421699|NCT00002115|Adenine|adenine
339408|NCT01493973|VO2 max|vo2 max
339409|NCT01493973|SARA|sara
339410|NCT01493973|EQ-5D|eq-5d
339411|NCT01493973|frataxin|frataxin
339412|NCT01493960|Colitis, Ulcerative|colitis, ulcerative
339413|NCT01493960|Gastrointestinal Diseases|gastrointestinal diseases
339414|NCT01493960|Inflammatory Bowel Diseases|inflammatory bowel diseases
339415|NCT01493960|Immunomodulatory Therapy|immunomodulatory therapy
339416|NCT01493960|Glucocorticoids|glucocorticoids
339417|NCT01493960|Anti-Inflammatory Agents|anti-inflammatory agents
339418|NCT01493960|Therapeutic uses|therapeutic uses
339419|NCT01493934|metabolic syndrome|metabolic syndrome
339420|NCT01493934|type 2 diabetes mellitus|type 2 diabetes mellitus
339421|NCT01493934|insulin resistance|insulin resistance
339422|NCT01493934|Scintigraphy|scintigraphy
339423|NCT01493921|SR-T100 Clinical treatment against Actinic Keratosis|sr-t100 clinical treatment against actinic keratosis
339424|NCT01493921|Actinic keratosis skin lesion treatment with SR-T100 gel|actinic keratosis skin lesion treatment with sr-t100 gel
339425|NCT01493921|Skin lesion treatment with SR-T100 gel|skin lesion treatment with sr-t100 gel
339426|NCT01493921|SR-T100 gel treatment against skin lesion|sr-t100 gel treatment against skin lesion
339427|NCT01493921|Clinical efficacy study of SR-T100 gel|clinical efficacy study of sr-t100 gel
339428|NCT01493908|Placebo effect;|placebo effect;
339429|NCT01493908|Pain; Analgesic;|pain; analgesic;
339430|NCT01493908|Electrical shock|electrical shock
339431|NCT01493908|control in healthy volunteers|control in healthy volunteers
339432|NCT01493882|Uncontrolled Persistent Asthma, Dyspnea, Wheezing|uncontrolled persistent asthma, dyspnea, wheezing
339433|NCT01493869|Normal healthy adult subjects|normal healthy adult subjects
339434|NCT01493869|Adult subjects with hepatic impairment|adult subjects with hepatic impairment
339435|NCT01493830|neuroblastoma|neuroblastoma
339436|NCT01493804|Near Infrared Spectroscopy|near infrared spectroscopy
339437|NCT01493804|EEG|eeg
339438|NCT01493804|Brain Connectivity|brain connectivity
339439|NCT01493804|Healthy Volunteer|healthy volunteer
339440|NCT01493804|HV|hv
339441|NCT01493791|CDB-2914|cdb-2914
339442|NCT01493791|Abnormal Urine Bleeding|abnormal urine bleeding
339443|NCT01493791|Abnormal Uterine Bleeding|abnormal uterine bleeding
339444|NCT01493700|heated circuit|heated circuit
339445|NCT01493700|body temperature|body temperature
339446|NCT01493674|folate|folate
339447|NCT01493674|homocysteine|homocysteine
339448|NCT01493674|cognitive function|cognitive function
339449|NCT01493674|eating disorders|eating disorders
339450|NCT01493674|depression.|depression.
339451|NCT01493661|Sleep|sleep
339452|NCT01493661|Polysomnography|polysomnography
339453|NCT01493661|Reaction Time|reaction time
339454|NCT01493661|Sleep Deprivation|sleep deprivation
339455|NCT01493661|Psychophysiology|psychophysiology
339456|NCT01493661|Chronic sleep restriction|chronic sleep restriction
339457|NCT01493661|healthy|healthy
339458|NCT01493661|without sleep complaints|without sleep complaints
339459|NCT01493648|statins|statins
339460|NCT01493648|side effects|side effects
339461|NCT01493648|muscle|muscle
339462|NCT01493648|vitamin D|vitamin d
339463|NCT01493648|biopsy|biopsy
339464|NCT01493648|strength|strength
339465|NCT01493648|fatigue|fatigue
339466|NCT01493622|Schizophrenia minocycline cognition|schizophrenia minocycline cognition
339467|NCT01493596|Safety|safety
339468|NCT01493596|Tolerability|tolerability
339469|NCT01493583|severely obese|severely obese
339470|NCT01493583|Roux-en Y gastric bypass surgery (RYGB)|roux-en y gastric bypass surgery (rygb)
339471|NCT01493583|brain activity by fMRI|brain activity by fmri
339472|NCT01493583|visual presentation of food and non-food-related pictures|visual presentation of food and non-food-related pictures
339473|NCT01493544|COPD|copd
339474|NCT01493544|smokers|smokers
339475|NCT01493544|primary care|primary care
339476|NCT01493531|Gout|gout
339477|NCT01493518|SAFETY|safety
339478|NCT01493518|ADULT|adult
339479|NCT01493518|PSORIASIS|psoriasis
339480|NCT01493518|INFLAMMATION|inflammation
339481|NCT01493505|Primary Peritoneal Cancer|primary peritoneal cancer
339482|NCT01493492|proteomics,urinary,sepsis,prognosis|proteomics,urinary,sepsis,prognosis
339483|NCT01493466|proteomics,|proteomics,
339484|NCT01493466|serum,|serum,
339485|NCT01493466|sepsis,|sepsis,
339486|NCT01493466|potential biomarkers,|potential biomarkers,
339487|NCT01493466|dynamic changes|dynamic changes
339488|NCT01493466|normal|normal
339489|NCT01493440|atosiban|atosiban
339490|NCT01493440|clinical pregnancy|clinical pregnancy
339491|NCT01493440|implantation rate|implantation rate
339492|NCT01493440|uterine contractility|uterine contractility
339493|NCT01493440|IVF-ET|ivf-et
339494|NCT01493427|Glaucoma|glaucoma
339496|NCT01493427|OHT|oht
339497|NCT01493414|INC424|inc424
339498|NCT01493414|Ruxolitinib|ruxolitinib
339499|NCT01493414|myelofibrosis|myelofibrosis
339500|NCT01493414|PMF|pmf
339147|NCT01494909|CF|cf
339501|NCT01493414|post polycythemia myelofibrosis|post polycythemia myelofibrosis
339502|NCT01493414|PPV MF|ppv mf
752626|NCT01173380|Endothelial function|endothelial function
339503|NCT01493414|post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
339504|NCT01493414|PET-MF|pet-mf
339505|NCT01493375|Contamination, hip operation, knee operation|contamination, hip operation, knee operation
339506|NCT01493362|Bulimia Nervosa|bulimia nervosa
339507|NCT01493362|PET Imaging|pet imaging
339508|NCT01493362|Dopamine|dopamine
339509|NCT01493349|Colonic diverticula|colonic diverticula
339510|NCT01493349|Diverticulitis|diverticulitis
339511|NCT01493167|cast|cast
339512|NCT01493167|splint|splint
339513|NCT01493167|circumferential casting|circumferential casting
339514|NCT01493167|casting techniques|casting techniques
339515|NCT01493167|fracture in extremity|fracture in extremity
339516|NCT01493154|HPV|hpv
339517|NCT01493154|Head and Neck Cancer|head and neck cancer
339518|NCT01493154|Vaccine|vaccine
339519|NCT01493154|Immunotherapy|immunotherapy
339520|NCT01493154|Cyclophosphamide|cyclophosphamide
339521|NCT01493154|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
339522|NCT01493141|MOMHR|momhr
339523|NCT01493141|THA|tha
339834|NCT01491958|Leukemia|leukemia
339524|NCT01493141|Osteoarthritis|osteoarthritis
339525|NCT01493128|atrial fibrillation|atrial fibrillation
339526|NCT01493128|atrial cells|atrial cells
339527|NCT01493128|myocardial tissue|myocardial tissue
339528|NCT01493128|t-tubules|t-tubules
339529|NCT01493128|immunofluorescence|immunofluorescence
339530|NCT01493102|septic shock|septic shock
339531|NCT01493102|norepinephrine|norepinephrine
339532|NCT01493102|vasopressin|vasopressin
339533|NCT01493102|hypotension|hypotension
339534|NCT01493076|ERCP|ercp
339535|NCT01493076|Cannulation|cannulation
339536|NCT01493076|Precut|precut
339537|NCT01493076|Mini-spincterotome|mini-spincterotome
339538|NCT01493063|preterm infant|preterm infant
339539|NCT01493050|Diabetic Nephropathy|diabetic nephropathy
339540|NCT01493050|Sevelamer Carbonate|sevelamer carbonate
339541|NCT01493037|STEMI|stemi
339542|NCT01493037|PICSO|picso
339543|NCT01493037|Coronary Sinus|coronary sinus
339544|NCT01493037|Involving Left Anterior Descending Coronary Artery|involving left anterior descending coronary artery
339545|NCT01492998|Hepatitis C virus|hepatitis c virus
339546|NCT01492998|Biliary salts|biliary salts
339547|NCT01492998|Farnesoid X receptor|farnesoid x receptor
339548|NCT01492998|Guggulsterone|guggulsterone
339549|NCT01492972|Prostate|prostate
339550|NCT01492972|proton|proton
339551|NCT01492972|radiation|radiation
339552|NCT01492972|intermediate risk|intermediate risk
339553|NCT01492946|Malnutrition|malnutrition
339554|NCT01492946|Post-operative outcome|post-operative outcome
339555|NCT01492946|Phase angle|phase angle
339556|NCT01492946|MUST|must
339557|NCT01492946|Clavien Dindo classification|clavien dindo classification
339558|NCT01492946|Bioelectrical impedance analysis|bioelectrical impedance analysis
339559|NCT01492933|Ethanol|ethanol
339560|NCT01492933|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
339561|NCT01492933|Spectroscopy|spectroscopy
339562|NCT01492933|Alcohol Use|alcohol use
339563|NCT01492907|Heterocyclic amine carcinogens|heterocyclic amine carcinogens
339564|NCT01492907|meat-borne carcinogens|meat-borne carcinogens
339565|NCT01492881|relapsed multiple myeloma|relapsed multiple myeloma
339566|NCT01492881|refractory multiple myeloma|refractory multiple myeloma
339567|NCT01492881|vorinostat|vorinostat
339568|NCT01492881|bortezomib|bortezomib
339569|NCT01492881|doxil|doxil
339570|NCT01492868|sinusitis|sinusitis
339571|NCT01492868|upper respiratory infection|upper respiratory infection
339572|NCT01492855|Meniscal lesions|meniscal lesions
339573|NCT01492855|MRI|mri
339574|NCT01492855|arthroscopic treatment|arthroscopic treatment
339575|NCT01492829|HIV prevention|hiv prevention
339576|NCT01492829|sexually transmitted infection prevention|sexually transmitted infection prevention
339577|NCT01492829|HIV knowledge|hiv knowledge
339578|NCT01492829|relationship power|relationship power
339579|NCT01492829|depression|depression
339580|NCT01492829|coping|coping
339581|NCT01492829|social support|social support
339582|NCT01492829|internally displaced persons|internally displaced persons
339583|NCT01492829|community health worker|community health worker
339584|NCT01492829|HIV/STI educational video|hiv/sti educational video
339585|NCT01492829|substance use|substance use
339586|NCT01492829|women's health|women's health
339587|NCT01492816|HIV prevention|hiv prevention
339588|NCT01492816|HIV positive communities|hiv positive communities
339589|NCT01492803|HIV infection|hiv infection
339590|NCT01492803|Probiotics|probiotics
339591|NCT01492764|Ventricular Tachyarrhythmia|ventricular tachyarrhythmia
339592|NCT01492764|Ablation|ablation
339593|NCT01492764|Electrophysiology|electrophysiology
339594|NCT01492764|Human|human
339595|NCT01492764|Mapping|mapping
339596|NCT01492751|Prostatic Neoplasms|prostatic neoplasms
339597|NCT01492751|Radiotherapy conformal|radiotherapy conformal
339598|NCT01492751|brachytherapy|brachytherapy
339599|NCT01492751|radical prostatectomy|radical prostatectomy
339600|NCT01492751|Quality of life|quality of life
339601|NCT01492751|biochemical relapse|biochemical relapse
339602|NCT01492751|biochemical failure|biochemical failure
586559|NCT00516698|stage IIIC breast cancer|stage iiic breast cancer
339604|NCT01492751|Clinically localized prostate cancer|clinically localized prostate cancer
339605|NCT01492738|Acupuncture|acupuncture
339606|NCT01492738|anxiety|anxiety
339607|NCT01492738|memory|memory
339608|NCT01492712|Propofol|propofol
339609|NCT01492712|Pharmacokinetics|pharmacokinetics
339610|NCT01492712|Pharmacodynamics|pharmacodynamics
339611|NCT01492712|Infusion Pumps|infusion pumps
339612|NCT01492699|PTSD|ptsd
339613|NCT01492699|Post Traumatic Stress Disorder|post traumatic stress disorder
339614|NCT01492686|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
339615|NCT01492673|Ewing's sarcoma|ewing's sarcoma
339616|NCT01492673|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
339617|NCT01492673|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
339618|NCT01492673|TOPOTECAN|topotecan
339619|NCT01492673|11-183|11-183
339620|NCT01492673|POETIC|poetic
339621|NCT01492660|Ultrasonography|ultrasonography
339622|NCT01492660|nerve block|nerve block
339623|NCT01492660|catheters|catheters
339624|NCT01492660|needle|needle
339625|NCT01492660|anesthesia|anesthesia
339626|NCT01492647|Acne vulgaris|acne vulgaris
339627|NCT01492647|JNJ 10229570-AAA|jnj 10229570-aaa
339628|NCT01492647|Japanese patients|japanese patients
339629|NCT01492647|Topical treatment|topical treatment
339630|NCT01492634|bioimpedance|bioimpedance
339631|NCT01492634|overhydration|overhydration
339632|NCT01492634|dry weight|dry weight
339633|NCT01492621|major depression|major depression
339634|NCT01492621|DTI|dti
339635|NCT01492621|inflammatory markers|inflammatory markers
339636|NCT01492621|cognition|cognition
339637|NCT01492608|magnesium sulphate|magnesium sulphate
339638|NCT01492608|preterm birth|preterm birth
339639|NCT01492608|cerebral palsy|cerebral palsy
339640|NCT01492595|contact|contact
339641|NCT01492556|Recurrent|recurrent
339642|NCT01492556|Metastatic|metastatic
339643|NCT01492556|Breast cancer|breast cancer
339644|NCT01492543|Advanced|advanced
339645|NCT01492543|Metastatic|metastatic
339646|NCT01492543|Breast cancer|breast cancer
339647|NCT01492530|Men who have sex with Men and Women|men who have sex with men and women
339648|NCT01492530|HIV Prevention|hiv prevention
339649|NCT01492530|Behavioral Intervention|behavioral intervention
339650|NCT01492530|Condom use|condom use
339651|NCT01492530|African American MSMW|african american msmw
339652|NCT01492517|Controlled Human exposure study|controlled human exposure study
339653|NCT01492517|Air Pollution|air pollution
339654|NCT01492517|Gene expression|gene expression
339655|NCT01492517|Epigenetic|epigenetic
339656|NCT01492517|Cardiovascular|cardiovascular
339657|NCT01492491|SUPRA-HFR|supra-hfr
339658|NCT01492491|adsorpition|adsorpition
339659|NCT01492491|vitamins|vitamins
339660|NCT01492491|large toxins|large toxins
339661|NCT01492465|Type 2 diabetes|type 2 diabetes
339662|NCT01492452|guidelines for nursing|guidelines for nursing
339663|NCT01492452|anxiety|anxiety
339664|NCT01492452|cardiac surgery|cardiac surgery
339665|NCT01492452|pediatrics|pediatrics
339666|NCT01492439|Psychosis|psychosis
339667|NCT01492439|Psychosis NOS|psychosis nos
339668|NCT01492439|Schizophrenia|schizophrenia
339669|NCT01492439|Schizoaffective Disorder|schizoaffective disorder
339670|NCT01492439|Bipolar Disorder|bipolar disorder
339671|NCT01492426|Hepatitis C Virus|hepatitis c virus
339672|NCT01492413|Overweight|overweight
339673|NCT01492413|Obesity|obesity
339674|NCT01492387|community-acquired pneumonia|community-acquired pneumonia
339675|NCT01492387|healthcare-associated pneumonia|healthcare-associated pneumonia
339676|NCT01492387|antibiotic therapy|antibiotic therapy
339677|NCT01492387|Duration of therapy|duration of therapy
339678|NCT01492361|Coronary Artery Disease|coronary artery disease
339679|NCT01492361|Myocardial Ischemia|myocardial ischemia
339680|NCT01492361|Coronary Disease|coronary disease
339681|NCT01492361|Heart Diseases|heart diseases
339682|NCT01492361|Acute Coronary Syndrome|acute coronary syndrome
339683|NCT01492361|Cardiovascular Diseases|cardiovascular diseases
339684|NCT01492361|Arteriosclerosis|arteriosclerosis
339685|NCT01492361|Arterial Occlusive Diseases|arterial occlusive diseases
339686|NCT01492361|Vascular Diseases|vascular diseases
339687|NCT01492361|Angina Pectoris|angina pectoris
339688|NCT01492361|Chest Pain|chest pain
339689|NCT01492361|Anticholesteremic Agents|anticholesteremic agents
339690|NCT01492361|Hypolipidemic Agents|hypolipidemic agents
339691|NCT01492361|Lipid Regulating Agents|lipid regulating agents
339692|NCT01492361|hypertriglyceridemia|hypertriglyceridemia
339693|NCT01492361|omega-3 fatty acids|omega-3 fatty acids
339694|NCT01492361|statin|statin
339695|NCT01492361|triglycerides|triglycerides
339696|NCT01492361|EPA|epa
339697|NCT01492361|docosahexaenoic acid|docosahexaenoic acid
339698|NCT01492361|fish|fish
339699|NCT01492361|fatty acids|fatty acids
339700|NCT01492361|fibrates|fibrates
339701|NCT01492361|niacin|niacin
339702|NCT01492361|lipids|lipids
339703|NCT01492361|lipoprotein|lipoprotein
339704|NCT01492361|atorvastatin|atorvastatin
330401|NCT01531842|CNV|cnv
339705|NCT01492361|Lovaza|lovaza
339706|NCT01492361|simvastatin|simvastatin
339707|NCT01492361|lovastatin|lovastatin
339708|NCT01492361|pravastatin|pravastatin
339709|NCT01492361|fluvastatin|fluvastatin
339710|NCT01492361|rosuvastatin|rosuvastatin
339711|NCT01492361|Trilipix|trilipix
339712|NCT01492361|Vytorin|vytorin
339713|NCT01492361|Simcor|simcor
339714|NCT01492361|ezetimibe|ezetimibe
339715|NCT01492361|Zetia|zetia
339716|NCT01492361|ethyl-EPA|ethyl-epa
339717|NCT01492361|ethyl icosapentate|ethyl icosapentate
339718|NCT01492361|Crestor|crestor
339719|NCT01492361|Zocor|zocor
339720|NCT01492361|Lipitor|lipitor
339721|NCT01492361|LDL|ldl
339722|NCT01492361|HDL|hdl
339723|NCT01492361|cholesterol|cholesterol
339724|NCT01492361|dyslipidemia|dyslipidemia
339725|NCT01492361|AMR101|amr101
339726|NCT01492361|Cardiovascular Disease, Unspecified|cardiovascular disease, unspecified
339727|NCT01492361|VASCEPA|vascepa
339728|NCT01492361|icosapent ethyl|icosapent ethyl
339729|NCT01492348|collaborative care|collaborative care
339730|NCT01492348|PTSD|ptsd
339731|NCT01492348|military|military
339732|NCT01492348|Depression|depression
339733|NCT01492348|primary care|primary care
339734|NCT01492348|care management|care management
339735|NCT01492348|stepped care|stepped care
339736|NCT01492348|telehealth|telehealth
339737|NCT01492348|OIF|oif
339738|NCT01492348|OEF|oef
339739|NCT01492348|preference-based treatment|preference-based treatment
339740|NCT01492348|cost effectiveness|cost effectiveness
339741|NCT01492348|web-based treatment|web-based treatment
339742|NCT01492348|telephonic CBT|telephonic cbt
339743|NCT01492348|evidence-based treatment|evidence-based treatment
339744|NCT01492335|Cognitive decline|cognitive decline
339745|NCT01492335|Cognitive impairment|cognitive impairment
339746|NCT01492322|Smoker|smoker
339747|NCT01492322|SPECT|spect
339748|NCT01492322|Dopamine|dopamine
339749|NCT01492322|Nicotine Sated condition|nicotine sated condition
339750|NCT01492322|Nicotine withdrawal condition|nicotine withdrawal condition
339751|NCT01492309|Major Depressive Disorder|major depressive disorder
339752|NCT01492309|Pregnancy|pregnancy
339753|NCT01492309|Brain Derived Neurotrophic Factor|brain derived neurotrophic factor
339754|NCT01492309|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
339755|NCT01492283|NAFLD|nafld
339756|NCT01492283|Incretin hormones|incretin hormones
339757|NCT01492270|Prostate Cancer|prostate cancer
339758|NCT01492270|Multi parametric MRI|multi parametric mri
339759|NCT01492270|Prostate HistoScanning|prostate histoscanning
339760|NCT01492270|Transperineal prostate mapping biopsy|transperineal prostate mapping biopsy
339761|NCT01492257|shared decision making|shared decision making
339762|NCT01492257|decision aids|decision aids
339763|NCT01492257|total joint arthroplasty|total joint arthroplasty
339764|NCT01492257|osteoarthritis|osteoarthritis
339765|NCT01492244|Knee pain|knee pain
339766|NCT01492244|map|map
339767|NCT01492244|questionnaire|questionnaire
339768|NCT01492244|survey|survey
339769|NCT01492231|gastroenterology|gastroenterology
339770|NCT01492231|Endoscopy, Digestive System|endoscopy, digestive system
339771|NCT01492231|Endosonography|endosonography
339772|NCT01492231|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
339773|NCT01492231|gastrointestinal endoscopy|gastrointestinal endoscopy
339774|NCT01492192|Angiogenesis|angiogenesis
339775|NCT01492192|PET-CT|pet-ct
339776|NCT01492192|Perfusion-CT|perfusion-ct
339777|NCT01492179|Surgery: Abdominal hysterectomy|surgery: abdominal hysterectomy
339778|NCT01492179|Anesthetics: Local|anesthetics: local
339779|NCT01492179|Postoperative: Pain|postoperative: pain
339780|NCT01492179|Drugs: Morphine|drugs: morphine
339781|NCT01492127|Hepatocellular carcinoma|hepatocellular carcinoma
339782|NCT01492127|cirrhosis|cirrhosis
339783|NCT01492127|proteasome|proteasome
339784|NCT01492127|alpha-fetoprotein|alpha-fetoprotein
339785|NCT01492114|C-reactive protein|c-reactive protein
339786|NCT01492114|Resveratrol|resveratrol
339787|NCT01492114|Redox index|redox index
339788|NCT01492088|Pediatric|pediatric
339789|NCT01492088|Lymphoma|lymphoma
339790|NCT01492088|Hodgkin|hodgkin
339791|NCT01492088|Anaplastic Large-cell|anaplastic large-cell
339792|NCT01492088|Relapsed|relapsed
339793|NCT01492088|Refractory|refractory
339794|NCT01492088|Drug therapy|drug therapy
339795|NCT01492075|Postoperative pain|postoperative pain
339796|NCT01492075|Anesthetics: Local anesthetics|anesthetics: local anesthetics
339797|NCT01492075|Surgery: Hysterectomy|surgery: hysterectomy
339798|NCT01492062|Type 1 diabetes mellitus|type 1 diabetes mellitus
339799|NCT01492062|artificial pancreas|artificial pancreas
339800|NCT01492062|closed-loop|closed-loop
339801|NCT01492049|Colorectal Neoplasms|colorectal neoplasms
339802|NCT01492049|Promoting Health Literacy|promoting health literacy
339803|NCT01492049|Patient education program|patient education program
339804|NCT01492049|Colorectal Cancer Screening|colorectal cancer screening
339805|NCT01492049|CRCS|crcs
339806|NCT01492049|Patient decision aid|patient decision aid
339807|NCT01492049|PtDA|ptda
339808|NCT01492049|Video|video
339809|NCT01492049|Questionnaires|questionnaires
339810|NCT01492049|Surveys|surveys
339811|NCT01492036|Replication-Competent Retrovirus|replication-competent retrovirus
339812|NCT01492036|RCR|rcr
339813|NCT01492036|Gene transfer therapy|gene transfer therapy
339814|NCT01492036|Registry|registry
339815|NCT01492036|Medical information database|medical information database
339816|NCT01492036|Vector or vector-treated cells|vector or vector-treated cells
339817|NCT01492036|Blood draw|blood draw
339818|NCT01492036|Computed tomography|computed tomography
339819|NCT01492036|CT|ct
339820|NCT01492036|Questionnaires|questionnaires
339821|NCT01492036|Surveys|surveys
339822|NCT01492036|Gene Transfer Research|gene transfer research
339823|NCT01492036|National Gene Vector Biorepository and Coordinating Center|national gene vector biorepository and coordinating center
339824|NCT01492036|NGVB|ngvb
339825|NCT01492023|neuropsychological|neuropsychological
339826|NCT01492023|rehabilitation|rehabilitation
339827|NCT01492023|multiple sclerosis|multiple sclerosis
339828|NCT01492023|RCT study|rct study
339829|NCT01492010|skeletal muscle|skeletal muscle
339830|NCT01492010|FSR|fsr
339831|NCT01492010|resistance exercise|resistance exercise
339832|NCT01492010|leucine|leucine
339833|NCT01492010|protein|protein
339836|NCT01491958|ALL|all
339837|NCT01491958|MDS|mds
339838|NCT01491945|Abdominal aortic aneurysm|abdominal aortic aneurysm
339839|NCT01491945|Renal stent|renal stent
339840|NCT01491945|Juxtarenal|juxtarenal
339841|NCT01491945|Pararenal|pararenal
339842|NCT01491945|Endovascular|endovascular
339843|NCT01491932|Parkinson Disease|parkinson disease
339844|NCT01491932|L-dopa|l-dopa
339845|NCT01491932|Levodopa|levodopa
339846|NCT01491932|Dyskinesia|dyskinesia
339847|NCT01491919|High Blood Pressure|high blood pressure
339848|NCT01491919|Hypertension|hypertension
339849|NCT01491919|Renal Transplantation|renal transplantation
339850|NCT01491919|Kidney Transplantation|kidney transplantation
339851|NCT01491893|GBM|gbm
339852|NCT01491893|Brain Tumor|brain tumor
339853|NCT01491893|Poliovirus Vaccine|poliovirus vaccine
339854|NCT01491893|WHO Grade IV Malignant Glioma|who grade iv malignant glioma
339855|NCT01491880|cognitive behavior therapy|cognitive behavior therapy
339856|NCT01491880|telemedicine|telemedicine
339857|NCT01491880|rural|rural
339858|NCT01491880|Latinos|latinos
339859|NCT01491880|children|children
339860|NCT01491867|intraocular pressure|intraocular pressure
339861|NCT01491854|Long-term|long-term
339862|NCT01491854|safety|safety
339863|NCT01491854|follow-up|follow-up
339864|NCT01491854|growth hormone treatment|growth hormone treatment
339865|NCT01491854|short children|short children
339866|NCT01491854|Small for Gestational Age|small for gestational age
339867|NCT01491854|Somatropin|somatropin
339868|NCT01491828|Apnea|apnea
339869|NCT01491828|Sleep apnea|sleep apnea
339870|NCT01491828|Snoring|snoring
339871|NCT01491828|Hypoglossal nerve stimulation|hypoglossal nerve stimulation
339872|NCT01491828|Laynx stimulation|laynx stimulation
339873|NCT01491802|COPD|copd
339874|NCT01491802|Combination therapy|combination therapy
339875|NCT01491802|Anticholinergic|anticholinergic
339876|NCT01491802|Beta2-agonist|beta2-agonist
339877|NCT01491802|Exercise|exercise
339878|NCT01491802|Dyspnea|dyspnea
339879|NCT01491802|Respiratory mechanics|respiratory mechanics
339880|NCT01491789|spinal cord injury|spinal cord injury
339881|NCT01491789|Virtual sailing|virtual sailing
339882|NCT01491789|Vsail|vsail
339883|NCT01491776|Group A Streptococcus|group a streptococcus
339884|NCT01491776|Strep A|strep a
339885|NCT01491776|Rapid Test|rapid test
339886|NCT01491776|Pharyngitis|pharyngitis
339887|NCT01491750|SURGERY|surgery
339888|NCT01491750|TOTAL JOINT REPLACEMENT|total joint replacement
339889|NCT01491750|TOTAL KNEE REPLACEMENT|total knee replacement
339890|NCT01491750|GUIDED IMAGERY|guided imagery
339891|NCT01491750|COMPLEMENTARY AND ALTERNATIVE THERAPY|complementary and alternative therapy
339892|NCT01491711|Superficial basal cell carcinoma|superficial basal cell carcinoma
339893|NCT01491711|Carcinoma, Basal Cell|carcinoma, basal cell
339894|NCT01491711|Skin diseases|skin diseases
339895|NCT01491711|Connective tissue diseases|connective tissue diseases
339896|NCT01491711|Treatment|treatment
339897|NCT01491711|Drug therapy|drug therapy
339898|NCT01491711|Efficacy|efficacy
339899|NCT01491711|Photodynamic therapy|photodynamic therapy
339900|NCT01491711|Photosensitizing Agents/therapeutic use|photosensitizing agents/therapeutic use
339901|NCT01491711|Aminolevulinic acid|aminolevulinic acid
339902|NCT01491711|Methylaminolevulinate|methylaminolevulinate
339903|NCT01491711|Pain measurement|pain measurement
339904|NCT01491711|Health Care Economics and Organizations|health care economics and organizations
339905|NCT01491698|stomach|stomach
339906|NCT01491698|surgery|surgery
339907|NCT01491698|Total Gastrectomy|total gastrectomy
339908|NCT01491698|Roux-En-Y Pouch Reconstruction|roux-en-y pouch reconstruction
339909|NCT01491698|Conventional Roux-En-Y Reconstruction|conventional roux-en-y reconstruction
339910|NCT01491698|Quality of Life|quality of life
339911|NCT01491698|11-170|11-170
339912|NCT01491672|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
339913|NCT01491672|Second Line|second line
339914|NCT01491672|Everolimus|everolimus
339915|NCT01491672|RAD001|rad001
339916|NCT01491646|pulmonary hypertension|pulmonary hypertension
339917|NCT01491646|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
339918|NCT01491646|Characterize and quantify RV vortex flow|characterize and quantify rv vortex flow
339919|NCT01491646|Assess feasibility of cardiac MR for RVDD diagnosis|assess feasibility of cardiac mr for rvdd diagnosis
339920|NCT01491646|Biomarker information to help diagnose|biomarker information to help diagnose
339921|NCT01491633|Lung cancer|lung cancer
339922|NCT01491633|NSCLC|nsclc
339923|NCT01491633|Stage IIIB|stage iiib
339924|NCT01491633|Stage IV|stage iv
339925|NCT01491620|poikiloderma of Civatte|poikiloderma of civatte
339926|NCT01491620|red dyschromia|red dyschromia
339927|NCT01491620|brown dyschromia|brown dyschromia
339928|NCT01491620|sun damage|sun damage
339929|NCT01491620|neck|neck
339930|NCT01491620|chest|chest
339931|NCT01491620|dyschromia|dyschromia
339932|NCT01491620|pigmentation disorders|pigmentation disorders
339933|NCT01491620|erythema|erythema
339934|NCT01491620|photosensitivity disorders|photosensitivity disorders
339935|NCT01491620|sun exposure|sun exposure
339936|NCT01491620|telangiectasia|telangiectasia
339937|NCT01491620|hyperpigmentation|hyperpigmentation
339938|NCT01491620|hypopigmentation|hypopigmentation
339939|NCT01491607|post-exposure prophylaxis|post-exposure prophylaxis
339940|NCT01491607|toxin neutralization assay|toxin neutralization assay
339941|NCT01491594|Metastatic sarcoma|metastatic sarcoma
339942|NCT01491594|Bone sarcoma|bone sarcoma
339943|NCT01491581|anthropometry|anthropometry
339944|NCT01491581|zinc|zinc
339945|NCT01491581|iodine|iodine
339946|NCT01491581|vitamin D|vitamin d
339947|NCT01491581|calcium|calcium
339948|NCT01491581|school children|school children
339949|NCT01491581|food supplement|food supplement
339950|NCT01491568|symptomatic degenerative disc disease at two levels|symptomatic degenerative disc disease at two levels
339951|NCT01491555|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
339953|NCT01491555|controls|controls
339954|NCT01491555|EIM|eim
339955|NCT01491555|QUS|qus
339956|NCT01491542|Symptomatic Degenerative Disc Disease|symptomatic degenerative disc disease
339957|NCT01491529|Parkinson Disease|parkinson disease
339958|NCT01491529|L-dopa|l-dopa
339959|NCT01491529|Levodopa|levodopa
339960|NCT01491529|Dyskinesia|dyskinesia
339961|NCT01491529|Amantadine|amantadine
339962|NCT01491516|Lumbar degenerative disc disease|lumbar degenerative disc disease
339963|NCT01491503|montelukast|montelukast
339964|NCT01491503|levocetirizine|levocetirizine
339965|NCT01491503|interaction|interaction
339966|NCT01491490|Schizophrenia|schizophrenia
339967|NCT01491490|Functional psychosis|functional psychosis
339968|NCT01491490|Schizophreniform|schizophreniform
339969|NCT01491490|Acute psychosis|acute psychosis
339970|NCT01491464|symptomatic degenerative disc disease|symptomatic degenerative disc disease
339971|NCT01491451|Degenerative lumbar disc disease|degenerative lumbar disc disease
339972|NCT01491425|symptomatic degenerative disc disease|symptomatic degenerative disc disease
339973|NCT01491412|Schizophrenia|schizophrenia
339974|NCT01491412|antipsychotics|antipsychotics
339975|NCT01491412|real life treatment|real life treatment
339976|NCT01491412|non-interventional|non-interventional
339977|NCT01491386|symptomatic degenerative disc disease|symptomatic degenerative disc disease
339978|NCT01491373|Degenerative Disc Disease|degenerative disc disease
339979|NCT01491373|Symptomatic Degenerative Disc Disease|symptomatic degenerative disc disease
339980|NCT01491360|Presbyopia|presbyopia
339981|NCT01491360|sclera|sclera
339982|NCT01491360|LaserACE|laserace
339983|NCT01491347|BDNF|bdnf
339984|NCT01491347|withdrawal|withdrawal
339985|NCT01491347|alcohol|alcohol
339986|NCT01491347|psychiatry|psychiatry
339987|NCT01491334|POP|pop
339988|NCT01491334|Pelvic Floor|pelvic floor
339989|NCT01491334|Pelvic Organ Prolapse|pelvic organ prolapse
339990|NCT01491321|chronic low back pain|chronic low back pain
340397|NCT01489865|Veliparib|veliparib
339991|NCT01491321|bee venom acupuncture|bee venom acupuncture
339992|NCT01491295|Lamivudine|lamivudine
339993|NCT01491295|adefovir add on treatment|adefovir add on treatment
339994|NCT01491295|tenofovir|tenofovir
339995|NCT01491295|chronic hepatitis B|chronic hepatitis b
339996|NCT01491282|human brown adipose tissue activity|human brown adipose tissue activity
339997|NCT01491282|obesity|obesity
339998|NCT01491282|energy metabolism|energy metabolism
339999|NCT01491282|adaptive thermogenesis|adaptive thermogenesis
340000|NCT01491269|chronic pain|chronic pain
340001|NCT01491269|internet delivered CBT|internet delivered cbt
340002|NCT01491269|tertiary intervention|tertiary intervention
340003|NCT01491269|mindfulness|mindfulness
340004|NCT01491269|applied relaxation|applied relaxation
340005|NCT01491269|guided self help|guided self help
340006|NCT01491256|Index of microcirculatory resistance|index of microcirculatory resistance
340007|NCT01491256|atorvastatin|atorvastatin
340008|NCT01491256|drug-eluting stent|drug-eluting stent
340009|NCT01491256|acute coronary syndrome|acute coronary syndrome
340010|NCT01491243|contrast-induced nephropathy|contrast-induced nephropathy
340011|NCT01491230|cancer|cancer
340012|NCT01491230|neutrophil extracellular traps|neutrophil extracellular traps
340013|NCT01491230|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
340014|NCT01491230|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
340015|NCT01491230|chemotaxis|chemotaxis
340016|NCT01491230|superoxide production|superoxide production
340017|NCT01491230|hydrogen peroxide production|hydrogen peroxide production
340018|NCT01491230|myeloperoxidase|myeloperoxidase
340019|NCT01491217|Oraxol®|oraxol®
340020|NCT01491217|oral paclitaxel|oral paclitaxel
340021|NCT01491217|paclitaxel|paclitaxel
340022|NCT01491217|HM30181A|hm30181a
340024|NCT01491217|DLT|dlt
340025|NCT01491217|RD|rd
340026|NCT01491191|surgical pain|surgical pain
340027|NCT01491191|chronic pain|chronic pain
340028|NCT01491191|prevention|prevention
340029|NCT01491191|palmitoylethanolamide|palmitoylethanolamide
340030|NCT01491165|umbilical cord mesenchyma stem cell|umbilical cord mesenchyma stem cell
340031|NCT01491152|Cerebral Palsy|cerebral palsy
340032|NCT01491152|Whole Body Vibration|whole body vibration
340033|NCT01491152|Infant|infant
340034|NCT01491152|Motor development|motor development
340035|NCT01491152|Physiotherapy|physiotherapy
340036|NCT01491139|Radiotherapy|radiotherapy
340037|NCT01491139|Biomarkers, pharmacological|biomarkers, pharmacological
340038|NCT01491139|Pharmacokinetics|pharmacokinetics
340039|NCT01491139|Genetic Markers|genetic markers
340040|NCT01491139|Cisplatin|cisplatin
340041|NCT01491139|Poly(ADP-ribose) Polymerases|poly(adp-ribose) polymerases
340042|NCT01491139|AZD 2281|azd 2281
340043|NCT01491139|Radiotherapy, Intensity-Modulated|radiotherapy, intensity-modulated
340044|NCT01491139|Head and Neck|head and neck
340045|NCT01491139|Chemoradiotherapy|chemoradiotherapy
340046|NCT01491139|SCC|scc
340047|NCT01491126|Gastroscopy|gastroscopy
340048|NCT01491126|Colonoscopy|colonoscopy
340049|NCT01491126|Anesthesia|anesthesia
340050|NCT01491126|Recovery|recovery
340051|NCT01491113|Levetiracetam|levetiracetam
340052|NCT01491113|Oral administration|oral administration
340053|NCT01491113|Japanese|japanese
340054|NCT01491113|Non-epileptic|non-epileptic
340055|NCT01491113|Healthy|healthy
340056|NCT01491113|Renal impaired subjects|renal impaired subjects
340057|NCT01491100|Cognition|cognition
340058|NCT01491100|Physical Activity|physical activity
340059|NCT01491100|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
340060|NCT01491087|Pentaxim®|pentaxim®
340061|NCT01491087|Whole-cell Pertussis vaccine|whole-cell pertussis vaccine
340062|NCT01491087|Acellular Pertussis vaccine|acellular pertussis vaccine
340063|NCT01491087|Haemophilus influenzae type b polysaccharide|haemophilus influenzae type b polysaccharide
340064|NCT01491087|Inactivated Polio vaccine|inactivated polio vaccine
340065|NCT01491087|Pentavac®|pentavac®
340066|NCT01491061|periprocedural myocardial infarction|periprocedural myocardial infarction
340067|NCT01491061|ranolazine|ranolazine
340068|NCT01491048|Hip osteoarthritis|hip osteoarthritis
340069|NCT01491048|Physiotherapy|physiotherapy
340070|NCT01491048|THA|tha
340071|NCT01491035|Children|children
340072|NCT01491035|Adolescents|adolescents
340073|NCT01491035|Pharmacokinetic|pharmacokinetic
340074|NCT01491035|Pharmacodynamic|pharmacodynamic
340075|NCT01491022|parkinson's|parkinson's
340076|NCT01491022|gait dysfunction|gait dysfunction
340077|NCT01491022|ampyra|ampyra
340078|NCT01491022|4-aminopyridine|4-aminopyridine
340079|NCT01491009|Dexmedetomidine|dexmedetomidine
340080|NCT01491009|midazolam|midazolam
340081|NCT01491009|remifentanil|remifentanil
340082|NCT01491009|mini-mental state examination|mini-mental state examination
340083|NCT01491009|monitored anaesthesia care|monitored anaesthesia care
340084|NCT01491009|cystoscopy|cystoscopy
340085|NCT01491009|sedation|sedation
340086|NCT01490996|Curcumin|curcumin
340087|NCT01490996|Colorectal cancer|colorectal cancer
340088|NCT01490996|metastases|metastases
340089|NCT01490996|FOLFOX|folfox
340398|NCT01489865|oxaliplatin|oxaliplatin
340090|NCT01490983|Chronic Myeloid Leukemia|chronic myeloid leukemia
340091|NCT01490983|Chronic Phase CML|chronic phase cml
340092|NCT01490970|Sarcoma Database|sarcoma database
340093|NCT01490957|HD|hd
340094|NCT01490957|NHL|nhl
340095|NCT01490931|acute pain|acute pain
340096|NCT01490931|dental pain|dental pain
340097|NCT01490931|intranasal ketorolac|intranasal ketorolac
340098|NCT01490931|dental implant surgery|dental implant surgery
340099|NCT01490918|Type-II diabetes mellitus|type-ii diabetes mellitus
340100|NCT01490918|Acarbose|acarbose
340101|NCT01490918|ACADEMIC|academic
340102|NCT01490905|Medical food|medical food
340103|NCT01490905|Theramine|theramine
340104|NCT01490905|Ibuprofen|ibuprofen
340105|NCT01490905|Amino acids|amino acids
330795|NCT01530191|anxiety|anxiety
340106|NCT01490905|Convenience Pack Kit|convenience pack kit
340107|NCT01490892|breast abnormality|breast abnormality
340108|NCT01490892|ultrasound imaging|ultrasound imaging
340109|NCT01490892|ultrasound contrast agent|ultrasound contrast agent
340110|NCT01490892|subharmonic imaging|subharmonic imaging
340111|NCT01490879|DFU|dfu
340113|NCT01490879|Ulcers|ulcers
340114|NCT01490879|Foot Ulcers|foot ulcers
340115|NCT01490879|chronic wound|chronic wound
340116|NCT01490879|wounds|wounds
340117|NCT01490879|Nexagon|nexagon
340118|NCT01490879|CoDa|coda
340119|NCT01490866|Colorectal Cancer|colorectal cancer
340120|NCT01490866|Axitinib|axitinib
340121|NCT01490866|FOLFOX/Bevacizumab|folfox/bevacizumab
340122|NCT01490853|Ph pos CML|ph pos cml
340123|NCT01490853|Philadelphia positive Chronic Myeloid Leukemia|philadelphia positive chronic myeloid leukemia
340124|NCT01490840|Fatigue|fatigue
340125|NCT01490840|MS|ms
340126|NCT01490840|Multiple Sclerosis|multiple sclerosis
340127|NCT01490840|Exercise|exercise
340128|NCT01490840|Physical activity|physical activity
340129|NCT01490840|Physical training|physical training
340130|NCT01490840|Fingolimod|fingolimod
340131|NCT01490814|PAF|paf
340132|NCT01490814|two episodes within the last twelve months one episode documented|two episodes within the last twelve months one episode documented
340133|NCT01490814|Documented treatment failure of at least one antiarrhythmic|documented treatment failure of at least one antiarrhythmic
340134|NCT01490814|drug AAD Type I or III including β-blocker and AAD intolerance|drug aad type i or iii including β-blocker and aad intolerance
340444|NCT01489618|prime boost|prime boost
340135|NCT01490801|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
340136|NCT01490801|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
340137|NCT01490801|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
340138|NCT01490801|Epstein-Barr virus infection|epstein-barr virus infection
340139|NCT01490775|Chronic Myeloid Leukemia|chronic myeloid leukemia
340140|NCT01490762|PK|pk
340141|NCT01490762|PD|pd
340142|NCT01490749|Esophageal Cancer|esophageal cancer
340143|NCT01490749|Neoplasms, Esophageal|neoplasms, esophageal
340144|NCT01490736|Acne|acne
340145|NCT01490736|Sebum gland disease|sebum gland disease
340146|NCT01490723|Leukemia|leukemia
340147|NCT01490723|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
340148|NCT01490723|Lymphoma|lymphoma
340149|NCT01490723|CD20+ lymphoid malignancies|cd20+ lymphoid malignancies
340150|NCT01490723|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
340151|NCT01490723|Allogeneic transplantation|allogeneic transplantation
340152|NCT01490723|Rituximab|rituximab
340153|NCT01490723|Rituxan|rituxan
340154|NCT01490723|In ibritumomab|in ibritumomab
340155|NCT01490723|Y ibritumomab|y ibritumomab
340156|NCT01490723|Zevalin|zevalin
340157|NCT01490723|Fludarabine Phosphate|fludarabine phosphate
340158|NCT01490723|Fludara|fludara
340159|NCT01490723|Bendamustine Hydrochloride|bendamustine hydrochloride
340160|NCT01490723|Bendamustine HCL|bendamustine hcl
340161|NCT01490723|CEP-18083|cep-18083
340162|NCT01490723|SDX-105|sdx-105
340163|NCT01490723|Treanda|treanda
340164|NCT01490723|Stem Cell Transplantation|stem cell transplantation
340165|NCT01490723|Planar Scintigraphy|planar scintigraphy
340166|NCT01490723|Spect Scan|spect scan
340167|NCT01490723|Single Photon Emission-Computed Tomography|single photon emission-computed tomography
340168|NCT01490723|CT Scan|ct scan
340169|NCT01490723|Computed Tomography|computed tomography
340170|NCT01490723|G-CSF|g-csf
340171|NCT01490723|Filgrastim|filgrastim
340172|NCT01490723|Neupogen|neupogen
340173|NCT01490723|Thymoglobulin|thymoglobulin
340174|NCT01490723|ATG|atg
340175|NCT01490723|Antithymocyte Globulin|antithymocyte globulin
340176|NCT01490723|Methotrexate|methotrexate
340177|NCT01490723|Mycophenolate|mycophenolate
340178|NCT01490723|MMF|mmf
340179|NCT01490723|Mycophenolate Mofetil|mycophenolate mofetil
340180|NCT01490723|CellCept|cellcept
340181|NCT01490723|Tacrolimus|tacrolimus
340182|NCT01490723|Prograf|prograf
340183|NCT01490710|NAVA|nava
340184|NCT01490710|Hemodynamic|hemodynamic
340185|NCT01490710|Cardiac Index|cardiac index
340186|NCT01490710|Children with admission weight > 5kg|children with admission weight > 5kg
340187|NCT01490697|stress disorders|stress disorders
340188|NCT01490697|posttraumatic|posttraumatic
340189|NCT01490697|memory|memory
340190|NCT01490697|mifepristone|mifepristone
340191|NCT01490697|d-cycloserine|d-cycloserine
340192|NCT01490697|psychophysiology|psychophysiology
340193|NCT01490684|candidiasis|candidiasis
340194|NCT01490684|critically ill|critically ill
340195|NCT01490684|outcomes|outcomes
340196|NCT01490645|ACS patients participating in a SCP|acs patients participating in a scp
340197|NCT01490645|QoL after ACS|qol after acs
340198|NCT01490645|ASC Patients's needs|asc patients's needs
340199|NCT01490632|Moderate|moderate
340200|NCT01490632|Severe|severe
340201|NCT01490632|Plaque|plaque
340202|NCT01490632|Chronic|chronic
340203|NCT01490619|Type 1 diabetes|type 1 diabetes
340204|NCT01490619|Adolescent|adolescent
340205|NCT01490619|Resilience|resilience
340206|NCT01490619|Prevention|prevention
340207|NCT01490619|Depression|depression
340208|NCT01490593|Canadian|canadian
340209|NCT01490593|Eye|eye
340210|NCT01490593|Injury|injury
340211|NCT01490593|Registry|registry
340212|NCT01490580|Pain|pain
340213|NCT01490580|Newborn|newborn
340214|NCT01490580|Anaesthesia|anaesthesia
340215|NCT01490580|opioids|opioids
340216|NCT01490580|propofol|propofol
340217|NCT01490580|neuromuscular blocker|neuromuscular blocker
340218|NCT01490580|atropine|atropine
340219|NCT01490567|Impaired Cognition Schizophrenia|impaired cognition schizophrenia
340220|NCT01490554|Skin aging|skin aging
340221|NCT01490554|fibroblasts|fibroblasts
340222|NCT01490554|transplantation|transplantation
340223|NCT01490554|autologous|autologous
340224|NCT01490541|Gastric intestinal metaplasia|gastric intestinal metaplasia
340225|NCT01490528|Pediatric IBD|pediatric ibd
340226|NCT01490515|non-invasive,|non-invasive,
340227|NCT01490515|metabolomics,|metabolomics,
340228|NCT01490515|morphology,|morphology,
340229|NCT01490515|embryo selection,|embryo selection,
340230|NCT01490515|implantation rates|implantation rates
340231|NCT01490489|EG-VEGF|eg-vegf
340232|NCT01490489|Endocrine Gland-derived Vascular Endothelial Growth Factor|endocrine gland-derived vascular endothelial growth factor
340233|NCT01490489|Pre-eclampsia|pre-eclampsia
340234|NCT01490489|intra-uterine growth retardation|intra-uterine growth retardation
340235|NCT01490489|prognosis|prognosis
340236|NCT01490476|Neurofibromatosis Type 2 with Vestibular Schwannoma|neurofibromatosis type 2 with vestibular schwannoma
340237|NCT01490476|Vestibular Schwannoma|vestibular schwannoma
340238|NCT01490476|Peripheral Nervous System Diseases|peripheral nervous system diseases
340239|NCT01490476|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
340240|NCT01490476|Vestibulocochlear Nerve Diseases|vestibulocochlear nerve diseases
340241|NCT01490463|Treatment of|treatment of
340242|NCT01490437|Advanced urothelial carcinoma|advanced urothelial carcinoma
340243|NCT01490424|TREM-1;|trem-1;
340244|NCT01490424|SNPs;|snps;
340245|NCT01490424|prognosis|prognosis
340246|NCT01490424|control（normal person）|control（normal person）
340247|NCT01490411|Specific immunotherapy|specific immunotherapy
340249|NCT01490411|SCIT|scit
340250|NCT01490411|recombinant|recombinant
340251|NCT01490398|Hypertension|hypertension
340252|NCT01490398|Rosuvastatin|rosuvastatin
340253|NCT01490398|Coronary flow reserve|coronary flow reserve
340254|NCT01490359|human immunodeficiency virus|human immunodeficiency virus
340255|NCT01490359|randomized controlled trial|randomized controlled trial
340256|NCT01490359|intervention studies|intervention studies
340257|NCT01490359|South Africa|south africa
340258|NCT01490359|men|men
340259|NCT01490359|sexually behavior|sexually behavior
340260|NCT01490359|social cognitive theory|social cognitive theory
340261|NCT01490346|HIV 1|hiv 1
340262|NCT01490346|Pharmacokinetics|pharmacokinetics
340263|NCT01490346|Drug levels|drug levels
340264|NCT01490346|Treatment naive|treatment naive
340265|NCT01490320|Violence prevention|violence prevention
340266|NCT01490320|Media|media
340267|NCT01490320|Primary care|primary care
340268|NCT01490320|Parenting|parenting
340269|NCT01490307|parenting intervention|parenting intervention
340270|NCT01490307|Family Check-Up|family check-up
340271|NCT01490307|Anxiety Disorders|anxiety disorders
340272|NCT01490307|Depression|depression
340273|NCT01490307|Depressive Disorder|depressive disorder
340274|NCT01490307|Conduct Disorder|conduct disorder
340275|NCT01490307|Mental Disorders|mental disorders
340276|NCT01490307|Behavioral Symptoms|behavioral symptoms
340277|NCT01490307|Mood Disorders|mood disorders
340278|NCT01490307|Mental Disorders Diagnosed in Childhood|mental disorders diagnosed in childhood
340279|NCT01490307|Substance-Related Disorders|substance-related disorders
340280|NCT01490294|Cardiac MRI|cardiac mri
340281|NCT01490294|gadobutrol|gadobutrol
340282|NCT01490281|Fibromyalgia|fibromyalgia
340283|NCT01490281|exercise|exercise
340284|NCT01490281|physical activity|physical activity
340285|NCT01490281|pain|pain
340286|NCT01490268|Pharmacokinetic-pharmacodynamic modeling|pharmacokinetic-pharmacodynamic modeling
340287|NCT01490268|Patient-controlled analgesia|patient-controlled analgesia
340288|NCT01490268|Target-controlled infusion|target-controlled infusion
340289|NCT01490268|Hydromorphone|hydromorphone
340290|NCT01490268|Sufentanil|sufentanil
340291|NCT01490268|after thoracotomy|after thoracotomy
340292|NCT01490268|cardiac surgery|cardiac surgery
340293|NCT01490255|platelet reactivity|platelet reactivity
340294|NCT01490255|aspirin|aspirin
340295|NCT01490255|clopidogrel|clopidogrel
340296|NCT01490229|nutraceuticals|nutraceuticals
340297|NCT01490229|statin|statin
340298|NCT01490216|cocaine|cocaine
340299|NCT01490216|lisdexamfetamine|lisdexamfetamine
340300|NCT01490216|vyvanse|vyvanse
340301|NCT01490203|Gd-EOB-DTPA|gd-eob-dtpa
340302|NCT01490203|MRI|mri
340303|NCT01490203|Hepatectomy|hepatectomy
340304|NCT01490203|Hepatocellular Carcinoma|hepatocellular carcinoma
340305|NCT01490203|Liver Function Tests|liver function tests
340306|NCT01490177|Multiple food allergies|multiple food allergies
340307|NCT01490151|Hormone|hormone
340308|NCT01490151|Diabetes|diabetes
340309|NCT01490151|Mellitus|mellitus
340310|NCT01490151|Type 1|type 1
340311|NCT01490151|Immune|immune
340312|NCT01490151|Metabolic disorder|metabolic disorder
340313|NCT01490138|β-D-Glucan test|β-d-glucan test
340314|NCT01490138|IFI|ifi
340315|NCT01490125|COPD|copd
340316|NCT01490125|Dyspnea|dyspnea
340317|NCT01490125|QVA149|qva149
340318|NCT01490125|tiotropium|tiotropium
340319|NCT01490073|Intrauterine device|intrauterine device
340320|NCT01490073|Pain|pain
340321|NCT01490073|Contraception|contraception
340322|NCT01490073|Nitroglycerin|nitroglycerin
340323|NCT01490073|Nitric oxide donor|nitric oxide donor
340324|NCT01490073|Intrauterine device insertion|intrauterine device insertion
340325|NCT01490060|cancer|cancer
340326|NCT01490060|fosaprepitant|fosaprepitant
340327|NCT01490060|Ifosfamide-based Multi-day Chemotherapy|ifosfamide-based multi-day chemotherapy
340328|NCT01490060|Chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
340329|NCT01490060|CINV|cinv
340330|NCT01490060|multi-day chemotherapy regimens|multi-day chemotherapy regimens
340331|NCT01490060|antiemetics|antiemetics
340332|NCT01490060|adverse effect|adverse effect
340333|NCT01490060|doxorubicin plus ifosfamide|doxorubicin plus ifosfamide
340335|NCT01490060|AI and vincristine|ai and vincristine
340336|NCT01490060|VAI|vai
340337|NCT01490060|aprepitant|aprepitant
340338|NCT01490060|prevention|prevention
340339|NCT01490060|nausea|nausea
340340|NCT01490060|vomiting|vomiting
340739|NCT01488318|Recurrent|recurrent
340341|NCT01490060|emetogenic chemotherapy|emetogenic chemotherapy
340342|NCT01490034|obesity|obesity
340343|NCT01490034|energy intake|energy intake
340344|NCT01490034|appetite|appetite
340345|NCT01490034|food form|food form
340346|NCT01490034|beverage|beverage
340347|NCT01490034|learning|learning
340348|NCT01490034|dietary compensation|dietary compensation
340349|NCT01490021|Healthy young men|healthy young men
340350|NCT01489995|Food effect|food effect
340351|NCT01489995|GR181413A|gr181413a
340352|NCT01489995|AT1001|at1001
340353|NCT01489995|migalastat hydrochloride|migalastat hydrochloride
340354|NCT01489995|Lysosomal storage disorders|lysosomal storage disorders
340355|NCT01489995|Pharmacokinetics|pharmacokinetics
340356|NCT01489982|Parkinson's disease|parkinson's disease
340357|NCT01489982|insomnia|insomnia
340358|NCT01489969|sleep latency|sleep latency
340359|NCT01489969|Sleep maintenance|sleep maintenance
340360|NCT01489969|Sleep fragmentation|sleep fragmentation
340361|NCT01489969|Polysomnography|polysomnography
340362|NCT01489956|Keyhole Limpet Hemocyanin (KLH)|keyhole limpet hemocyanin (klh)
340363|NCT01489956|Immucothel|immucothel
340364|NCT01489956|Native KLH|native klh
340365|NCT01489956|Healthy volunteers|healthy volunteers
340366|NCT01489956|Oral tolerance|oral tolerance
340367|NCT01489956|Immunogenicity|immunogenicity
340368|NCT01489956|Autoimmune diseases|autoimmune diseases
340369|NCT01489930|Exercise|exercise
340370|NCT01489930|Aging|aging
340371|NCT01489930|Sarcopenia|sarcopenia
340372|NCT01489930|Mitochondria|mitochondria
340373|NCT01489917|radial artery occlusion|radial artery occlusion
340374|NCT01489917|hemostasis|hemostasis
340375|NCT01489917|coronary intervention|coronary intervention
340376|NCT01489917|radial approach|radial approach
340377|NCT01489904|drooling|drooling
340378|NCT01489904|cerebral palsy|cerebral palsy
340379|NCT01489891|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
340380|NCT01489891|Lidocaine|lidocaine
340381|NCT01489891|Propofol|propofol
340382|NCT01489878|Coagulase-negative staphylococci|coagulase-negative staphylococci
340383|NCT01489878|Staphylococcus epidermidis|staphylococcus epidermidis
340384|NCT01489878|Staphylococcus aureus|staphylococcus aureus
340385|NCT01489878|Anti-bacterial agents|anti-bacterial agents
340386|NCT01489878|Drug resistance, Microbial|drug resistance, microbial
340387|NCT01489878|Methicillin resistance|methicillin resistance
340388|NCT01489878|Β-lactams|β-lactams
340389|NCT01489878|Fluoroquinolones|fluoroquinolones
340390|NCT01489878|Macrolides|macrolides
340391|NCT01489878|Synergistin|synergistin
340392|NCT01489878|General practitioners|general practitioners
340393|NCT01489878|Antibiotic selection pressure|antibiotic selection pressure
340394|NCT01489878|Ambulatory antibiotherapy|ambulatory antibiotherapy
340395|NCT01489878|Community patients|community patients
340396|NCT01489865|Pancreas cancer|pancreas cancer
340399|NCT01489852|Assisted reproductive treatment|assisted reproductive treatment
340400|NCT01489852|GnRH antagonist|gnrh antagonist
340401|NCT01489852|Estrogen pre-treatment|estrogen pre-treatment
340402|NCT01489852|Ovarian stimulation|ovarian stimulation
340403|NCT01489839|periodontal disease|periodontal disease
340404|NCT01489839|biomarkers|biomarkers
340405|NCT01489839|periodontal treatment|periodontal treatment
340406|NCT01489839|clinical attachment level|clinical attachment level
340407|NCT01489826|Cancer|cancer
340408|NCT01489800|feeding|feeding
340409|NCT01489800|complications|complications
340410|NCT01489800|radical cystectomy|radical cystectomy
340411|NCT01489787|Surgery|surgery
340412|NCT01489787|Ultrasonic therapy|ultrasonic therapy
340413|NCT01489787|Liver|liver
340414|NCT01489761|long lesions|long lesions
340415|NCT01489761|drug eluting stents|drug eluting stents
340416|NCT01489735|GERD|gerd
340417|NCT01489735|GERD Q QUESTIONNAIRE|gerd q questionnaire
340418|NCT01489722|Leukemia|leukemia
340420|NCT01489722|AZD1208|azd1208
340421|NCT01489709|overactive bladder|overactive bladder
340422|NCT01489709|solifenacin|solifenacin
340423|NCT01489709|Overactive bladder questionnaire|overactive bladder questionnaire
340424|NCT01489709|Overactive Bladder Symptom Score|overactive bladder symptom score
340425|NCT01489709|satisfaction score|satisfaction score
340426|NCT01489696|Pharmacokinetics|pharmacokinetics
340427|NCT01489696|Mirabegron|mirabegron
340428|NCT01489696|Tamsulosin|tamsulosin
340429|NCT01489696|Phase 1|phase 1
340430|NCT01489683|intubating conditions|intubating conditions
340431|NCT01489683|propofol|propofol
340432|NCT01489683|remifentanil|remifentanil
340433|NCT01489683|topical lidocaine|topical lidocaine
340434|NCT01489657|Obesity|obesity
340435|NCT01489657|Bariatric Surgery|bariatric surgery
340436|NCT01489657|Sleeve Gastrectomy|sleeve gastrectomy
340437|NCT01489657|Metabolite Profiling|metabolite profiling
340438|NCT01489631|Epidural|epidural
340439|NCT01489631|Local infiltration|local infiltration
340440|NCT01489631|Knee|knee
340441|NCT01489631|Arthroplasty|arthroplasty
340442|NCT01489618|Common variable immunodeficiency|common variable immunodeficiency
340443|NCT01489618|pneumococcal vaccine|pneumococcal vaccine
340445|NCT01489605|Orotracheal intubation, videolaryngoscopy|orotracheal intubation, videolaryngoscopy
340446|NCT01489566|Hepatocellular,Carcinoma,recurrence|hepatocellular,carcinoma,recurrence
340447|NCT01489553|Egg hypersensitivity|egg hypersensitivity
340448|NCT01489553|egg allergy|egg allergy
340449|NCT01489553|egg protein allergy|egg protein allergy
340450|NCT01489540|Burn|burn
340451|NCT01489540|Depth|depth
340452|NCT01489540|Diagnosis|diagnosis
340453|NCT01489540|Laser Doppler Imaging|laser doppler imaging
340454|NCT01489527|Vaccine|vaccine
340455|NCT01489527|Placebo|placebo
340456|NCT01489527|sexually transmitted infection (STI)|sexually transmitted infection (sti)
340457|NCT01489527|HIV|hiv
340458|NCT01489527|Human Immunodeficiency|human immunodeficiency
340459|NCT01489527|Gardasil|gardasil
340460|NCT01489527|HPV|hpv
340461|NCT01489527|human papillomavirus|human papillomavirus
340462|NCT01489514|peanut allergy|peanut allergy
340463|NCT01489514|hypoallergenic peanut extracts|hypoallergenic peanut extracts
340464|NCT01489514|epicutaneous skin prick testing|epicutaneous skin prick testing
340465|NCT01489501|Caomecs, Transplantation, Limbal stem cell deficiency,|caomecs, transplantation, limbal stem cell deficiency,
340466|NCT01489488|Relative bioavailability study|relative bioavailability study
340467|NCT01489475|children|children
340468|NCT01489475|congenital heart defects|congenital heart defects
340469|NCT01489475|cardiopulmonary bypass|cardiopulmonary bypass
340470|NCT01489475|modified ultrafiltration|modified ultrafiltration
340471|NCT01489475|angiopoietins|angiopoietins
340472|NCT01489475|cytokines|cytokines
340473|NCT01489462|Arthritis|arthritis
340474|NCT01489462|Osteoarthritis|osteoarthritis
340475|NCT01489462|Strength Training|strength training
340476|NCT01489449|drug coated balloon|drug coated balloon
340477|NCT01489449|NSTEMI|nstemi
340478|NCT01489436|gallstone disease|gallstone disease
340479|NCT01489436|cholecystectomy|cholecystectomy
340480|NCT01489436|minimally invasive|minimally invasive
340481|NCT01489436|surgical|surgical
340482|NCT01489436|laparoscopic|laparoscopic
340483|NCT01489436|single port|single port
340484|NCT01489436|cytokine|cytokine
340485|NCT01489423|stage IIIC melanoma|stage iiic melanoma
340486|NCT01489423|stage IV melanoma|stage iv melanoma
340487|NCT01489423|recurrent melanoma|recurrent melanoma
340488|NCT01489397|Confocol laser endomicroscopy|confocol laser endomicroscopy
340489|NCT01489397|Feasibility of Confocol laser endomicroscopy|feasibility of confocol laser endomicroscopy
340490|NCT01489384|Rheumatoid arthritis|rheumatoid arthritis
340491|NCT01489384|DAS28|das28
340492|NCT01489358|Vaccine-Mediated Protection|vaccine-mediated protection
340493|NCT01489358|Antibody Response|antibody response
340494|NCT01489358|Chikungunya Virus|chikungunya virus
340495|NCT01489358|Immune Response|immune response
340496|NCT01489358|Healthy Volunteer|healthy volunteer
340497|NCT01489358|Humoral Inmunity|humoral inmunity
340498|NCT01489358|Virus-like Particles|virus-like particles
340499|NCT01489345|ONO-2952|ono-2952
340500|NCT01489345|Healthy adult subjects|healthy adult subjects
340501|NCT01489345|Multiple dose|multiple dose
340502|NCT01489345|Safety|safety
340503|NCT01489345|Tolerability|tolerability
340504|NCT01489345|Pharmacokinetics|pharmacokinetics
340505|NCT01489332|rectal cancer|rectal cancer
340506|NCT01489332|capecitabine|capecitabine
340507|NCT01489332|radiotherapy|radiotherapy
340508|NCT01489332|locally advanced rectal cancer|locally advanced rectal cancer
340509|NCT01489319|inflammation|inflammation
340510|NCT01489319|body composition|body composition
340511|NCT01489319|hyperandrogenism|hyperandrogenism
340512|NCT01489319|insulin resistance|insulin resistance
340513|NCT01489306|Respiratory Syncytial Virus Infection|respiratory syncytial virus infection
340514|NCT01489306|RSV|rsv
340515|NCT01489280|Temple Touch Pro|temple touch pro
340516|NCT01489280|Medisim|medisim
340517|NCT01489280|temperature|temperature
340518|NCT01489280|surgery|surgery
340519|NCT01489267|cerebellar ataxia|cerebellar ataxia
340520|NCT01489267|hereditary disease|hereditary disease
340521|NCT01489267|stem cell|stem cell
340522|NCT01489254|Multiple Sclerosis,|multiple sclerosis,
340523|NCT01489254|Relapsing-Remitting Multiple Sclerosis,|relapsing-remitting multiple sclerosis,
340524|NCT01489254|glatiramer acetate,|glatiramer acetate,
340525|NCT01489254|MRI,|mri,
340526|NCT01489254|lesions,|lesions,
340527|NCT01489254|MS relapse rate,|ms relapse rate,
340528|NCT01489254|Copaxone|copaxone
340529|NCT01489241|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
340530|NCT01489241|Telemedicine|telemedicine
340531|NCT01489228|Chagas Disease|chagas disease
340532|NCT01489202|drug-eluting stent|drug-eluting stent
340533|NCT01489202|percutaneous coronary intervention|percutaneous coronary intervention
340534|NCT01489176|Stress Echocardiography|stress echocardiography
340535|NCT01489176|Real-Time Perfusion Imaging|real-time perfusion imaging
340536|NCT01489176|Regadenoson|regadenoson
340537|NCT01489176|Optison|optison
340538|NCT01489163|Gestational Diabetes|gestational diabetes
340539|NCT01489163|Weight Loss|weight loss
340540|NCT01489163|Physical Activity|physical activity
340541|NCT01489163|Pregnancy|pregnancy
340542|NCT01489163|Postpartum|postpartum
340543|NCT01489163|Intervention|intervention
340544|NCT01489150|Acute respiratory failure|acute respiratory failure
340545|NCT01489150|Hypercapnia|hypercapnia
340546|NCT01489150|Non invasive ventilation|non invasive ventilation
340547|NCT01489150|End-tidal CO2|end-tidal co2
340548|NCT01489124|Infection|infection
340549|NCT01489124|Imipenem|imipenem
340550|NCT01489124|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
340551|NCT01489124|pharmacokinetic|pharmacokinetic
340552|NCT01489124|pharmacodynamic|pharmacodynamic
340553|NCT01489098|Body composition|body composition
340554|NCT01489098|Protein Metabolism|protein metabolism
340555|NCT01489085|ventilation|ventilation
340556|NCT01489085|automated|automated
340557|NCT01489033|Allergic rhinitis|allergic rhinitis
340558|NCT01489033|Phleum pratense|phleum pratense
340559|NCT01489033|Timothy grass pollen allergy|timothy grass pollen allergy
340560|NCT01489033|subcutaneous immunotherapy|subcutaneous immunotherapy
340561|NCT01489020|Allergy|allergy
340562|NCT01489020|Immunotherapy|immunotherapy
340563|NCT01489020|Allergic Rhinoconjunctivitis|allergic rhinoconjunctivitis
340564|NCT01489020|D. pteronyssinus|d. pteronyssinus
340565|NCT01489020|house dust allergy|house dust allergy
340566|NCT01489007|vegetarian|vegetarian
340567|NCT01489007|children|children
340568|NCT01489007|iron|iron
340569|NCT01489007|iron absorption|iron absorption
340570|NCT01488981|Radio Frequency Microstimulator|radio frequency microstimulator
340571|NCT01488981|Traumatic Brain Injury|traumatic brain injury
340573|NCT01488981|Arm Rehabilitation|arm rehabilitation
340574|NCT01488981|electrical stimulation|electrical stimulation
340575|NCT01488981|FES|fes
340576|NCT01488968|high risk prostate cancer|high risk prostate cancer
340577|NCT01488968|hypofractionated radiation treatment|hypofractionated radiation treatment
340578|NCT01488968|higher biological doses|higher biological doses
340579|NCT01488968|acceptable rectal toxicity|acceptable rectal toxicity
340580|NCT01488968|Radiation Treatment|radiation treatment
340581|NCT01488955|bacterial infection|bacterial infection
340582|NCT01488942|HIV|hiv
340583|NCT01488942|reinforcement|reinforcement
340584|NCT01488942|medication adherence|medication adherence
340585|NCT01488942|patient compliance|patient compliance
340586|NCT01488942|antiretroviral therapy, highly active|antiretroviral therapy, highly active
340587|NCT01488916|Vitamin D|vitamin d
340588|NCT01488916|Postprandial Glucose|postprandial glucose
340589|NCT01488916|Type 2 Diabetes|type 2 diabetes
340590|NCT01488903|genetic susceptibility|genetic susceptibility
340591|NCT01488903|obesity|obesity
340592|NCT01488903|body composition|body composition
340593|NCT01488903|the metabolic syndrome|the metabolic syndrome
340594|NCT01488903|women|women
340595|NCT01488890|Dengue fever|dengue fever
340596|NCT01488890|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
340597|NCT01488890|CYD dengue vaccine|cyd dengue vaccine
340598|NCT01488890|Yellow Fever|yellow fever
340599|NCT01488890|Flavivirus|flavivirus
340600|NCT01488877|Type 2 diabetes mellitus. albuminuria.|type 2 diabetes mellitus. albuminuria.
340601|NCT01488864|Hot flashes|hot flashes
340602|NCT01488864|Vasomotor symptoms|vasomotor symptoms
340603|NCT01488864|Menopause|menopause
340604|NCT01488864|Applied Relaxation|applied relaxation
340605|NCT01488864|Health Related Quality of Life|health related quality of life
340606|NCT01488864|Salivary cortisol|salivary cortisol
340607|NCT01488851|Osteo necrosis of the Jaw|osteo necrosis of the jaw
340608|NCT01488812|Hip-fracture|hip-fracture
340609|NCT01488799|Anxiety|anxiety
340610|NCT01488799|Generalized Anxiety Disorder|generalized anxiety disorder
340611|NCT01488799|Motivational Interviewing|motivational interviewing
340612|NCT01488799|Cognitive Behavioural Therapy|cognitive behavioural therapy
340613|NCT01488799|Psychotherapy|psychotherapy
340614|NCT01488786|Assistive Technology|assistive technology
340615|NCT01488786|Non-Surgical Visual Prosthetic|non-surgical visual prosthetic
340616|NCT01488786|Sensory Substitution|sensory substitution
340617|NCT01488773|asthma|asthma
340618|NCT01488773|asthma control|asthma control
340619|NCT01488773|inhaled glucocorticosteroid|inhaled glucocorticosteroid
340620|NCT01488773|ICS|ics
340621|NCT01488773|leukotriene antagonist|leukotriene antagonist
340622|NCT01488773|LTRA|ltra
340623|NCT01488773|montelukast|montelukast
340624|NCT01488773|fluticasone|fluticasone
340625|NCT01488773|salmeterol|salmeterol
340626|NCT01488773|observational study|observational study
340627|NCT01488773|repeated measures|repeated measures
340628|NCT01488773|retrospective|retrospective
340629|NCT01488747|Omega-3 fatty acids|omega-3 fatty acids
340630|NCT01488747|Phospholipid fatty acids|phospholipid fatty acids
340631|NCT01488747|chymlomicron fatty acids|chymlomicron fatty acids
340632|NCT01488747|Bioavailability fo fish oil supplements in healthy adults|bioavailability fo fish oil supplements in healthy adults
340633|NCT01488734|Vitamin D|vitamin d
340634|NCT01488734|Mushroom|mushroom
340635|NCT01488734|Cholecalciferol|cholecalciferol
340636|NCT01488734|Prediabetes|prediabetes
340637|NCT01488734|Metabolic Syndrome|metabolic syndrome
340638|NCT01488708|Lupus|lupus
340639|NCT01488708|SLE|sle
340640|NCT01488708|Systemic Lupus Erythematosus|systemic lupus erythematosus
340641|NCT01488708|Immune System Disease|immune system disease
340642|NCT01488695|intubation|intubation
340643|NCT01488695|double lumen tube|double lumen tube
340644|NCT01488682|Head and neck cancer|head and neck cancer
340645|NCT01488682|Neck dissection|neck dissection
340646|NCT01488682|Harmonic scalpel|harmonic scalpel
340647|NCT01488669|head and neck neoplasms|head and neck neoplasms
340648|NCT01488669|neck dissection|neck dissection
340649|NCT01488669|robotics|robotics
340650|NCT01488656|Antioxidants|antioxidants
340651|NCT01488656|Dietary supplements|dietary supplements
340652|NCT01488656|Forced vital lung capacity|forced vital lung capacity
340653|NCT01488656|Exhaled nitric oxide|exhaled nitric oxide
340654|NCT01488656|Air pollution|air pollution
340655|NCT01488643|Bronchospasm|bronchospasm
340656|NCT01488643|Laparoscopic Gastrectomy|laparoscopic gastrectomy
340658|NCT01488630|substance abuse|substance abuse
340659|NCT01488630|alcohol|alcohol
340660|NCT01488630|drug|drug
340661|NCT01488630|smoking|smoking
340662|NCT01488630|HIV screening|hiv screening
340663|NCT01488617|Surgery|surgery
340664|NCT01488617|Psychosocial Factors|psychosocial factors
340665|NCT01488617|Psychological Distress|psychological distress
340666|NCT01488617|Outcome Assessment (Health Care)|outcome assessment (health care)
340667|NCT01488578|Overactive Bladder|overactive bladder
340668|NCT01488578|Japanese|japanese
340669|NCT01488578|Tolterodine|tolterodine
340670|NCT01488578|Detrusitol|detrusitol
340671|NCT01488578|Detrol|detrol
340672|NCT01488578|Postmarketing commitment plan.|postmarketing commitment plan.
340673|NCT01488552|pancreatic cancer|pancreatic cancer
340674|NCT01488552|pancreatic adenocarcinoma|pancreatic adenocarcinoma
340675|NCT01488552|Stage IV pancreatic cancer|stage iv pancreatic cancer
340676|NCT01488552|pancreas|pancreas
340677|NCT01488552|pancreatic|pancreatic
340678|NCT01488539|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
340679|NCT01488539|PTSD|ptsd
340680|NCT01488539|Adult Survivors of Child Abuse|adult survivors of child abuse
340681|NCT01488539|Women|women
340682|NCT01488539|Interpersonal violence|interpersonal violence
340683|NCT01488539|psychological trauma|psychological trauma
340684|NCT01488526|Hepatitis B|hepatitis b
340685|NCT01488526|Vertical transmission|vertical transmission
340686|NCT01488526|Pregnancy|pregnancy
340687|NCT01488526|Antiviral treatment|antiviral treatment
340688|NCT01488513|ABC294640|abc294640
340689|NCT01488513|RedHill Biopharma, Ltd.|redhill biopharma, ltd.
340690|NCT01488513|ABC-101|abc-101
340691|NCT01488513|Medical University of South Carolina|medical university of south carolina
340692|NCT01488513|Apogee Biotechnology Corporation|apogee biotechnology corporation
340693|NCT01488500|Wood smoke|wood smoke
340694|NCT01488500|inflammation|inflammation
340695|NCT01488500|lung function|lung function
340696|NCT01488500|arterial stiffness|arterial stiffness
340697|NCT01488500|heart rate variability|heart rate variability
340963|NCT01487603|Patients|patients
340698|NCT01488500|Respiratory and systemic inflammation following exposure to woodsmoke in healthy volunteers|respiratory and systemic inflammation following exposure to woodsmoke in healthy volunteers
340699|NCT01488487|HCC|hcc
340700|NCT01488487|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
340701|NCT01488487|Metastatic Hepatocellular Carcinoma|metastatic hepatocellular carcinoma
340702|NCT01488487|Liver Cancer|liver cancer
340703|NCT01488474|regional anesthesia|regional anesthesia
340704|NCT01488474|peripheral nerve stimulation|peripheral nerve stimulation
340705|NCT01488474|diabetes|diabetes
340706|NCT01488474|diabetic neuropathy|diabetic neuropathy
340707|NCT01488461|Congenital cerebellar ataxias|congenital cerebellar ataxias
340708|NCT01488461|Genetics|genetics
340709|NCT01488461|Gene ATCAY|gene atcay
340710|NCT01488461|Gene ABC7|gene abc7
340711|NCT01488461|Cerebellar atrophy|cerebellar atrophy
340712|NCT01488448|Hypertonic saline|hypertonic saline
340713|NCT01488448|Bronchiolitis|bronchiolitis
340714|NCT01488448|Infants|infants
340715|NCT01488448|Wheezing|wheezing
340716|NCT01488448|Nebulized|nebulized
340717|NCT01488448|Bronchodilator|bronchodilator
340718|NCT01488396|Cyclosporin|cyclosporin
340719|NCT01488396|Stevens-Johnson syndrome|stevens-johnson syndrome
340720|NCT01488396|Dry eye|dry eye
340721|NCT01488383|Hyperglycemia|hyperglycemia
340722|NCT01488383|Diabetes|diabetes
340723|NCT01488383|Blood glucose|blood glucose
340724|NCT01488383|Hypertension|hypertension
340725|NCT01488383|Anti hypertensive agents|anti hypertensive agents
340726|NCT01488383|Anti hypertensive drugs|anti hypertensive drugs
340727|NCT01488383|Anti hypertensive|anti hypertensive
340728|NCT01488370|breathing tube placement|breathing tube placement
340729|NCT01488357|Breast cancer|breast cancer
340730|NCT01488357|UNC|unc
340731|NCT01488357|Lineberger|lineberger
340732|NCT01488357|Breast Reconstruction|breast reconstruction
340733|NCT01488357|Mastectomy|mastectomy
340734|NCT01488318|Cetuximab|cetuximab
340735|NCT01488318|Dasatinib|dasatinib
340736|NCT01488318|Squamous Cell|squamous cell
340737|NCT01488318|Head and Neck|head and neck
340738|NCT01488318|After Cetuximab Containing Chemoradiotherapy|after cetuximab containing chemoradiotherapy
340740|NCT01488318|Metastatic|metastatic
340741|NCT01488305|MNP|mnp
340742|NCT01488305|AAMA program|aama program
340743|NCT01488305|Nepal|nepal
340744|NCT01488305|HFP|hfp
340745|NCT01488305|IYCF|iycf
340746|NCT01488305|BCC|bcc
340747|NCT01488292|mental health|mental health
340748|NCT01488292|social skills|social skills
340749|NCT01488279|Pre-diabetes|pre-diabetes
340750|NCT01488279|Impaired fasting glucose|impaired fasting glucose
340751|NCT01488279|Impaired glucose tolerance|impaired glucose tolerance
340752|NCT01488279|Steroid-induced hyperglycemia|steroid-induced hyperglycemia
340753|NCT01488266|depression|depression
340754|NCT01488266|depressive|depressive
340755|NCT01488266|major|major
340756|NCT01488266|aripiprazole|aripiprazole
340757|NCT01488266|switching|switching
340758|NCT01488266|augmentation|augmentation
340759|NCT01488266|antidepressant|antidepressant
340760|NCT01488253|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
340761|NCT01488253|Graft vs Host disease|graft vs host disease
340762|NCT01488253|Prevention|prevention
340763|NCT01488253|Sirolimus|sirolimus
340764|NCT01488253|Tacrolimus|tacrolimus
340765|NCT01488240|burn|burn
340766|NCT01488240|scar|scar
340767|NCT01488240|laser|laser
340768|NCT01488227|Vitamin D status in athletes|vitamin d status in athletes
340769|NCT01488227|Vitamin D|vitamin d
340770|NCT01488227|25(OH)D|25(oh)d
340771|NCT01488227|athletes|athletes
340772|NCT01488227|body composition|body composition
340773|NCT01488227|inflammatory markers|inflammatory markers
340774|NCT01488227|illness|illness
340775|NCT01488227|injury|injury
340776|NCT01488214|Systemic Sclerosis|systemic sclerosis
340777|NCT01488214|neuropsychiatric manifestations|neuropsychiatric manifestations
340778|NCT01488214|magnetic resonance imaging|magnetic resonance imaging
340779|NCT01488201|Psoriasis|psoriasis
340780|NCT01488188|Influenza vaccine|influenza vaccine
340781|NCT01488188|nasal route|nasal route
340782|NCT01488188|sublingual route|sublingual route
340783|NCT01488188|immunogenicity|immunogenicity
340784|NCT01488188|safety|safety
340785|NCT01488175|TKA|tka
340786|NCT01488175|RSA|rsa
340787|NCT01488175|Tourniquet|tourniquet
340788|NCT01488175|Arthroplasty|arthroplasty
340789|NCT01488175|Knee|knee
340790|NCT01488149|Fentanyl|fentanyl
340791|NCT01488149|Bupivacaine|bupivacaine
340792|NCT01488149|Nalbuphine|nalbuphine
340793|NCT01488136|Type 1 diabetes|type 1 diabetes
340794|NCT01488136|Hypoglycaemia|hypoglycaemia
340795|NCT01488136|Diazoxide|diazoxide
340796|NCT01488123|Breast, Cancer, Survivorship, Integrative, Complementary|breast, cancer, survivorship, integrative, complementary
340797|NCT01488097|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
340798|NCT01488097|Lysosomal Storage Disease|lysosomal storage disease
340799|NCT01488097|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
331686|NCT01526421|HIV|hiv
340800|NCT01488097|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
340801|NCT01488097|Acid lipase disease|acid lipase disease
340802|NCT01488097|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
340803|NCT01488097|LAL Deficiency|lal deficiency
340804|NCT01488097|LIPA Deficiency|lipa deficiency
340805|NCT01488097|Wolman disease|wolman disease
340806|NCT01488084|Saphenous vein graft patency|saphenous vein graft patency
340807|NCT01488084|Coronary artery bypass surgery|coronary artery bypass surgery
340808|NCT01488084|Coronary artery disease|coronary artery disease
340809|NCT01488071|Depression|depression
340810|NCT01488071|Multimodal antidepressant|multimodal antidepressant
340811|NCT01488045|Colonoscopy|colonoscopy
340812|NCT01488045|Propofol|propofol
340813|NCT01488045|Cancer Screening|cancer screening
340814|NCT01488006|Primary Glenohumeral Osteoarthritis|primary glenohumeral osteoarthritis
340815|NCT01488006|Total shoulder arthroplasty|total shoulder arthroplasty
340816|NCT01488006|Total shoulder replacement|total shoulder replacement
340817|NCT01488006|Osteoarthritis|osteoarthritis
340818|NCT01488006|Multicenter study|multicenter study
340820|NCT01487993|Children|children
340821|NCT01487993|Adolescents|adolescents
340822|NCT01487993|Metformin|metformin
340823|NCT01487993|Insulin resistance|insulin resistance
340824|NCT01487967|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
340825|NCT01487967|ADHD|adhd
340826|NCT01487967|Preferences|preferences
340827|NCT01487967|Goals|goals
340828|NCT01487967|Decision Making|decision making
340829|NCT01487954|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
340830|NCT01487928|breastfed|breastfed
340831|NCT01487928|human milk cream|human milk cream
340832|NCT01487928|human milk fat|human milk fat
340833|NCT01487928|caloric supplement|caloric supplement
340834|NCT01487915|Cisplatin-unfit condition|cisplatin-unfit condition
340835|NCT01487902|Chemotherapy-naive|chemotherapy-naive
340836|NCT01487876|DNA vaccine|dna vaccine
340837|NCT01487876|HBV|hbv
340838|NCT01487876|Chronic hepatitis B (CHB)|chronic hepatitis b (chb)
340839|NCT01487876|T-cell|t-cell
340840|NCT01487863|prostate cancer|prostate cancer
340841|NCT01487863|prostate|prostate
340842|NCT01487863|androgen independent prostate cancer (AIPC)|androgen independent prostate cancer (aipc)
340843|NCT01487863|androgen-independent|androgen-independent
340844|NCT01487863|androgen independent|androgen independent
340845|NCT01487863|hormone insensitive|hormone insensitive
340846|NCT01487863|hormone-insensitive|hormone-insensitive
340847|NCT01487863|prostate specific antigen (PSA)|prostate specific antigen (psa)
340848|NCT01487863|prostatic adenocarcinoma|prostatic adenocarcinoma
340849|NCT01487863|hormone-refractory|hormone-refractory
340850|NCT01487863|hormone refractory|hormone refractory
340851|NCT01487863|hormone refractory prostate cancer (HRPC)|hormone refractory prostate cancer (hrpc)
340852|NCT01487863|immune therapy|immune therapy
340853|NCT01487863|immunotherapy|immunotherapy
340854|NCT01487863|vaccine|vaccine
340855|NCT01487863|dendritic cells|dendritic cells
340856|NCT01487863|antigen-presenting cells|antigen-presenting cells
340857|NCT01487863|antigen presenting cells|antigen presenting cells
340858|NCT01487863|cancer vaccine|cancer vaccine
340859|NCT01487863|therapeutic vaccine|therapeutic vaccine
340860|NCT01487863|therapeutic cancer vaccine|therapeutic cancer vaccine
340861|NCT01487863|recombinant|recombinant
340862|NCT01487863|biological|biological
340863|NCT01487863|biopharmaceutical|biopharmaceutical
340864|NCT01487863|biotechnology|biotechnology
340865|NCT01487863|biotech|biotech
340866|NCT01487863|castration resistant prostate cancer (CRPC)|castration resistant prostate cancer (crpc)
340867|NCT01487863|castration-resistant prostate cancer (CRPC)|castration-resistant prostate cancer (crpc)
340868|NCT01487863|castration-resistance|castration-resistance
340869|NCT01487863|sipuleucel-T|sipuleucel-t
340870|NCT01487863|abiraterone|abiraterone
340871|NCT01487863|prednisone|prednisone
340872|NCT01487863|sequence|sequence
340873|NCT01487863|sequencing|sequencing
340874|NCT01487850|wind instruments|wind instruments
340875|NCT01487850|molds|molds
340876|NCT01487850|hypersensitivity pneumonitis|hypersensitivity pneumonitis
340877|NCT01487850|fungal contamination of wind instruments|fungal contamination of wind instruments
340878|NCT01487850|specific antibodies against molds in musicians' sera|specific antibodies against molds in musicians' sera
340879|NCT01487850|musicians|musicians
340880|NCT01487837|Fibrinogen|fibrinogen
340881|NCT01487837|Blood coagulation disorders|blood coagulation disorders
340882|NCT01487837|Postoperative bleeding|postoperative bleeding
340883|NCT01487837|Transfusions|transfusions
340884|NCT01487785|metastatic pancreatic cancer|metastatic pancreatic cancer
340885|NCT01487785|LDE225|lde225
340886|NCT01487785|gemcitabine|gemcitabine
340887|NCT01487785|locally advanced|locally advanced
340888|NCT01487785|adenocarcinoma|adenocarcinoma
340889|NCT01487746|APLA|apla
340891|NCT01487746|Stroke|stroke
340892|NCT01487746|minor anti body|minor anti body
340893|NCT01487746|major anti body|major anti body
340894|NCT01487746|APLA antibodies in Serum|apla antibodies in serum
340964|NCT01487603|undiagnosed enlarged|undiagnosed enlarged
340895|NCT01487733|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
340896|NCT01487733|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
331588|NCT01526772|Obesity|obesity
340897|NCT01487733|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
340898|NCT01487733|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
340899|NCT01487733|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
340900|NCT01487733|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
340901|NCT01487733|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
340902|NCT01487733|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
340903|NCT01487733|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
340904|NCT01487733|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
340905|NCT01487733|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
340906|NCT01487733|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
340907|NCT01487733|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
340908|NCT01487733|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
340909|NCT01487733|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
340910|NCT01487733|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
340911|NCT01487733|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
340912|NCT01487733|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
340913|NCT01487733|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
340914|NCT01487733|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
340915|NCT01487733|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
340916|NCT01487733|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
341211|NCT01486329|Inoperable|inoperable
340917|NCT01487733|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
340918|NCT01487733|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
340919|NCT01487733|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
340920|NCT01487733|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
340921|NCT01487733|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
340922|NCT01487733|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
340923|NCT01487733|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
340924|NCT01487733|recurrent salivary gland cancer|recurrent salivary gland cancer
340925|NCT01487733|stage III salivary gland cancer|stage iii salivary gland cancer
340926|NCT01487733|stage IVA salivary gland cancer|stage iva salivary gland cancer
340927|NCT01487733|stage IVB salivary gland cancer|stage ivb salivary gland cancer
340928|NCT01487733|stage IVC salivary gland cancer|stage ivc salivary gland cancer
340929|NCT01487720|Castration-resistant prostate cancer|castration-resistant prostate cancer
340930|NCT01487720|Docetaxel-refractory status|docetaxel-refractory status
340931|NCT01487707|pregnancy|pregnancy
340932|NCT01487707|maternal mortality|maternal mortality
340933|NCT01487707|neonatal mortality|neonatal mortality
340934|NCT01487707|community intervention|community intervention
340935|NCT01487707|voluntary health worker|voluntary health worker
340936|NCT01487707|safe birth kit|safe birth kit
340937|NCT01487707|maternal child health|maternal child health
340938|NCT01487694|back cohosh|back cohosh
340939|NCT01487694|cimicifuga racemosa|cimicifuga racemosa
340940|NCT01487694|menopausal symptoms|menopausal symptoms
340941|NCT01487694|hot flashes|hot flashes
340942|NCT01487694|Kupperman index|kupperman index
340943|NCT01487694|MENQOL|menqol
340944|NCT01487668|chronic mental disorders|chronic mental disorders
340945|NCT01487668|cardiovascular disease|cardiovascular disease
340946|NCT01487668|behavior change|behavior change
340947|NCT01487655|Open-angle glaucoma|open-angle glaucoma
340948|NCT01487655|Low tension glaucoma|low tension glaucoma
340949|NCT01487655|Color Doppler Imaging|color doppler imaging
340950|NCT01487629|Diabetic Retinopathy|diabetic retinopathy
340951|NCT01487629|Macular Edema|macular edema
340952|NCT01487629|Bevacizumab|bevacizumab
340953|NCT01487629|Ranibizumab|ranibizumab
340954|NCT01487616|Mullerian anomalies|mullerian anomalies
340955|NCT01487616|Congenital uterine malformations or anomalies|congenital uterine malformations or anomalies
340956|NCT01487616|Arcuate|arcuate
340957|NCT01487616|Septate|septate
340958|NCT01487616|Subseptate|subseptate
340959|NCT01487616|Bicornuate|bicornuate
340960|NCT01487616|Unicornuate|unicornuate
340961|NCT01487616|Didelphys|didelphys
340962|NCT01487616|T-shaped|t-shaped
340965|NCT01487603|lymph nodes|lymph nodes
340966|NCT01487590|pregnancy|pregnancy
340967|NCT01487590|breech|breech
340968|NCT01487590|acupuncture|acupuncture
340969|NCT01487590|moxibustion|moxibustion
340970|NCT01487590|version|version
340971|NCT01487577|Allogeneic blood and marrow transplantation (BMT)|allogeneic blood and marrow transplantation (bmt)
340972|NCT01487577|Graft versus host disease|graft versus host disease
340973|NCT01487577|Mycophenolate mofetil|mycophenolate mofetil
340974|NCT01487577|Pharmacokinetics|pharmacokinetics
340975|NCT01487564|Healthy volunteers|healthy volunteers
340976|NCT01487564|Pharmacokinetics|pharmacokinetics
340977|NCT01487564|OROS Hydromorphone|oros hydromorphone
340978|NCT01487564|Hydromorphone|hydromorphone
340979|NCT01487564|Taiwan|taiwan
340980|NCT01487564|UGT2B7 Gene|ugt2b7 gene
340981|NCT01487551|Systemic sclerosis|systemic sclerosis
340982|NCT01487551|Biomarkers|biomarkers
340983|NCT01487525|symptomatic knee osteoarthritis|symptomatic knee osteoarthritis
720769|NCT01050699|cytokines|cytokines
340984|NCT01487525|partial blood flow restriction|partial blood flow restriction
340985|NCT01487525|knee extensor strength|knee extensor strength
340986|NCT01487512|Healthy Volunteers|healthy volunteers
340987|NCT01487512|Dose Proportionality|dose proportionality
340988|NCT01487512|Pharmacokinetics|pharmacokinetics
340989|NCT01487512|OROS Hydromorphone|oros hydromorphone
340990|NCT01487512|Hydromorphone|hydromorphone
340991|NCT01487512|Taiwan|taiwan
340992|NCT01487486|Polycystic Ovary Syndrome|polycystic ovary syndrome
340993|NCT01487486|PCOS|pcos
340994|NCT01487486|Follicular Fluid|follicular fluid
340995|NCT01487486|Proteomics|proteomics
340996|NCT01487486|Glyco-proteomics|glyco-proteomics
340997|NCT01487473|Meditation|meditation
340998|NCT01487473|Mindfulness|mindfulness
340999|NCT01487473|Attention|attention
341000|NCT01487473|Chronic Pain|chronic pain
341001|NCT01487473|Depression|depression
341002|NCT01487473|Anxiety|anxiety
341003|NCT01487473|Stress|stress
341004|NCT01487473|Acceptance|acceptance
341005|NCT01487473|Pain intensity|pain intensity
341006|NCT01487473|Pain disability|pain disability
341007|NCT01487460|High cholesterol levels|high cholesterol levels
341008|NCT01487460|Hyperlipidemia|hyperlipidemia
341009|NCT01487460|High-density Lipoprotein|high-density lipoprotein
341010|NCT01487460|Low-density Lipoprotein|low-density lipoprotein
341011|NCT01487460|Simvastatin|simvastatin
341012|NCT01487434|Attendance|attendance
341013|NCT01487434|Truancy|truancy
341014|NCT01487434|Student engagement|student engagement
341015|NCT01487434|Mentoring|mentoring
341016|NCT01487434|Monitoring|monitoring
341017|NCT01487434|Case management|case management
341018|NCT01487395|Alzheimer|alzheimer
341019|NCT01487395|Donepezil|donepezil
341020|NCT01487395|biomarkers|biomarkers
341021|NCT01487395|battery|battery
341022|NCT01487395|cognition|cognition
341023|NCT01487395|imaging|imaging
341024|NCT01487395|neurophysiological|neurophysiological
341025|NCT01487356|Colonoscopy|colonoscopy
341026|NCT01487356|quality assurance|quality assurance
341027|NCT01487356|withdrawal time|withdrawal time
341028|NCT01487356|polyp detection rate|polyp detection rate
341029|NCT01487343|Oral Chemotherapy|oral chemotherapy
341030|NCT01487343|capecitabine|capecitabine
341031|NCT01487343|questionnaire|questionnaire
341032|NCT01487343|breast|breast
341033|NCT01487343|gastric|gastric
341034|NCT01487343|11-194|11-194
341035|NCT01487330|aortic stenosis|aortic stenosis
341036|NCT01487330|aortic valve stenosis|aortic valve stenosis
341037|NCT01487330|valvular heart disease|valvular heart disease
341038|NCT01487330|aortic valve replacement|aortic valve replacement
341039|NCT01487330|transcatheter aortic valve implantation|transcatheter aortic valve implantation
341040|NCT01487330|TAVI|tavi
341041|NCT01487330|TAVR|tavr
341042|NCT01487317|Delirium|delirium
341043|NCT01487317|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
341044|NCT01487317|Elderly|elderly
341045|NCT01487317|Emergency department|emergency department
341046|NCT01487291|Thrombophilia tests|thrombophilia tests
341047|NCT01487291|Hypofibrinolysis|hypofibrinolysis
341048|NCT01487291|Fibrinolysis|fibrinolysis
341049|NCT01487278|postpartum hemorrhage|postpartum hemorrhage
341050|NCT01487278|prevention|prevention
341051|NCT01487278|misoprostol|misoprostol
341052|NCT01487278|Uniject|uniject
341053|NCT01487278|oxytocin|oxytocin
341054|NCT01487265|Erlotinib|erlotinib
341055|NCT01487265|BKM120|bkm120
341056|NCT01487265|NSCLC|nsclc
341057|NCT01487226|Cervical cancer|cervical cancer
341058|NCT01487213|Medical abortion|medical abortion
341059|NCT01487213|Termination of pregnancy|termination of pregnancy
341060|NCT01487213|Mifepristone|mifepristone
341061|NCT01487213|Misoprostol|misoprostol
341062|NCT01487213|Urine hCG|urine hcg
341063|NCT01487213|Follow Up|follow up
403004|NCT01228643|To evaluate the efficacy of drugs in chronic renal failure|to evaluate the efficacy of drugs in chronic renal failure
423721|NCT00001836|EBCT|ebct
341064|NCT01487213|Termination of unwanted pregnancy. Self assessment (follow up) after medical abortion|termination of unwanted pregnancy. self assessment (follow up) after medical abortion
341065|NCT01487200|Osteoarthritis|osteoarthritis
341066|NCT01487200|Knee|knee
341067|NCT01487200|Steroid|steroid
341068|NCT01487200|intra-articular|intra-articular
341069|NCT01487200|injection|injection
341070|NCT01487187|Cord-milking|cord-milking
341071|NCT01487187|hemodynamic|hemodynamic
341072|NCT01487187|preterm infants|preterm infants
341073|NCT01487161|Osteoarthritis|osteoarthritis
341074|NCT01487161|Knee|knee
341075|NCT01487161|pain|pain
341076|NCT01487161|steroid|steroid
341077|NCT01487161|intra-articular|intra-articular
341078|NCT01487161|injection|injection
341079|NCT01487135|Thorough QT (TQT)|thorough qt (tqt)
341080|NCT01487135|EVP-6124|evp-6124
341081|NCT01487122|Diathermy|diathermy
341082|NCT01487122|Neck Pain|neck pain
341083|NCT01487109|Type 2 diabetes|type 2 diabetes
751930|NCT01171274|neck pain|neck pain
341084|NCT01487109|chronic kidney disease|chronic kidney disease
341085|NCT01487083|schizophrenia|schizophrenia
341086|NCT01487083|LY2140023|ly2140023
341087|NCT01487083|pomaglumetad methionil|pomaglumetad methionil
341088|NCT01487057|thyroid cancer|thyroid cancer
341089|NCT01487057|dislipidemia|dislipidemia
341090|NCT01487057|cardiovascular risk|cardiovascular risk
341092|NCT01487031|Autologous Stem Cell Transplantation|autologous stem cell transplantation
341093|NCT01487031|multiple myeloma|multiple myeloma
341094|NCT01487031|non-Hodgkin|non-hodgkin
341095|NCT01487031|Hodgkin lymphoma|hodgkin lymphoma
341096|NCT01487031|Music Therapy|music therapy
341097|NCT01487031|Nausea|nausea
341098|NCT01487031|Pain|pain
341099|NCT01487018|Zygomatic Fractures|zygomatic fractures
341100|NCT01487018|Surgery, Computer-Assisted|surgery, computer-assisted
341101|NCT01487018|Facial Asymmetry|facial asymmetry
341102|NCT01487005|ozone|ozone
341103|NCT01487005|air pollution|air pollution
341104|NCT01487005|vascular function|vascular function
341105|NCT01487005|cardiac function|cardiac function
341106|NCT01487005|inflammation|inflammation
341107|NCT01486953|respiratory resistance|respiratory resistance
341108|NCT01486953|lung compliance|lung compliance
341109|NCT01486953|desflurane|desflurane
341110|NCT01486953|sevoflurane|sevoflurane
341111|NCT01486836|Cardiac disease (ICD indication)|cardiac disease (icd indication)
341112|NCT01486810|cocaine|cocaine
341113|NCT01486810|lisdexamfetamine|lisdexamfetamine
341719|NCT01484249|embolic|embolic
341114|NCT01486797|Relapsed Chronic Lymphocytic Leukemia (CLL)|relapsed chronic lymphocytic leukemia (cll)
341115|NCT01486797|NOX-A12|nox-a12
341116|NCT01486797|Bendamustine|bendamustine
341117|NCT01486797|Rituximab|rituximab
341118|NCT01486797|Spiegelmer|spiegelmer
341119|NCT01486797|Chemosensitization|chemosensitization
341120|NCT01486797|Stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
341121|NCT01486797|CXCL12|cxcl12
341122|NCT01486784|equal to or greater than age 60 years|equal to or greater than age 60 years
341123|NCT01486784|non-M3 AML|non-m3 aml
341124|NCT01486784|relapsed disease|relapsed disease
341125|NCT01486784|primary refractory disease|primary refractory disease
341126|NCT01486784|not appropriate or willing candidates for aggressive therapy|not appropriate or willing candidates for aggressive therapy
341128|NCT01486771|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
341129|NCT01486732|Cerebral Palsy|cerebral palsy
341130|NCT01486732|Umbilical Cord Blood|umbilical cord blood
341131|NCT01486732|FLT-PET|flt-pet
341132|NCT01486719|Finger pulp reconstruction|finger pulp reconstruction
341133|NCT01486719|dorsal branch|dorsal branch
341134|NCT01486719|proper digital nerve|proper digital nerve
341135|NCT01486719|palmar arterial arch|palmar arterial arch
341136|NCT01486719|dorsal digital island flap|dorsal digital island flap
341137|NCT01486706|Overactive Bladder|overactive bladder
341138|NCT01486706|Gabapentin|gabapentin
341139|NCT01486706|Quality of Life|quality of life
341140|NCT01486706|Urodynamic|urodynamic
341141|NCT01486706|safety|safety
341142|NCT01486706|Efficacy|efficacy
341143|NCT01486693|cytomegalovirus|cytomegalovirus
341144|NCT01486693|uveitis|uveitis
341145|NCT01486680|Gastric bypass|gastric bypass
341146|NCT01486680|Silastic ring gastric bypass|silastic ring gastric bypass
341147|NCT01486680|Roux-en-Y gastric bypass|roux-en-y gastric bypass
341148|NCT01486680|Sleeve gastrectomy|sleeve gastrectomy
341149|NCT01486680|Body composition analysis|body composition analysis
341150|NCT01486667|focus of study instead|focus of study instead
341151|NCT01486654|Cortical stimulation|cortical stimulation
341152|NCT01486654|Ischemic Stroke|ischemic stroke
341153|NCT01486654|Aphasia|aphasia
341154|NCT01486654|Speech and Language Rehabilitation|speech and language rehabilitation
341155|NCT01486641|femoral neck fracture|femoral neck fracture
341156|NCT01486641|arthroplasty|arthroplasty
341157|NCT01486641|surgical approach|surgical approach
341158|NCT01486641|anterolateral|anterolateral
341159|NCT01486641|posterolateral|posterolateral
341160|NCT01486615|premedication|premedication
341161|NCT01486615|premedicants|premedicants
341162|NCT01486615|preoperative anxiety|preoperative anxiety
341163|NCT01486615|melatonin|melatonin
341164|NCT01486615|alprazolam|alprazolam
341264|NCT01486121|Neurological disorders|neurological disorders
341165|NCT01486602|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
341166|NCT01486602|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
341167|NCT01486589|emergency care|emergency care
341168|NCT01486589|cardiac autonomic function|cardiac autonomic function
341169|NCT01486589|deceleration capacity|deceleration capacity
341170|NCT01486537|samples|samples
341171|NCT01486537|children|children
341172|NCT01486537|the age group 3-13 years|the age group 3-13 years
341173|NCT01486524|pharmacogenomic biomarker|pharmacogenomic biomarker
341174|NCT01486524|predictive marker|predictive marker
341175|NCT01486524|prospective-retrospective|prospective-retrospective
341176|NCT01486524|propensity score|propensity score
341177|NCT01486524|matched-patients trial|matched-patients trial
341178|NCT01486511|Liver disease|liver disease
341179|NCT01486511|Pulmonary embolism|pulmonary embolism
341180|NCT01486511|Thrombophilia|thrombophilia
341181|NCT01486511|Death|death
341182|NCT01486485|renal replacement therapy|renal replacement therapy
341183|NCT01486472|Adjuvant chemotherapy|adjuvant chemotherapy
341184|NCT01486446|IEM|iem
341185|NCT01486446|EM|em
341186|NCT01486446|Erythromelalgia|erythromelalgia
341187|NCT01486446|Erythermalgia|erythermalgia
341188|NCT01486446|Red neuralgia|red neuralgia
341189|NCT01486446|Peripheral Vascular Disease|peripheral vascular disease
341190|NCT01486446|Vascular Disease|vascular disease
341191|NCT01486446|Cardiovascular Disease|cardiovascular disease
341192|NCT01486433|eicosapentaenoic acid|eicosapentaenoic acid
341193|NCT01486433|docosapentaenoic acid|docosapentaenoic acid
341194|NCT01486433|arachidonic acid|arachidonic acid
341195|NCT01486433|hypertriglyceridemia|hypertriglyceridemia
341196|NCT01486433|simvastatin|simvastatin
341197|NCT01486420|Quinell grade|quinell grade
341198|NCT01486420|Open surgery|open surgery
341199|NCT01486420|corticosteroid injections|corticosteroid injections
341200|NCT01486420|randomized controlled trial|randomized controlled trial
341201|NCT01486420|Trigger finger|trigger finger
341202|NCT01486407|Airway management|airway management
341203|NCT01486355|Mortality|mortality
341204|NCT01486355|Morbidity|morbidity
341205|NCT01486355|Hospitalisations/consultations|hospitalisations/consultations
341206|NCT01486355|Growth|growth
341207|NCT01486355|Measles infection|measles infection
341208|NCT01486329|Pancreatic cancer|pancreatic cancer
341209|NCT01486329|Cancer vaccine|cancer vaccine
341210|NCT01486329|Gemcitabine|gemcitabine
341212|NCT01486329|Gemcitabine chemotherapy|gemcitabine chemotherapy
341213|NCT01486329|Locally advanced|locally advanced
341214|NCT01486303|Facial Cosmetic acupuncture|facial cosmetic acupuncture
341215|NCT01486303|Skin Rejuvenation|skin rejuvenation
341216|NCT01486303|Skin Aging|skin aging
341217|NCT01486290|Intervention|intervention
341218|NCT01486290|Cost Effective|cost effective
341219|NCT01486290|Elderly|elderly
341220|NCT01486290|Glycemic Control|glycemic control
341221|NCT01486277|Lymphoma, T-Cell, Cutaneous|lymphoma, t-cell, cutaneous
341222|NCT01486277|T-cell lymphoma|t-cell lymphoma
341223|NCT01486277|Lymphoma|lymphoma
341224|NCT01486277|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
341225|NCT01486277|JNJ-26481585|jnj-26481585
341226|NCT01486238|Diabetic Macular Edema|diabetic macular edema
341227|NCT01486212|Ischemia-reperfusion injury|ischemia-reperfusion injury
341228|NCT01486212|Oxidative markers|oxidative markers
341229|NCT01486212|Inflammatory markers|inflammatory markers
341230|NCT01486199|cystic fibrosis|cystic fibrosis
341231|NCT01486199|mucociliary clearance|mucociliary clearance
341232|NCT01486199|airway surface liquid|airway surface liquid
341233|NCT01486199|nuclear medicine|nuclear medicine
341234|NCT01486186|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
341235|NCT01486186|Double-Blind Method|double-blind method
341236|NCT01486186|Medicine, Chinese Traditional|medicine, chinese traditional
341237|NCT01486186|Humans|humans
341238|NCT01486186|Treatment Outcome|treatment outcome
341239|NCT01486173|PUFA|pufa
341240|NCT01486173|Iron|iron
341241|NCT01486173|Neurological development|neurological development
341242|NCT01486173|Premature infant|premature infant
341243|NCT01486147|Food labeling|food labeling
341244|NCT01486147|Nutrition|nutrition
341245|NCT01486147|Memory|memory
341246|NCT01486147|Diet|diet
341247|NCT01486134|Hepatocellular carcinoma|hepatocellular carcinoma
341248|NCT01486134|Radiofrequency ablation|radiofrequency ablation
341249|NCT01486134|Multipolar mode|multipolar mode
341250|NCT01486134|Recurrence|recurrence
341251|NCT01486134|Cirrhosis|cirrhosis
341252|NCT01486134|MR temperature monitoring|mr temperature monitoring
341253|NCT01486134|large tumor|large tumor
341254|NCT01486121|Surgery|surgery
341255|NCT01486121|Critical illness|critical illness
341256|NCT01486121|Mechanical ventilation|mechanical ventilation
341257|NCT01486121|Organ dysfunction syndrome|organ dysfunction syndrome
341258|NCT01486121|Intensive Care Units Sedation|intensive care units sedation
341259|NCT01486121|Analgesia|analgesia
341260|NCT01486121|Treatment protocol|treatment protocol
341261|NCT01486121|Nursing protocol|nursing protocol
341262|NCT01486121|Outcome|outcome
341263|NCT01486121|Pain|pain
341265|NCT01486121|Delirium|delirium
341266|NCT01486121|Muscular weakness|muscular weakness
341267|NCT01486121|Psychological disorders|psychological disorders
341268|NCT01486121|Anxiety|anxiety
341269|NCT01486121|Depression|depression
341270|NCT01486121|Stress disorders|stress disorders
341271|NCT01486121|Post-Traumatic|post-traumatic
341272|NCT01486108|tonic, burst and placebo stimulation|tonic, burst and placebo stimulation
341273|NCT01486082|OCA 10|oca 10
341274|NCT01486082|Antibiogram|antibiogram
341275|NCT01486082|Eradication|eradication
341276|NCT01486069|Dentofacial Deformity|dentofacial deformity
341277|NCT01486069|Orthognathic Surgery|orthognathic surgery
341278|NCT01486069|Mandible|mandible
341279|NCT01486069|Orthognathic Surgical Procedures|orthognathic surgical procedures
341280|NCT01486056|epilepsy|epilepsy
341281|NCT01486056|ECG|ecg
341282|NCT01486056|device placement|device placement
341283|NCT01486043|Induction chemotherapy|induction chemotherapy
341284|NCT01486043|Transient hyperglycemia|transient hyperglycemia
341285|NCT01486043|Metformin|metformin
341286|NCT01486043|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
341287|NCT01486043|Insulin resistance|insulin resistance
341288|NCT01486043|Hyperglycemia|hyperglycemia
341289|NCT01486043|Insulin|insulin
341290|NCT01486030|Atherosclerosis|atherosclerosis
341291|NCT01486017|ASP015K|asp015k
341292|NCT01486017|healthy subjects|healthy subjects
341293|NCT01486017|bioavailability|bioavailability
341294|NCT01486017|rheumatoid arthritis|rheumatoid arthritis
341295|NCT01486017|psoriasis|psoriasis
341296|NCT01486017|transplantation|transplantation
341297|NCT01486004|Hepatitis C Virus|hepatitis c virus
341298|NCT01486004|TMC435|tmc435
341299|NCT01486004|TMC435-TiDP16-C124|tmc435-tidp16-c124
341300|NCT01486004|TMC435-C124|tmc435-c124
341302|NCT01486004|Hepatitis C|hepatitis c
341303|NCT01486004|Hep C|hep c
341304|NCT01486004|Healthy participants|healthy participants
341305|NCT01485991|Hepatitis C|hepatitis c
341306|NCT01485991|TMC435HPC3001|tmc435hpc3001
341307|NCT01485991|TMC435|tmc435
341308|NCT01485991|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
341309|NCT01485991|HEP C|hep c
341310|NCT01485991|Genotype 1|genotype 1
341311|NCT01485991|Treatment experienced|treatment experienced
341312|NCT01485991|Null responders|null responders
341313|NCT01485991|Partial responders|partial responders
341314|NCT01485978|Alport Syndrome|alport syndrome
341315|NCT01485978|chronic kidney disease|chronic kidney disease
341316|NCT01485978|renal fibrosis|renal fibrosis
341317|NCT01485978|nephroprotection|nephroprotection
341318|NCT01485978|pediatric study|pediatric study
341319|NCT01485965|Huntington Disease|huntington disease
341320|NCT01485965|Basal Ganglia Diseases|basal ganglia diseases
341321|NCT01485965|Brain Diseases|brain diseases
341322|NCT01485965|Central Nervous System Diseases|central nervous system diseases
341323|NCT01485965|Nervous System Diseases|nervous system diseases
341324|NCT01485965|Dementia|dementia
341325|NCT01485965|Chorea|chorea
341326|NCT01485965|Dyskinesias|dyskinesias
341327|NCT01485965|Movement Disorders|movement disorders
341328|NCT01485965|Heredodegenerative Disorders, Nervous System|heredodegenerative disorders, nervous system
341329|NCT01485965|Neurodegenerative Diseases|neurodegenerative diseases
341330|NCT01485965|Genetic Diseases, Inborn|genetic diseases, inborn
341331|NCT01485965|Cognition Disorders|cognition disorders
341332|NCT01485965|Mental Disorders|mental disorders
341333|NCT01485952|Huntington Disease|huntington disease
341334|NCT01485952|Basal Ganglia Diseases|basal ganglia diseases
341335|NCT01485952|Brain Diseases|brain diseases
341336|NCT01485952|Central Nervous System Diseases|central nervous system diseases
341337|NCT01485952|Nervous System Diseases|nervous system diseases
341338|NCT01485952|Dementia|dementia
341339|NCT01485952|Chorea|chorea
341340|NCT01485952|Dyskinesias|dyskinesias
341341|NCT01485952|Movement Disorders|movement disorders
341342|NCT01485952|Heredodegenerative Disorders, Nervous System|heredodegenerative disorders, nervous system
341343|NCT01485952|Neurodegenerative Diseases|neurodegenerative diseases
341344|NCT01485952|Genetic Diseases, Inborn|genetic diseases, inborn
341345|NCT01485952|Cognition Disorders|cognition disorders
341346|NCT01485952|Mental Disorders|mental disorders
341347|NCT01485939|lidocaine patch|lidocaine patch
341348|NCT01485939|laparoscopic cholecystectomy|laparoscopic cholecystectomy
341349|NCT01485913|Education|education
341350|NCT01485913|Diabetes|diabetes
341351|NCT01485913|Prevention complications|prevention complications
341352|NCT01485913|Prevention of complications of diabetes|prevention of complications of diabetes
341353|NCT01485887|Venlafaxine ER|venlafaxine er
341354|NCT01485887|long-term extension|long-term extension
341355|NCT01485887|Japan|japan
341356|NCT01485874|BIBF 1120|bibf 1120
341357|NCT01485835|Multiple Myeloma|multiple myeloma
341358|NCT01485835|Bortezomib|bortezomib
341360|NCT01485835|Ganetespib|ganetespib
341361|NCT01485822|Glaucoma|glaucoma
341362|NCT01485822|Travatan|travatan
341363|NCT01485822|Trabeculectomy|trabeculectomy
341364|NCT01485796|PIDD|pidd
341365|NCT01485783|Hypertension|hypertension
341366|NCT01485757|patients|patients
341367|NCT01485744|metastatic|metastatic
341368|NCT01485744|untreated|untreated
341369|NCT01485744|advanced|advanced
341370|NCT01485731|Cervical|cervical
341371|NCT01485731|Cancer|cancer
341372|NCT01485731|Uterine Cervix|uterine cervix
341373|NCT01485731|Squamous Cell|squamous cell
341374|NCT01485731|Adenocarcinoma|adenocarcinoma
341375|NCT01485718|Obesity|obesity
341376|NCT01485718|Overweight|overweight
341377|NCT01485718|Weight loss|weight loss
341378|NCT01485705|severe bacterial infection|severe bacterial infection
341379|NCT01485692|Violence|violence
341380|NCT01485692|Aggression|aggression
341381|NCT01485692|Psychiatric emergencies|psychiatric emergencies
341382|NCT01485692|Psychomotor agitation|psychomotor agitation
341383|NCT01485692|Violent patient|violent patient
341384|NCT01485679|18 fluoro deoxy glucose positrons emission tomography combined with computed tomography,|18 fluoro deoxy glucose positrons emission tomography combined with computed tomography,
341385|NCT01485679|Patients with intraductal papillary mucinous tumor of the pancreas|patients with intraductal papillary mucinous tumor of the pancreas
341386|NCT01485679|intraductal papillary mucinous|intraductal papillary mucinous
341387|NCT01485679|pancreas|pancreas
341388|NCT01485666|Thoratec|thoratec
341389|NCT01485666|HeartMate II|heartmate ii
341390|NCT01485666|heart-assist devices|heart-assist devices
341391|NCT01485666|driveline or percutaneous lead management|driveline or percutaneous lead management
341392|NCT01485666|HeartMate II Percutaneous Lead Management|heartmate ii percutaneous lead management
341393|NCT01485653|Brachial Plexus|brachial plexus
341394|NCT01485653|Mepivacaine|mepivacaine
341395|NCT01485653|Ultrasound|ultrasound
341396|NCT01485653|Axillary|axillary
341397|NCT01485653|Block|block
341398|NCT01485640|Schizophrenia|schizophrenia
341399|NCT01485640|bipolar disorder|bipolar disorder
341400|NCT01485640|Lurasidone|lurasidone
341401|NCT01485640|Latuda|latuda
341402|NCT01485627|Cancer|cancer
341403|NCT01485627|Communication|communication
341404|NCT01485627|prognosis|prognosis
341405|NCT01485575|Chromovitrectomy|chromovitrectomy
341406|NCT01485575|Indocyanine green|indocyanine green
341407|NCT01485575|ICG|icg
341408|NCT01485575|Brilliant Blue G|brilliant blue g
341409|NCT01485575|BBG|bbg
341410|NCT01485575|Trypan blue|trypan blue
341411|NCT01485575|TB|tb
341412|NCT01485575|Internal limiting membrane|internal limiting membrane
341413|NCT01485575|ILM|ilm
341414|NCT01485562|postpartum haemorrhage|postpartum haemorrhage
341415|NCT01485562|misoprostol|misoprostol
341416|NCT01485562|treatment|treatment
341417|NCT01485562|prophylaxis|prophylaxis
341418|NCT01485562|home births|home births
341419|NCT01485549|Multiple system atrophy (MSA)|multiple system atrophy (msa)
341420|NCT01485549|alpha-synucleinopathies|alpha-synucleinopathies
341421|NCT01485549|biological markers|biological markers
341422|NCT01485549|cerebrospinal fluid|cerebrospinal fluid
341423|NCT01485549|plasma|plasma
341424|NCT01485536|Lymphoma|lymphoma
341425|NCT01485536|Relapsed/refractory lymphoma|relapsed/refractory lymphoma
341426|NCT01485536|AUY922|auy922
341427|NCT01485523|Allergic rhinitis|allergic rhinitis
341428|NCT01485523|Nasal provocation test|nasal provocation test
341429|NCT01485510|Maltreatment|maltreatment
341430|NCT01485510|Infant Mental Health|infant mental health
341431|NCT01485510|Infant mental health in maltreated children|infant mental health in maltreated children
341432|NCT01485497|APNEA|apnea
341433|NCT01485471|Middle Ear Infection|middle ear infection
341434|NCT01485458|Incomplete spinal cord injury|incomplete spinal cord injury
341435|NCT01485458|Cervical canal stenosis|cervical canal stenosis
341436|NCT01485458|Ossification of the posterior longitudinal ligament|ossification of the posterior longitudinal ligament
341437|NCT01485458|Surgery|surgery
341438|NCT01485458|Decompression|decompression
341439|NCT01485445|bioequivalence|bioequivalence
341440|NCT01485445|pharmacokinetics|pharmacokinetics
341441|NCT01485445|Fluticasone Furoate|fluticasone furoate
341442|NCT01485445|Vilanterol|vilanterol
341443|NCT01485432|Renal transplant surgery|renal transplant surgery
341444|NCT01485432|hemodynamic management|hemodynamic management
341445|NCT01485432|PiCCO|picco
341446|NCT01485432|delayed graft function|delayed graft function
341447|NCT01485419|Sex hormones|sex hormones
341448|NCT01485419|Testosterone|testosterone
341449|NCT01485419|Estradiol|estradiol
341450|NCT01485406|Haemophilus influenzae|haemophilus influenzae
341451|NCT01485406|Safety|safety
341452|NCT01485406|Pneumococcal vaccine|pneumococcal vaccine
341453|NCT01485406|Streptococcus pneumoniae|streptococcus pneumoniae
341454|NCT01485406|Immunogenicity|immunogenicity
341455|NCT01485406|Toddlers|toddlers
341456|NCT01485380|Dexmedetomidine|dexmedetomidine
341457|NCT01485380|Sleep|sleep
341458|NCT01485380|MRI-PET|mri-pet
341459|NCT01485380|EEG|eeg
341460|NCT01485367|Senile Purpura|senile purpura
341461|NCT01485367|Adapalene 0.3%|adapalene 0.3%
341462|NCT01485354|Stroke|stroke
341463|NCT01485354|Rehabilitation|rehabilitation
341464|NCT01485341|gluten sensitivity|gluten sensitivity
341465|NCT01485328|Dyspepsia|dyspepsia
341466|NCT01485328|Flatulence|flatulence
341467|NCT01485328|Aerophagia|aerophagia
341468|NCT01485328|Constipation|constipation
341469|NCT01485302|mild to moderate Alzheimer's Disease|mild to moderate alzheimer's disease
341470|NCT01485276|Parkinson's Disease|parkinson's disease
341471|NCT01485276|Deep Brain Stimulation|deep brain stimulation
341472|NCT01485276|Gait|gait
341473|NCT01485276|Electrophysiology|electrophysiology
341474|NCT01485276|Parkinson Disease|parkinson disease
341475|NCT01485276|PD|pd
341476|NCT01485263|Deep Brain Stimulation|deep brain stimulation
341477|NCT01485263|OCD|ocd
341478|NCT01485250|Healthy Volunteers|healthy volunteers
341479|NCT01485250|Motivations|motivations
341480|NCT01485250|Decision Making|decision making
341481|NCT01485250|Motivation|motivation
341482|NCT01485224|Hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
341483|NCT01485224|Epistaxis|epistaxis
341484|NCT01485224|Thalidomide|thalidomide
341485|NCT01485211|progressive keratoconus|progressive keratoconus
341486|NCT01485211|thin corneas|thin corneas
341487|NCT01485211|cross-linking|cross-linking
341488|NCT01485211|hypo-osmolar riboflavin|hypo-osmolar riboflavin
341489|NCT01485198|osteoarthritis|osteoarthritis
341494|NCT01485185|Donepezil|donepezil
341495|NCT01485185|allodynia|allodynia
341496|NCT01485185|Gabapentin|gabapentin
341497|NCT01485185|Sural nerve stimulation|sural nerve stimulation
341498|NCT01485185|Electrical hyperalgesia|electrical hyperalgesia
341499|NCT01485159|prevalence|prevalence
341500|NCT01485159|COPD|copd
341501|NCT01485159|emphysema|emphysema
341502|NCT01485159|co-morbidities|co-morbidities
341503|NCT01485159|ischemic heart disease|ischemic heart disease
341504|NCT01485159|chronic bronchitis|chronic bronchitis
341505|NCT01485159|spirometry|spirometry
341506|NCT01485159|burden|burden
341507|NCT01485133|colonoscopy|colonoscopy
341508|NCT01485133|water|water
341509|NCT01485133|surgery|surgery
341510|NCT01485133|unsedated|unsedated
341511|NCT01485120|Blood pressure (low, normal, high)|blood pressure (low, normal, high)
341512|NCT01485107|Ulthera® System|ulthera® system
341513|NCT01485107|Ultherapy™ treatment|ultherapy™ treatment
341514|NCT01485107|Ulthera, Inc.|ulthera, inc.
341515|NCT01485107|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
341516|NCT01485094|neuralgia|neuralgia
341517|NCT01485094|postherpetic|postherpetic
341518|NCT01485081|Bifurcation|bifurcation
341519|NCT01485081|Drug-eluting balloon|drug-eluting balloon
341520|NCT01485081|Paclitaxel-eluting balloon|paclitaxel-eluting balloon
341521|NCT01485081|Angioplasty|angioplasty
341522|NCT01485081|Coronary artery disease|coronary artery disease
341523|NCT01485081|Coronary artery stenosis|coronary artery stenosis
341524|NCT01485068|Restenosis|restenosis
341525|NCT01485068|Paclitaxel-eluting balloon|paclitaxel-eluting balloon
341526|NCT01485068|Angioplasty|angioplasty
341527|NCT01485068|Coronary artery disease|coronary artery disease
341528|NCT01485068|Coronary artery stenosis|coronary artery stenosis
341529|NCT01485055|aGVHD|agvhd
341530|NCT01485055|GVHD|gvhd
341531|NCT01485055|Graft versus host disease|graft versus host disease
341532|NCT01485055|Acute graft versus host disease|acute graft versus host disease
341533|NCT01485055|Steroid refractory graft versus host disease|steroid refractory graft versus host disease
341534|NCT01485055|Bone marrow transplant|bone marrow transplant
341536|NCT01485055|HSCT|hsct
341537|NCT01485055|infliximab|infliximab
341538|NCT01485055|basiliximab|basiliximab
341539|NCT01485055|Monoclonal antibody treatment|monoclonal antibody treatment
341544|NCT01485016|epilepsy|epilepsy
341545|NCT01485016|ECG|ecg
341546|NCT01485016|accelerometer|accelerometer
341547|NCT01484990|Parkinson's Disease|parkinson's disease
341548|NCT01484990|levodopa|levodopa
341549|NCT01484990|carbidopa|carbidopa
341550|NCT01484990|Duodopa|duodopa
341551|NCT01484990|intestinal gel|intestinal gel
341552|NCT01484977|Lacosamide|lacosamide
341553|NCT01484977|Epilepsy|epilepsy
341554|NCT01484977|Levetiracetam|levetiracetam
341555|NCT01484977|Sodium Channel Blockers|sodium channel blockers
341556|NCT01484964|ASP015K|asp015k
341557|NCT01484964|healthy subjects|healthy subjects
341558|NCT01484964|bioavailability|bioavailability
341559|NCT01484964|food effect|food effect
341560|NCT01484964|rheumatoid arthritis|rheumatoid arthritis
341561|NCT01484964|psoriasis|psoriasis
341562|NCT01484964|transplantation|transplantation
341563|NCT01484951|Open-angle glaucoma|open-angle glaucoma
341564|NCT01484951|Ocular hypertension|ocular hypertension
341565|NCT01484951|Pigment dispersion glaucoma|pigment dispersion glaucoma
341566|NCT01484938|Soft contact lenses|soft contact lenses
341567|NCT01484938|Multi-purpose solution|multi-purpose solution
341568|NCT01484938|Corneal staining|corneal staining
341569|NCT01484925|Barrett's esophagus|barrett's esophagus
341570|NCT01484912|Green tea polyphenols|green tea polyphenols
341571|NCT01484912|Chronic Stable Angina|chronic stable angina
341572|NCT01484899|Pulmonary arterial Hypertension|pulmonary arterial hypertension
341573|NCT01484899|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
341574|NCT01484899|smoking|smoking
341575|NCT01484886|Hemoglobin|hemoglobin
341576|NCT01484886|Congenital heart disease|congenital heart disease
341577|NCT01484886|Cardiac surgery|cardiac surgery
342177|NCT01482156|Pl3K|pl3k
341578|NCT01484886|Red blood cell transfusion|red blood cell transfusion
341579|NCT01484886|Number of red blood cell transfusions|number of red blood cell transfusions
341580|NCT01484873|Exenatide|exenatide
341581|NCT01484873|Byetta|byetta
341582|NCT01484873|Hypothalamic Obesity|hypothalamic obesity
341583|NCT01484873|Obesity|obesity
341584|NCT01484873|Craniopharyngioma|craniopharyngioma
341585|NCT01484860|AUY922|auy922
341586|NCT01484860|Pancreas|pancreas
341587|NCT01484860|Pancreatic cancer|pancreatic cancer
341588|NCT01484860|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
341589|NCT01484860|Cancer of the pancreas|cancer of the pancreas
341590|NCT01484860|Metastatic|metastatic
341591|NCT01484860|Advanced|advanced
720770|NCT01050725|proteome|proteome
341592|NCT01484860|Advanced disease|advanced disease
341593|NCT01484860|Prior systemic anticancer therapy|prior systemic anticancer therapy
341594|NCT01484847|advanced|advanced
341595|NCT01484847|PF-00299804|pf-00299804
341596|NCT01484847|head and neck|head and neck
341597|NCT01484847|pharmacokinetic|pharmacokinetic
341598|NCT01484847|squamous cell carcinoma|squamous cell carcinoma
341599|NCT01484847|gastrojejunostomy|gastrojejunostomy
341600|NCT01484847|feeding tube|feeding tube
341601|NCT01484834|Physical Activity|physical activity
341602|NCT01484834|Occupational Health|occupational health
341603|NCT01484834|Quality of Life|quality of life
341604|NCT01484834|Health Promotion|health promotion
341605|NCT01484821|Sarcopenia|sarcopenia
341606|NCT01484821|ARFI|arfi
341607|NCT01484821|DEXA|dexa
341608|NCT01484821|Cancer|cancer
341609|NCT01484808|PSA Density|psa density
341610|NCT01484808|Prostate Cancer|prostate cancer
341611|NCT01484808|Prostate Biopsy|prostate biopsy
341612|NCT01484808|PSA|psa
341613|NCT01484795|noninvasive ventilation|noninvasive ventilation
341614|NCT01484795|autonomic nervous system|autonomic nervous system
341615|NCT01484782|Hypertension|hypertension
341616|NCT01484782|Telephone Care Management|telephone care management
341617|NCT01484782|Blood pressure|blood pressure
341618|NCT01484782|Medication adherence|medication adherence
341619|NCT01484782|Interactive Voice Response (IVR)|interactive voice response (ivr)
341620|NCT01484782|Cloud computing|cloud computing
341621|NCT01484756|respiratory infection|respiratory infection
341622|NCT01484756|independent elderly|independent elderly
341624|NCT01484756|vitamins|vitamins
341625|NCT01484743|recurrence|recurrence
341626|NCT01484743|readmission|readmission
341627|NCT01484743|reoperation|reoperation
341628|NCT01484743|mortality|mortality
341629|NCT01484743|morbidity|morbidity
341630|NCT01484704|Carcinoma ductale mammae|carcinoma ductale mammae
341631|NCT01484678|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
341632|NCT01484678|Magnetic Resonance Imaging|magnetic resonance imaging
341633|NCT01484678|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
341634|NCT01484678|Muscle|muscle
341635|NCT01484665|PSA screening|psa screening
341636|NCT01484665|Decision aids|decision aids
341637|NCT01484652|Moderate Post-Operative Pain|moderate post-operative pain
341638|NCT01484652|Severe Post-Operative Pain|severe post-operative pain
341639|NCT01484652|Bunionectomy|bunionectomy
341640|NCT01484639|transfusion|transfusion
341641|NCT01484639|cardiac surgery|cardiac surgery
341642|NCT01484626|Relapsed Multiple Myeloma|relapsed multiple myeloma
341643|NCT01484626|Refractory Multiple Myeloma|refractory multiple myeloma
341644|NCT01484626|Bendamustine|bendamustine
341645|NCT01484626|Bortezomib|bortezomib
341646|NCT01484626|Lenalidomide|lenalidomide
341647|NCT01484626|Dexamethasone|dexamethasone
341648|NCT01484626|Treanda|treanda
341649|NCT01484626|Velcade|velcade
341650|NCT01484626|Revlimid|revlimid
341651|NCT01484613|Hear Failure|hear failure
341652|NCT01484613|Cardiac resynchronization|cardiac resynchronization
341653|NCT01484613|CRT-D|crt-d
341654|NCT01484613|quadripolar|quadripolar
341655|NCT01484600|Volunteers|volunteers
341656|NCT01484587|Moderate to Severe Plaque-Type Psoriasis|moderate to severe plaque-type psoriasis
341657|NCT01484587|Psoriasis|psoriasis
341658|NCT01484587|Plaque-type psoriasis|plaque-type psoriasis
341659|NCT01484587|CNTO 1959|cnto 1959
341660|NCT01484587|Japanese participants|japanese participants
341661|NCT01484574|Critical limb ischemia|critical limb ischemia
341662|NCT01484574|Buerger's disease|buerger's disease
341663|NCT01484574|Critical limb ischemia due to Buerger's disease|critical limb ischemia due to buerger's disease
341664|NCT01484561|Phase 1|phase 1
341665|NCT01484522|Influenza|influenza
341666|NCT01484522|Perinatal|perinatal
341667|NCT01484522|immunogenicity|immunogenicity
341668|NCT01484522|Monovalent vaccine|monovalent vaccine
341669|NCT01484522|Children|children
341670|NCT01484522|Youth|youth
341671|NCT01484522|H1N1|h1n1
341672|NCT01484522|Adolescent|adolescent
341673|NCT01484522|Flu|flu
341674|NCT01484509|walking impairment|walking impairment
341675|NCT01484509|claudication|claudication
341676|NCT01484509|treadmill|treadmill
341677|NCT01484509|questionnaire|questionnaire
341678|NCT01484496|Subcutaneous|subcutaneous
341679|NCT01484496|Lupus|lupus
342178|NCT01482156|BEZ235|bez235
341680|NCT01484496|Systemic Lupus Erythematosus|systemic lupus erythematosus
341681|NCT01484496|SLE|sle
341682|NCT01484496|Belimumab|belimumab
341683|NCT01484496|Autoimmune Disease|autoimmune disease
341684|NCT01484496|Antibodies|antibodies
341685|NCT01484470|Stem cell transplantation|stem cell transplantation
341686|NCT01484470|Stem Cell expansion|stem cell expansion
341687|NCT01484470|Elderly|elderly
341688|NCT01484457|Diabetes Mellitus|diabetes mellitus
341689|NCT01484457|Closed Loop|closed loop
341690|NCT01484457|Artificial Pancreas|artificial pancreas
341691|NCT01484418|Chronic Low Back Pain|chronic low back pain
341692|NCT01484418|Cognitive Behavioural Therapy|cognitive behavioural therapy
341693|NCT01484418|Exposure|exposure
341694|NCT01484418|Fear avoidance|fear avoidance
720771|NCT01050725|biomarkers|biomarkers
341695|NCT01484418|Cognitive Behavioural Therapy in chronic low back pain|cognitive behavioural therapy in chronic low back pain
341696|NCT01484418|Exposure in vivo in chronic low back pain|exposure in vivo in chronic low back pain
341697|NCT01484405|surgical approach for total hip arthroplasty|surgical approach for total hip arthroplasty
341698|NCT01484392|open angle glaucoma|open angle glaucoma
341699|NCT01484392|compliance|compliance
341700|NCT01484392|adherence|adherence
341701|NCT01484379|Primary Hyperparathyroidism|primary hyperparathyroidism
341702|NCT01484379|multigland disease|multigland disease
341703|NCT01484379|neck exploration|neck exploration
341704|NCT01484379|elderly|elderly
341705|NCT01484366|fractures of both radius and ulna|fractures of both radius and ulna
341706|NCT01484353|Diabetes|diabetes
341707|NCT01484340|smoking|smoking
341708|NCT01484340|administration, cutaneous|administration, cutaneous
341709|NCT01484327|Heart Failure|heart failure
341710|NCT01484327|Acute Myocardial Infarction|acute myocardial infarction
341711|NCT01484327|LVEF|lvef
341712|NCT01484314|Relapsed|relapsed
341713|NCT01484301|Chronic pain|chronic pain
341714|NCT01484301|Opioids|opioids
341715|NCT01484301|Tolerability|tolerability
341716|NCT01484275|High-risk smoldering multiple myeloma|high-risk smoldering multiple myeloma
341717|NCT01484275|Multiple myeloma|multiple myeloma
341718|NCT01484275|Siltuximab|siltuximab
341720|NCT01484249|filters|filters
341721|NCT01484249|brachiocephalic|brachiocephalic
341722|NCT01484249|neurovasculature|neurovasculature
341723|NCT01484249|debris|debris
341724|NCT01484236|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
341725|NCT01484223|Primary Health Care|primary health care
341726|NCT01484223|Somatization symptoms|somatization symptoms
341727|NCT01484223|Cognitive Behavioral Therapy|cognitive behavioral therapy
341728|NCT01484223|Nursing intervention|nursing intervention
341729|NCT01484197|Asthma|asthma
341730|NCT01484197|Indacaterol|indacaterol
341731|NCT01484197|QAB149|qab149
341732|NCT01484184|Completely paralyzed|completely paralyzed
341733|NCT01484184|Chronically injured|chronically injured
341734|NCT01484184|Central Pattern Generator|central pattern generator
341735|NCT01484184|Locomotion|locomotion
341736|NCT01484184|Secondary complications|secondary complications
341737|NCT01484184|Activity-based training|activity-based training
341738|NCT01484184|Treadmill training|treadmill training
341739|NCT01484184|Spinal cord injury|spinal cord injury
341740|NCT01484184|Paraplegia|paraplegia
341741|NCT01484184|Tetraplegia|tetraplegia
341742|NCT01484171|Acute Myeloid Leukemia|acute myeloid leukemia
341743|NCT01484171|idarubicin|idarubicin
341744|NCT01484171|Microtransplantation|microtransplantation
341745|NCT01484158|Myocardial Infarction|myocardial infarction
341746|NCT01484145|Onychomycosis|onychomycosis
341747|NCT01484145|Nail fungus|nail fungus
341748|NCT01484145|Tinea Unguium|tinea unguium
341749|NCT01484132|Dental Caries|dental caries
341750|NCT01484132|Dental Restorative Materials|dental restorative materials
341751|NCT01484132|Dental Composite|dental composite
341752|NCT01484132|Bisphenol-A|bisphenol-a
341753|NCT01484119|seasonal allergic rhinitis|seasonal allergic rhinitis
341754|NCT01484093|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
341755|NCT01484093|CYTARABINE (ARA-C)|cytarabine (ara-c)
341756|NCT01484093|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
341757|NCT01484093|PREDNISONE|prednisone
341758|NCT01484093|RITUXIMAB|rituximab
341759|NCT01484093|TOSITUMOMAB (BEXXAR)|tositumomab (bexxar)
341760|NCT01484093|Iodine|iodine
341761|NCT01484093|VINCRISTIN|vincristin
341762|NCT01484093|Lymphoma|lymphoma
341763|NCT01484093|Chemo-Radioimmunotherapy|chemo-radioimmunotherapy
341764|NCT01484093|Autologous Transplantation|autologous transplantation
341765|NCT01484093|Untreated|untreated
341766|NCT01484093|11-095|11-095
341767|NCT01484067|Herpes Simplex Virus|herpes simplex virus
341768|NCT01484041|Breast cancer|breast cancer
341769|NCT01484041|postmenopausal|postmenopausal
341770|NCT01484002|Hip replacement|hip replacement
341771|NCT01484002|Crosslinked and conventional polyethylene|crosslinked and conventional polyethylene
341772|NCT01484002|Oxidation|oxidation
341773|NCT01484002|Crosslink density|crosslink density
341774|NCT01484002|Outcome|outcome
341775|NCT01483989|Dry Eye|dry eye
341776|NCT01483989|Epithelial changes|epithelial changes
341777|NCT01483950|Dyslipidemia|dyslipidemia
341778|NCT01483950|Statins|statins
341779|NCT01483950|Total Cholesterol|total cholesterol
341780|NCT01483950|Low density lipoprotein (LDL) cholesterol|low density lipoprotein (ldl) cholesterol
341781|NCT01483950|High density lipoprotein (HDL) cholesterol|high density lipoprotein (hdl) cholesterol
341782|NCT01483937|Keywords provided by BalanceSense, LLC:|keywords provided by balancesense, llc:
341783|NCT01483937|Physical Therapy|physical therapy
341784|NCT01483937|Rehabilitation|rehabilitation
341785|NCT01483937|Disequilibrium|disequilibrium
341786|NCT01483937|Balance dysfunction or disorder|balance dysfunction or disorder
341787|NCT01483937|Vestibular|vestibular
341788|NCT01483937|Mild Traumatic Brain Injury (mTBI)|mild traumatic brain injury (mtbi)
341789|NCT01483937|Vibrotactile|vibrotactile
341790|NCT01483924|Mild to Moderate Chronic Plaque Psoriasis|mild to moderate chronic plaque psoriasis
722155|NCT01055652|safety|safety
341791|NCT01483898|critical limb ischemia|critical limb ischemia
341792|NCT01483898|REVIVE|revive
341793|NCT01483898|peripheral vascular disease|peripheral vascular disease
341795|NCT01483898|PAD|pad
341797|NCT01483898|stem cells|stem cells
341798|NCT01483898|cell therapy|cell therapy
341799|NCT01483872|salvage infected hemodialysis catheters|salvage infected hemodialysis catheters
341800|NCT01483872|novel catheter lock solution|novel catheter lock solution
341801|NCT01483846|Neuropathic Pain|neuropathic pain
341802|NCT01483846|Capsaicin Induced Pain|capsaicin induced pain
341803|NCT01483807|speech|speech
341804|NCT01483807|speech therapy|speech therapy
341805|NCT01483807|apraxia of speech|apraxia of speech
341806|NCT01483794|genital warts|genital warts
341807|NCT01483781|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
341808|NCT01483781|Plasma Volume|plasma volume
341809|NCT01483781|Canagliflozin|canagliflozin
341810|NCT01483781|Metformin|metformin
341811|NCT01483781|Hemoglobin A1c|hemoglobin a1c
341812|NCT01483781|Hypertension|hypertension
341813|NCT01483781|Angiotensin-Converting Enzyme Inhibitors (ACEIs)|angiotensin-converting enzyme inhibitors (aceis)
341814|NCT01483781|Angiotensin Receptor Blockers (ARBs)|angiotensin receptor blockers (arbs)
341815|NCT01483781|Pharmacodynamics|pharmacodynamics
341816|NCT01483781|Pharmacokinetics|pharmacokinetics
341817|NCT01483768|Sleeve gastrectomy|sleeve gastrectomy
341818|NCT01483768|Obesity surgery|obesity surgery
341819|NCT01483768|Iron deficiency|iron deficiency
341820|NCT01483768|HEPCIDINE|hepcidine
341821|NCT01483755|Myocardial infarction|myocardial infarction
341822|NCT01483755|Postconditioning|postconditioning
341823|NCT01483690|Relapse|relapse
341824|NCT01483690|Lymphoblastic|lymphoblastic
341825|NCT01483690|Leukemia|leukemia
341826|NCT01483690|Decitabine|decitabine
341827|NCT01483690|Vorinostat|vorinostat
341828|NCT01483690|Refractory|refractory
341829|NCT01483690|Acute|acute
341830|NCT01483690|Childhood|childhood
341831|NCT01483690|Pediatric|pediatric
341832|NCT01483690|ALL|all
341833|NCT01483677|Laparoscopy|laparoscopy
341834|NCT01483677|video games|video games
341835|NCT01483677|Nintendo Wii|nintendo wii
341836|NCT01483677|Playstation|playstation
341837|NCT01483664|patient outcomes|patient outcomes
341838|NCT01483664|Survivorship|survivorship
341839|NCT01483664|Communication Skills|communication skills
341840|NCT01483664|Communication strategies|communication strategies
341841|NCT01483664|Physicians communication|physicians communication
341842|NCT01483664|11-180|11-180
341843|NCT01483651|diabetes|diabetes
341844|NCT01483651|glucagon|glucagon
341845|NCT01483651|insulin|insulin
341846|NCT01483651|dideuterated glucose|dideuterated glucose
341847|NCT01483638|duration of disease response|duration of disease response
341848|NCT01483638|axitinib|axitinib
341849|NCT01483612|Body Weight|body weight
341850|NCT01483612|Female|female
341851|NCT01483612|Infertility, Female/therapy|infertility, female/therapy
341852|NCT01483612|Infertility, Female/physiopathology|infertility, female/physiopathology
341853|NCT01483612|Obesity/physiopathology|obesity/physiopathology
341854|NCT01483612|Polycystic ovary syndrome|polycystic ovary syndrome
341855|NCT01483612|Pregnancy|pregnancy
341856|NCT01483612|Pregnancy Outcome|pregnancy outcome
341857|NCT01483612|Weight Loss|weight loss
341858|NCT01483599|Moderate to Severe Plaque-Type Psoriasis|moderate to severe plaque-type psoriasis
341859|NCT01483599|Psoriasis|psoriasis
341860|NCT01483599|Plaque-type psoriasis|plaque-type psoriasis
341861|NCT01483599|CNTO 1959|cnto 1959
341862|NCT01483599|adalimumab|adalimumab
341863|NCT01483573|low back pain|low back pain
341864|NCT01483573|straight leg raise|straight leg raise
341865|NCT01483560|REMOVAL|removal
341866|NCT01483560|metformin|metformin
341867|NCT01483560|carotid IMT|carotid imt
341868|NCT01483560|LDL Cholesterol|ldl cholesterol
341869|NCT01483560|endothelial function|endothelial function
341870|NCT01483560|retinopathy|retinopathy
341871|NCT01483560|HbA1c|hba1c
341872|NCT01483534|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
341873|NCT01483534|Pulmonary|pulmonary
341874|NCT01483534|Intervention|intervention
341875|NCT01483534|Device|device
341876|NCT01483534|Denervation|denervation
341877|NCT01483534|Lung|lung
341878|NCT01483534|Holaira, Inc.|holaira, inc.
342179|NCT01482156|RAD001|rad001
341879|NCT01483534|Innovative Pulmonary Solutions, Inc.|innovative pulmonary solutions, inc.
341880|NCT01483521|Randomized|randomized
341881|NCT01483521|Home visitation|home visitation
341882|NCT01483521|Externalizing disorder|externalizing disorder
341883|NCT01483521|Parenting stress|parenting stress
341884|NCT01483521|Childhood externalizing disorders|childhood externalizing disorders
341885|NCT01483521|Positional defiant|positional defiant
341886|NCT01483508|flavanols|flavanols
341887|NCT01483508|procyanidins|procyanidins
341888|NCT01483508|absorption|absorption
341889|NCT01483508|cocoa polyphenols|cocoa polyphenols
341890|NCT01483508|Flavanol and procyanidin absorption in healthy volunteers|flavanol and procyanidin absorption in healthy volunteers
341891|NCT01483482|clavicle fractures|clavicle fractures
341892|NCT01483482|midshaft clavicle fractures|midshaft clavicle fractures
341893|NCT01483482|conservative treatment|conservative treatment
341894|NCT01483482|surgical treatment|surgical treatment
341535|NCT01485055|BMT|bmt
341895|NCT01483482|functional outcome|functional outcome
341896|NCT01483482|clinical assessment|clinical assessment
341897|NCT01483482|adults|adults
341898|NCT01483456|Accidental falls|accidental falls
341899|NCT01483456|safety management|safety management
341900|NCT01483456|aged|aged
341901|NCT01483456|inpatient|inpatient
341902|NCT01483456|stepped wedge design|stepped wedge design
341903|NCT01483443|oophrectomy|oophrectomy
341904|NCT01483443|survival|survival
341905|NCT01483430|Blood pressure|blood pressure
341906|NCT01483430|Korea red ginseng|korea red ginseng
341907|NCT01483430|Ambulatory blood pressure|ambulatory blood pressure
341908|NCT01483430|Pulse wave velocity|pulse wave velocity
341909|NCT01483417|SILS|sils
341910|NCT01483417|Laparoscopic hysterectomy|laparoscopic hysterectomy
341911|NCT01483417|Cosmetic outcome|cosmetic outcome
341912|NCT01483417|Pain|pain
341913|NCT01483404|microcirculation|microcirculation
341914|NCT01483404|caput femoris|caput femoris
341915|NCT01483391|Bipolar disorder|bipolar disorder
341916|NCT01483391|Major depressive disorder|major depressive disorder
341917|NCT01483391|Mania|mania
341918|NCT01483391|Depression|depression
342119|NCT01482351|function|function
341919|NCT01483391|Cyclothymic Disorder|cyclothymic disorder
341920|NCT01483313|Anesthestics|anesthestics
341921|NCT01483313|Minor surgery|minor surgery
341922|NCT01483313|Wechsler Intelligence Scale for Children|wechsler intelligence scale for children
341923|NCT01483313|Cognitiion|cognitiion
341924|NCT01483300|breast cancer|breast cancer
341925|NCT01483300|gemcitabine|gemcitabine
341926|NCT01483300|lobaplatin|lobaplatin
341927|NCT01483300|cisplatin|cisplatin
341928|NCT01483287|Gastrointestinal Symptoms|gastrointestinal symptoms
341929|NCT01483287|Bloating|bloating
341930|NCT01483287|Distention|distention
341931|NCT01483274|AML|aml
341932|NCT01483274|vaccine|vaccine
341933|NCT01483261|Trauma-Focused Cognitive Behavior Therapy|trauma-focused cognitive behavior therapy
341934|NCT01483261|Sexually Exploited Girls|sexually exploited girls
341935|NCT01483261|Post-traumatic Stress Symptoms|post-traumatic stress symptoms
341936|NCT01483261|Psychosocial Distress|psychosocial distress
341937|NCT01483248|Menstrual blood|menstrual blood
341938|NCT01483248|Mesenchymal stem cell|mesenchymal stem cell
341939|NCT01483248|Liver cirrhosis|liver cirrhosis
341940|NCT01483235|cardiac rehabilitation|cardiac rehabilitation
341941|NCT01483235|prevention|prevention
341942|NCT01483235|exercise capacity|exercise capacity
341943|NCT01483222|Low Back Pain|low back pain
341944|NCT01483222|Braces|braces
341945|NCT01483222|Prevention|prevention
341946|NCT01483209|Digital ischemia|digital ischemia
341947|NCT01483209|Vasopressor|vasopressor
341948|NCT01483183|Atrial fibrillation|atrial fibrillation
341949|NCT01483183|Paroxysmal Atrial fibrillation|paroxysmal atrial fibrillation
341950|NCT01483183|Persistent Atrial fibrillation|persistent atrial fibrillation
341951|NCT01483183|A-fib|a-fib
341952|NCT01483144|Familial Adenomatous Polyposis|familial adenomatous polyposis
341953|NCT01483144|Eflornithine|eflornithine
341954|NCT01483144|Sulindac|sulindac
341955|NCT01483118|PCOS|pcos
341956|NCT01483118|Insulin resistance|insulin resistance
341957|NCT01483118|Cinnamon extract|cinnamon extract
341958|NCT01483118|Irregular menstrual cycles|irregular menstrual cycles
341959|NCT01483118|Ovarian cysts|ovarian cysts
341960|NCT01483105|VCUG|vcug
341961|NCT01483105|Child|child
341962|NCT01483105|Hypnosis|hypnosis
341963|NCT01483105|Relaxation|relaxation
341964|NCT01483105|Voiding cystourethrography|voiding cystourethrography
341965|NCT01483079|donor human milk products|donor human milk products
341966|NCT01483079|post-discharge|post-discharge
341967|NCT01483079|growth|growth
341968|NCT01483079|development|development
341969|NCT01483053|Major depressive disorder|major depressive disorder
341970|NCT01483053|Sympathetic nervous system activation|sympathetic nervous system activation
341971|NCT01483053|Cardiovascular risk factors|cardiovascular risk factors
341972|NCT01483053|Agomelatine|agomelatine
341973|NCT01483053|Escitalopram|escitalopram
341974|NCT01483040|wide angle view colonoscopy|wide angle view colonoscopy
341975|NCT01483040|PeerScope B System™|peerscope b system™
341976|NCT01483014|Gastrointestinal,|gastrointestinal,
341977|NCT01483014|stromal,|stromal,
341978|NCT01483014|neoadjuvant,|neoadjuvant,
341979|NCT01483014|imatinib,|imatinib,
341980|NCT01483014|mesylate,|mesylate,
341981|NCT01483014|pre-operatory|pre-operatory
341982|NCT01483001|Cancer Stem Cells|cancer stem cells
341983|NCT01483001|Chemo-Sensitivity Assay|chemo-sensitivity assay
341984|NCT01483001|Cancer Treatment|cancer treatment
341985|NCT01482988|prevalence of the Dectin-1 polymorphism (Tyr238X)|prevalence of the dectin-1 polymorphism (tyr238x)
341986|NCT01482975|tobacco|tobacco
341987|NCT01482975|alcohol|alcohol
341988|NCT01482975|diet|diet
341989|NCT01482975|exercise|exercise
341990|NCT01482949|RCC|rcc
341991|NCT01482949|Kidney Cancer|kidney cancer
341992|NCT01482949|Renal Cancer|renal cancer
341994|NCT01482923|Tobacco Use Assessment|tobacco use assessment
341995|NCT01482923|smoke tobacco|smoke tobacco
341996|NCT01482923|quit smoking|quit smoking
341997|NCT01482923|tobacco cessation|tobacco cessation
341998|NCT01482923|HIV/AIDS|hiv/aids
341999|NCT01482923|Community-Based Service Organizations|community-based service organizations
342000|NCT01482923|11-173|11-173
342001|NCT01482923|Low-Income Persons Living with HIV/AIDS|low-income persons living with hiv/aids
342002|NCT01482897|Discal sciatica, infiltrations|discal sciatica, infiltrations
342003|NCT01482897|Subjects|subjects
342004|NCT01482897|evolving|evolving
342005|NCT01482884|tralokinumab|tralokinumab
342006|NCT01482884|inflammatory bowel disease|inflammatory bowel disease
342007|NCT01482884|moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
342008|NCT01482871|Diabetic Macular Edema|diabetic macular edema
342009|NCT01482832|Randomized trial|randomized trial
342010|NCT01482832|Postpartum depression|postpartum depression
342011|NCT01482832|Adolescent pregnancy|adolescent pregnancy
342012|NCT01482832|Interpersonal psychotherapy|interpersonal psychotherapy
342013|NCT01482806|Depression|depression
342014|NCT01482806|Anxiety|anxiety
342015|NCT01482806|Primary care|primary care
342016|NCT01482806|Cognitive Behavioral Therapy|cognitive behavioral therapy
342017|NCT01482806|Internet|internet
342018|NCT01482806|Support groups|support groups
342019|NCT01482806|Technology assisted|technology assisted
342020|NCT01482741|Quality of Life|quality of life
342021|NCT01482741|Focus groups|focus groups
342022|NCT01482741|Risks of Ionizing Radiation|risks of ionizing radiation
342023|NCT01482741|Risk of medical imaging|risk of medical imaging
342024|NCT01482741|11-185|11-185
342025|NCT01482715|gBRCA ovarian cancer|gbrca ovarian cancer
342026|NCT01482715|platinum sensitive|platinum sensitive
342027|NCT01482715|PARP Inhibitor|parp inhibitor
342028|NCT01482715|Rucaparib|rucaparib
342029|NCT01482715|CO-338|co-338
342030|NCT01482715|PF 01367338|pf 01367338
342031|NCT01482715|AG 14699|ag 14699
342032|NCT01482715|BRCA1|brca1
342033|NCT01482715|BRCA2|brca2
342034|NCT01482715|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
342035|NCT01482715|platinum sensitive gBRCA ovarian cancer|platinum sensitive gbrca ovarian cancer
342036|NCT01482715|gynecological cancer|gynecological cancer
342037|NCT01482715|relapsed disease|relapsed disease
342038|NCT01482715|homologous recombination deficiency|homologous recombination deficiency
342039|NCT01482715|HRD|hrd
342040|NCT01482702|breast cancer survivor|breast cancer survivor
342041|NCT01482702|weight loss|weight loss
342042|NCT01482702|postmenopausal|postmenopausal
342043|NCT01482702|Weight loss for overweight postmenopausal breast cancer survivors|weight loss for overweight postmenopausal breast cancer survivors
342044|NCT01482689|Bioavailability|bioavailability
342045|NCT01482689|Vitamin D metabolism|vitamin d metabolism
342046|NCT01482689|Bone turnover|bone turnover
342047|NCT01482663|Hand eczema|hand eczema
342048|NCT01482663|Hand dermatitis|hand dermatitis
342049|NCT01482663|Chronic hand eczema|chronic hand eczema
342050|NCT01482663|Chronic hand dermatitis|chronic hand dermatitis
342051|NCT01482663|Contact dermatitis|contact dermatitis
342052|NCT01482663|Skin disease|skin disease
342053|NCT01482663|Self-management|self-management
342054|NCT01482650|Baska mask|baska mask
342055|NCT01482650|LMA|lma
342056|NCT01482650|laryngeal mask airway|laryngeal mask airway
342057|NCT01482650|supraglottic airway device|supraglottic airway device
342058|NCT01482624|hyaluronan|hyaluronan
342059|NCT01482624|hyaluronic acid|hyaluronic acid
342060|NCT01482611|Hepatitis C Virus|hepatitis c virus
342061|NCT01482611|JNJ-47910382|jnj-47910382
342062|NCT01482611|47910382HPC1001|47910382hpc1001
342063|NCT01482611|HCV|hcv
342064|NCT01482611|Hepatitis C|hepatitis c
342065|NCT01482611|Hep C|hep c
342066|NCT01482611|Healthy participants|healthy participants
342067|NCT01482611|Japanese|japanese
342068|NCT01482611|Caucasians|caucasians
342069|NCT01482598|Heart Failure|heart failure
342070|NCT01482598|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
342071|NCT01482598|Remote Care|remote care
342072|NCT01482598|Disease Management|disease management
342073|NCT01482585|lung adenocarcinoma|lung adenocarcinoma
342074|NCT01482585|prognosis|prognosis
342075|NCT01482585|tumor aggressiveness|tumor aggressiveness
342076|NCT01482585|imaging biomarker|imaging biomarker
342077|NCT01482585|genetic biomarker|genetic biomarker
342078|NCT01482572|biopsy|biopsy
342079|NCT01482572|needle aspiration|needle aspiration
342080|NCT01482572|mutational analysis|mutational analysis
342081|NCT01482559|Dopamine|dopamine
342082|NCT01482559|Intraventricular haemorrhage|intraventricular haemorrhage
342083|NCT01482559|Periventricular Leukomalacia|periventricular leukomalacia
342084|NCT01482559|Neurodisability|neurodisability
342085|NCT01482559|Infant|infant
342086|NCT01482546|colonoscopy|colonoscopy
342087|NCT01482546|trainees|trainees
342088|NCT01482546|water|water
342089|NCT01482546|adenoma detection rate|adenoma detection rate
342090|NCT01482546|cecal intubation rate|cecal intubation rate
342091|NCT01482494|Myopathies|myopathies
342092|NCT01482494|Pompe disease|pompe disease
342093|NCT01482494|Polymyositis|polymyositis
342094|NCT01482494|Respiratory Insufficiency|respiratory insufficiency
342095|NCT01482481|Patient Care Planning|patient care planning
342096|NCT01482481|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
342097|NCT01482481|Cardiovascular Risk Factors|cardiovascular risk factors
342098|NCT01482481|Primary Health Care|primary health care
342099|NCT01482481|Spain|spain
342100|NCT01482455|Insulin resistance|insulin resistance
342101|NCT01482455|vascular impairment|vascular impairment
342102|NCT01482455|diabetes|diabetes
342103|NCT01482442|Liver, HCC|liver, hcc
342104|NCT01482442|Liver, interventional procedures|liver, interventional procedures
342105|NCT01482442|Liver, randomized studies|liver, randomized studies
342106|NCT01482442|Liver, targeted therapy|liver, targeted therapy
342107|NCT01482442|Liver, RADIOEMBOLIZATION|liver, radioembolization
342108|NCT01482429|ventilator weaning|ventilator weaning
342109|NCT01482429|protocol|protocol
342110|NCT01482416|hormone replacement therapy|hormone replacement therapy
342111|NCT01482416|Doppler velocimetry|doppler velocimetry
342112|NCT01482416|Flow-mediated dilation|flow-mediated dilation
342113|NCT01482416|menopause|menopause
342114|NCT01482364|HOTMAN System|hotman system
342115|NCT01482364|Hemodynamic integrated management|hemodynamic integrated management
342117|NCT01482351|cognition|cognition
342118|NCT01482351|memory|memory
342120|NCT01482351|amnestic mild cognitive impairment|amnestic mild cognitive impairment
342121|NCT01482351|older adults|older adults
342122|NCT01482351|Alzheimer's Disease|alzheimer's disease
342123|NCT01482338|PMS|pms
342124|NCT01482338|Low-dose combine contraceptives pills|low-dose combine contraceptives pills
342125|NCT01482338|COC|coc
342126|NCT01482299|pS6 Ser 240/4|ps6 ser 240/4
342127|NCT01482299|RAD001 (everolimus)|rad001 (everolimus)
342128|NCT01482299|second-line treatment|second-line treatment
342129|NCT01482299|advanced gastric cancer|advanced gastric cancer
342130|NCT01482286|Exercise|exercise
342131|NCT01482286|Diet|diet
342132|NCT01482286|Insulin resistance|insulin resistance
342133|NCT01482286|Weight|weight
342134|NCT01482273|catheter-directed thrombolysis|catheter-directed thrombolysis
342135|NCT01482273|ilio-femoral deep vein thrombosis|ilio-femoral deep vein thrombosis
342136|NCT01482273|Postthrombotic syndrome|postthrombotic syndrome
342137|NCT01482273|Phlebographic scores|phlebographic scores
342138|NCT01482273|Phlebography|phlebography
342139|NCT01482273|Catheters|catheters
342140|NCT01482234|physical activity|physical activity
342141|NCT01482234|exercise|exercise
342142|NCT01482234|walking|walking
342143|NCT01482234|pedometers|pedometers
342144|NCT01482234|goal setting|goal setting
342145|NCT01482234|text messages|text messages
342146|NCT01482234|motivation|motivation
342147|NCT01482234|intrinsic motivation|intrinsic motivation
342148|NCT01482234|extrinsic motivation|extrinsic motivation
342149|NCT01482234|self determination theory|self determination theory
342150|NCT01482234|prompts|prompts
342151|NCT01482221|Major Depressive Disorder|major depressive disorder
342152|NCT01482221|MDD|mdd
342153|NCT01482221|Inadequate Response to Antidepressant Therapy|inadequate response to antidepressant therapy
342154|NCT01482221|Channel blocker of the NMDA class of glutamate receptors|channel blocker of the nmda class of glutamate receptors
342155|NCT01482208|Dehydration|dehydration
342156|NCT01482208|Hydration|hydration
342157|NCT01482208|Muscle composition|muscle composition
342158|NCT01482208|Diarrhea|diarrhea
342159|NCT01482208|Pediatrics|pediatrics
342160|NCT01482208|Neonatology|neonatology
342161|NCT01482208|Ultrasound|ultrasound
342162|NCT01482195|Retinal Disease|retinal disease
342163|NCT01482182|Non-small cell lung cancer|non-small cell lung cancer
342164|NCT01482182|Diffusion-weighted MRI|diffusion-weighted mri
342165|NCT01482182|18F-FDG PET|18f-fdg pet
342166|NCT01482182|Treatment response|treatment response
342167|NCT01482182|Prognosis|prognosis
342168|NCT01482169|Left heart catheterization|left heart catheterization
342169|NCT01482169|Fractional flow reserve|fractional flow reserve
342170|NCT01482169|Adenoscan®|adenoscan®
342171|NCT01482169|Regadenoson|regadenoson
342172|NCT01482156|Advanced solid tumors|advanced solid tumors
342173|NCT01482156|Metastatic renal cell carcinoma (mRCC)|metastatic renal cell carcinoma (mrcc)
342174|NCT01482156|ER+/HER2-Metastatic breast cancer (MBC)|er+/her2-metastatic breast cancer (mbc)
342175|NCT01482156|Dose finding study|dose finding study
342176|NCT01482156|mTOR|mtor
342180|NCT01482156|Everolimus|everolimus
342181|NCT01482156|Afinitor®|afinitor®
342182|NCT01482156|ER+/HER2- metastatic breast cancer|er+/her2- metastatic breast cancer
342183|NCT01482143|Fragile X Syndrome|fragile x syndrome
342184|NCT01482143|pharmacokinetics|pharmacokinetics
342185|NCT01482143|safety and tolerability|safety and tolerability
342186|NCT01482130|Exercise|exercise
342187|NCT01482130|osteoporosis|osteoporosis
342188|NCT01482130|prevention|prevention
342189|NCT01482117|CYP2C19|cyp2c19
342190|NCT01482117|CYP3A5|cyp3a5
342191|NCT01482117|Clopidogrel|clopidogrel
342192|NCT01482117|Cilostazol|cilostazol
342193|NCT01482117|Healthy|healthy
342194|NCT01482104|Photochemotherapy|photochemotherapy
342195|NCT01482104|methyl 5-aminolevulinate|methyl 5-aminolevulinate
342196|NCT01482091|fentanyl|fentanyl
342197|NCT01482091|intranasal|intranasal
342198|NCT01482091|sickle cell|sickle cell
342199|NCT01482091|vasoocclusive crisis|vasoocclusive crisis
342200|NCT01482091|pain crisis|pain crisis
342201|NCT01482091|pediatrics|pediatrics
342202|NCT01482078|Magnesium Sulphate|magnesium sulphate
342203|NCT01482078|Neuroprotection|neuroprotection
342204|NCT01482078|Neuraxial Anesthesia|neuraxial anesthesia
342205|NCT01482078|Sedation|sedation
342206|NCT01482078|Respiratory function|respiratory function
342207|NCT01482078|Cesarean Section|cesarean section
342208|NCT01482078|Obstetrical Anesthesia|obstetrical anesthesia
342209|NCT01482065|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
342210|NCT01482065|NAFLD|nafld
342211|NCT01482065|Continuous Positive Airway Pressure|continuous positive airway pressure
342212|NCT01482065|CPAP|cpap
342213|NCT01482065|CPAP Therapy|cpap therapy
342214|NCT01482065|Apnea Hypopnea Index|apnea hypopnea index
342215|NCT01482065|Non alcoholic steatohepatitis|non alcoholic steatohepatitis
342216|NCT01482065|NASH|nash
342218|NCT01482065|Obstructive Sleep Apnea|obstructive sleep apnea
342219|NCT01482065|AHI|ahi
342319|NCT01481649|HBsAg|hbsag
342220|NCT01482052|Central Nervous System Infections|central nervous system infections
342221|NCT01482052|Meningitis|meningitis
342222|NCT01482052|toxoid|toxoid
342223|NCT01482052|Meningococcal vaccine|meningococcal vaccine
342224|NCT01482052|conjugate vaccines|conjugate vaccines
342225|NCT01482039|short cervix|short cervix
342226|NCT01482039|cervical shortening|cervical shortening
342227|NCT01482039|preterm birth|preterm birth
342228|NCT01482026|Epilepsy|epilepsy
342229|NCT01482026|Attention deficit|attention deficit
342230|NCT01482026|ADHD rating scale IV|adhd rating scale iv
342231|NCT01482000|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
342232|NCT01482000|Adult|adult
342233|NCT01482000|therapeutic use|therapeutic use
342234|NCT01482000|Humans|humans
342235|NCT01482000|Treatment Outcome|treatment outcome
342236|NCT01482000|daoyin therapy|daoyin therapy
342237|NCT01481987|Microperimetry|microperimetry
342238|NCT01481987|OCT|oct
342239|NCT01481987|idiopathic epiretinal membrane|idiopathic epiretinal membrane
342240|NCT01481974|liver transplantation|liver transplantation
342241|NCT01481974|treprostinil|treprostinil
342242|NCT01481961|Alzheimer's disease|alzheimer's disease
342243|NCT01481961|rTMS|rtms
342244|NCT01481961|cognition|cognition
342245|NCT01481948|physical activity|physical activity
342246|NCT01481948|fruit and vegetable|fruit and vegetable
342247|NCT01481948|water|water
342248|NCT01481948|girls|girls
342249|NCT01481948|African American|african american
342250|NCT01481948|online|online
342251|NCT01481935|Antibiotic resistant bacteria|antibiotic resistant bacteria
342252|NCT01481935|Colonization|colonization
342253|NCT01481935|Hospital cleaning|hospital cleaning
342254|NCT01481935|Environmental cleaning|environmental cleaning
342255|NCT01481935|Infection Control|infection control
342256|NCT01481922|Lumbar puncture|lumbar puncture
342257|NCT01481922|Flow rate|flow rate
342258|NCT01481922|Backache|backache
342259|NCT01481922|Pain|pain
342260|NCT01481922|Undifferentiated headache|undifferentiated headache
342261|NCT01481922|Post-lumbar puncture headache|post-lumbar puncture headache
342262|NCT01481909|Assessment of wheal and flare development|assessment of wheal and flare development
342263|NCT01481909|Assessment of life quality|assessment of life quality
342264|NCT01481896|Hip replacement|hip replacement
342265|NCT01481896|Metal-on-metal bearings|metal-on-metal bearings
342266|NCT01481896|Osteolysis|osteolysis
342267|NCT01481896|Metal ion levels|metal ion levels
342268|NCT01481896|Outcome|outcome
342269|NCT01481883|Schizophrenia|schizophrenia
342270|NCT01481883|Mental Illness|mental illness
342271|NCT01481883|SERM|serm
342272|NCT01481883|Raloxifene|raloxifene
342273|NCT01481870|renal cell carcinoma|renal cell carcinoma
342274|NCT01481870|sorafenib|sorafenib
342275|NCT01481870|sunitinib|sunitinib
342276|NCT01481870|crossover|crossover
342277|NCT01481844|sequential therapy|sequential therapy
342278|NCT01481844|second line treatment|second line treatment
342279|NCT01481844|H pylori|h pylori
342280|NCT01481792|Keratorefractive Surgical Procedures|keratorefractive surgical procedures
342281|NCT01481766|child development|child development
342282|NCT01481766|screening|screening
342283|NCT01481766|Non-anemic iron deficiency|non-anemic iron deficiency
342284|NCT01481766|primary care pediatrics|primary care pediatrics
342285|NCT01481766|prevention and health promotion|prevention and health promotion
342286|NCT01481740|spinal induced hypotension|spinal induced hypotension
342287|NCT01481740|nausea and vomiting|nausea and vomiting
342288|NCT01481740|cesarean delivery|cesarean delivery
342289|NCT01481727|acute exacerbation of COPD number|acute exacerbation of copd number
342290|NCT01481727|acute exacerbation of COPD severity|acute exacerbation of copd severity
342291|NCT01481714|Sodium picosulphate|sodium picosulphate
342292|NCT01481714|Split-dose|split-dose
342293|NCT01481714|Bowel cleansing|bowel cleansing
342294|NCT01481714|colonoscopy|colonoscopy
751931|NCT01171274|yoga|yoga
342295|NCT01481714|Degree of bowel cleansing during colonoscopy|degree of bowel cleansing during colonoscopy
342296|NCT01481701|ovarian carcinoma|ovarian carcinoma
342298|NCT01481701|relapse|relapse
342299|NCT01481688|Dialysis adequacy|dialysis adequacy
342300|NCT01481688|Urea clearance|urea clearance
342301|NCT01481688|Phosphate clearance|phosphate clearance
342302|NCT01481688|Beta 2 microglobulin clearance|beta 2 microglobulin clearance
342303|NCT01481688|Intradialytic exercise|intradialytic exercise
342304|NCT01481688|Haemodialysis patients|haemodialysis patients
342305|NCT01481675|biliopancreatic diversion|biliopancreatic diversion
342306|NCT01481675|sleeve gastrectomy|sleeve gastrectomy
342307|NCT01481675|diabetes mellitus|diabetes mellitus
342308|NCT01481675|weight loss|weight loss
342309|NCT01481675|ghrelin|ghrelin
342310|NCT01481675|PYY|pyy
342311|NCT01481675|GLP-1|glp-1
342312|NCT01481662|SUSAC's Syndrome|susac's syndrome
342313|NCT01481662|encephalopathy|encephalopathy
342314|NCT01481662|hearing loss|hearing loss
342315|NCT01481662|retinal artery branch occlusions|retinal artery branch occlusions
342316|NCT01481662|Diffusion tensor MRI|diffusion tensor mri
342317|NCT01481649|hepatitis B|hepatitis b
342318|NCT01481649|anti-HBc|anti-hbc
342320|NCT01481649|HSCT|hsct
342321|NCT01481649|recipients|recipients
342322|NCT01481636|Obstructive sleep apnea|obstructive sleep apnea
342323|NCT01481636|correlation|correlation
342324|NCT01481636|AHI|ahi
342325|NCT01481636|symptoms|symptoms
342326|NCT01481636|mechanisms|mechanisms
342327|NCT01481623|Diabetes|diabetes
342328|NCT01481623|neonatal|neonatal
342329|NCT01481623|consanguinity|consanguinity
342330|NCT01481623|monogenic|monogenic
342331|NCT01481623|metabolism|metabolism
342332|NCT01481610|Kidney Failure, Chronic|kidney failure, chronic
342333|NCT01481610|Arthralgia|arthralgia
342334|NCT01481610|NSAID|nsaid
342335|NCT01481610|Diclofenac|diclofenac
342336|NCT01481610|Lumiracoxib|lumiracoxib
342337|NCT01481610|Safety|safety
342338|NCT01481597|deuteporfin|deuteporfin
342339|NCT01481597|safety|safety
342340|NCT01481597|tolerability|tolerability
342341|NCT01481597|pharmacokinetics|pharmacokinetics
342342|NCT01481597|healthy volunteers|healthy volunteers
342343|NCT01481584|Dietary protein|dietary protein
342344|NCT01481584|Canola protein|canola protein
342345|NCT01481584|Protein metabolism|protein metabolism
342346|NCT01481584|Protein-enriched drinks|protein-enriched drinks
342347|NCT01481584|Nitrogen balance|nitrogen balance
342348|NCT01481571|Media for vitrification/warming of human oocytes|media for vitrification/warming of human oocytes
342349|NCT01481558|Apathy|apathy
342350|NCT01481558|Alzheimer's Disease|alzheimer's disease
342351|NCT01481558|Dementia|dementia
342352|NCT01481545|locally advanced|locally advanced
342353|NCT01481545|high risk|high risk
342354|NCT01481545|preoperative therapy|preoperative therapy
342355|NCT01481532|Antineoplastic agent|antineoplastic agent
342356|NCT01481519|Conjunctivitis|conjunctivitis
342357|NCT01481519|Ocular diseases|ocular diseases
342358|NCT01481519|Artificial tears|artificial tears
342359|NCT01481493|rheumatoid arthritis|rheumatoid arthritis
342360|NCT01481480|shoulder|shoulder
342361|NCT01481480|rotator cuff|rotator cuff
342362|NCT01481480|tendon transfer|tendon transfer
342363|NCT01481480|arthroscopic repair|arthroscopic repair
342364|NCT01481467|influenza vaccination|influenza vaccination
342365|NCT01481467|intervention mapping|intervention mapping
342366|NCT01481467|hospital care|hospital care
342367|NCT01481467|respiratory infections|respiratory infections
342368|NCT01481467|vaccination|vaccination
342369|NCT01481454|Influenza|influenza
342370|NCT01481454|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
342371|NCT01481454|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
342372|NCT01481441|Contrast Enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
342373|NCT01481441|Prostate cancer|prostate cancer
342374|NCT01481441|Quantification|quantification
342375|NCT01481441|Prostate biopsies|prostate biopsies
342376|NCT01481441|Transrectal ultrasound (TRUS)|transrectal ultrasound (trus)
342377|NCT01481441|Microbubbles|microbubbles
342378|NCT01481428|High risk behavior|high risk behavior
342379|NCT01481428|Drug court clients|drug court clients
342380|NCT01481428|Substance abuse|substance abuse
342381|NCT01481428|HIV intervention|hiv intervention
342666|NCT01480167|VCF|vcf
342382|NCT01481428|Treatment Court Clients|treatment court clients
342383|NCT01481415|left atrial|left atrial
342384|NCT01481415|three-dimensional echocardioraphy|three-dimensional echocardioraphy
342385|NCT01481415|left atrial function|left atrial function
342386|NCT01481402|Heart failure|heart failure
342387|NCT01481402|Liothyronine|liothyronine
342388|NCT01481402|Low T3 syndrome|low t3 syndrome
342389|NCT01481389|Blood lipids|blood lipids
342390|NCT01481389|risk factor for cardiovascular diseases|risk factor for cardiovascular diseases
342391|NCT01481376|Parietex™ ProGrip™|parietex™ progrip™
342392|NCT01481376|Laparoscopic Transabdominal preperitoneal|laparoscopic transabdominal preperitoneal
342393|NCT01481376|TAPP|tapp
342394|NCT01481376|Inguinal hernia repair|inguinal hernia repair
342395|NCT01481363|dementia|dementia
342396|NCT01481363|communication|communication
342397|NCT01481363|carers|carers
342398|NCT01481363|caregivers|caregivers
342399|NCT01481363|psychosocial support systems|psychosocial support systems
342400|NCT01481363|education|education
342401|NCT01481337|colon|colon
342402|NCT01481337|endoscopy|endoscopy
342403|NCT01481337|resection|resection
342404|NCT01481324|Clubfoot|clubfoot
342405|NCT01481324|Compliance|compliance
342406|NCT01481324|Brace wear|brace wear
342407|NCT01481285|Bioelectrical Impedance Measurement|bioelectrical impedance measurement
342408|NCT01481285|Adults|adults
342409|NCT01481272|Salvage therapy in DLBCL|salvage therapy in dlbcl
342410|NCT01481259|Nonsquamous non-small cell lung cancer|nonsquamous non-small cell lung cancer
342411|NCT01481259|Maintenance therapy|maintenance therapy
342412|NCT01481259|Immunotherapy|immunotherapy
342413|NCT01481259|Autologous cytokine-induced killer cell|autologous cytokine-induced killer cell
342414|NCT01481259|Pemetrexed|pemetrexed
342415|NCT01481246|neurorehabilitation|neurorehabilitation
342416|NCT01481246|cognition|cognition
342417|NCT01481246|aging|aging
342419|NCT01481246|cognitive decline|cognitive decline
342420|NCT01481233|oral colchicine|oral colchicine
342421|NCT01481233|castrate-resistant prostate cancer|castrate-resistant prostate cancer
342422|NCT01481233|failed taxotere based chemotherapy|failed taxotere based chemotherapy
342423|NCT01481220|Myelodysplastic syndrome|myelodysplastic syndrome
342424|NCT01481220|azacitidine|azacitidine
342425|NCT01481220|Eltrombopag|eltrombopag
342426|NCT01481220|Thrombopoietin-receptor agonist|thrombopoietin-receptor agonist
342427|NCT01481220|Thrombocytopenia|thrombocytopenia
342428|NCT01481220|Transfusion dependency|transfusion dependency
342429|NCT01481220|Safety study|safety study
342430|NCT01481207|magnetic resonance spectroscopy|magnetic resonance spectroscopy
342431|NCT01481207|magnetic resonance imaging|magnetic resonance imaging
342432|NCT01481194|Multiple Myeloma|multiple myeloma
342433|NCT01481181|zinc water diarrhoea growth preschool children|zinc water diarrhoea growth preschool children
342434|NCT01481155|actinic keratosis|actinic keratosis
342435|NCT01481155|field cancerisation|field cancerisation
342436|NCT01481116|Drug Therapy|drug therapy
342437|NCT01481103|Over the counter medication|over the counter medication
342438|NCT01481103|Acupuncture|acupuncture
342439|NCT01481090|Infertility|infertility
342440|NCT01481090|acupuncture|acupuncture
342441|NCT01481090|frozen embryos|frozen embryos
342442|NCT01481090|endometrium|endometrium
342443|NCT01481090|TCM|tcm
342444|NCT01481064|Patient centredness|patient centredness
342445|NCT01481064|Quality of life|quality of life
342446|NCT01481064|Multifaceted approach|multifaceted approach
342447|NCT01481064|Fertility care|fertility care
342448|NCT01481038|early detection|early detection
342449|NCT01481038|CRBSI|crbsi
342450|NCT01481025|Climacteric|climacteric
342451|NCT01481025|Depression|depression
342452|NCT01481025|Herbal treatment|herbal treatment
342453|NCT01481012|Heart transplantation|heart transplantation
342454|NCT01481012|Coronary artery bypass graft (CABG) surgery|coronary artery bypass graft (cabg) surgery
342455|NCT01481012|Left ventricular assist device implantation surgeries|left ventricular assist device implantation surgeries
342456|NCT01480999|Laparotomy|laparotomy
342457|NCT01480999|Open Surgery|open surgery
342458|NCT01480999|Laparoscopy|laparoscopy
342459|NCT01480999|Robotic surgery|robotic surgery
342460|NCT01480960|lung transplantation|lung transplantation
342461|NCT01480960|whole body vibration|whole body vibration
342462|NCT01480960|exercise training|exercise training
333167|NCT01519895|stress|stress
342463|NCT01480960|pulmonary rehabilitation|pulmonary rehabilitation
342464|NCT01480947|probiotics|probiotics
342465|NCT01480947|pediatric|pediatric
342466|NCT01480947|salmonella|salmonella
342467|NCT01480947|rotavirus|rotavirus
342468|NCT01480947|gastroenteritis|gastroenteritis
342469|NCT01480934|Diabetes,posterior capsule opacification,case control study|diabetes,posterior capsule opacification,case control study
342470|NCT01480921|heart failure|heart failure
342471|NCT01480921|health related quality of life|health related quality of life
342472|NCT01480921|exercise capacity|exercise capacity
342473|NCT01480921|home based exercise training|home based exercise training
342474|NCT01480921|supervised exercise training|supervised exercise training
342475|NCT01480908|Right bundle branch block|right bundle branch block
342476|NCT01480908|Ventricular septal defect|ventricular septal defect
342477|NCT01480908|Echocardiography|echocardiography
342478|NCT01480908|MRI|mri
342479|NCT01480908|Exercise testing|exercise testing
342480|NCT01480895|Diabetes Mellitus Type 2|diabetes mellitus type 2
342481|NCT01480895|Gestational Diabetes Mellitus|gestational diabetes mellitus
342482|NCT01480895|Glucose Intolerance|glucose intolerance
342483|NCT01480895|Physical exercise|physical exercise
342484|NCT01480895|Nutritional Habits|nutritional habits
342485|NCT01480895|Dyslipidemia|dyslipidemia
342486|NCT01480882|Manual percussion|manual percussion
342487|NCT01480882|Mechanical percussion|mechanical percussion
342488|NCT01480882|Chronic bronchiectasis|chronic bronchiectasis
342489|NCT01480882|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
342490|NCT01480882|Wet sputum weight|wet sputum weight
342491|NCT01480882|Dry sputum weight|dry sputum weight
342492|NCT01480869|Breast cancer|breast cancer
342493|NCT01480869|Vitamin D supplementation|vitamin d supplementation
342494|NCT01480869|in neoadjuvant|in neoadjuvant
342495|NCT01480869|adjuvant setting|adjuvant setting
342496|NCT01480843|simplification|simplification
342497|NCT01480843|glargine|glargine
342498|NCT01480843|elderly|elderly
342499|NCT01480830|Quality|quality
342500|NCT01480830|indicators|indicators
342501|NCT01480804|Barriers|barriers
342502|NCT01480804|Intervention|intervention
342503|NCT01480804|Elderly|elderly
342504|NCT01480804|glycemic control|glycemic control
342505|NCT01480791|resistance arteries|resistance arteries
342506|NCT01480791|endothelial dysfunction|endothelial dysfunction
342507|NCT01480791|aortic stiffness|aortic stiffness
342508|NCT01480778|hormonal response, levonorgestrel, ethinyl estradiol|hormonal response, levonorgestrel, ethinyl estradiol
342509|NCT01480752|In the patients with symptomatic Irreversible Pulpitis|in the patients with symptomatic irreversible pulpitis
342510|NCT01480739|Phase 1, AZD5069, safety and tolerability, healthy volunteer,|phase 1, azd5069, safety and tolerability, healthy volunteer,
342511|NCT01480713|HIV-1|hiv-1
342512|NCT01480713|protease inhibitors|protease inhibitors
342810|NCT01479595|VAK694|vak694
342513|NCT01480713|integrase inhibitors|integrase inhibitors
342514|NCT01480713|raltegravir|raltegravir
342515|NCT01480713|viral replication|viral replication
342516|NCT01480713|treatment intensification|treatment intensification
342517|NCT01480713|viral pathogenesis|viral pathogenesis
342518|NCT01480713|immune activation|immune activation
342519|NCT01480700|eggs|eggs
342520|NCT01480700|Optical Macular Pigment|optical macular pigment
342521|NCT01480700|Age Macular Degeneration|age macular degeneration
342522|NCT01480700|study for the Age Macular Degeneration prevention|study for the age macular degeneration prevention
342523|NCT01480687|Hypertension|hypertension
342524|NCT01480687|Endothelial dysfunction|endothelial dysfunction
342525|NCT01480687|Vascular stiffness|vascular stiffness
342526|NCT01480661|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
342527|NCT01480661|Computed Tomography scan|computed tomography scan
342528|NCT01480661|Functional Respiratory Imaging|functional respiratory imaging
342529|NCT01480661|Roflumilast|roflumilast
342530|NCT01480661|Health Related Quality of Life|health related quality of life
342531|NCT01480635|Incomplete Colonoscopy|incomplete colonoscopy
342532|NCT01480635|Efficacy of PillCam Colon2|efficacy of pillcam colon2
342533|NCT01480622|healthy subjects|healthy subjects
342534|NCT01480622|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
342535|NCT01480622|hepatitis|hepatitis
342536|NCT01480622|pharmacokinetics|pharmacokinetics
342537|NCT01480583|GRN1005|grn1005
342538|NCT01480583|ANG1005|ang1005
342539|NCT01480583|Peptide-Drug Conjugate (PDC)|peptide-drug conjugate (pdc)
342540|NCT01480583|LRP-1|lrp-1
342541|NCT01480583|Targeted Therapy|targeted therapy
342542|NCT01480583|Breast Cancer|breast cancer
342543|NCT01480583|Brain Metastases|brain metastases
342544|NCT01480583|Brain Tumor|brain tumor
342545|NCT01480583|Blood Brain Barrier|blood brain barrier
342546|NCT01480583|Trastuzumab|trastuzumab
342547|NCT01480583|Herceptin|herceptin
342548|NCT01480583|Paclitaxel|paclitaxel
342549|NCT01480583|Taxol|taxol
342550|NCT01480583|Breast cancer with brain metastases|breast cancer with brain metastases
342551|NCT01480557|cataract|cataract
342552|NCT01480557|phacoemulsification|phacoemulsification
342553|NCT01480557|liquefaction|liquefaction
342554|NCT01480557|torsional ip|torsional ip
342555|NCT01480557|endothelial cell count|endothelial cell count
342556|NCT01480557|central corneal edema|central corneal edema
342557|NCT01480557|central corneal sensitivity|central corneal sensitivity
342558|NCT01480544|Institutional Deliveries|institutional deliveries
342559|NCT01480544|Maternal Health|maternal health
342560|NCT01480544|Infant Health|infant health
342561|NCT01480544|Private Medical Providers|private medical providers
342562|NCT01480544|Provider Incentives|provider incentives
342563|NCT01480544|Randomized Control Trial|randomized control trial
342564|NCT01480531|aorta|aorta
342565|NCT01480531|aneurysm|aneurysm
342566|NCT01480531|dissection|dissection
342567|NCT01480518|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
342568|NCT01480505|Retinal detachment|retinal detachment
342569|NCT01480505|high myopia|high myopia
342570|NCT01480505|macular hole|macular hole
342571|NCT01480505|axial length|axial length
342572|NCT01480505|Scleral buckling|scleral buckling
342573|NCT01480505|Vitrectomy|vitrectomy
342574|NCT01480505|Visual acuity|visual acuity
342575|NCT01480505|fundus examination results|fundus examination results
342577|NCT01480492|Immune|immune
342578|NCT01480492|antiviral therapy|antiviral therapy
342579|NCT01480479|EGFRvIII|egfrviii
342580|NCT01480479|Glioblastoma|glioblastoma
342581|NCT01480479|Small cell|small cell
342582|NCT01480479|Giant cell|giant cell
342583|NCT01480479|Gliosarcoma|gliosarcoma
342584|NCT01480479|oligodendroglial|oligodendroglial
342585|NCT01480479|Brain Cancer|brain cancer
342586|NCT01480479|Brain Tumor|brain tumor
342587|NCT01480479|radiotherapy|radiotherapy
342588|NCT01480479|chemoradiation|chemoradiation
342589|NCT01480479|Tumor|tumor
342590|NCT01480479|temozolomide|temozolomide
342591|NCT01480479|EGFR variant III|egfr variant iii
342592|NCT01480466|Overweight|overweight
342593|NCT01480466|Obesity|obesity
342594|NCT01480466|Body mass index|body mass index
342595|NCT01480466|Weight|weight
342596|NCT01480466|Primary care|primary care
342597|NCT01480453|Osteoarthritis|osteoarthritis
342598|NCT01480453|Rheumatoid arthritis|rheumatoid arthritis
342599|NCT01480453|Post-traumatic arthritis|post-traumatic arthritis
342600|NCT01480453|Ununited humeral head fracture|ununited humeral head fracture
342601|NCT01480453|Irreducible 3- and 4-part proximal humeral fractures|irreducible 3- and 4-part proximal humeral fractures
342602|NCT01480453|Avascular necrosis|avascular necrosis
342603|NCT01480440|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
342604|NCT01480440|Reverse TSA|reverse tsa
342605|NCT01480440|Osteoarthritis|osteoarthritis
342606|NCT01480440|Rheumatoid Arthritis|rheumatoid arthritis
342607|NCT01480440|Post-traumatic arthritis|post-traumatic arthritis
342608|NCT01480440|Ununited humeral head fracture|ununited humeral head fracture
342703|NCT01479998|smoking cessation|smoking cessation
342609|NCT01480440|Irreducible 3-and 4-part proximal humeral fractures|irreducible 3-and 4-part proximal humeral fractures
342610|NCT01480440|Avascular necrosis|avascular necrosis
342611|NCT01480440|Gross rotator cuff deficiency|gross rotator cuff deficiency
342612|NCT01480440|Failed total shoulder arthroplasty (both glenoid and humeral components require revision|failed total shoulder arthroplasty (both glenoid and humeral components require revision
342613|NCT01480427|Children aged 0-12 years|children aged 0-12 years
342614|NCT01480427|IgE mediated food allergy|ige mediated food allergy
342615|NCT01480414|bone marrow mono nuclear stem cell ischemic ulcer|bone marrow mono nuclear stem cell ischemic ulcer
342616|NCT01480401|Patients with stable heart failure|patients with stable heart failure
342617|NCT01480388|Rheumatoid arthritis|rheumatoid arthritis
342618|NCT01480388|Swollen and tender joints|swollen and tender joints
342619|NCT01480388|Dose range finding study|dose range finding study
342620|NCT01480388|Concurrent treatment with methotrexate|concurrent treatment with methotrexate
342621|NCT01480375|prostate cancer detection|prostate cancer detection
342622|NCT01480375|prostate biopsy|prostate biopsy
342623|NCT01480375|3d navigation|3d navigation
342624|NCT01480375|trans rectal ultrasound|trans rectal ultrasound
342625|NCT01480362|Diabetic foot wound|diabetic foot wound
342626|NCT01480362|Amputation wound|amputation wound
342627|NCT01480362|Chronic wound|chronic wound
342628|NCT01480349|Post-Hemorrhagic Hydrocephalus|post-hemorrhagic hydrocephalus
342629|NCT01480349|Intraventricular Hemorrhage|intraventricular hemorrhage
342630|NCT01480349|Low Birth Weight Premature Infants|low birth weight premature infants
342631|NCT01480336|Arrhythmia|arrhythmia
342632|NCT01480323|Malignant melanoma|malignant melanoma
342633|NCT01480297|Pain|pain
342634|NCT01480297|Neuropathy|neuropathy
342635|NCT01480297|Diabetes type 1|diabetes type 1
342636|NCT01480284|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
342637|NCT01480284|Chronic Hepatitis B|chronic hepatitis b
342638|NCT01480271|Allergic Rhinitis|allergic rhinitis
342639|NCT01480271|Healthy Volunteers|healthy volunteers
342640|NCT01480271|Single Dose Escalation|single dose escalation
342641|NCT01480271|TLR7 agonist|tlr7 agonist
342642|NCT01480271|First Time in Human Study|first time in human study
342643|NCT01480258|combination vaccine|combination vaccine
342644|NCT01480258|diphtheria|diphtheria
342645|NCT01480258|pertussis|pertussis
342646|NCT01480258|tetanus|tetanus
342647|NCT01480258|hepatitis B|hepatitis b
342648|NCT01480258|Hep B|hep b
342649|NCT01480258|Haemophilus influenzae b|haemophilus influenzae b
342651|NCT01480258|polio|polio
342652|NCT01480258|poliovirus|poliovirus
342653|NCT01480245|968|968
342654|NCT01480245|Duchenne|duchenne
342655|NCT01480245|DMD|dmd
342656|NCT01480245|drisapersen|drisapersen
342657|NCT01480219|voriconazole|voriconazole
342658|NCT01480219|non-melanoma skin cancer|non-melanoma skin cancer
342659|NCT01480219|confounding|confounding
342660|NCT01480219|statistical adjustment|statistical adjustment
342661|NCT01480219|risk adjustment|risk adjustment
342662|NCT01480219|lung transplant|lung transplant
342663|NCT01480219|heart/lung transplant|heart/lung transplant
342664|NCT01480219|immunosuppression|immunosuppression
342665|NCT01480193|Tinnitus|tinnitus
342667|NCT01480167|Osteoporosis|osteoporosis
342668|NCT01480167|Minimally Invasive|minimally invasive
342669|NCT01480167|Non-operative management|non-operative management
342670|NCT01480167|Medical Management|medical management
342671|NCT01480128|Single-port|single-port
342672|NCT01480128|Laparoscopy|laparoscopy
342673|NCT01480128|colectomy|colectomy
342674|NCT01480128|Single port|single port
342675|NCT01480128|colon cancer|colon cancer
342676|NCT01480128|minimally invasive surgery|minimally invasive surgery
342677|NCT01480115|antral follicle count|antral follicle count
342678|NCT01480115|automated antral follicle count|automated antral follicle count
342679|NCT01480115|ovarian reserve|ovarian reserve
342680|NCT01480102|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
342681|NCT01480102|Paravertebral block|paravertebral block
342682|NCT01480102|bupivacaine|bupivacaine
342683|NCT01480089|Surgical Pain Management|surgical pain management
342684|NCT01480089|Robotic surgery|robotic surgery
342685|NCT01480089|Ropivacaine|ropivacaine
342686|NCT01480076|Quality of Life|quality of life
342687|NCT01480076|Multiple Sclerosis|multiple sclerosis
342688|NCT01480050|adult giant cell glioblastoma|adult giant cell glioblastoma
342689|NCT01480050|adult glioblastoma|adult glioblastoma
342690|NCT01480050|adult anaplastic astrocytoma|adult anaplastic astrocytoma
342691|NCT01480050|adult anaplastic ependymoma|adult anaplastic ependymoma
342692|NCT01480050|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
342693|NCT01480050|adult mixed glioma|adult mixed glioma
342694|NCT01480050|recurrent adult brain tumor|recurrent adult brain tumor
342695|NCT01480024|healthy women|healthy women
342696|NCT01480024|oocytes|oocytes
342697|NCT01480024|in vitro fertilization|in vitro fertilization
342698|NCT01480024|pregnancy|pregnancy
342699|NCT01480024|childbearing-age|childbearing-age
342700|NCT01480011|Lactobacillus CD2 lozenges|lactobacillus cd2 lozenges
342701|NCT01480011|high-dose chemotherapy induced|high-dose chemotherapy induced
342702|NCT01480011|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
342704|NCT01479998|NRT nicotine replacement therapy|nrt nicotine replacement therapy
342705|NCT01479998|CBT cognitive behavioral therapy|cbt cognitive behavioral therapy
342706|NCT01479998|contingency management|contingency management
342707|NCT01479972|Tuberculosis|tuberculosis
342708|NCT01479972|Vaccine|vaccine
342709|NCT01479972|Live vaccine|live vaccine
342710|NCT01479972|rBCG|rbcg
342711|NCT01479959|Tracheostomy|tracheostomy
342712|NCT01479959|positive end expiratory pressure|positive end expiratory pressure
342713|NCT01479959|speech|speech
342714|NCT01479959|respiratory failure|respiratory failure
342715|NCT01479959|ventilation|ventilation
342716|NCT01479959|neuromuscular disorders|neuromuscular disorders
342717|NCT01479933|vitamin D|vitamin d
342718|NCT01479933|cholecalciferol|cholecalciferol
342719|NCT01479933|supplementation|supplementation
342720|NCT01479933|prediabetic state|prediabetic state
342721|NCT01479933|obesity|obesity
342722|NCT01479933|glucose metabolism|glucose metabolism
342723|NCT01479933|gene expression|gene expression
342724|NCT01479933|transcriptomics|transcriptomics
342725|NCT01479933|epigenomics|epigenomics
342726|NCT01479933|immunological function|immunological function
342727|NCT01479933|insulin sensitivity|insulin sensitivity
342728|NCT01479933|peripheral mononuclear cells|peripheral mononuclear cells
342729|NCT01479920|Depressive Disorder|depressive disorder
342730|NCT01479920|Depressive Symptoms|depressive symptoms
342731|NCT01479920|Depressive Syndrome|depressive syndrome
342732|NCT01479920|Emotional Depression|emotional depression
342733|NCT01479881|Hepatitis C Virus|hepatitis c virus
342734|NCT01479881|TMC435|tmc435
342735|NCT01479881|TMC435-TiDP16-C120|tmc435-tidp16-c120
342736|NCT01479881|TMC435-C120|tmc435-c120
342737|NCT01479881|HCV|hcv
342738|NCT01479881|Hepatitis C|hepatitis c
342739|NCT01479881|Hep C|hep c
342740|NCT01479881|Healthy participants|healthy participants
342741|NCT01479868|Hepatitis C virus genotype-1|hepatitis c virus genotype-1
342742|NCT01479868|Human immunodeficiency virus-type 1|human immunodeficiency virus-type 1
342743|NCT01479868|HCV-1|hcv-1
342744|NCT01479868|HIV-1|hiv-1
342745|NCT01479868|TMC435|tmc435
342746|NCT01479868|Pegylated interferon alpha-2a|pegylated interferon alpha-2a
342747|NCT01479868|PegIFNα-2a|pegifnα-2a
342748|NCT01479868|Pegasys|pegasys
342749|NCT01479868|Ribavirin|ribavirin
342750|NCT01479868|RBV|rbv
342751|NCT01479868|Copegus|copegus
342752|NCT01479855|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
342753|NCT01479855|Alzheimers disease|alzheimers disease
342754|NCT01479855|Vitamines|vitamines
342755|NCT01479855|Nutrients|nutrients
342756|NCT01479829|Bipolar depression|bipolar depression
342757|NCT01479829|Celecoxib|celecoxib
342758|NCT01479829|Escitalopram|escitalopram
342759|NCT01479829|Inflammation|inflammation
342760|NCT01479816|continence|continence
342761|NCT01479816|index|index
342762|NCT01479790|Visante AS-OCT|visante as-oct
342763|NCT01479790|Cirrus AS-OCT|cirrus as-oct
342764|NCT01479790|Thermography|thermography
342765|NCT01479790|Tear evaporation|tear evaporation
342766|NCT01479790|Tear evaporimetry|tear evaporimetry
342767|NCT01479777|Spinal Cord Injury|spinal cord injury
342768|NCT01479777|Functional electrical stimulation|functional electrical stimulation
342769|NCT01479777|Rehabilitation|rehabilitation
342770|NCT01479751|Rocuronium|rocuronium
342771|NCT01479751|magnesium|magnesium
342772|NCT01479751|priming|priming
342773|NCT01479751|ketamine|ketamine
342774|NCT01479751|intubation|intubation
342775|NCT01479738|arthroplasty|arthroplasty
342776|NCT01479738|graft|graft
342777|NCT01479738|capitate|capitate
342778|NCT01479738|artery|artery
342779|NCT01479725|interstitial cystitis|interstitial cystitis
342780|NCT01479712|Irrigation|irrigation
342781|NCT01479712|Cesarean Section|cesarean section
342782|NCT01479712|Nausea|nausea
342783|NCT01479712|Infection|infection
342784|NCT01479699|Olive leaf extract|olive leaf extract
342785|NCT01479699|Polyphenols|polyphenols
342786|NCT01479699|Vascular function|vascular function
342787|NCT01479699|Bioavailability|bioavailability
342788|NCT01479699|Cytokines|cytokines
342789|NCT01479686|GLIOMA|glioma
342790|NCT01479686|NEURONAVIGATION|neuronavigation
342791|NCT01479686|INTERVENTIONAL MRI|interventional mri
342792|NCT01479673|Enteral Nutrition|enteral nutrition
342793|NCT01479673|Parenteral Nutrition|parenteral nutrition
342794|NCT01479673|Indirect Calorimetry|indirect calorimetry
342795|NCT01479673|Intravenous Feeding|intravenous feeding
342796|NCT01479660|Probiotics|probiotics
342797|NCT01479660|ulcerative colitis|ulcerative colitis
342798|NCT01479660|inflammatory bowel disease|inflammatory bowel disease
342799|NCT01479634|HIV|hiv
342800|NCT01479634|ART|art
342801|NCT01479621|Dose Ranging|dose ranging
342802|NCT01479621|Fluticasone Propionate|fluticasone propionate
342803|NCT01479621|Dry Powder Inhaler (DPI)|dry powder inhaler (dpi)
342804|NCT01479621|Non-steroidal|non-steroidal
342805|NCT01479621|Asthma|asthma
342806|NCT01479595|Asthma|asthma
342807|NCT01479595|Interleukin|interleukin
342808|NCT01479595|QBX258|qbx258
342809|NCT01479595|QAX576|qax576
342811|NCT01479582|Adult and Pediatric|adult and pediatric
342812|NCT01479582|Unlicensed Cord Blood Unit IND|unlicensed cord blood unit ind
342813|NCT01479582|NMDP|nmdp
342814|NCT01479582|Transplant|transplant
342815|NCT01479582|Hematologic Malignancies|hematologic malignancies
342816|NCT01479582|Leukemia|leukemia
342817|NCT01479582|Multiple Myeloma|multiple myeloma
342818|NCT01479582|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
342820|NCT01479582|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
342821|NCT01479582|Myelodyplastic Syndrome|myelodyplastic syndrome
342822|NCT01479582|MDS|mds
342823|NCT01479582|Thalassemia|thalassemia
342824|NCT01479582|Lysosomal Storage Diseases|lysosomal storage diseases
342825|NCT01479569|MRI Catheterization|mri catheterization
342826|NCT01479569|Pericardiocentesis|pericardiocentesis
342827|NCT01479569|MRI Safety|mri safety
342828|NCT01479569|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
342829|NCT01479556|Pregabalin|pregabalin
342830|NCT01479556|Neuropathic pain|neuropathic pain
342831|NCT01479556|At-level neuropathic pain|at-level neuropathic pain
342832|NCT01479556|Non-evoked neuropathic pain|non-evoked neuropathic pain
342833|NCT01479556|Evoked neuropathic pain|evoked neuropathic pain
342834|NCT01479556|Sub-acute spinal cord injury|sub-acute spinal cord injury
342835|NCT01479543|Probiotic|probiotic
342836|NCT01479543|Immunity|immunity
342837|NCT01479543|Gastrointestinal symptoms|gastrointestinal symptoms
342838|NCT01479530|Rasagiline|rasagiline
342839|NCT01479530|Azilect|azilect
342840|NCT01479530|Parkinson´s Disease|parkinson´s disease
342841|NCT01479530|Motor fluctuations|motor fluctuations
342842|NCT01479517|operative|operative
342843|NCT01479517|dental procedure|dental procedure
342844|NCT01479504|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
342845|NCT01479504|neoadjuvant chemotherapy|neoadjuvant chemotherapy
342846|NCT01479504|concurrent chemoradiotherapy|concurrent chemoradiotherapy
342847|NCT01479504|Nedaplatin|nedaplatin
342848|NCT01479491|Japan|japan
342849|NCT01479491|Retrospective|retrospective
342850|NCT01479491|Observational|observational
342851|NCT01479491|Epidemiological study|epidemiological study
342852|NCT01479491|Children aged < 12 months|children aged < 12 months
342853|NCT01479491|Intussusception|intussusception
342854|NCT01479465|GSI|gsi
342855|NCT01479465|Gilead|gilead
342856|NCT01479465|Gilead Sciences|gilead sciences
342857|NCT01479465|GS-6624|gs-6624
342858|NCT01479465|Colorectal Cancer|colorectal cancer
342859|NCT01479465|KRAS|kras
342860|NCT01479465|Oncology|oncology
342861|NCT01479465|monoclonal antibody|monoclonal antibody
342862|NCT01479452|obesity|obesity
342863|NCT01479452|bariatric surgery|bariatric surgery
342864|NCT01479452|weight loss|weight loss
342865|NCT01479426|Erectile dysfunction|erectile dysfunction
342866|NCT01479426|Korean Red Ginseng|korean red ginseng
342867|NCT01479426|IIEF|iief
342868|NCT01479426|MSHQ|mshq
342869|NCT01479413|Schizophrenia|schizophrenia
342870|NCT01479413|Oxidative stress|oxidative stress
342871|NCT01479413|Mitochondria|mitochondria
342872|NCT01479400|antipsychotic|antipsychotic
342873|NCT01479400|schizophrenia|schizophrenia
342978|NCT01479127|Dyskinesia|dyskinesia
342874|NCT01479400|infant development|infant development
342875|NCT01479387|Zevalin|zevalin
342876|NCT01479387|CD20+|cd20+
342877|NCT01479387|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
342878|NCT01479387|Mantle cell lymphoma|mantle cell lymphoma
342879|NCT01479374|Allergic Conjunctivitis|allergic conjunctivitis
342880|NCT01479374|Ocular Allergy|ocular allergy
342881|NCT01479361|Atovaquone|atovaquone
342882|NCT01479361|Drug Interaction|drug interaction
342883|NCT01479361|Pharmacokinetics|pharmacokinetics
342884|NCT01479361|Efavirenz|efavirenz
342885|NCT01479361|Atazanavir-Ritonavir|atazanavir-ritonavir
342886|NCT01479361|HIV|hiv
342887|NCT01479348|Imaging|imaging
342888|NCT01479348|Radiopharmaceutical|radiopharmaceutical
342889|NCT01479348|Safety|safety
342890|NCT01479348|Dosimetry|dosimetry
342891|NCT01479348|Drug Distribution|drug distribution
342892|NCT01479348|Cancer|cancer
342893|NCT01479322|Intima-media thickness|intima-media thickness
342894|NCT01479322|Ghrelin|ghrelin
342895|NCT01479322|Prader-Willi syndrome|prader-willi syndrome
342896|NCT01479309|Advanced Malignancies|advanced malignancies
342897|NCT01479309|Solid Tumors|solid tumors
342898|NCT01479309|Melanoma|melanoma
342899|NCT01479309|Renal Cell Carcinoma|renal cell carcinoma
342900|NCT01479309|Phase I Studies|phase i studies
342901|NCT01479309|Sodium Stibogluconate|sodium stibogluconate
342902|NCT01479309|Interferon Alpha-2b|interferon alpha-2b
342903|NCT01479309|Intron A|intron a
342904|NCT01479309|SSG|ssg
342905|NCT01479283|Infection|infection
342906|NCT01479283|Bone Neoplasms|bone neoplasms
342907|NCT01479283|Prosthesis|prosthesis
342908|NCT01479283|Anti-Bacterial Agents|anti-bacterial agents
342909|NCT01479283|Randomized|randomized
342910|NCT01479270|recovery|recovery
342911|NCT01479270|postoperative|postoperative
342912|NCT01479270|pain|pain
342913|NCT01479270|laparoscopy|laparoscopy
342914|NCT01479270|hysterectomy|hysterectomy
342915|NCT01479270|ropivacaine|ropivacaine
342916|NCT01479270|TAP block|tap block
342917|NCT01479270|local anesthesia|local anesthesia
342918|NCT01479257|Cancer|cancer
342919|NCT01479257|Risk factors|risk factors
342920|NCT01479257|Latinos|latinos
342921|NCT01479257|Hispanic Americans|hispanic americans
342922|NCT01479257|Hispanics|hispanics
342923|NCT01479257|Latino resident|latino resident
342924|NCT01479257|Houston metropolitan area|houston metropolitan area
342925|NCT01479257|Spanish speaking|spanish speaking
342926|NCT01479257|Cancer risk behaviors|cancer risk behaviors
342927|NCT01479257|Questionnaires|questionnaires
342928|NCT01479257|Surveys|surveys
342929|NCT01479257|Accelerometer|accelerometer
342930|NCT01479244|HER2|her2
342931|NCT01479244|low or intermediate|low or intermediate
342932|NCT01479244|breast cancer|breast cancer
342933|NCT01479244|node-positive tumors|node-positive tumors
342934|NCT01479231|GERD|gerd
342935|NCT01479231|Eosinophilic esophagitis|eosinophilic esophagitis
342936|NCT01479231|Proton pump inhibitor|proton pump inhibitor
342937|NCT01479231|dysphagia|dysphagia
342938|NCT01479205|specific immunotherapy|specific immunotherapy
342939|NCT01479205|bronchial allergen provocation|bronchial allergen provocation
342940|NCT01479205|specific IgE|specific ige
342941|NCT01479205|specific IgG|specific igg
342942|NCT01479205|specific IgG4|specific igg4
342944|NCT01479192|breast|breast
342945|NCT01479192|cancer|cancer
342946|NCT01479192|prevention|prevention
342947|NCT01479192|fenretinide|fenretinide
342948|NCT01479179|Breast Cancer|breast cancer
342949|NCT01479179|Metastatic Breast Cancer|metastatic breast cancer
342950|NCT01479179|HER-2-overexpressing breast cancer|her-2-overexpressing breast cancer
342951|NCT01479179|Human epidermal growth factor receptor|human epidermal growth factor receptor
342952|NCT01479179|AMG 479|amg 479
342953|NCT01479179|Trastuzumab|trastuzumab
342954|NCT01479179|Herceptin|herceptin
342955|NCT01479166|cystic fibrosis|cystic fibrosis
342956|NCT01479166|HRCT|hrct
342957|NCT01479166|Sputum|sputum
342958|NCT01479166|Blood|blood
342959|NCT01479166|Inflammation|inflammation
342960|NCT01479166|adaptive immune system|adaptive immune system
342961|NCT01479166|innate immune system|innate immune system
342962|NCT01479153|Central venous catheterization|central venous catheterization
342963|NCT01479153|Major complications|major complications
342964|NCT01479153|Internal Jugular|internal jugular
342965|NCT01479153|Femoral|femoral
342966|NCT01479153|Subclavian|subclavian
342967|NCT01479140|myocardial infarction|myocardial infarction
342968|NCT01479140|dissection|dissection
342969|NCT01479140|coronary Fibromuscular Dysplasia|coronary fibromuscular dysplasia
342970|NCT01479140|coronary ectasia|coronary ectasia
342971|NCT01479140|atherosclerotic Coronary Artery Disease|atherosclerotic coronary artery disease
342972|NCT01479140|coronary vasculitis|coronary vasculitis
342973|NCT01479140|coronary embolism|coronary embolism
342974|NCT01479140|congenital coronary anomaly|congenital coronary anomaly
342975|NCT01479127|Levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
342976|NCT01479127|Advanced Parkinson's disease|advanced parkinson's disease
342977|NCT01479127|Severe motor fluctuations|severe motor fluctuations
342979|NCT01479101|neo adjuvant, breast cancer|neo adjuvant, breast cancer
342980|NCT01479088|Cinacalcet|cinacalcet
342981|NCT01479088|PK|pk
342982|NCT01479088|Secondary Hyperparathyroidism|secondary hyperparathyroidism
342983|NCT01479088|Paediatric|paediatric
342984|NCT01479088|Chronic Kidney Disease|chronic kidney disease
342985|NCT01479088|Dialysis|dialysis
342986|NCT01479075|central insulin|central insulin
342987|NCT01479075|insulin resistance|insulin resistance
342988|NCT01479075|energy metabolism|energy metabolism
342989|NCT01479062|behavior change|behavior change
342990|NCT01479062|pre-diabetes|pre-diabetes
342991|NCT01479062|prevention|prevention
342992|NCT01479062|diabetes prevention|diabetes prevention
342993|NCT01479062|Hemoglobin A1c|hemoglobin a1c
342994|NCT01479062|glucose|glucose
342995|NCT01479062|physical activity|physical activity
342996|NCT01479062|nutrition|nutrition
342997|NCT01479062|email|email
342998|NCT01479062|web|web
342999|NCT01479062|obesity|obesity
343000|NCT01479049|congenital heart disease|congenital heart disease
343001|NCT01479049|cardiac surgery|cardiac surgery
343002|NCT01479049|cardiopulmonary bypass|cardiopulmonary bypass
343003|NCT01479049|cardioplegia|cardioplegia
343004|NCT01479036|breast cancer|breast cancer
343005|NCT01479036|neoadjuvant chemotherapy|neoadjuvant chemotherapy
343006|NCT01479036|recombinant human endostatin (endostar)|recombinant human endostatin (endostar)
343007|NCT01479036|docetaxel|docetaxel
343008|NCT01479036|epirubicin|epirubicin
343009|NCT01478984|NSTEMI|nstemi
343010|NCT01478984|PCI|pci
343011|NCT01478984|onestage|onestage
343012|NCT01478984|multistaged|multistaged
343013|NCT01478971|Anemia|anemia
343014|NCT01478971|Chronic Renal Failure|chronic renal failure
343015|NCT01478971|CRF|crf
343016|NCT01478971|Chronic Kidney Disease|chronic kidney disease
343017|NCT01478971|CKD|ckd
343018|NCT01478971|Erythropoietin|erythropoietin
343019|NCT01478971|Hematide|hematide
343020|NCT01478971|Peginesatide|peginesatide
343021|NCT01478971|Hemoglobin|hemoglobin
343022|NCT01478971|Hgb|hgb
343023|NCT01478971|Red Blood Cell|red blood cell
343024|NCT01478971|Red Blood Cell Production|red blood cell production
343025|NCT01478971|Dialysis|dialysis
343026|NCT01478958|fatty acids|fatty acids
343027|NCT01478958|cardiovascular disease|cardiovascular disease
343028|NCT01478958|vascular function|vascular function
343029|NCT01478958|microparticles|microparticles
343030|NCT01478945|vitiligo|vitiligo
343031|NCT01478945|early vitiligo|early vitiligo
343032|NCT01478945|focal vitiligo|focal vitiligo
343033|NCT01478932|dyspnea|dyspnea
343034|NCT01478932|diaphragmatic breathing|diaphragmatic breathing
343035|NCT01478932|Heart failure|heart failure
343036|NCT01478919|Endoscopic Mucosal Resection|endoscopic mucosal resection
343037|NCT01478919|Laterally Spreading Tumor|laterally spreading tumor
343038|NCT01478919|Local Residual Neoplasia|local residual neoplasia
343039|NCT01478919|Colonoscopy|colonoscopy
343040|NCT01478919|Therapy|therapy
343041|NCT01478893|nicotine vaccine|nicotine vaccine
343042|NCT01478893|smoking vaccine|smoking vaccine
343043|NCT01478893|smoking cessation|smoking cessation
343044|NCT01478893|SEL-068|sel-068
343045|NCT01478867|celiac disease|celiac disease
343046|NCT01478867|gluten-free diet|gluten-free diet
343047|NCT01478867|gluten peptides|gluten peptides
343048|NCT01478867|feces|feces
343049|NCT01478841|insulin resistance|insulin resistance
343050|NCT01478841|type 2 diabetes (T2D)|type 2 diabetes (t2d)
343051|NCT01478841|cardiovascular complications|cardiovascular complications
343052|NCT01478841|polyphenolic compounds derived from red grape marc extracts|polyphenolic compounds derived from red grape marc extracts
343053|NCT01478841|oxidative stress|oxidative stress
343054|NCT01478802|Mechanical Ventilation|mechanical ventilation
343055|NCT01478802|High frequency oscillation|high frequency oscillation
343056|NCT01478802|Acute Respiratory Distress syndrome|acute respiratory distress syndrome
343057|NCT01478776|ASP|asp
343058|NCT01478776|LCN2|lcn2
343059|NCT01478776|RBP4|rbp4
343060|NCT01478776|C5L2|c5l2
343061|NCT01478763|PDRP|pdrp
343062|NCT01478763|vitreous|vitreous
343063|NCT01478763|protein|protein
343064|NCT01478763|vitrectomy|vitrectomy
343065|NCT01478750|obesity|obesity
343066|NCT01478750|fat|fat
343067|NCT01478750|appetite|appetite
343068|NCT01478750|digestion|digestion
343069|NCT01478737|PDRP|pdrp
343070|NCT01478737|vitreous hemorrhage|vitreous hemorrhage
343071|NCT01478737|vitrectomy|vitrectomy
343072|NCT01478698|peritoneal dialysis|peritoneal dialysis
343073|NCT01478698|peritoneal dialysis, continuous ambulatory|peritoneal dialysis, continuous ambulatory
343074|NCT01478698|peritonitis|peritonitis
343075|NCT01478685|Relapsed or Refractory Solid Tumors|relapsed or refractory solid tumors
343076|NCT01478672|Promotion health|promotion health
343077|NCT01478659|Diet|diet
343078|NCT01478659|Fiber|fiber
343079|NCT01478659|Adult|adult
343080|NCT01478659|Fructooligosaccharide|fructooligosaccharide
343081|NCT01478646|breathing therapy|breathing therapy
343082|NCT01478646|reflective breathing therapy|reflective breathing therapy
343083|NCT01478646|COPD|copd
343084|NCT01478646|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
343085|NCT01478633|Alzheimer's disease|alzheimer's disease
343086|NCT01478633|Dementia|dementia
343087|NCT01478633|Galantamine|galantamine
343088|NCT01478633|Donepezil|donepezil
343089|NCT01478607|Painful Diabetic Peripheral Neuropathy|painful diabetic peripheral neuropathy
343090|NCT01478607|Qutenza|qutenza
343091|NCT01478594|metastatic colorectal cancer|metastatic colorectal cancer
343092|NCT01478594|Avastin|avastin
343093|NCT01478594|bevacizumab|bevacizumab
343094|NCT01478594|tivozanib|tivozanib
343095|NCT01478594|mFOLFOX6|mfolfox6
343096|NCT01478594|BATON-CRC|baton-crc
343098|NCT01478594|ASP4130|asp4130
343099|NCT01478581|PCI-32765|pci-32765
343100|NCT01478581|Multiple Myeloma|multiple myeloma
343101|NCT01478581|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
343102|NCT01478581|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
343103|NCT01478568|Pharmacokinetics|pharmacokinetics
343104|NCT01478568|Mirabegron|mirabegron
343105|NCT01478568|Phase 1|phase 1
343106|NCT01478555|Dry Eye|dry eye
343107|NCT01478542|DLBCL|dlbcl
343108|NCT01478542|Liposomal Vincristine (Marqibo)|liposomal vincristine (marqibo)
343109|NCT01478542|Optimised Rituximab|optimised rituximab
343110|NCT01478542|Toxicity|toxicity
343111|NCT01478542|Elderly Patients|elderly patients
343112|NCT01478542|FDG-PET|fdg-pet
343113|NCT01478542|Bulky Disease|bulky disease
343114|NCT01478542|Radiation|radiation
343115|NCT01478542|age >60 years|age >60 years
343116|NCT01478542|First line Therapy|first line therapy
343117|NCT01478542|Vitamin D|vitamin d
343118|NCT01478529|Pharmacokinetics|pharmacokinetics
343119|NCT01478529|Mirabegron|mirabegron
343120|NCT01478529|Phase 1|phase 1
343121|NCT01478516|autologous plasmin|autologous plasmin
343122|NCT01478516|macular edema|macular edema
343123|NCT01478516|vitreous|vitreous
343124|NCT01478503|Pharmacokinetics|pharmacokinetics
343125|NCT01478503|Mirabegron|mirabegron
343126|NCT01478503|Phase 1|phase 1
343127|NCT01478503|Dose-Escalation|dose-escalation
343128|NCT01478490|Pharmacokinetics,|pharmacokinetics,
343129|NCT01478490|Mirabegron|mirabegron
343130|NCT01478490|Metoprolol|metoprolol
343131|NCT01478490|CYP2D6|cyp2d6
343132|NCT01478490|Phase 1|phase 1
343133|NCT01478477|Breast Cancer|breast cancer
343134|NCT01478451|DOMS|doms
343135|NCT01478438|Unifocal|unifocal
343136|NCT01478438|20mm in diameter|20mm in diameter
343137|NCT01478438|measures|measures
343138|NCT01478438|5mm away from the skin and chest|5mm away from the skin and chest
343139|NCT01478425|Prevention|prevention
343140|NCT01478425|Pollen|pollen
343141|NCT01478425|Allergy|allergy
343142|NCT01478425|Rhinitis|rhinitis
343143|NCT01478412|Prostate cancer|prostate cancer
343144|NCT01478412|Low risk|low risk
343145|NCT01478412|Intermediate risk|intermediate risk
343147|NCT01478412|T2a|t2a
343148|NCT01478412|T2b|t2b
343149|NCT01478412|Gleason 6|gleason 6
343150|NCT01478412|Gleason 7|gleason 7
343151|NCT01478412|PSA 10|psa 10
343152|NCT01478412|PSA 20|psa 20
343153|NCT01478373|GIST|gist
343154|NCT01478373|Dovitinib|dovitinib
343155|NCT01478360|Asthma|asthma
343156|NCT01478360|Secukinumab|secukinumab
343157|NCT01478360|Therapeutic Uses|therapeutic uses
343158|NCT01478360|Respiratory|respiratory
343159|NCT01478360|Lung|lung
343160|NCT01478360|Pulmonary|pulmonary
343161|NCT01478360|inhaled|inhaled
343162|NCT01478360|corticosteroids|corticosteroids
343163|NCT01478347|Neisseria, Meningitis, Group B, Vaccine, At-risk, Adults|neisseria, meningitis, group b, vaccine, at-risk, adults
343164|NCT01478334|High intensity exercise|high intensity exercise
343165|NCT01478334|cardiovascular risk factors|cardiovascular risk factors
343166|NCT01478321|Information Not Provided|information not provided
343167|NCT01478308|prostate|prostate
343168|NCT01478308|castration resistant|castration resistant
343169|NCT01478308|hormone resistant|hormone resistant
343170|NCT01478308|CRPC|crpc
343171|NCT01478295|Nursing intervention|nursing intervention
343172|NCT01478295|Primary Health care|primary health care
343173|NCT01478295|caregiver|caregiver
343174|NCT01478295|strain|strain
343175|NCT01478282|dabigatran|dabigatran
343176|NCT01478282|rivaroxaban|rivaroxaban
343177|NCT01478282|oral anticoagulants|oral anticoagulants
343178|NCT01478282|coagulation|coagulation
343179|NCT01478282|bleeding|bleeding
343180|NCT01478282|plasma concentrates|plasma concentrates
343181|NCT01478269|Aggressive B-cell lymphoma|aggressive b-cell lymphoma
343182|NCT01478269|R-CHOP|r-chop
343183|NCT01478256|blepharitis|blepharitis
343184|NCT01478256|topical erythromycin|topical erythromycin
343185|NCT01478256|topical besifloxocin|topical besifloxocin
343186|NCT01478243|Keloid|keloid
343187|NCT01478230|Pharmacokinetics|pharmacokinetics
343188|NCT01478217|lung ultrasonography|lung ultrasonography
343189|NCT01478217|pressure-volume loops|pressure-volume loops
343190|NCT01478217|ARDS|ards
343191|NCT01478204|Alzheimer's disease|alzheimer's disease
343192|NCT01478204|Sleep quality|sleep quality
343390|NCT01477476|DKA|dka
343193|NCT01478204|Anticholinesterase drugs|anticholinesterase drugs
343194|NCT01478191|Hodgkin's Lymphoma|hodgkin's lymphoma
343195|NCT01478191|Ifosfamide, Gemcitabine and Vinorelbine (IGEV)|ifosfamide, gemcitabine and vinorelbine (igev)
343196|NCT01478191|High Dose Chemotherapy (HDCT)|high dose chemotherapy (hdct)
343197|NCT01478191|Autologous Hematopoietic Stem Cells Transplantation (AHSCT)|autologous hematopoietic stem cells transplantation (ahsct)
343198|NCT01478178|Glioma|glioma
343199|NCT01478178|Glioblastoma|glioblastoma
343200|NCT01478178|Glioblastoma multiforme|glioblastoma multiforme
343201|NCT01478178|GBM|gbm
343202|NCT01478178|brain tumor|brain tumor
343203|NCT01478178|brain cancer|brain cancer
343204|NCT01478178|recurrent brain tumor|recurrent brain tumor
343205|NCT01478178|recurrent brain cancer|recurrent brain cancer
343206|NCT01478178|refractory brain tumor|refractory brain tumor
343207|NCT01478178|refractory brain cancer|refractory brain cancer
343208|NCT01478178|recurrent GBM|recurrent gbm
343209|NCT01478178|refractory GBM|refractory gbm
343210|NCT01478178|recurrent glioma|recurrent glioma
343211|NCT01478178|refractory glioma|refractory glioma
343212|NCT01478178|recurrent glioblastoma|recurrent glioblastoma
343213|NCT01478178|refractory glioblastoma|refractory glioblastoma
343214|NCT01478178|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
343215|NCT01478178|refractory glioblastoma multiforme|refractory glioblastoma multiforme
343216|NCT01478178|failed temodar|failed temodar
343217|NCT01478178|failed temozolomide|failed temozolomide
343218|NCT01478178|temodar refractory|temodar refractory
343219|NCT01478178|temozolomide refractory|temozolomide refractory
343220|NCT01478178|failed avastin|failed avastin
343221|NCT01478178|avastin refractory|avastin refractory
343222|NCT01478178|failed bevacizumab|failed bevacizumab
343223|NCT01478178|bevacizumab refractory|bevacizumab refractory
343224|NCT01478178|avastin failure|avastin failure
343225|NCT01478178|bevacizumab failure|bevacizumab failure
343226|NCT01478178|temodar failure|temodar failure
343227|NCT01478178|temozolomide failure|temozolomide failure
343228|NCT01478165|Palonosetron|palonosetron
343229|NCT01478165|PONV(postoperative nausea and vomiting)|ponv(postoperative nausea and vomiting)
343230|NCT01478165|TIVA(Total intravenous anesthesia)|tiva(total intravenous anesthesia)
343232|NCT01478152|Ectoin|ectoin
343233|NCT01478152|Ectoine|ectoine
343234|NCT01478152|FeNO|feno
343235|NCT01478152|Metacholin|metacholin
343236|NCT01478152|sRaw|sraw
343237|NCT01478139|anorectal fistula|anorectal fistula
343238|NCT01478139|acellular dermal matrix|acellular dermal matrix
343239|NCT01478139|ligation of intersphincteric fistula tract|ligation of intersphincteric fistula tract
343240|NCT01478139|ligation of intersphincteric fistula tract and plug|ligation of intersphincteric fistula tract and plug
343241|NCT01478139|complications of treatment|complications of treatment
343242|NCT01478139|recurrence|recurrence
343243|NCT01478113|Major Depressive Disorder|major depressive disorder
343244|NCT01478113|Therapy|therapy
343245|NCT01478113|Medication study|medication study
343246|NCT01478113|Depression|depression
343247|NCT01478113|Therapy study|therapy study
343248|NCT01478100|Coronary artery disease|coronary artery disease
343249|NCT01478100|CT|ct
343250|NCT01478100|Computational flow dynamics|computational flow dynamics
343251|NCT01478074|Acute Myeloid Leukemia|acute myeloid leukemia
343252|NCT01478074|Relapsed leukemia|relapsed leukemia
343253|NCT01478074|Refractory leukemia|refractory leukemia
343254|NCT01478074|Natural Killer Cells|natural killer cells
343255|NCT01478074|Adoptive immunotherapy|adoptive immunotherapy
343256|NCT01478074|NK cell infusion|nk cell infusion
343257|NCT01478074|Haploidentical|haploidentical
343258|NCT01478074|KIR mismatch|kir mismatch
343259|NCT01478074|Fludarabine|fludarabine
343260|NCT01478074|Cytarabine|cytarabine
343261|NCT01478074|Ara-C|ara-c
343262|NCT01478074|ALT-801|alt-801
343263|NCT01478048|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
343264|NCT01478035|Phenytoin prophylaxis|phenytoin prophylaxis
343265|NCT01478035|Pneumococcal meningitis|pneumococcal meningitis
343266|NCT01478035|Randomized|randomized
343267|NCT01478035|Placebo-controlled|placebo-controlled
343268|NCT01478035|Double blind|double blind
343269|NCT01478035|Patient 50 years or older|patient 50 years or older
343270|NCT01478022|DMD|dmd
343271|NCT01478022|Duchenne|duchenne
343272|NCT01478022|Muscular Dystrophy|muscular dystrophy
343273|NCT01477996|intravitreal therapy|intravitreal therapy
343274|NCT01477996|pain scales|pain scales
343275|NCT01477996|gauge|gauge
343276|NCT01477996|Pain Scores|pain scores
343277|NCT01477996|Visual Analog Scale|visual analog scale
343278|NCT01477983|atrial fibrillation|atrial fibrillation
343279|NCT01477983|catheter ablation|catheter ablation
343280|NCT01477983|adenosine triphosphate|adenosine triphosphate
343281|NCT01477983|antiarrhythmic drugs|antiarrhythmic drugs
343282|NCT01477970|GnRH antagonists|gnrh antagonists
343283|NCT01477970|OHSS|ohss
343284|NCT01477970|ovarian stimulation|ovarian stimulation
343285|NCT01477957|weight loss after bariatric surgery|weight loss after bariatric surgery
343286|NCT01477957|Insulin sensitivity|insulin sensitivity
343287|NCT01477957|insulin resistance|insulin resistance
343288|NCT01477944|Statins pattern of use|statins pattern of use
343289|NCT01477944|Hypercholesterolemic patients|hypercholesterolemic patients
343290|NCT01477944|Statins|statins
343291|NCT01477931|Bupropion hydrochloride extended release|bupropion hydrochloride extended release
343292|NCT01477931|Wellbutrin XL|wellbutrin xl
343293|NCT01477931|Major Depressive Disorder with Atypical Features|major depressive disorder with atypical features
343294|NCT01477918|prevalence|prevalence
343295|NCT01477918|Korea|korea
343296|NCT01477905|priming|priming
343297|NCT01477905|remifentanil|remifentanil
342943|NCT01479205|SIT|sit
343298|NCT01477905|target-controlled infusion|target-controlled infusion
343299|NCT01477840|Misoprostol|misoprostol
343300|NCT01477840|Oxytocin|oxytocin
343301|NCT01477840|Cesarean Delivery|cesarean delivery
343302|NCT01477840|Blood Loss|blood loss
343303|NCT01477814|colorectal cancer|colorectal cancer
343304|NCT01477814|screening|screening
343305|NCT01477814|colonoscopy|colonoscopy
343306|NCT01477814|fecal immunochemical test|fecal immunochemical test
343307|NCT01477814|clinical guidelines|clinical guidelines
343308|NCT01477788|pelvic mass|pelvic mass
343309|NCT01477788|ovarian mass|ovarian mass
343310|NCT01477788|ultrasound|ultrasound
343311|NCT01477788|serum markers|serum markers
343312|NCT01477788|ovarian malignancy|ovarian malignancy
343313|NCT01477775|myocardial infarction|myocardial infarction
343314|NCT01477775|coronary stent|coronary stent
343315|NCT01477775|Oral P2Y12 receptor blocker|oral p2y12 receptor blocker
343316|NCT01477775|Platelet reactivity units (PRU)|platelet reactivity units (pru)
343317|NCT01477762|startle response|startle response
343318|NCT01477762|fear conditioning|fear conditioning
343319|NCT01477762|PTSD|ptsd
343320|NCT01477749|prostate cancer|prostate cancer
343321|NCT01477749|prostate|prostate
343322|NCT01477749|immune therapy|immune therapy
343323|NCT01477749|immunotherapy|immunotherapy
343324|NCT01477749|vaccine|vaccine
343325|NCT01477749|dendritic cells|dendritic cells
343326|NCT01477749|antigen-presenting cells|antigen-presenting cells
343327|NCT01477749|antigen presenting cells|antigen presenting cells
343328|NCT01477749|cancer vaccine|cancer vaccine
343329|NCT01477749|PSA|psa
343330|NCT01477749|prostatic adenocarcinoma|prostatic adenocarcinoma
343331|NCT01477736|Neurogenic bladder|neurogenic bladder
343332|NCT01477736|Urodynamic|urodynamic
343333|NCT01477736|Quality of life|quality of life
343334|NCT01477710|Mechanical ventilation|mechanical ventilation
343335|NCT01477710|Tidal volume|tidal volume
343336|NCT01477710|Respiratory rate|respiratory rate
343337|NCT01477697|Trauma|trauma
343338|NCT01477671|Dengue|dengue
343339|NCT01477671|Dengue Fever|dengue fever
343340|NCT01477671|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
343341|NCT01477658|Congenital Complete Atrioventricular Heart Block|congenital complete atrioventricular heart block
343342|NCT01477658|Pacemaker|pacemaker
343343|NCT01477658|Cardiac pacing|cardiac pacing
343344|NCT01477658|Children|children
343345|NCT01477658|Heart failure|heart failure
343346|NCT01477658|Ventricular dyssynchrony|ventricular dyssynchrony
343347|NCT01477658|Echocardiography|echocardiography
343348|NCT01477658|Quality of life|quality of life
343349|NCT01477658|Six-minute walk test|six-minute walk test
343350|NCT01477658|Young adults|young adults
343351|NCT01477619|Pharmacokinetics|pharmacokinetics
343352|NCT01477606|Acute myeloid leukemia|acute myeloid leukemia
343353|NCT01477606|FLT3-ITD|flt3-itd
343354|NCT01477606|midostaurin (PKC412)|midostaurin (pkc412)
343355|NCT01477593|circumcision, chinese children, pain|circumcision, chinese children, pain
343356|NCT01477554|Women|women
343357|NCT01477554|Maternal morbidity|maternal morbidity
343358|NCT01477554|Maternal mortality|maternal mortality
343359|NCT01477554|Perinatal mortality|perinatal mortality
343360|NCT01477554|Perinatal morbidity|perinatal morbidity
343361|NCT01477554|Training|training
343362|NCT01477554|Obstetric Emergency|obstetric emergency
343363|NCT01477554|Medical team|medical team
343364|NCT01477554|Simulation|simulation
343365|NCT01477541|Prenatal care|prenatal care
343366|NCT01477541|Maternal mortality|maternal mortality
343367|NCT01477541|Perinatal mortality|perinatal mortality
343368|NCT01477541|Perinatal|perinatal
343369|NCT01477541|Puerperium|puerperium
343370|NCT01477541|Puerperium care|puerperium care
343371|NCT01477541|Midwives|midwives
343372|NCT01477541|Midwife|midwife
343373|NCT01477541|Obstetric|obstetric
343374|NCT01477541|Nurse|nurse
343375|NCT01477541|Integration|integration
343376|NCT01477541|Alternative personnel|alternative personnel
343377|NCT01477541|Skilled attendant|skilled attendant
343378|NCT01477541|Birth attendant|birth attendant
343379|NCT01477541|Delivery|delivery
343380|NCT01477541|Delivery services|delivery services
343381|NCT01477541|Best practices|best practices
343382|NCT01477541|Rural|rural
343383|NCT01477528|HeartMate II|heartmate ii
343384|NCT01477528|Anticoagulation|anticoagulation
343385|NCT01477528|Thoratec Corporation|thoratec corporation
343386|NCT01477502|urinary tract infection|urinary tract infection
343387|NCT01477502|spinal cord injury|spinal cord injury
343388|NCT01477502|homeopathy|homeopathy
343389|NCT01477502|prevention|prevention
343391|NCT01477476|Diabetes|diabetes
343392|NCT01477476|Type I Diabetes|type i diabetes
343393|NCT01477463|quality of life|quality of life
343394|NCT01477450|Hypobaric hypoxemia|hypobaric hypoxemia
343395|NCT01477450|Altitude|altitude
343396|NCT01477450|Oxygen|oxygen
343397|NCT01477450|oxygen concentrator|oxygen concentrator
343398|NCT01477437|teens|teens
343399|NCT01477437|adolescents|adolescents
343400|NCT01477437|Internet intervention|internet intervention
343401|NCT01477437|Hemophilia|hemophilia
343402|NCT01477424|Drug-drug interaction|drug-drug interaction
343403|NCT01477424|Pharmacokinetics|pharmacokinetics
343405|NCT01477411|Drug-drug interaction|drug-drug interaction
343406|NCT01477411|Pharmacokinetics|pharmacokinetics
343407|NCT01477411|PA21|pa21
343408|NCT01477385|dental caries|dental caries
343409|NCT01477385|primary teeth|primary teeth
343410|NCT01477385|permanent teeth|permanent teeth
343411|NCT01477385|silver diamine fluoride|silver diamine fluoride
343412|NCT01477372|Pregnancy|pregnancy
343413|NCT01477372|Exercise|exercise
343414|NCT01477372|Excessive weight gain|excessive weight gain
343415|NCT01477372|Outcomes|outcomes
343416|NCT01477372|Urinary incontinence|urinary incontinence
343417|NCT01477333|Tyvaso|tyvaso
343418|NCT01477333|UT-15C SR|ut-15c sr
343419|NCT01477333|PAH|pah
343420|NCT01477320|Enteral Nutrition|enteral nutrition
343421|NCT01477320|Stress Ulcer Prophylaxis|stress ulcer prophylaxis
343422|NCT01477320|Critically Ill Patients|critically ill patients
343423|NCT01477320|Overt and significant GI bleeding|overt and significant gi bleeding
343424|NCT01477320|Stress gastropathy|stress gastropathy
343425|NCT01477320|Clostridium Difficile pseudomembranous colitis|clostridium difficile pseudomembranous colitis
343426|NCT01477320|Vital AF|vital af
343427|NCT01477320|Small peptide fish oil structured lipids|small peptide fish oil structured lipids
343428|NCT01477320|Fructose oligosaccharide|fructose oligosaccharide
343429|NCT01477307|obesity|obesity
343430|NCT01477307|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
343431|NCT01477294|Total|total
343432|NCT01477294|Intra and Extracellular Water|intra and extracellular water
343433|NCT01477294|Energy Expenditure, Physical Activity|energy expenditure, physical activity
343434|NCT01477294|Body Composition|body composition
343435|NCT01477294|Dilution Techniques|dilution techniques
343436|NCT01477281|chronic venous insufficiency|chronic venous insufficiency
343437|NCT01477281|Daflon|daflon
343438|NCT01477281|Venaflon|venaflon
343439|NCT01477268|antidepressants|antidepressants
343440|NCT01477268|depression|depression
343441|NCT01477268|zoloft|zoloft
343442|NCT01477268|psychiatry|psychiatry
343443|NCT01477268|psychology|psychology
343444|NCT01477255|daily assessment|daily assessment
343445|NCT01477255|electronic diary|electronic diary
343446|NCT01477255|coping strategies|coping strategies
343447|NCT01477255|resiliency of cancer patients|resiliency of cancer patients
343448|NCT01477255|psychology|psychology
343449|NCT01477242|vomiting|vomiting
343450|NCT01477242|anti-emetics|anti-emetics
343451|NCT01477242|ketamine|ketamine
343452|NCT01477242|sedation|sedation
343453|NCT01477229|Rectal cancer|rectal cancer
343454|NCT01477229|Quality of Life|quality of life
343455|NCT01477229|Abdominoperineal Resection|abdominoperineal resection
343456|NCT01477229|Anterior Resection|anterior resection
343457|NCT01477229|Palliative cancer treatment|palliative cancer treatment
343458|NCT01477229|Radio chemotherapy|radio chemotherapy
343459|NCT01477216|Glycemic index|glycemic index
343460|NCT01477216|Glycemic responses|glycemic responses
343461|NCT01477216|Insulin responses|insulin responses
343462|NCT01477216|Insulinemic index|insulinemic index
343463|NCT01477216|Carbohydrates|carbohydrates
343464|NCT01477216|Methodology|methodology
343465|NCT01477216|Glucose metabolism|glucose metabolism
343466|NCT01477177|Barrett's esophagus dysplasia|barrett's esophagus dysplasia
343467|NCT01477164|Exercise|exercise
343468|NCT01477164|Aging|aging
343469|NCT01477164|Sarcopenia|sarcopenia
343470|NCT01477164|Muscle function|muscle function
343471|NCT01477151|isoflurane|isoflurane
343472|NCT01477151|sevoflurane|sevoflurane
343473|NCT01477151|troponin|troponin
343474|NCT01477151|anesthesia|anesthesia
343475|NCT01477151|cardioprotection|cardioprotection
343476|NCT01477151|preconditioning|preconditioning
343477|NCT01477151|cardiac surgery|cardiac surgery
343478|NCT01477151|cardiac anesthesia|cardiac anesthesia
343479|NCT01477138|Sick Sinus Syndrome|sick sinus syndrome
343480|NCT01477138|Cardiac Pacing, Artificial|cardiac pacing, artificial
343481|NCT01477138|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
343482|NCT01477138|Pacemaker, Artificial|pacemaker, artificial
343483|NCT01477138|SSS|sss
343484|NCT01477125|adhd|adhd
343485|NCT01477125|adults|adults
343486|NCT01477125|working memory|working memory
343487|NCT01477125|training|training
343488|NCT01477125|RCT|rct
343489|NCT01477112|Type 2 diabetes|type 2 diabetes
343490|NCT01477112|β-carotene|β-carotene
343491|NCT01477112|Oxidative balance|oxidative balance
343492|NCT01477112|Oxidants|oxidants
343493|NCT01477112|Antioxidants|antioxidants
343494|NCT01477086|Sarcopenia|sarcopenia
343495|NCT01477086|Hip fracture|hip fracture
343496|NCT01477086|Frailty|frailty
343497|NCT01477073|in-vitro fertilization|in-vitro fertilization
343498|NCT01477073|reproductive disorder|reproductive disorder
343499|NCT01477034|Vitamin D deficiency|vitamin d deficiency
343500|NCT01477034|Obesity|obesity
343501|NCT01477034|Inflammation|inflammation
343502|NCT01477034|Low-grade, chronic inflammation|low-grade, chronic inflammation
343503|NCT01477034|Adipose tissue inflammation|adipose tissue inflammation
343504|NCT01477034|Diabetes|diabetes
343505|NCT01477034|Type 2 diabetes mellitus|type 2 diabetes mellitus
343506|NCT01477034|Insulin resistance|insulin resistance
343507|NCT01477034|Intestinal permeability|intestinal permeability
343508|NCT01477008|Knee|knee
343509|NCT01477008|Cartilage repair|cartilage repair
343510|NCT01477008|Cartilage regeneration|cartilage regeneration
343511|NCT01477008|Chondral|chondral
343512|NCT01477008|Osteochondral|osteochondral
343513|NCT01477008|Biphasic scaffold|biphasic scaffold
343514|NCT01477008|Medical device|medical device
343515|NCT01477008|Autologous|autologous
343516|NCT01477008|Synthetic|synthetic
343517|NCT01477008|Medial condyle|medial condyle
343518|NCT01477008|Lateral condyle|lateral condyle
343519|NCT01477008|Trochlea|trochlea
343520|NCT01476995|Cardiovascular system|cardiovascular system
343521|NCT01476995|gastrointestinal system|gastrointestinal system
343522|NCT01476995|kidneys|kidneys
343523|NCT01476995|liver|liver
343524|NCT01476995|lungs|lungs
343525|NCT01476969|Ischemia reperfusion injury|ischemia reperfusion injury
343526|NCT01476969|Cardiopulmonary bypass|cardiopulmonary bypass
343527|NCT01476969|Remote Ischemic Postconditioning|remote ischemic postconditioning
343629|NCT01476657|Phase 1|phase 1
343528|NCT01476969|Other Functional Disturbances Following Cardiac Surgery|other functional disturbances following cardiac surgery
343529|NCT01476930|migraine|migraine
343530|NCT01476930|prophylactic treatment|prophylactic treatment
343531|NCT01476930|cupping|cupping
343532|NCT01476930|serkangabin|serkangabin
343533|NCT01476904|Asthma|asthma
343534|NCT01476904|Bronchial Asthma|bronchial asthma
343535|NCT01476904|Shortness of breath|shortness of breath
343536|NCT01476891|MBSR|mbsr
343537|NCT01476891|Cancer|cancer
343538|NCT01476891|Online|online
343539|NCT01476891|Mindfulness Meditation|mindfulness meditation
343540|NCT01476891|Randomized Waitlist Controlled Trial|randomized waitlist controlled trial
343541|NCT01476878|Radiosurgery|radiosurgery
343542|NCT01476878|Frameless radiosurgery|frameless radiosurgery
343543|NCT01476878|Accuracy|accuracy
343544|NCT01475786|nerve pain|nerve pain
343545|NCT01475786|diabetic nerve pain|diabetic nerve pain
343546|NCT01475786|throbbing|throbbing
343547|NCT01475786|burning|burning
343548|NCT01475786|painful feet|painful feet
343549|NCT01475786|tingling|tingling
343550|NCT01475786|numbness|numbness
343551|NCT01475773|self-esteem|self-esteem
343552|NCT01475773|personality|personality
343553|NCT01475773|quality of life|quality of life
343554|NCT01475773|malocclusion|malocclusion
343555|NCT01475773|orthodontics|orthodontics
343556|NCT01475760|chronic kidney disease|chronic kidney disease
343557|NCT01475760|serum phosphorus|serum phosphorus
343558|NCT01475760|salivary phosphorus|salivary phosphorus
343559|NCT01475760|FGF23|fgf23
343560|NCT01475734|glucose clamp|glucose clamp
343561|NCT01475734|hypoglycemia|hypoglycemia
343562|NCT01475721|ADVAIR|advair
343563|NCT01475721|Asthma|asthma
343564|NCT01475721|safety|safety
343565|NCT01475721|FLOVENT|flovent
343566|NCT01475708|Lyme borreliosis|lyme borreliosis
343567|NCT01475708|Erythema migrans|erythema migrans
343568|NCT01475708|Doxycycline|doxycycline
343569|NCT01475708|Subjective symptoms|subjective symptoms
343570|NCT01475708|Outcome|outcome
343571|NCT01475695|Mass balance|mass balance
343572|NCT01475695|intravenous|intravenous
343573|NCT01475695|GSK2251052|gsk2251052
343574|NCT01475695|Healthy volunteer|healthy volunteer
343575|NCT01475695|Antimicrobial|antimicrobial
343576|NCT01475695|Radiolabel|radiolabel
343577|NCT01475682|Obstructive sleep apnea|obstructive sleep apnea
343578|NCT01475682|cardiometabolic complications|cardiometabolic complications
343579|NCT01475682|Effects of CPAP treatment|effects of cpap treatment
343580|NCT01475643|Pediatric cataract|pediatric cataract
343581|NCT01475630|temporomandibular joint|temporomandibular joint
343582|NCT01475630|rehabilitation medicine|rehabilitation medicine
343583|NCT01475630|joint diseases|joint diseases
343584|NCT01475630|physical therapy|physical therapy
343585|NCT01475604|Pulsed Radio Frequency, Electromagnetic Field therapy|pulsed radio frequency, electromagnetic field therapy
343586|NCT01475591|persistent neuromusculoskeletal pain|persistent neuromusculoskeletal pain
343587|NCT01475591|neck|neck
343588|NCT01475591|shoulder|shoulder
343589|NCT01475591|back-area|back-area
343590|NCT01475591|risk|risk
343591|NCT01475591|longlasting|longlasting
343592|NCT01475591|pain syndrome|pain syndrome
343593|NCT01475578|Vascular Dementia|vascular dementia
343594|NCT01476800|Drugs, Investigational|drugs, investigational
343595|NCT01476800|pharmacokinetics|pharmacokinetics
343596|NCT01476800|Urinary Bladder, Overactive|urinary bladder, overactive
343597|NCT01476800|YM178|ym178
343598|NCT01476800|Mirabegron|mirabegron
343599|NCT01476787|Follicular lymphoma|follicular lymphoma
343600|NCT01476787|Non-Hodgkins Follicular Lymphoma|non-hodgkins follicular lymphoma
343601|NCT01476787|treatment for Follicular Lymphoma|treatment for follicular lymphoma
343602|NCT01476787|rituximab treatment|rituximab treatment
586745|NCT00524992|Lipodystrophy|lipodystrophy
343603|NCT01476787|rituximab and lenalidomide treatment|rituximab and lenalidomide treatment
343604|NCT01476761|Surgical tissue resection|surgical tissue resection
343605|NCT01476761|Tissue dissection|tissue dissection
343606|NCT01476761|Tissue transection|tissue transection
343607|NCT01476761|Anastomosis of gastrointestina tissue|anastomosis of gastrointestina tissue
343608|NCT01476722|Silicone Hydrogel|silicone hydrogel
343609|NCT01476722|Soft Contact Lenses|soft contact lenses
343610|NCT01476722|Multi-Purpose Solution|multi-purpose solution
343611|NCT01476709|Puncture; Instrument|puncture; instrument
343612|NCT01476709|Optics and Photonics|optics and photonics
343613|NCT01476709|Pain|pain
343614|NCT01476696|Sickle cell disease|sickle cell disease
343615|NCT01476696|pediatrics|pediatrics
343617|NCT01476696|children|children
343618|NCT01476696|child|child
343619|NCT01476696|kids|kids
343620|NCT01476696|pain crisis|pain crisis
343621|NCT01476696|sickle cell anemia|sickle cell anemia
343622|NCT01476696|sickle cell pain|sickle cell pain
343623|NCT01476683|Antidiarrheals|antidiarrheals
343624|NCT01476670|Posterior fossa brain tumor|posterior fossa brain tumor
343625|NCT01476670|Cerebral blood flow|cerebral blood flow
343626|NCT01476670|Cerebral autoregulation|cerebral autoregulation
343627|NCT01476670|Carbon dioxide reactivity|carbon dioxide reactivity
343628|NCT01476670|Transcranial Doppler|transcranial doppler
343630|NCT01476644|Health related quality of life|health related quality of life
343631|NCT01476644|Clinical measures of vision|clinical measures of vision
343632|NCT01476618|Provider Perspectives|provider perspectives
343633|NCT01476618|Barriers|barriers
343634|NCT01476618|OIF/OEF Veterans|oif/oef veterans
343635|NCT01476605|prolotherapy|prolotherapy
343636|NCT01476605|Platelet rich plasma|platelet rich plasma
343637|NCT01476605|tennis elbow|tennis elbow
343638|NCT01476605|lateral epicondylosis|lateral epicondylosis
343639|NCT01476592|gastrointestinal neuroendocrine tumor|gastrointestinal neuroendocrine tumor
343640|NCT01476579|Coronary CT|coronary ct
343641|NCT01476579|Sensitivity|sensitivity
343642|NCT01476579|Specificity|specificity
343643|NCT01476579|Radiation|radiation
343644|NCT01476579|Tomography, X-Ray Computed|tomography, x-ray computed
343645|NCT01476579|Coronary angiography|coronary angiography
343646|NCT01476566|aged|aged
343647|NCT01476566|family practice|family practice
343648|NCT01476553|gastric cancer|gastric cancer
343649|NCT01476553|extensive intraperitoneal lavage|extensive intraperitoneal lavage
343650|NCT01476553|EIPL|eipl
343651|NCT01476553|intraperitoneal tumor cells|intraperitoneal tumor cells
343652|NCT01476553|peritoneal carcinomatosis|peritoneal carcinomatosis
343653|NCT01476514|Hyperekplexia|hyperekplexia
343654|NCT01476514|Pain modulation|pain modulation
343655|NCT01476514|Glycine receptors|glycine receptors
343656|NCT01476514|Hyperalgesia|hyperalgesia
343657|NCT01476514|Spinal inhibitory interneurons|spinal inhibitory interneurons
343658|NCT01476501|vitamin D|vitamin d
343659|NCT01476501|bone health|bone health
343660|NCT01476501|diabetes|diabetes
343661|NCT01476501|nephropathy|nephropathy
343662|NCT01476462|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
343663|NCT01476462|Ponte-di-Legno consortium|ponte-di-legno consortium
343664|NCT01476462|Second cancer|second cancer
343665|NCT01476462|Survival|survival
343666|NCT01476449|Diabetic Macular Edema|diabetic macular edema
343667|NCT01476449|Diabetic Retinal Swelling|diabetic retinal swelling
343668|NCT01476449|DIabetic Eye Disease|diabetic eye disease
343669|NCT01476436|Cardio vascular risk factors|cardio vascular risk factors
343670|NCT01476423|Glanzmann's Thrombasthenia|glanzmann's thrombasthenia
343671|NCT01476397|full-term|full-term
343672|NCT01476397|formula-fed infants|formula-fed infants
343673|NCT01476384|Glucose|glucose
334441|NCT01514565|RB|rb
343674|NCT01476384|insulin|insulin
343675|NCT01476384|Glycocalyx|glycocalyx
343676|NCT01476384|Muscle|muscle
343677|NCT01476384|Vascularisation|vascularisation
343678|NCT01476384|young|young
343679|NCT01476384|elderly|elderly
343680|NCT01476371|Group treatment|group treatment
343681|NCT01476371|Mindfulness|mindfulness
343682|NCT01476371|Minor mental disorders|minor mental disorders
343683|NCT01476371|Inflammation|inflammation
343684|NCT01476332|eyes|eyes
343685|NCT01476332|cis-urocanic acid|cis-urocanic acid
343686|NCT01476332|safety|safety
343687|NCT01476332|tolerability|tolerability
343688|NCT01476332|pharmacokinetics|pharmacokinetics
343689|NCT01476306|feasibility|feasibility
343690|NCT01476306|effectiveness|effectiveness
343691|NCT01476306|Parkinson disease care|parkinson disease care
343692|NCT01476306|care via telemedicine|care via telemedicine
343693|NCT01476293|Infiltration|infiltration
343694|NCT01476293|Extravasation|extravasation
343695|NCT01476293|Leaking|leaking
343696|NCT01476293|PIV Infiltration|piv infiltration
343697|NCT01476293|IV Infiltration|iv infiltration
343698|NCT01476293|Optical Detection of Infiltration|optical detection of infiltration
343699|NCT01476293|Optical Monitoring|optical monitoring
343700|NCT01476280|antiemetics|antiemetics
343701|NCT01476280|ramosetron|ramosetron
343702|NCT01476280|palonosetron|palonosetron
343703|NCT01476280|PONV(postoperative nausea and vomiting)|ponv(postoperative nausea and vomiting)
343704|NCT01476254|Postoperative pulmonary complications|postoperative pulmonary complications
343705|NCT01476254|Laparoscopic surgery|laparoscopic surgery
343706|NCT01476215|paracetamol|paracetamol
343707|NCT01476202|craving, provoked craving, smoking cessation, nicotine replacement therapy, NRT|craving, provoked craving, smoking cessation, nicotine replacement therapy, nrt
343708|NCT01476189|pharmacokinetic|pharmacokinetic
343709|NCT01476189|paracetamol|paracetamol
343710|NCT01476189|Healthy volunteer|healthy volunteer
343711|NCT01476189|steady state|steady state
343712|NCT01476176|Bioequivalence|bioequivalence
343713|NCT01476176|Pharmacokinetics|pharmacokinetics
343714|NCT01476176|Healthy volunteers|healthy volunteers
343715|NCT01476176|paracetamol|paracetamol
343716|NCT01476176|caffeine|caffeine
343717|NCT01476163|AT1001|at1001
343718|NCT01476163|Lysosomal storage disease|lysosomal storage disease
343719|NCT01476163|Lysosomal Storage Disorder|lysosomal storage disorder
343720|NCT01476163|migalastat|migalastat
343721|NCT01476163|Fabry disease|fabry disease
343722|NCT01476163|Fabry|fabry
343723|NCT01476163|Amicus|amicus
343724|NCT01476137|oncology|oncology
343725|NCT01476137|solid tumors|solid tumors
343726|NCT01476137|multiple myeloma|multiple myeloma
343727|NCT01476137|AKT inhibitor|akt inhibitor
343728|NCT01476137|MEK inhibitor|mek inhibitor
343729|NCT01476111|tumor antigens|tumor antigens
343730|NCT01476111|observational|observational
343731|NCT01476111|breast cancer|breast cancer
343732|NCT01476111|biomarkers|biomarkers
343733|NCT01476111|Neoadjuvant|neoadjuvant
343734|NCT01476059|Treatment compliance|treatment compliance
343735|NCT01476059|Pediatric|pediatric
343736|NCT01476059|Asthma|asthma
343737|NCT01476046|Acute Lung Injury (ALI)|acute lung injury (ali)
343738|NCT01476046|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
343739|NCT01476033|Oxidative stress|oxidative stress
343740|NCT01476033|inflammation|inflammation
343741|NCT01476033|blood flow|blood flow
343742|NCT01476020|Drug eluting stent|drug eluting stent
343743|NCT01476020|Dual antiplatelet therapy|dual antiplatelet therapy
343744|NCT01476020|bleeding|bleeding
343745|NCT01476020|stent thrombosis|stent thrombosis
343746|NCT01476020|follow-up of the drug eluting stent|follow-up of the drug eluting stent
343747|NCT01476007|primary health care|primary health care
343748|NCT01476007|Vitamin B 12 Deficiency|vitamin b 12 deficiency
343749|NCT01475981|JTK-853|jtk-853
343750|NCT01475981|single dose|single dose
343751|NCT01475942|elderly|elderly
343752|NCT01475942|probiotic|probiotic
343753|NCT01475942|bowel function|bowel function
343754|NCT01475942|pathogen|pathogen
343755|NCT01475942|constipation|constipation
343756|NCT01475942|diarrhoea|diarrhoea
343757|NCT01475942|Subclinical levels|subclinical levels
343758|NCT01475929|irritable bowel syndrome|irritable bowel syndrome
343759|NCT01475929|probiotic|probiotic
343760|NCT01475916|Asthma|asthma
343761|NCT01475916|Educational program|educational program
343762|NCT01475916|Quality of life|quality of life
343763|NCT01475916|School-aged children|school-aged children
343764|NCT01475903|Obesity|obesity
343765|NCT01475903|Sleeve gastrectomy|sleeve gastrectomy
343766|NCT01475903|Nutritional impact|nutritional impact
343767|NCT01475903|Vitamin deficiency|vitamin deficiency
343768|NCT01475890|HIV/AIDS|hiv/aids
343769|NCT01475890|Nutrition|nutrition
343770|NCT01475877|bromfenac|bromfenac
343771|NCT01475877|nepafenac|nepafenac
343773|NCT01475877|epithelial healing,|epithelial healing,
343774|NCT01475864|Choledocholithiasis|choledocholithiasis
343775|NCT01475864|metal stents|metal stents
343776|NCT01475864|biliary duct stent|biliary duct stent
343777|NCT01475851|Tenofovir disoproxil fumarate, compensated chronic hepatitis B|tenofovir disoproxil fumarate, compensated chronic hepatitis b
343778|NCT01475838|HIV-1|hiv-1
343779|NCT01475838|HIV|hiv
343780|NCT01475838|Treatment Experienced|treatment experienced
343781|NCT01475812|COPD|copd
343782|NCT01475812|activities of daily living|activities of daily living
343783|NCT01475812|pulmonary hyperinflation|pulmonary hyperinflation
343784|NCT01475812|exercise|exercise
343785|NCT01475565|polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
343786|NCT01475565|insulin sensitivity|insulin sensitivity
343787|NCT01475565|insulin resistance|insulin resistance
343788|NCT01475565|gestational diabetes|gestational diabetes
343789|NCT01475565|pregnancy|pregnancy
343790|NCT01475565|estrogen|estrogen
343791|NCT01475565|glucose intolerance|glucose intolerance
343792|NCT01475565|obesity|obesity
343793|NCT01475565|ovulatory disorder|ovulatory disorder
343794|NCT01475565|racial differences|racial differences
343795|NCT01475565|hyperandrogenism|hyperandrogenism
343796|NCT01475552|platelet reactivity|platelet reactivity
343797|NCT01475552|platelet function assay|platelet function assay
343798|NCT01475552|abciximab|abciximab
343799|NCT01475552|tailored therapy|tailored therapy
343800|NCT01475539|Polio|polio
343801|NCT01475539|Poliovirus|poliovirus
343802|NCT01475539|Oral poliovirus vaccine|oral poliovirus vaccine
343803|NCT01475539|IMOVAX Polio®|imovax polio®
343804|NCT01475526|grocery store|grocery store
343805|NCT01475526|nutrition|nutrition
343806|NCT01475526|Latino|latino
343807|NCT01475526|Hispanic|hispanic
343808|NCT01475513|oral contraceptive|oral contraceptive
343809|NCT01475513|birth control pill|birth control pill
343810|NCT01475513|women|women
343811|NCT01475513|healthy volunteer|healthy volunteer
343812|NCT01475513|insulin sensitivity|insulin sensitivity
343813|NCT01475513|insulin resistance|insulin resistance
343814|NCT01475513|cardiovascular risk factors|cardiovascular risk factors
343815|NCT01475513|endothelial function|endothelial function
343816|NCT01475513|estrogen metabolism|estrogen metabolism
343817|NCT01475513|racial difference|racial difference
343818|NCT01475513|glucose intolerance|glucose intolerance
343819|NCT01475474|incontinence|incontinence
343820|NCT01475474|bowel|bowel
343821|NCT01475474|movement|movement
343822|NCT01475474|fecal|fecal
343823|NCT01475474|anal|anal
343824|NCT01475474|diarrhea|diarrhea
343825|NCT01475474|stool|stool
343826|NCT01475474|rectal|rectal
343827|NCT01475474|feces|feces
343828|NCT01475474|uncontrolled|uncontrolled
343829|NCT01475474|loose|loose
343830|NCT01475474|leakage|leakage
343831|NCT01475474|rectum|rectum
343832|NCT01475474|BM|bm
343833|NCT01475474|watery|watery
343834|NCT01475474|urgent|urgent
343835|NCT01475474|flatulence|flatulence
343836|NCT01475474|gas|gas
343837|NCT01475461|Phase 2|phase 2
343838|NCT01475461|type 2 diabetes mellitus|type 2 diabetes mellitus
343839|NCT01475461|PF-04937319|pf-04937319
343840|NCT01475448|biomechanics|biomechanics
343841|NCT01475448|motor control|motor control
343842|NCT01475448|movement|movement
343843|NCT01475448|walking|walking
343844|NCT01475448|running|running
343845|NCT01475448|sedentarism|sedentarism
343846|NCT01475448|joint moment|joint moment
343847|NCT01475409|anti-TNF|anti-tnf
343848|NCT01475409|tuberculosis|tuberculosis
343849|NCT01475409|QuantiFERON-TB Gold In-Tube|quantiferon-tb gold in-tube
343850|NCT01475409|tuberculin skin test|tuberculin skin test
343851|NCT01475409|rheumatoid arthritis|rheumatoid arthritis
343852|NCT01475409|spondyloarthritis|spondyloarthritis
343853|NCT01475396|exercise|exercise
343854|NCT01475396|physical activity|physical activity
343855|NCT01475396|cognition|cognition
343856|NCT01475396|brain|brain
343857|NCT01475396|aging|aging
343858|NCT01475396|BDNF|bdnf
343859|NCT01475383|Tourette's Syndrome in adults|tourette's syndrome in adults
343860|NCT01475383|Safety and Efficacy|safety and efficacy
343861|NCT01475383|Randomized|randomized
343862|NCT01475383|Placebo Control|placebo control
343863|NCT01475383|Cross-over|cross-over
343864|NCT01475370|Acute myeloid leukemia|acute myeloid leukemia
343865|NCT01475370|WT1|wt1
343866|NCT01475357|congenital heart defects|congenital heart defects
343867|NCT01475357|growth failure|growth failure
343868|NCT01475344|Trauma patient with major bleeding|trauma patient with major bleeding
343869|NCT01475331|pancreatic cyst|pancreatic cyst
343870|NCT01475331|chemotherapy|chemotherapy
343871|NCT01475331|ethanol|ethanol
343872|NCT01475331|ablation|ablation
343873|NCT01475318|complete abortion rate|complete abortion rate
343874|NCT01475318|side effects|side effects
343875|NCT01475318|induction-to-abortion interval|induction-to-abortion interval
343876|NCT01475305|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
343877|NCT01475305|Healthy adults|healthy adults
343878|NCT01475305|MEDI-557|medi-557
343879|NCT01475305|Intranasal challenge|intranasal challenge
343880|NCT01475305|Human model|human model
343881|NCT01475292|COPD|copd
343882|NCT01475279|Warfarin|warfarin
343883|NCT01475279|Dantonic|dantonic
343884|NCT01475279|Pharmacodynamics|pharmacodynamics
343885|NCT01475279|Pharmacokinetics|pharmacokinetics
343886|NCT01475279|Interaction|interaction
343887|NCT01475266|Bladder Cancer|bladder cancer
343888|NCT01475266|NMIBC|nmibc
343889|NCT01475266|TURBT|turbt
343890|NCT01475266|Apaziquone|apaziquone
343891|NCT01475266|EOquin|eoquin
343892|NCT01475266|Immediate instillation|immediate instillation
343893|NCT01475240|HIV|hiv
343894|NCT01475227|HIV|hiv
343895|NCT01475227|Bilirubin|bilirubin
343896|NCT01475214|potassium bicarbonate|potassium bicarbonate
343897|NCT01475214|urinary N-telopeptide|urinary n-telopeptide
343898|NCT01475214|urinary nitrogen|urinary nitrogen
343899|NCT01475214|net acid excretion|net acid excretion
343900|NCT01475201|Type 2 diabetes|type 2 diabetes
343901|NCT01475201|Hypertension|hypertension
343902|NCT01475201|Primary Care|primary care
343903|NCT01475201|Physical Activity|physical activity
343904|NCT01475201|Behavioural Intervention|behavioural intervention
343905|NCT01475201|Pedometer|pedometer
343906|NCT01475201|Accelerometer|accelerometer
343907|NCT01475201|Arterial Stiffness|arterial stiffness
343908|NCT01475201|Carotid femoral pulse wave velocity|carotid femoral pulse wave velocity
343909|NCT01475201|Vascular disease risk|vascular disease risk
343910|NCT01475201|Vascular disease prevention|vascular disease prevention
343911|NCT01475201|Intervention|intervention
343912|NCT01475188|specific subcutaneous immunotherapy|specific subcutaneous immunotherapy
343917|NCT01475162|acute Graft versus Host Disease (aGVHD)|acute graft versus host disease (agvhd)
343918|NCT01475162|steroid refractory acute Graft versus Host Disease (aGVHD)|steroid refractory acute graft versus host disease (agvhd)
343919|NCT01475162|chronic Graft versus Host Disease (cGVHD)|chronic graft versus host disease (cgvhd)
343921|NCT01475162|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
343922|NCT01475149|Antiphospholipid syndrome|antiphospholipid syndrome
343923|NCT01475149|Antiphospholipid antibodies|antiphospholipid antibodies
343924|NCT01475149|Systemic lupus erythematosus|systemic lupus erythematosus
343925|NCT01475149|Annexin A5 and Annexin A5 resistance assay|annexin a5 and annexin a5 resistance assay
343926|NCT01475123|Nicorandil|nicorandil
343927|NCT01475123|Randomized control study|randomized control study
343928|NCT01475123|Hemodialysis|hemodialysis
343929|NCT01475123|Coronary Artery Disease|coronary artery disease
343935|NCT01475097|AE - Adverse event|ae - adverse event
343936|NCT01475097|Arteriography|arteriography
343937|NCT01475097|IA - Intra-arterial|ia - intra-arterial
343938|NCT01475097|IOCM - Iso-Osmolar Contrast Medium|iocm - iso-osmolar contrast medium
343939|NCT01475097|LOCM - Low-Osmolar Contrast Medium|locm - low-osmolar contrast medium
343940|NCT01475097|Patient Comfort|patient comfort
343941|NCT01475097|Body Image Disturbance|body image disturbance
343943|NCT01475084|Flex-rigid pleuroscopy|flex-rigid pleuroscopy
343944|NCT01475084|cryobiopsy|cryobiopsy
343945|NCT01475084|pleural biopsy|pleural biopsy
343946|NCT01475084|pleural effusion|pleural effusion
343947|NCT01475084|safety|safety
343948|NCT01475084|thoracoscopy|thoracoscopy
343949|NCT01475045|COPD|copd
343950|NCT01475032|Asthma|asthma
343951|NCT01475032|children|children
343952|NCT01475032|chronic treatment|chronic treatment
343953|NCT01475019|Obesity|obesity
343954|NCT01475019|Polycystic Ovaries Syndrome|polycystic ovaries syndrome
343955|NCT01475019|Orlistat|orlistat
343956|NCT01475019|Sibutramine|sibutramine
343957|NCT01475019|Androgen levels|androgen levels
343958|NCT01475019|Insulin resistance|insulin resistance
343959|NCT01475006|Epidermal Growth Factor Receptor Variant III|epidermal growth factor receptor variant iii
343960|NCT01475006|EGFRvIII|egfrviii
343961|NCT01475006|Glioma|glioma
343962|NCT01475006|Anaplastic Astrocytomas|anaplastic astrocytomas
343963|NCT01475006|Glioblastoma Multiforme|glioblastoma multiforme
343964|NCT01475006|Antibody drug conjugate|antibody drug conjugate
343965|NCT01475006|brain tumor|brain tumor
343966|NCT01474980|Congenital Myasthenic Syndrome|congenital myasthenic syndrome
343967|NCT01474980|Pregnancy|pregnancy
343968|NCT01474980|Outcome|outcome
343969|NCT01474967|polycystic ovary syndrome|polycystic ovary syndrome
343970|NCT01474967|lipid profile|lipid profile
343971|NCT01474967|metformin|metformin
343972|NCT01474954|HIV|hiv
343973|NCT01474954|Antiretroviral Medication|antiretroviral medication
343974|NCT01474954|Cardiovascular Disease Risk|cardiovascular disease risk
343975|NCT01474941|Multiple Dose Study Overweight Healthy Subjects Body Weight Modified-Release Formulation|multiple dose study overweight healthy subjects body weight modified-release formulation
343976|NCT01474928|Asthma|asthma
343977|NCT01474928|Community-based participatory research|community-based participatory research
343978|NCT01474928|Educational intervention|educational intervention
343979|NCT01474928|Ethno-cultural community|ethno-cultural community
343980|NCT01474928|Video recording|video recording
343981|NCT01474928|Patient education handout|patient education handout
343982|NCT01474915|Neurosurgery|neurosurgery
343983|NCT01474902|pediatric|pediatric
343984|NCT01474902|asymptotic venous thrombosis|asymptotic venous thrombosis
343985|NCT01474902|Enoxaparin|enoxaparin
343986|NCT01474902|pediatric cardiac surgery|pediatric cardiac surgery
343987|NCT01474889|Hypoglycemia, Unawareness, RT-CGM, Type 1 Diabetes|hypoglycemia, unawareness, rt-cgm, type 1 diabetes
343988|NCT01474876|Post-marketing observational study (PMOS) Protocol|post-marketing observational study (pmos) protocol
343989|NCT01474876|Effectiveness of Adalimumab (HUMIRA®)|effectiveness of adalimumab (humira®)
343990|NCT01474876|Psoriatic Arthritis|psoriatic arthritis
343991|NCT01474876|Ankylosing Spondylitis|ankylosing spondylitis
343992|NCT01474850|mechanical ventilation|mechanical ventilation
343993|NCT01474850|pressure control ventilation|pressure control ventilation
343994|NCT01474850|lung recruitment|lung recruitment
343995|NCT01474850|positive end expiratory pressure|positive end expiratory pressure
343996|NCT01474850|opto-electronic plethysmography|opto-electronic plethysmography
343997|NCT01474850|chest wall volume variation|chest wall volume variation
343998|NCT01474850|intravenous anesthesia|intravenous anesthesia
343999|NCT01474837|depressive disorders|depressive disorders
344000|NCT01474837|exercise therapy|exercise therapy
344001|NCT01474824|Cardiac output|cardiac output
344002|NCT01474824|Stroke volume|stroke volume
344003|NCT01474811|Hepatitis|hepatitis
344004|NCT01474811|Hepatitis C|hepatitis c
344005|NCT01474811|HCV-TARGET|hcv-target
344006|NCT01474811|HCV|hcv
344007|NCT01474811|Observational Study|observational study
344008|NCT01474798|Acne Vulgaris|acne vulgaris
344009|NCT01474785|Obesity|obesity
344010|NCT01474785|Bariatric surgery|bariatric surgery
344011|NCT01474785|Nashville, Tennessee|nashville, tennessee
344012|NCT01474772|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
344013|NCT01474772|Pain on Walking|pain on walking
344014|NCT01474772|Pregabalin|pregabalin
344015|NCT01474746|Fragile X Syndrome|fragile x syndrome
344016|NCT01474746|Pediatrics|pediatrics
344017|NCT01474746|sertraline|sertraline
344018|NCT01474746|autism|autism
344019|NCT01474733|resident education|resident education
344020|NCT01474733|health literacy|health literacy
344021|NCT01474733|curriculum|curriculum
344022|NCT01474720|Systemic Lupus Erythematosus|systemic lupus erythematosus
344023|NCT01474720|Lupus|lupus
344024|NCT01474720|SLE|sle
344025|NCT01474720|Zostavax|zostavax
344026|NCT01474720|shingles|shingles
344027|NCT01474707|COPD|copd
344028|NCT01474707|Educational materials|educational materials
344029|NCT01474707|Cultural background|cultural background
344030|NCT01474707|Instructional videos|instructional videos
344031|NCT01474707|Patient education handouts|patient education handouts
344032|NCT01474707|Lung age|lung age
344033|NCT01474694|prospective study|prospective study
344034|NCT01474694|multicenter trial|multicenter trial
344035|NCT01474694|analysis, computer assisted image|analysis, computer assisted image
344036|NCT01474694|CE marked|ce marked
344037|NCT01474694|medical devices|medical devices
344038|NCT01474694|catheter ablation|catheter ablation
344039|NCT01474681|hematologic malignancies|hematologic malignancies
344040|NCT01474681|leukemia|leukemia
344041|NCT01474681|lymphoma|lymphoma
344042|NCT01474655|epiretinal membrane|epiretinal membrane
344043|NCT01474655|visual acuity|visual acuity
344044|NCT01474655|metamorphopsia|metamorphopsia
344045|NCT01474655|thickness of retinal layers|thickness of retinal layers
344046|NCT01474655|spectral domain optical coherence tomography|spectral domain optical coherence tomography
344047|NCT01474642|Advanced or recurrent esophageal squamous cell carcinoma|advanced or recurrent esophageal squamous cell carcinoma
344048|NCT01474642|Randomizes phase II trial|randomizes phase ii trial
344049|NCT01474642|Capecitabine|capecitabine
344050|NCT01474642|Cisplatin|cisplatin
344051|NCT01474642|Genexol|genexol
344052|NCT01474629|oxidative stress|oxidative stress
344053|NCT01474629|inflammation|inflammation
344054|NCT01474629|endotoxemia|endotoxemia
344055|NCT01474629|strenuous exercise|strenuous exercise
344056|NCT01474616|Aging|aging
344057|NCT01474616|Health Services|health services
344058|NCT01474616|Knowledge Translation|knowledge translation
344059|NCT01474616|Long-Term Care Facilities|long-term care facilities
344060|NCT01474616|Mobility|mobility
344061|NCT01474616|Psychosocial And Health Behaviours|psychosocial and health behaviours
344062|NCT01474603|observational study|observational study
344063|NCT01474577|stress test|stress test
344064|NCT01474577|cardiac issues|cardiac issues
344065|NCT01474577|Rb-82 PET Myocardial Perfusion Imaging|rb-82 pet myocardial perfusion imaging
344066|NCT01474577|11-150|11-150
344067|NCT01474577|one or more 82Rb myocardial perfusion stress tests|one or more 82rb myocardial perfusion stress tests
344068|NCT01474564|Blood draw|blood draw
344069|NCT01474564|pancreas|pancreas
344070|NCT01474564|Tumorigenic Cells|tumorigenic cells
344071|NCT01474564|11-141|11-141
344072|NCT01474551|Vemurafenib|vemurafenib
344073|NCT01474551|skin cancer|skin cancer
344074|NCT01474551|Stage IV|stage iv
344075|NCT01474551|advanced stage III|advanced stage iii
344076|NCT01474551|11-091|11-091
344077|NCT01474538|diabetes|diabetes
344078|NCT01474538|type 2 diabetes|type 2 diabetes
344079|NCT01474538|insulin pump|insulin pump
344080|NCT01474538|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
344081|NCT01474538|CSII|csii
344082|NCT01474538|A1C|a1c
344083|NCT01474486|thiamin|thiamin
344084|NCT01474486|pyridoxine|pyridoxine
344085|NCT01474486|vitamin D|vitamin d
344086|NCT01474486|zinc|zinc
344087|NCT01474486|congestive heart failure (CHF)|congestive heart failure (chf)
344088|NCT01474486|ischemic cardiomyopathy|ischemic cardiomyopathy
344089|NCT01474486|nutritional injury|nutritional injury
344090|NCT01474486|quality of life|quality of life
344091|NCT01474473|CACIPLIQ20|cacipliq20
344092|NCT01474473|Matrix Therapy|matrix therapy
344093|NCT01474473|Diabetic foot|diabetic foot
344094|NCT01474460|warfarin|warfarin
344095|NCT01474460|phytonadione|phytonadione
344096|NCT01474460|INR|inr
344097|NCT01474447|low back pain|low back pain
344098|NCT01474434|coronary artery disease,|coronary artery disease,
344099|NCT01474434|LCQ908,|lcq908,
344100|NCT01474434|hyperlipidemia,|hyperlipidemia,
344101|NCT01474434|hypertriglyceridemia,|hypertriglyceridemia,
344102|NCT01474434|pradigastat|pradigastat
723743|NCT01056965|PNFA|pnfa
344103|NCT01474421|Parkinson's disease|parkinson's disease
344104|NCT01474421|Dyskinesia|dyskinesia
344105|NCT01474421|Movement disorders|movement disorders
344106|NCT01474421|L-dopa|l-dopa
344107|NCT01474408|Coronary artery bypass|coronary artery bypass
344108|NCT01474408|Exercise therapy|exercise therapy
344109|NCT01474408|Revascularization (PCI)|revascularization (pci)
344110|NCT01474395|schizophrenia|schizophrenia
344111|NCT01474395|cognitive remediation|cognitive remediation
344112|NCT01474395|NMDA|nmda
344113|NCT01474382|OraVerse|oraverse
344115|NCT01474382|Efficacy|efficacy
344116|NCT01474382|Pediatric|pediatric
344117|NCT01474382|Reversal of dental anesthesia|reversal of dental anesthesia
344118|NCT01474369|Drug Therapy|drug therapy
344119|NCT01474356|brachytherapy|brachytherapy
344120|NCT01474356|interstitial hyperthermia|interstitial hyperthermia
344121|NCT01474356|cervical cancer|cervical cancer
344122|NCT01474356|side effects|side effects
344123|NCT01474356|Locally advanced cervical cancer patients|locally advanced cervical cancer patients
344124|NCT01474343|Neurodegenerative Diseases|neurodegenerative diseases
344125|NCT01474343|Nervous System Diseases|nervous system diseases
344126|NCT01474343|Genetic Diseases, Inborn|genetic diseases, inborn
344127|NCT01474343|Metabolic Diseases|metabolic diseases
344128|NCT01474343|Gene Therapy|gene therapy
344129|NCT01474343|Adenovirus Associated Vector|adenovirus associated vector
344328|NCT01473472|Prophylaxis|prophylaxis
344130|NCT01474330|Pomalidomide|pomalidomide
344131|NCT01474330|safety|safety
344132|NCT01474330|tolerability|tolerability
344133|NCT01474330|pharmacokinetics|pharmacokinetics
344134|NCT01474304|craniotomy|craniotomy
344135|NCT01474304|tumor resection|tumor resection
344136|NCT01474304|aneurysm|aneurysm
344137|NCT01474304|revascularization|revascularization
344138|NCT01474304|opioid|opioid
344139|NCT01474304|nausea|nausea
344140|NCT01474304|vomiting|vomiting
344141|NCT01474304|acetaminophen|acetaminophen
344142|NCT01474265|smoking cessation|smoking cessation
344143|NCT01474265|varenicline|varenicline
344144|NCT01474265|sympathovagal balance|sympathovagal balance
344145|NCT01474265|quit attempts|quit attempts
344146|NCT01474265|MSNA|msna
344147|NCT01474226|lysine|lysine
344148|NCT01474226|rice|rice
344149|NCT01474226|bioavailability|bioavailability
344150|NCT01474213|dexmedetomidine|dexmedetomidine
344151|NCT01474213|remifentanil|remifentanil
344152|NCT01474213|awake nasotracheal fibreoptic intubation|awake nasotracheal fibreoptic intubation
344153|NCT01474213|oral maxillofacial surgery|oral maxillofacial surgery
344154|NCT01474213|difficult airway|difficult airway
344155|NCT01474213|adult|adult
344156|NCT01474200|Ultrafiltration|ultrafiltration
344157|NCT01474200|Aquapheresis|aquapheresis
344158|NCT01474200|Diuretics|diuretics
344159|NCT01474200|Loop Diuretics|loop diuretics
344160|NCT01474200|Aquadex Flexflow System|aquadex flexflow system
344161|NCT01474200|Gambro UF Solutions|gambro uf solutions
344162|NCT01474187|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
344163|NCT01474187|rectal cancer|rectal cancer
344164|NCT01474187|phase I study|phase i study
344165|NCT01474187|irinotecan|irinotecan
344166|NCT01474148|paraplegia|paraplegia
344167|NCT01474148|tetraplegia|tetraplegia
344168|NCT01474148|Spinal cord injured|spinal cord injured
344169|NCT01474148|FES|fes
344170|NCT01474135|Glaucoma|glaucoma
344171|NCT01474135|Ocular Hypertension|ocular hypertension
344172|NCT01474122|digital ulcers|digital ulcers
344173|NCT01474122|systemic sclerosis|systemic sclerosis
344174|NCT01474109|systemic sclerosis|systemic sclerosis
344175|NCT01474109|digital ulcers|digital ulcers
344176|NCT01474096|clinical practice guideline-primary health care|clinical practice guideline-primary health care
344177|NCT01474083|Type 2 diabetes mellitus|type 2 diabetes mellitus
344178|NCT01474083|pharmacokinetics|pharmacokinetics
344179|NCT01474083|pharmacodynamics|pharmacodynamics
344180|NCT01474070|Glaucoma|glaucoma
344181|NCT01474070|Goldmann Tonometry|goldmann tonometry
344182|NCT01474070|Dynamic Contour Tonometry|dynamic contour tonometry
344183|NCT01474057|PTSD|ptsd
344184|NCT01474057|combat trauma|combat trauma
344185|NCT01474057|telemedicine|telemedicine
344186|NCT01474057|primary care interventions|primary care interventions
344187|NCT01474057|CBT|cbt
344188|NCT01474057|self-managed treatment|self-managed treatment
344189|NCT01474057|web-based intervention|web-based intervention
344190|NCT01474057|internet treatment|internet treatment
344191|NCT01474031|total hip arthroplasty|total hip arthroplasty
344192|NCT01474031|biomechanics|biomechanics
344193|NCT01474031|direct anterior approach|direct anterior approach
344194|NCT01474005|laryngectomy|laryngectomy
344195|NCT01474005|artificial larynx|artificial larynx
344196|NCT01474005|breathing|breathing
344197|NCT01474005|swallowing|swallowing
344198|NCT01474005|upper airway|upper airway
344199|NCT01473979|cardiac surgery|cardiac surgery
344200|NCT01473979|poststernotomy wound infections|poststernotomy wound infections
344201|NCT01473979|delayed secondary closure of sternum|delayed secondary closure of sternum
344202|NCT01473927|Inflammatory bowel diseases|inflammatory bowel diseases
344203|NCT01473927|Crohn disease|crohn disease
344204|NCT01473927|Ficolin-2|ficolin-2
344205|NCT01473927|C-Reactive Protein|c-reactive protein
344818|NCT01471444|Clolar|clolar
344206|NCT01473927|Calprotectin|calprotectin
344207|NCT01473927|Inflammatory markers|inflammatory markers
344208|NCT01473927|SES-CD|ses-cd
344209|NCT01473901|BKM120|bkm120
344210|NCT01473901|temozolomide|temozolomide
344211|NCT01473901|glioblastoma multiforme|glioblastoma multiforme
344212|NCT01473901|GBM|gbm
344214|NCT01473888|T89(Dantonic®)|t89(dantonic®)
344215|NCT01473888|Cooperstown 5+1 cocktail probes|cooperstown 5+1 cocktail probes
344216|NCT01473888|CYP450|cyp450
344217|NCT01473875|LIPA|lipa
344218|NCT01473875|Wolman Disease|wolman disease
344219|NCT01473875|Wolman Phenotype|wolman phenotype
344220|NCT01473875|Acid Lipase Deficiency|acid lipase deficiency
344221|NCT01473875|Acid Cholesteryl Hydrolase|acid cholesteryl hydrolase
344222|NCT01473875|Acid Lipase Disease Deficiency, type 2|acid lipase disease deficiency, type 2
344223|NCT01473875|Cholesteryl Ester Storage Disease (CESD)|cholesteryl ester storage disease (cesd)
344224|NCT01473875|Cholesteryl Ester Hydrolase Deficiency|cholesteryl ester hydrolase deficiency
344225|NCT01473875|Early Onset LAL-Deficiency (Wolman Disease)|early onset lal-deficiency (wolman disease)
344226|NCT01473875|LAL Deficiency|lal deficiency
344227|NCT01473875|Late Onset Lysosomal Acid Lipase Deficiency (CESD)|late onset lysosomal acid lipase deficiency (cesd)
344327|NCT01473485|Metastatic Brain Cancer|metastatic brain cancer
344228|NCT01473875|Wolman Disease (early onset LAL Deficiency)|wolman disease (early onset lal deficiency)
344229|NCT01473875|Related Disorders:|related disorders:
344230|NCT01473875|Non-alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
344231|NCT01473875|Non-alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
344232|NCT01473875|Alcoholic Liver Disease|alcoholic liver disease
344233|NCT01473875|Cryptogenic Cirrhosis|cryptogenic cirrhosis
344234|NCT01473875|Niemann-Pick Disease (NPD) Type C|niemann-pick disease (npd) type c
344235|NCT01473875|Chanarin Dorfman Syndrome|chanarin dorfman syndrome
344236|NCT01473862|adolescent|adolescent
344237|NCT01473862|bereavement|bereavement
344238|NCT01473862|cancer|cancer
344239|NCT01473862|coping skills|coping skills
344240|NCT01473849|Cytomegalovirus|cytomegalovirus
344241|NCT01473849|Liver transplantation|liver transplantation
344242|NCT01473849|Hepatitis C virus|hepatitis c virus
344243|NCT01473849|Patients who underwent first liver transplantation due to hepatopathy caused by HCV,confirmed by detection of HCV RNA previously to transplantation|patients who underwent first liver transplantation due to hepatopathy caused by hcv,confirmed by detection of hcv rna previously to transplantation
344244|NCT01473836|Metronidazole|metronidazole
344245|NCT01473836|intra-abdominal infection|intra-abdominal infection
344246|NCT01473836|pelvic inflammatory disease|pelvic inflammatory disease
344247|NCT01473836|anaerobe|anaerobe
344248|NCT01473823|food allergy|food allergy
344249|NCT01473823|eczema|eczema
344250|NCT01473823|sensitisation|sensitisation
344251|NCT01473823|omega-3 long chain polyunsaturated fatty acids|omega-3 long chain polyunsaturated fatty acids
344252|NCT01473823|prevention|prevention
344253|NCT01473823|asthma|asthma
344254|NCT01473810|HIV|hiv
344255|NCT01473810|vaccination|vaccination
344256|NCT01473810|T cells|t cells
344257|NCT01473810|mucosal immunity|mucosal immunity
344258|NCT01473810|safety|safety
344259|NCT01473810|nasal administration|nasal administration
344260|NCT01473810|DTH skin test|dth skin test
344261|NCT01473771|Suicide|suicide
344262|NCT01473771|Suicide, Attempted|suicide, attempted
344263|NCT01473758|COPD|copd
344264|NCT01473758|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
344265|NCT01473758|Roflumilast|roflumilast
344266|NCT01473745|Alar Base Suture; Nasolabial Change; 3D stereogrammetry|alar base suture; nasolabial change; 3d stereogrammetry
344267|NCT01473732|CNI toxicity|cni toxicity
344268|NCT01473732|CAI|cai
344269|NCT01473719|alcohol use|alcohol use
344270|NCT01473719|marijuana use|marijuana use
344271|NCT01473719|STI|sti
344272|NCT01473706|Malnutrition|malnutrition
344273|NCT01473706|Nutrition status|nutrition status
344274|NCT01473706|Elderly|elderly
344275|NCT01473706|Nutrition screening|nutrition screening
344276|NCT01473693|Quality of Life|quality of life
427061|NCT00001699|HIV|hiv
344277|NCT01473693|Lung cancer|lung cancer
344278|NCT01473693|MRI|mri
344279|NCT01473693|Surgery|surgery
344280|NCT01473693|induction chemotherapy|induction chemotherapy
344281|NCT01473693|11-145|11-145
344282|NCT01473680|minority breast cancer patients|minority breast cancer patients
344283|NCT01473680|EEG|eeg
344284|NCT01473680|Evaluation|evaluation
344285|NCT01473680|Questionnaires|questionnaires
344286|NCT01473680|11-139|11-139
344287|NCT01473641|Etonogestrel|etonogestrel
344288|NCT01473641|Contraceptive implant|contraceptive implant
344289|NCT01473641|Safety|safety
344290|NCT01473628|early stage follicular lymphoma|early stage follicular lymphoma
344291|NCT01473628|indolent non-Hodgkin's lymphomas|indolent non-hodgkin's lymphomas
344292|NCT01473628|Lymphoma|lymphoma
344293|NCT01473628|Follicular Lymphoma|follicular lymphoma
344294|NCT01473628|FL|fl
344295|NCT01473628|Rituximab|rituximab
344296|NCT01473628|Rituxan|rituxan
344297|NCT01473628|Radiation|radiation
344298|NCT01473628|Radiation Therapy|radiation therapy
344299|NCT01473628|XRT|xrt
344300|NCT01473576|type II diabetes|type ii diabetes
344301|NCT01473576|protein synthesis|protein synthesis
344302|NCT01473576|nitrate|nitrate
344303|NCT01473576|elderly|elderly
344304|NCT01473550|Mental Health|mental health
344305|NCT01473550|Smart Technology|smart technology
344306|NCT01473550|Mood disorder|mood disorder
344307|NCT01473550|Psychotic disorder|psychotic disorder
344308|NCT01473537|dental caries/prevention and control|dental caries/prevention and control
344309|NCT01473537|oral health|oral health
344310|NCT01473537|cariostatic agents|cariostatic agents
344311|NCT01473524|Primary Biliary Cholangitis|primary biliary cholangitis
344312|NCT01473524|Primary Biliary Cirrhosis|primary biliary cirrhosis
344313|NCT01473524|PBC|pbc
344314|NCT01473524|Cirrhosis|cirrhosis
344315|NCT01473524|Liver|liver
344316|NCT01473511|Behavioural intervention|behavioural intervention
344317|NCT01473511|Distance intervention|distance intervention
344318|NCT01473511|Parenting intervention|parenting intervention
344319|NCT01473498|Sepsis|sepsis
344320|NCT01473498|Acute kidney injury|acute kidney injury
344321|NCT01473498|Mean arterial pressure|mean arterial pressure
344322|NCT01473498|Catecholamines|catecholamines
344323|NCT01473498|Renal doppler|renal doppler
344324|NCT01473485|Brain Tumor|brain tumor
344325|NCT01473485|Glioma|glioma
344326|NCT01473485|Brain Cancer|brain cancer
344329|NCT01473472|HIV infection|hiv infection
344330|NCT01473472|tenofovir|tenofovir
344331|NCT01473472|emtricitabine|emtricitabine
344332|NCT01473472|men who have sex with men|men who have sex with men
344333|NCT01473459|best fertility protocol|best fertility protocol
344334|NCT01473459|(BMI > 30)|(bmi > 30)
344335|NCT01473459|women|women
344336|NCT01473459|PCOS|pcos
344337|NCT01473446|Goal directed fluid therapy|goal directed fluid therapy
344338|NCT01473446|perioperative fluid therapy|perioperative fluid therapy
344339|NCT01473446|LiDCOrapid|lidcorapid
344340|NCT01473446|Postoperative outcome|postoperative outcome
344341|NCT01473446|Open abdominal surgery|open abdominal surgery
344342|NCT01473433|Regenerative medicine|regenerative medicine
344343|NCT01473433|Myocardial infarction|myocardial infarction
344344|NCT01473394|Major depressive disorder|major depressive disorder
344345|NCT01473394|Depression|depression
344346|NCT01473381|Major Depressive Disorder|major depressive disorder
344347|NCT01473381|Depression|depression
344348|NCT01473368|human Gut Microbiota|human gut microbiota
344349|NCT01473368|gut microbiota|gut microbiota
344350|NCT01473368|gut microbiome|gut microbiome
344351|NCT01473368|probiotic|probiotic
344352|NCT01473368|antibiotic|antibiotic
344353|NCT01473368|antibiotic-associated diarrhea|antibiotic-associated diarrhea
344354|NCT01473368|intestinal bacterial overgrowth|intestinal bacterial overgrowth
344355|NCT01473342|Healthy survivorship|healthy survivorship
344356|NCT01473342|Smartphones|smartphones
344357|NCT01473342|Treatment|treatment
344358|NCT01473329|diabetes care|diabetes care
344359|NCT01473329|diabetes education|diabetes education
344360|NCT01473329|diabetes control|diabetes control
344361|NCT01473303|stage IV pancreatic cancer|stage iv pancreatic cancer
344362|NCT01473303|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
344363|NCT01473290|diarrhea|diarrhea
344364|NCT01473290|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
344365|NCT01473290|gastrointestinal complications|gastrointestinal complications
344366|NCT01473290|fatigue|fatigue
344367|NCT01473290|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
344368|NCT01473290|cognitive/functional effects|cognitive/functional effects
344369|NCT01473290|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
344370|NCT01473277|Hemiplegic shoulder pain|hemiplegic shoulder pain
344371|NCT01473277|Botulinum toxin type A (BT-A)|botulinum toxin type a (bt-a)
344372|NCT01473277|Steroid|steroid
344373|NCT01473277|Intra-articular injection|intra-articular injection
335052|NCT01511978|diaminopyridine|diaminopyridine
335053|NCT01511978|3,4-diaminopyridine|3,4-diaminopyridine
344374|NCT01473277|Pain score of 45 or greater on a 0-100 mm VAS|pain score of 45 or greater on a 0-100 mm vas
344375|NCT01473277|Duration of HSP for at least one month|duration of hsp for at least one month
344376|NCT01473277|Pain refractoriness to conventional treatment|pain refractoriness to conventional treatment
344377|NCT01473264|CC10|cc10
344378|NCT01473264|BPD|bpd
344379|NCT01473264|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
344380|NCT01473264|premature infants|premature infants
344381|NCT01473264|neonates|neonates
344382|NCT01473264|pulmonary inflammation|pulmonary inflammation
344383|NCT01473264|lung function|lung function
344384|NCT01473264|RDS|rds
344385|NCT01473238|Desktop computer|desktop computer
344386|NCT01473238|Mobile|mobile
344387|NCT01473238|iPad|ipad
344388|NCT01473238|Evaluation|evaluation
344389|NCT01473238|User experience|user experience
344390|NCT01473238|Benefits|benefits
344391|NCT01473238|Cost analysis|cost analysis
344392|NCT01473199|focal defect|focal defect
344393|NCT01473199|focal lesion|focal lesion
344394|NCT01473199|chondral lesion|chondral lesion
344395|NCT01473199|osteochondral lesion|osteochondral lesion
723744|NCT01056965|CBD|cbd
344396|NCT01473186|morbid obesity|morbid obesity
344397|NCT01473186|endometrial pathology|endometrial pathology
344398|NCT01473186|menstrual irregularities|menstrual irregularities
344399|NCT01473173|Safety|safety
344400|NCT01473173|Tolerability|tolerability
344401|NCT01473173|Pharmacokinetics|pharmacokinetics
344402|NCT01473173|Pharmacodynamics|pharmacodynamics
344403|NCT01473147|GLP-1 analogue|glp-1 analogue
344405|NCT01473147|insulin|insulin
344406|NCT01473147|type 2 diabetes mellitus|type 2 diabetes mellitus
344407|NCT01472107|Pregnancy|pregnancy
344408|NCT01472107|APL female patients|apl female patients
344409|NCT01472068|Incontinence|incontinence
344410|NCT01472068|NMES|nmes
344411|NCT01472055|Hematopoietic stem cell transplantation with fludarabine based conditioning|hematopoietic stem cell transplantation with fludarabine based conditioning
344412|NCT01472042|Traumatic Brain Injury|traumatic brain injury
344413|NCT01472042|Sport Concussion|sport concussion
344414|NCT01472042|Head Injury|head injury
344415|NCT01472042|Sports Injury|sports injury
344416|NCT01472029|Adenocarcinoma|adenocarcinoma
344417|NCT01472029|Gastroesophageal junction|gastroesophageal junction
344418|NCT01472029|Stomach|stomach
344419|NCT01472029|HER2|her2
344420|NCT01472016|c-Met overexpression|c-met overexpression
344421|NCT01472016|MET amplification|met amplification
344422|NCT01472016|Neoplasms|neoplasms
344423|NCT01472016|h224G11|h224g11
344739|NCT01471704|Inhibitex|inhibitex
344424|NCT01473121|Hepatocellular carcinoma|hepatocellular carcinoma
344425|NCT01473121|Registry|registry
344426|NCT01473121|Turkey|turkey
344427|NCT01473108|Healthy volunteers, proof-of-concept trial, PK and PD|healthy volunteers, proof-of-concept trial, pk and pd
344428|NCT01473095|AKT|akt
344429|NCT01473095|ARQ 092|arq 092
344430|NCT01473095|Targeted therapy|targeted therapy
344431|NCT01473095|Molecular therapy|molecular therapy
344432|NCT01473095|Biomarker|biomarker
344433|NCT01473095|Phase 1|phase 1
344434|NCT01473095|Phase I|phase i
344435|NCT01473095|Endometrial cancer|endometrial cancer
344436|NCT01473095|Lymphoma|lymphoma
344437|NCT01473095|AKT pathway|akt pathway
344438|NCT01473095|AKT signaling|akt signaling
344439|NCT01473095|AKT inhibitor|akt inhibitor
344440|NCT01473095|AKT pan inhibitor|akt pan inhibitor
344441|NCT01473095|AKT1|akt1
344442|NCT01473095|AKT2|akt2
344443|NCT01473095|AKT3|akt3
344444|NCT01473095|AKT1 mutation|akt1 mutation
344445|NCT01473095|AKT1-E17K|akt1-e17k
344446|NCT01473095|AKT1-E17K mutation|akt1-e17k mutation
344447|NCT01473095|AKT 2 inhibitor|akt 2 inhibitor
344448|NCT01473095|AKT 3 inhibitor|akt 3 inhibitor
344449|NCT01473095|AKT 3 amplification|akt 3 amplification
344450|NCT01473095|PI3K AKT mTOR signalling pathway|pi3k akt mtor signalling pathway
344451|NCT01473095|mTOR inhibitor|mtor inhibitor
344452|NCT01473095|PI3K inhibitor|pi3k inhibitor
344453|NCT01473095|Clinical oncology|clinical oncology
344454|NCT01473095|Tumor|tumor
344455|NCT01473095|Tumour|tumour
344456|NCT01473095|PIK3CA H1047R mutation|pik3ca h1047r mutation
344457|NCT01473069|JTK-853|jtk-853
344458|NCT01473069|Healthy subjects|healthy subjects
344459|NCT01473056|Hepatitis C|hepatitis c
344460|NCT01473056|JTK-853|jtk-853
344461|NCT01473043|Axitinib|axitinib
344462|NCT01473043|metastatic renal cell carcinoma|metastatic renal cell carcinoma
344463|NCT01473030|Benign prostate|benign prostate
344464|NCT01473030|serum DHT|serum dht
344465|NCT01473030|Dutasteride|dutasteride
344466|NCT01473030|PSA|psa
344467|NCT01473030|Avodart|avodart
344468|NCT01473004|Sir-spheres|sir-spheres
344469|NCT01473004|Liver Metastases|liver metastases
344470|NCT01473004|Selective internal radiation|selective internal radiation
344471|NCT01473004|Yttrium-90|yttrium-90
344472|NCT01473004|Uveal|uveal
344473|NCT01473004|Melanoma|melanoma
344474|NCT01473004|Ocular melanoma|ocular melanoma
344475|NCT01472991|ADHD|adhd
344476|NCT01472978|C. difficile|c. difficile
344477|NCT01472965|central line|central line
344478|NCT01472965|adolescents|adolescents
344479|NCT01472965|children|children
344480|NCT01472965|bloodstream infection|bloodstream infection
344481|NCT01472965|antibiotic lock therapy|antibiotic lock therapy
344482|NCT01472965|catheter lock therapy|catheter lock therapy
344483|NCT01472965|ethanol lock therapy|ethanol lock therapy
344484|NCT01472952|sepsis|sepsis
344485|NCT01472952|immune cells|immune cells
344486|NCT01472952|immune reaction|immune reaction
344487|NCT01472952|trauma|trauma
344488|NCT01472952|Immune activation|immune activation
344489|NCT01472926|acute ischaemic stroke|acute ischaemic stroke
344490|NCT01472926|stroke|stroke
344491|NCT01472926|thrombolysis|thrombolysis
344492|NCT01472926|thrombolytic drug therapy|thrombolytic drug therapy
344493|NCT01472926|CT perfusion|ct perfusion
344494|NCT01472926|CT angiography|ct angiography
344495|NCT01472926|brain imaging|brain imaging
344496|NCT01472913|Prospective randomised double-blind study|prospective randomised double-blind study
344497|NCT01472913|Fibrin sealant|fibrin sealant
344498|NCT01472913|Bilateral simultaneous total knee arthroplasty|bilateral simultaneous total knee arthroplasty
344499|NCT01472913|Blood loss|blood loss
344500|NCT01472913|Postoperative pain|postoperative pain
344501|NCT01472913|Complications|complications
344502|NCT01472900|acne vulgaris|acne vulgaris
344503|NCT01472874|Wilson Disease|wilson disease
344504|NCT01472874|Trientine|trientine
344505|NCT01472874|One Daily Dosage|one daily dosage
344506|NCT01472861|coculture|coculture
344507|NCT01472861|endometrial biopsy|endometrial biopsy
344508|NCT01472861|IVF poor responders|ivf poor responders
344509|NCT01472835|sedation|sedation
344510|NCT01472835|sensitivity|sensitivity
344511|NCT01472835|specificity|specificity
344512|NCT01472835|validity|validity
344513|NCT01472835|diagnostic injection|diagnostic injection
344514|NCT01472822|Omija|omija
344515|NCT01472822|knee osteoarthritis|knee osteoarthritis
344516|NCT01472809|ZYGK1|zygk1
344517|NCT01472809|Cadila|cadila
344518|NCT01472809|Zydus|zydus
344519|NCT01472809|ZRC|zrc
344520|NCT01472809|Zydus Research Center|zydus research center
344521|NCT01472809|Phase 1|phase 1
344522|NCT01472809|Diabetes|diabetes
344523|NCT01472796|African American|african american
344524|NCT01472796|Vitamin D deficient|vitamin d deficient
344525|NCT01472783|BRCA1 mutation|brca1 mutation
344526|NCT01472783|BRCA2 mutation|brca2 mutation
344527|NCT01472783|Ovarian cancer|ovarian cancer
344528|NCT01472783|PARP inhibitor|parp inhibitor
344529|NCT01472770|Colorectal cancer|colorectal cancer
344530|NCT01472770|Metastatic|metastatic
344531|NCT01472770|Treatment resistant|treatment resistant
344532|NCT01472744|Executive function|executive function
344533|NCT01472744|Aging|aging
344534|NCT01472744|Physical activity|physical activity
344535|NCT01472731|GC1008|gc1008
344536|NCT01472731|PET imaging|pet imaging
344537|NCT01472731|primary brain tumors|primary brain tumors
344538|NCT01472731|recurrent high grade glioma's|recurrent high grade glioma's
344539|NCT01472705|drug-eluting coronary stent|drug-eluting coronary stent
344540|NCT01472705|percutaneous coronary intervention|percutaneous coronary intervention
344541|NCT01472692|Prehypertension|prehypertension
344542|NCT01472692|Gout|gout
344543|NCT01472692|Puls Wave Velocity|puls wave velocity
344544|NCT01472692|Hypertension|hypertension
344545|NCT01472692|24 hour blood pressure|24 hour blood pressure
344546|NCT01472679|fat mass|fat mass
344547|NCT01472679|fat free mass|fat free mass
344548|NCT01472679|body mass index|body mass index
344549|NCT01472666|Medium chain fatty acids|medium chain fatty acids
344550|NCT01472666|Saturated fatty acids|saturated fatty acids
344551|NCT01472666|Whey protein|whey protein
344552|NCT01472666|Casein protein|casein protein
344553|NCT01472666|Metabolic syndrome|metabolic syndrome
344554|NCT01472666|Type 2 diabetes|type 2 diabetes
344555|NCT01472666|Cardiovascular disease|cardiovascular disease
344556|NCT01472666|Dairy products|dairy products
344557|NCT01472666|Dietary intervention|dietary intervention
344558|NCT01472653|Head and neck Cancer|head and neck cancer
344559|NCT01472653|Radiochemotherapy|radiochemotherapy
344560|NCT01472653|Radioimmunotherapy|radioimmunotherapy
344561|NCT01472653|Skin rush|skin rush
344562|NCT01472653|locoregional control|locoregional control
344563|NCT01472653|Survival|survival
344564|NCT01472653|Toxicity|toxicity
344565|NCT01472640|CHF, Diabetes; Liraglutid, Ecco|chf, diabetes; liraglutid, ecco
344566|NCT01472627|MM|mm
344567|NCT01472627|Bortezomib|bortezomib
344568|NCT01472627|Velcade|velcade
344569|NCT01472614|Type-2 diabetes mellitus|type-2 diabetes mellitus
344570|NCT01472614|Add-on therapy|add-on therapy
344571|NCT01472575|rotavirus|rotavirus
344572|NCT01472575|gastroenteritis|gastroenteritis
344573|NCT01472575|vaccination|vaccination
344574|NCT01472575|hospitalisation|hospitalisation
344575|NCT01472562|mantle cell lymphoma|mantle cell lymphoma
344576|NCT01472549|Preoperative|preoperative
344577|NCT01472549|Antiseptics|antiseptics
344578|NCT01472549|Comparative|comparative
344579|NCT01472549|Cost|cost
344580|NCT01472549|Effectiveness|effectiveness
344581|NCT01472536|Influenza|influenza
344582|NCT01472536|Non pharmaceutical intervention|non pharmaceutical intervention
344583|NCT01472536|Sequestration|sequestration
344584|NCT01472536|Social network|social network
344585|NCT01472510|Diabetic|diabetic
344586|NCT01472510|Macular|macular
344587|NCT01472510|Edema|edema
344588|NCT01472510|Ranibizumab|ranibizumab
344589|NCT01472510|anti-VEGF|anti-vegf
344590|NCT01472497|hypertension|hypertension
344591|NCT01472497|insulin resistance|insulin resistance
344592|NCT01472497|oral glucose tolerance test|oral glucose tolerance test
344593|NCT01472497|AGE|age
344594|NCT01472497|inflammatory cytokine|inflammatory cytokine
344595|NCT01472484|beans|beans
344596|NCT01472484|lpa mutant|lpa mutant
344597|NCT01472484|polyphenols|polyphenols
344598|NCT01472484|phytic acid|phytic acid
344599|NCT01472484|stable iron isotopes|stable iron isotopes
344600|NCT01472471|Childhood Asthma|childhood asthma
344601|NCT01472471|Oxidative stress|oxidative stress
344602|NCT01472471|Urinary 8-isoprostane|urinary 8-isoprostane
344603|NCT01472458|Cardiac arrest|cardiac arrest
344604|NCT01472458|Hypothermia|hypothermia
344605|NCT01472458|Post Cardiac Arrest Care|post cardiac arrest care
344819|NCT01471444|Busulfan|busulfan
344606|NCT01472458|Survivors of cardiac arrest|survivors of cardiac arrest
344607|NCT01472445|Vitamin D|vitamin d
344608|NCT01472445|Obesity|obesity
344609|NCT01472432|type 2 diabetes|type 2 diabetes
344610|NCT01472432|healing|healing
344611|NCT01472432|foot ulcers|foot ulcers
344612|NCT01472432|vildagliptin|vildagliptin
344613|NCT01472419|metastatic esophageal squamous cell carcinoma|metastatic esophageal squamous cell carcinoma
344614|NCT01472419|Fluoropyrimidine/platinum-based first-line chemotherapy|fluoropyrimidine/platinum-based first-line chemotherapy
344615|NCT01472419|prognosis|prognosis
344616|NCT01472406|type 1 diabetes mellitus|type 1 diabetes mellitus
344617|NCT01472406|closed-loop artificial pancreas|closed-loop artificial pancreas
344618|NCT01472393|creatine supplementation|creatine supplementation
344619|NCT01472393|bone mass|bone mass
344620|NCT01472393|postmenopausal women|postmenopausal women
344621|NCT01472393|muscle function|muscle function
344622|NCT01472393|bone markers|bone markers
344623|NCT01472354|HIV|hiv
344624|NCT01472354|Hepatitis C|hepatitis c
344625|NCT01472354|Decision-Making|decision-making
344626|NCT01472354|chronic|chronic
344627|NCT01472328|Oxidative stress|oxidative stress
344628|NCT01472328|Insulin resistance|insulin resistance
344629|NCT01472315|sleep apnea|sleep apnea
344630|NCT01472315|women|women
344631|NCT01472315|postmenopause|postmenopause
344632|NCT01472315|hormone treatment|hormone treatment
344633|NCT01472289|CLI|cli
344634|NCT01472289|Peripheral arterial disease|peripheral arterial disease
344635|NCT01472276|Behaviour change|behaviour change
344636|NCT01472276|Weight loss|weight loss
344637|NCT01472276|Cardiovascular risk|cardiovascular risk
344638|NCT01472276|Diet|diet
344639|NCT01472276|Physical activity|physical activity
344640|NCT01472276|Overweight|overweight
344641|NCT01472276|Obesity|obesity
344642|NCT01472276|Internet|internet
344643|NCT01472263|HTLV-1|htlv-1
344644|NCT01472263|tropical spastic paraparesis|tropical spastic paraparesis
344645|NCT01472263|Immune System Diseases|immune system diseases
344646|NCT01472263|Physical disability|physical disability
344647|NCT01472263|pentoxifylline|pentoxifylline
344648|NCT01472250|Advanced Gastric Cancer|advanced gastric cancer
344649|NCT01472250|chemotherapy|chemotherapy
344650|NCT01472250|quality of life|quality of life
344651|NCT01472250|treatment expense|treatment expense
344652|NCT01472250|patients accepted first-line chemotherapy|patients accepted first-line chemotherapy
344653|NCT01472224|Transcranial ultrasound|transcranial ultrasound
344654|NCT01472224|Haematoma expansion|haematoma expansion
344656|NCT01472198|Gilead|gilead
344657|NCT01472198|Gilead Sciences|gilead sciences
344658|NCT01472198|Pancreatic Cancer|pancreatic cancer
344659|NCT01472198|PC|pc
344660|NCT01472198|Gemcitabine|gemcitabine
344661|NCT01472198|Phase 2|phase 2
344662|NCT01472198|Phase II|phase ii
344663|NCT01472198|GS-6624|gs-6624
344664|NCT01472198|Oncology|oncology
344665|NCT01472198|Monoclonal Antibody|monoclonal antibody
344666|NCT01472185|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
344667|NCT01472172|Flex-rigid pleuroscopy|flex-rigid pleuroscopy
344668|NCT01472172|cryobiopsy|cryobiopsy
344669|NCT01472172|pleural biopsy|pleural biopsy
344670|NCT01472172|pleural effusion|pleural effusion
344671|NCT01472172|safety|safety
344672|NCT01472172|thoracoscopy|thoracoscopy
344673|NCT01472146|Neoadjuvant therapy|neoadjuvant therapy
344674|NCT01472146|Breast cancer HER2 positive|breast cancer her2 positive
344675|NCT01472146|zolendronic acid|zolendronic acid
344676|NCT01472133|Respiration Rate|respiration rate
344677|NCT01472133|ECG|ecg
344678|NCT01472133|Pulse oximetry|pulse oximetry
344679|NCT01472133|Photoplethysmograph|photoplethysmograph
344680|NCT01472133|PPG|ppg
344681|NCT01472133|Physiology|physiology
344682|NCT01471990|PACAP38|pacap38
344683|NCT01471990|MMA|mma
344684|NCT01471990|migraine|migraine
344685|NCT01471990|angiography|angiography
344686|NCT01471990|VIP|vip
344687|NCT01471990|vasodilatation|vasodilatation
344688|NCT01471912|Macular Holes|macular holes
344689|NCT01471912|spectral domain optical coherence tomography|spectral domain optical coherence tomography
344690|NCT01471912|elongation of foveal tissue|elongation of foveal tissue
344691|NCT01471912|M-score|m-score
344692|NCT01471873|Posterior corneal surface elevation|posterior corneal surface elevation
344693|NCT01471873|Pentacam-Scheimpflung imaging|pentacam-scheimpflung imaging
344694|NCT01471873|variability|variability
344695|NCT01471873|progressive keratoconus|progressive keratoconus
344696|NCT01471873|corneal cross-linking|corneal cross-linking
344697|NCT01471847|Locally advanced|locally advanced
344698|NCT01471847|metastatic|metastatic
344699|NCT01471847|breast cancer|breast cancer
344700|NCT01471847|HER2 positive|her2 positive
344701|NCT01471847|PI3K|pi3k
344702|NCT01471847|mTOR|mtor
344703|NCT01471847|trastuzumab|trastuzumab
344704|NCT01471847|targeted therapy|targeted therapy
344705|NCT01471847|LABC|labc
344706|NCT01471847|MBC|mbc
344707|NCT01471782|ALL|all
344708|NCT01471782|relapsed, refractory B-precursor ALL|relapsed, refractory b-precursor all
344709|NCT01471782|Leukemia|leukemia
344710|NCT01471782|Leukemia, Lymphoid|leukemia, lymphoid
344711|NCT01471782|Precursor Cell Lymphoblastic Leukemia|precursor cell lymphoblastic leukemia
344712|NCT01471782|Neoplasms by Histologic Type|neoplasms by histologic type
344713|NCT01471782|Neoplasms|neoplasms
344714|NCT01471782|Lymphoproliferative Disorders|lymphoproliferative disorders
344715|NCT01471782|Lymphatic Diseases|lymphatic diseases
344716|NCT01471782|Immunoproliferative Disorders|immunoproliferative disorders
344717|NCT01471782|Antibodies, Bispecific|antibodies, bispecific
344718|NCT01471769|pediatric|pediatric
344719|NCT01471769|pain|pain
344720|NCT01471756|sessile neoplasms|sessile neoplasms
344721|NCT01471756|flat neoplasms|flat neoplasms
344722|NCT01471756|gastric cancer|gastric cancer
344723|NCT01471743|nutrition|nutrition
344724|NCT01471743|surgery|surgery
344725|NCT01471743|immune|immune
344726|NCT01471730|Transfusions|transfusions
344727|NCT01471730|Fresh Frozen Plasma|fresh frozen plasma
344728|NCT01471730|Fibrinogen|fibrinogen
344729|NCT01471730|Prothrombin complex|prothrombin complex
344730|NCT01471717|PK|pk
344731|NCT01471717|pharmacokinetics|pharmacokinetics
344732|NCT01471717|INX08189|inx08189
344733|NCT01471717|Victrelis|victrelis
344734|NCT01471717|Inhibitex|inhibitex
344735|NCT01471704|Pharmacokinetics|pharmacokinetics
344736|NCT01471704|PK|pk
344737|NCT01471704|INX08189|inx08189
344738|NCT01471704|Verapamil|verapamil
344740|NCT01471678|Cross-over design|cross-over design
344741|NCT01471678|Pilot bioequivalence|pilot bioequivalence
344742|NCT01471678|North east Asian ancestry|north east asian ancestry
344743|NCT01471678|GI198745|gi198745
344744|NCT01471678|Tamsulosin hydrochloride|tamsulosin hydrochloride
344745|NCT01471678|healthy male subjects|healthy male subjects
344746|NCT01471678|Bioequivalence|bioequivalence
344747|NCT01471678|Dutasteride|dutasteride
344748|NCT01471652|myalgic encephalopathy|myalgic encephalopathy
344749|NCT01471652|chronic fatigue syndrome|chronic fatigue syndrome
344750|NCT01471652|post viral infection|post viral infection
344751|NCT01471652|fatigue|fatigue
344752|NCT01471652|muscle pain|muscle pain
344753|NCT01471652|unrefreshing sleep|unrefreshing sleep
344754|NCT01471652|fuzzy thought|fuzzy thought
344755|NCT01471652|poor memory|poor memory
344756|NCT01471652|forgetfulness|forgetfulness
344757|NCT01471639|18 years and older,|18 years and older,
344758|NCT01471639|previously healthy|previously healthy
344759|NCT01471639|men and nonpregnant women|men and nonpregnant women
344760|NCT01471639|emergency department|emergency department
344761|NCT01471626|sleep apnea|sleep apnea
344762|NCT01471626|polysomnography|polysomnography
344763|NCT01471626|telemedicine|telemedicine
344764|NCT01471613|spinal cord injury|spinal cord injury
344765|NCT01471613|umbilical cord blood cell|umbilical cord blood cell
344766|NCT01471613|cell transplant|cell transplant
344767|NCT01471613|lithium carbonate|lithium carbonate
344768|NCT01471600|upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
344769|NCT01471600|general anesthesia|general anesthesia
344770|NCT01471561|Osmolarity|osmolarity
344771|NCT01471561|Cataract|cataract
344772|NCT01471561|Dry Eye|dry eye
344773|NCT01471548|tumor|tumor
344774|NCT01471548|cancer|cancer
344775|NCT01471548|phase1|phase1
344776|NCT01471548|TKI258|tki258
344777|NCT01471535|chronic hepatitis B|chronic hepatitis b
344778|NCT01471509|Glycemic Index|glycemic index
344779|NCT01471509|LoBAG Diet|lobag diet
344780|NCT01471509|Insulin|insulin
344781|NCT01471509|Glucagon|glucagon
344782|NCT01471496|duodenal ulcer|duodenal ulcer
344783|NCT01471496|upper gastrointestinal system bleeding|upper gastrointestinal system bleeding
335441|NCT01510340|HIV|hiv
344784|NCT01471496|injection therapy|injection therapy
344785|NCT01471483|Geriatric Assessment|geriatric assessment
344786|NCT01471483|Quality of Life|quality of life
344787|NCT01471483|11-164|11-164
344788|NCT01471483|Fallopian Tubes|fallopian tubes
344789|NCT01471470|Advanced gastric cancer|advanced gastric cancer
344790|NCT01471470|Neoadjuvant|neoadjuvant
344791|NCT01471470|Bevacizumab|bevacizumab
344792|NCT01471457|bacterial|bacterial
344793|NCT01471457|vaginosis|vaginosis
344794|NCT01471457|pessary|pessary
344795|NCT01471457|discharge|discharge
344796|NCT01471444|Blood And Marrow Transplantation|blood and marrow transplantation
344797|NCT01471444|Leukemia|leukemia
344798|NCT01471444|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
344799|NCT01471444|Acute myeloid leukemia|acute myeloid leukemia
344800|NCT01471444|AML|aml
344801|NCT01471444|Myelodysplastic syndrome|myelodysplastic syndrome
344802|NCT01471444|MDS|mds
344803|NCT01471444|Progression free survival|progression free survival
344804|NCT01471444|Rate of engraftment|rate of engraftment
344805|NCT01471444|Toxicity|toxicity
344806|NCT01471444|Relapse rate|relapse rate
344807|NCT01471444|Graft-vs-host disease|graft-vs-host disease
344808|NCT01471444|GvHD|gvhd
344809|NCT01471444|Progression-free survival|progression-free survival
344810|NCT01471444|PFS|pfs
344811|NCT01471444|Overall survival|overall survival
344812|NCT01471444|OS|os
344813|NCT01471444|Fludarabine|fludarabine
344817|NCT01471444|Clofarex|clofarex
344820|NCT01471444|Busulfex|busulfex
344821|NCT01471444|Myleran|myleran
344822|NCT01471444|Thymoglobulin|thymoglobulin
344823|NCT01471444|ATG|atg
344824|NCT01471444|Antithymocyte Globulin|antithymocyte globulin
344825|NCT01471444|Methotrexate|methotrexate
344826|NCT01471444|Tacrolimus|tacrolimus
344827|NCT01471444|Prograf|prograf
344829|NCT01471418|orofacial pain|orofacial pain
344830|NCT01471418|synovitis|synovitis
344831|NCT01471418|arthroscopy|arthroscopy
344832|NCT01471392|Identigene|identigene
344833|NCT01471392|STD Test|std test
344834|NCT01471392|Chlamydia|chlamydia
344835|NCT01471392|Gonorrhoeae|gonorrhoeae
344836|NCT01471392|APTIMA|aptima
344837|NCT01471392|Sexually Transmitted Disease|sexually transmitted disease
344838|NCT01471379|Irritable Bowel Syndrome|irritable bowel syndrome
344839|NCT01471379|IBS|ibs
344840|NCT01471379|Savella|savella
344841|NCT01471379|Milnacipran|milnacipran
344842|NCT01471379|Abdominal Pain|abdominal pain
344843|NCT01471366|Hyperlipidemias|hyperlipidemias
344844|NCT01471366|Dyslipidemias|dyslipidemias
344845|NCT01471366|Fatty Acids, Omega-3|fatty acids, omega-3
344846|NCT01471366|Fish Oils|fish oils
344847|NCT01471353|Metastatic|metastatic
344848|NCT01471353|Colon Cancer|colon cancer
344849|NCT01471353|Rectal Cancer|rectal cancer
344850|NCT01471301|systemic lupus erythematosus|systemic lupus erythematosus
344851|NCT01471301|rheumatoid arthritis|rheumatoid arthritis
344852|NCT01471288|well differentiated thyroid cancer|well differentiated thyroid cancer
344853|NCT01471288|Carum Carvi|carum carvi
344854|NCT01471288|Normal controls|normal controls
344855|NCT01471275|type 2 diabetes|type 2 diabetes
344856|NCT01471275|obesity|obesity
344857|NCT01471275|hypertriglyceridemia|hypertriglyceridemia
344858|NCT01471262|Complications|complications
344859|NCT01471262|Mortality|mortality
344860|NCT01471262|Liver|liver
344861|NCT01471262|Failure|failure
344865|NCT01471236|cartilage|cartilage
344866|NCT01471236|bone|bone
344867|NCT01471184|Allergic Rhinitis|allergic rhinitis
344868|NCT01471184|Conjunctivitis|conjunctivitis
344869|NCT01471184|Bitop|bitop
344870|NCT01471184|Eye|eye
344871|NCT01471184|Eye Drops|eye drops
344872|NCT01471184|Nasal Spray|nasal spray
344873|NCT01471184|Total Nasal Symptom Score|total nasal symptom score
344874|NCT01471184|Total Ocular Symptom Score|total ocular symptom score
344875|NCT01471184|AUC|auc
344876|NCT01471171|COPD|copd
344877|NCT01471171|Antimuscarinic|antimuscarinic
344878|NCT01471158|Primary open-angle glaucoma|primary open-angle glaucoma
344879|NCT01471158|ocular hypertension|ocular hypertension
344880|NCT01471158|pigment dispersion glaucoma|pigment dispersion glaucoma
344881|NCT01471145|opioid dependence|opioid dependence
344882|NCT01471145|heroin dependence|heroin dependence
344883|NCT01471145|extended release depot naltrexone|extended release depot naltrexone
344884|NCT01471145|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
344885|NCT01471145|dopamine transporter|dopamine transporter
344886|NCT01471145|Single Photon Emission Computed Tomography|single photon emission computed tomography
344887|NCT01471119|sublingual immunotherapy|sublingual immunotherapy
344888|NCT01471119|atopic dermatitis|atopic dermatitis
344889|NCT01471119|Dermatophagoides Farinae Drops|dermatophagoides farinae drops
344890|NCT01471106|Breast Cancer|breast cancer
344891|NCT01471106|Estrogen Receptor Negative Breast Cancer|estrogen receptor negative breast cancer
344892|NCT01471106|Biomarker studies|biomarker studies
344893|NCT01471106|Ki-67|ki-67
344894|NCT01471106|Dasatinib|dasatinib
344895|NCT01471106|BMS-354825|bms-354825
344896|NCT01471106|Sprycel|sprycel
344897|NCT01471080|laparoscopic hepatectomy|laparoscopic hepatectomy
344898|NCT01471080|radio-frequency ablation|radio-frequency ablation
344899|NCT01471080|giant cavernous hemangiomas|giant cavernous hemangiomas
344900|NCT01471080|liver|liver
344901|NCT01471067|Blood And Marrow Transplantation|blood and marrow transplantation
344902|NCT01471067|Leukemia|leukemia
344903|NCT01471067|Lymphoma|lymphoma
344904|NCT01471067|Pediatrics|pediatrics
344905|NCT01471067|Cord blood transplant|cord blood transplant
344906|NCT01471067|Cord Blood Fucosylation|cord blood fucosylation
344907|NCT01471067|Hematologic Malignancies|hematologic malignancies
344908|NCT01471067|Acute Myelogenous Leukemia|acute myelogenous leukemia
344909|NCT01471067|AML|aml
344910|NCT01471067|Myelodysplastic Syndrome|myelodysplastic syndrome
344911|NCT01471067|MDS|mds
344912|NCT01471067|High-risk cytogenetics|high-risk cytogenetics
344913|NCT01471067|Secondary leukemia from prior chemotherapy|secondary leukemia from prior chemotherapy
344914|NCT01471067|Langerhan's cell histiocytosis|langerhan's cell histiocytosis
344915|NCT01471067|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
344916|NCT01471067|ALL|all
344917|NCT01471067|complete remission|complete remission
344918|NCT01471067|Philadelphia chromosome|philadelphia chromosome
344919|NCT01471067|translocation 4;11|translocation 4;11
344920|NCT01471067|Hypodiploidy|hypodiploidy
344921|NCT01471067|Chronic Myeloid Leukemia|chronic myeloid leukemia
344922|NCT01471067|CML|cml
344923|NCT01471067|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
344924|NCT01471067|NHL|nhl
344925|NCT01471067|Hodgkin's Disease|hodgkin's disease
344926|NCT01471067|HD|hd
344927|NCT01471067|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
344928|NCT01471067|CLL|cll
344929|NCT01471067|Melphalan|melphalan
344931|NCT01471067|Thiotepa|thiotepa
344932|NCT01471067|Fludarabine|fludarabine
344933|NCT01471067|Fludarabine Phosphate|fludarabine phosphate
344934|NCT01471067|Fludara|fludara
344935|NCT01471067|Mycophenolate Mofetil|mycophenolate mofetil
344936|NCT01471067|MMF|mmf
344937|NCT01471067|CellCept|cellcept
344938|NCT01471067|Tacrolimus|tacrolimus
344939|NCT01471067|Prograf|prograf
344940|NCT01471067|Rituximab|rituximab
344941|NCT01471067|Rituxan|rituxan
344942|NCT01471067|ATG|atg
344943|NCT01471067|Antithymocyte Globulin|antithymocyte globulin
344944|NCT01471067|Thymoglobulin|thymoglobulin
344945|NCT01471054|Plaque radiotherapy|plaque radiotherapy
344946|NCT01471054|Brachytherapy|brachytherapy
344947|NCT01471054|Macular edema|macular edema
344948|NCT01471054|Cystoid macular edema|cystoid macular edema
344949|NCT01471054|Uveal melanoma|uveal melanoma
344950|NCT01471054|Radiation maculopathy|radiation maculopathy
344951|NCT01471054|Radiation retinopathy|radiation retinopathy
344952|NCT01471054|Ozurdex|ozurdex
344953|NCT01471054|Dexamethasone intravitreal implant|dexamethasone intravitreal implant
344954|NCT01471041|End Stage Renal Disease|end stage renal disease
344955|NCT01471041|Hemodialysis|hemodialysis
344956|NCT01471041|AV fistula|av fistula
344957|NCT01471041|Kidney failure|kidney failure
344958|NCT01471028|Acute alcoholic hepatitis|acute alcoholic hepatitis
344959|NCT01471028|alcoholic|alcoholic
344960|NCT01471028|hepatitis|hepatitis
344961|NCT01471028|liver|liver
344962|NCT01471015|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
344963|NCT01471015|Cooling Therapy|cooling therapy
344964|NCT01471015|HIE|hie
344965|NCT01470989|gouty arthritis|gouty arthritis
344966|NCT01470976|Goal-directed therapy|goal-directed therapy
344967|NCT01470976|Hemodynamic optimization|hemodynamic optimization
344968|NCT01470976|Cardiac surgery|cardiac surgery
344969|NCT01470963|Referral|referral
344970|NCT01470963|Quality of Health Care|quality of health care
344971|NCT01470950|Functional Electrical Stimulation|functional electrical stimulation
344972|NCT01470950|Signalling Pathways|signalling pathways
344973|NCT01470937|diabetes acarbose alphaglucosidase prevention|diabetes acarbose alphaglucosidase prevention
344974|NCT01470924|acute lymphoblastic leukemia|acute lymphoblastic leukemia
344975|NCT01470924|relapse|relapse
344976|NCT01470924|salvage|salvage
344977|NCT01470924|prognostic|prognostic
344978|NCT01470911|Antisense oligonucleotide|antisense oligonucleotide
344979|NCT01470911|Asthma|asthma
344980|NCT01470911|Healthy subjects|healthy subjects
344981|NCT01470911|Phase 1|phase 1
344982|NCT01470911|Transcription factor GATA-3|transcription factor gata-3
344983|NCT01470911|Oral inhalation|oral inhalation
344984|NCT01470898|bispectral index monitoring|bispectral index monitoring
344985|NCT01470898|extubation|extubation
344986|NCT01470898|analgesia|analgesia
344987|NCT01470898|abdominal surgery|abdominal surgery
344988|NCT01470885|glucose|glucose
344989|NCT01470885|prognosis|prognosis
344990|NCT01470885|glycated hemoglobin|glycated hemoglobin
344991|NCT01470859|De Novo parkinson's disease|de novo parkinson's disease
344992|NCT01470859|initial treatment|initial treatment
344993|NCT01470859|pramipexole|pramipexole
344994|NCT01470859|Levodopa|levodopa
335634|NCT01509508|HIV|hiv
344995|NCT01470859|Parkinson's disease-related spatial covariance pattern|parkinson's disease-related spatial covariance pattern
344996|NCT01470846|epidural analgesia|epidural analgesia
344997|NCT01470846|morphin analgesia|morphin analgesia
344998|NCT01470846|laparotomy|laparotomy
344999|NCT01470833|Achilles tendon|achilles tendon
345000|NCT01470833|rupture|rupture
345001|NCT01470833|non-operative|non-operative
345002|NCT01470833|treatment|treatment
345003|NCT01470820|Neonates|neonates
345004|NCT01470820|Hyperbilirubinemia|hyperbilirubinemia
345005|NCT01470820|Phototherapy|phototherapy
345006|NCT01470820|Light irradiance|light irradiance
345007|NCT01470820|Saturation point|saturation point
345008|NCT01470807|Artificial Pancreas|artificial pancreas
345009|NCT01470807|Insulin Pump|insulin pump
345010|NCT01470807|Continuous Glucose Monitor|continuous glucose monitor
345011|NCT01470807|Closed Loop|closed loop
345012|NCT01470794|GBM|gbm
345013|NCT01470794|HGG|hgg
345014|NCT01470794|High grade glioma|high grade glioma
345015|NCT01470794|Malignant glioma|malignant glioma
345016|NCT01470794|Grade III glioma|grade iii glioma
345017|NCT01470794|Grad IV glioma|grad iv glioma
345018|NCT01470781|Bipolar Disorder|bipolar disorder
345019|NCT01470781|Psychosis|psychosis
345020|NCT01470781|Cognition|cognition
345021|NCT01470781|Cognitive Remediation|cognitive remediation
345022|NCT01470755|Pediatrics|pediatrics
345023|NCT01470755|Bronchial wheeze|bronchial wheeze
345024|NCT01470755|bronchodilator|bronchodilator
345025|NCT01470755|lung function|lung function
345026|NCT01470755|airway resistance|airway resistance
345027|NCT01470729|Spinocerebellar ataxia, energy metabolism, NMR spectroscopy|spinocerebellar ataxia, energy metabolism, nmr spectroscopy
345028|NCT01470716|EGFR mutation|egfr mutation
345029|NCT01470716|NSCLC|nsclc
345030|NCT01470703|Acute Respiratory Distress Syndrome,|acute respiratory distress syndrome,
345031|NCT01470703|ECMO, Extracorporeal Membrane Oxygenation|ecmo, extracorporeal membrane oxygenation
345032|NCT01470703|Randomized controlled trial|randomized controlled trial
345033|NCT01470703|Positive-Pressure ventilation|positive-pressure ventilation
345034|NCT01470703|Survival Rate|survival rate
345035|NCT01470690|HVC infection|hvc infection
345036|NCT01470690|gastric acid-related disorders|gastric acid-related disorders
345037|NCT01470690|proton pump inhibitor|proton pump inhibitor
345038|NCT01470690|interaction|interaction
345039|NCT01470690|pharmacokinetics|pharmacokinetics
345040|NCT01470690|boceprevir|boceprevir
345041|NCT01470690|omeprazole|omeprazole
345042|NCT01470677|lymph cyst|lymph cyst
345043|NCT01470677|lymphocele|lymphocele
345044|NCT01470677|fibrin|fibrin
345045|NCT01470677|collagen|collagen
345046|NCT01470677|prevention|prevention
345047|NCT01470677|cancer|cancer
345048|NCT01470651|HCV+|hcv+
345049|NCT01470651|HCV treatment|hcv treatment
345050|NCT01470651|Fatigue|fatigue
345051|NCT01470651|patients starting alpha interferon/ribavirin treatment|patients starting alpha interferon/ribavirin treatment
345052|NCT01470638|Flt3-L|flt3-l
345054|NCT01470625|Dying|dying
345055|NCT01470625|Patients|patients
345056|NCT01470625|Hospice|hospice
345057|NCT01470625|Liverpool Care Pathways|liverpool care pathways
345058|NCT01470612|Ulcerative colitis|ulcerative colitis
345059|NCT01470612|open-label|open-label
345060|NCT01470612|long term treatment|long term treatment
345061|NCT01470586|Colorectal cancer|colorectal cancer
345062|NCT01470586|Surgical resection|surgical resection
345063|NCT01470586|Oxidative Stress Markers|oxidative stress markers
345064|NCT01470586|Controls|controls
345065|NCT01470560|Mindfulness|mindfulness
345066|NCT01470560|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
345067|NCT01470560|Meditation|meditation
345068|NCT01470560|Yoga|yoga
345069|NCT01470547|Liver Cirrhosis|liver cirrhosis
345070|NCT01470547|Portal Vein Thrombosis|portal vein thrombosis
345071|NCT01470547|Cirrhosis Complications|cirrhosis complications
345072|NCT01470547|Registry|registry
345073|NCT01470547|Italian|italian
345074|NCT01470534|Dietary supplement|dietary supplement
345075|NCT01470534|Carbohydrate loading|carbohydrate loading
345076|NCT01470534|Insulin resistance|insulin resistance
345077|NCT01470534|Surgery|surgery
345078|NCT01470521|Multiple sclerosis|multiple sclerosis
345079|NCT01470521|Hookworm larvae|hookworm larvae
345080|NCT01470521|Necator americanus|necator americanus
345081|NCT01470521|Treg cells|treg cells
345082|NCT01470508|Bulimia|bulimia
345083|NCT01470508|Binge-Eating Disorder|binge-eating disorder
345084|NCT01470508|Eating Disorders|eating disorders
345085|NCT01470482|Total knee|total knee
345086|NCT01470482|Tourniquet|tourniquet
345087|NCT01470482|Blood loss|blood loss
345088|NCT01470482|pain|pain
345089|NCT01470482|range of motion|range of motion
345090|NCT01470391|Adductor-Canal-Blockade|adductor-canal-blockade
345091|NCT01470391|Femoral Nerve Block|femoral nerve block
345092|NCT01470391|Postoperative Pain|postoperative pain
345093|NCT01470391|Total Knee Arthroplasty|total knee arthroplasty
345094|NCT01470378|Lymphedema|lymphedema
345095|NCT01470378|Magnetic Resonance Imaging|magnetic resonance imaging
345096|NCT01470378|Plastic Surgery|plastic surgery
345097|NCT01470352|migraine|migraine
345098|NCT01470352|pain|pain
345099|NCT01470352|CPM|cpm
345100|NCT01470352|offset analgesia|offset analgesia
345101|NCT01470352|fMRI|fmri
345102|NCT01470339|endogenous pain modulation|endogenous pain modulation
345103|NCT01470339|migraine|migraine
345104|NCT01470339|fMRI|fmri
345105|NCT01470339|duloxetine|duloxetine
345106|NCT01470339|preventive migraine treatment|preventive migraine treatment
345107|NCT01470326|Osteoporosis|osteoporosis
345108|NCT01470326|Post menopausal women|post menopausal women
345109|NCT01470326|SERM|serm
345110|NCT01470326|Japanese|japanese
345111|NCT01470326|Viviant|viviant
345112|NCT01470326|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
345113|NCT01470326|Long term treatment|long term treatment
345114|NCT01470313|Safety and tolerability|safety and tolerability
345115|NCT01470313|cutaneous lupus erythematosus|cutaneous lupus erythematosus
345116|NCT01470313|efficacy|efficacy
345117|NCT01470287|Infants,|infants,
345118|NCT01470287|Immunogenicity,|immunogenicity,
345119|NCT01470287|Safety|safety
345120|NCT01470274|Blood volume|blood volume
345121|NCT01470274|CO-rebreathing|co-rebreathing
345122|NCT01470274|COPD|copd
345123|NCT01470274|CVD|cvd
345124|NCT01470261|methylphenidate|methylphenidate
345125|NCT01470261|ritalin|ritalin
345126|NCT01470261|Attention Deficit Disorder|attention deficit disorder
345127|NCT01470248|Lung Cancer|lung cancer
345128|NCT01470248|Carcinoma, small cell|carcinoma, small cell
345129|NCT01470248|Trisenox|trisenox
345130|NCT01470248|Arsenic trioxide|arsenic trioxide
345131|NCT01470248|phase II trial|phase ii trial
345132|NCT01470235|screening|screening
345133|NCT01470235|genetic|genetic
345134|NCT01470235|cancer|cancer
345135|NCT01470222|Worksite|worksite
345136|NCT01470222|group weight loss|group weight loss
345137|NCT01470222|behavioral components|behavioral components
345138|NCT01470209|lung cancer with activated mTOR/PI3K pathway|lung cancer with activated mtor/pi3k pathway
345139|NCT01470209|alterations in PIK3CA, NF1, TSC1/TSC2, mTOR, KRAS, LKB1, PTEN|alterations in pik3ca, nf1, tsc1/tsc2, mtor, kras, lkb1, pten
345140|NCT01470196|WM|wm
345141|NCT01470196|untreated|untreated
345142|NCT01470196|symptomatic|symptomatic
345143|NCT01470183|Lupus Nephritis|lupus nephritis
345144|NCT01470170|Sedative bronchoscope|sedative bronchoscope
345145|NCT01470170|Alfentanil doses|alfentanil doses
345146|NCT01470170|Propofol|propofol
345147|NCT01470170|Targeted controlled infusion|targeted controlled infusion
345148|NCT01470170|Hypoxemia|hypoxemia
345149|NCT01470131|multiple myeloma|multiple myeloma
345150|NCT01470131|relapse|relapse
345151|NCT01470131|second line therapy|second line therapy
345152|NCT01470131|bortezomib|bortezomib
345153|NCT01470131|dexamethasone|dexamethasone
345154|NCT01470105|questionnaire|questionnaire
345155|NCT01470105|11-121|11-121
345156|NCT01470092|Menopause|menopause
345157|NCT01470092|Depression|depression
345158|NCT01470066|peripheral T cell lymphomas|peripheral t cell lymphomas
345159|NCT01470066|interim PET/CT|interim pet/ct
345160|NCT01470066|prognosis|prognosis
345161|NCT01470066|Positron-emission tomography/Computerized tomography|positron-emission tomography/computerized tomography
345162|NCT01470053|mometasone furoate|mometasone furoate
345163|NCT01470053|azelastine HCl|azelastine hcl
345164|NCT01470053|perennial allergic rhinitis|perennial allergic rhinitis
345165|NCT01470040|traumatic brain injury|traumatic brain injury
345166|NCT01470040|chronic subdural hematoma|chronic subdural hematoma
345167|NCT01470040|aspirin|aspirin
345168|NCT01470040|antiplatelet therapy|antiplatelet therapy
345169|NCT01470027|magnetic resonance spectroscopy|magnetic resonance spectroscopy
345170|NCT01470027|N-acetylcysteine|n-acetylcysteine
345171|NCT01470027|antioxidant|antioxidant
345172|NCT01470027|glutathione|glutathione
345173|NCT01470014|isolated left ventricular non-compaction|isolated left ventricular non-compaction
345174|NCT01470014|cardiac computed tomography|cardiac computed tomography
345175|NCT01470014|cardiac magnet resonance imaging|cardiac magnet resonance imaging
345176|NCT01470014|echocardiography|echocardiography
345177|NCT01469975|cancer|cancer
345178|NCT01469975|relapse or refractory|relapse or refractory
345179|NCT01469962|morbid obesity|morbid obesity
345180|NCT01469962|bariatric surgery|bariatric surgery
345181|NCT01469962|NASH|nash
345182|NCT01469962|Liver fibrosis|liver fibrosis
345183|NCT01469962|Fibrotest|fibrotest
345184|NCT01469949|Improvement of the accuracy of Lumbar repositioning|improvement of the accuracy of lumbar repositioning
345185|NCT01469936|Fibromyalgia|fibromyalgia
345186|NCT01469936|Irritable Bowel Syndrome|irritable bowel syndrome
345187|NCT01469923|Phase 1|phase 1
345188|NCT01469923|obese|obese
345189|NCT01469923|healthy male volunteers|healthy male volunteers
345190|NCT01469923|multiple doses|multiple doses
345191|NCT01469923|dose escalation|dose escalation
345192|NCT01469923|pharmacokinetics|pharmacokinetics
345193|NCT01469923|pharmakodynamics|pharmakodynamics
345194|NCT01469897|JIA|jia
345195|NCT01469897|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
345196|NCT01469897|Cost of Care|cost of care
345197|NCT01469897|Quality of Life|quality of life
345198|NCT01469897|QOL|qol
345199|NCT01469884|Renal allograft recipients|renal allograft recipients
345200|NCT01469884|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
345201|NCT01469884|Certican|certican
345202|NCT01469884|Calcineurin inhibitor(tacrolimus or cyclosporin)|calcineurin inhibitor(tacrolimus or cyclosporin)
345203|NCT01469871|Dressing|dressing
345204|NCT01469871|Blisters|blisters
345205|NCT01469871|Silicone|silicone
345206|NCT01469845|hospital admissions|hospital admissions
345207|NCT01469845|acute bronchiolitis|acute bronchiolitis
345208|NCT01469845|under one year old|under one year old
345209|NCT01469845|requiring oxygen therapy|requiring oxygen therapy
345210|NCT01469832|fundus flavimaculatus|fundus flavimaculatus
345211|NCT01469832|Retinal Diseases|retinal diseases
345212|NCT01469832|Macular Degeneration|macular degeneration
345213|NCT01469832|SMD|smd
345214|NCT01469832|juvenile macular dystrophy|juvenile macular dystrophy
345215|NCT01469819|chronic constipation|chronic constipation
345216|NCT01469819|constipation|constipation
345217|NCT01469819|idiopathic constipation|idiopathic constipation
345218|NCT01469819|SmartPill|smartpill
345219|NCT01469819|Wireless Motility Capsule|wireless motility capsule
345220|NCT01469819|lubiprostone (Amitiza)|lubiprostone (amitiza)
345221|NCT01469819|small intestinal bacterial overgrowth|small intestinal bacterial overgrowth
345222|NCT01469780|Pain|pain
345223|NCT01469780|Health behavior change|health behavior change
345224|NCT01469780|Coronary angioplasty|coronary angioplasty
345225|NCT01469780|Cardiovascular disease|cardiovascular disease
345226|NCT01469780|Outcomes|outcomes
345227|NCT01469780|Morbidity|morbidity
345228|NCT01469780|Mortality|mortality
345229|NCT01469767|eczema|eczema
345230|NCT01469767|itch|itch
345231|NCT01469767|scratching|scratching
345232|NCT01469767|actigraphy|actigraphy
345233|NCT01469767|adherence|adherence
345234|NCT01469754|lymphoma|lymphoma
345235|NCT01469754|survivors|survivors
345236|NCT01469754|posttraumatic growth|posttraumatic growth
345237|NCT01469754|posttraumatic stress|posttraumatic stress
345238|NCT01469754|longitudinal|longitudinal
345239|NCT01469728|VATS|vats
345240|NCT01469728|awake thoracic surgery|awake thoracic surgery
345241|NCT01469728|pleurodesis|pleurodesis
345242|NCT01469728|talc|talc
345243|NCT01469728|TEA|tea
345244|NCT01469728|epidural anesthesia|epidural anesthesia
345245|NCT01469728|Video-Assisted|video-assisted
345246|NCT01469728|Anesthesia Epidural|anesthesia epidural
345247|NCT01469715|Continuous Glucose Monitor|continuous glucose monitor
345248|NCT01469702|cat-scratch disease|cat-scratch disease
345249|NCT01469702|Bartonella henselae|bartonella henselae
345250|NCT01469702|corticosteroids|corticosteroids
345251|NCT01469702|treatment|treatment
345252|NCT01469689|People|people
345253|NCT01469689|living|living
345254|NCT01469689|community|community
345255|NCT01469676|Coronary Artery Bypass Surgery|coronary artery bypass surgery
345256|NCT01469676|Cardiopulmonary Bypass|cardiopulmonary bypass
345257|NCT01469676|Leukocyte Reduction Filtrations|leukocyte reduction filtrations
345258|NCT01469676|Pulmonary Function|pulmonary function
345259|NCT01469676|Systemic Inflammatory Response|systemic inflammatory response
345260|NCT01469663|Borderline Personality Disorder|borderline personality disorder
345261|NCT01469663|Major Depression|major depression
345262|NCT01469663|Electroencephalogram|electroencephalogram
345263|NCT01469663|N2|n2
345264|NCT01469663|Error Related Negativity|error related negativity
345265|NCT01469663|Emotional Processing|emotional processing
345266|NCT01469663|Levels of Emotional Awareness|levels of emotional awareness
345267|NCT01469650|vitamin D3|vitamin d3
345268|NCT01469650|prematurity|prematurity
345269|NCT01469650|parathyroid hormone|parathyroid hormone
345270|NCT01469650|25(OH)D|25(oh)d
345271|NCT01469650|NICU hospitalization|nicu hospitalization
345272|NCT01469624|Contrast Induced Nephropathy|contrast induced nephropathy
345273|NCT01469624|Pentoxifylline|pentoxifylline
345274|NCT01469624|PCI|pci
345275|NCT01469611|advanced/metastatic colorectal carcinoma|advanced/metastatic colorectal carcinoma
345276|NCT01469585|continuous oral contraceptives|continuous oral contraceptives
345277|NCT01469585|MMP expression|mmp expression
345278|NCT01469572|Neuroendocrine hepatic tumors|neuroendocrine hepatic tumors
345279|NCT01469572|Liver cancer|liver cancer
345280|NCT01469572|Metastatic liver cancer|metastatic liver cancer
345281|NCT01469559|Insulin|insulin
345282|NCT01469559|Diabetic neuropathy|diabetic neuropathy
345283|NCT01469559|Intranasal administration|intranasal administration
345284|NCT01469559|Pilot project|pilot project
345285|NCT01469546|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
345286|NCT01469533|Spine|spine
345287|NCT01469533|Manipulation|manipulation
345288|NCT01469533|Pain Threshold|pain threshold
345289|NCT01469533|Electromyography.|electromyography.
345290|NCT01469520|HIV|hiv
345291|NCT01469520|AIDS|aids
345292|NCT01469520|Treatment|treatment
345293|NCT01469494|DIEP flap|diep flap
345294|NCT01469494|SIEA flap|siea flap
345295|NCT01469494|breast reconstruction|breast reconstruction
345296|NCT01469494|objective isokinetic abdominal strength testing|objective isokinetic abdominal strength testing
345297|NCT01469494|fat necrosis|fat necrosis
345298|NCT01469494|flap loss|flap loss
345299|NCT01469494|seroma rate|seroma rate
345300|NCT01469494|abdominal wound breakdown|abdominal wound breakdown
345301|NCT01469494|Breast-Q|breast-q
345302|NCT01469494|abdominal wall outcome questionnaire|abdominal wall outcome questionnaire
345303|NCT01469481|diabetes mellitus|diabetes mellitus
345304|NCT01469481|ADME|adme
345305|NCT01469455|Local metastatic melanoma|local metastatic melanoma
345306|NCT01469455|relapsed cutaneous/subcutaneous tumors|relapsed cutaneous/subcutaneous tumors
345307|NCT01469455|melanoma-in-transit|melanoma-in-transit
345308|NCT01469442|Biliary fistula|biliary fistula
345309|NCT01469442|prevention|prevention
345310|NCT01469442|hepatectomy|hepatectomy
345311|NCT01469442|external stent|external stent
345312|NCT01469442|Hepatectomy of more 2 segments|hepatectomy of more 2 segments
345313|NCT01469442|Not emergency or laparoscopy surgery|not emergency or laparoscopy surgery
345314|NCT01469429|oral cancer|oral cancer
345315|NCT01469416|rosuvastatin|rosuvastatin
345316|NCT01469416|clopidogrel|clopidogrel
345317|NCT01469416|pharmacokinetics|pharmacokinetics
345318|NCT01469416|drug interaction|drug interaction
345319|NCT01469416|healthy volunteer|healthy volunteer
345320|NCT01469416|drug transporter|drug transporter
345321|NCT01469403|Osteoarthritis, knee|osteoarthritis, knee
345323|NCT01469403|Weight Loss|weight loss
345324|NCT01469403|Arthroplasty|arthroplasty
345325|NCT01469377|Major Depressive Disorder|major depressive disorder
345326|NCT01469377|Depression|depression
345327|NCT01469364|Lung Transplant|lung transplant
345328|NCT01469364|Lung Transplant Recipient|lung transplant recipient
345329|NCT01469351|Alzheimers disease|alzheimers disease
345330|NCT01469325|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
345331|NCT01469325|Depression|depression
345332|NCT01469325|left prefrontal|left prefrontal
345333|NCT01469312|Low Biologically Available Glucose Diet (LoBAG diet)|low biologically available glucose diet (lobag diet)
345334|NCT01469312|Diabetes|diabetes
345335|NCT01469312|Glycemic Index|glycemic index
345336|NCT01469299|Ligament Balance, Total Knee Arthroplasty, Intra-operative Sensors|ligament balance, total knee arthroplasty, intra-operative sensors
345337|NCT01469286|delayed gastric emptying|delayed gastric emptying
345339|NCT01469286|vomiting|vomiting
345340|NCT01469286|abdominal discomfort|abdominal discomfort
345341|NCT01469273|Diarrhea|diarrhea
345342|NCT01469273|EcN|ecn
345343|NCT01469273|E. coli strain Nissle 1917|e. coli strain nissle 1917
345344|NCT01469273|Gastrointestinal infection|gastrointestinal infection
345345|NCT01469273|Infant|infant
345346|NCT01469273|Newborn|newborn
345347|NCT01469273|Probiotic drug|probiotic drug
345348|NCT01469273|Prevention|prevention
345349|NCT01469273|Prophylaxis|prophylaxis
345350|NCT01469260|Overweight|overweight
345351|NCT01469260|Obesity|obesity
345352|NCT01469260|Pregnancy|pregnancy
345353|NCT01469260|Weight gain|weight gain
345354|NCT01469260|Pedometer|pedometer
345355|NCT01469260|Exercise|exercise
345356|NCT01469247|Brain cancer|brain cancer
345357|NCT01469247|Recurrent or progressive brainstem glioma|recurrent or progressive brainstem glioma
345358|NCT01469247|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
345359|NCT01469247|DIPG|dipg
345360|NCT01469247|Reirradiation|reirradiation
345361|NCT01469247|ReRT|rert
345362|NCT01469247|Photon radiation therapy|photon radiation therapy
345364|NCT01469221|Bladder Cancer|bladder cancer
345365|NCT01469221|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
345366|NCT01469221|NMIBC|nmibc
345367|NCT01469221|Apaziquone|apaziquone
345368|NCT01469221|EOquin|eoquin
345369|NCT01469221|GU Cancer|gu cancer
345370|NCT01469221|TURBT|turbt
345371|NCT01469208|Gastroschisis|gastroschisis
345372|NCT01469208|NICU inpatients|nicu inpatients
345373|NCT01469208|Post surgical repair|post surgical repair
345374|NCT01469208|Music Therapy|music therapy
345375|NCT01469195|lead rectangle|lead rectangle
345376|NCT01469195|radiation exposure|radiation exposure
345377|NCT01469195|operators|operators
345378|NCT01469195|radial approach|radial approach
345379|NCT01469195|coronary procedures|coronary procedures
345380|NCT01469195|percutaneous coronary intervention|percutaneous coronary intervention
345381|NCT01469182|Immunology|immunology
345382|NCT01469169|Iloprost|iloprost
345383|NCT01469169|Inhalation|inhalation
345384|NCT01469169|Pulmonary Hypertension|pulmonary hypertension
345385|NCT01469169|Pulmonary Artery Hypertension|pulmonary artery hypertension
345386|NCT01469169|Japanese Patients|japanese patients
345387|NCT01469156|polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
345388|NCT01469156|choroidal neovascularization|choroidal neovascularization
345389|NCT01469156|ranibizumab|ranibizumab
345390|NCT01469156|Lucentis|lucentis
345391|NCT01469130|MEK, Advanced solid tumor|mek, advanced solid tumor
345392|NCT01469117|Developmental disabilities|developmental disabilities
345393|NCT01469117|Enteral Nutrition|enteral nutrition
345394|NCT01469117|Tube feeding|tube feeding
345395|NCT01469117|Nutrition support|nutrition support
345396|NCT01469104|Diabetes|diabetes
345397|NCT01469091|Acute admittance|acute admittance
345398|NCT01469091|Current smoker|current smoker
345399|NCT01469078|Chronic Kidney Disease|chronic kidney disease
345400|NCT01469078|CKD stage 5|ckd stage 5
345401|NCT01469078|Iron deficiency|iron deficiency
345402|NCT01469065|inpatient|inpatient
345403|NCT01469065|diabetes|diabetes
345404|NCT01469065|phase 1|phase 1
345405|NCT01469039|Alkermes|alkermes
345406|NCT01469039|schizophrenia|schizophrenia
345407|NCT01469039|ALKS 9072|alks 9072
345408|NCT01469039|ALKS 9070|alks 9070
345409|NCT01469039|aripiprazole lauroxil|aripiprazole lauroxil
345410|NCT01468948|Essential Tremor|essential tremor
345411|NCT01468948|Tremor|tremor
345412|NCT01468948|Octanol|octanol
345413|NCT01468948|Octanoic Acid|octanoic acid
345414|NCT01468935|Uterus|uterus
345415|NCT01468935|Endometrium|endometrium
345416|NCT01468935|Bone Marrow Transplant|bone marrow transplant
345417|NCT01468935|Gynecology|gynecology
345418|NCT01468935|Healthy Volunteer|healthy volunteer
345420|NCT01468935|Stem Cell Transplant|stem cell transplant
345421|NCT01468935|Endometriosis|endometriosis
345422|NCT01468922|Pazopanib|pazopanib
345423|NCT01468922|Tivantinib|tivantinib
345424|NCT01468922|MET Inhibitor|met inhibitor
345425|NCT01468922|Advanced Cancer|advanced cancer
345426|NCT01468922|Anti-Angiogenesis|anti-angiogenesis
345427|NCT01468922|Cancer|cancer
345428|NCT01468922|Solid Tumor|solid tumor
345429|NCT01468922|Sarcoma|sarcoma
345430|NCT01468883|Breast Cancer|breast cancer
345431|NCT01468883|Surgery|surgery
345432|NCT01468883|Radiation|radiation
345433|NCT01468857|Clinical Stress Markers|clinical stress markers
345434|NCT01468857|Chronic Stress|chronic stress
751932|NCT01171274|proprioception|proprioception
345435|NCT01468857|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
345436|NCT01468857|HSCT Caregivers|hsct caregivers
345437|NCT01468857|Cancer Caregivers|cancer caregivers
345438|NCT01468857|Stress|stress
345439|NCT01468857|Family Caregivers|family caregivers
345440|NCT01468844|Central Retinal Vein Occlusion|central retinal vein occlusion
345441|NCT01468844|Minocycline|minocycline
345442|NCT01468844|Retinal Vein Occlusion|retinal vein occlusion
345443|NCT01468844|CRVO|crvo
345444|NCT01468831|Branch Retinal Vein Occlusion|branch retinal vein occlusion
345445|NCT01468831|Minocycline|minocycline
345446|NCT01468831|Macular Edema|macular edema
345447|NCT01468831|Retinal Vein Occlusion|retinal vein occlusion
345448|NCT01468831|BRVO|brvo
345449|NCT01468818|Metastatic Melanoma|metastatic melanoma
345450|NCT01468818|Adoptive Cell Therapy|adoptive cell therapy
345451|NCT01468818|Skin Cancer|skin cancer
345452|NCT01468805|Environmental Intervention|environmental intervention
345453|NCT01468805|Indoor Allergens|indoor allergens
345454|NCT01468805|Cockroach|cockroach
345455|NCT01468805|Health Disparities|health disparities
345456|NCT01468805|Multi-Center|multi-center
345457|NCT01468805|Asthma|asthma
345458|NCT01468805|Environment|environment
345459|NCT01468792|systemic sclerosis|systemic sclerosis
345460|NCT01468792|pulmonary arterial hypertension|pulmonary arterial hypertension
345461|NCT01468779|Periampullary cancer|periampullary cancer
345462|NCT01468779|Surgery|surgery
345463|NCT01468779|Dietary supplementation|dietary supplementation
345464|NCT01468779|Nutritional assessment|nutritional assessment
345465|NCT01468753|Conception in HIV Discordant Couples|conception in hiv discordant couples
345466|NCT01468753|Reproduction in HIV Discordant Couples|reproduction in hiv discordant couples
345467|NCT01468753|Vaginal Insemination|vaginal insemination
345468|NCT01468727|dental caries|dental caries
345469|NCT01468727|mutans streptococci|mutans streptococci
345470|NCT01468727|lactobacilli|lactobacilli
345471|NCT01468727|bacterial transmission|bacterial transmission
345472|NCT01468727|bacterial colonization|bacterial colonization
345473|NCT01468714|Drug Interaction|drug interaction
345474|NCT01468714|pharmacokinetics|pharmacokinetics
345475|NCT01468714|ketoconazole|ketoconazole
345476|NCT01468714|CYP3A|cyp3a
345477|NCT01468688|Imatinib mesylate|imatinib mesylate
345478|NCT01468688|BKM120|bkm120
345479|NCT01468688|GIST|gist
345480|NCT01468649|Breast Cancer|breast cancer
345481|NCT01468649|Sentinel Lymph Node Mapping|sentinel lymph node mapping
345482|NCT01468649|Intraoperative Imaging|intraoperative imaging
345483|NCT01468636|Warts|warts
345485|NCT01468636|Zinc|zinc
345486|NCT01468623|Colorectal cancer, metastatic|colorectal cancer, metastatic
345487|NCT01468623|FOLFOX6|folfox6
345488|NCT01468623|5-FU|5-fu
345489|NCT01468623|First line|first line
345490|NCT01468623|bevacizumab|bevacizumab
345491|NCT01468610|depression|depression
345492|NCT01468610|cognition|cognition
345493|NCT01468610|occupational functioning|occupational functioning
345494|NCT01468610|productivity|productivity
345495|NCT01468610|neuropsychology|neuropsychology
345496|NCT01468610|desvenlafaxine|desvenlafaxine
345497|NCT01468610|antidepressants|antidepressants
345498|NCT01468597|Emergent|emergent
345499|NCT01468597|Cardiac surgery|cardiac surgery
345500|NCT01468597|On-pump|on-pump
345501|NCT01468597|Platelet function|platelet function
345502|NCT01468584|Genotype 2|genotype 2
345503|NCT01468571|Potassium Sparing Diuretics|potassium sparing diuretics
345504|NCT01468571|Right-sided heart failure|right-sided heart failure
345505|NCT01468571|Edema|edema
345506|NCT01468558|Drug Drug Interaction Study in Normal Healthy Volunteers|drug drug interaction study in normal healthy volunteers
345507|NCT01468545|Education|education
345508|NCT01468545|Ventavis|ventavis
345509|NCT01468545|Adherence|adherence
345510|NCT01468545|PAH|pah
345511|NCT01468545|Pulmonary artery hypertension|pulmonary artery hypertension
345512|NCT01468519|Diabetes mellitus, type 2|diabetes mellitus, type 2
345513|NCT01468519|Erectile dysfunction|erectile dysfunction
345514|NCT01468519|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
345515|NCT01468519|CSII|csii
345516|NCT01468519|insulin|insulin
345517|NCT01468506|Chronic Kidney Disease|chronic kidney disease
345518|NCT01468506|arteriovenous fistula|arteriovenous fistula
345519|NCT01468493|FSGS|fsgs
345520|NCT01468493|suPAR|supar
345521|NCT01468480|direct pulp capping|direct pulp capping
345522|NCT01468480|MTA|mta
345523|NCT01468480|Single visit pulp cap|single visit pulp cap
345524|NCT01468480|Multical|multical
345525|NCT01468467|AC220|ac220
345526|NCT01468467|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
345527|NCT01468467|Transplantation|transplantation
345528|NCT01468467|Stem Cell Transplantation|stem cell transplantation
345529|NCT01468467|Allogeneic Transplantation|allogeneic transplantation
345530|NCT01468467|FMS-like tyrosine kinase (FLT3)|fms-like tyrosine kinase (flt3)
345531|NCT01468467|FMS-like tyrosine kinase (FLT3) Inhibitor|fms-like tyrosine kinase (flt3) inhibitor
345532|NCT01468467|Kinase|kinase
345533|NCT01468467|Kinase Inhibitor|kinase inhibitor
345534|NCT01468467|Pharmacokinetics|pharmacokinetics
345535|NCT01468467|ASP2689|asp2689
345536|NCT01468467|quizartinib|quizartinib
345537|NCT01468454|Congenital Hyperinsulinism (CHI)|congenital hyperinsulinism (chi)
345538|NCT01468454|hyperinsulinism|hyperinsulinism
345539|NCT01468454|Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)|persistent hyperinsulinemic hypoglycemia of infancy (phhi)
345540|NCT01468454|CHI|chi
345541|NCT01468454|PHHI|phhi
345542|NCT01468454|Pancreatectomy|pancreatectomy
345543|NCT01468454|18F-DOPA|18f-dopa
345544|NCT01468454|PET/CT scan|pet/ct scan
345545|NCT01468441|ovarian stimulation|ovarian stimulation
345546|NCT01468441|GnRH agonist|gnrh agonist
345547|NCT01468441|GnRH antagonist|gnrh antagonist
345548|NCT01468441|hCG microdose|hcg microdose
345549|NCT01468441|ICSI|icsi
345550|NCT01468415|Methylprednisolone|methylprednisolone
345551|NCT01468415|trans sacral block|trans sacral block
345552|NCT01468415|phenol|phenol
345553|NCT01468402|Leiomyoma|leiomyoma
345554|NCT01468402|uterine artery embolization|uterine artery embolization
345555|NCT01468402|magnetic resonance imaging|magnetic resonance imaging
345556|NCT01468389|Gastric Cancer|gastric cancer
345557|NCT01468389|capecitabine|capecitabine
345558|NCT01468389|maintenance treatment|maintenance treatment
345559|NCT01468376|impaired glucose tolerance|impaired glucose tolerance
345560|NCT01468376|pre-diabetes|pre-diabetes
345561|NCT01468363|Dry weight|dry weight
345562|NCT01468363|Body composition monitor|body composition monitor
345563|NCT01468363|Hemodialysis|hemodialysis
345564|NCT01468363|Zonguldak|zonguldak
345565|NCT01468337|Central Serous Chorioretinopathy|central serous chorioretinopathy
345566|NCT01468337|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
345567|NCT01468337|Jakstat|jakstat
345568|NCT01468337|Retinal Eye Disease|retinal eye disease
345569|NCT01468337|Macular Eye Disease|macular eye disease
345570|NCT01468337|CSC|csc
345571|NCT01468324|Brain|brain
345572|NCT01468324|Angiogenesis|angiogenesis
345573|NCT01468324|Radiotherapy|radiotherapy
345574|NCT01468324|Malignant|malignant
345575|NCT01468324|Tumor|tumor
345576|NCT01468324|Glioma|glioma
345577|NCT01468324|Glioblastoma Multiforme|glioblastoma multiforme
345578|NCT01468324|Brain Tumor|brain tumor
345579|NCT01468311|Immunotherapy|immunotherapy
345580|NCT01468311|Resistant Hodgkins Lymphoma|resistant hodgkins lymphoma
345581|NCT01468311|Auto Stem Cell Transplant|auto stem cell transplant
345582|NCT01468311|Combination Chemo and Radiolabeled Monoclonal Antibody|combination chemo and radiolabeled monoclonal antibody
345583|NCT01468311|Hodgkin Lymphoma|hodgkin lymphoma
345584|NCT01468298|back pain|back pain
345585|NCT01468298|physical therapy|physical therapy
345586|NCT01468298|spine|spine
345587|NCT01468298|rehabilitation|rehabilitation
345588|NCT01468298|exercise|exercise
345589|NCT01468285|interventional,placebo controlled|interventional,placebo controlled
345590|NCT01468272|asthma children NEXT DPI LABA ICS inhalation|asthma children next dpi laba ics inhalation
345591|NCT01468246|Breast Cancer|breast cancer
345592|NCT01468246|Cohort|cohort
345593|NCT01468246|Young Women|young women
345594|NCT01468246|Survivorship|survivorship
345595|NCT01468246|Fertility|fertility
345596|NCT01468233|placebo controlled|placebo controlled
345597|NCT01468233|double blind|double blind
345598|NCT01468233|adalimumab|adalimumab
345599|NCT01468233|TNF|tnf
345600|NCT01468233|psoriasis|psoriasis
345601|NCT01468233|HS|hs
345602|NCT01468233|PIONEER II|pioneer ii
345603|NCT01468233|hidradenitis suppurativa|hidradenitis suppurativa
345604|NCT01468233|acne inversa|acne inversa
345605|NCT01468233|boil|boil
345606|NCT01468233|acne|acne
345607|NCT01468220|tissue metabolism|tissue metabolism
345608|NCT01468220|skeletal muscle|skeletal muscle
345609|NCT01468220|adipose tissue|adipose tissue
345610|NCT01468220|HIF|hif
345611|NCT01468207|acne|acne
345612|NCT01468207|psoriasis|psoriasis
345613|NCT01468207|hidradenitis suppurativa|hidradenitis suppurativa
345614|NCT01468207|TNF|tnf
345615|NCT01468207|HS|hs
345616|NCT01468207|PIONEER I|pioneer i
345617|NCT01468207|acne inversa|acne inversa
345618|NCT01468207|boil|boil
345619|NCT01468207|placebo controlled|placebo controlled
345620|NCT01468207|Double blind|double blind
345621|NCT01468207|adalimumab|adalimumab
345622|NCT01468194|AMS|ams
345623|NCT01468194|HAPE|hape
345624|NCT01468194|high altitude|high altitude
345625|NCT01468194|oxygen|oxygen
345626|NCT01468194|saturation|saturation
345627|NCT01468194|mountain|mountain
345628|NCT01468194|climbing|climbing
345629|NCT01468194|breathing|breathing
345630|NCT01468181|Type 2 diabetes mellitus|type 2 diabetes mellitus
345631|NCT01468181|Oral antihyperglycemic medications|oral antihyperglycemic medications
345632|NCT01468181|Long-Term Safety|long-term safety
345633|NCT01468181|GLP 1|glp 1
345634|NCT01468181|Glucagon like peptide 1|glucagon like peptide 1
345635|NCT01468155|PVA|pva
345636|NCT01468155|peri procedural bleeding complications|peri procedural bleeding complications
345637|NCT01468116|Type 2 diabetes|type 2 diabetes
345638|NCT01468116|Gastric bypass surgery|gastric bypass surgery
345640|NCT01468116|Mitochondrial function|mitochondrial function
345641|NCT01468103|intraocular pressure|intraocular pressure
345642|NCT01468103|Peripheral anterior synechiae|peripheral anterior synechiae
345643|NCT01468090|Inflammatory bowel disease|inflammatory bowel disease
345644|NCT01468090|Crohn's disease|crohn's disease
345645|NCT01468090|Ulcerative colitis|ulcerative colitis
345646|NCT01468090|Disease course|disease course
345647|NCT01468090|Phenotype|phenotype
345648|NCT01468090|Biological treatment|biological treatment
345649|NCT01468064|Central Nervous System Diseases|central nervous system diseases
345650|NCT01468064|Stroke|stroke
345651|NCT01468064|Infarction, Middle Cerebral Artery|infarction, middle cerebral artery
345652|NCT01468064|Cerebral Infarction|cerebral infarction
345653|NCT01468064|Cerebrovascular Accident|cerebrovascular accident
345654|NCT01468064|Stem Cell Transplantation|stem cell transplantation
345655|NCT01468064|Mesenchymal Stem Cell Transplantation|mesenchymal stem cell transplantation
345656|NCT01468064|Bone marrow stromal cells|bone marrow stromal cells
345657|NCT01468064|Mesenchymal Stem Cells|mesenchymal stem cells
345658|NCT01468064|Endothelial progenitor cells|endothelial progenitor cells
345659|NCT01468064|Adult Stem Cells|adult stem cells
345660|NCT01468064|Cell Therapy|cell therapy
345661|NCT01468051|predialysed|predialysed
345662|NCT01468051|chronic|chronic
345663|NCT01468051|renal failure patients|renal failure patients
345664|NCT01468025|NSAIDs|nsaids
345665|NCT01468025|Theramine|theramine
345666|NCT01468025|naproxen|naproxen
345667|NCT01468025|Low back pain|low back pain
345668|NCT01468025|amino acids|amino acids
345669|NCT01468025|CRP|crp
345670|NCT01468025|Medical Food|medical food
345671|NCT01468012|cocaine dependence|cocaine dependence
345672|NCT01468012|levodopa|levodopa
345673|NCT01468012|carbidopa|carbidopa
345674|NCT01468012|entacapone|entacapone
345675|NCT01467999|cannabis dependence|cannabis dependence
345676|NCT01467999|marijuana dependence|marijuana dependence
345677|NCT01467999|guanfacine|guanfacine
345678|NCT01467986|neuroblastoma|neuroblastoma
345679|NCT01467986|molecular targeted therapy|molecular targeted therapy
345680|NCT01467986|protein kinase inhibitor|protein kinase inhibitor
345681|NCT01467986|mTOR Inhibitor|mtor inhibitor
345682|NCT01467986|cytostatic topoisomerase-I-inhibitor|cytostatic topoisomerase-i-inhibitor
345683|NCT01467986|temozolomide|temozolomide
345684|NCT01467986|irinotecan|irinotecan
345685|NCT01467986|dasatinib|dasatinib
345686|NCT01467986|rapamycin|rapamycin
345687|NCT01467973|Heart Failure|heart failure
345688|NCT01467973|Heart Failure, Diastolic|heart failure, diastolic
345689|NCT01467973|Heart Failure, Systolic|heart failure, systolic
345690|NCT01467973|Middle-East|middle-east
345691|NCT01467908|Diagnosed vegetative state after stroke or traumatic brain injury|diagnosed vegetative state after stroke or traumatic brain injury
345692|NCT01467869|abnormal semen|abnormal semen
345693|NCT01467869|assisted conception|assisted conception
345694|NCT01467856|Tetraplegia|tetraplegia
345695|NCT01467843|Cognitive Behavioral Therapy|cognitive behavioral therapy
345696|NCT01467843|Mindfulness Based Stress Reduction|mindfulness based stress reduction
345697|NCT01467830|absorbable sutures efficacy|absorbable sutures efficacy
345698|NCT01467830|reducing Adverse effect to be caused from surgery|reducing adverse effect to be caused from surgery
345699|NCT01467830|Inguinal Hernia repair with mesh|inguinal hernia repair with mesh
345700|NCT01467817|body mass|body mass
345701|NCT01467817|abdominal fat|abdominal fat
345702|NCT01467817|whole body lean mass|whole body lean mass
345703|NCT01467817|insulin resistance|insulin resistance
345704|NCT01467817|caloric intake|caloric intake
345705|NCT01467817|expenditure|expenditure
345706|NCT01467817|endurance|endurance
345707|NCT01467817|Strength|strength
345708|NCT01467817|TC:HDL ratio|tc:hdl ratio
345709|NCT01467817|LDL:HDL ratio|ldl:hdl ratio
345710|NCT01467817|area under the TG response curve|area under the tg response curve
345711|NCT01467817|feeding challenge|feeding challenge
345712|NCT01467817|fasting and post-prandial whole body fat oxidation|fasting and post-prandial whole body fat oxidation
345713|NCT01467817|HRQoL|hrqol
345714|NCT01467804|efficacy,|efficacy,
345715|NCT01467804|safety,|safety,
345716|NCT01467804|JWXYJN|jwxyjn
345717|NCT01467791|ambrisentan|ambrisentan
345718|NCT01467791|Bosentan|bosentan
345719|NCT01467791|Iloprost|iloprost
345720|NCT01467778|skin|skin
345721|NCT01467752|reconstruction|reconstruction
345722|NCT01467752|metacarpophalangeal joint|metacarpophalangeal joint
345723|NCT01467752|bone graft|bone graft
345724|NCT01467752|MCP joint|mcp joint
723745|NCT01056965|PSP|psp
345725|NCT01467726|Alzheimer's disease|alzheimer's disease
345726|NCT01467726|Elderly|elderly
345727|NCT01467713|Drug Therapy|drug therapy
345728|NCT01467700|Drug Therapy|drug therapy
345729|NCT01467674|Diabetes mellitus|diabetes mellitus
345730|NCT01467674|Chronic periodontitis|chronic periodontitis
345731|NCT01467674|Malondialdehyde|malondialdehyde
345732|NCT01467674|Glutathione peroxidase|glutathione peroxidase
345733|NCT01467674|Paraoxonase|paraoxonase
345734|NCT01467648|Infection|infection
345735|NCT01467648|Doripenem|doripenem
345838|NCT01467115|radiation|radiation
345736|NCT01467648|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
345737|NCT01467648|pharmacokinetic|pharmacokinetic
345738|NCT01467648|pharmacodynamic|pharmacodynamic
345739|NCT01467635|Endobronchial ultrasound|endobronchial ultrasound
345740|NCT01467635|Transbronchial needle aspiration|transbronchial needle aspiration
345741|NCT01467635|Transbronchial biopsy forceps|transbronchial biopsy forceps
345742|NCT01467635|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
345743|NCT01467635|Hilar lymphadenopathy|hilar lymphadenopathy
345744|NCT01467622|chest tube drainage|chest tube drainage
345745|NCT01467622|pulmonary air leak|pulmonary air leak
345746|NCT01467622|lung resection|lung resection
345747|NCT01467609|Pillcam colon capsule endoscopy|pillcam colon capsule endoscopy
345748|NCT01467609|conventional colonoscopy|conventional colonoscopy
345749|NCT01467609|ulcerative colitis|ulcerative colitis
345750|NCT01467609|endoscopic manifestation|endoscopic manifestation
345751|NCT01467609|colonoscopy|colonoscopy
345752|NCT01467596|Ultrasound|ultrasound
345753|NCT01467596|Brachial block|brachial block
345754|NCT01467596|Levobupivacaine|levobupivacaine
345755|NCT01467596|Minimum|minimum
345756|NCT01467596|Volume|volume
345757|NCT01467596|Minimum volume of Levobupivacaine 0,5%|minimum volume of levobupivacaine 0,5%
345758|NCT01467583|Fondaparinux|fondaparinux
345759|NCT01467583|Renal Failure|renal failure
345760|NCT01467583|Critically Ill|critically ill
345761|NCT01467570|diarrhea|diarrhea
345762|NCT01467557|adverse events|adverse events
345763|NCT01467544|Tai Chi|tai chi
345764|NCT01467531|HIV, GSK1265744, GSK1349572, dolutegravir, rilpivirine, drug interaction, pharmacokinetics|hiv, gsk1265744, gsk1349572, dolutegravir, rilpivirine, drug interaction, pharmacokinetics
345765|NCT01467518|methadone|methadone
345766|NCT01467518|Opiate-dependent|opiate-dependent
345767|NCT01467492|VX-950, Incivek|vx-950, incivek
345768|NCT01467466|renal|renal
345769|NCT01467466|cardiovascular|cardiovascular
345770|NCT01467466|kidney|kidney
345771|NCT01467466|heart|heart
345772|NCT01467466|clinical trial|clinical trial
345773|NCT01467466|double-blind|double-blind
345774|NCT01467466|multi-site trial|multi-site trial
345775|NCT01467466|randomized|randomized
345776|NCT01467466|drug treatment|drug treatment
345777|NCT01467466|IV solutions|iv solutions
345778|NCT01467466|antioxidant|antioxidant
345779|NCT01467440|Glaucoma and Ocular Hypertension|glaucoma and ocular hypertension
345780|NCT01467388|patients with glaucoma or ocular hypertension|patients with glaucoma or ocular hypertension
345781|NCT01467362|xerosis|xerosis
345782|NCT01467362|dry skin|dry skin
345783|NCT01467362|dermatitis|dermatitis
345784|NCT01467362|pruritus|pruritus
345785|NCT01467362|eczema|eczema
345786|NCT01467362|emollient|emollient
345787|NCT01467362|corticosteroid|corticosteroid
345788|NCT01467349|Raltegravir|raltegravir
345789|NCT01467349|efficacy|efficacy
345790|NCT01467349|safety|safety
345791|NCT01467349|raltegravir-containing regimens|raltegravir-containing regimens
345792|NCT01467349|HIV urban clinic setting|hiv urban clinic setting
345793|NCT01467310|GSK1120212|gsk1120212
345794|NCT01467310|TNBC|tnbc
345795|NCT01467310|Triple Negative Breast Cancer|triple negative breast cancer
345796|NCT01467310|Surgical Resection|surgical resection
345797|NCT01467297|Chronic bronchitis|chronic bronchitis
345798|NCT01467297|exacerbations|exacerbations
345799|NCT01467297|treatment|treatment
345800|NCT01467297|ceftidoren|ceftidoren
345801|NCT01467297|levofloxacin|levofloxacin
345802|NCT01467297|inflammation|inflammation
345803|NCT01467284|Obesity|obesity
345804|NCT01467284|Workplace|workplace
345805|NCT01467284|Intervention|intervention
345806|NCT01467284|Diet|diet
345807|NCT01467284|Exercise|exercise
345808|NCT01467245|Thoracoscopy|thoracoscopy
345809|NCT01467245|congenital diaphragmatic hernia|congenital diaphragmatic hernia
345810|NCT01467245|oesophageal atresia|oesophageal atresia
345811|NCT01467245|hypercapnia|hypercapnia
345812|NCT01467245|acidosis|acidosis
345813|NCT01467245|cerebral oxygenation|cerebral oxygenation
345814|NCT01467245|neonates|neonates
345815|NCT01467219|early|early
345816|NCT01467219|high risk|high risk
345817|NCT01467206|Stroke|stroke
345818|NCT01467206|Physiotherapy|physiotherapy
345819|NCT01467206|Motor training|motor training
345820|NCT01467206|Rehabilitation|rehabilitation
345821|NCT01467206|Randomized Controlled Trial|randomized controlled trial
345822|NCT01467180|septeX|septex
345823|NCT01467180|CVVH|cvvh
345824|NCT01467180|CVHD|cvhd
345825|NCT01467180|myoglobin|myoglobin
345826|NCT01467167|Anesthesia|anesthesia
723833|NCT01057381|Pediatrics|pediatrics
345827|NCT01467167|Smart Pilot View|smart pilot view
345828|NCT01467167|Pain control|pain control
345829|NCT01467167|Recovery|recovery
345830|NCT01467128|Elderly|elderly
345831|NCT01467128|Hospital|hospital
345832|NCT01467128|Adverse Drug|adverse drug
345833|NCT01467128|Pharmacist|pharmacist
345834|NCT01467128|Prevention|prevention
345835|NCT01467115|loco regionally advanced|loco regionally advanced
345836|NCT01467115|head and neck cancer|head and neck cancer
345837|NCT01467115|chemotherapy|chemotherapy
345839|NCT01467102|chronic post surgical pain|chronic post surgical pain
345840|NCT01467102|Pain|pain
345841|NCT01467102|Risk factors of chronic post surgical pain|risk factors of chronic post surgical pain
345842|NCT01467102|predictive risk factors|predictive risk factors
345843|NCT01467102|chronic post-surgical pain (CPSP)|chronic post-surgical pain (cpsp)
345844|NCT01467102|international level|international level
345845|NCT01467102|epidemiology of CPSP|epidemiology of cpsp
345846|NCT01467102|Europe|europe
345847|NCT01467102|observational|observational
345848|NCT01467102|prospective|prospective
345849|NCT01467089|Schizophrenia|schizophrenia
345850|NCT01467089|Extrapyramidal symptoms|extrapyramidal symptoms
345851|NCT01467089|Tardive dyskinesia|tardive dyskinesia
345852|NCT01467089|Two Way Video Assessment|two way video assessment
345853|NCT01467063|Type I Diabetes|type i diabetes
345854|NCT01467063|Insulin Resistance|insulin resistance
345855|NCT01467063|Glutamine|glutamine
345856|NCT01467063|Amino Acids|amino acids
345857|NCT01467063|Glucagon like peptide 1|glucagon like peptide 1
345858|NCT01467063|Glutathione|glutathione
345859|NCT01467063|Citrulline|citrulline
345860|NCT01467063|Arginine|arginine
345861|NCT01467063|Nitric Oxide|nitric oxide
345862|NCT01467050|Adverse drug event|adverse drug event
345863|NCT01467050|Adverse drug reaction|adverse drug reaction
345864|NCT01467050|Inappropriate prescribing|inappropriate prescribing
345865|NCT01467050|Elderly|elderly
345866|NCT01467050|Hospital-acquired|hospital-acquired
345867|NCT01467037|Rotavirus|rotavirus
345868|NCT01467037|Gastroenteritis|gastroenteritis
345869|NCT01467037|Vaccination|vaccination
345870|NCT01467037|Pediatrics|pediatrics
345871|NCT01467024|HTLV|htlv
345872|NCT01467024|Confirmatory|confirmatory
345873|NCT01467024|Supplemental|supplemental
345874|NCT01467024|Blot|blot
345875|NCT01467024|HTLV-I|htlv-i
345876|NCT01467024|HTLV-II|htlv-ii
345877|NCT01467011|Myfortic|myfortic
345878|NCT01467011|Mycophenolic acid|mycophenolic acid
345879|NCT01467011|Prograf|prograf
345880|NCT01467011|Tacrolimus|tacrolimus
345881|NCT01467011|Liver transplantation|liver transplantation
345882|NCT01466972|Advanced|advanced
345883|NCT01466972|Breast|breast
345884|NCT01466972|Cancer|cancer
345885|NCT01466972|Hormone Resistance|hormone resistance
345886|NCT01466972|Pazopanib|pazopanib
345887|NCT01466972|anastrozole|anastrozole
345888|NCT01466972|arimidex|arimidex
345889|NCT01466972|letrozole|letrozole
345890|NCT01466972|femara|femara
345891|NCT01466959|hemodialysis|hemodialysis
345892|NCT01466959|dialysate|dialysate
345893|NCT01466959|acetate based dialysate|acetate based dialysate
345894|NCT01466959|citrasate dialysate|citrasate dialysate
345895|NCT01466959|heparin anticoagulation|heparin anticoagulation
345896|NCT01466959|hemodynamic stability|hemodynamic stability
345897|NCT01466946|lung cancer|lung cancer
345898|NCT01466946|Hispanic/Latino patients|hispanic/latino patients
345899|NCT01466946|interviews|interviews
345900|NCT01466946|11-109|11-109
345901|NCT01466933|parenting intervention|parenting intervention
345902|NCT01466933|child development|child development
345903|NCT01466933|low and middle income countries|low and middle income countries
345904|NCT01466920|Total knee arthroplasty|total knee arthroplasty
345905|NCT01466907|complication|complication
345906|NCT01466907|depression|depression
345907|NCT01466907|follow-up|follow-up
345908|NCT01466907|intervention|intervention
345909|NCT01466907|nurse-led|nurse-led
345910|NCT01466907|outcome|outcome
345911|NCT01466907|secondary prevention|secondary prevention
345912|NCT01466907|stroke|stroke
345913|NCT01466894|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
345914|NCT01466894|NAFLD|nafld
345915|NCT01466894|Fatty liver|fatty liver
345916|NCT01466894|NASH|nash
345917|NCT01466868|Diffuse Large B cell Lymphoma|diffuse large b cell lymphoma
345918|NCT01466868|AKT|akt
345919|NCT01466868|MK 2206|mk 2206
345920|NCT01466868|objective response rate|objective response rate
345921|NCT01466868|progression free survival|progression free survival
345922|NCT01466868|overall survival|overall survival
345923|NCT01466868|safety|safety
345924|NCT01466855|Retinoblastoma|retinoblastoma
345925|NCT01466829|sternotomy|sternotomy
345926|NCT01466829|parathyroid hormone|parathyroid hormone
345927|NCT01466829|bone healing|bone healing
345928|NCT01466816|Lipid metabolism|lipid metabolism
345929|NCT01466803|Buprenorphine|buprenorphine
345930|NCT01466803|Vorikonazole|vorikonazole
345931|NCT01466803|Interactions|interactions
724718|NCT01061541|Hiberix™|hiberix™
345932|NCT01466803|Pharmacokinetics|pharmacokinetics
345933|NCT01466803|Pharmacodynamics|pharmacodynamics
345934|NCT01466803|Voriconazole|voriconazole
345935|NCT01466790|Hepatitis C|hepatitis c
345936|NCT01466790|TMC435|tmc435
345937|NCT01466790|PSI-7977|psi-7977
345938|NCT01466790|GS7977|gs7977
345939|NCT01466790|Ribavirin|ribavirin
345940|NCT01466790|HCV|hcv
345941|NCT01466790|Hep C|hep c
345942|NCT01466790|Genotype 1|genotype 1
345943|NCT01466777|Endometrium cancer|endometrium cancer
347098|NCT01462188|stent|stent
345944|NCT01466777|Robotic-assisted laparoscopy|robotic-assisted laparoscopy
345945|NCT01466777|Traditional laparoscopy|traditional laparoscopy
345946|NCT01466777|Laparoscopic surgery|laparoscopic surgery
345947|NCT01466777|Treatment|treatment
345948|NCT01466777|Operation time|operation time
345949|NCT01466777|Bleeding|bleeding
345950|NCT01466777|Complications|complications
345951|NCT01466777|Conversions|conversions
345952|NCT01466777|Pelvic lymph node|pelvic lymph node
345953|NCT01466764|biomarkers|biomarkers
345954|NCT01466751|Computerized neurobehavioral intervention|computerized neurobehavioral intervention
345955|NCT01466738|Healthy volunteer|healthy volunteer
345956|NCT01466738|Rhinovirus|rhinovirus
345957|NCT01466738|Cold virus|cold virus
345958|NCT01466738|HRV-16|hrv-16
345959|NCT01466725|Lupus|lupus
345960|NCT01466725|Discoid Lupus|discoid lupus
345961|NCT01466725|DLE|dle
345962|NCT01466725|Cutaneous Lupus|cutaneous lupus
345963|NCT01466686|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
345964|NCT01466686|Recurrent Anaplastic Astrocytoma|recurrent anaplastic astrocytoma
345965|NCT01466686|Surgery|surgery
345966|NCT01466686|Adjuvant Radiation|adjuvant radiation
345967|NCT01466686|Adjuvant Temozolomide|adjuvant temozolomide
345968|NCT01466673|Acne Vulgaris|acne vulgaris
345969|NCT01466673|Ethinyl estradiol|ethinyl estradiol
345970|NCT01466673|Norgestimate|norgestimate
345971|NCT01466673|Desogestrel|desogestrel
345972|NCT01466673|Tricilest|tricilest
345973|NCT01466673|Oilezz|oilezz
345974|NCT01466647|NSCLC|nsclc
345975|NCT01466621|cardiac resynchronization therapy|cardiac resynchronization therapy
345976|NCT01466621|heart failure|heart failure
345977|NCT01466621|mortality|mortality
345978|NCT01466608|OATP1B1|oatp1b1
345979|NCT01466608|Rosuvastatin|rosuvastatin
345980|NCT01466608|lipidomics|lipidomics
345981|NCT01466608|pharmacodynamics|pharmacodynamics
345982|NCT01466582|HIV-1-infection|hiv-1-infection
345983|NCT01466582|comorbidity|comorbidity
345984|NCT01466582|ageing|ageing
345985|NCT01466569|Advanced Solid Tumor|advanced solid tumor
345986|NCT01466569|Gastric Cancer|gastric cancer
345987|NCT01466569|Oncology|oncology
345988|NCT01466569|monoclonal Antibody|monoclonal antibody
345989|NCT01466543|Vascular dementia|vascular dementia
345990|NCT01466543|Subcortical vascular dementia|subcortical vascular dementia
345991|NCT01466543|Phosphodiesterase 5|phosphodiesterase 5
345992|NCT01466543|Udenafil|udenafil
345993|NCT01466530|Full term pregnancy > 36 weeks|full term pregnancy > 36 weeks
345994|NCT01466530|Cesarean delivery|cesarean delivery
345995|NCT01466530|General anesthesia|general anesthesia
345996|NCT01466517|Relative Bioavailability Study|relative bioavailability study
345997|NCT01466517|Ibuprofen|ibuprofen
345998|NCT01466517|Alivium|alivium
345999|NCT01466504|P63|p63
346000|NCT01466504|Sorafenib|sorafenib
346001|NCT01466504|Regorafenib|regorafenib
346002|NCT01466504|rash|rash
346003|NCT01466504|skin toxicity|skin toxicity
346004|NCT01466504|RCC|rcc
346005|NCT01466504|HCC|hcc
346006|NCT01466504|colorectal carcinoma|colorectal carcinoma
346007|NCT01466491|Pain during first-trimester surgical abortion|pain during first-trimester surgical abortion
346008|NCT01466465|Vitamin D|vitamin d
346009|NCT01466465|SIT|sit
346010|NCT01466465|Grass pollen|grass pollen
346011|NCT01466465|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
346012|NCT01466439|rTMS|rtms
346013|NCT01466439|P50|p50
346014|NCT01466439|inhibitory|inhibitory
346015|NCT01466439|facilitatory|facilitatory
346016|NCT01466439|physiological process|physiological process
346017|NCT01466439|brain changes|brain changes
346018|NCT01466426|Venous thromboembolic disease|venous thromboembolic disease
346019|NCT01466426|Deep veinous thrombosis|deep veinous thrombosis
346020|NCT01466426|Pulmonary embolism|pulmonary embolism
346021|NCT01466413|Intrinsic Aging of Skin|intrinsic aging of skin
346022|NCT01466400|health benefits of infant formula|health benefits of infant formula
346023|NCT01466387|Adults|adults
346024|NCT01466387|international travel vaccination|international travel vaccination
346025|NCT01466387|Meningococcal disease|meningococcal disease
346026|NCT01466387|meningococcal meningitis|meningococcal meningitis
346027|NCT01466387|typhoid|typhoid
346028|NCT01466387|yellow fever|yellow fever
346029|NCT01466387|rabies|rabies
346030|NCT01466387|Japanese encephalitis|japanese encephalitis
346031|NCT01466361|Nicotine|nicotine
346032|NCT01466361|Nicotine craving|nicotine craving
346033|NCT01466348|Paracetomol|paracetomol
346034|NCT01466348|Caffeine|caffeine
346035|NCT01466348|Common cold|common cold
724719|NCT01061541|Hepatitis B|hepatitis b
346036|NCT01466322|Healthy volunteers|healthy volunteers
346037|NCT01466322|GSK2018682|gsk2018682
346038|NCT01466322|Pharmacokinetics|pharmacokinetics
346039|NCT01466322|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
346040|NCT01466322|Pharmacodynamics|pharmacodynamics
346041|NCT01466309|AHI|ahi
346042|NCT01466309|ESS|ess
346043|NCT01466309|VAS|vas
346044|NCT01466309|FOSQ|fosq
346045|NCT01466309|SF-36|sf-36
346047|NCT01466296|Poststroke/CVA Paresis|poststroke/cva paresis
346048|NCT01466296|REHABILITATION|rehabilitation
346049|NCT01466296|WALKING|walking
346050|NCT01466296|PERUTURBATION|peruturbation
346051|NCT01466283|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
346052|NCT01466270|fatigue|fatigue
346053|NCT01466270|sleep disorders|sleep disorders
346054|NCT01466270|depression|depression
346055|NCT01466270|anxiety disorder|anxiety disorder
346056|NCT01466270|cognitive/functional effects|cognitive/functional effects
346057|NCT01466270|breast cancer|breast cancer
346058|NCT01466270|cancer survivor|cancer survivor
346059|NCT01466257|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
346060|NCT01466257|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
346061|NCT01466257|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
346062|NCT01466257|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
346803|NCT01463332|Pain|pain
346063|NCT01466257|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
346064|NCT01466257|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
346065|NCT01466257|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
346066|NCT01466257|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
346067|NCT01466257|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
346068|NCT01466257|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
346069|NCT01466257|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
346070|NCT01466257|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
346071|NCT01466257|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
346072|NCT01466257|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
346073|NCT01466257|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
346074|NCT01466257|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
346075|NCT01466257|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
346076|NCT01466257|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
346077|NCT01466257|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
346078|NCT01466257|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
346079|NCT01466257|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
346080|NCT01466257|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
346081|NCT01466257|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
346082|NCT01466257|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
346083|NCT01466257|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
403005|NCT01228630|rhinitis, loratadine, coated pill|rhinitis, loratadine, coated pill
336754|NCT01504919|Surveys|surveys
346084|NCT01466257|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
346085|NCT01466244|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
346086|NCT01466244|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
346087|NCT01466244|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
346088|NCT01466244|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
346089|NCT01466244|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
346090|NCT01466244|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
346091|NCT01466244|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
346092|NCT01466244|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
346093|NCT01466244|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
346094|NCT01466244|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
346095|NCT01466244|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
725023|NCT01062711|muscle|muscle
346096|NCT01466244|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
346097|NCT01466244|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
346098|NCT01466244|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
346099|NCT01466244|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
346100|NCT01466244|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
347099|NCT01462136|PK study|pk study
346101|NCT01466244|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
346102|NCT01466244|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
346103|NCT01466244|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
346104|NCT01466244|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
346105|NCT01466244|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
346106|NCT01466244|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
346107|NCT01466244|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
346108|NCT01466244|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
346109|NCT01466244|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
346110|NCT01466231|refractory germ cell cancer|refractory germ cell cancer
346111|NCT01466231|everolimus|everolimus
346112|NCT01466218|pulmonary function abnormalities|pulmonary function abnormalities
346113|NCT01466218|pulmonary disease|pulmonary disease
346114|NCT01466218|cardiac disease|cardiac disease
346115|NCT01466218|cardiopulmonary disease|cardiopulmonary disease
346116|NCT01466218|obstructive sleep apnea|obstructive sleep apnea
346118|NCT01466218|cardiovascular disease|cardiovascular disease
346119|NCT01466218|CVD|cvd
346120|NCT01466218|particulate matter|particulate matter
346121|NCT01466205|schizotypal personality disorder|schizotypal personality disorder
346122|NCT01466205|cognitive impairment|cognitive impairment
346123|NCT01466205|working memory|working memory
346124|NCT01466192|Genotype 2|genotype 2
346125|NCT01466179|B-ALL|b-all
346126|NCT01466179|relapsed ALL|relapsed all
346127|NCT01466179|refractory ALL|refractory all
346128|NCT01466179|adult ALL|adult all
346129|NCT01466179|Leukemia|leukemia
346130|NCT01466179|Leukemia, Lymphoid|leukemia, lymphoid
346131|NCT01466179|precursor cell lymphoblastic leukemia-lymphoma|precursor cell lymphoblastic leukemia-lymphoma
346132|NCT01466179|Lymphatic diseases|lymphatic diseases
346133|NCT01466179|Lymphoproliferative disorders|lymphoproliferative disorders
346134|NCT01466179|bispecific antibody|bispecific antibody
346135|NCT01466179|anti-CD19|anti-cd19
346136|NCT01466179|Immunotherapeutic treatment|immunotherapeutic treatment
346137|NCT01466179|immunoproliferative disorders|immunoproliferative disorders
346138|NCT01466153|Chronic lymphocytic leukemia; leukemia; B-Cell malignancy; anti-CD19; monoclonal antibody; CLL; Refractory; Relapse; Non-Hodgkin's Lymphoma|chronic lymphocytic leukemia; leukemia; b-cell malignancy; anti-cd19; monoclonal antibody; cll; refractory; relapse; non-hodgkin's lymphoma
346139|NCT01466140|Patient Satisfaction|patient satisfaction
346140|NCT01466140|Request for help|request for help
346141|NCT01466140|General practice|general practice
346142|NCT01466127|Effect of oxytocin on learning|effect of oxytocin on learning
346143|NCT01466114|multiple sclerosis|multiple sclerosis
346144|NCT01466114|MS|ms
346145|NCT01466114|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
346146|NCT01466114|RRMS|rrms
346147|NCT01466114|secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
346148|NCT01466114|SPMS|spms
346149|NCT01466114|primary progressive multiple sclerosis|primary progressive multiple sclerosis
346150|NCT01466114|estrogen|estrogen
346151|NCT01466114|estriol|estriol
346152|NCT01466101|Hysterectomy|hysterectomy
346153|NCT01466101|Pain|pain
346154|NCT01466101|Pregabalin|pregabalin
346155|NCT01466088|Alzheimer's Disease|alzheimer's disease
346156|NCT01466088|AD|ad
346157|NCT01466088|Dementia|dementia
346158|NCT01466062|Immunocompromised medical conditions|immunocompromised medical conditions
346159|NCT01466062|Respiratory Syncytial Virus Infection|respiratory syncytial virus infection
346160|NCT01466062|Infant|infant
346161|NCT01466062|Newborn|newborn
346162|NCT01466062|Young children|young children
346163|NCT01466049|Ovarian Cancer|ovarian cancer
346164|NCT01466049|Adnexal Mass|adnexal mass
346165|NCT01466049|Pelvic Mass|pelvic mass
346166|NCT01466036|metastatic|metastatic
346167|NCT01466023|thyroid metabolism during pregnancy|thyroid metabolism during pregnancy
346168|NCT01466023|impact on neonate|impact on neonate
346169|NCT01466010|osteoma, osteoid|osteoma, osteoid
346170|NCT01466010|surgical procedures, operative|surgical procedures, operative
346171|NCT01466010|bone neoplasms|bone neoplasms
346172|NCT01465997|Lacosamide|lacosamide
346173|NCT01465984|Paracetamol|paracetamol
346174|NCT01465984|Morphine sulfates|morphine sulfates
346175|NCT01465984|Acute pain|acute pain
346176|NCT01465971|high|high
346177|NCT01465971|altitude|altitude
346178|NCT01465971|acute|acute
346179|NCT01465971|mountain|mountain
346180|NCT01465971|sickness|sickness
346181|NCT01465971|sleep|sleep
346182|NCT01465971|disorder|disorder
346183|NCT01465971|periodic|periodic
346184|NCT01465971|breathing|breathing
346185|NCT01465971|hyperventilation|hyperventilation
346186|NCT01465971|apnea|apnea
346187|NCT01465945|TEM for rectal lesions|tem for rectal lesions
346188|NCT01465945|Sutured defect|sutured defect
346189|NCT01465945|Unsutured defect|unsutured defect
346190|NCT01465932|Nursing staff|nursing staff
346191|NCT01465932|Physical Therapy (Specialty)|physical therapy (specialty)
346192|NCT01465919|depression|depression
346193|NCT01465919|interferon|interferon
346194|NCT01465919|chronic hepatitis C|chronic hepatitis c
346195|NCT01465919|mirtazapine|mirtazapine
346196|NCT01465906|COPD|copd
346197|NCT01465893|vitamin d|vitamin d
346198|NCT01465880|Smoking research study|smoking research study
346199|NCT01465867|Selenium|selenium
346200|NCT01465867|Pregnancy|pregnancy
346201|NCT01465867|Auto-immune thyroiditis|auto-immune thyroiditis
346202|NCT01465867|Post-partum thyroiditis|post-partum thyroiditis
346203|NCT01465867|Miscarriage|miscarriage
346204|NCT01465867|Pre-eclampsia|pre-eclampsia
346205|NCT01465867|Implantation and Pregnancy rate|implantation and pregnancy rate
346206|NCT01465867|Infertility|infertility
346207|NCT01465854|lung cancer|lung cancer
346208|NCT01465854|smoking|smoking
346209|NCT01465854|molecular epidemiology|molecular epidemiology
346210|NCT01465854|genetic polymorphism|genetic polymorphism
346211|NCT01465854|risk factors|risk factors
346212|NCT01465854|never smokers|never smokers
346213|NCT01465854|histologically/cytologically confirmed|histologically/cytologically confirmed
346214|NCT01465841|intracranial aneurysms|intracranial aneurysms
346215|NCT01465841|Peripheral aneurysms|peripheral aneurysms
346216|NCT01465841|acute treatment|acute treatment
346217|NCT01465841|PC 400 System|pc 400 system
346218|NCT01465841|packing density|packing density
346219|NCT01465828|antiplatelet effect|antiplatelet effect
346220|NCT01465828|prasugrel|prasugrel
346221|NCT01465828|clopidogrel|clopidogrel
346222|NCT01465828|ACS|acs
346223|NCT01465802|non-small cell lung cancer|non-small cell lung cancer
346224|NCT01465802|advanced|advanced
346225|NCT01465802|previously treated|previously treated
346226|NCT01465776|SCC of the oral cavity|scc of the oral cavity
346227|NCT01465776|black raspberries|black raspberries
346228|NCT01465763|tofacitinib|tofacitinib
346229|NCT01465763|CP-690|cp-690
346230|NCT01465763|550|550
346231|NCT01465763|Moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
346232|NCT01465763|phase 3 clinical trial|phase 3 clinical trial
346233|NCT01465763|Mayo score|mayo score
346234|NCT01465737|epidemiology|epidemiology
346235|NCT01465737|uterine cancer|uterine cancer
346236|NCT01465737|Taiwan|taiwan
346237|NCT01465724|Insulin resistance|insulin resistance
346238|NCT01465724|Insulin sensitivity|insulin sensitivity
346239|NCT01465724|HOMA-IR|homa-ir
346240|NCT01465724|blood pressure|blood pressure
346241|NCT01465724|Renal denervation|renal denervation
346242|NCT01465724|renal sympathetic denervation|renal sympathetic denervation
346243|NCT01465724|renal ablation|renal ablation
346244|NCT01465711|Peritonitis|peritonitis
346245|NCT01465711|Sepsis|sepsis
346246|NCT01465711|General Surgery|general surgery
346247|NCT01465711|Intensive Care Units|intensive care units
346248|NCT01465711|Sensitivity and Specificity|sensitivity and specificity
346249|NCT01465698|exercise|exercise
346250|NCT01465698|counseling|counseling
346251|NCT01465698|movement control|movement control
346252|NCT01465698|fear avoidance|fear avoidance
346253|NCT01465685|MDMA|mdma
346254|NCT01465685|pharmacokinetics|pharmacokinetics
346255|NCT01465685|pharmacodynamics|pharmacodynamics
346256|NCT01465685|emotions|emotions
346257|NCT01465685|Mechanism of action of MDMA|mechanism of action of mdma
346258|NCT01465685|Interaction study|interaction study
346259|NCT01465685|Effect of MDMA and methylphenidate on emotions|effect of mdma and methylphenidate on emotions
346260|NCT01465672|copeptin|copeptin
346261|NCT01465672|SIADH|siadh
346262|NCT01465672|Diabetes insipidus|diabetes insipidus
346263|NCT01465672|transphenoidal pituitary adenoma resection|transphenoidal pituitary adenoma resection
346264|NCT01465672|pituitary adenoma|pituitary adenoma
346265|NCT01465672|tumors close to pituitary gland|tumors close to pituitary gland
346266|NCT01465672|tumors close to hypothalamus|tumors close to hypothalamus
346267|NCT01465646|levothyroxine|levothyroxine
346268|NCT01465646|bioavailability|bioavailability
346269|NCT01465633|bioavailability|bioavailability
346270|NCT01465633|levothyroxine|levothyroxine
346271|NCT01465620|Peripheral Nervous System Diseases|peripheral nervous system diseases
346272|NCT01465620|Diabetic Polyneuropathy|diabetic polyneuropathy
346273|NCT01465620|Metabolic Syndrome X|metabolic syndrome x
346274|NCT01465607|Condom use|condom use
725024|NCT01062711|protein|protein
346275|NCT01465594|Pain Measurement|pain measurement
346276|NCT01465581|incontinence|incontinence
346277|NCT01465581|dysfunctional voiding|dysfunctional voiding
346278|NCT01465581|neurogenic bladder disturbance|neurogenic bladder disturbance
346279|NCT01465581|filum terminale|filum terminale
346280|NCT01465581|spinal cord tethering|spinal cord tethering
346281|NCT01465581|conus|conus
346282|NCT01465568|osteoporosis|osteoporosis
346283|NCT01465568|denosumab|denosumab
346284|NCT01465568|RANKL|rankl
346285|NCT01465568|glucocorticoids|glucocorticoids
346286|NCT01465555|Clinical Alert|clinical alert
346287|NCT01465555|Cognitive Behavioral Intervention|cognitive behavioral intervention
346288|NCT01465555|Web-based|web-based
347507|NCT01460472|NSCLC|nsclc
346289|NCT01465555|Substance Abuse Treatment|substance abuse treatment
346290|NCT01465542|Acetaminophen Toxicity|acetaminophen toxicity
346291|NCT01465542|Acetaminophen Overdose|acetaminophen overdose
346292|NCT01465542|N-acetylcysteine|n-acetylcysteine
346293|NCT01465542|Liver Toxicity|liver toxicity
346294|NCT01465503|bleeding|bleeding
346295|NCT01465503|percutaneous coronary intervention|percutaneous coronary intervention
346296|NCT01465503|heparin|heparin
346297|NCT01465503|bivalirudin|bivalirudin
346298|NCT01465490|Monitoring|monitoring
346299|NCT01465490|Feedback|feedback
346300|NCT01465490|Substance Abuse Treatment|substance abuse treatment
346301|NCT01465477|Fibromyalgia|fibromyalgia
346302|NCT01465477|Influenza vaccination|influenza vaccination
346303|NCT01465451|colorectal cancer|colorectal cancer
346304|NCT01465451|curative resection|curative resection
346305|NCT01465451|intra-operative chemotherapy|intra-operative chemotherapy
346306|NCT01465451|5-fluorouracil|5-fluorouracil
346307|NCT01465451|chemotherapy|chemotherapy
346308|NCT01465425|extracolonic findings|extracolonic findings
346309|NCT01465425|ECFs|ecfs
346310|NCT01465425|CT colonography|ct colonography
346507|NCT01464593|Liver Metastasis|liver metastasis
346311|NCT01465425|computed tomography colonography|computed tomography colonography
346312|NCT01465425|National CT Colonography Trial|national ct colonography trial
346313|NCT01465425|ACRIN 6664|acrin 6664
346314|NCT01465412|Parkinson disease|parkinson disease
346315|NCT01465373|In-Vitro Fertilization|in-vitro fertilization
346316|NCT01465373|Donor Egg IVF|donor egg ivf
346317|NCT01465360|Alzheimer's disease|alzheimer's disease
346319|NCT01465360|Non AD dementia|non ad dementia
346320|NCT01465360|Mild Cognitive Impairment|mild cognitive impairment
346321|NCT01465360|MCI|mci
346322|NCT01465360|Vascular dementia|vascular dementia
346323|NCT01465360|Fronto-temporal dementia|fronto-temporal dementia
346324|NCT01465360|Primary progressive aphasia|primary progressive aphasia
346325|NCT01465360|Parkinson's Disease dementia|parkinson's disease dementia
346326|NCT01465360|Mixed dementia|mixed dementia
346327|NCT01465360|Blood signature|blood signature
346328|NCT01465360|Diagnosis|diagnosis
346329|NCT01465360|AclarusDx|aclarusdx
346330|NCT01465360|Alzheimer's Disease and other non-AD dementia|alzheimer's disease and other non-ad dementia
346331|NCT01465360|Exonhit|exonhit
346332|NCT01465347|Primary brain tumor|primary brain tumor
346333|NCT01465347|Glioblastoma|glioblastoma
346334|NCT01465347|Glioma|glioma
346335|NCT01465347|GBM|gbm
346336|NCT01465347|Radiation therapy|radiation therapy
346337|NCT01465334|17p Deletion CLL|17p deletion cll
346338|NCT01465308|head and neck cancer|head and neck cancer
346339|NCT01465308|radiotherapy induced xerostomia|radiotherapy induced xerostomia
346340|NCT01465308|radiotherapy induced oral mucositis|radiotherapy induced oral mucositis
346341|NCT01465308|RCT|rct
346342|NCT01465308|symptom management|symptom management
346343|NCT01465295|Scoliosis|scoliosis
346344|NCT01465295|Adolescent Idiopathic Scoliosis (AIS)|adolescent idiopathic scoliosis (ais)
346345|NCT01465295|Scoliosis treatment|scoliosis treatment
346346|NCT01465295|Fusionless spinal surgery|fusionless spinal surgery
346347|NCT01465295|Vertebral stapling|vertebral stapling
346348|NCT01465295|Spinal stapling|spinal stapling
346349|NCT01465295|Non-fusion|non-fusion
346350|NCT01465295|Spinal curvature|spinal curvature
346351|NCT01465295|Curvature of the spine|curvature of the spine
346352|NCT01465295|Spinal bracing alternative|spinal bracing alternative
346353|NCT01465295|HemiBridge|hemibridge
346354|NCT01465295|SpineForm|spineform
346355|NCT01465295|Dr. Eric Wall|dr. eric wall
346356|NCT01465295|Dr. George Thompson|dr. george thompson
346357|NCT01465295|Spinal clip|spinal clip
346358|NCT01465295|Cincinnati Children's Hospital Medical Center|cincinnati children's hospital medical center
346359|NCT01465295|University Hospitals Case Medical Center, Rainbow Babies|university hospitals case medical center, rainbow babies
346360|NCT01465282|psoriasis vulgaris|psoriasis vulgaris
346361|NCT01465282|topical ointment|topical ointment
346362|NCT01465269|TBI|tbi
346363|NCT01465269|Social Competence|social competence
346364|NCT01465256|Aspirin|aspirin
346365|NCT01465256|Colon polypectomy|colon polypectomy
346366|NCT01465256|Bleeding|bleeding
346367|NCT01465243|Efficacy|efficacy
346368|NCT01465243|Safety|safety
346369|NCT01465243|EGFR-TKI|egfr-tki
346370|NCT01465243|phase IV|phase iv
346372|NCT01465243|Dose escalation|dose escalation
346373|NCT01465230|chronic lymphocytic leukemia|chronic lymphocytic leukemia
346374|NCT01465230|maintenance therapy|maintenance therapy
346375|NCT01465217|medication adherence|medication adherence
346376|NCT01465217|African Americans|african americans
346377|NCT01465204|Behavior Change|behavior change
346378|NCT01465204|Hygiene & Sanitation Marketing|hygiene & sanitation marketing
346379|NCT01465191|cesarean|cesarean
346380|NCT01465191|postoperative|postoperative
346381|NCT01465191|morphine|morphine
346382|NCT01465191|genetics|genetics
346383|NCT01465191|opioid|opioid
346384|NCT01465178|hypovitaminosis D|hypovitaminosis d
346385|NCT01465178|vitamin D insufficiency|vitamin d insufficiency
346386|NCT01465178|low vitamin D|low vitamin d
346387|NCT01465165|Depression|depression
346388|NCT01465165|Positron emission tomography|positron emission tomography
346389|NCT01465165|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
346390|NCT01465165|glucose metabolism|glucose metabolism
346391|NCT01465165|ATP|atp
346392|NCT01465165|phosphocreatine|phosphocreatine
346393|NCT01465113|Barrett's Esophagus|barrett's esophagus
346394|NCT01465113|Vitamin D3|vitamin d3
346395|NCT01465113|cholecalciferol|cholecalciferol
346396|NCT01465113|15-Prostaglandin Dehydrogenase Expression|15-prostaglandin dehydrogenase expression
346397|NCT01465113|metformin|metformin
346398|NCT01465100|phenylketonuria|phenylketonuria
346399|NCT01465100|hepatocyte|hepatocyte
346400|NCT01465087|Multiple Sclerosis|multiple sclerosis
346401|NCT01465087|Breath|breath
346402|NCT01465087|Diagnosis|diagnosis
346403|NCT01465087|Discrimination MS/healthy subj. via exhaled breath samples|discrimination ms/healthy subj. via exhaled breath samples
346404|NCT01465087|Discrimination MS/other neurological and autoimmune diseases|discrimination ms/other neurological and autoimmune diseases
346405|NCT01465074|nicotine|nicotine
346406|NCT01465074|memory|memory
346407|NCT01465074|plasticity|plasticity
346408|NCT01465074|TMS|tms
346409|NCT01465074|Paired Associative Stimulation|paired associative stimulation
346410|NCT01465061|Online social network|online social network
346411|NCT01465061|Psoriasis|psoriasis
346412|NCT01465061|Filipino|filipino
346414|NCT01465048|Protozoan Infections|protozoan infections
346415|NCT01465048|Parasitic Diseases|parasitic diseases
346416|NCT01465048|Malaria Challenge|malaria challenge
346417|NCT01465022|Breastfeeding rates|breastfeeding rates
346418|NCT01465022|Contraceptive continuation|contraceptive continuation
346419|NCT01465022|Birth control pills|birth control pills
346420|NCT01465022|Lactation|lactation
346421|NCT01465009|Sore Throat|sore throat
346422|NCT01464996|non-carious cervical lesions|non-carious cervical lesions
346423|NCT01464996|bonded restorations|bonded restorations
346424|NCT01464996|composites|composites
346425|NCT01464996|adhesives|adhesives
346426|NCT01464970|DIEP perfusion|diep perfusion
346427|NCT01464970|Zone IV|zone iv
346428|NCT01464970|Free Flap|free flap
346429|NCT01464970|Breast Cancer Reconstruction|breast cancer reconstruction
346430|NCT01464970|Perfusion of Zone IV of DIEP flaps|perfusion of zone iv of diep flaps
346431|NCT01464957|skin cancer prevention|skin cancer prevention
346432|NCT01464957|precaution adoption process model|precaution adoption process model
346433|NCT01464957|semi-tailored newsletter|semi-tailored newsletter
346434|NCT01464957|pediatric|pediatric
346435|NCT01464957|behavioral intervention|behavioral intervention
346436|NCT01464944|Upper Respiratory Tract Infections|upper respiratory tract infections
346437|NCT01464918|gastric cancer|gastric cancer
346438|NCT01464918|colon cancer|colon cancer
346439|NCT01464918|endoscopic submucosal dissection|endoscopic submucosal dissection
346440|NCT01464905|RRMS|rrms
346441|NCT01464892|Imagery rescripting|imagery rescripting
346442|NCT01464892|Imagery rescripting and reprocessing therapy|imagery rescripting and reprocessing therapy
346443|NCT01464892|Skills Training in affective and interpersonal regulation|skills training in affective and interpersonal regulation
346444|NCT01464892|Post-traumatic Stress Disorder|post-traumatic stress disorder
346445|NCT01464892|Childhood abuse|childhood abuse
346446|NCT01464892|Childhood sexual abuse|childhood sexual abuse
346447|NCT01464840|Pregnancy|pregnancy
346448|NCT01464840|Cesarean section|cesarean section
346449|NCT01464840|Antibiotic|antibiotic
346450|NCT01464827|Hepatitis C Genotype 1|hepatitis c genotype 1
346451|NCT01464827|Hepatitis C|hepatitis c
346452|NCT01464827|Interferon-Free|interferon-free
346453|NCT01464827|HCV|hcv
346454|NCT01464827|Chronic Hepatitis C|chronic hepatitis c
346455|NCT01464814|probiotic|probiotic
346456|NCT01464814|fish oil|fish oil
346457|NCT01464814|digestion|digestion
346458|NCT01464814|viability|viability
346459|NCT01464801|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
346460|NCT01464801|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
346461|NCT01464801|Resveratrol|resveratrol
346462|NCT01464801|Human study|human study
346463|NCT01464788|stroke|stroke
346464|NCT01464788|Argatroban|argatroban
346465|NCT01464788|thrombin-inhibition|thrombin-inhibition
346466|NCT01464788|thrombolysis|thrombolysis
346467|NCT01464788|anticoagulation|anticoagulation
346468|NCT01464775|Endometriosis|endometriosis
346469|NCT01464775|Laparoscopy|laparoscopy
346470|NCT01464775|Narrow Band Imaging|narrow band imaging
346471|NCT01464762|Tuberculosis|tuberculosis
346472|NCT01464762|TMC207TBC3001|tmc207tbc3001
346474|NCT01464762|Early access|early access
346475|NCT01464762|TB|tb
346476|NCT01464762|Drug resistant|drug resistant
346477|NCT01464762|Multi drug-resistant|multi drug-resistant
346478|NCT01464762|Extensively drug-resistant|extensively drug-resistant
346479|NCT01464749|multiple sclerosis|multiple sclerosis
346480|NCT01464749|gait rehabilitation|gait rehabilitation
346481|NCT01464736|aerobic exercise|aerobic exercise
346482|NCT01464736|noninvasive ventilation|noninvasive ventilation
346483|NCT01464736|functionality|functionality
346484|NCT01464697|hot flushes/hot flashes|hot flushes/hot flashes
346485|NCT01464697|night sweats|night sweats
346486|NCT01464697|sleep problems|sleep problems
346487|NCT01464697|negative mood|negative mood
346488|NCT01464697|anxiety|anxiety
346489|NCT01464697|perimenopause|perimenopause
346490|NCT01464697|progesterone|progesterone
346491|NCT01464697|vasomotor symptoms|vasomotor symptoms
346492|NCT01464697|premenopause|premenopause
346493|NCT01464671|Coronary Artery Disease|coronary artery disease
346494|NCT01464671|Stable Angina|stable angina
346495|NCT01464671|Percutaneous Coronary Intervention|percutaneous coronary intervention
346496|NCT01464658|panniculitis|panniculitis
346497|NCT01464658|panniculectomy|panniculectomy
346498|NCT01464632|medial knee replacement|medial knee replacement
346499|NCT01464619|Parenting|parenting
346500|NCT01464619|Early Child Development|early child development
346501|NCT01464606|pleuropulmonary blastoma|pleuropulmonary blastoma
346502|NCT01464606|pediatric|pediatric
346503|NCT01464606|lung cysts|lung cysts
346504|NCT01464593|Colorectal Liver Metastasis|colorectal liver metastasis
346505|NCT01464593|Colon Cancer|colon cancer
346506|NCT01464593|Liver Cancer|liver cancer
346508|NCT01464593|Liver metastases|liver metastases
346510|NCT01464567|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
346511|NCT01464567|Spontaneous Breathing Trial|spontaneous breathing trial
346512|NCT01464554|adolescents|adolescents
346513|NCT01464554|alcohol|alcohol
346514|NCT01464554|drugs|drugs
346515|NCT01464554|delinquency|delinquency
346516|NCT01464554|intervention|intervention
346517|NCT01464541|Orbit|orbit
346518|NCT01464541|Fracture|fracture
346519|NCT01464541|measurement|measurement
346520|NCT01464541|CT|ct
346521|NCT01464541|intraoperative|intraoperative
346522|NCT01464528|hysteroscopy|hysteroscopy
346523|NCT01464528|postoperative complications|postoperative complications
346524|NCT01464528|adhesions|adhesions
346525|NCT01464528|hyaluronic gel|hyaluronic gel
346526|NCT01464528|prevention|prevention
346527|NCT01464515|Mild Cognitive Impairment, So Stated|mild cognitive impairment, so stated
346528|NCT01464515|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
346529|NCT01464502|Heart failure|heart failure
346530|NCT01464502|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
346531|NCT01464502|Acute haemodynamic response|acute haemodynamic response
346532|NCT01464502|Responder|responder
346533|NCT01464489|Intubation time|intubation time
346534|NCT01464489|Atropine|atropine
346535|NCT01464489|Propofol anesthesia|propofol anesthesia
346536|NCT01464463|Depression|depression
346537|NCT01464463|Exercise|exercise
346538|NCT01464463|Psychoneuroimmunology|psychoneuroimmunology
346539|NCT01464463|Cognitive Behavioral Therapy|cognitive behavioral therapy
346540|NCT01464463|CBASP|cbasp
346541|NCT01464450|Pharmacokinetics|pharmacokinetics
346542|NCT01464450|Bioavailability|bioavailability
346543|NCT01464450|Healthy Participants|healthy participants
346544|NCT01464437|diabetes|diabetes
346545|NCT01464437|mellitus|mellitus
346546|NCT01464437|metformin|metformin
346547|NCT01464424|Glaucoma|glaucoma
346548|NCT01464424|Ocular Hypertension|ocular hypertension
346549|NCT01464424|Open-Angle Glaucoma|open-angle glaucoma
337248|NCT01502917|CNS|cns
346550|NCT01464424|Intraocular Pressure|intraocular pressure
346551|NCT01464411|chronic myelogenous leukemia|chronic myelogenous leukemia
346552|NCT01464411|chronic phase|chronic phase
346553|NCT01464411|Phase II|phase ii
346554|NCT01464411|dasatinib|dasatinib
346555|NCT01464398|Polycystic Ovary Syndrome|polycystic ovary syndrome
346556|NCT01464398|stress|stress
346557|NCT01464398|mindfulness|mindfulness
346558|NCT01464398|meditation|meditation
346559|NCT01464398|health education|health education
346560|NCT01464398|women|women
346561|NCT01464398|overweight|overweight
346562|NCT01464398|obesity|obesity
346563|NCT01464372|Urinary Incontinence, Urge|urinary incontinence, urge
346564|NCT01464372|Peripheral Nerve Stimulation|peripheral nerve stimulation
346565|NCT01464359|umbilical cord blood transplant|umbilical cord blood transplant
346566|NCT01464346|diabetes|diabetes
346567|NCT01464346|glucose sensor|glucose sensor
346568|NCT01464346|CGM|cgm
346569|NCT01464333|Crohn's Disease|crohn's disease
346570|NCT01464320|Safety|safety
346571|NCT01464320|Type 2 diabetes|type 2 diabetes
346572|NCT01464320|Kidney disease|kidney disease
346573|NCT01464294|CAD/CAM|cad/cam
346574|NCT01464294|crowns|crowns
346575|NCT01464294|onlays|onlays
346576|NCT01464294|composite block|composite block
346577|NCT01464294|milled restorations|milled restorations
346578|NCT01464281|nucleoside|nucleoside
346579|NCT01464281|peginterferon alfa-2a|peginterferon alfa-2a
346580|NCT01464268|Keratoconus|keratoconus
346581|NCT01464268|Corneal Ectasia|corneal ectasia
346582|NCT01464268|Collagen Crosslinking|collagen crosslinking
346583|NCT01464268|Riboflavin|riboflavin
346584|NCT01464255|contact lenses|contact lenses
346585|NCT01464242|Cutaneous Leishmaniasis|cutaneous leishmaniasis
346586|NCT01464242|pentoxifylline|pentoxifylline
346587|NCT01464242|immunomodulation|immunomodulation
346588|NCT01464216|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
346589|NCT01464216|Prostate cancer|prostate cancer
346590|NCT01464216|FACBC PET|facbc pet
346591|NCT01464216|Hypoxia imaging|hypoxia imaging
346592|NCT01464203|Computed tomographic coronary angiography|computed tomographic coronary angiography
346593|NCT01464203|multi-slice CT|multi-slice ct
346594|NCT01464203|angina|angina
346595|NCT01464203|cost-effectiveness|cost-effectiveness
346596|NCT01464190|PA21|pa21
346597|NCT01464190|Phosphate Binder|phosphate binder
346598|NCT01464177|malignant glioma|malignant glioma
346599|NCT01464177|glioblastoma|glioblastoma
346600|NCT01464177|radiotherapy|radiotherapy
346601|NCT01464177|randomized|randomized
346602|NCT01464164|Diamond Blackfan anemia|diamond blackfan anemia
346603|NCT01464164|DBA|dba
346604|NCT01464164|Blackfan Diamond anemia|blackfan diamond anemia
346605|NCT01464164|Congenital pure red cell aplasia|congenital pure red cell aplasia
346606|NCT01464164|Aase-Smith II Syndrome|aase-smith ii syndrome
346607|NCT01464164|Aase Syndrome|aase syndrome
346608|NCT01464164|Anemia, Congenital Pure Red Cell|anemia, congenital pure red cell
346609|NCT01464164|Aplasia, Congenital Pure Red Cell|aplasia, congenital pure red cell
346610|NCT01464164|BDA|bda
346611|NCT01464164|Congenital Hypoplastic Anemia|congenital hypoplastic anemia
346612|NCT01464164|Erythrogenesis Imperfecta|erythrogenesis imperfecta
346613|NCT01464164|Hypoplastic Congenital Anemia|hypoplastic congenital anemia
346614|NCT01464164|Inherited Erythroblastopenia|inherited erythroblastopenia
346615|NCT01464164|pure red cell aplasia|pure red cell aplasia
346616|NCT01464164|bone marrow failure syndrome|bone marrow failure syndrome
346617|NCT01464151|IBD|ibd
346618|NCT01464151|colitis|colitis
346619|NCT01464151|dysplasia|dysplasia
346620|NCT01464151|colorectal cancer|colorectal cancer
346621|NCT01464138|Malaria|malaria
346622|NCT01464125|Malaria|malaria
346623|NCT01464125|Plasmodium falciparum|plasmodium falciparum
346624|NCT01464125|acute uncomplicated|acute uncomplicated
346625|NCT01464112|Multiple myeloma that has relapsed or is progressive following prior therapy|multiple myeloma that has relapsed or is progressive following prior therapy
346626|NCT01464112|Relapsed Multiple Myeloma|relapsed multiple myeloma
346627|NCT01464112|JNJ 26481585|jnj 26481585
346628|NCT01464112|VELCADE|velcade
346629|NCT01464112|Bortezomib|bortezomib
346630|NCT01464112|Dexamethasone|dexamethasone
346631|NCT01464086|patients with Li Fraumeni syndrome|patients with li fraumeni syndrome
346632|NCT01464073|NIDDM|niddm
346633|NCT01464073|obesity|obesity
346634|NCT01464073|lifestyle intervention|lifestyle intervention
346635|NCT01464073|physical exercise|physical exercise
346636|NCT01464073|diet|diet
346637|NCT01464073|LIPOXmax|lipoxmax
346638|NCT01464073|FATmax|fatmax
346639|NCT01464073|fat oxydation rate|fat oxydation rate
346640|NCT01464060|Helicobacter pylori|helicobacter pylori
346641|NCT01464060|Quadruple therapy|quadruple therapy
346642|NCT01464060|Clarithromycin resistance|clarithromycin resistance
346643|NCT01464021|Study|study
346644|NCT01464021|prospective|prospective
346645|NCT01464021|Rheumatoid|rheumatoid
346646|NCT01464021|Observational study|observational study
346647|NCT01464021|Arthritis|arthritis
346648|NCT01464021|Adalimumab|adalimumab
346649|NCT01463995|severe neurological diseases|severe neurological diseases
346650|NCT01463995|neurological intensive care unit|neurological intensive care unit
346651|NCT01463995|prediction|prediction
346652|NCT01463995|long-term outcome|long-term outcome
346653|NCT01463995|biomarkers|biomarkers
346654|NCT01463995|prediction of long-term outcome|prediction of long-term outcome
346655|NCT01463982|Advanced solid cancer|advanced solid cancer
346656|NCT01463969|PCOS and PTX3 levels|pcos and ptx3 levels
346657|NCT01463956|Boceprevir|boceprevir
346658|NCT01463956|HCV infection|hcv infection
346659|NCT01463956|Antiviral therapy|antiviral therapy
346660|NCT01463956|Liver transplantation|liver transplantation
346661|NCT01463930|Total Knee Replacement|total knee replacement
346662|NCT01463930|Expectations|expectations
346663|NCT01463930|Audiovisual videodisc|audiovisual videodisc
346664|NCT01463917|Coronary Artery Bypass|coronary artery bypass
346665|NCT01463917|Off-Pump|off-pump
346666|NCT01463917|Saline Solution|saline solution
346667|NCT01463917|Hypertonic|hypertonic
346668|NCT01463904|Morbid obesity|morbid obesity
346669|NCT01463904|duodenal switch|duodenal switch
346670|NCT01463904|diabetes|diabetes
346671|NCT01463904|decrease in cardiac risk|decrease in cardiac risk
346672|NCT01463904|remission of T2DM|remission of t2dm
346673|NCT01463891|Eribulin Mesylate|eribulin mesylate
346674|NCT01463891|inoperable or recurrent breast cancer|inoperable or recurrent breast cancer
346675|NCT01463878|glycemic control|glycemic control
346676|NCT01463878|glycemic variability|glycemic variability
346677|NCT01463878|mean blood glucose level|mean blood glucose level
346678|NCT01463852|vincristine|vincristine
346679|NCT01463852|JNK|jnk
346680|NCT01463852|phosphorylation|phosphorylation
346681|NCT01463852|cll|cll
346682|NCT01463852|vinca alkaloid|vinca alkaloid
346683|NCT01463852|apoptosis|apoptosis
346684|NCT01463839|sleep disorder|sleep disorder
346685|NCT01463839|malocclusion|malocclusion
346687|NCT01463826|bruxism|bruxism
346688|NCT01463826|children|children
346689|NCT01463826|oral breathing|oral breathing
346690|NCT01463826|dental caries|dental caries
346691|NCT01463813|bone density conservation agents|bone density conservation agents
346692|NCT01463813|cancer|cancer
346693|NCT01463813|cardiovascular disease|cardiovascular disease
346694|NCT01463813|cholecalciferol|cholecalciferol
346695|NCT01463813|diabetes mellitus, type 2|diabetes mellitus, type 2
346696|NCT01463813|dietary supplements|dietary supplements
346697|NCT01463813|primary prevention|primary prevention
346698|NCT01463813|vitamin D|vitamin d
346699|NCT01463800|Heart Defects, congenital|heart defects, congenital
346700|NCT01463787|Infertility|infertility
346701|NCT01463787|varicocelectomy|varicocelectomy
346702|NCT01463787|microsurgery|microsurgery
346703|NCT01463787|Chinese men|chinese men
346704|NCT01463787|pregnancy rate|pregnancy rate
346705|NCT01463774|Healthy Volunteers|healthy volunteers
346706|NCT01463774|Bioequivalence|bioequivalence
346707|NCT01463774|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
346708|NCT01463774|Metformin|metformin
346709|NCT01463761|High-level athlete|high-level athlete
346802|NCT01463332|Propofol|propofol
346710|NCT01463761|ANS activity|ans activity
346711|NCT01463761|Overtraining|overtraining
346712|NCT01463735|Cirrhotic patients|cirrhotic patients
346713|NCT01463722|Respiratory distress syndrome|respiratory distress syndrome
346714|NCT01463722|Lung maturity|lung maturity
346715|NCT01463722|lamellar body|lamellar body
346716|NCT01463709|basal cell carcinoma|basal cell carcinoma
346717|NCT01463709|Basal Cell Nevus Syndrome|basal cell nevus syndrome
346718|NCT01463709|Electric Field|electric field
346719|NCT01463709|Nanosecond pulse|nanosecond pulse
346720|NCT01463670|LENALIDOMIDE (CC-5013)|lenalidomide (cc-5013)
346721|NCT01463670|BONE MARROW|bone marrow
346722|NCT01463670|11-107|11-107
346723|NCT01463657|Aging|aging
346724|NCT01463644|Mepolizumab|mepolizumab
346725|NCT01463644|COPD|copd
346726|NCT01463644|eosinophilic bronchitis|eosinophilic bronchitis
346727|NCT01463644|exacerbation|exacerbation
346728|NCT01463644|anti-interleukin 5 (IL5)|anti-interleukin 5 (il5)
346729|NCT01462799|PBL|pbl
346730|NCT01462799|patient education|patient education
346731|NCT01462799|coronary heart disease|coronary heart disease
346732|NCT01462799|empowerment|empowerment
346733|NCT01462799|self-efficacy|self-efficacy
346734|NCT01462799|self-care|self-care
346735|NCT01462799|Focus on to determine the long term effectiveness of PBL in patient education by comparison of standardized homesent information in patients with CHD.|focus on to determine the long term effectiveness of pbl in patient education by comparison of standardized homesent information in patients with chd.
346736|NCT01462799|Further focus is on patients' self-care goals, beliefs, self-efficacy and empowerment to make lifestyle changes.|further focus is on patients' self-care goals, beliefs, self-efficacy and empowerment to make lifestyle changes.
346737|NCT01462773|malignant|malignant
346738|NCT01462773|melanoma|melanoma
346739|NCT01463605|radiotherapy|radiotherapy
346740|NCT01463605|targeted therapy|targeted therapy
346741|NCT01463605|esophageal cancer|esophageal cancer
346742|NCT01463605|older|older
346743|NCT01463592|Renessans|renessans
346744|NCT01463592|HCV|hcv
337421|NCT01502189|parents|parents
346745|NCT01463579|Intensive Care Unit|intensive care unit
346746|NCT01463579|Critical Illness|critical illness
346747|NCT01463579|Rehabilitation|rehabilitation
346748|NCT01463579|Exercise Programme|exercise programme
346749|NCT01463566|arthritis|arthritis
346750|NCT01463553|primary spontaneous pneumothorax|primary spontaneous pneumothorax
346751|NCT01463553|VATS|vats
346752|NCT01463553|pleurodesis|pleurodesis
346753|NCT01463553|recurrence rate|recurrence rate
346754|NCT01463540|Enteral nutrition|enteral nutrition
346755|NCT01463540|Gastrostomy, adverse effects|gastrostomy, adverse effects
346756|NCT01463540|Gastrostomy, nursing|gastrostomy, nursing
346757|NCT01463540|Endoscopy,gastrointestinal|endoscopy,gastrointestinal
346758|NCT01463540|Surgical wound infection|surgical wound infection
346759|NCT01463527|Hypoventilation during sedation|hypoventilation during sedation
346760|NCT01463527|Hypoxia associated with hypoventilation|hypoxia associated with hypoventilation
346761|NCT01463514|Pulmonary Hypertension,|pulmonary hypertension,
346762|NCT01463514|NIRS,|nirs,
346763|NCT01463514|Near-infrared spectroscopy,|near-infrared spectroscopy,
346770|NCT01463475|MSC|msc
346771|NCT01463475|Allogeneic|allogeneic
346772|NCT01463475|Bone marrow cells|bone marrow cells
346773|NCT01463475|Healthy subject donors|healthy subject donors
346774|NCT01463475|Collection of MSC from bone marrow aspirate|collection of msc from bone marrow aspirate
346775|NCT01463475|Bronchiolitis obliterans syndrome (BOS)|bronchiolitis obliterans syndrome (bos)
346776|NCT01463449|Obesity|obesity
346777|NCT01463449|Soluble-CD163|soluble-cd163
346778|NCT01463449|Macrophage|macrophage
346779|NCT01463449|Inflammation|inflammation
346780|NCT01463436|endothelial function|endothelial function
346781|NCT01463436|postmenopausal|postmenopausal
346782|NCT01463436|soy isoflavone supplementation|soy isoflavone supplementation
346783|NCT01463436|osteoporosis|osteoporosis
346413|NCT01465048|Malaria|malaria
346784|NCT01463384|Magnetic Resonance Imaging|magnetic resonance imaging
346785|NCT01463384|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
346786|NCT01463384|Neuroinflammation|neuroinflammation
346787|NCT01463384|Mild Cognitive Impairment|mild cognitive impairment
346788|NCT01463384|Alzheimer's Disease|alzheimer's disease
346789|NCT01463384|Minocycline|minocycline
346790|NCT01463371|Bronchiectasis|bronchiectasis
346791|NCT01463371|Oxidative stress markers|oxidative stress markers
346792|NCT01463371|Airway inflammation|airway inflammation
346793|NCT01463358|Syncope|syncope
346794|NCT01463358|Bifascicular block|bifascicular block
346795|NCT01463358|Bradycardia pacing|bradycardia pacing
346796|NCT01463345|Blood conservation|blood conservation
346797|NCT01463345|Transfusion|transfusion
346798|NCT01463345|Hemoglobin trigger|hemoglobin trigger
346799|NCT01463345|Transfusion trigger|transfusion trigger
346800|NCT01463345|Cardiac surgery|cardiac surgery
346801|NCT01463345|Transfusion triggers post cardiac surgery|transfusion triggers post cardiac surgery
346804|NCT01463332|Dexmedetomidine|dexmedetomidine
346805|NCT01463319|colonoscopy|colonoscopy
346806|NCT01463319|warm water method|warm water method
346807|NCT01463319|hydrocolonoscopy|hydrocolonoscopy
346808|NCT01463319|unsedated colonoscopy|unsedated colonoscopy
346817|NCT01463293|constipation|constipation
346818|NCT01463293|probiotic|probiotic
346819|NCT01463293|functional constipation|functional constipation
346820|NCT01463293|IBS-C|ibs-c
346821|NCT01463280|Platelets|platelets
346822|NCT01463280|Inhibition|inhibition
346823|NCT01463280|Lidocaine|lidocaine
346824|NCT01463280|Thromboembolism|thromboembolism
346825|NCT01463280|Prevention|prevention
346826|NCT01463280|Lidocaine effects on platelets|lidocaine effects on platelets
346827|NCT01463267|Heart Failure|heart failure
346828|NCT01463254|Femplant|femplant
346829|NCT01463254|AE adverse event|ae adverse event
346830|NCT01463254|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
346831|NCT01463254|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
346832|NCT01463254|ART antiretroviral therapy|art antiretroviral therapy
346833|NCT01463254|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
346834|NCT01463254|DCF data collection forms|dcf data collection forms
346835|NCT01463254|DMC Data Monitoring Committee|dmc data monitoring committee
346836|NCT01463254|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
346837|NCT01463254|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
346838|NCT01463254|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
346839|NCT01463254|ICH International Conference of Harmonisation|ich international conference of harmonisation
346840|NCT01463254|IND Investigational New Drug Application|ind investigational new drug application
346841|NCT01463254|IRB Institutional Review Board|irb institutional review board
346842|NCT01463254|IU international units|iu international units
346843|NCT01463254|mg milligram(s)|mg milligram(s)
346844|NCT01463254|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
346845|NCT01463254|PCR polymerase chain reaction|pcr polymerase chain reaction
346846|NCT01463254|SAE serious adverse event|sae serious adverse event
346847|NCT01463254|µg microgram|µg microgram
346848|NCT01463254|ULN upper limit of the normal range|uln upper limit of the normal range
337526|NCT01501877|Smoking|smoking
346849|NCT01463254|WB Western Blot|wb western blot
346850|NCT01463228|Healthy Volunteers|healthy volunteers
346851|NCT01463228|Bioequivalence|bioequivalence
346852|NCT01463228|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
346853|NCT01463228|Metformin IR|metformin ir
346854|NCT01463215|Ambroxol|ambroxol
346855|NCT01463215|Type I Gaucher Disease|type i gaucher disease
346856|NCT01463202|Postpartum contraception|postpartum contraception
346857|NCT01463202|Contraceptive continuation|contraceptive continuation
346858|NCT01463202|Breastfeeding|breastfeeding
346859|NCT01463202|Postpartum depression|postpartum depression
346860|NCT01463202|Progestins|progestins
346861|NCT01463189|arthritis|arthritis
346862|NCT01463189|self management|self management
346863|NCT01463176|Music Therapy|music therapy
346864|NCT01463176|Child Psychology|child psychology
346865|NCT01463176|Vaccination|vaccination
346866|NCT01463163|Platelet reactivity|platelet reactivity
346867|NCT01463163|Ticagrelor|ticagrelor
346868|NCT01463163|Prasugrel|prasugrel
346869|NCT01463150|Platelet reactivity|platelet reactivity
346870|NCT01463150|Clopidogrel|clopidogrel
346871|NCT01463150|Prasugrel|prasugrel
346872|NCT01463137|social phobia|social phobia
346873|NCT01463137|anxiety|anxiety
346874|NCT01463124|School Nurse|school nurse
346875|NCT01463124|Overweight|overweight
346876|NCT01463124|Obesity|obesity
346877|NCT01463124|Counseling|counseling
346878|NCT01463124|Intervention|intervention
346879|NCT01463124|Exercise|exercise
346880|NCT01463111|Bipolar|bipolar
346881|NCT01463111|Manic depression|manic depression
346882|NCT01463111|Mood stabilizer|mood stabilizer
346883|NCT01463111|Decision|decision
346884|NCT01463111|Neuroeconomics|neuroeconomics
346885|NCT01463059|Rheumatoid Arthritis|rheumatoid arthritis
346886|NCT01463059|Monoclonal Antibody|monoclonal antibody
346887|NCT01463059|Interleukin-6|interleukin-6
346888|NCT01463059|Olokizumab|olokizumab
346889|NCT01463059|CDP6038|cdp6038
346890|NCT01463046|leukemia|leukemia
346891|NCT01463046|AML|aml
346892|NCT01463046|AMS|ams
346893|NCT01463046|panobinostat|panobinostat
346894|NCT01463046|cytarabine|cytarabine
346895|NCT01463046|daunorubicin|daunorubicin
346896|NCT01463046|HDAC|hdac
346897|NCT01463033|Post-Traumatic epilepsy|post-traumatic epilepsy
346898|NCT01463033|Traumatic brain injury|traumatic brain injury
346899|NCT01463033|Epilepsy prevention|epilepsy prevention
346900|NCT01463033|Levetiracetam|levetiracetam
346901|NCT01463020|Depression|depression
346902|NCT01463020|Smartphone|smartphone
346903|NCT01463020|Behavioural activation|behavioural activation
346904|NCT01463020|Mindfulness|mindfulness
346905|NCT01463007|invasive ductal cancer|invasive ductal cancer
346906|NCT01463007|tubular breast cancer|tubular breast cancer
346907|NCT01463007|breast cancer|breast cancer
346908|NCT01463007|colloid|colloid
346909|NCT01463007|ER positive|er positive
346910|NCT01463007|radiation|radiation
346911|NCT01462994|Patients with GIST treated with standard therapy harboring activating mutations of CKIT and PDGFRA|patients with gist treated with standard therapy harboring activating mutations of ckit and pdgfra
346912|NCT01462968|Heparin treatment during cardiac surgery|heparin treatment during cardiac surgery
346913|NCT01462968|Heparin reversal after cardiac surgery|heparin reversal after cardiac surgery
346914|NCT01462968|Thrombin generation|thrombin generation
346915|NCT01462968|Endogenous Thrombin potential|endogenous thrombin potential
346916|NCT01462942|COPD|copd
346917|NCT01462942|Bronchitis|bronchitis
346918|NCT01462942|Chronic|chronic
346919|NCT01462942|Emphysema|emphysema
346920|NCT01462929|COPD|copd
346921|NCT01462929|antimuscarinic|antimuscarinic
346922|NCT01462916|honey|honey
346923|NCT01462916|mucositis|mucositis
346924|NCT01462916|bee products|bee products
346925|NCT01462903|TIL|til
346926|NCT01462903|NPC|npc
346927|NCT01462903|hepatocellular carcinoma|hepatocellular carcinoma
346928|NCT01462903|immunotherapy|immunotherapy
346929|NCT01462890|Ovarian Carcinoma|ovarian carcinoma
346930|NCT01462890|Bevacizumab|bevacizumab
346931|NCT01462890|Paclitaxel|paclitaxel
346932|NCT01462890|Carboplatin|carboplatin
346933|NCT01462877|Lipid Regulating Agents|lipid regulating agents
346934|NCT01462877|Drug Therapy|drug therapy
346935|NCT01462877|cardiovascular diseases|cardiovascular diseases
346936|NCT01462877|hypertriglyceridemia|hypertriglyceridemia
346937|NCT01462877|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
346938|NCT01462877|fenofibrate|fenofibrate
346939|NCT01462877|Dyslipidemias|dyslipidemias
346940|NCT01462877|Combination|combination
346941|NCT01462864|Polycystic Ovary Syndrome|polycystic ovary syndrome
346942|NCT01462864|Lifestyle|lifestyle
346943|NCT01462864|Structured Education|structured education
346944|NCT01462864|Walking Activity|walking activity
346945|NCT01462864|Exercise|exercise
346946|NCT01462864|Overweight|overweight
346947|NCT01462864|Impaired Glucose Regulation|impaired glucose regulation
346948|NCT01462864|Diabetes Prevention|diabetes prevention
346949|NCT01462851|healthy volunteer|healthy volunteer
346950|NCT01462851|safety|safety
346951|NCT01462851|pharmacokinetic|pharmacokinetic
346952|NCT01462851|pharmacodynamic|pharmacodynamic
346953|NCT01462838|advanced HPV-|advanced hpv-
346954|NCT01462838|p16INK4a-positive|p16ink4a-positive
346955|NCT01462838|cervical|cervical
346956|NCT01462838|vulvar,|vulvar,
346957|NCT01462838|vaginal|vaginal
346958|NCT01462838|penile|penile
346959|NCT01462838|anal|anal
346960|NCT01462838|head|head
346961|NCT01462838|neck|neck
346962|NCT01462825|Inflammation|inflammation
346963|NCT01462825|cytokines|cytokines
346964|NCT01462825|chemotaxis|chemotaxis
346965|NCT01462825|tomatoes|tomatoes
346966|NCT01462825|cardiovascular disease|cardiovascular disease
346967|NCT01462812|Migraine|migraine
346968|NCT01462812|Headache|headache
346969|NCT01462812|Sumatriptan|sumatriptan
346970|NCT01462708|Parkinson Disease|parkinson disease
346971|NCT01462708|Molecular NeuroImaging|molecular neuroimaging
346972|NCT01462682|focus group study|focus group study
346973|NCT01462682|sleep deprivation|sleep deprivation
346974|NCT01462682|surgery|surgery
346975|NCT01462669|Ezogabine|ezogabine
346976|NCT01462669|Pharmacokinetics|pharmacokinetics
346977|NCT01462669|Retigabine|retigabine
346978|NCT01462656|anti-epileptic drug|anti-epileptic drug
346979|NCT01462656|ezogabine|ezogabine
346980|NCT01462656|AED polytherapy|aed polytherapy
346981|NCT01462656|epilepsy|epilepsy
346982|NCT01462656|AED monotherapy|aed monotherapy
346983|NCT01462656|retigabine|retigabine
346984|NCT01462656|urinary retention|urinary retention
346985|NCT01462643|Psoriasis Plaque Test|psoriasis plaque test
346986|NCT01462643|topical|topical
346987|NCT01462643|ointment|ointment
346988|NCT01462591|wave reflection|wave reflection
346989|NCT01462591|augmentation Index|augmentation index
346990|NCT01462591|heart rate variability|heart rate variability
346991|NCT01462591|wasted left ventricular energy|wasted left ventricular energy
346992|NCT01462578|Neoplasms benign, malignant and unspecified|neoplasms benign, malignant and unspecified
346993|NCT01462578|Acute myeloid leukemia|acute myeloid leukemia
346995|NCT01462578|Myelodysplastic syndrome|myelodysplastic syndrome
346996|NCT01462578|MDS|mds
346997|NCT01462565|flolan|flolan
347602|NCT01460108|COPD|copd
346998|NCT01462565|pulmonary arterial hypertension|pulmonary arterial hypertension
346999|NCT01462565|thermo stable formulation|thermo stable formulation
347000|NCT01462565|epoprostenol sodium|epoprostenol sodium
347001|NCT01462565|modified sterile diluent|modified sterile diluent
347002|NCT01462552|liver function testing|liver function testing
347003|NCT01462552|Breast cancer|breast cancer
347004|NCT01462552|lapatanib|lapatanib
347005|NCT01462513|Colon carcinoma|colon carcinoma
347006|NCT01462513|Rectum carcinoma|rectum carcinoma
347007|NCT01462513|Liver metastases|liver metastases
347008|NCT01462500|Miltefosine|miltefosine
347009|NCT01462500|pharmacokinetics|pharmacokinetics
347010|NCT01462500|cutaneous leishmaniasis|cutaneous leishmaniasis
347011|NCT01462487|Pregnancy safety|pregnancy safety
347012|NCT01462487|zanamivir|zanamivir
347013|NCT01462487|influenza|influenza
347014|NCT01462474|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
347015|NCT01462461|Phantom Limb|phantom limb
347016|NCT01462461|Amputation, Traumatic|amputation, traumatic
347017|NCT01462461|Electromyography|electromyography
347018|NCT01462461|Visual Analog Pain Scale|visual analog pain scale
347019|NCT01462448|Phantom Limb|phantom limb
347020|NCT01462448|Genetic Variation|genetic variation
347021|NCT01462448|DNA Sequence Analysis|dna sequence analysis
347022|NCT01462448|Amputation, Traumatic|amputation, traumatic
347023|NCT01462448|Single Nucleotide Polymorphism|single nucleotide polymorphism
347024|NCT01462448|Visual Analog Pain Scale|visual analog pain scale
347025|NCT01462448|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
347026|NCT01462448|Inflammatory Antibody|inflammatory antibody
347027|NCT01462448|Peripheral Nerve Damage|peripheral nerve damage
347028|NCT01462422|Postpartum hemorrhage|postpartum hemorrhage
347029|NCT01462422|Prevention|prevention
347030|NCT01462422|Misoprostol|misoprostol
347031|NCT01462422|Developing countries|developing countries
347032|NCT01462422|Nurse midwife|nurse midwife
347033|NCT01462409|obstructive sleep apnea|obstructive sleep apnea
347034|NCT01462409|humidification|humidification
347035|NCT01462409|mask|mask
347036|NCT01462409|heated tubing|heated tubing
347037|NCT01462396|Neuroblastoma|neuroblastoma
347038|NCT01462396|Relapsed|relapsed
347039|NCT01462396|Refractory|refractory
347040|NCT01462383|Advanced Cancer|advanced cancer
347041|NCT01462383|Malignancy|malignancy
347042|NCT01462383|Cardiac complications|cardiac complications
347043|NCT01462383|Electrocardiograms|electrocardiograms
347044|NCT01462383|ECG|ecg
347045|NCT01462383|Chart Review|chart review
347046|NCT01462383|Data Review|data review
347047|NCT01462383|Data Analysis|data analysis
347048|NCT01462383|Phase I|phase i
347049|NCT01462383|Clinical Research Study|clinical research study
347050|NCT01462357|Human papillomavirus|human papillomavirus
347051|NCT01462357|Safety|safety
347052|NCT01462357|HPV vaccine|hpv vaccine
347053|NCT01462357|Immune response|immune response
347054|NCT01462344|pediatric|pediatric
347055|NCT01462344|ADVAIR|advair
347056|NCT01462344|FLOVENT|flovent
347057|NCT01462344|asthma|asthma
347058|NCT01462331|Isomaltooligosaccharide|isomaltooligosaccharide
347059|NCT01462331|Human Consumption|human consumption
347060|NCT01462331|Dose tolerance|dose tolerance
347061|NCT01462331|Prebiotic|prebiotic
347062|NCT01462331|Short chain fatty acids|short chain fatty acids
347063|NCT01462331|Blood glucose|blood glucose
347064|NCT01462331|Dose tolerance and prebiotic effect|dose tolerance and prebiotic effect
725414|NCT01069367|Influenza A|influenza a
347065|NCT01462318|Pre-filled syringe|pre-filled syringe
347066|NCT01462318|Pharmacokinetic|pharmacokinetic
347067|NCT01462318|Daclizumab High Yield Process|daclizumab high yield process
347068|NCT01462318|immunogenicity|immunogenicity
347069|NCT01462305|SAD|sad
347070|NCT01462305|Seasonal Affective Disorder|seasonal affective disorder
347071|NCT01462305|Winter Blues|winter blues
347072|NCT01462305|Seasonal Depression|seasonal depression
347073|NCT01462292|968|968
347074|NCT01462292|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
347075|NCT01462292|Duchenne|duchenne
347076|NCT01462292|GSK|gsk
347077|NCT01462292|DMD|dmd
347078|NCT01462292|GSK2402968|gsk2402968
347079|NCT01462279|acute respiratory failure|acute respiratory failure
347080|NCT01462279|thiamine|thiamine
347081|NCT01462279|oxygen consumption|oxygen consumption
347082|NCT01462279|VO2|vo2
347083|NCT01462253|Adult patients|adult patients
347084|NCT01462253|Refractory|refractory
347085|NCT01462253|Relapsed|relapsed
347086|NCT01462253|clofarabine|clofarabine
347087|NCT01462253|cyclophosphamide|cyclophosphamide
347088|NCT01462253|refractory and relapsed acute lymphoblastic leukemia|refractory and relapsed acute lymphoblastic leukemia
347089|NCT01462253|ALL|all
347090|NCT01462240|arthritis|arthritis
347091|NCT01462227|Hypoglycemia|hypoglycemia
347092|NCT01462227|Type 1 diabetes|type 1 diabetes
347093|NCT01462201|focused ultrasound|focused ultrasound
347094|NCT01462201|mechanical fat destruction|mechanical fat destruction
347095|NCT01462201|Body Sculpting|body sculpting
347096|NCT01462188|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
347097|NCT01462188|Primary angioplasty|primary angioplasty
347100|NCT01462097|Chronic kidney disease|chronic kidney disease
347101|NCT01462097|Exercise|exercise
347102|NCT01462097|Aerobic capacity|aerobic capacity
347103|NCT01462097|Learning and memory|learning and memory
347104|NCT01462097|Executive function|executive function
347105|NCT01462097|Endothelial function|endothelial function
347106|NCT01462084|sleeping|sleeping
347107|NCT01462084|opioid medications|opioid medications
347108|NCT01462084|positive airway pressure|positive airway pressure
347109|NCT01462058|SPAQ|spaq
347110|NCT01462058|Sigh-SAD|sigh-sad
347111|NCT01462058|Hamilton 29|hamilton 29
347112|NCT01462058|Vitamin D3|vitamin d3
347113|NCT01462058|p25(OH)D|p25(oh)d
347114|NCT01462045|Exercise|exercise
347115|NCT01462045|Stress|stress
347116|NCT01462045|PTSD|ptsd
347117|NCT01462045|Mindfulness|mindfulness
347118|NCT01462045|Breathing|breathing
347119|NCT01462045|Cortisol|cortisol
347120|NCT01462032|Preschool Children|preschool children
347121|NCT01462032|ADHD|adhd
347122|NCT01462032|Treatment|treatment
347123|NCT01462032|Non-pharmacological|non-pharmacological
347124|NCT01462019|nipple trauma|nipple trauma
347125|NCT01462019|breast feeding|breast feeding
347126|NCT01462019|phototherapy|phototherapy
347127|NCT01462019|wound healing|wound healing
347128|NCT01461993|vaccine|vaccine
347129|NCT01461993|rLP2086|rlp2086
347130|NCT01461993|Gardasil|gardasil
347131|NCT01461993|HPV|hpv
347132|NCT01461993|meningitis B|meningitis b
347133|NCT01461993|N. meningitidis serogroup B|n. meningitidis serogroup b
347134|NCT01461993|adolescents|adolescents
347135|NCT01461993|single-blind|single-blind
347136|NCT01461993|Meningococcal Vaccines|meningococcal vaccines
347137|NCT01461980|vaccine|vaccine
347138|NCT01461980|rLP2086|rlp2086
347139|NCT01461980|MCV4|mcv4
347140|NCT01461980|Tdap|tdap
347141|NCT01461980|meningitis B|meningitis b
347142|NCT01461980|N. meningitidis serogroup B|n. meningitidis serogroup b
347143|NCT01461980|adolescents|adolescents
347144|NCT01461980|observer-blind|observer-blind
347145|NCT01461941|Dermatitis|dermatitis
347146|NCT01461941|Atopic|atopic
347147|NCT01461915|Pancreatic Cancer|pancreatic cancer
347148|NCT01461902|traumatic brain injury|traumatic brain injury
347149|NCT01461902|brain injury|brain injury
347150|NCT01461902|head injury|head injury
347151|NCT01461902|vasospasm|vasospasm
347152|NCT01461889|transfusion-related acute lung injury|transfusion-related acute lung injury
347153|NCT01461889|Blood Component Transfusion|blood component transfusion
347154|NCT01461889|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
347155|NCT01461889|Cirrhosis|cirrhosis
347156|NCT01461889|Fresh frozen plasma|fresh frozen plasma
347157|NCT01461837|sickle cell disease|sickle cell disease
347158|NCT01461837|stem cell transplantation|stem cell transplantation
347159|NCT01461837|haploidentical|haploidentical
347160|NCT01461824|Birth Control|birth control
347161|NCT01461824|Contraceptive Methods|contraceptive methods
347162|NCT01461824|Female Contraception|female contraception
347163|NCT01461824|Weight Gain|weight gain
347164|NCT01461824|Bone Density|bone density
347165|NCT01461811|toric|toric
347166|NCT01461811|contact lenses|contact lenses
347167|NCT01461811|daily disposable contact lenses|daily disposable contact lenses
347168|NCT01461811|astigmatism|astigmatism
347169|NCT01461811|soft contact lenses|soft contact lenses
726202|NCT01071603|Biomarkers|biomarkers
347170|NCT01461811|contact lens comfort|contact lens comfort
347171|NCT01461798|plant stanols|plant stanols
347173|NCT01461798|cardiovascular disease|cardiovascular disease
347174|NCT01461785|Platelet rich plasma|platelet rich plasma
347175|NCT01461785|Dermal improvement|dermal improvement
347176|NCT01461785|Graft survival|graft survival
347177|NCT01461733|atrial fibrillation|atrial fibrillation
347178|NCT01461733|amiodarone|amiodarone
347179|NCT01461720|Bone marrow|bone marrow
347180|NCT01461720|Autologous|autologous
347181|NCT01461720|Mesenchymal stem cells|mesenchymal stem cells
347182|NCT01461720|Unilateral middle cerebral artery infarct|unilateral middle cerebral artery infarct
347183|NCT01461707|Cellular phone|cellular phone
347184|NCT01461707|exercise|exercise
347185|NCT01461707|pregnant women|pregnant women
347186|NCT01461707|obesity|obesity
347187|NCT01461707|overweight|overweight
347188|NCT01461707|physical activity|physical activity
347189|NCT01461694|Hirsutism|hirsutism
347190|NCT01461694|Laser|laser
347191|NCT01461694|Hair Reduction|hair reduction
347192|NCT01461694|IPL|ipl
347193|NCT01461694|Intense Pulsed Light|intense pulsed light
347194|NCT01461681|Palliative care|palliative care
347195|NCT01461681|Symptom management|symptom management
347196|NCT01461681|Heart failure|heart failure
347197|NCT01461668|MRSA|mrsa
347198|NCT01461668|MRSA resistant to mupirocin|mrsa resistant to mupirocin
347199|NCT01461642|Asthma|asthma
347200|NCT01461642|ICT Support|ict support
347201|NCT01461642|ACT|act
347202|NCT01461642|PEF|pef
347203|NCT01461629|cognitive impairment|cognitive impairment
347204|NCT01461629|cognitive function|cognitive function
347205|NCT01461629|hospitalization|hospitalization
347603|NCT01460108|emphysema|emphysema
347206|NCT01461629|self-management|self-management
347207|NCT01461629|cardiac disease|cardiac disease
347208|NCT01461629|heart failure|heart failure
347209|NCT01461616|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
347210|NCT01461603|critical illness|critical illness
347211|NCT01461603|protein metabolism|protein metabolism
347212|NCT01461603|pharmaconutrients|pharmaconutrients
347213|NCT01461564|screening|screening
347214|NCT01461564|colonoscopy|colonoscopy
347215|NCT01461564|carbon dioxide|carbon dioxide
347216|NCT01461564|air|air
347217|NCT01461564|pain score|pain score
347218|NCT01461564|complications|complications
347219|NCT01461551|troponin I|troponin i
347220|NCT01461551|creatine kinase mb|creatine kinase mb
347221|NCT01461551|hospital days|hospital days
347222|NCT01461551|lymphocyte apoptosis|lymphocyte apoptosis
347223|NCT01461551|intensive care unit days|intensive care unit days
347224|NCT01461538|Acute Lymphoid Leukemia|acute lymphoid leukemia
347225|NCT01461538|Myelodysplastic Syndrome|myelodysplastic syndrome
347226|NCT01461538|Acute Myeloid Leukemia|acute myeloid leukemia
347227|NCT01461538|Solid Tumors|solid tumors
347228|NCT01461538|Anemia, Refractory, with Excess of Blasts|anemia, refractory, with excess of blasts
347229|NCT01461538|Antibodies, Monoclonal|antibodies, monoclonal
347230|NCT01461538|Antibody-Drug Conjugate|antibody-drug conjugate
347231|NCT01461538|Antigens, CD30|antigens, cd30
347232|NCT01461538|Drug Therapy|drug therapy
347233|NCT01461538|Hematologic Diseases|hematologic diseases
347234|NCT01461538|Immunotherapy|immunotherapy
347235|NCT01461538|Monomethyl Auristatin E|monomethyl auristatin e
347236|NCT01461525|Low Rectal Cancer|low rectal cancer
347237|NCT01461525|Sphincter preservation|sphincter preservation
347238|NCT01461525|Abdominoperineal resection|abdominoperineal resection
347239|NCT01461525|Quality of life|quality of life
347240|NCT01461525|Sexual function|sexual function
347241|NCT01461525|Urinary function|urinary function
347242|NCT01461525|Oncologic outcome|oncologic outcome
347243|NCT01461499|Hypertension|hypertension
347244|NCT01461499|Albuminuria|albuminuria
347245|NCT01461499|Direct renin inhibitor|direct renin inhibitor
347246|NCT01461499|Angiotensin receptor blocker|angiotensin receptor blocker
347247|NCT01461499|Type 2 diabetes|type 2 diabetes
347248|NCT01461486|Continuous positive airway pressure|continuous positive airway pressure
347249|NCT01461486|Oral appliance|oral appliance
347250|NCT01461486|mild Obstructive Sleep Apnea Syndrome|mild obstructive sleep apnea syndrome
347251|NCT01461473|Obstructive Sleep Apnea|obstructive sleep apnea
347252|NCT01461473|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
347253|NCT01461473|Sleep Apnea Syndrome, Obstructive|sleep apnea syndrome, obstructive
347254|NCT01461473|Syndrome, Obstructive Sleep Apnea|syndrome, obstructive sleep apnea
347255|NCT01461473|Syndrome, Sleep Apnea, Obstructive|syndrome, sleep apnea, obstructive
347256|NCT01461473|Syndrome, Upper Airway Resistance, Sleep Apnea|syndrome, upper airway resistance, sleep apnea
337930|NCT01500161|AML|aml
347257|NCT01461473|Upper Airway Resistance Sleep Apnea Syndrome|upper airway resistance sleep apnea syndrome
347258|NCT01461460|volunteer|volunteer
347259|NCT01461434|atrial fibrillation|atrial fibrillation
347260|NCT01461434|biomarkers|biomarkers
347261|NCT01461434|stroke prevention|stroke prevention
347262|NCT01461434|implantable loop recorder|implantable loop recorder
347263|NCT01461421|Obesity|obesity
347264|NCT01461421|Primary Care|primary care
347265|NCT01461421|Behavior Modification|behavior modification
347266|NCT01461408|HPV Vaccination|hpv vaccination
347267|NCT01461408|Beauty Salons|beauty salons
347268|NCT01461408|Health Education|health education
347269|NCT01461408|Sexual Health|sexual health
347270|NCT01461395|IVF|ivf
347271|NCT01461343|pulmonary hypertension, PET imaging, CT/PET|pulmonary hypertension, pet imaging, ct/pet
347272|NCT01461330|diabetes|diabetes
347273|NCT01461330|exercise|exercise
347274|NCT01461330|DASH diet|dash diet
347275|NCT01461330|ABPM|abpm
347276|NCT01461304|fatty acid oxidation|fatty acid oxidation
347277|NCT01461304|triheptanoin|triheptanoin
347278|NCT01461304|long-chain fatty acid oxidation disorders|long-chain fatty acid oxidation disorders
347279|NCT01461304|LCHADD|lchadd
347280|NCT01461304|VLCADD|vlcadd
347281|NCT01461304|CPT1|cpt1
347282|NCT01461304|CPT2|cpt2
347283|NCT01461304|TFP|tfp
347284|NCT01461304|Glycogen Storage Disorders|glycogen storage disorders
347285|NCT01461304|GSD|gsd
347286|NCT01461304|Pyruvate Carboxylase|pyruvate carboxylase
347287|NCT01461304|PC|pc
347288|NCT01461304|ACAD9|acad9
347289|NCT01461304|Barth|barth
347290|NCT01461291|Primary open-angle glaucoma|primary open-angle glaucoma
347291|NCT01461291|POAG|poag
347292|NCT01461291|Trabecular meshwork|trabecular meshwork
347293|NCT01461291|iStent inject|istent inject
347294|NCT01461278|Primary open-angle glaucoma|primary open-angle glaucoma
347295|NCT01461278|POAG|poag
347296|NCT01461278|Cataract surgery|cataract surgery
347297|NCT01461278|Suprachoroidal space|suprachoroidal space
347298|NCT01461278|Suprachoroidal stent|suprachoroidal stent
347299|NCT01461278|iStent supra|istent supra
347300|NCT01461265|Painful bone metastases|painful bone metastases
347301|NCT01461265|Bone metastases|bone metastases
347302|NCT01461265|Metastatic bone tumors|metastatic bone tumors
347303|NCT01461265|Metastatic bone pain|metastatic bone pain
347304|NCT01461265|Cryoablation|cryoablation
347305|NCT01461265|Cryotherapy|cryotherapy
347306|NCT01461265|Cryosurgery|cryosurgery
347307|NCT01461252|Painful bone metastases|painful bone metastases
347308|NCT01461252|Bone metastases|bone metastases
347309|NCT01461252|Metastatic bone tumors|metastatic bone tumors
347310|NCT01461252|Metastatic bone pain|metastatic bone pain
347311|NCT01461252|Cryoablation|cryoablation
347312|NCT01461252|Cryotherapy|cryotherapy
347313|NCT01461252|Cryosurgery|cryosurgery
347314|NCT01461252|Radiation therapy|radiation therapy
347315|NCT01461252|Radiotherapy|radiotherapy
347316|NCT01461239|survival|survival
347317|NCT01461239|debonding|debonding
347318|NCT01461239|endodontic treated teeth|endodontic treated teeth
347319|NCT01461226|overweight|overweight
347320|NCT01461226|cardiovascular risk factors|cardiovascular risk factors
347321|NCT01461226|exercise training|exercise training
347322|NCT01461226|endothelial function|endothelial function
347323|NCT01461226|endothelium|endothelium
347324|NCT01461226|endothelial progenitor cells|endothelial progenitor cells
347325|NCT01461213|Tapetoretinal degeneration, choroideraemia, X-linked|tapetoretinal degeneration, choroideraemia, x-linked
347326|NCT01461213|retinitis pigmentosa|retinitis pigmentosa
347327|NCT01461187|Exercise|exercise
347328|NCT01461187|Pregnancy|pregnancy
347329|NCT01461187|Childbirth|childbirth
347331|NCT01461187|Cesarean section|cesarean section
347332|NCT01461174|Sleep deprivation|sleep deprivation
347333|NCT01461174|Cognitive Functions|cognitive functions
347334|NCT01461174|young male|young male
347335|NCT01461148|UICC stage III/IV MSI-H colorectal cancer|uicc stage iii/iv msi-h colorectal cancer
347336|NCT01461109|Parkinson Disease|parkinson disease
347337|NCT01461109|Alzheimer Disease|alzheimer disease
347338|NCT01461109|[18F] CFPyPB|[18f] cfpypb
347339|NCT01461109|GlyT1|glyt1
347340|NCT01461083|Parkinson Disease|parkinson disease
347341|NCT01461083|[18F]MPPF|[18f]mppf
347342|NCT01461070|Breast Cancer|breast cancer
347343|NCT01461070|Post Menopausal Estrogens|post menopausal estrogens
347344|NCT01461070|Fecal Microbes|fecal microbes
347345|NCT01461031|pain|pain
347346|NCT01461031|orthognathic|orthognathic
347347|NCT01461018|Immune globulin subcutaneous|immune globulin subcutaneous
347348|NCT01461018|SCIG|scig
347349|NCT01461018|Primary immunodeficiency|primary immunodeficiency
347350|NCT01461018|PID|pid
347351|NCT01461005|Spondylolisthesis|spondylolisthesis
347352|NCT01461005|Neurologic impairment|neurologic impairment
347353|NCT01461005|Kyphosis|kyphosis
347354|NCT01461005|Pseudarthrosis|pseudarthrosis
347355|NCT01460992|Pacemaker therapy|pacemaker therapy
347356|NCT01460992|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
338058|NCT01499706|HIV|hiv
347357|NCT01460992|EVIA/ENTOVIS|evia/entovis
347358|NCT01460979|Ovarian Cancer|ovarian cancer
347359|NCT01460979|Endometrial Carcinoma|endometrial carcinoma
347360|NCT01460979|Temsirolimus|temsirolimus
347361|NCT01460966|Distal protection device|distal protection device
347362|NCT01460966|Thrombus aspiration|thrombus aspiration
347363|NCT01460966|Coronary Artery Disease|coronary artery disease
347364|NCT01460966|Coronary Disease|coronary disease
347365|NCT01460966|Acute Coronary Syndrome|acute coronary syndrome
347366|NCT01460953|curriculum|curriculum
347367|NCT01460953|training|training
347368|NCT01460953|Medical student Knowledge|medical student knowledge
347369|NCT01460940|refractory Hodgkin's lymphoma|refractory hodgkin's lymphoma
347370|NCT01460940|panobinostat|panobinostat
347371|NCT01460940|lenalidomide|lenalidomide
347373|NCT01460914|CTCL|ctcl
347374|NCT01460914|Extracorporeal photopheresis|extracorporeal photopheresis
347375|NCT01460914|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
347376|NCT01460914|GVHD|gvhd
347377|NCT01460914|Graft versus host disease|graft versus host disease
347378|NCT01460901|Neuroblastoma|neuroblastoma
347379|NCT01460901|Relapsed|relapsed
347380|NCT01460901|Refractory|refractory
347381|NCT01460875|high risk melanoma|high risk melanoma
347382|NCT01460875|lymph node disease|lymph node disease
347383|NCT01460862|Asthma|asthma
347384|NCT01460862|Omalizumab|omalizumab
347385|NCT01460849|Cystic fibrosis|cystic fibrosis
347386|NCT01460836|Cystic fibrosis|cystic fibrosis
347387|NCT01460823|Hearing loss|hearing loss
347388|NCT01460823|Cochlear Implantation|cochlear implantation
347389|NCT01460823|Image guided surgery|image guided surgery
347390|NCT01460797|Glycemic index|glycemic index
347391|NCT01460797|Caloric restriction|caloric restriction
347392|NCT01460797|Energy intake|energy intake
347393|NCT01460797|Glucose|glucose
347394|NCT01460797|Lipid Metabolism|lipid metabolism
347395|NCT01460797|Cholesterol|cholesterol
347396|NCT01460797|HDL Cholesterol|hdl cholesterol
347397|NCT01460797|LDL Cholesterol|ldl cholesterol
347398|NCT01460797|Obesity|obesity
347399|NCT01460797|Metformin|metformin
347400|NCT01460784|Metabolic dysfunction|metabolic dysfunction
347401|NCT01460784|Insulin resistance|insulin resistance
347402|NCT01460784|Brown adipose tissue|brown adipose tissue
347403|NCT01460784|Dyslipidemia|dyslipidemia
347404|NCT01460771|childhood dystonia|childhood dystonia
347405|NCT01460758|Depression|depression
347406|NCT01460758|Transcranial magnetic stimulation|transcranial magnetic stimulation
347407|NCT01460758|rTMS|rtms
347408|NCT01460758|DLPFC|dlpfc
347409|NCT01460758|medial frontal cortex|medial frontal cortex
347410|NCT01460758|anterior cingulate complex|anterior cingulate complex
347411|NCT01460745|Erbitux|erbitux
347412|NCT01460745|CRC|crc
347413|NCT01460745|mCRC|mcrc
347414|NCT01460745|Liver|liver
347415|NCT01460745|Metastases|metastases
347416|NCT01460732|Hypertension|hypertension
347417|NCT01460732|Nocturnal BP dipping|nocturnal bp dipping
347418|NCT01460732|Home Blood pressure Monitoring|home blood pressure monitoring
347419|NCT01460732|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
347420|NCT01460706|Glioma|glioma
347421|NCT01460706|68Ga-DOTATOC|68ga-dotatoc
347422|NCT01460706|PET/CT|pet/ct
347423|NCT01460706|Somatostatin receptor|somatostatin receptor
347424|NCT01460693|Leukemia|leukemia
347425|NCT01460693|Myeloid|myeloid
347426|NCT01460693|Chronic|chronic
347427|NCT01460693|Chronic-Phase|chronic-phase
347428|NCT01460693|CML|cml
347429|NCT01460680|Fibromyalgia|fibromyalgia
347430|NCT01460680|Systemic Lupus Erythematosus|systemic lupus erythematosus
347431|NCT01460680|Omega-3 Fatty acids|omega-3 fatty acids
347432|NCT01460680|Magnesium|magnesium
347433|NCT01460667|Laparoscopic Roux-en-Y Gastric Bypass|laparoscopic roux-en-y gastric bypass
347434|NCT01460667|Post-Operative Pain|post-operative pain
347435|NCT01460667|IV Acetaminophen|iv acetaminophen
347436|NCT01460667|Post-Operative Nausea and Vomiting|post-operative nausea and vomiting
347437|NCT01460628|fatigue|fatigue
347438|NCT01460628|menopausal symptoms|menopausal symptoms
347439|NCT01460628|hot flashes|hot flashes
347440|NCT01460628|Vasomotor symptoms|vasomotor symptoms
347441|NCT01460628|perimenopause|perimenopause
347442|NCT01460628|related Quality of life|related quality of life
347443|NCT01460615|Postoperative pancreatitis|postoperative pancreatitis
347444|NCT01460615|Postoperative complications|postoperative complications
347445|NCT01460615|Delayed gastric emptying|delayed gastric emptying
347446|NCT01460615|Leakage|leakage
347447|NCT01460615|Fistula|fistula
347448|NCT01460615|Acinar cell|acinar cell
347449|NCT01460615|Risk patient|risk patient
347450|NCT01460615|Pancreaticoduodenectomy|pancreaticoduodenectomy
347451|NCT01460615|Whipple|whipple
347452|NCT01460615|Cortisone|cortisone
347453|NCT01460602|Lymphoma|lymphoma
347454|NCT01460602|Follicular|follicular
347455|NCT01460602|Marginal Zone|marginal zone
347456|NCT01460602|Mantle Cell|mantle cell
347457|NCT01460602|Velcade|velcade
347458|NCT01460602|bortezomib|bortezomib
347459|NCT01460602|Nipent|nipent
347460|NCT01460602|pentastatin|pentastatin
347461|NCT01460602|Rituxan|rituxan
347462|NCT01460602|rituximab|rituximab
347463|NCT01460602|Turturro|turturro
347464|NCT01460602|Shreveport|shreveport
347465|NCT01460589|colon cancer|colon cancer
347466|NCT01460589|Chemotherapy|chemotherapy
347467|NCT01460589|adjuvant|adjuvant
347468|NCT01460576|prematurity|prematurity
347469|NCT01460576|respiratory disease|respiratory disease
347470|NCT01460576|bronchopulmonary dysplasia|bronchopulmonary dysplasia
347471|NCT01460563|craniotomy|craniotomy
347472|NCT01460563|sodium valproate|sodium valproate
347473|NCT01460563|rocuronium|rocuronium
347474|NCT01460550|delayed gastric emptying(DGE)|delayed gastric emptying(dge)
347475|NCT01460550|pancreaticoduodenectomy(PD)|pancreaticoduodenectomy(pd)
347476|NCT01460550|randomized controlled trial(RCT)|randomized controlled trial(rct)
347477|NCT01460550|gastro- or duodeno- jejunostomy reconstruction|gastro- or duodeno- jejunostomy reconstruction
347478|NCT01460550|morbidity|morbidity
347479|NCT01460537|phase I|phase i
347480|NCT01460537|phosphatidylinositol-3 kinase inhibitor|phosphatidylinositol-3 kinase inhibitor
347481|NCT01460537|gemcitabine|gemcitabine
347482|NCT01460537|cisplatin|cisplatin
347483|NCT01460537|maximum tolerated dose|maximum tolerated dose
347484|NCT01460524|bronchiolitis|bronchiolitis
347485|NCT01460524|saline|saline
347486|NCT01460524|nebulization|nebulization
347487|NCT01460524|hypertonic|hypertonic
347488|NCT01460511|Mild bronchial asthma|mild bronchial asthma
347489|NCT01460498|Leukemia|leukemia
347490|NCT01460498|Chronic Myeloid Leukemia|chronic myeloid leukemia
347491|NCT01460498|CML|cml
347492|NCT01460498|Complete cytogenetic remission|complete cytogenetic remission
347493|NCT01460498|CCyR|ccyr
347494|NCT01460498|Minimal residual disease|minimal residual disease
347495|NCT01460498|Philadelphia chromosome (Ph)-|philadelphia chromosome (ph)-
347496|NCT01460498|BCR/ABL-positive|bcr/abl-positive
347497|NCT01460498|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
347498|NCT01460498|TKI|tki
347499|NCT01460498|Azacitidine|azacitidine
347500|NCT01460498|5-Azacytidine|5-azacytidine
347501|NCT01460498|5-AZA|5-aza
347502|NCT01460498|Vidaza|vidaza
347503|NCT01460498|5-AZC|5-azc
347504|NCT01460498|AZA-CR|aza-cr
347505|NCT01460498|Ladakamycin|ladakamycin
347506|NCT01460498|NSC-102816|nsc-102816
347508|NCT01460472|Lung cancer, small-cell|lung cancer, small-cell
347509|NCT01460472|advanced lung cancer|advanced lung cancer
347510|NCT01460472|therapeutic vaccine|therapeutic vaccine
347511|NCT01460472|anti-idiotypic vaccine|anti-idiotypic vaccine
347512|NCT01460472|1E10|1e10
347513|NCT01460459|diabetes|diabetes
347514|NCT01460459|self-monitoring of blood glucose|self-monitoring of blood glucose
347515|NCT01460459|frequency|frequency
347516|NCT01460433|HIV 1|hiv 1
347517|NCT01460433|Herpes Simplex Type 2|herpes simplex type 2
347518|NCT01460433|Treatment experienced|treatment experienced
347519|NCT01460420|Allogeneic transplantation|allogeneic transplantation
347520|NCT01460420|Hematologic malignancies|hematologic malignancies
347521|NCT01460420|Multiple myeloma|multiple myeloma
347522|NCT01460420|RIC (Reduced Intensity Conditioning)|ric (reduced intensity conditioning)
347523|NCT01460394|Healthy|healthy
347524|NCT01460394|Control|control
347525|NCT01460355|strabismus surgery|strabismus surgery
347526|NCT01460355|botulinum toxin|botulinum toxin
347527|NCT01460355|esotropia|esotropia
347528|NCT01460355|exotropia|exotropia
347529|NCT01460355|blepharoptosis|blepharoptosis
347530|NCT01460342|Prostatic hyperplasia|prostatic hyperplasia
347531|NCT01460342|Benign prostatic hyperplasia|benign prostatic hyperplasia
347532|NCT01460342|Lower urinary tract|lower urinary tract
347533|NCT01460329|intensive care units|intensive care units
347534|NCT01460329|pediatric|pediatric
347535|NCT01460329|cardiac index|cardiac index
347536|NCT01460329|Doppler Ultrasonography|doppler ultrasonography
347537|NCT01460316|Conotruncal cardiac defects|conotruncal cardiac defects
347538|NCT01460316|methylation|methylation
347539|NCT01460316|genotype|genotype
347540|NCT01460316|cobalamin|cobalamin
347541|NCT01460316|folates|folates
347542|NCT01460316|nutrition|nutrition
347543|NCT01460303|Transurethral catheterization|transurethral catheterization
347544|NCT01460303|Urinary retention|urinary retention
347545|NCT01460303|Bladder dysfunction|bladder dysfunction
347546|NCT01460303|Patient comfort|patient comfort
347547|NCT01460303|Pelvic Reconstructive Surgery|pelvic reconstructive surgery
347548|NCT01460303|Postoperative bladder dysfunction|postoperative bladder dysfunction
347549|NCT01460303|Postoperative urinary retention|postoperative urinary retention
347550|NCT01460277|hemiplegic|hemiplegic
347551|NCT01460277|balance|balance
347552|NCT01460277|hydrotherapy|hydrotherapy
347553|NCT01460264|Prospective Cohort Study|prospective cohort study
347554|NCT01460264|Respiratory Function Tests|respiratory function tests
347555|NCT01460264|Computed Tomography|computed tomography
347556|NCT01460264|Electrocardiography|electrocardiography
347557|NCT01460264|Peripheral Arterial Disease|peripheral arterial disease
347558|NCT01460251|type 1 diabetes|type 1 diabetes
347559|NCT01460251|beta cell|beta cell
347560|NCT01460251|immunomodulation|immunomodulation
347561|NCT01460251|immunointervention|immunointervention
347562|NCT01460238|Lipoprotein Lipase|lipoprotein lipase
347563|NCT01460238|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
347565|NCT01460225|constipation|constipation
347566|NCT01460225|chronic idiopathic constipation|chronic idiopathic constipation
347567|NCT01460225|no prior history of surgery to the colon|no prior history of surgery to the colon
347568|NCT01460225|not on any type of medication that could alter gastrointestinal motility or transit|not on any type of medication that could alter gastrointestinal motility or transit
347569|NCT01460212|Cognitive-Behavior Therapy|cognitive-behavior therapy
347570|NCT01460212|Magnetic Resonance Imaging|magnetic resonance imaging
347571|NCT01460212|major depressive disorder|major depressive disorder
347572|NCT01460186|Germ line polymorphisms|germ line polymorphisms
347573|NCT01460173|alertness test|alertness test
347574|NCT01460173|sleepiness|sleepiness
347575|NCT01460173|vigilance|vigilance
347576|NCT01460173|Sleep Apnea, Obstructive|sleep apnea, obstructive
347577|NCT01460147|Hemophilia|hemophilia
347578|NCT01460134|CD27 expressing Hematologic Malignancies|cd27 expressing hematologic malignancies
347579|NCT01460134|CD27 expressing Solid Tumors|cd27 expressing solid tumors
347580|NCT01460134|chronic lymphocytic leukemia|chronic lymphocytic leukemia
347581|NCT01460134|Burkett's lymphoma|burkett's lymphoma
347582|NCT01460134|mantle cell lymphoma|mantle cell lymphoma
347583|NCT01460134|primary lymphoma of the central nervous system|primary lymphoma of the central nervous system
347584|NCT01460134|marginal zone B cell lymphoma|marginal zone b cell lymphoma
347585|NCT01460134|solid tumor|solid tumor
347586|NCT01460134|metastatic melanoma|metastatic melanoma
347587|NCT01460134|renal (clear) cell carcinoma|renal (clear) cell carcinoma
347588|NCT01460134|hormone-refractory prostate adenocarcinoma|hormone-refractory prostate adenocarcinoma
347589|NCT01460134|ovarian cancer|ovarian cancer
347590|NCT01460134|colorectal adenocarcinoma|colorectal adenocarcinoma
347591|NCT01460134|non-small cell lung cancer|non-small cell lung cancer
347592|NCT01460121|Phobic Postural Vertigo|phobic postural vertigo
347593|NCT01460121|Visual Vertigo|visual vertigo
347594|NCT01460121|Chronic Subjective Dizziness|chronic subjective dizziness
347595|NCT01460121|Motion and Space Discomfort|motion and space discomfort
347597|NCT01460108|PLVR|plvr
347598|NCT01460108|AeriSeal|aeriseal
347599|NCT01460108|Treatment|treatment
347600|NCT01460108|Device|device
347601|NCT01460108|Breathing|breathing
347604|NCT01460108|polymeric lung volume reduction|polymeric lung volume reduction
347605|NCT01460108|heterogeneous|heterogeneous
347606|NCT01460108|homogeneous|homogeneous
347607|NCT01460108|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
347608|NCT01460095|diabetes|diabetes
347609|NCT01460095|translational research|translational research
347610|NCT01460095|HbA1c|hba1c
347611|NCT01460095|education|education
347612|NCT01460082|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
347613|NCT01460082|acute exacerbation|acute exacerbation
347614|NCT01460082|endothelial dysfunction|endothelial dysfunction
347615|NCT01460082|flow mediated dilation|flow mediated dilation
347616|NCT01460082|systemic inflammation|systemic inflammation
347617|NCT01460069|psoriasis|psoriasis
347618|NCT01460069|liraglutide|liraglutide
347619|NCT01460069|morbidity|morbidity
347620|NCT01460069|PASI|pasi
347621|NCT01460069|DLQI|dlqi
347622|NCT01460056|peritoneal dialysis|peritoneal dialysis
347623|NCT01460056|endotoxin-associated sterile peritonitis|endotoxin-associated sterile peritonitis
347624|NCT01460030|Hypercalcemia in patients with parathyroid carcinoma or intractable PHPT|hypercalcemia in patients with parathyroid carcinoma or intractable phpt
347625|NCT01460004|patellar tendinopathy|patellar tendinopathy
347626|NCT01460004|jumper's knee|jumper's knee
347627|NCT01459991|walnut|walnut
347628|NCT01459991|mediterranean|mediterranean
347629|NCT01459978|CUmulative SUM (CUSUM)|cumulative sum (cusum)
347630|NCT01459978|quality indicators|quality indicators
347631|NCT01459978|obstetrics|obstetrics
347632|NCT01459965|Jaundice|jaundice
347633|NCT01459965|Biliary stents|biliary stents
347634|NCT01459965|Palliation|palliation
347635|NCT01459965|Quality of Life|quality of life
347636|NCT01459965|Endoscopic Retrograde Cholangiography|endoscopic retrograde cholangiography
347637|NCT01459952|occurences of flu|occurences of flu
347638|NCT01459952|occurences of common cold|occurences of common cold
347639|NCT01459939|Osteoarthritis|osteoarthritis
347640|NCT01459926|Opioid induced constipation|opioid induced constipation
347641|NCT01459926|OIC|oic
347642|NCT01459926|Constipation|constipation
347643|NCT01459926|Opioid side effects|opioid side effects
347644|NCT01459926|Morphine induced constipation|morphine induced constipation
347645|NCT01459926|Opioid therapy|opioid therapy
347646|NCT01459913|VX-950|vx-950
347647|NCT01459913|INCIVEK|incivek
347648|NCT01459913|INCIVO|incivo
347649|NCT01459900|Treatment Resistant Hypertension|treatment resistant hypertension
347650|NCT01459887|untreated, CD20-positive|untreated, cd20-positive
347651|NCT01459874|Home Monitoring|home monitoring
347652|NCT01459874|Remote monitoring|remote monitoring
430468|NCT00003552|cancer|cancer
347653|NCT01459874|Telecardiology|telecardiology
347654|NCT01459874|Organizational model|organizational model
347655|NCT01459874|Patient indicated for pacemaker, ICD, CRT-P, or CRT-D|patient indicated for pacemaker, icd, crt-p, or crt-d
347656|NCT01459861|early ambulation|early ambulation
347657|NCT01459861|knee arthroplasty|knee arthroplasty
347658|NCT01459848|Salivary cortisol measured after DVD watching or block play|salivary cortisol measured after dvd watching or block play
347659|NCT01459835|TV|tv
347660|NCT01459835|Violence|violence
347661|NCT01459835|DVDs|dvds
347662|NCT01459835|Behavior|behavior
347663|NCT01459835|Preschool children|preschool children
347664|NCT01459822|sepsis|sepsis
347665|NCT01459822|miRNA|mirna
347666|NCT01459783|Caregivers|caregivers
347667|NCT01459783|Comparative Effectiveness Research|comparative effectiveness research
347668|NCT01459783|Cost Effectiveness|cost effectiveness
347669|NCT01459783|Patient Care Management|patient care management
347670|NCT01459783|Social Work|social work
347671|NCT01459770|glomerular filtration rate|glomerular filtration rate
347672|NCT01459770|albuminuria|albuminuria
347673|NCT01459770|medical therapy|medical therapy
347674|NCT01459770|hospital discharge|hospital discharge
347675|NCT01459770|hospital readmission|hospital readmission
347676|NCT01459770|CKD complications|ckd complications
347677|NCT01459770|CKD risk factors|ckd risk factors
347678|NCT01459757|Retrospective|retrospective
347679|NCT01459757|GIST|gist
347680|NCT01459757|sunitinib|sunitinib
347681|NCT01459757|mutational|mutational
347682|NCT01459744|Heart failure|heart failure
347683|NCT01459744|Palliative care|palliative care
347684|NCT01459744|Communication|communication
347685|NCT01459718|Severe cardiac iron overload|severe cardiac iron overload
347686|NCT01459718|deferasirox|deferasirox
347687|NCT01459718|β-thalassaemia|β-thalassaemia
347688|NCT01459718|cardiac dysfunction|cardiac dysfunction
347689|NCT01459705|Combat Disorders|combat disorders
347690|NCT01459705|Exposure Therapy|exposure therapy
347691|NCT01459705|Army Personnel|army personnel
347692|NCT01459692|Seizures|seizures
347693|NCT01459692|Epilepsy|epilepsy
347694|NCT01459692|Auditory Stimulation|auditory stimulation
347695|NCT01459692|Music|music
347696|NCT01459666|Scar|scar
347697|NCT01459666|Forehead|forehead
347698|NCT01459666|Skin Cancer|skin cancer
347699|NCT01459666|MOHS Surgery|mohs surgery
347700|NCT01459666|Dermatology|dermatology
347701|NCT01459653|Febrile neutropenia|febrile neutropenia
347702|NCT01459653|cancer|cancer
347703|NCT01459653|chemotherapy,|chemotherapy,
347704|NCT01459653|primary prophylaxis|primary prophylaxis
347705|NCT01459653|secondary prophylaxis|secondary prophylaxis
347706|NCT01459653|filgrastim|filgrastim
347707|NCT01459653|granulocyte colony stimulating factor|granulocyte colony stimulating factor
347718|NCT01459601|diabetes mellitus|diabetes mellitus
347719|NCT01459601|FBS|fbs
347720|NCT01459601|HbA1C|hba1c
347721|NCT01459601|Cabergoline|cabergoline
347722|NCT01459575|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
347723|NCT01459575|antiretroviral therapy|antiretroviral therapy
347724|NCT01459575|China|china
347725|NCT01459549|hepatolithiasis|hepatolithiasis
347726|NCT01459549|sphincter of oddi laxity|sphincter of oddi laxity
347727|NCT01459549|choledochojejunostomy|choledochojejunostomy
347728|NCT01459536|Aging|aging
347729|NCT01459523|Peripheral Nerve Block|peripheral nerve block
347730|NCT01459523|Perineural Catheter|perineural catheter
347731|NCT01459523|Orthopedic Surgery|orthopedic surgery
347732|NCT01459523|Ultrasound|ultrasound
347733|NCT01459510|Violence prevention|violence prevention
347734|NCT01459510|Parenting|parenting
347735|NCT01459510|Discipline|discipline
347736|NCT01459497|non-small cell lung cancer|non-small cell lung cancer
347737|NCT01459497|Stages II or III non-small cell lung cancer|stages ii or iii non-small cell lung cancer
347738|NCT01459484|Non metastatic extremities high grade osteosarcoma|non metastatic extremities high grade osteosarcoma
347739|NCT01459458|intimate partner violence|intimate partner violence
347740|NCT01459458|gender-based violence|gender-based violence
347741|NCT01459458|domestic violence|domestic violence
347742|NCT01459458|unintended pregnancy|unintended pregnancy
347743|NCT01459445|ethinylestradiol 30µg-drospirenone|ethinylestradiol 30µg-drospirenone
347744|NCT01459445|flow-mediated dilatation|flow-mediated dilatation
347745|NCT01459445|endothelial dysfunction|endothelial dysfunction
347746|NCT01459445|hsCRP|hscrp
347747|NCT01459445|metformin|metformin
347748|NCT01459445|polycystic ovary syndrome|polycystic ovary syndrome
347749|NCT01459406|Gastrointestinal physiology|gastrointestinal physiology
347750|NCT01459406|Gastrointestinal response to sugars|gastrointestinal response to sugars
347751|NCT01459406|MRI|mri
347752|NCT01459406|gastrointestinal|gastrointestinal
347753|NCT01459406|stomach|stomach
347754|NCT01459406|small bowel|small bowel
347755|NCT01459406|colon|colon
347756|NCT01459406|glucose|glucose
347757|NCT01459406|fructose|fructose
347758|NCT01459406|fructan|fructan
347759|NCT01459406|FODMAP|fodmap
347760|NCT01459393|Actinic keratosis|actinic keratosis
347761|NCT01459393|Photodynamic therapy|photodynamic therapy
347762|NCT01459393|5-aminolevulinic acid|5-aminolevulinic acid
347763|NCT01459393|Cryotherapy|cryotherapy
347764|NCT01459367|Drug Therapy|drug therapy
347765|NCT01459341|CLI Critical limb ischemia|cli critical limb ischemia
347766|NCT01459341|PVD peripheral vascular disease|pvd peripheral vascular disease
347767|NCT01459341|NIRS near infrared spectroscopy|nirs near infrared spectroscopy
347768|NCT01459341|TCPO2 - transcutaneous oxygen pressure|tcpo2 - transcutaneous oxygen pressure
347769|NCT01459328|rectal carcinoma|rectal carcinoma
347770|NCT01459328|long course chemo-radiation|long course chemo-radiation
726316|NCT01072058|TNF blocker|tnf blocker
347771|NCT01459328|short course chemo-rdiation|short course chemo-rdiation
347772|NCT01459328|Locally Advanced Rectal Carcinoma|locally advanced rectal carcinoma
347774|NCT01459315|Male|male
347775|NCT01459315|GSK1349572|gsk1349572
347776|NCT01459315|Dolutegravir|dolutegravir
347777|NCT01459315|DTG|dtg
347778|NCT01459315|Integrase|integrase
347779|NCT01459315|HIV|hiv
347794|NCT01459276|seasonal|seasonal
347795|NCT01459276|prevention|prevention
347796|NCT01459276|influenza|influenza
347797|NCT01459276|infection|infection
347798|NCT01459276|influenza vaccine|influenza vaccine
347799|NCT01459276|vaccine|vaccine
347800|NCT01459276|influenza in humans|influenza in humans
347801|NCT01459263|GSV|gsv
347802|NCT01459263|insufficiency|insufficiency
347803|NCT01459263|ClariVein device|clarivein device
347804|NCT01459263|safety|safety
347805|NCT01459263|efficacy|efficacy
347806|NCT01459263|QOL|qol
347807|NCT01459250|AGO178C,|ago178c,
347808|NCT01459250|renal impairment,|renal impairment,
347809|NCT01459250|ESRD,|esrd,
347810|NCT01459250|pharmacokinetics|pharmacokinetics
347811|NCT01459237|Cushing's Disease|cushing's disease
347812|NCT01459237|Microadenoma|microadenoma
347813|NCT01459237|PET Imaging|pet imaging
347814|NCT01459237|Cushing Disease Tumor|cushing disease tumor
347815|NCT01459237|Pituitary Tumors|pituitary tumors
347817|NCT01459185|Non-small cell lung cancer|non-small cell lung cancer
347818|NCT01459185|Adjuvant chemotherapy|adjuvant chemotherapy
347819|NCT01459185|oral fluoropyrimidine|oral fluoropyrimidine
347821|NCT01459185|Feasibility study|feasibility study
347822|NCT01459185|Surgery|surgery
347823|NCT01459172|breast cancer prevention|breast cancer prevention
347824|NCT01459159|Hematology|hematology
347825|NCT01459159|MDS|mds
347826|NCT01459159|Myelodysplastic Syndrome|myelodysplastic syndrome
347827|NCT01459159|Low risk MDS|low risk mds
347936|NCT01458717|prognosis|prognosis
347828|NCT01459159|Int-1 risk MDS|int-1 risk mds
347829|NCT01459159|Transfusion dependence|transfusion dependence
347830|NCT01459159|Telintra|telintra
347831|NCT01459159|ezatiostat|ezatiostat
347832|NCT01459159|ezatiostat hydrochloride|ezatiostat hydrochloride
347833|NCT01459159|TLK199|tlk199
347834|NCT01459159|Glutathione|glutathione
347835|NCT01459159|Glutathione analog|glutathione analog
347836|NCT01459159|Glutathione Transferase|glutathione transferase
347837|NCT01459159|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
347838|NCT01459159|GST P1-1 inhibitor|gst p1-1 inhibitor
347839|NCT01459159|Apoptosis|apoptosis
347840|NCT01459159|Differentiation|differentiation
347841|NCT01459159|Enzyme inhibitor|enzyme inhibitor
347842|NCT01459159|non-del (5q)|non-del (5q)
347843|NCT01459159|non-deletion 5q|non-deletion 5q
347844|NCT01459146|IPT|ipt
347845|NCT01459146|malaria|malaria
347846|NCT01459146|ACT|act
347847|NCT01459146|schistosomiasis|schistosomiasis
347848|NCT01459146|Hemoglobin|hemoglobin
347849|NCT01459146|Anemia|anemia
347850|NCT01459146|Sustained attention|sustained attention
347851|NCT01459146|Recall|recall
347852|NCT01459146|Schoolchildren|schoolchildren
347853|NCT01459146|Kassena-Nankana|kassena-nankana
347854|NCT01459133|investigational|investigational
347855|NCT01459133|inhaled insulin product|inhaled insulin product
347856|NCT01459120|Home-based HIV-testing|home-based hiv-testing
347857|NCT01459120|Voluntary Counseling and Testing|voluntary counseling and testing
347858|NCT01459120|Community based testing|community based testing
347859|NCT01459120|HIV/AIDS|hiv/aids
347860|NCT01459120|Lesotho|lesotho
347861|NCT01459107|Hand Transplant|hand transplant
347862|NCT01459107|CTA|cta
347863|NCT01459107|VCA|vca
347864|NCT01459107|Composite Tissue|composite tissue
347865|NCT01459107|Amputation|amputation
347866|NCT01459107|Upper limb|upper limb
347867|NCT01459107|Immunosuppression|immunosuppression
347868|NCT01459094|Healthy Volunteers|healthy volunteers
347869|NCT01459094|Oral bioavailability|oral bioavailability
347870|NCT01459094|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
347871|NCT01459094|Metformin IR|metformin ir
347872|NCT01459029|Schizophrenia|schizophrenia
347873|NCT01459029|NMDA receptor|nmda receptor
347874|NCT01459029|D-serine|d-serine
347875|NCT01459029|Recent onset|recent onset
347876|NCT01459029|Negative symptoms|negative symptoms
347877|NCT01459029|Cognition|cognition
347878|NCT01459016|Mild Cognitive Impairment|mild cognitive impairment
347879|NCT01459016|Brain Imaging Biomarkers|brain imaging biomarkers
347880|NCT01459016|Magnetic resonance imaging biomarker|magnetic resonance imaging biomarker
347881|NCT01459016|Positron Emission Tomography|positron emission tomography
347882|NCT01458977|Lípid-lowering effect|lípid-lowering effect
347883|NCT01458977|Tenofovir|tenofovir
347884|NCT01458977|Dyslipidemia|dyslipidemia
347885|NCT01458964|Fibromyalgia|fibromyalgia
347886|NCT01458951|Tofacitinib|tofacitinib
347887|NCT01458951|CP-690|cp-690
347888|NCT01458951|550|550
347889|NCT01458951|Moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
347890|NCT01458951|phase 3 clinical trial|phase 3 clinical trial
347891|NCT01458951|Mayo score|mayo score
347892|NCT01458925|Colorectal cancer|colorectal cancer
347893|NCT01458925|Colonic polyps|colonic polyps
347894|NCT01458899|Phase 1|phase 1
347895|NCT01458899|healthy male|healthy male
347896|NCT01458899|nonpregnant female|nonpregnant female
347897|NCT01458899|volunteers|volunteers
347898|NCT01458899|pharmacokinetics|pharmacokinetics
347899|NCT01458899|TC 5214|tc 5214
347900|NCT01458899|The effect of food on the pharmacokinetics of TC-5214|the effect of food on the pharmacokinetics of tc-5214
347901|NCT01458873|infiltration|infiltration
347902|NCT01458873|extravasation|extravasation
347903|NCT01458847|bladder cancer|bladder cancer
347904|NCT01458847|cis-urocanic acid|cis-urocanic acid
347905|NCT01458847|primary|primary
347906|NCT01458847|recurrent|recurrent
347907|NCT01458847|non-muscle|non-muscle
347908|NCT01458834|Smoking|smoking
347909|NCT01458834|Attentional bias|attentional bias
347910|NCT01458834|Craving|craving
347911|NCT01458821|Tinnitus|tinnitus
347912|NCT01458808|salt|salt
347913|NCT01458808|inflammation|inflammation
347914|NCT01458808|hypervolemia|hypervolemia
347915|NCT01458808|diet|diet
347919|NCT01458756|liver transplant patients|liver transplant patients
347920|NCT01458756|hepatic transplantation|hepatic transplantation
347922|NCT01458730|PCNSL|pcnsl
347923|NCT01458730|Immunochemotherapy|immunochemotherapy
347924|NCT01458730|Intraspinal Depocyt|intraspinal depocyt
347925|NCT01458730|Maintenance temozolomide|maintenance temozolomide
347926|NCT01458717|pancreas|pancreas
347927|NCT01458717|cancer|cancer
347928|NCT01458717|borderline resectable|borderline resectable
347929|NCT01458717|locally advanced|locally advanced
347930|NCT01458717|resectability|resectability
347931|NCT01458717|chemotherapy|chemotherapy
347932|NCT01458717|radiation|radiation
347933|NCT01458717|chemoradiation|chemoradiation
347934|NCT01458717|neoadjuvant|neoadjuvant
347935|NCT01458717|survival|survival
347937|NCT01458717|recurrence|recurrence
347938|NCT01458717|response rate|response rate
347939|NCT01458652|AST-120|ast-120
347940|NCT01458652|HDF|hdf
347941|NCT01458652|Replacement Volume described above|replacement volume described above
347942|NCT01458639|Pulmonary embolism|pulmonary embolism
347943|NCT01458639|PE|pe
347948|NCT01458613|Mucopolysaccharidoses|mucopolysaccharidoses
347949|NCT01458613|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
347950|NCT01458613|Metabolism, Inborn Errors|metabolism, inborn errors
347951|NCT01458613|Genetic Diseases, Inborn|genetic diseases, inborn
347952|NCT01458613|Mucinoses|mucinoses
347953|NCT01458613|Connective Tissue Diseases|connective tissue diseases
347954|NCT01458613|Metabolic Diseases|metabolic diseases
347955|NCT01458600|ophthalmopathy|ophthalmopathy
347956|NCT01458600|prevention|prevention
347957|NCT01458600|diclofenac|diclofenac
347958|NCT01458587|Actinic keratosis|actinic keratosis
347959|NCT01458574|Janus kinase inhibitor|janus kinase inhibitor
347960|NCT01458574|JAK 3 inhibitor|jak 3 inhibitor
347961|NCT01458574|inflammatory bowel disease|inflammatory bowel disease
347962|NCT01458574|ulcerative colitis|ulcerative colitis
347963|NCT01458574|OCTAVE|octave
347964|NCT01458574|CP-690|cp-690
347965|NCT01458574|550|550
347966|NCT01458574|tofacitinib|tofacitinib
347967|NCT01458574|Xeljanz|xeljanz
347968|NCT01458561|Hemostatic agent|hemostatic agent
347969|NCT01458561|Liver surgery|liver surgery
347970|NCT01458561|Hemostasis|hemostasis
347971|NCT01458548|1st-line therapy|1st-line therapy
347972|NCT01458548|single agent rituximab|single agent rituximab
347973|NCT01458548|CHOP|chop
347974|NCT01458548|PTLD|ptld
347975|NCT01458535|Genotype 1|genotype 1
347976|NCT01458535|Genotype 2|genotype 2
347977|NCT01458535|Genotype 3|genotype 3
347978|NCT01458535|Hepatitis C Virus|hepatitis c virus
347979|NCT01458535|ABT-450/r|abt-450/r
347980|NCT01458535|Ribavirin|ribavirin
347981|NCT01458535|ABT-267|abt-267
347982|NCT01458535|Ombitasvir|ombitasvir
347983|NCT01458535|Paritaprevir|paritaprevir
347984|NCT01458522|Nonconvulsive Seizures|nonconvulsive seizures
347985|NCT01458509|Quality of Life|quality of life
347986|NCT01458509|patient outcomes|patient outcomes
347987|NCT01458509|questionaires|questionaires
347988|NCT01458509|11-101|11-101
347989|NCT01458470|huntington|huntington
347990|NCT01458470|huntingtin|huntingtin
347991|NCT01458470|memantine|memantine
347992|NCT01458470|ebixa|ebixa
347993|NCT01458470|namenda|namenda
347994|NCT01458444|Respiratory Insufficiency|respiratory insufficiency
347995|NCT01458444|Cardiothoracic Surgery|cardiothoracic surgery
347996|NCT01458444|Ventilation system|ventilation system
347997|NCT01458431|cesarean section|cesarean section
347998|NCT01458431|wound infusion|wound infusion
347999|NCT01458431|Local anesthetic levobupivacaine|local anesthetic levobupivacaine
348000|NCT01458431|Pain management|pain management
348001|NCT01458418|Eosinophil|eosinophil
348002|NCT01458418|Esophagitis|esophagitis
348003|NCT01458405|Myocardial Infarction|myocardial infarction
348004|NCT01458405|Heart Attack|heart attack
348005|NCT01458405|Stem cell|stem cell
348006|NCT01458405|Left ventricular dysfunction|left ventricular dysfunction
348007|NCT01458405|Congestive heart failure|congestive heart failure
348008|NCT01458366|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
348009|NCT01458366|Lymphoma|lymphoma
348010|NCT01458366|B-Cell Lymphoma|b-cell lymphoma
348011|NCT01458353|Right-sided colon cancer|right-sided colon cancer
348012|NCT01458353|Ileocolonic anastomosis|ileocolonic anastomosis
348013|NCT01458353|stapled anastomosis|stapled anastomosis
348014|NCT01458353|handsewn anastomosis|handsewn anastomosis
348015|NCT01458353|peritoneal contamination|peritoneal contamination
348016|NCT01458353|microbiological spectrum|microbiological spectrum
348017|NCT01458340|Adult ADHD|adult adhd
348146|NCT01457768|Treatment experienced|treatment experienced
348121|NCT01457807|biomarkers|biomarkers
348018|NCT01458340|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
348020|NCT01458327|PTSD|ptsd
348021|NCT01458327|psychotherapy|psychotherapy
348022|NCT01458314|Physical exercise|physical exercise
348023|NCT01458314|Rehabilitation|rehabilitation
348024|NCT01458314|NIV|niv
348025|NCT01458301|Drug Therapy|drug therapy
348026|NCT01458275|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
348027|NCT01458275|Ciclesonide|ciclesonide
348028|NCT01458275|Ciclesonide Nasal Aerosol|ciclesonide nasal aerosol
348029|NCT01458262|cerebral oxymetry|cerebral oxymetry
348030|NCT01458262|systemic oxymetry|systemic oxymetry
348031|NCT01458262|hepatic surgery|hepatic surgery
348032|NCT01458262|liver transplantation|liver transplantation
348033|NCT01458249|Soft Tissue Sarcoma|soft tissue sarcoma
348043|NCT01458171|Primary immunodeficiency|primary immunodeficiency
348045|NCT01458158|Gelatinases|gelatinases
348046|NCT01458158|kidney disease|kidney disease
348047|NCT01458158|diabetes mellitus type 2|diabetes mellitus type 2
348048|NCT01458132|subject follow-up|subject follow-up
348049|NCT01458132|HIV infection|hiv infection
348050|NCT01458132|registry|registry
348051|NCT01458132|seizures|seizures
348052|NCT01458132|GSK2248761|gsk2248761
348053|NCT01458119|Fabry disease|fabry disease
348054|NCT01458119|Lysosomal storage disease|lysosomal storage disease
348055|NCT01458119|migalastat HCl|migalastat hcl
348056|NCT01458119|AT1001|at1001
348057|NCT01458080|ENABLE|enable
348058|NCT01458080|invasive procedures|invasive procedures
348059|NCT01458080|Thrombocytopenia|thrombocytopenia
348060|NCT01458080|Thromboembolic events|thromboembolic events
348061|NCT01458080|Eltrombopag|eltrombopag
348062|NCT01458080|Hepatitis C|hepatitis c
348063|NCT01458080|HCV|hcv
348064|NCT01458054|pharmacokinetics|pharmacokinetics
348065|NCT01458054|omeprazole|omeprazole
348066|NCT01458054|ritonavir|ritonavir
348067|NCT01458054|healthy subjects|healthy subjects
348068|NCT01458054|drug interaction|drug interaction
348069|NCT01458041|Critical limb ischaemia|critical limb ischaemia
348070|NCT01458041|Iloprost|iloprost
348071|NCT01458041|Quality of life|quality of life
348072|NCT01458041|Visual analogue scale|visual analogue scale
348073|NCT01458028|BAY85-3934|bay85-3934
348074|NCT01458028|pharmacokinetics|pharmacokinetics
348075|NCT01458028|age|age
348076|NCT01458028|gender|gender
348077|NCT01458015|QST|qst
348078|NCT01458015|neuropathic pain|neuropathic pain
348079|NCT01458015|tapentadol pr|tapentadol pr
348080|NCT01458015|oxycodone|oxycodone
348081|NCT01457989|retention rate|retention rate
348082|NCT01457989|epilepsy|epilepsy
348083|NCT01457989|responder rate|responder rate
348084|NCT01457989|seizure freedom|seizure freedom
348085|NCT01457989|discontinuation rate|discontinuation rate
348086|NCT01457989|safety assessment|safety assessment
348087|NCT01457989|reduction in seizure frequency|reduction in seizure frequency
348088|NCT01457989|open-label|open-label
348089|NCT01457976|cancer|cancer
348090|NCT01457976|obesity|obesity
348091|NCT01457976|personal responsibility|personal responsibility
348092|NCT01457950|denosumab|denosumab
348093|NCT01457950|Republic of Korea|republic of korea
348094|NCT01457950|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
348095|NCT01457937|HCV|hcv
348096|NCT01457937|Menopause|menopause
348097|NCT01457937|Peg IFN|peg ifn
348098|NCT01457937|Ribavirin|ribavirin
348099|NCT01457937|Boceprevir|boceprevir
348100|NCT01457924|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
348101|NCT01457924|Ofatumumab|ofatumumab
348102|NCT01457898|Cardiac surgery|cardiac surgery
348103|NCT01457898|Non-invasive ventilation|non-invasive ventilation
348104|NCT01457885|AML|aml
348105|NCT01457872|Heroin addiction|heroin addiction
348106|NCT01457872|Substance use disorders|substance use disorders
348107|NCT01457872|Substitution treatment|substitution treatment
348108|NCT01457872|Syringe exchange|syringe exchange
348109|NCT01457846|gastro-oesophageal junction cancer|gastro-oesophageal junction cancer
348110|NCT01457846|gastric cancer|gastric cancer
348111|NCT01457846|lower third oesophageal cancer|lower third oesophageal cancer
348112|NCT01457846|polysomy|polysomy
348113|NCT01457846|amplification|amplification
348115|NCT01457820|Allopurinol|allopurinol
348116|NCT01457820|Angina|angina
348117|NCT01457820|Acute coronary syndrome|acute coronary syndrome
348118|NCT01457807|Phase 1|phase 1
348119|NCT01457807|Parkinson's disease|parkinson's disease
348120|NCT01457807|pharmacodynamic|pharmacodynamic
348122|NCT01457807|pharmacokinetics|pharmacokinetics
348123|NCT01457807|extended release formulation|extended release formulation
348124|NCT01457794|Metabolic Syndrome X|metabolic syndrome x
348125|NCT01457794|Fatty Acids, Omega-3|fatty acids, omega-3
348126|NCT01457794|Learning|learning
348127|NCT01457794|Attention|attention
348128|NCT01457794|Nutritional Status|nutritional status
348129|NCT01457794|Nutrition Assessments|nutrition assessments
348131|NCT01457794|Physical Activity|physical activity
348132|NCT01457794|Sleep|sleep
348133|NCT01457794|Child Nutrition Sciences|child nutrition sciences
348134|NCT01457781|Inhaled nitric oxide|inhaled nitric oxide
348135|NCT01457781|pulmonary arterial hypertension|pulmonary arterial hypertension
348136|NCT01457781|pulmonary hypertension|pulmonary hypertension
348137|NCT01457781|PAH|pah
348138|NCT01457768|Hepatitis C|hepatitis c
348139|NCT01457768|HCV|hcv
348140|NCT01457768|Sustained Virologic Response|sustained virologic response
348141|NCT01457768|Direct Acting Antiviral|direct acting antiviral
348142|NCT01457768|Combination Therapy|combination therapy
348143|NCT01457768|Tegobuvir|tegobuvir
348144|NCT01457768|Registry|registry
348145|NCT01457768|HCV RNA|hcv rna
348147|NCT01457768|Treatment naive|treatment naive
348148|NCT01457768|GS 9451|gs 9451
348149|NCT01457768|GS 5885|gs 5885
348150|NCT01457768|Sequence|sequence
348151|NCT01457768|GS 5816|gs 5816
348152|NCT01457768|GS 7977|gs 7977
348153|NCT01457768|Sofosbuvir|sofosbuvir
348154|NCT01457768|Sovaldi™|sovaldi™
348156|NCT01457768|Ledipasvir|ledipasvir
348157|NCT01457768|LDV|ldv
348158|NCT01457755|Hepatitis C|hepatitis c
348159|NCT01457755|HCV|hcv
348160|NCT01457755|Sustained Virologic Response|sustained virologic response
348161|NCT01457755|Direct Acting Antiviral|direct acting antiviral
348162|NCT01457755|Combination Therapy|combination therapy
348163|NCT01457755|Tegobuvir|tegobuvir
348164|NCT01457755|Registry|registry
348165|NCT01457755|HCV RNA|hcv rna
348166|NCT01457755|Treatment experienced|treatment experienced
348167|NCT01457755|Treatment naive|treatment naive
348168|NCT01457755|GS 9451|gs 9451
348169|NCT01457755|GS 5885|gs 5885
348170|NCT01457755|GS 7977|gs 7977
348171|NCT01457755|GS 5816|gs 5816
348172|NCT01457755|Sofosbuvir|sofosbuvir
348173|NCT01457755|Sovaldi™|sovaldi™
348174|NCT01457755|SOF|sof
348175|NCT01457755|Ledipasvir|ledipasvir
348176|NCT01457755|LDV|ldv
348177|NCT01457742|Osteoarthritis|osteoarthritis
348178|NCT01457729|ergometer|ergometer
348179|NCT01457729|training|training
348180|NCT01457729|motivation|motivation
348181|NCT01457729|telemonitoring|telemonitoring
348182|NCT01457729|sleep apnea|sleep apnea
348183|NCT01457716|Healthy volunteer study|healthy volunteer study
348184|NCT01457703|LH pulsatility|lh pulsatility
348185|NCT01457703|Obesity|obesity
348186|NCT01457703|Reproduction|reproduction
348187|NCT01457690|Vitamin E pegylated|vitamin e pegylated
348188|NCT01457690|chylomicron retention|chylomicron retention
348189|NCT01457690|Familial Hypocholesterolemia|familial hypocholesterolemia
348190|NCT01457690|Hypobetalipoproteinemias|hypobetalipoproteinemias
348191|NCT01457651|Recruitment|recruitment
348192|NCT01457651|Coronary artery bypass grafting|coronary artery bypass grafting
348193|NCT01457651|Postoperative period|postoperative period
348194|NCT01457638|nasal obstruction|nasal obstruction
348195|NCT01457638|rhinoplasty|rhinoplasty
348196|NCT01457638|turbinate surgery|turbinate surgery
348197|NCT01457638|quality of life|quality of life
348198|NCT01457638|acoustic rhinometry|acoustic rhinometry
348199|NCT01457625|fetuin A liver fat content visceral obesity mortality|fetuin a liver fat content visceral obesity mortality
348200|NCT01457612|Insulin Resistant|insulin resistant
348201|NCT01457612|Dietary Supplements|dietary supplements
348202|NCT01457612|Nutrition|nutrition
348203|NCT01457612|Antioxidant|antioxidant
348204|NCT01457612|Inflammation|inflammation
348205|NCT01457599|liver-colorectal metastases-computertomography-guided-wire-chemotherapy-complete response|liver-colorectal metastases-computertomography-guided-wire-chemotherapy-complete response
348206|NCT01457599|Feasibility, safety|feasibility, safety
348207|NCT01457586|Heart Surgery|heart surgery
348208|NCT01457586|Blood Transfusion|blood transfusion
348209|NCT01457586|Postoperative Complications|postoperative complications
348210|NCT01457560|Oral polio vaccine (OPV)|oral polio vaccine (opv)
348211|NCT01457560|DTPa-HBV-IPV/Hib vaccine|dtpa-hbv-ipv/hib vaccine
348212|NCT01457547|HEXAVACTM|hexavactm
348213|NCT01457547|InfanrixTM HEXA|infanrixtm hexa
348214|NCT01457547|DTPa-HBV-IPV-Hib|dtpa-hbv-ipv-hib
348215|NCT01457547|DTPa-HBV-IPV/Hib|dtpa-hbv-ipv/hib
348216|NCT01457521|pain|pain
348217|NCT01457521|medical abortion|medical abortion
348218|NCT01457508|combination vaccine|combination vaccine
348219|NCT01457508|DTPa-HBV-IPV|dtpa-hbv-ipv
348221|NCT01457495|Infants|infants
348222|NCT01457495|combined vaccine|combined vaccine
348223|NCT01457495|DTPa-HBV-IPV/Hib|dtpa-hbv-ipv/hib
348224|NCT01457495|DTPa-IPV/Hib|dtpa-ipv/hib
348225|NCT01457495|safety|safety
348226|NCT01457495|Immunogenicity|immunogenicity
348227|NCT01457495|HBV|hbv
348228|NCT01457482|Fear|fear
348229|NCT01457482|Childbirth|childbirth
348230|NCT01457482|Art therapy|art therapy
348231|NCT01457482|Therapeutic conversations|therapeutic conversations
348232|NCT01457482|W-DEQ|w-deq
348233|NCT01457456|Mucopolysaccharidoses|mucopolysaccharidoses
347816|NCT01459211|CLL|cll
348237|NCT01457456|Genetic Diseases, Inborn|genetic diseases, inborn
348238|NCT01457456|Lysosomal Storage Diseases|lysosomal storage diseases
348239|NCT01457456|Connective Tissue Diseases|connective tissue diseases
348240|NCT01457456|Metabolic Diseases|metabolic diseases
348241|NCT01457456|Musculoskeletal Diseases|musculoskeletal diseases
348242|NCT01457443|Glycogen Storage Disease|glycogen storage disease
348243|NCT01457443|Glycogen Storage Disease Type II|glycogen storage disease type ii
348244|NCT01457443|Metabolic Diseases|metabolic diseases
348245|NCT01457443|Carbohydrate Metabolism, Inborn Errors|carbohydrate metabolism, inborn errors
348246|NCT01457443|Metabolism, Inborn Errors|metabolism, inborn errors
348247|NCT01457443|Genetic Diseases, Inborn|genetic diseases, inborn
348248|NCT01457443|Lysosomal Storage Diseases, Nervous System|lysosomal storage diseases, nervous system
348249|NCT01457417|Cancer|cancer
348250|NCT01457417|Oncology|oncology
348251|NCT01457404|integrated cognitive behavioral therapy|integrated cognitive behavioral therapy
348252|NCT01457404|cognitive behavioral therapy|cognitive behavioral therapy
348253|NCT01457404|addiction|addiction
348254|NCT01457404|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
348255|NCT01457391|cognitive behavioral therapy|cognitive behavioral therapy
348256|NCT01457391|addiction|addiction
348257|NCT01457391|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
348258|NCT01457378|Gastrointestinal symptoms|gastrointestinal symptoms
348259|NCT01457378|healthy subjects|healthy subjects
348260|NCT01457378|IBS|ibs
348261|NCT01457378|HRQoL|hrqol
348262|NCT01457378|questionnaires|questionnaires
348263|NCT01457352|Baclofen, spasticity|baclofen, spasticity
348264|NCT01457339|Schizophrenia|schizophrenia
348265|NCT01457326|Immersion therapy|immersion therapy
348266|NCT01457326|early weight bearing physical therapy|early weight bearing physical therapy
348267|NCT01457300|Rehabilitation outcome|rehabilitation outcome
348268|NCT01457300|Aged|aged
348269|NCT01457300|Aged, 80 and over|aged, 80 and over
348270|NCT01457300|Activities of daily living|activities of daily living
348271|NCT01457274|AMBULATORY CARE|ambulatory care
348272|NCT01457274|AWARENESS AND RECALL|awareness and recall
348273|NCT01457274|Propofol|propofol
348274|NCT01457274|Patient Safety and Satisfaction|patient safety and satisfaction
348275|NCT01457274|Colonoscopy|colonoscopy
348276|NCT01457274|Elective outpatient colonoscopy|elective outpatient colonoscopy
348277|NCT01457274|Procedural sedation|procedural sedation
348278|NCT01457261|interstitial lung disease|interstitial lung disease
348279|NCT01457261|drug deposition|drug deposition
348280|NCT01457261|lung imaging|lung imaging
348281|NCT01457261|respiratory|respiratory
348282|NCT01457248|after aortic surgery|after aortic surgery
348283|NCT01457235|Bipolar disorder|bipolar disorder
348284|NCT01457235|Cognitive Remediation|cognitive remediation
348285|NCT01457235|Cognition|cognition
348286|NCT01457235|Cognitive function|cognitive function
348287|NCT01457235|Mood disorders|mood disorders
348288|NCT01457235|Affective disorders|affective disorders
348289|NCT01457222|Mindfulness|mindfulness
348290|NCT01457222|Stress|stress
348291|NCT01457222|Cognition|cognition
348292|NCT01457222|Psychological health|psychological health
348293|NCT01457222|Primary prevention|primary prevention
348294|NCT01457209|PCOS|pcos
348295|NCT01457209|Insulin resistance|insulin resistance
348296|NCT01457209|Acupuncture|acupuncture
348297|NCT01457196|Cancer Genetics|cancer genetics
348298|NCT01457183|pulsed lavage|pulsed lavage
348299|NCT01457183|evaluate containment|evaluate containment
348300|NCT01457183|evaluate tolerability|evaluate tolerability
348301|NCT01457170|Pulmonary Hypertension|pulmonary hypertension
348302|NCT01457170|Heart Failure|heart failure
348303|NCT01457170|Apelin|apelin
348304|NCT01457170|Haemodynamics|haemodynamics
348305|NCT01457170|pulmonary vascular resistance|pulmonary vascular resistance
348306|NCT01457170|cardiac output|cardiac output
348307|NCT01457144|Mantle cell lymphoma|mantle cell lymphoma
348308|NCT01457144|Rituximab|rituximab
348309|NCT01457144|bendamustine|bendamustine
348310|NCT01457144|Velcade|velcade
348311|NCT01457144|Dexamethasone|dexamethasone
348312|NCT01457131|Metastatic Cancer|metastatic cancer
348313|NCT01457131|Immunotherapy|immunotherapy
348314|NCT01457131|Gene Therapy|gene therapy
348315|NCT01457131|Metastatic Melanoma|metastatic melanoma
348316|NCT01457131|Metastatic Kidney Cancer|metastatic kidney cancer
348317|NCT01457118|Open Label multicenter extension study advanced solid tumors|open label multicenter extension study advanced solid tumors
348318|NCT01457105|Malignant strictures of the main biliary duct|malignant strictures of the main biliary duct
348319|NCT01457092|benign biliary strictures|benign biliary strictures
348320|NCT01457092|chronic pancreatitis|chronic pancreatitis
348321|NCT01457079|Keloid|keloid
348322|NCT01457079|Radiation Therapy|radiation therapy
348323|NCT01457079|Hypertrophic Scar|hypertrophic scar
348324|NCT01457053|Acute decompensated heart failure|acute decompensated heart failure
348325|NCT01457053|Myocardial blood flow|myocardial blood flow
348326|NCT01457053|Coronary flow reserve|coronary flow reserve
348327|NCT01457053|Ultrafiltration|ultrafiltration
348328|NCT01457053|Diuretics|diuretics
348329|NCT01457040|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
348330|NCT01457040|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
348331|NCT01457027|Influenza|influenza
348333|NCT01457027|Vaccination|vaccination
348334|NCT01457027|Immunisation|immunisation
348335|NCT01457014|chronic pain|chronic pain
348336|NCT01457014|sleep disordered breathing|sleep disordered breathing
348337|NCT01457014|Opioids|opioids
348338|NCT01457001|chronic haemodialysis|chronic haemodialysis
348339|NCT01457001|25-OH-D vitamin|25-oh-d vitamin
348340|NCT01456975|Ascending aorta aneurism|ascending aorta aneurism
348341|NCT01456975|Aortic insufficiency|aortic insufficiency
348342|NCT01456962|Immune reconstitution|immune reconstitution
348343|NCT01456962|CD4+ T cells|cd4+ t cells
348344|NCT01456949|Atrial fibrillation (AF)|atrial fibrillation (af)
348345|NCT01456949|Paroxysmal atrial fibrillation (PAF)|paroxysmal atrial fibrillation (paf)
348346|NCT01456949|Arrythmias|arrythmias
348347|NCT01456949|Cardiac Arrythmias|cardiac arrythmias
348348|NCT01456949|Cardiac ablation|cardiac ablation
348349|NCT01456949|Cryoablation|cryoablation
348350|NCT01456936|smoking cessation|smoking cessation
348351|NCT01456936|psychiatric disease|psychiatric disease
348352|NCT01455948|sinusitis|sinusitis
348353|NCT01455948|chronic|chronic
348354|NCT01455948|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
348355|NCT01455948|balloon sinuplasty|balloon sinuplasty
348356|NCT01456923|DNA damaging agents|dna damaging agents
348357|NCT01456910|Physical education|physical education
348358|NCT01456910|People with mental disabilities|people with mental disabilities
348359|NCT01456910|muscular strength dynamometer|muscular strength dynamometer
348360|NCT01456910|Performance Evaluation|performance evaluation
348361|NCT01456910|Occupational health|occupational health
348362|NCT01456884|Music therapy|music therapy
348363|NCT01456884|Infants|infants
348364|NCT01456884|Children|children
348365|NCT01456884|Adolescents|adolescents
348366|NCT01456884|pediatric|pediatric
348367|NCT01456884|palliative care|palliative care
348368|NCT01456884|neurological impairment|neurological impairment
348369|NCT01456884|metabolic condition|metabolic condition
348370|NCT01456884|pain management|pain management
348371|NCT01456871|Mechanoreceptors|mechanoreceptors
348372|NCT01456871|PIP joint|pip joint
348373|NCT01456871|Ligamento-muscular reflexes|ligamento-muscular reflexes
348374|NCT01456858|Malaria Prevention Refugee Emergency|malaria prevention refugee emergency
348375|NCT01456858|Malaria, Falciparum C03.752.530.650|malaria, falciparum c03.752.530.650
348376|NCT01456845|Plasma levels|plasma levels
348377|NCT01456845|isoniazid|isoniazid
348378|NCT01456845|rifampicin|rifampicin
348379|NCT01456845|pyrazinamide|pyrazinamide
348380|NCT01456845|hepatoxicity|hepatoxicity
348381|NCT01456832|hyponatremia|hyponatremia
348382|NCT01456832|renal transplant|renal transplant
348383|NCT01456819|autologous|autologous
348384|NCT01456819|bone marrow|bone marrow
348385|NCT01456819|critical limb ischemia|critical limb ischemia
348386|NCT01456819|efficacy|efficacy
348387|NCT01456819|mesenchymal stem cells|mesenchymal stem cells
348388|NCT01456819|mononuclear cells|mononuclear cells
348389|NCT01456806|T2DM|t2dm
348390|NCT01456806|Cardiovascular risk factors|cardiovascular risk factors
348391|NCT01456806|Metabolic control|metabolic control
348392|NCT01456806|Well-being|well-being
348393|NCT01456806|Cost|cost
348394|NCT01456806|Cost-consequence|cost-consequence
348395|NCT01456793|Pregnancy prevention|pregnancy prevention
348396|NCT01456793|Pregnancy|pregnancy
348397|NCT01456793|Birth|birth
348398|NCT01456793|Contraceptive use|contraceptive use
348399|NCT01456793|Adolescents|adolescents
348400|NCT01456780|Meibomian gland dysfunction|meibomian gland dysfunction
348401|NCT01456780|Blepharitis|blepharitis
348402|NCT01456780|Dry Eye|dry eye
348403|NCT01456780|Ocular Inflammation|ocular inflammation
348405|NCT01456780|Zylet|zylet
348406|NCT01456780|Lotemax|lotemax
348407|NCT01456780|Artificial Tear|artificial tear
348408|NCT01456754|Insulin Metabolism|insulin metabolism
348409|NCT01456754|Glucose Metabolism|glucose metabolism
348410|NCT01456754|Substrate Partitioning|substrate partitioning
339015|NCT01495546|THA|tha
348411|NCT01456754|Muscle Biopsies|muscle biopsies
348412|NCT01456754|Feeding Frequency|feeding frequency
348413|NCT01456754|Insulin|insulin
348414|NCT01456741|endobronchial needle aspiration (EBNA)|endobronchial needle aspiration (ebna)
348415|NCT01456741|transbronchial needle aspiration (TBNA)|transbronchial needle aspiration (tbna)
348416|NCT01456741|rapid on-site evaluation (ROSE)|rapid on-site evaluation (rose)
348417|NCT01456741|lung cancer|lung cancer
348418|NCT01456728|Helicobacter pylori|helicobacter pylori
348419|NCT01456728|Progastria|progastria
348520|NCT01456377|outcome|outcome
348420|NCT01456728|Lactobacillus reuteri|lactobacillus reuteri
348421|NCT01456728|omeprazole|omeprazole
348422|NCT01456728|triple therapy|triple therapy
348423|NCT01456728|probiotic|probiotic
348424|NCT01456715|Human Papillomavirus Vaccines|human papillomavirus vaccines
348425|NCT01456715|Immunogenicity Gardasil Cervarix|immunogenicity gardasil cervarix
348426|NCT01456715|Booster dose|booster dose
348428|NCT01456702|hemodynamic monitoring|hemodynamic monitoring
348429|NCT01456702|goal-directed volume therapie|goal-directed volume therapie
348430|NCT01456689|Myeloma|myeloma
348431|NCT01456689|Multiple Myeloma|multiple myeloma
348432|NCT01456689|MM|mm
348433|NCT01456676|LDE225|lde225
348434|NCT01456676|nilotinib|nilotinib
348435|NCT01456676|Chronic myeloid leukemia|chronic myeloid leukemia
348436|NCT01456676|CML|cml
348437|NCT01456676|Philadelphia positive|philadelphia positive
348438|NCT01456676|Ph+|ph+
348439|NCT01456676|resistant|resistant
348440|NCT01456676|Resistant Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP)|resistant philadelphia chromosome positive chronic myeloid leukemia (ph+ cml) in chronic phase (cp)
348441|NCT01456663|AFQ056|afq056
348442|NCT01456663|Hepatic impairment|hepatic impairment
348443|NCT01456663|Hepatic impaired|hepatic impaired
348444|NCT01456650|Type 2 diabetes|type 2 diabetes
348445|NCT01456650|ABCA1 alleles|abca1 alleles
348446|NCT01456650|Glyburide|glyburide
348447|NCT01456637|Insomnia|insomnia
348448|NCT01456637|Intervention|intervention
348449|NCT01456637|Self-help|self-help
348450|NCT01456637|Internet|internet
348451|NCT01456598|Stomach neoplasm|stomach neoplasm
348452|NCT01456598|Laparoscopy|laparoscopy
348453|NCT01456585|Histological documentation|histological documentation
348454|NCT01456585|primary adenocarcinoma of the pancreas|primary adenocarcinoma of the pancreas
348455|NCT01456585|surgically eligible|surgically eligible
348456|NCT01456585|tumor resection|tumor resection
348457|NCT01456585|curative intent|curative intent
348458|NCT01456572|glucagon-like peptide-1|glucagon-like peptide-1
348459|NCT01456572|peptide tyrosine tyrosine|peptide tyrosine tyrosine
348460|NCT01456572|ghrelin|ghrelin
348461|NCT01456572|stomach|stomach
348462|NCT01456572|small intestine|small intestine
348463|NCT01456572|gastric emptying|gastric emptying
348464|NCT01456559|Hypovolemia|hypovolemia
348465|NCT01456559|Lower body negative pressure|lower body negative pressure
348466|NCT01456559|Photoplethysmography|photoplethysmography
348467|NCT01456546|CYP2C19*17|cyp2c19*17
348468|NCT01456546|Pharmacokinetics|pharmacokinetics
348469|NCT01456546|Pharmacodynamics|pharmacodynamics
348470|NCT01456533|hyponatremia|hyponatremia
348471|NCT01456533|hypernatremia|hypernatremia
348472|NCT01456520|pharmacokinetics|pharmacokinetics
348473|NCT01456520|bioequivalence|bioequivalence
348474|NCT01456520|hydrocodone|hydrocodone
348475|NCT01456520|acetaminophen|acetaminophen
348476|NCT01456520|moderate to moderately severe pain|moderate to moderately severe pain
348477|NCT01456507|Food effect|food effect
348478|NCT01456507|bioavailability|bioavailability
348479|NCT01456507|oxycodone|oxycodone
348480|NCT01456507|sequestered Naltrexone|sequestered naltrexone
348481|NCT01456507|management of moderate to severe pain|management of moderate to severe pain
348482|NCT01456494|Obstructive Lung Disease|obstructive lung disease
348483|NCT01456494|COPD|copd
348484|NCT01456494|Asthma|asthma
348485|NCT01456494|Inhaler|inhaler
348486|NCT01456494|Metered-Dose Inhaler|metered-dose inhaler
348487|NCT01456494|Education|education
348488|NCT01456494|Hospital-based education|hospital-based education
348489|NCT01456481|reflex fainting|reflex fainting
348490|NCT01456481|vasovagal syncope|vasovagal syncope
348491|NCT01456481|midodrine|midodrine
348492|NCT01456468|Cholangitis, Sclerosing|cholangitis, sclerosing
348493|NCT01456468|Tretinoin|tretinoin
348494|NCT01456468|Ursodeoxycholic Acid|ursodeoxycholic acid
348495|NCT01456455|Central nervous system|central nervous system
348496|NCT01456455|pathological markers|pathological markers
348497|NCT01456429|invasive staging|invasive staging
348498|NCT01456429|mediastinal lymph nodes|mediastinal lymph nodes
348499|NCT01456429|endosonography|endosonography
348500|NCT01456429|surgical staging|surgical staging
348501|NCT01456429|lung cancer|lung cancer
348502|NCT01456416|RRMS|rrms
348503|NCT01456416|Multiple Sclerosis|multiple sclerosis
348504|NCT01456416|Glatiramer Acetate|glatiramer acetate
726317|NCT01072058|Anti-TNF|anti-tnf
348505|NCT01456416|Autoimmune Comorbidities|autoimmune comorbidities
348506|NCT01456416|Psoriasis|psoriasis
339110|NCT01495026|Food effect|food effect
339111|NCT01495026|Tamsulosin hydrochloride|tamsulosin hydrochloride
339112|NCT01495026|Cross-over design|cross-over design
339113|NCT01495026|Pilot bioequivalence|pilot bioequivalence
339114|NCT01495026|Dutasteride (GI198745)|dutasteride (gi198745)
339115|NCT01495013|non-inferiority|non-inferiority
339116|NCT01495013|glimepiride|glimepiride
339117|NCT01495013|LDL cholesterol|ldl cholesterol
339118|NCT01495013|fixed dose combination|fixed dose combination
339119|NCT01495013|atorvastatin|atorvastatin
339120|NCT01495013|Diabetes Mellitus|diabetes mellitus
339121|NCT01495000|India|india
339122|NCT01495000|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
348507|NCT01456416|Autoimmune Thyroiditis|autoimmune thyroiditis
348508|NCT01456416|Vasculitis|vasculitis
348509|NCT01456416|Rheumatoid Arthritis|rheumatoid arthritis
348510|NCT01456403|Carotid|carotid
348511|NCT01456403|endarterectomy|endarterectomy
348512|NCT01456403|vulnerable plaque|vulnerable plaque
348513|NCT01456403|Ultrasound|ultrasound
348514|NCT01456403|MRI|mri
348515|NCT01456403|PET/CT|pet/ct
348516|NCT01456390|Open angle glaucoma|open angle glaucoma
348517|NCT01456390|Prior trabeculectomy|prior trabeculectomy
348518|NCT01456377|lumbar stenosis|lumbar stenosis
348519|NCT01456377|systemic corticosteroids|systemic corticosteroids
348521|NCT01456377|security|security
348522|NCT01456364|clopidogrel low response|clopidogrel low response
348523|NCT01456364|ticagrelor|ticagrelor
348524|NCT01456364|prasugrel|prasugrel
348525|NCT01456364|platelet aggregation|platelet aggregation
348526|NCT01456351|Event free survival|event free survival
348527|NCT01456351|Remission rates|remission rates
348528|NCT01456351|Toxicity|toxicity
348529|NCT01456351|Overall survival|overall survival
348530|NCT01456351|Efficiency costs|efficiency costs
348531|NCT01456351|Recurrent low grade|recurrent low grade
348532|NCT01456338|cognitive behavior therapy|cognitive behavior therapy
348533|NCT01456338|addiction|addiction
348534|NCT01456338|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
348535|NCT01456312|Peginterferon alfa 2a|peginterferon alfa 2a
348536|NCT01456312|Entecavir|entecavir
348537|NCT01456312|Response Guided Therapy|response guided therapy
348538|NCT01456312|Chronic Hepatitis B|chronic hepatitis b
348539|NCT01456299|laryngeal mask airway|laryngeal mask airway
348540|NCT01456299|insertion|insertion
348541|NCT01456299|sevoflurane|sevoflurane
348542|NCT01456299|remifentanil|remifentanil
348543|NCT01456273|biopsychosocial model|biopsychosocial model
348544|NCT01456273|biomedical model|biomedical model
348545|NCT01456273|functional dyspepsia|functional dyspepsia
348546|NCT01456260|Drug Therapy|drug therapy
348547|NCT01456247|Drug Therapy|drug therapy
348548|NCT01456221|Obesity|obesity
348549|NCT01456221|Insulin resistance|insulin resistance
348550|NCT01456221|Omega3 long chain polyunsaturated fatty acids|omega3 long chain polyunsaturated fatty acids
348551|NCT01456195|Drug Therapy|drug therapy
348552|NCT01456169|High Blood Pressure|high blood pressure
348553|NCT01456169|Drug Therapy|drug therapy
348554|NCT01456156|hepatocellular carcinoma|hepatocellular carcinoma
348555|NCT01456156|postoperative radiotherapy|postoperative radiotherapy
348556|NCT01456143|Squamous Cell Carcinoma|squamous cell carcinoma
348557|NCT01456143|Neoplasia|neoplasia
348558|NCT01456143|Optical imaging|optical imaging
348559|NCT01456143|Head and Neck Cancer|head and neck cancer
348560|NCT01456143|Oropharynx|oropharynx
348561|NCT01456143|Larynx|larynx
348562|NCT01456143|Oral Cavity|oral cavity
348563|NCT01456117|Drug Therapy|drug therapy
348564|NCT01456117|pharmacodynamics|pharmacodynamics
348565|NCT01456117|pharmacokinetics|pharmacokinetics
348566|NCT01456104|vaccine|vaccine
348567|NCT01456104|stage IIB|stage iib
348568|NCT01456104|stage IIC|stage iic
348569|NCT01456104|stage III|stage iii
348570|NCT01456104|stage IV (MIa)|stage iv (mia)
348571|NCT01456104|Langerhans-type dendritic cells|langerhans-type dendritic cells
348572|NCT01456104|Immune Responses|immune responses
348573|NCT01456104|10-229|10-229
348574|NCT01456091|adolescent pregnancy|adolescent pregnancy
348575|NCT01456091|adolescent birth|adolescent birth
348576|NCT01456091|rapid repeat pregnancy|rapid repeat pregnancy
348577|NCT01456091|rapid repeat birth|rapid repeat birth
348578|NCT01456091|youth development|youth development
348579|NCT01456091|Pregnancy in Adolescence|pregnancy in adolescence
348580|NCT01456078|Neuroendocrine tumor|neuroendocrine tumor
348581|NCT01456078|Liver metastases|liver metastases
348582|NCT01456078|177Lu-DOTA-TATE|177lu-dota-tate
348583|NCT01456078|Safety|safety
348584|NCT01456078|Kidney dosimetry|kidney dosimetry
348585|NCT01456078|Dose escalation|dose escalation
348586|NCT01456078|Neuroendocrine tumors, with liver metastases.|neuroendocrine tumors, with liver metastases.
348587|NCT01456026|Diabetes|diabetes
348588|NCT01456026|Advanced glycation endproducts|advanced glycation endproducts
348589|NCT01456026|Endothelium|endothelium
348590|NCT01456000|atrial fibrillation|atrial fibrillation
348592|NCT01456000|PAF|paf
348593|NCT01456000|PVI|pvi
348594|NCT01456000|ablation|ablation
348595|NCT01456000|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
348596|NCT01456000|pulmonary vein isolation|pulmonary vein isolation
348597|NCT01455987|Osteochondritis dissecans|osteochondritis dissecans
348598|NCT01455987|Juvenile osteochondritis dissecans|juvenile osteochondritis dissecans
348599|NCT01455987|Knee|knee
348600|NCT01455987|Osteochondral|osteochondral
348601|NCT01455987|Outcome|outcome
348602|NCT01455974|hypertension|hypertension
348603|NCT01455974|arterial stiffness|arterial stiffness
348604|NCT01455974|left ventricular hypertrophy|left ventricular hypertrophy
348605|NCT01455961|Real life setting|real life setting
726416|NCT01072474|Safety|safety
348606|NCT01455961|Bipolar Disorder|bipolar disorder
348607|NCT01455961|Registry based Data Base Audit|registry based data base audit
348608|NCT01455844|Hypertriglyceridemia|hypertriglyceridemia
348610|NCT01455792|MRI and ultrasound soft image fusion|mri and ultrasound soft image fusion
348611|NCT01455792|Gold standard TRUS biopsy|gold standard trus biopsy
348612|NCT01455779|Stress Urinary Incontinence|stress urinary incontinence
348613|NCT01455779|Incontinence|incontinence
348614|NCT01455779|SUI|sui
348615|NCT01455779|Renessa|renessa
348616|NCT01455766|postpneumonectomy pulmonary edema|postpneumonectomy pulmonary edema
348617|NCT01455766|extravascular lung water|extravascular lung water
348618|NCT01455753|Influenza|influenza
348619|NCT01455753|Proximity|proximity
348620|NCT01455740|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
348622|NCT01455740|Commitment|commitment
348623|NCT01455740|Financial Incentives|financial incentives
348624|NCT01455727|Pharmaceutical care|pharmaceutical care
348625|NCT01455727|Diabetes Mellitus|diabetes mellitus
348626|NCT01455714|hypertenion|hypertenion
348627|NCT01455714|exertional dyspnoea|exertional dyspnoea
348628|NCT01455714|heart failure|heart failure
348629|NCT01455714|biomarkers|biomarkers
348630|NCT01455688|critically ill patients|critically ill patients
348631|NCT01455688|HIV infection|hiv infection
348632|NCT01455688|HAART|haart
348633|NCT01455688|mortality|mortality
348634|NCT01455675|cystic fibrosis|cystic fibrosis
348635|NCT01455662|cardiac arrest|cardiac arrest
348636|NCT01455649|Kidney|kidney
348637|NCT01455649|Transplant|transplant
348638|NCT01455649|Immunosuppression|immunosuppression
348639|NCT01455649|Everolimus|everolimus
348640|NCT01455649|Graft function|graft function
348641|NCT01455636|pediatric|pediatric
348642|NCT01455636|micronutrient powder|micronutrient powder
348643|NCT01455636|hand hygiene|hand hygiene
348644|NCT01455636|low birth weight|low birth weight
348645|NCT01455636|infant feeding|infant feeding
348646|NCT01455636|hand sanitizers|hand sanitizers
348647|NCT01455623|CMT|cmt
348648|NCT01455610|Computed tomography|computed tomography
348649|NCT01455610|Contrast enhancement|contrast enhancement
348650|NCT01455610|Pancreas|pancreas
348651|NCT01455610|Cancer|cancer
348652|NCT01455610|Resectability|resectability
348653|NCT01455597|Postmenopausal Women|postmenopausal women
348654|NCT01455597|Vaginal Dryness|vaginal dryness
348655|NCT01455597|Postmenopausal Vulvovaginal Atrophy|postmenopausal vulvovaginal atrophy
348656|NCT01455584|HM781-36B|hm781-36b
348657|NCT01455558|Pharmacokinetics|pharmacokinetics
348658|NCT01455545|Asthma|asthma
348659|NCT01455545|Degree of Control|degree of control
348660|NCT01455545|Exhaled Nitric Oxide|exhaled nitric oxide
348661|NCT01455545|Asthma Control Test|asthma control test
348662|NCT01455519|Low Back Pain|low back pain
348663|NCT01455519|Back Pain|back pain
348664|NCT01455519|Chronic back pain|chronic back pain
348665|NCT01455506|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
348666|NCT01455506|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
348667|NCT01455506|Bone Marrow Transplant|bone marrow transplant
348668|NCT01455506|Stem Cell Transplant|stem cell transplant
348669|NCT01455480|Second Degree Burn|second degree burn
348670|NCT01455480|partial thickness burns|partial thickness burns
348671|NCT01455467|Open angle glaucoma|open angle glaucoma
348672|NCT01455467|Pigmentary glaucoma|pigmentary glaucoma
348673|NCT01455467|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
348674|NCT01455441|GLP-1|glp-1
348675|NCT01455441|Training|training
348676|NCT01455441|Exercise|exercise
348677|NCT01455441|Type 2 Diabetes|type 2 diabetes
348678|NCT01455428|Pregabalin|pregabalin
348679|NCT01455428|Postherpetic Neuralgia ( PHN )|postherpetic neuralgia ( phn )
403006|NCT01228617|Smoking Cessation|smoking cessation
403007|NCT01228617|Nicotine pharmacokinetics|nicotine pharmacokinetics
339308|NCT01494350|Tunisia|tunisia
348680|NCT01455402|Respiratory Syncytial Virus, Chronic Obstructive Pulmonary Disease, Congestive Heart Failure, Observational|respiratory syncytial virus, chronic obstructive pulmonary disease, congestive heart failure, observational
348681|NCT01455389|Lung Cancer|lung cancer
348682|NCT01455389|Non-small cell lung cancer|non-small cell lung cancer
348683|NCT01455389|NSCLC|nsclc
348684|NCT01455389|FUS1-nanoparticles|fus1-nanoparticles
348685|NCT01455389|DOTAP:Chol-fus1|dotap:chol-fus1
348686|NCT01455389|DOTAP:Cholesterol-Fus1 Liposome Complex|dotap:cholesterol-fus1 liposome complex
348687|NCT01455389|Erlotinib|erlotinib
348688|NCT01455389|Erlotinib Hydrochloride|erlotinib hydrochloride
348689|NCT01455389|OSI-774|osi-774
348690|NCT01455389|Tarceva|tarceva
348691|NCT01455389|Dexamethasone|dexamethasone
348692|NCT01455389|Decadron|decadron
348693|NCT01455389|Diphenhydramine|diphenhydramine
348694|NCT01455389|Benadryl|benadryl
348695|NCT01455389|Benylin Cough SyrupPharmacokinetic|benylin cough syruppharmacokinetic
348696|NCT01455389|PK|pk
348697|NCT01455376|brain injury|brain injury
348698|NCT01455376|cognitive function|cognitive function
348699|NCT01455376|sodium lactate|sodium lactate
348700|NCT01455376|MMSE score|mmse score
348701|NCT01455350|provoked vestibulodynia|provoked vestibulodynia
348702|NCT01455350|multimodal physiotherapy|multimodal physiotherapy
348703|NCT01455350|lidocaine|lidocaine
348704|NCT01455337|severe alcoholic hepatitis|severe alcoholic hepatitis
348705|NCT01455324|prosthetic socket|prosthetic socket
348706|NCT01455324|residual limb volume fluctuation|residual limb volume fluctuation
348707|NCT01455324|conformable socket liner|conformable socket liner
348708|NCT01455311|cystic pancreatic tumors|cystic pancreatic tumors
348709|NCT01455311|cystic pancreatic lesions|cystic pancreatic lesions
348710|NCT01455311|gastrointestinal|gastrointestinal
348711|NCT01455311|GI|gi
348712|NCT01455311|EUS-FNA|eus-fna
348713|NCT01455311|EchoBrush®|echobrush®
348714|NCT01455311|cytology brush|cytology brush
348715|NCT01455311|endoscopic|endoscopic
348716|NCT01455298|Alpha-1 AT deficiency|alpha-1 at deficiency
348717|NCT01455298|liver injury|liver injury
348718|NCT01455298|Transient Elastography|transient elastography
348719|NCT01455298|FibroTest|fibrotest
348721|NCT01455285|transcutaneous electrical nerve stimulation (TENS|transcutaneous electrical nerve stimulation (tens
348722|NCT01455285|analgesia|analgesia
348723|NCT01455285|pain visual analog scale|pain visual analog scale
348724|NCT01455285|McGill pain questionnaire|mcgill pain questionnaire
348725|NCT01455259|AdCD40L|adcd40l
348726|NCT01455259|Adenoviral vector|adenoviral vector
348727|NCT01455259|CD40L|cd40l
348728|NCT01455259|CD154|cd154
348729|NCT01455259|malignant melanoma|malignant melanoma
348730|NCT01455246|Cirrhosis|cirrhosis
348731|NCT01455246|Nosocomial Spontaneous Bacterial Peritonitis|nosocomial spontaneous bacterial peritonitis
348732|NCT01455246|Ascites|ascites
348733|NCT01455246|Daptomycin|daptomycin
348734|NCT01455246|Meropenem|meropenem
348735|NCT01455246|Ceftazidime|ceftazidime
348736|NCT01455246|Nosocomial infection|nosocomial infection
348737|NCT01455246|Multi drug resistant bacteria|multi drug resistant bacteria
348738|NCT01455246|Sepsis|sepsis
348739|NCT01455246|Albumin|albumin
348740|NCT01455233|cornea|cornea
348741|NCT01455233|ocular antibiotic|ocular antibiotic
348742|NCT01455233|cataract surgery|cataract surgery
348743|NCT01455220|Multiple Sclerosis|multiple sclerosis
348744|NCT01455220|Sexual Dysfunction|sexual dysfunction
348745|NCT01455220|Quality of Life|quality of life
348848|NCT01454752|anaemia|anaemia
348746|NCT01455207|Magnetic Resonance Imaging|magnetic resonance imaging
348747|NCT01455207|Positon Emission Tomography|positon emission tomography
348748|NCT01455207|Behavior|behavior
348749|NCT01455194|ciclesonide|ciclesonide
348750|NCT01455194|asthma|asthma
348751|NCT01455181|Hypoparathyroidism|hypoparathyroidism
348752|NCT01455181|NPSP558|npsp558
348753|NCT01455181|Parathyroid Hormone 1-84|parathyroid hormone 1-84
348754|NCT01455181|PTH 1-84|pth 1-84
348755|NCT01455168|anterior capsule shrinkage|anterior capsule shrinkage
348756|NCT01455168|capsular tension ring|capsular tension ring
348757|NCT01455168|exfoliation syndrome|exfoliation syndrome
348758|NCT01455168|phacoemulsification and aspiration|phacoemulsification and aspiration
348759|NCT01455155|stroke|stroke
348760|NCT01455155|Art therapy|art therapy
348761|NCT01455155|Music therapy|music therapy
348762|NCT01455155|Creative therapy|creative therapy
348763|NCT01455155|Efficacy|efficacy
348764|NCT01455129|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
348765|NCT01455129|COPD|copd
348766|NCT01455129|COPD exacerbation|copd exacerbation
348767|NCT01455129|treatment|treatment
348768|NCT01455129|tiotropium|tiotropium
348769|NCT01455129|anticholinergic|anticholinergic
348770|NCT01455129|acute exacerbation of COPD (AECOPD)|acute exacerbation of copd (aecopd)
348771|NCT01455116|Sepsis|sepsis
348772|NCT01455116|Multi organ dysfunction syndrome|multi organ dysfunction syndrome
348773|NCT01455116|Mild Induced Hypothermia|mild induced hypothermia
348774|NCT01455077|obesity|obesity
348775|NCT01455077|sleep apnea|sleep apnea
348776|NCT01455077|portable monitoring|portable monitoring
348777|NCT01455025|Plerixafor granulocyte-colony stimulating factor|plerixafor granulocyte-colony stimulating factor
348778|NCT01455025|Chemotherapy in relapse|chemotherapy in relapse
348779|NCT01455025|Acute Myeloid Leukemia|acute myeloid leukemia
348780|NCT01455012|Rotigotine|rotigotine
348781|NCT01455012|Neupro|neupro
348783|NCT01455012|Cardiovascular Risk|cardiovascular risk
348784|NCT01455012|Nocturnal Blood Pressure|nocturnal blood pressure
348785|NCT01454999|veteran|veteran
348786|NCT01454999|smoking|smoking
348787|NCT01454999|stage of change|stage of change
348788|NCT01454999|cell phone|cell phone
348789|NCT01454999|computerized tailored intervention|computerized tailored intervention
348790|NCT01454986|Healthy subjects|healthy subjects
348791|NCT01454973|type 2 diabetes|type 2 diabetes
348792|NCT01454973|beta cell function|beta cell function
348793|NCT01454973|meal tolerance test|meal tolerance test
348794|NCT01454973|maximum stimulation test|maximum stimulation test
348795|NCT01454973|method standardization|method standardization
348796|NCT01454973|insulin secretion|insulin secretion
348797|NCT01454960|Antibiotics|antibiotics
348798|NCT01454960|Inappropriate Prescribing|inappropriate prescribing
348799|NCT01454960|Respiratory Tract Infections|respiratory tract infections
348800|NCT01454960|Behavioral Research|behavioral research
348801|NCT01454947|Antibiotics|antibiotics
348802|NCT01454947|Inappropriate Prescribing|inappropriate prescribing
348803|NCT01454947|Respiratory Tract Infections|respiratory tract infections
348804|NCT01454947|Behavioral Research|behavioral research
348806|NCT01454921|Adolescent Trials Network|adolescent trials network
348807|NCT01454908|partial knee arthroplasty|partial knee arthroplasty
348808|NCT01454895|noise-induced hearing loss|noise-induced hearing loss
348809|NCT01454895|prevention|prevention
348810|NCT01454895|farmers|farmers
348811|NCT01454882|Direct calorimetry|direct calorimetry
348812|NCT01454882|Indirect calorimetry|indirect calorimetry
348813|NCT01454882|Energy Expenditure|energy expenditure
348814|NCT01454869|heparin|heparin
348815|NCT01454843|Myopia|myopia
348816|NCT01454843|Astigmatism|astigmatism
348817|NCT01454843|Aberrations|aberrations
348818|NCT01454843|Wavefront|wavefront
348819|NCT01454843|LASIK|lasik
348820|NCT01454843|Wavefront LASIK|wavefront lasik
348821|NCT01454830|Social support|social support
348822|NCT01454830|Cognition|cognition
348823|NCT01454830|Adaptation, psychological|adaptation, psychological
348824|NCT01454830|Health behavior|health behavior
348825|NCT01454830|Patient education|patient education
348826|NCT01454817|Quality of Life|quality of life
348827|NCT01454817|Implantable Cardiac Defibrillators|implantable cardiac defibrillators
348828|NCT01454817|ICDs|icds
348829|NCT01454804|Advanced Cancers|advanced cancers
348830|NCT01454804|Solid Tumors|solid tumors
348831|NCT01454804|Pazopanib|pazopanib
348832|NCT01454804|GW786034|gw786034
348833|NCT01454804|Lapatinib|lapatinib
348834|NCT01454804|Tykerb|tykerb
348835|NCT01454804|GW572016|gw572016
348836|NCT01454804|Trastuzumab|trastuzumab
348837|NCT01454804|Herceptin|herceptin
348838|NCT01454791|multiple sclerosis|multiple sclerosis
348839|NCT01454791|diclofenac|diclofenac
348840|NCT01454791|subcutaneous injection|subcutaneous injection
348841|NCT01454791|glatiramer acetate|glatiramer acetate
348842|NCT01454791|Copaxone|copaxone
348843|NCT01454778|restenosis|restenosis
348844|NCT01454778|peripheral vascular disease|peripheral vascular disease
348845|NCT01454778|lower extremity ischemia|lower extremity ischemia
348846|NCT01454778|claudication|claudication
348847|NCT01454752|malaria|malaria
348849|NCT01454752|cognition|cognition
348850|NCT01454752|intermittent preventive treatment|intermittent preventive treatment
348851|NCT01454752|children|children
348852|NCT01454752|schools|schools
348853|NCT01454752|insecticide-treated nets|insecticide-treated nets
348854|NCT01454739|rFVIIIFc|rfviiifc
348855|NCT01454739|A-LONG Extension|a-long extension
348856|NCT01454726|Dizziness|dizziness
348857|NCT01454726|Meniere's disease|meniere's disease
348858|NCT01454726|Diaoshi Jifa therapy|diaoshi jifa therapy
348859|NCT01454700|Type 1 diabetes mellitus|type 1 diabetes mellitus
348860|NCT01454700|Albuminuria|albuminuria
348861|NCT01454700|Late diabetes complications|late diabetes complications
348862|NCT01454700|CSII|csii
348864|NCT01454700|Glycaemic control|glycaemic control
348865|NCT01454661|Probiotics|probiotics
348866|NCT01454661|Premature infant|premature infant
348867|NCT01454661|Intestinal microbiota|intestinal microbiota
348868|NCT01454661|Intestinal immunity|intestinal immunity
348869|NCT01454661|Breastfeeding|breastfeeding
348870|NCT01454648|Traumatic Brain Injury|traumatic brain injury
348871|NCT01454648|EMS|ems
348872|NCT01454648|Out-of-Hospital|out-of-hospital
348873|NCT01454635|depression|depression
348874|NCT01454635|treatment response|treatment response
348875|NCT01454635|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
348876|NCT01454622|Healthy Volunteers|healthy volunteers
348877|NCT01454622|Bioequivalence|bioequivalence
348878|NCT01454622|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
348879|NCT01454622|Metformin IR|metformin ir
348880|NCT01454609|cervical plexus block|cervical plexus block
348881|NCT01454609|thyroidectomy|thyroidectomy
348882|NCT01454609|postoperative analgesia|postoperative analgesia
348883|NCT01454596|Cell Therapy|cell therapy
348884|NCT01454596|Gene Therapy|gene therapy
348885|NCT01454596|Immunotherapy|immunotherapy
348886|NCT01454596|Brain Cancer|brain cancer
348887|NCT01454596|Glioma|glioma
348888|NCT01454596|Glioblastoma|glioblastoma
348889|NCT01454583|renin inhibitor|renin inhibitor
348890|NCT01454583|ACE inhibitor|ace inhibitor
348891|NCT01454583|ARB (AT1 receptor blockers)|arb (at1 receptor blockers)
348892|NCT01454583|RAS blockade|ras blockade
348893|NCT01454570|exoskeleton walking system|exoskeleton walking system
348894|NCT01454570|paraplegia|paraplegia
348895|NCT01454570|paralysis|paralysis
348896|NCT01454557|Acquired Brain Injury|acquired brain injury
348897|NCT01454557|Heart Rate Variability (HRV)|heart rate variability (hrv)
348898|NCT01454557|Auditory Stimuli|auditory stimuli
348899|NCT01454557|Physical Activity|physical activity
348900|NCT01454518|hip arthroscopy|hip arthroscopy
348901|NCT01454518|post operative analgesia|post operative analgesia
348902|NCT01454505|Healthy subjects|healthy subjects
348903|NCT01454505|Nasal allergies|nasal allergies
348904|NCT01454505|Allergies|allergies
348905|NCT01454505|Environmental Exposure Chamber|environmental exposure chamber
348906|NCT01454505|EEC|eec
348907|NCT01454505|Ragweed|ragweed
348908|NCT01454492|Allergy rhinitis|allergy rhinitis
348909|NCT01454492|Geographic tongue|geographic tongue
348910|NCT01454479|Lapatinib|lapatinib
348911|NCT01454479|Ixabepilone|ixabepilone
348912|NCT01454479|HER-2|her-2
348913|NCT01454479|Endometrial Carcinoma|endometrial carcinoma
348914|NCT01454466|prevention|prevention
348915|NCT01454466|retinal break|retinal break
348916|NCT01454466|vitrectomy|vitrectomy
348917|NCT01454466|partial posterior hyaloidectomy|partial posterior hyaloidectomy
348918|NCT01454453|amisulpride|amisulpride
348919|NCT01454453|receptor occupancy|receptor occupancy
348920|NCT01454453|antipsychotic sensitivity|antipsychotic sensitivity
348921|NCT01454440|Coronary artery disease|coronary artery disease
348923|NCT01454440|Percutaneous coronary intervention|percutaneous coronary intervention
348924|NCT01454440|stable coronary artery disease|stable coronary artery disease
348925|NCT01454440|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
348926|NCT01454440|DES|des
348927|NCT01454375|Smoking|smoking
348928|NCT01454362|nicotine|nicotine
348929|NCT01454362|inhalator|inhalator
348930|NCT01454362|electronic cigarette|electronic cigarette
348931|NCT01454362|tobacco|tobacco
348932|NCT01454349|Benign prostatic hyperplasia|benign prostatic hyperplasia
348933|NCT01454349|BPH|bph
348934|NCT01454349|Enlarged prostate|enlarged prostate
348935|NCT01454349|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
348936|NCT01454336|MSCs|mscs
348937|NCT01454336|Pioglitazon|pioglitazon
348938|NCT01454336|fibrosis|fibrosis
348939|NCT01454336|liver|liver
348940|NCT01454323|Chronic Myocardial Ischemia|chronic myocardial ischemia
348941|NCT01454323|Cell therapy|cell therapy
348942|NCT01454323|Bone marrow mononuclear cells|bone marrow mononuclear cells
348943|NCT01454310|Skin substitutes|skin substitutes
348944|NCT01454310|Split-thickness skin graft|split-thickness skin graft
348945|NCT01454310|Burn wound|burn wound
348946|NCT01454310|Scar formation|scar formation
348947|NCT01454310|Skin quality|skin quality
348948|NCT01454297|Myeloma|myeloma
348949|NCT01454297|Multiple Myeloma|multiple myeloma
348950|NCT01454297|Observational|observational
348951|NCT01454297|Longitudinal|longitudinal
348952|NCT01454271|Total Hip arthroplasty|total hip arthroplasty
348953|NCT01454271|Hip Osteoarthritis|hip osteoarthritis
348954|NCT01454271|Infection after Total Hip Arthroplasty|infection after total hip arthroplasty
348955|NCT01454245|39439335EDI1013|39439335edi1013
348956|NCT01454245|Bioavailability|bioavailability
348957|NCT01454245|Pharmacokinetics|pharmacokinetics
348958|NCT01454232|Obesity|obesity
348959|NCT01454232|adipose tissue inflammation|adipose tissue inflammation
348960|NCT01454232|Low grade systemic inflammation|low grade systemic inflammation
348961|NCT01454232|gut microbiota|gut microbiota
348962|NCT01454232|Bariatric surgery|bariatric surgery
348963|NCT01454206|cannabis abuse|cannabis abuse
348964|NCT01454206|alcohol abuse|alcohol abuse
348965|NCT01454206|substance abuse|substance abuse
348966|NCT01454180|Therapeutic targets in Pancreas|therapeutic targets in pancreas
348967|NCT01454167|vacum drains|vacum drains
348968|NCT01454167|operational wounds|operational wounds
348969|NCT01454167|infections|infections
348970|NCT01454167|seroma|seroma
348971|NCT01454167|acid base|acid base
348972|NCT01454167|glucose|glucose
348973|NCT01454167|lactate|lactate
348974|NCT01454154|TBI|tbi
348975|NCT01454154|Traumatic Brain Injury|traumatic brain injury
348976|NCT01454141|Depressed mood|depressed mood
348977|NCT01454128|exercise base rehabilitation|exercise base rehabilitation
348978|NCT01454128|heart failure|heart failure
348979|NCT01454128|periodic breathing|periodic breathing
348980|NCT01454128|aerobic fitness|aerobic fitness
348981|NCT01454089|bladder|bladder
348982|NCT01454089|urinary tract|urinary tract
348983|NCT01454089|transitional cell carcinoma|transitional cell carcinoma
348984|NCT01454089|metastatic bladder cancer|metastatic bladder cancer
348985|NCT01454089|chemotherapy|chemotherapy
348986|NCT01454076|Cmax: maximum plasma concentration|cmax: maximum plasma concentration
348987|NCT01454076|AUC0-tlast: time zero to the time of the last quantifiable concentration|auc0-tlast: time zero to the time of the last quantifiable concentration
348988|NCT01454063|cataract|cataract
348989|NCT01454063|lens replacement|lens replacement
348990|NCT01454050|ICD therapy|icd therapy
348991|NCT01454050|RV/LV Capture Control|rv/lv capture control
348992|NCT01454050|Safety and Efficacy|safety and efficacy
348993|NCT01454011|hypogonadism|hypogonadism
348994|NCT01454011|testosterone|testosterone
348995|NCT01454011|HDL cholesterol subgroups|hdl cholesterol subgroups
348996|NCT01454011|hsCRP|hscrp
348997|NCT01454011|HOMA-IR|homa-ir
348998|NCT01453972|Exercise|exercise
348999|NCT01453972|High-intensity|high-intensity
349000|NCT01453972|Interval training|interval training
349001|NCT01453959|hypertension|hypertension
349002|NCT01453959|salt sensitivity|salt sensitivity
349008|NCT01453933|Anti-Infective Agents|anti-infective agents
349009|NCT01453933|Lopinavir/ritonavir|lopinavir/ritonavir
349010|NCT01453920|Age Related Macular Degeneration|age related macular degeneration
349011|NCT01453920|Choroidal Neovascular Membrane|choroidal neovascular membrane
349012|NCT01453894|Colorectal Cancer Screening|colorectal cancer screening
349013|NCT01453894|Fecal Occult Blood Testing|fecal occult blood testing
349014|NCT01453881|Asthma|asthma
349015|NCT01453881|pMDI|pmdi
349016|NCT01453881|Beclomethasone|beclomethasone
349017|NCT01453881|Formoterol|formoterol
349018|NCT01453881|Efficacy|efficacy
349019|NCT01453868|Multiple Sclerosis|multiple sclerosis
349020|NCT01453868|non impact aerobics|non impact aerobics
349021|NCT01453855|Open-Angle Glaucoma|open-angle glaucoma
349022|NCT01453855|Ocular Hypertension|ocular hypertension
349023|NCT01453842|Glucagon-like peptide-1|glucagon-like peptide-1
348621|NCT01455740|HIV|hiv
349024|NCT01453842|Glucose-dependant insulinotropic polypeptide|glucose-dependant insulinotropic polypeptide
349025|NCT01453842|Glucagon|glucagon
349026|NCT01453842|Peptide PYY|peptide pyy
349027|NCT01453842|2-oleyl glycerol|2-oleyl glycerol
349028|NCT01453816|Renal insufficiency|renal insufficiency
349029|NCT01453816|kidney failure|kidney failure
349030|NCT01453803|Liposuction|liposuction
349032|NCT01453803|ASC|asc
349033|NCT01453803|stem cell|stem cell
349034|NCT01453803|Parkinson's Disease|parkinson's disease
349035|NCT01453803|Parkinson's|parkinson's
349036|NCT01453803|therapy|therapy
349037|NCT01453790|depression|depression
349038|NCT01453790|treatment|treatment
349039|NCT01453790|motivation to seek follow up|motivation to seek follow up
349040|NCT01453777|diffuse brain lesion|diffuse brain lesion
349041|NCT01453751|Diabetes|diabetes
349042|NCT01453751|Type 2 Diabetes|type 2 diabetes
349043|NCT01453738|Osteoarthritis|osteoarthritis
349044|NCT01453738|Knee|knee
349045|NCT01453738|Stem cells|stem cells
349046|NCT01453738|Mesenchymal Stem Cells|mesenchymal stem cells
349047|NCT01453712|coronary artery disease|coronary artery disease
349048|NCT01453712|coronary CT angiography|coronary ct angiography
349049|NCT01453712|radiation dose|radiation dose
349050|NCT01453712|iterative image reconstruction|iterative image reconstruction
349051|NCT01453712|detection|detection
349052|NCT01453699|Bereavement|bereavement
349053|NCT01453699|early parental death|early parental death
349054|NCT01453699|grief|grief
349055|NCT01453699|affective disorders|affective disorders
349056|NCT01453699|depression, depressive symptoms|depression, depressive symptoms
349057|NCT01453699|socioeconomic factors|socioeconomic factors
349058|NCT01453699|suicide|suicide
349059|NCT01453699|attempted suicide|attempted suicide
349060|NCT01453699|antidepressive agents|antidepressive agents
349061|NCT01453699|cardiovascular diseases|cardiovascular diseases
349062|NCT01453699|quality of life|quality of life
349063|NCT01453699|Long-term health effects|long-term health effects
349064|NCT01453699|Socioeconomic outcomes|socioeconomic outcomes
349065|NCT01453699|Psychosocial well-being|psychosocial well-being
349066|NCT01453686|Alopecia Areata|alopecia areata
349067|NCT01453686|Hydrocortisone|hydrocortisone
349068|NCT01453686|Clobetasol Propionate|clobetasol propionate
349069|NCT01453686|Randomized Controlled Trial|randomized controlled trial
349070|NCT01452711|Drug Therapy|drug therapy
349071|NCT01452698|Drug Therapy|drug therapy
349072|NCT01452685|Drug Therapy|drug therapy
349073|NCT01452672|Breast cancer|breast cancer
349074|NCT01452672|Radiotherapy|radiotherapy
349075|NCT01452672|Post-mastectomy|post-mastectomy
349076|NCT01452672|Molecular characterization|molecular characterization
349077|NCT01452659|Drug Therapy|drug therapy
349082|NCT01452633|pain|pain
349083|NCT01452633|laparoscopy|laparoscopy
349084|NCT01452633|reduction|reduction
349085|NCT01452620|Endovascular Abdominal Aortic Aneurysm Repair (EVAR)|endovascular abdominal aortic aneurysm repair (evar)
349086|NCT01452620|Abdominal Aortic aneurysm (AAA)|abdominal aortic aneurysm (aaa)
349087|NCT01452607|Ebselen|ebselen
349088|NCT01452581|Transfusion|transfusion
349089|NCT01452581|Red blood cells|red blood cells
349090|NCT01452581|Postoperative|postoperative
349091|NCT01452581|Dizziness|dizziness
349092|NCT01452581|Hip Arthroplasty|hip arthroplasty
349093|NCT01452568|Thromboembolic complications|thromboembolic complications
349094|NCT01452568|Bleeding complications|bleeding complications
349095|NCT01452568|Haemorrhagic complications|haemorrhagic complications
349096|NCT01452568|Anticoagulant therapy|anticoagulant therapy
349097|NCT01452568|Aspirin|aspirin
349098|NCT01452568|biological Aorta Valve|biological aorta valve
349099|NCT01452555|HIV|hiv
349100|NCT01452555|HIV Prevention|hiv prevention
349101|NCT01452555|HIV testing|hiv testing
349102|NCT01452555|HIV Rapid Test|hiv rapid test
349103|NCT01452542|Genz-112638|genz-112638
349104|NCT01452529|Pain|pain
349105|NCT01452529|Opioid|opioid
349106|NCT01452516|PLF|plf
349107|NCT01452516|lumbar fusion|lumbar fusion
349108|NCT01452516|bone graft|bone graft
349109|NCT01452516|biologics|biologics
349110|NCT01452503|AE adverse event|ae adverse event
349111|NCT01452503|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
349112|NCT01452503|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
349113|NCT01452503|ART antiretroviral therapy|art antiretroviral therapy
349114|NCT01452503|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
349115|NCT01452503|DCF data collection forms|dcf data collection forms
349116|NCT01452503|DMC Data Monitoring Committee|dmc data monitoring committee
349117|NCT01452503|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
349510|NCT01452035|exercise|exercise
349118|NCT01452503|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
349119|NCT01452503|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
349120|NCT01452503|ICH International Conference of Harmonization|ich international conference of harmonization
349121|NCT01452503|IND Investigational New Drug Application|ind investigational new drug application
349122|NCT01452503|IRB Institutional Review Board|irb institutional review board
349123|NCT01452503|IU International units|iu international units
349124|NCT01452503|mg milligram(s)|mg milligram(s)
349125|NCT01452503|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
349126|NCT01452503|PCR polymerase chain reaction|pcr polymerase chain reaction
349127|NCT01452503|SAE serious adverse event|sae serious adverse event
349128|NCT01452503|µg microgram|µg microgram
349129|NCT01452503|ULN upper limit of the normal range|uln upper limit of the normal range
349130|NCT01452503|WB Western Blot|wb western blot
349131|NCT01452490|Onychomycosis|onychomycosis
349132|NCT01452490|Toenail Fungus|toenail fungus
349133|NCT01452477|Polycystic Ovary Syndrome|polycystic ovary syndrome
349134|NCT01452477|Cryptotanshinone|cryptotanshinone
349135|NCT01452464|observational|observational
349136|NCT01452464|serogroup A, B, Y, W|serogroup a, b, y, w
349137|NCT01452464|meningococcal meningitis|meningococcal meningitis
349138|NCT01452464|meningococcal vaccines|meningococcal vaccines
349140|NCT01452464|MenACYW-CRM|menacyw-crm
349141|NCT01452464|post-marketing|post-marketing
349142|NCT01452464|adolescents|adolescents
349143|NCT01452438|observational|observational
349144|NCT01452438|serogroup A, B, Y, W|serogroup a, b, y, w
349145|NCT01452438|meningococcal meningitis|meningococcal meningitis
349146|NCT01452438|meningococcal vaccines|meningococcal vaccines
349147|NCT01452438|safety|safety
349148|NCT01452438|MenACYW-CRM|menacyw-crm
349149|NCT01452438|post-marketing|post-marketing
349150|NCT01452438|children|children
349151|NCT01452425|Human volunteers|human volunteers
349152|NCT01453673|knee|knee
349153|NCT01453673|Cruciate Ligament|cruciate ligament
349154|NCT01453673|Meniscus|meniscus
349155|NCT01453660|Endothelial Function|endothelial function
349156|NCT01453660|Endo-PAT2000 system|endo-pat2000 system
349157|NCT01453660|11-140|11-140
349158|NCT01453647|Fibromyalgia|fibromyalgia
349159|NCT01453647|self-efficacy|self-efficacy
349160|NCT01453647|fatigue|fatigue
349161|NCT01453647|stress|stress
349162|NCT01453647|cytokine|cytokine
349163|NCT01453634|chronic kidney disease (CKD)|chronic kidney disease (ckd)
349164|NCT01453634|secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
349165|NCT01453634|hemodialysis (HD)|hemodialysis (hd)
349166|NCT01453621|prediction rules|prediction rules
349167|NCT01453621|computerized clinical decision support|computerized clinical decision support
349168|NCT01453621|traumatic brain injury|traumatic brain injury
349169|NCT01453621|blunt head trauma|blunt head trauma
349170|NCT01453595|Kidney|kidney
349171|NCT01453595|renal cell carcinoma|renal cell carcinoma
349172|NCT01453595|BEZ235|bez235
349173|NCT01453595|11-080|11-080
349174|NCT01453582|Chest stuffiness of TCM|chest stuffiness of tcm
349175|NCT01453582|Qi deficiency and blood stasis of TCM|qi deficiency and blood stasis of tcm
349176|NCT01453556|Laparoscopic surgery|laparoscopic surgery
349177|NCT01453556|Right colectomy|right colectomy
349178|NCT01453556|Mechanical anastomosis|mechanical anastomosis
349179|NCT01453556|Post-operative ileum|post-operative ileum
349180|NCT01453530|Recovery|recovery
349181|NCT01453530|Street fitness|street fitness
349182|NCT01453530|Sugammadex|sugammadex
349183|NCT01453530|Alertness|alertness
349184|NCT01453530|Ambulatory surgery|ambulatory surgery
349185|NCT01453517|bariatric|bariatric
349186|NCT01453517|obesity|obesity
349187|NCT01453517|post-surgery|post-surgery
349188|NCT01453517|intervention|intervention
349189|NCT01453465|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
349190|NCT01453465|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
349191|NCT01453452|weight changes|weight changes
349192|NCT01453452|fatigue|fatigue
349193|NCT01453452|depression|depression
727198|NCT01065675|Pharmacist|pharmacist
349194|NCT01453452|anxiety disorder|anxiety disorder
349195|NCT01453452|pain|pain
349196|NCT01453452|cognitive/functional effects|cognitive/functional effects
349197|NCT01453452|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
349198|NCT01453452|cancer survivor|cancer survivor
349199|NCT01453452|stage IA breast cancer|stage ia breast cancer
349200|NCT01453452|stage IB breast cancer|stage ib breast cancer
349201|NCT01453452|stage II breast cancer|stage ii breast cancer
349202|NCT01453452|stage IIIA breast cancer|stage iiia breast cancer
349203|NCT01453452|stage IIIB breast cancer|stage iiib breast cancer
349204|NCT01453452|stage IIIC breast cancer|stage iiic breast cancer
349205|NCT01453452|stage I colon cancer|stage i colon cancer
349206|NCT01453452|stage IIA colon cancer|stage iia colon cancer
349207|NCT01453452|stage IIB colon cancer|stage iib colon cancer
349208|NCT01453452|stage IIC colon cancer|stage iic colon cancer
349209|NCT01453452|stage IIIA colon cancer|stage iiia colon cancer
349210|NCT01453452|stage IIIB colon cancer|stage iiib colon cancer
349211|NCT01453452|stage IIIC colon cancer|stage iiic colon cancer
349212|NCT01453452|stage I rectal cancer|stage i rectal cancer
349213|NCT01453452|stage IIA rectal cancer|stage iia rectal cancer
349214|NCT01453452|stage IIB rectal cancer|stage iib rectal cancer
349215|NCT01453452|stage IIC rectal cancer|stage iic rectal cancer
349216|NCT01453452|stage IIIA rectal cancer|stage iiia rectal cancer
349217|NCT01453452|stage IIIB rectal cancer|stage iiib rectal cancer
349218|NCT01453452|stage IIIC rectal cancer|stage iiic rectal cancer
349219|NCT01453439|Body dysmorphic disorder|body dysmorphic disorder
349220|NCT01453439|Obsessive compulsive spectrum disorder|obsessive compulsive spectrum disorder
349221|NCT01453439|Body image|body image
349222|NCT01453439|Appearance concerns|appearance concerns
349223|NCT01453400|aspirin|aspirin
349224|NCT01453400|acetylsalicylic acid|acetylsalicylic acid
349225|NCT01453400|pharyngitis|pharyngitis
349226|NCT01453400|sore throat|sore throat
349227|NCT01453387|MEK inhibitor|mek inhibitor
349228|NCT01453387|Solid Tumor|solid tumor
349229|NCT01453387|Phase I|phase i
349230|NCT01453374|opioid dependence|opioid dependence
349231|NCT01453374|VIVITROL|vivitrol
349232|NCT01453374|criminal justice|criminal justice
349233|NCT01453361|FANG|fang
349234|NCT01453361|Melanoma|melanoma
349235|NCT01453361|Vigil|vigil
349236|NCT01453348|meningococcal|meningococcal
349237|NCT01453348|conjugate|conjugate
349238|NCT01453348|vaccine|vaccine
349239|NCT01453348|adults|adults
349240|NCT01453335|Veins|veins
349241|NCT01453335|Catheter Segments|catheter segments
349242|NCT01453335|Vascular Access|vascular access
349243|NCT01453335|VeinViewer Vision|veinviewer vision
349244|NCT01453322|Veins|veins
349245|NCT01453322|Vascular Access|vascular access
349246|NCT01453322|IV complications|iv complications
349247|NCT01453322|VeinViewer Vision|veinviewer vision
349248|NCT01453309|lumbar fusion|lumbar fusion
349249|NCT01453309|transfusion|transfusion
349250|NCT01453309|cell-saver|cell-saver
349251|NCT01453309|cost-effectiveness|cost-effectiveness
349252|NCT01453296|Asthma|asthma
349253|NCT01453296|Tolerability|tolerability
349254|NCT01453296|Safety|safety
349255|NCT01453296|Pharmacokinetics|pharmacokinetics
349256|NCT01453296|GW642444|gw642444
349257|NCT01453283|DNA Repair|dna repair
349258|NCT01453283|Nucleotide Excision Repair|nucleotide excision repair
349259|NCT01453283|Trabectedine|trabectedine
349260|NCT01453283|Phase I|phase i
349261|NCT01453283|Sarcoma|sarcoma
349262|NCT01453283|Cytotoxic|cytotoxic
349263|NCT01453283|Chemotherapy|chemotherapy
349264|NCT01453283|Solid Tumor|solid tumor
349265|NCT01453283|Malignant Tumor|malignant tumor
349266|NCT01453283|Rhabdomyosarcoma|rhabdomyosarcoma
349267|NCT01453283|Ewing Sarcoma|ewing sarcoma
349268|NCT01453283|Neuroblastoma|neuroblastoma
349269|NCT01453283|Wilm's Tumor|wilm's tumor
349270|NCT01453283|Hepatic Tumor|hepatic tumor
349271|NCT01453283|Brain Tumor|brain tumor
349272|NCT01453270|Sepsis|sepsis
349273|NCT01453270|Emergency medicine|emergency medicine
349274|NCT01453270|Cardiac output|cardiac output
349275|NCT01453270|Stroke volume|stroke volume
349276|NCT01453270|Lactate|lactate
349277|NCT01453257|Molecular Targets|molecular targets
349278|NCT01453257|Personalize Treatment|personalize treatment
349279|NCT01453257|Colon Cancer|colon cancer
349280|NCT01453257|Complete Response Rate|complete response rate
349281|NCT01453244|Chronic hepatitis C|chronic hepatitis c
349282|NCT01453244|Pharmacogenomics|pharmacogenomics
349283|NCT01453244|IL28B|il28b
349284|NCT01453244|ITPA|itpa
349285|NCT01453231|bariatric surgery|bariatric surgery
349286|NCT01453231|plastic surgery|plastic surgery
349287|NCT01453231|thigh|thigh
349288|NCT01453231|obesity|obesity
349289|NCT01453231|body image|body image
349290|NCT01453231|quality of life|quality of life
349291|NCT01453218|Renal insufficiency|renal insufficiency
349292|NCT01453218|Liver transplant|liver transplant
349293|NCT01453218|Acute rejection|acute rejection
349294|NCT01453218|Infections|infections
727290|NCT01066143|Seroquel|seroquel
349295|NCT01453218|Hepatitis C recurrence|hepatitis c recurrence
349296|NCT01453205|Lymphoma, Non-Hodgkin's Lymphoma, Diffuse Large B-Cell Lymphoma, DLBCL, B-Cell Malignancy, anti-CD19, monoclonal antibody, second line, ASCT, Refractory|lymphoma, non-hodgkin's lymphoma, diffuse large b-cell lymphoma, dlbcl, b-cell malignancy, anti-cd19, monoclonal antibody, second line, asct, refractory
349297|NCT01453192|Raltegravir|raltegravir
349298|NCT01453192|Renal transplantation|renal transplantation
349299|NCT01453192|HIV-1|hiv-1
349300|NCT01453192|Acute renal graft rejection|acute renal graft rejection
349301|NCT01453179|actinic keratosis|actinic keratosis
349302|NCT01453179|invasive SCC|invasive scc
349303|NCT01453179|in situ SCC|in situ scc
349304|NCT01453179|histological classification|histological classification
349305|NCT01453179|histological progression|histological progression
349306|NCT01453179|clinical clearance|clinical clearance
349307|NCT01453179|cryotherapy|cryotherapy
349308|NCT01453153|pancreatic|pancreatic
349309|NCT01453153|Cancer|cancer
349310|NCT01453153|Stage IV|stage iv
349311|NCT01453153|untreated|untreated
349312|NCT01453127|dementia|dementia
349313|NCT01453127|parkinsonism|parkinsonism
349314|NCT01453127|mild cognitive impairment|mild cognitive impairment
349315|NCT01453127|REM sleep behavior disorder|rem sleep behavior disorder
349316|NCT01453114|Cognitive Behavioral Therapy|cognitive behavioral therapy
349319|NCT01453114|postpartum depression|postpartum depression
349320|NCT01453114|depression recurrence|depression recurrence
349321|NCT01453114|depression relapse|depression relapse
349322|NCT01453101|Multiple Myeloma|multiple myeloma
349323|NCT01453101|Transplant|transplant
349324|NCT01453088|multiple myeloma|multiple myeloma
349325|NCT01453088|transplant|transplant
349326|NCT01453075|hepatitis C|hepatitis c
349327|NCT01453075|herpes simplex type 2|herpes simplex type 2
349328|NCT01453075|veterans|veterans
349329|NCT01453062|Ofatumumab|ofatumumab
349330|NCT01453062|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
349331|NCT01453062|Arzerra|arzerra
349332|NCT01453049|rosiglitazone/glimepiride, fix dose, type 2 diabetes|rosiglitazone/glimepiride, fix dose, type 2 diabetes
349333|NCT01453036|Peptic ulcer|peptic ulcer
349334|NCT01453036|Helicobacter pylori|helicobacter pylori
349335|NCT01453036|Clarithromycin|clarithromycin
349336|NCT01453036|23S rRNA|23s rrna
349337|NCT01453036|Resistance|resistance
349338|NCT01453023|pediatric ages 5 to 11 years|pediatric ages 5 to 11 years
349339|NCT01453010|SaeboFlex|saeboflex
349340|NCT01453010|Stroke rehabilitation|stroke rehabilitation
349341|NCT01453010|Upper Limb Rehabilitation|upper limb rehabilitation
349342|NCT01453010|Acute Stroke|acute stroke
349343|NCT01452997|mosquito|mosquito
349344|NCT01452997|allergy|allergy
349345|NCT01452997|bite|bite
349346|NCT01452997|ant-inflammatory|ant-inflammatory
349347|NCT01452997|Aedes aegypti mosquito bite|aedes aegypti mosquito bite
349348|NCT01452984|Non-Melanoma skin cancer patients who have undergone or about to undergo Mohs surgery|non-melanoma skin cancer patients who have undergone or about to undergo mohs surgery
349349|NCT01452984|who are treated within the University of Pennsylvania Health System|who are treated within the university of pennsylvania health system
349350|NCT01452971|tumor susceptibility gene|tumor susceptibility gene
349351|NCT01452971|glycine N-methyltransferase (GNMT)|glycine n-methyltransferase (gnmt)
349352|NCT01452971|polycyclic aromatic hydrocarbons (PAHs)|polycyclic aromatic hydrocarbons (pahs)
349353|NCT01452971|lung cancer|lung cancer
349354|NCT01452958|Endotoxin|endotoxin
349355|NCT01452958|LPS|lps
349356|NCT01452958|TNF-α|tnf-α
349357|NCT01452958|insulin resistance|insulin resistance
349358|NCT01452958|metabolism|metabolism
349359|NCT01452932|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
349360|NCT01452932|Dyspnea|dyspnea
349361|NCT01452932|Exercise test|exercise test
349362|NCT01452932|Endurance training|endurance training
349363|NCT01452919|schizophrenia, LY2140023, pomaglumetad methionil|schizophrenia, ly2140023, pomaglumetad methionil
349364|NCT01452906|Drug-drug interaction|drug-drug interaction
349365|NCT01452906|Pharmacokinetics|pharmacokinetics
349366|NCT01452906|PA21|pa21
349367|NCT01452906|Drug Interaction Potentiation|drug interaction potentiation
349368|NCT01452880|Remifentanil|remifentanil
349369|NCT01452880|Lithotripsy|lithotripsy
349370|NCT01452880|Conscious Sedation|conscious sedation
349371|NCT01452867|Airway|airway
349372|NCT01452867|Bag-Valve -Mask- Ventilation|bag-valve -mask- ventilation
349373|NCT01452867|Laryngeal Mask - Ventilation|laryngeal mask - ventilation
349374|NCT01452867|Laryngeal Tube - Ventilation|laryngeal tube - ventilation
349375|NCT01452854|LGG|lgg
349376|NCT01452854|Temozolomide|temozolomide
349377|NCT01452854|Temodar|temodar
349378|NCT01452854|Ovarian Aging|ovarian aging
340023|NCT01491217|MTD|mtd
349379|NCT01452854|Infertility|infertility
349380|NCT01452854|Chemotherapy|chemotherapy
349381|NCT01452841|grapefruit|grapefruit
349382|NCT01452841|weight loss|weight loss
349383|NCT01452841|blood pressure|blood pressure
349384|NCT01452841|lipids|lipids
349385|NCT01452841|inflammation|inflammation
349386|NCT01452828|Renal Impairment|renal impairment
349387|NCT01452815|diabetic gastroparesis|diabetic gastroparesis
727491|NCT01066741|Oral cavity|oral cavity
349388|NCT01452815|delayed gastric emptying|delayed gastric emptying
349389|NCT01452815|gastroparesis|gastroparesis
349390|NCT01452815|diabetes mellitus, Type 1|diabetes mellitus, type 1
349391|NCT01452815|diabetes mellitus, Type 2|diabetes mellitus, type 2
349392|NCT01452802|HeartMate II|heartmate ii
349393|NCT01452802|heart-assist device|heart-assist device
349394|NCT01452802|medical management|medical management
349395|NCT01452802|optimal medical management|optimal medical management
349396|NCT01452802|Heart Failure NYHA Class IIIB/IV|heart failure nyha class iiib/iv
349397|NCT01452802|Thoratec Corporation|thoratec corporation
349398|NCT01452789|neonatal abstinence syndrome|neonatal abstinence syndrome
349399|NCT01452789|buprenorphine|buprenorphine
349400|NCT01452789|morphine|morphine
349401|NCT01452789|pharmacokinetics|pharmacokinetics
349402|NCT01452776|Drug Therapy|drug therapy
349403|NCT01452763|Drug Therapy|drug therapy
349404|NCT01452750|Drug Therapy|drug therapy
349405|NCT01452737|colonoscopy|colonoscopy
349406|NCT01452737|bowel preparation|bowel preparation
349407|NCT01452737|Golytely|golytely
349408|NCT01452724|Drug Therapy|drug therapy
349409|NCT01452412|Alkali|alkali
349410|NCT01452412|Sodium bicarbonate|sodium bicarbonate
349411|NCT01452412|Kidney disease|kidney disease
349412|NCT01452412|Acidosis|acidosis
349413|NCT01452386|Constipation|constipation
349414|NCT01452386|Stimulation Treatment|stimulation treatment
349415|NCT01452373|Hot flush(es)|hot flush(es)
349416|NCT01452373|Hot flash(es)|hot flash(es)
349417|NCT01452373|Vasomotor symptoms|vasomotor symptoms
349418|NCT01452373|Dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
349419|NCT01452373|Prasterone|prasterone
349420|NCT01452373|Acolbifene|acolbifene
349421|NCT01452373|Selective estrogen receptor modulator (SERM)|selective estrogen receptor modulator (serm)
349422|NCT01452373|Antiestrogen|antiestrogen
349423|NCT01452373|Menopause|menopause
349424|NCT01452373|Postmenopausal women|postmenopausal women
349425|NCT01452360|chronic kidney disease|chronic kidney disease
349426|NCT01452321|Transcranial Magnetic Stimulation;|transcranial magnetic stimulation;
349427|NCT01452321|Postpartum Depression;|postpartum depression;
349428|NCT01452321|Clinical Performance;|clinical performance;
349429|NCT01452321|Cognitive Performance;|cognitive performance;
349430|NCT01452321|Social Performance|social performance
349431|NCT01452308|Gilead|gilead
349432|NCT01452308|Gilead Sciences|gilead sciences
349434|NCT01452308|Liver Fibrosis|liver fibrosis
349435|NCT01452308|Liver|liver
349436|NCT01452308|Fibrosis|fibrosis
349437|NCT01452295|liver|liver
349438|NCT01452295|liver failure|liver failure
349439|NCT01452295|acute liver failure|acute liver failure
349440|NCT01452295|ELAD|elad
349441|NCT01452295|alcoholic hepatitis|alcoholic hepatitis
349442|NCT01452295|acute on chronic hepatitis|acute on chronic hepatitis
349443|NCT01452282|Ankle Brachial Index|ankle brachial index
349444|NCT01452282|Perioperative care|perioperative care
349445|NCT01452282|General Surgery|general surgery
349446|NCT01452282|Acute Coronary Syndromes|acute coronary syndromes
349447|NCT01452282|Cardiovascular Complications|cardiovascular complications
349448|NCT01452243|Vitamin D|vitamin d
349449|NCT01452243|Calcium|calcium
349450|NCT01452243|Elderly|elderly
349451|NCT01452230|Bariatric Surgery Candidate|bariatric surgery candidate
349452|NCT01452230|Severely obese|severely obese
349453|NCT01452230|Bariatric surgery|bariatric surgery
349454|NCT01452230|Physical activity|physical activity
349455|NCT01452230|Physical fitness|physical fitness
349456|NCT01452230|Comorbidities|comorbidities
349457|NCT01452230|Quality of life|quality of life
349458|NCT01452230|Surgical complications|surgical complications
349459|NCT01452217|Pancreas|pancreas
349460|NCT01452217|Chronic pancreatitis|chronic pancreatitis
349461|NCT01452217|Perfusion|perfusion
349462|NCT01452217|Blood flow|blood flow
349463|NCT01452217|Magnetic resonance imaging|magnetic resonance imaging
349464|NCT01452204|PEMF|pemf
349465|NCT01452204|magneto|magneto
349466|NCT01452204|shoulder|shoulder
349467|NCT01452204|impingement|impingement
349468|NCT01452191|Cluster Randomised Controlled Trial|cluster randomised controlled trial
349469|NCT01452191|Community Health Services|community health services
349470|NCT01452191|prevention & control|prevention & control
349471|NCT01452191|Accidents, Home|accidents, home
349472|NCT01452191|Child Health Services|child health services
349473|NCT01452178|Cardiovascular diseases|cardiovascular diseases
349474|NCT01452178|Glucometabolic disorders|glucometabolic disorders
349475|NCT01452178|Type-D personality|type-d personality
349476|NCT01452165|Cardiovascular diseases|cardiovascular diseases
349477|NCT01452165|Hypertrophy, Left ventricle|hypertrophy, left ventricle
349478|NCT01452165|Echocardiography|echocardiography
349479|NCT01452165|Prognosis|prognosis
349480|NCT01452152|Pharmacogenomics|pharmacogenomics
349481|NCT01452152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
349482|NCT01452139|STEMI|stemi
349483|NCT01452139|Pharmacogenetics|pharmacogenetics
349484|NCT01452139|Prasugrel|prasugrel
349485|NCT01452139|Clopidogrel|clopidogrel
727492|NCT01066741|Oral mucosa|oral mucosa
349486|NCT01452139|Percutaneous Coronary Intervention|percutaneous coronary intervention
349487|NCT01452113|Diabetes Mellitus|diabetes mellitus
349488|NCT01452113|DPP-IV protein|dpp-iv protein
349489|NCT01452113|Glucagon-Like Peptide 1|glucagon-like peptide 1
349490|NCT01452113|autonomic neuropathy|autonomic neuropathy
349491|NCT01452100|embolism|embolism
349492|NCT01452100|cholesterol cristal|cholesterol cristal
349493|NCT01452100|creatinine|creatinine
349494|NCT01452100|renal insufficiency|renal insufficiency
349495|NCT01452100|prednisone|prednisone
349496|NCT01452100|systemic atheroembolism|systemic atheroembolism
349497|NCT01452087|insulin sensitivity|insulin sensitivity
349498|NCT01452087|exercise|exercise
349499|NCT01452074|Insulin Sensitivity|insulin sensitivity
349500|NCT01452074|Exercise Training|exercise training
349501|NCT01452074|Weight Loss|weight loss
349502|NCT01452074|Fat Metabolism|fat metabolism
349503|NCT01452061|Autism Spectrum Disorder|autism spectrum disorder
349504|NCT01452061|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
349505|NCT01452061|Developmental Delay|developmental delay
349506|NCT01452048|insulin sensitivity|insulin sensitivity
349507|NCT01452048|fatty acid metabolism|fatty acid metabolism
349508|NCT01452035|insulin sensitivity|insulin sensitivity
349509|NCT01452035|fatty acid metabolism|fatty acid metabolism
349511|NCT01452022|inductigraft|inductigraft
349512|NCT01452022|osteoinductive|osteoinductive
349513|NCT01452022|synthetic bone graft|synthetic bone graft
349514|NCT01452022|posterolateral lumbar fusion|posterolateral lumbar fusion
349515|NCT01452022|post market|post market
349516|NCT01452022|lumbar spinal stenosis|lumbar spinal stenosis
349517|NCT01452009|open angle glaucoma|open angle glaucoma
349518|NCT01452009|ocular hypertension|ocular hypertension
349519|NCT01451996|direct-to-consumer advertising|direct-to-consumer advertising
349520|NCT01451983|Autism|autism
349521|NCT01451983|PTEN|pten
349522|NCT01451983|macrocephaly|macrocephaly
349523|NCT01451970|high fat diet treatment|high fat diet treatment
349524|NCT01451970|insulin sensitivity|insulin sensitivity
349525|NCT01451957|exercise|exercise
349526|NCT01451957|fatty acid metabolism|fatty acid metabolism
349527|NCT01451957|insulin sensitivity|insulin sensitivity
349528|NCT01451944|Asthma|asthma
349529|NCT01451944|Home Health Nursing|home health nursing
349530|NCT01451944|Patient education|patient education
349531|NCT01451931|kidney stone|kidney stone
349532|NCT01451931|urolithiasis|urolithiasis
349533|NCT01451931|urinary tract infection|urinary tract infection
349534|NCT01451931|ultrasound|ultrasound
349535|NCT01451931|computed tomography|computed tomography
349536|NCT01451931|safety|safety
349537|NCT01451931|cost|cost
349538|NCT01451931|accuracy|accuracy
349539|NCT01451918|Dyslipidaemia|dyslipidaemia
349540|NCT01451918|Insulin resistance|insulin resistance
349541|NCT01451918|Type 2 Diabetes|type 2 diabetes
349542|NCT01451892|Obesity|obesity
349543|NCT01451892|dance|dance
349544|NCT01451892|gait|gait
349545|NCT01451892|balance|balance
349546|NCT01451892|posture|posture
349547|NCT01451892|dance therapy|dance therapy
349548|NCT01451879|Pompe Disease|pompe disease
349549|NCT01451879|Infusion Associated Reaction|infusion associated reaction
349550|NCT01451879|Immune-modulation regimen|immune-modulation regimen
349551|NCT01451866|resistance training|resistance training
349552|NCT01451866|Healthy People Programs|healthy people programs
349553|NCT01451853|Lung Cancer|lung cancer
349554|NCT01451853|Head and Neck Cancer|head and neck cancer
349555|NCT01451853|Hearing Loss|hearing loss
349556|NCT01451853|Ototoxicity|ototoxicity
349557|NCT01451853|Tinnitus|tinnitus
349558|NCT01451853|Deafness|deafness
349559|NCT01451853|SPI-1005|spi-1005
349560|NCT01451853|Cisplatin|cisplatin
349561|NCT01451853|Carboplatin|carboplatin
349562|NCT01451853|Ebselen|ebselen
349563|NCT01451827|Kidney Disease|kidney disease
349564|NCT01451827|Polycystic Kidney Disease|polycystic kidney disease
349565|NCT01451827|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
349566|NCT01451827|PKD|pkd
349567|NCT01451827|ADPKD|adpkd
349568|NCT01451814|smoking cessation|smoking cessation
349569|NCT01451801|Hepatitis B|hepatitis b
349570|NCT01451801|non responders|non responders
349571|NCT01451801|cellular immune response|cellular immune response
349572|NCT01451801|cytokines|cytokines
349573|NCT01451801|predictors|predictors
349574|NCT01451801|HBsAg|hbsag
349575|NCT01451788|RCT|rct
349576|NCT01451788|Gelatin matrix|gelatin matrix
349577|NCT01451788|thrombin|thrombin
349578|NCT01451788|idiopathic scoliosis|idiopathic scoliosis
349579|NCT01451788|Surgery|surgery
340248|NCT01490411|SIT|sit
349580|NCT01451762|pain|pain
349581|NCT01451762|anesthesia|anesthesia
349582|NCT01451762|surgery|surgery
349583|NCT01451762|postoperative|postoperative
349584|NCT01451749|Mild cognitive impairment|mild cognitive impairment
349585|NCT01451736|First-episode Schizophrenia|first-episode schizophrenia
349586|NCT01451736|Schizoaffective Disorder, Depressed Type (recent-onset)|schizoaffective disorder, depressed type (recent-onset)
349587|NCT01451736|Schizophreniform Disorder|schizophreniform disorder
349588|NCT01451736|oral risperidone|oral risperidone
349589|NCT01451736|long-acting injectable paliperidone palmitate|long-acting injectable paliperidone palmitate
349590|NCT01451736|functional outcome|functional outcome
349591|NCT01451723|Multiple Sclerosis|multiple sclerosis
349592|NCT01451723|Polyphenon E|polyphenon e
349593|NCT01451723|Green tea|green tea
349594|NCT01451723|EGCG|egcg
349595|NCT01451723|Epigallocatechin-galleate|epigallocatechin-galleate
349596|NCT01451723|Placebo|placebo
349597|NCT01451723|Randomized controlled trial|randomized controlled trial
349598|NCT01451710|enough steroids|enough steroids
349599|NCT01451710|MCD|mcd
349600|NCT01451710|efficacy|efficacy
349601|NCT01451684|pregnancy|pregnancy
349602|NCT01451684|fetus|fetus
349603|NCT01451684|euploid|euploid
349604|NCT01451671|fetal|fetal
349605|NCT01451671|aneuploidy|aneuploidy
349606|NCT01451671|non-invasive|non-invasive
349607|NCT01451671|prenatal|prenatal
349608|NCT01451671|cell free DNA|cell free dna
349609|NCT01451658|Variceal bleeding|variceal bleeding
349610|NCT01451658|portal hypertension|portal hypertension
349611|NCT01451658|hepatocellular carcinoma|hepatocellular carcinoma
349612|NCT01451658|endoscopic variceal ligation|endoscopic variceal ligation
349613|NCT01451658|non-selective beta-blocker|non-selective beta-blocker
349614|NCT01451658|rebleeding|rebleeding
349615|NCT01451645|Gout|gout
349616|NCT01451632|Metastatic Colorectal cancer|metastatic colorectal cancer
349617|NCT01451632|Kras wild-type|kras wild-type
349618|NCT01451632|Squamous cell head and neck cancer|squamous cell head and neck cancer
349619|NCT01451632|Non-small cell lung cancer|non-small cell lung cancer
349620|NCT01451632|Triple negative breast cancer|triple negative breast cancer
349622|NCT01451632|ErbB3|erbb3
349623|NCT01451632|MM-121|mm-121
349624|NCT01451632|Cetuximab|cetuximab
349625|NCT01451632|Irinotecan|irinotecan
349626|NCT01451606|Chronic Pelvic Pain|chronic pelvic pain
349627|NCT01451606|CPP|cpp
349628|NCT01451606|Pelvic Pain|pelvic pain
349629|NCT01451593|Optic neuritis|optic neuritis
349630|NCT01451593|Multiple sclerosis|multiple sclerosis
349631|NCT01451593|Retinal nerve fibre layer|retinal nerve fibre layer
349632|NCT01451593|Axonal loss|axonal loss
349633|NCT01451593|Neuroprotection|neuroprotection
349634|NCT01451593|Phenytoin|phenytoin
349635|NCT01451593|MRI|mri
349636|NCT01451593|Optical coherence tomography|optical coherence tomography
349637|NCT01451593|Sodium Channel Blockers|sodium channel blockers
349638|NCT01451580|Phase II|phase ii
349639|NCT01451580|Metastatic Breast Cancer|metastatic breast cancer
349640|NCT01451567|Nurses, Workload, Musculoskeletal System, Intervention|nurses, workload, musculoskeletal system, intervention
349641|NCT01451554|weight|weight
349642|NCT01451554|body mass index|body mass index
349643|NCT01451554|obesity|obesity
349644|NCT01451554|portion control plate|portion control plate
349645|NCT01451554|diet|diet
349646|NCT01451554|exercise|exercise
349647|NCT01451528|Umbilical Cord Blood|umbilical cord blood
349648|NCT01451528|Allogeneic|allogeneic
349649|NCT01451528|Traumatic Brain Injury|traumatic brain injury
349650|NCT01451515|Lymphoblastic lymphoma|lymphoblastic lymphoma
349651|NCT01451502|umbilical cord blood|umbilical cord blood
349652|NCT01451489|FSGS|fsgs
349653|NCT01451489|FK506|fk506
349654|NCT01451489|CTX|ctx
349655|NCT01451476|Ageing|ageing
349656|NCT01451463|Huntington's Disease|huntington's disease
349657|NCT01451463|Chorea|chorea
349658|NCT01451463|Gait|gait
349659|NCT01451463|Balance|balance
349660|NCT01451450|Peanut Allergy|peanut allergy
349661|NCT01451411|Serum Sodium|serum sodium
349662|NCT01451411|Euvolemia|euvolemia
349663|NCT01451411|Hypervolemia|hypervolemia
349664|NCT01451411|Vaprisol®|vaprisol®
349665|NCT01451411|Conivaptan|conivaptan
349666|NCT01451411|YM087|ym087
349667|NCT01451372|Diabetes|diabetes
349668|NCT01451372|CGM|cgm
349669|NCT01451372|CSII|csii
349670|NCT01451346|Pilot study|pilot study
349671|NCT01451333|HIV|hiv
349672|NCT01451333|Efavirenz|efavirenz
349673|NCT01451333|Central Nervous System (CNS)|central nervous system (cns)
349674|NCT01451333|Lumbar puncture|lumbar puncture
349675|NCT01451333|Dose reduction|dose reduction
349676|NCT01451320|Prosthetic valve|prosthetic valve
349677|NCT01451320|thrombosis|thrombosis
349678|NCT01451320|TROIA|troia
349679|NCT01451320|tPA|tpa
349680|NCT01451320|TEE|tee
349681|NCT01451307|Congenital abnormalities|congenital abnormalities
349682|NCT01451307|Digestive system abnormalities|digestive system abnormalities
349683|NCT01451307|Neonatal surgery|neonatal surgery
349684|NCT01451307|Neonatal anesthesia|neonatal anesthesia
349685|NCT01451307|Bayley Scales of Infant Development II|bayley scales of infant development ii
349686|NCT01451294|Cerebral autoregulation|cerebral autoregulation
349687|NCT01451281|Ultrasonography|ultrasonography
349688|NCT01451281|Muscular Dystrophy|muscular dystrophy
349689|NCT01451281|Neuromuscular Disease|neuromuscular disease
349690|NCT01451281|Oligonucleotide|oligonucleotide
349691|NCT01451281|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
349692|NCT01451281|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
349693|NCT01451281|DND|dnd
349694|NCT01451268|60 to 150 Days After Allogeneic Stem Cell Transplantation|60 to 150 days after allogeneic stem cell transplantation
349695|NCT01451268|High Risk MDS|high risk mds
349696|NCT01451268|MDS|mds
349697|NCT01451268|AML|aml
349698|NCT01451255|pulsatility|pulsatility
349699|NCT01451255|normal subjects|normal subjects
349700|NCT01451255|mild pulmonary hypertension|mild pulmonary hypertension
349701|NCT01451255|exercise-associated pulmonary hypertension|exercise-associated pulmonary hypertension
349702|NCT01451242|Heart Rate Variability|heart rate variability
349703|NCT01451242|Acquired Brain Injury|acquired brain injury
349704|NCT01451242|Physical Activity|physical activity
349705|NCT01451229|pharmacokinetics|pharmacokinetics
349706|NCT01451229|pharmacodynamics|pharmacodynamics
349707|NCT01451216|Acquired brain injury|acquired brain injury
349708|NCT01451216|Balance control|balance control
349709|NCT01451216|Functional reach|functional reach
349710|NCT01451203|Cimzia|cimzia
349711|NCT01451203|Early RA|early ra
349712|NCT01451203|Certolizumab Pegol|certolizumab pegol
349713|NCT01451190|Androgenetic Alopecia|androgenetic alopecia
349714|NCT01451190|Male Pattern Baldness|male pattern baldness
349715|NCT01451190|Female Pattern Baldness|female pattern baldness
349716|NCT01451190|Hair Loss|hair loss
349717|NCT01451190|Baldness|baldness
349718|NCT01451177|Androgenetic Alopecia|androgenetic alopecia
349719|NCT01451177|Male Pattern Baldness|male pattern baldness
349720|NCT01451177|Female Pattern Baldness|female pattern baldness
349722|NCT01451177|Baldness|baldness
349723|NCT01451151|Androgenetic Alopecia|androgenetic alopecia
349724|NCT01451151|Male Pattern Baldness|male pattern baldness
349725|NCT01451151|Female Pattern Baldness|female pattern baldness
349726|NCT01451151|Hair Loss|hair loss
349727|NCT01451151|Baldness|baldness
349728|NCT01451138|Androgenetic Alopecia|androgenetic alopecia
349729|NCT01451138|Male Pattern Baldness|male pattern baldness
349730|NCT01451138|Female Pattern Baldness|female pattern baldness
349731|NCT01451138|Hair Loss|hair loss
349732|NCT01451138|Baldness|baldness
349733|NCT01451125|Androgenetic Alopecia|androgenetic alopecia
349734|NCT01451125|Male Pattern Baldness|male pattern baldness
349735|NCT01451125|Female Pattern Baldness|female pattern baldness
349736|NCT01451125|Hair Loss Baldness|hair loss baldness
349737|NCT01451112|Androgenetic Alopecia|androgenetic alopecia
349738|NCT01451112|Male Pattern Baldness|male pattern baldness
349739|NCT01451112|Female Pattern Baldness|female pattern baldness
349740|NCT01451112|Hair Loss|hair loss
349741|NCT01451112|Baldness|baldness
349742|NCT01451099|Androgenetic Alopecia|androgenetic alopecia
349743|NCT01451099|Male Pattern Baldness|male pattern baldness
349744|NCT01451099|Female Pattern Baldness|female pattern baldness
349745|NCT01451099|Hair Loss|hair loss
349746|NCT01451099|Baldness|baldness
349747|NCT01451086|Safety|safety
349748|NCT01451086|Immunogenicity|immunogenicity
349749|NCT01451086|Pneumococcal vaccine|pneumococcal vaccine
349750|NCT01451073|Androgenetic Alopecia|androgenetic alopecia
349751|NCT01451073|Male Pattern Baldness|male pattern baldness
349752|NCT01451073|Female Pattern Baldness|female pattern baldness
349753|NCT01451073|Hair Loss|hair loss
349754|NCT01451073|Baldness|baldness
349755|NCT01451060|vasopressors|vasopressors
349756|NCT01451060|cesarean anesthesia|cesarean anesthesia
349757|NCT01451060|hypotension|hypotension
349758|NCT01451047|Androgenetic Alopecia|androgenetic alopecia
349759|NCT01451047|Male Pattern Baldness|male pattern baldness
349760|NCT01451047|Female Pattern Baldness|female pattern baldness
349761|NCT01451047|Hair Loss|hair loss
349762|NCT01451047|Baldness|baldness
349763|NCT01451034|WHYX lesion|whyx lesion
349764|NCT01451034|endoscopic resection|endoscopic resection
349765|NCT01451034|complete resection|complete resection
349766|NCT01451034|complete resection rate|complete resection rate
349767|NCT01451034|endoscopic feature|endoscopic feature
349768|NCT01451034|Average size discrepancy|average size discrepancy
349769|NCT01451021|Androgenetic Alopecia|androgenetic alopecia
349770|NCT01451021|Male Pattern Baldness|male pattern baldness
349771|NCT01451021|Female Pattern Baldness|female pattern baldness
349772|NCT01451021|Hair Loss|hair loss
349773|NCT01451021|Baldness|baldness
349774|NCT01451008|Anastomosis|anastomosis
349775|NCT01451008|Compression|compression
349776|NCT01451008|Colon|colon
349777|NCT01450995|Migraine|migraine
349778|NCT01450995|Headache, Migraine|headache, migraine
349779|NCT01450982|Rheumatoid Arthritis|rheumatoid arthritis
349780|NCT01450982|JNJ-38518168|jnj-38518168
349781|NCT01450982|Methotrexate|methotrexate
349782|NCT01450969|Operator Comfort Assessment|operator comfort assessment
349783|NCT01450969|Radiation protection|radiation protection
349784|NCT01450969|Measurement of Radiation Exposure|measurement of radiation exposure
349785|NCT01450969|Endovascular Interventional Radiology|endovascular interventional radiology
349786|NCT01450956|congenital heart diseases|congenital heart diseases
349787|NCT01450956|cardiopulmonary bypass|cardiopulmonary bypass
349788|NCT01450956|Pediatric|pediatric
349789|NCT01450956|sevoflurane|sevoflurane
349790|NCT01450943|Diabetic Foot Ulcer|diabetic foot ulcer
349791|NCT01450943|Chronic wounds|chronic wounds
349792|NCT01450943|Chronic ulcers|chronic ulcers
349793|NCT01450943|Oasis|oasis
349794|NCT01450943|Dermagraft|dermagraft
349795|NCT01450943|Adaptic|adaptic
349796|NCT01450930|Adrenal insufficiency|adrenal insufficiency
349797|NCT01450930|Addison's disease|addison's disease
349798|NCT01450891|Alzheimer's disease|alzheimer's disease
349799|NCT01450891|Diagnosis|diagnosis
349800|NCT01450891|Costs|costs
349801|NCT01450891|Benefits|benefits
349802|NCT01450891|subjective and/or objective memory complaints|subjective and/or objective memory complaints
349803|NCT01450878|high dose of EPO|high dose of epo
349804|NCT01450878|transplant kidney|transplant kidney
349805|NCT01450878|cadaveric organ donor|cadaveric organ donor
349806|NCT01450878|mono-organ (kidney) retrieval|mono-organ (kidney) retrieval
349807|NCT01450878|patient|patient
349808|NCT01450878|kidney graft|kidney graft
349809|NCT01450865|neuropathy|neuropathy
349810|NCT01450865|axonal excitability|axonal excitability
349811|NCT01450865|myelinated nerve|myelinated nerve
349812|NCT01450865|human|human
349813|NCT01450865|ectopic discharge|ectopic discharge
349814|NCT01450865|flupirtine|flupirtine
349815|NCT01450852|Melanocortin Receptor|melanocortin receptor
349816|NCT01450852|Monocyte|monocyte
349817|NCT01450852|Resistance Training|resistance training
349818|NCT01450852|Inflammation|inflammation
349819|NCT01450852|Markers of Inflammation|markers of inflammation
349820|NCT01450839|Transdermal Administration|transdermal administration
349823|NCT01450839|male|male
349824|NCT01450839|volunteers|volunteers
349825|NCT01450826|Chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
349826|NCT01450826|CINV|cinv
349827|NCT01450826|Glioma|glioma
349828|NCT01450826|Temozolomide|temozolomide
349829|NCT01450826|Temodar|temodar
349830|NCT01450826|Aprepitant|aprepitant
349831|NCT01450826|Emend|emend
349832|NCT01450826|Ondansetron|ondansetron
349833|NCT01450826|Zofran|zofran
349834|NCT01450826|Pro00031206|pro00031206
349835|NCT01450826|Affronti|affronti
349836|NCT01450826|Peters|peters
349837|NCT01450826|Duke|duke
349838|NCT01450826|Preston Robert Tisch Brain Tumor Center|preston robert tisch brain tumor center
349839|NCT01450800|urinary tract infection|urinary tract infection
349840|NCT01450800|gynecologic surgery|gynecologic surgery
349841|NCT01450800|post-operative complications|post-operative complications
349842|NCT01450800|nitrofurantoin|nitrofurantoin
349843|NCT01450787|dry eyes|dry eyes
349844|NCT01450787|diabetes|diabetes
349845|NCT01450748|sodium alginate|sodium alginate
349846|NCT01450748|laryngopharyngeal reflux|laryngopharyngeal reflux
349847|NCT01450748|combined impedance-pH monitoring|combined impedance-ph monitoring
349848|NCT01450722|Chronic lower limb ischemia|chronic lower limb ischemia
349849|NCT01450722|claudication|claudication
349850|NCT01450722|chronic critical ischemia|chronic critical ischemia
349851|NCT01450709|Probiotics|probiotics
349852|NCT01450709|Kibow Biotics|kibow biotics
349853|NCT01450709|Dialysis|dialysis
349854|NCT01450709|Gut based uremic toxin removal|gut based uremic toxin removal
349855|NCT01450670|Probiotics|probiotics
349856|NCT01450670|Kibow Biotics|kibow biotics
349857|NCT01450670|Dialysis|dialysis
349858|NCT01450670|Gut based uremic toxin removal|gut based uremic toxin removal
349859|NCT01450657|Chronic Kidney failure stage three and four|chronic kidney failure stage three and four
349860|NCT01450657|Probiotics|probiotics
349861|NCT01450657|Kibow Biotics|kibow biotics
349862|NCT01450657|Dialysis|dialysis
349863|NCT01450657|Gut based uremic toxin removal|gut based uremic toxin removal
349864|NCT01450644|Advanced|advanced
349865|NCT01450644|Progressive|progressive
349866|NCT01450644|Idiopathic Fibrotic Interstitial Lung Disease|idiopathic fibrotic interstitial lung disease
349867|NCT01450644|Palliative Care|palliative care
349868|NCT01450644|Randomised|randomised
349869|NCT01450644|Controlled|controlled
349870|NCT01450631|surgical site infection|surgical site infection
349871|NCT01450631|nosocomial infection|nosocomial infection
349872|NCT01450631|post-operative complication|post-operative complication
349873|NCT01450631|surgical incision risk|surgical incision risk
349874|NCT01450631|surgical incision infection|surgical incision infection
349875|NCT01450631|negative pressure wound therapy|negative pressure wound therapy
349876|NCT01450631|wound management|wound management
349877|NCT01450631|cesarean section surgery|cesarean section surgery
349878|NCT01450631|wound dehiscence|wound dehiscence
349879|NCT01450631|wound infection|wound infection
349880|NCT01450631|surgical closure|surgical closure
349881|NCT01450631|wound disruption|wound disruption
340572|NCT01488981|TBI|tbi
349882|NCT01450631|subcutaneous approximation|subcutaneous approximation
349883|NCT01450631|wound separation|wound separation
349884|NCT01450631|seroma|seroma
349885|NCT01450631|hematoma|hematoma
349886|NCT01450631|subcutaneous closure|subcutaneous closure
349887|NCT01450631|obesity|obesity
349888|NCT01450631|cesarean|cesarean
349889|NCT01450631|incision|incision
349890|NCT01450631|massive obesity|massive obesity
349891|NCT01450631|obese|obese
349892|NCT01450631|pregnancy|pregnancy
349893|NCT01450631|cesarean delivery|cesarean delivery
349894|NCT01450631|superobesity|superobesity
349895|NCT01450631|wound complication|wound complication
349896|NCT01450592|Carbohydrate, Dietary|carbohydrate, dietary
349897|NCT01450579|Recombinant Influenza HA vaccine|recombinant influenza ha vaccine
349898|NCT01450579|Immunogenicity of ASP7373|immunogenicity of asp7373
349899|NCT01450566|ureteroscopy (URS)|ureteroscopy (urs)
349900|NCT01450566|ureteral stent placement|ureteral stent placement
349901|NCT01450566|Ureteral Calculi|ureteral calculi
349902|NCT01450566|Renal Calculi|renal calculi
349903|NCT01450553|Tissue Collection|tissue collection
349904|NCT01450553|Lung Cancer|lung cancer
349905|NCT01450553|Non-Small Cell Lung Cancer|non-small cell lung cancer
349906|NCT01450553|Early Stage Lung Cancer|early stage lung cancer
349907|NCT01450527|Etiology and outcomes of ARDS|etiology and outcomes of ards
349908|NCT01450488|primary progressive multiple sclerosis|primary progressive multiple sclerosis
349909|NCT01450488|relapse-free secondary progressive multiple sclerosis|relapse-free secondary progressive multiple sclerosis
349910|NCT01450449|GBM, fractionation, short course, standard course|gbm, fractionation, short course, standard course
349911|NCT01450423|Epilepsy|epilepsy
349912|NCT01450423|Physical activity|physical activity
349913|NCT01450423|Cardio exercise|cardio exercise
349914|NCT01450423|Physical fitness|physical fitness
349915|NCT01450423|Cognitive function|cognitive function
349916|NCT01450410|Dyslipemia, HDL composition|dyslipemia, hdl composition
349917|NCT01450397|Dupuytren's Contracture|dupuytren's contracture
349918|NCT01450384|protocol specific|protocol specific
349919|NCT01450371|Autonomic Nervous System|autonomic nervous system
349920|NCT01450371|Neuromodulation|neuromodulation
349921|NCT01450371|Blood flow control|blood flow control
349922|NCT01450371|Exercise|exercise
349923|NCT01450358|Sepsis|sepsis
349924|NCT01450358|Real time PCR|real time pcr
349925|NCT01450358|Blood culture|blood culture
349926|NCT01450358|Bacteremia diagnosis|bacteremia diagnosis
349927|NCT01450358|Fungemia diagnosis|fungemia diagnosis
349928|NCT01450345|Clinical diagnosis of inguinal hernia|clinical diagnosis of inguinal hernia
349929|NCT01450345|Patient undergo operation under daycare basis|patient undergo operation under daycare basis
349930|NCT01450345|ASA I-II|asa i-ii
349931|NCT01450345|Written consent|written consent
349933|NCT01450332|arthroscopy|arthroscopy
349934|NCT01450332|ligament|ligament
349935|NCT01450332|rupture|rupture
349936|NCT01450332|reconstruction|reconstruction
349937|NCT01450332|ACLR|aclr
349938|NCT01450332|accelerated rehabilitation program|accelerated rehabilitation program
349939|NCT01450319|K-RAS|k-ras
349940|NCT01450319|FcγRII/IIIa genotypes|fcγrii/iiia genotypes
349941|NCT01450319|CRC|crc
349942|NCT01450319|Colorectal cancer|colorectal cancer
349943|NCT01450293|Immune response|immune response
349944|NCT01450267|Cystic Fibrosis|cystic fibrosis
349945|NCT01450267|Glutathione|glutathione
349946|NCT01450254|Hip Osteoarthritis|hip osteoarthritis
349947|NCT01450254|Gait Patterns|gait patterns
349948|NCT01450254|Neuromuscular retraining|neuromuscular retraining
349949|NCT01450241|Febrile neutropenia|febrile neutropenia
349950|NCT01450241|Unexplained fever|unexplained fever
349951|NCT01450241|Duration|duration
349952|NCT01450241|Short-term antibiotic treatment|short-term antibiotic treatment
349953|NCT01450228|primary insomnia|primary insomnia
349954|NCT01450215|Relapsed and refractory Multiple Myeloma|relapsed and refractory multiple myeloma
349955|NCT01450202|Carbon dioxide insufflation|carbon dioxide insufflation
349956|NCT01450202|Colonoscopy|colonoscopy
349957|NCT01450202|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
349958|NCT01450202|Bowel insufflation|bowel insufflation
349959|NCT01450202|Postprocedure pain|postprocedure pain
349960|NCT01450202|Pain Due to Certain Specified Procedures|pain due to certain specified procedures
349961|NCT01450189|Acute HIV|acute hiv
349962|NCT01450189|Transmission Prevention|transmission prevention
349963|NCT01450189|Randomized Pilot study|randomized pilot study
349964|NCT01450176|eye|eye
349965|NCT01450176|itching|itching
349966|NCT01450176|allergies|allergies
349967|NCT01450163|Neuropathic pain|neuropathic pain
349968|NCT01450163|prevention|prevention
349969|NCT01450163|prophylaxis|prophylaxis
349970|NCT01450163|chemotherapy|chemotherapy
349971|NCT01450163|neuropathy|neuropathy
349972|NCT01450163|Oxaliplatin|oxaliplatin
349973|NCT01450163|pregabalin|pregabalin
349974|NCT01450150|Major Depression|major depression
349975|NCT01450150|Transcranial Direct Current Stimulation|transcranial direct current stimulation
349976|NCT01450150|Randomized, Sham-Controlled Trial|randomized, sham-controlled trial
349977|NCT01450150|tDCS|tdcs
349978|NCT01450137|Giant Cell Arteritis|giant cell arteritis
349979|NCT01450137|Tocilizumab|tocilizumab
349980|NCT01450137|Antibodies, Monoclonal|antibodies, monoclonal
349981|NCT01450137|Glucocorticoids|glucocorticoids
349982|NCT01450111|Lacosamide|lacosamide
349983|NCT01450059|Human Immunodeficiency Virus|human immunodeficiency virus
349984|NCT01450059|Microchimerism|microchimerism
349985|NCT01450059|Maternal-Fetal Exchange|maternal-fetal exchange
349986|NCT01450059|Gestation|gestation
350011|NCT01449994|hip|hip
350012|NCT01449994|ankle|ankle
350013|NCT01449994|foot|foot
350014|NCT01449994|pain|pain
350015|NCT01449994|lower limb|lower limb
350016|NCT01449994|activator|activator
350017|NCT01449994|instrumental|instrumental
350018|NCT01449994|chiropractic|chiropractic
350019|NCT01449994|Painful functional conditions of the lower extremity|painful functional conditions of the lower extremity
350020|NCT01449981|Adolescents|adolescents
350021|NCT01449981|Alcohol Abuse|alcohol abuse
350022|NCT01449981|Alcohol Dependence|alcohol dependence
350023|NCT01449981|Drug Abuse|drug abuse
350024|NCT01449981|Drug Dependence|drug dependence
350025|NCT01449981|Substance Use Disorder|substance use disorder
350026|NCT01449981|Alcoholics Anonymous|alcoholics anonymous
350027|NCT01449981|Motivational Enhancement Therapy|motivational enhancement therapy
350028|NCT01449981|Cognitive Behavioral Therapy|cognitive behavioral therapy
350029|NCT01449955|PTSD|ptsd
350030|NCT01449942|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
350031|NCT01449942|EBV|ebv
350032|NCT01449942|LMP1|lmp1
350033|NCT01449929|ritonavir|ritonavir
350034|NCT01449929|HIV|hiv
350035|NCT01449929|HAART|haart
350036|NCT01449929|darunavir|darunavir
350037|NCT01449929|antiretroviral|antiretroviral
350038|NCT01449929|dolutegravir|dolutegravir
350039|NCT01449929|GSK1349572|gsk1349572
350040|NCT01449916|Sepsis|sepsis
350041|NCT01449916|Severe Sepsis|severe sepsis
350042|NCT01449916|Protocol|protocol
350043|NCT01449916|Zambia|zambia
350044|NCT01449890|follow up care|follow up care
350045|NCT01449890|e-mail|e-mail
350046|NCT01449890|effectiveness|effectiveness
350047|NCT01449890|depressive disorders|depressive disorders
350048|NCT01449877|Ocular Toxoplasmosis|ocular toxoplasmosis
350049|NCT01449877|Retinochoroiditis|retinochoroiditis
350050|NCT01449877|Prophylaxis|prophylaxis
350051|NCT01449864|upper GI malignancies|upper gi malignancies
350052|NCT01449864|concurrent chemoradiation with continuous infusion 5-Fluorouracil chemotherapy|concurrent chemoradiation with continuous infusion 5-fluorouracil chemotherapy
350053|NCT01449825|hepatic safety|hepatic safety
350054|NCT01449825|prescriber compliance|prescriber compliance
350055|NCT01449825|pazopanib|pazopanib
350056|NCT01449825|epidemiology|epidemiology
350057|NCT01449812|combination vaccine|combination vaccine
350058|NCT01449812|booster vaccination|booster vaccination
350059|NCT01449786|Mal d 1, Bet v 1, sublingual immunotherapy,|mal d 1, bet v 1, sublingual immunotherapy,
350060|NCT01449760|Ankle sprain|ankle sprain
350061|NCT01449760|Balance|balance
350062|NCT01449760|Gait|gait
350063|NCT01449747|Type 2 diabetes mellitus|type 2 diabetes mellitus
350064|NCT01449747|Dipeptidyl peptidase IV inhibitors|dipeptidyl peptidase iv inhibitors
350065|NCT01449747|Glucagon-like peptide 1|glucagon-like peptide 1
350066|NCT01449721|Sepsis|sepsis
350067|NCT01449721|Multiple organ failure|multiple organ failure
350068|NCT01449721|Resuscitation|resuscitation
350069|NCT01449708|Bariatric Surgery|bariatric surgery
350070|NCT01449708|TIVA|tiva
350071|NCT01449708|PONV|ponv
350072|NCT01449708|non-opioid|non-opioid
350073|NCT01449708|OSA|osa
350074|NCT01449695|PAD|pad
350075|NCT01449695|CVA|cva
350076|NCT01449695|ACS|acs
350077|NCT01449682|BRVO|brvo
350078|NCT01449682|CRVO|crvo
350079|NCT01449682|Macular Edema|macular edema
350080|NCT01449682|Anti-VEGF|anti-vegf
350081|NCT01449682|Ozurdex|ozurdex
350082|NCT01449669|pharmacokinetics|pharmacokinetics
350083|NCT01449669|cefazolin|cefazolin
350084|NCT01449669|microdialysis sampling|microdialysis sampling
350085|NCT01449669|interstitial fluid|interstitial fluid
350086|NCT01449669|skeletal muscle|skeletal muscle
350087|NCT01449669|plasma|plasma
350088|NCT01449669|children|children
350089|NCT01449643|Obesity|obesity
350090|NCT01449643|Diaphragm|diaphragm
350091|NCT01449643|Inspiratory muscular training|inspiratory muscular training
350092|NCT01449617|Carotid stenosis|carotid stenosis
350093|NCT01449617|Aspirin plus Clopidogrel|aspirin plus clopidogrel
586746|NCT00524992|Metabolic Syndrome|metabolic syndrome
350094|NCT01449617|Residual platelet reactivity|residual platelet reactivity
350095|NCT01449604|Stereotactic radiotherapy|stereotactic radiotherapy
350096|NCT01449604|SRS|srs
350097|NCT01449604|SRT|srt
350098|NCT01449604|vestibular schwannoma|vestibular schwannoma
350099|NCT01449591|BFH772|bfh772
350100|NCT01449591|rosacea|rosacea
350101|NCT01449591|erythemato-telangiectatic rosacea|erythemato-telangiectatic rosacea
350102|NCT01449565|methamphetamine|methamphetamine
350103|NCT01449565|high-risk sexual behavior|high-risk sexual behavior
350104|NCT01449565|HIV prevention|hiv prevention
350105|NCT01449539|Hyperbaric oxygen|hyperbaric oxygen
350106|NCT01449539|mobilize|mobilize
350107|NCT01449539|stem cells|stem cells
350108|NCT01449539|growth factor|growth factor
350109|NCT01449526|contact lens|contact lens
350110|NCT01449500|Dyspeptic H.pylori-infection|dyspeptic h.pylori-infection
350111|NCT01449487|Experimental pain|experimental pain
350112|NCT01449487|IBS|ibs
350113|NCT01449487|Rectum|rectum
350114|NCT01449448|pain relief|pain relief
350115|NCT01449448|Hypermobility, Joint|hypermobility, joint
350116|NCT01449448|increased strength|increased strength
350117|NCT01449448|increased patient satisfaction|increased patient satisfaction
350118|NCT01449435|Asthma|asthma
350119|NCT01449435|children|children
350421|NCT01448213|DMEK|dmek
350120|NCT01449435|predictors of exacerbation|predictors of exacerbation
350121|NCT01449435|Methacholine challenge|methacholine challenge
350122|NCT01449435|Pulmonary function testing|pulmonary function testing
350123|NCT01449409|Uncontrolled asthma|uncontrolled asthma
350124|NCT01449409|Asthma risk|asthma risk
350125|NCT01449409|Asthma impairment|asthma impairment
350126|NCT01449409|Real time asthma outreach program|real time asthma outreach program
350127|NCT01449396|acupuncture|acupuncture
350128|NCT01449396|in vitro fertilization|in vitro fertilization
350129|NCT01449396|embryo transfer|embryo transfer
350130|NCT01449383|cross over|cross over
350131|NCT01449383|dietary intervention|dietary intervention
350132|NCT01449383|fibre|fibre
350133|NCT01449383|red meat|red meat
350134|NCT01449383|microbiota|microbiota
350135|NCT01449370|INK1117|ink1117
350136|NCT01449370|PIK3CA|pik3ca
350137|NCT01449370|KINASE|kinase
350138|NCT01449370|TUMOR|tumor
350139|NCT01449370|CANCER|cancer
350140|NCT01449370|Locally advanced or metastatic solid tumors|locally advanced or metastatic solid tumors
350141|NCT01449370|not eligible for standard of care therapy|not eligible for standard of care therapy
350143|NCT01449357|Zalutumumab|zalutumumab
350144|NCT01449357|Efficacy|efficacy
350145|NCT01449357|Safety|safety
350146|NCT01449344|relapsed|relapsed
350147|NCT01449344|refractory|refractory
350148|NCT01449318|Pain|pain
350149|NCT01449318|quantitative sensory testing|quantitative sensory testing
350150|NCT01449292|PLVR|plvr
350151|NCT01449292|ELVR|elvr
350152|NCT01449292|AeriSeal System|aeriseal system
350153|NCT01449292|foam sealant|foam sealant
350154|NCT01449292|emphysematous lung sealant|emphysematous lung sealant
350155|NCT01449292|ELS|els
350156|NCT01449292|COPD|copd
350157|NCT01449292|emphysema|emphysema
350158|NCT01449292|polymeric lung volume reduction|polymeric lung volume reduction
350159|NCT01449292|heterogeneous|heterogeneous
350160|NCT01449292|Respiratory Tract Diseases|respiratory tract diseases
350161|NCT01449292|Lung Diseases|lung diseases
350162|NCT01449292|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
350163|NCT01449266|Dotarem|dotarem
350164|NCT01449266|Dialyses|dialyses
350165|NCT01449266|Dialysed|dialysed
350166|NCT01449266|Safety|safety
350167|NCT01449266|Safety and dialysability of Dotarem in dialysed patients|safety and dialysability of dotarem in dialysed patients
350168|NCT01449240|Hunter syndrome|hunter syndrome
350169|NCT01449240|Mucopolysaccharidosis II|mucopolysaccharidosis ii
350170|NCT01449240|Iduronate 2-Sulfatase Deficiency|iduronate 2-sulfatase deficiency
350171|NCT01449240|Lumbar puncture|lumbar puncture
350172|NCT01449240|Cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
350173|NCT01449240|Pediatric|pediatric
350174|NCT01449240|Adult|adult
350175|NCT01449240|Biomarkers|biomarkers
350176|NCT01449227|adhesive capsulitis|adhesive capsulitis
350177|NCT01449227|hip|hip
350178|NCT01449214|Thoracic epidural|thoracic epidural
350179|NCT01449214|Epidural anesthesia|epidural anesthesia
350180|NCT01449214|Ultrasound|ultrasound
350181|NCT01449214|Palpation|palpation
350182|NCT01449214|Thoracic spine|thoracic spine
350183|NCT01449201|PF-00299804, head and neck cancer, squamous cell carcinoma|pf-00299804, head and neck cancer, squamous cell carcinoma
350184|NCT01449188|ondansetron|ondansetron
350185|NCT01449188|moxifloxacin|moxifloxacin
350186|NCT01449188|Zofran|zofran
350187|NCT01449188|thorough QT study|thorough qt study
350188|NCT01449188|IV|iv
350189|NCT01449175|AeriSeal|aeriseal
350190|NCT01449175|treatment|treatment
350191|NCT01449175|device|device
350192|NCT01449175|breathing|breathing
350193|NCT01449175|COPD|copd
350194|NCT01449175|emphysema|emphysema
350195|NCT01449175|polymeric lung volume reduction (PLVR)|polymeric lung volume reduction (plvr)
350196|NCT01449175|biologic lung volume reduction (BLVR)|biologic lung volume reduction (blvr)
350197|NCT01449175|heterogeneous|heterogeneous
350198|NCT01449175|homogeneous|homogeneous
350199|NCT01449175|Respiratory Tract Diseases|respiratory tract diseases
350200|NCT01449175|Lung Diseases|lung diseases
350201|NCT01449175|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
350202|NCT01449162|severe persistent asthma|severe persistent asthma
350203|NCT01449162|patients treated with oral corticosteroids|patients treated with oral corticosteroids
350204|NCT01449149|Age 18 or greater|age 18 or greater
350205|NCT01449149|No prior radiation|no prior radiation
350206|NCT01449136|Antibacterial agents|antibacterial agents
350207|NCT01449136|Deciduous Teeth|deciduous teeth
350208|NCT01449136|Clinical Trial|clinical trial
350210|NCT01449123|mannitol challenge test|mannitol challenge test
350211|NCT01449123|Sweden|sweden
350212|NCT01449123|primary care|primary care
350213|NCT01449110|Primary prevention|primary prevention
350214|NCT01449110|Secondary prevention|secondary prevention
350215|NCT01449110|Resveratrol|resveratrol
350216|NCT01449110|Grape|grape
350217|NCT01449110|Cardiovascular|cardiovascular
350218|NCT01449110|Nutraceutical|nutraceutical
350219|NCT01449110|Food complement|food complement
350220|NCT01449097|Adductor-Canal-blockade,|adductor-canal-blockade,
350221|NCT01449097|human volunteers,|human volunteers,
350222|NCT01449097|US-guided nerve block|us-guided nerve block
350223|NCT01449097|femoral nerve block|femoral nerve block
350224|NCT01449084|Pancreatic duct stenting|pancreatic duct stenting
350225|NCT01449084|Post-endoscopic pancreatitis|post-endoscopic pancreatitis
350226|NCT01449071|Lupus|lupus
350227|NCT01449071|Monoclonal antibody|monoclonal antibody
350228|NCT01449071|B-cell immunotherapy|b-cell immunotherapy
350229|NCT01449071|Epratuzumab|epratuzumab
350230|NCT01449058|Advanced solid tumor,|advanced solid tumor,
350232|NCT01449058|high risk and very high risk MDS|high risk and very high risk mds
350233|NCT01449058|dose escalation,|dose escalation,
350234|NCT01449058|RAS/BRAF mutation,|ras/braf mutation,
350235|NCT01449058|PI3K inhibitor,|pi3k inhibitor,
350236|NCT01449058|MEK inhibitor,|mek inhibitor,
350237|NCT01449058|BYL719,|byl719,
350238|NCT01449058|MEK162|mek162
350239|NCT01449045|IPTc|iptc
350240|NCT01449045|Community Case Management|community case management
350241|NCT01449045|Home Management for malaria|home management for malaria
350242|NCT01449032|Patients|patients
350243|NCT01449019|GLP-1|glp-1
350244|NCT01449019|Exendin(9-39)|exendin(9-39)
350245|NCT01449019|Insulin|insulin
350246|NCT01449019|Glucagon|glucagon
350247|NCT01449019|T2DM|t2dm
350248|NCT01449019|incretin effect|incretin effect
350249|NCT01449019|human physiology|human physiology
350250|NCT01449006|HIV|hiv
350251|NCT01449006|HAND|hand
350252|NCT01449006|Maraviroc|maraviroc
350253|NCT01449006|Neurocognitive|neurocognitive
350254|NCT01449006|Neurology|neurology
350255|NCT01449006|Human Immunodeficiency Virus|human immunodeficiency virus
350256|NCT01449006|HIV Associated Neurocognitive Disorders|hiv associated neurocognitive disorders
350257|NCT01448980|massage|massage
350258|NCT01448980|stroke spasticity|stroke spasticity
350259|NCT01448928|Zevalin|zevalin
350260|NCT01448928|CD20+|cd20+
350261|NCT01448928|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
350262|NCT01448928|Mantle Cell Lymphoma|mantle cell lymphoma
350263|NCT01448915|HIV|hiv
350264|NCT01448915|Human immunodeficiency virus|human immunodeficiency virus
350265|NCT01448915|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
350266|NCT01448915|AIDS virus|aids virus
350267|NCT01448915|Immunodeficiency Virus, Human|immunodeficiency virus, human
350268|NCT01448915|Virus, Human Immunodeficiency|virus, human immunodeficiency
350269|NCT01448915|Hepatitis C|hepatitis c
350270|NCT01448915|Hepatitis C, chronic|hepatitis c, chronic
350271|NCT01448915|Hepatitis C virus|hepatitis c virus
350272|NCT01448915|Hepatitis C antibodies|hepatitis c antibodies
350273|NCT01448915|Hepatitis C antigens|hepatitis c antigens
350274|NCT01448902|Allergic rhinitis|allergic rhinitis
350275|NCT01448902|CRTH2|crth2
350276|NCT01448889|contrast induced nephropathy|contrast induced nephropathy
350277|NCT01448889|oxigen|oxigen
350278|NCT01448889|coronary angiography|coronary angiography
350279|NCT01448876|Chlamydia trachomatis|chlamydia trachomatis
350280|NCT01448876|anorectal|anorectal
350281|NCT01448876|cervicovaginal|cervicovaginal
350282|NCT01448876|MSM|msm
350283|NCT01448876|women|women
350284|NCT01448876|treatment|treatment
350285|NCT01448876|RNA|rna
350286|NCT01448876|bacterial load|bacterial load
350287|NCT01448876|sexual behaviour|sexual behaviour
350288|NCT01448876|Azythromycin treated|azythromycin treated
350289|NCT01448850|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
350290|NCT01448850|MEDI8968|medi8968
350291|NCT01448824|Low High-density Lipoprotein (HDL)|low high-density lipoprotein (hdl)
350292|NCT01448824|Cholesterol (HDL-C)|cholesterol (hdl-c)
350293|NCT01448798|radical prostatectomy|radical prostatectomy
350294|NCT01448798|robotic surgery|robotic surgery
350301|NCT01448772|fasting|fasting
350302|NCT01448759|Patients receiving docetaxel or paclitaxel. All tumors.|patients receiving docetaxel or paclitaxel. all tumors.
350303|NCT01448746|gastric cancer|gastric cancer
350304|NCT01448746|VTE|vte
350305|NCT01448746|incidence|incidence
350306|NCT01448733|acne vulgaris|acne vulgaris
350307|NCT01448720|Schizophrenia|schizophrenia
350308|NCT01448720|Paliperidone palmitate|paliperidone palmitate
350309|NCT01448720|Long-acting injectable antipsychotic medication|long-acting injectable antipsychotic medication
350310|NCT01448707|Darunavir (DRV)|darunavir (drv)
350311|NCT01448707|TMC114|tmc114
350312|NCT01448707|Prezista|prezista
350313|NCT01448707|HIV|hiv
403008|NCT01228604|open label|open label
350314|NCT01448707|virologic response|virologic response
350315|NCT01448707|neurocognitive function|neurocognitive function
350316|NCT01448694|Hemorrhage|hemorrhage
350317|NCT01448681|Intracranial Hypertension|intracranial hypertension
350318|NCT01448681|Elevated ICP (Intracranial Pressure)|elevated icp (intracranial pressure)
350319|NCT01448668|pancreatic cancer|pancreatic cancer
350320|NCT01448668|mistletoe|mistletoe
350321|NCT01448668|supportive treatment|supportive treatment
350322|NCT01448668|long-term study|long-term study
350323|NCT01448668|non-interventional cohort study|non-interventional cohort study
350324|NCT01448668|controlled study with parallel groups|controlled study with parallel groups
350325|NCT01448655|colorectal cancer|colorectal cancer
350326|NCT01448655|mistletoe|mistletoe
350327|NCT01448655|supportive treatment|supportive treatment
350328|NCT01448655|long-term study|long-term study
350329|NCT01448655|non-interventional cohort study|non-interventional cohort study
350330|NCT01448655|controlled study with parallel groups|controlled study with parallel groups
350331|NCT01448603|Ragweed allergy|ragweed allergy
350332|NCT01448603|ToleroMune ragweed|toleromune ragweed
350333|NCT01448603|immunotherapy|immunotherapy
350334|NCT01448590|post dural puncture headache|post dural puncture headache
350335|NCT01448590|accidental dural puncture|accidental dural puncture
350336|NCT01448590|PDPH|pdph
350337|NCT01448590|ADP|adp
350338|NCT01448590|spinal catheter|spinal catheter
350339|NCT01448590|epidural catheter|epidural catheter
350340|NCT01448590|intrathecal catheter|intrathecal catheter
350341|NCT01448590|dural puncture|dural puncture
350342|NCT01448590|systemic review|systemic review
350343|NCT01448564|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
350344|NCT01448564|Fatigue|fatigue
350345|NCT01448564|laser therapy|laser therapy
350346|NCT01448551|Obesity|obesity
350347|NCT01448551|Treatment|treatment
350348|NCT01448551|Adolescents|adolescents
350349|NCT01448551|Text Messages|text messages
350350|NCT01448551|Mobile phones|mobile phones
350351|NCT01448551|Multidisciplinary|multidisciplinary
350352|NCT01448538|Medication Non-Adherence|medication non-adherence
350353|NCT01448538|Medication Persistence|medication persistence
350354|NCT01448538|wet macular degeneration|wet macular degeneration
350355|NCT01448512|HIV|hiv
350356|NCT01448512|Pregnancy|pregnancy
350357|NCT01448512|Prevention|prevention
350358|NCT01448512|Couples|couples
350359|NCT01448499|schizophrenia|schizophrenia
350360|NCT01448499|clozapine|clozapine
350361|NCT01448499|amisulpride|amisulpride
350362|NCT01448499|combination|combination
350363|NCT01448499|treatment resistant|treatment resistant
350364|NCT01448486|HIV|hiv
350365|NCT01448486|HAND|hand
350366|NCT01448486|Human Immunodeficiency Virus|human immunodeficiency virus
350367|NCT01448486|Raltegravir|raltegravir
350368|NCT01448486|HIV Associated Neurocognitive Disorders|hiv associated neurocognitive disorders
350369|NCT01448486|Neuro-HAART|neuro-haart
350370|NCT01448486|Neurocognitive|neurocognitive
350371|NCT01448486|Neurology|neurology
350372|NCT01448473|Head trauma|head trauma
350373|NCT01448473|Children|children
350374|NCT01448473|Radiography|radiography
350375|NCT01448434|Osteoarthritis|osteoarthritis
350376|NCT01448434|Knee|knee
350377|NCT01448434|Stem cell|stem cell
350378|NCT01448434|MSC|msc
350379|NCT01448421|TAVR|tavr
350380|NCT01448408|Forme Fruste Keratoconus|forme fruste keratoconus
350381|NCT01448408|Corneal Biomechanical properties|corneal biomechanical properties
350382|NCT01448408|Anterior Segment Parameters|anterior segment parameters
350383|NCT01448408|Diagnostic Capacity|diagnostic capacity
350388|NCT01448369|meibomian gland dysfunction|meibomian gland dysfunction
350389|NCT01448369|hot compress|hot compress
350390|NCT01448369|eyelid warming|eyelid warming
350391|NCT01448369|meibum|meibum
350392|NCT01448356|Controlled adverse chamber|controlled adverse chamber
350393|NCT01448356|tear film stability|tear film stability
350394|NCT01448356|tear film evaporation|tear film evaporation
350395|NCT01448356|tear film break up time|tear film break up time
350396|NCT01448356|humidity|humidity
350397|NCT01448356|temperature|temperature
350398|NCT01448343|transfusion|transfusion
350399|NCT01448343|potassium|potassium
350400|NCT01448330|clopidogrel|clopidogrel
350401|NCT01448330|aspinin|aspinin
350402|NCT01448330|combination|combination
350403|NCT01448291|Contraception|contraception
350404|NCT01448291|Nuvaring|nuvaring
350405|NCT01448291|Vaginal inflammation|vaginal inflammation
350406|NCT01448291|Bacterial vaginosis|bacterial vaginosis
350407|NCT01448291|Nugent score|nugent score
350408|NCT01448278|Anterior cruciate ligament|anterior cruciate ligament
350409|NCT01448278|Arthroscopy|arthroscopy
350410|NCT01448278|Incomplete bone tunnels|incomplete bone tunnels
350411|NCT01448278|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
350412|NCT01448265|atrial fibrillation|atrial fibrillation
350413|NCT01448265|catheter ablation|catheter ablation
350414|NCT01448265|circular mapping catheter|circular mapping catheter
350415|NCT01448265|cryoballoon|cryoballoon
350416|NCT01448252|T cell vaccination|t cell vaccination
350417|NCT01448252|Immunotherapy|immunotherapy
350418|NCT01448252|Tolerance|tolerance
350419|NCT01448252|safety|safety
350420|NCT01448252|clinical efficacy|clinical efficacy
350422|NCT01448213|Rejection|rejection
350423|NCT01448213|Corticosteroid|corticosteroid
350424|NCT01448200|hepatitis C|hepatitis c
350425|NCT01448200|NS5A inhibitor|ns5a inhibitor
350426|NCT01448200|Phase 1|phase 1
350427|NCT01448200|genotype-1|genotype-1
350428|NCT01448200|genotype-2|genotype-2
350429|NCT01448200|genotype-3|genotype-3
350430|NCT01448187|Lung cancer, France|lung cancer, france
350431|NCT01448174|salusin-alpha|salusin-alpha
350432|NCT01448174|atorvastatin|atorvastatin
350433|NCT01448174|CD36|cd36
350434|NCT01448174|Hemodialysis|hemodialysis
350435|NCT01448161|Pediatric|pediatric
350436|NCT01448161|Adult|adult
350437|NCT01448161|ICU|icu
350438|NCT01448148|Mild cognitive impairment|mild cognitive impairment
350439|NCT01448122|Prevention of pigmentation|prevention of pigmentation
350440|NCT01448109|Sepsis|sepsis
350441|NCT01448109|Corticosteroid|corticosteroid
350442|NCT01448096|primary breast diffuse large B cell lymphoma|primary breast diffuse large b cell lymphoma
350443|NCT01448096|rituximab|rituximab
350444|NCT01448096|prophylactic intrathecal chemotherapy|prophylactic intrathecal chemotherapy
350445|NCT01448096|CNS recurrence|cns recurrence
350446|NCT01448083|I-131 MIBG therapy|i-131 mibg therapy
350447|NCT01448083|whole body I-123 MIBG scintigraphy|whole body i-123 mibg scintigraphy
350448|NCT01448057|Paracetamol|paracetamol
350449|NCT01448057|dimethindene maleate|dimethindene maleate
350450|NCT01448057|phenylephrine hydrochloride|phenylephrine hydrochloride
350451|NCT01448057|cold and flu symptoms|cold and flu symptoms
350452|NCT01448044|hepatitis C virus|hepatitis c virus
350453|NCT01448031|Acetyl Salicylic Acid|acetyl salicylic acid
350454|NCT01448031|Bioavailability|bioavailability
350455|NCT01448031|Healthy Volunteers|healthy volunteers
350456|NCT01448005|Coronary Artery Bypass Grafting|coronary artery bypass grafting
350457|NCT01448005|Resuscitation|resuscitation
350458|NCT01448005|Sudden Cardiac Death|sudden cardiac death
350459|NCT01448005|Ventricular Dysfunction|ventricular dysfunction
350460|NCT01447992|Artificial Pancreas|artificial pancreas
350461|NCT01447992|Insulin Pump|insulin pump
350462|NCT01447992|Continuous Glucose Monitor|continuous glucose monitor
350463|NCT01447992|Closed Loop|closed loop
350464|NCT01447979|Artificial Pancreas|artificial pancreas
350465|NCT01447979|Insulin Pump|insulin pump
350466|NCT01447979|Continuous Glucose Monitor|continuous glucose monitor
350467|NCT01447979|Closed Loop|closed loop
350469|NCT01447966|Obsessive Compulsive Disorder|obsessive compulsive disorder
350470|NCT01447966|Child|child
350471|NCT01447966|Pediatric|pediatric
350472|NCT01447966|CBT|cbt
350473|NCT01447966|Therapy|therapy
350474|NCT01447966|ERP|erp
350475|NCT01447966|Exposure Response Prevention|exposure response prevention
350476|NCT01447966|Preschool|preschool
350477|NCT01447966|Cognitive Behavioral|cognitive behavioral
350478|NCT01447953|Activity|activity
350479|NCT01447953|disability|disability
350480|NCT01447953|life-role|life-role
350481|NCT01447953|multimodal rehabilitation|multimodal rehabilitation
350482|NCT01447953|primary health care|primary health care
350483|NCT01447953|persistent pain|persistent pain
350484|NCT01447953|randomized controlled trial|randomized controlled trial
350485|NCT01447953|Musculoskeletal back pain|musculoskeletal back pain
350486|NCT01447940|Telemedicine|telemedicine
350487|NCT01447940|Type 1 diabetes|type 1 diabetes
350488|NCT01447940|economic cost of Type 1 diabetes|economic cost of type 1 diabetes
350489|NCT01447940|ePortal Meos|eportal meos
350490|NCT01447914|c-Met Inhibitor ARQ-197|c-met inhibitor arq-197
350491|NCT01447914|tivantinib|tivantinib
350492|NCT01447914|multiple myeloma|multiple myeloma
350493|NCT01447914|plasma cell proliferative disorder|plasma cell proliferative disorder
350494|NCT01447914|Hypercalcemia|hypercalcemia
350495|NCT01447914|hematologic malignancy|hematologic malignancy
350496|NCT01447914|plasma cell dyscrasia|plasma cell dyscrasia
350497|NCT01447914|cast nephropathy|cast nephropathy
350498|NCT01447914|amyloidosis|amyloidosis
350499|NCT01447914|osteolysis|osteolysis
350500|NCT01447914|Renal insufficiency|renal insufficiency
350501|NCT01447914|Anemia|anemia
350502|NCT01447914|Bone lytic lesions|bone lytic lesions
350503|NCT01447914|severe osteopenia|severe osteopenia
350504|NCT01447914|pathologic fractures|pathologic fractures
350505|NCT01447914|biopsy-proven plasmacytoma|biopsy-proven plasmacytoma
350506|NCT01447901|Hyperlipoproteinemia Type I|hyperlipoproteinemia type i
350507|NCT01447888|Spine surgery|spine surgery
350508|NCT01447888|Chronic pain|chronic pain
350509|NCT01447888|Opioid tolerant|opioid tolerant
350510|NCT01447888|Pain management in spine surgery patients|pain management in spine surgery patients
350511|NCT01447862|recent-onset|recent-onset
350512|NCT01447849|Chronic Constipation|chronic constipation
350513|NCT01447836|indocyanine green|indocyanine green
350514|NCT01447836|sepsis|sepsis
350515|NCT01447836|liver injury|liver injury
350516|NCT01447836|abdominal perfusion pressure|abdominal perfusion pressure
350517|NCT01447823|Oesophageal bolus obstruction|oesophageal bolus obstruction
350518|NCT01447823|Gastroscopy|gastroscopy
341091|NCT01487044|DME|dme
350519|NCT01447823|phmetry|phmetry
350520|NCT01447810|Constraint-Induced Movement therapy|constraint-induced movement therapy
350521|NCT01447810|Pediatric|pediatric
350522|NCT01447810|Hemiplegia|hemiplegia
350523|NCT01447810|Brain Tumor|brain tumor
350524|NCT01447810|Rehabilitation|rehabilitation
350525|NCT01447797|Irbesartan|irbesartan
350526|NCT01447797|Atorvastatin|atorvastatin
350527|NCT01447797|combination|combination
350528|NCT01447784|HDM allergy|hdm allergy
350529|NCT01447784|Rhinoconunctivitis|rhinoconunctivitis
350530|NCT01447784|Environmental Exposure Chamber|environmental exposure chamber
350531|NCT01447784|Immunotherapy|immunotherapy
350532|NCT01447784|ToleroMune HDM|toleromune hdm
350533|NCT01447771|Decision making|decision making
350534|NCT01447771|Decisional aide|decisional aide
350535|NCT01447745|Visceral obesity|visceral obesity
350536|NCT01447745|Cardiometabolic risk|cardiometabolic risk
350537|NCT01447745|Atherosclerosis|atherosclerosis
350538|NCT01447745|Ectopic fat|ectopic fat
350539|NCT01447745|Carotid plaque|carotid plaque
350540|NCT01447745|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
350541|NCT01447745|Computed tomography (CT)|computed tomography (ct)
350542|NCT01447732|Monoclonal antibody (Mab)|monoclonal antibody (mab)
350543|NCT01447732|Antibody dependent cellular cytotoxicity (ADCC)|antibody dependent cellular cytotoxicity (adcc)
350544|NCT01447732|Complement-dependent toxicity (CDC)|complement-dependent toxicity (cdc)
350545|NCT01447732|Non-fucosylated immunoglobulin G|non-fucosylated immunoglobulin g
350546|NCT01447706|Ovarian Cancer|ovarian cancer
350547|NCT01447706|Platinum-resistant|platinum-resistant
350548|NCT01447706|Platinum-refractory|platinum-refractory
350549|NCT01447706|Fallopian tube cancer|fallopian tube cancer
350550|NCT01447706|Peritoneal Cancer|peritoneal cancer
350551|NCT01447706|Paclitaxel|paclitaxel
350552|NCT01447706|ErbB3|erbb3
350553|NCT01447706|Phase II|phase ii
350554|NCT01447706|locally advanced/metastatic or recurrent|locally advanced/metastatic or recurrent
350555|NCT01447693|uremia|uremia
350556|NCT01447693|pruritus|pruritus
350557|NCT01447693|oliva-omega 3|oliva-omega 3
350558|NCT01447680|HIV infection|hiv infection
350559|NCT01447680|HCV infection|hcv infection
350560|NCT01447680|SMARTube|smartube
350561|NCT01447680|SMARTplasma|smartplasma
350562|NCT01447667|Hepatic fibrosis|hepatic fibrosis
350563|NCT01447667|Magnetic resonance elastography|magnetic resonance elastography
350564|NCT01447667|Hepatocellular carcinoma|hepatocellular carcinoma
350565|NCT01447667|Recurrence|recurrence
350566|NCT01447654|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
350567|NCT01447654|Hypertrophic obstructive cardiomyopathy|hypertrophic obstructive cardiomyopathy
350568|NCT01447654|Hypertrophy|hypertrophy
350569|NCT01447654|Losartan|losartan
350570|NCT01447654|Angiotensin II receptor antagonist|angiotensin ii receptor antagonist
350571|NCT01447641|Cluster Headache|cluster headache
350572|NCT01447641|Trigeminal Autonomic Cephalalgias|trigeminal autonomic cephalalgias
350573|NCT01447641|Sleep|sleep
350574|NCT01447641|Circadian Rhythms|circadian rhythms
350575|NCT01447628|Idiopathic pulmonary arterial hypertension (IPAH)|idiopathic pulmonary arterial hypertension (ipah)
350576|NCT01447628|Iron deficiency|iron deficiency
350577|NCT01447615|Orphaned children and youth|orphaned children and youth
350578|NCT01447615|Economic empowerment|economic empowerment
350579|NCT01447615|Uganda|uganda
350580|NCT01447615|HIV/AIDS|hiv/aids
350581|NCT01447615|Sub-Saharan Africa|sub-saharan africa
350582|NCT01447602|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
350583|NCT01447602|Dysthymia|dysthymia
350584|NCT01447602|Depressive Disorder Not Otherwise Specified (DDNOS)|depressive disorder not otherwise specified (ddnos)
350585|NCT01447589|Radiosensitiser|radiosensitiser
350586|NCT01447563|Bioequivalence|bioequivalence
350587|NCT01447563|Bioavailability|bioavailability
350588|NCT01447550|Bosentan|bosentan
350589|NCT01447550|Buerguer disease|buerguer disease
350590|NCT01447537|Cirrhosis|cirrhosis
350591|NCT01447537|Exercise|exercise
350592|NCT01447537|Relaxation|relaxation
350593|NCT01447537|Muscle mass|muscle mass
350594|NCT01447537|Effort tolerance|effort tolerance
350595|NCT01447511|Drug Interactions|drug interactions
350596|NCT01447511|Warfarin|warfarin
350597|NCT01447511|Genetics|genetics
350598|NCT01447511|CYP2C9|cyp2c9
350599|NCT01447511|Healthy Volunteers|healthy volunteers
350600|NCT01447485|Hypertension, chronic kidney disease|hypertension, chronic kidney disease
350601|NCT01447485|nephrotic syndrome|nephrotic syndrome
350602|NCT01447485|pharmacokinetics|pharmacokinetics
350603|NCT01447472|MDMA,|mdma,
350604|NCT01447472|pharmacokinetics,|pharmacokinetics,
350605|NCT01447472|pharmacodynamics,|pharmacodynamics,
350606|NCT01447472|CYP2D6, COMT,|cyp2d6, comt,
350607|NCT01447472|SERT, 5-HTTLPR, gender,|sert, 5-httlpr, gender,
350608|NCT01447472|dextromethorphan,|dextromethorphan,
350609|NCT01447472|caffeine.|caffeine.
350610|NCT01447459|Asthma|asthma
350611|NCT01447459|Asthma Education|asthma education
350612|NCT01447433|Calcium Carbonate|calcium carbonate
350613|NCT01447433|Vitamin D|vitamin d
350614|NCT01447433|Body weight|body weight
350615|NCT01447433|Body fat|body fat
350616|NCT01447433|Metabolic parameters|metabolic parameters
350617|NCT01447433|Energy restriction|energy restriction
350618|NCT01447433|Very-low calcium consumers|very-low calcium consumers
350619|NCT01447433|Obesity|obesity
350620|NCT01447433|Overweight|overweight
350621|NCT01447407|Staphylococcal infections|staphylococcal infections
350622|NCT01447407|Yeast infections|yeast infections
350623|NCT01447407|Candidiasis|candidiasis
350624|NCT01447368|chronic kidney disease|chronic kidney disease
350625|NCT01447368|peritoneal dialysis|peritoneal dialysis
350626|NCT01447368|secondary hyperparathyroidism|secondary hyperparathyroidism
350627|NCT01447368|parathyroidectomy|parathyroidectomy
350628|NCT01447368|vascular calcification|vascular calcification
350629|NCT01447368|cinacalcet|cinacalcet
350630|NCT01447329|pain|pain
350631|NCT01447329|acupuncture|acupuncture
350632|NCT01447329|knee|knee
350633|NCT01447329|debridement|debridement
350634|NCT01447329|surgery|surgery
350635|NCT01447329|arthroscopic knee surgery debridement|arthroscopic knee surgery debridement
350636|NCT01447316|body composition|body composition
350637|NCT01447316|gait|gait
350638|NCT01447316|quality of life|quality of life
350639|NCT01447316|Patients|patients
350640|NCT01447316|undergoing|undergoing
350641|NCT01447316|bariatric surgery.|bariatric surgery.
350642|NCT01447303|knee|knee
350643|NCT01447303|osteoarthritis|osteoarthritis
350644|NCT01447303|hyaluronic acid|hyaluronic acid
350645|NCT01447303|viscosupplementation|viscosupplementation
350646|NCT01447290|preeclampsia|preeclampsia
350647|NCT01447290|protein|protein
350648|NCT01447290|creatinine|creatinine
350649|NCT01447290|protein:creatinine ratio|protein:creatinine ratio
350650|NCT01447277|ACL reconstruction|acl reconstruction
350651|NCT01447277|Femoral Block|femoral block
350652|NCT01447277|Sciatic Block|sciatic block
350653|NCT01447264|Rheumatoid arthritis|rheumatoid arthritis
350654|NCT01447264|Muscle strength|muscle strength
350655|NCT01447264|Body composition|body composition
350656|NCT01447264|Physical activity|physical activity
350657|NCT01447264|Water exercises|water exercises
350658|NCT01447264|Hydrotherapy|hydrotherapy
350659|NCT01447264|Randomized controlled clinical trial|randomized controlled clinical trial
350660|NCT01447251|Obstructive Sleep Apnea|obstructive sleep apnea
350661|NCT01447251|Diabetes Mellitus type 2|diabetes mellitus type 2
350663|NCT01447251|OSA|osa
350664|NCT01447251|CPAP|cpap
350665|NCT01447251|continuous positive airway pressure|continuous positive airway pressure
350666|NCT01447238|pancreatic cysts|pancreatic cysts
350667|NCT01447238|EUS/FNA|eus/fna
350668|NCT01447238|Needle-based Confocal Laser Endomicroscopy (nCLE)|needle-based confocal laser endomicroscopy (ncle)
350669|NCT01447238|fiber optic imaging|fiber optic imaging
350670|NCT01447238|EUS/FNA of pancreatic cysts|eus/fna of pancreatic cysts
350671|NCT01447225|Advanced-stage|advanced-stage
350672|NCT01447225|Solid Tumors|solid tumors
350673|NCT01447225|MM-121|mm-121
350674|NCT01447225|Carboplatin|carboplatin
350675|NCT01447225|Pemetrexed|pemetrexed
350676|NCT01447225|Gemcitabine|gemcitabine
350677|NCT01447225|Cabazitaxel|cabazitaxel
350678|NCT01447225|ErbB3|erbb3
350679|NCT01447225|Phase I|phase i
350680|NCT01447225|Cancer|cancer
350681|NCT01447212|Opioid Dependence|opioid dependence
350682|NCT01447212|Long-term Opioid Injectors|long-term opioid injectors
350683|NCT01447212|Opioid Substitution Treatment|opioid substitution treatment
350684|NCT01447212|Hydromorphone|hydromorphone
350685|NCT01447212|Diamorphine|diamorphine
350686|NCT01447212|Diacetylmorphine|diacetylmorphine
350687|NCT01447199|Bladder cancer|bladder cancer
350688|NCT01447199|Colorectal cancer|colorectal cancer
350689|NCT01447199|Endometrial cancer|endometrial cancer
350690|NCT01447199|Kidney cancer|kidney cancer
350691|NCT01447199|Skin cancer|skin cancer
350692|NCT01447199|Uterus cancer|uterus cancer
350693|NCT01447199|Molecular Predisposition|molecular predisposition
350694|NCT01447199|Hereditary Nonpolyposis Colon Cancer|hereditary nonpolyposis colon cancer
350695|NCT01447199|HNPCC|hnpcc
350696|NCT01447199|Molecular genetic testing|molecular genetic testing
350697|NCT01447199|Gene mutations|gene mutations
350698|NCT01447199|Mutation analyses|mutation analyses
350699|NCT01447199|Genetic polymorphisms|genetic polymorphisms
350700|NCT01447199|Family history of cancer|family history of cancer
350701|NCT01447199|Early age of cancer onset|early age of cancer onset
350702|NCT01447199|Little/no personal or family history of cancer|little/no personal or family history of cancer
350703|NCT01447199|Spouses|spouses
350704|NCT01447199|Questionnaires|questionnaires
350705|NCT01447199|Blood sample|blood sample
350706|NCT01447199|Saliva Sample|saliva sample
350707|NCT01447186|Prostate cancer screening|prostate cancer screening
350708|NCT01447186|Prostate Cancer|prostate cancer
350709|NCT01447186|Patient Decision Aid|patient decision aid
350710|NCT01447186|Spanish Speaking Men|spanish speaking men
350711|NCT01447186|Spanish-language slide set|spanish-language slide set
350712|NCT01447186|Focus group|focus group
350713|NCT01447186|Interview|interview
350714|NCT01447186|Survey|survey
350715|NCT01447173|Asthma|asthma
350716|NCT01447173|Pulmonary Function Test|pulmonary function test
341301|NCT01486004|HCV|hcv
350717|NCT01447173|Vitamin D|vitamin d
350718|NCT01447160|facet joint|facet joint
350719|NCT01447160|back pain|back pain
350720|NCT01447160|osteoarthritis|osteoarthritis
350721|NCT01447160|infiltration|infiltration
350722|NCT01447108|Trigeminal Neuralgia|trigeminal neuralgia
350723|NCT01447108|Tic Douloureux|tic douloureux
350724|NCT01447108|Low Intensity Low Frequency Surface Acoustic Wave Ultrasound|low intensity low frequency surface acoustic wave ultrasound
350725|NCT01447095|Subarachnoid hemorrhage|subarachnoid hemorrhage
350726|NCT01447095|vasospasm|vasospasm
350727|NCT01447095|prostacyclin|prostacyclin
350728|NCT01447082|atypical|atypical
350729|NCT01447082|antipsychotics|antipsychotics
350730|NCT01447082|quetiapine|quetiapine
350731|NCT01447069|heart failure stage 3|heart failure stage 3
350732|NCT01447069|beta 2 agonist|beta 2 agonist
350733|NCT01447069|N-terminal pro-brain natriuretic peptide|n-terminal pro-brain natriuretic peptide
350734|NCT01447069|ejection fraction <35%|ejection fraction <35%
350735|NCT01447056|Hodgkin lymphoma|hodgkin lymphoma
350736|NCT01447056|Non-Hodgkin lymphoma|non-hodgkin lymphoma
350737|NCT01447056|Lymphoproliferative disorder|lymphoproliferative disorder
350738|NCT01447056|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
350739|NCT01447056|Leiomyosarcoma|leiomyosarcoma
350740|NCT01447056|EBV Cytotoxic T Lymphocytes|ebv cytotoxic t lymphocytes
350741|NCT01447043|retrospective studies|retrospective studies
350742|NCT01447030|Biliary strictur|biliary strictur
350743|NCT01447030|Hepatojejunostomy|hepatojejunostomy
350744|NCT01447030|Iatrogenic major bile duct injury|iatrogenic major bile duct injury
350745|NCT01446991|prostate neoplasm|prostate neoplasm
350746|NCT01446991|brachytherapy|brachytherapy
350747|NCT01446991|androgen ablation|androgen ablation
350748|NCT01446991|benign prostatic hypertrophy|benign prostatic hypertrophy
350749|NCT01446991|prostate size reduction|prostate size reduction
350750|NCT01446991|localized prostate cancer with prostate volume > 40 cc|localized prostate cancer with prostate volume > 40 cc
350751|NCT01446978|hepatitis A vaccine|hepatitis a vaccine
350752|NCT01446978|TNF-alfa inhibitory drugs|tnf-alfa inhibitory drugs
350753|NCT01446978|Rheumatoid arthritis|rheumatoid arthritis
350754|NCT01446978|methotrexate|methotrexate
350755|NCT01446965|myocardial infarction, acute|myocardial infarction, acute
350756|NCT01446965|myocardial infarction|myocardial infarction
350757|NCT01446965|ventricular dysfunction|ventricular dysfunction
350758|NCT01446965|death, sudden, cardiac|death, sudden, cardiac
350759|NCT01446965|death, sudden|death, sudden
350760|NCT01446965|death|death
350761|NCT01446965|ventricular tachycardia|ventricular tachycardia
350762|NCT01446965|ventricular fibrillation|ventricular fibrillation
350763|NCT01446965|defibrillation, electric|defibrillation, electric
350764|NCT01446965|cardioversion, electric|cardioversion, electric
350765|NCT01446965|electric countershock|electric countershock
350766|NCT01446965|defibrillators, external|defibrillators, external
350767|NCT01446952|prevention|prevention
350768|NCT01446952|pancreas|pancreas
350769|NCT01446939|MRI|mri
350770|NCT01446939|Parkinson's disease|parkinson's disease
350771|NCT01446939|Essential tremor|essential tremor
350772|NCT01446939|Ultrasonography|ultrasonography
350773|NCT01446939|Diagnosis|diagnosis
350774|NCT01446926|Pneumonia|pneumonia
350775|NCT01446926|Pneumococcal Infections|pneumococcal infections
350776|NCT01446926|Streptococcus pneumoniae Infections|streptococcus pneumoniae infections
350777|NCT01446926|Pneumococcal vaccines|pneumococcal vaccines
350778|NCT01446913|Sleep Apnea|sleep apnea
350779|NCT01446913|CPAP adherence|cpap adherence
350780|NCT01446913|behavioral adherence|behavioral adherence
350781|NCT01446913|stroke|stroke
350782|NCT01446900|Rituximab|rituximab
350783|NCT01446900|Cladribine|cladribine
350784|NCT01446900|Chronic Lymphocytic Leukaemia|chronic lymphocytic leukaemia
350785|NCT01446900|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
350786|NCT01446887|Deep Vein Thrombosis|deep vein thrombosis
350787|NCT01446887|total hip arthroplasty|total hip arthroplasty
350788|NCT01446887|prophylactic anticoagulation|prophylactic anticoagulation
350789|NCT01446887|randomized study|randomized study
350790|NCT01446874|Incidence of post-operative pneumonia in patients undergoing surgery for primary lung cancer or primary esophageal cancer|incidence of post-operative pneumonia in patients undergoing surgery for primary lung cancer or primary esophageal cancer
350791|NCT01446861|Cystic fibrosis|cystic fibrosis
350792|NCT01446861|Pancreas|pancreas
350793|NCT01446861|Exocrine function|exocrine function
350794|NCT01446861|Ultrasound|ultrasound
350795|NCT01446861|Contrast ultrasound|contrast ultrasound
350796|NCT01446848|iron deficiency|iron deficiency
350797|NCT01446848|pulmonary hypertension|pulmonary hypertension
350798|NCT01446848|iron supplements|iron supplements
350799|NCT01446848|ferrous sulfate|ferrous sulfate
350800|NCT01446822|urinary bladder neoplasm|urinary bladder neoplasm
350801|NCT01446822|bipolar transurethral resection|bipolar transurethral resection
350802|NCT01446822|monopolar transurethral resection|monopolar transurethral resection
350803|NCT01446822|obturator nerve|obturator nerve
350804|NCT01446796|Ventricular assist device|ventricular assist device
350805|NCT01446783|COL5A1|col5a1
350806|NCT01446783|Collagen disorders|collagen disorders
350807|NCT01446783|IGF-I|igf-i
350808|NCT01446783|Collagen synthesis|collagen synthesis
350809|NCT01446757|quality of life|quality of life
350810|NCT01446757|feeling of security|feeling of security
350811|NCT01446757|costs|costs
350812|NCT01446757|multiprofessional team|multiprofessional team
350813|NCT01446757|geriatric competence|geriatric competence
350814|NCT01446731|Prostate cancer|prostate cancer
350815|NCT01446718|quadrivalent vaccine|quadrivalent vaccine
350816|NCT01446718|Human Papillomavirus|human papillomavirus
350817|NCT01446692|Major depressive disorder|major depressive disorder
350818|NCT01446692|primary care|primary care
350819|NCT01446692|real-world evidence|real-world evidence
350820|NCT01446692|database|database
350821|NCT01446679|Lipitor|lipitor
350822|NCT01446679|HMG-CoA reductase inhibitor|hmg-coa reductase inhibitor
350823|NCT01446666|hepatocellular carcinoma|hepatocellular carcinoma
350824|NCT01446666|surveillance|surveillance
350825|NCT01446666|gadoxetic acid|gadoxetic acid
350827|NCT01446653|Fetal Alcohol Spectrum Disorders|fetal alcohol spectrum disorders
350828|NCT01446653|FASDs|fasds
350829|NCT01446653|AEP risk|aep risk
350830|NCT01446653|binge drinking|binge drinking
350831|NCT01446653|ineffective contraception|ineffective contraception
350832|NCT01446627|Absorbable vicryl subcuticular staples|absorbable vicryl subcuticular staples
350833|NCT01446627|metal staples|metal staples
350834|NCT01446627|wound healing|wound healing
350835|NCT01446627|cesarean section|cesarean section
350836|NCT01446601|Apnea|apnea
350837|NCT01446601|OSA|osa
350838|NCT01446601|Sleep Apnea Syndromes|sleep apnea syndromes
350839|NCT01446601|Sleep Apnea, Obstructive|sleep apnea, obstructive
350840|NCT01446601|Hypoglossal Nerve Stimulation|hypoglossal nerve stimulation
350841|NCT01446601|Sleep Disorders|sleep disorders
350842|NCT01446601|Tongue|tongue
350843|NCT01446536|Quality|quality
350844|NCT01446536|Improvement|improvement
350845|NCT01446523|endotoxins HE|endotoxins he
350847|NCT01446510|DVT|dvt
350848|NCT01446510|PE|pe
350849|NCT01446510|Risk assessment|risk assessment
350850|NCT01446510|risk score|risk score
350851|NCT01446510|risk analysis|risk analysis
350852|NCT01446510|Venous thromboembolism risk|venous thromboembolism risk
350853|NCT01446497|Normal tension glaucoma|normal tension glaucoma
350854|NCT01446497|Antiglaucoma ophthalmic solution|antiglaucoma ophthalmic solution
350855|NCT01446497|Brimonidine|brimonidine
350856|NCT01446497|Timolol|timolol
350857|NCT01446497|Combination drugs|combination drugs
350858|NCT01446484|Renal transplantation|renal transplantation
350859|NCT01446484|Kidney transplantation|kidney transplantation
350860|NCT01446484|CD4+CD25+CD127lowFoxP3+ T Regulatory Cells|cd4+cd25+cd127lowfoxp3+ t regulatory cells
350861|NCT01446484|T reg|t reg
350862|NCT01446484|Campath|campath
350863|NCT01446471|Bedside Ultrasound|bedside ultrasound
350864|NCT01446471|Point of care ultrasound|point of care ultrasound
350865|NCT01446471|cardiac arrest|cardiac arrest
350866|NCT01446458|Cancer of Pancreas|cancer of pancreas
350867|NCT01446458|Cancer of the Pancreas|cancer of the pancreas
350868|NCT01446458|Neoplasms, Pancreatic|neoplasms, pancreatic
350869|NCT01446458|Pancreas Cancer|pancreas cancer
350870|NCT01446458|Pancreas Neoplasms|pancreas neoplasms
350871|NCT01446458|Entry Term Pancreatic Cancer|entry term pancreatic cancer
350872|NCT01446445|Cytomegalovirus|cytomegalovirus
350873|NCT01446445|renal transplant|renal transplant
350874|NCT01446432|Dupuytren's Contracture|dupuytren's contracture
350875|NCT01446419|chronic axial low back pain|chronic axial low back pain
350876|NCT01446419|vertebrogenic pain|vertebrogenic pain
350877|NCT01446419|Radio frequency ablation|radio frequency ablation
350878|NCT01446406|Bipolar disorder|bipolar disorder
350879|NCT01446406|Electronic daily monitoring|electronic daily monitoring
350880|NCT01446406|Affective episodes|affective episodes
350881|NCT01446354|Blood component transfusion|blood component transfusion
350882|NCT01446354|Hypothermic|hypothermic
350883|NCT01446341|Ankle sprain|ankle sprain
350884|NCT01446341|Functional rehabilitation|functional rehabilitation
350885|NCT01446341|Immobilization|immobilization
350886|NCT01446328|Antipsychotic Drugs|antipsychotic drugs
350887|NCT01446328|Randomized Controlled Trial|randomized controlled trial
350888|NCT01446328|Treatment Effectiveness|treatment effectiveness
350889|NCT01446328|Translational Research|translational research
350890|NCT01446315|asthma|asthma
350891|NCT01446315|asthma care system|asthma care system
350892|NCT01446315|effectiveness|effectiveness
350893|NCT01446315|primary care|primary care
350894|NCT01446315|practice based research network|practice based research network
350895|NCT01446302|Dialysis|dialysis
350896|NCT01446302|Protein-energy wasting|protein-energy wasting
350897|NCT01446302|Insulin-Like Growth Factor I|insulin-like growth factor i
350898|NCT01446302|Insulin-Like Growth Factor Binding Protein 1|insulin-like growth factor binding protein 1
350899|NCT01446302|Inflammation|inflammation
350900|NCT01446289|Group B streptococcus|group b streptococcus
350901|NCT01446289|GBS|gbs
350902|NCT01446289|Vaccine|vaccine
350903|NCT01446289|Prevention of group B streptococcus infection|prevention of group b streptococcus infection
350904|NCT01446276|Obesity|obesity
341490|NCT01485198|knee|knee
341491|NCT01485198|stem cell therapy|stem cell therapy
341492|NCT01485198|bone marrow|bone marrow
341493|NCT01485198|G-CSF|g-csf
350905|NCT01446276|Resveratrol|resveratrol
350906|NCT01446276|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
350907|NCT01446276|Insulin sensitivity|insulin sensitivity
350908|NCT01446276|Lipid turnover|lipid turnover
350909|NCT01446276|Liver fat content|liver fat content
350910|NCT01446263|Radial access|radial access
350911|NCT01446263|Femoral access|femoral access
350912|NCT01446263|Coronary angiography|coronary angiography
350913|NCT01446263|Coronary artery bypass graft|coronary artery bypass graft
350914|NCT01446250|Chronic hepatitis C|chronic hepatitis c
350915|NCT01446250|Cyclophilin inhibitor|cyclophilin inhibitor
350916|NCT01446224|adverse events|adverse events
350917|NCT01446224|pazopanib|pazopanib
350918|NCT01446224|Torsades des Pointes|torsades des pointes
350919|NCT01446224|renal cell carcinoma|renal cell carcinoma
350920|NCT01446224|anti-VEGF agents|anti-vegf agents
350921|NCT01446224|observational data|observational data
350922|NCT01446224|cardiac ischemia|cardiac ischemia
350923|NCT01446211|gusperimus|gusperimus
350924|NCT01446211|Wegeners granulomatosis|wegeners granulomatosis
350925|NCT01446211|relapse|relapse
350927|NCT01446185|HR+, N- or pN1(mi), Her2- breast cancer adjuvant population|hr+, n- or pn1(mi), her2- breast cancer adjuvant population
350928|NCT01446185|Early Breast cancer|early breast cancer
350929|NCT01446185|Gene Expression|gene expression
350930|NCT01446185|Node-Negative|node-negative
350931|NCT01446185|treatment options|treatment options
350932|NCT01446185|Hormone receptor positive|hormone receptor positive
350933|NCT01446172|Long term outcome|long term outcome
350934|NCT01446159|MEDI-573, breast cancer, metastatic, aromatase inhibitor, anti-IGF|medi-573, breast cancer, metastatic, aromatase inhibitor, anti-igf
350935|NCT01446146|Posttraumatic Stress Disorder|posttraumatic stress disorder
350936|NCT01446146|PTSD Treatment|ptsd treatment
350937|NCT01446146|Decision making|decision making
350938|NCT01446146|Veterans|veterans
350939|NCT01446133|Leukemia|leukemia
350941|NCT01446133|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
350942|NCT01446133|CLL|cll
350943|NCT01446133|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
350944|NCT01446133|SLL|sll
350945|NCT01446133|Initial Treatment|initial treatment
350946|NCT01446133|Subsequent Therapy|subsequent therapy
350947|NCT01446133|Rituximab|rituximab
350948|NCT01446133|Rituxan|rituxan
350949|NCT01446133|Lenalidomide|lenalidomide
350950|NCT01446133|CC-5013|cc-5013
350951|NCT01446133|Revlimid|revlimid
350952|NCT01446120|this is phase one study. The study population are healthy volunteers.|this is phase one study. the study population are healthy volunteers.
350953|NCT01446107|tooth decay|tooth decay
350954|NCT01446107|fluoride|fluoride
350955|NCT01446107|sealant|sealant
350956|NCT01446107|prevention|prevention
350957|NCT01446094|Coronary artery disease|coronary artery disease
350958|NCT01446081|chemotherapy|chemotherapy
350959|NCT01446081|exercise|exercise
350960|NCT01446081|quality of life|quality of life
350961|NCT01446081|cancer-related fatigue|cancer-related fatigue
350962|NCT01446081|elderly|elderly
350963|NCT01446081|physical fitness|physical fitness
350964|NCT01446055|Peripheral arterial disease|peripheral arterial disease
350965|NCT01446055|Buerger's disease|buerger's disease
350966|NCT01446055|atherosclerotic arterial occlusion|atherosclerotic arterial occlusion
350967|NCT01446055|bone marrow mononuclear cell|bone marrow mononuclear cell
350968|NCT01446055|chronic limb ischemia|chronic limb ischemia
350969|NCT01446029|Telemonitoring|telemonitoring
350970|NCT01446029|Chronic Kidney Disease|chronic kidney disease
350971|NCT01446016|Breast Cancer|breast cancer
350972|NCT01446016|Breast Tumors|breast tumors
350973|NCT01446016|Cancer of Breast|cancer of breast
350974|NCT01446016|Cancer of the Breast|cancer of the breast
350975|NCT01446016|Human Mammary Carcinoma|human mammary carcinoma
350976|NCT01446016|Mammary Carcinoma, Human|mammary carcinoma, human
350977|NCT01446016|Mammary Neoplasm, Human|mammary neoplasm, human
350978|NCT01446016|Mammary Neoplasms, Human|mammary neoplasms, human
350979|NCT01446016|Neoplasms, Breast|neoplasms, breast
350980|NCT01446016|Tumors, Breast|tumors, breast
350981|NCT01446016|Taxotere|taxotere
350982|NCT01446016|Chloroquine|chloroquine
350983|NCT01446016|Paclitaxel|paclitaxel
350984|NCT01446016|Taxol|taxol
350985|NCT01446016|Ixabepilone|ixabepilone
350986|NCT01446016|Abraxane|abraxane
350987|NCT01446016|Metastatic Breast Cancer|metastatic breast cancer
350988|NCT01446016|Advanced Breast Cancer|advanced breast cancer
350989|NCT01446016|Anthracycline|anthracycline
350990|NCT01445990|free tissue flaps|free tissue flaps
350991|NCT01445990|lactic acid|lactic acid
350992|NCT01445990|glucose|glucose
350993|NCT01445990|thrombosis|thrombosis
350994|NCT01445990|diagnostic test|diagnostic test
350995|NCT01445990|Pedicle postoperative complications diagnosis|pedicle postoperative complications diagnosis
403009|NCT01228604|Ritalin®|ritalin®
350996|NCT01445977|Sonitus Medical|sonitus medical
350997|NCT01445977|SoundBite|soundbite
350998|NCT01445977|Single Sided Deafness|single sided deafness
350999|NCT01445977|Conductive Hearing Loss|conductive hearing loss
351000|NCT01445977|Unilateral Hearing Loss|unilateral hearing loss
351001|NCT01445964|SLCO2B1 genotype|slco2b1 genotype
351002|NCT01445964|effect of apple juice|effect of apple juice
351003|NCT01445886|Nail Psoriasis|nail psoriasis
351004|NCT01445886|Indigo Naturalis|indigo naturalis
351005|NCT01445886|Indirubin|indirubin
351006|NCT01445886|Calcipotriol|calcipotriol
351007|NCT01445886|Nail Psoriasis Severity Index|nail psoriasis severity index
351008|NCT01445873|Pulmonary arterial hypertension|pulmonary arterial hypertension
351009|NCT01445873|sitaxentan sodium|sitaxentan sodium
351010|NCT01445873|Thelin|thelin
351011|NCT01445860|DDI|ddi
351012|NCT01445860|pharmacokinetics|pharmacokinetics
351013|NCT01445847|Laryngospasm|laryngospasm
351014|NCT01445847|Lidocaine|lidocaine
351015|NCT01445834|outcome of pelvic floor muscle physiotherapy|outcome of pelvic floor muscle physiotherapy
351016|NCT01445834|female|female
351017|NCT01445834|stress urinary incontinence|stress urinary incontinence
351018|NCT01445834|urgency urinary incontinence|urgency urinary incontinence
351019|NCT01445834|mixed urinary incontinence|mixed urinary incontinence
351020|NCT01445821|systemic scleroderma|systemic scleroderma
351021|NCT01445821|autologous stem cell transplantation|autologous stem cell transplantation
351022|NCT01445808|psychodynamic psychotherapy|psychodynamic psychotherapy
351023|NCT01445808|coronary heart disease|coronary heart disease
351024|NCT01445808|physical activity|physical activity
351025|NCT01445808|secondary prevention|secondary prevention
351026|NCT01445795|Inhibitex|inhibitex
351027|NCT01445795|Chronic Hepatitis|chronic hepatitis
351028|NCT01445795|Hepatitis C Virus|hepatitis c virus
351029|NCT01445782|Safety|safety
351030|NCT01445782|tolerability|tolerability
351031|NCT01445782|healthy|healthy
351032|NCT01445782|inhaled|inhaled
351033|NCT01445769|Myelofibrosis|myelofibrosis
351034|NCT01445769|Primary Myelofibrosis|primary myelofibrosis
351035|NCT01445769|PMF|pmf
351036|NCT01445769|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
351037|NCT01445769|PPV-MF|ppv-mf
351038|NCT01445769|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
351039|NCT01445769|PET-MF|pet-mf
351040|NCT01445769|Open label|open label
351041|NCT01445769|Ruxolitinib|ruxolitinib
351042|NCT01445769|18424|18424
351043|NCT01445769|Jak inhibitor|jak inhibitor
351044|NCT01445756|Intrauterine Device|intrauterine device
351045|NCT01445743|Tdap Vaccine|tdap vaccine
351046|NCT01445743|Pregnant woman|pregnant woman
351047|NCT01445743|Pertussis|pertussis
351048|NCT01445730|fructose|fructose
351049|NCT01445730|hypertriglyceridemia|hypertriglyceridemia
351050|NCT01445730|postprandial lipids|postprandial lipids
351051|NCT01445730|de novo lipogenesis|de novo lipogenesis
351052|NCT01445730|stable isotopes|stable isotopes
351053|NCT01445717|GBS, Streptococcus, .|gbs, streptococcus, .
351054|NCT01445717|Group B|group b
351055|NCT01445704|Weight loss|weight loss
351056|NCT01445704|Probiotics|probiotics
351057|NCT01445704|Gastric Bypass|gastric bypass
351058|NCT01445691|Benign Neoplasms, Brain|benign neoplasms, brain
351059|NCT01445691|Brain Cancer|brain cancer
351060|NCT01445691|Brain Neoplasms, Benign|brain neoplasms, benign
351061|NCT01445691|Brain Neoplasms, Malignant|brain neoplasms, malignant
351062|NCT01445691|Brain Tumor, Primary|brain tumor, primary
351063|NCT01445691|Brain Tumor, Recurrent|brain tumor, recurrent
351064|NCT01445691|Brain Tumors|brain tumors
351065|NCT01445691|Intracranial Neoplasms|intracranial neoplasms
351066|NCT01445691|Neoplasms, Brain|neoplasms, brain
351067|NCT01445691|Neoplasms, Intracranial|neoplasms, intracranial
351068|NCT01445691|Primary Brain Neoplasms|primary brain neoplasms
351069|NCT01445691|Primary Malignant Brain Neoplasms|primary malignant brain neoplasms
351070|NCT01445691|Primary Malignant Brain Tumors|primary malignant brain tumors
351071|NCT01445691|Gliomas|gliomas
351072|NCT01445691|Glioblastoma|glioblastoma
351073|NCT01445691|Surgery|surgery
351074|NCT01445691|5-ALA|5-ala
351075|NCT01445691|Aminolevulinic acid|aminolevulinic acid
351076|NCT01445691|Fluorescence|fluorescence
351078|NCT01445639|dexmedetomidine|dexmedetomidine
351079|NCT01445639|sedation|sedation
351080|NCT01445639|neurosurgery|neurosurgery
351081|NCT01445639|postoperative care|postoperative care
351082|NCT01445613|Carotid|carotid
351083|NCT01445613|Stent|stent
351084|NCT01445613|Carotid Endarterectomy|carotid endarterectomy
351085|NCT01445600|Impetigo|impetigo
351086|NCT01445600|secondarily-infected traumatic lesions|secondarily-infected traumatic lesions
351087|NCT01445600|retapamulin|retapamulin
351088|NCT01445587|bortezomib|bortezomib
351089|NCT01445587|AKT inhibitor|akt inhibitor
351090|NCT01445587|multiple myeloma|multiple myeloma
351091|NCT01445587|GSK2110183|gsk2110183
351092|NCT01445587|hematologic malignancies|hematologic malignancies
351093|NCT01445561|Interleukin-2|interleukin-2
351094|NCT01445561|IL-2|il-2
351095|NCT01445561|Stem Cells|stem cells
403010|NCT01228604|ADHD|adhd
351096|NCT01445561|Regulatory T Cells (T regs)|regulatory t cells (t regs)
351097|NCT01445561|Natural Killer Cells (NK cells)|natural killer cells (nk cells)
351098|NCT01445561|Healthy Volunteer|healthy volunteer
351099|NCT01445561|HV|hv
351100|NCT01445548|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
351101|NCT01445548|Geographic Atrophy|geographic atrophy
351102|NCT01445548|Bilateral Geographic Atrophy|bilateral geographic atrophy
351103|NCT01445548|Sirolimus|sirolimus
351104|NCT01445548|Age Related Macular Degeneration|age related macular degeneration
351110|NCT01445535|Maximum Tolerated Dose|maximum tolerated dose
351112|NCT01445535|T-Cell Lymphoma|t-cell lymphoma
351113|NCT01445535|NK T-Cell Lymphoma|nk t-cell lymphoma
351114|NCT01445522|PARP Inhibitor|parp inhibitor
351115|NCT01445522|DNA Damage|dna damage
351116|NCT01445522|Chemotherapy|chemotherapy
351117|NCT01445522|Advanced Cancer|advanced cancer
351118|NCT01445522|DNA Repair|dna repair
351119|NCT01445509|Angiogenesis|angiogenesis
351120|NCT01445509|VEGF|vegf
351121|NCT01445509|SRC|src
351122|NCT01445509|Targeted Therapy|targeted therapy
351123|NCT01445509|Cancer|cancer
351124|NCT01445509|Solid Tumor|solid tumor
351131|NCT01445444|Habit Reversal Training|habit reversal training
351132|NCT01445444|Hair Pulling|hair pulling
351133|NCT01445444|Children|children
351134|NCT01445444|Trich|trich
351135|NCT01445444|cognitive behavioral therapy|cognitive behavioral therapy
351136|NCT01445444|TTM|ttm
351137|NCT01445444|psychotherapy|psychotherapy
351138|NCT01445418|Genetic|genetic
351139|NCT01445418|BRCA|brca
351140|NCT01445418|Ovarian Cancer, sporadic epithelial ovarian cancer|ovarian cancer, sporadic epithelial ovarian cancer
351141|NCT01445418|Breast Cancer, triple negative breast cancer|breast cancer, triple negative breast cancer
351142|NCT01445418|Metastatic|metastatic
351143|NCT01445418|Breast Cancer|breast cancer
351144|NCT01445418|Ovarian Cancer|ovarian cancer
351145|NCT01445405|Proteasome|proteasome
351146|NCT01445405|Bortezomib|bortezomib
351147|NCT01445405|NF-kappaB|nf-kappab
351148|NCT01445405|Cetuximab|cetuximab
351149|NCT01445405|Epidermal Growth Factor|epidermal growth factor
351150|NCT01445405|Head and Neck Cancer|head and neck cancer
351151|NCT01445405|Squamous Cell Carcinoma|squamous cell carcinoma
351152|NCT01445405|Oral Cancer|oral cancer
351153|NCT01445392|Recombinant Immunotoxin|recombinant immunotoxin
351154|NCT01445392|Monoclonal Antibody|monoclonal antibody
351155|NCT01445392|Pseudomonas Exotoxin|pseudomonas exotoxin
351156|NCT01445392|Targeted Therapy|targeted therapy
351157|NCT01445392|Pleural Mesothelioma|pleural mesothelioma
351158|NCT01445392|Mesothelioma|mesothelioma
351159|NCT01445392|Epithelial Pleural Mesothelioma|epithelial pleural mesothelioma
351160|NCT01445379|Solid Tumor|solid tumor
351161|NCT01445379|Monoclonal Antibody|monoclonal antibody
351162|NCT01445379|Pediatrics|pediatrics
351163|NCT01445379|Pharmacokinetics|pharmacokinetics
351164|NCT01445379|Immunotherapy|immunotherapy
351165|NCT01445379|Sarcoma|sarcoma
351166|NCT01445379|Lymphoma|lymphoma
351167|NCT01445379|Neuroblastoma|neuroblastoma
351168|NCT01445340|Topical Depsi|topical depsi
351169|NCT01445340|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
351170|NCT01445340|CTCL|ctcl
351171|NCT01445340|Mycosis Fungoides|mycosis fungoides
351172|NCT01445327|Blood|blood
351173|NCT01445327|Urine|urine
351174|NCT01445327|Stool|stool
351175|NCT01445327|Tumor Marker|tumor marker
351176|NCT01445327|Radiation Therapy|radiation therapy
351177|NCT01445327|Gastrointestinal Cancer|gastrointestinal cancer
351178|NCT01445327|Esophageal Cancer|esophageal cancer
351179|NCT01445327|Stomach|stomach
351180|NCT01445327|Pancreatic Cancer|pancreatic cancer
351181|NCT01445314|Stored Data|stored data
351182|NCT01445314|Neurobehavioral|neurobehavioral
351183|NCT01445314|Behavior|behavior
351184|NCT01445314|Quality of Life|quality of life
351185|NCT01445301|twice daily|twice daily
351186|NCT01445301|once daily|once daily
351187|NCT01445301|CLDM 1%-BPO 3% gel|cldm 1%-bpo 3% gel
351188|NCT01445301|Clindamycin (CLDM)|clindamycin (cldm)
351189|NCT01445301|benzoyl peroxide (BPO)|benzoyl peroxide (bpo)
351190|NCT01445301|inflammatory lesion|inflammatory lesion
351191|NCT01445301|non-inflammatory lesion|non-inflammatory lesion
351192|NCT01445301|acne vulgaris|acne vulgaris
351193|NCT01445288|Neurotoxicity|neurotoxicity
351194|NCT01445288|Brain Tumor|brain tumor
351195|NCT01445288|Children|children
351196|NCT01445288|Angiogenesis|angiogenesis
351197|NCT01445288|Imaging|imaging
351198|NCT01445288|Central Nervous System Tumor|central nervous system tumor
351199|NCT01445288|CNS Tumor|cns tumor
351200|NCT01445249|regional anaesthetic techniques|regional anaesthetic techniques
351201|NCT01445249|surgery orthopaedic|surgery orthopaedic
351202|NCT01445236|Operational tolerance|operational tolerance
351203|NCT01445236|Biomarkers|biomarkers
351204|NCT01445236|Liver Transplantation|liver transplantation
351206|NCT01445223|Antiretroviral therapy|antiretroviral therapy
351207|NCT01445223|efavirenz|efavirenz
351208|NCT01445223|lopinavir|lopinavir
351209|NCT01445223|atazanavir|atazanavir
351512|NCT01443988|POAG|poag
341794|NCT01483898|CLI|cli
351210|NCT01445223|randomised controlled clinical trial|randomised controlled clinical trial
351211|NCT01445210|Postoperative pain|postoperative pain
351212|NCT01445210|Major ankle surgery|major ankle surgery
351213|NCT01445210|Continuous nerve block|continuous nerve block
351214|NCT01445210|Saphenous nerve|saphenous nerve
351215|NCT01445210|Ropivacaine|ropivacaine
351216|NCT01445171|Aortic Valve Replacement|aortic valve replacement
351217|NCT01445158|ShopTalk|shoptalk
351218|NCT01445158|Comprehension|comprehension
351219|NCT01445158|Donors|donors
351220|NCT01445158|Education|education
351221|NCT01445158|Stem Cell Transplant|stem cell transplant
351222|NCT01445158|Sibling Donor|sibling donor
351223|NCT01445145|End-of-Life|end-of-life
351224|NCT01445145|Advance Directive|advance directive
351225|NCT01445145|Pediatric Cancer|pediatric cancer
351226|NCT01445145|Adolescents|adolescents
351227|NCT01445145|Young Adults|young adults
351228|NCT01445132|Adoptive Immunotherapy|adoptive immunotherapy
351229|NCT01445132|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
351230|NCT01445132|Refractory Tumor|refractory tumor
351231|NCT01445132|Resection|resection
351232|NCT01445132|B-Cell Malignancies|b-cell malignancies
351233|NCT01445132|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
351235|NCT01445132|B-Cell Lymphoid Malignancy|b-cell lymphoid malignancy
351236|NCT01445119|Brain|brain
351237|NCT01445119|Tumor|tumor
351238|NCT01445119|Radiation|radiation
351239|NCT01445119|Antiangiogenesis|antiangiogenesis
351240|NCT01445119|Chemotherapy|chemotherapy
351241|NCT01445119|Brain Tumor|brain tumor
351242|NCT01445119|Glioma|glioma
351243|NCT01445106|HIV Protease Inhibitor|hiv protease inhibitor
351244|NCT01445106|Drug Repositioning|drug repositioning
351245|NCT01445106|Akt/Mtor Inhibitor|akt/mtor inhibitor
351246|NCT01445106|Targeted Therapy|targeted therapy
351247|NCT01445106|Off - Label Drugs|off - label drugs
351248|NCT01445106|Nelfinavir|nelfinavir
351249|NCT01445106|Protease Inhibitor|protease inhibitor
351250|NCT01445106|Solid Tumor|solid tumor
351251|NCT01445106|Phase I|phase i
351252|NCT01445106|Malignant Tumor|malignant tumor
351253|NCT01445080|MTD|mtd
351254|NCT01445080|Phase I/II|phase i/ii
351255|NCT01445080|Pediatric|pediatric
351257|NCT01445080|Leukemia|leukemia
351258|NCT01445080|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
351260|NCT01445080|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
351261|NCT01445080|ALL|all
351262|NCT01445080|Acute Myeloid Leukemia|acute myeloid leukemia
351263|NCT01445080|AML|aml
351264|NCT01445080|Juevenile Myelomoncytic Leukemia|juevenile myelomoncytic leukemia
351265|NCT01445080|JMML|jmml
351266|NCT01445054|111 Indium Trastuzumab Imaging|111 indium trastuzumab imaging
351267|NCT01445054|PET|pet
351268|NCT01445054|Breast Cancer|breast cancer
351269|NCT01445041|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
351270|NCT01445041|Autologous Umbilical Cord Blood|autologous umbilical cord blood
351271|NCT01445041|Newborn Infants|newborn infants
351272|NCT01445015|adolescents|adolescents
351273|NCT01445002|grass pollen allergy|grass pollen allergy
351274|NCT01445002|immunotherapy|immunotherapy
351275|NCT01445002|recombinant vaccine|recombinant vaccine
351276|NCT01444989|"Sun spots"|"sun spots"
351277|NCT01444989|"Pre-cancerous skin lesion"|"pre-cancerous skin lesion"
351278|NCT01444976|age range of 18-83|age range of 18-83
351279|NCT01444924|Pain control|pain control
351280|NCT01444924|Gynecologic Oncology|gynecologic oncology
351281|NCT01444924|Surgery|surgery
351282|NCT01444911|Sexual Dysfunction|sexual dysfunction
351283|NCT01444911|Gynecologic cancer|gynecologic cancer
351284|NCT01444911|Cancer survivor|cancer survivor
351285|NCT01444911|Vaginal dilator|vaginal dilator
351286|NCT01444898|Prader-Willi Syndrome|prader-willi syndrome
351287|NCT01444898|Obesity|obesity
351288|NCT01444898|Weight|weight
351289|NCT01444898|Exenatide|exenatide
351290|NCT01444898|Byetta|byetta
351291|NCT01444898|Pediatrics|pediatrics
351292|NCT01444898|Adolescents|adolescents
351293|NCT01444885|Variant angina|variant angina
351294|NCT01444885|Cilostazol|cilostazol
351497|NCT01444079|Rejection|rejection
351295|NCT01444846|Temporary Auditory Threshold Shift|temporary auditory threshold shift
351296|NCT01444846|Hearing Loss|hearing loss
351297|NCT01444846|Deafness|deafness
351298|NCT01444846|SPI-1005|spi-1005
351300|NCT01444833|hypertension|hypertension
351301|NCT01444833|obesity|obesity
351302|NCT01444833|metabolism|metabolism
351303|NCT01444833|angiotensin|angiotensin
351304|NCT01444820|radiation therapy|radiation therapy
351305|NCT01444820|hypofractionation|hypofractionation
351306|NCT01444820|hormonal therapy|hormonal therapy
351307|NCT01444820|high risk adenocarcinoma of the prostate|high risk adenocarcinoma of the prostate
351308|NCT01444807|sorafenib|sorafenib
351309|NCT01444807|metastatic renal cell carcinoma|metastatic renal cell carcinoma
351310|NCT01444807|metastasectomy|metastasectomy
351311|NCT01444794|Lower limb spasticity|lower limb spasticity
351312|NCT01444781|Diphtheria|diphtheria
351313|NCT01444781|Tetanus|tetanus
351314|NCT01444781|Whooping Cough|whooping cough
351315|NCT01444781|Hepatitis B|hepatitis b
351316|NCT01444781|Poliomyelitis|poliomyelitis
351317|NCT01444781|Pediatric combined vaccine|pediatric combined vaccine
351318|NCT01444781|Invasive Hib infections|invasive hib infections
351319|NCT01444768|Alert Systems, Medication|alert systems, medication
351320|NCT01444768|Computerized Physician Order Entry System|computerized physician order entry system
351321|NCT01444768|CPOE|cpoe
351322|NCT01444768|Medication Alert Systems|medication alert systems
351323|NCT01444768|Medical Order Entry Systems|medical order entry systems
351324|NCT01444755|Locally advanced gastric cancer|locally advanced gastric cancer
351325|NCT01444755|neoadjuvant chemotherapy|neoadjuvant chemotherapy
351326|NCT01444742|Leukemia|leukemia
351327|NCT01444742|Myeloproliferative Diseases|myeloproliferative diseases
351328|NCT01444742|Myelodysplastic Syndrome|myelodysplastic syndrome
351329|NCT01444742|(MDS)|(mds)
351330|NCT01444742|Relapsing|relapsing
351331|NCT01444742|Refractory|refractory
351332|NCT01444742|Clofarabine|clofarabine
351333|NCT01444742|Clofarex|clofarex
351334|NCT01444742|Clolar|clolar
351335|NCT01444742|Cytarabine|cytarabine
351336|NCT01444742|Ara-C|ara-c
351337|NCT01444742|Cytosar|cytosar
351338|NCT01444742|DepoCyt|depocyt
351339|NCT01444742|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
351340|NCT01444729|'Dupuytren's contracture'|'dupuytren's contracture'
351341|NCT01444729|'xiapex'|'xiapex'
351342|NCT01444729|'surgery'|'surgery'
351343|NCT01444716|Advanced Cancers|advanced cancers
351344|NCT01444716|Leukemia|leukemia
351345|NCT01444716|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
351346|NCT01444716|CLL|cll
351347|NCT01444716|Elderly|elderly
351348|NCT01444716|Ofatumumab|ofatumumab
351349|NCT01444716|Arzerra|arzerra
351350|NCT01444703|Thoracic surgery|thoracic surgery
351351|NCT01444703|double-lumen endotracheal tube|double-lumen endotracheal tube
351352|NCT01444703|intubation|intubation
351353|NCT01444703|extubation|extubation
351354|NCT01444703|sore throat|sore throat
351355|NCT01444703|prevention of post-extubation sore throat|prevention of post-extubation sore throat
351356|NCT01444690|Antiretroviral therapy|antiretroviral therapy
350926|NCT01446198|HPV|hpv
351357|NCT01444690|Acquired Immunodeficiency Syndrome/complications*|acquired immunodeficiency syndrome/complications*
351358|NCT01444690|Anti-HIV Agents/adverse effects|anti-hiv agents/adverse effects
351360|NCT01444677|Tolerability|tolerability
351361|NCT01444677|Pharmacokinetic|pharmacokinetic
351362|NCT01444651|Tadalafil|tadalafil
351363|NCT01444651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors
351364|NCT01444651|Cyclic Guanylyl Monophosphate Pathway|cyclic guanylyl monophosphate pathway
351365|NCT01444651|Pharmacologic Actions|pharmacologic actions
351366|NCT01444651|Vasodilator Agents|vasodilator agents
351367|NCT01444651|Cardiovascular Agents|cardiovascular agents
351368|NCT01444651|Obesity|obesity
351369|NCT01444651|Glycemic Traits|glycemic traits
351370|NCT01444651|Insulin Resistance|insulin resistance
351371|NCT01444651|Glucose Metabolism|glucose metabolism
351372|NCT01444638|pregnancy|pregnancy
351373|NCT01444638|Caesarian|caesarian
351374|NCT01444638|section|section
351375|NCT01444638|spinal|spinal
351376|NCT01444625|UV radiation|uv radiation
351377|NCT01444625|photoprotection|photoprotection
351378|NCT01444625|flavanols rich chocolate|flavanols rich chocolate
351379|NCT01444612|cancer surgery|cancer surgery
351380|NCT01444612|venous thromboembolism|venous thromboembolism
351381|NCT01444612|hospitalization|hospitalization
351382|NCT01444612|anticoagulants|anticoagulants
351383|NCT01444612|costs and cost analysis|costs and cost analysis
351384|NCT01444612|thromboprophylaxis|thromboprophylaxis
351385|NCT01444599|coronary atherosclerosis|coronary atherosclerosis
351386|NCT01444599|virtual histology intravascular ultrasound|virtual histology intravascular ultrasound
351387|NCT01444599|fractional flow reserve|fractional flow reserve
351388|NCT01444586|non-interventional|non-interventional
351389|NCT01444586|Xarelto|xarelto
351390|NCT01444586|knee replacement|knee replacement
351391|NCT01444586|hip replecement|hip replecement
351392|NCT01444586|Russia|russia
351393|NCT01444573|Rate control|rate control
351394|NCT01444573|ILR|ilr
351498|NCT01444079|Tolerance|tolerance
351395|NCT01444547|esophageal cancer|esophageal cancer
351396|NCT01444547|paclitaxel|paclitaxel
351397|NCT01444547|cisplatin|cisplatin
351398|NCT01444534|mobile phone application|mobile phone application
351399|NCT01444534|diabetes type 1|diabetes type 1
351400|NCT01444534|self-management|self-management
351401|NCT01444534|telemedicin|telemedicin
351402|NCT01444521|advanced gastric cancer|advanced gastric cancer
351403|NCT01444521|irinotecan|irinotecan
351404|NCT01444521|cisplatin|cisplatin
351405|NCT01444495|rectal cancer|rectal cancer
351406|NCT01444495|radiotherapy|radiotherapy
351407|NCT01444495|overall survival|overall survival
351408|NCT01444495|recurrence rate|recurrence rate
351409|NCT01444495|downstaging|downstaging
351410|NCT01444469|Asthma exacerbations|asthma exacerbations
351411|NCT01444469|Respiratory disease|respiratory disease
351412|NCT01444469|Viral infection|viral infection
351413|NCT01444469|Macrolide/ketolide antibiotics|macrolide/ketolide antibiotics
341993|NCT01482949|Arcelis|arcelis
351414|NCT01444469|Mycoplasma pneumoniae (M. pneumoniae)|mycoplasma pneumoniae (m. pneumoniae)
351415|NCT01444469|Chlamydophila pneumoniae (C. pneumoniae)|chlamydophila pneumoniae (c. pneumoniae)
351416|NCT01444456|Breast Cancer|breast cancer
351417|NCT01444456|Lung Cancer|lung cancer
351418|NCT01444456|Ovarian Cancer|ovarian cancer
351419|NCT01444456|Prostate Cancer|prostate cancer
351420|NCT01444456|Colorectal Cancer|colorectal cancer
351421|NCT01444456|Aranesp|aranesp
351422|NCT01444456|Chemotherapy induced anaemia|chemotherapy induced anaemia
351423|NCT01444456|Chemotherapy|chemotherapy
351424|NCT01444456|Bladder Cancer|bladder cancer
351425|NCT01444456|Endometrial Cancer|endometrial cancer
351426|NCT01444456|Renal Cancer|renal cancer
351427|NCT01444456|Pancreatic Cancer|pancreatic cancer
351428|NCT01444456|Esophageal Cancer|esophageal cancer
351429|NCT01444456|Gastric Cancer|gastric cancer
351430|NCT01444443|Type 1 diabetes|type 1 diabetes
351431|NCT01444443|Glucose control|glucose control
351432|NCT01444443|Closed-loop|closed-loop
351433|NCT01444443|Insulin pump|insulin pump
351434|NCT01444443|Glucose sensor|glucose sensor
351435|NCT01444430|Symbicort pMDI|symbicort pmdi
351436|NCT01444430|Asthma|asthma
351437|NCT01444430|safety|safety
351438|NCT01444430|budesonide|budesonide
351439|NCT01444417|Immune (Idiopathic) Thrombocytopenic Purpura|immune (idiopathic) thrombocytopenic purpura
351440|NCT01444417|Pediatric Immune (Idiopathic) Thrombocytopenic Purpura|pediatric immune (idiopathic) thrombocytopenic purpura
351441|NCT01444417|Immune Thrombocytopenia|immune thrombocytopenia
351442|NCT01444404|Solid Tumors|solid tumors
351443|NCT01444404|Phase 1|phase 1
351444|NCT01444404|Clinical Trial|clinical trial
351445|NCT01444391|Tympanostomy tube placement|tympanostomy tube placement
351446|NCT01444391|iontophoresis|iontophoresis
351447|NCT01444378|Atherosclerosis|atherosclerosis
351448|NCT01444378|Claudication|claudication
351449|NCT01444378|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
351450|NCT01444378|Stent|stent
351451|NCT01444365|Osteoarthritis of the knee|osteoarthritis of the knee
351452|NCT01444352|Pneumococcal infections|pneumococcal infections
351453|NCT01444352|Streptococcus pneumoniae Infections|streptococcus pneumoniae infections
351458|NCT01444326|Keywords;|keywords;
351459|NCT01444326|Cardiovascular disease|cardiovascular disease
351460|NCT01444326|Dairy|dairy
351461|NCT01444326|Inflammation|inflammation
351462|NCT01444326|Blood lipids|blood lipids
351463|NCT01444300|multiple sclerosis|multiple sclerosis
351464|NCT01444300|postural balance|postural balance
351465|NCT01444300|gait|gait
351466|NCT01444300|fatigue|fatigue
351467|NCT01444261|iron deficiency|iron deficiency
351468|NCT01444261|anemia|anemia
351469|NCT01444248|Amaryl MEX|amaryl mex
351470|NCT01444235|CAD, ACVB|cad, acvb
351471|NCT01444222|Myocardial contractility|myocardial contractility
351472|NCT01444222|Quantification of regurgitant flow|quantification of regurgitant flow
351473|NCT01444222|exercise capacity|exercise capacity
351474|NCT01444209|pituitary gland|pituitary gland
351475|NCT01444196|ACU|acu
351476|NCT01444196|acquired cold urticaria|acquired cold urticaria
351477|NCT01444183|Epilepsy|epilepsy
351478|NCT01444183|seizures|seizures
351479|NCT01444183|stress reduction|stress reduction
351480|NCT01444170|eccentric exercise|eccentric exercise
351481|NCT01444170|exercise induce muscle damage|exercise induce muscle damage
351482|NCT01444170|isometric strength|isometric strength
351483|NCT01444170|range of motion|range of motion
351484|NCT01444170|self report symptoms|self report symptoms
351485|NCT01444170|mechanical pain threshold|mechanical pain threshold
351486|NCT01444144|Ankle|ankle
351487|NCT01444144|Fracture|fracture
351488|NCT01444144|Elderly|elderly
351489|NCT01444144|At-risk Population|at-risk population
727493|NCT01066741|Cavum|cavum
351490|NCT01444144|Ankle Fracture in at-risk elderly population|ankle fracture in at-risk elderly population
351492|NCT01444131|Smoking cessation|smoking cessation
351493|NCT01444131|Pharmaceutical aids|pharmaceutical aids
351494|NCT01444105|Open angle glaucoma|open angle glaucoma
351495|NCT01444105|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
351496|NCT01444079|Liver transplantation|liver transplantation
351499|NCT01444040|Open angle glaucoma|open angle glaucoma
351500|NCT01444040|POAG|poag
351501|NCT01444040|Ocular hypertension|ocular hypertension
351502|NCT01444040|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
351503|NCT01444040|Naïve to treatment|naïve to treatment
351504|NCT01444014|YF476|yf476
351505|NCT01444014|netazepide|netazepide
351506|NCT01444014|hypergastrinaemia|hypergastrinaemia
351507|NCT01444014|gastric carcinoids|gastric carcinoids
351508|NCT01444001|Pneumococcal Infections|pneumococcal infections
351509|NCT01444001|Pneumococcal Vaccines|pneumococcal vaccines
351510|NCT01444001|pneumococcal protein|pneumococcal protein
351511|NCT01443988|Open angle glaucoma|open angle glaucoma
351513|NCT01443988|Ocular hypertension|ocular hypertension
351514|NCT01443988|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
351515|NCT01443988|Naïve to treatment|naïve to treatment
351516|NCT01443975|Total Hip Arthroplasty|total hip arthroplasty
351517|NCT01443975|Osteoarthritis|osteoarthritis
351518|NCT01443962|laparoscopic cholecystectomy|laparoscopic cholecystectomy
351519|NCT01443962|PEEP|peep
351520|NCT01443962|rSO2|rso2
351521|NCT01443949|fMRI|fmri
351522|NCT01443949|Reward|reward
351523|NCT01443949|Adolescents|adolescents
351524|NCT01443949|Impulse Control|impulse control
351525|NCT01443949|Cabergoline|cabergoline
351526|NCT01443936|Influenza Vaccine|influenza vaccine
351527|NCT01443936|H5N1 Influenza|h5n1 influenza
351528|NCT01443936|Normal Volunteer|normal volunteer
351529|NCT01443936|Adenovirus|adenovirus
351530|NCT01443936|Live Virus Vaccine|live virus vaccine
351531|NCT01443936|Healthy Volunteer|healthy volunteer
351532|NCT01443936|HV|hv
351533|NCT01443923|Hepatitis|hepatitis
351534|NCT01443923|Immunological Response|immunological response
351535|NCT01443923|Virological Response|virological response
351536|NCT01443923|Resistance Mutations|resistance mutations
351537|NCT01443923|Viral Kinetics|viral kinetics
351538|NCT01443923|Hepatitis C|hepatitis c
351539|NCT01443923|HCV|hcv
351540|NCT01443910|Body Weight|body weight
351541|NCT01443910|Immersive Virtual Enviroment Technology|immersive virtual enviroment technology
351542|NCT01443897|Vitamin D|vitamin d
351543|NCT01443871|Volunteer|volunteer
351544|NCT01443858|Smoking Cessation|smoking cessation
351545|NCT01443858|Cigarette Smoking|cigarette smoking
351546|NCT01443858|Meclizine|meclizine
351547|NCT01443858|Nicotine Patch|nicotine patch
351548|NCT01443845|COPD|copd
351549|NCT01443845|Exacerbations|exacerbations
351550|NCT01443845|Roflumilast|roflumilast
351105|NCT01445548|AMD|amd
351551|NCT01443845|Daliresp|daliresp
351552|NCT01443832|ferrous sulfate|ferrous sulfate
351553|NCT01443832|iron absorption|iron absorption
351554|NCT01443832|Beninese women|beninese women
351555|NCT01443832|fonio|fonio
351556|NCT01443819|Radiculopathy|radiculopathy
351557|NCT01443819|Transforaminal|transforaminal
351558|NCT01443819|Disc Protrusion|disc protrusion
351559|NCT01443806|oseltamivir metabolism|oseltamivir metabolism
351560|NCT01443806|Carboxylesterase 1|carboxylesterase 1
351561|NCT01443780|Selenium|selenium
351562|NCT01443780|Q10|q10
351563|NCT01443780|dietary supplement|dietary supplement
351564|NCT01443780|elderly population|elderly population
351565|NCT01443780|intervention|intervention
351566|NCT01443780|All-cause mortality|all-cause mortality
351567|NCT01443780|cardiac function|cardiac function
351568|NCT01443767|Cardiac Output|cardiac output
351569|NCT01443767|esCCO|escco
351570|NCT01443767|Pulse Wave Transit Time|pulse wave transit time
351571|NCT01443767|PiCCO|picco
351572|NCT01443767|Pulse Contour Analysis|pulse contour analysis
351573|NCT01443767|Non-invasive Monitoring|non-invasive monitoring
351574|NCT01443767|Partial Liver Resection|partial liver resection
351575|NCT01443741|FIT Therapy|fit therapy
351576|NCT01443741|Diabetes mellitus|diabetes mellitus
351577|NCT01443741|Insulin pump|insulin pump
351578|NCT01443741|Pediatric|pediatric
351579|NCT01443728|sickle cell disease|sickle cell disease
351580|NCT01443728|acute chest syndrome|acute chest syndrome
351581|NCT01443728|respiratory complications|respiratory complications
351582|NCT01443728|vitamin D|vitamin d
351583|NCT01443715|MDD|mdd
351584|NCT01443715|Dysthymia|dysthymia
351585|NCT01443715|Depressive Disorder Not Otherwise Specified (DDNOS)|depressive disorder not otherwise specified (ddnos)
351586|NCT01443702|Kidney Calculi|kidney calculi
351587|NCT01443702|Iranian traditional medicine|iranian traditional medicine
351588|NCT01443702|Lapis judaicus|lapis judaicus
351589|NCT01443689|Extensive Burn|extensive burn
351590|NCT01443689|Human Cord Blood Mononuclear Cells|human cord blood mononuclear cells
351591|NCT01443689|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
351592|NCT01443637|Coronary Artery Disease|coronary artery disease
351593|NCT01443637|CAD|cad
351594|NCT01443637|Atherosclerosis|atherosclerosis
351595|NCT01443637|Myocardial Infarction|myocardial infarction
351596|NCT01443637|MI|mi
351597|NCT01443637|CONFIRM|confirm
351598|NCT01443637|Coronary Computed Tomographic Angiography|coronary computed tomographic angiography
351599|NCT01443637|CCTA|ccta
351600|NCT01443624|iron|iron
351601|NCT01443624|critical illness|critical illness
351602|NCT01443624|oxidative stress|oxidative stress
351603|NCT01443611|Infants|infants
351604|NCT01443598|Pulmonary arterial hypertension,|pulmonary arterial hypertension,
351605|NCT01443598|Interstitial lung disease at HRCT|interstitial lung disease at hrct
351606|NCT01443585|Progressive Addition Lens|progressive addition lens
351607|NCT01443585|Multifocal|multifocal
351608|NCT01443585|Presbyopia|presbyopia
351609|NCT01443572|Kasai operation under general anesthesia|kasai operation under general anesthesia
351610|NCT01443559|Xenogenic|xenogenic
351611|NCT01443546|oocyte donor|oocyte donor
351612|NCT01443546|oocyte recipient|oocyte recipient
351613|NCT01443546|ovulation trigger|ovulation trigger
351614|NCT01443533|Contraception|contraception
351615|NCT01443533|Contraception behavior|contraception behavior
351616|NCT01443533|Postnatal care|postnatal care
351617|NCT01443533|Health education|health education
351618|NCT01443533|Randomized controlled trial|randomized controlled trial
351619|NCT01443520|Pharmacokinetics|pharmacokinetics
351620|NCT01443520|Pharmacodynamics|pharmacodynamics
351621|NCT01443507|aerobic capacity|aerobic capacity
351622|NCT01443507|maximal oxygen uptake|maximal oxygen uptake
351623|NCT01443507|aerobic endurance|aerobic endurance
351624|NCT01443507|work economy|work economy
351625|NCT01443507|lactate threshold|lactate threshold
351626|NCT01443507|endurance training|endurance training
351627|NCT01443507|exercise intensity|exercise intensity
351628|NCT01443494|septic shock|septic shock
351629|NCT01443494|microcirculation|microcirculation
351630|NCT01443494|norepinephrine|norepinephrine
351631|NCT01443494|fluid|fluid
351632|NCT01443481|solid tumors|solid tumors
351633|NCT01443481|hepatic impairment|hepatic impairment
351634|NCT01443481|Child-Pugh classification|child-pugh classification
351635|NCT01443481|pharmacokinetics|pharmacokinetics
351636|NCT01443481|PK|pk
351637|NCT01443481|RECIST 1.1|recist 1.1
351638|NCT01443468|Tp53|tp53
351639|NCT01443468|Cancer|cancer
351640|NCT01443468|Hereditary|hereditary
351641|NCT01443468|Genetic Testing|genetic testing
351642|NCT01443468|Screening|screening
351643|NCT01443468|Li-Fraumeni Syndrome|li-fraumeni syndrome
351644|NCT01443468|LFS|lfs
351645|NCT01443455|menopause|menopause
351646|NCT01443455|sedentary|sedentary
351647|NCT01443455|overweight|overweight
351648|NCT01443442|Conjunctivitis|conjunctivitis
351649|NCT01443442|Allergic|allergic
351650|NCT01443442|Bepotastine besilate|bepotastine besilate
351651|NCT01443442|Loteprednol etabonate|loteprednol etabonate
351652|NCT01443429|TRK-100STP|trk-100stp
351653|NCT01443429|PK|pk
351654|NCT01443429|beraprost sodium|beraprost sodium
351655|NCT01443429|Japanese males and females|japanese males and females
351656|NCT01443429|Subjects with mild/moderate/severe patients|subjects with mild/moderate/severe patients
351657|NCT01443429|renal impairment|renal impairment
351658|NCT01443416|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
351659|NCT01443416|invasive pneumococcal disease|invasive pneumococcal disease
351660|NCT01443416|vaccination|vaccination
351661|NCT01443416|children|children
351662|NCT01443403|Opioid Therapy|opioid therapy
351663|NCT01443403|Non-Malignant Chronic Pain|non-malignant chronic pain
351664|NCT01443403|Opioid-Induced Constipation|opioid-induced constipation
351665|NCT01443390|Whole genome sequencing|whole genome sequencing
351666|NCT01443390|Advanced Refractory Cancer|advanced refractory cancer
351667|NCT01443377|Neorec|neorec
351668|NCT01443377|rectal cancer|rectal cancer
351669|NCT01443377|KRAS|kras
351670|NCT01443377|Panitumumab|panitumumab
351671|NCT01443377|neoadjuvant|neoadjuvant
351672|NCT01443377|Radiochemotherapy|radiochemotherapy
351673|NCT01443377|antibody|antibody
351674|NCT01443377|locally advanced KRAS wild type rectal cancer|locally advanced kras wild type rectal cancer
351675|NCT01443364|Certolizumab pegol - Cimzia|certolizumab pegol - cimzia
351676|NCT01443364|Rheumatoid Arthritis|rheumatoid arthritis
351677|NCT01443364|Power Doppler Ultrasonography|power doppler ultrasonography
351678|NCT01443364|Italy|italy
351679|NCT01443364|Moderate-severe Rheumatoid Arthritis|moderate-severe rheumatoid arthritis
351680|NCT01443351|ITP|itp
351681|NCT01443351|romiplostim|romiplostim
351682|NCT01443351|eltrombopag|eltrombopag
351683|NCT01443351|bone marrow fibrosis|bone marrow fibrosis
351684|NCT01443351|long-term safety|long-term safety
351685|NCT01443338|Triptergium wilfordii|triptergium wilfordii
351686|NCT01443338|Acitretin|acitretin
351687|NCT01443338|psoriasis vulgaris|psoriasis vulgaris
351688|NCT01443325|Persistent Postherniorrhaphy inguinal Pain|persistent postherniorrhaphy inguinal pain
351689|NCT01443312|Beta globin gene|beta globin gene
351690|NCT01443312|Alfa globin gene|alfa globin gene
351691|NCT01443312|xmn1 polymorphism|xmn1 polymorphism
351692|NCT01443273|Newborns|newborns
351693|NCT01443260|oncolytic virus|oncolytic virus
351694|NCT01443260|oncolytic|oncolytic
351695|NCT01443260|GL-ONC1|gl-onc1
351696|NCT01443260|Vaccinia|vaccinia
351697|NCT01443260|Vaccinia virus|vaccinia virus
351698|NCT01443260|Genelux|genelux
351699|NCT01443260|Genelux GmbH|genelux gmbh
351700|NCT01443260|peritoneal|peritoneal
351701|NCT01443260|peritoneal carcinomatosis|peritoneal carcinomatosis
351702|NCT01443260|cancer|cancer
351703|NCT01443260|abdominal cancer|abdominal cancer
351704|NCT01443260|imaging|imaging
351705|NCT01443234|Depression|depression
351706|NCT01443234|Cognitive Bias|cognitive bias
351707|NCT01443234|Internet|internet
351708|NCT01443221|mitiglinide|mitiglinide
351709|NCT01443221|metformin|metformin
351710|NCT01443221|Pharmacokinetics|pharmacokinetics
351711|NCT01443221|Safety|safety
351712|NCT01443208|pharmacokinetics|pharmacokinetics
351713|NCT01443208|safety|safety
351714|NCT01443208|desvenlafaxine|desvenlafaxine
351715|NCT01443208|Korean healthy subjects|korean healthy subjects
351716|NCT01443169|Pharmacokinetic|pharmacokinetic
351717|NCT01443169|relative oral bioavailability|relative oral bioavailability
351718|NCT01443169|pregabalin|pregabalin
351719|NCT01443156|Diet|diet
351720|NCT01443156|Sleep deficiency|sleep deficiency
351721|NCT01443156|Cancer|cancer
351722|NCT01443156|Obesity|obesity
351723|NCT01443156|Diabetes|diabetes
351724|NCT01443156|Shift work|shift work
351725|NCT01443156|Work schedule|work schedule
351726|NCT01443156|Cardiovascular disease|cardiovascular disease
351727|NCT01443156|Body composition|body composition
351728|NCT01443156|Body mass index|body mass index
351729|NCT01443156|Body fat percentage|body fat percentage
351730|NCT01443143|Diabetes|diabetes
351731|NCT01443143|Obesity|obesity
351732|NCT01443143|Glycemic|glycemic
351733|NCT01443143|Portion-control|portion-control
351734|NCT01443143|Commercial diet|commercial diet
351735|NCT01443130|malaria,Malawi,pregnancy|malaria,malawi,pregnancy
351736|NCT01443104|coronary artery disease|coronary artery disease
351737|NCT01443104|drug-eluting stents|drug-eluting stents
351738|NCT01443104|polymers|polymers
351739|NCT01443091|very low birth weight infants|very low birth weight infants
351740|NCT01443091|VLBW infants|vlbw infants
351741|NCT01443091|colostrum|colostrum
351742|NCT01443078|Carboplatin|carboplatin
351743|NCT01443078|Cisplatin|cisplatin
351744|NCT01443078|Pemetrexed (Altima)|pemetrexed (altima)
351745|NCT01443078|Taxotere (Docetaxel)|taxotere (docetaxel)
351746|NCT01443078|Vinorelbine Tartrate (Navelbine)|vinorelbine tartrate (navelbine)
351747|NCT01443078|Stage IB-III|stage ib-iii
351748|NCT01443078|non squamous|non squamous
351749|NCT01443078|non-small cell lung cancer|non-small cell lung cancer
351750|NCT01443078|11-106|11-106
351751|NCT01443065|Adenocarcinoma|adenocarcinoma
351752|NCT01443065|Locally advanced (non operable) or metastatic|locally advanced (non operable) or metastatic
351753|NCT01443065|First line treatment|first line treatment
351754|NCT01443052|Gait stability|gait stability
351755|NCT01443052|Spatiotemporal parameters|spatiotemporal parameters
351756|NCT01443052|Walking|walking
351757|NCT01443052|Elderly people|elderly people
351758|NCT01443052|Stroke|stroke
351759|NCT01443052|Fallers|fallers
351760|NCT01443039|drug metabolizing enzymes and drug transporter|drug metabolizing enzymes and drug transporter
351761|NCT01443039|Roux-en Y-Gastric Bypass|roux-en y-gastric bypass
351762|NCT01443039|Obesity|obesity
351763|NCT01443039|Drug Availability|drug availability
351764|NCT01443039|BMI over 35kg/m² and comorbidities or >40kg/m²|bmi over 35kg/m² and comorbidities or >40kg/m²
351765|NCT01443026|Intraepithelial Prostatic Neoplasia|intraepithelial prostatic neoplasia
351766|NCT01443026|Prostatic neoplasms|prostatic neoplasms
351767|NCT01443026|Male urogenital disease|male urogenital disease
351768|NCT01443026|Prostate|prostate
351769|NCT01443013|Tolerance|tolerance
351770|NCT01443013|Renal Transplantation|renal transplantation
351771|NCT01443013|Chronic allograft nephropathy|chronic allograft nephropathy
351772|NCT01443000|Observational study|observational study
351773|NCT01443000|IOIS|iois
351774|NCT01443000|Orbital Pseudotumor|orbital pseudotumor
351775|NCT01443000|Outcome|outcome
351776|NCT01443000|Treatment|treatment
351777|NCT01442987|Irbesartan|irbesartan
351778|NCT01442987|Atorvastatin|atorvastatin
351779|NCT01442987|Hypertension|hypertension
351780|NCT01442987|Hyperlipidemia|hyperlipidemia
351781|NCT01442974|nab-paclitaxel|nab-paclitaxel
351782|NCT01442974|neoadjuvant treatment|neoadjuvant treatment
351783|NCT01442974|SPARC|sparc
351784|NCT01442974|Pancreatic Cancer|pancreatic cancer
351785|NCT01442961|pain, postoperative|pain, postoperative
351786|NCT01442961|hysterectomy, vaginal|hysterectomy, vaginal
351787|NCT01442961|surgery, gynecological|surgery, gynecological
351788|NCT01442948|-CD16+ monocytes|-cd16+ monocytes
351789|NCT01442935|Adenocarcinoma|adenocarcinoma
351790|NCT01442935|Non-resectable hepatic metastases|non-resectable hepatic metastases
351791|NCT01442935|First-line treatment|first-line treatment
351792|NCT01442922|L3-L4|l3-l4
351793|NCT01442922|L4-L5|l4-l5
351794|NCT01442922|L5-S1|l5-s1
351795|NCT01442922|Human Meniscus Allograft|human meniscus allograft
351796|NCT01442922|Nucleus pulposus|nucleus pulposus
351797|NCT01442922|Minimally invasive surgery|minimally invasive surgery
351798|NCT01442922|Degeneration of L3-L4 Intervertebral Disc|degeneration of l3-l4 intervertebral disc
351799|NCT01442922|Degeneration of L4-L5 Intervertebral Disc|degeneration of l4-l5 intervertebral disc
351800|NCT01442922|Degeneration of L5-S1 Intervertebral Disc|degeneration of l5-s1 intervertebral disc
351801|NCT01442909|lung cancer|lung cancer
351802|NCT01442909|docetaxel|docetaxel
351803|NCT01442909|pemetrexed|pemetrexed
351804|NCT01442883|Treatment Resistant|treatment resistant
351805|NCT01442857|Magnetic Resonance Imaging|magnetic resonance imaging
351806|NCT01442857|Nerve Net|nerve net
351807|NCT01442857|Brachial Plexus|brachial plexus
351808|NCT01442857|Nerve block|nerve block
351809|NCT01442844|Mohs|mohs
351810|NCT01442844|Scalp|scalp
351811|NCT01442831|metabolic profile of TR-700 in plasma urine|metabolic profile of tr-700 in plasma urine
351812|NCT01442818|vaginal reconstructive surgery|vaginal reconstructive surgery
351813|NCT01442805|Cognitive Behavior Therapy|cognitive behavior therapy
352007|NCT01441947|metastatic|metastatic
351814|NCT01442805|Virtual Reality Exposure Therapy|virtual reality exposure therapy
351815|NCT01442805|Psychophysiological Measures|psychophysiological measures
351816|NCT01442805|Driving Phobia|driving phobia
351817|NCT01442805|Flying Phobia|flying phobia
351818|NCT01442792|Angioplasty, Balloon, Coronary|angioplasty, balloon, coronary
351819|NCT01442779|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
351820|NCT01442779|Interferon alpha|interferon alpha
351821|NCT01442766|cholinesterase inhibitor|cholinesterase inhibitor
351822|NCT01442766|donepezil|donepezil
351823|NCT01442766|motor|motor
351824|NCT01442766|stroke|stroke
351825|NCT01442753|Spanish speaking|spanish speaking
351826|NCT01442740|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
351827|NCT01442740|Reverse Trendelenburg Position|reverse trendelenburg position
351828|NCT01442727|arsenical melanosis|arsenical melanosis
351829|NCT01442727|arsenical melanoses|arsenical melanoses
351830|NCT01442727|arsenical keratosis|arsenical keratosis
351831|NCT01442727|arsenical keratoses|arsenical keratoses
351832|NCT01442727|arsenical cancer|arsenical cancer
351833|NCT01442727|arsenic cancers|arsenic cancers
351834|NCT01442727|arsenic|arsenic
351835|NCT01442727|arsenicosis|arsenicosis
351836|NCT01442727|arsenic exposure|arsenic exposure
351837|NCT01442727|arsenic toxicity|arsenic toxicity
351838|NCT01442727|arsenic poisoning|arsenic poisoning
351839|NCT01442727|drinking water|drinking water
351840|NCT01442727|selenium|selenium
351841|NCT01442727|selenite|selenite
351842|NCT01442727|sodium selenite|sodium selenite
351843|NCT01442675|Meningitis|meningitis
351844|NCT01442675|Meningococcal Infection|meningococcal infection
351845|NCT01442675|Menactra®|menactra®
351846|NCT01442662|Metastatic or relapsed uterine or soft tissue leiomyosarcoma|metastatic or relapsed uterine or soft tissue leiomyosarcoma
351847|NCT01442649|Adenocarcinoma|adenocarcinoma
351848|NCT01442649|Metastatic|metastatic
351849|NCT01442649|Second-line treatment|second-line treatment
351850|NCT01442649|Progressive disease after first-line treatment with bevacizumab|progressive disease after first-line treatment with bevacizumab
351851|NCT01442649|Non-mutated (wild-type) KRAS.|non-mutated (wild-type) kras.
351852|NCT01442623|Vestibular Rehabilitation|vestibular rehabilitation
351853|NCT01442623|Balance|balance
351854|NCT01442623|Virtual Reality|virtual reality
351855|NCT01442623|Gait|gait
351856|NCT01442623|Dizziness|dizziness
351857|NCT01442610|Rasagiline|rasagiline
351858|NCT01442610|Sleep disorder|sleep disorder
351859|NCT01442610|Parkinson's disease|parkinson's disease
351860|NCT01442610|Sleep Disturbances in patients with parkinsons's disease|sleep disturbances in patients with parkinsons's disease
351861|NCT01442597|cognitive behavior therapy|cognitive behavior therapy
351862|NCT01442597|computer assisted instruction|computer assisted instruction
351863|NCT01442597|drug abuse therapy|drug abuse therapy
351864|NCT01442597|educational resource design and development|educational resource design and development
351865|NCT01442584|ovary|ovary
351866|NCT01442584|cortex|cortex
351867|NCT01442584|transplantation|transplantation
351868|NCT01442571|Adult Men and Women, who underwent arthroscopy of the knee with cartilage injury of ICRS grade 2 or higher|adult men and women, who underwent arthroscopy of the knee with cartilage injury of icrs grade 2 or higher
351869|NCT01442558|relief|relief
351870|NCT01442558|Intra-operative|intra-operative
351871|NCT01442545|Rheumatoid Arthritis|rheumatoid arthritis
351872|NCT01442545|JNJ-39758979|jnj-39758979
351873|NCT01442545|Methotrexate|methotrexate
351874|NCT01442532|Healthy male volunteer|healthy male volunteer
351875|NCT01442532|JNJ-38518168|jnj-38518168
351876|NCT01442532|Midazolam|midazolam
351877|NCT01442519|non-muscle invasive urothelial bladder cancer|non-muscle invasive urothelial bladder cancer
351878|NCT01442519|intravesical therapy|intravesical therapy
351879|NCT01442519|BCG|bcg
351880|NCT01442519|mitomycin|mitomycin
351881|NCT01442519|electromotive drug administration|electromotive drug administration
351882|NCT01442519|Bladder Cancer Stage 0, Without Cancer in Situ|bladder cancer stage 0, without cancer in situ
351883|NCT01442506|acetic acid|acetic acid
351884|NCT01442506|virtual chromoendosopy|virtual chromoendosopy
351885|NCT01442493|Methadone Treatment|methadone treatment
351886|NCT01442493|Opiate dependence|opiate dependence
351887|NCT01442493|Services research|services research
351888|NCT01442480|air pollution|air pollution
351889|NCT01442480|fatty acid supplementation|fatty acid supplementation
351890|NCT01442467|mitral annular calcification|mitral annular calcification
351891|NCT01442467|MAC|mac
352295|NCT01440829|TIPS|tips
351892|NCT01442467|left atrial pressure|left atrial pressure
351893|NCT01442467|LAP|lap
351894|NCT01442467|left ventricular end diastolic pressure|left ventricular end diastolic pressure
351895|NCT01442467|LVEDP|lvedp
351896|NCT01442467|Echocardiogram|echocardiogram
351897|NCT01442454|chronic pancreatitis|chronic pancreatitis
351898|NCT01442441|chronic pancreatitis|chronic pancreatitis
351899|NCT01442428|TB|tb
351900|NCT01442428|AIDS|aids
351901|NCT01442428|HIV|hiv
351902|NCT01442428|IRIS|iris
351903|NCT01442428|immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
351904|NCT01442428|anti-inflammatory|anti-inflammatory
351905|NCT01442428|treatment|treatment
352008|NCT01441921|pistachio intake|pistachio intake
403011|NCT01228578|Multivitamins|multivitamins
342576|NCT01480492|HBV|hbv
351906|NCT01442376|Prevention of Chemotherapy-Induced Nausea and Vomiting|prevention of chemotherapy-induced nausea and vomiting
351907|NCT01442376|Palonosetron|palonosetron
351908|NCT01442376|Ondansetron|ondansetron
351909|NCT01442376|Pediatric|pediatric
351910|NCT01442363|Crohn's disease|crohn's disease
351911|NCT01442363|perianal|perianal
351912|NCT01442363|inflammatory bowel disease|inflammatory bowel disease
351913|NCT01442363|fistula|fistula
351914|NCT01442350|Fabry disease|fabry disease
351915|NCT01442350|annexin 5|annexin 5
351916|NCT01442350|miosin|miosin
351917|NCT01442350|sarcoma|sarcoma
351918|NCT01442350|alfa-galactosidase|alfa-galactosidase
351919|NCT01442350|fibrosis|fibrosis
351920|NCT01442350|apoptosis|apoptosis
351921|NCT01442350|biomarkers|biomarkers
351922|NCT01442350|NT-proBNP|nt-probnp
351923|NCT01442337|de novo kidney transplant|de novo kidney transplant
351924|NCT01442337|kidney transplant|kidney transplant
351925|NCT01442337|ASP8597|asp8597
351926|NCT01442337|diannexin|diannexin
351927|NCT01442337|ischemia-reperfusion injury|ischemia-reperfusion injury
351928|NCT01442324|Laparotomic surgery|laparotomic surgery
351929|NCT01442324|Laparoscopic surgery|laparoscopic surgery
351930|NCT01442324|Percutaneos tumour ablation|percutaneos tumour ablation
351931|NCT01442324|Irreversible electroporation (IRE)|irreversible electroporation (ire)
351932|NCT01442311|Hepatitis C Virus|hepatitis c virus
351933|NCT01442311|Chronic Hepatitis C|chronic hepatitis c
351934|NCT01442311|Methadone|methadone
351935|NCT01442311|Injection Drug User|injection drug user
351936|NCT01442311|Adherence|adherence
351937|NCT01442311|Directly Observed Treatment|directly observed treatment
351938|NCT01442298|bloodless field|bloodless field
351939|NCT01442298|cuff pressure|cuff pressure
351940|NCT01442298|limb occlusion pressure|limb occlusion pressure
351941|NCT01442259|Renal impairment,|renal impairment,
351942|NCT01442259|pharmacokinetics,|pharmacokinetics,
351944|NCT01442246|Benefit of|benefit of
351945|NCT01442246|adjuvant|adjuvant
351946|NCT01442246|treatment|treatment
351947|NCT01442246|prostatectomy|prostatectomy
351948|NCT01442233|multiple sclerosis|multiple sclerosis
351949|NCT01442233|plasma exchange|plasma exchange
351950|NCT01442207|Premature Birth|premature birth
351951|NCT01442207|Placenta Previa|placenta previa
351952|NCT01442194|Multiple sclerosis|multiple sclerosis
351953|NCT01442194|fingolimod|fingolimod
351954|NCT01442194|observational study|observational study
351955|NCT01442168|Uncomplicated Falciparum Malaria|uncomplicated falciparum malaria
351956|NCT01442168|Plasmodium falciparum|plasmodium falciparum
351957|NCT01442168|Antimalarial treatment|antimalarial treatment
351958|NCT01442168|Sevuparin/DF02|sevuparin/df02
351959|NCT01442168|Adjuvant therapy|adjuvant therapy
351960|NCT01442168|Malanil|malanil
351961|NCT01442168|Peripheral blood parasitemia|peripheral blood parasitemia
351962|NCT01442168|Rosette formation|rosette formation
351963|NCT01442168|Maximum tolerated dose|maximum tolerated dose
351964|NCT01442155|Colorectal cancer|colorectal cancer
351965|NCT01442155|Adjuvant setting|adjuvant setting
351966|NCT01442155|Capecitabine|capecitabine
351967|NCT01442155|Oxaliplatin|oxaliplatin
351968|NCT01442142|obesity|obesity
351969|NCT01442142|pediatric|pediatric
351970|NCT01442142|childhood|childhood
351971|NCT01442142|overweight|overweight
351972|NCT01442129|Heart Failure|heart failure
351973|NCT01442129|Left Ventricular Assist Device|left ventricular assist device
351974|NCT01442129|Heart Transplantation|heart transplantation
351975|NCT01442129|Cardiomyopathy|cardiomyopathy
351976|NCT01442129|Destination Therapy|destination therapy
351977|NCT01442129|Cell Therapy|cell therapy
351978|NCT01442064|CNV|cnv
351979|NCT01442064|Lucentis|lucentis
351980|NCT01442064|AMD|amd
351981|NCT01442064|Age-related macular degeneration|age-related macular degeneration
351982|NCT01442064|RVO|rvo
586747|NCT00524992|Tubular Injury|tubular injury
351983|NCT01442064|Macular edema secondary to retinal vein occlusion|macular edema secondary to retinal vein occlusion
351984|NCT01442051|Acute Normovolemic Hemodilution|acute normovolemic hemodilution
351985|NCT01442051|Cytoreductive Surgery|cytoreductive surgery
351986|NCT01442051|laparotomy|laparotomy
351987|NCT01442051|11-149|11-149
351988|NCT01442051|advanced primary epithelial ovarian cancer|advanced primary epithelial ovarian cancer
351989|NCT01442025|Crohn's Disease|crohn's disease
351990|NCT01442025|IFX trough level|ifx trough level
351991|NCT01442012|PONV|ponv
351992|NCT01442012|ACUPUNCTURE|acupuncture
351993|NCT01441999|Rigid rods|rigid rods
351994|NCT01441999|less rigid rods|less rigid rods
351995|NCT01441999|prevent kyphosis|prevent kyphosis
351996|NCT01441999|long constructs|long constructs
351997|NCT01441986|dextromethorphan|dextromethorphan
351998|NCT01441986|amantadine|amantadine
351999|NCT01441986|blood glucose lowering effect|blood glucose lowering effect
352000|NCT01441986|oral glucose tolerance test|oral glucose tolerance test
352001|NCT01441960|Succinylcholine|succinylcholine
352002|NCT01441960|Rocuronium|rocuronium
352003|NCT01441960|ECT|ect
352004|NCT01441947|ER+|er+
352005|NCT01441947|PR+|pr+
403012|NCT01228578|HIV/AIDS|hiv/aids
352006|NCT01441947|Human Epidermal Growth Factor Receptor (HER) 2 negative|human epidermal growth factor receptor (her) 2 negative
352009|NCT01441921|insulin resistance|insulin resistance
352010|NCT01441921|type 2 diabetes mellitus|type 2 diabetes mellitus
352011|NCT01441908|Cardiovascular|cardiovascular
352012|NCT01441908|Multi-analyte|multi-analyte
352013|NCT01441908|Statin|statin
352014|NCT01441908|Dyslipidemia|dyslipidemia
352015|NCT01441895|Refractive Cataract Extraction|refractive cataract extraction
352016|NCT01441895|Femtosecond laser|femtosecond laser
352017|NCT01441895|arcuate relaxing incisions|arcuate relaxing incisions
352018|NCT01441895|Dry Eye post cataract refraction|dry eye post cataract refraction
352019|NCT01441869|Phase 1, Healthy male volunteers, pharmacokinetics, saxagliptin/ metformin , Diabex|phase 1, healthy male volunteers, pharmacokinetics, saxagliptin/ metformin , diabex
352020|NCT01441856|Open|open
352021|NCT01441856|Laparoscopic|laparoscopic
352022|NCT01441856|Hemihepatectomy|hemihepatectomy
352023|NCT01441856|Enhanced Recovery After Surgery|enhanced recovery after surgery
352024|NCT01441856|Functional recovery|functional recovery
352025|NCT01441843|quality of life|quality of life
352026|NCT01441843|lorazepam|lorazepam
352027|NCT01441843|anxiety|anxiety
352028|NCT01441843|premedication|premedication
352029|NCT01441843|surgery|surgery
352030|NCT01441843|Adult patients|adult patients
352031|NCT01441843|Ambulatory Surgical Procedures|ambulatory surgical procedures
352032|NCT01441843|Postoperative Period|postoperative period
352033|NCT01441830|shoulder|shoulder
352034|NCT01441830|subacromial|subacromial
352035|NCT01441830|impingement|impingement
352036|NCT01441830|tendinopathy|tendinopathy
352037|NCT01441830|rESWT|reswt
352038|NCT01441830|shock wave|shock wave
352039|NCT01441830|ESWT|eswt
352040|NCT01441830|RSWT|rswt
352041|NCT01441791|PEEP|peep
352042|NCT01441791|Positive end-expiratory pressure|positive end-expiratory pressure
352043|NCT01441791|Recruitment maneuver|recruitment maneuver
352044|NCT01441791|Open lung approach|open lung approach
352045|NCT01441791|Post-operative complications|post-operative complications
352046|NCT01441791|Open abdominal surgery|open abdominal surgery
352047|NCT01441778|nasal irrigation|nasal irrigation
352048|NCT01441778|allergic rhinitis|allergic rhinitis
352049|NCT01441778|children|children
352050|NCT01441765|Kidney|kidney
352051|NCT01441765|Metastatic|metastatic
352052|NCT01441765|Stage IV|stage iv
352053|NCT01441726|Advanced dementia|advanced dementia
352054|NCT01441726|Quality|quality
352055|NCT01441726|Terminal care|terminal care
352056|NCT01441713|Hormone treatment|hormone treatment
352057|NCT01441713|castration|castration
352058|NCT01441713|Orchiectomy|orchiectomy
352059|NCT01441713|treatment frequency|treatment frequency
352060|NCT01441713|treatment satisfaction|treatment satisfaction
352061|NCT01441713|side effects|side effects
352062|NCT01441700|Prone emergence|prone emergence
352063|NCT01441700|supine emergence|supine emergence
352064|NCT01441700|coughing|coughing
352065|NCT01441700|haemodynamic stimulation|haemodynamic stimulation
352066|NCT01441700|lumbar surgery|lumbar surgery
352067|NCT01441687|Health status unknown|health status unknown
352068|NCT01441687|healthy,no evidence of disease|healthy,no evidence of disease
352069|NCT01441674|Occupational Therapy|occupational therapy
352070|NCT01441661|Sunitinib|sunitinib
352071|NCT01441661|kidney diseases|kidney diseases
352072|NCT01441661|urogenital neoplasms|urogenital neoplasms
352073|NCT01441661|kidney cancer|kidney cancer
352074|NCT01441648|conjunctival injection|conjunctival injection
352075|NCT01441648|conjunctival papillary hypertrophy|conjunctival papillary hypertrophy
352076|NCT01441648|pannus formation|pannus formation
352077|NCT01441648|corneal epitheliopathy|corneal epitheliopathy
352078|NCT01441648|Schirmer test|schirmer test
352079|NCT01441648|Impression cytology|impression cytology
352080|NCT01441648|confocal microscopy|confocal microscopy
352081|NCT01441648|Scanning electronmicroscopy (SEM)|scanning electronmicroscopy (sem)
727872|NCT01074125|Dialysis|dialysis
352082|NCT01441648|bacterial adhesion determination|bacterial adhesion determination
352083|NCT01441635|Elagolix|elagolix
352084|NCT01441635|Uterine Fibroids|uterine fibroids
352085|NCT01441635|Elagolix sodium|elagolix sodium
352086|NCT01441635|Leiomyomata|leiomyomata
352087|NCT01441635|Heavy Uterine Bleeding|heavy uterine bleeding
352088|NCT01441635|Menorrhagia|menorrhagia
352089|NCT01441635|ABT-620|abt-620
352090|NCT01441622|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
352091|NCT01441622|AL539|al539
352092|NCT01441622|Home-monitoring|home-monitoring
352093|NCT01441609|Th9 cells|th9 cells
352094|NCT01441609|IL9|il9
352095|NCT01441609|non/poor responsiveness to hepatitis B|non/poor responsiveness to hepatitis b
352096|NCT01441609|collect blood samples after vaccination|collect blood samples after vaccination
352097|NCT01441583|pacemaker, CRT-P, auto threshold|pacemaker, crt-p, auto threshold
352098|NCT01441570|kidney|kidney
352099|NCT01441570|transplant|transplant
352100|NCT01441570|hypertension|hypertension
352101|NCT01441570|nebivolol|nebivolol
352102|NCT01441570|metoprolol|metoprolol
352103|NCT01441570|bystolic|bystolic
352104|NCT01441570|toprol|toprol
352105|NCT01441557|mechanical ventilation|mechanical ventilation
352106|NCT01441544|active video games|active video games
353110|NCT01437748|COPD|copd
352107|NCT01441544|Energy expenditure|energy expenditure
352108|NCT01441531|narcotic use|narcotic use
352109|NCT01441531|Other Acute Pain|other acute pain
352110|NCT01441492|Distal pancreatectomy|distal pancreatectomy
352111|NCT01441492|Pancreas resection|pancreas resection
352112|NCT01441466|bronchiolitis|bronchiolitis
352113|NCT01441466|RSV|rsv
352114|NCT01441453|Hepatocellular carcinoma|hepatocellular carcinoma
352115|NCT01441453|Cirrhosis|cirrhosis
352116|NCT01441453|Liver resection|liver resection
352117|NCT01441453|FibroScan|fibroscan
352118|NCT01441440|venlafaxine ER|venlafaxine er
352119|NCT01441440|Major depressive disorder|major depressive disorder
352120|NCT01441440|Japan|japan
352121|NCT01441440|placebo-controlled|placebo-controlled
352122|NCT01441427|feeding intolerance|feeding intolerance
352123|NCT01441427|recombinant growth factors|recombinant growth factors
352124|NCT01441427|G-CSF|g-csf
352125|NCT01441427|EPO|epo
352126|NCT01441427|necrotizing enterocolitis|necrotizing enterocolitis
352127|NCT01441414|CVX-060|cvx-060
352128|NCT01441414|PF-04856884|pf-04856884
352129|NCT01441414|AG-013736|ag-013736
352130|NCT01441414|axitinib|axitinib
352131|NCT01441414|mRCC|mrcc
352132|NCT01441414|metastatic renal cell cancer|metastatic renal cell cancer
352133|NCT01441414|second line|second line
352134|NCT01441414|anti-angiogenic|anti-angiogenic
352135|NCT01441414|Ang-2|ang-2
352136|NCT01441401|Gabapentin|gabapentin
352137|NCT01441401|Epilepsies|epilepsies
352138|NCT01441401|safety|safety
352139|NCT01441388|Phase 1b|phase 1b
352140|NCT01441388|crizotinib|crizotinib
352141|NCT01441388|sunitinib|sunitinib
352142|NCT01441388|axitinib|axitinib
352143|NCT01441388|sorafenib|sorafenib
352144|NCT01441388|bevacizumab|bevacizumab
352145|NCT01441388|cMET inhibitor|cmet inhibitor
352146|NCT01441388|VEGF inhibitor|vegf inhibitor
352147|NCT01441388|crizotinib combination|crizotinib combination
352148|NCT01441375|Sickle cell anemia|sickle cell anemia
352149|NCT01441362|during double-lumen|during double-lumen
352150|NCT01441362|tube intubation|tube intubation
352151|NCT01441349|Simvastatin|simvastatin
352152|NCT01441349|SCLC|sclc
352153|NCT01441349|Extensive Disease|extensive disease
352154|NCT01441323|Obesity|obesity
352155|NCT01441323|Type 2 Diabetes|type 2 diabetes
352156|NCT01441323|Cardiovascular Risk|cardiovascular risk
352157|NCT01441323|Cancer|cancer
352158|NCT01441323|African American|african american
352159|NCT01441323|Adolescents|adolescents
352160|NCT01441323|Strength Training|strength training
352161|NCT01441323|Nutrition|nutrition
352162|NCT01441310|Gastric cancer|gastric cancer
352163|NCT01441310|Sentinel node navigation surgery|sentinel node navigation surgery
352164|NCT01441310|Dual method|dual method
352165|NCT01441310|Recurrence|recurrence
352166|NCT01441297|recurrent small cell lung cancer|recurrent small cell lung cancer
352167|NCT01441284|pramipexole|pramipexole
352168|NCT01441284|essential tremor|essential tremor
352169|NCT01441284|cross-over|cross-over
352170|NCT01441245|acute heart failure|acute heart failure
352171|NCT01441245|diuretics|diuretics
352173|NCT01441245|Renal function|renal function
352174|NCT01441245|acute decompensated Heart Failure,|acute decompensated heart failure,
352175|NCT01441245|volume overload|volume overload
352176|NCT01441206|rifampin|rifampin
352177|NCT01441206|infants|infants
352178|NCT01441193|HIV|hiv
352179|NCT01441193|preventive vaccine|preventive vaccine
352180|NCT01441193|Tat|tat
352181|NCT01441193|Env|env
352182|NCT01441180|Direct Acting Antiviral|direct acting antiviral
352183|NCT01441180|Liver|liver
352184|NCT01441180|Hepatitis C|hepatitis c
352185|NCT01441180|HCV|hcv
352186|NCT01441167|Healthy Subjects|healthy subjects
352187|NCT01441167|Immunogenicity|immunogenicity
352188|NCT01441167|Vaccine-Mediated Protection|vaccine-mediated protection
352189|NCT01441167|Sporozoites|sporozoites
352190|NCT01441167|Parasitemia|parasitemia
352191|NCT01441167|Healthy Volunteer|healthy volunteer
352192|NCT01441167|HV|hv
352193|NCT01441154|Hypothyroidism|hypothyroidism
352194|NCT01441154|Thyroid Cancer|thyroid cancer
352195|NCT01441154|Triiodothyronine (T3)|triiodothyronine (t3)
352196|NCT01441154|Energy Expenditure|energy expenditure
352197|NCT01441154|Thyroid Hormone|thyroid hormone
352198|NCT01441141|GCH1|gch1
352199|NCT01441141|Pain Sensitivity|pain sensitivity
352200|NCT01441141|Quantitative Sensory Testing (QST)|quantitative sensory testing (qst)
352201|NCT01441141|Genetic Variation|genetic variation
352202|NCT01441141|Sickle Cell Anemia|sickle cell anemia
352203|NCT01441128|Lung Neoplasms|lung neoplasms
352204|NCT01441128|Epithelial-Mesenchymal Transition Factor (c-Met)|epithelial-mesenchymal transition factor (c-met)
352205|NCT01441128|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
352206|NCT01441128|Hepatocyte Growth Factor Receptor|hepatocyte growth factor receptor
352207|NCT01441128|Epidermal Growth Factor Receptor|epidermal growth factor receptor
352208|NCT01441128|Non Small Cell Lung Cancer|non small cell lung cancer
352209|NCT01441128|NSCLC|nsclc
352210|NCT01441115|Metastasis|metastasis
352211|NCT01441115|Cancer|cancer
352212|NCT01441115|Radiation Therapy|radiation therapy
352213|NCT01441115|Locally Advanced|locally advanced
352214|NCT01441115|Palliation|palliation
352215|NCT01441115|Metastatic Cancer|metastatic cancer
352216|NCT01441102|Diabetic Macular Edema|diabetic macular edema
352217|NCT01441102|Microglia|microglia
352218|NCT01441102|Dextromethorphan|dextromethorphan
352219|NCT01441089|Pharmacogenetics|pharmacogenetics
352220|NCT01441089|Pharmacokinetics|pharmacokinetics
352221|NCT01441089|Pharmacodynamics|pharmacodynamics
352222|NCT01441089|Clinical Outcome|clinical outcome
352223|NCT01441089|Drug Metabolism and Transport|drug metabolism and transport
352224|NCT01441089|Cancer|cancer
352225|NCT01441076|Behcet's Disease|behcet's disease
352226|NCT01441076|Aphthous Ulcer|aphthous ulcer
352227|NCT01441076|Uveitis|uveitis
352228|NCT01441076|IL-1|il-1
352229|NCT01441076|Autoinflammation|autoinflammation
352230|NCT01441076|BD|bd
352231|NCT01441063|Kaposi Sarcoma Herpesvirus|kaposi sarcoma herpesvirus
352232|NCT01441063|Human Immunodeficiency Virus|human immunodeficiency virus
352233|NCT01441063|Tocilizumab|tocilizumab
352234|NCT01441063|Multicentric Castleman Disease|multicentric castleman disease
352235|NCT01441063|Interleukin-6|interleukin-6
352236|NCT01441063|Castleman Disease|castleman disease
352237|NCT01441037|Aplastic Anemia|aplastic anemia
352238|NCT01441037|Androgen|androgen
352239|NCT01441037|Telomeres|telomeres
352240|NCT01441024|Immunocompromised|immunocompromised
352241|NCT01441024|Respiratory Tract Disease|respiratory tract disease
352242|NCT01441024|Viral Shedding|viral shedding
352243|NCT01441024|Fever|fever
352244|NCT01441024|Pharmacokinetics|pharmacokinetics
352245|NCT01441024|Parainfluenza Infection|parainfluenza infection
352247|NCT01441011|weight loss|weight loss
352248|NCT01441011|breast cancer|breast cancer
352249|NCT01441011|obesity|obesity
352250|NCT01441011|overweight|overweight
352251|NCT01441011|rural women|rural women
352252|NCT01441011|community based|community based
352253|NCT01441011|Secondary Prevention|secondary prevention
352254|NCT01440985|Tooth Staining|tooth staining
352255|NCT01440972|knee osteoarthritis|knee osteoarthritis
352256|NCT01440972|symptomatic knee osteoarthritis|symptomatic knee osteoarthritis
352257|NCT01440972|isotonic leg-press strength|isotonic leg-press strength
352258|NCT01440972|isokinetic knee extensor strength|isokinetic knee extensor strength
352259|NCT01440972|quadriceps volume|quadriceps volume
352260|NCT01440959|This is a single-center|this is a single-center
352261|NCT01440959|prospective|prospective
352262|NCT01440959|single-arm|single-arm
352263|NCT01440959|open-label phase II study|open-label phase ii study
352264|NCT01440933|sugammadex|sugammadex
352265|NCT01440933|rocuronium|rocuronium
352266|NCT01440933|magnesiumsulphate|magnesiumsulphate
352267|NCT01440933|neuromuscular monitoring|neuromuscular monitoring
352268|NCT01440920|Acute myeloid leukemia|acute myeloid leukemia
352269|NCT01440920|WT1|wt1
352270|NCT01440907|Health Information Technology|health information technology
352271|NCT01440907|Health Records, Personal|health records, personal
352272|NCT01440907|Hospital Information Systems|hospital information systems
352273|NCT01440907|Patient Access to Records|patient access to records
352274|NCT01440907|Medical Records|medical records
352275|NCT01440907|Medical Record Systems, Computerized|medical record systems, computerized
352276|NCT01440894|weight|weight
352277|NCT01440894|body fat|body fat
352278|NCT01440894|total body water|total body water
352279|NCT01440894|bone mass|bone mass
352280|NCT01440894|muscle mass|muscle mass
352281|NCT01440881|renal failure|renal failure
352282|NCT01440881|cardiopulmonary bypass|cardiopulmonary bypass
352283|NCT01440868|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
352284|NCT01440868|Delivery Rooms|delivery rooms
352285|NCT01440868|Resuscitation|resuscitation
352286|NCT01440868|Premature Birth|premature birth
352287|NCT01440868|Infant, Newborn|infant, newborn
352288|NCT01440868|Respiration, Artificial|respiration, artificial
352289|NCT01440855|Survivorship|survivorship
352290|NCT01440855|cancer control|cancer control
352291|NCT01440855|psychosocial interventions|psychosocial interventions
352292|NCT01440855|Facing Forward|facing forward
352293|NCT01440842|Stress hyperglycaemia|stress hyperglycaemia
352294|NCT01440829|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
352296|NCT01440829|Liver Cirrhosis|liver cirrhosis
352297|NCT01440829|LOLA|lola
352298|NCT01440829|L-ornithine-L-aspartate|l-ornithine-l-aspartate
352299|NCT01440829|Refractory Ascites|refractory ascites
352300|NCT01440803|osteoporosis|osteoporosis
352301|NCT01440803|premenopausal|premenopausal
352302|NCT01440803|forteo|forteo
352303|NCT01440803|idiopathic|idiopathic
352304|NCT01440803|Idiopathic Osteoporosis in Premenopausal Women|idiopathic osteoporosis in premenopausal women
352305|NCT01440777|Insomnia|insomnia
352306|NCT01440777|Sleep|sleep
352307|NCT01440777|Stress|stress
352308|NCT01440777|Online program|online program
352309|NCT01440777|Web-based program|web-based program
352310|NCT01440777|Cognitive Behavioral Therapy for Insomnia (CBT-i)|cognitive behavioral therapy for insomnia (cbt-i)
352311|NCT01440764|dyspnea|dyspnea
352312|NCT01440764|Laboratory model of dyspnea in healthy subjects|laboratory model of dyspnea in healthy subjects
352313|NCT01440751|ologen collagen matrix|ologen collagen matrix
352314|NCT01440751|mitomycin-C|mitomycin-c
352315|NCT01440751|trabeculectomy|trabeculectomy
352316|NCT01440751|glaucoma|glaucoma
352317|NCT01440751|filtering surgery|filtering surgery
352318|NCT01440738|general population|general population
352319|NCT01440725|muscle|muscle
352320|NCT01440725|injuries|injuries
352321|NCT01440725|platelet-rich plasma|platelet-rich plasma
352322|NCT01440725|autologous|autologous
352323|NCT01440725|haematoma|haematoma
352324|NCT01440712|Gastrografin|gastrografin
352325|NCT01440712|Postoperative ileus|postoperative ileus
352326|NCT01440712|Colo-rectal surgery|colo-rectal surgery
352327|NCT01440712|Effects on morbidity and mortality of postoperative ileus|effects on morbidity and mortality of postoperative ileus
352328|NCT01440699|Crohn's fistula|crohn's fistula
352329|NCT01440686|Pharmacokinetics|pharmacokinetics
352330|NCT01440686|Pharmacodynamics|pharmacodynamics
352331|NCT01440686|Safety|safety
352332|NCT01440686|Male|male
352333|NCT01440673|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
352334|NCT01440647|Respiration, Artificial|respiration, artificial
352335|NCT01440647|Infant, Premature|infant, premature
352336|NCT01440647|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
352337|NCT01440647|Continuous Positive Airway Pressure|continuous positive airway pressure
352338|NCT01440647|Non-Invasive Positive-Pressure Ventilation|non-invasive positive-pressure ventilation
352339|NCT01440647|Intermittent Positive-Pressure Ventilation|intermittent positive-pressure ventilation
352340|NCT01440647|High-Frequency Ventilation|high-frequency ventilation
352341|NCT01440634|Peripheral arterial disease|peripheral arterial disease
352342|NCT01440634|Community Medicine|community medicine
352343|NCT01440634|Exercise Test|exercise test
352344|NCT01440634|Exercise Therapy|exercise therapy
352345|NCT01440621|Cancer related fatigue|cancer related fatigue
352346|NCT01440621|Quality of life|quality of life
352347|NCT01440621|Modafinil|modafinil
352348|NCT01440621|Radiation therapy|radiation therapy
352349|NCT01440621|Radiotherapy|radiotherapy
352350|NCT01440582|Myeloma|myeloma
352351|NCT01440582|Multiple Myeloma|multiple myeloma
352352|NCT01440582|MM|mm
352353|NCT01440582|Newly diagnosed|newly diagnosed
352354|NCT01440582|Transplant eligible|transplant eligible
352355|NCT01440582|Panobinostat|panobinostat
352356|NCT01440582|LBH589B|lbh589b
352357|NCT01440582|Bortezomib|bortezomib
352358|NCT01440582|Velcade|velcade
352359|NCT01440582|LDP-341|ldp-341
352360|NCT01440582|MLN341|mln341
352361|NCT01440582|PS-341|ps-341
352362|NCT01440582|Lenalidomide|lenalidomide
352363|NCT01440582|CC-5013|cc-5013
352364|NCT01440582|Revlimid|revlimid
352365|NCT01440582|Dexamethasone|dexamethasone
352366|NCT01440582|Decadron|decadron
352367|NCT01440582|Symptom questionnaire|symptom questionnaire
352368|NCT01440582|Survey|survey
352369|NCT01440569|HIV-1|hiv-1
352370|NCT01440569|HIV|hiv
352371|NCT01440569|Treatment Naïve|treatment naïve
352372|NCT01440569|Treatment Experienced|treatment experienced
352373|NCT01440556|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
352374|NCT01440556|Multiple myeloma|multiple myeloma
352375|NCT01440543|colonoscopy|colonoscopy
352376|NCT01440543|water immersion|water immersion
352377|NCT01440543|CO2 insufflation|co2 insufflation
352378|NCT01440543|patients referred for diagnostic outpatient colonoscopy|patients referred for diagnostic outpatient colonoscopy
352379|NCT01440543|(screening, surveillance, symptoms)|(screening, surveillance, symptoms)
352380|NCT01440543|patient discomfort associated with diagnostic colonoscopy|patient discomfort associated with diagnostic colonoscopy
352384|NCT01440530|Diabetes Self-Management|diabetes self-management
352385|NCT01440530|Diabetes Behavior Intervention|diabetes behavior intervention
352386|NCT01440517|CE-MRI - Contrast-enhanced magnetic resonance imaging|ce-mri - contrast-enhanced magnetic resonance imaging
352387|NCT01440517|DM - Diabetes mellitus|dm - diabetes mellitus
352388|NCT01440517|EKG - Echocardiography|ekg - echocardiography
352389|NCT01440517|HFPEF - Heart failure preserved left ventricular ejection fraction|hfpef - heart failure preserved left ventricular ejection fraction
352390|NCT01440517|LVEF - Left Ventricular Ejection Fraction|lvef - left ventricular ejection fraction
352391|NCT01440504|Cancer|cancer
352392|NCT01440504|Ovarian|ovarian
352393|NCT01440504|chemotherapy|chemotherapy
352394|NCT01440504|BH3-mimetic|bh3-mimetic
352395|NCT01440504|platin|platin
352396|NCT01440504|ex-vivo|ex-vivo
352397|NCT01440491|low back pain|low back pain
352398|NCT01440491|exercise|exercise
352399|NCT01440491|booklet|booklet
352400|NCT01440465|chemotherapy|chemotherapy
352401|NCT01440465|cancer|cancer
352402|NCT01440465|nausea|nausea
352403|NCT01440465|vomiting|vomiting
352404|NCT01440452|TM|tm
352405|NCT01440452|MS|ms
352406|NCT01440452|Spinal Cord Injury|spinal cord injury
352407|NCT01440452|Functional electrical stimulation|functional electrical stimulation
353111|NCT01437735|Asthma|asthma
352408|NCT01440452|Rehabilitation|rehabilitation
352409|NCT01440452|Growth factors|growth factors
352410|NCT01440452|Cytokines|cytokines
352411|NCT01440439|insulin glargine|insulin glargine
352412|NCT01440439|insulin detemir|insulin detemir
352413|NCT01440439|hypoglycaemia|hypoglycaemia
352414|NCT01440439|metabolism|metabolism
352415|NCT01440439|Exercise|exercise
352416|NCT01440426|gingival recession|gingival recession
352417|NCT01440426|root coverage|root coverage
352418|NCT01440426|periodontal surgery|periodontal surgery
352419|NCT01440426|collagen matrix|collagen matrix
352420|NCT01440426|mucograft|mucograft
352421|NCT01440426|multiple exposed teeth|multiple exposed teeth
352422|NCT01440413|anti-tumor immune response|anti-tumor immune response
352423|NCT01440413|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
352424|NCT01440413|relapse|relapse
352425|NCT01440413|long term survival|long term survival
352426|NCT01440413|histo-pathological response|histo-pathological response
352427|NCT01440413|tumor cell death|tumor cell death
352428|NCT01440413|tumor associated antigens|tumor associated antigens
352429|NCT01440413|Calreticulin|calreticulin
352430|NCT01440413|Localized breast cancer|localized breast cancer
352431|NCT01440400|Ultrasound|ultrasound
352432|NCT01440400|Spinal anesthesia|spinal anesthesia
352433|NCT01440400|Cesarean section|cesarean section
352434|NCT01440387|Influenza|influenza
352435|NCT01440387|Phase III|phase iii
352436|NCT01440387|Seasonal influenza|seasonal influenza
352437|NCT01440374|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
352438|NCT01440374|acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
352439|NCT01440374|acute non lymphocytic leukemia (ANLL)|acute non lymphocytic leukemia (anll)
352440|NCT01440374|myeloproliferative disease (MDS)|myeloproliferative disease (mds)
352441|NCT01440374|myelodysplastic syndrome ( secondary acute myeloid leukemia)|myelodysplastic syndrome ( secondary acute myeloid leukemia)
352442|NCT01440374|refractory acute myeloid leukemia|refractory acute myeloid leukemia
352443|NCT01440348|Achilles allograft|achilles allograft
352444|NCT01440348|cruciate ligament|cruciate ligament
352445|NCT01440348|reconstruction|reconstruction
352446|NCT01440335|Fenoterol|fenoterol
352447|NCT01440335|Pharmacodynamics|pharmacodynamics
352448|NCT01440335|Pharmacokinetics|pharmacokinetics
352449|NCT01440335|Safety|safety
352450|NCT01440335|Beta Adrenergic Agonist|beta adrenergic agonist
352451|NCT01440322|Myopia|myopia
352452|NCT01440322|Contact lenses|contact lenses
352453|NCT01440309|biliary cirrhosis|biliary cirrhosis
352454|NCT01440283|Neuroblastoma|neuroblastoma
352455|NCT01440283|Radiation Therapy|radiation therapy
352456|NCT01440270|Oral cancer|oral cancer
352457|NCT01440270|Oropharyngeal cancer|oropharyngeal cancer
352458|NCT01440270|Induction chemotherapy|induction chemotherapy
352459|NCT01440270|Targeted chemotherapy|targeted chemotherapy
352460|NCT01440270|Surgery|surgery
352461|NCT01440270|Radiotherapy|radiotherapy
352462|NCT01440270|Effects of Chemotherapy|effects of chemotherapy
352467|NCT01440231|Rheumatology|rheumatology
352468|NCT01440231|Double-Blind|double-blind
352469|NCT01440231|Placebo-Controlled|placebo-controlled
352470|NCT01440231|Multidose|multidose
352471|NCT01440231|Dose-Response|dose-response
352472|NCT01440231|Phase II|phase ii
352473|NCT01440231|Systemic Lupus Erythematosus|systemic lupus erythematosus
352474|NCT01440231|SLE|sle
352475|NCT01440231|Atacicept|atacicept
352476|NCT01440218|Idiopathic diseases|idiopathic diseases
586748|NCT00524992|Renal Biopsy|renal biopsy
352477|NCT01440218|family member of the affected individual|family member of the affected individual
352478|NCT01440218|unknown etiology|unknown etiology
352479|NCT01440205|Flu Shot|flu shot
352480|NCT01440192|Sarcoidosis|sarcoidosis
352481|NCT01440192|Stem cells|stem cells
352482|NCT01440192|PDA001|pda001
352483|NCT01440192|Celgene|celgene
352484|NCT01440192|Human Placenta-Derived cells|human placenta-derived cells
352485|NCT01440192|Cenplacel-L|cenplacel-l
352486|NCT01440166|Human healthy volunteers|human healthy volunteers
352487|NCT01440153|Dance|dance
352488|NCT01440153|Injury|injury
352489|NCT01440153|Physical condition|physical condition
352490|NCT01440153|Exercise|exercise
352491|NCT01440114|emergence agitation|emergence agitation
352492|NCT01440114|pediatric patient|pediatric patient
352493|NCT01440114|fentanyl|fentanyl
352494|NCT01440114|incidence of emergence agitation|incidence of emergence agitation
352495|NCT01440114|severity of emergence agitation|severity of emergence agitation
352703|NCT01439334|Brief|brief
352496|NCT01440114|adverse outcome from intervention|adverse outcome from intervention
352497|NCT01440088|TH-302|th-302
352498|NCT01440088|TH-CR-406|th-cr-406
352499|NCT01440088|SARC021|sarc021
352500|NCT01440088|Locally Advanced Soft Tissue Sarcoma|locally advanced soft tissue sarcoma
352501|NCT01440088|Metastatic Soft Tissue Sarcoma|metastatic soft tissue sarcoma
352502|NCT01440088|Sarcoma|sarcoma
352503|NCT01440088|Doxorubicin|doxorubicin
352504|NCT01440088|Evofosfamide|evofosfamide
352505|NCT01440075|Kawasaki disease|kawasaki disease
353112|NCT01437735|QAW039|qaw039
352506|NCT01440049|patients with MI- on top of treatment add Eplerenone - assess LVEF and BP|patients with mi- on top of treatment add eplerenone - assess lvef and bp
343146|NCT01478412|T1|t1
352507|NCT01440036|carotid artery|carotid artery
352508|NCT01440036|Atherosclerotic plaque|atherosclerotic plaque
352509|NCT01440036|paraoxygenase 1 PON1|paraoxygenase 1 pon1
352510|NCT01440036|Patients undergoing carotid artery endarterectomy CEA for carotid artery stenosis|patients undergoing carotid artery endarterectomy cea for carotid artery stenosis
352511|NCT01440023|tic disorder|tic disorder
352512|NCT01440023|tourette syndrome|tourette syndrome
352513|NCT01440023|habit reversal|habit reversal
352514|NCT01440023|response inhibition|response inhibition
352515|NCT01440023|cognitive retraining|cognitive retraining
352516|NCT01440010|IORT|iort
352517|NCT01440010|Boost|boost
352518|NCT01440010|Breast cancer|breast cancer
352519|NCT01440010|Local recurrence|local recurrence
352520|NCT01440010|Toxicity|toxicity
352521|NCT01440010|LENT SOMA|lent soma
352522|NCT01440010|TARGIT|targit
352523|NCT01440010|Quality Control Registry|quality control registry
352524|NCT01439997|Nocturnal polyuria|nocturnal polyuria
352525|NCT01439984|PE|pe
352526|NCT01439984|IELT|ielt
352527|NCT01439984|DCIT|dcit
352528|NCT01439971|Phase 1|phase 1
352529|NCT01439971|Safety|safety
352530|NCT01439971|Pharmacokinetic|pharmacokinetic
352531|NCT01439971|Pharmacodynamic|pharmacodynamic
352532|NCT01439958|Inhalation|inhalation
352533|NCT01439958|Lung Transplantation|lung transplantation
352534|NCT01439958|Cyclosporine|cyclosporine
352535|NCT01439945|hot flashes|hot flashes
352536|NCT01439945|cancer survivor|cancer survivor
352537|NCT01439945|breast cancer|breast cancer
352538|NCT01439932|plantar fasciitis|plantar fasciitis
352539|NCT01439932|heel pain|heel pain
352540|NCT01439932|manual treatment|manual treatment
352541|NCT01439932|dorsi flexion|dorsi flexion
352542|NCT01439906|Degenerative scoliosis|degenerative scoliosis
352543|NCT01439906|Pain|pain
352544|NCT01439906|Deformity correction|deformity correction
352545|NCT01439906|Instrumented arthrodesis|instrumented arthrodesis
352546|NCT01439893|Chronic heart failure|chronic heart failure
352547|NCT01439893|rhNRG-1|rhnrg-1
352548|NCT01439893|Cardiac remodeling|cardiac remodeling
352549|NCT01439880|High cholesterol|high cholesterol
352550|NCT01439880|Raised cholesterol|raised cholesterol
352551|NCT01439880|Cholesterol|cholesterol
352552|NCT01439880|Elevated Cholesterol|elevated cholesterol
352553|NCT01439867|Dialysis|dialysis
352554|NCT01439867|Sensipar|sensipar
352555|NCT01439867|Mimpara|mimpara
352556|NCT01439867|Hemodialysis|hemodialysis
352557|NCT01439867|Peritoneal Dialysis|peritoneal dialysis
352558|NCT01439867|Renal|renal
352559|NCT01439867|Parathyroid hormone|parathyroid hormone
352560|NCT01439867|Pediatric|pediatric
352561|NCT01439854|Insulin sensitivity|insulin sensitivity
352562|NCT01439854|Mitochondrial function|mitochondrial function
352563|NCT01439854|Glucose toxicity|glucose toxicity
352564|NCT01439854|Glucosuria|glucosuria
352565|NCT01439841|HIV|hiv
352566|NCT01439841|microbial translocation|microbial translocation
352567|NCT01439841|immune activation|immune activation
352568|NCT01439841|probiotics|probiotics
352569|NCT01439828|Cannabis|cannabis
352570|NCT01439828|N-Acetylcystein|n-acetylcystein
352571|NCT01439828|Dependence|dependence
352572|NCT01439828|Abuse|abuse
352573|NCT01439828|Craving|craving
352574|NCT01439828|Genetic|genetic
352575|NCT01439802|Postpartum IUD|postpartum iud
352576|NCT01439802|Cesarean Delivery|cesarean delivery
352577|NCT01439802|6 months postpartum|6 months postpartum
352578|NCT01439802|satisfaction|satisfaction
352579|NCT01439789|Chronic Heart Failure|chronic heart failure
352580|NCT01439789|rhNRG-1|rhnrg-1
352581|NCT01439789|NT-proBNP|nt-probnp
352582|NCT01439776|chronic hepatitis C|chronic hepatitis c
352584|NCT01439776|Vit D|vit d
352585|NCT01439776|Peginterferon alfa 2a|peginterferon alfa 2a
352586|NCT01439776|Ribavirin|ribavirin
352587|NCT01439763|Bullies|bullies
352588|NCT01439763|Bully victims|bully victims
352589|NCT01439763|Psychiatric symptoms|psychiatric symptoms
352590|NCT01439750|mantle cell lymphoma|mantle cell lymphoma
352591|NCT01439750|lymphoma|lymphoma
352592|NCT01439737|Asthma|asthma
352593|NCT01439737|metabolomics|metabolomics
352594|NCT01439737|exhaled breath condensate|exhaled breath condensate
352595|NCT01439724|Oral mucositis|oral mucositis
352596|NCT01439724|Low Level Laser Therapy|low level laser therapy
352597|NCT01439724|Head and neck cancer|head and neck cancer
352598|NCT01439711|ductal breast carcinoma in situ|ductal breast carcinoma in situ
352599|NCT01439711|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
352600|NCT01439698|Cholangiocarcinoma|cholangiocarcinoma
352601|NCT01439698|Pancreatic Cancer|pancreatic cancer
352602|NCT01439698|Bile Duct Cancer|bile duct cancer
352603|NCT01439698|Biliary Stricture|biliary stricture
352604|NCT01439698|Bile duct obstruction|bile duct obstruction
352605|NCT01439698|ENDOHPB|endohpb
352606|NCT01439698|Radio Frequency Ablation|radio frequency ablation
352607|NCT01439698|RFA|rfa
352608|NCT01439698|ERCP|ercp
403013|NCT01228578|Immune reconstitution|immune reconstitution
352609|NCT01439698|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
352610|NCT01439698|Registry|registry
352611|NCT01439698|Multicenter|multicenter
352612|NCT01439685|Cholangiocarcinoma|cholangiocarcinoma
352613|NCT01439685|PDT|pdt
352614|NCT01439685|Photodynamic Therapy|photodynamic therapy
352615|NCT01439685|Bile Duct|bile duct
352616|NCT01439685|Bile Duct Obstruction|bile duct obstruction
352617|NCT01439685|Jaundice|jaundice
352618|NCT01439685|Biliary Stent|biliary stent
352619|NCT01439685|ERCP|ercp
352620|NCT01439685|Obstructive Jaundice|obstructive jaundice
352621|NCT01439672|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
352622|NCT01439659|Ovarian Cancer|ovarian cancer
352623|NCT01439659|Epithelial ovarian cancer|epithelial ovarian cancer
352624|NCT01439659|First clinical remission|first clinical remission
352625|NCT01439659|Nutritional Supplements|nutritional supplements
352626|NCT01439659|Juice Plus +|juice plus +
352627|NCT01439659|Juice Plus + Complete|juice plus + complete
352628|NCT01439659|Dietary counseling|dietary counseling
352629|NCT01439646|empirical|empirical
352630|NCT01439646|ICU|icu
352631|NCT01439646|high risk patient|high risk patient
352632|NCT01439633|Barrett's Esophagus|barrett's esophagus
352633|NCT01439633|Esophagus|esophagus
352634|NCT01439633|OCT|oct
352635|NCT01439633|Imaging|imaging
352636|NCT01439620|Biliary Stricture|biliary stricture
352637|NCT01439620|OCT|oct
352638|NCT01439620|Imaging|imaging
352639|NCT01439607|Gaucher disease|gaucher disease
352640|NCT01439594|Barrett's Esophagus|barrett's esophagus
352641|NCT01439594|Esophagus|esophagus
352642|NCT01439594|OCT|oct
352643|NCT01439594|Imaging|imaging
352644|NCT01439594|Radiofrequency Ablation|radiofrequency ablation
352645|NCT01439594|BARRX|barrx
352646|NCT01439581|patients|patients
352647|NCT01439581|susceptible to|susceptible to
352649|NCT01439581|acquired pressure|acquired pressure
352650|NCT01439568|Cancer|cancer
352651|NCT01439568|Lung|lung
352652|NCT01439568|Metastasis|metastasis
352653|NCT01439555|Early Alzheimer|early alzheimer
352654|NCT01439555|Mild Cognitive Impairment|mild cognitive impairment
352655|NCT01439555|Drug treatment|drug treatment
352656|NCT01439555|Cerebral blood flow|cerebral blood flow
352657|NCT01439555|Endothelial facilitation|endothelial facilitation
352658|NCT01439555|Cognitive improvement|cognitive improvement
352659|NCT01439542|High risk prostate cancer|high risk prostate cancer
352660|NCT01439529|Cardiac|cardiac
352661|NCT01439529|Resynchronization|resynchronization
352662|NCT01439529|Therapy|therapy
352663|NCT01439477|exercise|exercise
352664|NCT01439477|healthy eating|healthy eating
352665|NCT01439477|heart disease|heart disease
352666|NCT01439477|prevention & control|prevention & control
352667|NCT01439477|Middle aged|middle aged
352668|NCT01439477|Women|women
352669|NCT01439477|Health promotion|health promotion
352670|NCT01439451|Balance control|balance control
352671|NCT01439451|Aging|aging
352672|NCT01439451|Balance reactions|balance reactions
352673|NCT01439451|Perturbation|perturbation
352674|NCT01439451|above seventy years old|above seventy years old
352675|NCT01439425|psoriasis|psoriasis
352676|NCT01439425|obesity|obesity
352677|NCT01439425|body mass index|body mass index
352678|NCT01439425|disease remission|disease remission
352679|NCT01439425|diet|diet
352680|NCT01439412|Low back pain|low back pain
352681|NCT01439412|Acupuncture|acupuncture
352682|NCT01439412|General practice|general practice
352683|NCT01439399|postoperative pain|postoperative pain
352684|NCT01439399|postoperative care|postoperative care
352685|NCT01439399|intravenous lidocaine|intravenous lidocaine
352686|NCT01439399|intravenous ketamine|intravenous ketamine
352687|NCT01439399|morphine consumption|morphine consumption
352688|NCT01439373|chronic hepatitis C|chronic hepatitis c
352689|NCT01439373|NS5A inhibitor|ns5a inhibitor
352690|NCT01439373|ribavirin|ribavirin
352691|NCT01439373|pegylated interferon|pegylated interferon
352692|NCT01439373|GSK2336805|gsk2336805
352693|NCT01439360|Vaccine|vaccine
352694|NCT01439360|Seasonal Flu|seasonal flu
352695|NCT01439360|Efficacy|efficacy
352696|NCT01439360|Children|children
352697|NCT01439347|Marqibo|marqibo
352698|NCT01439347|HALLMARQ|hallmarq
352699|NCT01439347|leukemia|leukemia
352700|NCT01439347|front-line|front-line
352701|NCT01439347|ALL|all
352702|NCT01439347|acute lymphoblastic leukemia|acute lymphoblastic leukemia
352704|NCT01439334|Online|online
352705|NCT01439334|Image|image
352706|NCT01439334|Interactive|interactive
352707|NCT01439334|Young Adult|young adult
352708|NCT01439334|Primary Care|primary care
352709|NCT01439321|treatment satisfaction|treatment satisfaction
352710|NCT01439321|romiplostim|romiplostim
352711|NCT01439321|eltrombopag|eltrombopag
352712|NCT01439321|chronic immune thrombocytopenic pupura|chronic immune thrombocytopenic pupura
352713|NCT01439308|NAR|nar
352714|NCT01439308|Capsaicin challenge|capsaicin challenge
352715|NCT01439295|Ascorbyl peroxide|ascorbyl peroxide
352716|NCT01439295|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
352717|NCT01439295|Redox status|redox status
352718|NCT01439295|Necrotising entercolitis|necrotising entercolitis
352719|NCT01439295|Retinopathy of prematurity|retinopathy of prematurity
352720|NCT01439295|Patent ductus arteriosus|patent ductus arteriosus
352721|NCT01439295|Intraventricular hemorrhage|intraventricular hemorrhage
352722|NCT01439295|Periventricular leucomalacia|periventricular leucomalacia
352723|NCT01439282|Estrogen Receptor-Positive Early Stage Breast Cancer|estrogen receptor-positive early stage breast cancer
352724|NCT01439269|Separation stress|separation stress
352725|NCT01439269|Family Nurture|family nurture
352726|NCT01439269|Maternal Confidence|maternal confidence
352727|NCT01439269|Maternal Competence|maternal competence
352728|NCT01439269|Calming Cycle|calming cycle
352729|NCT01439269|Kangaroo Care|kangaroo care
352730|NCT01439269|Infant Neurodevelopment|infant neurodevelopment
352731|NCT01439269|Infant Psychological Development|infant psychological development
352732|NCT01439269|Post-partum depression|post-partum depression
352733|NCT01439269|Mother-infant Co-regulation|mother-infant co-regulation
352734|NCT01439243|Bioequivalence|bioequivalence
352735|NCT01439243|Healthy Subjects|healthy subjects
352736|NCT01439243|Donepezil|donepezil
352737|NCT01439230|Bioequivalence|bioequivalence
352738|NCT01439230|Healthy Subjects|healthy subjects
352739|NCT01439230|Donepezil|donepezil
352740|NCT01439217|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
352741|NCT01439217|Survivor|survivor
352742|NCT01439217|Sibling control|sibling control
352743|NCT01439191|HER2-Overexpressed|her2-overexpressed
352744|NCT01439165|Adacel vaccine|adacel vaccine
352745|NCT01439165|Tetanus|tetanus
352746|NCT01439165|Diphtheria|diphtheria
352747|NCT01439165|whooping cough|whooping cough
352748|NCT01439152|Oncology|oncology
352749|NCT01439152|solid tumors|solid tumors
352750|NCT01439152|Antibody drug conjugate|antibody drug conjugate
352751|NCT01439152|Maximum tolerable dose|maximum tolerable dose
352753|NCT01439139|Osteoporosis|osteoporosis
352754|NCT01439139|ultrasound|ultrasound
352755|NCT01439139|sonometer|sonometer
352756|NCT01439139|DXA|dxa
352757|NCT01439126|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
352758|NCT01439113|Ultrasound, Difficult access|ultrasound, difficult access
352759|NCT01439100|Parkinson's disease|parkinson's disease
352760|NCT01439100|severe pain|severe pain
352761|NCT01439100|OXN PR|oxn pr
352762|NCT01439100|randomised|randomised
352763|NCT01439087|Colonic Polyps|colonic polyps
352764|NCT01439087|OCT|oct
352765|NCT01439087|Imaging|imaging
352766|NCT01439087|Colon|colon
352767|NCT01439087|Polyp|polyp
352768|NCT01439074|Burn injuries|burn injuries
352769|NCT01439074|Mepilex Ag|mepilex ag
352770|NCT01439074|SSD Ag|ssd ag
352771|NCT01439074|Partial thickness|partial thickness
352772|NCT01439061|Growth disorders|growth disorders
352773|NCT01439061|Saizen|saizen
352774|NCT01439061|Easypod|easypod
352775|NCT01439061|Growth hormone|growth hormone
352776|NCT01439061|Pediatric subject|pediatric subject
352777|NCT01439048|Placenta|placenta
352778|NCT01439048|Cord Blood|cord blood
352779|NCT01439048|PAH|pah
352780|NCT01439048|Environmental Markers|environmental markers
352781|NCT01439048|Toll-Like Receptors|toll-like receptors
352782|NCT01439035|Celiac Disease|celiac disease
352783|NCT01439035|Duodenal|duodenal
352784|NCT01439035|OCT|oct
352785|NCT01439035|Imaging|imaging
352786|NCT01439022|Parkinson's Disease|parkinson's disease
352787|NCT01439022|Exercise|exercise
352788|NCT01439022|Treatment Outcome|treatment outcome
352789|NCT01439022|Patient Adherence|patient adherence
352790|NCT01439009|Heart failure|heart failure
352791|NCT01439009|Volume overload|volume overload
352792|NCT01439009|Tolvaptan|tolvaptan
352793|NCT01439009|loop diuretics|loop diuretics
352794|NCT01438996|Typhoid fever|typhoid fever
352795|NCT01438996|Glycoconjugate vaccine|glycoconjugate vaccine
352796|NCT01438996|Vi polysaccharide|vi polysaccharide
352797|NCT01438996|Immunogenicity|immunogenicity
352798|NCT01438957|Dexmedetomidine|dexmedetomidine
352799|NCT01438957|Sedation|sedation
352800|NCT01438957|Non-intubation|non-intubation
352801|NCT01438957|epidural anesthesia|epidural anesthesia
352802|NCT01438957|spinal anesthesia|spinal anesthesia
352804|NCT01438944|Patch|patch
352805|NCT01438944|smoking|smoking
352806|NCT01438944|addiction|addiction
352807|NCT01438931|Dexmedetomidine|dexmedetomidine
352808|NCT01438931|Sedation|sedation
352809|NCT01438931|Non-intubation|non-intubation
352810|NCT01438931|local anesthesia|local anesthesia
352811|NCT01438918|Knee|knee
352812|NCT01438918|Osteoarthritis|osteoarthritis
352813|NCT01438918|X-ray|x-ray
352814|NCT01438918|Joint Space Narrowing|joint space narrowing
352815|NCT01438905|Ankle Sprain|ankle sprain
352816|NCT01438905|Chronic Ankle Instability|chronic ankle instability
352817|NCT01438905|Ankle Mobilization|ankle mobilization
352818|NCT01438905|Talocrural Joint Mobilization|talocrural joint mobilization
352819|NCT01438905|Cortical Muscle Activation|cortical muscle activation
352820|NCT01438905|Spinal Muscle Activation|spinal muscle activation
352821|NCT01438892|rheumatoid arthritis|rheumatoid arthritis
352822|NCT01438892|therapy compliance|therapy compliance
352823|NCT01438879|CSF|csf
352824|NCT01438879|PCR|pcr
352825|NCT01438879|lymphocytic herpesvirus|lymphocytic herpesvirus
352826|NCT01438879|CNS|cns
352827|NCT01438866|Dental caries|dental caries
352828|NCT01438866|Fissure sealant|fissure sealant
352829|NCT01438866|Fluoride varnish|fluoride varnish
352830|NCT01438866|Primary molar|primary molar
352831|NCT01438853|Sepsis|sepsis
352832|NCT01438853|Acute Lung Injury|acute lung injury
352833|NCT01438853|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
352834|NCT01438853|ALI/ARDS|ali/ards
352835|NCT01438853|Lung Disease|lung disease
352836|NCT01438840|Chronic Immune Thrombocytopenia|chronic immune thrombocytopenia
352837|NCT01438788|Bethlem myopathy|bethlem myopathy
352838|NCT01438788|Ullrich congenital muscular dystrophy|ullrich congenital muscular dystrophy
352839|NCT01438788|Low protein diet|low protein diet
352840|NCT01438788|Autophagy|autophagy
352841|NCT01438788|Pilot clinical trial|pilot clinical trial
352842|NCT01438775|Benign prostatic hyperplasia|benign prostatic hyperplasia
352843|NCT01438775|BPH|bph
352844|NCT01438775|Enlarged prostate|enlarged prostate
352845|NCT01438775|Lower urinary tract symptoms|lower urinary tract symptoms
352846|NCT01438775|LUTS|luts
352847|NCT01438775|LUTS secondary to BPH|luts secondary to bph
352848|NCT01438775|LUTS/BPH|luts/bph
352849|NCT01438775|Benign prostatic obstruction|benign prostatic obstruction
352850|NCT01438775|BPO|bpo
352851|NCT01438775|Bladder outlet obstruction|bladder outlet obstruction
352852|NCT01438775|BOO|boo
352853|NCT01438762|Anterior Knee Pain|anterior knee pain
352854|NCT01438736|Focus:|focus:
352855|NCT01438736|preceding|preceding
352857|NCT01438736|pattern of following|pattern of following
352858|NCT01438736|etonogestrel implant|etonogestrel implant
352859|NCT01438723|ischemia reperfusion injury|ischemia reperfusion injury
352860|NCT01438723|CABG|cabg
352861|NCT01438723|metformin|metformin
352862|NCT01438723|Hs-troponin-I|hs-troponin-i
352863|NCT01438697|sleep|sleep
352864|NCT01438697|insomnia|insomnia
352865|NCT01438697|internet|internet
352866|NCT01438697|CBT|cbt
352867|NCT01438684|chronic vegetative state|chronic vegetative state
352868|NCT01438684|functional MRI|functional mri
352869|NCT01438671|WiiFit|wiifit
352870|NCT01438671|Standing Balance|standing balance
352871|NCT01438671|Neurological Population|neurological population
352872|NCT01438658|uveal melanoma|uveal melanoma
352873|NCT01438658|metastatic uveal melanoma|metastatic uveal melanoma
352874|NCT01438645|Colonoscopy|colonoscopy
352875|NCT01438645|Colon cancer screening|colon cancer screening
352876|NCT01438632|Insulin action|insulin action
352877|NCT01438632|Jet injector|jet injector
352878|NCT01438632|Diabetes Mellitus|diabetes mellitus
352879|NCT01438632|Pharmacodynamics|pharmacodynamics
352880|NCT01438632|Pharmacokinetics|pharmacokinetics
352881|NCT01438632|Insulin analogs|insulin analogs
352882|NCT01438632|Insulin aspart|insulin aspart
352883|NCT01438619|sodium|sodium
352884|NCT01438619|blood pressure|blood pressure
352885|NCT01438619|pulse wave velocity|pulse wave velocity
352886|NCT01438619|random digit dialling|random digit dialling
352887|NCT01438593|Stroke|stroke
352888|NCT01438593|Brain disease|brain disease
352889|NCT01438593|Ischemia|ischemia
352890|NCT01438593|Cerebral infraction|cerebral infraction
352891|NCT01438593|Cord Blood|cord blood
352892|NCT01438580|atrial ﬁbrillation|atrial ﬁbrillation
352893|NCT01438580|stroke|stroke
352894|NCT01438580|warfarin|warfarin
352895|NCT01438580|aspirin|aspirin
352896|NCT01438567|oxycodone naloxone combination|oxycodone naloxone combination
352897|NCT01438567|severe chronic and non-malignant pain|severe chronic and non-malignant pain
352898|NCT01438567|Malignant and non-malignant pain that requires around-the clock opioid therapy|malignant and non-malignant pain that requires around-the clock opioid therapy
352899|NCT01438567|Opioid related constipation|opioid related constipation
352900|NCT01438541|No skin breakdown|no skin breakdown
352901|NCT01438541|Prevention|prevention
352902|NCT01438541|protection of the skin|protection of the skin
352903|NCT01438528|Growth disorders|growth disorders
352904|NCT01438528|Saizen|saizen
352905|NCT01438528|Easypod|easypod
352906|NCT01438528|Growth hormone|growth hormone
352907|NCT01438528|Pediatric subject|pediatric subject
352908|NCT01438515|MRSA|mrsa
352909|NCT01438515|doxycycline|doxycycline
352910|NCT01438515|rifampin|rifampin
352911|NCT01438515|mupirocin|mupirocin
352912|NCT01438515|chlorhexidine gluconate|chlorhexidine gluconate
352913|NCT01438515|decolonization|decolonization
352914|NCT01438515|methicillin-resistant staphylococcus aureus|methicillin-resistant staphylococcus aureus
352915|NCT01438502|cardiac surgery|cardiac surgery
352916|NCT01438502|cardio-pulmonary-bypass|cardio-pulmonary-bypass
352917|NCT01438489|MEDI-546|medi-546
352918|NCT01438489|Anifrolumab|anifrolumab
352919|NCT01438489|Systemic Lupus Erythematosus|systemic lupus erythematosus
353113|NCT01437722|BV|bv
352920|NCT01438476|Liver Cancer|liver cancer
352921|NCT01438476|Pancreatic Cancer|pancreatic cancer
352922|NCT01438476|Thoracic epidural analgesia|thoracic epidural analgesia
352923|NCT01438476|TEA|tea
352924|NCT01438476|Intravenous patient-controlled analgesia|intravenous patient-controlled analgesia
352925|NCT01438476|IVPCA|ivpca
352926|NCT01438476|Pain control|pain control
352927|NCT01438476|Quality of life|quality of life
352928|NCT01438476|QOL|qol
352929|NCT01438476|Surgical resection|surgical resection
352930|NCT01438463|non-seasonal allergy|non-seasonal allergy
352931|NCT01438463|house dust mite|house dust mite
352932|NCT01438463|immunotherapy|immunotherapy
352933|NCT01438463|dose response|dose response
352934|NCT01438450|Thalidomide|thalidomide
352935|NCT01438450|Capecitabine|capecitabine
352936|NCT01438450|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
352937|NCT01438450|Therapy|therapy
352938|NCT01438450|Supportive care|supportive care
352939|NCT01438437|Hepatocellular carcinoma|hepatocellular carcinoma
352940|NCT01438437|Radiofrequency ablation|radiofrequency ablation
352941|NCT01438437|Percutaneous acetic acid ablation|percutaneous acetic acid ablation
352942|NCT01438437|Tumour response|tumour response
352943|NCT01438411|Cholic Acid|cholic acid
352944|NCT01438411|Inborn Error|inborn error
352945|NCT01438411|Bile Acid Metabolism|bile acid metabolism
352946|NCT01438411|Inborn Error of Bile Acid Synthesis|inborn error of bile acid synthesis
352947|NCT01438398|Submucosal endoscopic myotomy|submucosal endoscopic myotomy
352948|NCT01438398|Per Oral Endoscopic Myotomy|per oral endoscopic myotomy
352949|NCT01438398|Natural Orifice Transluminal Endoscopic Surgery|natural orifice transluminal endoscopic surgery
352950|NCT01438385|Pancreatico-biliary|pancreatico-biliary
352951|NCT01438385|Biliary|biliary
352952|NCT01438385|Bile Duct|bile duct
352953|NCT01438385|Gastrointestinal disorder|gastrointestinal disorder
352954|NCT01438385|Esophageal disorder|esophageal disorder
352955|NCT01438372|Iron Deficiency Anemia|iron deficiency anemia
352956|NCT01438372|Inflammatory Bowel Disease|inflammatory bowel disease
352957|NCT01438372|Children|children
352958|NCT01438359|Drug-drug interaction|drug-drug interaction
352959|NCT01438359|Pharmacokinetics|pharmacokinetics
352960|NCT01438359|PA21|pa21
352961|NCT01438359|Drug Interaction Potentiation|drug interaction potentiation
352962|NCT01438346|Substance Abuse|substance abuse
352963|NCT01438346|Substance Addiction|substance addiction
352964|NCT01438346|Substance Dependence|substance dependence
352965|NCT01438346|Treatment program|treatment program
352966|NCT01438333|Chronic Peridodontitis|chronic peridodontitis
352967|NCT01438333|probiotics|probiotics
352968|NCT01438333|lactobacillus brevis|lactobacillus brevis
352969|NCT01438333|full mouth disinfection|full mouth disinfection
352970|NCT01438320|Treatment naive|treatment naive
352971|NCT01438320|Contraindications to standard therapies|contraindications to standard therapies
352972|NCT01438320|Alternative hepatitis C therapy|alternative hepatitis c therapy
352973|NCT01438307|Non-small cell lung cancer|non-small cell lung cancer
352974|NCT01438307|Cabazitaxel-XRP6258|cabazitaxel-xrp6258
352975|NCT01438307|P-glycoprotein|p-glycoprotein
352976|NCT01438307|taxane|taxane
352977|NCT01438307|Advanced NSCLC|advanced nsclc
352978|NCT01438294|Asthma|asthma
352979|NCT01438294|childhood|childhood
352980|NCT01438294|exercise|exercise
352981|NCT01438281|ocular pain|ocular pain
352982|NCT01438281|dry eye|dry eye
352983|NCT01438281|siRNA|sirna
352984|NCT01438242|Major|major
352985|NCT01438242|Depressive|depressive
352986|NCT01438242|Disorder|disorder
352987|NCT01438242|Depression|depression
352988|NCT01438242|Treatment Resistant|treatment resistant
352989|NCT01438229|Catheter-based renal artery ablation|catheter-based renal artery ablation
352990|NCT01438229|Hypertension|hypertension
352991|NCT01438229|Resistant to Conventional Therapy|resistant to conventional therapy
352992|NCT01438216|Pharmacokinetics|pharmacokinetics
352993|NCT01438216|Intensive Care|intensive care
352994|NCT01438216|Candidemia|candidemia
352995|NCT01438216|Invasive candidiasis|invasive candidiasis
352996|NCT01438216|Anidulafungin|anidulafungin
352997|NCT01438203|manipulation|manipulation
352998|NCT01438203|mobilization|mobilization
352999|NCT01438203|low back pain|low back pain
353000|NCT01438203|treatment|treatment
353001|NCT01438177|myeloma|myeloma
353002|NCT01438177|multiple myeloma|multiple myeloma
353003|NCT01438177|relapsed myeloma|relapsed myeloma
353004|NCT01438177|refractory myeloma|refractory myeloma
353005|NCT01438164|FDG-PET|fdg-pet
353006|NCT01438164|cancer|cancer
353007|NCT01438164|staging|staging
353008|NCT01438164|Evaluate the cost impact in the evaluation of oncologic patients.|evaluate the cost impact in the evaluation of oncologic patients.
353009|NCT01438151|Crohn's disease|crohn's disease
353010|NCT01438151|Remicade|remicade
353011|NCT01438151|infliximab|infliximab
353012|NCT01438138|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
353013|NCT01438138|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
353014|NCT01438138|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
353114|NCT01437722|Bacterial vaginosis|bacterial vaginosis
353015|NCT01438138|childhood acute basophilic leukemia|childhood acute basophilic leukemia
353016|NCT01438138|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
353017|NCT01438138|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
353018|NCT01438138|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
353019|NCT01438138|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
353020|NCT01438138|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
353021|NCT01438138|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
353022|NCT01438138|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
353023|NCT01438138|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
353024|NCT01438138|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
353025|NCT01438112|cancer|cancer
353026|NCT01438112|bladder cancer|bladder cancer
353027|NCT01438112|transitional cell|transitional cell
353028|NCT01438112|virus|virus
353029|NCT01438112|oncolytic|oncolytic
353030|NCT01438112|GM-CSF|gm-csf
353031|NCT01438112|adenovirus|adenovirus
353032|NCT01438112|intravesical|intravesical
353033|NCT01438112|neoadjuvant|neoadjuvant
353034|NCT01438112|cystectomy|cystectomy
353035|NCT01438112|gene therapy|gene therapy
353036|NCT01438112|oncolytic virus|oncolytic virus
353037|NCT01438112|carcinoma in situ|carcinoma in situ
353165|NCT01437514|rectal cancer|rectal cancer
353038|NCT01438112|carcinoma in situ concurrent with papillary tumors|carcinoma in situ concurrent with papillary tumors
353039|NCT01438099|epidural analgesia|epidural analgesia
353040|NCT01438099|ultrasound|ultrasound
353041|NCT01438099|labor analgesia|labor analgesia
353042|NCT01438099|labor|labor
353043|NCT01438086|Heart Failure|heart failure
353044|NCT01438086|Myocardial Infarction|myocardial infarction
353045|NCT01438047|Port Wine Stain|port wine stain
353046|NCT01438021|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
353047|NCT01438008|Sucrose|sucrose
353048|NCT01438008|Pain|pain
353049|NCT01437995|Asthma|asthma
353050|NCT01437995|Step down therapy|step down therapy
353051|NCT01437995|Inhaled corticosteroids|inhaled corticosteroids
353052|NCT01437995|Long-acting beta agonists|long-acting beta agonists
353053|NCT01437995|Fluticasone Salmeterol|fluticasone salmeterol
353054|NCT01437982|post-operative inflammation|post-operative inflammation
353055|NCT01437982|conjunctivitis|conjunctivitis
353056|NCT01437982|safety|safety
353057|NCT01437982|Seasonal allergic conjunctivitis|seasonal allergic conjunctivitis
353058|NCT01437982|Giant papillary conjunctivitis|giant papillary conjunctivitis
353059|NCT01437969|Possible association|possible association
353060|NCT01437969|between severity|between severity
353061|NCT01437969|IL28B genetic variants|il28b genetic variants
353062|NCT01437969|patients|patients
353063|NCT01437969|different HCV genotypes|different hcv genotypes
353064|NCT01437956|Calcineurin|calcineurin
353065|NCT01437956|Bronchiolitis|bronchiolitis
353066|NCT01437956|Epithelial lung injury|epithelial lung injury
353067|NCT01437956|Rhinovirus|rhinovirus
353068|NCT01437956|Respiratory Syncytial Virus|respiratory syncytial virus
353069|NCT01437956|Asthma|asthma
353070|NCT01437943|Transplant|transplant
353071|NCT01437943|Failure|failure
353072|NCT01437943|Kidney|kidney
353073|NCT01437930|n-3 LC-PUFA|n-3 lc-pufa
353074|NCT01437930|hypertriglyceridemic|hypertriglyceridemic
353075|NCT01437930|human|human
353076|NCT01437930|TAG|tag
353077|NCT01437917|glycemic index|glycemic index
353078|NCT01437904|Renal Calculi|renal calculi
353079|NCT01437904|Percutaneous nephrolithotomy (PCNL)|percutaneous nephrolithotomy (pcnl)
353080|NCT01437891|PTSD|ptsd
353081|NCT01437891|Military veteran|military veteran
353082|NCT01437891|Gulf War|gulf war
353083|NCT01437891|Fibromyalgia|fibromyalgia
353084|NCT01437891|Gulf War Syndrome|gulf war syndrome
353085|NCT01437878|PH|ph
353086|NCT01437878|COPD|copd
353087|NCT01437865|MRI|mri
353088|NCT01437865|lymph node metastases|lymph node metastases
353089|NCT01437865|breast cancer|breast cancer
353090|NCT01437865|gadofosveset|gadofosveset
353091|NCT01437839|Food effect study|food effect study
353092|NCT01437839|Pharmacokinetics|pharmacokinetics
353093|NCT01437839|Apixaban|apixaban
353094|NCT01437826|chemoprevention|chemoprevention
353095|NCT01437826|colorectal cancer|colorectal cancer
353096|NCT01437826|metachronous adenoma|metachronous adenoma
353097|NCT01437826|randomized trial|randomized trial
353098|NCT01437813|DM2|dm2
353099|NCT01437813|glimepiride|glimepiride
353100|NCT01437813|metformin extended release|metformin extended release
353101|NCT01437800|DM2|dm2
353102|NCT01437800|glimepiride|glimepiride
353103|NCT01437800|metformin extended release|metformin extended release
353104|NCT01437774|Acute ischemic stroke|acute ischemic stroke
353105|NCT01437748|Small Airways|small airways
353106|NCT01437748|Closing volume|closing volume
353107|NCT01437748|Closing Capacity|closing capacity
353108|NCT01437748|Tiotropium|tiotropium
353109|NCT01437748|Indacaterol|indacaterol
353115|NCT01437722|recurrent|recurrent
353116|NCT01437722|SPL7013 Gel|spl7013 gel
353117|NCT01437722|VivaGel|vivagel
403014|NCT01228578|Weight Gain|weight gain
353118|NCT01437709|Bendamustine HCL|bendamustine hcl
353119|NCT01437709|Ofatumumab (GSK 1841157)|ofatumumab (gsk 1841157)
353120|NCT01437709|Immunotherapy|immunotherapy
353121|NCT01437709|Chemoimmunotherapy|chemoimmunotherapy
353122|NCT01437709|11-050|11-050
353123|NCT01437696|Aging|aging
353124|NCT01437696|Vitamin D|vitamin d
353125|NCT01437696|Bone health|bone health
353126|NCT01437696|Inflammation|inflammation
353127|NCT01437696|Men|men
353128|NCT01437683|Craniocerebral Trauma|craniocerebral trauma
353129|NCT01437683|Quality of life|quality of life
353130|NCT01437683|Long term outcome|long term outcome
353131|NCT01437683|Activities of Daily Living|activities of daily living
353132|NCT01437683|Cognitive Deficiency|cognitive deficiency
353133|NCT01437683|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
353134|NCT01437644|Cerebral Palsy|cerebral palsy
353135|NCT01437644|Hip displacement|hip displacement
353136|NCT01437644|Hip surgery|hip surgery
353137|NCT01437644|Post-operative pain|post-operative pain
353138|NCT01437644|Botulinum Toxin|botulinum toxin
353139|NCT01437631|colon polyp|colon polyp
353140|NCT01437631|endoscopic polypectomy|endoscopic polypectomy
353141|NCT01437631|postpolypectomy bleeding|postpolypectomy bleeding
353142|NCT01437631|prophylactic clip application|prophylactic clip application
353143|NCT01437605|Resected|resected
353144|NCT01437605|Skin|skin
353145|NCT01437605|Stage IV|stage iv
353146|NCT01437579|interstitial cystitis|interstitial cystitis
353147|NCT01437579|bladder pain syndrome|bladder pain syndrome
353148|NCT01437579|intratrigonal injection|intratrigonal injection
353149|NCT01437579|botulinum toxin|botulinum toxin
353150|NCT01437553|IVUS|ivus
353151|NCT01437553|iMAP|imap
353152|NCT01437553|Catheterization|catheterization
353153|NCT01437553|Acute Coronary Syndrome|acute coronary syndrome
353154|NCT01437540|COPD|copd
353155|NCT01437540|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
353156|NCT01437540|Chronic Bronchitis|chronic bronchitis
353157|NCT01437540|Emphysema|emphysema
353158|NCT01437540|Airflow Obstruction, Chronic|airflow obstruction, chronic
353159|NCT01437540|Chronic Airflow Obstruction|chronic airflow obstruction
353160|NCT01437540|Chronic Obstructive Airway Disease|chronic obstructive airway disease
353161|NCT01437540|Chronic Obstructive Lung Disease|chronic obstructive lung disease
353162|NCT01437527|anorexia nervosa|anorexia nervosa
353163|NCT01437527|CMME-TCA Unit|cmme-tca unit
353164|NCT01437527|Centre Hospitalier Sainte Anne|centre hospitalier sainte anne
353166|NCT01437514|Endosonography|endosonography
353167|NCT01437514|preoperative short-course radiotherapy|preoperative short-course radiotherapy
353168|NCT01437514|preoperative adjuvant therapy|preoperative adjuvant therapy
353169|NCT01437514|neoadjuvant therapy|neoadjuvant therapy
353170|NCT01437514|short-term high-dose preoperative radiotherapy|short-term high-dose preoperative radiotherapy
353171|NCT01437514|total mesorectal excision|total mesorectal excision
353172|NCT01437514|circumferential resection margin|circumferential resection margin
353173|NCT01437514|local recurrence|local recurrence
353174|NCT01437514|overall survival|overall survival
353175|NCT01437514|metastasis|metastasis
353176|NCT01437514|complication|complication
353177|NCT01437501|glucoraphanin|glucoraphanin
353178|NCT01437501|sulforaphane|sulforaphane
353179|NCT01437501|pharmacokinetics|pharmacokinetics
353180|NCT01437501|pharmacodynamics|pharmacodynamics
353181|NCT01437501|broccoli sprout|broccoli sprout
353182|NCT01437501|carcinogens, environment|carcinogens, environment
353183|NCT01437488|Urothelial carcinoma|urothelial carcinoma
353184|NCT01437488|Urothelial cancer|urothelial cancer
353187|NCT01437475|Immunization|immunization
353188|NCT01437475|HBV Immunization rate among HIV positive individuals|hbv immunization rate among hiv positive individuals
353189|NCT01437462|Pain, Postoperative|pain, postoperative
353190|NCT01437462|Anesthetics, intravenous|anesthetics, intravenous
353191|NCT01437462|Anesthetics, inhalation|anesthetics, inhalation
353192|NCT01437462|Otherwise healthy adults undergoing general anesthesia for gynecological disease.|otherwise healthy adults undergoing general anesthesia for gynecological disease.
353193|NCT01437449|Quality of Life|quality of life
353194|NCT01437436|otitis media|otitis media
353195|NCT01437436|obesity|obesity
353196|NCT01437436|ventilation tube|ventilation tube
353197|NCT01437423|Diphtheria|diphtheria
353198|NCT01437423|Tetanus|tetanus
353199|NCT01437423|Pertussis|pertussis
353200|NCT01437423|Poliomyelitis|poliomyelitis
353201|NCT01437423|TETRAXIM™|tetraxim™
353202|NCT01437397|COPD|copd
353203|NCT01437397|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
353204|NCT01437397|Chronic Bronchitis|chronic bronchitis
353205|NCT01437397|Emphysema|emphysema
353206|NCT01437397|Airflow Obstruction, Chronic|airflow obstruction, chronic
353207|NCT01437397|Chronic Airflow Obstruction|chronic airflow obstruction
353208|NCT01437397|Chronic Obstructive Airway Disease|chronic obstructive airway disease
353209|NCT01437397|Chronic Obstructive Lung Disease|chronic obstructive lung disease
353210|NCT01437371|Heart failure|heart failure
353211|NCT01437371|Aged and over 80|aged and over 80
353212|NCT01437371|clinical trial|clinical trial
353213|NCT01437371|quality of life|quality of life
353214|NCT01437358|Epidural catheter|epidural catheter
353215|NCT01437358|Epidural analgesia|epidural analgesia
353216|NCT01437358|Intensive care unit|intensive care unit
353217|NCT01437358|Safety|safety
353218|NCT01437306|lofexidine|lofexidine
353219|NCT01437306|food effect|food effect
353220|NCT01437306|pharmacokinetics|pharmacokinetics
353221|NCT01437306|healthy volunteer|healthy volunteer
353222|NCT01437293|cocaine|cocaine
353223|NCT01437280|Tumors|tumors
353224|NCT01437280|Solid Tumors|solid tumors
353225|NCT01437254|99mTc Pertechnetate|99mtc pertechnetate
353226|NCT01437254|thyroidectomy|thyroidectomy
353227|NCT01437241|HIV-infection|hiv-infection
353228|NCT01437241|Etravirine|etravirine
353229|NCT01437241|Treatment|treatment
353230|NCT01437241|Non-nucleoside reverse-transcriptase inhibitor|non-nucleoside reverse-transcriptase inhibitor
353231|NCT01437215|aneurysm|aneurysm
353232|NCT01437215|renal stent|renal stent
353233|NCT01437215|juxtarenal|juxtarenal
353234|NCT01437215|pararenal|pararenal
353235|NCT01437202|imatinib|imatinib
353236|NCT01437202|drug resistance|drug resistance
353237|NCT01437202|pharmacogenetics|pharmacogenetics
353238|NCT01437189|Parkinson's disease|parkinson's disease
353239|NCT01437189|depression|depression
353240|NCT01437189|sertraline|sertraline
353241|NCT01437189|intervention|intervention
353242|NCT01437176|surgery|surgery
353243|NCT01437176|fixation|fixation
353244|NCT01437176|intramedullary nail|intramedullary nail
353245|NCT01437150|surgery|surgery
353246|NCT01437150|fixation|fixation
353247|NCT01437150|bone plate|bone plate
353248|NCT01437137|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway
353249|NCT01437111|Osteoporosis|osteoporosis
353250|NCT01437111|Postmenopausal|postmenopausal
353251|NCT01437098|Valvular Heart Disease|valvular heart disease
353252|NCT01437098|Severe Aortic Stenosis|severe aortic stenosis
353253|NCT01437098|Aortic Valve Replacement|aortic valve replacement
353254|NCT01437085|Needle deflection|needle deflection
353255|NCT01437085|Prostate Deformation|prostate deformation
353256|NCT01437085|Prostate Brachytherapy|prostate brachytherapy
353258|NCT01437046|Alcohol drinking|alcohol drinking
353259|NCT01437046|Alcohol craving|alcohol craving
353260|NCT01437033|Breath Tests|breath tests
353261|NCT01437033|Human Volunteers|human volunteers
353262|NCT01437033|Pilot Study|pilot study
353263|NCT01437033|Breath Test|breath test
353264|NCT01437020|IL-10|il-10
353265|NCT01437020|Leishmaniasis|leishmaniasis
353266|NCT01437020|Immunotherapy|immunotherapy
353267|NCT01437007|SNALP|snalp
353268|NCT01437007|Regional Therapy|regional therapy
353269|NCT01437007|Stage IV Disease|stage iv disease
353270|NCT01437007|Adenocarcinoma|adenocarcinoma
353271|NCT01437007|Unresectable|unresectable
353272|NCT01437007|Liver Metastases|liver metastases
353273|NCT01437007|Colorectal Cancer|colorectal cancer
353274|NCT01437007|Stomach Cancer|stomach cancer
353275|NCT01437007|Gastric Cancer|gastric cancer
353276|NCT01437007|Breast Cancer|breast cancer
353277|NCT01437007|Ovarian Cancer|ovarian cancer
353278|NCT01437007|Pancreatic Cancer|pancreatic cancer
353279|NCT01437007|Liver Cancer|liver cancer
353280|NCT01436994|thyrotoxic|thyrotoxic
353281|NCT01436994|thyrotoxicosis|thyrotoxicosis
353282|NCT01436994|paediatric|paediatric
353283|NCT01436994|endocrinology|endocrinology
353284|NCT01436994|block and replace|block and replace
353285|NCT01436994|dose titration|dose titration
353286|NCT01436994|carbimazole|carbimazole
353287|NCT01436981|papaverine|papaverine
353288|NCT01436981|pharmacokinetic|pharmacokinetic
353289|NCT01436981|CABG|cabg
353290|NCT01436981|Injury of Internal Mammary Artery|injury of internal mammary artery
353291|NCT01436981|Complications Due to Coronary Artery Bypass Graft|complications due to coronary artery bypass graft
353292|NCT01436968|immunotherapy, cytotoxicity, tumor vaccine, prostate cancer, radiotherapy|immunotherapy, cytotoxicity, tumor vaccine, prostate cancer, radiotherapy
353293|NCT01436929|silymarin|silymarin
353294|NCT01436929|hepatotoxicity|hepatotoxicity
353295|NCT01436929|tuberculosis|tuberculosis
353296|NCT01436929|HREZ|hrez
353297|NCT01436916|prediabetes|prediabetes
353298|NCT01436916|oral cholecalciferol|oral cholecalciferol
353299|NCT01436903|menorrhagia|menorrhagia
353300|NCT01436903|dysfunctional uterine bleeding|dysfunctional uterine bleeding
353301|NCT01436903|endometrial ablation|endometrial ablation
353302|NCT01436903|cavatermTM|cavatermtm
353303|NCT01436903|probe|probe
353304|NCT01436890|Chronic Persistent Asthma|chronic persistent asthma
353306|NCT01436877|bladder neck obstruction|bladder neck obstruction
353307|NCT01436877|Bladder neck obstruction secondary to BPH|bladder neck obstruction secondary to bph
353308|NCT01436864|Recombinant Human VEGF Receptor-Fc Fusion Protein (KH902|recombinant human vegf receptor-fc fusion protein (kh902
353309|NCT01436864|)|)
353310|NCT01436864|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
353311|NCT01436864|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
353312|NCT01436864|intravitreal injection|intravitreal injection
343913|NCT01475188|seasonal allergic rhinitis|seasonal allergic rhinitis
343914|NCT01475188|regulatory lymphocytes|regulatory lymphocytes
343915|NCT01475188|signal transduction|signal transduction
343916|NCT01475188|histamine receptor|histamine receptor
343920|NCT01475162|corticosteroids|corticosteroids
353313|NCT01436864|best corrected visual acuity (BCVA)|best corrected visual acuity (bcva)
353314|NCT01436864|central retinal thickness|central retinal thickness
353315|NCT01436851|rhinitis|rhinitis
353316|NCT01436851|allergy|allergy
353317|NCT01436851|occupational|occupational
353318|NCT01436851|storage mites|storage mites
353319|NCT01436851|nasal lavage|nasal lavage
353320|NCT01436851|challenge test|challenge test
353321|NCT01436851|ECP|ecp
353322|NCT01436851|alfa2Macroglobuline|alfa2macroglobuline
353323|NCT01436838|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
353324|NCT01436838|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
353325|NCT01436825|Haemophilia A|haemophilia a
353326|NCT01436825|Factor VIII|factor viii
353327|NCT01436825|Pharmacokinetic|pharmacokinetic
353328|NCT01436825|Computer Tool validation|computer tool validation
353329|NCT01436812|cerebral oxymetry|cerebral oxymetry
353330|NCT01436812|laparoscopy|laparoscopy
353331|NCT01436812|PEEP|peep
353332|NCT01436799|propofol|propofol
353333|NCT01436799|desflurane|desflurane
353334|NCT01436799|cerebrovascular circulation|cerebrovascular circulation
353335|NCT01436799|sitting|sitting
353336|NCT01436786|cytokines|cytokines
353337|NCT01436786|Guided imagery|guided imagery
353338|NCT01436760|IBS|ibs
353339|NCT01436747|Kidney transplantation|kidney transplantation
353340|NCT01436747|Proteinuria|proteinuria
353341|NCT01436747|Albuminuria|albuminuria
353342|NCT01436747|Vitamin D|vitamin d
353343|NCT01436747|Paricalcitol|paricalcitol
353344|NCT01436721|Effectiveness|effectiveness
353345|NCT01436721|Device success|device success
353346|NCT01436721|Hepatectomy|hepatectomy
353347|NCT01436708|pelvic organ prolapse|pelvic organ prolapse
353348|NCT01436708|urinary symptoms|urinary symptoms
353349|NCT01436708|sexual function|sexual function
353350|NCT01436695|seizure early detection|seizure early detection
353351|NCT01436682|Nerve Blocks|nerve blocks
353352|NCT01436656|BRAF mutant,|braf mutant,
353353|NCT01436656|BRAF mutated,|braf mutated,
353354|NCT01436656|melanoma,|melanoma,
353355|NCT01436656|metastatic,|metastatic,
353356|NCT01436656|advanced,|advanced,
353357|NCT01436656|RAF kinase inhibitor|raf kinase inhibitor
353358|NCT01436656|BRAF V600 mutation|braf v600 mutation
353359|NCT01436643|Depression|depression
353360|NCT01436643|Multiple Sclerosis|multiple sclerosis
353361|NCT01436643|Fingolimod|fingolimod
353362|NCT01436643|Venlafaxine|venlafaxine
353363|NCT01436643|Fluoxetine|fluoxetine
353364|NCT01436630|Exercise Tolerance|exercise tolerance
353365|NCT01436630|Step Test|step test
353366|NCT01436630|Stroke|stroke
353367|NCT01436630|Walking|walking
353368|NCT01436617|cancer|cancer
353369|NCT01436617|colon|colon
353370|NCT01436617|Head and neck|head and neck
353371|NCT01436617|cetuximab|cetuximab
353372|NCT01436617|anti-cetuximab dosage|anti-cetuximab dosage
353373|NCT01436604|cardiac MRI|cardiac mri
353374|NCT01436604|Cancer|cancer
353375|NCT01436604|Breast|breast
353376|NCT01436604|Herceptin|herceptin
353377|NCT01436604|LV dysfunction|lv dysfunction
353378|NCT01436591|Cancer|cancer
353379|NCT01436591|Breast|breast
353380|NCT01436591|18FDG|18fdg
353381|NCT01436591|Axillary|axillary
353382|NCT01436591|Positron Emission Tomography|positron emission tomography
353384|NCT01436552|Depression|depression
353385|NCT01436552|Alzheimer|alzheimer
353386|NCT01436552|Life events|life events
353387|NCT01436526|Bioequivalence|bioequivalence
353388|NCT01436513|bioequivalence|bioequivalence
353389|NCT01436513|menometrorrhagia|menometrorrhagia
353390|NCT01436513|climacteric disturbance|climacteric disturbance
353391|NCT01436513|Estrogen Replacement Therapy|estrogen replacement therapy
353392|NCT01436513|Estrogens Conjugated|estrogens conjugated
353393|NCT01436500|Hepatorenal Syndrome|hepatorenal syndrome
353394|NCT01436500|HRS|hrs
353395|NCT01436500|ifetroban|ifetroban
353396|NCT01436487|ischemic stroke|ischemic stroke
353397|NCT01436487|adult stem cells|adult stem cells
353398|NCT01436474|Varenicline|varenicline
353399|NCT01436474|Chantix|chantix
353400|NCT01436474|Chronic Pain|chronic pain
353401|NCT01436474|Opioid dependence|opioid dependence
353402|NCT01436448|efficacy|efficacy
353403|NCT01436448|Lactobacillus Rhamnosus|lactobacillus rhamnosus
353404|NCT01436448|glucose intolerance|glucose intolerance
353405|NCT01436448|feasibility|feasibility
353406|NCT01436448|compliance and safety|compliance and safety
353407|NCT01436448|reducing glucose intolerance during and after pregnancy|reducing glucose intolerance during and after pregnancy
353408|NCT01436435|PAD|pad
353409|NCT01436435|peripheral artery disease|peripheral artery disease
353410|NCT01436435|atherectomy|atherectomy
353411|NCT01436422|Dengue Virus|dengue virus
353412|NCT01436422|Dengue Fever|dengue fever
353413|NCT01436422|Dengue Vaccine|dengue vaccine
353414|NCT01436422|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
353415|NCT01436422|Dengue Shock Syndrome|dengue shock syndrome
353416|NCT01436409|vaginal touch|vaginal touch
353417|NCT01436409|deliveries assisted|deliveries assisted
353418|NCT01436409|echography|echography
353419|NCT01436409|assisted delivery|assisted delivery
353420|NCT01436396|Dengue|dengue
353421|NCT01436396|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
353422|NCT01436396|CYD Dengue Vaccines|cyd dengue vaccines
353423|NCT01436396|Yellow Fever|yellow fever
353424|NCT01436396|Stamaril®|stamaril®
353425|NCT01436396|Flavivirus Infections|flavivirus infections
353426|NCT01436383|high altitude|high altitude
353427|NCT01436383|hypobaric hypoxia|hypobaric hypoxia
353428|NCT01436383|metabolomics|metabolomics
353429|NCT01436383|oxidative stress|oxidative stress
353430|NCT01436383|acute mountain sickness|acute mountain sickness
353431|NCT01436370|influenza, rheumatoid arthritis, TNF-alpha-inhibitor, Fluzone®, Fluzone® High Dose|influenza, rheumatoid arthritis, tnf-alpha-inhibitor, fluzone®, fluzone® high dose
353432|NCT01436357|AdCh3NSmut1|adch3nsmut1
353433|NCT01436357|Hepatitis C|hepatitis c
353434|NCT01436357|MVA-NSmut|mva-nsmut
353435|NCT01436357|vaccine|vaccine
353436|NCT01436344|esophageal electrocardiography|esophageal electrocardiography
353437|NCT01436344|electrocardiography|electrocardiography
353438|NCT01436344|atrial electrogram|atrial electrogram
353439|NCT01436344|atrial function, left|atrial function, left
353440|NCT01436331|First episode psychosis|first episode psychosis
353441|NCT01436331|Early Psychosis|early psychosis
353442|NCT01436331|Cognitive Behavioural therapy|cognitive behavioural therapy
353443|NCT01436331|Psychosocial Intervention|psychosocial intervention
353444|NCT01436331|Assertive Community treatment|assertive community treatment
353445|NCT01436331|Family Intervention|family intervention
353446|NCT01436331|Mental Disorders|mental disorders
353447|NCT01436331|Psychotic Disorders|psychotic disorders
353448|NCT01436331|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
353449|NCT01436331|Affective Disorders, Psychotic|affective disorders, psychotic
353450|NCT01436318|Healthy Kids|healthy kids
353451|NCT01436318|Respiratory|respiratory
353452|NCT01436318|Volunteers|volunteers
353453|NCT01436305|immunosuppressive (IS) regimens|immunosuppressive (is) regimens
353454|NCT01436305|long-term graft function|long-term graft function
353455|NCT01436305|CNI (calcineurin Inhibitor )-free IS regimen|cni (calcineurin inhibitor )-free is regimen
353456|NCT01436305|CNI (calcineurin Inhibitor ) IS regimen|cni (calcineurin inhibitor ) is regimen
353457|NCT01436305|corticosteroids|corticosteroids
353458|NCT01436292|Hypoalbuminemia|hypoalbuminemia
353459|NCT01436292|Burns|burns
353460|NCT01436292|Albumin|albumin
353461|NCT01436292|Organ dysfunction|organ dysfunction
353462|NCT01436292|Outcome|outcome
353463|NCT01436240|Patient-Reported Outcomes|patient-reported outcomes
353464|NCT01436240|Common Terminology Criteria for Adverse Events|common terminology criteria for adverse events
353465|NCT01436240|PRO-CTCAE|pro-ctcae
353466|NCT01436240|Native Spanish Speaking|native spanish speaking
353467|NCT01436240|Spanish Translation|spanish translation
353468|NCT01436240|Cognitive Interview|cognitive interview
353469|NCT01436240|Questionnaire|questionnaire
353470|NCT01436240|11-133|11-133
353471|NCT01436240|Adverse Events|adverse events
353472|NCT01436240|chemotherapy|chemotherapy
353473|NCT01436240|radiation therapy|radiation therapy
353474|NCT01436240|treatment in previous 6 months|treatment in previous 6 months
353475|NCT01436227|Von Hippel-Lindau Syndrome|von hippel-lindau syndrome
353476|NCT01436227|VHL|vhl
353477|NCT01436227|Von Hippel-Lindau related lesion|von hippel-lindau related lesion
353478|NCT01436227|Pazopanib|pazopanib
353479|NCT01436227|GW786034|gw786034
353480|NCT01436188|Biological Markers|biological markers
353481|NCT01436188|Healthy Volunteer|healthy volunteer
353482|NCT01436188|Alzheimer's Disease (AD)|alzheimer's disease (ad)
353483|NCT01436188|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
353484|NCT01436188|Cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
353485|NCT01436188|CSF proteins|csf proteins
353486|NCT01436136|Cardiovascular disease|cardiovascular disease
353488|NCT01436136|Antiretroviral treatment|antiretroviral treatment
353489|NCT01436136|team interventions|team interventions
353490|NCT01436136|Framingham risk score|framingham risk score
353491|NCT01436123|Plasmonic Photothermal Therapy|plasmonic photothermal therapy
353492|NCT01436123|Nanoparticles|nanoparticles
353493|NCT01436123|Stem cells|stem cells
353494|NCT01436123|Atherosclerosis|atherosclerosis
353495|NCT01436123|Bioengineering|bioengineering
353496|NCT01436123|Biodegradable stenting|biodegradable stenting
353497|NCT01436123|Repair disease|repair disease
353498|NCT01436097|Healthy Eating|healthy eating
353499|NCT01436097|Health Behavior|health behavior
353500|NCT01436097|Incentive|incentive
353501|NCT01436097|Work-site|work-site
353502|NCT01436084|Leukemia|leukemia
353503|NCT01436084|Myelodysplastic syndrome|myelodysplastic syndrome
353504|NCT01436084|MDS|mds
353505|NCT01436084|SB1518|sb1518
353506|NCT01436058|side effect|side effect
353507|NCT01436058|mesenchymal stem cell|mesenchymal stem cell
353508|NCT01436058|ankle|ankle
353509|NCT01436058|osteoarthritis|osteoarthritis
353510|NCT01436045|Memory|memory
353511|NCT01436045|Insulin glulisine|insulin glulisine
353512|NCT01436045|Alzheimer's Disease|alzheimer's disease
353513|NCT01436019|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
353514|NCT01436019|Rheumatic diseases|rheumatic diseases
353515|NCT01436019|Antibodies|antibodies
353516|NCT01436019|Biological therapy|biological therapy
353517|NCT01436006|MDCT|mdct
353518|NCT01436006|radiation|radiation
353519|NCT01436006|dose|dose
353520|NCT01435993|Multiple Sclerosis, Secondary-Progressive with relapses|multiple sclerosis, secondary-progressive with relapses
353521|NCT01435980|type 2 diabetes|type 2 diabetes
353522|NCT01435980|Gastric Bypass|gastric bypass
353523|NCT01435980|GLP-1|glp-1
353524|NCT01435980|adiponectin|adiponectin
353525|NCT01435967|Rotarix™|rotarix™
353526|NCT01435967|Observational|observational
353527|NCT01435967|ecological|ecological
353528|NCT01435954|benign prostatic hyperplasia|benign prostatic hyperplasia
353529|NCT01435954|surgery|surgery
353530|NCT01435954|5-alpha-reductase inhibitor|5-alpha-reductase inhibitor
353531|NCT01435954|enlarged prostate|enlarged prostate
353532|NCT01435954|acute urinary retention|acute urinary retention
353533|NCT01435941|mailed survey|mailed survey
353534|NCT01435941|non-steroidal anti-inflammatory drug|non-steroidal anti-inflammatory drug
353535|NCT01435941|migraine disorders|migraine disorders
353536|NCT01435941|headache|headache
353537|NCT01435928|Schizophrenia|schizophrenia
353538|NCT01435928|Lurasidone|lurasidone
353539|NCT01435928|Latuda|latuda
353540|NCT01435902|exercise-induced bronchospasm|exercise-induced bronchospasm
353541|NCT01435902|Activity/Exercise induced bronchospasm|activity/exercise induced bronchospasm
353542|NCT01435902|asthma|asthma
353543|NCT01435889|Acute respiratory distress syndrome|acute respiratory distress syndrome
353544|NCT01435889|Children|children
353545|NCT01435889|Long term respiratory sequelae|long term respiratory sequelae
353546|NCT01435889|Pulmonary function tests|pulmonary function tests
353547|NCT01435889|Computed tomography, lung|computed tomography, lung
353548|NCT01435850|hip arthroplasty|hip arthroplasty
353549|NCT01435850|primary stability|primary stability
353550|NCT01435850|secondary stability|secondary stability
353551|NCT01435850|EBRA|ebra
353552|NCT01435837|Voice|voice
353553|NCT01435837|aerodynamics|aerodynamics
353554|NCT01435837|acoustics|acoustics
353555|NCT01435824|healthy adult volunteers|healthy adult volunteers
353556|NCT01435824|comparative bioavailability|comparative bioavailability
353557|NCT01435824|amoxicillin|amoxicillin
353558|NCT01435824|breast milk|breast milk
353559|NCT01435824|Amoxicillin Bioavailability in breast milk|amoxicillin bioavailability in breast milk
353560|NCT01435811|Norovirus|norovirus
353561|NCT01435798|chronic pain|chronic pain
353562|NCT01435798|central neuropathic pain|central neuropathic pain
353563|NCT01435798|spinal cord injury|spinal cord injury
353564|NCT01435798|dextromethorphan|dextromethorphan
353565|NCT01435798|lidocaine|lidocaine
353566|NCT01435798|combination therapy|combination therapy
353567|NCT01435798|analgesia|analgesia
353568|NCT01435785|PKPD|pkpd
353569|NCT01435785|Propofol|propofol
353571|NCT01435785|Elderly patients|elderly patients
353572|NCT01435746|liver transplantation|liver transplantation
353573|NCT01435746|intensive care|intensive care
353574|NCT01435746|red blood cell transfusion|red blood cell transfusion
353575|NCT01435733|ASD|asd
353576|NCT01435733|Divorce|divorce
353577|NCT01435720|Multiple myeloma|multiple myeloma
353578|NCT01435720|B cell lymphoma|b cell lymphoma
353579|NCT01435720|Hematologic disease|hematologic disease
353580|NCT01435720|Blood protein disorder|blood protein disorder
353581|NCT01435720|Neoplasm, plasma cell|neoplasm, plasma cell
353582|NCT01435720|Mantle Cell Lymphoma|mantle cell lymphoma
353583|NCT01435720|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
353584|NCT01435720|Plasma Cell Leukemia|plasma cell leukemia
353585|NCT01435720|B cell malignancy|b cell malignancy
353586|NCT01435707|epidural steroid injection|epidural steroid injection
353587|NCT01435707|triamcinolone|triamcinolone
353588|NCT01435707|fasting blood glucose|fasting blood glucose
353589|NCT01435707|diabetes mellitus|diabetes mellitus
353590|NCT01435694|multiple sclerosis|multiple sclerosis
353591|NCT01435694|gait rehabilitation|gait rehabilitation
353592|NCT01435681|DYT-1|dyt-1
353593|NCT01435681|DYT1|dyt1
353594|NCT01435681|DYT 1|dyt 1
353595|NCT01435681|dystonia|dystonia
353597|NCT01435681|deep brain stimulation|deep brain stimulation
353598|NCT01435681|TMS|tms
353702|NCT01435226|Chronic Genotype 1a or 1b|chronic genotype 1a or 1b
353599|NCT01435681|transcranial magnetic stimulation|transcranial magnetic stimulation
353600|NCT01435668|alcohol|alcohol
353601|NCT01435668|hazardous or harmful drinking|hazardous or harmful drinking
353602|NCT01435668|emergency department (ED)|emergency department (ed)
353603|NCT01435616|diabetes mellitus|diabetes mellitus
353604|NCT01435616|type 2 diabetes mellitus|type 2 diabetes mellitus
353605|NCT01435616|insulin naive|insulin naive
353606|NCT01435616|insulin treatment|insulin treatment
353607|NCT01435603|Prevention & Control|prevention & control
353608|NCT01435603|Hyperglycemia|hyperglycemia
353609|NCT01435603|Obesity|obesity
353610|NCT01435603|Diabetes Mellitus|diabetes mellitus
353611|NCT01435603|Cost Benefit Analysis|cost benefit analysis
353612|NCT01435577|Bunionectomy|bunionectomy
353613|NCT01435577|Postsurgical Pain|postsurgical pain
353614|NCT01435577|Acute Pain|acute pain
353615|NCT01435564|Mobile phone|mobile phone
353616|NCT01435564|Sedentary lifestyle|sedentary lifestyle
353617|NCT01435564|Physical activity|physical activity
353618|NCT01435564|Prevention|prevention
353619|NCT01435564|Health Promotion|health promotion
353620|NCT01435564|Exercise|exercise
353621|NCT01435564|eHealth|ehealth
353622|NCT01435564|Electronic diary|electronic diary
353623|NCT01435551|Alzheimer|alzheimer
353624|NCT01435551|Dementia|dementia
353625|NCT01435538|interprofessional teamwork|interprofessional teamwork
353626|NCT01435538|care pathways|care pathways
353627|NCT01435538|team communication|team communication
353628|NCT01435538|team coordination|team coordination
353629|NCT01435538|Chronic Obstructive Pulmonary Disease Teams|chronic obstructive pulmonary disease teams
353630|NCT01435538|Proximal Femur Fracture Teams|proximal femur fracture teams
353631|NCT01435525|triple therapy|triple therapy
353632|NCT01435525|Helicobacter pylori|helicobacter pylori
353633|NCT01435525|eradication|eradication
353634|NCT01435525|Nexium|nexium
353635|NCT01435512|PTSD|ptsd
353636|NCT01435512|CBT|cbt
353637|NCT01435512|Intimate Partner Violence|intimate partner violence
353638|NCT01435512|Treatment|treatment
353639|NCT01435499|immunotherapy|immunotherapy
353640|NCT01435499|vaccine|vaccine
353641|NCT01435499|GVAX|gvax
353642|NCT01435499|GM-CSF|gm-csf
353643|NCT01435486|caffeine|caffeine
353644|NCT01435486|apnea|apnea
353645|NCT01435486|bronchiolitis|bronchiolitis
353646|NCT01435473|pediatrics|pediatrics
353647|NCT01435473|thrombosis|thrombosis
353648|NCT01435473|thromboembolic complications|thromboembolic complications
353649|NCT01435473|pediatric cardiac surgery|pediatric cardiac surgery
353650|NCT01435460|ocular allergy|ocular allergy
353651|NCT01435447|efficacy|efficacy
353653|NCT01435447|conditioning|conditioning
353654|NCT01435447|fludarabine|fludarabine
353655|NCT01435447|busulfan|busulfan
353656|NCT01435447|cyclophosphamide|cyclophosphamide
353657|NCT01435447|adult|adult
353658|NCT01435434|subjects sustaining Non union/delayed fractures and requiring surgical intervention for treatment|subjects sustaining non union/delayed fractures and requiring surgical intervention for treatment
353659|NCT01435408|STEMI|stemi
353660|NCT01435408|Ischemic postconditioning|ischemic postconditioning
353661|NCT01435408|Deferred stenting|deferred stenting
353662|NCT01435408|Primary PCI|primary pci
353663|NCT01435356|Urinary Bladder neoplasms|urinary bladder neoplasms
353664|NCT01435356|Lymphoproliferative Disorders|lymphoproliferative disorders
353665|NCT01435356|Immune System Diseases|immune system diseases
353666|NCT01435356|Cystectomy|cystectomy
353667|NCT01435356|Adjuvants, Immunologic|adjuvants, immunologic
353668|NCT01435356|Immunologic Factors|immunologic factors
353669|NCT01435330|Safety|safety
353670|NCT01435330|BVS857|bvs857
353671|NCT01435330|insulin resistance|insulin resistance
353672|NCT01435317|Acoustic CR®-neuromodulation|acoustic cr®-neuromodulation
353673|NCT01435317|ANM T30 CR®-System|anm t30 cr®-system
353674|NCT01435278|Weight maintenance|weight maintenance
353675|NCT01435278|BMI|bmi
353676|NCT01435278|Body weight|body weight
353677|NCT01435278|Overweight|overweight
353678|NCT01435278|Obesity|obesity
353679|NCT01435278|Satiety|satiety
353680|NCT01435265|Psoriasis|psoriasis
353681|NCT01435265|Dermatology|dermatology
353682|NCT01435265|Phase IV|phase iv
353683|NCT01435265|Nurse Education|nurse education
353684|NCT01435265|Adalimumab|adalimumab
353685|NCT01435265|Humira|humira
353686|NCT01435226|Hepatitis C|hepatitis c
353687|NCT01435226|HCV|hcv
353688|NCT01435226|Rapid Virologic Response|rapid virologic response
353689|NCT01435226|Sustained Virologic Response|sustained virologic response
353690|NCT01435226|Direct Acting Antiviral|direct acting antiviral
353691|NCT01435226|Combination Therapy|combination therapy
353692|NCT01435226|Tegobuvir|tegobuvir
353693|NCT01435226|Treatment Experienced|treatment experienced
353694|NCT01435226|HCV RNA|hcv rna
353695|NCT01435226|Polymerase inhibitor|polymerase inhibitor
353696|NCT01435226|Protease inhibitor|protease inhibitor
353697|NCT01435226|Interferon intolerant|interferon intolerant
353698|NCT01435226|Interferon ineligible|interferon ineligible
353699|NCT01435226|GS-9190|gs-9190
353700|NCT01435226|GS-9451|gs-9451
353701|NCT01435226|GS-5885|gs-5885
353703|NCT01435213|alpha2-adrenoceptor|alpha2-adrenoceptor
353704|NCT01435213|receptor occupancy|receptor occupancy
353705|NCT01435213|positron emission tomography|positron emission tomography
353706|NCT01435213|[11C]ORM-13070|[11c]orm-13070
353707|NCT01435213|striatum|striatum
353708|NCT01435213|brain|brain
353709|NCT01435213|noradrenaline|noradrenaline
353710|NCT01435213|norepinephrine|norepinephrine
353711|NCT01435213|endogenous|endogenous
353712|NCT01435213|binding|binding
353713|NCT01435213|Validation studies|validation studies
353714|NCT01435200|Intravenous iron|intravenous iron
353815|NCT01434745|SLOS|slos
353715|NCT01435200|gynecologic cancer blood transfusion|gynecologic cancer blood transfusion
353716|NCT01435174|ranolazine|ranolazine
353717|NCT01435174|end-stage renal disease|end-stage renal disease
353718|NCT01435174|pharmacokinetics|pharmacokinetics
353719|NCT01435174|cardiovascular disease|cardiovascular disease
353720|NCT01435161|paroxysmal atrial fibrillation, hypertension|paroxysmal atrial fibrillation, hypertension
353721|NCT01435148|Deep Brain Stimulation|deep brain stimulation
353722|NCT01435148|Treatment Resistant Depression|treatment resistant depression
353723|NCT01435122|progressive advanced carcinoid tumors|progressive advanced carcinoid tumors
353724|NCT01435122|advanced|advanced
353725|NCT01435122|unresectable|unresectable
353726|NCT01435122|metastatic|metastatic
353727|NCT01435122|cancerous tumors|cancerous tumors
353728|NCT01435122|neuroendocrine|neuroendocrine
353729|NCT01435122|digestive tract|digestive tract
353730|NCT01435122|lungs|lungs
353731|NCT01435122|renal|renal
353732|NCT01435122|ovarian|ovarian
353733|NCT01435122|thymic|thymic
353734|NCT01435122|hepatic|hepatic
353735|NCT01435109|Osteoarthritis|osteoarthritis
353736|NCT01435109|Exercise|exercise
353737|NCT01435109|Diet|diet
353738|NCT01435109|Coping Skills|coping skills
353739|NCT01435109|Education, Medical|education, medical
353740|NCT01435083|Nocturia|nocturia
353741|NCT01435070|Colles' fracture|colles' fracture
353742|NCT01435070|Radius fracture|radius fracture
353743|NCT01435070|grip strength|grip strength
353744|NCT01435070|pinch strength|pinch strength
353745|NCT01435070|range of movement|range of movement
353746|NCT01435070|PRWE|prwe
353747|NCT01435070|DASH|dash
353748|NCT01435070|EQ-5D|eq-5d
353749|NCT01435070|Kirschner wire|kirschner wire
353750|NCT01435070|Volar locking plate|volar locking plate
353751|NCT01435057|Abdominal Obesity|abdominal obesity
353752|NCT01435057|training|training
353753|NCT01435057|fat|fat
353754|NCT01435057|insulin|insulin
353755|NCT01435057|glucose|glucose
353756|NCT01435057|diet|diet
353757|NCT01435044|Hepatitis C|hepatitis c
353758|NCT01435044|Chronic|chronic
353759|NCT01435044|HCV|hcv
353760|NCT01435031|Angioplasty|angioplasty
353761|NCT01435031|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
353762|NCT01435031|Chronic total coronary occlusions|chronic total coronary occlusions
353763|NCT01435031|Coronary Artery Disease (CAD)|coronary artery disease (cad)
353764|NCT01435031|Coronary artery stenosis|coronary artery stenosis
353765|NCT01435031|Total coronary occlusion|total coronary occlusion
353766|NCT01435005|Prevention and control|prevention and control
353767|NCT01435005|Exercise|exercise
353768|NCT01435005|Sedentary lifestyle|sedentary lifestyle
353769|NCT01435005|Biological markers|biological markers
353770|NCT01434966|Lumbopelvic Manipulation|lumbopelvic manipulation
353771|NCT01434966|Lumbosacral Manipulation|lumbosacral manipulation
353772|NCT01434966|Sacroiliac Manipulation|sacroiliac manipulation
353773|NCT01434966|TENS Spine|tens spine
353774|NCT01434966|TENS Knee|tens knee
353775|NCT01434966|Knee Pain|knee pain
353776|NCT01434966|Chronic Knee Pain|chronic knee pain
353777|NCT01434953|Prehypertension|prehypertension
353778|NCT01434953|Blood pressure screening|blood pressure screening
353779|NCT01434953|White coat effect|white coat effect
353780|NCT01434940|Alzheimer disease|alzheimer disease
353781|NCT01434940|Depression|depression
586749|NCT00524992|Proteinuria|proteinuria
353782|NCT01434940|Differential diagnosis|differential diagnosis
353783|NCT01434940|Eye movement|eye movement
353784|NCT01434914|Ulcus cruris|ulcus cruris
353785|NCT01434914|chronic wounds|chronic wounds
353786|NCT01434914|octenisept®|octenisept®
353787|NCT01434901|Diabetes|diabetes
353788|NCT01434901|Blood Sugar|blood sugar
353789|NCT01434901|Xenin-25|xenin-25
353790|NCT01434901|GIP|gip
353791|NCT01434901|Muscarinic|muscarinic
353792|NCT01434888|pharmacokinetics|pharmacokinetics
353793|NCT01434862|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
353794|NCT01434849|infantile hemangioma|infantile hemangioma
353795|NCT01434849|very low birth weight infants|very low birth weight infants
353796|NCT01434849|premature infants|premature infants
353797|NCT01434836|Anti-depressant effects|anti-depressant effects
353798|NCT01434823|nocturnal staffing|nocturnal staffing
353799|NCT01434823|intensivist staffing|intensivist staffing
353800|NCT01434823|intensivist coverage|intensivist coverage
353801|NCT01434823|ICU patient-centered outcomes|icu patient-centered outcomes
353802|NCT01434823|ICU resource utilization|icu resource utilization
353803|NCT01434823|patients admitted to the medical intensive care unit|patients admitted to the medical intensive care unit
353804|NCT01434823|Sleep Deprivation|sleep deprivation
353805|NCT01434823|Inattention|inattention
353806|NCT01434823|Work Hours|work hours
353807|NCT01434810|Hyperbilirubinemia, Neonatal|hyperbilirubinemia, neonatal
353808|NCT01434797|Infection|infection
353809|NCT01434797|Permanent central venous catheter|permanent central venous catheter
353810|NCT01434797|Device Related|device related
353811|NCT01434784|lung cancer|lung cancer
353812|NCT01434784|quality of life|quality of life
353813|NCT01434758|Mycobacterium tuberculosis|mycobacterium tuberculosis
353814|NCT01434758|Culture yield|culture yield
353816|NCT01434745|Cholesterol Supplementation|cholesterol supplementation
353817|NCT01434745|Simvastatin|simvastatin
353818|NCT01434732|Superior vena cava flow|superior vena cava flow
353819|NCT01434732|umbilical cord milking|umbilical cord milking
353820|NCT01434732|hemodynamics|hemodynamics
353821|NCT01434732|systemic blood flow|systemic blood flow
353822|NCT01434719|Streptococcus suis|streptococcus suis
353823|NCT01434719|Sepsis|sepsis
353824|NCT01434719|Porcine Respiratory and Reproductive System virus|porcine respiratory and reproductive system virus
353825|NCT01434719|Pig disease|pig disease
353826|NCT01434719|Epidemiology|epidemiology
353828|NCT01434706|acute infection|acute infection
353829|NCT01434706|primary infection|primary infection
353830|NCT01434706|seroconverters|seroconverters
353831|NCT01434693|T. suis ova|t. suis ova
353832|NCT01434693|Crohn's disease|crohn's disease
353833|NCT01434680|Meningococcal disease|meningococcal disease
353834|NCT01434680|vaccines|vaccines
353835|NCT01434680|toddlers|toddlers
353836|NCT01434680|prevention|prevention
353837|NCT01434680|Meningitis|meningitis
353838|NCT01434667|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
353839|NCT01434667|Alzheimer's disease (AD)|alzheimer's disease (ad)
353840|NCT01434667|APOE|apoe
353841|NCT01434667|genetics|genetics
353842|NCT01434667|risk assessment|risk assessment
353843|NCT01434667|education|education
353844|NCT01434667|genetic counseling|genetic counseling
353845|NCT01434667|Mild Cognitive Impairment, So Stated|mild cognitive impairment, so stated
353846|NCT01434654|HAND|hand
353847|NCT01434654|HIV|hiv
353848|NCT01434654|Neurology|neurology
353849|NCT01434654|Neurocognitive|neurocognitive
353850|NCT01434654|Neuro-HAART|neuro-haart
353851|NCT01434654|HIV Associated Neurocognitive Disorders (HAND)|hiv associated neurocognitive disorders (hand)
353852|NCT01434641|myocardial perfusion SPECT|myocardial perfusion spect
353853|NCT01434641|wide beam reconstruction|wide beam reconstruction
353854|NCT01434641|Tc-99m sestamibi|tc-99m sestamibi
353855|NCT01434628|Male Circumcision|male circumcision
353856|NCT01434628|HIV Prevention|hiv prevention
353857|NCT01434628|HIV Infections|hiv infections
353858|NCT01434615|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
353859|NCT01434615|Moderate to advanced|moderate to advanced
353860|NCT01434615|patients|patients
353861|NCT01434615|current consensus guidelines|current consensus guidelines
353862|NCT01434602|Chemotherapy|chemotherapy
353863|NCT01434602|Brain Tumor|brain tumor
353864|NCT01434602|Glioblastoma|glioblastoma
353865|NCT01434602|Anaplastic Glioma|anaplastic glioma
353866|NCT01434589|internet addiction|internet addiction
353867|NCT01434589|computer game addiction|computer game addiction
353868|NCT01434589|STICA|stica
353869|NCT01434589|short-term treatment|short-term treatment
353870|NCT01434589|psychotherapy|psychotherapy
353871|NCT01434589|internet and computer game addiction|internet and computer game addiction
353872|NCT01434563|HIV|hiv
353873|NCT01434563|neurocognitive disorder|neurocognitive disorder
353874|NCT01434563|primary care|primary care
353875|NCT01434563|HIV negative|hiv negative
353876|NCT01434563|HAND|hand
353877|NCT01434563|CNS|cns
353878|NCT01434550|pancreas|pancreas
353879|NCT01434550|pancreatic cancer|pancreatic cancer
353880|NCT01434550|SBRT|sbrt
353881|NCT01434550|stereotactic body radiation|stereotactic body radiation
353882|NCT01434550|radiation therapy|radiation therapy
353883|NCT01434550|unresectable|unresectable
353884|NCT01434550|non-metastatic|non-metastatic
353885|NCT01434550|tissue, blood, research imaging|tissue, blood, research imaging
353886|NCT01434550|TBRI|tbri
353887|NCT01434537|pediatric anesthesia|pediatric anesthesia
353888|NCT01434537|venepuncture|venepuncture
353889|NCT01434537|peripheral venous access|peripheral venous access
353890|NCT01434511|hemophilia A|hemophilia a
353891|NCT01434511|haemophilia A|haemophilia a
353892|NCT01434511|blood coagulation disorders|blood coagulation disorders
353893|NCT01434511|hemorrhagic disorders|hemorrhagic disorders
353894|NCT01434511|coagulation protein disorder|coagulation protein disorder
353895|NCT01434511|hematologic diseases|hematologic diseases
353896|NCT01434511|congenital hemophilia A|congenital hemophilia a
353897|NCT01434498|Hepatitis C|hepatitis c
353898|NCT01434498|HCV|hcv
353899|NCT01434498|Rapid Virologic Response|rapid virologic response
353900|NCT01434498|Sustained Virologic Response|sustained virologic response
353901|NCT01434498|Direct Acting Antiviral|direct acting antiviral
353991|NCT01434173|Cefuroxime|cefuroxime
353902|NCT01434498|Combination Therapy|combination therapy
353903|NCT01434498|Tegobuvir|tegobuvir
353904|NCT01434498|Treatment naïve|treatment naïve
353905|NCT01434498|HCV RNA|hcv rna
353906|NCT01434498|Polymerase inhibitor|polymerase inhibitor
353907|NCT01434498|Protease inhibitor|protease inhibitor
353908|NCT01434498|Interferon intolerant|interferon intolerant
353909|NCT01434498|Interferon ineligible|interferon ineligible
353910|NCT01434498|GS-9190|gs-9190
353911|NCT01434498|GS-9451|gs-9451
353912|NCT01434498|GS-5885|gs-5885
354005|NCT01434147|preoperative induction chemotherapy chemoradiotherapy|preoperative induction chemotherapy chemoradiotherapy
354006|NCT01434134|Anthracyclines|anthracyclines
354007|NCT01434134|Trastuzumab|trastuzumab
353913|NCT01434485|gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux oesophagitis, non-erosive reflux disease, Zollinger-Ellison syndrome, Nexium|gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux oesophagitis, non-erosive reflux disease, zollinger-ellison syndrome, nexium
353914|NCT01434459|Pancreatic neoplasms|pancreatic neoplasms
353915|NCT01434459|Cholangiocarcinoma|cholangiocarcinoma
353916|NCT01434420|triple negative breast cancer|triple negative breast cancer
353917|NCT01434407|Advanced glycation endproducts|advanced glycation endproducts
353918|NCT01434407|Satiety|satiety
353919|NCT01434407|Obesity|obesity
353920|NCT01434407|Inflammation|inflammation
353921|NCT01434407|Insulin resistance|insulin resistance
353922|NCT01434394|Oral cancer|oral cancer
353923|NCT01434394|Oropharyngeal cancer|oropharyngeal cancer
353924|NCT01434394|Induction chemotherapy|induction chemotherapy
353925|NCT01434394|Targeted chemotherapy|targeted chemotherapy
353926|NCT01434394|Surgery|surgery
353927|NCT01434394|Radiotherapy|radiotherapy
353928|NCT01434381|Recombinant|recombinant
353929|NCT01434381|Proteins|proteins
353930|NCT01434381|Antigen|antigen
353931|NCT01434381|Membrane|membrane
353932|NCT01434381|Assay|assay
353933|NCT01434381|Malaria|malaria
353934|NCT01434368|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
353935|NCT01434368|Normal Development|normal development
353936|NCT01434368|Puberty|puberty
353937|NCT01434368|Brain Function|brain function
353938|NCT01434368|Gonadal Steroids|gonadal steroids
353939|NCT01434368|Brain Structure|brain structure
353940|NCT01434368|Healthy Volunteer|healthy volunteer
353941|NCT01434368|HV|hv
751933|NCT01171274|sensory thresholds|sensory thresholds
353942|NCT01434342|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
353943|NCT01434342|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
353944|NCT01434342|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
353945|NCT01434342|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
353946|NCT01434342|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
353947|NCT01434342|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
353948|NCT01434342|limited stage small cell lung cancer|limited stage small cell lung cancer
353949|NCT01434342|tobacco use disorder|tobacco use disorder
353950|NCT01434342|Breast Cancer|breast cancer
353951|NCT01434342|Cervical Cancer|cervical cancer
353952|NCT01434342|head & neck cancer|head & neck cancer
353953|NCT01434342|Prostate Cancer|prostate cancer
353954|NCT01434342|All histologies|all histologies
353955|NCT01434329|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
353956|NCT01434290|radiation toxicity|radiation toxicity
353957|NCT01434290|sexual dysfunction|sexual dysfunction
353958|NCT01434290|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
353959|NCT01434290|adenocarcinoma of the prostate|adenocarcinoma of the prostate
353960|NCT01434290|stage I prostate cancer|stage i prostate cancer
353961|NCT01434290|stage IIA prostate cancer|stage iia prostate cancer
353962|NCT01434277|Preservative|preservative
353963|NCT01434277|Eye Drops|eye drops
353964|NCT01434264|rehabilitation|rehabilitation
353965|NCT01434251|Hypotension|hypotension
353966|NCT01434251|premature infants|premature infants
353967|NCT01434251|near infrared spectroscopy|near infrared spectroscopy
353968|NCT01434238|infant feeding|infant feeding
353969|NCT01434238|HIV|hiv
353970|NCT01434238|growth|growth
353971|NCT01434238|anemia|anemia
353972|NCT01434225|Neonatal seizures|neonatal seizures
353973|NCT01434225|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
353974|NCT01434225|Electroencephalography|electroencephalography
353975|NCT01434225|Bumetanide|bumetanide
353976|NCT01434212|HCV dynamics|hcv dynamics
353977|NCT01434212|Mathematical model|mathematical model
353978|NCT01434212|Interferon|interferon
353979|NCT01434212|Predict|predict
353980|NCT01434212|Hepatitis C Virus|hepatitis c virus
353981|NCT01434199|magnetic endoscope imaging|magnetic endoscope imaging
353982|NCT01434199|colonoscopy|colonoscopy
353983|NCT01434199|caecal intubation|caecal intubation
353984|NCT01434173|Liver Diseases|liver diseases
353985|NCT01434173|Anti-Bacterial Agents|anti-bacterial agents
353986|NCT01434173|Fluoroquinolones|fluoroquinolones
353987|NCT01434173|Amoxicillin|amoxicillin
353988|NCT01434173|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination
353989|NCT01434173|Clarithromycin|clarithromycin
353990|NCT01434173|Doxycycline|doxycycline
353992|NCT01434173|Case-Control Studies|case-control studies
353993|NCT01434173|Retrospective Studies|retrospective studies
353994|NCT01434173|Cohort Studies|cohort studies
353995|NCT01434173|Epidemiologic Research Design|epidemiologic research design
353996|NCT01434173|Epidemiologic Studies|epidemiologic studies
353997|NCT01434173|HealthCore Integrated Research Database (non-MESH)|healthcore integrated research database (non-mesh)
353998|NCT01434173|United States|united states
353999|NCT01434173|Human|human
354000|NCT01434173|Insurance Claim Review|insurance claim review
354001|NCT01434160|Intrauterine|intrauterine
354002|NCT01434160|contraception|contraception
354003|NCT01434160|adolescent|adolescent
354004|NCT01434147|locally advanced rectal cancer|locally advanced rectal cancer
354008|NCT01434108|cirrhosis, gastrointestinal bleeding|cirrhosis, gastrointestinal bleeding
354009|NCT01434095|microperimetry|microperimetry
354010|NCT01434095|fixation point|fixation point
354011|NCT01434095|retinal sensitivity|retinal sensitivity
354012|NCT01434095|photodynamic therapy|photodynamic therapy
354013|NCT01434095|chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
354014|NCT01434082|sleep|sleep
354015|NCT01434082|school-age children|school-age children
354016|NCT01434082|Children with and without arthritis|children with and without arthritis
354017|NCT01434069|colon|colon
354018|NCT01434069|rectum|rectum
354019|NCT01434069|small bowel|small bowel
354020|NCT01434069|pancreas|pancreas
354021|NCT01434069|gastric|gastric
354022|NCT01434069|esophageal|esophageal
354023|NCT01434069|metastatic|metastatic
354024|NCT01434069|unresectable|unresectable
354025|NCT01434069|GI|gi
354026|NCT01434069|combination therapy|combination therapy
354027|NCT01434069|dose escalation|dose escalation
354028|NCT01434069|solid tumor|solid tumor
354029|NCT01434056|Liver disease|liver disease
354030|NCT01434056|Hepatic encephalopathy|hepatic encephalopathy
354031|NCT01434056|MELD|meld
354032|NCT01434056|Liver transplantation|liver transplantation
354033|NCT01434043|Cardiac CT perfusion|cardiac ct perfusion
354034|NCT01434043|Positron emission tomography perfusion|positron emission tomography perfusion
354035|NCT01434043|Quantitative perfusion|quantitative perfusion
354036|NCT01434017|PONV|ponv
354037|NCT01434017|Dexamethasone|dexamethasone
354038|NCT01434017|Droperidol|droperidol
354039|NCT01434017|Ondansetron|ondansetron
354040|NCT01434017|Tonsillectomy|tonsillectomy
354041|NCT01434004|prostate cancer|prostate cancer
354042|NCT01433965|Bone marrow transplantation|bone marrow transplantation
354043|NCT01433965|Maintenance lenalidomide|maintenance lenalidomide
354044|NCT01433939|colonoscopy|colonoscopy
354045|NCT01433939|position changes|position changes
354046|NCT01433939|patient comfort|patient comfort
354047|NCT01433926|Breast cancer.|breast cancer.
354048|NCT01433926|Trastuzumab.|trastuzumab.
354049|NCT01433926|Complete remission.|complete remission.
354050|NCT01433900|glaucoma|glaucoma
354051|NCT01433900|intraocular pressure|intraocular pressure
354052|NCT01433900|ocular surface|ocular surface
354053|NCT01433900|benzalkonium chloride|benzalkonium chloride
354054|NCT01433887|Peginterferon alfa-2a|peginterferon alfa-2a
354055|NCT01433887|ribavirin|ribavirin
354056|NCT01433874|Shoulder pain|shoulder pain
354057|NCT01433874|Upper abdominal pain|upper abdominal pain
354058|NCT01433874|Laparoscopic surgery|laparoscopic surgery
354059|NCT01433874|Abdominal fullness|abdominal fullness
354060|NCT01433861|gastric cancer|gastric cancer
354061|NCT01433861|proximal gastrectomy|proximal gastrectomy
354062|NCT01433861|total gastrectomy|total gastrectomy
354063|NCT01433861|laparoscopy|laparoscopy
354064|NCT01433861|reflux esophagitis|reflux esophagitis
354065|NCT01433861|double tract reconstruction|double tract reconstruction
354066|NCT01433835|Cytomegalovirus|cytomegalovirus
354067|NCT01433835|Antiviral|antiviral
354068|NCT01433835|Safety|safety
354069|NCT01433835|Healthy|healthy
354070|NCT01433809|thyroid cancer|thyroid cancer
354071|NCT01433809|thyroid neoplasm|thyroid neoplasm
354072|NCT01433809|thyroid adenoma|thyroid adenoma
354073|NCT01433796|antiretroviral therapy|antiretroviral therapy
354074|NCT01433796|tuberculosis|tuberculosis
354075|NCT01433796|health centres|health centres
354076|NCT01433796|Ethiopia|ethiopia
354077|NCT01433757|dystonia|dystonia
354079|NCT01433757|AMPICILLIN|ampicillin
354080|NCT01433744|C-Reactive protein|c-reactive protein
354081|NCT01433744|risk|risk
354082|NCT01433731|CTCL|ctcl
354083|NCT01433731|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
354084|NCT01433718|Effectivness|effectivness
354085|NCT01433718|Neuromuscular Training|neuromuscular training
354086|NCT01433718|Resistance Training|resistance training
354087|NCT01433718|Modification|modification
354088|NCT01433718|Anterior Cruciate Ligament Risk Factors|anterior cruciate ligament risk factors
354089|NCT01433718|Drop-Jump|drop-jump
354090|NCT01433718|Knee Separation|knee separation
354091|NCT01433718|Resistance training program|resistance training program
354092|NCT01433705|heart|heart
354093|NCT01433705|perfusion|perfusion
354094|NCT01433705|glucose|glucose
354095|NCT01433692|Addictions|addictions
354096|NCT01433692|Adolescents|adolescents
354097|NCT01433692|Primary Health Care|primary health care
354098|NCT01433692|Brief Intervention|brief intervention
354099|NCT01433679|Health Behavior|health behavior
354100|NCT01433679|Exercise|exercise
354101|NCT01433679|Adolescent Behavior|adolescent behavior
354102|NCT01433679|Motivation|motivation
354103|NCT01433679|Biological Markers|biological markers
354104|NCT01433653|Comorbid|comorbid
354105|NCT01433653|Complicated|complicated
354106|NCT01433640|image on multi-modalities|image on multi-modalities
354107|NCT01433640|visualize cancer lesions|visualize cancer lesions
354108|NCT01433640|highly suspicious lesions|highly suspicious lesions
354109|NCT01433627|acute coronary syndromes|acute coronary syndromes
354110|NCT01433627|myocardial infarction|myocardial infarction
354111|NCT01433627|access site|access site
354112|NCT01433627|bivalirudin|bivalirudin
354113|NCT01433627|bleedings|bleedings
354114|NCT01433601|Adherence|adherence
354115|NCT01433601|Peer support|peer support
354116|NCT01433601|Treatment failure|treatment failure
354117|NCT01433588|Managing infant pain|managing infant pain
354118|NCT01433588|27 - 36+6 weeks gestation|27 - 36+6 weeks gestation
354119|NCT01433588|Preterm infants|preterm infants
354120|NCT01433562|breast cancer|breast cancer
354121|NCT01433562|neoadjuvant therapy|neoadjuvant therapy
354122|NCT01433562|Stage II/III|stage ii/iii
354123|NCT01433536|cranial trauma with or without high velocity fracture to inferior limb|cranial trauma with or without high velocity fracture to inferior limb
354124|NCT01433536|spinal trauma with or without high velocity fracture to inferior limb|spinal trauma with or without high velocity fracture to inferior limb
354125|NCT01433536|high velocity fracture to inferior limb|high velocity fracture to inferior limb
354126|NCT01433523|HDM|hdm
354127|NCT01433523|AIT|ait
354128|NCT01433523|asthma|asthma
354129|NCT01433523|asthma exacerbation|asthma exacerbation
354130|NCT01433523|House dust mite induced asthma|house dust mite induced asthma
354131|NCT01433510|Allergic|allergic
354132|NCT01433510|Rhinoconjunctivitis|rhinoconjunctivitis
354133|NCT01433510|Immunotherapy|immunotherapy
354134|NCT01433497|multiple sclerosis|multiple sclerosis
354135|NCT01433497|primary progressive|primary progressive
354136|NCT01433497|relapse-free|relapse-free
354137|NCT01433497|secondary progressive|secondary progressive
354138|NCT01433484|cardiovascular disease|cardiovascular disease
354139|NCT01433484|coronary heart disease|coronary heart disease
354140|NCT01433484|obesity|obesity
354141|NCT01433484|weight loss|weight loss
354142|NCT01433484|genomics|genomics
354143|NCT01433471|Ulcerative Colitis|ulcerative colitis
354144|NCT01433471|Trichuris Suis Ova|trichuris suis ova
354145|NCT01433471|Inflammatory Bowel Disease|inflammatory bowel disease
354146|NCT01433471|Mucus|mucus
354147|NCT01433458|Hepatic impairment|hepatic impairment
354148|NCT01433458|healthy volunteers|healthy volunteers
354149|NCT01433458|RLX030|rlx030
354150|NCT01433458|pharmacokinetics|pharmacokinetics
354151|NCT01433445|Myelofibrosis|myelofibrosis
354152|NCT01433445|Panobinostat|panobinostat
354153|NCT01433445|Ruxolitinib|ruxolitinib
354154|NCT01433445|MF|mf
354155|NCT01433445|PMF|pmf
354156|NCT01433445|PPV|ppv
354157|NCT01433445|PPV-MF|ppv-mf
354158|NCT01433445|PET|pet
354159|NCT01433445|PET-MF|pet-mf
354160|NCT01433445|JAK2|jak2
354161|NCT01433445|DACi|daci
354162|NCT01433432|Crohn's Disease|crohn's disease
354163|NCT01433419|Drug Therapy|drug therapy
354164|NCT01433406|Drug Therapy|drug therapy
354165|NCT01433393|Drug Therapy|drug therapy
354166|NCT01433380|Phase 1|phase 1
354167|NCT01433380|Single Doses|single doses
354168|NCT01433380|Pharmacodynamics|pharmacodynamics
354169|NCT01433380|Healthy Volunteers|healthy volunteers
354170|NCT01433367|total disc replacement|total disc replacement
354171|NCT01433367|cervical disc disease|cervical disc disease
354172|NCT01433354|Fragile X Syndrome|fragile x syndrome
354173|NCT01433354|Martin-Bell Syndrome|martin-bell syndrome
354174|NCT01433354|Genetic Diseases|genetic diseases
354175|NCT01433354|X-Linked|x-linked
354176|NCT01433354|Escalante's syndrome|escalante's syndrome
354177|NCT01433341|Normal young athletes|normal young athletes
354178|NCT01433328|Remodulin|remodulin
354179|NCT01433328|Treprostinil|treprostinil
354180|NCT01433315|sleep deprivation|sleep deprivation
354181|NCT01433315|sleep restriction|sleep restriction
354182|NCT01433302|Breast cancer|breast cancer
354183|NCT01433302|Genitourinary cancer|genitourinary cancer
354184|NCT01433302|Gynecological cancer|gynecological cancer
354185|NCT01433302|Malignant Female Reproductive System Neoplasm|malignant female reproductive system neoplasm
354186|NCT01433302|Melanoma|melanoma
354188|NCT01433302|Inflammatory Response|inflammatory response
354189|NCT01433302|Inflammatory proteins|inflammatory proteins
354190|NCT01433302|Tissue Fibrosis|tissue fibrosis
354191|NCT01433302|Lymphatico-venous Bypass Surgery|lymphatico-venous bypass surgery
354192|NCT01433302|Punch biopsy|punch biopsy
354193|NCT01433302|Lab collections|lab collections
354194|NCT01433302|Th2 immune phenotype|th2 immune phenotype
354195|NCT01433302|Lymphedema|lymphedema
354196|NCT01433289|HIV|hiv
354197|NCT01433289|safety|safety
354198|NCT01433289|toxicity|toxicity
354199|NCT01433289|pharmacokinetics|pharmacokinetics
354200|NCT01433289|Polyphenon E|polyphenon e
344814|NCT01471444|Fludarabine Phosphate|fludarabine phosphate
344815|NCT01471444|Fludara|fludara
344816|NCT01471444|Clofarabine|clofarabine
354201|NCT01433289|EGCG|egcg
354202|NCT01433289|green tea|green tea
354203|NCT01433289|CD4|cd4
354204|NCT01433289|viral load|viral load
354205|NCT01433276|Fluid resuscitation|fluid resuscitation
354206|NCT01433276|hemorrhagic shock|hemorrhagic shock
354207|NCT01433276|Totilac|totilac
354208|NCT01433276|Ringer's|ringer's
354209|NCT01433276|trauma|trauma
354210|NCT01433263|Wasting syndrome|wasting syndrome
354211|NCT01433263|emaciation|emaciation
354212|NCT01433263|lung cancer|lung cancer
354213|NCT01433263|adenocarcinoma|adenocarcinoma
354214|NCT01433263|pancreatic cancer|pancreatic cancer
354215|NCT01433250|Multiple Sclerosis,|multiple sclerosis,
354216|NCT01433250|demyelinating autoimmune diseases,|demyelinating autoimmune diseases,
354217|NCT01433250|interleukin-17,|interleukin-17,
354218|NCT01433250|monoclonal human antibody|monoclonal human antibody
354219|NCT01433237|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
354220|NCT01433237|adult rhabdomyosarcoma|adult rhabdomyosarcoma
354221|NCT01433237|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
354222|NCT01433237|adult soft tissue sarcoma|adult soft tissue sarcoma
354223|NCT01433237|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
354224|NCT01433224|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
354225|NCT01433224|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
354226|NCT01433224|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
354227|NCT01433224|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
354228|NCT01433185|PMTCT|pmtct
354229|NCT01433185|SMS|sms
354230|NCT01433185|HIV Infections|hiv infections
354231|NCT01433185|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
354232|NCT01433185|Prevention & Control|prevention & control
354233|NCT01433185|Patient Compliance|patient compliance
354234|NCT01433185|Cellular Phone|cellular phone
354235|NCT01433185|Randomized Controlled Trial|randomized controlled trial
354236|NCT01433172|stage IV|stage iv
354237|NCT01433172|adenocarcinoma|adenocarcinoma
354238|NCT01433172|vaccine therapy|vaccine therapy
354239|NCT01433172|immunology|immunology
354240|NCT01433172|tumor vaccine|tumor vaccine
354241|NCT01433172|colony stimulating factor(CSF)|colony stimulating factor(csf)
354242|NCT01433172|granulocyte-macrophage colony-stimulating factor (GM-CSF)|granulocyte-macrophage colony-stimulating factor (gm-csf)
354243|NCT01433172|CC chemokine ligand 21 (CCL21)|cc chemokine ligand 21 (ccl21)
354244|NCT01433172|Chemokine [C-C motif] ligand 21 (CCL21)|chemokine [c-c motif] ligand 21 (ccl21)
354245|NCT01433172|human leukocyte antigen serotype (HLA)|human leukocyte antigen serotype (hla)
354246|NCT01433159|Pressure Ulcers|pressure ulcers
354247|NCT01433159|Spinal Cord Injury|spinal cord injury
354248|NCT01433159|Healthpoint|healthpoint
354249|NCT01433159|Xenaderm|xenaderm
354250|NCT01433159|011-101|011-101
354251|NCT01433146|Temperament|temperament
354252|NCT01433146|Anxiety|anxiety
354253|NCT01433146|Depression|depression
354254|NCT01433146|Colorectal Cancer|colorectal cancer
354255|NCT01433120|Obesity|obesity
354256|NCT01433120|Insulin resistance|insulin resistance
354257|NCT01433120|Microbiota|microbiota
354258|NCT01433120|Probiotic|probiotic
354259|NCT01433120|Prebiotic|prebiotic
354260|NCT01433107|Tinea pedis|tinea pedis
354261|NCT01433107|Terbinafine film forming solution|terbinafine film forming solution
354262|NCT01433094|Adherence|adherence
354263|NCT01433094|Psychoeducation|psychoeducation
354264|NCT01433094|Pharmacotherapy|pharmacotherapy
354265|NCT01433094|Schizophrenia|schizophrenia
354266|NCT01433094|Family support|family support
354267|NCT01433068|Adult Soft Tissue Sarcoma of the extremities and Trunk wall|adult soft tissue sarcoma of the extremities and trunk wall
354268|NCT01433055|Schizophrenia|schizophrenia
354269|NCT01433055|Cognitive Symptoms|cognitive symptoms
354270|NCT01433055|Clozapine|clozapine
354271|NCT01433042|small bowel disease|small bowel disease
354272|NCT01433029|Surgical Procedure|surgical procedure
354273|NCT01433029|Assessment|assessment
354274|NCT01433029|Cardiothoracic Surgery|cardiothoracic surgery
354275|NCT01433029|Coronary artery bypass|coronary artery bypass
354276|NCT01433029|CAB|cab
354277|NCT01433029|Video recordings|video recordings
354278|NCT01433029|Global rating scale|global rating scale
354279|NCT01433029|GRS|grs
354280|NCT01433029|Cardiothoracic surgeon|cardiothoracic surgeon
354281|NCT01433029|Surgical trainees|surgical trainees
354282|NCT01433016|HCC Hepatocellular carcinoma|hcc hepatocellular carcinoma
354283|NCT01433016|OBT Octanoate Breath Test|obt octanoate breath test
354284|NCT01433003|Thrombotic thrombocytopenia purpura|thrombotic thrombocytopenia purpura
354285|NCT01433003|hemolytic uremic syndrome|hemolytic uremic syndrome
354286|NCT01433003|plasma exchange|plasma exchange
354287|NCT01433003|Improve treatment response|improve treatment response
354288|NCT01433003|TTP/HUS|ttp/hus
354289|NCT01432990|SCI|sci
354290|NCT01432990|gait|gait
354291|NCT01432990|rehabilitation|rehabilitation
354292|NCT01432990|robotic|robotic
354293|NCT01432964|Orbital Fractures|orbital fractures
354294|NCT01432964|Fracture Fixation|fracture fixation
354295|NCT01432964|Blow-out Fractures|blow-out fractures
354296|NCT01432964|Surgical Mesh|surgical mesh
354297|NCT01432964|Titanium|titanium
354298|NCT01432964|Computer-assisted Image Processing|computer-assisted image processing
354299|NCT01432925|Buruli ulcer|buruli ulcer
354300|NCT01432925|Mycobacterium ulcerans|mycobacterium ulcerans
354301|NCT01432925|Streptomycin|streptomycin
354302|NCT01432925|Rifampicin|rifampicin
354303|NCT01432925|Functional limitations|functional limitations
354304|NCT01432925|surgery|surgery
354305|NCT01432925|Bénin|bénin
354306|NCT01432899|Neurophysiology|neurophysiology
354307|NCT01432899|Hemidystonia|hemidystonia
354308|NCT01432899|Childhood-onset|childhood-onset
354309|NCT01432899|Motion Analysis|motion analysis
354310|NCT01432899|Neuroimaging|neuroimaging
354311|NCT01432899|Childhood Onset Hemidystonia|childhood onset hemidystonia
354312|NCT01432899|Healthy Volunteer|healthy volunteer
354313|NCT01432899|HV|hv
354314|NCT01432886|Breast Cancer|breast cancer
354315|NCT01432873|BMT|bmt
354316|NCT01432873|HSCT|hsct
354317|NCT01432860|Skin Self Examination|skin self examination
354318|NCT01432847|Best Disease|best disease
354319|NCT01432847|Late-Onset Retinal Degeneration (L-ORD)|late-onset retinal degeneration (l-ord)
354320|NCT01432847|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
354321|NCT01432847|Induced Pluripotent Stem Cell (iPS) Cell Lines|induced pluripotent stem cell (ips) cell lines
354322|NCT01432847|Retinal Degeneration|retinal degeneration
354323|NCT01432847|Age-Related Macular Degeneration|age-related macular degeneration
354324|NCT01432847|AMD|amd
354325|NCT01432834|non-anterior astigmatism correction|non-anterior astigmatism correction
354326|NCT01432834|Allegretto Wave excimer laser|allegretto wave excimer laser
354327|NCT01432834|wavefront optimized ablation profile (WFO)|wavefront optimized ablation profile (wfo)
354328|NCT01432834|LASIK|lasik
354329|NCT01432834|PRK|prk
354330|NCT01432821|Epilepsy,|epilepsy,
354331|NCT01432821|dopamine|dopamine
354332|NCT01432821|yawning,|yawning,
354333|NCT01432821|blinking eyelids,|blinking eyelids,
354334|NCT01432821|electroencephalography|electroencephalography
354335|NCT01432795|chronic venous insufficiency|chronic venous insufficiency
354336|NCT01432795|post-thrombotic syndrome|post-thrombotic syndrome
354337|NCT01432795|medical compression therapy|medical compression therapy
354338|NCT01432795|compression stocking|compression stocking
354339|NCT01432795|gliding aid|gliding aid
354340|NCT01432795|stocking butler|stocking butler
354341|NCT01432795|adherence to treatment|adherence to treatment
354342|NCT01432782|Weight loss|weight loss
354343|NCT01432782|Dysphagia|dysphagia
354344|NCT01432782|Esophageal hypermotility|esophageal hypermotility
354345|NCT01432782|Chest Pain|chest pain
354346|NCT01432769|enteral nutrition|enteral nutrition
354347|NCT01432769|malnutrition|malnutrition
354348|NCT01432769|cardiac surgery|cardiac surgery
354350|NCT01432743|3D mapping|3d mapping
354351|NCT01432743|Image integration|image integration
354352|NCT01432743|Atrial fibrillation|atrial fibrillation
354353|NCT01432743|Catheter Ablation|catheter ablation
354354|NCT01432704|MS|ms
354355|NCT01432704|vitamin D|vitamin d
354356|NCT01432704|environment|environment
354357|NCT01432691|Hip-fracture|hip-fracture
354358|NCT01432691|RSA|rsa
354359|NCT01432678|vitamin D|vitamin d
354360|NCT01432678|asthma|asthma
354361|NCT01432665|HSDD|hsdd
354362|NCT01432639|Myocardial infarction|myocardial infarction
354363|NCT01432639|Autonomic function|autonomic function
354364|NCT01432639|Arterial Stiffness|arterial stiffness
354365|NCT01432639|Endothelial function|endothelial function
354366|NCT01432639|Inflammation|inflammation
354367|NCT01432639|Rehabilitation program|rehabilitation program
354368|NCT01432639|Exercise|exercise
354369|NCT01432626|stress induced cardiomyopathy|stress induced cardiomyopathy
354370|NCT01432626|broken heart syndrome|broken heart syndrome
354371|NCT01432626|Takotsubo cardiomyopathy|takotsubo cardiomyopathy
354372|NCT01432626|transient apical ballooning syndrome|transient apical ballooning syndrome
354373|NCT01432626|apical ballooning cardiomyopathy|apical ballooning cardiomyopathy
354374|NCT01432626|stress cardiomyopathy|stress cardiomyopathy
354375|NCT01432626|non-ischemic cardiomyopathy|non-ischemic cardiomyopathy
354376|NCT01432613|Myositis|myositis
354377|NCT01432613|Magnetic Resonance Imaging|magnetic resonance imaging
354378|NCT01432613|Muscle biopsy|muscle biopsy
354379|NCT01432613|Sensitivity and Specificity|sensitivity and specificity
354380|NCT01432600|Multiple Myeloma|multiple myeloma
354381|NCT01432600|Relapsed|relapsed
354382|NCT01432600|Refractory|refractory
354383|NCT01432600|Corticosteroids|corticosteroids
354384|NCT01432587|Amyloidosis|amyloidosis
354385|NCT01432587|Transthyretin|transthyretin
354386|NCT01432587|Neuropathies|neuropathies
354387|NCT01432587|Diflunisal|diflunisal
354388|NCT01432587|Familial|familial
354389|NCT01432574|HPV|hpv
354390|NCT01432561|Lysosomal Storage Diseases|lysosomal storage diseases
354391|NCT01432561|Metabolic Diseases|metabolic diseases
354392|NCT01432561|Metabolism, Inborn Errors|metabolism, inborn errors
354393|NCT01432548|Ischemic|ischemic
354394|NCT01432548|preconditioning|preconditioning
354395|NCT01432548|liver|liver
354396|NCT01432548|resection|resection
354397|NCT01432522|Intranasal epinephrine|intranasal epinephrine
354398|NCT01432522|Plasma epinephrine level|plasma epinephrine level
354399|NCT01432509|Pre-diabetes|pre-diabetes
354400|NCT01432509|Type 2 diabetes|type 2 diabetes
354401|NCT01432509|Biomarkers|biomarkers
354402|NCT01432509|Cohort|cohort
354403|NCT01432509|Diabetes Risk Score|diabetes risk score
354404|NCT01432509|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
354405|NCT01432509|Glucose Intolerance|glucose intolerance
354406|NCT01432509|Prediabetic State|prediabetic state
354407|NCT01432509|Glucose Metabolism Disorders|glucose metabolism disorders
354408|NCT01432509|Metabolic Diseases|metabolic diseases
354409|NCT01432509|Endocrine System Diseases|endocrine system diseases
354410|NCT01432509|Hyperglycemia|hyperglycemia
354411|NCT01432496|Laparoscopic|laparoscopic
354412|NCT01432496|Colectomy|colectomy
354413|NCT01432496|Nebulization|nebulization
354414|NCT01432496|Ropivacaine|ropivacaine
354415|NCT01432483|Cancer|cancer
354416|NCT01432483|ONTAK|ontak
354417|NCT01432483|Denileukin diftitox|denileukin diftitox
354418|NCT01432483|persistent or recurrent disease|persistent or recurrent disease
354419|NCT01432483|requiring continued delivery of essential cancer therapy|requiring continued delivery of essential cancer therapy
354420|NCT01432470|vaginal atrophy|vaginal atrophy
354421|NCT01432444|Schizophrenia|schizophrenia
354422|NCT01432418|rehabilitation|rehabilitation
354423|NCT01432418|wheelchairs|wheelchairs
354424|NCT01432418|safety|safety
354425|NCT01432418|disability evaluation|disability evaluation
354426|NCT01432418|motor skills|motor skills
354427|NCT01432405|Diabetes|diabetes
354428|NCT01432392|gastroesophageal reflux disease|gastroesophageal reflux disease
354429|NCT01432392|GERD questionnaire|gerd questionnaire
354430|NCT01432392|primary care setting|primary care setting
354431|NCT01432340|Influenza|influenza
354432|NCT01432340|Influenza vaccine|influenza vaccine
354433|NCT01432340|Influenza vaccine effectiveness study|influenza vaccine effectiveness study
354434|NCT01432327|motor activity|motor activity
354435|NCT01432327|randomized controlled trial|randomized controlled trial
354436|NCT01432327|feedback|feedback
354437|NCT01432314|patient's survival|patient's survival
354438|NCT01432314|tumor response|tumor response
354439|NCT01432314|safety|safety
354440|NCT01432301|fluorouracil overdose|fluorouracil overdose
354441|NCT01432301|fluorouracil toxicity|fluorouracil toxicity
354442|NCT01432301|capecitabine overdose|capecitabine overdose
354443|NCT01432301|capecitabine toxicity|capecitabine toxicity
354444|NCT01432275|Diabetes|diabetes
354445|NCT01432275|SMBG|smbg
354446|NCT01432275|Insulin calculator|insulin calculator
354447|NCT01432262|prevention of pneumococcal diseases|prevention of pneumococcal diseases
354448|NCT01432249|pediatric psoriasis|pediatric psoriasis
354449|NCT01432249|enbrel|enbrel
354450|NCT01432249|safety|safety
354451|NCT01432249|efficacy|efficacy
354452|NCT01432236|Pregabalin|pregabalin
354453|NCT01432236|Lyrica|lyrica
354454|NCT01432236|depression|depression
354455|NCT01432223|Trastuzumab|trastuzumab
354456|NCT01432223|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
354457|NCT01432223|Primary chemotherapy|primary chemotherapy
354458|NCT01432210|post-prandial absorption|post-prandial absorption
354459|NCT01432210|provitamin A carotenoids|provitamin a carotenoids
354460|NCT01432210|vitamin A|vitamin a
354461|NCT01432210|avocado|avocado
354462|NCT01432210|tomato|tomato
354463|NCT01432210|carrot|carrot
354464|NCT01432197|HRQOL|hrqol
354465|NCT01432197|Occupational therapy|occupational therapy
354466|NCT01432197|ADL intervention|adl intervention
354467|NCT01432197|Cancer patients|cancer patients
354468|NCT01432184|cerebral|cerebral
354469|NCT01432184|hypoxia|hypoxia
354470|NCT01432171|Brain cancer|brain cancer
354471|NCT01432171|Central nervous system|central nervous system
354472|NCT01432171|Seizure prophylaxis|seizure prophylaxis
354473|NCT01432171|High-Grade Gliomas|high-grade gliomas
354474|NCT01432171|HGG|hgg
354475|NCT01432171|Supratentorial high-grade glioma|supratentorial high-grade glioma
354476|NCT01432171|Malignant glioma|malignant glioma
354477|NCT01432171|Lacosamide|lacosamide
354478|NCT01432171|Vimpat|vimpat
354479|NCT01432171|Placebo|placebo
354480|NCT01432171|Sugar pill|sugar pill
354481|NCT01432158|Invasive pneumococcal disease|invasive pneumococcal disease
354482|NCT01432145|BRCA defective|brca defective
354483|NCT01432132|Head and Neck Cancer|head and neck cancer
354484|NCT01432132|Body Image Adaptation|body image adaptation
354485|NCT01432132|Post surgical body image|post surgical body image
354486|NCT01432132|Audio-recorded interview|audio-recorded interview
354487|NCT01432132|Questionnaire|questionnaire
354488|NCT01432132|Survey|survey
354489|NCT01432119|Advanced Cancers|advanced cancers
354490|NCT01432119|Advanced Malignancies|advanced malignancies
354491|NCT01432119|Liver Metastases|liver metastases
354492|NCT01432119|SIR-Spheres|sir-spheres
354493|NCT01432119|Selective internal radiation|selective internal radiation
354494|NCT01432119|Yttrium-90|yttrium-90
354495|NCT01432119|Cetuximab|cetuximab
354496|NCT01432119|C225|c225
354497|NCT01432119|Erbitux|erbitux
354498|NCT01432119|Erlotinib|erlotinib
354499|NCT01432119|Erlotinib Hydrochloride|erlotinib hydrochloride
354500|NCT01432119|Tarceva|tarceva
354501|NCT01432119|OSI-774|osi-774
354502|NCT01432106|Hypertension|hypertension
354503|NCT01432106|Metabolic Syndrome|metabolic syndrome
354504|NCT01432106|African American|african american
354505|NCT01432093|liver transplant|liver transplant
354506|NCT01432093|high blood sugars|high blood sugars
354507|NCT01432093|hospital hyperglycemia|hospital hyperglycemia
354708|NCT01431326|anaesthetic|anaesthetic
354508|NCT01432093|post-transplant hyperglycemia|post-transplant hyperglycemia
354509|NCT01432093|post liver transplant|post liver transplant
354510|NCT01432093|post liver-kidney transplant|post liver-kidney transplant
354511|NCT01432080|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
354512|NCT01432080|Viral respiratory tract infections|viral respiratory tract infections
354513|NCT01432080|Respiratory syncytial viruses|respiratory syncytial viruses
354514|NCT01432080|Influenza virus A|influenza virus a
354515|NCT01432080|Influenza virus B|influenza virus b
354516|NCT01432080|Transplantation, Allogeneic|transplantation, allogeneic
354517|NCT01432067|cancer|cancer
354518|NCT01432067|geriatry|geriatry
354519|NCT01432067|curative care|curative care
354520|NCT01432067|physical activity|physical activity
354521|NCT01432054|Human Tissue Repository|human tissue repository
354522|NCT01432041|Injury prevention|injury prevention
354523|NCT01432041|smoke alarms|smoke alarms
354524|NCT01432041|car seats|car seats
354525|NCT01432015|aprepitant|aprepitant
354526|NCT01432015|fosaprepitant|fosaprepitant
354527|NCT01432015|gynecologic cancer|gynecologic cancer
354528|NCT01432015|emesis|emesis
354529|NCT01432002|breast carcinoma|breast carcinoma
354530|NCT01432002|FDG|fdg
354531|NCT01432002|PET/CT|pet/ct
354532|NCT01432002|PET/IRM|pet/irm
354533|NCT01431950|fluticasone furoate|fluticasone furoate
354534|NCT01431937|Pharmacodynamics|pharmacodynamics
354535|NCT01431937|Pharmacokinetics|pharmacokinetics
354536|NCT01431924|outcomes|outcomes
354537|NCT01431924|observational|observational
354538|NCT01431924|retrospective|retrospective
354539|NCT01431924|database|database
354540|NCT01431924|asthma|asthma
354541|NCT01431898|HCV RNA|hcv rna
354542|NCT01431898|Polymerase inhibitor|polymerase inhibitor
354543|NCT01431898|Treatment naïve and Treatment experienced|treatment naïve and treatment experienced
354544|NCT01431898|GS-9669|gs-9669
354545|NCT01431898|Hepatitis C|hepatitis c
354546|NCT01431898|HCV|hcv
354547|NCT01431885|fibronectin|fibronectin
354548|NCT01431885|cervical length|cervical length
354549|NCT01431872|Aromatase Inhibitors|aromatase inhibitors
354550|NCT01431859|pollen|pollen
354551|NCT01431859|allergy|allergy
354552|NCT01431859|food|food
354553|NCT01431859|immunotherapy|immunotherapy
354554|NCT01431833|Hepatic Impairment|hepatic impairment
354555|NCT01431833|Matched control subjects|matched control subjects
354556|NCT01431820|Onychomycosis|onychomycosis
354557|NCT01431820|Toenail Fungus|toenail fungus
354558|NCT01431820|luliconazole|luliconazole
354559|NCT01431820|Antifungal|antifungal
354560|NCT01431820|Topical|topical
354561|NCT01431794|Pancreatic ductal adenocarcinoma (PDA)Neoplasms|pancreatic ductal adenocarcinoma (pda)neoplasms
354562|NCT01431794|LDE225|lde225
354563|NCT01431794|nab-paclitaxel|nab-paclitaxel
354564|NCT01431794|abraxane|abraxane
354565|NCT01431794|gemcitabine|gemcitabine
354566|NCT01431794|neoadjuvant|neoadjuvant
354567|NCT01431794|cytotoxic|cytotoxic
354568|NCT01431794|hedgehog (Hh) inhibitors|hedgehog (hh) inhibitors
354569|NCT01431794|stromal cells|stromal cells
354570|NCT01431794|resectable PDA|resectable pda
354571|NCT01431794|Pancreatic Diseases|pancreatic diseases
354572|NCT01431794|Carcinoma|carcinoma
354573|NCT01431768|Influenza|influenza
354574|NCT01431768|Human|human
354575|NCT01431768|Orthomyxoviridae infections|orthomyxoviridae infections
354576|NCT01431768|RNA Virus Infections|rna virus infections
354577|NCT01431768|Virus Diseases|virus diseases
354578|NCT01431768|Respiratory Tract infections|respiratory tract infections
354579|NCT01431768|Respiratory Tract Diseases|respiratory tract diseases
354580|NCT01431742|buccal soluble film|buccal soluble film
354581|NCT01431742|Pain|pain
354582|NCT01431742|Back Pain|back pain
354583|NCT01431742|Low Back Pain|low back pain
354584|NCT01431742|Buprenorphine|buprenorphine
354585|NCT01431742|Analgesics, Opioid|analgesics, opioid
354586|NCT01431742|Analgesics|analgesics
354587|NCT01431703|narrow band imaging|narrow band imaging
354588|NCT01431703|learning curve|learning curve
354589|NCT01431703|colorectal|colorectal
354590|NCT01431703|differential diagnosis|differential diagnosis
354591|NCT01431703|with colorectal lesion|with colorectal lesion
354592|NCT01431703|NBI with magnification|nbi with magnification
354593|NCT01431690|Eicosapentaenoic Acid|eicosapentaenoic acid
354594|NCT01431690|Docosahexaenoic Acid|docosahexaenoic acid
354595|NCT01431690|Warfarin|warfarin
354596|NCT01431690|Hypertriglyceridemia|hypertriglyceridemia
354597|NCT01431690|Omega-3 free fatty acids|omega-3 free fatty acids
354598|NCT01431690|Omega-3 ethyl ester acids|omega-3 ethyl ester acids
354599|NCT01431690|Epanova|epanova
354600|NCT01431690|Lovaza|lovaza
354601|NCT01431690|pharmacokinetics|pharmacokinetics
354602|NCT01431690|low-fat meal|low-fat meal
354603|NCT01431677|Muscle|muscle
354604|NCT01431677|Biopsy|biopsy
354605|NCT01431677|Energetics|energetics
354606|NCT01431677|Sarcopenia|sarcopenia
354607|NCT01431677|Frailty|frailty
354608|NCT01431664|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
354609|NCT01431664|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
354610|NCT01431664|acute leukemias of ambiguous lineage|acute leukemias of ambiguous lineage
354611|NCT01431664|acute undifferentiated leukemia|acute undifferentiated leukemia
354612|NCT01431664|secondary acute myeloid leukemia|secondary acute myeloid leukemia
354613|NCT01431651|Food and beverages|food and beverages
354614|NCT01431651|Food|food
354615|NCT01431651|Dietary supplements|dietary supplements
354616|NCT01431638|Gout|gout
354617|NCT01431638|arthritis|arthritis
354618|NCT01431638|gout flare|gout flare
354619|NCT01431638|acute gout|acute gout
354620|NCT01431638|gouty|gouty
354621|NCT01431638|rheumatic disease|rheumatic disease
354622|NCT01431638|uric acid|uric acid
354623|NCT01431638|podagra|podagra
354624|NCT01431625|COPD|copd
354625|NCT01431625|Exercise Training|exercise training
354626|NCT01431612|Pharmacokinetics, kidney;|pharmacokinetics, kidney;
354627|NCT01431612|Receptors, adrenergic;|receptors, adrenergic;
354628|NCT01431612|Fluids, i.v.;|fluids, i.v.;
354629|NCT01431612|Sympathetic nervous system, esmolol;|sympathetic nervous system, esmolol;
354630|NCT01431612|Sympathetic nervous system, phenylephrine|sympathetic nervous system, phenylephrine
354631|NCT01431599|Locally advanced rectal cancer|locally advanced rectal cancer
354632|NCT01431586|JDTic|jdtic
354633|NCT01431586|cocaine dependence|cocaine dependence
354634|NCT01431586|kappa-opioid antagonist|kappa-opioid antagonist
354635|NCT01431573|Depression|depression
354636|NCT01431560|ankle|ankle
354637|NCT01431560|metallic|metallic
354638|NCT01431560|biodegradable|biodegradable
354639|NCT01431560|Freedom|freedom
354640|NCT01431508|Hypertension|hypertension
354641|NCT01431495|platelet agregation|platelet agregation
354642|NCT01431495|clopidogrel|clopidogrel
354643|NCT01431495|major adverse cardiac events (MACE)|major adverse cardiac events (mace)
354644|NCT01431482|skin symptoms|skin symptoms
354645|NCT01431456|Prevention|prevention
354646|NCT01431456|venous thromboembolism after knee arthroplasty|venous thromboembolism after knee arthroplasty
354647|NCT01431443|Randomized double blind trial|randomized double blind trial
354648|NCT01431443|Cocoa flavonoids|cocoa flavonoids
354649|NCT01431443|Endothelial function|endothelial function
354650|NCT01431443|Blood pressure|blood pressure
354651|NCT01431443|Pregnant women|pregnant women
354652|NCT01431443|Preeclampsia|preeclampsia
354653|NCT01431443|Uterine artery flow|uterine artery flow
354654|NCT01431443|Pulsatility index|pulsatility index
354655|NCT01431430|Vitamine D|vitamine d
354656|NCT01431430|renal transplantation|renal transplantation
354657|NCT01431430|diabetes mellitus|diabetes mellitus
354658|NCT01431430|cancer|cancer
354659|NCT01431430|cardiovascular complications|cardiovascular complications
354660|NCT01431417|Shoulder|shoulder
354661|NCT01431417|Outcome treatment|outcome treatment
354662|NCT01431417|Validation Studies as topic|validation studies as topic
354663|NCT01431417|Biomechanics|biomechanics
354664|NCT01431417|Shoulder, Joint Instability|shoulder, joint instability
354665|NCT01431391|Immune therapy|immune therapy
354666|NCT01431391|Cancer vaccine|cancer vaccine
354667|NCT01431391|Therapeutic vaccine|therapeutic vaccine
354668|NCT01431391|Therapeutic cancer vaccine|therapeutic cancer vaccine
354669|NCT01431391|Vaccine|vaccine
354670|NCT01431391|Dendritic cells|dendritic cells
354671|NCT01431391|PSA|psa
354672|NCT01431391|Androgen deprivation therapy|androgen deprivation therapy
354673|NCT01431391|Prostatic Neoplasms|prostatic neoplasms
354674|NCT01431391|Genital Neoplasms, Male|genital neoplasms, male
354675|NCT01431391|Urogenital Neoplasms|urogenital neoplasms
354676|NCT01431391|Neoplasms|neoplasms
354677|NCT01431391|Prostatic Diseases|prostatic diseases
354678|NCT01431391|Androgens|androgens
354679|NCT01431391|Hormones|hormones
354680|NCT01431391|Adenocarcinoma|adenocarcinoma
354681|NCT01431391|Carcinoma|carcinoma
354682|NCT01431391|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
354683|NCT01431391|Immunology|immunology
354684|NCT01431391|Hormone therapy|hormone therapy
354685|NCT01431391|Immunotherapy|immunotherapy
354686|NCT01431391|Luteinizing hormone-releasing hormone (LHRH)|luteinizing hormone-releasing hormone (lhrh)
354687|NCT01431378|CT scan|ct scan
354688|NCT01431378|CNS|cns
354689|NCT01431378|Thorax|thorax
354690|NCT01431378|Abdomen|abdomen
354691|NCT01431378|staging of a known or suspected lung cancer|staging of a known or suspected lung cancer
345322|NCT01469403|Obesity|obesity
354692|NCT01431378|suspected urolithiasis|suspected urolithiasis
354693|NCT01431378|known or suspected focal liver lesion|known or suspected focal liver lesion
354694|NCT01431365|exercise|exercise
354695|NCT01431365|topography|topography
354696|NCT01431365|cravings|cravings
354697|NCT01431365|smoking behaviour|smoking behaviour
354698|NCT01431352|Polycystic ovary syndrome|polycystic ovary syndrome
354699|NCT01431352|Randomized controlled trial|randomized controlled trial
354700|NCT01431352|Chinese herbal medicine|chinese herbal medicine
354701|NCT01431352|Chinese herbal medicine granules|chinese herbal medicine granules
354702|NCT01431352|Letrozole|letrozole
354703|NCT01431352|Live birth|live birth
354704|NCT01431326|adenovirus|adenovirus
354705|NCT01431326|adrenal insufficiency|adrenal insufficiency
354706|NCT01431326|afterload inducer|afterload inducer
354707|NCT01431326|amnestic|amnestic
354709|NCT01431326|anesthesia|anesthesia
354710|NCT01431326|angina|angina
354711|NCT01431326|anticoagulant|anticoagulant
354712|NCT01431326|anti-epileptic|anti-epileptic
354713|NCT01431326|anti-inflammatory|anti-inflammatory
354714|NCT01431326|antimicrobial|antimicrobial
354715|NCT01431326|anti-psychotic|anti-psychotic
354716|NCT01431326|antiviral|antiviral
354717|NCT01431326|anxiety|anxiety
354718|NCT01431326|anxiolysis|anxiolysis
354719|NCT01431326|anxiolytic|anxiolytic
354720|NCT01431326|autism|autism
354721|NCT01431326|autistic disorder|autistic disorder
354722|NCT01431326|benzodiazepine|benzodiazepine
354723|NCT01431326|bipolar disorder|bipolar disorder
354724|NCT01431326|convulsions|convulsions
354725|NCT01431326|edema|edema
354726|NCT01431326|epilepsy|epilepsy
354727|NCT01431326|headaches|headaches
354728|NCT01431326|herpes simplex virus|herpes simplex virus
354729|NCT01431326|HSV|hsv
354730|NCT01431326|hypertension|hypertension
354731|NCT01431326|infantile hemangioma|infantile hemangioma
354732|NCT01431326|infection|infection
354733|NCT01431326|inflammation|inflammation
354734|NCT01431326|influenza|influenza
354735|NCT01431326|LRTI|lrti
354736|NCT01431326|meningitis|meningitis
354737|NCT01431326|migraines|migraines
354738|NCT01431326|muscle spasms|muscle spasms
354739|NCT01431326|pain|pain
354740|NCT01431326|pneumonia|pneumonia
354741|NCT01431326|prophylaxis|prophylaxis
354742|NCT01431326|retinitis|retinitis
354743|NCT01431326|schizophrenia|schizophrenia
354744|NCT01431326|sedation|sedation
354745|NCT01431326|sedative|sedative
354746|NCT01431326|seizures|seizures
354747|NCT01431326|septicemia|septicemia
354748|NCT01431326|swelling|swelling
354749|NCT01431326|thromboprophylaxis|thromboprophylaxis
354750|NCT01431326|thrombosis|thrombosis
354751|NCT01431326|urinary tract infection|urinary tract infection
354752|NCT01431326|UTI|uti
354753|NCT01431326|withdrawal|withdrawal
354754|NCT01431313|pulmonary hypertension|pulmonary hypertension
354755|NCT01431300|central veins|central veins
354756|NCT01431300|thorax|thorax
354757|NCT01431300|superior vena cava|superior vena cava
354758|NCT01431300|Central vein imaging|central vein imaging
354759|NCT01431261|Chronic neck pain|chronic neck pain
354760|NCT01431261|Whiplash|whiplash
354761|NCT01431261|Whiplash Associated Disorders|whiplash associated disorders
354762|NCT01431261|Chronic Pain|chronic pain
354763|NCT01431261|Neck exercises|neck exercises
354764|NCT01431261|Training|training
354765|NCT01431261|Pacing|pacing
354766|NCT01431261|Patient Education|patient education
354767|NCT01431261|Pain Management|pain management
354768|NCT01431261|Whiplash Injuries|whiplash injuries
354769|NCT01431261|Musculoskeletal|musculoskeletal
354770|NCT01431248|Preterm Premature Rupture of Membranes|preterm premature rupture of membranes
354771|NCT01431248|Erythromycin|erythromycin
354772|NCT01431248|Azithromycin|azithromycin
354773|NCT01431235|ADHD|adhd
354779|NCT01431222|EuroSCORE|euroscore
354780|NCT01431222|STS Risk Score|sts risk score
354781|NCT01431222|MitraClip|mitraclip
354782|NCT01431222|fluoroscopy|fluoroscopy
354783|NCT01431222|echocardiography|echocardiography
354784|NCT01431222|percutaneous treatment of mitral regurgitation|percutaneous treatment of mitral regurgitation
354785|NCT01431196|breast cancer|breast cancer
354786|NCT01431196|neoadjuvant chemotherapy|neoadjuvant chemotherapy
354787|NCT01431196|autologous dendritic cell vaccination|autologous dendritic cell vaccination
354788|NCT01431183|influenza|influenza
354789|NCT01431183|vaccine|vaccine
354790|NCT01431183|reminder / recall|reminder / recall
354791|NCT01431183|immunization registry|immunization registry
354792|NCT01431183|immunization information systems|immunization information systems
354793|NCT01431157|Sleep Apnea Syndrome|sleep apnea syndrome
354794|NCT01431157|Heart Failure|heart failure
354795|NCT01431157|Oxygen Inhalation Therapy|oxygen inhalation therapy
354796|NCT01431144|soft tissue thickness|soft tissue thickness
354797|NCT01431144|dental implant|dental implant
354798|NCT01431144|soft tissue recession|soft tissue recession
354799|NCT01431144|implant exposure|implant exposure
354800|NCT01431131|graft placement|graft placement
354801|NCT01431131|bone resorption|bone resorption
354802|NCT01431118|iron metabolism|iron metabolism
354803|NCT01431118|hepcidin|hepcidin
354804|NCT01431118|dragon boating|dragon boating
354805|NCT01431118|sport-specific stress|sport-specific stress
354806|NCT01431118|iron|iron
354807|NCT01431118|anaemia|anaemia
354808|NCT01431118|sport|sport
354809|NCT01431105|Kawasaki disease|kawasaki disease
354811|NCT01431079|College men|college men
354812|NCT01431079|HPV vaccine|hpv vaccine
354813|NCT01431079|Health belief model|health belief model
355198|NCT01429545|Tocolysis|tocolysis
354814|NCT01431079|HPV vaccine acceptance|hpv vaccine acceptance
354815|NCT01431053|exemestane|exemestane
354816|NCT01431053|aspirin|aspirin
354817|NCT01431053|quality of life|quality of life
354818|NCT01431040|Bowel Prep|bowel prep
354819|NCT01431040|No bowel prep|no bowel prep
354820|NCT01431040|Vaginal reconstructive or obliterative surgery|vaginal reconstructive or obliterative surgery
354821|NCT01431027|Heart Failure|heart failure
354822|NCT01431027|Diastolic Heart Failure|diastolic heart failure
354823|NCT01431027|Heart Failure with Normal Ejection Fraction|heart failure with normal ejection fraction
354824|NCT01431014|orthognathic surgery|orthognathic surgery
354825|NCT01431014|steroid|steroid
354826|NCT01431014|swelling|swelling
354827|NCT01431014|3-dimensional photogrammetry|3-dimensional photogrammetry
354828|NCT01431001|Depression|depression
354829|NCT01431001|MDD|mdd
354830|NCT01431001|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
354831|NCT01431001|Depressive Disorder|depressive disorder
354832|NCT01431001|TMS|tms
354833|NCT01430988|Head Injuries|head injuries
354834|NCT01430988|Head Trauma|head trauma
354835|NCT01430988|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
354836|NCT01430988|Emergency Department|emergency department
354837|NCT01430988|Accident & Emergency|accident & emergency
354838|NCT01430975|Radiation Exposure|radiation exposure
354839|NCT01430975|Rubidium 82|rubidium 82
354840|NCT01430975|Strontium 82|strontium 82
354841|NCT01430975|Strontium 85|strontium 85
354842|NCT01430962|EBUS|ebus
354843|NCT01430962|mediastinal lymph nodes|mediastinal lymph nodes
354844|NCT01430962|mediastinal masses|mediastinal masses
354845|NCT01430962|anesthesia|anesthesia
354846|NCT01430962|moderate sedation|moderate sedation
354847|NCT01430949|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
354848|NCT01430949|Catheter Ablation|catheter ablation
354849|NCT01430949|Pulmonary Vein Isolation|pulmonary vein isolation
354850|NCT01430949|Radio Frequency Ablation|radio frequency ablation
354851|NCT01430936|Vascular Diseases|vascular diseases
354853|NCT01430936|Chronic Kidney Disease|chronic kidney disease
354854|NCT01430936|COPD|copd
354855|NCT01430923|Refrigeration free latanoprost|refrigeration free latanoprost
354862|NCT01430897|d-TGA|d-tga
354863|NCT01430897|dextro Transposition of the great arteries|dextro transposition of the great arteries
354864|NCT01430897|systemic right ventricle|systemic right ventricle
354865|NCT01430897|right ventricular failure|right ventricular failure
354866|NCT01430897|Atrial switch procedure|atrial switch procedure
354867|NCT01430884|coronary aspirate blood|coronary aspirate blood
354868|NCT01430884|particular debris / microemboli|particular debris / microemboli
354869|NCT01430884|distal occlusion device|distal occlusion device
354870|NCT01430858|Fracture|fracture
354871|NCT01430858|Anabolic|anabolic
354872|NCT01430858|Vibration|vibration
354873|NCT01430858|Strain Gauge|strain gauge
354874|NCT01430858|Focus - Osteoporosis|focus - osteoporosis
354875|NCT01430845|GDD|gdd
354876|NCT01430845|CP|cp
354877|NCT01430845|MR|mr
354878|NCT01430845|PDD|pdd
354879|NCT01430845|ASD|asd
354880|NCT01430845|BSID|bsid
354881|NCT01430832|PTSD|ptsd
354882|NCT01430832|Preterm|preterm
354883|NCT01430832|Premature|premature
354884|NCT01430832|VLBW|vlbw
354885|NCT01430819|Influenza|influenza
354886|NCT01430819|Influenza Virus Vaccine|influenza virus vaccine
354887|NCT01430819|Fluzone® 2011-2012 Formulation|fluzone® 2011-2012 formulation
354888|NCT01430819|Fluzone® High-Dose 2011-2012 Formulation|fluzone® high-dose 2011-2012 formulation
354889|NCT01430819|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
354890|NCT01430780|Coronary artery disease|coronary artery disease
354891|NCT01430780|nitrate|nitrate
354892|NCT01430780|endothelium|endothelium
354893|NCT01430767|adherence|adherence
354894|NCT01430754|Blindness|blindness
354895|NCT01430754|Eye Diseases|eye diseases
354896|NCT01430754|Nap Disorders|nap disorders
354897|NCT01430754|Circadian Rhythm Disorders|circadian rhythm disorders
354898|NCT01430754|Sleep Disorders|sleep disorders
354899|NCT01430754|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
354900|NCT01430754|Dyssomnias|dyssomnias
354901|NCT01430754|Nervous System Diseases|nervous system diseases
354902|NCT01430741|Implementation Science|implementation science
354903|NCT01430741|Supportive Housing|supportive housing
354904|NCT01430741|Co-occurring disorders|co-occurring disorders
354905|NCT01430741|Cluster randomized controlled trial|cluster randomized controlled trial
403015|NCT01228578|Quality of Life|quality of life
354906|NCT01430741|Hybrid implementation-effectiveness trial|hybrid implementation-effectiveness trial
354907|NCT01430715|active video game|active video game
354908|NCT01430715|video gaming|video gaming
354909|NCT01430715|accelerometery|accelerometery
354910|NCT01430715|MVPA|mvpa
354911|NCT01430715|outdoor play|outdoor play
354912|NCT01430715|children|children
354913|NCT01430715|unstructured|unstructured
354914|NCT01430715|energy expenditure|energy expenditure
354915|NCT01430689|Influenza|influenza
354916|NCT01430689|Pregnancy|pregnancy
354917|NCT01430689|Neonates|neonates
354918|NCT01430676|Incisional hernia|incisional hernia
354919|NCT01430676|recurrence|recurrence
354920|NCT01430676|longterm|longterm
354921|NCT01430663|aspergillosis|aspergillosis
354922|NCT01430663|bronchoalveolar lavage|bronchoalveolar lavage
354923|NCT01430663|galactomannan|galactomannan
354924|NCT01430663|pcr|pcr
354925|NCT01430663|hematological patients|hematological patients
354926|NCT01430650|Oral estrogens|oral estrogens
354927|NCT01430650|transdermal estrogens|transdermal estrogens
354928|NCT01430650|endometrial priming|endometrial priming
354929|NCT01430637|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
354930|NCT01430637|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
354931|NCT01430637|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
354932|NCT01430637|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
354933|NCT01430637|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
354934|NCT01430637|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
354935|NCT01430637|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
354936|NCT01430637|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
354937|NCT01430637|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
354938|NCT01430637|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
354939|NCT01430624|Rape|rape
354940|NCT01430624|Secondary prevention|secondary prevention
354941|NCT01430624|Intervention|intervention
354942|NCT01430611|Meningitis|meningitis
354943|NCT01430611|Neisseria meningitidis|neisseria meningitidis
354944|NCT01430611|Meningo A+C®|meningo a+c®
354945|NCT01430611|Meng Ling Kang®|meng ling kang®
354946|NCT01430598|Full Thickness Rotator Cuff Tear and Acromial Spur|full thickness rotator cuff tear and acromial spur
354947|NCT01430585|Ki-67|ki-67
354948|NCT01430585|postmenopausal early breast cancer|postmenopausal early breast cancer
354949|NCT01430585|ER positive/HER2 negative early breast cancer|er positive/her2 negative early breast cancer
354950|NCT01430572|Advanced Cancers|advanced cancers
354951|NCT01430572|Solid Tumors|solid tumors
354952|NCT01430572|PI3KCA Mutation Positive/PTEN|pi3kca mutation positive/pten
354953|NCT01430572|Refractory to standard therapy|refractory to standard therapy
354954|NCT01430572|Relapsed after standard therapy|relapsed after standard therapy
354955|NCT01430572|Pazopanib|pazopanib
354956|NCT01430572|GW786034|gw786034
354957|NCT01430572|Everolimus|everolimus
354958|NCT01430572|Afinitor|afinitor
354959|NCT01430572|RAD001|rad001
354960|NCT01430559|Validation of the WOMAC in Chinese subjects with osteoarthritis of the knee|validation of the womac in chinese subjects with osteoarthritis of the knee
728946|NCT01086709|Crossover|crossover
354961|NCT01430546|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
354962|NCT01430533|dermal sensitization potential|dermal sensitization potential
354963|NCT01430507|Anti-inflammatory drugs, DMARD|anti-inflammatory drugs, dmard
354964|NCT01430481|rosehip|rosehip
354965|NCT01430481|osteoarthritis|osteoarthritis
354966|NCT01430481|pain|pain
354967|NCT01430481|knee|knee
354968|NCT01430481|RCT|rct
354969|NCT01430468|Glenoid component position|glenoid component position
354970|NCT01430468|patient specific instruments|patient specific instruments
354971|NCT01430455|Major Depressive Episode|major depressive episode
354972|NCT01430455|Depression NOS|depression nos
354973|NCT01430455|Bipolar Disorder|bipolar disorder
354974|NCT01430455|Bipolar Disorder I|bipolar disorder i
354975|NCT01430455|Bipolar Disorder II|bipolar disorder ii
354976|NCT01430455|Bipolar Depression|bipolar depression
354977|NCT01430455|Major Depression|major depression
354978|NCT01430416|Uveal melanoma|uveal melanoma
354979|NCT01430416|phase 1|phase 1
354980|NCT01430416|AEB071|aeb071
354981|NCT01430416|Metastatic|metastatic
354982|NCT01430403|persistent allergic asthma|persistent allergic asthma
354983|NCT01430403|asthma exacerbations reduction|asthma exacerbations reduction
354984|NCT01430403|Xolair® (omalizumab)|xolair® (omalizumab)
354985|NCT01430403|Flovent® Diskus® (fluticasone)|flovent® diskus® (fluticasone)
354986|NCT01430403|placebo|placebo
354987|NCT01430403|inhaled corticosteroid therapy|inhaled corticosteroid therapy
354988|NCT01430403|anti-immunoglobulin E therapy|anti-immunoglobulin e therapy
354989|NCT01430403|anti-IgE therapy|anti-ige therapy
354990|NCT01430390|In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic|in vitro expanded allogeneic epstein-barr virus specific cytotoxic
354991|NCT01430390|T-Lymphocytes (EBV-CTLs)|t-lymphocytes (ebv-ctls)
354992|NCT01430390|CD19 specific T-cells|cd19 specific t-cells
354993|NCT01430390|11-038|11-038
354994|NCT01430377|periprocedural myonecrosis|periprocedural myonecrosis
354995|NCT01430377|procedure time|procedure time
354996|NCT01430377|fluoroscopy time|fluoroscopy time
354997|NCT01430364|coronary bifurcation stenosis|coronary bifurcation stenosis
354998|NCT01430364|dedicated bifurcation stent|dedicated bifurcation stent
354999|NCT01430364|sirolymus|sirolymus
355000|NCT01430364|PTS|pts
355001|NCT01430364|BiOSS Lym|bioss lym
355002|NCT01430351|Brain cancer|brain cancer
355003|NCT01430351|Central nervous system|central nervous system
355004|NCT01430351|Glioblastoma Multiforme|glioblastoma multiforme
355005|NCT01430351|GBM|gbm
355006|NCT01430351|Post Radiation Therapy|post radiation therapy
355007|NCT01430351|Post-RT|post-rt
355008|NCT01430351|External beam radiotherapy|external beam radiotherapy
355009|NCT01430351|XRT|xrt
355010|NCT01430351|Supratentorial glioblastoma|supratentorial glioblastoma
355011|NCT01430351|Gliosarcoma|gliosarcoma
355012|NCT01430351|Grade IV astrocytoma|grade iv astrocytoma
355013|NCT01430351|Temozolomide|temozolomide
355014|NCT01430351|Temodar|temodar
355015|NCT01430351|Memantine|memantine
355016|NCT01430351|Namenda|namenda
355017|NCT01430351|Mefloquine|mefloquine
355018|NCT01430351|Apo-Mefloquine|apo-mefloquine
355019|NCT01430351|Lariam|lariam
355020|NCT01430351|Metformin|metformin
355021|NCT01430325|Hyperbaric oxygen|hyperbaric oxygen
355022|NCT01430312|dermal irritative potential|dermal irritative potential
355023|NCT01430286|Caregivers|caregivers
355024|NCT01430286|Alzheimer Disease|alzheimer disease
355025|NCT01430286|Psychological stress|psychological stress
355026|NCT01430286|Psychological adaptation|psychological adaptation
355027|NCT01430286|Self-efficacy|self-efficacy
355028|NCT01430286|Randomized controlled trial|randomized controlled trial
355029|NCT01430273|Antiplatelet therapy|antiplatelet therapy
355030|NCT01430273|Surgery|surgery
355031|NCT01430273|Bleeding|bleeding
355032|NCT01430273|Platelet aggregation|platelet aggregation
355033|NCT01430260|efficacy|efficacy
355034|NCT01430260|ciclesonide|ciclesonide
355035|NCT01430260|levocetirizine|levocetirizine
355036|NCT01430260|allergic rhinitis|allergic rhinitis
355037|NCT01430247|amblyopia|amblyopia
355038|NCT01430247|amblyogenic factors|amblyogenic factors
355039|NCT01430247|screening|screening
355040|NCT01430247|preschool children|preschool children
355041|NCT01430247|visual acuity|visual acuity
355042|NCT01430247|prevalence|prevalence
355043|NCT01430234|Chronic pancreatitis|chronic pancreatitis
355044|NCT01430234|Exocrine insufficiency|exocrine insufficiency
355045|NCT01430234|Pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
355046|NCT01430234|Self-administration|self-administration
355047|NCT01430221|prediabetes|prediabetes
355048|NCT01430221|severity of depressive symptoms|severity of depressive symptoms
355049|NCT01430221|mindfulness|mindfulness
355050|NCT01430221|personalized health planning|personalized health planning
355051|NCT01430221|cardiometabolic diseases prevention|cardiometabolic diseases prevention
355052|NCT01430208|endometrial pathology|endometrial pathology
355053|NCT01430195|vitiligo|vitiligo
355054|NCT01430195|depigmentation|depigmentation
355055|NCT01430195|phototherapy|phototherapy
355056|NCT01430195|non-segmental vitiligo|non-segmental vitiligo
355057|NCT01430182|Adult|adult
355058|NCT01430182|Female|female
355059|NCT01430182|Humans|humans
355060|NCT01430182|Intraoperative Care/methods|intraoperative care/methods
355061|NCT01430182|Male|male
355062|NCT01430182|Methadone/administration & dosage|methadone/administration & dosage
355063|NCT01430182|Analgesics/therapeutic use|analgesics/therapeutic use
355064|NCT01430182|Methadone/therapeutic use|methadone/therapeutic use
355065|NCT01430182|Morphine/therapeutic use|morphine/therapeutic use
355066|NCT01430182|Middle Aged|middle aged
355067|NCT01430182|Pain Measurement/drug effects|pain measurement/drug effects
355068|NCT01430182|Pain Measurement/methods|pain measurement/methods
355069|NCT01430182|Pain, Postoperative/prevention & control|pain, postoperative/prevention & control
355070|NCT01430182|Prospective Studies|prospective studies
355071|NCT01430182|Double-Blind Method|double-blind method
355072|NCT01430182|Tibial Fractures/surgery|tibial fractures/surgery
355073|NCT01430182|Young Adult|young adult
355074|NCT01430182|Orthopedics|orthopedics
355075|NCT01430169|Xiaflex|xiaflex
355076|NCT01430169|Xiapex|xiapex
355077|NCT01430169|Collagenase clostridium histolyticum|collagenase clostridium histolyticum
355078|NCT01430156|Renal Transplantation|renal transplantation
355079|NCT01430156|Ischemia-reperfusion injury|ischemia-reperfusion injury
355080|NCT01430156|Heme-oxygenase 1|heme-oxygenase 1
355081|NCT01430156|Heme arginate|heme arginate
355082|NCT01430143|Exercise|exercise
355083|NCT01430130|scar|scar
355084|NCT01430130|incision|incision
355085|NCT01430130|wound healing|wound healing
355086|NCT01430130|scarring|scarring
355087|NCT01430130|scar revision|scar revision
355088|NCT01430117|Immunotherapy|immunotherapy
355089|NCT01430117|Skin prick test|skin prick test
355090|NCT01430117|Standardization|standardization
355091|NCT01430117|Poa pratensis|poa pratensis
355092|NCT01430078|ASP015K|asp015k
355093|NCT01430078|Healthy subjects|healthy subjects
355094|NCT01430078|Pharmacokinetics of ASP015K|pharmacokinetics of asp015k
355095|NCT01430065|transplant|transplant
355096|NCT01430065|ASP015K|asp015k
355097|NCT01430065|tacrolimus|tacrolimus
355098|NCT01430065|Prograf|prograf
355099|NCT01430065|healthy volunteers|healthy volunteers
355100|NCT01430039|Crohn's disease|crohn's disease
355101|NCT01430039|ulcerative colitis|ulcerative colitis
355102|NCT01430039|Syndecan-1|syndecan-1
355103|NCT01430026|chronic sinusitis|chronic sinusitis
355104|NCT01430026|gentamicin nasal irrigation|gentamicin nasal irrigation
355105|NCT01429987|Chronic Idiopathic Constipation|chronic idiopathic constipation
355106|NCT01429987|Constipation|constipation
355107|NCT01429987|Sign and Symptoms: Digestive|sign and symptoms: digestive
355108|NCT01429974|amniotic fluid|amniotic fluid
355109|NCT01429974|post term pregnancies|post term pregnancies
355110|NCT01429948|Stroke, Ischemic|stroke, ischemic
355111|NCT01429948|Patent foramen ovale|patent foramen ovale
355112|NCT01429948|Magnetic resonance imaging|magnetic resonance imaging
355113|NCT01429948|Paradoxical embolism|paradoxical embolism
355114|NCT01429948|Transcranial Doppler|transcranial doppler
355115|NCT01429948|Silent cerebral infarct|silent cerebral infarct
355116|NCT01429935|dental pain model|dental pain model
355117|NCT01429935|Ginger powder|ginger powder
355119|NCT01429909|Functional magnetic resonance imaging|functional magnetic resonance imaging
355120|NCT01429909|T2*|t2*
355121|NCT01429909|cortex and basal ganglia|cortex and basal ganglia
355122|NCT01429909|Parkinson's disease|parkinson's disease
355123|NCT01429896|peanut allergy|peanut allergy
355124|NCT01429896|food allergy|food allergy
355125|NCT01429896|thresholds|thresholds
355126|NCT01429896|anaphylaxis|anaphylaxis
355127|NCT01429896|food labelling|food labelling
355128|NCT01429896|food challenges|food challenges
355129|NCT01429896|peanut challenges|peanut challenges
355130|NCT01429857|Troponin concentration in heart failure|troponin concentration in heart failure
355131|NCT01429844|Calcineurin inhibitors|calcineurin inhibitors
355132|NCT01429844|Bronchiolitis obliterans|bronchiolitis obliterans
355133|NCT01429844|Lung transplantation|lung transplantation
355134|NCT01429844|Cyclosporine|cyclosporine
355135|NCT01429844|Tacrolimus|tacrolimus
355136|NCT01429844|Mycophenolate|mycophenolate
355137|NCT01429844|Steroids|steroids
355138|NCT01429844|Chronic rejection|chronic rejection
355139|NCT01429844|Acute rejection|acute rejection
355140|NCT01429844|Obliterative bronchiolitis|obliterative bronchiolitis
355141|NCT01429818|Endothelial dysfunction|endothelial dysfunction
355142|NCT01429818|Diabetes mellitus|diabetes mellitus
355144|NCT01429818|metformin|metformin
355145|NCT01429805|Hip arthroscopy|hip arthroscopy
355146|NCT01429779|General surgery|general surgery
355147|NCT01429766|Breath holding times|breath holding times
355148|NCT01429766|Phases of respiration|phases of respiration
355149|NCT01429766|Radiotherapy|radiotherapy
355150|NCT01429753|Cardiac resychronisation therapy|cardiac resychronisation therapy
355151|NCT01429753|Heart failure|heart failure
355152|NCT01429753|Imaging guided LV lead placement|imaging guided lv lead placement
355153|NCT01429740|PF 05180999|pf 05180999
355154|NCT01429740|safety|safety
355155|NCT01429740|pharmacokinetics|pharmacokinetics
586750|NCT00524992|Tenofovir Toxicity|tenofovir toxicity
355156|NCT01429727|Spontaneous coronary artery dissection|spontaneous coronary artery dissection
355157|NCT01429727|SCAD|scad
355158|NCT01429727|coronary artery disease|coronary artery disease
355159|NCT01429727|myocardial infarction|myocardial infarction
355160|NCT01429727|coronary dissection|coronary dissection
355161|NCT01429714|Elastic Compression Stockings|elastic compression stockings
355162|NCT01429714|Deep Venous Thrombosis|deep venous thrombosis
355163|NCT01429714|Post Thrombotic Syndrome|post thrombotic syndrome
355164|NCT01429701|Dermatitis|dermatitis
355165|NCT01429701|Dermatitis, Atopic|dermatitis, atopic
355166|NCT01429662|postmenopause|postmenopause
355167|NCT01429662|hypertension|hypertension
355168|NCT01429662|relaxation|relaxation
355169|NCT01429662|SBP 140-159 mmHg|sbp 140-159 mmhg
355170|NCT01429662|DBP 90-99 mmHg|dbp 90-99 mmhg
355171|NCT01429662|stage 1 or mild hypertension|stage 1 or mild hypertension
355172|NCT01429649|pure pulmonary ground glass opacity|pure pulmonary ground glass opacity
355173|NCT01429636|perimenopause|perimenopause
355174|NCT01429636|postmenopause|postmenopause
355175|NCT01429636|vasomotor symptoms|vasomotor symptoms
355176|NCT01429636|relaxation|relaxation
355177|NCT01429623|Mild Cognitive Impairment|mild cognitive impairment
355178|NCT01429623|Early Stage Dementia|early stage dementia
355179|NCT01429623|Conversion to Alzheimer's disease|conversion to alzheimer's disease
355180|NCT01429623|Memory Impairment|memory impairment
355181|NCT01429610|acute lymphoblastic leukemia|acute lymphoblastic leukemia
355182|NCT01429610|rituximab|rituximab
355183|NCT01429610|VPDL|vpdl
355184|NCT01429610|CD20|cd20
355185|NCT01429597|Cerebrovascular Accident|cerebrovascular accident
355186|NCT01429597|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
355187|NCT01429597|Fabry Disease|fabry disease
355188|NCT01429597|Fabry´s Disease|fabry´s disease
355189|NCT01429597|Anderson-Fabry Disease|anderson-fabry disease
355190|NCT01429597|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
355191|NCT01429597|Stroke, Acute|stroke, acute
355192|NCT01429597|Cerebral Stroke|cerebral stroke
355193|NCT01429584|bupivacaine concentration|bupivacaine concentration
355194|NCT01429584|interscalene nerve block|interscalene nerve block
355195|NCT01429584|diaphragm function|diaphragm function
355196|NCT01429584|diaphragm weakness|diaphragm weakness
355197|NCT01429558|treatment resistant obsessive-compulsive disorder|treatment resistant obsessive-compulsive disorder
355199|NCT01429545|atosiban|atosiban
355200|NCT01429545|nifedipine|nifedipine
355201|NCT01429545|combination|combination
355202|NCT01429532|Cataract|cataract
355203|NCT01429519|chronic wound|chronic wound
355204|NCT01429519|ulcerated wound|ulcerated wound
355205|NCT01429519|venous insufficiency|venous insufficiency
355206|NCT01429519|lymphatic insufficiency|lymphatic insufficiency
355207|NCT01429519|neuropathic wound|neuropathic wound
355208|NCT01429519|diabetic ulcer|diabetic ulcer
355209|NCT01429519|post- operative|post- operative
355210|NCT01429519|post-traumatic chronic wound|post-traumatic chronic wound
355211|NCT01429506|Sleeve gastrectomy|sleeve gastrectomy
355212|NCT01429506|Intensive medical management|intensive medical management
355213|NCT01429480|Analgesia, postoperative|analgesia, postoperative
355214|NCT01429467|Glucose Variability|glucose variability
355215|NCT01429467|Continuous Glucose Monitoring|continuous glucose monitoring
355216|NCT01429467|Hypoxia-inducible Factor (HIF)|hypoxia-inducible factor (hif)
355217|NCT01429467|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
355218|NCT01429467|Erythropoietin|erythropoietin
355219|NCT01429467|Cortisol|cortisol
355220|NCT01429454|Prodromal|prodromal
355221|NCT01429454|Schizophrenia|schizophrenia
355222|NCT01429454|Psychosis|psychosis
355223|NCT01429454|Omega|omega
355224|NCT01429428|Cellulitis|cellulitis
355225|NCT01429428|Skin ultra-sound images|skin ultra-sound images
355226|NCT01429428|Treatment|treatment
355227|NCT01429428|Infra-red light|infra-red light
355228|NCT01429415|pediatric|pediatric
355229|NCT01429415|Acute Asthma|acute asthma
355230|NCT01429415|Inhaled Magnesium|inhaled magnesium
355231|NCT01429402|Botulinum toxin A.|botulinum toxin a.
355232|NCT01429402|Cleft lip scar|cleft lip scar
355233|NCT01429389|Down syndrome|down syndrome
355234|NCT01429389|fetal aneuploidy|fetal aneuploidy
355235|NCT01429389|trisomy|trisomy
355236|NCT01429389|noninvasive screening test|noninvasive screening test
355237|NCT01429376|Chronic heart failure|chronic heart failure
355238|NCT01429376|Pulmonary function abnormalities/impairment|pulmonary function abnormalities/impairment
355240|NCT01429376|Airway obstruction|airway obstruction
355241|NCT01429376|Diffusion impairment|diffusion impairment
355242|NCT01429376|Pulmonary function tests|pulmonary function tests
355243|NCT01429376|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
355244|NCT01429376|Prevalence|prevalence
355245|NCT01429376|Overdiagnosis|overdiagnosis
355246|NCT01429376|Underdiagnosis|underdiagnosis
355247|NCT01429376|Systemic inflammation|systemic inflammation
355248|NCT01429376|Diagnostic Errors|diagnostic errors
355249|NCT01429363|contained herniated lumbar discs|contained herniated lumbar discs
355251|NCT01429363|Case series|case series
355252|NCT01429363|RCT|rct
355253|NCT01429350|ischemic stroke|ischemic stroke
355254|NCT01429350|acute intervention|acute intervention
355255|NCT01429350|thrombolysis|thrombolysis
355256|NCT01429350|rtPA|rtpa
355257|NCT01429350|internal carotid artery|internal carotid artery
355258|NCT01429350|middle cerebral artery|middle cerebral artery
355259|NCT01429350|mechanical thrombectomy|mechanical thrombectomy
355260|NCT01429350|Penumbra System|penumbra system
355261|NCT01429350|clot length|clot length
355262|NCT01429350|mRS|mrs
355263|NCT01429350|NIHSS|nihss
355264|NCT01429337|Pharmacokinetics|pharmacokinetics
355265|NCT01429337|Hepatic impaired patients|hepatic impaired patients
355266|NCT01429337|Healthy volunteers|healthy volunteers
355267|NCT01429337|Varying degrees of hepatic impairment|varying degrees of hepatic impairment
355268|NCT01429324|Near infrared spectroscopy|near infrared spectroscopy
355269|NCT01429324|neuromonitoring|neuromonitoring
355270|NCT01429324|aortic arch surgery|aortic arch surgery
355271|NCT01429311|Atopic Dermatitis|atopic dermatitis
355272|NCT01429311|Eczema herpeticum|eczema herpeticum
355273|NCT01429311|Interferon gamma|interferon gamma
355274|NCT01429311|IFNγ|ifnγ
355275|NCT01429298|Acute|acute
355276|NCT01429298|Pain|pain
355277|NCT01429298|Emergency Department|emergency department
355278|NCT01429298|Hydromorphone|hydromorphone
355279|NCT01429298|Protocol|protocol
355280|NCT01429285|Pain|pain
355281|NCT01429285|Hydromorphone|hydromorphone
355282|NCT01429285|Acute|acute
355283|NCT01429285|Emergency Department|emergency department
355284|NCT01429272|Bipolar Disorder|bipolar disorder
355285|NCT01429272|Minocycline|minocycline
355286|NCT01429259|Cystic Fibrosis|cystic fibrosis
355287|NCT01429259|Acute Pulmonary Exacerbations|acute pulmonary exacerbations
355288|NCT01429259|Pseudomonas aeruginosa|pseudomonas aeruginosa
355289|NCT01429246|Hypertension|hypertension
355290|NCT01429246|Diet Therapy|diet therapy
355291|NCT01429246|Sodium Chloride, Dietary|sodium chloride, dietary
355293|NCT01429246|Aged|aged
355294|NCT01429233|Observational|observational
355295|NCT01429233|Colombia|colombia
355296|NCT01429220|deep brain stimulation|deep brain stimulation
355297|NCT01429220|monopolar review|monopolar review
355298|NCT01429220|motion sensors|motion sensors
355299|NCT01429220|tremor|tremor
355300|NCT01429220|bradykinesia|bradykinesia
355301|NCT01429207|levodopa|levodopa
355302|NCT01429207|tremor|tremor
355303|NCT01429207|bradykinesia|bradykinesia
355304|NCT01429207|motion sensors|motion sensors
355305|NCT01429194|Weight Loss|weight loss
355306|NCT01429194|Trans-oral Endoscopic Procedure|trans-oral endoscopic procedure
355307|NCT01429194|Gastric Plication|gastric plication
355308|NCT01429181|Peripheral Neuropathic Pain|peripheral neuropathic pain
355309|NCT01429155|End stage liver disease|end stage liver disease
355310|NCT01429155|Living donor liver transplantation|living donor liver transplantation
355311|NCT01429155|Hepatitis C|hepatitis c
355312|NCT01429155|Interleukin 28B|interleukin 28b
355313|NCT01429129|Smoking|smoking
355314|NCT01429129|Nicotine|nicotine
355315|NCT01429129|Nicotine Replacement Therapy|nicotine replacement therapy
355316|NCT01429129|Nicotine Patch|nicotine patch
355317|NCT01429129|Nicoderm|nicoderm
355318|NCT01429129|Mass Distribution|mass distribution
355319|NCT01429129|Tobacco Control|tobacco control
355320|NCT01429129|Randomized Controlled Trial|randomized controlled trial
355321|NCT01429116|Blindness|blindness
355322|NCT01429116|Eye Diseases|eye diseases
355323|NCT01429116|Nap Disorders|nap disorders
355324|NCT01429116|Circadian Rhythm Disorders|circadian rhythm disorders
355325|NCT01429116|Sleep Disorders|sleep disorders
355326|NCT01429116|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
355327|NCT01429116|Dyssomnias|dyssomnias
355328|NCT01429116|Nervous System Diseases|nervous system diseases
355329|NCT01429090|Pharmacokinetics|pharmacokinetics
355330|NCT01429090|Accommodation, Ocular|accommodation, ocular
355331|NCT01429090|Reflex, Pupillary|reflex, pupillary
355332|NCT01429090|Salivation|salivation
355333|NCT01429077|Levodopa|levodopa
355334|NCT01429077|Ischemic Stroke|ischemic stroke
355335|NCT01429077|Aphasia|aphasia
355336|NCT01429077|Speech Rehabilitation|speech rehabilitation
355337|NCT01429051|Break through pain|break through pain
355338|NCT01429051|BTP|btp
355339|NCT01429051|Cancer|cancer
355340|NCT01429051|Intranasal Fentanyl Spray|intranasal fentanyl spray
355341|NCT01429051|INFS|infs
355342|NCT01429051|cancer patients|cancer patients
355343|NCT01429038|end-stage|end-stage
355344|NCT01429038|liver diseases|liver diseases
355345|NCT01429038|cirrhosis|cirrhosis
355346|NCT01429038|cancer|cancer
355347|NCT01429038|fulminant hepatic failure|fulminant hepatic failure
355348|NCT01429038|metabolic hepatic diseases|metabolic hepatic diseases
355349|NCT01429038|congenital hepatic diseases|congenital hepatic diseases
355350|NCT01429038|renal diseases|renal diseases
355351|NCT01429025|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
355352|NCT01429025|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
728947|NCT01086709|Hepatitis A|hepatitis a
355353|NCT01429025|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
355354|NCT01429025|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
355355|NCT01429025|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
355356|NCT01429025|Waldenström macroglobulinemia|waldenström macroglobulinemia
355357|NCT01429025|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
355358|NCT01429025|splenic marginal zone lymphoma|splenic marginal zone lymphoma
355359|NCT01429012|bone|bone
355360|NCT01429012|nonunion fracture|nonunion fracture
355361|NCT01429012|atrophic nonunion fracture|atrophic nonunion fracture
355362|NCT01429012|callus|callus
355363|NCT01429012|mesenchymal stem cells|mesenchymal stem cells
355364|NCT01429012|cell therapy|cell therapy
355365|NCT01429012|autologous|autologous
355366|NCT01429012|indium|indium
355367|NCT01429012|Pet-scan|pet-scan
355368|NCT01428999|probiotics|probiotics
355369|NCT01428999|gastrointestinal function|gastrointestinal function
355370|NCT01428999|intestinal bacteria flora|intestinal bacteria flora
355371|NCT01428986|maraviroc|maraviroc
355372|NCT01428986|osteoclasts|osteoclasts
355373|NCT01428986|Receptors, CCR5|receptors, ccr5
355374|NCT01428986|Chemokine CCL5|chemokine ccl5
355375|NCT01428973|Allogeneic hematopoeitic cell transplantation|allogeneic hematopoeitic cell transplantation
355376|NCT01428973|Graft-Versus-Host Disease|graft-versus-host disease
355377|NCT01428973|Prophylaxis|prophylaxis
355378|NCT01428973|Reduced-intensity conditioning|reduced-intensity conditioning
355379|NCT01428973|Immunosuppressive regimen|immunosuppressive regimen
355380|NCT01428973|HLA-matched donor|hla-matched donor
355381|NCT01428973|Progression free survival|progression free survival
355382|NCT01428973|Overall survival|overall survival
355383|NCT01428960|Palm mid fraction|palm mid fraction
355384|NCT01428960|Shea butter|shea butter
355385|NCT01428960|sn-1, sn-3 fatty acids|sn-1, sn-3 fatty acids
355386|NCT01428960|Cholesterol|cholesterol
355387|NCT01428960|Postprandial lipemia,|postprandial lipemia,
355388|NCT01428960|Inflammatory markers|inflammatory markers
355389|NCT01428960|Satiety|satiety
355390|NCT01428960|Gut hormone|gut hormone
355391|NCT01428960|Insulin|insulin
355392|NCT01428921|Long-term efficacy|long-term efficacy
355393|NCT01428921|Education programme|education programme
355394|NCT01428921|Adherence|adherence
355396|NCT01428921|CPAP|cpap
355397|NCT01428908|immunogenicity|immunogenicity
355398|NCT01428908|safety|safety
355399|NCT01428908|group A, C polysaccharide meningitis|group a, c polysaccharide meningitis
355400|NCT01428908|type b haemophilus Influenza|type b haemophilus influenza
355401|NCT01428908|conjugate vaccine|conjugate vaccine
355402|NCT01428895|Bone Metastases|bone metastases
355403|NCT01428895|Femoral Metastases|femoral metastases
355404|NCT01428882|Propofol|propofol
355405|NCT01428882|Midazolam|midazolam
355406|NCT01428882|Moderate sedation|moderate sedation
355407|NCT01428882|Deep sedation|deep sedation
355408|NCT01428882|Colonoscopy|colonoscopy
355409|NCT01428869|Statins|statins
355410|NCT01428869|acetylsalicylic acid|acetylsalicylic acid
355411|NCT01428869|dutasteride|dutasteride
355412|NCT01428869|Prostate Cancer|prostate cancer
355413|NCT01428869|Lower urinary tract symptoms|lower urinary tract symptoms
355414|NCT01428869|prevention|prevention
355415|NCT01428869|drug interactions|drug interactions
355416|NCT01428843|Inflammatory Bowel Disease|inflammatory bowel disease
355417|NCT01428843|Anemia|anemia
355418|NCT01428843|Anti-TNF alpha theray|anti-tnf alpha theray
355419|NCT01428843|Ferrisat perfusion|ferrisat perfusion
355420|NCT01428830|fistula|fistula
355421|NCT01428830|catheter|catheter
355422|NCT01428830|surgery|surgery
355423|NCT01428830|obstetrics|obstetrics
355424|NCT01428830|gynecology|gynecology
355425|NCT01428830|urology|urology
355426|NCT01428817|pregnancy|pregnancy
355427|NCT01428817|postpartum hemorrhage|postpartum hemorrhage
355428|NCT01428817|Cesarean delivery|cesarean delivery
355429|NCT01428817|carbetocin|carbetocin
355430|NCT01428804|Resistant Major Depression|resistant major depression
355431|NCT01428804|Mood disorders|mood disorders
355432|NCT01428804|tDCS|tdcs
355433|NCT01428791|Geriatrics|geriatrics
355434|NCT01428791|Older adults|older adults
355435|NCT01428791|Health Disparities|health disparities
355436|NCT01428791|Health Services for the Aged|health services for the aged
355437|NCT01428791|Interdisciplinary Health Team|interdisciplinary health team
355438|NCT01428791|Depressive symptoms|depressive symptoms
355439|NCT01428791|Metabolic Syndrome X|metabolic syndrome x
355440|NCT01428791|Overweight|overweight
355441|NCT01428791|Obesity|obesity
355442|NCT01428791|Hypertension|hypertension
355443|NCT01428791|Hyperglycemia|hyperglycemia
355444|NCT01428791|Dyslipidemias|dyslipidemias
355445|NCT01428778|Marathon running|marathon running
355446|NCT01428778|Brain MRI|brain mri
355447|NCT01428778|ECG recording|ecg recording
355448|NCT01428778|Blood tests|blood tests
355449|NCT01428752|colonoscopy|colonoscopy
355450|NCT01428752|colorectal neoplasms|colorectal neoplasms
355451|NCT01428752|screening|screening
355452|NCT01428752|family history|family history
355453|NCT01428739|cancer|cancer
355454|NCT01428739|MRS|mrs
355455|NCT01428739|Treatment response|treatment response
355456|NCT01428726|NT-KO-003|nt-ko-003
355457|NCT01428726|RRMS|rrms
355458|NCT01428726|efficacy|efficacy
355459|NCT01428726|safety|safety
355460|NCT01428726|Phase IIa|phase iia
355461|NCT01428713|menorrhagia|menorrhagia
355462|NCT01428713|oral contraceptives|oral contraceptives
355463|NCT01428713|oral tranexamic acid|oral tranexamic acid
355464|NCT01428687|Weight loss|weight loss
355465|NCT01428687|Sleep duration|sleep duration
355466|NCT01428674|Interpersonal mindful compassion|interpersonal mindful compassion
355467|NCT01428674|Loving kindness meditation|loving kindness meditation
355468|NCT01428674|Autonomic Nervous System|autonomic nervous system
355469|NCT01428674|Heart rate variability|heart rate variability
355470|NCT01428674|Respiratory rate|respiratory rate
355471|NCT01428674|Relaxation|relaxation
355472|NCT01428661|tasimelteon|tasimelteon
355473|NCT01428661|Major Depressive Disorder|major depressive disorder
355474|NCT01428661|MDD|mdd
355475|NCT01428661|depression|depression
355476|NCT01428648|Parkinson|parkinson
355477|NCT01428648|ballroom dancing|ballroom dancing
355478|NCT01428635|Leukemia|leukemia
355479|NCT01428635|Thrombocytopenia|thrombocytopenia
355480|NCT01428635|Tyrosine kinase therapy|tyrosine kinase therapy
355481|NCT01428635|TKI|tki
355482|NCT01428635|Chronic myeloid leukemia|chronic myeloid leukemia
355483|NCT01428635|CML|cml
355484|NCT01428635|Platelet count|platelet count
355485|NCT01428635|Clonal evolution|clonal evolution
355486|NCT01428635|Eltrombopag|eltrombopag
355487|NCT01428635|Promacta|promacta
355488|NCT01428635|Myelofibrosis|myelofibrosis
355489|NCT01428635|MF|mf
355490|NCT01428609|Amalgam|amalgam
355491|NCT01428609|Mercury|mercury
355492|NCT01428609|Endodontics|endodontics
355493|NCT01428609|Apicoectomy|apicoectomy
355494|NCT01428596|HIV-1|hiv-1
355495|NCT01428596|therapeutic vaccine|therapeutic vaccine
355496|NCT01428596|immunotherapy|immunotherapy
355497|NCT01428596|AIDS|aids
355498|NCT01428583|Chronic noncancer pain|chronic noncancer pain
355499|NCT01428583|oxycodone|oxycodone
355500|NCT01428583|naltrexone|naltrexone
355501|NCT01428570|sleep apnea, obstructive|sleep apnea, obstructive
355502|NCT01428570|intubation|intubation
355503|NCT01428557|Heart Failure|heart failure
355504|NCT01428557|Epidemiology|epidemiology
355505|NCT01428557|Evidence-Based Practice|evidence-based practice
355506|NCT01428492|AKT Inhibitor|akt inhibitor
355507|NCT01428492|hematologic malignancies|hematologic malignancies
355508|NCT01428492|GSK2110183|gsk2110183
355509|NCT01428492|bortezomib|bortezomib
355510|NCT01428492|multiple myeloma|multiple myeloma
355511|NCT01428492|dexamethasone|dexamethasone
355512|NCT01428453|Alzheimer's disease|alzheimer's disease
355513|NCT01428427|Gemcitabine|gemcitabine
355514|NCT01428427|MEK inhibitor|mek inhibitor
355515|NCT01428427|GSK1120212|gsk1120212
355516|NCT01428414|HER2|her2
355517|NCT01428414|Breast cancer|breast cancer
355518|NCT01428414|neoadjuvant chemotherapy|neoadjuvant chemotherapy
355519|NCT01428414|efficacy|efficacy
355520|NCT01428414|safety|safety
355521|NCT01428401|Complementary therapies|complementary therapies
355522|NCT01428401|Acute hemorrhagic stroke|acute hemorrhagic stroke
355523|NCT01428388|macular edema|macular edema
355524|NCT01428388|vein occlusion|vein occlusion
355525|NCT01428388|bevacizumab|bevacizumab
355526|NCT01428388|ranibizumab|ranibizumab
355527|NCT01428388|vascular endothelial growth factor|vascular endothelial growth factor
355528|NCT01428375|intravenous paracetamol|intravenous paracetamol
355529|NCT01428375|intrapartum analgesia|intrapartum analgesia
355530|NCT01428375|labor pain|labor pain
355531|NCT01428375|intrapartum pains|intrapartum pains
355532|NCT01428362|donepezil|donepezil
355533|NCT01428362|VI-1121|vi-1121
355534|NCT01428349|Incarcerated offenders|incarcerated offenders
355535|NCT01428349|emotionally reactive|emotionally reactive
355536|NCT01428349|emotionally stable|emotionally stable
355537|NCT01428349|psychopathy|psychopathy
355538|NCT01428310|dietary supplement|dietary supplement
355539|NCT01428310|nutraceutical|nutraceutical
355540|NCT01428297|Atopic dermatitis|atopic dermatitis
355541|NCT01428297|Eczema|eczema
355542|NCT01428297|Skin Diseases, Eczematous|skin diseases, eczematous
355543|NCT01428297|Netherton syndrome|netherton syndrome
355544|NCT01428297|Skin Diseases, Genetic|skin diseases, genetic
355545|NCT01428297|BPR277|bpr277
355546|NCT01428284|Healthy Volunteers|healthy volunteers
355547|NCT01428284|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
355548|NCT01428284|Pharmacokinetic|pharmacokinetic
355549|NCT01428284|Probenecid|probenecid
355550|NCT01428258|Diet therapy|diet therapy
355551|NCT01428258|Low phenylalanine diet|low phenylalanine diet
355552|NCT01428258|Attention|attention
355553|NCT01428258|Executive function|executive function
355554|NCT01428232|Breastfeeding|breastfeeding
355555|NCT01428232|Baby Friendly Hospital Initiative|baby friendly hospital initiative
355556|NCT01428232|Well-child clinics|well-child clinics
355557|NCT01428219|Prostate|prostate
355558|NCT01428219|Cancer|cancer
355559|NCT01428219|Metastatic|metastatic
355560|NCT01428206|palliative care|palliative care
355561|NCT01428206|nursing homes|nursing homes
355562|NCT01428206|Liverpool care pathway|liverpool care pathway
355563|NCT01428193|PCOS|pcos
355564|NCT01428193|hyperandrogenemia|hyperandrogenemia
355565|NCT01428180|preterm neonates|preterm neonates
355566|NCT01428180|hemodynamically relevant patent ductus arteriosus|hemodynamically relevant patent ductus arteriosus
355567|NCT01428167|Thyroid cancer|thyroid cancer
355568|NCT01428167|Hashimotos thyroiditis|hashimotos thyroiditis
355569|NCT01428167|Thyroidectomy|thyroidectomy
355570|NCT01428167|Anti-inflammatory factors|anti-inflammatory factors
355571|NCT01428154|paediatric|paediatric
355572|NCT01428154|dialysis|dialysis
355574|NCT01428154|pediatric|pediatric
355575|NCT01428141|Cancer|cancer
355576|NCT01428141|Gastrointestinal Cancer|gastrointestinal cancer
355577|NCT01428115|monoclonal|monoclonal
355578|NCT01428115|anxiety|anxiety
355579|NCT01428115|antibodies|antibodies
355580|NCT01428115|adalimumab|adalimumab
355581|NCT01428115|severe crohn's disease|severe crohn's disease
355582|NCT01428115|quality of life|quality of life
355583|NCT01428115|biological products|biological products
355584|NCT01428102|Thromboelastography|thromboelastography
355585|NCT01428102|TEG|teg
355586|NCT01428102|Coagulation|coagulation
355587|NCT01428102|RapidTEG|rapidteg
355588|NCT01428102|Kaolin|kaolin
355589|NCT01428089|hyperandrogenemia|hyperandrogenemia
355590|NCT01428076|Varicose Veins|varicose veins
355591|NCT01428076|SFJ Reflux|sfj reflux
355592|NCT01428050|whipple|whipple
355593|NCT01428050|hypertonic saline|hypertonic saline
355594|NCT01428050|pancreaticoduodenectomy|pancreaticoduodenectomy
355595|NCT01428050|fluid restriction|fluid restriction
355596|NCT01428050|resuscitation strategy|resuscitation strategy
355597|NCT01428037|Vaginal Misoprostol|vaginal misoprostol
355598|NCT01428037|Cervical Ripening|cervical ripening
355599|NCT01428037|Labor Induced|labor induced
355600|NCT01428024|efficacy|efficacy
355601|NCT01428024|safety|safety
355602|NCT01428024|Restylane|restylane
355603|NCT01428024|Lip products|lip products
355604|NCT01428024|injection techniques|injection techniques
355605|NCT01428011|Hypertension|hypertension
355606|NCT01428011|Patient-Provider Communication|patient-provider communication
355607|NCT01428011|Medication Adherence|medication adherence
355608|NCT01428011|Race Concordance|race concordance
355609|NCT01427998|diabetes|diabetes
355610|NCT01427998|blood glucose|blood glucose
355611|NCT01427998|olive leaf extract|olive leaf extract
355612|NCT01427946|KRAS mutant|kras mutant
355613|NCT01427946|Non-Small Cell Lung Cancer|non-small cell lung cancer
355614|NCT01427946|NSCLC|nsclc
355615|NCT01427933|Breast Cancer|breast cancer
355616|NCT01427907|Serum phosphorus levels|serum phosphorus levels
355617|NCT01427894|Prematurity|prematurity
355618|NCT01427894|Music|music
355619|NCT01427894|Kangaroo Care|kangaroo care
355620|NCT01427894|Bonding Mother infant|bonding mother infant
355621|NCT01427868|LB80380|lb80380
355622|NCT01427868|bioequivalence|bioequivalence
355623|NCT01427855|Dietary Protein|dietary protein
355624|NCT01427855|Red Meat|red meat
355625|NCT01427855|White Meat|white meat
355626|NCT01427855|Vegetable Protein|vegetable protein
355627|NCT01427855|Saturated Fat|saturated fat
355628|NCT01427855|LDL Subclasses|ldl subclasses
355629|NCT01427855|Cholesterol|cholesterol
355630|NCT01427855|Atherogenic Dyslipidemia|atherogenic dyslipidemia
355631|NCT01427842|Trough concentration|trough concentration
355632|NCT01427842|Vancomycin|vancomycin
355633|NCT01427842|Pharmacokinetics|pharmacokinetics
355634|NCT01427829|pilot|pilot
355635|NCT01427829|randomized controlled trial|randomized controlled trial
355636|NCT01427829|RCT|rct
355637|NCT01427829|computer|computer
355638|NCT01427829|screening|screening
355639|NCT01427829|community heath center|community heath center
355640|NCT01427829|psychosocial|psychosocial
355641|NCT01427829|immigrant|immigrant
355642|NCT01427816|Dry eye syndromes|dry eye syndromes
355643|NCT01427816|Corneal diseases|corneal diseases
355644|NCT01427816|Conjunctival diseases|conjunctival diseases
355645|NCT01427803|Actual Use Trial|actual use trial
355646|NCT01427764|Dentin sensitivity|dentin sensitivity
355647|NCT01427764|Dental scaling|dental scaling
355648|NCT01427764|Ultrasonic|ultrasonic
355649|NCT01427764|manual and ultrasonic instrumentation|manual and ultrasonic instrumentation
355650|NCT01427725|Digestive System Diseases|digestive system diseases
355651|NCT01427725|Therapeutic Uses|therapeutic uses
355652|NCT01427725|Pancreatectomy|pancreatectomy
355653|NCT01427725|Gastrointestinal Agents|gastrointestinal agents
355654|NCT01427725|Pancreatic Diseases|pancreatic diseases
355655|NCT01427725|Pancrelipase|pancrelipase
355656|NCT01427725|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
355657|NCT01427712|Digestive System Diseases|digestive system diseases
355658|NCT01427712|Cystic Fibrosis|cystic fibrosis
355659|NCT01427712|Therapeutic Uses|therapeutic uses
355660|NCT01427712|Gastrointestinal Agents|gastrointestinal agents
355661|NCT01427712|Pancreatic Diseases|pancreatic diseases
355662|NCT01427712|Pancrelipase|pancrelipase
355663|NCT01427712|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
355664|NCT01427673|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
355665|NCT01427673|Obstructive Sleep Apnea|obstructive sleep apnea
355666|NCT01427673|Overlap Syndrome|overlap syndrome
355667|NCT01427673|COPD|copd
355669|NCT01427660|Diabetes|diabetes
355670|NCT01427660|Decision Aid|decision aid
355671|NCT01427660|AntiHyperglycemic Medication|antihyperglycemic medication
355672|NCT01427660|Tailored health information|tailored health information
355673|NCT01427660|Medication information|medication information
355674|NCT01427647|Laparoscopy|laparoscopy
355675|NCT01427647|Anesthesia, Epidural|anesthesia, epidural
355676|NCT01427634|Heart Failure|heart failure
355677|NCT01427634|Ventricular Assist Device|ventricular assist device
355678|NCT01427634|Palliative Care|palliative care
355679|NCT01427595|hyperandrogenemia|hyperandrogenemia
355680|NCT01427569|Diabetes|diabetes
355681|NCT01427569|Chronic wound|chronic wound
355682|NCT01427556|Food intake|food intake
355683|NCT01427556|Breakfast eating|breakfast eating
355684|NCT01427543|behavioral intervention|behavioral intervention
355685|NCT01427543|HIV risk reduction|hiv risk reduction
355686|NCT01427543|African Americans|african americans
355687|NCT01427543|incarceration|incarceration
355688|NCT01427543|bisexual|bisexual
355689|NCT01427543|reduce risk behaviors|reduce risk behaviors
355690|NCT01427530|brain activity|brain activity
355691|NCT01427530|implanted with DBS electrodes|implanted with dbs electrodes
355692|NCT01427517|Parkinson's disease|parkinson's disease
355693|NCT01427517|Gaucher's disease|gaucher's disease
355694|NCT01427517|Control|control
355695|NCT01427504|HCV|hcv
346318|NCT01465360|AD|ad
355696|NCT01427504|HIV|hiv
355697|NCT01427478|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
355698|NCT01427478|Post operative radio-chemotherapy|post operative radio-chemotherapy
355699|NCT01427478|Randomisation|randomisation
355700|NCT01427478|Maintenance treatment|maintenance treatment
355701|NCT01427478|Afatinib|afatinib
355702|NCT01427465|Brief|brief
355703|NCT01427465|Image|image
355704|NCT01427465|Intervention|intervention
355705|NCT01427465|Adolescents|adolescents
355706|NCT01427465|School|school
355707|NCT01427452|Live Donor|live donor
355708|NCT01427452|Kidney Donation|kidney donation
355709|NCT01427452|Living Donation|living donation
355710|NCT01427452|Live Donor Kidney Transplantation|live donor kidney transplantation
355711|NCT01427452|Donor Nephrectomy|donor nephrectomy
355712|NCT01427439|MDD|mdd
355713|NCT01427439|Non-interventional study|non-interventional study
355714|NCT01427439|Observational study|observational study
355715|NCT01427426|Health|health
355716|NCT01427426|Vitality|vitality
355717|NCT01427426|Well-being|well-being
355718|NCT01427426|Nutritional Supplement|nutritional supplement
355719|NCT01427426|Phytonutrient|phytonutrient
355720|NCT01427426|Greens|greens
355721|NCT01427413|blastocoele fluid|blastocoele fluid
355722|NCT01427413|mass spectrometry|mass spectrometry
355723|NCT01427413|metabolomics|metabolomics
355724|NCT01427400|Breast expander|breast expander
355725|NCT01427400|Breast reconstruction|breast reconstruction
355726|NCT01427400|Implants|implants
355727|NCT01427400|Botox|botox
355728|NCT01427387|ASP0456|asp0456
355729|NCT01427387|Pharmacokinetics|pharmacokinetics
355730|NCT01427387|safety|safety
355731|NCT01427387|tolerability|tolerability
355732|NCT01427387|food effect|food effect
355733|NCT01427374|hemodialysis|hemodialysis
355734|NCT01427374|peritoneal dialysis|peritoneal dialysis
355735|NCT01427374|chronic kidney disease|chronic kidney disease
355736|NCT01427374|cardiovascular risk factors|cardiovascular risk factors
355737|NCT01427374|cardiac imaging|cardiac imaging
355738|NCT01427374|dialysis|dialysis
355739|NCT01427374|parathyroid hormone|parathyroid hormone
355740|NCT01427374|vitamin D|vitamin d
355741|NCT01427374|coronary artery calcification|coronary artery calcification
355742|NCT01427374|left ventricular hypertrophy|left ventricular hypertrophy
355743|NCT01427374|genetic predisposition|genetic predisposition
355744|NCT01427374|biochemical markers|biochemical markers
355745|NCT01427374|infection|infection
355746|NCT01427374|pharmacogenomics|pharmacogenomics
355747|NCT01427335|OHSS|ohss
355748|NCT01427335|ICSI|icsi
355749|NCT01427335|calcium injection|calcium injection
355750|NCT01427322|lapatinib|lapatinib
355751|NCT01427322|radiation therapy|radiation therapy
355752|NCT01427322|metastases|metastases
355753|NCT01427309|Influenza|influenza
355754|NCT01427309|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
355755|NCT01427309|High-Dose Trivalent Inactivated Influenza Vaccine|high-dose trivalent inactivated influenza vaccine
355756|NCT01427309|Fluzone® High-Dose|fluzone® high-dose
355757|NCT01427309|Influenza vaccines|influenza vaccines
355758|NCT01427296|Colon Cleansing|colon cleansing
355759|NCT01427296|Bowel Prep|bowel prep
355760|NCT01427296|Colonoscopy|colonoscopy
355761|NCT01427283|Low back pain|low back pain
355762|NCT01427283|Chronic pain|chronic pain
355763|NCT01427283|Opioid|opioid
355764|NCT01427283|Constipation|constipation
355765|NCT01427283|Moderate to severe|moderate to severe
355766|NCT01427270|Low back pain|low back pain
355767|NCT01427270|Chronic pain|chronic pain
355768|NCT01427270|Opioid|opioid
355769|NCT01427270|Constipation|constipation
355770|NCT01427270|Moderate to severe chronic low back pain|moderate to severe chronic low back pain
355771|NCT01427244|HER2+|her2+
355772|NCT01427244|Histologic confirmation|histologic confirmation
355773|NCT01427244|measurable disease|measurable disease
355774|NCT01427244|HER2 positive|her2 positive
355775|NCT01427244|HER2 overexpression|her2 overexpression
355776|NCT01427244|persistent vulvar Paget's disease|persistent vulvar paget's disease
355777|NCT01427244|recurrent vulvar Paget's disease|recurrent vulvar paget's disease
355778|NCT01427231|Cognitive performance|cognitive performance
355779|NCT01427231|Attention|attention
355780|NCT01427231|Memory|memory
355781|NCT01427231|Glucose|glucose
355782|NCT01427231|Sacharose|sacharose
355783|NCT01427231|Elderly|elderly
355784|NCT01427231|Memory complaints|memory complaints
355785|NCT01427218|pharmacist|pharmacist
355786|NCT01427218|medication therapy management|medication therapy management
355787|NCT01427218|evidence based medicine|evidence based medicine
355788|NCT01427205|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
355789|NCT01427205|HNSCC|hnscc
355790|NCT01427205|recurrent|recurrent
355791|NCT01427205|metastatic|metastatic
355792|NCT01427205|oral cavity|oral cavity
355793|NCT01427205|Cetuximab|cetuximab
355794|NCT01427205|C225|c225
355795|NCT01427205|Erbitux|erbitux
355796|NCT01427205|IMC-C225|imc-c225
346371|NCT01465243|NSCLC|nsclc
355797|NCT01427205|OSI-906|osi-906
355798|NCT01427205|Placebo|placebo
355799|NCT01427205|sugar pill|sugar pill
355800|NCT01427205|oropharynx|oropharynx
355801|NCT01427205|larynx|larynx
355802|NCT01427205|hypopharynx|hypopharynx
355803|NCT01427192|Breathing-Related Sleep Disorder|breathing-related sleep disorder
355804|NCT01427192|Pulmonary Hypertension|pulmonary hypertension
355805|NCT01427179|Spontaneous coronary artery dissection|spontaneous coronary artery dissection
355806|NCT01427179|SCAD|scad
355807|NCT01427166|Breast Cancer|breast cancer
355808|NCT01427166|Cording|cording
355809|NCT01427166|Lymphedema|lymphedema
355810|NCT01427166|upper extremity cording|upper extremity cording
355811|NCT01427166|following treatment|following treatment
355812|NCT01427153|knee osteoarthritis|knee osteoarthritis
355813|NCT01427153|physical therapy|physical therapy
355814|NCT01427153|corticosteroid|corticosteroid
355815|NCT01427153|treatment|treatment
355816|NCT01427140|Liver fat|liver fat
355817|NCT01427140|Polyunsaturated fatty acids (PUFA)|polyunsaturated fatty acids (pufa)
355818|NCT01427140|Saturated fatty acids (SFA)|saturated fatty acids (sfa)
355819|NCT01427140|Weight gain|weight gain
355820|NCT01427140|Overfeed|overfeed
355821|NCT01427140|Dietary fatty acids|dietary fatty acids
355822|NCT01427140|Palm oil|palm oil
355823|NCT01427140|Sunflower oil|sunflower oil
355824|NCT01427114|extranodal marginal zone lymphoma|extranodal marginal zone lymphoma
355825|NCT01427114|ocular adnexal lymphoma|ocular adnexal lymphoma
355826|NCT01427114|mucosa associated lymphoid tissue|mucosa associated lymphoid tissue
355827|NCT01427114|cyclophosphamide|cyclophosphamide
355828|NCT01427114|vincristine|vincristine
355829|NCT01427114|prednisolone|prednisolone
355830|NCT01427101|Pseudomyxoma Peritonei|pseudomyxoma peritonei
355831|NCT01427101|Cytoreductive surgery|cytoreductive surgery
355832|NCT01427101|Debulking surgery|debulking surgery
355833|NCT01427101|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
355834|NCT01427088|rTMS-induced cumulative pattern of sBDNF|rtms-induced cumulative pattern of sbdnf
355835|NCT01427075|Magnetic Resonance Imaging|magnetic resonance imaging
355836|NCT01427075|Sleep Apnea, Obstructive|sleep apnea, obstructive
355837|NCT01427075|Pharyngeal Muscles|pharyngeal muscles
355838|NCT01427062|parkinson's disease|parkinson's disease
355839|NCT01427062|balance|balance
355840|NCT01427062|anticipatory postural adjustment|anticipatory postural adjustment
355841|NCT01427062|componsatory postural adjustment|componsatory postural adjustment
355842|NCT01427062|falls|falls
355843|NCT01427049|renal denervation|renal denervation
355844|NCT01427049|renal sympathetic denervation|renal sympathetic denervation
355845|NCT01427049|renal ablation|renal ablation
355846|NCT01427049|resistant hypertension|resistant hypertension
355848|NCT01427049|renal oxygenation|renal oxygenation
355849|NCT01427049|renal perfusion|renal perfusion
355850|NCT01427023|APTIMA Trichomonas vaginalis Assay|aptima trichomonas vaginalis assay
355851|NCT01427023|APTIMA|aptima
355852|NCT01427023|trichomonas|trichomonas
355853|NCT01427023|trichomonas vaginalis|trichomonas vaginalis
355854|NCT01426997|Major Depressive Disorder|major depressive disorder
355855|NCT01426997|Depression|depression
355856|NCT01426971|Migraine|migraine
355857|NCT01426945|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
355858|NCT01426945|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
728948|NCT01086709|Hepatitis B|hepatitis b
355859|NCT01426945|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
355860|NCT01426945|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
355861|NCT01426945|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
355862|NCT01426932|Vestibular Function Tests|vestibular function tests
355863|NCT01426932|Caloric Test|caloric test
355864|NCT01426932|Electronystagmography|electronystagmography
355865|NCT01426932|Prediction|prediction
355866|NCT01426919|Traumatic Brain Injury|traumatic brain injury
355867|NCT01426919|Head Injury|head injury
355868|NCT01426893|Respiratory disease|respiratory disease
355869|NCT01426893|COPD|copd
355870|NCT01426880|GBG|gbg
355871|NCT01426880|German Breast Group|german breast group
355872|NCT01426880|neo-adjuvant|neo-adjuvant
355873|NCT01426880|GBG Forschungs GmbH|gbg forschungs gmbh
355874|NCT01426880|Tubular breast cancer stage II|tubular breast cancer stage ii
355875|NCT01426880|Mucinous breast cancer stage II|mucinous breast cancer stage ii
355876|NCT01426880|Invasive ductal breast cancer|invasive ductal breast cancer
355877|NCT01426880|Tubular breast cancer stage III|tubular breast cancer stage iii
355878|NCT01426880|HER-2 positive breast cancer|her-2 positive breast cancer
355879|NCT01426880|Inflammatory breast cancer stage IV|inflammatory breast cancer stage iv
355880|NCT01426880|Inflammatory breast cancer|inflammatory breast cancer
355881|NCT01426867|Open-Angle Glaucoma|open-angle glaucoma
355882|NCT01426867|Ocular Hypertension|ocular hypertension
355883|NCT01426867|Intraocular Pressure|intraocular pressure
355884|NCT01426867|Brinzolamide|brinzolamide
355885|NCT01426867|Brimonidine|brimonidine
355886|NCT01426854|Cataract Surgery|cataract surgery
346473|NCT01464762|TMC207|tmc207
355887|NCT01426854|Anti-ocular Inflammation|anti-ocular inflammation
355888|NCT01426854|Anti-ocular Pain|anti-ocular pain
355889|NCT01426841|Small cell lung cancer|small cell lung cancer
355890|NCT01426841|Adaptive radiotherapy|adaptive radiotherapy
355891|NCT01426841|Thoracic radiotherapy|thoracic radiotherapy
355892|NCT01426828|adult|adult
355893|NCT01426828|symptomatic multiple myeloma|symptomatic multiple myeloma
355894|NCT01426828|myeloma|myeloma
355895|NCT01426828|diagnosis within 12 months of initiation of systemic therapy|diagnosis within 12 months of initiation of systemic therapy
355995|NCT01426347|Rheumatoid Arthritis|rheumatoid arthritis
355896|NCT01426815|Peripheral spondylarthritis according to ASAS- criteria|peripheral spondylarthritis according to asas- criteria
355897|NCT01426802|metformin|metformin
355898|NCT01426802|vildagliptin|vildagliptin
355899|NCT01426802|T2DM|t2dm
355900|NCT01426789|Rheumatoid Arthritis|rheumatoid arthritis
355901|NCT01426789|IgG1K monoclonal antibody|igg1k monoclonal antibody
355902|NCT01426789|Interleukin-17A neutralizing|interleukin-17a neutralizing
355903|NCT01426776|Cheyne-Stokes respiration|cheyne-stokes respiration
355904|NCT01426776|Heart valve disease|heart valve disease
355905|NCT01426776|Central Sleep Apnea|central sleep apnea
355906|NCT01426763|HAE|hae
355907|NCT01426763|C1 esterase inhibitor|c1 esterase inhibitor
355908|NCT01426763|C1 INH|c1 inh
355909|NCT01426763|Subcutaneous|subcutaneous
355910|NCT01426763|hyaluronidase|hyaluronidase
355911|NCT01426763|rHuPH20|rhuph20
355912|NCT01426750|Nutritional support.|nutritional support.
355913|NCT01426750|Cancer.|cancer.
355914|NCT01426750|Malnutrition.|malnutrition.
355915|NCT01426750|Child.|child.
355916|NCT01426750|Adolescent|adolescent
355917|NCT01426724|Vitamin D|vitamin d
355918|NCT01426724|Chronic Kidney Disease|chronic kidney disease
355919|NCT01426724|Hyperparathyroidism|hyperparathyroidism
355920|NCT01426724|Renal Blood Flow|renal blood flow
355921|NCT01426724|Proteinuria|proteinuria
355922|NCT01426724|Inflammation|inflammation
355923|NCT01426724|Renin Angiotensin System|renin angiotensin system
355924|NCT01426698|delayed cord clamping|delayed cord clamping
355925|NCT01426698|developmental delay|developmental delay
355926|NCT01426685|sudden death|sudden death
355927|NCT01426685|coronary artery disease|coronary artery disease
355928|NCT01426685|diabetes|diabetes
355929|NCT01426672|Strabismic deviation less than 12 prism diopeters|strabismic deviation less than 12 prism diopeters
355930|NCT01426659|language|language
355931|NCT01426659|constraints|constraints
355932|NCT01426659|premature|premature
355933|NCT01426659|phonology|phonology
355934|NCT01426659|implied|implied
355935|NCT01426659|early development (< 5 years)|early development (< 5 years)
355936|NCT01426646|gastric cancer|gastric cancer
355937|NCT01426646|S-1|s-1
355938|NCT01426646|cisplatin|cisplatin
355939|NCT01426646|adjuvant chemotherapy|adjuvant chemotherapy
355941|NCT01426620|NSCLC|nsclc
355942|NCT01426620|blueberry|blueberry
355943|NCT01426620|salvage therapy|salvage therapy
355944|NCT01426620|docetaxel|docetaxel
355945|NCT01426620|non-small cell lung cancer|non-small cell lung cancer
355946|NCT01426620|second-line|second-line
355947|NCT01426620|polyphenol|polyphenol
355948|NCT01426594|Observational|observational
355949|NCT01426594|Colombia|colombia
355950|NCT01426594|Metpure XL|metpure xl
355951|NCT01426581|Asthma|asthma
355952|NCT01426581|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
355953|NCT01426581|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
730003|NCT01076790|Surgery|surgery
355954|NCT01426581|Lung Disease, Obstructive|lung disease, obstructive
355955|NCT01426581|Self-management|self-management
355956|NCT01426581|Health Literacy|health literacy
355957|NCT01426568|Multi-Convergent Therapy|multi-convergent therapy
355958|NCT01426568|Mindfulness Meditation|mindfulness meditation
355959|NCT01426568|Functional Abdominal Symptoms|functional abdominal symptoms
355960|NCT01426568|Irritable Bowel Syndrome|irritable bowel syndrome
355961|NCT01426568|Inflammatory Bowel Disease|inflammatory bowel disease
355962|NCT01426568|Psychological Stress|psychological stress
355963|NCT01426555|Disorder of Bone Density and Structure, Unspecified|disorder of bone density and structure, unspecified
355964|NCT01426555|Weakening of the bone structure|weakening of the bone structure
355965|NCT01426542|brain injury|brain injury
355966|NCT01426542|stroke|stroke
355967|NCT01426542|cerebral palsy|cerebral palsy
355968|NCT01426542|seizures|seizures
355969|NCT01426516|Treatment Resistant|treatment resistant
355970|NCT01426516|Depression|depression
355971|NCT01426477|Ventral hernia|ventral hernia
355972|NCT01426477|Abdominal wall hernia|abdominal wall hernia
355973|NCT01426477|Incisional hernia|incisional hernia
355974|NCT01426477|Biologic mesh|biologic mesh
355975|NCT01426477|Veritas Collagen Matrix|veritas collagen matrix
355976|NCT01426477|Veritas|veritas
355977|NCT01426464|Glaucoma|glaucoma
355978|NCT01426464|Xalatan|xalatan
355979|NCT01426464|Transdermal|transdermal
355980|NCT01426451|Dramatherapy|dramatherapy
355981|NCT01426451|Group tutoring activities|group tutoring activities
355982|NCT01426451|Impairment|impairment
355983|NCT01426451|Emotional and behavioural problems|emotional and behavioural problems
355984|NCT01426451|Learning difficulties|learning difficulties
355985|NCT01426425|Cardiac cryoablation|cardiac cryoablation
355986|NCT01426425|AVNRT|avnrt
355987|NCT01426425|heart disease|heart disease
355988|NCT01426425|tachycardia|tachycardia
355989|NCT01426425|AtrioVentricular Nodal Reentrant Tachycardia|atrioventricular nodal reentrant tachycardia
355990|NCT01426425|Supraventricular tachycardia|supraventricular tachycardia
355991|NCT01426425|SVT|svt
355992|NCT01426360|dentifrice|dentifrice
355993|NCT01426360|potassium nitrate|potassium nitrate
355994|NCT01426360|strontium chloride|strontium chloride
355996|NCT01426347|Vitamin D deficiency|vitamin d deficiency
355997|NCT01426347|Disability|disability
355998|NCT01426321|Cardiac resynchronization therapy|cardiac resynchronization therapy
355999|NCT01426321|Echocardiography|echocardiography
356000|NCT01426321|Cardiac computed tomography|cardiac computed tomography
356001|NCT01426295|hematologic disease candidates for autologous or allogeneic bone marrow|hematologic disease candidates for autologous or allogeneic bone marrow
356002|NCT01426282|Out-patient Compliance|out-patient compliance
356003|NCT01426282|Nurse, Heath Education|nurse, heath education
356004|NCT01426282|Cardiovascular Diseases|cardiovascular diseases
356005|NCT01426282|Treatment and Prevention|treatment and prevention
356006|NCT01426256|vitamin D|vitamin d
356007|NCT01426256|cholecalciferol|cholecalciferol
356008|NCT01426256|cystic fibrosis|cystic fibrosis
356009|NCT01426256|respiratory tract infection|respiratory tract infection
356010|NCT01426256|immunity|immunity
356011|NCT01426256|intervention studies|intervention studies
356012|NCT01426256|inflammation|inflammation
356013|NCT01426256|dietary supplements|dietary supplements
356014|NCT01426256|alpha-Defensins|alpha-defensins
356015|NCT01426256|Cytokines|cytokines
356016|NCT01426256|mortality|mortality
356017|NCT01426256|biological markers|biological markers
356018|NCT01426256|Biomedical Research|biomedical research
356019|NCT01426230|PHN|phn
356020|NCT01426230|Post Herpetic Neuralgia|post herpetic neuralgia
356021|NCT01426230|Shingles|shingles
356022|NCT01426230|HZ roster|hz roster
356023|NCT01426204|Hepatitis C|hepatitis c
356024|NCT01426204|Retreatment|retreatment
356025|NCT01426204|Failures|failures
356026|NCT01426204|Infergen|infergen
356027|NCT01426204|Interferon Alfacon-1|interferon alfacon-1
356028|NCT01426191|Cefotaxime sulbactam sodium|cefotaxime sulbactam sodium
356029|NCT01426191|Phase IV clinical studies|phase iv clinical studies
356030|NCT01426191|Respiratory and urinary tract infections|respiratory and urinary tract infections
356031|NCT01426178|Respiratory Insufficiency|respiratory insufficiency
356032|NCT01426178|Respiration, Artificial|respiration, artificial
356033|NCT01426178|Intermittent Positive-Pressure Ventilation|intermittent positive-pressure ventilation
356034|NCT01426178|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
356035|NCT01426178|Non Invasive Ventilation|non invasive ventilation
356036|NCT01426165|hypomagnesemia|hypomagnesemia
356037|NCT01426165|magnesium|magnesium
356038|NCT01426165|magnesium sulfate|magnesium sulfate
356039|NCT01426152|IVF|ivf
356040|NCT01426152|progesterone|progesterone
356041|NCT01426152|ovulation induction|ovulation induction
356042|NCT01426152|pregnancy rates|pregnancy rates
356043|NCT01426152|Female Infertility Due to Nonimplantation|female infertility due to nonimplantation
356044|NCT01426126|urothelial carcinoma|urothelial carcinoma
356045|NCT01426126|gemcitabine|gemcitabine
356046|NCT01426126|platinum|platinum
356047|NCT01426126|refractory|refractory
730486|NCT01081210|Lung|lung
356048|NCT01426126|salvage chemotherapy|salvage chemotherapy
356049|NCT01426100|CKD-828|ckd-828
356050|NCT01426100|Hypertension|hypertension
356051|NCT01426100|Primary Hypertension|primary hypertension
356052|NCT01426100|S-Amlodipine|s-amlodipine
356053|NCT01426100|Telmisartan|telmisartan
356054|NCT01426100|Amlodipine|amlodipine
356055|NCT01426100|Non-Responder|non-responder
356056|NCT01426061|Complementary and alternative medicine|complementary and alternative medicine
356057|NCT01426061|Reflexology|reflexology
356058|NCT01426061|Homeopathy|homeopathy
356059|NCT01426061|Asthma|asthma
356060|NCT01426061|Randomized controlled trial|randomized controlled trial
356061|NCT01426035|SUPERFICIAL VARICOSE VEINS|superficial varicose veins
356062|NCT01426022|alcohol|alcohol
356063|NCT01426022|mood|mood
356064|NCT01426022|postprandial|postprandial
356065|NCT01426009|COPD|copd
356066|NCT01425996|HCC|hcc
356067|NCT01425996|PVTT|pvtt
356068|NCT01425983|stress|stress
356069|NCT01425983|lability and irritative disturbances|lability and irritative disturbances
356070|NCT01425983|dietary supplement|dietary supplement
356071|NCT01425983|amino acid composition|amino acid composition
356072|NCT01425983|psychological neurological questionnaire (PNF)|psychological neurological questionnaire (pnf)
356073|NCT01425970|Inhibitex|inhibitex
356074|NCT01425970|Chronic Hepatitis|chronic hepatitis
356075|NCT01425970|Hepatitis C Virus|hepatitis c virus
356076|NCT01425957|MEMORY and COGNITIVE IMPAIRMENT|memory and cognitive impairment
356077|NCT01425957|ALZHEIMER DISEASE CONVERSION|alzheimer disease conversion
356078|NCT01425957|Amyloid beta-Peptides|amyloid beta-peptides
356079|NCT01425944|Sturge Weber Syndrome|sturge weber syndrome
356080|NCT01425944|Biomarkers|biomarkers
356081|NCT01425944|DNA arrays|dna arrays
356082|NCT01425944|brain vessel malformations|brain vessel malformations
356083|NCT01425918|Autism Spectrum Disorder|autism spectrum disorder
356084|NCT01425918|language|language
356085|NCT01425918|social|social
356086|NCT01425918|toddlers|toddlers
356087|NCT01425905|Female|female
356088|NCT01425905|Depression|depression
356089|NCT01425905|Obesity|obesity
356090|NCT01425905|Insulin Resistance|insulin resistance
356091|NCT01425905|Adolescents|adolescents
356092|NCT01425905|Overweight|overweight
356093|NCT01425905|Type 2 Diabetes Risk|type 2 diabetes risk
356094|NCT01425905|Mood|mood
356095|NCT01425892|Salivary Gland|salivary gland
356096|NCT01425892|Pathogenesis|pathogenesis
356097|NCT01425892|Sj(SqrRoot)(Delta)gren s Syndrome|sj(sqrroot)(delta)gren s syndrome
356098|NCT01425892|Sjogren Syndrome|sjogren syndrome
356099|NCT01425866|Diabetes Mellitus|diabetes mellitus
356100|NCT01425866|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
356101|NCT01425866|Structured self-management education|structured self-management education
356102|NCT01425866|Therapeutic patient education|therapeutic patient education
356103|NCT01425866|Lifestyle changes|lifestyle changes
356104|NCT01425866|Self-management Blood glucose|self-management blood glucose
356105|NCT01425866|Empowerment|empowerment
356106|NCT01425866|Adult learning|adult learning
356107|NCT01425866|Socio-constructivism|socio-constructivism
356108|NCT01425866|Health management network|health management network
356109|NCT01425866|Reunion island|reunion island
356110|NCT01425840|Lidocaine,|lidocaine,
356111|NCT01425840|liposome encapsulation,|liposome encapsulation,
356112|NCT01425840|topical anesthesia,|topical anesthesia,
356113|NCT01425840|palatal mucosa|palatal mucosa
356114|NCT01425827|duloxetine|duloxetine
356115|NCT01425827|osteoarthritis|osteoarthritis
356116|NCT01425827|pain|pain
356117|NCT01425827|function|function
356118|NCT01425814|COPD|copd
356119|NCT01425801|COPD|copd
356120|NCT01425788|Grass pollen induced allergic rhinoconjunctivitis|grass pollen induced allergic rhinoconjunctivitis
356122|NCT01425775|disease activity markers|disease activity markers
356123|NCT01425775|vitamin D|vitamin d
356124|NCT01425749|melanoma|melanoma
356125|NCT01425749|MAGE-A3|mage-a3
356126|NCT01425749|immunotherapy|immunotherapy
356127|NCT01425749|adjuvant|adjuvant
356128|NCT01425749|skin cancer|skin cancer
356129|NCT01425749|skin diseases|skin diseases
356130|NCT01425749|immunology|immunology
356131|NCT01425736|Nimotuzumab|nimotuzumab
356132|NCT01425736|Chemotherapy|chemotherapy
356133|NCT01425736|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
356134|NCT01425723|B-LONG|b-long
356135|NCT01425723|B-YOND|b-yond
356136|NCT01425723|B-LONG Extension|b-long extension
356137|NCT01425723|rFIXFc|rfixfc
356138|NCT01425723|Severe Hemophilia B|severe hemophilia b
356139|NCT01425710|Pheochromocytoma|pheochromocytoma
356140|NCT01425710|Adrenalectomy|adrenalectomy
356141|NCT01425710|Cardiac output|cardiac output
356142|NCT01425710|Fluid managment|fluid managment
356143|NCT01425710|Esopagheal doppler sonography|esopagheal doppler sonography
356144|NCT01425697|Adult Cardiac surgery|adult cardiac surgery
356145|NCT01425697|Surgery site infections|surgery site infections
356146|NCT01425684|MRI|mri
356147|NCT01425684|Smoking|smoking
356148|NCT01425684|Schizophrenia|schizophrenia
356149|NCT01425671|Schizophrenia|schizophrenia
356150|NCT01425671|Family|family
356151|NCT01425671|Psychosis|psychosis
356152|NCT01425658|Fentanyl|fentanyl
356153|NCT01425658|clonidine|clonidine
356154|NCT01425658|intrathcal|intrathcal
356155|NCT01425658|bupivacaine|bupivacaine
356156|NCT01425645|gestational diabetes|gestational diabetes
356157|NCT01425645|GDM|gdm
356158|NCT01425645|prevention|prevention
356159|NCT01425632|TAU-284|tau-284
356160|NCT01425632|Bepotastine besilate|bepotastine besilate
356161|NCT01425632|Histamine H1 receptor antagonists|histamine h1 receptor antagonists
356162|NCT01425619|Anxiety Disorder due to Allergy Skin Testing|anxiety disorder due to allergy skin testing
356163|NCT01425580|Congestive Heart Failure|congestive heart failure
356164|NCT01425580|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
356165|NCT01425580|GLP-1|glp-1
356166|NCT01425580|Liraglutide|liraglutide
356167|NCT01425567|cholestasis|cholestasis
356168|NCT01425567|parenteral nutrition|parenteral nutrition
356169|NCT01425554|Vascular malformations in the internal jugular veins|vascular malformations in the internal jugular veins
356170|NCT01425515|hypertension|hypertension
356171|NCT01425515|genomics|genomics
356172|NCT01425502|High risk prescribing|high risk prescribing
356173|NCT01425502|Primary care|primary care
356174|NCT01425502|Non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
356175|NCT01425502|Anti-platelet agents|anti-platelet agents
356176|NCT01425502|Stepped wedge design|stepped wedge design
356177|NCT01425502|Cluster randomised controlled trial|cluster randomised controlled trial
356178|NCT01425502|United Kingdom|united kingdom
346764|NCT01463514|cerebral tissue oxygenation,|cerebral tissue oxygenation,
346765|NCT01463514|cerebral blood flow|cerebral blood flow
346766|NCT01463501|Esophageal cancer|esophageal cancer
346767|NCT01463501|Resectable|resectable
346768|NCT01463501|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
346769|NCT01463501|Adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
356179|NCT01425489|Leukodystrophy, Globoid Cell|leukodystrophy, globoid cell
356180|NCT01425489|Hereditary Central Nervous System Demyelinating Diseases|hereditary central nervous system demyelinating diseases
356181|NCT01425489|Brain Diseases, Metabolic, Inborn|brain diseases, metabolic, inborn
356182|NCT01425489|Central Nervous System Diseases|central nervous system diseases
356183|NCT01425489|Nervous System Diseases|nervous system diseases
356184|NCT01425489|Sphingolipidoses|sphingolipidoses
356185|NCT01425489|Leukoencephalopathies|leukoencephalopathies
356186|NCT01425489|Demyelinating Diseases|demyelinating diseases
356187|NCT01425489|Metabolism, Inborn Errors|metabolism, inborn errors
356188|NCT01425489|Genetic Diseases, Inborn|genetic diseases, inborn
356189|NCT01425489|Lipidoses|lipidoses
356190|NCT01425489|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
356191|NCT01425489|Lysosomal Storage Diseases|lysosomal storage diseases
356192|NCT01425489|Metabolic Diseases|metabolic diseases
356287|NCT01425112|Efficacy|efficacy
356193|NCT01425489|Lipid Metabolism DisordersLeukodystrophy, Globoid Cell|lipid metabolism disordersleukodystrophy, globoid cell
356194|NCT01425476|breast|breast
356195|NCT01425476|high risk women|high risk women
356196|NCT01425476|biomarkers|biomarkers
356197|NCT01425476|vitamin D|vitamin d
356198|NCT01425463|Ferrous (II) Glycine Sulphate Complex|ferrous (ii) glycine sulphate complex
356199|NCT01425463|Polyferose|polyferose
356200|NCT01425463|Ferro Sanol duodenal|ferro sanol duodenal
356201|NCT01425463|Niferex|niferex
356202|NCT01425463|Iron Deficiency Anemia|iron deficiency anemia
356203|NCT01425437|Keloid|keloid
356204|NCT01425424|Vitamin D|vitamin d
356205|NCT01425424|Prediabetes|prediabetes
356206|NCT01425424|Prehypertension|prehypertension
356207|NCT01425411|hypertension|hypertension
356208|NCT01425411|left ventricular hypertrophy|left ventricular hypertrophy
356209|NCT01425411|angiotensin receptor blocker|angiotensin receptor blocker
356210|NCT01425411|midwall mechanics|midwall mechanics
356211|NCT01425411|tissue Doppler imaging|tissue doppler imaging
356212|NCT01425411|Hypertension with left ventricular hypertrophy|hypertension with left ventricular hypertrophy
356213|NCT01425385|liver failure|liver failure
356214|NCT01425385|liver transplantation|liver transplantation
356215|NCT01425372|vaccine|vaccine
356216|NCT01425372|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
356217|NCT01425372|immune responses|immune responses
356218|NCT01425372|primary immunisation|primary immunisation
356219|NCT01425372|Vaccine responses to primary immunisation in the UK|vaccine responses to primary immunisation in the uk
356220|NCT01425359|Chronic angina|chronic angina
356221|NCT01425359|Angina pectoris|angina pectoris
356222|NCT01425359|Coronary artery disease|coronary artery disease
356223|NCT01425359|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
751934|NCT01171274|randomized controlled trial|randomized controlled trial
356224|NCT01425346|Ophthalmic, healthy eye, fluorescence, lens|ophthalmic, healthy eye, fluorescence, lens
356225|NCT01425333|Ovarian endometriomas|ovarian endometriomas
356226|NCT01425333|Laparoscopy|laparoscopy
356227|NCT01425333|Cystectomy|cystectomy
356228|NCT01425333|Ablation|ablation
356229|NCT01425307|Phase III|phase iii
356230|NCT01425307|Sickle cell anemia|sickle cell anemia
356231|NCT01425307|Abnormally high Transcranial Doppler velocities.|abnormally high transcranial doppler velocities.
356232|NCT01425307|Reduce risk of primary stroke|reduce risk of primary stroke
356233|NCT01425307|Pediatric patients|pediatric patients
356234|NCT01425307|Chelation therapy|chelation therapy
356235|NCT01425294|Chinese post-menopausal women|chinese post-menopausal women
356236|NCT01425294|oestrogen receptor-positive locally advanced|oestrogen receptor-positive locally advanced
356237|NCT01425294|metastatic breast cancer|metastatic breast cancer
356238|NCT01425294|fulvestrant 250 mg|fulvestrant 250 mg
730487|NCT01081210|Aorta|aorta
356239|NCT01425294|failure to adjuvant anti-oestrogen therapy|failure to adjuvant anti-oestrogen therapy
356240|NCT01425281|Bioabsorbable|bioabsorbable
356241|NCT01425281|Coronary scaffold|coronary scaffold
356242|NCT01425281|Coronary Stent|coronary stent
356243|NCT01425281|Everolimus|everolimus
356244|NCT01425281|Drug eluting stents|drug eluting stents
356245|NCT01425281|Angioplasty|angioplasty
356246|NCT01425281|Coronary artery disease|coronary artery disease
356247|NCT01425281|Total coronary occlusion|total coronary occlusion
356248|NCT01425281|Coronary artery restenosis|coronary artery restenosis
356249|NCT01425281|Stent thrombosis|stent thrombosis
356250|NCT01425281|Myocardial ischemia|myocardial ischemia
356251|NCT01425281|Coronary artery stenosis|coronary artery stenosis
356252|NCT01425268|Tissue Expansion|tissue expansion
356253|NCT01425268|Tissue Expander|tissue expander
356254|NCT01425268|Breast Tissue Expansion|breast tissue expansion
356255|NCT01425268|Breast Tissue Expander|breast tissue expander
356256|NCT01425268|Breast Reconstruction|breast reconstruction
356257|NCT01425268|Two Stage Breast Reconstruction|two stage breast reconstruction
356258|NCT01425268|2 Stage Breast Reconstruction|2 stage breast reconstruction
356259|NCT01425255|Type 1 diabetes|type 1 diabetes
356260|NCT01425255|Sleep quality|sleep quality
356261|NCT01425255|Parents|parents
356262|NCT01425242|inflammation|inflammation
356263|NCT01425242|aneurysm|aneurysm
356264|NCT01425242|hypertension|hypertension
356265|NCT01425242|aliskiren|aliskiren
356266|NCT01425229|steady state|steady state
356267|NCT01425229|bosentan|bosentan
356268|NCT01425229|clarithromycin|clarithromycin
356269|NCT01425216|Keloid|keloid
356270|NCT01425216|Patient who have extensive or massive keloids|patient who have extensive or massive keloids
356271|NCT01425177|Retained CBD Stones|retained cbd stones
356272|NCT01425177|Recurrent CBD Stones|recurrent cbd stones
356273|NCT01425164|hemodialysis|hemodialysis
356274|NCT01425164|coronary heart disease|coronary heart disease
356275|NCT01425164|angina|angina
356276|NCT01425164|betablocker|betablocker
356277|NCT01425164|carvedilol|carvedilol
356278|NCT01425164|ivabradine|ivabradine
356279|NCT01425138|psoriasis|psoriasis
356280|NCT01425138|systematic review|systematic review
356281|NCT01425138|meta-analyses|meta-analyses
356282|NCT01425125|nonedematous hyponatremia|nonedematous hyponatremia
356283|NCT01425125|fractional urate excretion|fractional urate excretion
356284|NCT01425112|trabeculectomy|trabeculectomy
356285|NCT01425112|bevacizumab|bevacizumab
356286|NCT01425112|anti-VEGF|anti-vegf
356288|NCT01425086|Incubator,|incubator,
356289|NCT01425086|hypothermia,|hypothermia,
356290|NCT01425086|preterm,|preterm,
356291|NCT01425086|low-birthweight infants,|low-birthweight infants,
356292|NCT01425086|embrace device,|embrace device,
356293|NCT01425086|phase change materials|phase change materials
356295|NCT01425073|HIV|hiv
356296|NCT01425073|Co-Infections|co-infections
356297|NCT01425073|Malaria|malaria
356298|NCT01425073|Pneumonia|pneumonia
356299|NCT01425073|Diarrhea|diarrhea
356300|NCT01425060|Contraception|contraception
356301|NCT01425060|Unintended pregnancy|unintended pregnancy
356302|NCT01425060|HIV|hiv
356303|NCT01425060|HIV Risk|hiv risk
356304|NCT01425060|Sexually Transmitted Infections|sexually transmitted infections
356305|NCT01425060|Women|women
356306|NCT01425060|Pregnancy|pregnancy
356307|NCT01425060|Neonatal Health|neonatal health
356308|NCT01425060|Drug Use|drug use
356309|NCT01425060|Drug Treatment|drug treatment
356310|NCT01425060|Opioids|opioids
356311|NCT01425047|mangosteen|mangosteen
356312|NCT01425047|xanthones|xanthones
356313|NCT01425047|dietary supplement|dietary supplement
356314|NCT01425047|botanical supplement|botanical supplement
356315|NCT01425047|bioavailability|bioavailability
356316|NCT01425047|Determine bioavailability of mangosteen xanthones in adults|determine bioavailability of mangosteen xanthones in adults
356317|NCT01425034|Cast|cast
356318|NCT01425034|motion|motion
356319|NCT01425034|thumb CMC arthritis|thumb cmc arthritis
356320|NCT01425034|Collateral Ligament of Metacarpophalangeal Joint|collateral ligament of metacarpophalangeal joint
356321|NCT01424995|trigger thumb|trigger thumb
751935|NCT01171287|Automobile Driving|automobile driving
356322|NCT01424995|flexor pollicis longus tendon of the thumb|flexor pollicis longus tendon of the thumb
356323|NCT01424995|stenosis tenosynovitis|stenosis tenosynovitis
356324|NCT01424982|Leukemia|leukemia
356325|NCT01424982|Ph-positive acute lymphoblastic leukemia|ph-positive acute lymphoblastic leukemia
356326|NCT01424982|ALL|all
356327|NCT01424982|Philadelphia (Ph) chromosome|philadelphia (ph) chromosome
356328|NCT01424982|BCR-ABL|bcr-abl
356329|NCT01424982|Depo-Medrol|depo-medrol
356330|NCT01424982|Medrol|medrol
356331|NCT01424982|Solu-Medrol|solu-medrol
356332|NCT01424982|Methylprednisolone|methylprednisolone
356333|NCT01424982|Vincristine|vincristine
356334|NCT01424982|Dexamethasone|dexamethasone
356335|NCT01424982|Decadron|decadron
356336|NCT01424982|Ponatinib|ponatinib
356337|NCT01424982|G-CSF|g-csf
356338|NCT01424982|Filgrastim|filgrastim
356339|NCT01424982|NeupogenTM|neupogentm
356340|NCT01424982|Cyclophosphamide|cyclophosphamide
356341|NCT01424982|Cytoxan|cytoxan
356342|NCT01424982|Neosar|neosar
356343|NCT01424982|Doxorubicin|doxorubicin
356344|NCT01424982|Doxorubicin Hydrochloride|doxorubicin hydrochloride
356345|NCT01424982|Adriamycin PFS|adriamycin pfs
356346|NCT01424982|Adriamycin RDF|adriamycin rdf
356347|NCT01424982|Adriamycin|adriamycin
356348|NCT01424982|Rubex|rubex
356349|NCT01424982|Rituximab|rituximab
356350|NCT01424982|Rituxan|rituxan
356351|NCT01424982|Mesna|mesna
356352|NCT01424982|Mesnex|mesnex
356353|NCT01424982|Cytarabine|cytarabine
356354|NCT01424982|Ara-C|ara-c
356355|NCT01424982|Cytosar|cytosar
356356|NCT01424982|DepoCyt|depocyt
356357|NCT01424982|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
356358|NCT01424982|Methotrexate|methotrexate
356359|NCT01424982|Leucovorin|leucovorin
356360|NCT01424982|Wellcovorin|wellcovorin
356361|NCT01424982|Citrovorum|citrovorum
356362|NCT01424982|Prednisone|prednisone
356363|NCT01424982|NeulastaTM|neulastatm
356364|NCT01424982|PEG-G-CSF|peg-g-csf
356365|NCT01424969|rotator cuff repair|rotator cuff repair
356366|NCT01424969|arthroscopic|arthroscopic
356367|NCT01424969|platelet-rich plasma|platelet-rich plasma
356368|NCT01424969|platelet-rich fibrin matrix|platelet-rich fibrin matrix
356369|NCT01424969|outcomes|outcomes
356370|NCT01424969|tendon healing|tendon healing
356371|NCT01424969|magnetic resonance imaging|magnetic resonance imaging
356372|NCT01424956|breast|breast
356373|NCT01424956|breast cancer|breast cancer
356374|NCT01424956|breast screening|breast screening
356375|NCT01424956|breast cancer screening|breast cancer screening
356376|NCT01424956|ultrasound|ultrasound
356377|NCT01424956|ultrasonography|ultrasonography
356378|NCT01424956|mammogram|mammogram
356379|NCT01424956|mammography|mammography
356380|NCT01424956|breast density|breast density
356381|NCT01424956|dense breasts|dense breasts
356382|NCT01424956|early detection|early detection
356383|NCT01424956|somo v|somo v
356384|NCT01424956|somo•v|somo•v
356385|NCT01424956|U-Systems|u-systems
356386|NCT01424956|Automated Breast Ultrasound|automated breast ultrasound
356387|NCT01424956|Ultrasonography, Mammary|ultrasonography, mammary
356388|NCT01424956|Breast Neoplasms|breast neoplasms
356389|NCT01424956|Breast Density > 50% (BI-RADS III & IV)|breast density > 50% (bi-rads iii & iv)
356390|NCT01424943|prevention|prevention
356391|NCT01424943|evidence-based parenting intervention|evidence-based parenting intervention
356392|NCT01424943|children|children
356393|NCT01424943|disabilities|disabilities
356394|NCT01424943|IDEA Part C|idea part c
356395|NCT01424943|Stepping Stones Triple P|stepping stones triple p
356396|NCT01424930|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
356397|NCT01424930|CRPC|crpc
356398|NCT01424930|Abiraterone Acetate|abiraterone acetate
356399|NCT01424930|Prednisone|prednisone
356400|NCT01424930|Food Safety|food safety
356401|NCT01424917|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
356402|NCT01424904|Ergogenic aid|ergogenic aid
356403|NCT01424904|Exercise endurance|exercise endurance
356404|NCT01424904|High performance|high performance
356405|NCT01424904|Time trial performance|time trial performance
356406|NCT01424904|Glutathione|glutathione
356407|NCT01424878|Molecular Analysis of Medullary Thyroid Carcinoma Tissues|molecular analysis of medullary thyroid carcinoma tissues
356408|NCT01424865|HER2-positive breast cancer|her2-positive breast cancer
356409|NCT01424865|stage II breast cancer|stage ii breast cancer
356410|NCT01424865|stage IIIA breast cancer|stage iiia breast cancer
356411|NCT01424852|Probiotics|probiotics
356412|NCT01424852|Caries|caries
356413|NCT01424852|Oral flora|oral flora
356414|NCT01424839|SIOP CNS GCT II|siop cns gct ii
356415|NCT01424839|Patients with the primary disease of an Intracranial Germ Cell Tumors|patients with the primary disease of an intracranial germ cell tumors
356416|NCT01424826|Healthy volunteers|healthy volunteers
356417|NCT01424813|Asthma|asthma
356418|NCT01424813|dry powder inhaler|dry powder inhaler
356419|NCT01424813|short-acting beta2-agonist|short-acting beta2-agonist
356420|NCT01424813|SABA|saba
356421|NCT01424813|bronchoconstriction|bronchoconstriction
356422|NCT01424813|bronchodilation|bronchodilation
356423|NCT01424813|bronchodilator|bronchodilator
356424|NCT01424813|metered dose inhaler|metered dose inhaler
356425|NCT01424774|Radiation Exposure|radiation exposure
356426|NCT01424774|Rubidium 82|rubidium 82
356427|NCT01424774|Strontium 82|strontium 82
356428|NCT01424774|Strontium 85|strontium 85
356429|NCT01424748|Noni juice|noni juice
356430|NCT01424748|Safety|safety
356431|NCT01424735|Best corrected Visual Acuity|best corrected visual acuity
356432|NCT01424735|Pupillary Reaction|pupillary reaction
356433|NCT01424735|Colour vision|colour vision
356434|NCT01424735|Disc edema|disc edema
356435|NCT01424722|ICD Indicated patients|icd indicated patients
356436|NCT01424722|documented CAD|documented cad
356437|NCT01424709|Chemotherapy|chemotherapy
356438|NCT01424709|Individual therapy|individual therapy
356439|NCT01424709|RRM1|rrm1
356440|NCT01424709|BRCA1|brca1
356441|NCT01424696|growth measures|growth measures
356442|NCT01424696|nutritional status|nutritional status
356443|NCT01424696|pulmonary infection|pulmonary infection
356444|NCT01424696|inflammatory markers|inflammatory markers
356445|NCT01424696|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
356447|NCT01424683|Quality of life|quality of life
356449|NCT01424683|Visual Analogue Scale|visual analogue scale
356450|NCT01424683|CABG|cabg
356451|NCT01424683|Coronary Artery Bypass Graft|coronary artery bypass graft
356452|NCT01424683|Qol conversion|qol conversion
356453|NCT01424683|post hoc HTA|post hoc hta
356454|NCT01424670|Multidrug resistant tuberculosis|multidrug resistant tuberculosis
356455|NCT01424657|MRCP|mrcp
356456|NCT01424657|ERCP|ercp
356457|NCT01424657|BILIARY OBSTRUCTION|biliary obstruction
356458|NCT01424657|EFFECTIVENESS|effectiveness
356459|NCT01424644|meningitis|meningitis
356460|NCT01424644|human papillomavirus|human papillomavirus
356461|NCT01424644|tetanus|tetanus
356462|NCT01424644|diptheria|diptheria
356463|NCT01424644|pertussis|pertussis
356464|NCT01424618|Donor eggs|donor eggs
356465|NCT01424618|Donor oocytes|donor oocytes
356466|NCT01424618|Pregnancy|pregnancy
356467|NCT01424618|Embryo Implantation|embryo implantation
356468|NCT01424618|Infertility|infertility
356469|NCT01424618|IVF|ivf
356470|NCT01424605|left-sided double lumen bronchial tube|left-sided double lumen bronchial tube
356471|NCT01424605|GlideScope videolaryngoscope|glidescope videolaryngoscope
356472|NCT01424605|direct laryngoscope|direct laryngoscope
356473|NCT01424592|Portable sleep apnea testing|portable sleep apnea testing
356474|NCT01424592|Positive airway pressure therapy|positive airway pressure therapy
356475|NCT01424592|Polysomnography|polysomnography
356476|NCT01424566|cancer pain|cancer pain
356477|NCT01424566|opioid therapy|opioid therapy
356478|NCT01424566|inadequate analgesia|inadequate analgesia
356479|NCT01424566|optimized chronic opioid therapy|optimized chronic opioid therapy
356480|NCT01424553|Low birthweight|low birthweight
356481|NCT01424553|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
356482|NCT01424553|Lung development|lung development
356483|NCT01424553|Airway obstruction|airway obstruction
356484|NCT01424553|Asthma|asthma
356485|NCT01424527|Chronic Obstructive Pulmonary Disease(COPD)|chronic obstructive pulmonary disease(copd)
356486|NCT01424527|COPD Assessment Test(CAT)|copd assessment test(cat)
356487|NCT01424501|Tuberculosis vaccine|tuberculosis vaccine
356488|NCT01424501|HIV-negative|hiv-negative
356489|NCT01424501|tuberculosis treatment|tuberculosis treatment
356490|NCT01424488|sugammadex|sugammadex
356491|NCT01424488|reversal|reversal
356591|NCT01424007|Weight loss|weight loss
356492|NCT01424488|pipecuronium-induced neuromuscular blockade|pipecuronium-induced neuromuscular blockade
356493|NCT01424462|healthy volunteers|healthy volunteers
356494|NCT01424462|firategrast|firategrast
356495|NCT01424462|Pharmacokinetics|pharmacokinetics
356496|NCT01424462|modified release|modified release
356497|NCT01424436|CSF sampling|csf sampling
356498|NCT01424436|Alzheimer's disease|alzheimer's disease
356499|NCT01424436|Amyloid beta levels|amyloid beta levels
356501|NCT01424423|GSK1223249|gsk1223249
356502|NCT01424423|Pharmacokinetics|pharmacokinetics
356503|NCT01424423|Single dose escalation|single dose escalation
356504|NCT01424423|anti-GSK1223249 antibodies|anti-gsk1223249 antibodies
356505|NCT01424423|Multiple Sclerosis|multiple sclerosis
356506|NCT01424410|paediatric schistosomiasis morbidity immunology|paediatric schistosomiasis morbidity immunology
356507|NCT01424384|healthy volunteers|healthy volunteers
356508|NCT01424384|Anxiety Disorder|anxiety disorder
356509|NCT01424384|neuropsychological tests|neuropsychological tests
356510|NCT01424345|Kidney Transplantation|kidney transplantation
356511|NCT01424345|Immunosuppression|immunosuppression
356512|NCT01424345|Immune monitoring|immune monitoring
356513|NCT01424332|Pharmacodynamics|pharmacodynamics
356514|NCT01424332|pharmacokinetics|pharmacokinetics
356515|NCT01424332|darexaban|darexaban
356516|NCT01424332|Acetyl Salicylic Acid|acetyl salicylic acid
356517|NCT01424332|darexaban glucuronide|darexaban glucuronide
356518|NCT01424332|YM150|ym150
356519|NCT01424332|YM-222714|ym-222714
356520|NCT01424332|Phase 1|phase 1
356521|NCT01424319|Endothelin Receptor Antagonists|endothelin receptor antagonists
356121|NCT01425775|SLE|sle
356522|NCT01424319|Proteinuria|proteinuria
356523|NCT01424306|Inflammation|inflammation
356524|NCT01424306|Intestinal permeability|intestinal permeability
356525|NCT01424306|Type 2 diabetes mellitus|type 2 diabetes mellitus
356526|NCT01424306|Cardiovascular disease|cardiovascular disease
356527|NCT01424306|Obesity|obesity
356528|NCT01424306|Sweetened beverages|sweetened beverages
356529|NCT01424306|Sugar|sugar
356530|NCT01424306|Fructose|fructose
356531|NCT01424306|Glucose|glucose
356532|NCT01424306|High-fructose corn syrup|high-fructose corn syrup
356533|NCT01424293|Rectal Cancer|rectal cancer
356534|NCT01424293|Colon Cancer|colon cancer
356535|NCT01424293|Diverticulitis|diverticulitis
356536|NCT01424293|Anastamosis|anastamosis
356537|NCT01424293|colectomy|colectomy
356538|NCT01424293|low anterior resection|low anterior resection
356539|NCT01424267|low profile|low profile
356540|NCT01424267|endovascular graft|endovascular graft
356541|NCT01424267|endovascular procedure|endovascular procedure
356542|NCT01424267|aortic aneurysm, abdominal aortic aneurysm|aortic aneurysm, abdominal aortic aneurysm
356543|NCT01424254|Gastrointestinal Bleeding of Obscure Origin|gastrointestinal bleeding of obscure origin
356544|NCT01424241|Sandostatin LAR|sandostatin lar
356545|NCT01424228|Long term|long term
356546|NCT01424228|Constipation|constipation
356547|NCT01424228|Digestive signs and symptoms|digestive signs and symptoms
356548|NCT01424202|Post extubation failure|post extubation failure
356549|NCT01424202|Mechanical Insufflation-Exsufflation|mechanical insufflation-exsufflation
356550|NCT01424202|Noninvasive Ventilation|noninvasive ventilation
356551|NCT01424202|Weaning|weaning
356552|NCT01424189|Cataract surgery|cataract surgery
356553|NCT01424189|Intraocular lens|intraocular lens
347172|NCT01461798|lipids|lipids
356554|NCT01424150|Postoperative fluid|postoperative fluid
356555|NCT01424150|surgery|surgery
356556|NCT01424150|anaesthesia|anaesthesia
356557|NCT01424150|fluid|fluid
356558|NCT01424150|mortality|mortality
356559|NCT01424150|morbidity|morbidity
356560|NCT01424111|Biomarkers|biomarkers
356561|NCT01424111|Depression|depression
356562|NCT01424111|Major Depressive Disorder|major depressive disorder
356563|NCT01424111|Escitalopram|escitalopram
356564|NCT01424072|stress psychological|stress psychological
356565|NCT01424072|coping behavior|coping behavior
356566|NCT01424059|fear|fear
356567|NCT01424059|labor|labor
356568|NCT01424059|induction|induction
356569|NCT01424059|amniotomy|amniotomy
356570|NCT01424059|WEDQ-B|wedq-b
356571|NCT01424059|parous|parous
356572|NCT01424059|cesarean section|cesarean section
356573|NCT01424046|type 1 diabetes|type 1 diabetes
356574|NCT01424046|basal insulin|basal insulin
356575|NCT01424046|developing world|developing world
356576|NCT01424046|comparative effectiveness|comparative effectiveness
356991|NCT01422434|randomised|randomised
356577|NCT01424033|Interstitial lung disease|interstitial lung disease
356578|NCT01424033|Connective tissue disease|connective tissue disease
356579|NCT01424033|Scleroderma|scleroderma
356580|NCT01424033|Rheumatoid arthritis|rheumatoid arthritis
356581|NCT01424033|Sjogren's syndrome|sjogren's syndrome
356582|NCT01424033|Mixed connective tissue disease|mixed connective tissue disease
356583|NCT01424033|Dermatomyositis|dermatomyositis
356584|NCT01424033|Polymyositis|polymyositis
356585|NCT01424033|Systemic lupus erythematosis|systemic lupus erythematosis
356586|NCT01424020|Questionnaire|questionnaire
356587|NCT01424020|peripheral artery disease|peripheral artery disease
356588|NCT01424020|execise|execise
356589|NCT01424007|Obese|obese
356590|NCT01424007|Women|women
356592|NCT01424007|Exercise|exercise
356593|NCT01424007|Physical activity|physical activity
356594|NCT01424007|Diet|diet
356595|NCT01424007|Female|female
356596|NCT01423994|syncope|syncope
356597|NCT01423994|fainting|fainting
356598|NCT01423994|implantable loop recorder|implantable loop recorder
356599|NCT01423994|pacemaker|pacemaker
356600|NCT01423994|heart block|heart block
356601|NCT01423994|bifascicular heart block|bifascicular heart block
356602|NCT01423981|Keloid|keloid
356603|NCT01423981|Scar|scar
356604|NCT01423981|hypertrophic scar|hypertrophic scar
356605|NCT01423981|familial keloid|familial keloid
356606|NCT01423968|Sepsis|sepsis
356607|NCT01423968|Inflammation|inflammation
356608|NCT01423968|Lipopolysaccharide|lipopolysaccharide
356609|NCT01423968|Muscle protein turnover|muscle protein turnover
356610|NCT01423968|Insulin resistance|insulin resistance
356611|NCT01423955|Erythropoietin|erythropoietin
356612|NCT01423955|Erythropoetin|erythropoetin
356613|NCT01423955|Cardiac surgery|cardiac surgery
356614|NCT01423955|Ischemia|ischemia
356615|NCT01423955|Reperfusion|reperfusion
356616|NCT01423955|Renal function|renal function
356617|NCT01423955|Cystatin C|cystatin c
356618|NCT01423955|Creatinine|creatinine
356619|NCT01423955|Safety|safety
356620|NCT01423929|Oxygen|oxygen
356621|NCT01423929|Myocardial infarction|myocardial infarction
356622|NCT01423929|Ambulance|ambulance
356623|NCT01423929|Percutaneous coronary intervention|percutaneous coronary intervention
356624|NCT01423929|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
356625|NCT01423916|Schizophrenia|schizophrenia
356626|NCT01423916|QTc Interval|qtc interval
356627|NCT01423903|Phase I|phase i
356628|NCT01423903|STAT-3 inhibitor|stat-3 inhibitor
356629|NCT01423903|solid tumors|solid tumors
356630|NCT01423890|Breast Cancer|breast cancer
356631|NCT01423890|Oncotype DX|oncotype dx
356632|NCT01423890|Adjuvant! Online|adjuvant! online
356633|NCT01423890|Decisional Conflict Scale|decisional conflict scale
356634|NCT01423877|bariatric surgery|bariatric surgery
356635|NCT01423877|diabetes|diabetes
356636|NCT01423877|sleeve gastrectomy|sleeve gastrectomy
356637|NCT01423877|gastric bypass|gastric bypass
356638|NCT01423877|gastric banding|gastric banding
356639|NCT01423864|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
356640|NCT01423864|Multi-organ Dysfunction Syndrome|multi-organ dysfunction syndrome
356641|NCT01423864|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
356642|NCT01423851|Keywords provided by NS Pharma, Inc.:|keywords provided by ns pharma, inc.:
356643|NCT01423851|JAK2 kinase inhibitor|jak2 kinase inhibitor
356644|NCT01423851|NS-018|ns-018
356645|NCT01423851|Myeloproliferative Neoplasms|myeloproliferative neoplasms
356646|NCT01423851|Primary Myelofibrosis|primary myelofibrosis
356647|NCT01423851|post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
356648|NCT01423851|post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
356649|NCT01423851|Additional relevant MeSH terms:|additional relevant mesh terms:
356650|NCT01423851|Bone Marrow Diseases|bone marrow diseases
356651|NCT01423851|Hematologic Diseases|hematologic diseases
356652|NCT01423851|Polycythemia Vera|polycythemia vera
356653|NCT01423851|Thrombocythemia, Essential|thrombocythemia, essential
356655|NCT01423851|post-PV MF|post-pv mf
356656|NCT01423851|post-ET MF|post-et mf
356657|NCT01423838|Overactive bladder|overactive bladder
356658|NCT01423838|Solifenacin|solifenacin
356659|NCT01423838|Oxybutynin|oxybutynin
356660|NCT01423812|HIV|hiv
356661|NCT01423812|treatment-experienced|treatment-experienced
356662|NCT01423812|protease inhibitor|protease inhibitor
356663|NCT01423812|adherence|adherence
356664|NCT01423812|lipids|lipids
356665|NCT01423799|Quality of life|quality of life
356666|NCT01423799|Cancer|cancer
356667|NCT01423799|Immunonutrition|immunonutrition
356668|NCT01423760|Vaccine|vaccine
356669|NCT01423760|Stimuvax|stimuvax
356670|NCT01423760|Tecemotide|tecemotide
356671|NCT01423760|L-BLP25|l-blp25
356672|NCT01423760|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
356673|NCT01423760|Multiple Myeloma|multiple myeloma
356674|NCT01423747|ALL|all
356675|NCT01423747|HSCT|hsct
356676|NCT01423747|children|children
356677|NCT01423747|adolescents|adolescents
356678|NCT01423734|ADRENAL GLAND|adrenal gland
356679|NCT01423734|MRI|mri
356680|NCT01423734|11-122|11-122
356681|NCT01423708|Liver Transplantation|liver transplantation
356682|NCT01423708|Graft Rejection|graft rejection
356683|NCT01423708|Graft Survival|graft survival
356684|NCT01423708|Transplantation Immunology|transplantation immunology
356685|NCT01423708|Anti-Rejection Therapy|anti-rejection therapy
356686|NCT01423708|Immunosuppression|immunosuppression
356687|NCT01423708|Organ Transplantation|organ transplantation
356688|NCT01423708|Host vs Graft Reaction|host vs graft reaction
356689|NCT01423708|Gastroenterology|gastroenterology
356690|NCT01423708|Hepatology|hepatology
356691|NCT01423669|Psychotic Disorders|psychotic disorders
356692|NCT01423643|HIV|hiv
356693|NCT01423643|Human immunodeficiency virus|human immunodeficiency virus
356694|NCT01423643|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
356695|NCT01423643|AIDS Virus|aids virus
356696|NCT01423643|Immunodeficiency Virus, Human|immunodeficiency virus, human
356697|NCT01423643|Virus, Human Immunodeficiency|virus, human immunodeficiency
356698|NCT01423643|Hepatitis C|hepatitis c
356699|NCT01423643|Hepatitis C, chronic|hepatitis c, chronic
356700|NCT01423643|Hepatitis C virus|hepatitis c virus
356701|NCT01423643|Hepatitis C antibodies|hepatitis c antibodies
356702|NCT01423643|Hepatitis C antigens|hepatitis c antigens
356703|NCT01423630|fatty liver|fatty liver
356704|NCT01423630|probiotics|probiotics
356705|NCT01423630|Lactobacillus|lactobacillus
356706|NCT01423630|fruit|fruit
356707|NCT01423630|fibre|fibre
356708|NCT01423630|dietary intervention|dietary intervention
356709|NCT01423630|obesity|obesity
356710|NCT01423617|overweight|overweight
356711|NCT01423617|weight loss|weight loss
356712|NCT01423617|body fat|body fat
356713|NCT01423617|waist circumference|waist circumference
356714|NCT01423617|satiety|satiety
356715|NCT01423617|appetite|appetite
356716|NCT01423604|Metastatic pancreatic cancer|metastatic pancreatic cancer
356717|NCT01423591|Infliximab|infliximab
356718|NCT01423591|polymyalgia rheumatica|polymyalgia rheumatica
356719|NCT01423591|refractory|refractory
356720|NCT01423591|double blind|double blind
356721|NCT01423591|placebo controlled|placebo controlled
356722|NCT01423591|trial|trial
356723|NCT01423578|craving|craving
356724|NCT01423578|mood|mood
356725|NCT01423578|cue reactivity|cue reactivity
356726|NCT01423578|smoking behavior|smoking behavior
356727|NCT01423578|quit smoking|quit smoking
356728|NCT01423578|prevention|prevention
356729|NCT01423578|Hatha yoga|hatha yoga
356730|NCT01423578|cardiovascular exercise|cardiovascular exercise
356731|NCT01423565|Deep Brain Stimulation|deep brain stimulation
356732|NCT01423565|Parkinson's Disease|parkinson's disease
356733|NCT01423565|Subthalamic Nucleus|subthalamic nucleus
356734|NCT01423565|Constant Current|constant current
356735|NCT01423552|Heart transplantation|heart transplantation
356736|NCT01423552|Immunosuppression|immunosuppression
356737|NCT01423552|Pharmacokinetics|pharmacokinetics
356738|NCT01423552|Pharmacogenetics|pharmacogenetics
356739|NCT01423513|ankle tape|ankle tape
356740|NCT01423513|Hoffmann reflex|hoffmann reflex
356741|NCT01423513|Balance|balance
356742|NCT01423500|ALL|all
356743|NCT01423500|HSCT|hsct
356744|NCT01423500|children|children
356745|NCT01423500|adolescents|adolescents
356746|NCT01423487|Metformin|metformin
356747|NCT01423487|Risperidone|risperidone
356748|NCT01423487|Prevention|prevention
356749|NCT01423487|weight gain|weight gain
356750|NCT01423487|Amenorrhea|amenorrhea
356751|NCT01423474|Radiotherapy|radiotherapy
356752|NCT01423474|Hypofractionation|hypofractionation
356753|NCT01423448|Depression|depression
356754|NCT01423448|mental health|mental health
356755|NCT01423448|wellbeing|wellbeing
356756|NCT01423448|online bulletin board|online bulletin board
356757|NCT01423448|online support group|online support group
356758|NCT01423435|TRK-100STP|trk-100stp
356759|NCT01423435|PK|pk
356760|NCT01423435|beraprost sodium|beraprost sodium
347372|NCT01460914|ECP|ecp
356761|NCT01423422|Exercise stress test|exercise stress test
356762|NCT01423422|Effort Angina|effort angina
356763|NCT01423422|Exercise induced angina|exercise induced angina
356764|NCT01423409|visual analog pain scale|visual analog pain scale
356765|NCT01423409|Deaf persons|deaf persons
356766|NCT01423409|clinical trial|clinical trial
356767|NCT01423409|multicentric|multicentric
356768|NCT01423396|Alzheimer's disease|alzheimer's disease
356769|NCT01423396|cardiovascular risk factors|cardiovascular risk factors
356770|NCT01423383|Keloid|keloid
356771|NCT01423370|Erectile Dysfunction|erectile dysfunction
356772|NCT01423370|YHD1023|yhd1023
356773|NCT01423370|YCD190|ycd190
356774|NCT01423370|Cialis|cialis
356775|NCT01423370|Yuhan|yuhan
356776|NCT01423357|HIV prevention|hiv prevention
356777|NCT01423357|condom distribution|condom distribution
356778|NCT01423357|youth peer education|youth peer education
356779|NCT01423357|high risk places|high risk places
356780|NCT01423357|condom use|condom use
356781|NCT01423357|prevention through increased condom use|prevention through increased condom use
356782|NCT01423344|multiple myeloma|multiple myeloma
356783|NCT01423344|Free light chains|free light chains
356784|NCT01423331|Postpartum depression|postpartum depression
356785|NCT01423331|maternal mental health|maternal mental health
356786|NCT01423305|Asthma|asthma
356787|NCT01423266|High Protein Diet in heart failure|high protein diet in heart failure
356788|NCT01423266|obesity and heart failure|obesity and heart failure
356789|NCT01423266|Weight management in Heart failure|weight management in heart failure
356790|NCT01423266|heart failure, diabetes and obesity|heart failure, diabetes and obesity
356791|NCT01423253|Depression|depression
356792|NCT01423253|Lurasidone|lurasidone
356793|NCT01423253|Latuda|latuda
356794|NCT01423240|Depression|depression
356795|NCT01423240|Lurasidone|lurasidone
356796|NCT01423240|Latuda|latuda
356797|NCT01423227|COPD|copd
356798|NCT01423227|exercise|exercise
356799|NCT01423227|rehabilitation|rehabilitation
356800|NCT01423227|dyspnea|dyspnea
356801|NCT01423227|quality of life|quality of life
356802|NCT01423227|economic evaluation|economic evaluation
356803|NCT01423214|rectal cancer|rectal cancer
356804|NCT01423214|robot|robot
356805|NCT01423214|laparoscopy|laparoscopy
356806|NCT01423214|total mesorectal excision|total mesorectal excision
356807|NCT01423214|robotic surgery|robotic surgery
356808|NCT01423201|TIA|tia
356809|NCT01423201|triage|triage
356810|NCT01423201|Lp-PLA2|lp-pla2
356811|NCT01423201|Proteomic|proteomic
356812|NCT01423201|Genomic|genomic
356813|NCT01423188|ApolipoproteinA1|apolipoproteina1
356814|NCT01423188|HDL-C|hdl-c
356815|NCT01423188|Atherosclerosis|atherosclerosis
356816|NCT01423175|high risk acute myeloid leukemia|high risk acute myeloid leukemia
356817|NCT01423175|advanced myelodysplastic syndrome|advanced myelodysplastic syndrome
356818|NCT01423175|allogenic stem cell transplantation|allogenic stem cell transplantation
356819|NCT01423175|clofarabine|clofarabine
356820|NCT01423162|Iron absorption|iron absorption
356821|NCT01423162|Oats|oats
356822|NCT01423162|fortified oat beverages|fortified oat beverages
356823|NCT01423149|subfoveal choroidal neovascularization|subfoveal choroidal neovascularization
356824|NCT01423149|pathologic myopia|pathologic myopia
356825|NCT01423136|Patients undergoing non-cardiac Surgery|patients undergoing non-cardiac surgery
356826|NCT01423123|Paclitaxel|paclitaxel
356827|NCT01423123|Trastuzumab|trastuzumab
356828|NCT01423123|Neratinib|neratinib
356829|NCT01423123|Breast Cancer|breast cancer
356830|NCT01423123|HER2-positive|her2-positive
753317|NCT01176240|lightheadedness|lightheadedness
356831|NCT01423110|sporadic Inclusion Body Myositis|sporadic inclusion body myositis
356832|NCT01423097|osteoarthritis symptoms|osteoarthritis symptoms
356833|NCT01423084|Meningococcal Meningitis|meningococcal meningitis
356834|NCT01423084|prevention, vaccination|prevention, vaccination
356835|NCT01423084|adolescents|adolescents
356836|NCT01423071|Pulmonary Hypertension|pulmonary hypertension
356837|NCT01423071|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
356838|NCT01423071|Prevalence|prevalence
356839|NCT01423071|Quality of life|quality of life
356840|NCT01423045|Chronic kidney disease|chronic kidney disease
356841|NCT01423045|Urine osmolarity|urine osmolarity
356842|NCT01423045|Glomerular filtration rate|glomerular filtration rate
356843|NCT01423032|relapsed|relapsed
356844|NCT01423019|Weight Loss|weight loss
356845|NCT01423019|Body Composition|body composition
356846|NCT01423019|Fat Free Mass|fat free mass
356847|NCT01423019|Bone Mineral Density|bone mineral density
356848|NCT01423019|Adipose Tissue|adipose tissue
586751|NCT00524992|HAART Toxicity|haart toxicity
356849|NCT01423019|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
356850|NCT01423019|Body Fat|body fat
356851|NCT01423019|Eating and appetite control|eating and appetite control
356852|NCT01423019|Basal Metabolic Rate|basal metabolic rate
356853|NCT01423006|Pilot|pilot
356854|NCT01423006|Ablation|ablation
356855|NCT01423006|Low Risk|low risk
356856|NCT01423006|Radio Frequency|radio frequency
356858|NCT01423006|minimally invasive|minimally invasive
356859|NCT01423006|prostate gland|prostate gland
356860|NCT01422993|Oxaliplatin Induced|oxaliplatin induced
356861|NCT01422993|Peripheral Neuropathy|peripheral neuropathy
356862|NCT01422993|Strength|strength
356863|NCT01422993|Balance|balance
356864|NCT01422993|Training Program|training program
356865|NCT01422993|Colon|colon
356866|NCT01422993|Rectal|rectal
356867|NCT01422980|dairy product|dairy product
356868|NCT01422980|upper gastric discomfort|upper gastric discomfort
356869|NCT01422980|adult|adult
356870|NCT01422967|Osteoarthritis|osteoarthritis
356871|NCT01422967|Sleep|sleep
356872|NCT01422967|muscle strength|muscle strength
356873|NCT01422967|balance|balance
356874|NCT01422928|Radiotherapy|radiotherapy
356875|NCT01422928|Acupuncture|acupuncture
356876|NCT01422928|Immune System|immune system
356877|NCT01422915|Sorbent|sorbent
356878|NCT01422915|Resin|resin
356879|NCT01422915|EPP|epp
356880|NCT01422915|Cutaneous porphyria|cutaneous porphyria
356881|NCT01422915|Adult|adult
356882|NCT01422915|over age 21|over age 21
356883|NCT01422915|without intercurrent illness|without intercurrent illness
356884|NCT01422915|not pregnant|not pregnant
356885|NCT01422915|willing to participate|willing to participate
356886|NCT01422902|Schizophrenia|schizophrenia
356887|NCT01422902|Cognitive deficits|cognitive deficits
356888|NCT01422902|Cognitive remediation|cognitive remediation
356889|NCT01422902|Software|software
356890|NCT01422902|Brain Plasticity|brain plasticity
356891|NCT01422889|Atherosclerosis|atherosclerosis
356892|NCT01422889|Coronary Artery Disease|coronary artery disease
356893|NCT01422863|weight loss|weight loss
356894|NCT01422863|exercise|exercise
356895|NCT01422863|diet|diet
356896|NCT01422863|sleep apnea|sleep apnea
356897|NCT01422863|aging|aging
356898|NCT01422850|hormone-refractory prostate cancer|hormone-refractory prostate cancer
356899|NCT01422850|Immunotherapy|immunotherapy
356900|NCT01422837|opioid|opioid
356901|NCT01422837|dependence|dependence
356902|NCT01422837|VIVITROL|vivitrol
356903|NCT01422811|Public health|public health
356904|NCT01422811|Policy|policy
356905|NCT01422811|Training|training
356906|NCT01422785|Acne Vulgaris|acne vulgaris
356907|NCT01422720|Epilepsy|epilepsy
356908|NCT01422720|ESL|esl
356909|NCT01422720|Eslicarbazepine Acetate|eslicarbazepine acetate
356910|NCT01422720|BIAL|bial
356911|NCT01422720|BIA|bia
356912|NCT01422720|Partial-onset Seizures|partial-onset seizures
356913|NCT01422694|Sacroiliitis|sacroiliitis
356914|NCT01422694|Ankylosing Spondylitis|ankylosing spondylitis
356915|NCT01422694|Spondyloarthritis|spondyloarthritis
356916|NCT01422694|HLA-B27|hla-b27
356917|NCT01422694|Enthesitis-Related Arthritis|enthesitis-related arthritis
356918|NCT01422681|COPD|copd
356919|NCT01422668|Glycemic index|glycemic index
356920|NCT01422668|Dates|dates
356921|NCT01422668|Diabetes|diabetes
356922|NCT01422668|Coffee|coffee
356923|NCT01422629|Breast Fibroadenoma|breast fibroadenoma
356924|NCT01422629|High Intensity Focused Ultrasound|high intensity focused ultrasound
356925|NCT01422616|Ischemic stroke|ischemic stroke
356926|NCT01422616|High blood pressure|high blood pressure
356927|NCT01422616|Thrombolysis|thrombolysis
356928|NCT01422616|Antihypertensive drugs|antihypertensive drugs
356929|NCT01422616|Disability|disability
356930|NCT01422616|Clinical trial|clinical trial
356931|NCT01422603|High risk|high risk
356932|NCT01422603|AML|aml
356933|NCT01422603|MDS|mds
356934|NCT01422590|sitagliptin|sitagliptin
356935|NCT01422590|mitiglinide|mitiglinide
356937|NCT01422590|Pharmacodynamics|pharmacodynamics
356938|NCT01422590|Safety|safety
356939|NCT01422551|stress management intervention|stress management intervention
356940|NCT01422551|breast cancer|breast cancer
356941|NCT01422551|quality of life|quality of life
356942|NCT01422551|psychosocial adaptation|psychosocial adaptation
356943|NCT01422538|Ulthera® System|ulthera® system
356944|NCT01422538|Ultherapy™ treatment|ultherapy™ treatment
356945|NCT01422538|Ulthera, Inc.|ulthera, inc.
356946|NCT01422538|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
356947|NCT01422538|Skin laxity on the face and neck.|skin laxity on the face and neck.
356948|NCT01422512|seasonal influenza|seasonal influenza
356949|NCT01422512|vaccine|vaccine
356950|NCT01422499|pediatric oncology|pediatric oncology
356951|NCT01422499|relapsed solid tumor|relapsed solid tumor
356952|NCT01422499|lymphoma|lymphoma
356953|NCT01422499|leukemia|leukemia
356954|NCT01422499|vorinostat|vorinostat
356955|NCT01422486|Hematology|hematology
356956|NCT01422486|MDS|mds
356957|NCT01422486|Myelodysplastic Syndrome|myelodysplastic syndrome
356958|NCT01422486|Low risk MDS|low risk mds
356959|NCT01422486|Intermediate-1 risk MDS|intermediate-1 risk mds
356960|NCT01422486|Int-1 risk MDS|int-1 risk mds
356961|NCT01422486|Transfusion dependence|transfusion dependence
356962|NCT01422486|Lenalidomide refractory|lenalidomide refractory
356963|NCT01422486|Revlimid refractory|revlimid refractory
356964|NCT01422486|Lenalidomide resistant|lenalidomide resistant
347596|NCT01460121|SpotOn|spoton
356965|NCT01422486|Revlimid resistant|revlimid resistant
356966|NCT01422486|Telintra|telintra
356967|NCT01422486|ezatiostat|ezatiostat
356968|NCT01422486|ezatiostat hydrochloride|ezatiostat hydrochloride
356969|NCT01422486|TLK199|tlk199
356970|NCT01422486|Glutathione|glutathione
356971|NCT01422486|Glutathione analog|glutathione analog
356972|NCT01422486|Glutathione Transferase|glutathione transferase
356973|NCT01422486|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
356974|NCT01422486|GST P1-1 inhibitor|gst p1-1 inhibitor
356975|NCT01422486|Apoptosis|apoptosis
356976|NCT01422486|Differentiation|differentiation
356977|NCT01422486|Enzyme inhibitor|enzyme inhibitor
356978|NCT01422473|Hemorrhoids|hemorrhoids
356979|NCT01422473|Rectal Diseases|rectal diseases
356980|NCT01422473|Intestinal Diseases|intestinal diseases
356981|NCT01422473|Gastrointestinal Diseases|gastrointestinal diseases
356982|NCT01422473|Digestive System Diseases|digestive system diseases
356983|NCT01422460|Osteoarthritis|osteoarthritis
356984|NCT01422460|PRP|prp
356985|NCT01422460|PRGF|prgf
356986|NCT01422447|mental health education|mental health education
356987|NCT01422447|community-based|community-based
356988|NCT01422434|A national|a national
356989|NCT01422434|multi-centre|multi-centre
356990|NCT01422434|prospective|prospective
356992|NCT01422434|double-blind|double-blind
356993|NCT01422434|active-controlled|active-controlled
356994|NCT01422434|3-arm|3-arm
356995|NCT01422434|parallel group|parallel group
356996|NCT01422434|4 week study|4 week study
356997|NCT01422421|type 2 diabetes|type 2 diabetes
356998|NCT01422421|coronary artery disease|coronary artery disease
356999|NCT01422421|hypertension|hypertension
357000|NCT01422421|dyslipidemia|dyslipidemia
357001|NCT01422395|Vitrification|vitrification
357002|NCT01422395|Egg Freezing|egg freezing
357003|NCT01422395|Oocyte Cryopreservation|oocyte cryopreservation
357004|NCT01422382|Healthy Volunteers|healthy volunteers
357005|NCT01422369|Healthy Volunteers|healthy volunteers
357006|NCT01422356|cohort study|cohort study
357007|NCT01422356|men who have sex with men|men who have sex with men
357008|NCT01422343|peripheral arterial disease|peripheral arterial disease
357009|NCT01422343|cell-derived microparticles|cell-derived microparticles
357010|NCT01422343|immunity, innate|immunity, innate
357011|NCT01422343|blood coagulation|blood coagulation
357012|NCT01422330|Human Immunodeficiency Virus (HIV) infection|human immunodeficiency virus (hiv) infection
357013|NCT01422330|TMC125IFD3002|tmc125ifd3002
357014|NCT01422330|TMC125|tmc125
357015|NCT01422330|Intelence|intelence
357016|NCT01422330|HIV|hiv
357017|NCT01422317|n-3 fatty acids|n-3 fatty acids
357018|NCT01422317|randomized double-blind study|randomized double-blind study
357019|NCT01422317|coronary events|coronary events
357020|NCT01422317|serum lipids|serum lipids
357021|NCT01422317|antithrombotic effects of omega-3 fatty acids|antithrombotic effects of omega-3 fatty acids
357022|NCT01422317|anti-inflammatory effects of omega-3 fatty acids|anti-inflammatory effects of omega-3 fatty acids
357023|NCT01422317|prognostic biomarkers in myocardial infarction (MI)-patients|prognostic biomarkers in myocardial infarction (mi)-patients
357024|NCT01422291|Low back pain|low back pain
357025|NCT01422291|paracetamol|paracetamol
357026|NCT01422291|dexketoprofen|dexketoprofen
357027|NCT01422291|morphine|morphine
357028|NCT01422252|Falls Elderly persons|falls elderly persons
357029|NCT01422252|Isolated At risk for falls|isolated at risk for falls
357030|NCT01422252|Fall detection device|fall detection device
356654|NCT01423851|PMF|pmf
357031|NCT01422252|Precocious detection Vigi'Fall®|precocious detection vigi'fall®
357032|NCT01422239|smoking|smoking
357033|NCT01422239|treatment|treatment
357034|NCT01422239|perceived risks|perceived risks
357035|NCT01422226|IUD|iud
357036|NCT01422226|contraception|contraception
357037|NCT01422226|nulliparous|nulliparous
357038|NCT01422226|women|women
357039|NCT01422213|MDD|mdd
357040|NCT01422213|Cognitive dysfunction|cognitive dysfunction
357041|NCT01422200|DMD|dmd
357042|NCT01422200|SMA|sma
357043|NCT01422200|CMD|cmd
357044|NCT01422200|flu vaccine|flu vaccine
357045|NCT01422187|enzyme replacement therapy|enzyme replacement therapy
357046|NCT01422174|Primary prevention|primary prevention
357047|NCT01422174|Latin America|latin america
357048|NCT01422174|Sudden death|sudden death
357049|NCT01422174|Myocardial infarction|myocardial infarction
357050|NCT01422174|Ejection Fraction|ejection fraction
357051|NCT01422174|ICD|icd
357052|NCT01422161|Rehabilitation|rehabilitation
357053|NCT01422161|Fingers|fingers
357054|NCT01422161|Grasp|grasp
357055|NCT01422161|Hand|hand
357056|NCT01422161|Strength|strength
357057|NCT01422161|Brain Infraction|brain infraction
357058|NCT01422161|Pathology|pathology
357059|NCT01422161|Physiopathology|physiopathology
357060|NCT01422161|Functional Laterality|functional laterality
357061|NCT01422161|Neuronal Plasticity|neuronal plasticity
357062|NCT01422161|Psychomotor Performance|psychomotor performance
357063|NCT01422161|Biomechanics|biomechanics
357064|NCT01422161|Touch|touch
357065|NCT01422161|Weight-Bearing|weight-bearing
357066|NCT01422148|cardiac surgery|cardiac surgery
357067|NCT01422148|atrial fibrillation|atrial fibrillation
357068|NCT01422148|minocycline|minocycline
357069|NCT01422148|amiodarone|amiodarone
357070|NCT01422135|PK and safety|pk and safety
357071|NCT01422135|Pharmacokinetic profile (PK) and safety|pharmacokinetic profile (pk) and safety
357072|NCT01422122|vitamin D|vitamin d
357073|NCT01422122|pregnancy|pregnancy
357074|NCT01422122|periodontal health|periodontal health
357075|NCT01422122|biomarkers|biomarkers
357076|NCT01422109|YH14659|yh14659
357077|NCT01422109|Aspirin|aspirin
357078|NCT01422109|Clopidogrel|clopidogrel
357079|NCT01422109|Yuhan|yuhan
357080|NCT01422070|mortality|mortality
357081|NCT01422070|intensive care|intensive care
357082|NCT01422070|critical care|critical care
357083|NCT01422070|intermediate care|intermediate care
357084|NCT01422057|diabetes|diabetes
357085|NCT01422057|coronary artery disease|coronary artery disease
357086|NCT01422057|ischemic heart disease|ischemic heart disease
357087|NCT01422057|autonomic function|autonomic function
357088|NCT01422057|heart rate turbulence|heart rate turbulence
357089|NCT01422057|deceleration capacity|deceleration capacity
357090|NCT01422057|severe autonomic failure|severe autonomic failure
357091|NCT01422044|aortic stenosis|aortic stenosis
357092|NCT01422044|autonomic function|autonomic function
357093|NCT01422031|Primary care|primary care
357094|NCT01422031|Family doctor|family doctor
357095|NCT01422031|Consultation|consultation
357096|NCT01422031|utilization|utilization
357097|NCT01422031|Non-drug managements|non-drug managements
357098|NCT01422031|Patient enablement index|patient enablement index
357099|NCT01422018|clinically significant macular edema|clinically significant macular edema
357100|NCT01422018|diabetic macular edema|diabetic macular edema
357101|NCT01422018|focal edema|focal edema
357102|NCT01422018|focal laser photocoagulation|focal laser photocoagulation
357103|NCT01422018|hard exudates|hard exudates
357104|NCT01422018|intravitreal bevacizumab|intravitreal bevacizumab
357105|NCT01422005|Rehabilitation|rehabilitation
357106|NCT01422005|Fingers|fingers
357107|NCT01422005|Grasp|grasp
357108|NCT01422005|Hand|hand
357109|NCT01422005|Strength|strength
357110|NCT01422005|Brain Infraction|brain infraction
357111|NCT01422005|Hand Function|hand function
357112|NCT01422005|Post Stroke|post stroke
357113|NCT01422005|Neural mechanisms|neural mechanisms
357114|NCT01422005|Motor Control|motor control
357115|NCT01422005|Motor Function|motor function
357116|NCT01421992|randomized|randomized
357117|NCT01421992|double-blind|double-blind
357118|NCT01421992|crossover|crossover
357119|NCT01421992|methylphenidate|methylphenidate
357120|NCT01421992|excessive daytime sleepiness|excessive daytime sleepiness
357121|NCT01421966|chronic ulcers|chronic ulcers
357122|NCT01421966|diabetic foot ulcers|diabetic foot ulcers
357123|NCT01421953|Positron Emission Tomography|positron emission tomography
357124|NCT01421953|Computed Tomography|computed tomography
357125|NCT01421953|Lung cancer|lung cancer
357126|NCT01421940|Udenafil|udenafil
357127|NCT01421940|rectal cancer|rectal cancer
357128|NCT01421940|penile rehabilitation|penile rehabilitation
357129|NCT01421940|total mesorectal excision|total mesorectal excision
357130|NCT01421927|lenalidomide|lenalidomide
357131|NCT01421914|Ultrasound|ultrasound
357132|NCT01421914|Axillary block|axillary block
357133|NCT01421914|Bupivacaine|bupivacaine
357134|NCT01421914|Minimum|minimum
357135|NCT01421914|Volume|volume
753318|NCT01176240|unsteadiness|unsteadiness
357136|NCT01421914|Minimum volume of bupivacaine 0,5%|minimum volume of bupivacaine 0,5%
357137|NCT01421901|Acute appendicitis|acute appendicitis
357138|NCT01421901|Surgery|surgery
357139|NCT01421901|Antibiotics|antibiotics
357140|NCT01421901|comparison surgery and antibiotics|comparison surgery and antibiotics
357141|NCT01421901|resolutions of symptoms|resolutions of symptoms
357142|NCT01421888|Immunity|immunity
357143|NCT01421888|Urea Cycle Disorder|urea cycle disorder
357144|NCT01421888|Nutrition|nutrition
357145|NCT01421888|Vaccination|vaccination
357146|NCT01421888|Influenza|influenza
357147|NCT01421875|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
357148|NCT01421875|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
357149|NCT01421875|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
357150|NCT01421875|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
357151|NCT01421875|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
586752|NCT00524992|HIV Positive|hiv positive
357152|NCT01421875|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
357153|NCT01421875|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
357154|NCT01421875|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
357155|NCT01421875|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
347773|NCT01459315|Healthy|healthy
357156|NCT01421875|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
357157|NCT01421875|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
357158|NCT01421875|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
357159|NCT01421875|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
357160|NCT01421875|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
357161|NCT01421875|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
357162|NCT01421862|adult acute basophilic leukemia|adult acute basophilic leukemia
357163|NCT01421862|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
357164|NCT01421862|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
357165|NCT01421862|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
357166|NCT01421862|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
357167|NCT01421862|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
357168|NCT01421862|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
357169|NCT01421862|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
357170|NCT01421862|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
357171|NCT01421862|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
357295|NCT01421407|Parathyroid hyperplasia|parathyroid hyperplasia
357172|NCT01421862|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
357173|NCT01421862|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
357174|NCT01421862|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
357175|NCT01421862|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
357176|NCT01421862|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
357177|NCT01421862|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
357178|NCT01421862|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
357179|NCT01421849|single implant denture|single implant denture
357180|NCT01421849|Elderly with an unstable mandibular denture|elderly with an unstable mandibular denture
357181|NCT01421836|stent patency|stent patency
357182|NCT01421836|EUS guided insertion|eus guided insertion
357183|NCT01421836|ERCP guided insertion|ercp guided insertion
357184|NCT01421823|Fecal Incontinence|fecal incontinence
357185|NCT01421823|Alpha agonist|alpha agonist
357186|NCT01421732|Dengue fever|dengue fever
357187|NCT01421732|severe dengue fever|severe dengue fever
357188|NCT01421732|NS1 detection assay|ns1 detection assay
357189|NCT01421732|Prognosis|prognosis
357190|NCT01421732|Diagnosis|diagnosis
357191|NCT01421719|Parkinson's Disease|parkinson's disease
357192|NCT01421719|Neurogenic Bladder|neurogenic bladder
357193|NCT01421719|Urinary Incontinence|urinary incontinence
357194|NCT01421719|botulinum toxin|botulinum toxin
357195|NCT01421719|cystoscopy|cystoscopy
357196|NCT01421719|Effect of Other Parasympatholytics [Anticholinergics and Antimuscarinics] and Spasmolytics|effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics
357197|NCT01421706|clarithromycin|clarithromycin
357198|NCT01421706|sibutramine|sibutramine
357199|NCT01421706|clopidogrel|clopidogrel
357200|NCT01421693|Gatifloxacin|gatifloxacin
357201|NCT01421693|Ceftriaxone|ceftriaxone
357202|NCT01421693|Enteric fever|enteric fever
357203|NCT01421693|Typhoid fever|typhoid fever
357204|NCT01421667|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
357205|NCT01421667|Antigens, CD30|antigens, cd30
357206|NCT01421667|Antibody-Drug Conjugate|antibody-drug conjugate
357207|NCT01421667|Antibodies, Monoclonal|antibodies, monoclonal
753319|NCT01176240|dizziness|dizziness
357208|NCT01421667|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
357209|NCT01421667|Monomethyl auristatin E|monomethyl auristatin e
357210|NCT01421667|Drug Therapy|drug therapy
357211|NCT01421667|Immunotherapy|immunotherapy
357212|NCT01421667|Hematologic Diseases|hematologic diseases
357213|NCT01421667|Lymphoma|lymphoma
357214|NCT01421667|Lymphoma, B-Cell|lymphoma, b-cell
357215|NCT01421667|Lymphoma, T-Cell|lymphoma, t-cell
357216|NCT01421654|OSA|osa
357217|NCT01421654|Sleep Apnea|sleep apnea
357218|NCT01421654|PAP|pap
357219|NCT01421654|positive airway pressure|positive airway pressure
357220|NCT01421641|Tenaculum|tenaculum
357221|NCT01421641|Pain|pain
357222|NCT01421641|Lidocaine|lidocaine
357223|NCT01421628|older adults|older adults
357224|NCT01421628|exercise|exercise
357225|NCT01421628|stretching|stretching
357226|NCT01421628|mobility|mobility
357227|NCT01421615|Bacterial vaginosis|bacterial vaginosis
357228|NCT01421615|Probiotics|probiotics
357229|NCT01421615|Lactobacilli|lactobacilli
730683|NCT01081795|Topiramate|topiramate
357230|NCT01421615|Pregnancy outcome|pregnancy outcome
357231|NCT01421615|Randomized controlled trial|randomized controlled trial
357232|NCT01421602|Inguinal Hernia|inguinal hernia
357233|NCT01421602|Self-fixating mesh|self-fixating mesh
357234|NCT01421602|Progrip|progrip
357235|NCT01421602|Hernia Recurrence|hernia recurrence
357236|NCT01421602|Mesh, Surgical|mesh, surgical
357237|NCT01421602|Recurrence|recurrence
357238|NCT01421589|Growth hormone|growth hormone
357239|NCT01421589|GH|gh
357240|NCT01421589|Obesity|obesity
357241|NCT01421589|Mitochondrial function|mitochondrial function
357242|NCT01421589|reduced growth hormone secretion|reduced growth hormone secretion
357243|NCT01421550|umbilical|umbilical
357244|NCT01421550|hernia|hernia
357245|NCT01421550|cirrhosis|cirrhosis
357246|NCT01421550|ascites|ascites
357247|NCT01421550|conservative|conservative
357248|NCT01421550|surgery|surgery
357249|NCT01421550|optimal management|optimal management
357250|NCT01421537|Thromboprophylaxis|thromboprophylaxis
357251|NCT01421537|enoxaparin|enoxaparin
357252|NCT01421524|Neoplasm|neoplasm
357253|NCT01421524|Malignancy|malignancy
357254|NCT01421524|Carcinoma|carcinoma
357255|NCT01421524|Lymphoma|lymphoma
357256|NCT01421524|Multiple Myeloma|multiple myeloma
357257|NCT01421524|DNA-PK inhibitor|dna-pk inhibitor
357258|NCT01421524|Advanced Solid Tumors|advanced solid tumors
357259|NCT01421524|Glioblastoma multiforme|glioblastoma multiforme
357260|NCT01421524|Hepatocellular Carcinoma|hepatocellular carcinoma
357261|NCT01421524|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
357262|NCT01421524|Mantel Cell Lymphoma|mantel cell lymphoma
357263|NCT01421524|Advanced unresectable Solid Tumors|advanced unresectable solid tumors
357264|NCT01421524|Primary CNS Lymphoma|primary cns lymphoma
357265|NCT01421511|ABSSSI|absssi
357266|NCT01421511|Tedizolid Phosphate|tedizolid phosphate
357267|NCT01421511|TR-701|tr-701
357268|NCT01421511|Acute Bacterial Skin and Skin Structure Infections|acute bacterial skin and skin structure infections
357269|NCT01421498|Dry Eye|dry eye
357270|NCT01421498|ophthalmic delivery|ophthalmic delivery
357271|NCT01421472|Breast Cancer|breast cancer
357272|NCT01421472|Neoadjuvant|neoadjuvant
357273|NCT01421472|Her2 negative|her2 negative
357274|NCT01421472|Her2 non-overexpressing|her2 non-overexpressing
357275|NCT01421472|Estrogen Receptor Positive|estrogen receptor positive
357276|NCT01421472|Triple Negative|triple negative
357277|NCT01421472|MM-121|mm-121
357278|NCT01421472|Paclitaxel|paclitaxel
357279|NCT01421459|Diabetes|diabetes
357280|NCT01421459|Type 2 Diabetes|type 2 diabetes
357281|NCT01421446|Neuropsychology|neuropsychology
357282|NCT01421433|Clonixin|clonixin
357283|NCT01421433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
357284|NCT01421433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
357285|NCT01421433|Lysine|lysine
357286|NCT01421433|L-Lysine|l-lysine
357287|NCT01421433|Lysine Acetate|lysine acetate
357288|NCT01421433|Lysine Hydrochloride|lysine hydrochloride
357289|NCT01421433|Amitriptyline|amitriptyline
357290|NCT01421420|Alzheimer's|alzheimer's
357291|NCT01421420|Dementia|dementia
357292|NCT01421420|Mild Cognitive Impairment|mild cognitive impairment
357293|NCT01421407|Secondary hyperparathyroidism|secondary hyperparathyroidism
357294|NCT01421407|End stage renal disease|end stage renal disease
357296|NCT01421407|High Intensity Focused Ultrasound|high intensity focused ultrasound
357297|NCT01421394|spinal cord injury(SCI)|spinal cord injury(sci)
357298|NCT01421394|diffusion tensor imaging(DTI)|diffusion tensor imaging(dti)
357299|NCT01421394|tractography|tractography
357300|NCT01421381|leber's hereditary optic neuropathy|leber's hereditary optic neuropathy
357301|NCT01421381|idebenone|idebenone
357302|NCT01421342|Mood Disorder|mood disorder
357303|NCT01421342|Depression|depression
357304|NCT01421342|Depressive Disorder|depressive disorder
357305|NCT01421342|Depressive Disorder, Major|depressive disorder, major
357306|NCT01421342|Bupropion|bupropion
357307|NCT01421342|Aripiprazole|aripiprazole
357308|NCT01421342|Remission|remission
357310|NCT01421342|Cost-Effectiveness|cost-effectiveness
357311|NCT01421342|Atypical Antipsychotic|atypical antipsychotic
357312|NCT01421342|Antidepressant|antidepressant
357313|NCT01421342|Augmentation|augmentation
357314|NCT01421342|Veterans|veterans
357315|NCT01421342|Mental Health|mental health
357316|NCT01421329|Interest in Exercising More|interest in exercising more
357317|NCT01421316|Patients treated with whole brain radiotherapy in the setting of brain metastases|patients treated with whole brain radiotherapy in the setting of brain metastases
357318|NCT01421316|Patients treated with whole brain radiotherapy in the prophylactic treatment for small cell lung cancer (extended disease).|patients treated with whole brain radiotherapy in the prophylactic treatment for small cell lung cancer (extended disease).
357319|NCT01421290|Cartilage lesions in the knee joint|cartilage lesions in the knee joint
357320|NCT01421264|concussion|concussion
357321|NCT01421264|gabapentin|gabapentin
357322|NCT01421264|neurontin|neurontin
357323|NCT01421264|insomnia|insomnia
357324|NCT01421251|H1N1|h1n1
357325|NCT01421251|Flu|flu
357326|NCT01421251|Influenza|influenza
357327|NCT01421251|Vaccine|vaccine
357328|NCT01421251|Manitoba|manitoba
357329|NCT01421251|Canada|canada
357330|NCT01421251|Safety|safety
357331|NCT01421238|Decision Making|decision making
357332|NCT01421238|Premature infant|premature infant
357333|NCT01421238|Informed consent|informed consent
357334|NCT01421238|Prematurity|prematurity
357335|NCT01421238|Framing|framing
357336|NCT01421238|Negotiation Model|negotiation model
357337|NCT01421225|Closed Loop Insulin Delivery|closed loop insulin delivery
357338|NCT01421225|Diabetes|diabetes
357339|NCT01421225|Type 1 Diabetes|type 1 diabetes
357340|NCT01421225|Artificial pancreas|artificial pancreas
357341|NCT01421212|Liver Transplantation|liver transplantation
357342|NCT01421212|Liver Disease|liver disease
357343|NCT01421212|Hepatitis B|hepatitis b
357344|NCT01421212|Hepatitis B Infection|hepatitis b infection
357345|NCT01421212|Hepatitis B Associated Liver Disease|hepatitis b associated liver disease
357346|NCT01421212|HBV|hbv
357347|NCT01421199|Otitis Media with Effusion|otitis media with effusion
357348|NCT01421199|Middle Ear Effusion|middle ear effusion
357349|NCT01421186|Multiple Myeloma|multiple myeloma
357350|NCT01421186|MOR03087 (MOR202)|mor03087 (mor202)
357351|NCT01421186|Lenalidomide|lenalidomide
357352|NCT01421186|Pomalidomide|pomalidomide
357353|NCT01421186|CD38|cd38
357354|NCT01421173|Lymphoma|lymphoma
357355|NCT01421173|Lymphoid malignancies|lymphoid malignancies
357356|NCT01421173|Relapsed|relapsed
357357|NCT01421173|Refractory|refractory
357358|NCT01421173|Autologous hematopoietic cell support|autologous hematopoietic cell support
357359|NCT01421173|Stem cell infusion|stem cell infusion
357360|NCT01421173|Hodgkin's lymphoma|hodgkin's lymphoma
357361|NCT01421173|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
357362|NCT01421173|Vorinostat|vorinostat
357363|NCT01421173|SAHA|saha
357364|NCT01421173|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
357365|NCT01421173|MSK-390|msk-390
357366|NCT01421173|Zolinza|zolinza
357367|NCT01421173|Busulfan|busulfan
357368|NCT01421173|Busulfex|busulfex
357369|NCT01421173|Myleran|myleran
357370|NCT01421173|Gemcitabine|gemcitabine
357371|NCT01421173|Gemcitabine Hydrochloride|gemcitabine hydrochloride
357372|NCT01421173|Gemzar|gemzar
357373|NCT01421173|Melphalan|melphalan
357374|NCT01421173|Alkeran|alkeran
357375|NCT01421173|Rituximab|rituximab
357376|NCT01421173|Rituxan|rituxan
357377|NCT01421173|Dexamethasone|dexamethasone
357378|NCT01421173|Decadron|decadron
357379|NCT01421173|G-CSF|g-csf
357380|NCT01421173|Filgrastim|filgrastim
357381|NCT01421173|NeupogenTM|neupogentm
357382|NCT01421173|Palifermin|palifermin
357383|NCT01421173|Kepivance|kepivance
357384|NCT01421160|Chronic|chronic
357385|NCT01421160|Inflammatory|inflammatory
357386|NCT01421160|Joint|joint
357387|NCT01421160|Pain|pain
357388|NCT01421147|Diabetes|diabetes
357389|NCT01421147|Type 1 Diabetes|type 1 diabetes
357390|NCT01421147|Diabetes Mellitus|diabetes mellitus
357391|NCT01421134|depression|depression
357392|NCT01421134|Lurasidone|lurasidone
357394|NCT01421108|oral health|oral health
357395|NCT01421108|dental brushing|dental brushing
357396|NCT01421108|dental flossing|dental flossing
357397|NCT01421095|Fertility|fertility
357398|NCT01421095|adolescent|adolescent
357399|NCT01421095|young adult|young adult
357400|NCT01421095|cancer survivors|cancer survivors
357401|NCT01421082|LVRS (Lung Volume Reduction Surgery)|lvrs (lung volume reduction surgery)
357402|NCT01421082|LVRC (Lung Volume Reduction Coil)|lvrc (lung volume reduction coil)
357403|NCT01421082|Emphysema|emphysema
357404|NCT01421082|coil|coil
357405|NCT01421082|RePneu|repneu
357406|NCT01421069|Use of etanercept to treat pediatric subjects with extended oligoarticular JIA|use of etanercept to treat pediatric subjects with extended oligoarticular jia
357407|NCT01421069|enthestitis related arthritis (ERA)|enthestitis related arthritis (era)
357408|NCT01421069|or psoriatic arthritis (PsA).|or psoriatic arthritis (psa).
357409|NCT01421043|bioequivalence study|bioequivalence study
357410|NCT01421043|triazolam|triazolam
357411|NCT01421043|liquid oral drops|liquid oral drops
357412|NCT01421043|tablet|tablet
357413|NCT01421030|quality of life|quality of life
357414|NCT01421030|congenital heart disease|congenital heart disease
357415|NCT01421030|open heart surgery|open heart surgery
357416|NCT01421030|percutaneous pulmonary valve implantation|percutaneous pulmonary valve implantation
357417|NCT01421030|costs|costs
357418|NCT01421017|radiation therapy|radiation therapy
357419|NCT01421017|combination therapy|combination therapy
357420|NCT01421017|immunotherapy|immunotherapy
357421|NCT01421017|immune response modifier|immune response modifier
357422|NCT01421017|immunostimulatory|immunostimulatory
357423|NCT01421017|immunomodulator|immunomodulator
357425|NCT01421004|tumors|tumors
357426|NCT01421004|phase I|phase i
357427|NCT01421004|crossover|crossover
357428|NCT01421004|bioequivalence|bioequivalence
357429|NCT01420965|Anti PD-1 Monoclonal Antibody|anti pd-1 monoclonal antibody
357430|NCT01420965|Vaccine|vaccine
357431|NCT01420965|Autologous Cellular Immunotherapy|autologous cellular immunotherapy
357432|NCT01420965|Prostate Cancer|prostate cancer
357433|NCT01420952|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
730684|NCT01081795|Migraine|migraine
357434|NCT01420952|Metabolic Glutamate Receptors|metabolic glutamate receptors
357435|NCT01420952|Brain|brain
357436|NCT01420939|TBI|tbi
357437|NCT01420939|Brain|brain
357438|NCT01420939|Traumatic Brain Injury|traumatic brain injury
348114|NCT01457846|FGFR|fgfr
357439|NCT01420939|Biomarkers|biomarkers
357440|NCT01420939|Healthy Volunteer|healthy volunteer
357441|NCT01420939|HV|hv
357442|NCT01420913|To evaluate the pharmacokinetic characteristics of Lyrica, YHD1119 A,B,C|to evaluate the pharmacokinetic characteristics of lyrica, yhd1119 a,b,c
357443|NCT01420887|CPM|cpm
357444|NCT01420887|elbow joint surgery|elbow joint surgery
357445|NCT01420887|continuous passive motion|continuous passive motion
357446|NCT01420887|Recovery after surgery to restore elbow motion|recovery after surgery to restore elbow motion
357447|NCT01420861|castrate resistant|castrate resistant
357448|NCT01420848|stress disorders|stress disorders
357449|NCT01420848|anxiety disorders|anxiety disorders
357450|NCT01420835|Stress|stress
357451|NCT01420835|Quality of life|quality of life
357452|NCT01420796|Parkinson's disease|parkinson's disease
357453|NCT01420796|dysphagia|dysphagia
357454|NCT01420796|swallowing treatment|swallowing treatment
357455|NCT01420757|operation time|operation time
357456|NCT01420757|length of hospital stay|length of hospital stay
357457|NCT01420744|Endotracheal ventilation|endotracheal ventilation
357458|NCT01420744|Bacterial pneumonia|bacterial pneumonia
357459|NCT01420731|sexual life, back pain|sexual life, back pain
357460|NCT01420718|partial pulpotomy|partial pulpotomy
357461|NCT01420718|Cvek pulpotomy|cvek pulpotomy
357462|NCT01420718|MTA|mta
357463|NCT01420718|iRootBP|irootbp
357464|NCT01420718|dentin bridge|dentin bridge
357465|NCT01420705|Bacille Calmette-Guérin|bacille calmette-guérin
357466|NCT01420705|DTP|dtp
357467|NCT01420705|Vaccination|vaccination
357468|NCT01420705|Allergy|allergy
357469|NCT01420705|Atopy|atopy
357470|NCT01420705|Guinea-Bissau|guinea-bissau
357471|NCT01420692|Tip 2 DM|tip 2 dm
357472|NCT01420692|Endothelium|endothelium
357473|NCT01420692|Gliclazide|gliclazide
357474|NCT01420692|Insulin detemir|insulin detemir
357475|NCT01420679|Lymphoproliferative Disorders|lymphoproliferative disorders
357476|NCT01420679|Lymphoma|lymphoma
357477|NCT01420679|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
357478|NCT01420679|T-cell Lymphoma|t-cell lymphoma
357479|NCT01420640|Fibromyalgia|fibromyalgia
357480|NCT01420640|Tai Chi|tai chi
357481|NCT01420640|mind-body exercise|mind-body exercise
357482|NCT01420640|aerobic exercise|aerobic exercise
357483|NCT01420640|exercise|exercise
357484|NCT01420640|pain|pain
357485|NCT01420614|radial access|radial access
357486|NCT01420614|primary angioplasty|primary angioplasty
357487|NCT01420614|trial|trial
357488|NCT01420614|randomization|randomization
357489|NCT01420614|outcome|outcome
357490|NCT01420601|Torisel|torisel
357491|NCT01420601|Long-term use|long-term use
357492|NCT01420601|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
357493|NCT01420588|Oncologic Investigations|oncologic investigations
357494|NCT01420588|Gastric Diseases|gastric diseases
357495|NCT01420588|Gastric Cancer|gastric cancer
357496|NCT01420588|Gastric Ulcer|gastric ulcer
357497|NCT01420588|Breath Analysis|breath analysis
357498|NCT01420588|Volatile Biomarkers|volatile biomarkers
357499|NCT01420588|Nanosensors Array|nanosensors array
357500|NCT01420588|Discriminant Factor Analysis|discriminant factor analysis
357501|NCT01420588|GC-MS|gc-ms
357502|NCT01420588|Breath Tests|breath tests
357503|NCT01420575|Schizophrenia|schizophrenia
357504|NCT01420575|Schizoaffective Disorder|schizoaffective disorder
357505|NCT01420575|Shared Decision|shared decision
357506|NCT01420575|Decision Aid|decision aid
357507|NCT01420575|Antipsychotic|antipsychotic
357508|NCT01420575|Weight Gain|weight gain
357509|NCT01420575|Olanzapine|olanzapine
357510|NCT01420575|Lexapro|lexapro
357511|NCT01420575|Perphenazine|perphenazine
357512|NCT01420562|allogeneic HSCT|allogeneic hsct
357513|NCT01420562|posaconazole|posaconazole
357514|NCT01420562|prophylaxis|prophylaxis
357515|NCT01420562|mucositis|mucositis
357516|NCT01420562|pharmacokinetics|pharmacokinetics
357517|NCT01420549|Hypercholesterolemia|hypercholesterolemia
357518|NCT01420549|Dyslipidemia|dyslipidemia
357519|NCT01420536|Bilateral Balanced Occlusion|bilateral balanced occlusion
357520|NCT01420536|Canine Guidance|canine guidance
357521|NCT01420536|Complete Denture|complete denture
357522|NCT01420536|Denture Retention|denture retention
357523|NCT01420536|Dental Occlusion|dental occlusion
357524|NCT01420536|Edentulous|edentulous
357525|NCT01420536|Edentulism|edentulism
357526|NCT01420536|Mandibular movement|mandibular movement
357527|NCT01420536|Mastication|mastication
357528|NCT01420536|Patient Acceptance of Health Care|patient acceptance of health care
357529|NCT01420536|Patient Satisfaction|patient satisfaction
357531|NCT01420523|Lipohypertrophy|lipohypertrophy
357532|NCT01420510|Patients satisfaction|patients satisfaction
357533|NCT01420510|Side effects|side effects
357534|NCT01420497|methylprednisolone|methylprednisolone
357535|NCT01420497|intra articular infiltration|intra articular infiltration
357536|NCT01420497|glycemia|glycemia
357537|NCT01420497|epidural infiltration|epidural infiltration
357538|NCT01420497|diabetes|diabetes
357539|NCT01420484|CNAP|cnap
348220|NCT01457508|Hib|hib
357540|NCT01420484|continuous non-invasive arterial pressure|continuous non-invasive arterial pressure
357541|NCT01420484|IAP|iap
357542|NCT01420484|blood pressure|blood pressure
357543|NCT01420484|analgosedation|analgosedation
357544|NCT01420484|high-risk patients|high-risk patients
357545|NCT01420484|rapid-pacing|rapid-pacing
357546|NCT01420471|Endoscopic Sinus Surgery|endoscopic sinus surgery
357547|NCT01420471|Triamcinolone|triamcinolone
357548|NCT01420471|Merocel Middle Meatus Spacers|merocel middle meatus spacers
357549|NCT01420458|bioequivalence|bioequivalence
357550|NCT01420432|Ankylosing Spondylitis|ankylosing spondylitis
357551|NCT01420432|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
357552|NCT01420432|Transplantation|transplantation
357553|NCT01420419|nipple pain|nipple pain
357554|NCT01420419|breastfeeding|breastfeeding
357555|NCT01420419|nipple damage|nipple damage
357556|NCT01420419|lanolin|lanolin
357557|NCT01420419|clinical trial|clinical trial
357558|NCT01420406|lactation|lactation
357559|NCT01420406|cryptoxanthin|cryptoxanthin
357560|NCT01420406|beta-carotene|beta-carotene
357561|NCT01420406|vitamin A|vitamin a
357562|NCT01420393|Heart Failure|heart failure
357563|NCT01420393|Atrial Fibrillation|atrial fibrillation
357564|NCT01420393|Catheter Ablation|catheter ablation
357565|NCT01420393|Anti-arrhythmic Medications|anti-arrhythmic medications
357566|NCT01420393|Cardiovascular Mortality|cardiovascular mortality
357567|NCT01420367|Paediatric|paediatric
357568|NCT01420367|Simple|simple
357569|NCT01420367|Non-perforated|non-perforated
357570|NCT01420354|Metabolic stones|metabolic stones
357571|NCT01420354|kidney stones|kidney stones
357572|NCT01420354|renal calculi|renal calculi
357573|NCT01420354|metabolic evaluation|metabolic evaluation
357574|NCT01420341|Meliodosis|meliodosis
357575|NCT01420341|Co-trimoxazole|co-trimoxazole
357576|NCT01420341|Relapse|relapse
357577|NCT01420315|vitamin D|vitamin d
357578|NCT01420315|deficiency|deficiency
357579|NCT01420315|alzheimer's disease|alzheimer's disease
357580|NCT01420302|critical illness|critical illness
357581|NCT01420302|intensive care|intensive care
357582|NCT01420302|insulin|insulin
357583|NCT01420302|glucose|glucose
357584|NCT01420302|algorithm|algorithm
357585|NCT01420302|blood glucose control|blood glucose control
357586|NCT01420289|Ischemic ulcers|ischemic ulcers
357587|NCT01420289|PAD|pad
357588|NCT01420289|Intermittent Claudication Pain|intermittent claudication pain
357589|NCT01420276|Female sexual function|female sexual function
357590|NCT01420263|premature infant|premature infant
357591|NCT01420263|feeding|feeding
357592|NCT01420263|residuals|residuals
357593|NCT01420263|fresh feeds|fresh feeds
357594|NCT01420263|full feeds|full feeds
357595|NCT01420263|digestive system|digestive system
357596|NCT01420250|Prostate cancer|prostate cancer
357597|NCT01420250|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
357598|NCT01420237|Noninflammatory joint disease of the hip.|noninflammatory joint disease of the hip.
357599|NCT01420224|Air travel|air travel
357600|NCT01420224|Aircraft cabin hypoxia|aircraft cabin hypoxia
357601|NCT01420224|Pulmonary artery pressure|pulmonary artery pressure
357602|NCT01420224|Hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
357603|NCT01420224|Pulmonary hypertension|pulmonary hypertension
357604|NCT01420211|pharmacokinetics|pharmacokinetics
357605|NCT01420211|MRI|mri
357606|NCT01420211|liver|liver
357607|NCT01420211|drug transporter|drug transporter
357608|NCT01420211|Gd-EOB-DTPA|gd-eob-dtpa
357609|NCT01420198|Diabetes type 2|diabetes type 2
357610|NCT01420198|Lifestyle intervention|lifestyle intervention
357611|NCT01420198|QALY|qaly
357612|NCT01420198|Ethnic group|ethnic group
357613|NCT01420198|Impaired glucose tolerance|impaired glucose tolerance
357614|NCT01420198|Impaired fasting glucose|impaired fasting glucose
753320|NCT01176240|weak|weak
357615|NCT01420185|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
357616|NCT01420185|stage II breast cancer|stage ii breast cancer
357617|NCT01420185|stage IIIA breast cancer|stage iiia breast cancer
357618|NCT01420159|Pain|pain
357619|NCT01420159|Trauma|trauma
357620|NCT01420159|Analgesia|analgesia
357621|NCT01420133|Corticosteroids|corticosteroids
357622|NCT01420133|Diet low in sugar and salt|diet low in sugar and salt
357623|NCT01420133|Dermatological disease|dermatological disease
357624|NCT01420133|Corticosteroids Allergy|corticosteroids allergy
357625|NCT01420133|3 Months|3 months
357626|NCT01420120|Biodegradable stent, PAD|biodegradable stent, pad
357627|NCT01420107|Infant, Premature|infant, premature
357628|NCT01420107|Delivery Rooms|delivery rooms
357629|NCT01420107|Video Recording|video recording
357630|NCT01420107|Outcome Assessment (Health Care)|outcome assessment (health care)
357631|NCT01420094|Drugs, Investigational|drugs, investigational
357632|NCT01420094|Acetylsalicylic Acid|acetylsalicylic acid
357633|NCT01420094|Aspirin|aspirin
357634|NCT01420094|dental pain|dental pain
357635|NCT01420081|uterine neoplasms|uterine neoplasms
357636|NCT01420081|endometrial|endometrial
357637|NCT01420081|uterine|uterine
357638|NCT01420081|cancer|cancer
357639|NCT01420081|PI3K|pi3k
357640|NCT01420081|mTOR|mtor
357641|NCT01420081|PI3K/mTOR|pi3k/mtor
357642|NCT01420081|recurrent|recurrent
357643|NCT01420081|metastatic|metastatic
357644|NCT01420068|Pediatric|pediatric
357645|NCT01420068|hypertension|hypertension
357646|NCT01420068|aliskiren|aliskiren
357647|NCT01420055|Multiple sclerosis|multiple sclerosis
357648|NCT01420055|Fingolimod|fingolimod
357649|NCT01420055|Coping|coping
357650|NCT01420055|Anxiety|anxiety
357651|NCT01420055|France|france
357652|NCT01420055|Treatment Satisfaction Questionnaire for Medication-9 items (TSQM 9)|treatment satisfaction questionnaire for medication-9 items (tsqm 9)
357653|NCT01420055|Active|active
357654|NCT01420029|Low birth weight neonates|low birth weight neonates
357655|NCT01420029|Neurodevelopmental outcome|neurodevelopmental outcome
357656|NCT01420029|Thyroid dysfunction|thyroid dysfunction
357657|NCT01420029|Extrauterine growth|extrauterine growth
357658|NCT01420029|Plasticizers|plasticizers
357659|NCT01420016|Cardiovascular risk|cardiovascular risk
357660|NCT01420003|Allergen Challenge|allergen challenge
357661|NCT01420003|B cell activation|b cell activation
357662|NCT01420003|M1 prime related biomarkers|m1 prime related biomarkers
357663|NCT01419977|sickle cell disease|sickle cell disease
357664|NCT01419977|vaso-occlusive crisis|vaso-occlusive crisis
357665|NCT01419977|anticoagulation|anticoagulation
357666|NCT01419964|Vitiligo|vitiligo
357667|NCT01419964|Macular depigmentation|macular depigmentation
357668|NCT01419964|Stachytarpheta cayensensis|stachytarpheta cayensensis
357669|NCT01419951|Behavioral treatment|behavioral treatment
357670|NCT01419951|Preschool aged children|preschool aged children
357671|NCT01419951|Obesity|obesity
357672|NCT01419938|Light therapy|light therapy
357673|NCT01419938|circadian rhythm|circadian rhythm
357674|NCT01419938|CBT|cbt
357675|NCT01419925|influenza vaccine|influenza vaccine
357676|NCT01419925|peptide|peptide
357677|NCT01419925|universal|universal
357678|NCT01419925|prime|prime
357679|NCT01419925|boost|boost
357680|NCT01419925|TIV|tiv
357681|NCT01419925|HAI|hai
357682|NCT01419925|Hemagglutination Inhibition|hemagglutination inhibition
357683|NCT01419925|elderly|elderly
357684|NCT01419899|Brief intervention|brief intervention
357685|NCT01419899|Rapid testing|rapid testing
357686|NCT01419873|Hyperglycaemia|hyperglycaemia
357687|NCT01419873|Very low birthweight infants|very low birthweight infants
357688|NCT01419873|Insulin|insulin
357689|NCT01419860|Microcirculation|microcirculation
357690|NCT01419860|Colon|colon
357691|NCT01419860|Anastomosis|anastomosis
357692|NCT01419860|ICG|icg
357693|NCT01419860|Gastro surgery|gastro surgery
357799|NCT01419522|Traumatic Brain Injury|traumatic brain injury
357694|NCT01419860|benign colon diseases requiring resection|benign colon diseases requiring resection
357695|NCT01419834|CNS|cns
357696|NCT01419834|Brain|brain
357697|NCT01419834|MAB 3F8|mab 3f8
357698|NCT01419834|Hu3F8|hu3f8
357699|NCT01419834|11-009|11-009
357700|NCT01419821|Vitamin D|vitamin d
357701|NCT01419821|Bone densitometry|bone densitometry
357702|NCT01419821|Vitamin D supplementation|vitamin d supplementation
357703|NCT01419821|Growth|growth
357704|NCT01419808|Scaphoid|scaphoid
357705|NCT01419808|Non-Union|non-union
357706|NCT01419808|Proximal pole|proximal pole
357707|NCT01419808|Bone Graft|bone graft
357708|NCT01419808|Vascularized|vascularized
357709|NCT01419808|Non-Vascularized|non-vascularized
357710|NCT01419808|PREE|pree
357711|NCT01419782|bone|bone
357712|NCT01419782|osteocyte|osteocyte
357713|NCT01419782|rest muscle electrical activity|rest muscle electrical activity
357714|NCT01419782|whole-body vibration|whole-body vibration
357715|NCT01419782|sclerostin|sclerostin
357716|NCT01419769|symptomatic pancreatic pseudocyst|symptomatic pancreatic pseudocyst
357717|NCT01419769|pancreatic pseudocyst|pancreatic pseudocyst
357719|NCT01419769|minimally invasive|minimally invasive
357720|NCT01419769|Nitinol stent|nitinol stent
357721|NCT01419769|transmural endoscopic drainage|transmural endoscopic drainage
357722|NCT01419769|catheter based|catheter based
357723|NCT01419743|Vitamin D deficiency|vitamin d deficiency
357724|NCT01419743|Supplementation|supplementation
357725|NCT01419743|Infertility|infertility
357726|NCT01419743|Clinical pregnancy rates|clinical pregnancy rates
357727|NCT01419717|cancer|cancer
357728|NCT01419717|bone metastases|bone metastases
357729|NCT01419717|breast cancer|breast cancer
357730|NCT01419717|prostate cancer|prostate cancer
357731|NCT01419704|other hemoglobinopathies|other hemoglobinopathies
357732|NCT01419704|chimerism|chimerism
357733|NCT01419704|sickle cell|sickle cell
357734|NCT01419704|thalassemia|thalassemia
357735|NCT01419704|Marrow/Enriched Hematopoetic Stem Cell Transplant|marrow/enriched hematopoetic stem cell transplant
357736|NCT01419691|auranofin|auranofin
357737|NCT01419691|chronic lymphocytic leukemia|chronic lymphocytic leukemia
357738|NCT01419691|relapsed|relapsed
357739|NCT01419691|refractory|refractory
357740|NCT01419691|CLL|cll
357741|NCT01419691|SLL|sll
357742|NCT01419691|PLL|pll
357743|NCT01419678|posaconazole|posaconazole
357744|NCT01419678|PK blood sampling|pk blood sampling
357745|NCT01419665|Follicular Lymphoma|follicular lymphoma
357746|NCT01419665|Biosimilar|biosimilar
357747|NCT01419665|GP13-301|gp13-301
357748|NCT01419665|rituximab|rituximab
357749|NCT01419665|Antibodies|antibodies
357750|NCT01419665|CD20|cd20
357751|NCT01419652|percutaneous coronary intervention|percutaneous coronary intervention
357752|NCT01419639|Neurofibromatosis Type II|neurofibromatosis type ii
357753|NCT01419639|cranial nerve schwannomas|cranial nerve schwannomas
357754|NCT01419639|meningiomas|meningiomas
357755|NCT01419639|ependymomas|ependymomas
357756|NCT01419613|healthy lifestyle|healthy lifestyle
357757|NCT01419613|physical activity|physical activity
357758|NCT01419613|behavior|behavior
357759|NCT01419613|motivational|motivational
357760|NCT01419613|interview|interview
357761|NCT01419613|breast cancer survivor|breast cancer survivor
357762|NCT01419600|Phase 1|phase 1
357763|NCT01419600|healthy volunteers|healthy volunteers
357764|NCT01419600|safety|safety
357765|NCT01419600|tolerability|tolerability
357766|NCT01419600|pharmacokinetics|pharmacokinetics
357767|NCT01419600|single ascending dose study|single ascending dose study
357768|NCT01419587|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
357769|NCT01419587|Non small cell lung cancer|non small cell lung cancer
357770|NCT01419587|NSCLC|nsclc
357771|NCT01419587|Ketogenic Diet|ketogenic diet
357772|NCT01419587|radiotherapy|radiotherapy
357773|NCT01419587|paclitaxel|paclitaxel
357774|NCT01419587|carboplatin|carboplatin
357775|NCT01419574|Carotid Artery Plaque|carotid artery plaque
357776|NCT01419574|Contrast Agents|contrast agents
357777|NCT01419574|Vasa Vasorum|vasa vasorum
357778|NCT01419574|MRI|mri
357779|NCT01419574|Intraplaque Hemorrhage|intraplaque hemorrhage
357780|NCT01419574|Solid Tumor|solid tumor
357781|NCT01419574|Metastatic Solid Tumor|metastatic solid tumor
357782|NCT01419561|KSHV|kshv
357783|NCT01419561|KICS|kics
357784|NCT01419561|HIV|hiv
357785|NCT01419561|Cytokines|cytokines
357786|NCT01419561|HHV-8|hhv-8
357787|NCT01419561|KSHV Inflammatory Cytokine Syndrome|kshv inflammatory cytokine syndrome
357788|NCT01419561|Kaposi Sarcoma Heres Virus|kaposi sarcoma heres virus
357789|NCT01419548|ABT-888|abt-888
357790|NCT01419548|Liver Dysfunction|liver dysfunction
357791|NCT01419548|Kidney Dysfunction|kidney dysfunction
357792|NCT01419548|PARP Inhibitor|parp inhibitor
357793|NCT01419548|Pharmacokinetics|pharmacokinetics
357794|NCT01419548|Cancer|cancer
357795|NCT01419535|Metabolism|metabolism
357796|NCT01419535|Cortisol|cortisol
357797|NCT01419535|Hypercortisolism|hypercortisolism
357798|NCT01419535|Glucose Intolerance|glucose intolerance
357800|NCT01419522|Walking Impairment|walking impairment
357801|NCT01419522|Gait Training|gait training
357802|NCT01419522|TBI|tbi
357803|NCT01419509|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
357804|NCT01419509|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
357805|NCT01419509|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
357806|NCT01419509|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
357807|NCT01419509|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
357808|NCT01419509|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
357809|NCT01419509|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
357810|NCT01419496|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
357811|NCT01419496|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
357812|NCT01419496|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
357813|NCT01419496|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
357393|NCT01421134|Latuda|latuda
357814|NCT01419496|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
357815|NCT01419496|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
357816|NCT01419496|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
357817|NCT01419496|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
357818|NCT01419483|Pancreatic neoplasms|pancreatic neoplasms
357819|NCT01419483|Pancreatic cancer|pancreatic cancer
357820|NCT01419483|Ketogenic Diet|ketogenic diet
357821|NCT01419483|radiotherapy|radiotherapy
357822|NCT01419483|gemcitabine|gemcitabine
357823|NCT01419457|Healthy|healthy
357824|NCT01419457|hepatic impairment|hepatic impairment
357825|NCT01419457|T-705a|t-705a
357826|NCT01419457|Favipiravir|favipiravir
357827|NCT01419444|Voice|voice
357828|NCT01419444|Muscle Tension Dysphonia|muscle tension dysphonia
357829|NCT01419444|Hyperfunction|hyperfunction
357830|NCT01419444|Treatment|treatment
357831|NCT01419431|Colon cancer|colon cancer
357832|NCT01419418|Peripheral Arterial Disease (PAD)|peripheral arterial disease (pad)
357833|NCT01419418|Qualitative analysis|qualitative analysis
730685|NCT01081808|PhaseI|phasei
357837|NCT01419405|cold pressor test|cold pressor test
357838|NCT01419405|pregabalin|pregabalin
357839|NCT01419405|remifentanil|remifentanil
357840|NCT01419392|sildenafil citrate|sildenafil citrate
357841|NCT01419392|Doppler Ultrasonography|doppler ultrasonography
357842|NCT01419392|nitric oxide|nitric oxide
357843|NCT01419392|total antioxidant capacity|total antioxidant capacity
357844|NCT01419379|COPD exacerbation rate|copd exacerbation rate
357845|NCT01419353|Infertility, IVF, Estrogen|infertility, ivf, estrogen
357849|NCT01419314|Physical Therapy|physical therapy
357850|NCT01419314|Splint|splint
357851|NCT01419314|Sleep|sleep
357852|NCT01419314|Pain|pain
357853|NCT01419314|6 min walk|6 min walk
357854|NCT01419314|forward reach|forward reach
357855|NCT01419314|Function|function
357856|NCT01419301|multiple sclerosis|multiple sclerosis
357857|NCT01419301|glatiramer acetate|glatiramer acetate
357858|NCT01419301|stress reduction|stress reduction
357859|NCT01419301|medication adherence|medication adherence
357860|NCT01419288|Amputees|amputees
357861|NCT01419262|Vitamin D|vitamin d
357862|NCT01419262|Randomized Controlled Trial|randomized controlled trial
357863|NCT01419262|Child, Preschool|child, preschool
357864|NCT01419262|Dietary Supplements|dietary supplements
357865|NCT01419262|Respiratory Tract Infections|respiratory tract infections
357866|NCT01419262|Asthma|asthma
357867|NCT01419249|Growth Hormone Deficiency|growth hormone deficiency
357868|NCT01419249|Turner syndrome|turner syndrome
357869|NCT01419249|Pharmacogenetics|pharmacogenetics
357870|NCT01419249|Recombinant Human Growth Hormone therapy|recombinant human growth hormone therapy
357871|NCT01419236|Ejaculatory Dysfunction|ejaculatory dysfunction
357872|NCT01419236|Orgasmic Dysfunction|orgasmic dysfunction
357873|NCT01419236|Sexual Dysfunction|sexual dysfunction
357874|NCT01419236|Climax Dysfunction|climax dysfunction
357875|NCT01419236|Erectile Dysfunction|erectile dysfunction
357876|NCT01419236|Impotence|impotence
357877|NCT01419236|Hypogonadism|hypogonadism
357878|NCT01419236|Low testosterone|low testosterone
357879|NCT01419236|Low t|low t
357880|NCT01419223|Qualitative research|qualitative research
357881|NCT01419223|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
357882|NCT01419223|Refusal to Participate|refusal to participate
357883|NCT01419210|Complementary Medicine|complementary medicine
357884|NCT01419210|Traditional Medicine|traditional medicine
357885|NCT01419184|Complicated Skin and Skin Structure Infections (cSSSI)|complicated skin and skin structure infections (csssi)
357886|NCT01419184|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
357887|NCT01419184|Daptomycin|daptomycin
357888|NCT01419184|Vancomycin|vancomycin
357889|NCT01419184|Antibiotics|antibiotics
357890|NCT01419158|Alpha-1 antitrypsin|alpha-1 antitrypsin
357891|NCT01419158|Alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
357892|NCT01419158|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
357893|NCT01419145|cachexia|cachexia
357894|NCT01419145|neoplasms|neoplasms
357895|NCT01419145|complications|complications
357896|NCT01419145|combined modality therapy|combined modality therapy
357897|NCT01419145|exercise therapy|exercise therapy
357898|NCT01419145|diet therapy|diet therapy
357899|NCT01419145|anti-inflammatory agents|anti-inflammatory agents
357900|NCT01419132|furosemide|furosemide
357901|NCT01419132|hypertonic saline solution|hypertonic saline solution
357902|NCT01419132|troponin I|troponin i
357903|NCT01419119|vitamin D insufficiency|vitamin d insufficiency
357904|NCT01419119|Cholecalciferol|cholecalciferol
357906|NCT01419119|Parathyroid Hormone|parathyroid hormone
357907|NCT01419119|25-hydroxyvitamin D3|25-hydroxyvitamin d3
357908|NCT01419119|RDA, recommended daily intake (nutrition policy)|rda, recommended daily intake (nutrition policy)
357909|NCT01419119|Vitamin D|vitamin d
357910|NCT01419119|Hypovitaminosis-D|hypovitaminosis-d
357911|NCT01419119|Pharmacologic treatment|pharmacologic treatment
357912|NCT01419106|Hypotension|hypotension
357913|NCT01419106|Emergency care|emergency care
357914|NCT01419106|Point of care Ultrasound|point of care ultrasound
357915|NCT01419106|Shock|shock
357916|NCT01419093|Physical Activity|physical activity
357917|NCT01419093|Exercise|exercise
357918|NCT01419080|Peripheral Arterial Disease|peripheral arterial disease
357919|NCT01419080|Quality of Life|quality of life
357920|NCT01419080|Quality of Care|quality of care
357921|NCT01419067|Proton Therapy|proton therapy
357922|NCT01419067|Radical resection|radical resection
357923|NCT01419041|renal impairment|renal impairment
357924|NCT01419041|crizotinib|crizotinib
357925|NCT01419041|pharmacokinetics|pharmacokinetics
357926|NCT01419028|Hypophosphatasia|hypophosphatasia
357928|NCT01419028|Bone disease|bone disease
357929|NCT01419028|Soft bones|soft bones
730686|NCT01081808|Solid Tumor|solid tumor
357930|NCT01419028|Low alkaline phosphatase|low alkaline phosphatase
357931|NCT01419028|Genetic metabolic disorder|genetic metabolic disorder
357932|NCT01419028|Alkaline phosphatase|alkaline phosphatase
357933|NCT01419028|Tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
357934|NCT01419028|Rickets|rickets
357935|NCT01419028|Osteomalacia|osteomalacia
357936|NCT01419015|SAPIEN XT Valve (20mm)|sapien xt valve (20mm)
357937|NCT01419015|Cardiovascular Disease|cardiovascular disease
348609|NCT01455792|Biopsy|biopsy
357938|NCT01419015|Valvular Heart Disease|valvular heart disease
357939|NCT01419015|Aortic Stenosis|aortic stenosis
357940|NCT01419015|Heart Valve Therapy|heart valve therapy
357941|NCT01419015|Transcatheter|transcatheter
357942|NCT01419015|Transfemoral|transfemoral
357943|NCT01419015|Efficacy endpoints|efficacy endpoints
357944|NCT01419015|Indexed Aortic Valve Area|indexed aortic valve area
357945|NCT01419015|NYHA|nyha
357946|NCT01419002|Pancreatic Cancer|pancreatic cancer
357947|NCT01419002|Adenocarcinoma|adenocarcinoma
357948|NCT01419002|Neoadjuvant Radiotherapy|neoadjuvant radiotherapy
357949|NCT01418976|physical therapy techniques|physical therapy techniques
357950|NCT01418976|brain injuries, traumatic|brain injuries, traumatic
357951|NCT01418976|walking|walking
357952|NCT01418976|gait|gait
357953|NCT01418976|postural balance|postural balance
357954|NCT01418950|Prematurity Counseling for pregnant women and their family|prematurity counseling for pregnant women and their family
357955|NCT01418937|HPV vaccine|hpv vaccine
357956|NCT01418937|serious adverse events (SAEs)|serious adverse events (saes)
357957|NCT01418937|medically significant conditions|medically significant conditions
357958|NCT01418937|cervical neoplasia|cervical neoplasia
357959|NCT01418924|sclerostin|sclerostin
357960|NCT01418924|estradiol|estradiol
357961|NCT01418924|progesterone|progesterone
357962|NCT01418924|testosteron|testosteron
357963|NCT01418924|sex hormones|sex hormones
357964|NCT01418898|Iron deficiency anemia|iron deficiency anemia
357965|NCT01418898|iron|iron
357966|NCT01418898|zinc|zinc
357967|NCT01418898|vitamin A|vitamin a
357968|NCT01418898|vitamin C|vitamin c
357969|NCT01418898|oats|oats
358168|NCT01417767|cytarabine|cytarabine
357970|NCT01418885|subcortical ischemic vascular disease|subcortical ischemic vascular disease
357971|NCT01418872|Obesity|obesity
357972|NCT01418872|Cardiovascular Diseases Prevention|cardiovascular diseases prevention
357973|NCT01418872|Paediatrics|paediatrics
357974|NCT01418859|cervical cancer|cervical cancer
357975|NCT01418859|postoperation|postoperation
357976|NCT01418859|chemotherapy|chemotherapy
357977|NCT01418859|radiotherapy|radiotherapy
357978|NCT01418846|voriconazole|voriconazole
357979|NCT01418846|saliva|saliva
357980|NCT01418846|pharmacokinetics|pharmacokinetics
357981|NCT01418833|voriconazole|voriconazole
357982|NCT01418833|therapeutic drug monitoring|therapeutic drug monitoring
357983|NCT01418833|plasma levels|plasma levels
357984|NCT01418833|dose adjustment|dose adjustment
357985|NCT01418820|hemianopia|hemianopia
357986|NCT01418820|visual field defect|visual field defect
357987|NCT01418820|stroke|stroke
357988|NCT01418820|non-invasive brain stimulation|non-invasive brain stimulation
357989|NCT01418820|alternating current stimulation|alternating current stimulation
357990|NCT01418794|Acute Coronary Syndromes|acute coronary syndromes
357991|NCT01418794|Drug eluting stent|drug eluting stent
357992|NCT01418794|Diffused lesion|diffused lesion
357993|NCT01418781|gout|gout
357994|NCT01418781|cost|cost
357995|NCT01418781|utilization|utilization
357996|NCT01418768|COPD|copd
357997|NCT01418768|CAT|cat
357998|NCT01418768|Rehabilitation|rehabilitation
357999|NCT01418768|chronic obstructive pulmonary disease GOLD III/IV|chronic obstructive pulmonary disease gold iii/iv
358000|NCT01418755|Platelet-Rich Plasma|platelet-rich plasma
358001|NCT01418755|Knee|knee
358002|NCT01418755|Tibiofemoral Chondromalacia|tibiofemoral chondromalacia
358003|NCT01418755|Injection|injection
358004|NCT01418742|skin toxicity|skin toxicity
358005|NCT01418716|Disease Management|disease management
358006|NCT01418716|Quality Improvement|quality improvement
358007|NCT01418716|Cooperative Behavior (collaboration)|cooperative behavior (collaboration)
358008|NCT01418677|Unspecified Advance Solid Tumor, Protocol Specific|unspecified advance solid tumor, protocol specific
358009|NCT01418664|vitamin D|vitamin d
358010|NCT01418664|adverse pregnancy outcome|adverse pregnancy outcome
358011|NCT01418664|Pakistan|pakistan
358012|NCT01418638|Major Depressive Disorder|major depressive disorder
358013|NCT01418638|Antidepressants|antidepressants
358014|NCT01418573|glucose, insulin, post prandial|glucose, insulin, post prandial
358015|NCT01418560|renal artery|renal artery
358016|NCT01418560|sympathetic nerves|sympathetic nerves
358017|NCT01418560|modification|modification
358018|NCT01418560|chronic renal failure|chronic renal failure
358019|NCT01418521|Cardiac surgery|cardiac surgery
358020|NCT01418521|Balanced 3rd generation Hydroxyethyl starch|balanced 3rd generation hydroxyethyl starch
358021|NCT01418521|Tetraspan|tetraspan
358022|NCT01418521|Ringer-albumin|ringer-albumin
358023|NCT01418469|COPD|copd
358024|NCT01418469|protein metabolism|protein metabolism
358025|NCT01418469|branched-chain amino acid metabolism|branched-chain amino acid metabolism
358026|NCT01418469|exercise|exercise
358027|NCT01418469|protein feeding|protein feeding
358028|NCT01418456|diabetes|diabetes
358029|NCT01418456|antibiotics|antibiotics
358030|NCT01418456|clean foot ulcers|clean foot ulcers
358031|NCT01418404|Stroke|stroke
358032|NCT01418404|Effects of TS in U/E motor recovery|effects of ts in u/e motor recovery
358033|NCT01418404|Brain mapping|brain mapping
358034|NCT01418404|Kinematics analysis|kinematics analysis
358035|NCT01418391|minimal laparotomy|minimal laparotomy
358036|NCT01418391|TAP block|tap block
358037|NCT01418391|morphine consumption|morphine consumption
358038|NCT01418391|post-operative analgesia|post-operative analgesia
358039|NCT01418378|Sigma|sigma
358040|NCT01418378|cruciate|cruciate
358041|NCT01418378|retaining|retaining
358042|NCT01418378|fixed|fixed
358043|NCT01418378|primary|primary
358044|NCT01418378|total|total
358045|NCT01418378|knee|knee
358046|NCT01418378|arthroplasty|arthroplasty
358047|NCT01418378|cemented|cemented
358048|NCT01418378|osteoarthritis|osteoarthritis
358049|NCT01418352|Tourette's Disorder|tourette's disorder
358050|NCT01418352|tic disorders|tic disorders
358051|NCT01418339|Tourette's Disorder|tourette's disorder
358052|NCT01418339|tic disorders|tic disorders
358053|NCT01418326|Cancer - breast|cancer - breast
358054|NCT01418326|colo-rectal|colo-rectal
358055|NCT01418326|skin|skin
358056|NCT01418313|Atherosclerosis|atherosclerosis
358057|NCT01418313|Non-invasive imaging|non-invasive imaging
358058|NCT01418313|Magnetic Resonance Imaging|magnetic resonance imaging
358059|NCT01418313|MRI|mri
358060|NCT01418313|Positron Emission Tomography|positron emission tomography
358061|NCT01418313|PET/CT|pet/ct
358062|NCT01418313|PET/MRI|pet/mri
358063|NCT01418313|Inflammation|inflammation
358064|NCT01418313|Neovascularization|neovascularization
358065|NCT01418261|uncontrolled hypertension|uncontrolled hypertension
358066|NCT01418261|renal denervation|renal denervation
358067|NCT01418248|cardiac catheterization|cardiac catheterization
358068|NCT01418248|echocardiography|echocardiography
358069|NCT01418235|HIV Infections|hiv infections
358070|NCT01418235|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
358071|NCT01418235|Lentivirus Infections|lentivirus infections
358072|NCT01418235|Retroviridae Infections|retroviridae infections
358073|NCT01418235|RNA Virus Infections|rna virus infections
358074|NCT01418235|Virus Diseases|virus diseases
358075|NCT01418235|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
358076|NCT01418235|Sexually Transmitted Diseases|sexually transmitted diseases
358077|NCT01418235|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
358078|NCT01418235|Immune System Diseases|immune system diseases
358079|NCT01418235|Slow Virus Diseases|slow virus diseases
358080|NCT01418209|Menopause|menopause
358081|NCT01418209|Vasomotor|vasomotor
358082|NCT01418209|Symptoms|symptoms
358083|NCT01418209|Estradiol|estradiol
358084|NCT01418209|Venlafaxine|venlafaxine
358085|NCT01418196|TMAO|tmao
358086|NCT01418196|Children|children
358087|NCT01418196|Dietary choline|dietary choline
358088|NCT01418196|Cardiovascular disease risk|cardiovascular disease risk
358089|NCT01418196|Atherogenic dyslipidemia|atherogenic dyslipidemia
358090|NCT01418183|Orthognathic surgery|orthognathic surgery
358091|NCT01418183|Pain control|pain control
358092|NCT01418183|Trigeminal nerve|trigeminal nerve
358093|NCT01418183|Levobupivacaine|levobupivacaine
358094|NCT01418170|myofascial pain syndrome|myofascial pain syndrome
358095|NCT01418170|myofascial trigger points|myofascial trigger points
358096|NCT01418170|spinal manipulative therapy|spinal manipulative therapy
358097|NCT01418170|algometer|algometer
358098|NCT01418170|pressure pain thresholds|pressure pain thresholds
358099|NCT01418157|Acute mountain sickness|acute mountain sickness
358100|NCT01418157|Rapid ascent|rapid ascent
358101|NCT01418157|High altitude headache|high altitude headache
358102|NCT01418157|Mountain Medicine Society Nepal|mountain medicine society nepal
358103|NCT01418131|Proctitis|proctitis
358104|NCT01418131|resistant|resistant
358105|NCT01418131|ulcerative colitis|ulcerative colitis
358106|NCT01418131|inflammatory bowel disease|inflammatory bowel disease
358107|NCT01418118|noradrenaline|noradrenaline
358108|NCT01418118|norepinephrine|norepinephrine
358109|NCT01418118|epinephrine|epinephrine
358110|NCT01418118|adrenaline|adrenaline
358111|NCT01418118|dobutamine|dobutamine
358112|NCT01418118|dopexamine|dopexamine
358113|NCT01418118|inotrope|inotrope
358114|NCT01418118|pressor|pressor
358115|NCT01418118|sympathomimetic|sympathomimetic
358116|NCT01418118|free flap|free flap
358117|NCT01418118|transplantation|transplantation
358118|NCT01418118|free tissue transfer|free tissue transfer
358119|NCT01418118|microsurgery|microsurgery
358120|NCT01418118|survival|survival
358121|NCT01418105|spine injuries|spine injuries
358122|NCT01418105|brain lesions|brain lesions
358123|NCT01418105|dysphagia|dysphagia
358124|NCT01418079|Spectroscopy, near infrared|spectroscopy, near infrared
358125|NCT01418079|cerebral oxygenation|cerebral oxygenation
358126|NCT01418027|NAFLD|nafld
358127|NCT01418027|exercise|exercise
358128|NCT01418027|hepatic triglycerides|hepatic triglycerides
358129|NCT01418001|GEMCITABINE|gemcitabine
358130|NCT01418001|GW786034 (PAZOPANIB)|gw786034 (pazopanib)
358131|NCT01418001|TAXOTERE (DOCETAXEL)|taxotere (docetaxel)
358132|NCT01418001|11-104|11-104
358133|NCT01417988|TB|tb
358134|NCT01417975|exercise|exercise
348805|NCT01454921|HIV|hiv
358135|NCT01417975|smoking satisfaction|smoking satisfaction
358136|NCT01417975|topography|topography
358137|NCT01417975|cravings|cravings
358138|NCT01417962|Autopsy|autopsy
358139|NCT01417962|MRI|mri
358140|NCT01417962|Stillbirths|stillbirths
358141|NCT01417962|Neonatal death|neonatal death
358142|NCT01417962|Sudden Infant death|sudden infant death
358143|NCT01417923|chronic musculo-skeletal pain|chronic musculo-skeletal pain
358144|NCT01417923|therapeutic&serology effects of vitamin D|therapeutic&serology effects of vitamin d
358145|NCT01417923|CRP, IL-6, IL-8, TNF and prostaglandin E2|crp, il-6, il-8, tnf and prostaglandin e2
358146|NCT01417923|patients suffering from chronic musculo-skeletal pain|patients suffering from chronic musculo-skeletal pain
358147|NCT01417884|molecular cardiology|molecular cardiology
358148|NCT01417884|molecular epidemiology|molecular epidemiology
358149|NCT01417884|platelets|platelets
358150|NCT01417884|cardiovascular disease|cardiovascular disease
358151|NCT01417858|intra-ocular pressure|intra-ocular pressure
358152|NCT01417858|iridectomy|iridectomy
358153|NCT01417858|gonioscopy|gonioscopy
358154|NCT01417858|ocular tonometry|ocular tonometry
358155|NCT01417832|Dental caries|dental caries
358156|NCT01417832|Proximal surfaces|proximal surfaces
358157|NCT01417832|Preventive therapy|preventive therapy
358158|NCT01417832|Dental radiography|dental radiography
358159|NCT01417832|Treatment efficacy|treatment efficacy
358160|NCT01417832|Young adults|young adults
358161|NCT01417806|small cell lung cancer|small cell lung cancer
358162|NCT01417806|somatostatin|somatostatin
358163|NCT01417806|topotecan|topotecan
358164|NCT01417793|Smoking cessation rate|smoking cessation rate
358165|NCT01417767|myelodysplastic syndromes|myelodysplastic syndromes
358166|NCT01417767|Decitabine|decitabine
358167|NCT01417767|homoharringtonine|homoharringtonine
358169|NCT01417767|G-CSF|g-csf
358170|NCT01417754|toremifene|toremifene
358171|NCT01417728|endomicroscopy|endomicroscopy
358172|NCT01417728|inflammatory bowel disease|inflammatory bowel disease
358173|NCT01417728|mucosal healing|mucosal healing
358174|NCT01417728|infliximab|infliximab
358175|NCT01417689|glaucoma|glaucoma
358176|NCT01417689|randomized controlled trial|randomized controlled trial
358177|NCT01417689|eye drops|eye drops
358178|NCT01417689|instillation|instillation
358179|NCT01417689|compliance|compliance
358180|NCT01417676|prostate cancer|prostate cancer
358181|NCT01417676|locally advanced|locally advanced
358182|NCT01417676|lymph node positive|lymph node positive
358183|NCT01417676|radiation therapy|radiation therapy
358184|NCT01417676|morbidity|morbidity
358185|NCT01417676|early morbidity|early morbidity
358186|NCT01417676|late morbidity|late morbidity
358187|NCT01417663|Aging|aging
358188|NCT01417663|Cardiovascular disease|cardiovascular disease
358189|NCT01417663|Endothelial function|endothelial function
358190|NCT01417663|Physical activity|physical activity
358191|NCT01417663|Advanced Glycation Endproducts|advanced glycation endproducts
358192|NCT01417663|AGE crosslink breakers|age crosslink breakers
358193|NCT01417650|temporomandibular disorder|temporomandibular disorder
358194|NCT01417650|laser therapy|laser therapy
358195|NCT01417650|osteoarthritis|osteoarthritis
358197|NCT01417637|myofacial pain syndrome|myofacial pain syndrome
358198|NCT01417637|low level laser therapy|low level laser therapy
358199|NCT01417637|LLLT|lllt
358200|NCT01417624|Heart Failure|heart failure
358201|NCT01417624|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
358202|NCT01417611|screening colonoscopy|screening colonoscopy
358203|NCT01417598|Balance|balance
358204|NCT01417598|Gait|gait
358205|NCT01417598|Physical activity|physical activity
358206|NCT01417585|Activities of daily living|activities of daily living
358207|NCT01417585|Caregiver burden|caregiver burden
358208|NCT01417585|Client centered|client centered
358209|NCT01417585|Life satisfaction|life satisfaction
358210|NCT01417585|Participation|participation
358211|NCT01417585|Patient satisfaction|patient satisfaction
358213|NCT01417585|Self rated impact of stroke|self rated impact of stroke
358214|NCT01417585|Stroke|stroke
358215|NCT01417546|Dose-Limiting Toxicity|dose-limiting toxicity
358216|NCT01417546|Maximum Tolerated Dose|maximum tolerated dose
358217|NCT01417546|Immune Response|immune response
358218|NCT01417546|Pharmacokinetics|pharmacokinetics
358219|NCT01417546|Dose Escalation|dose escalation
358220|NCT01417546|Cancer|cancer
358221|NCT01417546|Metastatic Solid Tumor|metastatic solid tumor
358222|NCT01417546|Solid Tumor|solid tumor
358223|NCT01417533|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
358224|NCT01417533|N-Acetyl-D-mannosamine (ManNAc)|n-acetyl-d-mannosamine (mannac)
358225|NCT01417533|UDP-N-acetyglucosamine 2-epimerase (GNE)|udp-n-acetyglucosamine 2-epimerase (gne)
358226|NCT01417533|Sialic Acid|sialic acid
730687|NCT01081808|biomarkers|biomarkers
358227|NCT01417533|Muscular Dystrophy|muscular dystrophy
358228|NCT01417533|HIBM|hibm
358229|NCT01417520|Histiocytosis|histiocytosis
358230|NCT01417520|Xanthomatosis|xanthomatosis
358231|NCT01417520|Fibrosis|fibrosis
358232|NCT01417520|Osteosclerosis|osteosclerosis
358233|NCT01417520|Erdheim-Chester Disease|erdheim-chester disease
358234|NCT01417520|ECD|ecd
358235|NCT01417494|adenocarcinoma of the colon|adenocarcinoma of the colon
358236|NCT01417494|stage IVA colon cancer|stage iva colon cancer
358237|NCT01417494|stage IVB colon cancer|stage ivb colon cancer
358238|NCT01417494|adenocarcinoma of the rectum|adenocarcinoma of the rectum
358239|NCT01417494|stage IVA rectal cancer|stage iva rectal cancer
358240|NCT01417494|stage IVB rectal cancer|stage ivb rectal cancer
358241|NCT01417481|cystic fibrosis|cystic fibrosis
358242|NCT01417481|glycine|glycine
358243|NCT01417481|airway inflammation|airway inflammation
358244|NCT01417468|Cognitive Rehabilitation|cognitive rehabilitation
358245|NCT01417468|Learning Styles|learning styles
358246|NCT01417468|Learning Modes|learning modes
358247|NCT01417468|Learning Modalities|learning modalities
358248|NCT01417468|Multiple Intelligences|multiple intelligences
358249|NCT01417468|Educational Intervention|educational intervention
358250|NCT01417468|Instructional Design|instructional design
358251|NCT01417455|Rheumatoid arthritis|rheumatoid arthritis
358252|NCT01417455|Ankylosing spondylitis|ankylosing spondylitis
358253|NCT01417455|Osteoclasts|osteoclasts
358254|NCT01417455|TNF antagonists|tnf antagonists
358255|NCT01417442|papillary thyroid carcinoma|papillary thyroid carcinoma
358256|NCT01417442|BRAF V600E|braf v600e
358257|NCT01417442|poor prognosis|poor prognosis
358258|NCT01417442|aggressive|aggressive
358259|NCT01417429|galantamine|galantamine
358260|NCT01417429|subjective nicotine|subjective nicotine
358261|NCT01417429|tobacco withdrawal symptoms|tobacco withdrawal symptoms
358262|NCT01417429|nicotine|nicotine
358263|NCT01417390|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
358264|NCT01417364|Sarcopenia|sarcopenia
358265|NCT01417364|Aging muscle|aging muscle
358266|NCT01417364|Testosterone administration|testosterone administration
358267|NCT01417364|Bone metabolism|bone metabolism
358268|NCT01417351|pregnancy|pregnancy
358269|NCT01417351|immune function|immune function
358270|NCT01417338|Hypertension,pulmonary|hypertension,pulmonary
358271|NCT01417338|Mortality|mortality
358272|NCT01417338|Risk factors|risk factors
358273|NCT01417312|Multiple sclerosis|multiple sclerosis
358274|NCT01417312|Green tea extract|green tea extract
358275|NCT01417312|Metabolism|metabolism
358276|NCT01417299|chronic vegetative state|chronic vegetative state
358277|NCT01417299|RPh201|rph201
358278|NCT01417299|functional MRI|functional mri
358279|NCT01417273|Multiple sclerosis|multiple sclerosis
358280|NCT01417273|immune system|immune system
358281|NCT01417273|vitamin A|vitamin a
358282|NCT01417273|(MSFC)Multiple Sclerosis Functional Composite|(msfc)multiple sclerosis functional composite
358283|NCT01417273|(EDSS)Expanded Disability Status Scale|(edss)expanded disability status scale
358284|NCT01417273|(MRI)Magnetic resonance imaging|(mri)magnetic resonance imaging
358285|NCT01417247|renal artery|renal artery
358286|NCT01417247|sympathetic nerves|sympathetic nerves
358287|NCT01417247|modification|modification
358288|NCT01417247|metabolic syndrome|metabolic syndrome
358289|NCT01417221|renal artery|renal artery
358290|NCT01417221|sympathetic nerves|sympathetic nerves
358291|NCT01417221|modification|modification
358292|NCT01417221|essential hypertension|essential hypertension
358293|NCT01417221|primary hypertension|primary hypertension
358294|NCT01417195|Assisted Reproductive Technology|assisted reproductive technology
358295|NCT01417182|Patients with Advanced Prostate Cancer|patients with advanced prostate cancer
358296|NCT01417143|dovitinib|dovitinib
358297|NCT01417130|Naproxen|naproxen
358298|NCT01417130|Celecoxib|celecoxib
358299|NCT01417130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
358300|NCT01417117|Intracerebral Hemorrhage|intracerebral hemorrhage
358301|NCT01417117|Ischemic Stroke|ischemic stroke
358302|NCT01417117|Diffusion Weight Imaging Abnormalities|diffusion weight imaging abnormalities
358303|NCT01417117|Neurologic Outcome|neurologic outcome
358304|NCT01417104|plaque|plaque
358305|NCT01417104|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
358306|NCT01417104|high blood pressure|high blood pressure
358308|NCT01417104|heart attack|heart attack
358309|NCT01417104|CVA|cva
358310|NCT01417104|stroke|stroke
358311|NCT01417104|PAD|pad
358312|NCT01417091|Brittle bone disease|brittle bone disease
358313|NCT01417091|inherited|inherited
358314|NCT01417091|connective tissue disorder|connective tissue disorder
358315|NCT01417091|fracture|fracture
358316|NCT01417065|Cancer|cancer
358317|NCT01417065|mTOR inhibitor Temsirolimus|mtor inhibitor temsirolimus
358318|NCT01417065|Torisel|torisel
358319|NCT01417065|CCI-779|cci-779
358320|NCT01417065|pharmacodynamic targets|pharmacodynamic targets
358321|NCT01417026|Autism Spectrum Disorders|autism spectrum disorders
358322|NCT01417026|Oxytocin|oxytocin
358323|NCT01417026|Clinical Trial|clinical trial
358324|NCT01417026|Computer-based Intervention|computer-based intervention
358325|NCT01417026|Social Perception|social perception
358326|NCT01417026|Social Motivation|social motivation
358327|NCT01417026|Social Cognition|social cognition
358328|NCT01417013|Dry eye or lubricant eye drops|dry eye or lubricant eye drops
349003|NCT01453959|fludrocortisone|fludrocortisone
349004|NCT01453946|Crohn's Disease|crohn's disease
349005|NCT01453933|Anti-HIV Agents|anti-hiv agents
349006|NCT01453933|Anti-Retroviral Agents|anti-retroviral agents
349007|NCT01453933|Antiviral Agents|antiviral agents
358329|NCT01417000|Cancer|cancer
358330|NCT01417000|Cancer vaccine|cancer vaccine
358331|NCT01417000|Listeria monocytogenes|listeria monocytogenes
358332|NCT01417000|Listeria-based vaccines|listeria-based vaccines
358333|NCT01417000|GVAX|gvax
358334|NCT01417000|Cyclophosphamide|cyclophosphamide
358335|NCT01417000|Cytoxan|cytoxan
358336|NCT01417000|T regulatory cells|t regulatory cells
358337|NCT01417000|Heterologous Prime-Boost|heterologous prime-boost
358338|NCT01417000|Immunotherapy|immunotherapy
358339|NCT01417000|Mesothelin|mesothelin
358340|NCT01417000|Pancreatic cancer|pancreatic cancer
358341|NCT01416974|19-28Z RETROVIRUS|19-28z retrovirus
358342|NCT01416974|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
358343|NCT01416974|autologous T cells|autologous t cells
358344|NCT01416974|Leukapheresis|leukapheresis
358345|NCT01416974|11-048|11-048
358346|NCT01416961|Squamous Cell|squamous cell
358347|NCT01416961|Non-squamous cell|non-squamous cell
358348|NCT01416948|Cognitive Complaints, TBI, PTSD|cognitive complaints, tbi, ptsd
358349|NCT01416935|Atrial Fibrillation|atrial fibrillation
358350|NCT01416935|Anti-Arrhythmic Medication|anti-arrhythmic medication
358351|NCT01416909|Medication-induced|medication-induced
358352|NCT01416909|Constipation in Cancer|constipation in cancer
358353|NCT01416896|End stage Renal Disease|end stage renal disease
358354|NCT01416896|Hemodialysis|hemodialysis
358355|NCT01416896|Oxidative Stress|oxidative stress
358356|NCT01416896|Inflammation|inflammation
358357|NCT01416883|oral mucosal absorption|oral mucosal absorption
358358|NCT01416883|pharmacokinetics|pharmacokinetics
358359|NCT01416883|safety|safety
358360|NCT01416883|bicalutamide|bicalutamide
358361|NCT01416883|Japanese|japanese
358362|NCT01416883|healthy subject|healthy subject
358363|NCT01416870|Bioequivalence|bioequivalence
358364|NCT01416870|pharmacokinetics|pharmacokinetics
358365|NCT01416870|safety|safety
358366|NCT01416870|bicalutamide|bicalutamide
358367|NCT01416870|Casodex|casodex
358368|NCT01416870|Japanese|japanese
358369|NCT01416870|healthy subject|healthy subject
358370|NCT01416857|Medicare|medicare
358371|NCT01416844|Metastatic melanoma|metastatic melanoma
358372|NCT01416844|anti-OX40|anti-ox40
358373|NCT01416844|Immunostimulatory|immunostimulatory
358374|NCT01416831|metastatic melanoma|metastatic melanoma
358375|NCT01416831|IL-2|il-2
358376|NCT01416831|Interleukin 2|interleukin 2
358377|NCT01416831|Radiation|radiation
358378|NCT01416831|Stereotactic Body Radiation Treatment|stereotactic body radiation treatment
358379|NCT01416831|SBRT|sbrt
358380|NCT01416831|Immunotherapy|immunotherapy
358381|NCT01416818|Depression;|depression;
358382|NCT01416818|Parkinson's disease;|parkinson's disease;
358383|NCT01416818|antidepressant|antidepressant
358384|NCT01416805|childhood anxiety disorders|childhood anxiety disorders
358385|NCT01416805|cognitive behavioral therapy|cognitive behavioral therapy
358387|NCT01416805|Generalized Anxiety Disorder|generalized anxiety disorder
358388|NCT01416805|Social Phobia|social phobia
358389|NCT01416805|Separation Anxiety Disorder|separation anxiety disorder
358390|NCT01416805|Psychotherapy|psychotherapy
358391|NCT01416805|Counseling|counseling
358392|NCT01416805|Social Anxiety Disorder|social anxiety disorder
358393|NCT01416779|Writing Intervention|writing intervention
358394|NCT01416779|Bereaved Caregivers|bereaved caregivers
358395|NCT01416779|Older Adults|older adults
358396|NCT01416779|hope|hope
358397|NCT01416779|inventory of daily widowed life|inventory of daily widowed life
358398|NCT01416766|Blood Pressure Monitors|blood pressure monitors
358399|NCT01416766|Medical Informatics|medical informatics
358400|NCT01416766|Disease Management|disease management
358401|NCT01416766|Comparative Effectiveness Research|comparative effectiveness research
358402|NCT01416753|hemodialysis|hemodialysis
358403|NCT01416753|blood volume monitoring|blood volume monitoring
358404|NCT01416740|Indirect magnetic resonance arthrogram|indirect magnetic resonance arthrogram
358405|NCT01416740|Direct magnetic resonance arthrogram|direct magnetic resonance arthrogram
358406|NCT01416740|Diagnostic tests for shoulder pain|diagnostic tests for shoulder pain
358407|NCT01416727|Patient Simulation|patient simulation
358408|NCT01416727|Education, Medical, Graduate|education, medical, graduate
358409|NCT01416727|Internship and Residency|internship and residency
358410|NCT01416727|Psychiatry|psychiatry
358411|NCT01416701|COPD|copd
358412|NCT01416701|Vitamin D|vitamin d
358413|NCT01416701|Pulmonary rehabilitation|pulmonary rehabilitation
358414|NCT01416688|therapy-related toxicity|therapy-related toxicity
358415|NCT01416688|dermatologic complications|dermatologic complications
358416|NCT01416688|stage I colon cancer|stage i colon cancer
358417|NCT01416688|stage IIA colon cancer|stage iia colon cancer
358418|NCT01416688|stage IIB colon cancer|stage iib colon cancer
358419|NCT01416688|stage IIC colon cancer|stage iic colon cancer
358420|NCT01416688|stage IIIA colon cancer|stage iiia colon cancer
358421|NCT01416688|stage IIIB colon cancer|stage iiib colon cancer
730688|NCT01081808|T cell|t cell
358422|NCT01416688|stage IIIC colon cancer|stage iiic colon cancer
358423|NCT01416688|stage IVA colon cancer|stage iva colon cancer
358424|NCT01416688|stage IVB colon cancer|stage ivb colon cancer
358425|NCT01416688|stage I rectal cancer|stage i rectal cancer
358426|NCT01416688|stage IIA rectal cancer|stage iia rectal cancer
358427|NCT01416688|stage IIB rectal cancer|stage iib rectal cancer
358428|NCT01416688|stage IIC rectal cancer|stage iic rectal cancer
358429|NCT01416688|stage IIIA rectal cancer|stage iiia rectal cancer
358430|NCT01416688|stage IIIB rectal cancer|stage iiib rectal cancer
358431|NCT01416688|stage IIIC rectal cancer|stage iiic rectal cancer
358432|NCT01416688|stage IVA rectal cancer|stage iva rectal cancer
358433|NCT01416688|stage IVB rectal cancer|stage ivb rectal cancer
358434|NCT01416688|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
358435|NCT01416688|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
358436|NCT01416688|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
358437|NCT01416688|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
358438|NCT01416688|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
358439|NCT01416688|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
358440|NCT01416688|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
358441|NCT01416688|extensive stage small cell lung cancer|extensive stage small cell lung cancer
358442|NCT01416688|limited stage small cell lung cancer|limited stage small cell lung cancer
358443|NCT01416688|recurrent small cell lung cancer|recurrent small cell lung cancer
358444|NCT01416688|recurrent colon cancer|recurrent colon cancer
358445|NCT01416688|recurrent rectal cancer|recurrent rectal cancer
358446|NCT01416688|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
358447|NCT01416662|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
358448|NCT01416662|stage IA pancreatic cancer|stage ia pancreatic cancer
358449|NCT01416662|stage IB pancreatic cancer|stage ib pancreatic cancer
358450|NCT01416662|stage IIA pancreatic cancer|stage iia pancreatic cancer
358554|NCT01416077|fluid|fluid
358451|NCT01416623|Advanced solid cancer|advanced solid cancer
358452|NCT01416623|Henatinib|henatinib
358454|NCT01416597|Influenza|influenza
358455|NCT01416597|Systematic review|systematic review
358456|NCT01416597|Meta-analysis|meta-analysis
358457|NCT01416597|Mismatched strains|mismatched strains
358458|NCT01416597|Cross-protection|cross-protection
358459|NCT01416571|H5N1|h5n1
358460|NCT01416571|Influenza vaccine|influenza vaccine
358461|NCT01416571|influenza infection|influenza infection
358462|NCT01416571|GSK1557484A|gsk1557484a
358463|NCT01416558|German Breast Group|german breast group
358464|NCT01416558|GBG Forschungs GmbH|gbg forschungs gmbh
358465|NCT01416558|GBG|gbg
358466|NCT01416558|GBG 65|gbg 65
358467|NCT01416558|Tiffany|tiffany
358468|NCT01416558|Breast Cancer|breast cancer
358469|NCT01416558|Metastatic Breast Cancer|metastatic breast cancer
358470|NCT01416558|Nab-Paclitaxel|nab-paclitaxel
358471|NCT01416558|Abraxane|abraxane
358472|NCT01416558|Taxane Failure|taxane failure
358473|NCT01416545|Primary Prevention|primary prevention
358474|NCT01416545|Cardiovascular disease|cardiovascular disease
358475|NCT01416545|Child|child
358476|NCT01416545|Behavior modification|behavior modification
358477|NCT01416545|Activities, Educational|activities, educational
358478|NCT01416532|coronary Atheroslcerosis|coronary atheroslcerosis
358479|NCT01416532|Computed Tomography|computed tomography
358480|NCT01416519|Continuous Positive Airway Pressure|continuous positive airway pressure
358481|NCT01416519|Cough|cough
358482|NCT01416519|Oxygen Inhalation Therapy|oxygen inhalation therapy
358483|NCT01416506|Pneumonia, surveillance|pneumonia, surveillance
358484|NCT01416493|acute rheumatoid arthritis|acute rheumatoid arthritis
358485|NCT01416480|Theobromine|theobromine
358486|NCT01416480|cough|cough
358487|NCT01416480|acute bronchitis|acute bronchitis
358488|NCT01416467|lysosomal storage disease|lysosomal storage disease
358489|NCT01416467|AAV vector|aav vector
358490|NCT01416467|gene transfer|gene transfer
358491|NCT01416467|disease characterization|disease characterization
358492|NCT01416441|Tourette's Disorder|tourette's disorder
358493|NCT01416441|tic disorders|tic disorders
358494|NCT01416428|multiple myeloma|multiple myeloma
358495|NCT01416428|waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
358496|NCT01416415|Glaucoma, Open-Angle|glaucoma, open-angle
358497|NCT01416415|Ophthalmic Solutions, Eye drops|ophthalmic solutions, eye drops
358498|NCT01416415|Instructional Films and Videos|instructional films and videos
358499|NCT01416402|Hyperuricemia|hyperuricemia
358500|NCT01416402|gout|gout
358501|NCT01416402|serum uric acid|serum uric acid
358502|NCT01416389|Locally|locally
358503|NCT01416389|Recurrent|recurrent
358504|NCT01416389|Breast|breast
358505|NCT01416389|Cancer|cancer
358506|NCT01416363|firategrast|firategrast
358507|NCT01416363|pharmacokinetics, modified release, firategrast,|pharmacokinetics, modified release, firategrast,
358508|NCT01416363|simulated gastro-retentive|simulated gastro-retentive
358509|NCT01416363|pharmacokinetics|pharmacokinetics
358510|NCT01416363|healthy volunteers, simulated gastro-retentive|healthy volunteers, simulated gastro-retentive
358511|NCT01416363|healthy volunteers|healthy volunteers
730689|NCT01081808|Cetuximab|cetuximab
358512|NCT01416363|modified release|modified release
358513|NCT01416324|pharmacodynamics|pharmacodynamics
358514|NCT01416324|first time in human|first time in human
358515|NCT01416324|pharmacokinetics|pharmacokinetics
358516|NCT01416298|Acute Kidney Injury|acute kidney injury
358517|NCT01416298|Critically ill children|critically ill children
358518|NCT01416298|Biomarkers|biomarkers
358520|NCT01416298|Fluid Overload|fluid overload
358521|NCT01416298|Continuous Renal Replacement Therapy (CRRT)|continuous renal replacement therapy (crrt)
358522|NCT01416285|Congestive heart failure (CHF)|congestive heart failure (chf)
358523|NCT01416285|CHF education|chf education
358524|NCT01416285|self-care training|self-care training
358525|NCT01416285|CHF center|chf center
358526|NCT01416259|QTc Prolongation|qtc prolongation
358527|NCT01416246|Stem cell Infusions|stem cell infusions
358528|NCT01416246|Autologous Stem Cell Transplant|autologous stem cell transplant
358529|NCT01416246|11-105|11-105
358530|NCT01416233|autologous|autologous
358531|NCT01416233|fat|fat
358532|NCT01416233|orbit|orbit
358533|NCT01416233|atrophy|atrophy
358534|NCT01416233|cannula|cannula
358535|NCT01416220|depression|depression
358536|NCT01416220|bipolar disorder|bipolar disorder
358537|NCT01416220|manic depressive illness|manic depressive illness
358538|NCT01416194|Osteoporosis|osteoporosis
358539|NCT01416181|Natalizumab|natalizumab
358540|NCT01416181|secondary|secondary
358541|NCT01416181|multiple sclerosis|multiple sclerosis
358542|NCT01416181|MS|ms
358543|NCT01416181|SPMS|spms
358544|NCT01416181|Tysabri|tysabri
358545|NCT01416168|Colon|colon
358546|NCT01416168|Geriatric|geriatric
358547|NCT01416168|McCorkle Model|mccorkle model
358548|NCT01416168|Questionnaire|questionnaire
358549|NCT01416116|QUTENZA|qutenza
358550|NCT01416116|Pre-treatment|pre-treatment
358551|NCT01416116|Tramadol|tramadol
358552|NCT01416116|Tolerability|tolerability
358553|NCT01416090|syndactyly|syndactyly
358555|NCT01416077|goal-directed|goal-directed
358556|NCT01416077|FloTrac|flotrac
358557|NCT01416077|pulse contour analysis|pulse contour analysis
358558|NCT01416077|postoperative complications|postoperative complications
358559|NCT01416077|anesthesia|anesthesia
358560|NCT01416077|esophagus|esophagus
358561|NCT01416038|vaccine|vaccine
358562|NCT01416038|immunotherapy|immunotherapy
358563|NCT01416038|ovarian|ovarian
358564|NCT01416038|fallopian tube|fallopian tube
358565|NCT01416038|peritoneal|peritoneal
358566|NCT01416038|cancer|cancer
358567|NCT01416038|tumor|tumor
358568|NCT01416038|Phase 1|phase 1
358569|NCT01416038|Phase I|phase i
358570|NCT01416038|combination therapy|combination therapy
358571|NCT01416025|Voriconazole|voriconazole
358572|NCT01416025|Therapeutic drug monitoring|therapeutic drug monitoring
358573|NCT01416025|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
358574|NCT01416025|Hematologic malignancy|hematologic malignancy
358575|NCT01416025|Invasive mould infection|invasive mould infection
358576|NCT01415999|anthracycline|anthracycline
358577|NCT01415999|cardiac function|cardiac function
358578|NCT01415999|echocardiography|echocardiography
358579|NCT01415999|biomarkers|biomarkers
358580|NCT01415986|Advanced head and neck cancer|advanced head and neck cancer
358581|NCT01415986|Squamous cell carcinoma|squamous cell carcinoma
358583|NCT01415986|HNSCC|hnscc
358584|NCT01415973|beef|beef
358585|NCT01415973|protein|protein
358586|NCT01415973|synergy|synergy
358587|NCT01415973|intact beef constituents|intact beef constituents
358588|NCT01415973|protein constituent|protein constituent
358589|NCT01415973|Nutrient Synergy|nutrient synergy
358590|NCT01415960|Prostate Cancer|prostate cancer
358591|NCT01415960|androgen deprivation therapy.|androgen deprivation therapy.
358592|NCT01415960|Leuprolide Acetate Depot Formulation|leuprolide acetate depot formulation
358593|NCT01415960|Pharmacokinetics|pharmacokinetics
358594|NCT01415960|testosterone|testosterone
358595|NCT01415960|serum luteinizing hormone|serum luteinizing hormone
358596|NCT01415960|follicle-stimulating hormone|follicle-stimulating hormone
358597|NCT01415960|prostate-specific antigen|prostate-specific antigen
358598|NCT01415947|Heart disease|heart disease
358599|NCT01415947|Device|device
358600|NCT01415947|Mitral valve|mitral valve
358601|NCT01415947|leaflet prolapse|leaflet prolapse
358602|NCT01415947|Heart valve disease|heart valve disease
358603|NCT01415947|Cardiovascular disease|cardiovascular disease
358604|NCT01415947|Neochordae|neochordae
358605|NCT01415921|heart failure|heart failure
358606|NCT01415921|autonomic function|autonomic function
358607|NCT01415921|sympathovagal balance|sympathovagal balance
358608|NCT01415921|cholinesterase inhibitors|cholinesterase inhibitors
358609|NCT01415921|pharmacology|pharmacology
358610|NCT01415908|advanced degenerative disease of the lumbosacral spine|advanced degenerative disease of the lumbosacral spine
358611|NCT01415908|lumbosacral spine|lumbosacral spine
358612|NCT01415908|radiculopathy|radiculopathy
358613|NCT01415908|degenerative instability|degenerative instability
358614|NCT01415908|spondylolisthesis|spondylolisthesis
358615|NCT01415908|retrolisthesis|retrolisthesis
358616|NCT01415908|lateral listhesis|lateral listhesis
358617|NCT01415908|spinal stenosis|spinal stenosis
358618|NCT01415908|disc herniation|disc herniation
358619|NCT01415908|INFUSE Bone Graft|infuse bone graft
358620|NCT01415908|CD HORIZON Spinal System|cd horizon spinal system
358621|NCT01415908|CAPSTONE Spinal System|capstone spinal system
358622|NCT01415895|back pain|back pain
358623|NCT01415895|cervical pain|cervical pain
358624|NCT01415895|neuropathic pain|neuropathic pain
358625|NCT01415895|radicular pain|radicular pain
358626|NCT01415869|Ventricular Assist Device|ventricular assist device
358627|NCT01415869|Gastrointestinal Bleeding|gastrointestinal bleeding
358629|NCT01415856|pulsed electromagnetic fields device|pulsed electromagnetic fields device
358630|NCT01415856|Torino II|torino ii
358631|NCT01415856|postoperative knee pain|postoperative knee pain
358632|NCT01415856|knee replacement|knee replacement
358633|NCT01415830|Anti-Scorpion venom serum|anti-scorpion venom serum
358634|NCT01415830|venom|venom
358635|NCT01415830|efficacy|efficacy
358636|NCT01415830|safety|safety
358637|NCT01415830|children|children
358638|NCT01415817|Quality Improvement|quality improvement
358639|NCT01415817|Adenoma Detection Rate|adenoma detection rate
358640|NCT01415817|Polyp detection rate|polyp detection rate
358641|NCT01415817|Colonoscopy|colonoscopy
358642|NCT01415817|Training|training
358643|NCT01415817|Colorectal cancer screening|colorectal cancer screening
358644|NCT01415804|Dissection|dissection
358645|NCT01415804|Aorta|aorta
358646|NCT01415804|Surgery|surgery
358647|NCT01415791|oral mucosal absorption|oral mucosal absorption
358648|NCT01415791|pharmacokinetics|pharmacokinetics
358649|NCT01415791|safety|safety
358650|NCT01415791|bicalutamide|bicalutamide
358651|NCT01415791|Japanese|japanese
358652|NCT01415791|healthy subject|healthy subject
358653|NCT01415778|Bioequivalence|bioequivalence
358654|NCT01415778|pharmacokinetics|pharmacokinetics
358655|NCT01415778|safety|safety
358656|NCT01415778|bicalutamide|bicalutamide
358657|NCT01415778|Casodex|casodex
358658|NCT01415778|Japanese|japanese
358659|NCT01415778|healthy subject|healthy subject
358660|NCT01415765|Germinal Center Like B-Cell (GCB) DLBCL|germinal center like b-cell (gcb) dlbcl
358661|NCT01415765|Activated B-Cell Like (ABC) DLBCL|activated b-cell like (abc) dlbcl
358662|NCT01415765|NF-KappaB Pathway|nf-kappab pathway
358663|NCT01415765|Drug Resistance|drug resistance
358664|NCT01415765|Nedd-8 Activating Enzyme Inhibitor|nedd-8 activating enzyme inhibitor
358665|NCT01415765|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
358666|NCT01415765|Lymphoma|lymphoma
358667|NCT01415752|neurotoxicity|neurotoxicity
358789|NCT01415310|Geriatric Psychiatry|geriatric psychiatry
358668|NCT01415752|therapy-related toxicity|therapy-related toxicity
358669|NCT01415752|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
358670|NCT01415752|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
358671|NCT01415752|stage I mantle cell lymphoma|stage i mantle cell lymphoma
358672|NCT01415752|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
358673|NCT01415752|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
358674|NCT01415739|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
358675|NCT01415739|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
358676|NCT01415739|adenocarcinoma of the lung|adenocarcinoma of the lung
358677|NCT01415739|squamous cell lung cancer|squamous cell lung cancer
358678|NCT01415726|Cord blood stem cells|cord blood stem cells
358679|NCT01415726|inflammation|inflammation
358680|NCT01415726|type 2 diabetes|type 2 diabetes
358681|NCT01415726|stem cell educator|stem cell educator
358682|NCT01415726|autoimmunity|autoimmunity
358683|NCT01415726|immune modulation|immune modulation
358684|NCT01415713|enroll the 80 patients in this trial|enroll the 80 patients in this trial
358685|NCT01415700|feet STEPPAGE of central neurological origin|feet steppage of central neurological origin
358686|NCT01415700|implanted functional electrical stimulation|implanted functional electrical stimulation
358687|NCT01415700|feet orthosis|feet orthosis
358688|NCT01415687|preoperative care|preoperative care
358689|NCT01415687|colonoscopy|colonoscopy
358690|NCT01415687|cathartics|cathartics
358691|NCT01415674|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
358692|NCT01415674|pre operative treatment|pre operative treatment
358693|NCT01415674|Afatinib|afatinib
358694|NCT01415674|BIBW2992|bibw2992
358695|NCT01415674|Biological markers|biological markers
358696|NCT01415648|with surgical indication|with surgical indication
358697|NCT01415648|Cerebral oximetry|cerebral oximetry
358698|NCT01415648|carotid endarterectomy|carotid endarterectomy
358699|NCT01415648|MRI|mri
358700|NCT01415648|ischemic lesion|ischemic lesion
358701|NCT01415648|cost/effectiveness analysis|cost/effectiveness analysis
358702|NCT01415648|Neurocognitive Outcome|neurocognitive outcome
358703|NCT01415648|protein S-100B|protein s-100b
358704|NCT01415635|Nutritional risk, Hospital food, Nutritional Intervention|nutritional risk, hospital food, nutritional intervention
358705|NCT01415622|plasma therapy|plasma therapy
358706|NCT01415622|ulcus cruris|ulcus cruris
358707|NCT01415609|Gastrointestinal neoplasia|gastrointestinal neoplasia
358708|NCT01415609|Submucosal resection|submucosal resection
358709|NCT01415570|Protein-energy wasting (PEW)|protein-energy wasting (pew)
358710|NCT01415570|racial disparities|racial disparities
358711|NCT01415570|hemodialysis|hemodialysis
358712|NCT01415570|survival paradoxes|survival paradoxes
358713|NCT01415570|Stage 5|stage 5
358714|NCT01415557|micronutrient|micronutrient
358715|NCT01415557|healthy children|healthy children
358716|NCT01415557|vitamins|vitamins
358717|NCT01415557|minerals|minerals
358718|NCT01415557|cognition|cognition
358719|NCT01415557|physical performance|physical performance
358720|NCT01415557|iron|iron
358721|NCT01415557|Micronutrient status|micronutrient status
358722|NCT01415557|Cognitive Performance|cognitive performance
358723|NCT01415544|Diabetes|diabetes
358724|NCT01415531|Stage 1|stage 1
358725|NCT01415531|Stage 2|stage 2
358726|NCT01415531|Hypertension|hypertension
358727|NCT01415518|Severe chronic obstructive pulmonary disease (COPD) patients|severe chronic obstructive pulmonary disease (copd) patients
358728|NCT01415505|Stage 1|stage 1
358729|NCT01415505|Stage 2|stage 2
358730|NCT01415505|Hypertension|hypertension
358731|NCT01415505|1 year open label safety study|1 year open label safety study
358732|NCT01415492|Exercise|exercise
358733|NCT01415492|Physical activity|physical activity
358734|NCT01415492|Cigarette Smoking|cigarette smoking
358735|NCT01415492|Smoking cessation|smoking cessation
358736|NCT01415492|Multi Vitamin intake|multi vitamin intake
358737|NCT01415492|Vegetable consumption|vegetable consumption
358738|NCT01415492|Fruit consumption|fruit consumption
358739|NCT01415492|Meat consumption|meat consumption
358740|NCT01415479|Colon cancer|colon cancer
358741|NCT01415479|Screening|screening
358742|NCT01415479|Decision-making|decision-making
358743|NCT01415453|retinitis pigmentosa|retinitis pigmentosa
358744|NCT01415453|acoustic radiation force ultrasound|acoustic radiation force ultrasound
358745|NCT01415453|RP|rp
358746|NCT01415453|visual field loss|visual field loss
358747|NCT01415453|Photoreceptor|photoreceptor
358748|NCT01415453|Vision loss|vision loss
358749|NCT01415453|retina|retina
358750|NCT01415453|progressive vision loss|progressive vision loss
358751|NCT01415453|ultrasound|ultrasound
358752|NCT01415440|ADHD|adhd
358753|NCT01415440|Vyvanse|vyvanse
358754|NCT01415440|stimulant medication|stimulant medication
358755|NCT01415440|ADD|add
358756|NCT01415427|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
358757|NCT01415427|MPS IV Type A|mps iv type a
358758|NCT01415427|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
358759|NCT01415427|MPS IVA|mps iva
358760|NCT01415427|Morquio A Syndrome|morquio a syndrome
358761|NCT01415427|Lysosomal Storage Disorder|lysosomal storage disorder
358762|NCT01415427|LSD|lsd
358763|NCT01415427|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
358764|NCT01415427|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
358765|NCT01415427|galactose-6-sulfatase|galactose-6-sulfatase
358766|NCT01415427|GALNS|galns
358767|NCT01415427|enzyme replacement therapy|enzyme replacement therapy
358768|NCT01415427|ERT|ert
358769|NCT01415414|Image quality|image quality
358770|NCT01415414|CNR|cnr
358771|NCT01415414|SNR|snr
358772|NCT01415414|Abdominal|abdominal
358773|NCT01415414|Pelvic|pelvic
358774|NCT01415401|Glaucoma|glaucoma
358775|NCT01415401|Ocular hypertension|ocular hypertension
358776|NCT01415401|Intraocular pressure (IOP)|intraocular pressure (iop)
358777|NCT01415401|Open angle glaucoma|open angle glaucoma
358778|NCT01415401|Pigment dispersion glaucoma|pigment dispersion glaucoma
358779|NCT01415401|Pigmentary|pigmentary
358780|NCT01415388|Maintenance of normal blood triglyceride levels|maintenance of normal blood triglyceride levels
358781|NCT01415375|prostate-specific antigen (146-154)|prostate-specific antigen (146-154)
358782|NCT01415375|prostate-specific antigen (154-163)|prostate-specific antigen (154-163)
358783|NCT01415362|transcranial direct current stimulation|transcranial direct current stimulation
358784|NCT01415362|electroencephalography|electroencephalography
358785|NCT01415323|Emergency services, psychiatric|emergency services, psychiatric
358786|NCT01415323|Psychomotor agitation|psychomotor agitation
358787|NCT01415323|Suicide|suicide
358788|NCT01415323|Violence|violence
358790|NCT01415310|Quality register|quality register
358386|NCT01416805|CBT|cbt
358791|NCT01415310|Quality improvement|quality improvement
358792|NCT01415310|Quality control|quality control
358793|NCT01415310|Research elderly patients with psychiatric disorders|research elderly patients with psychiatric disorders
358794|NCT01415297|Phase 1|phase 1
358795|NCT01415297|advanced solid tumors|advanced solid tumors
358796|NCT01415284|Obstetric anesthesia|obstetric anesthesia
358797|NCT01415284|Spinal anesthesia|spinal anesthesia
358798|NCT01415284|Hypotension|hypotension
358799|NCT01415284|Fluid therapy|fluid therapy
358800|NCT01415284|Cesarean section|cesarean section
358801|NCT01415284|phenylephrine|phenylephrine
358802|NCT01415284|cardiac output|cardiac output
358803|NCT01415271|diabetes|diabetes
358804|NCT01415271|A1c|a1c
358805|NCT01415271|internet|internet
358806|NCT01415271|long term care|long term care
358808|NCT01415258|vulnerability|vulnerability
358809|NCT01415258|frail|frail
358810|NCT01415232|Obesity|obesity
358811|NCT01415232|Ultrasound|ultrasound
358812|NCT01415219|rehabilitation|rehabilitation
358813|NCT01415219|exercise|exercise
358814|NCT01415219|efficacy|efficacy
358815|NCT01415219|functional status|functional status
358816|NCT01415206|Behavioral changes|behavioral changes
358817|NCT01415206|Multiple risks|multiple risks
358818|NCT01415180|sepsis|sepsis
358819|NCT01415180|health related quality of life|health related quality of life
358820|NCT01415180|functional status|functional status
358821|NCT01415180|chronic comorbid conditions|chronic comorbid conditions
358822|NCT01415180|organ dysfunction|organ dysfunction
358823|NCT01415154|TMS|tms
358824|NCT01415154|Major Depressive Disorder|major depressive disorder
358825|NCT01415154|NeuroStar TMS|neurostar tms
358826|NCT01415141|genotype 1|genotype 1
358827|NCT01415141|IL28B CC polymorphism|il28b cc polymorphism
358828|NCT01415141|telaprevir|telaprevir
358829|NCT01415141|peginterferon|peginterferon
358830|NCT01415141|ribavirin|ribavirin
358831|NCT01415115|diabetes|diabetes
358832|NCT01415115|hypertension|hypertension
358833|NCT01415089|Cancer|cancer
358834|NCT01415089|Quality of life|quality of life
358835|NCT01415089|Family caregiver|family caregiver
358836|NCT01415089|Stress and coping|stress and coping
358837|NCT01415089|Web-based intervention|web-based intervention
358838|NCT01415089|Communication|communication
358839|NCT01415063|Hepatocellular Carcinoma|hepatocellular carcinoma
358840|NCT01415063|RFA|rfa
358841|NCT01415063|TACE|tace
358842|NCT01415050|Osteoporosis|osteoporosis
358843|NCT01415050|Menopause|menopause
358844|NCT01415050|Raloxifane|raloxifane
358845|NCT01415050|Alendronate|alendronate
358846|NCT01415037|Annular Array Ultrasound|annular array ultrasound
358847|NCT01415037|Ultrasound Exam|ultrasound exam
358848|NCT01415037|Posterior Vitreous Detachment|posterior vitreous detachment
358849|NCT01415037|PVD|pvd
358850|NCT01415037|Diabetic Retinopathy|diabetic retinopathy
358851|NCT01415024|CRT|crt
358852|NCT01415024|Dual LV|dual lv
358853|NCT01415024|Triple Ventricle stimulation|triple ventricle stimulation
358854|NCT01415024|two leftventricular leads|two leftventricular leads
358855|NCT01415024|Av VV optimization|av vv optimization
358856|NCT01415024|Lv dp/dt measurement|lv dp/dt measurement
358857|NCT01415011|Afatinib (BIBW2992)|afatinib (bibw2992)
358858|NCT01415011|EGFR Mutation|egfr mutation
358859|NCT01415011|Non Small Cell Lung Cancer|non small cell lung cancer
358860|NCT01415011|Poor performance status|poor performance status
358861|NCT01415011|Elderly|elderly
358862|NCT01414985|Batten Disease|batten disease
358863|NCT01414972|Atherosclerosis|atherosclerosis
358864|NCT01414972|Coronary Artery Disease|coronary artery disease
358865|NCT01414972|Vitamin A|vitamin a
358866|NCT01414972|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
358867|NCT01414972|gene expression|gene expression
358868|NCT01414959|intensive care patient|intensive care patient
358869|NCT01414959|intubation|intubation
358968|NCT01414413|Cluster-randomised trial|cluster-randomised trial
358870|NCT01414959|(please change wording as you like!)|(please change wording as you like!)
358871|NCT01414920|Drug Therapy|drug therapy
358872|NCT01414907|Drinking Behavior|drinking behavior
358873|NCT01414907|Harm Reduction|harm reduction
358874|NCT01414907|Tobacco Use Cessation|tobacco use cessation
358875|NCT01414907|Smoking Cessation|smoking cessation
358876|NCT01414907|Rehabilitation|rehabilitation
358877|NCT01414907|Health Promotion|health promotion
358878|NCT01414907|Nutrition Therapy|nutrition therapy
358879|NCT01414907|Feeding Behavior|feeding behavior
358880|NCT01414907|Exercise|exercise
358881|NCT01414881|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
358882|NCT01414881|LDL (low density lipoprotein)|ldl (low density lipoprotein)
358883|NCT01414881|mipomersen|mipomersen
358884|NCT01414868|Leukotriene|leukotriene
358885|NCT01414868|leukotriene receptor antagonist|leukotriene receptor antagonist
358886|NCT01414868|bronchial provocation test|bronchial provocation test
358887|NCT01414868|therapeutic outcome|therapeutic outcome
358888|NCT01414829|Peptic disease|peptic disease
358889|NCT01414829|Helicobacter pylori|helicobacter pylori
358890|NCT01414829|Different methods|different methods
358891|NCT01414816|Multiple Sclerosis|multiple sclerosis
358892|NCT01414816|Clinical Isolated Syndrome (CIS)|clinical isolated syndrome (cis)
358893|NCT01414803|rosuvastatin, fenofibrate, creatine kinase, alanine aminotransferase|rosuvastatin, fenofibrate, creatine kinase, alanine aminotransferase
358894|NCT01414790|human acellular dermal matrix|human acellular dermal matrix
358895|NCT01414790|parotid tumor|parotid tumor
358896|NCT01414790|total parotidectomy|total parotidectomy
358897|NCT01414777|c-section|c-section
358898|NCT01414777|Hypotension after spinal anesthesia for C-section|hypotension after spinal anesthesia for c-section
358899|NCT01414764|rotator cuff tendon repair surgery|rotator cuff tendon repair surgery
358900|NCT01414764|supraspinatus tendon repair|supraspinatus tendon repair
358901|NCT01414751|Risk communication|risk communication
358902|NCT01414751|Shared decision making|shared decision making
358903|NCT01414751|Cardiovascular diseases|cardiovascular diseases
358904|NCT01414751|Hypercholesterolemia|hypercholesterolemia
358905|NCT01414751|Prevention|prevention
358906|NCT01414725|Multiple Sclerosis|multiple sclerosis
358907|NCT01414725|Mobility|mobility
358909|NCT01414725|Core Stability|core stability
358910|NCT01414725|Physiotherapy|physiotherapy
358911|NCT01414712|Low- and Intermediate-Risk Prostate Cancer|low- and intermediate-risk prostate cancer
358912|NCT01414699|dietary variety|dietary variety
358913|NCT01414699|course sequence|course sequence
358914|NCT01414699|preschool|preschool
358915|NCT01414699|child feeding|child feeding
358916|NCT01414673|IUI|iui
358917|NCT01414673|HCG|hcg
358918|NCT01414673|Spontaneous LH|spontaneous lh
358919|NCT01414673|pregnancy|pregnancy
358920|NCT01414660|interleukin 7|interleukin 7
358921|NCT01414660|transplantation|transplantation
358922|NCT01414660|liver|liver
358923|NCT01414660|kidney|kidney
358924|NCT01414660|islet|islet
358925|NCT01414660|diabetes|diabetes
358926|NCT01414647|Bilberry|bilberry
358927|NCT01414647|Vaccinium myrtillus|vaccinium myrtillus
358928|NCT01414647|Metabolic syndrome|metabolic syndrome
358929|NCT01414647|Glucose metabolism|glucose metabolism
358930|NCT01414647|Lipid metabolism|lipid metabolism
358931|NCT01414647|Inflammation|inflammation
358932|NCT01414647|Gene expression|gene expression
358933|NCT01414621|CABG|cabg
358934|NCT01414595|adenocarcinoma of the lung|adenocarcinoma of the lung
358935|NCT01414595|adenosquamous cell lung cancer|adenosquamous cell lung cancer
358936|NCT01414595|non-small cell lung cancer|non-small cell lung cancer
358937|NCT01414595|squamous cell lung cancer|squamous cell lung cancer
358938|NCT01414582|tDCS|tdcs
358939|NCT01414582|Stroke|stroke
358940|NCT01414582|Functional MRI|functional mri
358941|NCT01414582|Motor Learning|motor learning
358942|NCT01414543|violence|violence
358943|NCT01414517|Prebiotics|prebiotics
358944|NCT01414517|Acute Intestinal Injury|acute intestinal injury
358945|NCT01414517|Chronic radiation enteritis|chronic radiation enteritis
358946|NCT01414504|pneumococcal,|pneumococcal,
359051|NCT01414075|Hemodialysis|hemodialysis
358947|NCT01414504|pneumococcal polysaccharide vaccine,|pneumococcal polysaccharide vaccine,
358948|NCT01414504|challenge dose,|challenge dose,
358949|NCT01414504|hyporesponsiveness,|hyporesponsiveness,
358950|NCT01414504|Papua New Guinea|papua new guinea
358951|NCT01414478|emesis|emesis
358952|NCT01414478|nausea|nausea
358953|NCT01414465|Fatty acids|fatty acids
358954|NCT01414465|orlistat|orlistat
358955|NCT01414465|lipase|lipase
358956|NCT01414465|BMC (Body Mass Index) between 30 to 40 kg/m2|bmc (body mass index) between 30 to 40 kg/m2
358957|NCT01414465|Women|women
358958|NCT01414465|18 to 45 years|18 to 45 years
358959|NCT01414465|Premenopausal stage|premenopausal stage
358960|NCT01414452|Myocardial Infarction|myocardial infarction
358961|NCT01414452|Reperfusion injury|reperfusion injury
358962|NCT01414452|Adiponectin|adiponectin
358963|NCT01414452|endothelial progenitor cells|endothelial progenitor cells
358964|NCT01414413|HIV|hiv
358965|NCT01414413|AIDS|aids
358966|NCT01414413|Antiretroviral therapy|antiretroviral therapy
358967|NCT01414413|Community-based study|community-based study
358969|NCT01414413|HIV testing|hiv testing
358970|NCT01414413|Africa|africa
358971|NCT01414400|Bacteremia|bacteremia
358972|NCT01414400|Spyglass|spyglass
358973|NCT01414400|Cholangioscopy|cholangioscopy
358974|NCT01414387|carotid stenosis|carotid stenosis
358975|NCT01414387|cerebral embolization|cerebral embolization
358976|NCT01414387|stents|stents
358977|NCT01414387|stroke|stroke
358978|NCT01414374|iron|iron
358979|NCT01414374|anemia|anemia
358980|NCT01414374|herbal medicine|herbal medicine
358981|NCT01414374|phytotherapy|phytotherapy
358982|NCT01414374|Centella asiatica|centella asiatica
358983|NCT01414374|Hibiscus sabdariffa|hibiscus sabdariffa
358984|NCT01414361|Coronary artery stenosis|coronary artery stenosis
358985|NCT01414361|Fractional flow reserve|fractional flow reserve
358986|NCT01414361|Intravascular ultrasonography|intravascular ultrasonography
358987|NCT01414348|participation|participation
358988|NCT01414348|activities of daily living|activities of daily living
358989|NCT01414348|brain injuries|brain injuries
358990|NCT01414348|executive function|executive function
358991|NCT01414335|amino acids|amino acids
358582|NCT01415986|SCC|scc
358992|NCT01414335|immune system|immune system
358993|NCT01414335|vitamins|vitamins
358994|NCT01414335|chronic infection|chronic infection
358995|NCT01414335|common cold|common cold
358996|NCT01414335|ear|ear
358997|NCT01414335|nose|nose
358998|NCT01414335|throat|throat
358999|NCT01414309|Heart Failure|heart failure
359000|NCT01414309|Central Sleep Apnea|central sleep apnea
359001|NCT01414309|Sleep Disordered Breathing|sleep disordered breathing
359002|NCT01414309|Cardiac Dysfunction|cardiac dysfunction
359003|NCT01414257|Rheumatrex|rheumatrex
359004|NCT01414257|High Dose|high dose
359005|NCT01414244|Irritable Bowel Syndrome|irritable bowel syndrome
359006|NCT01414244|Glutamine|glutamine
359007|NCT01414244|Intestinal Permeability|intestinal permeability
359008|NCT01414231|AML|aml
359009|NCT01414231|acute myeloid leukaemia|acute myeloid leukaemia
359010|NCT01414231|low vs intermediate dose AraC|low vs intermediate dose arac
359011|NCT01414231|CR rate|cr rate
359012|NCT01414231|patients <60 years|patients <60 years
359013|NCT01414218|elderly|elderly
359014|NCT01414218|humor|humor
359015|NCT01414218|general well being|general well being
359016|NCT01414218|psychological distress|psychological distress
359017|NCT01414218|health quality of life|health quality of life
359018|NCT01414179|nutrition|nutrition
359019|NCT01414179|environnement|environnement
359020|NCT01414179|cardiovascular pathology|cardiovascular pathology
359021|NCT01414153|choroidal neovascularization|choroidal neovascularization
359022|NCT01414153|age-related macular degeneration|age-related macular degeneration
359023|NCT01414153|iSONEP|isonep
359024|NCT01414153|sonepcizumab|sonepcizumab
359025|NCT01414153|Lucentis|lucentis
359026|NCT01414153|ranibizumab|ranibizumab
359027|NCT01414153|Avastin|avastin
359028|NCT01414153|bevacizumab|bevacizumab
359029|NCT01414153|Eylea|eylea
359030|NCT01414153|aflibercept|aflibercept
359031|NCT01414140|Mirena, contraception|mirena, contraception
359032|NCT01414114|Clinical Trial, Phase 2|clinical trial, phase 2
359033|NCT01414114|Renal Dialysis|renal dialysis
359034|NCT01414114|Secondary Hyperparathyroidism|secondary hyperparathyroidism
359035|NCT01414114|Chronic kidney disease-mineral and bone disorder|chronic kidney disease-mineral and bone disorder
359036|NCT01414114|Parathyroid hormone|parathyroid hormone
359037|NCT01414101|Rheumatoid Arthritis|rheumatoid arthritis
359038|NCT01414088|Nephrology|nephrology
359039|NCT01414088|ENaC|enac
359040|NCT01414088|NCC|ncc
359041|NCT01414088|NKCC|nkcc
359042|NCT01414088|Sodium channels|sodium channels
359043|NCT01414088|renal biomarkers|renal biomarkers
359044|NCT01414075|Kidney|kidney
359045|NCT01414075|ESRD|esrd
359046|NCT01414075|Renal|renal
359047|NCT01414075|End-Stage Renal Disease|end-stage renal disease
359048|NCT01414075|Anemia|anemia
359049|NCT01414075|Oral anemia treatment|oral anemia treatment
359050|NCT01414075|Hemoglobin levels|hemoglobin levels
359052|NCT01414075|Peritoneal|peritoneal
359053|NCT01414075|HD|hd
359054|NCT01414075|PD|pd
359055|NCT01414075|Hb|hb
359056|NCT01414075|Erythropoietin|erythropoietin
359057|NCT01414075|Blood count|blood count
359058|NCT01414062|Breast Cancer|breast cancer
359059|NCT01414062|Healthy meals|healthy meals
359060|NCT01414062|Cocinar|cocinar
359061|NCT01414062|Dietary|dietary
359062|NCT01414062|Dietary Intervention|dietary intervention
359063|NCT01414062|fruits and vegetables|fruits and vegetables
359064|NCT01414062|Cancer survivor|cancer survivor
359065|NCT01414062|Nutrition|nutrition
359066|NCT01414049|CABG|cabg
359067|NCT01414049|Off-pump CABG|off-pump cabg
359068|NCT01414049|Beating heart|beating heart
359069|NCT01414049|Graft patency|graft patency
359070|NCT01414049|Computed tomography angiography|computed tomography angiography
359071|NCT01414049|Angiographic evaluation of coronary graft patency|angiographic evaluation of coronary graft patency
359072|NCT01414036|cigarette smoking|cigarette smoking
359073|NCT01414036|patient navigation|patient navigation
359074|NCT01414036|primary care|primary care
359075|NCT01414023|High OCI-R scores|high oci-r scores
359076|NCT01414010|healthy volunteers|healthy volunteers
359077|NCT01414010|gut microbiota|gut microbiota
359078|NCT01414010|gut microbiome|gut microbiome
359079|NCT01414010|prebiotic|prebiotic
359080|NCT01414010|probiotic|probiotic
359081|NCT01414010|antibiotic|antibiotic
359082|NCT01414010|antibiotic-associated diarrhea|antibiotic-associated diarrhea
359083|NCT01414010|intestinal bacterial overgrowth|intestinal bacterial overgrowth
359084|NCT01413984|Trauma|trauma
359085|NCT01413984|incarceration|incarceration
359086|NCT01413984|treatment|treatment
359087|NCT01413984|substance abuse|substance abuse
359088|NCT01413958|Nasal Decongestants|nasal decongestants
359089|NCT01413958|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
359090|NCT01413958|Rhinitis|rhinitis
359091|NCT01413958|Nose Conditions|nose conditions
359092|NCT01413958|Respiratory Tract Diseases|respiratory tract diseases
359093|NCT01413958|Phenylephrine|phenylephrine
359094|NCT01413945|Ileocecal valve|ileocecal valve
359095|NCT01413945|Irritable bowel syndrome|irritable bowel syndrome
359096|NCT01413945|small bowel bacteria|small bowel bacteria
359097|NCT01413867|hemorrhoids|hemorrhoids
359098|NCT01413867|circular staplers|circular staplers
359099|NCT01413867|mucosal resection|mucosal resection
359100|NCT01413867|hemostatic suture|hemostatic suture
359101|NCT01413841|PCI|pci
359102|NCT01413841|oxygen|oxygen
359103|NCT01413828|breast cancer|breast cancer
359104|NCT01413828|adjuvant chemotherapy|adjuvant chemotherapy
359105|NCT01413828|trastuzumab|trastuzumab
359106|NCT01413828|anthracycline|anthracycline
359107|NCT01413815|peri-operative|peri-operative
359108|NCT01413815|cardiovascular risk|cardiovascular risk
359109|NCT01413815|oral supplementation|oral supplementation
732000|NCT01093599|MBSR|mbsr
359110|NCT01413815|amino acid L-arginine|amino acid l-arginine
359111|NCT01413802|Thyroid surgery|thyroid surgery
359112|NCT01413763|Actinic keratosis|actinic keratosis
359113|NCT01413763|Atrial ectopy|atrial ectopy
359114|NCT01413724|Administered analgesic therapy|administered analgesic therapy
359115|NCT01413711|IS|is
359116|NCT01413711|Pharmacokinetics|pharmacokinetics
359117|NCT01413711|Area under the curve|area under the curve
359118|NCT01413711|Maximum plasma concentration|maximum plasma concentration
359119|NCT01413711|Time to maximum concentration|time to maximum concentration
359120|NCT01413685|tacrolimus|tacrolimus
359121|NCT01413685|calcineurin|calcineurin
359122|NCT01413685|pharmacodynamic|pharmacodynamic
359123|NCT01413685|TDM|tdm
359124|NCT01413685|pharmacokinetics|pharmacokinetics
359125|NCT01413672|ostomy|ostomy
359126|NCT01413672|colostomy|colostomy
359127|NCT01413672|ileostomy|ileostomy
359128|NCT01413672|barrier|barrier
359129|NCT01413672|irritation|irritation
359130|NCT01413659|Colorectal surgery|colorectal surgery
359131|NCT01413659|Surgical site infection|surgical site infection
359132|NCT01413659|Symbiotic|symbiotic
359133|NCT01413646|obesity|obesity
359134|NCT01413646|walnuts|walnuts
359135|NCT01413646|endothelial function|endothelial function
359136|NCT01413620|Vitamin E|vitamin e
359137|NCT01413620|Burn|burn
359138|NCT01413620|Oxidation|oxidation
359139|NCT01413620|Lung Dysfunction|lung dysfunction
359140|NCT01413620|Fatty Liver|fatty liver
359141|NCT01413620|Lipid Peroxidation|lipid peroxidation
359142|NCT01413607|nephrectomy|nephrectomy
359143|NCT01413607|self retaining sutures|self retaining sutures
359144|NCT01413607|laparoscopy|laparoscopy
359145|NCT01413594|cerebral palsy|cerebral palsy
359146|NCT01413594|constraint-induced therapy|constraint-induced therapy
359147|NCT01413594|constraint-induced movement therapy|constraint-induced movement therapy
359148|NCT01413594|CP|cp
359149|NCT01413594|hemiplegia|hemiplegia
359150|NCT01413594|hand|hand
359151|NCT01413594|forced use|forced use
359152|NCT01413594|motor control|motor control
359153|NCT01413594|children|children
359154|NCT01413594|HABIT|habit
359155|NCT01413594|Hand-arm bimanual intensive therapy|hand-arm bimanual intensive therapy
359156|NCT01413594|bilateral training|bilateral training
359157|NCT01413594|bimanual training|bimanual training
359158|NCT01413594|functional therapy|functional therapy
359159|NCT01413594|physical therapy|physical therapy
359160|NCT01413594|occupational therapy|occupational therapy
359161|NCT01413594|intensive|intensive
359162|NCT01413594|pediatric|pediatric
359163|NCT01413594|development|development
359164|NCT01413594|upper extremity|upper extremity
359165|NCT01413594|hemiplegic|hemiplegic
359166|NCT01413594|childhood stroke|childhood stroke
359167|NCT01413581|rhBSSL|rhbssl
359168|NCT01413581|preterm infants|preterm infants
359169|NCT01413581|Swedish Orphan Biovitrum|swedish orphan biovitrum
359170|NCT01413581|growth velocity|growth velocity
359171|NCT01413581|Prevention of growth restriction|prevention of growth restriction
359172|NCT01413555|blood culture|blood culture
359173|NCT01413555|emergency department|emergency department
359174|NCT01413555|quality improvement|quality improvement
359175|NCT01413542|DPPIV inhibitors|dppiv inhibitors
359176|NCT01413542|ACE inhibitors|ace inhibitors
359177|NCT01413542|Bradykinin|bradykinin
359178|NCT01413542|glucagon-like peptide (GLP-1)|glucagon-like peptide (glp-1)
359180|NCT01413542|diabetes|diabetes
359181|NCT01413542|hypertension|hypertension
359182|NCT01413529|HIV infected persons with co-occurring drug use|hiv infected persons with co-occurring drug use
359183|NCT01413516|Varenicline|varenicline
359184|NCT01413516|Placebo|placebo
359185|NCT01413516|Inpatient|inpatient
359186|NCT01413503|Pheochromocytoma|pheochromocytoma
359187|NCT01413503|Paraganglioma|paraganglioma
359188|NCT01413503|MIBG|mibg
359189|NCT01413503|131I-MIBG|131i-mibg
359190|NCT01413503|Resistant|resistant
359191|NCT01413503|Relapsed|relapsed
359192|NCT01413503|Treatment|treatment
359193|NCT01413503|UCSF|ucsf
359194|NCT01413503|Pediatric|pediatric
359195|NCT01413503|Adult|adult
359196|NCT01413503|Oncology|oncology
359197|NCT01413490|hepatitis C virus|hepatitis c virus
359198|NCT01413490|Interferon|interferon
359199|NCT01413490|rimantadine|rimantadine
359200|NCT01413490|liver|liver
359201|NCT01413477|Allergic contact dermatitis|allergic contact dermatitis
359202|NCT01413477|Nickel allergy|nickel allergy
359203|NCT01413477|Desensitization therapy|desensitization therapy
359204|NCT01413464|Renal Transplant|renal transplant
359205|NCT01413464|Venous Thrombosis|venous thrombosis
359206|NCT01413464|Deep Vein Thrombosis|deep vein thrombosis
359207|NCT01413464|Prophylaxis|prophylaxis
359208|NCT01413464|Bleeding|bleeding
359209|NCT01413451|Monoclonal IgG Antibody|monoclonal igg antibody
359210|NCT01413451|Biodistribution|biodistribution
359211|NCT01413451|Pharmacokinetics|pharmacokinetics
359213|NCT01413451|Safety|safety
359214|NCT01413451|Mesothelioma|mesothelioma
359215|NCT01413451|Ovarian Cancer|ovarian cancer
733300|NCT01099111|CD|cd
359216|NCT01413451|Pancreatic Duct Cancer|pancreatic duct cancer
359217|NCT01413451|Non-Small Cell Lung Cancer|non-small cell lung cancer
359218|NCT01413438|Bevacizumab|bevacizumab
359219|NCT01413438|Quality of Life|quality of life
359220|NCT01413438|Glioblastoma Multiforme|glioblastoma multiforme
359221|NCT01413438|Neurosurgery|neurosurgery
359222|NCT01413438|Glioblastoma|glioblastoma
359224|NCT01413438|Brain Tumor|brain tumor
359225|NCT01413425|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
359226|NCT01413425|Cholesterol|cholesterol
359227|NCT01413425|SLOS|slos
359228|NCT01413412|Ventral Hernia|ventral hernia
359229|NCT01413412|Postoperative Pain|postoperative pain
359230|NCT01413412|Ventral Hernia Pain Questionnaire|ventral hernia pain questionnaire
359231|NCT01413412|Postoperative Abdominal wall and muscle function|postoperative abdominal wall and muscle function
359232|NCT01413412|Biodex|biodex
359233|NCT01413386|paclitaxel|paclitaxel
359234|NCT01413386|drug eluting stent|drug eluting stent
359235|NCT01413373|cephalometry|cephalometry
359236|NCT01413373|three-dimensional|three-dimensional
359237|NCT01413373|CT scan|ct scan
359238|NCT01413373|lateral radiography|lateral radiography
359239|NCT01413373|facial symmetry|facial symmetry
359240|NCT01413373|maxillomandibular dysmorphoses|maxillomandibular dysmorphoses
359241|NCT01413334|Coronary artery disease|coronary artery disease
359242|NCT01413334|CT|ct
359243|NCT01413321|Brain Injuries|brain injuries
359244|NCT01413321|Post Traumatic Encephalopathy|post traumatic encephalopathy
359245|NCT01413321|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
359246|NCT01413321|Cerebral Stroke|cerebral stroke
359247|NCT01413321|Vascular Accidents, Brain|vascular accidents, brain
359248|NCT01413321|Cerebrovascular Apoplexy|cerebrovascular apoplexy
359249|NCT01413321|Cerebrovascular Accident|cerebrovascular accident
359250|NCT01413321|hemiparesis|hemiparesis
359251|NCT01413308|Fontan|fontan
359252|NCT01413308|lung function test|lung function test
359253|NCT01413308|nitric oxide production|nitric oxide production
359254|NCT01413308|NYHA class 1-2 without acute or chronic specified lung disease|nyha class 1-2 without acute or chronic specified lung disease
359255|NCT01413295|Colorectal Neoplasms|colorectal neoplasms
359256|NCT01413295|Dendritic Cells|dendritic cells
359257|NCT01413282|Acute coronary syndrome|acute coronary syndrome
359258|NCT01413269|breast cancer patients|breast cancer patients
359259|NCT01413269|breast conservation surgery|breast conservation surgery
359260|NCT01413269|hypofractionated radiotherapy|hypofractionated radiotherapy
359261|NCT01413243|Multipe sclerosis, Trichuris suis ova|multipe sclerosis, trichuris suis ova
359262|NCT01413230|Systemic lupus erythematosus|systemic lupus erythematosus
359263|NCT01413230|vitamin D supplementation|vitamin d supplementation
359264|NCT01413230|regulatory T cells|regulatory t cells
359265|NCT01413230|Th17 cells|th17 cells
359266|NCT01413204|TA-7284|ta-7284
359267|NCT01413204|JNJ-28431754|jnj-28431754
359268|NCT01413204|Canagliflozin|canagliflozin
359269|NCT01413204|Sodium Glucose Co-transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
359270|NCT01413178|Myeloma|myeloma
359271|NCT01413178|Multiple Myeloma|multiple myeloma
359272|NCT01413178|Light chain Multiple Myeloma|light chain multiple myeloma
359273|NCT01413178|MM|mm
359274|NCT01413178|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
359275|NCT01413178|Busulfan|busulfan
359276|NCT01413178|Busulfex|busulfex
359277|NCT01413178|Myleran|myleran
359278|NCT01413178|Melphalan|melphalan
359279|NCT01413178|Alkeran|alkeran
359280|NCT01413178|G-CSF|g-csf
359281|NCT01413178|Filgrastim|filgrastim
359282|NCT01413178|NeupogenTM|neupogentm
359283|NCT01413178|Questionnaire|questionnaire
359284|NCT01413178|Survey|survey
359285|NCT01413178|Quality of Life|quality of life
359287|NCT01413152|men having sex with men|men having sex with men
359288|NCT01413139|peripheral Vascular Disease|peripheral vascular disease
359289|NCT01413139|claudication|claudication
359290|NCT01413139|rest pain|rest pain
359291|NCT01413126|Peanut|peanut
359292|NCT01413126|Blood glucose|blood glucose
359293|NCT01413126|Insulin|insulin
359294|NCT01413126|Non-esterified free fatty acids|non-esterified free fatty acids
359295|NCT01413126|Glucagon-like peptide-1|glucagon-like peptide-1
359296|NCT01413126|Peptide YY|peptide yy
359297|NCT01413126|Cholecystokinin|cholecystokinin
359298|NCT01413126|Appetitive|appetitive
359299|NCT01413126|Food intake|food intake
359300|NCT01413087|Pancreatic cancer|pancreatic cancer
359301|NCT01413087|Gemcitabine|gemcitabine
359303|NCT01413087|Adenocarcinoma|adenocarcinoma
359304|NCT01413087|Resectable|resectable
359305|NCT01413087|H19 gene|h19 gene
359306|NCT01413087|DTA-H19|dta-h19
359307|NCT01413087|BioCancell|biocancell
359308|NCT01413074|End Stage Renal Disease|end stage renal disease
349987|NCT01450059|HiV-vertical transmission|hiv-vertical transmission
349988|NCT01450046|pancreas|pancreas
349989|NCT01450046|gastrointestinal|gastrointestinal
349990|NCT01450046|GI|gi
349991|NCT01450046|prevention|prevention
349992|NCT01450046|vitamin E|vitamin e
350006|NCT01450020|cancer survivor|cancer survivor
350007|NCT01450007|Pain blockade|pain blockade
350008|NCT01450007|Ropivacaine|ropivacaine
350009|NCT01450007|Dexamethasone|dexamethasone
350010|NCT01449994|knee|knee
359309|NCT01413074|ESRD|esrd
359310|NCT01413074|Peritoneal Dialysis|peritoneal dialysis
359311|NCT01413074|PD|pd
359312|NCT01413074|Hemodialysis|hemodialysis
359313|NCT01413074|HD|hd
359314|NCT01413061|Other Hindfoot Conditions requiring Subtalar Arthrodesis|other hindfoot conditions requiring subtalar arthrodesis
359315|NCT01413061|Post-traumatic Arthritis|post-traumatic arthritis
359316|NCT01413048|Essential Hypertension|essential hypertension
359317|NCT01413048|Hypertension|hypertension
359318|NCT01413035|Diabetes|diabetes
359319|NCT01413035|Diabetes Medicines: Oral Hypoglycemic Drugs and Insulins.|diabetes medicines: oral hypoglycemic drugs and insulins.
359320|NCT01413035|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
359321|NCT01413035|Transplantation|transplantation
359322|NCT01413009|delirium|delirium
359323|NCT01413009|ICU|icu
359324|NCT01413009|spontaneous awakening trials|spontaneous awakening trials
359325|NCT01413009|spontaneous breathing trials|spontaneous breathing trials
359326|NCT01413009|early mobility|early mobility
359327|NCT01412970|hemodynamic monitoring|hemodynamic monitoring
359328|NCT01412970|volume responsiveness|volume responsiveness
359329|NCT01412970|electrical impedance tomography|electrical impedance tomography
359330|NCT01412957|Best Supportive Care|best supportive care
359331|NCT01412957|Panitumumab|panitumumab
359332|NCT01412957|Chemorefractory|chemorefractory
359333|NCT01412957|Wild-type KRAS|wild-type kras
359334|NCT01412957|Overall Survival|overall survival
359335|NCT01412957|Phase 3|phase 3
359336|NCT01412944|Psoriasis|psoriasis
359337|NCT01412944|plaque|plaque
359338|NCT01412944|inflammatory skin disease|inflammatory skin disease
359339|NCT01412944|scaly patches|scaly patches
359340|NCT01412944|AIN457|ain457
359341|NCT01412944|secukinumab|secukinumab
359342|NCT01412944|Moderate to severe|moderate to severe
359343|NCT01412918|Tinnitus|tinnitus
359344|NCT01412918|Inhibitor Device|inhibitor device
359345|NCT01412918|SCN9 gene|scn9 gene
359346|NCT01412918|Ringing in the ears|ringing in the ears
359347|NCT01412918|Milwaukee|milwaukee
359348|NCT01412918|Medical College of Wisconsin|medical college of wisconsin
359349|NCT01412905|screening|screening
359350|NCT01412905|diabetic retinopathy|diabetic retinopathy
359351|NCT01412892|Neurofibromatosis type 1|neurofibromatosis type 1
359352|NCT01412892|Everolimus|everolimus
359353|NCT01412892|Plexiform neurofibromas|plexiform neurofibromas
359354|NCT01412892|Rapamycin|rapamycin
359355|NCT01412879|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
359356|NCT01412879|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
359357|NCT01412879|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
359358|NCT01412879|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
359359|NCT01412866|schizophrenia|schizophrenia
359360|NCT01412866|severe mental illness|severe mental illness
359361|NCT01412866|nicotine|nicotine
359362|NCT01412866|smoking|smoking
359363|NCT01412866|motivation|motivation
359364|NCT01412866|electronic decision support system|electronic decision support system
359365|NCT01412866|motivational interviewing|motivational interviewing
359366|NCT01412853|localized|localized
359367|NCT01412840|Ureterolithiasis|ureterolithiasis
359368|NCT01412840|Pain|pain
359369|NCT01412840|Complementary|complementary
359370|NCT01412840|RCT|rct
359371|NCT01412827|Single-photon emission computed tomography|single-photon emission computed tomography
359372|NCT01412827|myocardial perfusion imaging|myocardial perfusion imaging
359373|NCT01412827|rest/stress|rest/stress
359374|NCT01412827|treadmill|treadmill
359375|NCT01412827|persantine|persantine
359376|NCT01412827|half-dose|half-dose
359377|NCT01412827|radiotracer|radiotracer
359378|NCT01412827|tetrofosmin|tetrofosmin
359379|NCT01412827|Thallium|thallium
359380|NCT01412827|cadmium zinc telluride|cadmium zinc telluride
359381|NCT01412827|diagnostic|diagnostic
359382|NCT01412827|prognostic|prognostic
359383|NCT01412814|Total knee arthroplasty|total knee arthroplasty
359384|NCT01412814|Total knee replacement|total knee replacement
359385|NCT01412814|End-stage knee osteoarthritis|end-stage knee osteoarthritis
359386|NCT01412814|Gait patterns|gait patterns
359387|NCT01412814|Neuromuscular education|neuromuscular education
359388|NCT01412801|Group B streptococcus|group b streptococcus
359390|NCT01412801|Vaccine|vaccine
359391|NCT01412801|Prevention of group B streptococcus infection|prevention of group b streptococcus infection
359392|NCT01412788|breast cancer|breast cancer
359393|NCT01412788|Breast Conserving Surgery|breast conserving surgery
359394|NCT01412788|Peri-areolar Incision|peri-areolar incision
359395|NCT01412775|stress|stress
359396|NCT01412775|burnout|burnout
359397|NCT01412775|exhaustion|exhaustion
359398|NCT01412762|Surgery|surgery
359399|NCT01412762|interview|interview
359400|NCT01412762|11-087|11-087
359401|NCT01412749|registry|registry
359402|NCT01412749|database|database
359403|NCT01412749|eHNS|ehns
359404|NCT01412749|Endoscopic Head and Neck Surgery|endoscopic head and neck surgery
359405|NCT01412749|Transoral Endoscopic Surgery Trial|transoral endoscopic surgery trial
359406|NCT01412749|TEST|test
359407|NCT01412749|melanoma|melanoma
359408|NCT01412749|head and neck surgery|head and neck surgery
359409|NCT01412723|Iron Deficiency|iron deficiency
359410|NCT01412723|Child, Preschool|child, preschool
359411|NCT01412723|Dietary Iron|dietary iron
359412|NCT01412723|Ferrous sulfate|ferrous sulfate
359413|NCT01412723|Bis-glycino iron II|bis-glycino iron ii
359414|NCT01412710|Type 2 Diabetes|type 2 diabetes
733301|NCT01099111|CRAP/CRC|crap/crc
359415|NCT01412710|Cholecalciferol|cholecalciferol
359416|NCT01412710|Vitamin D|vitamin d
359417|NCT01412710|Insulin resistance|insulin resistance
359418|NCT01412710|Cardiovascular disease risk|cardiovascular disease risk
359419|NCT01412710|Minorities|minorities
359420|NCT01412697|Rural youth|rural youth
359421|NCT01412697|Theory-based intervention|theory-based intervention
359422|NCT01412697|Randomized by schools|randomized by schools
359423|NCT01412697|Fruit and vegetable intake|fruit and vegetable intake
359424|NCT01412697|Health classes|health classes
359425|NCT01412671|Nexavar|nexavar
359426|NCT01412671|unresectable or advanced renal cell carcinoma|unresectable or advanced renal cell carcinoma
359427|NCT01412645|Obesity|obesity
359428|NCT01412645|Inflammation|inflammation
359429|NCT01412645|Metabolic Syndrome|metabolic syndrome
359430|NCT01412645|Insulin sensitivity|insulin sensitivity
359431|NCT01412645|Osteoporosis|osteoporosis
359432|NCT01412645|Bone turnover|bone turnover
359433|NCT01412645|Ectopic fat accumulation|ectopic fat accumulation
359434|NCT01412645|Resveratrol|resveratrol
359435|NCT01412619|Neurological Outcome|neurological outcome
359436|NCT01412619|Intraoperative intracerebral Oxygen level|intraoperative intracerebral oxygen level
359437|NCT01412619|Mean arterial blood pressure|mean arterial blood pressure
359438|NCT01412619|Central venous blood pressure|central venous blood pressure
359439|NCT01412619|Cardiac output|cardiac output
359440|NCT01412619|Serum Lactate|serum lactate
359441|NCT01412619|Venous oxygen saturation|venous oxygen saturation
359442|NCT01412619|Fluid balance|fluid balance
359443|NCT01412606|Unexplained infertility-endometrial scratching|unexplained infertility-endometrial scratching
359543|NCT01412203|Physical activity|physical activity
359544|NCT01412203|Healthy weight|healthy weight
359545|NCT01412203|Healthy eating|healthy eating
359444|NCT01412606|effect of endometrial biopsy (scratching) on clinical pregnancy rates in women with unexplained infertility|effect of endometrial biopsy (scratching) on clinical pregnancy rates in women with unexplained infertility
359445|NCT01412567|Hepatitis B|hepatitis b
359446|NCT01412567|HBsAg|hbsag
359447|NCT01412567|Antenatal|antenatal
359448|NCT01412567|Pregnancy|pregnancy
359449|NCT01412567|Vertical transmission|vertical transmission
359450|NCT01412567|Placenta|placenta
359451|NCT01412567|HBV DNA|hbv dna
359452|NCT01412554|Insulin resistance|insulin resistance
359453|NCT01412554|Diabetes mellitus|diabetes mellitus
359454|NCT01412554|Adipositas|adipositas
359455|NCT01412541|Arms|arms
359456|NCT01412541|Experimental|experimental
359457|NCT01412541|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
359458|NCT01412541|Active Comparator|active comparator
359459|NCT01412541|Standard Angioplasty Balloon|standard angioplasty balloon
359460|NCT01412515|mTOR inhibitors|mtor inhibitors
359461|NCT01412502|Tissue Donors|tissue donors
359462|NCT01412502|Tissue and Organ Procurement|tissue and organ procurement
359463|NCT01412502|Brain death|brain death
359464|NCT01412502|Withdrawal of life support|withdrawal of life support
359465|NCT01412489|Uterine synechiae|uterine synechiae
359466|NCT01412489|HyalobarrierR Gel Endo|hyalobarrierr gel endo
359467|NCT01412489|Operative hysteroscopy|operative hysteroscopy
359468|NCT01412489|submucous myoma|submucous myoma
359469|NCT01412450|symptomatic popliteal artery stenosis or occlusion|symptomatic popliteal artery stenosis or occlusion
359470|NCT01412437|PKU|pku
359471|NCT01412437|MRI|mri
359472|NCT01412437|neurocognition|neurocognition
359473|NCT01412437|sapropterin dihydrochloride|sapropterin dihydrochloride
359474|NCT01412424|acromegaly|acromegaly
359475|NCT01412424|IGF-1|igf-1
359476|NCT01412424|growth hormone|growth hormone
359477|NCT01412424|Octreolin|octreolin
359478|NCT01412424|octreotide|octreotide
359479|NCT01412424|somatostatin analog|somatostatin analog
359480|NCT01412411|Anemia|anemia
359481|NCT01412411|Growth|growth
359482|NCT01412411|Infants|infants
350209|NCT01449123|Asthma|asthma
359483|NCT01412411|Focus of the study is to assess the level of anemia and growth indicators among the infants|focus of the study is to assess the level of anemia and growth indicators among the infants
359484|NCT01412398|Fosrenol|fosrenol
359485|NCT01412398|Hyperphosphatemia|hyperphosphatemia
359486|NCT01412398|Continuous Cyclic Peritoneal Dialysis|continuous cyclic peritoneal dialysis
359487|NCT01412372|Irritable Bowel Syndrome|irritable bowel syndrome
359488|NCT01412372|Diarrhea|diarrhea
359489|NCT01412372|Mesalamine|mesalamine
359490|NCT01412372|Gastroenteritis|gastroenteritis
359491|NCT01412372|abdominal pain|abdominal pain
359492|NCT01412372|hypersensitivity|hypersensitivity
359493|NCT01412359|TPN Cholestasis|tpn cholestasis
359494|NCT01412346|human|human
359495|NCT01412346|clinical trial|clinical trial
359496|NCT01412346|dietary intervention study|dietary intervention study
359498|NCT01412346|cardiovascular biomarkers|cardiovascular biomarkers
359499|NCT01412346|nutritional biomarkers|nutritional biomarkers
359500|NCT01412346|gene expression|gene expression
359501|NCT01412307|Hodgkin Lymphoma|hodgkin lymphoma
359502|NCT01412307|Lenalidomide|lenalidomide
359503|NCT01412307|Bendamustine|bendamustine
359504|NCT01412307|Salvage therapy|salvage therapy
359505|NCT01412307|Palliation|palliation
359506|NCT01412294|gastric cancer|gastric cancer
359507|NCT01412294|recurrent gastric cancer|recurrent gastric cancer
359508|NCT01412294|adenocarcinoma of the stomach|adenocarcinoma of the stomach
359509|NCT01412294|capecitabine|capecitabine
359510|NCT01412294|xp|xp
359511|NCT01412281|Influenza|influenza
359512|NCT01412281|Virus|virus
359513|NCT01412281|Vaccination|vaccination
359514|NCT01412281|Immunisation|immunisation
359515|NCT01412268|Obesity|obesity
359516|NCT01412268|Bariatric surgery|bariatric surgery
359517|NCT01412268|Behavioral changes|behavioral changes
359518|NCT01412268|Eating habits|eating habits
359519|NCT01412268|Eating addiction|eating addiction
359520|NCT01412242|Deep vein thrombosis|deep vein thrombosis
359521|NCT01412242|Ultrasonography|ultrasonography
359522|NCT01412242|Pulmonary embolism|pulmonary embolism
359523|NCT01412242|D-dimer|d-dimer
359524|NCT01412242|Pre-test probability|pre-test probability
359525|NCT01412229|Head and neck cancer|head and neck cancer
359526|NCT01412229|Phase II|phase ii
359527|NCT01412229|Locally advanced|locally advanced
359528|NCT01412229|Squamous Cell|squamous cell
359529|NCT01412229|Carboplatin|carboplatin
359530|NCT01412229|Nab-paclitaxel|nab-paclitaxel
359531|NCT01412229|Abraxane|abraxane
359532|NCT01412229|Cetuximab|cetuximab
359533|NCT01412229|Induction|induction
359534|NCT01412229|Chemotherapy|chemotherapy
359535|NCT01412216|Sedentarism|sedentarism
359536|NCT01412216|Physical inactivity|physical inactivity
359537|NCT01412216|Fish oil|fish oil
359538|NCT01412216|Omega-3 fatty acids|omega-3 fatty acids
359539|NCT01412216|Endothelial dysfunction|endothelial dysfunction
359540|NCT01412216|Insulin resistance|insulin resistance
359541|NCT01412216|Metabolic syndrome|metabolic syndrome
359542|NCT01412216|peripheral arterial disease|peripheral arterial disease
359745|NCT01411449|MRI agent|mri agent
359546|NCT01412203|Physical fitness|physical fitness
359547|NCT01412203|Children|children
359548|NCT01412203|School based|school based
359549|NCT01412203|Community based|community based
359550|NCT01412203|Obesity|obesity
359551|NCT01412203|Health promotion|health promotion
359552|NCT01412203|Socio-ecological|socio-ecological
359553|NCT01412203|Environment based|environment based
359554|NCT01412190|Skin rejuvenation|skin rejuvenation
359555|NCT01412177|Meniere's Disease|meniere's disease
359556|NCT01412177|Vertigo|vertigo
359557|NCT01412177|Definitive vertigo|definitive vertigo
359558|NCT01412177|Vertigo episodes|vertigo episodes
359559|NCT01412177|Vertigo frequency|vertigo frequency
359560|NCT01412177|Tinnitus|tinnitus
359561|NCT01412177|Hearing loss|hearing loss
359562|NCT01412177|Aural fullness|aural fullness
359563|NCT01412164|DES|des
359564|NCT01412164|CAD|cad
359565|NCT01412164|FIREHAWK|firehawk
359566|NCT01412164|MicroPort|microport
359567|NCT01412164|PCI|pci
359568|NCT01412151|Symptomatic|symptomatic
359569|NCT01412151|Huntington's Disease|huntington's disease
359570|NCT01412151|HD|hd
359571|NCT01412125|Biomarkers|biomarkers
359572|NCT01412125|Genetic polymorphism|genetic polymorphism
359573|NCT01412125|Neuroimaging markers|neuroimaging markers
359574|NCT01412125|Neuropsychology|neuropsychology
359575|NCT01412099|Exercise|exercise
359576|NCT01412099|Fast Foods|fast foods
359577|NCT01412099|Fruits|fruits
359578|NCT01412099|Vegetables|vegetables
359579|NCT01412099|Beverages|beverages
359580|NCT01412099|Non-traditional college students|non-traditional college students
359581|NCT01412099|Motivational Interviewing|motivational interviewing
359582|NCT01412099|Peer Counselors|peer counselors
359583|NCT01412099|Cancer Prevention|cancer prevention
350295|NCT01448798|erectile dysfunction|erectile dysfunction
350296|NCT01448798|continence|continence
350297|NCT01448785|obesity|obesity
350298|NCT01448785|gastric stimulation|gastric stimulation
350299|NCT01448785|morbid obesity|morbid obesity
350300|NCT01448772|Dronabinol|dronabinol
359584|NCT01412073|caesarean section, intrapartum haemorrhage|caesarean section, intrapartum haemorrhage
359585|NCT01412060|Schizophrenia|schizophrenia
359586|NCT01412060|Schizophrenic Disorder|schizophrenic disorder
359587|NCT01412047|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
359588|NCT01412047|PNH|pnh
359589|NCT01412047|Human Anti-Human Antibody|human anti-human antibody
359590|NCT01412047|HAHA|haha
359591|NCT01412047|Soliris|soliris
359592|NCT01412047|eculizumab|eculizumab
359593|NCT01412034|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
359594|NCT01412034|Familial Hypercholesterolemia|familial hypercholesterolemia
359595|NCT01412034|HDL mimetic|hdl mimetic
359596|NCT01412034|ApoA-1|apoa-1
359597|NCT01412021|Arthritis, Juvenile Rheumatoid|arthritis, juvenile rheumatoid
359598|NCT01412008|MRI|mri
359599|NCT01412008|Magnetic Resonance Imaging|magnetic resonance imaging
359601|NCT01412008|botulinum toxin|botulinum toxin
359602|NCT01412008|neurological|neurological
359603|NCT01412008|stroke|stroke
359604|NCT01412008|spasticity|spasticity
359605|NCT01412008|muscle stiffness|muscle stiffness
359606|NCT01412008|diffusion|diffusion
359607|NCT01412008|Weill Cornell|weill cornell
359608|NCT01412008|New York Presbyterian Hospital|new york presbyterian hospital
359609|NCT01412008|O'Dell|o'dell
359610|NCT01411995|intrauterine device|intrauterine device
359611|NCT01411995|pain|pain
359612|NCT01411995|lidocaine gel|lidocaine gel
359613|NCT01411982|PACAP (pituitary adenylate cyclase-activating polypeptide)|pacap (pituitary adenylate cyclase-activating polypeptide)
359614|NCT01411982|Nephrotic syndrome|nephrotic syndrome
359615|NCT01411982|Thrombosis|thrombosis
359616|NCT01411982|Platelets|platelets
359617|NCT01411969|external nasal dilator strip|external nasal dilator strip
359618|NCT01411969|nasal valve|nasal valve
359619|NCT01411969|acoustic rhinometry|acoustic rhinometry
359620|NCT01411956|Health Behavior Theory|health behavior theory
359621|NCT01411956|Patient Education|patient education
359622|NCT01411956|Hypertension|hypertension
359623|NCT01411956|Health beliefs related to hypertension and hypertension treatment|health beliefs related to hypertension and hypertension treatment
359624|NCT01411943|Epigenetics|epigenetics
359625|NCT01411943|Inflammatory|inflammatory
359626|NCT01411943|Psychoneurologic Symptoms|psychoneurologic symptoms
359627|NCT01411943|Cognitive Dysfunction|cognitive dysfunction
359628|NCT01411943|Pain|pain
359629|NCT01411943|Fatigue|fatigue
359630|NCT01411943|Sleep Disturbance|sleep disturbance
359631|NCT01411943|Depression|depression
359632|NCT01411943|Depressive Symptoms|depressive symptoms
359633|NCT01411943|Anxiety|anxiety
359634|NCT01411943|Breast Cancer|breast cancer
359635|NCT01411930|Insulin resistance|insulin resistance
359636|NCT01411930|Antipsychotics|antipsychotics
359637|NCT01411930|Olanzapine|olanzapine
359638|NCT01411930|Aripiprazole|aripiprazole
359639|NCT01411917|surgical stomas|surgical stomas
359640|NCT01411917|Nerve block|nerve block
359641|NCT01411904|Leukemia|leukemia
359642|NCT01411904|magnetic needle|magnetic needle
359746|NCT01411436|Nexavar|nexavar
359643|NCT01411904|magnetic nanoparticles|magnetic nanoparticles
359644|NCT01411904|CD34|cd34
359645|NCT01411891|Arthroplasty|arthroplasty
359646|NCT01411891|Infection Control|infection control
359647|NCT01411878|Teen Pregnancy Prevention|teen pregnancy prevention
359648|NCT01411865|Pragmatic randomized controlled trial|pragmatic randomized controlled trial
359649|NCT01411865|Cardiovascular risk reduction|cardiovascular risk reduction
359650|NCT01411865|Knowledge translation|knowledge translation
359651|NCT01411865|Clinical practice guidelines|clinical practice guidelines
359652|NCT01411865|Administrative databases|administrative databases
359653|NCT01411852|fluid volume resuscitation|fluid volume resuscitation
359654|NCT01411852|trauma|trauma
359655|NCT01411852|hemorrhagic shock|hemorrhagic shock
359656|NCT01411839|Depression|depression
359657|NCT01411839|Latinos|latinos
359658|NCT01411839|Adherence|adherence
359659|NCT01411839|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
359660|NCT01411839|HIV/AIDS|hiv/aids
359661|NCT01411826|Colon cancer screening|colon cancer screening
359662|NCT01411787|Breast cancer|breast cancer
359663|NCT01411787|neoadjuvant chemotherapy|neoadjuvant chemotherapy
359664|NCT01411787|exercise|exercise
359665|NCT01411787|Ki-67|ki-67
359666|NCT01411774|Obsessive-compulsive disorder|obsessive-compulsive disorder
359667|NCT01411774|OCD|ocd
359668|NCT01411761|indirect hyperbilirubinemia|indirect hyperbilirubinemia
359669|NCT01411761|very low birth weight infants|very low birth weight infants
359670|NCT01411722|Electrical Activity of Diaphragm|electrical activity of diaphragm
359671|NCT01411722|Weaning outcome|weaning outcome
359672|NCT01411722|NAVA|nava
359673|NCT01411683|Cost estimates|cost estimates
359674|NCT01411683|Complete Denture|complete denture
359675|NCT01411683|Dental Economics|dental economics
359881|NCT01410916|STEC-HUS|stec-hus
359676|NCT01411683|Dental Implants|dental implants
359677|NCT01411683|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
359678|NCT01411683|Denture Retention|denture retention
359679|NCT01411683|Edentulous|edentulous
359680|NCT01411683|Edentulism|edentulism
359681|NCT01411683|Mini dental implant|mini dental implant
359682|NCT01411683|Oral Health-Related Quality of Life|oral health-related quality of life
359683|NCT01411683|Overdenture|overdenture
359684|NCT01411683|Patient Acceptance of Health Care|patient acceptance of health care
359685|NCT01411683|Quality of Health Care|quality of health care
359686|NCT01411683|Quality of Life|quality of life
359687|NCT01411683|Patient Satisfaction|patient satisfaction
359688|NCT01411670|Human Protein C|human protein c
359689|NCT01411670|Activated protein C|activated protein c
359690|NCT01411670|Microcirculation|microcirculation
359691|NCT01411670|Septic Shock|septic shock
359692|NCT01411670|Sepsis|sepsis
359693|NCT01411644|POF|pof
359694|NCT01411644|IOF|iof
359695|NCT01411644|Poor response|poor response
359697|NCT01411644|Primary amenorrhea|primary amenorrhea
359698|NCT01411631|Polyphenols|polyphenols
359699|NCT01411631|Cognition|cognition
359700|NCT01411631|Cognitive function|cognitive function
359701|NCT01411631|Driving performance|driving performance
359702|NCT01411631|Stress|stress
359703|NCT01411618|Antiplaque agents|antiplaque agents
359704|NCT01411618|chemical plaque control|chemical plaque control
359705|NCT01411618|oral hygiene|oral hygiene
359706|NCT01411618|essential oils|essential oils
359707|NCT01411618|alcohol|alcohol
359708|NCT01411618|mouthwash|mouthwash
359709|NCT01411605|Obesity|obesity
359710|NCT01411605|Adolescent|adolescent
359711|NCT01411605|Exercise training|exercise training
359712|NCT01411605|Exercise tolerance|exercise tolerance
359714|NCT01411592|Resin-bonded Fixed Dental Protheses|resin-bonded fixed dental protheses
359716|NCT01411592|Randomized Clinical Trial|randomized clinical trial
359717|NCT01411592|Resin Bond|resin bond
359718|NCT01411592|Bonding System|bonding system
359719|NCT01411579|liver|liver
359720|NCT01411579|metastases|metastases
359721|NCT01411579|hepatocarcinoma|hepatocarcinoma
359722|NCT01411579|MR|mr
359723|NCT01411579|DWI|dwi
359724|NCT01411579|chemotherapy|chemotherapy
359725|NCT01411566|KLIPS|klips
359726|NCT01411553|ICU|icu
359727|NCT01411553|Telemetry|telemetry
359728|NCT01411553|ECG lead wire monitoring|ecg lead wire monitoring
359729|NCT01411553|Infection|infection
359730|NCT01411553|Nuisance alarms|nuisance alarms
359731|NCT01411540|Body composition|body composition
359732|NCT01411540|Health markers|health markers
359733|NCT01411540|Diet|diet
359734|NCT01411527|Hormones|hormones
359735|NCT01411527|Endocrine Disrupters|endocrine disrupters
359736|NCT01411527|Polymorphism, Genetic|polymorphism, genetic
359737|NCT01411514|Relapsing remittent multipse sclerosis|relapsing remittent multipse sclerosis
359738|NCT01411514|Secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
359739|NCT01411514|Clinically isolated syndrome|clinically isolated syndrome
359740|NCT01411514|Primary progressive multiple sclerosis|primary progressive multiple sclerosis
359741|NCT01411501|Acupuncture|acupuncture
359742|NCT01411501|Functional constipation|functional constipation
359743|NCT01411488|Focus: anal erosion|focus: anal erosion
359744|NCT01411449|Primovist|primovist
359747|NCT01411436|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
359748|NCT01411423|Nexavar|nexavar
359749|NCT01411423|Unresectable or advanced renal cell carcinoma|unresectable or advanced renal cell carcinoma
359750|NCT01411410|phase I|phase i
359751|NCT01411410|phosphatidylinositol 3΄-kinase (PI3K)|phosphatidylinositol 3΄-kinase (pi3k)
359752|NCT01411410|paclitaxel|paclitaxel
359753|NCT01411410|Maximum tolerated Dose|maximum tolerated dose
359754|NCT01411397|Infection|infection
359755|NCT01411397|Prosthesis|prosthesis
359756|NCT01411397|Recurrence|recurrence
359757|NCT01411397|Strangulation|strangulation
359758|NCT01411384|Keratoconus (KC)|keratoconus (kc)
359759|NCT01411384|Corneal collagen cross-linking (CXL)|corneal collagen cross-linking (cxl)
359760|NCT01411384|Corneal hysteresis (CH)|corneal hysteresis (ch)
359761|NCT01411384|Corneal resistance factor (CRF)|corneal resistance factor (crf)
359762|NCT01411384|Ocular Response Analyzer (ORA)|ocular response analyzer (ora)
359763|NCT01411371|Atrial fibrillation|atrial fibrillation
359764|NCT01411371|Heart failure|heart failure
359765|NCT01411371|Catheter ablation|catheter ablation
359766|NCT01411358|influenza|influenza
359767|NCT01411358|vaccine|vaccine
359768|NCT01411358|immunogenicity|immunogenicity
359771|NCT01411332|Prostate Cancer|prostate cancer
359772|NCT01411332|Prostate Adenocarcinoma|prostate adenocarcinoma
359773|NCT01411319|Prostate Cancer|prostate cancer
359774|NCT01411319|Prostate Adenocarcinoma|prostate adenocarcinoma
359775|NCT01411293|cardiovascular disease|cardiovascular disease
359776|NCT01411293|oxidative stress|oxidative stress
359777|NCT01411293|dairy consumption|dairy consumption
359778|NCT01411293|metabolic syndrome|metabolic syndrome
359779|NCT01411293|obesity|obesity
359780|NCT01411293|endothelial function|endothelial function
359781|NCT01411267|Relapse|relapse
359782|NCT01411267|Lymphoblastic|lymphoblastic
359783|NCT01411267|Leukemia|leukemia
359784|NCT01411267|AC220|ac220
359785|NCT01411267|Refractory|refractory
359786|NCT01411267|Myelogenous|myelogenous
359787|NCT01411267|Acute|acute
359788|NCT01411267|Childhood|childhood
359789|NCT01411267|Pediatric|pediatric
359790|NCT01411267|ALL|all
359791|NCT01411267|AML|aml
359792|NCT01411254|DME|dme
359793|NCT01411241|Dengue|dengue
359794|NCT01411241|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
359795|NCT01411241|CYD Dengue Vaccines|cyd dengue vaccines
359796|NCT01411241|Pentaxim™|pentaxim™
359797|NCT01411228|Gaucher disease|gaucher disease
359798|NCT01411228|pediatrics|pediatrics
359799|NCT01411215|Rheumatoid arthritis|rheumatoid arthritis
359800|NCT01411215|ankylosing spondylitis|ankylosing spondylitis
359801|NCT01411215|observational study|observational study
359802|NCT01411202|Malignant Pleural Effusion|malignant pleural effusion
359803|NCT01411202|Doxycycline|doxycycline
359804|NCT01411202|Pleurodesis|pleurodesis
359805|NCT01411202|Pleurx catheter|pleurx catheter
359806|NCT01411189|therapeutic upper gastrointestinal endoscopy|therapeutic upper gastrointestinal endoscopy
359807|NCT01411189|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
359808|NCT01411189|endoscopic mucosal resection|endoscopic mucosal resection
359809|NCT01411189|endoscopic submucosal dissection|endoscopic submucosal dissection
359811|NCT01411189|EMR|emr
359812|NCT01411189|ESD|esd
359813|NCT01411189|endoscopic hemostasis|endoscopic hemostasis
359814|NCT01411176|upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
359815|NCT01411176|suspected gastric cancer|suspected gastric cancer
359816|NCT01411163|Premanifest|premanifest
359817|NCT01411163|At-Risk|at-risk
359818|NCT01411163|Huntington's Disease|huntington's disease
359819|NCT01411163|HD|hd
359820|NCT01411150|Premanifest|premanifest
359821|NCT01411150|At-Risk|at-risk
359822|NCT01411150|Huntington's Disease|huntington's disease
359823|NCT01411150|HD|hd
359824|NCT01411124|gabapentin|gabapentin
359825|NCT01411124|restless leg syndrome|restless leg syndrome
359826|NCT01411111|Drug-drug interaction|drug-drug interaction
359827|NCT01411111|rosuvastatin|rosuvastatin
359828|NCT01411111|asthma|asthma
359829|NCT01411111|FLAP inhibitor|flap inhibitor
359830|NCT01411085|Schizophrenia|schizophrenia
359831|NCT01411085|Alcoholism|alcoholism
359832|NCT01411085|Dual Diagnosis|dual diagnosis
359833|NCT01411085|Desipramine|desipramine
359834|NCT01411085|Risperidone|risperidone
359835|NCT01411072|Biomarker directed adjuvant chemotherapy|biomarker directed adjuvant chemotherapy
359836|NCT01411072|resected pancreas cancer|resected pancreas cancer
359837|NCT01411059|yoga biomechanics seniors|yoga biomechanics seniors
359838|NCT01411046|Glucocorticoid|glucocorticoid
359839|NCT01411046|polymorphism|polymorphism
359840|NCT01411046|Glucocorticoid receptor gene|glucocorticoid receptor gene
359841|NCT01411046|rheumatoid arthritis|rheumatoid arthritis
359842|NCT01411046|adrenal insufficiency|adrenal insufficiency
359843|NCT01411046|prednisolone treatment|prednisolone treatment
359844|NCT01411007|Nicotine|nicotine
359845|NCT01411007|Cigarettes|cigarettes
359846|NCT01411007|Smoker|smoker
359847|NCT01411007|realtime fMRI|realtime fmri
359848|NCT01411007|brain imaging|brain imaging
359849|NCT01411007|imaging|imaging
359850|NCT01410994|glomerular filtration rate|glomerular filtration rate
359851|NCT01410955|probiotics|probiotics
359852|NCT01410955|diarrhoea|diarrhoea
359853|NCT01410955|prevention|prevention
359854|NCT01410955|colon cancer|colon cancer
359855|NCT01410955|irinotecan|irinotecan
359856|NCT01410942|Prostate Cancer|prostate cancer
359857|NCT01410942|Multimodal Therapy|multimodal therapy
359858|NCT01410942|MMT|mmt
359859|NCT01410942|Fatigue|fatigue
359860|NCT01410942|Cognitive Behavioral Therapy|cognitive behavioral therapy
359861|NCT01410942|CBT|cbt
359862|NCT01410942|Radiation therapy|radiation therapy
359863|NCT01410942|Radiotherapy|radiotherapy
359864|NCT01410942|RT|rt
359865|NCT01410942|Functional Assessment of Chronic Illness Therapy - Fatigue|functional assessment of chronic illness therapy - fatigue
359866|NCT01410942|FACIT-F|facit-f
359867|NCT01410942|Androgen deprivation therapy|androgen deprivation therapy
359868|NCT01410942|Methylphenidate|methylphenidate
359869|NCT01410942|Methylphenidate Hydrochloride|methylphenidate hydrochloride
359870|NCT01410942|Ritalin|ritalin
359871|NCT01410942|Concerta|concerta
359872|NCT01410942|Placebo|placebo
359873|NCT01410942|Sugar Pill|sugar pill
359874|NCT01410929|multiple myeloma|multiple myeloma
359875|NCT01410929|VCF|vcf
359876|NCT01410929|Vertebral Compression Fracture|vertebral compression fracture
359877|NCT01410929|Spine|spine
359878|NCT01410929|Kyphoplasty|kyphoplasty
359879|NCT01410929|Back pain|back pain
359880|NCT01410929|Cancer|cancer
359882|NCT01410916|Shiga-like toxin-producing Escherichia Coli Hemolytic-Uremic Syndrome|shiga-like toxin-producing escherichia coli hemolytic-uremic syndrome
359883|NCT01410916|uncontrolled complement activation|uncontrolled complement activation
359884|NCT01410864|cerebrospinal fluid leaks|cerebrospinal fluid leaks
359885|NCT01410864|dural opening|dural opening
359886|NCT01410864|dural sealing|dural sealing
359887|NCT01410838|Obesity|obesity
359888|NCT01410838|Food preferences|food preferences
359889|NCT01410838|Eating Behavior|eating behavior
359890|NCT01410825|WAS|was
359891|NCT01410825|Wiskott|wiskott
359892|NCT01410825|Gene Transfer|gene transfer
359893|NCT01410825|Gene Therapy|gene therapy
359894|NCT01410812|Interest in exercising more|interest in exercising more
359895|NCT01410799|Growth Hormone Releasing Hormone|growth hormone releasing hormone
359896|NCT01410799|Growth Hormone Insufficiency|growth hormone insufficiency
359897|NCT01410799|Aging|aging
359898|NCT01410799|Growth Hormone|growth hormone
359899|NCT01410799|Physiologic Effects of Drugs|physiologic effects of drugs
359900|NCT01410799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
359901|NCT01410799|Hormones|hormones
359902|NCT01410760|Imaging study|imaging study
359903|NCT01410760|Perfusion Computerised Tomography|perfusion computerised tomography
359904|NCT01410747|long-term treatment|long-term treatment
359905|NCT01410747|tacrolimus|tacrolimus
359906|NCT01410747|renal failure|renal failure
359907|NCT01410734|cholecystectomy|cholecystectomy
359908|NCT01410734|chronic right upper quadrant pain|chronic right upper quadrant pain
359909|NCT01410721|TBI|tbi
359910|NCT01410721|PTSD|ptsd
359911|NCT01410721|Veterans|veterans
359912|NCT01410708|Human Breast Cancer Tissue|human breast cancer tissue
359913|NCT01410708|Dasatinin|dasatinin
359914|NCT01410695|Rheumatoid Arthritis|rheumatoid arthritis
359915|NCT01410695|RA|ra
359916|NCT01410695|masitinib|masitinib
359917|NCT01410695|DMARD|dmard
359918|NCT01410695|methotrexate|methotrexate
359919|NCT01410682|oral hygiene|oral hygiene
359920|NCT01410682|ventilator-associated pneumonia|ventilator-associated pneumonia
359921|NCT01410682|infection control|infection control
359922|NCT01410682|intensive care|intensive care
359923|NCT01410682|pediatric nursing|pediatric nursing
359924|NCT01410682|pediatrics|pediatrics
359925|NCT01410669|Self-efficacy|self-efficacy
359926|NCT01410669|Intimate partner violence|intimate partner violence
359927|NCT01410669|Randomized clinical trial|randomized clinical trial
359928|NCT01410669|Depression|depression
359929|NCT01410656|Survivors|survivors
359930|NCT01410643|puberty|puberty
359931|NCT01410643|body composition|body composition
359932|NCT01410643|metabolism|metabolism
359933|NCT01410643|obesity|obesity
359934|NCT01410643|optimization of body composition|optimization of body composition
359935|NCT01410643|pubertal transition|pubertal transition
359936|NCT01410604|Metformin|metformin
359937|NCT01410604|Obesity|obesity
359938|NCT01410604|Insulin resistance|insulin resistance
359939|NCT01410604|Interleukin six|interleukin six
359940|NCT01410604|Adiponectin|adiponectin
359941|NCT01410604|High sensitivity C reactive protein.|high sensitivity c reactive protein.
359942|NCT01410604|Tumour Necrosis Factor alpha|tumour necrosis factor alpha
359943|NCT01410591|transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
359944|NCT01410591|TIPS|tips
359945|NCT01410591|liver cirrhosis|liver cirrhosis
359946|NCT01410591|variceal bleeding|variceal bleeding
359947|NCT01410591|8- or 10-mm covered stent|8- or 10-mm covered stent
359948|NCT01410578|sTRE-1|stre-1
359949|NCT01410578|PCT|pct
359950|NCT01410578|CRP|crp
359951|NCT01410578|sepsis|sepsis
359952|NCT01410578|bacteremia|bacteremia
359953|NCT01410578|FUO|fuo
359954|NCT01410578|diagnosis|diagnosis
359955|NCT01410578|prognosis|prognosis
359956|NCT01410565|Bladder Cancer|bladder cancer
359957|NCT01410565|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
359958|NCT01410565|NMIBC|nmibc
359959|NCT01410565|Apaziquone|apaziquone
359960|NCT01410565|EOquin|eoquin
359961|NCT01410565|GU Cancer|gu cancer
359962|NCT01410565|TURBT|turbt
359963|NCT01410552|Primary prevention|primary prevention
359964|NCT01410552|Secondary prevention|secondary prevention
359965|NCT01410539|Stent Thrombosis|stent thrombosis
359966|NCT01410539|Percutaneous Coronary Intervention|percutaneous coronary intervention
359967|NCT01410539|Bare Metal Stent|bare metal stent
359968|NCT01410539|Drug Eluting Stent|drug eluting stent
359969|NCT01410539|Residual Platelet Reactivity|residual platelet reactivity
359970|NCT01410539|Optical Coherence Tomography|optical coherence tomography
359971|NCT01410539|OCT|oct
359972|NCT01410526|VAC|vac
359973|NCT01410526|Severe abdominal sepsis|severe abdominal sepsis
359974|NCT01410526|Peritoneal immune reaction|peritoneal immune reaction
359975|NCT01410526|Peritonitis|peritonitis
359976|NCT01410526|Immune peritoneal reaction when abdominal sepsis is treated with VAC|immune peritoneal reaction when abdominal sepsis is treated with vac
359977|NCT01410500|multiple myeloma|multiple myeloma
359978|NCT01410487|pulmonary circulation|pulmonary circulation
359979|NCT01410474|Meningococcal|meningococcal
359983|NCT01410474|healthy|healthy
359984|NCT01410474|children|children
359985|NCT01410474|adolescents|adolescents
359986|NCT01410474|Taiwan|taiwan
359987|NCT01410461|painful bladder|painful bladder
359988|NCT01410461|physical therapy|physical therapy
359989|NCT01410461|levator ani|levator ani
359990|NCT01410448|Immunosuppression|immunosuppression
359991|NCT01410448|Kidney transplantation|kidney transplantation
359992|NCT01410448|everolimus|everolimus
359993|NCT01410448|safety|safety
359994|NCT01410422|COPD|copd
359995|NCT01410422|Bronchiectasis|bronchiectasis
359996|NCT01410422|Metabolomics|metabolomics
359997|NCT01410409|Osteoarthritis, Knee|osteoarthritis, knee
359998|NCT01410409|Treatment Outcome|treatment outcome
359999|NCT01410409|Time Factors|time factors
360000|NCT01410409|Arthroplasty, Replacement|arthroplasty, replacement
360001|NCT01410409|Rehabilitation|rehabilitation
360002|NCT01410409|Combined Modality Therapy|combined modality therapy
360003|NCT01410409|Middle Aged|middle aged
360004|NCT01410409|Aged|aged
360005|NCT01410409|Aged, 80 and over|aged, 80 and over
360006|NCT01410409|Male|male
360007|NCT01410409|Female|female
360008|NCT01410409|Humans|humans
360009|NCT01410409|Analysis of Variance|analysis of variance
360010|NCT01410396|Atrial Fibrillation|atrial fibrillation
360011|NCT01410396|Stroke|stroke
360012|NCT01410383|hypercholesterolemia,|hypercholesterolemia,
360013|NCT01410383|dyslipidemia,|dyslipidemia,
360014|NCT01410383|thyroid,|thyroid,
360015|NCT01410383|safety,|safety,
360016|NCT01410383|Heterozygous Familial Hypercholesterolaemia|heterozygous familial hypercholesterolaemia
360017|NCT01410383|coronary artery disease|coronary artery disease
360018|NCT01410370|Endostar|endostar
360019|NCT01410370|Radiotherapy|radiotherapy
360020|NCT01410370|Brain Metastases|brain metastases
360021|NCT01410357|serious mental illness|serious mental illness
360022|NCT01410357|diabetes|diabetes
360029|NCT01410331|peripheral vascular disease|peripheral vascular disease
360030|NCT01410331|PVD|pvd
360031|NCT01410331|PAD|pad
360032|NCT01410331|SDF-1|sdf-1
360033|NCT01410318|Atherosclerosis|atherosclerosis
360034|NCT01410318|PESA|pesa
360035|NCT01410318|Subclinical|subclinical
360036|NCT01410318|Cardiovascular diseases|cardiovascular diseases
360037|NCT01410318|Coronary disease|coronary disease
360038|NCT01410318|Heart diseases|heart diseases
360039|NCT01410318|Heart Failure|heart failure
360040|NCT01410318|Myocardial Infarction|myocardial infarction
360041|NCT01410318|Stroke|stroke
360042|NCT01410318|Arteriosclerosis|arteriosclerosis
360043|NCT01410305|Vitamin D Deficiency|vitamin d deficiency
360044|NCT01410305|HIV+ Children|hiv+ children
360045|NCT01410305|HIV+ Young Adults|hiv+ young adults
360046|NCT01410292|fiber|fiber
360047|NCT01410292|glycemic index|glycemic index
360048|NCT01410292|glycemic response|glycemic response
360049|NCT01410292|diabetes|diabetes
360050|NCT01410292|ghrelin|ghrelin
360051|NCT01410279|pulmonary hypertension|pulmonary hypertension
360052|NCT01410279|inspiratory muscle training|inspiratory muscle training
360053|NCT01410279|inspiratory muscle weakness|inspiratory muscle weakness
360054|NCT01410279|pulmonary functional|pulmonary functional
360055|NCT01410279|functional capacity|functional capacity
360056|NCT01410279|quality of life|quality of life
360057|NCT01410266|medical abortion|medical abortion
360058|NCT01410266|first trimester|first trimester
360059|NCT01410266|follow-up|follow-up
360060|NCT01410266|pregnancy test|pregnancy test
360061|NCT01410214|NSCLC|nsclc
360062|NCT01410214|EGFR Mutation Positive|egfr mutation positive
360063|NCT01410214|complete resection|complete resection
360161|NCT01409798|Hypercalcemia|hypercalcemia
360064|NCT01410214|Erlotinib Versus NVB/Cisplatin as Adjuvant treatment|erlotinib versus nvb/cisplatin as adjuvant treatment
360065|NCT01410201|Epiretinal Membrane|epiretinal membrane
360066|NCT01410201|Macular Edema|macular edema
360067|NCT01410201|Dexamethasone Intravitreal Implant (Ozurdex)|dexamethasone intravitreal implant (ozurdex)
360068|NCT01410201|Pars Plana Vitrectomy|pars plana vitrectomy
360069|NCT01410188|open-angle glaucoma|open-angle glaucoma
360070|NCT01410188|glaucoma|glaucoma
360071|NCT01410188|ocular hypertension|ocular hypertension
360072|NCT01410188|intraocular pressure|intraocular pressure
360073|NCT01410162|Renal|renal
360074|NCT01410162|Kidney/Pancreas|kidney/pancreas
360075|NCT01410162|Transplant|transplant
360076|NCT01410162|conversion|conversion
360077|NCT01410162|bioequivalence|bioequivalence
360078|NCT01410162|Mycophenolate Acid|mycophenolate acid
360079|NCT01410149|PAV (proportional assist ventilation); sleep; polysomnography; mechanical ventilation|pav (proportional assist ventilation); sleep; polysomnography; mechanical ventilation
360080|NCT01410136|Knee|knee
360081|NCT01410136|Femur|femur
360082|NCT01410136|Articular cartilage|articular cartilage
360083|NCT01410136|Lesions|lesions
360084|NCT01410136|Defects|defects
360085|NCT01410136|Osteochondral graft|osteochondral graft
360086|NCT01410136|Cartilage treatments|cartilage treatments
360087|NCT01410136|Osteochondritis Dissecans|osteochondritis dissecans
360089|NCT01410110|Substance Abuse|substance abuse
360090|NCT01410110|Substance Dependence|substance dependence
360091|NCT01410110|Cognitive Impairment|cognitive impairment
360092|NCT01410084|vitamin D|vitamin d
360093|NCT01410084|falls|falls
360094|NCT01410084|deficiency|deficiency
360095|NCT01410084|insufficiency|insufficiency
360096|NCT01410071|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
360097|NCT01410058|HIV|hiv
360098|NCT01410058|antiretroviral drug interaction|antiretroviral drug interaction
360099|NCT01410058|herbal medicine|herbal medicine
360100|NCT01410058|pharmacokinetics|pharmacokinetics
360101|NCT01410058|herbal pharmacology|herbal pharmacology
360102|NCT01410045|Turner syndrome|turner syndrome
360103|NCT01410045|infertility|infertility
360104|NCT01410045|ovarian insufficiency|ovarian insufficiency
360105|NCT01410045|ovarian cryopreservation|ovarian cryopreservation
360106|NCT01410032|clavicle|clavicle
360107|NCT01410032|clavicular|clavicular
360108|NCT01410032|fracture|fracture
360109|NCT01410032|midshaft|midshaft
360110|NCT01410032|plate|plate
360111|NCT01410032|ESIN|esin
360112|NCT01410032|intramedullary|intramedullary
360113|NCT01410032|flexible|flexible
360114|NCT01410032|nailing|nailing
751936|NCT01171287|Fracture Fixation/instrumentation|fracture fixation/instrumentation
360115|NCT01410019|X-linked Severe Combined Immunodeficiency (SCID-X1)|x-linked severe combined immunodeficiency (scid-x1)
360116|NCT01410019|severe infection|severe infection
360117|NCT01410019|gene therapy|gene therapy
360118|NCT01410019|HLA identical family donor|hla identical family donor
360119|NCT01410019|without HLA identical unrelated donor|without hla identical unrelated donor
360121|NCT01410006|neurofibromatosis|neurofibromatosis
360122|NCT01410006|NF|nf
360123|NCT01409993|BMI greater than 25|bmi greater than 25
360124|NCT01409993|Elevated fasting blood sugar (100-125mg/dL)|elevated fasting blood sugar (100-125mg/dl)
360125|NCT01409980|delta phalanx|delta phalanx
360126|NCT01409980|thumb reconstructed|thumb reconstructed
360127|NCT01409980|triphalangeal thumbs|triphalangeal thumbs
360128|NCT01409967|Anemia|anemia
360129|NCT01409967|Transfusion|transfusion
360130|NCT01409967|Biological markers|biological markers
360131|NCT01409954|Fusion|fusion
360132|NCT01409954|Spine|spine
360133|NCT01409954|Decompression|decompression
360134|NCT01409954|Pseudarthrosis|pseudarthrosis
360135|NCT01409954|bone harvest|bone harvest
360136|NCT01409954|Instrumented posterolateral fusion|instrumented posterolateral fusion
360137|NCT01409941|cerebral oxygen saturation,|cerebral oxygen saturation,
360138|NCT01409941|NTproBNP|ntprobnp
360139|NCT01409941|hsTNT|hstnt
360140|NCT01409941|GDF-15|gdf-15
360141|NCT01409928|obesity|obesity
360142|NCT01409928|adolescent|adolescent
360143|NCT01409928|pediatric|pediatric
360144|NCT01409928|weight loss|weight loss
360145|NCT01409928|bariatric surgery|bariatric surgery
360146|NCT01409928|gastric banding|gastric banding
360147|NCT01409915|Alzheimer's disease|alzheimer's disease
360148|NCT01409915|neuropsychological assessment|neuropsychological assessment
360149|NCT01409915|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
360150|NCT01409915|Leukine|leukine
360151|NCT01409876|histoscanning|histoscanning
360152|NCT01409876|brachytherapy|brachytherapy
360153|NCT01409863|post surgical or post traumatic scar on face or scalp|post surgical or post traumatic scar on face or scalp
360154|NCT01409837|Oligospermia|oligospermia
360155|NCT01409837|Male infertility|male infertility
360156|NCT01409837|Lisinopril|lisinopril
360157|NCT01409824|clinical decision support system|clinical decision support system
360158|NCT01409824|performance based incentives|performance based incentives
360159|NCT01409824|quality of maternal health care services|quality of maternal health care services
360160|NCT01409798|Hyperparathyroidism|hyperparathyroidism
360162|NCT01409785|supraglottic airway devices in children|supraglottic airway devices in children
360163|NCT01409759|Perforators|perforators
360164|NCT01409759|Interposition plasty|interposition plasty
360165|NCT01409759|Contracture release|contracture release
360166|NCT01409746|twin|twin
360167|NCT01409746|brain development|brain development
360168|NCT01409746|MRI|mri
360169|NCT01409720|bony metastases|bony metastases
360170|NCT01409720|physical exercise|physical exercise
360171|NCT01409694|Alzheimer Disease|alzheimer disease
360172|NCT01409694|Vitamin D|vitamin d
360173|NCT01409694|Cholecalciferol|cholecalciferol
360174|NCT01409694|Memantine|memantine
360175|NCT01409694|Cognition Disorders|cognition disorders
360176|NCT01409655|AIDS, HIV, Adherence, Compliance, Contingency management|aids, hiv, adherence, compliance, contingency management
360177|NCT01409616|Pharmacodynamics|pharmacodynamics
360178|NCT01409616|darexaban|darexaban
360179|NCT01409616|Acetyl Salicylic Acid|acetyl salicylic acid
360180|NCT01409616|clopidogrel|clopidogrel
360181|NCT01409616|YM150|ym150
360182|NCT01409616|Phase 1|phase 1
360183|NCT01409603|Pharmacodynamics|pharmacodynamics
360184|NCT01409603|darexaban|darexaban
360185|NCT01409603|naproxen|naproxen
360186|NCT01409603|YM150|ym150
360187|NCT01409603|Phase 1|phase 1
442911|NCT00005937|MDS|mds
360188|NCT01409590|Schizophrenia|schizophrenia
360189|NCT01409590|weight gain|weight gain
360190|NCT01409590|atypical neuroleptics|atypical neuroleptics
360191|NCT01409577|Coronary stenosis|coronary stenosis
360192|NCT01409577|stent|stent
360193|NCT01409577|fractional flow reserve|fractional flow reserve
360194|NCT01409564|Alzheimer's dementia|alzheimer's dementia
360195|NCT01409564|Cilostazol|cilostazol
360196|NCT01409551|Pleural effusion|pleural effusion
360197|NCT01409551|VATS|vats
360198|NCT01409551|hyperthermia|hyperthermia
360199|NCT01409551|thoracostomy|thoracostomy
360200|NCT01409551|pleurodesis|pleurodesis
360201|NCT01409512|Heart rate variability, anti cholinergic medication|heart rate variability, anti cholinergic medication
360202|NCT01409499|hepatocellular carcinoma, treatments, survival|hepatocellular carcinoma, treatments, survival
360203|NCT01409486|Pompe disease|pompe disease
360204|NCT01409486|Alpha glucosidase|alpha glucosidase
360205|NCT01409486|Newborn screening|newborn screening
360206|NCT01409486|Tandem Mass Spectrometry (LC-MS-MS)|tandem mass spectrometry (lc-ms-ms)
360207|NCT01409486|The study aims:|the study aims:
360208|NCT01409486|To establish the control mean values of alpha glucosidase activity in Dry blood spots of Newborn babies from Israel.|to establish the control mean values of alpha glucosidase activity in dry blood spots of newborn babies from israel.
360209|NCT01409486|To include the alpha glucosidase assay in the newborn screening program in Israel|to include the alpha glucosidase assay in the newborn screening program in israel
360210|NCT01409473|Prostate cancer|prostate cancer
360211|NCT01409473|Stereotactic body radiotherapy|stereotactic body radiotherapy
360212|NCT01409473|Radiosurgery|radiosurgery
360213|NCT01409473|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
360214|NCT01409473|SBRT|sbrt
360215|NCT01409473|IMRT|imrt
360216|NCT01409473|Early-stage prostate cancer|early-stage prostate cancer
360217|NCT01409473|Low-risk prostate cancer|low-risk prostate cancer
360218|NCT01409473|Intermediate-risk prostate cancer|intermediate-risk prostate cancer
360219|NCT01409473|Intraprostatic lesions|intraprostatic lesions
360220|NCT01409473|IPL|ipl
360221|NCT01409421|adherence|adherence
360222|NCT01409421|glaucoma|glaucoma
360223|NCT01409421|motivational interviewing|motivational interviewing
360224|NCT01409408|Hypertension|hypertension
360225|NCT01409408|Diabetes Mellitus|diabetes mellitus
360226|NCT01409408|Vascular stiffness|vascular stiffness
360227|NCT01409408|Endothelial function|endothelial function
360228|NCT01409395|Drug drug interaction|drug drug interaction
360229|NCT01409382|neonatal hypoglycemia|neonatal hypoglycemia
360230|NCT01409382|pregnancy|pregnancy
360231|NCT01409382|physical activity|physical activity
360232|NCT01409382|sedentary lifestyle|sedentary lifestyle
360233|NCT01409382|high-glycemic index diet|high-glycemic index diet
360234|NCT01409382|take-home baby|take-home baby
360235|NCT01409382|recurrent miscarriages|recurrent miscarriages
360236|NCT01409382|preterm delivery|preterm delivery
360237|NCT01409356|Obesity|obesity
360238|NCT01409356|Portal hypertension|portal hypertension
360239|NCT01409356|Cirrhosis|cirrhosis
360240|NCT01409356|Diet|diet
360241|NCT01409356|Exercise|exercise
360242|NCT01409343|advanced solid cancers|advanced solid cancers
360243|NCT01409343|metastatic solid cancers|metastatic solid cancers
360244|NCT01409330|insulin sensitivity|insulin sensitivity
360245|NCT01409330|type 2 diabetes|type 2 diabetes
360246|NCT01409330|diet intervention|diet intervention
360247|NCT01409317|Major Depression|major depression
360248|NCT01409317|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
360249|NCT01409317|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
360250|NCT01409317|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
360251|NCT01409317|rTMS|rtms
360252|NCT01409317|DTMS|dtms
360253|NCT01409317|fMRI|fmri
360254|NCT01409317|Randomized, Sham-Controlled Trial|randomized, sham-controlled trial
360255|NCT01409304|Major depression|major depression
360256|NCT01409304|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
360257|NCT01409304|Naturalistic Trial|naturalistic trial
360258|NCT01409304|DTMS|dtms
360259|NCT01409291|low socioeconomic status|low socioeconomic status
360260|NCT01409291|stress|stress
360261|NCT01409291|women|women
360262|NCT01409291|children|children
360263|NCT01409291|cortisol|cortisol
360264|NCT01409265|stroke rehabilitation|stroke rehabilitation
360265|NCT01409265|perceptual deficits|perceptual deficits
360266|NCT01409252|Stroke|stroke
360267|NCT01409252|intracerebral hemorrhage|intracerebral hemorrhage
360268|NCT01409252|surgery|surgery
360269|NCT01409239|hospital|hospital
360270|NCT01409239|diabetes|diabetes
360271|NCT01409239|glycemic variability|glycemic variability
360272|NCT01409239|autonomic tone|autonomic tone
360273|NCT01409226|high-risk of breast cancer|high-risk of breast cancer
360274|NCT01409226|BRCA1 mutation carrier|brca1 mutation carrier
360275|NCT01409226|BRCA2 mutation carrier|brca2 mutation carrier
360276|NCT01409226|diagnostic|diagnostic
360277|NCT01409226|MRI|mri
360278|NCT01409226|BI-RADS 4|bi-rads 4
360279|NCT01409226|mammographically occult|mammographically occult
360280|NCT01409200|Prostate cancer|prostate cancer
360281|NCT01409200|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
360282|NCT01409200|Ductal adenocarcinoma|ductal adenocarcinoma
360283|NCT01409200|Androgen deprivation therapy|androgen deprivation therapy
360285|NCT01409200|Hormonal therapy|hormonal therapy
360286|NCT01409200|Suspected lymph node metastasis|suspected lymph node metastasis
360287|NCT01409200|TxN1M0 or TxNxM1a|txn1m0 or txnxm1a
360288|NCT01409200|Progression-free|progression-free
360289|NCT01409200|Pathologic complete response|pathologic complete response
360290|NCT01409200|pCR|pcr
360291|NCT01409200|Systemic therapy|systemic therapy
360292|NCT01409200|Radical prostatectomy|radical prostatectomy
360293|NCT01409200|Pelvic lymph node dissection|pelvic lymph node dissection
360294|NCT01409200|Axitinib|axitinib
360295|NCT01409200|AG-013736|ag-013736
360296|NCT01409187|Melanoma|melanoma
360297|NCT01409187|Metastatic Melanoma|metastatic melanoma
360298|NCT01409187|Cytotoxic Drugs|cytotoxic drugs
360299|NCT01409187|IPI-Biotherapy|ipi-biotherapy
360300|NCT01409187|Ipilimumab|ipilimumab
360301|NCT01409187|Yervoy|yervoy
360302|NCT01409187|BMS-734016|bms-734016
360303|NCT01409187|MDX010|mdx010
360304|NCT01409187|Interferon|interferon
360305|NCT01409187|IFN Alpha-2b|ifn alpha-2b
360306|NCT01409187|Intron A|intron a
360311|NCT01409187|Proleukin|proleukin
360312|NCT01409174|Melanoma|melanoma
360313|NCT01409174|Metastatic|metastatic
360314|NCT01409174|IPI-Biochemotherapy|ipi-biochemotherapy
360315|NCT01409174|Chemonaive|chemonaive
360316|NCT01409174|Advanced stage IV|advanced stage iv
360317|NCT01409174|Unresectable stage III melanoma|unresectable stage iii melanoma
360318|NCT01409174|1.0 cm or larger|1.0 cm or larger
360319|NCT01409174|Ipilimumab|ipilimumab
360320|NCT01409174|Yervoy|yervoy
360321|NCT01409174|BMS-734016|bms-734016
360322|NCT01409174|MDX010|mdx010
360323|NCT01409174|Interferon Alpha-2b|interferon alpha-2b
360324|NCT01409174|Intron A|intron a
360325|NCT01409174|Temozolomide|temozolomide
360326|NCT01409174|Temodar|temodar
360327|NCT01409174|Cisplatin|cisplatin
360328|NCT01409174|Platinol-AQ|platinol-aq
360329|NCT01409174|Platinol|platinol
360330|NCT01409174|CDDP|cddp
360331|NCT01409174|Interleukin-2|interleukin-2
360332|NCT01409174|IL-2|il-2
360333|NCT01409174|Aldesleukin|aldesleukin
360334|NCT01409174|Proleukin|proleukin
360335|NCT01409161|Leukemia|leukemia
360336|NCT01409161|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
360337|NCT01409161|APL|apl
360338|NCT01409161|ATRA|atra
360339|NCT01409161|Tretinoin|tretinoin
360340|NCT01409161|All-trans retinoic acid|all-trans retinoic acid
360341|NCT01409161|Vesanoid|vesanoid
360342|NCT01409161|ATO|ato
360343|NCT01409161|Arsenic trioxide|arsenic trioxide
360344|NCT01409161|Trisenox|trisenox
360345|NCT01409161|GO|go
360346|NCT01409161|Gemtuzumab|gemtuzumab
360347|NCT01409161|Mylotarg|mylotarg
360348|NCT01409161|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
360349|NCT01409161|Methylprednisolone|methylprednisolone
360350|NCT01409161|Depo-Medrol|depo-medrol
360351|NCT01409161|Medrol|medrol
360352|NCT01409161|Solu-Medrol|solu-medrol
360353|NCT01409148|Radioimmunoimaging|radioimmunoimaging
360354|NCT01409148|AL Amyloidosis|al amyloidosis
360355|NCT01409148|PET/CT|pet/ct
360356|NCT01409135|Nectin 4 protein, humans|nectin 4 protein, humans
360357|NCT01409135|Cancer|cancer
360358|NCT01409135|Pharmacokinetics of AGS-22M6E|pharmacokinetics of ags-22m6e
360359|NCT01409135|Pharmacokinetics of ASG-22CE|pharmacokinetics of asg-22ce
360360|NCT01409135|Safety|safety
360361|NCT01409135|Clinical Trial, Phase 1|clinical trial, phase 1
360362|NCT01409135|ASG-22ME|asg-22me
360363|NCT01409135|AGS-22M6E|ags-22m6e
360364|NCT01409135|ASG-22CE|asg-22ce
360365|NCT01409135|ASG-22C3|asg-22c3
360366|NCT01409122|vasodilator|vasodilator
360367|NCT01409122|nitric oxide|nitric oxide
360368|NCT01409122|sodium nitrite|sodium nitrite
360369|NCT01409122|sildenafil|sildenafil
360370|NCT01409122|PDE-5|pde-5
360371|NCT01409122|pulmonary hypertension|pulmonary hypertension
360372|NCT01409122|pulmonary arterial hypertension|pulmonary arterial hypertension
360373|NCT01409109|Schizophrenia|schizophrenia
360374|NCT01409109|Schizoaffective|schizoaffective
360375|NCT01409109|Neuroimaging|neuroimaging
360376|NCT01409109|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
360377|NCT01409109|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
360378|NCT01409109|Spectroscopy|spectroscopy
360379|NCT01409083|infiltration|infiltration
360380|NCT01409083|extravasation|extravasation
360381|NCT01409083|end-tidal carbon dioxide|end-tidal carbon dioxide
360382|NCT01409083|sodium bicarbonate|sodium bicarbonate
360383|NCT01409070|MDS|mds
360384|NCT01409057|Inflammation parameters|inflammation parameters
360385|NCT01409057|Various blood values|various blood values
360386|NCT01409057|Clinical Outcome|clinical outcome
360387|NCT01409057|Residence in ICU/ Hospital|residence in icu/ hospital
360388|NCT01409057|SAPS-Score|saps-score
351077|NCT01445678|cIAI|ciai
360389|NCT01409057|SOFA-Score|sofa-score
360390|NCT01409057|Duration of artificial respiration|duration of artificial respiration
360391|NCT01409044|Patient-Controlled Analgesia (PCA)|patient-controlled analgesia (pca)
360392|NCT01409044|Music Listening|music listening
360393|NCT01409044|Opioids|opioids
360394|NCT01409044|Post Surgical Intensive Care Patient|post surgical intensive care patient
360395|NCT01409044|Patient-Controlled Analgesia|patient-controlled analgesia
360396|NCT01409031|newborns|newborns
360397|NCT01409031|respiratory failure|respiratory failure
360398|NCT01409031|pulmonary hypertension|pulmonary hypertension
360399|NCT01409031|treatment|treatment
360400|NCT01409018|pediatric|pediatric
360401|NCT01409018|cancer|cancer
360402|NCT01409018|invasive fungal disease|invasive fungal disease
360403|NCT01409018|antifungal agent|antifungal agent
360404|NCT01408992|Hearing screening|hearing screening
360405|NCT01408992|Questionnaire|questionnaire
360406|NCT01408992|Hearing disability|hearing disability
360407|NCT01408979|Severe preeclampsia|severe preeclampsia
360408|NCT01408979|magnesium sulfate|magnesium sulfate
360409|NCT01408979|anticonvulsivant|anticonvulsivant
360410|NCT01408966|Dark chocolate|dark chocolate
360411|NCT01408966|Catechins|catechins
360412|NCT01408966|Intrahepatic endothelial dysfunction|intrahepatic endothelial dysfunction
360413|NCT01408966|Cirrhosis|cirrhosis
360414|NCT01408966|Portal Hypertension|portal hypertension
360415|NCT01408953|Keloid|keloid
360416|NCT01408927|Thienopyridine resistance|thienopyridine resistance
360417|NCT01408927|Aspirin resistance|aspirin resistance
360418|NCT01408927|Platelet reactivity|platelet reactivity
360419|NCT01408901|peripheral arterial disease|peripheral arterial disease
360420|NCT01408901|granulocyte macrophage colony stimulating factor|granulocyte macrophage colony stimulating factor
360421|NCT01408901|PAD|pad
360422|NCT01408901|GM-CSF|gm-csf
360423|NCT01408901|sargramostim|sargramostim
360424|NCT01408901|leukine|leukine
360425|NCT01408901|treadmill exercise|treadmill exercise
360426|NCT01408875|Chronic Heart Failure|chronic heart failure
360427|NCT01408875|Cardiac rehabilitation|cardiac rehabilitation
360428|NCT01408875|Exercise training|exercise training
360429|NCT01408875|Peak VO2|peak vo2
360430|NCT01408875|Electrical myostimulation|electrical myostimulation
360431|NCT01408862|GLP1|glp1
360432|NCT01408862|GIP|gip
360433|NCT01408862|platelets|platelets
360434|NCT01408862|human|human
360435|NCT01408862|aggregation|aggregation
360436|NCT01408849|Endoscopy|endoscopy
360437|NCT01408849|Herbal medicine|herbal medicine
360438|NCT01408849|Phytotherapy|phytotherapy
360439|NCT01408836|Vasculitis|vasculitis
360440|NCT01408836|ANCA|anca
360441|NCT01408836|Therapy|therapy
360442|NCT01408836|Plasma exchange|plasma exchange
360443|NCT01408836|Immunosuppression|immunosuppression
360444|NCT01408823|Pediatrics|pediatrics
360445|NCT01408823|Scoliosis|scoliosis
360446|NCT01408823|Pharmacokinetics|pharmacokinetics
360447|NCT01408823|Hemorrhage|hemorrhage
360448|NCT01408823|Orthopedic Surgery|orthopedic surgery
360449|NCT01408810|infliximab|infliximab
360450|NCT01408810|ulcerative colitis|ulcerative colitis
360451|NCT01408810|histologic remission|histologic remission
360452|NCT01408797|clonal deletion|clonal deletion
360453|NCT01408797|kidney transplantation|kidney transplantation
360454|NCT01408784|calories|calories
360455|NCT01408784|counting|counting
360456|NCT01408784|obesity|obesity
360457|NCT01408784|overweight|overweight
360458|NCT01408784|categories|categories
360459|NCT01408784|calorie|calorie
360460|NCT01408784|method|method
360461|NCT01408784|counting calories|counting calories
360462|NCT01408784|lose weight|lose weight
360463|NCT01408784|diet|diet
360464|NCT01408784|energy balance|energy balance
360465|NCT01408784|energy intake|energy intake
360466|NCT01408784|24 hours recall|24 hours recall
360467|NCT01408784|food intake|food intake
360468|NCT01408771|Urodynamics|urodynamics
360469|NCT01408771|Overactive Bladder|overactive bladder
360470|NCT01408745|medical device|medical device
360471|NCT01408745|sternal closure|sternal closure
360472|NCT01408745|sternotomy|sternotomy
360473|NCT01408745|dehiscence|dehiscence
360474|NCT01408745|sternal wound healing|sternal wound healing
360475|NCT01408745|randomized trial|randomized trial
360476|NCT01408745|steel wire|steel wire
360477|NCT01408732|Epistaxis|epistaxis
360478|NCT01408732|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
360479|NCT01408732|HHT|hht
360480|NCT01408732|Sclerotherapy|sclerotherapy
360481|NCT01408732|Epistaxis (nosebleeds) due to Hereditary Hemorrhagic Telangiectasia|epistaxis (nosebleeds) due to hereditary hemorrhagic telangiectasia
360482|NCT01408719|Beta-Glucan|beta-glucan
360483|NCT01408719|Barley|barley
360484|NCT01408719|Molecular Weight|molecular weight
360485|NCT01408719|Viscosity|viscosity
360486|NCT01408719|Cholesterol|cholesterol
360487|NCT01408719|Stable isotope|stable isotope
360488|NCT01408719|Gene-nutrient interaction|gene-nutrient interaction
360489|NCT01408719|Gut microbiota|gut microbiota
360490|NCT01408693|hip fracture|hip fracture
351205|NCT01445223|HIV|hiv
360491|NCT01408693|hemiarthroplasty|hemiarthroplasty
360492|NCT01408693|endoprosthesis|endoprosthesis
360493|NCT01408693|elderly|elderly
360494|NCT01408693|minimally invasive surgery|minimally invasive surgery
360495|NCT01408693|anterior approach|anterior approach
360496|NCT01408693|geriatric patients|geriatric patients
360497|NCT01408680|End-stage Renal Disease|end-stage renal disease
360498|NCT01408680|Hemodialysis|hemodialysis
360499|NCT01408680|Cardiovascular Disease|cardiovascular disease
360500|NCT01408680|Antioxidants|antioxidants
360501|NCT01408680|Atherosclerosis|atherosclerosis
360502|NCT01408680|Coenzyme Q10|coenzyme q10
360503|NCT01408667|insulin sensitivity|insulin sensitivity
360504|NCT01408667|cardiometabolic risk|cardiometabolic risk
360505|NCT01408667|hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
360506|NCT01408654|Suicidal Ideation|suicidal ideation
360507|NCT01408654|Loneliness|loneliness
360508|NCT01408654|Social Support|social support
360509|NCT01408654|Voluntary Workers|voluntary workers
360510|NCT01408654|Friends/Companions|friends/companions
360511|NCT01408654|Prevention|prevention
360512|NCT01408654|Aged|aged
360513|NCT01408641|topiramate|topiramate
360514|NCT01408641|PTSD|ptsd
360515|NCT01408641|drinking|drinking
360516|NCT01408641|alcohol|alcohol
360517|NCT01408602|Rheumatoid Arthritis|rheumatoid arthritis
360518|NCT01408589|alcohol|alcohol
360519|NCT01408589|craving|craving
360520|NCT01408589|mood|mood
360521|NCT01408589|optimum dose of atomoxetine|optimum dose of atomoxetine
360522|NCT01408576|Lupus|lupus
360523|NCT01408576|Monoclonal antibody|monoclonal antibody
360524|NCT01408576|B-Cell immunotherapy|b-cell immunotherapy
360525|NCT01408576|Epratuzumab|epratuzumab
360526|NCT01408563|NHL|nhl
360527|NCT01408563|lymphoma|lymphoma
360528|NCT01408563|leukemia|leukemia
360529|NCT01408563|myelodysplastic disorder|myelodysplastic disorder
360530|NCT01408563|aplastic anemia|aplastic anemia
733302|NCT01099124|M2ES|m2es
360531|NCT01408550|IVIG in pemphigoid|ivig in pemphigoid
360532|NCT01408550|Patients with bullous pemphigoid unresponsive to corticosteroids|patients with bullous pemphigoid unresponsive to corticosteroids
360533|NCT01408537|inactivated Japanese encephalitis vaccine|inactivated japanese encephalitis vaccine
360534|NCT01408537|vero cell|vero cell
360535|NCT01408537|children|children
360536|NCT01408537|immunogenicity|immunogenicity
360537|NCT01408537|safety|safety
360538|NCT01408524|Hypertension|hypertension
360539|NCT01408524|emergence|emergence
360540|NCT01408524|craniotomy|craniotomy
360541|NCT01408524|Hypertension during the emergence after craniotomy|hypertension during the emergence after craniotomy
360542|NCT01408498|Testosterone|testosterone
360543|NCT01408498|Social psychology|social psychology
360544|NCT01408498|Human behavior|human behavior
360545|NCT01408459|Prostate cancer prevention|prostate cancer prevention
360546|NCT01408446|Hypertension|hypertension
360547|NCT01408446|Menthol|menthol
360548|NCT01408446|Metabolism|metabolism
360549|NCT01408433|embryo transfer|embryo transfer
360550|NCT01408433|in-vitro fertilization (IVF)|in-vitro fertilization (ivf)
360551|NCT01408433|pre-implantation diagnosis (PGD)|pre-implantation diagnosis (pgd)
360552|NCT01408433|infertility|infertility
360553|NCT01408433|single embryo transfer|single embryo transfer
360554|NCT01408433|two embryo transfer|two embryo transfer
360555|NCT01408433|double embryo transfer|double embryo transfer
360556|NCT01408420|Renal insufficiency|renal insufficiency
360557|NCT01408420|Acute Kidney Injury|acute kidney injury
360558|NCT01408420|Postoperative|postoperative
360559|NCT01408420|Extracorporeal Circulation|extracorporeal circulation
360560|NCT01408420|Heart surgery|heart surgery
360561|NCT01408407|Patients with anal canal, low rectal or gynecological cancer|patients with anal canal, low rectal or gynecological cancer
360562|NCT01408394|safety|safety
360563|NCT01408394|pharmacokinetics|pharmacokinetics
360564|NCT01408394|controlled release|controlled release
360565|NCT01408394|formulation|formulation
360844|NCT01407393|satiety|satiety
360566|NCT01408381|Critical Limb Ischemia (CLI)|critical limb ischemia (cli)
360567|NCT01408381|Cell Therapy|cell therapy
360568|NCT01408381|Bone marrow mononuclear cells|bone marrow mononuclear cells
360569|NCT01408368|Graves' disease|graves' disease
360570|NCT01408368|total thyroidectomy|total thyroidectomy
360571|NCT01408368|bilateral subtotal thyroidectomy|bilateral subtotal thyroidectomy
360572|NCT01408368|Graves' ophthalmopathy|graves' ophthalmopathy
360573|NCT01408368|morbidity rate|morbidity rate
360574|NCT01408342|Alemtuzumab|alemtuzumab
360575|NCT01408342|Rituximab|rituximab
360576|NCT01408342|Aplastic anemia|aplastic anemia
360577|NCT01408342|cyclosporine|cyclosporine
360578|NCT01408316|Healthy Volunteer|healthy volunteer
360579|NCT01408316|PX-866|px-866
360580|NCT01408316|PI3K Inhibitor|pi3k inhibitor
360581|NCT01408303|dyslipidemia|dyslipidemia
360582|NCT01408303|hyperlipidemia|hyperlipidemia
360583|NCT01408303|cardiovascular risk|cardiovascular risk
360584|NCT01408290|seasonal|seasonal
360585|NCT01408290|prevention|prevention
360586|NCT01408290|influenza|influenza
360587|NCT01408290|infection|infection
351299|NCT01444846|Ebselen|ebselen
360588|NCT01408290|influenza vaccine|influenza vaccine
360589|NCT01408290|vaccine|vaccine
360590|NCT01408290|influenza in humans|influenza in humans
360591|NCT01408277|Diabetic Foot Ulcers|diabetic foot ulcers
360592|NCT01408277|Diabetic Foot Wounds|diabetic foot wounds
360593|NCT01408238|Immunotherapy|immunotherapy
360594|NCT01408238|Skin prick test|skin prick test
360595|NCT01408238|Standardization|standardization
360596|NCT01408238|Secale cereale|secale cereale
360597|NCT01408225|MGUS|mgus
360598|NCT01408225|Multiple Myeloma|multiple myeloma
360599|NCT01408225|Tissue Bank|tissue bank
360600|NCT01408199|Lenalidomide|lenalidomide
360601|NCT01408199|Refractory Cutaneous Lupus|refractory cutaneous lupus
360602|NCT01408186|aspirin|aspirin
360604|NCT01408186|H2RA|h2ra
360605|NCT01408173|caffeine|caffeine
360606|NCT01408173|apnea|apnea
360607|NCT01408173|prematurity|prematurity
360608|NCT01408147|Postpartum weight retention|postpartum weight retention
360609|NCT01408147|Low income women|low income women
360610|NCT01408147|WIC|wic
360611|NCT01408147|Online|online
360612|NCT01408134|Inter-reader variability of myocardial viability imaging|inter-reader variability of myocardial viability imaging
360613|NCT01408121|Platelet reactivity|platelet reactivity
360614|NCT01408121|Genotyping|genotyping
360615|NCT01408108|Hiatal hernia|hiatal hernia
360616|NCT01408108|Gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
360617|NCT01408108|Laparoscopic hiatal repair|laparoscopic hiatal repair
360618|NCT01408108|Laparoscopic anti-reflux surgery|laparoscopic anti-reflux surgery
360619|NCT01408108|Partially absorbable lightweight mesh|partially absorbable lightweight mesh
360620|NCT01408095|diabetes|diabetes
360621|NCT01408095|glimepiride|glimepiride
360622|NCT01408095|diabetes type II|diabetes type ii
360623|NCT01408095|diabetes type 2|diabetes type 2
360624|NCT01408095|Type 2 diabetes|type 2 diabetes
360625|NCT01408095|diabetes mellitus|diabetes mellitus
360626|NCT01408069|headache|headache
360627|NCT01408069|migraine|migraine
360628|NCT01408056|Hemangioma|hemangioma
733303|NCT01099124|NSCLC|nsclc
360629|NCT01408056|Infantile Hemangioma|infantile hemangioma
360630|NCT01408056|Ulcerated Hemangioma|ulcerated hemangioma
360631|NCT01408056|Timolol|timolol
360632|NCT01408056|Beta blocker|beta blocker
360633|NCT01408056|Vascular anomaly|vascular anomaly
360634|NCT01408030|epistaxis|epistaxis
360636|NCT01408030|bevacizumab|bevacizumab
360637|NCT01408030|tranexamic acid|tranexamic acid
360638|NCT01408030|nosebleed|nosebleed
360639|NCT01408030|estrogen|estrogen
360640|NCT01408004|Renal carcinoma|renal carcinoma
360641|NCT01408004|Resistance|resistance
360642|NCT01408004|Reversible|reversible
360643|NCT01408004|Translational|translational
360644|NCT01407991|Enteral tube placement|enteral tube placement
360645|NCT01407978|Influenza|influenza
360646|NCT01407978|Pandemic vaccine|pandemic vaccine
360647|NCT01407978|Seasonal vaccine|seasonal vaccine
360648|NCT01407978|Prevention|prevention
360649|NCT01407978|Influenza vaccine|influenza vaccine
360650|NCT01407978|Influenza in humans|influenza in humans
360651|NCT01407978|Pandemic influenza in humans|pandemic influenza in humans
360652|NCT01407978|Influenza vaccine for children|influenza vaccine for children
360653|NCT01407978|Influenza vaccine for adolescents|influenza vaccine for adolescents
360654|NCT01407978|Seasonal vaccine for children|seasonal vaccine for children
360655|NCT01407978|Seasonal vaccine for adolescents|seasonal vaccine for adolescents
360656|NCT01407965|obesity|obesity
360657|NCT01407965|pharmacokinetic|pharmacokinetic
360658|NCT01407965|ertapenem|ertapenem
360659|NCT01407965|meropenem|meropenem
360660|NCT01407952|treatment trial|treatment trial
360661|NCT01407952|cerebral aneurysm|cerebral aneurysm
360662|NCT01407952|randomized|randomized
360663|NCT01407952|coils|coils
360664|NCT01407952|endovascular|endovascular
360665|NCT01407952|HEAT|heat
360666|NCT01407952|bare platinum|bare platinum
360667|NCT01407952|Hydrogel|hydrogel
360668|NCT01407952|Hydrocoil|hydrocoil
360669|NCT01407939|Bitter Taste|bitter taste
360670|NCT01407939|Bitter Blockers|bitter blockers
360671|NCT01407939|Pediatric Medications|pediatric medications
360672|NCT01407939|Sensory methodology|sensory methodology
360673|NCT01407939|Children|children
360674|NCT01407926|Depression|depression
360675|NCT01407926|Aging|aging
360676|NCT01407926|Clinical Effectiveness|clinical effectiveness
360677|NCT01407926|Home Care|home care
360678|NCT01407926|Nurse-Led|nurse-led
360679|NCT01407900|CD NP|cd np
360680|NCT01407900|dual receptor|dual receptor
360681|NCT01407900|NPR A|npr a
360682|NCT01407900|NPR B|npr b
360683|NCT01407900|Adult, aged over 45|adult, aged over 45
360684|NCT01407887|children|children
360685|NCT01407874|Gout|gout
360686|NCT01407874|Hyperuricemia|hyperuricemia
360687|NCT01407874|Arthritis|arthritis
360688|NCT01407874|Joint Disease|joint disease
360689|NCT01407874|Allopurinol|allopurinol
360690|NCT01407874|Renal Insufficiency|renal insufficiency
360691|NCT01407835|Immunotherapy|immunotherapy
443424|NCT00005108|MRI|mri
360692|NCT01407835|Skin prick test|skin prick test
360693|NCT01407835|Standardization|standardization
360694|NCT01407835|Dactylis glomerata|dactylis glomerata
360695|NCT01407822|Lung cancer|lung cancer
360696|NCT01407822|IIIA-N2|iiia-n2
360697|NCT01407822|Neo-adjuvant treatment|neo-adjuvant treatment
360698|NCT01407822|EGFR mutations|egfr mutations
360699|NCT01407822|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
360700|NCT01407796|lung inflammation|lung inflammation
360701|NCT01407796|positron emission tomography (PET)|positron emission tomography (pet)
360702|NCT01407796|fluorodeoxyglucose (FDG)|fluorodeoxyglucose (fdg)
360703|NCT01407796|inducible nitric oxide synthase (iNOS)|inducible nitric oxide synthase (inos)
360704|NCT01407796|lung anti-inflammatory therapy|lung anti-inflammatory therapy
360705|NCT01407783|Post-partum depression|post-partum depression
360706|NCT01407783|Low-income mothers|low-income mothers
360707|NCT01407783|home nurse visitation|home nurse visitation
360708|NCT01407770|radiation toxicity|radiation toxicity
360709|NCT01407770|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
360710|NCT01407770|pain|pain
360711|NCT01407770|fatigue|fatigue
360284|NCT01409200|ADT|adt
751937|NCT01171287|Lower Extremity|lower extremity
360712|NCT01407770|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
360713|NCT01407770|depression|depression
360714|NCT01407770|cognitive/functional effects|cognitive/functional effects
360715|NCT01407770|stage IA breast cancer|stage ia breast cancer
360716|NCT01407770|stage IB breast cancer|stage ib breast cancer
360717|NCT01407770|stage II breast cancer|stage ii breast cancer
360718|NCT01407770|stage IIIA breast cancer|stage iiia breast cancer
360719|NCT01407770|ductal breast carcinoma in situ|ductal breast carcinoma in situ
360720|NCT01407757|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
360721|NCT01407757|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
360722|NCT01407757|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
360723|NCT01407757|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
360724|NCT01407757|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
360725|NCT01407757|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
360726|NCT01407757|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
360727|NCT01407757|adult acute basophilic leukemia|adult acute basophilic leukemia
360728|NCT01407757|childhood acute basophilic leukemia|childhood acute basophilic leukemia
360729|NCT01407757|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
360730|NCT01407757|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
360731|NCT01407757|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
360732|NCT01407757|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
360733|NCT01407757|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
360734|NCT01407757|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
360735|NCT01407757|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
360736|NCT01407757|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
360737|NCT01407757|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
360738|NCT01407757|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
360739|NCT01407757|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
360740|NCT01407757|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
360741|NCT01407757|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
360742|NCT01407757|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
360743|NCT01407757|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
360744|NCT01407757|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
360745|NCT01407757|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
360845|NCT01407393|appetite|appetite
360746|NCT01407757|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
360747|NCT01407757|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
360748|NCT01407757|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
360749|NCT01407757|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
360750|NCT01407731|disseminated neuroblastoma|disseminated neuroblastoma
360751|NCT01407731|localized resectable neuroblastoma|localized resectable neuroblastoma
360752|NCT01407731|localized unresectable neuroblastoma|localized unresectable neuroblastoma
360753|NCT01407731|stage 4S neuroblastoma|stage 4s neuroblastoma
360754|NCT01407718|Knee pain|knee pain
360755|NCT01407718|tibial nailing|tibial nailing
360756|NCT01407705|spinal cord injury with traumatic event|spinal cord injury with traumatic event
360757|NCT01407692|menstrual cycle|menstrual cycle
360758|NCT01407692|estrogen|estrogen
360759|NCT01407679|cutaneous lupus erythematosus|cutaneous lupus erythematosus
351491|NCT01444131|Smoking|smoking
360760|NCT01407679|discoid lupus erythematosus|discoid lupus erythematosus
360761|NCT01407679|subacute cutaneous lupus erythematosus|subacute cutaneous lupus erythematosus
360762|NCT01407679|lupus erythematosus tumidus|lupus erythematosus tumidus
360763|NCT01407666|paravertebral block|paravertebral block
360764|NCT01407666|epidural block|epidural block
360765|NCT01407666|pain management|pain management
360766|NCT01407666|liver resection|liver resection
360767|NCT01407666|comparison|comparison
360768|NCT01407653|Low back pain|low back pain
360769|NCT01407653|virtual reality|virtual reality
360770|NCT01407640|Insulin allergy|insulin allergy
360771|NCT01407640|adverse drug reaction|adverse drug reaction
360772|NCT01407640|diabetes|diabetes
360773|NCT01407640|type 1 hypersensitivity|type 1 hypersensitivity
360774|NCT01407640|immediate hypersensitivity|immediate hypersensitivity
360775|NCT01407640|type 4 hypersensitivity|type 4 hypersensitivity
360776|NCT01407640|insulin analogs|insulin analogs
360777|NCT01407640|intradermal testing|intradermal testing
360778|NCT01407640|insulin antibody|insulin antibody
360779|NCT01407640|mast cell|mast cell
360780|NCT01407640|CD+ TCELL|cd+ tcell
360781|NCT01407627|human|human
360782|NCT01407627|fructose|fructose
360783|NCT01407627|dextrose|dextrose
360784|NCT01407627|renin angiotensin system|renin angiotensin system
360785|NCT01407627|kidney|kidney
360786|NCT01407627|renal hemodynamics|renal hemodynamics
360787|NCT01407614|Subarachnoid hemorrhage|subarachnoid hemorrhage
360788|NCT01407614|delayed cerebral ischemia|delayed cerebral ischemia
360789|NCT01407614|external lumbar drainage|external lumbar drainage
360790|NCT01407614|vasospasm|vasospasm
360791|NCT01407601|vitamin K|vitamin k
360792|NCT01407601|MK-7|mk-7
360793|NCT01407601|Hemodialysis|hemodialysis
360794|NCT01407601|vascular calcification|vascular calcification
360795|NCT01407601|Matrix Gla protein|matrix gla protein
360796|NCT01407601|Osteocalcin|osteocalcin
360797|NCT01407588|Atrial fibrillation|atrial fibrillation
360798|NCT01407588|Ablation|ablation
360799|NCT01407575|Buprenorphine|buprenorphine
360800|NCT01407575|Receptors, opioid|receptors, opioid
360801|NCT01407575|Receptors, opioid, kappa|receptors, opioid, kappa
360802|NCT01407536|Stroke|stroke
360803|NCT01407536|Thermal Stimulation|thermal stimulation
360804|NCT01407536|Upper Extremity|upper extremity
360805|NCT01407536|Motor Recovery|motor recovery
360806|NCT01407536|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
360807|NCT01407523|Levetiracetam|levetiracetam
360808|NCT01407523|Infusion|infusion
360809|NCT01407523|Epilepsy|epilepsy
360810|NCT01407523|Partial Onset Seizures|partial onset seizures
360812|NCT01407497|Vaccine|vaccine
360813|NCT01407497|DNA|dna
360814|NCT01407497|Prevention|prevention
360815|NCT01407484|Infertility|infertility
360816|NCT01407484|Assisted reproductive technology|assisted reproductive technology
360817|NCT01407484|Double blind therapeutical trial|double blind therapeutical trial
360818|NCT01407484|Multicentric study|multicentric study
360819|NCT01407484|Prospective randomized study|prospective randomized study
360820|NCT01407471|aldosterone|aldosterone
360821|NCT01407471|clobetasol|clobetasol
360822|NCT01407471|atrophy|atrophy
360823|NCT01407471|skin|skin
360824|NCT01407471|epidermis|epidermis
360825|NCT01407471|wound healing|wound healing
360826|NCT01407471|mineral corticoid receptor|mineral corticoid receptor
360827|NCT01407471|spironolactone|spironolactone
360828|NCT01407445|Menopause|menopause
360829|NCT01407445|Sexual dysfunction|sexual dysfunction
360830|NCT01407445|Tribulus|tribulus
360831|NCT01407445|Sexuality|sexuality
360832|NCT01407445|Phytotherapeutic Drugs|phytotherapeutic drugs
360833|NCT01407432|Male infertility|male infertility
360834|NCT01407432|folic acid|folic acid
360835|NCT01407432|in VITRO fertilization|in vitro fertilization
360836|NCT01407432|sperm parameters|sperm parameters
360837|NCT01407432|MTHFR genotype|mthfr genotype
360838|NCT01407419|Rheumatoid Arthritis|rheumatoid arthritis
360839|NCT01407393|overweight|overweight
360840|NCT01407393|obesity|obesity
360841|NCT01407393|weight loss|weight loss
360842|NCT01407393|body fat|body fat
360843|NCT01407393|waste cirumference|waste cirumference
360846|NCT01407380|Advanced malignancies|advanced malignancies
360847|NCT01407380|solid tumors|solid tumors
360848|NCT01407380|cancer|cancer
360849|NCT01407367|patient safety|patient safety
360850|NCT01407367|chronic kidney disease|chronic kidney disease
360851|NCT01407367|medical errors|medical errors
360852|NCT01407354|robotic weight support|robotic weight support
360853|NCT01407354|aquatic exercise|aquatic exercise
360854|NCT01407354|incomplete motor spinal cord injury|incomplete motor spinal cord injury
360855|NCT01407354|ASIA C and D|asia c and d
360856|NCT01407328|shoulder arthroscopic surgery|shoulder arthroscopic surgery
360857|NCT01407328|respiratory discomfort|respiratory discomfort
360858|NCT01407328|airway obstruction|airway obstruction
360859|NCT01407328|restrictive pathology|restrictive pathology
360860|NCT01407328|diaphragm palsy|diaphragm palsy
360861|NCT01407315|Continuous subcutaneous glucose monitoring|continuous subcutaneous glucose monitoring
360862|NCT01407315|Type 1 Diabetes|type 1 diabetes
360863|NCT01407302|Laryngeal mask airway|laryngeal mask airway
360864|NCT01407302|internal jugular vein cannulation|internal jugular vein cannulation
360865|NCT01407263|radical prostatectomy|radical prostatectomy
360866|NCT01407263|anastomotic suturing|anastomotic suturing
360867|NCT01407263|lymph node dissection|lymph node dissection
360868|NCT01407263|11-096|11-096
360869|NCT01407237|HIV-infection|hiv-infection
360870|NCT01407237|renin|renin
360871|NCT01407237|aldosterone|aldosterone
360872|NCT01407237|visceral fat|visceral fat
360873|NCT01407224|Exclusive Breastfeeding|exclusive breastfeeding
360874|NCT01407224|Skin to skin contact|skin to skin contact
360875|NCT01407224|Cord Clumping|cord clumping
360876|NCT01407224|Prelactial feeding|prelactial feeding
360877|NCT01407211|multiple sclerosis|multiple sclerosis
360878|NCT01407211|Myelin Oligodendrocyte Glycoprotein(MOG)|myelin oligodendrocyte glycoprotein(mog)
360879|NCT01407211|Vitamin A|vitamin a
360880|NCT01407211|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
360881|NCT01407211|gene expression|gene expression
360882|NCT01407211|Th1 Cells|th1 cells
360883|NCT01407211|Th2 Cells|th2 cells
360884|NCT01407198|High Risk Chordoma|high risk chordoma
360885|NCT01407185|heart failure|heart failure
360886|NCT01407185|quality of life|quality of life
360887|NCT01407185|fall prevention|fall prevention
360888|NCT01407185|endurance|endurance
360889|NCT01407185|resistive training|resistive training
360891|NCT01407172|Peripheral arterial disease|peripheral arterial disease
360892|NCT01407172|Hydrogen Sulfide|hydrogen sulfide
360893|NCT01407172|Gasotransmitter|gasotransmitter
360894|NCT01407159|type b dissection|type b dissection
360895|NCT01407159|thoracic stentgraft|thoracic stentgraft
360896|NCT01407159|aortic stent|aortic stent
360897|NCT01407159|clinical and technical success|clinical and technical success
360898|NCT01407159|safety and feasibility of E-XL aortic stent|safety and feasibility of e-xl aortic stent
360899|NCT01407146|acute myocardial infarction|acute myocardial infarction
360900|NCT01407146|care-seeking behavior|care-seeking behavior
360901|NCT01407146|acute coronary syndrome|acute coronary syndrome
360902|NCT01407146|care-seeking delay|care-seeking delay
360903|NCT01407146|cardiac delay|cardiac delay
360904|NCT01407146|prehospital delay|prehospital delay
360905|NCT01407146|acute myocardial infarction & PTSD|acute myocardial infarction & ptsd
360906|NCT01407146|help seeking behaviors|help seeking behaviors
360907|NCT01407146|seeking treatment|seeking treatment
360908|NCT01407146|cardiac patients|cardiac patients
360909|NCT01407146|decision time|decision time
360910|NCT01407133|Neuro-otology|neuro-otology
360911|NCT01407133|Chronic tinnitus|chronic tinnitus
360912|NCT01407133|Sensory disability|sensory disability
360913|NCT01407133|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
360914|NCT01407133|Dose escalation|dose escalation
360915|NCT01407120|Prevention|prevention
360916|NCT01407120|Divorce|divorce
360917|NCT01407107|nitroglycerin|nitroglycerin
360918|NCT01407107|5-flourouracil|5-flourouracil
360919|NCT01407107|radiation therapy|radiation therapy
360920|NCT01407107|neo-adjuvant treatment|neo-adjuvant treatment
360921|NCT01407094|Depression, Major Depressive Disorder, Mood Disorder|depression, major depressive disorder, mood disorder
360922|NCT01407081|cognitive rehabilitation|cognitive rehabilitation
360923|NCT01407081|SMART goals|smart goals
360924|NCT01407081|telehealth|telehealth
360925|NCT01407055|Coronary Artery Bypass Graft Surgery (CABG)|coronary artery bypass graft surgery (cabg)
360926|NCT01407055|Patients' Expectations|patients' expectations
360927|NCT01407055|Coronary Heart Disease|coronary heart disease
360928|NCT01407055|Illness Perception Intervention|illness perception intervention
360929|NCT01407055|Randomized Controlled Trial|randomized controlled trial
360930|NCT01407042|unicondylar knee arthroplasty|unicondylar knee arthroplasty
360931|NCT01407042|mobile-bearing|mobile-bearing
360932|NCT01407042|patellofemoral pain|patellofemoral pain
360933|NCT01407016|metronidazole infusion|metronidazole infusion
360934|NCT01407003|T2DM, blood glucose, OGTT, LIK066|t2dm, blood glucose, ogtt, lik066
360935|NCT01406990|aspirin resistance|aspirin resistance
360936|NCT01406990|hyporesponsive|hyporesponsive
360937|NCT01406990|CAD|cad
360938|NCT01406990|women|women
360939|NCT01406977|Hypophosphatasia|hypophosphatasia
360940|NCT01406977|HPP|hpp
360941|NCT01406977|Rathbun's disease|rathbun's disease
360942|NCT01406964|Chlamidia Antibody test, Hysterosalpyngography, Tubal disease|chlamidia antibody test, hysterosalpyngography, tubal disease
360943|NCT01406951|sTREM-1|strem-1
360944|NCT01406951|PCT|pct
360945|NCT01406951|CPIS|cpis
360946|NCT01406951|VAP|vap
360947|NCT01406951|EVC|evc
360948|NCT01406951|diagnosis|diagnosis
360949|NCT01406951|prognosis|prognosis
360950|NCT01406938|Psoriasis|psoriasis
360951|NCT01406938|plaque|plaque
360952|NCT01406938|inflammatory skin disease|inflammatory skin disease
360953|NCT01406938|scaly patches|scaly patches
360954|NCT01406938|AIN457|ain457
360955|NCT01406938|secukinumab|secukinumab
360956|NCT01406938|Moderate to Severe Plaque-type Psoriasis|moderate to severe plaque-type psoriasis
360957|NCT01406912|Stroke Rehabilitation|stroke rehabilitation
360958|NCT01406912|Ischemic Stroke|ischemic stroke
360959|NCT01406912|Virtual Reality|virtual reality
360960|NCT01406912|Nintendo Wii|nintendo wii
360961|NCT01406912|Recreational Activity|recreational activity
360962|NCT01406912|Motor Function|motor function
360963|NCT01406886|Modifiable environmental|modifiable environmental
360964|NCT01406886|behavioral factors|behavioral factors
360965|NCT01406873|Myotonic Dystrophy|myotonic dystrophy
360966|NCT01406873|Myotonic Dystrophy Type 1 (DM1)|myotonic dystrophy type 1 (dm1)
360967|NCT01406873|Muscular Dystrophy|muscular dystrophy
360968|NCT01406873|Mexiletine|mexiletine
360969|NCT01406860|Headaches|headaches
360970|NCT01406860|Migraines|migraines
360971|NCT01406860|Tension headaches|tension headaches
360972|NCT01406860|Cluster headaches|cluster headaches
360973|NCT01406847|Spinal Manipulation|spinal manipulation
360974|NCT01406847|Body-based intervention|body-based intervention
360975|NCT01406847|Experimental pain|experimental pain
360977|NCT01406834|Veterans|veterans
360978|NCT01406834|Killing|killing
360979|NCT01406834|Military|military
360980|NCT01406821|PRP|prp
360981|NCT01406821|platelet-rich-plasma|platelet-rich-plasma
360982|NCT01406821|platelet|platelet
360983|NCT01406821|tendinosis|tendinosis
360984|NCT01406821|tendinitis|tendinitis
360985|NCT01406821|tendonitis|tendonitis
360986|NCT01406821|tendinopathy|tendinopathy
360987|NCT01406821|enthesopathy|enthesopathy
360988|NCT01406821|muscle|muscle
360989|NCT01406821|sport|sport
360990|NCT01406821|tendon|tendon
360991|NCT01406821|patella|patella
360992|NCT01406821|patellar tendon|patellar tendon
360993|NCT01406808|genetic|genetic
360994|NCT01406808|atherosclerosis|atherosclerosis
360995|NCT01406808|myocardial infarction|myocardial infarction
360996|NCT01406808|risk|risk
360997|NCT01406808|preventive cardiology|preventive cardiology
360998|NCT01406795|Post Thrombotic Syndrome|post thrombotic syndrome
360999|NCT01406795|Venous Stasis|venous stasis
361000|NCT01406795|Venous Occlusions|venous occlusions
361001|NCT01406795|Venous Stenosis|venous stenosis
361002|NCT01406782|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
361003|NCT01406782|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
361004|NCT01406782|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
361005|NCT01406782|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
361006|NCT01406743|Spine and pelvis parameters|spine and pelvis parameters
361007|NCT01406743|Sagittal balance|sagittal balance
361008|NCT01406743|Database|database
361009|NCT01406730|running exercise|running exercise
361010|NCT01406730|cardiac hypertrophy|cardiac hypertrophy
361011|NCT01406730|blood|blood
361012|NCT01406730|maximum oxygen uptake|maximum oxygen uptake
361013|NCT01406730|intervention|intervention
361014|NCT01406730|untrained|untrained
361015|NCT01406730|males|males
361016|NCT01406717|SPIL1033|spil1033
361017|NCT01406717|type 2 diabetes mellitus|type 2 diabetes mellitus
361018|NCT01406691|sleep|sleep
361019|NCT01406691|delayed sleep phase disorder|delayed sleep phase disorder
361020|NCT01406691|circadian|circadian
361021|NCT01406691|teen|teen
361022|NCT01406691|adolescent|adolescent
361023|NCT01406678|remote ischemic preconditioning|remote ischemic preconditioning
361024|NCT01406678|coronary artery bypass grafting|coronary artery bypass grafting
361025|NCT01406678|myocardial injury|myocardial injury
361026|NCT01406665|diabetes|diabetes
361027|NCT01406665|impaired glucose tolerance|impaired glucose tolerance
361028|NCT01406652|septic bursitis|septic bursitis
361029|NCT01406652|bursectomy|bursectomy
361030|NCT01406652|primary closure|primary closure
361031|NCT01406639|Hereditary Hemorrhagic Telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
361032|NCT01406639|Nosebleeds|nosebleeds
361033|NCT01406639|Ranibizumab|ranibizumab
361034|NCT01406639|Lucentis|lucentis
361035|NCT01406626|HIV|hiv
361036|NCT01406626|AIDS|aids
361037|NCT01406626|Health navigation|health navigation
361038|NCT01406626|Viral load|viral load
361039|NCT01406626|Corrections|corrections
361040|NCT01406613|Observational|observational
361041|NCT01406613|Bone Density|bone density
361042|NCT01406613|alendronate|alendronate
361043|NCT01406613|ibandronate|ibandronate
361044|NCT01406613|risedronate|risedronate
361045|NCT01406613|postmenopausal|postmenopausal
361046|NCT01406613|osteoporosis|osteoporosis
361047|NCT01406600|recombinant hCG|recombinant hcg
361048|NCT01406600|poor responder|poor responder
361049|NCT01406600|oocyte maturity|oocyte maturity
361050|NCT01406587|Burning|burning
361051|NCT01406587|Dysuria|dysuria
361052|NCT01406587|Frequency|frequency
361053|NCT01406587|Pain|pain
361054|NCT01406587|Uncomplicated Urinary Tract Infection|uncomplicated urinary tract infection
361055|NCT01406587|Uncomplicated UTI|uncomplicated uti
361056|NCT01406587|Urinary Tract Infection|urinary tract infection
361057|NCT01406587|UTI|uti
361058|NCT01406587|Burning during urination associated with uncomplicated urinary tract infection|burning during urination associated with uncomplicated urinary tract infection
361059|NCT01406587|Urination frequency associated with uncomplicated urinary tract infection|urination frequency associated with uncomplicated urinary tract infection
361060|NCT01406587|Pain associated with uncomplicated urinary tract infection|pain associated with uncomplicated urinary tract infection
361061|NCT01406574|Hepatocellular carcinoma|hepatocellular carcinoma
361062|NCT01406561|Meniscectomy|meniscectomy
361063|NCT01406561|Knee Pain|knee pain
361064|NCT01406561|Postoperative Pain|postoperative pain
361065|NCT01406548|Osteopenia|osteopenia
361066|NCT01406548|osteoporosis|osteoporosis
361067|NCT01406548|low bone mineral density|low bone mineral density
361068|NCT01406535|Phosphodiesterase 5 inhibition|phosphodiesterase 5 inhibition
361069|NCT01406535|myocardial perfusion|myocardial perfusion
361070|NCT01406535|angiogenesis|angiogenesis
361071|NCT01406535|coronary artery disease|coronary artery disease
361072|NCT01406535|therapy refractory|therapy refractory
361073|NCT01406522|Acetylcholine|acetylcholine
361074|NCT01406522|Cholinesterases|cholinesterases
361075|NCT01406522|Cocaine|cocaine
361076|NCT01406522|Self-Administration|self-administration
361077|NCT01406509|Safety|safety
361078|NCT01406509|Conjugate vaccine|conjugate vaccine
361079|NCT01406496|Insulin bolus|insulin bolus
361080|NCT01406496|glucose excursions|glucose excursions
361081|NCT01406496|post-prandial|post-prandial
361082|NCT01406496|timing|timing
361083|NCT01406496|meal content|meal content
361084|NCT01406483|Platelet reactivity|platelet reactivity
361085|NCT01406483|CABG|cabg
361086|NCT01406483|Perioperative and in hospital bleeding|perioperative and in hospital bleeding
361087|NCT01406470|IGIV|igiv
361088|NCT01406470|Primary Immune Deficiency|primary immune deficiency
361089|NCT01406470|Immunoglobulin G|immunoglobulin g
361090|NCT01406457|Subarachnoid Hemorrhage|subarachnoid hemorrhage
361091|NCT01406444|Anorexia Nervosa|anorexia nervosa
361092|NCT01406444|Osteopenia|osteopenia
361093|NCT01406444|Osteoporosis|osteoporosis
361094|NCT01406444|Bone density|bone density
361095|NCT01406431|pitavastatin|pitavastatin
361096|NCT01406431|Livalo|livalo
361097|NCT01406418|Influenza|influenza
361098|NCT01406418|Virus|virus
361099|NCT01406418|Monoclonal|monoclonal
361100|NCT01406418|Antibody|antibody
361101|NCT01406418|Immunization|immunization
361102|NCT01406418|Treatment|treatment
361103|NCT01406405|Degenerative disc disease|degenerative disc disease
361104|NCT01406405|spinal stenosis|spinal stenosis
361105|NCT01406405|herniated disc|herniated disc
361106|NCT01406392|Misoprostol|misoprostol
361107|NCT01406392|Sublingual|sublingual
361108|NCT01406392|Induced|induced
361109|NCT01406392|Labor|labor
361110|NCT01406366|Pediatric oral health|pediatric oral health
361111|NCT01406366|Bright Futures|bright futures
361112|NCT01406366|Health promotion|health promotion
361113|NCT01406353|Mitral Stenosis|mitral stenosis
361114|NCT01406353|Mitral Valvuloplasty|mitral valvuloplasty
361115|NCT01406314|Phase 1|phase 1
361116|NCT01406314|Patient|patient
361117|NCT01406314|Systemic Amyloidosis|systemic amyloidosis
361118|NCT01406314|Amyloidosis|amyloidosis
361119|NCT01406301|prescribing information|prescribing information
361120|NCT01406288|hemolytic-uremic syndrome|hemolytic-uremic syndrome
361121|NCT01406288|shiga-toxin-producing E. Coli|shiga-toxin-producing e. coli
361122|NCT01406262|albiglutide|albiglutide
361123|NCT01406262|QT interval|qt interval
361124|NCT01406262|cardiac repolarization|cardiac repolarization
361125|NCT01406262|ECG study|ecg study
361126|NCT01406249|unresectable gastric cancer|unresectable gastric cancer
361127|NCT01406249|recurrent gastric cancer|recurrent gastric cancer
361128|NCT01406249|StageIV gastric cancer|stageiv gastric cancer
361129|NCT01406249|adenocarcinoma of the stomach|adenocarcinoma of the stomach
361130|NCT01406249|XP|xp
361131|NCT01406249|SP|sp
361132|NCT01406236|Female|female
361133|NCT01406236|urgent or elective percutaneous coronary intervention|urgent or elective percutaneous coronary intervention
361134|NCT01406236|PCI|pci
361135|NCT01406236|diagnostic angiography|diagnostic angiography
361136|NCT01406223|Nicotine addiction|nicotine addiction
361137|NCT01406223|Cigarette smoking|cigarette smoking
361138|NCT01406223|Smoking cessation|smoking cessation
361139|NCT01406223|Zyban|zyban
361140|NCT01406223|Chantix|chantix
361141|NCT01406223|Nicotine patches|nicotine patches
361142|NCT01406223|varenicline|varenicline
361143|NCT01406223|bupropion|bupropion
361144|NCT01406223|fMRI|fmri
361145|NCT01406210|Lung Transplant|lung transplant
361146|NCT01406210|REflux Surgery|reflux surgery
361147|NCT01406210|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
361148|NCT01406210|Fundoplication|fundoplication
361149|NCT01406197|Progesterone|progesterone
361150|NCT01406197|Progestins|progestins
361151|NCT01406197|Preterm labor|preterm labor
361152|NCT01406197|Premature birth|premature birth
361153|NCT01406197|Uterine electromyography|uterine electromyography
361154|NCT01406197|Uterine contractility|uterine contractility
361155|NCT01406184|Child Abuse|child abuse
361156|NCT01406184|Child Neglect|child neglect
361157|NCT01406184|Child Hospital Emergency Room Presentations|child hospital emergency room presentations
361158|NCT01406184|Child Well-Care Compliance|child well-care compliance
361159|NCT01406184|Child Immunization Compliance|child immunization compliance
361160|NCT01406171|Isavuconazole|isavuconazole
361161|NCT01406171|ASP9766|asp9766
361162|NCT01406171|BAL8557|bal8557
361163|NCT01406171|Midazolam|midazolam
361271|NCT01405599|Ulimorelin|ulimorelin
361164|NCT01406171|Healthy volunteers|healthy volunteers
361165|NCT01406158|Solifenacin succinate|solifenacin succinate
361166|NCT01406158|VESIcare|vesicare
361167|NCT01406158|Healthy Volunteers|healthy volunteers
361168|NCT01406158|YM905|ym905
361169|NCT01406145|Alzheimer's Disease|alzheimer's disease
361170|NCT01406145|ASP0777|asp0777
361171|NCT01406132|ASP015K|asp015k
361172|NCT01406132|Healthy volunteers|healthy volunteers
361173|NCT01406106|Hypercholesterolemia|hypercholesterolemia
361174|NCT01406106|Lipids|lipids
361175|NCT01406106|Cardiovascular disease|cardiovascular disease
361176|NCT01406106|Risks factors|risks factors
361177|NCT01406106|Primary Care|primary care
361178|NCT01406093|Candidemia|candidemia
361179|NCT01406093|Early-onset|early-onset
361180|NCT01406093|Late-onset|late-onset
361181|NCT01406093|Health-care associated|health-care associated
361182|NCT01406093|Nosocomial|nosocomial
361183|NCT01406080|Photoaging|photoaging
361184|NCT01406080|Photodamage|photodamage
361185|NCT01406080|Adapalene|adapalene
361186|NCT01406080|Differin|differin
361187|NCT01406067|social skills training,|social skills training,
361188|NCT01406067|social competence training,|social competence training,
361189|NCT01406067|Oppositional Defiant Disorder|oppositional defiant disorder
361190|NCT01406067|peer related aggressive behavior|peer related aggressive behavior
361191|NCT01406067|randomized controlled trial|randomized controlled trial
361192|NCT01406054|athletes|athletes
361193|NCT01406054|injury prevention|injury prevention
361194|NCT01406054|neuromuscular training|neuromuscular training
361195|NCT01406054|public school|public school
361196|NCT01406054|physical education|physical education
361197|NCT01406054|knee|knee
361198|NCT01406054|sports|sports
361199|NCT01406054|ACL|acl
361200|NCT01406054|KIPP|kipp
361201|NCT01406041|Fluid and electrolyte imbalance|fluid and electrolyte imbalance
361202|NCT01406041|Hyponatremia|hyponatremia
361203|NCT01406041|Hypernatremia|hypernatremia
361204|NCT01406041|Electrolytes disorder|electrolytes disorder
361205|NCT01406028|IVF|ivf
361206|NCT01406028|Stress|stress
361207|NCT01406028|Infertility|infertility
361208|NCT01406015|Obesity|obesity
361209|NCT01406015|Insulin resistance|insulin resistance
361210|NCT01406015|Mineralocorticoid receptor|mineralocorticoid receptor
361211|NCT01406002|Pharmacokinetics|pharmacokinetics
361212|NCT01406002|darexaban|darexaban
361213|NCT01406002|YM150|ym150
361214|NCT01406002|rifampicin|rifampicin
361215|NCT01406002|Phase 1|phase 1
361216|NCT01405989|Pharmacokinetics|pharmacokinetics
361217|NCT01405989|darexaban|darexaban
361218|NCT01405989|ketoconazole|ketoconazole
361219|NCT01405989|Phase 1|phase 1
361220|NCT01405976|sleep apneas|sleep apneas
361221|NCT01405976|noninvasive ventilation|noninvasive ventilation
361222|NCT01405976|CPAP|cpap
361223|NCT01405963|Amgen|amgen
361224|NCT01405963|AMG 157|amg 157
361225|NCT01405963|Asthma|asthma
361226|NCT01405898|hypertension|hypertension
361227|NCT01405898|nitrite|nitrite
361228|NCT01405898|blood pressure|blood pressure
361229|NCT01405898|endothelial function|endothelial function
361230|NCT01405885|Universal Influenza|universal influenza
361231|NCT01405885|Intradermal DNA vaccine|intradermal dna vaccine
361232|NCT01405885|Electroporation|electroporation
361233|NCT01405885|H1 and H5|h1 and h5
361234|NCT01405885|DNA Vaccination|dna vaccination
361235|NCT01405885|Influenza|influenza
361236|NCT01405885|INO-3510|ino-3510
361237|NCT01405859|Tourette|tourette
361238|NCT01405859|tic|tic
361239|NCT01405859|Tourette's|tourette's
361240|NCT01405859|Tourette syndrome|tourette syndrome
361241|NCT01405859|Tourette's syndrome|tourette's syndrome
361242|NCT01405807|Vasculitis|vasculitis
361243|NCT01405807|ANCA|anca
361244|NCT01405807|Refractory|refractory
361245|NCT01405742|Hemophilia|hemophilia
361246|NCT01405742|Prophylaxis|prophylaxis
361247|NCT01405742|Recombinant factor VIII|recombinant factor viii
361248|NCT01405716|Mindfulness|mindfulness
361249|NCT01405716|Back Pain|back pain
361250|NCT01405716|Older adults|older adults
361251|NCT01405703|Clavicle Fractures|clavicle fractures
361252|NCT01405703|Numbness|numbness
361253|NCT01405703|Percutaneous plate fixation|percutaneous plate fixation
361254|NCT01405703|open plate fixation|open plate fixation
361255|NCT01405703|incision related numbness|incision related numbness
361256|NCT01405703|union rates|union rates
361257|NCT01405703|subjective|subjective
361258|NCT01405703|questionnaire based outcomes|questionnaire based outcomes
361259|NCT01405703|Diaphyseal|diaphyseal
361260|NCT01405690|CAD|cad
361261|NCT01405690|CTCA|ctca
361262|NCT01405690|multidetector computer tomography (MDCT)|multidetector computer tomography (mdct)
361263|NCT01405677|Hepatitis A|hepatitis a
361264|NCT01405677|Vaccination|vaccination
361265|NCT01405677|Immunisation|immunisation
361266|NCT01405651|ONO-6950|ono-6950
361267|NCT01405651|Healthy adult subjects|healthy adult subjects
361268|NCT01405625|Asthma|asthma
361269|NCT01405625|Health literacy|health literacy
361270|NCT01405625|Parent knowledge of appropriate action plan steps|parent knowledge of appropriate action plan steps
361272|NCT01405599|Hepatic Impairment|hepatic impairment
361273|NCT01405586|elderly|elderly
361274|NCT01405586|chemotherapy|chemotherapy
361275|NCT01405573|Child Pugh B|child pugh b
361276|NCT01405573|first line|first line
361277|NCT01405547|Gestational Diabetes|gestational diabetes
361278|NCT01405547|Gestational Hyperglycemia|gestational hyperglycemia
361279|NCT01405547|Gestational Insulinemia|gestational insulinemia
361280|NCT01405547|Maternal Obesity|maternal obesity
361281|NCT01405547|Human Milk|human milk
361282|NCT01405547|Lactogenesis|lactogenesis
361283|NCT01405547|Obstetrics|obstetrics
361284|NCT01405547|Nutrition|nutrition
361285|NCT01405547|Infant Growth|infant growth
361286|NCT01405534|Catheterization, Central Venous|catheterization, central venous
361287|NCT01405521|typhoid vaccine M01ZH09|typhoid vaccine m01zh09
361288|NCT01405521|Ty21a typhoid vaccine|ty21a typhoid vaccine
361289|NCT01405508|N01258|n01258
361290|NCT01405508|Brivaracetam|brivaracetam
361291|NCT01405508|Epilepsy|epilepsy
361292|NCT01405508|IV|iv
361293|NCT01405508|intravenous|intravenous
361294|NCT01405495|Posttraumatic Stress Disorder|posttraumatic stress disorder
361295|NCT01405495|Working Memory|working memory
361296|NCT01405495|Attentional Bias|attentional bias
361297|NCT01405495|Connectivity|connectivity
361298|NCT01405495|Structural Neuroimaging|structural neuroimaging
361299|NCT01405495|Functional Neuroimaging|functional neuroimaging
361300|NCT01405495|Diffusion Tensor Imaging|diffusion tensor imaging
361301|NCT01405495|Arterial Spin Labelling|arterial spin labelling
361302|NCT01405495|Cortisol|cortisol
361303|NCT01405495|Psychophysiology|psychophysiology
361304|NCT01405495|Early development of|early development of
361305|NCT01405482|Botulinum Toxin Type A|botulinum toxin type a
361306|NCT01405482|Thoracic Outlet Syndrome|thoracic outlet syndrome
361307|NCT01405469|Achalasia|achalasia
361308|NCT01405469|Heller myotomy|heller myotomy
361309|NCT01405469|Dysphagia|dysphagia
361310|NCT01405469|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
361311|NCT01405456|HIV-infection|hiv-infection
361312|NCT01405456|eplerenone|eplerenone
361313|NCT01405456|aldosterone|aldosterone
361314|NCT01405456|visceral fat|visceral fat
361315|NCT01405456|lipodystrophy|lipodystrophy
361316|NCT01405443|Simulator training|simulator training
361317|NCT01405443|Flexible endoscopy|flexible endoscopy
361318|NCT01405443|Gastrointestinal endoscopy|gastrointestinal endoscopy
361319|NCT01405443|Colonoscopy|colonoscopy
361320|NCT01405443|Training|training
361321|NCT01405443|Performance|performance
361322|NCT01405417|Achalasia|achalasia
361323|NCT01405417|Heller myotomy|heller myotomy
361324|NCT01405417|Dysphagia|dysphagia
361325|NCT01405417|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
361326|NCT01405404|parenting childcare discounts child behavior|parenting childcare discounts child behavior
361327|NCT01405404|No Intervention Control|no intervention control
361328|NCT01405404|Intervention no childcare discount|intervention no childcare discount
361329|NCT01405404|Intervention with childcare discount|intervention with childcare discount
361330|NCT01405391|Pharma Mar|pharma mar
361332|NCT01405391|Non-Colorectal Cancer (non-CRC)|non-colorectal cancer (non-crc)
361333|NCT01405391|Dose finding phase I|dose finding phase i
361334|NCT01405365|Periodontitis|periodontitis
361335|NCT01405365|Periodontal diseases|periodontal diseases
361336|NCT01405365|Obesity|obesity
361337|NCT01405365|Metronidazole|metronidazole
361338|NCT01405365|Prognosis|prognosis
361339|NCT01405365|Probing depth|probing depth
361340|NCT01405365|Periodontal attachment loss|periodontal attachment loss
361341|NCT01405352|obesity|obesity
361342|NCT01405352|vitamin A|vitamin a
361343|NCT01405352|immune system|immune system
361344|NCT01405326|rheumatoid arthritis|rheumatoid arthritis
361345|NCT01405326|biological therapy|biological therapy
361346|NCT01405326|adalimumab|adalimumab
361347|NCT01405326|ability to work|ability to work
361348|NCT01405326|sick leaves|sick leaves
361349|NCT01405287|stent|stent
361350|NCT01405287|drug eluting stent|drug eluting stent
361351|NCT01405287|healing|healing
361352|NCT01405287|endothelium|endothelium
361353|NCT01405287|DES|des
361354|NCT01405287|OCT|oct
361355|NCT01405287|MI|mi
361356|NCT01405287|ACS|acs
361357|NCT01405248|Butylphthalide|butylphthalide
361358|NCT01405235|Paclitaxel/Topotecan|paclitaxel/topotecan
361359|NCT01405235|Cisplatin/Topotecan|cisplatin/topotecan
361360|NCT01405222|exacerbation|exacerbation
361361|NCT01405222|COPD|copd
361362|NCT01405222|Cough|cough
361363|NCT01405209|EKG|ekg
361364|NCT01405209|AF|af
361365|NCT01405209|biosignals|biosignals
361366|NCT01405196|double-blind|double-blind
361367|NCT01405196|placebo-controlled|placebo-controlled
361368|NCT01405196|multicenter|multicenter
361369|NCT01405196|dose-ranging|dose-ranging
361370|NCT01405196|efficacy|efficacy
361371|NCT01405196|safety|safety
361372|NCT01405196|lupus.|lupus.
361373|NCT01405183|Hepatitis C|hepatitis c
361374|NCT01405183|Renal Cell Carcinoma|renal cell carcinoma
361375|NCT01405183|Colorectal Cancer|colorectal cancer
361587|NCT01404390|Japanese|japanese
361376|NCT01405170|bioequivalence study|bioequivalence study
361377|NCT01405170|methylprednisolone|methylprednisolone
361378|NCT01405170|suspension|suspension
361379|NCT01405170|tablets|tablets
361381|NCT01405157|bioequivalence study|bioequivalence study
361382|NCT01405157|methylprednisolone|methylprednisolone
361383|NCT01405157|suspension|suspension
361384|NCT01405157|tablets|tablets
361385|NCT01405157|fasting|fasting
361386|NCT01405144|Photoaging|photoaging
361387|NCT01405144|Actinic keratosis|actinic keratosis
361388|NCT01405144|5-fluoruracil|5-fluoruracil
361389|NCT01405144|Carcinogenesis|carcinogenesis
361390|NCT01405131|bioequivalence study|bioequivalence study
361391|NCT01405131|methylprednisolone|methylprednisolone
361392|NCT01405131|suspension|suspension
361393|NCT01405131|tablets|tablets
361394|NCT01405118|Drug-Drug Interaction Healthy Volunteers CP-690|drug-drug interaction healthy volunteers cp-690
361395|NCT01405118|550 Metformin|550 metformin
361396|NCT01405092|volume|volume
361397|NCT01405092|acute kidney injury|acute kidney injury
361398|NCT01405092|continuous renal replacement|continuous renal replacement
361399|NCT01405079|Lung cancer|lung cancer
361400|NCT01405079|II-IIIA(N1-N2)|ii-iiia(n1-n2)
361401|NCT01405079|Adjuvant treatment|adjuvant treatment
361402|NCT01405079|EGFR mutations|egfr mutations
361403|NCT01405079|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
361404|NCT01405066|Computed Tomography (CT)|computed tomography (ct)
361405|NCT01405066|Ionizing radiation|ionizing radiation
361406|NCT01405066|Advanced medical imaging|advanced medical imaging
361407|NCT01405066|Radiation Dose Audit Reports|radiation dose audit reports
361408|NCT01405053|Central Nervous System|central nervous system
361409|NCT01405040|Cardiac|cardiac
361410|NCT01405040|Output|output
361411|NCT01405040|Preload|preload
361412|NCT01405040|Lung|lung
361413|NCT01405040|Water|water
361414|NCT01405027|HCV|hcv
361415|NCT01405027|Genotype1|genotype1
361416|NCT01405027|Naive|naive
361417|NCT01405027|Partial responder|partial responder
361418|NCT01405027|Relapser|relapser
361419|NCT01405014|Hold Me Tight|hold me tight
361420|NCT01405014|Emotionally Focused Therapy|emotionally focused therapy
361421|NCT01405014|Relationship enhancement|relationship enhancement
361422|NCT01405014|Couples counseling|couples counseling
361423|NCT01405014|Marital therapy|marital therapy
361424|NCT01405014|Acquired brain injury|acquired brain injury
361425|NCT01405014|Traumatic brain injury|traumatic brain injury
361426|NCT01405014|Stroke|stroke
361427|NCT01405001|Emergencies|emergencies
361428|NCT01405001|War|war
361429|NCT01405001|Intubation, Intratracheal|intubation, intratracheal
361430|NCT01404988|Heart Failure|heart failure
361431|NCT01404988|Telemedicine|telemedicine
361432|NCT01404988|Medication Adherence|medication adherence
361433|NCT01404975|Delirium|delirium
361434|NCT01404975|PVB|pvb
361435|NCT01404975|PCA|pca
361436|NCT01404975|Opioid|opioid
361437|NCT01404975|Aortic Valve replacement|aortic valve replacement
361438|NCT01404962|Haemophilus influenza type b|haemophilus influenza type b
361439|NCT01404962|children|children
361440|NCT01404962|Korea|korea
361441|NCT01404962|vaccine|vaccine
361442|NCT01404962|Prevention of haemophilus influenza type b|prevention of haemophilus influenza type b
361443|NCT01404949|Tretinoin|tretinoin
361444|NCT01404949|all-trans retinoic acid|all-trans retinoic acid
361445|NCT01404949|ATRA|atra
361446|NCT01404949|Vesanoid|vesanoid
361447|NCT01404949|Arsenic Trioxide|arsenic trioxide
361448|NCT01404949|ATO|ato
361449|NCT01404949|Trisenox|trisenox
361450|NCT01404949|11-040|11-040
361451|NCT01404936|Lymphoma|lymphoma
361452|NCT01404936|Hodgkin's Disease|hodgkin's disease
361453|NCT01404936|Stage III and IV|stage iii and iv
361454|NCT01404936|Adriamycin|adriamycin
361455|NCT01404936|Doxorubicin|doxorubicin
361456|NCT01404936|Rubex|rubex
361457|NCT01404936|Bleomycin|bleomycin
361458|NCT01404936|Bleomycin Sulfate|bleomycin sulfate
361459|NCT01404936|BLM|blm
361460|NCT01404936|Dacarbazine|dacarbazine
361461|NCT01404936|DTIC-DOME|dtic-dome
361462|NCT01404936|Interferon-2A|interferon-2a
361463|NCT01404936|Interferon-Alfa-2a|interferon-alfa-2a
361464|NCT01404936|Roferon-A|roferon-a
361465|NCT01404936|Velban|velban
361466|NCT01404936|Vinblastine|vinblastine
361467|NCT01404910|Pregnancy|pregnancy
361468|NCT01404910|Preeclampsia|preeclampsia
361469|NCT01404910|Pre-term|pre-term
361470|NCT01404910|sFlt-1|sflt-1
361471|NCT01404910|Apheresis|apheresis
361472|NCT01404910|Hypertension|hypertension
361473|NCT01404910|Proteinuria|proteinuria
361474|NCT01404910|VEGF|vegf
361475|NCT01404897|carbohydrate|carbohydrate
361476|NCT01404897|DASH diet|dash diet
361477|NCT01404897|blood pressure|blood pressure
361478|NCT01404897|cholesterol|cholesterol
361479|NCT01404884|myopia|myopia
361480|NCT01404884|astigmatism|astigmatism
361481|NCT01404884|presbyopia|presbyopia
361482|NCT01404884|SUPRACOR|supracor
361483|NCT01404884|multifocal|multifocal
361484|NCT01404871|OCD|ocd
361485|NCT01404871|pharmacogenetics|pharmacogenetics
361486|NCT01404871|cortical inhibition|cortical inhibition
361487|NCT01404871|genetics|genetics
361488|NCT01404858|IVF|ivf
361489|NCT01404858|Lifestyle habits|lifestyle habits
361490|NCT01404845|exudative AMD|exudative amd
361491|NCT01404845|dietary supplements|dietary supplements
361492|NCT01404845|macular pigment|macular pigment
361493|NCT01404845|lutein|lutein
361494|NCT01404845|zeaxanthin|zeaxanthin
361495|NCT01404845|Nutrof total|nutrof total
361496|NCT01404845|in one eye|in one eye
361497|NCT01404832|Gastroesophageal reflux|gastroesophageal reflux
361498|NCT01404832|Proton pump inhibitor|proton pump inhibitor
361499|NCT01404832|Eosinophilic esophagitis|eosinophilic esophagitis
361500|NCT01404793|Liver Transplantation|liver transplantation
361501|NCT01404793|Solid Phase Micro Extraction|solid phase micro extraction
361502|NCT01404793|Rocuronium|rocuronium
361503|NCT01404793|Metabolomics|metabolomics
361504|NCT01404793|Pharmacokinetics|pharmacokinetics
361505|NCT01404793|Clinical Marker|clinical marker
753321|NCT01176240|fatigue|fatigue
361506|NCT01404780|Double lumen ET intubation|double lumen et intubation
361507|NCT01404780|Laryngoscope|laryngoscope
361508|NCT01404780|Lung Surgery|lung surgery
361509|NCT01404767|Vascular surgery|vascular surgery
361510|NCT01404767|esmolol|esmolol
361511|NCT01404767|hemodynamic control|hemodynamic control
361512|NCT01404754|MDMA|mdma
361513|NCT01404754|mood|mood
361514|NCT01404754|subjective effects|subjective effects
361515|NCT01404754|interpersonal closeness|interpersonal closeness
361516|NCT01404741|MDS|mds
361517|NCT01404741|CMML|cmml
361518|NCT01404741|allogeneic stem cell transplantation|allogeneic stem cell transplantation
361519|NCT01404741|5-azacytidine|5-azacytidine
361520|NCT01404728|Vaginal length|vaginal length
361521|NCT01404728|Sexual dysfunction|sexual dysfunction
361522|NCT01404715|Drug drug interaction|drug drug interaction
361523|NCT01404702|Neuroblastoma|neuroblastoma
361524|NCT01404702|Pediatrics|pediatrics
361525|NCT01404702|Refractory|refractory
361526|NCT01404702|Immunotherapy|immunotherapy
361527|NCT01404702|Biological therapy|biological therapy
361528|NCT01404702|Lymphocytes|lymphocytes
361529|NCT01404702|Cancer|cancer
361530|NCT01404702|Bisphosphonate|bisphosphonate
361531|NCT01404689|dexmedetomidine|dexmedetomidine
361532|NCT01404689|midazolam|midazolam
361533|NCT01404689|ERCP|ercp
361534|NCT01404689|cholangiopancreatography|cholangiopancreatography
361535|NCT01404689|sedation|sedation
361536|NCT01404689|propofol|propofol
361537|NCT01404676|Glucose variability|glucose variability
361538|NCT01404676|Oxidative stress|oxidative stress
361539|NCT01404676|Endothelial cell function|endothelial cell function
361540|NCT01404663|bone marrow CD133 transplantation side effects|bone marrow cd133 transplantation side effects
361541|NCT01404663|side effects|side effects
361542|NCT01404650|GIST|gist
361543|NCT01404650|Refractory|refractory
361544|NCT01404650|Gastrointestinal|gastrointestinal
361545|NCT01404650|Stromal|stromal
361546|NCT01404650|Tumor|tumor
361547|NCT01404611|with tubes|with tubes
361548|NCT01404559|Amputee|amputee
361549|NCT01404559|Transtibial|transtibial
361550|NCT01404559|Military|military
361551|NCT01404559|Gait|gait
361552|NCT01404559|Rehabilitation|rehabilitation
361553|NCT01404546|stroke smoking cessation cost-free pharmacotherapy|stroke smoking cessation cost-free pharmacotherapy
361554|NCT01404533|NTBI|ntbi
361555|NCT01404533|Iron|iron
361556|NCT01404533|Absorption|absorption
361557|NCT01404520|#14 Cancer Related fatigue|#14 cancer related fatigue
361558|NCT01404520|#13 Quality of Life|#13 quality of life
361559|NCT01404520|"#12 Psychosocial Intervention[ti/ab]"|"#12 psychosocial intervention[ti/ab]"
361560|NCT01404520|#11 Rehabilitation[tw]|#11 rehabilitation[tw]
361561|NCT01404520|"#10 Physical Fitness[tw]"|"#10 physical fitness[tw]"
361562|NCT01404520|"#9 Physical Activity[tw]"|"#9 physical activity[tw]"
361563|NCT01404520|"#8 Exercise Therapy[tw]"|"#8 exercise therapy[tw]"
361564|NCT01404520|#7 Exercise[tw]|#7 exercise[tw]
361565|NCT01404520|#6 Hematologic[tw]|#6 hematologic[tw]
361566|NCT01404520|#5 Hematological[tw]|#5 hematological[tw]
361567|NCT01404520|#4 Leukemia, Myeloid, Acute[mh]|#4 leukemia, myeloid, acute[mh]
361568|NCT01404520|"#3 Acute Myeloid Leukemia[tw]"|"#3 acute myeloid leukemia[tw]"
361569|NCT01404520|"#2 Acute Lymphoblastic Leukemia[tw]"|"#2 acute lymphoblastic leukemia[tw]"
361570|NCT01404520|"#1 Acute Leukemia[tw]"|"#1 acute leukemia[tw]"
361571|NCT01404507|Acute Myocardial Infarction|acute myocardial infarction
361572|NCT01404494|Haptic Skills|haptic skills
361573|NCT01404494|Computer Assisted Interface|computer assisted interface
361574|NCT01404494|TBI|tbi
361575|NCT01404494|Traumatic Brain Injury|traumatic brain injury
361576|NCT01404481|Urinary retention|urinary retention
361577|NCT01404481|CISC|cisc
361578|NCT01404481|Single use|single use
361579|NCT01404481|Re use|re use
361580|NCT01404442|midazolam|midazolam
361581|NCT01404442|ketamine|ketamine
361582|NCT01404442|intrathecal|intrathecal
361583|NCT01404442|pain|pain
361584|NCT01404429|Rheumatoid arthritis|rheumatoid arthritis
361585|NCT01404429|Active|active
361586|NCT01404390|Phase I|phase i
361588|NCT01404377|breast surgery : postoperative pain; ropivacaine|breast surgery : postoperative pain; ropivacaine
361589|NCT01404364|Triamcinolone|triamcinolone
361590|NCT01404364|Chlorpromazine|chlorpromazine
361591|NCT01404364|Refractory glaucoma|refractory glaucoma
361592|NCT01404364|Blind painful eye|blind painful eye
361593|NCT01404351|Reduction mammaplasty|reduction mammaplasty
361594|NCT01404351|Breast reduction|breast reduction
361595|NCT01404351|PlasmaBlade|plasmablade
361596|NCT01404351|PEAK|peak
361597|NCT01404325|Lung transplantation|lung transplantation
361598|NCT01404325|everolimus|everolimus
361599|NCT01404325|kidney function|kidney function
361600|NCT01404299|Frailty,|frailty,
361601|NCT01404299|nutritional supplementation,|nutritional supplementation,
361602|NCT01404299|functional status|functional status
361603|NCT01404260|chemotherapy|chemotherapy
361604|NCT01404260|maintenance therapy|maintenance therapy
361605|NCT01404260|gefitinib|gefitinib
361606|NCT01404247|retina|retina
361607|NCT01404247|optic nerve|optic nerve
361608|NCT01404247|fovea|fovea
361609|NCT01404247|Eyes|eyes
361610|NCT01404247|Neonates|neonates
361611|NCT01404234|Cystic fibrosis|cystic fibrosis
361613|NCT01404234|PA|pa
361614|NCT01404234|Pseudomonas aeruginosa|pseudomonas aeruginosa
361615|NCT01404234|AZLI|azli
361616|NCT01404234|aztreonam|aztreonam
361617|NCT01404234|Chronic Pseudomonas aeruginosa|chronic pseudomonas aeruginosa
361618|NCT01404195|Nutritional supplement|nutritional supplement
361619|NCT01404195|CaHMB|cahmb
361620|NCT01404195|Barthel index|barthel index
361621|NCT01404195|Frailty|frailty
361622|NCT01404182|seasonal|seasonal
361623|NCT01404182|prevention|prevention
361624|NCT01404182|influenza|influenza
361625|NCT01404182|infection|infection
361626|NCT01404182|influenza vaccine|influenza vaccine
361627|NCT01404182|vaccine|vaccine
361628|NCT01404182|influenza in humans|influenza in humans
361629|NCT01404169|Alzheimer Disease|alzheimer disease
361630|NCT01404169|Dementia|dementia
361631|NCT01404169|Delirium|delirium
361632|NCT01404169|Amnestic|amnestic
361633|NCT01404169|Cognitive Disorders|cognitive disorders
361634|NCT01404169|Donepezil|donepezil
361635|NCT01404169|Brain Diseases|brain diseases
361636|NCT01404169|Central Nervous System Diseases|central nervous system diseases
361637|NCT01404169|Nervous System Diseases|nervous system diseases
361638|NCT01404169|Tauopathies|tauopathies
361639|NCT01404169|Neurodegenerative Diseases|neurodegenerative diseases
361640|NCT01404169|Mental Disorders|mental disorders
361641|NCT01404169|Cholinesterase Inhibitors|cholinesterase inhibitors
361642|NCT01404169|Enzy|enzy
361643|NCT01404156|Esophageal cancer|esophageal cancer
361644|NCT01404156|Neoadjuvant|neoadjuvant
361645|NCT01404156|Chemotherapy|chemotherapy
361646|NCT01404156|Chemoradiation|chemoradiation
361647|NCT01404156|Surgery|surgery
361648|NCT01404156|Esophagectomy|esophagectomy
361649|NCT01404156|Adenocarcinoma|adenocarcinoma
361650|NCT01404156|Gastroesophageal|gastroesophageal
361651|NCT01404130|isotretinoin|isotretinoin
361652|NCT01404130|hippocampus|hippocampus
361653|NCT01404130|memory|memory
361654|NCT01404130|learning|learning
361655|NCT01404130|CANTAB|cantab
361656|NCT01404065|transcranial direct current stimulation|transcranial direct current stimulation
361657|NCT01404052|transcranial direct current stimulation|transcranial direct current stimulation
361658|NCT01404052|transcranial ultrasound|transcranial ultrasound
361659|NCT01404039|learning|learning
361660|NCT01404039|pain perception|pain perception
361661|NCT01404026|Transcranial Direct Current Stimulation|transcranial direct current stimulation
361662|NCT01404013|Montelukast|montelukast
361663|NCT01404013|Cough variant asthma|cough variant asthma
361664|NCT01404013|Inhaled Corticosteroid|inhaled corticosteroid
361665|NCT01403987|Education|education
361666|NCT01403987|Ascites|ascites
361667|NCT01403987|Liver|liver
361668|NCT01403987|Guidelines|guidelines
361755|NCT01402531|Hereditary hemorrhagic telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
361756|NCT01402531|nosebleed|nosebleed
361757|NCT01402531|Bevacizumab|bevacizumab
361758|NCT01402531|Avastin|avastin
361669|NCT01403922|Phase I, Randomised, Placebo-Controlled, Double-Blind,Hypertensive Patients, Blood Pressure, Calcium Channel Blockers, Beta Blockers, ACE Inhibitors|phase i, randomised, placebo-controlled, double-blind,hypertensive patients, blood pressure, calcium channel blockers, beta blockers, ace inhibitors
361670|NCT01403922|Scientific terminology: To determine if treatment with TC5214 alone or in combination with Anti-Hypertensive Medications has an effect on sitting blood pressure|scientific terminology: to determine if treatment with tc5214 alone or in combination with anti-hypertensive medications has an effect on sitting blood pressure
361671|NCT01403922|Laymen terminology: Hypertension|laymen terminology: hypertension
361672|NCT01403896|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
361673|NCT01403896|Plerixafor|plerixafor
361674|NCT01403896|Healthy Donors|healthy donors
361675|NCT01403896|Stem Cell Graft|stem cell graft
352381|NCT01440530|Diabetes Internet Education|diabetes internet education
352382|NCT01440530|Diabetes Education|diabetes education
352383|NCT01440530|Diabetes Self-Care|diabetes self-care
361676|NCT01403883|Rectal cancer|rectal cancer
361677|NCT01403883|Temporary stoma|temporary stoma
361678|NCT01403883|Psychological disorders|psychological disorders
361679|NCT01403870|Low Back Pain|low back pain
361680|NCT01403857|Acceptability|acceptability
361681|NCT01403857|liking|liking
361682|NCT01403844|resonance Raman spectroscopy|resonance raman spectroscopy
361683|NCT01403844|Dietary Guidelines|dietary guidelines
361684|NCT01403844|fruits|fruits
361685|NCT01403844|biomarkers|biomarkers
361686|NCT01403844|carotenoids|carotenoids
361687|NCT01403844|MyPlate|myplate
361688|NCT01403844|vegetables|vegetables
361689|NCT01403818|ASP1941|asp1941
361690|NCT01403818|ipragliflozin|ipragliflozin
361691|NCT01403818|Mitiglinide calcium hydrate|mitiglinide calcium hydrate
361692|NCT01403818|Drug-Drug interaction|drug-drug interaction
361693|NCT01403818|Pharmacokinetics|pharmacokinetics
361694|NCT01403805|Oral care|oral care
361695|NCT01403805|Vaccine|vaccine
361696|NCT01403805|Pneumonia|pneumonia
361697|NCT01403805|Elderly|elderly
361698|NCT01403805|Prevention|prevention
361699|NCT01403805|Primary care|primary care
361700|NCT01403792|Human Immunodeficiency Virus|human immunodeficiency virus
361701|NCT01403792|Neutralising monoclonal antibody|neutralising monoclonal antibody
361702|NCT01403779|Intensity-Modulated Radiation Therapy (IMRT)|intensity-modulated radiation therapy (imrt)
361703|NCT01403779|Breast cancer|breast cancer
361704|NCT01403779|Hypofractionation|hypofractionation
361705|NCT01403766|pediatric|pediatric
361706|NCT01403766|kidney|kidney
361707|NCT01403766|transplant|transplant
361709|NCT01403766|creatinine|creatinine
361710|NCT01403766|cystatin C|cystatin c
361711|NCT01403766|iohexol|iohexol
361712|NCT01403753|Obesity|obesity
361713|NCT01403753|Child|child
361714|NCT01403753|Dietary Habits|dietary habits
361715|NCT01403740|acquired haemophilia|acquired haemophilia
361716|NCT01403740|factor VIII|factor viii
361717|NCT01403727|Biopsy of liver tumors|biopsy of liver tumors
361718|NCT01403714|acute heart failure|acute heart failure
361719|NCT01403701|physical therapy|physical therapy
361720|NCT01403701|pelvic prolapse|pelvic prolapse
361721|NCT01403701|incontinence|incontinence
361722|NCT01403701|quality of life|quality of life
361723|NCT01403688|fertility high risk, controlled ovarian stimulation, breast cancer|fertility high risk, controlled ovarian stimulation, breast cancer
361724|NCT01403675|women with cancer whose ovarian tissue has been collected and stored in liquid nitrogen before cancer therapy (surgery, chemotherapy, radiotherapy),|women with cancer whose ovarian tissue has been collected and stored in liquid nitrogen before cancer therapy (surgery, chemotherapy, radiotherapy),
361725|NCT01403675|who are in remission (no recurrence of disease for 5 years),|who are in remission (no recurrence of disease for 5 years),
361726|NCT01403675|who are in normal organ function and have no contraindication for surgery or pregnancy, and|who are in normal organ function and have no contraindication for surgery or pregnancy, and
361727|NCT01403675|who wish to restore ovarian function using stored ovarian tissue.|who wish to restore ovarian function using stored ovarian tissue.
361728|NCT01403662|bipolar disorder|bipolar disorder
361729|NCT01403662|depression|depression
361730|NCT01403662|major depression|major depression
361731|NCT01403662|bipolar I depression|bipolar i depression
361732|NCT01403662|bipolar II depression|bipolar ii depression
361733|NCT01403662|bipolar I disorder|bipolar i disorder
361734|NCT01403662|bipolar II disorder|bipolar ii disorder
361735|NCT01403662|minocycline|minocycline
361736|NCT01403662|minocin|minocin
361737|NCT01403623|Hypothermia|hypothermia
361738|NCT01403623|Newborn|newborn
361739|NCT01403623|Resuscitation|resuscitation
361740|NCT01403623|Plastic bag|plastic bag
361741|NCT01403610|TH-302|th-302
361742|NCT01403610|Bevacizumab|bevacizumab
361743|NCT01403610|Phase 2|phase 2
361744|NCT01403610|Glioma|glioma
361745|NCT01403610|High Grade Glioma|high grade glioma
361747|NCT01403597|Skin wrinkling|skin wrinkling
361748|NCT01403597|Skin aging|skin aging
361749|NCT01403597|Skin pigmentation|skin pigmentation
361750|NCT01402544|AMD|amd
361751|NCT01402544|Choroidal neovascularization|choroidal neovascularization
361752|NCT01402544|Ranibizumab|ranibizumab
361753|NCT01402544|Age-related Macular Degeneration|age-related macular degeneration
361754|NCT01402544|Genome|genome
361759|NCT01402518|achalasia|achalasia
361760|NCT01402518|myotomy|myotomy
361761|NCT01402518|endoscopic myotomy|endoscopic myotomy
361762|NCT01402518|difficulty swallowing|difficulty swallowing
361763|NCT01402505|obesity|obesity
361764|NCT01402505|sleeve gastrectomy|sleeve gastrectomy
361765|NCT01402505|transvaginal NOTES|transvaginal notes
361766|NCT01402492|Cocaine-Related disorders|cocaine-related disorders
361767|NCT01402492|Cocaine|cocaine
361768|NCT01402492|Substance-Related disorders|substance-related disorders
361769|NCT01402492|Opioid abuse|opioid abuse
361770|NCT01402492|Opioid dependence|opioid dependence
361771|NCT01402492|abuse|abuse
361772|NCT01402492|addiction|addiction
361773|NCT01402492|treatment|treatment
361774|NCT01402492|buprenorphine|buprenorphine
361775|NCT01402492|naltrexone|naltrexone
361776|NCT01402492|Suboxone|suboxone
361777|NCT01402492|Vivitrol|vivitrol
361778|NCT01402479|migraine,|migraine,
361779|NCT01402479|ramipril,|ramipril,
361780|NCT01402479|hypertension|hypertension
361781|NCT01402466|Drug users|drug users
361879|NCT01403298|Sexual risk|sexual risk
361782|NCT01402466|criminal justice|criminal justice
361783|NCT01402466|HIV care|hiv care
361784|NCT01402466|HAART|haart
361785|NCT01402466|incarceration|incarceration
361786|NCT01402453|Incentives|incentives
361787|NCT01402453|Social psychology|social psychology
361788|NCT01402453|Randomized trial|randomized trial
361789|NCT01402453|Hypertension|hypertension
361790|NCT01402453|Intervention|intervention
361791|NCT01402453|Pilot Study|pilot study
361792|NCT01402440|Diffuse Large B-Cell Lymphoma,|diffuse large b-cell lymphoma,
361793|NCT01402440|Phase 1,|phase 1,
361794|NCT01402440|CD79 Mutation|cd79 mutation
361795|NCT01402427|Coronary Artery Disease|coronary artery disease
361796|NCT01402427|Coronary Angiography|coronary angiography
361797|NCT01402427|Percutaneous Coronary Intervention|percutaneous coronary intervention
361798|NCT01402427|Transradial|transradial
361799|NCT01402427|Radial Artery Spasm|radial artery spasm
361800|NCT01402427|Verapamil|verapamil
361801|NCT01402427|Adverse Effects|adverse effects
361802|NCT01402414|atopic dermatitis|atopic dermatitis
361803|NCT01402414|NB-UVB|nb-uvb
361804|NCT01402414|phototherapy|phototherapy
361805|NCT01402414|balneophototherapy|balneophototherapy
361806|NCT01402414|Bath-PUVA|bath-puva
361807|NCT01402414|SCORAD index|scorad index
361808|NCT01402401|HER2+,|her2+,
361809|NCT01402401|Gastric Cancer,|gastric cancer,
361810|NCT01402401|HSP90,|hsp90,
361811|NCT01402401|2nd-line,|2nd-line,
361812|NCT01402401|Trastuzumab|trastuzumab
361813|NCT01402375|Pain Management|pain management
361814|NCT01402375|Emergency Medicine|emergency medicine
361815|NCT01402375|Extremity Injuries|extremity injuries
361816|NCT01402362|Ethiopians|ethiopians
361817|NCT01402362|Diabetes Mellitus|diabetes mellitus
361818|NCT01402362|Glucose tolerance|glucose tolerance
361819|NCT01402362|Israel|israel
361820|NCT01402362|Included in the year 2000 study|included in the year 2000 study
361821|NCT01402349|Chronic rhinosinusitis, SNOT 22, Quality of life|chronic rhinosinusitis, snot 22, quality of life
361822|NCT01403545|Safety|safety
361823|NCT01403545|Tolerability|tolerability
361824|NCT01403545|Pharmacokinetics|pharmacokinetics
361825|NCT01403545|Liposomal Curcumin|liposomal curcumin
361826|NCT01403532|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
361827|NCT01403532|Kallmann Syndrome|kallmann syndrome
361828|NCT01403532|LH|lh
361829|NCT01403532|FSH|fsh
361830|NCT01403506|kidney transplantation|kidney transplantation
361831|NCT01403506|N-Acetyl Cysteine|n-acetyl cysteine
361832|NCT01403506|living donor|living donor
361833|NCT01403506|delayed graft function|delayed graft function
361834|NCT01403493|Irritable bowel syndrome|irritable bowel syndrome
361835|NCT01403493|Patient education|patient education
361836|NCT01403480|Basal Cell Carcinoma|basal cell carcinoma
361837|NCT01403467|Bronchial disease|bronchial disease
361838|NCT01403467|asthma|asthma
361839|NCT01403467|continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
361840|NCT01403467|Bronchoconstriction|bronchoconstriction
361841|NCT01403454|chronic kidney disease|chronic kidney disease
361842|NCT01403454|web-based application|web-based application
361843|NCT01403454|dialysis education|dialysis education
361844|NCT01403441|Refractory Bipolar Depression|refractory bipolar depression
361845|NCT01403428|Asthma|asthma
361846|NCT01403428|non invasive ventilation|non invasive ventilation
361847|NCT01403428|pediatrics|pediatrics
361848|NCT01403428|noninvasive positive pressure ventilation (NPPV)|noninvasive positive pressure ventilation (nppv)
361849|NCT01403402|Congenital Muscular Dystrophy|congenital muscular dystrophy
361850|NCT01403402|Congenital Myopathy|congenital myopathy
361851|NCT01403402|Neuromuscular Diseases|neuromuscular diseases
361852|NCT01403402|Musculoskeletal Diseases|musculoskeletal diseases
361853|NCT01403389|Kidney Transplant|kidney transplant
361854|NCT01403389|Delayed Graft Function|delayed graft function
361855|NCT01403350|Malaria|malaria
361856|NCT01403350|Fever|fever
361857|NCT01403350|Acute febrile illness|acute febrile illness
361858|NCT01403350|Pneumonia|pneumonia
361859|NCT01403350|Community health worker|community health worker
361860|NCT01403350|Rapid diagnostic test|rapid diagnostic test
361861|NCT01403337|peripheral arterial disease|peripheral arterial disease
361862|NCT01403337|myocardial infarction|myocardial infarction
361863|NCT01403324|metastatic or locally advanced differentiated thyroid cancer|metastatic or locally advanced differentiated thyroid cancer
352583|NCT01439776|SVR|svr
361864|NCT01403324|planned for a therapeutic activity of 131I after thyroid hormone withdrawal|planned for a therapeutic activity of 131i after thyroid hormone withdrawal
361865|NCT01403311|Anaplastic astrocytoma|anaplastic astrocytoma
361866|NCT01403311|Astrocytoma|astrocytoma
361867|NCT01403311|Brain stem glioma|brain stem glioma
361868|NCT01403311|Ependymoma|ependymoma
361869|NCT01403311|Glioblastoma|glioblastoma
361870|NCT01403311|Glioblastoma multiforme|glioblastoma multiforme
361871|NCT01403311|Gliosarcoma|gliosarcoma
361872|NCT01403311|oligodendroglioma|oligodendroglioma
361873|NCT01403311|Medulloblastoma|medulloblastoma
361874|NCT01403311|Mixed astrocytoma-ependymoma|mixed astrocytoma-ependymoma
361875|NCT01403311|ALA|ala
361876|NCT01403298|Adolescent|adolescent
361877|NCT01403298|HIV|hiv
361878|NCT01403298|AIDS|aids
361882|NCT01403298|Juvenile Drug Court|juvenile drug court
361883|NCT01403298|Juvenile Justice|juvenile justice
361884|NCT01403298|Drug Use|drug use
361885|NCT01403298|Marijuana|marijuana
361886|NCT01403285|Glioblastoma|glioblastoma
361887|NCT01403285|stable disease|stable disease
361888|NCT01403272|pressure ulcers|pressure ulcers
361889|NCT01403272|stage 1|stage 1
361890|NCT01403272|stage 2|stage 2
361891|NCT01403272|stage 3|stage 3
361892|NCT01403272|stage 4|stage 4
361893|NCT01403272|wounds|wounds
361894|NCT01403272|sores|sores
361895|NCT01403272|infection|infection
361896|NCT01403272|bioburden|bioburden
361897|NCT01403272|bacterial contamination|bacterial contamination
361898|NCT01403272|bed linen|bed linen
361899|NCT01403272|sheets|sheets
361900|NCT01403272|underpad|underpad
361901|NCT01403272|skin assessment|skin assessment
361902|NCT01403272|microclimate|microclimate
361903|NCT01403272|shear|shear
361904|NCT01403272|friction|friction
361905|NCT01403272|moisture|moisture
361907|NCT01403272|long term care|long term care
361908|NCT01403272|nursing home|nursing home
361909|NCT01403272|decubitus ulcer|decubitus ulcer
361910|NCT01403272|bed ridden|bed ridden
361911|NCT01403272|anti-microbial|anti-microbial
361912|NCT01403259|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
361913|NCT01403259|S-1|s-1
361914|NCT01403259|Oxaliplatin|oxaliplatin
361915|NCT01403246|CLL|cll
361916|NCT01403246|Lenalidomide|lenalidomide
361917|NCT01403246|Chlorambucil|chlorambucil
361918|NCT01403246|No previous treatment|no previous treatment
734092|NCT01092923|emergence|emergence
361919|NCT01403233|Pharmacokinetics|pharmacokinetics
361920|NCT01403233|Safety|safety
361921|NCT01403207|Sex differences|sex differences
361922|NCT01403207|knee joint|knee joint
361923|NCT01403207|inflammatory mediators|inflammatory mediators
361924|NCT01403207|Vitamin D|vitamin d
361925|NCT01403207|osteoarthritis|osteoarthritis
361926|NCT01403194|Sleep Disordered Breathing|sleep disordered breathing
361927|NCT01403194|CPAP|cpap
361928|NCT01403194|BiPAP|bipap
361929|NCT01403194|Cardiovascular risk markers|cardiovascular risk markers
361930|NCT01403181|HCV|hcv
361931|NCT01403181|T cells|t cells
361932|NCT01403181|cytokines|cytokines
361933|NCT01403181|cytotoxicity|cytotoxicity
361934|NCT01403181|proliferation|proliferation
361935|NCT01403168|Osteopathy|osteopathy
361936|NCT01403168|Breast cancer|breast cancer
361937|NCT01403168|Pain|pain
361938|NCT01403155|H5N1|h5n1
361939|NCT01403155|Avian Influenza|avian influenza
361940|NCT01403155|DNA Vaccine|dna vaccine
361941|NCT01403155|Intradermal (ID) Injection|intradermal (id) injection
361942|NCT01403155|Electroporation|electroporation
361943|NCT01403155|Healthy Adults|healthy adults
361946|NCT01403129|keratoconus|keratoconus
361947|NCT01403129|keratoconus-suspect|keratoconus-suspect
361948|NCT01403129|ultrasound exam|ultrasound exam
361949|NCT01403129|acoustic radiation force ultrasound exam|acoustic radiation force ultrasound exam
361950|NCT01403116|testosterone|testosterone
361951|NCT01403116|male hypogonadism|male hypogonadism
361952|NCT01403116|low testosterone|low testosterone
361953|NCT01403090|Pulmonary Embolism|pulmonary embolism
361954|NCT01403090|Deep Vein Thrombosis|deep vein thrombosis
361955|NCT01403090|Venous Thromboembolism|venous thromboembolism
361956|NCT01403090|Central Line Catheter|central line catheter
361957|NCT01403090|Vena Cava Filters|vena cava filters
361958|NCT01403077|Superficial femoral artery|superficial femoral artery
361959|NCT01403077|Peripheral arterial disease|peripheral arterial disease
361960|NCT01403077|Atherosclerosis|atherosclerosis
361961|NCT01403077|Intermittent Claudication|intermittent claudication
361962|NCT01403077|Vascular Diseases|vascular diseases
361963|NCT01403077|Cardiovascular Diseases|cardiovascular diseases
361964|NCT01403064|Oral mucositis; head and neck cancer; chemotherapy; radiotherapy|oral mucositis; head and neck cancer; chemotherapy; radiotherapy
361965|NCT01403038|healthy volunteers|healthy volunteers
361966|NCT01403038|elagolix|elagolix
361967|NCT01403038|endometriosis|endometriosis
361968|NCT01403038|ovarian reserve|ovarian reserve
361969|NCT01403038|gonadotropin-releasing hormone antagonist|gonadotropin-releasing hormone antagonist
361970|NCT01403038|ovulation|ovulation
361971|NCT01403038|ovarian activity|ovarian activity
361972|NCT01403012|To identify clinical and metabolomic markers that underlie variability in response to systemic therapy in psoriasis|to identify clinical and metabolomic markers that underlie variability in response to systemic therapy in psoriasis
361973|NCT01403012|To identify metabolomic signatures associated with psoriasis|to identify metabolomic signatures associated with psoriasis
361974|NCT01403012|To identify possible treatment-specific metabolomic signatures|to identify possible treatment-specific metabolomic signatures
361975|NCT01402999|Growth disorders|growth disorders
361976|NCT01402999|Saizen|saizen
361977|NCT01402999|Easypod|easypod
361978|NCT01402999|Growth hormone|growth hormone
361979|NCT01402999|Pediatric subject|pediatric subject
361980|NCT01402986|Asthma|asthma
361981|NCT01402986|Tralokinumab|tralokinumab
361982|NCT01402986|CAT-354|cat-354
361983|NCT01402960|High-Definition Transcranial Direct Current Stimulation|high-definition transcranial direct current stimulation
361984|NCT01402908|Hepatocellular Carcinoma|hepatocellular carcinoma
361985|NCT01402908|PI-88|pi-88
361986|NCT01402908|Phase III|phase iii
361987|NCT01402908|Adjuvant Therapy|adjuvant therapy
361988|NCT01402908|Hepatoma|hepatoma
361989|NCT01402908|Liver Cancer|liver cancer
361990|NCT01402895|Nerve conduction|nerve conduction
361991|NCT01402895|H-reflex, mobilizations|h-reflex, mobilizations
361992|NCT01402895|with neurodynamic component|with neurodynamic component
361993|NCT01402882|traumatic brain injury|traumatic brain injury
361994|NCT01402882|tranexamic acid|tranexamic acid
361995|NCT01402882|antifibrinolytic|antifibrinolytic
361996|NCT01402882|randomised|randomised
361997|NCT01402882|clinical trial|clinical trial
361998|NCT01402869|Methemoglobin|methemoglobin
361999|NCT01402869|Methemoglobinemia|methemoglobinemia
362000|NCT01402869|Prilocaine|prilocaine
362001|NCT01402869|Lidocaine|lidocaine
362002|NCT01402856|Prevention|prevention
361612|NCT01404234|CF|cf
362004|NCT01402856|Trauma|trauma
362005|NCT01402856|Driving|driving
362006|NCT01402843|phase III combination study|phase iii combination study
362007|NCT01402830|cancer|cancer
362008|NCT01402830|depression|depression
362009|NCT01402830|pain|pain
362010|NCT01402817|NF1|nf1
362011|NCT01402817|plexiform neurofibromas|plexiform neurofibromas
362012|NCT01402817|Sunitinib|sunitinib
362013|NCT01402817|Sutent®|sutent®
362014|NCT01402739|PoC|poc
362015|NCT01402739|ROTEM|rotem
362016|NCT01402739|Multiplate|multiplate
362017|NCT01402739|transfusion|transfusion
362018|NCT01402739|cardiac surgery|cardiac surgery
362019|NCT01402739|drainage blood loss|drainage blood loss
362020|NCT01402739|chest tube output|chest tube output
362021|NCT01402726|renal artery|renal artery
362022|NCT01402726|sympathetic nerves|sympathetic nerves
362023|NCT01402726|modification|modification
362024|NCT01402726|heart failure|heart failure
362025|NCT01402700|Peripheral arterial disease|peripheral arterial disease
362026|NCT01402700|claudication|claudication
362027|NCT01402700|stent|stent
362028|NCT01402700|VISI-Pro|visi-pro
362029|NCT01402700|Iliac artery|iliac artery
362030|NCT01402687|Stem Cell Transplant|stem cell transplant
362031|NCT01402687|Mucositis|mucositis
362032|NCT01402674|Obesity treatment|obesity treatment
362033|NCT01402674|Phentermine|phentermine
362034|NCT01402674|Withholding treatment|withholding treatment
362035|NCT01402674|Phentermine dependence|phentermine dependence
362036|NCT01402661|rheumatoid arthritis|rheumatoid arthritis
362037|NCT01402661|psoriatic arthritis|psoriatic arthritis
362038|NCT01402661|disease registry|disease registry
362039|NCT01402648|Non adenomatous mucosa|non adenomatous mucosa
362040|NCT01402648|Estrogen Receptor beta and apoptosis|estrogen receptor beta and apoptosis
362041|NCT01402648|Adenoma recurrence|adenoma recurrence
362042|NCT01402648|Screening colonoscopy every 3-5 years|screening colonoscopy every 3-5 years
362043|NCT01402648|patients at intermediate risk for CRC|patients at intermediate risk for crc
362044|NCT01402635|crowding|crowding
362045|NCT01402635|Point-of-Care Systems|point-of-care systems
362046|NCT01402635|emergency medicine|emergency medicine
362047|NCT01402609|Continuity of care|continuity of care
362048|NCT01402609|Patient safety|patient safety
362049|NCT01402609|Communication between acute and community care providers|communication between acute and community care providers
362050|NCT01402596|Deep Sedation|deep sedation
362051|NCT01402596|Pediatrics|pediatrics
362052|NCT01402596|Emergency Hospital Services|emergency hospital services
362053|NCT01402596|Midazolam|midazolam
362054|NCT01402596|Chloral hydrate|chloral hydrate
362055|NCT01402596|Randomized controlled trial|randomized controlled trial
362056|NCT01402583|Hepatitis C|hepatitis c
362057|NCT01402583|Gender|gender
362058|NCT01402583|Menopause|menopause
362059|NCT01402583|Sustained viral response|sustained viral response
362060|NCT01402583|Cytokines|cytokines
362061|NCT01402570|disability|disability
362062|NCT01402570|polio|polio
362063|NCT01402570|rehabilitation|rehabilitation
362064|NCT01402570|wellness|wellness
362065|NCT01402557|Obesity|obesity
362066|NCT01402557|Body Weight Changes|body weight changes
362067|NCT01402557|Internet|internet
362068|NCT01402336|Polycystic ovary syndrome|polycystic ovary syndrome
362069|NCT01402336|ovulation induction|ovulation induction
362070|NCT01402336|In vitro fertilization-embryo transfer|in vitro fertilization-embryo transfer
362071|NCT01402310|Onset of labor|onset of labor
362072|NCT01402310|Bishop score|bishop score
362073|NCT01402310|Cervical length|cervical length
362074|NCT01402310|Multiple proteins|multiple proteins
362075|NCT01402310|Cervicovaginal fluid|cervicovaginal fluid
362076|NCT01402297|apocynin|apocynin
362077|NCT01402297|COPD|copd
362078|NCT01402284|Novel Drug Combinations|novel drug combinations
362079|NCT01402284|Protease Inhibitors|protease inhibitors
362080|NCT01402284|Decreased Peripheral Neuropathy|decreased peripheral neuropathy
362081|NCT01402284|Auto Stem Cell Transplant|auto stem cell transplant
362082|NCT01402284|Multiple Myeloma|multiple myeloma
362083|NCT01402271|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
362084|NCT01402271|recurrent fallopian tube cancer|recurrent fallopian tube cancer
362085|NCT01402271|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
362086|NCT01402245|pneumonia|pneumonia
362087|NCT01402245|pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
362088|NCT01402245|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
362089|NCT01402232|contrast-induced nephropathy|contrast-induced nephropathy
362090|NCT01402232|contrast medium|contrast medium
362091|NCT01402232|creatinine clearance|creatinine clearance
362092|NCT01402232|coronary angiography|coronary angiography
362093|NCT01402232|diabetes|diabetes
362094|NCT01402232|chronic kidney disease|chronic kidney disease
362095|NCT01402232|predictive model|predictive model
362096|NCT01402219|contrast-induced nephropathy|contrast-induced nephropathy
362097|NCT01402219|contrast medium|contrast medium
362098|NCT01402219|creatinine clearance|creatinine clearance
362099|NCT01402219|coronary angiography|coronary angiography
362100|NCT01402219|chronic kidney disease|chronic kidney disease
362101|NCT01402206|Depression|depression
362102|NCT01402206|Intervention|intervention
362103|NCT01402206|Primary health care|primary health care
362104|NCT01402193|Breast Cancer|breast cancer
362105|NCT01402193|Timing of Radiotherapy|timing of radiotherapy
362106|NCT01402193|TGF-beta1|tgf-beta1
362107|NCT01402180|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
362108|NCT01402180|lymph nodes recurrence|lymph nodes recurrence
362109|NCT01402180|chemoradiation|chemoradiation
362110|NCT01402180|Nimotuzumab|nimotuzumab
362111|NCT01402141|Chungkookjang|chungkookjang
362112|NCT01402141|histamine|histamine
362113|NCT01402141|skin reaction|skin reaction
362114|NCT01402141|wheal|wheal
362115|NCT01402128|Soluble fiber|soluble fiber
362116|NCT01402128|Polycan|polycan
362117|NCT01402128|Overweight|overweight
362118|NCT01402128|LDL-C(Low Density Lipoprotein-cholesterol)|ldl-c(low density lipoprotein-cholesterol)
362119|NCT01402115|Polycan|polycan
362120|NCT01402115|Bone metabolism|bone metabolism
362121|NCT01402115|Osteocalcin|osteocalcin
362122|NCT01402115|Deoxypyridinoline|deoxypyridinoline
362123|NCT01402102|Aged garlic|aged garlic
362124|NCT01402102|Hyperlipidemic|hyperlipidemic
362125|NCT01402102|LDL|ldl
362126|NCT01402102|HDL|hdl
362127|NCT01402102|Triglyceride|triglyceride
362128|NCT01402089|phenotyping|phenotyping
362129|NCT01402089|cytochrome p450|cytochrome p450
362130|NCT01402089|erlotinib|erlotinib
362131|NCT01402089|sunitinib|sunitinib
362132|NCT01402089|lung cancer|lung cancer
362133|NCT01402089|renal-cell cancer|renal-cell cancer
362134|NCT01402089|gastrointestinal stromal tumor|gastrointestinal stromal tumor
362135|NCT01402076|Pharmacokinetics|pharmacokinetics
362136|NCT01402076|Drug Interaction|drug interaction
362137|NCT01402063|Brain Tumors|brain tumors
362138|NCT01402063|Glioblastoma Multiforme|glioblastoma multiforme
362139|NCT01402063|GBM|gbm
362140|NCT01402050|Time from the start of the induction to delivery|time from the start of the induction to delivery
362141|NCT01402037|type 1 diabetes|type 1 diabetes
362142|NCT01402037|Prevention|prevention
362143|NCT01402037|First degree relatives|first degree relatives
362144|NCT01402037|High risk for type 1 diabetes|high risk for type 1 diabetes
362145|NCT01402011|Prolotherapy|prolotherapy
362146|NCT01402011|regenerative injection therapy|regenerative injection therapy
362147|NCT01402011|dextrose injections|dextrose injections
362148|NCT01401998|cystic kidney disease|cystic kidney disease
362149|NCT01401998|polycystic kidney disease|polycystic kidney disease
362150|NCT01401998|congenital hepatic fibrosis|congenital hepatic fibrosis
362151|NCT01401998|genetic disease|genetic disease
362152|NCT01401985|Opioid induced constipation|opioid induced constipation
362153|NCT01401985|OIC|oic
362154|NCT01401985|Constipation|constipation
362155|NCT01401985|Opioid side effects|opioid side effects
362156|NCT01401985|morphine induced constipation|morphine induced constipation
362157|NCT01401972|prostate|prostate
362158|NCT01401972|cancer|cancer
362159|NCT01401972|ultrasound|ultrasound
362160|NCT01401972|spectroscopy|spectroscopy
362365|NCT01400971|Diabetes|diabetes
362161|NCT01401959|Metastatic Breast Cancer|metastatic breast cancer
362162|NCT01401959|Adjuvant|adjuvant
362163|NCT01401959|Residual Disease|residual disease
362164|NCT01401959|eribulin|eribulin
362165|NCT01401959|Trastuzumab|trastuzumab
362166|NCT01401920|internal jugular vein cannulation|internal jugular vein cannulation
362167|NCT01401920|cross-sectional area|cross-sectional area
362168|NCT01401920|passive leg elevation|passive leg elevation
362169|NCT01401920|trendelenburg position|trendelenburg position
362170|NCT01401920|open heart surgery|open heart surgery
362171|NCT01401907|Palliative care|palliative care
362172|NCT01401907|Lung|lung
362173|NCT01401907|Gastric|gastric
362174|NCT01401907|Liver|liver
362175|NCT01401907|Pancreatic|pancreatic
362176|NCT01401907|Esophageal|esophageal
362177|NCT01401907|Caregiver|caregiver
362178|NCT01401894|advanced cancer|advanced cancer
362179|NCT01401868|solid tumor|solid tumor
362180|NCT01401868|recurrent|recurrent
362181|NCT01401868|advanced|advanced
362182|NCT01401868|metastatic|metastatic
362183|NCT01401855|Diagnosis|diagnosis
362184|NCT01401855|Fine Needle Aspiration Biopsy|fine needle aspiration biopsy
362185|NCT01401842|low back muscular strength and endurance|low back muscular strength and endurance
362186|NCT01401829|endometrial cancer|endometrial cancer
362187|NCT01401829|aerobic walking|aerobic walking
362188|NCT01401829|stretching/flexibility exercises|stretching/flexibility exercises
362189|NCT01401829|quality of life|quality of life
362190|NCT01401816|Adolescents|adolescents
362191|NCT01401816|Sexually Active|sexually active
362192|NCT01401816|Unprotected Sex|unprotected sex
362193|NCT01401816|Emergency Contraception|emergency contraception
362194|NCT01401803|periorbital|periorbital
362195|NCT01401803|glabella|glabella
362196|NCT01401803|ptosis|ptosis
362197|NCT01401803|eyelid|eyelid
362198|NCT01401803|brow|brow
362199|NCT01401790|Children|children
362200|NCT01401790|Adolescents|adolescents
362201|NCT01401790|Telehomecare|telehomecare
751938|NCT01171287|Orthopedic Fixation Devices|orthopedic fixation devices
362203|NCT01401751|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
362204|NCT01401751|Artificial Pancreas|artificial pancreas
362205|NCT01401738|Shoulder Arthroscopic Surgery|shoulder arthroscopic surgery
362206|NCT01401725|venous thromboembolism|venous thromboembolism
362207|NCT01401725|thromboprophylaxis|thromboprophylaxis
362208|NCT01401725|anticoagulants|anticoagulants
362209|NCT01401725|hospitalized medical patients|hospitalized medical patients
362210|NCT01401725|electronic order sets|electronic order sets
362211|NCT01401725|decision support|decision support
362212|NCT01401725|knowledge translation|knowledge translation
362213|NCT01401725|patient safety|patient safety
362215|NCT01401712|epidural|epidural
362216|NCT01401712|analgesia|analgesia
362217|NCT01401699|Barrett's|barrett's
362218|NCT01401699|esophagus|esophagus
362220|NCT01401699|imaging|imaging
362221|NCT01401673|Chronic Cough|chronic cough
362222|NCT01401673|Indantadol|indantadol
362223|NCT01401660|low back pain|low back pain
362224|NCT01401647|cardiac arrest|cardiac arrest
362225|NCT01401647|cardiopulmonary resuscitation|cardiopulmonary resuscitation
362226|NCT01401647|ventricular fibrillation|ventricular fibrillation
362227|NCT01401647|pulseless ventricular tachycardia|pulseless ventricular tachycardia
362228|NCT01401647|Non-traumatic Out of Hospital Cardiac Arrest (OOHCA)|non-traumatic out of hospital cardiac arrest (oohca)
362229|NCT01401634|Hyperglycemia Hydration|hyperglycemia hydration
362230|NCT01401621|behavioral economics|behavioral economics
362231|NCT01401621|nudge|nudge
362232|NCT01401621|scratch off|scratch off
362233|NCT01401621|blood pressure check|blood pressure check
362234|NCT01401621|cholesterol test|cholesterol test
362235|NCT01401608|VT|vt
362236|NCT01401608|ventricular tachycardia|ventricular tachycardia
362237|NCT01401608|ablation|ablation
362238|NCT01401608|magnetic navigation|magnetic navigation
362239|NCT01401608|robotic|robotic
362240|NCT01401582|health care|health care
362241|NCT01401582|dementia care|dementia care
362242|NCT01401582|caregiver support|caregiver support
362243|NCT01401582|epidemiological study|epidemiological study
362244|NCT01401569|Exercise,|exercise,
362245|NCT01401569|counseling,|counseling,
362246|NCT01401569|smoking cessation,|smoking cessation,
362247|NCT01401569|depressive disorders|depressive disorders
362248|NCT01401556|osteoporosis|osteoporosis
362249|NCT01401556|fracture|fracture
362250|NCT01401556|treatment|treatment
362251|NCT01401556|guidelines|guidelines
362252|NCT01401556|quality|quality
362253|NCT01401543|testosterone|testosterone
362254|NCT01401543|energy|energy
362255|NCT01401543|libido|libido
362256|NCT01401543|erectile function|erectile function
362257|NCT01401543|weak muscles|weak muscles
362258|NCT01401530|Neoplasms|neoplasms
362259|NCT01401530|Neoplasms by Histologic Type|neoplasms by histologic type
362260|NCT01401530|Lymphoma|lymphoma
362261|NCT01401530|Non-Hodgkin|non-hodgkin
362262|NCT01401530|T- Cell|t- cell
362263|NCT01401530|Lymphatic Diseases|lymphatic diseases
362264|NCT01401530|Lymphoproliferative Disorders|lymphoproliferative disorders
362265|NCT01401530|lmmune System Diseases|lmmune system diseases
362266|NCT01401530|lmmunoproliferative Disorders|lmmunoproliferative disorders
362267|NCT01401504|Anti-cancer|anti-cancer
362268|NCT01401504|ASP3026|asp3026
362269|NCT01401504|Anaplastic Lymphoma Kinase (ALK)|anaplastic lymphoma kinase (alk)
362270|NCT01401491|schizophrenia|schizophrenia
362271|NCT01401491|clozapine|clozapine
362272|NCT01401491|fluvoxamine|fluvoxamine
362273|NCT01401491|metabolic syndrome|metabolic syndrome
362274|NCT01401478|Secondary Hyperparathyroidism|secondary hyperparathyroidism
362275|NCT01401478|Chronic Renal Insufficiency|chronic renal insufficiency
362276|NCT01401465|perennial allergic rhinitis|perennial allergic rhinitis
362277|NCT01401465|PAR|par
362278|NCT01401452|Monoclonals|monoclonals
362279|NCT01401452|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
362280|NCT01401452|Psoriasis Area & Severity Index (PASI)|psoriasis area & severity index (pasi)
362281|NCT01401452|Adalimumab|adalimumab
362282|NCT01401452|Biological disease modifying anti-rheumatic drugs (BDMARD)|biological disease modifying anti-rheumatic drugs (bdmard)
362283|NCT01401452|Co-morbidities|co-morbidities
362284|NCT01401452|Antibodies|antibodies
362285|NCT01401452|Disease Life Quality Index (DLQI)|disease life quality index (dlqi)
362286|NCT01401439|cystic fibrosis|cystic fibrosis
362287|NCT01401439|body mass index|body mass index
362288|NCT01401439|fat free mass|fat free mass
362289|NCT01401439|Children with cystic fibrosis|children with cystic fibrosis
362290|NCT01401426|overweight|overweight
362291|NCT01401426|Obesity, Morbid|obesity, morbid
362292|NCT01401374|Vitiligo Vulgaris|vitiligo vulgaris
362293|NCT01401374|Autoimmunity|autoimmunity
362294|NCT01401374|Thyroid Disease|thyroid disease
362295|NCT01401296|Depression|depression
362296|NCT01401296|Online-Therapy|online-therapy
362297|NCT01401296|Deprexis|deprexis
362298|NCT01401296|Self-help|self-help
362299|NCT01401257|PXT3003|pxt3003
362300|NCT01401257|Charcot-Marie-Tooth Disease|charcot-marie-tooth disease
362301|NCT01401257|Hereditary Motor and Sensory Neuropathies|hereditary motor and sensory neuropathies
362303|NCT01401231|pregnancy|pregnancy
362304|NCT01401218|thoracic aortic surgery|thoracic aortic surgery
362305|NCT01401218|acute kidney injury|acute kidney injury
362306|NCT01401205|shoulder arthroscopic surgery|shoulder arthroscopic surgery
362307|NCT01401205|dyspnea|dyspnea
362308|NCT01401205|airway diameter|airway diameter
362309|NCT01401192|thymidylate synthase|thymidylate synthase
362310|NCT01401179|Preterm Premature Rupture of Fetal Membranes|preterm premature rupture of fetal membranes
362311|NCT01401179|antibiotic therapy|antibiotic therapy
362312|NCT01401140|Coronary Artery Bypass|coronary artery bypass
362313|NCT01401140|Coronary Artery Surgery|coronary artery surgery
362314|NCT01401140|Coronary Artery Bypass Graft|coronary artery bypass graft
362315|NCT01401140|Coronary Revascularization|coronary revascularization
362316|NCT01401140|Cardiac microdialysis|cardiac microdialysis
362317|NCT01401140|Custodiol|custodiol
362318|NCT01401140|St Thomas|st thomas
362319|NCT01401140|Cardioplegic solutions|cardioplegic solutions
362320|NCT01401127|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
362321|NCT01401127|Exercise|exercise
362322|NCT01401127|Continuous Subcutaneous Insulin Infusion|continuous subcutaneous insulin infusion
362323|NCT01401127|CSII|csii
362324|NCT01401127|Insulin Pump Therapy|insulin pump therapy
362325|NCT01401114|Wellnara|wellnara
362326|NCT01401114|Postmenopausal osteoporosis|postmenopausal osteoporosis
362327|NCT01401101|mental health|mental health
362328|NCT01401101|PTSD|ptsd
362329|NCT01401101|primary care|primary care
362330|NCT01401101|quality improvement|quality improvement
362331|NCT01401101|collaborative care|collaborative care
362332|NCT01401088|patient with refractory glaucoma|patient with refractory glaucoma
362333|NCT01401075|Quality of Life|quality of life
362334|NCT01401075|QoL|qol
362335|NCT01401075|EORTC QLQ-C30|eortc qlq-c30
362336|NCT01401075|EORTC QLQ-STO22|eortc qlq-sto22
362337|NCT01401075|5-FU|5-fu
362338|NCT01401075|Viscum album|viscum album
362339|NCT01401062|metastatic breast cancer|metastatic breast cancer
362340|NCT01401062|TGF-beta|tgf-beta
362341|NCT01401062|fresolimumab|fresolimumab
362342|NCT01401062|monoclonal antibody|monoclonal antibody
362343|NCT01401062|radiation therapy|radiation therapy
362344|NCT01401062|abscopal response|abscopal response
362345|NCT01401049|Fospropofol|fospropofol
362346|NCT01401049|Propofol|propofol
362347|NCT01401049|Colonoscopy|colonoscopy
362348|NCT01401049|Lusedra|lusedra
362349|NCT01401036|acute myocardial infarction|acute myocardial infarction
362350|NCT01401036|stents|stents
362351|NCT01401036|angioplasty|angioplasty
362352|NCT01401036|thrombosis|thrombosis
362353|NCT01401010|neutropenia|neutropenia
362354|NCT01401010|doripenem|doripenem
362355|NCT01400997|Growth disorders|growth disorders
362356|NCT01400997|Saizen|saizen
362357|NCT01400997|Easypod|easypod
362358|NCT01400997|Growth hormone|growth hormone
362359|NCT01400997|Pediatric subject|pediatric subject
362360|NCT01400984|Growth disorders|growth disorders
362361|NCT01400984|Saizen|saizen
362362|NCT01400984|Easypod|easypod
362363|NCT01400984|Growth hormone|growth hormone
362364|NCT01400984|Pediatric subject|pediatric subject
362366|NCT01400971|Insulin|insulin
362367|NCT01400971|Progression|progression
362368|NCT01400971|Patient Reported Measures|patient reported measures
362369|NCT01400971|Adherence|adherence
362370|NCT01400971|Heterogeneity|heterogeneity
362371|NCT01400971|Hypoglycemia|hypoglycemia
362372|NCT01400958|fatigue|fatigue
362373|NCT01400958|external beam radiation|external beam radiation
362374|NCT01400958|EBRT|ebrt
362375|NCT01400958|radiation therapy|radiation therapy
362376|NCT01400958|placebo|placebo
362377|NCT01400958|cognitive function|cognitive function
362378|NCT01400958|TMZ|tmz
362379|NCT01400958|Temozolomide|temozolomide
362380|NCT01400945|GERD|gerd
362381|NCT01400945|endoscopy|endoscopy
362382|NCT01400945|LA grade|la grade
362383|NCT01400945|heartburn|heartburn
362398|NCT01400893|Acute kidney injury|acute kidney injury
362399|NCT01400893|Acute tubular necrosis|acute tubular necrosis
362400|NCT01400893|Continuous Renal Replacement Therapy|continuous renal replacement therapy
362401|NCT01400893|Severe sepsis|severe sepsis
362402|NCT01400893|Selective cytopheretic device|selective cytopheretic device
362403|NCT01400880|Maternal Fetal Monitoring|maternal fetal monitoring
362404|NCT01400867|Infections|infections
362405|NCT01400867|Pediatrics|pediatrics
362406|NCT01400867|Teflaro|teflaro
362407|NCT01400867|cephalosporin|cephalosporin
362408|NCT01400854|breakthrough cancer pain|breakthrough cancer pain
362409|NCT01400841|Aortic Insufficiency, Aortic Regurgitation, Aortic Valve Repair|aortic insufficiency, aortic regurgitation, aortic valve repair
362410|NCT01400815|smoking|smoking
362411|NCT01400815|smoking cessation|smoking cessation
362412|NCT01400815|quitting smoking|quitting smoking
362413|NCT01400776|Postmenopausal Women, Vaginal Dryness|postmenopausal women, vaginal dryness
362414|NCT01400763|focus of study|focus of study
362415|NCT01400750|cystic fibrosis- P aeruginosa- eradication-child|cystic fibrosis- p aeruginosa- eradication-child
362417|NCT01400737|prophylaxis|prophylaxis
362418|NCT01400737|VELBW|velbw
362419|NCT01400724|menopause|menopause
362420|NCT01400724|metabolic syndrome|metabolic syndrome
362421|NCT01400724|myo-inositol|myo-inositol
362422|NCT01400724|insulin resistance|insulin resistance
362423|NCT01400724|cocoa polyphenols|cocoa polyphenols
362424|NCT01400724|isoflavones|isoflavones
362425|NCT01400711|Fast-tract surgery, Enhanced recovery after surgery, multimodal surgery.|fast-tract surgery, enhanced recovery after surgery, multimodal surgery.
734282|NCT01093534|Solifenacin|solifenacin
362426|NCT01400698|Intra-uterine growth retardation (IUGR)|intra-uterine growth retardation (iugr)
362427|NCT01400698|Saizen|saizen
362428|NCT01400698|Recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
362429|NCT01400698|Final height|final height
362430|NCT01400698|Bone age|bone age
362431|NCT01400698|SGA (Small for Gestational Age)|sga (small for gestational age)
362432|NCT01400685|CLL|cll
362433|NCT01400685|Leukemia|leukemia
362434|NCT01400685|Untreated|untreated
362435|NCT01400685|B-CLL|b-cll
362436|NCT01400685|SLL|sll
362437|NCT01400672|Diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
362438|NCT01400659|CSII|csii
362439|NCT01400659|prandial insulin requirements|prandial insulin requirements
362440|NCT01400659|bolus calculation|bolus calculation
362441|NCT01400659|dual-wave bolus|dual-wave bolus
362442|NCT01400646|Rivaroxaban|rivaroxaban
362443|NCT01400646|JNJ-39039039|jnj-39039039
362444|NCT01400646|BAY59-7939|bay59-7939
362445|NCT01400646|Warfarin|warfarin
362446|NCT01400646|Transition|transition
362447|NCT01400633|Myelodysplastic Syndrome|myelodysplastic syndrome
362448|NCT01400633|Dacogen|dacogen
362449|NCT01400633|decitabine|decitabine
362450|NCT01400633|epigenetic therapy|epigenetic therapy
362451|NCT01400633|hypomethylating agent|hypomethylating agent
362452|NCT01400620|oral mucositis|oral mucositis
362453|NCT01400620|chemoradiation|chemoradiation
362454|NCT01400620|head and neck cancer|head and neck cancer
362470|NCT01400594|Onychomycosis|onychomycosis
362471|NCT01400555|Prostate Cancer|prostate cancer
362472|NCT01400555|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
362473|NCT01400555|Abiraterone Acetate|abiraterone acetate
362474|NCT01400555|Docetaxel|docetaxel
362475|NCT01400555|Prednisone|prednisone
362476|NCT01400555|Dexamethasone|dexamethasone
362477|NCT01400542|Early Onset Alzheimer Disease|early onset alzheimer disease
362478|NCT01400542|Alzheimer Disease|alzheimer disease
362479|NCT01400542|Sleep Apnea Syndromes|sleep apnea syndromes
362480|NCT01400542|Obstructive Sleep Apnea Syndromes|obstructive sleep apnea syndromes
362481|NCT01400542|Cognitive functions|cognitive functions
362482|NCT01400542|Continuous Positive Airway Pressure (CPAP) treatment|continuous positive airway pressure (cpap) treatment
362483|NCT01400529|Osteoarthritis|osteoarthritis
362485|NCT01400529|hip|hip
362486|NCT01400529|population based|population based
362487|NCT01400516|Rheumatoid Arthritis|rheumatoid arthritis
362488|NCT01400516|Bone erosion|bone erosion
362489|NCT01400516|Osteopenia|osteopenia
362490|NCT01400503|Multicentric Castleman's Disease|multicentric castleman's disease
362491|NCT01400503|Multicentric|multicentric
362492|NCT01400503|Castleman|castleman
362493|NCT01400503|Siltuximab|siltuximab
362494|NCT01400503|Long term safety|long term safety
362495|NCT01400477|Drug Trial|drug trial
362496|NCT01400477|Smoking|smoking
362497|NCT01400477|Smoking Cessation|smoking cessation
362498|NCT01400477|Cognition|cognition
362499|NCT01400477|Mental Focus|mental focus
362500|NCT01400464|Giant Cell Arteritis|giant cell arteritis
362501|NCT01400464|prednisone|prednisone
362502|NCT01400464|pharmacokinetics|pharmacokinetics
362503|NCT01400438|Herceptin|herceptin
362504|NCT01400438|Breast cancer|breast cancer
362505|NCT01400438|Quality of life|quality of life
362506|NCT01400438|fatigue|fatigue
362507|NCT01400399|AJCC DCIS or T1- T2, N0|ajcc dcis or t1- t2, n0
362508|NCT01400373|Hypothermia, induced|hypothermia, induced
362509|NCT01400373|Intra-arrest cooling|intra-arrest cooling
362510|NCT01400373|Cardiac arrest|cardiac arrest
362511|NCT01400373|Prehospital emergency care|prehospital emergency care
362512|NCT01400373|Emergency Medical Services|emergency medical services
362513|NCT01400360|cerebral vasospasm|cerebral vasospasm
362514|NCT01400360|subarachnoid hemorrhage|subarachnoid hemorrhage
362515|NCT01400360|transluminal balloon angioplasty|transluminal balloon angioplasty
362516|NCT01400360|intraarterial treatment|intraarterial treatment
362517|NCT01400347|Motor activity, lower extremity, physical exercise|motor activity, lower extremity, physical exercise
362518|NCT01400334|Ischemic Cardiomyopathy|ischemic cardiomyopathy
362519|NCT01400334|Sudden Cardiac Death|sudden cardiac death
362520|NCT01400334|Positron Emission Tomography|positron emission tomography
362521|NCT01400334|Hibernating Myocardium|hibernating myocardium
362522|NCT01400334|Denervated Myocardium|denervated myocardium
362523|NCT01400321|dental implant|dental implant
362524|NCT01400321|soft tissue maintenance|soft tissue maintenance
362526|NCT01400321|inclined atrophy|inclined atrophy
362527|NCT01400308|Methicillin Resistant Staphylococcus Aureus colonization.|methicillin resistant staphylococcus aureus colonization.
362528|NCT01400308|Methicillin Resistant Staphylococcus Aureus infection.|methicillin resistant staphylococcus aureus infection.
362529|NCT01400295|contrast-induced nephropathy|contrast-induced nephropathy
362530|NCT01400295|contrast medium|contrast medium
362531|NCT01400295|creatinine clearance|creatinine clearance
362532|NCT01400295|coronary angiography|coronary angiography
362533|NCT01400295|diabetes|diabetes
362534|NCT01400295|chronic kidney disease|chronic kidney disease
362535|NCT01400269|PACE|pace
362536|NCT01400256|diagnostic|diagnostic
362537|NCT01400243|Marijuana|marijuana
362538|NCT01400243|Drug withdrawal symptoms|drug withdrawal symptoms
362539|NCT01400243|Nicotine|nicotine
362540|NCT01400230|computed tomography|computed tomography
362541|NCT01400230|intravascular ultrasound|intravascular ultrasound
362542|NCT01400230|coronary stenosis|coronary stenosis
362543|NCT01400230|fractional flow reserve|fractional flow reserve
362544|NCT01400217|Primary Care|primary care
362545|NCT01400217|Particle size|particle size
362546|NCT01400217|beclomethasone dipropionate|beclomethasone dipropionate
362547|NCT01400217|Asthma Management|asthma management
362548|NCT01400217|Maintenance Therapy|maintenance therapy
362549|NCT01400217|Metered-Dose Inhaler|metered-dose inhaler
362550|NCT01400204|hangover|hangover
362551|NCT01400204|next day effects|next day effects
362552|NCT01400204|MDMA|mdma
362553|NCT01400204|Alcohol|alcohol
362554|NCT01400191|Metformin|metformin
362555|NCT01400191|Hypoglycemic Agents|hypoglycemic agents
362556|NCT01400191|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
362557|NCT01400191|Gluconeogenesis|gluconeogenesis
362558|NCT01400191|Pharmacodynamics|pharmacodynamics
362559|NCT01400191|Pharmacogenetics|pharmacogenetics
362560|NCT01400178|cochlear implant|cochlear implant
362561|NCT01400178|children|children
362562|NCT01400178|follow up|follow up
362563|NCT01400178|results|results
362564|NCT01400165|Therapeutic Equivalency|therapeutic equivalency
362565|NCT01400165|Human Experimentation|human experimentation
362566|NCT01400165|Bioequivalence|bioequivalence
362567|NCT01400165|Brand name|brand name
362568|NCT01400165|Generic|generic
362569|NCT01400165|Healthy volunteers|healthy volunteers
362570|NCT01400152|Hypothermia, body temperature regulation,thermal comfort, active warming, passive warming, prehospital trauma care|hypothermia, body temperature regulation,thermal comfort, active warming, passive warming, prehospital trauma care
362571|NCT01400139|Pain|pain
362572|NCT01400139|Nonmalignant pain|nonmalignant pain
362573|NCT01400139|Nonneuropathic Pain|nonneuropathic pain
362574|NCT01400139|Opioid|opioid
362575|NCT01400126|Ultrapure water,hemodialysis, CRP, blood pressure|ultrapure water,hemodialysis, crp, blood pressure
362576|NCT01400113|Acute Agitation|acute agitation
362577|NCT01400113|schizophrenia|schizophrenia
362578|NCT01400113|bipolar|bipolar
362579|NCT01400113|psychosis|psychosis
362580|NCT01400113|panss-ec|panss-ec
362581|NCT01400100|octreotide|octreotide
362582|NCT01400100|intraarterial|intraarterial
362583|NCT01400100|pancreatic hardness|pancreatic hardness
362584|NCT01400100|pancreatoduodenectomy|pancreatoduodenectomy
362585|NCT01400100|durometer|durometer
362586|NCT01400100|dynamometer|dynamometer
362587|NCT01400087|colonoscopy|colonoscopy
362588|NCT01400087|Lower Gastrointestinal Tract|lower gastrointestinal tract
362589|NCT01400087|Cecal intubation|cecal intubation
362590|NCT01400087|Cap-attached colonoscopy|cap-attached colonoscopy
362591|NCT01400087|Trainee|trainee
362592|NCT01400061|obesity, etiology, pathogenesis, treatment|obesity, etiology, pathogenesis, treatment
362593|NCT01400035|acute cerebral infarction, Vinpocetine|acute cerebral infarction, vinpocetine
362594|NCT01400022|lichen|lichen
362595|NCT01400022|sclerosus|sclerosus
362596|NCT01400022|genital|genital
362597|NCT01400022|vulvar|vulvar
362598|NCT01400022|UVA1|uva1
362599|NCT01400009|Statin|statin
362600|NCT01400009|HMG COA Reductase Inhibitor|hmg coa reductase inhibitor
362601|NCT01400009|myalgia|myalgia
362602|NCT01400009|vitamin D|vitamin d
362603|NCT01399996|probiotic|probiotic
362604|NCT01399996|microbiota|microbiota
362605|NCT01399996|transit time|transit time
362606|NCT01399996|immunity|immunity
362607|NCT01399996|immune function|immune function
362608|NCT01399996|constipation|constipation
362609|NCT01399996|bowel function|bowel function
362610|NCT01399983|six minute walk|six minute walk
362611|NCT01399970|Mobile Teledermatology|mobile teledermatology
362612|NCT01399970|Telemedicine|telemedicine
362613|NCT01399970|Acne|acne
362614|NCT01399957|Multiple Sclerosis|multiple sclerosis
362615|NCT01399957|Dalfampridine-ER|dalfampridine-er
362616|NCT01399957|Walking speed|walking speed
362617|NCT01399944|bitter taste|bitter taste
362618|NCT01399944|psychophysics|psychophysics
362619|NCT01399944|genetics|genetics
362620|NCT01399944|epigenetics|epigenetics
362621|NCT01399944|bitterness sensitivity|bitterness sensitivity
362622|NCT01399931|Early stage|early stage
362624|NCT01399918|Everolimus|everolimus
362625|NCT01399918|Bevacizumab|bevacizumab
362626|NCT01399918|10-226|10-226
362627|NCT01399918|non-clear cell histology|non-clear cell histology
362628|NCT01399918|Advanced|advanced
362629|NCT01399905|Parkinson's disease|parkinson's disease
362630|NCT01399905|Levodopa|levodopa
362631|NCT01399905|Carbidopa|carbidopa
362632|NCT01399905|Blood brain barrier|blood brain barrier
362633|NCT01399879|Surface potential|surface potential
362634|NCT01399879|Electrical|electrical
362635|NCT01399879|Motion stabilization|motion stabilization
362636|NCT01399866|D-cycloserine|d-cycloserine
362637|NCT01399866|Smoking cues|smoking cues
362638|NCT01399866|Cognitive remediation|cognitive remediation
362639|NCT01399866|physiologic reactivity|physiologic reactivity
362640|NCT01399866|craving|craving
362641|NCT01399853|immunogenicity|immunogenicity
362642|NCT01399853|safety|safety
362643|NCT01399853|inactivated EV71 vaccine|inactivated ev71 vaccine
362644|NCT01399801|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
362645|NCT01399801|medically refractory heart failure patients|medically refractory heart failure patients
362646|NCT01399788|Bioequivalence|bioequivalence
362647|NCT01399788|Healthy Volunteers|healthy volunteers
362648|NCT01399775|Atrophy of Edentulous Alveolar Ridge|atrophy of edentulous alveolar ridge
362649|NCT01399775|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
362650|NCT01399775|Dental Implants, Single-Tooth|dental implants, single-tooth
362651|NCT01399762|stroke, acute|stroke, acute
362652|NCT01399762|mechanical recanalization|mechanical recanalization
362653|NCT01399762|interventional neuroradiology|interventional neuroradiology
362654|NCT01399762|clinical registry|clinical registry
362655|NCT01399749|Cartilage|cartilage
362656|NCT01399749|Articular|articular
362657|NCT01399749|Femoral|femoral
362658|NCT01399749|Knee|knee
362659|NCT01399749|Chondrocytes|chondrocytes
362660|NCT01399749|Adipose tissue-derived mesenchymal stem cells|adipose tissue-derived mesenchymal stem cells
362661|NCT01399736|PCI FFR STEMI MVD|pci ffr stemi mvd
362662|NCT01399736|FFR guided PCI in acute STEMI patients with MVD|ffr guided pci in acute stemi patients with mvd
362663|NCT01399723|Severe pneumonia|severe pneumonia
362664|NCT01399710|colorectal cancer|colorectal cancer
362665|NCT01399710|CT colonography|ct colonography
362666|NCT01399710|CAD|cad
362667|NCT01399671|depression|depression
362668|NCT01399671|vestibular|vestibular
362669|NCT01399658|Brachytherapy|brachytherapy
362670|NCT01399658|Gynecological cancer|gynecological cancer
362671|NCT01399645|Randomized trial|randomized trial
362672|NCT01399645|Open label|open label
362673|NCT01399645|Pilot study|pilot study
362674|NCT01399645|Single center|single center
362875|NCT01398761|Handoffs|handoffs
362675|NCT01399606|Excessive Daytime Sleepiness (EDS)|excessive daytime sleepiness (eds)
362676|NCT01399606|Narcolepsy|narcolepsy
362677|NCT01399593|Antibody Mediated Rejection|antibody mediated rejection
362678|NCT01399593|AMR|amr
362679|NCT01399593|Acute Humoral Rejection|acute humoral rejection
362680|NCT01399593|AHR|ahr
362681|NCT01399593|Living Donor|living donor
362682|NCT01399593|Kidney Transplant|kidney transplant
362683|NCT01399580|endothelin receptor antagonists|endothelin receptor antagonists
362684|NCT01399567|pain|pain
362685|NCT01399567|depression|depression
362686|NCT01399567|nursing homes|nursing homes
362687|NCT01399567|diffusion of innovations|diffusion of innovations
362688|NCT01399567|clinical trial|clinical trial
362689|NCT01399541|Symptoms|symptoms
362690|NCT01399541|Symptoms cluster|symptoms cluster
362691|NCT01399541|Fatigue|fatigue
362692|NCT01399541|Depression|depression
362693|NCT01399541|Sleeplessness|sleeplessness
362694|NCT01399541|Social support|social support
362695|NCT01399541|Stigma|stigma
362696|NCT01399515|Retinitis pigmentosa|retinitis pigmentosa
362697|NCT01399515|Valproic acid|valproic acid
362698|NCT01399502|Depression|depression
362699|NCT01399502|Self Care|self care
362700|NCT01399489|Aerobic exercise|aerobic exercise
362701|NCT01399489|Moderate intensity|moderate intensity
362702|NCT01399489|Ambulatory blood pressure|ambulatory blood pressure
362703|NCT01399489|Post exercise hypotension|post exercise hypotension
362704|NCT01399476|Achalasia|achalasia
362705|NCT01399463|Drug Eluting Stent, Drug Eluting Balloon, Fractional Flow Reserve, DES, DEB, FFR|drug eluting stent, drug eluting balloon, fractional flow reserve, des, deb, ffr
362706|NCT01399450|Schizophrenia, depressive symptom, paliperidone|schizophrenia, depressive symptom, paliperidone
362707|NCT01399437|Default Network|default network
362708|NCT01399437|Schizophrenia|schizophrenia
362709|NCT01399437|fMRI|fmri
362710|NCT01399437|Spatial Attention|spatial attention
362711|NCT01399437|Sentinel Function|sentinel function
362712|NCT01399424|Shigellosis|shigellosis
362713|NCT01399424|Safety and Immunogenicity|safety and immunogenicity
362714|NCT01399424|Conjugate Vaccine|conjugate vaccine
362715|NCT01399424|Shigella|shigella
362716|NCT01399424|Vaccine|vaccine
362717|NCT01399411|Self-Reported|self-reported
362718|NCT01399411|Farming|farming
362719|NCT01399411|Agriculture|agriculture
362733|NCT01399385|Heart Disease|heart disease
362734|NCT01399385|Healthy Volunteer|healthy volunteer
362736|NCT01399372|neurotoxicity|neurotoxicity
362737|NCT01399372|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
362738|NCT01399372|radiation toxicity|radiation toxicity
362739|NCT01399372|cognitive/functional effects|cognitive/functional effects
362740|NCT01399372|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
362741|NCT01399359|breast cancer|breast cancer
362742|NCT01399346|Insulin aspart|insulin aspart
362743|NCT01399346|Type 1 diabetes|type 1 diabetes
362744|NCT01399346|Glucose clamp|glucose clamp
362745|NCT01399346|Pharmacodynamics|pharmacodynamics
362746|NCT01399346|Pharmacokinetics|pharmacokinetics
362747|NCT01399346|Rapid Acting Insulin Analog|rapid acting insulin analog
362748|NCT01399333|PDCAAS|pdcaas
362749|NCT01399333|Bariatric patient|bariatric patient
362750|NCT01399320|Pilonidal disease|pilonidal disease
362751|NCT01399320|Excision|excision
362752|NCT01399320|cyanoacrylate|cyanoacrylate
362753|NCT01399307|Stem|stem
362754|NCT01399307|Cell|cell
362755|NCT01399307|Antria|antria
362756|NCT01399307|Adipose|adipose
362757|NCT01399307|Stromal|stromal
362758|NCT01399307|Vascular|vascular
362759|NCT01399307|Fraction|fraction
362760|NCT01399307|Shahram|shahram
362761|NCT01399307|Shah|shah
362762|NCT01399307|Rahimian|rahimian
362763|NCT01399294|Palliative Care|palliative care
362764|NCT01399294|Advanced Cancer|advanced cancer
362765|NCT01399294|Constipation|constipation
362766|NCT01399294|Traditional Chinese Medicine|traditional chinese medicine
362767|NCT01399294|Syndrome Distribution|syndrome distribution
362768|NCT01399281|juvenile idiopathic arthritis, biologics, methotrexate|juvenile idiopathic arthritis, biologics, methotrexate
362769|NCT01399268|Bilateral total knee replacement|bilateral total knee replacement
362770|NCT01399268|cytokine|cytokine
362771|NCT01399268|desmosine|desmosine
362772|NCT01399242|Disorder Related to Renal Transplantation|disorder related to renal transplantation
362980|NCT01398358|prevention|prevention
362773|NCT01399203|contrast-induced nephropathy|contrast-induced nephropathy
362774|NCT01399203|contrast medium|contrast medium
362775|NCT01399203|creatinine clearance|creatinine clearance
362776|NCT01399203|percutaneous coronary intervention|percutaneous coronary intervention
362777|NCT01399164|Vitamin B-12|vitamin b-12
362778|NCT01399151|Vitamin D|vitamin d
362779|NCT01399151|Immune function|immune function
362780|NCT01399138|Pre-diabetes|pre-diabetes
362781|NCT01399138|Metabolic syndrome|metabolic syndrome
362782|NCT01399138|Diabetes|diabetes
362783|NCT01399138|Hypertension|hypertension
362784|NCT01399138|Blueberries|blueberries
362785|NCT01399138|Anthocyanins|anthocyanins
362786|NCT01399138|Insulin sensitivity|insulin sensitivity
362787|NCT01399138|Insulin resistance|insulin resistance
362788|NCT01399125|Alzheimer's|alzheimer's
362789|NCT01399125|Rivastigmine|rivastigmine
362790|NCT01399125|Patch|patch
362791|NCT01399125|Dementia|dementia
362792|NCT01399112|Smoking Cessation|smoking cessation
362793|NCT01399112|First episode psychosis|first episode psychosis
362794|NCT01399112|Electronic Decision Support System|electronic decision support system
362795|NCT01399099|scar|scar
362796|NCT01399099|incision|incision
362797|NCT01399099|wound healing|wound healing
362798|NCT01399099|scarring|scarring
362799|NCT01399099|post-surgical|post-surgical
362800|NCT01399086|Cancer|cancer
362801|NCT01399086|Breast|breast
362802|NCT01399086|Metastatic|metastatic
362803|NCT01399086|Hormonotherapy|hormonotherapy
362804|NCT01399073|stroke|stroke
362805|NCT01399073|neglect|neglect
353487|NCT01436136|HIV|hiv
362807|NCT01399073|virtual reality|virtual reality
362808|NCT01399060|Cough|cough
362809|NCT01399060|tobacco smoke exposure|tobacco smoke exposure
362810|NCT01399047|Batten Disease|batten disease
362811|NCT01399034|Epigenomics|epigenomics
362812|NCT01399034|DNA methylation|dna methylation
362813|NCT01399034|MicroRNA|microrna
362814|NCT01399034|Periodontitis|periodontitis
362815|NCT01399034|Inflammation|inflammation
362816|NCT01399034|Obesity|obesity
362817|NCT01399021|Parotidectomy|parotidectomy
362818|NCT01399021|Drain removal|drain removal
362819|NCT01399021|Timing|timing
362820|NCT01399021|Hematoma|hematoma
362821|NCT01399021|Surgical wound infection|surgical wound infection
362822|NCT01399008|Hyperuricemia|hyperuricemia
362823|NCT01398995|Type 1 Diabetes|type 1 diabetes
362824|NCT01398995|Exercise|exercise
362825|NCT01398995|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
362826|NCT01398969|Randomized|randomized
362827|NCT01398969|Double Blind|double blind
362828|NCT01398969|Fecal Transplant|fecal transplant
362829|NCT01398969|Recurrent|recurrent
362830|NCT01398969|Clostridium difficile infection|clostridium difficile infection
362831|NCT01398969|CDI|cdi
362832|NCT01398969|HBT|hbt
362833|NCT01398969|Diarrhea|diarrhea
362834|NCT01398969|Frozen HBT|frozen hbt
362835|NCT01398969|Thawed HBT|thawed hbt
362836|NCT01398969|Fecal Enema|fecal enema
362837|NCT01398956|Levetiracetam|levetiracetam
362838|NCT01398956|Epilepsy|epilepsy
362839|NCT01398956|Generalized tonic-clonic seizures|generalized tonic-clonic seizures
362840|NCT01398943|flow-mediated dilation|flow-mediated dilation
362841|NCT01398943|arterial stiffness|arterial stiffness
362842|NCT01398943|intima-media thickness|intima-media thickness
362843|NCT01398943|pulse wave velocity|pulse wave velocity
362844|NCT01398943|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
362845|NCT01398943|inflammatory markers|inflammatory markers
362846|NCT01398943|blood lipids|blood lipids
362847|NCT01398943|tetrahydrobiopterin|tetrahydrobiopterin
362848|NCT01398943|body mass index|body mass index
362849|NCT01398943|hemoglobin A1c|hemoglobin a1c
362850|NCT01398943|complete blood count|complete blood count
362851|NCT01398943|oxidative stress biomarkers|oxidative stress biomarkers
362852|NCT01398943|pulmonary function test|pulmonary function test
362853|NCT01398943|lung|lung
362854|NCT01398943|COPD|copd
362855|NCT01398930|acupuncture; knee osteoarthritis; adjunctive therapy; chronic pain; algometer; etoricoxib.|acupuncture; knee osteoarthritis; adjunctive therapy; chronic pain; algometer; etoricoxib.
362856|NCT01398917|psc|psc
362857|NCT01398917|dominant stricture|dominant stricture
362858|NCT01398904|BDD|bdd
362859|NCT01398878|Medical education, graduate|medical education, graduate
362860|NCT01398878|Patient care|patient care
362861|NCT01398878|Outcome assessment (Health care)|outcome assessment (health care)
362862|NCT01398878|Work schedule tolerance|work schedule tolerance
362863|NCT01398865|BDD|bdd
362864|NCT01398826|Type 1 Diabetes|type 1 diabetes
362865|NCT01398826|Exercise|exercise
362866|NCT01398826|Continuous glucose monitoring|continuous glucose monitoring
362867|NCT01398813|HED|hed
362868|NCT01398813|XLHED|xlhed
362869|NCT01398774|Pseudohypoparathyroidism|pseudohypoparathyroidism
362870|NCT01398774|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
362871|NCT01398761|Continuity of patient care|continuity of patient care
362872|NCT01398761|Workflow|workflow
362873|NCT01398761|Quality of signout|quality of signout
362874|NCT01398761|Web based|web based
362876|NCT01398761|Multi disciplinary|multi disciplinary
362877|NCT01398761|Written signout|written signout
362878|NCT01398761|Information science|information science
362879|NCT01398748|Parkinson's disease|parkinson's disease
362880|NCT01398748|Neuroprotection|neuroprotection
362881|NCT01398748|Glutathione|glutathione
362882|NCT01398748|Intranasal|intranasal
362883|NCT01398722|cardiac surgery|cardiac surgery
362884|NCT01398722|prognosis|prognosis
362885|NCT01398722|intensive insulin therapy|intensive insulin therapy
362886|NCT01398709|Cardiopulmonary Bypass|cardiopulmonary bypass
362887|NCT01398709|Prognosis|prognosis
362888|NCT01398709|Cardiac Surgery|cardiac surgery
362889|NCT01398709|Rewarming Rate|rewarming rate
362890|NCT01398696|Patient Information Leaflets|patient information leaflets
362891|NCT01398696|primary care|primary care
362892|NCT01398696|patient behaviour|patient behaviour
362893|NCT01398696|pharyngitis|pharyngitis
362894|NCT01398696|gastroenteritis|gastroenteritis
362895|NCT01398670|Type I Diabetes|type i diabetes
362896|NCT01398670|Wockhardt's Insulin analogue Lispro|wockhardt's insulin analogue lispro
362897|NCT01398670|Humalog®|humalog®
362898|NCT01398670|Humalog Mix|humalog mix
362899|NCT01398670|Wockhardt|wockhardt
362900|NCT01398670|Biosimilar|biosimilar
362901|NCT01398670|Phase 3|phase 3
362902|NCT01398657|localized|localized
362903|NCT01398657|High risk|high risk
362904|NCT01398657|Prostate Cancer|prostate cancer
362905|NCT01398657|Randomized|randomized
362906|NCT01398657|Cryotherapy|cryotherapy
362907|NCT01398657|Cryoablation|cryoablation
362908|NCT01398657|Adjuvant|adjuvant
353596|NCT01435681|DBS|dbs
362909|NCT01398657|Androgen Deprivation Therapy|androgen deprivation therapy
362910|NCT01398657|Hormone therapy|hormone therapy
362911|NCT01398657|ADT|adt
362912|NCT01398644|Phlebotomy|phlebotomy
362913|NCT01398644|Therapeutic erythrocytapheresis|therapeutic erythrocytapheresis
362914|NCT01398644|Hereditary Hemochromatosis|hereditary hemochromatosis
362915|NCT01398644|maintenance therapy|maintenance therapy
362916|NCT01398631|Risk scores|risk scores
362917|NCT01398631|ACS|acs
362918|NCT01398631|HEART-score|heart-score
362919|NCT01398618|latent tuberculosis infection|latent tuberculosis infection
362920|NCT01398618|tuberculosis|tuberculosis
362921|NCT01398618|interferon-gamma release assay|interferon-gamma release assay
362922|NCT01398618|preventive therapy|preventive therapy
362923|NCT01398618|9-month isoniazid|9-month isoniazid
362924|NCT01398618|4-month rifampin|4-month rifampin
362925|NCT01398605|Postmenopausal women|postmenopausal women
362926|NCT01398605|Physical activity|physical activity
362927|NCT01398605|Cardiovascular risks|cardiovascular risks
362928|NCT01398605|Cardiac function|cardiac function
362929|NCT01398605|Dose-response|dose-response
362930|NCT01398592|Diabetes mellitus Type two|diabetes mellitus type two
362932|NCT01398592|vildagliptin|vildagliptin
362933|NCT01398592|sitagliptin|sitagliptin
362934|NCT01398592|FPG|fpg
362935|NCT01398592|DPP-4|dpp-4
362936|NCT01398579|intestinal metaplasia|intestinal metaplasia
362937|NCT01398579|dysplasia|dysplasia
362938|NCT01398579|probe-based confocal endomicroscopy|probe-based confocal endomicroscopy
362939|NCT01398566|TBI|tbi
362940|NCT01398566|concussion|concussion
362941|NCT01398566|brain injury|brain injury
362942|NCT01398553|stroke|stroke
362943|NCT01398553|tbi|tbi
362944|NCT01398553|rehabilitation|rehabilitation
362945|NCT01398553|upper limb|upper limb
362946|NCT01398527|Long-Term Care|long-term care
362947|NCT01398527|Vitamin D|vitamin d
362948|NCT01398501|AML|aml
362949|NCT01398501|FLT3-ITD|flt3-itd
362950|NCT01398501|Stem cell transplant|stem cell transplant
362951|NCT01398488|Trough levels|trough levels
362952|NCT01398488|Education|education
362953|NCT01398488|Adherence|adherence
362954|NCT01398449|thoracic esophageal squamous cell carcinoma|thoracic esophageal squamous cell carcinoma
362955|NCT01398449|esophagectomy|esophagectomy
362956|NCT01398449|elective nodal irradiation|elective nodal irradiation
362957|NCT01398449|adjuvant chemotherapy|adjuvant chemotherapy
362958|NCT01398436|Central venous saturation|central venous saturation
362959|NCT01398436|Mixed venous saturation|mixed venous saturation
362960|NCT01398436|Right atrium|right atrium
362961|NCT01398436|Central Venous Catheter position|central venous catheter position
362962|NCT01398423|Hypertension|hypertension
362963|NCT01398423|Diabetes mellitis|diabetes mellitis
362964|NCT01398423|Nephropathy|nephropathy
362965|NCT01398423|Albuminuria|albuminuria
362966|NCT01398410|Rabeprazole|rabeprazole
362967|NCT01398410|proton pump inhibitor|proton pump inhibitor
362968|NCT01398410|Acetylsalicylic Acid|acetylsalicylic acid
362969|NCT01398410|Aspirin|aspirin
362970|NCT01398410|Gastric Ulcer|gastric ulcer
362971|NCT01398410|Duodenal Ulcer|duodenal ulcer
362972|NCT01398397|HED|hed
362973|NCT01398397|XLHED|xlhed
362974|NCT01398397|X-linked Hypohidrotic Ectodermal Dysplasia (XLHED)|x-linked hypohidrotic ectodermal dysplasia (xlhed)
362975|NCT01398384|ST Elevation MI|st elevation mi
362976|NCT01398384|STEMI|stemi
362977|NCT01398371|Heart failure|heart failure
362978|NCT01398371|Digoxin withdrawal|digoxin withdrawal
362979|NCT01398358|obesity|obesity
362981|NCT01398358|children|children
362982|NCT01398319|prevention|prevention
362983|NCT01398319|alcohol abuse|alcohol abuse
362984|NCT01398306|Angiogenesis Inhibitors|angiogenesis inhibitors
362985|NCT01398306|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
362986|NCT01398306|Neoplasms by Histologic Type|neoplasms by histologic type
362987|NCT01398306|Neoplasms|neoplasms
362988|NCT01398306|Adenocarcinoma|adenocarcinoma
362989|NCT01398306|Kidney Neoplasms|kidney neoplasms
362990|NCT01398306|Urologic Neoplasms|urologic neoplasms
362991|NCT01398306|Urogenital Neoplasms|urogenital neoplasms
362992|NCT01398306|Neoplasms by Site|neoplasms by site
362993|NCT01398306|Kidney Diseases|kidney diseases
362994|NCT01398306|Angiogenesis Inducing Agents|angiogenesis inducing agents
362995|NCT01398306|Biological Markers|biological markers
362996|NCT01398280|Rosacea|rosacea
362997|NCT01398280|Dermatology|dermatology
362998|NCT01398280|UCSD|ucsd
362999|NCT01398280|Skin disease|skin disease
363000|NCT01398254|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
363001|NCT01398254|Mortality|mortality
363002|NCT01398228|Quality of care|quality of care
363003|NCT01398228|Acute Coronary Syndromes (ACS)|acute coronary syndromes (acs)
363004|NCT01398215|umbilical hernia|umbilical hernia
363005|NCT01398215|ventral hernia|ventral hernia
363006|NCT01398202|Vitamin D status|vitamin d status
363007|NCT01398202|25-hydroxyvitamin D|25-hydroxyvitamin d
363008|NCT01398202|Vitamin D3|vitamin d3
363009|NCT01398202|RCT|rct
363010|NCT01398202|Bio-efficacy|bio-efficacy
363011|NCT01398189|clozapine|clozapine
363013|NCT01398189|schizophrenia|schizophrenia
363014|NCT01398189|schizoaffective disorder|schizoaffective disorder
363015|NCT01398176|gamma delta T cell|gamma delta t cell
363016|NCT01398176|proliferation|proliferation
363017|NCT01398163|probiotics|probiotics
363018|NCT01398163|digestive well-being|digestive well-being
363019|NCT01398163|fMRI|fmri
363020|NCT01398163|brain-gut axis|brain-gut axis
363021|NCT01398150|gamma delta T cell|gamma delta t cell
363022|NCT01398150|proliferation|proliferation
363023|NCT01398150|cytokine secretion|cytokine secretion
363024|NCT01398150|immune function|immune function
363025|NCT01398150|antioxidant status|antioxidant status
363026|NCT01398137|Ragweed allergy|ragweed allergy
363027|NCT01398124|early stage non-small cell lung cancer|early stage non-small cell lung cancer
363028|NCT01398124|non-small cell lung cancer|non-small cell lung cancer
363029|NCT01398085|Papillary thyroid carcinoma|papillary thyroid carcinoma
363030|NCT01398085|Follicular thyroid carcinoma|follicular thyroid carcinoma
363031|NCT01398085|Hurthle cell carcinoma of the thyroid|hurthle cell carcinoma of the thyroid
363032|NCT01398085|Iodine Radioisotopes|iodine radioisotopes
363033|NCT01398059|Sedentary Behavior|sedentary behavior
363034|NCT01398059|Cardiometabolic Risk|cardiometabolic risk
363035|NCT01398059|Pediatrics|pediatrics
363036|NCT01398046|dasatinib|dasatinib
363037|NCT01398046|betaine|betaine
363038|NCT01398046|betaine hydrochloride|betaine hydrochloride
363039|NCT01398046|pharmacokinetics|pharmacokinetics
363040|NCT01398046|healthy volunteer|healthy volunteer
363041|NCT01398033|infrapopliteal arteries|infrapopliteal arteries
363042|NCT01398033|In-stent stenosis|in-stent stenosis
363043|NCT01398033|long lesions|long lesions
363044|NCT01398033|drug-coated balloon|drug-coated balloon
363045|NCT01398020|Bowel Preparation|bowel preparation
363046|NCT01398020|Patient comfort|patient comfort
363047|NCT01398020|Bi-Peglyte|bi-peglyte
363048|NCT01397994|Nicorandil therapy in patients of chronic stable angina|nicorandil therapy in patients of chronic stable angina
363049|NCT01397968|partial onset seizures|partial onset seizures
363050|NCT01397968|treatment resistant|treatment resistant
363051|NCT01397968|partial epilepsy|partial epilepsy
363052|NCT01397955|Julina|julina
363053|NCT01397955|Postmenopausal osteoporosis|postmenopausal osteoporosis
363054|NCT01397942|Diet intervention|diet intervention
363055|NCT01397942|Type 2 diabetes|type 2 diabetes
363056|NCT01397942|Vegetables|vegetables
363057|NCT01397942|Phytochemicals|phytochemicals
363058|NCT01397916|CLL|cll
363059|NCT01397916|IDO|ido
363060|NCT01397903|antidepressant therapy, inadequate control, add-on therapy|antidepressant therapy, inadequate control, add-on therapy
363061|NCT01397890|Severe chronic obstructive pulmonary disease (COPD) patients|severe chronic obstructive pulmonary disease (copd) patients
363062|NCT01397877|endometrial cancer|endometrial cancer
363063|NCT01397877|BKM|bkm
363064|NCT01397877|monotherapy|monotherapy
363065|NCT01397877|metastatic|metastatic
363066|NCT01397877|initial treatment|initial treatment
363067|NCT01397864|Hereditary Angioedema|hereditary angioedema
363068|NCT01397864|HAE|hae
363069|NCT01397864|Angioedema|angioedema
363070|NCT01397864|Recombinant C1 Inhibitor|recombinant c1 inhibitor
363071|NCT01397864|rhC1INH|rhc1inh
363072|NCT01397864|registry|registry
363073|NCT01397838|Osteopenia|osteopenia
363074|NCT01397812|Rejection of the Heart Transplant|rejection of the heart transplant
363075|NCT01397812|Heart Transplant Rejection, an immune-mediated allograft injury|heart transplant rejection, an immune-mediated allograft injury
363076|NCT01397812|Non-cellular or humoral rejection in cardiac transplant recipients|non-cellular or humoral rejection in cardiac transplant recipients
363077|NCT01397812|Right ventricular endomyocardial biopsy to detect Heart transplant rejection|right ventricular endomyocardial biopsy to detect heart transplant rejection
363078|NCT01397799|Acute Myelogenous Leukemia|acute myelogenous leukemia
363079|NCT01397799|AML|aml
363080|NCT01397799|Refractory|refractory
363081|NCT01397799|Elderly|elderly
363082|NCT01397773|Hemodialysis|hemodialysis
363083|NCT01397773|peritoneal dialysis|peritoneal dialysis
363084|NCT01397773|chronic kidney disease|chronic kidney disease
363085|NCT01397773|inflammation|inflammation
363086|NCT01397773|carotis intima media thickness|carotis intima media thickness
363087|NCT01397760|DIFFICULT TO CONTROL ASTHMA|difficult to control asthma
363088|NCT01397760|OMALIZUMABE|omalizumabe
363089|NCT01397747|Cancer|cancer
363090|NCT01397747|Colorectal Cancer|colorectal cancer
363091|NCT01397747|Neoplasm|neoplasm
363092|NCT01397747|Colorectal Neoplasm|colorectal neoplasm
363093|NCT01397747|Intestinal Neoplasms|intestinal neoplasms
363094|NCT01397747|Gastrointestinal Neoplasms|gastrointestinal neoplasms
363095|NCT01397747|Digestive System Neoplasms|digestive system neoplasms
363096|NCT01397747|Neoplasms by Site|neoplasms by site
363097|NCT01397747|Neoplasms|neoplasms
363098|NCT01397747|Digestive System Diseases|digestive system diseases
363099|NCT01397747|Gastrointestinal Diseases|gastrointestinal diseases
363100|NCT01397747|Colonic Diseases|colonic diseases
363101|NCT01397747|Intestinal Diseases|intestinal diseases
363102|NCT01397747|Rectal Diseases|rectal diseases
363103|NCT01397734|CML|cml
363104|NCT01397734|Chronic myelogenous leukemia|chronic myelogenous leukemia
363105|NCT01397734|Chronic Myeloid leukemia|chronic myeloid leukemia
363106|NCT01397734|Arsenic|arsenic
363107|NCT01397734|Arsenic trioxide|arsenic trioxide
363108|NCT01397734|Imatinib|imatinib
363109|NCT01397734|Dasatinib|dasatinib
363110|NCT01397734|Nilotinib|nilotinib
363111|NCT01397734|TKI|tki
363112|NCT01397734|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
363113|NCT01397721|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
363114|NCT01397721|pulmonary vasculature|pulmonary vasculature
363115|NCT01397721|pulmonary hypertension|pulmonary hypertension
363116|NCT01397721|atherosclerosis|atherosclerosis
363117|NCT01397721|smokers|smokers
363118|NCT01397721|emphysema|emphysema
363119|NCT01397708|Melanoma|melanoma
363120|NCT01397708|Unresectable|unresectable
363121|NCT01397682|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
363122|NCT01397682|Frail elderly|frail elderly
363123|NCT01397682|Italy/epidemiology|italy/epidemiology
363124|NCT01397682|Geriatric Health Service|geriatric health service
363125|NCT01397682|Polypharmacy|polypharmacy
363126|NCT01397682|Biological Markers|biological markers
363127|NCT01397682|Epidemiologic Research Design|epidemiologic research design
363128|NCT01397656|cardiac arrest|cardiac arrest
363129|NCT01397656|CPR|cpr
363130|NCT01397656|resuscitation|resuscitation
363131|NCT01397656|fatigue|fatigue
363132|NCT01397656|quality|quality
363133|NCT01397565|Cholecystectomy|cholecystectomy
363134|NCT01397565|Laparoscopy|laparoscopy
363135|NCT01397565|Minilaparoscopic surgery|minilaparoscopic surgery
363136|NCT01397565|Post-operative pain|post-operative pain
363137|NCT01397565|Recovery time|recovery time
363138|NCT01397526|Congenital heart disease|congenital heart disease
363139|NCT01397526|Cardiopulmonary bypass|cardiopulmonary bypass
363140|NCT01397526|Capillary leak|capillary leak
363141|NCT01397526|Colloid osmotic pressure|colloid osmotic pressure
363142|NCT01397526|Children|children
363143|NCT01397513|Fibrin network structure|fibrin network structure
363144|NCT01397513|Aspirin treatment|aspirin treatment
363145|NCT01397513|Platelet microparticles|platelet microparticles
363146|NCT01397487|morphometric parameters, embryo biopsy|morphometric parameters, embryo biopsy
363147|NCT01397474|peripheral perfusion|peripheral perfusion
363148|NCT01397474|critically ill patients|critically ill patients
363149|NCT01397474|fluid administration|fluid administration
363150|NCT01397448|Rabeprazole|rabeprazole
363151|NCT01397448|proton pump inhibitor|proton pump inhibitor
363152|NCT01397448|Acetylsalicylic Acid|acetylsalicylic acid
363153|NCT01397448|Aspirin|aspirin
363154|NCT01397448|Gastric Ulcer|gastric ulcer
363155|NCT01397448|Duodenal Ulcer|duodenal ulcer
363156|NCT01397435|Lysosomal diseases|lysosomal diseases
363157|NCT01397435|Magnetic resonance Spectroscopy|magnetic resonance spectroscopy
363158|NCT01397435|MRI|mri
363159|NCT01397422|Levodopa-induced dyskinesia|levodopa-induced dyskinesia
363160|NCT01397422|Parkinsonism|parkinsonism
363161|NCT01397370|Safety|safety
363162|NCT01397370|Tolerability|tolerability
363163|NCT01397370|Pharmacokinetics|pharmacokinetics
363164|NCT01397370|Pharmacodynamics|pharmacodynamics
363165|NCT01397357|Cardiac magnetic resonance|cardiac magnetic resonance
363166|NCT01397357|Myocardial Ischemia|myocardial ischemia
363167|NCT01397357|Coronary Artery Disease|coronary artery disease
363168|NCT01397357|suspected Myocardial Ischemia|suspected myocardial ischemia
363169|NCT01397344|People in the outpatient waiting room|people in the outpatient waiting room
363170|NCT01397331|inhalational anesthesia|inhalational anesthesia
363171|NCT01397331|intravenous anesthesia|intravenous anesthesia
363172|NCT01397331|cardiac surgery|cardiac surgery
363173|NCT01397318|TaiChi Exercise|taichi exercise
363174|NCT01397318|pregnant women|pregnant women
363175|NCT01397305|5,10-methylenetetrahydrofolate|5,10-methylenetetrahydrofolate
363176|NCT01397305|neoadjuvant therapy|neoadjuvant therapy
363177|NCT01397305|pemetrexed|pemetrexed
363178|NCT01397305|Neoplasms|neoplasms
363179|NCT01397305|Rectal Neoplasms|rectal neoplasms
363180|NCT01397305|Colorectal Neoplasms|colorectal neoplasms
363181|NCT01397305|Intestinal Neoplasms|intestinal neoplasms
363182|NCT01397305|Gastrointestinal Neoplasms|gastrointestinal neoplasms
363183|NCT01397305|Digestive System Neoplasms|digestive system neoplasms
363184|NCT01397305|Neoplasms by Site|neoplasms by site
363185|NCT01397305|Rectal Diseases|rectal diseases
363186|NCT01397305|Digestive System Diseases|digestive system diseases
363187|NCT01397305|Gastrointestinal Diseases|gastrointestinal diseases
363188|NCT01397305|Intestinal Diseases|intestinal diseases
363189|NCT01397305|Pharmacologic Actions|pharmacologic actions
363190|NCT01397305|Therapeutic Uses|therapeutic uses
363191|NCT01397305|Antineoplastic Agents|antineoplastic agents
363192|NCT01397305|Enzyme Inhibitors|enzyme inhibitors
363193|NCT01397305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
363194|NCT01397305|Folic Acid Antagonists|folic acid antagonists
363195|NCT01397305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
363196|NCT01397305|Antimetabolites|antimetabolites
363197|NCT01397292|Bronchoscopy|bronchoscopy
363198|NCT01397292|Interventional Pulmonary|interventional pulmonary
363199|NCT01397292|Pleuroscopy|pleuroscopy
363200|NCT01397292|Tracheostomy|tracheostomy
363201|NCT01397279|type 2 diabetes|type 2 diabetes
363202|NCT01397279|insulin sensitivity|insulin sensitivity
363203|NCT01397279|hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
363204|NCT01397266|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
363205|NCT01397266|Cocaine|cocaine
363206|NCT01397266|impulsivity|impulsivity
363207|NCT01397266|rating scale|rating scale
363208|NCT01397253|Automated Communication Tools|automated communication tools
363209|NCT01397253|Medication errors|medication errors
363210|NCT01397253|PCP communication|pcp communication
363211|NCT01397227|Malaria|malaria
363212|NCT01397227|Plasmodium falciparum|plasmodium falciparum
363213|NCT01397227|Vaccination|vaccination
363214|NCT01397227|Prophylaxis|prophylaxis
363215|NCT01397227|Adenovirus|adenovirus
363216|NCT01397188|PiCCO|picco
363217|NCT01397175|Coronary artery disease|coronary artery disease
587092|NCT00530517|sumatripatan|sumatripatan
363218|NCT01397175|Percutaneous coronary intervention|percutaneous coronary intervention
363219|NCT01397175|Drug-eluting stent|drug-eluting stent
363220|NCT01397149|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
363221|NCT01397149|Thrombocytopenia|thrombocytopenia
363222|NCT01397149|Alkylating agents|alkylating agents
363223|NCT01397149|Purine derivatives|purine derivatives
363224|NCT01397149|TPO receptor agonist|tpo receptor agonist
363225|NCT01397136|Human embryo|human embryo
363226|NCT01397136|Culture media|culture media
363227|NCT01397136|Cell-free DNA|cell-free dna
363228|NCT01397136|In vitro fertilization|in vitro fertilization
363229|NCT01397136|Infertility|infertility
363230|NCT01397123|BMI z-score|bmi z-score
363231|NCT01397123|children|children
363232|NCT01397123|overweight|overweight
363233|NCT01397123|school-based intervention|school-based intervention
363234|NCT01397123|trained teachers|trained teachers
363235|NCT01397123|fruit|fruit
363236|NCT01397123|vegetables|vegetables
363237|NCT01397123|Low nutrition energy dense foods|low nutrition energy dense foods
363238|NCT01397084|esomeprazole 20mg|esomeprazole 20mg
363239|NCT01397084|heartburn|heartburn
363240|NCT01397084|rabeprazole 10mg|rabeprazole 10mg
363241|NCT01397084|reflux esophagitis|reflux esophagitis
363242|NCT01397084|Phase IV|phase iv
363243|NCT01397071|Avocado, antioxidant|avocado, antioxidant
363244|NCT01397045|Lung|lung
363245|NCT01397045|Nodule|nodule
363246|NCT01397045|Rehabilitation|rehabilitation
363247|NCT01397045|VATS|vats
363248|NCT01397045|Thoracotomy|thoracotomy
363249|NCT01397032|attention bias modification treatment|attention bias modification treatment
363250|NCT01397032|cognitive bias modification|cognitive bias modification
363251|NCT01397032|attention training|attention training
363252|NCT01397032|social anxiety|social anxiety
363253|NCT01397019|Pancreatic cancer|pancreatic cancer
363254|NCT01397019|Chemotherapy|chemotherapy
363255|NCT01397019|Chemoradiotherapy|chemoradiotherapy
363256|NCT01397006|Fibromyalgia|fibromyalgia
363257|NCT01397006|pregabalin|pregabalin
363258|NCT01397006|Lyrica|lyrica
363259|NCT01396980|hemodialysis|hemodialysis
363260|NCT01396980|intensive care|intensive care
363261|NCT01396980|microcirculation|microcirculation
363262|NCT01396967|capsulorhexis|capsulorhexis
363263|NCT01396954|Liver cirrhosis|liver cirrhosis
363264|NCT01396954|Diabetes mellitus|diabetes mellitus
363265|NCT01396954|Hepatogenous diabetes|hepatogenous diabetes
363266|NCT01396954|Oral glucose tolerance test|oral glucose tolerance test
363267|NCT01396954|Insulin resistance.|insulin resistance.
363268|NCT01396941|Diabetes|diabetes
363269|NCT01396928|Low rectal adenocarcinoma|low rectal adenocarcinoma
363564|NCT01395459|screening|screening
363270|NCT01396915|Skeletal muscle lipid content|skeletal muscle lipid content
363271|NCT01396915|whole muscle volume|whole muscle volume
363272|NCT01396915|fasting glucose|fasting glucose
363273|NCT01396915|insulin|insulin
363274|NCT01396915|blood urea nitrogen|blood urea nitrogen
363275|NCT01396889|Upper Respiratory Tract Infections|upper respiratory tract infections
363276|NCT01396889|Echinacea|echinacea
363277|NCT01396889|viral infections|viral infections
363278|NCT01396876|Medical clown|medical clown
363279|NCT01396876|Pediatric emergency medicine|pediatric emergency medicine
363280|NCT01396876|Emergency procedures|emergency procedures
363281|NCT01396863|Renal dialysis|renal dialysis
363282|NCT01396863|Hemodiafiltration|hemodiafiltration
363283|NCT01396863|Hemodialysis|hemodialysis
363284|NCT01396863|MRI|mri
363285|NCT01396850|Psychotic Patients|psychotic patients
363286|NCT01396837|Diabetic Foot Ulcer|diabetic foot ulcer
363287|NCT01396837|Diabetic Ulcer|diabetic ulcer
363288|NCT01396837|Diabetic Wound|diabetic wound
363289|NCT01396837|Chronic Ulcer|chronic ulcer
363290|NCT01396837|Chronic Wound|chronic wound
363291|NCT01396837|Neuropathic Diabetic Foot Ulcer|neuropathic diabetic foot ulcer
363292|NCT01396837|Neuropathic DFU|neuropathic dfu
363293|NCT01396837|DFU|dfu
363294|NCT01396824|Malnutrition|malnutrition
363295|NCT01396824|Undernutrition|undernutrition
363296|NCT01396824|Nutrition Assessment|nutrition assessment
363297|NCT01396824|Nutritional Assessment|nutritional assessment
363298|NCT01396824|Nutritional Index|nutritional index
363299|NCT01396824|Prognostic Nutritional Index|prognostic nutritional index
363300|NCT01396824|Prognostic Nutritional Index (PNI)|prognostic nutritional index (pni)
363301|NCT01396824|Nutritional Status|nutritional status
363302|NCT01396824|Prognosis|prognosis
363303|NCT01396824|Heart Failure|heart failure
363304|NCT01396824|Cardiovascular Diseases|cardiovascular diseases
363305|NCT01396824|Body Composition|body composition
363306|NCT01396824|Body Weights and Measures|body weights and measures
363307|NCT01396811|Tinea Pedis|tinea pedis
363308|NCT01396811|Antifungal|antifungal
363309|NCT01396798|serious infections|serious infections
363310|NCT01396798|meningitis|meningitis
363311|NCT01396785|Tinea Pedis|tinea pedis
363312|NCT01396785|Antifungal|antifungal
363313|NCT01396772|prediabetes|prediabetes
363314|NCT01396772|diabetes prevention|diabetes prevention
363315|NCT01396772|adults|adults
363316|NCT01396772|lifestyle intervention|lifestyle intervention
363317|NCT01396772|Social Cognitive Theory|social cognitive theory
363318|NCT01396772|dietary intake|dietary intake
363319|NCT01396772|physical activity|physical activity
363320|NCT01396759|Bubble CPAP|bubble cpap
363321|NCT01396759|Humidified high flow|humidified high flow
363322|NCT01396759|Hypoxaemia|hypoxaemia
363323|NCT01396759|Nasal prong|nasal prong
363324|NCT01396759|Severe pneumonia|severe pneumonia
363325|NCT01396733|thyroid|thyroid
363326|NCT01396733|cancer|cancer
363327|NCT01396733|redifferentiation|redifferentiation
363328|NCT01396733|lipoic acid|lipoic acid
363329|NCT01396707|HER2|her2
363330|NCT01396707|Trastuzumab|trastuzumab
363331|NCT01396707|XELOX|xelox
363332|NCT01396707|PHASE 2|phase 2
363333|NCT01396681|resected pancreatic cancer|resected pancreatic cancer
363334|NCT01396668|locally advanced|locally advanced
363335|NCT01396655|breast cancer|breast cancer
363336|NCT01396655|neoadjuvant chemotherapy|neoadjuvant chemotherapy
363337|NCT01396655|molecular marker|molecular marker
363338|NCT01396655|FDG PET|fdg pet
363339|NCT01396655|locally advanced breast cancer|locally advanced breast cancer
363340|NCT01396642|Topical Emollient Therapy|topical emollient therapy
363341|NCT01396642|Emollient|emollient
363342|NCT01396642|Preterm|preterm
363343|NCT01396642|Hospital Acquired Infection|hospital acquired infection
363344|NCT01396629|cartridge IOL|cartridge iol
363345|NCT01396603|Optical Frequency Domain Imaging|optical frequency domain imaging
363346|NCT01396603|Optical Coherence Tomography|optical coherence tomography
363347|NCT01396603|Optical biopsy|optical biopsy
363348|NCT01396603|Comprehensive Microscopy|comprehensive microscopy
363349|NCT01396590|Central Nervous System|central nervous system
363350|NCT01396577|Central Nervous System|central nervous system
363351|NCT01396564|Type 2 diabetes|type 2 diabetes
363352|NCT01396564|Resistin|resistin
363353|NCT01396564|Inflammation|inflammation
363354|NCT01396564|Insulin Resistance|insulin resistance
363355|NCT01396551|Anchored Beacon Transponder|anchored beacon transponder
363356|NCT01396551|Anchored Transponder|anchored transponder
363357|NCT01396551|Lung cancer|lung cancer
363358|NCT01396551|Calypso system|calypso system
363359|NCT01396551|Realtime tracking|realtime tracking
363360|NCT01396538|anti-HBc alone ；occult HBV infection|anti-hbc alone ；occult hbv infection
363361|NCT01396525|Atherosclerosis|atherosclerosis
363362|NCT01396525|Peripheral artery disease|peripheral artery disease
363363|NCT01396525|Peripheral vascular disease|peripheral vascular disease
363364|NCT01396525|PAD|pad
363365|NCT01396525|Claudication|claudication
363366|NCT01396525|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
363367|NCT01396525|Stent|stent
363368|NCT01396525|PAOD|paod
363369|NCT01396525|PVD|pvd
363370|NCT01396512|Japanese Encephalitis|japanese encephalitis
363371|NCT01396512|Japanese Encephalitis Virus Disease|japanese encephalitis virus disease
363372|NCT01396512|IMOJEV™|imojev™
363373|NCT01396512|CD.JEVAX™|cd.jevax™
363374|NCT01396499|Leukemia|leukemia
363375|NCT01396499|Acute leukemias|acute leukemias
363376|NCT01396499|Relapsed/refractory leukemias|relapsed/refractory leukemias
363377|NCT01396499|Acute myelogenous leukemia|acute myelogenous leukemia
363378|NCT01396499|AML|aml
363379|NCT01396499|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
363380|NCT01396499|ALL|all
363381|NCT01396499|BKM120|bkm120
363382|NCT01396486|Omega-3 Fatty Acids|omega-3 fatty acids
363383|NCT01396486|Fish Oil|fish oil
363384|NCT01396486|Inositol|inositol
363385|NCT01396486|Natural supplements|natural supplements
363386|NCT01396486|Bipolar Spectrum Disorders|bipolar spectrum disorders
363387|NCT01396486|Mania|mania
363388|NCT01396486|Depression|depression
363389|NCT01396486|Children|children
363390|NCT01396473|afterschool|afterschool
363391|NCT01396473|accelerometers|accelerometers
363392|NCT01396473|plate waste|plate waste
363393|NCT01396473|policy|policy
363394|NCT01396473|environment|environment
363395|NCT01396460|respiratory quotient|respiratory quotient
363396|NCT01396460|fat oxidation|fat oxidation
363397|NCT01396460|morbid obesity|morbid obesity
363398|NCT01396460|bariatric|bariatric
363399|NCT01396460|Bariatric Surgery|bariatric surgery
354078|NCT01433757|DYT-1|dyt-1
363400|NCT01396447|Bipolar I Disorder|bipolar i disorder
363615|NCT01395277|Aging|aging
363401|NCT01396447|Bipolar Depression|bipolar depression
363402|NCT01396447|Depression|depression
363403|NCT01396447|Bipolar Disorder|bipolar disorder
363404|NCT01396395|Nicorandil|nicorandil
363405|NCT01396395|Stable angina|stable angina
363406|NCT01396382|neuroendocrine|neuroendocrine
363407|NCT01396382|neuroendocrine carcinoma|neuroendocrine carcinoma
363408|NCT01396382|neuroendocrine tumor|neuroendocrine tumor
363409|NCT01396382|carcinoid|carcinoid
363410|NCT01396382|carcinoid tumor|carcinoid tumor
363411|NCT01396382|islet cell tumor|islet cell tumor
363412|NCT01396382|APUDoma|apudoma
363413|NCT01396382|Gallium|gallium
363414|NCT01396382|PET Scan|pet scan
363415|NCT01396343|Pediatric Multiple Sclerosis|pediatric multiple sclerosis
363416|NCT01396343|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
363417|NCT01396343|Clinically Isolated Syndrome|clinically isolated syndrome
363418|NCT01396343|Demyelinating Disease|demyelinating disease
363419|NCT01396317|PMR|pmr
363420|NCT01396317|POLYMYALGIA RHEUMATICA|polymyalgia rheumatica
363421|NCT01396317|Tocilizumab|tocilizumab
363422|NCT01396317|Hospital for Special Surgery|hospital for special surgery
363423|NCT01396317|HSS|hss
363424|NCT01396317|Robert Spiera|robert spiera
363425|NCT01396304|leg ulcer|leg ulcer
363426|NCT01396304|infection|infection
363427|NCT01396304|closure|closure
363428|NCT01396304|wound dressings|wound dressings
363429|NCT01396239|DMD|dmd
363430|NCT01396226|Atrial refractoriness|atrial refractoriness
363431|NCT01396226|cardiac electrophysiology|cardiac electrophysiology
363432|NCT01396226|IKACh|ikach
363433|NCT01396213|celiac disease|celiac disease
363434|NCT01396213|gastrointestinal symptoms|gastrointestinal symptoms
363435|NCT01396213|gluten-free diet|gluten-free diet
363436|NCT01396213|patients with biopsy-proven celiac disease with symptoms|patients with biopsy-proven celiac disease with symptoms
363437|NCT01396187|Type 2 diabetes|type 2 diabetes
363438|NCT01396187|safety|safety
363439|NCT01396187|multiple dose|multiple dose
363440|NCT01396187|intravenous|intravenous
363441|NCT01396174|breast cancer|breast cancer
363442|NCT01396174|breast tumor|breast tumor
363443|NCT01396161|Phase 1|phase 1
363444|NCT01396161|Multiple Doses|multiple doses
363445|NCT01396161|Safety|safety
363446|NCT01396161|Pharmacokinetics|pharmacokinetics
363447|NCT01396161|Pharmacodynamics|pharmacodynamics
363448|NCT01396161|Healthy Volunteers|healthy volunteers
363449|NCT01396161|Type 2 Diabetic Patients|type 2 diabetic patients
363450|NCT01396148|Children and young adults with GIST|children and young adults with gist
363451|NCT01396148|sunitinib malate|sunitinib malate
363452|NCT01396148|pharmacokinetics|pharmacokinetics
363453|NCT01396148|tumor response|tumor response
363454|NCT01396148|overall survival|overall survival
363455|NCT01396148|tumor KIT mutation status|tumor kit mutation status
363456|NCT01396135|Phase 1|phase 1
363457|NCT01396135|Pharmacokinetics|pharmacokinetics
363458|NCT01396135|Healthy|healthy
363459|NCT01396135|Japanese|japanese
363460|NCT01396135|Non-smokers|non-smokers
363461|NCT01396135|Major Depressive Disorder|major depressive disorder
363462|NCT01396135|CP-601|cp-601
363463|NCT01396135|927|927
363464|NCT01396096|Bariatric Surgery|bariatric surgery
363465|NCT01396083|Visual impairment|visual impairment
363466|NCT01396083|macular edema|macular edema
363467|NCT01396083|Central retinal vein occlusion|central retinal vein occlusion
363468|NCT01396083|Dexamethasone implant|dexamethasone implant
363469|NCT01396083|Ranibizumab|ranibizumab
363470|NCT01396057|Visual impairment|visual impairment
363471|NCT01396057|macular edema|macular edema
363765|NCT01394679|Lung Cancer|lung cancer
363472|NCT01396057|branch retinal vein occlusion|branch retinal vein occlusion
363473|NCT01396057|Dexamethasone implant|dexamethasone implant
363474|NCT01396057|Ranibizumab|ranibizumab
363475|NCT01396044|Quality improvement|quality improvement
363476|NCT01396044|Checklist|checklist
363477|NCT01396044|Critical care|critical care
363478|NCT01396044|Anti-bacterial agents|anti-bacterial agents
363479|NCT01396044|Mechanical ventilation|mechanical ventilation
363480|NCT01395966|with tubes|with tubes
363481|NCT01395953|Buspirone|buspirone
363482|NCT01395953|Buspar|buspar
363483|NCT01395953|Autism Spectrum Disorders|autism spectrum disorders
363484|NCT01395953|Pervasive Developmental Disorders|pervasive developmental disorders
363485|NCT01395953|Children|children
363486|NCT01395953|Adolescents|adolescents
363487|NCT01395953|Anxiety|anxiety
363488|NCT01395940|Gonadotropin-Releasing Hormone (GnRH) antagonist|gonadotropin-releasing hormone (gnrh) antagonist
363489|NCT01395927|Canagliflozin|canagliflozin
363490|NCT01395927|Rifampin|rifampin
363491|NCT01395927|Pharmacokinetics|pharmacokinetics
363492|NCT01395901|Prevention of Postoperative Nausea and Vomiting|prevention of postoperative nausea and vomiting
363493|NCT01395901|Palonosetron|palonosetron
363494|NCT01395901|Ondansetron|ondansetron
363495|NCT01395901|Pediatric|pediatric
363496|NCT01395836|Coronary Artery Bypass Grafting|coronary artery bypass grafting
354187|NCT01433302|Sarcoma|sarcoma
363497|NCT01395836|Cardiology|cardiology
363498|NCT01395836|Cardiac Electrophysiology|cardiac electrophysiology
363499|NCT01395836|Cardiac Surgery|cardiac surgery
363500|NCT01395784|Oxycodone|oxycodone
363501|NCT01395784|Opioid abuse|opioid abuse
363502|NCT01395771|Effect|effect
363503|NCT01395771|Phone call|phone call
363504|NCT01395771|Intervention|intervention
363505|NCT01395771|Promote|promote
363506|NCT01395771|HAART adherence|haart adherence
363507|NCT01395758|KRAS mutation|kras mutation
363508|NCT01395758|metastatic NSCLC|metastatic nsclc
363510|NCT01395745|Lupus|lupus
363511|NCT01395745|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
363512|NCT01395745|Autoimmune Diseases|autoimmune diseases
363513|NCT01395745|A-623|a-623
363514|NCT01395745|Blisibimod|blisibimod
363515|NCT01395719|renal transplantation|renal transplantation
363516|NCT01395719|glomerular filtration rate|glomerular filtration rate
363517|NCT01395719|remote ischemic preconditioning|remote ischemic preconditioning
363526|NCT01395641|AADC|aadc
363527|NCT01395641|DDC|ddc
363528|NCT01395641|Gene Therapy|gene therapy
363529|NCT01395641|AAV2-AADC|aav2-aadc
363530|NCT01395641|Viral Vector|viral vector
363531|NCT01395641|Gene Transfer|gene transfer
363532|NCT01395641|Aromatic L-Amino Acid Decarboxylase Deficiency|aromatic l-amino acid decarboxylase deficiency
363533|NCT01395628|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
363534|NCT01395628|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
363535|NCT01395628|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
363536|NCT01395628|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
363537|NCT01395628|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
363538|NCT01395628|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
363539|NCT01395589|vitamin D|vitamin d
363540|NCT01395589|emergency visits in patients with moderate to severe asthma after correction of vitamin D status.|emergency visits in patients with moderate to severe asthma after correction of vitamin d status.
363541|NCT01395576|Genu recurvatum|genu recurvatum
363542|NCT01395576|Knee hyper extension|knee hyper extension
363543|NCT01395576|Orthosis|orthosis
363544|NCT01395576|Gait analysis|gait analysis
363545|NCT01395576|Post stroke|post stroke
363546|NCT01395524|Non-Cancer-Related Pain|non-cancer-related pain
363547|NCT01395524|Opioid-Induced Constipation.|opioid-induced constipation.
363548|NCT01395511|whiplash associated disorder,|whiplash associated disorder,
363549|NCT01395511|Intractable Traumatic Cervical Syndrome,|intractable traumatic cervical syndrome,
363550|NCT01395511|Acupuncture,|acupuncture,
363551|NCT01395511|Randomized controlled trial|randomized controlled trial
363552|NCT01395498|CMV|cmv
363553|NCT01395498|PCP|pcp
363554|NCT01395498|bronchoalveolar lavage|bronchoalveolar lavage
363555|NCT01395485|Amgen|amgen
363556|NCT01395485|Adolescent|adolescent
363557|NCT01395485|Single Dose|single dose
363558|NCT01395485|Safety|safety
363559|NCT01395485|Pharmacokinetics|pharmacokinetics
363560|NCT01395472|TBI|tbi
363561|NCT01395472|Acute physical exercise|acute physical exercise
363562|NCT01395472|Cognitive functions|cognitive functions
363563|NCT01395472|Mood|mood
363565|NCT01395459|cancer prevention|cancer prevention
363566|NCT01395459|IVR|ivr
363567|NCT01395433|Assessing the bioequivalence of escitalopram dosage forms|assessing the bioequivalence of escitalopram dosage forms
363576|NCT01395407|Brain|brain
363577|NCT01395407|Neoplasm|neoplasm
363578|NCT01395407|Neoplasm Metastasis|neoplasm metastasis
363579|NCT01395407|Radiosurgery|radiosurgery
363580|NCT01395394|Phenylketonuria|phenylketonuria
363581|NCT01395394|PKU|pku
363582|NCT01395394|tetrahydrobiopterin|tetrahydrobiopterin
363583|NCT01395394|sapropterin dihydrochloride|sapropterin dihydrochloride
363584|NCT01395394|BH4|bh4
363585|NCT01395394|Kuvan|kuvan
363586|NCT01395394|Oxidative stress|oxidative stress
363587|NCT01395368|subjective|subjective
363588|NCT01395368|unilateral|unilateral
363589|NCT01395368|bilateral|bilateral
363590|NCT01395368|non-pulsatile|non-pulsatile
363591|NCT01395368|6 month's duration or longer|6 month's duration or longer
363592|NCT01395355|binge eating|binge eating
363593|NCT01395355|loss of control eating|loss of control eating
363594|NCT01395355|eating in the absence of hunger|eating in the absence of hunger
363595|NCT01395355|emotional eating|emotional eating
363596|NCT01395342|Pregnant women|pregnant women
363597|NCT01395342|Pre-eclampsia|pre-eclampsia
363598|NCT01395342|Exercise|exercise
363599|NCT01395342|Hypertension, Pregnancy-Induced|hypertension, pregnancy-induced
363600|NCT01395342|Parturition|parturition
363601|NCT01395303|infarction|infarction
363602|NCT01395303|stroke|stroke
363603|NCT01395303|diabetes|diabetes
363604|NCT01395303|fracture|fracture
363605|NCT01395303|aortic stenosis|aortic stenosis
363606|NCT01395303|cancer|cancer
363607|NCT01395303|death|death
363608|NCT01395303|vitamin D|vitamin d
363609|NCT01395303|androgens|androgens
363610|NCT01395303|thyroid hormones|thyroid hormones
363611|NCT01395290|staphylococcus aureus|staphylococcus aureus
363612|NCT01395290|vitamin D|vitamin d
363613|NCT01395277|Nitric Oxide|nitric oxide
363614|NCT01395277|Vascular Function|vascular function
363616|NCT01395277|Blood Pressure|blood pressure
363617|NCT01395277|Arterial Stiffness|arterial stiffness
363618|NCT01395277|Cardiovascular Disease|cardiovascular disease
363619|NCT01395277|Cerebral Blood Flow|cerebral blood flow
363620|NCT01395251|rheumatoid arthritis|rheumatoid arthritis
363621|NCT01395251|diagnosis|diagnosis
363622|NCT01395251|sensitivity|sensitivity
363623|NCT01395251|glucocorticoids|glucocorticoids
363624|NCT01395238|fathers|fathers
363625|NCT01395238|parenting|parenting
363626|NCT01395238|high-risk|high-risk
363627|NCT01395238|child maltreatment|child maltreatment
363628|NCT01395238|prevention|prevention
363629|NCT01395225|Fat Emulsifying|fat emulsifying
363630|NCT01395225|Radical Cystectomy|radical cystectomy
363631|NCT01395225|Pelvic Lymph Node Dissection|pelvic lymph node dissection
363632|NCT01395225|Pathological Lymph Node Processing|pathological lymph node processing
363633|NCT01395225|Bladder Cancer|bladder cancer
363634|NCT01395225|Transitional Cell Carcinoma|transitional cell carcinoma
363635|NCT01395225|Urothelial Cell Carcinoma|urothelial cell carcinoma
363636|NCT01395212|Cell-based cardiac regenerative therapy|cell-based cardiac regenerative therapy
363637|NCT01395212|Intramyocardial injections|intramyocardial injections
363638|NCT01395212|NOGA procedure|noga procedure
363639|NCT01395212|Acute myocardial infarction|acute myocardial infarction
363640|NCT01395199|Magnetic resonance imaging|magnetic resonance imaging
363641|NCT01395199|Thalassemia|thalassemia
363642|NCT01395199|Iron overload|iron overload
363643|NCT01395186|varicocele|varicocele
363644|NCT01395186|pain|pain
363645|NCT01395173|detection|detection
363646|NCT01395160|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
363647|NCT01395160|ADHD|adhd
363648|NCT01395160|Bipolar Disorder|bipolar disorder
363649|NCT01395160|Electrophysiological|electrophysiological
363650|NCT01395160|EEG|eeg
363651|NCT01395160|ERP|erp
363652|NCT01395160|Attention|attention
363653|NCT01395160|Motivation|motivation
363654|NCT01395160|Mood instability|mood instability
363655|NCT01395147|Drug Therapy|drug therapy
363656|NCT01395134|External branch of the superior laryngeal nerve,|external branch of the superior laryngeal nerve,
363657|NCT01395134|Recurrent laryngeal nerve,|recurrent laryngeal nerve,
363658|NCT01395134|Intraoperative neuromonitoring,|intraoperative neuromonitoring,
363659|NCT01395134|Thyroid surgery|thyroid surgery
363660|NCT01395121|c-KIT mutation|c-kit mutation
363661|NCT01395121|advanced disease|advanced disease
363662|NCT01395121|tyrosine kinase inhibitors|tyrosine kinase inhibitors
363663|NCT01395095|cardiac rehabilitation|cardiac rehabilitation
363664|NCT01395095|risk factor|risk factor
363665|NCT01395095|lifestyle|lifestyle
363666|NCT01395082|Myocarditis|myocarditis
363667|NCT01395082|Pericarditis|pericarditis
363668|NCT01395082|Vaccinia virus|vaccinia virus
363669|NCT01395082|ACAM2000®|acam2000®
363670|NCT01395082|Smallpox vaccine|smallpox vaccine
363671|NCT01395069|Post-cataract surgery|post-cataract surgery
363672|NCT01395069|macular edema|macular edema
363673|NCT01395056|breast neoplasm|breast neoplasm
363674|NCT01395056|Neoplasm Metastasis|neoplasm metastasis
363675|NCT01395056|Drug Therapy|drug therapy
363676|NCT01395043|Transversus Abdominis Plane catheter|transversus abdominis plane catheter
363677|NCT01395043|TAP catheter|tap catheter
363678|NCT01395030|Liver|liver
363679|NCT01395030|Cancer|cancer
363680|NCT01395017|Pancreatic cancer|pancreatic cancer
363681|NCT01395017|Dasatinib|dasatinib
363682|NCT01395017|chemotherapy|chemotherapy
363683|NCT01395017|Locally advanced|locally advanced
363684|NCT01394991|Epoetin alfa (EPREX, ERYPO)|epoetin alfa (eprex, erypo)
363685|NCT01394978|Pleural air leak|pleural air leak
363686|NCT01394978|Pulmonary resection|pulmonary resection
363687|NCT01394978|Open thoracotomy|open thoracotomy
363689|NCT01394965|Mapping|mapping
363690|NCT01394965|ecg mapping|ecg mapping
363691|NCT01394965|arrythmias|arrythmias
363692|NCT01394952|Cardiovascular disease|cardiovascular disease
363693|NCT01394952|Diabetes Mellitus|diabetes mellitus
363694|NCT01394952|Dulaglutide|dulaglutide
363695|NCT01394939|Vaccinia|vaccinia
363696|NCT01394939|Vaccinia Virus|vaccinia virus
363697|NCT01394939|JX-594|jx-594
363698|NCT01394939|Jennerex|jennerex
363699|NCT01394939|Colorectal Carcinoma|colorectal carcinoma
363700|NCT01394939|Colorectal cancer|colorectal cancer
363701|NCT01394939|Colon Cancer|colon cancer
363702|NCT01394939|Rectal Cancer|rectal cancer
363703|NCT01394939|oncolytic virus|oncolytic virus
363704|NCT01394939|viral therapy|viral therapy
363705|NCT01394939|RAS mutant|ras mutant
363706|NCT01394939|Erbitux failure|erbitux failure
363707|NCT01394939|Oxaliplatin failure|oxaliplatin failure
363708|NCT01394939|FOLFOX failure|folfox failure
363709|NCT01394939|FOLFIRI failure|folfiri failure
363710|NCT01394939|Irinotecan failure|irinotecan failure
363711|NCT01394939|Pexa-Vec|pexa-vec
363712|NCT01394926|CE-U/S - Contrast-Enhanced U/S|ce-u/s - contrast-enhanced u/s
363713|NCT01394926|U/S - Ultrasound|u/s - ultrasound
363714|NCT01394926|Assess effectiveness|assess effectiveness
363716|NCT01394900|sexually transmitted infection|sexually transmitted infection
363717|NCT01394900|STI|sti
363718|NCT01394900|men who have sex with men|men who have sex with men
363719|NCT01394900|MSM|msm
363720|NCT01394900|couples|couples
363721|NCT01394900|African American|african american
363722|NCT01394900|Black|black
363723|NCT01394887|Metformin, inflammation|metformin, inflammation
363724|NCT01394887|resistin|resistin
363725|NCT01394887|impaired glucose tolerance|impaired glucose tolerance
363726|NCT01394887|children|children
363727|NCT01394874|osteoarthritis|osteoarthritis
363728|NCT01394874|exercise|exercise
363729|NCT01394861|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
363730|NCT01394861|ESD|esd
363731|NCT01394861|EMR|emr
363732|NCT01394861|Early Gastric Cancer|early gastric cancer
363733|NCT01394861|Flexible Endoscopic Robotic System|flexible endoscopic robotic system
363734|NCT01394861|Master Slave Robot|master slave robot
363735|NCT01394861|Ease & Safety of ESD by Flexible Master Slave Robotic System|ease & safety of esd by flexible master slave robotic system
363736|NCT01394835|Patient after lung transplantation|patient after lung transplantation
363737|NCT01394809|osteoporosis|osteoporosis
363738|NCT01394809|wrist fracture|wrist fracture
363739|NCT01394809|mental practice|mental practice
363740|NCT01394809|mirror therapy|mirror therapy
363741|NCT01394809|immobilization|immobilization
363742|NCT01394809|elderly|elderly
363743|NCT01394783|Endotracheal intubation, Teaching, Videolaryngoscope|endotracheal intubation, teaching, videolaryngoscope
363744|NCT01394770|hypertension|hypertension
363745|NCT01394770|dialysis|dialysis
363746|NCT01394770|aliskiren|aliskiren
363747|NCT01394770|amlodipine|amlodipine
363748|NCT01394770|outcome|outcome
363749|NCT01394744|metal|metal
363750|NCT01394744|ion|ion
363751|NCT01394744|cytokine|cytokine
363752|NCT01394744|hip arthroplasty|hip arthroplasty
363753|NCT01394744|blood|blood
363754|NCT01394744|Assessment|assessment
363755|NCT01394744|cytokine profile|cytokine profile
363756|NCT01394718|analgesic adjunct|analgesic adjunct
363757|NCT01394718|acetaminophen|acetaminophen
363758|NCT01394718|spine fusion surgery|spine fusion surgery
363759|NCT01394718|opiate reduction|opiate reduction
363760|NCT01394718|pain management after elective surgical operation|pain management after elective surgical operation
363761|NCT01394705|patients at increased risk for atherosclerosis|patients at increased risk for atherosclerosis
363762|NCT01394692|intraoperative MRI|intraoperative mri
363763|NCT01394692|glioma surgery|glioma surgery
363764|NCT01394692|extent of resection|extent of resection
363766|NCT01394679|Recurrent Lung Cancer no treatment within 3 months|recurrent lung cancer no treatment within 3 months
363767|NCT01394653|YM060|ym060
363768|NCT01394653|ramosetron|ramosetron
363769|NCT01394653|orally-disintegrating tablet|orally-disintegrating tablet
363770|NCT01394653|OD tablet|od tablet
363771|NCT01394653|bioequivalence|bioequivalence
363772|NCT01394614|Cataplexy|cataplexy
363773|NCT01394614|MSLT|mslt
363774|NCT01394614|Hypocretin|hypocretin
363775|NCT01394614|HLA typing|hla typing
363776|NCT01394614|Polysomnography|polysomnography
363777|NCT01394614|A/H1N1 vaccine|a/h1n1 vaccine
363778|NCT01394601|Antipsychotics|antipsychotics
363779|NCT01394601|schizophrenia|schizophrenia
363780|NCT01394601|acute inpatient|acute inpatient
363781|NCT01394588|Cardiac Surgery|cardiac surgery
363782|NCT01394588|Perioperative Glucose Control|perioperative glucose control
363783|NCT01394575|breast cancer|breast cancer
363784|NCT01394575|radiotherapy|radiotherapy
363785|NCT01394575|simultaneous integrated boost|simultaneous integrated boost
363786|NCT01394575|tumor bed|tumor bed
363787|NCT01394575|IMRT|imrt
363788|NCT01394536|Post-operative|post-operative
363789|NCT01394536|post-op|post-op
363790|NCT01394536|nausea|nausea
363791|NCT01394536|vomiting|vomiting
363792|NCT01394510|insulin secretion|insulin secretion
363793|NCT01394510|beta-cell function|beta-cell function
363794|NCT01394510|oxidative stress|oxidative stress
363795|NCT01394510|type 2 diabetes|type 2 diabetes
363796|NCT01394497|Liver Transplantation|liver transplantation
363797|NCT01394497|Graft Survival|graft survival
363798|NCT01394497|Graft Rejection|graft rejection
363799|NCT01394497|Primary Graft Dysfunction|primary graft dysfunction
363800|NCT01394497|Tissue and Organ Harvesting|tissue and organ harvesting
363801|NCT01394497|Tissue and Organ Procurement|tissue and organ procurement
363802|NCT01394497|Tissue Donors|tissue donors
363803|NCT01394497|Cold Ischemia|cold ischemia
363804|NCT01394471|schizophrenia|schizophrenia
363805|NCT01394471|schizoaffective disorder|schizoaffective disorder
363806|NCT01394471|oxytocin|oxytocin
363807|NCT01394471|OT|ot
363808|NCT01394471|social cognition|social cognition
363809|NCT01394471|social functioning|social functioning
363810|NCT01394471|paranoia|paranoia
363811|NCT01394471|psychosis|psychosis
363812|NCT01394471|psychotic symptoms|psychotic symptoms
363813|NCT01394471|social deficits|social deficits
363814|NCT01394471|intranasal administration|intranasal administration
363815|NCT01394458|catheter related infection|catheter related infection
363816|NCT01394458|bacteremia|bacteremia
363817|NCT01394458|hemodialysis|hemodialysis
751939|NCT01171287|Orthopedic Procedures|orthopedic procedures
363818|NCT01394432|Endocardial Stem Cells Injection|endocardial stem cells injection
363819|NCT01394432|Percutaneous Coronary Intervention|percutaneous coronary intervention
363820|NCT01394393|obesity treatment|obesity treatment
363821|NCT01394393|evidence based intervention|evidence based intervention
363822|NCT01394393|cognitive behavioral treatment|cognitive behavioral treatment
363823|NCT01394393|virtual reality environments|virtual reality environments
363825|NCT01394380|sweetened beverages|sweetened beverages
363826|NCT01394380|hepatic steatosis|hepatic steatosis
363827|NCT01394380|visceral obesity|visceral obesity
363828|NCT01394380|metabolic syndrome|metabolic syndrome
363829|NCT01394367|respiratory therapy|respiratory therapy
363830|NCT01394367|exercise therapy|exercise therapy
363831|NCT01394367|oxygen uptake|oxygen uptake
363832|NCT01394367|quality of life|quality of life
363833|NCT01394367|right ventricular function|right ventricular function
363834|NCT01394367|severe pulmonary hypertension|severe pulmonary hypertension
363835|NCT01394354|Multiple Myeloma relapsed refractory|multiple myeloma relapsed refractory
363836|NCT01394341|Liraglutide|liraglutide
363837|NCT01394341|Uremia|uremia
363838|NCT01394341|Dialysis|dialysis
363839|NCT01394341|Type 2 diabetes mellitus|type 2 diabetes mellitus
363840|NCT01394341|Safety|safety
363841|NCT01394341|Efficacy|efficacy
363842|NCT01394328|Delirium|delirium
363843|NCT01394328|Dementia|dementia
363844|NCT01394328|Confusion Assessment Method|confusion assessment method
363845|NCT01394328|Elderly|elderly
363846|NCT01394315|diffuse optical tomography|diffuse optical tomography
363847|NCT01394315|response|response
363848|NCT01394315|neoadjuvant chemotherapy|neoadjuvant chemotherapy
363849|NCT01394315|breast cancer|breast cancer
363850|NCT01394302|Trigger Finger|trigger finger
363851|NCT01394289|Standardization|standardization
363852|NCT01394289|Immunotherapy|immunotherapy
363853|NCT01394289|Skin prick test|skin prick test
363854|NCT01394263|prostate cancer|prostate cancer
363856|NCT01394263|testosterone suppression|testosterone suppression
363857|NCT01394250|Pain|pain
363858|NCT01394250|Anxiety|anxiety
363859|NCT01394250|IV Cannulation|iv cannulation
363860|NCT01394250|Topical Lidocaine|topical lidocaine
363861|NCT01394250|Buzzy|buzzy
363862|NCT01394250|Face, Legs, Activity, Crying, Consolability (FLACC) scale|face, legs, activity, crying, consolability (flacc) scale
363863|NCT01394250|Faces Pain Scale Revised (FPS-R)|faces pain scale revised (fps-r)
363864|NCT01394250|Child Rating of Anxiety Scale|child rating of anxiety scale
363865|NCT01394224|Healthy volunteers|healthy volunteers
363866|NCT01394224|Japanese|japanese
363867|NCT01394198|Osteopathic Manipulative Medicine (OMM)|osteopathic manipulative medicine (omm)
363868|NCT01394198|Neuromuscular Medicine (NMM)|neuromuscular medicine (nmm)
363869|NCT01394198|Somatic Dysfunction|somatic dysfunction
363870|NCT01394198|Correlational Study|correlational study
363871|NCT01394198|Endoscopy|endoscopy
363872|NCT01394185|marijuana|marijuana
363873|NCT01394185|dronabinol|dronabinol
363874|NCT01394185|pharmacotherapy|pharmacotherapy
363875|NCT01394172|Tidal Volume|tidal volume
363876|NCT01394172|Pediatric|pediatric
363877|NCT01394172|Difficult airway|difficult airway
363878|NCT01394172|Ventilation|ventilation
363879|NCT01394172|Airway management|airway management
363880|NCT01394159|passes required to establish diagnosis|passes required to establish diagnosis
363881|NCT01394146|phosphorus-based food additives|phosphorus-based food additives
363882|NCT01394146|phosphorus metabolism|phosphorus metabolism
363883|NCT01394133|HIV Infected Women|hiv infected women
363884|NCT01394120|Pancreas cancer|pancreas cancer
363885|NCT01394120|Targeted Therapy|targeted therapy
363886|NCT01394107|Thromboprophylaxis|thromboprophylaxis
363887|NCT01394107|Effect of LMWH on coagulation|effect of lmwh on coagulation
363888|NCT01394107|Pregnancy|pregnancy
363889|NCT01394107|Neuraxial anesthesia|neuraxial anesthesia
363890|NCT01394107|Spinal haematoma|spinal haematoma
363891|NCT01394094|Gum chewing|gum chewing
363892|NCT01394094|Bowel function|bowel function
363893|NCT01394094|benign gynecologic surgery|benign gynecologic surgery
363894|NCT01394081|Veterans|veterans
363895|NCT01394081|Health Care Utilization|health care utilization
363896|NCT01394081|Rural Health|rural health
363897|NCT01394081|Patient Navigation|patient navigation
363898|NCT01394081|Motivational Interviewing|motivational interviewing
363899|NCT01394068|Selenium level|selenium level
363900|NCT01394068|Various blood values|various blood values
363901|NCT01394068|Duration of artificial respiration|duration of artificial respiration
363902|NCT01394068|Residence in ICU/ Hospital|residence in icu/ hospital
363903|NCT01394068|SOFA-Score|sofa-score
363904|NCT01394068|SAPS-Score|saps-score
363905|NCT01394055|Diabetes Mellitus Type 1 and 2|diabetes mellitus type 1 and 2
363906|NCT01394055|Delayed Gastric Emptying|delayed gastric emptying
363907|NCT01394055|Gastroparesis|gastroparesis
363908|NCT01394055|Gastrointestinal Motility Disorder|gastrointestinal motility disorder
363909|NCT01394042|Biopsy proven primary prostate cancer|biopsy proven primary prostate cancer
363910|NCT01394029|iron overload|iron overload
363911|NCT01394029|iron chelation|iron chelation
363912|NCT01394029|deferasirox|deferasirox
363913|NCT01394029|observational|observational
363914|NCT01394003|Advanced cancer|advanced cancer
363915|NCT01393977|Spinal Cord Injuries|spinal cord injuries
363916|NCT01393977|Stem Cell Transplantation|stem cell transplantation
363917|NCT01393977|Rehabilitation|rehabilitation
363918|NCT01393951|Recombinant Influenza hemagglutinin vaccine|recombinant influenza hemagglutinin vaccine
363919|NCT01393938|Mullerian Duct Anomaly|mullerian duct anomaly
363920|NCT01393938|3-dimensional Ultrasound|3-dimensional ultrasound
363921|NCT01393938|Magnetic Resonance Imaging|magnetic resonance imaging
363922|NCT01393912|crenolanib|crenolanib
363923|NCT01393912|radiation therapy|radiation therapy
363924|NCT01393912|malignant brain tumors|malignant brain tumors
363925|NCT01393912|pediatric|pediatric
363926|NCT01393899|tofacitinib|tofacitinib
363927|NCT01393899|Xeljanz|xeljanz
363928|NCT01393899|CP-690,550|cp-690,550
363929|NCT01393899|maintenance therapy|maintenance therapy
363930|NCT01393886|Obesity Surgery|obesity surgery
363931|NCT01393873|Obesity|obesity
363932|NCT01393873|Type 2 DM|type 2 dm
363933|NCT01393860|Diabetes|diabetes
363934|NCT01393860|aliskiren|aliskiren
363935|NCT01393860|hypertension|hypertension
363936|NCT01393860|renal impairment|renal impairment
363937|NCT01393847|Sickle Cell|sickle cell
363938|NCT01393847|Pain|pain
363939|NCT01393847|Genetics|genetics
363940|NCT01393847|Sickle Cell Disease|sickle cell disease
363941|NCT01393847|Healthy Volunteer|healthy volunteer
363943|NCT01393834|Delayed cord clamping|delayed cord clamping
363944|NCT01393834|Umbilical cord|umbilical cord
363945|NCT01393834|Preterm|preterm
363946|NCT01393834|Cord milking|cord milking
363947|NCT01393808|Type 2 diabetes|type 2 diabetes
363948|NCT01393808|Paricalcitol|paricalcitol
363949|NCT01393808|Proteinuria|proteinuria
363950|NCT01393808|Sodium intake|sodium intake
363951|NCT01393795|Pulmonary Hypertension|pulmonary hypertension
363952|NCT01393795|Pain|pain
363953|NCT01393782|high output shock|high output shock
363954|NCT01393782|distributive shock|distributive shock
363955|NCT01393782|warm shock|warm shock
363956|NCT01393782|septic shock|septic shock
363957|NCT01393782|pressor|pressor
363958|NCT01393782|angiotensin|angiotensin
363959|NCT01393782|ATII|atii
363960|NCT01393782|vasopressor|vasopressor
363961|NCT01393769|Retinoblastoma|retinoblastoma
363962|NCT01393769|RTB|rtb
363963|NCT01393769|Ocular tumour|ocular tumour
363964|NCT01393769|Melfalan|melfalan
363965|NCT01393769|Enucleation|enucleation
363966|NCT01393769|Tumor of the eye|tumor of the eye
363968|NCT01393769|Ocular cancer|ocular cancer
363969|NCT01393769|Ocular chemotherapy|ocular chemotherapy
363970|NCT01393769|Ophthalmic artery|ophthalmic artery
363971|NCT01393769|Intra-arterial chemotherapy|intra-arterial chemotherapy
363972|NCT01393743|Central Nervous System|central nervous system
363973|NCT01393730|prostate|prostate
363974|NCT01393730|metastatic|metastatic
363975|NCT01393730|castrate resistant|castrate resistant
363976|NCT01393704|myomectomy|myomectomy
363977|NCT01393704|vasopressin|vasopressin
363978|NCT01393704|blood loss|blood loss
363979|NCT01393691|nighttime fears|nighttime fears
363980|NCT01393691|anxiety|anxiety
363981|NCT01393691|sleep|sleep
363982|NCT01393691|actigraphy|actigraphy
363983|NCT01393691|intervention|intervention
363984|NCT01393652|Pharmacokinetics Safety Tolerability Pharmacodynamics|pharmacokinetics safety tolerability pharmacodynamics
363985|NCT01393639|treatment of rheumatoid arthritis|treatment of rheumatoid arthritis
363986|NCT01393639|treatment of RA|treatment of ra
363987|NCT01393639|patients on methotrexate for rheumatoid arthritis|patients on methotrexate for rheumatoid arthritis
363988|NCT01393639|prednisone for rheumatoid arthritis|prednisone for rheumatoid arthritis
363989|NCT01393587|Oxidative Stress|oxidative stress
363990|NCT01393587|Laproscopy|laproscopy
363991|NCT01393561|Rhinitis|rhinitis
363992|NCT01393561|Common cold|common cold
363993|NCT01393561|Nasal symptoms|nasal symptoms
363994|NCT01393561|Children|children
363995|NCT01393548|Rhinitis|rhinitis
363996|NCT01393548|common cold|common cold
363997|NCT01393548|nasal symptoms|nasal symptoms
363998|NCT01393548|children|children
363999|NCT01393535|Adiponectin|adiponectin
364000|NCT01393535|Prognosis|prognosis
364001|NCT01393535|Cardiac Surgery|cardiac surgery
364002|NCT01393522|headache|headache
364003|NCT01393522|migraine|migraine
364004|NCT01393509|PU-H71|pu-h71
364005|NCT01393509|Solid Tumor|solid tumor
364006|NCT01393509|Lymphoma|lymphoma
364007|NCT01393509|11-041|11-041
587093|NCT00530530|ASP8825|asp8825
364019|NCT01393470|Vaccine|vaccine
364020|NCT01393470|long-term efficacy|long-term efficacy
364021|NCT01393470|registry-based study|registry-based study
752409|NCT01172912|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
446748|NCT00007228|DCM|dcm
364022|NCT01393470|Evaluation of long-term HPV vaccine efficacy: a population-based, registry-based cohort study in Finland.|evaluation of long-term hpv vaccine efficacy: a population-based, registry-based cohort study in finland.
364023|NCT01393457|cocaine|cocaine
364024|NCT01393457|cognition|cognition
364025|NCT01393457|medication|medication
364026|NCT01393457|treatment|treatment
364027|NCT01393444|Electrocorticography|electrocorticography
364028|NCT01393444|Tetraplegia|tetraplegia
364029|NCT01393444|Spinal cord injury|spinal cord injury
364030|NCT01393444|Brainstem stroke|brainstem stroke
364031|NCT01393444|Neuroprosthetic|neuroprosthetic
364032|NCT01393444|Brain-computer interface|brain-computer interface
364033|NCT01393444|Direct brain interface|direct brain interface
364034|NCT01393444|Neural activity|neural activity
364035|NCT01393444|Motor cortex|motor cortex
364036|NCT01393431|Exhaled breath condensate pH|exhaled breath condensate ph
364037|NCT01393431|Predictive value of pH|predictive value of ph
364038|NCT01393418|Erythropoietin|erythropoietin
364039|NCT01393418|Cardiac Surgery|cardiac surgery
364040|NCT01393418|Renal Biomarker|renal biomarker
364041|NCT01393418|Acute Kidney Injury|acute kidney injury
364042|NCT01393418|Hypothermic Circulatory Arrest|hypothermic circulatory arrest
364043|NCT01393392|smoking cessation|smoking cessation
364044|NCT01393392|methadone treatment|methadone treatment
364045|NCT01393392|nicotine addiction|nicotine addiction
364046|NCT01393392|drug treatment|drug treatment
364047|NCT01393392|drug addiction|drug addiction
364048|NCT01393392|tobacco dependence|tobacco dependence
364049|NCT01393327|physical training|physical training
364050|NCT01393327|remaining post-operative pulmonary vascular changes|remaining post-operative pulmonary vascular changes
364051|NCT01393327|right ventricular pump function|right ventricular pump function
364053|NCT01393301|Nicotine dependence|nicotine dependence
364054|NCT01393301|Smoking, cessation|smoking, cessation
364055|NCT01393301|Quitting|quitting
364056|NCT01393301|Anxiety symptoms|anxiety symptoms
364057|NCT01393301|Cognitive-behavioral therapy|cognitive-behavioral therapy
364058|NCT01393275|diabetes|diabetes
364059|NCT01393275|exercise|exercise
364060|NCT01393275|intervention|intervention
364061|NCT01393275|rehabilitation|rehabilitation
364062|NCT01393275|metabolic rate|metabolic rate
364063|NCT01393275|sport|sport
364064|NCT01393249|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
364065|NCT01393249|Pediatric|pediatric
364066|NCT01393249|Asparaginase|asparaginase
364067|NCT01393249|Pancreatitis|pancreatitis
364068|NCT01393223|Interstitial Cystitis|interstitial cystitis
364069|NCT01393223|Painful Bladder Syndrome|painful bladder syndrome
364070|NCT01393223|Bladder Pain Syndrome|bladder pain syndrome
364071|NCT01393223|Liposome|liposome
364072|NCT01393223|LP-08|lp-08
364073|NCT01393210|insulin sensitivity|insulin sensitivity
364074|NCT01393210|adipose tissue|adipose tissue
364075|NCT01393210|inflammation|inflammation
364076|NCT01393197|HCC|hcc
364077|NCT01393197|TACE|tace
364078|NCT01393184|Target therapy|target therapy
364079|NCT01393171|Anterior Vaginal Prolapse|anterior vaginal prolapse
364080|NCT01393171|Cystocele|cystocele
364081|NCT01393171|Pelvic Organ Prolapse|pelvic organ prolapse
364082|NCT01393145|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
364083|NCT01393145|salmeterol|salmeterol
364084|NCT01393145|fluticasone|fluticasone
364085|NCT01393145|formoterol|formoterol
364086|NCT01393145|FEV1|fev1
364087|NCT01393145|Moderate-to-severe|moderate-to-severe
364088|NCT01393132|Dry Eye|dry eye
364089|NCT01393132|Sjogren's Syndrome|sjogren's syndrome
364090|NCT01393132|Graft vs. Host Disease|graft vs. host disease
364091|NCT01393132|Rheumatoid arthritis|rheumatoid arthritis
364092|NCT01393132|Systemic lupus erythematosus|systemic lupus erythematosus
364093|NCT01393132|Scleroderma|scleroderma
364094|NCT01393106|HL|hl
364095|NCT01393106|idelalisib|idelalisib
364096|NCT01393106|CAL-101|cal-101
364097|NCT01393106|GS-1101|gs-1101
364098|NCT01393106|PI3K|pi3k
364099|NCT01393093|HCC|hcc
364100|NCT01393093|TACE|tace
364101|NCT01393080|nimotuzumab|nimotuzumab
364102|NCT01393080|non-small cell lung cancer|non-small cell lung cancer
364103|NCT01393080|chemotherapy|chemotherapy
364104|NCT01393067|cSEMS|csems
364105|NCT01393067|NEPS|neps
364106|NCT01393067|ERCP|ercp
364107|NCT01393067|biliary stricture|biliary stricture
364108|NCT01393067|biliary stenosis|biliary stenosis
364109|NCT01393067|liver transplantation|liver transplantation
364110|NCT01393054|Nigella sativa seed extract|nigella sativa seed extract
364111|NCT01393054|hypertension|hypertension
364112|NCT01393054|elderly|elderly
364113|NCT01393028|coronary artery disease|coronary artery disease
364114|NCT01393028|angina pectoris|angina pectoris
364115|NCT01393028|Stable chest pain complaints|stable chest pain complaints
364116|NCT01393015|automatic|automatic
364117|NCT01393015|automation|automation
364118|NCT01393015|oxygen|oxygen
364119|NCT01393015|weaning|weaning
364120|NCT01393015|COPD|copd
446838|NCT00007488|HIV-1|hiv-1
354774|NCT01431235|SUD|sud
354775|NCT01431235|cognitive behavioral therapy|cognitive behavioral therapy
354776|NCT01431222|severe mitral regurgitation|severe mitral regurgitation
354777|NCT01431222|interventional mitral valve reconstruction|interventional mitral valve reconstruction
354778|NCT01431222|inoperable|inoperable
354810|NCT01431079|HPV|hpv
364121|NCT01393015|exacerbation|exacerbation
364122|NCT01393002|intensive care|intensive care
364123|NCT01393002|candidemia|candidemia
364124|NCT01393002|fungal infection|fungal infection
364125|NCT01392976|cancer|cancer
364126|NCT01392976|advanced|advanced
364127|NCT01392976|solid|solid
364128|NCT01392976|tumor|tumor
364129|NCT01392976|gemcitabine|gemcitabine
364130|NCT01392976|human equilibrative nucleoside transporter-1 (hENT1)|human equilibrative nucleoside transporter-1 (hent1)
363715|NCT01394900|HIV|hiv
364131|NCT01392976|CO-1.01|co-1.01
364132|NCT01392976|CO-101|co-101
364133|NCT01392976|CO101|co101
364134|NCT01392963|botox|botox
364135|NCT01392963|depression|depression
364136|NCT01392950|silicone hydrogel contact lenses for daily wear|silicone hydrogel contact lenses for daily wear
364137|NCT01392937|AIOL|aiol
364138|NCT01392937|multipurpose solution|multipurpose solution
364139|NCT01392937|silicone hydrogel lenses|silicone hydrogel lenses
364140|NCT01392937|The safety and efficacy of the All-in-One Light multipurpose care regimen by comparison with the Aquify care regimen|the safety and efficacy of the all-in-one light multipurpose care regimen by comparison with the aquify care regimen
364141|NCT01392911|Dose Ranging|dose ranging
364142|NCT01392911|Extended Early Bactericidal Activity|extended early bactericidal activity
364143|NCT01392911|Maximum tolerable dose|maximum tolerable dose
364144|NCT01392911|Pharmacokinetics|pharmacokinetics
364145|NCT01392911|Pulmonary Tuberculosis|pulmonary tuberculosis
364146|NCT01392911|Rifampicin|rifampicin
364147|NCT01392911|Rifafour|rifafour
364148|NCT01392911|Safety|safety
364149|NCT01392911|Tolerability|tolerability
364150|NCT01392911|Max Tolerable Dose|max tolerable dose
364151|NCT01392898|liraglutide|liraglutide
364152|NCT01392898|insulin|insulin
364153|NCT01392898|type 2 diabetes mellitus|type 2 diabetes mellitus
364154|NCT01392885|Schizophrenia|schizophrenia
364155|NCT01392885|Schizoaffective Disorder|schizoaffective disorder
364156|NCT01392885|Brain Health|brain health
364157|NCT01392885|Exercise|exercise
364158|NCT01392885|Mental Health|mental health
364159|NCT01392885|Poor memory|poor memory
364160|NCT01392872|Immunosuppressant|immunosuppressant
364161|NCT01392872|Quality of life|quality of life
364162|NCT01392872|Cognitive function|cognitive function
364163|NCT01392872|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
364164|NCT01392846|Coronary artery disease requiring drug eluting stents|coronary artery disease requiring drug eluting stents
364165|NCT01392833|iga nephropathy|iga nephropathy
364273|NCT01392352|pazopanib|pazopanib
364166|NCT01392833|chronic kidney disease|chronic kidney disease
364167|NCT01392833|proteinuria|proteinuria
364168|NCT01392833|steroids|steroids
364169|NCT01392833|azathioprine|azathioprine
364170|NCT01392820|Phase I|phase i
364171|NCT01392820|Japan|japan
364172|NCT01392820|Elderly|elderly
364174|NCT01392820|SAD|sad
364175|NCT01392820|MAD|mad
364176|NCT01392807|Phase 1|phase 1
364177|NCT01392807|volunteers with hepatic impairment|volunteers with hepatic impairment
364178|NCT01392807|pharmacokinetics|pharmacokinetics
364179|NCT01392807|NKTR-118|nktr-118
364180|NCT01392807|Child-Pugh scale|child-pugh scale
364181|NCT01392807|AUC|auc
364182|NCT01392807|Cmax|cmax
364183|NCT01392807|tmax|tmax
364184|NCT01392807|t1/2|t1/2
364185|NCT01392794|YM060|ym060
364186|NCT01392794|ramosetron|ramosetron
364187|NCT01392794|orally-disintegrating tablet|orally-disintegrating tablet
364188|NCT01392794|OD tablet|od tablet
364189|NCT01392794|bioequivalence|bioequivalence
364190|NCT01392781|PCOS|pcos
364191|NCT01392781|hsC-RP|hsc-rp
364192|NCT01392781|Lp-PLA2|lp-pla2
364193|NCT01392781|cardiovascular risk|cardiovascular risk
364194|NCT01392768|Epilepsy|epilepsy
364195|NCT01392768|Partial|partial
364196|NCT01392768|Seizures|seizures
364197|NCT01392768|Adjunctive|adjunctive
364198|NCT01392690|No condition|no condition
364199|NCT01392690|Primary prevention|primary prevention
364200|NCT01392690|Anxiety|anxiety
364201|NCT01392677|dapagliflozin|dapagliflozin
364202|NCT01392677|diabetes|diabetes
364203|NCT01392677|hyperglycaemia|hyperglycaemia
364204|NCT01392651|Urinary stress incontinence|urinary stress incontinence
364205|NCT01392651|TVT|tvt
364206|NCT01392638|Sildenafil|sildenafil
364207|NCT01392638|Nitric oxide synthase|nitric oxide synthase
364208|NCT01392638|Polymorphism|polymorphism
364209|NCT01392638|Hemodynamics|hemodynamics
587094|NCT00530530|Restless legs Syndrome|restless legs syndrome
364210|NCT01392625|Non ischemic dilated cardiomyopathy|non ischemic dilated cardiomyopathy
364211|NCT01392625|Dilated cardiomyopathy|dilated cardiomyopathy
364212|NCT01392625|Heart failure|heart failure
364213|NCT01392625|Cardiac Stem Cell Transplantation|cardiac stem cell transplantation
364214|NCT01392625|Stem Cells|stem cells
364215|NCT01392612|thrombosis|thrombosis
364216|NCT01392612|hypertension|hypertension
364217|NCT01392612|gender|gender
364218|NCT01392612|endothelium|endothelium
364219|NCT01392599|CRPS Type II|crps type ii
364220|NCT01392599|Pain|pain
364221|NCT01392599|Surgery|surgery
364222|NCT01392599|Regional Subcutaneous Venous Sympathectomy(RSVS)|regional subcutaneous venous sympathectomy(rsvs)
364223|NCT01392599|Sudeck|sudeck
364224|NCT01392599|Reflex sympathetic dystrophy (RSD)|reflex sympathetic dystrophy (rsd)
364225|NCT01392599|Causalgia|causalgia
364226|NCT01392599|Algodystrophy|algodystrophy
364227|NCT01392586|survival|survival
364228|NCT01392586|systemic therapy|systemic therapy
364229|NCT01392586|upfront surgery|upfront surgery
364230|NCT01392534|Hypertension|hypertension
364231|NCT01392534|Telmisartan|telmisartan
364232|NCT01392534|Hydrochlorothiazide|hydrochlorothiazide
364234|NCT01392534|Glucose metabolism|glucose metabolism
364235|NCT01392534|Lipid metabolism|lipid metabolism
364236|NCT01392521|Safety|safety
364237|NCT01392521|Tolerability|tolerability
364238|NCT01392521|Pharmacokinetics|pharmacokinetics
364239|NCT01392495|Pulmonary arterial hypertension|pulmonary arterial hypertension
364240|NCT01392495|imatinib|imatinib
364241|NCT01392495|6MWD|6mwd
364242|NCT01392482|Schizophrenia|schizophrenia
364243|NCT01392482|Bipolar Disorder|bipolar disorder
364244|NCT01392469|Pulmonary arterial hypertension|pulmonary arterial hypertension
364245|NCT01392469|pulmonary vascular resistance|pulmonary vascular resistance
364246|NCT01392469|imatinib|imatinib
364247|NCT01392469|bosentan|bosentan
364248|NCT01392469|sildenafil|sildenafil
364249|NCT01392456|OHIP-EDENT, VALIDATION, OVERDENTURE, ROMANIAN|ohip-edent, validation, overdenture, romanian
364250|NCT01392443|INC424|inc424
364251|NCT01392443|Ruxolitinib|ruxolitinib
364252|NCT01392443|Myelofibrosis|myelofibrosis
364253|NCT01392443|MF|mf
364254|NCT01392430|Primary prophylaxis|primary prophylaxis
364255|NCT01392430|Secondary prophylaxis|secondary prophylaxis
364256|NCT01392430|Discontinuation|discontinuation
364257|NCT01392391|Stroke|stroke
364258|NCT01392391|Exercise|exercise
364259|NCT01392391|Protein synthesis|protein synthesis
364260|NCT01392391|Protein breakdown|protein breakdown
364261|NCT01392391|Muscle atrophy|muscle atrophy
364262|NCT01392391|Muscle phenotype|muscle phenotype
364263|NCT01392391|Inflammation|inflammation
364264|NCT01392391|Insulin resistance|insulin resistance
364265|NCT01392391|Fitness|fitness
364266|NCT01392378|Prevenar 13|prevenar 13
364267|NCT01392378|13vPnC|13vpnc
364268|NCT01392378|Antipyretic medication|antipyretic medication
364269|NCT01392378|Healthy subjects|healthy subjects
364270|NCT01392365|Crohn's disease|crohn's disease
364271|NCT01392365|Intestinal tuberculosis|intestinal tuberculosis
364272|NCT01392365|Diagnosis, Differential|diagnosis, differential
364274|NCT01392352|hypertension|hypertension
364275|NCT01392352|forearm blood flow|forearm blood flow
364276|NCT01392339|Obstructive Sleep Apnea|obstructive sleep apnea
364277|NCT01392339|CPAP|cpap
364278|NCT01392339|hypoxia|hypoxia
364279|NCT01392339|sleep|sleep
364280|NCT01392339|translational science|translational science
364281|NCT01392339|gene expression|gene expression
364282|NCT01392326|Psoriatic arthritis|psoriatic arthritis
364283|NCT01392326|PsA|psa
364284|NCT01392326|ACR|acr
364285|NCT01392326|CASPAR|caspar
364286|NCT01392313|carnitine, kidney|carnitine, kidney
364287|NCT01392287|Geriatric|geriatric
364288|NCT01392287|Older adults|older adults
364289|NCT01392287|Major Depressive Disorder|major depressive disorder
364290|NCT01392287|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
364291|NCT01392287|memantine hydrochloride|memantine hydrochloride
364292|NCT01392287|N-Acetylaspartylglutamate|n-acetylaspartylglutamate
364293|NCT01392287|NAAG|naag
364294|NCT01392287|Cognitive impairment|cognitive impairment
364295|NCT01392248|EEG|eeg
364296|NCT01392248|breast cancer surgery|breast cancer surgery
364297|NCT01392248|prediction|prediction
364298|NCT01392248|acute postoperative pain|acute postoperative pain
364299|NCT01392248|chronic pain|chronic pain
364300|NCT01392235|Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)|recurrent and/or metastatic nasopharyngeal carcinoma (npc)
364301|NCT01392222|focus group|focus group
364302|NCT01392222|11-108|11-108
364303|NCT01392209|BEVACIZUMAB|bevacizumab
364304|NCT01392209|HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY|hypofractionated stereotactic radiotherapy
364305|NCT01392209|Brain|brain
364306|NCT01392209|CNS|cns
364307|NCT01392209|anti-VEGF antibody|anti-vegf antibody
364308|NCT01392209|11-057|11-057
364309|NCT01392196|Renal Impairment|renal impairment
364310|NCT01392183|Kidney cancer|kidney cancer
364311|NCT01392183|Renal Cell Carcinoma|renal cell carcinoma
587095|NCT00530530|XP13512|xp13512
587096|NCT00530543|Robot|robot
364312|NCT01392183|Poor-Risk Clear-Cell Renal Cell Carcinoma|poor-risk clear-cell renal cell carcinoma
364313|NCT01392183|RCC|rcc
364314|NCT01392183|Metastatic|metastatic
364315|NCT01392183|Locally advanced|locally advanced
364316|NCT01392183|Complete response|complete response
364317|NCT01392183|CR|cr
364318|NCT01392183|Partial Response|partial response
364319|NCT01392183|PR|pr
364320|NCT01392183|Overall survival|overall survival
364321|NCT01392183|OS|os
364322|NCT01392183|Time to progression|time to progression
364323|NCT01392183|TTP|ttp
364324|NCT01392183|Pazopanib|pazopanib
364325|NCT01392183|GW786034|gw786034
364326|NCT01392183|Temsirolimus|temsirolimus
364327|NCT01392183|CCI-779|cci-779
364328|NCT01392183|Torisel|torisel
364329|NCT01392183|Benadryl|benadryl
364330|NCT01392183|Diphenhydramine|diphenhydramine
364331|NCT01392183|TemPa|tempa
364332|NCT01392170|Leukemia|leukemia
364333|NCT01392170|Chronic Myeloid Leukemia|chronic myeloid leukemia
364334|NCT01392170|CML|cml
364335|NCT01392170|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
364336|NCT01392170|TKI|tki
364337|NCT01392170|Complete cytogenetic remission|complete cytogenetic remission
364339|NCT01392170|Minimal residual disease|minimal residual disease
364340|NCT01392170|MRD|mrd
364341|NCT01392170|PEG-IFNa-2a|peg-ifna-2a
364342|NCT01392170|Pegasys|pegasys
364343|NCT01392170|Peginterferon Alpha-2a|peginterferon alpha-2a
364344|NCT01392170|Philadelphia chromosome (Ph)-positive|philadelphia chromosome (ph)-positive
364345|NCT01392170|BCR-ABL1-positive|bcr-abl1-positive
364346|NCT01392144|Radiation pneumonitis|radiation pneumonitis
364347|NCT01392144|RP|rp
364348|NCT01392144|Nitric oxide|nitric oxide
364349|NCT01392144|NO|no
364350|NCT01392144|Thoracic|thoracic
364351|NCT01392144|Esophagus cancer|esophagus cancer
364352|NCT01392144|Lung cancer|lung cancer
364353|NCT01392144|Radiation therapy|radiation therapy
364354|NCT01392144|radiotherapy|radiotherapy
364355|NCT01392144|RT|rt
364356|NCT01392144|XRT|xrt
364357|NCT01392144|Airway|airway
364358|NCT01392144|Alveolar|alveolar
364359|NCT01392144|Nitric oxide breath analyzer|nitric oxide breath analyzer
364360|NCT01392144|Questionnaires|questionnaires
364361|NCT01392131|Oncoxin|oncoxin
364362|NCT01392131|Safety of Oncoxin|safety of oncoxin
364363|NCT01392131|Therapeutic efficacy of Oncoxin|therapeutic efficacy of oncoxin
364364|NCT01392131|Improvement of quality of life with Oncoxin|improvement of quality of life with oncoxin
364365|NCT01392131|Survival benefit with Oncoxin|survival benefit with oncoxin
364366|NCT01392105|Mesenchymal stem cells|mesenchymal stem cells
364367|NCT01392105|Myocardial infarction|myocardial infarction
364368|NCT01392105|Left ventricular dysfunction|left ventricular dysfunction
364369|NCT01392092|Contingency Management|contingency management
364370|NCT01392092|Drug Self-Administration|drug self-administration
364371|NCT01392079|CLL|cll
364372|NCT01392079|17p deletion|17p deletion
364373|NCT01392079|refractory to fludarabine|refractory to fludarabine
364374|NCT01392079|subcutaneous alemtuzumab|subcutaneous alemtuzumab
364375|NCT01392079|CLL with 17p- or refractory to fludarabine|cll with 17p- or refractory to fludarabine
364376|NCT01392066|breast neoplasms|breast neoplasms
364377|NCT01392066|spouses/partners|spouses/partners
364378|NCT01392066|couples|couples
364379|NCT01392066|interpersonal relations|interpersonal relations
364380|NCT01392066|psychosocial adjustment|psychosocial adjustment
364381|NCT01392066|psychological adaptation|psychological adaptation
364382|NCT01392066|depression|depression
364383|NCT01392066|quality of life|quality of life
364384|NCT01392066|dyadic coping|dyadic coping
364385|NCT01392066|coping behavior|coping behavior
364386|NCT01392066|cohort|cohort
364387|NCT01392066|questionnaire|questionnaire
364388|NCT01392053|labor|labor
364389|NCT01392053|pain|pain
364390|NCT01392053|massage|massage
364391|NCT01392027|Pancreatic Cancer|pancreatic cancer
364392|NCT01392027|Chronic Pancreatitis|chronic pancreatitis
364393|NCT01392027|Diseases of the pancreas|diseases of the pancreas
364394|NCT01392014|malaria|malaria
364395|NCT01392014|DHP|dhp
364396|NCT01392014|PQ|pq
364397|NCT01392014|gametocytes|gametocytes
364398|NCT01391975|arteriovenous fistula|arteriovenous fistula
364399|NCT01391975|surveillance|surveillance
364400|NCT01391975|arterial stenosis|arterial stenosis
364401|NCT01391975|venous stenosis|venous stenosis
364402|NCT01391962|Pharmacodynamics|pharmacodynamics
364403|NCT01391962|VEGF Inhibitor|vegf inhibitor
364404|NCT01391962|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
364405|NCT01391962|Anti-Angiogenesis|anti-angiogenesis
364406|NCT01391962|Gene Expression Profiling|gene expression profiling
364407|NCT01391949|disability|disability
364408|NCT01391949|walking|walking
364409|NCT01391949|feedback|feedback
364410|NCT01391949|exercise|exercise
364411|NCT01391923|Lipolysis|lipolysis
364412|NCT01391923|Cryolipolysis|cryolipolysis
364413|NCT01391923|Fat Reduction|fat reduction
364414|NCT01391910|rhinosinusitis|rhinosinusitis
364415|NCT01391897|somatoform disorders|somatoform disorders
364416|NCT01391897|PTSD|ptsd
364417|NCT01391897|epigenetics|epigenetics
364418|NCT01391897|psychotherapy|psychotherapy
364419|NCT01391897|psychosomatics|psychosomatics
364420|NCT01391884|Incretin hormones|incretin hormones
364421|NCT01391884|GLP-1|glp-1
364423|NCT01391884|Uremia|uremia
364424|NCT01391884|Dialysis|dialysis
364425|NCT01391858|Pregabalin|pregabalin
364426|NCT01391858|Postoperative pain|postoperative pain
364427|NCT01391858|Mastectomy|mastectomy
364428|NCT01391845|progesterone|progesterone
364429|NCT01391845|glycodelin-A|glycodelin-a
364430|NCT01391845|ulipristal acetate|ulipristal acetate
364431|NCT01391832|rTMS|rtms
364432|NCT01391832|PTSD|ptsd
364433|NCT01391832|Post Traumatic Stress Disorder|post traumatic stress disorder
364533|NCT01391455|Testicular pain|testicular pain
364434|NCT01391832|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
364435|NCT01391832|combat related PTSD|combat related ptsd
364436|NCT01391832|OEF|oef
364437|NCT01391832|OIF|oif
364438|NCT01391832|Veterans|veterans
364439|NCT01391832|operation enduring freedom|operation enduring freedom
363967|NCT01393769|Eye|eye
364440|NCT01391832|operation iraqi freedom|operation iraqi freedom
364441|NCT01391832|CPT|cpt
364442|NCT01391832|cognitive processing therapy|cognitive processing therapy
364443|NCT01391819|Brazil|brazil
364444|NCT01391819|Incidence|incidence
364445|NCT01391819|Dengue virus|dengue virus
364446|NCT01391819|Dengue|dengue
364447|NCT01391819|Dengue infection|dengue infection
364448|NCT01391806|Breast cancer|breast cancer
364449|NCT01391806|Preoperative breast MRI|preoperative breast mri
364450|NCT01391806|Breast-conserving surgery|breast-conserving surgery
364451|NCT01391806|Mastectomy|mastectomy
364452|NCT01391806|Prospective study|prospective study
364453|NCT01391793|Renal scarring|renal scarring
364454|NCT01391793|Dexamethasone|dexamethasone
364455|NCT01391793|Child|child
364456|NCT01391793|Corticosteroids|corticosteroids
364457|NCT01391793|Pediatric|pediatric
364458|NCT01391793|Urinary tract infection|urinary tract infection
364459|NCT01391793|Escherichia Coli Urinary Tract Infection|escherichia coli urinary tract infection
364460|NCT01391780|pelvic floor evaluation,|pelvic floor evaluation,
364461|NCT01391780|women,|women,
364462|NCT01391780|stress urinary incontinence;|stress urinary incontinence;
364463|NCT01391780|urgency urinary incontinence.|urgency urinary incontinence.
364464|NCT01391767|Ridge Preservation|ridge preservation
364465|NCT01391767|Dental Implant|dental implant
364466|NCT01391767|Histology|histology
364467|NCT01391754|child abuse|child abuse
364468|NCT01391741|Parkinson´s Disease|parkinson´s disease
364469|NCT01391741|Walking|walking
364470|NCT01391741|Exercise|exercise
364471|NCT01391741|Automaticity|automaticity
364472|NCT01391741|Dual Task|dual task
364473|NCT01391741|Visual Cues|visual cues
364474|NCT01391741|Cueing|cueing
364475|NCT01391741|Neuroplasticity|neuroplasticity
364476|NCT01391741|Gait analysis|gait analysis
364477|NCT01391715|Gastroesophageal reflux disease|gastroesophageal reflux disease
364478|NCT01391715|Proton pump inhibitor|proton pump inhibitor
364479|NCT01391715|standard dose|standard dose
364480|NCT01391715|Double dose|double dose
364481|NCT01391676|glaucoma|glaucoma
364482|NCT01391676|trabeculectomy|trabeculectomy
364483|NCT01391676|filtering bleb|filtering bleb
364484|NCT01391676|spectral domain optical coherence tomography|spectral domain optical coherence tomography
364485|NCT01391663|Drug Therapy|drug therapy
364486|NCT01391650|ACL|acl
364487|NCT01391650|double-bundle|double-bundle
364488|NCT01391650|navigation system|navigation system
364489|NCT01391637|Long term follow-up|long term follow-up
364490|NCT01391637|HuCNS-SC cells|hucns-sc cells
364491|NCT01391637|human central nervous system stem cells|human central nervous system stem cells
364492|NCT01391624|chocolate|chocolate
364493|NCT01391624|craving|craving
364494|NCT01391624|addiction|addiction
364495|NCT01391624|compulsion|compulsion
364496|NCT01391598|fibromyalgia|fibromyalgia
364497|NCT01391598|intravenous lidocaine|intravenous lidocaine
364498|NCT01391598|substance P|substance p
364499|NCT01391598|interleukins|interleukins
364500|NCT01391585|Text|text
364501|NCT01391585|SMS|sms
364502|NCT01391585|diabetes|diabetes
364503|NCT01391585|self-monitoring|self-monitoring
364504|NCT01391585|self-management|self-management
364505|NCT01391585|adherence|adherence
364506|NCT01391572|thoracic esophageal squamous cell carcinoma|thoracic esophageal squamous cell carcinoma
364507|NCT01391572|esophagectomy|esophagectomy
364508|NCT01391572|radiation|radiation
364509|NCT01391572|tumor bed|tumor bed
364510|NCT01391572|elective nodal irradiation|elective nodal irradiation
364511|NCT01391559|breathing difficulty|breathing difficulty
364512|NCT01391520|Acute Kidney Injury|acute kidney injury
364513|NCT01391520|Contrast-Induced Nephropathy|contrast-induced nephropathy
364514|NCT01391520|Labile Iron|labile iron
364515|NCT01391520|Iron Chelation|iron chelation
364516|NCT01391520|Deferiprone|deferiprone
364517|NCT01391507|Anti-beta1-receptor autoantibodies|anti-beta1-receptor autoantibodies
364518|NCT01391507|COR-1|cor-1
364519|NCT01391507|Heart failure|heart failure
355250|NCT01429363|TDD|tdd
364520|NCT01391494|Human Enterovirus 71 (EV71)|human enterovirus 71 (ev71)
364521|NCT01391494|Hand, Foot and Mouth Disease|hand, foot and mouth disease
364522|NCT01391494|Inactivated Vaccine|inactivated vaccine
364523|NCT01391494|Human Diploid cell|human diploid cell
364524|NCT01391494|Safety|safety
364525|NCT01391494|Immunogenicity|immunogenicity
364526|NCT01391494|Adverse reactions associated with vaccine|adverse reactions associated with vaccine
364527|NCT01391481|Perfluorocarbon|perfluorocarbon
364528|NCT01391481|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
364529|NCT01391481|Acute lung injury|acute lung injury
364530|NCT01391455|Inguinal hernia repair|inguinal hernia repair
364531|NCT01391455|Mesh|mesh
364532|NCT01391455|Groin pain|groin pain
364822|NCT01390246|Pregnancy|pregnancy
364534|NCT01391442|follow up of troop,|follow up of troop,
364535|NCT01391442|MRI, Echocardiography, Functional indices|mri, echocardiography, functional indices
364536|NCT01391416|Hyperhomocysteinemia|hyperhomocysteinemia
364537|NCT01391416|Chronic kidney disease|chronic kidney disease
364538|NCT01391403|Schizophrenia|schizophrenia
364539|NCT01391403|Risperidone|risperidone
364541|NCT01391403|Toxoplasma|toxoplasma
364542|NCT01391403|Immune|immune
364543|NCT01391390|Tardive Dyskinesia|tardive dyskinesia
364544|NCT01391390|Schizophrenia|schizophrenia
364545|NCT01391390|Melatonin|melatonin
364546|NCT01391390|Oxidative Stress|oxidative stress
364547|NCT01391390|Antioxidant|antioxidant
364548|NCT01391377|HDL|hdl
364549|NCT01391377|High density Lipoprotein|high density lipoprotein
364550|NCT01391377|Peripheral arterial disease|peripheral arterial disease
364551|NCT01391377|Tredaptive|tredaptive
364552|NCT01391377|Niacin|niacin
364553|NCT01391377|Laropiprant|laropiprant
364554|NCT01391377|Plaque|plaque
364555|NCT01391377|Atherosclerosis|atherosclerosis
364556|NCT01391377|Lipid content|lipid content
364557|NCT01391351|carcinoma of the ovary, the fallopian tube or peritoneal serous-type advanced stage|carcinoma of the ovary, the fallopian tube or peritoneal serous-type advanced stage
364558|NCT01391351|chemotherapy with Taxol and Carboplatin|chemotherapy with taxol and carboplatin
364559|NCT01391351|predictors of therapeutic response|predictors of therapeutic response
364560|NCT01391351|serum miRNA|serum mirna
364561|NCT01391351|identification of polymorphisms or SNPs (Single Nucleotide Polymorphism)|identification of polymorphisms or snps (single nucleotide polymorphism)
364562|NCT01391338|Prostatitis|prostatitis
364563|NCT01391338|Chronic|chronic
364564|NCT01391338|Pelvic Pain|pelvic pain
364565|NCT01391338|NIH-CPSI|nih-cpsi
364566|NCT01391338|Pain domain score in NIH-CPSI|pain domain score in nih-cpsi
364567|NCT01391260|Locally Advanced NSCLC|locally advanced nsclc
364568|NCT01391260|EGFR Mutation Positive|egfr mutation positive
364569|NCT01391260|Radiotherapy combined Gefitinib|radiotherapy combined gefitinib
364570|NCT01391247|open angle glaucoma|open angle glaucoma
364571|NCT01391247|low tension glaucoma|low tension glaucoma
364572|NCT01391247|oximetry|oximetry
364573|NCT01391234|Metastatic bone disease|metastatic bone disease
364574|NCT01391234|Bone metastases|bone metastases
364575|NCT01391234|Radiation therapy|radiation therapy
364576|NCT01391234|TomoTherapy|tomotherapy
364577|NCT01391221|Depression|depression
364578|NCT01391221|Inflammation|inflammation
364579|NCT01391221|Cognition|cognition
364580|NCT01391221|Pain|pain
364581|NCT01391221|Allostatic load|allostatic load
364582|NCT01391208|Barrett's Esophagus with High Grade Dysplasia|barrett's esophagus with high grade dysplasia
364583|NCT01391208|Esophageal adenocarcinoma|esophageal adenocarcinoma
364584|NCT01391195|low level laser therapy|low level laser therapy
364585|NCT01391195|muscle performance|muscle performance
364586|NCT01391195|fatigue index|fatigue index
364587|NCT01391195|endurance training|endurance training
364588|NCT01391195|ventilatory threshold|ventilatory threshold
364589|NCT01391195|VO2Max|vo2max
364590|NCT01391195|VO2Peak|vo2peak
364591|NCT01391182|Epsilon Aminocaproic Acid|epsilon aminocaproic acid
364592|NCT01391182|blood loss|blood loss
364593|NCT01391182|total hip arthroplasty|total hip arthroplasty
364594|NCT01391182|reduction in blood transfusions|reduction in blood transfusions
364595|NCT01391182|Amicar|amicar
364596|NCT01391156|minoxidil|minoxidil
364597|NCT01391156|finasteride|finasteride
364598|NCT01391156|topical|topical
364599|NCT01391156|lotion|lotion
364600|NCT01391156|male pattern hair loss|male pattern hair loss
364601|NCT01391156|androgenetic alopecia|androgenetic alopecia
364602|NCT01391143|Prostate cancer|prostate cancer
364603|NCT01391143|Melanoma|melanoma
364604|NCT01391143|Renal cell carcinoma|renal cell carcinoma
364605|NCT01391143|Triple-negative breast cancer|triple-negative breast cancer
364606|NCT01391143|Head and neck cancer|head and neck cancer
364607|NCT01391143|Bladder cancer|bladder cancer
364608|NCT01391143|Non-small cell lung cancer|non-small cell lung cancer
364609|NCT01391143|Squamous cell carcinoma|squamous cell carcinoma
364610|NCT01391130|Cancer|cancer
364611|NCT01391130|Tumor|tumor
364612|NCT01391130|Metastasis|metastasis
364613|NCT01391117|TMC649128|tmc649128
364614|NCT01391117|HCV|hcv
364615|NCT01391117|TMC649128HPC1002|tmc649128hpc1002
364616|NCT01391117|Hepatitis C|hepatitis c
364617|NCT01391117|Hep C|hep c
364618|NCT01391104|Pulmonary Hypertension|pulmonary hypertension
364619|NCT01391104|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
364620|NCT01391104|Exercise|exercise
364621|NCT01391104|Six-minute walk test|six-minute walk test
364622|NCT01391104|sildenafil|sildenafil
364623|NCT01391078|glaucoma|glaucoma
364624|NCT01391078|IOP|iop
364625|NCT01391078|Sensimed Triggerfish|sensimed triggerfish
364626|NCT01391078|Goldmann Applanation Tonometry|goldmann applanation tonometry
364627|NCT01391078|fluctuation|fluctuation
364628|NCT01391078|comparison|comparison
364629|NCT01391065|Diffusion Weighted MRI|diffusion weighted mri
364630|NCT01391065|FLT PET|flt pet
364631|NCT01391065|F-Miso PET|f-miso pet
364632|NCT01391065|Image Guided Brachytherapy|image guided brachytherapy
364633|NCT01391065|Cervix|cervix
364634|NCT01391065|Postoperative Residual Disease/Postoperative recurrences|postoperative residual disease/postoperative recurrences
364635|NCT01391052|Intrauterine system|intrauterine system
364636|NCT01391052|reproductive age|reproductive age
364173|NCT01392820|PK|pk
364637|NCT01391052|menstrual bleeding|menstrual bleeding
364638|NCT01391039|Ductal Carcinoma In-situ|ductal carcinoma in-situ
364639|NCT01391039|Contrast Ultrasound|contrast ultrasound
364640|NCT01391039|Microinvasion|microinvasion
364641|NCT01391039|Elastography|elastography
364642|NCT01391026|Medical informatics|medical informatics
364643|NCT01391026|Health services accessibility|health services accessibility
364644|NCT01391013|Human immunodeficiency virus 1|human immunodeficiency virus 1
364645|NCT01391013|Acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
364646|NCT01391013|Immunologic deficiency syndrome|immunologic deficiency syndrome
364647|NCT01391013|Darunavir/ritonavir|darunavir/ritonavir
364648|NCT01391013|Darunavir|darunavir
364649|NCT01391013|Ritonavir|ritonavir
364650|NCT01391013|Nucleoside reverse transcriptase inhibitors (NRTIs)|nucleoside reverse transcriptase inhibitors (nrtis)
364651|NCT01391013|Prezista|prezista
364652|NCT01391000|rotator cuff surgery|rotator cuff surgery
364653|NCT01391000|pain|pain
364654|NCT01391000|exercise therapy|exercise therapy
364655|NCT01390974|ACS|acs
364656|NCT01390974|PCI|pci
364657|NCT01390974|thienopyridines|thienopyridines
364658|NCT01390974|prasugrel therapy|prasugrel therapy
364659|NCT01390974|clopidogrel therapy|clopidogrel therapy
364660|NCT01390961|Allergic conjunctivitis|allergic conjunctivitis
364661|NCT01390935|guideline adherence|guideline adherence
364662|NCT01390935|systolic heart failure|systolic heart failure
364663|NCT01390909|epilepsy|epilepsy
364664|NCT01390909|anti-epileptic drug|anti-epileptic drug
364665|NCT01390909|polytherapy|polytherapy
364666|NCT01390909|adherence|adherence
364667|NCT01390909|Medicaid|medicaid
364668|NCT01390870|Enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, adherence|enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, adherence
364669|NCT01390818|MEK inhibitor (Pimasertib)|mek inhibitor (pimasertib)
364670|NCT01390818|PI3K/mTOR Inhibitor|pi3k/mtor inhibitor
364671|NCT01390818|Solid Tumor|solid tumor
364672|NCT01390818|Phase I|phase i
364673|NCT01390766|Antirejection|antirejection
364674|NCT01390740|Transthoracic echocardiography|transthoracic echocardiography
364675|NCT01390727|hypertension|hypertension
364676|NCT01390727|device-guided breathing|device-guided breathing
364677|NCT01390727|autonomic function|autonomic function
364678|NCT01390727|Resperate|resperate
364679|NCT01390714|Proton Pump Inhibitors|proton pump inhibitors
364680|NCT01390714|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
364681|NCT01390714|pharmacokinetics|pharmacokinetics
364682|NCT01390714|pharmacodynamics|pharmacodynamics
364683|NCT01390701|randomized|randomized
364684|NCT01390701|cross-over|cross-over
364685|NCT01390701|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
364686|NCT01390701|felodipin|felodipin
364687|NCT01390701|hypertension|hypertension
364688|NCT01390701|blood pressure|blood pressure
364689|NCT01390701|treatment|treatment
364690|NCT01390688|Brain-derived Neurotrophic factor|brain-derived neurotrophic factor
364691|NCT01390688|Low-grade inflammation|low-grade inflammation
364692|NCT01390688|Cognitive dysfunction|cognitive dysfunction
364693|NCT01390662|serum 25-hydroxyvitamin d,vitamin D supplement, depression,|serum 25-hydroxyvitamin d,vitamin d supplement, depression,
364694|NCT01390662|parathyroid hormone|parathyroid hormone
364695|NCT01390649|ITP|itp
364696|NCT01390636|Continuous Glucose Monitoring|continuous glucose monitoring
364697|NCT01390636|Type 1 Diabetes and an Eating Disorder|type 1 diabetes and an eating disorder
364698|NCT01390636|Eating Disorder Only|eating disorder only
364699|NCT01390623|Acute Uncomplicated Pyelonephritis|acute uncomplicated pyelonephritis
364700|NCT01390623|Short-term antibiotic|short-term antibiotic
364701|NCT01390623|Ceftriaxone|ceftriaxone
364702|NCT01390623|Cefixime|cefixime
364703|NCT01390623|Women|women
364704|NCT01390623|Efficacy|efficacy
364705|NCT01390610|Continuous Glucose Monitoring|continuous glucose monitoring
587097|NCT00530543|Gait|gait
364706|NCT01390610|Self Monitored Blood Glucose|self monitored blood glucose
364707|NCT01390610|Type 2 Diabetes|type 2 diabetes
364708|NCT01390597|peripheral T-cell lymphoma|peripheral t-cell lymphoma
355395|NCT01428921|OSA|osa
364709|NCT01390597|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
364710|NCT01390597|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
364711|NCT01390597|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
364712|NCT01390597|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
364713|NCT01390597|anaplastic large cell lymphoma|anaplastic large cell lymphoma
364714|NCT01390584|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
364715|NCT01390584|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
364716|NCT01390584|adult favorable prognosis Hodgkin lymphoma|adult favorable prognosis hodgkin lymphoma
364717|NCT01390584|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
364718|NCT01390584|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
364719|NCT01390584|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
364720|NCT01390584|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
364721|NCT01390571|adult glioblastoma|adult glioblastoma
364722|NCT01390571|adult giant cell glioblastoma|adult giant cell glioblastoma
364723|NCT01390571|adult gliosarcoma|adult gliosarcoma
364724|NCT01390571|recurrent adult brain tumor|recurrent adult brain tumor
364725|NCT01390558|Down Syndrome|down syndrome
364726|NCT01390558|Orthotics|orthotics
364727|NCT01390558|Gait Analysis|gait analysis
364728|NCT01390545|Rheumatoid arthritis|rheumatoid arthritis
364729|NCT01390545|anti-CD20 antibody|anti-cd20 antibody
364730|NCT01390545|subcutaneous|subcutaneous
364731|NCT01390532|Left Ventricular Dyssynchrony|left ventricular dyssynchrony
364732|NCT01390532|Gated blood-pool|gated blood-pool
364733|NCT01390532|D-SPECT|d-spect
364734|NCT01390532|Pharmacological stress|pharmacological stress
364735|NCT01390532|NYHA III/IV|nyha iii/iv
364736|NCT01390532|LVEF < 35 %|lvef < 35 %
364737|NCT01390532|QRS > 120 ms|qrs > 120 ms
364738|NCT01390532|optimal medical treatment|optimal medical treatment
364739|NCT01390532|cardiac resynchronization therapy|cardiac resynchronization therapy
364740|NCT01390519|mRCC,|mrcc,
364741|NCT01390519|observational,|observational,
364742|NCT01390519|Afinitor,|afinitor,
364743|NCT01390519|everolimus,|everolimus,
364744|NCT01390519|2.line|2.line
364745|NCT01390506|cardiac arrest|cardiac arrest
364746|NCT01390506|resuscitation|resuscitation
364747|NCT01390506|neurological outcome|neurological outcome
364748|NCT01390493|neurofeedback, alpha, anorexia nervosa|neurofeedback, alpha, anorexia nervosa
364749|NCT01390480|vitamin D|vitamin d
364750|NCT01390480|Autoimmune disease|autoimmune disease
364751|NCT01390480|diabetes|diabetes
364752|NCT01390467|Paracetamol|paracetamol
364753|NCT01390467|Cognitive impact|cognitive impact
364754|NCT01390441|Rheumatoid arthritis|rheumatoid arthritis
364756|NCT01390441|Rituximab|rituximab
364757|NCT01390441|Rituxan|rituxan
364758|NCT01390441|MabThera|mabthera
364759|NCT01390441|Methotrexate|methotrexate
364760|NCT01390441|Rheumatrex|rheumatrex
364761|NCT01390441|Trexall|trexall
364762|NCT01390441|MK-8808|mk-8808
364763|NCT01390402|Alloreactive haploidentical NK cells|alloreactive haploidentical nk cells
364764|NCT01390402|Natural killer cells|natural killer cells
364765|NCT01390402|Stem Cell Transplantation|stem cell transplantation
364766|NCT01390402|Immune cells|immune cells
364767|NCT01390402|Chronic myelogenous leukemia|chronic myelogenous leukemia
364768|NCT01390402|CML|cml
364769|NCT01390402|Human leukocyte antigen|human leukocyte antigen
364770|NCT01390402|HLA|hla
364771|NCT01390402|Graft-vs-host disease|graft-vs-host disease
364772|NCT01390402|GVHD|gvhd
364773|NCT01390402|Antithymocyte globulin|antithymocyte globulin
364774|NCT01390402|ATG|atg
364775|NCT01390402|Thymoglobulin|thymoglobulin
364776|NCT01390402|Interleukin-2|interleukin-2
364777|NCT01390402|IL-2|il-2
364778|NCT01390402|Aldesleukin|aldesleukin
364779|NCT01390402|Proleukin|proleukin
364780|NCT01390402|Fludarabine|fludarabine
364781|NCT01390402|Fludarabine phosphate|fludarabine phosphate
364782|NCT01390402|Fludara|fludara
364783|NCT01390402|Tacrolimus|tacrolimus
364784|NCT01390402|Prograf|prograf
364785|NCT01390402|Busulfan|busulfan
364786|NCT01390402|Busulfex|busulfex
364787|NCT01390402|Myleran|myleran
364788|NCT01390402|Methotrexate|methotrexate
364789|NCT01390389|Geriatric bipolar depression|geriatric bipolar depression
364790|NCT01390389|MR Spectroscopy|mr spectroscopy
364791|NCT01390389|Coenzyme Q10|coenzyme q10
364792|NCT01390389|Mitochondrial Dysfunction|mitochondrial dysfunction
364793|NCT01390376|Schizophrenia|schizophrenia
364794|NCT01390376|NMDA|nmda
364795|NCT01390376|DAAOI|daaoi
364796|NCT01390376|Clozapine resistant schizophrenia|clozapine resistant schizophrenia
364797|NCT01390363|immunization|immunization
364798|NCT01390363|reminder systems|reminder systems
364799|NCT01390350|Schnitzler syndrome|schnitzler syndrome
364800|NCT01390350|autoinflammatory syndrome|autoinflammatory syndrome
364801|NCT01390337|AC220|ac220
364802|NCT01390337|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
364803|NCT01390337|De Novo Acute Myeloid Leukemia (AML)|de novo acute myeloid leukemia (aml)
364804|NCT01390337|Newly diagnosed Acute Myeloid Leukemia (AML)|newly diagnosed acute myeloid leukemia (aml)
364805|NCT01390337|FMS-like tyrosine kinase (FLT3)|fms-like tyrosine kinase (flt3)
364806|NCT01390337|FMS-like tyrosine kinase (FLT3) Inhibitor|fms-like tyrosine kinase (flt3) inhibitor
364807|NCT01390337|Kinase|kinase
364808|NCT01390337|Kinase Inhibitor|kinase inhibitor
364809|NCT01390337|Pharmacokinetics|pharmacokinetics
364810|NCT01390337|ASP2689|asp2689
364811|NCT01390337|quizartinib|quizartinib
364812|NCT01390324|Migraine|migraine
364813|NCT01390324|Naratriptan|naratriptan
364814|NCT01390324|Naproxen|naproxen
364815|NCT01390298|chronic pain after knee replacement surgery|chronic pain after knee replacement surgery
364816|NCT01390272|Hypertension|hypertension
364817|NCT01390272|Telephone|telephone
364818|NCT01390272|Disease Management|disease management
364819|NCT01390272|Veterans|veterans
364820|NCT01390272|Pharmacists|pharmacists
364821|NCT01390272|Nurses|nurses
364823|NCT01390246|Tobacco use disorder|tobacco use disorder
364824|NCT01390246|Smoking cessation|smoking cessation
364825|NCT01390246|Bupropion SR|bupropion sr
364826|NCT01390246|Zyban|zyban
364827|NCT01390233|Labor, obstetric|labor, obstetric
364828|NCT01390233|Labor, induced|labor, induced
364829|NCT01390220|Epilepsy|epilepsy
364830|NCT01390220|seizure clusters|seizure clusters
364831|NCT01390220|acute repetitive seizures|acute repetitive seizures
364832|NCT01390220|rescue treatment|rescue treatment
364833|NCT01390220|ARTEMIS|artemis
364834|NCT01390207|hCG triggering|hcg triggering
364835|NCT01390207|pregnancy|pregnancy
364836|NCT01390207|GnRH antagonist|gnrh antagonist
364837|NCT01390194|liver disease|liver disease
364838|NCT01390194|hepatocellular carcinoma|hepatocellular carcinoma
364839|NCT01390155|Electrocardiography|electrocardiography
364840|NCT01390155|Coronary Artery Disease|coronary artery disease
364841|NCT01390155|Atrial Fibrillation|atrial fibrillation
364842|NCT01390155|Heart Atria|heart atria
364843|NCT01390155|Coronary Circulation|coronary circulation
364844|NCT01390155|Ischemia|ischemia
364845|NCT01390116|gamma delta T cell|gamma delta t cell
364846|NCT01390116|natural killer cell|natural killer cell
364847|NCT01390116|proliferation|proliferation
364848|NCT01390116|cytokine secretion|cytokine secretion
364849|NCT01390116|Improvement in immune cell function in healthy humans|improvement in immune cell function in healthy humans
364850|NCT01390103|hip pain|hip pain
364851|NCT01390090|piriformis muscle|piriformis muscle
364852|NCT01390077|homogentisic acid|homogentisic acid
364853|NCT01390051|birth weight|birth weight
364854|NCT01390051|thrombosis|thrombosis
364855|NCT01390051|anticoagulant therapy|anticoagulant therapy
364856|NCT01390025|Influenza|influenza
364857|NCT01390025|Monoclonal antibody|monoclonal antibody
364858|NCT01389973|Diseases [C] - Digestive System Diseases [C06]|diseases [c] - digestive system diseases [c06]
364859|NCT01389973|primary biliary cirrhosis|primary biliary cirrhosis
364860|NCT01389973|ursodeoxycholic acid (UDCA)|ursodeoxycholic acid (udca)
364861|NCT01389973|STELARA|stelara
364862|NCT01389973|ustekinumab|ustekinumab
364863|NCT01389947|mesenteric ischemia|mesenteric ischemia
364864|NCT01389947|extracorporeal circulation|extracorporeal circulation
364865|NCT01389947|microcirculation|microcirculation
364866|NCT01389947|cardiac surgery|cardiac surgery
364867|NCT01389947|IFABP|ifabp
364868|NCT01389947|citrullinemia|citrullinemia
364869|NCT01389947|glycocalyx|glycocalyx
364870|NCT01389947|vascular occlusion test|vascular occlusion test
364871|NCT01389947|NIRS probe on thenar eminence|nirs probe on thenar eminence
364872|NCT01389934|levo-bupicaine|levo-bupicaine
364873|NCT01389934|Radical|radical
364874|NCT01389934|Mastectomy|mastectomy
364875|NCT01389921|lower urinary tract|lower urinary tract
364876|NCT01389921|sensory evoked potential|sensory evoked potential
364877|NCT01389921|contact heat evoked potential stimulation|contact heat evoked potential stimulation
364878|NCT01389921|electroencephalogram|electroencephalogram
364879|NCT01389921|cortical processing|cortical processing
364880|NCT01389921|bladder sensations|bladder sensations
364881|NCT01389921|lower urinary tract dysfunction|lower urinary tract dysfunction
364882|NCT01389921|overactive bladder|overactive bladder
364883|NCT01389895|Lupus|lupus
364884|NCT01389895|Cutaneous lupus|cutaneous lupus
364885|NCT01389882|mechanical ventilation|mechanical ventilation
364886|NCT01389882|diaphragm electrical activity|diaphragm electrical activity
364887|NCT01389882|pressure support|pressure support
364888|NCT01389869|Emotional tears|emotional tears
364889|NCT01389869|Postprandial plasma|postprandial plasma
364890|NCT01389869|Chemosignal|chemosignal
364891|NCT01389869|Obesity|obesity
364892|NCT01389869|Appetite|appetite
364893|NCT01389869|Food intake|food intake
364894|NCT01389856|Persistent pulmonary hypertension, newborn|persistent pulmonary hypertension, newborn
364895|NCT01389856|PPHN|pphn
364896|NCT01389843|Heart failure|heart failure
364897|NCT01389843|Registry|registry
364898|NCT01389843|Cohort|cohort
364899|NCT01389843|Heart Disease|heart disease
364900|NCT01389843|Cardiovascular Diseases|cardiovascular diseases
364901|NCT01389830|End of Life|end of life
364903|NCT01389830|Latinos|latinos
364904|NCT01389830|Hispanic American|hispanic american
364905|NCT01389830|Medicare beneficiaries|medicare beneficiaries
364906|NCT01389830|stage III diagnosis|stage iii diagnosis
364907|NCT01389830|Breast cancer|breast cancer
364908|NCT01389830|Colorectal cancer|colorectal cancer
364909|NCT01389830|Prostate cancer|prostate cancer
364910|NCT01389830|Lung cancer|lung cancer
364911|NCT01389830|Cancer Prevention and Treatment Demonstration|cancer prevention and treatment demonstration
364912|NCT01389830|CPTD|cptd
364913|NCT01389804|transplant, pediatric|transplant, pediatric
364914|NCT01389791|muscle relaxation|muscle relaxation
364915|NCT01389791|magnesium sulfate|magnesium sulfate
364916|NCT01389791|rocuronium|rocuronium
364917|NCT01389739|continuity of care|continuity of care
364918|NCT01389739|interprofessional collaboration|interprofessional collaboration
364919|NCT01389726|custodial grandparents|custodial grandparents
364920|NCT01389726|kinship caregivers|kinship caregivers
364921|NCT01389726|grandparents raising grandchildren|grandparents raising grandchildren
364922|NCT01389726|grandmothers|grandmothers
364923|NCT01389726|grandchildren|grandchildren
364924|NCT01389726|psychological well-being|psychological well-being
364925|NCT01389713|ovarian reserve|ovarian reserve
364926|NCT01389713|ovarian stimulation|ovarian stimulation
364927|NCT01389713|clomifene citrate|clomifene citrate
364928|NCT01389713|high doses Follicle Stimulating Hormone (FSH)|high doses follicle stimulating hormone (fsh)
364929|NCT01389687|Poliomyelitis|poliomyelitis
364930|NCT01389687|Inactivated polio vaccine|inactivated polio vaccine
364931|NCT01389687|Polio|polio
364932|NCT01389687|Poliovirus|poliovirus
364933|NCT01389674|coronary stenosis|coronary stenosis
364934|NCT01389674|Angina pectoris|angina pectoris
364935|NCT01389674|left ventricular wall motion abnormalities|left ventricular wall motion abnormalities
364936|NCT01389661|Maxillary bone cysts|maxillary bone cysts
364937|NCT01389661|Cell therapy|cell therapy
364938|NCT01389661|Mesenchymal stem cells|mesenchymal stem cells
364939|NCT01389661|Autologous serum scaffold|autologous serum scaffold
364940|NCT01389648|adult|adult
364941|NCT01389635|Abdominoplasty|abdominoplasty
364942|NCT01389635|Epidural|epidural
364943|NCT01389622|Acupuncture|acupuncture
364944|NCT01389622|smoking cessation|smoking cessation
364945|NCT01389609|Bioequivalence|bioequivalence
364946|NCT01389609|Orally-disintegrating Tablet|orally-disintegrating tablet
364947|NCT01389596|safety|safety
364948|NCT01389596|efficacy|efficacy
364949|NCT01389596|partial onset seizures|partial onset seizures
364950|NCT01389596|pediatric|pediatric
364951|NCT01389596|pregabalin|pregabalin
364952|NCT01389596|placebo-controlled|placebo-controlled
364953|NCT01389596|double-blind|double-blind
364954|NCT01389583|GIST(Gastrointestinal stromal tumor)|gist(gastrointestinal stromal tumor)
364955|NCT01389583|HSP(Heat Shock Protein)|hsp(heat shock protein)
364956|NCT01389583|Biomarker|biomarker
364957|NCT01389557|malaria|malaria
364958|NCT01389557|DHP|dhp
364959|NCT01389557|PQ|pq
364960|NCT01389557|MST|mst
364961|NCT01389518|Symptomatic treatment|symptomatic treatment
364962|NCT01389518|Common Cold|common cold
364963|NCT01389518|flu syndrome|flu syndrome
364964|NCT01389505|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
364965|NCT01389505|Bevacizumab|bevacizumab
364966|NCT01389505|Panretinal Photocoagulation|panretinal photocoagulation
364967|NCT01389492|meat|meat
364968|NCT01389492|LDL|ldl
364969|NCT01389492|MDA|mda
364970|NCT01389466|Avian influenza|avian influenza
364971|NCT01389453|umbilical cord mesenchyma stem cell transplantation|umbilical cord mesenchyma stem cell transplantation
364972|NCT01389440|Resectable pancreatic adenocarcinoma|resectable pancreatic adenocarcinoma
364973|NCT01389440|Gemcitabine|gemcitabine
364974|NCT01389440|Erlotinib|erlotinib
364975|NCT01389440|Radiotherapy|radiotherapy
364976|NCT01389440|Neoadjuvant treatment|neoadjuvant treatment
364977|NCT01389414|cholangiocarcinoma|cholangiocarcinoma
364978|NCT01389414|biliary|biliary
364979|NCT01389414|gallbladder|gallbladder
364980|NCT01389414|intrahepatic|intrahepatic
364981|NCT01389414|extrahepatic|extrahepatic
364982|NCT01389401|Larynx|larynx
364983|NCT01389401|GERD|gerd
364984|NCT01389401|saliva|saliva
364985|NCT01389401|epidermal growth factor|epidermal growth factor
364986|NCT01389388|Carotid plaques|carotid plaques
364987|NCT01389388|inflammatory joint disease|inflammatory joint disease
364988|NCT01389388|statins|statins
364989|NCT01389388|inflammation|inflammation
364990|NCT01389388|lipoprotein components|lipoprotein components
364991|NCT01389375|Closure Device|closure device
364992|NCT01389375|Coronary Angiography|coronary angiography
364993|NCT01389362|Diabetes|diabetes
364994|NCT01389362|foot ulcer|foot ulcer
364995|NCT01389362|Chinese herbal medicine|chinese herbal medicine
364996|NCT01389349|tonsillectomy|tonsillectomy
364997|NCT01389349|adenotonsillectomy|adenotonsillectomy
364998|NCT01389349|acupuncture|acupuncture
364999|NCT01389349|children|children
365000|NCT01389349|postoperative pain|postoperative pain
365001|NCT01389349|postoperative nausea|postoperative nausea
365002|NCT01389336|Fibromyalgia Syndrome|fibromyalgia syndrome
355668|NCT01427673|OSA|osa
365003|NCT01389336|Fibromyalgia|fibromyalgia
365004|NCT01389336|Ayurveda|ayurveda
365005|NCT01389336|Traditional Indian Medicine|traditional indian medicine
365006|NCT01389336|CAM|cam
365007|NCT01389336|Pain|pain
365008|NCT01389336|Chronic Widespread Pain|chronic widespread pain
365009|NCT01389297|alcohol dependence intervention|alcohol dependence intervention
365010|NCT01389297|Internet delivered intervention|internet delivered intervention
365011|NCT01389297|alcohol dependence treatment|alcohol dependence treatment
365012|NCT01389297|Internet delivered treatment|internet delivered treatment
365013|NCT01389284|Naproxen Sodium,|naproxen sodium,
365014|NCT01389284|dental pain|dental pain
365015|NCT01389271|Pulmonary hypertension|pulmonary hypertension
365016|NCT01389271|Inhaled iloprost|inhaled iloprost
365017|NCT01389271|Efficacy|efficacy
365018|NCT01389271|Safety|safety
365019|NCT01389271|Tolerability|tolerability
365020|NCT01389271|Survival|survival
365021|NCT01389271|NYHA class III and IV|nyha class iii and iv
365022|NCT01389219|Post partum|post partum
365023|NCT01389219|Neonate|neonate
365024|NCT01389219|community health care workers|community health care workers
365025|NCT01389193|ibudilast|ibudilast
365026|NCT01389193|migraine|migraine
365027|NCT01389193|glial cell|glial cell
365028|NCT01389154|diagnostic yield|diagnostic yield
365029|NCT01389154|Electromagnetic Tip Tracked|electromagnetic tip tracked
365030|NCT01389154|peripheral lung lesion|peripheral lung lesion
365031|NCT01389141|ovary|ovary
365032|NCT01389141|follicle|follicle
365033|NCT01389141|hormones|hormones
365034|NCT01389141|bone|bone
365035|NCT01389141|muscle|muscle
365036|NCT01389128|labor|labor
365037|NCT01389128|pain|pain
365038|NCT01389128|massage|massage
365039|NCT01389128|natural birth|natural birth
365040|NCT01389115|liver cirrhosis|liver cirrhosis
365041|NCT01389115|oxidative stress|oxidative stress
365042|NCT01389115|liver transplant|liver transplant
365043|NCT01389102|Postmenopause|postmenopause
365044|NCT01389102|Hot Flashes|hot flashes
365045|NCT01389102|Estradiol|estradiol
365046|NCT01389102|Polyestradiol phosphate|polyestradiol phosphate
365047|NCT01389102|Estradiol valerate|estradiol valerate
365048|NCT01389102|Estradiol 3-benzoate|estradiol 3-benzoate
365049|NCT01389102|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate
365050|NCT01389102|Estrogens|estrogens
365051|NCT01389102|Hormones|hormones
365052|NCT01389102|Hormones, Hormone Substitutes|hormones, hormone substitutes
365053|NCT01389102|Hormone Antagonists|hormone antagonists
365054|NCT01389089|edema reduction|edema reduction
365055|NCT01389089|ice|ice
365056|NCT01389089|multi-layer compression bandage|multi-layer compression bandage
365057|NCT01389089|A-V Impulse compression|a-v impulse compression
365058|NCT01389089|ankle|ankle
365059|NCT01389076|Previously Untreated, Advanced-Stage, Follicular Lymphoma|previously untreated, advanced-stage, follicular lymphoma
365060|NCT01389063|endothelial function|endothelial function
365061|NCT01389063|CCR5 receptor|ccr5 receptor
365062|NCT01389063|Maraviroc|maraviroc
365063|NCT01389063|Abacavir|abacavir
365064|NCT01389063|Flow Mediated Dilatation|flow mediated dilatation
365065|NCT01389063|EndoPAT|endopat
365066|NCT01389037|African American|african american
365067|NCT01389037|High blood pressure|high blood pressure
365068|NCT01389024|sickle cell disease|sickle cell disease
365069|NCT01389024|stroke|stroke
365070|NCT01389024|silent cerebral infarct|silent cerebral infarct
365071|NCT01389024|children|children
365072|NCT01389011|PI|pi
365074|NCT01389011|Interscalene block|interscalene block
365075|NCT01388998|fluid management|fluid management
365076|NCT01388998|fluid therapy|fluid therapy
365077|NCT01388998|dPP|dpp
365078|NCT01388998|difference in pulse pressure|difference in pulse pressure
365079|NCT01388998|PVI|pvi
365080|NCT01388998|pleth variability index|pleth variability index
365081|NCT01388998|external pressure applied on the caval vein|external pressure applied on the caval vein
365082|NCT01388985|Rabies|rabies
365083|NCT01388985|Vaccination|vaccination
365084|NCT01388985|Boostability|boostability
365085|NCT01388972|Community nutritional environment|community nutritional environment
365086|NCT01388972|Physical activity|physical activity
365087|NCT01388946|acute postoperative pain|acute postoperative pain
365088|NCT01388946|late pain|late pain
365089|NCT01388946|chronic pain|chronic pain
365090|NCT01388946|wound irrigation with local anesthetic|wound irrigation with local anesthetic
365091|NCT01388933|Crohn's Disease|crohn's disease
365092|NCT01388933|natural|natural
365093|NCT01388933|herbal|herbal
365094|NCT01388933|Kampo|kampo
365095|NCT01388933|inflammatory bowel disease|inflammatory bowel disease
365096|NCT01388933|Adult ages 18 to 75|adult ages 18 to 75
365097|NCT01388933|Male and female subjects|male and female subjects
365098|NCT01388920|COPD|copd
365099|NCT01388920|Muscle wasting|muscle wasting
365100|NCT01388907|myomectomy|myomectomy
365101|NCT01388907|adhesion prevention|adhesion prevention
365102|NCT01388907|pregnancy rate|pregnancy rate
587098|NCT00530543|Stroke|stroke
365103|NCT01388881|reading difficulties|reading difficulties
365104|NCT01388868|infusion dose|infusion dose
365105|NCT01388868|vecuronium|vecuronium
365106|NCT01388868|motor evoked potential|motor evoked potential
365107|NCT01388868|neuromuscular blocking agent|neuromuscular blocking agent
365108|NCT01388855|Heart Failure|heart failure
365109|NCT01388855|Vitamin D|vitamin d
365110|NCT01388855|Pain|pain
365111|NCT01388855|Pilot Study|pilot study
365112|NCT01388855|RCT|rct
365113|NCT01388842|severe malaria|severe malaria
365114|NCT01388842|children|children
365115|NCT01388842|adjunctive treatment|adjunctive treatment
365116|NCT01388829|formulation comparison|formulation comparison
365117|NCT01388816|Randomized|randomized
365118|NCT01388816|Double-Blind|double-blind
365119|NCT01388816|Placebo Controlled|placebo controlled
365120|NCT01388816|Parallel Arm|parallel arm
365121|NCT01388816|Type II Hyperlipidemia|type ii hyperlipidemia
365122|NCT01388816|Cholesteryl Ester Transferase Protein Inhibitor|cholesteryl ester transferase protein inhibitor
365123|NCT01388816|CETP Inhibitor|cetp inhibitor
365525|NCT01387204|oncology|oncology
365124|NCT01388803|bronchial blocker|bronchial blocker
365125|NCT01388803|VATS|vats
365126|NCT01388790|Gastric Cancer|gastric cancer
365127|NCT01388790|Cetuximab|cetuximab
365128|NCT01388790|EMD271786|emd271786
365129|NCT01388790|TS-1|ts-1
365130|NCT01388790|Cisplatin|cisplatin
365131|NCT01388777|Breast Cancer|breast cancer
365132|NCT01388777|Breast Carcinoma|breast carcinoma
365133|NCT01388777|Cryoablation|cryoablation
365134|NCT01388777|The Visica 2™ Treatment System|the visica 2™ treatment system
365135|NCT01388777|Unifocal primary invasive ductal breast carcinoma|unifocal primary invasive ductal breast carcinoma
365136|NCT01388777|Cryoprobe|cryoprobe
365137|NCT01388764|L-arginine supplement study|l-arginine supplement study
365138|NCT01388751|Mallet Finger splinting|mallet finger splinting
365139|NCT01388738|Navigation Brain Stimulation (NEXSTIM)|navigation brain stimulation (nexstim)
365140|NCT01388738|cerebroprotective drug effectiveness|cerebroprotective drug effectiveness
365141|NCT01388738|acute ischemic stroke|acute ischemic stroke
365142|NCT01388725|sTREM-1|strem-1
365143|NCT01388725|sCD163|scd163
365144|NCT01388725|PCT|pct
365145|NCT01388725|CRP|crp
365146|NCT01388725|WBC count|wbc count
365147|NCT01388725|SOFA score|sofa score
365148|NCT01388725|SIRS|sirs
365149|NCT01388725|sepsis|sepsis
365150|NCT01388725|severity|severity
365151|NCT01388725|prognosis|prognosis
365152|NCT01388712|Probiotics|probiotics
365153|NCT01388712|constipation|constipation
365154|NCT01388712|children|children
365155|NCT01388699|Migraine with aura|migraine with aura
365156|NCT01388686|sepsis|sepsis
365157|NCT01388686|catheter|catheter
365158|NCT01388686|blood stream infection|blood stream infection
365159|NCT01388686|blood culture|blood culture
365160|NCT01388673|prior RYGB procedure|prior rygb procedure
365161|NCT01388673|regained weight over time|regained weight over time
365162|NCT01388673|dilated pouch and/or stoma|dilated pouch and/or stoma
365163|NCT01388660|Healthy|healthy
365164|NCT01388660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
365165|NCT01388660|Pharmacokinetics|pharmacokinetics
365166|NCT01388647|Neoadjuvant Treatment|neoadjuvant treatment
365167|NCT01388647|HER-2 Positive Breast Cancer|her-2 positive breast cancer
365168|NCT01388634|Length of hospital stay|length of hospital stay
365169|NCT01388634|readmission|readmission
365170|NCT01388634|ventral hernia|ventral hernia
365171|NCT01388621|ovarian cancer|ovarian cancer
365172|NCT01388621|fallopian cancer|fallopian cancer
365173|NCT01388621|recurrent|recurrent
365174|NCT01388621|platinum-sensitive|platinum-sensitive
365175|NCT01388621|KRAS-Wildtype|kras-wildtype
365176|NCT01388608|rheumatoid arthritis|rheumatoid arthritis
365177|NCT01388608|etanercept|etanercept
365178|NCT01388608|step activity measure|step activity measure
365179|NCT01388582|contraceptives|contraceptives
365180|NCT01388582|hormonal|hormonal
365181|NCT01388582|breastfeeding|breastfeeding
365182|NCT01388582|infant weight|infant weight
365183|NCT01388569|stage IV melanoma|stage iv melanoma
365184|NCT01388556|exercise|exercise
365185|NCT01388556|Parkinson disease|parkinson disease
365186|NCT01388556|motor symptoms|motor symptoms
365187|NCT01388556|gait|gait
365188|NCT01388556|balance|balance
365189|NCT01388543|Pharmacokinetics|pharmacokinetics
365190|NCT01388543|Clinical Pharmacology|clinical pharmacology
365191|NCT01388543|Pharmacogenomics|pharmacogenomics
365192|NCT01388543|HIV|hiv
365193|NCT01388517|Pityriasis alba|pityriasis alba
365194|NCT01388517|Tacrolimus|tacrolimus
365195|NCT01388517|Calcitriol|calcitriol
365196|NCT01388517|Petrolatum|petrolatum
365197|NCT01388491|Contraception|contraception
365198|NCT01388491|Hemostasis|hemostasis
365199|NCT01388491|Blood Coagulation|blood coagulation
365200|NCT01388478|Safety|safety
365201|NCT01388478|Tolerability|tolerability
365202|NCT01388478|R(+)Pramipexole|r(+)pramipexole
365203|NCT01388478|Alzheimer's|alzheimer's
365204|NCT01388465|Adherence|adherence
365205|NCT01388465|Intervention|intervention
365207|NCT01388452|routine HIV testing|routine hiv testing
365208|NCT01388452|provider-initiated HIV testing and counseling|provider-initiated hiv testing and counseling
365209|NCT01388452|early infant diagnosis|early infant diagnosis
365210|NCT01388452|Africa South of the Sahara|africa south of the sahara
365211|NCT01388439|oseltamivir|oseltamivir
365212|NCT01388439|influenza|influenza
365213|NCT01388439|neonate|neonate
365214|NCT01388439|premature|premature
365215|NCT01388439|pharmacokinetics|pharmacokinetics
365216|NCT01388413|neurogenic bladder|neurogenic bladder
365217|NCT01388413|urinary tract infection|urinary tract infection
365218|NCT01388400|stroke|stroke
365219|NCT01388400|rehabilitation|rehabilitation
365220|NCT01388400|virtual reality|virtual reality
365221|NCT01388400|upper limb|upper limb
365222|NCT01388387|pharmacogenetics|pharmacogenetics
365223|NCT01388387|pharmacokinetics|pharmacokinetics
365224|NCT01388387|tacrolimus|tacrolimus
365225|NCT01388387|genetic polymorphism|genetic polymorphism
365226|NCT01388387|CYP3A5|cyp3a5
365227|NCT01388387|liver transplantation|liver transplantation
365073|NCT01389011|PVI|pvi
365228|NCT01388374|Delivery of Health Care|delivery of health care
365229|NCT01388374|Nurse Practitioners|nurse practitioners
365230|NCT01388374|Out of Hours Medical Care|out of hours medical care
365231|NCT01388374|Primary Health Care|primary health care
365232|NCT01388374|Emergency Medical Services|emergency medical services
365233|NCT01388348|benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
365234|NCT01388348|acoustic vibration|acoustic vibration
365236|NCT01388322|Preeclampsia|preeclampsia
365237|NCT01388322|Placental insufficiency|placental insufficiency
365238|NCT01388283|prognostic marker|prognostic marker
365239|NCT01388270|Hemodialysis|hemodialysis
365240|NCT01388270|Anticoagulation|anticoagulation
365241|NCT01388270|Clotting|clotting
365242|NCT01388270|Coagulation|coagulation
365243|NCT01388270|dalteparin|dalteparin
365244|NCT01388270|Clotting in the extracorporeal system during HD|clotting in the extracorporeal system during hd
365245|NCT01388270|Antithrombogenic property of Evodial HD filter|antithrombogenic property of evodial hd filter
365246|NCT01388270|Anticoagulation during HD|anticoagulation during hd
365247|NCT01388257|Crohn Disease|crohn disease
365248|NCT01388257|Anoperineal fistula|anoperineal fistula
365249|NCT01388257|Anal fistula|anal fistula
365250|NCT01388257|Proctology|proctology
365251|NCT01388257|Drainage|drainage
365252|NCT01388257|Colorectal Surgery|colorectal surgery
365253|NCT01388257|Fistulotomy|fistulotomy
365254|NCT01388257|Plug|plug
365255|NCT01388257|Advancement flap|advancement flap
365256|NCT01388257|Glue|glue
365257|NCT01388257|Anti Tumor Necrosis Factor-alpha|anti tumor necrosis factor-alpha
365258|NCT01388257|Adalimumab|adalimumab
365259|NCT01388244|Screening|screening
365260|NCT01388244|Risk Assessment|risk assessment
365261|NCT01388244|Fractures|fractures
365262|NCT01388244|Absorptiometry, Photon|absorptiometry, photon
365263|NCT01388244|Fracture prevention|fracture prevention
365264|NCT01388244|Women|women
365265|NCT01388244|Patient prespective|patient prespective
365266|NCT01388231|social phobia, cognitive-behavioral therapy, treatment|social phobia, cognitive-behavioral therapy, treatment
365267|NCT01388218|Physical Activity|physical activity
365268|NCT01388218|Patient Reported Outcome (PRO)|patient reported outcome (pro)
365269|NCT01388218|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
365270|NCT01388218|Innovative Medicines Initiative - Joint Undertaking (IMI-JU)|innovative medicines initiative - joint undertaking (imi-ju)
365271|NCT01388205|Myopia|myopia
365272|NCT01388205|Outdoor activity|outdoor activity
365273|NCT01388205|Physical activity|physical activity
365274|NCT01388205|Randomized Controlled Trial|randomized controlled trial
365275|NCT01388205|Pedometer|pedometer
365276|NCT01388205|Behavior modification|behavior modification
365277|NCT01388205|Obesity|obesity
365278|NCT01388192|Pancreaticoduodenectomy|pancreaticoduodenectomy
365279|NCT01388192|diabetes|diabetes
365280|NCT01388192|sugar metabolism|sugar metabolism
365281|NCT01388179|Autism|autism
365282|NCT01388179|TMS|tms
365283|NCT01388153|Bioequivalence, acarbose, ODT|bioequivalence, acarbose, odt
365284|NCT01388140|dissociation|dissociation
365285|NCT01388140|psychosis|psychosis
365286|NCT01388140|trauma|trauma
365287|NCT01388140|parenting|parenting
365288|NCT01388140|executive functions|executive functions
365289|NCT01388114|Procalcitonin Measurement|procalcitonin measurement
365290|NCT01388101|LECT2|lect2
365291|NCT01388088|Hypertension|hypertension
365292|NCT01388088|Potassium|potassium
365293|NCT01388088|Blood-pressure|blood-pressure
365294|NCT01388075|induction|induction
365295|NCT01388075|CYP2C9|cyp2c9
365296|NCT01388075|Genetic variability|genetic variability
365297|NCT01388075|Expression|expression
365298|NCT01388062|influenza virus|influenza virus
365299|NCT01388049|EV71|ev71
365300|NCT01388036|heart rate|heart rate
365301|NCT01388023|SmellX|smellx
365302|NCT01388023|malodor|malodor
365303|NCT01388023|halitosis|halitosis
365304|NCT01388023|herbal formulation|herbal formulation
365305|NCT01388023|natural medicinals|natural medicinals
365306|NCT01388023|slow release delivery system|slow release delivery system
365307|NCT01388023|gingivitis|gingivitis
365308|NCT01388023|Bad Breath|bad breath
365309|NCT01388010|probiotics|probiotics
365310|NCT01388010|gastrointestinal well being|gastrointestinal well being
365311|NCT01388010|digestive symptoms|digestive symptoms
365312|NCT01388010|healthy population|healthy population
365314|NCT01387984|Type 2 diabetes mellitus|type 2 diabetes mellitus
365315|NCT01387984|Diabetic complications|diabetic complications
365316|NCT01387984|YKL-40|ykl-40
365317|NCT01387971|impression cytology|impression cytology
365318|NCT01387971|ocular surface disorders|ocular surface disorders
365319|NCT01387971|ocular surface cells' variation|ocular surface cells' variation
365320|NCT01387971|Limbal insufficiency|limbal insufficiency
365321|NCT01387958|Hepatitis C virus|hepatitis c virus
365322|NCT01387958|Chronically infected|chronically infected
365323|NCT01387958|treatment naive|treatment naive
365324|NCT01387958|non responders to prior therapy|non responders to prior therapy
365325|NCT01387945|Home blood pressure monitoring|home blood pressure monitoring
365326|NCT01387945|Patient activation|patient activation
365327|NCT01387945|Patient-centered care|patient-centered care
365328|NCT01387945|Community Health Aides|community health aides
365329|NCT01387945|Primary Health Care|primary health care
365330|NCT01387932|Hepatocellular carcinoma|hepatocellular carcinoma
365331|NCT01387932|TACE|tace
365332|NCT01387932|HepaSphere Microspheres|hepasphere microspheres
365333|NCT01387932|QuadraSphere Microspheres|quadrasphere microspheres
365334|NCT01387932|Doxorubicin|doxorubicin
365335|NCT01387919|Set time points during 48 hours of fasting|set time points during 48 hours of fasting
365336|NCT01387906|mild|mild
365337|NCT01387906|moderate|moderate
365338|NCT01387893|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
365339|NCT01387893|BPH|bph
365340|NCT01387893|Lower Urinary Tract Symptoms|lower urinary tract symptoms
365341|NCT01387893|LUTS|luts
365342|NCT01387893|Self-Administered Maneuver|self-administered maneuver
365343|NCT01387893|Symptomatic Relief|symptomatic relief
365344|NCT01387893|Digital Repetitive Infrapubic Pressure maneuver|digital repetitive infrapubic pressure maneuver
365345|NCT01387880|Metastatic colorectal cancer|metastatic colorectal cancer
365346|NCT01387880|Third line therapy|third line therapy
365347|NCT01387880|Fourth line therapy|fourth line therapy
365348|NCT01387880|KRAS mutation status|kras mutation status
365349|NCT01387880|Cetuximab|cetuximab
365350|NCT01387880|Everolimus|everolimus
365351|NCT01387880|Irinotecan|irinotecan
365352|NCT01387867|Exercise|exercise
365353|NCT01387867|Hip osteoarthritis|hip osteoarthritis
365354|NCT01387867|Randomized controlled trial|randomized controlled trial
365355|NCT01387841|yoga|yoga
365356|NCT01387841|chemotherapy|chemotherapy
365357|NCT01387841|nausea|nausea
365358|NCT01387841|vomiting|vomiting
365359|NCT01387828|Splenic artery|splenic artery
365360|NCT01387828|Aneurysm|aneurysm
365361|NCT01387828|laparoscopic|laparoscopic
365362|NCT01387828|Vascular reconstruction|vascular reconstruction
365363|NCT01387828|Splenectomy|splenectomy
365364|NCT01387815|Adalimumab|adalimumab
365365|NCT01387815|Psoriasis|psoriasis
365366|NCT01387815|Topical Agents|topical agents
365367|NCT01387815|Observational|observational
365368|NCT01387815|Traditional Systemic Agents|traditional systemic agents
365369|NCT01387815|Prospective|prospective
365370|NCT01387815|Comparative|comparative
365371|NCT01387815|Effectiveness|effectiveness
365372|NCT01387802|Assessing Effectiveness in Ankylosing Spondylitis|assessing effectiveness in ankylosing spondylitis
365373|NCT01387789|Product Surveillance|product surveillance
365374|NCT01387789|Postmarketing|postmarketing
365375|NCT01387750|Acute Pain|acute pain
365376|NCT01387750|Musculoskeletal Pain|musculoskeletal pain
365377|NCT01387750|Topical Analgesic|topical analgesic
365378|NCT01387737|TA-7284|ta-7284
365379|NCT01387737|JNJ-28431754|jnj-28431754
365380|NCT01387737|Canagliflozin|canagliflozin
365381|NCT01387737|Sodium Glucose Co-Transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
365382|NCT01387724|disseminated neuroblastoma|disseminated neuroblastoma
365383|NCT01387724|localized resectable neuroblastoma|localized resectable neuroblastoma
365384|NCT01387724|localized unresectable neuroblastoma|localized unresectable neuroblastoma
365385|NCT01387724|regional neuroblastoma|regional neuroblastoma
365386|NCT01387724|stage 4S neuroblastoma|stage 4s neuroblastoma
365387|NCT01387672|postmenopausal|postmenopausal
365388|NCT01387672|osteoporosis|osteoporosis
365389|NCT01387672|bone turnover|bone turnover
365390|NCT01387672|nitrate|nitrate
365391|NCT01387672|headache|headache
365392|NCT01387659|Myfortic|myfortic
365393|NCT01387659|Simulect|simulect
365394|NCT01387659|Steroids|steroids
365395|NCT01387659|Diabetes|diabetes
365396|NCT01387659|Transplant|transplant
365397|NCT01387659|Gastric emptying|gastric emptying
365398|NCT01387659|Gastric motility|gastric motility
365399|NCT01387646|STI, abuse, substance use, unintended pregnancy|sti, abuse, substance use, unintended pregnancy
365400|NCT01387633|Nursing care|nursing care
365401|NCT01387633|Diabetes mellitus|diabetes mellitus
365402|NCT01387633|Health Education|health education
365403|NCT01387633|Patient compliance|patient compliance
365404|NCT01387633|Social support|social support
365405|NCT01387633|Self-efficacy|self-efficacy
365406|NCT01387633|Adaptation strategy|adaptation strategy
365407|NCT01387620|Phacoemulsification|phacoemulsification
365408|NCT01387620|Corneal Edema|corneal edema
365409|NCT01387620|Corneal Endothelium|corneal endothelium
365410|NCT01387620|Viscoelastic Substances|viscoelastic substances
365411|NCT01387607|Pregabalin|pregabalin
365412|NCT01387607|fibromyalgia|fibromyalgia
365413|NCT01387594|Crohn's disease lumbar puncture anti-MAdCAM monoclonal antibody PF-00547659 Ulcerative Colitis|crohn's disease lumbar puncture anti-madcam monoclonal antibody pf-00547659 ulcerative colitis
365414|NCT01387555|liver cancer|liver cancer
365415|NCT01387555|liver tumor|liver tumor
365416|NCT01387555|advanced hcc|advanced hcc
365417|NCT01387555|hepatocellular cancer|hepatocellular cancer
365418|NCT01387555|Jennerex|jennerex
365419|NCT01387555|HCC|hcc
365420|NCT01387555|sorafenib|sorafenib
365421|NCT01387555|sorafenib failure|sorafenib failure
365422|NCT01387555|sorafenib intolerant|sorafenib intolerant
365423|NCT01387555|Nexavar|nexavar
365424|NCT01387555|Nexavar failure|nexavar failure
365425|NCT01387555|JX594|jx594
365426|NCT01387555|oncolytic virus|oncolytic virus
365427|NCT01387555|vaccinia|vaccinia
365429|NCT01387555|JX|jx
365430|NCT01387555|Biotherapeutics|biotherapeutics
365431|NCT01387555|HEP018|hep018
365432|NCT01387555|traverse|traverse
365433|NCT01387555|biologic|biologic
365434|NCT01387555|Pexa-Vec|pexa-vec
365435|NCT01387542|Schizophrenia|schizophrenia
365436|NCT01387542|Paliperidone Extended Release (ER)|paliperidone extended release (er)
365437|NCT01387542|INVEGA|invega
365438|NCT01387529|Reference Values|reference values
365439|NCT01387516|nicotine|nicotine
365440|NCT01387516|juveniles|juveniles
365441|NCT01387516|detention|detention
365442|NCT01387503|Hepatocellular Carcinoma|hepatocellular carcinoma
365443|NCT01387503|Liver Transplantation|liver transplantation
365444|NCT01387503|Downstaging|downstaging
365445|NCT01387503|Trans-arterial chemoembolization (TACE)|trans-arterial chemoembolization (tace)
365446|NCT01387503|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
365447|NCT01387503|Liver resection|liver resection
365448|NCT01387503|Sorafenib|sorafenib
365449|NCT01387490|Mild Traumatic Brain Injury|mild traumatic brain injury
365450|NCT01387490|Telephone counseling|telephone counseling
365451|NCT01387477|hypoglycemia|hypoglycemia
365452|NCT01387477|lactate|lactate
365453|NCT01387477|glucose|glucose
365454|NCT01387477|ICU|icu
365455|NCT01387464|bromfenac concentrations|bromfenac concentrations
365456|NCT01387464|ISV-303|isv-303
365457|NCT01387464|Bromday|bromday
365458|NCT01387451|Brown adipose tissue|brown adipose tissue
365459|NCT01387451|Different regions|different regions
365460|NCT01387451|Chinese adults|chinese adults
365461|NCT01387438|Brown Adipose Tissue|brown adipose tissue
365462|NCT01387438|Cross sectional study|cross sectional study
365463|NCT01387438|Chinese Adults|chinese adults
365464|NCT01387438|Factor|factor
365465|NCT01387425|Smoking cessation of diabetic smoker|smoking cessation of diabetic smoker
365466|NCT01387412|genital warts|genital warts
365467|NCT01387412|HIV|hiv
365468|NCT01387412|MSM|msm
365469|NCT01387412|Peru|peru
365470|NCT01387412|HPV|hpv
365471|NCT01387399|ovarian cancer|ovarian cancer
365472|NCT01387399|recurrence|recurrence
365473|NCT01387399|platinum-sensitive recurrent ovarian cancer|platinum-sensitive recurrent ovarian cancer
365474|NCT01387399|HIPEC|hipec
365475|NCT01387399|intraperitoneal chemotherapy|intraperitoneal chemotherapy
365476|NCT01387399|hyperthermic intraperitoneal chemoperfusion|hyperthermic intraperitoneal chemoperfusion
365477|NCT01387399|cisplatin|cisplatin
365478|NCT01387373|breast cancer|breast cancer
365479|NCT01387373|metastatic|metastatic
365480|NCT01387373|liver metastases|liver metastases
365481|NCT01387373|intrahepatic|intrahepatic
365482|NCT01387373|chemotherapy|chemotherapy
365483|NCT01387360|Myopia|myopia
365484|NCT01387360|Hyperopia|hyperopia
365485|NCT01387360|Presbyopia|presbyopia
365486|NCT01387360|Pseudophakia|pseudophakia
365487|NCT01387360|LASIK|lasik
365488|NCT01387347|Thymosin beta 4|thymosin beta 4
365489|NCT01387347|Dry eye syndrome|dry eye syndrome
365490|NCT01387347|Dry eye|dry eye
365491|NCT01387334|resistive exercise|resistive exercise
365492|NCT01387334|Resistance Exercise Training Program|resistance exercise training program
365493|NCT01387334|Rubber Bands|rubber bands
365494|NCT01387334|Glycemic Control|glycemic control
365495|NCT01387334|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
365496|NCT01387321|Pi3K|pi3k
365497|NCT01387321|Advanced solid tumor|advanced solid tumor
365498|NCT01387308|Phase 1|phase 1
365499|NCT01387308|Healthy male volunteers|healthy male volunteers
365500|NCT01387308|pharmacokinetics|pharmacokinetics
365501|NCT01387308|fostamatinib|fostamatinib
587099|NCT00530569|Breast Cancer|breast cancer
365502|NCT01387308|Scientific Terminology: Bioavailability, R406 plasma AUC and C_maxR406 plasma AUC0-t, t1/2λz and t_max|scientific terminology: bioavailability, r406 plasma auc and c_maxr406 plasma auc0-t, t1/2λz and t_max
365503|NCT01387308|Laymen Terminology: Amount of R406 in blood|laymen terminology: amount of r406 in blood
365504|NCT01387295|breast cancer|breast cancer
365505|NCT01387295|liver metastases|liver metastases
365506|NCT01387295|intrahepatic chemotherapy|intrahepatic chemotherapy
365507|NCT01387256|abortion|abortion
365508|NCT01387256|mifepristone|mifepristone
365509|NCT01387256|misoprostol|misoprostol
365510|NCT01387256|with gestations > 63 days LMP|with gestations > 63 days lmp
365511|NCT01387243|behavior modification|behavior modification
365512|NCT01387243|overweight|overweight
365513|NCT01387243|orlistat|orlistat
365514|NCT01387230|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
365515|NCT01387230|long acting muscarinic antagonist|long acting muscarinic antagonist
365516|NCT01387217|GSK2018682|gsk2018682
365517|NCT01387217|First Time in Human|first time in human
365518|NCT01387217|Healthy Volunteer|healthy volunteer
365519|NCT01387204|MEK inhibitor|mek inhibitor
365520|NCT01387204|elimination|elimination
365521|NCT01387204|Phase 1|phase 1
365522|NCT01387204|GSK1120212|gsk1120212
365523|NCT01387204|cancer|cancer
365524|NCT01387204|Pharmacokinetics|pharmacokinetics
365526|NCT01387204|radiolabeled ADME|radiolabeled adme
365527|NCT01387178|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
365528|NCT01387178|cost and cost analysis|cost and cost analysis
365529|NCT01387178|bronchodilators|bronchodilators
365530|NCT01387178|healthcare utilization|healthcare utilization
365531|NCT01387178|fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
365532|NCT01387178|tiotropium|tiotropium
365533|NCT01387165|Latin America|latin america
365534|NCT01387165|diabetes complications|diabetes complications
365535|NCT01387165|patient compliance|patient compliance
365536|NCT01387165|Diabetes mellitus, type 2|diabetes mellitus, type 2
365537|NCT01387165|health services accessibility|health services accessibility
365538|NCT01387152|chest pain|chest pain
365539|NCT01387152|myocardial perfusion scintigraphy|myocardial perfusion scintigraphy
365540|NCT01387152|nuclear stress testing|nuclear stress testing
365541|NCT01387152|low radiation dose|low radiation dose
365542|NCT01387139|Ketamine|ketamine
365543|NCT01387139|Propofol|propofol
365544|NCT01387139|Procedural Sedation and Analgesia|procedural sedation and analgesia
365545|NCT01387113|stroke|stroke
365546|NCT01387113|tPA|tpa
365547|NCT01387113|Thrombolysis|thrombolysis
365548|NCT01387113|rt-PA|rt-pa
365549|NCT01387113|Ischemic|ischemic
365550|NCT01387113|CTP|ctp
365551|NCT01387113|Imaging|imaging
365552|NCT01387113|CT Perfusion Imaging|ct perfusion imaging
365553|NCT01387113|Perfusion|perfusion
365554|NCT01387113|CTA|cta
365555|NCT01387113|CT Angiography|ct angiography
365556|NCT01387113|Acute ischemic stroke|acute ischemic stroke
365557|NCT01387113|Acute stroke therapy|acute stroke therapy
365558|NCT01387113|(AIS)|(ais)
365559|NCT01387100|supportive employment|supportive employment
365560|NCT01387100|vocational rehabilitation|vocational rehabilitation
365561|NCT01387087|ASP015K|asp015k
365562|NCT01387087|Healthy subjects|healthy subjects
365563|NCT01387087|Pharmacodynamics|pharmacodynamics
365564|NCT01387087|Maximum tolerated dose|maximum tolerated dose
365565|NCT01387061|liver resection|liver resection
365566|NCT01387061|hepatic resection|hepatic resection
365567|NCT01387061|intraoperative ultrasound|intraoperative ultrasound
365568|NCT01387048|acne vulgaris|acne vulgaris
365569|NCT01387048|late-type acne|late-type acne
365570|NCT01387048|Skinoren|skinoren
365571|NCT01387048|maintenance|maintenance
365572|NCT01387022|Antiretroviral treatment|antiretroviral treatment
365573|NCT01387022|Tenofovir|tenofovir
365574|NCT01387022|Drug resistance|drug resistance
365575|NCT01387022|Treatment outcome|treatment outcome
365703|NCT01386502|Toxicity|toxicity
365704|NCT01386502|PD-1 ligand|pd-1 ligand
365576|NCT01386983|Enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, acute urinary retention, surgery, early, costs|enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, acute urinary retention, surgery, early, costs
365577|NCT01386983|benign prostatic hyperplasia|benign prostatic hyperplasia
365578|NCT01386970|Pharmacokinetics|pharmacokinetics
365579|NCT01386970|antiretroviral therapy|antiretroviral therapy
365580|NCT01386970|nucleoside analogs|nucleoside analogs
365581|NCT01386970|mitochondrial toxicity|mitochondrial toxicity
365582|NCT01386970|clinical pharmacology|clinical pharmacology
365583|NCT01386970|cellular pharmacology|cellular pharmacology
365584|NCT01386970|pharmacogenetics|pharmacogenetics
365585|NCT01386957|Nephrotic Syndrome|nephrotic syndrome
365586|NCT01386957|Steroid treatment|steroid treatment
365587|NCT01386957|Proteinuria|proteinuria
365589|NCT01386944|Rotigotine|rotigotine
365590|NCT01386944|Neupro®|neupro®
365591|NCT01386944|Augmentation|augmentation
365592|NCT01386944|Restless Legs Syndrome|restless legs syndrome
365593|NCT01386944|Moderate to severe|moderate to severe
365594|NCT01386944|idiopathic|idiopathic
365595|NCT01386944|adults|adults
365596|NCT01386931|Biopsy, Fine-Needle|biopsy, fine-needle
365597|NCT01386931|Endoscopic Ultrasonography|endoscopic ultrasonography
365598|NCT01386931|cytopathology|cytopathology
365599|NCT01386918|Hallucinations|hallucinations
365600|NCT01386918|Schizophrenia|schizophrenia
365601|NCT01386905|Obesity|obesity
365602|NCT01386879|suction|suction
365603|NCT01386879|aspiration|aspiration
365604|NCT01386879|general anesthesia|general anesthesia
365605|NCT01386879|intubation|intubation
365606|NCT01386879|endotracheal tube|endotracheal tube
365607|NCT01386879|respiratory complications|respiratory complications
365608|NCT01386866|AMG 706|amg 706
365609|NCT01386866|Motesanib|motesanib
365610|NCT01386866|Amgen|amgen
365611|NCT01386866|Phase 1|phase 1
365612|NCT01386853|Hyperlipidemia|hyperlipidemia
365613|NCT01386853|Pitavastatin|pitavastatin
365614|NCT01386853|Atorvastatin|atorvastatin
365615|NCT01386840|Efficacy of Treatment|efficacy of treatment
365616|NCT01386840|Severe|severe
365617|NCT01386840|home treatment|home treatment
365618|NCT01386840|treatment at hospital|treatment at hospital
365619|NCT01386827|Ixiaro|ixiaro
365620|NCT01386827|japanese encephalitis vaccine|japanese encephalitis vaccine
365621|NCT01386827|booster|booster
365622|NCT01386801|Diabetes|diabetes
365623|NCT01386801|Controls|controls
365624|NCT01386801|Biospecimen|biospecimen
365625|NCT01386788|Smoke, cyanide, closed space fires|smoke, cyanide, closed space fires
365626|NCT01386775|X-Linked Hypohidrotic Ectodermal Dysplasia|x-linked hypohidrotic ectodermal dysplasia
365627|NCT01386775|XLHED|xlhed
365628|NCT01386775|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
365629|NCT01386775|HED|hed
365630|NCT01386762|paralysis|paralysis
365631|NCT01386762|paraplegia|paraplegia
365632|NCT01386762|obesity|obesity
365633|NCT01386749|Vibration treatment|vibration treatment
365634|NCT01386749|Fracture healing|fracture healing
365635|NCT01386749|Muscular function|muscular function
365636|NCT01386736|insulin resistance|insulin resistance
365637|NCT01386736|obesity|obesity
365638|NCT01386736|adolescence|adolescence
365639|NCT01386736|vitamin D supplementation|vitamin d supplementation
365640|NCT01386723|eltrombopag|eltrombopag
365641|NCT01386723|promacta|promacta
365642|NCT01386723|immune thrombocytopenia (ITP)|immune thrombocytopenia (itp)
365643|NCT01386710|GBM|gbm
365644|NCT01386710|AA|aa
365645|NCT01386710|AO|ao
365646|NCT01386710|Brain|brain
365647|NCT01386710|Tumors|tumors
365648|NCT01386710|Malignant|malignant
365649|NCT01386710|Glioblastoma|glioblastoma
365650|NCT01386710|Multiforme|multiforme
365651|NCT01386710|Anaplastic|anaplastic
365652|NCT01386710|Astrocytoma|astrocytoma
365653|NCT01386684|Prostate Cancer|prostate cancer
365654|NCT01386671|Type 2 Diabetes|type 2 diabetes
365655|NCT01386671|metformin glycinate|metformin glycinate
365656|NCT01386671|metabolic control|metabolic control
365657|NCT01386658|Efficacy|efficacy
365658|NCT01386658|Hereditary angioedema|hereditary angioedema
365659|NCT01386658|HAE|hae
365660|NCT01386658|Pediatric|pediatric
365661|NCT01386658|Children|children
365662|NCT01386658|Pharmacokinetics|pharmacokinetics
365663|NCT01386658|Safety|safety
365664|NCT01386658|Firazyr|firazyr
365665|NCT01386658|icatibant|icatibant
365666|NCT01386645|impaired glucose tolerance|impaired glucose tolerance
365667|NCT01386645|prediabetes|prediabetes
365668|NCT01386645|dietary glycemic index|dietary glycemic index
365669|NCT01386645|beta-cell function|beta-cell function
365670|NCT01386645|insulin secretion|insulin secretion
365671|NCT01386645|oxidative stress|oxidative stress
365672|NCT01386645|glycemic variability|glycemic variability
365673|NCT01386632|Stage III-IV Squamous Cell Carcinoma|stage iii-iv squamous cell carcinoma
365674|NCT01386593|Cytochrome|cytochrome
365675|NCT01386593|Phenotyping|phenotyping
365676|NCT01386593|Pharmacokinetics|pharmacokinetics
365677|NCT01386580|Brain Neoplasms|brain neoplasms
365678|NCT01386580|Neoplasm Metastasis|neoplasm metastasis
365679|NCT01386580|Neoplasms|neoplasms
365680|NCT01386580|Central Nervous System Neoplasms|central nervous system neoplasms
365681|NCT01386580|Nervous System Neoplasms|nervous system neoplasms
365682|NCT01386580|Neoplasms by Site|neoplasms by site
365683|NCT01386580|Brain Diseases|brain diseases
365684|NCT01386580|Central Nervous System Diseases|central nervous system diseases
365685|NCT01386580|Nervous System Diseases|nervous system diseases
365686|NCT01386580|Neoplastic Processes|neoplastic processes
365687|NCT01386580|Pathologic Processes|pathologic processes
365688|NCT01386567|hypogonadism|hypogonadism
365689|NCT01386567|low testosterone|low testosterone
365690|NCT01386567|low T|low t
365691|NCT01386554|H.P. Acthar Gel|h.p. acthar gel
365692|NCT01386554|Acthar|acthar
365693|NCT01386554|nephrotic syndrome|nephrotic syndrome
365694|NCT01386554|idiopathic membranous nephropathy|idiopathic membranous nephropathy
365695|NCT01386554|proteinuria|proteinuria
365696|NCT01386515|Adaptation|adaptation
365697|NCT01386515|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
365698|NCT01386515|Communication about Duchenne Muscular Dystrophy|communication about duchenne muscular dystrophy
365699|NCT01386515|Sibling|sibling
365700|NCT01386502|Solid Tumors|solid tumors
365701|NCT01386502|Monoclonal Antibody|monoclonal antibody
365702|NCT01386502|Peptide Vaccine|peptide vaccine
365705|NCT01386502|Solid Tumor|solid tumor
365706|NCT01386502|Breast Cancer|breast cancer
365707|NCT01386502|Ovarian Cancer|ovarian cancer
365708|NCT01386502|Pancreatic Cancer|pancreatic cancer
365709|NCT01386502|Colon Cancer|colon cancer
365710|NCT01386502|Sarcoma|sarcoma
365711|NCT01386489|HIV-uninfected|hiv-uninfected
365712|NCT01386489|Mucosal Immunity|mucosal immunity
365713|NCT01386489|Kinetics|kinetics
365714|NCT01386489|Cytokines|cytokines
365715|NCT01386489|Chemokines|chemokines
365716|NCT01386489|Healthy Volunteer|healthy volunteer
365717|NCT01386489|HV|hv
365718|NCT01386476|5-HT1A Receptors|5-ht1a receptors
365719|NCT01386476|Blood Brain Barrier|blood brain barrier
365720|NCT01386476|Drug Resistance|drug resistance
365721|NCT01386476|Healthy Volunteer|healthy volunteer
365722|NCT01386476|HV|hv
365723|NCT01386437|Fungal Infection|fungal infection
365724|NCT01386437|Immunopathogenesis|immunopathogenesis
365725|NCT01386437|Genetics|genetics
365726|NCT01386437|Fungal Infections|fungal infections
365727|NCT01386437|Mucocutaneous Fungal Infection|mucocutaneous fungal infection
365728|NCT01386437|Invasive Fungal Infection|invasive fungal infection
365729|NCT01386424|Influenza|influenza
365730|NCT01386424|Human|human
365731|NCT01386424|Challenge Study|challenge study
365732|NCT01386424|Healthy Volunteer|healthy volunteer
365734|NCT01386411|Genetic testing|genetic testing
365735|NCT01386411|BRCA testing|brca testing
365736|NCT01386411|Ashkenazi descent|ashkenazi descent
365737|NCT01386411|11-086|11-086
365738|NCT01386398|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
365739|NCT01386398|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
365740|NCT01386398|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
365741|NCT01386398|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
365742|NCT01386398|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
365743|NCT01386398|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
365744|NCT01386398|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
365745|NCT01386398|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
365746|NCT01386372|Hyponatremia|hyponatremia
365747|NCT01386372|Vasopressin|vasopressin
365748|NCT01386372|Tolvaptan|tolvaptan
365749|NCT01386372|SIADH|siadh
365750|NCT01386346|gastroesophageal junction|gastroesophageal junction
365751|NCT01386346|GEJ|gej
365752|NCT01386346|esophageal|esophageal
365753|NCT01386346|esophagus|esophagus
365754|NCT01386333|Frontotemporal Dementia|frontotemporal dementia
365755|NCT01386333|oxytocin|oxytocin
365756|NCT01386333|Pick's disease|pick's disease
365757|NCT01386320|anaesthetic techniques, regional; surgery orthopaedic|anaesthetic techniques, regional; surgery orthopaedic
365758|NCT01386307|Pain|pain
365759|NCT01386307|Hospitalization|hospitalization
365760|NCT01386281|Julina|julina
365761|NCT01386281|Postmenopausal osteoporosis|postmenopausal osteoporosis
365762|NCT01386268|Kogenate FS|kogenate fs
365763|NCT01386268|Hemophilia A|hemophilia a
365764|NCT01386255|GERD|gerd
365765|NCT01386242|Colorectal Cancer|colorectal cancer
365766|NCT01386242|Novaferon|novaferon
365767|NCT01386229|hemodynamic stability|hemodynamic stability
365768|NCT01386229|etomidate|etomidate
365769|NCT01386229|ketamine|ketamine
365770|NCT01386229|coronary artery bypass surgery after induction of anesthesia, hemodynamic stability|coronary artery bypass surgery after induction of anesthesia, hemodynamic stability
365771|NCT01386216|Critical limb ischemia|critical limb ischemia
366049|NCT01384968|exercise|exercise
365772|NCT01386216|Peripheral vascular disease|peripheral vascular disease
365773|NCT01386216|platelet-rich plasma|platelet-rich plasma
365774|NCT01386203|lung cancer|lung cancer
365775|NCT01386203|biomarkers|biomarkers
365776|NCT01386203|breath|breath
365777|NCT01386203|early detection|early detection
365778|NCT01386190|preterm infant, body composition, exercise|preterm infant, body composition, exercise
365779|NCT01386177|MDMA|mdma
365780|NCT01386177|doxazosin|doxazosin
365781|NCT01386177|norepinephrine|norepinephrine
365782|NCT01386177|alpha1- receptor|alpha1- receptor
365783|NCT01386177|ecstasy|ecstasy
365784|NCT01386177|stimulants|stimulants
365785|NCT01386151|Moderate asthmatic, uncontrolled|moderate asthmatic, uncontrolled
365786|NCT01386138|HIV|hiv
365787|NCT01386138|HIV Risk|hiv risk
365788|NCT01386138|Sexually Transmitted Infections|sexually transmitted infections
365789|NCT01386138|Women|women
365790|NCT01386138|Pregnancy|pregnancy
365791|NCT01386138|Neonatal Health|neonatal health
365792|NCT01386138|Drug Use|drug use
365793|NCT01386138|Drug Treatment|drug treatment
365794|NCT01386138|Gender-specific Treatment|gender-specific treatment
365795|NCT01386138|Methamphetamine|methamphetamine
365796|NCT01386138|Opioids|opioids
365797|NCT01386138|Cocaine|cocaine
365798|NCT01386138|Injection Drugs|injection drugs
365799|NCT01386138|Stimulants|stimulants
365800|NCT01386138|Alcohol|alcohol
365801|NCT01386138|Mandrax|mandrax
365802|NCT01386138|Marijuana|marijuana
365803|NCT01386138|Nicotine|nicotine
365804|NCT01386086|Aripiprazole|aripiprazole
356446|NCT01424683|Qol|qol
365805|NCT01386086|adjunctive therapy|adjunctive therapy
365806|NCT01386086|mood stabilizers|mood stabilizers
365807|NCT01386086|major depressive disorder|major depressive disorder
365808|NCT01386086|postpartum|postpartum
365809|NCT01386086|Augmentation therapy|augmentation therapy
365810|NCT01386086|resistant|resistant
365811|NCT01386060|Stress|stress
365812|NCT01386060|Mindfulness|mindfulness
365813|NCT01386060|Meditation|meditation
365814|NCT01386047|Clinical Prediction Rules|clinical prediction rules
365815|NCT01386047|Electronic Health Records|electronic health records
365816|NCT01386047|Walsh Clinical Prediction Rule|walsh clinical prediction rule
365817|NCT01386047|Heckerling Clinical Prediction Rule|heckerling clinical prediction rule
365818|NCT01386034|Nutrition, protein metabolism, stable isotopes, mass spectrometry, intestinal failure|nutrition, protein metabolism, stable isotopes, mass spectrometry, intestinal failure
365819|NCT01386021|allograft|allograft
365820|NCT01386021|coronary|coronary
365821|NCT01386021|patency|patency
365822|NCT01386021|morbidity|morbidity
365823|NCT01385969|overinflation of LMAs|overinflation of lmas
365824|NCT01385956|metastatic|metastatic
366001|NCT01385124|Cannabidiol|cannabidiol
365825|NCT01385956|locally advanced|locally advanced
365826|NCT01385956|combination therapy|combination therapy
365827|NCT01385956|dose escalation|dose escalation
365828|NCT01385956|epithelial cancer|epithelial cancer
365829|NCT01385956|adenocarcinoma|adenocarcinoma
365830|NCT01385956|exocrine pancreas|exocrine pancreas
365831|NCT01385943|Reflectance Confocal Microscopy|reflectance confocal microscopy
365832|NCT01385943|Dermoscopy|dermoscopy
365833|NCT01385943|Clinical Photos|clinical photos
365834|NCT01385943|Telemedicine|telemedicine
365835|NCT01385930|Overweight|overweight
365836|NCT01385930|Obesity|obesity
365837|NCT01385930|lifestyle counseling|lifestyle counseling
365838|NCT01385917|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
365839|NCT01385917|strength and function tests|strength and function tests
365841|NCT01385878|Microcoaxial phacoemulsification, 1.8mm, 2.2mm|microcoaxial phacoemulsification, 1.8mm, 2.2mm
365842|NCT01385852|CME|cme
365843|NCT01385852|OCT|oct
365844|NCT01385852|Optical coherence tomography|optical coherence tomography
365845|NCT01385852|macular thickness|macular thickness
365846|NCT01385839|Alopecia|alopecia
365847|NCT01385839|Hair transplantation|hair transplantation
365848|NCT01385839|Needle irritation|needle irritation
365849|NCT01385839|Medical needling|medical needling
365850|NCT01385826|Uveitis|uveitis
365851|NCT01385826|Juvenile arthritis|juvenile arthritis
365852|NCT01385826|Anti-tumor necrosis factor alpha monoclonal antibody|anti-tumor necrosis factor alpha monoclonal antibody
365853|NCT01385826|treatment|treatment
365854|NCT01385813|pre-eclampsia|pre-eclampsia
365855|NCT01385813|inflammatory markers|inflammatory markers
365856|NCT01385813|serological biobank|serological biobank
365857|NCT01385813|To assess whether the inflammatory markers could be useful|to assess whether the inflammatory markers could be useful
365858|NCT01385813|in order to identify pregnant women at risk to|in order to identify pregnant women at risk to
365859|NCT01385813|develop preeclampsia|develop preeclampsia
365860|NCT01385800|Grass allergy|grass allergy
365861|NCT01385800|Rhinoconjunctivitis|rhinoconjunctivitis
365862|NCT01385800|Environmental Exposure Unit|environmental exposure unit
365863|NCT01385800|Immunotherapy|immunotherapy
365864|NCT01385800|ToleroMune Grass|toleromune grass
365865|NCT01385787|Pediatric (ages 0-21 years)|pediatric (ages 0-21 years)
365866|NCT01385787|myeloablative HCT|myeloablative hct
365867|NCT01385787|PBMTC sites|pbmtc sites
365868|NCT01385774|Intermittent Claudication|intermittent claudication
366050|NCT01384968|cycling|cycling
365869|NCT01385774|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
365870|NCT01385774|Supervised Exercise Therapy|supervised exercise therapy
365871|NCT01385774|Peripheral Arterial Disease|peripheral arterial disease
365872|NCT01385761|Supraglottic airway devices|supraglottic airway devices
365873|NCT01385735|Parkinson Disease|parkinson disease
365874|NCT01385735|Emotion|emotion
365875|NCT01385735|mood|mood
365876|NCT01385735|executive function|executive function
365877|NCT01385709|Lithium|lithium
365878|NCT01385709|Sertraline|sertraline
365879|NCT01385683|Healthy volunteer|healthy volunteer
365880|NCT01385683|Pharmacokinetic|pharmacokinetic
365881|NCT01385683|pharmacodynamic|pharmacodynamic
365882|NCT01385683|Polymorphism, Genetic|polymorphism, genetic
365883|NCT01385670|Patent Foramen Ovale|patent foramen ovale
365884|NCT01385670|PFO|pfo
365885|NCT01385644|Mesenchymal stem cells|mesenchymal stem cells
365886|NCT01385644|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
365887|NCT01385631|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
365888|NCT01385631|Intravascular ultrasound|intravascular ultrasound
365889|NCT01385631|IVUS|ivus
365890|NCT01385631|Optical coherence tomography|optical coherence tomography
365891|NCT01385631|OCT|oct
365892|NCT01385631|Ezetimibe|ezetimibe
365893|NCT01385631|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
365894|NCT01385631|Atorvastatin|atorvastatin
365895|NCT01385631|Randomized trial|randomized trial
365896|NCT01385631|Hypolipidemic Agents|hypolipidemic agents
365897|NCT01385631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
365898|NCT01385631|Pharmacologic Actions|pharmacologic actions
365899|NCT01385631|Enzyme Inhibitors|enzyme inhibitors
365900|NCT01385631|Lipid Regulating Agents|lipid regulating agents
365901|NCT01385631|Therapeutic Uses|therapeutic uses
365902|NCT01385592|Parkinson Disease|parkinson disease
365903|NCT01385592|L-dopa|l-dopa
365904|NCT01385592|Levodopa|levodopa
365905|NCT01385592|Dyskinesia|dyskinesia
365906|NCT01385592|Anti-Dyskinesia Agents|anti-dyskinesia agents
365907|NCT01385579|colorectal cancer screening|colorectal cancer screening
365908|NCT01385579|fecal occult blood testing (FOBT)|fecal occult blood testing (fobt)
365909|NCT01385579|vulnerable populations|vulnerable populations
365910|NCT01385579|community health center|community health center
365911|NCT01385540|Tinnitus, fMRI, task-based fMRI, attention network|tinnitus, fmri, task-based fmri, attention network
365912|NCT01385488|lymphedema|lymphedema
365913|NCT01385488|breast cancer|breast cancer
365914|NCT01385488|self care|self care
365915|NCT01385488|bioelectrical impedance|bioelectrical impedance
365916|NCT01385488|monitoring|monitoring
365917|NCT01385475|Resistance Training|resistance training
365919|NCT01385475|Older Adults|older adults
365920|NCT01385449|nerve block|nerve block
365921|NCT01385449|shoulder surgery|shoulder surgery
365922|NCT01385449|physical therapy|physical therapy
365923|NCT01385436|human papillomavirus (HPV)|human papillomavirus (hpv)
365924|NCT01385436|cervical cancer|cervical cancer
365925|NCT01385436|high grade cervical squamous intraepithelial lesion (HSIL)|high grade cervical squamous intraepithelial lesion (hsil)
365926|NCT01385423|acute myelogenous leukemia|acute myelogenous leukemia
365927|NCT01385423|natural killer cells|natural killer cells
365928|NCT01385423|haploidentical donor|haploidentical donor
365929|NCT01385410|breastfeeding exclusively|breastfeeding exclusively
365930|NCT01385397|Health system organization|health system organization
365931|NCT01385345|Vitamin D deficiency|vitamin d deficiency
365932|NCT01385345|Insulin resistance|insulin resistance
365933|NCT01385332|Metaphase II|metaphase ii
365934|NCT01385332|Ovarian stimulation|ovarian stimulation
365935|NCT01385332|Egg donors|egg donors
365936|NCT01385319|Bare metal stent|bare metal stent
365937|NCT01385319|zotarolimus eluting stent|zotarolimus eluting stent
365938|NCT01385319|triple anti-thrombotic therapy|triple anti-thrombotic therapy
365939|NCT01385319|high bleeding riskduration of dual anti-platelet therapy|high bleeding riskduration of dual anti-platelet therapy
365940|NCT01385293|BKM120|bkm120
365941|NCT01385293|prostate cancer|prostate cancer
365942|NCT01385293|metastatic castrate-resistant prostate cancer (mCRPC)|metastatic castrate-resistant prostate cancer (mcrpc)
365943|NCT01385254|very low birthweight|very low birthweight
365944|NCT01385254|premature|premature
365945|NCT01385254|sibling adjustment|sibling adjustment
365946|NCT01385254|preterm|preterm
366067|NCT01384942|Uncomplicated|uncomplicated
365947|NCT01385241|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
365948|NCT01385241|Stigma|stigma
365949|NCT01385241|Safe disclosure of seropositive status|safe disclosure of seropositive status
365950|NCT01385241|HIV positive women|hiv positive women
365951|NCT01385241|Self-efficacy|self-efficacy
365952|NCT01385228|prostate cancer|prostate cancer
365953|NCT01385228|metastatic|metastatic
365954|NCT01385228|pazopanib|pazopanib
365955|NCT01385228|docetaxel|docetaxel
365956|NCT01385228|metastatic prostate cancer|metastatic prostate cancer
365957|NCT01385215|Vaccination|vaccination
365958|NCT01385215|Mucosal Immunity|mucosal immunity
365959|NCT01385215|Nasal Immunization|nasal immunization
365960|NCT01385202|Atrial Fibrillation|atrial fibrillation
365961|NCT01385202|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
365962|NCT01385189|Human Hookworm Vaccine Initiative|human hookworm vaccine initiative
365963|NCT01385189|HHVI|hhvi
365964|NCT01385189|Human Hookworm|human hookworm
365965|NCT01385189|Hookworm|hookworm
365966|NCT01385189|Hookworm Disease|hookworm disease
365967|NCT01385189|N. americanus|n. americanus
365968|NCT01385189|Soil-transmitted helminth infection|soil-transmitted helminth infection
365969|NCT01385189|Intestinal blood loss|intestinal blood loss
365970|NCT01385189|Iron deficiency anemia|iron deficiency anemia
365971|NCT01385176|Heart failure|heart failure
365972|NCT01385176|Congestive heart failure|congestive heart failure
365973|NCT01385176|New York Heart Association Class II-III|new york heart association class ii-iii
365974|NCT01385176|Vagal therapy|vagal therapy
365975|NCT01385176|Vagal nerve stimulation|vagal nerve stimulation
365976|NCT01385163|mental health|mental health
365977|NCT01385163|gender-based violence|gender-based violence
365978|NCT01385163|Africa|africa
365979|NCT01385150|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
365980|NCT01385150|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
365981|NCT01385150|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
365982|NCT01385150|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
365983|NCT01385150|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
365984|NCT01385150|adult acute basophilic leukemia|adult acute basophilic leukemia
365985|NCT01385150|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
365986|NCT01385150|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
365987|NCT01385150|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
365988|NCT01385150|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
365989|NCT01385150|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
365990|NCT01385150|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
365991|NCT01385150|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
365992|NCT01385150|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
365993|NCT01385150|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
365994|NCT01385137|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
365995|NCT01385137|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
365996|NCT01385137|stage I breast cancer|stage i breast cancer
365997|NCT01385137|stage II breast cancer|stage ii breast cancer
365998|NCT01385137|stage IIIA breast cancer|stage iiia breast cancer
365999|NCT01385137|pain|pain
366000|NCT01385137|arthralgia|arthralgia
366002|NCT01385124|GVHD|gvhd
366003|NCT01385124|Allogeneic transplantation|allogeneic transplantation
366004|NCT01385124|Prophylaxis|prophylaxis
366005|NCT01385111|endobronchial ultrasound|endobronchial ultrasound
366006|NCT01385111|endoscopic ultrasound|endoscopic ultrasound
366007|NCT01385111|EBUS-TBNA|ebus-tbna
366008|NCT01385111|EUS-FNA|eus-fna
366009|NCT01385111|EUS-B-FNA|eus-b-fna
366010|NCT01385111|lung cancer|lung cancer
366011|NCT01385111|staging|staging
366012|NCT01385098|Vitamin D|vitamin d
366013|NCT01385098|Bariatric surgery|bariatric surgery
366014|NCT01385098|Roux-en Y surgery|roux-en y surgery
366015|NCT01385098|Gastric sleeve surgery|gastric sleeve surgery
366016|NCT01385098|Parathyroid Hormone|parathyroid hormone
366017|NCT01385085|Vitamin D|vitamin d
366018|NCT01385085|Sunlight|sunlight
366019|NCT01385085|Deficiency|deficiency
366020|NCT01385072|acute leukemia|acute leukemia
366021|NCT01385072|relapse|relapse
366022|NCT01385072|induction failure|induction failure
366023|NCT01385072|allogeneic transplantation|allogeneic transplantation
366024|NCT01385072|graft versus leukemia effect|graft versus leukemia effect
366025|NCT01385046|physical inactivity|physical inactivity
366026|NCT01385046|poor diet|poor diet
366027|NCT01385020|Red yeast rice|red yeast rice
366028|NCT01385020|Gemfibrozil|gemfibrozil
366029|NCT01385020|Drug-drug interaction|drug-drug interaction
366030|NCT01385020|Pharmacokinetics|pharmacokinetics
366031|NCT01385007|Rural|rural
366032|NCT01385007|Veterans|veterans
366033|NCT01385007|Dementia|dementia
366034|NCT01385007|Pain|pain
366035|NCT01385007|Aggression|aggression
366036|NCT01385007|residence in a VA designated rural area|residence in a va designated rural area
366037|NCT01385007|presence of a caregiver|presence of a caregiver
366038|NCT01384994|Colorectal Cancer|colorectal cancer
366039|NCT01384994|PARLIM|parlim
366040|NCT01384994|KRAS Wildtype|kras wildtype
366041|NCT01384994|Liver metastases|liver metastases
366042|NCT01384981|chronic obstructive pulmonary rehabilitation|chronic obstructive pulmonary rehabilitation
366043|NCT01384981|COPD|copd
366044|NCT01384981|non invasive ventilation|non invasive ventilation
366045|NCT01384981|NIV|niv
366046|NCT01384981|exercise capacity|exercise capacity
366047|NCT01384981|pulmonary rehabilitation|pulmonary rehabilitation
366048|NCT01384968|nitrite|nitrite
366051|NCT01384955|scoliosis|scoliosis
366052|NCT01384955|physical therapy|physical therapy
366053|NCT01384955|long term outcome|long term outcome
366054|NCT01384955|pulmonary function|pulmonary function
366055|NCT01384955|physical fitness|physical fitness
366056|NCT01384955|health related quality of life|health related quality of life
366057|NCT01384955|psychopathology|psychopathology
366058|NCT01384942|Bereavement|bereavement
366059|NCT01384942|Grief|grief
366060|NCT01384942|Mourning|mourning
366061|NCT01384942|Loss|loss
366062|NCT01384942|Death|death
366063|NCT01384942|Meaning|meaning
366064|NCT01384942|Group|group
366065|NCT01384942|Counseling|counseling
366066|NCT01384942|Psychotherapy|psychotherapy
366068|NCT01384942|Support|support
366069|NCT01384916|depression|depression
366070|NCT01384916|yoga|yoga
366071|NCT01384916|health education|health education
366072|NCT01384916|antidepressant|antidepressant
366073|NCT01384877|Pain|pain
366074|NCT01384877|Cancer|cancer
366075|NCT01384877|Lidocaine|lidocaine
366076|NCT01384877|Sodium Channel Blockers|sodium channel blockers
366077|NCT01384864|barrett's esophagus|barrett's esophagus
366078|NCT01384864|intraepithelial neoplasia|intraepithelial neoplasia
366079|NCT01384864|cross polarized reflectance examination|cross polarized reflectance examination
366080|NCT01384864|vital-dye enhanced fluorescence examination|vital-dye enhanced fluorescence examination
366081|NCT01384838|breast cancer|breast cancer
366082|NCT01384838|physical activity|physical activity
366083|NCT01384838|sports|sports
366084|NCT01384838|exercise|exercise
366085|NCT01384825|Multiple Sclerosis|multiple sclerosis
366086|NCT01384825|Other Neurodegenerative Diseases|other neurodegenerative diseases
366087|NCT01384825|Chronic CerebroSpinal Venous Insufficiency|chronic cerebrospinal venous insufficiency
366088|NCT01384825|Prevalence|prevalence
366089|NCT01384825|Case-control|case-control
366090|NCT01384773|Keratoconus|keratoconus
366091|NCT01384773|Ectasia|ectasia
366092|NCT01384773|UVA light|uva light
366093|NCT01384773|riboflavin|riboflavin
366094|NCT01384773|post-LASIK (laser in situ keratomileusis)|post-lasik (laser in situ keratomileusis)
366095|NCT01384773|pellucid marginal degeneration|pellucid marginal degeneration
366096|NCT01384773|irregular astigmatism|irregular astigmatism
366097|NCT01384721|Computed Tomography Coronary Angiography|computed tomography coronary angiography
366098|NCT01384721|Coronary Artery Disease|coronary artery disease
366099|NCT01384721|Prevalence Of Disease|prevalence of disease
366100|NCT01384721|Prognosis|prognosis
366101|NCT01384721|Risk Stratification|risk stratification
366102|NCT01384708|squamous cell cancer|squamous cell cancer
366103|NCT01384708|squamous cell neoplasia|squamous cell neoplasia
366104|NCT01384695|Barrett's esophagus|barrett's esophagus
366105|NCT01384695|confocal microendoscopy|confocal microendoscopy
366106|NCT01384617|distal pancreatectomy|distal pancreatectomy
366107|NCT01384617|pancreatic fistula|pancreatic fistula
366108|NCT01384617|pancreaticojejunostomy|pancreaticojejunostomy
366109|NCT01384617|Roux-en-Y anastomosis|roux-en-y anastomosis
366110|NCT01384617|stapling closure|stapling closure
366111|NCT01384604|Schizophrenia|schizophrenia
366112|NCT01384604|Schizoaffective disorder|schizoaffective disorder
366113|NCT01384604|Bipolar disorder|bipolar disorder
366114|NCT01384604|Psychosis|psychosis
366115|NCT01384604|Genetics|genetics
366116|NCT01384604|Phenotype|phenotype
366117|NCT01384591|oxidative stress|oxidative stress
366118|NCT01384591|blood flow|blood flow
366119|NCT01384591|antioxidant|antioxidant
366120|NCT01384591|muscle|muscle
366121|NCT01384591|elderly|elderly
366122|NCT01384552|normal weight|normal weight
366123|NCT01384552|overweight|overweight
366124|NCT01384552|dietary restraint|dietary restraint
366125|NCT01384552|package unit size|package unit size
366126|NCT01384552|food intake|food intake
366127|NCT01384539|chronic kidney disease|chronic kidney disease
366128|NCT01384539|vitamin D deficiency|vitamin d deficiency
366129|NCT01384526|hormone therapy|hormone therapy
366130|NCT01384526|ovarian aging|ovarian aging
366131|NCT01384526|ovarian reserve|ovarian reserve
366132|NCT01384526|fertility|fertility
366133|NCT01384526|breast cancer|breast cancer
366134|NCT01384513|Allogeneic HSCT|allogeneic hsct
366135|NCT01384513|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
366136|NCT01384487|Viewing and axial cross sectional imaging of ocular|viewing and axial cross sectional imaging of ocular
366137|NCT01384487|structures, including the anterior chamber|structures, including the anterior chamber
366138|NCT01384474|Crew Resource Management|crew resource management
366139|NCT01384474|Surgical safety checklist|surgical safety checklist
366140|NCT01384474|Postoperative complications|postoperative complications
366141|NCT01384448|stress echocardiography|stress echocardiography
366142|NCT01384448|coronary ct angiography|coronary ct angiography
366143|NCT01384435|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
366144|NCT01384435|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
366145|NCT01384422|methotrexate-refractory|methotrexate-refractory
366146|NCT01384383|Chronic Hepatitis C|chronic hepatitis c
366147|NCT01384383|IL28B CC Genotype|il28b cc genotype
366148|NCT01384383|Treatment naive|treatment naive
366149|NCT01384383|Peginterferon α-2a (PEG)|peginterferon α-2a (peg)
366150|NCT01384383|Genotype 1a/b|genotype 1a/b
366151|NCT01384383|GS 9451|gs 9451
366152|NCT01384383|GS 5885|gs 5885
366153|NCT01384383|Ribavirin (RBV)|ribavirin (rbv)
366154|NCT01384383|HCV NS5A inhibitor|hcv ns5a inhibitor
366155|NCT01384383|HCV NS3 protease inhibitor|hcv ns3 protease inhibitor
366156|NCT01384357|lymphadenopathy|lymphadenopathy
366157|NCT01384357|needle biopsy|needle biopsy
366158|NCT01384357|sonography|sonography
366159|NCT01384331|Implanon users|implanon users
366160|NCT01384331|Frequent bleeding|frequent bleeding
366161|NCT01384331|Prolonged bleeding|prolonged bleeding
366162|NCT01384331|Comparison of treatments|comparison of treatments
366163|NCT01384331|Placebo controlled|placebo controlled
734685|NCT01103037|Moderate|moderate
366164|NCT01384331|Randomly allocated tretment|randomly allocated tretment
366165|NCT01384292|Cancer-Related Pain|cancer-related pain
366166|NCT01384292|Opioid-Induced Constipation|opioid-induced constipation
366168|NCT01384279|metformin|metformin
366169|NCT01384279|topiramate|topiramate
366170|NCT01384279|obesity|obesity
366171|NCT01384279|metabolic syndrome|metabolic syndrome
366172|NCT01384266|Intraocular Inflammation following routine Cataract Surgery|intraocular inflammation following routine cataract surgery
366173|NCT01384253|HER2+|her2+
366174|NCT01384253|HER-2 positive|her-2 positive
366175|NCT01384253|intraperitoneal|intraperitoneal
366176|NCT01384253|intra-abdominal|intra-abdominal
366177|NCT01384253|Lead 212|lead 212
366178|NCT01384253|Radio Immunotherapy|radio immunotherapy
366179|NCT01384253|Alpha particle|alpha particle
366180|NCT01384253|Antibodies|antibodies
366181|NCT01384253|Immunoglobulins|immunoglobulins
366182|NCT01384253|Antibodies, Monoclonal|antibodies, monoclonal
366183|NCT01384253|Immunologic Factors|immunologic factors
366184|NCT01384253|Physiological Effects of Drugs|physiological effects of drugs
366185|NCT01384253|Pharmacologic Actions|pharmacologic actions
366186|NCT01384253|RIT|rit
366187|NCT01384240|colon polyps|colon polyps
366188|NCT01384240|colonic dysplasia|colonic dysplasia
366189|NCT01384240|anal dysplasia|anal dysplasia
366190|NCT01384240|microendoscopy|microendoscopy
366191|NCT01384227|Barrett's esophagus|barrett's esophagus
366192|NCT01384227|in vivo imaging|in vivo imaging
366193|NCT01384227|image guide microscope|image guide microscope
366194|NCT01384201|intestinal metaplasia, gastric cancer|intestinal metaplasia, gastric cancer
366195|NCT01384175|Epidural Analgesia|epidural analgesia
366196|NCT01384175|OPCAB|opcab
366197|NCT01384175|PCEA|pcea
366198|NCT01384162|ALS|als
366199|NCT01384162|VEGF165|vegf165
366200|NCT01384162|Safety|safety
366201|NCT01384162|Intracerebroventricular|intracerebroventricular
366202|NCT01384162|Infusion|infusion
366203|NCT01384162|Implantable|implantable
366880|NCT01381237|Therapy|therapy
366204|NCT01384149|intra ocular pressure|intra ocular pressure
366205|NCT01384149|open angle glaucoma|open angle glaucoma
366206|NCT01384149|selective laser trabeculoplasty|selective laser trabeculoplasty
366207|NCT01384149|external laser treatment|external laser treatment
366208|NCT01384123|stable pulmonary sarcoidosis with no change in medication during the last 3 months/|stable pulmonary sarcoidosis with no change in medication during the last 3 months/
366209|NCT01384110|Amylase|amylase
366210|NCT01384110|Glucosidase|glucosidase
366211|NCT01384110|Glycemic response|glycemic response
366212|NCT01384110|Sucrose|sucrose
366213|NCT01384110|Seaweed|seaweed
366214|NCT01384097|haemodynamic|haemodynamic
366215|NCT01384097|goal-directed therapy|goal-directed therapy
366216|NCT01384097|surgery|surgery
366217|NCT01384097|anaesthesia|anaesthesia
366218|NCT01384084|pelvic organ prolapse|pelvic organ prolapse
366219|NCT01384084|urinary incontinence|urinary incontinence
366220|NCT01384084|sacropexy|sacropexy
366221|NCT01384084|sling|sling
366222|NCT01384071|Low back pain|low back pain
366223|NCT01384071|Unstable shoes|unstable shoes
366224|NCT01384071|Gait|gait
366225|NCT01384071|Balance|balance
366226|NCT01384058|atherogenic lipoprotein|atherogenic lipoprotein
366227|NCT01384058|cardiovascular disease|cardiovascular disease
366228|NCT01384058|coronary artery disease|coronary artery disease
366229|NCT01384058|type 2 diabetes|type 2 diabetes
366230|NCT01384058|small, dense LDL|small, dense ldl
366231|NCT01384045|Type II Diabetes|type ii diabetes
366232|NCT01384045|Diabetes|diabetes
366233|NCT01384032|CVD, LDL-C, apoE, SFA, DHA|cvd, ldl-c, apoe, sfa, dha
366234|NCT01384019|ST-elevation myocardial infarction|st-elevation myocardial infarction
366235|NCT01384019|percutaneous coronary intervention|percutaneous coronary intervention
366236|NCT01384019|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
366237|NCT01384019|microvascular occlusion|microvascular occlusion
366238|NCT01384019|myocardial salvage|myocardial salvage
366239|NCT01384006|Pancreas transplantation|pancreas transplantation
366240|NCT01384006|extended donor criteria|extended donor criteria
366241|NCT01384006|organ survival|organ survival
366242|NCT01383993|Open-Label|open-label
366243|NCT01383993|Pharmacokinetics|pharmacokinetics
366244|NCT01383993|Intravenous to oral switch|intravenous to oral switch
366245|NCT01383993|Safety|safety
366246|NCT01383993|Voriconazole|voriconazole
366247|NCT01383993|Immunocompromise|immunocompromise
366248|NCT01383993|Children|children
366249|NCT01383993|High Risk For Systemic Fungal Infection|high risk for systemic fungal infection
366250|NCT01383980|Enteral Nutrition|enteral nutrition
366251|NCT01383980|Enteral Feeding|enteral feeding
366252|NCT01383980|nasogastric tubes|nasogastric tubes
366253|NCT01383980|gastrostomy tubes|gastrostomy tubes
366254|NCT01383980|jejunostomy tubes|jejunostomy tubes
366255|NCT01383954|Knee osteoarthritis|knee osteoarthritis
366256|NCT01383941|asthma|asthma
366257|NCT01383941|rhinitis|rhinitis
366258|NCT01383941|difficult-to-treat asthmatic|difficult-to-treat asthmatic
366259|NCT01383941|phenotypes|phenotypes
366260|NCT01383889|Physical exercise|physical exercise
366261|NCT01383889|Pregnancy|pregnancy
366262|NCT01383889|Fetal well being|fetal well being
366263|NCT01383876|cervical|cervical
366264|NCT01383876|laminectomy|laminectomy
366265|NCT01383876|fusion|fusion
366266|NCT01383876|neurological compression|neurological compression
366267|NCT01383876|spondylosis|spondylosis
366268|NCT01383850|preterm infants|preterm infants
366269|NCT01383850|nasal continuous positive airway pressure|nasal continuous positive airway pressure
366270|NCT01383850|heliox|heliox
366271|NCT01383850|bronchopulmonary dysplasia.|bronchopulmonary dysplasia.
366272|NCT01383837|HIV/STI|hiv/sti
366273|NCT01383837|Prevention|prevention
366274|NCT01383837|Adolescents|adolescents
366275|NCT01383837|Substance Use Disorders|substance use disorders
366276|NCT01383837|Family-based intervention|family-based intervention
366277|NCT01383824|Hip Replacement|hip replacement
366278|NCT01383824|Femoral Component|femoral component
366279|NCT01383811|Treatment Resistant Depression|treatment resistant depression
366280|NCT01383811|Exercise|exercise
366281|NCT01383798|iron deficiency, physical performance, female athletes|iron deficiency, physical performance, female athletes
366282|NCT01383785|Primary PTCA|primary ptca
366283|NCT01383785|Thrombus Aspiration Catheter|thrombus aspiration catheter
366284|NCT01383785|Intracoronary Abciximab|intracoronary abciximab
366285|NCT01383772|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
366286|NCT01383772|Pan retinal photocoagulation|pan retinal photocoagulation
366287|NCT01383772|Multi-spot Photocoagulator|multi-spot photocoagulator
366288|NCT01383772|Visual field tests|visual field tests
366289|NCT01383759|BORTEZOMIB (VELCADE)|bortezomib (velcade)
366290|NCT01383759|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
366291|NCT01383759|DEXAMETHASONE|dexamethasone
366292|NCT01383759|MELPHALAN|melphalan
366293|NCT01383759|11-061|11-061
366294|NCT01383746|Cholangiocarcinoma|cholangiocarcinoma
366295|NCT01383746|RADIOEMBOLIZATION|radioembolization
366296|NCT01383746|tumor response|tumor response
366297|NCT01383746|progression-free survival|progression-free survival
366298|NCT01383746|safety|safety
366299|NCT01383746|second-line therapy|second-line therapy
366300|NCT01383720|Aortic Valve Stenosis|aortic valve stenosis
366301|NCT01383720|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
366302|NCT01383655|wheezy bronchitis|wheezy bronchitis
366303|NCT01383655|asthma|asthma
366304|NCT01383655|rhinovirus|rhinovirus
366305|NCT01383655|magnesium|magnesium
366306|NCT01383629|Vitrectomy|vitrectomy
366307|NCT01383629|Local anaesthesia|local anaesthesia
366308|NCT01383629|Counselling|counselling
366309|NCT01383629|Fear|fear
366310|NCT01383629|Visual perception|visual perception
366311|NCT01383616|osteoporosis|osteoporosis
366312|NCT01383616|vertebral compression fractures|vertebral compression fractures
366313|NCT01383603|Cat Allergy|cat allergy
366314|NCT01383603|Rhinoconjunctivitis|rhinoconjunctivitis
366315|NCT01383603|Immunotherapy|immunotherapy
366316|NCT01383603|Cat-PAD|cat-pad
366317|NCT01383590|Cat allergy|cat allergy
366318|NCT01383590|Rhinoconjunctivitis|rhinoconjunctivitis
366319|NCT01383590|Immunotherapy|immunotherapy
366320|NCT01383590|Cat-PAD|cat-pad
366321|NCT01383577|Hemorrhoids|hemorrhoids
366322|NCT01383577|Ligation|ligation
366323|NCT01383577|Pain|pain
366324|NCT01383577|Morbidity|morbidity
366325|NCT01383577|Patient Satisfaction|patient satisfaction
366326|NCT01383577|Cost-Benefit Analysis|cost-benefit analysis
366327|NCT01383551|Depression|depression
366328|NCT01383551|Marital relationship|marital relationship
366329|NCT01383551|Parental competence|parental competence
366330|NCT01383538|pancreas|pancreas
366331|NCT01383538|cancer|cancer
366332|NCT01383538|adenocarcinoma|adenocarcinoma
366333|NCT01383538|Oxaliplatin|oxaliplatin
366334|NCT01383538|Leucovorin|leucovorin
366335|NCT01383538|Irinotecan|irinotecan
366336|NCT01383538|5-FU|5-fu
366337|NCT01383538|IPI-926|ipi-926
366338|NCT01383525|SLT, LTP|slt, ltp
366339|NCT01383525|non contact|non contact
366340|NCT01383525|Trabeculoplasty|trabeculoplasty
366341|NCT01383525|Laser|laser
366342|NCT01383525|intraocular pressure|intraocular pressure
366343|NCT01383512|stroke|stroke
366344|NCT01383512|rehabilitation|rehabilitation
366345|NCT01383512|robotics|robotics
366346|NCT01383512|motor control|motor control
366347|NCT01383512|upper limb|upper limb
366348|NCT01383486|Self Selection Tria|self selection tria
366349|NCT01383473|cancer therapy|cancer therapy
366350|NCT01383473|school attendance|school attendance
366351|NCT01383473|cancer diagnosis|cancer diagnosis
366352|NCT01383473|perception|perception
366353|NCT01383460|Acute-on-chronic liver failure|acute-on-chronic liver failure
366354|NCT01383460|ACLF|aclf
366355|NCT01383460|cirrhosis|cirrhosis
366356|NCT01383460|acute hepatitis|acute hepatitis
366357|NCT01383421|Rheumatoid Arthritis|rheumatoid arthritis
366358|NCT01383421|Patient Support Program|patient support program
366359|NCT01383421|adalimumab|adalimumab
366360|NCT01383408|breath sample analysis|breath sample analysis
366361|NCT01383408|exhalation analysis|exhalation analysis
366362|NCT01383408|volatile organic compounds|volatile organic compounds
366363|NCT01383408|screening|screening
366364|NCT01383408|lung cancer|lung cancer
366365|NCT01383408|breast cancer|breast cancer
366366|NCT01383408|ovarian cancer|ovarian cancer
366367|NCT01383408|canine scent detection|canine scent detection
366368|NCT01383382|Heart Diseases|heart diseases
366369|NCT01383382|Cardiovascular Diseases|cardiovascular diseases
366370|NCT01383382|Acute Myocardial Infarction|acute myocardial infarction
366371|NCT01383382|Decision Making|decision making
366372|NCT01383382|Percutaneous Coronary Intervention|percutaneous coronary intervention
366373|NCT01383382|Informed Consent|informed consent
366374|NCT01383382|Quality of Care|quality of care
366375|NCT01383330|megesterol|megesterol
366376|NCT01383317|Remote Ischemic Preconditioning|remote ischemic preconditioning
366377|NCT01383317|Acute Pain|acute pain
366378|NCT01383304|Platelet aggregation|platelet aggregation
366379|NCT01383304|Aspirin|aspirin
366380|NCT01383304|Drug resistance|drug resistance
366381|NCT01383304|Thromboxane B2|thromboxane b2
366382|NCT01383304|Pharmacologic Actions|pharmacologic actions
366383|NCT01383304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
366384|NCT01383291|pelvic floor prolapse|pelvic floor prolapse
366385|NCT01383291|prolift|prolift
366386|NCT01383291|IVS|ivs
366387|NCT01383291|Surgery|surgery
366388|NCT01383278|tobacco|tobacco
366389|NCT01383278|smoking|smoking
366390|NCT01383278|smoking cessation|smoking cessation
366391|NCT01383265|screening colonoscopy|screening colonoscopy
366392|NCT01383265|adenoma|adenoma
366393|NCT01383265|water method|water method
366394|NCT01383252|water method|water method
366395|NCT01383252|air method|air method
366396|NCT01383252|unsedated colonoscopy|unsedated colonoscopy
366397|NCT01383252|adenoma detection|adenoma detection
366398|NCT01383239|Rotator Cuff Tear Repair|rotator cuff tear repair
366399|NCT01383239|Rotator Cuff Tear Repair and postoperative treatment|rotator cuff tear repair and postoperative treatment
366400|NCT01383226|endosonography|endosonography
366401|NCT01383226|enlarged thoracic lymph adenopathies|enlarged thoracic lymph adenopathies
366402|NCT01383226|non-cancer patient|non-cancer patient
367291|NCT01379599|STIs|stis
366403|NCT01383213|Acute Respiratory Failure|acute respiratory failure
366404|NCT01383213|Pneumonia|pneumonia
366405|NCT01383213|Continuous Positive Airway Pressure|continuous positive airway pressure
366406|NCT01383200|efficacy|efficacy
366407|NCT01383200|comfort|comfort
366408|NCT01383187|Deep Burn Trauma|deep burn trauma
366409|NCT01383187|Dermo-Epidermal Graft|dermo-epidermal graft
366410|NCT01383187|Platelet Rich Plasma Concentrate (PRP)|platelet rich plasma concentrate (prp)
366411|NCT01383187|Vancouver Scar Score|vancouver scar score
366412|NCT01383187|Scarring|scarring
366413|NCT01383187|Hypertrophic Scarring|hypertrophic scarring
366414|NCT01383174|Breast cancer|breast cancer
366415|NCT01383174|Latinas|latinas
366416|NCT01383174|Peer support counselor|peer support counselor
366417|NCT01383174|Spanish speaking|spanish speaking
366418|NCT01383174|Community based|community based
366419|NCT01383161|Curcumin|curcumin
366420|NCT01383161|Turmeric|turmeric
366421|NCT01383161|Memory|memory
366422|NCT01383161|Cognitive Impairment|cognitive impairment
366423|NCT01383161|Brain Imaging|brain imaging
366424|NCT01383161|Supplement|supplement
366425|NCT01383148|NSCLC|nsclc
366426|NCT01383135|Healthy volunteers|healthy volunteers
366427|NCT01383122|Pulsed electromagnetic field device|pulsed electromagnetic field device
366428|NCT01383122|Cesarean section|cesarean section
366429|NCT01383109|Mass Balance|mass balance
366430|NCT01383109|Accelerated Mass Spectrometry (AMS)|accelerated mass spectrometry (ams)
366431|NCT01383109|microdose|microdose
366432|NCT01383109|Focus of the study: ADME|focus of the study: adme
366433|NCT01383096|OZ439|oz439
366434|NCT01383096|Bioavailability|bioavailability
366435|NCT01383096|Food Effect|food effect
366436|NCT01383083|Pulmonary arterial hypertension|pulmonary arterial hypertension
366437|NCT01383083|Congenital heart disease|congenital heart disease
366438|NCT01383083|Eisenmenger physiology|eisenmenger physiology
366439|NCT01383070|Timely initiation of breast feeding|timely initiation of breast feeding
366440|NCT01383070|Exclusive breast feeding|exclusive breast feeding
366441|NCT01383070|Timely introduction of complimentary feeding|timely introduction of complimentary feeding
366442|NCT01383070|Breast Feeding, Exclusive|breast feeding, exclusive
366443|NCT01383070|Childbirth and the Puerperium|childbirth and the puerperium
366444|NCT01383044|Carvedilol|carvedilol
366445|NCT01383044|Banding ligation with Carvedilol|banding ligation with carvedilol
366446|NCT01383044|the efficacy & safety of combining EVL and carvedilol in prevention of first variceal bleeding|the efficacy & safety of combining evl and carvedilol in prevention of first variceal bleeding
366447|NCT01383031|laparoscopic cholecystectomy|laparoscopic cholecystectomy
366448|NCT01383031|single site|single site
366449|NCT01383031|randomized controlled trail|randomized controlled trail
366450|NCT01383018|Erectile Dysfunction (ED)|erectile dysfunction (ed)
366451|NCT01383018|Penile Implant|penile implant
366452|NCT01383018|Impotence|impotence
366453|NCT01383018|Penile Prosthesis|penile prosthesis
366454|NCT01383018|Registry|registry
366455|NCT01383005|Treatment satisfaction|treatment satisfaction
734686|NCT01103037|Asthma|asthma
366456|NCT01383005|Adherence to treatment|adherence to treatment
366457|NCT01382992|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
366458|NCT01382992|erbB-1|erbb-1
366459|NCT01382979|Alcohol misuse prevention|alcohol misuse prevention
366460|NCT01382979|College students|college students
366461|NCT01382979|Intervention and control|intervention and control
366462|NCT01382966|sclerostin|sclerostin
366463|NCT01382966|arteriovenous fistula thrombosis|arteriovenous fistula thrombosis
366464|NCT01382966|carpal tunnel syndrome|carpal tunnel syndrome
366465|NCT01382966|echocardiography|echocardiography
366466|NCT01382953|Holter Monitor, Ambulatory Electrocardiography Monitoring|holter monitor, ambulatory electrocardiography monitoring
366467|NCT01382888|Haemodialysis|haemodialysis
366468|NCT01382888|Arteriovenous fistula|arteriovenous fistula
366469|NCT01382888|Severe chronic kidney disease|severe chronic kidney disease
366470|NCT01382888|Newly constructed primary arteriovenous fistulas in patients planned for haemodialysis|newly constructed primary arteriovenous fistulas in patients planned for haemodialysis
366471|NCT01382875|Multi-disciplinary management program|multi-disciplinary management program
366472|NCT01382875|Conventional care program|conventional care program
366473|NCT01382875|Balance Ability|balance ability
366474|NCT01382875|Quality of Life|quality of life
366475|NCT01382862|acute ischemic stroke|acute ischemic stroke
366476|NCT01382862|thrombolysis|thrombolysis
366477|NCT01382862|prehospital|prehospital
366478|NCT01382862|emergency medicine|emergency medicine
366479|NCT01382862|suspected acute stroke|suspected acute stroke
366480|NCT01382862|telemedicine|telemedicine
366481|NCT01382849|amyloid|amyloid
366482|NCT01382849|cerebral amyloid angiopathy|cerebral amyloid angiopathy
366483|NCT01382849|hemorrhages|hemorrhages
366484|NCT01382849|cerebral spot sign|cerebral spot sign
366485|NCT01382810|dry eye signs and symptoms|dry eye signs and symptoms
366486|NCT01382771|low back pain|low back pain
366487|NCT01382771|zygapophysial joint pain|zygapophysial joint pain
366488|NCT01382771|medial branch block|medial branch block
366490|NCT01382771|non-radicular|non-radicular
366491|NCT01382758|Near Infrared Spectroscopy (NIRS)|near infrared spectroscopy (nirs)
367292|NCT01379599|HIV|hiv
366492|NCT01382758|Acute kidney injury (AKI)|acute kidney injury (aki)
366493|NCT01382732|Pre-eclampsia|pre-eclampsia
366494|NCT01382732|Postpartum hemorrhage|postpartum hemorrhage
366495|NCT01382732|Carbetocin|carbetocin
366496|NCT01382732|Oxytocin|oxytocin
366497|NCT01382719|FSAD|fsad
366498|NCT01382719|HSDD|hsdd
366499|NCT01382719|female sexual dysfunction|female sexual dysfunction
366500|NCT01382719|FSD|fsd
366501|NCT01382719|Female Sexual Arousal Disorder|female sexual arousal disorder
366502|NCT01382719|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
366503|NCT01382693|Behavioral symptoms|behavioral symptoms
366504|NCT01382693|Long-term care|long-term care
366505|NCT01382667|mucositis|mucositis
366506|NCT01382667|dyspepsia|dyspepsia
366507|NCT01382667|chemotherapy|chemotherapy
366508|NCT01382667|GLP-2|glp-2
366509|NCT01382667|questionnaire|questionnaire
366510|NCT01382641|Cataract surgery|cataract surgery
366511|NCT01382628|Diabetes|diabetes
366512|NCT01382628|Ulcers|ulcers
366513|NCT01382628|Equinus Deformity|equinus deformity
366514|NCT01382628|Amputation|amputation
366515|NCT01382628|Achilles Tendon|achilles tendon
366516|NCT01382628|Limb Loss|limb loss
366517|NCT01382615|Multiple Myeloma|multiple myeloma
366518|NCT01382602|Urinary Incontinence, Stress|urinary incontinence, stress
366519|NCT01382602|Tissue Therapy (Cell Therapy)|tissue therapy (cell therapy)
366520|NCT01382602|Transplantation, Autologous|transplantation, autologous
366521|NCT01382589|vitiligo|vitiligo
366522|NCT01382589|depigmentation|depigmentation
366523|NCT01382589|phototherapy|phototherapy
366524|NCT01382589|non-segmental vitiligo|non-segmental vitiligo
366525|NCT01382576|polycystic ovary syndrome|polycystic ovary syndrome
366526|NCT01382576|chitotriosidase activity|chitotriosidase activity
366527|NCT01382563|Eosinophilic Gastrointestinal Disorders|eosinophilic gastrointestinal disorders
366528|NCT01382563|EGID|egid
366529|NCT01382563|Eosinophilic Esophagitis|eosinophilic esophagitis
366530|NCT01382563|Registry|registry
366531|NCT01382563|Eosinophils|eosinophils
366532|NCT01382563|Eosinophilia|eosinophilia
366533|NCT01382563|Eosinophilic enteropathy|eosinophilic enteropathy
366534|NCT01382563|Eosinophilic enteritis|eosinophilic enteritis
366535|NCT01382563|Eosinophilic gastritis|eosinophilic gastritis
366536|NCT01382563|Eosinophilic gastroenteritis|eosinophilic gastroenteritis
366739|NCT01381822|Phase 1|phase 1
366537|NCT01382563|Eosinophilic gastroenteropathy|eosinophilic gastroenteropathy
366538|NCT01382550|antithrombin|antithrombin
366539|NCT01382550|venous thrombosis|venous thrombosis
366540|NCT01382550|thrombosis risk factors|thrombosis risk factors
366541|NCT01382550|thrombophilia|thrombophilia
366543|NCT01382537|Chronic|chronic
366544|NCT01382537|Musculoskeletal|musculoskeletal
366545|NCT01382537|Shoulder|shoulder
366546|NCT01382524|PIV therapy|piv therapy
366547|NCT01382498|Endothelin-1 high sensitivity CRP|endothelin-1 high sensitivity crp
366548|NCT01382485|non union|non union
366549|NCT01382485|bone defect|bone defect
366550|NCT01382485|tibia non union|tibia non union
366551|NCT01382485|femur non union|femur non union
366552|NCT01382485|bone graft|bone graft
366553|NCT01382472|STEMI|stemi
366554|NCT01382472|PPCI|ppci
366555|NCT01382472|Statins|statins
366556|NCT01382472|Infarct size|infarct size
366557|NCT01382459|children|children
366558|NCT01382446|Trauma|trauma
366559|NCT01382446|Mechanical Ventilation|mechanical ventilation
366560|NCT01382446|Ventilator Associated Pneumonia|ventilator associated pneumonia
366561|NCT01382446|Oral Care|oral care
366562|NCT01382433|Chronic Cannabis Users|chronic cannabis users
366563|NCT01382433|negative symptoms|negative symptoms
366564|NCT01382433|cognitive electrophysiology functions|cognitive electrophysiology functions
366565|NCT01382420|subclinical cushing syndrome|subclinical cushing syndrome
366566|NCT01382420|hypercortisolism|hypercortisolism
366567|NCT01382420|adrenal incidentaloma|adrenal incidentaloma
366568|NCT01382420|adrenalectomy|adrenalectomy
366569|NCT01382407|skin rash reaction|skin rash reaction
366570|NCT01382407|ERBITUX® (cetuximab)|erbitux® (cetuximab)
366571|NCT01382407|acne|acne
366572|NCT01382394|Sepsis|sepsis
366573|NCT01382394|heart failure|heart failure
366574|NCT01382394|BNP|bnp
366575|NCT01382394|IL-6|il-6
366576|NCT01382394|Procalcitonin|procalcitonin
366577|NCT01382394|Prognosis|prognosis
366578|NCT01382368|Post Pneumonectomy Patients|post pneumonectomy patients
366579|NCT01382368|IPF|ipf
366580|NCT01382368|COPD|copd
366581|NCT01382355|Kidney transplant|kidney transplant
366582|NCT01382355|Kidney/Pancreas transplant|kidney/pancreas transplant
366583|NCT01382355|Antibody|antibody
366584|NCT01382355|Monitoring|monitoring
366585|NCT01382342|Parkinson's disease|parkinson's disease
366586|NCT01382342|cognition|cognition
366587|NCT01382342|executive function|executive function
366588|NCT01382342|rasagiline|rasagiline
751940|NCT01171287|Reaction Time|reaction time
366589|NCT01382329|Prophylaxis of influenza infection caused by a pandemic influenza virus (H5N1)|prophylaxis of influenza infection caused by a pandemic influenza virus (h5n1)
366590|NCT01382316|12-step facilitation|12-step facilitation
366591|NCT01382316|Alcoholics Anonymous|alcoholics anonymous
366592|NCT01382316|Narcotics Anonymous|narcotics anonymous
366593|NCT01382316|AA|aa
366594|NCT01382316|Self-help|self-help
366595|NCT01382303|Type 2 Diabetes|type 2 diabetes
366596|NCT01382303|pentoxifylline|pentoxifylline
366597|NCT01382303|proteinuria|proteinuria
366598|NCT01382290|MRI|mri
366599|NCT01382290|Spine|spine
366600|NCT01382290|Diffusion|diffusion
366601|NCT01382264|Poorly controlled diabetes Type 2|poorly controlled diabetes type 2
366602|NCT01382264|Computer Assisted Decision Support|computer assisted decision support
366603|NCT01382264|Primary Care Providers|primary care providers
366604|NCT01382251|Activities of Daily Living|activities of daily living
366605|NCT01382251|Caregivers|caregivers
366606|NCT01382251|Ambulatory Surgical Procedures|ambulatory surgical procedures
366607|NCT01382238|dolutegravir|dolutegravir
366608|NCT01382238|pediatric|pediatric
366609|NCT01382238|granule formulation|granule formulation
366610|NCT01382238|GSK1349572|gsk1349572
366611|NCT01382238|HIV|hiv
366612|NCT01382225|Dry eyes|dry eyes
366613|NCT01382225|Ocular discomfort|ocular discomfort
366614|NCT01382212|Evaluate safety through the evaluation of the incidence of hypercalcemia in pediatric subjects|evaluate safety through the evaluation of the incidence of hypercalcemia in pediatric subjects
366615|NCT01382199|Antibiotic Associated Diarrhea in Adult Patients|antibiotic associated diarrhea in adult patients
366616|NCT01382186|Qualitative|qualitative
366617|NCT01382186|User, Computer Interface|user, computer interface
366618|NCT01382186|quantitative|quantitative
366619|NCT01382186|survey|survey
366620|NCT01382186|telemedicine|telemedicine
366621|NCT01382173|Knee injury|knee injury
366622|NCT01382173|Osteoarthritis|osteoarthritis
366623|NCT01382173|Anterior Cruciate Ligament injury|anterior cruciate ligament injury
366624|NCT01382173|Patellar dislocation|patellar dislocation
366625|NCT01382160|Rheumatoid arthritis|rheumatoid arthritis
366626|NCT01382160|adalimumab|adalimumab
366627|NCT01382160|pharmacokinetic-pharmacodynamic relationship|pharmacokinetic-pharmacodynamic relationship
366628|NCT01382160|immunogenicity|immunogenicity
366629|NCT01382160|Fc gamma receptors polymorphisms|fc gamma receptors polymorphisms
366630|NCT01382134|Platelet dysfunction|platelet dysfunction
366631|NCT01382134|Hemodilution|hemodilution
366632|NCT01382134|Mild hypothermia|mild hypothermia
366633|NCT01382134|NSAID|nsaid
366634|NCT01382134|Desmopressin|desmopressin
366635|NCT01382121|Peer modeling|peer modeling
366636|NCT01382121|Observational learning|observational learning
366637|NCT01382121|Obesity|obesity
366638|NCT01382121|Adolescents|adolescents
366639|NCT01382121|Maximum ventilatory oxygen|maximum ventilatory oxygen
366640|NCT01382121|Aerobic fitness|aerobic fitness
366641|NCT01382121|Health behaviour|health behaviour
366642|NCT01382095|ETEC|etec
366643|NCT01382095|Diarrhea|diarrhea
366644|NCT01382095|Vaccine|vaccine
735555|NCT01105052|Co-morbid|co-morbid
366645|NCT01382082|cognitive function|cognitive function
366646|NCT01382082|memory|memory
366647|NCT01382082|attention|attention
366648|NCT01382082|breast cancer|breast cancer
366649|NCT01382082|lymphoma|lymphoma
366650|NCT01382069|androgen|androgen
366651|NCT01382069|male contraception|male contraception
366652|NCT01382069|dimethandrolone|dimethandrolone
366653|NCT01382069|healthy men|healthy men
366654|NCT01382056|Peripheral Artery Disease|peripheral artery disease
366655|NCT01382056|Pulses|pulses
366656|NCT01382056|Beans|beans
366657|NCT01382056|PAD|pad
366658|NCT01382043|percutaneous coronary angioplasty|percutaneous coronary angioplasty
366659|NCT01382043|zotarolimus-eluting stent|zotarolimus-eluting stent
366660|NCT01382043|sirolimus-eluting stent|sirolimus-eluting stent
366661|NCT01382043|biodegradable polymer|biodegradable polymer
366662|NCT01382043|biocompatible polymer|biocompatible polymer
366663|NCT01382030|Soft tissue sarcoma|soft tissue sarcoma
366664|NCT01382030|High-risk|high-risk
366665|NCT01382030|Neoadjuvant|neoadjuvant
366666|NCT01382030|Adjuvant|adjuvant
366667|NCT01382030|Chemotherapy|chemotherapy
366668|NCT01382030|Radiotherapy|radiotherapy
366669|NCT01382017|lacosamide|lacosamide
366670|NCT01382017|carbamazepine|carbamazepine
366671|NCT01382017|placebo|placebo
366672|NCT01382017|transcranial magnetic stimulation|transcranial magnetic stimulation
366673|NCT01382017|TMS|tms
366674|NCT01382017|motor cortex|motor cortex
366675|NCT01382017|sodium channel|sodium channel
366676|NCT01382017|inhibition|inhibition
366677|NCT01382017|threshold|threshold
366678|NCT01382004|Neglected diseases|neglected diseases
366679|NCT01382004|Children|children
366680|NCT01381991|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
366681|NCT01381991|Reflux esophagitis|reflux esophagitis
366682|NCT01381991|i-scan|i-scan
366683|NCT01381978|Nutritional status of scholars|nutritional status of scholars
366684|NCT01381978|Risk factors of obesity|risk factors of obesity
366685|NCT01381978|Socioeconomical status|socioeconomical status
366686|NCT01381978|Physical activity habits|physical activity habits
366810|NCT01381614|economic burden|economic burden
366687|NCT01381965|spectral-domain optical coherence tomography|spectral-domain optical coherence tomography
366688|NCT01381965|idiopathic macular hole|idiopathic macular hole
366689|NCT01381965|cone outer segment tips line|cone outer segment tips line
366690|NCT01381965|vitrectomy|vitrectomy
366691|NCT01381952|X-ray|x-ray
366692|NCT01381952|Image processing|image processing
366693|NCT01381952|Neuro angiography|neuro angiography
366694|NCT01381952|Radiation exposure|radiation exposure
366695|NCT01381939|Intrahepatic Cholestasis of Pregnancy|intrahepatic cholestasis of pregnancy
366696|NCT01381939|Induction of labor|induction of labor
366697|NCT01381939|Pregnancy|pregnancy
366698|NCT01381939|Caesarian section|caesarian section
366699|NCT01381939|Pruritus|pruritus
366700|NCT01381939|IUFD|iufd
366701|NCT01381926|Type 2 diabetes|type 2 diabetes
366702|NCT01381926|exenatide|exenatide
366703|NCT01381926|Byetta|byetta
366704|NCT01381913|Gastric cancer|gastric cancer
366705|NCT01381913|Chemoradiotherapy|chemoradiotherapy
366706|NCT01381913|Adjacent tissue invasion|adjacent tissue invasion
366707|NCT01381913|Feasibility trial|feasibility trial
366708|NCT01381900|Canagliflozin|canagliflozin
366709|NCT01381900|Placebo|placebo
366710|NCT01381900|Type 2 diabetes mellitus|type 2 diabetes mellitus
366711|NCT01381887|Canagliflozin|canagliflozin
366712|NCT01381887|Placebo|placebo
366713|NCT01381887|Type 2 diabetes mellitus|type 2 diabetes mellitus
366714|NCT01381874|Breast cancer|breast cancer
366715|NCT01381874|Abiraterone|abiraterone
366716|NCT01381874|Postmenopausal|postmenopausal
366717|NCT01381874|Metastatic|metastatic
366718|NCT01381848|Doripenem|doripenem
366719|NCT01381848|DORIPED1003|doriped1003
366720|NCT01381848|Intravenous|intravenous
366721|NCT01381848|Infection|infection
366722|NCT01381848|Colonization|colonization
366723|NCT01381848|Prophylaxis|prophylaxis
366724|NCT01381848|Pediatric|pediatric
366725|NCT01381848|Antibiotic|antibiotic
366726|NCT01381848|Pharmacokinetics|pharmacokinetics
366727|NCT01381835|TMC435-TiDP16-C126|tmc435-tidp16-c126
366728|NCT01381835|TMC435-C126|tmc435-c126
366729|NCT01381835|TMC435|tmc435
366731|NCT01381835|Hepatitis C|hepatitis c
366732|NCT01381835|Hep C|hep c
366733|NCT01381835|severe renal impairement|severe renal impairement
366734|NCT01381822|TH-302|th-302
366735|NCT01381822|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
366736|NCT01381822|RCC|rcc
366737|NCT01381822|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
366738|NCT01381822|GIST|gist
366740|NCT01381822|Sunitinib|sunitinib
366741|NCT01381822|Pancreatic Neuroendocrine Tumors|pancreatic neuroendocrine tumors
366742|NCT01381822|PNET|pnet
366743|NCT01381809|Myelodysplastic Syndromes|myelodysplastic syndromes
366744|NCT01381809|Myeloproliferative Disorders|myeloproliferative disorders
366745|NCT01381809|Bone Marrow disease|bone marrow disease
366746|NCT01381809|Anemia|anemia
366747|NCT01381809|Epoetin Alfa|epoetin alfa
366748|NCT01381809|Eprex|eprex
366749|NCT01381809|Erypo|erypo
366750|NCT01381809|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
366751|NCT01380821|clinical indication for myocardial SPECT|clinical indication for myocardial spect
366752|NCT01380821|suspected or known coronary artery disease|suspected or known coronary artery disease
366753|NCT01380795|non-small cell lung cancer carcinoma|non-small cell lung cancer carcinoma
366754|NCT01380795|circulating tumor cells|circulating tumor cells
366755|NCT01380795|EGFR|egfr
366756|NCT01380795|K-ras|k-ras
366757|NCT01380782|brain tumor|brain tumor
366758|NCT01380782|recurrent disease|recurrent disease
366759|NCT01380756|Amgen|amgen
366760|NCT01380756|Phase 1|phase 1
366761|NCT01380756|Clinical Trial|clinical trial
366762|NCT01380756|Aurora kinase inhibitor|aurora kinase inhibitor
366763|NCT01380756|Open label|open label
366764|NCT01380756|Oncology|oncology
366765|NCT01380756|Hematology|hematology
366766|NCT01380743|Pompe disease|pompe disease
366767|NCT01380730|Hypercholesterolemia|hypercholesterolemia
366768|NCT01380730|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
366769|NCT01380704|Depression|depression
366770|NCT01381783|topical anaesthesia|topical anaesthesia
366771|NCT01381783|Phacoemulsification|phacoemulsification
366772|NCT01381770|muscular lesions grade 2|muscular lesions grade 2
366773|NCT01381770|muscular lesions grade 3|muscular lesions grade 3
366774|NCT01381757|Extensively Drug-Resistant Tuberculosis|extensively drug-resistant tuberculosis
366775|NCT01381757|First-Line Antituberculous Drugs|first-line antituberculous drugs
366776|NCT01381757|Second-Line Antituberculous Drugs|second-line antituberculous drugs
366777|NCT01381757|Middlebrook Culture|middlebrook culture
366778|NCT01381757|Agar Proportion Method|agar proportion method
366779|NCT01381744|Yersinia pestis, vaccine, plague, Flagellin/F1/V, Parent Protocol of 15-0104|yersinia pestis, vaccine, plague, flagellin/f1/v, parent protocol of 15-0104
366780|NCT01381731|post PRK wound healing|post prk wound healing
366781|NCT01381718|childhood brain tumor|childhood brain tumor
366782|NCT01381718|neurotoxicity|neurotoxicity
366783|NCT01381718|fatigue|fatigue
366784|NCT01381718|cognitive/functional effects|cognitive/functional effects
366785|NCT01381718|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
366879|NCT01381237|Rehabilitation|rehabilitation
366786|NCT01381705|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
366787|NCT01381705|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
366788|NCT01381653|sexual risk|sexual risk
366789|NCT01381653|substance use|substance use
366790|NCT01381653|HIV prevention|hiv prevention
366791|NCT01381653|intervention acceptability and feasibility|intervention acceptability and feasibility
366792|NCT01381653|young men who have sex with men|young men who have sex with men
366793|NCT01381640|paracetamol|paracetamol
366794|NCT01381640|healthy volunteer|healthy volunteer
366795|NCT01381640|pharmacoscintography|pharmacoscintography
366796|NCT01381627|EBUS-TBNA|ebus-tbna
366797|NCT01381627|Dexmedetomidine|dexmedetomidine
366798|NCT01381627|Precedex|precedex
366799|NCT01381627|Remifentanil|remifentanil
366800|NCT01381627|Ultiva|ultiva
366801|NCT01381627|Monitored Anesthesia Care|monitored anesthesia care
366802|NCT01381627|Sedation|sedation
366803|NCT01381627|Bronchoscopy|bronchoscopy
366804|NCT01381627|Lung cancer|lung cancer
366805|NCT01381627|Mediastinal node|mediastinal node
366806|NCT01381627|Cancer staging|cancer staging
366807|NCT01381627|Anesthesia|anesthesia
366808|NCT01381627|Remote location|remote location
366809|NCT01381614|retrospective database analysis|retrospective database analysis
366811|NCT01381601|retrospective database analysis|retrospective database analysis
366812|NCT01381601|economic burden|economic burden
366813|NCT01381575|HPV infection|hpv infection
366814|NCT01381575|Human Papillomavirus|human papillomavirus
366815|NCT01381575|Cervical cancer|cervical cancer
366816|NCT01381575|HPV-16|hpv-16
366817|NCT01381575|HPV-18|hpv-18
366818|NCT01381575|vaccine|vaccine
366819|NCT01381562|intra-abdominal infection|intra-abdominal infection
366820|NCT01381562|belly|belly
366821|NCT01381562|Gram-negative pathogen|gram-negative pathogen
366822|NCT01381562|abscess|abscess
366823|NCT01381562|peritonitis|peritonitis
366824|NCT01381549|Gram-negative|gram-negative
366825|NCT01381549|uropathogens|uropathogens
366826|NCT01381549|complicated lower urinary tract infection|complicated lower urinary tract infection
366827|NCT01381549|pyelonephritis|pyelonephritis
366828|NCT01381536|Anti Blys Antibody|anti blys antibody
366829|NCT01381523|resource utilization|resource utilization
366830|NCT01381523|naproxen sodium|naproxen sodium
366831|NCT01381523|cost and cost analysis|cost and cost analysis
366832|NCT01381523|triptan|triptan
366833|NCT01381523|migraine|migraine
366927|NCT01381120|Urgency|urgency
366834|NCT01381510|Benign prostatic hyperplasia|benign prostatic hyperplasia
366835|NCT01381510|Adherence|adherence
366836|NCT01381510|Acute urinary retention|acute urinary retention
366837|NCT01381510|Enlarged prostate|enlarged prostate
366838|NCT01381510|5-alpha reductase inhibitor|5-alpha reductase inhibitor
366839|NCT01381510|Surgery|surgery
366840|NCT01381510|Cost and cost analysis|cost and cost analysis
366841|NCT01381497|presenteeism|presenteeism
366842|NCT01381497|migraine disorders|migraine disorders
366843|NCT01381497|work productivity|work productivity
366844|NCT01381497|triptan|triptan
366845|NCT01381497|sumatriptan and naproxen sodium|sumatriptan and naproxen sodium
366846|NCT01381497|absenteeism|absenteeism
366847|NCT01381484|Periorbital wrinkles|periorbital wrinkles
366848|NCT01381484|Efficacy and safety|efficacy and safety
366849|NCT01381432|Antirejection|antirejection
366850|NCT01381419|pharmacokinetics|pharmacokinetics
366851|NCT01381419|safety|safety
366852|NCT01381419|positron emission tomography (PET)|positron emission tomography (pet)
366853|NCT01381419|single ascending dose|single ascending dose
366854|NCT01381393|osteoporosis|osteoporosis
366855|NCT01381393|ibandronate|ibandronate
366856|NCT01381380|myofascial pain|myofascial pain
366857|NCT01381380|trigger point injection|trigger point injection
366858|NCT01381380|manual therapy|manual therapy
366859|NCT01381367|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
366860|NCT01381367|Inhaled corticosteroid|inhaled corticosteroid
366861|NCT01381367|Pneumococcal vaccine|pneumococcal vaccine
366862|NCT01381367|Acute exacerbation|acute exacerbation
366863|NCT01381367|High-dose daily inhaled corticosteroid usage|high-dose daily inhaled corticosteroid usage
366864|NCT01381367|Efficacy of the PPSV23 pneumococcal vaccine|efficacy of the ppsv23 pneumococcal vaccine
366865|NCT01381354|Secondary Progressive Multiple Sclerosis, primary progressive multiple sclerosis|secondary progressive multiple sclerosis, primary progressive multiple sclerosis
366866|NCT01381328|HIV-1 infected patients|hiv-1 infected patients
366867|NCT01381328|RALTEGRAVIR regimen|raltegravir regimen
366868|NCT01381328|genotypic evaluations|genotypic evaluations
366869|NCT01381328|phenotypic evaluations|phenotypic evaluations
366870|NCT01381315|Sentinel lymph node biopsy|sentinel lymph node biopsy
366871|NCT01381315|Axillary lymph node dissection|axillary lymph node dissection
366872|NCT01381315|Prevention of lymphedema|prevention of lymphedema
366873|NCT01381302|Severity of disease|severity of disease
366874|NCT01381276|Vitamin A|vitamin a
6530|NCT03249363|Pulse Irrigation Povidone Iodine Spine Surgery|pulse irrigation povidone iodine spine surgery
366875|NCT01381250|Pathological gambling according to DSM and having gambled at least once the past month.|pathological gambling according to dsm and having gambled at least once the past month.
366877|NCT01381237|Balance|balance
366878|NCT01381237|Postural|postural
366881|NCT01381237|computer-assisted|computer-assisted
366882|NCT01381237|Video Games|video games
366883|NCT01381237|Center of Pressure|center of pressure
366884|NCT01381224|low back pain|low back pain
366885|NCT01381224|lumbar|lumbar
366886|NCT01381224|injection|injection
366887|NCT01381224|lumbar pain|lumbar pain
366888|NCT01381211|Intermediate stage hepatocellular carcinoma|intermediate stage hepatocellular carcinoma
366889|NCT01381198|cerebral palsy|cerebral palsy
366890|NCT01381198|distal rectus femoris transfer|distal rectus femoris transfer
366891|NCT01381198|stiff knee gait pattern|stiff knee gait pattern
366892|NCT01381198|gait analysis|gait analysis
366893|NCT01381198|single event multilevel surgery|single event multilevel surgery
366894|NCT01381198|randomized trial|randomized trial
366895|NCT01381198|crouch gait|crouch gait
366896|NCT01381185|myocardial infarction|myocardial infarction
366897|NCT01381185|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
366898|NCT01381185|high platelet reactivity (HPR)|high platelet reactivity (hpr)
366899|NCT01381172|Heart Failure|heart failure
366900|NCT01381172|Congestive Heart Failure|congestive heart failure
366901|NCT01381172|Chronic heart disease|chronic heart disease
366902|NCT01381172|Cardiac contractility modulation|cardiac contractility modulation
366904|NCT01381172|CHF|chf
366905|NCT01381159|Adherence|adherence
366906|NCT01381159|Asthma Control|asthma control
366907|NCT01381159|Asthma Quality Of Life|asthma quality of life
366908|NCT01381159|Motivational Communication|motivational communication
366909|NCT01381159|Motivational Interviewing|motivational interviewing
366910|NCT01381146|criminal behavior|criminal behavior
366911|NCT01381146|substance abuse|substance abuse
366912|NCT01381146|HIV risk behavior|hiv risk behavior
366913|NCT01381146|criminogenic thinking|criminogenic thinking
366914|NCT01381146|shame|shame
366915|NCT01381146|guilt|guilt
366916|NCT01381146|empathy|empathy
366917|NCT01381146|jail inmates|jail inmates
366918|NCT01381146|restorative justice|restorative justice
366919|NCT01381146|Crime|crime
366920|NCT01381133|Substance abuse|substance abuse
366921|NCT01381133|Adolescent outpatient treatment|adolescent outpatient treatment
366922|NCT01381133|Continuing care|continuing care
366923|NCT01381133|Outcomes|outcomes
366924|NCT01381120|Flank Pain|flank pain
366925|NCT01381120|Lower Urinary Tract Symptoms|lower urinary tract symptoms
366926|NCT01381120|LUTS|luts
366928|NCT01381120|Nocturia|nocturia
366929|NCT01381120|Frequency|frequency
366930|NCT01381120|Ureteroscopy|ureteroscopy
366931|NCT01381120|Kidney Stones|kidney stones
366932|NCT01381120|Stent|stent
366933|NCT01381120|Incontinence|incontinence
366934|NCT01381120|VESIcare|vesicare
366935|NCT01381120|Ureter|ureter
366936|NCT01381120|Urinary Bladder, Overactive|urinary bladder, overactive
366937|NCT01381120|OAB|oab
366938|NCT01381120|Overactive Bladder Syndrome|overactive bladder syndrome
366939|NCT01381094|anemia|anemia
366940|NCT01381094|chronic kidney disease|chronic kidney disease
366941|NCT01381094|CKD|ckd
366942|NCT01381094|chronic renal insufficiency|chronic renal insufficiency
366943|NCT01381094|renal impairment|renal impairment
366944|NCT01381094|erythropoietin|erythropoietin
366945|NCT01381094|safety|safety
366946|NCT01381094|efficacy|efficacy
366947|NCT01381094|tolerability|tolerability
366948|NCT01381094|pharmacokinetics|pharmacokinetics
366949|NCT01381081|knee osteoarthritis|knee osteoarthritis
366950|NCT01381081|comparing platelet-rich plasma|comparing platelet-rich plasma
366951|NCT01381081|intra-articular knee injections|intra-articular knee injections
366952|NCT01381068|ventilation|ventilation
366953|NCT01381068|end tidal carbon dioxide|end tidal carbon dioxide
366954|NCT01381068|hypercapnia|hypercapnia
366955|NCT01381068|hypocapnia|hypocapnia
366956|NCT01381068|positive pressure ventilation|positive pressure ventilation
366957|NCT01381068|neonates|neonates
366958|NCT01381068|delivery room resuscitation|delivery room resuscitation
366959|NCT01381055|Cutaneous leishmaniasis|cutaneous leishmaniasis
366960|NCT01381055|Pentoxifylline|pentoxifylline
366961|NCT01381055|Meglumine antimoniate|meglumine antimoniate
366962|NCT01381055|L. braziliensis|l. braziliensis
366963|NCT01381042|Brown Adipose Tissue|brown adipose tissue
366964|NCT01381042|Incidence|incidence
366965|NCT01381042|Factor|factor
366966|NCT01381042|Human|human
366967|NCT01381016|LH pulsatility|lh pulsatility
366968|NCT01381016|Obesity|obesity
366969|NCT01381016|Reproduction|reproduction
366970|NCT01381003|Chronic Granulomatous Disease|chronic granulomatous disease
366971|NCT01381003|Gene therapy|gene therapy
366972|NCT01381003|X-CGD|x-cgd
366973|NCT01381003|NADPH-oxidase|nadph-oxidase
366974|NCT01381003|gp91-phox|gp91-phox
366975|NCT01380977|crime|crime
366976|NCT01380977|substance abuse|substance abuse
366977|NCT01380977|HIV risk|hiv risk
366978|NCT01380977|criminogenic thinking|criminogenic thinking
366979|NCT01380977|shame|shame
366980|NCT01380977|guilt|guilt
366981|NCT01380977|restorative justice|restorative justice
366982|NCT01380977|victim impact group|victim impact group
366983|NCT01380964|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
366984|NCT01380964|biomarkers|biomarkers
366985|NCT01380964|transcriptomics|transcriptomics
366986|NCT01380964|mironics|mironics
366987|NCT01380964|proteomics|proteomics
366988|NCT01380951|liver cirrhosis|liver cirrhosis
366989|NCT01380951|chronic hepatitis B|chronic hepatitis b
366990|NCT01380951|antiviral therapy|antiviral therapy
366991|NCT01380951|telbivudine|telbivudine
366992|NCT01380938|genotypes 2 and 3|genotypes 2 and 3
366993|NCT01380938|combination treatment|combination treatment
366994|NCT01380938|individualized treatment|individualized treatment
366995|NCT01380912|breast cancer|breast cancer
366996|NCT01380912|mastectomy|mastectomy
366997|NCT01380912|methylprednisoloneacetate|methylprednisoloneacetate
366998|NCT01380912|seroma|seroma
366999|NCT01380912|numbers of punctures|numbers of punctures
367000|NCT01380899|Parkinson Disease|parkinson disease
367001|NCT01380899|Parkinsonian Disorders|parkinsonian disorders
367002|NCT01380899|Lewy Bodies|lewy bodies
367003|NCT01380899|alpha-Synuclein|alpha-synuclein
367004|NCT01380860|mesh|mesh
367005|NCT01380860|hernia|hernia
367006|NCT01380847|Kidney Transplantation|kidney transplantation
367007|NCT01380847|Allograft|allograft
367008|NCT01380847|Kidney failure|kidney failure
367009|NCT01380847|Chronic allograft nephropathy|chronic allograft nephropathy
367010|NCT01380847|Monitoring|monitoring
367011|NCT01380847|Urine|urine
367012|NCT01380834|paravertebral nerve blocks|paravertebral nerve blocks
367013|NCT01380834|laparoscopic cholecystectomy|laparoscopic cholecystectomy
367014|NCT01380678|bevacizumab|bevacizumab
367015|NCT01380678|pterygium|pterygium
367016|NCT01380678|treatment|treatment
367017|NCT01380678|elevation|elevation
367018|NCT01380665|Prevena|prevena
367019|NCT01380665|Incision|incision
367020|NCT01380665|Management|management
367021|NCT01380665|System|system
367022|NCT01380665|total|total
367023|NCT01380665|knee|knee
367024|NCT01380665|hip|hip
367025|NCT01380665|replacement|replacement
367026|NCT01380665|Surgery|surgery
367027|NCT01380665|Negative|negative
367028|NCT01380665|Pressure|pressure
367029|NCT01380665|dressing|dressing
367030|NCT01380665|KCI|kci
367031|NCT01380652|COPD III/IV|copd iii/iv
367032|NCT01380652|Activity Monitoring|activity monitoring
367033|NCT01380652|SenseWear|sensewear
367034|NCT01380652|Vibration training|vibration training
367035|NCT01380652|Galileo|galileo
367036|NCT01380652|Pulmonary rehabilitation|pulmonary rehabilitation
367037|NCT01380639|COPD III/IV|copd iii/iv
367038|NCT01380639|6-Minutes-Walking-Distance|6-minutes-walking-distance
367039|NCT01380639|Vibration training|vibration training
367040|NCT01380639|Galileo|galileo
367041|NCT01380639|Pulmonary rehabilitation|pulmonary rehabilitation
367042|NCT01380626|alpha-1-antitrypsin-deficiency|alpha-1-antitrypsin-deficiency
367043|NCT01380626|COPD|copd
367044|NCT01380626|exercise training|exercise training
367045|NCT01380626|muscle biopsy|muscle biopsy
367046|NCT01380613|HIV|hiv
367047|NCT01380613|depression|depression
367048|NCT01380613|drug use,|drug use,
367049|NCT01380613|risk reduction|risk reduction
367050|NCT01380600|Vaccinia|vaccinia
367051|NCT01380600|Vaccinia Virus|vaccinia virus
367052|NCT01380600|JX-594|jx-594
367053|NCT01380600|Jennerex|jennerex
367054|NCT01380600|Colorectal Carcinoma|colorectal carcinoma
367055|NCT01380600|Colorectal cancer|colorectal cancer
367056|NCT01380600|Colon Cancer|colon cancer
367057|NCT01380600|Rectal Cancer|rectal cancer
367058|NCT01380600|Pexa-Vec|pexa-vec
367059|NCT01380587|ALL|all
367060|NCT01380587|XCL1|xcl1
367061|NCT01380587|Cytokines|cytokines
367062|NCT01380587|Prognosis|prognosis
367063|NCT01380574|atrial fibrillation|atrial fibrillation
367064|NCT01380574|cardioversion|cardioversion
367065|NCT01380574|stroke|stroke
367066|NCT01380574|thromboembolism|thromboembolism
367067|NCT01380561|asimadoline|asimadoline
367068|NCT01380561|pharmacokinetic|pharmacokinetic
367069|NCT01380561|excretion of 14C-derived radioactivity|excretion of 14c-derived radioactivity
367070|NCT01380561|metabolite profile|metabolite profile
367071|NCT01380561|14C-asimadoline|14c-asimadoline
367072|NCT01380561|metabolites|metabolites
367073|NCT01380561|single and multiple oral doses|single and multiple oral doses
367074|NCT01380535|Extracorporeal photopheresis therapy|extracorporeal photopheresis therapy
367075|NCT01380535|Methoxsalen|methoxsalen
367076|NCT01380535|UVADEX|uvadex
367077|NCT01380535|Chronic graft versus host disease (cGvHD): National Institute Health Consensus Criteria|chronic graft versus host disease (cgvhd): national institute health consensus criteria
367078|NCT01380522|Bioequivalence, single-dose, fed|bioequivalence, single-dose, fed
367079|NCT01380509|Bioequivalence, single-dose, fasting|bioequivalence, single-dose, fasting
367080|NCT01380496|bioequivalence|bioequivalence
367081|NCT01380496|doxycycline monohydrate|doxycycline monohydrate
367082|NCT01380496|fed|fed
367083|NCT01380483|bioequivalence|bioequivalence
367084|NCT01380483|doxycycline monohydrate|doxycycline monohydrate
367085|NCT01380483|fasting|fasting
367086|NCT01380470|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
367087|NCT01380470|Diagnosis differential|diagnosis differential
367088|NCT01380470|Dyspnea/classification|dyspnea/classification
367089|NCT01380470|Dyspnea/etiology|dyspnea/etiology
367090|NCT01380457|bioequivalence|bioequivalence
367091|NCT01380457|dronabinol|dronabinol
367092|NCT01380457|fasting|fasting
367093|NCT01380444|Intertrochanteric fracture|intertrochanteric fracture
367094|NCT01380444|Gamma3 intramedullary nail|gamma3 intramedullary nail
367095|NCT01380444|Sliding hip screw|sliding hip screw
367096|NCT01380431|bioequivalence, lisinopril, fed|bioequivalence, lisinopril, fed
367097|NCT01380418|Obesity|obesity
367098|NCT01380405|Inhalators|inhalators
367099|NCT01380405|Education|education
367100|NCT01380405|Primary care|primary care
367101|NCT01380392|Liver cancer|liver cancer
367102|NCT01380392|Uncertainty|uncertainty
367103|NCT01380392|Personality|personality
367104|NCT01380392|coping strategies|coping strategies
367105|NCT01380379|physical violence|physical violence
367106|NCT01380379|sexual violence|sexual violence
367107|NCT01380366|Malabsorption|malabsorption
367108|NCT01380353|Women undergoing total mastectomy|women undergoing total mastectomy
367109|NCT01380353|Breast cancer prevention|breast cancer prevention
367110|NCT01380340|Seniors|seniors
367111|NCT01380340|Driving|driving
367112|NCT01380340|Group work|group work
367113|NCT01380327|cockroach|cockroach
367114|NCT01380327|immunotherapy|immunotherapy
367115|NCT01380327|sublingual immunotherapy (SLIT)|sublingual immunotherapy (slit)
367116|NCT01380327|inner city asthma|inner city asthma
367117|NCT01380314|leishmaniasis|leishmaniasis
367118|NCT01380314|cutaneois leishmaniasis|cutaneois leishmaniasis
367119|NCT01380314|miltefosine|miltefosine
367120|NCT01380314|oral therapy|oral therapy
367121|NCT01380314|treatment|treatment
367122|NCT01380314|imiquimod|imiquimod
367123|NCT01380301|Leishmaniasis|leishmaniasis
367124|NCT01380301|Miltefosine|miltefosine
367125|NCT01380301|Antimony|antimony
367126|NCT01380301|Therapy|therapy
367127|NCT01380288|Alzheimer's disease|alzheimer's disease
367128|NCT01380288|rivastigmine patch|rivastigmine patch
367129|NCT01380288|white matter change|white matter change
367130|NCT01380275|recurrent, refractory, bone, soft tissue, sarcomas|recurrent, refractory, bone, soft tissue, sarcomas
367131|NCT01380262|Colorectal Cancer|colorectal cancer
367132|NCT01380262|Skin Rash|skin rash
367133|NCT01380262|Pre-emptive treatment|pre-emptive treatment
367134|NCT01380262|Doxycycline|doxycycline
367135|NCT01380262|Anti-EGFR antibody|anti-egfr antibody
367136|NCT01380262|Cetuximab|cetuximab
367137|NCT01380262|Panitumumab|panitumumab
367139|NCT01380249|Phase I multiple doses|phase i multiple doses
367140|NCT01380249|PDM08|pdm08
367141|NCT01380249|Cancer Treatment|cancer treatment
367142|NCT01380249|Pharmacokinetics and Pharmacodynamics|pharmacokinetics and pharmacodynamics
367143|NCT01380249|Advanced Solid Tumors|advanced solid tumors
367144|NCT01380249|Prodimed|prodimed
367145|NCT01380210|Carbon dioxide intoxication|carbon dioxide intoxication
367146|NCT01380210|Diffusion weighted images(DWI)|diffusion weighted images(dwi)
367147|NCT01380197|pain|pain
367148|NCT01380197|sickle cell|sickle cell
367149|NCT01380197|nubain|nubain
367150|NCT01380197|morphine|morphine
367151|NCT01380197|acute chest|acute chest
367152|NCT01380197|side effects|side effects
367153|NCT01380184|Relapsed cancer|relapsed cancer
367154|NCT01380158|pessary|pessary
367155|NCT01380158|preterm birth|preterm birth
367156|NCT01380158|short cervix|short cervix
357834|NCT01419418|Patients' perspective|patients' perspective
357835|NCT01419405|analgesia|analgesia
357836|NCT01419405|acute experimental pain|acute experimental pain
367157|NCT01380158|cervical incompetence|cervical incompetence
367158|NCT01380145|multiple myeloma|multiple myeloma
367159|NCT01380145|MAGE-A3|mage-a3
367160|NCT01380145|autologous stem cell transplant|autologous stem cell transplant
367161|NCT01380132|Fecal incontinence|fecal incontinence
367162|NCT01380132|Treatment|treatment
367163|NCT01380132|Surgery|surgery
367164|NCT01380119|sputum conversion|sputum conversion
367165|NCT01380119|liver biochemistry|liver biochemistry
367166|NCT01380119|weight loss|weight loss
367167|NCT01380119|quality of life|quality of life
367168|NCT01380106|Multiple myeloma|multiple myeloma
367169|NCT01380106|Relapsed|relapsed
367170|NCT01380106|Revlimid|revlimid
367171|NCT01380093|abuse potential|abuse potential
367172|NCT01380093|abuse liability|abuse liability
367173|NCT01380093|recreational opioid use|recreational opioid use
367174|NCT01380093|morphine|morphine
367175|NCT01380067|Inguinal hernia|inguinal hernia
367176|NCT01380067|Lateral umbilicus ligament|lateral umbilicus ligament
367177|NCT01380067|Recurrence|recurrence
367178|NCT01380054|Pulmonary Hypertension|pulmonary hypertension
367179|NCT01380054|Quality of life|quality of life
367180|NCT01380054|Coping|coping
367181|NCT01380054|Depression|depression
367182|NCT01380054|Anxiety|anxiety
367183|NCT01380054|Social support|social support
367184|NCT01380054|Control beliefs|control beliefs
367185|NCT01380041|Multiple sclerosisCerebrospinal fluidBiomarkerCytokineArray|multiple sclerosiscerebrospinal fluidbiomarkercytokinearray
367186|NCT01380028|chronic subdural hematomas|chronic subdural hematomas
367187|NCT01380028|corticosteroid|corticosteroid
367188|NCT01380028|treatment|treatment
367189|NCT01380028|neurosurgery|neurosurgery
367190|NCT01380028|recurrence, adjuvant|recurrence, adjuvant
367191|NCT01380015|osteoarthritis|osteoarthritis
367192|NCT01380015|spearmint|spearmint
367193|NCT01380015|rosmarinic acid|rosmarinic acid
367194|NCT01380002|care needs|care needs
367195|NCT01379976|lung|lung
367196|NCT01379976|cancer|cancer
367197|NCT01379976|non small cell lung cancer|non small cell lung cancer
367198|NCT01379976|Advanced or metastatic non small cell lung cancer|advanced or metastatic non small cell lung cancer
367199|NCT01379937|influenza|influenza
367200|NCT01379937|H5N1|h5n1
367201|NCT01379937|vaccine|vaccine
367202|NCT01379937|children|children
367203|NCT01379911|Satiety|satiety
367204|NCT01379911|Food intake|food intake
367205|NCT01379911|Yogurt|yogurt
367206|NCT01379898|Pheochromocytoma|pheochromocytoma
367207|NCT01379898|Doxazosin|doxazosin
367208|NCT01379898|Phenoxybenzamine|phenoxybenzamine
367209|NCT01379885|Pain|pain
367210|NCT01379885|immunization|immunization
367211|NCT01379885|distraction|distraction
367212|NCT01379885|hypnosis|hypnosis
367213|NCT01379885|injections|injections
367214|NCT01379885|anxiety|anxiety
367215|NCT01379872|Prostate|prostate
367216|NCT01379872|Head and Neck|head and neck
367217|NCT01379872|Anal|anal
367218|NCT01379846|Immunostimulation|immunostimulation
367219|NCT01379846|Haemophilus b conjugate vaccine|haemophilus b conjugate vaccine
367220|NCT01379846|HIB|hib
367221|NCT01379833|Chronic Inflammatory Demyelinating Polyneuropathy|chronic inflammatory demyelinating polyneuropathy
367222|NCT01379833|Neurotrophic corneal ulcer|neurotrophic corneal ulcer
367223|NCT01379820|NEONATAL RESPIRATORY FAILURE|neonatal respiratory failure
367224|NCT01379820|OROTRACHEAL cpap|orotracheal cpap
367225|NCT01379820|NASAL cpap|nasal cpap
367226|NCT01379820|MECHANICAL VENTILATION|mechanical ventilation
367227|NCT01379820|PNEUMOTHORAX|pneumothorax
367228|NCT01379820|COMPENSATION BAG|compensation bag
367229|NCT01378754|hydrodilation|hydrodilation
367230|NCT01378754|general anesthetic|general anesthetic
367231|NCT01378741|delirium|delirium
367232|NCT01378741|cardiac surgery|cardiac surgery
367233|NCT01378741|postoperative sedation|postoperative sedation
367234|NCT01378728|Optical imaging|optical imaging
367235|NCT01378728|Fluorescence imaging|fluorescence imaging
367236|NCT01378728|Chronic and acute wounds|chronic and acute wounds
367237|NCT01378728|Wound bacteria|wound bacteria
367238|NCT01378728|Bacterial biofilms|bacterial biofilms
367239|NCT01378728|Pathogenic bacteria|pathogenic bacteria
367240|NCT01378728|Microorganisms|microorganisms
367241|NCT01378728|Wound infection|wound infection
367242|NCT01378728|Wound healing|wound healing
735556|NCT01105052|CBT|cbt
367243|NCT01378728|Treatment response assessment|treatment response assessment
367244|NCT01378715|coronary artery disease|coronary artery disease
367245|NCT01378715|percutaneous coronary intervention|percutaneous coronary intervention
367246|NCT01378715|statins|statins
367247|NCT01378715|periprocedural myocardial infarction|periprocedural myocardial infarction
367248|NCT01378702|Mistletoe|mistletoe
367249|NCT01378702|Anthroposophical medicine|anthroposophical medicine
367250|NCT01379781|prevention|prevention
367251|NCT01379781|postpartum depression|postpartum depression
367252|NCT01379755|stability|stability
367253|NCT01379755|single-radius|single-radius
367254|NCT01379755|multi-radius|multi-radius
367255|NCT01379755|total knee arthroplasty|total knee arthroplasty
367256|NCT01379742|prostate cancer|prostate cancer
367257|NCT01379742|prostate brachytherapy|prostate brachytherapy
367258|NCT01379729|Type 1 Diabetes|type 1 diabetes
367259|NCT01379729|Transplantation|transplantation
367260|NCT01379729|Beta Cells|beta cells
367261|NCT01379729|Encapsulation|encapsulation
367262|NCT01379703|HIV-1 infected patients|hiv-1 infected patients
367263|NCT01379703|Protease inhibitor|protease inhibitor
367264|NCT01379703|Kaletra®|kaletra®
367265|NCT01379690|HbA1c|hba1c
367266|NCT01379677|Coronary Artery Disease|coronary artery disease
367267|NCT01379677|Myocardial perfusion imaging|myocardial perfusion imaging
367268|NCT01379677|Rubidium|rubidium
367269|NCT01379677|Technetium|technetium
367270|NCT01379664|Sevoflurane|sevoflurane
367271|NCT01379664|Isoflurane|isoflurane
367272|NCT01379664|volatile anesthetic|volatile anesthetic
367273|NCT01379664|duration of hospitalization|duration of hospitalization
367274|NCT01379651|Egg allergy,specific oral tolerance induction|egg allergy,specific oral tolerance induction
367275|NCT01379638|cardiopulmonary bypass|cardiopulmonary bypass
367276|NCT01379638|cardiac output|cardiac output
367277|NCT01379638|flow rate|flow rate
367278|NCT01379638|lactate|lactate
367279|NCT01379625|fatty acid oxidation|fatty acid oxidation
367280|NCT01379625|triheptanoin|triheptanoin
367281|NCT01379625|long-chain fatty acid oxidation disorders|long-chain fatty acid oxidation disorders
367282|NCT01379625|LCHADD|lchadd
367283|NCT01379625|VLCADD|vlcadd
367284|NCT01379625|CPT2|cpt2
367286|NCT01379612|Ultrasound elastography|ultrasound elastography
367287|NCT01379612|Rectal cancer|rectal cancer
367288|NCT01379612|Preoperative chemoradiation|preoperative chemoradiation
367289|NCT01379599|cocaine|cocaine
367290|NCT01379599|heroin|heroin
367293|NCT01379599|brief motivational intervention|brief motivational intervention
367294|NCT01379599|voluntary testing and counseling|voluntary testing and counseling
367295|NCT01379586|ONO-4053|ono-4053
367296|NCT01379586|Healthy adult subjects|healthy adult subjects
367297|NCT01379586|First time in humans|first time in humans
367298|NCT01379573|hydroxychloroquine|hydroxychloroquine
367299|NCT01379573|Plaquenil|plaquenil
367300|NCT01379573|congenital heart block|congenital heart block
367301|NCT01379573|neonatal lupus|neonatal lupus
367302|NCT01379573|systemic lupus erythematosus|systemic lupus erythematosus
367303|NCT01379573|Sjogren's syndrome|sjogren's syndrome
367304|NCT01379573|autoantibodies|autoantibodies
367305|NCT01379573|SSA/Ro|ssa/ro
367306|NCT01379573|SSB/La|ssb/la
367307|NCT01379573|autoimmunity|autoimmunity
367308|NCT01379573|pregnancy|pregnancy
367309|NCT01379573|immunoglobulin|immunoglobulin
367310|NCT01379547|Procalcitonin|procalcitonin
367311|NCT01379547|sepsis|sepsis
367312|NCT01379547|ICU|icu
367313|NCT01379547|antibiotic|antibiotic
367314|NCT01379547|antibiotic duration|antibiotic duration
367315|NCT01379547|Antibiotic treatment duration|antibiotic treatment duration
367316|NCT01379534|Solid tumors,|solid tumors,
367317|NCT01379534|advanced endometrial cancer,|advanced endometrial cancer,
367318|NCT01379534|Endometrial Cancer,|endometrial cancer,
367319|NCT01379534|Second-line treatment,|second-line treatment,
367320|NCT01379534|VEGF,|vegf,
367321|NCT01379534|Neoplasms,|neoplasms,
367322|NCT01379534|Endometrial Neoplasms,|endometrial neoplasms,
367323|NCT01379534|Uterine Neoplasms,|uterine neoplasms,
367324|NCT01379534|Female Genital Neoplasms,|female genital neoplasms,
367325|NCT01379534|Cancer,|cancer,
367326|NCT01379534|Carcinoma,|carcinoma,
367327|NCT01379534|Uterine Diseases,|uterine diseases,
367328|NCT01379534|Female Genital Diseases,|female genital diseases,
367329|NCT01379534|Tumors,|tumors,
367330|NCT01379534|Oral Administration,|oral administration,
367331|NCT01379534|Capsules,|capsules,
367332|NCT01379534|Tablets,|tablets,
367333|NCT01379534|CHIR258,|chir258,
367334|NCT01379534|CHIR-258,|chir-258,
367335|NCT01379534|CHIR 258,|chir 258,
367336|NCT01379534|TKI258,|tki258,
367337|NCT01379534|TKI-258,|tki-258,
367338|NCT01379534|TKI 258|tki 258
367339|NCT01379521|Localised|localised
367340|NCT01379521|unresectable|unresectable
367544|NCT01378585|safety|safety
367341|NCT01379521|chemoembolization|chemoembolization
367343|NCT01379495|rehabilitation|rehabilitation
367344|NCT01379482|Peritoneal carcinomatosis from gastric cancer|peritoneal carcinomatosis from gastric cancer
367345|NCT01379469|Carbamazepine (Tegretol) use|carbamazepine (tegretol) use
367346|NCT01379469|severe liver disease|severe liver disease
367347|NCT01379469|alpha-1-antitrypsin deficiency|alpha-1-antitrypsin deficiency
367348|NCT01379443|Children|children
367349|NCT01379443|Rehabilitation|rehabilitation
367350|NCT01379443|Family Functioning|family functioning
367351|NCT01379443|Mental Health|mental health
367352|NCT01379443|Costs|costs
367353|NCT01379443|Integration|integration
367354|NCT01379430|Vaccine|vaccine
367355|NCT01379430|Immune response|immune response
367356|NCT01379417|Prematurity|prematurity
367357|NCT01379417|Nutrition|nutrition
367358|NCT01379417|Growth|growth
367359|NCT01379404|sepsis, fluid status, BIA, CVP|sepsis, fluid status, bia, cvp
367360|NCT01379391|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
367361|NCT01379391|Platelet Engraftment|platelet engraftment
367362|NCT01379391|TPO|tpo
367363|NCT01379365|wrinkle rhytid aging|wrinkle rhytid aging
367364|NCT01379352|liver transplantation|liver transplantation
367365|NCT01379352|vecuronium|vecuronium
367366|NCT01379339|Cabazitaxel|cabazitaxel
367367|NCT01379339|Cabazitaxel and Cisplatin|cabazitaxel and cisplatin
367368|NCT01379339|Phase I|phase i
367369|NCT01379339|PF Induction Chemotherapy|pf induction chemotherapy
367370|NCT01379339|Squamous Cell Carcinoma|squamous cell carcinoma
367371|NCT01379339|Head and Neck|head and neck
367372|NCT01379339|Sanofi-Aventis Oncology|sanofi-aventis oncology
367373|NCT01379339|Locally Advanced|locally advanced
367374|NCT01379313|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
367375|NCT01379313|gas exchange|gas exchange
367376|NCT01379313|inspiratory time|inspiratory time
367377|NCT01379313|expiratory time|expiratory time
367378|NCT01379313|I:E ratio|i:e ratio
367379|NCT01379300|Hemophilia B|hemophilia b
367380|NCT01379287|Iso-Fludelone|iso-fludelone
367381|NCT01379287|KOS-1803|kos-1803
367382|NCT01379287|Dose-Escalation|dose-escalation
367383|NCT01379287|10-202|10-202
367384|NCT01379274|MDS|mds
367385|NCT01379274|Low risk disease|low risk disease
367386|NCT01379274|IPSS|ipss
367387|NCT01379261|STEMI|stemi
367388|NCT01379261|primary PCI|primary pci
367389|NCT01379261|Hypothermia|hypothermia
367390|NCT01379261|Endovascular cooling|endovascular cooling
367391|NCT01379261|Cardiac MRI|cardiac mri
367392|NCT01379235|independent 65 years old and above|independent 65 years old and above
367393|NCT01379222|AAA|aaa
367394|NCT01379222|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
367395|NCT01379222|EVAR|evar
367396|NCT01379222|Endovascular aneurysm repair|endovascular aneurysm repair
367397|NCT01379209|AHSCT|ahsct
367398|NCT01379209|Bone Marrow Transplant|bone marrow transplant
367399|NCT01379209|Leukemia|leukemia
367400|NCT01379209|myelodysplastic syndrome|myelodysplastic syndrome
367401|NCT01379209|hematological malignancies|hematological malignancies
367402|NCT01379209|Graft-versus-host-disease|graft-versus-host-disease
367403|NCT01379209|GvHD|gvhd
367404|NCT01379209|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
367405|NCT01379209|Stem Cell|stem cell
367406|NCT01379209|Transplantation|transplantation
367407|NCT01379196|Graves Orbitopathy|graves orbitopathy
367408|NCT01379196|Macrolide antibiotics|macrolide antibiotics
367409|NCT01379196|Inflammation|inflammation
367410|NCT01379196|Clinical Activity Score|clinical activity score
367411|NCT01379183|Healthy|healthy
367412|NCT01379183|Men|men
367413|NCT01379183|Women|women
367414|NCT01379183|No known gastrointestinal disease|no known gastrointestinal disease
367415|NCT01379183|Aged between 18-70 years|aged between 18-70 years
367416|NCT01379170|brown adipose tissue|brown adipose tissue
367417|NCT01379170|mitochondrial dysfunction|mitochondrial dysfunction
367418|NCT01379170|insulin resistance|insulin resistance
367419|NCT01379157|Patients with ventilator-associated pneumonia|patients with ventilator-associated pneumonia
367420|NCT01379131|Manifestation|manifestation
367421|NCT01379131|Coronary Heart Disease|coronary heart disease
367422|NCT01379131|Myocardial infarction|myocardial infarction
367423|NCT01379131|Angina pectoris|angina pectoris
367424|NCT01379131|Unheralded|unheralded
367425|NCT01379131|General Practice Research Database|general practice research database
367426|NCT01379131|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
367427|NCT01379131|CALIBER|caliber
367428|NCT01379118|Total knee replacement|total knee replacement
367429|NCT01379105|Electromyography|electromyography
367430|NCT01379105|Muscle Stretching Exercises|muscle stretching exercises
367431|NCT01379105|Neuromuscular agents|neuromuscular agents
367432|NCT01379105|Sedentary Lifestyle|sedentary lifestyle
367433|NCT01379092|Radiography|radiography
367434|NCT01379092|Breast Specimen Imaging|breast specimen imaging
367435|NCT01379066|Mycobacterium tuberculosis|mycobacterium tuberculosis
367436|NCT01379066|Pulmonary tuberculosis|pulmonary tuberculosis
367437|NCT01379066|Electronic nose|electronic nose
367438|NCT01379066|Gas chromatography|gas chromatography
367439|NCT01379053|Staphylococcus aureus|staphylococcus aureus
367440|NCT01379053|Methicillin-resistant staphylococcus aureus|methicillin-resistant staphylococcus aureus
367441|NCT01379053|Nosocomial disease|nosocomial disease
367442|NCT01379053|Electronic nose|electronic nose
367443|NCT01379053|Gas chromatography|gas chromatography
367444|NCT01379040|Cystic Fibrosis|cystic fibrosis
367445|NCT01379040|Pseudomonas aeruginosa|pseudomonas aeruginosa
367446|NCT01379040|Volatile Organic Compounds|volatile organic compounds
367447|NCT01379040|Electronic nose|electronic nose
367448|NCT01379040|Gas Chromatography|gas chromatography
367449|NCT01379027|Depression|depression
367450|NCT01379027|Website intervention|website intervention
367451|NCT01379027|CBT|cbt
367452|NCT01379014|Decisional conflict|decisional conflict
367453|NCT01379014|Disclosure|disclosure
367454|NCT01379014|Mental Health history|mental health history
367455|NCT01379014|Mental health service users|mental health service users
367456|NCT01379014|Decision Aid Tool|decision aid tool
367457|NCT01379014|Vocational Specialists|vocational specialists
367458|NCT01379001|cholinergic function|cholinergic function
367459|NCT01379001|aging|aging
367460|NCT01379001|pharmacologic MRI|pharmacologic mri
367461|NCT01378949|pain score|pain score
367462|NCT01378936|criminal behavior|criminal behavior
367463|NCT01378936|substance abuse|substance abuse
367464|NCT01378936|HIV risk behavior|hiv risk behavior
367465|NCT01378936|criminogenic thinking|criminogenic thinking
367466|NCT01378936|shame|shame
367467|NCT01378936|guilt|guilt
367468|NCT01378936|empathy|empathy
367469|NCT01378936|jail inmates|jail inmates
367470|NCT01378936|restorative justice|restorative justice
367471|NCT01378936|crime|crime
367472|NCT01378923|Mindfulness|mindfulness
367473|NCT01378923|Values|values
367474|NCT01378923|Jail Inmates|jail inmates
367475|NCT01378923|Impulsivity|impulsivity
367476|NCT01378923|Substance Abuse|substance abuse
367477|NCT01378923|HIV risk behavior|hiv risk behavior
367478|NCT01378923|Anxiety|anxiety
367479|NCT01378923|Depression|depression
367480|NCT01378923|Criminogenic Thinking|criminogenic thinking
367481|NCT01378910|HIV|hiv
367482|NCT01378910|TROPISM|tropism
367483|NCT01378910|PBMC|pbmc
367484|NCT01378910|GENOTYPE|genotype
367485|NCT01378910|454 SEQUENCING|454 sequencing
367486|NCT01378897|bariatric surgery|bariatric surgery
367487|NCT01378897|gastric bypass surgery|gastric bypass surgery
367488|NCT01378884|Gastroparesis|gastroparesis
367489|NCT01378884|Domperidone|domperidone
367490|NCT01378884|Motilium|motilium
367492|NCT01378871|T-Cell|t-cell
367493|NCT01378871|Leukemia|leukemia
367494|NCT01378871|Lymphoma|lymphoma
367495|NCT01378871|Leukemia/Lymphoma|leukemia/lymphoma
367496|NCT01378871|ATL|atl
367497|NCT01378858|Smoking|smoking
367498|NCT01378858|Substance-Related Disorders|substance-related disorders
367499|NCT01378858|medication adherence|medication adherence
367500|NCT01378858|Methadone|methadone
367501|NCT01378845|Morbus Raynaud|morbus raynaud
367502|NCT01378845|Ulcera Hands, Toes|ulcera hands, toes
367503|NCT01378845|Vasospastic disorder|vasospastic disorder
367504|NCT01378845|Raynaud's phenomenon|raynaud's phenomenon
367505|NCT01378832|Intra-abdominal abscess|intra-abdominal abscess
367506|NCT01378832|wound infection|wound infection
367507|NCT01378832|colorectal surgery|colorectal surgery
367508|NCT01378819|laparoscopic cholecystectomy|laparoscopic cholecystectomy
367509|NCT01378819|Postoperative pain|postoperative pain
367510|NCT01378806|overweight|overweight
367511|NCT01378806|obesity|obesity
367512|NCT01378806|adults|adults
367513|NCT01378806|children|children
367514|NCT01378793|Acupressure|acupressure
367515|NCT01378793|Insomnia|insomnia
367516|NCT01378793|Sleep Disorders|sleep disorders
367517|NCT01378780|Stroke|stroke
367518|NCT01378780|hypertension|hypertension
367519|NCT01378780|diet|diet
367520|NCT01378780|sodium|sodium
367521|NCT01378780|physical activity|physical activity
367522|NCT01378767|Dietary restriction|dietary restriction
367523|NCT01378767|oxidative stress|oxidative stress
367524|NCT01378767|fasting|fasting
367525|NCT01378663|Congenital cardiac surgery|congenital cardiac surgery
367526|NCT01378663|Postoperative pain management|postoperative pain management
367527|NCT01378650|Tinnitus|tinnitus
367528|NCT01378650|Medication therapy management|medication therapy management
367529|NCT01378650|Cilostazol|cilostazol
367530|NCT01378650|Antiplatelet agents|antiplatelet agents
367531|NCT01378637|Leg|leg
367532|NCT01378637|Robotic device|robotic device
367533|NCT01378637|AMES|ames
367534|NCT01378637|Stroke|stroke
367535|NCT01378637|Cerebrovascular Accident|cerebrovascular accident
367536|NCT01378637|Rehabilitation|rehabilitation
367537|NCT01378611|intractable childhood epilepsy|intractable childhood epilepsy
367538|NCT01378611|VNS|vns
367539|NCT01378611|immune system|immune system
367540|NCT01378598|erlotinib|erlotinib
367541|NCT01378598|educational intervention|educational intervention
367542|NCT01378598|direct care nurse|direct care nurse
367543|NCT01378585|DLBS1033|dlbs1033
367545|NCT01378585|fibrinolytic|fibrinolytic
367546|NCT01378585|fibrinogenolytic|fibrinogenolytic
367547|NCT01378585|antiplatelet|antiplatelet
367548|NCT01378572|ICD|icd
367549|NCT01378572|sudden cardiac death|sudden cardiac death
367550|NCT01378572|mapping|mapping
367551|NCT01378559|Penis prosthesis|penis prosthesis
367552|NCT01378559|Titan|titan
367553|NCT01378559|Satisfaction|satisfaction
367554|NCT01378559|Complications|complications
367555|NCT01378533|triple-negative breast cancer|triple-negative breast cancer
367556|NCT01378533|dose-dense|dose-dense
752410|NCT01172912|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
367557|NCT01378533|epirubicin and cyclophosphamide followed by paclitaxel（AC-T）|epirubicin and cyclophosphamide followed by paclitaxel（ac-t）
367558|NCT01378533|paclitaxel plus carboplatin（PC）|paclitaxel plus carboplatin（pc）
367559|NCT01378533|3 years DFS|3 years dfs
367560|NCT01378533|the tolerance|the tolerance
367561|NCT01378520|breathlessness|breathlessness
367562|NCT01378520|resistive load breathing|resistive load breathing
367563|NCT01378520|beta-endorphins|beta-endorphins
367564|NCT01378507|endoscopic submucosal dissection|endoscopic submucosal dissection
367565|NCT01378507|gastrointestinal neoplasm|gastrointestinal neoplasm
367566|NCT01378494|osteoporosis|osteoporosis
367567|NCT01378494|bone|bone
367568|NCT01378494|HIV|hiv
367569|NCT01378494|antiretrovirals|antiretrovirals
367570|NCT01378494|inflammation|inflammation
367571|NCT01378455|handwriting|handwriting
367572|NCT01378455|cerebral palsy|cerebral palsy
367573|NCT01378455|visual perception|visual perception
367574|NCT01378455|sensory function|sensory function
367575|NCT01378455|motor function|motor function
367576|NCT01378455|computerized handwriting programs|computerized handwriting programs
367577|NCT01378442|Cerebral palsy|cerebral palsy
367578|NCT01378442|bone density|bone density
367579|NCT01378442|bone strength|bone strength
367580|NCT01378429|Perennial Allergic Rhinitis|perennial allergic rhinitis
367581|NCT01378429|PAR|par
367582|NCT01378416|Acute myelogenous leukemia|acute myelogenous leukemia
367583|NCT01378416|myelodysplastic Syndrome|myelodysplastic syndrome
367584|NCT01378416|cancer|cancer
367585|NCT01378403|Schizophrenia|schizophrenia
367586|NCT01378403|Cognitive deficites|cognitive deficites
367587|NCT01378403|Degraded objects|degraded objects
367588|NCT01378403|Magnocellular pathway|magnocellular pathway
367589|NCT01378390|Complex perianal fistula|complex perianal fistula
367590|NCT01378390|Crohn disease|crohn disease
367591|NCT01378390|Adipose-derived stem cells|adipose-derived stem cells
367592|NCT01378390|Liposuction|liposuction
367593|NCT01378377|MEK inhibitor|mek inhibitor
367594|NCT01378377|Temsirolimus|temsirolimus
367595|NCT01378377|Solid Tumor|solid tumor
367596|NCT01378377|Phase I|phase i
367597|NCT01378377|Pimasertib|pimasertib
367598|NCT01378338|GERD|gerd
367599|NCT01378338|Comparison between ERD and NERD|comparison between erd and nerd
367600|NCT01378338|Rate of complete resolution|rate of complete resolution
367601|NCT01378338|rate of recurrence|rate of recurrence
367602|NCT01378338|QOL|qol
367603|NCT01378338|To investigate the frequency and related risk factors of recurrence, and quality of life in patients with GERD after treatment with PPI|to investigate the frequency and related risk factors of recurrence, and quality of life in patients with gerd after treatment with ppi
367604|NCT01378338|The aim of this study is to investigate the frequency and related risk factors of recurrence, and quality of life in patients with GERD after treatment with PPI|the aim of this study is to investigate the frequency and related risk factors of recurrence, and quality of life in patients with gerd after treatment with ppi
367605|NCT01378325|spinal|spinal
367606|NCT01378325|cesarean delivery|cesarean delivery
367607|NCT01378325|phenylephrine|phenylephrine
367608|NCT01378325|hypotension|hypotension
367609|NCT01378312|vaccine|vaccine
367610|NCT01378312|TB|tb
367611|NCT01378312|tuberculosis|tuberculosis
367612|NCT01378299|testosterone|testosterone
367613|NCT01378273|neuroprotection|neuroprotection
367614|NCT01378273|erythropoietin|erythropoietin
367615|NCT01378273|Epo|epo
367616|NCT01378273|ELGANs|elgans
367617|NCT01378273|preterm|preterm
367618|NCT01378273|neonate|neonate
367619|NCT01378260|Peripheral Arterial Disease|peripheral arterial disease
367620|NCT01378260|Claudication|claudication
367621|NCT01378260|Comparative Effectiveness Research|comparative effectiveness research
367622|NCT01378260|PAD Study|pad study
367623|NCT01378260|PAD|pad
367624|NCT01378260|atherosclerosis|atherosclerosis
367625|NCT01378260|Intermittent claudication|intermittent claudication
367626|NCT01378260|leg pain|leg pain
367627|NCT01378247|Heart Failure|heart failure
367628|NCT01378247|Family Nursing|family nursing
367629|NCT01378247|Health-Related Quality of Life|health-related quality of life
367630|NCT01378247|Heart Failure Clinic|heart failure clinic
367631|NCT01378221|vitamin D|vitamin d
367632|NCT01378221|cardiac surgery|cardiac surgery
367633|NCT01378221|inflammation|inflammation
367634|NCT01378221|immune system|immune system
367635|NCT01378221|age|age
367636|NCT01378208|Intermittent fasting|intermittent fasting
367637|NCT01378208|Meal frequency|meal frequency
367638|NCT01378208|body composition|body composition
367639|NCT01378208|cognitive function|cognitive function
367640|NCT01378208|glucose metabolism|glucose metabolism
367641|NCT01378195|Alzheimer's Disease|alzheimer's disease
367642|NCT01378195|Dementia|dementia
367643|NCT01378195|caregiving|caregiving
367644|NCT01378195|caregiver|caregiver
367645|NCT01378195|coping|coping
367646|NCT01378195|coping with caregiving|coping with caregiving
367647|NCT01378195|stress|stress
367648|NCT01378182|Transplantation,Stem Cell|transplantation,stem cell
367649|NCT01378182|Wilson's Disease|wilson's disease
367650|NCT01378169|SIRS|sirs
367651|NCT01378169|Sepsis|sepsis
367652|NCT01378169|Severe Sepsis|severe sepsis
367653|NCT01378169|Septic Shock|septic shock
367654|NCT01378169|Inflammatory processes|inflammatory processes
367655|NCT01378169|Cytokines|cytokines
367656|NCT01378169|HLA-DR|hla-dr
367657|NCT01378169|HLA type II|hla type ii
367658|NCT01378169|Chemokines|chemokines
367659|NCT01378169|TLR expression|tlr expression
367660|NCT01378169|mRNA expression in whole blood|mrna expression in whole blood
367661|NCT01378169|Bacterial DNA detection|bacterial dna detection
367662|NCT01378169|Prognosis factors|prognosis factors
367663|NCT01378169|Infection|infection
367664|NCT01378169|Diagnosis|diagnosis
367665|NCT01378156|Therapy for HIV Infection|therapy for hiv infection
367666|NCT01378156|Suppressive ART with no failures|suppressive art with no failures
367667|NCT01378156|Treatment interruption|treatment interruption
367668|NCT01378143|Colorectal Cancer|colorectal cancer
367669|NCT01378143|Pentamidine bis(2-hydroxyethanesulfonate)|pentamidine bis(2-hydroxyethanesulfonate)
367670|NCT01378143|OCZ103-OS|ocz103-os
367671|NCT01378143|Standard of Care|standard of care
367672|NCT01378130|CCS|ccs
367673|NCT01378130|CSC|csc
367674|NCT01378130|Subretinal Fluid|subretinal fluid
367675|NCT01378130|multimodal imaging|multimodal imaging
367676|NCT01378117|diabetes|diabetes
367677|NCT01378117|non critical care setting|non critical care setting
367678|NCT01378117|hyperglycemia|hyperglycemia
367679|NCT01378117|treatment|treatment
367680|NCT01378117|oral antidiabetic agents|oral antidiabetic agents
367681|NCT01378117|subcutaneous insulin|subcutaneous insulin
367682|NCT01378104|reducing dose of peginterferon|reducing dose of peginterferon
367683|NCT01378104|chronic hepatitis c|chronic hepatitis c
367684|NCT01378104|Koreans|koreans
367685|NCT01378104|IL28B polymorphism|il28b polymorphism
367686|NCT01378091|Androgen Independent Prostate Cancer|androgen independent prostate cancer
367688|NCT01378078|negative syndrome|negative syndrome
367689|NCT01378078|PANSS|panss
367690|NCT01378065|POP|pop
367691|NCT01378065|pelvic organ prolapse|pelvic organ prolapse
367692|NCT01378065|anterior prolapse|anterior prolapse
367693|NCT01378065|posterior prolapse|posterior prolapse
367694|NCT01378065|vaginal prolapse|vaginal prolapse
367900|NCT01377259|saturation|saturation
367695|NCT01378065|vaginal floor reconstruction|vaginal floor reconstruction
367696|NCT01378039|COPD|copd
367697|NCT01378039|Asthma|asthma
367698|NCT01378039|Pathophysiology|pathophysiology
367699|NCT01378039|Genetics|genetics
367700|NCT01378039|Phenotype|phenotype
367701|NCT01378039|Treatment response|treatment response
367702|NCT01378026|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
367703|NCT01378026|G72|g72
367704|NCT01378026|SNP|snp
367705|NCT01378013|Metabonomics|metabonomics
367706|NCT01378013|Systems biology|systems biology
367707|NCT01378013|Intelligent knife|intelligent knife
367708|NCT01378013|Colorectal cancer|colorectal cancer
367709|NCT01378013|NMR|nmr
367710|NCT01378013|Mass spectrometry|mass spectrometry
367711|NCT01377974|Leishmaniasis|leishmaniasis
367712|NCT01377974|Mucocutaneous Leishmaniasis|mucocutaneous leishmaniasis
367713|NCT01377974|Therapeutics|therapeutics
367714|NCT01377974|meglumine antimoniate|meglumine antimoniate
367715|NCT01377974|miltefosine|miltefosine
367716|NCT01377948|Anger|anger
367717|NCT01377948|Aggression|aggression
367718|NCT01377948|CBT|cbt
367719|NCT01377948|Videogame|videogame
367720|NCT01377948|biofeedback|biofeedback
367721|NCT01377909|chronic hepatitis C, interferon|chronic hepatitis c, interferon
367722|NCT01377883|Needle, Anxiety, Pain, Clowns|needle, anxiety, pain, clowns
367723|NCT01377870|multiple sclerosis mesenchymal stem cell intravenous injection|multiple sclerosis mesenchymal stem cell intravenous injection
367724|NCT01377844|Diabetes mellitus|diabetes mellitus
367725|NCT01377818|COPD|copd
367726|NCT01377818|Exercise trainig|exercise trainig
367727|NCT01377805|Multiple Sclerosis hydrocephalus|multiple sclerosis hydrocephalus
367728|NCT01377792|hypertonic saline|hypertonic saline
367729|NCT01377792|cystic fibrosis|cystic fibrosis
367730|NCT01377792|pulmonary inflammation|pulmonary inflammation
367731|NCT01377792|pulmonary exacerbation|pulmonary exacerbation
367732|NCT01377779|Oxiplex/AP gel|oxiplex/ap gel
367733|NCT01377779|Prevention of Asherman's syndrome|prevention of asherman's syndrome
367734|NCT01377779|Intra uterine adhesions|intra uterine adhesions
367735|NCT01377766|Bell's palsy|bell's palsy
367736|NCT01377766|psychological stress|psychological stress
367737|NCT01377766|personality factors|personality factors
367738|NCT01377766|psychological factors|psychological factors
367739|NCT01377753|Toxicity|toxicity
367740|NCT01377753|Thermal Ablation/Damage|thermal ablation/damage
367741|NCT01377753|Localized Prostate Cancer|localized prostate cancer
367742|NCT01377753|Laser Ablation|laser ablation
367743|NCT01377753|PSA Levels|psa levels
367744|NCT01377753|Prostate Cancer|prostate cancer
367745|NCT01377740|Lipolysis|lipolysis
367746|NCT01377740|Cryolipolysis|cryolipolysis
367747|NCT01377740|Fat Reduction|fat reduction
367748|NCT01377701|pituitary adenomas|pituitary adenomas
367749|NCT01377701|recovery of vision|recovery of vision
367750|NCT01377701|trans-sphenoidal surgery|trans-sphenoidal surgery
367751|NCT01377688|DKD|dkd
367752|NCT01377636|Isoproterenol|isoproterenol
367753|NCT01377636|Bispectral index (BIS)|bispectral index (bis)
367754|NCT01377636|electrophysiology studies (EPS)|electrophysiology studies (eps)
367755|NCT01377623|Spinal fusion|spinal fusion
367756|NCT01377623|Inflammatory response|inflammatory response
367757|NCT01377623|Inflammatory markers|inflammatory markers
367758|NCT01377623|Dexmedetomidine|dexmedetomidine
367759|NCT01377610|Outpatient detoxification|outpatient detoxification
367760|NCT01377610|Opioid dependence|opioid dependence
367761|NCT01377610|Naltrexone|naltrexone
367762|NCT01377610|Vivitrol|vivitrol
367763|NCT01377610|Buprenorphine|buprenorphine
367764|NCT01377597|retinal vein occlusion|retinal vein occlusion
367765|NCT01377597|branch retinal vein occlusion|branch retinal vein occlusion
367766|NCT01377597|central retinal vein occlusion|central retinal vein occlusion
367767|NCT01377597|visual impairment|visual impairment
367768|NCT01377597|macular edema|macular edema
367769|NCT01377597|ranibizumab|ranibizumab
367770|NCT01377584|Continuous Positive Airway Pressure|continuous positive airway pressure
367771|NCT01377584|Patient Compliance|patient compliance
367772|NCT01377584|Intervention Studies|intervention studies
367773|NCT01377584|Spouses|spouses
367774|NCT01377571|diarrhea|diarrhea
367775|NCT01377571|fever|fever
367776|NCT01377571|nausea|nausea
367777|NCT01377571|vomit|vomit
367778|NCT01377571|irritability|irritability
367779|NCT01377558|aerobic training|aerobic training
367780|NCT01377558|resistance training|resistance training
367781|NCT01377558|combination of aerobic and resistance training|combination of aerobic and resistance training
367782|NCT01377558|diabetes|diabetes
367783|NCT01377558|type 2 diabetes|type 2 diabetes
367784|NCT01377558|HbA1c|hba1c
367785|NCT01377558|endothelial dysfunction|endothelial dysfunction
367786|NCT01377558|inflammation markers|inflammation markers
367787|NCT01377558|Parodontitis|parodontitis
367788|NCT01377558|Exercise intervention|exercise intervention
367790|NCT01377545|Infraclavicular|infraclavicular
367791|NCT01377545|Nerve Block|nerve block
367792|NCT01377545|Needle|needle
367793|NCT01377545|Perineural Catheter|perineural catheter
367794|NCT01377545|Volunteer|volunteer
367901|NCT01377259|between|between
367795|NCT01377545|Upper Extremity Nerve Block|upper extremity nerve block
367796|NCT01377545|Sensation|sensation
367797|NCT01377545|Strength|strength
367798|NCT01377532|Pheochromocytoma|pheochromocytoma
367799|NCT01377532|Paraganglioma|paraganglioma
367800|NCT01377532|MIBG|mibg
367801|NCT01377532|131I-MIBG|131i-mibg
367802|NCT01377532|Resistant|resistant
367803|NCT01377532|Relapsed|relapsed
367804|NCT01377532|Treatment|treatment
367805|NCT01377532|UCSF|ucsf
367806|NCT01377532|Pediatric|pediatric
367807|NCT01377532|Adult|adult
367808|NCT01377532|Oncology|oncology
367809|NCT01377519|Fibroids|fibroids
367810|NCT01377519|Uterine|uterine
367811|NCT01377519|Focused Ultrasound|focused ultrasound
367812|NCT01377519|Magnetic Resonance focused ultrasound|magnetic resonance focused ultrasound
367813|NCT01377519|HIFU|hifu
367814|NCT01377519|NOninvasive|noninvasive
367815|NCT01377519|Treatment|treatment
367816|NCT01377506|behavioral weight control|behavioral weight control
367817|NCT01377506|lifestyle intervention|lifestyle intervention
367818|NCT01377506|memory training|memory training
367819|NCT01377506|cognitive training|cognitive training
367820|NCT01377506|community-based|community-based
367821|NCT01377493|chewing-gum|chewing-gum
367822|NCT01377493|enamel subsurface lesion|enamel subsurface lesion
367823|NCT01377493|calcium additives|calcium additives
367824|NCT01377493|fluoride|fluoride
367825|NCT01377493|in situ|in situ
367826|NCT01377467|Osteoporosis|osteoporosis
367827|NCT01377467|Osteopenia|osteopenia
367828|NCT01377467|Denosumab|denosumab
367829|NCT01377467|Transplantation|transplantation
367830|NCT01377467|Kidney|kidney
367831|NCT01377454|mTBI|mtbi
367832|NCT01377454|concussion|concussion
367833|NCT01377454|mild Traumatic Brain Injury|mild traumatic brain injury
367834|NCT01377454|balance|balance
367835|NCT01377454|sensors|sensors
367836|NCT01377441|Ibuprofen|ibuprofen
367837|NCT01377441|Cytokines|cytokines
367838|NCT01377441|Recovery|recovery
367839|NCT01377441|IV ibuprofen|iv ibuprofen
367840|NCT01377441|major surgery|major surgery
367841|NCT01377428|COPD|copd
367842|NCT01377428|Indacaterol|indacaterol
367843|NCT01377428|Formoterol|formoterol
367844|NCT01377415|arthroscopy|arthroscopy
367845|NCT01377415|shoulder surgery|shoulder surgery
367846|NCT01377415|subacromial|subacromial
367847|NCT01377415|continuous bupivacaine|continuous bupivacaine
367848|NCT01377389|Prostate cancer|prostate cancer
367849|NCT01377389|Castrate sensitive prostate carcinoma|castrate sensitive prostate carcinoma
367850|NCT01377389|Metastatic prostate carcinoma|metastatic prostate carcinoma
367851|NCT01377389|Androgen deprivation therapy|androgen deprivation therapy
367852|NCT01377389|ADT|adt
367853|NCT01377389|Prostate-specific antigen|prostate-specific antigen
367854|NCT01377389|PSA|psa
367855|NCT01377389|Ipilimumab|ipilimumab
367856|NCT01377389|Yervoy|yervoy
367857|NCT01377389|BMS-734016|bms-734016
358519|NCT01416298|NGAL|ngal
367858|NCT01377389|MDX010|mdx010
367859|NCT01377389|Leuprolide|leuprolide
367860|NCT01377389|Lupron Depot|lupron depot
367861|NCT01377389|Leuprolide Acetate|leuprolide acetate
367862|NCT01377389|Goserelin|goserelin
367863|NCT01377389|Zoladex|zoladex
367864|NCT01377389|Degarelix|degarelix
367865|NCT01377389|Firmagon|firmagon
367866|NCT01377363|metastatic breast cancer|metastatic breast cancer
367867|NCT01377363|primary breast cancer|primary breast cancer
367868|NCT01377350|Heart failure|heart failure
367869|NCT01377350|monitoring|monitoring
367870|NCT01377337|cardiac arrest|cardiac arrest
367871|NCT01377337|cardiopulmonary resuscitation|cardiopulmonary resuscitation
367872|NCT01377337|(sodium) bicarbonate|(sodium) bicarbonate
367873|NCT01377337|return of spontaneous circulation|return of spontaneous circulation
367874|NCT01377337|outcome|outcome
367875|NCT01377324|Breast cancer|breast cancer
367876|NCT01377324|Fulvestrant|fulvestrant
367877|NCT01377324|FES|fes
367878|NCT01377324|PET|pet
367879|NCT01377324|Positron|positron
367880|NCT01377324|Emission|emission
367881|NCT01377324|Tomography|tomography
367882|NCT01377324|Fluoroestradiol|fluoroestradiol
367883|NCT01377324|FES-PET|fes-pet
367884|NCT01377324|Molecular Imaging|molecular imaging
367885|NCT01377324|Estrogen Receptor|estrogen receptor
367886|NCT01377311|limbal stem cell|limbal stem cell
367887|NCT01377311|amniotic membrane|amniotic membrane
367888|NCT01377311|ex vivo expansion of autologous limbal stem cell|ex vivo expansion of autologous limbal stem cell
367889|NCT01377311|unilateral limbal stem cell insufficiency|unilateral limbal stem cell insufficiency
367890|NCT01377285|chronic kidney disease|chronic kidney disease
367891|NCT01377285|pentoxifylline|pentoxifylline
367892|NCT01377285|angiotensin receptor blockers(ARB)|angiotensin receptor blockers(arb)
367893|NCT01377272|HIV/AIDS|hiv/aids
367894|NCT01377272|spatial epidemiology|spatial epidemiology
367895|NCT01377272|geographic information system|geographic information system
367896|NCT01377272|HIV-infection/Aids|hiv-infection/aids
367897|NCT01377259|changes|changes
367898|NCT01377259|tissue|tissue
367899|NCT01377259|oxygenation|oxygenation
367902|NCT01377259|upper|upper
367903|NCT01377259|lower|lower
367904|NCT01377259|extremities|extremities
367905|NCT01377259|patients|patients
367906|NCT01377259|Adverse Effect|adverse effect
367907|NCT01377259|Spinal and Epidural|spinal and epidural
367908|NCT01377246|Somatostatin.|somatostatin.
367909|NCT01377246|Polycystic kidney disease.|polycystic kidney disease.
367910|NCT01377246|Renal insufficiency.|renal insufficiency.
367911|NCT01377233|Schizophrenia|schizophrenia
367912|NCT01377233|Antipsychotic|antipsychotic
367913|NCT01377233|Zicronapine|zicronapine
367914|NCT01377233|Lu 31-310|lu 31-310
367915|NCT01377220|Hepatocellular carcinoma|hepatocellular carcinoma
367916|NCT01377220|Positron Emission Tomography/computed tomography (PET-CT)|positron emission tomography/computed tomography (pet-ct)
367917|NCT01377220|11C-Choline|11c-choline
367918|NCT01377220|alpha fetoprotein|alpha fetoprotein
367919|NCT01377220|Dynamic magnetic resonance imaging|dynamic magnetic resonance imaging
367920|NCT01377220|Abdomen computed tomography|abdomen computed tomography
367921|NCT01377220|Tumoral liver biopsy|tumoral liver biopsy
367922|NCT01377207|ST segment Elevation Myocardial Infarction|st segment elevation myocardial infarction
367923|NCT01377207|Optical Coherence Tomography|optical coherence tomography
367924|NCT01377207|Percutaneous Coronary Intervention|percutaneous coronary intervention
367925|NCT01377207|Thrombus hystopathology|thrombus hystopathology
367926|NCT01377207|Gender differences|gender differences
367927|NCT01377194|Depression|depression
367928|NCT01377194|Major Depressive Disorder|major depressive disorder
367929|NCT01377181|Inguinal hernia|inguinal hernia
367930|NCT01377181|Laparoscope|laparoscope
367931|NCT01377181|Lateral us ligament|lateral us ligament
367932|NCT01377181|Recurrence|recurrence
367933|NCT01377181|Pediatric|pediatric
367934|NCT01377181|unilateral inguinal hernia|unilateral inguinal hernia
367935|NCT01377155|basal insulin|basal insulin
367936|NCT01377155|hypoglycemia|hypoglycemia
367937|NCT01377155|diabetes mellitus type two|diabetes mellitus type two
367938|NCT01377142|Uterovaginal prolapse|uterovaginal prolapse
367939|NCT01377142|hysteropexy|hysteropexy
367940|NCT01377142|mesh|mesh
735557|NCT01105052|Self-help|self-help
367941|NCT01377129|Residual Rotational Laxity|residual rotational laxity
367942|NCT01377103|heart failure|heart failure
367943|NCT01377103|hypogonadism|hypogonadism
367944|NCT01377103|testosterone|testosterone
367945|NCT01377077|vitiligo|vitiligo
367946|NCT01377077|piebaldism|piebaldism
367947|NCT01377077|punchgrafting|punchgrafting
367948|NCT01377077|minigrafting|minigrafting
367949|NCT01377077|stable for at least 12 months|stable for at least 12 months
367950|NCT01377064|HIV|hiv
367951|NCT01377064|physical activity|physical activity
367952|NCT01377064|cardiovascular disease risk|cardiovascular disease risk
367953|NCT01377051|COPD|copd
367954|NCT01377051|Inspiratory capacity|inspiratory capacity
358628|NCT01415869|VAD|vad
367955|NCT01377051|Residual volume|residual volume
367956|NCT01377051|Total lung resistance|total lung resistance
367957|NCT01377051|Arterial Oxygen|arterial oxygen
367958|NCT01377038|Osteoarthritis|osteoarthritis
367959|NCT01377038|Chronic pain|chronic pain
367960|NCT01377038|Central pain|central pain
367961|NCT01377012|Rheumatoid Arthritis|rheumatoid arthritis
367962|NCT01377012|RA|ra
367963|NCT01377012|ACR|acr
367964|NCT01377012|inflammatory joints|inflammatory joints
367965|NCT01376999|Sterility|sterility
367966|NCT01376999|FSH-r|fsh-r
367967|NCT01376999|intrauterine insemination|intrauterine insemination
367968|NCT01376999|unexplained sterility|unexplained sterility
367969|NCT01376973|stress, temporomandibular disorders.|stress, temporomandibular disorders.
367970|NCT01376960|forefoot surgery|forefoot surgery
367971|NCT01376960|Ankle Block|ankle block
367972|NCT01376960|Popliteal Fossa Block|popliteal fossa block
367973|NCT01376947|IUD device insertion|iud device insertion
367974|NCT01376947|Nulliparous|nulliparous
367975|NCT01376947|Multiparous|multiparous
367976|NCT01376947|Pain|pain
367977|NCT01376934|hysteroscopy|hysteroscopy
367978|NCT01376934|saline solution|saline solution
367979|NCT01376934|carbon dioxide|carbon dioxide
367980|NCT01376934|compare two techniques in office hysteroscopy co2 and saline solution|compare two techniques in office hysteroscopy co2 and saline solution
367981|NCT01376921|Growth disorders|growth disorders
367982|NCT01376921|Saizen|saizen
367983|NCT01376921|Easypod|easypod
367984|NCT01376921|Growth hormone|growth hormone
367985|NCT01376921|Pediatric subject|pediatric subject
367986|NCT01376908|Phenylketonuria (PKU)|phenylketonuria (pku)
367987|NCT01376908|Kuvan® (Sapropterin)|kuvan® (sapropterin)
367988|NCT01376908|Phe-restricted diet|phe-restricted diet
367989|NCT01376908|Paediatric <4 years old|paediatric <4 years old
367990|NCT01376908|responders to BH4|responders to bh4
367991|NCT01376908|Phe tolerance|phe tolerance
367993|NCT01376895|HIV|hiv
367994|NCT01376882|Caffeine|caffeine
367995|NCT01376882|Withdrawal|withdrawal
367996|NCT01376882|Cognitive function|cognitive function
367997|NCT01376882|Mood|mood
367998|NCT01376882|Cerebral haemodynamics|cerebral haemodynamics
367999|NCT01376869|Hops|hops
368000|NCT01376869|Mood|mood
368001|NCT01376869|Cognitive Function|cognitive function
368002|NCT01376869|Bioavailability|bioavailability
368003|NCT01376869|Satiety|satiety
368004|NCT01376869|Blood Pressure|blood pressure
368005|NCT01376869|Heart rate|heart rate
368006|NCT01376856|mediastinal lymph node with false positive FDG PET/CT results in lung cancer staging|mediastinal lymph node with false positive fdg pet/ct results in lung cancer staging
368007|NCT01376843|latent tuberculosis in health care workers|latent tuberculosis in health care workers
368008|NCT01376830|COPD|copd
368009|NCT01376830|Exacerbations|exacerbations
368010|NCT01376830|Viruses|viruses
368011|NCT01376817|Severe acute pancreatitis|severe acute pancreatitis
368012|NCT01376817|total parenteral nutrition|total parenteral nutrition
368013|NCT01376817|fat emulsions|fat emulsions
368014|NCT01376817|omega 3 fatty acids|omega 3 fatty acids
368015|NCT01376791|Periodontal disease|periodontal disease
368016|NCT01376791|Atherosclerosis|atherosclerosis
368017|NCT01376791|Oral Pathogens|oral pathogens
368018|NCT01376791|Native Americans|native americans
368019|NCT01376791|Inflammatory cytokines|inflammatory cytokines
368020|NCT01376791|Microbial metagenomics|microbial metagenomics
368021|NCT01376778|Perinatology|perinatology
368022|NCT01376778|Cytomegalovirus immune globulin|cytomegalovirus immune globulin
368023|NCT01376778|Cytogam|cytogam
368024|NCT01376778|CMVIG infusions|cmvig infusions
368025|NCT01376765|SARS, coronavirus, vaccine, adjuvant, Alhydrogel®, severe acute respiratory syndrome|sars, coronavirus, vaccine, adjuvant, alhydrogel®, severe acute respiratory syndrome
368026|NCT01376739|Magnevist|magnevist
368027|NCT01376739|MR angiography|mr angiography
368028|NCT01376713|Melanoma|melanoma
368029|NCT01376687|Osteopathic Medicine|osteopathic medicine
368030|NCT01376687|Cervical Spine|cervical spine
368031|NCT01376687|Kinetics|kinetics
368032|NCT01376674|localised|localised
368033|NCT01376674|prostate cancer|prostate cancer
368034|NCT01376674|radiotherapy|radiotherapy
368035|NCT01376674|immunology|immunology
368036|NCT01376661|Prostate Cancer|prostate cancer
368037|NCT01376661|Active Surveillance|active surveillance
735743|NCT01105819|Probiotics|probiotics
368038|NCT01376661|Low risk prostate cancer|low risk prostate cancer
368039|NCT01376635|Chronic Kidney Disease|chronic kidney disease
368040|NCT01376635|Autonomic Dysfunction|autonomic dysfunction
368041|NCT01376609|Stroke|stroke
368042|NCT01376609|Ischaemic Stroke|ischaemic stroke
368043|NCT01376609|Cerebral Infarction|cerebral infarction
368348|NCT01375374|Lacosamide|lacosamide
368044|NCT01376609|Cerebrovascular Disorders|cerebrovascular disorders
368045|NCT01376609|Brain Diseases|brain diseases
368046|NCT01376609|Nervous System Diseases|nervous system diseases
368047|NCT01376609|Vascular Diseases|vascular diseases
368048|NCT01376609|Brain Infarction|brain infarction
368049|NCT01376609|Brain Ischemia|brain ischemia
368050|NCT01376609|mismatch|mismatch
368051|NCT01376609|PWI/DWI mismatch|pwi/dwi mismatch
368052|NCT01376609|ischaemic penumbra|ischaemic penumbra
368053|NCT01376609|image analysis|image analysis
368054|NCT01376596|Remission|remission
368055|NCT01376596|Psychosocial Functioning|psychosocial functioning
368056|NCT01376596|Symptoms reduction|symptoms reduction
368057|NCT01376583|Breast cancer|breast cancer
368058|NCT01376583|Exercise|exercise
368059|NCT01376583|Myokines|myokines
368060|NCT01376583|AMPK|ampk
368061|NCT01376570|HIV|hiv
368062|NCT01376570|Opiate dependence|opiate dependence
368063|NCT01376570|Opiate replacement therapy|opiate replacement therapy
368064|NCT01376570|Cocaine-related disorders|cocaine-related disorders
368065|NCT01376570|Risk Reduction Behavior|risk reduction behavior
368066|NCT01376570|Medication Adherence|medication adherence
368067|NCT01376570|Motivation|motivation
368068|NCT01376557|diabetes mellitus|diabetes mellitus
368069|NCT01376544|Neonate|neonate
368070|NCT01376544|Weaning|weaning
368071|NCT01376544|Assist control ventilation|assist control ventilation
368072|NCT01376544|Pressure support ventilation|pressure support ventilation
368073|NCT01376531|acute renal failure|acute renal failure
368074|NCT01376531|cerebrovascular autoregulation|cerebrovascular autoregulation
368075|NCT01376531|transcranial Doppler|transcranial doppler
368076|NCT01376531|continuous veno-venous hemodialysis|continuous veno-venous hemodialysis
368077|NCT01376518|acute respiratory distress syndrome|acute respiratory distress syndrome
368078|NCT01376518|acute lung injury|acute lung injury
368079|NCT01376518|cerebrovascular autoregulation|cerebrovascular autoregulation
368080|NCT01376518|transcranial Doppler|transcranial doppler
368081|NCT01376518|ventilation|ventilation
368082|NCT01376505|Vaccine Therapy|vaccine therapy
368083|NCT01376492|Schizophrenia|schizophrenia
368084|NCT01376492|Sleep disturbances|sleep disturbances
368085|NCT01376492|Quality of sleep|quality of sleep
368086|NCT01376492|Functioning level|functioning level
368087|NCT01376492|Antipsychotic therapy.|antipsychotic therapy.
368088|NCT01376479|HFMD|hfmd
368089|NCT01376479|EV71|ev71
368090|NCT01376479|Enterovirus|enterovirus
368091|NCT01376479|INV21|inv21
368092|NCT01376479|Encephalitis|encephalitis
368093|NCT01376466|acute appendicitis|acute appendicitis
368094|NCT01376466|diagnosis|diagnosis
368095|NCT01376466|computed tomography|computed tomography
368096|NCT01376453|External Radiation Therapy|external radiation therapy
368097|NCT01376453|Locally Advanced Rectal|locally advanced rectal
368098|NCT01376453|Adenocarcinoma|adenocarcinoma
368099|NCT01376440|three or more loss stools in 24 hours|three or more loss stools in 24 hours
368100|NCT01376414|dyspepsia|dyspepsia
368101|NCT01376414|abdominal|abdominal
368102|NCT01376414|pain|pain
368103|NCT01376414|helicobacter|helicobacter
368104|NCT01376414|pylori|pylori
368105|NCT01376414|[C06.405.748.398]|[c06.405.748.398]
368106|NCT01376414|[C06.405.748.586]|[c06.405.748.586]
368107|NCT01376414|[C06.405.748.586.698]|[c06.405.748.586.698]
368108|NCT01376414|[C06.405.748.586.849]|[c06.405.748.586.849]
368109|NCT01376388|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
368110|NCT01376388|Pharmacogenetics|pharmacogenetics
368111|NCT01376388|GSK573719/GW642444|gsk573719/gw642444
368112|NCT01376375|Acupuncture|acupuncture
368113|NCT01376375|Low Back Pain|low back pain
368114|NCT01376362|Cystoid Macular Edema|cystoid macular edema
368115|NCT01376362|Intermediate Uveitis|intermediate uveitis
368116|NCT01376362|Uveitis|uveitis
368117|NCT01376362|OCT|oct
368118|NCT01376362|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
368119|NCT01376349|depression|depression
368120|NCT01376349|anxiety disorder|anxiety disorder
368121|NCT01376349|cognitive/functional effects|cognitive/functional effects
368122|NCT01376349|sexual dysfunction|sexual dysfunction
368123|NCT01376349|cancer survivor|cancer survivor
368124|NCT01376349|breast cancer|breast cancer
368125|NCT01376349|cervical cancer|cervical cancer
368126|NCT01376349|fallopian tube cancer|fallopian tube cancer
368127|NCT01376349|uterine sarcoma|uterine sarcoma
368128|NCT01376349|vaginal cancer|vaginal cancer
368129|NCT01376349|vulvar cancer|vulvar cancer
368130|NCT01376349|ovarian epithelial cancer|ovarian epithelial cancer
368131|NCT01376349|ovarian germ cell tumor|ovarian germ cell tumor
368132|NCT01376349|ovarian sarcoma|ovarian sarcoma
368133|NCT01376349|ovarian stromal cancer|ovarian stromal cancer
368134|NCT01376349|primary peritoneal cavity cancer|primary peritoneal cavity cancer
368135|NCT01376349|endometrial cancer|endometrial cancer
368136|NCT01376336|environmental health|environmental health
368137|NCT01376336|diarrhea|diarrhea
368138|NCT01376336|water|water
368139|NCT01376336|HIV|hiv
368140|NCT01376323|Safety|safety
368141|NCT01376323|Dose Ranging|dose ranging
368142|NCT01376323|Efficacy|efficacy
368143|NCT01376258|benign prostatic hyperplasia|benign prostatic hyperplasia
368144|NCT01376258|acute urinary retention|acute urinary retention
368145|NCT01376258|adherence|adherence
368146|NCT01376258|5-alpha reductase inhibitor|5-alpha reductase inhibitor
368147|NCT01376258|enlarged prostate|enlarged prostate
368148|NCT01376258|surgery|surgery
368149|NCT01376232|Anaemia|anaemia
358807|NCT01415258|cancer|cancer
368150|NCT01376232|Drug- Drug Interaction|drug- drug interaction
368151|NCT01376219|GINA|gina
368152|NCT01376219|direct / indirect costs|direct / indirect costs
368153|NCT01376219|exacerbations|exacerbations
368154|NCT01376219|European|european
368155|NCT01376219|asthma control|asthma control
368156|NCT01376219|Asthma Control Test (TM - QualityMetric Incorporated)|asthma control test (tm - qualitymetric incorporated)
368157|NCT01376102|osteoporosis|osteoporosis
368158|NCT01376102|ibandronate|ibandronate
368159|NCT01376089|Safety|safety
368160|NCT01376076|schizophrenia|schizophrenia
368162|NCT01376076|cardiac repolarization|cardiac repolarization
368163|NCT01376050|venous stasis ulcer|venous stasis ulcer
368164|NCT01376050|leg ulcer|leg ulcer
368165|NCT01376037|upper arm|upper arm
368166|NCT01376037|body contouring|body contouring
368167|NCT01376037|body shaping|body shaping
368168|NCT01376024|Carpometacarpal arthritis|carpometacarpal arthritis
368169|NCT01376024|Basal joint arthritis|basal joint arthritis
368170|NCT01376024|CMC arthritis|cmc arthritis
368171|NCT01376024|Osteoarthritis|osteoarthritis
368172|NCT01376011|quercetin|quercetin
368173|NCT01376011|brain blood flow|brain blood flow
368174|NCT01376011|aging|aging
368175|NCT01376011|memory|memory
368176|NCT01375998|YAZ|yaz
368177|NCT01375998|Dysmenorrhea|dysmenorrhea
368178|NCT01375972|biliary cancer|biliary cancer
368179|NCT01375972|systemic chemotherapy|systemic chemotherapy
368180|NCT01375972|S-1|s-1
368181|NCT01375972|gemcitabine|gemcitabine
368182|NCT01375972|cisplatin|cisplatin
368183|NCT01375959|resveratrol|resveratrol
368184|NCT01375959|glucose intolerance|glucose intolerance
368185|NCT01375959|insulin resistance|insulin resistance
368186|NCT01375959|endothelial function|endothelial function
6531|NCT03249350|Substance Use Disorders|substance use disorders
368187|NCT01375946|Pharmacokinetic Profile (PK) and Safety|pharmacokinetic profile (pk) and safety
368188|NCT01375946|PK analysis of EE and LNG|pk analysis of ee and lng
368189|NCT01375933|Smoking|smoking
368190|NCT01375933|NicVAX|nicvax
368191|NCT01375933|Smoking vaccine|smoking vaccine
368192|NCT01375920|Depression|depression
368193|NCT01375920|Antiglucocorticoid|antiglucocorticoid
368194|NCT01375920|Anti-depressants|anti-depressants
368195|NCT01375907|blood cell counts|blood cell counts
368196|NCT01375907|BUN|bun
368197|NCT01375907|ALT|alt
368198|NCT01375907|AST|ast
368199|NCT01375907|diarrhea|diarrhea
368200|NCT01375907|fever|fever
368201|NCT01375907|vomit|vomit
368202|NCT01375907|nausea|nausea
368203|NCT01375907|loss of appetite|loss of appetite
368204|NCT01375907|irritability|irritability
368205|NCT01375881|HIV|hiv
368206|NCT01375881|darunavir|darunavir
368207|NCT01375881|ritonavir|ritonavir
368208|NCT01375881|Prezista|prezista
368209|NCT01375881|naive|naive
368210|NCT01375881|experienced|experienced
368211|NCT01375868|HPV|hpv
368212|NCT01375868|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
368213|NCT01375868|antibodies|antibodies
368214|NCT01375855|Late stent malapposition|late stent malapposition
368215|NCT01375855|stent thrombosis|stent thrombosis
368216|NCT01375855|IVUS|ivus
368217|NCT01375855|non-polimeric stent|non-polimeric stent
368218|NCT01375816|adenocarcinoma of the colon|adenocarcinoma of the colon
368219|NCT01375816|recurrent colon cancer|recurrent colon cancer
368220|NCT01375816|stage IV colon cancer|stage iv colon cancer
368221|NCT01375816|adenocarcinoma of the rectum|adenocarcinoma of the rectum
368222|NCT01375816|recurrent rectal cancer|recurrent rectal cancer
368223|NCT01375816|stage IV rectal cancer|stage iv rectal cancer
368224|NCT01375803|dietary fiber|dietary fiber
368225|NCT01375803|fiber|fiber
368226|NCT01375803|insulin sensitivity|insulin sensitivity
368227|NCT01375803|insulin resistance|insulin resistance
368228|NCT01375803|glucose metabolism|glucose metabolism
368229|NCT01375790|whole-body vibration|whole-body vibration
368230|NCT01375790|older people|older people
368231|NCT01375790|exercise|exercise
368232|NCT01375790|body balance|body balance
368233|NCT01375790|muscle performance|muscle performance
368234|NCT01375790|falls|falls
368235|NCT01375790|physiotherapy|physiotherapy
368236|NCT01375777|High cholesterol|high cholesterol
368237|NCT01375777|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
368238|NCT01375777|Treatment for high cholesterol|treatment for high cholesterol
368239|NCT01375777|Lowering cholesterol|lowering cholesterol
368240|NCT01375777|Lowering high cholesterol|lowering high cholesterol
368241|NCT01375777|Hypercholesterolemia|hypercholesterolemia
368242|NCT01375764|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
368243|NCT01375764|Cholesterol|cholesterol
368244|NCT01375764|High Cholesterol|high cholesterol
368245|NCT01375764|Raised Cholesterol|raised cholesterol
368246|NCT01375764|Elevated Cholesterol|elevated cholesterol
368247|NCT01375764|Statin intolerant|statin intolerant
368248|NCT01375764|Hypercholesterolemia|hypercholesterolemia
368249|NCT01375751|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
368250|NCT01375751|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
368251|NCT01375738|Early gastric cancer|early gastric cancer
368252|NCT01375712|Hard or lumpy stools|hard or lumpy stools
368253|NCT01375712|Stool consistency|stool consistency
368254|NCT01375712|Stool frequency|stool frequency
368255|NCT01375712|Constipation related symptoms|constipation related symptoms
368256|NCT01375712|Constipation related quality of life|constipation related quality of life
368257|NCT01375699|Breast cancer|breast cancer
368258|NCT01375699|Gastrointestinal cancer|gastrointestinal cancer
368259|NCT01375699|Genitourinary cancer|genitourinary cancer
368260|NCT01375699|Sarcoma|sarcoma
368261|NCT01375699|Gynecologic cancer|gynecologic cancer
368262|NCT01375686|Diabetes|diabetes
368263|NCT01375673|Exercise|exercise
368264|NCT01375673|Heart Failure|heart failure
368265|NCT01375673|Mixed Effects Modeling|mixed effects modeling
368266|NCT01375660|Vitamin D|vitamin d
368267|NCT01375660|Glucose intolerance|glucose intolerance
368268|NCT01375660|African American men|african american men
368269|NCT01375647|Oral Vaccines|oral vaccines
368270|NCT01375647|Vaccine Responsiveness|vaccine responsiveness
368271|NCT01375647|Tropical Enteropathy|tropical enteropathy
368272|NCT01375634|Intubation|intubation
368273|NCT01375634|Gastrointestinal|gastrointestinal
368274|NCT01375621|Farming|farming
368275|NCT01375621|Antibiotic Resistant|antibiotic resistant
368276|NCT01375621|Bacteria|bacteria
368277|NCT01375608|Neutropenia|neutropenia
368278|NCT01375608|Hemaglobin|hemaglobin
368279|NCT01375608|Coagulation Disorders|coagulation disorders
368280|NCT01375608|Thrombocytosis|thrombocytosis
368281|NCT01375608|Red Blood Cells|red blood cells
368282|NCT01375608|Sickle Cell Disease|sickle cell disease
368283|NCT01375595|Working Memory|working memory
368284|NCT01375595|Repetitive TMS (rTMS)|repetitive tms (rtms)
368285|NCT01375595|Language|language
368286|NCT01375595|Healthy Volunteer|healthy volunteer
368287|NCT01375595|HV|hv
368288|NCT01375582|Dry Eye|dry eye
368289|NCT01375582|tear film|tear film
368290|NCT01375582|lipid|lipid
368291|NCT01375582|tear volume|tear volume
368292|NCT01375582|environmental chamber|environmental chamber
368293|NCT01375582|thermal imaging|thermal imaging
368294|NCT01375569|CD105|cd105
368295|NCT01375569|Monoclonal Antibody|monoclonal antibody
368296|NCT01375569|Anti-Angiogenic|anti-angiogenic
368297|NCT01375569|Chimeric|chimeric
368298|NCT01375569|Apoptosis|apoptosis
368299|NCT01375569|Liver Cancer|liver cancer
368300|NCT01375556|Alcohol Clamp|alcohol clamp
368301|NCT01375556|Pharmacogenetics|pharmacogenetics
368302|NCT01375556|Family History of Alcoholism|family history of alcoholism
368303|NCT01375556|Pharmacodynamics|pharmacodynamics
368304|NCT01375556|Healthy Volunteer|healthy volunteer
368305|NCT01375556|HV|hv
368306|NCT01375543|Gene Identification|gene identification
368307|NCT01375543|Genetics|genetics
368308|NCT01375543|Genetic Disorders|genetic disorders
368309|NCT01375530|Prevention|prevention
368310|NCT01375530|Vaccine|vaccine
368311|NCT01375530|Immunity|immunity
368312|NCT01375530|Evaluate|evaluate
368313|NCT01375530|Screen|screen
368314|NCT01375530|Healthy Volunteer|healthy volunteer
368315|NCT01375530|HV|hv
368316|NCT01375504|Obesity|obesity
368317|NCT01375504|Body Mass Index|body mass index
368318|NCT01375504|Mindfulness Training|mindfulness training
368319|NCT01375504|Attention and Interpretation Therapy|attention and interpretation therapy
368320|NCT01375491|doxycycline|doxycycline
368321|NCT01375491|insulin resistance|insulin resistance
368322|NCT01375491|obesity|obesity
368323|NCT01375491|inflammation|inflammation
368324|NCT01375439|Pregnancy|pregnancy
368325|NCT01375439|vulvovaginitis|vulvovaginitis
368326|NCT01375439|uterine cervicitis|uterine cervicitis
368327|NCT01375439|pregnancy outcome|pregnancy outcome
368328|NCT01375426|Non-severe pneumonia|non-severe pneumonia
368329|NCT01375426|Treatment failure|treatment failure
368330|NCT01375426|Double dose amoxicillin|double dose amoxicillin
368331|NCT01375426|Children|children
368332|NCT01375413|Parkinson's disease|parkinson's disease
368333|NCT01375413|Gait|gait
368334|NCT01375413|Rehabilitation|rehabilitation
368335|NCT01375413|Cognition|cognition
368336|NCT01375413|Freezing of gait|freezing of gait
368337|NCT01375400|aspirin|aspirin
368338|NCT01375400|platelet|platelet
368339|NCT01375387|Vimpat|vimpat
368340|NCT01375387|Pharmacokinetics|pharmacokinetics
368341|NCT01375387|Healthy Japanese male|healthy japanese male
368342|NCT01375387|Healthy Chinese male|healthy chinese male
368343|NCT01375374|Vimpat|vimpat
368344|NCT01375374|Partial seizures|partial seizures
368345|NCT01375374|Carbamazepine|carbamazepine
368346|NCT01375374|Hormone levels|hormone levels
368347|NCT01375374|Lipid levels|lipid levels
368349|NCT01375361|albuterol|albuterol
368350|NCT01375348|Cognitive function|cognitive function
368351|NCT01375348|Experimental pain|experimental pain
368352|NCT01375335|Postoperative|postoperative
368353|NCT01375335|Dobutamine|dobutamine
368354|NCT01375335|Inotropes|inotropes
368355|NCT01375335|Stunning|stunning
368356|NCT01375335|Heart failure|heart failure
368357|NCT01375309|probiotics|probiotics
368358|NCT01375309|preterm infants|preterm infants
368359|NCT01375309|enteral feeding|enteral feeding
368360|NCT01375309|Bifidobacterium on enteral feeding|bifidobacterium on enteral feeding
368361|NCT01375270|diabetes|diabetes
368362|NCT01375270|incretin|incretin
368363|NCT01375270|beta-cell function|beta-cell function
368364|NCT01375270|glucolipotoxicity|glucolipotoxicity
368365|NCT01375270|glucagon-like peptide 1|glucagon-like peptide 1
368366|NCT01375270|glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
368367|NCT01375244|bioequivalence|bioequivalence
368368|NCT01375244|lisinopril|lisinopril
368369|NCT01375244|fasting|fasting
368370|NCT01375205|atopic dermatitis|atopic dermatitis
368371|NCT01375205|skin care|skin care
368372|NCT01375179|Inflammatory Bowel disease|inflammatory bowel disease
368373|NCT01375179|Ulcerative colitis|ulcerative colitis
368374|NCT01375153|BNP administration|bnp administration
368375|NCT01375153|appetite|appetite
368376|NCT01375153|ghrelin|ghrelin
368377|NCT01375153|PYY|pyy
368378|NCT01375140|Myeloproliferative Diseases|myeloproliferative diseases
368379|NCT01375140|Myelofibrosis|myelofibrosis
368380|NCT01375140|Post essential thrombocythemia/polycythemia vera|post essential thrombocythemia/polycythemia vera
368381|NCT01375140|Ruxolitinib|ruxolitinib
368382|NCT01375140|INCB018424|incb018424
368383|NCT01375140|Lenalidomide|lenalidomide
368384|NCT01375140|CC-5013|cc-5013
368385|NCT01375140|Revlimid|revlimid
368386|NCT01375140|Prednisone|prednisone
368387|NCT01375140|Interactive Voice Response System|interactive voice response system
368388|NCT01375140|IVR|ivr
368389|NCT01375127|Observational|observational
368390|NCT01375127|clinical follow-up data|clinical follow-up data
368391|NCT01375114|Advanced Cancers|advanced cancers
368392|NCT01375114|Solid Tumors|solid tumors
368393|NCT01375114|Cancer related fatigue|cancer related fatigue
368394|NCT01375114|CRF|crf
368395|NCT01375114|Panax ginseng|panax ginseng
368396|NCT01375114|Placebo|placebo
368397|NCT01375114|Sugar pill|sugar pill
368398|NCT01375114|Functional Assessment of Chronic Illness Therapy-Fatigue|functional assessment of chronic illness therapy-fatigue
368399|NCT01375114|FACIT-F|facit-f
368400|NCT01375114|Quality of life|quality of life
368401|NCT01375114|QOL|qol
368402|NCT01375114|FACT-G|fact-g
368403|NCT01375114|Hospital Anxiety and Depression Inventory|hospital anxiety and depression inventory
368404|NCT01375114|Neurocognitive function|neurocognitive function
368405|NCT01375114|SDMT|sdmt
368406|NCT01375114|Global Symptom Evaluation|global symptom evaluation
368407|NCT01375114|GSE|gse
368408|NCT01375101|lichen planus|lichen planus
368409|NCT01375101|quercetin|quercetin
368410|NCT01375088|propolis|propolis
368411|NCT01375088|mucositis|mucositis
368412|NCT01375088|radiotherapy|radiotherapy
368413|NCT01375088|cancer|cancer
368414|NCT01375049|Cystic fibrosis|cystic fibrosis
368415|NCT01375049|CF|cf
368416|NCT01375049|PA|pa
368417|NCT01375049|Pseudomonas aeruginosa|pseudomonas aeruginosa
368418|NCT01375049|AZLI|azli
368419|NCT01375049|aztreonam|aztreonam
368420|NCT01375036|Cystic fibrosis|cystic fibrosis
368421|NCT01375036|PA|pa
368422|NCT01375036|Pseudomonas aeruginosa|pseudomonas aeruginosa
368423|NCT01375036|CF|cf
368424|NCT01375036|aztreonam|aztreonam
368425|NCT01375023|Allogenic Haematopoietic Cell Transplantation|allogenic haematopoietic cell transplantation
368426|NCT01375023|Total Lymphoid Irradiation|total lymphoid irradiation
368427|NCT01375023|Anti-Thymocyte Globulin|anti-thymocyte globulin
368428|NCT01375023|Triple Negative Breast Cancer|triple negative breast cancer
368429|NCT01375010|HIV|hiv
368430|NCT01375010|Postmenopausal women|postmenopausal women
368431|NCT01375010|Vitamin D|vitamin d
368432|NCT01374984|smallpox|smallpox
368433|NCT01374984|vaccination|vaccination
368434|NCT01374984|complications|complications
368435|NCT01374971|Rheumatoid Arthritis|rheumatoid arthritis
368436|NCT01374971|Cimzia|cimzia
368437|NCT01374971|Certolizumab Pegol|certolizumab pegol
368438|NCT01374971|Arthroscopic Synovial biopsy|arthroscopic synovial biopsy
368439|NCT01374971|Office Based Procedure|office based procedure
368440|NCT01374971|Biologic|biologic
368441|NCT01374971|Tumor Necrosis Factor (TNF)|tumor necrosis factor (tnf)
368442|NCT01374971|Anti-TNF|anti-tnf
368443|NCT01374932|Asthma|asthma
368444|NCT01374932|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
368445|NCT01374919|Intravenous iron|intravenous iron
368446|NCT01374919|ferumoxytol|ferumoxytol
368447|NCT01374919|iron deficiency anemia|iron deficiency anemia
368448|NCT01374919|Treatment of iron deficiency|treatment of iron deficiency
368449|NCT01374919|Intolerance of or ineffectiveness of oral iron|intolerance of or ineffectiveness of oral iron
368450|NCT01374906|Cushing's Disease|cushing's disease
368451|NCT01374906|Mean Urinary Free Cortisol|mean urinary free cortisol
368452|NCT01374906|Pasireotide|pasireotide
368453|NCT01374893|Function, hospitalization, elderly|function, hospitalization, elderly
368454|NCT01374880|Heart failure|heart failure
368455|NCT01374880|Dyspnea|dyspnea
368456|NCT01374880|Heart disease|heart disease
368457|NCT01374880|Pulmonary disease|pulmonary disease
368458|NCT01374880|Natriuretic peptide|natriuretic peptide
368459|NCT01374880|Rehabilitation|rehabilitation
368460|NCT01374867|Cardiogenic shock|cardiogenic shock
368461|NCT01374867|Myocardial infarction|myocardial infarction
368462|NCT01374867|Low-output syndrome|low-output syndrome
368463|NCT01374867|Prognosis|prognosis
368464|NCT01374867|Biomarkers|biomarkers
368465|NCT01374867|Pathophysiology|pathophysiology
368466|NCT01374854|type 1 diabetes mellitus|type 1 diabetes mellitus
368467|NCT01374854|umbilical mesenchymal stem cell|umbilical mesenchymal stem cell
368468|NCT01374854|mononuclear cell|mononuclear cell
368469|NCT01374841|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
368470|NCT01374841|High-Risk Hematologic Neoplasms|high-risk hematologic neoplasms
368471|NCT01374841|Haploidentical Donors|haploidentical donors
368472|NCT01374841|Cyclophosphamide|cyclophosphamide
368473|NCT01374828|Toradol|toradol
368474|NCT01374828|Ketorolac|ketorolac
368475|NCT01374828|Normal saline|normal saline
368476|NCT01374828|Laparoscopic|laparoscopic
368477|NCT01374828|Postoperative pain control|postoperative pain control
368478|NCT01374828|Incisional analgesia|incisional analgesia
368479|NCT01374815|Children's diet quality|children's diet quality
368480|NCT01374815|Health-related social problems|health-related social problems
368481|NCT01374763|Naloxone|naloxone
368482|NCT01374763|Oxycodone|oxycodone
368483|NCT01374763|Constipation|constipation
368484|NCT01374763|Pain, postoperative|pain, postoperative
368485|NCT01374763|Physiological effects of drugs|physiological effects of drugs
368486|NCT01374763|Analgesics, Opioid|analgesics, opioid
368487|NCT01374724|Tobacco Use|tobacco use
368488|NCT01374724|Relapse Prevention|relapse prevention
368489|NCT01374724|Military|military
368490|NCT01374724|Smokeless Tobacco Use|smokeless tobacco use
368491|NCT01374724|Dual Use|dual use
368493|NCT01374711|Inflammation|inflammation
368494|NCT01374711|Sepsis|sepsis
368495|NCT01374711|GM-CSF|gm-csf
368496|NCT01374711|IFN-y|ifn-y
368497|NCT01374698|PCI|pci
368498|NCT01374698|Aspirin|aspirin
368499|NCT01374698|Reload|reload
368500|NCT01374685|BRCA1|brca1
368501|NCT01374685|BRCA2|brca2
368502|NCT01374685|Breast Cancer|breast cancer
368503|NCT01374685|African American|african american
368504|NCT01374685|Women|women
368505|NCT01374659|124-I PET|124-i pet
368506|NCT01374659|FDG-PET|fdg-pet
368507|NCT01374659|PET/CT|pet/ct
368508|NCT01374659|recurrence|recurrence
368509|NCT01374659|differentiated thyroid carcinoma|differentiated thyroid carcinoma
368510|NCT01374659|diagnostic value|diagnostic value
368511|NCT01374646|Childhood Obesity|childhood obesity
368512|NCT01374646|Group Treatment|group treatment
368513|NCT01374646|Community-based Programs|community-based programs
368514|NCT01374633|Sevoflurane|sevoflurane
368515|NCT01374633|Brain injury|brain injury
368516|NCT01374633|Intra cranial pressure|intra cranial pressure
368517|NCT01374633|Sedation|sedation
368518|NCT01374633|Brain injury with initial Glasgow score less than 9|brain injury with initial glasgow score less than 9
368519|NCT01374620|Cancer|cancer
368520|NCT01374607|acute coronary syndrome|acute coronary syndrome
368521|NCT01374607|myocardial ischemia|myocardial ischemia
368522|NCT01374607|high-sensitivity cardiac troponin T|high-sensitivity cardiac troponin t
368523|NCT01374581|retreatment|retreatment
368524|NCT01374581|artemisinin-based combination|artemisinin-based combination
368525|NCT01374581|malaria|malaria
368526|NCT01374581|resistant|resistant
368527|NCT01374568|Type 2 diabetes|type 2 diabetes
368528|NCT01374568|sitagliptin|sitagliptin
368529|NCT01374568|Januvia|januvia
368530|NCT01374555|Coronary artery disease|coronary artery disease
368531|NCT01374542|Bronchoscopy|bronchoscopy
368532|NCT01374542|Thoracoscopy|thoracoscopy
368533|NCT01374516|Dengue Virus|dengue virus
368534|NCT01374516|Dengue fever|dengue fever
368535|NCT01374516|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
368536|NCT01374516|CYD dengue vaccine|cyd dengue vaccine
368537|NCT01374516|Flavivirus|flavivirus
368538|NCT01374516|Dengue Disease|dengue disease
368539|NCT01374490|HIV +|hiv +
368540|NCT01374490|HIV positive|hiv positive
368541|NCT01374490|HIV associated diarrhea|hiv associated diarrhea
368542|NCT01374490|AIDS|aids
368543|NCT01374490|Diarrhea|diarrhea
368544|NCT01374477|Preeclampsia in Adolescence|preeclampsia in adolescence
368545|NCT01374477|Adolescent|adolescent
368546|NCT01374477|Primipaternity|primipaternity
368547|NCT01374464|Interscalene brachial plexus nerve block|interscalene brachial plexus nerve block
368548|NCT01374464|Nerve block|nerve block
368549|NCT01374451|Pancreatic|pancreatic
368550|NCT01374451|Neuroendocrine tumors|neuroendocrine tumors
368551|NCT01374451|PNET|pnet
368552|NCT01374451|Pasireotide|pasireotide
368553|NCT01374451|Everolimus|everolimus
368554|NCT01374451|Advanced progressive pancreatic neuroendocrine tumor|advanced progressive pancreatic neuroendocrine tumor
359223|NCT01413438|GBM|gbm
368555|NCT01374438|Alzheimer's disease|alzheimer's disease
368556|NCT01374438|cognitive function|cognitive function
368557|NCT01374438|brain glucose utilization|brain glucose utilization
368558|NCT01374438|FDG-PET|fdg-pet
368559|NCT01374399|allogeneic stem cell transplantation|allogeneic stem cell transplantation
368560|NCT01374399|exercise|exercise
368561|NCT01374399|survival|survival
368562|NCT01374399|fatigue|fatigue
368563|NCT01374399|quality of life|quality of life
368564|NCT01374399|cancer|cancer
368565|NCT01374399|physical performance|physical performance
368566|NCT01374386|adolescent obesity|adolescent obesity
368567|NCT01374373|Chemotherapy|chemotherapy
368568|NCT01374373|Anemia|anemia
368569|NCT01374373|Epoetin alfa|epoetin alfa
368570|NCT01374373|Erythropoiesis stimulating agent (ESA)|erythropoiesis stimulating agent (esa)
368571|NCT01374360|PNH|pnh
368572|NCT01374360|Paroxysmal Nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
368573|NCT01374360|Soliris|soliris
368574|NCT01374360|Eculizumab|eculizumab
368575|NCT01374308|NASVAC|nasvac
368576|NCT01374308|Pegylated Interferon-2b|pegylated interferon-2b
368577|NCT01374308|CHB|chb
368578|NCT01373723|Uterine Cervical Neoplasms|uterine cervical neoplasms
368579|NCT01373723|cancer screening|cancer screening
368580|NCT01373723|Costs and Cost Analysis|costs and cost analysis
368581|NCT01373723|cost-effectiveness analysis|cost-effectiveness analysis
368582|NCT01373723|Clinical Trial|clinical trial
368583|NCT01373723|Primary Health Care|primary health care
368584|NCT01373710|Adverse Reaction to Trastuzumab Administered by intrathecal|adverse reaction to trastuzumab administered by intrathecal
368585|NCT01373697|Ibuprofen|ibuprofen
368586|NCT01373697|muscle pain|muscle pain
368587|NCT01373697|sprains|sprains
368588|NCT01373697|contusions|contusions
368589|NCT01373697|tendonitis|tendonitis
368590|NCT01373684|Chronic hepatitis B|chronic hepatitis b
368591|NCT01373684|HBeAg-negative|hbeag-negative
368592|NCT01373671|Mammography|mammography
368593|NCT01373671|Screening|screening
368594|NCT01373671|Diagnostic|diagnostic
368595|NCT01373632|significant stenosis (>70% of lumen stenosis)|significant stenosis (>70% of lumen stenosis)
368596|NCT01373632|epicardial coronary arteries|epicardial coronary arteries
368597|NCT01373632|clinical ischemic|clinical ischemic
368598|NCT01373619|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
368599|NCT01373619|hemodialysis patients|hemodialysis patients
368600|NCT01373619|ivabradine|ivabradine
368601|NCT01373619|Echocardiography|echocardiography
368602|NCT01373619|NYHA class|nyha class
368895|NCT01372826|Phase 1|phase 1
368603|NCT01373619|6-minutes walking test|6-minutes walking test
368604|NCT01373593|persistent postherniorrhaphy pain|persistent postherniorrhaphy pain
368605|NCT01373580|presbyopia|presbyopia
368606|NCT01373580|LASIK|lasik
368607|NCT01373580|loss of accommodation|loss of accommodation
368608|NCT01373580|Emmetrope|emmetrope
368609|NCT01373567|Plaque Psoriasis|plaque psoriasis
368610|NCT01374269|NSAIDS (Nonsteroidal anti-inflammatory drugs)|nsaids (nonsteroidal anti-inflammatory drugs)
368611|NCT01374269|Exercise|exercise
368612|NCT01374269|Physiotherapy|physiotherapy
368613|NCT01374269|Subacute Low Back Pain|subacute low back pain
368614|NCT01374269|Pain|pain
368615|NCT01374269|Visual Analogue Scale|visual analogue scale
368616|NCT01374269|oswesrty|oswesrty
368617|NCT01374269|Roland Morris|roland morris
368618|NCT01374269|SF-36|sf-36
368619|NCT01374269|Quality of life|quality of life
368620|NCT01374256|carbapenem|carbapenem
368621|NCT01374256|sulbactam|sulbactam
368622|NCT01374256|Acinetobacter baumannii|acinetobacter baumannii
368623|NCT01374230|clinical outcomes|clinical outcomes
368624|NCT01374230|radiographic outcomes|radiographic outcomes
368625|NCT01374230|total knee arthroplasty|total knee arthroplasty
368626|NCT01374230|survivorship|survivorship
368627|NCT01374204|Epilepsy|epilepsy
368628|NCT01374204|Stigma|stigma
368629|NCT01374191|botox|botox
368630|NCT01374191|neuroma pain|neuroma pain
368631|NCT01374191|pain|pain
368632|NCT01374191|chronic pain|chronic pain
368633|NCT01374191|botulinum toxin|botulinum toxin
368634|NCT01374191|botulinum toxin A|botulinum toxin a
368635|NCT01374191|botox and pain|botox and pain
368636|NCT01374191|botox and neuroma|botox and neuroma
368637|NCT01374191|botox treatment|botox treatment
368638|NCT01374191|onabotulinum|onabotulinum
368639|NCT01374191|onabotulinum toxin|onabotulinum toxin
737719|NCT01107613|follow-up|follow-up
368640|NCT01374191|onabotulinum toxin type A|onabotulinum toxin type a
368641|NCT01374165|SCD|scd
368642|NCT01374152|stroke|stroke
368643|NCT01374152|upper extremity|upper extremity
368644|NCT01374152|rehabilitation|rehabilitation
368645|NCT01374152|perfetti|perfetti
368646|NCT01374139|Bosutinib|bosutinib
368647|NCT01374139|Bioequivalence and Food Effect Studies|bioequivalence and food effect studies
368648|NCT01374113|safinamide|safinamide
368649|NCT01374113|pharmacokinetics|pharmacokinetics
368650|NCT01374113|renal impairment|renal impairment
368651|NCT01374113|Moderate and Severe Renal Impairment|moderate and severe renal impairment
368652|NCT01374100|Qigong|qigong
368653|NCT01374100|Complementary Medicine|complementary medicine
368654|NCT01374100|Exercise|exercise
368655|NCT01374100|Traditional Chinese Medicine|traditional chinese medicine
368656|NCT01374100|Meditation|meditation
368657|NCT01374100|Standard Exercise|standard exercise
368658|NCT01374100|Chemotherapy|chemotherapy
368659|NCT01374100|Advanced cancer|advanced cancer
368660|NCT01374100|Quality of Life|quality of life
368661|NCT01374100|Functional Assessment of Cancer Therapy|functional assessment of cancer therapy
368662|NCT01374100|Hospital Anxiety and Depression Scale|hospital anxiety and depression scale
368663|NCT01374100|Anxiety|anxiety
368664|NCT01374100|Depression|depression
368665|NCT01374100|Cancer Nutrition-Rehabilitation Program|cancer nutrition-rehabilitation program
368666|NCT01374100|Edmonton Symptom Assessment Scale|edmonton symptom assessment scale
368667|NCT01374100|Simmonds Functional Assessment|simmonds functional assessment
368668|NCT01374087|Recurrent Prostate Carcinoma|recurrent prostate carcinoma
368669|NCT01374087|Brachytherapy|brachytherapy
368670|NCT01374087|Triptorelin|triptorelin
368671|NCT01374087|Hormone Therapy|hormone therapy
368672|NCT01374074|Barrett's Esophagus (BE)|barrett's esophagus (be)
368673|NCT01374074|Intestinal metaplasia|intestinal metaplasia
368674|NCT01374074|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
368675|NCT01374074|Racial Disparity|racial disparity
368676|NCT01374061|Emergency intubation|emergency intubation
368677|NCT01374061|Glide scope Ranger|glide scope ranger
368678|NCT01374061|Pre hospital|pre hospital
368679|NCT01374035|Health Service|health service
368680|NCT01374035|Coordination|coordination
368681|NCT01374035|Referral letters|referral letters
368682|NCT01374035|Mental Health|mental health
368683|NCT01374035|Adults|adults
368684|NCT01374022|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
368685|NCT01374022|Randomized Controlled Trial|randomized controlled trial
368686|NCT01374022|Respiration, Artificial|respiration, artificial
368687|NCT01373996|Invasive blood pressure monitoring|invasive blood pressure monitoring
368688|NCT01373996|Intensive care unit|intensive care unit
368689|NCT01373996|Wireless Technology|wireless technology
368690|NCT01373983|Neuropathic pain|neuropathic pain
368691|NCT01373983|Intrathecal analgesia|intrathecal analgesia
368692|NCT01373983|Ziconotide|ziconotide
368693|NCT01373983|Bolus|bolus
368694|NCT01373983|trauma|trauma
368695|NCT01373983|central|central
368696|NCT01373983|severe|severe
368697|NCT01373983|chronic|chronic
368698|NCT01373970|Functional Dyspepsia|functional dyspepsia
368699|NCT01373970|Protonpump inhibitor|protonpump inhibitor
369395|NCT01370954|NAC|nac
368700|NCT01373970|Rebound Acid HyperSecretion|rebound acid hypersecretion
368701|NCT01373957|Acute Coronary Syndrome|acute coronary syndrome
368702|NCT01373957|antithrombotic management|antithrombotic management
368703|NCT01373957|STEMI|stemi
368704|NCT01373957|NSTE-ACS|nste-acs
368705|NCT01373944|MPI|mpi
368706|NCT01373944|SPECT|spect
368707|NCT01373944|Stress-Only|stress-only
368708|NCT01373944|Spectrum Dynamics Camera|spectrum dynamics camera
368709|NCT01373944|Anger|anger
368710|NCT01373918|cholestasis|cholestasis
368711|NCT01373918|neonates|neonates
368712|NCT01373918|parenteral nutrition|parenteral nutrition
368713|NCT01373918|gastrointestinal disorders|gastrointestinal disorders
368714|NCT01373905|ARDS|ards
368715|NCT01373905|PEEP|peep
368716|NCT01373905|Recruitment maneuver|recruitment maneuver
368717|NCT01373879|Vaccine|vaccine
368718|NCT01373879|Immune response|immune response
368719|NCT01373866|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
368720|NCT01373866|Neuronavigation|neuronavigation
368721|NCT01373866|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
368722|NCT01373866|Diffusion Tensor Imaging|diffusion tensor imaging
368723|NCT01373853|Lens Fragmentation|lens fragmentation
368724|NCT01373853|Cataract|cataract
368725|NCT01373853|Phacoemulsification|phacoemulsification
368726|NCT01373853|Femtosecond Laser|femtosecond laser
368727|NCT01373840|focal|focal
368728|NCT01373840|dystonia|dystonia
368729|NCT01373840|dopamine|dopamine
368730|NCT01373840|receptor|receptor
368731|NCT01373827|VASER|vaser
368732|NCT01373827|VASERShape|vasershape
368733|NCT01373827|MC1|mc1
368734|NCT01373827|ultrasound|ultrasound
587100|NCT00530569|Herceptin Therapy|herceptin therapy
368735|NCT01373801|Postpartum women, after surgical repair of vaginal and cervical lacerations|postpartum women, after surgical repair of vaginal and cervical lacerations
368736|NCT01373775|Heart failure|heart failure
368738|NCT01373775|Emergency room|emergency room
368739|NCT01373762|Adherence|adherence
368740|NCT01373762|Motivation|motivation
368741|NCT01373762|Health-related fitness|health-related fitness
368742|NCT01373762|Exercise videogames|exercise videogames
368743|NCT01373762|Physical Activity|physical activity
368744|NCT01373749|PPHN|pphn
368745|NCT01373749|NO inhalation|no inhalation
368746|NCT01373749|Sildenafil|sildenafil
368747|NCT01373749|Treatment|treatment
368748|NCT01373749|Safety|safety
368749|NCT01373528|Sinonasal Budesonide|sinonasal budesonide
368750|NCT01373528|Endoscopic sinus surgery|endoscopic sinus surgery
369756|NCT01369433|tivozanib|tivozanib
368751|NCT01373528|Hypothalamic-Pituitary-Adrenal Axis Function|hypothalamic-pituitary-adrenal axis function
368752|NCT01373515|DCOne|dcone
368753|NCT01373515|DCP-001|dcp-001
368754|NCT01373515|Second complete remission of AML|second complete remission of aml
368755|NCT01373515|Relapse AML|relapse aml
368756|NCT01373489|type 2 diabetes|type 2 diabetes
368757|NCT01373489|nurse case management|nurse case management
368758|NCT01373489|telemedicine|telemedicine
368759|NCT01373476|Diabetic Retinopathy|diabetic retinopathy
368760|NCT01373476|Traditional Chinese medicine|traditional chinese medicine
368761|NCT01373476|Diabetic Eye Problems|diabetic eye problems
368762|NCT01373476|Retinal Disorders|retinal disorders
368763|NCT01373463|resectable|resectable
368764|NCT01373437|Ultrasonography|ultrasonography
368765|NCT01373437|US|us
368766|NCT01373437|Confirming|confirming
368767|NCT01373437|Confirmation|confirmation
368768|NCT01373437|Proper|proper
368769|NCT01373437|Position|position
368770|NCT01373437|Endotracheal tube|endotracheal tube
368771|NCT01373437|ETT|ett
368772|NCT01373437|Emergency department|emergency department
368773|NCT01373437|ED|ed
368774|NCT01373437|Applicability|applicability
368775|NCT01373437|Accuracy|accuracy
368776|NCT01373424|Observational study|observational study
368777|NCT01373424|Cross-sectional and Prospective study|cross-sectional and prospective study
368778|NCT01373424|Cohort and case-control study|cohort and case-control study
368779|NCT01373411|CABG|cabg
368780|NCT01373411|Ticagrelor|ticagrelor
368781|NCT01373411|Coronary Artery Bypass Surgery|coronary artery bypass surgery
368782|NCT01373398|bladder cancer|bladder cancer
368783|NCT01373398|EO9|eo9
368784|NCT01373398|Apaziquone|apaziquone
368785|NCT01373385|pediatric urology|pediatric urology
368786|NCT01373385|vesicoureteral reflux|vesicoureteral reflux
368787|NCT01373385|ureteral reimplant|ureteral reimplant
368788|NCT01373385|Deflux|deflux
368789|NCT01373372|functional dyspepsia|functional dyspepsia
368790|NCT01373372|GI|gi
6532|NCT03249350|Adolescents|adolescents
6533|NCT03249350|Treatment|treatment
368791|NCT01373359|Misoprostol, oxytocin, postpartum blood loss, hemoglobin|misoprostol, oxytocin, postpartum blood loss, hemoglobin
368792|NCT01373346|type II diabetes|type ii diabetes
368793|NCT01373346|Gastric cancer|gastric cancer
368794|NCT01373346|Long limb Roux-en Y|long limb roux-en y
368795|NCT01373320|Smoking cessation|smoking cessation
368796|NCT01373320|Cancer screening|cancer screening
368797|NCT01373320|Appalachia|appalachia
368798|NCT01373320|Group-randomized trial|group-randomized trial
368799|NCT01373320|Faith-placed|faith-placed
368800|NCT01373307|Overweight|overweight
368801|NCT01373307|obesity|obesity
368802|NCT01373307|Appalachian|appalachian
368803|NCT01373307|intergenerational|intergenerational
368804|NCT01373307|families|families
368805|NCT01373307|energy balance|energy balance
368806|NCT01373307|group-randomized trial|group-randomized trial
368807|NCT01373294|non-muscle-invasive|non-muscle-invasive
368808|NCT01373294|transitional cell|transitional cell
368809|NCT01373294|oral lenalidomide|oral lenalidomide
368810|NCT01373294|intravesical|intravesical
368811|NCT01373281|Dengue|dengue
368812|NCT01373281|Dengue fever|dengue fever
368813|NCT01373281|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
368814|NCT01373281|CYD dengue vaccine|cyd dengue vaccine
368815|NCT01373281|Flavivirus|flavivirus
368816|NCT01373255|Placenta accreta|placenta accreta
368817|NCT01373255|Internal iliac artery catheterization|internal iliac artery catheterization
368818|NCT01373255|Post partum bleeding|post partum bleeding
368819|NCT01373229|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
368820|NCT01373229|CLL|cll
368821|NCT01373203|Acute Lung Injury(ALI)|acute lung injury(ali)
368822|NCT01373190|epilepsy|epilepsy
368823|NCT01373190|thermography|thermography
368824|NCT01373164|Neoplasms|neoplasms
368825|NCT01373164|Neoplasm Metastasis|neoplasm metastasis
368826|NCT01373164|Pancreatic Cancer|pancreatic cancer
368827|NCT01373138|Bioequivalence|bioequivalence
368828|NCT01373138|Desloratadine and pseudoephedrine|desloratadine and pseudoephedrine
368829|NCT01373138|crossover|crossover
368830|NCT01373125|Barrett's Esophagus|barrett's esophagus
368831|NCT01373125|Intestinal metaplasia|intestinal metaplasia
368832|NCT01373125|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
368833|NCT01373125|Neosquamous epithelium|neosquamous epithelium
368834|NCT01373125|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
368835|NCT01373112|arthroplasty|arthroplasty
368836|NCT01373112|knee replacement|knee replacement
368837|NCT01373112|Osteoarthritis|osteoarthritis
368838|NCT01373112|knee Infection|knee infection
368839|NCT01373112|Prosthetic Joint Infection|prosthetic joint infection
368840|NCT01373112|Complications; Arthroplasty, Infection or Inflammation|complications; arthroplasty, infection or inflammation
368841|NCT01373112|Complications; Arthroplasty|complications; arthroplasty
368842|NCT01373099|arthroplasty|arthroplasty
368843|NCT01373099|hip replacement|hip replacement
368844|NCT01373099|Osteoarthritis|osteoarthritis
368845|NCT01373099|knee Infection|knee infection
368846|NCT01373099|Prosthetic Joint Infection|prosthetic joint infection
368847|NCT01373099|Complications; Arthroplasty, Infection or Inflammation|complications; arthroplasty, infection or inflammation
368848|NCT01373099|Complications; Arthroplasty|complications; arthroplasty
368849|NCT01373086|Hypertension,|hypertension,
368850|NCT01373086|mild hypertension,|mild hypertension,
368851|NCT01373086|moderate hypertension,|moderate hypertension,
368852|NCT01373086|high blood pressure,|high blood pressure,
368853|NCT01373086|uncomplicated hypertension.|uncomplicated hypertension.
368855|NCT01373060|ipragliflozin|ipragliflozin
368856|NCT01373060|plasma glucose|plasma glucose
368857|NCT01373060|urine glucose|urine glucose
368858|NCT01373047|liver metastases|liver metastases
368859|NCT01373047|immunotherapy|immunotherapy
368860|NCT01373047|regional therapy|regional therapy
368861|NCT01373047|T cells|t cells
368862|NCT01373008|Inhaled steroids|inhaled steroids
368863|NCT01373008|bronchopulmonary dysplasia|bronchopulmonary dysplasia
368864|NCT01373008|Infants with moderate to severe BPD|infants with moderate to severe bpd
368865|NCT01372995|critical care|critical care
368866|NCT01372995|nosocomial infection|nosocomial infection
368867|NCT01372995|antiAntimicrobial peptide expression|antiantimicrobial peptide expression
368868|NCT01372995|LL-37|ll-37
368869|NCT01372995|hBD-2|hbd-2
368870|NCT01372995|cathelicidin|cathelicidin
368871|NCT01372995|microbial peptide|microbial peptide
368872|NCT01372956|LDL-C, cholesterol, risk factor|ldl-c, cholesterol, risk factor
368873|NCT01372943|Clostridium difficile|clostridium difficile
368874|NCT01372943|recurrent|recurrent
368875|NCT01372943|infection|infection
368876|NCT01372930|Etanercept|etanercept
368877|NCT01372930|acute ST segment elevated myocardial infarction|acute st segment elevated myocardial infarction
368878|NCT01372930|percutaneous coronary intervention|percutaneous coronary intervention
368879|NCT01372930|myocardial reperfusion injury|myocardial reperfusion injury
368880|NCT01372904|Cisplatin|cisplatin
368881|NCT01372904|Hearing loss|hearing loss
368882|NCT01372904|Ototoxicity|ototoxicity
368883|NCT01372904|Intratympanic injection|intratympanic injection
368884|NCT01372904|Dexamethasone|dexamethasone
368885|NCT01372904|Steroids|steroids
368886|NCT01372904|Prevention|prevention
368887|NCT01372891|Contrast Induced Nephropathy|contrast induced nephropathy
368888|NCT01372891|percutaneous coronary interventions|percutaneous coronary interventions
368889|NCT01372878|Polyps|polyps
368890|NCT01372878|Capsule endoscopy|capsule endoscopy
368891|NCT01372878|Colonoscopy|colonoscopy
368892|NCT01372852|Diabetes mellitus|diabetes mellitus
368893|NCT01372839|Myocardial Infarction|myocardial infarction
368894|NCT01372839|Unstable Angina|unstable angina
368896|NCT01372826|Pharmacokinetics|pharmacokinetics
368897|NCT01372826|NKTR-118|nktr-118
368898|NCT01372826|renal impairment|renal impairment
368899|NCT01372826|parallel study|parallel study
368900|NCT01372826|QTcF Interval|qtcf interval
368901|NCT01372826|AUC(0-t)|auc(0-t)
368902|NCT01372826|Cmax|cmax
368903|NCT01372826|tmax|tmax
368904|NCT01372813|Advanced Clear Cell Renal Cell Carcinoma|advanced clear cell renal cell carcinoma
368905|NCT01372813|Cancer|cancer
368906|NCT01372813|Renal|renal
368907|NCT01372813|Renal Cell Carcinoma|renal cell carcinoma
368908|NCT01372813|Kidney Cancer|kidney cancer
368909|NCT01372800|adiponectin|adiponectin
368910|NCT01372800|cardiovascular diseases|cardiovascular diseases
368911|NCT01372800|cerebrovascular diseases|cerebrovascular diseases
368912|NCT01372774|neurotoxicity|neurotoxicity
368913|NCT01372774|radiation toxicity|radiation toxicity
368914|NCT01372774|cognitive/functional effects|cognitive/functional effects
368915|NCT01372774|tumors metastatic to brain|tumors metastatic to brain
368916|NCT01372774|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
368917|NCT01372761|Obese|obese
368918|NCT01372761|Obesity|obesity
368919|NCT01372761|Overweight|overweight
368920|NCT01372748|cardiac arrest|cardiac arrest
368921|NCT01372748|cardiopulmonary resuscitation|cardiopulmonary resuscitation
368922|NCT01372735|pancreatic cancer|pancreatic cancer
368923|NCT01372735|intensity-modulated radiation therapy|intensity-modulated radiation therapy
368924|NCT01372735|intraoperative radiation therapy|intraoperative radiation therapy
368925|NCT01372722|treatment resistant|treatment resistant
368926|NCT01372709|abdominal|abdominal
368927|NCT01372709|aortic|aortic
368928|NCT01372709|aneurysm|aneurysm
368929|NCT01372683|Appetite|appetite
368930|NCT01372683|Satiety|satiety
368931|NCT01372683|Subjective energy|subjective energy
368932|NCT01372683|Oats|oats
368933|NCT01372670|Treating meal related anxiety|treating meal related anxiety
368934|NCT01372657|cataract|cataract
368935|NCT01372657|refraction|refraction
368936|NCT01372657|iol|iol
368937|NCT01372657|calculation|calculation
368938|NCT01372657|formula|formula
368939|NCT01372631|Reduction mammoplasty|reduction mammoplasty
368940|NCT01372631|mastectomy|mastectomy
368941|NCT01372631|partial mastectomy|partial mastectomy
368942|NCT01372631|lumpectomy|lumpectomy
368943|NCT01372631|breast conserving surgery|breast conserving surgery
368944|NCT01372631|breast cancer|breast cancer
368945|NCT01372605|Depression|depression
368946|NCT01372605|HIV|hiv
368947|NCT01372605|Adherence|adherence
368948|NCT01372605|Collaborative care|collaborative care
368949|NCT01372605|Measurement-Based Care|measurement-based care
368950|NCT01372553|Primary care|primary care
368951|NCT01372553|Family History|family history
368952|NCT01372553|Risk Stratification|risk stratification
368953|NCT01372553|Cancer|cancer
368954|NCT01372553|Thrombosis|thrombosis
368955|NCT01372540|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
368956|NCT01372540|MM|mm
368957|NCT01372540|Plasma Cell Leukemia|plasma cell leukemia
368958|NCT01372540|PCL|pcl
368959|NCT01372540|Arry-520|arry-520
368960|NCT01372540|Carfilzomib|carfilzomib
368961|NCT01372540|Dexamethasone|dexamethasone
368962|NCT01372540|Decadron|decadron
368963|NCT01372540|Filgrastim|filgrastim
368964|NCT01372540|G-CSF|g-csf
368965|NCT01372540|Neupogen|neupogen
368966|NCT01372527|medical informatics|medical informatics
368967|NCT01372527|health IT|health it
368968|NCT01372527|primary care|primary care
368969|NCT01372527|screening|screening
368970|NCT01372527|cervical cancer|cervical cancer
368971|NCT01372527|colorectal cancer|colorectal cancer
368972|NCT01372527|breast cancer|breast cancer
368973|NCT01372527|mammography|mammography
368974|NCT01372527|colonoscopy|colonoscopy
368975|NCT01372527|pap smear|pap smear
368976|NCT01372514|Thromboembolism|thromboembolism
368977|NCT01372514|Venous Thromboembolism|venous thromboembolism
368978|NCT01372514|Pulmonary Embolism|pulmonary embolism
368979|NCT01372501|Obesity|obesity
368980|NCT01372488|Suture self removal|suture self removal
368981|NCT01372488|non-absorbable sutures|non-absorbable sutures
368982|NCT01372475|Osteoarthritis|osteoarthritis
368983|NCT01372475|Knee|knee
368984|NCT01372475|Hyaluronan|hyaluronan
368985|NCT01372475|Hyaluronic Acid|hyaluronic acid
368986|NCT01372475|Viscoelastic|viscoelastic
368987|NCT01372475|Hydrogel|hydrogel
368988|NCT01372462|COPD|copd
368989|NCT01372462|Ventilator|ventilator
368990|NCT01372462|Constant work rate|constant work rate
368991|NCT01372449|Autism|autism
368992|NCT01372449|Psychopharmacology|psychopharmacology
368993|NCT01372449|Clinical Trial|clinical trial
368994|NCT01372449|Children|children
368995|NCT01372436|dental decay|dental decay
368996|NCT01372436|DMFT|dmft
368997|NCT01372436|Individual Caries Risk|individual caries risk
368998|NCT01372436|Risk factors|risk factors
368999|NCT01372410|Long acting muscarinic antagonist|long acting muscarinic antagonist
369000|NCT01372410|Tiotropium|tiotropium
369496|NCT01370434|MM|mm
369001|NCT01372410|Chronic Bronchitis|chronic bronchitis
369002|NCT01372410|Emphysema|emphysema
369003|NCT01372410|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
369004|NCT01372371|Vancomycin, Gentamycin|vancomycin, gentamycin
369005|NCT01372371|Local Powder Antibiotic's Efficacy in Controlling Post Surgical Infection|local powder antibiotic's efficacy in controlling post surgical infection
369006|NCT01372332|homonymous hemianopia|homonymous hemianopia
369007|NCT01372332|quality of life (QoL)|quality of life (qol)
369008|NCT01372332|visual exploration|visual exploration
369009|NCT01372332|on-road car driving|on-road car driving
369010|NCT01372332|driving simulator|driving simulator
369011|NCT01372332|useful field of view (UFOV)|useful field of view (ufov)
369012|NCT01372332|modified field of view (MAFOV)|modified field of view (mafov)
369013|NCT01372319|glaucoma|glaucoma
369014|NCT01372319|binocular visual field loss|binocular visual field loss
369015|NCT01372319|semi-automated kinetic perimetry (SKP)|semi-automated kinetic perimetry (skp)
369016|NCT01372319|quality of life (QoL)|quality of life (qol)
369017|NCT01372319|visual exploration|visual exploration
369018|NCT01372319|on-road car driving|on-road car driving
369019|NCT01372319|driving simulator|driving simulator
369020|NCT01372293|PCOS|pcos
369021|NCT01372293|oral contraceptive pill|oral contraceptive pill
369022|NCT01372293|polymorphisms|polymorphisms
369023|NCT01372267|Cognitive Behavioral Therapy|cognitive behavioral therapy
369024|NCT01372267|Chronic Pain|chronic pain
369025|NCT01372267|Substance Use Disorders|substance use disorders
587481|NCT00532389|LBH589|lbh589
369026|NCT01372267|Psychoeducational control group|psychoeducational control group
369027|NCT01372254|Cigarette Smoking|cigarette smoking
369028|NCT01372254|Drug Use|drug use
369029|NCT01372254|Depressed Mood|depressed mood
369030|NCT01372241|Papanicolaou test|papanicolaou test
369031|NCT01372241|Cervical cancer screening|cervical cancer screening
369032|NCT01372241|Randomized controlled trial|randomized controlled trial
369033|NCT01372241|Faith-placed|faith-placed
369034|NCT01372241|Appalachia|appalachia
369035|NCT01372228|hematopoietic stem cell transplant, chimerism, leukodystrophy|hematopoietic stem cell transplant, chimerism, leukodystrophy
369036|NCT01372215|Breast mass|breast mass
369037|NCT01372215|Breast lesion|breast lesion
369038|NCT01372202|Operable|operable
369039|NCT01372202|Based on CHFR Methylation Status|based on chfr methylation status
369040|NCT01372202|Diagnostic Biopsies|diagnostic biopsies
369041|NCT01372189|molecular imaging|molecular imaging
359713|NCT01411592|All-Ceramic|all-ceramic
359715|NCT01411592|Single Retainer|single retainer
369042|NCT01372189|epidermal growth factor receptor|epidermal growth factor receptor
369043|NCT01372189|colorectal neoplasia|colorectal neoplasia
369044|NCT01372189|confocal laser endomicroscopy|confocal laser endomicroscopy
369045|NCT01372176|Intensive care unit|intensive care unit
369046|NCT01372176|Critical illness|critical illness
369047|NCT01372176|Mortality|mortality
369048|NCT01372176|Reduced quality of life|reduced quality of life
369049|NCT01372176|Loss of lean body mass|loss of lean body mass
369050|NCT01372176|Loss of physical function|loss of physical function
369051|NCT01372176|Optimised nutritional support|optimised nutritional support
369052|NCT01372176|Early initiation of nutrition|early initiation of nutrition
369053|NCT01372176|Indirect calorimetry|indirect calorimetry
369054|NCT01372163|Phase 1|phase 1
369055|NCT01372163|Multiple Ascending Doses|multiple ascending doses
369056|NCT01372163|Safety|safety
369057|NCT01372163|Pharmacokinetics|pharmacokinetics
369058|NCT01372163|Healthy Volunteers|healthy volunteers
369059|NCT01372163|Type 2 Diabetic Patients|type 2 diabetic patients
369060|NCT01372150|major depressive disorder|major depressive disorder
369061|NCT01372150|MDD|mdd
369062|NCT01372150|depression|depression
369063|NCT01372137|NOX-H94|nox-h94
369064|NCT01372137|Hepcidin|hepcidin
369065|NCT01372137|Anemia|anemia
369066|NCT01372137|Inflammation|inflammation
369067|NCT01372124|Renal impairment|renal impairment
369068|NCT01372124|NOX-E36|nox-e36
369069|NCT01372111|Stg III or IVa Squamous Cell Carcinoma.|stg iii or iva squamous cell carcinoma.
369070|NCT01372111|Advanced|advanced
369071|NCT01372098|Domestic Violence|domestic violence
369072|NCT01372098|Spouse Abuse|spouse abuse
369073|NCT01372072|chronic respiratory hypercapnic failure|chronic respiratory hypercapnic failure
369074|NCT01372046|technology transfer|technology transfer
369075|NCT01372046|skill development|skill development
369076|NCT01372046|organizational change|organizational change
369077|NCT01372033|drug treatment|drug treatment
369078|NCT01372033|substance abuse|substance abuse
369079|NCT01372033|offenders|offenders
369080|NCT01372033|high risk|high risk
369081|NCT01372020|Varicose ulcer|varicose ulcer
369082|NCT01372020|wound healing|wound healing
369083|NCT01372020|electrical stimulation|electrical stimulation
369084|NCT01372007|Rectal carcinoma|rectal carcinoma
369085|NCT01371994|Radical Robotic Arm|radical robotic arm
369086|NCT01371994|Post Prostatectomy Incontinence|post prostatectomy incontinence
369087|NCT01371994|Vesicare|vesicare
369088|NCT01371994|YM905|ym905
369089|NCT01371968|Alfentanil|alfentanil
369090|NCT01371968|optimal dose|optimal dose
369091|NCT01371968|laryngeal mask airway|laryngeal mask airway
369092|NCT01371955|diabetic nephropathy|diabetic nephropathy
369093|NCT01371955|CYBA|cyba
369094|NCT01371955|p22phox|p22phox
369095|NCT01371955|RAGE|rage
369096|NCT01371955|12LOX|12lox
369097|NCT01371955|genetic|genetic
369098|NCT01371955|Type 1 Diabetes Mellitus with Diabetic Dermatitis|type 1 diabetes mellitus with diabetic dermatitis
369099|NCT01371955|caucasian|caucasian
369100|NCT01371955|more than twenty years of diabetes duration|more than twenty years of diabetes duration
369101|NCT01371955|older than 18 years|older than 18 years
369102|NCT01371955|no nephropathy other than diabetic nephropathy|no nephropathy other than diabetic nephropathy
369103|NCT01371942|Colorectal cancer(CRC)|colorectal cancer(crc)
369104|NCT01371916|tuberculous meningitis|tuberculous meningitis
369105|NCT01371916|early secretory antigenic target 6|early secretory antigenic target 6
369106|NCT01371916|diagnosis|diagnosis
369107|NCT01371903|morphine|morphine
369108|NCT01371903|fentanyl|fentanyl
369109|NCT01371903|dilaudid|dilaudid
369110|NCT01371903|opioid|opioid
369111|NCT01371903|capnography|capnography
369112|NCT01371890|hemodialysis|hemodialysis
369113|NCT01371890|end-stage renal disease|end-stage renal disease
369114|NCT01371890|hypertension|hypertension
369115|NCT01371877|urticaria|urticaria
369116|NCT01371877|angioedema|angioedema
369117|NCT01371877|hive|hive
369118|NCT01371877|swelling|swelling
369119|NCT01371864|Congenital cardiac disease|congenital cardiac disease
369120|NCT01371864|Teamwork|teamwork
369121|NCT01371864|Communication|communication
369122|NCT01371864|Peri-operative|peri-operative
587482|NCT00532389|Combination|combination
369123|NCT01371838|Community-Acquired Bacterial Pneumonia|community-acquired bacterial pneumonia
369124|NCT01371825|LIPA|lipa
369125|NCT01371825|Wolman Disease|wolman disease
369126|NCT01371825|Wolman Phenotype|wolman phenotype
369127|NCT01371825|Acid Lipase Deficiency|acid lipase deficiency
369128|NCT01371825|Acid Cholesteryl Hydrolase|acid cholesteryl hydrolase
369129|NCT01371825|Acid Lipase Disease Deficiency, type 2|acid lipase disease deficiency, type 2
369130|NCT01371825|Cholesteryl Ester Storage Disease (CESD)|cholesteryl ester storage disease (cesd)
369131|NCT01371825|Cholesteryl Ester Hydrolase Deficiency|cholesteryl ester hydrolase deficiency
369132|NCT01371825|Early Onset Lysosomal Acid Lipase Deficiency (Wolman Disease)|early onset lysosomal acid lipase deficiency (wolman disease)
369133|NCT01371825|LAL Deficiency|lal deficiency
369134|NCT01371825|Late Onset Lysosomal Acid Lipase Deficiency (CESD)|late onset lysosomal acid lipase deficiency (cesd)
369135|NCT01371825|Wolman Disease (early onset LAL Deficiency)|wolman disease (early onset lal deficiency)
369136|NCT01371825|Related Disorders:|related disorders:
369137|NCT01371825|Non-alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
369138|NCT01371825|Non-alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
369139|NCT01371825|Alcoholic Liver Disease|alcoholic liver disease
369140|NCT01371825|Cryptogenic Cirrhosis|cryptogenic cirrhosis
369141|NCT01371825|Niemann-Pick Disease (NPD) Type C|niemann-pick disease (npd) type c
369142|NCT01371825|Chanarin Dorfman Syndrome|chanarin dorfman syndrome
369143|NCT01371799|Schizophrenia|schizophrenia
369144|NCT01371786|Ciclesonide|ciclesonide
369145|NCT01371786|Allergic Rhinitis|allergic rhinitis
369146|NCT01371760|Multiple sclerosis|multiple sclerosis
369147|NCT01371760|Chronic cerebrospinal venous insufficiency|chronic cerebrospinal venous insufficiency
369148|NCT01371760|Percutaneous Transluminal Angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
369149|NCT01371760|Internal jugular vein|internal jugular vein
369150|NCT01371760|Azygous vein|azygous vein
369151|NCT01371747|Hyperkalemia|hyperkalemia
369152|NCT01371747|Chronic Kidney Disease|chronic kidney disease
369153|NCT01371747|Treatment of Hyperkalemia|treatment of hyperkalemia
369154|NCT01371747|Hypertension|hypertension
369155|NCT01371747|Diabetic Nephropathy|diabetic nephropathy
369156|NCT01371734|Major Depressive Disorder|major depressive disorder
369158|NCT01371734|Depression|depression
369159|NCT01371721|Major Depressive Disorder|major depressive disorder
369160|NCT01371721|MDD|mdd
369161|NCT01371721|Depression|depression
369162|NCT01371708|Major Depressive Disorder|major depressive disorder
369163|NCT01371708|MDD|mdd
369164|NCT01371708|Depression|depression
369165|NCT01371695|IGF-II levels|igf-ii levels
369166|NCT01371669|Pulmonary arterial hypertension|pulmonary arterial hypertension
369167|NCT01371669|Chronic post embolic disease|chronic post embolic disease
369168|NCT01371669|Sleep hypoxemia|sleep hypoxemia
369169|NCT01371669|polysomnography|polysomnography
369170|NCT01371669|sleep apnea|sleep apnea
369171|NCT01371669|periodic respiration|periodic respiration
369172|NCT01371630|Leukemia|leukemia
369173|NCT01371630|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
369174|NCT01371630|ALL|all
369175|NCT01371630|pre-B, Philadelphia chromosome (Ph-) negative|pre-b, philadelphia chromosome (ph-) negative
369176|NCT01371630|Maximum tolerated dose|maximum tolerated dose
369177|NCT01371630|Inotuzumab Ozogamycin|inotuzumab ozogamycin
369178|NCT01371630|CMC-544|cmc-544
369179|NCT01371630|Vincristine|vincristine
369180|NCT01371630|Rituximab|rituximab
369181|NCT01371630|Rituxan|rituxan
369182|NCT01371630|Cyclophosphamide|cyclophosphamide
369183|NCT01371630|Cytoxan|cytoxan
369184|NCT01371630|Neosar|neosar
369185|NCT01371630|Dexamethasone|dexamethasone
369186|NCT01371630|Decadron|decadron
369187|NCT01371630|Mesna|mesna
369188|NCT01371630|Mesnex|mesnex
369189|NCT01371630|Pegfilgrastim|pegfilgrastim
369190|NCT01371630|Neulasta|neulasta
369191|NCT01371630|PEG-G-CSF|peg-g-csf
369192|NCT01371630|Ara-C|ara-c
369193|NCT01371630|Cytarabine|cytarabine
369194|NCT01371630|Cytosar|cytosar
369195|NCT01371630|DepoCyt|depocyt
369196|NCT01371630|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
369197|NCT01371630|6-Mercaptopurine|6-mercaptopurine
369198|NCT01371630|Mercaptopurine|mercaptopurine
369199|NCT01371630|Purinethol|purinethol
369200|NCT01371630|6-MP|6-mp
369201|NCT01371630|Methotrexate|methotrexate
369202|NCT01371630|Otrexup|otrexup
369203|NCT01371630|Rasuvo|rasuvo
369204|NCT01371630|Rheumatrex|rheumatrex
369205|NCT01371630|Trexall|trexall
369206|NCT01371630|Amethopterin|amethopterin
369207|NCT01371630|Methotrexate Sodium|methotrexate sodium
369208|NCT01371630|MTX|mtx
369209|NCT01371630|Oncovin|oncovin
369210|NCT01371630|Vincristine Sulfate|vincristine sulfate
369211|NCT01371630|Vincasar Pfs|vincasar pfs
369212|NCT01371630|Prednisone|prednisone
369213|NCT01371630|Deltasone|deltasone
369214|NCT01371630|Sterapred|sterapred
369215|NCT01371630|Rayos|rayos
369216|NCT01371630|Meticorten|meticorten
369217|NCT01371630|Citrovorum|citrovorum
369218|NCT01371630|Leucovorin|leucovorin
369219|NCT01371630|Wellcovorin|wellcovorin
369220|NCT01371630|Calcium Leucovorin|calcium leucovorin
369221|NCT01371630|Folinic Acid|folinic acid
369222|NCT01371630|Citrovorum Factor|citrovorum factor
369223|NCT01371617|IPI-926|ipi-926
369224|NCT01371617|926|926
369225|NCT01371617|Myelofibrosis|myelofibrosis
369226|NCT01371617|Hedgehog|hedgehog
369227|NCT01371617|Infinity Pharmaceuticals|infinity pharmaceuticals
369228|NCT01371617|Post Essential thrombocythemia|post essential thrombocythemia
369229|NCT01371617|Post Polycythemia vera|post polycythemia vera
369230|NCT01371604|Hepatitis C|hepatitis c
369231|NCT01371604|HCV|hcv
369232|NCT01371604|treatment-naive|treatment-naive
369233|NCT01371591|Bleeding|bleeding
369234|NCT01371591|gastrointestinal|gastrointestinal
369235|NCT01371591|hemorrhage|hemorrhage
369236|NCT01371591|ulcer|ulcer
369237|NCT01371591|varix|varix
369238|NCT01371591|varices|varices
369239|NCT01371591|ulcers|ulcers
369240|NCT01371591|GI|gi
369241|NCT01371591|stomach|stomach
369242|NCT01371591|esophagus|esophagus
369243|NCT01371591|duodenum|duodenum
369244|NCT01371591|melena|melena
369245|NCT01371591|hematemesis|hematemesis
369246|NCT01371591|coffee-ground|coffee-ground
369247|NCT01371578|Hepatitis C|hepatitis c
369248|NCT01371578|HCV|hcv
369249|NCT01371578|Rapid Virologic Response|rapid virologic response
369250|NCT01371578|Sustained Virologic Response|sustained virologic response
369251|NCT01371578|Direct Acting Antiviral|direct acting antiviral
369252|NCT01371578|Combination Therapy HCV RNA|combination therapy hcv rna
369253|NCT01371578|Polymerase inhibitor|polymerase inhibitor
369254|NCT01371578|Protease inhibitor|protease inhibitor
369255|NCT01371578|Treatment naïve|treatment naïve
369256|NCT01371578|GS-5885|gs-5885
369257|NCT01371578|GS-9190|gs-9190
369258|NCT01371578|Tegobuvir|tegobuvir
369259|NCT01371578|GS-9451|gs-9451
369260|NCT01371565|Cushing's Disease|cushing's disease
369261|NCT01371565|Cushing's Syndrome|cushing's syndrome
369262|NCT01371565|Cushings|cushings
369263|NCT01371565|Pituitary|pituitary
369264|NCT01371565|Ectopic ACTH secretion|ectopic acth secretion
369265|NCT01371539|Myopia|myopia
369266|NCT01371539|Presbyopia|presbyopia
369267|NCT01371513|Serum prostate specific antigen|serum prostate specific antigen
369268|NCT01371422|Paravertebral nerve blockade|paravertebral nerve blockade
369269|NCT01371422|Percutaneous nephrolithotomy/nephrolithotripsy|percutaneous nephrolithotomy/nephrolithotripsy
369270|NCT01371422|opioids|opioids
369271|NCT01371422|pain|pain
369272|NCT01371409|Stroke|stroke
369273|NCT01371409|TMS|tms
369274|NCT01371409|Paired Pulse|paired pulse
369275|NCT01371409|EEG|eeg
369276|NCT01371409|Motor Learning|motor learning
369277|NCT01371396|Metabolic syndrome|metabolic syndrome
369278|NCT01371396|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
369279|NCT01371396|Obesity Metabolism|obesity metabolism
369280|NCT01371396|Stable isotopes|stable isotopes
369281|NCT01371396|Dietary weight loss|dietary weight loss
369282|NCT01371370|low intensity resistance exercise training|low intensity resistance exercise training
369283|NCT01371370|hypocaloric diet|hypocaloric diet
369284|NCT01371370|prehypertension|prehypertension
369285|NCT01371370|hypertension|hypertension
369286|NCT01371370|obesity|obesity
369287|NCT01371370|arterial function|arterial function
369288|NCT01371370|arterial stiffness|arterial stiffness
369289|NCT01371370|pulse wave velocity|pulse wave velocity
369290|NCT01371370|autonomic function|autonomic function
369291|NCT01371370|endothelial function|endothelial function
369292|NCT01371370|adipocytokines|adipocytokines
369293|NCT01371357|Remethylation|remethylation
369294|NCT01371357|Human Subjects|human subjects
369295|NCT01371357|Clinical Trial|clinical trial
369296|NCT01371357|B-vitamin|b-vitamin
369297|NCT01371357|Creatine|creatine
369298|NCT01371344|Liver Transplantation|liver transplantation
369299|NCT01371344|Kidney Transplantation|kidney transplantation
369300|NCT01371344|Heart Transplantation|heart transplantation
369301|NCT01371344|Pharmacokinetics|pharmacokinetics
369302|NCT01371331|Kidney Transplantation|kidney transplantation
369303|NCT01371331|Pharmacokinetics|pharmacokinetics
369304|NCT01371331|Heart Transplantation|heart transplantation
369305|NCT01371331|Liver Transplantation|liver transplantation
369306|NCT01371318|diabetic foot ulcer|diabetic foot ulcer
369307|NCT01371318|amputation|amputation
369308|NCT01371318|wounds|wounds
369309|NCT01371318|diabetic foot|diabetic foot
369310|NCT01371318|diabetes complications|diabetes complications
369311|NCT01371292|Physical activity|physical activity
369312|NCT01371292|Transformational leadership|transformational leadership
369313|NCT01371292|Physical education|physical education
369314|NCT01371266|Glucose intolerance|glucose intolerance
369315|NCT01371266|Insulin resistance|insulin resistance
369316|NCT01371266|Insulin|insulin
369317|NCT01371266|metabolic syndrome|metabolic syndrome
369318|NCT01371266|honey|honey
369319|NCT01371266|Inflammation|inflammation
369320|NCT01371266|oxidative stress|oxidative stress
369321|NCT01371253|Nintendo wii|nintendo wii
369322|NCT01371253|postural balance|postural balance
369323|NCT01371253|muscle strength|muscle strength
369324|NCT01371253|elderly|elderly
369325|NCT01371240|pancreas cancer|pancreas cancer
369326|NCT01371240|MRI|mri
369327|NCT01371240|CT scan|ct scan
369328|NCT01371227|Multiple myeloma|multiple myeloma
369329|NCT01371227|Relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
369330|NCT01371227|JNS002|jns002
369331|NCT01371227|Bortezomib|bortezomib
369332|NCT01371214|exercise|exercise
369333|NCT01371214|exercise movement techniques|exercise movement techniques
369334|NCT01371214|activities of daily living|activities of daily living
369335|NCT01371175|HIV|hiv
369336|NCT01371123|serum aluminum|serum aluminum
369337|NCT01371123|parenteral nutrition|parenteral nutrition
369338|NCT01371123|children|children
369339|NCT01371110|OCD|ocd
369340|NCT01371110|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
369341|NCT01371110|ketamine|ketamine
369342|NCT01371110|treatment|treatment
369343|NCT01371097|Barthel Index|barthel index
369344|NCT01371097|elderly hospitalised patients|elderly hospitalised patients
369345|NCT01371097|progressive resistance training|progressive resistance training
369346|NCT01371071|Clinically isolated syndrome (CIS)|clinically isolated syndrome (cis)
369347|NCT01371071|Multiple sclerosis (MS)|multiple sclerosis (ms)
369348|NCT01371071|Immunomodulatory therapy|immunomodulatory therapy
369349|NCT01371071|Prognostic markers|prognostic markers
369350|NCT01371071|MRI|mri
369351|NCT01371071|OCT|oct
369352|NCT01371058|high on-treatment platelet reactivity|high on-treatment platelet reactivity
369353|NCT01371058|percutaneous coronary intervention|percutaneous coronary intervention
369354|NCT01371058|stent thrombosis|stent thrombosis
369355|NCT01371045|Acromegaly|acromegaly
369356|NCT01371045|Growth Hormone|growth hormone
369357|NCT01371045|Carcinoid Syndrome|carcinoid syndrome
369358|NCT01371045|Somatostatin|somatostatin
369359|NCT01371019|Preterm Birth, Proteomics|preterm birth, proteomics
369360|NCT01370993|Hypoxemia|hypoxemia
369361|NCT01370993|Model|model
369362|NCT01370993|Bronchoscopes|bronchoscopes
369363|NCT01370993|Monitored anesthesia care|monitored anesthesia care
369364|NCT01370980|Medication Adherence|medication adherence
369365|NCT01370980|Patient Compliance|patient compliance
369366|NCT01370980|Patient Acceptance of Health Care|patient acceptance of health care
369367|NCT01370980|Administration, Oral|administration, oral
369368|NCT01370980|Cancer|cancer
369369|NCT01370980|Letrozol|letrozol
369370|NCT01370980|Exemestan|exemestan
369371|NCT01370980|Imatinib|imatinib
369372|NCT01370980|Sunitinib|sunitinib
369373|NCT01370980|Nilotinib|nilotinib
369374|NCT01370980|Everolimus|everolimus
369375|NCT01370980|Deferasirox|deferasirox
369376|NCT01370967|infant|infant
369377|NCT01370967|term birth|term birth
369378|NCT01370967|human milk|human milk
369379|NCT01370967|infant formula|infant formula
369380|NCT01370967|breast feeding|breast feeding
369381|NCT01370967|bottle feeding|bottle feeding
369382|NCT01370967|gastrointestinal tract|gastrointestinal tract
369383|NCT01370967|quality of life|quality of life
369384|NCT01370967|infant development|infant development
369385|NCT01370954|CerefolinNAC|cerefolinnac
369386|NCT01370954|early memory loss|early memory loss
6534|NCT03249350|Mediation|mediation
369387|NCT01370954|pre-alzheimer's disease|pre-alzheimer's disease
369388|NCT01370954|cognitive function|cognitive function
369389|NCT01370954|folic acid|folic acid
369390|NCT01370954|folate|folate
369391|NCT01370954|L-methylfolate|l-methylfolate
369392|NCT01370954|vitamin B12|vitamin b12
369393|NCT01370954|methylcobalamin|methylcobalamin
369394|NCT01370954|N-acetylcysteine|n-acetylcysteine
369396|NCT01370954|oxidative stress|oxidative stress
369397|NCT01370954|memory deficit|memory deficit
369398|NCT01370954|antioxidant|antioxidant
369399|NCT01370941|Chymosin|chymosin
369400|NCT01370941|24H urine calcium excretion|24h urine calcium excretion
369401|NCT01370941|Calcium absorption|calcium absorption
369402|NCT01370941|Intestinal Absorption of Calcium|intestinal absorption of calcium
369403|NCT01370928|Colonoscopy performance|colonoscopy performance
369404|NCT01370928|Pain|pain
369405|NCT01370928|Discomfort|discomfort
369406|NCT01370928|Screening|screening
369407|NCT01370928|Colorectal cancer|colorectal cancer
369408|NCT01370928|Colorectal cancer screening, diagnostics of adenomas|colorectal cancer screening, diagnostics of adenomas
369409|NCT01370915|postoperative pain, nasal septum surgery, pregabalin|postoperative pain, nasal septum surgery, pregabalin
369410|NCT01370876|Oxaliplatin|oxaliplatin
369411|NCT01370876|Head and Neck cancer|head and neck cancer
369412|NCT01370863|GERD|gerd
369413|NCT01370863|Gastroesophageal reflux disease|gastroesophageal reflux disease
369414|NCT01370863|SPD557|spd557
369415|NCT01370863|Proton pump inhibitors|proton pump inhibitors
369416|NCT01370850|Retina pathology|retina pathology
369417|NCT01370824|Diagnosis|diagnosis
369418|NCT01370824|Clinical|clinical
369419|NCT01370824|Punch biopsy|punch biopsy
369420|NCT01370824|Surgical excision|surgical excision
369421|NCT01370824|Histology|histology
369422|NCT01370824|Histopathology|histopathology
369423|NCT01370824|Observed agreement|observed agreement
369424|NCT01370824|Diagnostic value|diagnostic value
369425|NCT01370824|Accuracy|accuracy
369426|NCT01370824|Interobserver variability|interobserver variability
369427|NCT01370824|Intraobserver variability|intraobserver variability
369428|NCT01370811|oxybutynin|oxybutynin
369429|NCT01370811|clonidine|clonidine
369430|NCT01370811|OC Oral Solution|oc oral solution
369431|NCT01370811|sialorrhoea|sialorrhoea
369432|NCT01370811|Parkinson's disease|parkinson's disease
369433|NCT01370798|Severe hypospadias|severe hypospadias
369434|NCT01370798|local oestrogen|local oestrogen
369435|NCT01370798|promestriene|promestriene
369436|NCT01370798|Onlay-tube-onlay urethroplasty|onlay-tube-onlay urethroplasty
369437|NCT01370798|post-operative complications|post-operative complications
369438|NCT01370798|fistula dehiscence|fistula dehiscence
369439|NCT01370772|B CLL|b cll
369440|NCT01370772|Fist line treatment|fist line treatment
369441|NCT01370759|bowel prep|bowel prep
369442|NCT01370759|PillCam|pillcam
369443|NCT01370733|TMS,|tms,
369444|NCT01370733|MDD,|mdd,
369445|NCT01370733|Depression,|depression,
369446|NCT01370733|sTMS,|stms,
369447|NCT01370733|NEST,|nest,
369448|NCT01370733|NeoSync,|neosync,
369449|NCT01370733|EEG,|eeg,
369450|NCT01370733|synchronous,|synchronous,
369451|NCT01370733|non-invasive neuromodulation,|non-invasive neuromodulation,
369452|NCT01370733|transcranial magnetic stimulation,|transcranial magnetic stimulation,
369453|NCT01370733|antidepressant,|antidepressant,
369454|NCT01370720|IBS|ibs
369455|NCT01370720|mast cell activation|mast cell activation
369456|NCT01370720|low grade inflammation|low grade inflammation
369457|NCT01370720|visceral hyperalgesia|visceral hyperalgesia
369458|NCT01370668|functional remediation|functional remediation
369459|NCT01370668|psychoeducation|psychoeducation
369460|NCT01370668|neurocognition|neurocognition
369461|NCT01370629|atrial fibrillation|atrial fibrillation
369462|NCT01370629|cardioversion|cardioversion
369463|NCT01370616|Infection|infection
369464|NCT01370616|Diabetes complications|diabetes complications
369465|NCT01370616|Diabetes wound infection|diabetes wound infection
369466|NCT01370616|Soft tissue infection|soft tissue infection
369467|NCT01370616|Osteomyelitis|osteomyelitis
369468|NCT01370616|Diabetes mellitus|diabetes mellitus
369469|NCT01370577|Predictors for asthma control|predictors for asthma control
369470|NCT01370577|Asthma Exacerbation rate|asthma exacerbation rate
369471|NCT01370577|Mean frequency of PFT|mean frequency of pft
369472|NCT01370577|sputum assessments|sputum assessments
369473|NCT01370577|refill adherence(%)|refill adherence(%)
369474|NCT01370577|prescription persistence|prescription persistence
369475|NCT01370564|Heart failure|heart failure
369476|NCT01370564|Cardiac filling pressure|cardiac filling pressure
369477|NCT01370538|Heartburn|heartburn
369478|NCT01370525|Heartburn|heartburn
369479|NCT01370486|Lennox-Gastaut syndrome|lennox-gastaut syndrome
369480|NCT01370486|Epileptic encephalopathy|epileptic encephalopathy
369481|NCT01370486|Melatonin|melatonin
369482|NCT01370486|Tonic seizures|tonic seizures
369483|NCT01370486|Interictal discharges|interictal discharges
369484|NCT01370486|Quality of sleep|quality of sleep
369485|NCT01370473|Hyponatremia|hyponatremia
369486|NCT01370460|Tranexamic Acid|tranexamic acid
369487|NCT01370460|Blood transfusion|blood transfusion
369488|NCT01370460|Total knee arthroplasty|total knee arthroplasty
369489|NCT01370447|Leigh syndrome|leigh syndrome
369491|NCT01370447|Kearns-Sayre|kearns-sayre
369492|NCT01370447|Alper's|alper's
369493|NCT01370447|Inherited mitochondrial disease|inherited mitochondrial disease
369494|NCT01370447|Friedreich's ataxia|friedreich's ataxia
369495|NCT01370447|POLG1 deficiency|polg1 deficiency
369497|NCT01370408|Autologous stem cell transplant|autologous stem cell transplant
369498|NCT01370408|BEAM|beam
369499|NCT01370408|Oral busulfan|oral busulfan
369500|NCT01370408|Cyclophosphamide|cyclophosphamide
369501|NCT01370408|Etoposide|etoposide
369502|NCT01370408|Carboplatin|carboplatin
369503|NCT01370408|melphalan|melphalan
369504|NCT01370395|geriatrics|geriatrics
369505|NCT01370395|troponin|troponin
369506|NCT01370395|electrocardiography|electrocardiography
369507|NCT01370395|diagnosis|diagnosis
369508|NCT01370395|myocardial infarction|myocardial infarction
369509|NCT01370382|geriatrics|geriatrics
369510|NCT01370382|troponin|troponin
369511|NCT01370382|electrocardiography|electrocardiography
369512|NCT01370382|diagnosis|diagnosis
369513|NCT01370382|myocardial infarction|myocardial infarction
369514|NCT01370356|smoking reduction|smoking reduction
369515|NCT01370356|smoking cessation|smoking cessation
369516|NCT01370330|Neuroblastoma|neuroblastoma
369517|NCT01370330|MIBG|mibg
369518|NCT01370330|131I-MIBG|131i-mibg
369519|NCT01370330|Resistant|resistant
369520|NCT01370330|Relapsed|relapsed
369521|NCT01370330|Treatment|treatment
369522|NCT01370330|UCSF|ucsf
369523|NCT01370330|Pediatric|pediatric
369524|NCT01370330|Oncology|oncology
369525|NCT01370304|repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
369526|NCT01370304|Depression|depression
369527|NCT01370304|Venlafaxine|venlafaxine
369528|NCT01370304|fMRI|fmri
369529|NCT01370291|rTMS|rtms
369530|NCT01370291|Risperidone|risperidone
369531|NCT01370278|Central airway obstruction|central airway obstruction
369532|NCT01370278|lumen obstruction|lumen obstruction
369533|NCT01370278|Sodium bicarbonate|sodium bicarbonate
369534|NCT01370278|Baking soda|baking soda
369535|NCT01370278|Normal saline|normal saline
369536|NCT01370278|Salt water|salt water
369537|NCT01370278|Airway stents|airway stents
369538|NCT01370278|Bronchoscopy|bronchoscopy
369539|NCT01370278|mucus obstruction|mucus obstruction
369540|NCT01370265|Regadenoson (Lexiscan)|regadenoson (lexiscan)
369541|NCT01370265|PET N-13 ammonia imaging|pet n-13 ammonia imaging
369542|NCT01370265|Myocardial Blood Flow (MBF)|myocardial blood flow (mbf)
369543|NCT01370265|Regadenoson Stress|regadenoson stress
369544|NCT01370252|ankle arthrodesis|ankle arthrodesis
369545|NCT01370252|pain|pain
369546|NCT01370252|arthroscopic technique|arthroscopic technique
369547|NCT01370252|ankle osteoarthritis|ankle osteoarthritis
369548|NCT01370239|monoclonal antibody|monoclonal antibody
369549|NCT01370239|Lewis|lewis
369550|NCT01370239|breast cancer|breast cancer
369551|NCT01370213|non-myeloablative haploidentical transplant|non-myeloablative haploidentical transplant
369757|NCT01369420|locoregional cancer therapy|locoregional cancer therapy
369552|NCT01370213|hematopoietic cell transplant|hematopoietic cell transplant
369553|NCT01370213|natural killer cells|natural killer cells
369554|NCT01370213|adoptive cellular therapy|adoptive cellular therapy
369555|NCT01370200|citrate|citrate
369556|NCT01370200|anticoagulation|anticoagulation
369557|NCT01370200|plasma exchange|plasma exchange
369558|NCT01370200|efficacy|efficacy
369559|NCT01370187|Bronchiolitis|bronchiolitis
369560|NCT01370187|Postbronchiolitis wheezing|postbronchiolitis wheezing
369561|NCT01370187|Montelukast|montelukast
369562|NCT01370174|Falls|falls
369563|NCT01370174|Balance|balance
369564|NCT01370174|Protective Stepping|protective stepping
369565|NCT01370174|Lateral Balance|lateral balance
369566|NCT01370174|Elderly|elderly
369567|NCT01370161|transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
369568|NCT01370161|TIPS|tips
369569|NCT01370161|variceal bleeding|variceal bleeding
369570|NCT01370161|liver cirrhosis|liver cirrhosis
369571|NCT01370161|hepatitis B|hepatitis b
369572|NCT01370148|Pharmacokinetics|pharmacokinetics
369573|NCT01370148|Protein Binding|protein binding
369574|NCT01370148|Conivaptan|conivaptan
369575|NCT01370148|Vaprisol|vaprisol
369576|NCT01370148|Liver Disease|liver disease
369577|NCT01370148|YM087|ym087
369578|NCT01370135|neovascular glaucoma|neovascular glaucoma
369579|NCT01370135|rubeosis|rubeosis
369580|NCT01370135|anterior chamber|anterior chamber
369581|NCT01370135|intraocular|intraocular
369582|NCT01370135|intravitreal injections|intravitreal injections
369583|NCT01370135|Lucentis|lucentis
369584|NCT01370135|Ranibizumab|ranibizumab
369585|NCT01370135|short ans longterm effects|short ans longterm effects
369586|NCT01370135|best corrected visual acuity|best corrected visual acuity
369587|NCT01370135|gonioscopy|gonioscopy
369588|NCT01370135|BCVA|bcva
369589|NCT01370135|quality of life|quality of life
369590|NCT01370122|Women over the age of 20|women over the age of 20
369591|NCT01370083|Dysphagia|dysphagia
369592|NCT01370083|Viscosity|viscosity
369593|NCT01370083|Tongue|tongue
369594|NCT01370083|Pressure|pressure
369595|NCT01370057|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
369596|NCT01370057|Scoliosis|scoliosis
369597|NCT01370057|AIS|ais
369598|NCT01370057|Brace|brace
369599|NCT01370057|TLSO|tlso
369802|NCT01369342|colitis|colitis
369600|NCT01370044|Febrile Seizure|febrile seizure
369601|NCT01370044|Carbon Dioxide|carbon dioxide
369602|NCT01370044|Carbogen|carbogen
369603|NCT01370044|Respiratory Alkalosis|respiratory alkalosis
369604|NCT01370031|Asthma|asthma
369605|NCT01370031|PK|pk
369606|NCT01370031|Adults|adults
369607|NCT01370018|CD4 counts|cd4 counts
369608|NCT01369992|Metastatic Cancer|metastatic cancer
369609|NCT01369979|Lumped constant|lumped constant
369610|NCT01369979|FDG|fdg
369611|NCT01369979|PET|pet
369612|NCT01369966|Smoking Cessation|smoking cessation
369613|NCT01369966|Schizophrenic Smokers|schizophrenic smokers
369614|NCT01369966|fMRI|fmri
369615|NCT01369966|Neural Circuits|neural circuits
369616|NCT01369953|Civic Ideals/Social Norms|civic ideals/social norms
369617|NCT01369953|Genetic Counseling|genetic counseling
369618|NCT01369953|Genetic Disorders|genetic disorders
369619|NCT01369953|Genetic Testing|genetic testing
369620|NCT01369953|Whole Genome Sequencing|whole genome sequencing
369621|NCT01369940|Growth Discordancy|growth discordancy
369622|NCT01369940|Fetal Growth|fetal growth
369623|NCT01369940|Twin Growth|twin growth
369624|NCT01369927|Shigellosis|shigellosis
369625|NCT01369927|Safety and Immunogenicity|safety and immunogenicity
369626|NCT01369927|Conjugate Vaccine|conjugate vaccine
369627|NCT01369914|Graft-Versus-Host Disease|graft-versus-host disease
369628|NCT01369914|Natural History Study|natural history study
369629|NCT01369914|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
369630|NCT01369914|GVHD|gvhd
369631|NCT01369901|Exercise|exercise
369632|NCT01369901|Spinal Bulbar Muscular Atrophy|spinal bulbar muscular atrophy
369633|NCT01369901|Spinal and Bulbar Muscular Atrophy|spinal and bulbar muscular atrophy
369634|NCT01369901|SBMA|sbma
369635|NCT01369901|Motor Neuron Disease|motor neuron disease
369636|NCT01369888|Immunotherapy|immunotherapy
369637|NCT01369888|Cell Therapy|cell therapy
369638|NCT01369888|IL-15 Cytokine|il-15 cytokine
369639|NCT01369888|Melanoma|melanoma
369640|NCT01369888|Metastatic Melanoma|metastatic melanoma
369641|NCT01369888|Skin Cancer|skin cancer
369642|NCT01369875|Immunotherapy|immunotherapy
369643|NCT01369875|Cell Therapy|cell therapy
369644|NCT01369875|Metastatic Cancer|metastatic cancer
369645|NCT01369875|Melanoma|melanoma
369646|NCT01369875|Metastatic Melanoma|metastatic melanoma
369647|NCT01369875|Skin Cancer|skin cancer
369648|NCT01369862|live attenuated flu vaccines|live attenuated flu vaccines
369649|NCT01369862|influenza A (H1N1)|influenza a (h1n1)
369650|NCT01369862|intranasal application|intranasal application
369651|NCT01369862|replication-deficient influenza virus|replication-deficient influenza virus
369652|NCT01369836|Tafamidis|tafamidis
369653|NCT01369836|Pharmacokinetics|pharmacokinetics
369654|NCT01369836|TTR stabilization|ttr stabilization
369655|NCT01369823|HbA1c|hba1c
369656|NCT01369823|Paradigm 522/722 Infusion Pump|paradigm 522/722 infusion pump
369657|NCT01369823|Transmitter (MMT-7703WW)|transmitter (mmt-7703ww)
369658|NCT01369823|Sensor MMT-7002 (i.e. Glucose Sensor)|sensor mmt-7002 (i.e. glucose sensor)
369659|NCT01369823|Levels of HbA1c at enrollment higher than 7|levels of hba1c at enrollment higher than 7
369660|NCT01369810|Epidemiological|epidemiological
369661|NCT01369810|asthma|asthma
369662|NCT01369810|COPD|copd
369663|NCT01369810|reimbursement|reimbursement
369664|NCT01369810|switch|switch
369665|NCT01369810|outcomes associated with the change in reimbursement|outcomes associated with the change in reimbursement
369666|NCT01369797|UPSAV|upsav
369667|NCT01369797|autonomy|autonomy
369668|NCT01369797|the elderly of 75 years and older|the elderly of 75 years and older
369669|NCT01369784|Diffuse large B-cell Lymphoma|diffuse large b-cell lymphoma
369670|NCT01369784|R-IPI|r-ipi
369671|NCT01369771|Confocal microscopic findings|confocal microscopic findings
369672|NCT01369771|Ocular Hypertension|ocular hypertension
369673|NCT01369771|Open-Angle Glaucoma|open-angle glaucoma
369674|NCT01369771|Preservative-free eye drops|preservative-free eye drops
369675|NCT01369758|morcellator|morcellator
369676|NCT01369758|hysteroscope|hysteroscope
369677|NCT01369758|myomectomy|myomectomy
369678|NCT01369758|polypectomy|polypectomy
369679|NCT01369758|uterine fibroids|uterine fibroids
369680|NCT01369758|uterine polyps|uterine polyps
369681|NCT01369745|Rheumatoid Arthritis|rheumatoid arthritis
369682|NCT01369745|Moderate to severe|moderate to severe
369683|NCT01369719|Thalassemia|thalassemia
369684|NCT01369719|Iron overload|iron overload
369685|NCT01369719|transfusion|transfusion
369686|NCT01369719|osveral|osveral
369687|NCT01369719|desferal|desferal
369688|NCT01369706|electromagnetic interference|electromagnetic interference
369689|NCT01369706|hand-held metal detector|hand-held metal detector
369690|NCT01369706|pacemaker|pacemaker
369691|NCT01369706|cardioverter-defibrillator|cardioverter-defibrillator
369692|NCT01369693|smokeless tobacco|smokeless tobacco
369693|NCT01369693|Nicotine|nicotine
369695|NCT01369693|lead|lead
369696|NCT01369693|Tobacco Specific Nitrosamines|tobacco specific nitrosamines
369697|NCT01369680|Ketamine|ketamine
369698|NCT01369680|Chronic pain|chronic pain
369699|NCT01369680|Children|children
369700|NCT01369680|Oral pain medication|oral pain medication
369701|NCT01369654|hysterectomy with Bilateral Salpingo Oophorectomy|hysterectomy with bilateral salpingo oophorectomy
369702|NCT01369654|Oophorectomy|oophorectomy
369703|NCT01369654|Gynecologic condition|gynecologic condition
369704|NCT01369641|cisplatin|cisplatin
369706|NCT01369641|sodium thiosulfate|sodium thiosulfate
369707|NCT01369641|Adults|adults
369708|NCT01369641|dose range of 80-120mg/m2|dose range of 80-120mg/m2
369709|NCT01369628|Open label|open label
369710|NCT01369628|Dose Escalating|dose escalating
369711|NCT01369628|Phase Ib|phase ib
369712|NCT01369615|Malignant pain|malignant pain
369713|NCT01369615|Nonmalignant pain|nonmalignant pain
369714|NCT01369615|Pain|pain
369715|NCT01369615|Pediatric|pediatric
369716|NCT01369615|Opioid|opioid
369717|NCT01369615|Moderate to severe|moderate to severe
369718|NCT01369589|Xerostomia|xerostomia
369719|NCT01369589|dry mouth|dry mouth
369720|NCT01369589|Sjogren's Syndrome|sjogren's syndrome
369721|NCT01369563|rhinitis|rhinitis
369722|NCT01369563|ciclesonide|ciclesonide
369723|NCT01369563|intermittent rhinitis|intermittent rhinitis
369724|NCT01369563|persistent rhinitis|persistent rhinitis
369725|NCT01369524|fluid responsiveness|fluid responsiveness
369726|NCT01369524|microcirculation|microcirculation
369727|NCT01369524|Intensive Care|intensive care
369728|NCT01369511|Disuse Atrophy|disuse atrophy
369729|NCT01369511|Muscle|muscle
369730|NCT01369511|Strength|strength
369731|NCT01369511|Arthroplasty|arthroplasty
369732|NCT01369511|Hip|hip
369733|NCT01369511|Joint Replacement|joint replacement
369734|NCT01369498|Hematology|hematology
369735|NCT01369498|Myelofibrosis|myelofibrosis
369736|NCT01369498|Thrombocythemia Myelofibrosis|thrombocythemia myelofibrosis
369737|NCT01369498|Bone Marrow Diseases|bone marrow diseases
369738|NCT01369498|Hematologic Diseases|hematologic diseases
369739|NCT01369498|Blood Diseases|blood diseases
369740|NCT01369498|Leukemia|leukemia
369741|NCT01369498|Blood Disorders|blood disorders
369742|NCT01369485|Urinary Incontinence|urinary incontinence
369743|NCT01369485|Overactive Bladder|overactive bladder
369744|NCT01369485|Frequency|frequency
369745|NCT01369485|Urgency|urgency
369746|NCT01369459|Comorbid|comorbid
369747|NCT01369459|ADHD|adhd
369748|NCT01369459|SUD|sud
369749|NCT01369459|ASU|asu
369750|NCT01369446|In vitro fertilization|in vitro fertilization
369751|NCT01369446|Assisted reproduction|assisted reproduction
369752|NCT01369446|Noninvasive imaging of embryos|noninvasive imaging of embryos
369753|NCT01369446|Time lapse imaging of embryos|time lapse imaging of embryos
369754|NCT01369446|Traditional morphological grading of embryos|traditional morphological grading of embryos
369755|NCT01369446|Prediction of blastocysts|prediction of blastocysts
369758|NCT01369420|pancreatic cancer|pancreatic cancer
369759|NCT01369420|unresectable pancreatic cancer|unresectable pancreatic cancer
369760|NCT01369420|pancreatic adenocarcinoma|pancreatic adenocarcinoma
369761|NCT01369420|locally advanced, unresectable pancreatic cancer|locally advanced, unresectable pancreatic cancer
369762|NCT01369420|pancreatic cancer tumor ablation|pancreatic cancer tumor ablation
369763|NCT01369420|NanoKnife tumor ablation for pancreatic cancer|nanoknife tumor ablation for pancreatic cancer
369764|NCT01369420|NanoKnife LEDC system tumor ablation|nanoknife ledc system tumor ablation
369765|NCT01369420|Non thermal ablation|non thermal ablation
369766|NCT01369420|Irreversible electroporation for pancreatic cancer treatment|irreversible electroporation for pancreatic cancer treatment
369767|NCT01369420|IRE for unresectable pancreatic cancer|ire for unresectable pancreatic cancer
369768|NCT01369407|Heart failure|heart failure
369769|NCT01369407|HF|hf
369770|NCT01369407|Heart Diseases|heart diseases
369771|NCT01369407|Cardiovascular Diseases|cardiovascular diseases
369772|NCT01369407|Heart Failure NYHA class III|heart failure nyha class iii
369773|NCT01369407|Advanced heart failure|advanced heart failure
369774|NCT01369407|Systolic Heart Failure|systolic heart failure
369775|NCT01369394|Measles|measles
369776|NCT01369394|Mumps|mumps
369777|NCT01369394|Rubella|rubella
369778|NCT01369394|MMR|mmr
369779|NCT01369394|Prevention|prevention
369780|NCT01369394|Tailoring|tailoring
369781|NCT01369394|Persuasive communication|persuasive communication
369782|NCT01369394|Children|children
369783|NCT01369381|Cervical spine|cervical spine
369784|NCT01369381|Endotracheal intubation|endotracheal intubation
369785|NCT01369381|Laryngoscope|laryngoscope
369786|NCT01369381|Biomechanics|biomechanics
369787|NCT01369368|Acute myeloid leukemia|acute myeloid leukemia
369788|NCT01369368|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
369789|NCT01369368|Relapse|relapse
369790|NCT01369368|Disease stabilization, survival|disease stabilization, survival
369791|NCT01369355|Ustekinumab|ustekinumab
369792|NCT01369355|Stelara, Moderately to severely active Crohn's Disease|stelara, moderately to severely active crohn's disease
369793|NCT01369355|IBD, Crohn's|ibd, crohn's
369795|NCT01369355|colitis|colitis
369796|NCT01369355|IL-12|il-12
369797|NCT01369355|IL-23|il-23
369798|NCT01369342|ustekinumab|ustekinumab
369799|NCT01369342|moderately to severely active Crohn's Disease|moderately to severely active crohn's disease
369800|NCT01369342|Stelara|stelara
369801|NCT01369342|IBD|ibd
369803|NCT01369342|crohn|crohn
369804|NCT01369342|UNITI|uniti
369805|NCT01369342|Crohn's|crohn's
369806|NCT01369329|ustekinumab|ustekinumab
369807|NCT01369329|moderately to severely active Crohn's Disease|moderately to severely active crohn's disease
369808|NCT01369329|tumor necrosis factor, Stelara|tumor necrosis factor, stelara
369809|NCT01369329|Crohn|crohn
369810|NCT01369329|Crohn's|crohn's
369811|NCT01369329|IBD|ibd
369812|NCT01369329|UNITI|uniti
369813|NCT01369303|HIV|hiv
369814|NCT01369290|Depression|depression
369815|NCT01369290|Antidepressant Medication|antidepressant medication
369816|NCT01369290|CBT|cbt
369817|NCT01369277|PF-04991532|pf-04991532
369818|NCT01369277|safety and tolerability|safety and tolerability
369819|NCT01369277|PK|pk
369820|NCT01369277|Japanese and Western population|japanese and western population
369821|NCT01369264|Repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
369822|NCT01369264|Electroencephalography (EEG)|electroencephalography (eeg)
369823|NCT01369264|Magnetic Resonance Imaging|magnetic resonance imaging
369824|NCT01369264|Quantitative EEG (QEEG)|quantitative eeg (qeeg)
369825|NCT01369238|bee venom acupuncture|bee venom acupuncture
369826|NCT01369238|east west collaborative medicine|east west collaborative medicine
369827|NCT01369238|whiplash associated disorder|whiplash associated disorder
369828|NCT01369225|Randomized|randomized
369829|NCT01369225|Safety Study|safety study
369830|NCT01369225|Open Label|open label
369831|NCT01369199|Hepatitis B|hepatitis b
369832|NCT01369199|immune-tolerant hepatitis b|immune-tolerant hepatitis b
369833|NCT01369199|HBV|hbv
369834|NCT01369173|Healthy|healthy
369835|NCT01369147|SICU|sicu
369836|NCT01369147|calories|calories
369837|NCT01369147|TPN|tpn
369838|NCT01369147|tube feeding|tube feeding
369839|NCT01369147|Optimum Energy Dose in SICU|optimum energy dose in sicu
369840|NCT01369134|self-etch adhesive|self-etch adhesive
369841|NCT01369134|selective enamel etching|selective enamel etching
369842|NCT01369134|Adper Easy Bond|adper easy bond
369843|NCT01369134|Supreme Ultra|supreme ultra
369844|NCT01369134|Molar and premolar teeth|molar and premolar teeth
369845|NCT01369134|Adult|adult
369846|NCT01369134|Class I and II cavities|class i and ii cavities
369847|NCT01369121|peritumoral brain edema|peritumoral brain edema
369848|NCT01369121|edema|edema
369849|NCT01369121|malignant brain tumor|malignant brain tumor
369850|NCT01369121|brain tumor|brain tumor
369851|NCT01369121|dexamethasone|dexamethasone
369852|NCT01369121|Decadron|decadron
369853|NCT01369108|small Class I|small class i
369854|NCT01369108|molar and premolar|molar and premolar
370360|NCT01366859|Behavior|behavior
369855|NCT01369108|low stress flowable composite|low stress flowable composite
369856|NCT01369108|adult|adult
369857|NCT01369108|Restoration|restoration
369858|NCT01369108|small caries lesions|small caries lesions
369859|NCT01369082|islet allograft function|islet allograft function
369860|NCT01369082|c-peptide production|c-peptide production
369861|NCT01369082|maintenance immunosuppressive medications|maintenance immunosuppressive medications
369862|NCT01369069|stroke|stroke
369863|NCT01369069|diabetes|diabetes
369864|NCT01369069|hyperglycemia|hyperglycemia
369865|NCT01369056|antiretroviral therapy, highly active|antiretroviral therapy, highly active
369866|NCT01369056|treatment adherence|treatment adherence
369867|NCT01369043|Vitamin E|vitamin e
369868|NCT01369043|Vitamin C|vitamin c
369869|NCT01369043|Exercise|exercise
369870|NCT01369043|Antioxidant|antioxidant
369871|NCT01369030|L-methylfolate|l-methylfolate
369872|NCT01369030|Deplin|deplin
369873|NCT01369030|depression|depression
369874|NCT01369030|antidepressant|antidepressant
369875|NCT01369030|combination therapy|combination therapy
369876|NCT01369030|augmentation|augmentation
369877|NCT01369030|folate|folate
369878|NCT01369030|folic acid|folic acid
369879|NCT01369030|homocysteine|homocysteine
369880|NCT01369030|methionine|methionine
369881|NCT01369030|MTHFR genotype|mthfr genotype
369882|NCT01369030|C677T mutation|c677t mutation
369883|NCT01369030|vitamin B6|vitamin b6
369884|NCT01369030|vitamin B12|vitamin b12
369885|NCT01369017|healthy volunteer|healthy volunteer
369886|NCT01369017|endotoxin|endotoxin
369887|NCT01369004|self-weighing|self-weighing
369888|NCT01369004|self-monitoring|self-monitoring
369889|NCT01369004|weight loss|weight loss
369890|NCT01369004|obesity|obesity
369891|NCT01368991|Coronary Artery Bypass Grafts|coronary artery bypass grafts
369892|NCT01368991|Sternal Closure|sternal closure
369893|NCT01368991|Biologic Bone cement|biologic bone cement
369894|NCT01368978|TIDM|tidm
369895|NCT01368952|Obstructive Sleep Apnea|obstructive sleep apnea
369896|NCT01368952|Prone positioning|prone positioning
369897|NCT01368952|Positional Treatment|positional treatment
369898|NCT01368952|Hypoxemia|hypoxemia
369899|NCT01368939|breast imaging|breast imaging
369900|NCT01368939|MBI|mbi
369901|NCT01368939|dose reduction|dose reduction
369902|NCT01368939|Tc-99m|tc-99m
369903|NCT01368939|imaging|imaging
369904|NCT01368939|cardiac|cardiac
369905|NCT01368900|Ultherapy™ Treatment|ultherapy™ treatment
369906|NCT01368900|Ulthera, Inc.|ulthera, inc.
369907|NCT01368900|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
369908|NCT01368887|psoriasis|psoriasis
369909|NCT01368887|scalp psoriasis|scalp psoriasis
369910|NCT01368861|infant|infant
369911|NCT01368861|immunizations|immunizations
369912|NCT01368861|pain|pain
369913|NCT01368861|pain management|pain management
369914|NCT01368861|vaccines|vaccines
369915|NCT01368861|analgesia|analgesia
369916|NCT01368848|AGMT|agmt
369917|NCT01368848|NSCLC|nsclc
369918|NCT01368848|non-small cell lung cancer|non-small cell lung cancer
369919|NCT01368848|bevacizumab|bevacizumab
369920|NCT01368848|Avastin|avastin
369921|NCT01368848|Cisplatin|cisplatin
369922|NCT01368848|Docetaxel|docetaxel
369923|NCT01368848|Taxotere|taxotere
369924|NCT01368848|Inoperable|inoperable
369925|NCT01368848|stages IIIB and IV|stages iiib and iv
369926|NCT01368809|Ambulatory surgery|ambulatory surgery
369927|NCT01368809|Pain management|pain management
369928|NCT01368809|Perioperative outcomes|perioperative outcomes
369929|NCT01368809|Fentanyl|fentanyl
369930|NCT01368809|Coughing during insertion of an LMA|coughing during insertion of an lma
369931|NCT01368809|Ambulatory surgery procedures|ambulatory surgery procedures
369932|NCT01368796|Vaccine|vaccine
369933|NCT01368796|Influenza vaccine|influenza vaccine
369934|NCT01368796|Adjuvanted Influenza vaccine|adjuvanted influenza vaccine
369935|NCT01368796|Intradermal Influenza vaccine|intradermal influenza vaccine
369936|NCT01368796|Seniors|seniors
369937|NCT01368796|Acceptability of vaccines|acceptability of vaccines
369938|NCT01368796|Influenza|influenza
369939|NCT01368757|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
369940|NCT01368757|CMML|cmml
369941|NCT01368757|Lenalidomide|lenalidomide
369942|NCT01368757|Revlimid|revlimid
369943|NCT01368744|Breast Neoplasms|breast neoplasms
369944|NCT01368744|Breast Diseases|breast diseases
369945|NCT01368705|Infants|infants
369946|NCT01368705|Nitrogen Balance|nitrogen balance
369947|NCT01368705|Cardiothoracic surgery|cardiothoracic surgery
369948|NCT01368705|Congenital heart disease|congenital heart disease
369949|NCT01368705|Malnutrition|malnutrition
369950|NCT01368692|subclavian vein catheterization success rate|subclavian vein catheterization success rate
369951|NCT01368679|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
369952|NCT01368679|Abdominal Aortic|abdominal aortic
369953|NCT01368666|Aortic valve replacement|aortic valve replacement
369954|NCT01368666|Aortic stenosis|aortic stenosis
369955|NCT01368666|Biological valve|biological valve
369956|NCT01368666|Sutureless valve|sutureless valve
369957|NCT01368666|Stented valve|stented valve
369958|NCT01368666|Aortic Valve Disease|aortic valve disease
369959|NCT01368653|Tobacco|tobacco
369960|NCT01368653|Smoking|smoking
369961|NCT01368653|Smoking Cessation|smoking cessation
369962|NCT01368653|Tobacco Dependence|tobacco dependence
369963|NCT01368653|Tobacco Use|tobacco use
369964|NCT01368653|Nicotine Dependence|nicotine dependence
369965|NCT01368627|Coronary Artery Disease|coronary artery disease
369966|NCT01368627|Restenosis|restenosis
369967|NCT01368627|Stent thrombosis|stent thrombosis
369968|NCT01368627|Coronary stents|coronary stents
369969|NCT01368627|Angioplasty|angioplasty
369970|NCT01368627|Drug Eluting Stents(DES)|drug eluting stents(des)
369971|NCT01368614|OHS|ohs
369972|NCT01368601|Lung Cancer|lung cancer
369973|NCT01368601|CPAP|cpap
369974|NCT01368601|PPC|ppc
369975|NCT01368601|lobectomy|lobectomy
369976|NCT01368601|One-lung ventilation|one-lung ventilation
369977|NCT01368588|adenocarcinoma of the prostate|adenocarcinoma of the prostate
369978|NCT01368588|stage I prostate cancer|stage i prostate cancer
369979|NCT01368588|stage IIA prostate cancer|stage iia prostate cancer
369980|NCT01368588|stage IIB prostate cancer|stage iib prostate cancer
369981|NCT01368588|stage III prostate cancer|stage iii prostate cancer
369982|NCT01368575|Ischemic|ischemic
369983|NCT01368575|Mitral|mitral
369984|NCT01368575|Valve|valve
369985|NCT01368575|Insufficiency|insufficiency
369986|NCT01368575|SVR|svr
369987|NCT01368549|Metanx|metanx
369988|NCT01368549|diabetes|diabetes
369989|NCT01368549|neuropathy|neuropathy
369990|NCT01368549|folic acid|folic acid
369991|NCT01368549|folate|folate
369992|NCT01368549|L-methylfolate|l-methylfolate
369993|NCT01368549|vitamin B6|vitamin b6
369994|NCT01368549|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
369995|NCT01368549|vitamin B12|vitamin b12
369997|NCT01368549|DPN|dpn
369998|NCT01368536|High blood pressure|high blood pressure
369999|NCT01368536|diabetes|diabetes
370000|NCT01368523|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
370001|NCT01368523|chronic phase|chronic phase
370002|NCT01368523|accelerated phase|accelerated phase
370003|NCT01368523|blastic phase|blastic phase
370004|NCT01368523|nilotinib|nilotinib
370005|NCT01368510|obsessive-compulsive disorder (OCD)|obsessive-compulsive disorder (ocd)
370006|NCT01368510|cognitive-behavioral therapy (CBT)|cognitive-behavioral therapy (cbt)
370007|NCT01368510|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
370008|NCT01368510|glutamate|glutamate
370009|NCT01368510|cingulate gyrus|cingulate gyrus
370010|NCT01368471|STEMI|stemi
370011|NCT01368471|myocardial infarction|myocardial infarction
370012|NCT01368471|stent|stent
370013|NCT01368432|TBI|tbi
370014|NCT01368432|Depression|depression
370015|NCT01368432|Mood|mood
370016|NCT01368432|Behavior|behavior
370017|NCT01368419|Endostar|endostar
370018|NCT01368419|Radiotherapy|radiotherapy
370019|NCT01368419|Esophageal Cancer|esophageal cancer
370020|NCT01368406|schizophrenia|schizophrenia
370021|NCT01368406|weight gain|weight gain
370022|NCT01368406|intervention|intervention
370023|NCT01368380|Breast cancer|breast cancer
370024|NCT01368380|Partners|partners
370025|NCT01368380|Couples|couples
370026|NCT01368380|Attachment|attachment
370027|NCT01368380|Intervention|intervention
370028|NCT01368367|Burns|burns
370029|NCT01368354|Community Led Total Sanitation|community led total sanitation
370030|NCT01368354|Open Defecation|open defecation
370031|NCT01368354|Cysticercosis|cysticercosis
370032|NCT01368354|Soil transmitted helminths|soil transmitted helminths
370033|NCT01368354|Zambia|zambia
370034|NCT01368341|Antibiotics|antibiotics
370035|NCT01368341|General Practice|general practice
370036|NCT01368341|Erythema migrans|erythema migrans
370037|NCT01368341|Borrelia|borrelia
370038|NCT01368341|Ticks|ticks
370039|NCT01368328|Type 2 Diabetes|type 2 diabetes
370040|NCT01368328|Chromium|chromium
370041|NCT01368328|Insulin resistance|insulin resistance
370042|NCT01368302|attention bias modification treatment|attention bias modification treatment
370043|NCT01368302|cognitive bias modification|cognitive bias modification
370044|NCT01368302|attention training|attention training
370045|NCT01368302|anxiety|anxiety
370046|NCT01368276|Melanoma|melanoma
370047|NCT01368276|Stage IIIb, IIIc and IV Disease|stage iiib, iiic and iv disease
370048|NCT01368276|oncolytic|oncolytic
370049|NCT01368276|OncoVex|oncovex
370050|NCT01368276|OncoVEX^GM-CSF|oncovex^gm-csf
370051|NCT01368250|Aortic|aortic
370052|NCT01368250|Stenosis|stenosis
370053|NCT01368250|Valve|valve
370054|NCT01368250|VARC|varc
370055|NCT01368250|Transcatheter|transcatheter
370056|NCT01368250|Minimal-invasive|minimal-invasive
370057|NCT01368237|Computed tomography|computed tomography
370058|NCT01368237|Myocardial perfusion|myocardial perfusion
370059|NCT01368237|Coronary heart disease|coronary heart disease
370060|NCT01368224|Skin sensitivity|skin sensitivity
370061|NCT01368224|Trans-epidermal water loss|trans-epidermal water loss
370062|NCT01368224|Clinical score|clinical score
370063|NCT01368224|skin moisturization factors|skin moisturization factors
370064|NCT01368224|serum immune-regulatory cytokine|serum immune-regulatory cytokine
370065|NCT01368224|Evaluation of intestinal flora composition|evaluation of intestinal flora composition
370066|NCT01368211|Mirasol|mirasol
370067|NCT01368211|Thrombocytopenic|thrombocytopenic
370068|NCT01368211|Pathogen reduction|pathogen reduction
370069|NCT01368211|Platelets|platelets
370070|NCT01368211|Thromboelastography|thromboelastography
370071|NCT01368211|CCI|cci
370072|NCT01368211|Corrected Count Increment|corrected count increment
370073|NCT01368198|Ocular Emulsion|ocular emulsion
370074|NCT01368198|OPTIVE™ Lubricant|optive™ lubricant
370075|NCT01368198|Tear Film Break Up Time|tear film break up time
370076|NCT01368185|Essential hypertension Uric acid Retrospective Hyzaar|essential hypertension uric acid retrospective hyzaar
370077|NCT01368172|spinal cord injury|spinal cord injury
370078|NCT01368172|physical activity|physical activity
370079|NCT01368172|physical fitness|physical fitness
370080|NCT01368133|acromegaly|acromegaly
370081|NCT01368133|pituitary tumor|pituitary tumor
370082|NCT01368107|IL-7|il-7
370083|NCT01368107|metastatic breast cancer patients|metastatic breast cancer patients
370084|NCT01368107|lymphopenia|lymphopenia
370085|NCT01368094|Pancreaticoduodenectomy|pancreaticoduodenectomy
370086|NCT01368094|Drainage|drainage
370087|NCT01368094|Surgical site infection|surgical site infection
370088|NCT01368068|Perimenopause|perimenopause
370089|NCT01368068|Depression|depression
370090|NCT01368055|Proton Radiation, Prostate Cancer|proton radiation, prostate cancer
370091|NCT01368042|Quality of Life changes|quality of life changes
370092|NCT01368042|Secondary Hyperparathyroidism|secondary hyperparathyroidism
370093|NCT01368042|Chronic Kidney Disease|chronic kidney disease
370094|NCT01368042|Hemodialysis|hemodialysis
6535|NCT03249324|Pregnancy|pregnancy
370095|NCT01368042|Paricalcitol intravenous treatment|paricalcitol intravenous treatment
370096|NCT01368029|LGG|lgg
370097|NCT01368029|Immune response|immune response
370098|NCT01368029|Influenza vaccine|influenza vaccine
370099|NCT01368029|Elderly|elderly
370100|NCT01368029|Healthy|healthy
370101|NCT01368029|Microbiome|microbiome
370102|NCT01368016|Smoking Cessation|smoking cessation
370103|NCT01368016|Nicotine Pharmacodynamics|nicotine pharmacodynamics
370104|NCT01368003|Castration resistant prostate cancer|castration resistant prostate cancer
370105|NCT01367990|alopecia|alopecia
370106|NCT01367990|hair loss|hair loss
370107|NCT01367990|prevention|prevention
370108|NCT01367990|radiotherapy|radiotherapy
370109|NCT01367990|head & neck cancer|head & neck cancer
370110|NCT01367990|radiodermatitis|radiodermatitis
370111|NCT01367990|radiation dermatitis|radiation dermatitis
370112|NCT01367990|radiation-induced alopecia|radiation-induced alopecia
370113|NCT01367977|Ehlers Danlos Syndrome|ehlers danlos syndrome
370114|NCT01367977|External Communicating Hydrocephalus|external communicating hydrocephalus
370115|NCT01367977|Dysautonomia|dysautonomia
370116|NCT01367977|Postural orthostatic tachycardia syndrome|postural orthostatic tachycardia syndrome
370117|NCT01367977|Chronic cerebrospinal venous insufficiency|chronic cerebrospinal venous insufficiency
370118|NCT01367964|Hypsarrhythmia|hypsarrhythmia
370119|NCT01367964|Spasms, Infantile|spasms, infantile
370120|NCT01367964|West Syndrome|west syndrome
370121|NCT01367951|unstable chest injury|unstable chest injury
370122|NCT01367951|flail chest|flail chest
370123|NCT01367951|chest wall injury|chest wall injury
370124|NCT01367951|rib fracture|rib fracture
370125|NCT01367938|Osteoarthritis|osteoarthritis
370126|NCT01367938|Total Knee Replacement|total knee replacement
370127|NCT01367925|Osteoarthritis|osteoarthritis
370128|NCT01367925|Total Knee Replacement|total knee replacement
370129|NCT01367912|Luteal phase support|luteal phase support
370130|NCT01367912|estradiol supplementation|estradiol supplementation
370131|NCT01367912|IVF/ICSI|ivf/icsi
370132|NCT01367912|clinical pregnancy rate|clinical pregnancy rate
370133|NCT01367899|Safety|safety
370134|NCT01367899|Efficacy|efficacy
370135|NCT01367886|Urine proteomics|urine proteomics
370136|NCT01367886|overactive bladder|overactive bladder
370137|NCT01367860|spine surgery|spine surgery
370138|NCT01367860|low back pain|low back pain
370139|NCT01367860|herniated disk|herniated disk
370140|NCT01367847|Parenting|parenting
370141|NCT01367847|Parent-Child Relations|parent-child relations
370142|NCT01367847|Child Behavior|child behavior
370143|NCT01367834|Turner Syndrome|turner syndrome
370144|NCT01367834|growth hormone|growth hormone
370145|NCT01367834|brain development|brain development
370146|NCT01367821|Obstructive jaundice|obstructive jaundice
370147|NCT01367821|ERCP|ercp
370148|NCT01367821|Immune dysfunction|immune dysfunction
370149|NCT01367821|Endotoxin tolerance|endotoxin tolerance
370150|NCT01367821|Quorum sensing|quorum sensing
370151|NCT01367808|Buprenorphine|buprenorphine
370152|NCT01367808|Vorikonazole|vorikonazole
370153|NCT01367808|Posakonazole|posakonazole
370154|NCT01367808|Interactions|interactions
370155|NCT01367795|palliation|palliation
370156|NCT01367795|quality of life|quality of life
370157|NCT01367795|surgery|surgery
370158|NCT01367795|surgery; palliative|surgery; palliative
370159|NCT01367795|lifestyle|lifestyle
370160|NCT01367782|UPDRS|updrs
370161|NCT01367769|Deep vein thrombosis|deep vein thrombosis
370162|NCT01367769|superficial thrombophlebitis|superficial thrombophlebitis
370163|NCT01367769|contrast ultrasound|contrast ultrasound
370164|NCT01367743|myocardial infarction|myocardial infarction
370165|NCT01367743|epinephrine|epinephrine
370166|NCT01367743|norepinephrine|norepinephrine
370167|NCT01367743|cardiac output|cardiac output
370168|NCT01367730|osteopenia and osteoporosis|osteopenia and osteoporosis
370169|NCT01367717|Creatine|creatine
370170|NCT01367717|Creatinine|creatinine
370171|NCT01367717|Serum Creatinine|serum creatinine
370172|NCT01367717|Urine Creatinine|urine creatinine
370173|NCT01367717|Creatine Monohydrate|creatine monohydrate
370174|NCT01367717|Creatine Ethyl Ester|creatine ethyl ester
370175|NCT01367717|Acute Kidney Injury|acute kidney injury
370176|NCT01367717|Renal|renal
370177|NCT01367717|Kidney|kidney
370178|NCT01367704|gender-based violence|gender-based violence
370179|NCT01367704|intimate partner violence|intimate partner violence
370180|NCT01367704|relationship abuse|relationship abuse
370181|NCT01367704|sexual harassment|sexual harassment
370182|NCT01367704|sexual violence|sexual violence
370183|NCT01367691|CRT|crt
370184|NCT01367691|heart failure|heart failure
370185|NCT01367691|CMR|cmr
370186|NCT01367691|safety|safety
370187|NCT01367639|BRCA 1/2 Carriers|brca 1/2 carriers
370188|NCT01367639|IBSR|ibsr
370189|NCT01367639|The Work|the work
370190|NCT01367639|Randomized clinical trial|randomized clinical trial
370191|NCT01367613|Advanced medical illness|advanced medical illness
370192|NCT01367600|Advanced medical illness|advanced medical illness
370193|NCT01367574|Opioid-induced bowel dysfunction|opioid-induced bowel dysfunction
370194|NCT01367444|Stargardt Disease|stargardt disease
370195|NCT01367431|Xanthohumol|xanthohumol
370196|NCT01367431|Metabolic syndrome|metabolic syndrome
370197|NCT01367418|Analgesia: Thoracic epidural, patient controlled|analgesia: thoracic epidural, patient controlled
370198|NCT01367418|Surgery: Radical retropubic prostatectomy|surgery: radical retropubic prostatectomy
370199|NCT01367418|Immune system|immune system
370200|NCT01367418|Inflammation|inflammation
370201|NCT01367405|Surgical decompression|surgical decompression
370202|NCT01367405|conservative treatment|conservative treatment
370203|NCT01367405|incomplete spinal cord lesion|incomplete spinal cord lesion
370204|NCT01367405|recovery|recovery
370205|NCT01367379|Physician|physician
370206|NCT01367379|duty loading|duty loading
370207|NCT01367379|stress response|stress response
370208|NCT01367379|Physician with different amount of duty area|physician with different amount of duty area
370209|NCT01367366|malignant mediastinal lymphadenopathy|malignant mediastinal lymphadenopathy
370210|NCT01367366|positron emission tomography|positron emission tomography
370211|NCT01367366|endobronchial ultrasound|endobronchial ultrasound
370212|NCT01367366|transbronchial needle aspiration|transbronchial needle aspiration
370213|NCT01367327|Exercise|exercise
370214|NCT01367288|locally advanced breast cancer|locally advanced breast cancer
370215|NCT01367288|neoadjuvant chemotherapy|neoadjuvant chemotherapy
370216|NCT01367288|HER2-negative breast cancer|her2-negative breast cancer
370217|NCT01367288|stage IIb breast cancer|stage iib breast cancer
370218|NCT01367288|stage IIIa breast cancer|stage iiia breast cancer
370219|NCT01367288|Zoledronic acid|zoledronic acid
370220|NCT01367288|bisphosphonate|bisphosphonate
370221|NCT01367288|zometa|zometa
370222|NCT01367288|therapeutic response|therapeutic response
370223|NCT01367288|VEGF serum|vegf serum
370224|NCT01367288|tumors markers|tumors markers
370225|NCT01367288|neoangiogenesis|neoangiogenesis
370226|NCT01367288|apoptosis|apoptosis
370227|NCT01367288|proliferation|proliferation
370228|NCT01367288|disseminated tumors cells|disseminated tumors cells
370229|NCT01367288|gamma-delta T cells activation|gamma-delta t cells activation
370230|NCT01367275|colon|colon
370231|NCT01367275|Colorectum|colorectum
370232|NCT01367275|Colorectal Cancer|colorectal cancer
370233|NCT01367275|Plasma FGF|plasma fgf
370234|NCT01367275|Colorectal adenocarcinoma|colorectal adenocarcinoma
370235|NCT01367275|Bevacizumab|bevacizumab
370236|NCT01367275|Brivanib|brivanib
370237|NCT01367275|BMS-582664|bms-582664
370238|NCT01367275|Irinotecan|irinotecan
370239|NCT01367275|CPT-11|cpt-11
370240|NCT01367275|Camptosar|camptosar
370241|NCT01367275|Fibroblast Growth Factor|fibroblast growth factor
370242|NCT01367275|bFGF|bfgf
370243|NCT01367275|tyrosine kinase receptors|tyrosine kinase receptors
370244|NCT01367275|vascular endothelial growth factor receptors|vascular endothelial growth factor receptors
453273|NCT00013507|FIT|fit
370245|NCT01367275|VEGFR|vegfr
370246|NCT01367275|fibroblast growth factor receptors|fibroblast growth factor receptors
370247|NCT01367275|FGFR|fgfr
370248|NCT01367262|Absorption|absorption
370249|NCT01367262|Distribution|distribution
370250|NCT01367262|Metabolism|metabolism
370251|NCT01367262|Excretion|excretion
370252|NCT01367249|cataract surgery|cataract surgery
370253|NCT01367223|inflammatory response|inflammatory response
370254|NCT01367223|parenteral nutrition|parenteral nutrition
370255|NCT01367223|glutamine|glutamine
370256|NCT01367223|amino acid|amino acid
370257|NCT01367223|pediatric|pediatric
370258|NCT01367223|intensive care|intensive care
370259|NCT01367223|systemic infection|systemic infection
370260|NCT01367223|abdominal surgery|abdominal surgery
370261|NCT01367223|polytraumatised|polytraumatised
370262|NCT01367223|mortality|mortality
370263|NCT01367223|mean stay in the intensive care unit|mean stay in the intensive care unit
370264|NCT01367223|occurrence of infections|occurrence of infections
370266|NCT01367210|AIDS|aids
370267|NCT01367210|Highly Active AntiRetroviral Therapy|highly active antiretroviral therapy
370268|NCT01367210|Simplification|simplification
370269|NCT01367210|Maraviroc|maraviroc
370270|NCT01367210|Darunavir|darunavir
370271|NCT01367210|Treatment experienced|treatment experienced
370272|NCT01367210|Tropism|tropism
370273|NCT01367197|exercise training|exercise training
370274|NCT01367197|atrial fibrillation|atrial fibrillation
370275|NCT01367184|VTE|vte
370276|NCT01367184|Inferior vena cava|inferior vena cava
370277|NCT01367184|Venous thrombo-embolism|venous thrombo-embolism
370278|NCT01367184|Outcome data|outcome data
370279|NCT01367184|IVC Filters|ivc filters
370280|NCT01367158|Meningococcal disease|meningococcal disease
370281|NCT01367158|vaccines|vaccines
370282|NCT01367158|adolescents|adolescents
370283|NCT01367158|prevention|prevention
370284|NCT01367158|Meningitis|meningitis
370285|NCT01367145|OMEGA-3 polyunsaturated fatty-acids|omega-3 polyunsaturated fatty-acids
370286|NCT01367145|Peripheral Arterial Disease|peripheral arterial disease
370287|NCT01367145|Endothelial Function|endothelial function
370288|NCT01367145|Inflammation|inflammation
370289|NCT01367145|Platelet Function|platelet function
370290|NCT01367132|ultrasound|ultrasound
370291|NCT01367132|first trimester|first trimester
370292|NCT01367132|umbilical cord|umbilical cord
370293|NCT01367119|Depression|depression
370294|NCT01367119|Electroconvulsive therapy|electroconvulsive therapy
370295|NCT01367119|Ketamine|ketamine
370296|NCT01367119|Methohexital|methohexital
370297|NCT01367106|offspring of 21-hydroxylase enzyme block|offspring of 21-hydroxylase enzyme block
370298|NCT01367093|BIOLOGICAL MARKERS|biological markers
370299|NCT01367093|INTENSIVE CARE UNIT|intensive care unit
370300|NCT01367093|MORTALITY|mortality
370301|NCT01367093|QUALITY OF LIFE|quality of life
370302|NCT01367093|CARDIOVASCULAR|cardiovascular
370303|NCT01367080|depression|depression
370304|NCT01367067|claustrophobia|claustrophobia
370305|NCT01367067|magnetic resonance imaging|magnetic resonance imaging
370306|NCT01367067|MRI|mri
370307|NCT01367067|anxiety|anxiety
370308|NCT01367067|anxious patients|anxious patients
370309|NCT01367067|phobic disorders|phobic disorders
370310|NCT01367067|anxiety disorders|anxiety disorders
370311|NCT01367067|mental disorders|mental disorders
370312|NCT01367054|Metformine|metformine
370313|NCT01367054|adverse events|adverse events
370314|NCT01367054|bioequivalence|bioequivalence
370315|NCT01367041|bone|bone
370316|NCT01367041|muscle electrical activity|muscle electrical activity
370317|NCT01367041|whole-body vibration|whole-body vibration
370318|NCT01367028|HER2-positive early breast cancer|her2-positive early breast cancer
370319|NCT01367015|Preterm|preterm
370320|NCT01367015|SGA|sga
370321|NCT01367015|AREDF|aredf
370322|NCT01367015|Early feeding|early feeding
370323|NCT01367015|Late feeding|late feeding
370324|NCT01367015|Feed intolerance|feed intolerance
370325|NCT01367015|Necrotizing enterocolitis|necrotizing enterocolitis
370326|NCT01367015|Days to achieve Full Feeds defined as 150 mL/kg|days to achieve full feeds defined as 150 ml/kg
370327|NCT01367002|Uterine serous papillary carcinoma|uterine serous papillary carcinoma
370328|NCT01367002|Type II endometrial cancer|type ii endometrial cancer
370329|NCT01367002|HER2/neu|her2/neu
587483|NCT00532402|Monitoring|monitoring
370330|NCT01367002|Paclitaxel, Carboplatin, Trastuzumab|paclitaxel, carboplatin, trastuzumab
370331|NCT01366989|Total Ankle Arthroplasty|total ankle arthroplasty
370332|NCT01366976|oxidative stress|oxidative stress
370333|NCT01366976|cardiopulmonary bypass|cardiopulmonary bypass
370334|NCT01366976|acetaminophen|acetaminophen
370335|NCT01366976|hemolysis|hemolysis
370336|NCT01366963|postural tachycardia syndrome|postural tachycardia syndrome
370337|NCT01366963|brain fog|brain fog
370338|NCT01366963|cognitive dysfunction|cognitive dysfunction
370339|NCT01366937|vitamin B12|vitamin b12
370340|NCT01366937|egg|egg
370341|NCT01366937|14C|14c
370342|NCT01366937|fecal excretion|fecal excretion
370343|NCT01366924|protein turnover|protein turnover
453312|NCT00013546|TS|ts
370344|NCT01366924|whole body protein turnover|whole body protein turnover
370345|NCT01366924|essential amino acids|essential amino acids
370346|NCT01366924|leucine|leucine
370347|NCT01366911|stem cells|stem cells
370348|NCT01366911|QCT testing|qct testing
370349|NCT01366911|Bone density findings|bone density findings
370350|NCT01366911|mesenchymal stem cells|mesenchymal stem cells
370351|NCT01366885|Autism|autism
370352|NCT01366885|Pregnancy|pregnancy
370353|NCT01366885|Newborn siblings|newborn siblings
370354|NCT01366872|ankle|ankle
370355|NCT01366872|arthritis|arthritis
370356|NCT01366872|total ankle arthroplasty|total ankle arthroplasty
370357|NCT01366872|Agility LP,|agility lp,
370358|NCT01366859|Autism|autism
370359|NCT01366859|Children|children
370361|NCT01366859|Glutathione|glutathione
370362|NCT01366859|Whey Protein|whey protein
370363|NCT01366859|Immunocal|immunocal
370364|NCT01366859|Antioxidant|antioxidant
370365|NCT01366846|Peanut|peanut
370366|NCT01366833|Dysphagia|dysphagia
370367|NCT01366833|Esophagus|esophagus
370368|NCT01366833|Cancer|cancer
370369|NCT01366833|Esophageal Cancer|esophageal cancer
370370|NCT01366794|Gut hormones|gut hormones
370371|NCT01366794|Insulin secretion|insulin secretion
370372|NCT01366781|Gut hormones|gut hormones
370373|NCT01366781|Insulin secretion|insulin secretion
370374|NCT01366768|Gut hormones|gut hormones
370375|NCT01366768|Insulin secretion|insulin secretion
370376|NCT01366768|Normal physiology|normal physiology
370377|NCT01366729|hemiplegia|hemiplegia
370378|NCT01366729|walking|walking
370379|NCT01366729|canes|canes
370380|NCT01366729|TheraTogs|theratogs
370381|NCT01366729|EMG|emg
370382|NCT01366729|balance|balance
370383|NCT01366729|Timed up and go|timed up and go
370384|NCT01366716|Contingency Management|contingency management
370385|NCT01366716|Cash|cash
370386|NCT01366716|Substance Abuse|substance abuse
370387|NCT01366716|Ethics|ethics
370388|NCT01366703|heart failure|heart failure
370389|NCT01366703|implantable loop recorder|implantable loop recorder
370390|NCT01366690|HIV|hiv
370391|NCT01366690|community health workers|community health workers
370392|NCT01366690|randomized trial|randomized trial
370393|NCT01366690|task shifting|task shifting
370394|NCT01366690|Uganda|uganda
370395|NCT01366690|retention|retention
370396|NCT01366690|operations research|operations research
370397|NCT01366690|implementation research|implementation research
370398|NCT01366664|Premature Ejaculation|premature ejaculation
370399|NCT01366664|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
370400|NCT01366664|Dapoxetine|dapoxetine
370401|NCT01366664|PRILIGY|priligy
370402|NCT01366664|Terazosin|terazosin
370403|NCT01366664|Pharmacodynamic|pharmacodynamic
370404|NCT01366664|Pharmacokinetic|pharmacokinetic
370405|NCT01366651|Doripenem|doripenem
370406|NCT01366651|DORIPED1002|doriped1002
370407|NCT01366651|Intravenous|intravenous
370408|NCT01366651|Pediatric|pediatric
370409|NCT01366651|Antibiotic|antibiotic
370410|NCT01366651|Meningitis|meningitis
370411|NCT01366638|Hepatitis C, Chronic|hepatitis c, chronic
370412|NCT01366638|TMC435|tmc435
370413|NCT01366638|Hepatitis C|hepatitis c
370414|NCT01366638|Hepatitis C virus|hepatitis c virus
370415|NCT01366638|Interferon Alfa-2b|interferon alfa-2b
370416|NCT01366638|Ribavirin|ribavirin
370417|NCT01366638|Viral ribonucleic acid|viral ribonucleic acid
370418|NCT01366625|hypertension, resistant|hypertension, resistant
370419|NCT01366625|obstructive sleep apnea|obstructive sleep apnea
370420|NCT01366625|renal denervation|renal denervation
370421|NCT01366625|continuous positive airway pressure therapy|continuous positive airway pressure therapy
370422|NCT01366612|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
370423|NCT01366612|AML|aml
370424|NCT01366612|CML|cml
370425|NCT01366612|MDS|mds
370426|NCT01366599|highly emetogenic chemotherapy|highly emetogenic chemotherapy
370427|NCT01366599|HEC|hec
370428|NCT01366599|moderately emetogenic chemotherapy|moderately emetogenic chemotherapy
370429|NCT01366599|MEC|mec
370430|NCT01366573|Pharmacokinetics|pharmacokinetics
370431|NCT01366573|mu-opioid receptors|mu-opioid receptors
370432|NCT01366573|Addiction|addiction
370433|NCT01366573|Pharmacodynamics|pharmacodynamics
370434|NCT01366573|Alcohol|alcohol
370435|NCT01366547|Bioavailability|bioavailability
370436|NCT01366547|Lamivudine|lamivudine
588131|NCT00532753|education|education
370437|NCT01366547|Dolutegravir|dolutegravir
370438|NCT01366547|integrase|integrase
370439|NCT01366547|Abacavir|abacavir
370441|NCT01366534|Vaccine|vaccine
370442|NCT01366534|Phase 1/2|phase 1/2
370443|NCT01366534|immunogenicity|immunogenicity
370444|NCT01366534|Malaria|malaria
370445|NCT01366534|efficacy|efficacy
370446|NCT01366534|sporozoite challenge|sporozoite challenge
370447|NCT01366495|Seek|seek
370448|NCT01366495|Test|test
370449|NCT01366495|Treat|treat
370450|NCT01366482|Peripheral arterial disease,|peripheral arterial disease,
370451|NCT01366482|claudication,|claudication,
370452|NCT01366482|atherectomy,|atherectomy,
370453|NCT01366482|plaque excision,|plaque excision,
370454|NCT01366482|drug-coated balloon|drug-coated balloon
370455|NCT01366482|drug-eluting balloon|drug-eluting balloon
370456|NCT01366469|coronary artery bypass grafting|coronary artery bypass grafting
370457|NCT01366469|coronary artery disease|coronary artery disease
370458|NCT01366469|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
370459|NCT01366456|Temperature Change|temperature change
370460|NCT01366456|Moxibustion|moxibustion
370461|NCT01366456|Warming effect|warming effect
370462|NCT01366443|ROM PLUS|rom plus
370463|NCT01366443|conventional clinical tests of rupture of membranes (ROM)|conventional clinical tests of rupture of membranes (rom)
370464|NCT01366443|speculum exam|speculum exam
370465|NCT01366443|visualization of leakage|visualization of leakage
370559|NCT01366001|Dependence|dependence
370466|NCT01366443|pooling of amniotic fluid in the posterior fornix|pooling of amniotic fluid in the posterior fornix
370467|NCT01366443|nitrazine testing|nitrazine testing
370468|NCT01366443|ferning|ferning
370469|NCT01366430|BPPV(benign paroxysmal positional vertigo)|bppv(benign paroxysmal positional vertigo)
370470|NCT01366430|HC-BPPV(BPPV involving the horizontal semicircular canal)|hc-bppv(bppv involving the horizontal semicircular canal)
370471|NCT01366430|Nystagmus|nystagmus
370472|NCT01366430|Treatment outcome|treatment outcome
370473|NCT01366430|Horizontal Canal Benign Paroxysmal Positional Vertigo|horizontal canal benign paroxysmal positional vertigo
370474|NCT01366404|FFR|ffr
370475|NCT01366391|polycystic ovary syndrome|polycystic ovary syndrome
370476|NCT01366391|metformin|metformin
370477|NCT01366391|pharmacokinetic|pharmacokinetic
370478|NCT01366313|paracetamol|paracetamol
370479|NCT01366313|morphine|morphine
370480|NCT01366313|median effective dose|median effective dose
370481|NCT01366313|pain|pain
370482|NCT01366287|Relative bioavailability|relative bioavailability
370483|NCT01366287|food effect|food effect
370484|NCT01366287|tablet|tablet
370485|NCT01366287|suspension|suspension
370486|NCT01366287|single dose|single dose
370487|NCT01366287|crossover|crossover
370488|NCT01366287|healthy subjects|healthy subjects
370489|NCT01366274|Trauma|trauma
370490|NCT01366261|Flex-rigid pleuroscopy|flex-rigid pleuroscopy
370491|NCT01366261|pleural biopsy|pleural biopsy
370492|NCT01366261|pleural effusion|pleural effusion
370493|NCT01366261|safety|safety
370494|NCT01366261|thoracoscopy|thoracoscopy
370495|NCT01366222|asthma|asthma
370496|NCT01366209|Pirfenidone|pirfenidone
370497|NCT01366209|ASCEND|ascend
370499|NCT01366209|FVC|fvc
370500|NCT01366196|Orthopedic Procedures|orthopedic procedures
370501|NCT01366196|Spinal Fusions|spinal fusions
370502|NCT01366196|Pregabalin|pregabalin
370503|NCT01366196|Gamma-Aminobutyric Acid|gamma-aminobutyric acid
370504|NCT01366196|Analgesics|analgesics
370505|NCT01366196|Sensory System Agents|sensory system agents
370506|NCT01366196|Peripheral Nervous System Agents|peripheral nervous system agents
370507|NCT01366196|Physiological Effects of Drugs|physiological effects of drugs
370508|NCT01366196|Pharmacologic Actions|pharmacologic actions
370509|NCT01366196|Central Nervous System Agents|central nervous system agents
370510|NCT01366196|Therapeutic Uses|therapeutic uses
370511|NCT01366196|Anticonvulsants|anticonvulsants
370512|NCT01366196|GABA Agents|gaba agents
370513|NCT01366196|Neurotransmitter Agents|neurotransmitter agents
370514|NCT01366196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
370515|NCT01366170|childhood anaplastic large cell lymphoma|childhood anaplastic large cell lymphoma
370516|NCT01366157|childhood favorable prognosis Hodgkin lymphoma|childhood favorable prognosis hodgkin lymphoma
370517|NCT01366157|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
370518|NCT01366157|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
370519|NCT01366157|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
370520|NCT01366157|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
370521|NCT01366157|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
370522|NCT01366157|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
370523|NCT01366157|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
370524|NCT01366157|childhood nodular lymphocyte predominant Hodgkin lymphoma|childhood nodular lymphocyte predominant hodgkin lymphoma
370525|NCT01366157|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
370526|NCT01366118|Rectal cancer, Chemoradiotherapy, target therapy|rectal cancer, chemoradiotherapy, target therapy
370527|NCT01366105|Wound healing|wound healing
370528|NCT01366105|Negative Pressure Wound Therapy|negative pressure wound therapy
370529|NCT01366105|V.A.C.|v.a.c.
370530|NCT01366105|Incision|incision
370531|NCT01366092|stem cell transplant|stem cell transplant
370532|NCT01366092|GVHD|gvhd
370533|NCT01366092|bone marrow transplant|bone marrow transplant
370534|NCT01366092|cord blood transplant|cord blood transplant
370535|NCT01366092|regulatory T cell|regulatory t cell
370536|NCT01366092|interleukin|interleukin
370537|NCT01366066|Stress incontinence|stress incontinence
370538|NCT01366066|urge incontinence|urge incontinence
370539|NCT01366066|overactive bladder syndrome|overactive bladder syndrome
370540|NCT01366066|vibration|vibration
370541|NCT01366066|nerve stimulation|nerve stimulation
370542|NCT01366053|Prostate Cancer|prostate cancer
370543|NCT01366053|Androgen Deprivation Therapy|androgen deprivation therapy
370544|NCT01366053|Agonist|agonist
370545|NCT01366053|Antagonist|antagonist
370546|NCT01366053|PSA Failure|psa failure
370547|NCT01366053|PSA Rise|psa rise
370548|NCT01366040|Patient Satisfaction|patient satisfaction
370549|NCT01366040|Multiple Sclerosis|multiple sclerosis
370550|NCT01366040|Autoinjector|autoinjector
370551|NCT01366040|Avonex|avonex
370552|NCT01366027|pseudobulbar affect|pseudobulbar affect
370553|NCT01366014|osteoarthritis|osteoarthritis
370554|NCT01366014|knee|knee
370555|NCT01366014|pain|pain
370556|NCT01366014|NSAID|nsaid
370557|NCT01366001|Opioid|opioid
370558|NCT01366001|Cocaine|cocaine
370560|NCT01366001|Abuse|abuse
370561|NCT01366001|Intravenous|intravenous
370562|NCT01366001|Buprenorphine|buprenorphine
370563|NCT01365988|fMRI|fmri
370564|NCT01365988|Risk-Taking|risk-taking
370565|NCT01365988|Decision-Making|decision-making
370566|NCT01365988|Memory|memory
370567|NCT01365988|Resting-State Functional Connectivity|resting-state functional connectivity
370568|NCT01365975|Cohort Study|cohort study
370569|NCT01365975|Folinic Acid, peri-conception|folinic acid, peri-conception
370570|NCT01365975|Pediatric Leukemia|pediatric leukemia
370571|NCT01365975|Pediatric Cancer|pediatric cancer
370572|NCT01365962|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
370573|NCT01365962|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
370574|NCT01365962|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
370575|NCT01365962|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
370576|NCT01365962|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
370577|NCT01365949|Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)|ewing sarcoma/peripheral primitive neuroectodermal tumor (pnet)
370578|NCT01365936|IVF|ivf
370579|NCT01365936|ICSI|icsi
370580|NCT01365936|OHSS|ohss
370581|NCT01365936|PCOS|pcos
370582|NCT01365936|recFSH|recfsh
370583|NCT01365936|HMG|hmg
370584|NCT01365897|Modafinil|modafinil
370585|NCT01365897|Memory|memory
370586|NCT01365897|Executive Functions|executive functions
370587|NCT01365897|Memory, Short-Term|memory, short-term
370588|NCT01365897|Attention|attention
370589|NCT01365897|University Students|university students
370590|NCT01365897|Stroop Effect|stroop effect
370591|NCT01365897|Digit Span|digit span
370592|NCT01365897|Backwards Digit Span|backwards digit span
370593|NCT01365897|Biber Cognitive Estimation Test|biber cognitive estimation test
370594|NCT01365871|prostate biopsy|prostate biopsy
370595|NCT01365871|pain|pain
370596|NCT01365845|Proton Radiation|proton radiation
370597|NCT01365845|Breast Cancer|breast cancer
370598|NCT01365819|Crystal meth dependence|crystal meth dependence
370599|NCT01365819|crystal meth|crystal meth
370600|NCT01365819|methamphetamine dependence|methamphetamine dependence
370601|NCT01365819|substance abuse|substance abuse
370602|NCT01365806|heart transplantation|heart transplantation
370603|NCT01365806|allograft rejection|allograft rejection
370604|NCT01365806|QT interval|qt interval
370605|NCT01365806|electrocardiogram (ECG)|electrocardiogram (ecg)
370606|NCT01365793|cerebral edema|cerebral edema
370607|NCT01365793|diabetic ketoacidosis|diabetic ketoacidosis
370608|NCT01365793|pediatric diabetes|pediatric diabetes
370609|NCT01365793|fluid therapy|fluid therapy
370610|NCT01365780|microcirculation, O2c|microcirculation, o2c
370611|NCT01365767|Crohn disease|crohn disease
370612|NCT01365767|Ultrasonography, contrast enhanced|ultrasonography, contrast enhanced
370613|NCT01365767|Elasticity Imaging Techniques|elasticity imaging techniques
370614|NCT01365767|Small intestine|small intestine
370615|NCT01365767|Magnetic Resonance Imaging|magnetic resonance imaging
370616|NCT01365767|CDAI|cdai
370617|NCT01365767|Calprotectin|calprotectin
370618|NCT01365767|IBD|ibd
370619|NCT01365767|Sonography|sonography
370620|NCT01365754|Lumbar degenerative disease|lumbar degenerative disease
370621|NCT01365741|PCI|pci
370622|NCT01365741|STEMI|stemi
370623|NCT01365741|Interventions|interventions
370624|NCT01365741|Heart disease|heart disease
370625|NCT01365741|Thrombocytic inhibition|thrombocytic inhibition
370626|NCT01365741|Cross-over study|cross-over study
370627|NCT01365741|Percutaneous coronary intervention|percutaneous coronary intervention
370628|NCT01365728|Femtosecond Laser|femtosecond laser
370629|NCT01365728|FS60|fs60
370630|NCT01365728|iFS|ifs
370631|NCT01365728|Intralase|intralase
370632|NCT01365728|Wavefront-guided LASIK|wavefront-guided lasik
370633|NCT01365728|IntraLASIK|intralasik
370634|NCT01365728|LASIK|lasik
370635|NCT01365728|Myopia|myopia
370636|NCT01365728|Nearsightedness|nearsightedness
370637|NCT01365715|Preoperative embolization|preoperative embolization
370638|NCT01365715|Transcatheter arterial embolization|transcatheter arterial embolization
370639|NCT01365715|Therapeutic angiography|therapeutic angiography
370640|NCT01365715|Embolization|embolization
370641|NCT01365715|Surgical blood loss|surgical blood loss
370642|NCT01365715|Spinal metastases|spinal metastases
370643|NCT01365715|Spinal neoplasms|spinal neoplasms
370644|NCT01365715|Vertebral metastases|vertebral metastases
370645|NCT01365715|metastatic spine surgery|metastatic spine surgery
370646|NCT01365715|Spinal surgery|spinal surgery
370647|NCT01365702|COPD|copd
370648|NCT01365702|tiotropium|tiotropium
370649|NCT01365702|tuberculous destroyed lung|tuberculous destroyed lung
370650|NCT01365676|Edema|edema
370651|NCT01365676|Depression|depression
370652|NCT01365676|Hot Flashes|hot flashes
370653|NCT01365676|Anxiety|anxiety
370654|NCT01365676|Irritability|irritability
370655|NCT01365676|PMS|pms
370656|NCT01365663|Hypercholesterolemia|hypercholesterolemia
370657|NCT01365663|LDL|ldl
370658|NCT01365663|HDL|hdl
370659|NCT01365663|apoB|apob
370660|NCT01365663|hyperlipidemia|hyperlipidemia
370661|NCT01365663|LNA-oligonucleotide|lna-oligonucleotide
370663|NCT01365637|tolerability|tolerability
370664|NCT01365637|pharmacokinetics|pharmacokinetics
370665|NCT01365637|PF-05089771|pf-05089771
370666|NCT01365598|malaria|malaria
370667|NCT01365598|uncomplicated malaria|uncomplicated malaria
370668|NCT01365598|gametocytocidal drug|gametocytocidal drug
370669|NCT01365598|gametocytocidal|gametocytocidal
370670|NCT01365598|gametocyte|gametocyte
370671|NCT01365598|primaquine|primaquine
370672|NCT01365598|transmission blocking|transmission blocking
370673|NCT01365598|malaria transmission|malaria transmission
370674|NCT01365598|sexual parasite|sexual parasite
370675|NCT01365598|sexual stage|sexual stage
370676|NCT01365598|Uganda|uganda
370677|NCT01365598|Africa|africa
370678|NCT01365585|Pulmonary arterial hypertension|pulmonary arterial hypertension
370679|NCT01365585|sildenafil citrate|sildenafil citrate
370680|NCT01365585|Revatio|revatio
370681|NCT01365572|Drug-eluting stent|drug-eluting stent
370682|NCT01365559|multiple myeloma|multiple myeloma
370683|NCT01365559|carfilzomib|carfilzomib
370684|NCT01365559|relapsed|relapsed
370685|NCT01365559|refractory|refractory
370686|NCT01365559|bortezomib|bortezomib
370687|NCT01365559|Oncotherapeutics|oncotherapeutics
370688|NCT01365533|Airway Inflammation|airway inflammation
370689|NCT01365533|Roflumilast|roflumilast
370690|NCT01365494|Rabies|rabies
370691|NCT01365494|rabies vaccines|rabies vaccines
370692|NCT01365494|post-exposure prophylaxis|post-exposure prophylaxis
370693|NCT01365481|Hypertension, pediatric|hypertension, pediatric
6734|NCT03248011|ultrasound|ultrasound
370694|NCT01365481|Hypertension with or without chronic kidney disease|hypertension with or without chronic kidney disease
370695|NCT01365468|RAD001,|rad001,
370696|NCT01365468|Everolimus,|everolimus,
370697|NCT01365468|Plexiform Neurofibroma,|plexiform neurofibroma,
370698|NCT01365468|Neurofibromatosis Type 1|neurofibromatosis type 1
370699|NCT01365455|Psoriasis|psoriasis
370700|NCT01365455|plaque|plaque
370701|NCT01365455|plaque-type psoriasis|plaque-type psoriasis
370702|NCT01365455|IL-17 blocker|il-17 blocker
370703|NCT01365455|subcutaneous|subcutaneous
370704|NCT01365455|psoriatic arthritis|psoriatic arthritis
370705|NCT01365455|injection|injection
370706|NCT01365455|AIN457|ain457
370707|NCT01365455|AIN457A|ain457a
370708|NCT01365455|secukinumab|secukinumab
370709|NCT01365442|Cholera|cholera
370710|NCT01365442|Vaccination|vaccination
370711|NCT01365442|Oral cholera vaccine|oral cholera vaccine
370712|NCT01365442|Mass vaccination|mass vaccination
370713|NCT01365442|Oral whole cell cholera vaccine|oral whole cell cholera vaccine
370714|NCT01365429|Lung Transplant, Transplantation Lung|lung transplant, transplantation lung
370715|NCT01365416|diabetes|diabetes
370716|NCT01365416|diabetes remission|diabetes remission
370717|NCT01365416|obesity|obesity
370718|NCT01365416|bariatric surgery|bariatric surgery
370719|NCT01365416|gene expression|gene expression
370720|NCT01365416|genetic variation|genetic variation
370721|NCT01365416|metabolomics|metabolomics
370722|NCT01365416|metabonomics|metabonomics
370723|NCT01365416|epigenetic variation|epigenetic variation
370724|NCT01365416|mutations|mutations
370725|NCT01365390|prospective|prospective
370726|NCT01365390|Incidence|incidence
370727|NCT01365390|otitis|otitis
370728|NCT01365390|observational|observational
370729|NCT01365390|Epidemiological|epidemiological
370730|NCT01365390|retrospective|retrospective
370731|NCT01365377|Anxiety|anxiety
370732|NCT01365377|Depression|depression
370733|NCT01365377|Post-traumatic stress disorders|post-traumatic stress disorders
370734|NCT01365377|Quality of life|quality of life
370735|NCT01365377|Family|family
370736|NCT01365377|ICU|icu
370737|NCT01365364|PLM|plm
370738|NCT01365364|dopamine|dopamine
370739|NCT01365364|physical exercise|physical exercise
370740|NCT01365338|schizophrenia fMRI cognition working memory ASL|schizophrenia fmri cognition working memory asl
370741|NCT01365312|Central line associated infection|central line associated infection
370742|NCT01365312|PICC associated infection|picc associated infection
370743|NCT01365312|Neonatal central line associated sepsis|neonatal central line associated sepsis
370744|NCT01365312|Central line colonization|central line colonization
370745|NCT01365312|Ethanol Lock|ethanol lock
370746|NCT01365286|asthma, chronic obstructive pulmonary disease, COPD, ivabradine, heart rate|asthma, chronic obstructive pulmonary disease, copd, ivabradine, heart rate
370747|NCT01365273|Split thickness skin grafts|split thickness skin grafts
370748|NCT01365273|Mepitel One|mepitel one
370749|NCT01365273|Bridal Veil and staples|bridal veil and staples
370750|NCT01365273|Pain|pain
370751|NCT01365247|Co-morbid substance disorders and PTSD|co-morbid substance disorders and ptsd
370752|NCT01365247|Trauma|trauma
370753|NCT01365247|Alcohol and other drug use disorders|alcohol and other drug use disorders
370754|NCT01365247|Treatment outcome|treatment outcome
370755|NCT01365247|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
370756|NCT01365247|Co-morbid Alcohol and other drug use disorders (AOD)|co-morbid alcohol and other drug use disorders (aod)
370757|NCT01365247|Behavioral Treatment|behavioral treatment
370758|NCT01365221|Acute Coronary Syndrome|acute coronary syndrome
370759|NCT01365221|Clopidogrel|clopidogrel
370760|NCT01365221|Prasugrel|prasugrel
370761|NCT01365195|opioid|opioid
370762|NCT01365195|Fentanyl|fentanyl
370763|NCT01365195|Anesthetic adjuvant|anesthetic adjuvant
370764|NCT01365195|Pain management|pain management
370765|NCT01365195|Perioperative outcomes|perioperative outcomes
370766|NCT01365195|Constipation|constipation
370767|NCT01365195|Ileus|ileus
370768|NCT01365195|Colorectal|colorectal
370769|NCT01365182|prostate cancer|prostate cancer
370770|NCT01365182|urinary incontinence|urinary incontinence
370771|NCT01365182|pelvic floor muscle exercise|pelvic floor muscle exercise
370772|NCT01365182|self-management|self-management
370773|NCT01365182|behavioral intervention|behavioral intervention
370774|NCT01365182|quality of life|quality of life
370775|NCT01365169|Cyberinfrastructure|cyberinfrastructure
370776|NCT01365169|CI|ci
370777|NCT01365169|CYCORE|cycore
370778|NCT01365169|Quality of Life|quality of life
370779|NCT01365169|QOL|qol
370780|NCT01365169|Head and Neck|head and neck
370781|NCT01365169|H&N|h&n
370782|NCT01365169|Carbon Monoxide|carbon monoxide
370783|NCT01365169|CO|co
370784|NCT01365169|Colorectal Cancer|colorectal cancer
370785|NCT01365169|Oropharyngeal Cancer|oropharyngeal cancer
370786|NCT01365169|Laryngeal Cancer|laryngeal cancer
370787|NCT01365169|Hypopharyngeal Cancer|hypopharyngeal cancer
370788|NCT01365169|Nasopharyngeal Cancer|nasopharyngeal cancer
370789|NCT01365169|Smoker|smoker
370790|NCT01365169|Recent Smoking Cessation|recent smoking cessation
370791|NCT01365156|locally advanced cervical cancer|locally advanced cervical cancer
370792|NCT01365156|pretherapeutic para-aortic surgical staging|pretherapeutic para-aortic surgical staging
370793|NCT01365156|radiologic staging|radiologic staging
370794|NCT01365156|pretherapeutic surgical staging|pretherapeutic surgical staging
370795|NCT01365156|para-aortic metastatic disease|para-aortic metastatic disease
370796|NCT01365130|esophageal cancer|esophageal cancer
370797|NCT01365130|gastroesophageal cancer|gastroesophageal cancer
370798|NCT01365130|gastric cancer|gastric cancer
370799|NCT01365104|brain blood flow|brain blood flow
370800|NCT01365104|stroke|stroke
370801|NCT01365104|cerebrovascular|cerebrovascular
370802|NCT01365104|aging|aging
370803|NCT01365104|cerebrovascular hemodynamics|cerebrovascular hemodynamics
370804|NCT01365078|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
370805|NCT01365078|Stearidonic acid|stearidonic acid
370806|NCT01365078|Lipid metabolism|lipid metabolism
370807|NCT01365078|Serum triacylglycerol|serum triacylglycerol
370808|NCT01365052|Maximum Use Safety Trial|maximum use safety trial
370809|NCT01365039|contact lens|contact lens
370810|NCT01365026|Healthy Lifestyle|healthy lifestyle
370811|NCT01365026|Health promotion|health promotion
370812|NCT01365026|Counselling|counselling
370813|NCT01365026|Action Plan|action plan
370814|NCT01365026|Primary Health Care|primary health care
370815|NCT01365013|Lifestyle|lifestyle
370816|NCT01365013|Prediabetic State|prediabetic state
370817|NCT01365013|Patient Education|patient education
370818|NCT01365013|Primary Health Care|primary health care
370819|NCT01365000|Phase 1|phase 1
370820|NCT01365000|Pharmacokinetics|pharmacokinetics
370821|NCT01365000|NKTR-118|nktr-118
370822|NCT01365000|fasting or fed state|fasting or fed state
370823|NCT01365000|cross-over study|cross-over study
370824|NCT01365000|AUC(0-t)|auc(0-t)
370825|NCT01365000|Cmax|cmax
370826|NCT01365000|tmax|tmax
370827|NCT01365000|QTcF Interval|qtcf interval
370828|NCT01364987|transplant|transplant
370829|NCT01364987|ASP015K|asp015k
370830|NCT01364987|healthy subjects|healthy subjects
370836|NCT01364961|HDL-cholesterol|hdl-cholesterol
370837|NCT01364961|Macrovasculature|macrovasculature
370838|NCT01364961|Microvasculature|microvasculature
370839|NCT01364948|Preterm|preterm
370840|NCT01364948|VLBW|vlbw
370841|NCT01364948|Coconut Oil application|coconut oil application
370842|NCT01364948|Trans epidermal water loss|trans epidermal water loss
370843|NCT01364948|Weight gain|weight gain
370844|NCT01364909|Sepsis|sepsis
370845|NCT01364909|Severe sepsis|severe sepsis
370846|NCT01364909|Septic shock|septic shock
370847|NCT01364909|Septicaemia|septicaemia
370848|NCT01364909|Bacteremia|bacteremia
370849|NCT01364896|Non-corticosteroid immunosuppressive agent|non-corticosteroid immunosuppressive agent
370850|NCT01364883|Vaccine|vaccine
370851|NCT01364883|Immune response|immune response
370852|NCT01364870|Knee OA|knee oa
370853|NCT01364870|TENS|tens
370854|NCT01364870|Total knee replacement|total knee replacement
370855|NCT01364870|Knee arthroplasty|knee arthroplasty
370856|NCT01364870|total unilateral knee replacement|total unilateral knee replacement
370857|NCT01364857|port wine stain of a limb|port wine stain of a limb
370858|NCT01364831|sleep time|sleep time
370859|NCT01364831|athletic performance|athletic performance
370860|NCT01364792|schizophrenia|schizophrenia
370861|NCT01364792|treatment|treatment
370961|NCT01364363|HSCT|hsct
370862|NCT01364792|inflammation|inflammation
370863|NCT01364792|neuroinflammation|neuroinflammation
370864|NCT01364792|hippocampal|hippocampal
370865|NCT01364779|aspirin|aspirin
370866|NCT01364779|Chronic kidney disease|chronic kidney disease
370867|NCT01364753|Memory|memory
370868|NCT01364753|Aviation|aviation
370869|NCT01364714|ICU acquired weakness|icu acquired weakness
370870|NCT01364701|Erectile dysfunction|erectile dysfunction
370871|NCT01364701|combination therapy|combination therapy
370872|NCT01364701|Sildenafil|sildenafil
370873|NCT01364701|tadalafil|tadalafil
370874|NCT01364701|PDE5i|pde5i
370875|NCT01364701|No Conditions|no conditions
370876|NCT01364688|coronary calcification|coronary calcification
370877|NCT01364688|vascular calcification|vascular calcification
370878|NCT01364688|active vitamin D|active vitamin d
370879|NCT01364688|alfacalcidol|alfacalcidol
370880|NCT01364675|Impaired fasting glucose|impaired fasting glucose
370881|NCT01364675|Impaired glucose tolerance|impaired glucose tolerance
370882|NCT01364675|Pre-diabetes|pre-diabetes
370883|NCT01364675|Pre-hypertensives|pre-hypertensives
370884|NCT01364675|Cardiovascular events|cardiovascular events
370885|NCT01364662|Impulsive Aggression|impulsive aggression
370886|NCT01364662|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
370887|NCT01364662|ADHD|adhd
370888|NCT01364649|Sexual Dysfunction, Physiological|sexual dysfunction, physiological
370889|NCT01364649|Depressive Disorder, Major|depressive disorder, major
370890|NCT01364649|Depression|depression
370891|NCT01364649|Antidepressive Agents|antidepressive agents
370892|NCT01364649|Drug Therapy|drug therapy
370893|NCT01364636|1-Heart Failure|1-heart failure
370894|NCT01364636|2-Acute Heart Failure|2-acute heart failure
370895|NCT01364636|3-Acute Decompensated Heart Failure|3-acute decompensated heart failure
370896|NCT01364636|4-Worsening Renal Function|4-worsening renal function
370897|NCT01364636|5-Acute Kidney Injury|5-acute kidney injury
370898|NCT01364636|6-Cardiorenal Syndrome|6-cardiorenal syndrome
370899|NCT01364623|testosterone|testosterone
370900|NCT01364623|pharmacokinetics|pharmacokinetics
370901|NCT01364610|diagnosis|diagnosis
370902|NCT01364610|pH measurement|ph measurement
370903|NCT01364610|catheter|catheter
370904|NCT01364610|wireless|wireless
370910|NCT01364571|Staphylococcus aureus|staphylococcus aureus
370911|NCT01364571|vaccine|vaccine
370912|NCT01364571|staphylococcal infection|staphylococcal infection
370913|NCT01364532|transulnar arterial access|transulnar arterial access
370914|NCT01364532|transradial arterial access|transradial arterial access
371110|NCT01363791|Uric acid|uric acid
370915|NCT01364532|percutaneous coronary intervention|percutaneous coronary intervention
370916|NCT01364519|COPD|copd
370917|NCT01364506|Cardiovascular capacity|cardiovascular capacity
370918|NCT01364506|Water exercise|water exercise
370919|NCT01364506|Hydrokinetic Therapy|hydrokinetic therapy
370920|NCT01364506|Pregnancy|pregnancy
370921|NCT01364506|Perinatal outcomes|perinatal outcomes
370922|NCT01364493|HER2-positive|her2-positive
370923|NCT01364493|adenocarcinoma of the stomach or gastro-esophageal junction|adenocarcinoma of the stomach or gastro-esophageal junction
370924|NCT01364493|Inoperable|inoperable
370925|NCT01364493|locally advanced|locally advanced
370926|NCT01364493|recurrent|recurrent
370927|NCT01364493|metastatic|metastatic
370928|NCT01364480|Tetraplegia|tetraplegia
370929|NCT01364480|Spinal cord injury|spinal cord injury
370930|NCT01364480|Brainstem or spinal stroke|brainstem or spinal stroke
370931|NCT01364480|Neuroprosthetic|neuroprosthetic
370932|NCT01364480|Brain-machine interface|brain-machine interface
370933|NCT01364480|Brain-computer interface|brain-computer interface
370934|NCT01364480|Neural activity|neural activity
370935|NCT01364454|Colorectal Cancer Screening|colorectal cancer screening
370936|NCT01364454|Faecal Occult Blood test|faecal occult blood test
370937|NCT01364454|General Practitioners Involvement|general practitioners involvement
370938|NCT01364454|Patient's Participation|patient's participation
370939|NCT01364454|Reminder|reminder
370940|NCT01364441|ONO-2950|ono-2950
370941|NCT01364441|healthy adult subjects|healthy adult subjects
370942|NCT01364441|first in human|first in human
370943|NCT01364441|safety|safety
370944|NCT01364441|tolerability|tolerability
361708|NCT01403766|GFR|gfr
370945|NCT01364441|pharmacokinetics|pharmacokinetics
370946|NCT01364415|MTD|mtd
370947|NCT01364415|pasireotide|pasireotide
370948|NCT01364415|LAR|lar
370949|NCT01364415|NETs|nets
370950|NCT01364415|advanced neuroendocrine tumors|advanced neuroendocrine tumors
370951|NCT01364402|scheduled for PCI|scheduled for pci
370952|NCT01364389|Polymyalgia Rheumatica|polymyalgia rheumatica
370953|NCT01364389|Inflammatory Disease|inflammatory disease
370954|NCT01364389|Rheumatic Disease|rheumatic disease
370955|NCT01364376|Gastric Cancer|gastric cancer
370956|NCT01364363|Transplant|transplant
370957|NCT01364363|Allogeneic|allogeneic
370958|NCT01364363|Allogeneic transplant|allogeneic transplant
370959|NCT01364363|Unrelated donor transplant|unrelated donor transplant
370960|NCT01364363|MUD|mud
370962|NCT01364363|Stem cell transplant|stem cell transplant
370963|NCT01364350|type 2 diabetes mellitus|type 2 diabetes mellitus
370964|NCT01364350|pediatrics|pediatrics
370965|NCT01364350|post-intervention study|post-intervention study
370966|NCT01364350|metformin|metformin
370967|NCT01364350|complications|complications
370968|NCT01364337|Hypertension|hypertension
370969|NCT01364324|tuberculosis|tuberculosis
370970|NCT01364324|pharmacokinetics|pharmacokinetics
370971|NCT01364324|first-line drugs|first-line drugs
370972|NCT01364324|gastrectomy|gastrectomy
370973|NCT01364311|Dry Eye Syndromes|dry eye syndromes
370974|NCT01364311|Dietary Supplements|dietary supplements
370975|NCT01364311|Vitamac® Tag and Nacht capsules|vitamac® tag and nacht capsules
370976|NCT01364311|Lutein|lutein
370977|NCT01364311|Vitamin C|vitamin c
370978|NCT01364311|Zinc|zinc
370979|NCT01364311|ginkgo biloba|ginkgo biloba
370980|NCT01364311|Flavinoids|flavinoids
370981|NCT01364311|Fishoil|fishoil
370982|NCT01364311|Zeaxanthin|zeaxanthin
370983|NCT01364311|Vitamin E|vitamin e
370984|NCT01364311|Copper|copper
370985|NCT01364311|Selen|selen
370986|NCT01364311|Alpha Lipon acid|alpha lipon acid
370987|NCT01364311|Break up time (BUT)|break up time (but)
370988|NCT01364311|Improvement of subjective symptoms of dry eye syndrome|improvement of subjective symptoms of dry eye syndrome
370989|NCT01364311|Visual Acuity|visual acuity
370990|NCT01364311|Tear film osmolarity|tear film osmolarity
370991|NCT01364311|OSI (Objective Scattering Index)|osi (objective scattering index)
370992|NCT01364311|Schirmer I test|schirmer i test
370993|NCT01364311|Staining of the cornea with fluorescein|staining of the cornea with fluorescein
370994|NCT01364311|Impression cytology|impression cytology
370995|NCT01364311|Tear cytokines/chemokines|tear cytokines/chemokines
370996|NCT01364311|Data from patient diary how often Hylo-Comod® eye drops were used|data from patient diary how often hylo-comod® eye drops were used
370997|NCT01364298|Gabapentin/B complex|gabapentin/b complex
370998|NCT01364298|Pregabalin|pregabalin
371000|NCT01364298|Neuropathic|neuropathic
371001|NCT01364298|Gavindo|gavindo
371002|NCT01364298|Lyrica|lyrica
371003|NCT01364259|tic douloureux|tic douloureux
371004|NCT01364246|Progressive Multiple Sclerosis|progressive multiple sclerosis
371005|NCT01364246|neuromyelitis optica|neuromyelitis optica
371006|NCT01364246|Umbilical Cord Mesenchymal Stem Cell|umbilical cord mesenchymal stem cell
371007|NCT01364220|Additional relevant MeSH terms|additional relevant mesh terms
371008|NCT01364220|Stroke|stroke
371009|NCT01364220|Cerebral Infarction|cerebral infarction
371010|NCT01364220|Cerebrovascular Disorders|cerebrovascular disorders
371011|NCT01364220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
371532|NCT01362192|Cutera|cutera
371012|NCT01364220|Magnetic Resonance Imaging|magnetic resonance imaging
371013|NCT01364220|Recurrence|recurrence
371014|NCT01364194|Post operative pain|post operative pain
371015|NCT01364194|Total knee replacement|total knee replacement
371016|NCT01364194|Total knee arthroplasty|total knee arthroplasty
371017|NCT01364194|Bupivacaine|bupivacaine
371018|NCT01364194|Periarticular injection|periarticular injection
371019|NCT01364194|Placebo|placebo
371020|NCT01364194|Morphine consumption|morphine consumption
371021|NCT01364181|Udenafil|udenafil
371022|NCT01364181|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
371023|NCT01364181|pulmonary hypertension|pulmonary hypertension
371024|NCT01364181|Phosphodiesterase 5 inhibitors|phosphodiesterase 5 inhibitors
371025|NCT01364181|Exercise|exercise
371026|NCT01364181|Dyspnea|dyspnea
371027|NCT01364129|Diabetes|diabetes
371028|NCT01364129|Diabetic Retinopathy Screening|diabetic retinopathy screening
371029|NCT01364129|Ophthalmic Telemedicine|ophthalmic telemedicine
371030|NCT01364129|Comparative Effectiveness Research|comparative effectiveness research
371031|NCT01364116|Pulse CO-Oximetry™|pulse co-oximetry™
371032|NCT01364116|children|children
371033|NCT01364116|noninvasive|noninvasive
371034|NCT01364103|pulse pressure variation|pulse pressure variation
371035|NCT01364103|systolic pressure variation|systolic pressure variation
371036|NCT01364103|central venous pressure|central venous pressure
371037|NCT01364103|aortic blood flow velocity variation|aortic blood flow velocity variation
371038|NCT01364103|pleth variability index|pleth variability index
371039|NCT01364090|hepatitis C|hepatitis c
371040|NCT01364090|treatment|treatment
371041|NCT01364090|injection drug users or receiving opiate substitution therapy|injection drug users or receiving opiate substitution therapy
371042|NCT01364077|Heart rate|heart rate
371043|NCT01364077|Dialysis|dialysis
371044|NCT01364077|ESRD|esrd
371045|NCT01364077|ivabradine|ivabradine
371046|NCT01363973|oropharyngeal dysphagia|oropharyngeal dysphagia
371047|NCT01363973|post-stroke|post-stroke
371048|NCT01363960|Incidence|incidence
371049|NCT01363960|neonatal care|neonatal care
371050|NCT01363960|retinopathy of prematurity|retinopathy of prematurity
371051|NCT01363960|risk factors|risk factors
371052|NCT01363934|Erythropoietin|erythropoietin
371053|NCT01363934|EPO-hFC|epo-hfc
371054|NCT01363921|CKD5|ckd5
371055|NCT01363921|dialysis|dialysis
371056|NCT01363921|high porous membranes|high porous membranes
371057|NCT01363921|micro-inflammation|micro-inflammation
371058|NCT01363908|Beta-Thalassemia|beta-thalassemia
371059|NCT01363908|Sickle Cell Anemia|sickle cell anemia
371060|NCT01363908|Transfusional iron overload|transfusional iron overload
371061|NCT01363908|Iron Overload|iron overload
371062|NCT01363908|Iron Chelation|iron chelation
371063|NCT01363895|atrial fibrillation|atrial fibrillation
371064|NCT01363895|catheter ablation|catheter ablation
371065|NCT01363895|percutaneous closure of LAA|percutaneous closure of laa
371066|NCT01363895|intervention|intervention
371067|NCT01363882|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
371068|NCT01363882|Noninvasive Ventilation|noninvasive ventilation
371069|NCT01363882|Respiratory Dysfunction|respiratory dysfunction
371070|NCT01363882|Positive Pressure Ventilation|positive pressure ventilation
371071|NCT01363869|hyperuricemia|hyperuricemia
371072|NCT01363869|gout|gout
371073|NCT01363869|uric acid|uric acid
371074|NCT01363869|xanthine oxidase inhibitor|xanthine oxidase inhibitor
371075|NCT01363869|green tea|green tea
371076|NCT01363869|catechins|catechins
371077|NCT01363869|antioxidant|antioxidant
371078|NCT01363856|first ever stroke|first ever stroke
371079|NCT01363843|neoadjuvant|neoadjuvant
371080|NCT01363843|chemo/radiation|chemo/radiation
371081|NCT01363843|rectal cancer|rectal cancer
371082|NCT01363843|rectum cancer|rectum cancer
371083|NCT01363843|colon cancer|colon cancer
371084|NCT01363843|colorectal cancer|colorectal cancer
371085|NCT01363830|Disc|disc
371086|NCT01363830|lumbar|lumbar
371087|NCT01363830|herniation|herniation
371088|NCT01363804|AV-951|av-951
371089|NCT01363804|Tivozanib|tivozanib
371090|NCT01363804|Healthy Subjects|healthy subjects
371091|NCT01363804|rifampin|rifampin
371092|NCT01363804|Pharmacokinetics|pharmacokinetics
371093|NCT01363791|Systematic review and meta-analysis|systematic review and meta-analysis
371094|NCT01363791|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
370662|NCT01365637|safety|safety
371095|NCT01363791|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
371096|NCT01363791|Clinical practice guidelines|clinical practice guidelines
371097|NCT01363791|Clinical trials|clinical trials
371098|NCT01363791|Dietary sugars|dietary sugars
371099|NCT01363791|Fructose|fructose
371100|NCT01363791|High fructose corn syrup|high fructose corn syrup
371101|NCT01363791|Fruit|fruit
371102|NCT01363791|Isocaloric|isocaloric
371103|NCT01363791|Hypercaloric|hypercaloric
371104|NCT01363791|Cardiometabolic risk factors|cardiometabolic risk factors
371105|NCT01363791|Triglycerides|triglycerides
371106|NCT01363791|Cholesterol|cholesterol
371107|NCT01363791|Glycemic control|glycemic control
371108|NCT01363791|Insulin resistance|insulin resistance
371109|NCT01363791|Body weight|body weight
371111|NCT01363791|Blood pressure|blood pressure
371112|NCT01363791|Fatty liver|fatty liver
371113|NCT01363791|Fasting|fasting
371114|NCT01363791|Postprandial|postprandial
371115|NCT01363778|AV-951|av-951
371116|NCT01363778|Tivozanib|tivozanib
371117|NCT01363778|Healthy Subjects|healthy subjects
371118|NCT01363778|ketoconazole|ketoconazole
371119|NCT01363778|Pharmacokinetics|pharmacokinetics
371120|NCT01363765|diagnosis|diagnosis
371121|NCT01363765|polymerase chain reaction|polymerase chain reaction
371122|NCT01363765|sputum smear|sputum smear
371123|NCT01363765|stepped-wedge design|stepped-wedge design
371124|NCT01363765|cost-effectiveness|cost-effectiveness
371125|NCT01363765|Xpert MTB/Rif|xpert mtb/rif
371126|NCT01363752|Kidney|kidney
371127|NCT01363752|Transplant|transplant
371128|NCT01363752|Immunosuppression|immunosuppression
371129|NCT01363752|Kidney Failure, Acute|kidney failure, acute
371130|NCT01363752|Advagraf|advagraf
371131|NCT01363752|Tacrolimus|tacrolimus
371132|NCT01363752|Astagraf XL|astagraf xl
371133|NCT01363739|VEGF polymorphism Bevacizumab|vegf polymorphism bevacizumab
371134|NCT01363726|surveillance Rotavirus Gastroenteritis Children|surveillance rotavirus gastroenteritis children
371135|NCT01363726|< 5 years of age|< 5 years of age
371136|NCT01363726|southern Israel|southern israel
371137|NCT01363726|Signed informed concent|signed informed concent
371138|NCT01363674|Growth disorders|growth disorders
371140|NCT01363674|Easypod|easypod
371141|NCT01363674|Growth hormone|growth hormone
371142|NCT01363674|Pediatric subject|pediatric subject
371143|NCT01363661|angina pectoris|angina pectoris
371144|NCT01363661|atherosclerosis|atherosclerosis
371145|NCT01363661|endothelial dysfunction|endothelial dysfunction
371146|NCT01363648|VCI-HS|vci-hs
371147|NCT01363648|stroke|stroke
371148|NCT01363648|choline alphoscerate|choline alphoscerate
371149|NCT01363635|severe sepsis/septic shock|severe sepsis/septic shock
371150|NCT01363635|organ failure|organ failure
371151|NCT01363635|AKI|aki
371152|NCT01363635|PMI|pmi
371153|NCT01363635|ALI|ali
371154|NCT01363635|Stroke|stroke
371155|NCT01363635|ICU death|icu death
371156|NCT01363622|Vaspin|vaspin
371157|NCT01363622|LGA|lga
371158|NCT01363622|SGA|sga
371159|NCT01363622|Insulin|insulin
371160|NCT01363622|Blood glucose|blood glucose
371161|NCT01363596|Infertility|infertility
371162|NCT01363596|Fertility|fertility
371163|NCT01363596|Reproductive Medicine|reproductive medicine
371164|NCT01363596|Pregnancy|pregnancy
371165|NCT01363596|Conception|conception
371166|NCT01363596|Miscarriage|miscarriage
371167|NCT01363596|Ovulation Detection|ovulation detection
371168|NCT01363596|Cervical Mucus|cervical mucus
371169|NCT01363596|IVF Alternative|ivf alternative
371170|NCT01363583|traumatic brain injury|traumatic brain injury
371171|NCT01363570|Macular Degeneration|macular degeneration
371172|NCT01363570|Age related macular degeneration|age related macular degeneration
371173|NCT01363570|Macula Risk|macula risk
371174|NCT01363570|Genetic test|genetic test
371175|NCT01363570|Anti-inflammatory|anti-inflammatory
371176|NCT01363570|Anti-vascular endothelial growth factor (Anti-VEGF)|anti-vascular endothelial growth factor (anti-vegf)
371177|NCT01363570|Lucentis|lucentis
371178|NCT01363570|Ranibizumab|ranibizumab
371179|NCT01363570|Vision loss|vision loss
371180|NCT01363557|Randomized|randomized
371181|NCT01363557|Brain Radiation Therapy|brain radiation therapy
371182|NCT01363557|Lung Cancer|lung cancer
371183|NCT01363557|Brain Metastasis|brain metastasis
371184|NCT01363557|Gefitinib|gefitinib
371185|NCT01363544|ADHD|adhd
371186|NCT01363544|neurofeedback|neurofeedback
371187|NCT01363544|exercise|exercise
371188|NCT01363544|neurophysiology|neurophysiology
371189|NCT01363531|Prescription|prescription
371190|NCT01363531|Antibiotic|antibiotic
371191|NCT01363531|Acute respiratory infections|acute respiratory infections
371192|NCT01363531|Satisfaction|satisfaction
371193|NCT01363531|Perception|perception
371194|NCT01363531|Pharyngitis and/or acute tonsillitis|pharyngitis and/or acute tonsillitis
371195|NCT01363531|Rhinosinusitis|rhinosinusitis
371196|NCT01363531|Acute bronchitis|acute bronchitis
371197|NCT01363531|Acute exacerbation of chronic obstructive pulmonary disease (mild to moderate)|acute exacerbation of chronic obstructive pulmonary disease (mild to moderate)
371198|NCT01363518|humerus|humerus
371199|NCT01363518|fracture|fracture
371200|NCT01363518|operative treatment|operative treatment
371201|NCT01363518|non-operative treatment|non-operative treatment
371202|NCT01363492|agalsidase alfa|agalsidase alfa
371203|NCT01363492|Replagal|replagal
371204|NCT01363492|Enzyme Replacement Therapy|enzyme replacement therapy
371205|NCT01363440|Diabetic Macular Edema|diabetic macular edema
371206|NCT01363440|Diabetic Retinopathy|diabetic retinopathy
371207|NCT01363414|Dry eye|dry eye
371208|NCT01363414|Ocular aberration|ocular aberration
371209|NCT01363401|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
371210|NCT01363401|ALS|als
371211|NCT01363401|Motor neuron disease|motor neuron disease
371212|NCT01363401|MND|mnd
371213|NCT01363401|HYNR-CS inj|hynr-cs inj
371214|NCT01363401|Autologous bone marrow derived stem cell|autologous bone marrow derived stem cell
371215|NCT01363401|Intrathecal injection|intrathecal injection
371216|NCT01363375|Plantar fascia|plantar fascia
371217|NCT01363375|Plantar fasciitis|plantar fasciitis
371218|NCT01363375|Foot orthosis|foot orthosis
371219|NCT01363375|Finite element analysis|finite element analysis
371220|NCT01363375|Gait analysis|gait analysis
371221|NCT01363375|Plantar pressure measurement|plantar pressure measurement
371222|NCT01363362|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
371223|NCT01363362|pulsatile ocular blood flow|pulsatile ocular blood flow
371224|NCT01363336|Adalat|adalat
371225|NCT01363336|Hypertension|hypertension
371226|NCT01363336|Diabetes|diabetes
371227|NCT01363336|Chronic kidney disease|chronic kidney disease
371228|NCT01363297|Relapsed/Refractory Acute Lymphocytic Leukemia (ALL)|relapsed/refractory acute lymphocytic leukemia (all)
371229|NCT01363258|Elderly|elderly
371230|NCT01363258|Dementia|dementia
371231|NCT01363258|Care-resistant behavior|care-resistant behavior
371232|NCT01363258|Oral health|oral health
371233|NCT01363258|Long-term care|long-term care
371234|NCT01363245|cost effectiveness|cost effectiveness
371235|NCT01363245|behavioral health counseling|behavioral health counseling
371236|NCT01363232|BKM120|bkm120
371237|NCT01363232|MEK162|mek162
371238|NCT01363232|RAS RAF mutations|ras raf mutations
371239|NCT01363232|triple negative breast cancer|triple negative breast cancer
371240|NCT01363232|pancreatic cancer, ovarian cancer|pancreatic cancer, ovarian cancer
371241|NCT01363232|NSCLC progressed on EGFR TKI|nsclc progressed on egfr tki
371242|NCT01363232|PI3K inhibitor|pi3k inhibitor
371243|NCT01363232|MEK inhibitor|mek inhibitor
371244|NCT01363206|Melanoma|melanoma
371245|NCT01363206|GM-CSF|gm-csf
371246|NCT01363206|Ipilimumab|ipilimumab
371247|NCT01363206|Immunologic Response|immunologic response
371248|NCT01363193|Weight-based heparin dosing|weight-based heparin dosing
371249|NCT01363193|Obesity|obesity
371250|NCT01363193|Body Mass Index|body mass index
371251|NCT01363193|Venous thromboembolism|venous thromboembolism
371252|NCT01363193|Atrial fibrillation|atrial fibrillation
371253|NCT01363193|Lean body weight|lean body weight
371254|NCT01363193|Unfractionated heparin|unfractionated heparin
371255|NCT01363193|heparin|heparin
371256|NCT01363167|vitamin D|vitamin d
371257|NCT01363167|preterm infants|preterm infants
371258|NCT01363167|calcium|calcium
371259|NCT01363167|bone|bone
371260|NCT01363167|parathyroid hormone|parathyroid hormone
371261|NCT01363154|Children's Health|children's health
371262|NCT01363154|Pediatrics|pediatrics
371263|NCT01363154|Epilepsy|epilepsy
371264|NCT01363154|Photoparoxysmal|photoparoxysmal
371265|NCT01363154|Photosensitive|photosensitive
371266|NCT01363154|Music|music
371267|NCT01363154|Mozart|mozart
371268|NCT01363154|K-448|k-448
371269|NCT01363141|Cardiovascular Diseases|cardiovascular diseases
371270|NCT01363141|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
371271|NCT01363141|Abdominal Fat|abdominal fat
371272|NCT01363141|Atherogenic Dyslipidemia|atherogenic dyslipidemia
371273|NCT01363141|Hypertension|hypertension
371274|NCT01363141|Hyperglycemia|hyperglycemia
371275|NCT01363141|Insulin Resistance|insulin resistance
371276|NCT01363141|Thrombosis state|thrombosis state
371277|NCT01363128|Leukemia|leukemia
371278|NCT01363128|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
371279|NCT01363128|CD-20 Positive Acute Lymphoblastic Leukemia|cd-20 positive acute lymphoblastic leukemia
371280|NCT01363128|Any level of CD20 expression|any level of cd20 expression
371281|NCT01363128|Lymphoblastic lymphoma|lymphoblastic lymphoma
371282|NCT01363128|Central Venous Catheter|central venous catheter
371283|NCT01363128|CVC|cvc
371284|NCT01363128|HCVAD|hcvad
371285|NCT01363128|Cyclophosphamide|cyclophosphamide
371286|NCT01363128|Cytoxan|cytoxan
371287|NCT01363128|Neosar|neosar
371288|NCT01363128|Mesna|mesna
371289|NCT01363128|Mesnex|mesnex
371290|NCT01363128|Doxorubicin|doxorubicin
371291|NCT01363128|Adriamycin|adriamycin
371292|NCT01363128|Rubex|rubex
371293|NCT01363128|Vincristine|vincristine
371294|NCT01363128|Dexamethasone|dexamethasone
371295|NCT01363128|Decadron|decadron
371296|NCT01363128|Ofatumumab|ofatumumab
371297|NCT01363128|Arzerra|arzerra
371298|NCT01363128|Methotrexate|methotrexate
371299|NCT01363128|Cytarabine|cytarabine
371300|NCT01363128|Ara-C|ara-c
371301|NCT01363128|Cytosar|cytosar
371302|NCT01363128|DepoCyt|depocyt
371303|NCT01363128|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
371304|NCT01363115|Body Weight|body weight
371305|NCT01363115|Dietary Supplement|dietary supplement
371306|NCT01363115|Calcium|calcium
371307|NCT01363115|Vitamin D|vitamin d
371308|NCT01363102|Muscle strength|muscle strength
371309|NCT01363102|functional mobility|functional mobility
371310|NCT01363102|outcome|outcome
371311|NCT01363102|intensive care unit|intensive care unit
371312|NCT01363102|quality of life|quality of life
371313|NCT01363037|HIV infections|hiv infections
371314|NCT01363037|Anti-HIV agents|anti-hiv agents
371315|NCT01363037|HIV-1|hiv-1
371316|NCT01363024|Solid Cancers|solid cancers
371317|NCT01363011|HIV-1|hiv-1
371318|NCT01363011|Treatment Naive|treatment naive
371319|NCT01363011|Treatment Experienced|treatment experienced
371320|NCT01362998|fentanyl, morphine, duramorph, Cesarean section, epidural|fentanyl, morphine, duramorph, cesarean section, epidural
371321|NCT01362959|Delirium|delirium
371322|NCT01362959|Psychomotor Agitation|psychomotor agitation
371323|NCT01362959|Substance Withdrawal Syndrome|substance withdrawal syndrome
371324|NCT01362959|Nicotine replacement therapy|nicotine replacement therapy
371325|NCT01362946|Conduct problems|conduct problems
588694|NCT00538447|CML|cml
371328|NCT01362933|PE|pe
371329|NCT01362933|DVT|dvt
371330|NCT01362933|SVT|svt
371331|NCT01362933|LMWH|lmwh
371332|NCT01362933|VKA|vka
371333|NCT01362933|international Venous Thromboembolism Recommendations|international venous thromboembolism recommendations
371334|NCT01362920|Sepsis|sepsis
371335|NCT01362920|Septic shock|septic shock
371336|NCT01362920|Procalcitonin|procalcitonin
371337|NCT01362920|PCT|pct
371341|NCT01362868|Glaucoma|glaucoma
371342|NCT01362868|Triggerfish|triggerfish
371343|NCT01362868|Water drinking test|water drinking test
371344|NCT01362855|Advance Care Planning|advance care planning
371345|NCT01362855|End of life|end of life
371346|NCT01362855|Knowledge translation|knowledge translation
371347|NCT01362855|Goals of care|goals of care
371348|NCT01362855|Advance directive|advance directive
371349|NCT01362855|Lining will|lining will
371350|NCT01362842|Lung Cancer|lung cancer
371351|NCT01362842|Symptom distress|symptom distress
371352|NCT01362842|Post-operation|post-operation
371353|NCT01362842|Anxiety|anxiety
371354|NCT01362842|Depression|depression
371355|NCT01362842|Uncertainty|uncertainty
371356|NCT01362842|Fear of recurrence|fear of recurrence
371357|NCT01362842|Self-efficacy|self-efficacy
371358|NCT01362842|Needs|needs
371359|NCT01362803|Maximum Tolerated Dose|maximum tolerated dose
371360|NCT01362803|Pharmacokinetics|pharmacokinetics
371361|NCT01362803|Pharmacodynamics|pharmacodynamics
371362|NCT01362803|Response Rate|response rate
371363|NCT01362803|pain, quality of life and physical functioning|pain, quality of life and physical functioning
371364|NCT01362803|Neurofibromatosis Type 1|neurofibromatosis type 1
371366|NCT01362803|Plexiform Neurofibroma|plexiform neurofibroma
371367|NCT01362790|Immune Therapy|immune therapy
371368|NCT01362790|Immunotoxin|immunotoxin
371369|NCT01362790|T-Cell Depletion|t-cell depletion
371370|NCT01362790|Mesothelioma|mesothelioma
371371|NCT01362777|Obstructive Sleep Apnea/Hypopnea Syndrome|obstructive sleep apnea/hypopnea syndrome
371372|NCT01362777|Exercise training program|exercise training program
371373|NCT01362777|Inflammation|inflammation
371374|NCT01362777|Oxidative Stress|oxidative stress
371375|NCT01362777|Resistance to insulin|resistance to insulin
371376|NCT01362764|Abiraterone Acetate|abiraterone acetate
371377|NCT01362764|ZYTIGA|zytiga
371378|NCT01362738|Long-standing persistent atrial fibrillation|long-standing persistent atrial fibrillation
371379|NCT01362725|spinal cord stimulation|spinal cord stimulation
371380|NCT01362725|systolic heart failure|systolic heart failure
371381|NCT01362712|breast cancer|breast cancer
371382|NCT01362712|radiotherapy|radiotherapy
371383|NCT01362712|chemoradiotherapy|chemoradiotherapy
371384|NCT01362712|radiation|radiation
371385|NCT01362712|chemoradiation|chemoradiation
371386|NCT01362712|[F-18]|[f-18]
371387|NCT01362699|Alcoholism|alcoholism
371388|NCT01362699|Alcohol-Related Disorders|alcohol-related disorders
371389|NCT01362699|Substance-Related Disorders|substance-related disorders
371390|NCT01362699|Mental Disorders|mental disorders
371391|NCT01362699|Alcohol Dependence|alcohol dependence
371392|NCT01362699|JNJ-31001074|jnj-31001074
371393|NCT01362699|Bavisant|bavisant
371394|NCT01362686|diagnosis of Alzheimer's disease|diagnosis of alzheimer's disease
371395|NCT01362686|medication adherence|medication adherence
371396|NCT01362673|Phase 1|phase 1
371397|NCT01362673|Pharmacokinetics|pharmacokinetics
371398|NCT01362673|food effect|food effect
371399|NCT01362673|Healthy Japanese|healthy japanese
371400|NCT01362673|rheumatoid arthritis|rheumatoid arthritis
371401|NCT01362660|post-natal monitoring|post-natal monitoring
371402|NCT01362660|exposure in utero|exposure in utero
371403|NCT01362647|Muscle Relaxation|muscle relaxation
371404|NCT01362634|HIV/AIDS|hiv/aids
371405|NCT01362634|substance use|substance use
371406|NCT01362634|club drugs|club drugs
371407|NCT01362634|sexual risk|sexual risk
371408|NCT01362621|Allergic asthma|allergic asthma
371409|NCT01362621|Pediatrics|pediatrics
371410|NCT01362621|Exacerbations|exacerbations
371411|NCT01362621|Perennial aeroallergens|perennial aeroallergens
371412|NCT01362621|Inhaled corticosteroids|inhaled corticosteroids
371413|NCT01362608|Gout|gout
371414|NCT01362608|Inflammatory gout|inflammatory gout
371415|NCT01362608|acute gout|acute gout
371416|NCT01362595|leucine administration|leucine administration
371417|NCT01362595|red blood cell transfusion|red blood cell transfusion
371418|NCT01362595|Diamond Blackfan anemia|diamond blackfan anemia
371419|NCT01362582|Pancreatic cancer|pancreatic cancer
371420|NCT01362582|progression under chemotherapy|progression under chemotherapy
371421|NCT01362582|parenteral nutrition|parenteral nutrition
371422|NCT01362582|pancreatic adenocarcinoma|pancreatic adenocarcinoma
371423|NCT01362582|chemotherapy|chemotherapy
371424|NCT01362569|endotoxin|endotoxin
371425|NCT01362569|neutrophil function|neutrophil function
371426|NCT01362569|albumin function|albumin function
371427|NCT01362543|PTSD|ptsd
371428|NCT01362543|Depression|depression
371429|NCT01362543|Refugees|refugees
371430|NCT01362543|Trauma|trauma
371431|NCT01362517|Vaccination|vaccination
371432|NCT01362517|Immunisation|immunisation
371433|NCT01362517|Virus|virus
371434|NCT01362517|Diphtheria|diphtheria
371435|NCT01362517|Pertussis|pertussis
371436|NCT01362517|Tetanus|tetanus
371437|NCT01362517|Hepatitis B|hepatitis b
371438|NCT01362517|Haemophilus Influenzae|haemophilus influenzae
371439|NCT01362517|Immunity|immunity
371440|NCT01362504|Pro-adrenomedullin|pro-adrenomedullin
371441|NCT01362504|Neonatal sepsis|neonatal sepsis
371442|NCT01362504|Prognosis|prognosis
371443|NCT01362504|Sepsis marker|sepsis marker
371444|NCT01362504|Clinical sepsis|clinical sepsis
371445|NCT01362504|Proven sepsis|proven sepsis
371446|NCT01362491|Headache|headache
371447|NCT01362478|schizophrenia|schizophrenia
371448|NCT01362478|gene promoter|gene promoter
371449|NCT01362478|methylation|methylation
371450|NCT01362478|endophenotype|endophenotype
371451|NCT01362478|epigenetic|epigenetic
371452|NCT01362452|Leukemia|leukemia
371453|NCT01362452|Lymphoma|lymphoma
371454|NCT01362452|CD19-specific T cells|cd19-specific t cells
371455|NCT01362452|Umbilical cord blood transplantation|umbilical cord blood transplantation
371456|NCT01362452|B-Lineage Lymphoid Malignancies|b-lineage lymphoid malignancies
371457|NCT01362452|B-cell leukemia|b-cell leukemia
371458|NCT01362452|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
371460|NCT01362452|Biphenotypic Leukemia|biphenotypic leukemia
371461|NCT01362452|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
371462|NCT01362452|NHL|nhl
371463|NCT01362452|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
371464|NCT01362452|SLL|sll
371465|NCT01362452|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
371466|NCT01362452|CLL|cll
371467|NCT01362452|White blood cells|white blood cells
371468|NCT01362452|T cells|t cells
371469|NCT01362452|Melphalan|melphalan
371471|NCT01362452|Thiotepa|thiotepa
371472|NCT01362452|Fludarabine|fludarabine
371473|NCT01362452|Fludarabine Phosphate|fludarabine phosphate
371474|NCT01362452|Fludara|fludara
371475|NCT01362452|ATG|atg
371476|NCT01362452|Antithymocyte Globulin|antithymocyte globulin
371477|NCT01362452|Thymoglobulin|thymoglobulin
371478|NCT01362452|Rituxan|rituxan
371479|NCT01362452|Rituximab|rituximab
371480|NCT01362452|Cyclophosphamide|cyclophosphamide
371481|NCT01362452|Cytoxan|cytoxan
371482|NCT01362452|Neosar|neosar
371483|NCT01362439|Schizophrenia|schizophrenia
371484|NCT01362439|Paliperidone|paliperidone
371485|NCT01362426|schizophrenia|schizophrenia
371486|NCT01362426|paliperidone palmitate|paliperidone palmitate
371487|NCT01362426|INVEGA SUSTENNA|invega sustenna
371488|NCT01362426|registries|registries
371489|NCT01362426|quality of healthcare|quality of healthcare
371490|NCT01362413|pseudarthrosis|pseudarthrosis
371491|NCT01362413|mineralization|mineralization
371492|NCT01362413|platelet-rich-plasma|platelet-rich-plasma
371493|NCT01362413|serum|serum
371494|NCT01362400|LUNG NEOPLASMS|lung neoplasms
371495|NCT01362400|LARGE CELL CARCINOMA|large cell carcinoma
371496|NCT01362400|SQUAMOUS CELL CARCINOMA|squamous cell carcinoma
371497|NCT01362387|Medical abortion|medical abortion
371498|NCT01362387|abortion follow-up|abortion follow-up
371499|NCT01362361|Second line colorectal cancer|second line colorectal cancer
371500|NCT01362348|Age-related Macular Degeneration|age-related macular degeneration
371501|NCT01362322|dTpa|dtpa
371502|NCT01362322|Boostrix|boostrix
371503|NCT01362309|Alcohol|alcohol
371504|NCT01362309|Cues|cues
371505|NCT01362309|Extinction|extinction
371506|NCT01362309|D-Cycloserine|d-cycloserine
371507|NCT01362296|NRAS|nras
371508|NCT01362296|docetaxel|docetaxel
371509|NCT01362296|NSCLC|nsclc
371510|NCT01362296|GSK1120212|gsk1120212
371511|NCT01362296|MEK inhibitor|mek inhibitor
371512|NCT01362296|targeted therapy|targeted therapy
371513|NCT01362296|KRAS|kras
371514|NCT01362296|BRAF|braf
371515|NCT01362270|Anxiolytics|anxiolytics
371516|NCT01362270|Sedatives|sedatives
371517|NCT01362270|Acupuncture Therapy|acupuncture therapy
371518|NCT01362244|Quality of Life|quality of life
371519|NCT01362244|Intranasal Steroids|intranasal steroids
371520|NCT01362244|Severe Nasal Polyposis|severe nasal polyposis
371521|NCT01362244|Polyp Relapse|polyp relapse
371522|NCT01362244|Endoscopic Polyp Score|endoscopic polyp score
371523|NCT01362244|Surgery|surgery
371524|NCT01362231|Fibrosis|fibrosis
371525|NCT01362231|Pulmonary Fibrosis|pulmonary fibrosis
371526|NCT01362231|Lung Diseases|lung diseases
371527|NCT01362231|Interstitial|interstitial
371528|NCT01362205|Severe Alcohol Withdrawal Delirium Tremens|severe alcohol withdrawal delirium tremens
371529|NCT01362192|Telangiectasis|telangiectasis
371530|NCT01362192|Spider Veins|spider veins
371531|NCT01362192|Excel V|excel v
371533|NCT01362192|Laser|laser
371534|NCT01362192|Leg Veins|leg veins
371535|NCT01362192|Venulectasia|venulectasia
371536|NCT01362192|Lower Extremity veins|lower extremity veins
371537|NCT01362192|Laser light|laser light
371538|NCT01362192|KTP|ktp
371539|NCT01362192|532nm|532nm
371540|NCT01362179|malignant myeloid hematologic disorders|malignant myeloid hematologic disorders
371541|NCT01362179|filgrastim|filgrastim
371542|NCT01362179|long term incidence|long term incidence
371543|NCT01362179|donors who received and in those who did not receive filgrastim.|donors who received and in those who did not receive filgrastim.
371544|NCT01362166|Chinese medicine|chinese medicine
371545|NCT01362166|channel|channel
371546|NCT01362166|acupuncture|acupuncture
371547|NCT01362166|ZuSanLi|zusanli
371548|NCT01362166|XianGu|xiangu
371549|NCT01362166|frequency response|frequency response
371550|NCT01362166|resonance|resonance
371551|NCT01362166|male volunteer|male volunteer
371552|NCT01362166|aged within 20-35 years old|aged within 20-35 years old
371553|NCT01362153|Golimumab|golimumab
371554|NCT01362153|Simponi|simponi
371555|NCT01362153|Rheumatoid Arthritis|rheumatoid arthritis
371556|NCT01362153|PK|pk
371557|NCT01362153|PD|pd
371558|NCT01362140|Randomized|randomized
371559|NCT01362140|Darbepoetin alfa|darbepoetin alfa
371560|NCT01362140|Myelodysplastic Syndromes|myelodysplastic syndromes
371561|NCT01362140|Placebo-controlled|placebo-controlled
362214|NCT01401712|ON-Q|on-q
371562|NCT01362140|low risk MDS|low risk mds
371563|NCT01362140|intermediate-1 risk MDS|intermediate-1 risk mds
371564|NCT01362140|International Prognostic Scoring System|international prognostic scoring system
371565|NCT01362127|Histologically confirmed squamos cell carcinoma or adenocarcinoma of the esophagus and gastric cardia.Suitable for surgery.|histologically confirmed squamos cell carcinoma or adenocarcinoma of the esophagus and gastric cardia.suitable for surgery.
371566|NCT01362114|Hwa-byung|hwa-byung
371567|NCT01362114|Sihogayonggolmoryeo-tang|sihogayonggolmoryeo-tang
371568|NCT01362114|Anxiety|anxiety
371569|NCT01362101|cue reactivity|cue reactivity
371570|NCT01362101|physiologic activation|physiologic activation
371571|NCT01362101|craving|craving
371572|NCT01362101|smoking cues|smoking cues
371573|NCT01362101|Behavioral therapy|behavioral therapy
371574|NCT01362088|microcirculation|microcirculation
371575|NCT01362088|intensive care|intensive care
371576|NCT01362088|ultrafiltration|ultrafiltration
371577|NCT01362088|CVVH|cvvh
371578|NCT01362075|Shoulder Arthroplasty|shoulder arthroplasty
371579|NCT01362075|Local infiltration analgesia|local infiltration analgesia
371580|NCT01362049|Stabilization exercise|stabilization exercise
371581|NCT01362049|Physical therapy|physical therapy
371582|NCT01362049|Rehabilitation|rehabilitation
371583|NCT01362049|Movement System Impairment exercise|movement system impairment exercise
371584|NCT01362010|Acne|acne
371585|NCT01362010|Acne Vulgaris|acne vulgaris
371586|NCT01362010|Topical|topical
371587|NCT01362010|Minocycline|minocycline
371588|NCT01362010|Foam|foam
371589|NCT01362010|Phase II|phase ii
371590|NCT01361997|Antiseptics|antiseptics
371591|NCT01361997|Hemoculture contamination|hemoculture contamination
371592|NCT01361997|Anti-infecting agents, local|anti-infecting agents, local
371593|NCT01361984|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
371594|NCT01361984|COPD|copd
371595|NCT01361984|Emphysema|emphysema
371596|NCT01361984|Chronic Bronchitis|chronic bronchitis
371597|NCT01361984|Brovana|brovana
371598|NCT01361984|Serevent|serevent
371599|NCT01361971|Insulin resistance|insulin resistance
371600|NCT01361971|Inflammation|inflammation
371601|NCT01361971|Hypoxia|hypoxia
371602|NCT01361945|ER+|er+
371603|NCT01361945|HER2+|her2+
371604|NCT01361945|Breast|breast
371605|NCT01361919|compressions|compressions
371606|NCT01361919|quality|quality
371607|NCT01361919|teaching method|teaching method
371608|NCT01361919|feedback|feedback
371609|NCT01361919|CPR performance - how well do students perform CPR when taught with feedback?|cpr performance - how well do students perform cpr when taught with feedback?
371610|NCT01361919|Cardiopulmonary resuscitation (CPR)|cardiopulmonary resuscitation (cpr)
371611|NCT01361906|Musculoskeletal and Neural Physiological Phenomena|musculoskeletal and neural physiological phenomena
371612|NCT01361906|Postural Balance|postural balance
371613|NCT01361906|Eye/hand coordination|eye/hand coordination
371615|NCT01361893|African American|african american
371616|NCT01361893|Infants|infants
371617|NCT01361893|Disparity|disparity
371618|NCT01361880|African American|african american
371619|NCT01361880|Anticipatory Guidance|anticipatory guidance
371620|NCT01361880|Health Promotion|health promotion
371621|NCT01361880|Infant Mortality|infant mortality
371622|NCT01361880|Injury Prevention|injury prevention
371623|NCT01361880|Nurses|nurses
371624|NCT01361880|Parent Education|parent education
371625|NCT01361880|sudden Infant Death Syndrome|sudden infant death syndrome
371626|NCT01361867|motor adaptation|motor adaptation
371627|NCT01361867|lower extremity motor learning|lower extremity motor learning
371628|NCT01361854|polysomnography|polysomnography
371629|NCT01361854|portable monitoring|portable monitoring
371630|NCT01361854|sleep|sleep
588695|NCT00538460|tomography|tomography
371631|NCT01361854|sleep disordered breathing|sleep disordered breathing
371632|NCT01361854|home based polysomnography|home based polysomnography
371633|NCT01361841|Latanoprost|latanoprost
371634|NCT01361841|bimatoprost|bimatoprost
371635|NCT01361841|travoprost|travoprost
371636|NCT01361841|non responders|non responders
371637|NCT01361828|Bevacizumab|bevacizumab
371638|NCT01361828|VEP|vep
371639|NCT01361828|ERG|erg
371640|NCT01361828|Optic nerve and retinal functions following intravitreal bevacizumab|optic nerve and retinal functions following intravitreal bevacizumab
371641|NCT01361815|Depression|depression
371642|NCT01361815|MDD|mdd
371643|NCT01361815|SSRIs|ssris
371644|NCT01361815|TMS|tms
371645|NCT01361789|Arthroscopic reconstruction|arthroscopic reconstruction
371646|NCT01361789|Anterior crucial ligament|anterior crucial ligament
371647|NCT01361789|Coxib|coxib
371648|NCT01361789|Dexamethasone|dexamethasone
371649|NCT01361776|immune response|immune response
371650|NCT01361776|TBE-vaccine|tbe-vaccine
371651|NCT01361776|elderly|elderly
371652|NCT01361776|additional doses|additional doses
371653|NCT01361763|Dabigatran|dabigatran
371654|NCT01361763|Microbleeds|microbleeds
371655|NCT01361763|Microthrombi|microthrombi
371656|NCT01361763|CADASIL|cadasil
371657|NCT01361763|Small Vessel Disease|small vessel disease
371658|NCT01360762|Secondary prophylaxis|secondary prophylaxis
371659|NCT01360762|Visceral leishmaniasis|visceral leishmaniasis
371660|NCT01360762|Relapses|relapses
371661|NCT01360762|HIV co-infection|hiv co-infection
371662|NCT01360762|Pentamidine|pentamidine
371663|NCT01360762|Ethiopia|ethiopia
371664|NCT01360749|Pain management|pain management
371665|NCT01360749|Lidocaine|lidocaine
371666|NCT01360736|Suicide Prevention|suicide prevention
371667|NCT01360736|Suicide Attempt|suicide attempt
371668|NCT01360736|Suicide Ideation|suicide ideation
371669|NCT01360736|Randomized Controlled Trial|randomized controlled trial
371670|NCT01360736|Safety Planning|safety planning
371671|NCT01360710|male age 18-30 years old|male age 18-30 years old
371672|NCT01360710|presence of central obesity|presence of central obesity
371673|NCT01360710|no history of cardiovascular disease, depression|no history of cardiovascular disease, depression
371674|NCT01360710|not on any medication|not on any medication
371675|NCT01360697|Diabetes|diabetes
371676|NCT01360697|Structured care|structured care
371677|NCT01360671|PPHN|pphn
371678|NCT01360671|persistent pulmonary hypertension of the newborn|persistent pulmonary hypertension of the newborn
371679|NCT01360671|sildenafil|sildenafil
371680|NCT01360671|iv|iv
371681|NCT01360658|Intravenous immunoglobulins|intravenous immunoglobulins
371682|NCT01360658|Solar urticaria|solar urticaria
371683|NCT01360658|Minimal urticaria dose|minimal urticaria dose
371684|NCT01360658|Quality of life|quality of life
371685|NCT01360658|Safety|safety
371686|NCT01360645|OPC-34712|opc-34712
371687|NCT01360645|brexpiprazole|brexpiprazole
371688|NCT01360645|Major Depressive Disorder|major depressive disorder
371689|NCT01360645|Adjunctive Treatment|adjunctive treatment
371690|NCT01360632|OPC-34712|opc-34712
371691|NCT01360632|brexpiprazole|brexpiprazole
371692|NCT01360632|Major Depressive Disorder|major depressive disorder
371693|NCT01360632|Adjunctive Treatment|adjunctive treatment
371694|NCT01360619|To demonstrate that multifunction Keito is as effective, as safe and accurate as the predicate K014009 on its body fat measurement.|to demonstrate that multifunction keito is as effective, as safe and accurate as the predicate k014009 on its body fat measurement.
371695|NCT01360606|Liver|liver
371696|NCT01360606|Mets|mets
371697|NCT01360593|Pancreas|pancreas
371698|NCT01360567|green tea|green tea
371699|NCT01360567|EGCG|egcg
371700|NCT01360567|type 2 diabetes|type 2 diabetes
371701|NCT01360567|hyperlipidemia|hyperlipidemia
371702|NCT01360554|comparative study of PF-00299804 and Erlotinib|comparative study of pf-00299804 and erlotinib
371703|NCT01360554|Double-Blind Phase 3 trial of TKI|double-blind phase 3 trial of tki
371704|NCT01360541|Barrett oesophagus|barrett oesophagus
371705|NCT01360541|Low grade dysplasia|low grade dysplasia
371706|NCT01360541|Radiofrequency ablation|radiofrequency ablation
371707|NCT01361737|Preeclampsia|preeclampsia
371708|NCT01361737|serological bio-bank|serological bio-bank
371709|NCT01361737|adiponectin|adiponectin
371710|NCT01361737|suPAR|supar
371711|NCT01361724|Parkinson's disease|parkinson's disease
371712|NCT01361724|PD|pd
371713|NCT01361724|Exercise|exercise
371714|NCT01361724|Balance|balance
371715|NCT01361724|Mobility|mobility
371716|NCT01361698|recovery|recovery
371717|NCT01361698|illness management|illness management
371718|NCT01361698|rehabilitation|rehabilitation
371719|NCT01361698|mental illness|mental illness
371720|NCT01361698|psychosocial intervention|psychosocial intervention
371721|NCT01361698|Clinical recovery (increase in functioning, decrease in symptoms)|clinical recovery (increase in functioning, decrease in symptoms)
371722|NCT01361698|Personal recovery (Hope, optimism, living a fulfilling life)|personal recovery (hope, optimism, living a fulfilling life)
371723|NCT01361659|anginal complaints|anginal complaints
371724|NCT01361659|Lithotripsy|lithotripsy
371725|NCT01361659|no option patients|no option patients
371726|NCT01361633|d-cycloserine|d-cycloserine
371727|NCT01361633|geriatric|geriatric
371728|NCT01361633|neuropsychology|neuropsychology
371729|NCT01361633|cognition|cognition
371730|NCT01361633|cognitive-enhancer|cognitive-enhancer
371731|NCT01361633|aging|aging
371732|NCT01361633|neuropsychological functioning|neuropsychological functioning
371733|NCT01361620|genomic markers|genomic markers
371734|NCT01361620|aspirin resistance|aspirin resistance
371735|NCT01361607|Cancer pain|cancer pain
371736|NCT01361607|Opioid therapy|opioid therapy
371737|NCT01361607|Inadequate analgesia|inadequate analgesia
371738|NCT01361607|Optimized chronic opioid therapy|optimized chronic opioid therapy
371739|NCT01361594|Diabetes|diabetes
371740|NCT01361594|Coronary Artery Bypass Surgery|coronary artery bypass surgery
371741|NCT01361594|Glycemic control|glycemic control
371742|NCT01361594|Insulin infusion|insulin infusion
371743|NCT01361581|Acute renal failure|acute renal failure
371744|NCT01361581|Anticoagulation|anticoagulation
371745|NCT01361581|Citrate|citrate
371746|NCT01361581|Haemodiafiltration|haemodiafiltration
371747|NCT01361581|Haemofiltration|haemofiltration
371748|NCT01361581|Renal replacement therapy|renal replacement therapy
371749|NCT01361568|pain|pain
371750|NCT01361568|acute pain|acute pain
371751|NCT01361568|visceral pain|visceral pain
371752|NCT01361568|kappa agonist|kappa agonist
371753|NCT01361568|opioid analgesics|opioid analgesics
371754|NCT01361568|peripheral nervous system agents|peripheral nervous system agents
371755|NCT01361568|physiological effects of drugs|physiological effects of drugs
371756|NCT01361568|surgery|surgery
371757|NCT01361568|hysterectomy|hysterectomy
371758|NCT01361568|post-operative|post-operative
371759|NCT01361568|post-operative complications|post-operative complications
371760|NCT01361542|TNF|tnf
371761|NCT01361542|BMD|bmd
371762|NCT01361542|Ankylosing spondylitis|ankylosing spondylitis
371763|NCT01361542|bone health|bone health
371764|NCT01361542|Anti TNF therapy|anti tnf therapy
371765|NCT01361542|Disease activity|disease activity
371766|NCT01361529|dose escalation|dose escalation
371767|NCT01361516|Urolithiasis|urolithiasis
371768|NCT01361516|ESWL|eswl
371769|NCT01361516|Stone Fragmentation efficacy|stone fragmentation efficacy
371770|NCT01361516|Sedation|sedation
371771|NCT01361516|General Anaesthesia|general anaesthesia
371772|NCT01361503|Autism Spectrum Disorders|autism spectrum disorders
371773|NCT01361503|Pervasive Developmental Disorders|pervasive developmental disorders
371774|NCT01361503|Asperger's Syndrome|asperger's syndrome
371775|NCT01361503|Adolescents|adolescents
371776|NCT01361503|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
371777|NCT01361503|Diffusion Tensor Imaging|diffusion tensor imaging
371778|NCT01361477|General surgical ICU|general surgical icu
371779|NCT01361477|ICU Siamitra|icu siamitra
371780|NCT01361477|ICU Salad-Samung|icu salad-samung
371781|NCT01361477|Data registry|data registry
371782|NCT01361477|ICU refusal|icu refusal
371783|NCT01361477|ICU complications|icu complications
371784|NCT01361477|ICU resource utilization|icu resource utilization
371785|NCT01361477|Adverse events|adverse events
371786|NCT01361477|ICU readmission|icu readmission
371787|NCT01361451|parasternal electromyogram|parasternal electromyogram
371788|NCT01361451|neural respiratory drive|neural respiratory drive
371789|NCT01361451|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
371790|NCT01361451|respiratory physiology|respiratory physiology
371791|NCT01361451|Acute exacerbation|acute exacerbation
371792|NCT01361425|hypertension|hypertension
371793|NCT01361425|ultrasonography|ultrasonography
371794|NCT01361425|preeclampsia|preeclampsia
371795|NCT01361425|clinical trials|clinical trials
371796|NCT01361425|treatment|treatment
371797|NCT01361425|methyldopa|methyldopa
371798|NCT01361412|ragweed allergy|ragweed allergy
371799|NCT01361412|immunotherapy|immunotherapy
371800|NCT01361399|Sore Throat|sore throat
371801|NCT01361386|Long-term follow up|long-term follow up
371802|NCT01361386|Antithrombotic management patterns|antithrombotic management patterns
371803|NCT01361386|Acute Coronary Syndrome|acute coronary syndrome
371804|NCT01361386|Asia|asia
371805|NCT01361386|quality of life|quality of life
371806|NCT01361347|milk allergy|milk allergy
371808|NCT01361347|anaphylaxis|anaphylaxis
371809|NCT01361347|school-age|school-age
371810|NCT01361334|(other than AML M3)|(other than aml m3)
371811|NCT01361321|follow up|follow up
371812|NCT01361321|Guided bone regeneration|guided bone regeneration
371813|NCT01361321|Micro computerized tomography|micro computerized tomography
371814|NCT01361321|histological examination|histological examination
371815|NCT01361308|Menopause|menopause
371816|NCT01361308|Vasomotor Symptoms|vasomotor symptoms
371817|NCT01361308|Hot Flashes Perimenopause|hot flashes perimenopause
371818|NCT01361308|Climacteric Symptoms|climacteric symptoms
371819|NCT01361308|Mesafem|mesafem
371820|NCT01361308|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
371821|NCT01361295|Atrial fibrillation|atrial fibrillation
371822|NCT01361295|cerebral embolism|cerebral embolism
371823|NCT01361295|catheter ablation|catheter ablation
371824|NCT01361282|Total Corneal Power|total corneal power
371825|NCT01361282|Optical Coherence Tomography|optical coherence tomography
371826|NCT01361282|Descemet Stripping Endothelial Keratoplasty|descemet stripping endothelial keratoplasty
371827|NCT01361256|Macular Degeneration|macular degeneration
371828|NCT01361256|Visual Impairment|visual impairment
371829|NCT01361256|Implantable Telescope|implantable telescope
371830|NCT01361243|Pediatric Overweight|pediatric overweight
371831|NCT01361243|Pediatric Obesity|pediatric obesity
371832|NCT01361217|Fluoxetine|fluoxetine
371833|NCT01361217|CYP3A4|cyp3a4
371834|NCT01361217|CYP2D6|cyp2d6
371835|NCT01361217|CYP2C19|cyp2c19
371836|NCT01361217|Drug-Drug Interaction|drug-drug interaction
371837|NCT01361217|Multi-CYP Inhibition|multi-cyp inhibition
371838|NCT01361204|stress|stress
371839|NCT01361204|students|students
371840|NCT01361204|pharmacy practice|pharmacy practice
371841|NCT01361204|theanine|theanine
371842|NCT01361204|pharmacy training|pharmacy training
371843|NCT01361191|DLBCL|dlbcl
371844|NCT01361191|PET|pet
371845|NCT01361191|IPI|ipi
371846|NCT01361191|R-MegaCHOP|r-megachop
371847|NCT01361191|Autologous stem cell transplantation|autologous stem cell transplantation
371848|NCT01361165|Pediatric|pediatric
371849|NCT01361165|Data Analysis|data analysis
371850|NCT01361152|total knee arthroplasty|total knee arthroplasty
371851|NCT01361152|fixed-bearing|fixed-bearing
371852|NCT01361152|mobile-bearing|mobile-bearing
371853|NCT01361152|long-term|long-term
371854|NCT01361139|Chronic obstructive lung disease|chronic obstructive lung disease
371855|NCT01361139|Interstitial lung disease|interstitial lung disease
371856|NCT01361139|Asthma|asthma
371857|NCT01361139|Sarcoidosis|sarcoidosis
371858|NCT01361139|Pulmonary hypertension|pulmonary hypertension
371859|NCT01361139|Ultrasound|ultrasound
371860|NCT01361139|Doppler|doppler
371861|NCT01361139|Lung disease diagnosis|lung disease diagnosis
371862|NCT01361113|Renal Cell Carcinoma|renal cell carcinoma
371863|NCT01361113|RCC|rcc
371864|NCT01361113|Votrient|votrient
371865|NCT01361113|Pazopanib|pazopanib
371866|NCT01361113|Nephrectomy|nephrectomy
371867|NCT01361113|Neoadjuvant|neoadjuvant
371868|NCT01361113|Phase II|phase ii
371869|NCT01361113|LCCC 1028|lccc 1028
371870|NCT01361113|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
371871|NCT01361100|Otolaryngology|otolaryngology
371872|NCT01361087|TGF-B blood levels Atenolol vs, Losartan Study, NIH, NIHLB and NMF|tgf-b blood levels atenolol vs, losartan study, nih, nihlb and nmf
371873|NCT01361074|Virtual reality|virtual reality
371874|NCT01361074|Augmented reality|augmented reality
371875|NCT01361074|In vivo exposure|in vivo exposure
371876|NCT01361074|One session treatment|one session treatment
371878|NCT01361074|Efficacy|efficacy
371879|NCT01361074|Specific phobia|specific phobia
371880|NCT01361074|Anxiety disorders|anxiety disorders
371881|NCT01361061|liver cirrhosis|liver cirrhosis
371882|NCT01361061|screening|screening
371883|NCT01361061|hepatocellular carcinoma|hepatocellular carcinoma
371884|NCT01361061|liver cancer markers: AFP, AFP-L3% and DCP|liver cancer markers: afp, afp-l3% and dcp
371885|NCT01361048|trichomonas|trichomonas
371886|NCT01361035|health literacy|health literacy
371887|NCT01361035|cancer screening|cancer screening
371888|NCT01361035|doctor-patient communication|doctor-patient communication
371889|NCT01361035|standardized patient|standardized patient
371890|NCT01361035|continuing medical education|continuing medical education
371891|NCT01360996|PCOS|pcos
371892|NCT01360970|hepatitis A vaccine|hepatitis a vaccine
371893|NCT01360970|TNF-alfa inhibitory drugs|tnf-alfa inhibitory drugs
371894|NCT01360970|Rheumatoid arthritis|rheumatoid arthritis
371895|NCT01360970|methotrexate|methotrexate
371896|NCT01360957|Obesity|obesity
371897|NCT01360944|PPT, topical, psoriasis|ppt, topical, psoriasis
371898|NCT01360931|Lung cancer|lung cancer
371899|NCT01360931|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
371900|NCT01360905|PTL|ptl
371901|NCT01360905|Multiples|multiples
371902|NCT01360892|Hepatitis B virus|hepatitis b virus
371903|NCT01360892|Hepatitis C virus|hepatitis c virus
371904|NCT01360892|Chronic hepatitis|chronic hepatitis
371905|NCT01360892|Liver chlorosis|liver chlorosis
371906|NCT01360892|Liver stiffness|liver stiffness
371907|NCT01360892|Liver fibrosis|liver fibrosis
371908|NCT01360879|Hepatitis B virus|hepatitis b virus
371909|NCT01360879|Hepatitis C virus|hepatitis c virus
371910|NCT01360879|Chronic hepatitis|chronic hepatitis
371911|NCT01360879|Liver cirrhosis|liver cirrhosis
371912|NCT01360879|Liver stiffness|liver stiffness
371913|NCT01360879|Liver fibrosis|liver fibrosis
371914|NCT01360866|OPC-34712|opc-34712
371915|NCT01360866|brexpiprazole|brexpiprazole
371916|NCT01360866|Major Depressive Disorder|major depressive disorder
371917|NCT01360866|Adjunctive Treatment|adjunctive treatment
371918|NCT01360853|pancreatic cancer|pancreatic cancer
371919|NCT01360853|gemcitabine|gemcitabine
371920|NCT01360853|ON 01910.Na|on 01910.na
371921|NCT01360853|rigosertib sodium|rigosertib sodium
371922|NCT01360840|Asymptomatic|asymptomatic
371923|NCT01360840|mildly symptomatic|mildly symptomatic
371924|NCT01360840|metastatic castrate-resistant prostate cancer|metastatic castrate-resistant prostate cancer
371925|NCT01360840|mCRPC|mcrpc
371926|NCT01360827|Safety|safety
371927|NCT01360827|tolerability|tolerability
371928|NCT01360827|maximum tolerated dose of EMD 1201081|maximum tolerated dose of emd 1201081
371929|NCT01360827|TLR9 agonists|tlr9 agonists
371930|NCT01360827|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
371931|NCT01360827|First line subjects|first line subjects
371932|NCT01360827|recurrent/metastatic|recurrent/metastatic
371933|NCT01360788|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
371934|NCT01360788|lung function|lung function
371935|NCT01360788|symptoms|symptoms
371936|NCT01360788|activity-related dyspnea|activity-related dyspnea
371937|NCT01360788|quadriceps muscle function|quadriceps muscle function
371938|NCT01360788|exercise capacity|exercise capacity
371939|NCT01360788|physical activity in daily life|physical activity in daily life
371940|NCT01360788|muscle biopsy|muscle biopsy
371941|NCT01360788|systemic inflammation|systemic inflammation
371942|NCT01360788|GOLD stage I|gold stage i
371943|NCT01360788|pulmonary function|pulmonary function
371944|NCT01360775|Nutritional status|nutritional status
371945|NCT01360775|Dependent patients|dependent patients
371946|NCT01360775|Nutritional educational intervention|nutritional educational intervention
371947|NCT01360775|Caregivers|caregivers
371948|NCT01360775|Clinical assay|clinical assay
371949|NCT01360528|Folic acid replacement|folic acid replacement
371950|NCT01360528|Folic acid|folic acid
371951|NCT01360528|Preterm neonate|preterm neonate
371952|NCT01360515|esophagoscope|esophagoscope
371953|NCT01360515|esophageal disease|esophageal disease
371954|NCT01360515|gastroesophageal reflux|gastroesophageal reflux
371955|NCT01360515|esophageal varices|esophageal varices
371956|NCT01360502|capsule endoscopy|capsule endoscopy
371957|NCT01360502|cardiac pacemaker|cardiac pacemaker
371958|NCT01360502|implantable cardiac defibrillator|implantable cardiac defibrillator
371959|NCT01360476|hypertension|hypertension
371960|NCT01360476|left ventricular hypertrophy|left ventricular hypertrophy
371961|NCT01360476|Vitamin D|vitamin d
371962|NCT01360476|African-Americans|african-americans
372335|NCT01358994|creatinine|creatinine
371963|NCT01360463|drug abuse counseling|drug abuse counseling
371964|NCT01360463|HIV risk reduction counseling|hiv risk reduction counseling
371965|NCT01360463|HIV infection|hiv infection
371966|NCT01360463|injection drug users|injection drug users
371967|NCT01360463|AIDS|aids
371968|NCT01360450|opioid withdrawal|opioid withdrawal
371969|NCT01360450|NPASS|npass
371970|NCT01360450|duraclon|duraclon
371971|NCT01360437|coronary angioplasty|coronary angioplasty
371972|NCT01360437|clopidogrel hyporesponsiveness|clopidogrel hyporesponsiveness
371973|NCT01360437|prasugrel|prasugrel
371974|NCT01360437|ticagrelor|ticagrelor
371975|NCT01360437|CAD|cad
371976|NCT01360437|ACS|acs
371977|NCT01360424|osteoporosis|osteoporosis
371978|NCT01360424|teriparatide|teriparatide
371979|NCT01360424|bone turnover|bone turnover
371980|NCT01360424|New forms of inherited low-turnover osteoporosis|new forms of inherited low-turnover osteoporosis
371981|NCT01360411|elastography|elastography
371982|NCT01360411|strain ratio|strain ratio
371983|NCT01360411|pancreas|pancreas
371984|NCT01360411|GI wall lesions|gi wall lesions
371985|NCT01360411|lymph nodes|lymph nodes
371986|NCT01360398|pathogen|pathogen
371987|NCT01360398|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
371988|NCT01360398|Acute Exacerbations of Chronic Obstructive Pulmonary Disease|acute exacerbations of chronic obstructive pulmonary disease
371989|NCT01360398|COPD|copd
371990|NCT01360398|respiratory|respiratory
371991|NCT01360398|AECOPD|aecopd
371992|NCT01360398|exacerbation|exacerbation
371993|NCT01360385|Central retinal rein occlusion|central retinal rein occlusion
371994|NCT01360385|Retinal oximetry|retinal oximetry
371995|NCT01360385|Oxymap Retinal Oximeter|oxymap retinal oximeter
371996|NCT01360385|Visual acuity|visual acuity
371997|NCT01360385|Central retinal thickness|central retinal thickness
371998|NCT01360372|Hydrogen breath test value and gastric residual volume measurements|hydrogen breath test value and gastric residual volume measurements
371999|NCT01360372|Tube feeding tolerance while taking a stable dose of opiate|tube feeding tolerance while taking a stable dose of opiate
372000|NCT01360359|low back pain|low back pain
372001|NCT01360359|core stabilization|core stabilization
372002|NCT01360359|trunk muscle exercises|trunk muscle exercises
372003|NCT01360359|physical therapy|physical therapy
372004|NCT01360359|RCT|rct
372005|NCT01360346|Enteral Sedation|enteral sedation
372006|NCT01360346|Intravenous Sedation|intravenous sedation
372007|NCT01360346|Critically ill ICU patient|critically ill icu patient
372008|NCT01360346|Conscious Sedation|conscious sedation
372009|NCT01360346|Deep Sedation|deep sedation
372010|NCT01360346|RASS|rass
372011|NCT01360346|CAM-ICU|cam-icu
372012|NCT01360346|VNR|vnr
372013|NCT01360346|BPS|bps
372014|NCT01360346|Propofol|propofol
372015|NCT01360346|Midazolam|midazolam
372016|NCT01360346|Hydroxyzine|hydroxyzine
372017|NCT01360346|Lorazepam|lorazepam
372018|NCT01360346|Melatonin|melatonin
372019|NCT01360333|Dehydration|dehydration
372020|NCT01360333|Hydration|hydration
372021|NCT01360320|Green tea|green tea
372022|NCT01360320|polyphenol|polyphenol
372023|NCT01360320|catechin|catechin
372024|NCT01360320|EGCG|egcg
372025|NCT01360320|Epigallocatechin gallate|epigallocatechin gallate
372026|NCT01360320|colorectal adenoma|colorectal adenoma
372027|NCT01360320|adenoma prevention|adenoma prevention
372028|NCT01360320|colon cancer prevention|colon cancer prevention
372029|NCT01360307|psychometric validation|psychometric validation
372030|NCT01360307|major depressive disorder|major depressive disorder
372031|NCT01360307|patient-reported outcome|patient-reported outcome
372032|NCT01360294|Asthma|asthma
372033|NCT01360294|Small airways disease|small airways disease
372034|NCT01360294|Questionnaire|questionnaire
372035|NCT01360281|Quadriceps strength|quadriceps strength
372036|NCT01360281|osteoarthritis rehabilitation|osteoarthritis rehabilitation
372037|NCT01360281|NMES|nmes
372038|NCT01360255|Hepatocellular Carcinoma|hepatocellular carcinoma
372039|NCT01360255|transarterial chemoembolisation|transarterial chemoembolisation
372040|NCT01360255|liver cancer markers: AFP, AFP-L3% and DCP|liver cancer markers: afp, afp-l3% and dcp
372041|NCT01360242|Acute STEMI|acute stemi
372042|NCT01360242|Thrombus aspiration|thrombus aspiration
372043|NCT01360242|Angioplasty|angioplasty
455151|NCT00010985|Pain|pain
362735|NCT01399385|HV|hv
372044|NCT01360242|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
372045|NCT01360229|Parkinsons Disease|parkinsons disease
372046|NCT01360229|Fatigue|fatigue
372047|NCT01360216|Long-acting reversible contraception|long-acting reversible contraception
372048|NCT01360216|Intrauterine contraception|intrauterine contraception
372049|NCT01360216|Intrauterine devices|intrauterine devices
372050|NCT01360216|Single-rod implant|single-rod implant
372051|NCT01360216|Hormonal contraception|hormonal contraception
372052|NCT01360190|MDD|mdd
372053|NCT01360190|major depressive disorder|major depressive disorder
372054|NCT01360190|QEEG|qeeg
372055|NCT01360190|electroencephalograph|electroencephalograph
372056|NCT01360190|fluoxtine|fluoxtine
372057|NCT01360190|placebo|placebo
372058|NCT01360164|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
372147|NCT01359865|range of motion|range of motion
372059|NCT01360151|VEGF (Vascular endothelial growth factor)|vegf (vascular endothelial growth factor)
372060|NCT01360125|adult acute basophilic leukemia|adult acute basophilic leukemia
372061|NCT01360125|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
372062|NCT01360125|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
372063|NCT01360125|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
372064|NCT01360125|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
372065|NCT01360125|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
372066|NCT01360125|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
372067|NCT01360125|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
372068|NCT01360125|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
372069|NCT01360125|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
372070|NCT01360125|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
372071|NCT01360125|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
372072|NCT01360125|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
372073|NCT01360125|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
372074|NCT01360125|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
372075|NCT01360125|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
372076|NCT01360112|Mosquito|mosquito
372077|NCT01360112|Membrane|membrane
372079|NCT01360112|Parasites|parasites
372080|NCT01360112|Infection|infection
372081|NCT01360112|Malaria|malaria
372082|NCT01360099|Atypical Hip Fracture|atypical hip fracture
372083|NCT01360099|Biosphosphonates|biosphosphonates
372084|NCT01360099|Subtrochanteric Hip Fracture|subtrochanteric hip fracture
372085|NCT01360099|Osteoporosis|osteoporosis
372086|NCT01360086|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
372087|NCT01360086|adenocarcinoma of the stomach|adenocarcinoma of the stomach
372088|NCT01360086|stage IB gastric cancer|stage ib gastric cancer
372089|NCT01360086|stage IIA gastric cancer|stage iia gastric cancer
372090|NCT01360086|stage IIB gastric cancer|stage iib gastric cancer
372091|NCT01360086|stage IIIA gastric cancer|stage iiia gastric cancer
372092|NCT01360086|stage IIIB gastric cancer|stage iiib gastric cancer
372093|NCT01360086|stage IIIC gastric cancer|stage iiic gastric cancer
372094|NCT01360073|MI|mi
372095|NCT01360073|low dose aspirin|low dose aspirin
372096|NCT01360073|PPI|ppi
372097|NCT01360073|epidemiology|epidemiology
372098|NCT01360073|Nonfatal MI and coronary death|nonfatal mi and coronary death
372099|NCT01360047|MI|mi
372100|NCT01360047|low dose aspirin|low dose aspirin
372101|NCT01360047|PPI|ppi
372102|NCT01360047|epidemiology|epidemiology
372103|NCT01360034|Obstetric labor, premature|obstetric labor, premature
372104|NCT01360034|Short cervix|short cervix
372105|NCT01360034|Nifedipine|nifedipine
372106|NCT01360034|Indomethacin|indomethacin
372107|NCT01360008|Cardiac arrhythmia|cardiac arrhythmia
372108|NCT01360008|Catheter ablation|catheter ablation
372109|NCT01360008|Cohort Study|cohort study
372110|NCT01360008|cryoballoon|cryoballoon
372111|NCT01360008|radiofrequency|radiofrequency
372112|NCT01359995|cytomegalovirus endotheliitis|cytomegalovirus endotheliitis
372113|NCT01359982|Advanced Solid Tumors|advanced solid tumors
372114|NCT01359982|Lymphomas|lymphomas
372115|NCT01359982|Safety|safety
372116|NCT01359982|Blood flow|blood flow
372117|NCT01359982|Nitric oxide|nitric oxide
372118|NCT01359982|Cancer|cancer
372119|NCT01359982|Dynamic contrast enhanced MRI (DCE-MRI)|dynamic contrast enhanced mri (dce-mri)
372120|NCT01359982|Contrast Enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
372121|NCT01359969|Hereditary Angioedema|hereditary angioedema
372122|NCT01359969|HAE|hae
372123|NCT01359969|Angioedema|angioedema
372124|NCT01359969|Recombinant C1 Inhibitor|recombinant c1 inhibitor
372125|NCT01359969|rhC1INH|rhc1inh
455329|NCT00011531|SCI|sci
372126|NCT01359969|Pediatrics|pediatrics
372127|NCT01359943|Rheumatoid Arthritis|rheumatoid arthritis
372128|NCT01359943|RA|ra
372129|NCT01359943|secukinumab|secukinumab
372130|NCT01359943|AIN457|ain457
372131|NCT01359943|inflammatory joints|inflammatory joints
372132|NCT01359943|American College of Rheumatology|american college of rheumatology
372133|NCT01359943|ACR|acr
372134|NCT01359904|dialysate glucose|dialysate glucose
372135|NCT01359904|glycemic control|glycemic control
372136|NCT01359904|hypoglycemic episodes|hypoglycemic episodes
372137|NCT01359878|Postpartum haemorrhage|postpartum haemorrhage
372138|NCT01359878|Postpartum bleeding|postpartum bleeding
372139|NCT01359878|Postnatal bleeding|postnatal bleeding
372140|NCT01359878|Fibrinogen concentrate|fibrinogen concentrate
372141|NCT01359878|Transfusion|transfusion
372142|NCT01359878|Haemostatis|haemostatis
372143|NCT01359878|Thrombelastography|thrombelastography
372144|NCT01359865|Total hip arthroplasty|total hip arthroplasty
372145|NCT01359865|lumbar plexus block|lumbar plexus block
372146|NCT01359865|spinal anesthesia|spinal anesthesia
372148|NCT01359865|Anesthetic Technique|anesthetic technique
372149|NCT01359865|Post-operative Pain Scores|post-operative pain scores
372150|NCT01359852|JNJ-42491293|jnj-42491293
372151|NCT01359852|JNJ-40411813|jnj-40411813
372152|NCT01359852|Metabotropic glutamate subtype 2 receptor (mGlu2R)|metabotropic glutamate subtype 2 receptor (mglu2r)
372153|NCT01359852|Positive allosteric modulator (PAM)|positive allosteric modulator (pam)
372154|NCT01359852|positron emission tomography (PET)|positron emission tomography (pet)
372155|NCT01359826|Systemic Lupus Erythematosus|systemic lupus erythematosus
372156|NCT01359826|Widespread Pain|widespread pain
372157|NCT01359826|Fibromyalgia|fibromyalgia
372158|NCT01359826|Fatigue|fatigue
372159|NCT01359826|Pain|pain
372160|NCT01359826|Quality of Life|quality of life
372161|NCT01359800|HIV|hiv
372162|NCT01359800|HAART|haart
372163|NCT01359774|Energy|energy
372164|NCT01359774|Metabolism|metabolism
372165|NCT01359774|Spectroscopy|spectroscopy
372166|NCT01359761|Suicide|suicide
372167|NCT01359761|Cognitive Therapy|cognitive therapy
372168|NCT01359761|Inpatient|inpatient
372169|NCT01359761|Military|military
372170|NCT01359748|Non Invasive Blood Pressure measurement study.|non invasive blood pressure measurement study.
372171|NCT01359735|Wound|wound
372172|NCT01359735|non-melanoma skin cancer|non-melanoma skin cancer
372173|NCT01359735|Mohs micrographic surgery|mohs micrographic surgery
372174|NCT01359735|Head or neck|head or neck
372175|NCT01359722|N-acetylcysteine|n-acetylcysteine
372176|NCT01359722|Myocardial Revascularization|myocardial revascularization
372177|NCT01359722|Acute Renal Failure|acute renal failure
372178|NCT01359722|Oxidative Stress|oxidative stress
372179|NCT01359696|solid cancers|solid cancers
372180|NCT01359670|Duchenne|duchenne
372181|NCT01359670|muscular dystrophy|muscular dystrophy
372182|NCT01359670|tadalafil|tadalafil
372183|NCT01359670|sildenafil|sildenafil
372184|NCT01359670|muscle ischemia|muscle ischemia
372185|NCT01359670|exercise|exercise
372186|NCT01359657|Relapsed|relapsed
372187|NCT01359657|Refractory|refractory
372188|NCT01359631|Chronic Cluster Headache|chronic cluster headache
372189|NCT01359618|Phase I|phase i
372190|NCT01359618|Safety|safety
372191|NCT01359618|tolerability|tolerability
372192|NCT01359618|healthy|healthy
372193|NCT01359618|major depressive disorder|major depressive disorder
372194|NCT01359618|thorough QT|thorough qt
372195|NCT01359618|maximum tolerated dose|maximum tolerated dose
372196|NCT01359618|elimination|elimination
372197|NCT01359618|heart electrical signal|heart electrical signal
372198|NCT01359605|ADME|adme
372199|NCT01359605|Healthy volunteers|healthy volunteers
372200|NCT01359592|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
372201|NCT01359592|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
372202|NCT01359592|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
372203|NCT01359592|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
372204|NCT01359592|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
372205|NCT01359579|renal impairment|renal impairment
372207|NCT01359579|healthy volunteers|healthy volunteers
372208|NCT01359540|Total Hip Arthroplasty|total hip arthroplasty
372209|NCT01359540|Bone Loss|bone loss
372210|NCT01359540|Femoral Remodeling|femoral remodeling
372211|NCT01359527|Total Hip Replacement|total hip replacement
372212|NCT01359527|Hip Resurfacing|hip resurfacing
372213|NCT01359527|Femoral Remodeling|femoral remodeling
372214|NCT01359527|Bone Loss|bone loss
372215|NCT01359501|patients receiving chemotherapy|patients receiving chemotherapy
372216|NCT01359488|Growth Hormone Deficiency|growth hormone deficiency
372217|NCT01359488|rhGH|rhgh
372218|NCT01359488|hGH|hgh
372219|NCT01359488|Versartis|versartis
372220|NCT01359488|AGHD|aghd
372221|NCT01359488|Hormones|hormones
372222|NCT01359488|Hormone substitute|hormone substitute
362931|NCT01398592|T2DM|t2dm
372223|NCT01359488|Endocrin System disease|endocrin system disease
372224|NCT01359488|Bone disease|bone disease
372225|NCT01359488|Bone disease, developmental|bone disease, developmental
372226|NCT01359488|Bone diseases|bone diseases
372227|NCT01359488|Musculoskeletal diseases|musculoskeletal diseases
372228|NCT01359488|Bone diseases, endocrine|bone diseases, endocrine
372229|NCT01359488|Metabolism diseases|metabolism diseases
372230|NCT01359488|Hypopituitarism|hypopituitarism
372231|NCT01359488|Pituitary disease|pituitary disease
372232|NCT01359488|Hypothalmic disease|hypothalmic disease
372233|NCT01359488|Brain disease|brain disease
372234|NCT01359488|Growth Hormone Releasing Hormone|growth hormone releasing hormone
372235|NCT01359488|Hormone replacement therapy|hormone replacement therapy
372236|NCT01359488|IGF-I|igf-i
372237|NCT01359488|IGFBP-3|igfbp-3
372238|NCT01359475|Acetal crowns|acetal crowns
372239|NCT01359475|Primary molars|primary molars
372240|NCT01359475|The retention of acetal crowns in primary dentition|the retention of acetal crowns in primary dentition
372241|NCT01359475|Color changes of acetal crowns|color changes of acetal crowns
372242|NCT01359462|hepatic cirrhosis patients with ascites|hepatic cirrhosis patients with ascites
372243|NCT01359449|Meningitis|meningitis
372244|NCT01359449|Meningococcal Infection|meningococcal infection
372245|NCT01359449|Menactra®|menactra®
372246|NCT01359449|MenC|menc
372247|NCT01359410|Pancreas adenocarcinoma|pancreas adenocarcinoma
372248|NCT01359410|Precancerous lesions of the pancreas (mucinous cystic neoplasms, IPMN)|precancerous lesions of the pancreas (mucinous cystic neoplasms, ipmn)
372249|NCT01359410|Pancreas neuroendocrine cancer|pancreas neuroendocrine cancer
372250|NCT01359397|Adenoca. stomach/gastr. Junct.|adenoca. stomach/gastr. junct.
372251|NCT01359384|severe primary immune deficieny|severe primary immune deficieny
372252|NCT01359371|Smoking Cessation|smoking cessation
372253|NCT01359371|Telephone|telephone
372254|NCT01359371|Hospital Volunteers|hospital volunteers
372255|NCT01359358|MRSA|mrsa
372256|NCT01359358|MLST|mlst
372257|NCT01359358|PFGE|pfge
372258|NCT01359358|Resistance|resistance
372259|NCT01359358|isolated from colonization|isolated from colonization
372260|NCT01359345|NSF|nsf
372261|NCT01359345|ESRD|esrd
372262|NCT01359345|MRA|mra
372263|NCT01359345|MRI|mri
372264|NCT01359345|occurrence of NSF|occurrence of nsf
372265|NCT01359345|Use of Gadollinum|use of gadollinum
372266|NCT01359332|Convulsive status EPILEPTICUS|convulsive status epilepticus
372267|NCT01359332|hypothermia therapy|hypothermia therapy
372268|NCT01359332|(defined as continuous SEIZURING for longer than 5 min or three seizures|(defined as continuous seizuring for longer than 5 min or three seizures
372269|NCT01359332|not separated by recovery of normal consciousness|not separated by recovery of normal consciousness
372270|NCT01359332|or of the level of consciousness present before the|or of the level of consciousness present before the
372271|NCT01359332|seizures)|seizures)
372272|NCT01359319|Phase 1 Safety and Pharmacokinetic Study|phase 1 safety and pharmacokinetic study
372273|NCT01359306|Acute myocardial infarction|acute myocardial infarction
372274|NCT01359306|Right ventricular infarction|right ventricular infarction
372275|NCT01359306|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
372276|NCT01359306|Prognosis|prognosis
372277|NCT01359280|HIV|hiv
372278|NCT01359280|AIDS|aids
372279|NCT01359280|Medication|medication
372280|NCT01359280|Adherence|adherence
372281|NCT01359241|dysglycemia|dysglycemia
372282|NCT01359241|diabetes|diabetes
372283|NCT01359241|closed loop insulin delivery|closed loop insulin delivery
372284|NCT01359228|Rosacea|rosacea
372285|NCT01359202|Stroke|stroke
372286|NCT01359202|ICH|ich
372287|NCT01359202|Intracerebral hemorrhage|intracerebral hemorrhage
372288|NCT01359202|acute stroke|acute stroke
372289|NCT01359202|rfVIIa|rfviia
372290|NCT01359202|Niastase|niastase
372291|NCT01359189|Suspected Primary Prostate Cancer|suspected primary prostate cancer
372292|NCT01359163|bioequivalence study|bioequivalence study
372293|NCT01359163|marketed vs reformulation tablets|marketed vs reformulation tablets
372294|NCT01359163|Femulen|femulen
372295|NCT01359137|Behavior|behavior
372296|NCT01359137|Drug users|drug users
372297|NCT01359137|Criminal Justice|criminal justice
372298|NCT01359137|Probation|probation
372299|NCT01359124|Osteoarthritis, Knee|osteoarthritis, knee
372300|NCT01359124|Exercise Therapies|exercise therapies
372301|NCT01359111|Intradermal injections|intradermal injections
372302|NCT01359111|Vaccination|vaccination
372303|NCT01359098|swimmer's ear|swimmer's ear
372304|NCT01359098|ear drops|ear drops
372305|NCT01359098|ear foam|ear foam
372306|NCT01359098|otic foam|otic foam
372307|NCT01359098|ear infection|ear infection
372308|NCT01359098|ear pain|ear pain
372309|NCT01359098|ear inflammation|ear inflammation
372310|NCT01359085|To compare postoperative pain relief by pregabalin versus ISBPB following arthroscopic rotator cuff repair|to compare postoperative pain relief by pregabalin versus isbpb following arthroscopic rotator cuff repair
372311|NCT01359085|To compare postoperative opioid consumption and opioid related AEs|to compare postoperative opioid consumption and opioid related aes
455529|NCT00027248|CVC|cvc
372312|NCT01359085|To compare patients recovery profile and patients satisfaction|to compare patients recovery profile and patients satisfaction
372313|NCT01359072|coping|coping
372314|NCT01359072|psychological distress|psychological distress
372315|NCT01359072|self-administered intervention|self-administered intervention
372316|NCT01359059|assess the beneficial effects of PGL administered either pre or post surgery|assess the beneficial effects of pgl administered either pre or post surgery
372317|NCT01359059|assess the satisfaction rate in the orthopedic oncologic patients|assess the satisfaction rate in the orthopedic oncologic patients
372318|NCT01359046|CAUTI|cauti
372319|NCT01359046|UTI|uti
372320|NCT01359033|Myocardial Infarction|myocardial infarction
372321|NCT01359033|UK|uk
372322|NCT01359033|Sweden|sweden
372323|NCT01359033|National audit registry|national audit registry
372324|NCT01359033|MINAP|minap
372325|NCT01359033|RIKS-HIA|riks-hia
372326|NCT01359020|Fever|fever
372327|NCT01359020|Ibuprofen|ibuprofen
372328|NCT01359020|Acetaminophen|acetaminophen
372329|NCT01359020|Dipyrone|dipyrone
372330|NCT01359007|Locally advanced unresectable adenocarcinoma of pancreas|locally advanced unresectable adenocarcinoma of pancreas
372331|NCT01359007|Borderline resectable adenocarcinoma of pancreas|borderline resectable adenocarcinoma of pancreas
372332|NCT01358994|metformin|metformin
372333|NCT01358994|type 2 diabetes|type 2 diabetes
372334|NCT01358994|e-GFR|e-gfr
372336|NCT01358994|lactic acidosis|lactic acidosis
372337|NCT01358955|mild cognitive impairment|mild cognitive impairment
372338|NCT01358955|cognitive therapy|cognitive therapy
372339|NCT01358955|prevention|prevention
372340|NCT01358916|antimicrobial resistance|antimicrobial resistance
372341|NCT01358916|antibiotic prescription|antibiotic prescription
372342|NCT01358916|primary health care|primary health care
372343|NCT01358916|cluster-randomized trial|cluster-randomized trial
372344|NCT01358890|over weight|over weight
372345|NCT01358890|obesity|obesity
372346|NCT01358838|Patients with either hypertrophic or atrophic scars|patients with either hypertrophic or atrophic scars
372347|NCT01358838|Efficacy of ablative 10600nm fractional laser therapy|efficacy of ablative 10600nm fractional laser therapy
372348|NCT01358838|Laser therapy compared to no treatment of (part of) the scar|laser therapy compared to no treatment of (part of) the scar
372349|NCT01358825|Infanrix-IPV/Hib|infanrix-ipv/hib
372350|NCT01358825|Long-term follow up|long-term follow up
372351|NCT01358825|Persistence|persistence
372352|NCT01358825|Infanrix hexa|infanrix hexa
372353|NCT01358812|RAS Wild-Type|ras wild-type
372354|NCT01358812|BRAF Wild-Type|braf wild-type
372355|NCT01358799|Chlamydia trachomatis|chlamydia trachomatis
372356|NCT01358799|APTIMA Assay for Chlamydia trachomatis|aptima assay for chlamydia trachomatis
372357|NCT01358786|Quilting suture|quilting suture
372358|NCT01358786|seroma|seroma
372359|NCT01358786|Procedure|procedure
372360|NCT01358786|Surgery|surgery
372361|NCT01358773|Obesity|obesity
372362|NCT01358773|Therapy|therapy
372363|NCT01358773|Interdisciplinary|interdisciplinary
372364|NCT01358760|Vulvar/vaginal atrophy|vulvar/vaginal atrophy
372365|NCT01358760|Atrophic Vaginitis|atrophic vaginitis
372366|NCT01358760|Dehydroepiandrosterone|dehydroepiandrosterone
372367|NCT01358760|DHEA|dhea
372368|NCT01358760|Prasterone|prasterone
372369|NCT01358760|Vaginorm|vaginorm
372370|NCT01358760|Menopause|menopause
372371|NCT01358760|Intrarosa|intrarosa
372372|NCT01358734|AML|aml
372374|NCT01358734|acute myelogenous leukemia|acute myelogenous leukemia
372375|NCT01358734|vidaza|vidaza
372376|NCT01358734|azacitidine|azacitidine
372377|NCT01358734|elderly AML|elderly aml
372378|NCT01358734|revlimid|revlimid
372379|NCT01358734|lenalidomide|lenalidomide
372380|NCT01358695|Lateral Canthal Lines|lateral canthal lines
372381|NCT01358695|Crow's Feet|crow's feet
372382|NCT01358669|Denosumab|denosumab
372383|NCT01358669|Total Hip Arthroplasty|total hip arthroplasty
372384|NCT01358643|OEF/OIF|oef/oif
372385|NCT01358643|Physical Activity|physical activity
372386|NCT01358643|Preferences|preferences
372387|NCT01358630|Periodontitis|periodontitis
372388|NCT01358630|Vascular disease|vascular disease
372389|NCT01358630|Proinflammatory cytokines|proinflammatory cytokines
372390|NCT01358604|localized resectable neuroblastoma|localized resectable neuroblastoma
372391|NCT01358604|recurrent neuroblastoma|recurrent neuroblastoma
372392|NCT01358604|regional neuroblastoma|regional neuroblastoma
372393|NCT01358604|stage 4S neuroblastoma|stage 4s neuroblastoma
372394|NCT01358604|localized unresectable neuroblastoma|localized unresectable neuroblastoma
372396|NCT01358578|inflammatory skin disease,|inflammatory skin disease,
372397|NCT01358578|scaly patches|scaly patches
372398|NCT01358578|Psoriasis|psoriasis
372399|NCT01358578|inflammatory skin disease|inflammatory skin disease
372400|NCT01358552|Neevo|neevo
372401|NCT01358552|Neevo DHA|neevo dha
372402|NCT01358552|L-methylfolate|l-methylfolate
372403|NCT01358552|anemia during pregnancy|anemia during pregnancy
372404|NCT01358552|folic acid|folic acid
372405|NCT01358552|vitamin B12|vitamin b12
372406|NCT01358552|prenatal vitamins|prenatal vitamins
372407|NCT01358552|hemoglobin|hemoglobin
372408|NCT01358552|iron deficiency|iron deficiency
372409|NCT01358552|Pregnancy|pregnancy
372410|NCT01358539|palliation|palliation
372411|NCT01358539|pain education|pain education
372412|NCT01358526|Low back pain|low back pain
372413|NCT01358526|Chronic pain|chronic pain
372414|NCT01358526|Opioid|opioid
372415|NCT01358526|Moderate to severe chronic low back pain|moderate to severe chronic low back pain
372416|NCT01358513|Positron Emission Tomography|positron emission tomography
372417|NCT01358513|Inflammation|inflammation
372418|NCT01358513|Calcification|calcification
372419|NCT01358500|opioid dependence|opioid dependence
372420|NCT01358500|tolerant|tolerant
372421|NCT01358500|dependent|dependent
372422|NCT01358487|Major depression|major depression
372423|NCT01358487|Cognitive Behavioral preventive intervention|cognitive behavioral preventive intervention
372424|NCT01358487|Mood Management|mood management
372425|NCT01358487|Self-help|self-help
372426|NCT01358487|Internet|internet
372427|NCT01358474|Parkinson disease|parkinson disease
372428|NCT01358474|idiopathic rapid eye movement sleep disorder|idiopathic rapid eye movement sleep disorder
372429|NCT01358474|Gaucher disease|gaucher disease
372430|NCT01358474|healthy volunteer|healthy volunteer
372431|NCT01358448|Treatment of childhood obesity|treatment of childhood obesity
372432|NCT01358422|Prospective observational study|prospective observational study
372532|NCT01358058|Brain tumors|brain tumors
372433|NCT01358422|major adverse cardiac events (MACE)|major adverse cardiac events (mace)
372434|NCT01358422|clinically significant bleeding events|clinically significant bleeding events
372435|NCT01358422|Dual anti-platelet therapy|dual anti-platelet therapy
372436|NCT01358422|aspirin alone therapy|aspirin alone therapy
372437|NCT01358422|non-cardiac surgery|non-cardiac surgery
372438|NCT01358422|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
372439|NCT01358422|placement of a bare metal or drug eluting stent|placement of a bare metal or drug eluting stent
372440|NCT01358422|OBTAIN|obtain
372441|NCT01358422|Simon Howell|simon howell
372442|NCT01358422|ESA|esa
372443|NCT01358422|European Society of Anaesthesiology|european society of anaesthesiology
372444|NCT01358409|steatosis|steatosis
372445|NCT01358409|MR spectroscopy|mr spectroscopy
372446|NCT01358409|Nebivolol|nebivolol
372447|NCT01358409|cardiac MRI|cardiac mri
372448|NCT01358396|Diabetic Macular Edema, Glycemic Control|diabetic macular edema, glycemic control
372449|NCT01358383|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
372450|NCT01358383|Pharmacokinetics|pharmacokinetics
372451|NCT01358383|VIMOVO|vimovo
372452|NCT01358383|fasting state|fasting state
372453|NCT01358383|Amount of VIMOVO in the blood|amount of vimovo in the blood
372454|NCT01358383|taken on empty stomach|taken on empty stomach
372455|NCT01358370|LAL Deficiency|lal deficiency
372456|NCT01358370|LIPA|lipa
372457|NCT01358370|Wolman disease|wolman disease
372458|NCT01358370|Wolman Phenotype|wolman phenotype
372459|NCT01358370|Early Onset LAL Deficiency|early onset lal deficiency
372460|NCT01358370|Acid Lipase Deficiency|acid lipase deficiency
372461|NCT01358357|Lurasidone|lurasidone
372462|NCT01358357|Latuda|latuda
372463|NCT01358357|Bipolar I|bipolar i
372464|NCT01358318|obesity|obesity
372465|NCT01358318|satiety|satiety
372466|NCT01358318|soy protein|soy protein
372467|NCT01358318|soy fiber|soy fiber
372468|NCT01358318|control appetite|control appetite
372469|NCT01358318|reduce food intake|reduce food intake
372470|NCT01358305|muscle|muscle
372471|NCT01358305|synthesis|synthesis
372472|NCT01358305|mTOR|mtor
372473|NCT01358305|antioxidant|antioxidant
372474|NCT01358305|inflammatory markers|inflammatory markers
372475|NCT01358305|soy protein|soy protein
372476|NCT01358305|whey|whey
372477|NCT01358305|casein|casein
372478|NCT01358292|Intramedullary tibia nailing|intramedullary tibia nailing
372479|NCT01358292|Anterior Knee Pain|anterior knee pain
372480|NCT01358292|Nail positioning|nail positioning
372481|NCT01358253|Rituximab|rituximab
372482|NCT01358253|HyperCVAD|hypercvad
372483|NCT01358240|Econazole Nitrate|econazole nitrate
372484|NCT01358240|Foam|foam
372485|NCT01358240|Quinnova|quinnova
372486|NCT01358240|Tinea Pedis|tinea pedis
372487|NCT01358214|Sub-urethral Sling|sub-urethral sling
372488|NCT01358214|Treatment Outcome|treatment outcome
372489|NCT01358214|Quality of Life|quality of life
372490|NCT01358201|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
372491|NCT01358188|Gaucher disease|gaucher disease
372492|NCT01358188|immunity|immunity
372493|NCT01358188|inflammation|inflammation
372494|NCT01358188|macrophage activation|macrophage activation
372495|NCT01358175|Ankylosing spondylitis|ankylosing spondylitis
372496|NCT01358175|AS|as
372497|NCT01358175|ASAS|asas
372498|NCT01358175|inflammatory back pain|inflammatory back pain
372499|NCT01358162|Tuberculosis|tuberculosis
372500|NCT01358136|Thyroidectomy|thyroidectomy
372501|NCT01358136|Mitochondria|mitochondria
372502|NCT01358123|liver cirrhosis|liver cirrhosis
372503|NCT01358123|portal hypertension|portal hypertension
372504|NCT01358123|survival|survival
372505|NCT01358123|von willebrand factor|von willebrand factor
372506|NCT01358123|hepatic venous pressure gradient|hepatic venous pressure gradient
372507|NCT01358110|palliative care|palliative care
372508|NCT01358110|cancer|cancer
372509|NCT01358110|emergency medicine|emergency medicine
372510|NCT01358110|end- of- life care|end- of- life care
372511|NCT01358097|Head and neck cancer|head and neck cancer
372512|NCT01358097|Oropharyngeal cancer|oropharyngeal cancer
372513|NCT01358097|Human papillomavirus|human papillomavirus
372514|NCT01358097|Squamous cell carcinoma|squamous cell carcinoma
372515|NCT01358097|Radiation treatment|radiation treatment
372516|NCT01358097|Chemotherapy|chemotherapy
372517|NCT01358097|Induction chemotherapy|induction chemotherapy
372518|NCT01358097|Immune status|immune status
372519|NCT01358097|Immune monitoring|immune monitoring
372520|NCT01358097|head and neck robotic surgery|head and neck robotic surgery
372521|NCT01358084|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
372522|NCT01358084|MPM|mpm
372523|NCT01358084|Maintenance treatment|maintenance treatment
372524|NCT01358084|NGR-hTNF|ngr-htnf
372525|NCT01358071|NGR-hTNF|ngr-htnf
372526|NCT01358071|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
372527|NCT01358071|Doxorubicin|doxorubicin
372528|NCT01358071|Platinum-resistant|platinum-resistant
372529|NCT01358071|Progression or recurrence Ovarian Cancer|progression or recurrence ovarian cancer
372530|NCT01358071|Ovarian Cancer|ovarian cancer
372531|NCT01358071|Advanced or metastatic|advanced or metastatic
372533|NCT01358058|Radiation|radiation
372534|NCT01358058|Proton|proton
372535|NCT01358058|Gliomas|gliomas
372536|NCT01358045|Topical|topical
372537|NCT01358045|Diclofenac|diclofenac
372538|NCT01358045|Vitamin D3|vitamin d3
372539|NCT01358032|Fear of falling|fear of falling
372540|NCT01358032|Cognitive behavioral therapy|cognitive behavioral therapy
372541|NCT01358032|Randomized controlled trial|randomized controlled trial
372542|NCT01358032|Frailty|frailty
372543|NCT01358032|Accidental Falls|accidental falls
372544|NCT01358006|JNJ-40411813|jnj-40411813
372545|NCT01358006|Positron Emission Tomography (PET)|positron emission tomography (pet)
372546|NCT01358006|Serotonin-2A (5-HT2A) receptor antagonist|serotonin-2a (5-ht2a) receptor antagonist
372547|NCT01358006|Male Volunteers|male volunteers
372548|NCT01357993|Methylphenidate hydrochloride|methylphenidate hydrochloride
372549|NCT01357993|Concerta|concerta
372550|NCT01357993|Adults|adults
372551|NCT01357993|Attention-Deficit / Hyperactivity Disorder|attention-deficit / hyperactivity disorder
372552|NCT01357993|ADHD|adhd
372553|NCT01357993|Long term safety|long term safety
372554|NCT01357980|Detrusor Muscle Overactivity|detrusor muscle overactivity
372555|NCT01357954|Postural control|postural control
372556|NCT01357954|Targeted Training|targeted training
372557|NCT01357954|Gross motor function|gross motor function
372558|NCT01357954|Cerebral palsy|cerebral palsy
372559|NCT01357941|venous thromboembolism|venous thromboembolism
372560|NCT01357941|thromboembolism|thromboembolism
372561|NCT01357941|deep vein thrombosis|deep vein thrombosis
372562|NCT01357941|pulmonary embolism|pulmonary embolism
372563|NCT01357941|thromboprophylaxis|thromboprophylaxis
372564|NCT01357941|thrombosis|thrombosis
372565|NCT01357941|embolism and thrombosis|embolism and thrombosis
372566|NCT01357941|cardiovascular diseases|cardiovascular diseases
372567|NCT01357941|venous thrombosis|venous thrombosis
372568|NCT01357941|vascular diseases|vascular diseases
372569|NCT01357941|anticoagulants|anticoagulants
372570|NCT01357941|hematologic agents|hematologic agents
372571|NCT01357941|cardiovascular agents|cardiovascular agents
372572|NCT01357941|enoxaparin|enoxaparin
372573|NCT01357941|dalteparin|dalteparin
372574|NCT01357941|tinzaparin|tinzaparin
372575|NCT01357941|pregnancy complications|pregnancy complications
372576|NCT01357928|TEG|teg
372577|NCT01357928|Thromboelastography|thromboelastography
372578|NCT01357928|Coagulation|coagulation
372579|NCT01357915|Cytomegalovirus|cytomegalovirus
372580|NCT01357915|Vaccine|vaccine
372581|NCT01357889|pharmacokinetics|pharmacokinetics
372582|NCT01357889|pharmacodynamics|pharmacodynamics
372583|NCT01357889|GSK716155|gsk716155
372584|NCT01357889|albiglutide|albiglutide
372585|NCT01357863|Lapatinib|lapatinib
372586|NCT01357863|Observational Study|observational study
372587|NCT01357863|Trastuzumab|trastuzumab
372588|NCT01357863|Brazil|brazil
372589|NCT01357863|Metastatic Breast Cancer|metastatic breast cancer
372590|NCT01357837|Osteoarthritis, knee|osteoarthritis, knee
372591|NCT01357837|Analgesia|analgesia
372592|NCT01357837|Pain|pain
372593|NCT01357837|Painful|painful
372594|NCT01357824|Intubation|intubation
372595|NCT01357824|Sellick´s maneuver|sellick´s maneuver
372596|NCT01357824|aspiration|aspiration
372597|NCT01357824|[E05.497.578]|[e05.497.578]
372598|NCT01357811|Genz-112638|genz-112638
372599|NCT01357811|digoxin|digoxin
372600|NCT01357798|Headache|headache
372601|NCT01357798|Allodynia|allodynia
372602|NCT01357798|Botulinum Toxin Type A|botulinum toxin type a
372603|NCT01357785|Periodontal ligament stem cells|periodontal ligament stem cells
372604|NCT01357785|Periodontal regeneration|periodontal regeneration
372605|NCT01357785|Clinical trial|clinical trial
372606|NCT01357785|Deep intraosseous defects|deep intraosseous defects
372607|NCT01357746|Pulmonary arterial blood pressure doppler|pulmonary arterial blood pressure doppler
372608|NCT01357733|Diffuse, Large B-Cell, Lymphoma|diffuse, large b-cell, lymphoma
372609|NCT01357733|18F Fluorodeoxyglucose|18f fluorodeoxyglucose
372610|NCT01357733|Radionuclide-Emission Computed Tomography|radionuclide-emission computed tomography
372611|NCT01357720|Vaccination|vaccination
372612|NCT01357720|Immunisation|immunisation
372613|NCT01357720|Virus|virus
372614|NCT01357720|Diphtheria|diphtheria
372615|NCT01357720|Pertussis|pertussis
372616|NCT01357720|Tetanus|tetanus
372617|NCT01357720|Hepatitis B|hepatitis b
372618|NCT01357720|Haemophilus Influenzae|haemophilus influenzae
372619|NCT01357720|Immunity|immunity
372620|NCT01357694|psychotherapy|psychotherapy
372621|NCT01357694|depression|depression
372622|NCT01357694|anxiety|anxiety
372623|NCT01357694|surgical patients|surgical patients
372624|NCT01357681|Huntington Disease|huntington disease
372625|NCT01357681|Cognition|cognition
372626|NCT01357681|Motor|motor
372627|NCT01357681|Behaviour|behaviour
372628|NCT01357681|Functional Capacity|functional capacity
372629|NCT01357681|Quality of Life|quality of life
372630|NCT01357681|Biomarker|biomarker
372631|NCT01357681|MRI|mri
372632|NCT01357681|Huntingtin|huntingtin
372633|NCT01357681|EGCG|egcg
372634|NCT01357655|Myelogenous|myelogenous
372635|NCT01357655|Chronic|chronic
373042|NCT01355666|sores|sores
372636|NCT01357655|BCR-ABL Positive|bcr-abl positive
372637|NCT01357642|asthma|asthma
372638|NCT01357642|bronchial asthma|bronchial asthma
372639|NCT01357642|shortness of breath|shortness of breath
372640|NCT01357629|Vaccination follow-up|vaccination follow-up
372641|NCT01357616|Glaucoma|glaucoma
372642|NCT01357616|Open-angle glaucoma|open-angle glaucoma
372643|NCT01357616|Ocular hypertension|ocular hypertension
372644|NCT01357616|OAG|oag
372645|NCT01357616|OH|oh
372646|NCT01357590|aneurysm, penetrating ulcer, descending thoracic aorta|aneurysm, penetrating ulcer, descending thoracic aorta
372647|NCT01357577|PTSD|ptsd
372648|NCT01357577|Substance Use Disorders|substance use disorders
372649|NCT01357564|dementia|dementia
372650|NCT01357564|caregivers|caregivers
372651|NCT01357564|tailored activity|tailored activity
372652|NCT01357551|obesity|obesity
372653|NCT01357551|intervention studies|intervention studies
372654|NCT01357551|patient adherence|patient adherence
372655|NCT01357538|Bibrocathol|bibrocathol
372656|NCT01357538|eye ointment|eye ointment
372657|NCT01357538|blepharitis|blepharitis
372658|NCT01357538|eye lid|eye lid
372659|NCT01357525|Pancreas|pancreas
372660|NCT01357525|Resected|resected
372661|NCT01357512|prostate cancer diagnosis|prostate cancer diagnosis
372662|NCT01357512|magnetic resonance imaging|magnetic resonance imaging
372663|NCT01357512|prostate biopsy|prostate biopsy
372664|NCT01357486|Hepatocellular Carcinoma|hepatocellular carcinoma
372665|NCT01357486|CHILD B|child b
372666|NCT01357486|palliative management|palliative management
372667|NCT01357486|Sorafenib|sorafenib
372668|NCT01357486|Pravastatin|pravastatin
372669|NCT01357473|hormonal values|hormonal values
372670|NCT01357473|menstruations|menstruations
372671|NCT01357473|pregnancy|pregnancy
372672|NCT01357473|antagonist|antagonist
372673|NCT01357460|Emphysema|emphysema
372674|NCT01357460|alpha1 antitrypsin deficiency|alpha1 antitrypsin deficiency
372675|NCT01357460|endoscopic lung volume reduction|endoscopic lung volume reduction
372676|NCT01357447|Sjogren's syndrome|sjogren's syndrome
372678|NCT01357408|without an indication for ICD or CRT|without an indication for icd or crt
372679|NCT01357408|left ventricular function greater than or equal to 40%|left ventricular function greater than or equal to 40%
372680|NCT01357395|Small Cell Lung Carcinoma|small cell lung carcinoma
372681|NCT01357382|low fat diet|low fat diet
372682|NCT01357382|low carbohydrate diet|low carbohydrate diet
372683|NCT01357369|bacteria infections|bacteria infections
372684|NCT01357343|Low back pain|low back pain
372685|NCT01357343|Chiropractic|chiropractic
372686|NCT01357343|Acupuncture|acupuncture
372687|NCT01357343|Integrated care|integrated care
372688|NCT01357330|locally advanced or metastatic|locally advanced or metastatic
372689|NCT01357317|Kidney disease|kidney disease
372690|NCT01357317|Hyperphosphatemia|hyperphosphatemia
372691|NCT01357317|Parathyroid hormone|parathyroid hormone
372692|NCT01357304|Group treatment|group treatment
372693|NCT01357304|Physical activity referral|physical activity referral
372694|NCT01357304|Type 2 diabetes|type 2 diabetes
372695|NCT01357304|Hypertension|hypertension
372696|NCT01357291|Behavior|behavior
372697|NCT01357291|Drug users|drug users
372698|NCT01357291|Inmates|inmates
372699|NCT01357278|osteoporosis|osteoporosis
372700|NCT01357278|exercise|exercise
372701|NCT01357278|intervention|intervention
372702|NCT01357278|rehabilitation|rehabilitation
372703|NCT01357278|bone mineral density|bone mineral density
372704|NCT01357278|muscle strength|muscle strength
372705|NCT01357265|Seasonal Influenza|seasonal influenza
372706|NCT01357265|vaccine|vaccine
372707|NCT01357252|Diabetes mellitus|diabetes mellitus
372708|NCT01357252|vildagliptin|vildagliptin
372709|NCT01357239|Fragile X Syndrome|fragile x syndrome
372710|NCT01357239|Martin-Bell Syndrome|martin-bell syndrome
372711|NCT01357239|Genetic Diseases|genetic diseases
372712|NCT01357239|X-Linked|x-linked
372713|NCT01357239|Escalante's syndrome|escalante's syndrome
372714|NCT01357226|measurement in two environments|measurement in two environments
372715|NCT01357213|Botulism, Clostridium|botulism, clostridium
372716|NCT01357187|Lumbar pathology|lumbar pathology
372717|NCT01357187|requiring elective lumbar interbody fusion|requiring elective lumbar interbody fusion
372718|NCT01357096|intervention|intervention
372719|NCT01357096|CABG or PTCA|cabg or ptca
372720|NCT01357083|Melatonin|melatonin
372721|NCT01357083|Periodicity|periodicity
372722|NCT01357083|Depressive disorder, major|depressive disorder, major
372723|NCT01357083|Serum|serum
372724|NCT01357083|Depression|depression
372725|NCT01357057|Medical records|medical records
372726|NCT01357057|Outcome scale|outcome scale
372727|NCT01357057|Biological biomarkers|biological biomarkers
372728|NCT01357044|Semen quality|semen quality
372729|NCT01357044|Plant extracts|plant extracts
372730|NCT01357031|Amitriptyline|amitriptyline
372731|NCT01357031|Placebo|placebo
372732|NCT01357031|Melatonin|melatonin
372733|NCT01357031|Migraine|migraine
372734|NCT01357031|Headache|headache
372735|NCT01357031|Drug therapy|drug therapy
372736|NCT01357031|Preventive treatment of migraine|preventive treatment of migraine
372737|NCT01357018|Ankylosing spondylitis|ankylosing spondylitis
372738|NCT01357018|Disease activity|disease activity
372739|NCT01357018|EQ-5D|eq-5d
372740|NCT01357018|Quality of life|quality of life
372741|NCT01357018|Rheumatoid arthritis|rheumatoid arthritis
372742|NCT01356992|non-inferiority phase III study|non-inferiority phase iii study
372743|NCT01356992|Low-Molecular Weight Heparin|low-molecular weight heparin
372744|NCT01356992|Versa® (enoxaparin - Eurofarma)|versa® (enoxaparin - eurofarma)
372745|NCT01356992|Clexane® (enoxaparin - Sanofi-Aventis)|clexane® (enoxaparin - sanofi-aventis)
372746|NCT01356992|Acute coronary syndrome without ST-segment elevation|acute coronary syndrome without st-segment elevation
372747|NCT01356979|Medical thoracoscopy|medical thoracoscopy
372748|NCT01356979|Pleural effusion|pleural effusion
372749|NCT01356979|Malignant pleural diseases|malignant pleural diseases
372750|NCT01356979|Tuberculous pleuritis|tuberculous pleuritis
372751|NCT01356979|Fibrinous pleuritis|fibrinous pleuritis
372752|NCT01356953|Aerobic Exercise|aerobic exercise
372753|NCT01356953|Blood Pressure|blood pressure
372754|NCT01356940|Ambulation|ambulation
372755|NCT01356927|long acting reversible contraception|long acting reversible contraception
372756|NCT01356927|medical abortion|medical abortion
372757|NCT01356927|DMPA|dmpa
372758|NCT01356927|etonogestrel implant|etonogestrel implant
372759|NCT01356927|Implanon|implanon
372760|NCT01356927|contraceptive continuation|contraceptive continuation
372761|NCT01356875|myelodysplastic syndrome|myelodysplastic syndrome
372762|NCT01356875|Transfusion|transfusion
372763|NCT01356875|Hydralazine|hydralazine
372764|NCT01356875|valproic acid|valproic acid
372765|NCT01356862|mastectomy|mastectomy
372766|NCT01356862|axillary node dissection|axillary node dissection
372767|NCT01356862|adjuvant or neoadjuvant|adjuvant or neoadjuvant
372768|NCT01356849|Endothelin Receptor Antagonists|endothelin receptor antagonists
372769|NCT01356849|Proteinuria|proteinuria
372770|NCT01356836|Coronary collateral development|coronary collateral development
372771|NCT01356836|monocyte subsets|monocyte subsets
372772|NCT01356836|collateralization|collateralization
372773|NCT01356823|Human Papilloma Virus 16|human papilloma virus 16
372774|NCT01356823|Human Papilloma Virus 18|human papilloma virus 18
372776|NCT01356823|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
372777|NCT01356823|cervical Cancer|cervical cancer
372778|NCT01356810|Delirium|delirium
588798|NCT00525564|Salmeterol|salmeterol
372779|NCT01356810|Primary Prevention|primary prevention
372781|NCT01356797|knee arthroscopy|knee arthroscopy
372782|NCT01356797|hyperbaric bupivacaine|hyperbaric bupivacaine
372783|NCT01356797|hypobaric levobupivacaine plus fentanyl|hypobaric levobupivacaine plus fentanyl
372784|NCT01356784|Sick-listed|sick-listed
372785|NCT01356784|Tailored physical activity|tailored physical activity
372786|NCT01356784|Patient education|patient education
372787|NCT01356784|Returning to work|returning to work
372788|NCT01356784|DK-Sønderborg Municipality|dk-sønderborg municipality
372789|NCT01356784|columna|columna
372790|NCT01356784|upper body|upper body
372791|NCT01356771|Risk Assessment|risk assessment
372792|NCT01356771|Intervention|intervention
372793|NCT01356745|premixed nitrous oxide and oxygen|premixed nitrous oxide and oxygen
372794|NCT01356745|acute pain|acute pain
372795|NCT01356745|prehospital setting|prehospital setting
372796|NCT01356732|mechanical ventilation|mechanical ventilation
372797|NCT01356732|Midazolam|midazolam
372798|NCT01356732|Ramsay|ramsay
372799|NCT01356732|Sufentanil|sufentanil
372800|NCT01356719|Tracheostomy|tracheostomy
372801|NCT01356719|adverse effects|adverse effects
372802|NCT01356719|Critical Care|critical care
372803|NCT01356719|standards|standards
363518|NCT01395719|remote ischemic conditioning|remote ischemic conditioning
363519|NCT01395706|Malignant Neoplasm of Breast|malignant neoplasm of breast
363520|NCT01395706|Sentinel lymph node detection|sentinel lymph node detection
363521|NCT01395706|ICG fluorescence technique|icg fluorescence technique
363522|NCT01395706|Population of male and female patients with mamma carcinoma|population of male and female patients with mamma carcinoma
363523|NCT01395680|cancer adolescent|cancer adolescent
363524|NCT01395680|resilience|resilience
363525|NCT01395641|Aromatic Amino Acid Decarboxylase|aromatic amino acid decarboxylase
372804|NCT01356719|safety|safety
372805|NCT01356706|liver metastases|liver metastases
372806|NCT01356706|colorectal cancer|colorectal cancer
372807|NCT01356706|surgery|surgery
372808|NCT01356706|prognosis|prognosis
372809|NCT01356693|Cough|cough
372810|NCT01356693|Common cold|common cold
372811|NCT01356693|Child|child
372812|NCT01356693|Adolescent|adolescent
372813|NCT01356680|Hodgkin Lymphoma|hodgkin lymphoma
372814|NCT01356680|intermediate stage|intermediate stage
372815|NCT01356680|PET|pet
372816|NCT01356667|American Indians|american indians
372817|NCT01356667|Native Americans|native americans
372818|NCT01356667|substance abuse|substance abuse
372819|NCT01356667|culture|culture
372820|NCT01356654|Stroke|stroke
372821|NCT01356654|TDCS|tdcs
372822|NCT01356654|Gait|gait
372823|NCT01356654|Balance|balance
372824|NCT01356654|loss of postural balance|loss of postural balance
372825|NCT01356641|Antibiotic treatment|antibiotic treatment
372826|NCT01356641|Non perforated appendicitis|non perforated appendicitis
372827|NCT01356641|Children|children
372828|NCT01356628|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
372829|NCT01356628|HCC|hcc
372830|NCT01356628|Liver Cancer|liver cancer
372831|NCT01356628|PD-0332991|pd-0332991
372832|NCT01356615|anticoagulation|anticoagulation
372833|NCT01356615|hemodialysis|hemodialysis
372834|NCT01356615|heparin|heparin
372835|NCT01356615|lipids|lipids
373043|NCT01355666|infection|infection
372836|NCT01356615|low molecular weight heparins|low molecular weight heparins
372837|NCT01356602|Gout|gout
372838|NCT01356602|arthritis|arthritis
372839|NCT01356602|gout flare|gout flare
372840|NCT01356602|acute gout|acute gout
372841|NCT01356602|gouty|gouty
372842|NCT01356602|rheumatic disease|rheumatic disease
372843|NCT01356602|uric acid|uric acid
372844|NCT01356563|hemodialysis|hemodialysis
372845|NCT01356563|pharmacist|pharmacist
372846|NCT01356563|medication-related problems|medication-related problems
372847|NCT01356563|compliance|compliance
372848|NCT01356511|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
372849|NCT01356498|gout|gout
372850|NCT01356498|chronic gout|chronic gout
372851|NCT01356485|Sickle cell anemia|sickle cell anemia
372852|NCT01356485|Sickle cell disease|sickle cell disease
372853|NCT01356485|Sickling crisis|sickling crisis
372854|NCT01356485|Vaso-occlusive crisis|vaso-occlusive crisis
372855|NCT01356485|Carboxyhemoglobin|carboxyhemoglobin
372856|NCT01356485|Oxygen therapeutic|oxygen therapeutic
372857|NCT01356485|Hemoglobin solutions|hemoglobin solutions
372858|NCT01356485|Pegylated hemoglobin|pegylated hemoglobin
372859|NCT01356472|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
372860|NCT01356472|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
372861|NCT01356472|linezolid|linezolid
372862|NCT01356472|imipenem/cilastatin|imipenem/cilastatin
372863|NCT01356459|Pressure ulcers|pressure ulcers
372864|NCT01356459|ICU|icu
372865|NCT01356459|Prevention|prevention
372866|NCT01356446|safety|safety
372867|NCT01356446|team|team
372868|NCT01356446|team performance|team performance
372869|NCT01356446|surgery|surgery
372870|NCT01356446|outcome|outcome
372871|NCT01356433|dialysis,inflammation,vitamin C|dialysis,inflammation,vitamin c
372872|NCT01356420|SLOS|slos
372873|NCT01356394|Obesity|obesity
372875|NCT01356394|Microalbuminuria|microalbuminuria
372876|NCT01356394|Chronic Kidney Disease|chronic kidney disease
372877|NCT01356381|Diabetes mellitus|diabetes mellitus
372878|NCT01356381|vildagliptin|vildagliptin
372879|NCT01356368|Lung cancer|lung cancer
372880|NCT01356355|Stent discomfort|stent discomfort
372881|NCT01356355|Herbmed plus|herbmed plus
372882|NCT01356355|Tolterodine|tolterodine
372883|NCT01356342|Influenza|influenza
372884|NCT01356342|Vaccine|vaccine
372885|NCT01356342|Immunogenicity|immunogenicity
372886|NCT01356329|Gynecologic malignancy ,major surgery|gynecologic malignancy ,major surgery
372887|NCT01356316|Influenza|influenza
456246|NCT00029029|pain|pain
372888|NCT01356316|Vaccine|vaccine
372889|NCT01356316|Immunogenicity|immunogenicity
372890|NCT01356303|Lung cancer|lung cancer
372891|NCT01356290|Medulloblastoma|medulloblastoma
372892|NCT01356290|Relapse|relapse
372893|NCT01356290|Children|children
372894|NCT01356290|antiangiogenic|antiangiogenic
372895|NCT01356290|metronomic|metronomic
372896|NCT01356290|intrathecal|intrathecal
372897|NCT01356277|renal|renal
372898|NCT01356277|allograft|allograft
372899|NCT01356277|immunosuppressive|immunosuppressive
372900|NCT01356277|immunosuppression|immunosuppression
372901|NCT01356277|adherence|adherence
372902|NCT01356277|medication|medication
372903|NCT01356277|compliance|compliance
372904|NCT01356264|colorectal cancer|colorectal cancer
372905|NCT01356264|colorectal surgery|colorectal surgery
372906|NCT01356264|prehabilitation|prehabilitation
372907|NCT01356264|surgical recovery|surgical recovery
372908|NCT01356264|exercise|exercise
372909|NCT01356264|referred for scheduled resection|referred for scheduled resection
372910|NCT01356251|Quality of life|quality of life
372911|NCT01356251|support group|support group
372912|NCT01356251|questionnaires|questionnaires
372913|NCT01356251|Internet-based support group|internet-based support group
372914|NCT01356251|11-066|11-066
372915|NCT01356225|pain following dental impaction surgery|pain following dental impaction surgery
372916|NCT01356199|Gonalgia|gonalgia
372917|NCT01356199|Quality of Life|quality of life
372918|NCT01356199|Dietary supplement|dietary supplement
372919|NCT01356199|Nutrition|nutrition
372920|NCT01356186|Suicide|suicide
372921|NCT01356186|Cognitive Therapy|cognitive therapy
372922|NCT01356186|Inpatient|inpatient
372923|NCT01356186|Military|military
372924|NCT01356173|solid cancers|solid cancers
372925|NCT01356160|Hepatitis C|hepatitis c
372926|NCT01356160|HCV|hcv
372927|NCT01356160|Rapid Virologic Response|rapid virologic response
372928|NCT01356160|Sustained Virologic Response|sustained virologic response
372929|NCT01356160|Direct Acting Antiviral|direct acting antiviral
372930|NCT01356160|Combination Therapy HCV RNA|combination therapy hcv rna
372931|NCT01356160|Protease inhibitor|protease inhibitor
372932|NCT01356160|Treatment naïve|treatment naïve
372933|NCT01356160|GS-5885|gs-5885
372934|NCT01356160|GS-9451|gs-9451
372935|NCT01356147|ventilator associated pulmonary infections|ventilator associated pulmonary infections
372936|NCT01356134|multiple sclerosis|multiple sclerosis
372937|NCT01356134|ehlers danlos syndrome|ehlers danlos syndrome
372938|NCT01356134|CCSVI|ccsvi
373044|NCT01355666|bioburden|bioburden
372939|NCT01356134|chronic cerebrospinal venous insufficiency|chronic cerebrospinal venous insufficiency
372940|NCT01356134|fundus|fundus
372941|NCT01356134|retina|retina
372942|NCT01356108|Conduit|conduit
372943|NCT01356108|Pulmonic|pulmonic
372944|NCT01356108|Stenosis|stenosis
372945|NCT01356108|Regurgitation|regurgitation
372946|NCT01356108|Dysfunctional|dysfunctional
372947|NCT01356095|Tuberculosis|tuberculosis
372948|NCT01356095|Treatment Adherence|treatment adherence
372949|NCT01356095|knowledge translation|knowledge translation
372950|NCT01356095|Educational outreach|educational outreach
372951|NCT01356069|BPD|bpd
372952|NCT01356069|MHS|mhs
372953|NCT01356069|heavy users|heavy users
372954|NCT01356069|sequential psychotherapy|sequential psychotherapy
372955|NCT01356004|severe resistant|severe resistant
372956|NCT01355991|Spinal Cord Injury|spinal cord injury
372957|NCT01355991|Tetraplegia|tetraplegia
372958|NCT01355991|Pulmonary Function|pulmonary function
372959|NCT01355991|Bronchodilator|bronchodilator
372960|NCT01355965|completed standard first line therapy|completed standard first line therapy
372961|NCT01355965|platinum based double regimen|platinum based double regimen
372962|NCT01355965|Progressive Disease|progressive disease
372963|NCT01355965|chosen not to pursue primary standard of care therapy|chosen not to pursue primary standard of care therapy
372964|NCT01355952|Obesity|obesity
372965|NCT01355952|Weight Loss|weight loss
372966|NCT01355952|Schizophrenia|schizophrenia
372967|NCT01355952|Alpha Lipoic Acid|alpha lipoic acid
372968|NCT01355939|Hernia|hernia
372969|NCT01355939|Adhesiolysis|adhesiolysis
372970|NCT01355939|Adhesions|adhesions
372971|NCT01355939|Intraperitoneal Mesh|intraperitoneal mesh
372972|NCT01355939|Abdominal Re-exploration|abdominal re-exploration
372973|NCT01355939|Mesh|mesh
372974|NCT01355939|Barrier-Coated Mesh|barrier-coated mesh
372975|NCT01355939|Non-Barrier-Coated Mesh|non-barrier-coated mesh
372976|NCT01355939|Laparoscopic Approach|laparoscopic approach
372977|NCT01355939|Open Approach|open approach
372978|NCT01355939|Abdominal Re-Exploration Surgery|abdominal re-exploration surgery
372979|NCT01355926|Flexible Fiber-based CO2 Laser|flexible fiber-based co2 laser
372980|NCT01355926|Monopolar Cautery|monopolar cautery
372981|NCT01355926|Oral Cavity Lesions|oral cavity lesions
372982|NCT01355926|Quality of life|quality of life
372983|NCT01355926|Assessing Pain|assessing pain
372985|NCT01355913|Myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
372986|NCT01355913|chromosmal aberrations|chromosmal aberrations
372987|NCT01355913|cytogenetics|cytogenetics
372988|NCT01355913|Fluorescence in situ hybridization (FISH)|fluorescence in situ hybridization (fish)
372989|NCT01355913|CD34+ cells|cd34+ cells
372990|NCT01355913|peripheral blood|peripheral blood
372991|NCT01355900|Total knee arthroplasty|total knee arthroplasty
372992|NCT01355900|Tourniquet|tourniquet
372993|NCT01355900|Blood loss|blood loss
372994|NCT01355900|Volume loading test|volume loading test
372995|NCT01355887|blood loss|blood loss
372996|NCT01355887|hepatectomy|hepatectomy
372997|NCT01355887|prospective study|prospective study
372998|NCT01355887|PTC|ptc
372999|NCT01355874|Internal Symptomatic Hemorrhoids|internal symptomatic hemorrhoids
373000|NCT01355861|sarcopenia|sarcopenia
373001|NCT01355861|aging|aging
373002|NCT01355861|rehabilitation|rehabilitation
373003|NCT01355861|exercise|exercise
373004|NCT01355848|Suicide|suicide
373005|NCT01355848|Brief Intervention|brief intervention
373006|NCT01355848|Youth|youth
373007|NCT01355848|Acute Medical Setting|acute medical setting
373008|NCT01355848|Readiness to Change|readiness to change
373009|NCT01355848|Suicidality|suicidality
373010|NCT01355835|Parkinson's disease|parkinson's disease
373011|NCT01355835|gait|gait
373012|NCT01355835|deep brain stimulation|deep brain stimulation
373013|NCT01355835|substantia nigra pars reticulata|substantia nigra pars reticulata
373014|NCT01355835|subthalamic nucleus|subthalamic nucleus
373015|NCT01355822|abortion|abortion
373016|NCT01355822|perinatal death|perinatal death
373017|NCT01355822|IUGR|iugr
373018|NCT01355822|preterm birth|preterm birth
373019|NCT01355822|placental abruption|placental abruption
373020|NCT01355822|preeclampsia|preeclampsia
373021|NCT01355809|Six-Minute Walk Test|six-minute walk test
373022|NCT01355757|shoulder arthroscopy|shoulder arthroscopy
373023|NCT01355757|24-week follow-up|24-week follow-up
373024|NCT01355757|quality of life|quality of life
373025|NCT01355757|rehabilitation achievement|rehabilitation achievement
373026|NCT01355757|rotator cuff repair|rotator cuff repair
373027|NCT01355744|humans|humans
373028|NCT01355744|insect bites|insect bites
373029|NCT01355731|Registered Nurse|registered nurse
373030|NCT01355731|Behaviors|behaviors
373031|NCT01355731|Attitudes|attitudes
373032|NCT01355692|DME|dme
373033|NCT01355692|Laser|laser
373034|NCT01355692|Selective laser therapy|selective laser therapy
373035|NCT01355692|photocoagulation|photocoagulation
373036|NCT01355666|pressure ulcers|pressure ulcers
373037|NCT01355666|stage 1|stage 1
373038|NCT01355666|stage 2|stage 2
373039|NCT01355666|stage 3|stage 3
373040|NCT01355666|stage 4|stage 4
373041|NCT01355666|wounds|wounds
373045|NCT01355666|bacterial contamination|bacterial contamination
373046|NCT01355666|bed linen|bed linen
373047|NCT01355666|sheets|sheets
373048|NCT01355666|underpad|underpad
373049|NCT01355666|skin assessment|skin assessment
373050|NCT01355666|microclimate|microclimate
373051|NCT01355666|shear|shear
373052|NCT01355666|friction|friction
373053|NCT01355666|moisture|moisture
373054|NCT01355666|fabrics|fabrics
373055|NCT01355666|long term care|long term care
373056|NCT01355666|nursing home|nursing home
373057|NCT01355666|decubitus ulcer|decubitus ulcer
373058|NCT01355666|bed ridden|bed ridden
373059|NCT01355666|anti-microbial|anti-microbial
373060|NCT01355653|heat|heat
373061|NCT01355653|device|device
373062|NCT01355653|safety|safety
373063|NCT01355653|performance|performance
373064|NCT01355653|heatwrap|heatwrap
373065|NCT01355653|elderly|elderly
373066|NCT01355653|overweight|overweight
373067|NCT01355640|heel lance|heel lance
373068|NCT01355640|pain|pain
373069|NCT01355640|newborn|newborn
373070|NCT01355627|CSF leaks|csf leaks
373071|NCT01355627|Skull base surgery|skull base surgery
373072|NCT01355627|pseudomeningocele|pseudomeningocele
373073|NCT01355627|TachoSil®|tachosil®
373074|NCT01355627|Prevention|prevention
373075|NCT01355627|post-operative|post-operative
373076|NCT01355614|Crohn's Disease|crohn's disease
373077|NCT01355614|Fistula|fistula
373078|NCT01355575|Microbiota|microbiota
373079|NCT01355575|Insulin resistance|insulin resistance
373080|NCT01355575|Bacterial endotoxin|bacterial endotoxin
373081|NCT01355575|Hepatic triglyceride|hepatic triglyceride
373082|NCT01355575|Inflammation|inflammation
373083|NCT01355549|Shoulder pain|shoulder pain
373084|NCT01355549|Rotator cuff disease|rotator cuff disease
373085|NCT01355549|Spinal cord injuries|spinal cord injuries
373086|NCT01355549|Platelet-rich plasma therapy|platelet-rich plasma therapy
373087|NCT01355549|Rehabilitation|rehabilitation
373088|NCT01355536|Preterm birth|preterm birth
373089|NCT01355536|Preterm labour|preterm labour
373090|NCT01355536|Polycystic Ovary Syndrome|polycystic ovary syndrome
373091|NCT01355536|PCOS|pcos
373092|NCT01355536|Diabetes Mellitus|diabetes mellitus
373093|NCT01355536|Hyperandrogenism|hyperandrogenism
373094|NCT01355536|Hirsutism|hirsutism
373095|NCT01355536|Ovarian cysts|ovarian cysts
373096|NCT01355536|Anti Muller Hormone|anti muller hormone
363855|NCT01394263|PSA|psa
373097|NCT01355536|Hypertension|hypertension
373295|NCT01354600|Obesity|obesity
373098|NCT01355523|Breast cancer surgery|breast cancer surgery
373099|NCT01355523|Melatonin|melatonin
373100|NCT01355523|Depression|depression
373101|NCT01355523|Anxiety|anxiety
373102|NCT01355523|Sleep disturbances|sleep disturbances
373103|NCT01355523|Cognitive function|cognitive function
373104|NCT01355471|rosacea|rosacea
373105|NCT01355458|rosacea|rosacea
373106|NCT01355419|Obstructive sleep apnea|obstructive sleep apnea
373107|NCT01355419|CPAP|cpap
373108|NCT01355419|actigraphy|actigraphy
373109|NCT01355419|sleep|sleep
373110|NCT01355419|physical activity|physical activity
373111|NCT01355406|FlexStent|flexstent
373112|NCT01355406|Superficial Femoral Artery or SFA|superficial femoral artery or sfa
373113|NCT01355406|Self Expanding Stent|self expanding stent
373114|NCT01355406|Stent|stent
373115|NCT01355406|Bare Metal Stent|bare metal stent
373116|NCT01355393|Breast Cancer|breast cancer
373117|NCT01355393|HER2+|her2+
373118|NCT01355393|Vaccine|vaccine
373119|NCT01355393|Stage II|stage ii
373120|NCT01355393|Stage III|stage iii
373121|NCT01355393|Stage IV|stage iv
373122|NCT01355380|Pulmonary arterial hypertension|pulmonary arterial hypertension
373123|NCT01355380|Inhaled iloprost|inhaled iloprost
373124|NCT01355380|Quality of life|quality of life
373125|NCT01355367|BAYA1040 CR|baya1040 cr
373126|NCT01355367|Nifedipine|nifedipine
373127|NCT01355367|Essential hypertension|essential hypertension
373128|NCT01355367|Japanese Patients|japanese patients
373129|NCT01355367|Phase III|phase iii
373130|NCT01355367|Extension study|extension study
373131|NCT01355354|Phase 1|phase 1
373132|NCT01355354|healthy volunteers|healthy volunteers
373133|NCT01355354|pharmacokinetics|pharmacokinetics
373134|NCT01355354|Rheumatoid arthritis|rheumatoid arthritis
373135|NCT01355354|RA, Fostamatinib|ra, fostamatinib
373136|NCT01355354|Digoxin, drug-drug interaction|digoxin, drug-drug interaction
373137|NCT01355354|Scientific terminology: Rheumatoid arthritis|scientific terminology: rheumatoid arthritis
373138|NCT01355354|Fostamatinib|fostamatinib
373139|NCT01355354|Digoxin|digoxin
373140|NCT01355354|drug-drug interaction|drug-drug interaction
373141|NCT01355354|Laymen terminology: Rheumatoid arthritis|laymen terminology: rheumatoid arthritis
373142|NCT01355354|Amount of Digoxin in blood|amount of digoxin in blood
373143|NCT01355341|RENAL CALCULI HERBMED PLUS|renal calculi herbmed plus
373144|NCT01355328|light|light
373145|NCT01355315|EECP|eecp
373146|NCT01355315|ischemic cardiomyopathy|ischemic cardiomyopathy
373147|NCT01355315|endothelin-1|endothelin-1
373148|NCT01355315|ischemia coronary artery diseases|ischemia coronary artery diseases
373248|NCT01354808|Platelet|platelet
373249|NCT01354808|Inflammation|inflammation
373149|NCT01355315|congestive heart failure not amenable to standard procedures|congestive heart failure not amenable to standard procedures
373150|NCT01355302|Cancer|cancer
373151|NCT01355302|Solid Tumors|solid tumors
373152|NCT01355302|Gastric|gastric
373153|NCT01355302|Phase I|phase i
373154|NCT01355302|Phase II|phase ii
373155|NCT01355289|Chronic Hepatitis C related|chronic hepatitis c related
373156|NCT01355276|Cinitapride|cinitapride
373157|NCT01355276|efficacy|efficacy
373158|NCT01355276|safety|safety
373159|NCT01355276|mild to moderate functional dyspepsia|mild to moderate functional dyspepsia
373160|NCT01355263|vitamin a|vitamin a
373161|NCT01355263|preschool children|preschool children
373162|NCT01355263|iron metabolic homeostasis|iron metabolic homeostasis
373163|NCT01355263|supplementation effect|supplementation effect
373164|NCT01355237|Complementary and alternative medicine (CAM)|complementary and alternative medicine (cam)
373165|NCT01355224|obesity|obesity
373166|NCT01355224|genetics|genetics
373167|NCT01355224|risk assessment|risk assessment
373168|NCT01355224|health behaviors|health behaviors
373169|NCT01355224|randomized controlled trial|randomized controlled trial
373170|NCT01355211|Altered Mental Status|altered mental status
373171|NCT01355211|non-convulsive seizure|non-convulsive seizure
373172|NCT01355211|status epilepticus|status epilepticus
373173|NCT01355211|electroencephalography|electroencephalography
373174|NCT01355185|Seed movement|seed movement
373175|NCT01355185|implants|implants
373176|NCT01355185|prostate brachytherapy|prostate brachytherapy
373177|NCT01355185|localized|localized
373178|NCT01355172|Influenza|influenza
373179|NCT01355172|Vaccine|vaccine
373180|NCT01355172|Immunogenicity|immunogenicity
373181|NCT01355159|Pregnancy|pregnancy
373182|NCT01355159|Folic Acid supplementation|folic acid supplementation
373183|NCT01355159|Preeclampsia|preeclampsia
373184|NCT01355146|Patients with proven Fabry's Disease|patients with proven fabry's disease
373185|NCT01355133|Urinary incontinence|urinary incontinence
373186|NCT01355133|Myoblasts|myoblasts
373187|NCT01355133|Muscle derived cells|muscle derived cells
373188|NCT01355133|Stem cells|stem cells
373189|NCT01355120|advanced ocular melanoma|advanced ocular melanoma
373190|NCT01355107|selenium level measurement|selenium level measurement
363942|NCT01393847|HV|hv
373191|NCT01355094|temporary abdomen closure|temporary abdomen closure
373192|NCT01355094|peritoneal vacuum therapy|peritoneal vacuum therapy
373193|NCT01355094|open abdomen|open abdomen
373194|NCT01355094|abdominal compartment syndrome|abdominal compartment syndrome
373195|NCT01355094|intra-abdominal sepsis|intra-abdominal sepsis
373196|NCT01355094|intra-abdominal hypertension|intra-abdominal hypertension
373197|NCT01355094|critical care|critical care
373198|NCT01355081|Drug Therapy|drug therapy
373199|NCT01355068|phenytoin|phenytoin
373200|NCT01355068|chewable tablets|chewable tablets
373201|NCT01355068|dilantin|dilantin
373202|NCT01355068|epanutin|epanutin
373203|NCT01355068|infatabs|infatabs
373204|NCT01355068|bioequivalence|bioequivalence
373205|NCT01355068|Partial seizure|partial seizure
373206|NCT01355068|Tonic-clonic seizure|tonic-clonic seizure
373207|NCT01355029|Stroke caregivers|stroke caregivers
373208|NCT01355029|Family Caregivers|family caregivers
373209|NCT01355029|Stroke|stroke
373210|NCT01355016|RSV|rsv
373211|NCT01354977|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
373212|NCT01354977|Glucose Metabolism Disorders|glucose metabolism disorders
373213|NCT01354977|Metabolic Diseases|metabolic diseases
373214|NCT01354977|Diabetes Mellitus|diabetes mellitus
373215|NCT01354977|Endocrin System Diseases|endocrin system diseases
373216|NCT01354977|Resveratrol|resveratrol
373217|NCT01354977|Therapeutic Uses|therapeutic uses
373218|NCT01354964|Glucose Metabolism Disorders|glucose metabolism disorders
373219|NCT01354964|Insulin Resistance|insulin resistance
373220|NCT01354964|Endocrine System|endocrine system
373221|NCT01354964|Vitamin D|vitamin d
373222|NCT01354951|Focal Brachytherapy|focal brachytherapy
373223|NCT01354951|Endorectal coil MRI|endorectal coil mri
373224|NCT01354951|Quality of Life|quality of life
373225|NCT01354951|11-056|11-056
373226|NCT01354938|Bronchitis|bronchitis
373227|NCT01354925|Diabetes type 2|diabetes type 2
373228|NCT01354925|Fasting|fasting
373229|NCT01354925|Ramadan|ramadan
373230|NCT01354925|Insulin analogues|insulin analogues
373231|NCT01354912|mycobacterial infection|mycobacterial infection
373232|NCT01354912|culture|culture
373233|NCT01354912|ct scan|ct scan
373234|NCT01354886|in-vitro fertilization|in-vitro fertilization
373235|NCT01354886|reproductive disorder|reproductive disorder
373236|NCT01354873|Colonoscopy|colonoscopy
373237|NCT01354873|Colon Polyps|colon polyps
373238|NCT01354860|knee osteoarthritis|knee osteoarthritis
373239|NCT01354847|extracorporeal circulation|extracorporeal circulation
373240|NCT01354847|platelet dysfunction|platelet dysfunction
373241|NCT01354847|Multiplate electrode aggregometry analyses|multiplate electrode aggregometry analyses
373242|NCT01354847|Multiplate|multiplate
373243|NCT01354821|Aorta|aorta
373244|NCT01354821|Aneurysm|aneurysm
373245|NCT01354821|endovascular|endovascular
373246|NCT01354821|stent-graft|stent-graft
373247|NCT01354808|Cilostazol|cilostazol
373250|NCT01354808|Myonecrosis|myonecrosis
373251|NCT01354795|EUS FNA|eus fna
373252|NCT01354795|stylet|stylet
373253|NCT01354795|suction|suction
373254|NCT01354782|Pharmacokinetic|pharmacokinetic
373255|NCT01354782|Roflumilast|roflumilast
373256|NCT01354756|sleep apnea|sleep apnea
373257|NCT01354756|polysomnography|polysomnography
373258|NCT01354756|obesity|obesity
373259|NCT01354756|bariatric surgery|bariatric surgery
373260|NCT01354743|atrophy|atrophy
373261|NCT01354743|rhytids|rhytids
373262|NCT01354743|glabellar|glabellar
373263|NCT01354743|periorbital|periorbital
373264|NCT01354730|incidence|incidence
373265|NCT01354730|nature|nature
373266|NCT01354730|seriousness|seriousness
373267|NCT01354730|ADRs|adrs
373268|NCT01354730|vaccination|vaccination
373269|NCT01354704|deep veinous thrombosis|deep veinous thrombosis
373270|NCT01354704|enoxaparin|enoxaparin
373271|NCT01354691|Alzheimer's Disease|alzheimer's disease
373272|NCT01354691|Dementia|dementia
373273|NCT01354691|Memory Loss|memory loss
373274|NCT01354691|Cognitive Impairment|cognitive impairment
373275|NCT01354691|Brain Diseases|brain diseases
373276|NCT01354691|Central Nervous System Diseases|central nervous system diseases
373277|NCT01354691|Nervous System Diseases|nervous system diseases
373278|NCT01354691|Neurodegenerative Diseases|neurodegenerative diseases
373279|NCT01354691|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
373280|NCT01354691|Mental Disorders|mental disorders
373281|NCT01354691|Depression|depression
373282|NCT01354691|Anxiety|anxiety
373283|NCT01354678|heart failure|heart failure
373284|NCT01354678|bone marrow mononuclear cells|bone marrow mononuclear cells
373285|NCT01354665|Multiple sclerosis|multiple sclerosis
373286|NCT01354665|Interferon beta-1b|interferon beta-1b
373287|NCT01354665|Fatigue|fatigue
373288|NCT01354665|Depression|depression
373289|NCT01354652|lactic acidosis|lactic acidosis
373290|NCT01354652|entecavir|entecavir
373291|NCT01354652|lamivudine|lamivudine
373292|NCT01354626|Hepatic fat accumulation|hepatic fat accumulation
373293|NCT01354626|Dietary protein|dietary protein
373294|NCT01354626|NAFLD|nafld
364008|NCT01393509|incurable, locally advanced or metastatic solid tumor malignancy or lymphoma|incurable, locally advanced or metastatic solid tumor malignancy or lymphoma
364009|NCT01393496|prematurity|prematurity
364010|NCT01393496|anemia|anemia
364011|NCT01393496|transfusion|transfusion
364018|NCT01393470|HPV|hpv
373296|NCT01354600|Appetite|appetite
373297|NCT01354600|Hormones|hormones
373298|NCT01354600|Exercise|exercise
373299|NCT01354600|Body Weight|body weight
373300|NCT01354587|immunodeficiency|immunodeficiency
373301|NCT01354574|energy metabolism|energy metabolism
373302|NCT01354574|lipids|lipids
373303|NCT01354574|lipoproteins|lipoproteins
373304|NCT01354574|satiety|satiety
373305|NCT01354574|glycemic load|glycemic load
373306|NCT01354574|insulin|insulin
373307|NCT01354561|respiratory physiotherapy|respiratory physiotherapy
373308|NCT01354561|cardiac autonomic modulation|cardiac autonomic modulation
373309|NCT01354561|paediatric patients|paediatric patients
373310|NCT01354548|Trismus|trismus
373311|NCT01354548|Cancer|cancer
373312|NCT01354548|Radiotherapy|radiotherapy
373313|NCT01354548|Quality of life|quality of life
373314|NCT01354535|periprosthetic|periprosthetic
373315|NCT01354535|femur fractures|femur fractures
373316|NCT01354535|Vancouver B1|vancouver b1
373317|NCT01354509|Normothermia|normothermia
373318|NCT01354509|fever control|fever control
373319|NCT01354509|Outcome study|outcome study
373320|NCT01354496|Healthy Volunteers|healthy volunteers
373321|NCT01354496|Bioavailability|bioavailability
373322|NCT01354483|spinal cord injury|spinal cord injury
373323|NCT01354483|umbilical cord blood mononuclear cell|umbilical cord blood mononuclear cell
373324|NCT01354483|lithium carbonate|lithium carbonate
373325|NCT01354470|Meth|meth
373326|NCT01354470|Methamphetamine Addiction|methamphetamine addiction
373327|NCT01354470|Methamphetamine Treatment|methamphetamine treatment
373328|NCT01354470|Modafinil|modafinil
373329|NCT01354457|Patient with relapsing or refractory CD22+B-acute lymphoblastic leukemia (ALL)|patient with relapsing or refractory cd22+b-acute lymphoblastic leukemia (all)
373330|NCT01354444|Memory problems|memory problems
373331|NCT01354444|Alzheimer's Disease|alzheimer's disease
373332|NCT01354431|Advanced/Metastatic|advanced/metastatic
373333|NCT01354431|clear cell component|clear cell component
373334|NCT01354392|Relapsed or refractory|relapsed or refractory
373335|NCT01354392|Large B-Cell|large b-cell
373336|NCT01354392|Diffuse|diffuse
373337|NCT01354340|Cholesterol|cholesterol
373338|NCT01354340|LDL-cholesterol|ldl-cholesterol
373339|NCT01354340|Coronary artery disease|coronary artery disease
373340|NCT01354340|Red yeast rice|red yeast rice
373341|NCT01354340|Plants extract|plants extract
373342|NCT01354340|Cholesterol excess|cholesterol excess
373343|NCT01354340|Delivery of Health Care|delivery of health care
373344|NCT01354327|Delivery of Health Care|delivery of health care
373345|NCT01354327|Cholesterol|cholesterol
373346|NCT01354327|LDL-cholesterol|ldl-cholesterol
373347|NCT01354327|Coronary artery disease|coronary artery disease
373348|NCT01354327|Red yeast rice|red yeast rice
373349|NCT01354327|Plants extract|plants extract
373350|NCT01354327|Cholesterol excess|cholesterol excess
373352|NCT01354314|Neurocognitive impairment|neurocognitive impairment
373353|NCT01354314|Memory|memory
373354|NCT01354314|Dementia|dementia
373355|NCT01354314|CSF marker|csf marker
373356|NCT01354314|Functional assessment|functional assessment
373358|NCT01354314|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
373359|NCT01354314|Arterial spin labeling|arterial spin labeling
373360|NCT01354314|SSRI|ssri
373361|NCT01354301|kidney transplantation|kidney transplantation
373362|NCT01354301|thymoglobulin|thymoglobulin
373363|NCT01354301|everolimus|everolimus
373364|NCT01354288|Diabetes|diabetes
373365|NCT01354288|Children|children
373366|NCT01354288|Disease management|disease management
373367|NCT01354288|Ketosis|ketosis
373368|NCT01354288|Hypoglycemia|hypoglycemia
373369|NCT01354288|Parents|parents
373370|NCT01354288|Education|education
373371|NCT01354275|PCOS|pcos
373372|NCT01354275|IVF/ICSI|ivf/icsi
373373|NCT01354275|Clinical Pregnancy rates|clinical pregnancy rates
373374|NCT01354275|GnRH Antagonist|gnrh antagonist
373375|NCT01354275|GnRH Agonist|gnrh agonist
373376|NCT01354262|Diabetes|diabetes
373377|NCT01354262|Vitamin D deficiency|vitamin d deficiency
373378|NCT01354262|Hemoglobin A1c|hemoglobin a1c
373379|NCT01354249|preoperative fasting|preoperative fasting
373380|NCT01354249|insulin resistance|insulin resistance
373381|NCT01354249|carbohydrates|carbohydrates
373382|NCT01354249|whey protein|whey protein
373383|NCT01354249|inflammatory response|inflammatory response
373384|NCT01354223|silicone hydrogel contact lens|silicone hydrogel contact lens
373385|NCT01354223|SHCL|shcl
373386|NCT01354223|stenfilcon A|stenfilcon a
373387|NCT01354223|ocufilcon B|ocufilcon b
373388|NCT01354223|daily disposable|daily disposable
373389|NCT01354223|substantial equivalence|substantial equivalence
373390|NCT01354223|CooperVision ClearSight™ 1 Day SCL|coopervision clearsight™ 1 day scl
373391|NCT01354210|Patient Adherence|patient adherence
373392|NCT01354210|HIV|hiv
373393|NCT01354197|Adverse events|adverse events
373394|NCT01354197|Mortality|mortality
373395|NCT01354197|Readmission|readmission
373396|NCT01354197|Surgical intensive care unit|surgical intensive care unit
373397|NCT01354171|active surveillance|active surveillance
373398|NCT01354171|low risk prostate cancer|low risk prostate cancer
373399|NCT01354132|schizophrenia|schizophrenia
373400|NCT01354132|schizoaffective|schizoaffective
588902|NCT00525876|Fludara|fludara
373401|NCT01354132|schizophreniform|schizophreniform
373402|NCT01354132|early schizophrenia spectrum psychosis|early schizophrenia spectrum psychosis
373403|NCT01354106|Skin condition after wear|skin condition after wear
373404|NCT01354093|MacTel|mactel
373405|NCT01354093|Macular telangiectasia type 2|macular telangiectasia type 2
373406|NCT01354080|constipation|constipation
373407|NCT01354080|massage|massage
373408|NCT01354080|tensegrity|tensegrity
373409|NCT01354067|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
373410|NCT01354067|Lung Diseases, Obstructive|lung diseases, obstructive
373411|NCT01354067|Single Limb|single limb
373412|NCT01354067|Elastic Resistance|elastic resistance
373413|NCT01354067|Resistance Training|resistance training
373414|NCT01354067|Minor Muscle Mass|minor muscle mass
373415|NCT01354067|Local muscle training|local muscle training
373416|NCT01354054|Knee OA|knee oa
373417|NCT01354054|TENS|tens
373418|NCT01354041|fear and health worries about cancer recurrence|fear and health worries about cancer recurrence
373419|NCT01354028|premature infant|premature infant
373420|NCT01354028|massage therapy|massage therapy
373421|NCT01354028|sleep induction|sleep induction
373422|NCT01354028|relaxation|relaxation
373423|NCT01354015|Diabetes|diabetes
373424|NCT01354015|Technology|technology
373425|NCT01354002|human biological samples|human biological samples
373426|NCT01354002|tissue banking|tissue banking
373427|NCT01353989|hepatitis A|hepatitis a
373428|NCT01353989|vaccination|vaccination
373429|NCT01353989|elderly|elderly
373430|NCT01353989|protection to hepatitis A after vaccination|protection to hepatitis a after vaccination
373431|NCT01353976|Econazole Nitrate|econazole nitrate
373432|NCT01353976|Foam|foam
373433|NCT01353976|Quinnova|quinnova
373434|NCT01353976|Tinea Pedis|tinea pedis
373435|NCT01353950|Costimulatory molecules|costimulatory molecules
373436|NCT01353950|Cystic Fibrosis|cystic fibrosis
373437|NCT01353950|Biomarkers|biomarkers
373438|NCT01353937|wound healing|wound healing
373439|NCT01353924|Allergy|allergy
373440|NCT01353924|Vaccine|vaccine
373441|NCT01353924|rBet v 1|rbet v 1
373442|NCT01353924|Prevention|prevention
373443|NCT01353885|Primary Osteoarthritis, Hip|primary osteoarthritis, hip
373444|NCT01353885|Total Hip Arthroplasty|total hip arthroplasty
373445|NCT01353885|Anterior Approach|anterior approach
373446|NCT01353885|Posterior Approach|posterior approach
373447|NCT01353885|Anterolateral Approach|anterolateral approach
373448|NCT01353885|Cohort Study|cohort study
373449|NCT01353885|Outcomes, Complication Rate|outcomes, complication rate
373450|NCT01353885|Outcomes, Quality of Life|outcomes, quality of life
373451|NCT01353872|Fatigue|fatigue
373452|NCT01353872|Tennis|tennis
373453|NCT01353872|Nutrition|nutrition
373454|NCT01353872|Tournament simulation|tournament simulation
373455|NCT01353872|Delivery of Health Care|delivery of health care
373754|NCT01352663|Wockhardt|wockhardt
373456|NCT01353846|oocyte donation program|oocyte donation program
373457|NCT01353846|natural cycle|natural cycle
373458|NCT01353846|hormone replacement therapy|hormone replacement therapy
373459|NCT01353820|Midly hypercholesterolemic subjects|midly hypercholesterolemic subjects
373460|NCT01353820|Probiotic|probiotic
373461|NCT01353820|Cholesterol lowering|cholesterol lowering
373462|NCT01353820|Dairy|dairy
373463|NCT01353807|Fish oil|fish oil
373464|NCT01353807|Pregnancy|pregnancy
373465|NCT01353807|RCT|rct
373466|NCT01353807|Birth weight|birth weight
373467|NCT01353807|Gestational age|gestational age
373468|NCT01353807|Asthma and allergies|asthma and allergies
373469|NCT01353807|Metabolic syndrome|metabolic syndrome
373470|NCT01353807|Obesity|obesity
373471|NCT01353794|SORAFENIB|sorafenib
373472|NCT01353794|RENAL CELL CARCINOMA|renal cell carcinoma
373473|NCT01353794|TYROSINE KINASE INHIBITOR|tyrosine kinase inhibitor
373474|NCT01353794|OBSERVATIONAL STUDY|observational study
373475|NCT01353781|Phase 1|phase 1
373476|NCT01353781|advanced solid tumor|advanced solid tumor
373477|NCT01353781|AKT|akt
373478|NCT01353781|Ascending|ascending
373479|NCT01353781|Japanese|japanese
373480|NCT01353768|Influenza|influenza
373481|NCT01353755|specific immunotherapy|specific immunotherapy
373482|NCT01353755|SIT|sit
373483|NCT01353729|12-lead ECG|12-lead ecg
373484|NCT01353729|cardiac repolarization|cardiac repolarization
373485|NCT01353729|QTc|qtc
373486|NCT01353729|influenza|influenza
373487|NCT01353729|GR121167|gr121167
373488|NCT01353729|zanamivir|zanamivir
373489|NCT01353703|Infanrix hexa™|infanrix hexa™
373490|NCT01353703|Primary vaccination|primary vaccination
373491|NCT01353703|India|india
373493|NCT01353703|infants|infants
373494|NCT01353690|Cell Therapy|cell therapy
373495|NCT01353690|Heart Failure|heart failure
373496|NCT01353690|Heart Disease|heart disease
373497|NCT01353690|Myocardial Infarction|myocardial infarction
373498|NCT01353690|Myocardial Ischemia|myocardial ischemia
373499|NCT01353690|Autologous|autologous
373500|NCT01353690|Muscle-derived Cell|muscle-derived cell
589283|NCT00527787|Naproxen|naproxen
373501|NCT01353677|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
373502|NCT01353677|QOL|qol
373503|NCT01353664|rollover protocol|rollover protocol
373504|NCT01353664|romidepsin|romidepsin
373505|NCT01353664|Gloucester Pharmaceuticals|gloucester pharmaceuticals
373506|NCT01353664|Celgene Corporation|celgene corporation
373507|NCT01353664|continuing treatment|continuing treatment
373508|NCT01353638|Peritoneal dialysis|peritoneal dialysis
373509|NCT01353638|Alanyl-Glutamine-Dipeptide|alanyl-glutamine-dipeptide
373510|NCT01353638|Heat shock protein|heat shock protein
373511|NCT01353638|Peritoneal cells|peritoneal cells
373512|NCT01353638|functional maintenance of the peritoneal membrane|functional maintenance of the peritoneal membrane
373513|NCT01353625|Neoplasm|neoplasm
373514|NCT01353625|Malignancy|malignancy
373515|NCT01353625|Carcinoma|carcinoma
373516|NCT01353625|Lymphoma|lymphoma
373517|NCT01353625|Leukemia|leukemia
373518|NCT01353625|Multiple myeloma|multiple myeloma
373519|NCT01353625|mTOR kinase inhibitor|mtor kinase inhibitor
373520|NCT01353625|Castration-resistant prostate cancer|castration-resistant prostate cancer
373521|NCT01353625|Hormone-resistant prostate cancer|hormone-resistant prostate cancer
373522|NCT01353625|Diffuse Large B-cell lymphoma|diffuse large b-cell lymphoma
373523|NCT01353599|Spinal Cord Injury|spinal cord injury
373524|NCT01353599|Tetraplegia|tetraplegia
373525|NCT01353599|Pulmonary Function|pulmonary function
373526|NCT01353573|Brain Neoplasms|brain neoplasms
373527|NCT01353573|Neoplasm Metastasis|neoplasm metastasis
373528|NCT01353573|Neoplasms|neoplasms
373529|NCT01353560|integrative medicine|integrative medicine
373530|NCT01353560|barriers to utilization|barriers to utilization
373531|NCT01353560|communication|communication
373532|NCT01353534|Immunogenicity and Safety|immunogenicity and safety
373533|NCT01353521|complex renal cysts|complex renal cysts
373534|NCT01353521|Contrast enhanced ultrasound|contrast enhanced ultrasound
373535|NCT01353508|Sodium excretion,|sodium excretion,
373536|NCT01353508|LCZ696|lcz696
373537|NCT01353495|Diabetic Foot Ulcers|diabetic foot ulcers
373538|NCT01353482|mesothelioma|mesothelioma
373539|NCT01353482|vorinostat|vorinostat
373540|NCT01353456|Ambulation|ambulation
373541|NCT01353456|Side effects|side effects
373542|NCT01353456|Serum sCD40L|serum scd40l
373543|NCT01353456|Bowel function|bowel function
373544|NCT01353456|Postoperative pain|postoperative pain
373545|NCT01353443|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
373546|NCT01353443|AAA|aaa
373547|NCT01353430|IBMPFD - Inclusion Body Myopathy associated with|ibmpfd - inclusion body myopathy associated with
373548|NCT01353430|Paget's disease of bone and Frontotemporal Dementia|paget's disease of bone and frontotemporal dementia
373549|NCT01353430|VCP gene - Valosin-containing protein gene|vcp gene - valosin-containing protein gene
373550|NCT01353417|Grafting, kidney|grafting, kidney
373551|NCT01353417|Transplantation, kidney|transplantation, kidney
373552|NCT01353391|Diabetes|diabetes
373553|NCT01353391|MiTy|mity
373554|NCT01353391|Metformin in Women|metformin in women
373555|NCT01353391|Type 2 Diabetes Pregnancy|type 2 diabetes pregnancy
373556|NCT01353378|dexmedetomidine|dexmedetomidine
373557|NCT01353378|emergence delirium|emergence delirium
373558|NCT01353378|sevoflurane anesthesia|sevoflurane anesthesia
373559|NCT01353378|preschool children|preschool children
373560|NCT01353378|oral maxillofacial surgery|oral maxillofacial surgery
373561|NCT01353352|Evaluation|evaluation
373562|NCT01353352|C-Spine|c-spine
373563|NCT01353352|Nursing|nursing
373564|NCT01353352|Clinical Decision Rule|clinical decision rule
373565|NCT01353339|Kidney Transplant|kidney transplant
373566|NCT01353339|BK Polyomavirus Infection|bk polyomavirus infection
373567|NCT01353326|non-inflammatory degenerative joint disease|non-inflammatory degenerative joint disease
373568|NCT01353326|hip resurfacing|hip resurfacing
373569|NCT01353326|bone mineral density|bone mineral density
373570|NCT01353326|cemented|cemented
373571|NCT01353326|cementless|cementless
373572|NCT01353313|NICHD Neonatal Research Network|nichd neonatal research network
373573|NCT01353313|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
373574|NCT01353313|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
373575|NCT01353313|Prematurity|prematurity
373576|NCT01353313|Mechanical ventilation|mechanical ventilation
373577|NCT01353313|Intubation|intubation
373578|NCT01353313|Neurodevelopmental impairment|neurodevelopmental impairment
373579|NCT01353300|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
373580|NCT01353300|cystic nephroma|cystic nephroma
373581|NCT01353300|neuroblastoma|neuroblastoma
373582|NCT01353300|childhood medulloblastoma|childhood medulloblastoma
373583|NCT01353300|childhood hepatoblastoma|childhood hepatoblastoma
373584|NCT01353300|stromal predominant Wilms tumor|stromal predominant wilms tumor
373585|NCT01353300|hereditary Wilms tumor|hereditary wilms tumor
373586|NCT01353300|pleuropulmonary blastoma|pleuropulmonary blastoma
373587|NCT01353287|Transcatheter Aortic Valve Intervention (TAVI)|transcatheter aortic valve intervention (tavi)
373588|NCT01353287|Live case transmission|live case transmission
373589|NCT01353261|Platelet reactivity|platelet reactivity
373590|NCT01353248|Hepatitis C|hepatitis c
373592|NCT01353248|Rapid Virologic Response|rapid virologic response
373994|NCT01351688|Japanese|japanese
373593|NCT01353248|Sustained Virologic Response|sustained virologic response
373594|NCT01353248|Direct Acting Antiviral|direct acting antiviral
373595|NCT01353248|Combination Therapy|combination therapy
373596|NCT01353248|HCV RNA|hcv rna
373597|NCT01353248|Polymerase inhibitor|polymerase inhibitor
373598|NCT01353248|Protease inhibitor|protease inhibitor
373599|NCT01353248|Treatment naïve|treatment naïve
373600|NCT01353248|GS-5885|gs-5885
373601|NCT01353248|GS-9451|gs-9451
373602|NCT01353248|Tegobuvir|tegobuvir
373603|NCT01353235|COPD|copd
373604|NCT01353235|acute respiratory failure|acute respiratory failure
373605|NCT01353235|mechanical ventilation|mechanical ventilation
373606|NCT01353235|non invasive ventilation|non invasive ventilation
373607|NCT01353235|steroids|steroids
373608|NCT01353222|Bladder cancer|bladder cancer
373609|NCT01353222|Renal pelvis cancer|renal pelvis cancer
373610|NCT01353222|Ureteral cancer|ureteral cancer
373611|NCT01353222|Urethral cancer|urethral cancer
373612|NCT01353222|Bladder|bladder
373613|NCT01353222|Renal pelvis|renal pelvis
373614|NCT01353222|Ureter|ureter
373615|NCT01353222|Urethra|urethra
373616|NCT01353222|Immune therapy|immune therapy
373617|NCT01353222|Immunotherapy|immunotherapy
373618|NCT01353222|Vaccine|vaccine
373619|NCT01353222|Dendritic cells|dendritic cells
373620|NCT01353222|Antigen-presenting cells|antigen-presenting cells
373621|NCT01353222|Antigen presenting cells|antigen presenting cells
373622|NCT01353222|Cancer vaccine|cancer vaccine
373623|NCT01353222|Urothelial carcinoma|urothelial carcinoma
373624|NCT01353222|Urothelial neoplasms|urothelial neoplasms
373625|NCT01353222|Neoplasms by site|neoplasms by site
373626|NCT01353222|Neoplasms|neoplasms
373627|NCT01353196|carotid|carotid
373628|NCT01353196|atherosclerosis|atherosclerosis
373629|NCT01353196|cognitive function|cognitive function
373630|NCT01353183|biopsies, enteric nervous system, biomarker|biopsies, enteric nervous system, biomarker
373631|NCT01353170|Serum calcium|serum calcium
373632|NCT01353170|Dialysate|dialysate
373633|NCT01353170|Mass balance|mass balance
373634|NCT01353170|Blood pressure|blood pressure
373635|NCT01353157|cytokine|cytokine
373636|NCT01353157|cardiac surgery|cardiac surgery
373637|NCT01353157|clinical scoring system|clinical scoring system
373638|NCT01353144|aspirin|aspirin
373639|NCT01353144|peptic ulcer|peptic ulcer
373640|NCT01353131|electrocardiogram,|electrocardiogram,
373641|NCT01353131|cardiac magnetic resonance|cardiac magnetic resonance
373642|NCT01353131|heart failure|heart failure
373643|NCT01353131|sudden cardiac death|sudden cardiac death
373644|NCT01353131|ECG scoring|ecg scoring
373645|NCT01353131|Delayed enhancement|delayed enhancement
373646|NCT01353118|diabetes|diabetes
373647|NCT01353118|bariatric surgery|bariatric surgery
373648|NCT01353118|Roux-en-y gastric bypass|roux-en-y gastric bypass
373649|NCT01353118|retinopathy|retinopathy
373650|NCT01353118|neuropathy|neuropathy
373651|NCT01353118|nephropathy|nephropathy
373652|NCT01353105|cystic fibrosis|cystic fibrosis
373653|NCT01353105|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
373654|NCT01353105|pulmonary fibrosis|pulmonary fibrosis
373655|NCT01353092|Randomized Controlled Trial|randomized controlled trial
373656|NCT01353092|Major depression|major depression
373657|NCT01353092|Hamilton|hamilton
373658|NCT01353092|PEMF|pemf
373659|NCT01353066|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
373660|NCT01353066|BMI 30.0-34.9 kg/m2|bmi 30.0-34.9 kg/m2
373661|NCT01353053|Immunosuppression|immunosuppression
373662|NCT01353053|Cytomegalovirus|cytomegalovirus
373663|NCT01353053|Renal Transplant|renal transplant
373664|NCT01353053|Atrophy/interstitial|atrophy/interstitial
373665|NCT01353053|Conversion of tacrolimus everolimus|conversion of tacrolimus everolimus
373666|NCT01353014|Nutrigenomics|nutrigenomics
373667|NCT01353014|Diet|diet
373668|NCT01353014|Nutrition|nutrition
373669|NCT01353001|Intervention Studies|intervention studies
373670|NCT01353001|Magnetic Resonance Imaging|magnetic resonance imaging
373671|NCT01353001|C-Reactive Protein|c-reactive protein
373672|NCT01352988|C17.300.475|c17.300.475
373673|NCT01352988|C17.800.480|c17.800.480
373674|NCT01352975|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
373675|NCT01352975|Dark Adaptation|dark adaptation
373676|NCT01352975|Age Related Macular Degeneration|age related macular degeneration
373677|NCT01352975|AMD|amd
373678|NCT01352962|Dose Limiting Toxicity|dose limiting toxicity
373679|NCT01352962|Urethra Cancer|urethra cancer
364422|NCT01391884|GIP|gip
373680|NCT01352962|Carcinoma of the Bladder|carcinoma of the bladder
373681|NCT01352962|Cancer of the Renal Pelvis|cancer of the renal pelvis
373682|NCT01352962|Ureter Cancer|ureter cancer
373683|NCT01352962|Urethral Cancer|urethral cancer
373684|NCT01352962|Solid Tumor|solid tumor
373685|NCT01352962|Pancreatic Cancer|pancreatic cancer
373686|NCT01352962|Ovarian Cancer|ovarian cancer
373687|NCT01352962|Non-Small Cell Lung Cancer|non-small cell lung cancer
373688|NCT01352949|Anthropometry|anthropometry
373689|NCT01352949|Stereophotogrammetry|stereophotogrammetry
373690|NCT01352949|Torso|torso
373691|NCT01352949|Spinal Deformity|spinal deformity
374097|NCT01351181|Diabetes|diabetes
373692|NCT01352949|Chest Wall Deformity|chest wall deformity
373693|NCT01352949|Overweight|overweight
373694|NCT01352949|Obese|obese
373695|NCT01352949|Healthy Volunteer|healthy volunteer
373696|NCT01352949|HV|hv
373697|NCT01352936|nephrotoxicity|nephrotoxicity
373698|NCT01352936|hospital cost|hospital cost
373699|NCT01352936|Staphylococcus aureus|staphylococcus aureus
373700|NCT01352936|bacteremia|bacteremia
373701|NCT01352936|vancomycin|vancomycin
373702|NCT01352936|teicoplanin|teicoplanin
373703|NCT01352923|PEAR1 gene|pear1 gene
373704|NCT01352923|whether and how PEAR 1 modulate intracellular signaling pathways relevant for platelet function|whether and how pear 1 modulate intracellular signaling pathways relevant for platelet function
373705|NCT01352897|Cholesterol|cholesterol
373706|NCT01352897|rosuvastatin|rosuvastatin
373707|NCT01352897|retrospective|retrospective
373708|NCT01352884|Cancer|cancer
373709|NCT01352884|Carcinoma|carcinoma
373710|NCT01352884|Tumor|tumor
373711|NCT01352884|Solid tumor|solid tumor
373712|NCT01352884|Metastatic|metastatic
373713|NCT01352884|Melanoma|melanoma
373714|NCT01352871|Immunity, Innate|immunity, innate
373715|NCT01352871|Attention|attention
373716|NCT01352871|Concentration|concentration
373717|NCT01352858|Arthritis|arthritis
373718|NCT01352858|RA|ra
373719|NCT01352858|Auto-immune disorders|auto-immune disorders
373720|NCT01352832|Chronic NSAID use|chronic nsaid use
373721|NCT01352806|accuracy of identifying intralaminar space|accuracy of identifying intralaminar space
373722|NCT01352793|phase 3 safety study|phase 3 safety study
373723|NCT01352793|5700 healthy subjects|5700 healthy subjects
373724|NCT01352793|3 vaccine doses at month 0|3 vaccine doses at month 0
373725|NCT01352793|2|2
373726|NCT01352793|and 6|and 6
373727|NCT01352793|control HAV/saline/HAV|control hav/saline/hav
373728|NCT01352780|motivational interviewing|motivational interviewing
373729|NCT01352780|psoriasis|psoriasis
373730|NCT01352780|self management|self management
373731|NCT01352767|insulin injection|insulin injection
373732|NCT01352754|Hip fracture|hip fracture
373733|NCT01352754|Troponin T|troponin t
373734|NCT01352754|myocardial infarction|myocardial infarction
373735|NCT01352741|low back pain|low back pain
373736|NCT01352741|neuropathic|neuropathic
373737|NCT01352741|pain assessment|pain assessment
373738|NCT01352741|centrally acting tapentadol pregabalin|centrally acting tapentadol pregabalin
373739|NCT01352741|severe chronic|severe chronic
373740|NCT01352728|Unresectable|unresectable
373741|NCT01352689|CKD-828|ckd-828
373742|NCT01352689|Hypertension|hypertension
373743|NCT01352689|Primary Hypertension|primary hypertension
373744|NCT01352689|Healthy Volunteer|healthy volunteer
373745|NCT01352689|S-Amlodipine|s-amlodipine
373746|NCT01352689|Telmisartan|telmisartan
373747|NCT01352689|Amlodipine|amlodipine
373748|NCT01352689|Pharmacokinetic|pharmacokinetic
373749|NCT01352689|Phase 1|phase 1
373750|NCT01352676|renal colic|renal colic
373751|NCT01352676|flank pain|flank pain
373752|NCT01352676|back pain|back pain
373753|NCT01352663|Type I Diabetes|type i diabetes
373755|NCT01352663|Insulin Analogue|insulin analogue
373756|NCT01352650|leukemia|leukemia
373757|NCT01352637|Traumatic Event|traumatic event
373758|NCT01352637|Trauma Survivor|trauma survivor
373759|NCT01352637|Exposure Therapy|exposure therapy
373760|NCT01352637|PTSD DCS|ptsd dcs
373761|NCT01352637|Virtual Reality Exposure|virtual reality exposure
373762|NCT01352637|Veteran|veteran
373763|NCT01352637|Combat-related PTSD|combat-related ptsd
373764|NCT01352611|Tactile Defensiveness|tactile defensiveness
373765|NCT01352611|Autistic Disorder|autistic disorder
373766|NCT01352598|prostate cancer|prostate cancer
373767|NCT01352598|stereotactic radiotherapy|stereotactic radiotherapy
373768|NCT01352572|Antidepressant Response|antidepressant response
373769|NCT01352572|Signal Transduction|signal transduction
373770|NCT01352572|Lymphocyte|lymphocyte
373771|NCT01352572|Biomarkers|biomarkers
373772|NCT01352572|Depressed Patients|depressed patients
373773|NCT01352572|Antidepressant Drug Adverse Reaction|antidepressant drug adverse reaction
373774|NCT01352559|Pharmacogenomics|pharmacogenomics
373775|NCT01352559|Prediction of Antidepressant Response|prediction of antidepressant response
373776|NCT01352559|Depressed Patients|depressed patients
373777|NCT01352559|biomarkers|biomarkers
373778|NCT01352559|phenotype|phenotype
373779|NCT01352559|Antidepressant Response|antidepressant response
373780|NCT01352559|Adverse Reaction to Drug|adverse reaction to drug
373781|NCT01352546|vaginismus|vaginismus
373782|NCT01352546|painful sex|painful sex
373783|NCT01352546|painful intercourse|painful intercourse
373784|NCT01352546|dyspareunia|dyspareunia
373785|NCT01352546|inability to have intercourse|inability to have intercourse
373786|NCT01352546|inability to consummate marriage|inability to consummate marriage
373787|NCT01352546|vaginal spasm|vaginal spasm
373788|NCT01352546|"hitting a wall"|"hitting a wall"
373789|NCT01352546|pain during sex|pain during sex
373790|NCT01352546|pain during intercourse|pain during intercourse
373791|NCT01352546|burning with intercourse|burning with intercourse
373792|NCT01352520|systemic therapy|systemic therapy
374202|NCT01350648|Hepatitis C|hepatitis c
373793|NCT01352520|cutaneous anaplastic large T cell lymphoma|cutaneous anaplastic large t cell lymphoma
373794|NCT01352520|ALCL|alcl
373795|NCT01352520|lymphomatoid papulosis|lymphomatoid papulosis
373796|NCT01352520|LyP|lyp
373797|NCT01352520|mycosis fungoides|mycosis fungoides
373798|NCT01352520|MF|mf
373799|NCT01352520|SGN-35 (brentuximab vedotin)|sgn-35 (brentuximab vedotin)
373800|NCT01352520|skin lymphomas|skin lymphomas
373801|NCT01352520|CD30-positive lymphoproliferative disorders|cd30-positive lymphoproliferative disorders
373802|NCT01352520|tumor lymphocytes|tumor lymphocytes
373803|NCT01352520|cutaneous lymphomas|cutaneous lymphomas
373804|NCT01352520|CD30+ expression|cd30+ expression
373805|NCT01352520|Hematologic Disorder|hematologic disorder
373806|NCT01352520|Lymphoma|lymphoma
373807|NCT01352494|locally advanced breast cancer|locally advanced breast cancer
373808|NCT01352494|docetaxel|docetaxel
373809|NCT01352494|gemcitabine|gemcitabine
373810|NCT01352481|Speech sound development|speech sound development
373811|NCT01352468|ADHD|adhd
373812|NCT01352468|cognitive training|cognitive training
373813|NCT01352455|Hemodialysis|hemodialysis
373814|NCT01352455|Pediatric|pediatric
373815|NCT01352455|Outcomes|outcomes
373816|NCT01352455|Comparative Effectiveness|comparative effectiveness
373817|NCT01352455|End Stage Renal Disease|end stage renal disease
373818|NCT01352442|Presbyopia|presbyopia
373819|NCT01352442|Accommodation|accommodation
373820|NCT01352442|Near visual acuity|near visual acuity
373821|NCT01352442|LASIK|lasik
373822|NCT01352429|adult|adult
373823|NCT01352429|histologically confirmed|histologically confirmed
373824|NCT01352416|Suppress Atrial Fibrillation|suppress atrial fibrillation
373825|NCT01352416|heart bypass surgery|heart bypass surgery
373826|NCT01352416|heart valve surgery|heart valve surgery
373827|NCT01352403|obesity|obesity
373828|NCT01352403|bariatric surgery|bariatric surgery
373829|NCT01352403|gastric bypass|gastric bypass
373830|NCT01352403|life style intervention|life style intervention
373831|NCT01352403|cardiac function|cardiac function
373832|NCT01352390|behavioral economics|behavioral economics
373833|NCT01352390|nudge|nudge
373834|NCT01352390|artwork|artwork
373835|NCT01352390|Pap smear|pap smear
373836|NCT01352390|Blood pressure check|blood pressure check
373837|NCT01352390|Cholesterol test|cholesterol test
373838|NCT01352390|Fasting plasma glucose test|fasting plasma glucose test
373839|NCT01352364|Physiotherapy.|physiotherapy.
373840|NCT01352364|Deafness.|deafness.
373841|NCT01352364|Postural balance.|postural balance.
373842|NCT01352364|Motor skills.|motor skills.
373843|NCT01352351|Breast feeding Exclusive|breast feeding exclusive
373844|NCT01352351|Initiation of breastfeeding|initiation of breastfeeding
373845|NCT01352338|REPEAT|repeat
373846|NCT01352338|multiple myeloma|multiple myeloma
373847|NCT01352338|revlimid|revlimid
373848|NCT01352338|lenalidomide|lenalidomide
373849|NCT01352338|cyclophosphamide|cyclophosphamide
373850|NCT01352338|endoxan|endoxan
373851|NCT01352338|prednisone|prednisone
373852|NCT01352338|lenalidomide refractory|lenalidomide refractory
373951|NCT01351805|prevention|prevention
373853|NCT01352312|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
373854|NCT01352312|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
373855|NCT01352312|B-cell|b-cell
373856|NCT01352312|leukemia|leukemia
373857|NCT01352312|lymphoma|lymphoma
373858|NCT01352312|bendamustine|bendamustine
373859|NCT01352312|pentostatin|pentostatin
373860|NCT01352312|ofatumumab|ofatumumab
373862|NCT01352312|CLL|cll
373863|NCT01352299|Macintosh laryngoscope blade|macintosh laryngoscope blade
373864|NCT01352299|MacCoy laryngoscope blade|maccoy laryngoscope blade
373865|NCT01352299|Miller laryngoscope blade|miller laryngoscope blade
373866|NCT01352299|TrueView laryngoscope|trueview laryngoscope
373867|NCT01352286|Multiple myeloma|multiple myeloma
373868|NCT01352286|Autologous stem cell transplantation|autologous stem cell transplantation
373869|NCT01352286|Received initial treatment previously|received initial treatment previously
373870|NCT01352273|advanced Solid tumors|advanced solid tumors
373871|NCT01352273|harboring RAS|harboring ras
373872|NCT01352273|harboring BRAFV600E|harboring brafv600e
373873|NCT01352260|Near Infrared Spectroscopy|near infrared spectroscopy
373874|NCT01352260|Neuromonitoring|neuromonitoring
373875|NCT01352260|Aortic Arch Replacement|aortic arch replacement
457358|NCT00023569|TMS|tms
373876|NCT01352221|iron deficiency|iron deficiency
373877|NCT01352221|anaemia|anaemia
373878|NCT01352221|inflammatory bowel disease|inflammatory bowel disease
373879|NCT01352221|Crohn's Disease|crohn's disease
373880|NCT01352208|ASP9521|asp9521
373881|NCT01352208|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
373882|NCT01352208|Phase 1/2|phase 1/2
373883|NCT01352195|Forever Free|forever free
373884|NCT01352143|Neonates|neonates
373885|NCT01352130|Postoperative nausea and vomiting|postoperative nausea and vomiting
373886|NCT01352130|Ondansetron|ondansetron
373887|NCT01352130|Granisetron|granisetron
373888|NCT01352130|QTc interval|qtc interval
373889|NCT01352104|Externalizing Problem Behaviour in Preschoolers|externalizing problem behaviour in preschoolers
373890|NCT01352091|breast cancer|breast cancer
373891|NCT01352091|adjuvant endocrine therapy|adjuvant endocrine therapy
373893|NCT01352091|Zoladex|zoladex
373894|NCT01352078|Non healing ulcer|non healing ulcer
373895|NCT01352078|Wound|wound
373896|NCT01352078|Hidradenitis suppurativa|hidradenitis suppurativa
373897|NCT01352078|Acne Inversa|acne inversa
373898|NCT01352078|Hidradenitis|hidradenitis
373899|NCT01352065|Pharmacokinetics|pharmacokinetics
373900|NCT01352065|Exercise performance|exercise performance
373901|NCT01352065|Athletes|athletes
373902|NCT01352052|chronic widespread pain|chronic widespread pain
373903|NCT01352052|fibromyalgia|fibromyalgia
373904|NCT01352052|outcome assessment|outcome assessment
373905|NCT01352052|functional ability|functional ability
373906|NCT01352052|AMPS|amps
373907|NCT01352052|rehabilitation|rehabilitation
373908|NCT01352039|Heparin Sodium|heparin sodium
373909|NCT01352039|Thromboprophylaxis|thromboprophylaxis
373910|NCT01352039|Hip Fracture Surgery.|hip fracture surgery.
373911|NCT01352013|Fibromyalgia|fibromyalgia
373912|NCT01352013|Omega-3|omega-3
373913|NCT01352013|Chronic Pain|chronic pain
373914|NCT01352013|Fatigue|fatigue
373915|NCT01352013|Mood|mood
373916|NCT01352013|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
373917|NCT01352013|eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
373918|NCT01352000|self help|self help
373919|NCT01352000|smoking cessation|smoking cessation
373920|NCT01352000|cancer prevention|cancer prevention
373921|NCT01351987|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
373922|NCT01351974|breast cancer|breast cancer
373923|NCT01351974|sentinel lymph node biopsy|sentinel lymph node biopsy
373924|NCT01351974|axillary recurrence|axillary recurrence
373925|NCT01351961|Hypertension|hypertension
373926|NCT01351961|Cognitive function|cognitive function
373927|NCT01351948|Immune response|immune response
373928|NCT01351935|non-hodgkin's lymphoma|non-hodgkin's lymphoma
373929|NCT01351935|lymphoma|lymphoma
373930|NCT01351935|leukemia|leukemia
373931|NCT01351935|chronic lymphocytic leukemia|chronic lymphocytic leukemia
373932|NCT01351935|b-cell malignancies|b-cell malignancies
373933|NCT01351935|Btk inhibitor|btk inhibitor
373934|NCT01351935|Phase 1b|phase 1b
373935|NCT01351935|Avila Therapeutics|avila therapeutics
373936|NCT01351935|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
373937|NCT01351883|immunomodulating diet|immunomodulating diet
373938|NCT01351883|postoperative infection|postoperative infection
373939|NCT01351857|Type 1 Diabetes|type 1 diabetes
373940|NCT01351857|17 to 20 years of age|17 to 20 years of age
373941|NCT01351844|Aromatase inhibitor|aromatase inhibitor
373942|NCT01351844|Arthralgia Syndrome|arthralgia syndrome
373943|NCT01351844|Exercise|exercise
373944|NCT01351831|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
373945|NCT01351831|Resistance training|resistance training
373946|NCT01351831|Physical Therapy Modalities|physical therapy modalities
373947|NCT01351831|Randomized Controlled Trial|randomized controlled trial
373948|NCT01351805|vitamin D|vitamin d
373949|NCT01351805|omega-3 fatty acid|omega-3 fatty acid
373950|NCT01351805|fish oil|fish oil
373952|NCT01351805|trial|trial
373953|NCT01351805|autoimmune disease|autoimmune disease
373954|NCT01351805|rheumatoid arthritis|rheumatoid arthritis
373955|NCT01351805|psoriasis|psoriasis
373956|NCT01351805|systemic inflammation|systemic inflammation
373957|NCT01351805|Interleukin-6|interleukin-6
373958|NCT01351805|C-reactive peptide|c-reactive peptide
373959|NCT01351805|tumor necrosis factor|tumor necrosis factor
373960|NCT01351805|osteoarthritis|osteoarthritis
373961|NCT01351779|Intraocular pressure|intraocular pressure
373962|NCT01351779|Contact lens sensor|contact lens sensor
373963|NCT01351779|Optic disc hemorrhage|optic disc hemorrhage
373964|NCT01351766|Behavioral Activation|behavioral activation
373965|NCT01351753|Obesity|obesity
373966|NCT01351753|Metabolic Syndrome X|metabolic syndrome x
373967|NCT01351753|Hypertension|hypertension
373968|NCT01351753|Dyslipidemia|dyslipidemia
373969|NCT01351753|Impaired glucose tolerance|impaired glucose tolerance
373971|NCT01351740|Anti-HIV Agents|anti-hiv agents
373972|NCT01351740|HIV Protease Inhibitors|hiv protease inhibitors
373973|NCT01351727|seniors|seniors
373974|NCT01351727|seizures|seizures
373975|NCT01351727|epilepsy|epilepsy
373976|NCT01351727|quality of life|quality of life
364755|NCT01390441|RA|ra
373977|NCT01351714|D3 resection|d3 resection
373978|NCT01351714|right colectomy|right colectomy
373979|NCT01351714|MDCT angiography|mdct angiography
373980|NCT01351714|lymphadenectomy|lymphadenectomy
373981|NCT01351714|safe|safe
373982|NCT01351714|right colon|right colon
373983|NCT01351714|preoperative|preoperative
373984|NCT01351701|Diabetic foot|diabetic foot
373985|NCT01351701|Bacteriological epidemiology|bacteriological epidemiology
373986|NCT01351701|Wagner's Grading|wagner's grading
373987|NCT01351701|eastern India|eastern india
373988|NCT01351688|Phase 1|phase 1
373989|NCT01351688|Metastatic|metastatic
373990|NCT01351688|Castration resistant|castration resistant
373991|NCT01351688|Prostate cancer|prostate cancer
373992|NCT01351688|Androgen receptor|androgen receptor
373993|NCT01351688|Down regulation|down regulation
373995|NCT01351675|Chronic kidney disease|chronic kidney disease
373996|NCT01351675|Type 2 diabetes|type 2 diabetes
373997|NCT01351675|Diabetic nephropathy|diabetic nephropathy
373998|NCT01351662|Lupus|lupus
373999|NCT01351662|stress|stress
374000|NCT01351649|exercise|exercise
374001|NCT01351649|adolescent|adolescent
374002|NCT01351649|intervention|intervention
374003|NCT01351649|female|female
374004|NCT01351649|counseling|counseling
374005|NCT01351636|chronic kidney disease|chronic kidney disease
374006|NCT01351636|hypertension|hypertension
374007|NCT01351623|PR-171 (CARFILZOMIB)|pr-171 (carfilzomib)
374008|NCT01351623|Chemotherapy|chemotherapy
374009|NCT01351623|10-228|10-228
374010|NCT01351610|Critical Limb Ischemia|critical limb ischemia
374011|NCT01351610|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
374012|NCT01351610|Peripheral Artery Disease|peripheral artery disease
374013|NCT01351610|Peripheral Vascular Disease|peripheral vascular disease
374014|NCT01351610|Stem Cell Therapy|stem cell therapy
374015|NCT01351610|Mesenchymal Stem Cells|mesenchymal stem cells
374016|NCT01351597|recurrent breast cancer|recurrent breast cancer
374017|NCT01351597|metastatic breast cancer|metastatic breast cancer
374018|NCT01351597|docetaxel|docetaxel
374019|NCT01351597|oxaliplatin|oxaliplatin
374020|NCT01351584|Breast Cancer|breast cancer
374021|NCT01351584|Advanced Breast Cancer|advanced breast cancer
374022|NCT01351584|Epidemiology|epidemiology
374023|NCT01351584|Registry|registry
374024|NCT01351584|Health Services Research|health services research
374025|NCT01351584|Germany|germany
374026|NCT01351584|Palliative Treatment|palliative treatment
374027|NCT01351584|Adjuvant Drug Therapy|adjuvant drug therapy
374028|NCT01351584|Nutrition Assessment|nutrition assessment
374029|NCT01351584|Physical Activity|physical activity
374030|NCT01351519|Glioma|glioma
374031|NCT01351519|Glioblastoma|glioblastoma
374032|NCT01351519|Glioblastoma Multiforme|glioblastoma multiforme
374033|NCT01351519|Astrocytoma|astrocytoma
374034|NCT01351519|Brain Tumor|brain tumor
374035|NCT01351506|Body weight|body weight
374036|NCT01351506|Body mass index|body mass index
374037|NCT01351506|Weight change|weight change
374038|NCT01351506|ICU outcomes|icu outcomes
374039|NCT01351493|pressure sore|pressure sore
374040|NCT01351493|nitric oxide|nitric oxide
374041|NCT01351480|Auto-immune Disease|auto-immune disease
374042|NCT01351480|Arthritis|arthritis
374043|NCT01351480|Rheumatoid Arthritis|rheumatoid arthritis
374044|NCT01351467|Parkinson's|parkinson's
374045|NCT01351467|genetic|genetic
374046|NCT01351467|online|online
374047|NCT01351467|GWAS|gwas
374048|NCT01351467|genome wide association|genome wide association
374049|NCT01351454|Depression|depression
374050|NCT01351454|Substance Use|substance use
374051|NCT01351454|HIV Medication Adherence|hiv medication adherence
374052|NCT01351454|Behavioral Activation|behavioral activation
374053|NCT01351441|Geriatric|geriatric
374054|NCT01351441|Pharmacoeconomics|pharmacoeconomics
374055|NCT01351441|Health Literacy|health literacy
374056|NCT01351441|Adherence|adherence
374057|NCT01351428|Non invasive cardiac output monitor|non invasive cardiac output monitor
374058|NCT01351428|NICOM|nicom
374059|NCT01351428|Hypertension|hypertension
374060|NCT01351428|Pregnancy|pregnancy
374061|NCT01351428|Pre-Eclampsia|pre-eclampsia
374062|NCT01351402|Massage|massage
374063|NCT01351402|Rest|rest
374064|NCT01351389|Brief|brief
374065|NCT01351389|Alcohol|alcohol
374066|NCT01351389|Intervention|intervention
374067|NCT01351389|Sex|sex
374068|NCT01351389|Risk|risk
374069|NCT01351376|Lymphedema, Low Level Laser, Breast Cancer|lymphedema, low level laser, breast cancer
374070|NCT01351363|Arthroscopic shoulder surgery|arthroscopic shoulder surgery
374071|NCT01351363|Pain threshold|pain threshold
374072|NCT01351350|Solid tumor, mTORC1/2 inhibitors, HER2|solid tumor, mtorc1/2 inhibitors, her2
374073|NCT01351337|Diffusion tensor imaging, Glioma, Intraoperative monitoring, Pyramidal tract, Subcortical|diffusion tensor imaging, glioma, intraoperative monitoring, pyramidal tract, subcortical
374074|NCT01351337|stimulation, Tractography|stimulation, tractography
374075|NCT01351324|Endothelial function|endothelial function
374076|NCT01351324|Non-esterified fatty acids|non-esterified fatty acids
374077|NCT01351324|Insulin sensitivity|insulin sensitivity
374078|NCT01351311|treatment|treatment
374079|NCT01351311|exercise|exercise
374080|NCT01351311|resistance training|resistance training
374081|NCT01351311|swiss ball|swiss ball
374082|NCT01351311|functional capacity|functional capacity
374083|NCT01351259|Mechanical ventilation|mechanical ventilation
374084|NCT01351259|Intubation|intubation
374085|NCT01351259|Cuff pressure|cuff pressure
374086|NCT01351259|Microaspiration|microaspiration
374087|NCT01351246|Program Evaluation|program evaluation
374088|NCT01351246|ADHD|adhd
374089|NCT01351233|Cataract|cataract
374090|NCT01351220|CRC screening|crc screening
374091|NCT01351220|Prevention and early detection of CRC|prevention and early detection of crc
374092|NCT01351220|Filipino|filipino
374093|NCT01351220|Dissemination|dissemination
374094|NCT01351194|Hepatocellular Carcinoma|hepatocellular carcinoma
374096|NCT01351194|HR|hr
374098|NCT01351168|Parkinson's disease|parkinson's disease
374099|NCT01351168|zolpidem|zolpidem
374100|NCT01351155|acute respiratory failure|acute respiratory failure
374101|NCT01351155|noninvasive ventilation|noninvasive ventilation
374102|NCT01351129|formulation comparison|formulation comparison
374103|NCT01351116|brachytherapy|brachytherapy
374104|NCT01351116|external beam radiation|external beam radiation
374105|NCT01351116|high dose rate intraluminal brachytherapy|high dose rate intraluminal brachytherapy
374106|NCT01351116|lung cancer|lung cancer
374107|NCT01351116|quality of life|quality of life
374108|NCT01351116|radiation treatment|radiation treatment
374109|NCT01351116|bronchus|bronchus
374110|NCT01351103|LGK974|lgk974
374111|NCT01351103|pancreatic adenocarcinoma|pancreatic adenocarcinoma
374112|NCT01351103|BRAF mutant colorectal cancer|braf mutant colorectal cancer
374113|NCT01351103|other tumor types with documented genetic alterations upstream in the Wnt signaling pathway|other tumor types with documented genetic alterations upstream in the wnt signaling pathway
374114|NCT01351103|RNF43 mutation|rnf43 mutation
374115|NCT01351103|RSPO fusion|rspo fusion
374116|NCT01351103|melanoma|melanoma
374117|NCT01351103|triple negative breast cancer|triple negative breast cancer
374118|NCT01351103|PDR001|pdr001
374119|NCT01351103|immunotherapy|immunotherapy
374120|NCT01351103|head and neck cancer|head and neck cancer
374121|NCT01351077|Developmental Delay|developmental delay
374122|NCT01351064|ADHD|adhd
374123|NCT01351012|Canola oil|canola oil
374124|NCT01351012|High oleic canola oil|high oleic canola oil
374125|NCT01351012|Flax oil|flax oil
374126|NCT01351012|ALA|ala
374127|NCT01351012|DHA|dha
374128|NCT01351012|Metabolic syndrome|metabolic syndrome
374129|NCT01351012|Cardiovascular disease|cardiovascular disease
374130|NCT01351012|Endothelial function|endothelial function
374131|NCT01351012|FADS1|fads1
374132|NCT01351012|Gut microbiome|gut microbiome
374133|NCT01351012|Body composition|body composition
374134|NCT01351012|Psychosocial status|psychosocial status
374135|NCT01351012|Cholesterol|cholesterol
374136|NCT01351012|Lipids|lipids
374137|NCT01351012|Lipoproteins|lipoproteins
374138|NCT01351012|Inflammation|inflammation
374139|NCT01351012|Lipid peroxidation|lipid peroxidation
374140|NCT01350999|Drug Therapy|drug therapy
374141|NCT01350986|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
374142|NCT01350973|Drug Therapy|drug therapy
374143|NCT01350960|hypercholesterolemia|hypercholesterolemia
374144|NCT01350960|hyperlipidemia|hyperlipidemia
374145|NCT01350960|LDL|ldl
374146|NCT01350960|HDL|hdl
374147|NCT01350960|PCSK9|pcsk9
374148|NCT01350960|LNA-oligonucleotide|lna-oligonucleotide
374149|NCT01350947|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
374150|NCT01350947|CMML|cmml
374151|NCT01350921|phase 1|phase 1
374152|NCT01350921|ticagrelor|ticagrelor
374153|NCT01350921|venlafaxine|venlafaxine
374256|NCT01350388|Hyperuricemia|hyperuricemia
374157|NCT01350882|rituximab|rituximab
374158|NCT01350856|Uncomplicated P. falciparum malaria|uncomplicated p. falciparum malaria
374159|NCT01350843|Men|men
374160|NCT01350843|Orange Juice|orange juice
374161|NCT01350843|Cholesterol|cholesterol
374162|NCT01350843|Obesity|obesity
374163|NCT01350830|inguinal hernia|inguinal hernia
374164|NCT01350830|groin hernia|groin hernia
374165|NCT01350830|chronic pain|chronic pain
374166|NCT01350830|mesh repair|mesh repair
374167|NCT01350804|Rheumatoid Arthritis|rheumatoid arthritis
374168|NCT01350804|RA|ra
374169|NCT01350804|ACR|acr
374170|NCT01350804|inflammatory joints|inflammatory joints
374171|NCT01350778|Coronary artery disease requiring drug eluting stents|coronary artery disease requiring drug eluting stents
374172|NCT01350765|Birth asphyxia|birth asphyxia
374173|NCT01350765|Low birth weight|low birth weight
374174|NCT01350765|neonatal sepsis|neonatal sepsis
374175|NCT01350765|mortality|mortality
374176|NCT01350765|community based interventions|community based interventions
374177|NCT01350752|cost effectiveness|cost effectiveness
374178|NCT01350752|provider knowledge|provider knowledge
374179|NCT01350752|schools|schools
374180|NCT01350726|Cirrhosis|cirrhosis
374181|NCT01350726|Hepatic Carcinoma|hepatic carcinoma
374182|NCT01350713|skin|skin
374183|NCT01350713|burn|burn
374184|NCT01350713|povidone iodine|povidone iodine
374185|NCT01350713|cold water|cold water
374186|NCT01350700|QOL|qol
374187|NCT01350687|Calcium Phosphore|calcium phosphore
374188|NCT01350687|Renagel|renagel
374189|NCT01350674|mediastinal tuberculosis|mediastinal tuberculosis
374190|NCT01350674|endoscopy|endoscopy
374191|NCT01350674|EBUS|ebus
374192|NCT01350674|tuberculous lymphadenopathy|tuberculous lymphadenopathy
374193|NCT01350674|endobronchial ultrasound|endobronchial ultrasound
374194|NCT01350661|Asthma|asthma
374195|NCT01350661|Questionnaires|questionnaires
374196|NCT01350648|Viral Hepatitis|viral hepatitis
374197|NCT01350648|Prospective Cohort|prospective cohort
374198|NCT01350648|Hepatocellular Carcinoma|hepatocellular carcinoma
374199|NCT01350648|HIV-HCV Co-Infection|hiv-hcv co-infection
374200|NCT01350648|HIV-HBV Co-Infection|hiv-hbv co-infection
374201|NCT01350648|Hepatitis B|hepatitis b
374203|NCT01350648|Hepatitis|hepatitis
374204|NCT01350635|Specific Immunotherapy|specific immunotherapy
374205|NCT01350635|Grass pollen vaccine|grass pollen vaccine
374206|NCT01350635|Allergy|allergy
374207|NCT01350635|Grass Pollen Allergy|grass pollen allergy
374208|NCT01350622|pain management|pain management
374209|NCT01350609|essential hypertension, blood pressure, nifedipine, candesartan, FDC|essential hypertension, blood pressure, nifedipine, candesartan, fdc
374210|NCT01350596|Bioequivalence Study|bioequivalence study
374211|NCT01350596|Ibuprofen|ibuprofen
374212|NCT01350596|Alivium|alivium
374213|NCT01350583|tumor related pain|tumor related pain
374214|NCT01350570|acupuncture|acupuncture
374215|NCT01350570|loperamide|loperamide
374216|NCT01350570|functional diarrhea|functional diarrhea
374218|NCT01350557|Elderly|elderly
374219|NCT01350557|Hip fracture|hip fracture
374220|NCT01350557|Intervention program|intervention program
374221|NCT01350544|HIV|hiv
374222|NCT01350544|Adherence|adherence
374223|NCT01350544|African American/Black|african american/black
374224|NCT01350544|Disparities|disparities
374225|NCT01350531|Obesity|obesity
374226|NCT01350531|African American adolescents|african american adolescents
374227|NCT01350531|Motivation|motivation
374231|NCT01350505|Postural Balance|postural balance
374232|NCT01350505|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
374233|NCT01350492|pain|pain
374234|NCT01350492|brain imaging|brain imaging
374235|NCT01350492|exercise|exercise
374236|NCT01350479|Cross infection|cross infection
374237|NCT01350479|Long term care|long term care
374238|NCT01350466|Chronic rhinosinusitis|chronic rhinosinusitis
374239|NCT01350453|CIT|cit
374240|NCT01350453|Stroke|stroke
374241|NCT01350427|leucine supplementation|leucine supplementation
374242|NCT01350427|BCCA supplementation|bcca supplementation
374243|NCT01350427|resistance exercise-induced muscle remodeling|resistance exercise-induced muscle remodeling
374244|NCT01350401|Melanoma|melanoma
374245|NCT01350401|Cell Therapy|cell therapy
374246|NCT01350401|T Cell Therapy|t cell therapy
374247|NCT01350401|NY-ESO-1|ny-eso-1
374248|NCT01350401|Immuno-oncology|immuno-oncology
374249|NCT01350401|Metastatic|metastatic
374250|NCT01350401|Previously treated|previously treated
374251|NCT01350401|T Cell Receptor|t cell receptor
374252|NCT01350388|Chronic Kidney Disease|chronic kidney disease
374253|NCT01350388|Diabetes|diabetes
374254|NCT01350388|Febuxostat|febuxostat
374255|NCT01350388|Inflammation|inflammation
374257|NCT01350362|tideglusib|tideglusib
374258|NCT01350362|Alzheimer|alzheimer
374259|NCT01350362|NP-12|np-12
374260|NCT01350362|NP031112|np031112
374261|NCT01350362|ARGO|argo
374262|NCT01350362|Noscira|noscira
374263|NCT01350349|Depression|depression
374264|NCT01350349|Dementia|dementia
374265|NCT01350349|Geriatrics|geriatrics
374266|NCT01350310|Heart failure|heart failure
374267|NCT01350310|Dilated cardiomyopathy|dilated cardiomyopathy
374268|NCT01350310|Stem cells|stem cells
374269|NCT01350297|tetraplegia|tetraplegia
374270|NCT01350297|reinnervation|reinnervation
374271|NCT01350297|phrenic nerve|phrenic nerve
374272|NCT01350284|Antioxidants|antioxidants
374273|NCT01350284|Glucose Intolerance prevention and control|glucose intolerance prevention and control
374274|NCT01350284|Diabetes Mellitus prevention and control|diabetes mellitus prevention and control
374275|NCT01350271|Hookworm|hookworm
374276|NCT01350271|Necator americanus|necator americanus
374277|NCT01350271|Mebendazole|mebendazole
374278|NCT01350258|allogeneic HSCT|allogeneic hsct
374279|NCT01350258|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
374280|NCT01350245|Acute Myeloid Leukemia|acute myeloid leukemia
374281|NCT01350245|Myelodysplastic Syndromes|myelodysplastic syndromes
374282|NCT01350245|Biphenotypic Leukemia|biphenotypic leukemia
374283|NCT01350245|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
374284|NCT01350245|Chronic Myeloid Leukemia|chronic myeloid leukemia
374285|NCT01350245|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
374286|NCT01350245|Plasma Cell Neoplasms|plasma cell neoplasms
374287|NCT01350245|Lymphoma|lymphoma
374288|NCT01350245|Hodgkin's Disease|hodgkin's disease
374289|NCT01350245|Aplastic Anemia|aplastic anemia
374290|NCT01350245|Hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
374291|NCT01350245|myeloablative haploidentical HSCT|myeloablative haploidentical hsct
374292|NCT01350245|graft versus host disease (GVHD)|graft versus host disease (gvhd)
374293|NCT01350232|sickle cell|sickle cell
374295|NCT01350232|SC disease|sc disease
374296|NCT01350232|S-thalassemia|s-thalassemia
374297|NCT01350232|transplant|transplant
374298|NCT01350232|bone marrow transplant|bone marrow transplant
374299|NCT01350232|stem cell transplant|stem cell transplant
374300|NCT01350232|matched sibling|matched sibling
374301|NCT01350232|haploidentical|haploidentical
374302|NCT01350232|hemoglobinopathy|hemoglobinopathy
374303|NCT01350232|anemia|anemia
374304|NCT01350232|desensitization|desensitization
374305|NCT01350219|Cord blood stem cells|cord blood stem cells
374306|NCT01350219|Immune modulation|immune modulation
374307|NCT01350219|Stem cell educator|stem cell educator
374308|NCT01350219|Autoimmunity|autoimmunity
374309|NCT01350219|Islet beta cell regeneration|islet beta cell regeneration
374310|NCT01350219|Type 1 diabetes|type 1 diabetes
374311|NCT01350206|Carcinoma,Hepatocellular|carcinoma,hepatocellular
374312|NCT01350206|Liver Neoplasms|liver neoplasms
374313|NCT01350206|Therapeutic|therapeutic
374314|NCT01350206|Chemoembolization,|chemoembolization,
374315|NCT01350206|TACE|tace
374316|NCT01350206|hepatic resection|hepatic resection
374317|NCT01350193|Manuka Honey|manuka honey
374318|NCT01350193|Irrigation|irrigation
374319|NCT01350193|Endoscopic Sinus Surgery|endoscopic sinus surgery
374320|NCT01350180|biochemical failure|biochemical failure
374321|NCT01350180|hormonal therapy|hormonal therapy
374322|NCT01350167|Hepatocellular Carcinoma|hepatocellular carcinoma
374323|NCT01350167|Liver Cancer|liver cancer
374324|NCT01350167|Ultrasound|ultrasound
374325|NCT01350167|Computed Tomography|computed tomography
374326|NCT01350167|Alpha fetoprotein|alpha fetoprotein
374327|NCT01350167|Cirrhosis|cirrhosis
374328|NCT01350167|Screening|screening
374329|NCT01350167|Advanced Liver Disease|advanced liver disease
374330|NCT01350154|clinical trial|clinical trial
374331|NCT01350154|sildenafil|sildenafil
374332|NCT01350154|revatio|revatio
374333|NCT01350154|muscular dystrophy|muscular dystrophy
374334|NCT01350154|adult|adult
374335|NCT01350154|nNOS|nnos
374336|NCT01350141|Hypercholesterolemia|hypercholesterolemia
374337|NCT01350141|dyslipidemia|dyslipidemia
374338|NCT01350141|high cholesterol|high cholesterol
374340|NCT01350141|antibody|antibody
374341|NCT01350141|PCSK9|pcsk9
374342|NCT01350141|PF-04950615|pf-04950615
374343|NCT01350141|RN316|rn316
374344|NCT01350128|COPD|copd
374345|NCT01350115|Basal Cell Carcinoma|basal cell carcinoma
374346|NCT01350115|Gorlin Syndrome,|gorlin syndrome,
374347|NCT01350115|Gorlin-Goltz Syndrome,|gorlin-goltz syndrome,
374348|NCT01350115|Basal Cell Nevus Syndrome,|basal cell nevus syndrome,
374349|NCT01350115|Nevoid Basal Cell Carcinoma Syndrome,|nevoid basal cell carcinoma syndrome,
374350|NCT01350115|Basal Cell Carcinoma Nevus Syndrome|basal cell carcinoma nevus syndrome
374351|NCT01350115|Smo inhibitor,|smo inhibitor,
374352|NCT01350115|Hedgehog pathway inhibitor|hedgehog pathway inhibitor
374353|NCT01350115|BCCs|bccs
374354|NCT01350102|Adult|adult
374355|NCT01350089|energy drinks|energy drinks
374356|NCT01350089|alcohol intoxication|alcohol intoxication
374357|NCT01350076|intraoperative fluid|intraoperative fluid
374358|NCT01350076|pediatric|pediatric
374359|NCT01350076|goal directed therapy|goal directed therapy
374360|NCT01350076|pediatric with major abdominal surgery|pediatric with major abdominal surgery
374361|NCT01350076|ASA less than or equal to 3|asa less than or equal to 3
374362|NCT01350076|Duration of surgery less than 2 hours|duration of surgery less than 2 hours
374363|NCT01350076|Body weight more than or equal to 15 kg|body weight more than or equal to 15 kg
374364|NCT01350063|water|water
374365|NCT01350063|tubewell|tubewell
374366|NCT01350063|diarrhea|diarrhea
374367|NCT01350063|chlorination|chlorination
374368|NCT01350063|safe storage|safe storage
374369|NCT01350050|topical pharyngeal anesthesia|topical pharyngeal anesthesia
374370|NCT01350050|articaine|articaine
374371|NCT01350037|patient-controlled sedation|patient-controlled sedation
374372|NCT01350037|propofol|propofol
374373|NCT01350037|alfentanil|alfentanil
374374|NCT01350037|remifentanil|remifentanil
374375|NCT01350037|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
374376|NCT01350024|Conjunctival Mullerectomy|conjunctival mullerectomy
374377|NCT01350024|Blepharoptosis|blepharoptosis
374378|NCT01350024|Ptosis surgery|ptosis surgery
374379|NCT01350024|Pain Control|pain control
374380|NCT01350011|Nicotine Replacement Therapy|nicotine replacement therapy
374381|NCT01350011|Buprenorphine|buprenorphine
374382|NCT01350011|Varenicline|varenicline
374383|NCT01350011|Smoking Cessation|smoking cessation
374384|NCT01350011|Addiction|addiction
374385|NCT01350011|The Innovative System (IS) Treatment|the innovative system (is) treatment
374386|NCT01350011|The Standard Treatment Control (STC)|the standard treatment control (stc)
374387|NCT01349985|Naltrexone|naltrexone
374388|NCT01349985|problem drinking|problem drinking
374389|NCT01349985|medication adherence|medication adherence
374390|NCT01349985|adherence|adherence
374391|NCT01349985|smartphone|smartphone
374392|NCT01349920|biological markers|biological markers
374394|NCT01349920|gastrointestinal|gastrointestinal
374395|NCT01349881|Eflornithine/sulindac prevention trial|eflornithine/sulindac prevention trial
374396|NCT01349868|COPD|copd
374397|NCT01349829|Hepatitis A|hepatitis a
374398|NCT01349829|Vaccination|vaccination
374399|NCT01349829|Immunity|immunity
374400|NCT01349816|COPD|copd
374401|NCT01349803|COPD|copd
374403|NCT01349790|Primary immune thrombocytopenia|primary immune thrombocytopenia
374404|NCT01349777|antiplatelet therapy post drug eluting stents|antiplatelet therapy post drug eluting stents
374405|NCT01349764|vitamin D replacement|vitamin d replacement
374406|NCT01349764|Urolithiasis|urolithiasis
374407|NCT01349764|deficiency|deficiency
374408|NCT01349764|insufficiency|insufficiency
374409|NCT01349751|abdominal incision|abdominal incision
374410|NCT01349751|hyperbaric|hyperbaric
374411|NCT01349751|isobaric|isobaric
374412|NCT01349751|levobupivacaine|levobupivacaine
374413|NCT01349751|spinal anaesthesia|spinal anaesthesia
374414|NCT01349725|Safety|safety
374415|NCT01349699|endotoxemia|endotoxemia
374416|NCT01349699|inflammation|inflammation
374417|NCT01349699|iron|iron
374418|NCT01349699|iron chelation|iron chelation
374419|NCT01349699|cytokines|cytokines
374420|NCT01349686|Food|food
374421|NCT01349686|Fluids|fluids
374422|NCT01349686|Labor|labor
374423|NCT01349673|Open-label|open-label
374424|NCT01349673|Proctitis|proctitis
374425|NCT01349673|Proctosigmoiditis|proctosigmoiditis
374426|NCT01349673|Ulcerative|ulcerative
374427|NCT01349673|Salix|salix
374428|NCT01349673|Budesonide foam|budesonide foam
374429|NCT01349673|Budesonide|budesonide
374430|NCT01349673|Rectal|rectal
374431|NCT01349673|Gastrointestinal|gastrointestinal
374432|NCT01349673|Colitis|colitis
374433|NCT01349673|UC|uc
374434|NCT01349673|UP|up
374435|NCT01349673|UPS|ups
374436|NCT01349673|Additional relevant MeSH terms:|additional relevant mesh terms:
374437|NCT01349673|Proctocolitis|proctocolitis
374438|NCT01349673|Ulcer|ulcer
374439|NCT01349673|Colitis, Ulcerative|colitis, ulcerative
374440|NCT01349673|Gastroenteritis|gastroenteritis
374441|NCT01349673|Gastrointestinal Diseases|gastrointestinal diseases
374442|NCT01349673|Digestive System Diseases|digestive system diseases
374443|NCT01349673|Rectal Diseases|rectal diseases
374444|NCT01349673|Intestinal Diseases|intestinal diseases
374445|NCT01349673|Colonic Diseases|colonic diseases
374446|NCT01349673|Sigmoid Diseases|sigmoid diseases
374447|NCT01349673|Pathologic Processes|pathologic processes
374448|NCT01349673|Inflammatory Bowel Diseases|inflammatory bowel diseases
374449|NCT01349673|Bronchodilator Agents|bronchodilator agents
374450|NCT01349673|Autonomic Agents|autonomic agents
374451|NCT01349673|Peripheral Nervous System Agents|peripheral nervous system agents
374452|NCT01349673|Physiological Effects of Drugs|physiological effects of drugs
374453|NCT01349673|Pharmacologic Actions|pharmacologic actions
374454|NCT01349673|Anti-Asthmatic Agents|anti-asthmatic agents
374455|NCT01349673|Respiratory System Agents|respiratory system agents
374456|NCT01349673|Therapeutic Uses|therapeutic uses
374457|NCT01349673|Glucocorticoids|glucocorticoids
374458|NCT01349673|Hormones|hormones
374459|NCT01349673|Hormones, Hormone Substitutes and Hormone Antagonists|hormones, hormone substitutes and hormone antagonists
374460|NCT01349673|Anti-inflammatory Agents|anti-inflammatory agents
374461|NCT01349660|Glioblastoma multiforme|glioblastoma multiforme
374462|NCT01349660|GBM|gbm
374463|NCT01349660|Bevacizumab|bevacizumab
374464|NCT01349660|PI3K Pathway|pi3k pathway
374465|NCT01349660|BKM120|bkm120
374466|NCT01349647|FUCOSYL-GM1-KLH|fucosyl-gm1-klh
374467|NCT01349647|GLOBO H-KLH CONJUGATE|globo h-klh conjugate
374468|NCT01349647|OPT-821|opt-821
374469|NCT01349647|POLYSIALIC ACID - KLH|polysialic acid - klh
374470|NCT01349647|Vaccine|vaccine
374471|NCT01349647|08-095|08-095
374472|NCT01349634|iodine|iodine
374473|NCT01349634|goiter|goiter
374474|NCT01349634|cretinism|cretinism
374475|NCT01349634|child nutrition|child nutrition
374476|NCT01349634|cognition|cognition
374477|NCT01349621|Abnormal Pap results|abnormal pap results
374478|NCT01349621|Colposcopy|colposcopy
374479|NCT01349608|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
374480|NCT01349608|Motivational Interviewing|motivational interviewing
374481|NCT01349608|Health Coaching|health coaching
374482|NCT01349608|Physical Activity|physical activity
374483|NCT01349582|flow diversion|flow diversion
374484|NCT01349582|endovascular treatment|endovascular treatment
374485|NCT01349582|symptomatic aneurysm|symptomatic aneurysm
374486|NCT01349582|cavernous carotid aneurysm|cavernous carotid aneurysm
374487|NCT01349582|ophthalmic aneurysm|ophthalmic aneurysm
374488|NCT01349582|vertebral aneurysm|vertebral aneurysm
374489|NCT01349556|cancer|cancer
374490|NCT01349556|chemotherapy|chemotherapy
374491|NCT01349556|EGFR inhibitors|egfr inhibitors
374492|NCT01349556|tretinoin|tretinoin
374493|NCT01349556|EGFRi drug rash|egfri drug rash
374494|NCT01349543|Respiratory syncytial virus|respiratory syncytial virus
374495|NCT01349543|RSV|rsv
374496|NCT01349543|Immunology|immunology
374500|NCT01349543|Viral lung disease|viral lung disease
374501|NCT01349530|Usual medical care|usual medical care
374502|NCT01349530|Anticoagulation by VKAs: COUMADINE® & PREVISCAN®|anticoagulation by vkas: coumadine® & previscan®
374503|NCT01349530|Anticoagulation clinic care, CREATIF|anticoagulation clinic care, creatif
374504|NCT01349517|health-related quality of life(HRQL)|health-related quality of life(hrql)
374505|NCT01349517|Esophageal Cancer|esophageal cancer
374506|NCT01349491|Atrial Fibrillation|atrial fibrillation
374508|NCT01349478|paraplegia|paraplegia
374509|NCT01349478|tetraplegia|tetraplegia
374510|NCT01349478|passive gait training|passive gait training
374511|NCT01349478|O2 consumption|o2 consumption
374512|NCT01349478|exercise capacity|exercise capacity
374513|NCT01349478|CVD risk factors|cvd risk factors
374514|NCT01349478|spasticity|spasticity
374515|NCT01349478|pain|pain
374516|NCT01349478|bladder, bowel|bladder, bowel
374517|NCT01349478|well being|well being
374518|NCT01349465|Hepatitis C|hepatitis c
374519|NCT01349465|Hepatitis|hepatitis
374520|NCT01349465|TMC435|tmc435
374521|NCT01349465|Liver disease|liver disease
374522|NCT01349465|Virus Infection|virus infection
374523|NCT01349452|Conjunctivitis, Viral|conjunctivitis, viral
374524|NCT01349452|Adenoviridae Infections|adenoviridae infections
374525|NCT01349452|Ganciclovir|ganciclovir
374526|NCT01349452|Adenovirus Keratoconjunctivitis|adenovirus keratoconjunctivitis
374527|NCT01349452|Treatment of viral conjunctivitis|treatment of viral conjunctivitis
374528|NCT01349426|Lung resection|lung resection
374529|NCT01349426|Parenchymal pneumostasis, haemostasis|parenchymal pneumostasis, haemostasis
374530|NCT01349426|Fissure closure|fissure closure
374531|NCT01349426|Automatic staplers,LigaSure, Force Triad Generator|automatic staplers,ligasure, force triad generator
374532|NCT01349426|Bipolar fusion|bipolar fusion
374533|NCT01349426|Procedure cost|procedure cost
374534|NCT01349413|Functional dyspepsia|functional dyspepsia
374535|NCT01349413|symptom response|symptom response
374536|NCT01349413|postprandial fullness|postprandial fullness
374537|NCT01349413|gastroesophageal reflux disease|gastroesophageal reflux disease
374538|NCT01349413|acid suppression|acid suppression
374539|NCT01349400|asymptomatic|asymptomatic
374540|NCT01349400|minimally symptomatic|minimally symptomatic
374541|NCT01349348|Tolvaptan treatment to ascites and hepatic cirrhosis|tolvaptan treatment to ascites and hepatic cirrhosis
374542|NCT01349322|stage IA breast cancer|stage ia breast cancer
374543|NCT01349322|stage IB breast cancer|stage ib breast cancer
374544|NCT01349322|stage II breast cancer|stage ii breast cancer
374545|NCT01349322|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
374546|NCT01349322|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
374547|NCT01349322|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
374548|NCT01349322|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
374549|NCT01349322|ductal breast carcinoma in situ|ductal breast carcinoma in situ
374550|NCT01349309|Prophylactic Swallowing Exercises|prophylactic swallowing exercises
376235|NCT01342575|ACDF|acdf
374551|NCT01349309|Head and Neck Cancer|head and neck cancer
374552|NCT01349309|Dysphagia|dysphagia
374553|NCT01349296|Solid Tumors|solid tumors
374554|NCT01349283|Hepatitis B Vaccine|hepatitis b vaccine
374555|NCT01349283|Hepatitis B Virus|hepatitis b virus
374556|NCT01349283|Antigen|antigen
374557|NCT01349283|Antibody|antibody
374558|NCT01349283|Vaccination|vaccination
374559|NCT01349270|chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy
374560|NCT01349270|immunoglobulin|immunoglobulin
374561|NCT01349270|prednisone|prednisone
374562|NCT01349257|Asthmatic patients|asthmatic patients
374563|NCT01349244|hydronephrosis|hydronephrosis
374564|NCT01349244|CT|ct
374565|NCT01349244|POC US|poc us
374566|NCT01349231|obsessive-compulsive disorder|obsessive-compulsive disorder
374567|NCT01349231|ketamine|ketamine
374568|NCT01349231|glutamate|glutamate
374569|NCT01349218|Potassium|potassium
374570|NCT01349218|Infants|infants
374571|NCT01349218|Heel Stick|heel stick
374572|NCT01349218|Less than or equal to 6 months of age|less than or equal to 6 months of age
374573|NCT01349218|IV catheter blood samples|iv catheter blood samples
374574|NCT01349218|perioperatively|perioperatively
374575|NCT01349218|elective surgical procedures|elective surgical procedures
374576|NCT01349205|OSA|osa
374577|NCT01349205|Caffeine|caffeine
374578|NCT01349205|Tonsillectomy|tonsillectomy
374579|NCT01349205|Adenoidectomy|adenoidectomy
374580|NCT01349205|Sleep Study|sleep study
374581|NCT01349192|MRSA|mrsa
374582|NCT01349192|Cystic Fibrosis|cystic fibrosis
374583|NCT01349192|Early Infection|early infection
374584|NCT01349192|Treatment|treatment
374585|NCT01349179|Hip|hip
374586|NCT01349179|Arthroplasty|arthroplasty
374587|NCT01349179|Metal on metal|metal on metal
365313|NCT01387997|HPV|hpv
589382|NCT00528164|children|children
374588|NCT01349179|operated on 2002|operated on 2002
374589|NCT01349166|Obesity|obesity
374590|NCT01349166|Type 2 diabetes|type 2 diabetes
374591|NCT01349166|glucose intolerance|glucose intolerance
374592|NCT01349166|Physical Activity|physical activity
374593|NCT01349166|Inflammation|inflammation
374594|NCT01349166|HPA axis|hpa axis
374595|NCT01349166|Cytokines|cytokines
374596|NCT01349153|Physical Activity|physical activity
374597|NCT01349153|Young Adults|young adults
374598|NCT01349153|Cancer Survivors|cancer survivors
374599|NCT01349127|Vitamin D|vitamin d
374600|NCT01349127|Cholecalciferol|cholecalciferol
374601|NCT01349127|Nutrient requirements|nutrient requirements
374602|NCT01349127|Randomised Controlled Trial|randomised controlled trial
374603|NCT01349127|Lactation|lactation
374604|NCT01349127|pregnancy|pregnancy
374605|NCT01349127|Cord blood|cord blood
374606|NCT01349127|Human milk|human milk
374607|NCT01349127|serum 25-hydroxyvitamin D|serum 25-hydroxyvitamin d
374608|NCT01349127|deficiency|deficiency
374609|NCT01349127|insufficiency|insufficiency
374610|NCT01349127|nutrition|nutrition
374611|NCT01349114|aliskiren|aliskiren
374612|NCT01349114|endothelial function|endothelial function
374613|NCT01349114|hypertension|hypertension
374614|NCT01349101|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
374615|NCT01349101|HSCT|hsct
374616|NCT01349101|allogeneic marrow transplantation|allogeneic marrow transplantation
374617|NCT01349101|cyclophosphamide|cyclophosphamide
374618|NCT01349101|graft-versus-host disease|graft-versus-host disease
374619|NCT01349101|GVHD|gvhd
374620|NCT01349088|breast cancer|breast cancer
374621|NCT01349088|metastatic breast cancer|metastatic breast cancer
374622|NCT01349088|stage IV breast cancer|stage iv breast cancer
374623|NCT01349088|motesanib|motesanib
374624|NCT01349088|ixabepilone|ixabepilone
374625|NCT01349088|capecitabine|capecitabine
374626|NCT01349075|Unresectable|unresectable
374627|NCT01349075|Hepatocellular Carcinoma|hepatocellular carcinoma
374628|NCT01349075|TheraSphere|therasphere
374629|NCT01349075|Yttrium-90|yttrium-90
374630|NCT01349062|Prolonged Viral Suppression|prolonged viral suppression
374631|NCT01349062|HIV Infections|hiv infections
374633|NCT01349049|relapsed|relapsed
374634|NCT01349049|refractory|refractory
374636|NCT01349036|Glioblastoma|glioblastoma
374637|NCT01349036|brain cancer|brain cancer
374638|NCT01349023|energy content|energy content
374639|NCT01349023|energy density|energy density
374640|NCT01349023|energy intake|energy intake
374641|NCT01349023|pre-portioned entrees|pre-portioned entrees
374642|NCT01349010|hyperlipidemia|hyperlipidemia
374643|NCT01348997|cancer|cancer
374644|NCT01348997|cancer survivors|cancer survivors
374645|NCT01348997|internet|internet
374646|NCT01348997|depression|depression
374647|NCT01348997|anxiety|anxiety
374648|NCT01348984|postoperative|postoperative
374649|NCT01348984|pain score|pain score
374650|NCT01348984|morphine consumption|morphine consumption
374651|NCT01348971|sodium nitrate|sodium nitrate
374652|NCT01348971|coronary artery bypass surgery|coronary artery bypass surgery
374653|NCT01348971|ischemia-reperfusion|ischemia-reperfusion
374654|NCT01348971|myocardial injury|myocardial injury
374655|NCT01348958|Patello femoral|patello femoral
376442|NCT01341548|Nasal|nasal
374656|NCT01348958|osteoarthritis|osteoarthritis
374657|NCT01348958|arthroplasty|arthroplasty
374658|NCT01348945|Partial tear ACL|partial tear acl
374659|NCT01348945|Stump preserved ACL surgery|stump preserved acl surgery
374660|NCT01348932|asthma|asthma
374661|NCT01348932|Chitinase 3-like 1 (CHI3L1)|chitinase 3-like 1 (chi3l1)
374662|NCT01348932|YKL-40|ykl-40
374663|NCT01348932|single nucleotide polymorphism(SNP)|single nucleotide polymorphism(snp)
374664|NCT01348932|Real time PCR|real time pcr
374665|NCT01348932|gene|gene
374666|NCT01348919|Cancer|cancer
374667|NCT01348919|Multiple myeloma|multiple myeloma
374668|NCT01348919|CEP-18770|cep-18770
374669|NCT01348919|Lenalidomide|lenalidomide
374670|NCT01348919|Dexamethasone|dexamethasone
374671|NCT01348906|cardiopulmonary bypass|cardiopulmonary bypass
374672|NCT01348893|Mental health|mental health
374673|NCT01348893|Education|education
374674|NCT01348893|Mind Body Therapies|mind body therapies
374675|NCT01348880|drug-drug interaction|drug-drug interaction
374676|NCT01348867|Diabetes|diabetes
374677|NCT01348867|Structured Care|structured care
374678|NCT01348854|astigmatism|astigmatism
374679|NCT01348841|community wound care|community wound care
374680|NCT01348841|systematic wound team referral|systematic wound team referral
374681|NCT01348841|Advanced in-home nurse wound training|advanced in-home nurse wound training
374682|NCT01348828|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
374683|NCT01348828|Fenestrated|fenestrated
374684|NCT01348828|Renal Stent|renal stent
374685|NCT01348828|Juxtarenal|juxtarenal
374686|NCT01348828|Pararenal|pararenal
374687|NCT01348828|Endologix|endologix
374688|NCT01348828|Renal|renal
374689|NCT01348802|Knowledge Translation|knowledge translation
374690|NCT01348802|Push-out Evidence|push-out evidence
374691|NCT01348802|Technology-Based Knowledge Translation|technology-based knowledge translation
374692|NCT01348802|Pain|pain
374693|NCT01348802|Interdisciplinary|interdisciplinary
374694|NCT01348802|Physician|physician
374695|NCT01348802|Rehabilitation|rehabilitation
374696|NCT01348802|Nursing|nursing
374697|NCT01348802|Knowledge Uptake|knowledge uptake
374698|NCT01348789|Hair removal|hair removal
374699|NCT01348789|Hair Clearance|hair clearance
374700|NCT01348789|Epilation|epilation
374701|NCT01348776|hair reduction|hair reduction
374702|NCT01348776|hair removal|hair removal
374703|NCT01348776|hair clearance|hair clearance
374704|NCT01348750|PTSD|ptsd
374705|NCT01348750|Healing Touch|healing touch
374706|NCT01348750|Guided Imagery|guided imagery
374707|NCT01348750|Military|military
374708|NCT01348750|Complementary Medicine|complementary medicine
374709|NCT01348737|Phase 1|phase 1
374710|NCT01348737|healthy volunteers|healthy volunteers
374711|NCT01348737|double-blind|double-blind
374712|NCT01348737|placebo-controlled|placebo-controlled
374713|NCT01348737|AZD3839|azd3839
374714|NCT01348737|pharmacokinetics|pharmacokinetics
374715|NCT01348737|Alzheimer's Disease|alzheimer's disease
374716|NCT01348724|Radioactive carbon|radioactive carbon
374717|NCT01348724|Absorption|absorption
374718|NCT01348724|Distribution|distribution
374719|NCT01348724|Metabolism|metabolism
374720|NCT01348724|Excretion|excretion
374721|NCT01348724|Healthy Volunteers|healthy volunteers
374722|NCT01348711|Pre-eclampsia|pre-eclampsia
374723|NCT01348698|Adrenal Cancer|adrenal cancer
374724|NCT01348698|Pheochromocytoma|pheochromocytoma
374725|NCT01348698|Functioning Tumor|functioning tumor
374726|NCT01348698|Nonfunctioning Tumor|nonfunctioning tumor
374727|NCT01348698|Gene Expression|gene expression
374728|NCT01348698|Adrenal Tumor|adrenal tumor
374729|NCT01348672|Age related macular degeneration|age related macular degeneration
374730|NCT01348672|Glaucoma|glaucoma
374731|NCT01348672|Diabetic retinopathy|diabetic retinopathy
374732|NCT01348672|Retinal oxygen saturation|retinal oxygen saturation
374733|NCT01348672|Blood flow|blood flow
374734|NCT01348672|Vascular function|vascular function
374735|NCT01348672|High resolution imaging|high resolution imaging
374736|NCT01348659|Hypertonic saline|hypertonic saline
374737|NCT01348659|Extracellular fluid|extracellular fluid
374738|NCT01348659|cardiopulmonary bypass|cardiopulmonary bypass
374739|NCT01348646|Smoking|smoking
374740|NCT01348646|Adolescence|adolescence
374741|NCT01348646|Brief intervention|brief intervention
374742|NCT01348633|Doppler SD-OCT Blood Flow Technology|doppler sd-oct blood flow technology
374743|NCT01348633|Retinal and choroidal blood flow|retinal and choroidal blood flow
374744|NCT01348633|Canon Laser Blood Flowmeter|canon laser blood flowmeter
374745|NCT01348620|single port cholecystectomy|single port cholecystectomy
374746|NCT01348607|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
374747|NCT01348607|sleep disorders|sleep disorders
374748|NCT01348607|fatigue|fatigue
374749|NCT01348607|childhood craniopharyngioma|childhood craniopharyngioma
374750|NCT01348594|Vitamin D|vitamin d
374751|NCT01348594|In vitro Fertilization|in vitro fertilization
374752|NCT01348581|Adult|adult
374753|NCT01348581|Aged|aged
374754|NCT01348581|Aged, 80 and over|aged, 80 and over
374755|NCT01348581|Bandages|bandages
374756|NCT01348581|Biological Dressings|biological dressings
374757|NCT01348581|Chronic Disease|chronic disease
374758|NCT01348581|Collagen|collagen
374759|NCT01348581|Epithelium|epithelium
374760|NCT01348581|Extracellular Matrix|extracellular matrix
374761|NCT01348581|Fibroblasts|fibroblasts
374762|NCT01348581|Granulation Tissue|granulation tissue
374763|NCT01348581|Humans|humans
374764|NCT01348581|Leg Ulcer|leg ulcer
374765|NCT01348581|Middle Aged|middle aged
374766|NCT01348581|Prospective Studies|prospective studies
374767|NCT01348581|Soft Tissue Injuries|soft tissue injuries
374768|NCT01348581|Treatment Outcome|treatment outcome
374769|NCT01348581|Varicose Ulcer|varicose ulcer
374770|NCT01348581|Wound Healing|wound healing
374771|NCT01348581|Wounds and Injuries|wounds and injuries
374772|NCT01348555|COPD|copd
374773|NCT01348542|Chronic Insomnia|chronic insomnia
374774|NCT01348542|Short Sleep Duration|short sleep duration
374775|NCT01348542|Trazodone|trazodone
374776|NCT01348542|Cognitive Behavioral Therapy|cognitive behavioral therapy
374777|NCT01348542|Efficacy|efficacy
374778|NCT01348529|OCD|ocd
374779|NCT01348529|CBT|cbt
374780|NCT01348529|Reducing OCD symptoms|reducing ocd symptoms
374781|NCT01348516|HIV|hiv
374782|NCT01348490|PMF|pmf
374783|NCT01348490|PPV-MF|ppv-mf
374784|NCT01348490|PET-MF|pet-mf
374785|NCT01348477|inguinal|inguinal
374786|NCT01348477|hernia|hernia
374787|NCT01348477|pain|pain
374788|NCT01348477|inguinodynia|inguinodynia
374789|NCT01348477|mesh|mesh
374790|NCT01348464|appendectomy|appendectomy
374791|NCT01348464|appendicitis|appendicitis
374792|NCT01348464|laparoscopic surgery|laparoscopic surgery
374402|NCT01349790|ITP|itp
589383|NCT00528164|overweight|overweight
374793|NCT01348451|Human spinal cord derived neural stem cell transplantation|human spinal cord derived neural stem cell transplantation
374795|NCT01348438|high risk|high risk
374796|NCT01348438|surgical valve replacement|surgical valve replacement
374797|NCT01348425|PAD|pad
374798|NCT01348412|non resectable metastases|non resectable metastases
374799|NCT01348412|liver of colic or rectal origin|liver of colic or rectal origin
374800|NCT01348412|after failure of the conventional treatments|after failure of the conventional treatments
374801|NCT01348399|Coronary artery disease requiring drug eluting stents|coronary artery disease requiring drug eluting stents
374802|NCT01348386|Potassium hydroxide.|potassium hydroxide.
374803|NCT01348386|Molluscum Contagiosum|molluscum contagiosum
374804|NCT01348373|drug eluting stents|drug eluting stents
374805|NCT01348334|Sling surgery|sling surgery
374806|NCT01348334|synthetic meshes|synthetic meshes
374807|NCT01348334|ultrapromesh®|ultrapromesh®
374808|NCT01348334|mix mesh|mix mesh
374809|NCT01348334|incontinence|incontinence
374907|NCT01347944|Monitoring Revlimid|monitoring revlimid
374908|NCT01347944|Myelodysplastic Syndrome|myelodysplastic syndrome
375105|NCT01347216|Bosentan|bosentan
374810|NCT01348334|The Ultrapromesh® synthetic sling procedures have lower complications incidence and higher success rates than the other synthetic slings in 3-year follow-up.|the ultrapromesh® synthetic sling procedures have lower complications incidence and higher success rates than the other synthetic slings in 3-year follow-up.
374811|NCT01348308|Late diagnosed HIV-1 infected patients|late diagnosed hiv-1 infected patients
374812|NCT01348308|AIDS-defining events|aids-defining events
374813|NCT01348308|Immune restoration|immune restoration
374814|NCT01348295|Mechanical ventilation|mechanical ventilation
374815|NCT01348295|Children|children
374816|NCT01348295|Neonates|neonates
374817|NCT01348295|Pediatric intensive care|pediatric intensive care
374818|NCT01348282|Neurocognitive Impairment|neurocognitive impairment
374819|NCT01348282|Controlled Randomized Trial|controlled randomized trial
374820|NCT01348282|Coadjunctive Treatments|coadjunctive treatments
374821|NCT01348282|Lithium; Rivastigmine|lithium; rivastigmine
374822|NCT01348282|Antiretroviral Therapy|antiretroviral therapy
374823|NCT01348282|HIV Infection|hiv infection
374824|NCT01348269|bone marrow edema|bone marrow edema
374825|NCT01348269|Aclasta|aclasta
374826|NCT01348256|colorectal carcinoma|colorectal carcinoma
374827|NCT01348256|resectable hepatic metastasis|resectable hepatic metastasis
374828|NCT01348256|adjuvant treatment|adjuvant treatment
374829|NCT01348256|dendritic cells|dendritic cells
374830|NCT01348230|Premature prolonged rupture of membranes|premature prolonged rupture of membranes
374831|NCT01348230|Premature labor|premature labor
374832|NCT01348230|Uromodulin|uromodulin
374833|NCT01348230|Glycosylation|glycosylation
374834|NCT01348217|unoperated cancers|unoperated cancers
374835|NCT01348217|oesophagus|oesophagus
374836|NCT01348217|radiochemotherapy|radiochemotherapy
374837|NCT01348217|with and without increased doses|with and without increased doses
374838|NCT01348204|Cystic Fibrosis|cystic fibrosis
374839|NCT01348191|Thyrotrophin|thyrotrophin
374840|NCT01348191|Pregnancy|pregnancy
374841|NCT01348191|Human myometrium|human myometrium
374842|NCT01348191|Relaxation|relaxation
374843|NCT01348191|Contractility|contractility
374844|NCT01348152|Gastric Emptying|gastric emptying
374845|NCT01348139|Asthma|asthma
374846|NCT01348139|patients|patients
374847|NCT01348139|lung function|lung function
374848|NCT01348126|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
374849|NCT01348126|NSCLC|nsclc
374850|NCT01348126|Lung cancer|lung cancer
374851|NCT01348113|Alcohol Use Disorders Identification Test|alcohol use disorders identification test
374852|NCT01348113|alcohol dependence|alcohol dependence
374853|NCT01348113|Alcohol problem|alcohol problem
374854|NCT01348100|Schizophrenia|schizophrenia
374855|NCT01348100|Iloperidone|iloperidone
374857|NCT01348100|Injection|injection
374858|NCT01348087|Fragile X Syndrome|fragile x syndrome
374859|NCT01348087|Martin-Bell Syndrome|martin-bell syndrome
374860|NCT01348087|Genetic Diseases|genetic diseases
374861|NCT01348087|X-Linked|x-linked
374862|NCT01348087|Escalante's syndrome|escalante's syndrome
374863|NCT01348074|warfarin|warfarin
374864|NCT01348074|surgery|surgery
374865|NCT01348074|management|management
374866|NCT01348074|thromboembolism|thromboembolism
374867|NCT01348074|bleeding|bleeding
374868|NCT01348061|Alzheimers Disease|alzheimers disease
374869|NCT01348061|Progressive Supranuclear Palsy|progressive supranuclear palsy
374870|NCT01348061|CSF|csf
374871|NCT01348061|Cerebrospinal Fluid|cerebrospinal fluid
374872|NCT01348061|Biomarker|biomarker
374873|NCT01348061|Heavy Water|heavy water
374874|NCT01348061|Cargo proteins|cargo proteins
374875|NCT01348048|palliative care|palliative care
374876|NCT01348048|end-of-life care|end-of-life care
374877|NCT01348048|randomized clinical trial|randomized clinical trial
374878|NCT01348048|quality of life|quality of life
374879|NCT01348048|needs assessment|needs assessment
374880|NCT01348048|patient satisfaction|patient satisfaction
374881|NCT01348048|cost-effectiveness|cost-effectiveness
374882|NCT01348048|Screening|screening
374883|NCT01348035|Autosomal Dominant Polycystic Kidney Disease.|autosomal dominant polycystic kidney disease.
374884|NCT01348035|Arginine vasopressin|arginine vasopressin
374885|NCT01348035|Total Kidney Volume|total kidney volume
374886|NCT01348035|Glomerular Filtration Rate|glomerular filtration rate
374887|NCT01348009|Gastric cancer|gastric cancer
374888|NCT01348009|First-line therapy|first-line therapy
374889|NCT01348009|Tesetaxel|tesetaxel
374890|NCT01348009|Taxane|taxane
374891|NCT01348009|Capecitabine|capecitabine
374892|NCT01348009|Oral fluoropyrimidine|oral fluoropyrimidine
374893|NCT01348009|Cisplatin|cisplatin
374894|NCT01348009|Platinum|platinum
374895|NCT01347996|AML|aml
374896|NCT01347996|Leukemia|leukemia
374897|NCT01347996|Acute Myeloid Leukemia|acute myeloid leukemia
374898|NCT01347996|Minimal Residual Disease|minimal residual disease
374899|NCT01347996|Ceplene|ceplene
374900|NCT01347996|Histamine|histamine
374901|NCT01347996|interleukin 2|interleukin 2
374902|NCT01347983|RA|ra
374903|NCT01347970|childhood cancer survivor|childhood cancer survivor
374904|NCT01347970|CHF|chf
374905|NCT01347970|risk of congestive heart failure|risk of congestive heart failure
374906|NCT01347944|MORE|more
374909|NCT01347944|Transfusion-dependent anemia|transfusion-dependent anemia
374910|NCT01347944|5q deletion|5q deletion
374911|NCT01347944|lenalidomide|lenalidomide
374912|NCT01347918|Fluorine MRI, small intestinal transit and motor activity|fluorine mri, small intestinal transit and motor activity
374913|NCT01347892|Talar injury|talar injury
374914|NCT01347892|ankle|ankle
374915|NCT01347892|lesion|lesion
374916|NCT01347892|defect|defect
374917|NCT01347892|cartilage repair|cartilage repair
374918|NCT01347879|Acne vulgaris|acne vulgaris
374919|NCT01347879|PDT|pdt
374920|NCT01347866|Advanced metastatic cancer (solid tumors)|advanced metastatic cancer (solid tumors)
374921|NCT01347866|PI3K|pi3k
374922|NCT01347866|mTOR|mtor
374923|NCT01347866|MEK|mek
374924|NCT01347840|Obesity Gastric Bypass Roux en Y|obesity gastric bypass roux en y
374925|NCT01347827|Coronary artery bypass surgery|coronary artery bypass surgery
374926|NCT01347827|Oximetry|oximetry
374927|NCT01347827|Brain metabolism|brain metabolism
374928|NCT01347814|Domperidone|domperidone
374929|NCT01347814|gastric emptying|gastric emptying
374930|NCT01347814|obesity|obesity
374931|NCT01347814|diabetes mellitus|diabetes mellitus
374932|NCT01347814|Domperidone/pharmacology|domperidone/pharmacology
374933|NCT01347814|Pharmacologic Actions|pharmacologic actions
374934|NCT01347814|Physiological Effects of Drugs|physiological effects of drugs
374935|NCT01347814|Gastrointestinal Agents|gastrointestinal agents
374936|NCT01347814|Humans|humans
374937|NCT01347801|GLP-1|glp-1
374938|NCT01347801|Inflammation|inflammation
374939|NCT01347801|Glucose|glucose
374940|NCT01347788|Prostate cancer|prostate cancer
374941|NCT01347788|Castration Resistant|castration resistant
374942|NCT01347788|Bone Metastases|bone metastases
374943|NCT01347775|Renal failure|renal failure
374944|NCT01347775|Respiratory muscles|respiratory muscles
374945|NCT01347775|Resistance training|resistance training
374946|NCT01347762|cannabis dependence|cannabis dependence
374947|NCT01347762|marijuana dependence|marijuana dependence
374948|NCT01347762|cannabis use disorders|cannabis use disorders
374949|NCT01347762|cannabis withdrawal|cannabis withdrawal
374950|NCT01347762|nabilone|nabilone
374951|NCT01347749|Meditation|meditation
374952|NCT01347749|Mindfulness|mindfulness
374953|NCT01347749|Compassion|compassion
374954|NCT01347749|Group Psychotherapy|group psychotherapy
374955|NCT01347749|Emotional Regulation|emotional regulation
374956|NCT01347749|fMRI|fmri
374957|NCT01347710|Coronary Artery Disease.|coronary artery disease.
374958|NCT01347710|Positron Emission Tomography Myocardial Perfusion Imaging.|positron emission tomography myocardial perfusion imaging.
374959|NCT01347710|Single Positron Emission Computed Tomography.|single positron emission computed tomography.
374960|NCT01347710|Flurpiridaz F18 Injection.|flurpiridaz f18 injection.
374961|NCT01347697|rectal neoplasms|rectal neoplasms
374962|NCT01347697|reconstructive surgical procedure|reconstructive surgical procedure
374963|NCT01347697|bioprosthesis|bioprosthesis
374964|NCT01347697|surgical flaps|surgical flaps
374965|NCT01347697|locomotion|locomotion
374966|NCT01347697|lesser pelvis|lesser pelvis
374967|NCT01347684|headache|headache
374968|NCT01347684|elavil|elavil
374969|NCT01347684|splints|splints
374970|NCT01347684|physical therapy|physical therapy
374971|NCT01347684|behavioral therapy|behavioral therapy
374972|NCT01347671|analgesia|analgesia
374973|NCT01347671|analgesics|analgesics
374974|NCT01347671|pain|pain
374975|NCT01347671|chronic pain|chronic pain
374976|NCT01347671|neuropathic pain|neuropathic pain
374977|NCT01347658|etravirine|etravirine
374978|NCT01347658|Echinacea purpurea|echinacea purpurea
374979|NCT01347658|interaction|interaction
374980|NCT01347645|locally advanced|locally advanced
374981|NCT01347645|metastatic colon|metastatic colon
374982|NCT01347645|rectal cancer|rectal cancer
374983|NCT01347632|Bacterial Vaginosis|bacterial vaginosis
374984|NCT01347632|Vaginal discharge|vaginal discharge
374985|NCT01347632|Vaginal infections|vaginal infections
374986|NCT01347619|Comparative Effectiveness Research Summary Guide (CERSG)|comparative effectiveness research summary guide (cersg)
374987|NCT01347619|anti-psychotic use|anti-psychotic use
374988|NCT01347619|Nursing Home|nursing home
374989|NCT01347619|Long-term care|long-term care
374990|NCT01347619|Qualitative assessment of influences on CERSG adoption in NH|qualitative assessment of influences on cersg adoption in nh
374991|NCT01347619|Development of toolkit of CERSG-based products for NHs|development of toolkit of cersg-based products for nhs
374992|NCT01347619|Evaluation of 3 implementation strategies of the toolkit|evaluation of 3 implementation strategies of the toolkit
374993|NCT01347606|thyroid|thyroid
374994|NCT01347606|secure|secure
374995|NCT01347606|surgery|surgery
374996|NCT01347606|methylene|methylene
374997|NCT01347606|blue|blue
374998|NCT01347593|ceftizoxime|ceftizoxime
374999|NCT01347593|Cesarean|cesarean
375000|NCT01347593|post caesarean febrile morbidity|post caesarean febrile morbidity
375001|NCT01347580|Heart attack|heart attack
375002|NCT01347580|heart disease|heart disease
375003|NCT01347580|cardiovascular disease|cardiovascular disease
375004|NCT01347580|stroke|stroke
375005|NCT01347580|reperfusion|reperfusion
375006|NCT01347580|pre hospital settings|pre hospital settings
375007|NCT01347580|ticagrelor|ticagrelor
375008|NCT01347580|Percutaneous Coronary Intervention|percutaneous coronary intervention
375009|NCT01347567|Fingerstick BNP test|fingerstick bnp test
375010|NCT01347567|Home Health Management System|home health management system
375011|NCT01347567|Acute Decompensated Heart Failure|acute decompensated heart failure
375012|NCT01347567|Hospital Readmission|hospital readmission
375013|NCT01347567|Prevention|prevention
375014|NCT01347554|drug-eluting stent|drug-eluting stent
375015|NCT01347554|everolimus|everolimus
375016|NCT01347554|zotarolimus|zotarolimus
375017|NCT01347554|myocardial ischemia|myocardial ischemia
375018|NCT01347554|cardiovascular diseases|cardiovascular diseases
375019|NCT01347554|MACE|mace
375020|NCT01347554|safety|safety
375021|NCT01347541|PTSD|ptsd
375022|NCT01347528|Medication adherence|medication adherence
375023|NCT01347528|Heart failure|heart failure
375024|NCT01347528|Telemonitoring|telemonitoring
375025|NCT01347528|Determinants of adherence|determinants of adherence
375026|NCT01347515|Phenol-enriched olive oil|phenol-enriched olive oil
375027|NCT01347515|bioavailability|bioavailability
375028|NCT01347515|bioactivity|bioactivity
375029|NCT01347489|gender|gender
375030|NCT01347476|prostate-specific antigen|prostate-specific antigen
375031|NCT01347476|radical prostatectomy|radical prostatectomy
375032|NCT01347450|Flavonoids|flavonoids
375033|NCT01347450|cacao|cacao
375034|NCT01347450|lipid peroxidation|lipid peroxidation
375035|NCT01347450|plasma|plasma
375036|NCT01347437|HIV|hiv
375037|NCT01347437|antiretroviral medication|antiretroviral medication
375038|NCT01347437|adherence|adherence
375039|NCT01347437|adolescent|adolescent
375040|NCT01347424|NSCLC|nsclc
375041|NCT01347424|NPC|npc
375042|NCT01347398|Sleep apnoea|sleep apnoea
375043|NCT01347398|Diagnosis|diagnosis
375044|NCT01347398|Blood pressure|blood pressure
375045|NCT01347398|Body mass index|body mass index
375046|NCT01347398|Breath analysis|breath analysis
375047|NCT01347385|Fibroids|fibroids
375048|NCT01347385|Laparoscopic myomectomy|laparoscopic myomectomy
375049|NCT01347385|Barbed suture|barbed suture
375050|NCT01347372|peer support|peer support
375051|NCT01347372|peer mentoring|peer mentoring
375052|NCT01347372|peer counselling|peer counselling
375053|NCT01347372|arthritis|arthritis
375054|NCT01347372|chronic disease|chronic disease
375055|NCT01347372|inflammatory arthritis|inflammatory arthritis
375056|NCT01347372|early inflammatory arthritis|early inflammatory arthritis
375057|NCT01347372|rheumatoid arthritis|rheumatoid arthritis
375058|NCT01347359|Peer support|peer support
375059|NCT01347359|Peer mentoring|peer mentoring
375060|NCT01347359|Peer counselling|peer counselling
375061|NCT01347359|Arthritis|arthritis
375062|NCT01347359|Inflammatory arthritis|inflammatory arthritis
375063|NCT01347359|Early inflammatory arthritis|early inflammatory arthritis
375064|NCT01347359|Rheumatoid arthritis|rheumatoid arthritis
375065|NCT01347359|Chronic disease|chronic disease
375066|NCT01347346|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
375067|NCT01347346|Primary immune deficiency|primary immune deficiency
375068|NCT01347346|ex vivo gene therapy|ex vivo gene therapy
375069|NCT01347346|hematopoietic stem cells|hematopoietic stem cells
375070|NCT01347333|liver metastases|liver metastases
375071|NCT01347333|stereotactic radiosurgery|stereotactic radiosurgery
375072|NCT01347320|Prostate cancer|prostate cancer
375073|NCT01347320|preoperative staging|preoperative staging
375074|NCT01347320|MRI|mri
375075|NCT01347320|Free surgical margins|free surgical margins
375076|NCT01347307|stereotactic radiotherapy|stereotactic radiotherapy
375077|NCT01347307|spinal metastases|spinal metastases
458684|NCT00021541|NF1|nf1
365840|NCT01385917|MRI|mri
375078|NCT01347307|vertebral metastases|vertebral metastases
375079|NCT01347307|benign spinal tumors|benign spinal tumors
375080|NCT01347281|Cancer of the Head and Neck|cancer of the head and neck
375081|NCT01347281|[18F]HX4|[18f]hx4
375082|NCT01347281|hypoxia|hypoxia
375083|NCT01347281|PET|pet
375084|NCT01347281|phase II trial|phase ii trial
375085|NCT01347268|coasting|coasting
375086|NCT01347268|withdrawing GnRH agonist|withdrawing gnrh agonist
375087|NCT01347268|GnRH antagonist|gnrh antagonist
375088|NCT01347268|IVF|ivf
375089|NCT01347242|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
375090|NCT01347242|Primary immune deficiency|primary immune deficiency
375091|NCT01347242|ex vivo gene therapy|ex vivo gene therapy
375092|NCT01347242|hematopoietic stem cells|hematopoietic stem cells
375093|NCT01347229|Glaucoma|glaucoma
375094|NCT01347229|Triggerfish|triggerfish
375095|NCT01347229|body position|body position
375096|NCT01347216|Drug treatment|drug treatment
375097|NCT01347216|Treatment pathways|treatment pathways
375098|NCT01347216|Clinical routine|clinical routine
375099|NCT01347216|Registry|registry
375100|NCT01347216|Treatment outcomes|treatment outcomes
375101|NCT01347216|Endothelin receptor antagonist|endothelin receptor antagonist
375102|NCT01347216|Phosphodiesterase-V inhibitor|phosphodiesterase-v inhibitor
375103|NCT01347216|Prostanoid|prostanoid
375104|NCT01347216|Sildenafil|sildenafil
375106|NCT01347216|Macitentan|macitentan
375107|NCT01347216|Sitaxentan|sitaxentan
375108|NCT01347216|Ambrisentan|ambrisentan
375109|NCT01347216|Imatinib|imatinib
375110|NCT01347216|Epoprostenol|epoprostenol
375111|NCT01347216|Treprostinil|treprostinil
375112|NCT01347216|Iloprost|iloprost
375113|NCT01347216|Infusion pump|infusion pump
375114|NCT01347216|Riociguat|riociguat
375115|NCT01347216|soluble guanylate cyclase stimulator|soluble guanylate cyclase stimulator
375116|NCT01347216|Quality of life|quality of life
375117|NCT01347216|Patient-related outcomes|patient-related outcomes
375118|NCT01347216|Economic model|economic model
375119|NCT01347216|Adverse event|adverse event
375120|NCT01347216|Safety|safety
375121|NCT01347216|Combination therapy|combination therapy
375122|NCT01347216|Internet|internet
375123|NCT01347216|Europe|europe
375124|NCT01347216|Australia|australia
375125|NCT01347216|Japan|japan
375126|NCT01347216|Eisenmenger|eisenmenger
375127|NCT01347216|Adults|adults
375128|NCT01347216|Children|children
375129|NCT01347216|Selexipag|selexipag
375130|NCT01347203|phase I|phase i
375131|NCT01347203|healthy volunteers|healthy volunteers
375132|NCT01347203|crossover study|crossover study
375133|NCT01347203|pharmacokinetics|pharmacokinetics
375134|NCT01347203|pharmacodynamics|pharmacodynamics
375135|NCT01347190|Cystic Fibrosis|cystic fibrosis
375136|NCT01347164|bisexual|bisexual
375137|NCT01347164|HIV prevention|hiv prevention
375138|NCT01347151|Glide scope|glide scope
375139|NCT01347151|Pentax|pentax
375140|NCT01347151|C spine movement|c spine movement
375141|NCT01347138|Screening|screening
375142|NCT01347138|depression|depression
375143|NCT01347138|case management|case management
375144|NCT01347125|DHF (diastolic heart failure)|dhf (diastolic heart failure)
375145|NCT01347125|HFNEF (heart failure with normal ejection fraction|hfnef (heart failure with normal ejection fraction
375146|NCT01347112|smoking|smoking
375147|NCT01347112|tobacco dependence|tobacco dependence
375148|NCT01347112|alcohol dependence|alcohol dependence
375149|NCT01347099|CBT|cbt
375150|NCT01347099|OCD|ocd
375151|NCT01347099|Internet|internet
375152|NCT01347099|Reduce symptom burden|reduce symptom burden
375153|NCT01347073|Urea Cycle Disorder|urea cycle disorder
375154|NCT01347073|UCD|ucd
375155|NCT01347073|GT4P|gt4p
375156|NCT01347073|Buphenyl|buphenyl
375157|NCT01347073|hyperammonemia|hyperammonemia
375158|NCT01347073|sodium phenylbutyrate|sodium phenylbutyrate
375159|NCT01347060|Asthma|asthma
375160|NCT01347060|treatment|treatment
375161|NCT01347060|Advair and inhaled corticosteroids|advair and inhaled corticosteroids
375162|NCT01347060|Medicare|medicare
375163|NCT01347060|Outcomes|outcomes
375164|NCT01347060|costs|costs
375165|NCT01347047|Amyloidosis|amyloidosis
375166|NCT01347047|Known or Suspected|known or suspected
375167|NCT01347034|radiation|radiation
375168|NCT01347034|neoadjuvant|neoadjuvant
375169|NCT01347034|intratumoral|intratumoral
375170|NCT01347034|autologous|autologous
375171|NCT01347034|dendritic cells|dendritic cells
375172|NCT01347021|vaginal colpopexy sacrospinous|vaginal colpopexy sacrospinous
375173|NCT01347021|vaginal colpopexy uterosacral|vaginal colpopexy uterosacral
375174|NCT01347008|Sildenafil|sildenafil
375175|NCT01347008|Endothelial Progenitor Cells|endothelial progenitor cells
375176|NCT01347008|Laser Doppler Imaging|laser doppler imaging
375177|NCT01346982|Darunavir|darunavir
375178|NCT01346982|Silimarine|silimarine
375179|NCT01346982|interaction|interaction
375180|NCT01346969|Skin scarring|skin scarring
375181|NCT01346969|cicatrix|cicatrix
375182|NCT01346969|breast scar|breast scar
375183|NCT01346956|Cigarette|cigarette
375184|NCT01346956|Smoking|smoking
375185|NCT01346956|Cardiovascular Effects|cardiovascular effects
375186|NCT01346956|2D Echocardiography|2d echocardiography
375187|NCT01346956|Doppler|doppler
589384|NCT00528164|obesity|obesity
375188|NCT01346943|Abdominal Aortic Aneurysms, AAA|abdominal aortic aneurysms, aaa
375189|NCT01346930|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
375191|NCT01346930|pulmonary fibrosis|pulmonary fibrosis
375192|NCT01346917|Colorectal cancer|colorectal cancer
375193|NCT01346917|Laparoscopic surgery|laparoscopic surgery
375194|NCT01346917|Postoperative ileus|postoperative ileus
375195|NCT01346917|Lidocaine|lidocaine
375196|NCT01346917|Early oral feeding|early oral feeding
375197|NCT01346878|Ultra deep sequencing|ultra deep sequencing
375198|NCT01346878|Virological failure|virological failure
375199|NCT01346878|Salvage antiretroviral therapy|salvage antiretroviral therapy
375200|NCT01346865|triple anti-platelet therapy|triple anti-platelet therapy
375201|NCT01346865|dual antiplatelet therapy|dual antiplatelet therapy
375202|NCT01346865|DES|des
375203|NCT01346865|Coronary Artery Disease|coronary artery disease
375204|NCT01346852|pediatrics|pediatrics
375205|NCT01346852|Medicaid|medicaid
375206|NCT01346852|asthma|asthma
375207|NCT01346852|outcomes|outcomes
375208|NCT01346852|asthma medication ratio|asthma medication ratio
375209|NCT01346839|Diagnostic delay|diagnostic delay
375210|NCT01346839|Prevention|prevention
375306|NCT01346527|diabetes|diabetes
375211|NCT01346839|Diagnostic errors|diagnostic errors
375212|NCT01346826|Crohn's disease|crohn's disease
375213|NCT01346826|Ulcerative colitis|ulcerative colitis
375214|NCT01346826|Infliximab|infliximab
375215|NCT01346826|Infusion reaction|infusion reaction
375216|NCT01346813|Newborns|newborns
375217|NCT01346813|Premature|premature
375218|NCT01346813|Pain|pain
375219|NCT01346813|Pain assessment|pain assessment
375220|NCT01346813|Painful Procedures|painful procedures
375221|NCT01346813|Stressful Procedures|stressful procedures
375222|NCT01346813|Endotracheal Intubation|endotracheal intubation
375223|NCT01346813|Analgesia|analgesia
375224|NCT01346813|Sedation|sedation
375225|NCT01346813|Longterm effects of pain|longterm effects of pain
375226|NCT01346813|Epidemiology|epidemiology
375227|NCT01346787|carfilzomib|carfilzomib
375228|NCT01346787|dexamethasone|dexamethasone
375229|NCT01346787|cyclophosphamide|cyclophosphamide
375230|NCT01346787|multiple myeloma|multiple myeloma
375231|NCT01346787|newly diagnosed|newly diagnosed
375232|NCT01346774|cystitis|cystitis
375233|NCT01346774|pyelonephritis|pyelonephritis
375234|NCT01346774|bladder infection|bladder infection
375235|NCT01346774|kidney infection|kidney infection
375236|NCT01346761|Genetic Counseling|genetic counseling
375237|NCT01346761|Genetic Counseling Interventions|genetic counseling interventions
375238|NCT01346761|Genetic Testing|genetic testing
375239|NCT01346761|BRCA1 gene|brca1 gene
375240|NCT01346761|BRCA2 gene|brca2 gene
375241|NCT01346761|Risk Communication|risk communication
375242|NCT01346748|vasospasm prevention|vasospasm prevention
375243|NCT01346735|Ventilator associated pneumonia|ventilator associated pneumonia
375244|NCT01346735|Catheter related blood stream infection|catheter related blood stream infection
375245|NCT01346735|Catheter associated urinary tract infection|catheter associated urinary tract infection
375246|NCT01346735|ICU-related infections (VAP, CAUTI and CRBSI)|icu-related infections (vap, cauti and crbsi)
375247|NCT01346735|India|india
375248|NCT01346709|Operative surgical procedures|operative surgical procedures
375249|NCT01346709|Postoperative pulmonary complications (PPC)|postoperative pulmonary complications (ppc)
375250|NCT01346709|Epidemiological Study|epidemiological study
375251|NCT01346709|ARISCAT score|ariscat score
375252|NCT01346709|Risk Score|risk score
375253|NCT01346709|Europe|europe
375254|NCT01346709|PERISCOPE|periscope
375255|NCT01346709|observational study|observational study
376735|NCT01340300|Colorectal|colorectal
375256|NCT01346709|Mild respiratory failure|mild respiratory failure
375257|NCT01346709|Severe respiratory failure|severe respiratory failure
375258|NCT01346709|acute lung injury (ALI)|acute lung injury (ali)
375259|NCT01346709|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
375260|NCT01346709|Suspected pulmonary infection|suspected pulmonary infection
375261|NCT01346709|Pulmonary infiltrate|pulmonary infiltrate
375262|NCT01346709|Pleural effusion|pleural effusion
375263|NCT01346709|Atelectasis|atelectasis
375264|NCT01346709|Pneumothorax|pneumothorax
375265|NCT01346709|Bronchospasm|bronchospasm
375266|NCT01346709|Aspiration Pneumonitis|aspiration pneumonitis
375267|NCT01346709|Cardiopulmonary edema|cardiopulmonary edema
375268|NCT01346709|Prospective Evaluation|prospective evaluation
375269|NCT01346709|nonobstetric in-hospital surgical procedure|nonobstetric in-hospital surgical procedure
375270|NCT01346709|general or regional anaesthesia|general or regional anaesthesia
375271|NCT01346709|continued 7-day period recruitment|continued 7-day period recruitment
375272|NCT01346670|Red yeast rice|red yeast rice
375273|NCT01346670|Lovastatin|lovastatin
375274|NCT01346670|Bioavailability|bioavailability
375275|NCT01346657|Nifidipine|nifidipine
375276|NCT01346657|red yeast rice|red yeast rice
375277|NCT01346657|drug-drug interaction|drug-drug interaction
375278|NCT01346644|Probiotic|probiotic
375279|NCT01346644|infant nutrition|infant nutrition
375280|NCT01346644|safety|safety
375281|NCT01346644|infections|infections
375282|NCT01346618|bone age|bone age
374856|NCT01348100|Depot|depot
375284|NCT01346618|x-ray|x-ray
375285|NCT01346618|ultrasound|ultrasound
375286|NCT01346618|ultrasound based method|ultrasound based method
375287|NCT01346618|safe|safe
375288|NCT01346618|valid|valid
375289|NCT01346618|reproducable|reproducable
375290|NCT01346605|Cardiac CT, heart disease|cardiac ct, heart disease
375291|NCT01346592|Adjuvanted Trivalent Subunit Influenza Vaccine|adjuvanted trivalent subunit influenza vaccine
375292|NCT01346592|vaccine|vaccine
375293|NCT01346592|influenza|influenza
375294|NCT01346592|adjuvant|adjuvant
375295|NCT01346592|MF-59|mf-59
375296|NCT01346592|pediatric|pediatric
375297|NCT01346579|stage IA breast cancer|stage ia breast cancer
375298|NCT01346579|stage IB breast cancer|stage ib breast cancer
375299|NCT01346579|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
375300|NCT01346566|Cionni Ring|cionni ring
375301|NCT01346566|In-the-bag IOL|in-the-bag iol
375302|NCT01346566|Subluxated lenses|subluxated lenses
375303|NCT01346566|Intraoperative Performance|intraoperative performance
375304|NCT01346566|Postoperative Outcome|postoperative outcome
375305|NCT01346553|Chronic Venous Insufficiency (CVI)|chronic venous insufficiency (cvi)
375307|NCT01346527|pregnancy|pregnancy
375308|NCT01346527|left ventricular dysfunction|left ventricular dysfunction
375309|NCT01346527|neonatal|neonatal
375310|NCT01346527|lipid|lipid
375311|NCT01346527|lipotoxicity|lipotoxicity
375312|NCT01346527|neurodevelopment|neurodevelopment
375313|NCT01346514|Homeless Persons|homeless persons
375314|NCT01346514|Housing|housing
375315|NCT01346514|Case Management|case management
375316|NCT01346514|Veterans|veterans
375317|NCT01346514|Substance Related Disorders|substance related disorders
375318|NCT01346514|Mental Disorders|mental disorders
375319|NCT01346514|Social Adjustment|social adjustment
375320|NCT01346501|Rheumatoid arthritis|rheumatoid arthritis
375321|NCT01346488|Rheumatoid arthritis|rheumatoid arthritis
375322|NCT01346449|Obesity|obesity
375323|NCT01346423|Sick leave|sick leave
375324|NCT01346423|musculoskeletal pain|musculoskeletal pain
375325|NCT01346423|return to work|return to work
375326|NCT01346423|multidisciplinary intervention|multidisciplinary intervention
375327|NCT01346423|randomised controlled trial|randomised controlled trial
375328|NCT01346410|pancreatic cancer|pancreatic cancer
375329|NCT01346397|rejection|rejection
375330|NCT01346397|survival|survival
375331|NCT01346397|alemtuzumab|alemtuzumab
375332|NCT01346397|cyclosporine|cyclosporine
375333|NCT01346397|tacrolimus|tacrolimus
375334|NCT01346384|intracuff pressure|intracuff pressure
375335|NCT01346384|laryngeal tube|laryngeal tube
375336|NCT01346384|nitrous oxide|nitrous oxide
375337|NCT01346371|Allergic|allergic
375338|NCT01346371|conjunctivitis|conjunctivitis
375339|NCT01346371|Allergic conjunctivitis|allergic conjunctivitis
375340|NCT01346358|Advanced Solid Tumors|advanced solid tumors
375341|NCT01346345|Recession|recession
375342|NCT01346319|dose escalating|dose escalating
375343|NCT01346293|Tetanus|tetanus
375344|NCT01346293|Diphtheria|diphtheria
375345|NCT01346293|Pertussis|pertussis
375346|NCT01346293|DTap-IPV|dtap-ipv
375347|NCT01346293|DAPTACEL®|daptacel®
375348|NCT01346293|VARIVAX®|varivax®
375349|NCT01346280|Adherence to Evidence-Based Guidelines|adherence to evidence-based guidelines
375350|NCT01346280|Multidisciplinary Care|multidisciplinary care
375351|NCT01346280|Patient Experiences|patient experiences
375352|NCT01346280|Quality of Care Outcomes|quality of care outcomes
375353|NCT01346267|nausea and vomiting|nausea and vomiting
375437|NCT01345890|electrical stimulation|electrical stimulation
375354|NCT01346267|unspecified childhood solid tumor|unspecified childhood solid tumor
375355|NCT01346267|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
375356|NCT01346267|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
375357|NCT01346267|childhood central nervous system germinoma|childhood central nervous system germinoma
375358|NCT01346267|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
375359|NCT01346267|childhood central nervous system teratoma|childhood central nervous system teratoma
375360|NCT01346267|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
375361|NCT01346267|childhood mixed glioma|childhood mixed glioma
375362|NCT01346267|childhood oligodendroglioma|childhood oligodendroglioma
375363|NCT01346267|untreated childhood brain stem glioma|untreated childhood brain stem glioma
375364|NCT01346267|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
375365|NCT01346267|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
458999|NCT00041990|Gleevec|gleevec
375366|NCT01346267|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
375367|NCT01346267|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
375368|NCT01346267|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
375369|NCT01346267|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
375495|NCT01345643|Hemoglobin level|hemoglobin level
589385|NCT00528164|family|family
375370|NCT01346267|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
375371|NCT01346267|untreated childhood cerebral astrocytoma|untreated childhood cerebral astrocytoma
375372|NCT01346267|untreated childhood subependymal giant cell astrocytoma|untreated childhood subependymal giant cell astrocytoma
375373|NCT01346267|childhood ependymoblastoma|childhood ependymoblastoma
375374|NCT01346267|untreated childhood medulloblastoma|untreated childhood medulloblastoma
375375|NCT01346267|untreated childhood pineoblastoma|untreated childhood pineoblastoma
375376|NCT01346267|childhood choroid plexus tumor|childhood choroid plexus tumor
375377|NCT01346267|childhood craniopharyngioma|childhood craniopharyngioma
375378|NCT01346267|childhood supratentorial ependymoma|childhood supratentorial ependymoma
375379|NCT01346267|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
375380|NCT01346267|childhood medulloepithelioma|childhood medulloepithelioma
375381|NCT01346267|childhood infratentorial ependymoma|childhood infratentorial ependymoma
375382|NCT01346267|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
375383|NCT01346267|childhood meningioma|childhood meningioma
375384|NCT01346254|after|after
375385|NCT01346241|Panic|panic
375386|NCT01346241|Anxiety|anxiety
375387|NCT01346228|Panic|panic
375388|NCT01346228|Panic Disorder|panic disorder
375389|NCT01346228|Anxiety|anxiety
375390|NCT01346215|heparin|heparin
375391|NCT01346215|renal insufficiency, chronic|renal insufficiency, chronic
375392|NCT01346215|extracorporeal dialysis|extracorporeal dialysis
375393|NCT01346215|fibrinolytic agents|fibrinolytic agents
375394|NCT01346215|anticoagulants|anticoagulants
375395|NCT01346215|aPTT|aptt
375396|NCT01346202|multi-modal pain therapy, chronic pain|multi-modal pain therapy, chronic pain
375397|NCT01346189|Cardiovascular Disease|cardiovascular disease
375398|NCT01346163|Schizophrenia|schizophrenia
375399|NCT01346163|Cognitive Impairment|cognitive impairment
375400|NCT01346163|Electrophysiology|electrophysiology
375401|NCT01346163|H3 receptor antagonist|h3 receptor antagonist
375402|NCT01346137|ovulation|ovulation
375403|NCT01346137|unruptured luteinized follicle|unruptured luteinized follicle
375404|NCT01346137|meloxicam|meloxicam
375405|NCT01346124|radiation|radiation
375406|NCT01346124|IMRT|imrt
375407|NCT01346124|IMPT|impt
375408|NCT01346098|diabetes|diabetes
375409|NCT01346098|islet transplantation|islet transplantation
375410|NCT01346098|pancreas|pancreas
375411|NCT01346098|pancreatectomy|pancreatectomy
375412|NCT01346085|islet transplantation|islet transplantation
375413|NCT01346085|brittle diabetes|brittle diabetes
375414|NCT01346085|type 1 diabetes|type 1 diabetes
375415|NCT01346072|tolvaptan|tolvaptan
375416|NCT01346072|copeptin|copeptin
375417|NCT01346072|heart failure|heart failure
375418|NCT01346072|vasopressin antagonist|vasopressin antagonist
375419|NCT01346059|Clostridium|clostridium
375420|NCT01346059|Colitis|colitis
375421|NCT01346059|Intracolonic vancomycin|intracolonic vancomycin
375422|NCT01346059|psuedomembranous colitis|psuedomembranous colitis
375423|NCT01346046|Type 2 Diabetes|type 2 diabetes
375424|NCT01346046|Adults 18 years and older|adults 18 years and older
375425|NCT01346046|Taking Control of Your Diabetes Health Fair|taking control of your diabetes health fair
375426|NCT01346033|Type 2 Diabetes|type 2 diabetes
375427|NCT01346033|Adults 18 years and older|adults 18 years and older
375428|NCT01346033|Taking Control of Your Diabetes Health Fair|taking control of your diabetes health fair
375429|NCT01345968|anemia|anemia
375430|NCT01345968|transfusion|transfusion
375431|NCT01345968|intravenous ferric carboxymaltose|intravenous ferric carboxymaltose
375432|NCT01345929|cUTI|cuti
375433|NCT01345890|swallowing|swallowing
375434|NCT01345890|stroke|stroke
375435|NCT01345890|aspiration|aspiration
375436|NCT01345890|human|human
375748|NCT01344720|Oxycodone|oxycodone
375438|NCT01345890|post stroke dysphagia|post stroke dysphagia
375439|NCT01345877|burn injury|burn injury
375440|NCT01345877|cold pressor test|cold pressor test
375441|NCT01345877|gender|gender
375442|NCT01345877|pain|pain
375443|NCT01345877|pain sensitivity|pain sensitivity
375444|NCT01345877|pain prediction|pain prediction
375445|NCT01345877|psychometrics|psychometrics
375446|NCT01345877|quantitative sensory testing|quantitative sensory testing
375447|NCT01345864|attention cognition memory problem solving scopolamine challenge|attention cognition memory problem solving scopolamine challenge
375448|NCT01345825|osteoarthrosis|osteoarthrosis
375449|NCT01345825|unicompartmental knee replacement|unicompartmental knee replacement
375450|NCT01345825|knee|knee
375451|NCT01345825|resistance training|resistance training
366167|NCT01384292|OIC|oic
375452|NCT01345825|Muscle power|muscle power
375453|NCT01345825|gait analysis|gait analysis
375454|NCT01345825|gait|gait
375455|NCT01345825|physiotherapy|physiotherapy
375456|NCT01345825|Gyro sensor|gyro sensor
375458|NCT01345812|IVF|ivf
375459|NCT01345812|Timelapse|timelapse
375460|NCT01345799|Crohn's Disease Activity Index|crohn's disease activity index
375461|NCT01345799|Crohn's Disease|crohn's disease
375462|NCT01345799|Inflammatory Bowel Disease|inflammatory bowel disease
375463|NCT01345760|Basal Cell Carcinoma|basal cell carcinoma
375464|NCT01345760|Squamous Cell Carcinoma|squamous cell carcinoma
375465|NCT01345760|Actinic Keratosis|actinic keratosis
375466|NCT01345760|microRNA|microrna
375467|NCT01345760|Dicer|dicer
375468|NCT01345760|Drosha|drosha
375469|NCT01345760|RISC|risc
375470|NCT01345760|microprocessor complex|microprocessor complex
375471|NCT01345760|Argonaute|argonaute
375472|NCT01345760|DGCR8|dgcr8
375473|NCT01345760|TARBP|tarbp
375474|NCT01345747|laryngeal tube suction|laryngeal tube suction
375475|NCT01345747|gynecology|gynecology
375476|NCT01345747|laparoscopic surgery|laparoscopic surgery
375477|NCT01345721|Meningococcal|meningococcal
375478|NCT01345721|ACWY|acwy
375479|NCT01345721|Conjugate Vaccine|conjugate vaccine
375480|NCT01345721|Meningitis|meningitis
375481|NCT01345721|Toddlers|toddlers
375482|NCT01345721|Children|children
375483|NCT01345721|Persistence|persistence
375484|NCT01345721|Boost|boost
375485|NCT01345708|Low dose rituximab|low dose rituximab
375486|NCT01345708|WAIHA|waiha
375488|NCT01345695|Childhood diarrhea|childhood diarrhea
375489|NCT01345695|childhood pneumonia|childhood pneumonia
375490|NCT01345695|telemedicine|telemedicine
375491|NCT01345695|cluster|cluster
375492|NCT01345695|treatment-control trial|treatment-control trial
375493|NCT01345656|Chronic Heart Failure|chronic heart failure
375494|NCT01345643|Transfusion|transfusion
375496|NCT01345630|Double-blind|double-blind
375497|NCT01345630|comparative|comparative
375498|NCT01345630|trial|trial
375499|NCT01345630|maraviroc|maraviroc
375500|NCT01345630|versus|versus
375501|NCT01345630|emtricitabine/tenofovir|emtricitabine/tenofovir
375502|NCT01345630|both with darunavir/ritonavir|both with darunavir/ritonavir
375503|NCT01345630|antiretroviral-naive|antiretroviral-naive
375504|NCT01345630|Ccr5 tropic|ccr5 tropic
375505|NCT01345630|Hiv 1|hiv 1
375506|NCT01345630|patients.|patients.
375508|NCT01345591|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
375509|NCT01345591|Facial Trauma|facial trauma
375510|NCT01345591|Fat Grafts|fat grafts
375511|NCT01345591|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
375512|NCT01345591|Wounded warriors|wounded warriors
375513|NCT01345578|Urea Cycle Disorders|urea cycle disorders
375514|NCT01345578|Carbamoyl-Phosphate Synthase I Deficiency Disease|carbamoyl-phosphate synthase i deficiency disease
375515|NCT01345578|Citrullinemia|citrullinemia
375516|NCT01345578|Ornithine Carbamoyltransferase Deficiency Disease|ornithine carbamoyltransferase deficiency disease
375517|NCT01345578|Crigler-Najjar Syndrome|crigler-najjar syndrome
375518|NCT01345565|fulminant hepatic failure|fulminant hepatic failure
375519|NCT01345552|Oligo mets|oligo mets
375520|NCT01345552|Oligometastatic disease|oligometastatic disease
375521|NCT01345539|Oligo mets|oligo mets
375522|NCT01345539|Oligometastatic disease|oligometastatic disease
375523|NCT01345513|Genomic Analysis|genomic analysis
375524|NCT01345513|Sequencing|sequencing
375525|NCT01345513|Genetic|genetic
375526|NCT01345513|Biopsy|biopsy
375527|NCT01345513|Solid tumors|solid tumors
375528|NCT01345500|Overweight|overweight
375529|NCT01345500|Obese|obese
375530|NCT01345500|Type 2 Diabetic|type 2 diabetic
375531|NCT01345500|Diabetes|diabetes
375532|NCT01345500|Weight loss|weight loss
375533|NCT01345500|Physical activity|physical activity
375534|NCT01345500|Diet|diet
375535|NCT01345500|Prepackaged meals|prepackaged meals
375536|NCT01345487|appetite|appetite
375537|NCT01345487|protein|protein
375538|NCT01345487|legumes|legumes
375539|NCT01345487|meat|meat
375540|NCT01345474|noise-induced hearing loss|noise-induced hearing loss
375541|NCT01345474|hearing loss|hearing loss
375542|NCT01345474|tinnitus|tinnitus
375543|NCT01345474|weapons training|weapons training
375544|NCT01345474|hearing protection|hearing protection
375545|NCT01345474|impulse noise|impulse noise
375546|NCT01345448|Glaucoma|glaucoma
375547|NCT01345448|Brimonidine|brimonidine
375548|NCT01345448|Transdermal|transdermal
375549|NCT01345435|telemonitoring|telemonitoring
375550|NCT01345435|usual care|usual care
375551|NCT01345435|telemedicine|telemedicine
375552|NCT01345435|telehealth|telehealth
375553|NCT01345435|home care|home care
375554|NCT01345435|Health Care Quality|health care quality
375555|NCT01345435|Access|access
375556|NCT01345435|Evaluation|evaluation
375557|NCT01345409|Musculoskeletal pain|musculoskeletal pain
375558|NCT01345409|Chronic pain|chronic pain
375559|NCT01345409|Acupuncture|acupuncture
375560|NCT01345409|Chiropractic|chiropractic
375561|NCT01345396|Asthma|asthma
375562|NCT01345396|Health education|health education
375563|NCT01345396|Pregnancy|pregnancy
375564|NCT01345383|smoking|smoking
375565|NCT01345383|bronchoscopy|bronchoscopy
375566|NCT01345383|cough|cough
375567|NCT01345370|Glioblastoma|glioblastoma
375568|NCT01345357|Solid tumors|solid tumors
375569|NCT01345357|mantle cell lymphoma|mantle cell lymphoma
375570|NCT01345357|Gemcitabine|gemcitabine
375571|NCT01345357|Cisplatin|cisplatin
375572|NCT01345357|Cancer|cancer
375573|NCT01345357|Neoplasms|neoplasms
375574|NCT01345357|Antineoplastic agents|antineoplastic agents
375575|NCT01345318|Crohn's Disease|crohn's disease
375576|NCT01345318|safety|safety
375577|NCT01345318|efficacy|efficacy
375578|NCT01345318|pharmacokinetics|pharmacokinetics
375579|NCT01345318|pharmacodynamics|pharmacodynamics
375580|NCT01345318|Crohn's Disease Activity Index (CDAI)|crohn's disease activity index (cdai)
375581|NCT01345305|Sturge-Weber Syndrome|sturge-weber syndrome
375582|NCT01345305|Biomarkers|biomarkers
375583|NCT01345305|Quantitative EEG|quantitative eeg
375584|NCT01345305|Transcranial Doppler Ultrasound|transcranial doppler ultrasound
375585|NCT01345305|Medical Rehabilitation Scales|medical rehabilitation scales
375586|NCT01345305|Optical Coherence Tomography|optical coherence tomography
375587|NCT01345266|Pharyngometry|pharyngometry
375588|NCT01345266|Novel Dry Powder Inhaler|novel dry powder inhaler
375589|NCT01345266|HRCT|hrct
375590|NCT01345266|Inhalation Profiles|inhalation profiles
375591|NCT01345253|SLEDAI|sledai
375592|NCT01345253|Asia|asia
375593|NCT01345253|placebo|placebo
375594|NCT01345253|BLys|blys
375596|NCT01345253|BILAG|bilag
375597|NCT01345253|systemic lupus erythematosus|systemic lupus erythematosus
375598|NCT01345253|SELENA|selena
375599|NCT01345253|Lupus|lupus
375600|NCT01345253|SRI|sri
375601|NCT01345253|efficacy|efficacy
375602|NCT01345253|B cell|b cell
375603|NCT01345253|SLE Flare Index|sle flare index
375604|NCT01345253|belimumab|belimumab
375605|NCT01345253|safety|safety
375606|NCT01345253|phase III|phase iii
375607|NCT01345253|B lymphocyte|b lymphocyte
375608|NCT01345240|Africa|africa
375609|NCT01345240|Plasmodium falciparum|plasmodium falciparum
375610|NCT01345240|Malaria vaccine|malaria vaccine
375611|NCT01345240|hepatitis B|hepatitis b
375612|NCT01345240|EPI|epi
375613|NCT01345227|Type 1 diabetes|type 1 diabetes
375614|NCT01345227|islet transplantation|islet transplantation
375615|NCT01345227|autotransplantation|autotransplantation
375616|NCT01345214|ONO-7746|ono-7746
375617|NCT01345214|Chemotherapy Induced Thrombocytopenia|chemotherapy induced thrombocytopenia
375618|NCT01345214|Thrombocytopenia|thrombocytopenia
375619|NCT01345201|Phase 1|phase 1
375620|NCT01345201|dose escalation|dose escalation
375621|NCT01345201|histologically confirmed|histologically confirmed
375622|NCT01345201|malignancy metastatic|malignancy metastatic
375623|NCT01345175|rectal|rectal
375624|NCT01345175|colon|colon
375625|NCT01345175|PLACEBO|placebo
375626|NCT01345175|RIFAXIMIN|rifaximin
375627|NCT01345175|metronidazole|metronidazole
375628|NCT01345175|11-045|11-045
375629|NCT01345162|Herniotomy|herniotomy
375630|NCT01345149|Obesity|obesity
375631|NCT01345149|Pregnancy|pregnancy
375632|NCT01345149|Intervention|intervention
375633|NCT01345149|Diet|diet
375634|NCT01345149|Physical activity|physical activity
375635|NCT01345136|Neurofibromatosis Type 2|neurofibromatosis type 2
375636|NCT01345136|Vestibular schwannoma|vestibular schwannoma
375637|NCT01345136|Hearing|hearing
375638|NCT01345110|dementia|dementia
375639|NCT01345110|mild cognitive impairment|mild cognitive impairment
375640|NCT01345110|prevalence|prevalence
375641|NCT01345110|incidence|incidence
375642|NCT01345110|elderly|elderly
375643|NCT01345110|longitudinal study|longitudinal study
375644|NCT01345110|population study|population study
375645|NCT01345097|short, metaphyseal-fitting femoral stem|short, metaphyseal-fitting femoral stem
375646|NCT01345097|cementless anatomical femoral stem|cementless anatomical femoral stem
375647|NCT01345097|young patient|young patient
375648|NCT01345097|elderly patient|elderly patient
375649|NCT01345071|Rheumatoid Arthritis|rheumatoid arthritis
375650|NCT01345071|Pregnancy|pregnancy
375651|NCT01345071|Anti-TNF|anti-tnf
375652|NCT01345071|Preconceptional counselling|preconceptional counselling
375653|NCT01345071|Disease activity|disease activity
375654|NCT01345058|Epilepsy|epilepsy
375655|NCT01345058|antiepileptic drug|antiepileptic drug
375656|NCT01345058|polytherapy|polytherapy
375657|NCT01345045|Diabetic Asymmetric Polyneuropathy|diabetic asymmetric polyneuropathy
375658|NCT01345045|Symmetric Diabetic Proximal Motor Neuropathy|symmetric diabetic proximal motor neuropathy
375659|NCT01345045|Diabetic Mononeuropathy Simplex,|diabetic mononeuropathy simplex,
375660|NCT01345045|Diabetic Autonomic Neuropathy,|diabetic autonomic neuropathy,
375661|NCT01345045|Diabetic Amyotrophy|diabetic amyotrophy
375662|NCT01345045|Mononeuropathy|mononeuropathy
375663|NCT01345045|Diabetic Neuropathy|diabetic neuropathy
375664|NCT01345045|Asymmetric Diabetic Proximal Motor Neuropathy|asymmetric diabetic proximal motor neuropathy
375665|NCT01345045|Diabetic Polyneuropathy|diabetic polyneuropathy
375666|NCT01345045|Painful|painful
375667|NCT01345045|Diabetic Mononeuropathy|diabetic mononeuropathy
375668|NCT01345045|Neuralgia|neuralgia
375669|NCT01345019|zoledronic acid|zoledronic acid
375670|NCT01345019|hematologic malignancies|hematologic malignancies
375671|NCT01345019|SRE|sre
375672|NCT01345019|skeletal-related event|skeletal-related event
375673|NCT01345019|blood cancer|blood cancer
375674|NCT01345019|lytic bone lesions|lytic bone lesions
375675|NCT01345019|bone metastases|bone metastases
375676|NCT01345019|myeloma|myeloma
375677|NCT01345019|fractures|fractures
375678|NCT01345019|spinal cord compression|spinal cord compression
375679|NCT01345019|radiation to bone|radiation to bone
375680|NCT01345019|surgery to bone|surgery to bone
375681|NCT01345019|bisphosphonates|bisphosphonates
375682|NCT01345019|Neoplasms, Plasma Cell|neoplasms, plasma cell
375683|NCT01345019|Paraproteinemias|paraproteinemias
375684|NCT01345019|Neoplasms|neoplasms
375685|NCT01345019|Neoplasm Metastasis|neoplasm metastasis
375686|NCT01345019|Bone Neoplasms|bone neoplasms
375687|NCT01345019|Bone Marrow Diseases|bone marrow diseases
375688|NCT01345019|Blood Protein Disorders|blood protein disorders
375689|NCT01345019|Hematologic Diseases|hematologic diseases
375690|NCT01345019|multiple myeloma|multiple myeloma
375691|NCT01345019|denosumab|denosumab
375692|NCT01345019|Neoplastic Processes|neoplastic processes
375693|NCT01345019|Bone Diseases|bone diseases
375694|NCT01345019|Diphosphonates|diphosphonates
375695|NCT01345019|Bone Density Conservation Agents|bone density conservation agents
375696|NCT01345006|juvenile macular dystrophy|juvenile macular dystrophy
375697|NCT01345006|SMD|smd
375698|NCT01345006|fundus flavimaculatus|fundus flavimaculatus
375699|NCT01344993|Dry AMD|dry amd
375700|NCT01344993|Geographic atrophy|geographic atrophy
375701|NCT01344941|Vaccine response|vaccine response
375702|NCT01344941|Human Lymphocytes|human lymphocytes
375703|NCT01344915|Patella|patella
375704|NCT01344915|Knee|knee
375705|NCT01344915|Brace|brace
375706|NCT01344876|multiple myeloma [MM]|multiple myeloma [mm]
375707|NCT01344876|non-Hodgkin lymphoma [NHL]|non-hodgkin lymphoma [nhl]
375708|NCT01344876|acute myeloid leukemia [AML]|acute myeloid leukemia [aml]
375709|NCT01344876|acute lymphoid leukemia [ALL]|acute lymphoid leukemia [all]
375710|NCT01344876|chronic myeloid leukemia [CML]|chronic myeloid leukemia [cml]
375711|NCT01344824|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
375712|NCT01344824|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
375713|NCT01344824|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
375714|NCT01344824|adenocarcinoma of the lung|adenocarcinoma of the lung
375715|NCT01344824|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
375716|NCT01344824|large cell lung cancer|large cell lung cancer
375717|NCT01344811|telemonitoring|telemonitoring
375718|NCT01344811|usual care|usual care
375719|NCT01344811|telehealth|telehealth
375720|NCT01344811|home care|home care
375721|NCT01344811|Health Care Quality|health care quality
375722|NCT01344811|Access|access
375723|NCT01344811|Evaluation|evaluation
375724|NCT01344798|limb girdle muscular dystrophy type 2C|limb girdle muscular dystrophy type 2c
375725|NCT01344798|gamma-sarcoglycanopathy|gamma-sarcoglycanopathy
375726|NCT01344798|gene therapy|gene therapy
375727|NCT01344798|AAV vector|aav vector
375728|NCT01344798|neuromuscular disease|neuromuscular disease
375729|NCT01344798|orphan disease|orphan disease
375730|NCT01344785|Intertrochanteric Fractures|intertrochanteric fractures
375731|NCT01344785|Intramedullary nailing|intramedullary nailing
375732|NCT01344785|Hip function|hip function
375733|NCT01344785|Pain|pain
375734|NCT01344772|femoral neck fracture|femoral neck fracture
375735|NCT01344772|total hip arthroplasty|total hip arthroplasty
375736|NCT01344772|internal fixation|internal fixation
375737|NCT01344759|Obstructive Sleep Apnea|obstructive sleep apnea
375738|NCT01344759|MRI|mri
375739|NCT01344759|Pediatrics|pediatrics
375740|NCT01344759|Dexmedetomidine|dexmedetomidine
375741|NCT01344759|Propofol|propofol
375742|NCT01344759|Anesthesia|anesthesia
375743|NCT01344746|sleep-disordered breathing|sleep-disordered breathing
375744|NCT01344733|Major Depressive Disorder|major depressive disorder
375745|NCT01344733|MDD|mdd
375746|NCT01344720|Low Back Pain|low back pain
375747|NCT01344720|Etoricoxib|etoricoxib
375749|NCT01344707|Hematologic Malignancies|hematologic malignancies
375750|NCT01344707|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
375751|NCT01344707|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
375752|NCT01344707|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
375753|NCT01344707|Multiple Myeloma (MM)|multiple myeloma (mm)
375754|NCT01344707|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
375755|NCT01344707|Malignant Lymphomas|malignant lymphomas
375756|NCT01344707|Histone Deacetylase (HDAC)|histone deacetylase (hdac)
375757|NCT01344707|4SC-202|4sc-202
375758|NCT01344707|Phase I|phase i
375759|NCT01344694|Epicardial fat|epicardial fat
375760|NCT01344694|Visceral fat|visceral fat
375761|NCT01344694|atherosclerosis|atherosclerosis
375762|NCT01344694|coronary computed tomography angiography|coronary computed tomography angiography
375763|NCT01344694|Carotid Doppler ultrasound|carotid doppler ultrasound
375764|NCT01344668|Diabetes|diabetes
375765|NCT01344642|HIV|hiv
375766|NCT01344642|RNA|rna
375767|NCT01344616|computer-based behavioral support|computer-based behavioral support
375768|NCT01343641|Kidney Disease|kidney disease
589667|NCT00529204|exenatide|exenatide
375769|NCT01343641|Chronic Kidney Disease|chronic kidney disease
375770|NCT01343641|Growth Hormone|growth hormone
6735|NCT03248011|intervention|intervention
6930|NCT03246620|acute agitation|acute agitation
375771|NCT01343628|Alcohol, atomoxetine, Strattera, alcohol dependence, alcoholism|alcohol, atomoxetine, strattera, alcohol dependence, alcoholism
375772|NCT01343602|stroke|stroke
375773|NCT01343602|Constraint Induced Movement Therapy|constraint induced movement therapy
375774|NCT01343602|participation|participation
375775|NCT01343602|Physical Therapy|physical therapy
375776|NCT01343602|Occupational Therapy|occupational therapy
375777|NCT01344603|cardiac surgery|cardiac surgery
375778|NCT01344603|cardiac anesthesia|cardiac anesthesia
375779|NCT01344603|epidural|epidural
375780|NCT01344590|central line associated blood stream infections|central line associated blood stream infections
375781|NCT01344577|Buccal Plate Augmentation technique|buccal plate augmentation technique
375782|NCT01344577|socket preservation|socket preservation
375783|NCT01344577|porcine biomaterial|porcine biomaterial
375784|NCT01344564|Prostate cancer|prostate cancer
375785|NCT01344564|Hormone therapy|hormone therapy
375786|NCT01344564|Testosterone measures|testosterone measures
375787|NCT01344538|ginger|ginger
375788|NCT01344538|Zingiber officinale|zingiber officinale
375789|NCT01344538|Cancer Risk Reductive|cancer risk reductive
375790|NCT01344538|Eicosanoids|eicosanoids
375791|NCT01344538|Colorectal Cancer|colorectal cancer
375792|NCT01344538|Inflammation|inflammation
375793|NCT01344525|obesity therapy|obesity therapy
375794|NCT01344525|metabolic syndrome|metabolic syndrome
375795|NCT01344525|gastrointestinal tract|gastrointestinal tract
375796|NCT01344525|microbiota|microbiota
375797|NCT01344525|metabolomics|metabolomics
375798|NCT01344525|micronutrients|micronutrients
375799|NCT01344525|outcome|outcome
375800|NCT01344525|sustainability|sustainability
375801|NCT01344512|Pharmacokinetic|pharmacokinetic
375802|NCT01344512|Population|population
375803|NCT01344512|Children|children
375804|NCT01344512|Ceftazidime|ceftazidime
375805|NCT01344512|Ciprofloxacin|ciprofloxacin
375806|NCT01344512|Voriconazole|voriconazole
375807|NCT01344512|Pediatric|pediatric
375808|NCT01344499|women|women
375809|NCT01344499|laparoscopic subtotal hysterectomy|laparoscopic subtotal hysterectomy
375810|NCT01344486|women undergoing laparoscopic surgery|women undergoing laparoscopic surgery
375811|NCT01344473|Remineralisation|remineralisation
375812|NCT01344473|White Spot Lesions|white spot lesions
375813|NCT01344473|Orthodontic treatment|orthodontic treatment
375814|NCT01344473|Tooth Mousse creme|tooth mousse creme
375815|NCT01344473|Casein Phosphopeptide|casein phosphopeptide
375816|NCT01344460|magnetic resonance angiography (MRA) of the renal arteries|magnetic resonance angiography (mra) of the renal arteries
375817|NCT01344447|Supra-aortic vascular disease|supra-aortic vascular disease
375818|NCT01344447|MRA|mra
375819|NCT01344447|CTA|cta
375820|NCT01344447|Males and females aged 18 years or older|males and females aged 18 years or older
375821|NCT01344447|Stroke|stroke
375822|NCT01344447|Transient Ischemic Attack (TIA)|transient ischemic attack (tia)
375823|NCT01344421|Movement capture system|movement capture system
375824|NCT01344421|Movement analysis|movement analysis
375825|NCT01344421|Hip dysplasia|hip dysplasia
375826|NCT01344421|Hip pain|hip pain
375827|NCT01344421|Quality of life|quality of life
375828|NCT01344421|Physical function|physical function
375829|NCT01344408|Dizziness|dizziness
375830|NCT01344408|rehabilitation|rehabilitation
375831|NCT01344408|geriatric|geriatric
375832|NCT01344408|IT-technology|it-technology
375833|NCT01344382|Adolescent|adolescent
375834|NCT01344382|Parent|parent
375835|NCT01344382|Substance Abuse|substance abuse
375836|NCT01344382|Parent Training|parent training
375837|NCT01344382|Community Reinforcement and Family Training|community reinforcement and family training
375838|NCT01344382|CRAFT|craft
375839|NCT01344382|Community Reinforcement Approach|community reinforcement approach
375840|NCT01344382|Addiction|addiction
375841|NCT01344382|Family Intervention|family intervention
375842|NCT01344369|Healthy Subjects|healthy subjects
375843|NCT01344369|Bioequivalence|bioequivalence
376031|NCT01343420|Dog Hair|dog hair
375844|NCT01344356|stereotactic radiosurgery|stereotactic radiosurgery
375845|NCT01344356|head and neck tumors|head and neck tumors
375846|NCT01344356|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
375847|NCT01344330|Colon cancer|colon cancer
375848|NCT01344330|Prevention|prevention
375849|NCT01344330|Cruciferous vegetables|cruciferous vegetables
375850|NCT01344330|Histone status|histone status
375851|NCT01344304|aprepitant therapy|aprepitant therapy
375852|NCT01344304|fosaprepitant therapy|fosaprepitant therapy
375853|NCT01344304|5HT3-receptor antagonist|5ht3-receptor antagonist
375854|NCT01344304|dexamethasone|dexamethasone
375855|NCT01344304|colorectal cancer|colorectal cancer
375856|NCT01344304|FOLFOX|folfox
375857|NCT01344304|XELOX|xelox
375858|NCT01344304|SOX|sox
375859|NCT01344291|hyperprolactinoma|hyperprolactinoma
375860|NCT01344291|turmeric|turmeric
375861|NCT01344291|amenorrhea|amenorrhea
375862|NCT01344265|B-type natriuretic peptide|b-type natriuretic peptide
375863|NCT01344265|global end diastolic volume|global end diastolic volume
375864|NCT01344239|aortic aneurysm|aortic aneurysm
375865|NCT01344239|ischemia/reperfusion|ischemia/reperfusion
375866|NCT01344239|preconditioning|preconditioning
375867|NCT01344239|pulmonary injury|pulmonary injury
375868|NCT01344239|intestinal injury|intestinal injury
375869|NCT01344226|steroid responder|steroid responder
375871|NCT01344213|Celecoxib|celecoxib
375872|NCT01344213|Intrathecal morphine|intrathecal morphine
375873|NCT01344213|Total knee arthroplasty|total knee arthroplasty
375874|NCT01344200|Pharmacokinetics|pharmacokinetics
375875|NCT01344200|Celecoxib|celecoxib
375876|NCT01344200|Pediatric|pediatric
375877|NCT01344200|Peds QL|peds ql
375878|NCT01344200|CYP2C9|cyp2c9
375879|NCT01344174|Acute-on-chronic liver failure|acute-on-chronic liver failure
375880|NCT01344174|HBV|hbv
375881|NCT01344174|Dexamethasone|dexamethasone
375882|NCT01344174|Prognosis|prognosis
375883|NCT01344161|Vitamin D|vitamin d
375884|NCT01344161|Metabolic profile|metabolic profile
375885|NCT01344161|Overweight|overweight
375886|NCT01344161|Obesity|obesity
375887|NCT01344148|Anti- TB|anti- tb
375888|NCT01344148|HAART|haart
375889|NCT01344148|choice of the right moment|choice of the right moment
375890|NCT01344135|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
375891|NCT01344135|Muscular Atrophy|muscular atrophy
375892|NCT01344135|Nutritional rehabilitation|nutritional rehabilitation
375893|NCT01344135|Counselling|counselling
375894|NCT01344096|Gaucher disease|gaucher disease
375895|NCT01344096|Thrombocytopathy|thrombocytopathy
375896|NCT01344096|Imiglucerase|imiglucerase
375897|NCT01344070|innovator formulations|innovator formulations
375898|NCT01344070|generic formulations|generic formulations
375899|NCT01344070|bioequivalence|bioequivalence
375900|NCT01344070|interchangeability|interchangeability
375901|NCT01344070|inter-patch variation|inter-patch variation
375902|NCT01344070|quality of generic drug formulations on the market|quality of generic drug formulations on the market
375903|NCT01344070|Interchangeability between marketed generic formulations|interchangeability between marketed generic formulations
375904|NCT01344070|prevalence of large intrasubject variability despite average bioequivalence|prevalence of large intrasubject variability despite average bioequivalence
375905|NCT01344070|Causes of large intrasubject variability|causes of large intrasubject variability
375906|NCT01344057|Seasonal Influenza, vaccine|seasonal influenza, vaccine
375907|NCT01344044|Brain-Computer Interface|brain-computer interface
375908|NCT01344018|adult angiosarcoma|adult angiosarcoma
375909|NCT01344018|adult fibrosarcoma|adult fibrosarcoma
375910|NCT01344018|adult leiomyosarcoma|adult leiomyosarcoma
375911|NCT01344018|adult liposarcoma|adult liposarcoma
375912|NCT01344018|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
375913|NCT01344018|adult malignant mesenchymoma|adult malignant mesenchymoma
375914|NCT01344018|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
375915|NCT01344018|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
375916|NCT01344018|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
375917|NCT01344005|non-small cell lung cancer|non-small cell lung cancer
375918|NCT01344005|small cell lung cancer|small cell lung cancer
375919|NCT01344005|tobacco use disorder|tobacco use disorder
375920|NCT01343992|Embryo transfer|embryo transfer
375921|NCT01343992|Implantation rate|implantation rate
375922|NCT01343992|Pregnancy rate|pregnancy rate
375923|NCT01343992|bedrest|bedrest
375924|NCT01343992|neutral|neutral
375925|NCT01343992|benevolent|benevolent
375926|NCT01343992|deterious|deterious
375927|NCT01343992|implantation|implantation
375928|NCT01343992|gestation rates|gestation rates
375929|NCT01343953|severe aplastic anemia|severe aplastic anemia
375930|NCT01343953|cord blood transplantation|cord blood transplantation
375931|NCT01343940|RCT|rct
375932|NCT01343940|randomized block repeated measures design|randomized block repeated measures design
375933|NCT01343940|efficacy trial|efficacy trial
375934|NCT01343940|high risk population|high risk population
375935|NCT01343927|Chronic low back pain|chronic low back pain
375936|NCT01343927|Community health center|community health center
375937|NCT01343927|Yoga|yoga
375938|NCT01343927|Physical therapy|physical therapy
375939|NCT01343927|Minority populations|minority populations
375940|NCT01343927|Health education|health education
375941|NCT01343862|moderate traumatic brain injury|moderate traumatic brain injury
375942|NCT01343862|brain contusion|brain contusion
375943|NCT01343849|breast cancer|breast cancer
375944|NCT01343849|auto antibodies|auto antibodies
375945|NCT01343836|autologous tenocytes|autologous tenocytes
375946|NCT01343836|cell therapy|cell therapy
375947|NCT01343836|eccentric exercises|eccentric exercises
375948|NCT01343810|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
375949|NCT01343810|Meditation|meditation
375950|NCT01343810|Psychological stress|psychological stress
375951|NCT01343810|Sleep quality|sleep quality
375952|NCT01343810|Cardiovascular disease|cardiovascular disease
375953|NCT01343810|Inflammation|inflammation
375954|NCT01343797|Glycemic index|glycemic index
375955|NCT01343797|Insulinemic index|insulinemic index
590699|NCT00540904|prevention|prevention
375956|NCT01343797|Fructo-oligosaccharide syrup|fructo-oligosaccharide syrup
375957|NCT01343797|Fructose syrup|fructose syrup
375958|NCT01343797|Aged between eighteen and fifty years old|aged between eighteen and fifty years old
375959|NCT01343797|BMI between nineteen and twenty five kg/m²|bmi between nineteen and twenty five kg/m²
375960|NCT01343797|Non diabetic or pre-diabetic|non diabetic or pre-diabetic
375961|NCT01343797|Without liver, renal or gastro-intestinal disorder|without liver, renal or gastro-intestinal disorder
375962|NCT01343797|Non-smoker|non-smoker
375963|NCT01343784|Voiding trial|voiding trial
375964|NCT01343784|sling|sling
375965|NCT01343784|post-operative assessment|post-operative assessment
375966|NCT01343784|urinary retention|urinary retention
375967|NCT01343771|Anorexia Nervosa (AN)|anorexia nervosa (an)
375968|NCT01343771|bone density|bone density
375969|NCT01343771|DHEA|dhea
375970|NCT01343771|estrogen therapy|estrogen therapy
375971|NCT01343771|eating disorder|eating disorder
375973|NCT01343693|Deformity|deformity
375974|NCT01343693|Tumor|tumor
375975|NCT01343693|Fracture|fracture
375976|NCT01343693|Cervical|cervical
375977|NCT01343667|GORE Neuro Protection System|gore neuro protection system
375978|NCT01343667|GORE Flow Reversal System|gore flow reversal system
375979|NCT01343667|carotid artery stenosis|carotid artery stenosis
375980|NCT01343667|embolic protection device|embolic protection device
375981|NCT01343667|reverse flow|reverse flow
375982|NCT01343667|proximal occlusion device|proximal occlusion device
375983|NCT01343667|GNPS|gnps
375984|NCT01343667|Parodi|parodi
375985|NCT01343667|EMPiRE|empire
375986|NCT01343667|distal embolization|distal embolization
375987|NCT01343667|minimizing risks of CAS|minimizing risks of cas
375988|NCT01343667|PAES|paes
375989|NCT01343667|embolic filter|embolic filter
375990|NCT01343654|HIV medication adherence|hiv medication adherence
375991|NCT01343654|drug use|drug use
375992|NCT01343654|rural|rural
375993|NCT01343654|nonadherence to HIV medications|nonadherence to hiv medications
375994|NCT01343563|Depression|depression
375995|NCT01343563|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
375996|NCT01343563|EEG|eeg
375997|NCT01343563|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
375998|NCT01343550|Borderline Personality Disorder|borderline personality disorder
375999|NCT01343550|Borderline Personality|borderline personality
376000|NCT01343550|Borderline|borderline
376001|NCT01343537|Brain Bleed|brain bleed
376002|NCT01343537|SAH|sah
376003|NCT01343537|Vasospasm|vasospasm
376004|NCT01343524|cystic fibrosis|cystic fibrosis
376005|NCT01343524|spirometry|spirometry
376006|NCT01343524|PFT's|pft's
376007|NCT01343524|pulmonary function test|pulmonary function test
376008|NCT01343511|Autism|autism
376009|NCT01343511|human cord blood mononuclear cells|human cord blood mononuclear cells
376010|NCT01343511|human umbilical cord mesenchymal stem cells|human umbilical cord mesenchymal stem cells
376011|NCT01343498|Solid Tumor Malignancy|solid tumor malignancy
376012|NCT01343498|Advanced Solid Tumors|advanced solid tumors
376013|NCT01343498|BEZ235|bez235
376014|NCT01343498|mTOR Inhibitor|mtor inhibitor
376015|NCT01343485|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
376016|NCT01343485|Gardasil vaccine|gardasil vaccine
376017|NCT01343472|Behavior|behavior
376018|NCT01343472|Drug users|drug users
376019|NCT01343459|Hypofractionated Whole breast irradiation|hypofractionated whole breast irradiation
376020|NCT01343459|Hypofractionated Whole breast irradiation long term results|hypofractionated whole breast irradiation long term results
376021|NCT01343459|Breast conserving therapy|breast conserving therapy
376022|NCT01343459|IORT with electrons in breast cancer|iort with electrons in breast cancer
376023|NCT01343459|IOERT as anticipated Boost|ioert as anticipated boost
376024|NCT01343459|IOERT and hypofractionated whole breast irradiation|ioert and hypofractionated whole breast irradiation
376025|NCT01343446|Sleep impairment, Coping Style, Diabetes Mellitus|sleep impairment, coping style, diabetes mellitus
376026|NCT01343433|Delirium|delirium
376027|NCT01343433|Intensive Care Unit Syndrome|intensive care unit syndrome
376028|NCT01343433|Bright light therapy|bright light therapy
376029|NCT01343433|Intensive Care Unit|intensive care unit
376030|NCT01343420|Skin tests|skin tests
376035|NCT01343394|Hearing Loss|hearing loss
376036|NCT01343394|Children|children
376038|NCT01343381|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
376039|NCT01343381|Anti-coagulation efficacy|anti-coagulation efficacy
376040|NCT01343368|Post-menarchal|post-menarchal
459827|NCT00031798|fatigue|fatigue
376041|NCT01343355|Tropical Spastic Paraparesis|tropical spastic paraparesis
376042|NCT01343355|HAM|ham
376043|NCT01343355|TSP|tsp
376044|NCT01343342|omega-3|omega-3
376045|NCT01343342|PUFA|pufa
376046|NCT01343342|fatty acids|fatty acids
376047|NCT01343342|cardiovascular disease|cardiovascular disease
376048|NCT01343342|gene expression|gene expression
376049|NCT01343329|Traumatic Brain Injury|traumatic brain injury
376050|NCT01343329|Dysautonomia|dysautonomia
376051|NCT01343329|Brain Injury|brain injury
376052|NCT01343329|Sympathetic hyperactivity|sympathetic hyperactivity
376053|NCT01343316|Enteral Feeds|enteral feeds
376054|NCT01343316|Supplemental Feeds|supplemental feeds
376055|NCT01343316|Transpyloric Tube|transpyloric tube
376056|NCT01343316|Nasogastric Tube|nasogastric tube
376057|NCT01343303|Osteoarthritis, knee|osteoarthritis, knee
376058|NCT01343303|knee pain|knee pain
376059|NCT01343303|pain measurement|pain measurement
376060|NCT01343290|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
376061|NCT01343290|Pharmacokinetic|pharmacokinetic
376062|NCT01343290|Oral Bioavailability|oral bioavailability
376063|NCT01343290|Food effect|food effect
376064|NCT01343277|Advanced Liposarcoma or Leiomyosarcoma|advanced liposarcoma or leiomyosarcoma
376065|NCT01343277|Trabectedin|trabectedin
376066|NCT01343277|Yondelis|yondelis
376067|NCT01343277|Dacarbazine|dacarbazine
376068|NCT01343277|Anthracycline|anthracycline
376069|NCT01343277|L-sarcoma|l-sarcoma
376070|NCT01343264|Radical Pleurectomy|radical pleurectomy
376071|NCT01343264|Pleurectomy/decortication|pleurectomy/decortication
376072|NCT01343264|Cisplatin|cisplatin
376073|NCT01343264|Pemetrexed|pemetrexed
376074|NCT01343264|Radiation|radiation
376075|NCT01343251|dialysis|dialysis
376076|NCT01343251|HeRO graft|hero graft
376077|NCT01343251|catheter|catheter
376078|NCT01343251|chronic renal failure|chronic renal failure
376079|NCT01343251|end stage renal disease|end stage renal disease
376080|NCT01343251|renal insufficiency|renal insufficiency
376082|NCT01343238|diet|diet
376083|NCT01343238|exercise|exercise
376084|NCT01343225|African american vitamin d bone density|african american vitamin d bone density
376085|NCT01343225|African American male or female treatment naive|african american male or female treatment naive
376086|NCT01343212|hepatocellular carcinoma|hepatocellular carcinoma
376087|NCT01343212|stiffness|stiffness
376088|NCT01343186|Peginterferon|peginterferon
376089|NCT01343186|Healthy subject|healthy subject
376090|NCT01343186|Pharmacokinetics|pharmacokinetics
376091|NCT01343186|Pharmacodynamics|pharmacodynamics
376092|NCT01343186|Safety|safety
376093|NCT01343173|Leukemia|leukemia
376094|NCT01343173|Adult Chronic|adult chronic
376095|NCT01343173|Myeloid|myeloid
376096|NCT01343147|Hyperthermia|hyperthermia
376097|NCT01343147|Microwave diathermy|microwave diathermy
376098|NCT01343147|Hot packs|hot packs
376099|NCT01343147|Pain|pain
376100|NCT01343147|Physical function|physical function
376101|NCT01343134|Retina|retina
376102|NCT01343134|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
376103|NCT01343134|Macular detachment|macular detachment
376104|NCT01343134|Spectral domain OCT|spectral domain oct
376105|NCT01343134|Microperimetry|microperimetry
376106|NCT01343121|Radiotherapy|radiotherapy
376107|NCT01343121|GemX Chemoradiotherapy|gemx chemoradiotherapy
376108|NCT01343121|Bladder Cancer|bladder cancer
376109|NCT01343108|Emotional Labor|emotional labor
376110|NCT01343108|Burnout|burnout
376111|NCT01343108|Job Satisfaction|job satisfaction
376112|NCT01343108|Emotional Intelligence|emotional intelligence
376113|NCT01343108|Job stress|job stress
376114|NCT01343108|Job involvement|job involvement
376115|NCT01343095|ICU Delirium|icu delirium
376116|NCT01343095|Delirium|delirium
376117|NCT01343095|Sleep Quality|sleep quality
376118|NCT01343095|Sleep Efficiency|sleep efficiency
376119|NCT01343095|ICU Noise|icu noise
376120|NCT01343095|Noise Reduction|noise reduction
376121|NCT01343095|Earplugs|earplugs
376122|NCT01343095|Noise Canceling Headphones|noise canceling headphones
376123|NCT01343069|safety|safety
376124|NCT01343069|team|team
376125|NCT01343069|team performance|team performance
376126|NCT01343069|surgery|surgery
376127|NCT01343069|outcome|outcome
376128|NCT01343056|Diabetes Self Management Education (DSME)|diabetes self management education (dsme)
376129|NCT01343056|Diabetes|diabetes
376130|NCT01343056|Self Management Support (SMS)|self management support (sms)
376234|NCT01342588|safety|safety
376142|NCT01343017|Cardiac output|cardiac output
376143|NCT01343017|Sevoflurane|sevoflurane
376144|NCT01343004|BA058|ba058
376145|NCT01343004|abaloparatide|abaloparatide
376146|NCT01343004|Abaloparatide-SC|abaloparatide-sc
376147|NCT01343004|osteoporosis|osteoporosis
376148|NCT01343004|postmenopausal|postmenopausal
376149|NCT01343004|bone loss|bone loss
376150|NCT01343004|ACTIVE|active
376151|NCT01343004|fracture|fracture
376152|NCT01342991|Haemorrhoids|haemorrhoids
376153|NCT01342991|Haemorrhoidectomy|haemorrhoidectomy
366903|NCT01381172|CCM|ccm
376154|NCT01342991|Laser Haemorrhoidectomy|laser haemorrhoidectomy
376155|NCT01342991|Milligan-Morgan Haemorrhoidectomy|milligan-morgan haemorrhoidectomy
376156|NCT01342991|Open Haemorrhoidectomy|open haemorrhoidectomy
376158|NCT01342978|HNSCC|hnscc
376159|NCT01342952|pulmonary arterial hypertension|pulmonary arterial hypertension
376160|NCT01342952|pediatrics|pediatrics
376161|NCT01342939|Monogenetic diabetes|monogenetic diabetes
376162|NCT01342939|Diabetes mellitus|diabetes mellitus
376163|NCT01342926|age-related macular degeneration|age-related macular degeneration
376164|NCT01342926|geographic atrophy|geographic atrophy
376165|NCT01342926|dry AMD|dry amd
376166|NCT01342900|tissue oxygenation|tissue oxygenation
376167|NCT01342900|higk risk surgery|higk risk surgery
376168|NCT01342900|high risk patient|high risk patient
376169|NCT01342900|postoperative complications|postoperative complications
376170|NCT01342874|inositol|inositol
376171|NCT01342874|gestational diabetes mellitus|gestational diabetes mellitus
376172|NCT01342874|obstetric adverse outcomes|obstetric adverse outcomes
376173|NCT01342861|protein supplementation|protein supplementation
376174|NCT01342861|caloric intake|caloric intake
376175|NCT01342861|breakfast|breakfast
376176|NCT01342861|transthyretin (prealbumin)|transthyretin (prealbumin)
376177|NCT01342861|albumin|albumin
376178|NCT01342861|Length of stay|length of stay
376179|NCT01342848|NSTE-ACS|nste-acs
376180|NCT01342848|PCI|pci
376181|NCT01342848|Thrombus Aspiration|thrombus aspiration
376182|NCT01342848|IVUS|ivus
376183|NCT01342848|Periprocedural Myocardial Infarction|periprocedural myocardial infarction
376184|NCT01342835|propofol|propofol
376185|NCT01342835|sevoflurane|sevoflurane
376186|NCT01342835|postoperative pain|postoperative pain
376187|NCT01342835|children|children
376188|NCT01342822|Heart disease|heart disease
376189|NCT01342822|Coronary Revascularization|coronary revascularization
376190|NCT01342809|Depression|depression
376191|NCT01342809|Hopelessness|hopelessness
376192|NCT01342809|Suicidal ideation|suicidal ideation
376193|NCT01342796|Cell mediated immunity|cell mediated immunity
376194|NCT01342796|cell mediated immune response|cell mediated immune response
376195|NCT01342796|Children|children
376196|NCT01342796|adjuvanted|adjuvanted
376197|NCT01342783|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
376301|NCT01342237|etoposide|etoposide
376198|NCT01342783|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
376199|NCT01342783|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
376200|NCT01342783|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
376201|NCT01342783|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
376202|NCT01342783|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
376203|NCT01342744|Cardiovascular risk factors|cardiovascular risk factors
376204|NCT01342731|Tigecycline|tigecycline
376205|NCT01342731|A.baumannii|a.baumannii
376206|NCT01342731|Drug safety|drug safety
376207|NCT01342718|Irritable bowel syndrome|irritable bowel syndrome
376208|NCT01342718|Herbal medicine|herbal medicine
376209|NCT01342718|Probiotics|probiotics
376210|NCT01342679|chronic myeloid leukemia|chronic myeloid leukemia
376211|NCT01342679|dasatinib|dasatinib
376212|NCT01342679|complete molecular response|complete molecular response
376213|NCT01342666|High density lipoprotein cholesterol|high density lipoprotein cholesterol
376214|NCT01342666|Tomato|tomato
376215|NCT01342666|Lycopene|lycopene
376216|NCT01342666|Hypoalphalipoproteinemia|hypoalphalipoproteinemia
376217|NCT01342666|Dyslipidemia|dyslipidemia
376218|NCT01342653|Peritoneal|peritoneal
376219|NCT01342653|Carcinomatosis|carcinomatosis
376220|NCT01342653|Gastric|gastric
376221|NCT01342653|Cancer|cancer
376222|NCT01342653|NIPS|nips
376223|NCT01342653|HIPEC|hipec
376224|NCT01342627|Renal Carcinoma|renal carcinoma
376225|NCT01342627|Metastatic|metastatic
376226|NCT01342627|Sorafenib|sorafenib
376227|NCT01342627|Elderly|elderly
376228|NCT01342614|Hypertension|hypertension
376229|NCT01342614|Insulin Resistance|insulin resistance
376230|NCT01342614|Hyperinsulinemia|hyperinsulinemia
376231|NCT01342614|Metformin|metformin
376232|NCT01342614|Fosinopril|fosinopril
376233|NCT01342588|Pedicle screws|pedicle screws
376236|NCT01342549|Alcohol Use Disorders|alcohol use disorders
376237|NCT01342549|Traumatic Brain Injury|traumatic brain injury
376238|NCT01342549|Mood and Anxiety Disorders|mood and anxiety disorders
376239|NCT01342536|Depression|depression
376240|NCT01342523|Smoking Cessation|smoking cessation
376241|NCT01342523|Smoking|smoking
376242|NCT01342523|Nicotine|nicotine
376243|NCT01342510|Intravenous Anesthesia|intravenous anesthesia
376244|NCT01342510|General Anesthesia|general anesthesia
376245|NCT01342497|diabetic foot ulcer|diabetic foot ulcer
376246|NCT01342471|Physical activity intervention|physical activity intervention
376247|NCT01342471|walking|walking
376249|NCT01342471|sedentary|sedentary
376250|NCT01342458|Knee osteoarthritis|knee osteoarthritis
376251|NCT01342458|Shoes|shoes
376252|NCT01342458|Gait|gait
376253|NCT01342458|Biomechanics|biomechanics
376254|NCT01342432|low back pain|low back pain
376255|NCT01342432|balance reeducation|balance reeducation
376256|NCT01342432|pain|pain
376257|NCT01342432|function|function
376258|NCT01342367|Prostate cancer|prostate cancer
376259|NCT01342367|Quality of Life|quality of life
376260|NCT01342354|Pancreatic Cancer|pancreatic cancer
376261|NCT01342354|Stereotactic Radiation|stereotactic radiation
376262|NCT01342328|Sleep disruption|sleep disruption
376263|NCT01342328|Sleep hygiene|sleep hygiene
376264|NCT01342328|Sedative agents and sleep|sedative agents and sleep
376265|NCT01342328|Electroencephalography|electroencephalography
376266|NCT01342328|REM sleep|rem sleep
376267|NCT01342328|Magnetoencephalography|magnetoencephalography
376268|NCT01342315|Tinea Cruris, antifungal|tinea cruris, antifungal
376269|NCT01342302|Breast Cancer|breast cancer
376270|NCT01342302|Couples|couples
376271|NCT01342302|Distress|distress
376272|NCT01342302|Online Support|online support
376273|NCT01342302|e-health|e-health
376274|NCT01342302|Intervention|intervention
376275|NCT01342302|Relationships|relationships
376276|NCT01342289|Nonmyeloablative|nonmyeloablative
376277|NCT01342289|Allogeneic|allogeneic
376278|NCT01342289|Bone Marrow Transplant (BMT)|bone marrow transplant (bmt)
376279|NCT01342289|Tacrolimus|tacrolimus
376280|NCT01342289|Cyclophosphamide|cyclophosphamide
376281|NCT01342276|Heart failure|heart failure
376282|NCT01342276|Self-management|self-management
376283|NCT01342276|Telehealth|telehealth
376284|NCT01342276|Internet|internet
376285|NCT01342263|Chronic disease management|chronic disease management
376286|NCT01342263|Ischemic heart disease|ischemic heart disease
376287|NCT01342263|Heart failure|heart failure
376288|NCT01342263|Chronic kidney disease|chronic kidney disease
376289|NCT01342263|Diabetes|diabetes
376290|NCT01342263|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
376291|NCT01342263|Telehealth|telehealth
376292|NCT01342263|Internet|internet
376293|NCT01342250|Decompensated Liver Cirrhosis|decompensated liver cirrhosis
376294|NCT01342250|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
376295|NCT01342237|Brain tumors|brain tumors
376296|NCT01342237|Stem cell transplantation|stem cell transplantation
376297|NCT01342237|topotecan|topotecan
376298|NCT01342237|thiotepa|thiotepa
376299|NCT01342237|carboplatin|carboplatin
376300|NCT01342237|melphalan|melphalan
376302|NCT01342224|pancreatic|pancreatic
376304|NCT01342224|adenocarcinoma|adenocarcinoma
376305|NCT01342224|vaccine|vaccine
376306|NCT01342211|PF-04950615|pf-04950615
376307|NCT01342211|RN316|rn316
376308|NCT01342198|pregabalin|pregabalin
376309|NCT01342198|pharmacokinetics|pharmacokinetics
376310|NCT01342198|bioavailability|bioavailability
376311|NCT01342198|bioequivalence|bioequivalence
376312|NCT01342185|Medical ozone therapy|medical ozone therapy
376313|NCT01342185|chronic hepatitis B|chronic hepatitis b
376314|NCT01342172|Bladder Cancer|bladder cancer
376315|NCT01342172|Urothelial Cancer|urothelial cancer
376316|NCT01342172|Chemotherapy|chemotherapy
376317|NCT01342172|First-line|first-line
376318|NCT01342172|Metastatic|metastatic
376319|NCT01342159|bevacizumab, diabetic macular edema, triamcinolone|bevacizumab, diabetic macular edema, triamcinolone
376320|NCT01342146|pegylated Somatropin|pegylated somatropin
376321|NCT01342146|PEG-GH|peg-gh
376322|NCT01342146|Growth hormone|growth hormone
376323|NCT01342146|PEG-rhGH|peg-rhgh
376324|NCT01342146|Growth hormone deficiency (GHD)|growth hormone deficiency (ghd)
376325|NCT01342146|Phase 2 study|phase 2 study
376326|NCT01342120|atypical antipsychotics|atypical antipsychotics
376327|NCT01342120|quetiapine|quetiapine
376328|NCT01342107|Contact Lenses|contact lenses
376329|NCT01342107|Contact Lens Care|contact lens care
376330|NCT01342107|Multi-Purpose Solution Wettability|multi-purpose solution wettability
376331|NCT01342107|Myopia|myopia
376332|NCT01342094|Primary open angle glaucoma or ocular hypertension|primary open angle glaucoma or ocular hypertension
376333|NCT01342081|Primary open angle glaucoma or ocular hypertension|primary open angle glaucoma or ocular hypertension
376334|NCT01342068|Thoracic outlet syndrome|thoracic outlet syndrome
376335|NCT01342068|Osteopathic medicine|osteopathic medicine
376336|NCT01342068|Osteopathic Manual Manipulations|osteopathic manual manipulations
376337|NCT01342068|OMT|omt
376338|NCT01342068|Wright's Test|wright's test
376339|NCT01342068|Adson's Test|adson's test
376340|NCT01342068|Halstead's Maneuver|halstead's maneuver
376341|NCT01342068|TOS|tos
376342|NCT01342068|Vascular Sonography|vascular sonography
376343|NCT01342042|diabetes|diabetes
376344|NCT01342042|rRE-4|rre-4
376345|NCT01342042|exenatide|exenatide
376346|NCT01342042|metformin|metformin
376347|NCT01342042|CSPC ZhongQi|cspc zhongqi
376348|NCT01342029|Microvascular Coronary Dysfunction (MCD)|microvascular coronary dysfunction (mcd)
376349|NCT01342016|prograf|prograf
376350|NCT01342016|nephritis|nephritis
376351|NCT01342016|leflunomide|leflunomide
376352|NCT01342016|immunosuppressant|immunosuppressant
376353|NCT01342003|HCV infection|hcv infection
376354|NCT01342003|genotype 1a|genotype 1a
376355|NCT01342003|genotype 1 b|genotype 1 b
376356|NCT01341990|Contact Lenses|contact lenses
376357|NCT01341990|Contact Lens Care|contact lens care
376358|NCT01341990|Multi-Purpose Solution|multi-purpose solution
376359|NCT01341977|Contact Lenses|contact lenses
376360|NCT01341977|Contact Lens Care|contact lens care
376361|NCT01341977|Multi-Purpose Solution|multi-purpose solution
376362|NCT01341964|Clopidogrel|clopidogrel
376363|NCT01341964|Aspirin|aspirin
376364|NCT01341964|Interaction|interaction
376365|NCT01341951|liver failure, Acute|liver failure, acute
376366|NCT01341938|Smokeless Tobacco Use|smokeless tobacco use
376367|NCT01341925|childhood depression|childhood depression
376368|NCT01341899|Type 1 diabetes|type 1 diabetes
376369|NCT01341899|stem cell|stem cell
376370|NCT01341899|C-peptide|c-peptide
376371|NCT01341899|Immune function|immune function
376372|NCT01341886|differentiated thyroid cancer|differentiated thyroid cancer
376373|NCT01341886|THS suppression|ths suppression
376374|NCT01341886|metformin|metformin
376377|NCT01341821|Team Climate|team climate
376378|NCT01341808|Crohn's disease|crohn's disease
376379|NCT01341808|Ulcerative colitis|ulcerative colitis
376380|NCT01341808|Hepatitis A|hepatitis a
376382|NCT01341795|Newly diagnosed type 2 diabetes patients|newly diagnosed type 2 diabetes patients
376383|NCT01341782|Secondary hyperparathyroidism|secondary hyperparathyroidism
376384|NCT01341782|Paricalcitol|paricalcitol
376385|NCT01341782|Hemodialysis|hemodialysis
376386|NCT01341782|Maxacalcitol|maxacalcitol
376387|NCT01341756|Gastric Cancer|gastric cancer
376388|NCT01341756|Radiotherapy|radiotherapy
376389|NCT01341756|palliation|palliation
376390|NCT01341756|bleeding|bleeding
376391|NCT01341756|pain|pain
376392|NCT01341756|obstruction|obstruction
376393|NCT01341743|chronic hepatitis B|chronic hepatitis b
376394|NCT01341743|inadequate response|inadequate response
376395|NCT01341743|NUC therapy|nuc therapy
376396|NCT01341730|Atherosclerosis|atherosclerosis
376397|NCT01341730|Pioglitazone|pioglitazone
376398|NCT01341730|Atorvastatin|atorvastatin
376399|NCT01341730|PET CT|pet ct
376400|NCT01341717|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
376401|NCT01341717|Sitagliptin|sitagliptin
376402|NCT01341717|Insulin|insulin
376403|NCT01341704|malaria|malaria
376404|NCT01341704|vaccine|vaccine
376405|NCT01341704|clinical trials|clinical trials
376406|NCT01341704|proof of concept|proof of concept
376407|NCT01341704|efficacy|efficacy
376408|NCT01341691|chronic kidney disease|chronic kidney disease
376409|NCT01341691|K2CG chewing gum|k2cg chewing gum
376410|NCT01341691|phosphorus|phosphorus
376411|NCT01341691|saliva|saliva
376412|NCT01341678|chronic kidney disease|chronic kidney disease
376413|NCT01341678|phosphorus|phosphorus
376414|NCT01341678|circadian rhythm|circadian rhythm
376415|NCT01341678|saliva|saliva
376416|NCT01341665|hyponatremia|hyponatremia
376417|NCT01341665|SIADH|siadh
376418|NCT01341665|copeptin|copeptin
376419|NCT01341639|combination vaccine|combination vaccine
376420|NCT01341639|diphtheria|diphtheria
376421|NCT01341639|pertussis|pertussis
376422|NCT01341639|tetanus|tetanus
376423|NCT01341639|hepatitis B|hepatitis b
376424|NCT01341639|Hep B|hep b
376425|NCT01341639|Haemophilus influenzae b|haemophilus influenzae b
376426|NCT01341639|Hib|hib
376427|NCT01341639|polio|polio
376428|NCT01341639|poliovirus|poliovirus
376429|NCT01341626|delinquency|delinquency
376430|NCT01341626|drug use|drug use
376431|NCT01341626|HIV risk behavior|hiv risk behavior
376432|NCT01341626|economic costs|economic costs
376433|NCT01341600|Clopidogrel|clopidogrel
376434|NCT01341600|Pharmacogenetics|pharmacogenetics
376435|NCT01341600|Platelets|platelets
376436|NCT01341600|Healthy Subjects|healthy subjects
376437|NCT01341587|SMBG (self monitoring of blood glucose)|smbg (self monitoring of blood glucose)
376438|NCT01341587|diabetes|diabetes
376439|NCT01341587|mobile technology|mobile technology
376440|NCT01341574|spatial neglect|spatial neglect
376441|NCT01341574|stroke|stroke
376443|NCT01341548|Cluster Headache|cluster headache
376444|NCT01341548|Episodic Cluster|episodic cluster
376445|NCT01341548|Headache|headache
376446|NCT01341548|Phase 3|phase 3
376447|NCT01341548|Civamide|civamide
376448|NCT01341548|TRPV-1 Receptor|trpv-1 receptor
376449|NCT01341509|Surgical Treatment of Insertional Achilles Tendinopathy|surgical treatment of insertional achilles tendinopathy
376450|NCT01341496|Metastatic Cancer|metastatic cancer
376451|NCT01341496|Cancer Vaccine|cancer vaccine
376452|NCT01341496|Immunotherapy|immunotherapy
376453|NCT01341496|Chest Metastases|chest metastases
376454|NCT01341496|Sarcoma|sarcoma
376455|NCT01341496|Melanoma|melanoma
376456|NCT01341483|erectile dysfunction|erectile dysfunction
376457|NCT01341483|internal pudendal artery|internal pudendal artery
376458|NCT01341483|erection|erection
376459|NCT01341483|coronary artery disease|coronary artery disease
376460|NCT01341483|peripheral atherosclerotic disease|peripheral atherosclerotic disease
376461|NCT01341431|Parkinson disease|parkinson disease
376462|NCT01341431|Bee venom|bee venom
376463|NCT01341431|Motor fluctuations|motor fluctuations
376464|NCT01341431|Disease progression|disease progression
376465|NCT01341418|tibia|tibia
376466|NCT01341418|suprapatellar|suprapatellar
376467|NCT01341392|Drug-Drug interaction between the CKD-501 and Amlodipine|drug-drug interaction between the ckd-501 and amlodipine
376468|NCT01341379|Ureagenesis|ureagenesis
376469|NCT01341379|Urea cycle|urea cycle
376470|NCT01341379|Inborn errors of metabolism|inborn errors of metabolism
376471|NCT01341366|Laparoscopic surgery|laparoscopic surgery
376472|NCT01341340|Stent|stent
376473|NCT01341340|Infrapopliteal|infrapopliteal
376474|NCT01341340|Tibial|tibial
376475|NCT01341340|Limb Salvage|limb salvage
376476|NCT01341327|Left Main|left main
376481|NCT01341301|HSCT|hsct
376482|NCT01341301|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
376483|NCT01341288|prostate cancer|prostate cancer
376484|NCT01341288|EUCLIDIAN|euclidian
376485|NCT01341288|Endo-Uro Computed Lattice for Intratumoral Delivery, Implantation, Ablation with Nanosensing|endo-uro computed lattice for intratumoral delivery, implantation, ablation with nanosensing
376486|NCT01341288|robot|robot
376487|NCT01341288|brachytherapy|brachytherapy
376488|NCT01341288|seed implantation|seed implantation
376489|NCT01341275|hepatitis B vaccine|hepatitis b vaccine
376490|NCT01341275|duration of protection|duration of protection
376491|NCT01341275|adolescent immunization|adolescent immunization
376492|NCT01341275|anamnestic response|anamnestic response
376493|NCT01341275|booster dose|booster dose
376494|NCT01341275|Immunity to hepatitis B as measured by anti-HBSAg titers|immunity to hepatitis b as measured by anti-hbsag titers
376495|NCT01341262|autologous stem cell transplantation|autologous stem cell transplantation
376496|NCT01341262|thalidomide|thalidomide
376497|NCT01341262|induction therapy|induction therapy
376498|NCT01341236|VLBW|vlbw
376499|NCT01341236|IUGR|iugr
376500|NCT01341236|NIRS|nirs
376501|NCT01341236|enteral nutrition|enteral nutrition
376502|NCT01341236|superior mesenteric artery doppler|superior mesenteric artery doppler
376503|NCT01341210|Patients Satisfaction|patients satisfaction
376504|NCT01341210|Decision Making|decision making
376505|NCT01341210|Informed Consent|informed consent
376506|NCT01341197|Fecal immunochemical test|fecal immunochemical test
376507|NCT01341197|Guaiac fecal occult blood test|guaiac fecal occult blood test
376508|NCT01341197|Helicobacter pylori stool antigen test|helicobacter pylori stool antigen test
376509|NCT01341197|Mass screening|mass screening
376510|NCT01341197|Bidirectional endoscopy|bidirectional endoscopy
376511|NCT01341184|rifabutin|rifabutin
376512|NCT01341184|rifampin|rifampin
376513|NCT01341184|TMC207|tmc207
376514|NCT01341184|tuberculosis|tuberculosis
376515|NCT01341171|tamoxifen|tamoxifen
376516|NCT01341171|aromatase inhibitors|aromatase inhibitors
376517|NCT01341171|breast cancer|breast cancer
376518|NCT01341171|platelets|platelets
376519|NCT01341158|Malignatn Melanoma|malignatn melanoma
376520|NCT01341145|hypertension|hypertension
376521|NCT01341145|aerobic exercise|aerobic exercise
376522|NCT01341145|relaxation|relaxation
376523|NCT01341145|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
376524|NCT01341145|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
376525|NCT01341145|brain health|brain health
376526|NCT01341132|HCC|hcc
376527|NCT01341132|Hepatocellular Carcinoma|hepatocellular carcinoma
376528|NCT01341132|MRI|mri
376529|NCT01341132|Liver|liver
376530|NCT01340157|Fexinidazole|fexinidazole
376531|NCT01340157|Phase I|phase i
376532|NCT01340157|Bioavailability study|bioavailability study
376533|NCT01340157|Food effect|food effect
376534|NCT01340157|Human African Trypanosomiasis|human african trypanosomiasis
376535|NCT01340144|total knee replacement|total knee replacement
376536|NCT01340144|patellar crepitus|patellar crepitus
376537|NCT01340144|Replacement of knee joint|replacement of knee joint
376538|NCT01340131|CKD-828|ckd-828
376539|NCT01340131|Hypertension|hypertension
376540|NCT01340131|Primary Hypertension|primary hypertension
376541|NCT01340131|Healthy Volunteer|healthy volunteer
376542|NCT01340131|S-Amlodipine|s-amlodipine
376543|NCT01340131|Telmisartan|telmisartan
376544|NCT01340131|Amlodipine|amlodipine
376545|NCT01340131|Pharmacokinetic|pharmacokinetic
376546|NCT01340131|Phase 1|phase 1
376547|NCT01340118|Asthma|asthma
376548|NCT01340118|FEF25-75|fef25-75
376549|NCT01340118|exhaled nitric oxide|exhaled nitric oxide
376550|NCT01340118|inhaled corticosteroid|inhaled corticosteroid
376551|NCT01340118|children|children
376552|NCT01340105|Microwave ablation|microwave ablation
376553|NCT01340105|Radiofrequency ablation|radiofrequency ablation
376554|NCT01340105|Randomised controlled trial|randomised controlled trial
376555|NCT01340092|Family Navigator|family navigator
376556|NCT01340092|Autistic Disorder|autistic disorder
376557|NCT01340092|Early Intervention|early intervention
376558|NCT01340092|Developmental Disabilities|developmental disabilities
376559|NCT01340092|Child Development Disorders|child development disorders
376560|NCT01341106|chronic hepatitis B|chronic hepatitis b
376561|NCT01341106|liver fibrosis|liver fibrosis
367285|NCT01379625|TFP|tfp
376562|NCT01341106|treatment with Entecavir|treatment with entecavir
376563|NCT01341080|Balance|balance
376564|NCT01341080|Postural impairment|postural impairment
376565|NCT01341080|Falls|falls
376566|NCT01341080|Parkinson Disease|parkinson disease
376567|NCT01341054|mucositis|mucositis
376568|NCT01341054|chamomilla|chamomilla
590700|NCT00540943|cetuximab|cetuximab
376569|NCT01341054|therapeutics|therapeutics
376571|NCT01341028|appetite|appetite
376572|NCT01341028|ghrelin|ghrelin
376573|NCT01341028|PYY|pyy
376574|NCT01341028|GLP-1|glp-1
376575|NCT01341028|insulin|insulin
376576|NCT01341028|laparoscopic|laparoscopic
376577|NCT01341028|Roux-en-Y gastric bypass|roux-en-y gastric bypass
376578|NCT01341028|gastric fundus resection|gastric fundus resection
376579|NCT01341002|Postoperative Care|postoperative care
376580|NCT01341002|red blood cell transfusion|red blood cell transfusion
376581|NCT01341002|venous oxygen saturation|venous oxygen saturation
376582|NCT01340989|women undergoing laparoscopic surgery for: hysterectomy, colpopexy, endometriosis, adhesions or myomas|women undergoing laparoscopic surgery for: hysterectomy, colpopexy, endometriosis, adhesions or myomas
376583|NCT01340976|Cancer Related Anemia|cancer related anemia
376584|NCT01340963|Chagas heart disease|chagas heart disease
376585|NCT01340963|ventricular tachycardia|ventricular tachycardia
376586|NCT01340963|atrial fibrillation|atrial fibrillation
376587|NCT01340963|stroke|stroke
376588|NCT01340963|cardiac death|cardiac death
376589|NCT01340963|signal averaged electrocardiogram|signal averaged electrocardiogram
376590|NCT01340950|Prevention|prevention
376591|NCT01340950|Anti-Retroviral Agents|anti-retroviral agents
376592|NCT01340950|Neuropsychological Tests|neuropsychological tests
376593|NCT01340937|Diphtheria|diphtheria
376594|NCT01340937|Tetanus|tetanus
376595|NCT01340937|Whooping Cough (pertussis)|whooping cough (pertussis)
376596|NCT01340937|Poliomyelitis|poliomyelitis
376597|NCT01340937|Hepatitis B infection|hepatitis b infection
376598|NCT01340937|Haemophilus influenzae type b infection|haemophilus influenzae type b infection
376599|NCT01340924|Gestational diabetes|gestational diabetes
376600|NCT01340924|Type 2 diabetes|type 2 diabetes
376601|NCT01340898|meningococcal conjugate vaccine|meningococcal conjugate vaccine
376602|NCT01340898|serogroups A,C, W-135 or Y|serogroups a,c, w-135 or y
376603|NCT01340898|meningococcal diseases|meningococcal diseases
376604|NCT01340898|Immunogenicity|immunogenicity
376605|NCT01340898|Neisseria meningitidis|neisseria meningitidis
376606|NCT01340898|co-administration|co-administration
376607|NCT01340898|routine vaccines|routine vaccines
376608|NCT01340885|attention|attention
376609|NCT01340885|mild cognitive impairment|mild cognitive impairment
376610|NCT01340885|dementia|dementia
376611|NCT01340872|iron deficiency|iron deficiency
376612|NCT01340872|anaemia|anaemia
376613|NCT01340872|inflammatory bowel disease|inflammatory bowel disease
376614|NCT01340872|ulcerative colitis|ulcerative colitis
376615|NCT01340859|Suicide|suicide
376616|NCT01340859|Cognitive Therapy|cognitive therapy
376617|NCT01340859|Inpatient|inpatient
376618|NCT01340859|Military|military
376619|NCT01340846|ketoconazole|ketoconazole
376620|NCT01340846|GSK2118436|gsk2118436
376621|NCT01340846|warfarin|warfarin
376622|NCT01340846|gemfibrozil|gemfibrozil
376623|NCT01340846|oncology|oncology
376624|NCT01340846|BRAF inhibitor|braf inhibitor
376625|NCT01340846|BRAF|braf
376626|NCT01340846|BRAF positive tumor|braf positive tumor
376627|NCT01340846|Drug Interactions|drug interactions
376628|NCT01340833|GSK2118436|gsk2118436
376629|NCT01340833|BRAF inhibitor|braf inhibitor
376630|NCT01340833|BRAF-mutation positive tumor|braf-mutation positive tumor
376631|NCT01340833|Oncology|oncology
376632|NCT01340833|absolute bioavailability|absolute bioavailability
376633|NCT01340833|microtracer|microtracer
376634|NCT01340781|inpatients|inpatients
376635|NCT01340781|medical|medical
376636|NCT01340781|polysomnogram|polysomnogram
376637|NCT01340781|questionnaires|questionnaires
376736|NCT01340300|Breast|breast
376638|NCT01340768|Glucose metabolism disorders Metabolic diseases Peptidase inhibitors|glucose metabolism disorders metabolic diseases peptidase inhibitors
376639|NCT01340755|Rectal cancer|rectal cancer
376640|NCT01340742|Remote ischemic preconditioning|remote ischemic preconditioning
376641|NCT01340742|Abdominal surgery|abdominal surgery
376642|NCT01340742|Perioperative complications|perioperative complications
376643|NCT01340729|melanoma|melanoma
376644|NCT01340729|TPI 287|tpi 287
376645|NCT01340729|tumor recurrence|tumor recurrence
376646|NCT01340729|tumor progression|tumor progression
376647|NCT01340729|novel taxane analog|novel taxane analog
376648|NCT01340703|optic disc pit|optic disc pit
376649|NCT01340703|retinal detachment|retinal detachment
376650|NCT01340703|retinoschisis|retinoschisis
376651|NCT01340703|vitrectomy|vitrectomy
376652|NCT01340703|posterior vitreous detachment|posterior vitreous detachment
376653|NCT01340690|ADHD|adhd
376654|NCT01340690|children|children
376655|NCT01340690|adolescents|adolescents
376656|NCT01340690|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
376657|NCT01340690|ADHDRS - IV|adhdrs - iv
376658|NCT01340677|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
376659|NCT01340677|Pharmacokinetic|pharmacokinetic
376660|NCT01340677|Dose proportionality|dose proportionality
376661|NCT01340664|Canagliflozin|canagliflozin
376662|NCT01340664|Placebo|placebo
376663|NCT01340664|Metformin|metformin
376664|NCT01340664|Hemoglobin A1c|hemoglobin a1c
376248|NCT01342471|TV|tv
376665|NCT01340664|Type 2 diabetes mellitus|type 2 diabetes mellitus
376667|NCT01340651|myeloproliferative neoplasms|myeloproliferative neoplasms
376669|NCT01340651|PET-MF|pet-mf
376670|NCT01340651|PPV-MF|ppv-mf
376671|NCT01340638|Seal pressure|seal pressure
376672|NCT01340638|Cookgas|cookgas
376673|NCT01340638|AirQ|airq
376675|NCT01340638|supraglottic device|supraglottic device
376676|NCT01340625|Healthy Subjects|healthy subjects
376677|NCT01340612|large aneurysm|large aneurysm
376678|NCT01340612|wide-necked aneurysm|wide-necked aneurysm
376679|NCT01340612|recurring aneurysm|recurring aneurysm
376680|NCT01340586|PHARMACOKINETIC|pharmacokinetic
376681|NCT01340586|NOS|nos
376682|NCT01340573|Chronic Hepatitis C|chronic hepatitis c
376683|NCT01340573|pegylated interferon|pegylated interferon
376684|NCT01340573|PegIntron Pen|pegintron pen
376685|NCT01340573|Ribavirin|ribavirin
376686|NCT01340560|Endometrium, local injury, implantation, pregnancy, in vitro fertilization|endometrium, local injury, implantation, pregnancy, in vitro fertilization
376687|NCT01340547|Phase I|phase i
376688|NCT01340547|Safety|safety
376689|NCT01340547|PK|pk
376690|NCT01340547|ECG QTc|ecg qtc
376691|NCT01340547|Efficacy|efficacy
376692|NCT01340547|Palifosfamide-tris|palifosfamide-tris
376693|NCT01340547|non-randomized|non-randomized
376694|NCT01340534|Surgical wound infection|surgical wound infection
376695|NCT01340534|Oxygen|oxygen
376696|NCT01340534|Cesarean|cesarean
376697|NCT01340521|Pituitary Hormone Response|pituitary hormone response
376698|NCT01340521|Clomiphene Citrate|clomiphene citrate
376699|NCT01340521|Follicle Stimulating Hormone|follicle stimulating hormone
376700|NCT01340521|Luteinizing Hormone|luteinizing hormone
376701|NCT01340508|Pathological complete response|pathological complete response
376702|NCT01340508|Intensity modulated radiotherapy|intensity modulated radiotherapy
376703|NCT01340508|Rectal cancer|rectal cancer
376704|NCT01340495|Breast Cancer|breast cancer
376705|NCT01340495|Mastectomy|mastectomy
376706|NCT01340482|XLH|xlh
376707|NCT01340469|nosocomial infections|nosocomial infections
376708|NCT01340469|necrotizing enterocolitis|necrotizing enterocolitis
376709|NCT01340469|preterm infants|preterm infants
376710|NCT01340469|ver low birth weight|ver low birth weight
376711|NCT01340469|probiotics|probiotics
376712|NCT01340456|4beta-OHcholesterol|4beta-ohcholesterol
376713|NCT01340456|Midazolam|midazolam
376714|NCT01340456|CYP3A4|cyp3a4
376715|NCT01340456|Enzyme induction|enzyme induction
376716|NCT01340456|Drug metabolism|drug metabolism
376717|NCT01340430|her2 positive breast cancer|her2 positive breast cancer
376718|NCT01340430|her2 positive non operable breast cancer|her2 positive non operable breast cancer
376719|NCT01340430|her2 positive locally advanced breast cancer|her2 positive locally advanced breast cancer
376720|NCT01340430|neoadjuvant trastuzumab|neoadjuvant trastuzumab
376721|NCT01340430|pathologic complete response|pathologic complete response
376722|NCT01340417|melatonin|melatonin
376723|NCT01340417|preterm|preterm
376724|NCT01340417|deficiency|deficiency
376725|NCT01340417|neuroprotection|neuroprotection
376726|NCT01340391|cast, radius fracture|cast, radius fracture
376727|NCT01340378|neonatal surgery|neonatal surgery
376728|NCT01340378|Blalock-Taussig shunt|blalock-taussig shunt
376729|NCT01340339|Jaundice|jaundice
376730|NCT01340339|Hyperbilirubinemia|hyperbilirubinemia
376731|NCT01340339|Phototherapy and Super-LED Fluorescent lamps|phototherapy and super-led fluorescent lamps
376732|NCT01340326|Post myocardial infarction ventricular remodeling|post myocardial infarction ventricular remodeling
376733|NCT01340326|valsartan|valsartan
376734|NCT01340313|caudal block, children, ultrasound, urological surgery|caudal block, children, ultrasound, urological surgery
376737|NCT01340300|Insulin|insulin
376738|NCT01340300|Exercise|exercise
376739|NCT01340287|Plant sterol|plant sterol
376740|NCT01340287|Hypercholesterolemia|hypercholesterolemia
376741|NCT01340287|diet|diet
376742|NCT01340287|dairy|dairy
376743|NCT01340287|isoprostanes|isoprostanes
376744|NCT01340287|Midly hypercholesterolemic subjects|midly hypercholesterolemic subjects
376745|NCT01340274|Community Reinforcement and Family Training|community reinforcement and family training
376746|NCT01340274|Concerned Significant Others|concerned significant others
376747|NCT01340274|Identified Problem Gambler|identified problem gambler
376748|NCT01340274|Therapeutics|therapeutics
376749|NCT01340248|food effect|food effect
376750|NCT01340248|pharmacokinetics|pharmacokinetics
376751|NCT01340248|healthy male volunteers|healthy male volunteers
376752|NCT01340222|Preterm labour|preterm labour
376753|NCT01340222|monocyte|monocyte
376754|NCT01340222|lymphocyte|lymphocyte
376756|NCT01340222|Treg Lymphocytes|treg lymphocytes
376757|NCT01340222|biologic markers|biologic markers
376758|NCT01340222|immunology|immunology
376759|NCT01340222|HLA-DR|hla-dr
376760|NCT01340222|Th17|th17
376761|NCT01340183|Phase I|phase i
376762|NCT01340183|safety|safety
376763|NCT01340183|tolerability|tolerability
376764|NCT01340183|pharmacokinetics|pharmacokinetics
376765|NCT01340183|AZD5099|azd5099
376766|NCT01340183|volunteers|volunteers
376767|NCT01340183|safety of the drug AZD5099|safety of the drug azd5099
376768|NCT01340183|blood and urine levels of AZD5099|blood and urine levels of azd5099
376769|NCT01340183|single intravenous doses|single intravenous doses
376770|NCT01340183|healthy volunteers|healthy volunteers
376771|NCT01340079|diabetes mellitus, non-insulin dependent|diabetes mellitus, non-insulin dependent
376772|NCT01340066|urinary incontinence|urinary incontinence
376773|NCT01340066|stress incontinence|stress incontinence
376774|NCT01340066|urge incontinence|urge incontinence
376775|NCT01340066|mixed incontinence|mixed incontinence
376776|NCT01340040|Phase I|phase i
376777|NCT01340040|cancer|cancer
376778|NCT01340040|solid tumours|solid tumours
376779|NCT01340040|advanced solid malignancies|advanced solid malignancies
376780|NCT01340040|dose escalation|dose escalation
376781|NCT01340040|Insulin like growth factor|insulin like growth factor
376782|NCT01340040|Japanese|japanese
376783|NCT01340027|Overactive bladder (OAB)|overactive bladder (oab)
376784|NCT01340027|Frequency|frequency
376785|NCT01340027|Micturition|micturition
376786|NCT01340027|Urgency|urgency
376787|NCT01340027|Urinary incontinence|urinary incontinence
376788|NCT01340027|Urgency incontinence|urgency incontinence
376789|NCT01340027|YM178|ym178
376790|NCT01340014|Glaucoma|glaucoma
376791|NCT01340014|Intraocular pressure|intraocular pressure
376792|NCT01340014|Tonometry, ocular|tonometry, ocular
376793|NCT01340001|Dementia with Lewy bodies|dementia with lewy bodies
376794|NCT01340001|Nucleus basalis of Meynert|nucleus basalis of meynert
376795|NCT01340001|Deep brain stimulation|deep brain stimulation
376796|NCT01339988|Stem-cells|stem-cells
376797|NCT01339988|Transplantation|transplantation
376798|NCT01339988|Busulfex|busulfex
376799|NCT01339988|Cyclophosphamide|cyclophosphamide
376800|NCT01339988|Total-Body-Ittadiation|total-body-ittadiation
376801|NCT01339975|Renal Cell Carcinoma|renal cell carcinoma
376802|NCT01339975|Nephrectomy|nephrectomy
376803|NCT01339975|Antiangiogenics|antiangiogenics
376804|NCT01339975|Chemokines|chemokines
376805|NCT01339975|Prognostic value|prognostic value
376806|NCT01339975|Carcinoma|carcinoma
376807|NCT01339975|Carcinoma, Renal Cell|carcinoma, renal cell
376808|NCT01339975|Kidney Neoplasms|kidney neoplasms
376809|NCT01339975|Kidney Diseases|kidney diseases
376810|NCT01339975|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
377011|NCT01339130|Stroke|stroke
376811|NCT01339975|Neoplasms by Histologic Type|neoplasms by histologic type
376812|NCT01339975|Neoplasms|neoplasms
376813|NCT01339975|Adenocarcinoma|adenocarcinoma
376814|NCT01339975|Urologic Neoplasms|urologic neoplasms
376815|NCT01339975|Urogenital Neoplasms|urogenital neoplasms
376816|NCT01339975|Neoplasms by Site|neoplasms by site
376817|NCT01339975|Urologic Diseases|urologic diseases
376818|NCT01339975|Adjuvants, Immunologic|adjuvants, immunologic
376819|NCT01339975|Physiological Effects of Drugs|physiological effects of drugs
376820|NCT01339975|Pharmacologic Actions|pharmacologic actions
376821|NCT01339975|Biomarkers|biomarkers
376822|NCT01339975|Targeted therapies|targeted therapies
376823|NCT01339975|Surgery|surgery
376824|NCT01339962|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
376825|NCT01339949|AMD|amd
376826|NCT01339949|wet AMD|wet amd
376827|NCT01339949|Macular Degeneration|macular degeneration
376828|NCT01339949|wet Age-related Macular Degeneration|wet age-related macular degeneration
376829|NCT01339949|Age-Related Macular Degeneration|age-related macular degeneration
376830|NCT01339949|IRay|iray
376831|NCT01339949|radiation|radiation
376832|NCT01339949|Oraya|oraya
376833|NCT01339949|Oraya Therapeutics, Inc|oraya therapeutics, inc
376834|NCT01339949|Low-voltage stereotactic radiosurgery|low-voltage stereotactic radiosurgery
376835|NCT01339949|radiosurgery|radiosurgery
376836|NCT01339949|x-ray|x-ray
376837|NCT01339949|Lucentis|lucentis
376838|NCT01339949|external beam radiation|external beam radiation
376839|NCT01339923|Meningococcal disease|meningococcal disease
376840|NCT01339923|Vaccines|vaccines
376841|NCT01339923|intercalated administration|intercalated administration
376842|NCT01339910|Acute Myelogenous Leukemia|acute myelogenous leukemia
376843|NCT01339910|Myelodysplastic Syndrome|myelodysplastic syndrome
376844|NCT01339897|N6022, GSNORi|n6022, gsnori
376845|NCT01339884|Friedreich ataxia|friedreich ataxia
376846|NCT01339884|Resveratrol|resveratrol
376847|NCT01339884|Frataxin|frataxin
376848|NCT01339884|Cardiomyopathy|cardiomyopathy
376849|NCT01339884|Oxidative stress|oxidative stress
376850|NCT01339871|Pazopanib|pazopanib
376851|NCT01339871|Vorinostat|vorinostat
376852|NCT01339871|Advanced Malignancies|advanced malignancies
376853|NCT01339845|Cholera vaccine|cholera vaccine
376854|NCT01339845|Behaviour change intervention|behaviour change intervention
376855|NCT01339845|Cost effectiveness and cost-benefit|cost effectiveness and cost-benefit
376856|NCT01339845|Prevention of cholera|prevention of cholera
376857|NCT01339845|Control of Cholera|control of cholera
376858|NCT01339845|Vaccination|vaccination
376859|NCT01339806|mTBI|mtbi
376860|NCT01339806|Concussion|concussion
376861|NCT01339793|corporate social responsibility|corporate social responsibility
376862|NCT01339793|social identity theory|social identity theory
376863|NCT01339793|stakeholder theory|stakeholder theory
376864|NCT01339793|organizational commitment|organizational commitment
376865|NCT01339793|organizational performance|organizational performance
376866|NCT01339767|Autism|autism
376867|NCT01339767|Language Acquisition|language acquisition
376868|NCT01339767|Language Development|language development
376869|NCT01339767|Toddlers|toddlers
376870|NCT01339754|recurrent pancreatic cancer|recurrent pancreatic cancer
376871|NCT01339754|stage IV pancreatic cancer|stage iv pancreatic cancer
376872|NCT01339754|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
376873|NCT01339741|Psoriasis Vulgaris|psoriasis vulgaris
376874|NCT01339741|Vitamin D Deficiency|vitamin d deficiency
376875|NCT01339741|Vitamin D Insufficiency|vitamin d insufficiency
376876|NCT01339741|Vitamin D Supplement|vitamin d supplement
376877|NCT01339741|Psoriasis Area and Severity Index (PASI Score)|psoriasis area and severity index (pasi score)
376878|NCT01339741|Dermatologic Life Qualify Index (DLQI)|dermatologic life qualify index (dlqi)
376879|NCT01339715|Ryodoraku|ryodoraku
376880|NCT01339715|Heart Rate Variability|heart rate variability
376881|NCT01339715|Traditional medicine|traditional medicine
376882|NCT01339715|Autonomic Nervous System|autonomic nervous system
376883|NCT01339715|Acupuncture|acupuncture
376884|NCT01339715|Far Infrared Ray|far infrared ray
376885|NCT01339715|CV12 Acupoint|cv12 acupoint
376886|NCT01339702|Traumatic Brain Injury|traumatic brain injury
376887|NCT01339702|TBI|tbi
376888|NCT01339702|Head Trauma|head trauma
376889|NCT01339702|Acute Traumatic Brain Injury|acute traumatic brain injury
376890|NCT01339702|Trauma, Brain|trauma, brain
376891|NCT01339689|PTSD|ptsd
376892|NCT01339689|Posttraumatic Stress Disorder|posttraumatic stress disorder
376893|NCT01339689|pharmacotherapy|pharmacotherapy
376894|NCT01339689|ganaxolone|ganaxolone
376895|NCT01339676|Vitamin D|vitamin d
376896|NCT01339676|Multiple Sclerosis|multiple sclerosis
376897|NCT01339676|MRI|mri
376898|NCT01339676|Randomised Trial|randomised trial
376899|NCT01339676|Finland|finland
376900|NCT01339650|Solid Tumor|solid tumor
376901|NCT01339650|BRCA 1 and BRCA 2 Mutations|brca 1 and brca 2 mutations
376902|NCT01339650|Breast Cancer 1|breast cancer 1
376903|NCT01339650|Breast Cancer 2|breast cancer 2
376904|NCT01339650|High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancers|high grade serous ovarian, fallopian tube, or primary peritoneal cancers
376905|NCT01339650|Solid Tumors|solid tumors
376906|NCT01339637|Impaired Glucose Tolerance|impaired glucose tolerance
376907|NCT01339637|Diabetes Risk Factors|diabetes risk factors
376908|NCT01339637|Dark Skin|dark skin
376909|NCT01339624|analgesia|analgesia
376910|NCT01339624|renal colic|renal colic
376911|NCT01339624|ketorolac|ketorolac
376912|NCT01339624|nasal fentanyl|nasal fentanyl
376913|NCT01339624|morphine.|morphine.
376914|NCT01339624|treatment of acute renal colic|treatment of acute renal colic
376915|NCT01339611|quality of life|quality of life
376916|NCT01339611|medical adherence|medical adherence
376917|NCT01339611|warfarin|warfarin
376918|NCT01339611|Health education|health education
376919|NCT01339572|autologous transplantation|autologous transplantation
376920|NCT01339572|peripheral stem cell mobilization|peripheral stem cell mobilization
376921|NCT01339559|Epilepsy|epilepsy
376922|NCT01339559|Brivaracetam|brivaracetam
376923|NCT01339559|Partial Onset Seizures|partial onset seizures
376924|NCT01339559|Adjunctive treatment|adjunctive treatment
376925|NCT01339546|ecologic|ecologic
376926|NCT01339546|cross sectional|cross sectional
376927|NCT01339546|trend analysis|trend analysis
376928|NCT01339533|ALI|ali
376929|NCT01339533|ARDS|ards
376930|NCT01339481|Orencia|orencia
376931|NCT01339481|Abatacept|abatacept
376932|NCT01339481|Rheumatoid Arthritis|rheumatoid arthritis
376933|NCT01339481|Infusion|infusion
376934|NCT01339468|advagraf|advagraf
376935|NCT01339468|prograf|prograf
376936|NCT01339468|living donor liver transplantation|living donor liver transplantation
376937|NCT01339468|FK506|fk506
376938|NCT01339468|Immunosuppressant|immunosuppressant
376939|NCT01339455|Neuromyelitis Optica|neuromyelitis optica
376940|NCT01339455|NMO|nmo
376941|NCT01339455|Devic's Disease|devic's disease
376942|NCT01339455|Stem Cell Transplant|stem cell transplant
376943|NCT01339429|wound|wound
376944|NCT01339429|negative pressure wound therapy|negative pressure wound therapy
376945|NCT01339429|non-powered negative pressure wound therapy|non-powered negative pressure wound therapy
376946|NCT01339390|Obesity|obesity
376947|NCT01339390|Veteran|veteran
376948|NCT01339390|Self Care|self care
376949|NCT01339390|Patient Education|patient education
376950|NCT01339390|Peer Group|peer group
376951|NCT01339377|Ozone|ozone
376952|NCT01339377|Oxygen|oxygen
376953|NCT01339377|Oxygen-Ozone|oxygen-ozone
376954|NCT01339377|AO-1000|ao-1000
376955|NCT01339377|ActiveO|activeo
376956|NCT01339377|Herniated Disc|herniated disc
376957|NCT01339377|Disc|disc
376958|NCT01339377|Lumbar|lumbar
376959|NCT01339351|breast cancer|breast cancer
376960|NCT01339351|social connection|social connection
590701|NCT00540943|irinotecan,|irinotecan,
376961|NCT01339325|Laparo-endoscopic single site cholecystectomy|laparo-endoscopic single site cholecystectomy
376962|NCT01339325|Quality of Life|quality of life
376963|NCT01339325|Postoperative Pain|postoperative pain
376964|NCT01339325|Cosmetics|cosmetics
376965|NCT01339325|Complication|complication
376966|NCT01339312|Rabies|rabies
376967|NCT01339312|Rabies virus|rabies virus
376968|NCT01339312|Purified Vero Rabies Vaccine - Serum Free|purified vero rabies vaccine - serum free
376969|NCT01339299|COS|cos
376970|NCT01339299|ART|art
376971|NCT01339299|Infertility|infertility
376972|NCT01339273|TAP block|tap block
376973|NCT01339273|Laparoscopic hemicolectomy|laparoscopic hemicolectomy
376974|NCT01339273|Laparoscopic anterior resection|laparoscopic anterior resection
376975|NCT01339273|laparoscopic colonic resection|laparoscopic colonic resection
376976|NCT01339247|Bioequivalence|bioequivalence
376977|NCT01339247|Paroxetine reference/test|paroxetine reference/test
376978|NCT01339247|healthy volunteers|healthy volunteers
376979|NCT01339247|Fed condition|fed condition
376980|NCT01339234|treadmill exercise|treadmill exercise
376981|NCT01339234|rehabilitation|rehabilitation
376982|NCT01339234|progressive multiple sclerosis|progressive multiple sclerosis
376983|NCT01339234|functional ability|functional ability
376984|NCT01339234|quality of life|quality of life
376985|NCT01339234|fatigue|fatigue
376986|NCT01339221|Observational|observational
376987|NCT01339221|Rotarix™|rotarix™
376988|NCT01339221|post-marketing|post-marketing
376989|NCT01339208|Type 2 Diabetes|type 2 diabetes
376990|NCT01339195|Dementia|dementia
376991|NCT01339195|Alzheimer disease|alzheimer disease
376992|NCT01339195|stroke|stroke
376993|NCT01339195|cognitive impairment|cognitive impairment
376994|NCT01339182|somatropin|somatropin
376995|NCT01339182|PK|pk
376996|NCT01339182|PD|pd
376997|NCT01339182|male|male
376998|NCT01339182|pharmacokinetics|pharmacokinetics
376999|NCT01339182|pharmacodynamics|pharmacodynamics
377000|NCT01339182|safety|safety
377001|NCT01339169|YF476|yf476
377002|NCT01339169|Hypergastrinaemia|hypergastrinaemia
377003|NCT01339169|netazepide|netazepide
377004|NCT01339169|gastric carcinoids|gastric carcinoids
377005|NCT01339156|Safety|safety
377006|NCT01339156|Tolerability|tolerability
377007|NCT01339156|Food Effect|food effect
377008|NCT01339156|Pharmacokinetics|pharmacokinetics
377009|NCT01339143|Vildagliptin|vildagliptin
377010|NCT01339130|Alzheimer disease|alzheimer disease
377012|NCT01339130|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
377013|NCT01339130|Lewy Body Dementia|lewy body dementia
377014|NCT01339130|Huntington Disease|huntington disease
377015|NCT01339130|mild cognitive impairment|mild cognitive impairment
377016|NCT01339130|vascular injury|vascular injury
377017|NCT01339130|Parkinson's disease|parkinson's disease
377018|NCT01339117|irritable bowel syndrome|irritable bowel syndrome
377019|NCT01339117|children|children
377020|NCT01339117|chronic abdominal pain|chronic abdominal pain
377021|NCT01339117|recurrent abdominal pain|recurrent abdominal pain
377022|NCT01339104|Cardiovascular safety|cardiovascular safety
377023|NCT01339078|Biliary strictures|biliary strictures
377024|NCT01339078|liver transplantation|liver transplantation
377025|NCT01339065|ketamine|ketamine
377026|NCT01339065|inflammatory|inflammatory
377027|NCT01339065|pro inflammatory|pro inflammatory
377028|NCT01339065|pro inflammatory markers IL-6 and IL-1beta|pro inflammatory markers il-6 and il-1beta
377029|NCT01339052|BKM120|bkm120
377030|NCT01339052|Brain tumor|brain tumor
377031|NCT01339039|AMD3100|amd3100
377032|NCT01339039|plerixafor|plerixafor
377033|NCT01339039|Mozobil|mozobil
377034|NCT01339039|bevacizumab|bevacizumab
377035|NCT01339026|Acute coronary syndrome|acute coronary syndrome
377036|NCT01339026|Platelet reactivity|platelet reactivity
377037|NCT01339026|Clopidogrel|clopidogrel
377038|NCT01339026|Percutaneous coronary intervention|percutaneous coronary intervention
377039|NCT01339013|Quantification|quantification
377040|NCT01339013|ventilatory requirements|ventilatory requirements
377041|NCT01339013|charcoal filter|charcoal filter
377042|NCT01339000|Colorectal Cancer|colorectal cancer
377043|NCT01339000|Breast Cancer|breast cancer
377044|NCT01339000|Immunization|immunization
377045|NCT01339000|Immunocompromised Host|immunocompromised host
377046|NCT01339000|Bladder Cancer|bladder cancer
377047|NCT01339000|Colon Cancer|colon cancer
377049|NCT01338987|Lupron|lupron
377050|NCT01338987|Thymic Renewal|thymic renewal
377051|NCT01338987|Stem Cell Transplant|stem cell transplant
377052|NCT01338987|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
377053|NCT01338987|Acute Myelogenous Leukemia|acute myelogenous leukemia
377054|NCT01338987|Myelodyplastic Syndrome|myelodyplastic syndrome
377055|NCT01338974|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
377056|NCT01338974|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
377057|NCT01338974|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
377058|NCT01338974|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
377059|NCT01338974|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
377060|NCT01338974|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
377061|NCT01338974|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
377062|NCT01338974|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
377063|NCT01338974|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
377064|NCT01338974|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
377065|NCT01338974|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
377066|NCT01338974|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
377067|NCT01338974|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
377068|NCT01338974|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
377069|NCT01338974|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
377070|NCT01338974|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
377071|NCT01338961|Cardiopulmonary Bypass|cardiopulmonary bypass
377072|NCT01338961|Hypothermia|hypothermia
377073|NCT01338961|Normothermia|normothermia
377074|NCT01338961|Troponin I|troponin i
377075|NCT01338961|Bleeding|bleeding
377076|NCT01338935|CW 002|cw 002
377077|NCT01338935|Phase I trial|phase i trial
377078|NCT01338935|safety|safety
377079|NCT01338935|efficacy|efficacy
377080|NCT01338935|pharmacokinetics|pharmacokinetics
377081|NCT01338935|estimated dose|estimated dose
377082|NCT01338935|Neuromuscular Blocking Agents|neuromuscular blocking agents
377083|NCT01338935|Treatment Effectiveness|treatment effectiveness
377084|NCT01338935|Drug Antagonism|drug antagonism
377085|NCT01338909|prasugrel|prasugrel
377086|NCT01338909|clopidogrel|clopidogrel
377087|NCT01338909|primary percutaneous coronary intervention|primary percutaneous coronary intervention
377088|NCT01338909|high platelet reactivity|high platelet reactivity
377089|NCT01338896|Rotigotine|rotigotine
377090|NCT01338896|Neupro|neupro
377091|NCT01338883|HIV-1 Infection|hiv-1 infection
377092|NCT01338883|CCR5-tropic|ccr5-tropic
377093|NCT01338883|Anti-retroviral naive|anti-retroviral naive
377094|NCT01338870|Phase 2|phase 2
377095|NCT01338870|safety and efficacy study with PF-04991532|safety and efficacy study with pf-04991532
377096|NCT01338870|Type 2 diabetes|type 2 diabetes
377097|NCT01338857|neurofibromatosis1 (NF1)|neurofibromatosis1 (nf1)
377098|NCT01338857|Recurrent or progressive optic pathway gliomas (OPG)|recurrent or progressive optic pathway gliomas (opg)
377197|NCT01338428|rape|rape
377099|NCT01338857|Recurrent or progressive low-grade glioma|recurrent or progressive low-grade glioma
377100|NCT01338857|sorafenib|sorafenib
377101|NCT01338857|low-grade astrocytoma|low-grade astrocytoma
377102|NCT01338844|Poor oocyte quality|poor oocyte quality
377103|NCT01338844|IVF failure|ivf failure
377104|NCT01338831|prostate cancer,|prostate cancer,
377105|NCT01338831|breast cancer,|breast cancer,
377106|NCT01338831|prolactin,|prolactin,
377107|NCT01338831|prolactin receptor|prolactin receptor
377108|NCT01338831|uterine leiomyoma|uterine leiomyoma
377109|NCT01338818|Attention Deficit /Hyperactivity Disorder,|attention deficit /hyperactivity disorder,
377110|NCT01338818|hyperactivity|hyperactivity
377111|NCT01338805|Partial onset seizure|partial onset seizure
377112|NCT01338805|seizure frequency|seizure frequency
377113|NCT01338805|nervous system diseases|nervous system diseases
377114|NCT01338805|central nervous system diseases|central nervous system diseases
377116|NCT01338805|brain diseases|brain diseases
377117|NCT01338805|neurologic manifestations|neurologic manifestations
377118|NCT01338805|adjunctive treatment|adjunctive treatment
377119|NCT01338805|AEDs|aeds
377120|NCT01338805|antiepileptic drug|antiepileptic drug
377121|NCT01338779|Tolerance|tolerance
377122|NCT01338779|Renal|renal
377123|NCT01338779|Allograft|allograft
377124|NCT01338779|B Cell Signature|b cell signature
377125|NCT01338766|spondylolisthesis|spondylolisthesis
377126|NCT01338766|lumbar spinal stenosis|lumbar spinal stenosis
377127|NCT01338753|breast|breast
377128|NCT01338753|cancer|cancer
377129|NCT01338753|Pharmacogenomics|pharmacogenomics
377130|NCT01338753|bevacizumab|bevacizumab
377131|NCT01338740|Chrohn's disease|chrohn's disease
377132|NCT01338740|Moderate to severely active Crohn's disease patients|moderate to severely active crohn's disease patients
377133|NCT01338714|HBV carrier|hbv carrier
377134|NCT01338714|HBV DNA title|hbv dna title
377135|NCT01338714|Chinese Medicine|chinese medicine
377136|NCT01338714|Liver function|liver function
377137|NCT01338714|RHD-1|rhd-1
377138|NCT01338701|TBI|tbi
377139|NCT01338701|Headaches|headaches
377140|NCT01338701|Military|military
377141|NCT01338701|Acupuncture|acupuncture
377142|NCT01338701|Walter Reed Army Medical Center|walter reed army medical center
377143|NCT01338701|Fort Belvoir Community Hospital|fort belvoir community hospital
377144|NCT01338675|Chronic granulomatous disease|chronic granulomatous disease
377145|NCT01338675|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
377146|NCT01338662|Parkinson`s disease|parkinson`s disease
377147|NCT01338649|Parkinson's disease|parkinson's disease
377148|NCT01338649|Daytime somnolence|daytime somnolence
377149|NCT01338649|Sleepiness|sleepiness
377150|NCT01338649|Light therapy|light therapy
377151|NCT01338636|Exercise-induced pulmonary arterial hypertension (EIPAH)|exercise-induced pulmonary arterial hypertension (eipah)
377152|NCT01338636|Pulmonary arterial hypertension (PAH)|pulmonary arterial hypertension (pah)
377154|NCT01338636|Advanced cardiopulmonary exercise test (CPET)|advanced cardiopulmonary exercise test (cpet)
377155|NCT01338623|bioequivalence|bioequivalence
377156|NCT01338623|tansulosine|tansulosine
377157|NCT01338610|Ocular discomfort|ocular discomfort
377158|NCT01338597|thyroidectomy|thyroidectomy
377159|NCT01338597|invasiveness|invasiveness
377160|NCT01338584|Pelvic floor muscle training|pelvic floor muscle training
377161|NCT01338584|Post prostatectomy|post prostatectomy
377162|NCT01338584|Early regaining of urinary continence|early regaining of urinary continence
377163|NCT01338584|Positive improvement in quality of life|positive improvement in quality of life
377164|NCT01338571|stool fatty acid|stool fatty acid
377165|NCT01338532|Hip osteoarthritis|hip osteoarthritis
377166|NCT01338532|Exercise|exercise
377167|NCT01338532|Patient Education|patient education
377168|NCT01338532|Total Hip Replacement|total hip replacement
377169|NCT01338506|Military|military
377170|NCT01338506|Posttraumatic Stress Disorder|posttraumatic stress disorder
377172|NCT01338506|PostTraumatic Stress Disorders|posttraumatic stress disorders
377173|NCT01338506|Combat|combat
377174|NCT01338506|Psychological Treatment|psychological treatment
377175|NCT01338506|Psychotherapy|psychotherapy
377176|NCT01338506|Trauma|trauma
377177|NCT01338506|Posttraumatic Stress|posttraumatic stress
377178|NCT01338506|Prolonged Exposure|prolonged exposure
377179|NCT01338506|Exposure therapy|exposure therapy
377180|NCT01338506|Behavior Therapy|behavior therapy
377181|NCT01338506|Cognitive Behavior Therapy|cognitive behavior therapy
377182|NCT01338506|Stress Disorders|stress disorders
377183|NCT01338506|Drug Abuse|drug abuse
377184|NCT01338506|Drug Dependence|drug dependence
377185|NCT01338506|Alcohol Abuse|alcohol abuse
377186|NCT01338506|Alcohol Dependence|alcohol dependence
377187|NCT01338506|Substance Use Disorders|substance use disorders
377188|NCT01338506|Alcoholism|alcoholism
377189|NCT01338480|trauma|trauma
377190|NCT01338480|surgery|surgery
377191|NCT01338480|informed consent|informed consent
377192|NCT01338467|Glaucoma|glaucoma
377193|NCT01338467|Refractory glaucoma|refractory glaucoma
377194|NCT01338467|Cyclocoagulation|cyclocoagulation
377195|NCT01338467|High Intensity Focused Ultrasound|high intensity focused ultrasound
377196|NCT01338441|Drug induced QT prolongation|drug induced qt prolongation
377198|NCT01338428|sexual assault|sexual assault
377199|NCT01338428|intervention|intervention
377200|NCT01338428|female university students|female university students
377201|NCT01338415|pediatric|pediatric
377202|NCT01338415|pulmonary arterial hypertension|pulmonary arterial hypertension
377203|NCT01338415|bosentan|bosentan
377204|NCT01338415|Tracleer|tracleer
377205|NCT01338363|acid suppressing drugs|acid suppressing drugs
377206|NCT01338363|pharmacoepidemiology|pharmacoepidemiology
377207|NCT01338363|children|children
377208|NCT01338350|safety|safety
377209|NCT01338350|tolerability|tolerability
377210|NCT01338350|pharmacokinetics|pharmacokinetics
377211|NCT01338350|pharmacodynamics|pharmacodynamics
377212|NCT01338350|AZD5423|azd5423
377213|NCT01338350|Japanese|japanese
377214|NCT01338337|Low risk International Prognostic Scoring System (IPSS) (0 or Int-1)|low risk international prognostic scoring system (ipss) (0 or int-1)
377215|NCT01338337|Patients who have not responded to previous treatment with erythropoietin (EPO)|patients who have not responded to previous treatment with erythropoietin (epo)
377216|NCT01338337|Eastern Cooperative Oncology Group (ECOG) score ≤ 3|eastern cooperative oncology group (ecog) score ≤ 3
377217|NCT01338324|Biomarker|biomarker
377423|NCT01337466|Prosthetic|prosthetic
377218|NCT01338324|Pharmacokinetics|pharmacokinetics
377219|NCT01338324|Villous|villous
377220|NCT01338324|Simvastatin|simvastatin
377221|NCT01338324|Celiac disease|celiac disease
377222|NCT01338298|Schizophrenia|schizophrenia
377223|NCT01338298|Symptomatic Hyperprolactinemia|symptomatic hyperprolactinemia
377224|NCT01338298|Hormone|hormone
377225|NCT01338298|Menstrual|menstrual
377226|NCT01338285|Industry Hygiene|industry hygiene
377227|NCT01338285|Molecular Epidemiology|molecular epidemiology
377228|NCT01338285|Cancer Susceptability|cancer susceptability
377229|NCT01338285|Genotoxocity|genotoxocity
377230|NCT01338285|FISH|fish
377231|NCT01338142|postmenopausal|postmenopausal
377232|NCT01338142|women|women
377233|NCT01338142|absorption|absorption
377234|NCT01338142|calcium|calcium
377235|NCT01338142|amorphous calcium|amorphous calcium
377236|NCT01338129|vitamin c|vitamin c
377237|NCT01338129|ascorbic acid|ascorbic acid
377238|NCT01338129|ankle fracture|ankle fracture
377239|NCT01338129|crps|crps
377240|NCT01338129|rds|rds
377241|NCT01338129|crps prevention|crps prevention
377242|NCT01338116|computerized decision support system|computerized decision support system
377243|NCT01338116|PCR|pcr
377244|NCT01338116|antibiotic treatment|antibiotic treatment
377245|NCT01338103|Pemphigus|pemphigus
377246|NCT01338103|Rituximab|rituximab
377247|NCT01338103|Cylex|cylex
377248|NCT01338090|VEGF imaging|vegf imaging
377249|NCT01338090|neuroendocrine tumors|neuroendocrine tumors
377250|NCT01338090|biomarker|biomarker
377251|NCT01338090|mTOR inhibition|mtor inhibition
377252|NCT01338077|Alginate|alginate
377253|NCT01338077|Gastroesophageal reflux disease|gastroesophageal reflux disease
377254|NCT01338064|Silicosis|silicosis
377255|NCT01338051|Community based participatory research|community based participatory research
377256|NCT01338025|HIV|hiv
377257|NCT01338025|Bridging|bridging
377258|NCT01338025|Strategy|strategy
377259|NCT01338012|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
377260|NCT01338012|prostate cancer|prostate cancer
377261|NCT01338012|prostate|prostate
377262|NCT01338012|immune therapy|immune therapy
377263|NCT01338012|immunotherapy|immunotherapy
377264|NCT01338012|vaccine|vaccine
377265|NCT01338012|dendritic cells|dendritic cells
377266|NCT01338012|antigen-presenting cells|antigen-presenting cells
377267|NCT01338012|antigen presenting cells|antigen presenting cells
377268|NCT01338012|cancer vaccine|cancer vaccine
377269|NCT01338012|prostatic adenocarcinoma|prostatic adenocarcinoma
377270|NCT01338012|Sipuleucel-T|sipuleucel-t
377271|NCT01338012|castration resistant prostate cancer (CRPC)|castration resistant prostate cancer (crpc)
377272|NCT01338012|booster|booster
377273|NCT01338012|retreatment|retreatment
377274|NCT01338012|immune memory|immune memory
377275|NCT01338012|immune response|immune response
377276|NCT01337986|Multiple Sclerosis|multiple sclerosis
377277|NCT01337986|Optic Neuritis|optic neuritis
377278|NCT01337986|Ampyra|ampyra
377279|NCT01337986|Dalfampridine|dalfampridine
377280|NCT01337986|Fampridine|fampridine
377281|NCT01337986|Remote Optic Neuritis|remote optic neuritis
377282|NCT01337986|Contrast Sensitivity|contrast sensitivity
377283|NCT01337986|Treatment|treatment
377284|NCT01337973|violence|violence
377285|NCT01337973|aggression|aggression
377286|NCT01337973|Substance-Related Disorders|substance-related disorders
377287|NCT01337973|Alcohol-Related Disorders|alcohol-related disorders
377288|NCT01337973|Drug-Related Disorders|drug-related disorders
377289|NCT01337960|Stroke|stroke
377290|NCT01337960|Robotics|robotics
377291|NCT01337960|Neurorehabilitation|neurorehabilitation
377292|NCT01337947|Type 1 diabetes|type 1 diabetes
377293|NCT01337947|adolescents|adolescents
377294|NCT01337947|exercise|exercise
377295|NCT01337947|vascular function|vascular function
377296|NCT01337934|Septic shock|septic shock
377297|NCT01337934|Sepsis|sepsis
377298|NCT01337934|Albumin|albumin
377299|NCT01337934|Lactated Ringer|lactated ringer
377300|NCT01337908|depression|depression
377301|NCT01337908|quality of life|quality of life
377302|NCT01337908|disability|disability
377303|NCT01337895|Dairy|dairy
377304|NCT01337895|obesity|obesity
377305|NCT01337895|overweight|overweight
377306|NCT01337895|weight loss|weight loss
377307|NCT01337895|adults|adults
377308|NCT01337882|Air Pollution|air pollution
377309|NCT01337882|Diesel exhaust|diesel exhaust
377310|NCT01337882|Biodiesel exhaust|biodiesel exhaust
377311|NCT01337882|Vascular function|vascular function
377312|NCT01337882|Fibrinolysis|fibrinolysis
377313|NCT01337882|Acute vascular and endothelial responses|acute vascular and endothelial responses
377314|NCT01337869|Bascom Procedure, Limberg, Pilonidal Disease|bascom procedure, limberg, pilonidal disease
377315|NCT01337856|time-effectiveness|time-effectiveness
377316|NCT01337856|hand hygiene protocols|hand hygiene protocols
377317|NCT01337843|Chronic low back pain|chronic low back pain
377318|NCT01337843|cognitive behavioral pain management|cognitive behavioral pain management
377319|NCT01337843|coping|coping
377320|NCT01337843|mindfulness|mindfulness
377321|NCT01337843|physical activity|physical activity
377322|NCT01337843|Back Pain Lower Back Chronic|back pain lower back chronic
377323|NCT01337830|smoking|smoking
377324|NCT01337830|smokeless|smokeless
377325|NCT01337830|aversion|aversion
377326|NCT01337830|nicotine|nicotine
377327|NCT01337830|nicotine replacement|nicotine replacement
377328|NCT01337817|smoking|smoking
377329|NCT01337817|smokeless|smokeless
377330|NCT01337817|aversion|aversion
377331|NCT01337817|nicotine|nicotine
377332|NCT01337817|nicotine replacement|nicotine replacement
377333|NCT01337791|chronic hepatitis B|chronic hepatitis b
377334|NCT01337791|hepatitis B virus|hepatitis b virus
461396|NCT00046774|Lupus|lupus
377335|NCT01337791|perinatal transmission|perinatal transmission
377336|NCT01337791|Telbivudine|telbivudine
377337|NCT01337778|gender based violence|gender based violence
377338|NCT01337778|maternal and child health|maternal and child health
377339|NCT01337778|women|women
377340|NCT01337778|India|india
377341|NCT01337765|BEZ235,|bez235,
377342|NCT01337765|MEK162|mek162
590702|NCT00540943|pazopanib,|pazopanib,
377343|NCT01337765|RAS RAF mutations,|ras raf mutations,
377344|NCT01337765|triple negative breast cancer|triple negative breast cancer
377345|NCT01337765|pancreatic cancer,|pancreatic cancer,
377346|NCT01337765|NSCLC progressed on EGFR TKI|nsclc progressed on egfr tki
377347|NCT01337765|PI3K/mTOR inhibitor,|pi3k/mtor inhibitor,
377348|NCT01337765|MEK inhibitor|mek inhibitor
6931|NCT03246594|atrial fibrillation|atrial fibrillation
377349|NCT01337765|Advanced and selected solid tumors|advanced and selected solid tumors
377350|NCT01337752|multiple myeloma|multiple myeloma
377351|NCT01337752|renal insufficiency|renal insufficiency
377352|NCT01337752|untreated multiple myeloma|untreated multiple myeloma
377353|NCT01337739|Hysteroscopic Surgery|hysteroscopic surgery
377355|NCT01337739|Sedation|sedation
377356|NCT01337739|Opioids|opioids
377357|NCT01337726|Depression|depression
377358|NCT01337726|Heart Failure|heart failure
377359|NCT01337726|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
377360|NCT01337726|Quality of Life|quality of life
377361|NCT01337726|Functional Impairment|functional impairment
377362|NCT01337713|Anxiety, GAD, Massage|anxiety, gad, massage
377364|NCT01337700|Autism|autism
377365|NCT01337700|Autism Spectrum Disorder|autism spectrum disorder
377366|NCT01337700|Asperger Syndrome|asperger syndrome
377367|NCT01337700|Asperger|asperger
377368|NCT01337700|PDD|pdd
377369|NCT01337700|PDD-NOS|pdd-nos
377370|NCT01337687|Autism|autism
377371|NCT01337687|Autism Spectrum Disorders|autism spectrum disorders
377372|NCT01337687|Oxytocin|oxytocin
377373|NCT01337687|Hollander|hollander
377374|NCT01337687|ASD|asd
377375|NCT01337687|Asperger Syndrome|asperger syndrome
377376|NCT01337687|Asperger|asperger
377377|NCT01337661|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
377378|NCT01337661|COPD|copd
377379|NCT01337661|Acute Exacerbation of COPD|acute exacerbation of copd
377380|NCT01337661|AECOPD|aecopd
377381|NCT01337648|Fecal biomarkers|fecal biomarkers
377382|NCT01337648|Radiation biodosimetry|radiation biodosimetry
377383|NCT01337648|Total-body irradiation (TBI)|total-body irradiation (tbi)
377384|NCT01337648|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
377385|NCT01337648|Gene expression profiles|gene expression profiles
377386|NCT01337648|Fecal metabolites|fecal metabolites
377387|NCT01337609|Depression|depression
377388|NCT01337609|Irritable Bowel Syndrome|irritable bowel syndrome
377389|NCT01337609|Probiotic|probiotic
377390|NCT01337609|Bacillus Coagulans|bacillus coagulans
377391|NCT01337596|pain|pain
377392|NCT01337596|neuropathic pain|neuropathic pain
377393|NCT01337596|headaches|headaches
377394|NCT01337583|HIV Infections|hiv infections
377395|NCT01337583|Anti-HIV agents|anti-hiv agents
377396|NCT01337583|HIV-1|hiv-1
377397|NCT01337570|HIV Infections|hiv infections
377398|NCT01337570|Anti-HIV agents|anti-hiv agents
377399|NCT01337570|HIV-1|hiv-1
377400|NCT01337557|Allergic conjunctivitis|allergic conjunctivitis
377401|NCT01337544|HAPLOIDENTICAL STEM CELL TRANSPLANTATION|haploidentical stem cell transplantation
377402|NCT01337544|NK CELL|nk cell
377403|NCT01337544|IL-15|il-15
377404|NCT01337531|Ovarian Response in PCOS|ovarian response in pcos
377405|NCT01337531|pregnancy rate in PCOS|pregnancy rate in pcos
377406|NCT01337531|miscarriage rate in PCOS|miscarriage rate in pcos
377407|NCT01337518|Prostate Specific Antigen|prostate specific antigen
377408|NCT01337518|Castration Resistant Prostate Cancer|castration resistant prostate cancer
377409|NCT01337518|Adenocarcinoma|adenocarcinoma
377410|NCT01337518|Androgen Receptor|androgen receptor
377411|NCT01337518|Metastases|metastases
377412|NCT01337505|INNO-206|inno-206
377413|NCT01337505|Phase 1|phase 1
377414|NCT01337505|DOXO-EMCH|doxo-emch
377415|NCT01337505|Advanced solid tumors|advanced solid tumors
377416|NCT01337492|Hepatocellular Carcinoma|hepatocellular carcinoma
377417|NCT01337492|Orthotopic Liver Transplant|orthotopic liver transplant
377418|NCT01337466|Phase I|phase i
377419|NCT01337466|FIAU|fiau
377420|NCT01337466|Fialuridine|fialuridine
377421|NCT01337466|Biodistribution|biodistribution
377422|NCT01337466|Dosimetry|dosimetry
377424|NCT01337466|Joint|joint
377425|NCT01337466|Infection|infection
377426|NCT01337466|PET-CT|pet-ct
377427|NCT01337453|botulinum toxin|botulinum toxin
377428|NCT01337453|flu like symptoms|flu like symptoms
377429|NCT01337453|frequency of FLS|frequency of fls
377430|NCT01337453|Botox|botox
377431|NCT01337440|Ursodeoxycholic Acid|ursodeoxycholic acid
377432|NCT01337440|sitagliptin|sitagliptin
377433|NCT01337440|bile acids|bile acids
377434|NCT01337440|GLP-1|glp-1
377435|NCT01337427|multiple sclerosis|multiple sclerosis
377436|NCT01337427|relapsing|relapsing
377437|NCT01337427|MS|ms
377438|NCT01337427|injectable|injectable
377439|NCT01337427|subcutaneous|subcutaneous
377440|NCT01337427|SC|sc
377441|NCT01337427|PEGylated|pegylated
377442|NCT01337427|interferon|interferon
377443|NCT01337427|PEG|peg
377444|NCT01337427|OCT|oct
377445|NCT01337427|Optical Coherence Tomography|optical coherence tomography
377446|NCT01337414|age-related macular degeneration|age-related macular degeneration
377447|NCT01337414|screening|screening
377448|NCT01337414|monitoring|monitoring
377449|NCT01337414|diagnosis|diagnosis
377450|NCT01337414|dry or non-neovascular age-related macular degeneration (high risk, intermediate, geographic atrophy or AREDS grade 3/4 AMD)|dry or non-neovascular age-related macular degeneration (high risk, intermediate, geographic atrophy or areds grade 3/4 amd)
377451|NCT01337401|Cediranib|cediranib
377452|NCT01337401|ASPS|asps
377453|NCT01337401|Sarcoma|sarcoma
377454|NCT01337362|Diabetes|diabetes
377455|NCT01337362|Hypoglycaemia|hypoglycaemia
377456|NCT01337362|EEG|eeg
377457|NCT01337362|Thermography|thermography
377458|NCT01337362|Hypoglycaemia-associated autonomic failure|hypoglycaemia-associated autonomic failure
377459|NCT01337362|QTc interval|qtc interval
377460|NCT01337362|Hypoglycemic alarm device|hypoglycemic alarm device
377461|NCT01337362|Hormone response|hormone response
377462|NCT01337349|Pentoxifylline|pentoxifylline
377463|NCT01337349|Chronic Congestive Heart Failure|chronic congestive heart failure
377464|NCT01337349|Left Systolic Function|left systolic function
377465|NCT01337349|Biomarkers|biomarkers
377466|NCT01337323|allergic rhinitis, allergies, concomitant medications, allergy symptoms|allergic rhinitis, allergies, concomitant medications, allergy symptoms
377467|NCT01337310|Advanced solid tumors|advanced solid tumors
377468|NCT01337297|crack cocaine|crack cocaine
377469|NCT01337297|addiction|addiction
377470|NCT01337297|tDCS|tdcs
377471|NCT01337297|ERP|erp
377472|NCT01337297|P300|p300
377473|NCT01337297|attention|attention
377474|NCT01337297|inhibitory control|inhibitory control
377475|NCT01337297|working memory|working memory
377476|NCT01337271|artificial, ventilation|artificial, ventilation
377477|NCT01337271|mechanical ventilation|mechanical ventilation
377478|NCT01337271|weaning|weaning
377479|NCT01337258|cost effectiveness|cost effectiveness
377480|NCT01337258|dutasteride|dutasteride
377481|NCT01337258|elevated risk population|elevated risk population
377482|NCT01337258|Prostate cancer|prostate cancer
377483|NCT01337258|prevention|prevention
377484|NCT01337245|Envenomation|envenomation
377485|NCT01337245|Coral Snake|coral snake
377486|NCT01337245|Antivenom|antivenom
377487|NCT01337245|Micrurus fulvius|micrurus fulvius
377488|NCT01337232|language development disorders|language development disorders
377489|NCT01337232|learning disorders|learning disorders
377490|NCT01337232|sentences|sentences
377491|NCT01337232|syntax|syntax
377492|NCT01337232|school-age|school-age
377493|NCT01337232|language|language
377494|NCT01337219|cystic fibrosis|cystic fibrosis
377495|NCT01337219|bioequivalence|bioequivalence
377496|NCT01337219|pharmacokinetic|pharmacokinetic
377498|NCT01337219|plasma|plasma
377499|NCT01337206|Esophageal Stenosis|esophageal stenosis
377500|NCT01337206|Esopageal Strictures|esopageal strictures
377501|NCT01337206|Esophageal Dysphagia|esophageal dysphagia
377605|NCT01336816|nicotine|nicotine
377502|NCT01337193|stress urinary incontinence|stress urinary incontinence
377503|NCT01337193|exercise|exercise
377504|NCT01337193|pelvic floor muscles|pelvic floor muscles
377505|NCT01337193|biofeedback|biofeedback
377506|NCT01337193|rehabilitative ultrasound imaging|rehabilitative ultrasound imaging
377507|NCT01337180|lung function|lung function
377508|NCT01337180|respiratory symptoms|respiratory symptoms
377509|NCT01337180|dust|dust
377510|NCT01337180|inflammation|inflammation
377511|NCT01337180|prospective|prospective
377512|NCT01337167|Diphtheria|diphtheria
377513|NCT01337167|Tetanus|tetanus
377514|NCT01337167|Whooping Cough (pertussis)|whooping cough (pertussis)
377515|NCT01337167|Poliomyelitis|poliomyelitis
377516|NCT01337167|Hepatitis B infection|hepatitis b infection
377517|NCT01337167|Haemophilus influenzae type b infection|haemophilus influenzae type b infection
377518|NCT01337154|NSCLC|nsclc
377519|NCT01337154|non-small cell lung cancer|non-small cell lung cancer
377520|NCT01337154|tamibarotene|tamibarotene
377521|NCT01337141|Telemedicine|telemedicine
377522|NCT01337141|Type 1 diabetes|type 1 diabetes
377523|NCT01337141|Metabolic control optimisation|metabolic control optimisation
377524|NCT01337141|Health care costs|health care costs
377525|NCT01337141|Intervention study|intervention study
377526|NCT01337141|Access to internet|access to internet
377527|NCT01337115|Postoperative pain|postoperative pain
377528|NCT01337115|Knee arthroplasty|knee arthroplasty
377529|NCT01337115|Peripheral nerve blocks|peripheral nerve blocks
377530|NCT01337115|Sciatic nerve block|sciatic nerve block
377531|NCT01337115|Femoral nerve block|femoral nerve block
377532|NCT01337102|Lung Cancer|lung cancer
377533|NCT01337102|Stage 3b|stage 3b
377534|NCT01337102|Stage 4|stage 4
377535|NCT01337102|First Line Chemotherapy Treatment|first line chemotherapy treatment
377536|NCT01337102|Quality Of Life|quality of life
377537|NCT01337102|Palliative Care|palliative care
377538|NCT01337102|Randomized|randomized
377539|NCT01337102|Lung Cancer Scale|lung cancer scale
377540|NCT01337089|cancer pain|cancer pain
377541|NCT01337089|opioid therapy|opioid therapy
377542|NCT01337089|inadequate analgesia|inadequate analgesia
591672|NCT00535990|Procedures|procedures
377543|NCT01337089|optimized chronic opioid therapy|optimized chronic opioid therapy
377544|NCT01337063|Adverse drug events|adverse drug events
377545|NCT01337050|Hepatocellular Carcinoma|hepatocellular carcinoma
377546|NCT01337050|Advanced/Metastatic solid tumors|advanced/metastatic solid tumors
377547|NCT01337037|video-assisted thoracic surgery|video-assisted thoracic surgery
377548|NCT01337037|Lung cancer|lung cancer
377549|NCT01337037|lobectomy|lobectomy
377550|NCT01337024|HRV|hrv
377551|NCT01337024|NDO|ndo
377552|NCT01337024|BoNT/A,|bont/a,
377553|NCT01337024|adverse effects|adverse effects
377554|NCT01337011|Chronic Ischemic Cardiomyopathy|chronic ischemic cardiomyopathy
377555|NCT01336998|necrotizing enterocolitis|necrotizing enterocolitis
377556|NCT01336998|arginine supplementation|arginine supplementation
377557|NCT01336998|calprotectin|calprotectin
377558|NCT01336985|Chemoembolization|chemoembolization
377559|NCT01336985|Hepatic Metastases|hepatic metastases
377560|NCT01336985|Irinotecan|irinotecan
377561|NCT01336985|Drug Eluding Beads|drug eluding beads
377562|NCT01336985|Colorectal Cancer|colorectal cancer
377563|NCT01336985|Liver Cancer|liver cancer
377564|NCT01336985|Hepatic Cancer|hepatic cancer
377565|NCT01336985|Melanoma|melanoma
377566|NCT01336959|Acute Kidney Injury|acute kidney injury
377567|NCT01336959|Cardiopulmonary Bypass|cardiopulmonary bypass
377568|NCT01336959|CABG|cabg
377569|NCT01336959|Cardiac Surgery|cardiac surgery
377570|NCT01336946|lifestyle|lifestyle
377571|NCT01336946|mental disorder|mental disorder
377572|NCT01336907|CNV|cnv
377573|NCT01336907|AMD|amd
377574|NCT01336907|Wet-treated CNV|wet-treated cnv
377575|NCT01336894|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
377576|NCT01336894|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
377577|NCT01336855|HIV|hiv
377578|NCT01336855|Observational|observational
377579|NCT01336855|Pathogenesis|pathogenesis
377580|NCT01336855|Immunology|immunology
377581|NCT01336855|Virology|virology
377582|NCT01336855|Control|control
377583|NCT01336855|Healthy control|healthy control
377584|NCT01336855|Men who have sex with men|men who have sex with men
377585|NCT01336842|panobinostat|panobinostat
377586|NCT01336842|cisplatin|cisplatin
377587|NCT01336842|pemetrexed|pemetrexed
377588|NCT01336842|dose escalation|dose escalation
377589|NCT01336829|Hepatitis C|hepatitis c
377590|NCT01336829|HIV|hiv
377591|NCT01336829|TMC125IFD1001|tmc125ifd1001
377592|NCT01336829|TMC125|tmc125
377593|NCT01336829|Intelence|intelence
377594|NCT01336829|etravirine|etravirine
377595|NCT01336829|ETR|etr
377596|NCT01336829|TMC278|tmc278
377597|NCT01336829|telaprevir|telaprevir
377598|NCT01336829|TVR|tvr
377599|NCT01336829|VX-950|vx-950
377600|NCT01336829|healthy volunteers|healthy volunteers
377601|NCT01336829|crossover|crossover
377602|NCT01336816|smoking|smoking
377603|NCT01336816|smokeless|smokeless
377604|NCT01336816|aversion|aversion
377606|NCT01336816|nicotine replacement|nicotine replacement
377607|NCT01336790|Lymphatic disease|lymphatic disease
377608|NCT01336790|Lymphedema|lymphedema
377609|NCT01336790|Lymphangiomatosis|lymphangiomatosis
377610|NCT01336790|Lymphangiectasia|lymphangiectasia
377611|NCT01336790|Protein-losing enteropathy|protein-losing enteropathy
377612|NCT01336790|Vascular Anomalies|vascular anomalies
377613|NCT01336777|obesity|obesity
377614|NCT01336777|adipocyte differentiation|adipocyte differentiation
377615|NCT01336777|inflammation|inflammation
377616|NCT01336777|insulin resistance|insulin resistance
377617|NCT01336777|visceral fat|visceral fat
377618|NCT01336777|regional fat depots|regional fat depots
377619|NCT01336764|driving distress|driving distress
377620|NCT01336764|veterans|veterans
377621|NCT01336764|OEF/OIF|oef/oif
377622|NCT01336738|Phase 2|phase 2
377623|NCT01336738|safety and efficacy study with PF-04991532|safety and efficacy study with pf-04991532
377624|NCT01336738|Type 2 diabetes|type 2 diabetes
377625|NCT01336725|Morbid obesity|morbid obesity
377626|NCT01336725|Patient education|patient education
377627|NCT01336712|CML|cml
377628|NCT01336712|CLL|cll
377629|NCT01336712|AML|aml
377630|NCT01336712|ALL|all
377631|NCT01336712|MDS|mds
377632|NCT01336712|HD|hd
377633|NCT01336712|NHL|nhl
377634|NCT01336712|MFB|mfb
377635|NCT01336712|P.vera|p.vera
377636|NCT01336712|Essential Thrombocytosis|essential thrombocytosis
377637|NCT01336699|shigellosis, vaccine, Shigella sonnei, WRSs2, WRSs3|shigellosis, vaccine, shigella sonnei, wrss2, wrss3
377638|NCT01336673|Glucophage XR|glucophage xr
377639|NCT01336673|Tolerability|tolerability
377640|NCT01336660|Effectiveness|effectiveness
377641|NCT01336660|New Antivenom|new antivenom
377642|NCT01336660|North Africa and Middle East Scorpio Envenomation|north africa and middle east scorpio envenomation
377643|NCT01336634|BRAF V600E|braf v600e
377644|NCT01336634|trametinib|trametinib
377645|NCT01336634|dabrafenib|dabrafenib
377646|NCT01336634|GSK2118436|gsk2118436
377647|NCT01336634|GSK1120212|gsk1120212
377648|NCT01336634|Oncology|oncology
377649|NCT01336634|Non-Small Cell Lung Cancer|non-small cell lung cancer
377650|NCT01336621|Partial-onset seizures|partial-onset seizures
377651|NCT01336621|retigabine IR|retigabine ir
377652|NCT01336621|Open Label Extension|open label extension
377653|NCT01336621|GW582892|gw582892
377654|NCT01336621|Epilepsy|epilepsy
377655|NCT01336595|total knee arthroplasty|total knee arthroplasty
377656|NCT01336595|oxidized zirconium|oxidized zirconium
377657|NCT01336595|genesis II|genesis ii
377658|NCT01336595|femoral component|femoral component
377660|NCT01336582|suitable candidate|suitable candidate
377661|NCT01336582|single agent docetaxel therapy|single agent docetaxel therapy
377662|NCT01336582|Advanced Solid Tumor|advanced solid tumor
377663|NCT01336569|Primary Open-Angle Glaucoma|primary open-angle glaucoma
377664|NCT01336569|Ocular Hypertension|ocular hypertension
377665|NCT01336569|Pigment Dispersion Glaucoma|pigment dispersion glaucoma
377667|NCT01336556|Oral appliance|oral appliance
377668|NCT01336556|Continuous positive airway pressure|continuous positive airway pressure
377669|NCT01336556|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
377670|NCT01336556|Snore|snore
377671|NCT01336543|Non small cell lung cancer|non small cell lung cancer
377672|NCT01336543|Inoperable Stage III|inoperable stage iii
377673|NCT01336543|Inoperable|inoperable
377674|NCT01336543|Stage III|stage iii
377675|NCT01336530|Oesophageal pain|oesophageal pain
377676|NCT01336530|Radiotherapy|radiotherapy
377677|NCT01336530|Combined radio-chemotherapy|combined radio-chemotherapy
377678|NCT01336530|Oesophageal symptoms|oesophageal symptoms
377679|NCT01336517|Stroke|stroke
377680|NCT01336517|Hemiplegia|hemiplegia
377681|NCT01336517|AFO|afo
377682|NCT01336517|Gait|gait
377683|NCT01336478|NK|nk
377684|NCT01336478|natural killer|natural killer
377685|NCT01336478|immunotherapy|immunotherapy
377686|NCT01336478|leukemia|leukemia
377687|NCT01336478|hematological malignancies|hematological malignancies
377688|NCT01336478|stem cell transplantation|stem cell transplantation
377689|NCT01336478|adoptive therapy|adoptive therapy
377690|NCT01336439|Bruxism|bruxism
377691|NCT01336439|Polysomnography|polysomnography
377692|NCT01336439|Botulinum toxin type A|botulinum toxin type a
377693|NCT01336439|Masseter muscle|masseter muscle
377694|NCT01336439|Temporal muscle|temporal muscle
377695|NCT01336426|Peripheral Artery Disease|peripheral artery disease
377696|NCT01336426|PAD|pad
377697|NCT01336413|brain injuries, traumatic|brain injuries, traumatic
377698|NCT01336413|pregnenolone|pregnenolone
377699|NCT01336413|Veteran|veteran
377700|NCT01336413|OEF/OIF|oef/oif
377701|NCT01336413|neurosteroid|neurosteroid
377702|NCT01336400|Single cell haplotyping|single cell haplotyping
377703|NCT01336400|Preimplantation genetic diagnosis|preimplantation genetic diagnosis
377704|NCT01336361|Palliative Care|palliative care
377705|NCT01336361|Physical Therapy|physical therapy
377706|NCT01336361|Functionally Dependent Elderly|functionally dependent elderly
377707|NCT01336348|Prasugrel|prasugrel
377708|NCT01336348|Tirofiban|tirofiban
377709|NCT01336348|Clopidogrel|clopidogrel
377710|NCT01336348|glycoprotein IIa/IIIa inhibitors|glycoprotein iia/iiia inhibitors
377711|NCT01336348|P2Y12 blockers|p2y12 blockers
377712|NCT01336335|sleep apnea, obstructive|sleep apnea, obstructive
377713|NCT01336335|sympathetic nerve activity|sympathetic nerve activity
377714|NCT01336335|treatment|treatment
377715|NCT01336322|beta-cell function|beta-cell function
377716|NCT01336322|insulin resistance|insulin resistance
377717|NCT01336309|Yoga|yoga
377718|NCT01336283|COPD|copd
377719|NCT01336283|Exercise Training|exercise training
377720|NCT01336270|Melanoma|melanoma
377721|NCT01336270|NK cells|nk cells
377722|NCT01336270|T lymphocytes|t lymphocytes
377723|NCT01336270|macrophages|macrophages
377724|NCT01336257|Decision Support Techniques|decision support techniques
377725|NCT01336257|Electronic Health Records|electronic health records
377726|NCT01336257|Reminder Systems|reminder systems
377727|NCT01336257|Early Detection of Cancer|early detection of cancer
377728|NCT01336257|Mammography|mammography
377729|NCT01336257|Women|women
377730|NCT01336244|Safety|safety
377731|NCT01336244|Tolerability|tolerability
377732|NCT01336244|Pharmacokinetics|pharmacokinetics
377733|NCT01336231|quality of life|quality of life
377734|NCT01336231|cognitive functions|cognitive functions
377735|NCT01336231|antiangiogenic agents|antiangiogenic agents
377736|NCT01336231|kidney cancer|kidney cancer
377737|NCT01336231|metastatic|metastatic
377738|NCT01336218|Phase 1|phase 1
377739|NCT01336218|healthy volunteers|healthy volunteers
377740|NCT01336218|Rheumatoid arthritis|rheumatoid arthritis
377741|NCT01336218|RA|ra
377742|NCT01336218|Fostamatinib|fostamatinib
377743|NCT01336218|Rifampicin|rifampicin
377744|NCT01336218|drug-drug interaction|drug-drug interaction
377745|NCT01336218|Pharmacokinetics|pharmacokinetics
377746|NCT01336218|Amount of Rifampicin in blood|amount of rifampicin in blood
377747|NCT01336205|Non-Cancer-Related Pain|non-cancer-related pain
377748|NCT01336205|Opioid-Induced Constipation|opioid-induced constipation
377749|NCT01336192|Advanced NSCLC|advanced nsclc
377750|NCT01336192|Maintenance therapy|maintenance therapy
377751|NCT01336192|Gemcitabine|gemcitabine
377752|NCT01336179|gingivitis|gingivitis
377753|NCT01336179|dental plaque|dental plaque
377754|NCT01336179|oral hygiene|oral hygiene
377755|NCT01336179|toothbrush|toothbrush
377756|NCT01336179|chewing sticks|chewing sticks
377758|NCT01336166|Vaccine|vaccine
377759|NCT01336166|Immunogenicity|immunogenicity
377760|NCT01336166|Safety|safety
377761|NCT01336153|Safety|safety
377763|NCT01336153|MLC601|mlc601
377764|NCT01336153|motor recovery|motor recovery
377765|NCT01336140|regadenoson|regadenoson
377766|NCT01336140|chronic kidney disease|chronic kidney disease
377767|NCT01336140|renal failure|renal failure
377768|NCT01336140|lexiscan|lexiscan
377769|NCT01336140|aminophylline|aminophylline
377770|NCT01336140|SPECT|spect
377771|NCT01336140|Myocardial Perfusion Imaging|myocardial perfusion imaging
377772|NCT01336140|pharmacologic stress test|pharmacologic stress test
377773|NCT01336140|Patients with stage IV or V chronic kidney disease being assessed with nuclear stress testing of the heart using the stress agent regadenoson (Lexiscan ®)|patients with stage iv or v chronic kidney disease being assessed with nuclear stress testing of the heart using the stress agent regadenoson (lexiscan ®)
377774|NCT01336127|Occupational Therapy|occupational therapy
377775|NCT01336127|Parkinson's Disease|parkinson's disease
377776|NCT01336127|Effectiveness|effectiveness
377777|NCT01336127|RCT|rct
377778|NCT01336127|Activities of daily living|activities of daily living
377779|NCT01336127|Participation|participation
377780|NCT01336127|Caregiver's Burden|caregiver's burden
377781|NCT01336127|Economic evaluation|economic evaluation
377782|NCT01336101|PAD|pad
377783|NCT01336101|SFA|sfa
377784|NCT01336088|dyskinesia|dyskinesia
377785|NCT01336088|Parkinson's disease|parkinson's disease
377786|NCT01336075|Percutaneous radiofrequency catheter ablation|percutaneous radiofrequency catheter ablation
377787|NCT01336075|Mini invasive thoracoscopic radiofrequency ablation|mini invasive thoracoscopic radiofrequency ablation
377788|NCT01336062|advanced|advanced
377789|NCT01336062|resistant to prior chemotherapy|resistant to prior chemotherapy
377790|NCT01336010|Hepatitis C|hepatitis c
377791|NCT01336010|Acute Hepatitis C|acute hepatitis c
377792|NCT01336010|Early chronic Hepatitis C|early chronic hepatitis c
377793|NCT01335997|Low-density lipoprotein|low-density lipoprotein
377794|NCT01335997|LDL|ldl
377795|NCT01335997|High-density lipoprotein|high-density lipoprotein
377796|NCT01335997|HDL|hdl
377797|NCT01335997|Niacin|niacin
377798|NCT01335997|Lipid modifying therapy|lipid modifying therapy
377799|NCT01335997|Cholesterol|cholesterol
377800|NCT01335997|High cholesterol|high cholesterol
377801|NCT01335997|Triglycerides|triglycerides
377802|NCT01335984|telemonitoring|telemonitoring
377803|NCT01335984|usual care|usual care
377804|NCT01335984|telemedicine|telemedicine
377805|NCT01335984|telehealth|telehealth
377806|NCT01335984|home care|home care
377807|NCT01335984|Health Care Quality|health care quality
377808|NCT01335984|Access|access
377809|NCT01335984|Evaluation|evaluation
377810|NCT01335971|COPD|copd
377811|NCT01335971|Nrf2|nrf2
377812|NCT01335971|Sulforaphane|sulforaphane
377813|NCT01335945|Cryoablation|cryoablation
377814|NCT01335945|Cryotherapy|cryotherapy
377815|NCT01335945|Cryosurgery|cryosurgery
377816|NCT01335945|Pancreas|pancreas
377817|NCT01335945|Pancreatic Cancer|pancreatic cancer
377818|NCT01335945|Celiac Plexus|celiac plexus
377819|NCT01335945|Pain|pain
377820|NCT01335945|Abdominal pain|abdominal pain
377821|NCT01335932|Acute Lung Injury|acute lung injury
377822|NCT01335932|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
377823|NCT01335932|Respiratory Failure|respiratory failure
377824|NCT01335932|Cytomegalovirus seropositive|cytomegalovirus seropositive
377825|NCT01335932|Infection|infection
377826|NCT01335932|Intravenous Ganciclovir|intravenous ganciclovir
377827|NCT01335932|Non-immunocompromised|non-immunocompromised
377828|NCT01335932|Valganciclovir|valganciclovir
377829|NCT01335919|Hemoglobin|hemoglobin
377830|NCT01335919|Monitoring, Physiologic|monitoring, physiologic
377831|NCT01335919|Blood Gas Monitoring, Transcutaneous|blood gas monitoring, transcutaneous
377832|NCT01335906|Cancer Screening Tests|cancer screening tests
378033|NCT01334983|function|function
377835|NCT01335906|Informed Consent|informed consent
377836|NCT01335906|Consent Forms|consent forms
377837|NCT01335893|Imaging|imaging
377838|NCT01335893|Indocyanine Green|indocyanine green
377839|NCT01335893|Lung Cancer|lung cancer
377840|NCT01335893|Lung Neoplasms|lung neoplasms
377841|NCT01335893|Preliminary Study|preliminary study
377842|NCT01335880|Obesity|obesity
377843|NCT01335880|Heart Disease|heart disease
377844|NCT01335880|Seniors|seniors
377845|NCT01335880|Elderly|elderly
377846|NCT01335880|Chronic Disease|chronic disease
377847|NCT01335880|Prevention|prevention
377848|NCT01335854|Apnea-hypopnea index|apnea-hypopnea index
377849|NCT01335854|Continuous positive airway pressure|continuous positive airway pressure
377850|NCT01335854|CPAP adherence|cpap adherence
377851|NCT01335828|Echography|echography
377852|NCT01335828|Elastography|elastography
377853|NCT01335828|Thyroid nodules|thyroid nodules
377854|NCT01335828|Needles punction|needles punction
377855|NCT01335828|Thyroid surgery|thyroid surgery
377856|NCT01335828|Patients with thyroids nodules|patients with thyroids nodules
377857|NCT01335802|Abortion, Spontaneous|abortion, spontaneous
377858|NCT01335802|Pre-eclampsia|pre-eclampsia
377859|NCT01335802|Gestational hypertension|gestational hypertension
377860|NCT01335802|Pregnancy Complications|pregnancy complications
377861|NCT01335802|Subclinical hypothyroidism|subclinical hypothyroidism
377862|NCT01335802|Thyroperoxidase antibodies (TPOab)|thyroperoxidase antibodies (tpoab)
377863|NCT01335802|Mitochondrial dysfunction|mitochondrial dysfunction
377864|NCT01335789|marijuana|marijuana
377865|NCT01335789|substance abuse|substance abuse
377866|NCT01335789|drug abuse|drug abuse
377867|NCT01335789|marijuana dependence|marijuana dependence
377868|NCT01335789|drug addiction|drug addiction
377869|NCT01335776|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
377870|NCT01335776|Cognitive Behavior Therapy|cognitive behavior therapy
377871|NCT01335776|Actigraphy|actigraphy
377872|NCT01335776|Noninferiority|noninferiority
377873|NCT01335776|MBSR|mbsr
377874|NCT01335776|CBT-I|cbt-i
377875|NCT01335763|HbA1c|hba1c
377876|NCT01335763|Multicentre before-after design|multicentre before-after design
377877|NCT01335763|Glycemic control|glycemic control
377878|NCT01335763|Community pharmacists|community pharmacists
377879|NCT01335750|corneal staining|corneal staining
377880|NCT01335698|Pediatric|pediatric
377881|NCT01335672|Myocardial infarction|myocardial infarction
377882|NCT01335672|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
377883|NCT01335672|General Practice Research Database|general practice research database
377884|NCT01335672|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
377885|NCT01335672|CALIBER|caliber
377886|NCT01335659|FFR|ffr
377887|NCT01335659|IVUS|ivus
377888|NCT01335659|QCA|qca
377889|NCT01335633|MS|ms
377890|NCT01335633|Neuropsychological tests|neuropsychological tests
377891|NCT01335607|HCV|hcv
377892|NCT01335607|Hepatitis C Virus|hepatitis c virus
377893|NCT01335594|Sleep apnea, obstructive|sleep apnea, obstructive
377894|NCT01335594|Deglutition Disorders|deglutition disorders
377895|NCT01335594|Manometry|manometry
377896|NCT01335594|Endoscopy|endoscopy
377897|NCT01335568|Hepatocyte|hepatocyte
377898|NCT01335568|Scaffold|scaffold
377899|NCT01335568|Matrix|matrix
377900|NCT01335568|Liver cirrhosis|liver cirrhosis
377901|NCT01335568|Liver insufficiency|liver insufficiency
377902|NCT01335529|HCV infection|hcv infection
377903|NCT01335529|HIV-1 infection|hiv-1 infection
377904|NCT01335503|gluten|gluten
377905|NCT01335451|AZD5213|azd5213
377906|NCT01335451|safety|safety
377907|NCT01335451|pharmacokinetics|pharmacokinetics
377908|NCT01335451|single dose|single dose
377909|NCT01335451|repeated dose|repeated dose
377910|NCT01335451|young|young
377911|NCT01335451|elderly|elderly
377912|NCT01335451|Japanese|japanese
377913|NCT01335451|healthy subject|healthy subject
377914|NCT01335438|total knee arthroplasty|total knee arthroplasty
377915|NCT01335438|cemented|cemented
377916|NCT01335438|cementless|cementless
377917|NCT01335438|fixation|fixation
377918|NCT01335438|posterior stabilized|posterior stabilized
377919|NCT01335438|cruciate retaining|cruciate retaining
377920|NCT01335425|Language problems|language problems
377921|NCT01335425|childhood epilepsy|childhood epilepsy
377922|NCT01335425|bening (rolandic) epilepsy (of childhood) with centro temporal spikes|bening (rolandic) epilepsy (of childhood) with centro temporal spikes
377923|NCT01335425|brain maturation|brain maturation
377924|NCT01335425|structral connectivity|structral connectivity
377925|NCT01335425|functional connectivity|functional connectivity
377928|NCT01335373|Vaginal candidiasis|vaginal candidiasis
377929|NCT01335373|Bacterial vaginosis (also known as non-specific, or Gardnerellosis, or anaerobic vaginosis)|bacterial vaginosis (also known as non-specific, or gardnerellosis, or anaerobic vaginosis)
377930|NCT01335373|Trichomonal vaginitis|trichomonal vaginitis
378034|NCT01334983|fatigue|fatigue
377931|NCT01335373|Vaginitis due to mixed infection|vaginitis due to mixed infection
377932|NCT01335360|nevirapine|nevirapine
377933|NCT01335360|pharmacokinetics|pharmacokinetics
377934|NCT01335347|Influenza|influenza
377935|NCT01335347|pandemic|pandemic
377936|NCT01335347|avian influenza|avian influenza
377938|NCT01335347|flu|flu
377939|NCT01335334|Effectiveness|effectiveness
377940|NCT01335334|eradication|eradication
377941|NCT01335334|Asymptomatic|asymptomatic
377942|NCT01335321|viscosupplementation|viscosupplementation
462085|NCT00039715|Stress|stress
377943|NCT01335321|intra-articular injection|intra-articular injection
377944|NCT01335321|hyaluronic acid|hyaluronic acid
377945|NCT01335321|osteoarthritis|osteoarthritis
377946|NCT01335321|knee|knee
377947|NCT01335308|Pediatric Obesity|pediatric obesity
377948|NCT01335308|Motivational Interviewing|motivational interviewing
377949|NCT01335308|Overweight|overweight
377950|NCT01335308|Behavior Change|behavior change
377951|NCT01335295|Flavocoxid|flavocoxid
377952|NCT01335295|Duchenne muscular dystrophy|duchenne muscular dystrophy
377953|NCT01335295|pilot study|pilot study
377954|NCT01335256|Phase I, dose escalation, kinase inhibitor, cyclin-dependent kinase inhibitor, target therapy, small molecule|phase i, dose escalation, kinase inhibitor, cyclin-dependent kinase inhibitor, target therapy, small molecule
377955|NCT01335243|Orthopedic Procedures|orthopedic procedures
377956|NCT01335243|Spine|spine
377957|NCT01335243|Interbody fusion|interbody fusion
377958|NCT01335243|Arthrodesis|arthrodesis
377959|NCT01335243|Lumbar Vertebrae|lumbar vertebrae
377961|NCT01335243|Spine balance|spine balance
377962|NCT01335243|Instrumented fusion|instrumented fusion
377963|NCT01335243|Posterior fusion|posterior fusion
377964|NCT01335243|Degenerative spine|degenerative spine
377965|NCT01335243|painful|painful
377967|NCT01335230|HCV|hcv
377968|NCT01335230|Hepatitis C|hepatitis c
377969|NCT01335230|HIV and Hepatitis C coinfection|hiv and hepatitis c coinfection
377970|NCT01335230|HIV/HCV|hiv/hcv
377971|NCT01335217|Depression|depression
377972|NCT01335217|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
377973|NCT01335217|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
377974|NCT01335217|Post Traumatic Stress Disorder|post traumatic stress disorder
377975|NCT01335204|Castration-resistant prostate cancer|castration-resistant prostate cancer
377976|NCT01335204|Prostate Cancer|prostate cancer
377977|NCT01335204|JEVTANA|jevtana
377978|NCT01335204|Cabazitaxel|cabazitaxel
377979|NCT01335204|Bavituximab|bavituximab
377980|NCT01335191|HIV|hiv
377981|NCT01335191|vaccine|vaccine
377982|NCT01335191|lipopeptide|lipopeptide
377983|NCT01335191|Tat|tat
377984|NCT01335191|TUTI-16|tuti-16
377985|NCT01335191|THYMON|thymon
377986|NCT01335178|Tobacco smoke exposure|tobacco smoke exposure
377987|NCT01335178|Secondhand smoke exposure|secondhand smoke exposure
377988|NCT01335178|Passive smoking|passive smoking
377989|NCT01335178|Child health|child health
377990|NCT01335178|Prevention|prevention
377991|NCT01335178|Tobacco control|tobacco control
377992|NCT01335178|Motivational Interviewing|motivational interviewing
377993|NCT01335178|Air quality|air quality
377994|NCT01335178|Pilot Study|pilot study
377995|NCT01335165|PNH|pnh
377996|NCT01335152|stress|stress
377997|NCT01335152|depression|depression
377998|NCT01335152|anxiety|anxiety
377999|NCT01335152|web|web
378000|NCT01335152|internet|internet
378001|NCT01335152|coping|coping
378002|NCT01335139|sublingual immunotherapy|sublingual immunotherapy
378003|NCT01335139|subcutaneous immunotherapy|subcutaneous immunotherapy
378004|NCT01335126|Artificial tears|artificial tears
378005|NCT01335100|Functional outcome|functional outcome
378006|NCT01335100|Quality of life|quality of life
378007|NCT01335100|Global Positioning System (GPS)|global positioning system (gps)
378008|NCT01335100|Advanced tracking technologies|advanced tracking technologies
378009|NCT01335100|Time-space activity.|time-space activity.
378010|NCT01335100|walking speed|walking speed
378011|NCT01335100|distances|distances
378012|NCT01335100|number of walking events and destinations|number of walking events and destinations
378013|NCT01335087|sleep apnea|sleep apnea
378014|NCT01335087|secondary prevention|secondary prevention
378015|NCT01335087|cardiovascular endpoint|cardiovascular endpoint
378016|NCT01335061|Hemophilia B|hemophilia b
378017|NCT01335061|on-demand|on-demand
378018|NCT01335061|prophylaxis|prophylaxis
378019|NCT01335061|nonacog alfa|nonacog alfa
378020|NCT01335061|BeneFIX|benefix
378021|NCT01335061|FIX|fix
378022|NCT01335048|Clopidogrel|clopidogrel
378023|NCT01335048|Statins|statins
378024|NCT01335048|Platelet reactivity|platelet reactivity
378025|NCT01335048|Point-of-care platelet function test|point-of-care platelet function test
378026|NCT01335035|Iron metabolism,|iron metabolism,
378027|NCT01335035|Allogenetic Hematopoietic Stem Cell Transplant,|allogenetic hematopoietic stem cell transplant,
378028|NCT01335035|haematological diseases|haematological diseases
378029|NCT01335009|melanoma|melanoma
378030|NCT01335009|malignant|malignant
378031|NCT01335009|metastatic|metastatic
378032|NCT01334983|cancer|cancer
378035|NCT01334983|late stage|late stage
378036|NCT01334983|metastases|metastases
378037|NCT01334983|quality of life|quality of life
378038|NCT01334983|functional decline in cancer|functional decline in cancer
378039|NCT01334944|Pain|pain
378040|NCT01334944|Fever|fever
378041|NCT01334931|Exposure to Ionizing Radiation|exposure to ionizing radiation
378042|NCT01334931|Occupational Exposure to Radiation|occupational exposure to radiation
378043|NCT01334918|Coronary Artery Disease (CAD)|coronary artery disease (cad)
368737|NCT01373775|Revisit|revisit
378044|NCT01334918|ischemia|ischemia
378045|NCT01334918|pharmacologic stress|pharmacologic stress
378046|NCT01334918|regadenoson|regadenoson
378047|NCT01334905|Overactive Bladder|overactive bladder
378048|NCT01334905|Urinary incontinence|urinary incontinence
378049|NCT01334905|YM178|ym178
378050|NCT01334905|mirabegron|mirabegron
378051|NCT01334905|Food effect|food effect
378052|NCT01334879|radiation|radiation
378053|NCT01334879|retinopathy|retinopathy
378054|NCT01334879|anti-VEGF|anti-vegf
378055|NCT01334879|eye|eye
378056|NCT01334866|Minimally invasive coronary surgery|minimally invasive coronary surgery
378057|NCT01334866|Coronary artery bypass grafting|coronary artery bypass grafting
378058|NCT01334866|MICS CABG|mics cabg
378059|NCT01334840|Cardiovascular risk|cardiovascular risk
378060|NCT01334840|Cholecystokinin|cholecystokinin
378061|NCT01334840|Gallbladder emptying|gallbladder emptying
378062|NCT01334840|Lipid absorption|lipid absorption
378063|NCT01334840|Postprandial triacylglycerols|postprandial triacylglycerols
378064|NCT01334840|Sodium-bicarbonated mineral water|sodium-bicarbonated mineral water
378066|NCT01334827|primary prevention|primary prevention
378067|NCT01334827|HIV|hiv
378068|NCT01334827|AIDS|aids
378069|NCT01334827|drug delivery systems|drug delivery systems
378070|NCT01334801|aortic stenosis|aortic stenosis
378071|NCT01334801|von Willebrand factor|von willebrand factor
378072|NCT01334801|mitral valve replacement|mitral valve replacement
378073|NCT01334801|aortic valve replacement|aortic valve replacement
378074|NCT01334801|prosthetic valve dysfunction|prosthetic valve dysfunction
378075|NCT01334801|brain natriuretic peptide|brain natriuretic peptide
378076|NCT01334801|mitral valve regurgitation|mitral valve regurgitation
378077|NCT01334801|aortic valve regurgitation|aortic valve regurgitation
378078|NCT01334801|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
378079|NCT01334801|tricuspid insufficiency|tricuspid insufficiency
378080|NCT01334788|sleep deprivation|sleep deprivation
378081|NCT01334788|sleep restriction|sleep restriction
378082|NCT01334775|Inguinal hernia|inguinal hernia
378083|NCT01334775|Postoperative pain|postoperative pain
378084|NCT01334775|Surgical mesh|surgical mesh
378085|NCT01334762|minimal to mild endometriosis|minimal to mild endometriosis
378086|NCT01334762|letrozole|letrozole
378087|NCT01334762|clomiphene citrate|clomiphene citrate
378088|NCT01334762|IUI|iui
378089|NCT01334749|Stroke|stroke
378090|NCT01334749|Dementia|dementia
378091|NCT01334749|Dementia, Vascular|dementia, vascular
378092|NCT01334749|Alzheimer's Disease|alzheimer's disease
378093|NCT01334749|Intracranial Hemorrhage|intracranial hemorrhage
378094|NCT01334749|Brain Ischemia|brain ischemia
378095|NCT01334736|smoking cessation|smoking cessation
378096|NCT01334736|contingency management|contingency management
378097|NCT01334736|spirometry|spirometry
378098|NCT01334736|lung age|lung age
378099|NCT01334723|Benign prostatic hyperplasia, enlarged prostate, 5-alpha-reductase inhibitor, adherence, surgery, acute urinary retention|benign prostatic hyperplasia, enlarged prostate, 5-alpha-reductase inhibitor, adherence, surgery, acute urinary retention
378100|NCT01334710|Liver cancer|liver cancer
378101|NCT01334697|Cardiotrophin-1|cardiotrophin-1
378102|NCT01334697|CT-1|ct-1
378103|NCT01334684|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
378104|NCT01334684|Metformin Efficacy|metformin efficacy
378105|NCT01334684|Gene Expression Profiles|gene expression profiles
378106|NCT01334684|Personalized Medicine|personalized medicine
378107|NCT01334671|ST-elevation myocardial infarction(STEMI)|st-elevation myocardial infarction(stemi)
378108|NCT01334671|emergency percutaneous coronary intervention(PCI)|emergency percutaneous coronary intervention(pci)
378109|NCT01334671|lipitor or Atorvastatin|lipitor or atorvastatin
378110|NCT01334658|Corneal endothelium|corneal endothelium
378111|NCT01334658|Cataract surgery|cataract surgery
378112|NCT01334658|Irrigation solutions intraocular|irrigation solutions intraocular
378113|NCT01334658|Phacoemulsification|phacoemulsification
378114|NCT01334645|Copeptin|copeptin
378115|NCT01334645|Troponin|troponin
378116|NCT01334645|Diagnosis|diagnosis
378117|NCT01334645|Chest pain|chest pain
378118|NCT01334645|Acute Coronary Syndrome|acute coronary syndrome
378119|NCT01334645|Acute Myocardial Infarction|acute myocardial infarction
378120|NCT01334645|Unstable Angina|unstable angina
378121|NCT01334632|Electrophysiological study|electrophysiological study
378122|NCT01334632|Nerve block|nerve block
378123|NCT01334632|Analgesia, patient-controlled|analgesia, patient-controlled
378124|NCT01334632|Shoulder surgery|shoulder surgery
378125|NCT01334619|Anesthetic techniques,regional|anesthetic techniques,regional
378126|NCT01334619|Drug delivery,volume|drug delivery,volume
378127|NCT01334619|Anesthetic, local: ropivacaine|anesthetic, local: ropivacaine
378128|NCT01334606|diabetes|diabetes
378129|NCT01334606|pen needle|pen needle
378130|NCT01334606|basal insulin|basal insulin
378131|NCT01334606|long-acting insulin|long-acting insulin
378132|NCT01334554|African American|african american
378133|NCT01334554|Women|women
378134|NCT01334554|Metabolic Syndrome|metabolic syndrome
462347|NCT00040651|Mesna|mesna
368854|NCT01373060|ASP1941|asp1941
378135|NCT01334554|Endothelial function|endothelial function
378136|NCT01334554|Sildenafil citrate|sildenafil citrate
378137|NCT01334528|Deployment Acquired Mild Traumatic Brain Injury|deployment acquired mild traumatic brain injury
378138|NCT01334528|Persistent Post-Concussive Symptoms|persistent post-concussive symptoms
378139|NCT01334528|Repeated measures|repeated measures
402059|NCT01233336|acute coronary syndrome (ACS)|acute coronary syndrome (acs)
378140|NCT01334502|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
378141|NCT01334502|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
378142|NCT01334502|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
378143|NCT01334502|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
378144|NCT01334489|Monochorionic pregnancy|monochorionic pregnancy
378145|NCT01334489|Twin to twin transfusion syndrome|twin to twin transfusion syndrome
378146|NCT01334489|Cervical pessary|cervical pessary
378147|NCT01334489|Cervical lenght|cervical lenght
378148|NCT01334476|Data Repository|data repository
378149|NCT01334476|Facilitate Recruitment of Participants for Ongoing and Future Research|facilitate recruitment of participants for ongoing and future research
378152|NCT01334437|ovarian cancer|ovarian cancer
378153|NCT01334437|Associated Auto Antibodies|associated auto antibodies
378154|NCT01334424|Robot assisted laparoscopic radical prostatectomy|robot assisted laparoscopic radical prostatectomy
378155|NCT01334424|Hypoperfusion reperfusion injury,|hypoperfusion reperfusion injury,
378156|NCT01334424|Propofol|propofol
378157|NCT01334424|oxidative stress|oxidative stress
378158|NCT01334398|Traumatic Brain Injury|traumatic brain injury
378159|NCT01334372|suicide|suicide
378160|NCT01334372|veterans|veterans
378161|NCT01334372|assessment|assessment
378162|NCT01334372|CAMS|cams
378163|NCT01334359|physical activity|physical activity
378164|NCT01334359|fitness|fitness
378165|NCT01334359|brain health|brain health
378166|NCT01334359|cognition|cognition
378167|NCT01334359|scholastic achievement|scholastic achievement
378168|NCT01334359|preadolescent children|preadolescent children
378169|NCT01334346|Running|running
378170|NCT01334346|Footwear|footwear
378171|NCT01334346|Injury incidence|injury incidence
378172|NCT01334346|injury risk|injury risk
378173|NCT01334346|pain|pain
378174|NCT01334333|kidney transplant|kidney transplant
378175|NCT01334333|tacrolimus|tacrolimus
378176|NCT01334333|medication adherence|medication adherence
378177|NCT01334333|depression|depression
378178|NCT01334333|neuropsychological|neuropsychological
378179|NCT01334333|cognition|cognition
378180|NCT01334333|Self-efficacy|self-efficacy
378181|NCT01334333|everyday problem solving|everyday problem solving
378182|NCT01334320|oral squamous cell carcinoma|oral squamous cell carcinoma
378183|NCT01334320|elective neck dissection|elective neck dissection
378184|NCT01334320|"watchful waiting"|"watchful waiting"
378185|NCT01334320|survival benefit|survival benefit
378186|NCT01334320|recurrence rate|recurrence rate
378187|NCT01334307|Emphysema|emphysema
378188|NCT01334307|RePneu|repneu
378190|NCT01334294|AMD|amd
378191|NCT01334281|Panel Reactive Antibody (PRA)|panel reactive antibody (pra)
378192|NCT01334281|Sensitization|sensitization
378193|NCT01334281|Organ Transplant|organ transplant
378194|NCT01334268|In-stent Late Lumen Loss (LLL)|in-stent late lumen loss (lll)
378195|NCT01334268|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
378196|NCT01334268|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
378197|NCT01334268|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
378198|NCT01334268|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
378199|NCT01334268|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
378200|NCT01334268|STENT THROMBOSIS|stent thrombosis
378201|NCT01334268|RESTENOTIC LESION|restenotic lesion
378202|NCT01334268|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
378203|NCT01334268|REAL-WORLD|real-world
379106|NCT01330446|Sugar Pill|sugar pill
378204|NCT01334268|THE RANDOMIZED CONTROLLED TRIAL|the randomized controlled trial
378205|NCT01334255|Pigment epithelial detachment|pigment epithelial detachment
378206|NCT01334255|Exudative age-related macular degeneration|exudative age-related macular degeneration
378207|NCT01334255|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
378208|NCT01334242|Pharmacodynamics|pharmacodynamics
378209|NCT01334229|sitagliptin|sitagliptin
378210|NCT01334229|diabetes|diabetes
378211|NCT01334229|apolipoprotein B48 and B100|apolipoprotein b48 and b100
378212|NCT01334216|smoking|smoking
378213|NCT01334216|quitting|quitting
378214|NCT01334216|tobacco|tobacco
378215|NCT01334216|Parental|parental
378216|NCT01334203|Chronic angina|chronic angina
378217|NCT01334203|Angina pectoris|angina pectoris
378218|NCT01334203|Coronary artery disease|coronary artery disease
378219|NCT01334203|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
378220|NCT01334203|ETT|ett
378221|NCT01334190|AE adverse event|ae adverse event
378222|NCT01334190|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
378223|NCT01334190|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
378224|NCT01334190|ART antiretroviral therapy|art antiretroviral therapy
378225|NCT01334190|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
378226|NCT01334190|DCF data collection forms|dcf data collection forms
378227|NCT01334190|DMC Data Monitoring Committee|dmc data monitoring committee
378228|NCT01334190|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
378229|NCT01334190|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
378230|NCT01334190|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
378231|NCT01334190|ICH International Conference of Harmonisation|ich international conference of harmonisation
378232|NCT01334190|IND Investigational New Drug Application|ind investigational new drug application
378233|NCT01334190|IRB Institutional Review Board|irb institutional review board
378234|NCT01334190|IU international units|iu international units
378235|NCT01334190|mg milligram(s)|mg milligram(s)
378236|NCT01334190|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
378237|NCT01334190|PCR polymerase chain reaction|pcr polymerase chain reaction
378238|NCT01334190|SAE serious adverse event|sae serious adverse event
378239|NCT01334190|µg microgram|µg microgram
378240|NCT01334190|ULN upper limit of the normal range|uln upper limit of the normal range
378241|NCT01334190|WB Western Blot|wb western blot
378242|NCT01334190|post-marketing monitoring|post-marketing monitoring
378244|NCT01334190|efficacy|efficacy
378245|NCT01334190|acceptability|acceptability
378246|NCT01334164|substance use disorder|substance use disorder
378247|NCT01334164|offenders|offenders
378248|NCT01334164|reentry|reentry
378249|NCT01334164|HIV risk behavior|hiv risk behavior
378250|NCT01334164|recidivism|recidivism
378251|NCT01334138|hypertension|hypertension
378252|NCT01334138|sodium|sodium
378253|NCT01334138|diet|diet
378254|NCT01334125|Double Diabetes|double diabetes
378255|NCT01334125|Type 1 diabetes|type 1 diabetes
378256|NCT01334125|Type 2 diabetes|type 2 diabetes
378257|NCT01334125|Obesity|obesity
378258|NCT01334125|Acanthosis nigricans|acanthosis nigricans
378259|NCT01334125|Diabetes associated autoantibodies|diabetes associated autoantibodies
378260|NCT01334112|Hepatocellular Carcinoma|hepatocellular carcinoma
378261|NCT01334112|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
378262|NCT01334112|Liver Cancer|liver cancer
378263|NCT01334112|Axitinib|axitinib
378264|NCT01334112|AG-013736|ag-013736
378266|NCT01334073|Phase I|phase i
378267|NCT01334073|Axitinib|axitinib
378268|NCT01334073|Everolimus|everolimus
378269|NCT01334073|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
378270|NCT01334073|solid tumor|solid tumor
378271|NCT01334073|Renal cell cancer (RCC)|renal cell cancer (rcc)
378272|NCT01334073|Pharmacokinetics (PK/PD)|pharmacokinetics (pk/pd)
378273|NCT01334021|Genomic Testing|genomic testing
378274|NCT01334021|Genetic Testing|genetic testing
378275|NCT01334021|HER2 Negative|her2 negative
378276|NCT01334021|Primary Invasive Breast Cancer|primary invasive breast cancer
378277|NCT01334021|Stage I|stage i
378278|NCT01334021|Stage II|stage ii
378279|NCT01334021|Stage III|stage iii
378280|NCT01334021|Registry|registry
378281|NCT01334021|Biopsy|biopsy
378282|NCT01334021|Tumor sampling|tumor sampling
378283|NCT01334008|Circulating tumor DNA|circulating tumor dna
378284|NCT01334008|Choroidal Melanoma|choroidal melanoma
378285|NCT01333995|Peer counselling|peer counselling
378286|NCT01333995|Infant|infant
378287|NCT01333995|Intervention|intervention
378288|NCT01333995|breastfeeding|breastfeeding
378289|NCT01333995|complementary feeding|complementary feeding
378290|NCT01333995|stunting|stunting
378291|NCT01333982|Neonatal Sepsis|neonatal sepsis
378292|NCT01333982|Evaluation|evaluation
378293|NCT01333982|Bangladesh|bangladesh
378294|NCT01333982|Drying|drying
378295|NCT01333982|Wrapping|wrapping
378296|NCT01333982|Bathing|bathing
378297|NCT01333943|Total Knee Replacement|total knee replacement
378298|NCT01333943|Regional Anesthesia|regional anesthesia
378299|NCT01333943|Quadriceps|quadriceps
378300|NCT01333943|Muscle Strength|muscle strength
378301|NCT01333943|Muscle Strength Dynamometer|muscle strength dynamometer
378302|NCT01333943|Quadriceps muscle strength after regional anesthesia for TKA|quadriceps muscle strength after regional anesthesia for tka
378303|NCT01333930|immunological effects|immunological effects
378304|NCT01333930|Active O2|active o2
378305|NCT01333930|strenuous exercise|strenuous exercise
378306|NCT01333930|procedures|procedures
378307|NCT01333930|pharmacodynamic parameters|pharmacodynamic parameters
378308|NCT01333930|blood sampling scheme|blood sampling scheme
378309|NCT01333917|Curcumin|curcumin
378310|NCT01333917|Colorectal Cancer|colorectal cancer
378311|NCT01333917|GWAS|gwas
378312|NCT01333865|Memantine|memantine
378313|NCT01333865|Namenda|namenda
378314|NCT01333865|Autism Spectrum Disorders|autism spectrum disorders
378315|NCT01333865|Pervasive Developmental Disorders|pervasive developmental disorders
378316|NCT01333865|Adults|adults
378317|NCT01333852|head and neck cancer|head and neck cancer
378318|NCT01333852|paclitaxel|paclitaxel
378319|NCT01333852|metformin|metformin
378320|NCT01333852|squamous cell carcinoma|squamous cell carcinoma
378321|NCT01333839|CABG surgery|cabg surgery
378322|NCT01333839|exercise intervention|exercise intervention
378323|NCT01333839|insulin sensitivity|insulin sensitivity
378324|NCT01333839|muscle mass|muscle mass
378325|NCT01333813|immune response|immune response
378326|NCT01333813|Engerix-B™Kinder|engerix-b™kinder
378327|NCT01333813|Persistence|persistence
378328|NCT01333813|challenge dose|challenge dose
378329|NCT01333787|dietary fiber|dietary fiber
378330|NCT01333787|clinical trial|clinical trial
378331|NCT01333787|constipation|constipation
378332|NCT01333787|children|children
378333|NCT01333774|Diabetes|diabetes
378334|NCT01333774|Acarbose|acarbose
378335|NCT01333774|Diet|diet
378336|NCT01333774|Compliance|compliance
378337|NCT01333774|Advising|advising
378338|NCT01333761|right to left cardiac shunt finding|right to left cardiac shunt finding
378339|NCT01333748|breast cancer|breast cancer
378340|NCT01333748|ovarian cancer|ovarian cancer
378341|NCT01333748|BRCA 1 and BRCA 2|brca 1 and brca 2
378342|NCT01333735|cognitive functions|cognitive functions
377937|NCT01335347|H5N1|h5n1
378343|NCT01333735|quality of life|quality of life
378344|NCT01333735|breast cancer|breast cancer
378345|NCT01333735|chemotherapy|chemotherapy
378346|NCT01333735|ages patients|ages patients
378347|NCT01333709|locally advanced rectal carcinoma|locally advanced rectal carcinoma
378348|NCT01333709|Tailored treatment strategy|tailored treatment strategy
378349|NCT01333709|MRI volumetry|mri volumetry
378350|NCT01333709|Early tumor response|early tumor response
378351|NCT01333696|Squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
378352|NCT01333696|Pemetrexed|pemetrexed
378353|NCT01333683|tinnitus|tinnitus
378354|NCT01333683|hearing loss|hearing loss
378355|NCT01333683|arterial hypertension|arterial hypertension
378356|NCT01333683|ototoxicity|ototoxicity
378358|NCT01333657|sepsis|sepsis
378359|NCT01333657|SIRS|sirs
378360|NCT01333657|blood|blood
378361|NCT01333657|urine|urine
378362|NCT01333657|diagnosis|diagnosis
378363|NCT01333657|prognosis|prognosis
378364|NCT01333644|HIV Infection|hiv infection
378365|NCT01333644|Endothelial function|endothelial function
378366|NCT01333644|Cardiovascular Disease|cardiovascular disease
378367|NCT01333644|Inflammation|inflammation
378368|NCT01333644|Antiretroviral medication|antiretroviral medication
378369|NCT01333644|Treatment naive|treatment naive
378370|NCT01333644|Treatment experienced|treatment experienced
378371|NCT01333631|Locally advanced unresectable pancreatic cancer|locally advanced unresectable pancreatic cancer
378372|NCT01333618|Filter Tilt|filter tilt
378373|NCT01333618|Preventional efficiency|preventional efficiency
378374|NCT01333618|Günther Tulip filter|günther tulip filter
378375|NCT01333618|Transfemoral Approach|transfemoral approach
378376|NCT01333605|Hodgkin lymphoma|hodgkin lymphoma
378377|NCT01333605|Chemotherapy|chemotherapy
378378|NCT01333605|IGEV|igev
378379|NCT01333605|Autologous stem cell transplantation|autologous stem cell transplantation
378380|NCT01333592|Type 2 diabetes|type 2 diabetes
378381|NCT01333592|HbA1c|hba1c
378382|NCT01333592|Long-term study|long-term study
378383|NCT01333553|birthmark|birthmark
378384|NCT01333540|constipation|constipation
378385|NCT01333540|opioid induced|opioid induced
378386|NCT01333514|diabetes|diabetes
378387|NCT01333514|prandial|prandial
378388|NCT01333514|insulin|insulin
378389|NCT01333514|aspart|aspart
378390|NCT01333514|carbohydrate|carbohydrate
378391|NCT01333514|inpatient|inpatient
378392|NCT01333514|novolog|novolog
378393|NCT01333501|Multiple sclerosis|multiple sclerosis
378394|NCT01333501|cognitive symptoms|cognitive symptoms
378395|NCT01333501|relapsing-remitting multiple sclerosis (RRMS)|relapsing-remitting multiple sclerosis (rrms)
378396|NCT01333501|fingolimod|fingolimod
378397|NCT01333501|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
378398|NCT01333488|Traumatic|traumatic
378399|NCT01333488|Brain|brain
378400|NCT01333488|Injury|injury
378401|NCT01333475|Targeted Therapy|targeted therapy
378402|NCT01333475|KRAS Mutation|kras mutation
379211|NCT01329900|Apheresis|apheresis
378403|NCT01333475|Metastatic Colorectal Cancer|metastatic colorectal cancer
378404|NCT01333475|Colorectal Cancer|colorectal cancer
378405|NCT01333449|Decitabine|decitabine
378406|NCT01333449|MDS, myelodysplastic syndrome|mds, myelodysplastic syndrome
378407|NCT01333449|prospective open label, phaseII|prospective open label, phaseii
378408|NCT01333449|Allogeneic Hematopoietic cell transplant|allogeneic hematopoietic cell transplant
378409|NCT01333423|Breast Cancer|breast cancer
378410|NCT01333423|Metastatic Triple Negative|metastatic triple negative
378411|NCT01333423|ER/PR/HER2 negative|er/pr/her2 negative
378412|NCT01333423|Locally advanced|locally advanced
378413|NCT01333423|Stage IV|stage iv
378414|NCT01333423|Metastatic|metastatic
378415|NCT01333423|Seliciclib|seliciclib
378416|NCT01333423|Liposomal Doxorubicin|liposomal doxorubicin
378417|NCT01333423|Doxil|doxil
378418|NCT01333423|Doxorubicin Hydrochloride (Liposomal)|doxorubicin hydrochloride (liposomal)
378419|NCT01333410|vitiligo|vitiligo
378420|NCT01333410|tacrolimus|tacrolimus
378421|NCT01333410|mometasone furoate|mometasone furoate
378422|NCT01333371|Distal Radius|distal radius
378423|NCT01333371|Volar locked plating|volar locked plating
378424|NCT01333371|Cost Effectiveness|cost effectiveness
378425|NCT01333371|Randomization|randomization
378426|NCT01333371|Outcomes|outcomes
378427|NCT01333358|Relapsing|relapsing
378428|NCT01333358|remitting|remitting
378429|NCT01333345|Cataract replacement surgery|cataract replacement surgery
378430|NCT01333345|implantation|implantation
378431|NCT01333345|EC-3 IOL|ec-3 iol
378432|NCT01333332|Pancreas|pancreas
378433|NCT01333332|Radiation|radiation
378434|NCT01333319|liver transplantation|liver transplantation
378435|NCT01333319|acute kidney injury|acute kidney injury
378436|NCT01333306|tDCS|tdcs
378437|NCT01333306|cognitive training|cognitive training
378438|NCT01333293|mastocytosis|mastocytosis
378439|NCT01333293|omalizumab|omalizumab
378440|NCT01333267|Endocrine System Diseases|endocrine system diseases
378441|NCT01333267|MusculoSkeletal System Disease|musculoskeletal system disease
378442|NCT01333267|Hormones|hormones
378443|NCT01333267|Postmenopausal Women|postmenopausal women
378444|NCT01333267|Bone metabolism|bone metabolism
378445|NCT01333267|Physiologic Properties|physiologic properties
378446|NCT01333267|African-Americans|african-americans
378447|NCT01333254|urinary tract infections|urinary tract infections
378448|NCT01333254|urinary catheterisation|urinary catheterisation
378449|NCT01333241|Hispanic Americans|hispanic americans
378450|NCT01333241|Cardiovascular disease|cardiovascular disease
378451|NCT01333241|Obesity|obesity
378452|NCT01333241|Intervention|intervention
378453|NCT01333215|Suicide, Attempted|suicide, attempted
378454|NCT01333215|Cognitive Symptoms|cognitive symptoms
378455|NCT01333202|Fresh lime|fresh lime
378456|NCT01333202|nicotine gum|nicotine gum
378457|NCT01333202|smoking cessation|smoking cessation
378458|NCT01333202|craving|craving
378459|NCT01333189|total knee arthroplasty|total knee arthroplasty
378460|NCT01333189|osteoarthritis|osteoarthritis
378461|NCT01333189|biomechanics|biomechanics
378462|NCT01333189|gait|gait
378463|NCT01333176|Type 2 Diabetes|type 2 diabetes
378464|NCT01333176|Hb A1c screening for diabetes in aboriginals|hb a1c screening for diabetes in aboriginals
378465|NCT01333150|Temporomandibular disorders|temporomandibular disorders
378466|NCT01333150|Orofacial pain|orofacial pain
378467|NCT01333137|Triple negative breast cancer|triple negative breast cancer
378468|NCT01333124|Preoperative chemoradiotherapy with Gemcitabine|preoperative chemoradiotherapy with gemcitabine
378469|NCT01333098|anxiety|anxiety
378470|NCT01333098|older adult|older adult
378471|NCT01333098|memory|memory
378472|NCT01333098|cognitive|cognitive
378473|NCT01333098|Saint Louis|saint louis
378474|NCT01333098|treatment|treatment
378475|NCT01333098|Non-dementia cognitive impairment in older adults with anxiety disorders.|non-dementia cognitive impairment in older adults with anxiety disorders.
378476|NCT01333085|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
378477|NCT01333085|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
378478|NCT01333085|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
378479|NCT01333085|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
378480|NCT01333085|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
378481|NCT01333085|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
378482|NCT01333085|tongue cancer|tongue cancer
378483|NCT01333072|Autistic Disorder|autistic disorder
378484|NCT01333059|Sedation|sedation
378485|NCT01333059|Cycling|cycling
378486|NCT01333059|Pediatric|pediatric
378487|NCT01333046|Hodgkin Lymphoma|hodgkin lymphoma
378488|NCT01333046|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
378489|NCT01333046|CTL|ctl
378490|NCT01333033|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
378491|NCT01333033|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
378492|NCT01333033|stage IB esophageal cancer|stage ib esophageal cancer
378493|NCT01333033|stage IIA esophageal cancer|stage iia esophageal cancer
378494|NCT01333033|stage IIB esophageal cancer|stage iib esophageal cancer
378495|NCT01333033|stage IIIA esophageal cancer|stage iiia esophageal cancer
378496|NCT01333033|stage IIIB esophageal cancer|stage iiib esophageal cancer
378497|NCT01333033|stage IIIC esophageal cancer|stage iiic esophageal cancer
378498|NCT01333020|emulsion|emulsion
378499|NCT01333020|protein|protein
378500|NCT01333020|cross-linking|cross-linking
378501|NCT01333020|gastric emptying|gastric emptying
378502|NCT01332955|Hepatitis C, Chronic|hepatitis c, chronic
378503|NCT01332955|HIV Infection|hiv infection
378504|NCT01332955|Telaprevir|telaprevir
378505|NCT01332955|Peginterferon alfa-2a|peginterferon alfa-2a
378506|NCT01332955|Ribavirin|ribavirin
378507|NCT01332955|Pharmacokinetic|pharmacokinetic
378508|NCT01332955|Pharmacogenetic|pharmacogenetic
378509|NCT01332955|Previous peginterferon-ribavirin regimen failure|previous peginterferon-ribavirin regimen failure
378510|NCT01332942|Anemia|anemia
378511|NCT01332929|brain radiation therapy|brain radiation therapy
378512|NCT01332929|Bevacizumab|bevacizumab
378513|NCT01332929|brain metastasis|brain metastasis
378514|NCT01332929|solid tumor|solid tumor
378515|NCT01332916|No metastatic breast cancer|no metastatic breast cancer
378516|NCT01332916|cognitive troubles|cognitive troubles
591673|NCT00535990|Surgery|surgery
378517|NCT01332916|adjuvant chemotherapy|adjuvant chemotherapy
378518|NCT01332890|Drug interaction|drug interaction
378519|NCT01332890|revaprazan|revaprazan
378520|NCT01332890|Itopride HCI|itopride hci
378521|NCT01332877|Obesity|obesity
378522|NCT01332877|Weight loss|weight loss
378523|NCT01332877|Ghrelin|ghrelin
378524|NCT01332877|Satiety|satiety
378525|NCT01332877|Hunger|hunger
378526|NCT01332864|headache|headache
378527|NCT01332864|migraine|migraine
378528|NCT01332864|cephalgia|cephalgia
378529|NCT01332864|osteopathic manipulative treatment|osteopathic manipulative treatment
378530|NCT01332851|child welfare|child welfare
378531|NCT01332851|child protective services|child protective services
378532|NCT01332851|child abuse|child abuse
378533|NCT01332851|child neglect|child neglect
378534|NCT01332851|infant|infant
378535|NCT01332851|parenting|parenting
378536|NCT01332825|olfaction|olfaction
378537|NCT01332825|smell dysfunction|smell dysfunction
378538|NCT01332812|Dexamethasone|dexamethasone
378539|NCT01332812|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
378540|NCT01332812|General Anesthesia|general anesthesia
378541|NCT01332812|neuropsychological tests|neuropsychological tests
378542|NCT01332799|cardiovascular disease|cardiovascular disease
378543|NCT01332799|kidney transplantation|kidney transplantation
378545|NCT01332760|ergonomics|ergonomics
378546|NCT01332760|workplace|workplace
378547|NCT01332760|occupational|occupational
378548|NCT01332760|tool|tool
378549|NCT01332760|dental|dental
378550|NCT01332760|dentist|dentist
378551|NCT01332747|TC|tc
378552|NCT01332747|TG|tg
378553|NCT01332747|HDL|hdl
378554|NCT01332747|LDL|ldl
378555|NCT01332747|VLDL|vldl
378556|NCT01332734|microcirculation|microcirculation
378557|NCT01332734|SDF|sdf
378558|NCT01332734|magnesium sulfate|magnesium sulfate
378559|NCT01332721|TRC105|trc105
378560|NCT01332721|CD105|cd105
378561|NCT01332721|Endoglin|endoglin
378562|NCT01332721|Solid Tumors|solid tumors
378563|NCT01332721|Avastin|avastin
378564|NCT01332721|Bevacizumab|bevacizumab
378565|NCT01332708|high complex carbohydrates|high complex carbohydrates
378566|NCT01332708|hypocaloric diet|hypocaloric diet
378567|NCT01332708|cholinergic status|cholinergic status
378568|NCT01332708|overweight|overweight
378569|NCT01332708|obese|obese
378570|NCT01332695|tremor|tremor
378571|NCT01332695|WHIGET|whiget
378572|NCT01332695|Fahn Tolosa Marin Scale|fahn tolosa marin scale
378573|NCT01332682|head and neck cancer|head and neck cancer
378574|NCT01332682|resistance training|resistance training
378575|NCT01332682|nutrition counseling|nutrition counseling
378576|NCT01332682|pharyngeal or laryngeal cancer|pharyngeal or laryngeal cancer
378577|NCT01332669|hepatocellular carcinoma|hepatocellular carcinoma
378578|NCT01332669|chemoembolization|chemoembolization
378579|NCT01332669|drug eluting beads|drug eluting beads
378580|NCT01332669|HCC|hcc
378581|NCT01332669|Liver cancer|liver cancer
378582|NCT01332669|Korea|korea
378583|NCT01332643|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
378584|NCT01332643|recurrent pregnancy loss|recurrent pregnancy loss
378585|NCT01332643|infertility|infertility
378586|NCT01332643|genetic screening|genetic screening
378587|NCT01332643|trisomy 21|trisomy 21
378588|NCT01332643|Down syndrome|down syndrome
378589|NCT01332630|Breast cancer|breast cancer
378590|NCT01332630|Brain metastases|brain metastases
378591|NCT01332630|TPI 287|tpi 287
378592|NCT01332630|Computed Tomography|computed tomography
378593|NCT01332630|CT|ct
378594|NCT01332630|Magnetic Resonance Imaging|magnetic resonance imaging
378595|NCT01332630|MRI|mri
378596|NCT01332617|Multiple Myeloma|multiple myeloma
378597|NCT01332617|Simvastatin|simvastatin
378598|NCT01332617|Zoledronic|zoledronic
378599|NCT01332617|Bortezomib|bortezomib
378600|NCT01332617|Bendamustine|bendamustine
378601|NCT01332617|Methylprednisolone|methylprednisolone
378602|NCT01332591|STEMI, primary PCI, non-infarct, non-culprit lesion, CABG|stemi, primary pci, non-infarct, non-culprit lesion, cabg
378603|NCT01332565|GSK1349572|gsk1349572
378604|NCT01332565|pharmacokinetics|pharmacokinetics
378605|NCT01332565|Japanese|japanese
378606|NCT01332565|HIV|hiv
378607|NCT01332552|pharmacokinetics|pharmacokinetics
378608|NCT01332552|First administration to human|first administration to human
378609|NCT01332552|antiviral activity|antiviral activity
378610|NCT01332552|safety|safety
378611|NCT01332552|hepatitis C|hepatitis c
378612|NCT01332526|FFT|fft
378613|NCT01332526|inflammation|inflammation
378614|NCT01332526|lipid metabolism|lipid metabolism
378615|NCT01332526|hyperuricemia|hyperuricemia
378616|NCT01332526|Agents Affecting Uric Acid Metabolism|agents affecting uric acid metabolism
378617|NCT01332513|Healthy Volunteers|healthy volunteers
378618|NCT01332500|Triptans|triptans
378619|NCT01332500|Migraine|migraine
378620|NCT01332487|5-alpha-reductase inhibitor|5-alpha-reductase inhibitor
378621|NCT01332487|prostate surgery|prostate surgery
378622|NCT01332487|alpha-blocker|alpha-blocker
378623|NCT01332487|enlarged prostate|enlarged prostate
378624|NCT01332487|acute urinary retention|acute urinary retention
378625|NCT01332487|Benign prostatic hyperplasia|benign prostatic hyperplasia
378626|NCT01332474|Botox|botox
378627|NCT01332474|JCP|jcp
378628|NCT01332448|Xenical|xenical
378629|NCT01332448|Alli|alli
378630|NCT01332448|safety|safety
378631|NCT01332448|meta-analysis|meta-analysis
378632|NCT01332448|liver-function test|liver-function test
378633|NCT01332448|Roche|roche
378634|NCT01332448|orlistat|orlistat
378635|NCT01332435|Enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, early, costs|enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, early, costs
378636|NCT01332370|Retrospective|retrospective
378637|NCT01332370|Type 2 Diabetes|type 2 diabetes
378638|NCT01332370|Cost Analysis|cost analysis
378639|NCT01332370|Rosiglitazone|rosiglitazone
378640|NCT01332370|Sitagliptin|sitagliptin
378641|NCT01332357|fluticasone/propionate salmeterol combination|fluticasone/propionate salmeterol combination
378642|NCT01332357|hospitalization|hospitalization
378643|NCT01332357|emergency department|emergency department
378644|NCT01332357|asthma|asthma
378645|NCT01332344|fluticasone propionate/salmeterol combination|fluticasone propionate/salmeterol combination
378646|NCT01332344|Asthma|asthma
378647|NCT01332344|inhaled corticosteroids|inhaled corticosteroids
378648|NCT01332344|outcomes|outcomes
378649|NCT01332331|pulmonary arterial hypertension|pulmonary arterial hypertension
378650|NCT01332331|pediatric|pediatric
378651|NCT01332292|inhalation profiles|inhalation profiles
378652|NCT01332292|pharmacokinetics|pharmacokinetics
378653|NCT01332292|pharyngometry|pharyngometry
378654|NCT01332292|asthma|asthma
378655|NCT01332292|pediatric subjects|pediatric subjects
378656|NCT01332292|GW685698|gw685698
378657|NCT01332292|Fluticasone furoate|fluticasone furoate
378658|NCT01332292|safety|safety
378659|NCT01332266|Cancer|cancer
378660|NCT01332266|head and neck|head and neck
378661|NCT01332266|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
378662|NCT01332266|phase I|phase i
378663|NCT01332266|phase II|phase ii
378664|NCT01332253|Tonsillectomy, Pediatric|tonsillectomy, pediatric
378665|NCT01332240|staging|staging
378666|NCT01332240|endosonography|endosonography
378667|NCT01332240|lung cancer|lung cancer
378668|NCT01332240|stage III|stage iii
378669|NCT01332214|Phase 1|phase 1
378670|NCT01332214|healthy male volunteers|healthy male volunteers
378671|NCT01332214|dose escalation|dose escalation
378672|NCT01332214|pharmacokinetics|pharmacokinetics
378673|NCT01332214|Single Ascending Dose|single ascending dose
378674|NCT01332214|AZD2820 Cmax|azd2820 cmax
378675|NCT01332214|tmax|tmax
378676|NCT01332214|t1/2λz|t1/2λz
378677|NCT01332201|Advagraf|advagraf
378678|NCT01332201|Heart|heart
378679|NCT01332201|Lung|lung
378680|NCT01332201|Pancreas|pancreas
378681|NCT01332201|Transplant|transplant
378682|NCT01332201|Immunosuppression|immunosuppression
378683|NCT01332201|Pharmacokinetics|pharmacokinetics
378684|NCT01332162|Hypertrophic Obstructive Cardiomyopathy (HOCM)|hypertrophic obstructive cardiomyopathy (hocm)
378685|NCT01332162|Pacing|pacing
378686|NCT01332149|Diabetic Neuropathies|diabetic neuropathies
378687|NCT01332149|Pain|pain
378688|NCT01332149|Efficacy of pregabalin|efficacy of pregabalin
378689|NCT01332149|Placebo controlled|placebo controlled
378690|NCT01332110|Footwear|footwear
378691|NCT01332110|Motion Analysis|motion analysis
378692|NCT01332110|Running Injury|running injury
378693|NCT01332097|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
378694|NCT01332097|Exacerbation|exacerbation
378695|NCT01332097|Pulmonary Inflammation|pulmonary inflammation
378696|NCT01332084|SOTI|soti
378697|NCT01332084|tolerance|tolerance
378698|NCT01332084|desensitization|desensitization
378699|NCT01332084|challenge test|challenge test
378700|NCT01332084|HA wheat cereals|ha wheat cereals
378701|NCT01332071|Metformin|metformin
378702|NCT01332071|Rosiglitazone|rosiglitazone
378703|NCT01332071|Healthy volunteers|healthy volunteers
378704|NCT01332071|Avandamet|avandamet
378705|NCT01332071|Fed conditions|fed conditions
378706|NCT01332071|Bioequivalence|bioequivalence
378707|NCT01332058|Peripheral arterial disease|peripheral arterial disease
378708|NCT01332058|Walking|walking
378709|NCT01332058|Motivational Interviewing|motivational interviewing
378710|NCT01332032|cost effectiveness|cost effectiveness
378711|NCT01332032|screening mammography|screening mammography
378712|NCT01332032|repeat mammography|repeat mammography
378713|NCT01332032|telephone counseling|telephone counseling
378714|NCT01332032|computerized reminders|computerized reminders
378715|NCT01332032|compliance|compliance
378716|NCT01332019|Subcutaneous|subcutaneous
378717|NCT01332019|Extension|extension
378718|NCT01332019|Interferon|interferon
378720|NCT01332019|PEGylated|pegylated
378721|NCT01332019|Injectable|injectable
378722|NCT01332019|SC|sc
378723|NCT01332019|PEG|peg
378724|NCT01332019|peginterferon beta-1a|peginterferon beta-1a
378725|NCT01332019|Relapsing|relapsing
378726|NCT01331993|Phase 1|phase 1
378727|NCT01331993|crossover|crossover
378728|NCT01331993|bioequivalence|bioequivalence
378729|NCT01331993|naproxen|naproxen
378730|NCT01331993|esomeprazole|esomeprazole
378731|NCT01331993|vimovo|vimovo
378732|NCT01331993|healthy volunteers|healthy volunteers
378733|NCT01331980|cystic fibrosis|cystic fibrosis
378734|NCT01331980|bone|bone
378735|NCT01331967|pioglitazone|pioglitazone
378736|NCT01331967|optical coherence tomography|optical coherence tomography
378737|NCT01331967|microRNA|microrna
378738|NCT01331967|neointima|neointima
378739|NCT01331967|major adverse cardiovascular event|major adverse cardiovascular event
378740|NCT01331941|AMG 386|amg 386
378741|NCT01331941|Pharmacokinetic|pharmacokinetic
378742|NCT01331941|Renal Impairment|renal impairment
378743|NCT01331928|Sequential chemotherapy, gastric cancer|sequential chemotherapy, gastric cancer
378744|NCT01331915|Metastatic Melanoma|metastatic melanoma
378745|NCT01331915|Safety|safety
378746|NCT01331915|Theravac vaccine|theravac vaccine
378747|NCT01331915|HLA-A2 typing|hla-a2 typing
378748|NCT01331915|Tyrosinase.A2 gene expression|tyrosinase.a2 gene expression
378749|NCT01331902|Adenosine|adenosine
378750|NCT01331902|Nicorandil|nicorandil
378751|NCT01331902|Fractional Flow Reserve|fractional flow reserve
378752|NCT01331902|Maximal Hyperemia|maximal hyperemia
378753|NCT01331889|transfusion|transfusion
378754|NCT01331889|liver transplantation|liver transplantation
378755|NCT01331889|potassium|potassium
378756|NCT01331876|Cognitive and Behavioral Therapy|cognitive and behavioral therapy
378757|NCT01331863|Bronchial disease|bronchial disease
378758|NCT01331863|Lung cancer surgery|lung cancer surgery
378759|NCT01331863|Aorta/aortic Allograft|aorta/aortic allograft
378760|NCT01331863|homograft|homograft
378761|NCT01331863|Tracheal disease|tracheal disease
378762|NCT01331863|Benign|benign
378763|NCT01331863|Malignant|malignant
378764|NCT01331824|Bladder Cancer|bladder cancer
378765|NCT01331824|Urothelial Cancer|urothelial cancer
378766|NCT01331824|Chemotherapy|chemotherapy
378767|NCT01331824|Second-line|second-line
378768|NCT01331824|Metastatic|metastatic
378770|NCT01331811|Tuberculosis|tuberculosis
378771|NCT01331811|Diagnosis|diagnosis
378772|NCT01331811|Pediatrics|pediatrics
378773|NCT01331811|Asia|asia
378774|NCT01331811|Africa|africa
378775|NCT01331798|Abdominoplasty|abdominoplasty
378776|NCT01331785|paracentesis|paracentesis
378777|NCT01331785|ascites|ascites
378778|NCT01331785|hypotension|hypotension
378779|NCT01331772|Breast cancer|breast cancer
378780|NCT01331772|Adapted Physical activity|adapted physical activity
378781|NCT01331772|Nutrition|nutrition
378782|NCT01331772|Assessment|assessment
378783|NCT01331772|Patient education|patient education
378784|NCT01331759|Burnout|burnout
378785|NCT01331759|Subthreshold Disorder|subthreshold disorder
378786|NCT01331707|drug-eluting stent|drug-eluting stent
378787|NCT01331707|Zotarolimus|zotarolimus
378788|NCT01331707|Everolimus|everolimus
378789|NCT01331707|all comers population|all comers population
378790|NCT01331707|target vessel failure|target vessel failure
378791|NCT01331707|coronary artery disease|coronary artery disease
378792|NCT01331681|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
378793|NCT01331681|VEGF Trap-Eye|vegf trap-eye
378794|NCT01331681|Best-corrected visual acuity (BCVA)|best-corrected visual acuity (bcva)
378795|NCT01331642|Lymphatic Diseases|lymphatic diseases
378796|NCT01331642|Metabolism, Inborn Errors|metabolism, inborn errors
378797|NCT01331642|Genetic Diseases, Inborn|genetic diseases, inborn
378798|NCT01331642|Lipidoses|lipidoses
378799|NCT01331642|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
378800|NCT01331642|Metabolic Diseases|metabolic diseases
378801|NCT01331642|Lipid Metabolism Disorders|lipid metabolism disorders
378802|NCT01331629|breast cancer|breast cancer
378803|NCT01331629|fatigue|fatigue
378804|NCT01331629|quality of life|quality of life
378805|NCT01331629|art-therapie|art-therapie
378806|NCT01331629|adjuvant radiotherapy|adjuvant radiotherapy
378807|NCT01331616|Prospective study|prospective study
378808|NCT01331616|Glioblastoma|glioblastoma
378809|NCT01331616|Avastin|avastin
378810|NCT01331616|Visual Evoked Potential|visual evoked potential
378811|NCT01331616|Optic neuropathy|optic neuropathy
378812|NCT01331616|Chemo-radiotherapy|chemo-radiotherapy
378813|NCT01331603|MDS|mds
378814|NCT01331603|primary myelofibrosis|primary myelofibrosis
378815|NCT01331603|low+high risk MDS patients|low+high risk mds patients
378816|NCT01331603|patients|patients
378817|NCT01331577|Healthy|healthy
378818|NCT01331577|Primary Prevention|primary prevention
378819|NCT01331577|Stress|stress
378820|NCT01331577|Kinesiology|kinesiology
378821|NCT01331577|cognitive behavioural therapy|cognitive behavioural therapy
378822|NCT01331577|Prevention|prevention
378823|NCT01331564|Pregnancy|pregnancy
378824|NCT01331564|Postpartum|postpartum
378825|NCT01331564|Weight gain|weight gain
378826|NCT01331564|Weight retention|weight retention
378827|NCT01331564|Behavior|behavior
378828|NCT01331564|Electronic Media|electronic media
378829|NCT01331564|Randomized Clinical Trial|randomized clinical trial
378830|NCT01331551|Inflammatory Bowel disease|inflammatory bowel disease
378831|NCT01331538|temporomandibular dysfunction|temporomandibular dysfunction
378832|NCT01331538|posture|posture
378833|NCT01331525|Small cell lung cancer|small cell lung cancer
378834|NCT01331525|Chemotherapy|chemotherapy
378835|NCT01331525|Immunotherapy|immunotherapy
378836|NCT01331525|CTLA-4|ctla-4
378837|NCT01331525|Ipilimumab|ipilimumab
378838|NCT01331512|Clinical Geriatrics|clinical geriatrics
378839|NCT01331512|Biomechanics|biomechanics
378840|NCT01331512|Epidemiology|epidemiology
378841|NCT01331512|Decline in Ambulation|decline in ambulation
378842|NCT01331499|Blood loss|blood loss
378843|NCT01331499|transfusions|transfusions
378844|NCT01331499|instrumented spinal fusion|instrumented spinal fusion
378845|NCT01331486|Prehypertension|prehypertension
378846|NCT01331486|Mild hypertension|mild hypertension
378847|NCT01331486|Flow mediated dilation|flow mediated dilation
378848|NCT01331486|Hawthorn|hawthorn
378849|NCT01331473|Carotid Artery|carotid artery
378850|NCT01331473|Stenting|stenting
378851|NCT01331473|CAS|cas
378852|NCT01331473|proximal protection|proximal protection
378853|NCT01331460|HIV|hiv
378854|NCT01331460|HIV risk|hiv risk
378855|NCT01331460|Sexually Transmitted Diseases|sexually transmitted diseases
378856|NCT01331460|Drug Use|drug use
378857|NCT01331460|Women|women
378858|NCT01331460|Drug Treatment|drug treatment
378859|NCT01331460|opioids|opioids
378860|NCT01331460|injection drug use|injection drug use
378861|NCT01331460|stimulants|stimulants
378862|NCT01331460|gender-specific treatment|gender-specific treatment
378863|NCT01331395|Infertility|infertility
378864|NCT01331395|IVF|ivf
378865|NCT01331395|Acupuncture|acupuncture
378866|NCT01331382|Resveratrol|resveratrol
378867|NCT01331382|Piperine|piperine
378868|NCT01331382|Cerebral blood flow|cerebral blood flow
378869|NCT01331382|Near- infrared spectroscopy|near- infrared spectroscopy
378870|NCT01331382|Bioavailability|bioavailability
378871|NCT01331369|adherence|adherence
378872|NCT01331369|compliance|compliance
378873|NCT01331369|persistence|persistence
378874|NCT01331369|drop out|drop out
378875|NCT01331369|abandon|abandon
378876|NCT01331356|Chronic proctalgia|chronic proctalgia
378877|NCT01331356|Botulinum toxin type A|botulinum toxin type a
378878|NCT01331356|Ganglion Impar|ganglion impar
378879|NCT01331356|Perineal pain|perineal pain
378880|NCT01331356|Pudendal neuralgia|pudendal neuralgia
378881|NCT01331356|Refractory chronic proctalgia|refractory chronic proctalgia
378882|NCT01331343|Diabetes|diabetes
378883|NCT01331343|Glycemic Control|glycemic control
378884|NCT01331343|Continuous Glucose Monitoring|continuous glucose monitoring
378885|NCT01331330|Depressive Disorder|depressive disorder
378886|NCT01331330|Unipolar|unipolar
378887|NCT01331330|Implantable Stimulation Electrodes|implantable stimulation electrodes
378888|NCT01331317|Cardiovascular disease and mortality|cardiovascular disease and mortality
378889|NCT01331317|Plasma NTproBNP|plasma ntprobnp
378890|NCT01331317|UAER|uaer
378891|NCT01331304|Bipolar disorder|bipolar disorder
378892|NCT01331304|Comparative effectiveness trial|comparative effectiveness trial
378893|NCT01331304|Lithium|lithium
378894|NCT01331304|Quetiapine|quetiapine
378895|NCT01331291|bosutinib|bosutinib
378896|NCT01331291|SKI-606|ski-606
378897|NCT01331278|total joint replacement|total joint replacement
378898|NCT01331278|knee|knee
378899|NCT01331265|perceived lactose intolerance|perceived lactose intolerance
378900|NCT01331265|calcium/dairy consumption|calcium/dairy consumption
378901|NCT01331265|specific health outcomes|specific health outcomes
378902|NCT01331239|Cushing Disease|cushing disease
378903|NCT01331239|LCI699|lci699
378904|NCT01331239|Pituitary Gland|pituitary gland
378905|NCT01331239|Adrenocorticotropic Hormone|adrenocorticotropic hormone
378906|NCT01331213|Pregabalin|pregabalin
378907|NCT01331213|Irritable Bowel Syndrome|irritable bowel syndrome
378908|NCT01331213|motor|motor
378909|NCT01331213|sensation|sensation
378910|NCT01331213|colon|colon
378911|NCT01331213|human|human
378912|NCT01331200|ischemic stroke|ischemic stroke
378913|NCT01331200|tissue plasminogen activator|tissue plasminogen activator
378914|NCT01331200|early mobilization|early mobilization
378915|NCT01331200|patient safety|patient safety
378916|NCT01331200|length of stay|length of stay
378917|NCT01331187|Echocardiography|echocardiography
378918|NCT01331187|Heart failure|heart failure
378919|NCT01331187|Ultrasonography|ultrasonography
378920|NCT01331187|pocket-size device|pocket-size device
378921|NCT01331187|Aorta|aorta
378922|NCT01331187|Education|education
378923|NCT01331174|knee|knee
378924|NCT01331174|osteoarthritis|osteoarthritis
378925|NCT01331174|physical therapy|physical therapy
378926|NCT01331174|pulsed short wave|pulsed short wave
378927|NCT01331161|shingles vaccine|shingles vaccine
378928|NCT01331161|immune responses|immune responses
378929|NCT01331148|sickle cell disease|sickle cell disease
378930|NCT01331148|vitamin D|vitamin d
378931|NCT01331148|pediatrics|pediatrics
378932|NCT01331148|pain|pain
378933|NCT01331135|pediatrics|pediatrics
378934|NCT01331135|sirolimus|sirolimus
378935|NCT01331135|relapse|relapse
378936|NCT01331109|Fibromyalgia|fibromyalgia
378937|NCT01331109|Pediatric Fibromyalgia|pediatric fibromyalgia
378938|NCT01331109|Adolescent Fibromyalgia|adolescent fibromyalgia
378939|NCT01331109|milnacipran|milnacipran
378940|NCT01331109|Savella|savella
378941|NCT01331109|loss of therapeutic response|loss of therapeutic response
378942|NCT01331109|Forest Research Institute|forest research institute
378943|NCT01331109|Pain|pain
378944|NCT01331109|Fatigue|fatigue
378945|NCT01331109|Serotonin Norepinephrine Reuptake Inhibitors|serotonin norepinephrine reuptake inhibitors
378946|NCT01331096|thyroid gland resection surgery|thyroid gland resection surgery
378947|NCT01331096|total intravenous anesthesia|total intravenous anesthesia
378948|NCT01331070|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
378949|NCT01331057|Bilingualism|bilingualism
378950|NCT01331057|Language|language
378951|NCT01331057|Evaluation transcultural|evaluation transcultural
378952|NCT01331057|Intra Familial Relationship|intra familial relationship
378954|NCT01331057|Tongue french|tongue french
378955|NCT01331057|Language tamil|language tamil
378956|NCT01331057|Language arabic|language arabic
378957|NCT01331057|Language soninke|language soninke
378958|NCT01331057|Language cultural|language cultural
378959|NCT01331057|Affiliations crossbreeding|affiliations crossbreeding
378960|NCT01331044|RUTF|rutf
378961|NCT01331044|Severe Acute Malnutrition|severe acute malnutrition
378962|NCT01331044|Children|children
378963|NCT01331044|Body composition|body composition
378964|NCT01331044|Microbiota|microbiota
378965|NCT01331044|Short Chain Fatty Acid|short chain fatty acid
378966|NCT01331044|Acceptability of RUTF|acceptability of rutf
378967|NCT01331044|Edema free 15 percent weight gain|edema free 15 percent weight gain
378968|NCT01331044|Changes in body composition|changes in body composition
378969|NCT01331044|Gut microbiota|gut microbiota
378970|NCT01331044|Genome wide association|genome wide association
378971|NCT01331031|temporomandibular disorder|temporomandibular disorder
378972|NCT01331031|adolescents|adolescents
378973|NCT01331005|Macular Edema|macular edema
378974|NCT01331005|Non steroidal anti-inflammatories|non steroidal anti-inflammatories
378975|NCT01330992|Circadian rhythms|circadian rhythms
378976|NCT01330992|Melatonin|melatonin
378977|NCT01330992|Ocular light exposure|ocular light exposure
378978|NCT01330992|Darkness Exposure|darkness exposure
378979|NCT01330992|Performance|performance
378980|NCT01330992|Alertness|alertness
378981|NCT01330979|Intraocular pressure|intraocular pressure
378982|NCT01330966|surgically unresectable chondrosarcoma|surgically unresectable chondrosarcoma
378983|NCT01330953|Anemia|anemia
378984|NCT01330940|Kidney stones|kidney stones
378985|NCT01330940|Calcium|calcium
378986|NCT01330940|citrate|citrate
378987|NCT01330927|VA106483|va106483
378988|NCT01330927|Nocturia|nocturia
378989|NCT01330927|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
378991|NCT01330927|Elderly|elderly
378992|NCT01330927|Males|males
378993|NCT01330927|Nocturnal voids|nocturnal voids
378994|NCT01330927|Anti-diuretic|anti-diuretic
378995|NCT01330914|Obesity, Morbid|obesity, morbid
378996|NCT01330914|Bariatric Surgery|bariatric surgery
378997|NCT01330914|Gastric Bypass|gastric bypass
378998|NCT01330914|Calcium Metabolism Disorders|calcium metabolism disorders
378999|NCT01330914|Vitamin D|vitamin d
379000|NCT01330914|Bone Density|bone density
379001|NCT01330914|Body Composition|body composition
379002|NCT01330914|Weight Loss|weight loss
379003|NCT01330888|war|war
379004|NCT01330888|religion|religion
379005|NCT01330888|caregiver|caregiver
379006|NCT01330888|combat stress disorder|combat stress disorder
379007|NCT01330862|patient outcomes|patient outcomes
379008|NCT01330849|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
379009|NCT01330849|School|school
379010|NCT01330849|Behavioral Intervention|behavioral intervention
379011|NCT01330849|RCT|rct
379012|NCT01330823|pancreatic carcinoma|pancreatic carcinoma
379013|NCT01330823|L-Carnitine|l-carnitine
379014|NCT01330823|quality of life|quality of life
379015|NCT01330823|survival|survival
379016|NCT01330823|malnutrition|malnutrition
379017|NCT01330823|cancer cachexia|cancer cachexia
379018|NCT01330823|fatigue|fatigue
379019|NCT01330810|Pharmacokinetics|pharmacokinetics
379020|NCT01330810|Dietary Supplements|dietary supplements
379021|NCT01330810|Curcumin|curcumin
379022|NCT01330797|Cataract|cataract
379023|NCT01330797|Intravitreal|intravitreal
379024|NCT01330797|Ranibizumab|ranibizumab
379025|NCT01330797|LOCS III|locs iii
379026|NCT01330758|Phase I|phase i
379120|NCT01330368|children with SLE|children with sle
379027|NCT01330758|Healthy male and non-fertile female volunteers|healthy male and non-fertile female volunteers
379028|NCT01330758|Bioavailability|bioavailability
379029|NCT01330758|AZD8931|azd8931
379030|NCT01330745|cardiopulmonary bypass|cardiopulmonary bypass
379031|NCT01330745|mesenteric|mesenteric
379032|NCT01330745|microcirculatory function|microcirculatory function
379033|NCT01330732|SPINESCAN®|spinescan®
379034|NCT01330732|kyphosis|kyphosis
379035|NCT01330719|Periodontitis|periodontitis
379036|NCT01330706|Skin Diseases [C17.800]|skin diseases [c17.800]
379037|NCT01330706|Nail Diseases [C17.800.529]|nail diseases [c17.800.529]
379038|NCT01330706|Nails, Ingrown [C17.800.529.406]|nails, ingrown [c17.800.529.406]
379039|NCT01330693|ADHD|adhd
379040|NCT01330693|Atomoxetine|atomoxetine
379041|NCT01330693|Biomarker|biomarker
379042|NCT01330680|coffee|coffee
379043|NCT01330680|caffeine|caffeine
379044|NCT01330680|blood pressure|blood pressure
379045|NCT01330680|nutrigenetics|nutrigenetics
379046|NCT01330680|gene polymorphisms|gene polymorphisms
379047|NCT01330680|Acute Cardiovascular and Neuropsychologic Effects|acute cardiovascular and neuropsychologic effects
379048|NCT01330667|Hyperbilirubinemia|hyperbilirubinemia
379049|NCT01330667|Breastfeeding|breastfeeding
379050|NCT01330667|Limited Formula|limited formula
379051|NCT01330654|Intermediate risk of adverse cardiac event|intermediate risk of adverse cardiac event
379052|NCT01330654|Undergoing laparoscopic surgical procedure|undergoing laparoscopic surgical procedure
379053|NCT01330654|Age forty to seventy five|age forty to seventy five
379055|NCT01330641|Rotator Cuff|rotator cuff
379056|NCT01330641|Shoulder|shoulder
379057|NCT01330641|Injection|injection
379058|NCT01330628|peripheral arterial disease|peripheral arterial disease
379059|NCT01330628|in stent restenosis|in stent restenosis
379060|NCT01330628|peripheral vascular disease|peripheral vascular disease
379061|NCT01330615|EMLA|emla
379062|NCT01330615|plantar warts|plantar warts
379063|NCT01330615|cryotherapy|cryotherapy
379064|NCT01330589|Percutaneous coronary intervention|percutaneous coronary intervention
379065|NCT01330589|Clopidogrel|clopidogrel
379066|NCT01330589|St. John's Wort|st. john's wort
379067|NCT01330589|CYP 2C19 loss-of-function allele|cyp 2c19 loss-of-function allele
379068|NCT01330576|Hypothermia|hypothermia
379069|NCT01330576|cooling|cooling
379070|NCT01330576|necrotizing enterocolitis|necrotizing enterocolitis
379071|NCT01330576|NEC|nec
379072|NCT01330576|neonates|neonates
379073|NCT01330576|preterm|preterm
379074|NCT01330563|Drug-Drug interaction between the CKD-501 and ketoconazole|drug-drug interaction between the ckd-501 and ketoconazole
379075|NCT01330550|High fiber sugar free biscuit|high fiber sugar free biscuit
379076|NCT01330550|pre-diabetics|pre-diabetics
379077|NCT01330537|perceptual development|perceptual development
379078|NCT01330537|topological perception theory|topological perception theory
379079|NCT01330537|familiarization/novelty preference method|familiarization/novelty preference method
379080|NCT01330537|Discriminate a disk and a ring (topologically different),|discriminate a disk and a ring (topologically different),
379081|NCT01330537|Discriminate a disk and a triangle (geometrically different)|discriminate a disk and a triangle (geometrically different)
379082|NCT01330537|Detect a change in the number of holes|detect a change in the number of holes
379083|NCT01330537|Detect the size of the hole|detect the size of the hole
379084|NCT01330511|Newborn infant|newborn infant
379085|NCT01330511|Congenital hydronephrosis|congenital hydronephrosis
379086|NCT01330511|Postnatal imaging evaluation|postnatal imaging evaluation
379087|NCT01330511|Diagnostic algorithm|diagnostic algorithm
379088|NCT01330498|Longitudinal assessment of biomarkers|longitudinal assessment of biomarkers
379089|NCT01330498|duration of natalizumab|duration of natalizumab
379090|NCT01330498|stratification of risk for PML|stratification of risk for pml
379091|NCT01330472|Alprazolam|alprazolam
379092|NCT01330472|Xanax|xanax
379093|NCT01330472|Bioequivalence|bioequivalence
379094|NCT01330472|Panic disorder with or without agoraphobia.|panic disorder with or without agoraphobia.
379095|NCT01330459|Pain during first trimester surgical abortion|pain during first trimester surgical abortion
379096|NCT01330446|Head and Neck Cancer|head and neck cancer
379097|NCT01330446|HNC|hnc
379098|NCT01330446|Fatigue|fatigue
379099|NCT01330446|Patient-Reported Fatigue|patient-reported fatigue
379100|NCT01330446|Fatigue-Symptom Intervention|fatigue-symptom intervention
379101|NCT01330446|Postoperative Radiation Therapy|postoperative radiation therapy
379102|NCT01330446|Postoperative Chemoradiation Therapy|postoperative chemoradiation therapy
379103|NCT01330446|Armodafinil|armodafinil
379104|NCT01330446|Nuvigil|nuvigil
379105|NCT01330446|Placebo|placebo
379107|NCT01330446|Questionnaires|questionnaires
379108|NCT01330446|Surveys|surveys
379109|NCT01330394|Alcoholism|alcoholism
379110|NCT01330394|Lesch's typology|lesch's typology
379111|NCT01330394|tDCS|tdcs
379112|NCT01330394|ERP|erp
379113|NCT01330394|P300|p300
379114|NCT01330394|FAB|fab
379115|NCT01330394|MMSE|mmse
379116|NCT01330394|Cognitive tasks|cognitive tasks
379117|NCT01330368|Systemic Lupus Erythematosus|systemic lupus erythematosus
379118|NCT01330368|SLE|sle
379119|NCT01330368|Lupus|lupus
379222|NCT01329848|Reading|reading
379121|NCT01330355|Ocular infections, bacterial|ocular infections, bacterial
379122|NCT01330329|Obesity|obesity
379123|NCT01330329|Weight loss|weight loss
379124|NCT01330329|Exercise|exercise
379125|NCT01330329|Intervention studies|intervention studies
379126|NCT01330303|Bioequivalence|bioequivalence
379127|NCT01330303|Healthy volunteers|healthy volunteers
379128|NCT01330303|tamsulosin hydrochloride|tamsulosin hydrochloride
379129|NCT01330303|Fed administration|fed administration
379130|NCT01330290|Rotigotine|rotigotine
379131|NCT01330290|Neupro®|neupro®
379132|NCT01330290|Parkinson|parkinson
379133|NCT01330290|Treatment preference|treatment preference
379134|NCT01330290|Care-giving|care-giving
379135|NCT01330277|Metabolic Diseases|metabolic diseases
379136|NCT01330277|Biomarker|biomarker
379137|NCT01330277|Mucopolysaccharidosis II|mucopolysaccharidosis ii
379138|NCT01330277|Lysosomal Storage Diseases|lysosomal storage diseases
379139|NCT01330277|Morbus Hunter|morbus hunter
379140|NCT01330277|Mucopolysaccharidoses|mucopolysaccharidoses
379141|NCT01330264|Intracranial Pressure (ICP) Monitoring|intracranial pressure (icp) monitoring
379142|NCT01330264|Admission to Intensive Care Unit (ICU)|admission to intensive care unit (icu)
379143|NCT01330238|Low back pain|low back pain
379144|NCT01330238|Modic changes|modic changes
379145|NCT01330238|Vertebral endplate signal changes|vertebral endplate signal changes
379146|NCT01330238|Efficacy|efficacy
379147|NCT01330238|Zoledronic acid|zoledronic acid
379148|NCT01330238|Bisphosphonates|bisphosphonates
379149|NCT01330238|RCT|rct
379150|NCT01330199|Healthy|healthy
379151|NCT01330199|Female|female
379152|NCT01330199|Volunteer|volunteer
379153|NCT01330160|stroke|stroke
379154|NCT01330160|Brain ischemia|brain ischemia
379155|NCT01330160|Intracranial hemorrhage|intracranial hemorrhage
379156|NCT01330160|Dementia, Vascular|dementia, vascular
379157|NCT01330160|Alzheimer's disease|alzheimer's disease
379158|NCT01330147|HPV|hpv
379159|NCT01330147|oral cancer|oral cancer
379160|NCT01330147|oropharyngeal cancer|oropharyngeal cancer
379161|NCT01330147|tonsillectomy|tonsillectomy
379162|NCT01330134|procedural|procedural
379163|NCT01330121|Adherence with discharge diabetes medications|adherence with discharge diabetes medications
379164|NCT01330121|Diabeted mellitus type 2 greater than one year|diabeted mellitus type 2 greater than one year
379165|NCT01330121|Patient with provider and prescriptions filled within CCHS|patient with provider and prescriptions filled within cchs
379166|NCT01330108|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
379167|NCT01330108|PAH|pah
379168|NCT01330108|WHO Group 1|who group 1
379169|NCT01330095|Bifidobacterium bifidum|bifidobacterium bifidum
379170|NCT01330095|Very low birth weight infant|very low birth weight infant
379171|NCT01330095|Enteral feeding|enteral feeding
379172|NCT01330095|Growth|growth
379173|NCT01330095|amount of enteral feeding|amount of enteral feeding
379174|NCT01330082|Photodynamic therapy|photodynamic therapy
379175|NCT01330082|Light-emitting diode|light-emitting diode
379176|NCT01330082|toluidine blue|toluidine blue
379177|NCT01330082|scaling and root planing|scaling and root planing
379178|NCT01330056|Laryngeal and pharyngeal preservation, survivals|laryngeal and pharyngeal preservation, survivals
379179|NCT01330043|smoking cessation intervention|smoking cessation intervention
379180|NCT01330017|Seasonal allergies|seasonal allergies
379181|NCT01329991|RA|ra
379182|NCT01329991|Methotrexate|methotrexate
379183|NCT01329978|Hepatitis C|hepatitis c
379184|NCT01329978|HCV|hcv
379185|NCT01329978|Chronic Hepatitis C|chronic hepatitis c
379186|NCT01329965|Cardiovascular disease|cardiovascular disease
379187|NCT01329965|Inflammation|inflammation
379188|NCT01329965|LPS|lps
379189|NCT01329965|Endotoxin|endotoxin
379190|NCT01329939|Asthma|asthma
379191|NCT01329939|Obesity|obesity
379192|NCT01329939|Pediatric|pediatric
379193|NCT01329939|Inflammation|inflammation
379194|NCT01329939|Leukotriene|leukotriene
379195|NCT01329939|Montelukast|montelukast
379196|NCT01329926|Parkinson's disease|parkinson's disease
379197|NCT01329926|Neural stem cells|neural stem cells
379198|NCT01329900|Chemotherapy|chemotherapy
379199|NCT01329900|Stem Cell Collection|stem cell collection
379200|NCT01329900|Ofatumumab|ofatumumab
379201|NCT01329900|Arzerra|arzerra
379202|NCT01329900|Ifosfamide|ifosfamide
379203|NCT01329900|Ifex|ifex
379204|NCT01329900|Etoposide|etoposide
379205|NCT01329900|VePesid|vepesid
379206|NCT01329900|Mesna|mesna
379207|NCT01329900|Mesnex|mesnex
379208|NCT01329900|G-CSF|g-csf
379209|NCT01329900|Filgrastim|filgrastim
379210|NCT01329900|Neupogen|neupogen
379212|NCT01329887|microcirculation|microcirculation
379213|NCT01329887|SDF|sdf
379214|NCT01329887|ketanserin|ketanserin
379215|NCT01329887|severe sepsis|severe sepsis
379216|NCT01329861|chronic back pain|chronic back pain
379217|NCT01329861|internet based treatment|internet based treatment
379218|NCT01329861|pain management programme|pain management programme
379219|NCT01329861|cognitive behavioural therapy|cognitive behavioural therapy
379220|NCT01329861|minimal therapist contact|minimal therapist contact
379221|NCT01329848|Accommodation|accommodation
379223|NCT01329848|Autorefraction|autorefraction
379224|NCT01329822|type 2 diabetes|type 2 diabetes
379225|NCT01329822|overweight|overweight
379226|NCT01329809|metastatic colorectal cancer|metastatic colorectal cancer
379227|NCT01329809|colon cancer|colon cancer
379228|NCT01329809|liver metastasis|liver metastasis
379229|NCT01329809|Pexa-vec|pexa-vec
379231|NCT01329796|dysmenorrhea,|dysmenorrhea,
379232|NCT01329796|pelvic pain|pelvic pain
379233|NCT01329796|dyspareunia|dyspareunia
379234|NCT01329796|endometriosis|endometriosis
379235|NCT01329770|Neurodevelopmental disability|neurodevelopmental disability
379236|NCT01329770|Hyperactivity|hyperactivity
379237|NCT01329770|Anxiety|anxiety
379238|NCT01329770|Cognitive problems|cognitive problems
379239|NCT01329770|Behavioural symptoms|behavioural symptoms
379240|NCT01329770|Fragile X syndrome|fragile x syndrome
379241|NCT01329770|Autism|autism
379242|NCT01329770|inherited Genetic condition|inherited genetic condition
379243|NCT01329757|Spinal Cord Injury|spinal cord injury
379244|NCT01329757|Growth Hormone|growth hormone
379245|NCT01329757|Trauma|trauma
379246|NCT01329757|Incomplete|incomplete
379247|NCT01329757|ASIA|asia
379248|NCT01329744|HIV lipodystrophy|hiv lipodystrophy
379249|NCT01329731|white spot lesion|white spot lesion
379250|NCT01329731|initial caries|initial caries
379251|NCT01329731|fluoride|fluoride
379252|NCT01329731|amine fluoride|amine fluoride
379253|NCT01329731|orthodontics|orthodontics
379254|NCT01329731|remineralization|remineralization
379255|NCT01329731|brackets|brackets
379256|NCT01329718|Stability of the Septin 9 biomarker|stability of the septin 9 biomarker
379257|NCT01329718|Epi Pro Colon Test|epi pro colon test
379259|NCT01329692|RYGB|rygb
379260|NCT01329692|Intervention|intervention
379261|NCT01329692|follow-up|follow-up
379262|NCT01329692|standard-of-care|standard-of-care
379263|NCT01329692|Back on Track program|back on track program
379264|NCT01329692|poor weight loss|poor weight loss
379265|NCT01329692|morbidly obese|morbidly obese
379266|NCT01329666|Primary Hyperparathyroidism|primary hyperparathyroidism
379267|NCT01329666|Endocrinology|endocrinology
379268|NCT01329666|Hypercalcemia|hypercalcemia
379269|NCT01329666|Vitamin D deficiency|vitamin d deficiency
379270|NCT01329666|Parathyroid Hormone|parathyroid hormone
379271|NCT01329666|Osteoporosis|osteoporosis
379272|NCT01329666|Bone Density|bone density
379273|NCT01329666|Vitamin D repletion|vitamin d repletion
379274|NCT01329666|Vitamin D Supplements|vitamin d supplements
379275|NCT01329653|cerebral blood volume|cerebral blood volume
379276|NCT01329653|aging|aging
379277|NCT01329653|exercise|exercise
379278|NCT01329640|Metronimic chemotherapy|metronimic chemotherapy
379279|NCT01329640|Locally Advanced HER2-positive Breast Cancer|locally advanced her2-positive breast cancer
379280|NCT01329601|cognitive training|cognitive training
379281|NCT01329601|Alzheimer disease|alzheimer disease
379282|NCT01329601|tertiary prevention|tertiary prevention
379283|NCT01329588|Female sex workers|female sex workers
379284|NCT01329588|West Africa|west africa
379285|NCT01329588|Presumptive treatment|presumptive treatment
379286|NCT01329588|Sexually transmitted infections|sexually transmitted infections
379287|NCT01329575|endoluminal ultrasound|endoluminal ultrasound
379288|NCT01329575|Mediastinal LN invasion|mediastinal ln invasion
379289|NCT01329562|Menstrual migraine|menstrual migraine
379290|NCT01329562|Menstrually-related migraine|menstrually-related migraine
379291|NCT01329562|Treximet|treximet
379292|NCT01329562|CGRP|cgrp
379293|NCT01329562|calcitonin gene-related peptide|calcitonin gene-related peptide
379294|NCT01329536|Alzheimer's Disease|alzheimer's disease
379295|NCT01329536|Agitation|agitation
379296|NCT01329536|Genetics|genetics
379297|NCT01329536|Apolipoprotein|apolipoprotein
379298|NCT01329536|ApoE4|apoe4
379299|NCT01329523|Dementia|dementia
379300|NCT01329523|Insulin-like growth factor|insulin-like growth factor
379302|NCT01329523|APO E4|apo e4
379303|NCT01329523|Genetics|genetics
379304|NCT01329510|ADHD|adhd
379305|NCT01329510|Adult|adult
379306|NCT01329484|Alzheimer|alzheimer
379307|NCT01329484|Dementia|dementia
379308|NCT01329484|Computer|computer
379309|NCT01329484|Cognitive training|cognitive training
379310|NCT01329484|Reminiscence therapy|reminiscence therapy
379311|NCT01329458|FLL|fll
379312|NCT01329458|CEUS|ceus
379313|NCT01329458|SonoVue|sonovue
379314|NCT01329458|HCC|hcc
379315|NCT01329458|Liver metastases|liver metastases
379316|NCT01329458|Hemangiomas|hemangiomas
379317|NCT01329458|FNH|fnh
379318|NCT01329445|Cartilage repair|cartilage repair
379319|NCT01329445|Articular cartilage defects|articular cartilage defects
379320|NCT01329432|surfactant|surfactant
379321|NCT01329432|intubation|intubation
379322|NCT01329432|spontaneous breathing|spontaneous breathing
379323|NCT01329432|bronchopulmonary dysplasia|bronchopulmonary dysplasia
379324|NCT01329406|Osteoarthritis (OA)|osteoarthritis (oa)
379325|NCT01329406|Milnacipran|milnacipran
379426|NCT01328964|asthma|asthma
379326|NCT01329406|Serotonin-norepinephrine reuptake inhibitor (SNRI)|serotonin-norepinephrine reuptake inhibitor (snri)
379327|NCT01329406|Knee pain|knee pain
379328|NCT01329393|Disability|disability
379329|NCT01329393|Social Security|social security
379330|NCT01329393|Representative Payee|representative payee
379331|NCT01329380|Ankylosing Spondylitis|ankylosing spondylitis
379332|NCT01329367|EVASYON|evasyon
379333|NCT01329367|GENOI|genoi
379334|NCT01329367|antioxidants|antioxidants
379335|NCT01329367|legume|legume
379336|NCT01329367|fish|fish
379337|NCT01329354|Follicular lymphoma|follicular lymphoma
379338|NCT01329354|Follicular non-Hodgkin´s lymphoma|follicular non-hodgkin´s lymphoma
379339|NCT01329354|Autologous effector lymphocytes|autologous effector lymphocytes
379340|NCT01329354|Cell Therapy|cell therapy
379341|NCT01329354|Maintenance therapy|maintenance therapy
379342|NCT01329354|Rituximab|rituximab
379343|NCT01329341|PTSD|ptsd
379344|NCT01329341|Service Dogs|service dogs
379345|NCT01329328|whole-body vibration|whole-body vibration
379346|NCT01329328|radiofrequency|radiofrequency
379347|NCT01329328|hormonal status|hormonal status
379348|NCT01329328|muscular strength|muscular strength
379349|NCT01329328|balance|balance
378990|NCT01330927|BPH|bph
379350|NCT01329276|COPD|copd
379351|NCT01329276|Symbicort|symbicort
379352|NCT01329276|Turbohaler|turbohaler
379353|NCT01329276|Computational Fluid Dynamics|computational fluid dynamics
379354|NCT01329276|Functional Imaging|functional imaging
379355|NCT01329276|Budesonide|budesonide
379356|NCT01329276|Formoterol|formoterol
379357|NCT01329263|menthol cigarettes|menthol cigarettes
379358|NCT01329250|Tuberculosis|tuberculosis
379359|NCT01329250|Moxifloxacin|moxifloxacin
379360|NCT01329250|Pharmacokinetics|pharmacokinetics
379361|NCT01329250|Safety|safety
379362|NCT01329237|drug-eluting stent|drug-eluting stent
379363|NCT01329237|coronary endothelial function|coronary endothelial function
379364|NCT01329237|coronary imaging|coronary imaging
379365|NCT01329224|acetylsalicylic acid resistance|acetylsalicylic acid resistance
379366|NCT01329211|Gastroparesis|gastroparesis
379367|NCT01329211|Quality of Life|quality of life
379368|NCT01329198|tourette|tourette
379369|NCT01329198|tourette's|tourette's
379370|NCT01329198|TS|ts
379371|NCT01329198|tourette syndrome|tourette syndrome
379372|NCT01329198|tourette's syndrome|tourette's syndrome
379373|NCT01329185|EBV Viremia in posttransplant kidney recipients|ebv viremia in posttransplant kidney recipients
379374|NCT01329185|CMV viremia in posttransplant kidney recipients|cmv viremia in posttransplant kidney recipients
379375|NCT01329172|PUFA|pufa
379376|NCT01329172|Cystic Fibrosis|cystic fibrosis
379377|NCT01329172|Nasal brushing|nasal brushing
379378|NCT01329172|Mucins|mucins
379379|NCT01329172|Mucin production|mucin production
379380|NCT01329159|High altitude|high altitude
379381|NCT01329159|respiratory function|respiratory function
379382|NCT01329159|cardiorespiratory health|cardiorespiratory health
379383|NCT01329159|indoor pollution|indoor pollution
379384|NCT01329146|pulse pressure variation|pulse pressure variation
379385|NCT01329146|preload dependency|preload dependency
379386|NCT01329146|one-lung ventilation|one-lung ventilation
379387|NCT01329146|thoracic surgery|thoracic surgery
379388|NCT01329133|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
379389|NCT01329133|Obsessive compulsive disorder|obsessive compulsive disorder
379390|NCT01329133|ventral striatum|ventral striatum
379391|NCT01329133|subthalamic nucleus|subthalamic nucleus
379392|NCT01329107|Rehabilitation|rehabilitation
379393|NCT01329107|Enhanced Recovery|enhanced recovery
379394|NCT01329107|Health related Qouality of Life|health related qouality of life
379395|NCT01329107|Patient outcomes|patient outcomes
379396|NCT01329094|Severe mental illness|severe mental illness
379397|NCT01329094|physical activity|physical activity
379398|NCT01329094|evaluation|evaluation
379399|NCT01329081|Rehabilitation|rehabilitation
379400|NCT01329081|Strength training|strength training
379401|NCT01329081|Long-term effect|long-term effect
379402|NCT01329081|Activity and participation after fast-track knee arthroplasty|activity and participation after fast-track knee arthroplasty
379403|NCT01329068|breast cancer|breast cancer
379404|NCT01329042|Potassium sodium citrate|potassium sodium citrate
379405|NCT01329042|stone recurrence|stone recurrence
379406|NCT01329042|ESWL|eswl
379407|NCT01329042|PCNL|pcnl
379408|NCT01329042|Hypocitraturia|hypocitraturia
379409|NCT01329042|intervention|intervention
379410|NCT01329029|COPD|copd
379411|NCT01329029|Roflumilast|roflumilast
379412|NCT01329029|Daxas|daxas
379413|NCT01329016|Pregnancy|pregnancy
379414|NCT01329016|Glyburide|glyburide
379415|NCT01329016|Metformin|metformin
379416|NCT01329016|Pharmacokinetics|pharmacokinetics
379417|NCT01329016|Pharmacodynamics|pharmacodynamics
379418|NCT01329003|Silicosis|silicosis
379419|NCT01328990|IPTc|iptc
379420|NCT01328990|malaria|malaria
379421|NCT01328990|children|children
379422|NCT01328990|pharmacokinetics|pharmacokinetics
379423|NCT01328990|amodiaquiane|amodiaquiane
379424|NCT01328990|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
379425|NCT01328964|pediatric|pediatric
379427|NCT01328964|outcomes|outcomes
379428|NCT01328964|inhaled cortcosteroids|inhaled cortcosteroids
379429|NCT01328938|Pegfilgrastim|pegfilgrastim
379430|NCT01328938|neutropenia|neutropenia
379431|NCT01328925|Rotavirus|rotavirus
379432|NCT01328925|Viral gastroenteritis|viral gastroenteritis
379433|NCT01328925|Gastroenteritis|gastroenteritis
379434|NCT01328912|ischemic preconditioning|ischemic preconditioning
379435|NCT01328912|cardiac surgery|cardiac surgery
379436|NCT01328912|vascular surgery|vascular surgery
379437|NCT01328899|Emphysema|emphysema
379439|NCT01328899|RePneu|repneu
379440|NCT01328886|omalizumab|omalizumab
379441|NCT01328886|allergic asthma|allergic asthma
379442|NCT01328886|pediatric patients|pediatric patients
379443|NCT01328873|Pulmonary infiltrates|pulmonary infiltrates
379444|NCT01328873|stem cell transplant|stem cell transplant
379445|NCT01328873|leukemia|leukemia
379446|NCT01328860|Autologous|autologous
379447|NCT01328860|Stem Cells|stem cells
379448|NCT01328860|Spinal Cord Injury|spinal cord injury
379449|NCT01328860|Children|children
379450|NCT01328834|Nephritis, Lupus|nephritis, lupus
379451|NCT01328834|Tacrolimus|tacrolimus
379452|NCT01328821|Safety|safety
379453|NCT01328821|Tolerability|tolerability
379454|NCT01328821|Pharmacokinetics|pharmacokinetics
379455|NCT01328821|Healthy volunteers|healthy volunteers
379456|NCT01328808|Acetaminophen|acetaminophen
379457|NCT01328808|Preterm Infants|preterm infants
379458|NCT01328795|Cardiogoniometry|cardiogoniometry
379459|NCT01328795|Chest Pain Unit|chest pain unit
379460|NCT01328795|ST-elevation|st-elevation
379461|NCT01328795|Troponin|troponin
379462|NCT01328795|Catheter intervention|catheter intervention
379463|NCT01328795|Fast Track|fast track
379464|NCT01328782|elbow fracture|elbow fracture
379465|NCT01328782|supracondylar elbow fracture|supracondylar elbow fracture
379466|NCT01328782|elbow|elbow
379467|NCT01328782|fracture|fracture
379468|NCT01328782|pain management|pain management
379469|NCT01328782|pediatric|pediatric
379470|NCT01328769|uric acid|uric acid
379471|NCT01328769|febuxostat|febuxostat
379472|NCT01328769|hypertension|hypertension
379473|NCT01328769|intra-renal renin-angiotensin system|intra-renal renin-angiotensin system
379474|NCT01328769|renal plasma flow|renal plasma flow
379475|NCT01328769|angiotensin II|angiotensin ii
379476|NCT01328756|ADHD|adhd
379477|NCT01328730|significant stenosis (>70% of lumen stenosis)|significant stenosis (>70% of lumen stenosis)
379478|NCT01328730|epicardial coronary arteries.|epicardial coronary arteries.
379479|NCT01328704|Iron deficiency|iron deficiency
379480|NCT01328704|Vitamin D deficiency|vitamin d deficiency
379481|NCT01328704|Anemia|anemia
379482|NCT01328704|Athletes|athletes
379483|NCT01328704|Triathletes|triathletes
379484|NCT01328704|Triathlon|triathlon
379485|NCT01328691|Carcinoma, Renal Cell|carcinoma, renal cell
379486|NCT01328691|thrombus|thrombus
379487|NCT01328691|body mass index|body mass index
379488|NCT01328691|grade|grade
379489|NCT01328678|Alopecia Areata|alopecia areata
379490|NCT01328678|Vitamin D|vitamin d
379491|NCT01328678|Parathyroid|parathyroid
379492|NCT01328678|Calcium|calcium
379493|NCT01328652|LPR|lpr
379494|NCT01328652|LTH|lth
379495|NCT01328639|Collaborative care|collaborative care
379496|NCT01328639|Diabetes management|diabetes management
379497|NCT01328639|Depression management|depression management
379498|NCT01328639|Primary care|primary care
379499|NCT01328626|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
379500|NCT01328626|Maximum Tolerated Dose|maximum tolerated dose
379501|NCT01328626|ABT-199|abt-199
379502|NCT01328626|Safety|safety
379503|NCT01328626|Preliminary Efficacy|preliminary efficacy
379504|NCT01328626|Cancer|cancer
379505|NCT01328626|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
379506|NCT01328626|Pharmacokinetics|pharmacokinetics
379507|NCT01328613|BDNF|bdnf
379508|NCT01328613|Homeosis|homeosis
379509|NCT01328613|Women|women
379510|NCT01328613|Childbirth|childbirth
379511|NCT01328613|Major Depressive Disorder|major depressive disorder
379512|NCT01328600|Placenta|placenta
379513|NCT01328600|Pregnancy|pregnancy
379514|NCT01328600|Hypertension|hypertension
379515|NCT01328600|Supplementation|supplementation
379516|NCT01328600|Antibody|antibody
379517|NCT01328587|Eltrombopag|eltrombopag
379518|NCT01328587|Aplastic Anemia|aplastic anemia
379519|NCT01328587|Aplastic Anemia Treatment|aplastic anemia treatment
379520|NCT01328587|Moderate Aplastic Anemia|moderate aplastic anemia
379521|NCT01328587|Moderate Aplastic Anemia Treatment|moderate aplastic anemia treatment
379522|NCT01328574|Progression-Free Survival|progression-free survival
379523|NCT01328574|Carcinoma of the Bladder|carcinoma of the bladder
379524|NCT01328574|Cancer of the Renal Pelvis|cancer of the renal pelvis
379525|NCT01328574|Ureter Cancer|ureter cancer
379526|NCT01328574|Survival|survival
379527|NCT01328574|Bladder Cancer|bladder cancer
379528|NCT01328574|Renal Pelvis Cancer|renal pelvis cancer
379529|NCT01328574|Urothelial Cancer|urothelial cancer
379530|NCT01328561|Arginine|arginine
379531|NCT01328561|Oxytocin|oxytocin
379532|NCT01328561|Vasopressin|vasopressin
379533|NCT01328561|Placebo|placebo
379534|NCT01328561|Analgesia|analgesia
379535|NCT01328561|Healthy Volunteer|healthy volunteer
379536|NCT01328561|HV|hv
379537|NCT01328548|varicella-zoster virus|varicella-zoster virus
379538|NCT01328548|vaccine|vaccine
379539|NCT01328548|T-cell|t-cell
379540|NCT01328548|genes|genes
379541|NCT01328548|frail elderly|frail elderly
379542|NCT01328548|immunosenescence|immunosenescence
379543|NCT01328548|immune and genetic correlates of response to zoster vaccine in the elderly|immune and genetic correlates of response to zoster vaccine in the elderly
379544|NCT01328509|Zinc|zinc
379545|NCT01328496|Hematologic Malignancies|hematologic malignancies
379546|NCT01328496|Umbilical Cord Blood transplantation|umbilical cord blood transplantation
379547|NCT01328496|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
379548|NCT01328483|Neonates|neonates
379549|NCT01328483|Intrapartum Oropharyngeal Suctioning|intrapartum oropharyngeal suctioning
379550|NCT01328483|Meconium Aspiration Syndrome|meconium aspiration syndrome
379551|NCT01328470|platelet|platelet
379552|NCT01328470|cilostazol|cilostazol
379553|NCT01328470|clopidogrel|clopidogrel
379554|NCT01328470|chronic kidney disease|chronic kidney disease
379556|NCT01328457|kala-azar|kala-azar
379557|NCT01328457|Paromomycin|paromomycin
379558|NCT01328457|Bangladesh|bangladesh
379559|NCT01328457|Injections, Intramuscular|injections, intramuscular
379560|NCT01328457|Treatment Outcome|treatment outcome
379561|NCT01328457|Patient compliance|patient compliance
379562|NCT01328457|Medication adherence|medication adherence
379563|NCT01328457|Drug toxicity|drug toxicity
379564|NCT01328431|Tobacco Use Cessation|tobacco use cessation
379565|NCT01328431|Smoking Cessation|smoking cessation
379566|NCT01328431|Nicotine Replacement Therapy|nicotine replacement therapy
379567|NCT01328431|Brief Intervention|brief intervention
379568|NCT01328418|Lengthening|lengthening
379569|NCT01328392|LPR|lpr
379570|NCT01328392|GERD|gerd
379571|NCT01328366|Quality of Life|quality of life
379572|NCT01328366|Psychosocial factors|psychosocial factors
379573|NCT01328353|triage|triage
379574|NCT01328353|aprn|aprn
379575|NCT01328353|telehealth|telehealth
379576|NCT01328353|CCHCN|cchcn
379577|NCT01328353|advanced practice nurse|advanced practice nurse
379578|NCT01328353|improve family quality of life|improve family quality of life
379579|NCT01328353|reduce unplanned use of health care services|reduce unplanned use of health care services
379580|NCT01328353|telehealth triage intervention|telehealth triage intervention
379581|NCT01328340|muscle power, exercise, aging|muscle power, exercise, aging
379582|NCT01328301|gait|gait
379583|NCT01328301|hemiplegia|hemiplegia
379584|NCT01328301|treadmill|treadmill
379585|NCT01328301|physiotherapy|physiotherapy
379586|NCT01328301|rehabilitation|rehabilitation
379587|NCT01328288|HIV related adverse events|hiv related adverse events
379588|NCT01328288|Immunological failure|immunological failure
379589|NCT01328288|virological failure|virological failure
379590|NCT01328288|quality of life|quality of life
379591|NCT01328288|depression|depression
379592|NCT01328288|genotypic resistance|genotypic resistance
379593|NCT01328275|HIV related adverse events|hiv related adverse events
379594|NCT01328275|immunological failure|immunological failure
379595|NCT01328275|virological failure|virological failure
379596|NCT01328275|quality of life|quality of life
379597|NCT01328275|depression|depression
379598|NCT01328275|genotypic resistance|genotypic resistance
379599|NCT01328262|Hemoglobins|hemoglobins
379600|NCT01328249|Breast Cancer|breast cancer
379601|NCT01328249|HER2-normal Stage I to III invasive breast cancer|her2-normal stage i to iii invasive breast cancer
379602|NCT01328236|Bortezomib|bortezomib
379603|NCT01328236|PCL|pcl
379604|NCT01328223|Hepatocellular carcinoma|hepatocellular carcinoma
379605|NCT01328223|radiotherapy|radiotherapy
379606|NCT01328223|sorafenib|sorafenib
379607|NCT01328210|metabolic syndrome|metabolic syndrome
379608|NCT01328210|Phlebotomy|phlebotomy
379609|NCT01328210|blood letting|blood letting
379610|NCT01328210|hypertension|hypertension
379611|NCT01328210|insulin sensitivity|insulin sensitivity
379612|NCT01328197|Treovance|treovance
379613|NCT01328197|aneurysm|aneurysm
379614|NCT01328197|AAA|aaa
379615|NCT01328158|Kaletra, Lopinavir (LPV)/Ritonavir (RTV), Human Immunodeficiency Virus (HIV) infection|kaletra, lopinavir (lpv)/ritonavir (rtv), human immunodeficiency virus (hiv) infection
379616|NCT01328132|Liver|liver
379617|NCT01328132|transplant|transplant
379618|NCT01328132|albumin|albumin
379619|NCT01328067|MRgFus|mrgfus
379620|NCT01328067|Uterine Fibroids|uterine fibroids
379621|NCT01328067|Pelvic Pain|pelvic pain
379622|NCT01328067|Quality of Life|quality of life
379623|NCT01328067|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
379624|NCT01328054|cancer|cancer
379625|NCT01328054|cardiac repolarization|cardiac repolarization
379626|NCT01328054|Holter monitor|holter monitor
379627|NCT01328054|pharmacokinetics|pharmacokinetics
379628|NCT01328054|GW572016|gw572016
379629|NCT01328054|lapatinib|lapatinib
379630|NCT01328054|QTc interval|qtc interval
379631|NCT01328054|safety|safety
379633|NCT01328041|GSK1349572|gsk1349572
379634|NCT01328041|resistance to raltegravir or elvitegravir|resistance to raltegravir or elvitegravir
379635|NCT01328041|Integrase inhibitor|integrase inhibitor
379636|NCT01328041|ART-experienced|art-experienced
379637|NCT01328041|dolutegravir|dolutegravir
379638|NCT01328028|Invasive cervical cancer|invasive cervical cancer
379639|NCT01328028|Human papillomavirus|human papillomavirus
379640|NCT01328015|hyperhidrosis|hyperhidrosis
379641|NCT01328015|oxybutynin|oxybutynin
379642|NCT01328015|plantar sweating|plantar sweating
379643|NCT01328015|compensatory sweating|compensatory sweating
379644|NCT01328002|Fibromyalgia|fibromyalgia
379645|NCT01328002|Pediatric Fibromyalgia|pediatric fibromyalgia
379646|NCT01328002|Adolescent Fibromyalgia|adolescent fibromyalgia
379647|NCT01328002|milnacipran|milnacipran
379648|NCT01328002|Savella|savella
379649|NCT01328002|loss of therapeutic response|loss of therapeutic response
379650|NCT01328002|Forest Research Institute|forest research institute
379651|NCT01328002|Pain|pain
379652|NCT01328002|Fatigue|fatigue
379653|NCT01328002|Serotonin Norepinephrine Reuptake Inhibitors|serotonin norepinephrine reuptake inhibitors
379654|NCT01328002|Randomized Withdrawal|randomized withdrawal
379655|NCT01327989|Solitaire FR Device|solitaire fr device
379656|NCT01327989|Mechanical Thrombectomy|mechanical thrombectomy
379657|NCT01327989|Recanalization|recanalization
379658|NCT01327989|Brain artery recanalization|brain artery recanalization
379659|NCT01327989|Neurovascular intervention|neurovascular intervention
379660|NCT01327989|Interventional Neuroradiology|interventional neuroradiology
379661|NCT01327989|STAR|star
379662|NCT01327989|Acute Ischemic Stroke|acute ischemic stroke
379663|NCT01327976|Obesity|obesity
379664|NCT01327976|Bariatric surgery|bariatric surgery
379665|NCT01327976|Excess weight loss|excess weight loss
379666|NCT01327976|Vagus nerve|vagus nerve
379667|NCT01327976|Vagal blocking|vagal blocking
379668|NCT01327976|vBloc Therapy|vbloc therapy
379669|NCT01327963|Gastroesophageal reflux disease|gastroesophageal reflux disease
379670|NCT01327963|GERD|gerd
379671|NCT01327963|Heartburn|heartburn
379672|NCT01327963|Reflux|reflux
379673|NCT01327963|Regurgitation|regurgitation
379674|NCT01327963|Hoarseness|hoarseness
379675|NCT01327963|Cough|cough
379676|NCT01327950|Percutaneous treatment|percutaneous treatment
379677|NCT01327950|Superficial Femoral Artery lesions|superficial femoral artery lesions
379678|NCT01327950|EPIC Nitinol Vascular Stent System|epic nitinol vascular stent system
379679|NCT01327911|Mactel|mactel
379680|NCT01327911|Macular Telangiectasia Type 2|macular telangiectasia type 2
379682|NCT01327898|HIV/AIDS|hiv/aids
379683|NCT01327898|sexual risk|sexual risk
379684|NCT01327898|substance use|substance use
379685|NCT01327872|Idiopathic Thrombocytopenia Purpura(ITP)|idiopathic thrombocytopenia purpura(itp)
379686|NCT01327872|Acute and Chronic Thrombocytopenia Associated with Chronic Liver Disease|acute and chronic thrombocytopenia associated with chronic liver disease
379687|NCT01327872|TLD|tld
379688|NCT01327846|Cardiovascular Death|cardiovascular death
379689|NCT01327846|Myocardial Infarction|myocardial infarction
379690|NCT01327846|Stroke|stroke
379691|NCT01327846|Canakinumab|canakinumab
379692|NCT01327846|IL-1B|il-1b
379693|NCT01327846|hsCRP|hscrp
379694|NCT01327820|Oxygen consumption|oxygen consumption
379695|NCT01327820|Aortic Aneurysm|aortic aneurysm
379696|NCT01327820|Peripheral Arterial Disease|peripheral arterial disease
379697|NCT01327807|Registries|registries
379698|NCT01327807|Cystinosis|cystinosis
379699|NCT01327807|Nephropathic Cystinosis|nephropathic cystinosis
379700|NCT01327807|Renal Fanconi Syndrome|renal fanconi syndrome
379701|NCT01327807|Cystine|cystine
379702|NCT01327807|Kidney|kidney
379703|NCT01327807|Rare Diseases|rare diseases
379704|NCT01327794|recurrent pancreatic cancer|recurrent pancreatic cancer
379705|NCT01327794|stage III pancreatic cancer|stage iii pancreatic cancer
379706|NCT01327794|stage IV pancreatic cancer|stage iv pancreatic cancer
379707|NCT01327768|Stroke,|stroke,
379708|NCT01327768|Stem Cell,|stem cell,
379709|NCT01327768|Olfactory Ensheathing Cells,|olfactory ensheathing cells,
379710|NCT01327768|Intracerebral Implantation of Olfactory Ensheathing Cells.|intracerebral implantation of olfactory ensheathing cells.
379711|NCT01327755|Selenium|selenium
379712|NCT01327755|HIV/ AIDS|hiv/ aids
379713|NCT01327755|CD4 counts|cd4 counts
379714|NCT01327755|Antiretroviral therapy|antiretroviral therapy
379715|NCT01327742|Relay|relay
379716|NCT01327742|Thoracic|thoracic
379717|NCT01327742|Aneurysm|aneurysm
379718|NCT01327729|pegylated interferon|pegylated interferon
379719|NCT01327729|interferon|interferon
379720|NCT01327729|HCV|hcv
379721|NCT01327729|genotype 4|genotype 4
379722|NCT01327703|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
379723|NCT01327703|Cystic Fibrosis|cystic fibrosis
379724|NCT01327703|Steatorrhea|steatorrhea
379725|NCT01327703|Malabsorption|malabsorption
379726|NCT01327703|Malnutrition|malnutrition
379727|NCT01327677|pain management|pain management
379728|NCT01327677|opioid analgesic therapy|opioid analgesic therapy
379730|NCT01327677|craniotomy|craniotomy
379731|NCT01327664|Quiescent uveitis|quiescent uveitis
379732|NCT01327664|intermediate uveitis|intermediate uveitis
379733|NCT01327664|panuveitis|panuveitis
379734|NCT01327664|posterior uveitis|posterior uveitis
370440|NCT01366534|safety|safety
379735|NCT01327664|uveitis|uveitis
379736|NCT01327651|Drug Administration Schedule|drug administration schedule
379737|NCT01327651|Nucleoside Reverse Transcriptase Inhibitors|nucleoside reverse transcriptase inhibitors
379738|NCT01327651|Pharmacokinetics|pharmacokinetics
379739|NCT01327625|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
379740|NCT01327625|Graft versus host disease|graft versus host disease
379741|NCT01327625|Bronchiolitis obliterans|bronchiolitis obliterans
379742|NCT01327625|Azithromycin|azithromycin
379743|NCT01327625|N-acetylcystein|n-acetylcystein
379744|NCT01327625|Fluticasone|fluticasone
379745|NCT01327625|Inhaled steroid|inhaled steroid
379746|NCT01327612|AMG 655|amg 655
379747|NCT01327612|AMG 479|amg 479
379748|NCT01327612|Apoptosis|apoptosis
379749|NCT01327612|Monoclonal Antibody|monoclonal antibody
379750|NCT01327612|Tumor Necrosis Factor|tumor necrosis factor
379751|NCT01327612|Insulin-like Growth Factor|insulin-like growth factor
379752|NCT01327612|Bevacizumab|bevacizumab
379753|NCT01327612|Modified FOLFOX6|modified folfox6
379755|NCT01327612|FOLFOX|folfox
379756|NCT01327612|Lymphoma|lymphoma
379757|NCT01327612|Trail Receptor|trail receptor
379758|NCT01327612|ganitumab|ganitumab
379759|NCT01327612|conatumumab|conatumumab
379760|NCT01327599|Open-angle glaucoma|open-angle glaucoma
379761|NCT01327599|Ocular hypertension|ocular hypertension
379762|NCT01327599|Pigment dispersion glaucoma|pigment dispersion glaucoma
379763|NCT01327599|Intraocular pressure|intraocular pressure
379764|NCT01327586|disability|disability
379765|NCT01327586|substance abuse|substance abuse
379766|NCT01327586|cocaine abuse|cocaine abuse
379767|NCT01327586|dual diagnosis|dual diagnosis
379768|NCT01327586|representative payee|representative payee
379769|NCT01327586|HIV risk reduction|hiv risk reduction
379770|NCT01327573|chronic kidney allograft injury|chronic kidney allograft injury
379771|NCT01327573|complement protein|complement protein
379772|NCT01327573|eculizumab|eculizumab
379773|NCT01327573|Kidney transplantation|kidney transplantation
379774|NCT01327560|hemodialysis patients|hemodialysis patients
379775|NCT01327560|sleep quality|sleep quality
379776|NCT01327560|restless legs syndrome|restless legs syndrome
379777|NCT01327560|excessive daytime sleepiness|excessive daytime sleepiness
379778|NCT01327560|sleep apnea syndrome|sleep apnea syndrome
379779|NCT01327547|HIV coinfection|hiv coinfection
379780|NCT01327547|maraviroc|maraviroc
379781|NCT01327547|CCR5 blocker|ccr5 blocker
379782|NCT01327547|entry inhibitor|entry inhibitor
379783|NCT01327547|liver disease|liver disease
379784|NCT01327547|viral hepatitis|viral hepatitis
379785|NCT01327534|STEMI|stemi
379786|NCT01327534|clopidogrel|clopidogrel
379787|NCT01327534|prasugrel|prasugrel
379788|NCT01327534|platelet reactivity index|platelet reactivity index
379789|NCT01327534|ST resolution|st resolution
379790|NCT01327495|Androgen replacement in men|androgen replacement in men
379791|NCT01327482|Raltegravir|raltegravir
379792|NCT01327482|Pharmacokinetics|pharmacokinetics
379793|NCT01327456|health literacy|health literacy
379794|NCT01327456|self-management|self-management
379795|NCT01327456|inhaler technique|inhaler technique
379796|NCT01327443|NAFLD|nafld
379797|NCT01327443|NASH|nash
379798|NCT01327443|Weight loss|weight loss
379799|NCT01327443|Exercise|exercise
379800|NCT01327443|NAS scores|nas scores
379801|NCT01327443|Mitochondrial dysfunction|mitochondrial dysfunction
379802|NCT01327430|glycerophosphates|glycerophosphates
379803|NCT01327430|sphingomyelins|sphingomyelins
379804|NCT01327417|Depression|depression
379805|NCT01327404|Depression|depression
379806|NCT01327404|Diabetes Mellitus|diabetes mellitus
379807|NCT01327391|on line hemodiafiltration|on line hemodiafiltration
379808|NCT01327391|tolerance|tolerance
379809|NCT01327391|quality of life|quality of life
379810|NCT01327391|cardiovascular risk|cardiovascular risk
379811|NCT01327391|Hemodialysis patients|hemodialysis patients
379812|NCT01327365|significant coronary artery disease|significant coronary artery disease
379813|NCT01327365|PCI|pci
379814|NCT01327365|radial approach|radial approach
379815|NCT01327365|women|women
379816|NCT01327365|bifurcation lesion|bifurcation lesion
379817|NCT01327365|ostial lesion|ostial lesion
379818|NCT01327365|7 Fr guiding catheter|7 fr guiding catheter
379819|NCT01327365|percutaneous coronary intervention|percutaneous coronary intervention
379820|NCT01327352|lupus|lupus
379821|NCT01327326|Pain modulation|pain modulation
379822|NCT01327326|Experimental pain|experimental pain
379823|NCT01327313|alpha v integrin|alpha v integrin
379824|NCT01327313|antibody|antibody
379825|NCT01327313|solid tumor|solid tumor
379826|NCT01327313|Japanese|japanese
379827|NCT01327313|EMD525797|emd525797
379828|NCT01327300|Irritable Bowel Syndrome|irritable bowel syndrome
379829|NCT01327300|Irritable Bowel Syndrome Treatment|irritable bowel syndrome treatment
379830|NCT01327300|Mesalamine|mesalamine
379831|NCT01327300|Anti-inflammatory drugs|anti-inflammatory drugs
379832|NCT01327300|5-ASA drugs|5-asa drugs
379833|NCT01327300|Apriso ™|apriso ™
379834|NCT01327287|thoracic epidural|thoracic epidural
379835|NCT01327287|blunt|blunt
379836|NCT01327287|blunt thoracic injury|blunt thoracic injury
379837|NCT01327274|Pectus excavatum|pectus excavatum
379838|NCT01327274|Chest wall deformity|chest wall deformity
379839|NCT01327274|Magnetic Mini-Mover Procedure|magnetic mini-mover procedure
379840|NCT01327274|Pectus Severity Index|pectus severity index
379841|NCT01327274|pediatric medical device|pediatric medical device
379842|NCT01327274|magnetic alteration|magnetic alteration
379843|NCT01327274|sunken chest|sunken chest
379844|NCT01327261|levodopa|levodopa
379845|NCT01327261|benserazide|benserazide
379846|NCT01327261|bioequivalence|bioequivalence
379847|NCT01327261|pharmacokinetics|pharmacokinetics
379848|NCT01327261|A Single - Dose|a single - dose
379849|NCT01327261|Randomized- Sequence|randomized- sequence
379850|NCT01327261|Open -Label Crossover Study|open -label crossover study
379851|NCT01327248|Bronchiolitis obliterans|bronchiolitis obliterans
379852|NCT01327248|HRCT|hrct
379853|NCT01327248|Sputum|sputum
379855|NCT01327248|Inflammation|inflammation
379856|NCT01327248|adaptive immune system|adaptive immune system
379857|NCT01327248|innate immune system|innate immune system
379858|NCT01327222|age-related macular degeneration|age-related macular degeneration
379859|NCT01327222|bevacizumab|bevacizumab
379860|NCT01327196|dementia|dementia
379861|NCT01327196|cardiovascular risk|cardiovascular risk
379862|NCT01327196|elderly|elderly
379863|NCT01327196|aging|aging
379864|NCT01327196|older 65-100 years|older 65-100 years
379865|NCT01327157|Facial Paralysis / rehabilitation.|facial paralysis / rehabilitation.
379866|NCT01327157|Dental Occlusion.|dental occlusion.
379867|NCT01327157|Occlusal Adjustment.|occlusal adjustment.
379868|NCT01327157|Malocclusion / therapy.|malocclusion / therapy.
379869|NCT01327092|Injury|injury
379870|NCT01327092|Injury Prevention|injury prevention
379871|NCT01327092|Cincinnati Home Injury Prevention|cincinnati home injury prevention
379872|NCT01327092|Injury Hazards|injury hazards
379873|NCT01327092|Modifiable Injury Hazards|modifiable injury hazards
379874|NCT01327092|CHIP|chip
379875|NCT01327092|Literacy Promotion|literacy promotion
379876|NCT01327092|Reduce exposure to injury hazards|reduce exposure to injury hazards
379877|NCT01327092|preventable and medically attended injury|preventable and medically attended injury
379878|NCT01327092|young children|young children
379879|NCT01327079|NICU|nicu
379880|NCT01327079|Methadone|methadone
379881|NCT01327079|neonates|neonates
379882|NCT01327066|QTc|qtc
379883|NCT01327066|ECG Effects|ecg effects
379884|NCT01327053|locally advanced basal cell carcinoma,|locally advanced basal cell carcinoma,
379885|NCT01327053|metastatic basal cell carcinoma|metastatic basal cell carcinoma
379886|NCT01327040|light|light
379887|NCT01327040|melatonin|melatonin
379888|NCT01327040|circadian|circadian
379889|NCT01327040|delayed sleep phase disorder|delayed sleep phase disorder
379890|NCT01327040|circadian light sensitivity|circadian light sensitivity
379891|NCT01327040|circadian timing system|circadian timing system
379892|NCT01327027|vasopressin|vasopressin
379893|NCT01327027|antisocial|antisocial
379894|NCT01327027|affiliation|affiliation
379895|NCT01327014|Hyperlipidemia|hyperlipidemia
379896|NCT01327014|Cholesterol|cholesterol
379897|NCT01327014|Lipids|lipids
379898|NCT01327014|Lipoproteins|lipoproteins
379899|NCT01327014|XueZhiKang|xuezhikang
379900|NCT01327014|Botanical|botanical
379901|NCT01327001|Asthma bronchiale, fixed combination|asthma bronchiale, fixed combination
379902|NCT01326988|Spinal anesthesia|spinal anesthesia
379903|NCT01326988|ultrasound|ultrasound
379904|NCT01326988|real-time|real-time
379905|NCT01326975|infant, premature|infant, premature
379906|NCT01326975|infant, very low birth weight|infant, very low birth weight
379907|NCT01326975|diaphragm|diaphragm
379908|NCT01326975|apnea|apnea
379909|NCT01326975|continuous positive airway pressure|continuous positive airway pressure
379910|NCT01326936|Online education|online education
379911|NCT01326936|Medical education|medical education
379912|NCT01326936|Substance abuse training|substance abuse training
379913|NCT01326936|Drug abuse training|drug abuse training
379914|NCT01326923|Head|head
379915|NCT01326923|Neck|neck
379916|NCT01326923|Locally advanced|locally advanced
379917|NCT01326923|Squamous Cell|squamous cell
379918|NCT01326923|Hypopharynx|hypopharynx
379919|NCT01326923|Larynx|larynx
379920|NCT01326923|Oral Cavity|oral cavity
379921|NCT01326923|Base of Tongue|base of tongue
379922|NCT01326923|Tonsil|tonsil
379923|NCT01326923|Neck lymph node|neck lymph node
379924|NCT01326923|Resection|resection
379925|NCT01326910|Eczema|eczema
379926|NCT01326884|aortic aneurysm|aortic aneurysm
379927|NCT01326884|iliac aneurysm|iliac aneurysm
380029|NCT01326559|cisplatin|cisplatin
379928|NCT01326884|endovascular procedures|endovascular procedures
379929|NCT01326871|cancer|cancer
379930|NCT01326871|immunotherapy|immunotherapy
380426|NCT01324869|KH902|kh902
379931|NCT01326871|immunochemotherapy|immunochemotherapy
379932|NCT01326871|combinational therapy|combinational therapy
379933|NCT01326871|targeted|targeted
379934|NCT01326871|metastatic|metastatic
379935|NCT01326871|muscle invasive|muscle invasive
379936|NCT01326871|interleukin-2|interleukin-2
379937|NCT01326871|cisplatin|cisplatin
379938|NCT01326871|gemcitabine|gemcitabine
379939|NCT01326871|antitumor|antitumor
379941|NCT01326871|T-cell receptor|t-cell receptor
379942|NCT01326871|p53|p53
379943|NCT01326871|p53 gene|p53 gene
379944|NCT01326871|p53 tumor supressor protein|p53 tumor supressor protein
379945|NCT01326871|urothelial cancer|urothelial cancer
379946|NCT01326871|bladder cancer|bladder cancer
379947|NCT01326871|renal pelvis cancer|renal pelvis cancer
379948|NCT01326871|ureters cancer|ureters cancer
379949|NCT01326871|urethra cancer|urethra cancer
379950|NCT01326871|HLA-A2 positive|hla-a2 positive
379951|NCT01326871|HLA-A*0201/p53 aa264-272|hla-a*0201/p53 aa264-272
379952|NCT01326871|HLA complex|hla complex
379953|NCT01326871|Muscle Invasive or Metastatic|muscle invasive or metastatic
379954|NCT01326858|Ocular discomfort|ocular discomfort
379955|NCT01326858|AL-4943A Ophthalmic Solution|al-4943a ophthalmic solution
379956|NCT01326845|Gastrointestinal adverse events,|gastrointestinal adverse events,
379957|NCT01326845|myelodysplastic syndrome,|myelodysplastic syndrome,
379958|NCT01326845|transfusional iron overload diarrhea,|transfusional iron overload diarrhea,
379959|NCT01326845|constipation abdominal pain,|constipation abdominal pain,
379960|NCT01326845|vomiting|vomiting
379961|NCT01326832|THA|tha
379962|NCT01326819|Near infrared spectroscopy|near infrared spectroscopy
379963|NCT01326819|Skin pigmentation|skin pigmentation
379964|NCT01326819|Regional oxygen saturation|regional oxygen saturation
379965|NCT01326806|Parent-based intervention|parent-based intervention
379966|NCT01326806|Sexual risk behavior|sexual risk behavior
379967|NCT01326806|Adolescents|adolescents
379968|NCT01326793|telepsychiatry|telepsychiatry
379969|NCT01326793|MDD|mdd
379970|NCT01326793|Depression|depression
379971|NCT01326793|Major Depressive Disorder|major depressive disorder
379972|NCT01326793|Skype|skype
379973|NCT01326793|college|college
379974|NCT01326793|university|university
379975|NCT01326780|Acne|acne
379976|NCT01326780|Irritation|irritation
379977|NCT01326780|Safety|safety
379978|NCT01326780|Sebum|sebum
379979|NCT01326741|clonal mast cell disorder|clonal mast cell disorder
379980|NCT01326741|exercise-induced anaphylaxis|exercise-induced anaphylaxis
379981|NCT01326741|hypotension|hypotension
379982|NCT01326728|Relapse|relapse
379983|NCT01326728|Hematologic Malignancy|hematologic malignancy
379984|NCT01326728|Allogeneic|allogeneic
379985|NCT01326728|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
379986|NCT01326728|Leukemia|leukemia
379987|NCT01326728|Lymphoma|lymphoma
379988|NCT01326728|Hodgkin Lymphoma|hodgkin lymphoma
379989|NCT01326715|Multiple Sclerosis|multiple sclerosis
379990|NCT01326715|MRI|mri
379991|NCT01326715|Manganese Enhanced MRI|manganese enhanced mri
379992|NCT01326715|Optic Neuritis|optic neuritis
379993|NCT01326715|Healthy Volunteer|healthy volunteer
379994|NCT01326676|Polypill|polypill
379995|NCT01326676|Red Heart Pill|red heart pill
379996|NCT01326676|Cardiovascular disease|cardiovascular disease
379997|NCT01326676|Secondary prevention|secondary prevention
379998|NCT01326676|carotid intima media thickness|carotid intima media thickness
379999|NCT01326663|Veterans|veterans
380000|NCT01326663|TBI|tbi
380001|NCT01326663|Alcoholism|alcoholism
380002|NCT01326663|Mood|mood
380003|NCT01326650|vitamin D, mortality, event-free survival, heart failure|vitamin d, mortality, event-free survival, heart failure
380004|NCT01326637|primary health care|primary health care
380005|NCT01326637|aged|aged
380006|NCT01326624|heart failure|heart failure
380007|NCT01326624|ventricular dysfunction|ventricular dysfunction
380008|NCT01326624|sudden death|sudden death
380009|NCT01326624|sudden cardiac arrest|sudden cardiac arrest
380010|NCT01326624|ventricular tachycardia|ventricular tachycardia
380011|NCT01326624|ventricular fibrillation|ventricular fibrillation
380012|NCT01326624|wearable defibrillator|wearable defibrillator
380013|NCT01326611|Chronic lung disease|chronic lung disease
380014|NCT01326611|Clarithromycin|clarithromycin
380015|NCT01326611|Ureaplasma urealyticum|ureaplasma urealyticum
380016|NCT01326598|V Go™|v go™
380017|NCT01326598|Type 2 Diabetes|type 2 diabetes
380018|NCT01326598|Insulin|insulin
380019|NCT01326598|Oral Anti Hypoglycemic Drugs|oral anti hypoglycemic drugs
380020|NCT01326585|Scleral Buckling|scleral buckling
380021|NCT01326585|Dexamethasone|dexamethasone
380022|NCT01326585|Post-operative Nausea and Vomiting|post-operative nausea and vomiting
380023|NCT01326572|HIV|hiv
380024|NCT01326572|Pulmonary disease|pulmonary disease
380025|NCT01326572|emphysema|emphysema
380026|NCT01326572|COPD|copd
380027|NCT01326559|induction chemotherapy|induction chemotherapy
380028|NCT01326559|docetaxel|docetaxel
380030|NCT01326559|fluorouracil|fluorouracil
380031|NCT01326559|cetuximab|cetuximab
380032|NCT01326559|intensity-modulated radiotherapy|intensity-modulated radiotherapy
380033|NCT01326546|Therapeutic HBV Vaccine|therapeutic hbv vaccine
380034|NCT01326546|Chronic Hepatitis B|chronic hepatitis b
380035|NCT01326546|HBeAg positive|hbeag positive
380036|NCT01326533|pre-diabetes|pre-diabetes
380037|NCT01326533|hydroxychloroquine|hydroxychloroquine
380038|NCT01326533|frequently sampled intravenous glucose tolerance testing|frequently sampled intravenous glucose tolerance testing
380039|NCT01326533|insulin resistance|insulin resistance
380040|NCT01326533|insulin secretion|insulin secretion
380041|NCT01326533|glucose tolerance|glucose tolerance
380042|NCT01326507|pulmonary embolism|pulmonary embolism
380043|NCT01326507|Heart-type fatty acid-binding protein|heart-type fatty acid-binding protein
380044|NCT01326507|cardiac biomarkers|cardiac biomarkers
380045|NCT01326507|risk stratification|risk stratification
380046|NCT01326494|Upper Respiratory Tract Infection|upper respiratory tract infection
380048|NCT01326494|URTI induced exacerbation of Asthma|urti induced exacerbation of asthma
380049|NCT01326481|TRC105|trc105
380050|NCT01326481|Breast Cancer|breast cancer
380051|NCT01326481|CD105|cd105
380052|NCT01326481|Endoglin|endoglin
380053|NCT01326481|TRACON Pharma|tracon pharma
380054|NCT01326481|Roswell Park Cancer Institute|roswell park cancer institute
380055|NCT01326481|Department of Defense|department of defense
380056|NCT01326468|head and neck cancer|head and neck cancer
380057|NCT01326468|temsirolimus|temsirolimus
380058|NCT01326468|cetuximab|cetuximab
380059|NCT01326468|cisplatin|cisplatin
380060|NCT01326468|radiation therapy|radiation therapy
380061|NCT01326455|transradial|transradial
380062|NCT01326455|angiogram|angiogram
380063|NCT01326455|device|device
380064|NCT01326455|Care of the radial artery post transradial angiogram|care of the radial artery post transradial angiogram
380065|NCT01326442|weight loss|weight loss
380066|NCT01326442|overweight|overweight
380067|NCT01326442|body composition|body composition
380068|NCT01326442|visceral obesity|visceral obesity
380069|NCT01326442|insulin|insulin
380070|NCT01326442|glucose tolerance|glucose tolerance
380071|NCT01326442|cholesterol|cholesterol
380072|NCT01326442|hypertriglyceridemia|hypertriglyceridemia
380073|NCT01326429|Sodium|sodium
380074|NCT01326429|Hyponatremia|hyponatremia
380075|NCT01326429|Hypernatremia|hypernatremia
380076|NCT01326429|Emergency department|emergency department
380077|NCT01326416|obesity|obesity
380078|NCT01326416|metabolic syndrome|metabolic syndrome
380079|NCT01326416|leucine|leucine
380080|NCT01326416|arginine|arginine
380081|NCT01326416|physical activity|physical activity
380082|NCT01326403|proximal|proximal
380084|NCT01326403|fractures|fractures
380085|NCT01326338|Diarrhea|diarrhea
380086|NCT01326325|Cancer|cancer
380087|NCT01326325|Refractory pain|refractory pain
380088|NCT01326325|Uncontrolled pain|uncontrolled pain
380089|NCT01326325|Ketamine|ketamine
380090|NCT01326286|Comparative Effectiveness Research|comparative effectiveness research
380091|NCT01326286|Prostatectomy|prostatectomy
380092|NCT01326286|radiotherapy|radiotherapy
380093|NCT01326286|quality of life|quality of life
380094|NCT01326273|CMV|cmv
380095|NCT01326273|cytomegalovirus|cytomegalovirus
380096|NCT01326273|autologous|autologous
380097|NCT01326273|leukemia|leukemia
380098|NCT01326273|hematological malignancies|hematological malignancies
380099|NCT01326273|stem cell transplantation|stem cell transplantation
380100|NCT01326273|CMV reactivation|cmv reactivation
380101|NCT01326273|adoptive therapy|adoptive therapy
380102|NCT01326260|resuscitation|resuscitation
380103|NCT01326260|trauma|trauma
380104|NCT01326260|THAM|tham
380105|NCT01326260|colloids|colloids
380106|NCT01326260|crystalloids|crystalloids
380107|NCT01326234|Smoking|smoking
380108|NCT01326234|Motivation|motivation
380109|NCT01326234|Cessation|cessation
380110|NCT01326221|Truvada|truvada
380111|NCT01326221|tenofovir|tenofovir
380112|NCT01326221|emtricitabine|emtricitabine
380113|NCT01326221|Pharmacokinetics|pharmacokinetics
380114|NCT01326221|Healthy Volunteers|healthy volunteers
380115|NCT01326208|electrical impedance tomography|electrical impedance tomography
380116|NCT01326208|positive end-expiratory pressure|positive end-expiratory pressure
380117|NCT01326208|regional ventilation delay index|regional ventilation delay index
380118|NCT01326195|HIV Prevention|hiv prevention
380119|NCT01326195|Dating Violence|dating violence
380120|NCT01326195|Females|females
380121|NCT01326195|Romantic relationships|romantic relationships
380122|NCT01326195|Adolescents|adolescents
380123|NCT01326195|Sexuality|sexuality
380124|NCT01326195|Underserved youth|underserved youth
380125|NCT01326182|asthma|asthma
380126|NCT01326182|depression|depression
380127|NCT01326182|Latino|latino
380128|NCT01326169|Alcohol|alcohol
380129|NCT01326169|brief intervention|brief intervention
380130|NCT01326169|injuries|injuries
380131|NCT01326156|Osteoarthritis|osteoarthritis
380132|NCT01326156|Knee|knee
380133|NCT01326156|Knee cap|knee cap
380134|NCT01326156|Patella|patella
380135|NCT01326156|Patellofemoral|patellofemoral
380136|NCT01326143|MRD|mrd
380137|NCT01326143|Narval|narval
380138|NCT01326143|Oral appliance|oral appliance
380139|NCT01326143|Obstructive Sleep apnea|obstructive sleep apnea
380140|NCT01326143|OSAH|osah
380141|NCT01326143|OSA treatment|osa treatment
380142|NCT01326130|Integrated care network|integrated care network
370831|NCT01364974|ASP015K|asp015k
370832|NCT01364974|Healthy subjects|healthy subjects
370833|NCT01364961|Resveratrol|resveratrol
370834|NCT01364961|FMD|fmd
370835|NCT01364961|PWV|pwv
380143|NCT01326130|Chronic care model|chronic care model
380144|NCT01326130|Health services research|health services research
380145|NCT01326117|gastroparesis|gastroparesis
380146|NCT01326117|gastric emptying|gastric emptying
380147|NCT01326117|diabetes|diabetes
380148|NCT01326117|Stomach Diseases|stomach diseases
380149|NCT01326117|Gastrointestinal Diseases|gastrointestinal diseases
380150|NCT01326117|Digestive System Diseases|digestive system diseases
380151|NCT01326117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
380152|NCT01326117|Neurologic Manifestations|neurologic manifestations
380153|NCT01326117|Paralysis|paralysis
380154|NCT01326117|Signs and Symptoms|signs and symptoms
380155|NCT01326117|Pharmacologic Actions|pharmacologic actions
380156|NCT01326104|Medulloblastoma|medulloblastoma
380157|NCT01326104|Primitive Neuroectodermal Tumor|primitive neuroectodermal tumor
380158|NCT01326091|Lumbar fusion surgery|lumbar fusion surgery
380159|NCT01326078|sedation|sedation
380160|NCT01326078|children|children
380161|NCT01326078|leukemia|leukemia
380162|NCT01326078|bone marrow biopsy|bone marrow biopsy
380164|NCT01326013|Feces|feces
380165|NCT01326013|Gastrointestinal|gastrointestinal
380166|NCT01326013|Pathogen|pathogen
380167|NCT01326013|Panel|panel
380168|NCT01326013|xTAG GPP|xtag gpp
380169|NCT01326013|Infectious colitis|infectious colitis
380170|NCT01326013|Gastroenteritis|gastroenteritis
380171|NCT01326013|Detection|detection
380172|NCT01325987|Type 2 diabetes|type 2 diabetes
380173|NCT01325987|Vitamin D deficiency|vitamin d deficiency
380174|NCT01325987|Glycemic control|glycemic control
380175|NCT01325974|Malaria|malaria
380176|NCT01325974|Plasmodium falciparum|plasmodium falciparum
380177|NCT01325974|Diagnosis|diagnosis
380178|NCT01325974|Rapid diagnostic test|rapid diagnostic test
380179|NCT01325974|malaria transmission|malaria transmission
380180|NCT01325961|prostate, cervical and anal canal cancers with pelvic lymph node irradiation|prostate, cervical and anal canal cancers with pelvic lymph node irradiation
380181|NCT01325948|COPD|copd
380182|NCT01325935|Coronary Artery Disease|coronary artery disease
380183|NCT01325935|Coronary Disease|coronary disease
380184|NCT01325935|Myocardial Ischemia|myocardial ischemia
380185|NCT01325935|Heart Disease|heart disease
380186|NCT01325935|Cardiovascular Disease|cardiovascular disease
380187|NCT01325935|Arteriosclerosis|arteriosclerosis
380188|NCT01325935|Arterial Occlusive Disease|arterial occlusive disease
380189|NCT01325935|Vascular Disease|vascular disease
380190|NCT01325935|Clopidogrel|clopidogrel
380191|NCT01325935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
380192|NCT01325896|Multiple Mieloma, PEG-Intron|multiple mieloma, peg-intron
380193|NCT01325870|cardiopulmonary resuscitation|cardiopulmonary resuscitation
380194|NCT01325818|Coronary Artery Disease|coronary artery disease
380195|NCT01325818|Coronary Disease|coronary disease
380196|NCT01325818|Dyslipidemia|dyslipidemia
380197|NCT01325818|Stable Angina Pectoris|stable angina pectoris
380198|NCT01325818|Heart Diseases|heart diseases
380199|NCT01325818|Cardiovascular Diseases|cardiovascular diseases
380200|NCT01325818|Arteriosclerosis|arteriosclerosis
380201|NCT01325818|Arterial Occlusive Diseases|arterial occlusive diseases
380202|NCT01325818|Vascular Diseases Pravastatin|vascular diseases pravastatin
380203|NCT01325818|Rosuvastatin|rosuvastatin
380204|NCT01325818|Anticholesteremic Agents|anticholesteremic agents
380205|NCT01325818|Antilipemic Agents|antilipemic agents
380206|NCT01325818|Antimetabolites|antimetabolites
380207|NCT01325818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
380208|NCT01325818|Pharmacologic Actions|pharmacologic actions
380209|NCT01325818|Therapeutic Uses|therapeutic uses
380210|NCT01325818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
380211|NCT01325805|Miscarriage|miscarriage
380212|NCT01325805|Recurrent Pregnancy Loss|recurrent pregnancy loss
380213|NCT01325805|Obesity|obesity
380214|NCT01325805|Overweight|overweight
380215|NCT01325805|Diet|diet
380216|NCT01325792|Complex ventral incisional hernia repair|complex ventral incisional hernia repair
380217|NCT01325792|reapproximation of the rectus abdominis muscle|reapproximation of the rectus abdominis muscle
380218|NCT01325792|retrorectus or intraperitoneal placement technique|retrorectus or intraperitoneal placement technique
380219|NCT01325792|mobility for midline fascial closure|mobility for midline fascial closure
380220|NCT01325779|deep venous thrombosis|deep venous thrombosis
380222|NCT01325779|enoxaparin|enoxaparin
380223|NCT01325779|heparin|heparin
380224|NCT01325779|surgical intensive care|surgical intensive care
380225|NCT01325766|Cystic Fibrosis|cystic fibrosis
380226|NCT01325766|Yoga|yoga
380227|NCT01325701|PCI-32765|pci-32765
380228|NCT01325701|Lymphoma, B-Cell|lymphoma, b-cell
380229|NCT01325701|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
380230|NCT01325701|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
380231|NCT01325701|Germinal Center B-Cell|germinal center b-cell
380232|NCT01325701|Activated B-Cell|activated b-cell
380234|NCT01325688|Peplin|peplin
380235|NCT01325688|sBCC|sbcc
380236|NCT01325675|Atrial fibrillation|atrial fibrillation
380237|NCT01325675|Motor activity|motor activity
380238|NCT01325649|rectal cancer|rectal cancer
380239|NCT01325649|MRI|mri
380240|NCT01325649|selective preoperative radiochemotherapy|selective preoperative radiochemotherapy
380241|NCT01325649|involvement of circumferential resection margin|involvement of circumferential resection margin
380242|NCT01325649|locoregional recurrence rate|locoregional recurrence rate
380243|NCT01325636|Allogenic haematopoietic stem cell transplant|allogenic haematopoietic stem cell transplant
380244|NCT01325636|Cytomegalovirus or Adenovirus infection|cytomegalovirus or adenovirus infection
380245|NCT01325636|Graft versus Host|graft versus host
380246|NCT01325623|Automatic Magnet Mode (AMM)|automatic magnet mode (amm)
380247|NCT01325623|Vagal Nerve Stimulation|vagal nerve stimulation
380248|NCT01325610|vitamin D|vitamin d
380249|NCT01325610|kidney|kidney
380250|NCT01325610|renal|renal
380251|NCT01325597|Heart failure|heart failure
380252|NCT01325597|Electric stimulation|electric stimulation
380253|NCT01325597|Breathing exercises|breathing exercises
380254|NCT01325571|prograf|prograf
380255|NCT01325571|immunosuppressant|immunosuppressant
380257|NCT01325558|tissue factor|tissue factor
380258|NCT01325558|solid tumor|solid tumor
380259|NCT01325558|ovarian cancer|ovarian cancer
380260|NCT01325558|breast cancer|breast cancer
380261|NCT01325558|non-small cell lung cancer|non-small cell lung cancer
380262|NCT01325558|colon cancer|colon cancer
380263|NCT01325558|pancreatic cancer|pancreatic cancer
380264|NCT01325558|head and neck cancer|head and neck cancer
380265|NCT01325558|prostate cancer|prostate cancer
380266|NCT01325558|soft-tissue sarcoma|soft-tissue sarcoma
380267|NCT01325558|metastatic|metastatic
380268|NCT01325558|gemcitabine|gemcitabine
380269|NCT01325558|anti-tumor|anti-tumor
380270|NCT01325558|venous thromboembolism|venous thromboembolism
380271|NCT01325545|Stroke|stroke
380272|NCT01325545|Atrial Fibrillation|atrial fibrillation
380273|NCT01325532|depression|depression
380274|NCT01325532|Major Depressive Disorder|major depressive disorder
380275|NCT01325532|MDD|mdd
380276|NCT01325532|Cranial Electrical Stimulation|cranial electrical stimulation
380277|NCT01325532|CES|ces
380278|NCT01325506|Prostatectomy|prostatectomy
380279|NCT01325493|opioid tolerance|opioid tolerance
380280|NCT01325493|hyperalgesia|hyperalgesia
380281|NCT01325493|scoliosis|scoliosis
380282|NCT01325493|pupillometry|pupillometry
380283|NCT01325480|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
380284|NCT01325480|Pacing|pacing
380285|NCT01325480|His Bundle|his bundle
380286|NCT01325467|coronary artery disease|coronary artery disease
380287|NCT01325467|high frequency QRS analysis|high frequency qrs analysis
380288|NCT01325467|ischemia|ischemia
380289|NCT01325467|exercise testing|exercise testing
380290|NCT01325467|diagnosis of coronary artery disease|diagnosis of coronary artery disease
380291|NCT01325454|Pleural effusion|pleural effusion
380292|NCT01325454|angiogenic cytokine|angiogenic cytokine
380293|NCT01325454|fibrinolytic activity|fibrinolytic activity
380294|NCT01325441|BBI608|bbi608
380295|NCT01325415|Phase 1|phase 1
380296|NCT01325415|healthy male volunteers|healthy male volunteers
380297|NCT01325415|cross-over study|cross-over study
380298|NCT01325415|NKTR-118|nktr-118
380299|NCT01325402|Radioligand|radioligand
380300|NCT01325402|Alzheimers disease|alzheimers disease
380301|NCT01325402|Maximum Diagnostic Mass|maximum diagnostic mass
380302|NCT01325402|Beta amyloid|beta amyloid
380303|NCT01325376|overweight|overweight
380304|NCT01325376|obesity|obesity
380305|NCT01325363|Schizophrenia|schizophrenia
380306|NCT01325363|Novel metaphor|novel metaphor
380307|NCT01325298|Keratoconus|keratoconus
380308|NCT01325298|Ectasia|ectasia
380309|NCT01325298|cross linking|cross linking
380310|NCT01325298|collagen cross linking|collagen cross linking
380311|NCT01325298|corneal crosslinking|corneal crosslinking
380312|NCT01325298|corneal diseases|corneal diseases
380313|NCT01325298|eye diseases|eye diseases
380314|NCT01325285|Intraocular pressure|intraocular pressure
380315|NCT01325285|Hypercapnia|hypercapnia
380316|NCT01325285|Hyperoxia|hyperoxia
380317|NCT01325285|Rebreathing circuit|rebreathing circuit
380318|NCT01325272|otoacoustic emissions in newborns|otoacoustic emissions in newborns
380319|NCT01325246|ventral hernia|ventral hernia
380320|NCT01325246|repair|repair
380321|NCT01325246|clinical|clinical
380322|NCT01325246|reoperation|reoperation
591674|NCT00535990|Gastric|gastric
380323|NCT01325233|Astragulus polysaccharides|astragulus polysaccharides
380324|NCT01325233|Hemorrhagic stroke|hemorrhagic stroke
380325|NCT01325207|Breast Cancer|breast cancer
380326|NCT01325194|DLBCL|dlbcl
380327|NCT01325194|FL grade 3B|fl grade 3b
380328|NCT01325194|high risk|high risk
380329|NCT01325194|CNS prophylaxis|cns prophylaxis
380330|NCT01325194|chemoimmunotherapy|chemoimmunotherapy
464678|NCT00056186|FA|fa
380331|NCT01325181|Chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
380332|NCT01325181|Ranibizumab|ranibizumab
380333|NCT01325181|Photodynamic therapy|photodynamic therapy
380334|NCT01325168|PTSD|ptsd
380335|NCT01325168|empathy|empathy
380336|NCT01325168|oxytocin|oxytocin
380337|NCT01325155|Air Pollution|air pollution
380338|NCT01325155|particulate matter|particulate matter
380339|NCT01325155|cardiovascular Disease|cardiovascular disease
380340|NCT01325142|Osteonecrosis of the Jaw (ONJ)|osteonecrosis of the jaw (onj)
380341|NCT01325129|ESIN|esin
380342|NCT01325129|Clavicular Fracture|clavicular fracture
380343|NCT01325129|Dislocation|dislocation
380344|NCT01325129|Children|children
380345|NCT01325129|Adolescents|adolescents
380346|NCT01325116|STEMI|stemi
380347|NCT01325116|Medication Adherence|medication adherence
380348|NCT01325116|Quality Improvement|quality improvement
380349|NCT01325103|Spinal cord injury|spinal cord injury
380350|NCT01325103|Mesenchymal stem cells|mesenchymal stem cells
380351|NCT01325103|Bone marrow|bone marrow
380352|NCT01325090|neuropathic pain due to thoracotomy|neuropathic pain due to thoracotomy
380353|NCT01325090|Neuropathic Pain Due to Thoracoscopy|neuropathic pain due to thoracoscopy
380354|NCT01325077|Nurse-based, acute pain service, pediatric, postoperative,|nurse-based, acute pain service, pediatric, postoperative,
380356|NCT01325064|Carotid Artery Diseases|carotid artery diseases
380357|NCT01325064|Blood Pressure|blood pressure
380358|NCT01325064|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
380359|NCT01325064|Peripheral Vascular Diseases|peripheral vascular diseases
380360|NCT01325064|Retinal Vessels|retinal vessels
380361|NCT01325051|raltegravir|raltegravir
380362|NCT01325051|pharmacokinetics|pharmacokinetics
380363|NCT01325051|healthy|healthy
380364|NCT01325051|male|male
380365|NCT01325051|volunteers|volunteers
380366|NCT01325051|gastrointestinal|gastrointestinal
380367|NCT01325051|tract|tract
380368|NCT01325038|resting metabolic rate|resting metabolic rate
380369|NCT01325025|Metachromatic Leukodystrophy|metachromatic leukodystrophy
380370|NCT01325025|Demyelinating Diseases|demyelinating diseases
380371|NCT01325025|Magnetic Resonance Imaging|magnetic resonance imaging
380372|NCT01325025|Diffusion Tensor Imaging|diffusion tensor imaging
380373|NCT01325025|Relaxometry|relaxometry
380374|NCT01325025|Spectroscopy|spectroscopy
380375|NCT01325025|Longitudinal Studies|longitudinal studies
380376|NCT01325012|Pain|pain
380377|NCT01325012|Surgery|surgery
380378|NCT01325012|Catheter|catheter
380379|NCT01325012|Nerve Block|nerve block
380380|NCT01325012|Popliteal|popliteal
380381|NCT01325012|Subgluteal|subgluteal
380382|NCT01325012|Sciatic|sciatic
380383|NCT01325012|UCSD|ucsd
380384|NCT01325012|Moderate-to-severe pain|moderate-to-severe pain
380385|NCT01325012|Perineural Catheter|perineural catheter
380386|NCT01325012|Orthopedic Surgery|orthopedic surgery
380387|NCT01325012|foot surgery surgery|foot surgery surgery
380388|NCT01325012|sciatic perineural catheter|sciatic perineural catheter
380389|NCT01325012|age =>18|age =>18
380763|NCT01323400|Pazopanib|pazopanib
380390|NCT01324999|Sarcoidosis Associated Pulmonary Hypertension|sarcoidosis associated pulmonary hypertension
380391|NCT01324986|extraesophageal symptoms of gastroesophageal reflux disease|extraesophageal symptoms of gastroesophageal reflux disease
380392|NCT01324973|Medical Informatics|medical informatics
380393|NCT01324973|Therapy, Computer-Assisted|therapy, computer-assisted
380394|NCT01324973|Health Education|health education
380396|NCT01324973|Exercise|exercise
380397|NCT01324960|IPSS|ipss
380398|NCT01324960|High risk|high risk
380399|NCT01324960|Azacitidine|azacitidine
380400|NCT01324960|Ceplene|ceplene
380401|NCT01324947|Myeloma|myeloma
380402|NCT01324947|Multiple Myeloma|multiple myeloma
380403|NCT01324947|Relapsed Multiple Myeloma|relapsed multiple myeloma
380404|NCT01324947|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
380405|NCT01324947|Refractory Myeloma|refractory myeloma
380406|NCT01324947|Resistant Multiple Myeloma|resistant multiple myeloma
380407|NCT01324947|Treatment-resistant Multiple Myeloma|treatment-resistant multiple myeloma
380408|NCT01324947|Pomalidomide|pomalidomide
380409|NCT01324947|Lenalidomide-resistant|lenalidomide-resistant
380410|NCT01324947|Bortezomib-resistant|bortezomib-resistant
380411|NCT01324947|Companion|companion
380412|NCT01324934|acute rejection|acute rejection
380413|NCT01324934|chronic rejection|chronic rejection
380414|NCT01324934|subclinical rejection|subclinical rejection
380415|NCT01324934|renal transplantation|renal transplantation
380416|NCT01324934|steroid-free|steroid-free
380417|NCT01324934|kidney transplantation|kidney transplantation
402060|NCT01233336|prognostic factors in patients with ACS|prognostic factors in patients with acs
380418|NCT01324895|Small intestinal bacterial overgrowth syndrome (SIBO)|small intestinal bacterial overgrowth syndrome (sibo)
380419|NCT01324895|bacterial overgrowth syndrome|bacterial overgrowth syndrome
380420|NCT01324895|Small Bowel Bacterial Overgrowth Syndrome (SBBOS)|small bowel bacterial overgrowth syndrome (sbbos)
380421|NCT01324895|14-Co2 D-Xylose Breath Testing|14-co2 d-xylose breath testing
380422|NCT01324895|Antibiotics|antibiotics
464692|NCT00056251|Bladder|bladder
371139|NCT01363674|Saizen|saizen
380423|NCT01324895|Prokinteics|prokinteics
380424|NCT01324895|Prokinetic Agents|prokinetic agents
380425|NCT01324882|colonoscopy|colonoscopy
380427|NCT01324869|Diabetic macular Edema|diabetic macular edema
380428|NCT01324869|Intravitreal injection|intravitreal injection
380429|NCT01324869|Multiple injections|multiple injections
380430|NCT01324869|20 patients|20 patients
380431|NCT01324869|0.5mg/eye/time|0.5mg/eye/time
380432|NCT01324856|pancreatic cancer|pancreatic cancer
380433|NCT01324856|periampulary cancer|periampulary cancer
380434|NCT01324856|pancreaticogastro vs pancreaticojejuno anastomosis|pancreaticogastro vs pancreaticojejuno anastomosis
380435|NCT01324843|Safety and Tolerability|safety and tolerability
380436|NCT01324843|Intradermal Electroporation|intradermal electroporation
380437|NCT01324817|Non-Contact|non-contact
380438|NCT01324817|Radar|radar
380439|NCT01324817|Doppler|doppler
380440|NCT01324817|Respiratory|respiratory
380441|NCT01324817|Respiration|respiration
380442|NCT01324817|Breathing|breathing
380443|NCT01324817|Rate|rate
380444|NCT01324817|Frequency|frequency
380445|NCT01324817|Respiratory Mechanics|respiratory mechanics
380446|NCT01324817|Respiratory Rate Measurement|respiratory rate measurement
380447|NCT01324817|Apnea|apnea
380448|NCT01324817|Sleep Apnea|sleep apnea
380449|NCT01324804|postoperative wound healing|postoperative wound healing
380450|NCT01324778|Edentulism in the Upper Jaw|edentulism in the upper jaw
380452|NCT01324765|PTSD|ptsd
380453|NCT01324765|Group Therapy|group therapy
380454|NCT01324765|Incarceration|incarceration
380455|NCT01324752|Drug-drug interaction|drug-drug interaction
380456|NCT01324752|Pharmacokinetics|pharmacokinetics
380457|NCT01324752|PA21|pa21
380458|NCT01324726|Bacterial colonization|bacterial colonization
380459|NCT01324726|Extended spectrum beta lactamase producing organisms|extended spectrum beta lactamase producing organisms
380460|NCT01324687|Telemedicine|telemedicine
380461|NCT01324687|Geriatrics|geriatrics
380462|NCT01324674|Common Mental Disorder|common mental disorder
380463|NCT01324674|Efficacy of Bach´s flower remedy|efficacy of bach´s flower remedy
380464|NCT01324674|Spiritual well-being|spiritual well-being
380465|NCT01324648|Guided self-help|guided self-help
380466|NCT01324648|Telephone delivery|telephone delivery
380467|NCT01324648|Cognitive behavior therapy|cognitive behavior therapy
380468|NCT01324648|Bibliotherapy|bibliotherapy
380469|NCT01324635|glioma|glioma
380470|NCT01324635|meningioma|meningioma
380471|NCT01324635|brain metastasis|brain metastasis
380472|NCT01324635|stereotactic|stereotactic
380473|NCT01324635|radiotherapy|radiotherapy
380474|NCT01324635|radiosurgery|radiosurgery
380475|NCT01324622|Spinal Cord Diseases|spinal cord diseases
380476|NCT01324622|Myelopathy|myelopathy
380477|NCT01324622|Myeloradiculopathy|myeloradiculopathy
380478|NCT01324622|Laminectomy|laminectomy
380479|NCT01324622|Laminoplasty|laminoplasty
380480|NCT01324609|choroidal nevus|choroidal nevus
380481|NCT01324609|vitrectomy|vitrectomy
380482|NCT01324596|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
380483|NCT01324596|Bortezomib|bortezomib
380484|NCT01324596|R-CHOP|r-chop
380485|NCT01324596|Molecular profiling|molecular profiling
380486|NCT01324596|Chemotherapy|chemotherapy
380487|NCT01324570|Pain|pain
380488|NCT01324570|Opioid|opioid
380489|NCT01324570|Analgesia|analgesia
380490|NCT01324570|Moderate to severe pain|moderate to severe pain
380491|NCT01324557|Continuous glucose monitoring|continuous glucose monitoring
380492|NCT01324557|CAPD patients|capd patients
380493|NCT01324557|Insulin pump|insulin pump
380494|NCT01324544|Acute Pain|acute pain
380495|NCT01324544|Opioid|opioid
380496|NCT01324544|Analgesia|analgesia
380497|NCT01324531|Bankart repair|bankart repair
380498|NCT01324531|remplissage|remplissage
380499|NCT01324531|Hill-Sachs defect|hill-sachs defect
380500|NCT01324531|shoulder instability|shoulder instability
380501|NCT01324531|anterior shoulder instability|anterior shoulder instability
380502|NCT01324492|phase Ib,|phase ib,
380503|NCT01324492|RAD001,|rad001,
380504|NCT01324492|advanced pulmonary neuroendocrine tumor|advanced pulmonary neuroendocrine tumor
380505|NCT01324479|Non-small cell lung cancer,|non-small cell lung cancer,
380506|NCT01324479|hepatocellular,|hepatocellular,
380507|NCT01324479|gastric,|gastric,
380508|NCT01324479|renal cell,|renal cell,
380509|NCT01324479|c-MET,|c-met,
380510|NCT01324479|refractory,|refractory,
380511|NCT01324479|glioblastoma,|glioblastoma,
380512|NCT01324479|breast,|breast,
380513|NCT01324479|nasopharyngeal,|nasopharyngeal,
380514|NCT01324479|confirmed evidence of c-MET dysregulation|confirmed evidence of c-met dysregulation
380515|NCT01324453|Acute Myocardial Infarction|acute myocardial infarction
380516|NCT01324453|STEMI|stemi
380517|NCT01324453|Post Conditioning|post conditioning
380518|NCT01324453|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
380519|NCT01324440|Bacterial Vaccines|bacterial vaccines
380520|NCT01324440|Staphylococcus Aureus|staphylococcus aureus
380521|NCT01324440|Adjuvanted Vaccine|adjuvanted vaccine
380522|NCT01324427|Telemedicine|telemedicine
380523|NCT01324427|Virtual Medical Visit|virtual medical visit
380524|NCT01324427|Quality of Life|quality of life
380526|NCT01324401|Peanut Allergy|peanut allergy
380833|NCT01323192|Adults|adults
380527|NCT01324401|Peanut Hypersensitivity|peanut hypersensitivity
380529|NCT01324362|Asthma|asthma
380530|NCT01324362|Sont|sont
380531|NCT01324362|FSC|fsc
380532|NCT01324362|BHR|bhr
380533|NCT01324349|Hepatic|hepatic
380534|NCT01324349|Topical Hemostat|topical hemostat
380535|NCT01324336|ALL|all
380536|NCT01324336|acute lymphoblastic leukemia|acute lymphoblastic leukemia
380537|NCT01324336|6-Mercaptopurine|6-mercaptopurine
380538|NCT01324336|Pediatric|pediatric
380539|NCT01324323|ROMI-001|romi-001
380540|NCT01324323|romi|romi
380541|NCT01324323|Romidepsin|romidepsin
380542|NCT01324323|Istodax|istodax
380543|NCT01324323|advanced malignancy|advanced malignancy
380544|NCT01324323|PK|pk
380545|NCT01324323|pharmacokinetics|pharmacokinetics
380546|NCT01324310|ROMI-001|romi-001
380547|NCT01324310|romi|romi
380548|NCT01324310|Romidepsin|romidepsin
380549|NCT01324310|Istodax|istodax
380550|NCT01324310|advanced malignancy|advanced malignancy
380551|NCT01324310|PK|pk
380552|NCT01324310|pharmacokinetics|pharmacokinetics
380553|NCT01324297|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
380554|NCT01324297|Sensitivity and Specificity|sensitivity and specificity
380555|NCT01324297|Skin Tests|skin tests
380556|NCT01324297|Biological Markers|biological markers
380557|NCT01324284|Lubiprostone|lubiprostone
380558|NCT01324284|Bowel preparation regime|bowel preparation regime
380559|NCT01324271|Tympanostomy tube placement|tympanostomy tube placement
380560|NCT01324258|pancreatic cancer (combination with gemcitabine)|pancreatic cancer (combination with gemcitabine)
380561|NCT01324258|Non-small cell lung cancer (combination with gemcitabine)|non-small cell lung cancer (combination with gemcitabine)
380562|NCT01324258|solid tumors (single agent)|solid tumors (single agent)
380563|NCT01324258|MEK inhibitor|mek inhibitor
380564|NCT01324258|GSK1120212|gsk1120212
380565|NCT01324258|biliary cancer (combination with gemcitabine)|biliary cancer (combination with gemcitabine)
380566|NCT01324258|urothelial cancer (combination with gemcitabine)|urothelial cancer (combination with gemcitabine)
380568|NCT01324245|Balance|balance
380569|NCT01324245|Renin Angiotensin System|renin angiotensin system
380570|NCT01324245|Fenoldopam\blood Pressure|fenoldopam\blood pressure
380571|NCT01324245|Sodium|sodium
380572|NCT01324219|nursing staff|nursing staff
380573|NCT01324219|residents|residents
380574|NCT01324206|Whole-Body|whole-body
380575|NCT01324206|Development|development
380576|NCT01324206|Exposure|exposure
380577|NCT01324206|Magnetic|magnetic
380578|NCT01324206|Resonance|resonance
380579|NCT01324180|ALL|all
380580|NCT01324180|Relapsed|relapsed
380581|NCT01324180|Refractory|refractory
380582|NCT01324167|schizophrenia|schizophrenia
380583|NCT01324167|schizoaffective disorder|schizoaffective disorder
380584|NCT01324141|Anal Cancer|anal cancer
380585|NCT01324141|Radioprotector|radioprotector
380586|NCT01324141|Topical|topical
380587|NCT01324141|Radiation|radiation
380588|NCT01324141|Dermatitis|dermatitis
380589|NCT01324128|PA21|pa21
380590|NCT01324128|Phosphate Binder|phosphate binder
380591|NCT01324115|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
380592|NCT01324102|Neoplasms|neoplasms
380593|NCT01324089|Resveratrol|resveratrol
380594|NCT01324089|Piperine|piperine
380595|NCT01324076|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
380596|NCT01324076|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
380597|NCT01324076|advanced adult primary liver cancer|advanced adult primary liver cancer
380598|NCT01324063|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
380599|NCT01324037|suspected upper extremity deep vein thrombosis|suspected upper extremity deep vein thrombosis
380600|NCT01324037|diagnostic algorithm|diagnostic algorithm
380601|NCT01324024|Menopause|menopause
380602|NCT01324024|Aging|aging
380603|NCT01324024|Memory|memory
380604|NCT01324024|Women|women
380605|NCT01323998|enlarged prostate|enlarged prostate
380606|NCT01323998|Benign prostatic hyperplasia|benign prostatic hyperplasia
380607|NCT01323998|alpha-blocker|alpha-blocker
380608|NCT01323998|5-alpha-reductase inhibitor|5-alpha-reductase inhibitor
380609|NCT01323972|Malaria|malaria
380610|NCT01323972|Plasmodium falciparum|plasmodium falciparum
380611|NCT01323959|BoostrixTM Polio|boostrixtm polio
380612|NCT01323959|dTpa-IPV|dtpa-ipv
380613|NCT01323959|booster|booster
380614|NCT01323946|H5N1|h5n1
380615|NCT01323946|influenza infection|influenza infection
380616|NCT01323946|Influenza vaccine GSK1562902A|influenza vaccine gsk1562902a
380617|NCT01323933|Solid tumors|solid tumors
380618|NCT01323933|Oncology|oncology
380619|NCT01323933|Cancer|cancer
380620|NCT01323920|Stem Cell Transplant|stem cell transplant
371326|NCT01362946|callous-unemotional traits|callous-unemotional traits
371327|NCT01362946|disruptive behavior disorders|disruptive behavior disorders
380621|NCT01323920|Allogeneic Transplant|allogeneic transplant
380622|NCT01323920|Donors|donors
380623|NCT01323907|Total Parenteral Nutrition-induced Cholestasis|total parenteral nutrition-induced cholestasis
380624|NCT01323907|Omegaven|omegaven
380625|NCT01323907|liver disease|liver disease
380626|NCT01323907|Cholestasis|cholestasis
380627|NCT01323907|Fat emulsions|fat emulsions
380628|NCT01323881|theta burst stimulation, stroke, motor, plasticity|theta burst stimulation, stroke, motor, plasticity
380629|NCT01323842|renal colic|renal colic
380630|NCT01323842|hydronephrosis|hydronephrosis
380631|NCT01323842|abdominal aortic aneurysm|abdominal aortic aneurysm
380632|NCT01323842|ultrasound|ultrasound
380633|NCT01323842|emergency medicine|emergency medicine
380634|NCT01323842|urolithiasis|urolithiasis
380635|NCT01323829|High Tone Pelvic Floor Dysfunction|high tone pelvic floor dysfunction
380636|NCT01323829|Botulinum toxin type A|botulinum toxin type a
380637|NCT01323829|EMG|emg
380638|NCT01323803|Eosinophilic Esophagitis|eosinophilic esophagitis
380639|NCT01323790|Non-Cancer-Related Pain|non-cancer-related pain
380640|NCT01323790|Opioid-Induced Constipation|opioid-induced constipation
380641|NCT01323777|Cataracts|cataracts
380642|NCT01323777|Intraocular lens|intraocular lens
380643|NCT01323777|Multifocal|multifocal
380644|NCT01323777|Toric|toric
380645|NCT01323777|Astigmatism|astigmatism
380646|NCT01323777|Presbyopia|presbyopia
380647|NCT01323764|Hydrocephalus|hydrocephalus
380648|NCT01323764|CSF shunts|csf shunts
380233|NCT01325688|PEP005|pep005
380649|NCT01323764|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
380651|NCT01323764|ShuntCheck|shuntcheck
380652|NCT01323764|Shunt Malfunction|shunt malfunction
380653|NCT01323764|Suspected shunt malfunction in adult hydrocephalus patients|suspected shunt malfunction in adult hydrocephalus patients
380654|NCT01323738|Psychoeducation|psychoeducation
380655|NCT01323738|Group Control|group control
380656|NCT01323725|Team-based financial incentives|team-based financial incentives
380657|NCT01323725|Smoking cessation|smoking cessation
380659|NCT01323712|LV mass|lv mass
380660|NCT01323712|Vitamin D|vitamin d
380661|NCT01323712|LV function|lv function
380662|NCT01323699|Parkinson Disease|parkinson disease
380663|NCT01323699|Anxiety|anxiety
380664|NCT01323699|Depression|depression
380665|NCT01323647|IPV|ipv
380666|NCT01323647|PoliorixTM|poliorixtm
380667|NCT01323647|China|china
380668|NCT01323608|Thalassemia|thalassemia
380669|NCT01323608|hypercalciuria|hypercalciuria
380670|NCT01323608|vitamin D|vitamin d
380671|NCT01323608|To conduct a pilot study to determine the effect of various doses of|to conduct a pilot study to determine the effect of various doses of
380672|NCT01323608|vitamin D supplementation on vitamin D stores and their association with calcium excretion|vitamin d supplementation on vitamin d stores and their association with calcium excretion
380673|NCT01323595|Pain control|pain control
380674|NCT01323595|testicular sperm extraction|testicular sperm extraction
380675|NCT01323595|sperm|sperm
380676|NCT01323582|Gastroparesis|gastroparesis
380677|NCT01323582|Gastroparesis Treatment|gastroparesis treatment
380678|NCT01323582|Gastric Emptying|gastric emptying
380679|NCT01323582|Prokinetic Agents|prokinetic agents
380680|NCT01323582|Macrolides|macrolides
380681|NCT01323582|Erythromycin|erythromycin
380682|NCT01323582|Azithromycin|azithromycin
380683|NCT01323582|Erythromycin Cardiac Side-effects|erythromycin cardiac side-effects
380684|NCT01323582|Erythromycin drug interactions|erythromycin drug interactions
380685|NCT01323582|AZI|azi
380686|NCT01323569|Sativex|sativex
380687|NCT01323569|Cannabinoids|cannabinoids
380688|NCT01323569|Abuse potential|abuse potential
380689|NCT01323569|Addiction|addiction
380690|NCT01323556|Panic disorder|panic disorder
380691|NCT01323556|agoraphobia|agoraphobia
380692|NCT01323556|panic attacks|panic attacks
380693|NCT01323556|exposure based learning|exposure based learning
380694|NCT01323556|interoceptive exposure exercises|interoceptive exposure exercises
380695|NCT01323556|fear augmentation|fear augmentation
380696|NCT01323556|in vivo exposure|in vivo exposure
380697|NCT01323543|Back Pain,|back pain,
380698|NCT01323543|Back Pains, Low|back pains, low
380699|NCT01323543|Low Back Pains|low back pains
380700|NCT01323543|Pain, Low Back|pain, low back
380701|NCT01323543|Pains, Low Back|pains, low back
380702|NCT01323543|Lumbago|lumbago
380703|NCT01323543|Lower Back Pain|lower back pain
380704|NCT01323543|Back Pain, Lower|back pain, lower
380705|NCT01323543|Back Pains, Lower|back pains, lower
380706|NCT01323543|Lower Back Pains|lower back pains
380707|NCT01323543|Pain, Lower Back|pain, lower back
380708|NCT01323543|Pains, Lower Back|pains, lower back
380709|NCT01323543|Low Back Ache|low back ache
380710|NCT01323543|Ache, Low Back|ache, low back
380711|NCT01323543|Aches, Low Back|aches, low back
380712|NCT01323543|Back Ache, Low|back ache, low
380713|NCT01323543|Back Aches, Low|back aches, low
465110|NCT00057707|HV|hv
380714|NCT01323543|Low Back Aches|low back aches
380715|NCT01323543|Low Backache|low backache
380716|NCT01323543|Backache, Low|backache, low
380717|NCT01323543|Backaches, Low|backaches, low
380718|NCT01323543|Low Backaches|low backaches
380719|NCT01323543|Low Back Pain, Recurrent|low back pain, recurrent
380720|NCT01323543|Recurrent Low Back Pain|recurrent low back pain
380827|NCT01323231|truancy|truancy
380721|NCT01323543|Low Back Pain, Postural|low back pain, postural
380722|NCT01323543|Postural Low Back Pain|postural low back pain
380723|NCT01323543|Low Back Pain, Mechanical|low back pain, mechanical
380724|NCT01323543|Mechanical Low Back Pain|mechanical low back pain
381040|NCT01322308|endothelial function|endothelial function
380725|NCT01323543|Low Back Pain, Posterior Compartment|low back pain, posterior compartment
380726|NCT01323530|metastatic breast cancer|metastatic breast cancer
380727|NCT01323517|skin|skin
380728|NCT01323517|DACTINOMYCIN|dactinomycin
380729|NCT01323517|MDX-010 (Ipilimumab)|mdx-010 (ipilimumab)
380730|NCT01323517|MELPHALAN|melphalan
380731|NCT01323517|Isolated Limb Infusion|isolated limb infusion
380732|NCT01323517|10-101|10-101
380733|NCT01323504|Stage 5 arteritis|stage 5 arteritis
380734|NCT01323504|Stage 6 arteritis|stage 6 arteritis
380735|NCT01323504|rutherford classification|rutherford classification
380736|NCT01323491|smoking cessation|smoking cessation
380737|NCT01323491|nicotine replacement therapy|nicotine replacement therapy
380738|NCT01323491|routine smokers|routine smokers
380739|NCT01323478|Depressive Disorder|depressive disorder
380740|NCT01323478|Depression|depression
380741|NCT01323478|Depressive Disorder, Major|depressive disorder, major
380742|NCT01323478|Mood Disorders|mood disorders
380743|NCT01323478|Mental Disorders|mental disorders
380744|NCT01323478|Behavioural Symptoms|behavioural symptoms
380745|NCT01323465|Sativex|sativex
380746|NCT01323465|Cytochrome P450|cytochrome p450
380747|NCT01323465|Pharmacokinetics|pharmacokinetics
380748|NCT01323465|Cannabinoids|cannabinoids
380749|NCT01323465|ketoconazole|ketoconazole
380750|NCT01323465|omeprazole|omeprazole
380751|NCT01323465|rifampicin|rifampicin
380752|NCT01323452|entecavir|entecavir
380753|NCT01323452|hepatitis B|hepatitis b
380754|NCT01323439|Patients presenting with an intracranial aneurysm|patients presenting with an intracranial aneurysm
380755|NCT01323426|urinary incontinence, stress|urinary incontinence, stress
380756|NCT01323426|autologous|autologous
380757|NCT01323413|stroke|stroke
380758|NCT01323413|penumbra|penumbra
380759|NCT01323413|determinants|determinants
380760|NCT01323413|CT perfusion|ct perfusion
380761|NCT01323400|GIST|gist
380762|NCT01323400|Resistant|resistant
380764|NCT01323400|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
380765|NCT01323400|Best supportive care|best supportive care
380766|NCT01323400|Progression-free survival|progression-free survival
380767|NCT01323400|Overall survival|overall survival
380768|NCT01323400|Objective response rate|objective response rate
380769|NCT01323400|Best response|best response
380770|NCT01323400|Tolerance profile|tolerance profile
380771|NCT01323374|Fibromyalgia|fibromyalgia
380773|NCT01323374|droxidopa|droxidopa
380774|NCT01323374|pain|pain
380775|NCT01323361|inflammation|inflammation
380776|NCT01323361|laparoscopy|laparoscopy
380777|NCT01323361|hernia|hernia
380778|NCT01323361|incisional|incisional
380779|NCT01323361|trauma|trauma
380780|NCT01323348|Diabetes|diabetes
380781|NCT01323348|Diabetes Education|diabetes education
380782|NCT01323348|Diabetic Retinopathy|diabetic retinopathy
380783|NCT01323348|HbA1c|hba1c
380784|NCT01323335|Uric Acid|uric acid
380785|NCT01323335|Rasburicase|rasburicase
380786|NCT01323335|Inflammatory Markers|inflammatory markers
380787|NCT01323322|Health Disparities|health disparities
380788|NCT01323322|Diversity|diversity
380789|NCT01323322|Socioeconomic Status|socioeconomic status
380790|NCT01323322|Epidemiology|epidemiology
380791|NCT01323309|Supportive Psychotherapy|supportive psychotherapy
380792|NCT01323309|Therapy|therapy
380793|NCT01323309|11-021|11-021
380794|NCT01323296|Myocardial infarction|myocardial infarction
380795|NCT01323296|Magnetic resonance|magnetic resonance
380796|NCT01323296|Nanoparticle|nanoparticle
380797|NCT01323296|Iron|iron
380798|NCT01323296|Inflammation|inflammation
380799|NCT01323283|Omega-3|omega-3
380800|NCT01323283|physical activity|physical activity
380801|NCT01323283|children|children
380802|NCT01323283|obesity|obesity
380803|NCT01323283|sedentary|sedentary
380804|NCT01323283|accelerometry|accelerometry
380805|NCT01323283|BMI|bmi
380806|NCT01323283|fatty acids|fatty acids
380807|NCT01323283|inflammatory markers|inflammatory markers
380808|NCT01323283|intervention|intervention
380809|NCT01323283|randomized|randomized
380810|NCT01323283|double blind|double blind
380811|NCT01323270|Healthy adolescents|healthy adolescents
380812|NCT01323257|TMC435-TiDP16-C115|tmc435-tidp16-c115
380813|NCT01323257|TMC435-C115|tmc435-c115
380814|NCT01323257|TMC435|tmc435
380815|NCT01323257|HCV|hcv
380816|NCT01323257|Hepatitis C|hepatitis c
380817|NCT01323257|Hep C|hep c
380818|NCT01323257|healthy volunteers|healthy volunteers
380819|NCT01323244|TMC435-TiDP16-C213|tmc435-tidp16-c213
380820|NCT01323244|TMC435-C213|tmc435-c213
380821|NCT01323244|TMC435|tmc435
380823|NCT01323244|Hepatitis C|hepatitis c
380824|NCT01323231|XY-Zone|xy-zone
380825|NCT01323231|school drop-out risk|school drop-out risk
380826|NCT01323231|protective factors|protective factors
380828|NCT01323218|Obstructive sleep apnea-hypopnea syndrome|obstructive sleep apnea-hypopnea syndrome
380829|NCT01323218|OSAHS|osahs
380830|NCT01323218|Vitamin D|vitamin d
380831|NCT01323205|JNJ-40411813|jnj-40411813
380832|NCT01323192|Concerta|concerta
380834|NCT01323192|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
380835|NCT01323192|ADHD|adhd
380836|NCT01323192|Methylphenidate hydrochloride|methylphenidate hydrochloride
380837|NCT01323179|Postoperative pain|postoperative pain
380838|NCT01323179|Postoperative opioid requirements|postoperative opioid requirements
380839|NCT01323166|rectal cancer|rectal cancer
380840|NCT01323140|hypogonadism, testosterone, transdermal system|hypogonadism, testosterone, transdermal system
380841|NCT01323114|type 2 diabetes mellitus|type 2 diabetes mellitus
380842|NCT01323114|non-morbidly obese|non-morbidly obese
380843|NCT01323114|laparoscopic duodenal exclusion|laparoscopic duodenal exclusion
380844|NCT01323088|Childhood obesity|childhood obesity
380845|NCT01323088|Visceral fat|visceral fat
380846|NCT01323088|Insulin resistance|insulin resistance
380847|NCT01323088|Liver fat|liver fat
380848|NCT01323088|Skeletal muscle lipid|skeletal muscle lipid
380849|NCT01323088|Regular exercise|regular exercise
380850|NCT01323062|chemotherapy naive|chemotherapy naive
380851|NCT01323062|stage IV non squamous non small cell lung cancer|stage iv non squamous non small cell lung cancer
380852|NCT01323062|Phase 1b|phase 1b
380853|NCT01323062|Bavituximab|bavituximab
380854|NCT01323062|Chimeric 3G4|chimeric 3g4
380855|NCT01323062|U of North Carolina at Chapel Hill|u of north carolina at chapel hill
380856|NCT01323049|extubation strategy|extubation strategy
380858|NCT01323010|albuterol|albuterol
380859|NCT01323010|metered dose inhalers|metered dose inhalers
380860|NCT01322984|ASD|asd
380861|NCT01322984|Startle|startle
380862|NCT01322971|Bacterial Vaginosis|bacterial vaginosis
380863|NCT01322971|Infertility|infertility
380864|NCT01322971|Miscarriage|miscarriage
380865|NCT01322971|Metronidazole|metronidazole
380866|NCT01322958|bedside ultrasound|bedside ultrasound
380867|NCT01322932|Medication Adherence|medication adherence
380868|NCT01322932|HIV Infection|hiv infection
380869|NCT01322932|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination [Substance Name]|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination [substance name]
380870|NCT01322932|efavirenz|efavirenz
380871|NCT01322932|emtricitabine|emtricitabine
380872|NCT01322932|Patient Satisfaction|patient satisfaction
380873|NCT01322932|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
380874|NCT01322919|PresbyLASIK|presbylasik
380875|NCT01322919|Presbyopia|presbyopia
380876|NCT01322919|LASIK|lasik
380877|NCT01322919|Supracor|supracor
380878|NCT01322919|refractive|refractive
380879|NCT01322919|Myopia|myopia
380880|NCT01322919|Hyperopia|hyperopia
380881|NCT01322906|ABMLF|abmlf
380882|NCT01322906|Allogenic Bone marrow Mesenchymal Stem Cells|allogenic bone marrow mesenchymal stem cells
380883|NCT01322906|Liver Failure|liver failure
380884|NCT01322906|Transplantation|transplantation
380885|NCT01322893|Metastatic breast cancer|metastatic breast cancer
380886|NCT01322893|Circulating tumour cells|circulating tumour cells
380887|NCT01322893|CTC|ctc
380888|NCT01322893|Prognostic factors|prognostic factors
380889|NCT01322893|Treatment response|treatment response
380890|NCT01322880|domestic violence|domestic violence
380891|NCT01322867|bioequivalence study|bioequivalence study
380892|NCT01322867|alprazolam|alprazolam
380893|NCT01322867|frontal|frontal
380894|NCT01322854|IMRT|imrt
380895|NCT01322854|Integrated boost|integrated boost
380896|NCT01322854|adjuvant radiotherapy|adjuvant radiotherapy
380897|NCT01322854|breast cancer|breast cancer
380898|NCT01322854|breast conserving surgery|breast conserving surgery
380899|NCT01322841|CHICA|chica
380900|NCT01322841|clinical decision support|clinical decision support
380901|NCT01322828|Bicep|bicep
380902|NCT01322828|Tendon|tendon
380903|NCT01322828|Distal|distal
380904|NCT01322828|Ruptures|ruptures
380905|NCT01322828|Randomized|randomized
380906|NCT01322828|Surgery|surgery
380907|NCT01322815|colon cancer|colon cancer
380908|NCT01322815|metastatic|metastatic
380909|NCT01322815|vaccine|vaccine
380910|NCT01322802|Ovarian Cancer|ovarian cancer
380911|NCT01322802|Vaccine|vaccine
380912|NCT01322802|Stage III|stage iii
380913|NCT01322802|Stage IV|stage iv
380914|NCT01322802|Remission|remission
380915|NCT01322789|Diabetes mellitus|diabetes mellitus
380916|NCT01322789|Stem cells|stem cells
380917|NCT01322789|Autologous stem cell transplantation|autologous stem cell transplantation
380918|NCT01322789|Autoimmune diseases|autoimmune diseases
380919|NCT01322776|Mantle Cell Lymphoma|mantle cell lymphoma
380920|NCT01322776|Recurrent|recurrent
380921|NCT01322776|Bortezomib|bortezomib
380922|NCT01322776|Combination Treatment|combination treatment
380923|NCT01322737|resection|resection
380924|NCT01322737|open|open
380925|NCT01322737|laparoscopic|laparoscopic
380926|NCT01322737|benign|benign
380927|NCT01322737|malignant|malignant
380928|NCT01322737|disease|disease
380929|NCT01322737|colon|colon
380930|NCT01322737|gastric|gastric
380931|NCT01322724|colonoscopy|colonoscopy
380932|NCT01322724|colon cancer screening|colon cancer screening
380933|NCT01322724|patient discomfort scores|patient discomfort scores
381228|NCT01320566|breathing|breathing
380934|NCT01322724|sedation medication requirements|sedation medication requirements
380935|NCT01322724|water insertion method|water insertion method
380936|NCT01322711|Thromboxane|thromboxane
380937|NCT01322711|Aspirin|aspirin
380938|NCT01322711|Atorvastatin|atorvastatin
380939|NCT01322711|Platelet activation|platelet activation
380940|NCT01322711|Thrombin Activation|thrombin activation
380941|NCT01322711|Oxidative stress|oxidative stress
380942|NCT01322698|ICU|icu
380943|NCT01322685|Tuberculosis|tuberculosis
380944|NCT01322685|Lung cancer|lung cancer
380945|NCT01322672|Anesthetic Agents|anesthetic agents
380946|NCT01322672|POCD|pocd
380947|NCT01322672|Delirium|delirium
380948|NCT01322672|Cognitive Testing|cognitive testing
380949|NCT01322672|Aging|aging
380950|NCT01322672|Surgery|surgery
380951|NCT01322672|fMRI|fmri
380952|NCT01322672|Diffusion Tensor Imaging|diffusion tensor imaging
380953|NCT01322672|White Matter|white matter
380954|NCT01322659|Mechanical ventilation|mechanical ventilation
380955|NCT01322659|Weaning|weaning
380956|NCT01322659|Noninvasive ventilation|noninvasive ventilation
380957|NCT01322659|Acute respiratory failure|acute respiratory failure
380958|NCT01322659|Helmet|helmet
380959|NCT01322646|ADHD|adhd
380960|NCT01322646|Driving|driving
380961|NCT01322646|Behavior modification|behavior modification
380962|NCT01322633|Pantoprazole|pantoprazole
380963|NCT01322633|proton pump inhibitor|proton pump inhibitor
380964|NCT01322633|gastric cancer|gastric cancer
380965|NCT01322633|digestive system cancer|digestive system cancer
380966|NCT01322633|cancer|cancer
380967|NCT01322607|Exercise|exercise
380968|NCT01322607|Rehabilitation|rehabilitation
380969|NCT01322607|Stroke|stroke
380970|NCT01322594|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
380971|NCT01322594|COPD|copd
380972|NCT01322581|Plasmodium Falciparum|plasmodium falciparum
380973|NCT01322581|Genome-Wide Expression|genome-wide expression
380974|NCT01322581|Antibody Profiling by Protein Microarray|antibody profiling by protein microarray
380975|NCT01322581|Multiplex Cytokine Analysis|multiplex cytokine analysis
380976|NCT01322581|Children and Adults|children and adults
380977|NCT01322581|Malaria|malaria
380978|NCT01322568|Aging|aging
380979|NCT01322568|Gene|gene
380980|NCT01322568|Environment|environment
380981|NCT01322568|Inflammation|inflammation
380982|NCT01322568|Iceland|iceland
380983|NCT01322555|PBR28|pbr28
380984|NCT01322555|Positron Emission Tomography (PET)|positron emission tomography (pet)
380985|NCT01322555|Propofol|propofol
380986|NCT01322555|Autism|autism
380987|NCT01322555|Immune Response|immune response
380988|NCT01322555|Autism Spectrum Disorders|autism spectrum disorders
380990|NCT01322555|Healthy Volunteer|healthy volunteer
380991|NCT01322555|HV|hv
380992|NCT01322529|nulliparity|nulliparity
380993|NCT01322529|pregnant women|pregnant women
380994|NCT01322529|pregnancy outcomes|pregnancy outcomes
380995|NCT01322529|pregnancy complications|pregnancy complications
380996|NCT01322490|PROSTVAC|prostvac
380997|NCT01322490|metastatic|metastatic
380998|NCT01322490|prostate cancer|prostate cancer
380999|NCT01322490|castrate-resistant|castrate-resistant
381000|NCT01322490|vaccine|vaccine
381001|NCT01322490|immunotherapy|immunotherapy
381002|NCT01322490|Phase 3|phase 3
381003|NCT01322477|Identification of treatment efficacy in patients with advanced HCC by PET/CT F18-FDG|identification of treatment efficacy in patients with advanced hcc by pet/ct f18-fdg
381004|NCT01322464|Sativex|sativex
381005|NCT01322464|bio-availability|bio-availability
381006|NCT01322464|cannabinoid|cannabinoid
381007|NCT01322464|pharmacokinetics|pharmacokinetics
381008|NCT01322451|Safety|safety
381009|NCT01322451|Tolerability|tolerability
381010|NCT01322451|Pharmacokinetics|pharmacokinetics
381011|NCT01322438|healthy volunteers|healthy volunteers
381012|NCT01322438|rifampin|rifampin
381013|NCT01322438|pharmacokinetics|pharmacokinetics
381014|NCT01322438|single dose|single dose
381015|NCT01322412|Adapted physical activity|adapted physical activity
381016|NCT01322412|breast cancer|breast cancer
381017|NCT01322399|low back pain|low back pain
381018|NCT01322399|chronic pain|chronic pain
381019|NCT01322399|manual therapy|manual therapy
381020|NCT01322399|Structural Integration|structural integration
381021|NCT01322386|PSC|psc
381022|NCT01322386|BA|ba
381023|NCT01322373|Alzheimer's disease|alzheimer's disease
591675|NCT00535990|bypass|bypass
381024|NCT01322373|magnetoencephalography|magnetoencephalography
381026|NCT01322373|SNI|sni
381027|NCT01322347|End Stage Renal Disease|end stage renal disease
381028|NCT01322347|Hemodialysis|hemodialysis
381029|NCT01322347|SFP|sfp
381030|NCT01322347|Hemodialysis-dependent chronic renal failure|hemodialysis-dependent chronic renal failure
381031|NCT01322334|Snoring|snoring
381032|NCT01322334|Sleep apnea|sleep apnea
381033|NCT01322334|Pharyngeal muscle tone|pharyngeal muscle tone
381034|NCT01322321|ACZ885|acz885
381035|NCT01322321|diabetes|diabetes
381036|NCT01322321|type 1|type 1
381037|NCT01322321|C-peptide|c-peptide
381038|NCT01322308|lupus|lupus
381039|NCT01322308|HDL particles|hdl particles
381041|NCT01322308|pioglitazone|pioglitazone
381042|NCT01322243|Anxiety|anxiety
381043|NCT01322243|Metabolic state|metabolic state
381044|NCT01322243|Stress|stress
381045|NCT01322230|Instructional Design|instructional design
381046|NCT01322230|Online learning module|online learning module
381047|NCT01322230|Surgical education|surgical education
381048|NCT01322217|Medication adherence|medication adherence
381049|NCT01322217|Substance use|substance use
381050|NCT01322217|Sexual risk behaviors|sexual risk behaviors
381051|NCT01322204|codeine, neonates, pediatric pharmacology|codeine, neonates, pediatric pharmacology
381052|NCT01322191|pain, pain management, pediatrics, morphine pharmacokinetics|pain, pain management, pediatrics, morphine pharmacokinetics
381053|NCT01322178|cetuximab|cetuximab
381054|NCT01322178|colorectal carcinoma|colorectal carcinoma
381055|NCT01322165|Marfan syndrome|marfan syndrome
381056|NCT01322165|Turner syndrome|turner syndrome
381057|NCT01322165|Bicuspid aortic valve|bicuspid aortic valve
381058|NCT01322165|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
381059|NCT01322165|Loeys-Dietz syndrome|loeys-dietz syndrome
381060|NCT01322165|Aneurysm|aneurysm
381061|NCT01322165|Genetic|genetic
381062|NCT01322165|aortic|aortic
381063|NCT01322165|thoracic|thoracic
381064|NCT01322165|mutation|mutation
381065|NCT01322165|dissection|dissection
381066|NCT01322152|metastases|metastases
381067|NCT01322152|neoplasm|neoplasm
381068|NCT01322139|Sativex|sativex
381069|NCT01322139|Cannabinoid|cannabinoid
381070|NCT01322139|Electrocardiogram|electrocardiogram
381071|NCT01322139|QT interval|qt interval
381072|NCT01322113|BIPOLAR|bipolar
381073|NCT01322113|MANIA|mania
381074|NCT01322113|DEPRESSION|depression
381075|NCT01322100|Brain Metastases, CNS Metastases|brain metastases, cns metastases
381076|NCT01322087|Nutrition|nutrition
381077|NCT01322087|new energy dense food concept|new energy dense food concept
381078|NCT01322074|Acute postoperative pain|acute postoperative pain
381079|NCT01322074|systemic inflammation|systemic inflammation
381080|NCT01322074|CRP|crp
381081|NCT01322074|IL6|il6
381082|NCT01322061|Gallbladder removal|gallbladder removal
381083|NCT01322061|acute cholecystitis|acute cholecystitis
381084|NCT01322061|Laparoscopic cholecestectomy|laparoscopic cholecestectomy
381085|NCT01322048|Sympathetic Hyperactivity|sympathetic hyperactivity
381086|NCT01322048|Traumatic Brain Injury|traumatic brain injury
381087|NCT01322048|Agitation|agitation
381088|NCT01322048|Severe TBI|severe tbi
381089|NCT01322048|TBI|tbi
381090|NCT01322048|Catecholamines|catecholamines
381091|NCT01322048|Heart rate variability|heart rate variability
381092|NCT01322048|Adrenergic alpha-Agonists|adrenergic alpha-agonists
381093|NCT01322048|Adrenergic beta-Antagonists|adrenergic beta-antagonists
381094|NCT01322048|Cognitive Impairment|cognitive impairment
381095|NCT01322022|Autism|autism
381096|NCT01322022|Autism Spectrum Disorders|autism spectrum disorders
381097|NCT01322022|Sleep Problems|sleep problems
381098|NCT01322022|Sleep Disturbances|sleep disturbances
381099|NCT01322022|Interventions|interventions
381100|NCT01322009|Children|children
381101|NCT01322009|Brain injury|brain injury
381102|NCT01322009|Trauma|trauma
381103|NCT01321996|PET/CT|pet/ct
381104|NCT01321996|68Ga-DOTANOC|68ga-dotanoc
381105|NCT01321996|IPF|ipf
381106|NCT01321996|NSIP|nsip
381107|NCT01321996|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
381108|NCT01321931|Smoking Cessation|smoking cessation
381109|NCT01321931|Nicotine pharmacokinetics|nicotine pharmacokinetics
381110|NCT01321892|HRME|hrme
381111|NCT01321892|High-resolution microendoscope|high-resolution microendoscope
381112|NCT01321892|Optical imaging technology|optical imaging technology
381113|NCT01321892|Non-invasive fluorescence and reflectance imaging|non-invasive fluorescence and reflectance imaging
381114|NCT01321892|Upper aerodigestive tract|upper aerodigestive tract
381115|NCT01321892|Cancer surgery|cancer surgery
381116|NCT01321892|Squamous cell carcinoma|squamous cell carcinoma
381117|NCT01321892|Oral cavity|oral cavity
381118|NCT01321892|Oropharynx|oropharynx
381119|NCT01321892|Larynx|larynx
381120|NCT01321892|Hypopharynx|hypopharynx
381121|NCT01321892|Squamous cell carcinoma of the oral cavity, oropharynx, larynx, and/or hypopharynx|squamous cell carcinoma of the oral cavity, oropharynx, larynx, and/or hypopharynx
381122|NCT01321879|Gram Positive Bloodstream Infections|gram positive bloodstream infections
381123|NCT01321879|Sepsis|sepsis
381124|NCT01321879|Staphylococcus aureus|staphylococcus aureus
381125|NCT01321879|Enterococci|enterococci
381126|NCT01321879|Streptococci|streptococci
381127|NCT01321879|Pneumococci|pneumococci
381128|NCT01321879|Corynebacterium|corynebacterium
381129|NCT01321879|Propionibacterium or Bacillus species|propionibacterium or bacillus species
381130|NCT01321879|Telavancin|telavancin
381131|NCT01321879|Vibativ|vibativ
381132|NCT01321866|Angioplasty|angioplasty
381133|NCT01321866|cutting balloon|cutting balloon
381134|NCT01321853|Home health care|home health care
381135|NCT01321853|Medication Management|medication management
381136|NCT01321853|Cognitive impairment|cognitive impairment
381137|NCT01321853|Medication adherence|medication adherence
381138|NCT01321853|Older adults|older adults
381229|NCT01320566|COPD|copd
381139|NCT01321853|Care Coordination management|care coordination management
381140|NCT01321840|Endometriosis|endometriosis
381141|NCT01321840|pain|pain
381142|NCT01321840|sart|sart
381143|NCT01321840|autonomic nervous system|autonomic nervous system
381144|NCT01321840|fMRI|fmri
381145|NCT01321840|perfusion|perfusion
381146|NCT01321840|connectivity|connectivity
381147|NCT01321840|hypnotherapy|hypnotherapy
381148|NCT01321840|traditional Chinese medicine|traditional chinese medicine
381149|NCT01321827|ABPA|abpa
381150|NCT01321814|Hyperacusis|hyperacusis
381151|NCT01321814|Personality|personality
381152|NCT01321814|Comorbidity|comorbidity
381153|NCT01321814|Treatment|treatment
381154|NCT01321814|Cognitive behavioral therapy|cognitive behavioral therapy
381155|NCT01321801|Pregabalin|pregabalin
381156|NCT01321801|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
381157|NCT01321801|Postoperative pain|postoperative pain
381158|NCT01321801|Opioid consumption|opioid consumption
381159|NCT01321788|thromboprophylaxis|thromboprophylaxis
381160|NCT01321788|pregnancy|pregnancy
381161|NCT01321788|post-cesarian section|post-cesarian section
381162|NCT01321762|Prolapse|prolapse
381163|NCT01321762|Childbirth|childbirth
381164|NCT01321762|Pregnancy|pregnancy
381165|NCT01321749|ischemic cerebral vascular disease|ischemic cerebral vascular disease
381166|NCT01321749|stroke secondary prevention|stroke secondary prevention
381167|NCT01321749|remote ischemic preconditioning|remote ischemic preconditioning
381168|NCT01321736|dietary fiber|dietary fiber
381169|NCT01321736|enteral nutrition|enteral nutrition
381170|NCT01321736|laxation|laxation
381171|NCT01321723|Osteoporosis|osteoporosis
381172|NCT01321723|Bone Diseases, Metabolic|bone diseases, metabolic
381173|NCT01321723|Bone Diseases|bone diseases
381174|NCT01321723|Bone Density Conservation Agents|bone density conservation agents
381175|NCT01321710|sleep hygiene|sleep hygiene
381176|NCT01321710|actigraphy|actigraphy
381177|NCT01321710|maternal|maternal
381178|NCT01321710|infant|infant
381179|NCT01321710|postpartum period|postpartum period
381180|NCT01321710|immunization|immunization
381181|NCT01321710|acetaminophen|acetaminophen
381182|NCT01321697|Being seen in the Winthrop P. Rockefeller Cancer Institute for vulvar|being seen in the winthrop p. rockefeller cancer institute for vulvar
381183|NCT01321697|cancer requiring lymph node evaluation for the ipsilateral or contralateral|cancer requiring lymph node evaluation for the ipsilateral or contralateral
381184|NCT01321697|groin|groin
381185|NCT01321671|pregabalin|pregabalin
381186|NCT01321671|pharmacokinetics|pharmacokinetics
381187|NCT01321671|bioavailability|bioavailability
381188|NCT01321671|bioequivalence|bioequivalence
381189|NCT01321658|Geriatric Assessment|geriatric assessment
381190|NCT01321658|Perioperative Care|perioperative care
381191|NCT01321658|Colorectal Neoplasms|colorectal neoplasms
381192|NCT01321658|Frail Elderly|frail elderly
381193|NCT01321645|Acne Vulgaris|acne vulgaris
381194|NCT01321645|Homoeopathy|homoeopathy
381195|NCT01321645|Homeopathy|homeopathy
381196|NCT01321645|Azadirachta Indica|azadirachta indica
381197|NCT01321632|Acne Vulgaris|acne vulgaris
381198|NCT01321632|Homoeopathy|homoeopathy
381199|NCT01321632|Zingiber officinalis|zingiber officinalis
381200|NCT01321619|Chronic venous insufficiency|chronic venous insufficiency
381201|NCT01321619|Hemorrhoidal syndrome|hemorrhoidal syndrome
381202|NCT01321619|Varicell|varicell
381203|NCT01321606|infection|infection
381204|NCT01321606|probiotics|probiotics
381205|NCT01320631|uterine prolapse|uterine prolapse
381206|NCT01320631|vaginal prolapse|vaginal prolapse
381207|NCT01320618|uterine prolapse|uterine prolapse
381208|NCT01320618|vaginal prolapse|vaginal prolapse
381209|NCT01320618|mesh erosion|mesh erosion
381210|NCT01320618|urinary incontinence|urinary incontinence
381211|NCT01320618|bowel symptoms|bowel symptoms
381212|NCT01320592|Patient must have histologically or cytologically-confirmed metastatic|patient must have histologically or cytologically-confirmed metastatic
381213|NCT01320592|breast cancer|breast cancer
381214|NCT01320592|Any ER, PR or Her2 status is allowed.|any er, pr or her2 status is allowed.
381215|NCT01320592|Tumor must express Retinoblastoma (Rb) protein, defined as|tumor must express retinoblastoma (rb) protein, defined as
402061|NCT01233323|Phrenic nerve stimulation|phrenic nerve stimulation
594742|NCT00555542|rituximab|rituximab
381216|NCT01320592|any measurable staining by immunohistochemistry on the invasive tumor component|any measurable staining by immunohistochemistry on the invasive tumor component
381217|NCT01320592|<3 prior cyttoxic chemotherapy regimens for metastatic disease.|<3 prior cyttoxic chemotherapy regimens for metastatic disease.
381218|NCT01320592|Performance status of 0-1 on the ECOG Performance Scale and life expectancy > 3 months.|performance status of 0-1 on the ecog performance scale and life expectancy > 3 months.
381219|NCT01320592|Patient must have evaluable disease. Measureable disease is not required.|patient must have evaluable disease. measureable disease is not required.
381220|NCT01320592|The subject has adequate organ function|the subject has adequate organ function
381221|NCT01320579|atopic dermatitis|atopic dermatitis
381317|NCT01321346|Myelogenous|myelogenous
381222|NCT01320579|cis-urocanic acid|cis-urocanic acid
381223|NCT01320566|Polymeric Lung Volume Reduction (PLVR)|polymeric lung volume reduction (plvr)
381224|NCT01320566|Bolilogic Lung Volume Reduction (BLVR)|bolilogic lung volume reduction (blvr)
381225|NCT01320566|AeriSeal|aeriseal
381226|NCT01320566|treatment|treatment
381227|NCT01320566|device|device
381230|NCT01320566|emphysema|emphysema
381231|NCT01320566|heterogeneous|heterogeneous
381232|NCT01320566|homogeneous|homogeneous
381233|NCT01320566|Pathologic Processes|pathologic processes
381234|NCT01320566|Respiratory Tract Diseases|respiratory tract diseases
381235|NCT01320566|Lung Diseases|lung diseases
381236|NCT01320566|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
381237|NCT01320527|dietary supplement|dietary supplement
381238|NCT01320527|cognition|cognition
381239|NCT01320527|mood|mood
381240|NCT01320527|Alzheimer's disease|alzheimer's disease
381241|NCT01320527|memory loss|memory loss
381242|NCT01320501|Lung Cancer|lung cancer
381243|NCT01320488|Breast Cancer|breast cancer
381244|NCT01320475|thoracic epidural analgesia|thoracic epidural analgesia
381245|NCT01320475|epidural opioid|epidural opioid
381246|NCT01320475|ketamine|ketamine
381247|NCT01320475|adverse effect|adverse effect
381248|NCT01320462|Smoking|smoking
381249|NCT01320462|quit|quit
381250|NCT01320462|surgery|surgery
381251|NCT01320462|anesthesia|anesthesia
381252|NCT01320462|champix|champix
381253|NCT01320449|EPO|epo
381254|NCT01320449|Proteomics|proteomics
381255|NCT01320449|Carbohydrate metabolism|carbohydrate metabolism
381256|NCT01320449|Fat metabolism|fat metabolism
381257|NCT01320449|Protein metabolism|protein metabolism
381258|NCT01320436|Ulcerative colitis|ulcerative colitis
381259|NCT01320436|Curcumin|curcumin
381260|NCT01320423|Intracerebral Haemorrhage|intracerebral haemorrhage
381261|NCT01320384|ALI|ali
381262|NCT01321567|rabeprazole sodium|rabeprazole sodium
381263|NCT01321567|refractory reflux esophagitis|refractory reflux esophagitis
381264|NCT01321541|non-hodgkin lymphoma|non-hodgkin lymphoma
381265|NCT01321541|DLBCL|dlbcl
381266|NCT01321541|relapsed|relapsed
381267|NCT01321541|aggressive NHL|aggressive nhl
381268|NCT01321541|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
381269|NCT01321541|Rituximab|rituximab
381270|NCT01321541|Rituxan|rituxan
381271|NCT01321541|Pixantrone|pixantrone
381272|NCT01321541|NHL|nhl
381273|NCT01321541|non hodgkin's lymphoma|non hodgkin's lymphoma
381274|NCT01321541|de novo DLBCL|de novo dlbcl
381275|NCT01321541|DLBCL transformed from Indolent Lymphoma|dlbcl transformed from indolent lymphoma
381276|NCT01321541|Follicular Grade 3 Lymphoma|follicular grade 3 lymphoma
381277|NCT01321502|treatment of herpes|treatment of herpes
381278|NCT01321489|Phase III|phase iii
381279|NCT01321489|Sildenafil Citrate Tablet Sublingual|sildenafil citrate tablet sublingual
381280|NCT01321489|Erectile dysfunction|erectile dysfunction
381281|NCT01321437|Melanoma|melanoma
381282|NCT01321437|Axitinib|axitinib
381283|NCT01321437|Anti-angiogenesis|anti-angiogenesis
381284|NCT01321437|Neoadjuvant Melanoma|neoadjuvant melanoma
381285|NCT01321424|Dry Eye|dry eye
381286|NCT01321424|Tear Osmolarity|tear osmolarity
381287|NCT01321424|Meibomain Gland Disease|meibomain gland disease
381288|NCT01321424|Aqueous Dificiency|aqueous dificiency
381289|NCT01321424|Tear film abnormality|tear film abnormality
381290|NCT01321411|Respiratory Muscle Blood Flow|respiratory muscle blood flow
381291|NCT01321411|Work of Breathing|work of breathing
381292|NCT01321411|Near Infrared Spectroscopy|near infrared spectroscopy
381293|NCT01321398|High Frequency Oscillation|high frequency oscillation
381294|NCT01321398|Oscillation|oscillation
381295|NCT01321398|HFO|hfo
381296|NCT01321398|Transpulmonary pressure|transpulmonary pressure
381297|NCT01321385|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
381298|NCT01321385|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
381299|NCT01321385|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
381300|NCT01321385|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
381301|NCT01321385|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
381302|NCT01321385|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
381303|NCT01321385|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
381304|NCT01321385|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
381305|NCT01321385|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
381306|NCT01321385|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
381307|NCT01321385|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
381308|NCT01321346|Relapse|relapse
381309|NCT01321346|Lymphoblastic|lymphoblastic
381310|NCT01321346|Leukemia|leukemia
381311|NCT01321346|Panobinostat|panobinostat
381312|NCT01321346|LBH589|lbh589
381313|NCT01321346|Refractory|refractory
381314|NCT01321346|Hodgkin's|hodgkin's
381315|NCT01321346|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
381316|NCT01321346|Lymphoma|lymphoma
381318|NCT01321346|Acute|acute
381319|NCT01321346|Childhood|childhood
381320|NCT01321346|Pediatric|pediatric
381321|NCT01321346|ALL|all
381322|NCT01321346|AML|aml
381323|NCT01321346|NHL|nhl
381324|NCT01321346|HD|hd
381430|NCT01320956|A-VAS|a-vas
381325|NCT01321333|thoracic spinal cord injury|thoracic spinal cord injury
381326|NCT01321333|spinal cord injury thoracic|spinal cord injury thoracic
381327|NCT01321333|sub-acute spinal cord injury|sub-acute spinal cord injury
381328|NCT01321333|human neural stem cells|human neural stem cells
381329|NCT01321333|stem cells|stem cells
381330|NCT01321333|stem cells transplant|stem cells transplant
381331|NCT01321333|stem cells transplant spinal cord injury|stem cells transplant spinal cord injury
381332|NCT01321320|ICUAP|icuap
381333|NCT01321320|Critical illness|critical illness
381334|NCT01321320|Muscle wasting|muscle wasting
381335|NCT01321320|ICU|icu
381336|NCT01321307|Aphtostomatitis|aphtostomatitis
381337|NCT01321307|Mucositis|mucositis
381338|NCT01321307|Mouth sores|mouth sores
381339|NCT01321307|Natural|natural
381340|NCT01321307|Herbal|herbal
381341|NCT01321281|Osteoarthritis|osteoarthritis
381342|NCT01321268|orange peel skin|orange peel skin
381343|NCT01321268|cellulite|cellulite
381344|NCT01321255|Myocardial Infarction|myocardial infarction
381345|NCT01321255|Treatment Adherence|treatment adherence
381346|NCT01321242|Resting heart rate|resting heart rate
381347|NCT01321242|Stable Angina|stable angina
381348|NCT01321242|Hypertension|hypertension
381349|NCT01321242|beta-blockers|beta-blockers
381350|NCT01321229|Sleep apnea|sleep apnea
381351|NCT01321229|NIHSS scale|nihss scale
381352|NCT01321229|FIM scale|fim scale
381353|NCT01321229|FUGL-MEYER scale|fugl-meyer scale
381354|NCT01321216|rotavirus|rotavirus
381355|NCT01321216|gastroenteritis|gastroenteritis
381356|NCT01321216|children|children
381357|NCT01321216|Pediatric|pediatric
381358|NCT01321216|dehydration|dehydration
381359|NCT01321216|vaccine|vaccine
381360|NCT01321203|carbon dioxide insufflation|carbon dioxide insufflation
381361|NCT01321177|Schizophrenia|schizophrenia
381362|NCT01321177|Schizoaffective Disorder|schizoaffective disorder
381363|NCT01321177|Schizophreniform Disorder|schizophreniform disorder
381364|NCT01321177|Brief Psychotic Disorder|brief psychotic disorder
381365|NCT01321177|Psychotic Disorder NOS|psychotic disorder nos
381366|NCT01321177|First Episode|first episode
381367|NCT01321151|Mild Brain Injury|mild brain injury
381368|NCT01321151|Concussions|concussions
381369|NCT01321151|Resveratrol|resveratrol
381370|NCT01321151|Boxers|boxers
381371|NCT01321151|ImPACT|impact
381372|NCT01321151|MRI|mri
381373|NCT01321138|Electrophysiological study|electrophysiological study
381374|NCT01321138|Nerve block|nerve block
381375|NCT01321138|Analgesia, Patient-Controlled|analgesia, patient-controlled
381376|NCT01321138|Anterior cruciate ligament|anterior cruciate ligament
381377|NCT01321125|Antiseptics|antiseptics
381378|NCT01321125|Administration cutaneously|administration cutaneously
381379|NCT01321125|Chlorine compounds|chlorine compounds
381380|NCT01321125|Anti-infecting agents, local|anti-infecting agents, local
381381|NCT01321112|Conversion|conversion
381382|NCT01321112|Mycophenolate mofetil|mycophenolate mofetil
381383|NCT01321112|Calcineurin inhibitors|calcineurin inhibitors
381384|NCT01321112|Liver transplantation|liver transplantation
381385|NCT01321112|Gene expression|gene expression
381386|NCT01321099|Iron absorption|iron absorption
381387|NCT01321099|Complementary food fortificant|complementary food fortificant
381388|NCT01321099|Young children|young children
381389|NCT01321086|PAD|pad
381390|NCT01321060|severe acute pancreatitis|severe acute pancreatitis
381391|NCT01321060|acute fluid collection|acute fluid collection
381392|NCT01321060|catheter drainage|catheter drainage
381393|NCT01321060|repeated aspiration|repeated aspiration
381394|NCT01321047|sedation|sedation
381395|NCT01321047|benzodiazepine|benzodiazepine
381396|NCT01321047|opioid|opioid
381397|NCT01321047|propofol|propofol
381398|NCT01321034|Lipoprotein (a)|lipoprotein (a)
381400|NCT01321034|Niacin|niacin
381401|NCT01321034|Kringle IV-2 repeats|kringle iv-2 repeats
381402|NCT01321008|NK cell lymphoma-nasal type|nk cell lymphoma-nasal type
381403|NCT01321008|Stage I/II|stage i/ii
381404|NCT01321008|Radiation therapy|radiation therapy
381405|NCT01321008|XRT|xrt
381406|NCT01321008|chemotherapy|chemotherapy
381407|NCT01321008|CHOP|chop
381408|NCT01321008|Cyclophosphamide|cyclophosphamide
381409|NCT01321008|Cytoxan|cytoxan
381410|NCT01321008|Neosar|neosar
381411|NCT01321008|Adriamycin|adriamycin
381412|NCT01321008|Doxorubicin|doxorubicin
381413|NCT01321008|Rubex|rubex
381414|NCT01321008|Vincristine|vincristine
381415|NCT01321008|Oncovin|oncovin
381416|NCT01321008|Prednisone|prednisone
381417|NCT01320995|Second degree vaginal tear|second degree vaginal tear
381418|NCT01320995|Perineal ultrasound|perineal ultrasound
381419|NCT01320995|Anal incontinence|anal incontinence
381420|NCT01320982|Schizophrenia|schizophrenia
381421|NCT01320982|schizoaffective disorder|schizoaffective disorder
381422|NCT01320969|mindfulness, fear conditioning|mindfulness, fear conditioning
381423|NCT01320956|hypnosis|hypnosis
381424|NCT01320956|HYPNOANALGESIA|hypnoanalgesia
381425|NCT01320956|surgery|surgery
381426|NCT01320956|children|children
381427|NCT01320956|anxiety|anxiety
381428|NCT01320956|morphine|morphine
381429|NCT01320956|pain|pain
381431|NCT01320956|orthopaedics|orthopaedics
381432|NCT01320956|osteotomy|osteotomy
381433|NCT01320956|tenotomy|tenotomy
381434|NCT01320956|arthrodesis|arthrodesis
381435|NCT01320956|spinal column surgery|spinal column surgery
381436|NCT01320943|stopping oral antiviral therapy|stopping oral antiviral therapy
381437|NCT01320943|HBsAg loss|hbsag loss
381438|NCT01320943|seroconversion|seroconversion
381439|NCT01320943|restarting oral antiviral therapy|restarting oral antiviral therapy
381440|NCT01320930|Effect of Pulmonary rehabilitation.|effect of pulmonary rehabilitation.
381441|NCT01320930|Exercise capacity|exercise capacity
381442|NCT01320930|Quality of life|quality of life
381443|NCT01320917|obesity|obesity
381444|NCT01320917|contraceptives hormonal|contraceptives hormonal
381445|NCT01320917|levonorgestrel-releasing intrauterine device|levonorgestrel-releasing intrauterine device
381446|NCT01320917|cardiovascular risk|cardiovascular risk
381447|NCT01320904|Closed Kinetic Chain|closed kinetic chain
381448|NCT01320904|NMES|nmes
381449|NCT01320904|Knee Osteoarthritis|knee osteoarthritis
381450|NCT01320891|general anaesthesia for major abdominal surgery|general anaesthesia for major abdominal surgery
381451|NCT01320878|pulmonary hypertension|pulmonary hypertension
381452|NCT01320852|Transplant|transplant
381453|NCT01320826|colonoscopy|colonoscopy
381454|NCT01320826|primary care physicians|primary care physicians
381455|NCT01320826|quality assurance|quality assurance
381456|NCT01320813|da vinci robot|da vinci robot
381457|NCT01320813|Thyroidectomy|thyroidectomy
381458|NCT01320787|Brain|brain
381459|NCT01320787|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
381460|NCT01320787|Locally advanced breast cancer|locally advanced breast cancer
381461|NCT01320787|Estrogen receptor|estrogen receptor
381463|NCT01320787|Progesterone receptor|progesterone receptor
381464|NCT01320787|PR|pr
381465|NCT01320787|Negative for ErbB2|negative for erbb2
381466|NCT01320787|Malignant tumor of the central nervous system|malignant tumor of the central nervous system
381467|NCT01320787|CNS|cns
381468|NCT01320761|Formulation Comparison|formulation comparison
381469|NCT01320748|Abstinence from alcohol|abstinence from alcohol
381470|NCT01320748|Substance Abuse and Mental Health Services|substance abuse and mental health services
381471|NCT01320748|Social Support|social support
381472|NCT01320748|Psychosocial Support Systems|psychosocial support systems
381473|NCT01320748|Psychological support|psychological support
381474|NCT01320748|Cognitive Support|cognitive support
381475|NCT01320748|Emotional Support|emotional support
381476|NCT01320748|Mental Support|mental support
381477|NCT01320748|Psychosocial Support|psychosocial support
381478|NCT01320748|Intervention Studies|intervention studies
381479|NCT01320748|Prevention & control|prevention & control
381480|NCT01320748|Preventive therapy|preventive therapy
381481|NCT01320748|Treatment|treatment
381482|NCT01320748|Therapy|therapy
381483|NCT01320748|Magnetic Resonance Imaging|magnetic resonance imaging
381484|NCT01320748|fMRI|fmri
381485|NCT01320748|Imaging|imaging
381486|NCT01320748|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
381487|NCT01320748|MRI Scans|mri scans
381488|NCT01320748|MRI, Functional|mri, functional
381489|NCT01320748|Clinical Protocols|clinical protocols
381490|NCT01320748|Protocols, Treatment|protocols, treatment
381491|NCT01320748|Drug Abuse Treatment Center|drug abuse treatment center
381492|NCT01320748|Substance Abuse Treatment Center|substance abuse treatment center
381493|NCT01320735|Lucrin Depot|lucrin depot
381494|NCT01320735|intermittent adjuvant regimen|intermittent adjuvant regimen
381495|NCT01320735|advanced prostate cancer|advanced prostate cancer
381496|NCT01320735|Leuprorelin|leuprorelin
381497|NCT01320722|renin angiotensin system|renin angiotensin system
381498|NCT01320722|vitamin D|vitamin d
381499|NCT01320722|uric acid|uric acid
381500|NCT01320722|allopurinol|allopurinol
381501|NCT01320722|probenecid|probenecid
381502|NCT01320722|endothelial function|endothelial function
381503|NCT01320709|Emergency contraception|emergency contraception
381504|NCT01320709|Contraception|contraception
381505|NCT01320670|pharmacoresistance|pharmacoresistance
381506|NCT01320657|Self-ligating|self-ligating
372206|NCT01359579|phase 1|phase 1
381507|NCT01320657|orthodontic|orthodontic
381508|NCT01320657|appliance|appliance
381509|NCT01320657|expansion|expansion
381510|NCT01320657|dental inclination|dental inclination
381511|NCT01320657|Expansion and inclination changes arising with orthodontic treatment|expansion and inclination changes arising with orthodontic treatment
381512|NCT01320644|Uterine prolapse|uterine prolapse
381513|NCT01320644|vaginal prolapse|vaginal prolapse
381514|NCT01320644|mesh erosion|mesh erosion
381515|NCT01320644|urinary incontinence|urinary incontinence
381516|NCT01320644|bowel symptoms|bowel symptoms
381517|NCT01320371|barbed sutures|barbed sutures
381518|NCT01320371|knotted sutures|knotted sutures
381519|NCT01320371|total knee arthroplasty|total knee arthroplasty
381520|NCT01320371|knee surgery|knee surgery
381521|NCT01320358|Patient compliance|patient compliance
381522|NCT01320358|ECMPS-IEM|ecmps-iem
381523|NCT01320358|transplantation|transplantation
381524|NCT01320358|renal maintenance|renal maintenance
381525|NCT01320358|Proteus|proteus
381526|NCT01320345|Diabetes Mellitus|diabetes mellitus
381527|NCT01320345|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
381528|NCT01320345|Retinopathy|retinopathy
381529|NCT01320345|Diabetic Nephropathy|diabetic nephropathy
381530|NCT01320345|Fenofibrate|fenofibrate
381531|NCT01320332|Ulcerative colitis|ulcerative colitis
381532|NCT01320332|ASP3291|asp3291
381533|NCT01320293|Moderate to Severe Chronic plaque type psoriasis|moderate to severe chronic plaque type psoriasis
381534|NCT01320280|Prostate cancer, BIBW 2992 (Afatinib) , HER inhibitor|prostate cancer, bibw 2992 (afatinib) , her inhibitor
381535|NCT01320267|Resectable right colon cancer|resectable right colon cancer
381536|NCT01320254|Palliative treatment|palliative treatment
381537|NCT01320254|Panitumumab|panitumumab
381538|NCT01320254|Cisplatin|cisplatin
381539|NCT01320254|Cisplatinum|cisplatinum
381540|NCT01320254|Gemcitabine|gemcitabine
381541|NCT01320254|Vectibix|vectibix
381542|NCT01320228|Obesity|obesity
381543|NCT01320228|orlistat|orlistat
381544|NCT01320228|fat excretion|fat excretion
381545|NCT01320228|fiber|fiber
381546|NCT01320228|dairy calcium|dairy calcium
381547|NCT01320215|da Vinci Robot|da vinci robot
381548|NCT01320215|uterine prolapse|uterine prolapse
381549|NCT01320215|vaginal prolapse|vaginal prolapse
381550|NCT01320215|sacrohysteropexy|sacrohysteropexy
381551|NCT01320202|End Stage Renal Disease|end stage renal disease
381552|NCT01320202|Hemodialysis|hemodialysis
381553|NCT01320202|SFP|sfp
381554|NCT01320202|Hemodialysis-dependent chronic renal failure|hemodialysis-dependent chronic renal failure
381555|NCT01320189|Energy intake|energy intake
381556|NCT01320189|Protein requirement|protein requirement
381557|NCT01320189|Satiety|satiety
381558|NCT01320189|Protein leverage hypothesis|protein leverage hypothesis
381559|NCT01320150|persistent postsurgical pain (PPP)|persistent postsurgical pain (ppp)
381560|NCT01320137|Immunological assay|immunological assay
381561|NCT01320137|Birch allergy|birch allergy
381562|NCT01320124|Contractures|contractures
381563|NCT01320124|Total knee arthroplasty|total knee arthroplasty
381564|NCT01320124|Tissue bank|tissue bank
381565|NCT01320124|Osteoarthritis|osteoarthritis
381566|NCT01320124|Gene expressions|gene expressions
381567|NCT01320111|progression free survival|progression free survival
381568|NCT01320111|paclitaxel|paclitaxel
381569|NCT01320111|sorafenib|sorafenib
381570|NCT01320111|metastatic breast cancer|metastatic breast cancer
381571|NCT01320098|Attention|attention
381572|NCT01320098|Behavior Problems|behavior problems
381573|NCT01320098|Compliance|compliance
381574|NCT01320098|Evaluation|evaluation
381575|NCT01320098|Preschool|preschool
381576|NCT01320098|ADHD|adhd
381577|NCT01320098|Overactive|overactive
381578|NCT01320098|Inattentive|inattentive
381579|NCT01320098|Attention Deficit Hyperactivity Disorder in Preschoolers|attention deficit hyperactivity disorder in preschoolers
381580|NCT01320085|Metastatic melanoma,|metastatic melanoma,
381581|NCT01320085|BRAF-mutant,|braf-mutant,
381582|NCT01320085|NRAS-mutant|nras-mutant
381583|NCT01320072|aspirin|aspirin
381584|NCT01320072|asthma|asthma
381585|NCT01320072|diagnosis|diagnosis
381586|NCT01320072|prostaglandins|prostaglandins
381587|NCT01320072|leukotrienes|leukotrienes
381588|NCT01320059|18F-Fluoro-PEG6-IPQA|18f-fluoro-peg6-ipqa
381589|NCT01320059|Radioactive Imaging Solution|radioactive imaging solution
381590|NCT01320059|Non-Small Cell Lung Cancer|non-small cell lung cancer
381591|NCT01320059|Positron Emission Tomography|positron emission tomography
381592|NCT01320059|PET Scan|pet scan
381593|NCT01320059|CT|ct
381594|NCT01320059|Computed Tomography|computed tomography
381595|NCT01320046|Urinary Incontinence|urinary incontinence
381596|NCT01320046|Vulvar pruritus|vulvar pruritus
381597|NCT01320046|Vulvar contact dermatitis|vulvar contact dermatitis
381598|NCT01320033|acne vulgaris|acne vulgaris
381599|NCT01320033|inflammatory lesions|inflammatory lesions
381600|NCT01320020|Cancer|cancer
381601|NCT01320020|Neoplasm|neoplasm
381602|NCT01320020|Carcinoma|carcinoma
381603|NCT01320020|intravenous|intravenous
381604|NCT01320020|Monoclonal Antibody|monoclonal antibody
381605|NCT01320020|Removab|removab
381606|NCT01319994|glucocorticoid|glucocorticoid
381607|NCT01319981|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
381609|NCT01319981|Lymphoblastic lymphoma|lymphoblastic lymphoma
381610|NCT01319981|Cytoxan|cytoxan
381611|NCT01319981|Neosar|neosar
381612|NCT01319981|Mesnex|mesnex
381613|NCT01319981|Liposomal Vincristine|liposomal vincristine
381614|NCT01319981|Vincristine Sulfate Liposomes Injection|vincristine sulfate liposomes injection
381615|NCT01319981|Marqibo|marqibo
381616|NCT01319981|Dexamethasone|dexamethasone
381617|NCT01319981|Adriamycin|adriamycin
381618|NCT01319981|Rubex|rubex
381619|NCT01319981|Cytarabine|cytarabine
381620|NCT01319981|Cytosar|cytosar
381621|NCT01319981|DepoCyt|depocyt
381726|NCT01319578|chitosan|chitosan
381622|NCT01319981|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
381623|NCT01319981|Imatinib Mesylate|imatinib mesylate
381624|NCT01319981|Gleevec|gleevec
381625|NCT01319981|ST1571|st1571
381626|NCT01319981|NSC-716051|nsc-716051
381627|NCT01319981|Filgrastim|filgrastim
381628|NCT01319981|Neupogen|neupogen
381629|NCT01319968|Postpartum dyspareunia|postpartum dyspareunia
381630|NCT01319968|Vaginal atrophy|vaginal atrophy
381631|NCT01319955|Pneumonia|pneumonia
381632|NCT01319955|Influenza|influenza
381633|NCT01319955|Child|child
381634|NCT01319955|Respiratory|respiratory
381635|NCT01319955|Pathogen|pathogen
381636|NCT01319942|Radiotherapy|radiotherapy
381637|NCT01319942|Sorafenib|sorafenib
381638|NCT01319942|Treatment outcome|treatment outcome
381639|NCT01319929|Osteoarthritis, knee pain, osteoarthritic knee pain|osteoarthritis, knee pain, osteoarthritic knee pain
381640|NCT01319903|sepsis|sepsis
381641|NCT01319903|inflammation|inflammation
381642|NCT01319903|complement|complement
381643|NCT01319903|immune system|immune system
381644|NCT01319890|all histologic subtypes|all histologic subtypes
381645|NCT01319890|benign|benign
381646|NCT01319890|malignant|malignant
381647|NCT01319864|leukemia|leukemia
381648|NCT01319851|bone marrow transplant|bone marrow transplant
381649|NCT01319851|sickle cell disease|sickle cell disease
381650|NCT01319851|thalassemia|thalassemia
381651|NCT01319851|Glanzmann thrombasthenia|glanzmann thrombasthenia
381652|NCT01319851|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
381653|NCT01319851|chronic-granulomatous disease|chronic-granulomatous disease
381654|NCT01319851|severe congenital neutropenia|severe congenital neutropenia
381655|NCT01319851|leukocyte adhesion deficiency|leukocyte adhesion deficiency
381656|NCT01319851|Schwachman-Diamond syndrome|schwachman-diamond syndrome
381657|NCT01319851|Diamond-Blackfan anemia|diamond-blackfan anemia
381658|NCT01319851|Fanconi anemia|fanconi anemia
381659|NCT01319851|dyskeratosis-congenita|dyskeratosis-congenita
381660|NCT01319851|Chediak-Higashi syndrome|chediak-higashi syndrome
381661|NCT01319851|severe aplastic anemia|severe aplastic anemia
381662|NCT01319838|neuroblastoma|neuroblastoma
381663|NCT01319838|isotretinoin|isotretinoin
381664|NCT01319812|Vascular intervention|vascular intervention
381665|NCT01319812|Endovascular|endovascular
381666|NCT01319812|Peripheral stent|peripheral stent
381667|NCT01319799|Embolism|embolism
381668|NCT01319799|Nervous system|nervous system
381670|NCT01319799|Valves|valves
381671|NCT01319799|Ultrasonics|ultrasonics
381672|NCT01319786|Hypertension|hypertension
381673|NCT01319786|Microvascular function|microvascular function
381674|NCT01319760|STEMI|stemi
381675|NCT01319747|atrial|atrial
381676|NCT01319747|fibrillation|fibrillation
381677|NCT01319747|pvi|pvi
381678|NCT01319747|vats|vats
381679|NCT01319747|ablation|ablation
381680|NCT01319734|Vitamin C|vitamin c
381681|NCT01319734|Oxidative stress|oxidative stress
381682|NCT01319734|Type 2DM|type 2dm
381683|NCT01319721|Amniotic membrane|amniotic membrane
381684|NCT01319721|Limbal conjunctival autograft|limbal conjunctival autograft
381685|NCT01319721|Limbal|limbal
381686|NCT01319721|Conjunctival|conjunctival
381687|NCT01319721|Mitomycin C|mitomycin c
381688|NCT01319721|Recurrent pterygium|recurrent pterygium
381689|NCT01319721|Pterygium|pterygium
381690|NCT01319708|ovarian stimulation|ovarian stimulation
381691|NCT01319708|climiphene citrate|climiphene citrate
381692|NCT01319708|Gonadotropin-Releasing Hormone agonists/antagonists|gonadotropin-releasing hormone agonists/antagonists
381693|NCT01319708|Follicle Stimulating Hormone|follicle stimulating hormone
381694|NCT01319695|corifollitropin alfa|corifollitropin alfa
381695|NCT01319695|FSH ovarian stimulation|fsh ovarian stimulation
381696|NCT01319695|IVF|ivf
381697|NCT01319682|Pain|pain
381698|NCT01319682|Preemptive|preemptive
381699|NCT01319682|Lidocaine|lidocaine
381700|NCT01319682|Intravenous|intravenous
381701|NCT01319682|Lumbar fusion|lumbar fusion
381702|NCT01319656|Chronic diseases|chronic diseases
381703|NCT01319656|Primary care|primary care
381704|NCT01319656|Rehabilitation|rehabilitation
381705|NCT01319656|Chronic Care Model|chronic care model
381706|NCT01319656|Patient centered medical home|patient centered medical home
372395|NCT01358578|Psoriasis,|psoriasis,
381707|NCT01319643|Oxygen|oxygen
381708|NCT01319643|Hyperoxia|hyperoxia
381709|NCT01319643|Intensive care unit|intensive care unit
381710|NCT01319643|Mortality|mortality
381711|NCT01319643|Organ dysfunction|organ dysfunction
381712|NCT01319643|Postoperative care|postoperative care
381713|NCT01319630|sepsis|sepsis
381714|NCT01319630|microcirculation|microcirculation
381715|NCT01319630|saline|saline
381716|NCT01319630|crystalloid|crystalloid
381717|NCT01319630|colloid|colloid
381718|NCT01319630|albumin|albumin
381719|NCT01319630|hydroxyethyl starch|hydroxyethyl starch
381720|NCT01319578|chronic kidney disease|chronic kidney disease
381721|NCT01319578|phosphorus|phosphorus
381722|NCT01319578|phosphate|phosphate
381723|NCT01319578|saliva|saliva
381724|NCT01319578|K2CG|k2cg
381725|NCT01319578|medical food|medical food
381727|NCT01319565|Young TIL|young til
381728|NCT01319565|Metastatic Melanoma|metastatic melanoma
381729|NCT01319565|Immunotherapy|immunotherapy
381730|NCT01319565|Adoptive Cell Therapy|adoptive cell therapy
381731|NCT01319565|Skin Cancer|skin cancer
381732|NCT01319552|red blood cells|red blood cells
381733|NCT01319552|transfusion|transfusion
381735|NCT01319552|sickle cell disease|sickle cell disease
381736|NCT01319552|β-thalassemia|β-thalassemia
381737|NCT01319552|hemoglobin-associated iron|hemoglobin-associated iron
381738|NCT01319526|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
381739|NCT01319526|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
381740|NCT01319526|HIV infection|hiv infection
381741|NCT01319500|Drug Utilization|drug utilization
381742|NCT01319500|Oral Contraceptives|oral contraceptives
381743|NCT01319474|Deep vein thrombosis|deep vein thrombosis
381744|NCT01319474|Pulmonary embolism|pulmonary embolism
381745|NCT01319474|Ultrasound|ultrasound
381746|NCT01319474|Pregnancy|pregnancy
381747|NCT01319461|Osteoarthritis|osteoarthritis
381748|NCT01319461|Hyalgan|hyalgan
381749|NCT01319448|Sickle cell disease|sickle cell disease
381750|NCT01319448|Malaria|malaria
381751|NCT01319448|Intermittent Preventive Treatment (IPT)|intermittent preventive treatment (ipt)
381752|NCT01319448|prophylaxis|prophylaxis
381753|NCT01319435|Ciprofloxacin|ciprofloxacin
381754|NCT01319435|Neonates|neonates
381755|NCT01319435|Gram negative infection|gram negative infection
381756|NCT01319422|myeloma|myeloma
381757|NCT01319422|multiple myeloma|multiple myeloma
381758|NCT01319422|pomalidomide|pomalidomide
381759|NCT01319422|immunomodulatory|immunomodulatory
381760|NCT01319409|Anterior cruciate ligament surgery|anterior cruciate ligament surgery
381761|NCT01319409|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
381762|NCT01319409|Single bundle anterior cruciate ligament reconstruction|single bundle anterior cruciate ligament reconstruction
381763|NCT01319409|Double bundle anterior cruciate ligament reconstruction|double bundle anterior cruciate ligament reconstruction
381764|NCT01319409|Randomized clinical trial|randomized clinical trial
381765|NCT01319396|breathing rate|breathing rate
381766|NCT01319383|HIV-1 Infection|hiv-1 infection
381767|NCT01319383|HIV RNA <50 copies/mL|hiv rna <50 copies/ml
381768|NCT01319383|Stable ART|stable art
381769|NCT01319383|Resting CD4+ T cells|resting cd4+ t cells
381770|NCT01319383|Leukapheresis|leukapheresis
381771|NCT01319383|Vorinostat|vorinostat
381772|NCT01319383|HIV RNA expression|hiv rna expression
381773|NCT01319383|PK visits|pk visits
381774|NCT01319331|diabetes|diabetes
381775|NCT01319331|type 1 diabetes|type 1 diabetes
381776|NCT01319331|AAT|aat
381777|NCT01319331|Alpha-1 Antitrypsin|alpha-1 antitrypsin
381778|NCT01319279|Pharmacokinetics|pharmacokinetics
381779|NCT01319279|Hydrocodone|hydrocodone
381780|NCT01319279|Extended Release|extended release
381781|NCT01319279|Hepatic impairment|hepatic impairment
381782|NCT01319266|hydrocodone|hydrocodone
381783|NCT01319266|extended release|extended release
381784|NCT01319266|pharmacokinetics|pharmacokinetics
381785|NCT01319266|renal impairment|renal impairment
381786|NCT01319253|Cystic Fibrosis|cystic fibrosis
381787|NCT01319253|Pseudomonas aeruginosa|pseudomonas aeruginosa
381788|NCT01319227|Periprosthetic bone remodeling|periprosthetic bone remodeling
381789|NCT01319227|Stress shielding|stress shielding
381790|NCT01319227|Short femoral stem|short femoral stem
381791|NCT01319227|Porous Titanium Construct|porous titanium construct
381792|NCT01319227|Polyethylene wear|polyethylene wear
381793|NCT01319214|cocaine addiction treatment craving|cocaine addiction treatment craving
381794|NCT01319188|Age-related macular degeneration|age-related macular degeneration
381795|NCT01319188|ranibizumab|ranibizumab
381796|NCT01319188|acute thromboembolic events|acute thromboembolic events
381797|NCT01319188|coronary artery disease|coronary artery disease
381798|NCT01319188|cerebrovascular disease|cerebrovascular disease
381799|NCT01318356|Q fever|q fever
381800|NCT01318356|Cognitive behavioral therapy|cognitive behavioral therapy
381801|NCT01318356|Doxycycline|doxycycline
381802|NCT01318356|Fatigue|fatigue
381803|NCT01318356|Coxiella|coxiella
381804|NCT01319175|hip flexion strength training|hip flexion strength training
381805|NCT01319175|elastic bands|elastic bands
381806|NCT01319175|external resistance|external resistance
381807|NCT01319162|PCOS|pcos
381808|NCT01319149|molecular methods|molecular methods
381809|NCT01319136|new infusion test method|new infusion test method
381810|NCT01319136|reference method|reference method
381811|NCT01319136|cerebrospinal fluid dynamics|cerebrospinal fluid dynamics
381812|NCT01319123|dressing for venous leg ulcers|dressing for venous leg ulcers
381813|NCT01319110|Cardiac Arrest|cardiac arrest
381814|NCT01319110|Post Cardiac Arrest|post cardiac arrest
381815|NCT01319110|CoQ10|coq10
381816|NCT01319110|Ubiquinone|ubiquinone
381817|NCT01319110|Post Arrest|post arrest
381818|NCT01319097|Reduction on local soft tissue edema|reduction on local soft tissue edema
381819|NCT01319058|obstructive sleep apnea|obstructive sleep apnea
381820|NCT01319058|Tonsillectomy|tonsillectomy
381821|NCT01319058|Tonsillotomy|tonsillotomy
381822|NCT01319058|Inflammation|inflammation
381823|NCT01319058|Pain|pain
381824|NCT01319058|Post tonsillectomy bleeding|post tonsillectomy bleeding
381825|NCT01319045|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
381826|NCT01319045|Congenital Heart Disease|congenital heart disease
381827|NCT01319045|Eisenmenger's Syndrome|eisenmenger's syndrome
381828|NCT01319045|Prostacyclin|prostacyclin
381829|NCT01319045|Iloprost|iloprost
381830|NCT01319019|lung function|lung function
381831|NCT01319019|bronchodilator|bronchodilator
381832|NCT01319019|COPD, dose response, dosing interval, efficacy, safety, PD, PK|copd, dose response, dosing interval, efficacy, safety, pd, pk
381833|NCT01319006|relative bioavailability|relative bioavailability
381834|NCT01318993|GSK1605786A; Inflammatory Bowel Disease; Crohn's disease; long-term treatment; quality of life; CCR9 antagonist|gsk1605786a; inflammatory bowel disease; crohn's disease; long-term treatment; quality of life; ccr9 antagonist
381835|NCT01318980|ADME|adme
381836|NCT01318980|IV radiolabelled|iv radiolabelled
381837|NCT01318980|pharmacokinetics|pharmacokinetics
381838|NCT01318967|Renal blood flow|renal blood flow
381839|NCT01318967|Regional renal blood flow|regional renal blood flow
381840|NCT01318967|MRI|mri
381841|NCT01318941|Ophthalmology, age-related macular degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, ranibizumab|ophthalmology, age-related macular degeneration, diabetic macular edema, retinal vein occlusion, ranibizumab
381842|NCT01318941|Ophthalmology|ophthalmology
381843|NCT01318941|Age-related macular degeneration|age-related macular degeneration
381844|NCT01318941|Diabetic Macular Edema|diabetic macular edema
381845|NCT01318941|Retinal Vein Occlusion|retinal vein occlusion
381846|NCT01318941|LUMINOUS|luminous
381847|NCT01318941|Ranibizumab|ranibizumab
381848|NCT01318928|Periodontitis|periodontitis
381849|NCT01318928|antibiotics|antibiotics
381850|NCT01318928|treatment period|treatment period
381851|NCT01318928|microbiology|microbiology
381852|NCT01318915|Kidney transplantation|kidney transplantation
381853|NCT01318915|Immunosuppression|immunosuppression
381854|NCT01318915|Graft rejection|graft rejection
381855|NCT01318915|Graft loss|graft loss
381856|NCT01318915|Renal transplant|renal transplant
381857|NCT01318915|Transplantation|transplantation
381858|NCT01318915|kidney disease|kidney disease
381859|NCT01318915|Renal disease|renal disease
381860|NCT01318915|Organ transplant|organ transplant
381861|NCT01318915|Living donor transplant|living donor transplant
381862|NCT01318915|Living-donor|living-donor
381863|NCT01318889|Dexpanthenol|dexpanthenol
381864|NCT01318889|Radiotherapy|radiotherapy
381865|NCT01318889|chemotherapy|chemotherapy
381866|NCT01318889|Mucositis|mucositis
381867|NCT01318876|influenza|influenza
381868|NCT01318876|vaccine safety|vaccine safety
381869|NCT01318876|adverse events|adverse events
381870|NCT01318876|health care workers|health care workers
381871|NCT01318863|aged matched normal control samples|aged matched normal control samples
381872|NCT01318850|schizophrenia|schizophrenia
381873|NCT01318850|cognitive remediation|cognitive remediation
381874|NCT01318850|fMRI|fmri
381875|NCT01318837|OABSS|oabss
381876|NCT01318837|IPSS|ipss
381877|NCT01318837|PPBC|ppbc
381878|NCT01318837|Solifenacin|solifenacin
381879|NCT01318824|Neonatal Respiratory Failure|neonatal respiratory failure
381880|NCT01318824|Newborn Infant|newborn infant
381881|NCT01318824|BiPAP|bipap
381882|NCT01318824|NIPPV|nippv
381883|NCT01318811|Heparin|heparin
381884|NCT01318811|CRRT|crrt
381885|NCT01318811|Continuous renal replacement therapy|continuous renal replacement therapy
381886|NCT01318811|CVVHD|cvvhd
381887|NCT01318811|Anticoagulation|anticoagulation
381888|NCT01318798|Development|development
381889|NCT01318798|Pre- and intra-operative predictors|pre- and intra-operative predictors
381890|NCT01318798|Acute renal failure|acute renal failure
381891|NCT01318798|Liver Surgery|liver surgery
381892|NCT01318798|Prediction score|prediction score
381893|NCT01318798|Validation|validation
381894|NCT01318798|Clinical consequences|clinical consequences
381895|NCT01318798|Decision curve analysis|decision curve analysis
381896|NCT01318798|predictors of acute renal failure after liver resection|predictors of acute renal failure after liver resection
381897|NCT01318785|secondary arm-lymphedema|secondary arm-lymphedema
381898|NCT01318785|breast cancer related arm-lymphedema|breast cancer related arm-lymphedema
381899|NCT01318746|change of potassium amount, circadian and day-to-day variability|change of potassium amount, circadian and day-to-day variability
381900|NCT01318733|Rosacea|rosacea
381901|NCT01318720|Neck Pain|neck pain
381902|NCT01318720|Thrust Manipulation|thrust manipulation
381903|NCT01318720|Non-Thrust Manipulation|non-thrust manipulation
381904|NCT01318707|Severe Hemophilia A|severe hemophilia a
381905|NCT01318707|Hemophilia A Patients|hemophilia a patients
381906|NCT01318707|Serum collection vs a method of added FVIII to blood samples|serum collection vs a method of added fviii to blood samples
381907|NCT01318694|Chronic hepatitis C|chronic hepatitis c
381908|NCT01318694|Cyclophilin inhibitor|cyclophilin inhibitor
381909|NCT01318681|driving, memory, cognition|driving, memory, cognition
381910|NCT01318668|fmri smoking vaccination mood|fmri smoking vaccination mood
381911|NCT01318655|Phase I|phase i
381912|NCT01318655|Japan|japan
381913|NCT01318655|SAD|sad
381914|NCT01318655|MAD|mad
381915|NCT01318642|Adenocarcinoma|adenocarcinoma
381916|NCT01318642|pancreas|pancreas
381917|NCT01318642|pancreatic cancer|pancreatic cancer
381918|NCT01318642|local|local
381919|NCT01318642|unresectable|unresectable
381920|NCT01318642|stage II|stage ii
381921|NCT01318642|stage III|stage iii
381922|NCT01318616|hip adduction strength training|hip adduction strength training
381923|NCT01318616|Improvement in adductor strength|improvement in adductor strength
381924|NCT01318590|Pancreatitis, Chronic|pancreatitis, chronic
381925|NCT01318590|Abdominal Pain|abdominal pain
381926|NCT01318590|Celiac bloc|celiac bloc
381927|NCT01318590|Endosonography|endosonography
381928|NCT01318564|Type II Diabetes|type ii diabetes
381929|NCT01318564|Unit dose packaging devices|unit dose packaging devices
381930|NCT01318564|Metformin|metformin
381931|NCT01318564|Lisinopril|lisinopril
381932|NCT01318564|Enalapril|enalapril
381933|NCT01318564|Atorvastatin|atorvastatin
381934|NCT01318564|Lipitor|lipitor
381935|NCT01318564|Simvastatin|simvastatin
381936|NCT01318564|Aspirin|aspirin
381937|NCT01318564|Questionnaires|questionnaires
381938|NCT01318551|Anemia|anemia
381939|NCT01318538|Substance use disorders, Gender differences, women, treatment outcomes, group therapy|substance use disorders, gender differences, women, treatment outcomes, group therapy
381940|NCT01318499|cataract|cataract
381941|NCT01318499|inflammation|inflammation
381942|NCT01318499|pain|pain
381943|NCT01318499|inflammatory cells|inflammatory cells
381944|NCT01318499|aqueous flare|aqueous flare
381945|NCT01318473|cancer|cancer
381946|NCT01318460|coronary artery disease|coronary artery disease
381947|NCT01318460|levosimendan|levosimendan
381948|NCT01318460|coronary artery bypass grafting|coronary artery bypass grafting
381949|NCT01318460|cardiac surgery|cardiac surgery
381950|NCT01318447|Hepatic metastases|hepatic metastases
381951|NCT01318447|Liver metastases|liver metastases
381952|NCT01318447|Colorectal cancer|colorectal cancer
381953|NCT01318447|Colorectal adenocarcinoma|colorectal adenocarcinoma
381954|NCT01318447|Accuray|accuray
381955|NCT01318447|CyberKnife|cyberknife
381956|NCT01318434|Outpatient|outpatient
381957|NCT01318421|Relapsing forms of secondary progressive multiple sclerosis (SPMS)or relapsing-remitting multiple sclerosis (RRMS)|relapsing forms of secondary progressive multiple sclerosis (spms)or relapsing-remitting multiple sclerosis (rrms)
381958|NCT01318343|Cryolipolysis|cryolipolysis
381959|NCT01318343|Abdominal Fat|abdominal fat
381960|NCT01318343|Adipose Tissue|adipose tissue
381961|NCT01318343|Fat Reduction|fat reduction
381962|NCT01318343|Non Invasive|non invasive
381963|NCT01318304|innate immunity|innate immunity
381965|NCT01318304|pregnancy|pregnancy
381966|NCT01318304|vaginal immunity|vaginal immunity
381967|NCT01318291|IVF|ivf
381968|NCT01318291|Drop out|drop out
381969|NCT01318278|Hypotension|hypotension
381970|NCT01318278|Low blood pressure|low blood pressure
381971|NCT01318278|Neonate|neonate
381972|NCT01318278|Dopamine|dopamine
381973|NCT01318278|Vasopressin|vasopressin
381974|NCT01318278|Extremely Low Birth Weight Infant|extremely low birth weight infant
381975|NCT01318265|drug interactions|drug interactions
381976|NCT01318265|ketoconazole|ketoconazole
381977|NCT01318265|pharmacokinetics|pharmacokinetics
381978|NCT01318265|human volunteers|human volunteers
381979|NCT01318252|Elevated IOP|elevated iop
381980|NCT01318226|postherpetic neuralgia|postherpetic neuralgia
381981|NCT01318226|shingles|shingles
381982|NCT01318226|analgesia|analgesia
381983|NCT01318226|neuropathic pain|neuropathic pain
381984|NCT01318213|VRE|vre
381985|NCT01318213|MRSA|mrsa
381986|NCT01318200|Primary liver cancer|primary liver cancer
381987|NCT01318200|Hepatocellular carcinoma|hepatocellular carcinoma
381988|NCT01318200|CyberKnife|cyberknife
381989|NCT01318200|Accuray|accuray
381990|NCT01318200|TACE|tace
381991|NCT01318200|Transarterial chemoembolization|transarterial chemoembolization
381992|NCT01318187|renal colic|renal colic
381993|NCT01318187|paracetamol|paracetamol
381994|NCT01318187|morphine|morphine
381995|NCT01318187|emergency department|emergency department
381996|NCT01318174|Pulmonary embolism|pulmonary embolism
381997|NCT01318174|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
381998|NCT01318161|Epidural analgesia|epidural analgesia
381999|NCT01318161|Patient controlled analgesia|patient controlled analgesia
382000|NCT01318161|Colorectal cancer|colorectal cancer
382001|NCT01318161|Morbidity|morbidity
382002|NCT01318161|Mortality|mortality
382003|NCT01318148|Echinocandins|echinocandins
382004|NCT01318148|Caspofungin|caspofungin
382005|NCT01318148|Pharmacokinetics|pharmacokinetics
382006|NCT01318148|Prophylaxis|prophylaxis
382007|NCT01318148|Antifungal|antifungal
382008|NCT01318148|Aspergillosis|aspergillosis
382009|NCT01318148|Acute Leucemia|acute leucemia
382010|NCT01318135|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
382011|NCT01318135|Diabetes Mellitus|diabetes mellitus
382012|NCT01318135|Drug Therapy|drug therapy
382013|NCT01318122|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
382014|NCT01318122|Diabetes Mellitus|diabetes mellitus
382015|NCT01318122|Drug Therapy|drug therapy
382016|NCT01318109|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
382017|NCT01318109|Diabetes Mellitus|diabetes mellitus
382018|NCT01318109|Drug Therapy|drug therapy
382019|NCT01318096|safety|safety
382020|NCT01318096|efficacy|efficacy
382021|NCT01318096|raltegravir|raltegravir
382022|NCT01318096|HBV/HIV co-infection|hbv/hiv co-infection
382023|NCT01318083|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
382024|NCT01318083|Diabetes Mellitus|diabetes mellitus
382025|NCT01318083|Drug Therapy|drug therapy
382026|NCT01318070|Diabetes Mellitus - Type2|diabetes mellitus - type2
382027|NCT01318070|Diabetes Mellitus|diabetes mellitus
382028|NCT01318070|Drug Therapy|drug therapy
382029|NCT01318057|Pharmacogenetics|pharmacogenetics
382030|NCT01318057|Warfarin|warfarin
382031|NCT01318057|Personalized Medicine|personalized medicine
382032|NCT01318057|Puerto Ricans|puerto ricans
382033|NCT01318057|Physiogenomics|physiogenomics
382034|NCT01318057|Hispanics|hispanics
382035|NCT01318057|Anticoagulants|anticoagulants
382036|NCT01318057|Cardiovascular|cardiovascular
382037|NCT01318057|Deep Vein Thrombosis with or without Pulmonary Embolism|deep vein thrombosis with or without pulmonary embolism
382038|NCT01318057|Cardiac Valvular Replacement|cardiac valvular replacement
382039|NCT01318044|thiopental|thiopental
382040|NCT01318044|propofol|propofol
382043|NCT01318031|DDI|ddi
382044|NCT01318031|Healthy Volunteers|healthy volunteers
382045|NCT01318018|depression|depression
382046|NCT01318018|bispectral index|bispectral index
382047|NCT01318018|electroconvulsive therapy|electroconvulsive therapy
382048|NCT01318018|magnetic seizure therapy|magnetic seizure therapy
382049|NCT01317992|Medication overuse headache|medication overuse headache
382050|NCT01317992|ibudilast|ibudilast
382051|NCT01317992|glia|glia
382052|NCT01317940|Leukemia|leukemia
382053|NCT01317940|ALL|all
382054|NCT01317940|Vitamin D|vitamin d
382055|NCT01317940|Bone Density|bone density
382056|NCT01317940|Body Fat|body fat
382057|NCT01317940|Obesity|obesity
382058|NCT01317940|Adipose|adipose
382059|NCT01317927|belionstat|belionstat
382060|NCT01317927|warfarin|warfarin
382061|NCT01317927|hematological malignancy|hematological malignancy
382062|NCT01317927|solid tumors|solid tumors
382063|NCT01317927|PK/PD study|pk/pd study
382064|NCT01317901|follicular lymphoma|follicular lymphoma
382065|NCT01317901|small lymphocytic lymphoma|small lymphocytic lymphoma
382066|NCT01317901|marginal zone lymphoma|marginal zone lymphoma
382067|NCT01317901|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
382068|NCT01317901|indolent lymphoma|indolent lymphoma
382069|NCT01317888|high grade gliomas of the brain|high grade gliomas of the brain
382070|NCT01317888|anti-body treatment|anti-body treatment
382071|NCT01317888|survival|survival
382072|NCT01317862|labor induction, transcervical foley catheter, prostaglandin|labor induction, transcervical foley catheter, prostaglandin
382073|NCT01317849|folic acid|folic acid
382074|NCT01317849|B vitamins|b vitamins
382075|NCT01317849|secondary prevention|secondary prevention
382076|NCT01317849|stroke|stroke
382077|NCT01317849|randomized controlled trial|randomized controlled trial
382078|NCT01317849|homocysteine|homocysteine
382079|NCT01317836|pancreatic cystic lesion|pancreatic cystic lesion
382080|NCT01317836|PET|pet
382081|NCT01317836|PET-CT|pet-ct
382082|NCT01317836|diagnosis|diagnosis
382083|NCT01317823|Multiparas, Bishop score, Cervical length, Cervical ripening|multiparas, bishop score, cervical length, cervical ripening
382084|NCT01317810|Overactive Bladder (OAB)|overactive bladder (oab)
382085|NCT01317810|Observational|observational
382086|NCT01317810|Registry|registry
382087|NCT01317797|Rheumatoid Arthritis|rheumatoid arthritis
382088|NCT01317797|MT203|mt203
382089|NCT01317797|Human IgG1 monoclonal antibody|human igg1 monoclonal antibody
382090|NCT01317797|GM-CSF monoclonal antibody|gm-csf monoclonal antibody
382091|NCT01317784|diagnosis screening|diagnosis screening
372780|NCT01356810|Elderly|elderly
382092|NCT01317784|HIV serodiagnosis|hiv serodiagnosis
382093|NCT01317784|HCV antibodies|hcv antibodies
382094|NCT01317784|serologic tests|serologic tests
382095|NCT01317784|Bedside testing|bedside testing
382096|NCT01317784|diagnostic test kits|diagnostic test kits
382097|NCT01317784|syphilis serodiagnosis|syphilis serodiagnosis
382098|NCT01317771|Proximal Biceps Pathology|proximal biceps pathology
382099|NCT01317758|influenza, vaccine, H5N1|influenza, vaccine, h5n1
382100|NCT01317745|H5N1, vaccine, influenza|h5n1, vaccine, influenza
382101|NCT01317732|Energy expenditure, physical activity, accelerometer, magnetometer, monitoring|energy expenditure, physical activity, accelerometer, magnetometer, monitoring
382102|NCT01317719|Rupture of Distal Bicep Tendon|rupture of distal bicep tendon
382103|NCT01317706|Bishop score, Cervical length, Cervical ripening, Labor induction|bishop score, cervical length, cervical ripening, labor induction
382104|NCT01317693|LI-ESWT|li-eswt
382105|NCT01317693|Erectile Dysfunction|erectile dysfunction
382106|NCT01317693|ED|ed
382107|NCT01317693|Shock waves|shock waves
382108|NCT01317693|Therapy|therapy
382109|NCT01317680|Erectile Dysfunction|erectile dysfunction
382110|NCT01317680|ED|ed
382111|NCT01317680|PDE5 inhibitors|pde5 inhibitors
382112|NCT01317680|LI-ESWT|li-eswt
382113|NCT01317667|Ricin|ricin
382114|NCT01317667|RVEc|rvec
382314|NCT01316848|AV-951|av-951
382115|NCT01317654|Tuberculosis meningitis|tuberculosis meningitis
382116|NCT01317628|tobacco smoke, intervention program|tobacco smoke, intervention program
382117|NCT01317615|Large cell carcinoma,|large cell carcinoma,
382118|NCT01317615|Lung cancer,|lung cancer,
382119|NCT01317615|Neuroendocrine Tumors,|neuroendocrine tumors,
382120|NCT01317615|RAD001|rad001
382121|NCT01317602|Atrial Fibrillation|atrial fibrillation
382122|NCT01317602|AF|af
382123|NCT01317589|Pain|pain
382124|NCT01317589|Cancer of Head and Neck|cancer of head and neck
382125|NCT01317589|methadone|methadone
382126|NCT01317589|Fentanyl|fentanyl
382127|NCT01317576|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
382128|NCT01317576|Exercise|exercise
382129|NCT01317563|asthma|asthma
382130|NCT01317563|obesity|obesity
382131|NCT01317563|nutrition|nutrition
382132|NCT01317563|antioxidant|antioxidant
382133|NCT01317550|Non-Small Cell Lung Cancer|non-small cell lung cancer
382134|NCT01317550|NSCLC|nsclc
382135|NCT01317550|Symptoms|symptoms
382136|NCT01317550|Concurrent Chemoradiation|concurrent chemoradiation
382137|NCT01317550|CXRT|cxrt
382138|NCT01317550|Fatigue|fatigue
382139|NCT01317550|Pain|pain
382140|NCT01317550|Disturbed Sleep|disturbed sleep
382141|NCT01317550|Lack of Appetite|lack of appetite
382142|NCT01317550|Drowsiness|drowsiness
382143|NCT01317550|Armodafinil|armodafinil
382144|NCT01317550|Nuvigil|nuvigil
382145|NCT01317550|Minocycline|minocycline
382146|NCT01317550|Dynacin|dynacin
382147|NCT01317550|Minocin|minocin
382148|NCT01317550|Minocin PAC|minocin pac
382149|NCT01317550|Myrac|myrac
382150|NCT01317550|Solodyn|solodyn
382151|NCT01317550|Placebo|placebo
382152|NCT01317537|personal health records|personal health records
382153|NCT01317524|Milk|milk
382154|NCT01317524|Homogenization|homogenization
382155|NCT01317524|Postprandial hyperlipidemia|postprandial hyperlipidemia
382156|NCT01317524|Postprandial inflammation|postprandial inflammation
382157|NCT01317524|Overweight|overweight
382158|NCT01317498|ART|art
382159|NCT01317498|antiretroviral|antiretroviral
382160|NCT01317498|treatment|treatment
382161|NCT01317498|Vietnam|vietnam
382162|NCT01317498|Asia|asia
382163|NCT01317498|viral load|viral load
382164|NCT01317485|diverticulitis|diverticulitis
382165|NCT01317485|perforation|perforation
382166|NCT01317485|sigmoidectomy|sigmoidectomy
382167|NCT01317485|sigmoid resection|sigmoid resection
382168|NCT01317485|lavage|lavage
382169|NCT01317485|laparoscopic|laparoscopic
382170|NCT01317485|wash-out|wash-out
382171|NCT01317485|rinsing|rinsing
382172|NCT01317485|hartmann|hartmann
382173|NCT01317485|end-colostomy|end-colostomy
382174|NCT01317485|primary anastomosis|primary anastomosis
382175|NCT01317472|laryngopharyngeal reflux, acid reflux, throat reflux|laryngopharyngeal reflux, acid reflux, throat reflux
382176|NCT01317459|Self management|self management
382177|NCT01317459|Diabetes type one|diabetes type one
382178|NCT01317459|Empowerment|empowerment
382179|NCT01317459|Intrinsic motivation|intrinsic motivation
382180|NCT01317446|gingivitis index|gingivitis index
382181|NCT01317446|plaque index|plaque index
382182|NCT01317446|discoloration index|discoloration index
382183|NCT01317446|mouth rinse|mouth rinse
382184|NCT01317446|amine fluoride/stannous fluoride|amine fluoride/stannous fluoride
382185|NCT01317446|clinical trial|clinical trial
382186|NCT01317433|Metastatic Colorectal Cancer|metastatic colorectal cancer
382187|NCT01317433|K-RAS wild-type|k-ras wild-type
382188|NCT01317433|FOLFIRI|folfiri
382189|NCT01317433|Cetuximab|cetuximab
382190|NCT01317407|postoperative delirium|postoperative delirium
382191|NCT01317394|non-albicans candidemia|non-albicans candidemia
382192|NCT01317368|Postoperative analgesic treatment|postoperative analgesic treatment
382193|NCT01317368|TAP block|tap block
382194|NCT01317368|Prostatectomy|prostatectomy
382195|NCT01317368|Double blinded randomized clinical trial|double blinded randomized clinical trial
382196|NCT01317355|Cancer|cancer
382197|NCT01317355|Symptom burden|symptom burden
382198|NCT01317355|Symptom cluster|symptom cluster
382199|NCT01317355|Distress|distress
382200|NCT01317355|Pain|pain
382201|NCT01317355|Fatigue|fatigue
382202|NCT01317355|Sleep disorder|sleep disorder
382203|NCT01317355|HRQoL|hrqol
382204|NCT01317342|liver transplantation|liver transplantation
382205|NCT01317342|machine liver perfusion|machine liver perfusion
382206|NCT01317342|extended criteria liver grafts|extended criteria liver grafts
382207|NCT01317342|donation after cardiac death|donation after cardiac death
382208|NCT01317342|hypothermic machine liver perfusion|hypothermic machine liver perfusion
382209|NCT01317342|liver reperfusion injury|liver reperfusion injury
382210|NCT01317303|paired associative stimulation|paired associative stimulation
382211|NCT01317303|theta burst stimulation|theta burst stimulation
382212|NCT01317303|transcranial magnetic stimulation|transcranial magnetic stimulation
382213|NCT01317303|neuroplasticity|neuroplasticity
382214|NCT01317303|healthy controls|healthy controls
382215|NCT01317290|Conversion of ALA|conversion of ala
382216|NCT01317277|interventions|interventions
382217|NCT01317277|technology|technology
382218|NCT01317277|drug abuse|drug abuse
382219|NCT01317277|methamphetamine|methamphetamine
382220|NCT01317264|β-glucan|β-glucan
382221|NCT01317264|cholesterol|cholesterol
382222|NCT01317264|bile acids|bile acids
382223|NCT01317264|blood glucose|blood glucose
382224|NCT01317264|appetite|appetite
382225|NCT01317251|Obesity prevention|obesity prevention
382226|NCT01317251|appetite regulation|appetite regulation
382227|NCT01317251|hyperlipidemia|hyperlipidemia
382228|NCT01317238|Smallpox vaccine efficacy|smallpox vaccine efficacy
382229|NCT01317225|Progesterone|progesterone
382230|NCT01317225|Obstetric labor, premature|obstetric labor, premature
382231|NCT01317225|Short cervix|short cervix
382232|NCT01317212|Glioblastoma multiforme|glioblastoma multiforme
382233|NCT01317212|Carboplatin|carboplatin
382234|NCT01317212|Convection-enhanced delivery|convection-enhanced delivery
382235|NCT01317199|Rising psa|rising psa
382236|NCT01317186|FGF 23|fgf 23
382237|NCT01317186|ADMA|adma
382238|NCT01317186|chronic kidney disease|chronic kidney disease
382239|NCT01317186|Ca-P metabolism disorder|ca-p metabolism disorder
382240|NCT01317173|Chronic kidney disease progression|chronic kidney disease progression
382241|NCT01317173|FGF 23|fgf 23
382242|NCT01317173|Klotho|klotho
382243|NCT01317160|Achilles Tendon|achilles tendon
382244|NCT01317160|Immobilization|immobilization
382245|NCT01317160|Wound Healing|wound healing
382246|NCT01317160|Intermittent Pneumatic Compression|intermittent pneumatic compression
382247|NCT01317160|Ultrasonography|ultrasonography
382248|NCT01317160|Microdialysis|microdialysis
382249|NCT01317147|pharmacokinetics|pharmacokinetics
382250|NCT01317147|serotonin reuptake inhibitors|serotonin reuptake inhibitors
382251|NCT01317147|gastric bypass|gastric bypass
382252|NCT01317147|depression|depression
382253|NCT01317147|bioavailability|bioavailability
382254|NCT01317147|drug absorption|drug absorption
382255|NCT01317147|area under curve|area under curve
382256|NCT01317134|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
382257|NCT01317134|Prognostic factors|prognostic factors
382258|NCT01317134|Signal transduction|signal transduction
382259|NCT01317134|Genetics|genetics
382260|NCT01317121|Patients with a first episode of schizophrenia|patients with a first episode of schizophrenia
382261|NCT01317121|Subjects at risk for psychosis|subjects at risk for psychosis
382262|NCT01317108|node-negative|node-negative
382263|NCT01317095|Rigid fixation|rigid fixation
382264|NCT01317095|Sternal closure|sternal closure
382265|NCT01317095|Open heart surgery|open heart surgery
382266|NCT01317082|Postoperative Nausea & Vomiting.|postoperative nausea & vomiting.
382267|NCT01317017|Psoriasis|psoriasis
382268|NCT01317004|Multiple sclerosis|multiple sclerosis
382269|NCT01317004|Fingolimod|fingolimod
382270|NCT01317004|Disease Modifying Therapy|disease modifying therapy
382272|NCT01316991|chewing gum|chewing gum
382273|NCT01316991|appetite|appetite
382274|NCT01316991|hunger|hunger
382275|NCT01316991|satiety|satiety
382276|NCT01316991|metabolic|metabolic
382277|NCT01316991|nutrition|nutrition
382278|NCT01316991|gut peptide hormones|gut peptide hormones
382279|NCT01316991|psychological phenomena and processes|psychological phenomena and processes
382280|NCT01316965|Postoperative delirium|postoperative delirium
382281|NCT01316965|elderly|elderly
382282|NCT01316965|prevention|prevention
382283|NCT01316965|stepped wedge design|stepped wedge design
382284|NCT01316965|healthcare workers|healthcare workers
382285|NCT01316952|carvedilol|carvedilol
382286|NCT01316952|propranolol|propranolol
382287|NCT01316952|hypersensitivity reactions|hypersensitivity reactions
382288|NCT01316952|beta- blockers|beta- blockers
382289|NCT01316952|Coreg|coreg
403016|NCT01228565|Head and neck carcinoma treated by radiotherapy plus erbitux|head and neck carcinoma treated by radiotherapy plus erbitux
382290|NCT01316939|Crohn's disease, oral CCR9 antagonist, placebo-controlled, maintenance of remission, 52-week treatment, quality of life|crohn's disease, oral ccr9 antagonist, placebo-controlled, maintenance of remission, 52-week treatment, quality of life
382291|NCT01316926|fast condition|fast condition
382292|NCT01316926|Paroxetine reference/test|paroxetine reference/test
382293|NCT01316926|healthy volunteers|healthy volunteers
382294|NCT01316926|Bioequivalence|bioequivalence
382295|NCT01316913|tiotropium|tiotropium
594846|NCT00555958|Vagus nerve|vagus nerve
382296|NCT01316913|long-acting muscarinic antagonist|long-acting muscarinic antagonist
382297|NCT01316913|COPD|copd
382298|NCT01316913|long-acting beta agonist|long-acting beta agonist
382299|NCT01316900|long-acting muscarinic antagonist|long-acting muscarinic antagonist
382300|NCT01316900|tiotropium|tiotropium
382301|NCT01316900|COPD|copd
382302|NCT01316900|long-acting beta agonist|long-acting beta agonist
382303|NCT01316887|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
382304|NCT01316887|COPD|copd
382305|NCT01316887|nDPI|ndpi
382306|NCT01316887|long-acting beta agonist|long-acting beta agonist
382307|NCT01316887|long-acting muscarinic antagonist|long-acting muscarinic antagonist
382308|NCT01316887|tolerability|tolerability
382309|NCT01316887|safety|safety
382310|NCT01316874|Valrubicin|valrubicin
382312|NCT01316874|AD 32, BCG-refractory CIS|ad 32, bcg-refractory cis
382313|NCT01316874|Carcinoma in situ (CIS) previously treated with BCG|carcinoma in situ (cis) previously treated with bcg
382315|NCT01316848|tivozanib|tivozanib
382316|NCT01316848|healthy Subjects|healthy subjects
382317|NCT01316848|food Effect|food effect
382318|NCT01316848|pharmacokinetics|pharmacokinetics
382319|NCT01316835|retrospective,sitagliptin, glycemia control,real world|retrospective,sitagliptin, glycemia control,real world
382320|NCT01316822|CSF1R|csf1r
382321|NCT01316822|M-CSF|m-csf
382322|NCT01316822|CSF-1|csf-1
382323|NCT01316822|c-FMS|c-fms
382324|NCT01316822|Tumor-associated macrophage|tumor-associated macrophage
382325|NCT01316822|Macrophage-Colony Stimulating Factor-1|macrophage-colony stimulating factor-1
382326|NCT01316822|Receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
382327|NCT01316822|Tumor cell-induced osteolysis|tumor cell-induced osteolysis
382328|NCT01316809|Brain|brain
382329|NCT01316809|Tumor|tumor
382330|NCT01316809|Recurrent|recurrent
382331|NCT01316809|Surgery|surgery
382332|NCT01316809|Radiation|radiation
382333|NCT01316809|Glioma|glioma
382334|NCT01316809|Brain Tumor|brain tumor
382335|NCT01316809|Glioblastoma Multiforme|glioblastoma multiforme
382336|NCT01316809|Astrocytoma|astrocytoma
382337|NCT01316809|Brainstem Glioma|brainstem glioma
382338|NCT01316796|Sickle Cell Disease|sickle cell disease
381964|NCT01318304|HIV|hiv
382339|NCT01316796|Hemolysis|hemolysis
382340|NCT01316796|Anemia|anemia
382341|NCT01316796|Nitric Oxide|nitric oxide
382342|NCT01316796|Blood Flow|blood flow
382343|NCT01316796|Leg Ulcer|leg ulcer
382344|NCT01316796|Sickle Cell Anemia|sickle cell anemia
382345|NCT01316796|Thalassemia|thalassemia
382346|NCT01316796|Hemolytic Blood Disorder|hemolytic blood disorder
382347|NCT01316783|Africans|africans
382348|NCT01316783|Obesity|obesity
382349|NCT01316783|Diabetes|diabetes
382350|NCT01316783|Heart Disease|heart disease
382351|NCT01316783|Genetic|genetic
382352|NCT01316783|African Descent|african descent
382353|NCT01316783|Cardiovascular Disease|cardiovascular disease
382354|NCT01316770|Xerostomia|xerostomia
382355|NCT01316770|Sj(SqrRoot)(Delta)gren s Syndrome|sj(sqrroot)(delta)gren s syndrome
382356|NCT01316770|Interventional Study|interventional study
382357|NCT01316770|Sjogren Syndrome|sjogren syndrome
382358|NCT01316770|Dry Mouth|dry mouth
382359|NCT01316744|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
382360|NCT01316744|anxiety disorder|anxiety disorder
382361|NCT01316744|depression|depression
382362|NCT01316744|pain|pain
382363|NCT01316744|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
382364|NCT01316744|neuropathy|neuropathy
382365|NCT01316744|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
382366|NCT01316744|acute undifferentiated leukemia|acute undifferentiated leukemia
382367|NCT01316744|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
382368|NCT01316744|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
382369|NCT01316744|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
382370|NCT01316744|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
382371|NCT01316744|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
382372|NCT01316744|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
382373|NCT01316744|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
382374|NCT01316744|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
382375|NCT01316744|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
382376|NCT01316744|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
382377|NCT01316744|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
382378|NCT01316744|mast cell leukemia|mast cell leukemia
382379|NCT01316744|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
382380|NCT01316744|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
382381|NCT01316744|prolymphocytic leukemia|prolymphocytic leukemia
402062|NCT01233323|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
382382|NCT01316744|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
382383|NCT01316744|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
382384|NCT01316744|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
382385|NCT01316744|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
382386|NCT01316744|refractory hairy cell leukemia|refractory hairy cell leukemia
382387|NCT01316744|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
382388|NCT01316744|secondary acute myeloid leukemia|secondary acute myeloid leukemia
382389|NCT01316744|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
382390|NCT01316744|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
382391|NCT01316744|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
382392|NCT01316744|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
382393|NCT01316744|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
382394|NCT01316744|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
382519|NCT01316744|refractory multiple myeloma|refractory multiple myeloma
382395|NCT01316744|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
382396|NCT01316744|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
382397|NCT01316744|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
382398|NCT01316744|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
382399|NCT01316744|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
382625|NCT01316250|nilotinib|nilotinib
382400|NCT01316744|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
382401|NCT01316744|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
382402|NCT01316744|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
382403|NCT01316744|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
382404|NCT01316744|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
382405|NCT01316744|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
382406|NCT01316744|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
382407|NCT01316744|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
382408|NCT01316744|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
382409|NCT01316744|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
382410|NCT01316744|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
382411|NCT01316744|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
382412|NCT01316744|anaplastic large cell lymphoma|anaplastic large cell lymphoma
382413|NCT01316744|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
382414|NCT01316744|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
382415|NCT01316744|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
382416|NCT01316744|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
382417|NCT01316744|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
382418|NCT01316744|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
382419|NCT01316744|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
382420|NCT01316744|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
382421|NCT01316744|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
382422|NCT01316744|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
382423|NCT01316744|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
382424|NCT01316744|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
382425|NCT01316744|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
382426|NCT01316744|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
382427|NCT01316744|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
382428|NCT01316744|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
382429|NCT01316744|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
382430|NCT01316744|splenic marginal zone lymphoma|splenic marginal zone lymphoma
382431|NCT01316744|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
382432|NCT01316744|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
382433|NCT01316744|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
382434|NCT01316744|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
382435|NCT01316744|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
403017|NCT01228552|Acute Migraine Treatment|acute migraine treatment
382436|NCT01316744|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
382437|NCT01316744|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
382438|NCT01316744|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
382439|NCT01316744|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
382440|NCT01316744|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
382441|NCT01316744|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
382442|NCT01316744|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
382443|NCT01316744|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
382444|NCT01316744|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
382445|NCT01316744|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
382446|NCT01316744|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
382447|NCT01316744|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
382448|NCT01316744|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
382449|NCT01316744|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
382450|NCT01316744|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
382451|NCT01316744|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
382452|NCT01316744|stage I mantle cell lymphoma|stage i mantle cell lymphoma
382453|NCT01316744|stage I marginal zone lymphoma|stage i marginal zone lymphoma
382454|NCT01316744|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
382455|NCT01316744|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
382456|NCT01316744|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
382457|NCT01316744|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
382458|NCT01316744|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
382459|NCT01316744|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
382460|NCT01316744|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
382461|NCT01316744|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
382462|NCT01316744|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
382463|NCT01316744|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
382464|NCT01316744|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
382465|NCT01316744|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
382466|NCT01316744|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
382467|NCT01316744|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
382468|NCT01316744|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
382469|NCT01316744|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
382470|NCT01316744|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
382471|NCT01316744|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
382472|NCT01316744|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
382473|NCT01316744|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
382474|NCT01316744|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
382475|NCT01316744|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
382476|NCT01316744|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
382477|NCT01316744|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
382478|NCT01316744|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
382479|NCT01316744|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
382480|NCT01316744|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
382481|NCT01316744|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
382482|NCT01316744|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
382483|NCT01316744|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
382484|NCT01316744|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
382485|NCT01316744|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
382486|NCT01316744|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
382487|NCT01316744|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
382488|NCT01316744|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
382489|NCT01316744|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
382490|NCT01316744|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
382491|NCT01316744|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
382492|NCT01316744|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
382493|NCT01316744|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
382494|NCT01316744|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
403018|NCT01228552|Migraine Treatment|migraine treatment
403019|NCT01228552|Migraine|migraine
382495|NCT01316744|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
382496|NCT01316744|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
382497|NCT01316744|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
382498|NCT01316744|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
382499|NCT01316744|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
382500|NCT01316744|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
382501|NCT01316744|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
382502|NCT01316744|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
382503|NCT01316744|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
382504|NCT01316744|intraocular lymphoma|intraocular lymphoma
382505|NCT01316744|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
382506|NCT01316744|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
382507|NCT01316744|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
382508|NCT01316744|chronic eosinophilic leukemia|chronic eosinophilic leukemia
382509|NCT01316744|chronic neutrophilic leukemia|chronic neutrophilic leukemia
382510|NCT01316744|primary myelofibrosis|primary myelofibrosis
382511|NCT01316744|essential thrombocythemia|essential thrombocythemia
382512|NCT01316744|polycythemia vera|polycythemia vera
382513|NCT01316744|extramedullary plasmacytoma|extramedullary plasmacytoma
382514|NCT01316744|isolated plasmacytoma of bone|isolated plasmacytoma of bone
382515|NCT01316744|stage I multiple myeloma|stage i multiple myeloma
382516|NCT01316744|stage II multiple myeloma|stage ii multiple myeloma
382517|NCT01316744|stage III multiple myeloma|stage iii multiple myeloma
382518|NCT01316744|primary systemic amyloidosis|primary systemic amyloidosis
382520|NCT01316744|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
382521|NCT01316744|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
382522|NCT01316744|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
382523|NCT01316744|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
382524|NCT01316718|IBS|ibs
382525|NCT01316718|diarrhoea|diarrhoea
382526|NCT01316679|HCC|hcc
382527|NCT01316679|Liver Disease without HCC|liver disease without hcc
382917|NCT01315054|IDUs|idus
382528|NCT01316666|orthostatic hypotension|orthostatic hypotension
382529|NCT01316666|Multiple System Atrophy|multiple system atrophy
382530|NCT01316666|Pure Autonomic Failure|pure autonomic failure
382531|NCT01316666|Parkinson's Disease|parkinson's disease
382532|NCT01316627|Body Dysmorphic Disorder (BDD)|body dysmorphic disorder (bdd)
382533|NCT01316627|Cognitive Behavior Therapy (CBT)|cognitive behavior therapy (cbt)
382534|NCT01316627|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
382535|NCT01316627|Mirror Retraining|mirror retraining
6933|NCT03246594|thermolesion|thermolesion
382536|NCT01316627|Crooked Mirror Externalization Therapy|crooked mirror externalization therapy
382537|NCT01316614|Fine-Needle Aspiration|fine-needle aspiration
382538|NCT01316614|Stylet|stylet
382539|NCT01316614|Solid Mass|solid mass
382540|NCT01316614|Endoscopic Ultrasound (EUS)|endoscopic ultrasound (eus)
382541|NCT01316588|recolonization|recolonization
382542|NCT01316588|Plastic adhesive drape|plastic adhesive drape
382543|NCT01316588|microbial sealant|microbial sealant
382545|NCT01316588|bacterial growth|bacterial growth
382546|NCT01316575|Continuous Positive Airway Pressure|continuous positive airway pressure
382547|NCT01316575|Postoperative Complications|postoperative complications
382548|NCT01316575|Respiratory Insufficiency|respiratory insufficiency
382549|NCT01316575|Colorectal Surgery|colorectal surgery
382550|NCT01316549|fludarabine|fludarabine
382551|NCT01316549|pharmacokinetics|pharmacokinetics
382552|NCT01316549|pediatric|pediatric
382553|NCT01316549|allogeneic|allogeneic
382554|NCT01316549|hematopoietic cell transplantation|hematopoietic cell transplantation
382555|NCT01316536|pain, agitation, music|pain, agitation, music
382556|NCT01316523|Lenalidomide|lenalidomide
382557|NCT01316523|Rituximab|rituximab
382558|NCT01316523|untreated indolent Non-Hodgkin's Lymphoma|untreated indolent non-hodgkin's lymphoma
382559|NCT01316510|Probiotic|probiotic
382560|NCT01316510|bifidobacteria|bifidobacteria
382561|NCT01316510|intestinal motility|intestinal motility
382562|NCT01316497|Acute kidney injury|acute kidney injury
382563|NCT01316497|Ischemic preconditioning|ischemic preconditioning
382564|NCT01316497|Congenital heart defects|congenital heart defects
382565|NCT01316497|Cardiac surgical procedures|cardiac surgical procedures
382566|NCT01316497|Infant|infant
382567|NCT01316497|Child|child
382568|NCT01316484|Cognitive Debriefing|cognitive debriefing
382569|NCT01316471|Chronic Pain|chronic pain
382570|NCT01316471|Abdominal Pain|abdominal pain
382571|NCT01316471|Headache|headache
382572|NCT01316471|Adolescents|adolescents
382573|NCT01316471|Internet Interventions|internet interventions
382574|NCT01316471|Behavioral Interventions|behavioral interventions
382575|NCT01316458|Prostate cancer,|prostate cancer,
382576|NCT01316458|radical prostatectomy,|radical prostatectomy,
467336|NCT00054652|TMS|tms
382577|NCT01316458|PSA rise|psa rise
382578|NCT01316445|Electroencephalography|electroencephalography
382579|NCT01316445|Benzodiazepines|benzodiazepines
382580|NCT01316445|Midazolam|midazolam
382581|NCT01316432|Cenderitide|cenderitide
382582|NCT01316432|CD-NP|cd-np
382583|NCT01316432|Natriuretic peptide|natriuretic peptide
382584|NCT01316432|Heart failure|heart failure
382585|NCT01316432|Chronic heart failure|chronic heart failure
382586|NCT01316432|HF|hf
382587|NCT01316432|CHF|chf
382588|NCT01316406|safety|safety
382589|NCT01316406|efficacy|efficacy
382590|NCT01316406|treatment|treatment
382591|NCT01316406|PPES|ppes
382592|NCT01316406|Palmar-Plantar Erythrodysesthesia Syndrome|palmar-plantar erythrodysesthesia syndrome
382593|NCT01316406|Hand-foot syndrome|hand-foot syndrome
382594|NCT01316406|capecitabine|capecitabine
382595|NCT01316393|xerostomia, saliva, mucoprotection, oral health|xerostomia, saliva, mucoprotection, oral health
382596|NCT01316367|Health Promotion Education|health promotion education
382597|NCT01316367|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
382598|NCT01316367|Cardiovascular Risk Factors|cardiovascular risk factors
382599|NCT01316367|Spain|spain
382600|NCT01316354|Arabinoxylan|arabinoxylan
382601|NCT01316354|Beta glucan|beta glucan
382602|NCT01316354|Whole grain|whole grain
382603|NCT01316354|Dietary fibre|dietary fibre
382604|NCT01316354|Metabolic syndrome|metabolic syndrome
382605|NCT01316354|Glycemic index|glycemic index
382606|NCT01316354|Satiety|satiety
382607|NCT01316328|toxicity after single shot partial breast irradiation (SSPBI)|toxicity after single shot partial breast irradiation (sspbi)
382608|NCT01316302|Social Anxiety Disorder|social anxiety disorder
382609|NCT01316302|Social Phobia|social phobia
382610|NCT01316302|SAD|sad
382611|NCT01316289|tibial fractures|tibial fractures
382612|NCT01316289|pilon|pilon
382613|NCT01316289|pilon fractures|pilon fractures
382614|NCT01316289|tibial plafond|tibial plafond
382615|NCT01316289|reduction quality|reduction quality
382616|NCT01316289|anatomical reduction|anatomical reduction
382617|NCT01316289|functional outcome|functional outcome
382618|NCT01316289|ankle joint|ankle joint
382619|NCT01316276|Cystic Fibrosis|cystic fibrosis
382620|NCT01316276|Respiratory Infections|respiratory infections
382621|NCT01316276|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
382622|NCT01316276|CFTR|cftr
382623|NCT01316276|Anti-bacterial Agent|anti-bacterial agent
382624|NCT01316250|chronic myelogenous leukemia|chronic myelogenous leukemia
382626|NCT01316250|complete cytogenetic response|complete cytogenetic response
382627|NCT01316250|imatinib mesylate|imatinib mesylate
382628|NCT01316237|Hepatitis C|hepatitis c
382629|NCT01316237|HCV|hcv
382630|NCT01316237|HCV RNA|hcv rna
382631|NCT01316237|Polymerase inhibitor|polymerase inhibitor
382632|NCT01316237|Treatment naïve|treatment naïve
382633|NCT01316237|GS-6620|gs-6620
382634|NCT01316224|Psoriasis|psoriasis
382635|NCT01316224|Incidence|incidence
382636|NCT01316224|Quality of Life|quality of life
382637|NCT01316224|Psoriatic Arthritis|psoriatic arthritis
382638|NCT01316224|Prevalence|prevalence
382639|NCT01316211|Back Pains|back pains
382640|NCT01316211|Pain, Back|pain, back
382641|NCT01316211|Pains, Back|pains, back
382642|NCT01316211|Backache|backache
382643|NCT01316211|Backaches|backaches
382644|NCT01316211|Back Ache|back ache
382645|NCT01316211|Ache, Back|ache, back
382646|NCT01316211|Aches, Back|aches, back
382647|NCT01316211|Back Aches|back aches
382648|NCT01316211|Back Pain without Radiation|back pain without radiation
382649|NCT01316211|Vertebrogenic Pain Syndrome|vertebrogenic pain syndrome
382650|NCT01316211|Pain Syndrome, Vertebrogenic|pain syndrome, vertebrogenic
382651|NCT01316211|Pain Syndromes, Vertebrogenic|pain syndromes, vertebrogenic
382652|NCT01316211|Syndrome, Vertebrogenic Pain|syndrome, vertebrogenic pain
382653|NCT01316211|Syndromes, Vertebrogenic Pain|syndromes, vertebrogenic pain
382654|NCT01316211|Vertebrogenic Pain Syndromes|vertebrogenic pain syndromes
382655|NCT01316211|Back Pain with Radiation|back pain with radiation
382656|NCT01316211|Stenosis, spinal|stenosis, spinal
382657|NCT01316211|Caudal stenosis|caudal stenosis
382658|NCT01316211|Spondylopathy|spondylopathy
382659|NCT01316211|Spondylopathies|spondylopathies
382660|NCT01316211|Low back pain|low back pain
382661|NCT01316211|Lower back pain|lower back pain
382662|NCT01316198|human study|human study
382663|NCT01316198|AMD|amd
382664|NCT01316198|lutein|lutein
382665|NCT01316198|zeaxanthin|zeaxanthin
382666|NCT01316198|optical density|optical density
382667|NCT01316185|Hepatitis D|hepatitis d
382668|NCT01316185|HDV|hdv
382669|NCT01316185|Hepatitis|hepatitis
382670|NCT01316172|consultation|consultation
382671|NCT01316146|Hodgkin's Lymphoma|hodgkin's lymphoma
382672|NCT01316146|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
382673|NCT01316146|Lymphoma|lymphoma
382674|NCT01316146|T lymphocytes|t lymphocytes
382675|NCT01316133|Tacrolimus|tacrolimus
382676|NCT01316133|Prograf|prograf
382677|NCT01316133|FK506|fk506
382678|NCT01316133|Proteinuria|proteinuria
382679|NCT01316133|Calcineurin inhibitor|calcineurin inhibitor
382680|NCT01316120|Self-collected vaginal samples|self-collected vaginal samples
382681|NCT01316120|HPV|hpv
382682|NCT01316120|HPV self-obtained sample|hpv self-obtained sample
382683|NCT01316120|HPV specimen transport medium|hpv specimen transport medium
382684|NCT01316107|ASP1941|asp1941
382685|NCT01316107|Diabetes mellitus|diabetes mellitus
382686|NCT01316107|nateglinide|nateglinide
382687|NCT01316107|long-term safety|long-term safety
382688|NCT01316094|Renal impairment|renal impairment
382689|NCT01316094|ASP1941|asp1941
382690|NCT01316094|Pharmacokinetics|pharmacokinetics
595055|NCT00559806|aging|aging
382691|NCT01316081|antioxidant supplementation|antioxidant supplementation
382692|NCT01316081|childhood obesity|childhood obesity
382693|NCT01316081|hepcidin|hepcidin
382694|NCT01316081|iron status|iron status
382695|NCT01316081|oxidative stress|oxidative stress
382696|NCT01316081|inflammation|inflammation
382697|NCT01316068|diabetic nephropathy|diabetic nephropathy
382698|NCT01316068|albuminuria|albuminuria
382699|NCT01316068|type 2 diabetes|type 2 diabetes
382700|NCT01316068|sulodexide|sulodexide
382701|NCT01316042|Puberty|puberty
382702|NCT01316042|Hormones|hormones
382703|NCT01316029|Laying-on-of-hands|laying-on-of-hands
382704|NCT01316029|Therapeutic touch|therapeutic touch
382705|NCT01316029|cross-sectional study|cross-sectional study
382706|NCT01316029|healing environment|healing environment
382707|NCT01316029|safety and effectiveness|safety and effectiveness
382708|NCT01316029|optimal condition for the intervention|optimal condition for the intervention
382709|NCT01316016|obesity|obesity
382710|NCT01316016|glucose intolerance|glucose intolerance
382711|NCT01316016|cholesterol|cholesterol
382712|NCT01316016|blood pressure|blood pressure
382713|NCT01316003|cone outer segment tips line|cone outer segment tips line
382714|NCT01316003|Optical coherence tomography|optical coherence tomography
382715|NCT01315990|Phase IV Study|phase iv study
383203|NCT01313806|dementia|dementia
382716|NCT01315990|Metastatic Colorectal Cancer (mCRC|metastatic colorectal cancer (mcrc
382717|NCT01315990|Cetuximab (Erbitux)|cetuximab (erbitux)
382718|NCT01315990|first-line treatment|first-line treatment
382719|NCT01315990|acneiform follicular exanthema|acneiform follicular exanthema
382720|NCT01315990|rash|rash
382721|NCT01315990|vitamin K1|vitamin k1
382722|NCT01315977|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
382723|NCT01315977|Antioxidant oxidant balance|antioxidant oxidant balance
382724|NCT01315977|Activation of Antioxidant Response Element|activation of antioxidant response element
382725|NCT01315964|cholesterol|cholesterol
382726|NCT01315964|plant sterols|plant sterols
383218|NCT01313754|Pain|pain
382727|NCT01315964|atherosclerosis|atherosclerosis
382728|NCT01315964|arterial stiffness|arterial stiffness
382729|NCT01315951|Non scalp Seborrheic Dermatitis|non scalp seborrheic dermatitis
382730|NCT01315925|Acute myeloid leukemia|acute myeloid leukemia
382731|NCT01315925|invasive fungal infection|invasive fungal infection
382732|NCT01315925|Aspergillosis|aspergillosis
382733|NCT01315925|candidiasis|candidiasis
382734|NCT01315912|clomiphene citrate|clomiphene citrate
382735|NCT01315912|infertility|infertility
382736|NCT01315912|letrozole|letrozole
382737|NCT01315899|Raynaud's phenomenon|raynaud's phenomenon
382738|NCT01315899|Systemic sclerosis|systemic sclerosis
382739|NCT01315886|sublingual|sublingual
382740|NCT01315886|fentanyl|fentanyl
382741|NCT01315886|titration|titration
382742|NCT01315886|conversion|conversion
382743|NCT01315886|breakthrough cancer pain|breakthrough cancer pain
382744|NCT01315886|pain intensity difference|pain intensity difference
382745|NCT01315886|PID|pid
382746|NCT01315886|Edmonton Symptom Assessment System|edmonton symptom assessment system
382747|NCT01315886|ESAS|esas
382748|NCT01315873|myeloma|myeloma
382749|NCT01315873|multiple myeloma|multiple myeloma
382750|NCT01315873|relapsed myeloma|relapsed myeloma
382751|NCT01315873|refractory myeloma|refractory myeloma
382752|NCT01315860|Low Back Pain|low back pain
382753|NCT01315860|Pregnancy|pregnancy
382754|NCT01315860|Biomechanics|biomechanics
382755|NCT01315821|Saccharomyces boulardii|saccharomyces boulardii
382756|NCT01315821|necrotizing enterocolitis|necrotizing enterocolitis
382757|NCT01315795|polycystic liver disease|polycystic liver disease
382758|NCT01315782|Sepsis|sepsis
382759|NCT01315782|Severe sepsis|severe sepsis
382760|NCT01315782|Septic shock|septic shock
382761|NCT01315782|Alveolar dead space|alveolar dead space
382762|NCT01315782|Multi-organ failure|multi-organ failure
382763|NCT01315730|stuttering|stuttering
382764|NCT01315730|haptic|haptic
382765|NCT01315730|feedback|feedback
382766|NCT01315730|fluency|fluency
382767|NCT01315691|Cystic Fibrosis|cystic fibrosis
382768|NCT01315691|Respiratory Infections|respiratory infections
382769|NCT01315691|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
382770|NCT01315691|Amikacin|amikacin
382771|NCT01315691|Anti-bacterial agents|anti-bacterial agents
382772|NCT01315678|Cystic Fibrosis|cystic fibrosis
382773|NCT01315678|Respiratory Infections|respiratory infections
382774|NCT01315678|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
382775|NCT01315678|CFTR|cftr
467498|NCT00055055|SLE|sle
382776|NCT01315678|Amikacin|amikacin
382777|NCT01315678|Anti-bacterial Agents|anti-bacterial agents
382778|NCT01315665|broccoli sprouts|broccoli sprouts
382779|NCT01315665|sulforaphane|sulforaphane
382780|NCT01315665|triterpenoid|triterpenoid
382781|NCT01315665|Nrf2 activation|nrf2 activation
382782|NCT01315665|cystic fibrosis|cystic fibrosis
382783|NCT01315665|healthy volunteers|healthy volunteers
382784|NCT01315665|anti-inflammatory|anti-inflammatory
382785|NCT01315652|1 Rheumatoid arthritis|1 rheumatoid arthritis
382786|NCT01315652|2 Education|2 education
382787|NCT01315652|3 Co-morbidities|3 co-morbidities
382788|NCT01315652|4 Nurse|4 nurse
382789|NCT01315639|Dementia|dementia
382790|NCT01315639|Cognitive impairment|cognitive impairment
382791|NCT01315639|Memory impairment|memory impairment
382792|NCT01315639|Mild Cognitive Impairment|mild cognitive impairment
382793|NCT01315639|Cerebrospinal fluid|cerebrospinal fluid
382794|NCT01315639|Plasma|plasma
382795|NCT01315639|Biomarker|biomarker
382796|NCT01315639|Longitudinal|longitudinal
382797|NCT01315639|Abeta peptide amyloid, saPP alpha|abeta peptide amyloid, sapp alpha
382798|NCT01315639|Oculomotor impairment|oculomotor impairment
382799|NCT01315626|Bronchiectasis|bronchiectasis
382800|NCT01315626|pulmonary exacerbations|pulmonary exacerbations
382801|NCT01315626|pulmonary infections|pulmonary infections
382802|NCT01315574|Glaucoma|glaucoma
382803|NCT01315574|Xalatan|xalatan
382804|NCT01315574|Travatan Z|travatan z
382805|NCT01315574|Latanoprost|latanoprost
382806|NCT01315574|Travoprost|travoprost
382807|NCT01315574|Dry Eye|dry eye
382808|NCT01315561|acute low back pain|acute low back pain
382809|NCT01315561|motion stlye acupuncture treatment|motion stlye acupuncture treatment
382810|NCT01315561|disability|disability
382811|NCT01315561|MSAT|msat
382812|NCT01315548|Contrast enhanced harmonic endoscopic ultrasound|contrast enhanced harmonic endoscopic ultrasound
382813|NCT01315548|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
382814|NCT01315548|Chronic pancreatitis|chronic pancreatitis
382815|NCT01315535|Mandibular Advancement|mandibular advancement
382816|NCT01315535|Oral Appliance|oral appliance
382817|NCT01315535|TMD|tmd
382818|NCT01315522|Stents|stents
382819|NCT01315522|Endoscopy|endoscopy
382820|NCT01315522|Cholangiopancreatography|cholangiopancreatography
382821|NCT01315522|Endoscopic Retrograde|endoscopic retrograde
382822|NCT01315509|Severe mental illness|severe mental illness
382823|NCT01315509|Dental measures|dental measures
382824|NCT01315509|Resistant depression|resistant depression
382825|NCT01315496|Human Immunoglobulin G|human immunoglobulin g
382826|NCT01315496|Sepsis|sepsis
382827|NCT01315496|Septic shock|septic shock
382828|NCT01315483|Breast cancer|breast cancer
382829|NCT01315483|survivors|survivors
382830|NCT01315483|weight lose|weight lose
382831|NCT01315483|dietary pattern|dietary pattern
382832|NCT01315470|improving pregnancy rate and endometrial thickness|improving pregnancy rate and endometrial thickness
382833|NCT01315457|alemtuzumab, infection, prophylaxis, treatment|alemtuzumab, infection, prophylaxis, treatment
382834|NCT01315431|Solid tumor malignancy, excluding lymphoma|solid tumor malignancy, excluding lymphoma
382835|NCT01315418|Probiotic - Lactobacillus casei DN-114 001 - dairy product -|probiotic - lactobacillus casei dn-114 001 - dairy product -
382836|NCT01315418|infections - firemen|infections - firemen
382837|NCT01315418|Common infectious diseases, occuring in healthy subjects,|common infectious diseases, occuring in healthy subjects,
382838|NCT01315418|including upper respiratory tract infections (defined as|including upper respiratory tract infections (defined as
382839|NCT01315418|rhinopharyngitis, sore throat, sinusitis and otitis)|rhinopharyngitis, sore throat, sinusitis and otitis)
382840|NCT01315418|lower respiratory tract infections (defined as bronchitis|lower respiratory tract infections (defined as bronchitis
382841|NCT01315418|pneumopathy and flu and flu-like syndromes)|pneumopathy and flu and flu-like syndromes)
382842|NCT01315418|gastrointestinal tract infection defined as gastroenteritis|gastrointestinal tract infection defined as gastroenteritis
382843|NCT01315405|Emotional facial expression|emotional facial expression
382845|NCT01315405|Mirror neurons|mirror neurons
382846|NCT01315379|Prolonged Exposure|prolonged exposure
382847|NCT01315379|CBT|cbt
382848|NCT01315379|PTSD|ptsd
382849|NCT01315379|Mild Traumatic Brain Injury|mild traumatic brain injury
382850|NCT01315379|Post Concussive Syndrome|post concussive syndrome
382851|NCT01315366|Vitamin D|vitamin d
382852|NCT01315366|Elderly|elderly
382853|NCT01315366|Cardiovascular profile|cardiovascular profile
382854|NCT01315366|Insulin resistance|insulin resistance
382855|NCT01315366|Gene polymorphisms|gene polymorphisms
382856|NCT01315327|Tourette's Disorder, Obsessive-Compulsive Disorder, tics|tourette's disorder, obsessive-compulsive disorder, tics
382857|NCT01315314|Glucose degradation products|glucose degradation products
382858|NCT01315314|Inflammation|inflammation
382859|NCT01315314|Endothelial dysfunction|endothelial dysfunction
382860|NCT01315314|Soluble adhesion molecules|soluble adhesion molecules
382861|NCT01315314|Peritoneal dialysis|peritoneal dialysis
382862|NCT01315301|Efavirenz|efavirenz
382863|NCT01315301|Rifampicin|rifampicin
382864|NCT01315301|HAART|haart
382865|NCT01315301|Anti Tuberculosis|anti tuberculosis
382866|NCT01315288|Medical decision making|medical decision making
382867|NCT01315288|Asymptomatic Carotid Stenosis|asymptomatic carotid stenosis
382868|NCT01315275|visual impairment|visual impairment
382869|NCT01315275|macular edema|macular edema
382870|NCT01315275|ranibizumab|ranibizumab
382871|NCT01315275|visual impairment due to macular edema|visual impairment due to macular edema
382872|NCT01315262|Sildenafil 100|sildenafil 100
382873|NCT01315262|restoring erectile function after radical prostatectomy|restoring erectile function after radical prostatectomy
382874|NCT01315249|QVA149|qva149
382875|NCT01315249|indacaterol|indacaterol
382876|NCT01315249|NVA237|nva237
382877|NCT01315249|COPD|copd
382878|NCT01315249|fluticasone/salmeterol|fluticasone/salmeterol
382879|NCT01315210|Fibromyalgia|fibromyalgia
382880|NCT01315210|Fatigue|fatigue
382881|NCT01315210|D-Ribose|d-ribose
382882|NCT01315197|Low back Pain|low back pain
382883|NCT01315184|Interactive Voice Response|interactive voice response
382884|NCT01315184|Computer-based Treatment|computer-based treatment
382885|NCT01315184|Opioid Agonist|opioid agonist
382886|NCT01315184|Buprenorphine|buprenorphine
382887|NCT01315184|Methadone|methadone
382888|NCT01315171|medium chain triglycerides|medium chain triglycerides
382889|NCT01315171|hypoglycemia|hypoglycemia
382890|NCT01315171|cognitive function|cognitive function
382891|NCT01315171|functional MRI|functional mri
382892|NCT01315158|Obstructive Sleep Apnea|obstructive sleep apnea
382893|NCT01315158|Body Mass Index|body mass index
382894|NCT01315132|Myeloablative Hematopoietic Stem Cell Transplant|myeloablative hematopoietic stem cell transplant
382895|NCT01315132|Cyclophosphamide tolerization|cyclophosphamide tolerization
382896|NCT01315132|2 Step Approach|2 step approach
382897|NCT01315132|Hematological malignancies|hematological malignancies
382898|NCT01315132|leukemia|leukemia
382899|NCT01315132|lymphoma|lymphoma
382900|NCT01315132|multiple myeloma|multiple myeloma
382901|NCT01315132|Hodgkin's Disease|hodgkin's disease
382902|NCT01315093|In Vitro Fertilisation|in vitro fertilisation
382903|NCT01315093|poor responders|poor responders
382904|NCT01315080|mammillary fistula|mammillary fistula
382905|NCT01315080|triamcinolone|triamcinolone
382906|NCT01315080|ultrasound management|ultrasound management
382907|NCT01315080|percutaneous treatment|percutaneous treatment
382908|NCT01315067|kidney transplantation|kidney transplantation
382909|NCT01315067|acute rejection|acute rejection
382910|NCT01315067|diagnosis|diagnosis
382911|NCT01315067|urine analysis|urine analysis
382912|NCT01315067|urinary peptides|urinary peptides
382913|NCT01315067|mass spectrometry|mass spectrometry
382914|NCT01315067|allograft biopsy|allograft biopsy
382915|NCT01315067|pathology|pathology
382916|NCT01315067|diagnostic study|diagnostic study
382918|NCT01315054|high risk behaviors|high risk behaviors
382919|NCT01315054|HIV|hiv
382920|NCT01315054|MMT dosage and retention|mmt dosage and retention
382921|NCT01315054|psychosocial services|psychosocial services
382922|NCT01315028|mania|mania
382923|NCT01315028|hypomania|hypomania
382924|NCT01315028|bipolar affective disorder|bipolar affective disorder
382925|NCT01315028|psychological intervention|psychological intervention
382926|NCT01315028|cognitive therapy|cognitive therapy
382927|NCT01315015|Breast cancer|breast cancer
382928|NCT01315015|Breast neoplasm|breast neoplasm
382929|NCT01315015|Magnetic Resonance Imaging|magnetic resonance imaging
382930|NCT01315015|Breast density|breast density
382931|NCT01315015|Early detection of cancer|early detection of cancer
382932|NCT01315015|Cancer screening test|cancer screening test
382933|NCT01315015|Secondary prevention|secondary prevention
382934|NCT01315002|nicotine|nicotine
382935|NCT01315002|schizophrenia|schizophrenia
382936|NCT01315002|endophenotype|endophenotype
382937|NCT01314976|Children|children
382938|NCT01314976|parasite|parasite
382939|NCT01314976|intestinal|intestinal
382940|NCT01314976|treatment|treatment
382941|NCT01314976|RCT|rct
382942|NCT01314937|preschool-age children|preschool-age children
382943|NCT01314937|soil-transmitted helminths|soil-transmitted helminths
382944|NCT01314937|growth|growth
382945|NCT01314937|development|development
382946|NCT01314937|deworming|deworming
382947|NCT01314924|Hypertension|hypertension
382948|NCT01314924|Endothelial dysfunction|endothelial dysfunction
382949|NCT01314924|Vascular stiffness|vascular stiffness
382950|NCT01314924|Use of one or two antihypertensive drugs|use of one or two antihypertensive drugs
382951|NCT01314911|H1N1|h1n1
382952|NCT01314911|Complications|complications
382953|NCT01314911|PCR|pcr
382954|NCT01314911|Seasonal Influenza|seasonal influenza
382955|NCT01314911|Viral Shedding|viral shedding
382956|NCT01314898|Single dose|single dose
382957|NCT01314898|cross-over|cross-over
382958|NCT01314898|active-control|active-control
382959|NCT01314898|placebo control|placebo control
382960|NCT01314898|antimineralocorticoid activity|antimineralocorticoid activity
382961|NCT01314885|Healthy|healthy
382962|NCT01314872|Overactive bladder|overactive bladder
382963|NCT01314872|MK-4618|mk-4618
382964|NCT01314872|tolterodine|tolterodine
382965|NCT01314859|Nifedipine|nifedipine
382966|NCT01314859|Obstetric Labor|obstetric labor
382967|NCT01314859|Premature|premature
382968|NCT01314859|Tocolysis|tocolysis
382969|NCT01314833|Luminal A|luminal a
382970|NCT01314833|Luminal B|luminal b
382971|NCT01314833|Her-2 overexpression|her-2 overexpression
382972|NCT01314833|DFS|dfs
382973|NCT01314833|DDFS|ddfs
382974|NCT01314833|OS|os
382975|NCT01314820|Knee|knee
382976|NCT01314820|Osteoarthritis|osteoarthritis
382977|NCT01314820|Effusion.|effusion.
382978|NCT01314807|COPD|copd
382979|NCT01314781|Overactive Bladder|overactive bladder
382980|NCT01314781|urinary frequency|urinary frequency
382981|NCT01314755|Head and Neck neoplasm|head and neck neoplasm
382982|NCT01314755|Nutrition|nutrition
382983|NCT01314755|Carcinoma|carcinoma
382984|NCT01314755|Infection|infection
382985|NCT01314755|Post-operative|post-operative
382986|NCT01314755|Surgery|surgery
382987|NCT01314755|Immune-enhancing|immune-enhancing
382988|NCT01314742|neonates|neonates
382989|NCT01314742|mechanical ventilation|mechanical ventilation
382990|NCT01314742|oral care|oral care
382991|NCT01314742|duration of mechanical ventilation|duration of mechanical ventilation
382992|NCT01314742|feasibility|feasibility
382993|NCT01314742|ventilator-associated pneumonia|ventilator-associated pneumonia
382994|NCT01314729|Orthodontic fixed retainer|orthodontic fixed retainer
382995|NCT01314729|fiber-reinforced-composite retainer|fiber-reinforced-composite retainer
382996|NCT01314729|composite-wire retainer|composite-wire retainer
382997|NCT01314690|obesity|obesity
382998|NCT01314690|low calorie diet|low calorie diet
382999|NCT01314690|intestinal microbiota|intestinal microbiota
383000|NCT01314690|inflammation (systemic and in adipose tissue)|inflammation (systemic and in adipose tissue)
383001|NCT01314690|fat mass|fat mass
383002|NCT01314690|Impact of nutritional transition on intestinal microbiota|impact of nutritional transition on intestinal microbiota
383003|NCT01314690|relation between food intake, clinical parameters and intestinal microbiota|relation between food intake, clinical parameters and intestinal microbiota
383004|NCT01314664|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
383005|NCT01314664|CIS|cis
383006|NCT01314664|BCG Refractory|bcg refractory
383007|NCT01314651|Migraine Disorders|migraine disorders
383008|NCT01314651|Chronic migraine|chronic migraine
383009|NCT01314651|Insomnia|insomnia
383010|NCT01314651|Behavioral sleep management|behavioral sleep management
383011|NCT01314612|Insomnia|insomnia
383012|NCT01314612|group psychotherapy|group psychotherapy
383013|NCT01314612|nightmares|nightmares
383014|NCT01314612|PTSD|ptsd
383015|NCT01314612|posttraumatic stress disorder|posttraumatic stress disorder
383016|NCT01314612|Veterans|veterans
383017|NCT01314612|cognitive-behavioral intervention|cognitive-behavioral intervention
383018|NCT01314599|Leukemia|leukemia
383019|NCT01314599|lurbinectedin|lurbinectedin
383020|NCT01314599|PM01183|pm01183
383021|NCT01314599|Pharma Mar|pharma mar
383022|NCT01314599|Acute Leukemia in Relapse and Primary Refractory|acute leukemia in relapse and primary refractory
383023|NCT01314586|hypercholesterolemia|hypercholesterolemia
383024|NCT01314586|postmenopause|postmenopause
383025|NCT01314586|secoisolariciresinol diglucoside|secoisolariciresinol diglucoside
383027|NCT01314586|lignans|lignans
383028|NCT01314586|enterolactone|enterolactone
383029|NCT01314586|enterodiol|enterodiol
383030|NCT01314586|serum cholesterol|serum cholesterol
383031|NCT01314586|LDL cholesterol|ldl cholesterol
383032|NCT01314573|High intensity exercise training|high intensity exercise training
383033|NCT01314573|Vascular health|vascular health
383034|NCT01314573|Endothelial function|endothelial function
383035|NCT01314573|Circulating angiogenic cells|circulating angiogenic cells
383036|NCT01314573|endothelial progenitor cells|endothelial progenitor cells
383037|NCT01314573|Aerobic capacity|aerobic capacity
383038|NCT01314573|Arterial stiffness|arterial stiffness
383039|NCT01314573|Traditional and emerging cardiovascular disease risk factors|traditional and emerging cardiovascular disease risk factors
383040|NCT01314560|Lowe syndrome|lowe syndrome
383041|NCT01314560|OCRL|ocrl
383042|NCT01314560|Haemostasis|haemostasis
383043|NCT01314560|Bleeding Disorders|bleeding disorders
383044|NCT01314560|Platelet Function Tests|platelet function tests
383045|NCT01314547|Environment|environment
383046|NCT01314547|spondylarthritis|spondylarthritis
383047|NCT01314547|vasculitis|vasculitis
383048|NCT01314547|stress|stress
383049|NCT01314547|life event|life event
383050|NCT01314547|vaccine|vaccine
383051|NCT01314534|Kabuki syndrome|kabuki syndrome
383052|NCT01314534|Genetic|genetic
383053|NCT01314534|CGH-array|cgh-array
383054|NCT01314521|Suicide|suicide
383055|NCT01314521|Depression|depression
383056|NCT01314521|Adolescents|adolescents
383057|NCT01314508|pre-pubertal children|pre-pubertal children
383058|NCT01314508|pre-transplant|pre-transplant
383059|NCT01314508|not treated with growth hormone for at least 3 months|not treated with growth hormone for at least 3 months
383060|NCT01314495|Alopecia Areata|alopecia areata
383061|NCT01314482|Neuropathic pain|neuropathic pain
383062|NCT01314482|Minocycline|minocycline
403020|NCT01228552|Headache|headache
467863|NCT00063245|HV|hv
383063|NCT01314469|Quality of life in patients with macular edema compared to patients without macular edema.|quality of life in patients with macular edema compared to patients without macular edema.
383064|NCT01314456|Prostate biopsy|prostate biopsy
383065|NCT01314456|Trans-rectal ultrasound|trans-rectal ultrasound
383066|NCT01314456|Prostate cancer|prostate cancer
383067|NCT01314443|smoking cessation|smoking cessation
383068|NCT01314443|gamma-tocopherol|gamma-tocopherol
383069|NCT01314443|nicotine-replacement therapy|nicotine-replacement therapy
383070|NCT01314443|oxidative stress|oxidative stress
383071|NCT01314417|Uveitis|uveitis
383072|NCT01314417|Macular Edema|macular edema
383073|NCT01314417|Methotrexate|methotrexate
383074|NCT01314404|Human papillomavirus|human papillomavirus
383075|NCT01314404|Prevalence|prevalence
383076|NCT01314404|Knowledge Attitude and Practice|knowledge attitude and practice
383077|NCT01314404|Willingness to Participate|willingness to participate
383078|NCT01314404|Vaccine|vaccine
383079|NCT01314404|HPV|hpv
383080|NCT01314391|stage I Wilms tumor|stage i wilms tumor
383081|NCT01314391|stage II Wilms tumor|stage ii wilms tumor
383082|NCT01314391|stage III Wilms tumor|stage iii wilms tumor
383083|NCT01314391|stage IV Wilms tumor|stage iv wilms tumor
383084|NCT01314391|stage V Wilms tumor|stage v wilms tumor
383085|NCT01314391|renal failure|renal failure
383086|NCT01314378|Mindfulness|mindfulness
383087|NCT01314378|Cognitive behavioral therapy|cognitive behavioral therapy
383088|NCT01314378|Smoking|smoking
383089|NCT01314378|Impulsivity|impulsivity
383090|NCT01314378|Inhibitory Control|inhibitory control
383091|NCT01314326|Optical Coherence Tomography|optical coherence tomography
383092|NCT01314326|Glaucoma|glaucoma
383093|NCT01314326|Advanced Imaging|advanced imaging
383094|NCT01314313|SAPIEN XT|sapien xt
383095|NCT01314313|SAPIEN 3|sapien 3
383096|NCT01314313|Transfemoral|transfemoral
383097|NCT01314313|Transapical|transapical
383098|NCT01314313|Transaortic|transaortic
383099|NCT01314313|NovaFlex|novaflex
383100|NCT01314313|TAVI|tavi
383101|NCT01314313|Aortic Stenosis|aortic stenosis
383102|NCT01314313|THV|thv
383103|NCT01314313|Aortic Valve|aortic valve
383104|NCT01314313|Transcatheter Heart Valve|transcatheter heart valve
383105|NCT01314313|tAVR|tavr
383106|NCT01314300|Child, adolescent, young adult|child, adolescent, young adult
383107|NCT01314300|Plaster|plaster
383108|NCT01314300|Lidocaine|lidocaine
383109|NCT01314287|Anaesthesia|anaesthesia
383110|NCT01314287|pulmonary complications|pulmonary complications
383111|NCT01314287|Atelectasis|atelectasis
383112|NCT01314274|Epistaxis|epistaxis
383113|NCT01314274|Osler|osler
383114|NCT01314274|Weber|weber
383115|NCT01314274|Rendu|rendu
383116|NCT01314274|HHT|hht
383117|NCT01314274|Hereditary haemorrhagic telangiectasia|hereditary haemorrhagic telangiectasia
383118|NCT01314248|airway sealing pressure|airway sealing pressure
383119|NCT01314248|fiberoptic assessment|fiberoptic assessment
383120|NCT01314248|ease and time for successful insertion|ease and time for successful insertion
383121|NCT01314248|incidence of gastric insufflation|incidence of gastric insufflation
383122|NCT01314248|complications were also evaluated|complications were also evaluated
383123|NCT01314235|anticoagulation with ASS|anticoagulation with ass
383124|NCT01314235|anticoagulation with clopidogrel|anticoagulation with clopidogrel
383126|NCT01314209|pharmacokinetics|pharmacokinetics
383127|NCT01314209|critical illness|critical illness
383128|NCT01314209|continuous renal replacement therapy|continuous renal replacement therapy
383129|NCT01314196|biceps|biceps
383130|NCT01314196|resistance training|resistance training
383131|NCT01314196|rehabilitation|rehabilitation
383132|NCT01314196|impact syndrome|impact syndrome
383133|NCT01314183|Knee|knee
383134|NCT01314183|Physical Therapy|physical therapy
383135|NCT01314183|Exercise|exercise
383136|NCT01314170|Implant, glaucoma, refractory glaucoma.|implant, glaucoma, refractory glaucoma.
383137|NCT01314157|low back pain|low back pain
383138|NCT01314157|pain|pain
383139|NCT01314157|incapacity|incapacity
383140|NCT01314157|life quality|life quality
383141|NCT01314157|rehabilitation|rehabilitation
383142|NCT01314144|axillary clearance|axillary clearance
383143|NCT01314144|wound infiltration|wound infiltration
383144|NCT01314144|wound infusion|wound infusion
383145|NCT01314144|local anaesthetic wound infusion|local anaesthetic wound infusion
383146|NCT01314118|abiraterone acetate|abiraterone acetate
383147|NCT01314118|prednisone|prednisone
383148|NCT01314118|zytiga|zytiga
383149|NCT01314092|crohn's disease|crohn's disease
383150|NCT01314092|fistula|fistula
383151|NCT01314092|complex|complex
383152|NCT01314079|Crohn's fistula|crohn's fistula
383153|NCT01314079|Autologous adipose derived stem cell|autologous adipose derived stem cell
383154|NCT01314053|Daptomycin|daptomycin
383155|NCT01314053|Serious Gram-positive Infections|serious gram-positive infections
383156|NCT01314040|Dietary protein|dietary protein
383157|NCT01314040|Biomarkers|biomarkers
383158|NCT01314040|filtration rate|filtration rate
383159|NCT01314040|urinary acid excretion|urinary acid excretion
403021|NCT01228552|Treatment|treatment
383160|NCT01314014|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
383161|NCT01314014|Lymphoma, Low Grade|lymphoma, low grade
383162|NCT01314014|Lymphoma, Intermediate Grade|lymphoma, intermediate grade
383163|NCT01314014|Lymphoma, High Grade|lymphoma, high grade
383164|NCT01314014|Lymphoma, B Cell|lymphoma, b cell
383165|NCT01314001|Tobacco, Smoking, Varenicline, Nicotine Patch|tobacco, smoking, varenicline, nicotine patch
383166|NCT01313988|dose-response study|dose-response study
383167|NCT01313988|blood lipid profile|blood lipid profile
383168|NCT01313988|plant sterols|plant sterols
383169|NCT01313988|fish oil|fish oil
383170|NCT01313975|Electrolyte disturbances|electrolyte disturbances
383171|NCT01313975|Fluid balance|fluid balance
383172|NCT01313975|subarachnoid hemorrhage|subarachnoid hemorrhage
383173|NCT01313975|traumatic brain injury|traumatic brain injury
383174|NCT01313975|Cerebral salt wasting|cerebral salt wasting
383175|NCT01313975|SIADH|siadh
383176|NCT01313975|Diabetes insipidus|diabetes insipidus
383177|NCT01313962|antiviral|antiviral
383178|NCT01313962|intranasal|intranasal
383179|NCT01313962|influenza|influenza
383180|NCT01313949|Diabetes|diabetes
383181|NCT01313949|Peer Support|peer support
383182|NCT01313949|Structured Care|structured care
383183|NCT01313936|Neuroblastoma|neuroblastoma
383184|NCT01313936|MIBG|mibg
383185|NCT01313936|131I-MIBG|131i-mibg
383186|NCT01313936|Irinotecan|irinotecan
383187|NCT01313936|Vincristine|vincristine
383188|NCT01313936|Resistant|resistant
383189|NCT01313936|Relapsed|relapsed
383190|NCT01313936|Treatment|treatment
383191|NCT01313936|UCSF|ucsf
383192|NCT01313936|Pediatric|pediatric
383193|NCT01313936|Oncology|oncology
383194|NCT01313923|Pemphigus|pemphigus
383195|NCT01313910|HIV|hiv
383196|NCT01313910|diarrhea|diarrhea
383197|NCT01313897|Multiple Myeloma|multiple myeloma
383198|NCT01313832|ventricular septal defect|ventricular septal defect
383199|NCT01313832|remote ischemic preconditioning|remote ischemic preconditioning
383200|NCT01313832|pulmonary hypertension|pulmonary hypertension
383201|NCT01313832|infant with ventricular septal defect and pulmonary hypertension|infant with ventricular septal defect and pulmonary hypertension
383202|NCT01313819|Freezing|freezing
383204|NCT01313806|memory loss|memory loss
383205|NCT01313806|cognitive decline|cognitive decline
383206|NCT01313793|Bioequivalence (BE) Study|bioequivalence (be) study
383207|NCT01313793|Healthy Volunteers|healthy volunteers
383208|NCT01313780|cancer related pain|cancer related pain
383209|NCT01313767|spasticity|spasticity
383210|NCT01313767|upperlimb|upperlimb
383211|NCT01313767|Botulinum toxin|botulinum toxin
383212|NCT01313754|Skin closure|skin closure
383213|NCT01313754|dermabond|dermabond
383214|NCT01313754|vicryl|vicryl
383215|NCT01313754|monocryl|monocryl
383216|NCT01313754|Suburethral sling|suburethral sling
383217|NCT01313754|Transobturator Sling|transobturator sling
383219|NCT01313754|Discomfort|discomfort
383220|NCT01313754|Skin irritation|skin irritation
383221|NCT01313728|Acne|acne
383222|NCT01313728|Irritation|irritation
383223|NCT01313715|Safety|safety
383224|NCT01313715|Immunogenicity|immunogenicity
383225|NCT01313715|inactivated EV71 vaccine|inactivated ev71 vaccine
383226|NCT01313702|polypill, compliance, cardiovascular disease|polypill, compliance, cardiovascular disease
383227|NCT01313689|Safety|safety
383228|NCT01313689|Refractory|refractory
383229|NCT01313689|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
383230|NCT01313689|Oncology|oncology
383231|NCT01313689|Ofatumumab|ofatumumab
383232|NCT01313689|Efficacy|efficacy
383233|NCT01313676|COPD|copd
383234|NCT01313676|Cardiovascular disease|cardiovascular disease
383235|NCT01313676|Novel Dry Powder Inhaler|novel dry powder inhaler
383236|NCT01313676|Survival|survival
383237|NCT01313663|GW786034|gw786034
383238|NCT01313663|non-small cell lung cancer|non-small cell lung cancer
383239|NCT01313663|NSCLC|nsclc
383240|NCT01313663|pemetrexed|pemetrexed
383241|NCT01313663|pazopanib|pazopanib
383242|NCT01313650|long-acting beta agonist|long-acting beta agonist
383243|NCT01313650|anticholinergic|anticholinergic
383244|NCT01313637|anticholinergic|anticholinergic
383245|NCT01313637|long-acting beta agonist|long-acting beta agonist
383246|NCT01313598|Patients with solid tumors|patients with solid tumors
383247|NCT01313598|Treatment-refractory|treatment-refractory
383248|NCT01313585|Primary care|primary care
383249|NCT01313585|asthma management|asthma management
383250|NCT01313585|inhaler device|inhaler device
383251|NCT01313585|maintenance therapy|maintenance therapy
383252|NCT01313585|reliever therapy|reliever therapy
383253|NCT01313585|Easibreathe salbutamol|easibreathe salbutamol
383254|NCT01313572|Coronary Artery Disease|coronary artery disease
383255|NCT01313572|Myocardial Perfusion Imaging|myocardial perfusion imaging
383256|NCT01313559|Castrate Resistant|castrate resistant
383257|NCT01313559|Chemotherapy Naive|chemotherapy naive
383258|NCT01313559|Prostate Cancer|prostate cancer
383259|NCT01313559|SOM230|som230
383260|NCT01313559|Everolimus|everolimus
383261|NCT01313546|Femoral nerve block|femoral nerve block
383262|NCT01313546|total knee arthroplasty|total knee arthroplasty
383263|NCT01313533|Atherosclerosis of Autologous Vein Bypass Graft|atherosclerosis of autologous vein bypass graft
383264|NCT01313507|Primary Immunodeficiency Disease|primary immunodeficiency disease
383265|NCT01313507|PID|pid
383266|NCT01313494|COPD|copd
383267|NCT01313494|Roflumilast|roflumilast
383268|NCT01313494|FEV1|fev1
383269|NCT01313494|China|china
383270|NCT01313481|Older persons|older persons
383271|NCT01313481|Exercise|exercise
383272|NCT01313481|Balance|balance
383273|NCT01313468|NEAT|neat
383274|NCT01313468|maximal oxygen uptake|maximal oxygen uptake
595440|NCT00561587|depression|depression
383275|NCT01313468|stroke volume|stroke volume
383276|NCT01313455|Oligomenorrhea|oligomenorrhea
383277|NCT01313455|Adrenal Hyperplasia|adrenal hyperplasia
383278|NCT01313455|Obesity|obesity
383279|NCT01313455|Hyperandrogenism|hyperandrogenism
383280|NCT01313455|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
383281|NCT01313455|PCOS|pcos
383282|NCT01313455|Polycystic Ovary|polycystic ovary
383283|NCT01313455|Healthy Volunteer|healthy volunteer
383284|NCT01313455|HV|hv
383285|NCT01313442|Gut Microbiota|gut microbiota
383286|NCT01313442|Analysis of immune subsets with regard to their function|analysis of immune subsets with regard to their function
383287|NCT01313442|Samples|samples
383288|NCT01313442|Gastrointestinal Cancer|gastrointestinal cancer
383289|NCT01313442|Gastrointestinal Tract Cancer|gastrointestinal tract cancer
383290|NCT01313429|Metastatic Cancer|metastatic cancer
383291|NCT01313429|Cancer Vaccine|cancer vaccine
383292|NCT01313429|Immunotherapy|immunotherapy
383293|NCT01313429|Adjuvant Therapy|adjuvant therapy
383294|NCT01313429|Chest Metastases|chest metastases
383295|NCT01313429|Cancer|cancer
383296|NCT01313429|Melanoma|melanoma
383297|NCT01313429|Lung Cancer|lung cancer
383298|NCT01313429|Sarcoma|sarcoma
383299|NCT01313416|Adjuvant Therapy|adjuvant therapy
383300|NCT01313416|Recombinant Monoclonal Antibody|recombinant monoclonal antibody
383301|NCT01313416|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
383302|NCT01313416|Vaccination|vaccination
383303|NCT01313416|PD-1 Receptor|pd-1 receptor
383304|NCT01313416|Pancreas Cancer|pancreas cancer
383305|NCT01313416|Pancreatic Cancer|pancreatic cancer
383306|NCT01313403|5-HT1A Receptors|5-ht1a receptors
383307|NCT01313403|Major Depression|major depression
383308|NCT01313403|PET Imaging|pet imaging
383309|NCT01313403|Depression|depression
383310|NCT01313403|Healthy Volunteer|healthy volunteer
383311|NCT01313403|HV|hv
383312|NCT01313390|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
383313|NCT01313390|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
383314|NCT01313390|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
383315|NCT01313390|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
383316|NCT01313390|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
383317|NCT01313390|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
383318|NCT01313390|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
383319|NCT01313390|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
383320|NCT01313390|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
383321|NCT01313390|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
383322|NCT01313390|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
383323|NCT01313390|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
383324|NCT01313390|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
383325|NCT01313390|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
383326|NCT01313390|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
383327|NCT01313390|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
383328|NCT01313390|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
383329|NCT01313390|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
383330|NCT01313390|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
383331|NCT01313390|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
383332|NCT01313390|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
383333|NCT01313390|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
383334|NCT01313390|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
383335|NCT01313390|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
383336|NCT01313390|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
403022|NCT01228539|PTSD|ptsd
403023|NCT01228539|Anger|anger
468229|NCT00064896|MRI|mri
383337|NCT01313390|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
383338|NCT01313390|recurrent salivary gland cancer|recurrent salivary gland cancer
383339|NCT01313390|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
383340|NCT01313390|stage III salivary gland cancer|stage iii salivary gland cancer
383341|NCT01313390|stage IV salivary gland cancer|stage iv salivary gland cancer
383342|NCT01313390|tongue cancer|tongue cancer
383343|NCT01313377|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
383344|NCT01313377|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
383345|NCT01313377|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
383346|NCT01313377|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
383347|NCT01313377|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
383348|NCT01313377|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
383349|NCT01313377|localized gallbladder cancer|localized gallbladder cancer
383350|NCT01313325|hippotherapy|hippotherapy
383351|NCT01313325|neuromuscular disorders|neuromuscular disorders
383352|NCT01313325|balance deficits|balance deficits
383353|NCT01313325|participation|participation
383354|NCT01313286|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
383355|NCT01313260|Refractory partial epilepsies|refractory partial epilepsies
383356|NCT01313247|Paracetamol|paracetamol
383358|NCT01313247|cancer pain|cancer pain
383359|NCT01313221|plaque psoriasis|plaque psoriasis
383360|NCT01313221|moderate|moderate
383361|NCT01313221|severe|severe
383362|NCT01313221|etanercept|etanercept
383363|NCT01313221|Enbrel|enbrel
383364|NCT01313221|topical|topical
383365|NCT01313208|RA|ra
383366|NCT01313208|Enbrel|enbrel
383367|NCT01313208|DMARD|dmard
383368|NCT01313208|Joint Count|joint count
383369|NCT01313208|Rheumatoid Arthritis|rheumatoid arthritis
383370|NCT01313208|Etanercept|etanercept
383371|NCT01313208|disease modifying anti-rheumatic drug|disease modifying anti-rheumatic drug
383372|NCT01313169|Electronic medical record reminders, Panel management|electronic medical record reminders, panel management
383373|NCT01313156|Metabolic Syndrome, Syndrome X, MetS,|metabolic syndrome, syndrome x, mets,
383374|NCT01313156|Type 2 Diabetes|type 2 diabetes
383476|NCT01312701|immunomonitoring|immunomonitoring
383375|NCT01313143|AOP200704, Esmolol, Pharmacokinetics, Pharmacodynamics|aop200704, esmolol, pharmacokinetics, pharmacodynamics
383376|NCT01313130|traumatic brain injury|traumatic brain injury
383377|NCT01313130|post traumatic stress disorder|post traumatic stress disorder
383378|NCT01313130|Diffusion tensor imaging|diffusion tensor imaging
383379|NCT01313130|resting state functional connectivity|resting state functional connectivity
383380|NCT01313130|genetic factors|genetic factors
383381|NCT01313117|chemotherapy|chemotherapy
383382|NCT01313117|peripheral neuropathy|peripheral neuropathy
383383|NCT01313117|paclitaxel|paclitaxel
383384|NCT01313117|breast cancer|breast cancer
383385|NCT01313078|Ovarian Cancer|ovarian cancer
383386|NCT01313078|Fallopian Tube Cancer|fallopian tube cancer
383387|NCT01313078|Primary Peritoneal Cancer|primary peritoneal cancer
383388|NCT01313078|Relapsed or Refractory|relapsed or refractory
383389|NCT01313078|Pegaspargase|pegaspargase
383390|NCT01313078|Pegylated L-Asparaginase|pegylated l-asparaginase
383391|NCT01313065|VX15/2503|vx15/2503
383392|NCT01313065|Semaphorin 4D|semaphorin 4d
383393|NCT01313065|SEMA4D|sema4d
383394|NCT01313065|CD100|cd100
383395|NCT01313065|safety|safety
383396|NCT01313065|tolerability|tolerability
383397|NCT01313065|pharmacokinetics|pharmacokinetics
383398|NCT01313065|pharmacodynamics|pharmacodynamics
383399|NCT01313065|advanced solid tumors|advanced solid tumors
383400|NCT01313052|Psychotic|psychotic
383401|NCT01313052|Criminal|criminal
383402|NCT01313039|Breast Cancer|breast cancer
383403|NCT01313039|ER-negative|er-negative
383404|NCT01313039|Allred Score|allred score
383405|NCT01313026|Percutaneous nerve evaluation|percutaneous nerve evaluation
383406|NCT01313026|Transanal irrigation|transanal irrigation
383407|NCT01313026|Low anterior resection syndrome|low anterior resection syndrome
383408|NCT01313000|fat, transfer, autologous fat transfer, bicep|fat, transfer, autologous fat transfer, bicep
383409|NCT01312948|Obstructive sleep apnea|obstructive sleep apnea
383411|NCT01312948|CPAP|cpap
383412|NCT01312948|CPAP mask|cpap mask
383413|NCT01312948|Non-invasive ventilation|non-invasive ventilation
383414|NCT01312948|NIV|niv
383415|NCT01312935|Percutaneous Coronary Intervention|percutaneous coronary intervention
383416|NCT01312935|Heparin|heparin
383417|NCT01312935|Angioplasty|angioplasty
383418|NCT01312935|LMWH|lmwh
383419|NCT01312909|smoking cessation in adolescents|smoking cessation in adolescents
383420|NCT01312857|colon|colon
383421|NCT01312857|rectal|rectal
383422|NCT01312857|liver|liver
383423|NCT01312857|AMG 954 (Panitumumab)|amg 954 (panitumumab)
383424|NCT01312857|DEXAMETHASONE|dexamethasone
383425|NCT01312857|FLOXURIDINE|floxuridine
383426|NCT01312857|FLUOROURACIL|fluorouracil
403024|NCT01228539|Aggression|aggression
383427|NCT01312857|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
383428|NCT01312857|LEUCOVORIN|leucovorin
383429|NCT01312857|10-137|10-137
383430|NCT01312831|cobalamin|cobalamin
383431|NCT01312831|B12|b12
383432|NCT01312831|homocysteine|homocysteine
383433|NCT01312831|MMA|mma
383434|NCT01312831|holotranscobalamin|holotranscobalamin
383435|NCT01312831|Eligen|eligen
383436|NCT01312805|asthma|asthma
383437|NCT01312805|clinical decision support|clinical decision support
383438|NCT01312805|CHICA|chica
383439|NCT01312792|Severe Pneumonia|severe pneumonia
383440|NCT01312792|Pneumonia|pneumonia
383441|NCT01312792|ARI|ari
383442|NCT01312792|IMCI|imci
383443|NCT01312792|Modified IMCI|modified imci
383444|NCT01312792|1st level Health facilities|1st level health facilities
383445|NCT01312792|Children|children
383446|NCT01312792|Operational Research|operational research
383447|NCT01312792|Bangladesh|bangladesh
383448|NCT01312792|Treatment of Severe Pneumonia|treatment of severe pneumonia
383449|NCT01312779|Mitral Valve Replacement|mitral valve replacement
383450|NCT01312779|23mm CEP|23mm cep
383451|NCT01312779|Magna|magna
383452|NCT01312740|obesity|obesity
383453|NCT01312740|dietary treatment|dietary treatment
383454|NCT01312740|high protein diet|high protein diet
383455|NCT01312740|Low glycaemic index|low glycaemic index
383456|NCT01312740|adipocytes|adipocytes
383457|NCT01312740|fat mass|fat mass
383458|NCT01312740|systemic inflammatory markers|systemic inflammatory markers
383459|NCT01312740|improvement of complications|improvement of complications
383460|NCT01312740|effect on weight loss|effect on weight loss
383461|NCT01312727|Tubulointerstitial renal diseases|tubulointerstitial renal diseases
383462|NCT01312727|Hereditary renal diseases|hereditary renal diseases
383463|NCT01312727|Uromodulin|uromodulin
383464|NCT01312727|Renin gene|renin gene
383465|NCT01312714|Hemodialysis|hemodialysis
383466|NCT01312714|Peritoneal dialysis|peritoneal dialysis
383467|NCT01312714|Vitamin D Deficiency|vitamin d deficiency
383468|NCT01312714|blood pressure|blood pressure
383469|NCT01312714|arterial stiffness|arterial stiffness
383470|NCT01312714|Heart function|heart function
383471|NCT01312714|Renin-angiotensin system|renin-angiotensin system
383472|NCT01312714|Calcium|calcium
383473|NCT01312714|FGF-23|fgf-23
383474|NCT01312714|Brain natriuretic peptide|brain natriuretic peptide
383475|NCT01312701|cancer|cancer
383477|NCT01312701|CD247 -zeta chain|cd247 -zeta chain
383478|NCT01312701|chronic inflamation|chronic inflamation
383479|NCT01312701|anticancertherapy|anticancertherapy
383480|NCT01312688|Early Goal Directed Hemodunamic Therapy in Sepsis|early goal directed hemodunamic therapy in sepsis
383481|NCT01312675|severe sepsis|severe sepsis
383482|NCT01312675|mechanical ventilation|mechanical ventilation
383483|NCT01312610|orange juice|orange juice
383484|NCT01312610|cognitive function|cognitive function
383485|NCT01312610|flavonoids|flavonoids
383486|NCT01312610|flavanones|flavanones
383487|NCT01312597|Flavonoid|flavonoid
383488|NCT01312597|Cognitive performance|cognitive performance
383489|NCT01312597|Cognitive function|cognitive function
383490|NCT01312597|Executive function|executive function
383491|NCT01312597|fMRI|fmri
383492|NCT01312597|Cerebral blood flow|cerebral blood flow
383493|NCT01312597|Acute|acute
383494|NCT01312584|Flavanol|flavanol
383495|NCT01312584|Cocoa|cocoa
383496|NCT01312584|Vascular function|vascular function
383497|NCT01312584|Absorption|absorption
383498|NCT01312584|Metabolism|metabolism
383499|NCT01312584|Alkalisation|alkalisation
383500|NCT01312558|obstructive sleep apnoea/hypopnoea syndrome|obstructive sleep apnoea/hypopnoea syndrome
383501|NCT01312558|Mediterranean diet|mediterranean diet
383502|NCT01312558|exercise|exercise
383503|NCT01312558|weight loss|weight loss
383504|NCT01312558|continuous positive airway pressure|continuous positive airway pressure
383505|NCT01312558|lipid peroxidation|lipid peroxidation
383506|NCT01312545|orbital implant|orbital implant
383507|NCT01312545|evisceration|evisceration
383508|NCT01312545|economic|economic
383509|NCT01312545|polyethylene|polyethylene
383510|NCT01312545|porous|porous
383511|NCT01312532|Total knee arthroplasty|total knee arthroplasty
383512|NCT01312532|Fixed-bearing|fixed-bearing
383513|NCT01312532|Mobile-bearing|mobile-bearing
383514|NCT01312519|Bone marrow biopsy of iliac crest|bone marrow biopsy of iliac crest
383515|NCT01312506|metastatic|metastatic
383516|NCT01312506|melanoma|melanoma
383517|NCT01312506|CNS|cns
383518|NCT01312493|Head and neck cancer|head and neck cancer
383519|NCT01312493|Phase II|phase ii
383520|NCT01312493|Locally advanced|locally advanced
383521|NCT01312493|Panitumumab|panitumumab
383522|NCT01312493|Vectibix|vectibix
383523|NCT01312493|Lineberger|lineberger
383524|NCT01312493|Radiation Therapy|radiation therapy
383525|NCT01312493|Intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
383526|NCT01312493|Stage III to IVB|stage iii to ivb
383527|NCT01312480|Tobacco|tobacco
383528|NCT01312480|Tobacco Prevention|tobacco prevention
383529|NCT01312480|Tobacco Cessation|tobacco cessation
383530|NCT01312480|5A's Model|5a's model
383531|NCT01312480|Adolescence|adolescence
383532|NCT01312480|Media Use|media use
383533|NCT01312454|intravitreal injection|intravitreal injection
383534|NCT01312454|intraocular pressure|intraocular pressure
383535|NCT01312454|open-angle glaucoma|open-angle glaucoma
383536|NCT01312454|ocular hypertension|ocular hypertension
383537|NCT01312441|Vitamin D|vitamin d
383538|NCT01312441|Ergocalciferol|ergocalciferol
383539|NCT01312415|total knee arthroplasty|total knee arthroplasty
383540|NCT01312415|total knee replacement|total knee replacement
383541|NCT01312415|local infiltration analgesia|local infiltration analgesia
383542|NCT01312415|intra-articular local anaesthesia|intra-articular local anaesthesia
595537|NCT00561912|RCC|rcc
383543|NCT01312415|patients undergoing total knee arthroplasty (total knee replacement)|patients undergoing total knee arthroplasty (total knee replacement)
383544|NCT01312363|Alzheimer's disease|alzheimer's disease
383545|NCT01312363|Rivastigmine|rivastigmine
383546|NCT01312363|Patch|patch
383547|NCT01312363|Tolerability|tolerability
383548|NCT01312350|neoadjuvant chemotherapy|neoadjuvant chemotherapy
383549|NCT01312350|definitive chemoradiation therapy|definitive chemoradiation therapy
383550|NCT01312350|head and neck cancer|head and neck cancer
383551|NCT01312350|base of tongue|base of tongue
383552|NCT01312350|Locally advanced|locally advanced
383553|NCT01312337|gefitinib|gefitinib
383554|NCT01312337|EGFR mutation negative|egfr mutation negative
383555|NCT01312337|NSCLC|nsclc
383556|NCT01312324|neoadjuvant chemotherapy|neoadjuvant chemotherapy
383557|NCT01312324|thymic cancer|thymic cancer
383558|NCT01312311|nasopharyngeal cancer|nasopharyngeal cancer
383559|NCT01312311|weekly docetaxel|weekly docetaxel
383560|NCT01312311|cisplatin|cisplatin
383561|NCT01312298|Arthritis|arthritis
383562|NCT01312298|General anaesthesia|general anaesthesia
383563|NCT01312298|Spinal anaesthesia|spinal anaesthesia
383564|NCT01312285|osteoarthritis|osteoarthritis
383565|NCT01312285|painful hips|painful hips
383566|NCT01312272|Schizophrenia|schizophrenia
383567|NCT01312272|Social Intelligence|social intelligence
383568|NCT01312272|Perception, Social|perception, social
383569|NCT01312272|Oxytocin|oxytocin
383570|NCT01312259|Painful Bladder Syndrome|painful bladder syndrome
383571|NCT01312259|Interstitial Cystitis|interstitial cystitis
383572|NCT01312259|Pelvic Floor dysfunction|pelvic floor dysfunction
383573|NCT01312259|Fecal incontinence|fecal incontinence
383574|NCT01312259|Constipation|constipation
383575|NCT01312259|Sexual dysfunction|sexual dysfunction
383576|NCT01312259|Dyspareunia|dyspareunia
383577|NCT01312259|Vulvodynia|vulvodynia
383578|NCT01312246|vessel ligation|vessel ligation
383579|NCT01312246|colon resection|colon resection
383580|NCT01312207|tractional retinoschisis|tractional retinoschisis
383581|NCT01312207|traction retinal detachment|traction retinal detachment
383582|NCT01312194|Periapical Periodontitis|periapical periodontitis
383583|NCT01312194|Dental Pulp Necrosis|dental pulp necrosis
383584|NCT01312194|Root canal Therapy|root canal therapy
383585|NCT01312194|Adolescent|adolescent
383586|NCT01312181|Technology based intervention|technology based intervention
383587|NCT01312181|HIV primary care clinic|hiv primary care clinic
383588|NCT01312181|Brief behavioral intervention|brief behavioral intervention
383589|NCT01312181|Drug abuse|drug abuse
383590|NCT01312168|Cardiovascular disease|cardiovascular disease
383591|NCT01312168|Continuous positive airway pressure|continuous positive airway pressure
383592|NCT01312168|Endothelium|endothelium
383594|NCT01312168|Inflammation|inflammation
383595|NCT01312168|Sleep Apnea|sleep apnea
383596|NCT01312168|Obstructive|obstructive
383597|NCT01312155|endotracheal|endotracheal
383598|NCT01312155|intubation|intubation
383599|NCT01312155|video|video
383600|NCT01312155|time|time
383601|NCT01312129|Alcohol|alcohol
383602|NCT01312129|Sulfasalazine|sulfasalazine
383603|NCT01312116|Internet treatment|internet treatment
383604|NCT01312116|GAD|gad
383605|NCT01312116|guided self-help|guided self-help
383606|NCT01312103|Safety Planning|safety planning
383607|NCT01312090|Weight loss|weight loss
383608|NCT01312090|brown adipose tissue|brown adipose tissue
383609|NCT01312090|white adipose tissue|white adipose tissue
383610|NCT01312090|muscle, metabolism|muscle, metabolism
383611|NCT01312090|cold exposure|cold exposure
383612|NCT01312077|total hip arthroplasty|total hip arthroplasty
383613|NCT01312077|total hip replacement|total hip replacement
383614|NCT01312077|local infiltration analgesia|local infiltration analgesia
383615|NCT01312077|wound infusion|wound infusion
383616|NCT01312077|patients undergoing total hip replacement (total hip arthroplasty)|patients undergoing total hip replacement (total hip arthroplasty)
383617|NCT01312064|rituximab|rituximab
383618|NCT01312064|everolimus|everolimus
383619|NCT01312038|Eustachian tube|eustachian tube
383620|NCT01312038|otitis|otitis
383621|NCT01312038|middle-ear pressure|middle-ear pressure
383622|NCT01312038|simethicone|simethicone
403025|NCT01228539|Military|military
468585|NCT00066053|Stroke|stroke
383623|NCT01312012|hepatitis B virus,mother-infant transmission, nucleoside analog,pregnant women|hepatitis b virus,mother-infant transmission, nucleoside analog,pregnant women
383624|NCT01311999|latent tuberculosis, renal failure, dialysis, interferon-gamma release assay|latent tuberculosis, renal failure, dialysis, interferon-gamma release assay
383625|NCT01311986|atopic dermatitis|atopic dermatitis
383626|NCT01311986|nummular eczema|nummular eczema
383627|NCT01311986|chemokines|chemokines
383628|NCT01311973|Chronic kidney disease, phosphorus, salivary phosphorus|chronic kidney disease, phosphorus, salivary phosphorus
383629|NCT01311960|pterygium|pterygium
383630|NCT01311960|recurrent pterygium|recurrent pterygium
383631|NCT01311960|bevacizumab|bevacizumab
383632|NCT01311960|VEGF|vegf
383633|NCT01311960|anti-VEGF|anti-vegf
383634|NCT01311947|Chronic hepatitis B|chronic hepatitis b
383635|NCT01311947|Peginterferon alfa-2a|peginterferon alfa-2a
383636|NCT01311921|enterovirus 71, host genetics, social, behavior, environmental factors|enterovirus 71, host genetics, social, behavior, environmental factors
383637|NCT01311908|Pancreaticoduodenectomy|pancreaticoduodenectomy
383638|NCT01311908|Roux-en-Y reconstruction|roux-en-y reconstruction
383639|NCT01311908|Reflux esophagitis|reflux esophagitis
383640|NCT01311895|acute|acute
383641|NCT01311895|pain|pain
383642|NCT01311895|emergency department|emergency department
383643|NCT01311895|hydromorphone|hydromorphone
383644|NCT01311856|Behavioral intervention|behavioral intervention
383645|NCT01311856|Exercise|exercise
383646|NCT01311856|Physical Assessment|physical assessment
383647|NCT01311856|Questionnaire|questionnaire
383648|NCT01311856|Survey|survey
383649|NCT01311856|Telephone counseling|telephone counseling
383650|NCT01311856|Internet interventions|internet interventions
383651|NCT01311856|Overweight cancer survivors|overweight cancer survivors
383652|NCT01311856|Exercise and weight management program|exercise and weight management program
383653|NCT01311791|Left ventricular augmentation|left ventricular augmentation
383654|NCT01311791|Left ventricular restoration|left ventricular restoration
383655|NCT01311765|Postoperative peritonitis|postoperative peritonitis
383656|NCT01311765|Intra-abdominal infection|intra-abdominal infection
383657|NCT01311765|Surgery|surgery
383658|NCT01311765|Laparotomy|laparotomy
383659|NCT01311765|Nosocomial infection|nosocomial infection
383660|NCT01311765|Antibiotic therapy|antibiotic therapy
383661|NCT01311765|Duration of treatment|duration of treatment
383662|NCT01311765|Multidrug resistant bacteria|multidrug resistant bacteria
383663|NCT01311752|human papillomavirus|human papillomavirus
383664|NCT01311752|follow up|follow up
383665|NCT01311739|Pharmacokinetics|pharmacokinetics
383666|NCT01311713|cancer|cancer
383667|NCT01311713|tumors|tumors
383668|NCT01311713|PARP|parp
383669|NCT01311700|Ischemia|ischemia
383670|NCT01311700|Reperfusion|reperfusion
383671|NCT01311700|Myocardial infarction|myocardial infarction
383672|NCT01311700|Beta blockers|beta blockers
383673|NCT01311700|Metoprolol|metoprolol
383674|NCT01311700|Acute myocardial infarction|acute myocardial infarction
383675|NCT01311700|Necrosis|necrosis
383676|NCT01311700|Salvaged Myocardium|salvaged myocardium
383677|NCT01311687|Myeloma|myeloma
383678|NCT01311687|Multiple Myeloma|multiple myeloma
383679|NCT01311687|Relapsed Multiple Myeloma|relapsed multiple myeloma
383680|NCT01311687|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
383681|NCT01311687|Refractory Myeloma|refractory myeloma
383682|NCT01311687|Resistant Multiple Myeloma|resistant multiple myeloma
383683|NCT01311687|Treatment-resistant Multiple Myeloma|treatment-resistant multiple myeloma
383684|NCT01311687|Pomalidomide|pomalidomide
383685|NCT01311687|Lenalidomide-resistant|lenalidomide-resistant
383686|NCT01311687|Bortezomib-resistant|bortezomib-resistant
383687|NCT01311648|recombinant factor VIII|recombinant factor viii
383688|NCT01311648|pediatric use|pediatric use
383689|NCT01311635|Phase 1|phase 1
383690|NCT01311635|bioavailability study|bioavailability study
383691|NCT01311635|AZD1981|azd1981
383692|NCT01311635|tablets|tablets
383693|NCT01311635|To study the relative bioavailability of single dose AZD1981 via three different tablets|to study the relative bioavailability of single dose azd1981 via three different tablets
383694|NCT01311635|To compare the bioavailability between three different AZD1981 tablets|to compare the bioavailability between three different azd1981 tablets
383695|NCT01311622|drug-drug interaction|drug-drug interaction
383696|NCT01311622|Phase 1|phase 1
383697|NCT01311622|healthy subjects|healthy subjects
383698|NCT01311622|warfarin|warfarin
383699|NCT01311622|Rheumatoid arthritis|rheumatoid arthritis
383701|NCT01311622|fostamatinib open-label|fostamatinib open-label
383702|NCT01311622|pharmacokinetics|pharmacokinetics
383703|NCT01311622|pharmacodynamics|pharmacodynamics
383704|NCT01311622|level of Warfarin in the blood|level of warfarin in the blood
383705|NCT01311609|Systane, Dry Eye|systane, dry eye
383706|NCT01311596|icons in clinic or office for patients with Autism|icons in clinic or office for patients with autism
383707|NCT01311583|Self-care|self-care
383708|NCT01311583|Teach Back|teach back
383709|NCT01311557|Tetanus|tetanus
383710|NCT01311557|Diphtheria|diphtheria
374635|NCT01349036|GBM|gbm
383711|NCT01311557|Pertussis|pertussis
383712|NCT01311557|Tdap vaccine|tdap vaccine
383713|NCT01311557|Adacel®|adacel®
383714|NCT01311531|Fracture|fracture
383715|NCT01311531|Radius|radius
383716|NCT01311531|Surgery|surgery
383717|NCT01311531|Osteosynthesis|osteosynthesis
383718|NCT01311518|Thymosin Beta 4|thymosin beta 4
383719|NCT01311518|Thymosin β4 (Tβ4) Injectable Solution|thymosin β4 (tβ4) injectable solution
383720|NCT01311518|RGN-352|rgn-352
383721|NCT01311505|bioequivalence; rifampicin|bioequivalence; rifampicin
383722|NCT01311492|Alzheimer's Disease|alzheimer's disease
383723|NCT01311492|exercise|exercise
383724|NCT01311492|physical activity|physical activity
383725|NCT01311492|intervention|intervention
383726|NCT01311479|Osteopathic Manipulation|osteopathic manipulation
383727|NCT01311479|Interstitial Cystitis|interstitial cystitis
383728|NCT01311479|Sacroiliac Joint Dysfunction|sacroiliac joint dysfunction
383729|NCT01311466|Liver transplantation|liver transplantation
383730|NCT01311466|Overall survival|overall survival
383731|NCT01311440|RCT|rct
383732|NCT01311440|modified Atkins diet|modified atkins diet
383733|NCT01311440|epilepsy|epilepsy
383734|NCT01311440|adults|adults
383735|NCT01311440|ketogenic diet|ketogenic diet
383736|NCT01311401|2 diabetes mellitus,Circassians, High fasting glucose|2 diabetes mellitus,circassians, high fasting glucose
383737|NCT01311388|cancer|cancer
383738|NCT01311375|spinal,, bone, cord injury, lipid,antioxidant|spinal,, bone, cord injury, lipid,antioxidant
383739|NCT01311362|Steady-state|steady-state
383740|NCT01311362|Ambrisentan|ambrisentan
383741|NCT01311362|St. Johns Wort|st. johns wort
383742|NCT01311349|Susceptibility of tigecycline|susceptibility of tigecycline
383743|NCT01311349|Drug Resistance, Bacterial|drug resistance, bacterial
383744|NCT01311336|Pegfilgrastim|pegfilgrastim
383745|NCT01311336|Loratadine|loratadine
383746|NCT01311336|Myalgia/arthralgia|myalgia/arthralgia
383747|NCT01311323|Multivessel Coronary Artery Disease|multivessel coronary artery disease
383748|NCT01311323|Left Main Narrowing|left main narrowing
383749|NCT01311323|Percutaneous Coronary Intervention|percutaneous coronary intervention
383750|NCT01311323|Coronary Artery Bypass Grafting|coronary artery bypass grafting
383751|NCT01311323|Drug-Eluting Stent|drug-eluting stent
383752|NCT01311310|troponin, open heart surgery, children|troponin, open heart surgery, children
383753|NCT01311284|Nasotracheal intubation|nasotracheal intubation
383754|NCT01311284|Macintosh laryngoscope|macintosh laryngoscope
383755|NCT01311284|Airtraq|airtraq
383756|NCT01311284|McGrath|mcgrath
383757|NCT01311284|Manikin|manikin
383758|NCT01311284|airway management|airway management
383759|NCT01311271|Stroke|stroke
383760|NCT01311271|Cerebrovascular disease|cerebrovascular disease
383761|NCT01311271|hemiplegia|hemiplegia
384057|NCT01310166|RRMS|rrms
383762|NCT01311271|Transcranial magnetic stimulation|transcranial magnetic stimulation
383763|NCT01311271|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
383764|NCT01311271|rTMS|rtms
383765|NCT01311271|rehabilitation|rehabilitation
383766|NCT01311271|Upper Extremity|upper extremity
383767|NCT01311258|AML|aml
383768|NCT01311258|MDS|mds
383769|NCT01311245|Risky drinking|risky drinking
383770|NCT01311245|Brief intervention|brief intervention
383771|NCT01311245|Computer-generated feedback|computer-generated feedback
383772|NCT01311245|Stage-tailored|stage-tailored
383773|NCT01311245|Non-stage-tailored|non-stage-tailored
383774|NCT01311232|rituximab, lymphoma, hepatitis B virus|rituximab, lymphoma, hepatitis b virus
383775|NCT01311206|knee osteoarthritis|knee osteoarthritis
383776|NCT01311206|isokinetic knee extensor strength|isokinetic knee extensor strength
383777|NCT01311206|quadriceps volume|quadriceps volume
383778|NCT01311206|symptomatic knee osteoarthritis|symptomatic knee osteoarthritis
383779|NCT01311193|Circadian rhythms|circadian rhythms
383780|NCT01311193|Sleep-wake cycles|sleep-wake cycles
383781|NCT01311193|Melatonin|melatonin
383782|NCT01311193|Borderline Personality Disorder|borderline personality disorder
383783|NCT01311193|Light therapy|light therapy
383784|NCT01311167|Dexamethasone|dexamethasone
383785|NCT01311167|Sodium|sodium
383786|NCT01311154|carriers|carriers
383787|NCT01311154|resistant Enterobacteriaceae|resistant enterobacteriaceae
383788|NCT01311154|AMR|amr
383789|NCT01311154|antibiotic|antibiotic
383790|NCT01311128|Blood pressure|blood pressure
383791|NCT01311128|Heart rate|heart rate
383792|NCT01311128|Cardiac output|cardiac output
383793|NCT01311128|Critical care|critical care
383794|NCT01311128|Perioperative care|perioperative care
383795|NCT01311102|Pain score|pain score
383796|NCT01311102|IUD placement|iud placement
383797|NCT01311076|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
383798|NCT01311076|Insulin|insulin
383799|NCT01311076|Glucose|glucose
383800|NCT01311076|Drug Therapy|drug therapy
383801|NCT01311050|Metastatic Colorectal Cancer|metastatic colorectal cancer
383802|NCT01311037|Premenopausal Women with Advanced Breast Cancer|premenopausal women with advanced breast cancer
383803|NCT01311024|Children|children
383804|NCT01311024|Pneumococcal Vaccines|pneumococcal vaccines
383805|NCT01310049|Exploratory study in healthy subjects|exploratory study in healthy subjects
383806|NCT01310023|Conditions and diagnoses potentially related to perinatal exposure to antiretroviral medications|conditions and diagnoses potentially related to perinatal exposure to antiretroviral medications
383807|NCT01309997|Imatinib|imatinib
383808|NCT01309997|Rituximab|rituximab
383809|NCT01309997|Chronic Graft-vs-Host Disease|chronic graft-vs-host disease
383810|NCT01309984|Monitored anesthesia care|monitored anesthesia care
383811|NCT01309971|Assessment|assessment
383812|NCT01309971|Questionable Caries|questionable caries
383813|NCT01309958|Dental Caries|dental caries
383814|NCT01309958|Intervention|intervention
383815|NCT01309958|Non-invasive treatment for early caries|non-invasive treatment for early caries
383816|NCT01309919|intrauterine device|intrauterine device
383817|NCT01309919|Mirena|mirena
383818|NCT01309919|levonorgestrel intrauterine system|levonorgestrel intrauterine system
383819|NCT01309919|postpartum contraception|postpartum contraception
383820|NCT01309074|Anxiety|anxiety
383821|NCT01309074|Epilepsy|epilepsy
383822|NCT01309048|bone metastasis|bone metastasis
383823|NCT01309048|Patients with bone metastasis|patients with bone metastasis
383824|NCT01309035|Prothesis fixation|prothesis fixation
383825|NCT01309035|Bloodlessness|bloodlessness
383826|NCT01309022|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
383827|NCT01309022|T1D|t1d
383828|NCT01309022|T1DM|t1dm
383829|NCT01309022|Islets of Langerhans Transplantation|islets of langerhans transplantation
383830|NCT01309022|Pancreatic Islets Transplantation|pancreatic islets transplantation
383831|NCT01309022|Islet Transplant|islet transplant
383832|NCT01309022|Tacrolimus|tacrolimus
383833|NCT01309022|Sirolimus|sirolimus
383834|NCT01309022|Mycophenolate mofetil|mycophenolate mofetil
383835|NCT01309022|Mycophenolic acid|mycophenolic acid
383836|NCT01309009|Infantile Colic|infantile colic
383837|NCT01309009|Tachykinin antagonist|tachykinin antagonist
383838|NCT01309009|Nepadutant|nepadutant
383839|NCT01308996|alveolar ridge augmentation|alveolar ridge augmentation
383840|NCT01308996|edentulous ridge|edentulous ridge
383841|NCT01308996|alveolar ridge defect|alveolar ridge defect
383842|NCT01308996|posterior mandible defect|posterior mandible defect
383843|NCT01308996|bone morphogenic protein|bone morphogenic protein
383844|NCT01308996|osseointegration|osseointegration
383845|NCT01311011|Critical Limb Ischemia|critical limb ischemia
383846|NCT01310998|Schizophrenia|schizophrenia
383847|NCT01310998|high intensity exercise|high intensity exercise
383848|NCT01310998|interval training exercise|interval training exercise
383849|NCT01310985|Rectal Cancer|rectal cancer
383850|NCT01310972|Adjuvant Colon Cancer|adjuvant colon cancer
383851|NCT01310959|Aplastic Anemia Marrow Failure Syndrome|aplastic anemia marrow failure syndrome
383852|NCT01310946|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
383853|NCT01310894|Prostatic Disease|prostatic disease
383854|NCT01310894|Genital Neoplasm,male|genital neoplasm,male
383855|NCT01310894|Urogenital neoplasm|urogenital neoplasm
383856|NCT01310894|Genital disease,male|genital disease,male
383857|NCT01310894|Male urogenital disease|male urogenital disease
383858|NCT01310894|Neoplasms|neoplasms
383859|NCT01310894|Neoplasms by site|neoplasms by site
383860|NCT01310894|Prostatic neoplasm|prostatic neoplasm
383861|NCT01310894|Carcinoma|carcinoma
383862|NCT01310881|Neurogenesis|neurogenesis
383863|NCT01310881|hippocampal stem cells|hippocampal stem cells
383864|NCT01310881|depression|depression
383865|NCT01310881|stroke|stroke
383866|NCT01310868|adult giant cell glioblastoma|adult giant cell glioblastoma
383867|NCT01310868|adult gliosarcoma|adult gliosarcoma
383868|NCT01310868|adult glioblastoma|adult glioblastoma
383869|NCT01310855|adult giant cell glioblastoma|adult giant cell glioblastoma
383870|NCT01310855|adult glioblastoma|adult glioblastoma
383871|NCT01310855|adult gliosarcoma|adult gliosarcoma
383872|NCT01310855|recurrent adult brain tumor|recurrent adult brain tumor
383873|NCT01310842|Smoker|smoker
383874|NCT01310842|Smoking Cessation|smoking cessation
383875|NCT01310842|Social Determinants|social determinants
383876|NCT01310842|Environmental Effects|environmental effects
383877|NCT01310842|Individual-level effects|individual-level effects
383878|NCT01310842|Nicotine patch|nicotine patch
383879|NCT01310842|Smart Phone|smart phone
383881|NCT01310842|Global Positioning System|global positioning system
383882|NCT01310842|GPS|gps
383883|NCT01310842|Questionnaires|questionnaires
383884|NCT01310842|Saliva samples|saliva samples
383885|NCT01310829|Genetic counselor|genetic counselor
383886|NCT01310829|Genetic counseling degree program|genetic counseling degree program
383887|NCT01310829|Genetic counseling students|genetic counseling students
383888|NCT01310829|Virtual reality-based intervention|virtual reality-based intervention
383889|NCT01310829|VR|vr
383890|NCT01310829|Genetic counseling|genetic counseling
383891|NCT01310829|hereditary cancers|hereditary cancers
383892|NCT01310829|Questionnaires|questionnaires
383893|NCT01310829|Physiological measurements|physiological measurements
383894|NCT01310829|Skin sensors|skin sensors
383895|NCT01310816|malignant neoplasms of the bone|malignant neoplasms of the bone
383896|NCT01310816|bone sarcoma|bone sarcoma
383897|NCT01310803|Urinary Bladder Neoplasms|urinary bladder neoplasms
383898|NCT01310803|Neoplasms|neoplasms
383899|NCT01310803|Urologic Neoplasms|urologic neoplasms
383900|NCT01310803|Urogenital Neoplasms|urogenital neoplasms
383901|NCT01310803|Neoplasms by Site|neoplasms by site
383902|NCT01310803|Urinary Bladder Diseases|urinary bladder diseases
383903|NCT01310803|Urologic Diseases|urologic diseases
383904|NCT01310803|TURBT|turbt
383905|NCT01310803|Valstar|valstar
383906|NCT01310790|septic shock|septic shock
383907|NCT01310790|lactic acid clearance|lactic acid clearance
383908|NCT01310790|ScVO2|scvo2
383909|NCT01310777|Open-Angle glaucoma|open-angle glaucoma
383910|NCT01310777|Ocular Hypertension|ocular hypertension
383911|NCT01310777|OAG|oag
383912|NCT01310777|OHT|oht
383913|NCT01310764|Intraocular pressure|intraocular pressure
383914|NCT01310764|Trabeculectomy|trabeculectomy
383915|NCT01310764|Mitomycin C|mitomycin c
383916|NCT01310764|Bevacizumab|bevacizumab
383917|NCT01310738|Visceral leishmaniasis|visceral leishmaniasis
595638|NCT00552409|Kidney|kidney
383918|NCT01310738|Leishmania infantum|leishmania infantum
383919|NCT01310738|Leishmania chagasi|leishmania chagasi
383920|NCT01310725|CABG|cabg
383921|NCT01310725|LIMA|lima
383922|NCT01310725|saphenous vein|saphenous vein
383923|NCT01310725|radial artery|radial artery
383924|NCT01310712|hyperhidrosis|hyperhidrosis
383925|NCT01310712|oxybutynin|oxybutynin
383926|NCT01310699|Colonoscopy|colonoscopy
383927|NCT01310699|Diagnostic imaging|diagnostic imaging
383928|NCT01310699|Colorectal Neoplasm|colorectal neoplasm
383929|NCT01310699|Tandem Colonoscopy|tandem colonoscopy
383930|NCT01310699|Flat Polyp|flat polyp
383931|NCT01310699|Nonpolypoid|nonpolypoid
383932|NCT01310699|Flat and Depressed Lesions|flat and depressed lesions
383933|NCT01310699|Primary Prevention|primary prevention
383934|NCT01310699|Endoscopy|endoscopy
383935|NCT01310686|wet AMD anti-VEGF|wet amd anti-vegf
383936|NCT01310686|Genetic analysis of patients with Wet AMD who have not responded fully to anti-VEGF treatments|genetic analysis of patients with wet amd who have not responded fully to anti-vegf treatments
383937|NCT01310673|Gout|gout
383938|NCT01310673|Allopurinol|allopurinol
383939|NCT01310673|Acute gout|acute gout
383940|NCT01310647|estradiol|estradiol
383941|NCT01310647|testosterone|testosterone
383942|NCT01310647|combined oral contraceptive|combined oral contraceptive
383943|NCT01310647|low responders|low responders
383944|NCT01310647|ICSI|icsi
383945|NCT01310634|Neonates|neonates
383946|NCT01310634|Parenting|parenting
383947|NCT01310634|Anxiety|anxiety
383948|NCT01310634|Depression|depression
383949|NCT01310621|Neonate|neonate
383950|NCT01310621|Meconium aspiration syndrome|meconium aspiration syndrome
383951|NCT01310621|surfactant lung lavage|surfactant lung lavage
383952|NCT01310608|Atherosclerosis aorta|atherosclerosis aorta
383953|NCT01310608|A-View|a-view
383954|NCT01310608|Distal ascending aorta|distal ascending aorta
383955|NCT01310608|Transoesophageal echocardiography|transoesophageal echocardiography
383956|NCT01310608|CABG|cabg
383957|NCT01310608|Cerebral embolisation|cerebral embolisation
383958|NCT01310595|Musculoskeletal manipulations|musculoskeletal manipulations
383959|NCT01310595|Proprioception|proprioception
383960|NCT01310595|Postural balance|postural balance
383961|NCT01310582|Sevoflurane|sevoflurane
383962|NCT01310582|Desflurane|desflurane
383963|NCT01310569|PCOS, Skinfold thickness, HOMA-IR|pcos, skinfold thickness, homa-ir
383964|NCT01310556|OGTT|ogtt
383965|NCT01310556|coronary artery disease|coronary artery disease
383966|NCT01310543|Teenage pregnancy|teenage pregnancy
383967|NCT01310543|Adolescent|adolescent
383968|NCT01310543|Sexual health|sexual health
383969|NCT01310543|Youth development|youth development
383970|NCT01310530|Breast Cancer|breast cancer
383971|NCT01310530|Partial Breast|partial breast
383972|NCT01310530|Proton Beam|proton beam
383973|NCT01310517|Angiogram|angiogram
383974|NCT01310517|Injected Contrast|injected contrast
383975|NCT01310517|Heart Function|heart function
383976|NCT01310517|contrast dye|contrast dye
383977|NCT01310478|Recombinant human endostatin|recombinant human endostatin
383978|NCT01310478|Metastatic colorectal cancer|metastatic colorectal cancer
383979|NCT01310478|DLT|dlt
383980|NCT01310478|MTD|mtd
383981|NCT01310478|Pharmacokinetics|pharmacokinetics
383982|NCT01310452|diabetes, basal insulin, metformin, liver fat, visceral fat|diabetes, basal insulin, metformin, liver fat, visceral fat
383983|NCT01310426|Anal Sphincter injury|anal sphincter injury
383984|NCT01310426|Fecal Incontinence|fecal incontinence
383985|NCT01310413|Influenza|influenza
383986|NCT01310413|H5N1|h5n1
383987|NCT01310413|Pandemic|pandemic
383988|NCT01310400|Influenza|influenza
383989|NCT01310400|Virus|virus
383990|NCT01310400|Vaccination|vaccination
383991|NCT01310400|Immunisation|immunisation
383992|NCT01310387|Lung cancer|lung cancer
383993|NCT01310387|Cancer pain|cancer pain
383994|NCT01310387|Opioid|opioid
383995|NCT01310374|influenza vaccine|influenza vaccine
383996|NCT01310374|immune response|immune response
383997|NCT01310374|dynamic changes|dynamic changes
383998|NCT01310361|Pharyngitis|pharyngitis
383999|NCT01310361|Group A β-hemolytic Streptococci|group a β-hemolytic streptococci
384000|NCT01310361|Exudate|exudate
384001|NCT01310361|Erythema Penicillin|erythema penicillin
384002|NCT01310361|Amoxicillin|amoxicillin
384003|NCT01310348|Bone|bone
384004|NCT01310348|Muscle strength|muscle strength
384005|NCT01310348|whole-body vibration|whole-body vibration
384006|NCT01310335|sclerostin|sclerostin
384007|NCT01310335|whole-body vibration|whole-body vibration
384008|NCT01310322|Phase I|phase i
384009|NCT01310322|Healthy male volunteers|healthy male volunteers
384010|NCT01310322|mild asthmatics|mild asthmatics
384011|NCT01310322|pharmacokinetics|pharmacokinetics
384012|NCT01310322|Bioavailability and AUC|bioavailability and auc
384013|NCT01310322|Level of AZD5423 in your blood|level of azd5423 in your blood
384014|NCT01310309|Stents|stents
384015|NCT01310309|Drug-eluting Stent|drug-eluting stent
384016|NCT01310309|Angioplasty|angioplasty
384017|NCT01310309|Coronary Artery stenosis|coronary artery stenosis
595639|NCT00552409|Renal|renal
384018|NCT01310309|Coronary Artery Stent Restenosis|coronary artery stent restenosis
384019|NCT01310309|Stent Thrombosis|stent thrombosis
384020|NCT01310296|Phase 1|phase 1
384021|NCT01310296|Normal Healthy Volunteers|normal healthy volunteers
384022|NCT01310296|Mass Balance|mass balance
384023|NCT01310296|ADME|adme
384024|NCT01310296|Absolute Bioavailability|absolute bioavailability
384025|NCT01310283|dental caries|dental caries
384026|NCT01310283|children|children
384027|NCT01310283|mutans streptococci|mutans streptococci
384028|NCT01310283|lactobacilli|lactobacilli
384029|NCT01310283|cariogenic bacteria|cariogenic bacteria
384030|NCT01310244|Phase 1/2|phase 1/2
384031|NCT01310244|MTD|mtd
384032|NCT01310244|stage IV|stage iv
384033|NCT01310244|NSCLC|nsclc
384034|NCT01310244|chemo-naive|chemo-naive
384035|NCT01310244|Mixed-cell dose escalation|mixed-cell dose escalation
384036|NCT01310244|lung cancer|lung cancer
384037|NCT01310244|non-small-cell|non-small-cell
384038|NCT01310244|phase I|phase i
384039|NCT01310244|Belinostat|belinostat
384040|NCT01310244|Carboplatin|carboplatin
384041|NCT01310244|Paclitaxel|paclitaxel
384042|NCT01310244|adenocarcinoma|adenocarcinoma
384043|NCT01310244|PXD-101|pxd-101
384044|NCT01310231|Metastatic Breast Cancer|metastatic breast cancer
384045|NCT01310231|Metformin|metformin
384046|NCT01310218|orthopedics, carpal tunnel syndrome, postoperative care|orthopedics, carpal tunnel syndrome, postoperative care
384047|NCT01310205|HCV|hcv
384048|NCT01310205|Genotype 1|genotype 1
384049|NCT01310205|relapsers|relapsers
384050|NCT01310205|non cirrhotic|non cirrhotic
384051|NCT01310205|Chronic Hepatitis C|chronic hepatitis c
384052|NCT01310179|gene therapy|gene therapy
384053|NCT01310179|advanced solid tumors|advanced solid tumors
384054|NCT01310179|Head and Neck cancer|head and neck cancer
384055|NCT01310179|intratumoral therapy|intratumoral therapy
384056|NCT01310166|Multiple sclerosis|multiple sclerosis
384058|NCT01310166|relapsing-remitting|relapsing-remitting
384059|NCT01310166|fingolimod|fingolimod
384060|NCT01310166|biomarkers|biomarkers
384061|NCT01310140|Metabolic Syndrome|metabolic syndrome
384062|NCT01310140|Insulin Resistance|insulin resistance
384063|NCT01310140|Massachusetts General Hospital|massachusetts general hospital
384064|NCT01310140|Major Depressive Disorder|major depressive disorder
384065|NCT01310140|Major Depressive Disorder with Psychotic Features|major depressive disorder with psychotic features
384066|NCT01310140|Cortisol|cortisol
384067|NCT01310140|Dexamethasone Suppression Test|dexamethasone suppression test
384068|NCT01310127|NSAID|nsaid
384069|NCT01310127|Ocular Inflammation|ocular inflammation
384070|NCT01310127|bromfenac|bromfenac
384071|NCT01310114|Human Placenta-Derived Cells|human placenta-derived cells
384072|NCT01310114|Stem cells|stem cells
384073|NCT01310114|Stroke|stroke
384074|NCT01310114|PDA001|pda001
384075|NCT01310114|Celgene|celgene
384076|NCT01310114|cenplacel-L|cenplacel-l
384077|NCT01310101|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
384078|NCT01310101|Refractory|refractory
384079|NCT01310101|Relapse|relapse
384080|NCT01310101|Ofatumumab|ofatumumab
384081|NCT01310101|Dexamethasone|dexamethasone
384082|NCT01310088|Childhood|childhood
384083|NCT01310088|Child|child
384084|NCT01310088|adolescent|adolescent
384085|NCT01310088|central blood pressure|central blood pressure
384086|NCT01310088|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
384087|NCT01310088|ABPM|abpm
384088|NCT01310088|clinic blood pressure|clinic blood pressure
384089|NCT01310088|pulse wave velocity|pulse wave velocity
384091|NCT01310088|Pulse cave analysis|pulse cave analysis
384092|NCT01310088|PWA|pwa
384093|NCT01310088|heart rate variability|heart rate variability
384094|NCT01310088|HRV|hrv
384095|NCT01310088|Echocardiography|echocardiography
384096|NCT01310088|Urine microalbuminuria|urine microalbuminuria
384097|NCT01310088|blood samples|blood samples
384098|NCT01310075|Mastectomy|mastectomy
384099|NCT01310075|Bioprosthetic Mesh|bioprosthetic mesh
384100|NCT01310075|Breast Reconstruction|breast reconstruction
384101|NCT01310075|Tissue Expander|tissue expander
469139|NCT00060138|pain|pain
384102|NCT01310075|Alloderm|alloderm
384103|NCT01310075|Surgimend|surgimend
384104|NCT01310062|hepatocellular carcinoma|hepatocellular carcinoma
384105|NCT01310062|microarray|microarray
384106|NCT01310062|gene expression profiling|gene expression profiling
384107|NCT01310062|biomarkers|biomarkers
384108|NCT01309893|Contact lens|contact lens
384109|NCT01309880|Contact lens|contact lens
384110|NCT01309854|Phase 1|phase 1
384111|NCT01309854|healthy volunteers|healthy volunteers
384112|NCT01309854|pharmacokinetics|pharmacokinetics
384113|NCT01309854|Rheumatoid arthritis|rheumatoid arthritis
384114|NCT01309854|RA|ra
384115|NCT01309854|fostamatinib|fostamatinib
384116|NCT01309854|pioglitazone|pioglitazone
384117|NCT01309854|drug-drug interaction|drug-drug interaction
384118|NCT01309841|Non-Cancer-Related Pain, Opioid-Induced Constipation|non-cancer-related pain, opioid-induced constipation
596388|NCT00564499|Symbicort|symbicort
384119|NCT01309828|Renal Insufficiency|renal insufficiency
384120|NCT01309828|Kidney Diseases|kidney diseases
384121|NCT01309828|Hypertension|hypertension
384122|NCT01309828|Drug Therapy|drug therapy
384123|NCT01309815|neoplasms|neoplasms
384124|NCT01309815|existentialism|existentialism
384125|NCT01309815|existential concerns|existential concerns
384126|NCT01309815|Meaning making|meaning making
384127|NCT01309815|early palliative phase|early palliative phase
384128|NCT01309815|elderly|elderly
384129|NCT01309802|botox|botox
384130|NCT01309802|raynaud's|raynaud's
384131|NCT01309802|botulinum toxin|botulinum toxin
384132|NCT01309802|botulinum toxin A|botulinum toxin a
384133|NCT01309802|raynaud's disease|raynaud's disease
384134|NCT01309802|raynaud's syndrome|raynaud's syndrome
384135|NCT01309802|raynaud's phenomenon|raynaud's phenomenon
384136|NCT01309802|ischemic digits|ischemic digits
384137|NCT01309802|ischemia|ischemia
384138|NCT01309802|botox treatment|botox treatment
384139|NCT01309802|onabotulinum|onabotulinum
384140|NCT01309802|onabotulinum toxin|onabotulinum toxin
384141|NCT01309802|onabotulinum toxin type A|onabotulinum toxin type a
384142|NCT01309789|Antibodies, Monoclonal|antibodies, monoclonal
384143|NCT01309789|Antibody-Drug Conjugate|antibody-drug conjugate
384144|NCT01309789|Antigens, CD30|antigens, cd30
384145|NCT01309789|Drug Therapy|drug therapy
384146|NCT01309789|Hematologic Diseases|hematologic diseases
384147|NCT01309789|Lymphoma|lymphoma
384148|NCT01309789|monomethyl auristatin E|monomethyl auristatin e
384149|NCT01309789|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
384150|NCT01309789|Lymphoma, T-cell|lymphoma, t-cell
384151|NCT01309789|Lymphoma, NK-cell|lymphoma, nk-cell
384152|NCT01309737|Xeljanz|xeljanz
384153|NCT01309737|tofacitinib|tofacitinib
384154|NCT01309737|Jak-inhibitor|jak-inhibitor
384155|NCT01309737|oral treatment|oral treatment
384156|NCT01309737|chronic|chronic
384157|NCT01309737|severe|severe
384158|NCT01309737|moderate|moderate
384159|NCT01309737|Pruritus|pruritus
384160|NCT01309737|Itch|itch
384161|NCT01309737|DLQI|dlqi
384162|NCT01309737|treatment|treatment
384163|NCT01309737|safety|safety
384164|NCT01309737|efficacy|efficacy
384165|NCT01309737|CP-690,550|cp-690,550
384166|NCT01309737|Plaque Psoriasis|plaque psoriasis
384167|NCT01309737|Psoriasis Vulgaris|psoriasis vulgaris
384168|NCT01309724|Hypotension|hypotension
384169|NCT01309724|Fluid|fluid
384170|NCT01309711|MRI|mri
384171|NCT01309711|Biomarkers|biomarkers
384172|NCT01309711|Neonatal encephalopathy|neonatal encephalopathy
384173|NCT01309711|Therapeutic hypothermia|therapeutic hypothermia
384174|NCT01309698|Drug interaction|drug interaction
384175|NCT01309685|Cognition|cognition
384176|NCT01309685|Smoking|smoking
384177|NCT01309685|Nicotine|nicotine
384178|NCT01309685|Varenicline|varenicline
384179|NCT01309685|Withdrawal|withdrawal
384180|NCT01309672|adenocarcinoma of the prostate|adenocarcinoma of the prostate
384181|NCT01309672|hormone-resistant prostate cancer|hormone-resistant prostate cancer
384182|NCT01309672|stage IV prostate cancer|stage iv prostate cancer
384183|NCT01309672|recurrent prostate cancer|recurrent prostate cancer
384184|NCT01309659|Anemia|anemia
384185|NCT01309659|Unexplained anemia|unexplained anemia
384186|NCT01309659|elderly|elderly
384187|NCT01309659|geriatric|geriatric
384188|NCT01309659|older adults|older adults
384190|NCT01309659|over 65|over 65
384191|NCT01309659|iron|iron
384192|NCT01309659|pactte|pactte
384193|NCT01309659|pactee|pactee
384194|NCT01309659|aging|aging
384195|NCT01309659|aged|aged
384196|NCT01309659|old|old
384197|NCT01309659|older|older
384198|NCT01309646|Primary vaccination|primary vaccination
384199|NCT01309646|combination vaccine|combination vaccine
384200|NCT01309646|South Korea|south korea
384201|NCT01309633|locally advanced|locally advanced
384202|NCT01309633|metastatic|metastatic
384203|NCT01309620|zinc, oxidative stress, vascular indices, type 2 diabetes|zinc, oxidative stress, vascular indices, type 2 diabetes
384204|NCT01309581|depression|depression
384205|NCT01309581|electroconvulsive therapy|electroconvulsive therapy
384206|NCT01309581|ketamine|ketamine
384207|NCT01309581|antidepressant|antidepressant
384208|NCT01309555|Growth disorders|growth disorders
384209|NCT01309555|Saizen|saizen
384210|NCT01309555|easypod™|easypod™
384211|NCT01309555|Growth hormone|growth hormone
384212|NCT01309555|Pediatric subject|pediatric subject
384213|NCT01309542|major depressive disorder|major depressive disorder
384214|NCT01309542|desvenlafaxine|desvenlafaxine
384215|NCT01309542|antidepressant|antidepressant
384216|NCT01309529|general thoracic surgery|general thoracic surgery
384217|NCT01309529|epidural analgesia|epidural analgesia
384218|NCT01309529|postoperative retention of urine|postoperative retention of urine
384219|NCT01309529|postoperative urinary tract infection|postoperative urinary tract infection
384220|NCT01309529|catheter associated urinary tract infection|catheter associated urinary tract infection
384221|NCT01309516|Postnatal depression|postnatal depression
384222|NCT01309516|Maternal depression|maternal depression
384223|NCT01309516|Psychosocial intervention|psychosocial intervention
384224|NCT01309490|high eIF4E expression|high eif4e expression
384225|NCT01309490|solid tumor cancer|solid tumor cancer
384226|NCT01309477|Refractory Nephrotic Syndrome|refractory nephrotic syndrome
384227|NCT01309477|Tacrolimus|tacrolimus
384228|NCT01309451|diabetic macular edema|diabetic macular edema
384229|NCT01309451|DME|dme
384230|NCT01309438|Healthy|healthy
384231|NCT01309438|Renal Insufficiency|renal insufficiency
384232|NCT01309438|Rivaroxaban (BAY 59-7939, JNJ-39039039)|rivaroxaban (bay 59-7939, jnj-39039039)
384233|NCT01309438|Erythromycin|erythromycin
384234|NCT01309438|Pharmacokinetic|pharmacokinetic
384235|NCT01309438|Pharmacodynamic|pharmacodynamic
384236|NCT01309425|tapentadol|tapentadol
384237|NCT01309425|NUCYNTA|nucynta
384238|NCT01309425|CG5503|cg5503
384239|NCT01309425|R331333|r331333
384240|NCT01309425|pharmacokinetics|pharmacokinetics
384241|NCT01309425|healthy volunteer|healthy volunteer
384242|NCT01309412|Relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
384243|NCT01309412|CNTO 328|cnto 328
384244|NCT01309412|siltuximab|siltuximab
384245|NCT01309412|bortezomib|bortezomib
384246|NCT01309412|dexamethasone|dexamethasone
384247|NCT01309399|bone formation rate|bone formation rate
384248|NCT01309399|total hip arthroplasty|total hip arthroplasty
384249|NCT01309386|Tapentadol|tapentadol
384250|NCT01309386|Tumor related pain|tumor related pain
384251|NCT01309386|Opioid|opioid
384252|NCT01309386|Cancer related pain|cancer related pain
384253|NCT01309386|Morphine|morphine
384254|NCT01309373|Schizophrenia|schizophrenia
384255|NCT01309373|Schizoaffective Disorder|schizoaffective disorder
384256|NCT01309373|Remission|remission
384257|NCT01309373|Psychosocial|psychosocial
384258|NCT01309373|Symtomatic|symtomatic
384259|NCT01309373|Integration|integration
384260|NCT01309373|Schizoaffective|schizoaffective
384261|NCT01309373|Adherence|adherence
384262|NCT01309360|ultrasound|ultrasound
384263|NCT01309360|methaemoglobin|methaemoglobin
384264|NCT01309360|prilocaine|prilocaine
384265|NCT01309360|regional anesthesia|regional anesthesia
384266|NCT01309360|ASA risk groups I-II|asa risk groups i-ii
384267|NCT01309360|adult outpatients|adult outpatients
384268|NCT01309360|surgical spectrum covered procedures|surgical spectrum covered procedures
384269|NCT01309360|distal forearm|distal forearm
384270|NCT01309360|hand|hand
384271|NCT01309347|prosthetic socket, residual limb volume fluctuation|prosthetic socket, residual limb volume fluctuation
384272|NCT01309334|MRI|mri
384273|NCT01309334|PET-scan|pet-scan
384274|NCT01309334|multiple myeloma|multiple myeloma
384275|NCT01309334|prognosis|prognosis
384276|NCT01309334|pharmacoeconomic analysis|pharmacoeconomic analysis
384277|NCT01309321|Perinatal|perinatal
384278|NCT01309321|Handwashing|handwashing
384279|NCT01309321|Neonatal|neonatal
384280|NCT01309321|Morbidity|morbidity
384281|NCT01309321|Mortality|mortality
383880|NCT01310842|SP|sp
384282|NCT01309321|Primiparous|primiparous
384283|NCT01309321|Health behavior|health behavior
384385|NCT01308697|Flail|flail
384284|NCT01309321|Developing countries|developing countries
384285|NCT01309321|Sepsis|sepsis
384286|NCT01309321|Omphalitis|omphalitis
384287|NCT01309321|Infectious disease|infectious disease
384288|NCT01309321|Bangladesh|bangladesh
384289|NCT01309308|cervical length|cervical length
384290|NCT01309308|sweeping the membranes|sweeping the membranes
384291|NCT01309256|distal gastrectomy|distal gastrectomy
384292|NCT01309256|Robotic gastrectomy|robotic gastrectomy
384293|NCT01309256|registry|registry
384294|NCT01309256|learning curve|learning curve
384295|NCT01309256|cost-effectiveness|cost-effectiveness
384296|NCT01309256|quality of life|quality of life
384297|NCT01309256|acute inflammatory reaction|acute inflammatory reaction
384298|NCT01309256|Robotic and laparoscopic surgery|robotic and laparoscopic surgery
384299|NCT01309243|HIV|hiv
384300|NCT01309243|HIV-1|hiv-1
384301|NCT01309243|Antiretroviral Treatment-Naïve|antiretroviral treatment-naïve
384302|NCT01309230|Stage III|stage iii
384303|NCT01309230|Stage IV|stage iv
384304|NCT01309230|epithelial ovarian cancer|epithelial ovarian cancer
384305|NCT01309230|ovarian cancer|ovarian cancer
384306|NCT01309230|Adjuvant|adjuvant
384307|NCT01309230|immunotherapy|immunotherapy
384308|NCT01309204|open-angle glaucoma|open-angle glaucoma
384309|NCT01309204|ocular hypertension|ocular hypertension
384310|NCT01309204|OAG|oag
384311|NCT01309204|OHT|oht
384312|NCT01309191|Androgenetic Alopecia|androgenetic alopecia
384313|NCT01309191|Minoxidil|minoxidil
384314|NCT01309191|Microarray|microarray
384315|NCT01309165|stroke|stroke
384316|NCT01309165|cognition|cognition
384317|NCT01309165|cognitive strategies|cognitive strategies
384318|NCT01309165|motor skill acquisition|motor skill acquisition
384319|NCT01309165|participation|participation
384320|NCT01309152|cefazolin|cefazolin
384321|NCT01309152|microdialysis|microdialysis
384322|NCT01309152|morbid obesity|morbid obesity
384323|NCT01309152|pharmacokinetics|pharmacokinetics
384324|NCT01309126|Colorectal Cancer|colorectal cancer
384325|NCT01309126|KRAS Wild Type|kras wild type
384326|NCT01309126|Imprime PGG|imprime pgg
384327|NCT01309126|Cetuximab|cetuximab
384328|NCT01309126|Phase 3|phase 3
384329|NCT01309126|Efficacy|efficacy
384330|NCT01309126|Safety|safety
384331|NCT01309126|Recurrent or Progressive KRAS Wild Type Colorectal Cancer|recurrent or progressive kras wild type colorectal cancer
384332|NCT01309087|Gene Expression|gene expression
384333|NCT01309087|Lung Cancer|lung cancer
384334|NCT01309087|Smoking|smoking
384335|NCT01308983|Prehypertension|prehypertension
384336|NCT01308983|Flow mediated dilation|flow mediated dilation
384337|NCT01308983|Pulse wave velocity|pulse wave velocity
384338|NCT01308983|carotid compliance|carotid compliance
384339|NCT01308983|Prehypertension and amiloride|prehypertension and amiloride
384340|NCT01308944|invasive epithelial ovarian cancer,|invasive epithelial ovarian cancer,
384341|NCT01308944|primary peritoneal carcinoma,|primary peritoneal carcinoma,
384342|NCT01308944|fallopian tube cancer|fallopian tube cancer
384343|NCT01308931|Contraception|contraception
384344|NCT01308931|IUD|iud
384345|NCT01308931|Essure|essure
384346|NCT01308931|Tubal ligation|tubal ligation
384347|NCT01308931|Anti-Mullerian hormone|anti-mullerian hormone
384348|NCT01308918|Thoracic surgery|thoracic surgery
384349|NCT01308918|Double lumen tube intubation|double lumen tube intubation
384350|NCT01308918|GlideScope|glidescope
384351|NCT01308918|Stylet|stylet
384352|NCT01308905|Neuroblastoma|neuroblastoma
384353|NCT01308879|Contextualized Feedback System (CFS)|contextualized feedback system (cfs)
384354|NCT01308879|Mental health outcomes|mental health outcomes
384355|NCT01308879|Quality improvement|quality improvement
384356|NCT01308879|Feedback|feedback
384357|NCT01308879|Clinical trial|clinical trial
384358|NCT01308866|cardiovascular diseases|cardiovascular diseases
384359|NCT01308866|patient education|patient education
384360|NCT01308866|primary health care|primary health care
384361|NCT01308866|consumer participation|consumer participation
384362|NCT01308866|decision aids|decision aids
384363|NCT01308840|Unresectable|unresectable
384364|NCT01308840|metastatic|metastatic
384365|NCT01308840|biliary tract|biliary tract
384366|NCT01308840|gallbladder cancer|gallbladder cancer
384367|NCT01308827|Children 28 days to 36 months of age with suspected pneumococcal disease|children 28 days to 36 months of age with suspected pneumococcal disease
384368|NCT01308814|Perimenopause|perimenopause
384369|NCT01308814|Menopause|menopause
384370|NCT01308814|Depression|depression
384371|NCT01308814|Cardiovascular health|cardiovascular health
384372|NCT01308801|fibromyalgia|fibromyalgia
384373|NCT01308801|pain|pain
384374|NCT01308801|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
384375|NCT01308801|rehabilitation exercise|rehabilitation exercise
384376|NCT01308801|quality of life|quality of life
384377|NCT01308788|glaucoma blood flow|glaucoma blood flow
384378|NCT01308775|SIS.NET|sis.net
384379|NCT01308736|tobacco|tobacco
384380|NCT01308736|nicotine|nicotine
384381|NCT01308736|cigarette smoking|cigarette smoking
384382|NCT01308710|endothelial function|endothelial function
384383|NCT01308710|lipids|lipids
384384|NCT01308710|pediatrics|pediatrics
384387|NCT01308671|coronary artery disease|coronary artery disease
384388|NCT01308671|varenicline|varenicline
384389|NCT01308671|clopidogrel|clopidogrel
384390|NCT01308658|TMC114-C176|tmc114-c176
384391|NCT01308658|TMC114|tmc114
384392|NCT01308658|DRV|drv
384393|NCT01308658|HIV|hiv
384394|NCT01308658|Healthy volunteers|healthy volunteers
384395|NCT01308645|SBP Injection|sbp injection
384396|NCT01308645|HCC|hcc
384397|NCT01308632|glioblastoma|glioblastoma
384398|NCT01308632|temozolamide|temozolamide
384399|NCT01308632|radiotherapy|radiotherapy
384400|NCT01308632|TMZ|tmz
384401|NCT01308632|irinotecan|irinotecan
384402|NCT01308606|TMC435-TiDP16-C116|tmc435-tidp16-c116
384403|NCT01308606|TMC435-C116|tmc435-c116
384404|NCT01308606|TMC435|tmc435
384405|NCT01308606|HCV|hcv
384406|NCT01308606|Hepatitis C|hepatitis c
384407|NCT01308606|Hep C|hep c
384408|NCT01308606|healthy volunteers|healthy volunteers
384409|NCT01308554|TAP block|tap block
384410|NCT01308554|Pain|pain
384411|NCT01308554|Obesity|obesity
384412|NCT01308554|Surgery|surgery
384413|NCT01308554|Laparoscopic gastric bypass|laparoscopic gastric bypass
384414|NCT01308528|Venous Thromboembolism|venous thromboembolism
384415|NCT01308515|knee|knee
384416|NCT01308515|osteoarthritis|osteoarthritis
384417|NCT01308515|joint|joint
384418|NCT01308515|replacement|replacement
384419|NCT01308515|knee surgery|knee surgery
384420|NCT01308502|laryngopharyngeal reflux|laryngopharyngeal reflux
384421|NCT01308502|LPR|lpr
384422|NCT01308502|GERD|gerd
384423|NCT01308502|gastroesophageal reflux|gastroesophageal reflux
384424|NCT01308502|nasopharyngeal probe|nasopharyngeal probe
384425|NCT01308463|elbow long-term Survivorship|elbow long-term survivorship
384426|NCT01308463|Study participant Discovery Elbow Multi-center Study who|study participant discovery elbow multi-center study who
384427|NCT01308463|consent for the Discovery Elbow Long-term SurvivorshipStudy|consent for the discovery elbow long-term survivorshipstudy
384428|NCT01308450|ADHD Normative Control Group|adhd normative control group
384429|NCT01308424|Herpes Labialis|herpes labialis
384430|NCT01308424|Herpes Simplex|herpes simplex
384432|NCT01308411|Asthma|asthma
384433|NCT01308411|Inhaled Corticosteroids|inhaled corticosteroids
384434|NCT01308411|Exhaled Nitric oxide|exhaled nitric oxide
384435|NCT01308411|Airways inflammation|airways inflammation
384436|NCT01308411|Step down|step down
384437|NCT01308411|Predicting response|predicting response
384438|NCT01308372|cardiovascular risk|cardiovascular risk
384439|NCT01308372|France|france
384440|NCT01308372|General practice|general practice
384441|NCT01308372|Primary prevention|primary prevention
384442|NCT01308372|Non treated patients|non treated patients
384443|NCT01308359|fetal movement|fetal movement
384444|NCT01308346|Bioabsorbable|bioabsorbable
384445|NCT01308346|Coronary Stent|coronary stent
384446|NCT01308346|Everolimus|everolimus
384447|NCT01308346|drug eluting stents|drug eluting stents
384448|NCT01308346|stents|stents
384449|NCT01308346|angioplasty|angioplasty
384450|NCT01308346|coronary artery disease|coronary artery disease
384451|NCT01308346|total coronary occlusion|total coronary occlusion
384452|NCT01308346|coronary artery restenosis|coronary artery restenosis
384453|NCT01308346|stent thrombosis|stent thrombosis
384454|NCT01308346|myocardial ischemia|myocardial ischemia
384455|NCT01308346|coronary artery stenosis|coronary artery stenosis
384456|NCT01308307|Non-cycloplegic photorefraction|non-cycloplegic photorefraction
384457|NCT01308307|cycloplegic refraction,|cycloplegic refraction,
384458|NCT01308307|Amblyopia|amblyopia
384459|NCT01308294|Melanoma|melanoma
384460|NCT01308294|Stage II-IV|stage ii-iv
384461|NCT01308294|Immunotherapy|immunotherapy
384462|NCT01308294|Vaccination|vaccination
384463|NCT01308294|HLA class I and II tumor-specific peptides|hla class i and ii tumor-specific peptides
384464|NCT01308294|IMP321|imp321
384465|NCT01308294|Montanide ISA-51 VG|montanide isa-51 vg
384466|NCT01308268|STH|sth
384467|NCT01308268|Soil-transmitted Helminthiasis|soil-transmitted helminthiasis
384468|NCT01308268|mass drug administration|mass drug administration
384469|NCT01308229|Bifurcation|bifurcation
384470|NCT01308229|Dedicated|dedicated
384471|NCT01308229|Drug-eluting stent|drug-eluting stent
384472|NCT01308229|Angioplasty|angioplasty
384473|NCT01308229|Coronary artery disease|coronary artery disease
384474|NCT01308229|Coronary artery stenosis|coronary artery stenosis
384475|NCT01308216|Transcranial Laser Therapy|transcranial laser therapy
384476|NCT01308216|Hemiplegia|hemiplegia
384477|NCT01308216|Rehabilitation|rehabilitation
384478|NCT01308216|Physiotherapy|physiotherapy
384479|NCT01308216|Ischemic stroke|ischemic stroke
384480|NCT01308190|Preoperative chemoradiotherapy|preoperative chemoradiotherapy
384481|NCT01308190|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
384482|NCT01308190|Rectal Cancer|rectal cancer
384483|NCT01308190|T2-T3s-N0|t2-t3s-n0
384484|NCT01308164|Type 1 diabetes|type 1 diabetes
384485|NCT01308164|Insulin Pump Therapy|insulin pump therapy
7220|NCT03244644|Microbial Suspension|microbial suspension
384486|NCT01308151|CBT, self harm, depression, cultural adaptation, Pakistan|cbt, self harm, depression, cultural adaptation, pakistan
384487|NCT01308138|Physical Activity|physical activity
384488|NCT01308138|pathology|pathology
384489|NCT01308138|Physical Deconditioning|physical deconditioning
384490|NCT01308125|Stable Angina|stable angina
384491|NCT01308125|Coronary artery disease|coronary artery disease
384492|NCT01308125|PCI|pci
384493|NCT01308125|Reperfusion|reperfusion
384494|NCT01308125|Myocardial Infarction|myocardial infarction
384495|NCT01308125|collateral flow pressure index|collateral flow pressure index
384496|NCT01308125|CFpI|cfpi
384497|NCT01308125|pressure controlled intermittent coronary sinus occlusion|pressure controlled intermittent coronary sinus occlusion
384498|NCT01308125|PICSO|picso
384499|NCT01308112|Iron|iron
384500|NCT01308112|Plasmodium|plasmodium
384501|NCT01308112|Malaria|malaria
384502|NCT01308112|Pregnancy|pregnancy
384503|NCT01308112|Kenya|kenya
384504|NCT01308099|POTS|pots
384505|NCT01308099|Vascular Endothelial Function|vascular endothelial function
384506|NCT01308086|Cancer|cancer
384507|NCT01308086|colorectal cancer|colorectal cancer
384508|NCT01308086|adjuvant chemotherapy|adjuvant chemotherapy
384509|NCT01308086|capecitabine|capecitabine
384510|NCT01308086|oxaliplatin|oxaliplatin
384511|NCT01308086|5 fluorouracil|5 fluorouracil
384512|NCT01308060|Canthal lines|canthal lines
384513|NCT01308034|non GIST sarcomas|non gist sarcomas
384514|NCT01308034|sunitinib|sunitinib
384515|NCT01308034|radiotherapy|radiotherapy
384516|NCT01308034|dose escalation|dose escalation
384517|NCT01308021|Rhinoconjunctivitis|rhinoconjunctivitis
384518|NCT01308021|Allergy|allergy
384519|NCT01308021|Grass pollen|grass pollen
384520|NCT01308021|Hypersensitivity|hypersensitivity
384521|NCT01308021|Immune system disorder|immune system disorder
384522|NCT01308008|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
384523|NCT01308008|Mobility Limitation|mobility limitation
384524|NCT01307995|GDM|gdm
384525|NCT01307995|incretin effect|incretin effect
384526|NCT01307995|gestation|gestation
384527|NCT01307995|reversibility|reversibility
384528|NCT01307982|Gastroesophageal Reflux|gastroesophageal reflux
384529|NCT01307982|Nervous System Diseases|nervous system diseases
384530|NCT01307982|Fundoplication|fundoplication
384531|NCT01307982|Enteral Nutrition|enteral nutrition
384532|NCT01307969|liposomes|liposomes
384533|NCT01307969|ropivacaine|ropivacaine
384534|NCT01307969|dental anesthesia|dental anesthesia
384535|NCT01307969|dentistry|dentistry
384536|NCT01307943|MBSR|mbsr
384537|NCT01307943|adolescent|adolescent
384538|NCT01307943|mental health|mental health
384539|NCT01307930|Echinocandin|echinocandin
384540|NCT01307930|Obesity|obesity
384541|NCT01307930|Pharmacokinetics|pharmacokinetics
384542|NCT01307930|Pharmacodynamics|pharmacodynamics
384543|NCT01307930|Fungal infection|fungal infection
384544|NCT01307917|diabetes mellitus|diabetes mellitus
384545|NCT01307917|diabetic nephropathy|diabetic nephropathy
384546|NCT01307917|vascular endothelial dysfunction|vascular endothelial dysfunction
384547|NCT01307917|flavonoids|flavonoids
384548|NCT01307917|flow-mediated dilation|flow-mediated dilation
384549|NCT01307904|Glycemic index|glycemic index
384550|NCT01307904|Dates|dates
384551|NCT01307904|Blood glucose|blood glucose
384552|NCT01307891|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
384553|NCT01307891|Metastatic breast cancer|metastatic breast cancer
384554|NCT01307891|Tigatuzumab (CS-1008)|tigatuzumab (cs-1008)
384555|NCT01307891|Abraxane (ABI-007)|abraxane (abi-007)
384556|NCT01307891|HER-2-neu negative|her-2-neu negative
384557|NCT01307891|ER negative, PR negative|er negative, pr negative
384558|NCT01307865|midface volume loss|midface volume loss
384559|NCT01307865|aging of midface|aging of midface
384560|NCT01307865|sculptra|sculptra
384561|NCT01307865|sculptra aesthetic|sculptra aesthetic
384562|NCT01307865|poly-L-lactic acid|poly-l-lactic acid
384563|NCT01307852|Fiber optic radiation detectors|fiber optic radiation detectors
384564|NCT01307852|Enhanced endorectal balloon|enhanced endorectal balloon
384565|NCT01307852|Radiation treatment|radiation treatment
384566|NCT01307852|Radiotherapy|radiotherapy
385050|NCT01306071|Cirrhosis|cirrhosis
384567|NCT01307852|External beam radiation|external beam radiation
384568|NCT01307852|Dosimetry|dosimetry
384569|NCT01307839|labor|labor
384570|NCT01307839|epidural|epidural
384571|NCT01307826|massage|massage
384572|NCT01307826|shoulder|shoulder
384573|NCT01307826|pain|pain
384574|NCT01307826|range of motion|range of motion
384575|NCT01307826|restricted range of motion|restricted range of motion
384576|NCT01307813|colon distal|colon distal
384577|NCT01307813|surgical resection|surgical resection
384578|NCT01307787|exercise|exercise
384579|NCT01307787|education|education
384580|NCT01307787|self-management|self-management
384581|NCT01307787|rehabilitation|rehabilitation
384582|NCT01307774|parental acceptability of HPV vaccine|parental acceptability of hpv vaccine
384583|NCT01307761|fine needle aspiration; predictor; ultrasonography; thyroid cancer|fine needle aspiration; predictor; ultrasonography; thyroid cancer
384584|NCT01307748|aromatherapy|aromatherapy
384585|NCT01307748|stress|stress
384586|NCT01307748|older adults|older adults
384587|NCT01307748|stress-related change|stress-related change
384588|NCT01307735|myocarditis|myocarditis
384589|NCT01307735|edema|edema
384590|NCT01307735|hyperemia|hyperemia
384591|NCT01307735|fibrosis|fibrosis
384592|NCT01307735|necrosis|necrosis
384593|NCT01307735|cardiovascular magnetic resonance imaging|cardiovascular magnetic resonance imaging
384594|NCT01307722|left atrial distensibility|left atrial distensibility
384595|NCT01307722|advanced chronic heart failure|advanced chronic heart failure
384596|NCT01307722|decompensation|decompensation
384597|NCT01307722|rehospitalization|rehospitalization
384598|NCT01307722|prognosis|prognosis
384599|NCT01307722|all-cause mortality|all-cause mortality
384600|NCT01307722|heart failure with hospitalization|heart failure with hospitalization
384601|NCT01307722|the duration of hospitalization|the duration of hospitalization
384602|NCT01307696|Umbilical Hernia Repair|umbilical hernia repair
384603|NCT01307696|PVP Mesh|pvp mesh
384604|NCT01307683|Pregnancy|pregnancy
384605|NCT01307683|Overweight|overweight
384606|NCT01307683|Obese|obese
384607|NCT01307683|Stress|stress
384608|NCT01307683|Mindfulness|mindfulness
384609|NCT01307657|clopidogrel|clopidogrel
384610|NCT01307657|platelet|platelet
384611|NCT01307657|platelet function test|platelet function test
384612|NCT01307657|healthy|healthy
384613|NCT01307657|Platelet function tests|platelet function tests
384614|NCT01307644|Overweight|overweight
384615|NCT01307644|Obesity|obesity
384616|NCT01307644|Rural Health|rural health
384617|NCT01307644|Weight Loss|weight loss
384618|NCT01307644|Weight Maintenance|weight maintenance
384619|NCT01307644|Rural Middle Aged and Older Women|rural middle aged and older women
384620|NCT01307644|Web Intervention Weight Loss|web intervention weight loss
384621|NCT01307644|Class I, II, & III obese (BMI 28 to 45)|class i, ii, & iii obese (bmi 28 to 45)
384622|NCT01307605|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
384623|NCT01307605|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
384624|NCT01307605|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
384625|NCT01307605|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
384626|NCT01307605|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
384627|NCT01307605|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
384628|NCT01307605|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
384629|NCT01307605|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
384630|NCT01307605|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
384631|NCT01307605|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
384632|NCT01307605|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
384633|NCT01307605|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
384634|NCT01307592|peripheral T-cell lymphoma|peripheral t-cell lymphoma
384635|NCT01307592|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
384636|NCT01307592|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
384637|NCT01307592|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
384638|NCT01307592|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
384639|NCT01307514|DIABETES|diabetes
384640|NCT01307514|PHARMACOKINETICS|pharmacokinetics
384641|NCT01307514|PHARMACODYNAMICS|pharmacodynamics
384642|NCT01307514|INSULIN|insulin
384643|NCT01307501|Cryoablation|cryoablation
384644|NCT01307501|Cryotherapy|cryotherapy
384645|NCT01307501|Cryosurgery|cryosurgery
384646|NCT01307501|Metastatic|metastatic
384647|NCT01307501|Lung|lung
384648|NCT01307501|Pleura|pleura
384649|NCT01307501|Tumors|tumors
384650|NCT01307488|HIV|hiv
384651|NCT01307488|AIDS|aids
384652|NCT01307488|Atazanavir|atazanavir
384653|NCT01307488|Simplification|simplification
384654|NCT01307475|Chronic Post-Traumatic Stress Disorder|chronic post-traumatic stress disorder
384655|NCT01307475|Delayed Onset Post-Traumatic Stress Disorder|delayed onset post-traumatic stress disorder
384656|NCT01307475|Post-Traumatic Neuroses|post-traumatic neuroses
384657|NCT01307475|Posttraumatic Neuroses|posttraumatic neuroses
384658|NCT01307475|Post-Traumatic Stress Disorders|post-traumatic stress disorders
384659|NCT01307475|Posttraumatic Stress Disorders|posttraumatic stress disorders
384660|NCT01307475|PTSD|ptsd
384661|NCT01307475|Post TraumaticStress Disorder|post traumaticstress disorder
384662|NCT01307475|Endogenous Depression|endogenous depression
384663|NCT01307475|Neurotic Depression|neurotic depression
384664|NCT01307475|Depressive Syndrome|depressive syndrome
384665|NCT01307475|Melancholia|melancholia
384666|NCT01307475|Depressive Neurosis|depressive neurosis
384667|NCT01307475|Unipolar Depression|unipolar depression
384668|NCT01307475|Depressive Symptoms|depressive symptoms
384669|NCT01307475|Emotional Depression|emotional depression
384670|NCT01307475|Quality of Life|quality of life
384671|NCT01307449|pneumococcal vaccine|pneumococcal vaccine
384672|NCT01307449|immune responses|immune responses
384673|NCT01307436|Hepatitis A Vaccine|hepatitis a vaccine
384674|NCT01307436|Combined Vaccines|combined vaccines
384676|NCT01307436|MMR Vaccine|mmr vaccine
384677|NCT01307423|psoriasis|psoriasis
384678|NCT01307423|Arthritis|arthritis
384679|NCT01307423|Psoriatic Arthritis|psoriatic arthritis
384680|NCT01307423|inflammation|inflammation
384681|NCT01307423|skin condition|skin condition
384682|NCT01307423|inflammatory cells|inflammatory cells
384683|NCT01307423|apremilast|apremilast
384684|NCT01307423|CC-10004|cc-10004
384685|NCT01307423|phosphodiesterase type 4|phosphodiesterase type 4
384686|NCT01307410|Patients with type 2 diabetes and participated in 3B Study|patients with type 2 diabetes and participated in 3b study
384687|NCT01307384|Total hip Arthroplasty|total hip arthroplasty
384688|NCT01307384|Total Hip Replacement (THR)|total hip replacement (thr)
384689|NCT01307384|Primary Hip Arthroplasty|primary hip arthroplasty
384691|NCT01307384|THR|thr
384692|NCT01307371|Bone Marrow Mononuclear cells;|bone marrow mononuclear cells;
384693|NCT01307371|Diabetes;|diabetes;
384694|NCT01307371|ST-segment Elevation Myocardial Infarction;|st-segment elevation myocardial infarction;
403026|NCT01228487|Oxidative Dysbalance|oxidative dysbalance
375595|NCT01345253|PGA|pga
384695|NCT01307371|Percutaneous Coronary Intervention;|percutaneous coronary intervention;
384696|NCT01307371|Left Ventricular Function|left ventricular function
384697|NCT01307332|Multiple Sclerosis|multiple sclerosis
384698|NCT01307332|MS|ms
384699|NCT01307332|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
384700|NCT01307332|RRMS|rrms
384701|NCT01307332|Alemtuzumab|alemtuzumab
384702|NCT01307332|Demyelination|demyelination
384703|NCT01307332|Remyelination|remyelination
384704|NCT01307332|Tolerogenic|tolerogenic
384705|NCT01307332|T cells|t cells
384706|NCT01307332|Demyelinating Autoimmune Diseases, CNS|demyelinating autoimmune diseases, cns
384707|NCT01307332|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
384708|NCT01307332|Nervous System Diseases|nervous system diseases
384709|NCT01307332|Demyelinating Diseases|demyelinating diseases
384710|NCT01307332|Autoimmune Diseases|autoimmune diseases
384711|NCT01307332|Immune System Diseases|immune system diseases
384712|NCT01307319|Allergies|allergies
384713|NCT01307319|Hayfever|hayfever
384714|NCT01307306|Thermal injury|thermal injury
384715|NCT01307306|Chemical Burn|chemical burn
384716|NCT01307306|Flame Burn|flame burn
384717|NCT01307280|Behavioral Weight Management Intervention|behavioral weight management intervention
384718|NCT01307280|weight loss|weight loss
384719|NCT01307280|cost-effective analysis|cost-effective analysis
384720|NCT01307280|high blood pressure|high blood pressure
384721|NCT01307280|randomized clinical trial|randomized clinical trial
384722|NCT01307280|behavioral interventions|behavioral interventions
384723|NCT01307280|physical activity|physical activity
384724|NCT01307280|dietary change|dietary change
384725|NCT01307280|obesity|obesity
384726|NCT01307267|Phase 1|phase 1
384727|NCT01307267|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
384728|NCT01307267|Advanced malignancies|advanced malignancies
384729|NCT01307241|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
384730|NCT01307241|prognostic factor|prognostic factor
384731|NCT01307241|pharmacogenetics.|pharmacogenetics.
384732|NCT01307228|Knowledge translation|knowledge translation
384733|NCT01307228|Policymakers|policymakers
384734|NCT01307228|Health systems|health systems
384735|NCT01307215|TAP block|tap block
384736|NCT01307215|incision pain|incision pain
384737|NCT01307215|total hysterectomy|total hysterectomy
384738|NCT01307202|knee|knee
384739|NCT01307202|arthroplasty|arthroplasty
384740|NCT01307202|postoperative pain|postoperative pain
384741|NCT01307202|gabapentin|gabapentin
384742|NCT01307189|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
384743|NCT01307189|Exercise|exercise
384744|NCT01307189|Endurance shuttle walking test|endurance shuttle walking test
384745|NCT01307189|Bronchodilation|bronchodilation
384746|NCT01307189|Tiotropium|tiotropium
384747|NCT01307176|ataxia|ataxia
384748|NCT01307176|exercise|exercise
384749|NCT01307176|training|training
384750|NCT01307176|cerebellar|cerebellar
384751|NCT01307176|rehabilitation|rehabilitation
384752|NCT01307163|saliva|saliva
384753|NCT01307163|liver transplantation|liver transplantation
384754|NCT01307163|children|children
384755|NCT01307163|In this prospective study 60 subjects will be examined|in this prospective study 60 subjects will be examined
384756|NCT01307163|children and adolescents|children and adolescents
384757|NCT01307163|after a successful liver transplantation|after a successful liver transplantation
384758|NCT01307163|informed consent forms signed be the examinees parents|informed consent forms signed be the examinees parents
384759|NCT01307150|Atopic Dermatitis|atopic dermatitis
384760|NCT01307150|Dead Sea|dead sea
384761|NCT01307150|Climatotherapy|climatotherapy
384762|NCT01307150|SCORAD|scorad
384763|NCT01307124|safety and efficacy|safety and efficacy
384764|NCT01307124|low dose LPV/r|low dose lpv/r
384765|NCT01307124|standard dose LPV/r|standard dose lpv/r
384766|NCT01307124|HIV infected children|hiv infected children
384767|NCT01307111|Misoprostol|misoprostol
384768|NCT01307111|IUD insertion|iud insertion
384769|NCT01307111|Nulliparous Women|nulliparous women
384770|NCT01307111|Contraception|contraception
384771|NCT01307111|Family Planning|family planning
384772|NCT01307111|IUD insertion in nulliparous women|iud insertion in nulliparous women
384773|NCT01307098|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
384774|NCT01307098|Lysosomal Storage Disease|lysosomal storage disease
384775|NCT01307098|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
384776|NCT01307098|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
384777|NCT01307098|Acid lipase disease|acid lipase disease
384778|NCT01307098|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
384779|NCT01307098|LAL Deficiency|lal deficiency
384780|NCT01307098|LIPA Deficiency|lipa deficiency
384781|NCT01307098|Wolman disease|wolman disease
384782|NCT01307085|remote ischemic preconditioning|remote ischemic preconditioning
384783|NCT01307085|lung injury|lung injury
384784|NCT01307085|pulmonary resection|pulmonary resection
384785|NCT01307072|periodic examinations, compliance|periodic examinations, compliance
384786|NCT01307059|Growth disorders|growth disorders
384787|NCT01307059|Saizen|saizen
384788|NCT01307059|Easypod|easypod
384789|NCT01307059|Growth hormone|growth hormone
384790|NCT01307059|Pediatric subject|pediatric subject
384791|NCT01307046|Essential hypertension|essential hypertension
384792|NCT01307046|Uncontrolled hypertension|uncontrolled hypertension
384793|NCT01307046|Antihypertensive agents|antihypertensive agents
384794|NCT01307046|Blood pressure|blood pressure
384795|NCT01307033|Essential hypertension|essential hypertension
384796|NCT01307033|Uncontrolled hypertension|uncontrolled hypertension
384797|NCT01307033|Antihypertensive agents|antihypertensive agents
384798|NCT01307033|Blood pressure|blood pressure
384799|NCT01307020|Moderate to severe pain|moderate to severe pain
384800|NCT01307020|Postoperative pain|postoperative pain
384801|NCT01307020|Analgesics|analgesics
384802|NCT01307020|Dexketoprofen|dexketoprofen
384803|NCT01307020|Tramadol|tramadol
384804|NCT01306994|Exercise Test|exercise test
384805|NCT01306994|Bicycle Ergometry Test|bicycle ergometry test
384806|NCT01306994|Stress Test|stress test
384807|NCT01306981|Diabetes Mellitus|diabetes mellitus
384808|NCT01306981|Diabetes Complications|diabetes complications
384809|NCT01306981|Retinal Diseases|retinal diseases
384810|NCT01306981|Endothelial Growth Factors|endothelial growth factors
384811|NCT01306981|Monoclonal Antibodies|monoclonal antibodies
384812|NCT01306981|Ranibizumab|ranibizumab
384813|NCT01306981|Vitrectomy|vitrectomy
384814|NCT01306981|Vitreoretinal Surgery|vitreoretinal surgery
384815|NCT01306968|mild tramatic brain injury|mild tramatic brain injury
384816|NCT01306968|mTBI|mtbi
384817|NCT01306968|hyperbaric oxygen|hyperbaric oxygen
384818|NCT01306968|post concussive symptoms|post concussive symptoms
384819|NCT01306968|active duty military|active duty military
384820|NCT01306968|veterans|veterans
384821|NCT01306955|retinal vasculitis|retinal vasculitis
384822|NCT01306955|posterior uveitis|posterior uveitis
384823|NCT01306955|methylprednisolone|methylprednisolone
384824|NCT01306942|HER2+ metastatic breast cancer|her2+ metastatic breast cancer
384825|NCT01306942|first line treatment|first line treatment
384826|NCT01306929|Huntington Disease.|huntington disease.
384827|NCT01306916|thyroid disease, hyperthyroidism|thyroid disease, hyperthyroidism
384828|NCT01306903|Minimizing Cardiopulmonary Bypass MECC damage organ failure|minimizing cardiopulmonary bypass mecc damage organ failure
384829|NCT01306877|hemorrhoid|hemorrhoid
384830|NCT01306877|hemorrhoid stapler|hemorrhoid stapler
384831|NCT01306864|Endoscopic Hemostasis|endoscopic hemostasis
384832|NCT01306864|Peptic Ulcer|peptic ulcer
384833|NCT01306864|Recurrent Bleeding|recurrent bleeding
384834|NCT01306864|Injection Therapy|injection therapy
384835|NCT01306864|Thermal Probe|thermal probe
384836|NCT01306851|fibrin glue|fibrin glue
384837|NCT01306851|anastomotic leak|anastomotic leak
384838|NCT01306851|gastrointestinal high risk anastomosis|gastrointestinal high risk anastomosis
384839|NCT01306838|Short bowel syndrome|short bowel syndrome
384840|NCT01306838|Necrotizing enterocolitis|necrotizing enterocolitis
384841|NCT01306838|Small intestine perforation|small intestine perforation
384842|NCT01306838|Enterostomy|enterostomy
384843|NCT01306838|Intralipid|intralipid
384844|NCT01306838|Microlipid|microlipid
384845|NCT01306838|Fish oil|fish oil
384846|NCT01306825|Daptomycin|daptomycin
384847|NCT01306825|Bone disease,infectious|bone disease,infectious
384848|NCT01306825|Osteomyelitis|osteomyelitis
384849|NCT01306825|Diabetic foot|diabetic foot
384850|NCT01306825|Staphylococcus aureus|staphylococcus aureus
384851|NCT01306812|Adolescent|adolescent
384852|NCT01306812|Alcohol|alcohol
384853|NCT01306812|Criminology|criminology
384854|NCT01306812|Genes|genes
384855|NCT01306812|Environment|environment
384856|NCT01306812|Mono amine Oxidase|mono amine oxidase
384857|NCT01306812|Serotonin|serotonin
384858|NCT01306812|Social Support|social support
384859|NCT01306799|Barrett's Esophagus|barrett's esophagus
384860|NCT01306799|Erosive Esophagitis|erosive esophagitis
384861|NCT01306799|Proton Pump Inhibitor (PPI)|proton pump inhibitor (ppi)
384862|NCT01306799|Bone|bone
384863|NCT01306799|Bone Density|bone density
384864|NCT01306799|GERD|gerd
384865|NCT01306799|ulcer prophylaxis|ulcer prophylaxis
384866|NCT01306773|Influenza A|influenza a
384867|NCT01306773|convalescent plasma|convalescent plasma
384868|NCT01306773|death|death
384869|NCT01306760|depression|depression
384870|NCT01306760|electroconvulsive therapy|electroconvulsive therapy
384871|NCT01306760|ketamine|ketamine
384872|NCT01306747|Chronic pain|chronic pain
384873|NCT01306747|Stanford chronic pain self-management programme|stanford chronic pain self-management programme
384874|NCT01306747|Patient education|patient education
384875|NCT01306734|Extracorporeal circulation|extracorporeal circulation
384876|NCT01306734|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
384877|NCT01306734|aortic aneurism|aortic aneurism
384878|NCT01306734|neurological injury|neurological injury
384879|NCT01306734|inflammation|inflammation
384880|NCT01306734|coagulation|coagulation
384881|NCT01306708|Adhesive Capsulitis|adhesive capsulitis
384882|NCT01306708|Shoulder|shoulder
384883|NCT01306708|SPADI|spadi
384884|NCT01306695|Dementia|dementia
384885|NCT01306695|Depressive symptoms|depressive symptoms
384886|NCT01306695|Caregiver Burden|caregiver burden
384887|NCT01306695|Hispanic|hispanic
384888|NCT01306695|Latino|latino
384889|NCT01306695|Intervention|intervention
384890|NCT01306695|Geriatric Depression Scale|geriatric depression scale
384891|NCT01306695|Zarit Caregiver Burden Scale|zarit caregiver burden scale
384892|NCT01306656|Endocrinology|endocrinology
384893|NCT01306656|Metabolic Bone Disease|metabolic bone disease
384894|NCT01306656|Primary Hyperparathyroidism|primary hyperparathyroidism
384895|NCT01306656|PHPT|phpt
384896|NCT01306656|Vitamin D Deficiency|vitamin d deficiency
384897|NCT01306656|Bone Mineral Density|bone mineral density
384898|NCT01306656|Hyper-calcemia|hyper-calcemia
384899|NCT01306643|Indolent Non-Hodgkin's Lymphoma|indolent non-hodgkin's lymphoma
384900|NCT01306643|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
384901|NCT01306643|iNHL|inhl
384903|NCT01306643|CAL-101|cal-101
384904|NCT01306643|PI3K|pi3k
384905|NCT01306643|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
384906|NCT01306643|Follicular Lymphoma (FL)|follicular lymphoma (fl)
384907|NCT01306643|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
384908|NCT01306643|Marginal Zone Lymphoma (MZL)|marginal zone lymphoma (mzl)
384909|NCT01306630|AV-951|av-951
384910|NCT01306630|tivozanib|tivozanib
384911|NCT01306630|capecitabine (Xeloda®)|capecitabine (xeloda®)
384912|NCT01306604|Genetic Diseases|genetic diseases
384913|NCT01306604|Lipidoses|lipidoses
384914|NCT01306604|Lipid Metabolism|lipid metabolism
384915|NCT01306604|Lysosomal Storage Diseases|lysosomal storage diseases
384916|NCT01306604|Metabolic Diseases|metabolic diseases
384917|NCT01306604|Lipid Metabolism Disorders|lipid metabolism disorders
384918|NCT01306591|neovascular age-related macular degeneration|neovascular age-related macular degeneration
384919|NCT01306591|Bevacizumab|bevacizumab
384920|NCT01306591|Multicenter Randomized Study|multicenter randomized study
384921|NCT01306578|Guillain Barre syndrome|guillain barre syndrome
384922|NCT01306578|IVIG|ivig
384923|NCT01306578|Plasma exchange|plasma exchange
384924|NCT01306565|Unstable angina|unstable angina
384925|NCT01306565|NSTMI|nstmi
384926|NCT01306565|Statin|statin
384927|NCT01306565|Atorvastatin|atorvastatin
384928|NCT01306552|Tobacco use|tobacco use
384929|NCT01306552|Adolescents|adolescents
384930|NCT01306552|Primary prevention|primary prevention
384931|NCT01306552|Program effectiveness|program effectiveness
384932|NCT01306552|Parental component|parental component
384933|NCT01306539|deep brain stimulation|deep brain stimulation
384934|NCT01306539|subthalamic nucleus|subthalamic nucleus
384935|NCT01306526|Thin-cap fibroatheroma|thin-cap fibroatheroma
384936|NCT01306526|Vulnerable plaque|vulnerable plaque
384937|NCT01306526|Coronary artery disease|coronary artery disease
384938|NCT01306526|Obstructive sleep apnea|obstructive sleep apnea
384939|NCT01306526|Intravascular Ultrasound|intravascular ultrasound
384940|NCT01306513|emphysema|emphysema
384941|NCT01306513|lung volume reduction surgery|lung volume reduction surgery
384942|NCT01306513|mesenchymal stromal cells|mesenchymal stromal cells
384943|NCT01306500|Gastric lavage|gastric lavage
384944|NCT01306500|Neonate|neonate
384945|NCT01306500|Meconium stained amniotic fluid|meconium stained amniotic fluid
384946|NCT01306500|Feeding problems|feeding problems
384947|NCT01306487|macular hole|macular hole
384948|NCT01306474|CD4/CD25 Tr cell,TNF,IFN-γ,IL-2|cd4/cd25 tr cell,tnf,ifn-γ,il-2
384949|NCT01306448|constipation|constipation
384950|NCT01306448|gastro|gastro
384951|NCT01306448|vibrating capsule|vibrating capsule
384952|NCT01306448|safety|safety
384953|NCT01306435|Osteoarthritis|osteoarthritis
384954|NCT01306435|Low Power Laser Therapy|low power laser therapy
384955|NCT01306435|Exercise|exercise
384956|NCT01306435|Knee|knee
384957|NCT01306422|hoodia gordonii|hoodia gordonii
384958|NCT01306422|energy intake|energy intake
384959|NCT01306422|food intake|food intake
384960|NCT01306422|efficacy|efficacy
384961|NCT01306422|body weight|body weight
384962|NCT01306422|functional food|functional food
384963|NCT01306422|plant extract|plant extract
384964|NCT01306422|safety|safety
384965|NCT01306422|steroid glycosides|steroid glycosides
384966|NCT01306422|tolerability|tolerability
384967|NCT01306409|anemia|anemia
384968|NCT01306409|kidney disease|kidney disease
384969|NCT01306396|NAFLD|nafld
384970|NCT01306396|metabolic syndrome|metabolic syndrome
384971|NCT01306396|children|children
384972|NCT01306396|fructose|fructose
384973|NCT01306383|SODIS|sodis
384974|NCT01306383|waterborne|waterborne
384975|NCT01306383|Disease|disease
384976|NCT01306383|Diarrhoea|diarrhoea
384977|NCT01306383|dysentery|dysentery
384978|NCT01306370|primary knee arthroplasty|primary knee arthroplasty
384979|NCT01306370|fibrin glue|fibrin glue
384980|NCT01306370|tranexamic acid|tranexamic acid
384981|NCT01306370|topic|topic
384982|NCT01306357|Turner's syndrome|turner's syndrome
384983|NCT01306357|somatropin|somatropin
384984|NCT01306357|human growth hormone deficiency|human growth hormone deficiency
384985|NCT01306344|Qualitative Research|qualitative research
384986|NCT01306344|Interview, Psychological|interview, psychological
384987|NCT01306344|Patients|patients
384988|NCT01306344|Nurses|nurses
384989|NCT01306344|Physicians|physicians
384990|NCT01306305|Influenza|influenza
384991|NCT01306305|Virus|virus
384992|NCT01306305|Vaccination|vaccination
384993|NCT01306305|Immunisation|immunisation
384994|NCT01306292|Pulmonary hypertension|pulmonary hypertension
384995|NCT01306292|Right heart Catheterization|right heart catheterization
384996|NCT01306279|Cystic Fibrosis|cystic fibrosis
384997|NCT01306279|Infection|infection
384998|NCT01306279|Pulmonary exacerbation|pulmonary exacerbation
384999|NCT01306279|Hypermutators|hypermutators
385000|NCT01306279|Bacterial diversity|bacterial diversity
385001|NCT01306279|Quorum sensing|quorum sensing
385002|NCT01306266|active duty|active duty
385003|NCT01306266|blast induced|blast induced
385004|NCT01306266|headache|headache
385005|NCT01306253|Influenza|influenza
385006|NCT01306253|Virus|virus
385007|NCT01306253|Vaccination|vaccination
385008|NCT01306253|Immunisation|immunisation
385009|NCT01306240|Infant newborn|infant newborn
385010|NCT01306240|Infant preterm|infant preterm
385011|NCT01306240|Acute respiratory distress syndrome|acute respiratory distress syndrome
385012|NCT01306240|surfactant|surfactant
385013|NCT01306240|Hyaline Membrane disease|hyaline membrane disease
385014|NCT01306240|Newborn acute respiratory distress syndrome (ARDS)|newborn acute respiratory distress syndrome (ards)
385015|NCT01306227|Infant, newborn|infant, newborn
385016|NCT01306227|Infant, preterm|infant, preterm
385017|NCT01306227|Thyroid|thyroid
385018|NCT01306227|Outcome|outcome
385019|NCT01306227|Newborns less than 32 weeks of gestation|newborns less than 32 weeks of gestation
385020|NCT01306227|TSH < 20 mIU/L and a FT4 < 0.80 ng/dL|tsh < 20 miu/l and a ft4 < 0.80 ng/dl
385021|NCT01306201|Hospital Setting|hospital setting
385022|NCT01306188|metastatic cancer|metastatic cancer
385023|NCT01306188|lymphopenia|lymphopenia
385024|NCT01306188|T cell receptor diversity|t cell receptor diversity
385025|NCT01306149|biochemical parameters|biochemical parameters
385026|NCT01306149|mineral metabolism|mineral metabolism
385027|NCT01306149|protein-bound uremic retention solutes|protein-bound uremic retention solutes
385028|NCT01306149|incident PD patients|incident pd patients
385029|NCT01306136|Posttraumatic stress disorder|posttraumatic stress disorder
385030|NCT01306136|Prolonged exposure|prolonged exposure
385031|NCT01306136|Cognitive behavior therapy|cognitive behavior therapy
385032|NCT01306123|bioavailability|bioavailability
385033|NCT01306123|pharmacokinetics|pharmacokinetics
385034|NCT01306123|cyanocobalamin|cyanocobalamin
385035|NCT01306123|intranasal|intranasal
385036|NCT01306123|intramuscular|intramuscular
385037|NCT01306110|Liver fibrosis|liver fibrosis
385038|NCT01306110|diabetes|diabetes
385039|NCT01306110|Fibroscan|fibroscan
385040|NCT01306110|Fibrotest|fibrotest
385041|NCT01306110|noninvasive fibrosis biomarkers|noninvasive fibrosis biomarkers
385042|NCT01306097|Zinc Supplement|zinc supplement
385043|NCT01306097|Diarrhea|diarrhea
385044|NCT01306097|Sever Diarrhea|sever diarrhea
385045|NCT01306084|Respiratory Infections|respiratory infections
385046|NCT01306084|Norovirus|norovirus
385047|NCT01306084|Adenovirus|adenovirus
385048|NCT01306084|Viral Infection|viral infection
385049|NCT01306084|Respiratory Viruses|respiratory viruses
385051|NCT01306071|Natural History|natural history
385052|NCT01306071|Hepatitis B|hepatitis b
385053|NCT01306058|Hepatocellular Carcinoma|hepatocellular carcinoma
385054|NCT01306058|TRC105|trc105
385055|NCT01306058|Sorafenib|sorafenib
385056|NCT01306058|Liver Cancer|liver cancer
385057|NCT01306058|Monoclonal Antibody|monoclonal antibody
385058|NCT01306045|AZD6244|azd6244
385059|NCT01306045|MK-2206|mk-2206
385060|NCT01306045|Lapatinib|lapatinib
385061|NCT01306045|Erlotinib|erlotinib
385062|NCT01306045|Sunitinib|sunitinib
385063|NCT01306045|Lung Cancer|lung cancer
385064|NCT01306045|Thymic Cancer|thymic cancer
385065|NCT01306045|Small Cell Lung Cancer|small cell lung cancer
385066|NCT01306045|Non-Small Cell Lung Cancer|non-small cell lung cancer
385067|NCT01306032|PARP Inhibitor|parp inhibitor
385068|NCT01306032|BRCA Mutations|brca mutations
385069|NCT01306032|DNA Damage Repair|dna damage repair
385070|NCT01306032|Pharmacodynamics|pharmacodynamics
385071|NCT01306032|Metronomic Cyclophosphamide|metronomic cyclophosphamide
385072|NCT01306032|Ovarian Cancer|ovarian cancer
385073|NCT01306032|Breast Cancer|breast cancer
385074|NCT01306032|Fallopian Tube Cancer|fallopian tube cancer
385075|NCT01306032|Peritoneal Cancer|peritoneal cancer
385076|NCT01306019|X-Linked Severe Combined Immunodeficiency (XSCID)|x-linked severe combined immunodeficiency (xscid)
385077|NCT01306019|Gene Transfer|gene transfer
385078|NCT01306019|Peripheral Blood Stem Cells|peripheral blood stem cells
385079|NCT01306019|Common Gamma Chain (GC), Immune Reconstitution|common gamma chain (gc), immune reconstitution
385080|NCT01306019|Immune Reconstitution|immune reconstitution
385081|NCT01306019|X-Linked Severe Combined Immunodeficiency|x-linked severe combined immunodeficiency
470192|NCT00063388|Non|non
385083|NCT01306006|Mortality|mortality
385084|NCT01306006|Vaccines|vaccines
385085|NCT01305954|Breast|breast
385086|NCT01305954|Cancer|cancer
385087|NCT01305954|Breast Cancer|breast cancer
385088|NCT01305954|New Diagnosis|new diagnosis
385089|NCT01305954|Treatment|treatment
385090|NCT01305954|Chemotherapy|chemotherapy
385091|NCT01305954|Blood|blood
385092|NCT01305954|Blood Draw|blood draw
385093|NCT01305954|Lab Draw|lab draw
385094|NCT01305954|Gene|gene
385095|NCT01305954|Gene Therapy|gene therapy
385096|NCT01305954|Geriatric|geriatric
385097|NCT01305954|Oncology|oncology
385098|NCT01305954|Muss|muss
385100|NCT01305954|North Carolina Cancer Hospital|north carolina cancer hospital
385101|NCT01305954|Initial Treatment|initial treatment
385102|NCT01305954|CBC|cbc
385103|NCT01305941|everolimus|everolimus
385104|NCT01305941|trastuzumab|trastuzumab
385105|NCT01305941|vinorelbine|vinorelbine
385107|NCT01305941|Breast Cancer|breast cancer
385108|NCT01305941|Herceptin|herceptin
385109|NCT01305941|Navelbine|navelbine
385110|NCT01305941|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
385111|NCT01305941|Brain Metastases|brain metastases
385112|NCT01305915|single-session group|single-session group
385113|NCT01305915|psychoeducational intervention|psychoeducational intervention
385114|NCT01305889|Depression|depression
385115|NCT01305889|Cerebral perfusion|cerebral perfusion
385116|NCT01305889|Brain derived neurotropic factor|brain derived neurotropic factor
385117|NCT01305889|Problem Solving Therapy|problem solving therapy
385118|NCT01305889|Sertraline|sertraline
385119|NCT01305876|yoga|yoga
385120|NCT01305876|emotional behavioral disorder|emotional behavioral disorder
385121|NCT01305876|intervention|intervention
385122|NCT01305876|school|school
385123|NCT01305876|meditation|meditation
385124|NCT01305876|focus: yoga intervention in students with emotional behavioral disorders in an urban school|focus: yoga intervention in students with emotional behavioral disorders in an urban school
385125|NCT01305863|Peripheral Vascular Disease (PVD)|peripheral vascular disease (pvd)
385126|NCT01305850|Aliskiren|aliskiren
385127|NCT01305850|Losartan|losartan
385128|NCT01305850|Peritoneal membrane dysfunction|peritoneal membrane dysfunction
385129|NCT01305837|multiple sclerosis|multiple sclerosis
385130|NCT01305837|methylprednisolone|methylprednisolone
385131|NCT01305837|osteopontin|osteopontin
385132|NCT01305837|inflammation|inflammation
385133|NCT01305837|demyelinating|demyelinating
385134|NCT01305824|arteriovenous fistula|arteriovenous fistula
385135|NCT01305824|AVF|avf
385136|NCT01305824|hemodialysis|hemodialysis
385137|NCT01305824|vascular access|vascular access
385138|NCT01305824|dialysis|dialysis
385139|NCT01305824|fistula|fistula
385140|NCT01305824|PRT-201|prt-201
385141|NCT01305824|vonapanitase|vonapanitase
385142|NCT01305824|kidney|kidney
385143|NCT01305824|renal|renal
385144|NCT01305811|Complex Medical Illness|complex medical illness
385145|NCT01305811|Gulf War Illness|gulf war illness
385146|NCT01305811|Veteran|veteran
385147|NCT01305798|Biometric Screenings|biometric screenings
385148|NCT01305798|Active Choice|active choice
385149|NCT01305798|Behavioral Economics|behavioral economics
385150|NCT01305798|Default|default
385151|NCT01305772|SCCHN|scchn
385152|NCT01305772|untreated|untreated
385153|NCT01305772|Stage III or IVa-b (M0)|stage iii or iva-b (m0)
385154|NCT01305759|Total knee arthroplasty|total knee arthroplasty
385155|NCT01305759|Total hip arthroplasty|total hip arthroplasty
385156|NCT01305759|Peri acetabular osteotomy|peri acetabular osteotomy
385157|NCT01305759|Social class|social class
385158|NCT01305759|Health related quality of life|health related quality of life
385159|NCT01305746|SLE|sle
385160|NCT01305746|Lupus|lupus
385161|NCT01305746|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
385162|NCT01305746|A-623|a-623
385163|NCT01305746|Autoimmune Diseases|autoimmune diseases
385164|NCT01305746|Blisibimod|blisibimod
385165|NCT01305733|Pain relief|pain relief
385166|NCT01305720|mydriatic|mydriatic
385167|NCT01305720|NIRS|nirs
385168|NCT01305720|preterm|preterm
385169|NCT01305720|eye drops|eye drops
385170|NCT01305720|cerebral|cerebral
385171|NCT01305720|mesenteric oxygenation|mesenteric oxygenation
385172|NCT01305707|Consolidation ECT|consolidation ect
385173|NCT01305707|Pharmacotherapy|pharmacotherapy
385175|NCT01305707|Depression|depression
385176|NCT01305707|Prevention|prevention
385177|NCT01305707|Electroconvulsive therapy|electroconvulsive therapy
385178|NCT01305707|Drug therapy|drug therapy
385179|NCT01305668|COPD|copd
385180|NCT01305668|Emphysema phenotype|emphysema phenotype
385181|NCT01305655|Drug: Glucarpidase|drug: glucarpidase
385182|NCT01305642|Postnatal development|postnatal development
385183|NCT01305642|Breast milk fortification|breast milk fortification
385184|NCT01305642|Composition of breast milk|composition of breast milk
385185|NCT01305629|HIV|hiv
385186|NCT01305629|Medication Adherence|medication adherence
385187|NCT01305629|Substance Use|substance use
376081|NCT01343238|obesity|obesity
385188|NCT01305629|Older adults|older adults
385189|NCT01305629|Treatment|treatment
385190|NCT01305616|Open angle Glaucoma|open angle glaucoma
385191|NCT01305616|Yellow-tinted intraocular lens|yellow-tinted intraocular lens
385192|NCT01305616|Short-wavelength Automated Perimetry (SWAP)|short-wavelength automated perimetry (swap)
385193|NCT01305616|Standard Automated Perimetry (SAP)|standard automated perimetry (sap)
385194|NCT01305616|cataract|cataract
385195|NCT01305590|HIV|hiv
385196|NCT01305590|AIDS|aids
385197|NCT01305590|Medication Adherence|medication adherence
385198|NCT01305590|Commitment Devices|commitment devices
385199|NCT01305590|Behavioral Economics|behavioral economics
385200|NCT01305564|Pulmonary embolism (PE)|pulmonary embolism (pe)
385201|NCT01305564|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
385202|NCT01305564|Vena cava|vena cava
385203|NCT01305564|Vena cava filter|vena cava filter
385204|NCT01305564|Inferior vena cava|inferior vena cava
385205|NCT01305564|Venous thromboembolic disease (VTED)|venous thromboembolic disease (vted)
385206|NCT01305525|SCS|scs
385207|NCT01305525|St. Jude Medical|st. jude medical
385208|NCT01305525|Neuromodulation|neuromodulation
385209|NCT01305512|Solid|solid
385210|NCT01305512|Tumor|tumor
385211|NCT01305512|Taxane|taxane
385212|NCT01305499|AML|aml
385213|NCT01305447|smoking cessation|smoking cessation
385214|NCT01305447|exercise maintenance|exercise maintenance
385215|NCT01305447|preventing relapse|preventing relapse
385216|NCT01305447|weight gain|weight gain
385217|NCT01305447|group-mediated cognitive behavioural therapy|group-mediated cognitive behavioural therapy
385218|NCT01305434|diabetes mellitus type 2|diabetes mellitus type 2
385219|NCT01305434|mulberry leaf extract|mulberry leaf extract
385220|NCT01305434|post prandial blood glucose|post prandial blood glucose
385221|NCT01305421|ICU|icu
385222|NCT01305421|muscle strength|muscle strength
385223|NCT01305421|mechanical ventilation|mechanical ventilation
385224|NCT01305421|weaning|weaning
385225|NCT01305408|Bipolar I Disorder|bipolar i disorder
385226|NCT01305395|Cardiac Allograft Vasculopathy in Heart Transplant|cardiac allograft vasculopathy in heart transplant
385227|NCT01305382|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
385228|NCT01305369|ASTHMA|asthma
385229|NCT01305369|PLATELET RECEPTOR P2Y12|platelet receptor p2y12
385230|NCT01305369|PRASUGREL|prasugrel
385231|NCT01305369|INFLAMMATION|inflammation
385232|NCT01305356|degenerative joint disease|degenerative joint disease
385233|NCT01305356|DJD|djd
385234|NCT01305356|joint fusion|joint fusion
385235|NCT01305356|hindfoot|hindfoot
385236|NCT01305356|congenital deformity|congenital deformity
385237|NCT01305356|osteoarthritis|osteoarthritis
385238|NCT01305356|rheumatoid arthritis|rheumatoid arthritis
385239|NCT01305356|post-traumatic arthritis|post-traumatic arthritis
385240|NCT01305356|ankylosing spondylitis|ankylosing spondylitis
385241|NCT01305356|Augment(tm) Injectable Bone Graft|augment(tm) injectable bone graft
385242|NCT01305356|autologous bone graft|autologous bone graft
385243|NCT01305356|autogenous bone graft|autogenous bone graft
385244|NCT01305356|beta-TCP|beta-tcp
385245|NCT01305356|bovine collagen|bovine collagen
385246|NCT01305356|rhPDGF(bb)|rhpdgf(bb)
385247|NCT01305343|Spinal Deformity|spinal deformity
385248|NCT01305343|Scoliosis|scoliosis
385249|NCT01305343|Neurologic complications|neurologic complications
385250|NCT01305330|small renal mass|small renal mass
385251|NCT01305330|active surveillance|active surveillance
385252|NCT01305330|kidney mass|kidney mass
385253|NCT01305330|kidney tumour|kidney tumour
385254|NCT01305317|Statin|statin
385255|NCT01305291|dietary fiber|dietary fiber
385256|NCT01305291|satiety response|satiety response
385257|NCT01305291|hunger|hunger
385258|NCT01305291|CCK|cck
385259|NCT01305291|PYY|pyy
385260|NCT01305291|ghrelin|ghrelin
385261|NCT01305291|GIP|gip
385262|NCT01305291|GLP-1|glp-1
385263|NCT01305278|Balance|balance
385264|NCT01305278|Rehabilitation|rehabilitation
385265|NCT01305278|Vestibular|vestibular
385266|NCT01305265|sore throat|sore throat
385267|NCT01305265|dysphagia|dysphagia
385268|NCT01305265|hoarseness|hoarseness
385269|NCT01305265|post operative|post operative
385270|NCT01305265|endotracheal intubation|endotracheal intubation
385271|NCT01305239|Observational|observational
385272|NCT01305239|epidemiological|epidemiological
385273|NCT01305239|cohort|cohort
385274|NCT01305239|cross-sectional|cross-sectional
385279|NCT01305226|THR 100|thr 100
385280|NCT01305174|Common Iliac Artery and External Iliac Artery|common iliac artery and external iliac artery
385281|NCT01305161|1Allergy|1allergy
385282|NCT01305161|2 Neuromuscular blockers|2 neuromuscular blockers
385283|NCT01305148|warfarin|warfarin
385284|NCT01305148|genetic testing|genetic testing
385285|NCT01305148|personalized medicine|personalized medicine
385286|NCT01305148|anti-coagulants|anti-coagulants
385287|NCT01305148|coumadin|coumadin
385288|NCT01305135|myelodysplastic syndrome, azacitidine, idarubicin|myelodysplastic syndrome, azacitidine, idarubicin
385289|NCT01305122|Glioma|glioma
385290|NCT01305122|Neurocognitive functions|neurocognitive functions
385291|NCT01305096|heart rate variability|heart rate variability
385292|NCT01305096|oxygen uptake|oxygen uptake
385293|NCT01305096|heart rate recovery|heart rate recovery
385294|NCT01305096|perceived stress|perceived stress
385295|NCT01305096|sleep|sleep
385296|NCT01305096|blood pressure|blood pressure
385297|NCT01305096|body mass index|body mass index
385298|NCT01305096|body weight|body weight
385299|NCT01305096|hand grip strength|hand grip strength
385300|NCT01305096|sleep quality|sleep quality
385301|NCT01305096|subjective health complaints|subjective health complaints
385302|NCT01305096|blood lipids|blood lipids
385303|NCT01305096|salivary cortisol|salivary cortisol
385304|NCT01305096|blood sugar|blood sugar
385305|NCT01305096|HbA1C|hba1c
385306|NCT01305096|Adiponectin|adiponectin
385307|NCT01305096|Leptin|leptin
385308|NCT01305096|Adipolipoproteins|adipolipoproteins
385309|NCT01305096|blood proteins|blood proteins
385310|NCT01305096|cytokines|cytokines
385311|NCT01305096|insomnia|insomnia
385446|NCT01304550|hemoglobin|hemoglobin
385316|NCT01305070|Angioplasty with paclitaxel-eluting balloon|angioplasty with paclitaxel-eluting balloon
385317|NCT01305070|Superficial femoral artery|superficial femoral artery
385318|NCT01305057|dry skin condition|dry skin condition
385319|NCT01305044|tai chi|tai chi
385320|NCT01305044|elderly cancer survivor|elderly cancer survivor
385321|NCT01305044|mind body intervention|mind body intervention
385322|NCT01305031|Asphyxia|asphyxia
385323|NCT01305031|Resuscitation|resuscitation
385324|NCT01305031|Room Air|room air
385325|NCT01305018|Branched-chain amino acids|branched-chain amino acids
385326|NCT01305018|Leucine|leucine
385327|NCT01305018|Muscle damage|muscle damage
385328|NCT01305018|Inflammation|inflammation
385329|NCT01305018|supplementation|supplementation
385330|NCT01305018|resistance exercise-induced|resistance exercise-induced
385331|NCT01305005|blood flow|blood flow
385332|NCT01304992|Dietary protein|dietary protein
385333|NCT01304992|Lupin protein|lupin protein
385334|NCT01304992|Cholesterol metabolism|cholesterol metabolism
385335|NCT01304992|Protein metabolism|protein metabolism
385336|NCT01304992|Hypercholesterolemia|hypercholesterolemia
385337|NCT01304992|Protein-enriched drinks|protein-enriched drinks
385338|NCT01304979|acupuncture|acupuncture
385339|NCT01304979|auricular acu-therapy|auricular acu-therapy
385340|NCT01304979|gua sha therapy|gua sha therapy
385341|NCT01304979|low back 'spine fusion'|low back 'spine fusion'
385342|NCT01304979|post surgical pain|post surgical pain
385343|NCT01304979|post surgical recovery|post surgical recovery
385344|NCT01304979|Pain and recovery from 'spine fusion' surgery|pain and recovery from 'spine fusion' surgery
385345|NCT01304966|RRP|rrp
385346|NCT01304966|HPV|hpv
385347|NCT01304953|General anaesthetics|general anaesthetics
385348|NCT01304953|gynaecological laparoscopy|gynaecological laparoscopy
385349|NCT01304953|anaesthetic i.v.|anaesthetic i.v.
385350|NCT01304953|propofol|propofol
385351|NCT01304953|anaesthetic volatile|anaesthetic volatile
385352|NCT01304953|evoflurane|evoflurane
385353|NCT01304953|antiemetics|antiemetics
385354|NCT01304953|reopisetron|reopisetron
385355|NCT01304953|postoperative pain|postoperative pain
385359|NCT01304927|Reproduction|reproduction
385360|NCT01304927|Sex hormones|sex hormones
385361|NCT01304927|Glucose metabolism|glucose metabolism
385362|NCT01304927|Bone metabolism|bone metabolism
385363|NCT01304927|Calcium|calcium
385364|NCT01304927|Sperm|sperm
385365|NCT01304927|testis|testis
385366|NCT01304927|bone|bone
385367|NCT01304927|endocrinology|endocrinology
385368|NCT01304914|Respiratory tract infections|respiratory tract infections
385369|NCT01304914|Gastrointestinal tract infections|gastrointestinal tract infections
385370|NCT01304914|Pediatrics|pediatrics
385371|NCT01304914|Specimen collection|specimen collection
385372|NCT01304901|Acute asthma|acute asthma
385373|NCT01304901|Children|children
385374|NCT01304901|Montelukast|montelukast
385375|NCT01304901|Emergency room|emergency room
385376|NCT01304888|Food consumption|food consumption
385377|NCT01304875|Fabry disease|fabry disease
385378|NCT01304875|alpha-galactosidase deficiency|alpha-galactosidase deficiency
385379|NCT01304875|exercise|exercise
385380|NCT01304875|pulmonary|pulmonary
385381|NCT01304849|Hodgkin's Lymphoma|hodgkin's lymphoma
385382|NCT01304849|PET CT scan|pet ct scan
385383|NCT01304849|Escalated BEACOPP|escalated beacopp
385384|NCT01304849|ABVD|abvd
385385|NCT01304849|Response adapted therapy|response adapted therapy
385390|NCT01304823|T1R2/T1R3|t1r2/t1r3
385391|NCT01304823|gastric emptying|gastric emptying
385392|NCT01304823|gut|gut
385393|NCT01304823|lactisole|lactisole
385394|NCT01304823|nutrient sensing|nutrient sensing
385395|NCT01304810|NicVAX|nicvax
385396|NCT01304810|Smoking cessation|smoking cessation
385397|NCT01304797|MM302|mm302
385398|NCT01304797|Breast Cancer|breast cancer
385399|NCT01304797|Locally advanced/unresectable|locally advanced/unresectable
385400|NCT01304797|metastatic|metastatic
385401|NCT01304784|Solid tumors|solid tumors
385402|NCT01304784|Failed at least one line of standard therapy|failed at least one line of standard therapy
385403|NCT01304771|Safety|safety
385404|NCT01304771|AKSB|aksb
385405|NCT01304771|probiotic|probiotic
385406|NCT01304771|synbiotic|synbiotic
385407|NCT01304771|enterococcus|enterococcus
385408|NCT01304771|Saccharomyces|saccharomyces
385409|NCT01304771|elderly|elderly
385410|NCT01304771|influenza|influenza
385411|NCT01304771|vaccine|vaccine
385412|NCT01304771|immune|immune
385413|NCT01304771|response|response
385414|NCT01304693|AMD|amd
385415|NCT01304693|Wet AMD|wet amd
385416|NCT01304693|Exudative|exudative
385417|NCT01304693|CNV|cnv
385418|NCT01304667|Vulvar cancer|vulvar cancer
385419|NCT01304667|Radiotherapy|radiotherapy
385420|NCT01304667|Chemotherapy|chemotherapy
385421|NCT01304654|acute lung injury|acute lung injury
385422|NCT01304654|respiratory distress syndrome|respiratory distress syndrome
385423|NCT01304654|neoplasms|neoplasms
385424|NCT01304654|child|child
385425|NCT01304641|Dyslipidemia|dyslipidemia
385426|NCT01304641|Cardiovascular|cardiovascular
385427|NCT01304641|Statin|statin
385428|NCT01304628|asthma|asthma
385429|NCT01304615|Overweight|overweight
385430|NCT01304615|Obesity|obesity
385431|NCT01304615|Young Adults|young adults
385432|NCT01304615|Energy Density|energy density
385433|NCT01304615|Culinary Skills|culinary skills
385434|NCT01304615|Physical Activity|physical activity
385435|NCT01304615|Consumption of Self-made Meals|consumption of self-made meals
385436|NCT01304615|Family History of diabetes|family history of diabetes
385437|NCT01304602|colorectal cancer|colorectal cancer
385438|NCT01304602|BKM120|bkm120
385439|NCT01304602|irinotecan|irinotecan
385440|NCT01304589|provoked vestibulodynia|provoked vestibulodynia
385441|NCT01304589|vulvodynia|vulvodynia
385442|NCT01304589|PVD|pvd
385443|NCT01304576|stroke|stroke
385444|NCT01304576|parietal lesions|parietal lesions
385445|NCT01304550|non-invasive|non-invasive
385447|NCT01304524|CIN 2/3 or CIN 3|cin 2/3 or cin 3
385448|NCT01304524|Cervical cancer|cervical cancer
385449|NCT01304524|Papillomavirus|papillomavirus
385450|NCT01304485|Recurrent Prostate Carcinoma|recurrent prostate carcinoma
385451|NCT01304485|sodium acetate c11|sodium acetate c11
385452|NCT01304485|PET|pet
385453|NCT01304485|prostate cancer|prostate cancer
385454|NCT01304485|rising PSA|rising psa
385455|NCT01304485|PSA recurrence|psa recurrence
385456|NCT01304485|biochemical recurrence|biochemical recurrence
385457|NCT01304472|coronary angioplasty|coronary angioplasty
385458|NCT01304472|clopidogrel resistance|clopidogrel resistance
385459|NCT01304472|prasugrel|prasugrel
385460|NCT01304446|Nutritional support|nutritional support
385461|NCT01304446|Cancer|cancer
385462|NCT01304446|Malnutrition|malnutrition
385463|NCT01304446|Child|child
385464|NCT01304446|Adolescent|adolescent
385465|NCT01304446|pediatric|pediatric
385466|NCT01304420|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
385467|NCT01304420|Ultrasonography|ultrasonography
385468|NCT01304420|Cartilage|cartilage
385469|NCT01304420|Cartilage biomarkers|cartilage biomarkers
385470|NCT01304420|Bone biomarkers|bone biomarkers
385471|NCT01304407|Rothmund-Thomson Syndrome|rothmund-thomson syndrome
385472|NCT01304407|Calcium absorption|calcium absorption
385473|NCT01304407|Bone density|bone density
385474|NCT01304394|Parenteral Nutrition|parenteral nutrition
385475|NCT01304394|Multi Chamber Bag|multi chamber bag
385476|NCT01304381|Heart failure|heart failure
385477|NCT01304381|Palliative care|palliative care
385478|NCT01304381|Integrated care|integrated care
385479|NCT01304368|Hyperthermia, Induced|hyperthermia, induced
385581|NCT01303952|eculizumab|eculizumab
385480|NCT01304368|Randomized Controlled Trial|randomized controlled trial
385481|NCT01304368|Neck Pain|neck pain
385482|NCT01304368|Sensory Thresholds|sensory thresholds
385483|NCT01304368|Pain Measurements|pain measurements
385484|NCT01304355|IBS|ibs
385485|NCT01304355|Cognition|cognition
385486|NCT01304355|Kynurenine Pathway|kynurenine pathway
385487|NCT01304355|Gastrointestinal|gastrointestinal
385488|NCT01304342|Propofol|propofol
385489|NCT01304342|remifentanil|remifentanil
385490|NCT01304342|fentanyl|fentanyl
385491|NCT01304342|ERCP|ercp
385492|NCT01304342|Quality of sedation|quality of sedation
385493|NCT01304342|recovery|recovery
385494|NCT01304342|satisfaction|satisfaction
385495|NCT01304342|respiratory depression|respiratory depression
385496|NCT01304303|solid|solid
385497|NCT01304303|tumor|tumor
385498|NCT01304303|taxane|taxane
385499|NCT01304303|platinum|platinum
385500|NCT01304290|inflammatory process|inflammatory process
385501|NCT01304290|hyperglycaemia|hyperglycaemia
385502|NCT01304290|inflammatory cytokine response|inflammatory cytokine response
385503|NCT01304290|organ survival|organ survival
385504|NCT01304290|hyperinsulinemic clamp|hyperinsulinemic clamp
385505|NCT01304277|Replagal|replagal
385506|NCT01304264|glaucoma, ocular, blood flow, fluctuations|glaucoma, ocular, blood flow, fluctuations
385507|NCT01304251|short-term fasting|short-term fasting
385508|NCT01304251|adjuvant chemotherapy|adjuvant chemotherapy
385509|NCT01304251|toxicity|toxicity
385510|NCT01304251|side-effects|side-effects
376381|NCT01341808|vaccine|vaccine
385511|NCT01304238|Retrospective evaluation of patients with acute Heparin-induced Thrombocytopenia type II treated with Fondaparinux|retrospective evaluation of patients with acute heparin-induced thrombocytopenia type ii treated with fondaparinux
385512|NCT01304225|diabetic retinopathy|diabetic retinopathy
385513|NCT01304225|photocoagulation|photocoagulation
385514|NCT01304225|PASCAL laser|pascal laser
385515|NCT01304212|total knee arthroplasty|total knee arthroplasty
385516|NCT01304212|intraarticular infiltration|intraarticular infiltration
385517|NCT01304212|femoral block|femoral block
385518|NCT01304199|Cancer survivor|cancer survivor
385519|NCT01304199|Neoplasms|neoplasms
385520|NCT01304199|Treatments|treatments
385521|NCT01304199|Physical status|physical status
385522|NCT01304199|Psychosocial status|psychosocial status
385523|NCT01304199|Survivorship survey|survivorship survey
385524|NCT01304199|Survivorship care|survivorship care
385525|NCT01304199|Research|research
385526|NCT01304199|Cancer patient|cancer patient
385527|NCT01304186|Health literacy|health literacy
385528|NCT01304186|HIV|hiv
385529|NCT01304186|Medication Adherence|medication adherence
385530|NCT01304186|IMB Model|imb model
385531|NCT01304173|BCG|bcg
385532|NCT01304173|refractory|refractory
385533|NCT01304173|NMIBC|nmibc
385534|NCT01304173|CIS|cis
385535|NCT01304173|non-muscle invasive|non-muscle invasive
385536|NCT01304160|pancreatic cancer|pancreatic cancer
385537|NCT01304160|stereotactic body radiotherapy|stereotactic body radiotherapy
385538|NCT01304160|radiation|radiation
385539|NCT01304160|gemcitabine|gemcitabine
385540|NCT01304160|locally advanced|locally advanced
385541|NCT01304147|ketamine|ketamine
385542|NCT01304147|depression|depression
385543|NCT01304147|treatment resistance|treatment resistance
385544|NCT01304147|intranasal, antidepressant|intranasal, antidepressant
385545|NCT01304147|glutamate|glutamate
385546|NCT01304147|NMDA receptor|nmda receptor
385547|NCT01304121|Bone tumors|bone tumors
385548|NCT01304121|Bioactive glass|bioactive glass
385549|NCT01304121|Autogenous bone grafting|autogenous bone grafting
385550|NCT01304121|Allogeneic bone grafting|allogeneic bone grafting
385551|NCT01304121|PET imaging|pet imaging
385552|NCT01304108|Venous Thromboembolism|venous thromboembolism
385553|NCT01304108|Delivery of Health Care|delivery of health care
385554|NCT01304108|Quality Improvement|quality improvement
385555|NCT01304108|Evidence-Based Practice|evidence-based practice
385556|NCT01304095|Coronary Artery Disease, Angina, Metabolic Syndrome|coronary artery disease, angina, metabolic syndrome
385557|NCT01304082|pain pH local anesthetics|pain ph local anesthetics
385558|NCT01304069|Pharmacokinetics|pharmacokinetics
385559|NCT01304069|Pharmacodynamics|pharmacodynamics
385560|NCT01304056|Ventilatory physiology|ventilatory physiology
385561|NCT01304043|ovarian tumors|ovarian tumors
385562|NCT01304043|rare ovarian tumors|rare ovarian tumors
385563|NCT01304043|germinal tumors|germinal tumors
385564|NCT01304043|sexual cords tumors|sexual cords tumors
385565|NCT01304043|observatory|observatory
385566|NCT01304043|forum|forum
385567|NCT01304030|Empathy|empathy
385568|NCT01304017|rehabilitation|rehabilitation
385569|NCT01304017|stroke|stroke
385570|NCT01304017|intervention|intervention
385571|NCT01304017|physical activity|physical activity
385572|NCT01304017|participation|participation
385573|NCT01304004|Obesity|obesity
385574|NCT01304004|Yogurt|yogurt
385575|NCT01304004|Proteins|proteins
385576|NCT01304004|Fibres|fibres
385577|NCT01304004|Women|women
385578|NCT01304004|Satiety|satiety
385579|NCT01303952|cold agglutinin disease|cold agglutinin disease
385580|NCT01303952|hemolysis|hemolysis
385582|NCT01303952|terminal complement inhibition|terminal complement inhibition
385583|NCT01303939|Glaucoma|glaucoma
385584|NCT01303939|MRI Brain Scan|mri brain scan
385585|NCT01303939|Voxel-Based Morphometry|voxel-based morphometry
385587|NCT01303926|EQ5D score|eq5d score
385588|NCT01303926|cisplatin pemetrexed|cisplatin pemetrexed
385589|NCT01303926|carboplatin paclitaxel bevacizumab|carboplatin paclitaxel bevacizumab
385590|NCT01303926|maintenance|maintenance
385591|NCT01303913|COPD|copd
385592|NCT01303913|Oxygen desaturation|oxygen desaturation
385593|NCT01303913|Walking test|walking test
385594|NCT01303900|Haemophilia|haemophilia
385595|NCT01303900|Cardiovascular disease|cardiovascular disease
385596|NCT01303900|Cardiovascular disease risk factors|cardiovascular disease risk factors
385597|NCT01303900|Prospective|prospective
385598|NCT01303900|QRISK2|qrisk2
385602|NCT01303900|Obesity|obesity
385603|NCT01303887|PACIFICO|pacifico
385604|NCT01303887|Follicular Lymphoma|follicular lymphoma
385605|NCT01303887|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
385606|NCT01303887|Rituximab|rituximab
385607|NCT01303887|R-CVP|r-cvp
385608|NCT01303887|R-FC|r-fc
385609|NCT01303887|Older|older
385610|NCT01303874|Rheumatoid arthritis|rheumatoid arthritis
385611|NCT01303874|Inflammatory arthritis|inflammatory arthritis
385612|NCT01303874|Undifferentiated arthritis|undifferentiated arthritis
385613|NCT01303874|Etanercept|etanercept
385614|NCT01303874|Combination Therapy|combination therapy
385615|NCT01303861|Nicotine addiction|nicotine addiction
385616|NCT01303861|Cigarette smoking|cigarette smoking
385617|NCT01303861|Smoking cessation|smoking cessation
385618|NCT01303861|Zyban|zyban
385619|NCT01303861|Chantix|chantix
385620|NCT01303861|Nicotine patches|nicotine patches
385621|NCT01303861|Nicotrol Inhaler|nicotrol inhaler
385622|NCT01303861|varenicline|varenicline
385623|NCT01303861|bupropion|bupropion
385624|NCT01303848|Blood lactate|blood lactate
385625|NCT01303848|Lipid transfer proteins|lipid transfer proteins
385626|NCT01303848|Lactate|lactate
385627|NCT01303848|PLTP|pltp
385628|NCT01303848|CETP|cetp
385629|NCT01303848|PPARs|ppars
385630|NCT01303848|CLOCk|clock
385631|NCT01303848|Bal1|bal1
385632|NCT01303835|malignant glioma|malignant glioma
385633|NCT01303835|glioblastoma multiforme|glioblastoma multiforme
385634|NCT01303835|quality of life|quality of life
385635|NCT01303835|naltrexone|naltrexone
385636|NCT01303809|Perioperative care|perioperative care
385637|NCT01303809|Fast-track|fast-track
385638|NCT01303809|Enhanced Recovery After Surgery|enhanced recovery after surgery
385639|NCT01303809|ERAS|eras
385640|NCT01303809|Obesity|obesity
385641|NCT01303809|Bariatric surgery|bariatric surgery
385642|NCT01303809|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
385643|NCT01303796|AML|aml
385644|NCT01303783|Nifedipine GITS|nifedipine gits
385645|NCT01303783|Candesartan|candesartan
385646|NCT01303783|mild to moderate Hypertension|mild to moderate hypertension
385647|NCT01303783|Combination therapy|combination therapy
385648|NCT01303770|Multiple Sclerosis|multiple sclerosis
385649|NCT01303770|Cognitive impairment|cognitive impairment
385650|NCT01303770|Self-management programs|self-management programs
385651|NCT01303770|Occupational Therapy|occupational therapy
385652|NCT01303770|Rehabilitation|rehabilitation
385653|NCT01303757|obesity|obesity
385654|NCT01303731|Spinal anesthesia|spinal anesthesia
385655|NCT01303731|Cesarean section|cesarean section
385656|NCT01303731|Marcaine Spinal 0.5% Heavy minidose|marcaine spinal 0.5% heavy minidose
385657|NCT01303731|Fentanyl|fentanyl
385658|NCT01303731|Local Anesthetics|local anesthetics
385659|NCT01303718|LV Dysfunction|lv dysfunction
385660|NCT01303718|Heart Failure|heart failure
385661|NCT01303705|progressive metastatic prostate cancer|progressive metastatic prostate cancer
385662|NCT01303705|cancer of the prostate|cancer of the prostate
385663|NCT01303705|prostate cancer|prostate cancer
385664|NCT01303692|bone mineral loss|bone mineral loss
385665|NCT01303692|prostate cancer|prostate cancer
385666|NCT01303692|GnRH agonist alone vs. GnRH agonist plus anti-androgen combination|gnrh agonist alone vs. gnrh agonist plus anti-androgen combination
385667|NCT01303679|First line metastatic breast cancer|first line metastatic breast cancer
385668|NCT01303679|Positive estrogen receptors|positive estrogen receptors
385669|NCT01303679|Negative HER2 receptors|negative her2 receptors
385670|NCT01303679|At least stable disease after 4 months of paclitaxel-bevcizumab induction chemotheray|at least stable disease after 4 months of paclitaxel-bevcizumab induction chemotheray
385671|NCT01303653|endoscopic tissue closure,|endoscopic tissue closure,
385672|NCT01303653|gastro-gastric fistulas,|gastro-gastric fistulas,
385673|NCT01303653|gastrointestinal perforations|gastrointestinal perforations
385674|NCT01303640|Coronary stent|coronary stent
385675|NCT01303627|Remifentanil|remifentanil
385676|NCT01303627|Laryngeal mask airway removal|laryngeal mask airway removal
385677|NCT01303627|Hemodynamic changing|hemodynamic changing
385678|NCT01303627|Infusion|infusion
385679|NCT01303627|Ureterorenoscopy|ureterorenoscopy
385680|NCT01303614|hysterosalpingography|hysterosalpingography
385681|NCT01303614|prilocaine|prilocaine
385682|NCT01303614|local anaesthetic|local anaesthetic
385683|NCT01303614|pain relief|pain relief
385684|NCT01303614|gynecological pathology|gynecological pathology
385685|NCT01303601|Olanzapine|olanzapine
385686|NCT01303601|Monotherapy|monotherapy
385687|NCT01303601|bipolar Ⅰ depression|bipolar ⅰ depression
385688|NCT01303588|elderly patients|elderly patients
385689|NCT01303575|Adolescents|adolescents
385690|NCT01303575|Youth|youth
385691|NCT01303575|Sexual Health|sexual health
385692|NCT01303575|Sex Education|sex education
385693|NCT01303575|Pregnancy Prevention|pregnancy prevention
385694|NCT01303575|Abstinence Education|abstinence education
385695|NCT01303575|HIV|hiv
385696|NCT01303575|Human Immunodeficiency Virus|human immunodeficiency virus
385697|NCT01303575|STI|sti
385698|NCT01303575|Chlamydia|chlamydia
385699|NCT01303575|Gonorrhea|gonorrhea
385700|NCT01303575|Sexually Transmitted Infections|sexually transmitted infections
385701|NCT01303575|American Indian|american indian
385702|NCT01303575|Alaska Native|alaska native
385703|NCT01303575|Native American|native american
385704|NCT01303575|Internet-Based|internet-based
385705|NCT01303575|Computer-based Education|computer-based education
385706|NCT01303575|Computer-based learning|computer-based learning
385707|NCT01303562|oat|oat
385708|NCT01303562|barley|barley
385709|NCT01303562|whole grain|whole grain
385710|NCT01303562|bioavailability|bioavailability
385711|NCT01303562|phytochemical|phytochemical
385712|NCT01303549|Liver transplantation|liver transplantation
385713|NCT01303549|Hepatic transplant|hepatic transplant
385714|NCT01303549|Antifungal prophylaxis|antifungal prophylaxis
385715|NCT01303549|Anidulafungin|anidulafungin
385716|NCT01303549|Liposomal Amphotericin B|liposomal amphotericin b
385717|NCT01303523|LMWH|lmwh
385718|NCT01303523|heparin|heparin
385719|NCT01303523|immobilization|immobilization
385720|NCT01303523|anticoagulant prophylaxis|anticoagulant prophylaxis
385721|NCT01303523|leg injuries|leg injuries
385722|NCT01303523|thromboembolism|thromboembolism
385723|NCT01303510|Influenza|influenza
385725|NCT01303510|Vaccination|vaccination
385726|NCT01303510|Immunisation|immunisation
385727|NCT01303497|Angiosarcoma|angiosarcoma
385728|NCT01303497|Paclitaxel|paclitaxel
385729|NCT01303497|bevacizumab|bevacizumab
385730|NCT01303471|pain assessment|pain assessment
385731|NCT01303471|anesthesia|anesthesia
385732|NCT01303471|analgesia|analgesia
385733|NCT01303471|opioid|opioid
385734|NCT01303471|HRV|hrv
385735|NCT01303471|APV|apv
385736|NCT01303471|autonomic nervous system (ANS)|autonomic nervous system (ans)
385737|NCT01303471|pupil size|pupil size
385738|NCT01303458|community resource|community resource
385739|NCT01303458|well-child care visit|well-child care visit
385740|NCT01303458|low-income|low-income
385741|NCT01303432|Joint discomfort|joint discomfort
385742|NCT01303432|Functional Food|functional food
385743|NCT01303432|Joint function|joint function
385744|NCT01303432|Mobilee|mobilee
385745|NCT01303419|mammography|mammography
385746|NCT01303406|randomized withdrawal|randomized withdrawal
385747|NCT01303406|idebenone|idebenone
385748|NCT01303406|friedreich's ataxia|friedreich's ataxia
385749|NCT01303406|Miconos|miconos
385750|NCT01303406|Patient reported outcome|patient reported outcome
385751|NCT01303406|ICARS|icars
385752|NCT01303393|Patient education. Patient discharge. Needs assessment.|patient education. patient discharge. needs assessment.
385753|NCT01303380|Hyper IgD syndrome|hyper igd syndrome
385754|NCT01303380|canakinumab|canakinumab
385755|NCT01303380|HIDS|hids
385756|NCT01303380|mevalonate kinase deficiency|mevalonate kinase deficiency
385757|NCT01303380|MKD|mkd
385758|NCT01303367|Dementia|dementia
385759|NCT01303367|behavioral and psychological symptoms of dementia|behavioral and psychological symptoms of dementia
385760|NCT01303354|Epidural, Transforaminal, Steroid Injection, Dexamethasone|epidural, transforaminal, steroid injection, dexamethasone
385761|NCT01303315|C19 246 300|c19 246 300
385762|NCT01303302|C19 246 300|c19 246 300
385763|NCT01303289|Total Enteral Nutrition|total enteral nutrition
385764|NCT01303289|Severe insufficient nutrition|severe insufficient nutrition
385765|NCT01303289|T-Diet plus Standard|t-diet plus standard
385766|NCT01303289|Lipidic profile|lipidic profile
385767|NCT01303289|Quality of life|quality of life
385768|NCT01303276|retinal vein occlusion|retinal vein occlusion
385769|NCT01303276|anti-VEGF|anti-vegf
385770|NCT01303276|blood flow|blood flow
385771|NCT01303263|efficiency|efficiency
385772|NCT01303263|cost-awareness|cost-awareness
385773|NCT01303263|hospitals|hospitals
385774|NCT01303263|graduate medical education|graduate medical education
385775|NCT01303250|goal-directed fluid optimization|goal-directed fluid optimization
385776|NCT01303250|hemodynamic optimization|hemodynamic optimization
385777|NCT01303250|crystalloid|crystalloid
385778|NCT01303250|colloid|colloid
385779|NCT01303237|LA SCCHN|la scchn
385780|NCT01303237|Cetuximab|cetuximab
385781|NCT01303237|RT|rt
385782|NCT01303237|PMS|pms
385783|NCT01303224|Irritable Bowel Syndrome|irritable bowel syndrome
385784|NCT01303224|Colon, irritable|colon, irritable
385785|NCT01303224|Bowel disease|bowel disease
385786|NCT01303211|Meningococcal serogroup A conjugate vaccine|meningococcal serogroup a conjugate vaccine
386266|NCT01301183|Teenagers|teenagers
385787|NCT01303211|Vaccine efficacy|vaccine efficacy
385788|NCT01303211|Serogroup A meningococcal diseases|serogroup a meningococcal diseases
385790|NCT01303198|APAP|apap
385791|NCT01303198|sleep apnea|sleep apnea
385792|NCT01303185|Psoriatic Nail|psoriatic nail
385793|NCT01303185|Pulsed dye laser|pulsed dye laser
385794|NCT01303159|Cholangiocarcinoma|cholangiocarcinoma
385795|NCT01303159|Pancreatic Cancer|pancreatic cancer
385796|NCT01303159|Radiofrequency|radiofrequency
385797|NCT01303159|Ablation|ablation
385798|NCT01303146|Metachromatic Leukodystrophy|metachromatic leukodystrophy
385799|NCT01303146|Enzyme replacement therapy|enzyme replacement therapy
385800|NCT01303146|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
385801|NCT01303133|beta amyloid, Down Syndrome, Alzheimer's Disease|beta amyloid, down syndrome, alzheimer's disease
385802|NCT01303081|Smoking Cessation|smoking cessation
385803|NCT01303081|Work-site|work-site
385804|NCT01303081|Incentives|incentives
385805|NCT01303081|Health Behavior|health behavior
385806|NCT01303081|Smoking|smoking
385807|NCT01303068|CF|cf
385808|NCT01303055|Pancreatic beta Cell|pancreatic beta cell
385809|NCT01303055|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
385810|NCT01303055|Glucose Metabolism Disorders|glucose metabolism disorders
385811|NCT01303055|Metabolic Diseases|metabolic diseases
376674|NCT01340638|LMA|lma
385812|NCT01303055|Endocrine System Diseases|endocrine system diseases
385813|NCT01303055|Metformin|metformin
385814|NCT01303055|Hypoglycemic Agents|hypoglycemic agents
385815|NCT01303055|Physiological Effects of Drugs|physiological effects of drugs
385816|NCT01303055|Pharmacologic Actions|pharmacologic actions
385817|NCT01303055|hemoglobin A1c protein, human|hemoglobin a1c protein, human
385818|NCT01303055|Oral Glucose Tolerance Test|oral glucose tolerance test
385819|NCT01303042|insulin LISPRO|insulin lispro
385820|NCT01303042|Insulin therapy|insulin therapy
385821|NCT01303042|hemoglobin A1c protein, human|hemoglobin a1c protein, human
385822|NCT01303042|Blood Glucose Self-Monitoring|blood glucose self-monitoring
385823|NCT01303042|Quality of Life|quality of life
385824|NCT01303042|Hypoglycemia|hypoglycemia
385825|NCT01303042|Diabetes Mellitus|diabetes mellitus
385826|NCT01303042|1,5-Anhydroglucitol|1,5-anhydroglucitol
385827|NCT01303029|Pancreatic cancer|pancreatic cancer
385828|NCT01303029|gemcitabine|gemcitabine
385829|NCT01303029|erlotinib|erlotinib
385830|NCT01303029|capecitabine|capecitabine
385831|NCT01302990|Influenza|influenza
385832|NCT01302990|Respiratory disease|respiratory disease
385833|NCT01302990|Prevention|prevention
385834|NCT01302977|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
385835|NCT01302977|Fetal anomalies|fetal anomalies
385836|NCT01302964|Autistic Disorder|autistic disorder
385837|NCT01302964|Asperger's Disorder|asperger's disorder
385838|NCT01302964|Pervasive Developmental Disorder|pervasive developmental disorder
385839|NCT01302951|pharmacokinetics|pharmacokinetics
385840|NCT01302951|liver resection|liver resection
385841|NCT01302938|Double-blind|double-blind
385842|NCT01302938|Placebo-controlled|placebo-controlled
385843|NCT01302938|frequency|frequency
385844|NCT01302938|urgency|urgency
385845|NCT01302938|web-based|web-based
385846|NCT01302938|incontinence|incontinence
385847|NCT01302938|methodology|methodology
385848|NCT01302938|ediary|ediary
385849|NCT01302938|safety|safety
385850|NCT01302938|efficacy|efficacy
385851|NCT01302938|tolerability ER|tolerability er
385852|NCT01302938|overactive bladder|overactive bladder
385853|NCT01302912|ocular adnexal lymphomas|ocular adnexal lymphomas
385854|NCT01302886|High risk Smoldering multiple myeloma,|high risk smoldering multiple myeloma,
385855|NCT01302886|BHQ880,|bhq880,
385856|NCT01302886|MM|mm
385857|NCT01302873|Tinnitus|tinnitus
385858|NCT01302873|AMPA Receptor antagonist|ampa receptor antagonist
385859|NCT01302860|Cryopyrin-associated periodic syndromes (CAPS)|cryopyrin-associated periodic syndromes (caps)
385860|NCT01302860|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
385861|NCT01302860|Muckle-Wells Syndrome (MWS) or Neonatal Onset Multisystem Inflammatory Disease (NOMID)|muckle-wells syndrome (mws) or neonatal onset multisystem inflammatory disease (nomid)
385862|NCT01302860|children|children
385863|NCT01302860|systemic autoinflammatory disease|systemic autoinflammatory disease
385864|NCT01302860|CIAS-1 gene|cias-1 gene
385865|NCT01302860|NALP-3|nalp-3
385866|NCT01302860|NLRP3|nlrp3
385867|NCT01302860|ACZ885|acz885
385868|NCT01302860|Ilaris|ilaris
385869|NCT01302860|human monoclonal anti-human interleukin-1 beta (IL-beta)|human monoclonal anti-human interleukin-1 beta (il-beta)
385870|NCT01302860|antibody|antibody
385871|NCT01302860|autosomal dominant|autosomal dominant
385872|NCT01302860|familial autoinflammatory syndrome|familial autoinflammatory syndrome
385873|NCT01302847|Integrase Inhibitors|integrase inhibitors
385874|NCT01302847|Infant|infant
385875|NCT01302847|Child|child
385876|NCT01302847|Adolescent|adolescent
385877|NCT01302834|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
385878|NCT01302834|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
385879|NCT01302834|human papilloma virus infection|human papilloma virus infection
386875|NCT01298531|Etanercept|etanercept
385880|NCT01302821|breast - male|breast - male
385881|NCT01302821|breast - female|breast - female
385882|NCT01302821|metastatic|metastatic
385883|NCT01302821|invasive|invasive
385884|NCT01302808|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
385885|NCT01302808|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
385886|NCT01302808|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
385887|NCT01302808|malignant pleural effusion|malignant pleural effusion
385888|NCT01302808|adenocarcinoma of the lung|adenocarcinoma of the lung
385889|NCT01302808|adenosquamous cell lung cancer|adenosquamous cell lung cancer
385890|NCT01302808|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
385891|NCT01302808|large cell lung cancer|large cell lung cancer
385892|NCT01302808|squamous cell lung cancer|squamous cell lung cancer
385893|NCT01302795|Interleukin 1 beta|interleukin 1 beta
385895|NCT01302795|autoinflammatory syndrome|autoinflammatory syndrome
385896|NCT01302782|Altitude|altitude
385897|NCT01302782|Glucose|glucose
385898|NCT01302769|Acute Sore Throat|acute sore throat
385899|NCT01302769|Ear Acupuncture|ear acupuncture
385900|NCT01302756|gestational diabetes|gestational diabetes
385901|NCT01302756|gestational hypertension|gestational hypertension
385902|NCT01302756|folic acid|folic acid
385903|NCT01302743|Diabetes|diabetes
385904|NCT01302743|Metformin|metformin
385905|NCT01302743|Cinnamon|cinnamon
385906|NCT01302730|ankylosing spondylitis|ankylosing spondylitis
385907|NCT01302730|spondylarthritis|spondylarthritis
600187|NCT00581464|Craving|craving
385908|NCT01302730|inflammatory back pain|inflammatory back pain
385909|NCT01302730|seronegative|seronegative
385910|NCT01302717|Left ventricular pacing|left ventricular pacing
385911|NCT01302704|Vitamin D|vitamin d
385912|NCT01302704|Proton Pump Inhibitors|proton pump inhibitors
385913|NCT01302691|Essential hypertension|essential hypertension
385914|NCT01302691|Uncontrolled hypertension|uncontrolled hypertension
385915|NCT01302691|Antihypertensive agents|antihypertensive agents
385916|NCT01302691|Blood pressure|blood pressure
385917|NCT01302652|acromegaly|acromegaly
385918|NCT01302652|growth hormone|growth hormone
385919|NCT01302652|growth hormone deficiency|growth hormone deficiency
385921|NCT01302626|SCLC|sclc
385922|NCT01302626|lung cancer|lung cancer
385923|NCT01302626|RNA|rna
385924|NCT01302626|DNA|dna
385925|NCT01302626|imaging|imaging
385926|NCT01302626|genomics|genomics
385927|NCT01302626|proteomics|proteomics
385928|NCT01302626|predictive model|predictive model
385929|NCT01302626|prospective study|prospective study
385930|NCT01302613|rectal cancer|rectal cancer
385931|NCT01302574|T1R2/T1R3|t1r2/t1r3
385932|NCT01302574|gastric emptying|gastric emptying
385933|NCT01302574|gut|gut
385934|NCT01302574|lactisole|lactisole
385935|NCT01302574|nutrient sensing|nutrient sensing
385936|NCT01302561|adults|adults
385937|NCT01302561|fiber|fiber
385938|NCT01302561|cold|cold
385939|NCT01302561|flu|flu
385940|NCT01302561|immune function|immune function
385941|NCT01302561|microbiota|microbiota
385942|NCT01302548|Abscess|abscess
385943|NCT01302548|Wound Irrigation|wound irrigation
385944|NCT01302548|Wound Debridement|wound debridement
385945|NCT01302548|Wound Healing|wound healing
385946|NCT01302548|Incision and drainage|incision and drainage
385947|NCT01302548|Chlorhexidine|chlorhexidine
385948|NCT01302535|Yoga|yoga
385949|NCT01302535|Hypertension|hypertension
385950|NCT01302535|Quality of Life|quality of life
385951|NCT01302535|Primary Health Care|primary health care
385952|NCT01302509|Nutritional support.|nutritional support.
385953|NCT01302509|Cancer.|cancer.
385954|NCT01302509|Malnutrition.|malnutrition.
385955|NCT01302509|Child.|child.
385956|NCT01302509|Adolescent|adolescent
385957|NCT01302496|Previously Treated|previously treated
385958|NCT01302496|Unresectable|unresectable
385959|NCT01302496|Stage III or IV Melanoma|stage iii or iv melanoma
385960|NCT01302470|biventricular pacing|biventricular pacing
385961|NCT01302457|Thermal Burn Trauma|thermal burn trauma
385962|NCT01302444|treprostinil|treprostinil
385963|NCT01302444|pulmonary hypertension, tadalafil|pulmonary hypertension, tadalafil
385964|NCT01302431|experimental|experimental
385965|NCT01302431|intervention|intervention
385966|NCT01302431|nurse-led|nurse-led
385967|NCT01302431|nurse specialist|nurse specialist
385968|NCT01302431|multiple sclerosis|multiple sclerosis
385969|NCT01302431|support of caregivers|support of caregivers
385970|NCT01302418|Respiratory Virus|respiratory virus
385971|NCT01302418|Influenza|influenza
385972|NCT01302418|RSV|rsv
385973|NCT01302418|Parainfluenza|parainfluenza
385974|NCT01302418|Metapneumovirus|metapneumovirus
385975|NCT01302418|Rhinovirus|rhinovirus
385976|NCT01302418|Coxsackie virus|coxsackie virus
385977|NCT01302418|Echo virus|echo virus
385978|NCT01302418|Adenovirus|adenovirus
385979|NCT01302418|Coronavirus|coronavirus
385980|NCT01302418|Bocavirus|bocavirus
385981|NCT01302405|Advanced solid tumor|advanced solid tumor
385982|NCT01302405|cancer|cancer
385983|NCT01302405|phase 1|phase 1
385984|NCT01302405|pancreatic cancer|pancreatic cancer
385985|NCT01302405|colon cancer|colon cancer
385986|NCT01302405|unresectable neoplastic disease|unresectable neoplastic disease
385987|NCT01302405|Progressive cancer|progressive cancer
385988|NCT01302405|metastatic solid tumor|metastatic solid tumor
385989|NCT01302379|Obesity|obesity
385990|NCT01302379|Survival|survival
385991|NCT01302379|Weight loss|weight loss
385992|NCT01302379|Metformin|metformin
385993|NCT01302379|Biological markers|biological markers
385994|NCT01302366|multiple myeloma|multiple myeloma
385995|NCT01302366|myeloma|myeloma
385996|NCT01302366|asymptomatic myeloma|asymptomatic myeloma
385997|NCT01302366|smoldering myeloma|smoldering myeloma
385998|NCT01302366|Asymptomatic (smoldering) myeloma|asymptomatic (smoldering) myeloma
385999|NCT01302353|Phase I trial|phase i trial
386000|NCT01302353|Emulsified Isoflurane|emulsified isoflurane
386001|NCT01302353|Health volunteer|health volunteer
386002|NCT01302340|Dementia|dementia
386003|NCT01302340|Alzheimer|alzheimer
386004|NCT01302340|Cannabis|cannabis
386005|NCT01302340|THC|thc
386006|NCT01302340|Behavioral Disturbances|behavioral disturbances
386007|NCT01302340|Neuropsychiatric Inventory|neuropsychiatric inventory
386008|NCT01302327|Wolfram syndrome|wolfram syndrome
386009|NCT01302327|Diabetes mellitus|diabetes mellitus
386010|NCT01302327|Exenatide|exenatide
386011|NCT01302327|GLP-1 analog|glp-1 analog
386012|NCT01302327|beta cell function|beta cell function
386013|NCT01302301|endolumenal myotomy, per oral endoscopic myotomy|endolumenal myotomy, per oral endoscopic myotomy
386014|NCT01302288|endolumenal myotomy, per oral endoscopic myotomy|endolumenal myotomy, per oral endoscopic myotomy
386015|NCT01302275|neuropathic pain|neuropathic pain
386016|NCT01302275|oxcarbazepine|oxcarbazepine
386017|NCT01302275|pain mechanism|pain mechanism
386018|NCT01302262|Smoking-induced dopamine release|smoking-induced dopamine release
386019|NCT01302262|[11C]-(+)-PHNO PET Study|[11c]-(+)-phno pet study
386020|NCT01302249|Glaucoma|glaucoma
386021|NCT01302249|Intraocular pressure|intraocular pressure
386022|NCT01302249|Ocular hypertension|ocular hypertension
386023|NCT01302236|Elderly|elderly
386024|NCT01302236|Early stage chronic kidney disease|early stage chronic kidney disease
386025|NCT01302236|Hypertension|hypertension
386026|NCT01302236|Eplerenone|eplerenone
386027|NCT01302223|burns|burns
386028|NCT01302223|Growth Factors, Combined Defect of|growth factors, combined defect of
386029|NCT01302223|inflammation|inflammation
386030|NCT01302223|Cytokine Storm|cytokine storm
386031|NCT01302210|MRSA|mrsa
386032|NCT01302210|Cluster Randomized Trial|cluster randomized trial
386033|NCT01302210|Infection Control Intervention|infection control intervention
386034|NCT01302197|Stroke|stroke
386035|NCT01302197|Body Composition|body composition
386036|NCT01302197|Glucose Tolerance|glucose tolerance
386037|NCT01302171|dilated cardiomyopathy|dilated cardiomyopathy
386038|NCT01302171|adult stem cells|adult stem cells
386039|NCT01302171|bone marrow progenitor cells|bone marrow progenitor cells
386040|NCT01302171|bone marrow stem cells|bone marrow stem cells
386041|NCT01302171|autologous|autologous
386042|NCT01302171|granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
386043|NCT01302171|intracoronary injection|intracoronary injection
386044|NCT01302171|left ventricular function|left ventricular function
386045|NCT01302171|To determine if patient's own bone marrow derived stem cells can be used to improve cardiac function|to determine if patient's own bone marrow derived stem cells can be used to improve cardiac function
386046|NCT01302158|Drug-Drug interaction|drug-drug interaction
386047|NCT01302158|ASP1941|asp1941
386048|NCT01302158|Glimepiride|glimepiride
386049|NCT01302158|Healthy subjects|healthy subjects
386050|NCT01302145|pharmacokinetics|pharmacokinetics
386051|NCT01302145|metformin|metformin
386052|NCT01302145|Drug to drug interaction|drug to drug interaction
386053|NCT01302145|ASP1941|asp1941
386054|NCT01302132|Mass Balance|mass balance
386055|NCT01302132|ASP1941|asp1941
386056|NCT01302132|Pharmacokinetics|pharmacokinetics
386057|NCT01302119|Onychomycosis|onychomycosis
386058|NCT01302119|nail fungus|nail fungus
386059|NCT01302119|toenail fungus|toenail fungus
386060|NCT01302119|fungal nail|fungal nail
386061|NCT01302119|hyperkeratosis|hyperkeratosis
386062|NCT01302119|nail infection|nail infection
386063|NCT01302119|nail treatment|nail treatment
386064|NCT01302119|toenail infection|toenail infection
386065|NCT01302119|toenail treatment|toenail treatment
386066|NCT01302119|foot dermatoses|foot dermatoses
386067|NCT01302119|fungal culture|fungal culture
386068|NCT01302119|onycholysis|onycholysis
386069|NCT01302119|podiatrist|podiatrist
386070|NCT01302119|podiatry|podiatry
386071|NCT01302119|subungual|subungual
386072|NCT01302119|tinea unguium|tinea unguium
386073|NCT01302119|antifungal|antifungal
386074|NCT01302119|anti-fungal|anti-fungal
386075|NCT01302119|dermatologist|dermatologist
386076|NCT01302119|dermatology|dermatology
386077|NCT01302119|dermatophyte|dermatophyte
386078|NCT01302119|distal subungual onychomycosis|distal subungual onychomycosis
386079|NCT01302119|yellow nail|yellow nail
386080|NCT01302119|thick nail|thick nail
386081|NCT01302119|brittle nail|brittle nail
386082|NCT01302119|crumbling nail|crumbling nail
386083|NCT01302119|discolored nail|discolored nail
386084|NCT01302119|weak nail|weak nail
386085|NCT01302106|Myelodysplastic Syndromes|myelodysplastic syndromes
386086|NCT01302106|Clofarabine|clofarabine
386087|NCT01302106|Low Dose Cytarabine|low dose cytarabine
386088|NCT01302106|Poor risk MDS|poor risk mds
386089|NCT01302080|prospective|prospective
386090|NCT01302080|cohort|cohort
386091|NCT01302080|sertraline|sertraline
386093|NCT01302080|cognition|cognition
386094|NCT01302080|emotional and physical development|emotional and physical development
386095|NCT01302080|pubertal maturation|pubertal maturation
386096|NCT01302054|Bladder Overactive|bladder overactive
386097|NCT01302054|Overactive urinary bladder|overactive urinary bladder
386098|NCT01302054|Overactive Bladder|overactive bladder
386099|NCT01302041|bone turnover|bone turnover
386100|NCT01302041|hormone-naïve|hormone-naïve
386101|NCT01302041|prostate specific antigen|prostate specific antigen
386102|NCT01302041|Prostate Cancer|prostate cancer
386103|NCT01302028|Renal Impairment|renal impairment
386104|NCT01302028|ASP1941|asp1941
386105|NCT01302028|Pharmacokinetics|pharmacokinetics
386106|NCT01302002|Breast Cancer|breast cancer
386107|NCT01302002|Metformin|metformin
386108|NCT01302002|Pre-Surgery|pre-surgery
386109|NCT01301989|Sleep|sleep
386110|NCT01301989|Children|children
386111|NCT01301989|Disparities|disparities
386112|NCT01301989|Minority|minority
386113|NCT01301989|Urban|urban
386114|NCT01301976|nutritional state|nutritional state
386115|NCT01301976|nutrients intake|nutrients intake
386116|NCT01301976|ulcerative colitis|ulcerative colitis
386117|NCT01301950|Arthroplasties, Knee Replacement|arthroplasties, knee replacement
386118|NCT01301950|Arthroplasties, Replacement, Knee|arthroplasties, replacement, knee
386119|NCT01301950|Arthroplasty, Knee Replacement|arthroplasty, knee replacement
386120|NCT01301950|Knee Replacement Arthroplasties|knee replacement arthroplasties
386121|NCT01301950|Knee Replacement Arthroplasty|knee replacement arthroplasty
386122|NCT01301950|Knee Replacement, Total|knee replacement, total
386123|NCT01301950|Replacement Arthroplasties, Knee|replacement arthroplasties, knee
386124|NCT01301950|Replacement Arthroplasty, Knee|replacement arthroplasty, knee
386125|NCT01301950|Replacement, Total Knee|replacement, total knee
386126|NCT01301950|Total Knee Replacement|total knee replacement
386127|NCT01301937|Mucosal Leishmaniasis|mucosal leishmaniasis
386128|NCT01301937|Leishmania braziliensis|leishmania braziliensis
386129|NCT01301937|Meglumine Antimoniate|meglumine antimoniate
386130|NCT01301937|Treatment Effectiveness|treatment effectiveness
386131|NCT01301937|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
386132|NCT01301924|Leishmaniasis Cutaneous|leishmaniasis cutaneous
386133|NCT01301924|Leishmania braziliensis|leishmania braziliensis
386134|NCT01301924|Meglumine Antimoniate|meglumine antimoniate
386135|NCT01301924|Treatment Effectiveness|treatment effectiveness
386136|NCT01301924|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
386137|NCT01301911|Breast cancer, Advanced|breast cancer, advanced
386138|NCT01301911|Cipatinib|cipatinib
386139|NCT01301911|phase I|phase i
386140|NCT01301911|HER2 positive or uncertain advanced breast cancer|her2 positive or uncertain advanced breast cancer
386141|NCT01301898|Hunter syndrome|hunter syndrome
386142|NCT01301898|MPS II|mps ii
386143|NCT01301898|Idursulfase|idursulfase
386144|NCT01301885|endometriosis|endometriosis
386145|NCT01301885|dysmenorrhea|dysmenorrhea
386146|NCT01301885|infertility|infertility
386147|NCT01301885|biomarker|biomarker
386148|NCT01301885|drug target|drug target
386149|NCT01301859|older adults|older adults
386150|NCT01301859|adherence|adherence
386151|NCT01301859|antidepressant|antidepressant
386152|NCT01301859|depression|depression
386153|NCT01301833|insulin resistance|insulin resistance
386154|NCT01301820|maintenance treatment|maintenance treatment
386155|NCT01301820|Disease free survival|disease free survival
386156|NCT01301807|Relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
386157|NCT01301807|RRMM|rrmm
386158|NCT01301807|Carfilzomib|carfilzomib
386159|NCT01301807|Panobinostat|panobinostat
386160|NCT01301807|LBH589B|lbh589b
386161|NCT01301794|Hypertriglyceridemia|hypertriglyceridemia
386162|NCT01301794|Fish oil|fish oil
386163|NCT01301794|Omega 3 fatty acids|omega 3 fatty acids
386164|NCT01301768|Dietary Intervention|dietary intervention
386165|NCT01301768|Pregnancy Jail|pregnancy jail
386166|NCT01301768|Iodine Deficiency|iodine deficiency
386167|NCT01301768|Iodine Nutrition|iodine nutrition
386168|NCT01301768|Dietary Habits|dietary habits
386169|NCT01301768|Urinary Iodine|urinary iodine
386170|NCT01301768|Pregnancy|pregnancy
386171|NCT01301768|Group Education|group education
386172|NCT01301768|Cluster Randomized Trial|cluster randomized trial
386173|NCT01301768|Primary Health Care|primary health care
386174|NCT01301703|rheumatoid pertussis tetanus|rheumatoid pertussis tetanus
386175|NCT01301690|neck mass|neck mass
386176|NCT01301690|ultrasound|ultrasound
386177|NCT01301690|FNA|fna
386178|NCT01301690|BMVC|bmvc
386267|NCT01301183|IGF-1|igf-1
386268|NCT01301170|Neck pain|neck pain
386264|NCT01301183|Anorexia Nervosa|anorexia nervosa
386265|NCT01301183|Estrogen|estrogen
386179|NCT01301664|The bone marrow-derived mesenchymal stem cells (BMMSCs) were obtained from redundant bone marrow from drilling during the joint replacement surgery.|the bone marrow-derived mesenchymal stem cells (bmmscs) were obtained from redundant bone marrow from drilling during the joint replacement surgery.
386180|NCT01301664|The synovial-derived mesenchymal stem cells (SMSCs) were isolated from synovial membranes in the joint replacement surgery.|the synovial-derived mesenchymal stem cells (smscs) were isolated from synovial membranes in the joint replacement surgery.
386181|NCT01301664|Cartilage slices were obtained from discard cartilage in the joint replacement surgery.|cartilage slices were obtained from discard cartilage in the joint replacement surgery.
386182|NCT01301651|Virtual Reality|virtual reality
386183|NCT01301651|Balance|balance
386184|NCT01301651|Parkinson's disease|parkinson's disease
386185|NCT01301651|Dual Task|dual task
386186|NCT01301625|MitraClip|mitraclip
386187|NCT01301625|mitral regurgitation (MR)|mitral regurgitation (mr)
386188|NCT01301625|mitral valve insufficiency|mitral valve insufficiency
386189|NCT01301625|percutaneous mitral valve repair|percutaneous mitral valve repair
386190|NCT01301625|congestive heart failure|congestive heart failure
403027|NCT01228487|Oxidative Stress|oxidative stress
403028|NCT01228487|Biomarker|biomarker
377115|NCT01338805|CNS|cns
386191|NCT01301612|carcinoma or adenocarcinoma or uterine cervix adenosquamous carcinoma|carcinoma or adenocarcinoma or uterine cervix adenosquamous carcinoma
386192|NCT01301599|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
386193|NCT01301599|alpha blocker|alpha blocker
386194|NCT01301599|5-alpha reductase inhibitor|5-alpha reductase inhibitor
386195|NCT01301599|combination therapy|combination therapy
386196|NCT01301560|Asymptomatic brain metastasis|asymptomatic brain metastasis
386197|NCT01301560|NSCLC|nsclc
386198|NCT01301560|GKS|gks
386199|NCT01301534|abdominal aortic aneurysm|abdominal aortic aneurysm
386200|NCT01301521|Pre-Diabetes|pre-diabetes
386201|NCT01301521|cinnamon|cinnamon
386202|NCT01301508|atopic dermatitis|atopic dermatitis
386203|NCT01301495|Esophageal Cancer, Malignant, Dysphagia, Esophagus, Cancer|esophageal cancer, malignant, dysphagia, esophagus, cancer
386204|NCT01301482|Acute Sore Throat|acute sore throat
386205|NCT01301482|Ear Acupuncture|ear acupuncture
386206|NCT01301456|Phase 1|phase 1
386207|NCT01301456|Type 2 Diabetes|type 2 diabetes
386208|NCT01301456|CVX-096|cvx-096
386209|NCT01301443|Age Related Macular Degeneration|age related macular degeneration
386210|NCT01301430|Progressive glioblastoma multiforme|progressive glioblastoma multiforme
386211|NCT01301430|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
386212|NCT01301430|Oncolytic virus|oncolytic virus
386213|NCT01301417|Compression Anastomosis|compression anastomosis
386214|NCT01301404|Postoperative nausea and vomiting (PONV)|postoperative nausea and vomiting (ponv)
386215|NCT01301404|Spinal morphine|spinal morphine
386216|NCT01301404|Total knee replacement (TKR)|total knee replacement (tkr)
386217|NCT01301404|blood sugar|blood sugar
386218|NCT01301404|carbohydrate drink|carbohydrate drink
386219|NCT01301391|B3 and C malignant thymoma|b3 and c malignant thymoma
386220|NCT01301365|autonomic response|autonomic response
386221|NCT01301352|Critical Care|critical care
386222|NCT01301352|Intubation, gastrointestinal|intubation, gastrointestinal
386223|NCT01301352|Child|child
386224|NCT01301352|Infant|infant
386225|NCT01301352|Adolescent|adolescent
386226|NCT01301352|Continuous positive airway pressure|continuous positive airway pressure
386227|NCT01301352|Enteral Nutrition|enteral nutrition
386228|NCT01301339|Pre-Diabetes|pre-diabetes
386229|NCT01301339|Diabetes|diabetes
386230|NCT01301339|cardiovascular risks|cardiovascular risks
386231|NCT01301326|retinal arterial macroaneurysm|retinal arterial macroaneurysm
386232|NCT01301326|laser treatment|laser treatment
386233|NCT01301313|Acute heart failure|acute heart failure
386234|NCT01301313|Children|children
386235|NCT01301313|Levosimendan|levosimendan
386236|NCT01301313|Inotropic treatment|inotropic treatment
386237|NCT01301274|hyponatremia|hyponatremia
386238|NCT01301274|maintenance solutions|maintenance solutions
386239|NCT01301274|pediatrics|pediatrics
386240|NCT01301261|Sugammadex|sugammadex
386241|NCT01301261|entropy|entropy
386242|NCT01301261|bispectral index|bispectral index
386243|NCT01301261|blood pressure|blood pressure
386244|NCT01301261|heart rate|heart rate
386245|NCT01301261|oxygenation|oxygenation
386246|NCT01301261|end-tidal CO2|end-tidal co2
386247|NCT01301261|hemodynamics|hemodynamics
386248|NCT01301261|general anesthesia|general anesthesia
386249|NCT01301248|locally advanced,|locally advanced,
386250|NCT01301248|unresectable,|unresectable,
386251|NCT01301248|head and neck squamous cell carcinoma,|head and neck squamous cell carcinoma,
386252|NCT01301248|stage III/IV|stage iii/iv
386253|NCT01301235|Mitochondria|mitochondria
386254|NCT01301222|octreotide|octreotide
386255|NCT01301222|pancreatic fistula|pancreatic fistula
386256|NCT01301222|soft pancreas|soft pancreas
386257|NCT01301222|pancreatoduodenectomy|pancreatoduodenectomy
386258|NCT01301196|sedentary behaviour|sedentary behaviour
386259|NCT01301196|diabetes|diabetes
386260|NCT01301196|structured education|structured education
386261|NCT01301196|18-30 years olds|18-30 years olds
386262|NCT01301196|family history of T2DM or CVD|family history of t2dm or cvd
386263|NCT01301196|BMI ≥ 25 (≥23 for south Asians)|bmi ≥ 25 (≥23 for south asians)
386269|NCT01301170|Dry Needling|dry needling
386270|NCT01301170|Manual Therapy|manual therapy
386271|NCT01301170|Manipulation|manipulation
386272|NCT01301144|Tuberculosis|tuberculosis
386273|NCT01301144|Urea Breath Test|urea breath test
386274|NCT01301118|Transplantation Infection|transplantation infection
386275|NCT01301118|Wound of skin|wound of skin
386276|NCT01301118|Burns|burns
386277|NCT01301118|Graft Loss|graft loss
386278|NCT01301118|Infection|infection
386279|NCT01301105|pain regulation|pain regulation
386280|NCT01301105|social stress|social stress
386281|NCT01301105|affect|affect
386282|NCT01301105|attention|attention
386283|NCT01301105|brain|brain
386284|NCT01301105|immune|immune
386285|NCT01301105|endocrine|endocrine
386286|NCT01301079|Remifentanil|remifentanil
386287|NCT01301079|Hyperalgesia|hyperalgesia
377171|NCT01338506|PTSD|ptsd
386288|NCT01301079|Ketamine|ketamine
386289|NCT01301079|Von Frey's filament|von frey's filament
386290|NCT01301079|Algometer|algometer
386291|NCT01301079|Interleukines|interleukines
386292|NCT01301079|Opioid-induced hyperalgesia|opioid-induced hyperalgesia
386293|NCT01301053|hyperglycemia and increased mortality in the ICU|hyperglycemia and increased mortality in the icu
386294|NCT01301053|hypoglycemia and increased mortality in the ICU|hypoglycemia and increased mortality in the icu
386295|NCT01301053|glucose variability and increased mortality in the ICU|glucose variability and increased mortality in the icu
386296|NCT01301053|Continuous Glucose Monitoring (CGM) and hypoglycemia|continuous glucose monitoring (cgm) and hypoglycemia
386297|NCT01301053|hypoglycemia|hypoglycemia
386298|NCT01301053|reducing ICU mortality|reducing icu mortality
386299|NCT01301040|breast cancer, elderly, early cardiac toxicity|breast cancer, elderly, early cardiac toxicity
386300|NCT01301027|End stage renal disease|end stage renal disease
386301|NCT01301027|Hemodialysis|hemodialysis
386302|NCT01301027|Pioglitazone|pioglitazone
386303|NCT01301027|Adipokines|adipokines
386304|NCT01301014|accuracy, anterior cruciate ligament, diagnostic value, examination, knee, Lachman test, sensitivity, specificity|accuracy, anterior cruciate ligament, diagnostic value, examination, knee, lachman test, sensitivity, specificity
386305|NCT01301001|Vulvodynia|vulvodynia
386306|NCT01300988|HIV infection|hiv infection
386307|NCT01300988|Neurokinin-1 receptor antagonist|neurokinin-1 receptor antagonist
386308|NCT01300988|CCR5 expression|ccr5 expression
386309|NCT01300988|Treatment Naive|treatment naive
386310|NCT01300975|Leishmaniasis|leishmaniasis
386311|NCT01300975|intralesional antimony|intralesional antimony
386312|NCT01300975|cryotherapy|cryotherapy
386313|NCT01300962|Xeloda|xeloda
386314|NCT01300962|Capecitabine|capecitabine
386315|NCT01300962|BKM120|bkm120
386316|NCT01300962|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
386317|NCT01300962|Metastatic|metastatic
386318|NCT01300962|BYL719 Breast Cancer|byl719 breast cancer
386319|NCT01300949|Contrast Sensitivity|contrast sensitivity
386320|NCT01300949|Pelli-Robson Test|pelli-robson test
386321|NCT01300923|Fragile X Syndrome|fragile x syndrome
386322|NCT01300923|Acamprosate|acamprosate
386323|NCT01300910|Adult Males|adult males
386324|NCT01300910|Circumcision|circumcision
386325|NCT01300910|HIV prevention|hiv prevention
386326|NCT01300910|Device|device
386327|NCT01300910|Shang Ring|shang ring
386328|NCT01300897|cortical function, motor evoked potential responses|cortical function, motor evoked potential responses
386329|NCT01300845|Oxygen mask|oxygen mask
386330|NCT01300845|Oxygen cannula|oxygen cannula
386331|NCT01300845|Humidification|humidification
386332|NCT01300845|Oxygen therapy|oxygen therapy
386333|NCT01300845|Intensive Care Unit|intensive care unit
386334|NCT01300832|Surgery|surgery
386335|NCT01300832|Deep Vein Thrombosis|deep vein thrombosis
386336|NCT01300832|Preoperative|preoperative
386337|NCT01300819|Rotigotine|rotigotine
386338|NCT01300819|Neupro®|neupro®
386339|NCT01300819|Non-motor symptoms|non-motor symptoms
386341|NCT01300806|harmful substance use|harmful substance use
386342|NCT01300793|V-RICE|v-rice
386343|NCT01300793|Relapsed NHL|relapsed nhl
386344|NCT01300793|Primary Refractory NHL|primary refractory nhl
386345|NCT01300780|bleaching agent|bleaching agent
386346|NCT01300780|tooth bleaching|tooth bleaching
386347|NCT01300780|sensibility|sensibility
386348|NCT01300754|Osgood-Schlatter|osgood-schlatter
386349|NCT01300754|Tendinosis|tendinosis
386350|NCT01300754|Apophysitis|apophysitis
386351|NCT01300754|Enthesopathy|enthesopathy
386352|NCT01300754|Dextrose.|dextrose.
386353|NCT01300728|Intravenous immunotherapy|intravenous immunotherapy
386354|NCT01300728|Conversion to Alzheimer Disease|conversion to alzheimer disease
386355|NCT01300715|zygapophysial joint|zygapophysial joint
386356|NCT01300715|facet joint|facet joint
386357|NCT01300715|low back pain|low back pain
386358|NCT01300715|radiofrequency|radiofrequency
386359|NCT01300715|neurotomy|neurotomy
386360|NCT01300689|HPV|hpv
386361|NCT01300689|MSM|msm
386362|NCT01300689|Vaccine|vaccine
386363|NCT01300689|China|china
386364|NCT01300676|Tualang honey|tualang honey
386365|NCT01300676|HRT|hrt
386366|NCT01300676|safety profiles|safety profiles
386367|NCT01300676|cardiovascular parameters|cardiovascular parameters
386368|NCT01300676|hormonal levels|hormonal levels
386369|NCT01300676|bone changes|bone changes
386370|NCT01300676|postmenopausal women|postmenopausal women
386371|NCT01300650|Heart failure|heart failure
386372|NCT01300650|Inflammation|inflammation
386373|NCT01300650|Interleukin-1|interleukin-1
386374|NCT01300650|Cardiopulmonary exercise|cardiopulmonary exercise
386375|NCT01300637|schizophrenia|schizophrenia
386376|NCT01300637|clozapine|clozapine
386377|NCT01300637|metabolic dysregulation|metabolic dysregulation
386378|NCT01300637|metformin|metformin
386379|NCT01300624|Aphasia|aphasia
386380|NCT01300624|therapy|therapy
386381|NCT01300624|treatment|treatment
386382|NCT01300624|verbs|verbs
386383|NCT01300624|sentences|sentences
386384|NCT01300611|Double Cord Blood Transplantation|double cord blood transplantation
386385|NCT01300611|Neutrophil Engraftment|neutrophil engraftment
386386|NCT01300611|Platelet Engraftment|platelet engraftment
386387|NCT01300611|Immune Reconstitution|immune reconstitution
386388|NCT01300611|Mucositis|mucositis
386389|NCT01300585|Breast|breast
386390|NCT01300585|Cancer|cancer
386391|NCT01300559|efficacy|efficacy
386392|NCT01300559|hemoglobin|hemoglobin
386393|NCT01300559|spine|spine
386394|NCT01300546|Frequent migraine|frequent migraine
386395|NCT01300546|Migraine transformation|migraine transformation
386396|NCT01300546|Migraine|migraine
386397|NCT01300546|Treximet|treximet
386398|NCT01300546|Naproxen|naproxen
386399|NCT01300546|Sumatriptan|sumatriptan
386400|NCT01300533|Cancer|cancer
386401|NCT01300533|Neoplasms|neoplasms
386402|NCT01300533|Solid Tumor|solid tumor
386403|NCT01300533|Ovarian Cancer|ovarian cancer
386404|NCT01300533|Lung Cancer|lung cancer
386405|NCT01300533|Non-Small Cell Lung Cancer|non-small cell lung cancer
386406|NCT01300533|Pancreatic Cancer|pancreatic cancer
386407|NCT01300533|Breast Cancer|breast cancer
386408|NCT01300533|Endometrial Cancer|endometrial cancer
386409|NCT01300533|Melanoma|melanoma
386410|NCT01300533|Prostate Cancer|prostate cancer
386411|NCT01300533|Skin Cancer|skin cancer
386412|NCT01300533|Head and Neck Cancer|head and neck cancer
386413|NCT01300533|Solid Malignancies|solid malignancies
386414|NCT01300520|Fluoroscopy|fluoroscopy
386415|NCT01300520|Femoral fracture|femoral fracture
386416|NCT01300520|Tibial fracture|tibial fracture
386417|NCT01300520|Spinal Fusion|spinal fusion
386418|NCT01300507|stent thrombosis|stent thrombosis
386419|NCT01300507|intra coronary imaging|intra coronary imaging
386420|NCT01300507|blood platelet function testing|blood platelet function testing
386421|NCT01300494|bifurcation lesion|bifurcation lesion
386422|NCT01300494|optimal viewing angle|optimal viewing angle
386423|NCT01300494|automated software|automated software
386424|NCT01300468|advanced/metastatic solid tumors|advanced/metastatic solid tumors
386425|NCT01300455|Insomnia|insomnia
386426|NCT01300455|obstructive sleep apnea|obstructive sleep apnea
386427|NCT01300455|orexin receptor antagonist|orexin receptor antagonist
386428|NCT01300442|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
386429|NCT01300442|diaphragm|diaphragm
386430|NCT01300442|electrical stimulation|electrical stimulation
386431|NCT01300442|pulmonary rehabilitation|pulmonary rehabilitation
386432|NCT01300429|core biopsy|core biopsy
386433|NCT01300429|Resistance to Crizotinib|resistance to crizotinib
386434|NCT01300429|Non-small Cell Lung Cancer|non-small cell lung cancer
386435|NCT01300429|11-014|11-014
386436|NCT01300416|Kidney transplantation|kidney transplantation
386437|NCT01300416|mycophenolate sodium|mycophenolate sodium
386438|NCT01300416|EC-MPS|ec-mps
386439|NCT01300416|Health Related Quality of Life|health related quality of life
386440|NCT01300416|GI symptoms|gi symptoms
386441|NCT01300416|Immunosuppressants|immunosuppressants
386442|NCT01300416|HRQL|hrql
386443|NCT01300416|PGWB|pgwb
386444|NCT01300416|GIQLI|giqli
386445|NCT01300390|liver transplant|liver transplant
386446|NCT01300390|end-stage liver disease|end-stage liver disease
386447|NCT01300390|cirrhosis|cirrhosis
386448|NCT01300377|Post-operative pain|post-operative pain
386449|NCT01300377|pain|pain
386450|NCT01300377|pacemaker|pacemaker
386451|NCT01300377|defibrillator|defibrillator
386452|NCT01300377|post-operative narcotic use|post-operative narcotic use
386453|NCT01300377|local anesthesia|local anesthesia
386454|NCT01300351|Advanced breast cancer|advanced breast cancer
386455|NCT01300351|metastatic breast cancer|metastatic breast cancer
386456|NCT01300338|Diabetes|diabetes
386457|NCT01300325|Bronchiolitis, 3% Hypertonic Saline Solution|bronchiolitis, 3% hypertonic saline solution
386458|NCT01300312|eperisone|eperisone
386459|NCT01300312|diclofenac|diclofenac
386460|NCT01300312|low back pain|low back pain
386461|NCT01300299|lung cancer|lung cancer
386462|NCT01300299|radiation|radiation
386463|NCT01300299|stereotactic|stereotactic
386464|NCT01300273|Diabetic nephropathy|diabetic nephropathy
386465|NCT01300273|Podocyte|podocyte
386466|NCT01300273|Low Protein Diet|low protein diet
386467|NCT01300273|Ketoanalogs|ketoanalogs
386468|NCT01300234|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
386469|NCT01300234|chronic hepatitis B|chronic hepatitis b
386470|NCT01300234|adefovir dipivoxil|adefovir dipivoxil
386471|NCT01300221|Three dimension echocardiography|three dimension echocardiography
386472|NCT01300221|Congenital heart disease|congenital heart disease
386474|NCT01300208|cutaneous lupus erythematosus|cutaneous lupus erythematosus
386475|NCT01300208|subacute lupus erythematosus|subacute lupus erythematosus
386476|NCT01300208|discoid lupus erythematosus|discoid lupus erythematosus
386477|NCT01300208|lupus|lupus
386478|NCT01300195|VATS|vats
386479|NCT01300195|standardized surgery|standardized surgery
386480|NCT01300195|persistent pain|persistent pain
386481|NCT01300182|ACLR|aclr
386482|NCT01300169|Suicide|suicide
386483|NCT01300169|Assessment|assessment
386484|NCT01300169|Intervention|intervention
386485|NCT01300169|CAMS|cams
386486|NCT01300156|Hodgkin's disease|hodgkin's disease
386487|NCT01300156|lymphoma|lymphoma
386488|NCT01300156|Relapsed|relapsed
386489|NCT01300156|refractory|refractory
386490|NCT01300130|neurological development|neurological development
386491|NCT01300130|preterm infants|preterm infants
386492|NCT01300130|fatty acid status|fatty acid status
386493|NCT01300117|cardiac surgery|cardiac surgery
386494|NCT01300117|adamts13|adamts13
386495|NCT01300117|TTP|ttp
386496|NCT01300117|extracorporeal circulation|extracorporeal circulation
386497|NCT01300117|Heart-Lung Machine|heart-lung machine
386498|NCT01300104|prostate cancer progression|prostate cancer progression
386499|NCT01300104|active surveillance|active surveillance
386500|NCT01300104|whole grain rye|whole grain rye
386501|NCT01300104|exercise|exercise
386502|NCT01300104|insulin sensitivity|insulin sensitivity
386503|NCT01300104|quality of life|quality of life
386504|NCT01300091|Shoulder|shoulder
386505|NCT01300091|Pain|pain
386506|NCT01300091|Range of Motion|range of motion
386507|NCT01300091|Disability Evaluation|disability evaluation
386508|NCT01300091|Function|function
386509|NCT01300091|Sick Leave|sick leave
386510|NCT01300091|Primary Health Care|primary health care
386511|NCT01300091|Visual Analog Scale|visual analog scale
386512|NCT01300091|Visual Analog Pain Scale|visual analog pain scale
386513|NCT01300091|The American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form|the american shoulder and elbow surgeons standardized shoulder assessment form
386514|NCT01300078|Hot Flashes|hot flashes
386515|NCT01300078|Hot Flushes|hot flushes
386516|NCT01300078|Vasomotor Symptoms|vasomotor symptoms
386517|NCT01300078|Menopausal Symptoms|menopausal symptoms
386518|NCT01300052|psoriasis|psoriasis
386519|NCT01300039|nephrolithiasis|nephrolithiasis
386520|NCT01300039|urolithiasis|urolithiasis
386521|NCT01300039|hyperoxaluria|hyperoxaluria
386522|NCT01300039|Helicobacter pylori|helicobacter pylori
386523|NCT01300026|Low intermediate grade B cell Lymphoma|low intermediate grade b cell lymphoma
386524|NCT01300026|Non-cutaneous T-cell NHL|non-cutaneous t-cell nhl
386525|NCT01300026|Mantle Cell Lymphoma|mantle cell lymphoma
386526|NCT01300026|PI3K delta|pi3k delta
386527|NCT01300026|Lymphoid|lymphoid
386528|NCT01300026|NHL|nhl
386529|NCT01300026|MCL|mcl
386530|NCT01300026|Hematologic|hematologic
386531|NCT01300026|CLL|cll
386532|NCT01300026|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
386533|NCT01300013|Intravenous|intravenous
386534|NCT01300013|IV|iv
386535|NCT01300013|Left Ventricular Systolic Dysfunction|left ventricular systolic dysfunction
386536|NCT01300013|Hospitalized|hospitalized
386537|NCT01300013|Acute heart failure|acute heart failure
386538|NCT01300013|Heart failure|heart failure
386539|NCT01300013|Left ventricular ejection fraction|left ventricular ejection fraction
386540|NCT01300013|pharmacokinetics|pharmacokinetics
386541|NCT01300013|Pharmacodynamics|pharmacodynamics
386542|NCT01300013|Dyspnea|dyspnea
386543|NCT01300013|hospitalization|hospitalization
386544|NCT01300013|In-patient|in-patient
386545|NCT01300013|Omecamtiv mecarbil|omecamtiv mecarbil
386546|NCT01300013|Double-blind|double-blind
386547|NCT01300013|Randomized|randomized
386548|NCT01300013|Placebo-controlled|placebo-controlled
386549|NCT01299987|Keywords provided by University Hospital Mannheim:|keywords provided by university hospital mannheim:
386550|NCT01299987|Intraoperative Radiotherapy|intraoperative radiotherapy
386551|NCT01299987|Early Breast Cancer|early breast cancer
386552|NCT01299987|Elderly Patients|elderly patients
386553|NCT01299974|Family-centered|family-centered
386554|NCT01299974|teaching|teaching
386555|NCT01299974|residents|residents
386556|NCT01299974|family faculty|family faculty
386557|NCT01299961|Rheumatoid Arthritis|rheumatoid arthritis
386558|NCT01299961|Subcutaneous Abatacept|subcutaneous abatacept
386559|NCT01299961|Ultrasound|ultrasound
386560|NCT01299948|HIV|hiv
386561|NCT01299948|AIDS|aids
386562|NCT01299948|CD4|cd4
386563|NCT01299948|progression|progression
386564|NCT01299948|immune activation|immune activation
386565|NCT01299935|stress reduction|stress reduction
386566|NCT01299935|Transcendental Meditation technique|transcendental meditation technique
386567|NCT01299935|secondary prevention of coronary heart disease|secondary prevention of coronary heart disease
386568|NCT01299922|Lupus nephritis|lupus nephritis
386569|NCT01299922|Therapy|therapy
386570|NCT01299922|Cyclosporin|cyclosporin
386571|NCT01299922|Mycophenolic acid|mycophenolic acid
386572|NCT01299909|Mindfulness Training for Smokers|mindfulness training for smokers
386573|NCT01299909|Smoking|smoking
386574|NCT01299909|Smoking cessation|smoking cessation
386575|NCT01299909|Addiction|addiction
386576|NCT01299909|behavioral intervention|behavioral intervention
386577|NCT01299909|Nicotine|nicotine
386578|NCT01299909|Tobacco|tobacco
386580|NCT01299909|Meditation|meditation
386581|NCT01299909|MBSR|mbsr
386582|NCT01299909|Mindfulness Based Stress Reduction|mindfulness based stress reduction
386583|NCT01299909|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
386584|NCT01299909|MBCT|mbct
386585|NCT01299909|Mindfulness Based Relapse Prevention|mindfulness based relapse prevention
386586|NCT01299909|MBRP|mbrp
386587|NCT01299909|Mindfulness Training|mindfulness training
386588|NCT01299909|Nicotine Patch|nicotine patch
386589|NCT01299909|Quit Line|quit line
386590|NCT01299909|Phone counseling|phone counseling
386591|NCT01299909|Freedom from Smoking|freedom from smoking
386592|NCT01299896|Cigarette Smoking|cigarette smoking
386593|NCT01299896|Smoking, Tobacco|smoking, tobacco
386594|NCT01299896|Tobacco Smoking|tobacco smoking
386595|NCT01299896|Smoking Cessation|smoking cessation
386596|NCT01299896|Tobacco Dependence|tobacco dependence
386597|NCT01299883|Cancer|cancer
386599|NCT01299883|African American|african american
386600|NCT01299883|Health Education Intervention|health education intervention
386601|NCT01299883|Intervention RCT|intervention rct
386602|NCT01299883|Study focus is to examine the influence of health education regarding either CVD or CVD and cancer on health behaviors.|study focus is to examine the influence of health education regarding either cvd or cvd and cancer on health behaviors.
386603|NCT01299857|pemphigus|pemphigus
386604|NCT01299857|Mabthéra (R)|mabthéra (r)
386605|NCT01299857|B lymphocytes|b lymphocytes
386606|NCT01299857|desmogleines|desmogleines
386607|NCT01299844|Type 2 Diabetes|type 2 diabetes
386608|NCT01299818|central pain|central pain
386609|NCT01299818|spine surgey|spine surgey
386610|NCT01299818|outcome|outcome
386611|NCT01299818|patients undergo spinal surgery|patients undergo spinal surgery
386612|NCT01299805|Drug Therapy|drug therapy
386613|NCT01299805|pharmacodynamic|pharmacodynamic
386614|NCT01299792|spinal cord injury|spinal cord injury
386615|NCT01299792|urodynamics|urodynamics
386616|NCT01299792|ultrasound|ultrasound
386617|NCT01299792|neurogenic bladder dysfunction|neurogenic bladder dysfunction
386618|NCT01299779|hyponatremia|hyponatremia
386619|NCT01299779|PEG-SD|peg-sd
386620|NCT01299779|PEG-ELS|peg-els
386621|NCT01299766|Mild Cognitive Impairment|mild cognitive impairment
386622|NCT01299766|Memory|memory
386623|NCT01299727|Recombinant Human Heparan N-Sulfatase (rhHNS)|recombinant human heparan n-sulfatase (rhhns)
386624|NCT01299727|Sanfilippo Syndrome Type A (MPS IIIA)|sanfilippo syndrome type a (mps iiia)
386625|NCT01299727|Lysosomal storage disease (LSD)|lysosomal storage disease (lsd)
386626|NCT01299727|Mucopolysaccharidosis (MPS) III|mucopolysaccharidosis (mps) iii
386627|NCT01299714|Human Papilloma Virus|human papilloma virus
386628|NCT01299714|vaccine|vaccine
386629|NCT01299714|stress|stress
386630|NCT01299714|cervical cancer|cervical cancer
386631|NCT01299714|GARDASIL|gardasil
386632|NCT01299701|Advanced or metastatic cancer|advanced or metastatic cancer
386633|NCT01299701|refractory|refractory
386634|NCT01299701|core phase|core phase
386635|NCT01299701|extension phase|extension phase
386636|NCT01299701|dose escalation|dose escalation
386637|NCT01299701|standard chemotherapy|standard chemotherapy
386638|NCT01299701|docetaxel|docetaxel
386639|NCT01299701|paclitaxel|paclitaxel
386640|NCT01299701|carboplatin|carboplatin
386641|NCT01299701|safety|safety
386642|NCT01299701|tolerability|tolerability
386643|NCT01299675|MR conditional|mr conditional
386644|NCT01299649|CAD|cad
386645|NCT01299636|PM060184|pm060184
386646|NCT01299636|Phase I|phase i
386647|NCT01299636|Pharma Mar|pharma mar
386648|NCT01299623|breast cancer|breast cancer
386649|NCT01299623|breast cancer prevention|breast cancer prevention
386650|NCT01299623|African American women|african american women
386651|NCT01299610|Atopic Dermatitis|atopic dermatitis
386652|NCT01299610|GW870086X|gw870086x
386653|NCT01299610|TIS|tis
386654|NCT01299610|IGA|iga
386655|NCT01299597|repeat dose|repeat dose
386656|NCT01299597|statins|statins
386657|NCT01299597|safety and tolerability|safety and tolerability
386658|NCT01299597|drug interaction|drug interaction
386659|NCT01299597|sb649868|sb649868
386660|NCT01299597|healthy male subjects|healthy male subjects
386661|NCT01299597|pharmacokinetics|pharmacokinetics
386662|NCT01299558|pharmacokinetics|pharmacokinetics
386663|NCT01299558|GW642444|gw642444
386664|NCT01299558|absolute bioavailability|absolute bioavailability
386665|NCT01299558|healthy subjects|healthy subjects
386666|NCT01299558|fluticasone furoate|fluticasone furoate
386667|NCT01299558|GW685698|gw685698
386668|NCT01299545|Rheumatoid Arthritis|rheumatoid arthritis
386669|NCT01299545|Anti TNF|anti tnf
386670|NCT01299545|Infliximab|infliximab
386671|NCT01299545|Methotrexate|methotrexate
386672|NCT01299545|DMARDs|dmards
386673|NCT01299545|Gene expression biomarkers|gene expression biomarkers
386674|NCT01299519|obesity|obesity
386675|NCT01299519|weight loss|weight loss
386676|NCT01299519|insulin resistance|insulin resistance
386677|NCT01299506|soft tissue sarcoma|soft tissue sarcoma
386678|NCT01299506|trabectedin|trabectedin
386679|NCT01299506|Netherlands|netherlands
386680|NCT01299493|carcinoma|carcinoma
386681|NCT01299493|colorectal cancer|colorectal cancer
386682|NCT01299493|community health centers|community health centers
386683|NCT01299493|cluster-randomized|cluster-randomized
386684|NCT01299493|health behavior|health behavior
386685|NCT01299480|Healthy adolescents|healthy adolescents
386686|NCT01299467|Asthma|asthma
386687|NCT01299467|duration of action|duration of action
386688|NCT01299467|allergen challenge|allergen challenge
386689|NCT01299428|CEREBRAL OXYGENATION|cerebral oxygenation
386690|NCT01299428|HYPERNATREMİA|hypernatremia
386691|NCT01299428|NEWBORN|newborn
386692|NCT01299428|NA VALUES|na values
386694|NCT01299415|Phase I,|phase i,
386695|NCT01299415|Oncology,|oncology,
386696|NCT01299415|CYP1A2,|cyp1a2,
386697|NCT01299415|fluvoxamine,|fluvoxamine,
386698|NCT01299415|drug drug interaction,|drug drug interaction,
386699|NCT01299415|Novartis,|novartis,
386700|NCT01299415|Antisoma|antisoma
386701|NCT01299389|Paliperidone palmitate|paliperidone palmitate
386702|NCT01299389|Schizophrenia|schizophrenia
386703|NCT01299376|Essential hypertension|essential hypertension
386704|NCT01299376|Antihypertensive agents|antihypertensive agents
386705|NCT01299376|Blood pressure|blood pressure
386706|NCT01299376|Uncontrolled hypertension|uncontrolled hypertension
386707|NCT01299363|Prolapse|prolapse
386708|NCT01299363|Pain with intercourse|pain with intercourse
386709|NCT01299363|Dyspareunia|dyspareunia
386710|NCT01299363|Post operative pain|post operative pain
386711|NCT01299350|Heart failure|heart failure
386712|NCT01299350|Nt-proBNP|nt-probnp
386714|NCT01299311|insulin sensitivity|insulin sensitivity
386715|NCT01299285|Absorption|absorption
386716|NCT01299285|Distribution|distribution
386717|NCT01299285|Metabolism|metabolism
386718|NCT01299285|Excretion|excretion
386719|NCT01299285|Mass balance|mass balance
386720|NCT01299285|Metabolic profile|metabolic profile
386721|NCT01299285|Radiolabeled study|radiolabeled study
386722|NCT01299285|14C|14c
386723|NCT01299259|Text message reminders|text message reminders
386724|NCT01299259|Pelvic inflammatory disease|pelvic inflammatory disease
386725|NCT01299259|PID|pid
386726|NCT01299259|Primary care follow-up|primary care follow-up
386727|NCT01299259|Emergency department care|emergency department care
386728|NCT01299259|Discharge instructions|discharge instructions
386729|NCT01299246|Diabetic Foot|diabetic foot
386730|NCT01299246|non-invasive DFP assessment tools|non-invasive dfp assessment tools
386731|NCT01299246|early detection of DFP|early detection of dfp
386732|NCT01299220|Erlotinib|erlotinib
386733|NCT01299220|Acitretin|acitretin
386734|NCT01299220|Rash|rash
386735|NCT01299220|Dermatology|dermatology
386736|NCT01299220|Oncology|oncology
386737|NCT01299207|Stents|stents
386738|NCT01299207|Drug-Eluting Stents|drug-eluting stents
386739|NCT01299207|Stent Thrombosis|stent thrombosis
386740|NCT01299207|Bleeding|bleeding
386741|NCT01299207|Dual-Antiplatelet Therapy|dual-antiplatelet therapy
386742|NCT01299194|BRONCHIECTASIS|bronchiectasis
386743|NCT01299194|PSEUDOMONAS AERUGINOSA|pseudomonas aeruginosa
386744|NCT01299194|STATIN|statin
386745|NCT01299194|OUTCOME|outcome
386746|NCT01299181|Bronchiectasis|bronchiectasis
386747|NCT01299181|Outcome|outcome
386748|NCT01299181|Statin therapy|statin therapy
386749|NCT01299168|global gene expression|global gene expression
386750|NCT01299168|molecular diagnostic classifiers|molecular diagnostic classifiers
386751|NCT01299155|Intraocular Lens|intraocular lens
386752|NCT01299155|Presbyopia Correcting IOL|presbyopia correcting iol
386753|NCT01299142|Influenza|influenza
386754|NCT01299142|antibodies|antibodies
386755|NCT01299142|monoclonal|monoclonal
386756|NCT01299142|virus|virus
386757|NCT01299129|Uveitis|uveitis
386758|NCT01299129|Cystoid macular edema|cystoid macular edema
386759|NCT01299129|microperimetry|microperimetry
386760|NCT01299129|functional visual acuity|functional visual acuity
386761|NCT01299129|intravitreal triamcinolone|intravitreal triamcinolone
386762|NCT01299116|AE adverse event|ae adverse event
386763|NCT01299116|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
386764|NCT01299116|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
386765|NCT01299116|ICH International Conference of Harmonisation|ich international conference of harmonisation
386766|NCT01299116|IRB Institutional Review Board|irb institutional review board
386767|NCT01299116|IU International units|iu international units
386768|NCT01299116|mg milligram(s)|mg milligram(s)
386769|NCT01299116|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
386770|NCT01299116|LARC Long-Acting reversible contraception|larc long-acting reversible contraception
386870|NCT01298557|Brain imaging|brain imaging
386771|NCT01299116|PPCNC Planned Parenthood of North Carolina|ppcnc planned parenthood of north carolina
386772|NCT01299116|SAE serious adverse event|sae serious adverse event
387153|NCT01297335|clonidine|clonidine
386773|NCT01299116|SARC Short-Acting reversible contraception|sarc short-acting reversible contraception
386774|NCT01299116|µg microgram|µg microgram
386775|NCT01299116|ULN upper limit of the normal range|uln upper limit of the normal range
386776|NCT01299103|wrinkle|wrinkle
386777|NCT01299103|rhytide|rhytide
386778|NCT01299090|wrinkles|wrinkles
386779|NCT01299090|rhytides|rhytides
386780|NCT01299077|Lumbar disc degenerative disease|lumbar disc degenerative disease
386782|NCT01299064|mindfulness-based intervention|mindfulness-based intervention
386783|NCT01299064|symptoms reduction|symptoms reduction
377666|NCT01336569|IOP|iop
386784|NCT01299064|mental health|mental health
386785|NCT01299051|Weight Management|weight management
386786|NCT01299051|Employee Health|employee health
386787|NCT01299038|Crestor|crestor
386788|NCT01299038|TFBP|tfbp
386789|NCT01299038|rosuvastatin|rosuvastatin
386790|NCT01299025|balance|balance
386791|NCT01299025|walking|walking
386792|NCT01298999|Barrett's Esophagus|barrett's esophagus
386793|NCT01298999|Esophageal Adenocarcinoma|esophageal adenocarcinoma
386794|NCT01298999|GERD|gerd
386795|NCT01298999|Acid Reflux|acid reflux
386796|NCT01298986|atrial fibrillation ablation procedures|atrial fibrillation ablation procedures
386797|NCT01298960|Poor Ovarian response in IVF|poor ovarian response in ivf
386798|NCT01298960|Metaphase II oocytes|metaphase ii oocytes
386799|NCT01298960|Pregnancy Rate|pregnancy rate
386800|NCT01298960|Growth Hormone|growth hormone
386801|NCT01298947|Photoablative Atherectomy|photoablative atherectomy
386802|NCT01298947|Paclitaxel-Coated Balloon|paclitaxel-coated balloon
386803|NCT01298947|Instent Femoro-popliteal Obstructions|instent femoro-popliteal obstructions
386804|NCT01298921|Headache|headache
386805|NCT01298921|Cluster Headache|cluster headache
386806|NCT01298921|Oxygen Therapy|oxygen therapy
386807|NCT01298908|varicose veins, oedema|varicose veins, oedema
386808|NCT01298895|optical components|optical components
386809|NCT01298895|pseudoexfoliation|pseudoexfoliation
386810|NCT01298895|cataract|cataract
386811|NCT01298895|LENSTAR® LS 900®|lenstar® ls 900®
386812|NCT01298882|Type 2 diabetes mellitus|type 2 diabetes mellitus
386813|NCT01298882|Overweight|overweight
386814|NCT01298882|Obesity|obesity
386816|NCT01298869|HPV infection|hpv infection
386817|NCT01298869|HPV vaccine|hpv vaccine
386818|NCT01298869|antibodies titer|antibodies titer
386819|NCT01298856|hydrotherapy|hydrotherapy
386820|NCT01298856|chronic ankle instability|chronic ankle instability
386821|NCT01298856|ankle taping|ankle taping
386822|NCT01298843|Confirmed or Suspected Infections|confirmed or suspected infections
386823|NCT01298817|Obesity|obesity
386824|NCT01298817|Aging|aging
386825|NCT01298817|Soy|soy
386826|NCT01298817|Weight Loss|weight loss
386827|NCT01298817|Ectopic Fat|ectopic fat
386828|NCT01298778|chronic pain post delivery|chronic pain post delivery
386829|NCT01298778|postpartum depression|postpartum depression
386830|NCT01298778|tailored pain management|tailored pain management
386831|NCT01298765|buccal soluble film|buccal soluble film
386832|NCT01298739|asthma control level , ACQ|asthma control level , acq
386833|NCT01298726|PHARMACEUTICAL SERVICES|pharmaceutical services
386834|NCT01298726|DIABETES MELLITUS|diabetes mellitus
386835|NCT01298713|Hormonoresistance|hormonoresistance
386836|NCT01298713|tamoxifen|tamoxifen
386837|NCT01298713|Previously received anti-aromatase treatment|previously received anti-aromatase treatment
386838|NCT01298713|mTor inhibitor|mtor inhibitor
386839|NCT01298687|open-angle glaucoma|open-angle glaucoma
386840|NCT01298687|ocular hypertension|ocular hypertension
386841|NCT01298687|divided dose|divided dose
386842|NCT01298661|Exercise Test|exercise test
386843|NCT01298661|Reproducibility of Results|reproducibility of results
386844|NCT01298661|Mortality|mortality
386845|NCT01298648|Crohn's Disease|crohn's disease
386846|NCT01298635|Primary angle-closure glaucoma|primary angle-closure glaucoma
386847|NCT01298635|cataract|cataract
386848|NCT01298635|trabeculectomy|trabeculectomy
386849|NCT01298635|phacotrabeculectomy|phacotrabeculectomy
386850|NCT01298609|Fibromyalgia|fibromyalgia
386851|NCT01298609|Occipital Nerve Stimulation|occipital nerve stimulation
386852|NCT01298570|Metastatic Colorectal Cancer|metastatic colorectal cancer
386853|NCT01298570|K-RAS mutation|k-ras mutation
386854|NCT01298570|BRAF mutation|braf mutation
386855|NCT01298570|Regorafenib|regorafenib
386856|NCT01298570|BAY 73-4506|bay 73-4506
386857|NCT01298570|FOLFIRI|folfiri
386858|NCT01298570|Irinotecan|irinotecan
386859|NCT01298570|5-FU|5-fu
386860|NCT01298570|Leucovorin|leucovorin
386861|NCT01298570|Placebo|placebo
386862|NCT01298570|Phase II|phase ii
386863|NCT01298570|Multi-Center|multi-center
386864|NCT01298570|Randomized|randomized
386865|NCT01298570|Lineberger|lineberger
386866|NCT01298570|North Carolina Cancer Hospital|north carolina cancer hospital
386867|NCT01298570|UNC|unc
386868|NCT01298557|Traumatic brain injury|traumatic brain injury
386869|NCT01298557|Post-concussive symptoms|post-concussive symptoms
386871|NCT01298557|Neurocognitive testing|neurocognitive testing
386872|NCT01298544|Vaccine|vaccine
386873|NCT01298544|Prevenar|prevenar
386874|NCT01298544|Pneumococcal disease|pneumococcal disease
386876|NCT01298531|Axial Spondyloarthritis|axial spondyloarthritis
386877|NCT01298531|NSAIDs sparing effect|nsaids sparing effect
386878|NCT01298518|multiple dose study in type 2 diabetes patients|multiple dose study in type 2 diabetes patients
7221|NCT03244592|Minocycline|minocycline
7521|NCT03242512|RANKL|rankl
386879|NCT01298505|Phase 1 multiple dose safety toleration fexofenadine|phase 1 multiple dose safety toleration fexofenadine
386880|NCT01298492|Active Crohn's disease|active crohn's disease
377757|NCT01336166|H1N1|h1n1
386881|NCT01298492|Anti-TNF Refractory|anti-tnf refractory
386882|NCT01298492|Immunosuppressant Refractory|immunosuppressant refractory
386883|NCT01298479|volume delivery|volume delivery
386884|NCT01298466|identification|identification
386885|NCT01298466|chronic|chronic
386886|NCT01298466|neuropathic|neuropathic
386887|NCT01298466|low back pain|low back pain
386888|NCT01298466|primary care|primary care
386889|NCT01298466|pregabalin|pregabalin
386890|NCT01298414|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
386891|NCT01298401|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
386892|NCT01298401|stage IIB pancreatic cancer|stage iib pancreatic cancer
386893|NCT01298401|stage III pancreatic cancer|stage iii pancreatic cancer
386894|NCT01298388|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
386895|NCT01298388|cancer survivor|cancer survivor
386896|NCT01298388|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
386897|NCT01298388|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
386898|NCT01298388|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
386899|NCT01298388|non-T, non-B childhood acute lymphoblastic leukemia|non-t, non-b childhood acute lymphoblastic leukemia
386900|NCT01298388|non-T, non-B, cALLa positive childhood acute lymphoblastic leukemia|non-t, non-b, calla positive childhood acute lymphoblastic leukemia
386901|NCT01298388|non-T, non-B, cALLa negative childhood acute lymphoblastic leukemia|non-t, non-b, calla negative childhood acute lymphoblastic leukemia
386902|NCT01298388|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
386903|NCT01298388|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
386904|NCT01298375|Metabolic flexibility|metabolic flexibility
386905|NCT01298375|Mitochondrial function|mitochondrial function
386906|NCT01298375|Human primary myoblasts|human primary myoblasts
386907|NCT01298375|Lipid metabolism|lipid metabolism
386908|NCT01298336|Mycobacterium Xenopi Pulmonary Infection|mycobacterium xenopi pulmonary infection
386909|NCT01298336|Clarithromycin|clarithromycin
386910|NCT01298336|Moxifloxacin|moxifloxacin
386911|NCT01298323|Medullary Thyroid Cancer|medullary thyroid cancer
386912|NCT01298323|Locally advanced|locally advanced
386913|NCT01298323|Metastatic|metastatic
386914|NCT01298323|Vandetanib|vandetanib
386915|NCT01298323|Patient Outreach|patient outreach
386916|NCT01298310|Morton's neuroma, QST measurements|morton's neuroma, qst measurements
386917|NCT01298297|Buprenorphine, acute pain, analgesia|buprenorphine, acute pain, analgesia
386918|NCT01298284|Variceal bleeding|variceal bleeding
386919|NCT01298284|portal hypertension|portal hypertension
386920|NCT01298284|hepatocelluar carcinoma|hepatocelluar carcinoma
386921|NCT01298284|endoscopic variceal ligation|endoscopic variceal ligation
386922|NCT01298284|non-selective beta-blocker|non-selective beta-blocker
386923|NCT01298284|rebleeding|rebleeding
386924|NCT01298271|gastric variceal bleeding|gastric variceal bleeding
386925|NCT01298271|primaryprevention|primaryprevention
386926|NCT01298271|cyanoacrylate injection|cyanoacrylate injection
386927|NCT01298271|non-selective beta-blocker|non-selective beta-blocker
386928|NCT01298245|diabetes|diabetes
386929|NCT01298245|diabetic retinopathy|diabetic retinopathy
386930|NCT01298245|Chinese|chinese
386931|NCT01298245|gene|gene
386932|NCT01298245|associations|associations
386933|NCT01298206|A/H1N1 Influenza|a/h1n1 influenza
386934|NCT01298206|swine flu|swine flu
386935|NCT01298206|virus disease|virus disease
386936|NCT01298206|Avian flu|avian flu
386937|NCT01298193|Early-stage breast cancer patients|early-stage breast cancer patients
386938|NCT01298180|Prader-Willi Syndrome|prader-willi syndrome
386939|NCT01298180|Growth Hormone Deficiency|growth hormone deficiency
386940|NCT01298167|Cyanoacrylate|cyanoacrylate
386941|NCT01298167|Fast Absorbing Gut|fast absorbing gut
386942|NCT01298167|Mohs Surgery|mohs surgery
386943|NCT01298167|Epidermal closure method|epidermal closure method
386944|NCT01298154|Food intake|food intake
386945|NCT01298154|Blood glucose|blood glucose
386946|NCT01298154|Pulses|pulses
386947|NCT01298154|Protein|protein
386948|NCT01298141|Replagal|replagal
386949|NCT01298141|Enzyme Replacement Therapy|enzyme replacement therapy
386950|NCT01298141|agalsidase alfa|agalsidase alfa
386951|NCT01298115|chronic kidney disease|chronic kidney disease
386952|NCT01298115|dialysis|dialysis
386953|NCT01298115|pre dialysis education|pre dialysis education
386954|NCT01298115|transplantation|transplantation
386955|NCT01298115|conservative care|conservative care
386956|NCT01298102|kidney|kidney
386957|NCT01298102|transplantation|transplantation
386958|NCT01298102|haemodialysis|haemodialysis
386959|NCT01298102|vaccination|vaccination
386960|NCT01298102|influenza H1N1 2009|influenza h1n1 2009
386961|NCT01298089|Flap|flap
386962|NCT01298089|LASIK|lasik
386963|NCT01298089|Corneal|corneal
386964|NCT01298076|Diabetes|diabetes
386965|NCT01298076|Retinopathy|retinopathy
386966|NCT01298076|Macular oedema|macular oedema
472396|NCT00071227|AMD|amd
386968|NCT01298076|Photocoagulation|photocoagulation
386969|NCT01298076|Fovea|fovea
386970|NCT01298076|Steroid|steroid
386971|NCT01298076|Bevacizumab|bevacizumab
386972|NCT01298076|Intravitreal|intravitreal
386973|NCT01298037|Immunology, Hepatitis B, HBV|immunology, hepatitis b, hbv
386974|NCT01298024|Achilles tendon rupture|achilles tendon rupture
386975|NCT01298024|Non-surgical treatment|non-surgical treatment
386976|NCT01298024|Exercise|exercise
386977|NCT01298024|Neuromuscular training|neuromuscular training
386978|NCT01298011|operable|operable
386979|NCT01298011|pancreas|pancreas
386980|NCT01298011|Abraxane|abraxane
386981|NCT01298011|Gemcitabine|gemcitabine
386982|NCT01298011|Preoperative|preoperative
386983|NCT01298011|potentially|potentially
386984|NCT01298011|Pancreatic Cancer|pancreatic cancer
386985|NCT01297985|Serious mental illness|serious mental illness
386986|NCT01297985|Psychiatric disability|psychiatric disability
386987|NCT01297985|Mental health peer-led|mental health peer-led
386988|NCT01297985|Mental illness education|mental illness education
386989|NCT01297985|Illness self-management|illness self-management
386990|NCT01297972|Aplastic Anemia|aplastic anemia
386991|NCT01297972|Mesenchymal Stem Cells|mesenchymal stem cells
386992|NCT01297959|Surgical Wound Infection|surgical wound infection
386993|NCT01297959|Therapeutic Enzyme System|therapeutic enzyme system
386994|NCT01297959|Singlet Oxygen|singlet oxygen
386995|NCT01297959|Peroxidase|peroxidase
386996|NCT01297959|Glucose Oxidase|glucose oxidase
386997|NCT01297959|Colorectal surgery|colorectal surgery
386998|NCT01297959|Incisional Surgical Site Infections (SSI)|incisional surgical site infections (ssi)
386999|NCT01297959|Anti-infective Agents, Local|anti-infective agents, local
387000|NCT01297959|Clinical Trial, Phase III|clinical trial, phase iii
387001|NCT01297933|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
387002|NCT01297933|cholestasis|cholestasis
387003|NCT01297933|short bowel syndrome|short bowel syndrome
387004|NCT01297933|Omegaven|omegaven
387005|NCT01297920|Open-Angle Glaucoma|open-angle glaucoma
387006|NCT01297920|Ocular Hypertension|ocular hypertension
387007|NCT01297920|Brinzolamide|brinzolamide
387008|NCT01297920|Brimonidine|brimonidine
387009|NCT01297920|Intraocular pressure|intraocular pressure
387010|NCT01297907|Crohn's Disease|crohn's disease
387011|NCT01297907|Bronchial hyper reactivity|bronchial hyper reactivity
387012|NCT01297907|Fractional exhaled NO|fractional exhaled no
387013|NCT01297907|Methacholine Challenge Test|methacholine challenge test
387014|NCT01297907|Pediatric Crohn's Disease Activity Index|pediatric crohn's disease activity index
387015|NCT01297907|To determine the frequency of bronchial hyperreactivity in pediatric patients followed and treated for Crohn disease|to determine the frequency of bronchial hyperreactivity in pediatric patients followed and treated for crohn disease
387016|NCT01297894|A. baumannii|a. baumannii
387017|NCT01297894|colistin|colistin
387018|NCT01297894|fosfomycin|fosfomycin
387019|NCT01297881|Caucasian outpatients|caucasian outpatients
387020|NCT01297881|undiagnosed respiratory symptoms|undiagnosed respiratory symptoms
387021|NCT01297881|dyspnea|dyspnea
387022|NCT01297881|cough|cough
387023|NCT01297881|sputum|sputum
387024|NCT01297829|ibuprofen|ibuprofen
387025|NCT01297829|postoperative narcotics|postoperative narcotics
387026|NCT01297829|visual analog pain scale|visual analog pain scale
387027|NCT01297829|inguinal hernia repair|inguinal hernia repair
387028|NCT01297829|umbilical hernia repair|umbilical hernia repair
387029|NCT01297790|Cough|cough
387030|NCT01297790|Inhalational cough challenges|inhalational cough challenges
387031|NCT01297790|Cough reflex sensitivity|cough reflex sensitivity
387032|NCT01297790|Chronic cough.|chronic cough.
387033|NCT01297777|Mast cell|mast cell
387034|NCT01297777|Mastocytosis|mastocytosis
387035|NCT01297777|Mast cell disease|mast cell disease
387036|NCT01297738|diet manipulation|diet manipulation
387037|NCT01297738|serotonin|serotonin
387038|NCT01297738|dopamine|dopamine
387039|NCT01297738|insulin sensitivity|insulin sensitivity
387040|NCT01297725|Cesarean section|cesarean section
387041|NCT01297725|Cesarean section[*methods]|cesarean section[*methods]
387042|NCT01297725|Fascia [*surgery]|fascia [*surgery]
387043|NCT01297725|Randomized Controlled Trial|randomized controlled trial
387044|NCT01297725|Abdominal Wall [*surgery]|abdominal wall [*surgery]
387045|NCT01297725|Pain, postoperative|pain, postoperative
387046|NCT01297725|Surgical wound infection|surgical wound infection
387047|NCT01297712|screening colonoscopy|screening colonoscopy
387048|NCT01297712|adenoma|adenoma
387049|NCT01297712|hyperplastic polyp|hyperplastic polyp
387050|NCT01297712|differential diagnosis|differential diagnosis
387051|NCT01297699|Graves´ orbitopathy|graves´ orbitopathy
387149|NCT01297348|safety|safety
387052|NCT01297699|Graves´ ophthalmopathy|graves´ ophthalmopathy
387053|NCT01297699|Thyroid eye disease|thyroid eye disease
387154|NCT01297335|poorly|poorly
387054|NCT01297699|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
387055|NCT01297699|Tocilizumab|tocilizumab
387056|NCT01297699|EUGOGO|eugogo
387058|NCT01297686|Chronic plantar fasciitis|chronic plantar fasciitis
377966|NCT01335230|HIV|hiv
387059|NCT01297686|Workplace injury|workplace injury
387060|NCT01297686|Foot and Ankle Disability Index|foot and ankle disability index
387061|NCT01297686|Ultrasound measure of disease severity|ultrasound measure of disease severity
387062|NCT01297673|vesico-ureteral reflux|vesico-ureteral reflux
387063|NCT01297673|neurogenic bladder dysfunction|neurogenic bladder dysfunction
387064|NCT01297673|spinal cord injury|spinal cord injury
387065|NCT01297660|neurogenic detrusor overactivity|neurogenic detrusor overactivity
387066|NCT01297660|detrusor sphincter dyssynergia|detrusor sphincter dyssynergia
387067|NCT01297660|compliance|compliance
387068|NCT01297660|video urodynamic|video urodynamic
387069|NCT01297660|spinal cord injury|spinal cord injury
387070|NCT01297647|urinary tract infection|urinary tract infection
387071|NCT01297647|urodynamics|urodynamics
387072|NCT01297647|spinal cord injury|spinal cord injury
387073|NCT01297634|Botulinum toxin type A|botulinum toxin type a
387074|NCT01297634|Hyperfunctional forehead lines|hyperfunctional forehead lines
387075|NCT01297634|Randomized controlled trial|randomized controlled trial
387076|NCT01297634|Double-blinded trial|double-blinded trial
387077|NCT01297634|Electromyogram (EMG)|electromyogram (emg)
387078|NCT01297634|Electromyographic activity|electromyographic activity
387079|NCT01297634|Frontal Area|frontal area
387080|NCT01297621|breast hypertrophy|breast hypertrophy
387081|NCT01297621|physical activity|physical activity
387082|NCT01297621|sexuality|sexuality
387083|NCT01297621|patient satisfaction|patient satisfaction
387084|NCT01297595|relative bioavailability|relative bioavailability
387085|NCT01297595|pharmacokinetics|pharmacokinetics
387086|NCT01297595|crizotinib|crizotinib
387087|NCT01297595|oral liquid formulation|oral liquid formulation
387088|NCT01297595|formulated capsule|formulated capsule
387089|NCT01297582|ONO-6950|ono-6950
387090|NCT01297582|Healthy Adult Subjects|healthy adult subjects
387091|NCT01297569|Diabetic macular edema|diabetic macular edema
387092|NCT01297569|Macular edema|macular edema
387094|NCT01297569|Diabetic retinopathy|diabetic retinopathy
387095|NCT01297569|Diabetic eye disease|diabetic eye disease
387096|NCT01297569|anti-VEGF|anti-vegf
387097|NCT01297569|ranibizumab|ranibizumab
387098|NCT01297569|Lucentis|lucentis
387099|NCT01297556|Irritable Bowel Syndrome|irritable bowel syndrome
387100|NCT01297543|Induction chemotherapy|induction chemotherapy
387101|NCT01297543|Re-induction chemotherapy|re-induction chemotherapy
387102|NCT01297543|Consolidation chemotherapy|consolidation chemotherapy
387103|NCT01297543|Leukemia|leukemia
387104|NCT01297543|Myelodysplasia|myelodysplasia
387105|NCT01297530|Phase I|phase i
387106|NCT01297530|Dose Escalation|dose escalation
387107|NCT01297530|Hypoxia inducible factor 1 alpha|hypoxia inducible factor 1 alpha
387108|NCT01297530|Neoplasms|neoplasms
387109|NCT01297517|AOG|aog
387110|NCT01297517|OHT|oht
387111|NCT01297517|Open-Angle Glaucoma|open-angle glaucoma
387112|NCT01297517|Ocular Hypertension|ocular hypertension
387113|NCT01297504|palivizumab|palivizumab
387114|NCT01297504|lower respiratory tract infection|lower respiratory tract infection
387115|NCT01297504|Respiratory syncytial virus|respiratory syncytial virus
387116|NCT01297504|usage patterns|usage patterns
387117|NCT01297491|NSCLC|nsclc
387118|NCT01297491|PI3K|pi3k
387119|NCT01297465|Ovulation Induction|ovulation induction
387120|NCT01297465|Ovarian Stimulation|ovarian stimulation
387121|NCT01297465|Reproductive Technique, Assisted|reproductive technique, assisted
387122|NCT01297465|Assisted Reproductive Technics|assisted reproductive technics
387123|NCT01297465|Assisted Reproductive Technique|assisted reproductive technique
387124|NCT01297465|Reproductive Technology, Assisted|reproductive technology, assisted
387125|NCT01297452|BKM120|bkm120
387126|NCT01297452|CARBOPLATIN|carboplatin
387127|NCT01297452|TAXOL (PACLITAXEL)|taxol (paclitaxel)
387128|NCT01297452|Chemotherapy|chemotherapy
387129|NCT01297452|10-192|10-192
387130|NCT01297439|shoulder dystocia,|shoulder dystocia,
387131|NCT01297439|Mac Roberts' maneuver,|mac roberts' maneuver,
387132|NCT01297439|pushing maneuver|pushing maneuver
387133|NCT01297413|allogeneic|allogeneic
387134|NCT01297413|adult|adult
387135|NCT01297413|stem|stem
387136|NCT01297413|cells|cells
387137|NCT01297413|stroke|stroke
387138|NCT01297413|ischemic|ischemic
387139|NCT01297400|Burns, Partial Thickness Burns|burns, partial thickness burns
387140|NCT01297387|Diabetic Patients|diabetic patients
387141|NCT01297387|Critical Limb Ischemia|critical limb ischemia
387142|NCT01297387|Revascularization|revascularization
387143|NCT01297374|Obesity|obesity
387144|NCT01297348|Lybrel|lybrel
387145|NCT01297348|levonorgestrel|levonorgestrel
387146|NCT01297348|ethinyl estradiol|ethinyl estradiol
387147|NCT01297348|venus thromboembolism (VTE)|venus thromboembolism (vte)
387148|NCT01297348|oral contraceptives (OC)|oral contraceptives (oc)
387150|NCT01297348|database study|database study
387151|NCT01297348|case-control study|case-control study
387152|NCT01297335|intrathecal|intrathecal
387155|NCT01297335|controlled|controlled
387156|NCT01297335|hypertension|hypertension
387157|NCT01297322|vascular closure system|vascular closure system
386815|NCT01298869|CKD|ckd
387158|NCT01297322|manual compression|manual compression
387159|NCT01297322|femoral arteriotomy|femoral arteriotomy
387160|NCT01297322|percutaneous endovascular procedures|percutaneous endovascular procedures
387162|NCT01297309|Hypoparathyroidism|hypoparathyroidism
600278|NCT00572195|RNS System|rns system
387163|NCT01297309|Parathyroid Hormone 1-84|parathyroid hormone 1-84
387164|NCT01297309|NPSP558|npsp558
387165|NCT01297296|heart failure|heart failure
387166|NCT01297296|percutaneous|percutaneous
387167|NCT01297296|interventional cardiology|interventional cardiology
387168|NCT01297296|apical remodeling|apical remodeling
387169|NCT01297296|LV dilatation|lv dilatation
387170|NCT01297296|akinesis|akinesis
387171|NCT01297296|dyskinesis|dyskinesis
387172|NCT01297296|myocardial infarction|myocardial infarction
387173|NCT01297283|Heart failure|heart failure
387174|NCT01297283|Cardiac resynchronization|cardiac resynchronization
387175|NCT01297283|Leadless ECG|leadless ecg
387176|NCT01297283|Follow-up|follow-up
387177|NCT01297244|AV-951|av-951
387178|NCT01297244|Tivozanib|tivozanib
387179|NCT01297244|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
387180|NCT01297244|RCC|rcc
387181|NCT01297244|Biomarkers|biomarkers
387182|NCT01297231|fibroglandular tissue|fibroglandular tissue
387183|NCT01297231|tamoxifen|tamoxifen
387184|NCT01297231|MRI|mri
387185|NCT01297231|Background Parenchymal Enhancement|background parenchymal enhancement
387187|NCT01297218|Alzheimer, Mesenchymal Stem Cells, Umbilical Cord Blood|alzheimer, mesenchymal stem cells, umbilical cord blood
387188|NCT01297205|Human Umbilical Cord Blood Derived Mesenchymal Stem Cells|human umbilical cord blood derived mesenchymal stem cells
387189|NCT01297205|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
387190|NCT01297205|Premature infants|premature infants
387191|NCT01297192|YM178|ym178
387192|NCT01297192|Mirabegron|mirabegron
387193|NCT01297192|DDI|ddi
387194|NCT01297192|Phase I|phase i
387195|NCT01297192|Solifenacin|solifenacin
387196|NCT01297192|Pharmacokinetics|pharmacokinetics
387197|NCT01297192|Pharmacokinetics of mirabegron|pharmacokinetics of mirabegron
387198|NCT01297179|Pharmacokinetics|pharmacokinetics
387199|NCT01297179|Oral contraceptives|oral contraceptives
387200|NCT01297179|Drug interactions|drug interactions
387201|NCT01297179|Pharmacokinetics of mirabegron|pharmacokinetics of mirabegron
387202|NCT01297153|Congenital Cataract|congenital cataract
387203|NCT01297153|Children younger than 2 years|children younger than 2 years
387204|NCT01297153|Aphakia|aphakia
387205|NCT01297153|Primary IOL Implantation|primary iol implantation
387206|NCT01297140|Psychiatry|psychiatry
387207|NCT01297140|Behaviour|behaviour
387208|NCT01297140|Alzheimer's|alzheimer's
387209|NCT01297140|Personality|personality
387210|NCT01297088|Proof of Mechanism|proof of mechanism
387211|NCT01297088|Phase I|phase i
387212|NCT01297088|Neoplasm|neoplasm
387213|NCT01297088|Inflammation|inflammation
387214|NCT01297075|Health Services Research|health services research
387215|NCT01297075|Chronic Care|chronic care
387216|NCT01297075|Outreach Visits|outreach visits
387217|NCT01297075|Primary care|primary care
387218|NCT01297075|chronic disease management|chronic disease management
387219|NCT01297062|Diabetes|diabetes
387220|NCT01297062|exenatide|exenatide
387221|NCT01297062|Amylin|amylin
387222|NCT01297062|Lilly|lilly
387223|NCT01297062|QT interval|qt interval
387224|NCT01297049|Diabetes|diabetes
387225|NCT01297049|obesity|obesity
387226|NCT01297049|behavior therapy|behavior therapy
387227|NCT01297049|self management|self management
387228|NCT01297036|Pharmacokinetics|pharmacokinetics
387229|NCT01297036|Bioequivalence|bioequivalence
387230|NCT01297036|Donepezil|donepezil
387231|NCT01297023|calcium phosphate|calcium phosphate
387232|NCT01297023|vitamin d3|vitamin d3
387233|NCT01297023|bone metabolism|bone metabolism
387234|NCT01297023|human study|human study
387235|NCT01297010|Nausea and Vomiting|nausea and vomiting
387236|NCT01297010|Vomiting|vomiting
387237|NCT01297010|Postoperative|postoperative
387238|NCT01297010|Anesthesia|anesthesia
387239|NCT01296997|calcium phosphate|calcium phosphate
387240|NCT01296997|incretins|incretins
387241|NCT01296997|human study|human study
387242|NCT01296984|Rectal cancer|rectal cancer
387243|NCT01296984|APR|apr
387244|NCT01296958|Taenia solium|taenia solium
387245|NCT01296958|cysticercosis|cysticercosis
387246|NCT01296958|neurocysticercosis|neurocysticercosis
387247|NCT01296919|Chronic rhinosinusitis|chronic rhinosinusitis
387248|NCT01296919|Histopathology|histopathology
387249|NCT01296919|Infundibulum|infundibulum
387250|NCT01296919|Lamina propria|lamina propria
387251|NCT01296919|Uncinate process|uncinate process
387252|NCT01296906|Reminder/recall messages|reminder/recall messages
387253|NCT01296906|reminders|reminders
387254|NCT01296906|recall|recall
387255|NCT01296906|immunizations|immunizations
387256|NCT01296906|immunization information systems|immunization information systems
378189|NCT01334294|CNV|cnv
387257|NCT01296906|effectiveness of reminder/recall|effectiveness of reminder/recall
387258|NCT01296906|population-based reminder/recall|population-based reminder/recall
387259|NCT01296867|Laser ablation algorithms|laser ablation algorithms
387260|NCT01296867|Excimer laser|excimer laser
387261|NCT01296867|Refractive correction|refractive correction
387262|NCT01296867|Corneal Asphericity Adjustment|corneal asphericity adjustment
387263|NCT01296854|spa therapy|spa therapy
387264|NCT01296841|telemedicine|telemedicine
387265|NCT01296841|remote consultation|remote consultation
387266|NCT01296841|telehealth|telehealth
387267|NCT01296841|ehealth|ehealth
387268|NCT01296841|image archiving|image archiving
387269|NCT01296841|inflammatory bowel disease|inflammatory bowel disease
387270|NCT01296815|Kaposi sarcoma|kaposi sarcoma
387271|NCT01296815|HIV|hiv
387272|NCT01296815|Bevacizumab|bevacizumab
387273|NCT01296802|Ecstasy|ecstasy
387274|NCT01296802|MDMA|mdma
387275|NCT01296802|Serotonin|serotonin
387276|NCT01296802|Neurotoxicity|neurotoxicity
387277|NCT01296802|dexfenfluramine|dexfenfluramine
387278|NCT01296802|Positron emission tomography|positron emission tomography
387279|NCT01296802|altanserin|altanserin
387280|NCT01296802|5-HT2A receptor|5-ht2a receptor
387281|NCT01296776|exercise|exercise
387282|NCT01296776|whole-body electromyostimulation|whole-body electromyostimulation
387283|NCT01296776|bone mineral density|bone mineral density
387284|NCT01296776|falls|falls
387285|NCT01296776|physical fitness|physical fitness
387286|NCT01296776|pain|pain
387287|NCT01296763|Irinotecan|irinotecan
387288|NCT01296763|Cisplatin|cisplatin
387289|NCT01296763|Carboplatin|carboplatin
387290|NCT01296763|Mitomycin-C|mitomycin-c
387291|NCT01296763|Olaparib|olaparib
387292|NCT01296763|AZD2281|azd2281
387293|NCT01296711|Rheumatoid arthritis|rheumatoid arthritis
387294|NCT01296711|CDP6038|cdp6038
387295|NCT01296711|Interleukin-6|interleukin-6
387296|NCT01296698|Smoking Cessation|smoking cessation
387297|NCT01296698|Tobacco Use Disorder|tobacco use disorder
387298|NCT01296685|cardiovascular surgical procedure|cardiovascular surgical procedure
387299|NCT01296672|Finasteride|finasteride
387300|NCT01296672|Placebo|placebo
387301|NCT01296672|Prostate cancer|prostate cancer
387302|NCT01296672|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
387303|NCT01296672|Men at intermediate risk of prostate cancer|men at intermediate risk of prostate cancer
387304|NCT01296672|Men scheduled for prostate biopsy|men scheduled for prostate biopsy
387305|NCT01296659|sarcoma|sarcoma
387306|NCT01296659|Ridaforolimus|ridaforolimus
387307|NCT01296659|soft tissue sarcoma|soft tissue sarcoma
387308|NCT01296659|unresectable sarcoma|unresectable sarcoma
387309|NCT01296646|Alcohol|alcohol
387310|NCT01296646|Alcoholics|alcoholics
387311|NCT01296646|Substance Abuse|substance abuse
387312|NCT01296646|Alcohol Abuse|alcohol abuse
387313|NCT01296646|Alcohol Addiction|alcohol addiction
387314|NCT01296633|health literacy|health literacy
387315|NCT01296633|patient education|patient education
387316|NCT01296633|medication adherence|medication adherence
387317|NCT01296633|patient/provider communication|patient/provider communication
387318|NCT01296633|Diabetes Mellitus|diabetes mellitus
387319|NCT01296607|Pharmacodynamics|pharmacodynamics
387320|NCT01296607|Pharmacokinetics|pharmacokinetics
387321|NCT01296607|Urocortin 2|urocortin 2
387322|NCT01296607|Urocortin 3|urocortin 3
387323|NCT01296607|Reproducibility|reproducibility
387324|NCT01296607|Onset/ Offset|onset/ offset
387325|NCT01296607|Forearm blood flow|forearm blood flow
387326|NCT01296607|Plethysmography|plethysmography
387327|NCT01296607|Heart Failure|heart failure
387328|NCT01296581|Cancer|cancer
387329|NCT01296581|Tumors|tumors
387330|NCT01296581|VEGFR|vegfr
387331|NCT01296581|PDGFR|pdgfr
387332|NCT01296568|metastatic solid tumors|metastatic solid tumors
387333|NCT01296568|Malignant/M-Neoplasm|malignant/m-neoplasm
387334|NCT01296568|Pancreas NOS|pancreas nos
387335|NCT01296568|Absorption|absorption
387336|NCT01296568|Distribution|distribution
387337|NCT01296568|Metabolism|metabolism
387338|NCT01296568|Excretion|excretion
387339|NCT01296568|Mass balance|mass balance
387340|NCT01296568|Metabolic profile|metabolic profile
387341|NCT01296568|Radiolabeled study|radiolabeled study
387342|NCT01296516|Women|women
387343|NCT01296516|Postpartum|postpartum
387344|NCT01296516|GDM|gdm
387345|NCT01296503|Multiple Myeloma|multiple myeloma
387346|NCT01296503|Treatment|treatment
387347|NCT01296503|Maintenance|maintenance
387348|NCT01296503|Thalidomide|thalidomide
387349|NCT01296490|oxidative stress, physical exercise, fitness level|oxidative stress, physical exercise, fitness level
387350|NCT01296477|Asthma|asthma
387351|NCT01296477|ASTHMA IQ tool|asthma iq tool
387352|NCT01296477|Asthma Control Test (ACT)|asthma control test (act)
387353|NCT01296477|EPR-3 Guidelines, Exacerbations|epr-3 guidelines, exacerbations
387354|NCT01296464|Parkinson's Disease|parkinson's disease
387355|NCT01296464|Motor response|motor response
387356|NCT01296464|Wearing-off|wearing-off
387357|NCT01296451|Hepatitis C|hepatitis c
387358|NCT01296451|vaccine|vaccine
378265|NCT01334086|AML|aml
387359|NCT01296451|Adenovirus|adenovirus
387360|NCT01296451|MVA|mva
387361|NCT01296451|chronic infection|chronic infection
387362|NCT01296451|interferon|interferon
387363|NCT01296451|ribavirin|ribavirin
387364|NCT01296425|Growth disorders|growth disorders
387366|NCT01296425|Easypod|easypod
387367|NCT01296425|Growth hormone|growth hormone
387368|NCT01296425|Pediatric subject|pediatric subject
387374|NCT01296373|immune|immune
387375|NCT01296373|restoration|restoration
387376|NCT01296373|observational|observational
387377|NCT01296360|immune response|immune response
387378|NCT01296360|IC51-325|ic51-325
387379|NCT01296360|Japanese Encephalitis|japanese encephalitis
387380|NCT01296360|Intercell AG|intercell ag
387381|NCT01296347|Ketamine|ketamine
387382|NCT01296347|Thoracotomy|thoracotomy
387383|NCT01296347|VATS|vats
387384|NCT01296347|Pain|pain
387385|NCT01296334|opioids|opioids
387386|NCT01296334|analgesia|analgesia
387387|NCT01296334|secondary hyperalgesia|secondary hyperalgesia
387388|NCT01296334|quantitative sensory testing|quantitative sensory testing
387389|NCT01296334|inflammatory injury|inflammatory injury
387390|NCT01296308|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
387391|NCT01296308|Diabetic Neuropathy|diabetic neuropathy
387392|NCT01296308|Complementary Medicine|complementary medicine
387393|NCT01296308|Alternative Medicine|alternative medicine
387394|NCT01296308|Integrative Medicine|integrative medicine
387395|NCT01296308|Quality of Life|quality of life
387396|NCT01296308|Quantitative Sensory Testing|quantitative sensory testing
387397|NCT01296295|smoking cessation advice|smoking cessation advice
387398|NCT01296295|spirometry|spirometry
387399|NCT01296295|primary health care|primary health care
387400|NCT01296269|social cognition|social cognition
387401|NCT01296269|oxytocin|oxytocin
387402|NCT01296269|vasopressin|vasopressin
387403|NCT01296269|decision making|decision making
387404|NCT01296269|social decision making|social decision making
387405|NCT01296256|Bendamustine|bendamustine
387406|NCT01296256|Conditioning Therapy|conditioning therapy
387407|NCT01296256|Autologous Stem Cell Transplant|autologous stem cell transplant
387408|NCT01296256|Aggressive Non Hodgkin's Lymphoma|aggressive non hodgkin's lymphoma
387409|NCT01296243|Castration-resistant prostate cancer|castration-resistant prostate cancer
387410|NCT01296243|Tesetaxel|tesetaxel
387411|NCT01296243|Taxanes|taxanes
387412|NCT01296243|Chemotherapy-naive|chemotherapy-naive
387413|NCT01296243|Chemotherapy-exposed|chemotherapy-exposed
387414|NCT01296243|Progressive, metastatic castration-resistant prostate cancer|progressive, metastatic castration-resistant prostate cancer
387415|NCT01296217|Patients with infiltrant prostatic carcinoma|patients with infiltrant prostatic carcinoma
387416|NCT01296165|Travel|travel
387417|NCT01296165|Spread|spread
387418|NCT01296165|Antibiotic resistance|antibiotic resistance
387419|NCT01296139|Non-Cutaneous Malignancy|non-cutaneous malignancy
387420|NCT01296139|Prostatectomy|prostatectomy
387421|NCT01296139|Metastatic Prostate Cancer|metastatic prostate cancer
387422|NCT01296139|Imaging Study|imaging study
387423|NCT01296139|Magnetic Resonance Imaging|magnetic resonance imaging
387424|NCT01296139|Prostate Cancer|prostate cancer
387425|NCT01296126|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
387426|NCT01296126|MRI|mri
387427|NCT01296126|TBI|tbi
387428|NCT01296126|Traumatic Brain Injury|traumatic brain injury
387429|NCT01296126|Post Traumatic Stress Disorder|post traumatic stress disorder
387430|NCT01296126|PTSD|ptsd
387431|NCT01296100|impaired glucose tolerance|impaired glucose tolerance
387432|NCT01296100|nutrition|nutrition
387433|NCT01296100|physical activity|physical activity
387434|NCT01296087|Asthma|asthma
387435|NCT01296087|Mild to Moderate Asthma|mild to moderate asthma
387436|NCT01296074|monocyte|monocyte
387437|NCT01296074|cardiopulmonary bypass|cardiopulmonary bypass
387438|NCT01296074|cardiac surgery|cardiac surgery
387439|NCT01296061|Dialysis|dialysis
387440|NCT01296061|Renal Transplantation|renal transplantation
387441|NCT01296061|Failure of allograft|failure of allograft
387442|NCT01296048|weight|weight
387443|NCT01296048|body fat|body fat
387444|NCT01296048|total body water|total body water
387445|NCT01296048|bone mass|bone mass
387446|NCT01296048|muscle mass|muscle mass
387447|NCT01296035|recurrent ovarian cancer|recurrent ovarian cancer
387448|NCT01296035|platinum-refractory ovarian cancer|platinum-refractory ovarian cancer
387449|NCT01296022|Heart rhythm disturbances|heart rhythm disturbances
387450|NCT01296022|Implantable cardiac defibrillator|implantable cardiac defibrillator
387451|NCT01296009|embryonic implantation|embryonic implantation
387452|NCT01296009|endometrial receptivity|endometrial receptivity
387453|NCT01296009|traditional Chinese medicines|traditional chinese medicines
387454|NCT01296009|in vitro fertilization-embryo transfer|in vitro fertilization-embryo transfer
387455|NCT01296009|pregnant rate|pregnant rate
387456|NCT01295970|Surgery of the brain|surgery of the brain
387457|NCT01295970|Radiosurgery|radiosurgery
387458|NCT01295970|Brain Metastasis|brain metastasis
387464|NCT01295931|Near-infrared|near-infrared
387465|NCT01295931|NIR|nir
387466|NCT01295931|Indocyanine green|indocyanine green
387467|NCT01295931|ICG|icg
387468|NCT01295931|Melanoma|melanoma
387469|NCT01295931|Fluorescent dyes|fluorescent dyes
387470|NCT01295931|Lymph nodes|lymph nodes
387471|NCT01295931|Experimental camera|experimental camera
387472|NCT01295918|probiotic|probiotic
387473|NCT01295918|AAD|aad
387474|NCT01295918|Lactobacillus reuteri|lactobacillus reuteri
387475|NCT01295918|diarrhea|diarrhea
387476|NCT01295892|menopause|menopause
387477|NCT01295892|obesity|obesity
387478|NCT01295892|capillary|capillary
387479|NCT01295892|microcirculation|microcirculation
387480|NCT01295892|estrogen|estrogen
387481|NCT01295892|Microvascular Function|microvascular function
387482|NCT01295879|Vitamin D insufficiency|vitamin d insufficiency
387483|NCT01295866|chronic nasal inflammation|chronic nasal inflammation
387484|NCT01295866|nasal nitric oxide|nasal nitric oxide
387485|NCT01295866|atopy|atopy
387486|NCT01295827|Melanoma|melanoma
387487|NCT01295827|Carcinoma|carcinoma
387488|NCT01295827|Cancer|cancer
387489|NCT01295827|Advanced cancer|advanced cancer
387490|NCT01295827|Metastatic cancer|metastatic cancer
387491|NCT01295827|Metastatic melanoma|metastatic melanoma
387492|NCT01295827|PD-1|pd-1
387493|NCT01295827|PD1|pd1
387494|NCT01295814|Interstitial cystitis|interstitial cystitis
387495|NCT01295814|Humira|humira
387496|NCT01295814|Adalimumab|adalimumab
387497|NCT01295801|Linezolid|linezolid
387498|NCT01295801|Vitamin B6|vitamin b6
387499|NCT01295801|Linezolid-associated cytopenias|linezolid-associated cytopenias
387500|NCT01295775|diabetic retinopathy|diabetic retinopathy
387501|NCT01295775|sulodexide|sulodexide
387502|NCT01295775|hard exudates|hard exudates
387503|NCT01295775|microaneurysms|microaneurysms
387504|NCT01295775|hemorrhages|hemorrhages
387505|NCT01295775|intraretinal microvascular abnormalities|intraretinal microvascular abnormalities
387506|NCT01295762|Children|children
387507|NCT01295762|Cancer|cancer
387508|NCT01295762|Immunomonitoring|immunomonitoring
387509|NCT01295762|Prognostic/Predictive Factors|prognostic/predictive factors
387510|NCT01295762|Immunotherapy|immunotherapy
387511|NCT01295749|cardiac arrest|cardiac arrest
387512|NCT01295749|No Flow|no flow
387513|NCT01295749|Emergency|emergency
387514|NCT01295749|Nurse|nurse
387515|NCT01295749|laryngeal Tube|laryngeal tube
387516|NCT01295736|scleroderma|scleroderma
387517|NCT01295736|digital|digital
387518|NCT01295736|ulcer|ulcer
387519|NCT01295723|Breast cancer|breast cancer
387520|NCT01295723|Radiation therapy|radiation therapy
387521|NCT01295723|Mobetron|mobetron
387522|NCT01295723|IOERT|ioert
387523|NCT01295723|IORT|iort
387524|NCT01295723|Hypofractionated radiation therapy|hypofractionated radiation therapy
387525|NCT01295723|Partial breast radiation|partial breast radiation
387526|NCT01295710|adult acute myeloid leukemia|adult acute myeloid leukemia
387527|NCT01295710|adult acute lymphoid leukemia|adult acute lymphoid leukemia
387528|NCT01295710|adult myelodysplastic syndrome|adult myelodysplastic syndrome
387529|NCT01295710|allogenic stem cell transplantation|allogenic stem cell transplantation
387530|NCT01295710|unrelated donor|unrelated donor
387531|NCT01295710|GVHD|gvhd
387532|NCT01295710|US-ATG-F (Anti-human-T-lymphocyte Immune Globulin, Rabbit)|us-atg-f (anti-human-t-lymphocyte immune globulin, rabbit)
387533|NCT01295697|Patients with non-CNS or CNS tumors|patients with non-cns or cns tumors
387534|NCT01295697|Pediatric patients with Relapsed/Refractory Solid Tumors|pediatric patients with relapsed/refractory solid tumors
387535|NCT01295684|cranberry|cranberry
387536|NCT01295684|cardiovascular|cardiovascular
387537|NCT01295684|adhesion|adhesion
387538|NCT01295684|polyphenol|polyphenol
387539|NCT01295658|cancer|cancer
387540|NCT01295658|cancer survivor ship|cancer survivor ship
387541|NCT01295658|psychosocial needs|psychosocial needs
387542|NCT01295658|cancer experience|cancer experience
387543|NCT01295658|metastatic breast cancer|metastatic breast cancer
387544|NCT01295658|multiple myeloma|multiple myeloma
387545|NCT01295658|chronic myeloid leukemia|chronic myeloid leukemia
387546|NCT01295658|breast cancer|breast cancer
387547|NCT01295658|Prostate|prostate
387548|NCT01295658|Colon|colon
387549|NCT01295658|Kidney|kidney
387550|NCT01295658|Lung|lung
387551|NCT01295645|Stem Cell Transplant|stem cell transplant
387552|NCT01295645|Hemorrhagic Cystitis|hemorrhagic cystitis
387553|NCT01295645|Bladder inflammation|bladder inflammation
387554|NCT01295645|Frequent urination|frequent urination
387555|NCT01295645|Pain|pain
387556|NCT01295645|Polyomavirus hominis type I|polyomavirus hominis type i
387557|NCT01295645|BK virus|bk virus
387558|NCT01295645|BKV|bkv
387559|NCT01295645|Cidofovir|cidofovir
387560|NCT01295645|Vistide|vistide
387561|NCT01295632|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
387562|NCT01295632|Hormone resistant prostate cancer|hormone resistant prostate cancer
387563|NCT01295632|Relapsed ovarian carcinoma|relapsed ovarian carcinoma
402063|NCT01233323|Heart Failure|heart failure
387564|NCT01295632|Refractory ovarian carcinoma|refractory ovarian carcinoma
387679|NCT01295268|Vulvar vestibulitis|vulvar vestibulitis
473076|NCT00079612|RCC|rcc
387565|NCT01295632|Refractory breast cancer|refractory breast cancer
387566|NCT01295632|Relapsed breast cancer|relapsed breast cancer
387567|NCT01295619|Dura|dura
387568|NCT01295619|Sealant|sealant
387569|NCT01295619|Cranial|cranial
387570|NCT01295619|Craniotomy|craniotomy
387571|NCT01295619|CSF leakage|csf leakage
387572|NCT01295619|CSF leakage following cranial surgery|csf leakage following cranial surgery
387573|NCT01295606|cefazolin|cefazolin
387574|NCT01295606|prophylaxis|prophylaxis
387575|NCT01295606|pharmacokinetics|pharmacokinetics
387576|NCT01295606|newborn|newborn
387577|NCT01295593|CLL previously treated|cll previously treated
387578|NCT01295567|ischemia reperfusion injury|ischemia reperfusion injury
387579|NCT01295567|CABG|cabg
387580|NCT01295567|dipyridamole|dipyridamole
387581|NCT01295567|HS-troponin-I|hs-troponin-i
387582|NCT01295554|Peripheral arterial disease, MRA|peripheral arterial disease, mra
387583|NCT01295541|ICU LOS|icu los
387584|NCT01295541|Progressive Mobility|progressive mobility
387585|NCT01295541|Deconditioning|deconditioning
387586|NCT01295528|blood pressure|blood pressure
387587|NCT01295528|heart rate|heart rate
387588|NCT01295515|HIV|hiv
387589|NCT01295515|Replication|replication
387590|NCT01295515|Antiretroviral|antiretroviral
387591|NCT01295515|Interferon|interferon
387592|NCT01295515|Reservoirs|reservoirs
387593|NCT01295476|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
387594|NCT01295476|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
387595|NCT01295476|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
387596|NCT01295476|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
387597|NCT01295476|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
387598|NCT01295476|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
387599|NCT01295463|sexual dysfunction|sexual dysfunction
387600|NCT01295463|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
387601|NCT01295463|infertility|infertility
387602|NCT01295463|colon cancer|colon cancer
387603|NCT01295463|male breast cancer|male breast cancer
387604|NCT01295463|breast cancer|breast cancer
387605|NCT01295463|germ cell tumor|germ cell tumor
387606|NCT01295463|ovarian sarcoma|ovarian sarcoma
387607|NCT01295463|uterine sarcoma|uterine sarcoma
387608|NCT01295463|chronic lymphocytic leukemia|chronic lymphocytic leukemia
387609|NCT01295463|osteosarcoma|osteosarcoma
387610|NCT01295463|chronic myelogenous leukemia|chronic myelogenous leukemia
387611|NCT01295463|non-Hodgkin lymphoma|non-hodgkin lymphoma
387612|NCT01295463|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
387613|NCT01295463|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
387614|NCT01295463|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
387615|NCT01295463|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
387616|NCT01295463|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
387617|NCT01295463|mast cell leukemia|mast cell leukemia
387618|NCT01295463|hairy cell leukemia|hairy cell leukemia
387619|NCT01295463|prolymphocytic leukemia|prolymphocytic leukemia
387620|NCT01295463|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
387621|NCT01295463|adult acute myeloid leukemia|adult acute myeloid leukemia
387622|NCT01295463|adult Hodgkin lymphoma|adult hodgkin lymphoma
387623|NCT01295463|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
387624|NCT01295463|small intestine lymphoma|small intestine lymphoma
387625|NCT01295463|anaplastic large cell lymphoma|anaplastic large cell lymphoma
387626|NCT01295463|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
387627|NCT01295463|mycosis fungoides/Sezary syndrome|mycosis fungoides/sezary syndrome
387628|NCT01295463|intraocular lymphoma|intraocular lymphoma
387629|NCT01295463|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
387630|NCT01295463|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
387631|NCT01295463|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
387632|NCT01295463|secondary acute myeloid leukemia|secondary acute myeloid leukemia
387633|NCT01295463|acute undifferentiated leukemia|acute undifferentiated leukemia
387634|NCT01295463|central nervous system leukemia|central nervous system leukemia
387635|NCT01295463|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
387636|NCT01295463|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
387637|NCT01295463|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
387638|NCT01295463|Kaposi sarcoma|kaposi sarcoma
387639|NCT01295463|adult soft tissue sarcoma|adult soft tissue sarcoma
387640|NCT01295463|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
387641|NCT01295463|secondary central nervous system Hodgkin lymphoma|secondary central nervous system hodgkin lymphoma
387642|NCT01295463|cutaneous lymphoma|cutaneous lymphoma
387643|NCT01295463|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
387644|NCT01295450|Phase III|phase iii
387645|NCT01295450|Apevinat BC|apevinat bc
387646|NCT01295450|Lack of appetite|lack of appetite
387647|NCT01295437|inguinal hernia, Lichtenstein hernioplasty, chronic pain|inguinal hernia, lichtenstein hernioplasty, chronic pain
387648|NCT01295424|Cardiac Arrest|cardiac arrest
387649|NCT01295424|Intensive Care Unit|intensive care unit
387650|NCT01295424|Emergency Medical Service|emergency medical service
387651|NCT01295385|type 2 diabetes|type 2 diabetes
387652|NCT01295385|Cardiovascular diseases|cardiovascular diseases
387653|NCT01295385|coronary syndrome have abnormalities of glucidic metabolism|coronary syndrome have abnormalities of glucidic metabolism
387654|NCT01295372|Schizophrenia|schizophrenia
387655|NCT01295372|Antipsychotic|antipsychotic
387656|NCT01295372|Risperidone|risperidone
387657|NCT01295372|Lu 31-130|lu 31-130
387658|NCT01295359|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
387659|NCT01295359|Walking|walking
387660|NCT01295359|Hospital|hospital
387661|NCT01295359|Exercise Tolerance|exercise tolerance
387662|NCT01295359|Physical Therapy|physical therapy
387663|NCT01295320|Herpes Zoster|herpes zoster
387664|NCT01295320|vaccine|vaccine
387665|NCT01295320|safety|safety
387666|NCT01295320|immunogenicity|immunogenicity
387667|NCT01295307|acute myeloid leukemia|acute myeloid leukemia
387668|NCT01295307|relapsed|relapsed
387669|NCT01295307|refractory|refractory
387670|NCT01295307|Relapsed or refractory AML|relapsed or refractory aml
387671|NCT01295294|Uterine Hemorrhage|uterine hemorrhage
387672|NCT01295294|Contraception|contraception
387673|NCT01295294|Contraceptive Methods|contraceptive methods
387674|NCT01295294|Intrauterine devices|intrauterine devices
387675|NCT01295294|Mirena|mirena
387676|NCT01295268|Vulvar pain|vulvar pain
387677|NCT01295268|Vulvodynia|vulvodynia
387678|NCT01295268|Vestibulodynia|vestibulodynia
387680|NCT01295255|Allergic rhinitis|allergic rhinitis
387681|NCT01295255|Psychological status|psychological status
387682|NCT01295255|Asthma|asthma
387683|NCT01295255|Aeroallergen|aeroallergen
387684|NCT01295242|HPV|hpv
387685|NCT01295242|Cervical Cancer|cervical cancer
387686|NCT01295216|prehypertension|prehypertension
387687|NCT01295216|blood pressure|blood pressure
387688|NCT01295216|mobile technology|mobile technology
387689|NCT01295216|Latin America|latin america
387690|NCT01295216|behavioral change|behavioral change
387691|NCT01295216|healthy lifestyles|healthy lifestyles
387692|NCT01295216|mHealth|mhealth
387693|NCT01295177|wound healing|wound healing
387694|NCT01295177|diabetes mellitus|diabetes mellitus
387695|NCT01295164|keratoconus, wave-front sensing technology, aberrometer|keratoconus, wave-front sensing technology, aberrometer
387696|NCT01295138|Constipation|constipation
387697|NCT01295138|Caesarean section|caesarean section
387698|NCT01295138|Abdominal Pain|abdominal pain
387699|NCT01295138|Nausea|nausea
387700|NCT01295138|Vomiting|vomiting
387701|NCT01295125|Infected ventral hernia|infected ventral hernia
387702|NCT01295125|Contaminated incisional hernia|contaminated incisional hernia
387703|NCT01295099|scar formation|scar formation
387704|NCT01295099|5-FU|5-fu
387705|NCT01295099|genetic link|genetic link
387706|NCT01295099|psychological impact|psychological impact
387707|NCT01295099|social impact|social impact
387708|NCT01295086|Adenocarcinoma of the gastro-esophageal|adenocarcinoma of the gastro-esophageal
387709|NCT01295086|Her2|her2
387710|NCT01295086|Dose finding|dose finding
387711|NCT01295086|Taxotere (Docetaxel)|taxotere (docetaxel)
387712|NCT01295086|Eloxatin (Oxaliplatin)|eloxatin (oxaliplatin)
387713|NCT01295086|Xeloda (Capecitabine)|xeloda (capecitabine)
387714|NCT01295086|Herceptin (Trastuzumab)|herceptin (trastuzumab)
387715|NCT01295073|Trientine|trientine
387716|NCT01295073|Cataract surgery|cataract surgery
387717|NCT01295073|Macular Edema|macular edema
387718|NCT01295060|Acromegaly|acromegaly
387719|NCT01295060|Octreotide|octreotide
387720|NCT01295060|IGF-1|igf-1
387721|NCT01295060|Growth Hormone|growth hormone
387722|NCT01295060|Implant|implant
387723|NCT01295060|Hydrogel|hydrogel
387724|NCT01295047|Marfan Syndrome|marfan syndrome
387725|NCT01295047|Large arterial function|large arterial function
387726|NCT01295047|LV function|lv function
387727|NCT01295047|atenolol|atenolol
387728|NCT01295047|perindopril|perindopril
387729|NCT01295047|verapamil|verapamil
387730|NCT01295047|central arterial pressure|central arterial pressure
387731|NCT01295034|HIV|hiv
387732|NCT01295034|combination antiretroviral therapy|combination antiretroviral therapy
387733|NCT01295034|vitamin D|vitamin d
387734|NCT01295034|low bone density|low bone density
387735|NCT01295021|The prevalence of sympathetic overactivity in hypertensive patients.|the prevalence of sympathetic overactivity in hypertensive patients.
387736|NCT01295008|Fabry disease|fabry disease
387737|NCT01295008|Male pattern baldness|male pattern baldness
387738|NCT01295008|Alopecia|alopecia
387739|NCT01295008|GLA gene mutation|gla gene mutation
387740|NCT01295008|Alpha-galactosidase A|alpha-galactosidase a
387741|NCT01294995|short term consumption|short term consumption
387742|NCT01294995|Chinese liquor|chinese liquor
387743|NCT01294995|serum lipids|serum lipids
387744|NCT01294995|uric acid|uric acid
387745|NCT01294995|inflammation biomarkers|inflammation biomarkers
387746|NCT01294982|OAB|oab
387747|NCT01294982|Over Active Bladder|over active bladder
387748|NCT01294982|overactive bladder|overactive bladder
387749|NCT01294982|Urinary Urge Incontinence|urinary urge incontinence
387750|NCT01294982|Urinary Incontinence|urinary incontinence
387751|NCT01294969|Allergic conjunctivitis|allergic conjunctivitis
387752|NCT01294956|Dry eye|dry eye
387753|NCT01294956|artificial tears|artificial tears
387754|NCT01294956|corneal staining|corneal staining
387755|NCT01294943|Intensive Care Units|intensive care units
387756|NCT01294943|Biofilms|biofilms
387757|NCT01294943|Tongue|tongue
387758|NCT01294943|Infection|infection
387759|NCT01294943|Pneumonia/Aspiration|pneumonia/aspiration
387760|NCT01294930|hip fracture|hip fracture
387761|NCT01294930|mortality|mortality
387762|NCT01294930|complications|complications
387763|NCT01294904|Hormone|hormone
387764|NCT01294904|Sperm|sperm
387765|NCT01294904|Chronic kidney disease|chronic kidney disease
387766|NCT01294891|Rheology|rheology
387767|NCT01294891|Sickle cell|sickle cell
387768|NCT01294891|Paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
387769|NCT01294891|contrast ultrasound|contrast ultrasound
387770|NCT01294878|anti-IgE treatment|anti-ige treatment
387771|NCT01294878|interstitial cystitis/bladder pain syndrome|interstitial cystitis/bladder pain syndrome
387772|NCT01294878|omalizumab|omalizumab
387773|NCT01294865|Sepsis|sepsis
387774|NCT01294865|late-onset|late-onset
387775|NCT01294865|suPAR|supar
387776|NCT01294852|prophylactic|prophylactic
387777|NCT01294852|surfactant|surfactant
387778|NCT01294852|premature|premature
387779|NCT01294852|mechanical ventilation|mechanical ventilation
387780|NCT01294852|mortality|mortality
387781|NCT01294852|morbidities|morbidities
387782|NCT01294839|sinus-node dysfunction|sinus-node dysfunction
387783|NCT01294839|RVOTs pacing|rvots pacing
387784|NCT01294839|RVA pacing|rva pacing
387785|NCT01294826|Colorectal Neoplasms|colorectal neoplasms
387786|NCT01294826|Intestinal Neoplasms|intestinal neoplasms
387787|NCT01294826|Gastrointestinal Neoplasms|gastrointestinal neoplasms
387788|NCT01294826|Digestive System Neoplasms|digestive system neoplasms
387789|NCT01294826|Neoplasms by Site|neoplasms by site
387790|NCT01294826|Neoplasms|neoplasms
387791|NCT01294826|Digestive System Diseases|digestive system diseases
387792|NCT01294826|Gastrointestinal Diseases|gastrointestinal diseases
387793|NCT01294826|Colonic Diseases|colonic diseases
387794|NCT01294826|Intestinal Diseases|intestinal diseases
387795|NCT01294826|Rectal Diseases|rectal diseases
387796|NCT01294826|Cetuximab|cetuximab
387797|NCT01294826|HSP90 Heat-Shock Proteins|hsp90 heat-shock proteins
387798|NCT01294826|EGFR protein, human|egfr protein, human
387799|NCT01294813|Electric Impedance Tomography (EIT)|electric impedance tomography (eit)
387800|NCT01294813|Ventilation|ventilation
387801|NCT01294813|Bronchoscopy|bronchoscopy
387802|NCT01294813|Lung Impedance|lung impedance
387803|NCT01294813|Recruitment|recruitment
387804|NCT01294800|Parkinson's disease|parkinson's disease
387805|NCT01294787|COPD|copd
387806|NCT01294787|QVA149|qva149
387807|NCT01294787|tiotropium|tiotropium
387808|NCT01294787|exercise|exercise
387809|NCT01294787|exercise tolerance|exercise tolerance
387810|NCT01294787|combination bronchodilator|combination bronchodilator
387811|NCT01294787|moderate to severe COPD|moderate to severe copd
387812|NCT01294774|Lupus erythematosus|lupus erythematosus
387813|NCT01294774|skin lupus|skin lupus
387814|NCT01294761|HIV-1|hiv-1
387815|NCT01294761|AIDS|aids
387816|NCT01294761|Clinical Trials, Randomized|clinical trials, randomized
387817|NCT01294748|Coronary Artery Disease|coronary artery disease
387818|NCT01294748|Drug-eluting Stent|drug-eluting stent
387819|NCT01294748|Sirolimus|sirolimus
387820|NCT01294735|Temozolomide|temozolomide
387821|NCT01294735|glioblastoma multiforme|glioblastoma multiforme
387822|NCT01294735|melanoma|melanoma
387823|NCT01294735|advanced neoplasm|advanced neoplasm
387824|NCT01294722|Rheumatoid Arthritis|rheumatoid arthritis
387825|NCT01294722|anti-TNF α|anti-tnf α
387826|NCT01294709|angina pectoris|angina pectoris
387827|NCT01294709|coronary artery disease|coronary artery disease
387828|NCT01294709|calcitonin gene-related peptide|calcitonin gene-related peptide
387829|NCT01294709|exercise tolerance,|exercise tolerance,
387830|NCT01294696|Osteoarthritis|osteoarthritis
387831|NCT01294696|Standard of care|standard of care
387832|NCT01294683|Low-density lipoprotein|low-density lipoprotein
387834|NCT01294683|High-density lipoprotein|high-density lipoprotein
387835|NCT01294683|HDL|hdl
387836|NCT01294683|Niacin|niacin
387837|NCT01294683|Lipid modifying therapy|lipid modifying therapy
387838|NCT01294683|Cholesterol|cholesterol
387839|NCT01294683|High cholesterol|high cholesterol
387840|NCT01294683|Triglycerides|triglycerides
387841|NCT01294683|Mixed Dyslipidemia|mixed dyslipidemia
387842|NCT01294670|ETOPOSIDE (VP-16)|etoposide (vp-16)
600279|NCT00572195|NeuroPace|neuropace
387843|NCT01294670|SAHA (SUBEROYLANILIDE HYDROXAMIC ACID) (Vorinostat)|saha (suberoylanilide hydroxamic acid) (vorinostat)
387844|NCT01294670|Pediatric|pediatric
387846|NCT01294670|POETIC|poetic
387847|NCT01294670|phase II component: the population will be restricted to relapsed/refractory sarcomas.|phase ii component: the population will be restricted to relapsed/refractory sarcomas.
387848|NCT01294657|Obesity|obesity
387849|NCT01294657|Cancer Risk|cancer risk
387850|NCT01294657|African Americans|african americans
387851|NCT01294657|Diet|diet
387852|NCT01294657|Physical Activity|physical activity
387853|NCT01294631|Canagliflozin|canagliflozin
387854|NCT01294631|JNJ-28431754|jnj-28431754
387855|NCT01294631|Hydrochlorothiazide|hydrochlorothiazide
387856|NCT01294631|Pharmacokinetic|pharmacokinetic
387857|NCT01294631|Pharmacodynamic|pharmacodynamic
387858|NCT01294618|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
387859|NCT01294618|nilotinib|nilotinib
387860|NCT01294618|pegylated interferon|pegylated interferon
387861|NCT01294618|BCR-ABL Philadelphia chromosome|bcr-abl philadelphia chromosome
387862|NCT01294618|Hematologic, cytogenetic and molecular response rates and kinetics will be studied in addition to the safety of the combination|hematologic, cytogenetic and molecular response rates and kinetics will be studied in addition to the safety of the combination
387863|NCT01294605|DTPa|dtpa
387864|NCT01294605|Td|td
387865|NCT01294605|IPV|ipv
387866|NCT01294579|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
387867|NCT01294579|Ofatumumab|ofatumumab
387868|NCT01294579|Relapsed|relapsed
387869|NCT01294579|Rituximab|rituximab
387870|NCT01294579|Bendamustine|bendamustine
387871|NCT01294566|safety|safety
387872|NCT01294566|motilin agonist|motilin agonist
387873|NCT01294566|single dose|single dose
387874|NCT01294566|ascending dose|ascending dose
387875|NCT01294566|GSK1322888|gsk1322888
387876|NCT01294566|migrating motor complex|migrating motor complex
387877|NCT01294566|tolerability|tolerability
387878|NCT01294566|FTIH|ftih
387879|NCT01294566|gastric emptying|gastric emptying
387880|NCT01294527|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
387881|NCT01294527|cardiac pacing|cardiac pacing
387882|NCT01294527|electrical stimulation|electrical stimulation
387883|NCT01294527|bi-ventricular pacing|bi-ventricular pacing
387884|NCT01294514|Respiratory Rate|respiratory rate
387885|NCT01294501|Medication administration|medication administration
387886|NCT01294501|Medication errors|medication errors
387887|NCT01294501|Health Literacy|health literacy
387888|NCT01294501|Pediatric Emergency Department|pediatric emergency department
387889|NCT01294501|Web-based education|web-based education
387890|NCT01294488|PCIT|pcit
387891|NCT01294488|Child Maltreatment Prevention|child maltreatment prevention
387892|NCT01294488|Practitioner Fidelity|practitioner fidelity
387893|NCT01294462|acute coronary syndrome|acute coronary syndrome
387894|NCT01294462|coronary disease|coronary disease
387895|NCT01294462|coronary artery disease|coronary artery disease
387896|NCT01294436|Phase3|phase3
387897|NCT01294436|Clinical trial|clinical trial
387898|NCT01294436|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
387899|NCT01294423|Phase3|phase3
387900|NCT01294423|Clinical trial|clinical trial
387901|NCT01294423|Type2 Diabetes Mellitus|type2 diabetes mellitus
387902|NCT01294397|Amgen|amgen
387903|NCT01294397|Phase 1|phase 1
387904|NCT01294397|Postmenopausal|postmenopausal
387905|NCT01294397|Osteopenia|osteopenia
387906|NCT01294397|Rheumatoid|rheumatoid
387907|NCT01294397|Bone Mineral Density|bone mineral density
387908|NCT01294397|Arthritis|arthritis
387909|NCT01294397|Pharmacokinetics|pharmacokinetics
387910|NCT01294397|Osteoporosis|osteoporosis
387911|NCT01294371|Lucrin Depot|lucrin depot
387912|NCT01294371|genital endometriosis|genital endometriosis
387913|NCT01294371|6 months therapy|6 months therapy
387914|NCT01294358|Pancreatic Cancer|pancreatic cancer
387915|NCT01294358|Regional Therapy|regional therapy
387916|NCT01294358|Selective Arterial Infusion|selective arterial infusion
387917|NCT01294358|Locally Advanced Disease|locally advanced disease
387918|NCT01294345|Birth Defects|birth defects
387919|NCT01294345|Genomics|genomics
387920|NCT01294345|Congenital Malformations|congenital malformations
387921|NCT01294332|Cognition|cognition
387922|NCT01294332|TBI|tbi
387923|NCT01294332|Mood|mood
387924|NCT01294332|Aerobic Exercise Training|aerobic exercise training
387925|NCT01294332|Cardiorespiratory Fitness|cardiorespiratory fitness
387926|NCT01294332|Traumatic Brain Injury|traumatic brain injury
387927|NCT01294319|Cortical Resistance|cortical resistance
387928|NCT01294319|ACTH|acth
387929|NCT01294319|Glucocorticoid|glucocorticoid
387930|NCT01294319|Mifepristone|mifepristone
387931|NCT01294319|SPIRONOLACTONE|spironolactone
387932|NCT01294319|Exercise|exercise
387933|NCT01294319|Hypothalamic-Pituitary-Adrenal Axis|hypothalamic-pituitary-adrenal axis
387934|NCT01294319|Healthy Volunteer|healthy volunteer
387935|NCT01294319|HV|hv
387936|NCT01294280|Stage I Non-Small Cell Lung Cancer|stage i non-small cell lung cancer
387937|NCT01294280|Stage II Non-Small Cell Lung Cancer|stage ii non-small cell lung cancer
387938|NCT01294267|Ventricular Tachycardia|ventricular tachycardia
387939|NCT01294267|Radio Frequency Ablation|radio frequency ablation
387940|NCT01294267|Percutaneous Left Ventricular Assist Device|percutaneous left ventricular assist device
387941|NCT01294267|Hemodynamic Management|hemodynamic management
387942|NCT01294267|Interventional Cardiac Procedure|interventional cardiac procedure
387943|NCT01294267|Mechanical Cardiac Assistance|mechanical cardiac assistance
387944|NCT01294267|Intra-Aortic Balloon Pump|intra-aortic balloon pump
387945|NCT01294267|Coronary Intervention|coronary intervention
387946|NCT01294267|Impella 2.5|impella 2.5
387947|NCT01294267|Circulation Support system|circulation support system
387948|NCT01294254|wound reepithelialization|wound reepithelialization
387949|NCT01294241|Epidermolysis bullosa|epidermolysis bullosa
387950|NCT01294241|Wound healing|wound healing
387951|NCT01294241|Epithelialization|epithelialization
387952|NCT01294215|BAYA1040|baya1040
387953|NCT01294215|Nifedipine|nifedipine
387954|NCT01294215|Essential hypertension|essential hypertension
387955|NCT01294215|Japanese Patients|japanese patients
387956|NCT01294215|Phase III|phase iii
387957|NCT01294215|combination study|combination study
387958|NCT01294215|14024|14024
387959|NCT01294202|GIST|gist
387960|NCT01294202|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
387961|NCT01294202|unresectable|unresectable
387962|NCT01294202|metastatic|metastatic
387963|NCT01294202|AT13387|at13387
387964|NCT01294202|Astex|astex
387965|NCT01294202|Gleevec|gleevec
387966|NCT01294202|Imatinib|imatinib
387967|NCT01294189|end-of-life decisions, critical care, advance directive|end-of-life decisions, critical care, advance directive
387968|NCT01294176|Optic Neuritis|optic neuritis
387969|NCT01294176|Lipoic Acid|lipoic acid
387970|NCT01294176|Multiple Sclerosis|multiple sclerosis
387971|NCT01294176|Antioxidant|antioxidant
387972|NCT01294176|OCT|oct
387973|NCT01294176|Acute|acute
387974|NCT01294163|Xenon|xenon
387975|NCT01294163|Sevoflurane|sevoflurane
387976|NCT01294163|Propofol|propofol
387977|NCT01294163|Total intravenous anaesthesia|total intravenous anaesthesia
387978|NCT01294163|Anaesthesia|anaesthesia
387979|NCT01294163|Coronary artery disease|coronary artery disease
387980|NCT01294163|Coronary artery bypass graft|coronary artery bypass graft
387981|NCT01294137|frail|frail
387982|NCT01294137|elderly|elderly
387983|NCT01294137|hospitalized|hospitalized
387984|NCT01294137|sleep apnea|sleep apnea
387985|NCT01294137|oximetry|oximetry
387986|NCT01294111|Fatigue|fatigue
387987|NCT01294111|Quality of life|quality of life
387988|NCT01294111|Elderly|elderly
387989|NCT01294098|Femoral Fractures|femoral fractures
387990|NCT01294098|Pediatrics|pediatrics
387991|NCT01294098|Pain, Postoperative|pain, postoperative
387992|NCT01294072|curcumin|curcumin
387993|NCT01294072|plant exosomes|plant exosomes
387994|NCT01294072|malignant colon tissue|malignant colon tissue
387995|NCT01294059|Fibromyalgia|fibromyalgia
387996|NCT01294059|Hyperalgesia|hyperalgesia
387997|NCT01294059|Pain|pain
387998|NCT01294059|Central Sensitization|central sensitization
387999|NCT01294046|Episodic migraine headache|episodic migraine headache
388000|NCT01294020|Transplant|transplant
388001|NCT01294020|Liver|liver
388002|NCT01294020|Kidney|kidney
388003|NCT01294020|Heart|heart
388004|NCT01294020|Lung|lung
388005|NCT01294020|Immunosuppression|immunosuppression
388006|NCT01294020|Advagraf|advagraf
388007|NCT01294020|Pharmacokinetics|pharmacokinetics
388008|NCT01293994|Chronic Pain, Genetic Variation, Opioid Medications, Pain|chronic pain, genetic variation, opioid medications, pain
388009|NCT01293968|Aphthous Stomatitis|aphthous stomatitis
388010|NCT01293968|Ibuprofen|ibuprofen
388011|NCT01293968|treatment efficacy|treatment efficacy
388012|NCT01293955|cartilage|cartilage
388013|NCT01293955|knee osteoarthritis|knee osteoarthritis
388014|NCT01293955|protective effect|protective effect
388015|NCT01293942|unresectable liver-only metastases in colorectal cancer|unresectable liver-only metastases in colorectal cancer
388016|NCT01293916|pediatric|pediatric
388017|NCT01293916|femur|femur
388018|NCT01293916|femoral|femoral
388019|NCT01293916|fracture|fracture
388020|NCT01293916|spica|spica
388021|NCT01293916|cast|cast
388022|NCT01293916|diaphyseal|diaphyseal
388023|NCT01293916|single|single
388024|NCT01293916|double|double
388025|NCT01293916|patient age 2 to 6 years old|patient age 2 to 6 years old
388026|NCT01293903|Immunomodulation|immunomodulation
388027|NCT01293890|adherence|adherence
388028|NCT01293890|medication|medication
388029|NCT01293890|exacerbations|exacerbations
388030|NCT01293890|hospital admission|hospital admission
388031|NCT01293877|Laparoscopy|laparoscopy
388032|NCT01293877|obesity|obesity
388033|NCT01293877|gastric|gastric
388034|NCT01293877|restrictive|restrictive
388035|NCT01293864|structural analysis, diffusible proteins, glycosaminoglycans|structural analysis, diffusible proteins, glycosaminoglycans
388036|NCT01293851|Biomarkers|biomarkers
388037|NCT01293851|Gene Expression|gene expression
388038|NCT01293851|Neuropathic Pain|neuropathic pain
600485|NCT00581633|kidney|kidney
388039|NCT01293851|Neurotoxicity|neurotoxicity
388535|NCT01291836|biomarker|biomarker
388040|NCT01293851|Chemotherapy|chemotherapy
388041|NCT01293851|Peripheral Neuropathic Pain|peripheral neuropathic pain
388042|NCT01293851|Cancer|cancer
388043|NCT01293838|Adolescents|adolescents
388044|NCT01293838|Anxiety Disorder|anxiety disorder
388045|NCT01293838|Cipralex|cipralex
388046|NCT01293838|Social Phobia|social phobia
388047|NCT01293838|Separation Anxiety Disorder|separation anxiety disorder
388048|NCT01293838|Panic Disorder|panic disorder
388049|NCT01293838|Generalized Anxiety Disorder|generalized anxiety disorder
388050|NCT01293838|physiological arousal|physiological arousal
388051|NCT01293838|stress response|stress response
388052|NCT01293838|salivary cortisol|salivary cortisol
388053|NCT01293838|salivary alpha-amylase|salivary alpha-amylase
388054|NCT01293838|heart rate variability|heart rate variability
388055|NCT01293799|Randomized|randomized
388056|NCT01293799|Peritoneal dialysis|peritoneal dialysis
388057|NCT01293799|Peritonitis|peritonitis
388058|NCT01293799|Primary prevention|primary prevention
388059|NCT01293799|Quality control|quality control
388060|NCT01293799|Self care|self care
388061|NCT01293799|Kidney failure, chronic|kidney failure, chronic
388062|NCT01293786|magnesium|magnesium
388063|NCT01293786|kidney transplantation|kidney transplantation
388064|NCT01293786|hypomagnesemia|hypomagnesemia
388065|NCT01293773|Randomized controlled trial|randomized controlled trial
388066|NCT01293773|Drug-eluting Stent|drug-eluting stent
388067|NCT01293773|Multicenter study|multicenter study
388068|NCT01293760|intrauterine device|intrauterine device
388069|NCT01293760|contraception|contraception
388070|NCT01293747|Estrogen|estrogen
388071|NCT01293747|Progesterone|progesterone
388072|NCT01293747|Microspheres|microspheres
388073|NCT01293747|Menopause|menopause
388074|NCT01293747|Pharmacokinetics|pharmacokinetics
388075|NCT01293734|bronchial asthma|bronchial asthma
388076|NCT01293734|cold type|cold type
388077|NCT01293734|heat type|heat type
388078|NCT01293734|Asthenia type|asthenia type
388079|NCT01293734|TCM syndrome|tcm syndrome
388080|NCT01293734|symptoms|symptoms
388081|NCT01293734|physical signs|physical signs
388082|NCT01293721|Bone Mineral Density|bone mineral density
388083|NCT01293721|Vibration|vibration
388084|NCT01293721|Rehabilitation|rehabilitation
388085|NCT01293721|Fracture healing rate|fracture healing rate
388086|NCT01293708|Octogenarians|octogenarians
388087|NCT01293708|HRQOL|hrqol
388088|NCT01293708|mortality|mortality
388089|NCT01293708|prospective observational|prospective observational
388090|NCT01293708|Elderly|elderly
388091|NCT01293695|hot flashes|hot flashes
388092|NCT01293695|post menopausal women|post menopausal women
388093|NCT01293695|skin conductance monitors|skin conductance monitors
388094|NCT01293695|hypnosis|hypnosis
388095|NCT01293695|hypnotizability|hypnotizability
388096|NCT01293669|Type 2 Diabetes|type 2 diabetes
388097|NCT01293669|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
388098|NCT01293604|Barley|barley
388099|NCT01293604|Oats|oats
388100|NCT01293604|Whole grains|whole grains
388101|NCT01293604|Cardiovascular disease|cardiovascular disease
388102|NCT01293604|adults not taking lipid-lowering or glucoregulatory medications.|adults not taking lipid-lowering or glucoregulatory medications.
388103|NCT01293591|Garlic|garlic
388104|NCT01293591|Cancer biomarkers|cancer biomarkers
388105|NCT01293591|Gene expression|gene expression
388106|NCT01293591|Oxidative stress|oxidative stress
388107|NCT01293591|DNA damage|dna damage
388108|NCT01293578|Decision Aids|decision aids
388109|NCT01293578|Shared Medical Decision Making|shared medical decision making
388110|NCT01293578|Patient Education|patient education
388111|NCT01293578|Endocrine System Diseases|endocrine system diseases
388112|NCT01293578|Glucose Metabolism Disorders|glucose metabolism disorders
388113|NCT01293578|Metabolic Diseases|metabolic diseases
388114|NCT01293565|X-Linked Hypohidrotic Ectodermal Dysplasia|x-linked hypohidrotic ectodermal dysplasia
388115|NCT01293565|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
388116|NCT01293565|XLHED|xlhed
388117|NCT01293565|HED|hed
388118|NCT01293539|Retinoblastoma|retinoblastoma
388119|NCT01293539|intra-arterial chemotherapy|intra-arterial chemotherapy
388120|NCT01293539|angiography|angiography
388121|NCT01293526|Heart failure|heart failure
388122|NCT01293526|echocardiography|echocardiography
388123|NCT01293513|Only patients with Acute or Primary HIV infection will be studied|only patients with acute or primary hiv infection will be studied
388124|NCT01293500|SIRS|sirs
388125|NCT01293500|shock|shock
388126|NCT01293500|sepsis|sepsis
388127|NCT01293500|pediatric|pediatric
388128|NCT01293500|inter-facility transport|inter-facility transport
388129|NCT01293500|specialized transport|specialized transport
388130|NCT01293500|NIRS monitoring|nirs monitoring
388131|NCT01293487|Phase 1|phase 1
388132|NCT01293487|Osteopenia|osteopenia
388133|NCT01293487|RN564|rn564
388134|NCT01293448|Esophagectomy|esophagectomy
388135|NCT01293448|Barrett's Esophagus|barrett's esophagus
388136|NCT01293435|Community Acquired Pneumonia (CAP)|community acquired pneumonia (cap)
403029|NCT01228461|Hodgkin Lymphoma Survivors|hodgkin lymphoma survivors
473764|NCT00081926|CSTI571|csti571
388137|NCT01293435|Complicated Skin and Skin Structures Infections (cSSSI)|complicated skin and skin structures infections (csssi)
388536|NCT01291823|gefitinib|gefitinib
388138|NCT01293435|Complicated Skin and Soft Tissues Infections (cSSTI)|complicated skin and soft tissues infections (cssti)
388139|NCT01293435|Antibiotics|antibiotics
388140|NCT01293435|Infection management|infection management
388141|NCT01293435|Use of Resources|use of resources
388142|NCT01293435|MRSA|mrsa
388143|NCT01293435|PRSP|prsp
388144|NCT01293422|PXR, glucose, cholesterol|pxr, glucose, cholesterol
388145|NCT01293396|insulin aspart 30|insulin aspart 30
388146|NCT01293396|insulin aspart 70|insulin aspart 70
388147|NCT01293396|insulin aspart|insulin aspart
388148|NCT01293396|postprandial glucose and lipid metabolism|postprandial glucose and lipid metabolism
388149|NCT01293396|consecutive mixed meals|consecutive mixed meals
388150|NCT01293344|Cardiovascular diseases|cardiovascular diseases
388151|NCT01293344|Controlled nutritional intervention|controlled nutritional intervention
388152|NCT01293344|Sex differences|sex differences
388153|NCT01293344|Women|women
388155|NCT01293344|Cardiovascular risk|cardiovascular risk
388156|NCT01293344|Lipid profile|lipid profile
388157|NCT01293344|Blood pressure|blood pressure
388158|NCT01293344|Insulin sensitivity|insulin sensitivity
388159|NCT01293344|Inflammatory markers|inflammatory markers
388160|NCT01293344|Endothelial function|endothelial function
388161|NCT01293344|Oxidative stress|oxidative stress
388162|NCT01293331|Dengue Fever Fever Seroprevalence|dengue fever fever seroprevalence
388163|NCT01293318|Copeptin|copeptin
388164|NCT01293318|Vasopressin|vasopressin
388165|NCT01293318|antidiuretic hormone (ADH)|antidiuretic hormone (adh)
388166|NCT01293305|osteoarthritis|osteoarthritis
388167|NCT01293292|Osteoporosis|osteoporosis
388168|NCT01293292|Forsteo|forsteo
388169|NCT01293292|Teriparatide|teriparatide
388170|NCT01293279|HCV viral genotypes|hcv viral genotypes
388171|NCT01293279|host genotypes|host genotypes
388172|NCT01293279|IL28B|il28b
388173|NCT01293279|ITPA|itpa
388174|NCT01293279|RNA|rna
388175|NCT01293279|China|china
388176|NCT01293266|Propofol|propofol
388177|NCT01293266|Metabolic Acidosis|metabolic acidosis
388178|NCT01293266|Pediatric Cardiology|pediatric cardiology
388179|NCT01293266|Anesthesia|anesthesia
388180|NCT01293227|Wrist Fracture|wrist fracture
388181|NCT01293214|limb transplantation|limb transplantation
388182|NCT01293214|limb allotransplantation|limb allotransplantation
388183|NCT01293214|hand transplantation|hand transplantation
388184|NCT01293214|hand allotransplantation|hand allotransplantation
388185|NCT01293214|hand amputation|hand amputation
388186|NCT01293214|leg transplantation|leg transplantation
388187|NCT01293201|SAR|sar
388188|NCT01293201|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
388189|NCT01293188|Aortic Valve Replacement|aortic valve replacement
388190|NCT01293188|Bioprosthetic|bioprosthetic
388191|NCT01293175|whole grains|whole grains
388192|NCT01293175|polyphenols|polyphenols
388193|NCT01293175|overweight|overweight
388194|NCT01293175|bioavailability|bioavailability
388195|NCT01293175|antioxidant status|antioxidant status
388196|NCT01293175|inflammation|inflammation
388197|NCT01293162|Metabolic syndrome|metabolic syndrome
388198|NCT01293162|Cardiovascular risk|cardiovascular risk
388199|NCT01293149|knee, reconstructive surgery|knee, reconstructive surgery
388200|NCT01293149|femoral nerve block|femoral nerve block
388201|NCT01293136|knee|knee
388202|NCT01293136|reconstructive surgery|reconstructive surgery
388203|NCT01293136|femoral nerve block|femoral nerve block
388204|NCT01293123|HIV|hiv
388205|NCT01293123|raltegravir|raltegravir
388206|NCT01293123|cerebrospinal fluid|cerebrospinal fluid
388207|NCT01293110|urodynamics|urodynamics
388208|NCT01293110|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
388209|NCT01293110|neurological disease/injury|neurological disease/injury
388210|NCT01293084|mucociliary clearance|mucociliary clearance
388211|NCT01293084|children|children
388212|NCT01293084|cystic fibrosis|cystic fibrosis
388213|NCT01293084|hypertonic saline|hypertonic saline
388214|NCT01293071|Antibiotic rotation|antibiotic rotation
388215|NCT01293071|Cycling|cycling
388216|NCT01293071|Mixing|mixing
388217|NCT01293071|Gram-negative|gram-negative
388218|NCT01293071|EU|eu
388219|NCT01293071|Multi center|multi center
388220|NCT01293071|Multi Centre|multi centre
388221|NCT01293071|Cluster randomized trial|cluster randomized trial
388222|NCT01293071|Cross over|cross over
388223|NCT01293058|opioid|opioid
388224|NCT01293058|overdose|overdose
388225|NCT01293058|naloxone|naloxone
388226|NCT01293058|intranasal|intranasal
388227|NCT01293045|Osteoporosis|osteoporosis
388228|NCT01293045|Postmenopausal women|postmenopausal women
388229|NCT01293045|Functional food|functional food
388230|NCT01293045|Hydrolysed collagen|hydrolysed collagen
388231|NCT01293045|Bone metabolism|bone metabolism
388232|NCT01293045|Bone marker of resorption|bone marker of resorption
388233|NCT01293045|Bone marker of formation|bone marker of formation
600486|NCT00581633|tachycardia|tachycardia
388234|NCT01293032|Estrogen Receptor Positive|estrogen receptor positive
388235|NCT01293032|Progesterone Receptor Positive|progesterone receptor positive
388236|NCT01293032|HER2/Neu Negative|her2/neu negative
388237|NCT01293032|Breast Cancer|breast cancer
388238|NCT01293019|Complementary and alternative medicine|complementary and alternative medicine
388239|NCT01293019|Osteopathic treatment|osteopathic treatment
388240|NCT01293006|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
388241|NCT01292980|sDTI|sdti
388242|NCT01292980|Pressure ulcers|pressure ulcers
388243|NCT01292980|Therapy surfaces|therapy surfaces
388244|NCT01292980|Mattresses|mattresses
388245|NCT01292980|Deep Tissue Injury|deep tissue injury
388246|NCT01292980|pressure ulcer treatment|pressure ulcer treatment
388247|NCT01292967|Flavanol|flavanol
388249|NCT01292967|maltitol|maltitol
388250|NCT01292967|absorption|absorption
388251|NCT01292967|metabolism|metabolism
388252|NCT01292967|chocolate|chocolate
388253|NCT01292967|food matrix|food matrix
388254|NCT01292967|bioavailability|bioavailability
388255|NCT01292954|blueberries|blueberries
388256|NCT01292954|vascular function|vascular function
388257|NCT01292954|FMD|fmd
388258|NCT01292954|Blood pressure|blood pressure
388259|NCT01292954|Laser Doppler|laser doppler
388260|NCT01292954|pharmacokinetics|pharmacokinetics
388261|NCT01292954|absorption|absorption
388262|NCT01292954|metabolism|metabolism
388263|NCT01292954|polyphenols|polyphenols
388264|NCT01292954|flavonoids|flavonoids
388265|NCT01292928|Atherosclerosis, Superficial Femoral Artery (SFA), Proximal Popliteal Artery (PPA), lower extremities, Stenting|atherosclerosis, superficial femoral artery (sfa), proximal popliteal artery (ppa), lower extremities, stenting
388266|NCT01292915|Re-bleeding, NVUGIB|re-bleeding, nvugib
388267|NCT01292889|Seasonal Affective Disorder|seasonal affective disorder
388268|NCT01292889|Major Depressive Disorder|major depressive disorder
388269|NCT01292889|Depression|depression
388270|NCT01292889|Winter Blues|winter blues
388271|NCT01292876|MTURR|mturr
388272|NCT01292876|ECM|ecm
388273|NCT01292876|Muscle Loss|muscle loss
388274|NCT01292876|Tendon|tendon
388275|NCT01292876|Tendon Repair|tendon repair
388276|NCT01292876|Muscle Repair|muscle repair
388277|NCT01292876|Soft Tissue Repair|soft tissue repair
388278|NCT01292876|Scaffold|scaffold
388279|NCT01292876|Extracellular Matrix|extracellular matrix
388280|NCT01292863|Peritoneal dialysis|peritoneal dialysis
388281|NCT01292863|Biocompatible dialysis fluid|biocompatible dialysis fluid
388282|NCT01292850|Topical|topical
388283|NCT01292850|Skin|skin
388284|NCT01292850|sterility|sterility
388285|NCT01292850|ethylchloride|ethylchloride
388286|NCT01292850|ethyl|ethyl
388287|NCT01292850|chloride|chloride
388288|NCT01292850|spray|spray
388289|NCT01292837|Levetiracetam|levetiracetam
388290|NCT01292837|Epilepsy|epilepsy
388291|NCT01292837|Generalized tonic-clonic seizures|generalized tonic-clonic seizures
388292|NCT01292824|Hepatitis C virus|hepatitis c virus
388293|NCT01292824|Entry|entry
388294|NCT01292824|Scavenger receptor-BI|scavenger receptor-bi
388295|NCT01292824|High density lipoprotein|high density lipoprotein
388296|NCT01292824|Liver transplantation|liver transplantation
388297|NCT01292811|Spinal Cord Injury|spinal cord injury
388298|NCT01292811|Functional Electrical Stimulation|functional electrical stimulation
388299|NCT01292811|Hand function|hand function
388300|NCT01292811|Tetraplegia|tetraplegia
388301|NCT01292798|Diabetes|diabetes
388302|NCT01292798|Macula|macula
388303|NCT01292798|Edema|edema
388304|NCT01292798|Retina|retina
388305|NCT01292772|breast cancer|breast cancer
388306|NCT01292772|bilateral mastectomy|bilateral mastectomy
388307|NCT01292772|immediate breast reconstruction|immediate breast reconstruction
388308|NCT01292772|locally advanced unilateral breast cancer|locally advanced unilateral breast cancer
388309|NCT01292772|bilateral mastectomy for prophylaxis|bilateral mastectomy for prophylaxis
388310|NCT01292759|stroke volume|stroke volume
388311|NCT01292759|cardiac output|cardiac output
388312|NCT01292759|validation|validation
388313|NCT01292733|Women with increased risk for developing ovarian cancer|women with increased risk for developing ovarian cancer
388314|NCT01292733|Women diagnosed with reproductive cancer|women diagnosed with reproductive cancer
388315|NCT01292733|Women with relatives who have had ovarian or breast cancer|women with relatives who have had ovarian or breast cancer
388316|NCT01292720|vitamin D deficiency, vitamin D insufficiency, heart failure|vitamin d deficiency, vitamin d insufficiency, heart failure
388317|NCT01292707|malaria|malaria
388318|NCT01292707|rdt|rdt
388319|NCT01292707|fever|fever
388320|NCT01292707|treatment|treatment
388321|NCT01292694|supine hypertension|supine hypertension
388322|NCT01292694|autonomic failure|autonomic failure
388323|NCT01292694|angiotensin|angiotensin
388324|NCT01292694|losartan|losartan
388325|NCT01292694|captopril|captopril
388326|NCT01292681|colorectal cancer|colorectal cancer
388327|NCT01292681|FDG-PET-CT|fdg-pet-ct
388328|NCT01292681|MRS,|mrs,
388329|NCT01292681|DCE-MRI|dce-mri
388330|NCT01292681|DWI|dwi
379258|NCT01329718|CRC|crc
388331|NCT01292681|colorectal cancer with histologically proven distant metastases|colorectal cancer with histologically proven distant metastases
388332|NCT01292642|cognitive behavioral therapy|cognitive behavioral therapy
388333|NCT01292642|nicotine dependence|nicotine dependence
388334|NCT01292642|cannabis dependence|cannabis dependence
388335|NCT01292642|smoking cessation|smoking cessation
388336|NCT01292642|nicotine replacement therapy|nicotine replacement therapy
388337|NCT01292629|intraocular lens|intraocular lens
388338|NCT01292629|IOL|iol
388339|NCT01292629|cataract|cataract
388340|NCT01292629|Hoya|hoya
388341|NCT01292629|surgical|surgical
388342|NCT01292629|optics|optics
388343|NCT01292629|ocular|ocular
388344|NCT01292629|visual acuity|visual acuity
388345|NCT01292577|Schizophrenia|schizophrenia
388346|NCT01292577|Schizoaffective Disorder|schizoaffective disorder
388347|NCT01292577|Cannabis|cannabis
388348|NCT01292577|Alcohol|alcohol
388349|NCT01292577|Substance Misuse|substance misuse
388350|NCT01292577|Cognition|cognition
388351|NCT01292577|Psychosocial Treatment|psychosocial treatment
388352|NCT01292577|Cognitive Enhancement Therapy|cognitive enhancement therapy
388353|NCT01292577|Personal Therapy|personal therapy
388354|NCT01292577|Treatment as Usual|treatment as usual
388355|NCT01292551|single ventricle physiology|single ventricle physiology
388356|NCT01292551|Fontan procedure|fontan procedure
388357|NCT01292525|Withdrawal of Tacrolimus and renal graft|withdrawal of tacrolimus and renal graft
388358|NCT01292525|renal allograft|renal allograft
388359|NCT01292525|stable renal function|stable renal function
388360|NCT01292512|Bereavement management|bereavement management
388361|NCT01292512|Complicated grief|complicated grief
388362|NCT01292499|psychotherapy|psychotherapy
388363|NCT01292499|psychoeducation|psychoeducation
388364|NCT01292499|depression|depression
388365|NCT01292447|Pain measurement|pain measurement
388366|NCT01292447|Intrauterine devices|intrauterine devices
388367|NCT01292447|Lidocaine|lidocaine
388368|NCT01292434|Diet|diet
388369|NCT01292434|Obesity|obesity
388370|NCT01292434|Child Preschool|child preschool
388371|NCT01292434|Treatment Outcome|treatment outcome
388372|NCT01292434|Body Mass Index|body mass index
388373|NCT01292434|Intervention Studies|intervention studies
388374|NCT01292434|Randomized Controlled Trial|randomized controlled trial
388375|NCT01292434|Child Day Care Centers|child day care centers
388376|NCT01292434|Schools Nursery|schools nursery
388377|NCT01292434|Child Care|child care
388378|NCT01292408|autophagy|autophagy
388379|NCT01292408|hydroxychloroquine|hydroxychloroquine
388380|NCT01292408|hypoxia|hypoxia
388381|NCT01292408|proven invasive adenocarcinoma of the breast: tumors are found to be ER negative (<10% ER pos cells)|proven invasive adenocarcinoma of the breast: tumors are found to be er negative (<10% er pos cells)
388382|NCT01292395|dietary supplement|dietary supplement
388383|NCT01292395|protein metabolism|protein metabolism
388384|NCT01292395|bone turnover|bone turnover
388385|NCT01292382|Elderly|elderly
388386|NCT01292382|Memory|memory
388387|NCT01292382|Cognition|cognition
388388|NCT01292382|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
388389|NCT01292369|breath test|breath test
388390|NCT01292369|colon cancer|colon cancer
388391|NCT01292369|breast cancer|breast cancer
388392|NCT01292343|third molars|third molars
388393|NCT01292343|triclosan|triclosan
388394|NCT01292343|toothpaste|toothpaste
388395|NCT01292343|dry socket|dry socket
388396|NCT01292343|wound infection|wound infection
388397|NCT01292330|liver Tumor|liver tumor
388398|NCT01292317|NGAL|ngal
388399|NCT01292317|neutrophil gelatinase-associated Lipocalin|neutrophil gelatinase-associated lipocalin
388400|NCT01292317|contrast media nephropathy|contrast media nephropathy
388401|NCT01292317|CIN|cin
388402|NCT01292317|volume expansion|volume expansion
388403|NCT01292317|acute kidney injury|acute kidney injury
388404|NCT01292317|contrast media|contrast media
388405|NCT01292304|Cirrhotic|cirrhotic
388406|NCT01292304|Tolvaptan|tolvaptan
388407|NCT01292304|v2 receptor antagonist|v2 receptor antagonist
388408|NCT01292291|stage I prostate cancer|stage i prostate cancer
388409|NCT01292291|stage IIA prostate cancer|stage iia prostate cancer
388410|NCT01292291|stage IIB prostate cancer|stage iib prostate cancer
388411|NCT01292278|subarachnoid hemorrhage|subarachnoid hemorrhage
388412|NCT01292278|cerebral vasospasm|cerebral vasospasm
388413|NCT01292278|neuropeptide Y|neuropeptide y
388414|NCT01292278|spontaneous|spontaneous
388415|NCT01292278|aneurysmal|aneurysmal
388416|NCT01292265|Arthritis|arthritis
388417|NCT01292265|Joint pain|joint pain
388418|NCT01292265|Inflammation|inflammation
388419|NCT01292265|Rheumatoid Arthritis|rheumatoid arthritis
388420|NCT01292239|Hepatitis C, Chronic|hepatitis c, chronic
388421|NCT01292239|Hepatitis C|hepatitis c
388422|NCT01292239|Hepatitis C virus|hepatitis c virus
388423|NCT01292239|Interferon Alfa-2a|interferon alfa-2a
388424|NCT01292239|Ribavirin|ribavirin
388425|NCT01292239|Viral RNA|viral rna
388426|NCT01292213|Chronic cough|chronic cough
388427|NCT01292213|Haemophilus influenzae|haemophilus influenzae
388428|NCT01292200|Chinese women|chinese women
388429|NCT01292200|Mammography|mammography
388430|NCT01292200|Breast Cancer|breast cancer
388431|NCT01292187|Osteoporosis|osteoporosis
388432|NCT01292187|Osteopenia|osteopenia
388433|NCT01292187|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
388434|NCT01292187|Bone Diseases, Metabolic|bone diseases, metabolic
388435|NCT01292187|Bone Diseases|bone diseases
388436|NCT01292187|Musculoskeletal Diseases|musculoskeletal diseases
388437|NCT01292187|Salmon calcitonin|salmon calcitonin
388438|NCT01292187|Calcitonin|calcitonin
388439|NCT01292174|HIV prevention|hiv prevention
388440|NCT01292161|Hepatitis C|hepatitis c
388441|NCT01292161|Silymarin|silymarin
388442|NCT01292161|Quality of life|quality of life
388443|NCT01292148|resuscitation, hypothermia|resuscitation, hypothermia
388444|NCT01292135|Lymphoma, B-Cell|lymphoma, b-cell
388445|NCT01292135|Leukemia, Lymphoid|leukemia, lymphoid
388446|NCT01292135|Leukemia, B-Cell|leukemia, b-cell
388447|NCT01292135|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
388448|NCT01292122|Wounds|wounds
388449|NCT01292122|Grafts|grafts
388450|NCT01292122|Wound Healing|wound healing
388451|NCT01292122|Cell Therapy|cell therapy
388452|NCT01292122|Split-thickness skin graft donor site wound|split-thickness skin graft donor site wound
388453|NCT01292109|endoscopy|endoscopy
388454|NCT01292109|colonoscopy|colonoscopy
388455|NCT01292109|preparation for surgery|preparation for surgery
388456|NCT01292096|homelessness|homelessness
388457|NCT01292096|substance use|substance use
388458|NCT01292096|frequent hospitalization|frequent hospitalization
388459|NCT01292096|frequent users of health services|frequent users of health services
388460|NCT01292096|enhanced care management|enhanced care management
388461|NCT01292096|coordination services p|coordination services p
388462|NCT01292096|high risk for frequent hospitalization|high risk for frequent hospitalization
388463|NCT01292070|Fel d 1 protein, Felis domesticus|fel d 1 protein, felis domesticus
388464|NCT01292070|Injections, Intradermal|injections, intradermal
388465|NCT01292057|Alcohol|alcohol
388466|NCT01292057|Aripiprazole|aripiprazole
388467|NCT01292057|Impulsivity|impulsivity
388468|NCT01292057|Alcoholism|alcoholism
388469|NCT01292057|drinking|drinking
388470|NCT01292057|treatment|treatment
388471|NCT01292057|craving|craving
388472|NCT01292057|brain imaging|brain imaging
388473|NCT01292057|genetics|genetics
388474|NCT01292044|elastography|elastography
388475|NCT01292044|cytology|cytology
388476|NCT01292031|VAP|vap
388477|NCT01292031|MDR-GNB|mdr-gnb
388478|NCT01292031|colistin|colistin
388479|NCT01292031|meropenem|meropenem
388480|NCT01292018|Management of dyslipidemia in Type 2 Diabetes Mellitus adult patients in India|management of dyslipidemia in type 2 diabetes mellitus adult patients in india
388481|NCT01292018|Dyslipidemia control rates in Type 2 diabetic Mellitus patients|dyslipidemia control rates in type 2 diabetic mellitus patients
388482|NCT01292005|pancreatitis|pancreatitis
388483|NCT01292005|pancreatic necrosis|pancreatic necrosis
388484|NCT01292005|severe acute pancreatitis (SAP)|severe acute pancreatitis (sap)
388485|NCT01292005|Alcoholic pancreatitis|alcoholic pancreatitis
388486|NCT01292005|gallstone pancreatitis|gallstone pancreatitis
388487|NCT01291992|Non-convulsive seizures|non-convulsive seizures
388488|NCT01291992|Cardiac Surgery|cardiac surgery
388489|NCT01291992|Postop|postop
388490|NCT01291992|24 hour EEG Monitoring|24 hour eeg monitoring
388491|NCT01291979|Pain|pain
388492|NCT01291979|Preemptive|preemptive
388493|NCT01291979|Lidocaine|lidocaine
388494|NCT01291979|Intravenous|intravenous
388495|NCT01291979|Tonsillectomy|tonsillectomy
388496|NCT01291966|medication errors|medication errors
388497|NCT01291966|Patient Compliance|patient compliance
388498|NCT01291966|patient safety|patient safety
388499|NCT01291966|polypharmacy|polypharmacy
388500|NCT01291953|atrial fibrillation|atrial fibrillation
388501|NCT01291953|screening|screening
388502|NCT01291953|prevention|prevention
388503|NCT01291953|case finding|case finding
388504|NCT01291953|primary care|primary care
388505|NCT01291927|Periampullary carcinoma|periampullary carcinoma
388506|NCT01291927|Pancreas-sparing Duodenectomy|pancreas-sparing duodenectomy
388507|NCT01291927|pancreaticoduodenectomy|pancreaticoduodenectomy
388508|NCT01291927|lymphadenectomy|lymphadenectomy
388509|NCT01291914|Osteoarthritis|osteoarthritis
388510|NCT01291914|knee|knee
388511|NCT01291914|intra-articular|intra-articular
388512|NCT01291914|safety|safety
388513|NCT01291914|efficacy|efficacy
388514|NCT01291914|pharmacokinetics|pharmacokinetics
388515|NCT01291914|pain|pain
388516|NCT01291901|pain|pain
388517|NCT01291901|cancer|cancer
388518|NCT01291901|malignancy|malignancy
388519|NCT01291901|intractable|intractable
388520|NCT01291901|gene therapy|gene therapy
388521|NCT01291901|enkephalin|enkephalin
388522|NCT01291901|opioid|opioid
388523|NCT01291875|Type 2 Diabetes mellitus|type 2 diabetes mellitus
388524|NCT01291875|Periodontal Disease|periodontal disease
388525|NCT01291875|metabolic control|metabolic control
388526|NCT01291875|periodontal treatment|periodontal treatment
388527|NCT01291875|inflammatory markers|inflammatory markers
388533|NCT01291836|Acute Decompensated Heart Failure (ADHF)|acute decompensated heart failure (adhf)
388534|NCT01291836|Neutrophil Gelatinase Associated Lipocalin (NGAL)|neutrophil gelatinase associated lipocalin (ngal)
388537|NCT01291823|radiation|radiation
388538|NCT01291823|esophageal cancer|esophageal cancer
388539|NCT01291797|congenital heart disease|congenital heart disease
388540|NCT01291797|neurodevelopmental outcome|neurodevelopmental outcome
388542|NCT01291797|sleep wake cycles|sleep wake cycles
388543|NCT01291784|monoclonal antibody|monoclonal antibody
388544|NCT01291771|End stage renal disease|end stage renal disease
388545|NCT01291771|myocardial microvascular disease|myocardial microvascular disease
388546|NCT01291771|cardiorenal syndrome|cardiorenal syndrome
388547|NCT01291771|coronary flow reserve|coronary flow reserve
388548|NCT01291771|index of microvascular resistance|index of microvascular resistance
388549|NCT01291771|Patients with end stage renal disease scheduled or not for kidney or kidney + pancreatic transplantation|patients with end stage renal disease scheduled or not for kidney or kidney + pancreatic transplantation
388550|NCT01291758|Persian Gulf War|persian gulf war
388551|NCT01291758|Gulf War Syndrome|gulf war syndrome
388552|NCT01291758|GWI|gwi
388553|NCT01291758|Gulf War Illness|gulf war illness
388554|NCT01291758|Exercise|exercise
388555|NCT01291758|Chronic Fatigue|chronic fatigue
388556|NCT01291758|Fibromyalgia|fibromyalgia
388557|NCT01291758|Veterans|veterans
388558|NCT01291758|Irritable Bowel Syndrome|irritable bowel syndrome
388559|NCT01291758|Migraine headaches|migraine headaches
388560|NCT01291758|Neuropathy|neuropathy
388561|NCT01291719|closed loop glucose control|closed loop glucose control
388562|NCT01291719|intensive care glucose control|intensive care glucose control
388563|NCT01291706|Transcranial Doppler|transcranial doppler
388564|NCT01291706|Mild and moderate Traumatic Brain Injury|mild and moderate traumatic brain injury
388565|NCT01291706|Neurological deterioration|neurological deterioration
388566|NCT01291706|Brain CT scan|brain ct scan
388567|NCT01291693|Hazardous drinking|hazardous drinking
388568|NCT01291693|general hospital|general hospital
388569|NCT01291693|brief intervention|brief intervention
388570|NCT01291693|Motivational Interviewing|motivational interviewing
388571|NCT01291693|computer-generated feedback|computer-generated feedback
388572|NCT01291693|stage-tailored|stage-tailored
388573|NCT01291693|delivery channel|delivery channel
388574|NCT01291680|Pregnancy|pregnancy
388575|NCT01291680|Chronic pain|chronic pain
388576|NCT01291680|Fibromyalgia|fibromyalgia
388577|NCT01291654|PDA|pda
388578|NCT01291654|Paracetamol|paracetamol
388579|NCT01291654|Indomethacin|indomethacin
388580|NCT01291654|Ibuprofen|ibuprofen
388581|NCT01291641|Hyperlipidemias|hyperlipidemias
388582|NCT01291641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
388583|NCT01291641|Probucol|probucol
388584|NCT01291641|Cilostazol|cilostazol
388585|NCT01291628|Capecitabine|capecitabine
388586|NCT01291628|Hand and foot syndrome|hand and foot syndrome
388587|NCT01291628|Socks|socks
388588|NCT01291628|Copper|copper
388589|NCT01291628|Toxicity|toxicity
388596|NCT01291589|HIV-infected|hiv-infected
388597|NCT01291589|MSM|msm
388598|NCT01291589|HIV prevention|hiv prevention
388599|NCT01291576|Deep infiltrating endometriosis|deep infiltrating endometriosis
388600|NCT01291576|Rectal endometriosis|rectal endometriosis
388601|NCT01291576|Colorectal resection|colorectal resection
388602|NCT01291576|Nodule excision|nodule excision
388603|NCT01291576|Rectal shaving|rectal shaving
388604|NCT01291576|Functional outcomes|functional outcomes
388605|NCT01291576|Constipation|constipation
388606|NCT01291563|TMC207TBC1003|tmc207tbc1003
388607|NCT01291563|TMC207|tmc207
388608|NCT01291563|M.Tuberculosis|m.tuberculosis
388609|NCT01291563|TBC|tbc
388610|NCT01291563|Moxifloxacin|moxifloxacin
388611|NCT01291563|ECG|ecg
388612|NCT01291563|QT/QTc|qt/qtc
388613|NCT01291563|Healthy volunteers|healthy volunteers
388614|NCT01291550|Detecting volatile biomarkers using breath sample|detecting volatile biomarkers using breath sample
388615|NCT01291537|Advanced|advanced
388616|NCT01291537|Severe form|severe form
388617|NCT01291524|pregabalin|pregabalin
388618|NCT01291524|pharmacokinetics|pharmacokinetics
388619|NCT01291524|bioavailability|bioavailability
388620|NCT01291524|bioequivalence|bioequivalence
388621|NCT01291511|Schizophrenia|schizophrenia
388622|NCT01291511|Mental Disorders|mental disorders
388623|NCT01291511|Antipsychotic Agents|antipsychotic agents
388624|NCT01291511|Iloperdione|iloperdione
600487|NCT00581672|Anxiety|anxiety
388625|NCT01291511|Relapse Prevention|relapse prevention
388626|NCT01291498|Primary Parathyroid Adenomas|primary parathyroid adenomas
388627|NCT01291485|HIV|hiv
388628|NCT01291485|Medication adherence|medication adherence
388629|NCT01291485|computer-based intervention|computer-based intervention
388630|NCT01291472|ketorolac|ketorolac
388631|NCT01291472|pain|pain
388632|NCT01291472|pregnancy|pregnancy
388633|NCT01291472|non-pregnant state|non-pregnant state
388634|NCT01291459|HIV|hiv
388635|NCT01291459|naive patients|naive patients
388636|NCT01291459|maraviroc|maraviroc
388637|NCT01291459|raltegravir|raltegravir
474350|NCT00083265|HV|hv
388638|NCT01291446|Intestinal gas production|intestinal gas production
388639|NCT01291446|Intestinal microbiota|intestinal microbiota
388640|NCT01291407|Combined Modality|combined modality
388641|NCT01291407|Gastric Cancer|gastric cancer
388642|NCT01291407|Radiation Therapy|radiation therapy
388643|NCT01291407|S-1|s-1
388644|NCT01291394|Growth disorders|growth disorders
388645|NCT01291394|Saizen|saizen
388646|NCT01291394|Easypod|easypod
388647|NCT01291394|Growth hormone|growth hormone
388648|NCT01291394|Pediatric subject|pediatric subject
388649|NCT01291381|allergic rhinitis|allergic rhinitis
388650|NCT01291381|peripheral tolerance|peripheral tolerance
388651|NCT01291381|regulatory T cells|regulatory t cells
388652|NCT01291381|specific immunotherapy|specific immunotherapy
388653|NCT01291381|Tr1 cells|tr1 cells
388654|NCT01291368|Sedation|sedation
388655|NCT01291368|Delirium|delirium
388656|NCT01291368|PTSD|ptsd
388657|NCT01291368|Depression|depression
388658|NCT01291368|Anxiety|anxiety
388659|NCT01291368|HRQoL|hrqol
388660|NCT01291368|CAM-ICU|cam-icu
388661|NCT01291368|RASS|rass
388662|NCT01291368|SF-36|sf-36
388663|NCT01291368|ICU-memory tool|icu-memory tool
388664|NCT01291368|Antipsychotic Agents|antipsychotic agents
388665|NCT01291368|Mobilization|mobilization
388666|NCT01291368|ICU-nursing|icu-nursing
388667|NCT01291368|ICU|icu
388668|NCT01291368|intensive care|intensive care
388669|NCT01291368|critical care|critical care
388670|NCT01291368|critical care nursing|critical care nursing
388671|NCT01291355|Maternal position|maternal position
388672|NCT01291355|Occipitoposterior position|occipitoposterior position
388673|NCT01291355|Labor|labor
388674|NCT01291355|Dystocia|dystocia
388675|NCT01291355|Fetal presentation Abnormalities|fetal presentation abnormalities
388676|NCT01291342|Pregnancy|pregnancy
388677|NCT01291342|Preeclampsia|preeclampsia
388678|NCT01291342|Volatile biomarkers|volatile biomarkers
388679|NCT01291342|Chemical sensors|chemical sensors
388680|NCT01291342|Nanomaterials|nanomaterials
388681|NCT01291342|Nanosensors|nanosensors
388682|NCT01291342|NA-NOSE|na-nose
388683|NCT01291329|stem cell|stem cell
388684|NCT01291329|acute ST-Elevation Myocardial Infarction|acute st-elevation myocardial infarction
388685|NCT01291303|Non invasive ventilation|non invasive ventilation
388686|NCT01291303|acute exacerbation of COPD|acute exacerbation of copd
388687|NCT01291303|optimized ventilation|optimized ventilation
388688|NCT01291290|rAAA|raaa
388689|NCT01291290|Platelets|platelets
388690|NCT01291290|TEG|teg
388691|NCT01291290|Massive bleeding|massive bleeding
388692|NCT01291290|Coagulopathy|coagulopathy
388693|NCT01291277|gastrointestinal hemorrhage|gastrointestinal hemorrhage
388694|NCT01291277|esophageal varices|esophageal varices
388695|NCT01291277|gastrointestinal endoscopy|gastrointestinal endoscopy
388696|NCT01291277|ligation|ligation
388697|NCT01291264|Chlamydia trachomatis|chlamydia trachomatis
388698|NCT01291264|Neisseria gonorrhoeae|neisseria gonorrhoeae
388699|NCT01291264|Sexually Transmitted Diseases|sexually transmitted diseases
388700|NCT01291238|learning disability|learning disability
388701|NCT01291238|blood lipids|blood lipids
388702|NCT01291238|cardio metabolic risk factors|cardio metabolic risk factors
388703|NCT01291238|upper secondary school for learning disability students|upper secondary school for learning disability students
388704|NCT01291238|adolescents|adolescents
388705|NCT01291238|cardio respiratory fitness|cardio respiratory fitness
388706|NCT01291238|absorptiometry photos|absorptiometry photos
388707|NCT01291225|playgrounds|playgrounds
388708|NCT01291225|farms|farms
388709|NCT01291225|injury prevention|injury prevention
388710|NCT01291225|safety knowledge, attitudes and practices|safety knowledge, attitudes and practices
388711|NCT01291225|safe play|safe play
388712|NCT01291225|rural|rural
388713|NCT01291212|In Vitro Fertilization|in vitro fertilization
388714|NCT01291212|Testosterone|testosterone
388715|NCT01291212|Ovarian Stimulation|ovarian stimulation
388716|NCT01291212|Luteinizing Hormone|luteinizing hormone
388717|NCT01291199|double-blind placebo controlled cross-over study|double-blind placebo controlled cross-over study
388718|NCT01291186|spinal anesthesia|spinal anesthesia
388719|NCT01291186|intrathecal bupivacaine|intrathecal bupivacaine
388720|NCT01291186|median effective dose|median effective dose
388721|NCT01291186|height|height
388722|NCT01291147|pain|pain
388723|NCT01291147|anaesthetic|anaesthetic
388731|NCT01291069|Fontan|fontan
388732|NCT01291069|Tadalafil|tadalafil
388733|NCT01291069|Exercise performance|exercise performance
388734|NCT01291056|Clomiphene citrate|clomiphene citrate
388735|NCT01291056|Mood symptoms|mood symptoms
388736|NCT01291056|Infertility|infertility
388737|NCT01291056|Superovulation|superovulation
388738|NCT01291056|Effects of clomiphene on mood|effects of clomiphene on mood
388739|NCT01291043|Shiatsu|shiatsu
388740|NCT01291043|Fibromyalgia|fibromyalgia
388741|NCT01291043|Pain|pain
388742|NCT01291043|Quality of sleep|quality of sleep
388743|NCT01291043|Balance|balance
379632|NCT01328054|ECG|ecg
388744|NCT01291043|Quality of life|quality of life
388745|NCT01291017|Advanced stage|advanced stage
388746|NCT01290952|off-pump|off-pump
388747|NCT01290952|bypass|bypass
388748|NCT01290952|coronary artery surgery|coronary artery surgery
388749|NCT01290939|adult glioblastoma|adult glioblastoma
388750|NCT01290939|recurrent adult brain tumor|recurrent adult brain tumor
388751|NCT01290939|Cognition Disorders|cognition disorders
388752|NCT01290939|functional defects|functional defects
388753|NCT01290926|advanced chemorefractory colorectal cancer|advanced chemorefractory colorectal cancer
388754|NCT01290926|sorafenib|sorafenib
388755|NCT01290926|capecitabine|capecitabine
388756|NCT01290926|FDG-PET|fdg-pet
388757|NCT01290926|early metabolic response|early metabolic response
388758|NCT01290913|peanut allergy|peanut allergy
388759|NCT01290913|Xolair|xolair
388769|NCT01290874|Asthma|asthma
388770|NCT01290874|Blacks|blacks
388771|NCT01290874|LABA|laba
388772|NCT01290874|Tiotropium|tiotropium
388773|NCT01290874|Spiriva|spiriva
388774|NCT01290874|African American|african american
388775|NCT01290874|Serevent|serevent
388776|NCT01290874|salmeterol|salmeterol
388777|NCT01290874|Foradil|foradil
388778|NCT01290874|formoterol|formoterol
388779|NCT01290874|Advair|advair
388780|NCT01290874|Symbicort|symbicort
388781|NCT01290874|Dulera|dulera
388782|NCT01290861|Huntington's Disease|huntington's disease
388783|NCT01290861|Cognitive Battery|cognitive battery
388784|NCT01290861|Cognitive Testing|cognitive testing
388785|NCT01290861|Cognition|cognition
388786|NCT01290861|pre-manifest Huntington's Disease|pre-manifest huntington's disease
388787|NCT01290848|pediatrics|pediatrics
388788|NCT01290848|Health Promotion Campaign|health promotion campaign
388789|NCT01290848|Community events|community events
388790|NCT01290835|Stereotactic radiotherapy|stereotactic radiotherapy
388791|NCT01290835|CyberKnife following lumpectomy|cyberknife following lumpectomy
388792|NCT01290835|Breast cancer|breast cancer
388793|NCT01290822|Biventricular pacing|biventricular pacing
388794|NCT01290822|Dilated Cardiomyopathy|dilated cardiomyopathy
388795|NCT01290822|Ischemic Cardiomyopathy|ischemic cardiomyopathy
388796|NCT01290822|Congestive heart failure|congestive heart failure
388797|NCT01290822|Cardiac allograft|cardiac allograft
388798|NCT01290822|Cardiac surgery|cardiac surgery
388799|NCT01290822|AVD|avd
388800|NCT01290822|VVD|vvd
388801|NCT01290822|LV pacing site|lv pacing site
388802|NCT01290822|pacing optimization|pacing optimization
388803|NCT01290809|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
388804|NCT01290809|lung cancer|lung cancer
388805|NCT01290783|mCRC|mcrc
388806|NCT01290783|CRC|crc
388807|NCT01290783|colorectal|colorectal
388808|NCT01290783|irinotecan|irinotecan
388809|NCT01290783|Hyaluronic acid|hyaluronic acid
388810|NCT01290783|Hyaluronan|hyaluronan
388811|NCT01290770|obesity|obesity
388812|NCT01290770|men|men
388813|NCT01290770|TFPI|tfpi
388814|NCT01290770|Lipoprotein(a)|lipoprotein(a)
388815|NCT01290770|Lp(a)|lp(a)
388816|NCT01290770|Tissue Factor pathway inhibitor|tissue factor pathway inhibitor
388817|NCT01290770|aspirin|aspirin
388818|NCT01290744|leprosy|leprosy
388820|NCT01290744|clofazimine|clofazimine
388821|NCT01290731|Hepatitis C, Chronic|hepatitis c, chronic
388822|NCT01290731|Hepatitis C virus|hepatitis c virus
388823|NCT01290731|Interferon Alfa-2a|interferon alfa-2a
388824|NCT01290731|Ribavirin|ribavirin
388825|NCT01290731|Viral RNA|viral rna
388826|NCT01290705|Knee|knee
388827|NCT01290705|Anterior Cruciate Ligament|anterior cruciate ligament
388828|NCT01290705|Pain|pain
388829|NCT01290705|Patella|patella
388830|NCT01290705|Exercise Therapy|exercise therapy
388831|NCT01290692|Brain Neoplasms|brain neoplasms
388832|NCT01290692|Central Nervous System Neoplasms|central nervous system neoplasms
388833|NCT01290692|Brain Diseases|brain diseases
388834|NCT01290692|Neoplasms|neoplasms
388835|NCT01290692|Nervous System Neoplasms|nervous system neoplasms
388836|NCT01290692|Glioblastoma|glioblastoma
388837|NCT01290692|Astrocytoma|astrocytoma
388838|NCT01290692|Nervous System Diseases|nervous system diseases
388839|NCT01290692|Central Nervous System Diseases|central nervous system diseases
388840|NCT01290692|Glioma|glioma
388841|NCT01290692|Recurrent astrocytoma|recurrent astrocytoma
388842|NCT01290692|Recurrent glioma|recurrent glioma
388843|NCT01290692|Cancer vaccine|cancer vaccine
388844|NCT01290692|Immunotherapy|immunotherapy
388845|NCT01290692|Killer T cells|killer t cells
388846|NCT01290692|Activated T cells|activated t cells
388847|NCT01290692|GM-CSF|gm-csf
388848|NCT01290692|Activated lymphocytes|activated lymphocytes
388849|NCT01290679|Hepatitis C|hepatitis c
388850|NCT01290679|TMC435|tmc435
388851|NCT01290679|HCV|hcv
388852|NCT01290679|Hep C|hep c
388853|NCT01290679|genotype 1|genotype 1
388854|NCT01290601|malaria|malaria
388855|NCT01290601|Plasmodium vivax|plasmodium vivax
388856|NCT01290601|adults|adults
388857|NCT01290601|treatment|treatment
474599|NCT00084032|PHI|phi
379729|NCT01327677|safety|safety
388858|NCT01290601|tafenoquine|tafenoquine
388859|NCT01290562|SBRT|sbrt
388860|NCT01290562|spinal Metastases|spinal metastases
388861|NCT01290562|Paraspinal Metastases|paraspinal metastases
388862|NCT01290562|spinal Metastases and SBRT|spinal metastases and sbrt
388863|NCT01290562|Paraspinal Metastases and SBRT|paraspinal metastases and sbrt
388864|NCT01290536|Liver metastases|liver metastases
388865|NCT01290510|tendinopathy|tendinopathy
388866|NCT01290510|hyaluronan|hyaluronan
388867|NCT01290510|tendon|tendon
388868|NCT01290510|hyaluronic acid|hyaluronic acid
388869|NCT01290484|Lymphatic malformation, vascular malformation|lymphatic malformation, vascular malformation
388870|NCT01290458|Eccentric training|eccentric training
388871|NCT01290458|Free radicals|free radicals
388872|NCT01290458|Antioxidant supplements|antioxidant supplements
388873|NCT01290458|Training adaptations|training adaptations
388874|NCT01290458|Lipid profile|lipid profile
388875|NCT01290445|varenicline|varenicline
388876|NCT01290445|smoking|smoking
388877|NCT01290445|smoking cessation|smoking cessation
388878|NCT01290445|cohort study|cohort study
388879|NCT01290445|drug safety|drug safety
388880|NCT01290445|prospective study|prospective study
388881|NCT01290432|female fertility|female fertility
388882|NCT01290432|ovarian reserve|ovarian reserve
388883|NCT01290432|oocyte quality|oocyte quality
388884|NCT01290432|oocyte quantity|oocyte quantity
388885|NCT01290432|antimullerian hormone|antimullerian hormone
388886|NCT01290432|AMH|amh
388887|NCT01290432|dietary supplements|dietary supplements
388888|NCT01290432|inofolic plus|inofolic plus
388889|NCT01290432|myoinositol|myoinositol
388890|NCT01290432|folic acid|folic acid
388891|NCT01290419|RSV|rsv
388892|NCT01290406|Endometrial cancer,|endometrial cancer,
388893|NCT01290406|uterine cancer,|uterine cancer,
388894|NCT01290406|PI3K,|pi3k,
388895|NCT01290406|mTOR,|mtor,
388896|NCT01290406|targeted therapy|targeted therapy
388897|NCT01290393|vaccine|vaccine
388898|NCT01290393|Spontaneous abortions|spontaneous abortions
388899|NCT01290393|Human papillomavirus|human papillomavirus
388900|NCT01290393|HPV|hpv
388901|NCT01290393|Cervarix|cervarix
388902|NCT01290393|pregnancy|pregnancy
388903|NCT01290380|Solid tumor malignancies,|solid tumor malignancies,
388904|NCT01290380|simvastatin,|simvastatin,
388905|NCT01290380|caffeine,|caffeine,
388906|NCT01290380|omeprazole and diclofenac,|omeprazole and diclofenac,
388907|NCT01290380|ASA404,|asa404,
388908|NCT01290380|PK data|pk data
388909|NCT01290367|Chronic Lumbar Back Pain|chronic lumbar back pain
388910|NCT01290367|Low back pain|low back pain
388911|NCT01290367|Back pain|back pain
388912|NCT01290367|Degenerative Disc Disease|degenerative disc disease
388913|NCT01290367|Injection of Degenerated Lumbar Disc|injection of degenerated lumbar disc
388914|NCT01290367|Stem Cells|stem cells
388915|NCT01290367|Adult Stem Cells|adult stem cells
388916|NCT01290367|Allogeneic Mesenchymal Precursor cells (MPCs)|allogeneic mesenchymal precursor cells (mpcs)
388917|NCT01290367|Mesoblast|mesoblast
388918|NCT01290354|Brain penetration|brain penetration
388919|NCT01290354|positron emission tomography|positron emission tomography
388920|NCT01290354|Lapatinib|lapatinib
388921|NCT01290341|fungal infection|fungal infection
388922|NCT01290341|athlete foot|athlete foot
388923|NCT01290328|anemia|anemia
388924|NCT01290328|kidney transplant|kidney transplant
388925|NCT01290328|alloimmunity|alloimmunity
388926|NCT01290289|Labor|labor
388927|NCT01290289|Epidural|epidural
388928|NCT01290289|Combined spinal epidural|combined spinal epidural
388929|NCT01290289|pethidine|pethidine
388930|NCT01290276|Ondansetron|ondansetron
388931|NCT01290276|Methylphenidate|methylphenidate
388932|NCT01290263|Glioblastoma|glioblastoma
388933|NCT01290263|GBM|gbm
388934|NCT01290263|Brain Tumor|brain tumor
388935|NCT01290263|Glioma|glioma
388936|NCT01290237|vancomycin|vancomycin
388937|NCT01290237|loading dose|loading dose
388938|NCT01290237|pharmacokinetic|pharmacokinetic
388939|NCT01290237|pediatric|pediatric
388940|NCT01290237|Methicillin-Resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
388941|NCT01290237|Serious infection with Gram positive bacteria|serious infection with gram positive bacteria
388942|NCT01290211|maraviroc|maraviroc
388943|NCT01290211|fosamprenavir|fosamprenavir
388944|NCT01290211|drug interaction|drug interaction
388945|NCT01290211|pharmacokinetics|pharmacokinetics
388946|NCT01290211|HIV|hiv
388947|NCT01290211|AIDS|aids
388948|NCT01290211|CCR5|ccr5
388949|NCT01290211|protease inhibitor|protease inhibitor
388950|NCT01290198|epoxy-eicosatrienoic acid|epoxy-eicosatrienoic acid
388951|NCT01290198|Laser Doppler|laser doppler
388952|NCT01290198|Endothelium derived hyperpolarizing factor|endothelium derived hyperpolarizing factor
388953|NCT01290198|cutaneous microcirculation|cutaneous microcirculation
388954|NCT01290198|post-occlusive hyperaemia|post-occlusive hyperaemia
388955|NCT01290198|thermal hyperemia|thermal hyperemia
388956|NCT01290198|intradermal microdialysis|intradermal microdialysis
388957|NCT01290198|fluconazole|fluconazole
388958|NCT01290185|Arthroplasty|arthroplasty
388959|NCT01290185|Pharmacol Nerve Block|pharmacol nerve block
388960|NCT01290172|Liver transplant|liver transplant
388961|NCT01290172|portal hypertension|portal hypertension
388962|NCT01290159|tolerance to heat|tolerance to heat
388963|NCT01290146|Heart Failure|heart failure
388964|NCT01290146|Levosimendan|levosimendan
388965|NCT01290146|Inotropic agents|inotropic agents
388966|NCT01290146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
388967|NCT01290146|Vasodilators|vasodilators
388968|NCT01290146|Diuretics|diuretics
388969|NCT01290120|Burkitt Lymphoma|burkitt lymphoma
388970|NCT01290120|B-ALL|b-all
388971|NCT01290120|Adult patients|adult patients
388972|NCT01290107|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
388973|NCT01290107|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
388974|NCT01290081|Tuberculosis|tuberculosis
388975|NCT01290081|Injecting drug users|injecting drug users
388976|NCT01290081|Case management|case management
388977|NCT01290068|Intraocular Lens|intraocular lens
388978|NCT01290055|yellow fever|yellow fever
388979|NCT01290055|vaccine|vaccine
388980|NCT01290055|memory T cells|memory t cells
388981|NCT01290029|pediatric|pediatric
388982|NCT01290029|CKD|ckd
388983|NCT01290029|dialysis|dialysis
388984|NCT01290029|paediatric|paediatric
388985|NCT01290016|randomized controlled trial|randomized controlled trial
388986|NCT01290016|children|children
388987|NCT01290016|obesity|obesity
388988|NCT01290016|nutrition|nutrition
388989|NCT01290016|exercise|exercise
388990|NCT01290003|Antibacterial agents|antibacterial agents
388991|NCT01290003|Neonate|neonate
388992|NCT01290003|Meconium stained amniotic fluid|meconium stained amniotic fluid
388993|NCT01290003|Neonatal sepsis|neonatal sepsis
388994|NCT01289977|Sandfly|sandfly
388995|NCT01289977|leishmaniasis|leishmaniasis
388996|NCT01289977|immune response|immune response
388997|NCT01289977|individuals age 18-50|individuals age 18-50
388998|NCT01289951|HIV|hiv
388999|NCT01289951|VHC|vhc
389000|NCT01289951|Advanced hepatic cirrhosis|advanced hepatic cirrhosis
389001|NCT01289951|Pharmacokinetic|pharmacokinetic
389002|NCT01289951|Raltegravir|raltegravir
389003|NCT01289938|pharmacokinetic|pharmacokinetic
389004|NCT01289938|pharmacogenetic|pharmacogenetic
389005|NCT01289938|Metoclopramide|metoclopramide
389006|NCT01289938|Diphenhydramine|diphenhydramine
389007|NCT01289938|CYP2D6 polymorphisms|cyp2d6 polymorphisms
389008|NCT01289925|dietary supplement|dietary supplement
389009|NCT01289925|selenium|selenium
389010|NCT01289925|healthy volunteer|healthy volunteer
389011|NCT01289925|Johns Hopkins|johns hopkins
389012|NCT01289925|older|older
389013|NCT01289925|aging|aging
389014|NCT01289925|geriatrics|geriatrics
389015|NCT01289925|baltimore|baltimore
389016|NCT01289925|mineral|mineral
389017|NCT01289925|over 70|over 70
389018|NCT01289912|Tuberous Sclerosis Complex|tuberous sclerosis complex
389019|NCT01289912|Autism|autism
389020|NCT01289912|Neurocognition|neurocognition
389021|NCT01289912|RAD001|rad001
389022|NCT01289912|Everolimus|everolimus
389023|NCT01289912|Afinitor|afinitor
389024|NCT01289912|TSC|tsc
389025|NCT01289899|BR-A-657|br-a-657
389026|NCT01289899|Fimasartan|fimasartan
389027|NCT01289899|multiple-dose|multiple-dose
389028|NCT01289899|pharmacokinetic|pharmacokinetic
389029|NCT01289899|pharmacodynamic|pharmacodynamic
389030|NCT01289899|safety|safety
389031|NCT01289886|single-dose|single-dose
389032|NCT01289886|pharmacokinetic|pharmacokinetic
389033|NCT01289886|pharmacodynamic|pharmacodynamic
389034|NCT01289886|safety|safety
389035|NCT01289847|Primary Immune Deficiency Disorders|primary immune deficiency disorders
389036|NCT01289847|Common Variable Immunodeficiency|common variable immunodeficiency
389037|NCT01289847|X-linked agammaglobulinemia|x-linked agammaglobulinemia
389038|NCT01289847|Hyper-IgM syndrome|hyper-igm syndrome
389039|NCT01289847|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
389040|NCT01289847|Immunoglobulins|immunoglobulins
389041|NCT01289847|Bacterial Infections|bacterial infections
389042|NCT01289834|RSA|rsa
389043|NCT01289834|Bone Cement|bone cement
389044|NCT01289808|Glucose|glucose
389045|NCT01289808|analgesic|analgesic
389046|NCT01289808|newborns|newborns
389047|NCT01289795|Stroke|stroke
389048|NCT01289795|Cerebral Infarction|cerebral infarction
389049|NCT01289795|Cerebrovascular Disorders|cerebrovascular disorders
389050|NCT01289795|Brain Diseases|brain diseases
389051|NCT01289795|Central Nervous System Diseases|central nervous system diseases
389052|NCT01289782|Hepatitis C|hepatitis c
389053|NCT01289782|TMC435|tmc435
389054|NCT01289782|HCV|hcv
389055|NCT01289782|Hep C|hep c
389056|NCT01289782|Genotype 1|genotype 1
389057|NCT01289756|pharmacokinetic|pharmacokinetic
389058|NCT01289756|clomiphene|clomiphene
389059|NCT01289756|CYP2D6 polymorphisms|cyp2d6 polymorphisms
389060|NCT01289756|inhibition of CYP2D6 and CYP3A4|inhibition of cyp2d6 and cyp3a4
389061|NCT01289743|ankylosing spondylitis|ankylosing spondylitis
389062|NCT01289743|atanercept|atanercept
389063|NCT01289743|therapy|therapy
389064|NCT01289743|magnetic resonance imaging|magnetic resonance imaging
389065|NCT01289730|undifferentiated spondyloarthritis|undifferentiated spondyloarthritis
389066|NCT01289730|etanercept|etanercept
389067|NCT01289730|therapy|therapy
389068|NCT01289730|magnetic resonance imaging|magnetic resonance imaging
389069|NCT01289717|biomarkers|biomarkers
389070|NCT01289717|proteogenomic profiling|proteogenomic profiling
389071|NCT01289717|acute rejection|acute rejection
389072|NCT01289717|chronic allograft nephropathy/interstitial fibrosis and tubular atrophy|chronic allograft nephropathy/interstitial fibrosis and tubular atrophy
389073|NCT01289704|Charcot−Marie−Tooth disease,|charcot−marie−tooth disease,
389074|NCT01289704|CMT1A,|cmt1a,
389075|NCT01289704|rehabilitation,|rehabilitation,
389076|NCT01289704|treadmill,|treadmill,
389077|NCT01289704|stretching,|stretching,
389078|NCT01289704|proprioception,|proprioception,
389079|NCT01289704|Randomised Controlled Trial.|randomised controlled trial.
389080|NCT01289691|One Lung Ventilation|one lung ventilation
389081|NCT01289691|Atelectasis|atelectasis
389082|NCT01289691|Oxygenation|oxygenation
389083|NCT01289678|acute myelogenous leukemia|acute myelogenous leukemia
389084|NCT01289678|interleukin-2|interleukin-2
389085|NCT01289665|lubricating|lubricating
389087|NCT01289665|speculum|speculum
389088|NCT01289665|Pain, Pelvic|pain, pelvic
389089|NCT01289665|Examination, Gynecological|examination, gynecological
389090|NCT01289652|Acute hepatitis C (HCV)|acute hepatitis c (hcv)
389091|NCT01289652|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
389092|NCT01289639|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
389093|NCT01289639|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
389094|NCT01289639|insulin resistance|insulin resistance
389095|NCT01289639|pioglitazone|pioglitazone
389096|NCT01289639|fenofibrate|fenofibrate
389097|NCT01289626|Calciphylaxis, dialysis|calciphylaxis, dialysis
389098|NCT01289613|Bispectral Index|bispectral index
389099|NCT01289613|Anesthesia|anesthesia
389100|NCT01289613|Asymmetry|asymmetry
389101|NCT01289587|Diabetes|diabetes
389102|NCT01289587|Physical activity|physical activity
389103|NCT01289587|Body composition|body composition
389104|NCT01289587|Aerobic fitness|aerobic fitness
389105|NCT01289587|Metabolic control|metabolic control
389106|NCT01289574|androgen receptor degradation enhancer|androgen receptor degradation enhancer
389107|NCT01289548|remote ischaemic preconditioning|remote ischaemic preconditioning
389108|NCT01289548|kidney transplantation|kidney transplantation
389109|NCT01289535|Influenza vaccine|influenza vaccine
389110|NCT01289535|immune response|immune response
389111|NCT01289535|elderly|elderly
389112|NCT01289522|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
389113|NCT01289522|recurrent or metastatic|recurrent or metastatic
389114|NCT01289522|first line chemotherapy|first line chemotherapy
389115|NCT01289522|cetuximab|cetuximab
389116|NCT01289522|docetaxel|docetaxel
389117|NCT01289522|cisplatin|cisplatin
389118|NCT01289522|antineoplastic agents|antineoplastic agents
389119|NCT01289522|First Line Palliative Treatment|first line palliative treatment
389120|NCT01289496|Ribavirin|ribavirin
389121|NCT01289496|Pegasys|pegasys
389122|NCT01289496|Hepatitis|hepatitis
389123|NCT01289483|awake fiberoptic intubation (AFI)|awake fiberoptic intubation (afi)
389124|NCT01289483|difficult airway|difficult airway
389125|NCT01289483|fospropofol|fospropofol
389126|NCT01289470|NIRS Technology|nirs technology
389127|NCT01289470|Cardiovascular surgery|cardiovascular surgery
389128|NCT01289470|valvular surgery with cardiopulmonary bypass|valvular surgery with cardiopulmonary bypass
389129|NCT01289457|Acute Myelogenous Leukemia|acute myelogenous leukemia
389130|NCT01289457|AML|aml
389131|NCT01289457|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
389132|NCT01289457|MDS|mds
389168|NCT01289405|speech therapy|speech therapy
389169|NCT01289392|Obstructive Sleep Apnea|obstructive sleep apnea
389170|NCT01289392|CPAP|cpap
389171|NCT01289392|Oral appliance|oral appliance
389172|NCT01289392|Aerobic exercise|aerobic exercise
389173|NCT01289392|Resistance training|resistance training
389174|NCT01289379|pneumoperitoneum|pneumoperitoneum
389175|NCT01289379|laparoscopy|laparoscopy
389176|NCT01289379|HFJV|hfjv
389177|NCT01289379|cardiovascular|cardiovascular
389178|NCT01289379|Symptomatic|symptomatic
389179|NCT01289353|triple negative|triple negative
389180|NCT01289353|breast cancer|breast cancer
389181|NCT01289353|adjuvant therapy|adjuvant therapy
389182|NCT01289353|Carboplatin|carboplatin
389183|NCT01289353|chemotherapy|chemotherapy
389184|NCT01289353|radiation therapy|radiation therapy
389185|NCT01289353|chemo-radiotherapy|chemo-radiotherapy
389186|NCT01289353|accelerated radiotherapy|accelerated radiotherapy
389187|NCT01289340|wound healing|wound healing
389188|NCT01289340|pain|pain
389189|NCT01289340|burn|burn
389190|NCT01289314|total laparoscopic hysterectomy|total laparoscopic hysterectomy
389191|NCT01289314|laparoscopic supracervical hysterectomy|laparoscopic supracervical hysterectomy
380047|NCT01326494|Asthma|asthma
389192|NCT01289301|renal transplantation|renal transplantation
389193|NCT01289301|polyoma BK virus infection|polyoma bk virus infection
389194|NCT01289301|everolimus|everolimus
389195|NCT01289301|calcineurin inhibitor|calcineurin inhibitor
389196|NCT01289301|mTOR inhibitor|mtor inhibitor
389197|NCT01289288|colorectal cancer screening|colorectal cancer screening
389198|NCT01289288|Chinese Americans|chinese americans
389199|NCT01289288|patients nonadherent with CRC Screening|patients nonadherent with crc screening
389200|NCT01289275|tobacco cessation|tobacco cessation
389201|NCT01289275|smoking cessation|smoking cessation
389202|NCT01289275|telephone|telephone
389203|NCT01289275|self-help|self-help
389204|NCT01289275|smoking abstinence|smoking abstinence
389205|NCT01289275|tobacco use disorder|tobacco use disorder
389206|NCT01289275|hospital|hospital
389207|NCT01289275|cardiopulmonary diseases|cardiopulmonary diseases
389208|NCT01289275|disparity|disparity
389209|NCT01289262|Cesarean section|cesarean section
389210|NCT01289262|Kerr incision|kerr incision
389211|NCT01289262|Purse string suturing in CS|purse string suturing in cs
389212|NCT01289262|Continuous locked suturing in CS|continuous locked suturing in cs
389213|NCT01289249|meropenem|meropenem
389214|NCT01289249|child|child
389215|NCT01289249|bacterial infection|bacterial infection
389216|NCT01289249|treatment evaluation|treatment evaluation
389217|NCT01289236|Shoulder Pain|shoulder pain
389218|NCT01289223|Indolent B-cell NHL, bendamustine, rituximab, progression-free survival|indolent b-cell nhl, bendamustine, rituximab, progression-free survival
389219|NCT01289210|B cell|b cell
389220|NCT01289210|lymphoma|lymphoma
389221|NCT01289184|Occupational Health Hazards|occupational health hazards
389222|NCT01289184|Air Pollution|air pollution
389223|NCT01289184|Photocopiers|photocopiers
389224|NCT01289184|Other Specified Personal Exposures|other specified personal exposures
389225|NCT01289184|History Presenting Hazards to Health|history presenting hazards to health
402064|NCT01233323|Heart Diseases|heart diseases
402065|NCT01233310|Crohn's Disease|crohn's disease
402066|NCT01233297|wheeze|wheeze
402067|NCT01233297|infections|infections
389226|NCT01289171|The efficacy, tolerability and safety of 15% glycolic acid lotion for treatment of diffuse flat warts among HIV+ children were investigated|the efficacy, tolerability and safety of 15% glycolic acid lotion for treatment of diffuse flat warts among hiv+ children were investigated
389227|NCT01289158|malonic and methylmalonic aciduria|malonic and methylmalonic aciduria
389228|NCT01289158|malonyl-coenzyme A decarboxylase|malonyl-coenzyme a decarboxylase
389229|NCT01289158|MLYCD|mlycd
389230|NCT01289145|Action Planning|action planning
389231|NCT01289145|Positive Outcome Expectancies|positive outcome expectancies
389232|NCT01289145|Randomized Controlled Trial|randomized controlled trial
389233|NCT01289145|Stages of change|stages of change
389234|NCT01289145|Health behavior|health behavior
389235|NCT01289145|Motivation|motivation
389236|NCT01289132|Drug Therapy|drug therapy
389237|NCT01289119|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
389238|NCT01289119|Drug Therapy|drug therapy
389239|NCT01289106|Hepatitis B vaccine|hepatitis b vaccine
389240|NCT01289106|HIV infection|hiv infection
389241|NCT01289106|Modified HBV vaccine dose|modified hbv vaccine dose
389242|NCT01289106|Modified HBV vaccine schedule|modified hbv vaccine schedule
389243|NCT01289093|inguinal hernia|inguinal hernia
389244|NCT01289093|incisional hernia|incisional hernia
389245|NCT01289093|quality of life|quality of life
389246|NCT01289093|disease-specific|disease-specific
389247|NCT01289080|Schizophrenia|schizophrenia
389248|NCT01289080|psychiatric disorders|psychiatric disorders
389249|NCT01289080|renal failure|renal failure
389250|NCT01289067|Metastatic|metastatic
389251|NCT01289067|Castration Resistant|castration resistant
389252|NCT01289067|Prostate Cancer|prostate cancer
389253|NCT01289054|Female|female
389254|NCT01289054|Pregnancy|pregnancy
389255|NCT01289054|Hematologic Pregnancy|hematologic pregnancy
389256|NCT01289054|Complications|complications
389257|NCT01289054|Registry|registry
389258|NCT01289054|Pregnant Registry|pregnant registry
389259|NCT01289054|CML|cml
389260|NCT01289054|GIST|gist
389261|NCT01289054|Gleevec|gleevec
389262|NCT01289054|Tasigna|tasigna
389263|NCT01289054|Glivec|glivec
389264|NCT01289054|Pregnancy Exposure|pregnancy exposure
389265|NCT01289041|Advanced endometrial cancer|advanced endometrial cancer
389266|NCT01289041|PI3K pathway|pi3k pathway
389267|NCT01289041|second-line treatment|second-line treatment
389268|NCT01289028|GIST|gist
389269|NCT01289028|Imatinib|imatinib
389270|NCT01289028|Sunitinib|sunitinib
389271|NCT01289028|Gastrointestinal|gastrointestinal
389272|NCT01289028|Stromal|stromal
389273|NCT01289028|Tumors|tumors
389274|NCT01289015|fungal infection|fungal infection
389275|NCT01289015|athlete foot|athlete foot
389276|NCT01288989|Advanced Solid Tumors|advanced solid tumors
389277|NCT01288976|Mitral Valve|mitral valve
389278|NCT01288976|Mitral Regurgitation|mitral regurgitation
389279|NCT01288976|MitraClip|mitraclip
389280|NCT01288976|Mitral Valve Surgery|mitral valve surgery
475014|NCT00085683|HV|hv
389281|NCT01288976|Mitral Valve Insufficiency or Mitral Regurgitation|mitral valve insufficiency or mitral regurgitation
389282|NCT01288963|melanoma|melanoma
389283|NCT01288963|IL-2|il-2
389284|NCT01288963|Aldesleukin|aldesleukin
389285|NCT01288950|BCG vaccine|bcg vaccine
389286|NCT01288950|Vitamin D|vitamin d
389287|NCT01288950|Cholecalciferol|cholecalciferol
389288|NCT01288950|Tuberculosis|tuberculosis
389289|NCT01288937|Milnacipran|milnacipran
389290|NCT01288937|Idiopathic Peripheral Neuropathy|idiopathic peripheral neuropathy
389291|NCT01288937|Diabetic neuropathy|diabetic neuropathy
389292|NCT01288937|Neuropathic pain|neuropathic pain
389293|NCT01288911|Metastatic|metastatic
389294|NCT01288911|MDV3100|mdv3100
389295|NCT01288911|Prostate|prostate
389296|NCT01288911|progressive|progressive
389297|NCT01288911|Cancer|cancer
389298|NCT01288911|enzalutamide|enzalutamide
389299|NCT01288898|ASP1941|asp1941
389300|NCT01288898|Diabetes Mellitus|diabetes mellitus
389301|NCT01288898|Multiple ascending doses|multiple ascending doses
389302|NCT01288898|Healthy subjects|healthy subjects
389303|NCT01288885|ASP1941|asp1941
389304|NCT01288885|Diabetes Mellitus|diabetes mellitus
389305|NCT01288885|First in Men|first in men
389405|NCT01288430|Epidermal growth factor receptor|epidermal growth factor receptor
389306|NCT01288872|Praziquantal, Schistosomiasis, pregnant women, Philippines|praziquantal, schistosomiasis, pregnant women, philippines
389307|NCT01288859|polyphenols|polyphenols
389308|NCT01288859|curcumin|curcumin
389309|NCT01288859|bioavailability|bioavailability
389310|NCT01288859|cocoa|cocoa
389311|NCT01288846|medication list|medication list
389312|NCT01288846|changes in medication|changes in medication
389313|NCT01288846|prescription medication|prescription medication
389314|NCT01288833|Colonoscopy|colonoscopy
389315|NCT01288833|Diagnostic Imaging|diagnostic imaging
389316|NCT01288833|Colorectal Neoplasm|colorectal neoplasm
389317|NCT01288833|Primary Prevention|primary prevention
389318|NCT01288833|Cost and Cost Analysis|cost and cost analysis
389319|NCT01288833|Endoscopy|endoscopy
389320|NCT01288807|Fibromyalgia|fibromyalgia
389321|NCT01288807|pain|pain
389322|NCT01288794|Cirrhosis|cirrhosis
389323|NCT01288794|Uncomplicated ascites|uncomplicated ascites
389324|NCT01288794|Refractory ascites|refractory ascites
389325|NCT01288794|Chronic albumin treatment|chronic albumin treatment
389326|NCT01288781|High Altitude Headache; intra-cranial pressure; hypoxia|high altitude headache; intra-cranial pressure; hypoxia
389327|NCT01288768|Meniscal injury|meniscal injury
389328|NCT01288768|Knee arthroscopy|knee arthroscopy
389329|NCT01288768|Middleaged|middleaged
389330|NCT01288768|Functional outcome|functional outcome
389331|NCT01288755|TMC278-TiDP6-C153|tmc278-tidp6-c153
389332|NCT01288755|TMC278-C153|tmc278-c153
389333|NCT01288755|TMC278|tmc278
389334|NCT01288755|HIV|hiv
389335|NCT01288742|TMC435-TiDP16-C108|tmc435-tidp16-c108
389336|NCT01288742|TMC435-C108|tmc435-c108
389337|NCT01288742|TMC435|tmc435
389338|NCT01288742|HPC|hpc
389339|NCT01288742|HCV|hcv
389340|NCT01288742|Hepatitis C|hepatitis c
389341|NCT01288716|ASD|asd
389342|NCT01288716|Autism|autism
389343|NCT01288716|Asperger Syndrome|asperger syndrome
389344|NCT01288703|urinary incontinence|urinary incontinence
389345|NCT01288690|Refugees|refugees
389346|NCT01288690|Trauma|trauma
389347|NCT01288690|Narrative|narrative
389348|NCT01288690|Exposure|exposure
389349|NCT01288690|Middle East|middle east
389350|NCT01288690|Therapy|therapy
391204|NCT01279980|Painbuster|painbuster
389351|NCT01288677|Healthy volunteer|healthy volunteer
389352|NCT01288677|TMC649128HPC1001|tmc649128hpc1001
389353|NCT01288677|TMC649128|tmc649128
389355|NCT01288677|Hepatitis C|hepatitis c
389356|NCT01288677|healthy volunteers|healthy volunteers
389357|NCT01288677|Phase I trial|phase i trial
389358|NCT01288664|Lupus Nephritis|lupus nephritis
389359|NCT01288664|Tacrolimus|tacrolimus
389360|NCT01288664|Induction Phase|induction phase
389361|NCT01288651|Pulmonary arterial hypertension|pulmonary arterial hypertension
389362|NCT01288651|Iron deficiency|iron deficiency
389363|NCT01288651|Exercise|exercise
389364|NCT01288638|Polycystic Ovary Syndrome|polycystic ovary syndrome
389365|NCT01288638|Metabolic Syndrome|metabolic syndrome
389366|NCT01288638|Pulse|pulse
389367|NCT01288638|Lifestyle Intervention|lifestyle intervention
389368|NCT01288638|Aerobic Exercise|aerobic exercise
389369|NCT01288638|Diet|diet
389370|NCT01288625|Identify whether Cytofos can reduce the incidence and duration of HNC patients' oral mucositis caused by radiotherapy.|identify whether cytofos can reduce the incidence and duration of hnc patients' oral mucositis caused by radiotherapy.
389371|NCT01288612|Barrett's Esophagus|barrett's esophagus
389372|NCT01288599|Laparoscopy|laparoscopy
389373|NCT01288599|Randomized|randomized
389374|NCT01288599|Single port access|single port access
389375|NCT01288599|Adnexal disease|adnexal disease
389376|NCT01288599|LESS|less
389377|NCT01288586|Post Traumatic Arthritis|post traumatic arthritis
389378|NCT01288586|Rheumatoid Arthritis|rheumatoid arthritis
389379|NCT01288586|Osteoarthritis|osteoarthritis
389380|NCT01288560|medical imaging|medical imaging
389381|NCT01288560|heart failure|heart failure
389382|NCT01288560|morbidity and mortality|morbidity and mortality
389383|NCT01288560|PET/CT,CMR,SPECT, echo, coronary angiography|pet/ct,cmr,spect, echo, coronary angiography
389384|NCT01288560|knowledge translation|knowledge translation
389385|NCT01288560|cost effectiveness|cost effectiveness
389386|NCT01288560|quality of life|quality of life
389387|NCT01288560|prospective comparative effectiveness randomized clinical trial|prospective comparative effectiveness randomized clinical trial
389388|NCT01288547|cognition|cognition
389389|NCT01288547|attention|attention
389390|NCT01288547|methylxanthine|methylxanthine
389391|NCT01288521|kidney transplantation|kidney transplantation
389392|NCT01288521|tacrolimus|tacrolimus
389393|NCT01288521|P-glycoprotein|p-glycoprotein
389394|NCT01288521|ABCB1|abcb1
389395|NCT01288521|genotyping|genotyping
389396|NCT01288482|Methacholine challenge|methacholine challenge
389397|NCT01288482|nebulizer|nebulizer
389398|NCT01288482|English-Wright|english-wright
389399|NCT01288482|AeroEclipse II|aeroeclipse ii
389400|NCT01288469|10020603|10020603
389401|NCT01288456|medical device, space-occupying device|medical device, space-occupying device
389402|NCT01288430|Heat shock protein 90|heat shock protein 90
389403|NCT01288430|Advanced solid tumors|advanced solid tumors
389404|NCT01288430|Non-small cell lung carcinoma|non-small cell lung carcinoma
389406|NCT01288430|Tyrosine kinase inhibitor acquired resistance|tyrosine kinase inhibitor acquired resistance
7809|NCT03240536|Choosing Wisely|choosing wisely
7810|NCT03240510|Breast cancer|breast cancer
389407|NCT01288430|Non-small cell lung carcinoma with acquired resistance to erlotinib, gefitinib, afatinib or others.|non-small cell lung carcinoma with acquired resistance to erlotinib, gefitinib, afatinib or others.
389408|NCT01288417|HIV infections|hiv infections
389409|NCT01288417|HCV infections|hcv infections
389410|NCT01288417|interaction|interaction
389411|NCT01288417|pharmacokinetics|pharmacokinetics
389412|NCT01288417|raltegravir|raltegravir
389413|NCT01288417|boceprevir|boceprevir
389414|NCT01288404|Bevacizumab, impending recurrent pterygium|bevacizumab, impending recurrent pterygium
389415|NCT01288378|fungal infection|fungal infection
389416|NCT01288378|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
389417|NCT01288378|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
389418|NCT01288378|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
389419|NCT01288378|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
389420|NCT01288378|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
389421|NCT01288378|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
389422|NCT01288378|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
389423|NCT01288378|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
389424|NCT01288378|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
389425|NCT01288378|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
389426|NCT01288378|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
389427|NCT01288378|secondary acute myeloid leukemia|secondary acute myeloid leukemia
389428|NCT01288365|heart failure|heart failure
389429|NCT01288365|preserved ejection fraction|preserved ejection fraction
389430|NCT01288352|early treatment|early treatment
389431|NCT01288352|rhythm control|rhythm control
389432|NCT01288352|atrial fibrillation|atrial fibrillation
389433|NCT01288352|cardiovascular complications|cardiovascular complications
389434|NCT01288313|human milk|human milk
389435|NCT01288313|polyunsaturated fatty acids|polyunsaturated fatty acids
389436|NCT01288313|linolenic acid|linolenic acid
389437|NCT01288313|rapeseed oil|rapeseed oil
389438|NCT01288287|Certolizumab pegol|certolizumab pegol
389439|NCT01288287|Cimzia®|cimzia®
389440|NCT01288274|Contraception|contraception
389441|NCT01288274|Family planning|family planning
389442|NCT01288274|Task Shifting|task shifting
389443|NCT01288274|Community based distribution|community based distribution
389444|NCT01288274|Ethiopia|ethiopia
389447|NCT01288248|Airway laryngeal mask|airway laryngeal mask
389448|NCT01288248|Endotracheal tube|endotracheal tube
389449|NCT01288248|Respiration artificial|respiration artificial
389450|NCT01288248|Laryngospasm|laryngospasm
389451|NCT01288248|Safety of airway laryngeal mask|safety of airway laryngeal mask
389452|NCT01288235|proton radiotherapy|proton radiotherapy
389453|NCT01288222|acute myelogenous leukemia|acute myelogenous leukemia
389454|NCT01288222|hematopoietic cell transplantation|hematopoietic cell transplantation
389455|NCT01288222|unrelated donor|unrelated donor
389456|NCT01288209|Hepatitis C, Chronic|hepatitis c, chronic
389457|NCT01288209|Hepatitis C|hepatitis c
389458|NCT01288209|Hepatitis C virus|hepatitis c virus
389459|NCT01288209|Interferon Alfa-2a|interferon alfa-2a
389460|NCT01288209|Ribavirin|ribavirin
389461|NCT01288209|Viral RNA|viral rna
389462|NCT01288196|CNTO 6785|cnto 6785
389463|NCT01288196|Intravenous|intravenous
389464|NCT01288196|Subcutaneous|subcutaneous
389465|NCT01288196|Pharmacokinetics|pharmacokinetics
389466|NCT01288196|Immunogenicity|immunogenicity
389467|NCT01288196|Safety|safety
389468|NCT01288196|Tolerability|tolerability
389469|NCT01288183|tobacco|tobacco
389470|NCT01288183|smoking|smoking
389471|NCT01288183|tDCS|tdcs
389472|NCT01288183|DLPFC|dlpfc
389473|NCT01288170|cystic fibrosis, bioequivalence, pharmacokinetic, sputum, plasma|cystic fibrosis, bioequivalence, pharmacokinetic, sputum, plasma
389474|NCT01288157|healthy|healthy
389475|NCT01288157|adult|adult
389476|NCT01288157|Chinese|chinese
389477|NCT01288157|male|male
389478|NCT01288157|Simponi|simponi
389479|NCT01288157|CNTO 148|cnto 148
389480|NCT01288144|Screening|screening
389481|NCT01288144|Gestational diabetes mellitus|gestational diabetes mellitus
389482|NCT01288131|Anti-r-HuEpo antibody|anti-r-huepo antibody
389483|NCT01288131|Anti-r-HuEpo associated PRCA|anti-r-huepo associated prca
389484|NCT01288131|Treatment|treatment
389485|NCT01288131|Absolute reticulocyte count|absolute reticulocyte count
389486|NCT01288105|drug-eluting stents|drug-eluting stents
389487|NCT01288105|noncardiac surgery|noncardiac surgery
389488|NCT01288092|Metastatic breast cancer|metastatic breast cancer
389489|NCT01288092|HER2 negative|her2 negative
389490|NCT01288092|HR positive|hr positive
389491|NCT01288092|PI3K pathway|pi3k pathway
389492|NCT01288092|no more than 2 prior lines of chemotherapy|no more than 2 prior lines of chemotherapy
389493|NCT01288092|Metastatic Breast Cancer(MBC)|metastatic breast cancer(mbc)
389689|NCT01287208|Steps|steps
389494|NCT01288079|Major Depressive Disorder|major depressive disorder
389495|NCT01288079|MDD|mdd
389496|NCT01288079|Monotherapy|monotherapy
389497|NCT01288079|Inadequate Response to Antidepressant Therapy|inadequate response to antidepressant therapy
389498|NCT01288066|Shoulder|shoulder
389499|NCT01288066|Total arthroplasty|total arthroplasty
389500|NCT01288066|Hemiarthroplasty|hemiarthroplasty
389501|NCT01288066|Resurfacing|resurfacing
389503|NCT01288066|Constant score|constant score
389504|NCT01288040|stroke|stroke
389505|NCT01288040|treadmill|treadmill
389506|NCT01288040|walking|walking
389507|NCT01288040|hemiparesis|hemiparesis
389508|NCT01288040|training|training
389509|NCT01288014|immune response|immune response
389510|NCT01288014|varicella zoster virus (VZV)|varicella zoster virus (vzv)
402068|NCT01233271|algorithm|algorithm
389511|NCT01288014|cytokine levels|cytokine levels
389512|NCT01288014|immunization|immunization
389513|NCT01287975|Stroke Rehabilitation|stroke rehabilitation
389514|NCT01287975|Brain Computer Interface|brain computer interface
389515|NCT01287975|Upper Limb Rehabilitation|upper limb rehabilitation
389516|NCT01287975|EEG-based Motor Imagery|eeg-based motor imagery
389517|NCT01287975|Robotic Rehabilitation|robotic rehabilitation
389518|NCT01287975|Haptic Knob|haptic knob
389519|NCT01287962|Apatinib|apatinib
389520|NCT01287962|Non-small Cell Lung Cancer|non-small cell lung cancer
389521|NCT01287962|VEGFR TKIs|vegfr tkis
389522|NCT01287949|Diphtheria|diphtheria
389523|NCT01287949|Tetanus|tetanus
389524|NCT01287949|Poliomyelitis|poliomyelitis
389525|NCT01287949|Pertussis (acellular)|pertussis (acellular)
389526|NCT01287949|Biological/vaccine|biological/vaccine
389527|NCT01287936|Chronic Stroke|chronic stroke
389528|NCT01287936|Stable Stroke|stable stroke
389529|NCT01287923|Hematology|hematology
389530|NCT01287923|Secondary lymphoid organs|secondary lymphoid organs
389531|NCT01287910|Cardiac|cardiac
389532|NCT01287910|Angina|angina
389533|NCT01287910|Chest pain|chest pain
389534|NCT01287897|Crohn's Disease|crohn's disease
389535|NCT01287897|safety|safety
389536|NCT01287897|efficacy|efficacy
389537|NCT01287897|pharmacokinetics|pharmacokinetics
389538|NCT01287897|pharmacodynamics|pharmacodynamics
389539|NCT01287897|Crohn's Disease Activity Index (CDAI)|crohn's disease activity index (cdai)
389540|NCT01287884|ABG|abg
389541|NCT01287884|VBG|vbg
389542|NCT01287884|pH|ph
389543|NCT01287884|pCO2|pco2
389544|NCT01287871|Cervical Cancer Screening|cervical cancer screening
389545|NCT01287845|Prostate cancer|prostate cancer
389546|NCT01287845|Neoplasm|neoplasm
389547|NCT01287845|Diagnostic Imaging|diagnostic imaging
389548|NCT01287845|PET (Positron Emission Tomography) -tracer|pet (positron emission tomography) -tracer
389549|NCT01287845|PET-diagnosis|pet-diagnosis
389550|NCT01287832|Methicillin-resistant|methicillin-resistant
389551|NCT01287832|Staphylococcus aureus|staphylococcus aureus
389552|NCT01287806|ulinastatin|ulinastatin
389553|NCT01287806|inhalation injury|inhalation injury
389554|NCT01287780|Humans|humans
389555|NCT01287780|Prostheses and Implants|prostheses and implants
389556|NCT01287780|Gentamicin administration and dosage|gentamicin administration and dosage
389557|NCT01287780|Surgical sponges|surgical sponges
389558|NCT01287780|Treatment outcomes|treatment outcomes
389559|NCT01287767|Dementia|dementia
389560|NCT01287767|Depression|depression
389561|NCT01287767|Burden of care|burden of care
389562|NCT01287767|Psychosocial intervention|psychosocial intervention
389563|NCT01287767|Family home care|family home care
389564|NCT01287702|early feeding|early feeding
389565|NCT01287702|varices bleeding|varices bleeding
389566|NCT01287702|to evaluate impact of early feeding on early rebleeding after ligation of varices|to evaluate impact of early feeding on early rebleeding after ligation of varices
389567|NCT01287689|Non-interventional trial|non-interventional trial
389568|NCT01287689|immunodeficiency|immunodeficiency
389569|NCT01287689|outcome study, registry|outcome study, registry
389570|NCT01287689|long-term outcomes, drug utilization|long-term outcomes, drug utilization
389571|NCT01287689|effectiveness, treatment patterns|effectiveness, treatment patterns
389572|NCT01287689|patient characteristics under real life conditions|patient characteristics under real life conditions
389573|NCT01287689|factors for treatment success|factors for treatment success
389574|NCT01287689|long-term tolerability|long-term tolerability
389575|NCT01287689|quality of life|quality of life
389576|NCT01287637|Rectal cancer|rectal cancer
389577|NCT01287637|Temporary ileostomy|temporary ileostomy
389578|NCT01287637|Ealy reversal|ealy reversal
389579|NCT01287637|Morbidity|morbidity
389580|NCT01287637|Mortality|mortality
389581|NCT01287637|Quality of life|quality of life
389582|NCT01287637|Economic effect|economic effect
389583|NCT01287624|triple negative breast cancer|triple negative breast cancer
389584|NCT01287624|fine line chemotherapy|fine line chemotherapy
389585|NCT01287611|Cesarean section|cesarean section
389586|NCT01287611|Kerr incision|kerr incision
389587|NCT01287611|Purse string suturing in C/S|purse string suturing in c/s
389588|NCT01287611|Continuous locked suturing in C/S|continuous locked suturing in c/s
389589|NCT01287598|Phase I|phase i
389590|NCT01287598|Probe substrate|probe substrate
389591|NCT01287598|target therapy|target therapy
389592|NCT01287598|small molecule|small molecule
389593|NCT01287598|pharmacokinetics|pharmacokinetics
389594|NCT01287585|Hepatocellular carcinoma|hepatocellular carcinoma
389595|NCT01287585|Arginine|arginine
389596|NCT01287585|Arginine deiminase|arginine deiminase
389597|NCT01287585|ADI-PEG 20|adi-peg 20
389599|NCT01287572|sedation|sedation
389600|NCT01287572|procedure|procedure
389601|NCT01287572|PICU|picu
389602|NCT01287559|NEC|nec
389603|NCT01287559|Premature Infant|premature infant
389604|NCT01287533|Rheumatoid arthritis|rheumatoid arthritis
389605|NCT01287533|Glucocorticoid induced osteoporosis|glucocorticoid induced osteoporosis
389606|NCT01287533|Vertebral fracture|vertebral fracture
600488|NCT00581672|Black men|black men
389607|NCT01287507|VLBW, NEC, Late onset sepsis|vlbw, nec, late onset sepsis
389608|NCT01287494|elderly|elderly
389609|NCT01287494|care management|care management
389610|NCT01287494|primary care|primary care
389611|NCT01287481|Fibromyalgia|fibromyalgia
389612|NCT01287481|Behavioral interventions|behavioral interventions
389613|NCT01287481|Psychological interventions|psychological interventions
389614|NCT01287468|phytomedicines|phytomedicines
389615|NCT01287468|breast cancer|breast cancer
389616|NCT01287468|stromal fibroblasts|stromal fibroblasts
389617|NCT01287468|MDSCs|mdscs
389618|NCT01287468|functional mechanism|functional mechanism
389619|NCT01287455|Asthma|asthma
389620|NCT01287455|Vitamin D|vitamin d
389621|NCT01287455|airway reactivity|airway reactivity
389622|NCT01287455|metacholine challenge test|metacholine challenge test
389623|NCT01287429|Ultrasonography|ultrasonography
389624|NCT01287416|Suicide Intervention|suicide intervention
389625|NCT01287416|Applied Suicide Intervention Skills Training (ASIST)|applied suicide intervention skills training (asist)
389626|NCT01287416|Resilience Retreat|resilience retreat
389627|NCT01287416|First Nations|first nations
389628|NCT01287416|Suicide Intervention and Response Inventory (SIRI)|suicide intervention and response inventory (siri)
389629|NCT01287403|Cereals|cereals
389630|NCT01287403|Alkylresorcinols|alkylresorcinols
389631|NCT01287403|Betaine|betaine
389632|NCT01287403|Phenolics|phenolics
389633|NCT01287403|Plasma and urine cereal phytochemicals|plasma and urine cereal phytochemicals
389634|NCT01287390|squamous cell carcinoma|squamous cell carcinoma
389635|NCT01287390|oral cavity|oral cavity
389636|NCT01287390|oropharynx|oropharynx
389637|NCT01287390|hypopharynx|hypopharynx
389638|NCT01287390|larynx|larynx
389639|NCT01287377|tobacco cessation|tobacco cessation
389640|NCT01287377|smoking cessation|smoking cessation
389641|NCT01287377|nicotine|nicotine
389642|NCT01287377|counseling|counseling
389643|NCT01287377|telephone|telephone
389644|NCT01287377|self-help|self-help
389645|NCT01287377|smoking abstinence|smoking abstinence
389646|NCT01287377|tobacco use disorder|tobacco use disorder
389647|NCT01287377|nicotine replacement therapy|nicotine replacement therapy
389648|NCT01287364|perennial allergic rhinitis|perennial allergic rhinitis
389649|NCT01287364|PAR|par
389650|NCT01287351|Real-world|real-world
389651|NCT01287351|observational|observational
389652|NCT01287351|Fluticasone propionate|fluticasone propionate
389653|NCT01287351|Metred dose inhaler|metred dose inhaler
389654|NCT01287351|Extra-fine hydrofluoroalkane|extra-fine hydrofluoroalkane
389655|NCT01287351|Asthma management|asthma management
389656|NCT01287351|Inhaled corticosteroids|inhaled corticosteroids
389657|NCT01287351|Beclomethasone dipropionate|beclomethasone dipropionate
389658|NCT01287351|USA|usa
389659|NCT01287325|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
380525|NCT01324427|11-022|11-022
389660|NCT01287325|Cough|cough
389661|NCT01287325|DNK333|dnk333
389662|NCT01287312|We will treat children age 1 month to 20 years with recurrent TEF after surgical failure|we will treat children age 1 month to 20 years with recurrent tef after surgical failure
389663|NCT01287299|pregnancy|pregnancy
389664|NCT01287299|obesity|obesity
389665|NCT01287299|diet glycemic load|diet glycemic load
389666|NCT01287299|body composition|body composition
389667|NCT01287299|body fat|body fat
389668|NCT01287299|gestational weight gain|gestational weight gain
389669|NCT01287299|insulin resistance|insulin resistance
389670|NCT01287286|Cancers|cancers
389671|NCT01287286|Antrodia cinnamomea|antrodia cinnamomea
389672|NCT01287286|Chemotherapy|chemotherapy
389673|NCT01287286|Gastrointestinal Disorder|gastrointestinal disorder
389674|NCT01287273|frozen-thawed|frozen-thawed
389675|NCT01287273|IVF|ivf
389676|NCT01287273|incubation|incubation
389677|NCT01287273|pregnancy rate|pregnancy rate
389678|NCT01287273|Pregnancy rate of frozen-thawed embryos of IVF treatments|pregnancy rate of frozen-thawed embryos of ivf treatments
389679|NCT01287260|BAYA1040_Nifedipine|baya1040_nifedipine
389680|NCT01287260|Nifedipine|nifedipine
389681|NCT01287260|Essential hypertension|essential hypertension
389682|NCT01287260|Japanese Patients|japanese patients
389683|NCT01287260|Phase III|phase iii
389684|NCT01287260|13176|13176
389685|NCT01287247|Cervical dystonia|cervical dystonia
389686|NCT01287247|Blepharospasm|blepharospasm
389687|NCT01287208|Physical activity|physical activity
389688|NCT01287208|Accelerometer|accelerometer
389690|NCT01287208|Medical residents|medical residents
389691|NCT01287195|Ulcerative Colitis|ulcerative colitis
389692|NCT01287195|Inflammatory Bowel Disease|inflammatory bowel disease
389693|NCT01287182|Asymptomatic Myocardial Ischemic patients|asymptomatic myocardial ischemic patients
389694|NCT01287169|Bisphenol A|bisphenol a
389695|NCT01287156|Recruitment|recruitment
389697|NCT01287156|Screening|screening
389698|NCT01287156|Traumatic Brain Injury|traumatic brain injury
389699|NCT01287143|Fever|fever
389700|NCT01287143|Signs and Symptoms|signs and symptoms
389701|NCT01287143|Febrile Assessment Tool (FAST)|febrile assessment tool (fast)
389702|NCT01287130|Antibodies|antibodies
389703|NCT01287130|Pharmacokinetics|pharmacokinetics
389704|NCT01287130|Kinase Inhibitors|kinase inhibitors
389705|NCT01287130|Colon Cancer|colon cancer
389706|NCT01287130|K-Ras|k-ras
389707|NCT01287130|Colorectal Cancer|colorectal cancer
389708|NCT01287130|Solid Tumor|solid tumor
389709|NCT01287104|Leukemia/Lymphoma|leukemia/lymphoma
389710|NCT01287104|Hematologic Malignacies|hematologic malignacies
389711|NCT01287104|Leukemia|leukemia
389712|NCT01287104|Lymphoma|lymphoma
389713|NCT01287104|Ewing Sarcoma|ewing sarcoma
389714|NCT01287104|Rhabdomyosarcoma|rhabdomyosarcoma
389715|NCT01287104|Neuroblastoma|neuroblastoma
389716|NCT01287104|Healthy Donor|healthy donor
389717|NCT01287078|Chronic GVHD of the Lung|chronic gvhd of the lung
389718|NCT01287078|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
389719|NCT01287078|Inhaled Cyclosporine|inhaled cyclosporine
389720|NCT01287078|Graft-Versus-Host Disease|graft-versus-host disease
389721|NCT01287078|GVHD|gvhd
389722|NCT01287078|Bronchiolitis Obliterans|bronchiolitis obliterans
389723|NCT01287078|Lung|lung
389724|NCT01287065|Fluticasone furoate|fluticasone furoate
389725|NCT01287065|Vilanterol|vilanterol
389726|NCT01287065|Efficacy|efficacy
389727|NCT01287065|FEV1|fev1
389728|NCT01287065|FF/VI Inhalation powder|ff/vi inhalation powder
389729|NCT01287052|Migraine|migraine
389730|NCT01287052|Pediatric|pediatric
389731|NCT01287052|Adolescent|adolescent
389732|NCT01287052|Nitrous Oxide|nitrous oxide
389733|NCT01287026|MRI Catheterization|mri catheterization
389734|NCT01287026|Right Heart Catheterization|right heart catheterization
389735|NCT01287026|Pulmonary Artery Catheterization|pulmonary artery catheterization
389736|NCT01287026|MRI Safety|mri safety
389737|NCT01287026|Jugular Vein Catheterization|jugular vein catheterization
389738|NCT01287026|Heart Catheterization|heart catheterization
389739|NCT01287026|Heart Disease|heart disease
389740|NCT01287026|Cardiovascular Disease|cardiovascular disease
389741|NCT01287013|Image Guided Procedures|image guided procedures
389742|NCT01287013|Xperguide CT|xperguide ct
389743|NCT01287013|Electromagnetic Tracking|electromagnetic tracking
389744|NCT01287013|Navigation|navigation
389745|NCT01287013|Image Guided Procedure|image guided procedure
389746|NCT01287013|Cancer|cancer
389747|NCT01287013|Granuloma|granuloma
389748|NCT01287000|Respiratory Health Outcomes|respiratory health outcomes
389749|NCT01287000|Petroleum|petroleum
389750|NCT01287000|Dispersant(s)|dispersant(s)
389751|NCT01287000|Oil Spill|oil spill
389752|NCT01287000|Longitudinal Study|longitudinal study
389753|NCT01286987|BRCA1 Protein|brca1 protein
389754|NCT01286987|BRCA2 Protein|brca2 protein
389755|NCT01286961|Bowel preparation|bowel preparation
389756|NCT01286961|Polyethylene glycols|polyethylene glycols
389757|NCT01286961|Colonoscopy|colonoscopy
389758|NCT01286961|Outpatient|outpatient
389759|NCT01286948|LNG gel|lng gel
389760|NCT01286948|oral LNG|oral lng
389761|NCT01286948|follicle rupture|follicle rupture
389762|NCT01286948|intra-vaginal administration|intra-vaginal administration
389763|NCT01286948|growth of the leading follicle|growth of the leading follicle
389764|NCT01286948|preovulatory peak of serum luteinizing hormone|preovulatory peak of serum luteinizing hormone
389765|NCT01286948|characteristics of the cervical mucus|characteristics of the cervical mucus
389766|NCT01286948|serum levels of estradiol (E2) and progesterone (P)|serum levels of estradiol (e2) and progesterone (p)
389767|NCT01286935|Parkinson's Disease|parkinson's disease
389768|NCT01286935|PD|pd
389769|NCT01286935|Levodopa|levodopa
389770|NCT01286935|Patients with idiopathic Parkinson's Disease with motor fluctuations,|patients with idiopathic parkinson's disease with motor fluctuations,
389771|NCT01286922|diabetes|diabetes
389772|NCT01286922|exercise|exercise
389773|NCT01286922|insulin resistance|insulin resistance
389774|NCT01286922|interval training|interval training
389775|NCT01286922|physical activity|physical activity
389776|NCT01286909|Metabolic|metabolic
389777|NCT01286896|advanced solid tumors|advanced solid tumors
389778|NCT01286883|stem cell markers|stem cell markers
389779|NCT01286883|prognostic markers|prognostic markers
389780|NCT01286883|metastatic colorectal cancer|metastatic colorectal cancer
389781|NCT01286883|circulating tumor cells|circulating tumor cells
389782|NCT01286883|tumor microenvironment|tumor microenvironment
389783|NCT01286883|colorectal cancer|colorectal cancer
389784|NCT01286883|advanced colorectal cancer|advanced colorectal cancer
7812|NCT03240471|Distal radius fracture|distal radius fracture
389785|NCT01286870|Primary Breast Reconstruction|primary breast reconstruction
389786|NCT01286831|Accelerator Mass Spectrometry (AMS)|accelerator mass spectrometry (ams)
389788|NCT01286831|Absorption, Distribution, Metabolism and Excretion (ADME)|absorption, distribution, metabolism and excretion (adme)
389789|NCT01286831|Radiolabel|radiolabel
389790|NCT01286818|Colon Cancer|colon cancer
389791|NCT01286818|Rectal Cancer|rectal cancer
389792|NCT01286766|unresectable|unresectable
389793|NCT01286766|locally advanced|locally advanced
389794|NCT01286740|HIV-1|hiv-1
389795|NCT01286740|HIV|hiv
389796|NCT01286740|Treatment Experienced|treatment experienced
389797|NCT01286701|Bioequivalence|bioequivalence
389798|NCT01286701|crossover|crossover
389799|NCT01286701|Terbinafine hydrochloride|terbinafine hydrochloride
389800|NCT01286701|fed|fed
389801|NCT01286688|Bioequivalence|bioequivalence
389802|NCT01286688|crossover|crossover
389803|NCT01286688|Terbinafine hydrochloride|terbinafine hydrochloride
389804|NCT01286688|Fasting|fasting
389805|NCT01286675|ASCT|asct
389806|NCT01286675|G-CSF|g-csf
389807|NCT01286662|gardner syndrome|gardner syndrome
389808|NCT01286662|colorectal carcinoma|colorectal carcinoma
389809|NCT01286662|desmoid tumor|desmoid tumor
389810|NCT01286662|resection|resection
389811|NCT01286662|colon|colon
389812|NCT01286649|Alopecia|alopecia
389813|NCT01286649|Alopecia, Androgenetic|alopecia, androgenetic
389814|NCT01286649|Androgenetic Alopecia|androgenetic alopecia
389815|NCT01286636|artificial neural network|artificial neural network
389816|NCT01286610|vibration|vibration
389817|NCT01286610|ICU|icu
389818|NCT01286610|blood pressure|blood pressure
389819|NCT01286610|intracranial pressure|intracranial pressure
389820|NCT01286610|infection|infection
389821|NCT01286610|indirect calorimetry|indirect calorimetry
389822|NCT01286597|lactose intolerance|lactose intolerance
389823|NCT01286597|DNA sequencing|dna sequencing
389824|NCT01286597|psychosocial factors|psychosocial factors
389825|NCT01286597|irritable bowel syndrome|irritable bowel syndrome
389826|NCT01286597|visceral hypersensitivity|visceral hypersensitivity
389827|NCT01286584|varenicline|varenicline
389828|NCT01286584|alcohol|alcohol
389829|NCT01286584|placebo|placebo
389830|NCT01286584|smoking cessation|smoking cessation
389831|NCT01286545|Ankylosing spondylitis|ankylosing spondylitis
389832|NCT01286545|Infliximab|infliximab
389833|NCT01286545|Radiographic progression|radiographic progression
389834|NCT01286532|Asthma, Asthma in Children|asthma, asthma in children
389835|NCT01286519|pharmacokinetics|pharmacokinetics
389836|NCT01286506|Pulse pressure variation|pulse pressure variation
389837|NCT01286506|Continuous venovenous hemodialysis|continuous venovenous hemodialysis
389838|NCT01286506|Volume status|volume status
389839|NCT01286506|Critical care|critical care
389840|NCT01286493|HIV|hiv
389841|NCT01286493|booster|booster
389842|NCT01286493|rabies|rabies
389843|NCT01286493|immune response|immune response
389844|NCT01286480|Health Care Transition|health care transition
389845|NCT01286480|Adolescent|adolescent
389846|NCT01286467|PF-04449913|pf-04449913
389847|NCT01286467|Hedgehog Inhibitor|hedgehog inhibitor
389848|NCT01286467|Solid tumor|solid tumor
389849|NCT01286467|Pharmacokinetics|pharmacokinetics
389850|NCT01286467|Safety|safety
389851|NCT01286467|Pharmacodynamics|pharmacodynamics
389852|NCT01286454|BIOAVAILABILITY|bioavailability
389853|NCT01286454|FOOD EFFECT|food effect
389854|NCT01286441|Verruca vulgaris|verruca vulgaris
389855|NCT01286428|liver|liver
389856|NCT01286428|cancer|cancer
389857|NCT01286428|tumor|tumor
389858|NCT01286428|ablation|ablation
389859|NCT01286428|Pathfinder|pathfinder
389860|NCT01286415|Posttraumatic Stress Disorder|posttraumatic stress disorder
389861|NCT01286415|Cognitive Processing Therapy|cognitive processing therapy
389862|NCT01286415|combat|combat
389863|NCT01286415|military|military
389864|NCT01286415|CPT|cpt
389865|NCT01286415|group therapy|group therapy
389866|NCT01286402|Smoking cessation during pregnancy|smoking cessation during pregnancy
389867|NCT01286402|bupropion|bupropion
389868|NCT01286389|Mild cognitive impairment|mild cognitive impairment
389869|NCT01286389|Dementia|dementia
389870|NCT01286389|Obesity|obesity
389871|NCT01286389|Overweight|overweight
389872|NCT01286389|diet|diet
389873|NCT01286389|caloric restriction|caloric restriction
389874|NCT01286389|body composition|body composition
389875|NCT01286389|weight loss|weight loss
389876|NCT01286376|Symbiotics|symbiotics
389877|NCT01286376|Fiber|fiber
389878|NCT01286376|Constipation|constipation
389879|NCT01286363|Bite force|bite force
389880|NCT01286363|Dental occlusion|dental occlusion
389881|NCT01286363|Face|face
389882|NCT01286363|Mastication|mastication
389883|NCT01286363|Morphology|morphology
389884|NCT01286350|motivational interviewing|motivational interviewing
389885|NCT01286350|problem solving skills training|problem solving skills training
389886|NCT01286350|family communication|family communication
389887|NCT01286350|social support|social support
389888|NCT01286350|adolescents|adolescents
389889|NCT01286337|axilla|axilla
389890|NCT01286337|surgery|surgery
389891|NCT01286337|technique|technique
389892|NCT01286337|bipolar vessel sealing|bipolar vessel sealing
389893|NCT01286324|Matricaria|matricaria
389894|NCT01286324|Chamomile|chamomile
389895|NCT01286324|Herb|herb
389896|NCT01286324|Insomnia|insomnia
389897|NCT01286311|Health Education|health education
389898|NCT01286311|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
389899|NCT01286311|Hypolipidemic Agents/therapeutic use|hypolipidemic agents/therapeutic use
389900|NCT01286311|Patient Education as Topic|patient education as topic
389901|NCT01286298|diode laser|diode laser
389902|NCT01286298|gingival enlargement|gingival enlargement
389903|NCT01286298|gingival overgrowth|gingival overgrowth
389904|NCT01286298|gingival hyperplasia|gingival hyperplasia
389905|NCT01286298|orthodontics|orthodontics
389906|NCT01286285|influenza|influenza
389907|NCT01286285|acute respiratory infections|acute respiratory infections
389908|NCT01286285|paediatric|paediatric
389909|NCT01286285|intensive care units|intensive care units
389910|NCT01286285|epidemiology|epidemiology
389911|NCT01286259|HIV|hiv
389912|NCT01286259|HAART suppressed|haart suppressed
389913|NCT01286259|Disulfiram|disulfiram
389914|NCT01286259|Antabuse|antabuse
389915|NCT01286259|Latent reservoir|latent reservoir
389916|NCT01286259|Eradication|eradication
389917|NCT01286259|Cure|cure
389918|NCT01286246|Progesterone|progesterone
389919|NCT01286246|Randomized controlled trial|randomized controlled trial
389920|NCT01286233|fatigue|fatigue
389921|NCT01286233|sleep disorders|sleep disorders
389922|NCT01286233|depression|depression
389923|NCT01286233|stage IA breast cancer|stage ia breast cancer
389924|NCT01286233|stage IB breast cancer|stage ib breast cancer
389925|NCT01286233|stage II breast cancer|stage ii breast cancer
389926|NCT01286233|stage IIIA breast cancer|stage iiia breast cancer
389927|NCT01286207|Migraine headache|migraine headache
389928|NCT01286181|COPD|copd
389929|NCT01286181|Biofeedback|biofeedback
389930|NCT01286181|Dyspnea|dyspnea
389931|NCT01286181|Quality of life|quality of life
389932|NCT01286181|Stress|stress
389933|NCT01286168|Bilateral breast mastectomy|bilateral breast mastectomy
391205|NCT01279980|Epidural|epidural
389934|NCT01286168|Immediate tissue expanders reconstruction|immediate tissue expanders reconstruction
389935|NCT01286155|Barrett's esophagus|barrett's esophagus
389936|NCT01286155|gastroesophageal reflux disease|gastroesophageal reflux disease
389937|NCT01286155|GERD|gerd
389938|NCT01286142|Prospective, Observational Safety Study|prospective, observational safety study
389939|NCT01286116|heart failure|heart failure
389940|NCT01286116|percutaneous|percutaneous
389941|NCT01286116|interventional cardiology|interventional cardiology
389942|NCT01286116|apical remodeling|apical remodeling
389943|NCT01286116|LV dilatation|lv dilatation
389944|NCT01286116|akinesis|akinesis
389945|NCT01286116|dyskinesis|dyskinesis
389946|NCT01286116|myocardial infarction|myocardial infarction
389947|NCT01286103|Canagliflozin|canagliflozin
389948|NCT01286103|Pharmacokinetics|pharmacokinetics
389949|NCT01286103|Pharmacodynamics|pharmacodynamics
389950|NCT01286090|Cisapride (PREPULSID)|cisapride (prepulsid)
389951|NCT01286090|Placebo|placebo
389952|NCT01286090|Diabetes mellitus|diabetes mellitus
389953|NCT01286090|Diabetic gastroparesis|diabetic gastroparesis
389954|NCT01286077|Multiple Myeloma|multiple myeloma
389955|NCT01286077|bortezomib|bortezomib
389956|NCT01286077|hematology|hematology
380822|NCT01323244|HCV|hcv
389957|NCT01286077|bone marrow cancer|bone marrow cancer
389958|NCT01286077|Myeloma-related bone disease|myeloma-related bone disease
389959|NCT01286077|bone mineral density|bone mineral density
389960|NCT01286077|bone markers|bone markers
389961|NCT01286064|adenocarcinoma,|adenocarcinoma,
389962|NCT01286064|colorectal tumors,|colorectal tumors,
389963|NCT01286064|endogenous porphyrins,|endogenous porphyrins,
389964|NCT01286064|fluorescence,|fluorescence,
389965|NCT01286064|tumor markers.|tumor markers.
389966|NCT01286051|ovulation induction, GnRH|ovulation induction, gnrh
389967|NCT01286038|platelets|platelets
389968|NCT01286025|medical education|medical education
389969|NCT01286025|problem-based learning|problem-based learning
389970|NCT01286025|interactive tutorial|interactive tutorial
389971|NCT01286012|End Stage Renal Disease, Hemodialysis, SFP|end stage renal disease, hemodialysis, sfp
389972|NCT01285986|Graft patency|graft patency
389973|NCT01285986|Limb salvage|limb salvage
389974|NCT01285960|Uterine fibroids|uterine fibroids
389975|NCT01285960|MRgFUS|mrgfus
389976|NCT01285960|ExAblate|exablate
389977|NCT01285960|Focused Ultrasound|focused ultrasound
389978|NCT01285960|Symptomatic uterine fibroids|symptomatic uterine fibroids
389979|NCT01285947|pain experience|pain experience
389980|NCT01285947|energy devices|energy devices
389981|NCT01285947|Ulthera|ulthera
389982|NCT01285947|Thermage|thermage
389983|NCT01285947|VBeam|vbeam
389984|NCT01285921|hippocampal|hippocampal
389985|NCT01285921|vestibular test|vestibular test
389986|NCT01285908|Baroreceptor|baroreceptor
389987|NCT01285908|Norepinephrine|norepinephrine
389988|NCT01285908|Orthostatic Hypotension|orthostatic hypotension
389989|NCT01285908|Sympathetic Nervous System|sympathetic nervous system
389990|NCT01285908|Blood Pressure|blood pressure
389991|NCT01285895|Lung and heart transplantations|lung and heart transplantations
389992|NCT01285895|Mucoviscidosis|mucoviscidosis
389993|NCT01285895|Educational needs|educational needs
389994|NCT01285882|Lung transplantations|lung transplantations
389995|NCT01285882|Representations|representations
389996|NCT01285882|Mucoviscidosis|mucoviscidosis
389997|NCT01285869|Pneumonia|pneumonia
389998|NCT01285869|Intervention Studies|intervention studies
389999|NCT01285869|Aged|aged
390000|NCT01285869|Aged, 80 and over|aged, 80 and over
390001|NCT01285869|Geriatric Assessment|geriatric assessment
390002|NCT01285856|patients|patients
390003|NCT01285856|illicit consumption of psychotropic agents and alcohol|illicit consumption of psychotropic agents and alcohol
390004|NCT01285856|buprenorphine|buprenorphine
390005|NCT01285856|methadone|methadone
390006|NCT01285830|Infants|infants
390007|NCT01285830|Probiotics|probiotics
390008|NCT01285830|Prevention|prevention
390009|NCT01285830|Lactobacillus reuteri|lactobacillus reuteri
390010|NCT01285830|Eczema|eczema
390011|NCT01285830|IgE|ige
390012|NCT01285830|Sensitization|sensitization
390013|NCT01285830|Microbiota|microbiota
390014|NCT01285830|Chemokines|chemokines
390015|NCT01285791|morbid obesity|morbid obesity
390016|NCT01285791|intra-abdominal visceral fat|intra-abdominal visceral fat
390017|NCT01285791|gastric bypass|gastric bypass
390018|NCT01285791|sleeve gastrectomy|sleeve gastrectomy
390019|NCT01285791|gastric banding|gastric banding
390020|NCT01285791|visceral fat|visceral fat
390021|NCT01285778|Anal squamous cell carcinoma|anal squamous cell carcinoma
390022|NCT01285778|panitumumab|panitumumab
390023|NCT01285778|chemoradiation|chemoradiation
390024|NCT01285778|anal cancer|anal cancer
390025|NCT01285778|GEMCAD-09-02|gemcad-09-02
390026|NCT01285739|Pulmonary Disease, Chronic Obstructive.|pulmonary disease, chronic obstructive.
390027|NCT01285739|Tracheostomy.|tracheostomy.
390028|NCT01285739|Invasive Mechanical Ventilation.|invasive mechanical ventilation.
390029|NCT01285739|Non-Invasive Mechanical Ventilation.|non-invasive mechanical ventilation.
390030|NCT01285726|Peritoneal dialysis|peritoneal dialysis
390031|NCT01285726|Hydration status|hydration status
390032|NCT01285726|Residual renal function|residual renal function
390033|NCT01285726|Bioimpedance spectroscopy|bioimpedance spectroscopy
390034|NCT01285726|Body composition monitor|body composition monitor
390035|NCT01285713|Dehydration|dehydration
390036|NCT01285713|Gastroenteritis|gastroenteritis
390037|NCT01285713|Dehydration in Gastroenteritis|dehydration in gastroenteritis
390038|NCT01285687|Tonsillectomy|tonsillectomy
390039|NCT01285687|Post-Operative Pain|post-operative pain
390040|NCT01285687|Acupuncture|acupuncture
390041|NCT01285674|cisplatin|cisplatin
390042|NCT01285674|ototoxicity|ototoxicity
390043|NCT01285674|intratympanic steroids|intratympanic steroids
390044|NCT01285661|Deep venous thrombosis|deep venous thrombosis
390045|NCT01285661|Pulmonary embolism|pulmonary embolism
390046|NCT01285661|Ultrasonography|ultrasonography
390047|NCT01285661|D-dimer|d-dimer
390048|NCT01285661|Venous thromboembolism|venous thromboembolism
390049|NCT01285661|Bleeding|bleeding
390050|NCT01285648|chest tubes,|chest tubes,
390051|NCT01285648|Continuous Positive Airway Pressure,|continuous positive airway pressure,
390052|NCT01285648|lung resection, thoracic surgery,|lung resection, thoracic surgery,
390053|NCT01285648|noninvasive ventilation,|noninvasive ventilation,
390054|NCT01285648|postoperative|postoperative
390055|NCT01285622|Surgery; gynecological|surgery; gynecological
390056|NCT01285622|Stroke volume|stroke volume
390057|NCT01285596|Pharmacokinetics|pharmacokinetics
390058|NCT01285596|Cardiography|cardiography
390059|NCT01285596|Impedance|impedance
390060|NCT01285596|Age groups|age groups
390061|NCT01285596|Gender Identity|gender identity
390062|NCT01285583|Amyotrophoc Lateral Sclerosis|amyotrophoc lateral sclerosis
390063|NCT01285583|TRO19622|tro19622
390064|NCT01285583|Olesoxime|olesoxime
390065|NCT01285583|Trophos|trophos
390066|NCT01285557|Gastric Cancer , S-1, Phase 3|gastric cancer , s-1, phase 3
390067|NCT01285544|statins|statins
390068|NCT01285544|cholesterol|cholesterol
390069|NCT01285544|hypercholesterolemia|hypercholesterolemia
390070|NCT01285544|atorvastatin|atorvastatin
390071|NCT01285544|Dyslipidemia in cardiovascular disease (KoLipinon)|dyslipidemia in cardiovascular disease (kolipinon)
390072|NCT01285531|lumbar puncture|lumbar puncture
390073|NCT01285531|Compass|compass
390074|NCT01285531|pressure transducer|pressure transducer
390075|NCT01285531|manometry|manometry
390076|NCT01285531|The focus of the study is to improve lumbar puncture(LP)success, reduce the number of LP attempts, reduce the number of traumatic attempts.|the focus of the study is to improve lumbar puncture(lp)success, reduce the number of lp attempts, reduce the number of traumatic attempts.
390077|NCT01285518|Type 2 diabetes|type 2 diabetes
390078|NCT01285518|intravenous|intravenous
390079|NCT01285518|single dose|single dose
390080|NCT01285505|alprazolam|alprazolam
390081|NCT01285505|sublingual|sublingual
390082|NCT01285505|bioequivalence|bioequivalence
390083|NCT01285492|COPD|copd
390085|NCT01285492|NVA237|nva237
390086|NCT01285492|indacaterol|indacaterol
390087|NCT01285492|combination bronchodilator|combination bronchodilator
390088|NCT01285479|Fingolimod|fingolimod
390089|NCT01285479|FTY720|fty720
390090|NCT01285479|Gilenya|gilenya
390091|NCT01285479|Multiple sclerosis|multiple sclerosis
390092|NCT01285479|MS|ms
390093|NCT01285479|Safety|safety
390094|NCT01285479|Pregnancy|pregnancy
390095|NCT01285479|Pregnancy outcomes|pregnancy outcomes
390096|NCT01285466|Cancer|cancer
390097|NCT01285466|BEZ235|bez235
390098|NCT01285466|BKM120|bkm120
390099|NCT01285466|paclitaxel|paclitaxel
390100|NCT01285466|trastuzumab|trastuzumab
390101|NCT01285453|ASA404,|asa404,
390102|NCT01285453|vadimezan,|vadimezan,
390103|NCT01285453|docetaxel|docetaxel
390104|NCT01285440|breast|breast
390105|NCT01285440|biopsy|biopsy
390106|NCT01285440|suspicious lesion|suspicious lesion
390107|NCT01285440|molecular breast imaging|molecular breast imaging
390108|NCT01285427|DNA, sequencing|dna, sequencing
390109|NCT01285427|Identification and definition of Class I and II Human Leukocyte Antigens (HLA)|identification and definition of class i and ii human leukocyte antigens (hla)
390110|NCT01285414|Glioblastoma|glioblastoma
390111|NCT01285414|Brain Neoplasms|brain neoplasms
390112|NCT01285414|Brain Cancer|brain cancer
390113|NCT01285414|Verubulin|verubulin
390114|NCT01285401|Multiple Sclerosis|multiple sclerosis
390115|NCT01285401|Rebif|rebif
390116|NCT01285401|VigantOL® oil|vigantol® oil
390117|NCT01285401|Vitamin D|vitamin d
390118|NCT01285401|Add-on treatment|add-on treatment
390119|NCT01285388|Safety|safety
390120|NCT01285388|Tolerability|tolerability
390121|NCT01285388|Pharmacokinetic|pharmacokinetic
390122|NCT01285362|Fatty Liver Disease|fatty liver disease
390123|NCT01285362|Hepatic Steatosis|hepatic steatosis
390124|NCT01285362|Docosahexaenoic Acid|docosahexaenoic acid
390125|NCT01285362|Eicosapentanoic Acid|eicosapentanoic acid
390126|NCT01285362|Omega-3 Fatty Acids|omega-3 fatty acids
390127|NCT01285362|Elevated Transaminases|elevated transaminases
390128|NCT01285362|Fish oil supplements|fish oil supplements
390129|NCT01285349|HIV, STI, condom use, drug use,|hiv, sti, condom use, drug use,
390130|NCT01285336|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
391976|NCT01276873|Nursing|nursing
390131|NCT01285336|DNA repair system|dna repair system
390132|NCT01285336|polymorphism|polymorphism
390133|NCT01285336|susceptibility|susceptibility
390134|NCT01285336|copy number variation (CNV)|copy number variation (cnv)
390135|NCT01285310|Rheumatoid, Arthritis|rheumatoid, arthritis
390136|NCT01285297|Transmyocardial revascularization (TMR)|transmyocardial revascularization (tmr)
390137|NCT01285297|Bone marrow aspirate concentrate (BMAC)|bone marrow aspirate concentrate (bmac)
390138|NCT01285297|Angina|angina
390139|NCT01285284|Colonoscopy|colonoscopy
390140|NCT01285284|Music|music
390141|NCT01285284|Tolerance|tolerance
390142|NCT01285284|Pain|pain
390143|NCT01285284|Anxiety|anxiety
390144|NCT01285284|Dose of sedative drugs administered during the procedure|dose of sedative drugs administered during the procedure
390145|NCT01285271|xenon|xenon
390146|NCT01285271|sevoflurane|sevoflurane
390147|NCT01285271|cardiac anesthesia|cardiac anesthesia
390148|NCT01285271|CABG|cabg
390149|NCT01285271|Bypass surgery|bypass surgery
390150|NCT01285258|Peripartum|peripartum
390151|NCT01285258|hysterectomy|hysterectomy
381025|NCT01322373|MEG|meg
390152|NCT01285258|placenta accreta|placenta accreta
390153|NCT01285258|mortality|mortality
390154|NCT01285245|insulin sensitivity|insulin sensitivity
390155|NCT01285245|interleukin-1 receptor antagonist|interleukin-1 receptor antagonist
390156|NCT01285245|inflammation|inflammation
390157|NCT01285245|hyperglycemia-induced insulin resistance|hyperglycemia-induced insulin resistance
390158|NCT01285219|Granulocyte colony-stimulating factor , recombinant|granulocyte colony-stimulating factor , recombinant
390159|NCT01285219|Polyethylene glycols|polyethylene glycols
390160|NCT01285219|Neutropenia|neutropenia
390161|NCT01285219|Drug therapy, combination|drug therapy, combination
390162|NCT01285193|hypertension|hypertension
390163|NCT01285193|high blood pressure|high blood pressure
390164|NCT01285193|treatment|treatment
390165|NCT01285193|breath control|breath control
390166|NCT01285193|breathing exercise|breathing exercise
390167|NCT01285193|audio CD|audio cd
390168|NCT01285180|COPD|copd
390169|NCT01285180|Quality of life|quality of life
390170|NCT01285180|sociodemographic data|sociodemographic data
390171|NCT01285180|cost-of-illness data|cost-of-illness data
390172|NCT01285180|roflumilast|roflumilast
390173|NCT01285180|Daxas|daxas
390174|NCT01285167|COPD|copd
390175|NCT01285167|Quality of life|quality of life
390176|NCT01285167|lung function|lung function
390177|NCT01285167|spirometry|spirometry
390178|NCT01285167|roflumilast|roflumilast
390179|NCT01285167|Daxas|daxas
390180|NCT01285167|severe COPD|severe copd
390181|NCT01285154|Hip dysplasia|hip dysplasia
390182|NCT01285154|Triple Osteotomy|triple osteotomy
390183|NCT01285154|Femoral Head Coverage|femoral head coverage
390184|NCT01285154|Femoral Head Medialization|femoral head medialization
390185|NCT01285141|HIV Infections|hiv infections
390186|NCT01285141|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
390187|NCT01285115|Generalized anxiety disorder|generalized anxiety disorder
390188|NCT01285115|Jingji-zhengchong|jingji-zhengchong
390189|NCT01285115|Gamisoyosan|gamisoyosan
390190|NCT01285115|anxiety|anxiety
390191|NCT01285063|overweight|overweight
390192|NCT01285063|obesity|obesity
390193|NCT01285063|physical fitness|physical fitness
390194|NCT01285063|kinder garden|kinder garden
390195|NCT01285063|preschool|preschool
390197|NCT01285050|Human immunodeficiency virus|human immunodeficiency virus
390198|NCT01285050|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
390199|NCT01285050|AIDS Virus|aids virus
390200|NCT01285050|Immunodeficiency Virus, Human|immunodeficiency virus, human
390201|NCT01285050|Virus, Human Immunodeficiency|virus, human immunodeficiency
390202|NCT01285050|Hepatitis C|hepatitis c
390203|NCT01285050|Hepatitis C, chronic|hepatitis c, chronic
390204|NCT01285050|Hepatitis C virus|hepatitis c virus
390205|NCT01285050|Hepatitis C antibodies|hepatitis c antibodies
390206|NCT01285050|Hepatitis C antigens|hepatitis c antigens
390207|NCT01285024|total hip arthroplasty|total hip arthroplasty
390208|NCT01285024|transfusion|transfusion
390209|NCT01285024|hemostat|hemostat
390210|NCT01285011|arthrodesis|arthrodesis
390211|NCT01285011|PIP joint|pip joint
390212|NCT01284998|forefoot deformities|forefoot deformities
390213|NCT01284998|basal osteotomy|basal osteotomy
390214|NCT01284959|cognitive function|cognitive function
390215|NCT01284959|subjective experiences|subjective experiences
390216|NCT01284959|neuroleptic-induced deficit syndrome|neuroleptic-induced deficit syndrome
390217|NCT01284959|paliperidone extended-release|paliperidone extended-release
390218|NCT01284959|risperidone|risperidone
390219|NCT01284946|PCT sporadic or familial|pct sporadic or familial
390220|NCT01284946|Skin fragility and bullae lesions|skin fragility and bullae lesions
390221|NCT01284946|non-transfusion iron overload|non-transfusion iron overload
390222|NCT01284933|Stroke|stroke
390223|NCT01284933|Ischemic Attack, Transient|ischemic attack, transient
390224|NCT01284933|Magnetic Resonance Imaging|magnetic resonance imaging
390225|NCT01284933|Carotid Arteries|carotid arteries
390226|NCT01284933|Carotid Artery Plaque|carotid artery plaque
390227|NCT01284933|Atherosclerosis|atherosclerosis
390229|NCT01284920|Response Evaluation Criteria in Solid Tumor (RECIST)|response evaluation criteria in solid tumor (recist)
390230|NCT01284920|docetaxel|docetaxel
390231|NCT01284920|PSA level|psa level
390232|NCT01284907|Asthma|asthma
390233|NCT01284907|Asthma therapy|asthma therapy
390234|NCT01284907|Randomized controlled trial|randomized controlled trial
390235|NCT01284907|children|children
390236|NCT01284894|Dysphagia|dysphagia
390237|NCT01284894|Conventional manometry|conventional manometry
390238|NCT01284894|High resolution manometry|high resolution manometry
390240|NCT01284881|compliance|compliance
390241|NCT01284881|OSAHS|osahs
390242|NCT01284868|Mechanisms of Pharmacological Action|mechanisms of pharmacological action
390243|NCT01284868|Pharmacodynamics|pharmacodynamics
390244|NCT01284868|Pharmacokinetics|pharmacokinetics
390245|NCT01284855|neurotoxic envenoming (WHO ICD-10 T63.0)|neurotoxic envenoming (who icd-10 t63.0)
390246|NCT01284842|sleep-deprivation|sleep-deprivation
390247|NCT01284842|virtual reality|virtual reality
390248|NCT01284842|residency|residency
390249|NCT01284842|performance|performance
390250|NCT01284816|severely obese patients|severely obese patients
390251|NCT01284803|patients|patients
390252|NCT01284803|moderate depression|moderate depression
390253|NCT01284777|cancerology|cancerology
390254|NCT01284777|genetic|genetic
390255|NCT01284764|Endoscopy|endoscopy
390256|NCT01284764|Gastrectomy|gastrectomy
390257|NCT01284764|Stomach neoplasms|stomach neoplasms
390258|NCT01284738|TM|tm
390259|NCT01284738|TI|ti
390260|NCT01284738|MP|mp
390261|NCT01284712|treatment by bleedings|treatment by bleedings
390262|NCT01284699|Parkinson|parkinson
390263|NCT01284699|contraindication to Intracerebral electrode implantation|contraindication to intracerebral electrode implantation
390264|NCT01284699|Gamma Knife radiosurgery|gamma knife radiosurgery
390265|NCT01284686|Pathophysiology|pathophysiology
390266|NCT01284686|Parkinson|parkinson
390267|NCT01284686|neuronal oscillations|neuronal oscillations
390268|NCT01284673|Cord blood stem|cord blood stem
390269|NCT01284673|neonatal asphyxia|neonatal asphyxia
390270|NCT01284647|Chronic Erosive Gastritis|chronic erosive gastritis
390271|NCT01284647|Teprenone|teprenone
390272|NCT01284647|Sucralfate|sucralfate
390273|NCT01284634|Cannabidiol|cannabidiol
390274|NCT01284634|Fatty liver|fatty liver
390275|NCT01284634|Diabetes|diabetes
390276|NCT01284634|Body fat|body fat
390277|NCT01284608|Observational|observational
390278|NCT01284608|prospective|prospective
390279|NCT01284608|metabolic changes|metabolic changes
390280|NCT01284608|metabolic syndrome|metabolic syndrome
390281|NCT01284608|diabetes|diabetes
390282|NCT01284608|prostatic cancer|prostatic cancer
390283|NCT01284608|risk fracture|risk fracture
390284|NCT01284595|Radioactive carbon|radioactive carbon
390285|NCT01284595|Absorption|absorption
390286|NCT01284595|Distribution|distribution
390287|NCT01284595|Metabolism|metabolism
390288|NCT01284595|Excretion|excretion
390289|NCT01284595|Healthy Volunteers|healthy volunteers
390290|NCT01284582|CETP|cetp
390291|NCT01284582|Vaccine|vaccine
390292|NCT01284582|Cholesterol|cholesterol
390293|NCT01284582|Inhibition|inhibition
390294|NCT01284556|partial onset seizures|partial onset seizures
390295|NCT01284530|Epilepsy|epilepsy
390296|NCT01284530|Pediatrics|pediatrics
390297|NCT01284530|Young Adults|young adults
390298|NCT01284517|Bipolar I Depression|bipolar i depression
390299|NCT01284517|Lurasidone|lurasidone
390300|NCT01284517|Latuda|latuda
390301|NCT01284491|Breast reduction|breast reduction
390302|NCT01284491|PlasmaBlade|plasmablade
390303|NCT01284491|Electrosurgery|electrosurgery
390304|NCT01284491|PEAK Surgical|peak surgical
390305|NCT01284491|Medtronic Advanced Energy|medtronic advanced energy
390306|NCT01284491|Medtronic|medtronic
390307|NCT01284478|pseudophakic cystoid macular edema, diabetic macular edema, Irvine Gass Syndrome, cataract surgery, ozurdex, dexamethasone|pseudophakic cystoid macular edema, diabetic macular edema, irvine gass syndrome, cataract surgery, ozurdex, dexamethasone
390308|NCT01284465|Type 2 diabetes self-management|type 2 diabetes self-management
390309|NCT01284465|Minority women|minority women
390310|NCT01284465|Barriers to diabetes self-management|barriers to diabetes self-management
390311|NCT01284452|Septic shock|septic shock
390312|NCT01284452|Severe sepsis|severe sepsis
390313|NCT01284452|Acute lung injury|acute lung injury
390565|NCT01283152|Hepatic coma|hepatic coma
390314|NCT01284452|Acute respiratory distress syndrome|acute respiratory distress syndrome
390315|NCT01284452|ARDS|ards
390316|NCT01284426|Chronic urticaria|chronic urticaria
390317|NCT01284426|Natural course|natural course
390318|NCT01284426|Remission|remission
390319|NCT01284400|heart failure|heart failure
390320|NCT01284400|disease management|disease management
390321|NCT01284387|Mild to moderate Alzheimer's disease|mild to moderate alzheimer's disease
390322|NCT01284387|immunization|immunization
390323|NCT01284387|amyloid imaging|amyloid imaging
390324|NCT01284387|injection|injection
390325|NCT01284387|vaccine|vaccine
390326|NCT01284374|HPV Vaccines|hpv vaccines
390327|NCT01284374|Attitude to Health|attitude to health
390333|NCT01284348|Non-small cell lung cancer|non-small cell lung cancer
390334|NCT01284335|Advanced solid tumors|advanced solid tumors
390335|NCT01284335|Unresectable|unresectable
390336|NCT01284335|Metastatic|metastatic
390337|NCT01284335|Limited treatment options|limited treatment options
390338|NCT01284335|Measurable or nonmeasurable disease|measurable or nonmeasurable disease
390339|NCT01284309|Intraocular Pressure (IOP)|intraocular pressure (iop)
390340|NCT01284309|YM178|ym178
390346|NCT01284270|Cardiac MRI|cardiac mri
390347|NCT01284270|Plaque|plaque
390348|NCT01284257|EC-MPS|ec-mps
390349|NCT01284257|MMF|mmf
390350|NCT01284257|kidney transplant|kidney transplant
390351|NCT01284257|outcomes|outcomes
390352|NCT01284257|mycophenolate sodium|mycophenolate sodium
390353|NCT01284257|mycophenolic acid (MPA)|mycophenolic acid (mpa)
390354|NCT01284244|Urinary Incontinence, Stress|urinary incontinence, stress
390355|NCT01284244|pessary|pessary
390356|NCT01284244|conservative management|conservative management
390357|NCT01284231|MEDI-565, gastrointestinal adenocarcinomas, carcinoembryonic antigen, bispecific T-cell engager|medi-565, gastrointestinal adenocarcinomas, carcinoembryonic antigen, bispecific t-cell engager
390358|NCT01284205|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
390359|NCT01284205|superficial bladder cancer|superficial bladder cancer
390360|NCT01284192|B-cell Lymphoma|b-cell lymphoma
390361|NCT01284192|Advanced Malignancies|advanced malignancies
390362|NCT01284192|Anaplastic Lymphoma Kinase (ALK)|anaplastic lymphoma kinase (alk)
390363|NCT01284192|ASP3026|asp3026
390364|NCT01284192|Solid Tumor|solid tumor
390365|NCT01284179|Functional Chest Pain|functional chest pain
390366|NCT01284179|Functional GI Disorders|functional gi disorders
390367|NCT01284179|Home Hypnotherapy|home hypnotherapy
390368|NCT01284153|respiratory gating|respiratory gating
390369|NCT01284153|prone radiotherapy|prone radiotherapy
390370|NCT01284153|breast cancer|breast cancer
390371|NCT01284140|Critical illness|critical illness
390372|NCT01284140|Sleep|sleep
390373|NCT01284140|Polysomnography|polysomnography
390374|NCT01284140|Respiratory failure|respiratory failure
390375|NCT01284140|Circadian rhythm|circadian rhythm
390376|NCT01284140|Sedation|sedation
390377|NCT01284127|superficial siderosis|superficial siderosis
390378|NCT01284114|Elderly chronic kidney disease|elderly chronic kidney disease
390379|NCT01284114|Hypertension|hypertension
390380|NCT01284114|Aliskiren|aliskiren
390381|NCT01284088|Male Circumcision|male circumcision
390382|NCT01284088|HIV Prevention|hiv prevention
390383|NCT01284088|Medical Device|medical device
390384|NCT01284062|Active Ulcerative Colitis|active ulcerative colitis
390385|NCT01284062|Phase 2A|phase 2a
390386|NCT01284062|Double-blind|double-blind
390387|NCT01284062|Randomized|randomized
390388|NCT01284062|PK/PD Biomarker Study|pk/pd biomarker study
390389|NCT01284049|Home Parenteral Nutrition|home parenteral nutrition
390390|NCT01284049|Intralipid 20%®|intralipid 20%®
390391|NCT01284049|OMEGAVEN 10%®|omegaven 10%®
390392|NCT01284049|Liver diseases|liver diseases
390393|NCT01284036|Healthy subject|healthy subject
390395|NCT01284036|PK study|pk study
390396|NCT01284036|healthy volunteers|healthy volunteers
390397|NCT01284023|near infrared spectroscopy|near infrared spectroscopy
390398|NCT01284023|acute compartment syndrome|acute compartment syndrome
390399|NCT01284010|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
390400|NCT01283997|Multiple Myeloma|multiple myeloma
390401|NCT01283997|Neuropathy|neuropathy
390402|NCT01283997|Peripheral Nerve Function|peripheral nerve function
390403|NCT01283997|Touch Detection Threshold|touch detection threshold
390404|NCT01283997|Nerve Damage|nerve damage
390405|NCT01283997|Thalidomide|thalidomide
390406|NCT01283997|Bortezomib|bortezomib
390407|NCT01283997|Velcade|velcade
390408|NCT01283997|Minocycline|minocycline
390409|NCT01283997|Dynacin|dynacin
390410|NCT01283997|Minocin|minocin
390411|NCT01283997|Minocin PAC|minocin pac
390412|NCT01283997|Myrac|myrac
390413|NCT01283997|Solodyn|solodyn
390414|NCT01283984|Safety|safety
390415|NCT01283984|tolerability|tolerability
390416|NCT01283984|healthy|healthy
390417|NCT01283984|inhaled|inhaled
390418|NCT01283984|respiratory disease|respiratory disease
390419|NCT01283958|Iloprost, Eisenmenger's syndrome|iloprost, eisenmenger's syndrome
390420|NCT01283945|VEGFRs|vegfrs
390421|NCT01283945|FGFR1|fgfr1
390422|NCT01283945|angiogenesis|angiogenesis
390423|NCT01283906|Mucositis|mucositis
390424|NCT01283906|Head and Neck Cancer|head and neck cancer
390425|NCT01283906|Squamous Cell Cancer|squamous cell cancer
390426|NCT01283906|Chemotherapy|chemotherapy
390427|NCT01283906|Radiation Therapy|radiation therapy
390428|NCT01283906|Oral Rinse|oral rinse
390429|NCT01283880|kidney|kidney
390430|NCT01283880|transplantation|transplantation
390431|NCT01283880|metabolic acidosis|metabolic acidosis
390432|NCT01283880|renal tubular acidosis|renal tubular acidosis
390433|NCT01283880|nephrocalcinosis|nephrocalcinosis
390434|NCT01283815|Laparoscopy|laparoscopy
390435|NCT01283815|Drainage|drainage
390436|NCT01283815|Appendectomy|appendectomy
390437|NCT01283789|breast|breast
390438|NCT01283789|cancer|cancer
390439|NCT01283789|metastatic|metastatic
390440|NCT01283789|metastasis|metastasis
390441|NCT01283763|Cervical Intraepithelial Neoplasia, Imiquimod, conization|cervical intraepithelial neoplasia, imiquimod, conization
390442|NCT01283750|care coordination|care coordination
390443|NCT01283750|dementia care|dementia care
390444|NCT01283750|intervention|intervention
390445|NCT01283750|unmet needs|unmet needs
390446|NCT01283750|community|community
390447|NCT01283750|older adults|older adults
390448|NCT01283750|caregiver|caregiver
390449|NCT01283737|Osteochondritis Dissecans|osteochondritis dissecans
390450|NCT01283737|OCD|ocd
390451|NCT01283737|Mosaicplasty|mosaicplasty
390452|NCT01283737|Demineralised Bone Matrix|demineralised bone matrix
390453|NCT01283737|DBX|dbx
390454|NCT01283737|DBX Putty|dbx putty
390455|NCT01283724|Endometriosis|endometriosis
390456|NCT01283724|DEXA|dexa
390457|NCT01283724|Adolescent|adolescent
390458|NCT01283724|Safety|safety
390459|NCT01283724|Efficacy|efficacy
390460|NCT01283724|Post-menarche|post-menarche
390461|NCT01283711|wrinkles reduction|wrinkles reduction
390462|NCT01283711|rhytides reduction|rhytides reduction
390463|NCT01283711|RF treatment|rf treatment
390464|NCT01283698|psoriasis|psoriasis
390465|NCT01283698|topical|topical
390466|NCT01283698|PPT|ppt
390467|NCT01283685|Exercise, Physical|exercise, physical
390468|NCT01283672|Whole grains|whole grains
390469|NCT01283672|Barley|barley
390470|NCT01283672|Oats|oats
390471|NCT01283672|Cardiovascular disease|cardiovascular disease
390472|NCT01283672|Postprandial lipid metabolism|postprandial lipid metabolism
390473|NCT01283672|Endothelial function|endothelial function
390474|NCT01283672|Risk of cardiovascular disease in healthy men and women|risk of cardiovascular disease in healthy men and women
390475|NCT01283659|computed tomographic angiography|computed tomographic angiography
390476|NCT01283659|coronary angiogram|coronary angiogram
390477|NCT01283659|cost effectiveness|cost effectiveness
390478|NCT01283659|QoL|qol
390479|NCT01283659|Heart failure|heart failure
390480|NCT01283659|diagnostic accuracy|diagnostic accuracy
390481|NCT01283659|prospective comparative effectiveness randomized clinical trial|prospective comparative effectiveness randomized clinical trial
390482|NCT01283633|neuromodulation|neuromodulation
390483|NCT01283633|remote presence robotics|remote presence robotics
390484|NCT01283620|stroke|stroke
390485|NCT01283620|extremity, upper|extremity, upper
390486|NCT01283607|in vitro fertilization|in vitro fertilization
390487|NCT01283607|e-health|e-health
390488|NCT01283607|cognitive behavioral therapy|cognitive behavioral therapy
390489|NCT01283607|psychosocial risk profile|psychosocial risk profile
390490|NCT01283607|emotional maladjustment|emotional maladjustment
390491|NCT01283568|PMS, climacteric, depression|pms, climacteric, depression
390492|NCT01283555|Microbicide, Applicator, Safety|microbicide, applicator, safety
390493|NCT01283542|Non-functioning pituitary adenoma,|non-functioning pituitary adenoma,
390494|NCT01283542|pasireotide LAR,|pasireotide lar,
390495|NCT01283542|tumor volume|tumor volume
390496|NCT01283529|Intrathoracal blood volume|intrathoracal blood volume
390497|NCT01283529|Cardiac output|cardiac output
390498|NCT01283529|Children|children
390499|NCT01283516|ALK inhibitor,|alk inhibitor,
390501|NCT01283516|LDK378,|ldk378,
390502|NCT01283516|ceritinib,|ceritinib,
390503|NCT01283516|genetic abnormalities|genetic abnormalities
390504|NCT01283503|PI3K,|pi3k,
390505|NCT01283503|Advanced solid tumor|advanced solid tumor
390506|NCT01283490|topical anesthetic, sonophoresis|topical anesthetic, sonophoresis
390507|NCT01283477|Caesarean Delivery|caesarean delivery
390508|NCT01283477|Pruritis|pruritis
390509|NCT01283477|Intrathecal Morphine|intrathecal morphine
390510|NCT01283477|Acupuncture At LI11|acupuncture at li11
390511|NCT01283464|Retinol|retinol
390512|NCT01283464|Tretinoin|tretinoin
390513|NCT01283451|near-infrared spectroscopy|near-infrared spectroscopy
390514|NCT01283425|MiniMed Paradigm insulin pump|minimed paradigm insulin pump
390515|NCT01283425|insulin Lispro|insulin lispro
390516|NCT01283425|Insulin Aspart|insulin aspart
390517|NCT01283425|Quick-set infusion set|quick-set infusion set
390518|NCT01283412|Delirium|delirium
390519|NCT01283412|Dexmedetomidine|dexmedetomidine
390520|NCT01283412|Adult Patients|adult patients
390521|NCT01283412|Elective Major Surgery|elective major surgery
390522|NCT01283412|General Anesthesia|general anesthesia
390523|NCT01283360|MSM|msm
390524|NCT01283360|HIV negative|hiv negative
390525|NCT01283360|microbicide|microbicide
390526|NCT01283360|prevention|prevention
390527|NCT01283347|Parkinson's disease|parkinson's disease
390528|NCT01283334|Head and Neck Cancer|head and neck cancer
390529|NCT01283334|Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|recurrent metastatic squamous cell carcinoma of the head and neck (scchn)
390530|NCT01283321|Hemostasis|hemostasis
390531|NCT01283321|Cardiopulmonary bypass (heart-lung machine)|cardiopulmonary bypass (heart-lung machine)
390532|NCT01283321|Fibrinogen|fibrinogen
390533|NCT01283321|platelet|platelet
390534|NCT01283308|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
390535|NCT01283308|India|india
390536|NCT01283308|Prevention & Control|prevention & control
390537|NCT01283308|Lifestyle Intervention|lifestyle intervention
390538|NCT01283308|Translational Research|translational research
390539|NCT01283269|Rehabilitation|rehabilitation
390540|NCT01283269|Cognitive Intervention|cognitive intervention
390541|NCT01283269|Prevention|prevention
390542|NCT01283243|ARFI Imaging|arfi imaging
390543|NCT01283243|Normal values|normal values
390544|NCT01283243|HIV infection|hiv infection
390545|NCT01283230|ARFI imaging|arfi imaging
390546|NCT01283230|normal values|normal values
390547|NCT01283230|chronic liver disease|chronic liver disease
390548|NCT01283230|liver donors|liver donors
390549|NCT01283230|kidney donors|kidney donors
390550|NCT01283191|substance use|substance use
390551|NCT01283191|drug use|drug use
390552|NCT01283191|drug abuse|drug abuse
390553|NCT01283191|exercise|exercise
390554|NCT01283191|physical activity|physical activity
403030|NCT01228461|Adolescent and Young Adults|adolescent and young adults
381462|NCT01320787|ER|er
390555|NCT01283178|squamous cell carcinoma of the paranasal sinus and nasal cavity|squamous cell carcinoma of the paranasal sinus and nasal cavity
390556|NCT01283165|health education|health education
390557|NCT01283165|Polyparasitism|polyparasitism
390558|NCT01283165|school based deworming program|school based deworming program
390559|NCT01283165|integrated control of parasites|integrated control of parasites
390560|NCT01283152|Hepatic Encephalopathy|hepatic encephalopathy
390562|NCT01283152|Cirrhosis|cirrhosis
390563|NCT01283152|PSE|pse
390564|NCT01283152|Portosystemic Encephalopathy|portosystemic encephalopathy
390566|NCT01283152|AMS|ams
390567|NCT01283152|Altered mental status|altered mental status
390568|NCT01283152|Complications of cirrhosis|complications of cirrhosis
390569|NCT01283152|Chronic liver disease|chronic liver disease
390570|NCT01283139|SLE|sle
390571|NCT01283139|Systemic Lupus Erythematosus|systemic lupus erythematosus
390572|NCT01283139|Sifalimumab|sifalimumab
390573|NCT01283139|MEDI-545|medi-545
390574|NCT01283126|Hypoglycemia, cognitive function|hypoglycemia, cognitive function
390575|NCT01283113|Visceral Fat|visceral fat
390576|NCT01283113|Waist Circumference|waist circumference
390577|NCT01283113|Bioelectrical Impedance|bioelectrical impedance
390578|NCT01283113|Metabolic Syndrome|metabolic syndrome
390579|NCT01283113|Obesity|obesity
390580|NCT01283113|Type 2 Diabetes|type 2 diabetes
390581|NCT01283100|HIV, GSK2248761, GSK1349572, drug interaction, pharmacokinetics|hiv, gsk2248761, gsk1349572, drug interaction, pharmacokinetics
390582|NCT01283087|TNS|tns
390583|NCT01283087|Spinal anesthesia|spinal anesthesia
390584|NCT01283087|Lidocaine|lidocaine
390585|NCT01283048|Kidney Cancer|kidney cancer
390586|NCT01283048|Avastin|avastin
390587|NCT01283022|Pharmacokinetics|pharmacokinetics
390588|NCT01283022|Misoprostol Vaginal Insert|misoprostol vaginal insert
390589|NCT01283022|Induction of labor|induction of labor
390590|NCT01283022|Cervical Ripening|cervical ripening
390591|NCT01283022|Rate of Cesarean section|rate of cesarean section
390592|NCT01283009|pneumoniae|pneumoniae
390593|NCT01282996|Mechanical ventilation|mechanical ventilation
390594|NCT01282996|Postoperative pulmonary complications|postoperative pulmonary complications
390595|NCT01282996|Positive end-expiratory pressure|positive end-expiratory pressure
390596|NCT01282996|Protective lung ventilation|protective lung ventilation
390597|NCT01282996|Alveolar recruitment maneuver|alveolar recruitment maneuver
390598|NCT01282996|General anesthesia|general anesthesia
390599|NCT01282996|Abdominal surgery|abdominal surgery
390600|NCT01282983|fiber|fiber
390601|NCT01282983|orange juice|orange juice
390602|NCT01282983|digestive symptom|digestive symptom
390603|NCT01282944|physical activity in adults 65 or older|physical activity in adults 65 or older
390604|NCT01282931|Women|women
390605|NCT01282931|Stage IV|stage iv
390606|NCT01282931|Metastatic|metastatic
390607|NCT01282931|Breast Cancer|breast cancer
390608|NCT01282931|Progressed|progressed
390609|NCT01282931|Progression|progression
390611|NCT01282918|DF Test|df test
390612|NCT01282918|intra-operative DF testing|intra-operative df testing
390613|NCT01282918|VT|vt
390614|NCT01282892|Visceral fat|visceral fat
390615|NCT01282892|fatty liver|fatty liver
390616|NCT01282892|atherosclerosis|atherosclerosis
390617|NCT01282892|coronary computed tomography angiography|coronary computed tomography angiography
390618|NCT01282879|Itraconazole oral solution|itraconazole oral solution
390619|NCT01282879|invasive fungal infections|invasive fungal infections
390620|NCT01282879|prophylaxis|prophylaxis
390621|NCT01282879|Graft vs Host Disease|graft vs host disease
390622|NCT01282879|transplantation|transplantation
390623|NCT01282853|peptic ulcer|peptic ulcer
390624|NCT01282853|hemorrhage|hemorrhage
390625|NCT01282853|rapid urease test|rapid urease test
390626|NCT01282853|urea breath test|urea breath test
390627|NCT01282840|LUTS|luts
390628|NCT01282814|Bioequivalence|bioequivalence
390629|NCT01282814|Healthy Subjects|healthy subjects
390630|NCT01282801|Bioequivalence|bioequivalence
390631|NCT01282801|Healthy Subjects|healthy subjects
390632|NCT01282788|infant nutrition|infant nutrition
390633|NCT01282788|complementary feeding|complementary feeding
390634|NCT01282788|malnutrition|malnutrition
390635|NCT01282788|stunting of growth|stunting of growth
390636|NCT01282775|overweight|overweight
390637|NCT01282775|obesity|obesity
390638|NCT01282775|worksite|worksite
390639|NCT01282762|Prevention of Hepatitis B infection.|prevention of hepatitis b infection.
390640|NCT01282762|End Stage Renal Disease|end stage renal disease
390641|NCT01282762|Hepatitis B vaccination|hepatitis b vaccination
390642|NCT01282762|Hepatitis B virus (HBV)|hepatitis b virus (hbv)
390643|NCT01282749|Overweight|overweight
390644|NCT01282749|Obesity|obesity
390645|NCT01282749|African American|african american
390646|NCT01282749|Women|women
390647|NCT01282749|Translational|translational
390648|NCT01282749|Faith based|faith based
390649|NCT01282749|Community based participatory research|community based participatory research
390650|NCT01282736|eating disorder|eating disorder
390651|NCT01282736|binge eating|binge eating
390652|NCT01282684|Safety|safety
390653|NCT01282684|Tolerability|tolerability
390654|NCT01282684|Pharmacokinetics|pharmacokinetics
390655|NCT01282684|PLX5622|plx5622
390656|NCT01282671|breathing exercises|breathing exercises
390657|NCT01282671|cardiac surgery|cardiac surgery
390658|NCT01282671|lung function|lung function
390659|NCT01282671|postoperative complication|postoperative complication
390660|NCT01282671|positive expiratory pressure|positive expiratory pressure
390661|NCT01282658|CPT-11,pharmacogenomics,colorectal cancer|cpt-11,pharmacogenomics,colorectal cancer
390662|NCT01282645|Cranial defect|cranial defect
390663|NCT01282645|PSI|psi
390664|NCT01282645|patient specific implant|patient specific implant
390665|NCT01282645|PEEK|peek
390666|NCT01282645|polyether ether ketone|polyether ether ketone
390667|NCT01282645|craniectomy|craniectomy
390668|NCT01282645|craniotomy|craniotomy
390669|NCT01282632|depression|depression
390670|NCT01282632|treatment resistant depression|treatment resistant depression
390671|NCT01282632|unipolar|unipolar
390672|NCT01282632|non- psychotic major depression|non- psychotic major depression
390673|NCT01282632|add-on to a serotonin type antidepressants|add-on to a serotonin type antidepressants
390674|NCT01282632|risperidone|risperidone
390675|NCT01282632|olanzapine|olanzapine
390676|NCT01282632|double blind comparison|double blind comparison
390677|NCT01282632|randomized|randomized
390678|NCT01282606|Chemonucleolysis|chemonucleolysis
390679|NCT01282606|Lumbar Vertebrae|lumbar vertebrae
390680|NCT01282606|Hernia|hernia
390681|NCT01282593|TEL/ALM1_positive ALL relapses|tel/alm1_positive all relapses
390682|NCT01282580|Women at high risk of developing breast cancer|women at high risk of developing breast cancer
390683|NCT01282541|Tearing, Epiphora, Botulinum Toxin A|tearing, epiphora, botulinum toxin a
390684|NCT01282502|rectal cancer|rectal cancer
390685|NCT01282502|chemotherapy|chemotherapy
390686|NCT01282502|chemoradiation|chemoradiation
390687|NCT01282476|DLBCL (Diffuse Large B Cell Lymphoma)|dlbcl (diffuse large b cell lymphoma)
390688|NCT01282476|Panobinostat|panobinostat
390689|NCT01282476|LBH589 (Panobinostat)|lbh589 (panobinostat)
390693|NCT01282476|deacetylase inhibitor|deacetylase inhibitor
390694|NCT01282476|lymphoma|lymphoma
390695|NCT01282463|Carcinoma, Renal Cell|carcinoma, renal cell
390696|NCT01282450|Radiotherapy|radiotherapy
390697|NCT01282450|NSCLC|nsclc
390698|NCT01282424|indolent Non-Hodgkin Lymphoma|indolent non-hodgkin lymphoma
390699|NCT01282424|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
390700|NCT01282424|iNHL|inhl
390701|NCT01282424|NHL|nhl
390702|NCT01282424|GS-1101|gs-1101
390703|NCT01282424|CAL-101|cal-101
390704|NCT01282424|PI3K|pi3k
390705|NCT01282424|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
390706|NCT01282424|Follicular Lymphoma (FL)|follicular lymphoma (fl)
390707|NCT01282424|Small lymphocytic lymphoma (SLL)|small lymphocytic lymphoma (sll)
390708|NCT01282424|Lymphoplasmacytoid lymphoma (LPL)|lymphoplasmacytoid lymphoma (lpl)
390709|NCT01282424|Marginal zone lymphoma (MZL)|marginal zone lymphoma (mzl)
390710|NCT01282372|Ankylosing spondylitis|ankylosing spondylitis
390711|NCT01282372|Sleep|sleep
390712|NCT01282372|Psoriatic arthritis|psoriatic arthritis
390713|NCT01282372|Work Productivity|work productivity
390714|NCT01282372|Rheumatoid Arthritis|rheumatoid arthritis
390715|NCT01282359|Educational asthma program|educational asthma program
390716|NCT01282359|Clusters analysis study|clusters analysis study
390717|NCT01282359|Asthma Control Test|asthma control test
390718|NCT01282346|Glaucoma shunt|glaucoma shunt
390719|NCT01282346|Ocular implant|ocular implant
390720|NCT01282346|Gold|gold
390721|NCT01282346|Trabeculectomy|trabeculectomy
390722|NCT01282320|Randomized Controlled Trial|randomized controlled trial
390723|NCT01282320|Clinical Tria|clinical tria
390724|NCT01282320|Postmenopause|postmenopause
390725|NCT01282320|Hot-flashes|hot-flashes
390726|NCT01282320|Quality of life|quality of life
390727|NCT01282320|Physical Fitness|physical fitness
390728|NCT01282307|Guided Self-Determination|guided self-determination
390729|NCT01282307|Improving insight|improving insight
390730|NCT01282307|Autonomy-supportive problem solving intervention|autonomy-supportive problem solving intervention
390731|NCT01282307|Evaluate the effects of the method Guided Self-Determination|evaluate the effects of the method guided self-determination
390732|NCT01282307|Improving insight in patients diagnosed with schizophrenia|improving insight in patients diagnosed with schizophrenia
390733|NCT01282281|Bipolar Disorder|bipolar disorder
390734|NCT01282281|Youth|youth
390735|NCT01282281|Adults|adults
390736|NCT01282281|Endocrine-metabolic changes|endocrine-metabolic changes
390737|NCT01282268|fragile X syndrome|fragile x syndrome
390738|NCT01282268|autism spectrum disorder|autism spectrum disorder
390739|NCT01282242|acute stroke, IV rt-PA, Activase, Alteplase|acute stroke, iv rt-pa, activase, alteplase
390740|NCT01282229|LANAP, Laser dentistry|lanap, laser dentistry
390741|NCT01282203|General surgery|general surgery
390742|NCT01282203|General anesthesia|general anesthesia
390743|NCT01282203|Inhalation anesthesia|inhalation anesthesia
390744|NCT01282203|Sevorane|sevorane
390745|NCT01282203|Sevoflurane|sevoflurane
390746|NCT01282190|dyslipidemia, motivational interview, prevention|dyslipidemia, motivational interview, prevention
381608|NCT01319981|ALL|all
390747|NCT01282177|surveillance, safety , tolerability , vaccine|surveillance, safety , tolerability , vaccine
390748|NCT01282164|glucagon stimulation test|glucagon stimulation test
390749|NCT01282164|insulin tolerance test|insulin tolerance test
390750|NCT01282164|growth hormone deficiency|growth hormone deficiency
390751|NCT01282164|hypothalamic-pituitary disorders|hypothalamic-pituitary disorders
390752|NCT01282151|NSCLC|nsclc
390753|NCT01282151|Non Squamous cell|non squamous cell
390754|NCT01282151|Docetaxel|docetaxel
390755|NCT01282151|Pemetrexed|pemetrexed
390756|NCT01282138|Allergic conjunctivitis|allergic conjunctivitis
390757|NCT01282125|general population|general population
390758|NCT01282125|prevalence|prevalence
390759|NCT01282125|Norway|norway
390760|NCT01282099|all children entering the PICU eligible for enrollment|all children entering the picu eligible for enrollment
390761|NCT01282099|age range: neonate to 16 years|age range: neonate to 16 years
390762|NCT01282086|Sevorane|sevorane
390763|NCT01282086|Sevoflurane|sevoflurane
390764|NCT01282086|General anesthesia|general anesthesia
390765|NCT01282086|Inhalation anesthesia|inhalation anesthesia
390766|NCT01282086|General surgery|general surgery
390767|NCT01282073|Idiopathic membranous nephropathy|idiopathic membranous nephropathy
390768|NCT01282073|Mycophenolate mofetil|mycophenolate mofetil
390769|NCT01282073|Proteinuria|proteinuria
390770|NCT01282073|Renal function|renal function
390771|NCT01282060|HBA1C|hba1c
390772|NCT01282060|DIABETES-RELATED COMPLICATIONS|diabetes-related complications
390773|NCT01282060|GLYCAEMIC BALANCE|glycaemic balance
390774|NCT01282047|Lenalidomide|lenalidomide
390775|NCT01282047|Kaposi|kaposi
390777|NCT01282047|efficacy|efficacy
390778|NCT01282047|safety|safety
390779|NCT01282034|CHONDRAL|chondral
390780|NCT01282034|OSTEOCHONDRAL|osteochondral
390781|NCT01282021|RBC Antigens|rbc antigens
390782|NCT01282021|Molecular Typing|molecular typing
390783|NCT01282021|Ethiopian Sub-Populations|ethiopian sub-populations
390784|NCT01282021|Immunohematology|immunohematology
390785|NCT01282021|Immune Response|immune response
390786|NCT01282008|Online Surveys|online surveys
390787|NCT01282008|Tobacco Corrective Statements|tobacco corrective statements
390788|NCT01282008|Message Testing|message testing
390789|NCT01282008|Focus Groups|focus groups
390790|NCT01281995|Biologic Samples|biologic samples
390791|NCT01281995|Hydrocortisone|hydrocortisone
390792|NCT01281995|Laboratory Research Specimens|laboratory research specimens
390793|NCT01281995|Glucocorticoids|glucocorticoids
390794|NCT01281995|Immune Modulation|immune modulation
390795|NCT01281995|Healthy Volunteer|healthy volunteer
390797|NCT01281982|Imaging|imaging
390798|NCT01281982|Gliomas|gliomas
390799|NCT01281982|Pet Scan|pet scan
390800|NCT01281982|Blood Brain Barrier|blood brain barrier
390801|NCT01281982|P-Glycoprotein|p-glycoprotein
390802|NCT01281982|Brain Tumor|brain tumor
390803|NCT01281982|Glioma|glioma
390804|NCT01281982|Glioblastoma Multiforme|glioblastoma multiforme
390805|NCT01281982|Astrocytoma|astrocytoma
390806|NCT01281969|Placebo Controlled|placebo controlled
390807|NCT01281969|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
390808|NCT01281969|Children and Adolescents|children and adolescents
390809|NCT01281969|Intravenous Immunoglobulin|intravenous immunoglobulin
390810|NCT01281969|PANDAS|pandas
390811|NCT01281956|Epilepsy|epilepsy
390812|NCT01281956|Drug Trial|drug trial
390813|NCT01281956|Serotonin|serotonin
390814|NCT01281956|Serotonin 1A Receptor|serotonin 1a receptor
390815|NCT01281956|Temporal Lobe Epilepsy|temporal lobe epilepsy
390816|NCT01281956|Partial Epilepsy|partial epilepsy
390817|NCT01281930|Superficial abscess|superficial abscess
390818|NCT01281930|packing material|packing material
390820|NCT01281930|incision and drainage|incision and drainage
390821|NCT01281917|velcade|velcade
390822|NCT01281917|temsirolimus|temsirolimus
390823|NCT01281917|non-hodgkins lymphoma|non-hodgkins lymphoma
390824|NCT01281891|Drug: Morphine intrathecal|drug: morphine intrathecal
390825|NCT01281891|Pain: Postoperative|pain: postoperative
390826|NCT01281891|Surgery: Total hip arthroplasty|surgery: total hip arthroplasty
390827|NCT01281878|primary hyperoxaluria|primary hyperoxaluria
390828|NCT01281878|Pyridoxal-phosphate|pyridoxal-phosphate
390829|NCT01281839|Hepatitis C|hepatitis c
390830|NCT01281839|TMC435|tmc435
390831|NCT01281839|HCV|hcv
390832|NCT01281839|Hep C|hep c
390833|NCT01281839|Genotype 1|genotype 1
390834|NCT01281813|TMC114IFD3001|tmc114ifd3001
390835|NCT01281813|TMC114|tmc114
390836|NCT01281813|HIV|hiv
390837|NCT01281813|Darunavir|darunavir
390838|NCT01281813|PREZISTA|prezista
390839|NCT01281787|FAP= post-surgery atrial fibrillation|fap= post-surgery atrial fibrillation
390840|NCT01281787|ACEI= angiotensin converting enzyme-inhibitors|acei= angiotensin converting enzyme-inhibitors
390841|NCT01281787|ARBs= angiotensin II receptor blockers|arbs= angiotensin ii receptor blockers
390842|NCT01281787|NT-proBNP= brain natriuretic peptide|nt-probnp= brain natriuretic peptide
390843|NCT01281748|acute exacerbation of COPD|acute exacerbation of copd
390844|NCT01281735|treatment outcome|treatment outcome
390845|NCT01281735|side effects|side effects
390846|NCT01281735|Protein Kinase Inhibitors|protein kinase inhibitors
390847|NCT01281735|pediatrics|pediatrics
390848|NCT01281722|healthy adults|healthy adults
390849|NCT01281722|melanoma|melanoma
390850|NCT01281696|Breast cancer|breast cancer
390851|NCT01281696|CNS metastasis|cns metastasis
390852|NCT01281696|Brain metastasis|brain metastasis
390853|NCT01281696|Leptomeningeal metastasis|leptomeningeal metastasis
390854|NCT01281696|Bevacizumab|bevacizumab
390855|NCT01281696|Etoposide|etoposide
390856|NCT01281696|Cisplatin|cisplatin
390857|NCT01281670|H reflex; muscle activation; rate of force development; whole body vibration|h reflex; muscle activation; rate of force development; whole body vibration
390858|NCT01281657|Fingolimod|fingolimod
390859|NCT01281657|FTY720|fty720
390860|NCT01281657|Relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
390861|NCT01281657|Multiple sclerosis|multiple sclerosis
390862|NCT01281657|MS|ms
390863|NCT01281657|Safety|safety
390864|NCT01281657|Efficacy|efficacy
390865|NCT01281644|Keratosis pilaris (KP)|keratosis pilaris (kp)
390866|NCT01281631|ALS|als
390867|NCT01281618|Barrett's esophagus|barrett's esophagus
390868|NCT01281605|Type 2 diabetes|type 2 diabetes
390869|NCT01281605|Basal insulin|basal insulin
390870|NCT01281605|Insulin detemir|insulin detemir
390871|NCT01281605|Insulin titration algorithm|insulin titration algorithm
390872|NCT01281579|Pharmacokinetics|pharmacokinetics
390873|NCT01281579|Pharmacodynamics|pharmacodynamics
390874|NCT01281579|Canagliflozin|canagliflozin
390875|NCT01281566|Cisapride (Prepulsid)|cisapride (prepulsid)
390876|NCT01281566|Feeding intolerance|feeding intolerance
390878|NCT01281566|Nasogastric tube|nasogastric tube
390879|NCT01281566|Neonate|neonate
390880|NCT01281553|Cisapride (PREPULSID)|cisapride (prepulsid)
390881|NCT01281553|Placebo|placebo
390882|NCT01281553|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
390883|NCT01281553|Gastro-oesophageal Reflux Disease (GORD)|gastro-oesophageal reflux disease (gord)
390884|NCT01281540|Cisapride ( PREPULSID )|cisapride ( prepulsid )
390885|NCT01281540|Placebo|placebo
390886|NCT01281540|Idiopathic|idiopathic
390887|NCT01281540|Stomach Diseases|stomach diseases
390888|NCT01281540|Stomach|stomach
390889|NCT01281527|Paliperidone palmitate|paliperidone palmitate
390890|NCT01281527|Schizophrenia|schizophrenia
390891|NCT01281527|Intramuscular injection|intramuscular injection
390892|NCT01281501|Dyspepsia|dyspepsia
390893|NCT01281501|Emergency treatment|emergency treatment
390894|NCT01281501|Pantoprazole|pantoprazole
390895|NCT01281501|Antacid|antacid
390896|NCT01281501|Pain measurement|pain measurement
390897|NCT01281475|Angelman syndrome|angelman syndrome
390898|NCT01281475|Levodopa|levodopa
390899|NCT01281475|Carbidopa|carbidopa
390900|NCT01281475|L-dopa|l-dopa
390901|NCT01281462|complicated Urinary Tract Infection|complicated urinary tract infection
390902|NCT01281462|Acute Pyelonephritis|acute pyelonephritis
390903|NCT01281436|childhood|childhood
390904|NCT01281436|overweight|overweight
390905|NCT01281436|obesity|obesity
390906|NCT01281436|Health information technology|health information technology
390907|NCT01281436|HeartSmartKids|heartsmartkids
390908|NCT01281436|Motivational Interviewing|motivational interviewing
390909|NCT01281410|respiratory muscles|respiratory muscles
390910|NCT01281410|hematopoetic stem cell transplantation|hematopoetic stem cell transplantation
390911|NCT01281410|inspiratory muscle training|inspiratory muscle training
390912|NCT01281397|cardiac surgery|cardiac surgery
390913|NCT01281397|aggregometry|aggregometry
390914|NCT01281397|thromboelastometry|thromboelastometry
390915|NCT01281397|platelet function|platelet function
390916|NCT01281397|bleeding|bleeding
390917|NCT01281397|antiplatelet therapy|antiplatelet therapy
390918|NCT01281384|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
390919|NCT01281384|echocardiography|echocardiography
390920|NCT01281384|heart failure|heart failure
390921|NCT01281384|imaging|imaging
390922|NCT01281384|cost effectiveness|cost effectiveness
390923|NCT01281384|quality of life|quality of life
390924|NCT01281384|definitive diagnosis|definitive diagnosis
390925|NCT01281384|prospective comparative effectiveness randomized clinical trial|prospective comparative effectiveness randomized clinical trial
390926|NCT01281358|Premature infants|premature infants
390927|NCT01281358|Motor Development|motor development
390928|NCT01281345|icu|icu
390929|NCT01281345|candida|candida
390930|NCT01281345|epidemiology|epidemiology
390931|NCT01281345|blood stream infection|blood stream infection
390932|NCT01281345|candidemia|candidemia
390933|NCT01281332|menopause|menopause
390934|NCT01281332|hot flash|hot flash
390935|NCT01281332|quality of life|quality of life
390936|NCT01281319|preterm labor|preterm labor
390937|NCT01281319|PROM|prom
390938|NCT01281319|mycoplasma|mycoplasma
390939|NCT01281319|ureaplasma|ureaplasma
390940|NCT01281319|high risk pregnancy|high risk pregnancy
390941|NCT01281306|hypertension|hypertension
390942|NCT01281306|blood pressure|blood pressure
390943|NCT01281306|LCZ696|lcz696
390944|NCT01281306|dual-acting|dual-acting
390945|NCT01281306|neprilysin|neprilysin
390946|NCT01281306|nep inhibitor|nep inhibitor
390947|NCT01281306|vasopeptidase|vasopeptidase
390948|NCT01281306|angiotensin receptor|angiotensin receptor
390949|NCT01281306|angiotensin receptor neprilysin inhibitor (ARNi)|angiotensin receptor neprilysin inhibitor (arni)
390950|NCT01281293|V-COMPAS; Vagus Nerve Stimulation Clinical Outcomes;|v-compas; vagus nerve stimulation clinical outcomes;
390951|NCT01281280|PuLsE 2, Drug-resistant Epilepsy Partial-onset Seizures|pulse 2, drug-resistant epilepsy partial-onset seizures
390952|NCT01281267|facial transplantation|facial transplantation
390953|NCT01281267|face transplantation|face transplantation
390954|NCT01281267|composite tissue allotransplantation|composite tissue allotransplantation
390955|NCT01281267|VCA|vca
390956|NCT01281267|composite tissue allograft|composite tissue allograft
390957|NCT01281267|facial allograft|facial allograft
390958|NCT01281254|Fallopian tube cancer|fallopian tube cancer
390959|NCT01281254|Primary peritoneal cancer|primary peritoneal cancer
390960|NCT01281254|AMG386|amg386
390961|NCT01281254|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
390962|NCT01281254|Recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
390963|NCT01281241|MTWA|mtwa
390964|NCT01281241|mechanical alternans|mechanical alternans
390965|NCT01281228|Exenatide|exenatide
390966|NCT01281228|Type 2 diabetes mellitus|type 2 diabetes mellitus
390967|NCT01281228|Incretin hormones|incretin hormones
390968|NCT01281228|GLP-1 agonist|glp-1 agonist
390969|NCT01281228|Satiety|satiety
390970|NCT01281228|Reward|reward
390971|NCT01281215|Pharmaceutical Education|pharmaceutical education
390972|NCT01281215|Rational Drug Use|rational drug use
390973|NCT01281215|Asthma|asthma
390974|NCT01281202|Cocaine|cocaine
390975|NCT01281202|Cocaine Addiction Treatment|cocaine addiction treatment
390976|NCT01281202|Cocaine Treatment|cocaine treatment
390977|NCT01281202|Vigabatrin|vigabatrin
390978|NCT01281202|CPP-109|cpp-109
390979|NCT01281202|Catalyst|catalyst
390980|NCT01281202|National Institute on Drug Abuse|national institute on drug abuse
390981|NCT01281189|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
390982|NCT01281189|ALS|als
390983|NCT01281189|Motor Neurone Disease|motor neurone disease
390984|NCT01281137|stage IA breast cancer|stage ia breast cancer
390985|NCT01281137|stage IB breast cancer|stage ib breast cancer
390986|NCT01281137|stage II breast cancer|stage ii breast cancer
390987|NCT01281137|stage IIIA breast cancer|stage iiia breast cancer
390988|NCT01281098|High Risk Proliferative Diabetic Retinopathy|high risk proliferative diabetic retinopathy
390989|NCT01281098|Diabetes Mellitus Type I, Type II|diabetes mellitus type i, type ii
390990|NCT01281098|Pegaptanib|pegaptanib
390991|NCT01281098|Panretinal Photocoagulation|panretinal photocoagulation
390992|NCT01281085|Shoulder|shoulder
390993|NCT01281085|Outcome treatment|outcome treatment
390994|NCT01281085|Validation Studies|validation studies
390995|NCT01281085|Biomechanics|biomechanics
390996|NCT01281033|primary PCI|primary pci
390997|NCT01281033|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
390998|NCT01281033|thrombus aspiration|thrombus aspiration
390999|NCT01281020|Glaucoma|glaucoma
391000|NCT01281020|Adherence|adherence
391001|NCT01281020|Fixed combination therapy|fixed combination therapy
391002|NCT01281007|Herpes Simplex Virus|herpes simplex virus
391003|NCT01280994|Lung Disease|lung disease
391004|NCT01280994|Pulmonary Disease|pulmonary disease
391005|NCT01280994|Diagnostic Imaging|diagnostic imaging
391006|NCT01280994|MRI|mri
391007|NCT01280981|Menorrhagia|menorrhagia
391008|NCT01280981|Heavy Menstrual Bleeding|heavy menstrual bleeding
391009|NCT01280981|Lysteda|lysteda
391010|NCT01280955|Plerixafor and Allogeneic Myeloablative Stem Cell Transplant|plerixafor and allogeneic myeloablative stem cell transplant
391011|NCT01280942|clinical deterioration|clinical deterioration
391012|NCT01280942|detection algorithms|detection algorithms
391013|NCT01280942|automated warning systems|automated warning systems
391014|NCT01280929|High Risk Proliferative Diabetic Retinopathy|high risk proliferative diabetic retinopathy
391015|NCT01280929|Ranibizumab|ranibizumab
391016|NCT01280929|Panretinal Photocoagulation|panretinal photocoagulation
391017|NCT01280903|Osteoarthritis, Knee|osteoarthritis, knee
391018|NCT01280903|Hypertension|hypertension
391019|NCT01280903|Exercise|exercise
391020|NCT01280903|Physical activity|physical activity
391021|NCT01280903|Self Efficacy|self efficacy
391022|NCT01280903|Patient Compliance|patient compliance
391023|NCT01280903|Aged|aged
391024|NCT01280890|Dementia|dementia
391025|NCT01280890|Nursing home|nursing home
391026|NCT01280890|Person-centred Care|person-centred care
391027|NCT01280890|Staff training|staff training
391028|NCT01280877|optic neuropathy|optic neuropathy
391029|NCT01280877|visual field|visual field
391030|NCT01280877|electric stimulation|electric stimulation
391031|NCT01280877|alternating current|alternating current
391032|NCT01280877|perimetry|perimetry
391033|NCT01280851|Living renal donor|living renal donor
391034|NCT01280851|Magnetic Resonance Imaging|magnetic resonance imaging
391035|NCT01280851|Renal vascular anatomy|renal vascular anatomy
391036|NCT01280851|Renal function|renal function
391037|NCT01280812|mobile phone|mobile phone
391038|NCT01280812|physical activity|physical activity
391039|NCT01280812|women|women
391040|NCT01280812|maintenance|maintenance
391041|NCT01280812|health promotion|health promotion
391042|NCT01280812|prevention|prevention
391043|NCT01280799|Anorexia Nervosa|anorexia nervosa
391044|NCT01280799|Adolescents|adolescents
391045|NCT01280799|Family Treatment|family treatment
391046|NCT01280799|Eating Disorder|eating disorder
391047|NCT01280799|Acceptance and Commitment Therapy|acceptance and commitment therapy
391048|NCT01280786|AML|aml
391049|NCT01280786|leukemia|leukemia
391050|NCT01280786|relapsed or refractory AML|relapsed or refractory aml
391051|NCT01280773|weaning, mechanical ventilation|weaning, mechanical ventilation
391052|NCT01280747|Prior authorization|prior authorization
391053|NCT01280747|Fibromyalgia|fibromyalgia
391054|NCT01280747|Painful Diabetic Peripheral Neuropathy|painful diabetic peripheral neuropathy
391055|NCT01280747|Policy|policy
391056|NCT01280747|Real World Data|real world data
391057|NCT01280734|melatonin|melatonin
391058|NCT01280734|circadin|circadin
391059|NCT01280734|zolpidem|zolpidem
391060|NCT01280734|body sway|body sway
391061|NCT01280734|postural instability|postural instability
391062|NCT01280708|Urology|urology
391063|NCT01280708|Nephrology|nephrology
391064|NCT01280708|Renal and pancreas transplantation|renal and pancreas transplantation
391065|NCT01280708|Data base|data base
391066|NCT01280708|Epidemiology|epidemiology
391067|NCT01280695|Type 2|type 2
391068|NCT01280695|Diabetes Mellitus|diabetes mellitus
391069|NCT01280695|Diabetes|diabetes
391070|NCT01280695|High blood sugar|high blood sugar
391071|NCT01280695|Blood sugar|blood sugar
391072|NCT01280695|Blood glucose|blood glucose
391073|NCT01280695|Glucose|glucose
391074|NCT01280682|type 1 diabetes|type 1 diabetes
391076|NCT01280682|course of disease|course of disease
391077|NCT01280682|autoantibodies|autoantibodies
391078|NCT01280682|C-peptide levels|c-peptide levels
391079|NCT01280669|Non-infectious|non-infectious
391080|NCT01280669|Uveitis|uveitis
391081|NCT01280669|Panuveitis|panuveitis
391082|NCT01280643|stage IVA colon cancer|stage iva colon cancer
391083|NCT01280643|stage IVA rectal cancer|stage iva rectal cancer
391084|NCT01280643|stage IVB colon cancer|stage ivb colon cancer
391085|NCT01280643|stage IVB rectal cancer|stage ivb rectal cancer
391086|NCT01280630|ACS: Acute coronary syndrome Retrospective Registry|acs: acute coronary syndrome retrospective registry
391087|NCT01280617|Renal Transplant|renal transplant
391088|NCT01280617|Thymoglubulin|thymoglubulin
391089|NCT01280591|Naproxen sodium|naproxen sodium
391090|NCT01280591|Diphenhydramine|diphenhydramine
391091|NCT01280578|Migraine|migraine
391092|NCT01280565|non-resectable or metastatic stage 3 or stage 4 melanoma carrying a mutation in the juxta membrane domain of c-kit|non-resectable or metastatic stage 3 or stage 4 melanoma carrying a mutation in the juxta membrane domain of c-kit
391093|NCT01280552|Glioblastoma Multiforme|glioblastoma multiforme
391094|NCT01280539|Multiple Sclerosis|multiple sclerosis
391095|NCT01280539|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
391096|NCT01280539|Cortical Excitability|cortical excitability
391097|NCT01280487|ZSTK474|zstk474
391098|NCT01280487|PI3K inhibitor|pi3k inhibitor
391099|NCT01280474|depression during pregnancy|depression during pregnancy
391100|NCT01280474|postpartum depression|postpartum depression
391101|NCT01280474|pregnancy outcomes|pregnancy outcomes
391102|NCT01280474|newborn development|newborn development
391103|NCT01280474|paternal psychopathology|paternal psychopathology
391104|NCT01280461|Pneumonia|pneumonia
391105|NCT01280448|Lung Cancer|lung cancer
391106|NCT01280448|Tobacco Smoking|tobacco smoking
391107|NCT01280448|gene polymorphism|gene polymorphism
391108|NCT01280435|Online Discourse|online discourse
391109|NCT01280435|e-Learning|e-learning
391110|NCT01280435|Biopsy|biopsy
391111|NCT01280435|Virtual Pathologic Section|virtual pathologic section
391112|NCT01280422|ROCDR|rocdr
391113|NCT01280396|metabolic|metabolic
391114|NCT01280396|SGAs|sgas
391115|NCT01280396|clozapine|clozapine
391116|NCT01280383|non-invasive ventilation|non-invasive ventilation
391117|NCT01280383|diaphragm|diaphragm
391118|NCT01280383|electrical activity|electrical activity
391119|NCT01280383|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
391120|NCT01280383|critically ill patients|critically ill patients
391121|NCT01280370|Incisional hernia repair|incisional hernia repair
391122|NCT01280357|Fetal Heart Rate (FHR)|fetal heart rate (fhr)
391123|NCT01280357|Uterine Activity (UA)|uterine activity (ua)
391124|NCT01280357|Labor & Delivery|labor & delivery
391125|NCT01280331|Bunionectomy|bunionectomy
391126|NCT01280305|schizophrenia|schizophrenia
391127|NCT01280305|schizoaffective disorder|schizoaffective disorder
391128|NCT01280292|central hypothyroidism, hypopituitarism, eltroxin|central hypothyroidism, hypopituitarism, eltroxin
391129|NCT01280279|Behavior modification, Behavior therapy, Nocturia, Polyuria, Quality of life|behavior modification, behavior therapy, nocturia, polyuria, quality of life
391130|NCT01280266|Pathological Conditions|pathological conditions
391131|NCT01280266|Signs and Symptoms|signs and symptoms
391132|NCT01280266|Blood circulation|blood circulation
391133|NCT01280253|Predictor|predictor
391134|NCT01280253|outcome|outcome
391135|NCT01280253|biochemical|biochemical
391136|NCT01280240|anemia|anemia
391137|NCT01280240|cancer|cancer
391138|NCT01280240|CIA|cia
391139|NCT01280227|Symptom management|symptom management
391140|NCT01280227|Symptom assessment|symptom assessment
391141|NCT01280227|Patient satisfaction|patient satisfaction
391142|NCT01280227|Patient-provider communication|patient-provider communication
391143|NCT01280201|Neuroendocrine Tumors|neuroendocrine tumors
391144|NCT01280201|Pazopanib|pazopanib
391145|NCT01280201|GETNE|getne
391146|NCT01280201|Biomarkers|biomarkers
391147|NCT01280188|Diabetes|diabetes
391148|NCT01280175|BDP|bdp
391149|NCT01280175|Formoterol|formoterol
391150|NCT01280175|pMDI|pmdi
391151|NCT01280175|Aerochamber Plus|aerochamber plus
391152|NCT01280175|Charcoal|charcoal
391153|NCT01280162|Plasmodium falciparum, Plasmodium vivax|plasmodium falciparum, plasmodium vivax
391154|NCT01280149|substance P|substance p
391155|NCT01280149|allergic rhinitis|allergic rhinitis
391156|NCT01280149|allergen immunotherapy|allergen immunotherapy
391157|NCT01280136|HIV|hiv
391158|NCT01280136|Sexually Transmitted Diseases|sexually transmitted diseases
391159|NCT01280136|Pregnancy Prevention|pregnancy prevention
391160|NCT01280136|Abstinence Education|abstinence education
391161|NCT01280136|Adolescents|adolescents
391162|NCT01280136|Sexual Health|sexual health
391163|NCT01280123|Parkinson's Disease|parkinson's disease
391164|NCT01280123|Biomarkers|biomarkers
391165|NCT01280110|dry eye|dry eye
391166|NCT01280110|pseudophakia|pseudophakia
391168|NCT01280110|lubricating drop|lubricating drop
391169|NCT01280110|BAK|bak
391170|NCT01280110|blood aqueous barrier|blood aqueous barrier
391171|NCT01280110|blood-retina barrier|blood-retina barrier
391172|NCT01280097|Intensive care unit delirium|intensive care unit delirium
391173|NCT01280097|Sleep disruption|sleep disruption
391174|NCT01280097|Sleep hygiene|sleep hygiene
391175|NCT01280097|Early mobilization in the Intensive care unit|early mobilization in the intensive care unit
391176|NCT01280097|Sedative agents and sleep|sedative agents and sleep
391177|NCT01280097|Circadian rhythm|circadian rhythm
391178|NCT01280097|Cognitive disorder|cognitive disorder
391179|NCT01280097|Electroencephalography (EEG) to measure sleep|electroencephalography (eeg) to measure sleep
391180|NCT01280097|Confusion Assessment Method in the Intensive Care Unit|confusion assessment method in the intensive care unit
391181|NCT01280097|Immune function|immune function
391182|NCT01280097|REM sleep|rem sleep
391183|NCT01280084|neonate activity|neonate activity
391184|NCT01280084|labour analgesia|labour analgesia
391185|NCT01280032|intraoperative radiotherapy|intraoperative radiotherapy
391186|NCT01280032|kyphoplasty|kyphoplasty
391187|NCT01280032|spinal metastases|spinal metastases
391188|NCT01280019|functional residual capacity|functional residual capacity
391189|NCT01280019|electrical impedance tomography|electrical impedance tomography
391190|NCT01280019|inflammatory parameters|inflammatory parameters
391191|NCT01280006|Obstructive Sleep Apnea|obstructive sleep apnea
391192|NCT01280006|Hypoxia|hypoxia
391193|NCT01280006|Sleep|sleep
391194|NCT01280006|Blood Pressure|blood pressure
391195|NCT01280006|Hypertension|hypertension
391196|NCT01280006|Myocardial Infarction|myocardial infarction
391197|NCT01280006|Stroke|stroke
391198|NCT01280006|Ventilation|ventilation
391199|NCT01280006|Brain|brain
391200|NCT01280006|Cerebral Blood Flow|cerebral blood flow
391201|NCT01280006|Renal Blood Flow|renal blood flow
391202|NCT01279980|ERAS|eras
391203|NCT01279980|Local anaesthetic wound catheter|local anaesthetic wound catheter
391206|NCT01279980|colorectal surgery|colorectal surgery
391207|NCT01279980|enhanced recovery program|enhanced recovery program
391208|NCT01279967|Pleural Mesothelioma|pleural mesothelioma
391209|NCT01279967|ADI-PEG 20|adi-peg 20
391210|NCT01279928|paediatric and adolescent population|paediatric and adolescent population
391211|NCT01279928|nailfold capillaroscopy|nailfold capillaroscopy
391212|NCT01279928|laser Doppler flowmetry|laser doppler flowmetry
391213|NCT01279928|retinal vessel calibre|retinal vessel calibre
391214|NCT01279928|retinal vessel fractal analysis|retinal vessel fractal analysis
391215|NCT01279928|24 hour Ambulatory Blood Pressure Monitoring|24 hour ambulatory blood pressure monitoring
391216|NCT01279915|ASP0456|asp0456
391217|NCT01279915|Pharmacokinetics|pharmacokinetics
391218|NCT01279915|safety|safety
391219|NCT01279915|tolerability|tolerability
391220|NCT01279902|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
391221|NCT01279902|rituximab|rituximab
391222|NCT01279902|CHOP|chop
391223|NCT01279902|abbreviated therapy|abbreviated therapy
391224|NCT01279889|hypotension|hypotension
391225|NCT01279889|cesarean delivery|cesarean delivery
391226|NCT01279889|cardiac output|cardiac output
391227|NCT01279889|blood pressure|blood pressure
391228|NCT01279889|plethysmography variability index|plethysmography variability index
391229|NCT01279863|Pneumonia|pneumonia
391230|NCT01279863|Cough|cough
391231|NCT01279863|Shortness of breath|shortness of breath
391233|NCT01279850|Lyrica|lyrica
391234|NCT01279850|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
391235|NCT01279850|Safety|safety
391236|NCT01279850|Neuropathic Pain|neuropathic pain
391237|NCT01279850|Post Marketing Surveillance|post marketing surveillance
391238|NCT01279837|swallowing disorders|swallowing disorders
391239|NCT01279837|swallowing therapy|swallowing therapy
391240|NCT01279837|head neck cancer|head neck cancer
391241|NCT01279837|oropharyngeal dysphagia|oropharyngeal dysphagia
391242|NCT01279824|swallowing, treatment, stroke,rehabilitation|swallowing, treatment, stroke,rehabilitation
391243|NCT01279811|spinal cord injury, CSF, biomarkers, CSF pressure|spinal cord injury, csf, biomarkers, csf pressure
391244|NCT01279798|Lung Cancer|lung cancer
391245|NCT01279798|NSCLC|nsclc
391246|NCT01279798|stage III or IV NSCLC|stage iii or iv nsclc
391247|NCT01279785|Molecular Imaging|molecular imaging
391248|NCT01279785|PSMA|psma
391249|NCT01279785|adenocarcinoma|adenocarcinoma
391250|NCT01279785|prostatectomy|prostatectomy
391251|NCT01279759|Anterior Cruciate Ligament Reconstruction Predictive Factors|anterior cruciate ligament reconstruction predictive factors
391252|NCT01279759|Function Downstairs walking Step time Symmetry|function downstairs walking step time symmetry
391253|NCT01279746|DVT Ultrasound compression Hypoxia Pulmonary Emboli|dvt ultrasound compression hypoxia pulmonary emboli
391254|NCT01279746|Occult DVT in hypoxic patients|occult dvt in hypoxic patients
391255|NCT01279733|microarray|microarray
391256|NCT01279720|Adenosine deaminase deficiency|adenosine deaminase deficiency
391257|NCT01279720|Gene therapy|gene therapy
391258|NCT01279694|newly-diagnosed multiple myeloma.|newly-diagnosed multiple myeloma.
391259|NCT01279681|neurotoxicity|neurotoxicity
391260|NCT01279681|cognitive/functional effects|cognitive/functional effects
391261|NCT01279681|stage IVA colon cancer|stage iva colon cancer
391262|NCT01279681|stage IVA rectal cancer|stage iva rectal cancer
391263|NCT01279681|stage IVB colon cancer|stage ivb colon cancer
391264|NCT01279681|stage IVB rectal cancer|stage ivb rectal cancer
391265|NCT01279681|recurrent colon cancer|recurrent colon cancer
391266|NCT01279681|recurrent rectal cancer|recurrent rectal cancer
391267|NCT01279668|Montelukast|montelukast
391268|NCT01279668|Persistent cough|persistent cough
391269|NCT01279668|Adults|adults
391270|NCT01279668|Double-blind randomised placebo controlled trial|double-blind randomised placebo controlled trial
391271|NCT01279642|Catheterization, Peripheral|catheterization, peripheral
391272|NCT01279642|Ultrasonography, Interventional|ultrasonography, interventional
391273|NCT01279642|Nursing|nursing
391274|NCT01279642|Pediatric|pediatric
391275|NCT01279629|chronic plaque psoriasis|chronic plaque psoriasis
391276|NCT01279629|To evaluate the efficacy of the drugs under study for treating chronic plaque psoriasis|to evaluate the efficacy of the drugs under study for treating chronic plaque psoriasis
391277|NCT01279616|sickle cell|sickle cell
391278|NCT01279616|stem cell transplant|stem cell transplant
391279|NCT01279603|Cancer|cancer
391280|NCT01279590|Hyperlipidemia|hyperlipidemia
391281|NCT01279590|Dyslipidemia|dyslipidemia
391282|NCT01279590|Metabolic diseases|metabolic diseases
391283|NCT01279590|Lipid metabolism disorders|lipid metabolism disorders
391284|NCT01279590|Hyperlipoproteinemia Type IIa|hyperlipoproteinemia type iia
391285|NCT01279590|Hyperlipoproteinemia Type IIb|hyperlipoproteinemia type iib
391286|NCT01279590|Hypercholesterolemia, Autosomal Dominant|hypercholesterolemia, autosomal dominant
391287|NCT01279590|Hypercholesterolemia, Autosomal Dominant, Type B|hypercholesterolemia, autosomal dominant, type b
391288|NCT01279590|Frederickson Type IIa|frederickson type iia
391289|NCT01279590|Frederickson Type IIb Hyperlipidemia|frederickson type iib hyperlipidemia
391290|NCT01279577|Crohn´s disease|crohn´s disease
391291|NCT01279577|Trichuris suis|trichuris suis
391292|NCT01279577|randomized|randomized
391293|NCT01279577|placebo|placebo
391294|NCT01279577|induction of remission|induction of remission
391295|NCT01279577|porcine whipworm|porcine whipworm
391296|NCT01279564|Endotracheal intubation and its outcomes|endotracheal intubation and its outcomes
391297|NCT01279538|Kidney Transplantation|kidney transplantation
391298|NCT01279538|Pharmacokinetics|pharmacokinetics
391299|NCT01279538|Pharmacology|pharmacology
391300|NCT01279538|ASKP1240|askp1240
391301|NCT01279525|Falls|falls
391302|NCT01279525|Prevention|prevention
391303|NCT01279525|Elderly|elderly
391304|NCT01279512|Metformin Acarbose pco infertility overweight|metformin acarbose pco infertility overweight
391305|NCT01279499|Morbid obesity|morbid obesity
391306|NCT01279499|Sevoflurane|sevoflurane
391307|NCT01279499|Propofol|propofol
391308|NCT01279499|Remifentanyl|remifentanyl
391309|NCT01279499|BIS|bis
391310|NCT01279499|Cardiovascular stability|cardiovascular stability
391311|NCT01279499|Recovery scores|recovery scores
391312|NCT01279499|Drug consumption|drug consumption
391313|NCT01279486|Pregnancy,|pregnancy,
391314|NCT01279473|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
391315|NCT01279473|CML|cml
391316|NCT01279473|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
391317|NCT01279473|Philadelphia Chromosome Positive, ph+ ALL|philadelphia chromosome positive, ph+ all
391318|NCT01279473|Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)|acute lymphoblastic leukemia (philadelphia chromosome positive)
391319|NCT01279460|chronic kidney disease|chronic kidney disease
391320|NCT01279460|CKD|ckd
391321|NCT01279460|pulse wave velocity|pulse wave velocity
391322|NCT01279460|PWV|pwv
391323|NCT01279447|infrapatellar nerve|infrapatellar nerve
391324|NCT01279447|saphenous nerve|saphenous nerve
391325|NCT01279447|knee arthroscopy|knee arthroscopy
391326|NCT01279447|nerve block|nerve block
391327|NCT01279408|Palliative treatment|palliative treatment
391328|NCT01279408|advanced non-small cell lung cancer|advanced non-small cell lung cancer
391329|NCT01279408|Patients with Asymptomatic Centrally Located Advance NSCLC who are palliative|patients with asymptomatic centrally located advance nsclc who are palliative
391330|NCT01279395|atherosclerosis|atherosclerosis
391331|NCT01279395|cholesterol|cholesterol
391332|NCT01279395|cyclooxygenase|cyclooxygenase
391333|NCT01279395|gene expression|gene expression
391334|NCT01279395|lipid metabolism|lipid metabolism
391335|NCT01279382|Symptoms|symptoms
391336|NCT01279382|Psychological status|psychological status
391337|NCT01279382|Hypnotherapy|hypnotherapy
391338|NCT01279382|Relaxation training|relaxation training
391339|NCT01279369|Pregnancy|pregnancy
391340|NCT01279369|Trauma|trauma
391341|NCT01279369|Placental Abruption|placental abruption
391342|NCT01279369|Fetal fibronectin|fetal fibronectin
391343|NCT01279356|Liver diseases|liver diseases
391344|NCT01279356|Volatile organic compounds|volatile organic compounds
391345|NCT01279356|Inflammation|inflammation
391346|NCT01279356|Oxidative stress|oxidative stress
391347|NCT01279356|non-invasive tests|non-invasive tests
391348|NCT01279343|labor induction|labor induction
391349|NCT01279343|foley bulb|foley bulb
391350|NCT01279343|misoprostol|misoprostol
391351|NCT01279330|Colorectal Cancer|colorectal cancer
391352|NCT01279330|Screening|screening
391353|NCT01279330|General Practitioner|general practitioner
391354|NCT01279330|Fecal Occult Blood Tests|fecal occult blood tests
391355|NCT01279304|breast cancer|breast cancer
391356|NCT01279304|locoregional recurrence rate|locoregional recurrence rate
391357|NCT01279304|neoadjuvant chemotherapy and surgery|neoadjuvant chemotherapy and surgery
391358|NCT01279304|radiotherapy|radiotherapy
391359|NCT01279304|risk model|risk model
391360|NCT01279304|overall survival|overall survival
391361|NCT01279304|relapse free survival|relapse free survival
391362|NCT01279304|cT1-2cN0-1 breast cancer|ct1-2cn0-1 breast cancer
391363|NCT01279291|advanced solid tumor|advanced solid tumor
391364|NCT01279291|Ovarian cancer|ovarian cancer
391365|NCT01279291|Primary peritoneal cancer|primary peritoneal cancer
391366|NCT01279291|Fallopian tube cancer|fallopian tube cancer
391367|NCT01279278|Colorectal Cancer|colorectal cancer
391368|NCT01279278|Screening|screening
391369|NCT01279278|General Practitioner|general practitioner
391370|NCT01279278|Fecal Occult Blood Tests|fecal occult blood tests
391371|NCT01279265|Lactobacillus|lactobacillus
391372|NCT01279265|Probiotic|probiotic
391373|NCT01279265|Crying time|crying time
391374|NCT01279265|Fecal microbiota|fecal microbiota
391375|NCT01279265|Calprotectin|calprotectin
391376|NCT01279265|Colic|colic
391377|NCT01279265|Infant Crying|infant crying
391378|NCT01279265|Barr Diary|barr diary
391379|NCT01279265|Breath Hydrogen|breath hydrogen
391380|NCT01279265|Clinical Design|clinical design
391381|NCT01279239|Poly Trauma|poly trauma
391382|NCT01279239|Metabonomics|metabonomics
391383|NCT01279239|NMR|nmr
391384|NCT01279239|MOF|mof
391385|NCT01279200|letrozole|letrozole
391386|NCT01279200|ovulation monitoring|ovulation monitoring
391387|NCT01279200|pregnancy rate|pregnancy rate
391388|NCT01279187|dental|dental
391389|NCT01279187|implant|implant
391390|NCT01279174|Hip, arthrosis|hip, arthrosis
391489|NCT01278758|extension phase,|extension phase,
391977|NCT01276873|Neonatology|neonatology
391391|NCT01279161|overweight, obesity, children, insulin, pump therapy, FTO|overweight, obesity, children, insulin, pump therapy, fto
391392|NCT01279148|biopsy guidance|biopsy guidance
391393|NCT01279148|tracking device|tracking device
391394|NCT01279135|IGRT,Postoperative, Cervix, Late toxicity, Bowel|igrt,postoperative, cervix, late toxicity, bowel
391395|NCT01279109|gestational weight gain|gestational weight gain
391396|NCT01279096|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
391397|NCT01279096|relapse|relapse
391398|NCT01279096|childhood|childhood
391399|NCT01279096|clofarabine|clofarabine
391400|NCT01279070|Schizophrenia|schizophrenia
391401|NCT01279070|Cognitive remediation|cognitive remediation
391402|NCT01279070|Group training|group training
391403|NCT01279070|Executive function|executive function
391404|NCT01279070|Social functioning|social functioning
391405|NCT01279057|Rhinitis, allergic, seasonal, fluticasone furoate, equivalence|rhinitis, allergic, seasonal, fluticasone furoate, equivalence
391406|NCT01279044|HIV|hiv
391407|NCT01279044|MSM|msm
391408|NCT01279044|SUMSM|sumsm
391409|NCT01279018|Persistent postsurgical pain|persistent postsurgical pain
391410|NCT01279018|breast cancer|breast cancer
391411|NCT01279018|postmastectomy pain syndrome|postmastectomy pain syndrome
391412|NCT01279018|neuropathic pain|neuropathic pain
391413|NCT01279005|MSM|msm
391414|NCT01279005|focus group|focus group
391415|NCT01279005|HIV|hiv
391416|NCT01279005|risk-taking|risk-taking
391417|NCT01279005|risk-denial|risk-denial
391418|NCT01279005|signature on inform consent, willing to participate, MSM either HIV positive or negative, age 20-50 years old|signature on inform consent, willing to participate, msm either hiv positive or negative, age 20-50 years old
391419|NCT01278992|fatigue|fatigue
391420|NCT01278992|adaptogen|adaptogen
391421|NCT01278992|Rhodiola rosea|rhodiola rosea
391422|NCT01278979|obstetric|obstetric
391423|NCT01278979|perineal tear|perineal tear
391424|NCT01278979|perineal injury|perineal injury
391425|NCT01278979|diagnosis|diagnosis
391426|NCT01278966|Epilepsy|epilepsy
391427|NCT01278966|Diet|diet
391428|NCT01278966|the Modified Atkins Diet|the modified atkins diet
391429|NCT01278966|Ketogenic diet|ketogenic diet
391430|NCT01278953|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
391431|NCT01278953|atrial fibrillation|atrial fibrillation
391432|NCT01278953|radiofrequency ablation|radiofrequency ablation
391433|NCT01278953|pulmonary vein isolation|pulmonary vein isolation
391434|NCT01278953|ablation catheter|ablation catheter
391435|NCT01278953|RF|rf
391436|NCT01278953|contact force sensing|contact force sensing
391437|NCT01278953|contact force|contact force
391438|NCT01278953|contact force assisted ablation|contact force assisted ablation
391439|NCT01278927|exercise|exercise
391440|NCT01278927|stress management|stress management
391441|NCT01278927|post transplant|post transplant
391442|NCT01278927|physical and emotional relaxation|physical and emotional relaxation
391443|NCT01278901|helicobacter pylori|helicobacter pylori
391444|NCT01278901|urease test|urease test
391445|NCT01278901|13C-UBT|13c-ubt
7813|NCT03240471|Conservative treatment|conservative treatment
7909|NCT03239964|surgical excision|surgical excision
391446|NCT01278901|the focus of the study is to evaluate a possible effect of PPI therapy on Helicobacter pylori diagnostic tests|the focus of the study is to evaluate a possible effect of ppi therapy on helicobacter pylori diagnostic tests
391447|NCT01278888|Lung cancer|lung cancer
391448|NCT01278888|Pain|pain
391449|NCT01278888|Quality of life|quality of life
391450|NCT01278888|Economy|economy
391451|NCT01278875|High density lipoproteins|high density lipoproteins
391452|NCT01278875|Acute coronary syndromes|acute coronary syndromes
391453|NCT01278875|Cellular cholesterol efflux|cellular cholesterol efflux
391454|NCT01278875|HDL: proteomics|hdl: proteomics
391455|NCT01278875|Nitric Acid production|nitric acid production
391456|NCT01278862|Crowns|crowns
391457|NCT01278862|posterior teeth|posterior teeth
391458|NCT01278862|CAD CAM crowns|cad cam crowns
391459|NCT01278862|digital veneer system|digital veneer system
391460|NCT01278862|Lava|lava
391461|NCT01278862|clinical|clinical
391462|NCT01278849|Advanced or metastatic cancer,|advanced or metastatic cancer,
391463|NCT01278849|refractory,|refractory,
391464|NCT01278849|core phase,|core phase,
391465|NCT01278849|extension phase,|extension phase,
391466|NCT01278849|dose escalation,|dose escalation,
391467|NCT01278849|standard chemotherapy,|standard chemotherapy,
391468|NCT01278849|pharmacokinetics,|pharmacokinetics,
391469|NCT01278849|doctaxel,|doctaxel,
391470|NCT01278849|paclitaxel,|paclitaxel,
391471|NCT01278849|carboplatin,|carboplatin,
391472|NCT01278849|safety,|safety,
391473|NCT01278849|tolerability,|tolerability,
391474|NCT01278849|hepatic impairment|hepatic impairment
391475|NCT01278836|Flap|flap
391476|NCT01278836|leg defect|leg defect
391477|NCT01278836|reconstruction|reconstruction
391478|NCT01278836|tissue|tissue
391479|NCT01278823|obesity|obesity
391480|NCT01278823|type 2 diabetes|type 2 diabetes
391481|NCT01278810|Icaritin,|icaritin,
391482|NCT01278810|ERa36|era36
391483|NCT01278784|Dry eye syndromes|dry eye syndromes
391484|NCT01278784|Chitosan-N-Acetylcysteine|chitosan-n-acetylcysteine
391486|NCT01278758|Advanced or metastatic cancer,|advanced or metastatic cancer,
391487|NCT01278758|refractory,|refractory,
391488|NCT01278758|core phase,|core phase,
391490|NCT01278758|dose escalation,|dose escalation,
391491|NCT01278758|standard chemotherapy,|standard chemotherapy,
391492|NCT01278758|doctaxel,|doctaxel,
391493|NCT01278758|paclitaxel,|paclitaxel,
391494|NCT01278758|carboplatin,|carboplatin,
391495|NCT01278758|safety,|safety,
391496|NCT01278758|tolerability|tolerability
391497|NCT01278745|cardiac allograft vasculopathy (CAV)|cardiac allograft vasculopathy (cav)
391498|NCT01278745|prevention|prevention
391499|NCT01278745|cardiac transplantation|cardiac transplantation
391500|NCT01278745|rituximab|rituximab
391501|NCT01278732|arterial hypertension|arterial hypertension
391502|NCT01278719|Antrochoanal polyp|antrochoanal polyp
391503|NCT01278719|Ethmoidal polyp|ethmoidal polyp
391504|NCT01278719|Recurrence|recurrence
391505|NCT01278719|Risk factors|risk factors
391506|NCT01278719|Environmental factors|environmental factors
391507|NCT01278719|Gene expression|gene expression
391508|NCT01278719|Micro array|micro array
391509|NCT01278719|Mutation|mutation
391510|NCT01278693|Renal failure, hemodialysis, dyslipidemia, L-carnitine.|renal failure, hemodialysis, dyslipidemia, l-carnitine.
391511|NCT01278680|Behavioral economics|behavioral economics
391512|NCT01278680|Incentives|incentives
391513|NCT01278680|Health|health
391514|NCT01278667|ADHD|adhd
391515|NCT01278667|Memory|memory
391516|NCT01278667|Social|social
391517|NCT01278667|Emotion|emotion
391518|NCT01278667|Methylphenidate|methylphenidate
391519|NCT01278641|Fibromyalgia|fibromyalgia
391520|NCT01278641|Widespread pain|widespread pain
391521|NCT01278641|Fatigue|fatigue
391522|NCT01278641|Physical exercise|physical exercise
391523|NCT01278602|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
391524|NCT01278602|Chemotherapy|chemotherapy
391525|NCT01278602|R-ESHAP|r-eshap
391526|NCT01278602|Autologous stem cell transplantation|autologous stem cell transplantation
391527|NCT01278576|Muscle spasticity|muscle spasticity
391528|NCT01278576|Stroke|stroke
391529|NCT01278576|Botulinum Toxins|botulinum toxins
391530|NCT01278576|Lower extremity|lower extremity
391531|NCT01278576|Ankle|ankle
391532|NCT01278563|Low Glycemic Index Diet|low glycemic index diet
391533|NCT01278537|elderly|elderly
391534|NCT01278537|cancer surgery|cancer surgery
391535|NCT01278537|quality of life|quality of life
391536|NCT01278537|empowerment|empowerment
391537|NCT01278537|shared-decision|shared-decision
391538|NCT01278524|Delirium|delirium
391539|NCT01278524|Analgosedation|analgosedation
391540|NCT01278524|ICU|icu
391541|NCT01278524|Pain|pain
391542|NCT01278524|Implementation|implementation
391543|NCT01278511|Canadian C-Spine Rule|canadian c-spine rule
391544|NCT01278511|Prehospital Emergency Care|prehospital emergency care
391545|NCT01278511|Cervical Spine Injuries|cervical spine injuries
391546|NCT01278511|Cervical Spine Fractures|cervical spine fractures
391547|NCT01278511|Emergency Medicine Undergraduates|emergency medicine undergraduates
391548|NCT01278498|Escitalopram|escitalopram
391549|NCT01278498|Depression|depression
391550|NCT01278498|Stroke|stroke
391551|NCT01278485|Diabetes complications|diabetes complications
391552|NCT01278472|cholecystectomy|cholecystectomy
391553|NCT01278472|laparoscopic|laparoscopic
391554|NCT01278472|single-port|single-port
391555|NCT01278472|gallstones|gallstones
391556|NCT01278459|endothelial function|endothelial function
391557|NCT01278459|cardiovascular|cardiovascular
391558|NCT01278446|Cow's Milk Allergy|cow's milk allergy
391560|NCT01278433|Polio|polio
391561|NCT01278433|Poliovirus|poliovirus
391562|NCT01278433|IMOVAX Polio™|imovax polio™
391563|NCT01278420|Visual outcomes with bilateral implantation of Tecnis MF and ReSTOR IOLs Six months post cataract surgery|visual outcomes with bilateral implantation of tecnis mf and restor iols six months post cataract surgery
391564|NCT01278407|DLB|dlb
391565|NCT01278407|Dementia with Lewy bodies|dementia with lewy bodies
391566|NCT01278407|Lewy Body Disease|lewy body disease
391567|NCT01278407|Dementia|dementia
391568|NCT01278407|E2020|e2020
391569|NCT01278407|Donepezil|donepezil
391570|NCT01278407|Aricept|aricept
391669|NCT01278095|Safety|safety
391571|NCT01278394|Onychomycosis|onychomycosis
391572|NCT01278394|Fungal Nail|fungal nail
391573|NCT01278381|pancreas, pancreaticoduodenectomy, major complications|pancreas, pancreaticoduodenectomy, major complications
391574|NCT01278368|pancreatic cancer, neoadjuvant chemotherapy|pancreatic cancer, neoadjuvant chemotherapy
391575|NCT01278355|pain|pain
391576|NCT01278355|acupuncture|acupuncture
391577|NCT01278342|Sandostatin LAR|sandostatin lar
391578|NCT01278342|High Dose|high dose
391579|NCT01278342|GH-receptor antagonist|gh-receptor antagonist
391580|NCT01278342|combination with dopamine-agonist|combination with dopamine-agonist
391581|NCT01278342|acromegalic patients|acromegalic patients
391582|NCT01278342|octreotide acetate|octreotide acetate
391583|NCT01278342|Somavert|somavert
391584|NCT01278342|Dostinex|dostinex
391585|NCT01278342|pegvisomant|pegvisomant
391586|NCT01278342|cabergoline|cabergoline
391587|NCT01278342|not adequately controlled|not adequately controlled
391588|NCT01278342|active acromegaly|active acromegaly
391589|NCT01278329|Music|music
391590|NCT01278329|Foetal learning|foetal learning
391782|NCT01277640|microbicide|microbicide
391591|NCT01278329|Brazelton Neonatal Behavioral Assessment Scale|brazelton neonatal behavioral assessment scale
391592|NCT01278316|PTSD|ptsd
391593|NCT01278316|TBI|tbi
391594|NCT01278316|Cognition|cognition
391595|NCT01278316|Cognitive Training|cognitive training
391596|NCT01278303|Coarctation|coarctation
391597|NCT01278303|Aorta|aorta
391598|NCT01278290|Triptorelin acetate|triptorelin acetate
391599|NCT01278290|precocious puberty|precocious puberty
391600|NCT01278290|premature thelarche|premature thelarche
391601|NCT01278290|GnRH analog|gnrh analog
391602|NCT01278290|Diagnostic validation study|diagnostic validation study
391603|NCT01278277|Stargardt disease|stargardt disease
391604|NCT01278277|macula|macula
391605|NCT01278277|electroretinogram|electroretinogram
391606|NCT01278277|saffron|saffron
391607|NCT01278264|Transversus abdominis plane block|transversus abdominis plane block
391608|NCT01278264|Ultrasound guided|ultrasound guided
391609|NCT01278264|Abdominoplasty|abdominoplasty
391610|NCT01278238|Hypotension|hypotension
391611|NCT01278238|Caesarean section|caesarean section
391612|NCT01278238|Spinal anaesthesia|spinal anaesthesia
477745|NCT00097747|CKD|ckd
391613|NCT01278238|Lower limb compression / wrapping|lower limb compression / wrapping
391614|NCT01278238|Phenylephrine|phenylephrine
391615|NCT01278225|Neurofeedback|neurofeedback
391616|NCT01278225|Neural Function|neural function
391617|NCT01278225|Neuromodulation|neuromodulation
391618|NCT01278225|Chemotherapy-Induced Neuropathic Pain|chemotherapy-induced neuropathic pain
391619|NCT01278225|Electroencephalogram|electroencephalogram
391620|NCT01278225|EEG|eeg
391621|NCT01278225|Biofeedback|biofeedback
391622|NCT01278225|BF|bf
391623|NCT01278225|Quality of Life|quality of life
391624|NCT01278225|QOL|qol
391625|NCT01278225|Pain Quality Assessment Scale|pain quality assessment scale
391626|NCT01278225|PQAS|pqas
391627|NCT01278225|Brief Symptom Inventory|brief symptom inventory
391628|NCT01278225|BSI|bsi
391629|NCT01278225|Sleep Disturbances|sleep disturbances
391630|NCT01278225|Fatigue|fatigue
391631|NCT01278225|Questionnaires|questionnaires
391632|NCT01278212|breast cancer|breast cancer
391633|NCT01278212|breast neoplasm|breast neoplasm
391634|NCT01278212|breast tumor|breast tumor
391635|NCT01278212|radiotherapy|radiotherapy
391636|NCT01278212|radiation|radiation
391637|NCT01278212|accelerated|accelerated
391638|NCT01278212|lumpectomy|lumpectomy
391639|NCT01278199|Bronchial Artery Embolization|bronchial artery embolization
391640|NCT01278199|Non-severe Hemoptysis|non-severe hemoptysis
391641|NCT01278199|Bleeding mild-to-moderate abundance|bleeding mild-to-moderate abundance
391642|NCT01278199|Volume ranging from 100 ml to 200 ml|volume ranging from 100 ml to 200 ml
391643|NCT01278186|Coronary stenosis|coronary stenosis
391644|NCT01278186|Bifurcation|bifurcation
391645|NCT01278186|Drug-eluting balloon|drug-eluting balloon
391646|NCT01278186|Drug-eluting stent|drug-eluting stent
391647|NCT01278186|Angiographic follow-up|angiographic follow-up
391648|NCT01278186|Late Lumen Loss|late lumen loss
391649|NCT01278186|Restenosis|restenosis
391650|NCT01278173|Vigabatrin-associated vision change|vigabatrin-associated vision change
391651|NCT01278173|Adult refractory complex partial seizures|adult refractory complex partial seizures
391652|NCT01278173|CPS|cps
391653|NCT01278173|Epilepsy|epilepsy
391654|NCT01278173|Seizures|seizures
391655|NCT01278173|Brain diseases|brain diseases
391656|NCT01278173|Central Nervous System Diseases|central nervous system diseases
391657|NCT01278173|Nervous System Diseases|nervous system diseases
391658|NCT01278173|Neurologic Manifestations|neurologic manifestations
391659|NCT01278173|Enzyme Inhibitors|enzyme inhibitors
391660|NCT01278173|GABA Agents|gaba agents
391661|NCT01278147|cancer|cancer
391662|NCT01278147|fatigue program education|fatigue program education
391663|NCT01278121|Obesity|obesity
391664|NCT01278121|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
391665|NCT01278121|Cardiovascular diseases|cardiovascular diseases
391666|NCT01278108|Safety|safety
391667|NCT01278108|Tolerability|tolerability
391668|NCT01278108|Pharmacokinetics|pharmacokinetics
391670|NCT01278095|Tolerability|tolerability
391671|NCT01278095|Pharmacokinetics|pharmacokinetics
391672|NCT01278082|Randomized|randomized
391673|NCT01278082|double-blind|double-blind
391674|NCT01278082|Placebo-controlled|placebo-controlled
391675|NCT01278082|budesonide|budesonide
391676|NCT01278082|collagenous colitis|collagenous colitis
391677|NCT01278082|acute treatment|acute treatment
391678|NCT01278082|maintaining remission|maintaining remission
391679|NCT01278069|Acute myeloid Leukemia|acute myeloid leukemia
391680|NCT01278069|Myeloid Sarcoma|myeloid sarcoma
391681|NCT01278069|Extramedullary Acute myeloid Leukemia|extramedullary acute myeloid leukemia
391682|NCT01278069|18FDG-PET-CT|18fdg-pet-ct
391683|NCT01278056|Non-alcoholic steatohepatitis (NASH) and increased iron storage / disturbed distribution|non-alcoholic steatohepatitis (nash) and increased iron storage / disturbed distribution
391684|NCT01278043|Antiplatelet|antiplatelet
391685|NCT01278043|Percutaneous Coronary Intervention|percutaneous coronary intervention
391686|NCT01278043|Coronary artery disease|coronary artery disease
391886|NCT01277198|kidney calculi|kidney calculi
391887|NCT01277198|ureteral calculi|ureteral calculi
391687|NCT01278043|Antiplatelet Response, Interval Variability & Events in Percutaneous Coronary Intervention|antiplatelet response, interval variability & events in percutaneous coronary intervention
391688|NCT01278017|nontyphoidal salmonellae|nontyphoidal salmonellae
391689|NCT01278017|enterocolitis|enterocolitis
391690|NCT01278017|ceftriaxone|ceftriaxone
391691|NCT01278004|Adult cancer patients with chemotherapy-induced painful peripheral neuropathy|adult cancer patients with chemotherapy-induced painful peripheral neuropathy
391692|NCT01277991|Bioequivalence|bioequivalence
391693|NCT01277991|healthy volunteer study|healthy volunteer study
391694|NCT01277991|Rheumatoid Arthritis|rheumatoid arthritis
391695|NCT01277978|Caesarean section|caesarean section
391696|NCT01277978|Cardiovascular effects|cardiovascular effects
391697|NCT01277978|Postpartum hemorrhage|postpartum hemorrhage
391698|NCT01277978|Carbetocin|carbetocin
391699|NCT01277978|Oxytocin|oxytocin
391700|NCT01277965|Algorithm basal insulin|algorithm basal insulin
391701|NCT01277965|physical activity|physical activity
391702|NCT01277965|Type 1 diabetes|type 1 diabetes
391703|NCT01277965|Insulin pump treatment|insulin pump treatment
391704|NCT01277952|Traumatic Brain Injury|traumatic brain injury
391706|NCT01277926|Breast Cancer|breast cancer
391707|NCT01277926|Hormone Receptor Positive, Advanced Breast Cancer|hormone receptor positive, advanced breast cancer
391708|NCT01277913|diabetes|diabetes
391709|NCT01277913|vitamin D|vitamin d
391710|NCT01277913|bone density|bone density
391711|NCT01277913|children|children
391712|NCT01277887|Smoking|smoking
391713|NCT01277887|Nicotine|nicotine
391714|NCT01277887|Nicotine polacrilex|nicotine polacrilex
391715|NCT01277887|Nicotine replacement|nicotine replacement
391716|NCT01277861|Desflurane, Fentanyl, Airway responses|desflurane, fentanyl, airway responses
391717|NCT01277848|PLAC1|plac1
391718|NCT01277848|pregnant|pregnant
391719|NCT01277848|first prenatal visit|first prenatal visit
391720|NCT01277848|pre-eclampsia|pre-eclampsia
391721|NCT01277835|video-assisted|video-assisted
391722|NCT01277835|thoracic surgery|thoracic surgery
391723|NCT01277835|VATS|vats
391724|NCT01277835|lidocaine infusion|lidocaine infusion
391725|NCT01277835|VATS procedures|vats procedures
391726|NCT01277822|Hypertension|hypertension
391727|NCT01277822|Uncontrolled hypertension|uncontrolled hypertension
391728|NCT01277822|High blood pressure|high blood pressure
391729|NCT01277822|Uncontrolled high blood pressure|uncontrolled high blood pressure
391730|NCT01277822|Untreated high blood pressure|untreated high blood pressure
391731|NCT01277822|Untreated hypertension|untreated hypertension
391732|NCT01277822|Essential hypertension|essential hypertension
391733|NCT01277809|Long term care|long term care
391734|NCT01277809|Aging|aging
391735|NCT01277809|Accidental Falls|accidental falls
391736|NCT01277809|Muscle Weakness|muscle weakness
391737|NCT01277809|Gait|gait
391738|NCT01277809|Physical Fitness|physical fitness
391739|NCT01277809|Muscle Strength|muscle strength
391740|NCT01277809|Postural Balance|postural balance
391741|NCT01277809|Activities of Daily Living|activities of daily living
391742|NCT01277809|Body Weight|body weight
600684|NCT00583102|Cytarabine|cytarabine
391743|NCT01277809|Blood Pressure|blood pressure
391744|NCT01277809|Depression|depression
391745|NCT01277809|Behavior|behavior
391746|NCT01277809|Dementia|dementia
391747|NCT01277770|Thymoglobulin|thymoglobulin
391748|NCT01277770|Kidney Transplant Recipients|kidney transplant recipients
391749|NCT01277770|Steroid-Free|steroid-free
391750|NCT01277770|Immunosuppression|immunosuppression
391751|NCT01277744|Desmoplastic small round cell tumor|desmoplastic small round cell tumor
391753|NCT01277744|Hyperthermic peritoneal perfusion|hyperthermic peritoneal perfusion
391754|NCT01277744|HIPEC|hipec
391755|NCT01277744|Complete abdominal tumor excision|complete abdominal tumor excision
391756|NCT01277744|Extensive abdominal disease|extensive abdominal disease
391757|NCT01277744|Non-carcinoma tumors|non-carcinoma tumors
391758|NCT01277744|Abdominal cavity|abdominal cavity
391759|NCT01277744|Cisplatin|cisplatin
391760|NCT01277744|Platinol-AQ|platinol-aq
391761|NCT01277744|Platinol|platinol
391762|NCT01277744|CDDP|cddp
391763|NCT01277744|Diffuse peritoneal tumor|diffuse peritoneal tumor
391764|NCT01277744|Retroperitoneal tumor|retroperitoneal tumor
391765|NCT01277744|Ovarian germ cell|ovarian germ cell
391766|NCT01277744|Wilms' tumor|wilms' tumor
391767|NCT01277705|Booster vaccination|booster vaccination
391768|NCT01277692|First administration to human, safety, pharmacokinetics, healthy subjects, antiviral activity, hepatitis C patients|first administration to human, safety, pharmacokinetics, healthy subjects, antiviral activity, hepatitis c patients
391769|NCT01277679|lung water measures|lung water measures
391770|NCT01277679|pulmonary edema|pulmonary edema
391771|NCT01277679|MRI|mri
391772|NCT01277679|heart failure|heart failure
391773|NCT01277666|Crohn's disease|crohn's disease
391774|NCT01277666|capsule|capsule
391775|NCT01277666|GSK1605786A|gsk1605786a
391776|NCT01277666|quality of life|quality of life
391777|NCT01277666|inflammatory bowel disease|inflammatory bowel disease
391778|NCT01277666|oral therapy|oral therapy
391779|NCT01277653|Hepatocellular carcinoma|hepatocellular carcinoma
391780|NCT01277640|male tolerance|male tolerance
391781|NCT01277640|HIV-1|hiv-1
391783|NCT01277640|The study will assess the safety and tolerability of dapivirine when applied topically to the penis of healthy, HIV-uninfected, adult males, both circumcised|the study will assess the safety and tolerability of dapivirine when applied topically to the penis of healthy, hiv-uninfected, adult males, both circumcised
391784|NCT01277640|and uncircumcised|and uncircumcised
391786|NCT01277627|HIV|hiv
391787|NCT01277627|Nevirapine|nevirapine
391788|NCT01277627|HCV viral load|hcv viral load
391789|NCT01277627|Efavirenz|efavirenz
391790|NCT01277627|Protease inhibitors|protease inhibitors
391791|NCT01277614|lifestyle|lifestyle
391792|NCT01277614|diet|diet
391793|NCT01277614|exercise|exercise
391794|NCT01277601|Chronic Hepatitis B|chronic hepatitis b
391795|NCT01277601|Hep B|hep b
391796|NCT01277601|Non cirrhotic|non cirrhotic
391797|NCT01277601|Tenofovir disoproxil fumarate (TDF)|tenofovir disoproxil fumarate (tdf)
391798|NCT01277601|Peginterferon α-2a (Peg-IFN)|peginterferon α-2a (peg-ifn)
391799|NCT01277588|fetal scalp sampling|fetal scalp sampling
391800|NCT01277588|experience questionnaire|experience questionnaire
391801|NCT01277575|stroke|stroke
391802|NCT01277575|aphasia|aphasia
391803|NCT01277575|language|language
391804|NCT01277562|Breast Cancer|breast cancer
391805|NCT01277562|Prostate Cancer|prostate cancer
391806|NCT01277562|Osteopenia|osteopenia
391807|NCT01277562|Osteoporosis|osteoporosis
391808|NCT01277562|Secondary causes of bone loss|secondary causes of bone loss
391809|NCT01277549|Leukapheresis|leukapheresis
391810|NCT01277549|Hematopoetic Stem Cell Mobilization|hematopoetic stem cell mobilization
391811|NCT01277510|dialysis|dialysis
391812|NCT01277510|sensipar|sensipar
391813|NCT01277510|mimpara|mimpara
391814|NCT01277510|hemodialysis|hemodialysis
391815|NCT01277510|peritoneal dialysis|peritoneal dialysis
391816|NCT01277510|renal|renal
391817|NCT01277510|parathyroid hormone|parathyroid hormone
391818|NCT01277510|pediatric|pediatric
391819|NCT01277497|Chronic kidney disease|chronic kidney disease
391820|NCT01277497|Phosphate binder|phosphate binder
391821|NCT01277497|Sevelamer carbonate|sevelamer carbonate
391822|NCT01277497|Calcium acetate|calcium acetate
391823|NCT01277497|Vascular calcification|vascular calcification
391824|NCT01277497|Endothelial Dysfunction|endothelial dysfunction
391825|NCT01277484|decitabine|decitabine
391826|NCT01277484|dose|dose
391827|NCT01277484|schedule|schedule
391828|NCT01277484|safety|safety
391829|NCT01277484|allogeneic stem cell transplantation|allogeneic stem cell transplantation
391830|NCT01277471|meal frequency|meal frequency
391831|NCT01277471|type two diabetes|type two diabetes
391832|NCT01277458|HIV|hiv
391833|NCT01277458|MSM|msm
391834|NCT01277458|Ethnicity|ethnicity
391835|NCT01277445|gut microbiome|gut microbiome
391836|NCT01277445|prebiotics|prebiotics
391837|NCT01277445|immunological status|immunological status
391838|NCT01277445|fructans|fructans
391839|NCT01277432|Diabetes|diabetes
391840|NCT01277432|Depression|depression
391841|NCT01277406|Colorectal Carcinoma|colorectal carcinoma
391842|NCT01277406|Resminostat|resminostat
391843|NCT01277406|HDAC|hdac
391844|NCT01277406|4SC-201|4sc-201
391845|NCT01277406|Phase I|phase i
391846|NCT01277406|Phase II|phase ii
391847|NCT01277393|Enteral nutrition feeding|enteral nutrition feeding
391848|NCT01277380|H1N1 Influenza virus|h1n1 influenza virus
391849|NCT01277380|swine flu|swine flu
391850|NCT01277380|Real Time RT-PCR|real time rt-pcr
391851|NCT01277367|Obesity|obesity
391852|NCT01277367|Sedentary|sedentary
391853|NCT01277367|Physical activity|physical activity
391854|NCT01277367|exercise|exercise
391855|NCT01277367|incentives|incentives
391856|NCT01277354|Cognitive Processing Therapy (CPT)|cognitive processing therapy (cpt)
391857|NCT01277315|ALS|als
391858|NCT01277315|Anakinra|anakinra
391859|NCT01277315|Kineret|kineret
391860|NCT01277315|Progressive Muscular Atrophy|progressive muscular atrophy
391861|NCT01277315|PMA|pma
391862|NCT01277315|Safety Trial|safety trial
391863|NCT01277315|Tolerability Trial|tolerability trial
391864|NCT01277289|dexamethasone|dexamethasone
391865|NCT01277289|ery-dex|ery-dex
391866|NCT01277289|Chron's disease|chron's disease
391867|NCT01277289|CD|cd
391868|NCT01277276|Medical tool|medical tool
391870|NCT01277250|Hospitalized adults|hospitalized adults
391871|NCT01277250|Tobacco users|tobacco users
391872|NCT01277250|Smokers|smokers
391873|NCT01277250|Smoking cessation|smoking cessation
391874|NCT01277250|Web-based|web-based
391875|NCT01277250|Transition coach|transition coach
391876|NCT01277237|Non alcoholic fatty liver disease|non alcoholic fatty liver disease
391877|NCT01277224|physical activity|physical activity
391878|NCT01277224|obesity|obesity
391879|NCT01277224|adiposity|adiposity
391880|NCT01277224|children|children
391881|NCT01277224|blood lipids|blood lipids
391882|NCT01277224|blood pressure|blood pressure
391883|NCT01277224|randomized controlled trials|randomized controlled trials
391884|NCT01277211|Contraception|contraception
391885|NCT01277211|NuvaRing|nuvaring
391888|NCT01277198|cystoscopes|cystoscopes
391889|NCT01277198|laparoscopes|laparoscopes
391890|NCT01277185|calcium|calcium
391891|NCT01277185|healthy|healthy
391892|NCT01277185|Mexican-American adolescents|mexican-american adolescents
391893|NCT01277185|camp|camp
391894|NCT01277185|girls|girls
391895|NCT01277185|boys|boys
391896|NCT01277185|bone|bone
391897|NCT01277172|DLBCL|dlbcl
391898|NCT01277172|pharmacokinetics|pharmacokinetics
391899|NCT01277172|pharmacodynamics|pharmacodynamics
391900|NCT01277172|Rituximab|rituximab
391901|NCT01277172|LymphomaLymphoma|lymphomalymphoma
391902|NCT01277172|Non-HodgkinLymphoma|non-hodgkinlymphoma
391903|NCT01277172|B-CellLymphoma|b-celllymphoma
391904|NCT01277172|Large B-Cell|large b-cell
391905|NCT01277172|Disorders Lymphatic Diseases|disorders lymphatic diseases
391906|NCT01277172|Immunoproliferative Disorders|immunoproliferative disorders
391907|NCT01277172|Antineoplastic Agents|antineoplastic agents
391908|NCT01277172|Adverse Effects|adverse effects
391909|NCT01277159|Analgesia|analgesia
391910|NCT01277159|Duration|duration
391911|NCT01277159|Popliteal Fossa Nerve Block|popliteal fossa nerve block
391912|NCT01277159|Dexamethasone|dexamethasone
391913|NCT01277159|Buprenorphine|buprenorphine
391914|NCT01277159|Additives|additives
391915|NCT01277159|Ankle surgery|ankle surgery
391916|NCT01277146|Phase 1|phase 1
391917|NCT01277146|dose escalation|dose escalation
391918|NCT01277146|histologically confirmed|histologically confirmed
391919|NCT01277146|malignancy metastatic|malignancy metastatic
391920|NCT01277107|PSG|psg
391921|NCT01277107|LPS|lps
391922|NCT01277107|TST|tst
391923|NCT01277107|WASO|waso
391924|NCT01277107|Subjects With Insomnia characterized by both Difficulty in Falling Asleep and Staying Asleep|subjects with insomnia characterized by both difficulty in falling asleep and staying asleep
391925|NCT01277081|Paracetamol|paracetamol
391926|NCT01277081|Common cold|common cold
391927|NCT01277068|obese patients|obese patients
391929|NCT01277068|the bariatric surgery|the bariatric surgery
391930|NCT01277042|Safety|safety
391931|NCT01277042|HPV vaccine|hpv vaccine
391932|NCT01277042|Immune response|immune response
391933|NCT01277042|Human papillomavirus|human papillomavirus
391934|NCT01277042|China|china
391935|NCT01277016|Amyloidosis|amyloidosis
391936|NCT01277016|Bortezomib|bortezomib
391937|NCT01276977|Migraine|migraine
391938|NCT01276977|Acute Migraine|acute migraine
391939|NCT01276977|Headache|headache
391940|NCT01276964|menses|menses
391941|NCT01276964|quantitative determination of menstrual losses|quantitative determination of menstrual losses
391942|NCT01276964|kinetic definition of menses|kinetic definition of menses
391943|NCT01276951|Cocoa|cocoa
391944|NCT01276951|Chocolate|chocolate
391945|NCT01276951|Endothelial disfunction|endothelial disfunction
391946|NCT01276951|Cardiovascular disease|cardiovascular disease
391947|NCT01276951|Blood Pressure|blood pressure
391948|NCT01276951|Hypertension|hypertension
391949|NCT01276938|Breast cancer|breast cancer
391950|NCT01276938|Intra Operative Radiation Therapy|intra operative radiation therapy
391951|NCT01276938|Toxicity|toxicity
391952|NCT01276925|Hip arthroplasty|hip arthroplasty
391953|NCT01276925|Peripheral nervous blockade|peripheral nervous blockade
391954|NCT01276925|Postoperative|postoperative
391955|NCT01276925|Pain|pain
391956|NCT01276925|Ropivacaine|ropivacaine
391957|NCT01276899|Breast Cancer|breast cancer
391958|NCT01276899|Triple negative breast cancer|triple negative breast cancer
391959|NCT01276899|ERnegative, PRnegative and Her2negative|ernegative, prnegative and her2negative
391960|NCT01276899|Taxanes|taxanes
391961|NCT01276899|Metastases|metastases
391962|NCT01276899|Biomarkers|biomarkers
391963|NCT01276899|Resistance|resistance
391964|NCT01276899|Biobanking|biobanking
391965|NCT01276899|Breast cancer with unresectable metastases to the liver|breast cancer with unresectable metastases to the liver
391966|NCT01276899|Breast cancer with unresectable metastases to the skin|breast cancer with unresectable metastases to the skin
391967|NCT01276899|Breast cancer with unresectable metastases to the lymph node|breast cancer with unresectable metastases to the lymph node
392157|NCT01276028|Menopause|menopause
391968|NCT01276899|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
391969|NCT01276886|Left sided acute diverticulitis diagnosed clinically by the presence of abdominal pain, leukocytosis (>11x109) and/or fever >38°C, confirmed by imaging.|left sided acute diverticulitis diagnosed clinically by the presence of abdominal pain, leukocytosis (>11x109) and/or fever >38°c, confirmed by imaging.
391970|NCT01276886|CT criteria: localized thickening (≥4 mm) of the colonic wall and signs of inflammation of the pericolic fat, abscess and/or extraluminal air and/or contrast.|ct criteria: localized thickening (≥4 mm) of the colonic wall and signs of inflammation of the pericolic fat, abscess and/or extraluminal air and/or contrast.
391971|NCT01276886|US criteria: bowel wall thickening (>4 mm), diverticular inflammation, pericolic fat edema, intramural or pericolic inflammatory mass, intramural fistula.|us criteria: bowel wall thickening (>4 mm), diverticular inflammation, pericolic fat edema, intramural or pericolic inflammatory mass, intramural fistula.
391972|NCT01276886|WSCE criteria: segmental luminal narrowing and a tethered mucosa with or without a mass effect or extravasation of contrast and/or extraluminal air.|wsce criteria: segmental luminal narrowing and a tethered mucosa with or without a mass effect or extravasation of contrast and/or extraluminal air.
391973|NCT01276873|Artificial Respiration|artificial respiration
391974|NCT01276873|Suction|suction
391975|NCT01276873|Pain|pain
391978|NCT01276860|Obstructive Sleep Apnea|obstructive sleep apnea
391979|NCT01276860|Pediatric Obstructive Sleep Apnea|pediatric obstructive sleep apnea
391980|NCT01276860|OSA|osa
391981|NCT01276860|PVT|pvt
391982|NCT01276860|Psychomotor Vigilance Testing|psychomotor vigilance testing
391983|NCT01276860|Psychomotor Vigilance Task|psychomotor vigilance task
391984|NCT01276847|psoriasis|psoriasis
391985|NCT01276847|Ustekinumab|ustekinumab
391986|NCT01276847|Stelara|stelara
391987|NCT01276847|Etanercept|etanercept
391988|NCT01276847|Enbrel|enbrel
391989|NCT01276821|Bronchiolitis|bronchiolitis
391990|NCT01276821|L-Epinephrine|l-epinephrine
391991|NCT01276821|3% Hypertonic Saline|3% hypertonic saline
391992|NCT01276821|Clinical Severity Score|clinical severity score
391993|NCT01276808|Magnetic navigation, percutaneous coronary intervention|magnetic navigation, percutaneous coronary intervention
391994|NCT01276769|Triple Negative Breast Cancer|triple negative breast cancer
391995|NCT01276769|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
391996|NCT01276769|Platinum|platinum
391997|NCT01276730|Advanced cervical cancer|advanced cervical cancer
391998|NCT01276730|India|india
391999|NCT01276691|Vascular function|vascular function
392000|NCT01276691|Inflammation|inflammation
392001|NCT01276691|Oxidative stress|oxidative stress
392002|NCT01276691|Hemostatic balance|hemostatic balance
392003|NCT01276691|Aspirin|aspirin
392004|NCT01276691|Firefighting|firefighting
392005|NCT01276678|CAD|cad
392006|NCT01276665|Bladder cancer|bladder cancer
392007|NCT01276665|urinary diversion|urinary diversion
392008|NCT01276665|Postoperative Complications|postoperative complications
392009|NCT01276665|Fluid Therapy|fluid therapy
392010|NCT01276665|Norepinephrine|norepinephrine
392011|NCT01276652|Polysomnography|polysomnography
392012|NCT01276652|Circadian rhythmicity|circadian rhythmicity
392013|NCT01276639|Xeljanz|xeljanz
392014|NCT01276639|tofacitinib|tofacitinib
392015|NCT01276639|chronic|chronic
392016|NCT01276639|Pruritus|pruritus
392017|NCT01276639|Itch|itch
392018|NCT01276639|DLQI|dlqi
392019|NCT01276639|severe|severe
392020|NCT01276639|moderate|moderate
392021|NCT01276639|treatment|treatment
392022|NCT01276639|safety|safety
392023|NCT01276639|efficacy|efficacy
392024|NCT01276639|CP-690,550|cp-690,550
392025|NCT01276639|Plaque Psoriasis|plaque psoriasis
392026|NCT01276639|Psoriasis Vulgaris|psoriasis vulgaris
392027|NCT01276639|Jax-inhibitor|jax-inhibitor
392028|NCT01276639|Oral Treatment|oral treatment
392029|NCT01276613|Resectable Adenocarcinoma of the Pancreas|resectable adenocarcinoma of the pancreas
392030|NCT01276613|Gemcitabine|gemcitabine
392031|NCT01276613|Gemcitabine Hydrochloride|gemcitabine hydrochloride
392032|NCT01276613|Gemzar|gemzar
392033|NCT01276587|sickle cell disease|sickle cell disease
392034|NCT01276587|children|children
392035|NCT01276587|vitamin D|vitamin d
392036|NCT01276587|safety|safety
392037|NCT01276574|PET/CT|pet/ct
392038|NCT01276574|Ovarian cancer|ovarian cancer
392039|NCT01276574|HE4|he4
392040|NCT01276561|laparoscopy|laparoscopy
392041|NCT01276561|splenectomy|splenectomy
392042|NCT01276561|single site|single site
392043|NCT01276561|trial|trial
392044|NCT01276522|Schnitzler syndrome|schnitzler syndrome
392045|NCT01276522|IL-1 beta|il-1 beta
392046|NCT01276522|Canakinumab|canakinumab
392047|NCT01276522|Ilaris|ilaris
392048|NCT01276522|Treatment|treatment
392049|NCT01276522|Efficacy|efficacy
392050|NCT01276522|Safety|safety
392051|NCT01276509|Crohn's disease Safety Efficacy Pharmacokinetics Pharmacodynamics Crohn's Disease Activity Index (CDAI)|crohn's disease safety efficacy pharmacokinetics pharmacodynamics crohn's disease activity index (cdai)
392052|NCT01276483|GIST|gist
392053|NCT01276483|Response Monitoring|response monitoring
392054|NCT01276483|Functional Magnetic Imaging|functional magnetic imaging
392055|NCT01276483|Positron Emission Tomography|positron emission tomography
392056|NCT01276483|Computer Tomography|computer tomography
392057|NCT01276470|Adult and Pediatric Autoimmune Disease|adult and pediatric autoimmune disease
392058|NCT01276470|Antibody|antibody
392059|NCT01276470|Autoimmune Diseases|autoimmune diseases
392060|NCT01276470|Autoimmunity Pathogenesis|autoimmunity pathogenesis
392061|NCT01276470|Environmental Risk Factors|environmental risk factors
392062|NCT01276470|Myositis|myositis
392063|NCT01276457|immunosuppression|immunosuppression
392064|NCT01276457|kidney transplantation|kidney transplantation
392065|NCT01276457|everolimus|everolimus
392066|NCT01276457|safety|safety
392067|NCT01276444|valve repair|valve repair
392068|NCT01276444|postoperative period|postoperative period
392069|NCT01276444|goal-directed therapy|goal-directed therapy
392070|NCT01276444|pulmonary artery catheter|pulmonary artery catheter
392071|NCT01276444|transpulmonary thermodilution|transpulmonary thermodilution
392072|NCT01276444|central venous oxygen saturation|central venous oxygen saturation
392073|NCT01276392|regional and systemical anticoagulation|regional and systemical anticoagulation
392074|NCT01276392|continuous renal replacement therapy|continuous renal replacement therapy
392075|NCT01276392|multiplate|multiplate
392076|NCT01276392|rotational thrombelastometry|rotational thrombelastometry
392077|NCT01276379|colorectal cancer|colorectal cancer
392078|NCT01276379|advanced|advanced
392079|NCT01276379|metastatic|metastatic
392080|NCT01276379|KRAS|kras
392081|NCT01276379|biomarkers (BRAF, IGF1P/MMp7,PI3K-PTEN)|biomarkers (braf, igf1p/mmp7,pi3k-pten)
392082|NCT01276379|cetuximab|cetuximab
392083|NCT01276366|Heel lance|heel lance
392084|NCT01276366|Premature|premature
392085|NCT01276366|Breast milk|breast milk
392086|NCT01276353|Alzheimer Disease|alzheimer disease
392087|NCT01276353|Dementia|dementia
392088|NCT01276353|Delirium|delirium
392089|NCT01276353|Amnestic|amnestic
392090|NCT01276353|Cognitive Disorders|cognitive disorders
392091|NCT01276353|Donepezil|donepezil
392092|NCT01276353|Brain Diseases|brain diseases
392093|NCT01276353|Central Nervous System Diseases|central nervous system diseases
392094|NCT01276353|Nervous System Diseases|nervous system diseases
392095|NCT01276353|Tauopathies|tauopathies
392096|NCT01276353|Neurodegenerative Diseases|neurodegenerative diseases
392097|NCT01276353|Mental Disorders|mental disorders
392098|NCT01276353|Cholinesterase Inhibitors|cholinesterase inhibitors
392099|NCT01276353|Enzy|enzy
392100|NCT01276340|Urinary Incontinence|urinary incontinence
392101|NCT01276340|Urinary stress incontinence|urinary stress incontinence
392102|NCT01276340|Urinary urge incontinence|urinary urge incontinence
392103|NCT01276340|Women|women
392104|NCT01276340|electrical stimulation|electrical stimulation
392105|NCT01276340|KEAT stimulator|keat stimulator
392106|NCT01276340|quality of life|quality of life
392107|NCT01276314|SCAR|scar
392108|NCT01276314|anti-TNF-a|anti-tnf-a
392109|NCT01276275|Acute coronary syndrome, thienopyridine, epidemiology|acute coronary syndrome, thienopyridine, epidemiology
392110|NCT01276262|Phase 1, healthy female volunteers, oral contraceptive, pharmacokinetics, Rheumatoid arthritis, RA, fostamatinib|phase 1, healthy female volunteers, oral contraceptive, pharmacokinetics, rheumatoid arthritis, ra, fostamatinib
392111|NCT01276249|Aptus Endosystem|aptus endosystem
392112|NCT01276249|EndoStaple|endostaple
392113|NCT01276249|Endograft|endograft
392114|NCT01276249|Stent Graft|stent graft
392115|NCT01276249|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
392116|NCT01276249|Heli-FX|heli-fx
392117|NCT01276249|EndoAnchor|endoanchor
392118|NCT01276236|Kaposi's Sarcoma|kaposi's sarcoma
392119|NCT01276236|Maraviroc|maraviroc
392120|NCT01276236|CCR5|ccr5
392121|NCT01276236|HIV|hiv
392122|NCT01276223|Dry eye|dry eye
392123|NCT01276223|ocular discomfort|ocular discomfort
392124|NCT01276197|hypertension|hypertension
392125|NCT01276197|healthcare disparities|healthcare disparities
392126|NCT01276197|minority health|minority health
392127|NCT01276197|health behavior|health behavior
392128|NCT01276184|HPV Vaccine|hpv vaccine
392129|NCT01276184|HPV vaccination|hpv vaccination
392130|NCT01276184|SMS|sms
392131|NCT01276184|Text Message|text message
392132|NCT01276184|Gardasil|gardasil
392133|NCT01276145|pudendal artery disease|pudendal artery disease
392134|NCT01276145|erectile dysfunction|erectile dysfunction
392135|NCT01276145|coronary angiography|coronary angiography
392136|NCT01276145|coronary disease|coronary disease
392138|NCT01276132|percutaneous coronary artery intervention|percutaneous coronary artery intervention
392139|NCT01276132|coronary disease|coronary disease
392140|NCT01276119|CDP6038|cdp6038
392141|NCT01276119|single-dose|single-dose
392142|NCT01276119|pharmacokinetics|pharmacokinetics
392143|NCT01276119|healthy subjects|healthy subjects
392144|NCT01276106|AC-201|ac-201
392145|NCT01276106|Interleukin 1 inhibitor|interleukin 1 inhibitor
392146|NCT01276093|Atrial fibrillation|atrial fibrillation
392147|NCT01276093|PVI ablation|pvi ablation
392148|NCT01276093|Elderly patients|elderly patients
392149|NCT01276093|Efficacy|efficacy
392150|NCT01276041|MAB 2C4 (PERTUZUMAB)|mab 2c4 (pertuzumab)
392151|NCT01276041|MAB HER 2 (HERCEPTIN) (TRASTUZUMAB)|mab her 2 (herceptin) (trastuzumab)
392152|NCT01276041|TAXOL (PACLITAXEL)|taxol (paclitaxel)
392153|NCT01276041|10-142|10-142
392154|NCT01276041|Stage IV HER2 (+) breast cancer|stage iv her2 (+) breast cancer
392155|NCT01276028|Acupuncture|acupuncture
392156|NCT01276028|Hot Flashes|hot flashes
392158|NCT01276028|Vasomotor Symptoms|vasomotor symptoms
392159|NCT01276015|BoNT-A-botulinum neurotoxin type A|bont-a-botulinum neurotoxin type a
392160|NCT01276015|CMAP-compound muscle action potential|cmap-compound muscle action potential
392161|NCT01276015|CP-cerebral palsy|cp-cerebral palsy
392162|NCT01276015|LG-lateral gastrocnemius|lg-lateral gastrocnemius
392163|NCT01276015|MG-medial gastrocnemius|mg-medial gastrocnemius
392164|NCT01276015|TA-tibialis anterior|ta-tibialis anterior
392165|NCT01276015|PROMS-passive range of movement|proms-passive range of movement
392166|NCT01276015|MAS-modified Ashworth scale|mas-modified ashworth scale
392167|NCT01276015|EVGS-Edinburgh visual gait scale|evgs-edinburgh visual gait scale
392168|NCT01276015|GMF-CS-gross motor function classification system|gmf-cs-gross motor function classification system
392169|NCT01276002|disrupted duct|disrupted duct
392170|NCT01276002|pancreatic pseudocysts|pancreatic pseudocysts
392171|NCT01275976|C1-esterase inhibitor|c1-esterase inhibitor
392172|NCT01275976|Systemic inflammation|systemic inflammation
392173|NCT01275976|Sepsis|sepsis
392174|NCT01275976|Trauma|trauma
392175|NCT01275976|Multiple Organ Dysfunction Syndrome|multiple organ dysfunction syndrome
392176|NCT01275976|Cytokines|cytokines
392177|NCT01275963|Echocardiography|echocardiography
392178|NCT01275963|Strain imaging|strain imaging
392179|NCT01275963|Ventricular Dysfunction|ventricular dysfunction
392180|NCT01275963|Cardiomyopathy|cardiomyopathy
392181|NCT01275963|Longitudinal left ventricular function|longitudinal left ventricular function
392182|NCT01275950|Tobacco vendor|tobacco vendor
392183|NCT01275950|students|students
392184|NCT01275950|knowledge|knowledge
392185|NCT01275950|attitude|attitude
392186|NCT01275950|practice|practice
392187|NCT01275950|direct advertisements|direct advertisements
392188|NCT01275950|surrogate advertisements|surrogate advertisements
392189|NCT01275924|Syndesmosis|syndesmosis
392190|NCT01275924|Injury|injury
392191|NCT01275924|Ankle|ankle
392192|NCT01275924|Fracture|fracture
392193|NCT01275898|NIRS|nirs
392194|NCT01275898|cerebral oxygenation|cerebral oxygenation
392195|NCT01275885|cholecalciferol|cholecalciferol
392196|NCT01275885|infant|infant
392197|NCT01275885|bone mineral density|bone mineral density
392198|NCT01275872|guided imagery|guided imagery
392199|NCT01275872|progressive muscle relaxation|progressive muscle relaxation
392200|NCT01275872|complimentary and alternative medicine|complimentary and alternative medicine
392201|NCT01275872|quality of life|quality of life
392202|NCT01275872|stress|stress
392203|NCT01275872|pain|pain
392204|NCT01275872|anxiety|anxiety
392205|NCT01275859|Neoadjuvant|neoadjuvant
392206|NCT01275859|Letrozole|letrozole
392207|NCT01275859|Lapatinib|lapatinib
392208|NCT01275859|Postmenopausal|postmenopausal
392209|NCT01275846|heart failure|heart failure
392210|NCT01275846|congestive heart failure|congestive heart failure
392211|NCT01275846|telemedicine|telemedicine
392212|NCT01275833|Implantable ICD|implantable icd
392213|NCT01275833|First Degree AV block|first degree av block
392214|NCT01275820|diabetes, insulin, blood sugar|diabetes, insulin, blood sugar
392215|NCT01275807|climacteric, climacteric syndrome|climacteric, climacteric syndrome
392216|NCT01275794|Type 2 Diabetes|type 2 diabetes
392217|NCT01275781|Phase 1|phase 1
392218|NCT01275781|healthy male volunteers|healthy male volunteers
392219|NCT01275781|radioactivity|radioactivity
392220|NCT01275781|excretion|excretion
392221|NCT01275781|metabolism|metabolism
392222|NCT01275781|AZD9742|azd9742
392223|NCT01275781|amount of radioactive AZD9742 in urine, feces, and vomitus (if appropriate)|amount of radioactive azd9742 in urine, feces, and vomitus (if appropriate)
392224|NCT01275768|radio-frequency ablation|radio-frequency ablation
392225|NCT01275768|Malignant jaundice|malignant jaundice
392226|NCT01275755|opioid therapy|opioid therapy
391785|NCT01277627|HCV|hcv
392227|NCT01275755|constipation|constipation
392228|NCT01275755|chronic noncancer pain|chronic noncancer pain
392229|NCT01275755|mu opioid receptor antagonist|mu opioid receptor antagonist
392230|NCT01275755|ADL5945|adl5945
392231|NCT01275755|Opioid Induced Constipation|opioid induced constipation
392232|NCT01275742|Heart failure|heart failure
392233|NCT01275742|Depression|depression
392234|NCT01275742|Depressive symptoms|depressive symptoms
392235|NCT01275742|Cognitive therapy|cognitive therapy
392236|NCT01275742|Hospitalization|hospitalization
392237|NCT01275742|Quality of life|quality of life
392238|NCT01275729|Renal Replacement Therapy|renal replacement therapy
392239|NCT01275729|Diuretics|diuretics
392240|NCT01275729|Biomarkers|biomarkers
392241|NCT01275729|Renal Insufficiency|renal insufficiency
392242|NCT01275729|Furosemide|furosemide
392243|NCT01275729|Therapeutic Uses|therapeutic uses
392244|NCT01275729|Physiological Effects of Drugs|physiological effects of drugs
392245|NCT01275729|Biological Markers|biological markers
392246|NCT01275716|Patient Education|patient education
392247|NCT01275716|coronary artery disease|coronary artery disease
392248|NCT01275716|Impact of Coronary Images Used During Patient Education on Coronary Artery Disease and Subsequent Lifestyle Modifications.|impact of coronary images used during patient education on coronary artery disease and subsequent lifestyle modifications.
392340|NCT01275326|Indoor Air Quality|indoor air quality
392341|NCT01275326|Infectious Aerosols|infectious aerosols
392249|NCT01275703|To determine the utility of a noninvasive method of measuring cardiac output during exercise testing in patients with PH|to determine the utility of a noninvasive method of measuring cardiac output during exercise testing in patients with ph
392250|NCT01275690|cardiac|cardiac
392251|NCT01275690|pulmonary hypertension|pulmonary hypertension
392252|NCT01275690|To determine the accuracy of a noninvasive method of measuring cardiac output as compared to the standard invasive approach in patients with PH|to determine the accuracy of a noninvasive method of measuring cardiac output as compared to the standard invasive approach in patients with ph
392253|NCT01275651|adenocarcinoma of the prostate|adenocarcinoma of the prostate
392254|NCT01275651|recurrent prostate cancer|recurrent prostate cancer
392255|NCT01275638|cortisol, prednisolone, adrenal insufficiency, sepsis|cortisol, prednisolone, adrenal insufficiency, sepsis
392256|NCT01275625|maraviroc|maraviroc
392257|NCT01275625|naive|naive
392259|NCT01275625|zidovudine|zidovudine
392260|NCT01275625|lamivudine|lamivudine
392261|NCT01275625|combivir|combivir
392262|NCT01275625|Clade A|clade a
392263|NCT01275612|Mesenchymal Stromal Cells|mesenchymal stromal cells
392264|NCT01275612|Solid tumors|solid tumors
392265|NCT01275612|Cisplatin therapy|cisplatin therapy
392362|NCT01275209|CD40|cd40
392266|NCT01275612|Acute kidney injury|acute kidney injury
392268|NCT01275586|plexiform neurofibromas|plexiform neurofibromas
392269|NCT01275586|nilotinib|nilotinib
392270|NCT01275586|Tasigna|tasigna
392271|NCT01275573|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
392272|NCT01275573|pain threshold|pain threshold
392273|NCT01275573|Parkinson's disease|parkinson's disease
392274|NCT01275573|Pain threshold in Parkinson's disease|pain threshold in parkinson's disease
392275|NCT01275547|Patient controlled analgesia|patient controlled analgesia
392276|NCT01275547|Morphine|morphine
392277|NCT01275547|S-Ketamine intranasal|s-ketamine intranasal
392278|NCT01275547|Midazolam intranasal|midazolam intranasal
392279|NCT01275534|Stem cell transplantation|stem cell transplantation
392280|NCT01275534|Symptom experience|symptom experience
392281|NCT01275534|Late effects|late effects
392282|NCT01275534|Self-management|self-management
392283|NCT01275508|Subjects with active Crohn's disease|subjects with active crohn's disease
392284|NCT01275508|Safety and tolerability of FITC-Adalimumab|safety and tolerability of fitc-adalimumab
392285|NCT01275508|Intestinal topical application|intestinal topical application
392286|NCT01275495|Stroke|stroke
392287|NCT01275495|Family Caregivers|family caregivers
392288|NCT01275495|Cerebrovascular Accident|cerebrovascular accident
392289|NCT01275495|Carers|carers
392290|NCT01275495|Care Givers|care givers
392291|NCT01275495|Depression|depression
392292|NCT01275495|Life change events|life change events
392293|NCT01275495|Family health|family health
392294|NCT01275495|Quality of life|quality of life
392295|NCT01275495|Cost|cost
392296|NCT01275495|Intervention studies|intervention studies
392297|NCT01275495|Clinical trial|clinical trial
392298|NCT01275482|Latent Myofascial trigger point.|latent myofascial trigger point.
392299|NCT01275482|Transverse friction massage|transverse friction massage
392300|NCT01275482|Local twitch response|local twitch response
392301|NCT01275482|Effectiveness|effectiveness
392302|NCT01275469|Impaired Glucose tolerance|impaired glucose tolerance
392303|NCT01275469|OGTT|ogtt
392304|NCT01275469|PPARs|ppars
392305|NCT01275456|allergen provocation|allergen provocation
392306|NCT01275456|environmental challenge|environmental challenge
392307|NCT01275456|allergen chamber|allergen chamber
392308|NCT01275456|house dust mite|house dust mite
392309|NCT01275456|immunotherapy|immunotherapy
392310|NCT01275443|HIV|hiv
392311|NCT01275430|central venous catheters|central venous catheters
392312|NCT01275430|peripherally inserted central catheters (PICC_|peripherally inserted central catheters (picc_
600789|NCT00583674|AMG 386|amg 386
392313|NCT01275430|Electrocardiography (ECG)|electrocardiography (ecg)
392314|NCT01275430|intravascular ECG|intravascular ecg
392315|NCT01275430|Tip Positioning System|tip positioning system
392316|NCT01275417|Acupuncture|acupuncture
392317|NCT01275404|Erectile Dysfunction|erectile dysfunction
392318|NCT01275404|focus group|focus group
392319|NCT01275404|Quality of Life|quality of life
392320|NCT01275404|10-204|10-204
392321|NCT01275391|Tobacco use|tobacco use
392322|NCT01275391|Alcohol abuse|alcohol abuse
392323|NCT01275391|Drug abuse|drug abuse
392324|NCT01275391|Substance use|substance use
392325|NCT01275391|Prevention|prevention
392326|NCT01275391|Brief intervention|brief intervention
392327|NCT01275391|Screening|screening
392328|NCT01275391|Adolescents|adolescents
392329|NCT01275365|Mobility Limitation|mobility limitation
392330|NCT01275365|Low Protein Intake|low protein intake
392331|NCT01275365|Older Men|older men
392332|NCT01275365|Testosterone|testosterone
392333|NCT01275352|left ventricular hypertrophy|left ventricular hypertrophy
392334|NCT01275352|heart failure|heart failure
392335|NCT01275339|Aortic valve stenosis|aortic valve stenosis
392336|NCT01275339|Tadalafil|tadalafil
392337|NCT01275339|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
392338|NCT01275339|Hypertension, pulmonary|hypertension, pulmonary
392339|NCT01275339|Hypertrophy, left ventricular|hypertrophy, left ventricular
392342|NCT01275313|Pressure ulcers|pressure ulcers
392343|NCT01275313|wheelchairs|wheelchairs
392344|NCT01275313|wheelchair functional capacity|wheelchair functional capacity
392345|NCT01275313|custom-fitted wheelchair|custom-fitted wheelchair
392346|NCT01275287|Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis|anti-neutrophil cytoplasmic antibody-associated vasculitis
392347|NCT01275287|Complement Activation|complement activation
392348|NCT01275274|ANCA|anca
392349|NCT01275274|Vasculitis|vasculitis
392350|NCT01275274|Pauci-immune vasculitis|pauci-immune vasculitis
392351|NCT01275261|Stroke|stroke
392352|NCT01275261|Urinary Tract Infection|urinary tract infection
392353|NCT01275248|OCD|ocd
392354|NCT01275248|Obsessive Compulsive Disorder|obsessive compulsive disorder
392355|NCT01275222|GIST|gist
392356|NCT01275222|everolimus|everolimus
392357|NCT01275222|mTOR|mtor
392358|NCT01275222|Imatinib resistant|imatinib resistant
392359|NCT01275222|Imatinib-refractory/resistant gastrointestinal stromal tumors|imatinib-refractory/resistant gastrointestinal stromal tumors
392360|NCT01275209|HCD122|hcd122
392361|NCT01275209|Lucatumumab|lucatumumab
392363|NCT01275209|Follicular Lymphoma|follicular lymphoma
392364|NCT01275209|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
392365|NCT01275209|Antibody|antibody
392366|NCT01275196|Newly diagnosed,|newly diagnosed,
392367|NCT01275196|Ph+ chronic myeloid leukemia,|ph+ chronic myeloid leukemia,
392368|NCT01275196|CML-CP|cml-cp
392369|NCT01275183|HNSCC|hnscc
392370|NCT01275183|SCC|scc
392371|NCT01275183|head and neck|head and neck
392372|NCT01275183|squamous cell|squamous cell
392373|NCT01275183|nasopharyngeal|nasopharyngeal
392374|NCT01275157|Absorption|absorption
392375|NCT01275157|Distribution|distribution
392376|NCT01275157|Metabolism|metabolism
392377|NCT01275157|Excretion|excretion
392378|NCT01275157|Mass balance|mass balance
392379|NCT01275157|Metabolic profile|metabolic profile
392380|NCT01275157|Radiolabeled study|radiolabeled study
392381|NCT01275157|14C|14c
392382|NCT01275131|Insulin analog|insulin analog
392383|NCT01275131|Type 1 diabetes mellitus|type 1 diabetes mellitus
392384|NCT01275131|Pharmacokinetic|pharmacokinetic
392385|NCT01275131|Glucodynamic|glucodynamic
392386|NCT01275131|Phase 1|phase 1
392387|NCT01275092|robotic-assisted PCI|robotic-assisted pci
392388|NCT01275092|coronary intervention|coronary intervention
392389|NCT01275092|CorPath PRECISE|corpath precise
392390|NCT01275092|PCI|pci
392391|NCT01275079|tonsillectomy|tonsillectomy
392392|NCT01275079|nasalance|nasalance
392393|NCT01275079|tonsil volume|tonsil volume
392394|NCT01275079|Thai|thai
392395|NCT01275079|adult|adult
392396|NCT01275066|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
392397|NCT01275066|MPS IV Type A|mps iv type a
392398|NCT01275066|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
392399|NCT01275066|MPS IVA|mps iva
392400|NCT01275066|Morquio A Syndrome|morquio a syndrome
392401|NCT01275066|Lysosomal Storage Disorder|lysosomal storage disorder
392402|NCT01275066|LSD|lsd
392403|NCT01275066|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
392404|NCT01275066|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
392405|NCT01275066|galactose-6-sulfatase|galactose-6-sulfatase
392406|NCT01275066|GALNS|galns
392407|NCT01275066|enzyme replacement therapy|enzyme replacement therapy
392408|NCT01275066|ERT|ert
392409|NCT01275053|Leptin|leptin
392410|NCT01275053|In Vivo|in vivo
392411|NCT01275053|Diabetic|diabetic
392412|NCT01275053|Obese|obese
392413|NCT01275053|Lean|lean
392414|NCT01275040|diabetes|diabetes
392415|NCT01275040|mobile screening|mobile screening
392416|NCT01275040|complications|complications
392417|NCT01275040|primary care|primary care
392418|NCT01275040|specialised care|specialised care
392419|NCT01275040|quality of care|quality of care
392421|NCT01275027|blood sugar|blood sugar
392422|NCT01275027|insulin|insulin
392423|NCT01275027|nutritional supplement|nutritional supplement
392424|NCT01275027|nutraceutical|nutraceutical
392426|NCT01275014|corticosteroids|corticosteroids
392427|NCT01275014|osteoarthritis|osteoarthritis
392428|NCT01275014|arthrocentesis|arthrocentesis
392429|NCT01275014|pain|pain
392430|NCT01275001|brain|brain
392431|NCT01275001|brain development|brain development
392432|NCT01275001|MRI|mri
392433|NCT01275001|preschool children|preschool children
392434|NCT01275001|cortical mantle thickness|cortical mantle thickness
392435|NCT01275001|hippocampal volume|hippocampal volume
392436|NCT01274988|Opiate dependence|opiate dependence
392437|NCT01274988|Deep brain stimulation|deep brain stimulation
392438|NCT01274988|Nucleus accumbens|nucleus accumbens
392439|NCT01274949|LI-ESWT|li-eswt
392440|NCT01274949|Erectile Dysfunction|erectile dysfunction
392441|NCT01274949|Radical Prostatectomy|radical prostatectomy
392442|NCT01274949|Non PDE5 inhibitor responders|non pde5 inhibitor responders
392443|NCT01274949|Shock wave|shock wave
392444|NCT01274923|Erectile dysfunction|erectile dysfunction
392445|NCT01274923|Low Intensity Shock Wave|low intensity shock wave
392446|NCT01274910|Fish Oil|fish oil
392447|NCT01274910|Knee|knee
392448|NCT01274910|Analgetics|analgetics
392449|NCT01274897|Meningococcal|meningococcal
392450|NCT01274897|ACWY-CRM|acwy-crm
392451|NCT01274897|Conjugate Vaccine|conjugate vaccine
392452|NCT01274897|Meningitis|meningitis
392453|NCT01274897|Adolescents|adolescents
392454|NCT01274897|Persistence|persistence
392455|NCT01274897|Adults|adults
392456|NCT01274884|Acromioclavicular|acromioclavicular
392457|NCT01274884|Injury|injury
392458|NCT01274884|Dislocation|dislocation
392459|NCT01274884|Surgery|surgery
392460|NCT01274871|Thoracotomy|thoracotomy
392461|NCT01274871|Chronic Pain|chronic pain
392462|NCT01274871|persistent post-surgical pain|persistent post-surgical pain
392463|NCT01274858|persistent pain|persistent pain
392464|NCT01274858|neuropathic pain|neuropathic pain
392465|NCT01274858|Thoracotomy|thoracotomy
392466|NCT01274858|Chronic Pain|chronic pain
392467|NCT01274845|Meconium aspiration syndrome|meconium aspiration syndrome
392468|NCT01274845|Heliox|heliox
392469|NCT01274845|Mechanical ventilation|mechanical ventilation
392470|NCT01274845|Newborn|newborn
392471|NCT01274832|Parkinson|parkinson
392472|NCT01274832|DBS of STN|dbs of stn
392473|NCT01274832|PD|pd
392474|NCT01274832|Deep Brain stimulation of STN|deep brain stimulation of stn
392475|NCT01274832|Early treatment|early treatment
392476|NCT01274819|delirium|delirium
392477|NCT01274819|confusion|confusion
392478|NCT01274806|breast cancer|breast cancer
392479|NCT01274806|physical therapy|physical therapy
392480|NCT01274806|massage|massage
392481|NCT01274806|core stability|core stability
392482|NCT01274793|functional constipation|functional constipation
392483|NCT01274793|functional diarrhea|functional diarrhea
392484|NCT01274793|acupuncture|acupuncture
392485|NCT01274754|neuroprotection|neuroprotection
392486|NCT01274754|erythromycin|erythromycin
392487|NCT01274754|neurocognitive assessment|neurocognitive assessment
392488|NCT01274741|Posttraumatic stress disorder|posttraumatic stress disorder
392489|NCT01274741|Substance use disorder|substance use disorder
392490|NCT01274741|Treatment efficacy|treatment efficacy
392491|NCT01274741|Randomized trial|randomized trial
392492|NCT01274728|Acute myocardial infarction|acute myocardial infarction
392493|NCT01274728|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
392494|NCT01274728|Drug-eluting balloon|drug-eluting balloon
392495|NCT01274728|Bivalirudin|bivalirudin
392496|NCT01274715|Behavioral health coaching|behavioral health coaching
392497|NCT01274715|Diabetes|diabetes
392498|NCT01274715|Emotional health|emotional health
392499|NCT01274702|History of|history of
392500|NCT01274702|Patients|patients
392501|NCT01274702|acute|acute
392502|NCT01274689|lagophthalmos|lagophthalmos
392503|NCT01274689|parotis tumor|parotis tumor
392504|NCT01274689|m. orbicularis oculi paresis|m. orbicularis oculi paresis
392505|NCT01274676|stenting|stenting
392506|NCT01274676|carotid plaque|carotid plaque
392507|NCT01274676|stenosis|stenosis
392508|NCT01274676|angioplasty|angioplasty
392509|NCT01274663|Single Ascending Dose|single ascending dose
392510|NCT01274663|Phase 1|phase 1
392511|NCT01274663|Safety and Tolerability|safety and tolerability
392512|NCT01274663|PK|pk
392513|NCT01274663|Healthy Subjects|healthy subjects
392514|NCT01274637|postpartum|postpartum
392515|NCT01274637|low molecular weight heparin|low molecular weight heparin
600790|NCT00583674|Cisplatin|cisplatin
392516|NCT01274637|venous thromboembolism|venous thromboembolism
392517|NCT01274637|prophylaxis|prophylaxis
392518|NCT01274637|Dalteparin Sodium|dalteparin sodium
392519|NCT01274624|Colorectal|colorectal
392520|NCT01274624|Cancer|cancer
392521|NCT01274624|REOLYSIN®|reolysin®
392522|NCT01274624|Chemotherapy|chemotherapy
392523|NCT01274624|FOLFIRI|folfiri
392524|NCT01274624|Reovirus|reovirus
392525|NCT01274624|Oncolytic virus|oncolytic virus
392526|NCT01274624|Fluorouracil|fluorouracil
392527|NCT01274624|Irinotecan|irinotecan
392528|NCT01274624|Leucovorin|leucovorin
392529|NCT01274624|Bevacizumab|bevacizumab
392530|NCT01274611|sweating|sweating
392531|NCT01274611|sweat|sweat
392532|NCT01274611|underarm|underarm
392533|NCT01274611|axillary|axillary
392534|NCT01274611|hyperhidrosis|hyperhidrosis
392535|NCT01274611|botox|botox
392536|NCT01274611|liposuction|liposuction
392537|NCT01274611|suction-curettage|suction-curettage
392538|NCT01274611|suction|suction
392539|NCT01274611|curettage|curettage
392540|NCT01274598|Probiotics|probiotics
392541|NCT01274598|Safety|safety
392542|NCT01274598|Elderly|elderly
392543|NCT01274598|Lactobacillus|lactobacillus
392545|NCT01274559|MK-0524A/ER|mk-0524a/er
392546|NCT01274559|Hypercholesterolemia|hypercholesterolemia
392547|NCT01274559|Dyslipidemia|dyslipidemia
392548|NCT01274559|Niacin|niacin
392549|NCT01274559|Laropiprant|laropiprant
392550|NCT01274533|ATLL|atll
392551|NCT01274520|ECD liver transplant allografts|ecd liver transplant allografts
392552|NCT01274520|Hypothermic machine perfusion|hypothermic machine perfusion
392553|NCT01274520|Cold storage preservation|cold storage preservation
392554|NCT01274520|liver transplant|liver transplant
392555|NCT01274520|portable bypass system|portable bypass system
392556|NCT01274520|machine perfusion preservation|machine perfusion preservation
392557|NCT01274520|extended criteria liver|extended criteria liver
392558|NCT01274507|Asthma|asthma
392559|NCT01274507|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
392560|NCT01274507|Healthy|healthy
392561|NCT01274507|Longitudinal Study|longitudinal study
392562|NCT01274507|Bronchoscopy|bronchoscopy
392563|NCT01274494|Hypertension|hypertension
392564|NCT01274481|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
392565|NCT01274481|Acute Lung Injury|acute lung injury
392566|NCT01274481|pulmonary hypertension|pulmonary hypertension
392567|NCT01274481|oxygenation|oxygenation
392568|NCT01274481|lung mechanics|lung mechanics
392569|NCT01274481|gas exchange|gas exchange
392570|NCT01274455|Gene therapy|gene therapy
392571|NCT01274455|pancreatic carcinoma|pancreatic carcinoma
392572|NCT01274455|gemcitabine|gemcitabine
392573|NCT01274455|endoscopic ultrasound|endoscopic ultrasound
392670|NCT01274052|Insulin|insulin
392574|NCT01274442|dental implant|dental implant
392575|NCT01274429|Peanut allergy|peanut allergy
392576|NCT01274429|Immunotherapy|immunotherapy
392577|NCT01274429|OIT|oit
392578|NCT01274416|Anorexia Nervosa|anorexia nervosa
392579|NCT01274416|Eating Disorder|eating disorder
392580|NCT01274416|Treatment|treatment
392581|NCT01274416|Acceptance and Commitment Therapy|acceptance and commitment therapy
392582|NCT01274416|Separated Family Treatment|separated family treatment
392583|NCT01274403|Multiple Myeloma|multiple myeloma
392584|NCT01274403|Elderly patients|elderly patients
392585|NCT01274390|Cardiac Surgery|cardiac surgery
392586|NCT01274390|Red Blood Cell|red blood cell
392587|NCT01274390|Transfusion|transfusion
392588|NCT01274390|Oxygen Saturation|oxygen saturation
392589|NCT01274390|Microvascular Flow|microvascular flow
392590|NCT01274377|nonmyeloablative allogeneic stem cell transplantation|nonmyeloablative allogeneic stem cell transplantation
392591|NCT01274377|cytomegalovirus|cytomegalovirus
392592|NCT01274377|donor lymphocyte infusions|donor lymphocyte infusions
392593|NCT01274377|cytotoxic T lymphocyte|cytotoxic t lymphocyte
392594|NCT01274364|Diabetes|diabetes
392595|NCT01274364|Structured Care|structured care
392596|NCT01274351|First line treatment|first line treatment
392597|NCT01274351|newly diagnosed|newly diagnosed
392598|NCT01274351|Philadelphia chromosome positive|philadelphia chromosome positive
392599|NCT01274351|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
392600|NCT01274351|Ph+|ph+
392601|NCT01274351|CML-CP|cml-cp
392602|NCT01274351|major molecular response|major molecular response
392603|NCT01274351|Social risk|social risk
392604|NCT01274325|asthma|asthma
392605|NCT01274312|Somato-sensory reflex arch|somato-sensory reflex arch
392606|NCT01274312|Spinal cord injury|spinal cord injury
392607|NCT01274312|Xiao Procedure|xiao procedure
392608|NCT01274299|Infants|infants
392609|NCT01274299|morphometry|morphometry
392610|NCT01274299|face|face
392611|NCT01274299|3D|3d
392612|NCT01274286|hospital accreditation|hospital accreditation
392613|NCT01274286|patient-centered|patient-centered
392614|NCT01274286|healthcare quality index|healthcare quality index
392615|NCT01274286|documentary analysis|documentary analysis
392616|NCT01274286|meta analysis|meta analysis
392617|NCT01274273|Bevacizumab|bevacizumab
392618|NCT01274273|interleukin-2|interleukin-2
392619|NCT01274273|interferon-alpha|interferon-alpha
392620|NCT01274260|child|child
392621|NCT01274260|infant|infant
392622|NCT01274260|lung injury|lung injury
392623|NCT01274260|inflammation|inflammation
392624|NCT01274260|pneumonia|pneumonia
392625|NCT01274260|ventilator|ventilator
392627|NCT01274247|Ankyloglossia|ankyloglossia
392628|NCT01274234|EPC capturing sirolimus eluting COMBO stent|epc capturing sirolimus eluting combo stent
392629|NCT01274234|Optical coherence tomography (OCT)|optical coherence tomography (oct)
392630|NCT01274234|Early neointimal healing and stent coverage|early neointimal healing and stent coverage
392631|NCT01274234|Late neointimal thickness, neointimal area, and lumen loss|late neointimal thickness, neointimal area, and lumen loss
392632|NCT01274208|Gaucher disease, Hepatitis C , Glucocerebroside immunity|gaucher disease, hepatitis c , glucocerebroside immunity
392633|NCT01274195|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
392634|NCT01274156|Erectile dysfunction|erectile dysfunction
392635|NCT01274156|Low Intensity Shock Wave|low intensity shock wave
392636|NCT01274143|Colorectal|colorectal
392637|NCT01274143|Cancer|cancer
392638|NCT01274143|Colon|colon
392639|NCT01274143|Rectal|rectal
392640|NCT01274143|Behavioral Intervention|behavioral intervention
392641|NCT01274143|Screening|screening
392642|NCT01274143|Motivational Interviewing|motivational interviewing
392643|NCT01274143|Extended Parallel Process Model|extended parallel process model
392644|NCT01274143|Implementation Intentions|implementation intentions
392645|NCT01274143|Family CARE|family care
392646|NCT01274117|Chronic renal failure|chronic renal failure
392647|NCT01274117|Basilic vein transposition fistula|basilic vein transposition fistula
392648|NCT01274104|statin-related myalgia|statin-related myalgia
392649|NCT01274104|high cholesterol|high cholesterol
393107|NCT01272531|Depakote|depakote
392650|NCT01274091|Gene-diet interaction|gene-diet interaction
392651|NCT01274091|PPARgamma gene|ppargamma gene
392652|NCT01274091|Pro12Ala|pro12ala
392653|NCT01274091|Fatty acids|fatty acids
392654|NCT01274091|Dietary modification|dietary modification
392655|NCT01274091|Insulin sensitivity|insulin sensitivity
392656|NCT01274091|Glucose metabolism|glucose metabolism
392657|NCT01274078|inflammation|inflammation
392658|NCT01274078|lipids|lipids
392659|NCT01274078|CRP|crp
392660|NCT01274065|psychiatry|psychiatry
392661|NCT01274065|psychiatric illness|psychiatric illness
392662|NCT01274065|developmental disability|developmental disability
392663|NCT01274065|mental health|mental health
392664|NCT01274065|medication burden|medication burden
392665|NCT01274052|Gestational diabetes mellitus|gestational diabetes mellitus
392666|NCT01274052|Meal test|meal test
392667|NCT01274052|Incretin hormones|incretin hormones
392668|NCT01274052|Glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
392669|NCT01274052|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
392671|NCT01274052|C-peptide|c-peptide
392672|NCT01274052|Glucagon|glucagon
392673|NCT01274026|phenylketonuria|phenylketonuria
392674|NCT01274026|PKU|pku
392675|NCT01274026|phenylalanine|phenylalanine
392676|NCT01274026|neurotransmitters|neurotransmitters
392677|NCT01274026|gene|gene
392678|NCT01274026|Kuvan|kuvan
392679|NCT01274026|sapropterin|sapropterin
392680|NCT01274013|Hepatitis C|hepatitis c
392681|NCT01274013|Chronic Hepatitis C|chronic hepatitis c
392682|NCT01274013|Vitamin D|vitamin d
392683|NCT01274013|Vitamin D deficiency|vitamin d deficiency
392684|NCT01274000|diarrhea|diarrhea
392685|NCT01274000|IBS|ibs
392686|NCT01274000|Colonic disease|colonic disease
392687|NCT01274000|YM060|ym060
392688|NCT01274000|Ramosetron|ramosetron
392689|NCT01273974|intradermal influenza vaccine|intradermal influenza vaccine
392690|NCT01273974|hemodialysis patients|hemodialysis patients
392691|NCT01273935|Aspirin, Acute Cerebrovascular Ischemia, Platelet Function|aspirin, acute cerebrovascular ischemia, platelet function
392692|NCT01273922|NDV-3|ndv-3
392693|NCT01273922|vaccine|vaccine
392694|NCT01273922|Staphylococcus aureus|staphylococcus aureus
392695|NCT01273922|MRSA|mrsa
392696|NCT01273922|Candida|candida
392697|NCT01273909|Breast Cancer|breast cancer
392698|NCT01273909|BRACA1/2 Genotype|braca1/2 genotype
392699|NCT01273909|Acquired Lymphedema|acquired lymphedema
392700|NCT01273909|Congenital Lymphedema|congenital lymphedema
392701|NCT01273896|STA-9090|sta-9090
392702|NCT01273896|advanced breast cancer|advanced breast cancer
392703|NCT01273896|10-145|10-145
392704|NCT01273883|hearing|hearing
392705|NCT01273883|magnesium|magnesium
392706|NCT01273870|hemodialysis|hemodialysis
392707|NCT01273870|high-flux-dialyzer|high-flux-dialyzer
392708|NCT01273870|performance|performance
392709|NCT01273870|blood compatibility|blood compatibility
392710|NCT01273857|Cardiac progenitor cells|cardiac progenitor cells
392711|NCT01273857|Cell therapy|cell therapy
392712|NCT01273857|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
392713|NCT01273857|Single Ventricle|single ventricle
392714|NCT01273857|Norwood|norwood
392715|NCT01273857|Sano modification|sano modification
392716|NCT01273857|Glenn|glenn
392717|NCT01273857|Fontan|fontan
392718|NCT01273844|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
392719|NCT01273844|amyloidosis|amyloidosis
392720|NCT01273844|Bortezomib|bortezomib
392721|NCT01273831|intraocular pressure, anesthesia,cisatracurium,atracurium.|intraocular pressure, anesthesia,cisatracurium,atracurium.
392722|NCT01273818|inguinal hernia|inguinal hernia
392723|NCT01273818|infection prophylaxis|infection prophylaxis
392724|NCT01273818|topical gentamicin|topical gentamicin
392725|NCT01273805|metastatic pancreatic cancer|metastatic pancreatic cancer
392726|NCT01273805|hydroxychloroquine|hydroxychloroquine
392727|NCT01273779|sepsis|sepsis
392728|NCT01273779|talactoferrin|talactoferrin
392729|NCT01273779|lactoferrin|lactoferrin
392730|NCT01273779|recombinant human lactoferrin|recombinant human lactoferrin
392731|NCT01273753|End-stage renal disease|end-stage renal disease
392732|NCT01273753|Hemodialysis|hemodialysis
392733|NCT01273753|Bioimpedance analysis|bioimpedance analysis
392734|NCT01273753|Blood volume monitoring|blood volume monitoring
392735|NCT01273740|PTFE bypass|ptfe bypass
392736|NCT01273740|femoro-popliteal|femoro-popliteal
392737|NCT01273740|femoro-crural|femoro-crural
392738|NCT01273740|popliteal arteries|popliteal arteries
392739|NCT01273740|crural arteries|crural arteries
392740|NCT01273740|external support|external support
392741|NCT01273740|crtical limb ischemia|crtical limb ischemia
392742|NCT01273727|epiretinal membrane|epiretinal membrane
392743|NCT01273727|macular pucker|macular pucker
392744|NCT01273727|cellophane maculopathy|cellophane maculopathy
392745|NCT01273727|macular edema|macular edema
392746|NCT01273727|retinal edema|retinal edema
392747|NCT01273727|ozurdex|ozurdex
392748|NCT01273727|dexamethasone|dexamethasone
392749|NCT01273727|intravitreal implant|intravitreal implant
392750|NCT01273714|benign thyroid disease|benign thyroid disease
392751|NCT01273714|incidental thyroid cancer|incidental thyroid cancer
392752|NCT01273714|recurrent goiter|recurrent goiter
392753|NCT01273714|revision thyroid surgery|revision thyroid surgery
392754|NCT01273701|amphetamine|amphetamine
392755|NCT01273701|methamphetamine|methamphetamine
392756|NCT01273701|psychosocial intervention|psychosocial intervention
392757|NCT01273701|contingency management|contingency management
392758|NCT01273701|slow prosecution|slow prosecution
392759|NCT01273701|substance use disorder|substance use disorder
392760|NCT01273688|pain|pain
392761|NCT01273688|elbow|elbow
392762|NCT01273688|tendinopathy|tendinopathy
392763|NCT01273675|Hypertension|hypertension
392764|NCT01273675|Primary disease|primary disease
392765|NCT01273662|HCC|hcc
392766|NCT01273649|muscle activation|muscle activation
392767|NCT01273649|ACL reconstruction|acl reconstruction
392768|NCT01273649|cryotherapy|cryotherapy
392769|NCT01273649|TENS|tens
392770|NCT01273636|Endometrial hyperplasia|endometrial hyperplasia
392771|NCT01273636|Hysterectomy|hysterectomy
392772|NCT01273636|Endometrial carcinoma|endometrial carcinoma
392773|NCT01273623|PAD, Peripheral Arterial Disease, Calcium, Atherectomy, Jetstream|pad, peripheral arterial disease, calcium, atherectomy, jetstream
392774|NCT01273610|Breast Neoplasms|breast neoplasms
392775|NCT01273610|HER2 protein, human|her2 protein, human
392776|NCT01273610|Geriatric Health Services|geriatric health services
392777|NCT01273610|Antineoplastic Agents, Combined|antineoplastic agents, combined
392778|NCT01273610|Geriatric Assessment|geriatric assessment
392779|NCT01273610|Pharmacokinetics|pharmacokinetics
392780|NCT01273610|Toxicity|toxicity
392781|NCT01273610|Patient Adherence|patient adherence
392782|NCT01273597|Parathyroid hormone,Kidney failure, chronic,Hyperparathyroidism, secondary|parathyroid hormone,kidney failure, chronic,hyperparathyroidism, secondary
392783|NCT01273584|Metformin, obese, pregnancy, gestational diabetes|metformin, obese, pregnancy, gestational diabetes
392784|NCT01273571|Canagliflozin|canagliflozin
392785|NCT01273571|Metformin (GLUCOPHAGE IR)|metformin (glucophage ir)
392786|NCT01273571|Pharmacokinetics|pharmacokinetics
392787|NCT01273571|Pharmacodynamics|pharmacodynamics
392788|NCT01273558|Canagliflozin|canagliflozin
392789|NCT01273558|Renal threshold for glucose|renal threshold for glucose
392790|NCT01273558|Pharmacodynamics|pharmacodynamics
392791|NCT01273545|Dapoxetine hydrochloride (PRILIGY)|dapoxetine hydrochloride (priligy)
392792|NCT01273545|Premature ejaculation|premature ejaculation
392793|NCT01273532|tapentadol|tapentadol
392794|NCT01273532|NUCYNTA|nucynta
392795|NCT01273532|CG5503|cg5503
392796|NCT01273532|R331333|r331333
392797|NCT01273532|pharmacokinetics|pharmacokinetics
392798|NCT01273532|healthy volunteer|healthy volunteer
392799|NCT01273519|Ankylosing|ankylosing
392800|NCT01273519|Rheumatoid|rheumatoid
392801|NCT01273519|Antibodies|antibodies
392802|NCT01273519|Arthritis|arthritis
392803|NCT01273519|Pain|pain
392804|NCT01273519|Antirheumatic Agents|antirheumatic agents
392805|NCT01273519|Psoriatic|psoriatic
392806|NCT01273519|Spondylitis|spondylitis
392807|NCT01273519|Monoclonals|monoclonals
392808|NCT01273506|tapentadol|tapentadol
392809|NCT01273506|NUCYNTA|nucynta
392810|NCT01273506|CG5503|cg5503
392811|NCT01273506|R331333|r331333
392812|NCT01273506|pharmacokinetics|pharmacokinetics
392813|NCT01273506|healthy volunteer|healthy volunteer
392814|NCT01273493|Trabectedin, YONDELIS|trabectedin, yondelis
392815|NCT01273493|Antineoplastic Agents|antineoplastic agents
392816|NCT01273493|Solid tumors|solid tumors
392817|NCT01273493|Locally advanced or metastatic disease|locally advanced or metastatic disease
392818|NCT01273493|Chemotherapy|chemotherapy
392819|NCT01273493|Pharmacokinetics|pharmacokinetics
392820|NCT01273493|Hepatic Dysfunction|hepatic dysfunction
392821|NCT01273480|Trabectedin, YONDELIS|trabectedin, yondelis
392822|NCT01273480|Rifampin (RIFADIN)|rifampin (rifadin)
392823|NCT01273480|Antineoplastic Agents|antineoplastic agents
392824|NCT01273480|Solid tumors|solid tumors
392825|NCT01273480|Locally advanced or metastatic disease|locally advanced or metastatic disease
392826|NCT01273480|Chemotherapy|chemotherapy
392827|NCT01273480|Pharmacokinetics|pharmacokinetics
392828|NCT01273467|Ischemic Cerebral Infarction|ischemic cerebral infarction
392829|NCT01273467|Stroke|stroke
392830|NCT01273467|CNTO0007|cnto0007
392831|NCT01273467|42037788|42037788
392832|NCT01273454|Open-label|open-label
392833|NCT01273454|Non-interventional|non-interventional
392834|NCT01273454|OROS hydromorphone|oros hydromorphone
392835|NCT01273454|Korean cancer patients|korean cancer patients
392836|NCT01273415|hormone receptor-positive breast cancer|hormone receptor-positive breast cancer
392837|NCT01273415|nomogram|nomogram
392838|NCT01273415|Ki67|ki67
392839|NCT01273415|Effects of Chemotherapy|effects of chemotherapy
392840|NCT01273402|colorectal cancer|colorectal cancer
392841|NCT01273402|TF2 (Recombinant, humanized Tri-Fab bsMAb composed of 2 humanized MN-14 anti-CEA Fab x and one 679 anti-HSG Fab)|tf2 (recombinant, humanized tri-fab bsmab composed of 2 humanized mn-14 anti-cea fab x and one 679 anti-hsg fab)
392842|NCT01273402|IMP288 (DOTA-di-HSG hapten-peptide for 111In/90Y labeling)|imp288 (dota-di-hsg hapten-peptide for 111in/90y labeling)
392843|NCT01273389|Lupus nephritis|lupus nephritis
392844|NCT01273389|CNTO 136|cnto 136
392845|NCT01273389|Sirukumab|sirukumab
392846|NCT01273389|Kidney diseases|kidney diseases
392847|NCT01273389|Proteinuria|proteinuria
392848|NCT01273389|Glomerulonephritis|glomerulonephritis
392850|NCT01273376|Depression|depression
392851|NCT01273376|Major Depression|major depression
392852|NCT01273363|Asthma|asthma
392853|NCT01273363|Asthma in Children|asthma in children
392854|NCT01273350|internal carotid artery|internal carotid artery
392855|NCT01273350|common carotid artery|common carotid artery
392856|NCT01273350|bruit|bruit
392857|NCT01273350|tia|tia
392858|NCT01273337|Stroke|stroke
392859|NCT01273337|Ischemia|ischemia
392860|NCT01273337|Ischemic Stroke|ischemic stroke
392861|NCT01273337|Middle Cerebral Artery|middle cerebral artery
392862|NCT01273337|MCA|mca
392863|NCT01273337|Stem Cells|stem cells
392864|NCT01273337|Stem Cell|stem cell
392865|NCT01273337|Autologous Bone Marrow|autologous bone marrow
392866|NCT01273337|Ipsilateral MCA|ipsilateral mca
392867|NCT01273324|Osteoarthritis|osteoarthritis
392868|NCT01273311|Brain Aging|brain aging
392869|NCT01273311|Diabetes|diabetes
392871|NCT01273311|Obesity|obesity
392872|NCT01273311|CARDIA|cardia
392873|NCT01273298|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
392874|NCT01273298|exercise|exercise
392875|NCT01273298|dynamic hyperinflation|dynamic hyperinflation
479267|NCT00104156|Qi|qi
392876|NCT01273298|cardioselective beta blockers|cardioselective beta blockers
392877|NCT01273272|Cognitive Behavior Therapy|cognitive behavior therapy
392878|NCT01273272|Early dementia, Alzheimer type|early dementia, alzheimer type
392879|NCT01273259|Hypertension, pulmonary|hypertension, pulmonary
392880|NCT01273259|DHEA|dhea
392881|NCT01273259|six-minute walk test|six-minute walk test
392882|NCT01273259|pulmonary arterial pressure|pulmonary arterial pressure
392883|NCT01273220|Epidemiology|epidemiology
392884|NCT01273220|Epidemiologic Survey|epidemiologic survey
392885|NCT01273220|Alcohol|alcohol
392886|NCT01273207|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
392887|NCT01273207|Inhaled Cyclosporine|inhaled cyclosporine
392888|NCT01273207|Graft-Versus-Host Disease|graft-versus-host disease
392889|NCT01273207|Bone Marrow Transplant|bone marrow transplant
392890|NCT01273207|Lung Transplantation|lung transplantation
392891|NCT01273207|Bronchiolitis Obliterans|bronchiolitis obliterans
392892|NCT01273207|Graft Versus Host Disease|graft versus host disease
392893|NCT01273194|Palliative Care|palliative care
392894|NCT01273194|Survey|survey
392895|NCT01273194|Quality of Life|quality of life
392896|NCT01273194|Attitudes|attitudes
392897|NCT01273194|Pediatric Cancer|pediatric cancer
392898|NCT01273181|Immunotherapy|immunotherapy
392899|NCT01273181|Gene Therapy|gene therapy
392900|NCT01273181|Metastatic Cancer|metastatic cancer
392901|NCT01273181|Clinical Response|clinical response
392902|NCT01273181|Metastatic Melanoma|metastatic melanoma
392903|NCT01273181|Metastatic Renal Cell Cancer|metastatic renal cell cancer
392904|NCT01273168|Pharmacokinetics|pharmacokinetics
392905|NCT01273168|Advanced Cancer|advanced cancer
392906|NCT01273168|Cytochrome P 450|cytochrome p 450
392907|NCT01273168|Selective Estrogen Receptor Modulator|selective estrogen receptor modulator
392908|NCT01273168|Tamoxifen Metabolite|tamoxifen metabolite
392909|NCT01273168|Gynecologic Cancer|gynecologic cancer
392910|NCT01273168|Breast Cancer|breast cancer
392911|NCT01273168|Desmoid Tumor|desmoid tumor
392912|NCT01273168|Endometrial Cancer|endometrial cancer
392913|NCT01273168|Ovarian Cancer|ovarian cancer
392914|NCT01273168|Uterine Cancer|uterine cancer
392915|NCT01273168|Fallopian Tube Cancer|fallopian tube cancer
392916|NCT01273168|Peritoneal Cancer|peritoneal cancer
392917|NCT01273155|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
392918|NCT01273155|Liver Dysfunction|liver dysfunction
392919|NCT01273155|Pharmacokinetics|pharmacokinetics
392920|NCT01273155|UGT1A1 Polymorphisms|ugt1a1 polymorphisms
392922|NCT01273155|Cancer|cancer
392923|NCT01273155|Lymphoma|lymphoma
392924|NCT01273142|Human Immunodeficiency Virus, liver toxicity, hapatitis co-infection|human immunodeficiency virus, liver toxicity, hapatitis co-infection
392925|NCT01273129|Neurosurgery|neurosurgery
392926|NCT01273129|Childhood Epilepsy|childhood epilepsy
392927|NCT01273129|Epilepsy|epilepsy
392928|NCT01273129|Frontal Lobe Epilepsy|frontal lobe epilepsy
392929|NCT01273129|Temporal Lobe Epilepsy|temporal lobe epilepsy
392930|NCT01273116|frailty|frailty
392931|NCT01273116|integrated care|integrated care
392932|NCT01273116|hospital|hospital
392933|NCT01273116|geriatrics|geriatrics
392934|NCT01273116|hospital-wide intervention|hospital-wide intervention
392935|NCT01273090|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
392936|NCT01273090|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
392937|NCT01273090|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
392938|NCT01273090|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
392939|NCT01273090|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
392940|NCT01273090|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
393010|NCT01272960|Contraception|contraception
392941|NCT01273090|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
392942|NCT01273090|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
392943|NCT01273090|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
392944|NCT01273090|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
392945|NCT01273090|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
392946|NCT01273090|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
392947|NCT01273090|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
392948|NCT01273090|recurrent childhood diffuse astrocytoma|recurrent childhood diffuse astrocytoma
392949|NCT01273090|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
392950|NCT01273090|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
392951|NCT01273090|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
392952|NCT01273090|recurrent childhood glioblastoma|recurrent childhood glioblastoma
392953|NCT01273090|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
392954|NCT01273090|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
392955|NCT01273090|recurrent childhood oligoastrocytoma|recurrent childhood oligoastrocytoma
392956|NCT01273090|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
392957|NCT01273090|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
392958|NCT01273090|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
392959|NCT01273090|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
392960|NCT01273090|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
392961|NCT01273090|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
392962|NCT01273090|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
392963|NCT01273090|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
392964|NCT01273090|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
392965|NCT01273090|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
392966|NCT01273090|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
392967|NCT01273090|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
392968|NCT01273090|childhood central nervous system germinoma|childhood central nervous system germinoma
392969|NCT01273090|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
392970|NCT01273090|childhood central nervous system teratoma|childhood central nervous system teratoma
392971|NCT01273090|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
392972|NCT01273090|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
402070|NCT01233271|glucose control|glucose control
392973|NCT01273090|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
392974|NCT01273090|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
392975|NCT01273090|childhood nodular lymphocyte predominant Hodgkin lymphoma|childhood nodular lymphocyte predominant hodgkin lymphoma
392976|NCT01273090|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
392977|NCT01273090|childhood Burkitt lymphoma|childhood burkitt lymphoma
392978|NCT01273090|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
392979|NCT01273090|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
392980|NCT01273090|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
392981|NCT01273090|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
392982|NCT01273090|intraocular lymphoma|intraocular lymphoma
392983|NCT01273090|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
392984|NCT01273090|peripheral T-cell lymphoma|peripheral t-cell lymphoma
392985|NCT01273090|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
392986|NCT01273090|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
392987|NCT01273090|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
392988|NCT01273090|small intestine lymphoma|small intestine lymphoma
392989|NCT01273077|Rotavirus|rotavirus
392990|NCT01273077|Rotarix|rotarix
392991|NCT01273064|HCV|hcv
392992|NCT01273064|Null Responders|null responders
392993|NCT01273051|Rectal Cancer|rectal cancer
392994|NCT01273051|Radiochemotherapy|radiochemotherapy
392995|NCT01273051|TEM|tem
392996|NCT01273051|Organ preservation|organ preservation
392997|NCT01273025|pharmacokinetic|pharmacokinetic
392998|NCT01273025|lime powder regimen|lime powder regimen
392999|NCT01273025|kidney stone|kidney stone
393000|NCT01273025|Oxidative stress|oxidative stress
393001|NCT01273012|probiotic|probiotic
393002|NCT01273012|cost-effectiveness|cost-effectiveness
393003|NCT01273012|diarrhea|diarrhea
393004|NCT01273012|children|children
393005|NCT01273012|Sum of the monetary cost of the hospitalization|sum of the monetary cost of the hospitalization
393006|NCT01272999|Acute otitis media|acute otitis media
393007|NCT01272999|Prevnar 13|prevnar 13
393008|NCT01272999|Streptococcus pneumoniae|streptococcus pneumoniae
393009|NCT01272986|Determination of the level of oxidised LDL by measuring the level of IgG in Blood|determination of the level of oxidised ldl by measuring the level of igg in blood
393011|NCT01272960|Postnatal care|postnatal care
393012|NCT01272947|Blunt soft tissue injury/contusion|blunt soft tissue injury/contusion
393013|NCT01272934|Ankle Sprain, soft tissue injury|ankle sprain, soft tissue injury
393014|NCT01272895|OCT images|oct images
393015|NCT01272895|Stent strut coverage|stent strut coverage
393016|NCT01272895|Endothelialization|endothelialization
393017|NCT01272895|Neointimal thickness, area and hyperplasia|neointimal thickness, area and hyperplasia
393018|NCT01272895|Stent malapposition|stent malapposition
393019|NCT01272830|total joint arthroplasty|total joint arthroplasty
393020|NCT01272830|synovitis|synovitis
393021|NCT01272830|ALVAL|alval
393022|NCT01272830|osteolysis|osteolysis
393023|NCT01272830|periprosthetic metallosis|periprosthetic metallosis
393024|NCT01272817|Nonmyeloablative transplant|nonmyeloablative transplant
393025|NCT01272817|Allogeneic transplant|allogeneic transplant
393026|NCT01272817|Transplant|transplant
393129|NCT01272440|acute lymphoblastic leukaemia|acute lymphoblastic leukaemia
393130|NCT01272440|adverse effects|adverse effects
403031|NCT01228448|external beam proton radiotherapy|external beam proton radiotherapy
393027|NCT01272804|Pharmacokinetics PK Pharmacodynamics PD T2DM Phase 1 Type 2 diabetes mellitus safety and tolerability|pharmacokinetics pk pharmacodynamics pd t2dm phase 1 type 2 diabetes mellitus safety and tolerability
393028|NCT01272791|metastatic stage IV pancreatic cancer|metastatic stage iv pancreatic cancer
393029|NCT01272765|obesity|obesity
393030|NCT01272765|weight loss|weight loss
393031|NCT01272765|weight management|weight management
393032|NCT01272765|anti-psychotic medication|anti-psychotic medication
393033|NCT01272765|Zyprexa|zyprexa
393034|NCT01272765|Seroquel|seroquel
393035|NCT01272765|Risperdal|risperdal
393036|NCT01272752|obesity|obesity
393037|NCT01272752|weight loss|weight loss
393038|NCT01272752|weight management|weight management
393039|NCT01272752|anti-psychotic medication|anti-psychotic medication
393040|NCT01272752|nutriceutical|nutriceutical
393041|NCT01272739|obesity|obesity
393042|NCT01272739|weight loss|weight loss
393043|NCT01272739|weight management|weight management
393044|NCT01272739|overweight|overweight
393045|NCT01272739|nutriceutical|nutriceutical
393046|NCT01272687|Parkinson Disease|parkinson disease
393047|NCT01272687|Parkinsonian Disorders|parkinsonian disorders
393048|NCT01272687|Brain Diseases|brain diseases
393049|NCT01272687|Central Nervous System Diseases|central nervous system diseases
393050|NCT01272687|Nervous System Diseases|nervous system diseases
393051|NCT01272687|Neurodegenerative Diseases|neurodegenerative diseases
393052|NCT01272661|breastfeeding|breastfeeding
393053|NCT01272661|low-income|low-income
393054|NCT01272661|high-risk|high-risk
600900|NCT00584129|Dysphagia|dysphagia
393055|NCT01272661|African-American|african-american
393056|NCT01272661|health disparity|health disparity
393057|NCT01272648|Rehabilitation|rehabilitation
393058|NCT01272648|Coping|coping
393059|NCT01272648|Prostate cancer|prostate cancer
393060|NCT01272648|Nursing|nursing
393061|NCT01272648|Physiotherapy|physiotherapy
393062|NCT01272648|Pelvic floor exercises|pelvic floor exercises
393063|NCT01272648|Motivational Interviewing|motivational interviewing
393064|NCT01272635|Asthma|asthma
393065|NCT01272635|Wheezing|wheezing
393066|NCT01272635|Respiratory Tract Illness|respiratory tract illness
393067|NCT01272635|Azythromycin|azythromycin
393068|NCT01272635|Prednisolone|prednisolone
393069|NCT01272635|Preschool-age|preschool-age
393070|NCT01272622|Quality of life|quality of life
393071|NCT01272622|Endocrinology|endocrinology
393072|NCT01272622|Oncology|oncology
393073|NCT01272622|Hypothalamus|hypothalamus
393074|NCT01272622|Irradiation|irradiation
393075|NCT01272622|Neurosurgery|neurosurgery
393076|NCT01272622|Pediatric Brain tumors|pediatric brain tumors
393077|NCT01272622|Randomized trial|randomized trial
393078|NCT01272596|Multiple Sclerosis|multiple sclerosis
393079|NCT01272596|Visual Contrast Acuity|visual contrast acuity
393080|NCT01272596|Visual Contrast Sensitivity|visual contrast sensitivity
393081|NCT01272596|Sloan Charts|sloan charts
393082|NCT01272583|Type 1 diabetes|type 1 diabetes
393083|NCT01272583|DPP-4 inhibitor|dpp-4 inhibitor
393084|NCT01272583|Glucagon|glucagon
393085|NCT01272570|breast|breast
393086|NCT01272570|oral|oral
393087|NCT01272570|cancer|cancer
393088|NCT01272557|HCC|hcc
393089|NCT01272544|Dental caries|dental caries
393090|NCT01272544|Epidemiology|epidemiology
393091|NCT01272544|Gingivitis|gingivitis
393092|NCT01272544|Oral health|oral health
393093|NCT01272531|pharmacogenetics|pharmacogenetics
393094|NCT01272531|bipolar disorders|bipolar disorders
393095|NCT01272531|affective disorders|affective disorders
393096|NCT01272531|mood disorders|mood disorders
393097|NCT01272531|pharmacologic actions|pharmacologic actions
393098|NCT01272531|psychotropic drugs|psychotropic drugs
393099|NCT01272531|antimanic agents|antimanic agents
393100|NCT01272531|antidepressant agents|antidepressant agents
393101|NCT01272531|lithium|lithium
393102|NCT01272531|lithium carbonate|lithium carbonate
393103|NCT01272531|Lithobid|lithobid
393104|NCT01272531|Eskalith|eskalith
393105|NCT01272531|divalproex|divalproex
393106|NCT01272531|divalproex sodium|divalproex sodium
393108|NCT01272531|valproate|valproate
393109|NCT01272518|chaos theory heart rate variability mania bipolar disorder|chaos theory heart rate variability mania bipolar disorder
393110|NCT01272479|hemodialysis|hemodialysis
393111|NCT01272479|hepatitis C|hepatitis c
393112|NCT01272479|inflammation|inflammation
393113|NCT01272479|iron stores|iron stores
393114|NCT01272479|prohepcidin|prohepcidin
393115|NCT01272466|multiple myeloma|multiple myeloma
393116|NCT01272466|vaccination|vaccination
393117|NCT01272466|antiapoptotic proteins|antiapoptotic proteins
393118|NCT01272466|proteasome inhibition|proteasome inhibition
393119|NCT01272453|coronary artery disease|coronary artery disease
393120|NCT01272453|CT scan|ct scan
393121|NCT01272453|coronary angiography|coronary angiography
393122|NCT01272453|chest pain|chest pain
393123|NCT01272453|aortic aneurysm|aortic aneurysm
393124|NCT01272453|pulmonary embolism|pulmonary embolism
393125|NCT01272440|PEG-asparaginase|peg-asparaginase
393126|NCT01272440|children|children
393127|NCT01272440|pharmacokinetics|pharmacokinetics
393128|NCT01272440|antibodies|antibodies
393131|NCT01272414|Eyelid retraction|eyelid retraction
393132|NCT01272414|Botulinum Toxins|botulinum toxins
393133|NCT01272388|Aortic valve stenosis|aortic valve stenosis
393134|NCT01272388|Tadalafil|tadalafil
393135|NCT01272388|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
393136|NCT01272388|Hypertension, pulmonary|hypertension, pulmonary
393137|NCT01272388|Hypertrophy, left ventricular|hypertrophy, left ventricular
393138|NCT01272362|Indacaterol|indacaterol
393139|NCT01272362|COPD|copd
393140|NCT01272362|LABA|laba
393141|NCT01272362|Reversibility|reversibility
393142|NCT01272349|spinal cord injury|spinal cord injury
393143|NCT01272349|walking|walking
393144|NCT01272349|low oxygen|low oxygen
393146|NCT01272349|strength|strength
393147|NCT01272336|spinal cord injury, low oxygen, strength, motor control|spinal cord injury, low oxygen, strength, motor control
393148|NCT01272323|Cat allergy|cat allergy
393149|NCT01272323|Rhinoconjunctivitis|rhinoconjunctivitis
393150|NCT01272310|Chronic Hepatitis C|chronic hepatitis c
393151|NCT01272310|Combination Therapy|combination therapy
393152|NCT01272310|Hydroxychloroquine|hydroxychloroquine
393153|NCT01272310|Pegylated Interferon Alpha-2a|pegylated interferon alpha-2a
393154|NCT01272310|Ribavirin|ribavirin
393155|NCT01272310|Chronic Hepatitis C Genotype 1 infected adult subjects|chronic hepatitis c genotype 1 infected adult subjects
393156|NCT01272297|LI-ESWT|li-eswt
393157|NCT01272297|Erectile Dysfunction|erectile dysfunction
600901|NCT00584129|Radiation|radiation
393158|NCT01272297|Non PDE5 inhibitor responders|non pde5 inhibitor responders
393159|NCT01272297|Shock wave|shock wave
393160|NCT01272284|Female|female
393161|NCT01272284|Stress urinary incontinence|stress urinary incontinence
393162|NCT01272284|Mini sling|mini sling
393163|NCT01272284|Single incision sling|single incision sling
393164|NCT01272284|Urinary incontinence|urinary incontinence
393165|NCT01272284|Mixed urinary incontinence|mixed urinary incontinence
393166|NCT01272284|Additional relevant MeSH terms:|additional relevant mesh terms:
393167|NCT01272284|Stress|stress
393168|NCT01272284|Urinary Incontinence, Stress|urinary incontinence, stress
393169|NCT01272284|Pathological Processes|pathological processes
393170|NCT01272284|Urination Disorders|urination disorders
393171|NCT01272284|Urological Disorders|urological disorders
393172|NCT01272284|Urological Manifestations|urological manifestations
393173|NCT01272284|Signs and Symptoms|signs and symptoms
393174|NCT01272271|Contact lens|contact lens
393176|NCT01272271|Cornea|cornea
393177|NCT01272245|Acute Myelogenous Leukemia|acute myelogenous leukemia
393178|NCT01272245|AML|aml
393179|NCT01272245|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
393180|NCT01272245|MDS|mds
393181|NCT01272245|Omacetaxine|omacetaxine
393182|NCT01272245|Cytarabine|cytarabine
393183|NCT01272245|ARA-C|ara-c
393184|NCT01272245|Cytosar|cytosar
393185|NCT01272245|DepoCyt|depocyt
393186|NCT01272245|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
393187|NCT01272180|Safety|safety
393188|NCT01272180|Immunogenicity|immunogenicity
393189|NCT01272180|Vaccine|vaccine
393190|NCT01272180|Meningococcal|meningococcal
393191|NCT01272180|Seroresponse|seroresponse
393192|NCT01272167|Post-menopausal women|post-menopausal women
393193|NCT01272167|Grapefruit juice|grapefruit juice
393194|NCT01272167|Naringin|naringin
393195|NCT01272167|Vascular protection|vascular protection
393196|NCT01272167|Bone metabolism|bone metabolism
393197|NCT01272154|Cerebellum|cerebellum
393198|NCT01272154|Cortical plasticity|cortical plasticity
393199|NCT01272154|Sensorimotor adaptation|sensorimotor adaptation
393200|NCT01272154|Dystonia|dystonia
393201|NCT01272154|Cerebral Palsy|cerebral palsy
393202|NCT01272154|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
393203|NCT01272154|and|and
393204|NCT01272141|Metastatic breast cancer|metastatic breast cancer
393205|NCT01272141|Triple negative breast cancer|triple negative breast cancer
393206|NCT01272141|Estrogen receptor (ER)/progesterone receptor (PR)/human epidermal growth factor receptor 2 (HER2)-negative breast cancer|estrogen receptor (er)/progesterone receptor (pr)/human epidermal growth factor receptor 2 (her2)-negative breast cancer
393207|NCT01272115|Climacteric stage|climacteric stage
393208|NCT01272115|Integrative health care model|integrative health care model
393209|NCT01272115|Empowerment approach|empowerment approach
393210|NCT01272115|Primary care services|primary care services
393211|NCT01272076|Age Related Macular Degeneration|age related macular degeneration
393212|NCT01272076|Geographic Atrophy|geographic atrophy
393213|NCT01272076|Imaging|imaging
393214|NCT01272076|OCT|oct
393215|NCT01272063|Drusen|drusen
393216|NCT01272063|Dry AMD|dry amd
393217|NCT01272063|OCT|oct
393218|NCT01272063|Imaging|imaging
393219|NCT01272050|adenocarcinoma of the prostate|adenocarcinoma of the prostate
393220|NCT01272050|recurrent prostate cancer|recurrent prostate cancer
393221|NCT01272050|stage IIA prostate cancer|stage iia prostate cancer
393222|NCT01272050|stage IIB prostate cancer|stage iib prostate cancer
393223|NCT01272050|stage III prostate cancer|stage iii prostate cancer
393224|NCT01272024|clinical trial|clinical trial
393225|NCT01272024|symptom education|symptom education
393226|NCT01272024|advanced cancer|advanced cancer
393227|NCT01272011|Respiration|respiration
393234|NCT01271985|Drug Combinations|drug combinations
393235|NCT01271985|prevention and control|prevention and control
393236|NCT01271985|Aspirin|aspirin
393237|NCT01271985|Antihypertensive Agents|antihypertensive agents
393238|NCT01271985|Antilipemic Agents|antilipemic agents
393239|NCT01271959|Ovarian|ovarian
393240|NCT01271959|Fallopian Tube|fallopian tube
393241|NCT01271959|Peritoneal|peritoneal
393242|NCT01271959|Uterine Neoplasms|uterine neoplasms
393243|NCT01271959|Vulva|vulva
393244|NCT01271959|Endometrial|endometrial
393245|NCT01271959|Cervical|cervical
393246|NCT01271959|Lung|lung
393247|NCT01271959|Carcinoid|carcinoid
393248|NCT01271959|Sarcoma|sarcoma
393249|NCT01271959|Mesothelioma|mesothelioma
393250|NCT01271959|Adenocarcinoma|adenocarcinoma
393251|NCT01271959|Colorectal|colorectal
393252|NCT01271959|Breast|breast
393253|NCT01271959|Assay|assay
393254|NCT01271959|Chemotherapy|chemotherapy
393255|NCT01271959|Recurrent|recurrent
393256|NCT01271959|Refractory|refractory
393257|NCT01271959|Persistent|persistent
393258|NCT01271959|Chemoresponse|chemoresponse
393259|NCT01271933|fibromyalgia|fibromyalgia
393260|NCT01271933|pain|pain
393261|NCT01271933|pregabalin|pregabalin
393262|NCT01271933|Lyrica|lyrica
393263|NCT01271920|Trastuzumab-refractory|trastuzumab-refractory
393264|NCT01271920|advanced HER2-positive breast cancer,|advanced her2-positive breast cancer,
393265|NCT01271920|Hsp90,|hsp90,
393266|NCT01271920|2nd or 3rd line treatment|2nd or 3rd line treatment
393267|NCT01271907|Skin Cancer|skin cancer
393268|NCT01271907|Malignancy|malignancy
393269|NCT01271907|Immunotherapy|immunotherapy
393270|NCT01271907|Melanoma Peptides|melanoma peptides
393271|NCT01271907|Melanoma|melanoma
393272|NCT01271907|Metastatic Melanoma|metastatic melanoma
393273|NCT01271894|HIV|hiv
393274|NCT01271894|efavirenz|efavirenz
393275|NCT01271894|pharmacokinetic|pharmacokinetic
393276|NCT01271881|Hemodialysis|hemodialysis
393277|NCT01271881|Fistula|fistula
393278|NCT01271881|Angiograph|angiograph
393279|NCT01271881|Angiogram|angiogram
393280|NCT01271881|Adult patients who are currently receiving hemodialysis treatment via an AV vascular graft or fistula located in the upper extremity|adult patients who are currently receiving hemodialysis treatment via an av vascular graft or fistula located in the upper extremity
393281|NCT01271868|Recombinant Factor IX|recombinant factor ix
393282|NCT01271829|Avocados|avocados
393283|NCT01271829|Satiety|satiety
393284|NCT01271829|Feeding study|feeding study
393285|NCT01271816|genetics|genetics
393286|NCT01271816|sudden death|sudden death
393287|NCT01271816|monitoring|monitoring
393288|NCT01271816|loop recorder|loop recorder
393289|NCT01271816|cardiomyopathy|cardiomyopathy
393290|NCT01271790|Hepatitis C|hepatitis c
393291|NCT01271790|HCV|hcv
393292|NCT01271790|Rapid Virologic Response|rapid virologic response
393293|NCT01271790|Sustained Virologic Response|sustained virologic response
393294|NCT01271790|Direct Acting Antiviral|direct acting antiviral
393295|NCT01271790|Combination Therapy|combination therapy
393296|NCT01271790|HCV RNA|hcv rna
393297|NCT01271790|Polymerase inhibitor|polymerase inhibitor
393298|NCT01271790|Protease inhibitor|protease inhibitor
393299|NCT01271790|Treatment naïve|treatment naïve
393300|NCT01271790|GS-9190|gs-9190
393301|NCT01271790|GS-9451|gs-9451
393302|NCT01271777|Pre-diabetes|pre-diabetes
393303|NCT01271777|Clamp technique|clamp technique
393304|NCT01271777|PPARs|ppars
393305|NCT01271777|Insulin resistance|insulin resistance
393306|NCT01271751|Atherogenic-dyslipidaemia|atherogenic-dyslipidaemia
393307|NCT01271751|PPARs|ppars
393308|NCT01271738|Breast Cancer|breast cancer
393309|NCT01271738|Tumors or cancer of the human breast|tumors or cancer of the human breast
393310|NCT01271738|Breast Tumors|breast tumors
393311|NCT01271738|Cancer of Breast|cancer of breast
393312|NCT01271738|Cancer of the Breast|cancer of the breast
393313|NCT01271738|Human Mammary Carcinoma|human mammary carcinoma
393314|NCT01271738|Neoplasms, Breast|neoplasms, breast
393707|NCT01269931|simulation|simulation
393315|NCT01271712|Gastrointestinal stromal cancer|gastrointestinal stromal cancer
393316|NCT01271712|GIST|gist
393317|NCT01271712|multikinase inhibitor|multikinase inhibitor
393318|NCT01271699|Fabry Disease|fabry disease
393319|NCT01271699|Fabry´s Disease|fabry´s disease
393320|NCT01271699|Anderson-Fabry Disease|anderson-fabry disease
393321|NCT01271699|Multiple Sclerosis|multiple sclerosis
393322|NCT01271660|muscle cramp|muscle cramp
393323|NCT01271660|liver cirrhosis|liver cirrhosis
393324|NCT01271660|pregabalin|pregabalin
393325|NCT01271647|osteopenia,chinese herb|osteopenia,chinese herb
393326|NCT01271634|cross-transmission|cross-transmission
393327|NCT01271634|offending vessel|offending vessel
393328|NCT01271621|Airtraq, Intraocular pressure|airtraq, intraocular pressure
393329|NCT01271608|Accident prevention|accident prevention
393330|NCT01271608|Blood-borne pathogens|blood-borne pathogens
393331|NCT01271608|Protective devices.|protective devices.
393332|NCT01271608|Needlestick injuries|needlestick injuries
393333|NCT01271608|Injections subcutaneous|injections subcutaneous
393334|NCT01271608|Injections intradermal|injections intradermal
393335|NCT01271595|acupuncture|acupuncture
393336|NCT01271595|autonomic nervous system|autonomic nervous system
393337|NCT01271595|seasonal allergic rhinitis|seasonal allergic rhinitis
393338|NCT01271582|Colorecatal cancer|colorecatal cancer
393339|NCT01271582|Gastric cancer|gastric cancer
393340|NCT01271582|Irinotecan|irinotecan
393342|NCT01271582|Neutropenia|neutropenia
393343|NCT01271556|COPD|copd
393344|NCT01271556|LABA|laba
393345|NCT01271556|salmeterol|salmeterol
393346|NCT01271543|Comparison of hemodynamic|comparison of hemodynamic
393347|NCT01271543|endotracheal intubation|endotracheal intubation
393348|NCT01271543|changes induced by|changes induced by
393349|NCT01271543|performed|performed
393350|NCT01271543|the aid of the SOS|the aid of the sos
393351|NCT01271543|as compared to the Macintosh Laryngoscope|as compared to the macintosh laryngoscope
393352|NCT01271530|Late Effects of Polio|late effects of polio
393353|NCT01271530|Cardiovascular Fitness|cardiovascular fitness
393354|NCT01271530|Fatigue|fatigue
393355|NCT01271530|Energy cost of Walking|energy cost of walking
393356|NCT01271530|Pain|pain
393357|NCT01271517|Basal insulin|basal insulin
393358|NCT01271517|long acting insulin analogs|long acting insulin analogs
393359|NCT01271517|metabolic control|metabolic control
393360|NCT01271517|HbA1c|hba1c
393361|NCT01271517|C-peptide|c-peptide
393362|NCT01271517|IGF-I|igf-i
393363|NCT01271517|GH|gh
393364|NCT01271517|IGFBP|igfbp
393365|NCT01271504|Cancer|cancer
393366|NCT01271504|liver|liver
393367|NCT01271504|hepatocellular carcinoma|hepatocellular carcinoma
393368|NCT01271504|phase I|phase i
393369|NCT01271504|phase II|phase ii
393370|NCT01271491|Pediatric|pediatric
393371|NCT01271478|inflammation|inflammation
393372|NCT01271478|telmisartan|telmisartan
393373|NCT01271478|captopril|captopril
393374|NCT01271478|hemodialysis|hemodialysis
393375|NCT01271426|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
393376|NCT01271426|Ranibizumab|ranibizumab
393377|NCT01271400|Infertility treatments|infertility treatments
393378|NCT01271400|Frozen embryo transfers (FET).|frozen embryo transfers (fet).
393379|NCT01271400|IVF.|ivf.
393380|NCT01271400|ART.|art.
393381|NCT01271400|Cryopreservation|cryopreservation
393382|NCT01271400|Slow-Freeze|slow-freeze
393383|NCT01271400|Freeze / thaw survival rates|freeze / thaw survival rates
393384|NCT01271400|Blastocyst formation|blastocyst formation
393385|NCT01271400|Pregnancy|pregnancy
393386|NCT01271387|Liver disease|liver disease
393387|NCT01271387|pharmacokinetics|pharmacokinetics
393388|NCT01271374|African American|african american
393389|NCT01271374|Hypertension|hypertension
393390|NCT01271374|Cardiometabolic Syndrome|cardiometabolic syndrome
393391|NCT01271361|thrombus aspiration|thrombus aspiration
393392|NCT01271361|Drug-Eluting Stent|drug-eluting stent
393393|NCT01271361|optical frequency domain imaging (OFDI)|optical frequency domain imaging (ofdi)
393394|NCT01271335|CTO|cto
393395|NCT01271335|Angioplasty|angioplasty
393396|NCT01271335|PCI|pci
393397|NCT01271322|PET|pet
393398|NCT01271322|response evaluation|response evaluation
393399|NCT01271322|neoadjuvant|neoadjuvant
393400|NCT01271322|radiochemotherapy|radiochemotherapy
393401|NCT01271322|adenocarcinoma of the esophagogastric junction|adenocarcinoma of the esophagogastric junction
393402|NCT01271322|esophageal carcinoma|esophageal carcinoma
393403|NCT01271322|evaluation of preoperative (radio)-chemotherapy in patients with adenocarcinomas of the oesophagogastric junction|evaluation of preoperative (radio)-chemotherapy in patients with adenocarcinomas of the oesophagogastric junction
393404|NCT01271296|Addison Disease|addison disease
393405|NCT01271296|Pharmacokinetics|pharmacokinetics
393406|NCT01271296|Hormone Replacement Therapy|hormone replacement therapy
393407|NCT01271296|cortisone acetate|cortisone acetate
393408|NCT01271296|Quality of Life|quality of life
393409|NCT01271270|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
393410|NCT01271270|Palomid 529|palomid 529
393411|NCT01271270|Age Related Macular Degeneration|age related macular degeneration
393412|NCT01271270|AMD|amd
395006|NCT01264614|EEG|eeg
393413|NCT01271257|misoprostol, pharmacokinetics|misoprostol, pharmacokinetics
393414|NCT01271231|periodontal treatment, diabetes, glycemia, glycated hemoglobin|periodontal treatment, diabetes, glycemia, glycated hemoglobin
393415|NCT01271205|pneumonia|pneumonia
393416|NCT01271205|RDW|rdw
393417|NCT01271205|mortality|mortality
393418|NCT01271205|prognostic factor|prognostic factor
393419|NCT01271192|local recurrent rectal cancer|local recurrent rectal cancer
393420|NCT01271192|surgical resection|surgical resection
393421|NCT01271192|adjuvant therapy|adjuvant therapy
393422|NCT01271179|orthotopic liver transplantation|orthotopic liver transplantation
393423|NCT01271179|preservation solution|preservation solution
393424|NCT01271179|peribiliary plexus|peribiliary plexus
393425|NCT01271179|nonanastomotic biliary strictures|nonanastomotic biliary strictures
393426|NCT01271179|primary non-function|primary non-function
393427|NCT01271166|Colorectal,|colorectal,
479981|NCT00098319|Brazil|brazil
393428|NCT01271166|Cancer|cancer
393429|NCT01271153|Septic shock|septic shock
393430|NCT01271127|radiation therapy|radiation therapy
393431|NCT01271127|coronary artery disease|coronary artery disease
393432|NCT01271127|Hodgkin Lymphoma|hodgkin lymphoma
393433|NCT01271101|Non-ST-elevated acute coronary syndromes (NSTE-ACS)|non-st-elevated acute coronary syndromes (nste-acs)
393434|NCT01271101|anticoagulation|anticoagulation
393435|NCT01271088|ototoxicity|ototoxicity
393436|NCT01271088|aminoglycoside|aminoglycoside
393437|NCT01271088|vancomycine|vancomycine
393438|NCT01271088|peritoneal dialysis|peritoneal dialysis
393439|NCT01271088|peritonitis|peritonitis
393440|NCT01271075|urticaria|urticaria
393441|NCT01271075|bilastine|bilastine
393442|NCT01271062|Resolvment of Diabetes Mellitus, Type 2|resolvment of diabetes mellitus, type 2
393443|NCT01271062|gastric bypass|gastric bypass
393444|NCT01271036|Lubricating Agents|lubricating agents
393445|NCT01271036|Personal Lubricant|personal lubricant
393446|NCT01270984|Imatinib mesylate|imatinib mesylate
393447|NCT01270984|Pharmacokinetics|pharmacokinetics
393448|NCT01270984|Healthy volunteers|healthy volunteers
393449|NCT01270971|Onychomycosis|onychomycosis
393450|NCT01270971|nail fungus|nail fungus
393451|NCT01270971|toenail fungus|toenail fungus
393452|NCT01270971|fungal nail|fungal nail
393453|NCT01270971|hyperkeratosis|hyperkeratosis
393454|NCT01270971|nail infection|nail infection
393455|NCT01270971|nail treatment|nail treatment
601195|NCT00577174|Diabetes|diabetes
393456|NCT01270971|toenail infection|toenail infection
393457|NCT01270971|toenail treatment|toenail treatment
393458|NCT01270971|foot dermatoses|foot dermatoses
393459|NCT01270971|fungal culture|fungal culture
393460|NCT01270971|onycholysis|onycholysis
393461|NCT01270971|podiatrist|podiatrist
393462|NCT01270971|podiatry|podiatry
393463|NCT01270971|subungual|subungual
393464|NCT01270971|tinea unguium|tinea unguium
393465|NCT01270971|antifungal|antifungal
393466|NCT01270971|anti-fungal|anti-fungal
393467|NCT01270971|dermatologist|dermatologist
393468|NCT01270971|dermatology|dermatology
393469|NCT01270971|dermatophyte|dermatophyte
393470|NCT01270971|distal subungual onychomycosis|distal subungual onychomycosis
393471|NCT01270971|yellow nail|yellow nail
393472|NCT01270971|thick nail|thick nail
393473|NCT01270971|brittle nail|brittle nail
393474|NCT01270971|crumbling nail|crumbling nail
393475|NCT01270971|discolored nail|discolored nail
393476|NCT01270971|weak nail|weak nail
393477|NCT01270958|AVY-REG00108VN|avy-reg00108vn
393478|NCT01270906|Neoplasms|neoplasms
393479|NCT01270906|Cancer|cancer
393480|NCT01270906|Tumors|tumors
393481|NCT01270906|Administration|administration
393482|NCT01270906|oral|oral
393483|NCT01270906|CHIR258|chir258
393484|NCT01270906|CHIR-258|chir-258
393485|NCT01270906|CHIR 258|chir 258
393486|NCT01270906|TKI258|tki258
393487|NCT01270906|TKI-258|tki-258
393488|NCT01270906|TKI 258|tki 258
393489|NCT01270906|dose finding|dose finding
393490|NCT01270893|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
393491|NCT01270893|GIST|gist
393492|NCT01270893|Nilotinib|nilotinib
393493|NCT01270893|AMN107|amn107
393494|NCT01270893|Tasigna|tasigna
393495|NCT01270867|Ischemia|ischemia
393496|NCT01270867|Stroke|stroke
393497|NCT01270867|Ischemic Stroke|ischemic stroke
393498|NCT01270867|Mechanical Thrombectomy|mechanical thrombectomy
393499|NCT01270867|Brain|brain
393500|NCT01270867|Brain clot|brain clot
393501|NCT01270867|Cerebrovascular disease|cerebrovascular disease
393502|NCT01270867|Recanalization|recanalization
393503|NCT01270867|Revascularization|revascularization
393504|NCT01270854|Normal saline|normal saline
393505|NCT01270854|Plasmalyte|plasmalyte
393506|NCT01270854|Intravenous fluid|intravenous fluid
393507|NCT01270854|Traumatic injury|traumatic injury
393508|NCT01270854|Fluid resuscitation|fluid resuscitation
393509|NCT01270828|Control Release Pregabalin in Post Herpetic Neuralgia|control release pregabalin in post herpetic neuralgia
393510|NCT01270815|pregabalin|pregabalin
393511|NCT01270815|pharmacokinetics|pharmacokinetics
393512|NCT01270815|bioavailability|bioavailability
393513|NCT01270815|bioequivalence|bioequivalence
395516|NCT01262118|Tasocitinib|tasocitinib
393514|NCT01270802|Endothelial function|endothelial function
393515|NCT01270802|Vitamin D|vitamin d
393516|NCT01270802|Efavirenz|efavirenz
393517|NCT01270802|Raltegravir|raltegravir
393518|NCT01270789|beta-cell function|beta-cell function
393519|NCT01270789|GLP-1 analogue|glp-1 analogue
393520|NCT01270789|diabetes|diabetes
393521|NCT01270776|Randomized Controlled Trial|randomized controlled trial
393522|NCT01270776|Chlorhexidine|chlorhexidine
393523|NCT01270776|Infant, Premature|infant, premature
393524|NCT01270763|Obesity|obesity
393525|NCT01270763|physical fitness|physical fitness
393526|NCT01270763|cholesterol levels|cholesterol levels
393527|NCT01270763|genetics|genetics
393528|NCT01270763|weight loss|weight loss
393529|NCT01270750|ENDOTHELIN RECEPTOR ANTAGONIST|endothelin receptor antagonist
393530|NCT01270750|BOSENTAN|bosentan
403032|NCT01228448|PET|pet
393531|NCT01270750|SECONDARY PULMONARY HYPERTENSION|secondary pulmonary hypertension
393532|NCT01270750|RHEUMATOID FEVER|rheumatoid fever
393533|NCT01270750|CONGESTIVE HEART FAILURE|congestive heart failure
393534|NCT01270750|SECONDARY PULMONARY HYPERTENSION DUE TO MITRAL STENOSIS|secondary pulmonary hypertension due to mitral stenosis
393535|NCT01270711|compliance study|compliance study
393536|NCT01270711|effectiveness study|effectiveness study
393537|NCT01270711|hyperprolactinemia|hyperprolactinemia
393538|NCT01270711|Parkinson's disease|parkinson's disease
393539|NCT01270711|retrospective cohort study|retrospective cohort study
393540|NCT01270698|colorectal cancer|colorectal cancer
393541|NCT01270672|MDMA|mdma
393542|NCT01270672|carvedilol|carvedilol
393543|NCT01270672|norepinephrine|norepinephrine
393544|NCT01270672|alpha - beta receptor|alpha - beta receptor
393545|NCT01270672|Ecstasy|ecstasy
393546|NCT01270672|stimulant|stimulant
393547|NCT01270659|Fentanyl buccal tablet|fentanyl buccal tablet
393548|NCT01270646|Cardiac insufficiency|cardiac insufficiency
393549|NCT01270646|Invasive procedure|invasive procedure
393550|NCT01270646|Heart Failure|heart failure
393551|NCT01270646|Noninvasive procedure|noninvasive procedure
393552|NCT01270646|Congestive Heart Failure|congestive heart failure
393553|NCT01270646|Mapping|mapping
393554|NCT01270646|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
393555|NCT01270646|Open study|open study
393556|NCT01270646|Cardiac Pacings, Artificial|cardiac pacings, artificial
393557|NCT01270646|Hemodynamics|hemodynamics
393558|NCT01270620|elderly obese|elderly obese
393559|NCT01270581|transient tachypnea of the newborn|transient tachypnea of the newborn
393560|NCT01270581|high flow nasal cannula|high flow nasal cannula
393561|NCT01270581|bubble nasal|bubble nasal
393562|NCT01270581|continuous positive airway pressure|continuous positive airway pressure
393563|NCT01270568|positive psychology|positive psychology
393564|NCT01270568|cardiovascular disease|cardiovascular disease
393565|NCT01270542|Traction Retinal Detachment (PDR)|traction retinal detachment (pdr)
393566|NCT01270542|Proliferative Diabetic Retinopathy (PDR)|proliferative diabetic retinopathy (pdr)
393567|NCT01270529|Physical Activity|physical activity
393568|NCT01270529|Physical Performance|physical performance
393569|NCT01270529|Physical Functioning|physical functioning
393570|NCT01270529|CKD|ckd
393571|NCT01270529|ESRD|esrd
393572|NCT01270529|Transplant Recipients|transplant recipients
393573|NCT01270516|diaphragm|diaphragm
393574|NCT01270516|limb muscle|limb muscle
393575|NCT01270516|EPA|epa
393576|NCT01270516|HMB|hmb
393577|NCT01270516|ICU patients|icu patients
393578|NCT01270503|Meningitis|meningitis
393579|NCT01270503|Meningococcal disease|meningococcal disease
393580|NCT01270503|Menactra®|menactra®
393584|NCT01270477|Frost injury|frost injury
393585|NCT01270451|Weight maintenance|weight maintenance
393586|NCT01270451|Group counseling|group counseling
393587|NCT01270451|Prevention of diseases|prevention of diseases
393588|NCT01270425|systemic sclerosis|systemic sclerosis
393589|NCT01270425|hashimoto thyroiditis|hashimoto thyroiditis
393590|NCT01270425|thyroid nodules|thyroid nodules
393591|NCT01270412|Osteoarthritis|osteoarthritis
393593|NCT01270412|PRGF|prgf
393594|NCT01270412|Hyaluronic acid|hyaluronic acid
393595|NCT01270386|NSCLC|nsclc
393596|NCT01270386|apatinib|apatinib
393597|NCT01270386|phase II|phase ii
393598|NCT01270386|lung|lung
393599|NCT01270386|cancer|cancer
393600|NCT01270373|neoadjuvant therapy|neoadjuvant therapy
393601|NCT01270373|drug therapy|drug therapy
393602|NCT01270321|Thyroid Cancer|thyroid cancer
393603|NCT01270308|Bioequivalence|bioequivalence
393604|NCT01270308|two way crossover|two way crossover
393605|NCT01270295|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
393606|NCT01270295|Soluble RAGE (sRAGE)|soluble rage (srage)
393607|NCT01270295|Endogenous secretory RAGE (esRAGE)|endogenous secretory rage (esrage)
393608|NCT01270295|High-mobility group box-1 protein (HMGB-1)|high-mobility group box-1 protein (hmgb-1)
393609|NCT01270295|Extracellular newly-identified RAGE-binding protein (EN-RAGE or S100A12)|extracellular newly-identified rage-binding protein (en-rage or s100a12)
393610|NCT01270295|Advanced glycation endproducts (AGEs)|advanced glycation endproducts (ages)
393611|NCT01270295|Pentosidine|pentosidine
393612|NCT01270295|N--carboxymethyllysine|n--carboxymethyllysine
393613|NCT01270295|Acute lung injury (ALI)|acute lung injury (ali)
393614|NCT01270295|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
393615|NCT01270295|Alveolar epithelium|alveolar epithelium
393616|NCT01270295|Mechanical ventilation|mechanical ventilation
393617|NCT01270295|Intensive Care Unit (ICU)|intensive care unit (icu)
393618|NCT01270269|Asthenia|asthenia
393619|NCT01270269|Muscle Weakness|muscle weakness
393620|NCT01270269|Brain Injuries|brain injuries
393621|NCT01270269|Critical Illness|critical illness
393622|NCT01270269|Critical Illness Myoneuropathy|critical illness myoneuropathy
393623|NCT01270269|Rehabilitation|rehabilitation
393624|NCT01270269|Sepsis|sepsis
393625|NCT01270269|Respiratory Failure|respiratory failure
393626|NCT01270269|Delirium|delirium
393627|NCT01270269|Over-sedation|over-sedation
393628|NCT01270269|Immobility|immobility
384431|NCT01308424|Herpes|herpes
393629|NCT01270269|Aging|aging
393630|NCT01270269|Signs and Symptoms|signs and symptoms
393631|NCT01270269|Muscular Diseases|muscular diseases
393632|NCT01270269|Musculoskeletal Diseases|musculoskeletal diseases
393633|NCT01270269|Neuromuscular Manifestations|neuromuscular manifestations
393634|NCT01270269|Neurologic Manifestations|neurologic manifestations
393635|NCT01270269|Pathologic Processes|pathologic processes
393636|NCT01270269|Brain Diseases|brain diseases
393637|NCT01270269|Central Nervous System Diseases|central nervous system diseases
393638|NCT01270269|Craniocerebral Trauma|craniocerebral trauma
393639|NCT01270269|Trauma, Nervous System|trauma, nervous system
393640|NCT01270269|Wounds and Injuries|wounds and injuries
393641|NCT01270269|Disorders of Environmental Origin|disorders of environmental origin
393642|NCT01270256|allergy|allergy
393643|NCT01270230|HIV Prevention Intervention|hiv prevention intervention
393644|NCT01270230|African American Men who have Sex with Men|african american men who have sex with men
393645|NCT01270217|Automobile driving|automobile driving
393646|NCT01270217|Driving under the influence|driving under the influence
393647|NCT01270217|Interview, psychological|interview, psychological
393648|NCT01270217|Brief intervention|brief intervention
402071|NCT01233271|intensive care|intensive care
393649|NCT01270217|Brief motivational interview|brief motivational interview
393650|NCT01270204|Dysphagia|dysphagia
393651|NCT01270204|Swallowing Problems|swallowing problems
393652|NCT01270204|Dynamic Fluoroscopic Swallow Study|dynamic fluoroscopic swallow study
393653|NCT01270204|Aspiration|aspiration
393654|NCT01270204|Regurgitation|regurgitation
393655|NCT01270204|Acid Reflux|acid reflux
393656|NCT01270191|Exenatide, Beta-Cell Function, Glycemic Control|exenatide, beta-cell function, glycemic control
393657|NCT01270191|in Newly Diagnosed Type 2 Diabetic Patients|in newly diagnosed type 2 diabetic patients
393658|NCT01270165|lamivudine|lamivudine
393659|NCT01270165|telbivudine|telbivudine
393660|NCT01270165|adefovir|adefovir
393661|NCT01270165|lamivudine resistance|lamivudine resistance
393662|NCT01270152|ascorbic acid|ascorbic acid
393663|NCT01270152|catheterization central venous|catheterization central venous
393664|NCT01270152|nursing care|nursing care
393665|NCT01270139|nanoparticles|nanoparticles
393666|NCT01270139|mesenchymal stem cell|mesenchymal stem cell
393667|NCT01270139|plasmonics|plasmonics
393668|NCT01270139|atherosclerosis|atherosclerosis
393669|NCT01270139|IVUS|ivus
393671|NCT01270126|optic neuropathy|optic neuropathy
393672|NCT01270126|alternating current stimulation|alternating current stimulation
393673|NCT01270126|vision recovery|vision recovery
393674|NCT01270126|restoration|restoration
393675|NCT01270126|plasticity|plasticity
393676|NCT01270087|Rheumatoid arthritis, cardiovascular disease, adalimumab|rheumatoid arthritis, cardiovascular disease, adalimumab
393677|NCT01270074|double blind placebo controlled randomised clinical trial|double blind placebo controlled randomised clinical trial
393678|NCT01270074|azithromycin|azithromycin
393679|NCT01270074|infant|infant
393680|NCT01270074|pediatric|pediatric
393681|NCT01270074|cystic fibrosis|cystic fibrosis
393682|NCT01270074|bronchiectasis|bronchiectasis
393683|NCT01270061|HIV testing|hiv testing
393684|NCT01270061|black Africans|black africans
393685|NCT01270061|immigrants|immigrants
393686|NCT01270061|health screening|health screening
393687|NCT01270048|Hwa-byung, Bunsimgi-eum(Fenxinqiyin)|hwa-byung, bunsimgi-eum(fenxinqiyin)
393688|NCT01269996|type 2 diabetes mellitus|type 2 diabetes mellitus
393689|NCT01269996|JUBILEE Study|jubilee study
393690|NCT01269996|Janumet|janumet
393691|NCT01269996|Lantus|lantus
393692|NCT01269983|low back pain|low back pain
393693|NCT01269983|fascial manipulation|fascial manipulation
393694|NCT01269983|physioterapy|physioterapy
393695|NCT01269983|physical activity|physical activity
393696|NCT01269957|halitosis|halitosis
393697|NCT01269957|pediatric dentistry|pediatric dentistry
393698|NCT01269957|mouth breathing|mouth breathing
393699|NCT01269944|osteoarthritis|osteoarthritis
393700|NCT01269944|knee|knee
393701|NCT01269944|high wedge tibial osteotomy|high wedge tibial osteotomy
393702|NCT01269944|dGEMRIC|dgemric
393703|NCT01269931|endobronchial ultrasound|endobronchial ultrasound
393704|NCT01269931|bronchoscopy|bronchoscopy
393705|NCT01269931|education|education
393706|NCT01269931|interventional bronchoscopy|interventional bronchoscopy
393708|NCT01269918|Craniotomy, pain relief|craniotomy, pain relief
393709|NCT01269918|Adult solid neoplasm|adult solid neoplasm
393710|NCT01269892|diarrhea, lactose, milk, weight, acute.|diarrhea, lactose, milk, weight, acute.
393711|NCT01269879|epicondylitis|epicondylitis
393712|NCT01269879|pain|pain
393713|NCT01269879|tendon|tendon
393714|NCT01269866|Lupus Pain|lupus pain
393715|NCT01269866|Lupus|lupus
393716|NCT01269866|Pain|pain
393717|NCT01269866|Systemic Lupus Erythematosus|systemic lupus erythematosus
393718|NCT01269866|Duloxetine|duloxetine
393719|NCT01269866|Cymbalta|cymbalta
393720|NCT01269853|GBM|gbm
393721|NCT01269853|AA|aa
393722|NCT01269853|AO|ao
393723|NCT01269853|Brain|brain
393724|NCT01269853|Tumors|tumors
393725|NCT01269853|Malignant|malignant
393726|NCT01269853|Glioblastoma|glioblastoma
393727|NCT01269853|Multiforme|multiforme
393728|NCT01269853|Anaplastic|anaplastic
393729|NCT01269853|Astrocytoma|astrocytoma
393730|NCT01269827|inflammation|inflammation
393731|NCT01269827|pentoxifylline|pentoxifylline
393732|NCT01269827|hemodialysis|hemodialysis
393733|NCT01269814|Gastrointestinal bleeding|gastrointestinal bleeding
393734|NCT01269814|Emergency endoscopy|emergency endoscopy
393735|NCT01269814|Rockall Risk Scoring System|rockall risk scoring system
393736|NCT01269801|BOTOX|botox
393737|NCT01269801|JUVEDERM|juvederm
393738|NCT01269801|Prospective|prospective
393739|NCT01269801|Open Label|open label
393740|NCT01269801|Randomized|randomized
393741|NCT01269801|Crossover Study|crossover study
393742|NCT01269788|non-erosive reflux disease|non-erosive reflux disease
393743|NCT01269788|heartburn|heartburn
393744|NCT01269788|functional|functional
393745|NCT01269788|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation
393746|NCT01269788|Proton Pump Inhibitors|proton pump inhibitors
393747|NCT01269762|Red yeast rice|red yeast rice
393748|NCT01269762|Lovastatin|lovastatin
402072|NCT01233271|insulin|insulin
393749|NCT01269762|Drug-drug interaction|drug-drug interaction
393750|NCT01269762|Pharmacokinetics|pharmacokinetics
393751|NCT01269749|Hyperthyroidism|hyperthyroidism
393752|NCT01269749|Antithyroid drugs|antithyroid drugs
393753|NCT01269749|Cancer|cancer
393754|NCT01269749|Dosimetry|dosimetry
393755|NCT01269749|Children|children
393756|NCT01269736|electrocardiographic monitoring|electrocardiographic monitoring
393757|NCT01269736|arrhythmia|arrhythmia
393758|NCT01269736|myocardial ischemia|myocardial ischemia
393759|NCT01269723|Smoking|smoking
393760|NCT01269723|influenza|influenza
393761|NCT01269723|influenza vaccine|influenza vaccine
393762|NCT01269710|Second Generation Antipsychotics|second generation antipsychotics
393763|NCT01269710|Schizophrenia|schizophrenia
393764|NCT01269710|Schizoaffective|schizoaffective
393765|NCT01269710|Schizophreniform|schizophreniform
393766|NCT01269710|Psychosis NOS|psychosis nos
393767|NCT01269710|Mood Disorders|mood disorders
393768|NCT01269710|Weight|weight
393769|NCT01269710|Autism|autism
393771|NCT01269697|food supplementation|food supplementation
393772|NCT01269697|macular pigments|macular pigments
393773|NCT01269697|luthéine|luthéine
393774|NCT01269697|zéaxanthine|zéaxanthine
393775|NCT01269697|visual acuity|visual acuity
393776|NCT01269697|prevention|prevention
393777|NCT01269697|genetique risk|genetique risk
393778|NCT01269684|Kidney|kidney
393779|NCT01269684|renal|renal
393780|NCT01269684|transplantation|transplantation
393781|NCT01269684|tacrolimus|tacrolimus
393782|NCT01269684|everolimus|everolimus
393783|NCT01269684|stable allograft recipients|stable allograft recipients
393784|NCT01269671|Functional Abdominal Pain|functional abdominal pain
393785|NCT01269671|Irritable Bowel Syndrome|irritable bowel syndrome
393786|NCT01269671|IBS|ibs
393787|NCT01269671|Functional Dyspepsia|functional dyspepsia
393788|NCT01269671|Melatonin|melatonin
393789|NCT01269671|Simethicone|simethicone
393790|NCT01269671|Peppermint Oil|peppermint oil
393791|NCT01269671|mentharil|mentharil
393792|NCT01269671|functional bowel disorders|functional bowel disorders
393793|NCT01269671|quality of life|quality of life
393794|NCT01269645|Cancer|cancer
393795|NCT01269645|Clinical trials|clinical trials
393796|NCT01269632|teenagers to adult transition|teenagers to adult transition
393797|NCT01269632|comparison|comparison
393798|NCT01269619|back pain|back pain
393799|NCT01269619|posture|posture
393800|NCT01269619|lumbar support|lumbar support
393801|NCT01269619|dynamic support|dynamic support
393802|NCT01269593|PET Scan|pet scan
393803|NCT01269593|124I-PUH71|124i-puh71
393804|NCT01269593|10-139|10-139
393805|NCT01269567|RectalNeoplasms|rectalneoplasms
393806|NCT01269567|Colorectal Neoplasms|colorectal neoplasms
393807|NCT01269567|Intestinal Neoplasms|intestinal neoplasms
393808|NCT01269567|Gastrointestinal Neoplasms|gastrointestinal neoplasms
393809|NCT01269567|Digestive System Neoplasms|digestive system neoplasms
393810|NCT01269567|Neoplasms by Site|neoplasms by site
393811|NCT01269567|Digestive System Diseases|digestive system diseases
393812|NCT01269567|Gastrointestinal Diseases|gastrointestinal diseases
393813|NCT01269567|Intestinal Diseases|intestinal diseases
393814|NCT01269567|Rectal Diseases|rectal diseases
393815|NCT01269554|diarrhea|diarrhea
393816|NCT01269554|Guinea-Bissau|guinea-bissau
393817|NCT01269554|Finland|finland
393818|NCT01269554|Children|children
393819|NCT01269554|Adults|adults
393820|NCT01269554|Intestinal pathogens|intestinal pathogens
393821|NCT01269554|Bacteria|bacteria
393822|NCT01269554|Virus|virus
393823|NCT01269554|Parasites|parasites
393824|NCT01269528|Palivizumab|palivizumab
393825|NCT01269528|Airway Hyperreactivity|airway hyperreactivity
393826|NCT01269528|EBC|ebc
393827|NCT01269528|MCT|mct
393828|NCT01269515|Cox-2 inhibitor|cox-2 inhibitor
393829|NCT01269515|HIV|hiv
393830|NCT01269515|immune activation|immune activation
393831|NCT01269515|immune modulating|immune modulating
393832|NCT01269515|progression markers|progression markers
393833|NCT01269515|vaccine|vaccine
393834|NCT01269489|quality of life|quality of life
393835|NCT01269489|general Slovenian population|general slovenian population
393836|NCT01269489|EORTC QLQ C30|eortc qlq c30
393837|NCT01269463|Attention deficit|attention deficit
393838|NCT01269463|Hyperactivity|hyperactivity
393839|NCT01269463|Impulsivity|impulsivity
393840|NCT01269463|Inattention|inattention
393841|NCT01269450|second trimester vaginal bleeding|second trimester vaginal bleeding
393842|NCT01269450|late abortion|late abortion
393843|NCT01269450|preterm birth|preterm birth
393844|NCT01269450|progesterone|progesterone
393845|NCT01269437|mild to moderate asthma|mild to moderate asthma
393846|NCT01269424|adult giant cell glioblastoma|adult giant cell glioblastoma
393847|NCT01269424|adult glioblastoma|adult glioblastoma
393848|NCT01269424|adult gliosarcoma|adult gliosarcoma
393849|NCT01269385|Imprime PGG|imprime pgg
393850|NCT01269372|polyps|polyps
393851|NCT01269372|capsule endoscopy|capsule endoscopy
393852|NCT01269372|colonoscopy|colonoscopy
393853|NCT01269346|Locally recurrent|locally recurrent
393854|NCT01269346|metastatic HER2Positive breast cancer|metastatic her2positive breast cancer
393855|NCT01269307|Anesthesia|anesthesia
393856|NCT01269307|Pain|pain
393857|NCT01269307|Procedural sedation|procedural sedation
393858|NCT01269307|Airway/Anesthesia/Analgesia|airway/anesthesia/analgesia
393859|NCT01269294|Hepatitis C|hepatitis c
393860|NCT01269294|TMC435-TiDP16-C117|tmc435-tidp16-c117
393861|NCT01269294|TMC435-C117|tmc435-c117
393862|NCT01269294|TMC435|tmc435
393863|NCT01269294|HCV|hcv
393864|NCT01269294|Moxifloxacin|moxifloxacin
393865|NCT01269294|ECG|ecg
393866|NCT01269294|QT|qt
393867|NCT01269294|QTc|qtc
393868|NCT01269281|Bioequivalence|bioequivalence
393869|NCT01269281|two way crossover|two way crossover
393870|NCT01269242|coronary restenosis|coronary restenosis
393871|NCT01269242|angioplasty|angioplasty
393872|NCT01269242|stent|stent
393873|NCT01269242|MCP-1/CCL2|mcp-1/ccl2
393874|NCT01269242|MCP-3/CCL7|mcp-3/ccl7
393875|NCT01269203|multiple myeloma|multiple myeloma
393876|NCT01269203|MM|mm
393877|NCT01269203|maintenance therapy|maintenance therapy
393878|NCT01269203|lenalidomide|lenalidomide
393879|NCT01269203|bone marrow transplantation|bone marrow transplantation
393880|NCT01269203|auto-HSCT|auto-hsct
393881|NCT01269203|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
393882|NCT01269203|NF-kB inhibition|nf-kb inhibition
393883|NCT01269203|reducing symptoms|reducing symptoms
393884|NCT01269203|maintenance chemotherapy|maintenance chemotherapy
393885|NCT01269203|inflammatory cytokines|inflammatory cytokines
393886|NCT01269203|nuclear factor kappa B|nuclear factor kappa b
393887|NCT01269203|NF-kB|nf-kb
393888|NCT01269203|interleukin|interleukin
393889|NCT01269203|IL-6|il-6
393890|NCT01269203|tumor necrosis factor|tumor necrosis factor
393891|NCT01269203|TNF-a|tnf-a
393892|NCT01269203|NF-kB activation levels|nf-kb activation levels
393893|NCT01269190|oral mucosa in vivo|oral mucosa in vivo
393894|NCT01269190|Wide-Field In Vivo Imaging|wide-field in vivo imaging
393895|NCT01269190|High Resolution In Vivo Imaging|high resolution in vivo imaging
393896|NCT01269190|Oral Neoplasia|oral neoplasia
393897|NCT01269190|Topical Fluorescent Dyes|topical fluorescent dyes
393898|NCT01269190|contrast dye|contrast dye
393899|NCT01269190|oral dysplasia|oral dysplasia
393900|NCT01269190|Proflavine|proflavine
393901|NCT01269190|oral lesions|oral lesions
393902|NCT01269190|surgical resection|surgical resection
393903|NCT01269190|High Resolution Microendoscope|high resolution microendoscope
393904|NCT01269190|HRME|hrme
393905|NCT01269190|Identafi 3000|identafi 3000
393906|NCT01269190|Multispectral Digital Microscope|multispectral digital microscope
393907|NCT01269190|MDM|mdm
393908|NCT01269190|Portable Screening System|portable screening system
393909|NCT01269190|PS2|ps2
393910|NCT01269177|ACPE|acpe
393911|NCT01269177|Acute respiratory failure|acute respiratory failure
393912|NCT01269177|Non invasive ventilation|non invasive ventilation
393913|NCT01269177|acute cardiogenic pulmonary edema|acute cardiogenic pulmonary edema
393914|NCT01269164|Face Transplant|face transplant
393915|NCT01269164|Facial Transplantation|facial transplantation
393916|NCT01269164|Composite Facial Allograft Transplantation|composite facial allograft transplantation
393917|NCT01269151|Age-Related Macular Degeneration|age-related macular degeneration
393918|NCT01269151|Retinal Function|retinal function
393919|NCT01269151|multifocal-ERG|multifocal-erg
393920|NCT01269151|Electroretinography|electroretinography
393921|NCT01269151|microperimetry|microperimetry
393922|NCT01269151|Lucentis|lucentis
393923|NCT01269151|Ranibizumab|ranibizumab
393924|NCT01269151|longterm effects|longterm effects
393925|NCT01269151|best corrected visual acuity|best corrected visual acuity
393926|NCT01269151|BCVA|bcva
403033|NCT01228435|NSCLC|nsclc
393927|NCT01269138|Inherited Factor VII deficiency|inherited factor vii deficiency
393928|NCT01269138|Inhibitor development in Factor VII deficiency|inhibitor development in factor vii deficiency
393929|NCT01269138|Bleeding in Factor VII Deficiency|bleeding in factor vii deficiency
393930|NCT01269138|Surgery in Factor VII deficiency|surgery in factor vii deficiency
393931|NCT01269138|Prophylaxis in Factor VII Deficiency|prophylaxis in factor vii deficiency
393932|NCT01269125|cytokines|cytokines
393933|NCT01269125|endometriosis|endometriosis
393934|NCT01269125|fertilization rate|fertilization rate
393935|NCT01269125|follicular fluid|follicular fluid
393936|NCT01269125|pregnancy rate|pregnancy rate
393937|NCT01269099|hypokalemia|hypokalemia
393938|NCT01269099|intravenous patient controlled analgesia|intravenous patient controlled analgesia
393939|NCT01269086|Primary Heath Care|primary heath care
393940|NCT01269086|Preventive Medicine|preventive medicine
393941|NCT01269086|Adolescent Health Services|adolescent health services
393942|NCT01269086|Spouses|spouses
393943|NCT01269086|Family|family
393944|NCT01269086|Family Practice|family practice
393945|NCT01269073|Obstructive Sleep Apnea|obstructive sleep apnea
393946|NCT01269060|Colorectal Cancer, laparoscopic surgery|colorectal cancer, laparoscopic surgery
393947|NCT01269047|type 1 diabetes|type 1 diabetes
393948|NCT01269047|Symlin|symlin
393949|NCT01269047|Byetta|byetta
393950|NCT01269047|CGMS iPro|cgms ipro
393951|NCT01269034|Type 1 diabetes Milletus|type 1 diabetes milletus
393952|NCT01269034|diabetes|diabetes
393953|NCT01269034|healthy controls|healthy controls
393954|NCT01269034|exenatide|exenatide
393955|NCT01269034|byetta|byetta
393956|NCT01269021|MMF treatment IgA Nephropathy (IgAN)|mmf treatment iga nephropathy (igan)
393957|NCT01269008|Closed loop|closed loop
393958|NCT01269008|type 1 diabetes|type 1 diabetes
393959|NCT01269008|Symlin|symlin
393960|NCT01269008|Byetta|byetta
393961|NCT01269008|diabetes|diabetes
393962|NCT01269008|insulin|insulin
393963|NCT01269008|insulin pump|insulin pump
393964|NCT01268995|NODAT|nodat
393965|NCT01268995|kidney transplantation|kidney transplantation
393966|NCT01268995|beta cell function|beta cell function
393967|NCT01268995|insulin|insulin
393968|NCT01268995|Tacrolimus|tacrolimus
393969|NCT01268995|Cyclosporine A|cyclosporine a
393970|NCT01268982|socket preservation|socket preservation
393971|NCT01268982|alveolar ridge augmentation|alveolar ridge augmentation
393972|NCT01268969|pilonidal disease PND|pilonidal disease pnd
393973|NCT01268943|rectal neoplasms|rectal neoplasms
393974|NCT01268943|aged|aged
393975|NCT01268943|radiotherapy|radiotherapy
393976|NCT01268943|drug therapy|drug therapy
393977|NCT01268943|dose-escalation|dose-escalation
393978|NCT01268943|capecitabine|capecitabine
393979|NCT01268930|ovarian reserve|ovarian reserve
393980|NCT01268930|endometrioma excision|endometrioma excision
393981|NCT01268930|hemostatic matrix|hemostatic matrix
393982|NCT01268930|bipolar electrocoagulation|bipolar electrocoagulation
393983|NCT01268930|thermal injury|thermal injury
393984|NCT01268917|coronary artery disease|coronary artery disease
393985|NCT01268917|off-pump coronary artery bypass|off-pump coronary artery bypass
393986|NCT01268917|aspirin|aspirin
393987|NCT01268891|Azilect|azilect
393988|NCT01268891|Motor fluctuations|motor fluctuations
393989|NCT01268891|Parkinson´s Disease|parkinson´s disease
393990|NCT01268891|Rasagiline|rasagiline
393991|NCT01268878|effect of febrile neutropenia resulting chemotherapy by TPF|effect of febrile neutropenia resulting chemotherapy by tpf
393992|NCT01268865|Acoustic Radiation Force Impulse (ARFI)|acoustic radiation force impulse (arfi)
393993|NCT01268865|Virtual Touch Quantification (VTQ)|virtual touch quantification (vtq)
393994|NCT01268865|liver stiffness measurement (LSM)|liver stiffness measurement (lsm)
393995|NCT01268865|liver fibrosis|liver fibrosis
393996|NCT01268865|cirrhosis|cirrhosis
393997|NCT01268865|hepatitis B|hepatitis b
393998|NCT01268865|hepatitis C|hepatitis c
393999|NCT01268839|TMC278, rilpivirine, efavirenz, healthy volunteer|tmc278, rilpivirine, efavirenz, healthy volunteer
394000|NCT01268800|AML|aml
394001|NCT01268800|Induction|induction
394002|NCT01268761|Ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
394003|NCT01268761|GnRH antagonist|gnrh antagonist
394004|NCT01268761|Ascitis.|ascitis.
394005|NCT01268748|single site surgery|single site surgery
394006|NCT01268748|laparoscopic surgery|laparoscopic surgery
394007|NCT01268748|pain|pain
394008|NCT01268748|nausea|nausea
394009|NCT01268735|Dysfunctional Tear Syndrome|dysfunctional tear syndrome
394010|NCT01268735|Dry Eye|dry eye
394011|NCT01268735|LIPCOF|lipcof
394012|NCT01268735|Hydroxypropyl-guar|hydroxypropyl-guar
394013|NCT01268722|Nitinol Stent|nitinol stent
394014|NCT01268722|Balloon angioplasty|balloon angioplasty
394015|NCT01268722|Chronic total occlusions|chronic total occlusions
394016|NCT01268722|Femoropopliteal|femoropopliteal
394017|NCT01268696|diabetes|diabetes
394018|NCT01268696|obesity|obesity
394019|NCT01268696|hypertension|hypertension
394020|NCT01268696|dyslipidemia|dyslipidemia
394021|NCT01268683|Ischemic stroke|ischemic stroke
394022|NCT01268657|PTSD|ptsd
394023|NCT01268657|Fear of Falling|fear of falling
394024|NCT01268657|Older Adults|older adults
394025|NCT01268657|Injurious Falls|injurious falls
394026|NCT01268657|Exposure Therapy|exposure therapy
394027|NCT01268644|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
394028|NCT01268631|Fibromyalgia|fibromyalgia
394029|NCT01268631|Pain modulation|pain modulation
394030|NCT01268618|IBS|ibs
394031|NCT01268618|Diarrhea|diarrhea
394032|NCT01268618|Dyspepsia|dyspepsia
394033|NCT01268605|Dental caries|dental caries
394034|NCT01268605|Resin based composite|resin based composite
394035|NCT01268605|Hypersensitivity|hypersensitivity
394036|NCT01268605|Teeth|teeth
394037|NCT01268605|Dentistry|dentistry
394038|NCT01268605|Practice-based research network|practice-based research network
394039|NCT01268592|fertility preservation|fertility preservation
394040|NCT01268592|oocyte cryopreservation|oocyte cryopreservation
394041|NCT01268592|vitrification|vitrification
394042|NCT01268592|egg freezing|egg freezing
394043|NCT01268592|fertility preservation in female cancer patients|fertility preservation in female cancer patients
394044|NCT01268579|ribavirin|ribavirin
394045|NCT01268579|VIRAZOLE|virazole
394046|NCT01268579|tonsil|tonsil
394047|NCT01268579|base of tongue|base of tongue
394048|NCT01268579|squamous cell carcinoma|squamous cell carcinoma
394049|NCT01268579|10-218|10-218
394050|NCT01268566|Glioblastoma|glioblastoma
394056|NCT01268540|refractive astigmatism|refractive astigmatism
394057|NCT01268540|Aspheric|aspheric
394058|NCT01268540|Toric|toric
394059|NCT01268540|Hoya|hoya
394060|NCT01268540|Surgical|surgical
394061|NCT01268540|Optics|optics
394062|NCT01268540|visual acuity|visual acuity
394063|NCT01268527|Psoriasis vulgaris|psoriasis vulgaris
394064|NCT01268514|Complex|complex
394065|NCT01268514|Abdominal Wall Reconstruction|abdominal wall reconstruction
394066|NCT01268514|AWR|awr
394067|NCT01268514|Hernia|hernia
394068|NCT01268475|Bronchiectasis|bronchiectasis
394069|NCT01268475|Quality of Life|quality of life
394070|NCT01268475|Respiratory Function Tests|respiratory function tests
394071|NCT01268475|Exercise Test|exercise test
394072|NCT01268449|Tinnitus|tinnitus
394073|NCT01268449|Low power laser|low power laser
394074|NCT01268423|Percutaneous tracheostomy|percutaneous tracheostomy
394075|NCT01268423|Swallowing dysfunction|swallowing dysfunction
394076|NCT01268423|Mechanical ventilation|mechanical ventilation
394077|NCT01268423|Intensive Care|intensive care
394078|NCT01268410|Acute respiratory failure|acute respiratory failure
394079|NCT01268410|Acute lung injury|acute lung injury
394080|NCT01268410|Acute respiratory distress syndrome|acute respiratory distress syndrome
394081|NCT01268410|Mechanical Ventilation|mechanical ventilation
394082|NCT01268410|Non-Invasive Ventilation|non-invasive ventilation
394084|NCT01268397|wrist fracture|wrist fracture
394085|NCT01268397|fracture of the distal radius|fracture of the distal radius
394086|NCT01268397|volar plate|volar plate
394087|NCT01268397|plaster cast|plaster cast
394088|NCT01268384|pancreatic cancer|pancreatic cancer
394089|NCT01268384|neoadjuvant chemotherapy|neoadjuvant chemotherapy
394090|NCT01268384|gemcitabine|gemcitabine
394091|NCT01268384|capecitabine|capecitabine
394092|NCT01268371|Coronary artery disease|coronary artery disease
394093|NCT01268371|Stent|stent
394094|NCT01268345|blood glucose|blood glucose
394095|NCT01268332|Placebo IVR as a delivery method|placebo ivr as a delivery method
394096|NCT01268319|Myocardial Infarction|myocardial infarction
394097|NCT01268319|percutaneous coronary intervention|percutaneous coronary intervention
394098|NCT01268319|embolization|embolization
394099|NCT01268319|necrotic core|necrotic core
394100|NCT01268319|vulnerable plaque|vulnerable plaque
394101|NCT01268319|coronary plaque rupture|coronary plaque rupture
394102|NCT01268306|contact lens|contact lens
394103|NCT01268306|corneal staining|corneal staining
394104|NCT01268306|fluorescein staining|fluorescein staining
394105|NCT01268306|preservatives|preservatives
394106|NCT01268306|keratitis|keratitis
394107|NCT01268306|punctate keratopathy|punctate keratopathy
394108|NCT01268306|superficial punctate keratopathy|superficial punctate keratopathy
394109|NCT01268306|SPK|spk
394110|NCT01268293|Cancer|cancer
394111|NCT01268254|wine|wine
394112|NCT01268254|aging|aging
394113|NCT01268254|atherosclerosis|atherosclerosis
394114|NCT01268254|telomere|telomere
394115|NCT01268254|tomography|tomography
394116|NCT01268254|coronary vessels|coronary vessels
394117|NCT01268241|Fabry Disease|fabry disease
394118|NCT01268241|Fabry´s Disease|fabry´s disease
394119|NCT01268241|Anderson-Fabry Disease|anderson-fabry disease
394120|NCT01268228|intracoronary ECG|intracoronary ecg
396336|NCT01258673|Fimasartan|fimasartan
394121|NCT01268228|coronary bifurcation stenosis|coronary bifurcation stenosis
394122|NCT01268228|side branch compromise|side branch compromise
394123|NCT01268228|Periprocedural myonecrosis during coronary bifurcation lesion stenting assessed with ic ECG|periprocedural myonecrosis during coronary bifurcation lesion stenting assessed with ic ecg
394124|NCT01268215|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
394125|NCT01268215|Budesonide|budesonide
394126|NCT01268215|Infasurf|infasurf
403034|NCT01228435|IPI-504|ipi-504
394127|NCT01268202|cutaneous radioinduced fibrosis|cutaneous radioinduced fibrosis
394128|NCT01268189|burn wound|burn wound
394129|NCT01268189|management with oxygen|management with oxygen
394130|NCT01268176|Vitamin D|vitamin d
394131|NCT01268176|vitamin D deficiency|vitamin d deficiency
394132|NCT01268176|vitamin D absorption|vitamin d absorption
394133|NCT01268163|Docetaxel|docetaxel
394134|NCT01268163|Phase I|phase i
394135|NCT01268163|Pharmacokinetic|pharmacokinetic
394136|NCT01268163|Bioequivalence|bioequivalence
394137|NCT01268137|MDD|mdd
394138|NCT01268137|DBS|dbs
394139|NCT01268124|Japanese|japanese
394140|NCT01268111|vitamin D deficiency, insulin sensitivity|vitamin d deficiency, insulin sensitivity
394141|NCT01268098|Hypoparathyroidism, rhPTH[1-84], NPSP558|hypoparathyroidism, rhpth[1-84], npsp558
394142|NCT01268085|Radiation Safety|radiation safety
394143|NCT01268085|Computerized Physician Order Entry|computerized physician order entry
394144|NCT01268085|Decision Support|decision support
394145|NCT01268085|Cat Scans|cat scans
394146|NCT01268072|COPD|copd
402073|NCT01233271|ICU|icu
394147|NCT01268059|Non-small cell lung cancer|non-small cell lung cancer
394148|NCT01268059|NSCLC|nsclc
394149|NCT01268046|aging|aging
394150|NCT01268046|postmenopausal women|postmenopausal women
394151|NCT01268046|estrogen|estrogen
394152|NCT01268046|memory|memory
394153|NCT01268033|rituximab|rituximab
394154|NCT01268033|idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
394155|NCT01268033|minimal change disease|minimal change disease
394156|NCT01268033|focal and segmental glomerulosclerosis|focal and segmental glomerulosclerosis
394157|NCT01268020|Alzheimer|alzheimer
394158|NCT01268020|AD|ad
394159|NCT01267994|Steroid|steroid
394160|NCT01267994|Steroid-Resistant|steroid-resistant
394161|NCT01267994|Autoimmune Inner Ear Disease|autoimmune inner ear disease
394162|NCT01267994|Immune Mediated Hearing Loss|immune mediated hearing loss
394163|NCT01267994|Sudden Sensorineural Hearing Loss|sudden sensorineural hearing loss
394164|NCT01267994|Meniere's Disease|meniere's disease
394165|NCT01267994|Autoimmune|autoimmune
394166|NCT01267994|Hearing|hearing
394167|NCT01267981|Small bowel|small bowel
394168|NCT01267981|video-capsule endoscopy|video-capsule endoscopy
394169|NCT01267981|gastrointestinal bleeding|gastrointestinal bleeding
394170|NCT01267981|polyethylene glycol|polyethylene glycol
394171|NCT01267968|pharmacokinetics|pharmacokinetics
394172|NCT01267968|bronchoalveolar lavage|bronchoalveolar lavage
394173|NCT01267968|GSK2251052|gsk2251052
394174|NCT01267968|pulmonary|pulmonary
394175|NCT01267968|healthy volunteer|healthy volunteer
394176|NCT01267968|antimicrobial|antimicrobial
394177|NCT01267942|Adenotonsillectomy.|adenotonsillectomy.
394178|NCT01267929|Children with cerebral palsy|children with cerebral palsy
394179|NCT01267929|Gross Motor Function Measure|gross motor function measure
394180|NCT01267929|Imitative learning|imitative learning
394181|NCT01267929|Mirror neuron|mirror neuron
394182|NCT01267929|Action observation|action observation
394183|NCT01267929|Conventional physical therapy|conventional physical therapy
394184|NCT01267916|intrinsic positive end-expiratory pressure|intrinsic positive end-expiratory pressure
394185|NCT01267916|obesity|obesity
394186|NCT01267916|ventilator setting|ventilator setting
394187|NCT01267916|respiratory rate|respiratory rate
394188|NCT01267903|Vaccines Adverse Reaction|vaccines adverse reaction
394189|NCT01267890|ethics|ethics
394190|NCT01267890|law|law
394191|NCT01267890|surrogate|surrogate
394192|NCT01267890|conflict|conflict
394193|NCT01267877|U.S. Preventive Services Task Force|u.s. preventive services task force
394194|NCT01267877|Patient attitude|patient attitude
394195|NCT01267877|Mammogram|mammogram
394196|NCT01267877|Guideline|guideline
394197|NCT01267864|migraine|migraine
394198|NCT01267864|emergency|emergency
394199|NCT01267864|metoclopramide|metoclopramide
394200|NCT01267864|ketorolac|ketorolac
394201|NCT01267864|valproate|valproate
394202|NCT01267851|gynecologic disease|gynecologic disease
394203|NCT01267838|Coronary artery disease|coronary artery disease
394204|NCT01267838|Restenosis|restenosis
394205|NCT01267838|Stent thrombosis|stent thrombosis
394206|NCT01267825|Disc herniation|disc herniation
394207|NCT01267825|Lumbosacral radiculopathy|lumbosacral radiculopathy
394208|NCT01267825|Corticosteroids|corticosteroids
394209|NCT01267786|Oxidotic stress|oxidotic stress
394210|NCT01267773|depression|depression
394211|NCT01267773|conduct problems|conduct problems
394212|NCT01267760|dialysis|dialysis
394213|NCT01267760|hemodialysis|hemodialysis
394214|NCT01267760|Effect of recycled low-volume dialysate on dialysis efficacy|effect of recycled low-volume dialysate on dialysis efficacy
394215|NCT01267747|Atrial fibrillation|atrial fibrillation
394216|NCT01267747|Atrial Flutter|atrial flutter
394217|NCT01267747|Primary Aldosteronism|primary aldosteronism
394218|NCT01267747|Aldosterone Producing Adenoma|aldosterone producing adenoma
394219|NCT01267734|Everolimus|everolimus
394220|NCT01267734|Zotarolimus|zotarolimus
394221|NCT01267734|Cilostazol|cilostazol
394222|NCT01267734|Clopidogrel|clopidogrel
394223|NCT01267721|heart surgery|heart surgery
394224|NCT01267695|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
385099|NCT01305954|UNC|unc
394225|NCT01267695|Imatinib mesylate|imatinib mesylate
394226|NCT01267695|Perioperative therapy|perioperative therapy
394227|NCT01267682|Delirium|delirium
394228|NCT01267682|Dementia|dementia
394229|NCT01267682|Non-pharmacological Intervention|non-pharmacological intervention
394230|NCT01267682|Post-acute care|post-acute care
394231|NCT01267669|Variceal bleeding|variceal bleeding
394232|NCT01267669|Endoscopic therapy|endoscopic therapy
394233|NCT01267669|Band ligation|band ligation
394234|NCT01267669|Somatostatin|somatostatin
394235|NCT01267669|Vasoactive drugs|vasoactive drugs
394236|NCT01267669|Octreotide|octreotide
394237|NCT01267643|Alefacept|alefacept
394238|NCT01267643|Amevive|amevive
394239|NCT01267643|Aplastic Anemia|aplastic anemia
394240|NCT01267643|Moderate to Severe Aplastic Anemia|moderate to severe aplastic anemia
394241|NCT01267630|Delirium of Mixed Origin|delirium of mixed origin
394242|NCT01267630|Subacute Delirium|subacute delirium
394243|NCT01267630|Mental Disorders, Organic|mental disorders, organic
394244|NCT01267630|Organic Brain Syndrome, Nonpsychotic|organic brain syndrome, nonpsychotic
394245|NCT01267630|Organic Mental Disorders|organic mental disorders
394246|NCT01267630|Organic Mental Disorders, Psychotic|organic mental disorders, psychotic
394247|NCT01267630|Psychoses, Traumatic|psychoses, traumatic
394248|NCT01267630|Cognition Disorder|cognition disorder
394249|NCT01267630|Confusion state|confusion state
394250|NCT01267630|Disorientation|disorientation
394251|NCT01267617|hemodialysis|hemodialysis
394252|NCT01267617|hypotension|hypotension
394253|NCT01267617|circulatory stress|circulatory stress
394254|NCT01267617|photo-plethysmography|photo-plethysmography
394255|NCT01267578|Epitope peptide, CTL, Esophageal cancer, Vaccination|epitope peptide, ctl, esophageal cancer, vaccination
394256|NCT01267565|ventilator-acquired pneumonia|ventilator-acquired pneumonia
394257|NCT01267565|prevention|prevention
394258|NCT01267565|amylase|amylase
394259|NCT01267565|tracheal aspiration|tracheal aspiration
394260|NCT01267565|microaspiration|microaspiration
394261|NCT01267552|Breast cancer|breast cancer
394262|NCT01267552|Surgery|surgery
394263|NCT01267552|Complications|complications
394264|NCT01267552|Drainage|drainage
394265|NCT01267552|Seroma|seroma
394266|NCT01267539|Suan Zao Ren Tang, climacteric, PSQI, WHOQOL-BREF|suan zao ren tang, climacteric, psqi, whoqol-bref
394267|NCT01267526|Growth disorders|growth disorders
394268|NCT01267526|Saizen|saizen
394269|NCT01267526|Easypod|easypod
394270|NCT01267526|Growth hormone|growth hormone
394271|NCT01267526|Pediatric subject|pediatric subject
394272|NCT01267513|oxygen saturation|oxygen saturation
394273|NCT01267513|pulse rate|pulse rate
394274|NCT01267513|tachycardia|tachycardia
394275|NCT01267513|bradycardia|bradycardia
394276|NCT01267513|hypoxia|hypoxia
394277|NCT01267487|Heparin|heparin
394278|NCT01267487|Protamine|protamine
394279|NCT01267487|Cardiopulmonary Bypass|cardiopulmonary bypass
394280|NCT01267487|Titration|titration
394281|NCT01267474|School children|school children
394282|NCT01267474|Sugar intake|sugar intake
394283|NCT01267474|Nutritional education program|nutritional education program
394284|NCT01267461|To asses the biological actions of insulin analogs in primary tumor cells|to asses the biological actions of insulin analogs in primary tumor cells
394285|NCT01267448|Diabetes Mellitus Type2.|diabetes mellitus type2.
394286|NCT01267448|Severe Hyperglycemia - blood glucose levels >300mg/dl.|severe hyperglycemia - blood glucose levels >300mg/dl.
394287|NCT01267435|Arthroscopy, Anterior Cruciate Ligament, Tibial Tunnel.|arthroscopy, anterior cruciate ligament, tibial tunnel.
394288|NCT01267422|Leber's Hereditary Optic Neuropathy,11778 LHON mutation,|leber's hereditary optic neuropathy,11778 lhon mutation,
394289|NCT01267422|rAAV2-ND4,triamcinolone acetonide|raav2-nd4,triamcinolone acetonide
394290|NCT01267409|Mapping the emotional territories of the STN|mapping the emotional territories of the stn
394291|NCT01267409|Identifying the emotional spectral signature of the STN single unit activity|identifying the emotional spectral signature of the stn single unit activity
394292|NCT01267409|Manipulating emotional processing of PD patients by high and low frequency stimulation|manipulating emotional processing of pd patients by high and low frequency stimulation
394293|NCT01267409|Affecting long-term emotional states of the PD patients|affecting long-term emotional states of the pd patients
394294|NCT01267396|Bioequivalence|bioequivalence
394295|NCT01267396|Sertraline|sertraline
394296|NCT01267396|crossover|crossover
394297|NCT01267383|Bioequivalence|bioequivalence
394298|NCT01267383|Sertraline|sertraline
394299|NCT01267383|crossover|crossover
394300|NCT01267370|clinical trial|clinical trial
394301|NCT01267370|dietary fiber|dietary fiber
394302|NCT01267370|constipation|constipation
394303|NCT01267370|children|children
394304|NCT01267357|Serous Papillary Endometrial Cancer|serous papillary endometrial cancer
396431|NCT01256489|KPro|kpro
394305|NCT01267357|Endometrioid endometrial cancer|endometrioid endometrial cancer
394306|NCT01267357|biomarkers|biomarkers
394307|NCT01267357|P16|p16
394308|NCT01267357|P53|p53
394309|NCT01267357|Prognosis|prognosis
394310|NCT01267344|biliary tract cancer|biliary tract cancer
394311|NCT01267344|BTC|btc
394312|NCT01267344|cetuximaba|cetuximaba
394313|NCT01267331|Old Myocardial Infarction|old myocardial infarction
385106|NCT01305941|RAD001|rad001
394314|NCT01267331|Stem Cell Therapy|stem cell therapy
394315|NCT01267331|Coronary Artery Bypass Grafting|coronary artery bypass grafting
394316|NCT01267331|Coronary Artery Disease|coronary artery disease
394317|NCT01267318|Gastric juice|gastric juice
394318|NCT01267318|Stomach|stomach
394319|NCT01267318|GI|gi
394320|NCT01267318|Gastric juice samples with presence of blood.|gastric juice samples with presence of blood.
394321|NCT01267305|esophagectomy|esophagectomy
394322|NCT01267305|lung resection|lung resection
394323|NCT01267305|venous thromboembolism|venous thromboembolism
394324|NCT01267305|low molecular weight heparin|low molecular weight heparin
394325|NCT01267305|chest drainage|chest drainage
394326|NCT01267305|TEG|teg
394327|NCT01267292|cocaine dependence|cocaine dependence
394328|NCT01267292|psychopharmacology|psychopharmacology
394329|NCT01267292|attentional bias|attentional bias
394330|NCT01267292|risky decision making|risky decision making
394331|NCT01267292|buspirone|buspirone
394332|NCT01267292|methylphenidate|methylphenidate
394333|NCT01267227|Hyperlipidemia|hyperlipidemia
394334|NCT01267227|Cholesterol|cholesterol
394335|NCT01267227|Blood Pressure|blood pressure
394336|NCT01267227|Oxidative Stress|oxidative stress
394337|NCT01267227|Pterostilbene|pterostilbene
394338|NCT01267227|Blueberry|blueberry
394339|NCT01267227|Grape Extract|grape extract
394340|NCT01267201|Single dose bioavailability study of methylprednisolone powder for oral suspension (4mg/mL) versus methylprednisolone tablet (32 mg)|single dose bioavailability study of methylprednisolone powder for oral suspension (4mg/ml) versus methylprednisolone tablet (32 mg)
394341|NCT01267162|CHB|chb
394342|NCT01267149|superficial vertical perioral lines|superficial vertical perioral lines
394343|NCT01267149|superficial horizontal and lateral canthal lines|superficial horizontal and lateral canthal lines
394344|NCT01267149|correct moderate to severe facial wrinkles and folds|correct moderate to severe facial wrinkles and folds
394345|NCT01267136|Tonsillectomy|tonsillectomy
394346|NCT01267136|Pain|pain
394347|NCT01267136|Pediatric|pediatric
394348|NCT01267136|Opioids|opioids
394349|NCT01267136|Tramadol|tramadol
394350|NCT01267136|Codeine|codeine
394351|NCT01267097|Pediatric Obesity|pediatric obesity
394352|NCT01267097|Treatment|treatment
394353|NCT01267097|Cognitive Behavioural Therapy|cognitive behavioural therapy
394354|NCT01267097|Psychoeducation|psychoeducation
394355|NCT01267097|Canada|canada
394356|NCT01267084|Trabectedin (YONDELIS)|trabectedin (yondelis)
394357|NCT01267084|Ketoconazole|ketoconazole
394358|NCT01267084|Antineoplastic Agents|antineoplastic agents
394359|NCT01267084|Solid tumors|solid tumors
394360|NCT01267084|Locally advanced or metastatic disease|locally advanced or metastatic disease
394361|NCT01267084|Chemotherapy|chemotherapy
394362|NCT01267084|Pharmacokinetics|pharmacokinetics
394363|NCT01267071|Entero-test|entero-test
394364|NCT01267071|Phase I|phase i
394365|NCT01267071|GSK962040|gsk962040
394366|NCT01267071|i.v. microtracer|i.v. microtracer
394367|NCT01267071|radioactivity|radioactivity
394368|NCT01267071|pharmacokinetics|pharmacokinetics
394369|NCT01267071|healthy volunteer|healthy volunteer
394370|NCT01267058|Booster vaccination|booster vaccination
394371|NCT01267045|Persian Gulf Syndrome|persian gulf syndrome
394372|NCT01267045|Pain|pain
394373|NCT01267045|Fatigue|fatigue
394374|NCT01267045|Attention|attention
394375|NCT01267045|Meditation|meditation
394376|NCT01267019|social cognition|social cognition
394377|NCT01267019|training intervention|training intervention
394378|NCT01266993|Immunogenicity|immunogenicity
394379|NCT01266993|Persistence|persistence
394380|NCT01266993|Safety|safety
394381|NCT01266993|Conjugate vaccine|conjugate vaccine
394382|NCT01266993|Meningococcal vaccine|meningococcal vaccine
394383|NCT01266980|cortisol|cortisol
394384|NCT01266980|renal impairment|renal impairment
394385|NCT01266980|serum potassium|serum potassium
394386|NCT01266980|pharmacokinetics|pharmacokinetics
394387|NCT01266980|Fluticasone furoate|fluticasone furoate
394388|NCT01266980|heart rate|heart rate
394389|NCT01266967|GSK2118436|gsk2118436
394390|NCT01266967|Metastatic melanoma to the brain|metastatic melanoma to the brain
394391|NCT01266967|Brain metastases|brain metastases
394392|NCT01266967|Braf mutation|braf mutation
394393|NCT01266967|Brain neoplasm|brain neoplasm
394394|NCT01266967|BRAF inhibitor|braf inhibitor
394395|NCT01266954|Cancer|cancer
394396|NCT01266954|18F FDG|18f fdg
394397|NCT01266954|PK|pk
394398|NCT01266954|PET|pet
394399|NCT01266954|Positron Emission Tomography|positron emission tomography
394400|NCT01266954|PD|pd
394401|NCT01266954|AKT Inhibitor|akt inhibitor
394402|NCT01266954|GSK2141795|gsk2141795
394403|NCT01266941|pharmacokinetics|pharmacokinetics
394404|NCT01266941|hepatic impairment|hepatic impairment
394405|NCT01266941|heart rate|heart rate
394406|NCT01266941|serum potassium|serum potassium
394407|NCT01266941|serum cortisol|serum cortisol
394408|NCT01266941|GW642444M|gw642444m
394409|NCT01266941|Fluticasone furoate (GW685698)|fluticasone furoate (gw685698)
394410|NCT01266915|SCLE|scle
394411|NCT01266915|CLE|cle
394412|NCT01266915|DLE|dle
394413|NCT01266902|HIV-1 Infection|hiv-1 infection
394414|NCT01266902|HIV-1|hiv-1
394415|NCT01266902|HIV|hiv
394416|NCT01266902|TMC278-TiDP6-C222|tmc278-tidp6-c222
394417|NCT01266902|TMC278-C222|tmc278-c222
394418|NCT01266902|TMC278|tmc278
394419|NCT01266902|Rilpivirine|rilpivirine
394623|NCT01266096|10-155|10-155
394420|NCT01266889|preterm infant,cerebral oxygenation, intracranial haemorrhagia|preterm infant,cerebral oxygenation, intracranial haemorrhagia
394421|NCT01266863|Hospital-acquired pneumonia|hospital-acquired pneumonia
394422|NCT01266863|E test|e test
394423|NCT01266863|Antibiogram|antibiogram
394424|NCT01266863|Bronchoalveolar lavage|bronchoalveolar lavage
394425|NCT01266850|vaccine, rotavirus, gastroenteritis, infants|vaccine, rotavirus, gastroenteritis, infants
394426|NCT01266837|metastatic renal cell carcinoma|metastatic renal cell carcinoma
394427|NCT01266837|biomarker|biomarker
394428|NCT01266837|Everolimus|everolimus
394429|NCT01266824|Pain|pain
394430|NCT01266824|Retinopathy of Prematurity|retinopathy of prematurity
394431|NCT01266824|Neonates|neonates
394432|NCT01266811|dexamethasone|dexamethasone
394433|NCT01266811|Siltuximab|siltuximab
394434|NCT01266811|CNTO 328|cnto 328
394435|NCT01266811|IL-6|il-6
394436|NCT01266811|Monoclonal Antibody|monoclonal antibody
394437|NCT01266811|Multiple Myeloma|multiple myeloma
394438|NCT01266811|Relapsed or Refractory|relapsed or refractory
394439|NCT01266811|Velcade|velcade
394440|NCT01266811|bortezomib|bortezomib
394441|NCT01266798|Health literacy, participation|health literacy, participation
394442|NCT01266785|crohn's|crohn's
394443|NCT01266785|Infliximab|infliximab
394444|NCT01266785|Inflammatory bowel disease|inflammatory bowel disease
394445|NCT01266785|digestive tract|digestive tract
394446|NCT01266785|Interleukin|interleukin
394447|NCT01266772|asthma; children; montelukast; treatment; exacerbation|asthma; children; montelukast; treatment; exacerbation
394448|NCT01266759|Menorrhagia|menorrhagia
394449|NCT01266759|Vaginal ring|vaginal ring
394450|NCT01266759|Norethisterone Acetate|norethisterone acetate
394451|NCT01266746|gas tamponade,|gas tamponade,
394452|NCT01266746|macular hole,|macular hole,
394453|NCT01266746|macular hole retinal detachment,|macular hole retinal detachment,
394454|NCT01266746|optical coherence tomography|optical coherence tomography
394455|NCT01266733|fibromyalgia, non pharmacological intervention|fibromyalgia, non pharmacological intervention
394456|NCT01266720|pancreatic cancer|pancreatic cancer
394457|NCT01266720|peptide vaccine|peptide vaccine
394458|NCT01266720|VEGFR|vegfr
394459|NCT01266720|gemcitabine|gemcitabine
394460|NCT01266707|Hepatocellular carcinoma|hepatocellular carcinoma
394461|NCT01266707|peptide vaccine|peptide vaccine
394462|NCT01266707|VEGFR|vegfr
394463|NCT01266694|Pericardial effusion|pericardial effusion
394464|NCT01266694|Cardiac surgery|cardiac surgery
394465|NCT01266694|Tamponade|tamponade
394466|NCT01266694|colchicine|colchicine
394467|NCT01266668|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
394468|NCT01266668|Breast|breast
394469|NCT01266668|Rituximab|rituximab
394470|NCT01266642|Breast cancer|breast cancer
394471|NCT01266642|Early invasive breast cancer|early invasive breast cancer
394472|NCT01266642|Ductal carcinoma in situ of the breast|ductal carcinoma in situ of the breast
394474|NCT01266642|T1|t1
394475|NCT01266642|T2|t2
394476|NCT01266642|N0|n0
394477|NCT01266642|N1mic|n1mic
394478|NCT01266642|N1a|n1a
394479|NCT01266642|Lumpectomy|lumpectomy
394480|NCT01266642|Hypofractionated whole breast irradiation|hypofractionated whole breast irradiation
394481|NCT01266642|HF-WBI|hf-wbi
394482|NCT01266642|Conventionally fractionated whole breast irradiation|conventionally fractionated whole breast irradiation
394483|NCT01266642|CF-WBI|cf-wbi
394484|NCT01266642|Radiation therapy|radiation therapy
394485|NCT01266642|Radiotherapy|radiotherapy
394486|NCT01266629|small bowel|small bowel
394487|NCT01266616|Interleukin-12|interleukin-12
394488|NCT01266616|Electroporation|electroporation
394489|NCT01266616|HIV Therapeutic Vaccine|hiv therapeutic vaccine
394490|NCT01266603|Metastatic Melanoma|metastatic melanoma
394491|NCT01266603|Unresectable Melanoma|unresectable melanoma
394492|NCT01266603|HDIL-2|hdil-2
394493|NCT01266603|Interleukin-2|interleukin-2
394494|NCT01266603|IL-2|il-2
394495|NCT01266603|Aldesleukin|aldesleukin
394496|NCT01266603|Proleukin|proleukin
394497|NCT01266603|recMAGE-A3 + AS15|recmage-a3 + as15
394498|NCT01266603|ASCI|asci
394499|NCT01266603|recMAGE-A3|recmage-a3
394500|NCT01266603|Recombinant MAGE-A3 protein|recombinant mage-a3 protein
394501|NCT01266603|recMAGE-A3 + AS15 ASCI|recmage-a3 + as15 asci
394502|NCT01266603|MAGE-A3|mage-a3
394503|NCT01266603|MAGE-A3 ASCI|mage-a3 asci
394504|NCT01266577|Brain Metabolism|brain metabolism
394505|NCT01266577|Neurochemistry|neurochemistry
394506|NCT01266577|Magnetic Resonance Imaging|magnetic resonance imaging
394507|NCT01266577|Mental Illness|mental illness
394508|NCT01266577|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
394509|NCT01266577|Healthy Volunteer|healthy volunteer
394510|NCT01266577|HV|hv
394511|NCT01266551|Antireflux procedure|antireflux procedure
394512|NCT01266551|Gastroesophageal reflux|gastroesophageal reflux
385312|NCT01305096|sleeplessness|sleeplessness
385313|NCT01305096|yoga|yoga
385314|NCT01305070|Standard balloon angioplasty|standard balloon angioplasty
385315|NCT01305070|POBA|poba
394513|NCT01266551|Infant sleep position|infant sleep position
394514|NCT01266551|pH monitoring|ph monitoring
394515|NCT01266499|Klebsiella , pneumonia, carbapenem-hydrolyzing lactamase, carbapenem-resistant Klebsiella (KPC), eradication,|klebsiella , pneumonia, carbapenem-hydrolyzing lactamase, carbapenem-resistant klebsiella (kpc), eradication,
394516|NCT01266486|Breast cancer|breast cancer
394517|NCT01266486|Pharmacodynamics|pharmacodynamics
394518|NCT01266486|AMPK|ampk
394519|NCT01266486|PET Scan|pet scan
394520|NCT01266473|Adults|adults
394521|NCT01266434|moderate persistent asthma|moderate persistent asthma
394522|NCT01266434|Inhaled corticosteroids|inhaled corticosteroids
394523|NCT01266421|DNG|dng
394524|NCT01266421|Anemia|anemia
394525|NCT01266421|Depression|depression
394526|NCT01266408|Drospirenone|drospirenone
394527|NCT01266408|Dienogest|dienogest
394528|NCT01266408|Metafolin|metafolin
394529|NCT01266408|Folic acid|folic acid
394530|NCT01266408|Safety|safety
394531|NCT01266395|morning symptoms COPD|morning symptoms copd
394532|NCT01266369|mastocytosis|mastocytosis
394533|NCT01266369|D816V|d816v
394534|NCT01266369|handicaps|handicaps
394535|NCT01266356|Minor Traumatic Brain Injury|minor traumatic brain injury
394536|NCT01266356|Translation|translation
394537|NCT01266343|Glaucoma|glaucoma
394538|NCT01266343|anterior chamber paracentesis|anterior chamber paracentesis
394539|NCT01266343|conventional Mannitol infusion|conventional mannitol infusion
394540|NCT01266330|dairy|dairy
394541|NCT01266330|inflammation|inflammation
394542|NCT01266330|reactive oxygen species|reactive oxygen species
394543|NCT01266330|oxidative stress|oxidative stress
394544|NCT01266330|body composition|body composition
394545|NCT01266291|Tuberous sclerosis|tuberous sclerosis
394546|NCT01266291|TS|ts
394547|NCT01266291|Seizures|seizures
394548|NCT01266278|shoulder injuries|shoulder injuries
394549|NCT01266265|pulmonary arterial hypertension|pulmonary arterial hypertension
394550|NCT01266265|PAH|pah
394551|NCT01266265|treprostinil sodium|treprostinil sodium
394552|NCT01266265|Tyvaso|tyvaso
394553|NCT01266265|inhalation|inhalation
394554|NCT01266265|Ventavis|ventavis
394555|NCT01266265|iloprost|iloprost
394556|NCT01266265|prostacyclin|prostacyclin
394557|NCT01266265|epoprostenol sodium|epoprostenol sodium
394558|NCT01266265|Flolan|flolan
394559|NCT01266265|Veletri|veletri
394560|NCT01266265|subcutaneous and intravenous prostacyclin analogue|subcutaneous and intravenous prostacyclin analogue
394561|NCT01266265|Remodulin|remodulin
394562|NCT01266265|oral ERA|oral era
394563|NCT01266265|bosentan|bosentan
394564|NCT01266265|Tracleer|tracleer
394565|NCT01266265|ambrisentan|ambrisentan
394566|NCT01266265|Letairis|letairis
394567|NCT01266265|oral PDE5 inhibitors|oral pde5 inhibitors
394568|NCT01266265|sildenafil|sildenafil
394569|NCT01266265|Revatio|revatio
394570|NCT01266265|tadalafil|tadalafil
394571|NCT01266265|Adcirca|adcirca
394572|NCT01266265|Opsumit|opsumit
394573|NCT01266265|macitentan|macitentan
394574|NCT01266265|Adempas|adempas
394575|NCT01266265|riociguat|riociguat
394576|NCT01266265|Orenitram|orenitram
394577|NCT01266265|oral treprostinil|oral treprostinil
394578|NCT01266252|neonates|neonates
394579|NCT01266252|single organ respiratory failure|single organ respiratory failure
394580|NCT01266239|Bifurcation lesion, drug-eluting stent, symmetric expansion|bifurcation lesion, drug-eluting stent, symmetric expansion
394581|NCT01266226|Rotator cuff tears|rotator cuff tears
394582|NCT01266226|ACP|acp
394583|NCT01266213|fulvestrant|fulvestrant
394584|NCT01266213|anastrozole|anastrozole
394585|NCT01266213|goserelin|goserelin
394586|NCT01266213|tamoxifen|tamoxifen
394587|NCT01266213|premenopausal|premenopausal
394588|NCT01266213|hormone receptor positive|hormone receptor positive
394589|NCT01266200|microcirculation|microcirculation
394590|NCT01266200|vertebral fracture|vertebral fracture
394591|NCT01266200|inflammation|inflammation
394592|NCT01266200|minimal-invasive surgery|minimal-invasive surgery
394593|NCT01266187|FOLFOX|folfox
394594|NCT01266187|liver metastasis|liver metastasis
394595|NCT01266187|cetuximab|cetuximab
394596|NCT01266174|CIAS|cias
394597|NCT01266174|Cognition|cognition
394598|NCT01266174|Schizophrenia|schizophrenia
394599|NCT01266174|Eltoprazine|eltoprazine
394600|NCT01266161|dental pain|dental pain
394601|NCT01266161|multiple dose|multiple dose
394602|NCT01266161|ibuprofen|ibuprofen
394603|NCT01266161|third molar extraction|third molar extraction
394604|NCT01266135|Interstitial Lung Disease|interstitial lung disease
394605|NCT01266135|Usual Interstitial Pneumonia|usual interstitial pneumonia
394606|NCT01266135|Fibrosis,|fibrosis,
394607|NCT01266135|Pulmonary Fibrosis,|pulmonary fibrosis,
394608|NCT01266135|Respiratory Disease,|respiratory disease,
394609|NCT01266135|Interstitial Lung Disease,|interstitial lung disease,
394610|NCT01266135|Biological Therapy,|biological therapy,
394611|NCT01266135|Therapeutic Uses,|therapeutic uses,
394612|NCT01266122|HIV|hiv
394613|NCT01266122|Psychosocial problems|psychosocial problems
394614|NCT01266122|MSM|msm
394615|NCT01266122|India|india
394616|NCT01266109|Substance Use|substance use
394617|NCT01266109|Delinquency|delinquency
394618|NCT01266109|Juvenile Drug Court|juvenile drug court
394619|NCT01266109|Contingency Management|contingency management
394620|NCT01266109|Family Engagement|family engagement
394621|NCT01266096|124I-cRGDY-PEG-dots|124i-crgdy-peg-dots
394622|NCT01266096|Pet scan|pet scan
394624|NCT01266096|melanoma|melanoma
394625|NCT01266096|brain|brain
394626|NCT01266083|MONTANIDE ISA 51|montanide isa 51
394627|NCT01266083|WT1 PEPTIDE SPECIFIC T CELLS|wt1 peptide specific t cells
394628|NCT01266083|vaccine|vaccine
394629|NCT01266083|10-143|10-143
394630|NCT01266070|VHL|vhl
394631|NCT01266070|Hemangioblastoma|hemangioblastoma
394632|NCT01266070|Tumor of the central nervous system|tumor of the central nervous system
394633|NCT01266070|TKI258|tki258
394634|NCT01266057|Advanced Malignancies|advanced malignancies
394635|NCT01266057|Metastatic cancers|metastatic cancers
394636|NCT01266057|Sirolimus|sirolimus
394637|NCT01266057|Hydroxychloroquine|hydroxychloroquine
394638|NCT01266057|Vorinostat|vorinostat
394639|NCT01266057|Plaquenil|plaquenil
394640|NCT01266057|Rapamune|rapamune
394641|NCT01266057|Saha|saha
394642|NCT01266057|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
394643|NCT01266057|MSK-390|msk-390
394644|NCT01266057|Zolinza|zolinza
394645|NCT01266044|Radiation-induced xerostomia|radiation-induced xerostomia
394646|NCT01266044|Acupuncture|acupuncture
394647|NCT01266044|Oropharyngeal cancer|oropharyngeal cancer
394648|NCT01266044|Radiation Therapy|radiation therapy
394649|NCT01266044|IMRT|imrt
394650|NCT01266044|Dry mouth|dry mouth
394651|NCT01266031|Glioblastoma Multiforme|glioblastoma multiforme
394652|NCT01266018|small cell lung cancer|small cell lung cancer
394653|NCT01266018|SCLC|sclc
394654|NCT01266018|ADI-PEG 20|adi-peg 20
394655|NCT01266018|arginine deiminase pegylated|arginine deiminase pegylated
394656|NCT01266005|HBe Ag(-) Chronic Hepatitis B|hbe ag(-) chronic hepatitis b
394657|NCT01265992|Secondary hyperparathyroidism|secondary hyperparathyroidism
394658|NCT01265992|Mineral and Bone Disorder (CKD-MBD)|mineral and bone disorder (ckd-mbd)
394659|NCT01265992|Chronic Kidney Disease|chronic kidney disease
394660|NCT01265979|advanced|advanced
394661|NCT01265979|metastatic|metastatic
394662|NCT01265979|gastro-intestinal|gastro-intestinal
394663|NCT01265979|stromal|stromal
394664|NCT01265979|GIST|gist
394665|NCT01265979|regorafenib|regorafenib
394666|NCT01265966|Moderate Sedation|moderate sedation
394667|NCT01265966|Sedation, Deep|sedation, deep
394668|NCT01265953|cancer prevention|cancer prevention
394669|NCT01265953|isothiocyanate|isothiocyanate
394670|NCT01265953|sulforaphane|sulforaphane
394671|NCT01265940|bladder cancer|bladder cancer
394672|NCT01265940|urothelial cancer|urothelial cancer
394673|NCT01265940|metastatic urothelial cancer|metastatic urothelial cancer
394674|NCT01265940|advanced urothelial cancer|advanced urothelial cancer
394676|NCT01265927|Breast Tumors|breast tumors
394677|NCT01265927|Cancer of Breast|cancer of breast
394678|NCT01265927|Cancer of the Breast|cancer of the breast
394679|NCT01265927|Genes, HER-2|genes, her-2
394680|NCT01265927|Genes, HER2|genes, her2
394681|NCT01265901|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
394682|NCT01265901|First line|first line
394683|NCT01265901|Eligible for sunitinib|eligible for sunitinib
394684|NCT01265888|PAH|pah
394685|NCT01265888|PH IPF|ph ipf
394686|NCT01265875|Chronic Pancreatitis|chronic pancreatitis
394687|NCT01265862|Tracheal intubation|tracheal intubation
394688|NCT01265862|Supraglottic airway devices|supraglottic airway devices
394689|NCT01265862|Patients undergoing general anesthesia|patients undergoing general anesthesia
394690|NCT01265836|Dyslipidemia Treatment and Cardiovascular Outcomes|dyslipidemia treatment and cardiovascular outcomes
394691|NCT01265823|Humira|humira
394692|NCT01265823|Adalimumab|adalimumab
394693|NCT01265823|Plaque Psoriasis|plaque psoriasis
394694|NCT01265810|oral mucositis|oral mucositis
394695|NCT01265810|targeted therapy|targeted therapy
394696|NCT01265810|Caphosol|caphosol
394697|NCT01265810|management|management
394698|NCT01265771|Arrhythmia|arrhythmia
394699|NCT01265771|Children|children
394700|NCT01265758|Atrial fibrillation|atrial fibrillation
394701|NCT01265758|Cardiac arrhythmia|cardiac arrhythmia
394702|NCT01265758|ECG|ecg
394703|NCT01265758|Telemonitoring|telemonitoring
394704|NCT01265758|Telemetry|telemetry
394705|NCT01265758|Holter|holter
394706|NCT01265745|Phase I|phase i
394707|NCT01265732|Phase 1|phase 1
394708|NCT01265732|relative bioavailability|relative bioavailability
394709|NCT01265732|healthy volunteers|healthy volunteers
394710|NCT01265732|pharmacokinetics|pharmacokinetics
394711|NCT01265732|suspension|suspension
394712|NCT01265732|dispersion|dispersion
394713|NCT01265719|Prospective|prospective
394714|NCT01265719|non-interventional|non-interventional
394715|NCT01265719|longitudinal|longitudinal
394716|NCT01265719|cohort study|cohort study
394717|NCT01265706|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
394718|NCT01265680|Blood Transfusion|blood transfusion
394719|NCT01265680|Heart surgery|heart surgery
394720|NCT01265680|Erythropoietin|erythropoietin
394721|NCT01265680|HRE|hre
394722|NCT01265667|Psoriasis|psoriasis
394723|NCT01265667|Plaque psoriasis|plaque psoriasis
394724|NCT01265654|Advanced Breast Cancer|advanced breast cancer
394725|NCT01265654|Hormonal Treatment|hormonal treatment
394726|NCT01265615|chronic allograft nephropathy|chronic allograft nephropathy
394727|NCT01265615|stem-progenitor cells|stem-progenitor cells
394728|NCT01265615|cardiorenal syndrome|cardiorenal syndrome
394729|NCT01265615|calcitriol|calcitriol
394730|NCT01265615|paricalcitol|paricalcitol
394731|NCT01265615|cholecalciferol|cholecalciferol
394732|NCT01265615|cardiac repair|cardiac repair
394733|NCT01265615|renal repair|renal repair
394734|NCT01265602|Actinic Keratosis|actinic keratosis
394735|NCT01265602|AK|ak
394736|NCT01265602|NMSC|nmsc
394737|NCT01265589|RDS|rds
394738|NCT01265589|Infant, newborn|infant, newborn
394739|NCT01265589|Vitamin A|vitamin a
394740|NCT01265589|Surfactant|surfactant
394741|NCT01265563|silymarin|silymarin
394742|NCT01265563|glutathione|glutathione
394743|NCT01265563|diabetic nephropathies|diabetic nephropathies
394744|NCT01265563|oxidative stress|oxidative stress
394745|NCT01265563|N-acetylcysteine|n-acetylcysteine
394746|NCT01265563|protein tholation|protein tholation
394747|NCT01265537|Transplant|transplant
394748|NCT01265537|Tacrolimus|tacrolimus
394749|NCT01265537|Diabetes after transplant|diabetes after transplant
394750|NCT01265537|Acute rejection prevention|acute rejection prevention
394751|NCT01265537|New onset diabetes after transplant|new onset diabetes after transplant
394752|NCT01265511|Hepatitis C|hepatitis c
394753|NCT01265511|SCY-635|scy-635
394754|NCT01265511|Ribavirin|ribavirin
394755|NCT01265511|Interferon|interferon
394756|NCT01265498|Farnesoid X Receptor|farnesoid x receptor
394758|NCT01265498|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
394759|NCT01265498|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
394760|NCT01265498|NAFLD|nafld
394761|NCT01265498|NASH|nash
394762|NCT01265498|obeticholic acid|obeticholic acid
394763|NCT01265472|Translocator Protein|translocator protein
394764|NCT01265472|Basal Cell Carcinoma|basal cell carcinoma
394765|NCT01265472|Squamous Cell Carcinoma|squamous cell carcinoma
394766|NCT01265472|Malignancy|malignancy
394767|NCT01265446|Sore throat, upper respiratory tract infection, lozenge with lidocaine and cetylpyridinium chloride.|sore throat, upper respiratory tract infection, lozenge with lidocaine and cetylpyridinium chloride.
394768|NCT01265433|GM-CSF|gm-csf
394769|NCT01265433|MONTANIDE ISA 51|montanide isa 51
394770|NCT01265433|WT1 PEPTIDE SPECIFIC T CELLS|wt1 peptide specific t cells
394771|NCT01265433|Vaccine|vaccine
394772|NCT01265433|10-134|10-134
394773|NCT01265420|Dupuytren|dupuytren
394774|NCT01265420|Dupuytren's Disease|dupuytren's disease
394775|NCT01265407|Children|children
394777|NCT01265407|Epidemiology|epidemiology
394778|NCT01265407|Malaria|malaria
394779|NCT01265394|Amyloid|amyloid
394780|NCT01265394|Magnetic resonance imaging|magnetic resonance imaging
394781|NCT01265394|Positron Emission Tomography|positron emission tomography
394782|NCT01265394|Standard uptake value ratios|standard uptake value ratios
394783|NCT01265394|Healthy Subjects|healthy subjects
394784|NCT01265381|Cohort|cohort
394785|NCT01265381|Radiation|radiation
394786|NCT01265381|Thyroid Cancer|thyroid cancer
394787|NCT01265368|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
394788|NCT01265368|Tumor Vaccine|tumor vaccine
394789|NCT01265368|Cell-based Therapy|cell-based therapy
394790|NCT01265342|Bronchial Spasm|bronchial spasm
394791|NCT01265342|Respiratory Tract Infections|respiratory tract infections
394792|NCT01265342|Viral wheezing|viral wheezing
394793|NCT01265342|Child, Preschool|child, preschool
394794|NCT01265342|Beclomethasone|beclomethasone
394795|NCT01265342|Italy|italy
394796|NCT01265342|Physicians, Primary Care|physicians, primary care
394797|NCT01265342|Pediatrics|pediatrics
394798|NCT01265316|Cardiac arrest, CPR, pediatric|cardiac arrest, cpr, pediatric
394799|NCT01265303|ablation, cardiac arrhythmia, atrial fibrillation, telemonitoring, telemetry|ablation, cardiac arrhythmia, atrial fibrillation, telemonitoring, telemetry
394800|NCT01265290|Cardiac arrhythmia|cardiac arrhythmia
394801|NCT01265290|Cardiogenic syncope|cardiogenic syncope
394802|NCT01265290|Pediatrics|pediatrics
394803|NCT01265290|Children|children
394804|NCT01265277|sudden infant death syndrome|sudden infant death syndrome
394805|NCT01265277|SIDS|sids
394806|NCT01265277|infant|infant
394807|NCT01265277|licensed day care|licensed day care
394808|NCT01265277|sleep patterns|sleep patterns
394809|NCT01265277|stress levels|stress levels
481559|NCT00111514|T-cell|t-cell
394810|NCT01265264|Gout|gout
394811|NCT01265264|hyperuricemia|hyperuricemia
394812|NCT01265264|arthritis|arthritis
394813|NCT01265264|joint diseases|joint diseases
394814|NCT01265264|allopurinol|allopurinol
394815|NCT01265251|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
394816|NCT01265251|Neuropsychological Test|neuropsychological test
394817|NCT01265251|Assessment of cognitive disorders/dementia|assessment of cognitive disorders/dementia
394818|NCT01265251|Neuropsychological assessment|neuropsychological assessment
394819|NCT01265238|Spastic equinovarus foot|spastic equinovarus foot
394820|NCT01265238|Stroke|stroke
394821|NCT01265238|Neurotomy|neurotomy
394822|NCT01265238|Tendon surgery|tendon surgery
394823|NCT01265225|breast cancer stages 0-II|breast cancer stages 0-ii
394824|NCT01265199|AML|aml
394825|NCT01265186|Sedation|sedation
394826|NCT01265186|BIS|bis
394827|NCT01265186|aEEG|aeeg
394828|NCT01265186|Neonatal Pain and Sedation Scale|neonatal pain and sedation scale
394829|NCT01265186|neonate|neonate
394830|NCT01265186|newborn|newborn
394831|NCT01265173|SBP|sbp
394832|NCT01265173|liver cirrhosis|liver cirrhosis
394833|NCT01265173|antibiotics|antibiotics
394834|NCT01265134|the elders|the elders
394835|NCT01265134|falling|falling
394836|NCT01265134|loss balance|loss balance
394837|NCT01265121|Acromegaly|acromegaly
394838|NCT01265121|Insulin resistance|insulin resistance
394839|NCT01265121|Euglycemic Clamp|euglycemic clamp
394840|NCT01265121|Somatostatin analogues|somatostatin analogues
394841|NCT01265095|VRE|vre
394842|NCT01265069|Helicobacter pylori|helicobacter pylori
394843|NCT01265069|concomitant therapy|concomitant therapy
394844|NCT01265069|high dose dual therapy|high dose dual therapy
394845|NCT01265069|antibiotic resistance|antibiotic resistance
394846|NCT01265043|oral health|oral health
394847|NCT01265043|oral hygiene|oral hygiene
394848|NCT01265043|bacteria|bacteria
394849|NCT01265043|quality of life|quality of life
394850|NCT01265043|Clinical oral health in patients following acute stroke|clinical oral health in patients following acute stroke
394851|NCT01265043|Oral opportunistic pathogens in patients following acute stroke|oral opportunistic pathogens in patients following acute stroke
394852|NCT01265043|Oral health-related quality of life in patients following acute stroke|oral health-related quality of life in patients following acute stroke
394853|NCT01265030|Desmoid Tumor|desmoid tumor
394854|NCT01265030|Sirolimus|sirolimus
394855|NCT01265030|Surgically-Resectable Desmoid Tumor|surgically-resectable desmoid tumor
394856|NCT01265017|type 1 diabetes|type 1 diabetes
394857|NCT01265017|pregnancy|pregnancy
394858|NCT01265017|insulin requirement|insulin requirement
394859|NCT01265004|Functional outcome|functional outcome
394860|NCT01264991|Sham|sham
394861|NCT01264991|Meniscus tear|meniscus tear
394862|NCT01264991|Meniscectomy|meniscectomy
394863|NCT01264978|COPD|copd
394864|NCT01264978|Rehabilitation|rehabilitation
394865|NCT01264978|Neuromuscular stimulation|neuromuscular stimulation
394866|NCT01264978|Quadriceps muscle|quadriceps muscle
394867|NCT01264978|Magnetic stimulation|magnetic stimulation
394868|NCT01264965|Pain|pain
394869|NCT01264965|Analgesia|analgesia
394870|NCT01264965|Cognitive impairment|cognitive impairment
394871|NCT01264965|Randomized controlled trial|randomized controlled trial
394872|NCT01264965|Physical function|physical function
394873|NCT01264952|Liver metastases of colorectal cancer|liver metastases of colorectal cancer
394874|NCT01264952|Bleomycin|bleomycin
394875|NCT01264952|Electrochemotherapy|electrochemotherapy
394876|NCT01263951|Differentiated metastatic thyroid cancer|differentiated metastatic thyroid cancer
394877|NCT01263938|HIV|hiv
394878|NCT01263938|monocytes|monocytes
394879|NCT01263938|CD16+|cd16+
394880|NCT01263938|statins|statins
394881|NCT01263938|mcp1|mcp1
394882|NCT01263938|inflammation|inflammation
394883|NCT01263925|Alprostadil|alprostadil
394884|NCT01263925|Prostaglandin E1|prostaglandin e1
394885|NCT01263925|Prostavasin®|prostavasin®
394886|NCT01263925|PAOD|paod
394887|NCT01263912|Polyunsaturated fatty acids|polyunsaturated fatty acids
394888|NCT01263912|Cognitive development|cognitive development
394889|NCT01263912|Growth|growth
394890|NCT01263912|Infection|infection
394891|NCT01263899|Lymphoid malignancies|lymphoid malignancies
394892|NCT01263899|Hodgkin lymphoma|hodgkin lymphoma
394893|NCT01263899|Mantle Cell Lymphoma|mantle cell lymphoma
394894|NCT01263899|Indolent Lymphoma|indolent lymphoma
394895|NCT01263899|SB1518|sb1518
394896|NCT01263847|Dietary Supplement: Galactooligosaccharide|dietary supplement: galactooligosaccharide
394897|NCT01263834|Trabeculectomy|trabeculectomy
394898|NCT01263834|bevacizumab|bevacizumab
394899|NCT01263834|intraocular pressure|intraocular pressure
394900|NCT01263821|glioma|glioma
394901|NCT01263821|biologic imaging|biologic imaging
394902|NCT01263821|magnetic resonance spectroscopy|magnetic resonance spectroscopy
394903|NCT01263821|magnetic resonance imaging|magnetic resonance imaging
394904|NCT01263821|perfusion imaging|perfusion imaging
394905|NCT01263821|diffusion imaging|diffusion imaging
385724|NCT01303510|Virus|virus
396627|NCT01257594|Gliosarcoma|gliosarcoma
394906|NCT01263821|functional magnetic resonance imaging|functional magnetic resonance imaging
394907|NCT01263821|radiation therapy|radiation therapy
394908|NCT01263821|intensity modulated radiation therapy|intensity modulated radiation therapy
394909|NCT01263808|Indacaterol|indacaterol
394910|NCT01263808|Moxifloxacin|moxifloxacin
394911|NCT01263782|Non-Small Cell Lung Cancer|non-small cell lung cancer
394913|NCT01263782|Nonsquamous cell|nonsquamous cell
394914|NCT01263782|Metastatic disease|metastatic disease
394915|NCT01263782|Cixutumumab|cixutumumab
394916|NCT01263782|IMC-A12|imc-a12
394917|NCT01263782|Carboplatin|carboplatin
394918|NCT01263782|Paraplatin|paraplatin
394919|NCT01263782|Pemetrexed|pemetrexed
394920|NCT01263782|LY231514|ly231514
394921|NCT01263782|Alimta|alimta
394922|NCT01263782|MTA|mta
394923|NCT01263782|Multitargeted Antifolate|multitargeted antifolate
394924|NCT01263782|NSC-698037|nsc-698037
394925|NCT01263782|Bevacizumab|bevacizumab
394926|NCT01263782|Avastin|avastin
394927|NCT01263782|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
394928|NCT01263782|rhuMAb-VEGF|rhumab-vegf
394929|NCT01263769|Locally advanced clear cell renal cell carcinoma|locally advanced clear cell renal cell carcinoma
394930|NCT01263769|AG-013736|ag-013736
394931|NCT01263769|Axitinib|axitinib
394932|NCT01263769|Radical nephrectomy|radical nephrectomy
394933|NCT01263756|Driving|driving
394934|NCT01263756|Autism Spectrum Disorders|autism spectrum disorders
394935|NCT01263756|ASD|asd
394936|NCT01263756|Attention Deficits|attention deficits
394937|NCT01263756|Adults|adults
394938|NCT01263756|Adolescents|adolescents
394939|NCT01263756|Pervasive Developmental Disorders|pervasive developmental disorders
394940|NCT01263743|Stage 1 hypertension|stage 1 hypertension
394941|NCT01264900|Psychotherapy|psychotherapy
394942|NCT01264900|Cognitive Behavioral Therapy|cognitive behavioral therapy
394943|NCT01264900|Aggression|aggression
394944|NCT01264900|fMRI|fmri
394945|NCT01264900|Behavioral Intervention|behavioral intervention
394946|NCT01264887|analgesia|analgesia
394947|NCT01264887|analgesics|analgesics
394948|NCT01264887|chronic pain|chronic pain
394949|NCT01264887|tumour related pain|tumour related pain
394950|NCT01264887|chronic malignant tumor-related pain|chronic malignant tumor-related pain
394951|NCT01264861|Evaluate dopamine and serotonin activity in the brain at 3 doses of Safinamide|evaluate dopamine and serotonin activity in the brain at 3 doses of safinamide
394952|NCT01264848|multiple sclerosis|multiple sclerosis
394953|NCT01264848|venous insufficiency|venous insufficiency
394954|NCT01264822|Rabeprazole Sodium|rabeprazole sodium
394955|NCT01264822|Helicobacter pylori|helicobacter pylori
394956|NCT01264822|stomach neoplasms|stomach neoplasms
394957|NCT01264809|diabetes|diabetes
394958|NCT01264796|Korean American, type 2 diabetes, culturally tailored|korean american, type 2 diabetes, culturally tailored
394959|NCT01264770|Rheumatoid Arthritis|rheumatoid arthritis
394960|NCT01264770|OSKIRA|oskira
394961|NCT01264770|fostamatinib|fostamatinib
394962|NCT01264757|pedometer|pedometer
394963|NCT01264757|accelerometer|accelerometer
394964|NCT01264757|moderate-to-vigorous physical activity|moderate-to-vigorous physical activity
394965|NCT01264757|adult|adult
394966|NCT01264757|randomized trial|randomized trial
394967|NCT01264744|Bladder cancer|bladder cancer
394968|NCT01264744|Chromosomal aberrations|chromosomal aberrations
394969|NCT01264744|FISH|fish
394970|NCT01264744|Urine sample|urine sample
394971|NCT01264731|melanoma|melanoma
394972|NCT01264731|peptide vaccine|peptide vaccine
394973|NCT01264731|aldara|aldara
394974|NCT01264731|imiquimod|imiquimod
394975|NCT01264731|immunotherapy|immunotherapy
394976|NCT01264718|minority health|minority health
394977|NCT01264718|child|child
394978|NCT01264718|Medicaid|medicaid
394979|NCT01264705|Cirrhosis|cirrhosis
394980|NCT01264705|GI Cancer|gi cancer
394981|NCT01264705|Hepatitis|hepatitis
394982|NCT01264705|Oncology|oncology
394983|NCT01264679|Iron deficiency anemia, Feraheme, ferumoxytol, CKD, pediatric, dialysis-dependent, pediatric nondialysis-dependent|iron deficiency anemia, feraheme, ferumoxytol, ckd, pediatric, dialysis-dependent, pediatric nondialysis-dependent
394984|NCT01264666|Chinese tea flavor liquor|chinese tea flavor liquor
394985|NCT01264666|postprandial|postprandial
394986|NCT01264666|uric acid|uric acid
394987|NCT01264666|high-sensitive C-reactive protein|high-sensitive c-reactive protein
394988|NCT01264653|cataract|cataract
394989|NCT01264640|Brain-derived neurotrophic factor (BDNF)|brain-derived neurotrophic factor (bdnf)
394990|NCT01264640|Platelets|platelets
394991|NCT01264640|Aspirin|aspirin
394992|NCT01264640|Clopidogrel|clopidogrel
394993|NCT01264627|Hypertension|hypertension
394994|NCT01264627|Blood pressure|blood pressure
394995|NCT01264627|Breathing|breathing
394996|NCT01264627|PetCO2|petco2
394997|NCT01264627|Stress|stress
394998|NCT01264614|exercise|exercise
394999|NCT01264614|neuropsychological|neuropsychological
395000|NCT01264614|dementia|dementia
395001|NCT01264614|Alzheimer's Disease|alzheimer's disease
395002|NCT01264614|mild cognitive impairment|mild cognitive impairment
395003|NCT01264614|strength|strength
395004|NCT01264614|MCI|mci
395005|NCT01264614|AD|ad
395007|NCT01264614|neurophysiological|neurophysiological
395008|NCT01264614|growth factor|growth factor
395009|NCT01264614|cognitive decline|cognitive decline
395010|NCT01264614|executive function|executive function
395011|NCT01264601|Anaphylaxis to Egg|anaphylaxis to egg
395012|NCT01264601|Severe Egg Allergy|severe egg allergy
395013|NCT01264575|spinal anesthesia|spinal anesthesia
395014|NCT01264575|intrathecal bupivacaine|intrathecal bupivacaine
395015|NCT01264575|epinephrine|epinephrine
395016|NCT01264575|ED50|ed50
395017|NCT01264575|ED95|ed95
395018|NCT01264562|chemotherapy, adjuvant|chemotherapy, adjuvant
395019|NCT01264562|adverse effects|adverse effects
395020|NCT01264562|breast neoplasms|breast neoplasms
395021|NCT01264562|cognition disorders|cognition disorders
395022|NCT01264562|Stress Disorders, post-traumatic|stress disorders, post-traumatic
395023|NCT01264562|cortisol|cortisol
395024|NCT01264549|ischemic stroke|ischemic stroke
395025|NCT01264549|stroke-associated infections|stroke-associated infections
395026|NCT01264549|biomarkers|biomarkers
395027|NCT01264549|PCT|pct
395028|NCT01264549|immune and infection parameters|immune and infection parameters
395029|NCT01264536|lactoferrin|lactoferrin
395030|NCT01264536|sepsis|sepsis
395031|NCT01264536|neonates|neonates
395032|NCT01264536|prevention|prevention
395033|NCT01264536|infections|infections
395034|NCT01264523|chrononutrition|chrononutrition
395035|NCT01264523|moderately high protein|moderately high protein
395036|NCT01264523|glycemic index|glycemic index
395037|NCT01264523|type-2 diabetes|type-2 diabetes
395038|NCT01264523|overweight|overweight
395039|NCT01264523|obesity|obesity
395040|NCT01264523|weight management|weight management
395041|NCT01264510|conductive hearing loss|conductive hearing loss
395042|NCT01264510|mixed hearing loss|mixed hearing loss
395043|NCT01264510|unilateral deafness|unilateral deafness
395044|NCT01264510|implanted with Baha|implanted with baha
395045|NCT01264510|conductive or mixed hearing loss implanted with a Baha or|conductive or mixed hearing loss implanted with a baha or
395046|NCT01264510|unilateral deafness implanted with a Baha|unilateral deafness implanted with a baha
395047|NCT01264484|Advantage|advantage
395048|NCT01264484|Non-interventional|non-interventional
395049|NCT01264484|Post market release study|post market release study
395050|NCT01264484|Germany|germany
395051|NCT01264484|Treated with Advantage prosthetic heart valve|treated with advantage prosthetic heart valve
395052|NCT01264471|Gulf War Syndrome|gulf war syndrome
395053|NCT01264471|Gulf War Illness|gulf war illness
395054|NCT01264471|Mitochondrial defects|mitochondrial defects
395055|NCT01264471|Mitochondrial disorders|mitochondrial disorders
395056|NCT01264471|Persian Gulf Syndrome|persian gulf syndrome
395057|NCT01264445|HIV|hiv
395058|NCT01264328|Head and neck cancer, panitumumab, TTCC-2009-03|head and neck cancer, panitumumab, ttcc-2009-03
395059|NCT01264315|Lenalidomide|lenalidomide
395060|NCT01264315|Tandem Autologous-Allogeneic Transplant|tandem autologous-allogeneic transplant
395061|NCT01264302|Bioequivalence|bioequivalence
395062|NCT01264302|Finasteride|finasteride
395063|NCT01264302|crossover|crossover
395064|NCT01264289|Bioequivalence|bioequivalence
395065|NCT01264289|Finasteride|finasteride
395066|NCT01264289|crossover|crossover
395067|NCT01264276|ROP|rop
395068|NCT01264276|Retinopathy of Prematurity|retinopathy of prematurity
395069|NCT01264276|Telemedicine|telemedicine
395070|NCT01264263|cIMT|cimt
395071|NCT01264263|hs CRP (C-reactive protein)|hs crp (c-reactive protein)
395072|NCT01264263|DM (Diabetic Mellitus)|dm (diabetic mellitus)
395073|NCT01264263|Korea|korea
395074|NCT01264263|Corelation between cIMT (carotid intima media thickness)|corelation between cimt (carotid intima media thickness)
395075|NCT01264263|Cardio Vascular risk in Diabetic Mellitus|cardio vascular risk in diabetic mellitus
395076|NCT01264250|Safety|safety
395077|NCT01264250|Tolerability|tolerability
395078|NCT01264250|pharmacokinetics|pharmacokinetics
395079|NCT01264250|drug metabolism|drug metabolism
395080|NCT01264237|Postherpetic neuralgia|postherpetic neuralgia
395081|NCT01264237|Neuropathic pain|neuropathic pain
395082|NCT01264237|Etoricoxib|etoricoxib
395083|NCT01264211|Efficacy of Diacerein|efficacy of diacerein
395084|NCT01264211|Safety of Diacerein|safety of diacerein
395085|NCT01264211|Carry-over effect of Diacerein|carry-over effect of diacerein
395086|NCT01264172|Functional outcome|functional outcome
395087|NCT01264172|Microcirculation|microcirculation
395088|NCT01264172|Inflammatory response|inflammatory response
395089|NCT01264159|Developing acute heart failure|developing acute heart failure
395090|NCT01264146|hyperbaric oxygen therapy|hyperbaric oxygen therapy
395091|NCT01264146|calcaneal fracture|calcaneal fracture
395092|NCT01264146|calcaneal plating|calcaneal plating
395093|NCT01264146|wound infection|wound infection
395094|NCT01264146|microcirculation|microcirculation
395095|NCT01264120|Obesity|obesity
395096|NCT01264120|Bariatric surgery|bariatric surgery
395097|NCT01264120|Health Psychology|health psychology
385920|NCT01302626|NSCLC|nsclc
395098|NCT01264081|Lapatinib|lapatinib
395099|NCT01264081|Melanoma|melanoma
395100|NCT01264081|ERBB4 Mutation|erbb4 mutation
395101|NCT01264081|Malignant Melanoma|malignant melanoma
395102|NCT01264081|Skin Cancer|skin cancer
395103|NCT01264068|Suan-Tsao-Jen-Tang ,Jia-Wey-Shiau-Yau-San,metabolomics,menopause|suan-tsao-jen-tang ,jia-wey-shiau-yau-san,metabolomics,menopause
395104|NCT01264055|Rare Diseases of Airways|rare diseases of airways
395105|NCT01264055|Bronchiectasis|bronchiectasis
395106|NCT01264055|Idiopathic Bronchiectasis|idiopathic bronchiectasis
395107|NCT01264055|Chronic Cough|chronic cough
395108|NCT01264055|Nontuberculous Mycobacteriam Infection|nontuberculous mycobacteriam infection
395109|NCT01264042|Iron Supplementation,|iron supplementation,
395110|NCT01264042|week 24 to 28 at study day|week 24 to 28 at study day
395111|NCT01264029|Well-Being|well-being
395112|NCT01264029|Tai Chi|tai chi
395113|NCT01264029|Obesity|obesity
395114|NCT01264029|Mindfulness|mindfulness
395115|NCT01264029|Meditation|meditation
395116|NCT01264029|Overweight|overweight
395117|NCT01264003|inguinal hernia, antibiotic, prophylaxis|inguinal hernia, antibiotic, prophylaxis
395118|NCT01263990|hemodynamic monitoring systems|hemodynamic monitoring systems
395119|NCT01263990|stroke volume|stroke volume
395120|NCT01263977|septic shock|septic shock
395121|NCT01263977|goal directed volume therapy|goal directed volume therapy
395122|NCT01263977|outcome|outcome
395123|NCT01263964|ischemic stroke|ischemic stroke
395124|NCT01263964|troponin elevation|troponin elevation
395125|NCT01263964|transient apical ballooning|transient apical ballooning
395126|NCT01263964|acute coronary syndrome|acute coronary syndrome
395127|NCT01263964|troponin elevation,|troponin elevation,
395128|NCT01263964|culprit lesion on coronary angiogram,|culprit lesion on coronary angiogram,
395129|NCT01263964|troponin elevation and stroke localisation (temporal lobe?)|troponin elevation and stroke localisation (temporal lobe?)
395130|NCT01263717|HIV|hiv
395131|NCT01263717|lipodystrophy|lipodystrophy
395132|NCT01263717|tesamorelin|tesamorelin
395133|NCT01263717|Egrifta|egrifta
395134|NCT01263717|growth hormone releasing hormone|growth hormone releasing hormone
395135|NCT01263691|AVA|ava
395136|NCT01263691|AV7909|av7909
395137|NCT01263691|Anthrax vaccine|anthrax vaccine
395138|NCT01263678|Decisional Conflict|decisional conflict
395139|NCT01263678|Coaching|coaching
395140|NCT01263678|Decisional Regret|decisional regret
395141|NCT01263665|stent-graft|stent-graft
395142|NCT01263665|superficial femoral artery|superficial femoral artery
395143|NCT01263665|SFA|sfa
395144|NCT01263665|peripheral artery disease|peripheral artery disease
395145|NCT01263665|PAD|pad
395146|NCT01263652|Pain|pain
395147|NCT01263652|intramuscular|intramuscular
395148|NCT01263652|oral|oral
395149|NCT01263652|spine|spine
395150|NCT01263652|preference|preference
395151|NCT01263639|patient satisfaction|patient satisfaction
395152|NCT01263639|patient-physician relationship|patient-physician relationship
395153|NCT01263639|orthopaedic trauma|orthopaedic trauma
395154|NCT01263626|Cough|cough
395155|NCT01263626|Chronic Cough|chronic cough
395156|NCT01263626|Reflux|reflux
395157|NCT01263600|Hepatitis B|hepatitis b
395158|NCT01263600|HBV|hbv
395159|NCT01263600|Pediatric|pediatric
395160|NCT01263587|Hepatitis B|hepatitis b
395161|NCT01263587|HBV|hbv
395162|NCT01263587|Cohort Study|cohort study
395163|NCT01263574|Catheter related infections prevention/control|catheter related infections prevention/control
395164|NCT01263574|Anti infective agents|anti infective agents
395165|NCT01263574|Catheter related infections prevention|catheter related infections prevention
395166|NCT01263561|glaucoma|glaucoma
395167|NCT01263561|filtration surgery|filtration surgery
395168|NCT01263561|trabeculectomy|trabeculectomy
395169|NCT01263561|ExPRESS shunt|express shunt
395170|NCT01263522|primary prevention|primary prevention
395171|NCT01263522|endurance|endurance
395172|NCT01263522|cardiovascular risk factors|cardiovascular risk factors
395173|NCT01263522|training|training
395174|NCT01263522|exercise|exercise
395175|NCT01263522|non-responder|non-responder
395176|NCT01263509|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
395177|NCT01263509|Diabetes Mellitus|diabetes mellitus
395178|NCT01263509|Drug Therapy|drug therapy
395179|NCT01263496|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
395180|NCT01263496|Diabetes Mellitus|diabetes mellitus
395181|NCT01263496|Drug Therapy|drug therapy
395182|NCT01263483|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
395183|NCT01263483|Diabetes Mellitus|diabetes mellitus
395184|NCT01263483|Drug Therapy|drug therapy
395185|NCT01263470|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
395186|NCT01263470|Diabetes Mellitus|diabetes mellitus
395187|NCT01263470|Drug Therapy|drug therapy
395188|NCT01263457|Growth disorders|growth disorders
395189|NCT01263457|Saizen|saizen
395190|NCT01263457|EasypodTM|easypodtm
395191|NCT01263457|Growth hormone|growth hormone
395192|NCT01263457|Pediatric subject|pediatric subject
395193|NCT01263444|AZARGA®|azarga®
395194|NCT01263444|Open angle glaucoma|open angle glaucoma
395195|NCT01263444|Prostaglandin Therapy|prostaglandin therapy
395196|NCT01263431|Hemorrhoidectomy, haemorrhoidal dearterialisation, anopexy|hemorrhoidectomy, haemorrhoidal dearterialisation, anopexy
395197|NCT01263418|Follicular Lymphoma|follicular lymphoma
395198|NCT01263418|Marginal Zone Lymphoma|marginal zone lymphoma
395199|NCT01263418|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
395200|NCT01263418|Elderly|elderly
395201|NCT01263418|Newly Diagnosed|newly diagnosed
395202|NCT01263418|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
395203|NCT01263418|University of North Carolina|university of north carolina
395204|NCT01263418|Ofatumumab|ofatumumab
395205|NCT01263418|Arzerra|arzerra
395206|NCT01263418|Phase 2|phase 2
395207|NCT01263418|Geriatric|geriatric
395208|NCT01263418|Lymphoma|lymphoma
395209|NCT01263405|Sarcoma|sarcoma
395210|NCT01263392|Neurogenic bladder|neurogenic bladder
395211|NCT01263392|Spina bifida|spina bifida
395212|NCT01263392|Intermittent catheterization|intermittent catheterization
395213|NCT01263392|Urinary tract infections|urinary tract infections
395214|NCT01263379|gene transfer|gene transfer
395215|NCT01263366|Radiodermatitis|radiodermatitis
395216|NCT01263366|Prevention|prevention
395217|NCT01263366|Radiotherapy|radiotherapy
395218|NCT01263366|Breast|breast
395891|NCT01260350|GS-9669|gs-9669
395219|NCT01263366|Radiation Dermatitis|radiation dermatitis
395220|NCT01263353|Carcinoid tumor,|carcinoid tumor,
395221|NCT01263353|Gastroenteropancreatic Neuroendocrine Tumors,|gastroenteropancreatic neuroendocrine tumors,
601515|NCT00578201|Oxaliplatin|oxaliplatin
395222|NCT01263353|Pulmonary Neuroendocrine Tumors,|pulmonary neuroendocrine tumors,
395223|NCT01263353|pasireotide LAR,|pasireotide lar,
395224|NCT01263353|SOM230 LAR,|som230 lar,
395225|NCT01263353|everolimus,|everolimus,
395226|NCT01263353|RAD001,|rad001,
395227|NCT01263353|Advanced Neuroendocrine Tumor,|advanced neuroendocrine tumor,
395228|NCT01263353|Gastroenteropancreatic System|gastroenteropancreatic system
395229|NCT01263340|COPD|copd
395230|NCT01263340|observational study|observational study
395231|NCT01263340|prevalence|prevalence
395232|NCT01263340|characterisation|characterisation
395233|NCT01263327|human papillomavirus vaccine|human papillomavirus vaccine
395234|NCT01263314|Hypertension|hypertension
395235|NCT01263301|subclavian steal|subclavian steal
395236|NCT01263301|carotid duplex|carotid duplex
395237|NCT01263301|subclavian stenosis|subclavian stenosis
395238|NCT01263301|hemodialysis with vascular access in the upper limbs|hemodialysis with vascular access in the upper limbs
395239|NCT01263301|the focus of this study is to see if duplex can be used as an tool to differentiate the different causes of subclavian steal syndromes|the focus of this study is to see if duplex can be used as an tool to differentiate the different causes of subclavian steal syndromes
395240|NCT01263275|depression|depression
395241|NCT01263275|direct current stimulation|direct current stimulation
395242|NCT01263275|alternative electrode montage|alternative electrode montage
395243|NCT01263262|Surgical site infection|surgical site infection
395244|NCT01263262|Corneal toxicity|corneal toxicity
395245|NCT01263262|Ototoxicity|ototoxicity
395246|NCT01263262|Povidone-iodine|povidone-iodine
395247|NCT01263262|Chlorhexidine-alcohol|chlorhexidine-alcohol
395248|NCT01263249|Femoral|femoral
395249|NCT01263249|Nerve Block|nerve block
395250|NCT01263249|Anterior|anterior
395251|NCT01263249|Posterior|posterior
395252|NCT01263249|Continuous Infusion|continuous infusion
395253|NCT01263249|Perineural Catheter|perineural catheter
395254|NCT01263249|Volunteer|volunteer
395255|NCT01263249|Lower Extremity Nerve Blocks|lower extremity nerve blocks
395256|NCT01263236|Depression|depression
395257|NCT01263210|Recurrent acute otitis media|recurrent acute otitis media
395258|NCT01263210|Conjugate pneumococcal vaccine|conjugate pneumococcal vaccine
395259|NCT01263210|Ventilation tube treatment|ventilation tube treatment
395260|NCT01263210|Nasopharyngeal flora|nasopharyngeal flora
395261|NCT01263184|shoulder|shoulder
395262|NCT01263184|strength|strength
395263|NCT01263184|quality of life|quality of life
395264|NCT01263171|adenocarcinoma of the rectum|adenocarcinoma of the rectum
395265|NCT01263171|stage IIIB rectal cancer|stage iiib rectal cancer
395266|NCT01263171|stage IIIC rectal cancer|stage iiic rectal cancer
395267|NCT01263158|randomised controlled trial|randomised controlled trial
395268|NCT01263158|nulliparous women|nulliparous women
395269|NCT01263158|slow labour progress|slow labour progress
395270|NCT01263158|prolonged labour|prolonged labour
395271|NCT01263158|oxytocin augmentation|oxytocin augmentation
395272|NCT01263158|operative delivery|operative delivery
395273|NCT01263158|childbirth experience|childbirth experience
395274|NCT01263132|Polyneuropathy|polyneuropathy
395275|NCT01263132|Diabetes Mellitus|diabetes mellitus
395276|NCT01263132|Diabetic peripheral neuropathy|diabetic peripheral neuropathy
395277|NCT01263080|mirtazapine|mirtazapine
395278|NCT01263080|folic acid|folic acid
395279|NCT01263080|schizophrenia|schizophrenia
395280|NCT01263067|Posttraumatic Stress Disorder|posttraumatic stress disorder
395282|NCT01263067|Car Accident|car accident
395283|NCT01263067|Auto Accident|auto accident
395284|NCT01263067|Lifespan Integration|lifespan integration
395285|NCT01263054|Back Pain|back pain
395286|NCT01263054|Low Back Pain|low back pain
395287|NCT01263054|Discogenic Back Pain|discogenic back pain
395288|NCT01263041|Glutamine, NEC, L-arginine,Preterm,Sepsis|glutamine, nec, l-arginine,preterm,sepsis
395289|NCT01263015|GSK1349572|gsk1349572
395290|NCT01263015|Abacavir/Lamivudine|abacavir/lamivudine
395291|NCT01263015|Treatment-naive|treatment-naive
395292|NCT01263015|HIV Infection|hiv infection
396628|NCT01257594|Glioma|glioma
395293|NCT01263015|Dolutegravir|dolutegravir
395294|NCT01263015|integrase inhibitor|integrase inhibitor
395295|NCT01263015|Atripla|atripla
395296|NCT01262989|Bioequivalence|bioequivalence
395297|NCT01262989|Tamsulosin|tamsulosin
395298|NCT01262989|Healthy volunteers|healthy volunteers
395299|NCT01262989|Fast conditions|fast conditions
395300|NCT01262976|Tuberculosis vaccine|tuberculosis vaccine
395301|NCT01262963|GSK2118436|gsk2118436
395302|NCT01262963|BRAF inhibitor|braf inhibitor
395303|NCT01262963|BRAF positive tumor|braf positive tumor
395304|NCT01262963|ADME|adme
395305|NCT01262963|Oncology|oncology
395306|NCT01262937|confocal, biliary, esophagus|confocal, biliary, esophagus
395307|NCT01262924|Booster vaccination|booster vaccination
395308|NCT01262898|13 C oral breath test|13 c oral breath test
395309|NCT01262898|pharmacokinetics|pharmacokinetics
395310|NCT01262898|symptoms|symptoms
395311|NCT01262898|tolerability|tolerability
395892|NCT01260350|FDC|fdc
395312|NCT01262898|gut motility|gut motility
395313|NCT01262898|repeat dose|repeat dose
601723|NCT00585169|Treatment|treatment
395314|NCT01262898|pharmacodynamics|pharmacodynamics
395315|NCT01262898|GSK962040|gsk962040
395316|NCT01262898|phase II|phase ii
395317|NCT01262898|Type I and II Diabetes mellitus|type i and ii diabetes mellitus
395318|NCT01262898|gastric emptying|gastric emptying
395319|NCT01262898|gastroparesis|gastroparesis
395320|NCT01262885|pharmacokinetics|pharmacokinetics
395321|NCT01262885|tolerability|tolerability
395322|NCT01262885|single dose|single dose
395323|NCT01262885|antibiotics|antibiotics
395324|NCT01262885|repeat dose|repeat dose
395325|NCT01262885|GSK2251052|gsk2251052
395327|NCT01262872|Haemophilus influenzae|haemophilus influenzae
395328|NCT01262872|Streptococcus pneumoniae|streptococcus pneumoniae
395329|NCT01262872|The Gambia|the gambia
395330|NCT01262872|immunogenicity|immunogenicity
395331|NCT01262872|nasopharyngeal carriage|nasopharyngeal carriage
395332|NCT01262872|infants|infants
395333|NCT01262872|safety|safety
395334|NCT01262872|Pneumococcal vaccine|pneumococcal vaccine
395335|NCT01262872|children|children
395336|NCT01262846|HIV|hiv
395337|NCT01262846|Flu vaccination|flu vaccination
395338|NCT01262846|HIV infected individuals|hiv infected individuals
395339|NCT01262846|Fluzone SD|fluzone sd
395340|NCT01262846|Fluzone HD|fluzone hd
395341|NCT01262820|Pazopanib|pazopanib
395342|NCT01262820|Non Squamous Non Small Cell Lung Cancer|non squamous non small cell lung cancer
395343|NCT01262820|After Progress on first line therapy|after progress on first line therapy
395344|NCT01262820|Using Bevacizumab|using bevacizumab
395345|NCT01262807|fracture|fracture
395346|NCT01262807|radius|radius
395347|NCT01262807|adult|adult
395348|NCT01262807|range of motion|range of motion
395349|NCT01262794|Healthy volunteers|healthy volunteers
395350|NCT01262794|Japanese|japanese
395351|NCT01262781|neonatal adiposity|neonatal adiposity
395352|NCT01262781|metabolic syndrome|metabolic syndrome
395353|NCT01262781|fructose|fructose
395354|NCT01262781|maternal diet|maternal diet
395355|NCT01262768|Nutrition|nutrition
395356|NCT01262768|Obesity|obesity
395357|NCT01262768|Parent|parent
395358|NCT01262768|Portion Size Estimation|portion size estimation
395359|NCT01262768|Accuracy|accuracy
395360|NCT01262755|GERD|gerd
395361|NCT01262755|IBS|ibs
395362|NCT01262755|Minority|minority
395363|NCT01262742|pregnancy|pregnancy
395364|NCT01262742|postpartum hemorrhage|postpartum hemorrhage
395365|NCT01262742|Cesarean delivery|cesarean delivery
395366|NCT01262742|carbetocin|carbetocin
395367|NCT01262729|xenon inhalation|xenon inhalation
395368|NCT01262729|therapeutical hypothermia|therapeutical hypothermia
395369|NCT01262729|patients after cardiopulmonary resuscitation|patients after cardiopulmonary resuscitation
395370|NCT01262729|efficacy|efficacy
395371|NCT01262729|safety|safety
395372|NCT01262716|Chest wall progression breast cancer|chest wall progression breast cancer
395373|NCT01262716|PDT|pdt
395374|NCT01262716|Photofrin|photofrin
395375|NCT01262716|Photosensitizer|photosensitizer
395376|NCT01262690|First-in-human (FIH)|first-in-human (fih)
395377|NCT01262690|Single Ascending Dose (SAD) Study|single ascending dose (sad) study
395378|NCT01262690|TAM-163|tam-163
395379|NCT01262690|PF-05230901|pf-05230901
395380|NCT01262690|Cachexia|cachexia
395381|NCT01262677|Partial epilepsy|partial epilepsy
395382|NCT01262677|partial seizures|partial seizures
395383|NCT01262677|epilepsy|epilepsy
395384|NCT01262677|seizures|seizures
395385|NCT01262677|adjunctive therapy|adjunctive therapy
395386|NCT01262677|intervention|intervention
482315|NCT00116038|RSA|rsa
395387|NCT01262677|controlled-release|controlled-release
395388|NCT01262677|placebo-controlled|placebo-controlled
395389|NCT01262677|seizure|seizure
395390|NCT01262664|Advanced prostate cancer|advanced prostate cancer
395391|NCT01262664|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
395392|NCT01262664|Prohibitin-TP01|prohibitin-tp01
395393|NCT01262651|Cancer pain|cancer pain
395394|NCT01262651|Opioid therapy|opioid therapy
395395|NCT01262651|Inadequate analgesia|inadequate analgesia
395396|NCT01262651|Optimized chronic opioid therapy|optimized chronic opioid therapy
395397|NCT01262625|stable angina|stable angina
395398|NCT01262625|recurrent chest pain|recurrent chest pain
395399|NCT01262625|chest pain|chest pain
395400|NCT01262625|angina equivalent|angina equivalent
395401|NCT01262625|diagnosis|diagnosis
395402|NCT01262625|coronary artery disease|coronary artery disease
395403|NCT01262612|cediranib|cediranib
395404|NCT01262612|malignant ascites|malignant ascites
395405|NCT01262612|malignant pleural effusion|malignant pleural effusion
395406|NCT01262599|Breast and abdomen morbidities after TRAM flap surgery|breast and abdomen morbidities after tram flap surgery
395407|NCT01262599|TRAM flap surgery|tram flap surgery
395408|NCT01262599|Post-mastectomy breast reconstructive surgery|post-mastectomy breast reconstructive surgery
395409|NCT01262586|Type II Diabetes Mellitus|type ii diabetes mellitus
395410|NCT01262586|Vildagliptin|vildagliptin
395411|NCT01262586|Glimepiride|glimepiride
395893|NCT01260350|ribavirin|ribavirin
395440|NCT01262417|resorbable barrier membrane|resorbable barrier membrane
395441|NCT01262417|abdominal and peri-hepatic adhesion|abdominal and peri-hepatic adhesion
395442|NCT01262391|Overactive bladder|overactive bladder
395443|NCT01262391|Pediatric|pediatric
395444|NCT01262391|Pharmacokinetics|pharmacokinetics
395445|NCT01262391|Single-dose|single-dose
395446|NCT01262391|Solifenacin suspension|solifenacin suspension
395447|NCT01262365|Lupus|lupus
395448|NCT01262365|Monoclonal antibody|monoclonal antibody
395449|NCT01262365|B-Cell immunotherapy|b-cell immunotherapy
395450|NCT01262365|Epratuzumab|epratuzumab
395451|NCT01262339|Primary focal hyperhidrosis|primary focal hyperhidrosis
395452|NCT01262339|interdermal injections|interdermal injections
395453|NCT01262339|iontophoresis|iontophoresis
395454|NCT01262339|BTX-A|btx-a
395455|NCT01262300|Immunosenescence|immunosenescence
395456|NCT01262300|Shingles|shingles
395457|NCT01262300|Vitamin D|vitamin d
395458|NCT01262300|Varicella Zoster Virus|varicella zoster virus
395459|NCT01262300|Vaccine|vaccine
395460|NCT01262300|Immune Response|immune response
395461|NCT01262300|Geriatrics|geriatrics
395462|NCT01262287|Randomized Trial|randomized trial
395463|NCT01262287|Medication for Heavy Drinking|medication for heavy drinking
395464|NCT01262287|Dutasteride Treatment|dutasteride treatment
395465|NCT01262261|opioid dependence|opioid dependence
395466|NCT01262261|opioid addiction|opioid addiction
395467|NCT01262261|buprenorphine|buprenorphine
395468|NCT01262261|implant|implant
395469|NCT01262261|methadone|methadone
395470|NCT01262261|heroin|heroin
395471|NCT01262261|suboxone|suboxone
395472|NCT01262261|opioid pain medication|opioid pain medication
395473|NCT01262261|opioid withdrawal|opioid withdrawal
395474|NCT01262248|small colorectal polyps|small colorectal polyps
395475|NCT01262248|narrow band imaging|narrow band imaging
395476|NCT01262248|vascularization|vascularization
395477|NCT01262248|computer-based classification|computer-based classification
395478|NCT01262235|Solid tumor|solid tumor
395479|NCT01262235|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
395480|NCT01262235|Hodgkin's Disease|hodgkin's disease
395481|NCT01262235|Neuroendocrine tumors (NET)|neuroendocrine tumors (net)
395482|NCT01262235|Adrenocortical carcinoma (ACC)|adrenocortical carcinoma (acc)
395483|NCT01262235|Carcinoid|carcinoid
395484|NCT01262222|Predictive Value For Postoperative Cardiac Events|predictive value for postoperative cardiac events
395485|NCT01262222|Endothelial Dysfunction|endothelial dysfunction
395487|NCT01262209|Vision loss|vision loss
395488|NCT01262209|Chronic glaucoma|chronic glaucoma
395489|NCT01262209|Low vision rehabilitation|low vision rehabilitation
395490|NCT01262196|Trauma|trauma
395491|NCT01262196|Hemorrhage|hemorrhage
395492|NCT01262196|Hemorrhagic shock|hemorrhagic shock
395493|NCT01262196|Lactic acidosis|lactic acidosis
395494|NCT01262196|Oxygen carriers|oxygen carriers
395495|NCT01262196|Oxygen therapeutics|oxygen therapeutics
395496|NCT01262196|Hemoglobin solutions|hemoglobin solutions
395497|NCT01262196|Red cell substitutes|red cell substitutes
395498|NCT01262196|PEG-hemoglobin|peg-hemoglobin
395499|NCT01262183|oesophagus cancer|oesophagus cancer
395500|NCT01262183|chemoradiotherapy|chemoradiotherapy
395501|NCT01262183|panitumumab|panitumumab
395502|NCT01262183|irresectable|irresectable
395503|NCT01262170|dietary supplement|dietary supplement
395504|NCT01262170|nutraceutical|nutraceutical
395894|NCT01260350|RBV|rbv
395505|NCT01262157|Erectile dysfunction|erectile dysfunction
395506|NCT01262157|PDE5 Inhibitor|pde5 inhibitor
395507|NCT01262157|Low intensity shock wave therapy.|low intensity shock wave therapy.
395508|NCT01262144|Cervical Cancer|cervical cancer
395509|NCT01262144|PET CT|pet ct
395510|NCT01262144|SUV Max|suv max
395511|NCT01262131|Fibromyalgia|fibromyalgia
395512|NCT01262131|Pain associated with Fibromyalgia|pain associated with fibromyalgia
395513|NCT01262118|Cholesterol metabolism|cholesterol metabolism
395514|NCT01262118|Cholesterol flux|cholesterol flux
395515|NCT01262118|Rheumatoid Arthritis|rheumatoid arthritis
395517|NCT01262118|CP-690|cp-690
395519|NCT01262105|CFU|cfu
395520|NCT01262105|surgery site|surgery site
395521|NCT01262092|opioid dependent|opioid dependent
395522|NCT01262092|detoxification|detoxification
395523|NCT01262092|buprenorphine|buprenorphine
395524|NCT01262092|suboxone|suboxone
395525|NCT01262092|opiate|opiate
395526|NCT01262079|influenza|influenza
395527|NCT01262079|healthy volunteer|healthy volunteer
395528|NCT01262079|immunity|immunity
395529|NCT01262079|antibody|antibody
395530|NCT01262079|blood sample|blood sample
395531|NCT01262066|hypertension|hypertension
395532|NCT01262066|stress reduction|stress reduction
395533|NCT01262053|Computerized Physician Order Entry|computerized physician order entry
395534|NCT01262053|CPOE|cpoe
395535|NCT01262053|Wrong Patient|wrong patient
395536|NCT01262053|Juxtaposition|juxtaposition
395537|NCT01262053|Patient Safety|patient safety
395538|NCT01262053|Medical Errors|medical errors
395539|NCT01262040|NBI|nbi
395540|NCT01262040|ENDOMETRIUM|endometrium
395541|NCT01262040|FALLOPIAN TUBE|fallopian tube
395542|NCT01262040|OVARY|ovary
395543|NCT01262040|PERITONEUM|peritoneum
395544|NCT01262040|Surgery|surgery
395545|NCT01262040|Lung|lung
395546|NCT01262040|Pancreatic|pancreatic
395547|NCT01262040|Esophageal|esophageal
395548|NCT01262040|thorascopic|thorascopic
395549|NCT01262040|laparoscopic|laparoscopic
395550|NCT01262040|robotic|robotic
395551|NCT01262040|10-180|10-180
395552|NCT01262027|Metastatic inflammatory breast cancer|metastatic inflammatory breast cancer
395553|NCT01262027|Stage IV disease|stage iv disease
395554|NCT01262027|HER2-negative|her2-negative
395555|NCT01262027|Dovitinib|dovitinib
395556|NCT01262027|TKI258|tki258
395557|NCT01262014|platinum|platinum
395558|NCT01262014|resistant|resistant
395559|NCT01262014|advanced|advanced
395560|NCT01262014|ovarian|ovarian
395561|NCT01262014|cancer|cancer
395562|NCT01261975|Ocular Surgery|ocular surgery
395563|NCT01261975|Intraocular Lens|intraocular lens
395564|NCT01261962|Humoral immunity|humoral immunity
395565|NCT01261962|Neutrophil function|neutrophil function
395566|NCT01261962|Gene expression|gene expression
395567|NCT01261949|Tinnitus|tinnitus
395568|NCT01261949|chronic subjective tinnitus|chronic subjective tinnitus
395569|NCT01261949|transcranial magnetic stimulation|transcranial magnetic stimulation
395570|NCT01261949|sensation disorders|sensation disorders
395571|NCT01261949|hearing disorders|hearing disorders
395572|NCT01261936|Menorrhagia|menorrhagia
395573|NCT01261936|Congenital Bleeding Disorders(CBDs)|congenital bleeding disorders(cbds)
395574|NCT01261936|Diagnosis and treatment of menorrhagia in CBDs|diagnosis and treatment of menorrhagia in cbds
395575|NCT01261897|Adductor-Canal-Blockade|adductor-canal-blockade
395576|NCT01261897|postoperative pain|postoperative pain
395577|NCT01261897|US-guided nerve block|us-guided nerve block
395578|NCT01261897|total knee arthroplasty|total knee arthroplasty
395579|NCT01261884|Pregnancy|pregnancy
395580|NCT01261884|Exercise|exercise
395581|NCT01261884|Hypertension|hypertension
395582|NCT01261884|Preeclampsia|preeclampsia
395583|NCT01261884|Resistance exercise|resistance exercise
395584|NCT01261858|Sternal closure|sternal closure
395585|NCT01261858|Coronary artery bypass grafting|coronary artery bypass grafting
395586|NCT01261858|Biologic bone cement|biologic bone cement
395587|NCT01261845|Delivery of Health Care|delivery of health care
395588|NCT01261845|Equity in Health Services|equity in health services
395589|NCT01261845|Ethnic Groups|ethnic groups
395590|NCT01261845|Health Services Research|health services research
395591|NCT01261845|Health Surveys|health surveys
395592|NCT01261845|Immigration|immigration
395593|NCT01261845|Referral and Consultation|referral and consultation
395594|NCT01261845|Resource Allocation|resource allocation
395595|NCT01261845|Social Justice|social justice
395596|NCT01261845|Vulnerable Populations|vulnerable populations
395597|NCT01261832|Acute Myocardial Infarction|acute myocardial infarction
395598|NCT01261832|Percutaneous coronary intervention|percutaneous coronary intervention
395599|NCT01261819|cystoscopy, minimally invasive hysterectomy|cystoscopy, minimally invasive hysterectomy
395600|NCT01261793|Lupus|lupus
395601|NCT01261793|Monoclonal antibody|monoclonal antibody
395602|NCT01261793|B-Cell immunotherapy|b-cell immunotherapy
395603|NCT01261793|Epratuzumab|epratuzumab
395604|NCT01261780|neuropathy,paraneoplastic|neuropathy,paraneoplastic
395605|NCT01261780|paraneoplastic peripheral neuropathy|paraneoplastic peripheral neuropathy
395606|NCT01261780|pain|pain
395617|NCT01261702|Pain|pain
395618|NCT01261689|Epidural analgesia|epidural analgesia
395619|NCT01261689|Instrumental delivery|instrumental delivery
395620|NCT01261689|Maternal outcome|maternal outcome
395621|NCT01261689|Neonatal outcome|neonatal outcome
395622|NCT01261676|caesarean section|caesarean section
395623|NCT01261676|labour, obstetric|labour, obstetric
395624|NCT01261676|implementation guidelines|implementation guidelines
395625|NCT01261676|quality indicators|quality indicators
395626|NCT01261650|widespread chronic pain, transcranial direct current stimulation, fibromyalgia|widespread chronic pain, transcranial direct current stimulation, fibromyalgia
395627|NCT01261637|cesarean, pain, transversus abdominus plane block|cesarean, pain, transversus abdominus plane block
395628|NCT01261624|poly JIA|poly jia
395629|NCT01261598|Positron-Emission Tomography|positron-emission tomography
395630|NCT01261598|PET Scan|pet scan
395631|NCT01261598|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
395632|NCT01261598|Radiation Oncology|radiation oncology
395634|NCT01261585|Positron-Emission Tomography|positron-emission tomography
395635|NCT01261585|PET Scan|pet scan
395636|NCT01261585|FDG|fdg
395637|NCT01261585|FLT|flt
395638|NCT01261585|FMISO|fmiso
395639|NCT01261585|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
395640|NCT01261585|chemo-Radiation Oncology|chemo-radiation oncology
395641|NCT01261585|SUV|suv
395642|NCT01261572|ASP3550|asp3550
395643|NCT01261572|Degarelix|degarelix
395644|NCT01261572|Prostate cancer|prostate cancer
395645|NCT01261572|Prostatic neoplasms|prostatic neoplasms
395646|NCT01261559|Computed tomography|computed tomography
395647|NCT01261559|Radiation dose|radiation dose
395648|NCT01261559|Dose reduction|dose reduction
395649|NCT01261559|Breast displacement|breast displacement
395650|NCT01261559|Chrysalis device|chrysalis device
395651|NCT01261559|Image quality|image quality
395652|NCT01261546|pleural effusion, empyema, corticoids, dexamethasone|pleural effusion, empyema, corticoids, dexamethasone
395653|NCT01261533|vitreous body substitute|vitreous body substitute
395654|NCT01261533|foldable capsular vitreous body|foldable capsular vitreous body
395655|NCT01261507|lung neoplasm nodule image processing computer-assisted|lung neoplasm nodule image processing computer-assisted
395656|NCT01261494|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
395657|NCT01261494|Glucose Metabolism Disorders|glucose metabolism disorders
395658|NCT01261494|Metabolic Diseases|metabolic diseases
395659|NCT01261494|Cardiovascular Diseases|cardiovascular diseases
395660|NCT01261494|PPARs|ppars
395661|NCT01261494|OGTT|ogtt
395662|NCT01261481|Bioavailability|bioavailability
395663|NCT01261468|Chronic pain|chronic pain
395664|NCT01261468|Electric Stimulation Therapy|electric stimulation therapy
395665|NCT01261468|Neurologic Examination|neurologic examination
395666|NCT01261442|distal symmetric polyneuropathy|distal symmetric polyneuropathy
395667|NCT01261442|diabetic peripheral neuropathy|diabetic peripheral neuropathy
395668|NCT01261442|posterior tibial nerve|posterior tibial nerve
395669|NCT01261442|regional anesthesia|regional anesthesia
395670|NCT01261442|nerve conduction study|nerve conduction study
395671|NCT01261429|Pigmented villonodular synovitis|pigmented villonodular synovitis
395672|NCT01261429|tenosynovial giant cell tumour|tenosynovial giant cell tumour
395673|NCT01261429|nilotinib|nilotinib
395674|NCT01261416|seizures|seizures
395675|NCT01261416|epilepsy|epilepsy
395676|NCT01261416|neonatal|neonatal
395677|NCT01261416|levetiracetam|levetiracetam
395678|NCT01261403|Human Placenta-Derived Cells|human placenta-derived cells
395679|NCT01261390|Sleep Apnea|sleep apnea
395680|NCT01261390|Heart Disease|heart disease
395681|NCT01261390|Risk factors for heart disease|risk factors for heart disease
395682|NCT01261377|COPD, obstructive sleep apnea, OSA, BPAP, CPAP|copd, obstructive sleep apnea, osa, bpap, cpap
395683|NCT01261364|GeneSight|genesight
395684|NCT01261364|Assurex|assurex
395685|NCT01261364|AssureRx|assurerx
395686|NCT01261351|Pre eclampsia|pre eclampsia
395687|NCT01261351|Endogenous thrombin potential|endogenous thrombin potential
395688|NCT01261338|PCBs|pcbs
395689|NCT01261338|Olestra|olestra
395690|NCT01261325|Epilepsy|epilepsy
395691|NCT01261325|Brivaracetam|brivaracetam
395692|NCT01261325|Partial Onset Seizures|partial onset seizures
395693|NCT01261325|Adjunctive treatment|adjunctive treatment
395695|NCT01261312|DNA Hypomethylating Agent|dna hypomethylating agent
395696|NCT01261312|Intermediate 1, Intermediate 2, CMML or High Risk MDS|intermediate 1, intermediate 2, cmml or high risk mds
395697|NCT01261312|AML|aml
395698|NCT01261299|Phase 0 Clinical trial|phase 0 clinical trial
395699|NCT01261299|Human microdosing trial|human microdosing trial
396097|NCT01259596|rural|rural
395700|NCT01261299|Drug resistance, neoplasm|drug resistance, neoplasm
395701|NCT01261299|Carcinoma, Non-small cell lung|carcinoma, non-small cell lung
395702|NCT01261299|Urinary Bladder Neoplasm|urinary bladder neoplasm
395703|NCT01261299|Individualized Medicine|individualized medicine
395704|NCT01261299|Carboplatin|carboplatin
395705|NCT01261299|Carboplatin-DNA adducts|carboplatin-dna adducts
395706|NCT01261286|inflammation|inflammation
395707|NCT01261286|receptor downregulation|receptor downregulation
395708|NCT01261286|reduced response|reduced response
395709|NCT01261286|calcium channels|calcium channels
395710|NCT01261286|PK-PD relationship|pk-pd relationship
395711|NCT01261273|PCI|pci
395712|NCT01261273|observational registry|observational registry
395713|NCT01261260|uridine|uridine
395714|NCT01261260|gamma-amino butyric acid|gamma-amino butyric acid
395715|NCT01261260|Magnetic Resonance Imaging|magnetic resonance imaging
395716|NCT01261260|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
395717|NCT01261260|Proton Echo-Planar Spectroscopic Imaging|proton echo-planar spectroscopic imaging
395718|NCT01261234|Carotid Artery Disease|carotid artery disease
395719|NCT01261234|Carotid Artery Stenting|carotid artery stenting
395720|NCT01261234|In stent restenosis|in stent restenosis
395721|NCT01261234|Cardiovascular event|cardiovascular event
395722|NCT01261234|Intima Media Thickness|intima media thickness
395723|NCT01261208|HIV, AIDS, Helicobacter pylori|hiv, aids, helicobacter pylori
395724|NCT01261182|Malnutrition|malnutrition
395725|NCT01261182|School feeding|school feeding
395726|NCT01261182|Infant nutrition|infant nutrition
395727|NCT01261182|Mother's nutrition|mother's nutrition
395728|NCT01261182|Fortified food|fortified food
395729|NCT01261182|Anemia|anemia
395730|NCT01261182|Cluster randomized controlled trials|cluster randomized controlled trials
395731|NCT01261182|Effectiveness|effectiveness
395732|NCT01261182|Impact evaluation studies|impact evaluation studies
395733|NCT01261182|Uganda|uganda
395734|NCT01261169|Mycophenolate sodium (Myfortic®)|mycophenolate sodium (myfortic®)
395735|NCT01261169|Corticosteroid-refractory autoimmune Uveitis|corticosteroid-refractory autoimmune uveitis
395736|NCT01261130|Human Hookworm Vaccine Initiative|human hookworm vaccine initiative
395737|NCT01261130|HHVI|hhvi
395738|NCT01261130|Human Hookworm|human hookworm
395739|NCT01261130|Hookworm|hookworm
395740|NCT01261130|Hookworm Disease|hookworm disease
395741|NCT01261130|N. americanus|n. americanus
395742|NCT01261130|Soil-transmitted helminth infection|soil-transmitted helminth infection
395743|NCT01261130|Intestinal blood loss|intestinal blood loss
395744|NCT01261130|Iron deficiency anemia|iron deficiency anemia
395745|NCT01261117|Patent ductus arteriosis|patent ductus arteriosis
395746|NCT01261117|İbuprofen|ibuprofen
395747|NCT01261117|Extremely Low Birth Weigh infant|extremely low birth weigh infant
395748|NCT01261104|hearing loss|hearing loss
395749|NCT01261104|handicap|handicap
395750|NCT01261104|counseling|counseling
395751|NCT01261091|Neurocritical Care|neurocritical care
395752|NCT01261091|Ischemic Stroke|ischemic stroke
395753|NCT01261091|Intracerebral Hemorrhage|intracerebral hemorrhage
395754|NCT01261091|Subarachnoid Hemorrhage|subarachnoid hemorrhage
395755|NCT01261091|Tracheostomy|tracheostomy
395756|NCT01261091|Tracheotomy|tracheotomy
395757|NCT01261091|Percutaneous Dilatative Tracheostomy|percutaneous dilatative tracheostomy
395758|NCT01261091|Weaning|weaning
395759|NCT01261091|Ventilation|ventilation
395760|NCT01261078|intrathecal epinephrine|intrathecal epinephrine
395761|NCT01261078|duration of anesthesia|duration of anesthesia
395762|NCT01261078|quality of anesthesia|quality of anesthesia
395763|NCT01261078|intrathecal fentanyl|intrathecal fentanyl
395764|NCT01261065|beta blockers|beta blockers
395765|NCT01261065|heart failure|heart failure
395766|NCT01261065|contractility|contractility
395767|NCT01261065|remodeling|remodeling
395768|NCT01261052|glucose sensors|glucose sensors
395769|NCT01261052|artificial pancreas|artificial pancreas
395770|NCT01261052|Diabetes Mellitus|diabetes mellitus
395771|NCT01261013|Keratoconus|keratoconus
395772|NCT01261013|intrastromal corneal ring segment|intrastromal corneal ring segment
395773|NCT01261013|To evaluate the visual and refractive outcomes of intrastromal corneal ring segment in keratoconic eyes at different stages|to evaluate the visual and refractive outcomes of intrastromal corneal ring segment in keratoconic eyes at different stages
395774|NCT01261000|Acromegaly|acromegaly
395775|NCT01260987|Moderate to severe actinic keratoses|moderate to severe actinic keratoses
395776|NCT01260987|Difficult to treat nodular basal cell carcinomas|difficult to treat nodular basal cell carcinomas
395777|NCT01260974|Invasive fungal infections|invasive fungal infections
395778|NCT01260974|Liver Transplantation|liver transplantation
395779|NCT01260974|Organ Transplantation|organ transplantation
395780|NCT01260974|Mycoses|mycoses
395797|NCT01260883|postoperative analgesia|postoperative analgesia
395799|NCT01260857|Spirinolactone|spirinolactone
395800|NCT01260857|Hydroflumethiazide|hydroflumethiazide
395801|NCT01260857|Hypertension|hypertension
395802|NCT01260857|Filipinos|filipinos
395803|NCT01260857|Diabetes mellitus|diabetes mellitus
395804|NCT01260857|Proteinuria|proteinuria
395805|NCT01260831|BedsidePEWS|bedsidepews
395806|NCT01260831|Intensive Care|intensive care
395807|NCT01260818|Tranexamic Acid|tranexamic acid
395808|NCT01260805|bioequivalence|bioequivalence
395809|NCT01260805|study|study
395810|NCT01260805|ethinylestradiol|ethinylestradiol
395811|NCT01260805|gestodene|gestodene
395812|NCT01260740|Traumatic Brain Injury|traumatic brain injury
395813|NCT01260740|Explicit Learning|explicit learning
395814|NCT01260740|Primary Motor Cortex|primary motor cortex
395815|NCT01260740|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
395816|NCT01260740|Implicit Learning|implicit learning
395817|NCT01260740|Healthy Volunteer|healthy volunteer
395818|NCT01260740|HV|hv
395819|NCT01260727|HIV Preventive Vaccine|hiv preventive vaccine
395820|NCT01260675|phase 1 study|phase 1 study
395821|NCT01260675|volunteers|volunteers
395822|NCT01260662|Deep Procedural Sedation|deep procedural sedation
395823|NCT01260662|Propofol|propofol
395824|NCT01260662|Ketamine|ketamine
395825|NCT01260662|Emergency Department|emergency department
395826|NCT01260662|Monitoring|monitoring
395827|NCT01260662|Capnography|capnography
395828|NCT01260662|Procedural Sedation in the Emergency Department|procedural sedation in the emergency department
395829|NCT01260649|Electroconvulsive treatment|electroconvulsive treatment
395830|NCT01260649|ketamine|ketamine
395831|NCT01260649|Major Depression|major depression
395832|NCT01260649|Treatment-resistant Major Depressive Disorder|treatment-resistant major depressive disorder
395833|NCT01260623|asthma|asthma
601724|NCT00585169|Memantine|memantine
396629|NCT01257581|ALS|als
395834|NCT01260623|pharmacokinetics|pharmacokinetics
395835|NCT01260623|prednisone|prednisone
395836|NCT01260623|prednisolone|prednisolone
395837|NCT01260623|asthma exacerbation|asthma exacerbation
395838|NCT01260623|pharmacokinetic profile|pharmacokinetic profile
395839|NCT01260610|Hepatitis B, Tenofovir, Telbivudine|hepatitis b, tenofovir, telbivudine
395840|NCT01260597|smoking|smoking
395841|NCT01260597|quit line re-enrollment and IVR systems|quit line re-enrollment and ivr systems
395842|NCT01260584|thienopyridine|thienopyridine
395843|NCT01260584|antiplatelet|antiplatelet
395844|NCT01260584|prasugrel|prasugrel
395845|NCT01260584|clopidogrel|clopidogrel
395846|NCT01260571|blackheads and pimples|blackheads and pimples
395847|NCT01260571|Acne vulgaris grade II|acne vulgaris grade ii
395848|NCT01260532|Autoimmune thyroid disease|autoimmune thyroid disease
395849|NCT01260506|Relapsed Glioblastoma Multiforme, GBM|relapsed glioblastoma multiforme, gbm
395850|NCT01260493|very frail|very frail
395851|NCT01260493|case manager|case manager
395852|NCT01260493|integrated care|integrated care
395853|NCT01260493|multiprofessional|multiprofessional
395854|NCT01260493|intervention|intervention
395855|NCT01260480|Carcinoma, non-small-cell lung|carcinoma, non-small-cell lung
395856|NCT01260480|Head and neck neoplasms|head and neck neoplasms
395857|NCT01260480|Diagnostic imaging|diagnostic imaging
395858|NCT01260467|recurrent|recurrent
395859|NCT01260454|Qutenza|qutenza
395860|NCT01260454|Capsaicin|capsaicin
395861|NCT01260454|Remodulin|remodulin
395862|NCT01260454|Treprostinil|treprostinil
395863|NCT01260428|hypoxia|hypoxia
395864|NCT01260428|O2 diffusion and convection|o2 diffusion and convection
395865|NCT01260428|cardiac output|cardiac output
395866|NCT01260428|PEEP|peep
395867|NCT01260428|Effects of hypoxia|effects of hypoxia
395868|NCT01260415|colorectal cancer|colorectal cancer
395869|NCT01260415|liver metastases|liver metastases
395870|NCT01260415|panitumumab|panitumumab
395871|NCT01260415|FOLFOX|folfox
395872|NCT01260415|Colorectal cancer with liver metastases|colorectal cancer with liver metastases
395873|NCT01260402|heart failure|heart failure
395874|NCT01260402|Cardiomyopathy, dilated|cardiomyopathy, dilated
395875|NCT01260402|Coronary disease|coronary disease
395876|NCT01260402|Cardiac Pacing, Artificial|cardiac pacing, artificial
395877|NCT01260402|cardiac resynchronization therapy|cardiac resynchronization therapy
395878|NCT01260402|Hemodynamics|hemodynamics
395879|NCT01260402|Randomized Controlled Trials|randomized controlled trials
395880|NCT01260402|Open Study|open study
395881|NCT01260389|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
395882|NCT01260389|COPD|copd
395883|NCT01260376|VLDL-TG|vldl-tg
395884|NCT01260376|Metabolism|metabolism
395885|NCT01260376|Exercise|exercise
395886|NCT01260376|Free Fatty Acids|free fatty acids
395887|NCT01260350|PSI-7977|psi-7977
395888|NCT01260350|Sofosbuvir|sofosbuvir
395889|NCT01260350|GS-7977|gs-7977
395890|NCT01260350|GS-5885|gs-5885
395895|NCT01260350|Pegylated Interferon|pegylated interferon
395896|NCT01260350|PEG-IFN|peg-ifn
395897|NCT01260350|Chronic Hepatitis C Infection|chronic hepatitis c infection
395899|NCT01260350|Hepatitis|hepatitis
395900|NCT01260350|Genotype 1|genotype 1
395901|NCT01260350|Genotype 2|genotype 2
395902|NCT01260350|Genotype 3|genotype 3
395903|NCT01260350|GT 1|gt 1
395904|NCT01260350|GT 2|gt 2
395905|NCT01260350|GT 3|gt 3
395906|NCT01260350|Hemophilia|hemophilia
395907|NCT01260337|Weight loss|weight loss
395908|NCT01260337|Type 2 Diabetes|type 2 diabetes
395909|NCT01260337|Behavior Modification|behavior modification
395910|NCT01260337|portion control|portion control
395911|NCT01260324|Phosphodiesterase type 5 inhibitors|phosphodiesterase type 5 inhibitors
395912|NCT01260324|non-arteritic anterior ischemic optic neuropathy|non-arteritic anterior ischemic optic neuropathy
395913|NCT01260324|descriptive epidemiology study|descriptive epidemiology study
395914|NCT01260311|Observational|observational
395915|NCT01260298|MC1 VASER VASERShape|mc1 vaser vasershape
395916|NCT01260272|Cardiovascular|cardiovascular
395917|NCT01260272|Risk Factors|risk factors
395918|NCT01260272|Cardiovascular Disease|cardiovascular disease
395919|NCT01260272|Glucose|glucose
395920|NCT01260272|Blood Pressure|blood pressure
386693|NCT01299415|ASA404,|asa404,
395921|NCT01260272|BMI|bmi
395922|NCT01260272|Weight|weight
395923|NCT01260272|Waist Circumference|waist circumference
395924|NCT01260259|Pediatric|pediatric
395925|NCT01260259|Cardiac|cardiac
395926|NCT01260259|Surgery|surgery
395927|NCT01260259|Cardiopulmonary|cardiopulmonary
395928|NCT01260259|Bypass|bypass
395929|NCT01260259|Myocardial|myocardial
395930|NCT01260259|Kidney|kidney
395931|NCT01260259|Lung|lung
395932|NCT01260259|Injury|injury
395933|NCT01260233|smoking cessation|smoking cessation
395934|NCT01260233|complications|complications
395935|NCT01260233|cigarettes|cigarettes
395936|NCT01260233|preoperative|preoperative
395937|NCT01260233|perioperative|perioperative
395938|NCT01260233|surgery|surgery
395939|NCT01260233|education|education
602133|NCT00588536|MTX|mtx
395940|NCT01260233|nicotine replacement therapy|nicotine replacement therapy
395941|NCT01260207|Acute Coronary Syndrome|acute coronary syndrome
395942|NCT01260207|Interactive Voice Response Technology|interactive voice response technology
395943|NCT01260207|Best Practice Guidelines|best practice guidelines
395944|NCT01260207|Compliance|compliance
395945|NCT01260207|Health Care Utilization|health care utilization
395946|NCT01260168|Cancer|cancer
395947|NCT01260168|Colorectal Cancer|colorectal cancer
395948|NCT01260168|Neoplasm|neoplasm
395949|NCT01260168|Colorectal Neoplasm|colorectal neoplasm
395950|NCT01260168|Intestinal Neoplasms|intestinal neoplasms
395951|NCT01260168|Gastrointestinal Neoplasms|gastrointestinal neoplasms
395952|NCT01260168|Digestive System Neoplasms|digestive system neoplasms
395953|NCT01260168|Neoplasms by Site|neoplasms by site
395954|NCT01260168|Neoplasms|neoplasms
395955|NCT01260168|Digestive System Diseases|digestive system diseases
395956|NCT01260168|Gastrointestinal Diseases|gastrointestinal diseases
395957|NCT01260168|Colonic Diseases|colonic diseases
395958|NCT01260168|Intestinal Diseases|intestinal diseases
395959|NCT01260168|Rectal Diseases|rectal diseases
395960|NCT01260129|BPH|bph
395961|NCT01260129|silodosin|silodosin
395962|NCT01260116|Efficacy,safety,ziprasidone,depressive symptoms ,schizophrenia|efficacy,safety,ziprasidone,depressive symptoms ,schizophrenia
395963|NCT01260103|Optic pathway glioma, recurrent|optic pathway glioma, recurrent
395964|NCT01260103|Optic pathway glioma, progressive|optic pathway glioma, progressive
395965|NCT01260103|Temozolomide|temozolomide
395966|NCT01260103|Temodar|temodar
395967|NCT01260103|TMZ|tmz
395973|NCT01260090|Persistently vegetative states|persistently vegetative states
395974|NCT01260090|Traumatic brain injury|traumatic brain injury
395975|NCT01260064|Appendicitis|appendicitis
395976|NCT01260064|Open appendectomy|open appendectomy
395977|NCT01260064|Laparoscopic appendectomy|laparoscopic appendectomy
395978|NCT01260064|Endoclip|endoclip
395979|NCT01260064|Intracorporeal suture|intracorporeal suture
395980|NCT01260064|Quality-of-life|quality-of-life
395981|NCT01260038|Non Small Cell Lung Cancer|non small cell lung cancer
395982|NCT01260038|observational study|observational study
395983|NCT01260038|EGFR mutation analysis|egfr mutation analysis
395984|NCT01260038|EGFR mutation status|egfr mutation status
395985|NCT01260038|testing turn around time|testing turn around time
395986|NCT01260025|Tolerability|tolerability
395987|NCT01260025|Pharmacokinetics|pharmacokinetics
395988|NCT01260025|Endostatin|endostatin
395989|NCT01260025|antiangiogenesis|antiangiogenesis
395990|NCT01260025|cancer|cancer
395991|NCT01260012|Schistosoma mansoni|schistosoma mansoni
395992|NCT01260012|Schistosomiasis|schistosomiasis
395993|NCT01260012|periportal fibrosis|periportal fibrosis
395994|NCT01260012|antioxidant|antioxidant
395995|NCT01260012|fibrosis reversal|fibrosis reversal
395996|NCT01259999|malnutrition|malnutrition
395997|NCT01259999|oleic-acid|oleic-acid
395998|NCT01259999|micronutrient supplement|micronutrient supplement
395999|NCT01259999|old peoples home|old peoples home
396000|NCT01259986|Vitiligo|vitiligo
396001|NCT01259986|Laser|laser
396002|NCT01259986|Segmental vitiligo|segmental vitiligo
396003|NCT01259986|Acral vitiligo|acral vitiligo
396004|NCT01259973|Pharmacogenetics|pharmacogenetics
396005|NCT01259973|Antipsychotics|antipsychotics
396006|NCT01259973|Extrapyramidal Symptoms|extrapyramidal symptoms
396007|NCT01259947|headache|headache
396008|NCT01259947|migraine|migraine
396009|NCT01259947|medicinal plant|medicinal plant
396010|NCT01259947|essential oil|essential oil
396011|NCT01259947|phytotherapy|phytotherapy
396012|NCT01259934|Randomized Phase III trial|randomized phase iii trial
396013|NCT01259934|Adjuvant therapy|adjuvant therapy
396014|NCT01259934|Interferon|interferon
396015|NCT01259934|Melanoma|melanoma
396016|NCT01259921|EEG biofeedback|eeg biofeedback
396017|NCT01259921|neurofeedback|neurofeedback
396019|NCT01259921|Affect Regulation|affect regulation
396020|NCT01259921|Chronic Trauma|chronic trauma
396021|NCT01259908|laparoscopic aortic surgery|laparoscopic aortic surgery
396022|NCT01259908|aorto-iliac occlusive disease|aorto-iliac occlusive disease
403035|NCT01228435|ALK translocation|alk translocation
396023|NCT01259882|Pharmacokinetics Safety Tolerability Pharmacodynamics|pharmacokinetics safety tolerability pharmacodynamics
396024|NCT01259856|Polycythemia vera|polycythemia vera
396025|NCT01259856|Essential thrombocythemia|essential thrombocythemia
396026|NCT01259856|Hydroxyurea|hydroxyurea
396027|NCT01259856|PEGASYS|pegasys
396028|NCT01259856|Pegylated Interferon Alfa-2a|pegylated interferon alfa-2a
396029|NCT01259843|Acute aortic syndrome|acute aortic syndrome
396030|NCT01259830|fast-track|fast-track
396031|NCT01259830|colon or rectal surgery|colon or rectal surgery
396032|NCT01259830|pain relief|pain relief
396033|NCT01259817|Polycythemia Vera|polycythemia vera
396034|NCT01259817|Essential Thrombocythemia|essential thrombocythemia
602134|NCT00588536|94-132|94-132
396035|NCT01259817|Hydroxyurea Resistant|hydroxyurea resistant
396036|NCT01259817|Abdominal Vein Thrombosis|abdominal vein thrombosis
396037|NCT01259817|PEGASYS|pegasys
396038|NCT01259804|peanut|peanut
396039|NCT01259804|food allergy|food allergy
396040|NCT01259804|anaphylaxis|anaphylaxis
396041|NCT01259804|immunotherapy|immunotherapy
396042|NCT01259778|Growth disorders|growth disorders
396043|NCT01259778|Saizen|saizen
396044|NCT01259778|easypod™|easypod™
396045|NCT01259778|Growth hormone|growth hormone
396046|NCT01259778|Pediatric subject|pediatric subject
396047|NCT01259765|llama antibody|llama antibody
396048|NCT01259765|rotavirus diarrhoea|rotavirus diarrhoea
396049|NCT01259765|children|children
396050|NCT01259752|Trauma|trauma
396051|NCT01259752|ankle sprain|ankle sprain
396052|NCT01259752|emergency|emergency
396053|NCT01259752|compression stocking|compression stocking
396054|NCT01259739|trained cyclists|trained cyclists
396055|NCT01259739|no medications|no medications
396056|NCT01259739|no diseases|no diseases
396057|NCT01259739|non-smokers|non-smokers
396058|NCT01259726|Diarrhea|diarrhea
396059|NCT01259726|Clostridium difficile|clostridium difficile
396060|NCT01259726|Clostridium infections|clostridium infections
396061|NCT01259726|Signs and Symptoms Digestive|signs and symptoms digestive
395607|NCT01261780|hyperalgesia|hyperalgesia
396062|NCT01259726|Bacterial Infections|bacterial infections
396063|NCT01259726|Pharmacologic Actions|pharmacologic actions
396064|NCT01259713|Ambisome|ambisome
396065|NCT01259713|ALL|all
396066|NCT01259713|invasive fungal infection|invasive fungal infection
396067|NCT01259713|prophylaxis|prophylaxis
396068|NCT01259713|liposomal amphotericin B|liposomal amphotericin b
396069|NCT01259713|Invasive fungal infection prophylaxis|invasive fungal infection prophylaxis
396070|NCT01259700|High blood pressure|high blood pressure
396071|NCT01259700|Primary care|primary care
396072|NCT01259700|Cardiovascular disease prevention|cardiovascular disease prevention
396073|NCT01259700|Salt reduction|salt reduction
396074|NCT01259687|Electrocardiogram|electrocardiogram
396075|NCT01259687|Arterial line waveform|arterial line waveform
396076|NCT01259687|Cardiac output|cardiac output
396077|NCT01259674|Pediatric|pediatric
396078|NCT01259674|children|children
396079|NCT01259674|acute cough|acute cough
396080|NCT01259674|treatment|treatment
396081|NCT01259674|syrup|syrup
396082|NCT01259674|protective natural extracts|protective natural extracts
396083|NCT01259661|physical activity|physical activity
396084|NCT01259661|metabolic syndrome|metabolic syndrome
396085|NCT01259661|postmenopausal women|postmenopausal women
396086|NCT01259661|exercise training|exercise training
396087|NCT01259648|remifentanil|remifentanil
396088|NCT01259648|anesthesia induction|anesthesia induction
396089|NCT01259648|reactional tachycardia|reactional tachycardia
396090|NCT01259635|Parkinson's disease|parkinson's disease
396091|NCT01259635|freezing of gait|freezing of gait
396092|NCT01259609|Diabetic Macular Edema|diabetic macular edema
396093|NCT01259609|Ciliary Body|ciliary body
396094|NCT01259609|Ultrasound Biomicroscopy|ultrasound biomicroscopy
396095|NCT01259609|Vitrectomy|vitrectomy
396096|NCT01259596|anxiety|anxiety
396098|NCT01259596|elderly|elderly
396099|NCT01259544|CP-Chronic Pancreatitis|cp-chronic pancreatitis
396100|NCT01259544|DPT-Di peptide breath test|dpt-di peptide breath test
396101|NCT01259544|ePFT- Endoscopic pancreatic function test|epft- endoscopic pancreatic function test
396102|NCT01259531|strong|strong
396103|NCT01259531|silodosin|silodosin
396104|NCT01259531|benign prostatic hyperplasia|benign prostatic hyperplasia
396105|NCT01259531|BPH|bph
396106|NCT01259531|lower urinary tract symptoms associated with severe BPH|lower urinary tract symptoms associated with severe bph
396107|NCT01259505|no number|no number
396108|NCT01259492|Attention Deficit /Hyperactivity Disorder, hyperactivity|attention deficit /hyperactivity disorder, hyperactivity
396109|NCT01259479|Solid Tumors|solid tumors
396110|NCT01259479|Maximum Tolerated Dose|maximum tolerated dose
396111|NCT01259479|Parmacokinetics|parmacokinetics
396112|NCT01259479|Pharmacogenomics|pharmacogenomics
396113|NCT01259479|Satraplatin|satraplatin
396114|NCT01259479|Cancer|cancer
396115|NCT01259479|Solid Tumor|solid tumor
396116|NCT01259479|Brain Tumor|brain tumor
396117|NCT01259466|Smoking cessation|smoking cessation
396118|NCT01259466|Overweight|overweight
483180|NCT00109018|Nitrite|nitrite
396119|NCT01259466|Obesity|obesity
396120|NCT01259466|Internet treatment|internet treatment
396121|NCT01259453|Hepatitis B vaccination|hepatitis b vaccination
396122|NCT01259453|Syringe exchange programs|syringe exchange programs
396123|NCT01259453|Injection drug users|injection drug users
396124|NCT01259453|Hepatitis B prevention through vaccination|hepatitis b prevention through vaccination
396125|NCT01259440|Telemedicine|telemedicine
396126|NCT01259440|continuous positive airway pressure|continuous positive airway pressure
396127|NCT01259440|treatment adherence|treatment adherence
396128|NCT01259427|Mental Disorders|mental disorders
396129|NCT01259427|Psychotic Disorders|psychotic disorders
396130|NCT01259427|Schizophrenia|schizophrenia
396131|NCT01259427|Stigmatization|stigmatization
396132|NCT01259427|Mood Disorders|mood disorders
396133|NCT01259427|Schizophrenia and Disorders with Psychotic Feature|schizophrenia and disorders with psychotic feature
396134|NCT01259414|Carcinoma,Hepatocellular|carcinoma,hepatocellular
396135|NCT01259414|Liver Neoplasms|liver neoplasms
396136|NCT01259414|Survival analysis|survival analysis
396137|NCT01259414|treatment outcome|treatment outcome
396138|NCT01259414|administration drugs|administration drugs
396139|NCT01259414|Chemoembolization,|chemoembolization,
396140|NCT01259414|TACE|tace
396141|NCT01259414|polyvinyl alcohol|polyvinyl alcohol
396142|NCT01259414|water-soluble contrast mesium|water-soluble contrast mesium
396143|NCT01259414|iopamidol|iopamidol
396144|NCT01259414|lipiodol|lipiodol
396145|NCT01259414|distilled water|distilled water
396146|NCT01259401|Sleep|sleep
396147|NCT01259401|Rehabilitation|rehabilitation
396148|NCT01259401|Behavior therapy|behavior therapy
396149|NCT01259401|Insomnia|insomnia
396150|NCT01259388|Multiple sclerosis|multiple sclerosis
396151|NCT01259388|Lithium|lithium
396152|NCT01259349|cataract,|cataract,
396153|NCT01259349|phacoemulsification,|phacoemulsification,
396154|NCT01259349|one percent ultrasound|one percent ultrasound
396155|NCT01259349|endothelial cell density|endothelial cell density
396156|NCT01259336|Itraconazole|itraconazole
396157|NCT01259336|chronic cavitary pulmonary aspergillosis|chronic cavitary pulmonary aspergillosis
396158|NCT01259336|Aspergillosis|aspergillosis
396159|NCT01259336|fungal ball|fungal ball
396160|NCT01259336|mycetoma|mycetoma
396161|NCT01259336|efficacy|efficacy
396162|NCT01259336|safety|safety
396163|NCT01259310|fertility|fertility
396164|NCT01259310|women|women
396165|NCT01259310|epilepsy|epilepsy
396166|NCT01259310|pregnancy|pregnancy
396167|NCT01259310|seizures|seizures
396168|NCT01259310|seizure frequency|seizure frequency
396169|NCT01259310|ovulation|ovulation
396170|NCT01259310|menstruation|menstruation
396171|NCT01259310|hormones|hormones
396172|NCT01259310|progesterone|progesterone
396173|NCT01259297|Aliskiren|aliskiren
396174|NCT01259297|Elderly|elderly
396175|NCT01259297|Major Cardiovascular Events|major cardiovascular events
396176|NCT01259297|Effect of aliskiren-based regimen on major CV events (composite of CV death, non-fatal MI, non-fatal stroke and significant heart failure) in the elderly|effect of aliskiren-based regimen on major cv events (composite of cv death, non-fatal mi, non-fatal stroke and significant heart failure) in the elderly
396177|NCT01259284|Breast cancer|breast cancer
396178|NCT01259284|Colorectal cancer|colorectal cancer
396179|NCT01259284|Genitourinary cancer|genitourinary cancer
396180|NCT01259284|Head and neck cancers|head and neck cancers
396181|NCT01259284|Lung cancer|lung cancer
396182|NCT01259284|Melanoma|melanoma
396183|NCT01259284|Sarcoma|sarcoma
396184|NCT01259284|Atorvastatin|atorvastatin
396185|NCT01259284|Lipitor|lipitor
396186|NCT01259284|Fish Oil supplement|fish oil supplement
396187|NCT01259284|Placebo|placebo
396188|NCT01259258|varicocele, methylene blue, varicocelectomy, hydrocele,|varicocele, methylene blue, varicocelectomy, hydrocele,
396189|NCT01259245|Chronic obstructive pulmonary disease COPD|chronic obstructive pulmonary disease copd
396190|NCT01259245|pulmonary rehabilitation program PRP|pulmonary rehabilitation program prp
396191|NCT01259245|Tai chi|tai chi
396192|NCT01259219|HIV|hiv
396193|NCT01259219|Completion of TB treamtment|completion of tb treamtment
396194|NCT01259206|Calcaneal Spur, Diabetic Obese Patients|calcaneal spur, diabetic obese patients
396195|NCT01259193|Hepatocellular Carcinoma|hepatocellular carcinoma
396196|NCT01259193|Sorafenib|sorafenib
396197|NCT01259193|Zoledronic Acid|zoledronic acid
396198|NCT01259193|toxic reaction|toxic reaction
396199|NCT01259180|acupuncture|acupuncture
396200|NCT01259167|JOBA, Low Back Pain, Physical Exercise|joba, low back pain, physical exercise
396201|NCT01256983|Sleep quality|sleep quality
396202|NCT01256983|Daytime Sleepiness|daytime sleepiness
396204|NCT01256944|DM|dm
396205|NCT01256944|Hypertension|hypertension
396206|NCT01256944|CVD|cvd
396207|NCT01256931|2009 H1N1 influenza vaccine, organ transplant patients,|2009 h1n1 influenza vaccine, organ transplant patients,
396208|NCT01256931|booster with Fluarix|booster with fluarix
396209|NCT01256918|cataract|cataract
396210|NCT01256918|phacoemulsification|phacoemulsification
396211|NCT01256918|phacochop|phacochop
396212|NCT01256918|phacotip|phacotip
396213|NCT01256827|age-related macular degeneration|age-related macular degeneration
396214|NCT01256827|ranibizumab|ranibizumab
396215|NCT01256827|geographic atrophy|geographic atrophy
396216|NCT01256827|ANCHOR Study|anchor study
396217|NCT01256827|MARINA Study|marina study
396218|NCT01256814|HIV/AIDS|hiv/aids
396219|NCT01256814|Adult|adult
396220|NCT01256814|Behavioral Intervention|behavioral intervention
396221|NCT01256814|Sleep|sleep
396222|NCT01256814|Physical Activity|physical activity
396223|NCT01256801|Metastatic Breast Neoplasms|metastatic breast neoplasms
396224|NCT01256801|Gene Expression Profiling|gene expression profiling
396225|NCT01256801|immunotherapy|immunotherapy
396226|NCT01256788|viscosupplementation|viscosupplementation
396227|NCT01256788|meniscus tear|meniscus tear
396228|NCT01256788|degenerative joint disease|degenerative joint disease
396229|NCT01256775|atherosclerosis|atherosclerosis
396230|NCT01256775|carotid intima-media thickness|carotid intima-media thickness
396231|NCT01256775|intermittent claudication|intermittent claudication
396232|NCT01256775|Nitric Oxide / NO|nitric oxide / no
396233|NCT01256762|imetelstat|imetelstat
396234|NCT01256762|imetelstat sodium|imetelstat sodium
396235|NCT01256762|GRN163L|grn163l
396236|NCT01256762|telomerase inhibitor|telomerase inhibitor
396237|NCT01256762|telomerase inhibition|telomerase inhibition
396238|NCT01256762|metastatic breast cancer|metastatic breast cancer
396239|NCT01256762|locally recurrent breast cancer|locally recurrent breast cancer
396240|NCT01256762|Bevacizumab|bevacizumab
396241|NCT01256762|Paclitaxel|paclitaxel
396242|NCT01256762|Avastin|avastin
396243|NCT01256762|Taxol|taxol
396244|NCT01256762|HER-2-negative|her-2-negative
396245|NCT01256762|First-Line Chemotherapy|first-line chemotherapy
396246|NCT01256762|Second-Line Chemotherapy|second-line chemotherapy
396247|NCT01256723|drug eluting stent (DES)|drug eluting stent (des)
396248|NCT01256723|unprotected left main coronary artery (ULMCA)|unprotected left main coronary artery (ulmca)
396249|NCT01259141|macrolide- resistant Mycoplasma pneumoniae,|macrolide- resistant mycoplasma pneumoniae,
396250|NCT01259141|Mycoplasm pneumonia antibiotic therapy|mycoplasm pneumonia antibiotic therapy
396251|NCT01259115|Healthy subjects|healthy subjects
396252|NCT01259115|Opioid|opioid
396253|NCT01259115|Transdermal|transdermal
396254|NCT01259102|Healthy subjects|healthy subjects
396256|NCT01259102|Transdermal|transdermal
396257|NCT01259089|Adenocarcinoma of the Lung|adenocarcinoma of the lung
396258|NCT01259089|Non-small Cell Lung Cancer|non-small cell lung cancer
396259|NCT01259063|GEMCITABINE|gemcitabine
396260|NCT01259063|RAD001(EVEROLIMUS)|rad001(everolimus)
396261|NCT01259063|urinary|urinary
396262|NCT01259063|BCG-Refractory|bcg-refractory
396263|NCT01259063|Intravesical|intravesical
396264|NCT01259063|10-165|10-165
396265|NCT01259050|ALS treatment|als treatment
396266|NCT01259050|Zinc|zinc
396267|NCT01259050|Copper|copper
396268|NCT01259050|BMAA|bmaa
396269|NCT01259050|ALS|als
396270|NCT01259037|Elastography|elastography
396271|NCT01259037|Cutaneous|cutaneous
396272|NCT01259037|Imaging|imaging
396273|NCT01259024|hepatocellular carcinoma|hepatocellular carcinoma
396274|NCT01259024|chemoembolization|chemoembolization
396275|NCT01259024|transarterial chemoembolization|transarterial chemoembolization
396276|NCT01259024|liver cancer|liver cancer
396277|NCT01259024|doxorubicin|doxorubicin
396278|NCT01259024|drug-eluting beads|drug-eluting beads
396279|NCT01259024|LC Bead|lc bead
396280|NCT01259011|end stage renal disease|end stage renal disease
396281|NCT01259011|dialysis|dialysis
396282|NCT01259011|end of life decision making|end of life decision making
396283|NCT01259011|surrogate psychological morbidities|surrogate psychological morbidities
396284|NCT01258985|Knee|knee
396285|NCT01258985|Knee osteoarthritis|knee osteoarthritis
396286|NCT01258985|osteoarthritis|osteoarthritis
396287|NCT01258985|Knee pain|knee pain
396288|NCT01258985|Tai Chi|tai chi
396289|NCT01258985|Physical Therapy|physical therapy
396290|NCT01258985|mind-body exercise|mind-body exercise
396291|NCT01258972|Bifurcation lesions|bifurcation lesions
396292|NCT01258959|Ultrasound, retrobulbar, parabulbar, ophthalmic surgery.|ultrasound, retrobulbar, parabulbar, ophthalmic surgery.
396293|NCT01258946|epicardial adipose pcos|epicardial adipose pcos
396294|NCT01258933|Leukemia|leukemia
396295|NCT01258933|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
396296|NCT01258933|CLL|cll
396297|NCT01258933|Lymphoma|lymphoma
396298|NCT01258933|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
396299|NCT01258933|SLL|sll
396300|NCT01258933|Ofatumumab|ofatumumab
396301|NCT01258920|Schizophrenia|schizophrenia
396302|NCT01258920|Paliperidone palmitate|paliperidone palmitate
396303|NCT01258920|Intramascular Injection|intramascular injection
396304|NCT01258907|BI-204|bi-204
396305|NCT01258868|Mesothelioma|mesothelioma
396306|NCT01258868|Esophageal Cancer|esophageal cancer
396307|NCT01258868|Lung Cancer|lung cancer
396308|NCT01258868|Thoracic Malignancies|thoracic malignancies
396309|NCT01258868|Tumor Cell Vaccine|tumor cell vaccine
396310|NCT01258842|Influenza|influenza
396311|NCT01258842|Prevention|prevention
396312|NCT01258842|Probiotic|probiotic
396313|NCT01258829|Heart Failure Cardiac Resynchronisation Therapy|heart failure cardiac resynchronisation therapy
396314|NCT01258816|Acute Myeloid Leukaemia (AML)|acute myeloid leukaemia (aml)
396315|NCT01258816|Pharmacokinetics|pharmacokinetics
396316|NCT01258816|Elacytarabine|elacytarabine
396317|NCT01258816|CP-4055|cp-4055
396318|NCT01258803|asthma|asthma
396319|NCT01258803|children|children
396320|NCT01258803|persistent|persistent
396321|NCT01258790|TS|ts
396322|NCT01258790|tics|tics
396323|NCT01258790|tourette|tourette
396324|NCT01258777|Healthy volunteers|healthy volunteers
396325|NCT01258777|Japanese male|japanese male
396326|NCT01258777|Caucasian male|caucasian male
396327|NCT01258777|Simponi|simponi
396328|NCT01258764|hypertension|hypertension
396329|NCT01258764|Blood Pressure control|blood pressure control
396330|NCT01258764|hypertension treatment|hypertension treatment
396331|NCT01258764|antihypertensive|antihypertensive
396332|NCT01258764|N of 1 study|n of 1 study
396333|NCT01258751|Healthy Volunteers|healthy volunteers
396334|NCT01258738|Early ankylosing spondylitis (SpA) study; efficacy and safety and health out comes|early ankylosing spondylitis (spa) study; efficacy and safety and health out comes
396335|NCT01258725|amnioinfusion, severe idiopahic oligohydramnios|amnioinfusion, severe idiopahic oligohydramnios
396337|NCT01258673|Fimasartan/Hydrochlorothiazide combination|fimasartan/hydrochlorothiazide combination
396338|NCT01258647|infant nutrition|infant nutrition
396339|NCT01258647|complementary feeding|complementary feeding
396340|NCT01258647|malnutrition|malnutrition
396341|NCT01258647|stunting of growth|stunting of growth
396342|NCT01258634|Osteosarcoma|osteosarcoma
396343|NCT01258634|Surgically Resectable High Grade Osteosarcoma|surgically resectable high grade osteosarcoma
396344|NCT01258634|Lung Metastases Only|lung metastases only
396345|NCT01258621|distal pancreatectomy, laparoscopy, learning curve|distal pancreatectomy, laparoscopy, learning curve
396346|NCT01258608|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
396347|NCT01258608|Mapatumumab|mapatumumab
396348|NCT01258608|HGS1012|hgs1012
396349|NCT01258608|sorafenib|sorafenib
396350|NCT01258595|Influenza|influenza
396351|NCT01258595|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
7910|NCT03239964|steroids injection|steroids injection
396352|NCT01258595|High-Dose Trivalent Inactivated Influenza Vaccine|high-dose trivalent inactivated influenza vaccine
396353|NCT01258595|Influenza vaccines|influenza vaccines
396355|NCT01258582|Testing|testing
396356|NCT01258582|HIV Seronegativity|hiv seronegativity
396357|NCT01258569|laparoscopic|laparoscopic
396358|NCT01258569|colon|colon
396359|NCT01258569|resection|resection
396360|NCT01258569|Entereg|entereg
396361|NCT01258543|Global osteopathic evaluation|global osteopathic evaluation
396362|NCT01258543|Non-specific back pain|non-specific back pain
396363|NCT01258543|Inter-examiner reliability|inter-examiner reliability
396364|NCT01258530|influenza, bioequivalence, oseltamivir, Tamiflu, over-encapsulation|influenza, bioequivalence, oseltamivir, tamiflu, over-encapsulation
396365|NCT01258517|RDS|rds
396366|NCT01258517|surfactant|surfactant
396367|NCT01258517|cerebral oxygenation|cerebral oxygenation
396368|NCT01258517|near infrared spectroscopy|near infrared spectroscopy
396369|NCT01258504|Steady-state|steady-state
396370|NCT01258504|Bosentan|bosentan
396371|NCT01258504|St. Johns Wort|st. johns wort
396372|NCT01258478|NSCLC, rehabilitation, CPET, lung resection|nsclc, rehabilitation, cpet, lung resection
396373|NCT01258465|Communication|communication
396374|NCT01258465|Pivotal Response Training|pivotal response training
396375|NCT01258465|Picture Exchange Communication System|picture exchange communication system
396376|NCT01258439|HIV|hiv
396377|NCT01258439|cardiovascular disease|cardiovascular disease
396378|NCT01258439|post prandial lipids|post prandial lipids
396379|NCT01258439|ritonavir|ritonavir
396380|NCT01258439|darunavir|darunavir
396381|NCT01258439|raltegravir|raltegravir
396382|NCT01258439|arterial stiffness|arterial stiffness
396383|NCT01258439|tonometry|tonometry
396384|NCT01256684|Vulvar/vaginal atrophy|vulvar/vaginal atrophy
396385|NCT01256684|Atrophic Vaginitis|atrophic vaginitis
397088|NCT01255007|Weighted|weighted
396386|NCT01256684|Dehydroepiandrosterone|dehydroepiandrosterone
396387|NCT01256684|DHEA|dhea
396388|NCT01256684|Prasterone|prasterone
396389|NCT01256684|Vaginorm|vaginorm
396390|NCT01256684|Menopause|menopause
396391|NCT01256684|Intrarosa|intrarosa
396392|NCT01256671|Vulvar/Vaginal Atrophy|vulvar/vaginal atrophy
396393|NCT01256671|Atrophic Vaginitis|atrophic vaginitis
396394|NCT01256671|Dehydroepiandrosterone|dehydroepiandrosterone
396395|NCT01256671|DHEA|dhea
396396|NCT01256671|Prasterone|prasterone
396397|NCT01256671|Vaginorm|vaginorm
396398|NCT01256671|Menopause|menopause
396399|NCT01256658|P. falciparum|p. falciparum
396400|NCT01256658|malaria|malaria
396401|NCT01256658|asymptomatic carriers|asymptomatic carriers
396402|NCT01256658|bed-nets|bed-nets
396403|NCT01256658|ITN-insecticide-treated net|itn-insecticide-treated net
396404|NCT01256658|idiopathic trigeminal neuralgia|idiopathic trigeminal neuralgia
396405|NCT01256658|RDT-Rapid diagnostic test|rdt-rapid diagnostic test
396406|NCT01256645|weaning|weaning
396407|NCT01256645|mechanical ventilation|mechanical ventilation
396408|NCT01256645|blood transfusion|blood transfusion
396409|NCT01256645|spontaneous breathing trials|spontaneous breathing trials
396410|NCT01256619|Marvelon|marvelon
396411|NCT01256619|PMS|pms
396412|NCT01256619|serum Lipids|serum lipids
396413|NCT01256593|Lyrica|lyrica
396414|NCT01256593|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
396415|NCT01256593|Safety|safety
396416|NCT01256593|Neuropathic Pain|neuropathic pain
396417|NCT01256593|Post Marketing Surveillance|post marketing surveillance
396418|NCT01256554|Stereotactic Radiosurgery|stereotactic radiosurgery
396419|NCT01256554|SSRS|ssrs
396420|NCT01256554|Radiation|radiation
396421|NCT01256554|Radiotherapy|radiotherapy
396422|NCT01256554|Metastatic Epidural Spinal Cord Compression|metastatic epidural spinal cord compression
396423|NCT01256554|MESCC|mescc
396424|NCT01256528|Invasive breast carcinoma|invasive breast carcinoma
396425|NCT01256528|Breast reconstruction|breast reconstruction
396426|NCT01256528|Mastectomy|mastectomy
396427|NCT01256528|Breast cancer|breast cancer
396428|NCT01256528|Delayed-delayed breast reconstruction|delayed-delayed breast reconstruction
396429|NCT01256528|Post-mastectomy radiation therapy|post-mastectomy radiation therapy
396430|NCT01256515|Healthy adults aged 50 or older|healthy adults aged 50 or older
396432|NCT01256489|Keratoprosthesis|keratoprosthesis
396433|NCT01256489|Stevens-Johnson Syndrome|stevens-johnson syndrome
396434|NCT01256489|Infliximab|infliximab
396435|NCT01256489|Corneal Blindness|corneal blindness
396436|NCT01256450|buccal soluble film|buccal soluble film
396437|NCT01256450|enriched enrollment|enriched enrollment
396438|NCT01256450|randomized withdrawal|randomized withdrawal
396439|NCT01258413|Cervical Cancer|cervical cancer
396440|NCT01258413|Radical hysterectomy, Laparoscopic|radical hysterectomy, laparoscopic
396441|NCT01258413|Overall survival|overall survival
396442|NCT01258413|Disease-free five-years survival|disease-free five-years survival
396443|NCT01258374|Pharmacokinetics, raltegravir, darunavir, NRTI sparing regimen|pharmacokinetics, raltegravir, darunavir, nrti sparing regimen
396444|NCT01258361|preoperative fasting|preoperative fasting
396445|NCT01258296|Postoperative pain|postoperative pain
396446|NCT01258296|Breast reconstruction|breast reconstruction
396447|NCT01258296|Abdominal flap breast reconstruction|abdominal flap breast reconstruction
396448|NCT01258257|Aneurysm|aneurysm
396449|NCT01258257|Subarachnoid hemorrhage|subarachnoid hemorrhage
396450|NCT01258257|Lumbar drain|lumbar drain
396451|NCT01258257|Cerebral vasospasm|cerebral vasospasm
396452|NCT01258257|Cerebral Ventricles|cerebral ventricles
396453|NCT01258257|Cerebrospinal Fluid|cerebrospinal fluid
396454|NCT01258257|Prospective Studies|prospective studies
396455|NCT01258257|Drainage/methods*|drainage/methods*
396456|NCT01258257|Humans|humans
396457|NCT01258257|Subarachnoid Hemorrhage/cerebrospinal fluid*|subarachnoid hemorrhage/cerebrospinal fluid*
396458|NCT01258257|Subarachnoid Hemorrhage/complications*|subarachnoid hemorrhage/complications*
396459|NCT01258257|Subarachnoid Space/surgery*|subarachnoid space/surgery*
396460|NCT01258257|Vasospasm, Intracranial/etiology|vasospasm, intracranial/etiology
396461|NCT01258257|Vasospasm, Intracranial/surgery*|vasospasm, intracranial/surgery*
396462|NCT01258244|Out-of-Hospital Cardiac Arrest, OHCA|out-of-hospital cardiac arrest, ohca
396463|NCT01258205|Amgen|amgen
396464|NCT01258205|AMG 139|amg 139
396465|NCT01258205|Crohn's Disease|crohn's disease
396466|NCT01258192|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
396467|NCT01258192|neoadjuvant chemotherapy|neoadjuvant chemotherapy
396468|NCT01258192|albumin-bound paclitaxel|albumin-bound paclitaxel
396469|NCT01258192|cisplatin|cisplatin
396470|NCT01258153|Infantile Colic|infantile colic
396471|NCT01258153|tachykinin antagonist|tachykinin antagonist
396472|NCT01258153|Nepadutant|nepadutant
396473|NCT01258140|CT angiography|ct angiography
396474|NCT01258140|radiation dose|radiation dose
396475|NCT01258140|contrast medium|contrast medium
396476|NCT01258127|Pemetrexed|pemetrexed
396477|NCT01258127|Vinorelbine|vinorelbine
396478|NCT01258127|Carboplatin|carboplatin
396479|NCT01258114|Overweight|overweight
396480|NCT01258114|Obesity|obesity
396481|NCT01258114|Balneotherapy|balneotherapy
396482|NCT01258114|Spa Therapy|spa therapy
396483|NCT01258114|balneology|balneology
396484|NCT01258114|hydrotherapy|hydrotherapy
396485|NCT01258114|SF 12|sf 12
396486|NCT01258114|Nutritional counselling|nutritional counselling
396487|NCT01258114|Zelen double consent|zelen double consent
396488|NCT01258114|Lifestyle modification program|lifestyle modification program
396489|NCT01258114|IMC|imc
396490|NCT01258088|psoriasis|psoriasis
396491|NCT01258075|type 2 diabetes mellitus|type 2 diabetes mellitus
396492|NCT01258075|blood glucose|blood glucose
396493|NCT01258075|anti-diabetic|anti-diabetic
396494|NCT01258075|bile acid sequestrant|bile acid sequestrant
396495|NCT01258075|colesevelam HCl|colesevelam hcl
396496|NCT01258075|oral suspension|oral suspension
396497|NCT01258075|pediatric|pediatric
396498|NCT01258075|add-on therapy|add-on therapy
396499|NCT01258075|add-on to metformin|add-on to metformin
396500|NCT01258075|metformin|metformin
396501|NCT01258075|adolescent|adolescent
396502|NCT01258075|lipid|lipid
396503|NCT01258049|Plasmodium infections|plasmodium infections
396504|NCT01258049|Remittent fever|remittent fever
396505|NCT01258049|Artemether|artemether
396506|NCT01258049|Artemesinins|artemesinins
396507|NCT01258049|Quinine|quinine
396508|NCT01258049|Malaria|malaria
396509|NCT01258049|Protozoan infections|protozoan infections
396510|NCT01258049|sublingual drug delivery|sublingual drug delivery
396511|NCT01258049|Parasitic disease|parasitic disease
396512|NCT01258049|Antiprotozoan agents|antiprotozoan agents
396513|NCT01258036|Bone microarchitecture|bone microarchitecture
602135|NCT00588562|PH|ph
396514|NCT01258036|Bone mineral density|bone mineral density
396515|NCT01258036|Bone markers|bone markers
396516|NCT01258036|hereditary determinism|hereditary determinism
396517|NCT01258010|Red blood cell transfusion|red blood cell transfusion
396518|NCT01258010|Neurosurgery|neurosurgery
396519|NCT01258010|Orthopedic surgery|orthopedic surgery
396520|NCT01258010|Tranexamic acid|tranexamic acid
396521|NCT01258010|Surgical blood loss|surgical blood loss
396522|NCT01257997|No specific experimental conditions|no specific experimental conditions
396523|NCT01257971|Cholesterol|cholesterol
396524|NCT01257971|HMG-CoA reductase inhibitor|hmg-coa reductase inhibitor
396525|NCT01257971|cardiovascular risk|cardiovascular risk
396526|NCT01257971|LDLl|ldll
396527|NCT01256879|cimetidine|cimetidine
396528|NCT01256879|pharmacokinetics|pharmacokinetics
396529|NCT01256879|formulation|formulation
396530|NCT01256866|Dexmedetomidine|dexmedetomidine
396531|NCT01256866|Midazolam|midazolam
396532|NCT01256866|Sedation|sedation
396533|NCT01256866|Mechanical ventilation|mechanical ventilation
396534|NCT01256866|Critically ill patients|critically ill patients
396535|NCT01256853|histologically confirmed EBV+ NPC patients|histologically confirmed ebv+ npc patients
396536|NCT01257958|Vitamin D, 19 nor Vitamin D, Multiple Sclerosis|vitamin d, 19 nor vitamin d, multiple sclerosis
396537|NCT01257932|Breast Cancer|breast cancer
396538|NCT01257906|acne|acne
396539|NCT01257906|Ziana|ziana
396540|NCT01257906|clindamycin|clindamycin
396541|NCT01257906|tretinoin|tretinoin
396542|NCT01257893|migraine|migraine
396543|NCT01257893|chronic migraine|chronic migraine
396545|NCT01257893|migraine without aura|migraine without aura
396546|NCT01257893|aspirin|aspirin
396547|NCT01257893|platelets|platelets
396548|NCT01257880|Migraine|migraine
396549|NCT01257880|Migraine with Aura|migraine with aura
396550|NCT01257880|Aura|aura
396551|NCT01257880|Patent Foramen Ovale|patent foramen ovale
396552|NCT01257880|Platelets|platelets
396553|NCT01257880|Sleep Apnea|sleep apnea
396554|NCT01257880|Cognitive Function|cognitive function
396555|NCT01257867|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
396556|NCT01257867|Oxidative stress|oxidative stress
396557|NCT01257867|Neurogenesis|neurogenesis
396558|NCT01257867|Lithium|lithium
396559|NCT01257867|Lithia water|lithia water
396560|NCT01257854|busulfan|busulfan
396561|NCT01257854|pharmacogenetic|pharmacogenetic
396562|NCT01257854|pharmacokinetic|pharmacokinetic
396563|NCT01257854|toxicity|toxicity
396564|NCT01257854|survival|survival
396565|NCT01257841|Fasting|fasting
396566|NCT01257841|Gut hormones|gut hormones
396567|NCT01257841|Inflammatory Cytokines|inflammatory cytokines
396568|NCT01257815|Diabetes mellitus|diabetes mellitus
396569|NCT01257815|Diabetic retinopathy|diabetic retinopathy
396570|NCT01257815|Macular oedema|macular oedema
396571|NCT01257815|Visual acuity|visual acuity
396572|NCT01257789|laparoscopic gastric bypass|laparoscopic gastric bypass
396573|NCT01257789|learning curve|learning curve
396574|NCT01257789|complications|complications
396575|NCT01257789|operative time|operative time
396576|NCT01257776|Critical Limb Ischemia (CLI)|critical limb ischemia (cli)
396577|NCT01257776|Diabetes|diabetes
396578|NCT01257776|Mesenchymal Stem Cells|mesenchymal stem cells
396579|NCT01257776|Regenerative Therapy|regenerative therapy
396580|NCT01257763|needles/adverse effects|needles/adverse effects
396581|NCT01257763|administration, cutaneous|administration, cutaneous
396582|NCT01257763|erythema|erythema
396583|NCT01257763|pain measurement|pain measurement
396584|NCT01257763|Safety|safety
396585|NCT01257763|Microstructure Transdermal System|microstructure transdermal system
396586|NCT01257750|corneal neovascularization|corneal neovascularization
396587|NCT01257750|pazopanib|pazopanib
396588|NCT01257750|votrient|votrient
396589|NCT01257750|rosacea|rosacea
396590|NCT01257737|Urea Cycle Disorders|urea cycle disorders
396591|NCT01257737|GT4P|gt4p
396592|NCT01257737|HPN-100|hpn-100
396593|NCT01257737|Sodium Phenylbutyrate|sodium phenylbutyrate
396594|NCT01257737|Glyceryl tri-(4-phenylbutyrate)|glyceryl tri-(4-phenylbutyrate)
396595|NCT01257737|Phenylbutyrate|phenylbutyrate
396596|NCT01257737|Hyperion|hyperion
396597|NCT01257737|Buphenyl|buphenyl
396598|NCT01257737|hyperammonemia|hyperammonemia
387369|NCT01296399|in stent restenosis|in stent restenosis
387370|NCT01296399|bare metal stent|bare metal stent
387371|NCT01296399|drug eluting stent|drug eluting stent
387372|NCT01296399|de novo lesion|de novo lesion
387373|NCT01296373|HIV-1|hiv-1
396599|NCT01257724|Knowledge translation|knowledge translation
396600|NCT01257724|Community based organizations|community based organizations
396601|NCT01257724|HIV/AIDS|hiv/aids
396602|NCT01257711|Gastric Cancer|gastric cancer
396603|NCT01257711|Gastrectomy|gastrectomy
396604|NCT01257711|Billroth 2|billroth 2
396605|NCT01257711|Roux-en-Y|roux-en-y
396606|NCT01257698|Vitrectomy|vitrectomy
396607|NCT01257698|Gas bubble|gas bubble
396608|NCT01257698|Retinal detachment|retinal detachment
396609|NCT01257698|Macular hole|macular hole
396610|NCT01257698|Aqueous suppressant|aqueous suppressant
396611|NCT01257672|acute gastroenteritis|acute gastroenteritis
396612|NCT01257672|vomiting|vomiting
396613|NCT01257672|ondansetron|ondansetron
396614|NCT01257672|domperidon|domperidon
396615|NCT01257672|symptomatic treatment|symptomatic treatment
396616|NCT01257659|Rectocele|rectocele
396617|NCT01257659|Trans anal STARR resection|trans anal starr resection
396618|NCT01257659|Transvaginal repair|transvaginal repair
396619|NCT01257633|da Vinci surgical robot|da vinci surgical robot
396620|NCT01257633|laryngeal cancer|laryngeal cancer
396621|NCT01257620|Inflammatory Bowel Disease|inflammatory bowel disease
396622|NCT01257620|Coeliac Disease|coeliac disease
396623|NCT01257594|Gliomas|gliomas
396624|NCT01257594|Erlotinib|erlotinib
396625|NCT01257594|Glioblastoma|glioblastoma
396626|NCT01257594|GBM|gbm
396630|NCT01257581|Lou Gehrig's Disease|lou gehrig's disease
396631|NCT01257581|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
396632|NCT01257581|Creatine|creatine
396633|NCT01257581|Tamoxifen|tamoxifen
396634|NCT01257581|Selection Design|selection design
396635|NCT01257542|randomized|randomized
396636|NCT01257542|parallel|parallel
396637|NCT01257542|double-blind|double-blind
396638|NCT01257542|placebo-controlled|placebo-controlled
396639|NCT01257542|cough|cough
396640|NCT01257542|efficacy|efficacy
396641|NCT01257542|safety|safety
396642|NCT01257542|dextromethorphan|dextromethorphan
396643|NCT01257529|pregabalin|pregabalin
396644|NCT01257529|pharmacokinetics|pharmacokinetics
396645|NCT01257529|bioavailability|bioavailability
396646|NCT01257529|bioequivalence|bioequivalence
396647|NCT01257516|pregabalin|pregabalin
396648|NCT01257516|pharmacokinetics|pharmacokinetics
396649|NCT01257516|bioavailability|bioavailability
396650|NCT01257516|bioequivalence|bioequivalence
396651|NCT01257503|children|children
396652|NCT01257503|upper respiratory tract infections|upper respiratory tract infections
396653|NCT01257503|homeopathy|homeopathy
396654|NCT01257477|Diarrhea|diarrhea
396655|NCT01257477|IBS|ibs
396656|NCT01257477|Irritable Bowel Syndrome|irritable bowel syndrome
396657|NCT01257464|CFRD|cfrd
396658|NCT01257464|sitagliptin|sitagliptin
396659|NCT01257464|cystic fibrosis-related diabetes|cystic fibrosis-related diabetes
396660|NCT01257464|incretins|incretins
396661|NCT01257464|hyperglycemia|hyperglycemia
396662|NCT01257464|GIP|gip
396663|NCT01257464|GLP-1|glp-1
396664|NCT01257451|Type 2 Diabetes Mellitus, Vildagliptin, Elderly Patients|type 2 diabetes mellitus, vildagliptin, elderly patients
396665|NCT01257412|Phase III|phase iii
396666|NCT01257412|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
396667|NCT01257412|inadequate glycaemic control|inadequate glycaemic control
396668|NCT01257360|RAS-Wildtype|ras-wildtype
396669|NCT01257360|Radiotherapy|radiotherapy
396670|NCT01257360|Neoadjuvant treatment|neoadjuvant treatment
396671|NCT01257347|Medication adherence|medication adherence
396672|NCT01257347|clinical inertia|clinical inertia
396673|NCT01257347|treatment intensification|treatment intensification
396674|NCT01257347|quality of care|quality of care
396675|NCT01257334|type 2 diabetes|type 2 diabetes
396676|NCT01257308|lung cancer|lung cancer
396677|NCT01257295|dietary fiber|dietary fiber
396678|NCT01257295|energy intake|energy intake
396679|NCT01257295|appetite|appetite
396680|NCT01257295|satiety hormones|satiety hormones
396681|NCT01257295|glucose|glucose
396682|NCT01257295|gastric emptying|gastric emptying
396683|NCT01257269|Thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
396684|NCT01257269|ADAMTS13|adamts13
396685|NCT01257269|Von Willebrand factor|von willebrand factor
397089|NCT01255007|3T|3t
396686|NCT01257269|Von Willebrand factor cleaving protease|von willebrand factor cleaving protease
396687|NCT01257269|Thrombocytopenia|thrombocytopenia
396688|NCT01257269|Hemolytic anemia|hemolytic anemia
396689|NCT01257256|infertile patients|infertile patients
396690|NCT01257243|cough|cough
396691|NCT01257243|symptoms|symptoms
396692|NCT01257243|cold|cold
396693|NCT01257243|flu|flu
396694|NCT01257217|Intraocular Lens|intraocular lens
396695|NCT01257217|Presbyopia|presbyopia
396696|NCT01257217|multifocal|multifocal
396697|NCT01257191|Vehicle Emissions|vehicle emissions
396698|NCT01257191|Diesel Exhaust|diesel exhaust
396699|NCT01257165|Automobile driving|automobile driving
396700|NCT01257165|Zopiclone|zopiclone
396701|NCT01257165|Drug safety|drug safety
396702|NCT01257165|Traffic accidents|traffic accidents
396703|NCT01257139|To evaluate a geriatric scale designed to help with treatment|to evaluate a geriatric scale designed to help with treatment
396704|NCT01257139|allocation to dual-agent therapy based on platinum or to|allocation to dual-agent therapy based on platinum or to
396705|NCT01257139|single-agent chemotherapy in elderly subjects with advancedstage|single-agent chemotherapy in elderly subjects with advancedstage
396706|NCT01257139|NSCLC, based on the time to failure in the two arms|nsclc, based on the time to failure in the two arms
396707|NCT01257126|Upper respiratory tract infections|upper respiratory tract infections
396708|NCT01257126|diclofenac potassium|diclofenac potassium
396709|NCT01257126|nimesulide|nimesulide
396710|NCT01257126|fever|fever
396711|NCT01257126|pain|pain
396712|NCT01257113|shoulder pain|shoulder pain
396713|NCT01257113|shoulder impingement|shoulder impingement
396714|NCT01257113|rotatorcuff pathology|rotatorcuff pathology
396715|NCT01257113|supervised exercise|supervised exercise
396716|NCT01257113|homebased exercise|homebased exercise
396717|NCT01257100|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
396718|NCT01257100|Epstein-Barr Virus|epstein-barr virus
396719|NCT01257100|NPC|npc
396720|NCT01257087|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
396721|NCT01257087|Obesity|obesity
396722|NCT01257087|Bariatric Surgery|bariatric surgery
396723|NCT01257087|Glycaemic control|glycaemic control
396724|NCT01257087|Microvascular complications|microvascular complications
396725|NCT01257087|Intensive|intensive
396726|NCT01257087|Conservative|conservative
396727|NCT01257074|Herpes Simplex|herpes simplex
396728|NCT01257061|Dermatitis|dermatitis
396729|NCT01257061|Dermatitis, Atopic|dermatitis, atopic
396730|NCT01257048|Oxygen enhanced magnetic resonance imaging|oxygen enhanced magnetic resonance imaging
396731|NCT01257048|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
396732|NCT01257048|method evaluation|method evaluation
396733|NCT01257035|Rectum cancer|rectum cancer
396734|NCT01257035|FAZA|faza
396735|NCT01257035|18F-FAZA-PET/CT|18f-faza-pet/ct
396736|NCT01257035|Radiotherapy|radiotherapy
396737|NCT01257035|Chemoradiotherapy|chemoradiotherapy
396738|NCT01257022|Prevention|prevention
396739|NCT01257022|HIV|hiv
396740|NCT01257022|Substance use|substance use
396741|NCT01257022|Hispanic|hispanic
396742|NCT01257022|Adolescents|adolescents
396743|NCT01257022|Unsafe sexual behavior|unsafe sexual behavior
396744|NCT01257022|Behavioral intervention|behavioral intervention
396745|NCT01257009|sympathetic activity|sympathetic activity
396746|NCT01257009|chronic kidney disease|chronic kidney disease
396747|NCT01257009|atorvastatin|atorvastatin
396748|NCT01257009|lipitor|lipitor
396749|NCT01256437|Acneiform eruption|acneiform eruption
396750|NCT01256437|papulopustular|papulopustular
396751|NCT01256437|EGFR|egfr
396752|NCT01256437|cetuximab|cetuximab
396753|NCT01256437|erlotinib|erlotinib
396754|NCT01256437|gefitinib|gefitinib
396755|NCT01256437|panitumumab|panitumumab
396756|NCT01256437|eruption secondary to treatment with either cetuximab|eruption secondary to treatment with either cetuximab
396757|NCT01256424|CIN|cin
396758|NCT01256411|hypertension|hypertension
396759|NCT01256411|blood pressure|blood pressure
396760|NCT01256411|LCZ696|lcz696
396761|NCT01256411|dual-acting|dual-acting
396762|NCT01256411|neprilysin|neprilysin
396763|NCT01256411|nep inhibitor|nep inhibitor
396764|NCT01256411|vasopeptidase|vasopeptidase
396765|NCT01256411|angiotensin receptor|angiotensin receptor
396766|NCT01256411|angiotensin receptor neprilysin inhibitor (ARNi)|angiotensin receptor neprilysin inhibitor (arni)
396767|NCT01256372|Cardiac surgery|cardiac surgery
396768|NCT01256372|Acute kidney injury|acute kidney injury
396769|NCT01256346|Premature|premature
396770|NCT01256346|baby|baby
396771|NCT01256346|heart rate|heart rate
396772|NCT01256346|resuscitation|resuscitation
396773|NCT01256307|Obstructive Sleep Apnea/Hypopnea Syndrome|obstructive sleep apnea/hypopnea syndrome
396774|NCT01256307|Exercise training program|exercise training program
396775|NCT01256307|Inflammation|inflammation
396776|NCT01256307|Oxidative Stress|oxidative stress
396777|NCT01256307|Insulin resistance|insulin resistance
396778|NCT01256294|Renal transplant|renal transplant
396779|NCT01256294|kidney transplant|kidney transplant
396780|NCT01256294|immunosuppressive therapy|immunosuppressive therapy
396781|NCT01256294|anti-rejection medication|anti-rejection medication
397090|NCT01254994|hepatitis B|hepatitis b
396785|NCT01256281|Pain|pain
396786|NCT01256281|Vasoocclusion|vasoocclusion
396787|NCT01256281|Nerve Block|nerve block
484061|NCT00112307|MRI|mri
396788|NCT01256281|Regional Anesthesia|regional anesthesia
396792|NCT01256255|transplant|transplant
396793|NCT01256255|influenza infection|influenza infection
396794|NCT01256242|tendon|tendon
396795|NCT01256242|shoulder|shoulder
396796|NCT01256242|rotator cuff|rotator cuff
396797|NCT01256242|Glenohumeral|glenohumeral
396798|NCT01256229|deafness|deafness
396799|NCT01256229|hearing loss|hearing loss
396800|NCT01256229|developmental delay|developmental delay
396801|NCT01256229|mental retardation|mental retardation
396802|NCT01256216|Arthritis|arthritis
396803|NCT01256216|Osteoarthritis|osteoarthritis
396804|NCT01256216|Arthroplasty|arthroplasty
396806|NCT01256203|Porfimer sodium|porfimer sodium
396807|NCT01256203|Phototoxicity|phototoxicity
396808|NCT01256203|Sunscreen|sunscreen
396809|NCT01256177|Bipolar Depression|bipolar depression
396810|NCT01256177|Mental disease,|mental disease,
396811|NCT01256164|fibrin sealants|fibrin sealants
396812|NCT01256164|hemostatics|hemostatics
396813|NCT01256164|time to hemostasis|time to hemostasis
396814|NCT01256151|Bioequivalence|bioequivalence
396815|NCT01256151|sublingual|sublingual
396816|NCT01256151|alprazolam|alprazolam
396817|NCT01256151|pharmacokinetics|pharmacokinetics
396818|NCT01256138|Allogene MSCs|allogene mscs
396819|NCT01256138|transplantation|transplantation
396820|NCT01256138|chronic liver diseases|chronic liver diseases
396821|NCT01256138|portal vein|portal vein
396822|NCT01256125|allogene MSCs|allogene mscs
396823|NCT01256125|transplantation|transplantation
396824|NCT01256125|chronic liver diseases|chronic liver diseases
396825|NCT01256125|peripheral vein|peripheral vein
396826|NCT01256112|obesity|obesity
396827|NCT01256112|behavioral intervention|behavioral intervention
396828|NCT01256112|family based|family based
396829|NCT01256112|weight loss|weight loss
396830|NCT01256099|Self-help treatment|self-help treatment
396831|NCT01256099|Internet treatment|internet treatment
396832|NCT01256099|CBT|cbt
396833|NCT01256099|Prevention|prevention
396834|NCT01256099|Comorbidity|comorbidity
396835|NCT01256060|Autism Spectrum disorder|autism spectrum disorder
396836|NCT01256060|Oxytocin|oxytocin
396837|NCT01256060|Clinical Trial|clinical trial
396838|NCT01256060|Children|children
396839|NCT01256060|Pharmacology|pharmacology
396840|NCT01256047|immunonutrition|immunonutrition
396841|NCT01256047|hepatectomy|hepatectomy
396842|NCT01256047|Th1|th1
396843|NCT01256047|Th2|th2
396844|NCT01256034|immunonutrition|immunonutrition
396845|NCT01256034|pancreaticoduodenectomy|pancreaticoduodenectomy
396846|NCT01256034|Th1|th1
396847|NCT01256034|Th2|th2
396848|NCT01256008|Breast Cancer|breast cancer
396849|NCT01256008|Depression|depression
396850|NCT01256008|Anxiety|anxiety
396851|NCT01256008|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
396852|NCT01255995|PXF|pxf
396853|NCT01255982|Bipolar depression|bipolar depression
396854|NCT01255982|subsyndromal symptoms|subsyndromal symptoms
396855|NCT01255982|functioning|functioning
396856|NCT01255982|cognitive function|cognitive function
396857|NCT01255969|Dialysis|dialysis
396858|NCT01255969|Physical exercise|physical exercise
396859|NCT01255969|Clinical Trial|clinical trial
396860|NCT01255969|Quality of Life|quality of life
396861|NCT01255969|Performance|performance
396862|NCT01255969|Fitness|fitness
396863|NCT01255969|Cardiovascular Mortality|cardiovascular mortality
396864|NCT01255969|Vascular access|vascular access
396865|NCT01255956|restenosis|restenosis
396866|NCT01255956|ISR|isr
396867|NCT01255956|in-stent restenosis|in-stent restenosis
396868|NCT01255956|drug eluting stent|drug eluting stent
396869|NCT01255956|rapamycin eluting stent|rapamycin eluting stent
396870|NCT01255956|paclitaxel eluting balloon catheter|paclitaxel eluting balloon catheter
396871|NCT01255943|MRSA|mrsa
396872|NCT01255943|bloodstream infections|bloodstream infections
396873|NCT01255943|hemodialysis|hemodialysis
396874|NCT01255930|Pregnant Women|pregnant women
396875|NCT01255930|Sonographic Textures|sonographic textures
396876|NCT01255917|Tio identify role of NGF in pain in CP|tio identify role of ngf in pain in cp
396877|NCT01255917|Identify biomarkers related to progression of CP|identify biomarkers related to progression of cp
396878|NCT01255891|high risk localized adenocarcinoma of the prostate|high risk localized adenocarcinoma of the prostate
396879|NCT01255878|Sleep bruxism|sleep bruxism
396880|NCT01255878|Gabapentine|gabapentine
396881|NCT01255878|Occlusal splint|occlusal splint
396882|NCT01255878|Polysomnography|polysomnography
396883|NCT01255865|Thermometry|thermometry
396884|NCT01255865|Deep Tissue Temperature|deep tissue temperature
396885|NCT01255865|Core Temperature|core temperature
396886|NCT01255865|Body Temperature|body temperature
396887|NCT01255865|Rectal Temperature|rectal temperature
396894|NCT01255839|prostaglandin|prostaglandin
396895|NCT01255839|minprostin|minprostin
396896|NCT01255839|induction of labour|induction of labour
396897|NCT01255839|fetal outcome|fetal outcome
396905|NCT01255813|Chronic Cluster Headache|chronic cluster headache
396906|NCT01255787|Major Depressive Disorder|major depressive disorder
396907|NCT01255787|Depression|depression
396908|NCT01255787|Melancholia|melancholia
396909|NCT01255787|Drug Therapy|drug therapy
396910|NCT01255774|subfoveal CNV|subfoveal cnv
396911|NCT01255774|Wet (Exudative) AMD|wet (exudative) amd
396912|NCT01255774|macular degeneration|macular degeneration
396913|NCT01255761|Certolizumab Pegol|certolizumab pegol
396914|NCT01255761|Cimzia|cimzia
396915|NCT01255761|Rheumatoid Arthritis|rheumatoid arthritis
396916|NCT01255761|CDAI|cdai
396917|NCT01255761|RAPID3|rapid3
396918|NCT01255748|cancer, proton, radiation|cancer, proton, radiation
396919|NCT01255735|pediatrics|pediatrics
396920|NCT01255735|voice|voice
396921|NCT01255735|voice therapy|voice therapy
396922|NCT01255735|vocal therapy|vocal therapy
396923|NCT01255735|hoarseness|hoarseness
396924|NCT01255722|iodinated contrast media, coronary artery disease|iodinated contrast media, coronary artery disease
396925|NCT01255709|Asthma|asthma
396926|NCT01255709|shortness of breath|shortness of breath
396927|NCT01255709|wheezing|wheezing
396928|NCT01255696|Celiac Disease|celiac disease
396929|NCT01255696|Coeliac Disease|coeliac disease
396930|NCT01255696|Celiac Sprue|celiac sprue
396931|NCT01255696|Keliakia Disease|keliakia disease
396932|NCT01255683|Chronic|chronic
396933|NCT01255683|Sinusitis|sinusitis
396934|NCT01255683|Steroid|steroid
396935|NCT01255683|treatment|treatment
396936|NCT01255670|Peritonsillar Abscess|peritonsillar abscess
396937|NCT01255670|Quinsy|quinsy
396938|NCT01255670|Penicillin|penicillin
396939|NCT01255670|Metronidazole|metronidazole
396940|NCT01255670|Recurrence|recurrence
396941|NCT01255605|Intermittent preventive treatment with sulfadoxin-pyrimethamine|intermittent preventive treatment with sulfadoxin-pyrimethamine
396942|NCT01255605|in Bobo-Dioulasso peri-urban areas, 5 years after its implementation|in bobo-dioulasso peri-urban areas, 5 years after its implementation
396943|NCT01255605|Burkina Faso.|burkina faso.
396944|NCT01255592|Bronchiectasis|bronchiectasis
396945|NCT01255592|Neutrophil|neutrophil
396946|NCT01255592|Respiratory disease|respiratory disease
396947|NCT01255592|Sputum|sputum
396948|NCT01255579|asthma|asthma
396949|NCT01255579|small airways|small airways
396950|NCT01255579|inhaled corticosteroids|inhaled corticosteroids
396951|NCT01255540|Coronary heart disease in patients over|coronary heart disease in patients over
396952|NCT01255540|80 years of age.|80 years of age.
396953|NCT01255488|Search engine|search engine
396954|NCT01255488|Clinical decision-making|clinical decision-making
396955|NCT01255488|Research abstracts|research abstracts
396956|NCT01255488|Full-text manuscripts|full-text manuscripts
396957|NCT01255488|Family Nurse Practitioners|family nurse practitioners
396958|NCT01255462|AMD,|amd,
396959|NCT01255462|ARMD,|armd,
396960|NCT01255462|Age-related Macular Degeneration,|age-related macular degeneration,
396961|NCT01255462|Eye Disease,|eye disease,
396962|NCT01255462|Wet AMD,|wet amd,
396963|NCT01255462|Neovascular AMD,|neovascular amd,
396964|NCT01255462|Choroidal Neovascular Membrane,|choroidal neovascular membrane,
396965|NCT01255462|Choroidal Neovascularization,|choroidal neovascularization,
396966|NCT01255462|Drusen,|drusen,
396967|NCT01255462|Geographic Atrophy,|geographic atrophy,
396968|NCT01255462|Complement,|complement,
396969|NCT01255462|C5,|c5,
396970|NCT01255462|Antibody|antibody
396971|NCT01255449|Forced oscillation technique|forced oscillation technique
396972|NCT01255449|Respiratory input impedance|respiratory input impedance
396973|NCT01255449|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
396974|NCT01255449|Obliterative bronchiolitis|obliterative bronchiolitis
396975|NCT01255423|Ankle sprain, soft tissue injury|ankle sprain, soft tissue injury
396976|NCT01255397|male infertility|male infertility
396977|NCT01255397|natural cycle IVF|natural cycle ivf
396978|NCT01255397|in-vitro fertilization|in-vitro fertilization
396979|NCT01255397|intrauterine inseminatio|intrauterine inseminatio
396980|NCT01255371|HIV|hiv
396981|NCT01255371|Second line antiretroviral treatment|second line antiretroviral treatment
396982|NCT01255371|Sub saharian Africa|sub saharian africa
396983|NCT01255371|Generic|generic
396984|NCT01255358|Ataxia Teleangiectasia|ataxia teleangiectasia
396985|NCT01255358|AT|at
396986|NCT01255358|Ery-Dex|ery-dex
396987|NCT01255358|Dexamethasone|dexamethasone
396988|NCT01255358|Dexamethasone sodium phosphate|dexamethasone sodium phosphate
396989|NCT01255345|Physiotherapy|physiotherapy
396990|NCT01255345|Multidisciplinary Pain Centers|multidisciplinary pain centers
396991|NCT01255345|Pain measurements|pain measurements
396992|NCT01255345|Physical activity|physical activity
396993|NCT01255345|Quality of life|quality of life
396994|NCT01255332|ITP|itp
396995|NCT01255319|MDS|mds
396996|NCT01255306|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
396997|NCT01255306|Pars plana vitrectomy|pars plana vitrectomy
396998|NCT01255306|Silicone oil|silicone oil
396999|NCT01255306|Retinal nerve fibre layer|retinal nerve fibre layer
397000|NCT01255293|Retinal detachment|retinal detachment
397001|NCT01255293|Proliferative vitreoretinopathy|proliferative vitreoretinopathy
397002|NCT01255293|Diabetic retinopathy|diabetic retinopathy
397003|NCT01255293|Vitrectomy|vitrectomy
397004|NCT01255293|Silicone oil|silicone oil
397005|NCT01255280|Crystal methamphetamine abuse|crystal methamphetamine abuse
397006|NCT01255280|Crystal methamphetamine dependence|crystal methamphetamine dependence
397007|NCT01255280|Sexual risk behavior|sexual risk behavior
397008|NCT01255280|Men who have sex with men (MSM)|men who have sex with men (msm)
397009|NCT01255280|Behavioral activation|behavioral activation
397010|NCT01255267|Acute coronary syndrome and chronic coronary artery disease patients|acute coronary syndrome and chronic coronary artery disease patients
397011|NCT01255254|he effect of gingival scaling on Metabolic control|he effect of gingival scaling on metabolic control
397012|NCT01255241|Lower Limbs Deformities|lower limbs deformities
397013|NCT01255241|kinetics|kinetics
397014|NCT01255241|kinematics|kinematics
397015|NCT01255241|gait|gait
397016|NCT01255241|energy expenditure|energy expenditure
397017|NCT01255228|obesity|obesity
397018|NCT01255228|body composition|body composition
397019|NCT01255228|adipocyte-derived cytokine|adipocyte-derived cytokine
397020|NCT01255228|low glycemic index|low glycemic index
397021|NCT01255215|malaria|malaria
397022|NCT01255215|children|children
397023|NCT01255202|preeclampsia|preeclampsia
397024|NCT01255202|toxemia|toxemia
397025|NCT01255202|twin|twin
397026|NCT01255202|pregnancy|pregnancy
397027|NCT01255202|pp13|pp13
397028|NCT01255202|prediction|prediction
397029|NCT01255202|kongo red|kongo red
397030|NCT01255189|NIRS|nirs
397031|NCT01255176|Infant|infant
397032|NCT01255176|Physical Therapy|physical therapy
397033|NCT01255163|Alzheimer's|alzheimer's
397034|NCT01255163|Memory|memory
397035|NCT01255163|Diabetes|diabetes
397036|NCT01255163|Placebo|placebo
397037|NCT01255163|Alzheimer Disease|alzheimer disease
397038|NCT01255150|Genetic Ancestry Analysis|genetic ancestry analysis
397039|NCT01255150|Molecular Profiling|molecular profiling
397040|NCT01255150|Smoking Status|smoking status
397041|NCT01255150|Wood Smoke Exposure|wood smoke exposure
397042|NCT01255150|EGFR Mutation Analysis|egfr mutation analysis
397043|NCT01255150|Non Small Cell Lung Cancer|non small cell lung cancer
397044|NCT01255137|Selective VEGF Inhibitor|selective vegf inhibitor
397045|NCT01255137|Clinical Activity|clinical activity
397046|NCT01255137|Response Rate|response rate
397047|NCT01255137|Measurable Disease|measurable disease
397048|NCT01255137|Biological Markers|biological markers
397049|NCT01255137|Adrenocortical Cancer|adrenocortical cancer
397050|NCT01255111|Chronic respiratory failure|chronic respiratory failure
397051|NCT01255111|Noninvasive ventilation|noninvasive ventilation
397052|NCT01255111|Patient-ventilator interactions|patient-ventilator interactions
397053|NCT01255111|Sleep|sleep
397054|NCT01255111|Sleep fragmentation|sleep fragmentation
397055|NCT01255085|Obesity|obesity
397056|NCT01255085|Food intake regulation|food intake regulation
397057|NCT01255085|blood glucose regulation|blood glucose regulation
397058|NCT01255085|protein|protein
397059|NCT01255085|fiber|fiber
397060|NCT01255085|pulses|pulses
397061|NCT01255085|yellow peas|yellow peas
397062|NCT01255072|TMS|tms
397063|NCT01255072|elderly|elderly
397064|NCT01255072|depression|depression
397065|NCT01255072|neuronavegation|neuronavegation
397066|NCT01255072|neurocognition|neurocognition
397067|NCT01255059|Genome-wide association studies(GWAS)|genome-wide association studies(gwas)
397068|NCT01255059|Single nucleotide polymorphism(SNP)|single nucleotide polymorphism(snp)
397069|NCT01255059|Lung cancer|lung cancer
397070|NCT01255033|perioperative surgery|perioperative surgery
397071|NCT01255033|regional oxygenation|regional oxygenation
397072|NCT01255033|hypoxemia|hypoxemia
397073|NCT01255033|brain hypoxemia|brain hypoxemia
397074|NCT01255033|spectroscopy, near-infrared|spectroscopy, near-infrared
397075|NCT01255020|α-Keto Acid|α-keto acid
397076|NCT01255020|Restricted Protein Diet|restricted protein diet
397077|NCT01255020|Residual Renal Function|residual renal function
397078|NCT01255007|Colorectal|colorectal
397079|NCT01255007|liver|liver
397080|NCT01255007|metastases|metastases
397081|NCT01255007|Primovist|primovist
397082|NCT01255007|MRI|mri
397083|NCT01255007|CT|ct
397084|NCT01255007|cancer|cancer
397085|NCT01255007|resection|resection
397086|NCT01255007|MDCT|mdct
397087|NCT01255007|Diffusion|diffusion
397091|NCT01254994|acute on chronic liver failure (ACHBLF)|acute on chronic liver failure (achblf)
397092|NCT01254994|entecavir|entecavir
397093|NCT01254994|treatment|treatment
397094|NCT01254994|predicting|predicting
397095|NCT01254981|Percutaneous coronary intervention|percutaneous coronary intervention
397096|NCT01254981|DES|des
397097|NCT01254981|Angina pectoris|angina pectoris
397098|NCT01254981|Stent|stent
397099|NCT01254968|blood flow in the middle cerebral artery of brain|blood flow in the middle cerebral artery of brain
397100|NCT01254955|2009 H1N1 influenza vaccine, organ transplant patients|2009 h1n1 influenza vaccine, organ transplant patients
397101|NCT01254942|exercise|exercise
397102|NCT01254942|hip fractures|hip fractures
397103|NCT01254942|rehabilitation|rehabilitation
397104|NCT01254942|aged|aged
397105|NCT01254942|aged 80 and over|aged 80 and over
397106|NCT01254929|Cancer|cancer
387845|NCT01294670|10-096|10-096
397107|NCT01254929|Bone metastases|bone metastases
397108|NCT01254916|Chronic Rhinosinusitis|chronic rhinosinusitis
397109|NCT01254916|Sinonasal Outcome test 22|sinonasal outcome test 22
397110|NCT01254903|Stereotactic Radiosurgery|stereotactic radiosurgery
397111|NCT01254903|Radiation|radiation
397112|NCT01254903|Radiotherapy|radiotherapy
397113|NCT01254903|Metastatic Epidural Spinal Cord Compression|metastatic epidural spinal cord compression
397114|NCT01254903|MESCC|mescc
397115|NCT01254890|Relapsed Acute Leukemia|relapsed acute leukemia
397116|NCT01254890|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
397117|NCT01254890|CMML|cmml
397118|NCT01254890|Myelodysplastic Syndrome|myelodysplastic syndrome
397119|NCT01254890|MDS|mds
397120|NCT01254890|Acute myeloid leukemia|acute myeloid leukemia
397121|NCT01254890|AML|aml
397122|NCT01254890|5-azacitidine|5-azacitidine
397123|NCT01254890|Azacitidine|azacitidine
397124|NCT01254890|5-aza|5-aza
397125|NCT01254890|Vidaza|vidaza
397126|NCT01254890|5-AZC|5-azc
397127|NCT01254890|AZA-CR|aza-cr
397128|NCT01254890|Ladakamycin|ladakamycin
397129|NCT01254890|NSC-102816|nsc-102816
397130|NCT01254890|Sorafenib|sorafenib
397131|NCT01254890|Nexavar|nexavar
397132|NCT01254890|BAY43-9006|bay43-9006
397133|NCT01254877|HIV|hiv
397134|NCT01254864|Castrate resistant prostate cancer|castrate resistant prostate cancer
397135|NCT01254864|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
397136|NCT01254864|Sunitinib Malate|sunitinib malate
397137|NCT01254864|SUO11248|suo11248
397138|NCT01254864|Sutent|sutent
397139|NCT01254864|BMS-354825|bms-354825
397140|NCT01254864|Sprycel|sprycel
397141|NCT01254851|discharge criteria, gynecologic surgery, post-op ambulation|discharge criteria, gynecologic surgery, post-op ambulation
397142|NCT01254825|Adductor Canal Block (ACB)|adductor canal block (acb)
397143|NCT01254825|Diagnostic Knee Arthroscopy|diagnostic knee arthroscopy
397144|NCT01254825|Saphenous nerve|saphenous nerve
397145|NCT01254825|Pain|pain
397146|NCT01254825|Ultrasound block|ultrasound block
397147|NCT01254812|pulmonary function|pulmonary function
397148|NCT01254812|BD-TAP-block|bd-tap-block
397149|NCT01254786|VATS|vats
397150|NCT01254786|one lung ventilation|one lung ventilation
397434|NCT01253421|MDD|mdd
397151|NCT01254786|continuous positive pressure ventilation|continuous positive pressure ventilation
397152|NCT01254786|high frequency positive pressure ventilation|high frequency positive pressure ventilation
397153|NCT01254721|Acute bipolar mania|acute bipolar mania
397154|NCT01254721|Seroquel XR|seroquel xr
397155|NCT01254721|Seroquel XR plus lithium|seroquel xr plus lithium
397156|NCT01254721|Quetiapine fumarate|quetiapine fumarate
397157|NCT01254695|Idiopathic Fecal Incontinence|idiopathic fecal incontinence
397158|NCT01254695|Fecal Incontinence|fecal incontinence
397159|NCT01254695|Sacral Nerve Stimulation|sacral nerve stimulation
397160|NCT01254695|Sacral Nerve Neuromodulation|sacral nerve neuromodulation
397161|NCT01254682|wrist|wrist
397162|NCT01254682|joint|joint
397163|NCT01254682|arthroscopy|arthroscopy
397164|NCT01254682|hyaluronan|hyaluronan
397165|NCT01254682|hyaluronic acid|hyaluronic acid
397166|NCT01254682|Necessity of Arthroscopic surgery|necessity of arthroscopic surgery
8111|NCT03238794|bile acid|bile acid
397169|NCT01254669|cognitive behavioral intervention|cognitive behavioral intervention
397170|NCT01254669|HPV vaccine|hpv vaccine
397171|NCT01254669|cervical cancer|cervical cancer
397172|NCT01254643|Papillomavirus vaccines|papillomavirus vaccines
397173|NCT01254643|Uterine cervical cancer|uterine cervical cancer
397174|NCT01254643|Human Papilloma Virus infections|human papilloma virus infections
397175|NCT01254630|Herpes zoster|herpes zoster
397176|NCT01254630|vaccine|vaccine
397177|NCT01254630|solid tumor malignancy|solid tumor malignancy
397178|NCT01254630|hematologic malignancy|hematologic malignancy
397179|NCT01254630|immunocompromised|immunocompromised
397180|NCT01254630|herpes-zoster-related complications|herpes-zoster-related complications
397181|NCT01254604|Tafluprost|tafluprost
397182|NCT01254604|Glaucoma|glaucoma
397183|NCT01254604|Ocular Hypertension|ocular hypertension
397184|NCT01254604|Timolol|timolol
397185|NCT01254604|Eye Disorder|eye disorder
397186|NCT01254604|Preservative-Free|preservative-free
397187|NCT01254604|Prostaglandin Analogue|prostaglandin analogue
397188|NCT01254591|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
397189|NCT01254591|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
397190|NCT01254591|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
397191|NCT01254591|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
397192|NCT01254591|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
397193|NCT01254591|stage I colon cancer|stage i colon cancer
397194|NCT01254591|stage IIA colon cancer|stage iia colon cancer
397195|NCT01254591|stage IIB colon cancer|stage iib colon cancer
397196|NCT01254591|stage IIC colon cancer|stage iic colon cancer
397197|NCT01254591|stage IIIA colon cancer|stage iiia colon cancer
397198|NCT01254591|stage I rectal cancer|stage i rectal cancer
397199|NCT01254591|stage IIA rectal cancer|stage iia rectal cancer
397200|NCT01254591|stage IIB rectal cancer|stage iib rectal cancer
397201|NCT01254591|stage IIC rectal cancer|stage iic rectal cancer
397202|NCT01254591|stage IIIA rectal cancer|stage iiia rectal cancer
397203|NCT01254591|stage IA breast cancer|stage ia breast cancer
397204|NCT01254591|stage IB breast cancer|stage ib breast cancer
397205|NCT01254591|stage II breast cancer|stage ii breast cancer
397206|NCT01254591|stage IIIA breast cancer|stage iiia breast cancer
397207|NCT01254591|stage IIIB breast cancer|stage iiib breast cancer
397208|NCT01254591|stage I esophageal cancer|stage i esophageal cancer
397209|NCT01254591|stage II esophageal cancer|stage ii esophageal cancer
397210|NCT01254591|stage III esophageal cancer|stage iii esophageal cancer
397211|NCT01254591|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
397212|NCT01254591|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
397213|NCT01254591|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
397214|NCT01254591|stage I laryngeal cancer|stage i laryngeal cancer
397215|NCT01254591|stage II laryngeal cancer|stage ii laryngeal cancer
397216|NCT01254591|stage III laryngeal cancer|stage iii laryngeal cancer
397217|NCT01254591|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
402074|NCT01233258|Haemophilia treatment|haemophilia treatment
397218|NCT01254591|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
397219|NCT01254591|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
397220|NCT01254591|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
397221|NCT01254591|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
397222|NCT01254591|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
397223|NCT01254591|stage I oropharyngeal cancer|stage i oropharyngeal cancer
397224|NCT01254591|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
397225|NCT01254591|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
397226|NCT01254591|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
397227|NCT01254591|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
397228|NCT01254591|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
397229|NCT01254591|stage I salivary gland cancer|stage i salivary gland cancer
397230|NCT01254591|stage II salivary gland cancer|stage ii salivary gland cancer
397231|NCT01254591|stage III salivary gland cancer|stage iii salivary gland cancer
397232|NCT01254591|tongue cancer|tongue cancer
397233|NCT01254565|Clinical Trial, Phase 2|clinical trial, phase 2
397234|NCT01254565|Renal Dialysis|renal dialysis
397235|NCT01254565|Secondary Hyperparathyroidism|secondary hyperparathyroidism
397236|NCT01254565|Parathyroid hormone|parathyroid hormone
397237|NCT01254539|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
397238|NCT01254539|Bone marrow|bone marrow
397239|NCT01254539|Stem cells|stem cells
397240|NCT01254539|Autologous|autologous
397241|NCT01254539|Safety|safety
397242|NCT01254513|Metastatic Prostate cancer|metastatic prostate cancer
397243|NCT01254513|Elderly patients|elderly patients
397244|NCT01254513|Vulnerable and Frail (SIOG classification)|vulnerable and frail (siog classification)
8112|NCT03238794|weight loss|weight loss
397250|NCT01254474|Action potentials, monophasic|action potentials, monophasic
397251|NCT01254474|Mapping, Catheter|mapping, catheter
397252|NCT01254474|Cardiac activation|cardiac activation
397253|NCT01254461|Phase 1|phase 1
397254|NCT01254461|Drug-Drug interaction|drug-drug interaction
397255|NCT01254461|pravastatin|pravastatin
397256|NCT01254461|AZD1981|azd1981
397257|NCT01254461|The pharmacokinetics resulting from AZD1981 and pravastatin interaction|the pharmacokinetics resulting from azd1981 and pravastatin interaction
397258|NCT01254461|The effects of taking a combination of AZD1981 and pravastatin|the effects of taking a combination of azd1981 and pravastatin
397259|NCT01254448|Alzheimer's Disease|alzheimer's disease
397260|NCT01254435|Colonoscopy|colonoscopy
397261|NCT01254435|Positioning in colonoscopy|positioning in colonoscopy
397262|NCT01254435|Quality control|quality control
397263|NCT01254422|Dengue fever|dengue fever
397264|NCT01254422|Dengue hemorrhagic fever|dengue hemorrhagic fever
397265|NCT01254422|CYD dengue vaccine|cyd dengue vaccine
397266|NCT01254409|pulmonary, fibrosis|pulmonary, fibrosis
397267|NCT01254396|Bioavailability Food Effect Oral Dissolving Tablet (ODT)|bioavailability food effect oral dissolving tablet (odt)
397268|NCT01254383|Bioequivalence Oral Dissolving Tablet|bioequivalence oral dissolving tablet
397270|NCT01254357|Trauma|trauma
397271|NCT01254357|Outcomes|outcomes
397272|NCT01254357|Quality of Life|quality of life
397273|NCT01254344|Colorectal surgery|colorectal surgery
397274|NCT01254318|hematological malignancy|hematological malignancy
397275|NCT01254318|fungal infection|fungal infection
397276|NCT01254318|leukemia|leukemia
397277|NCT01254305|Depression|depression
397278|NCT01254305|Fatigue|fatigue
397279|NCT01254305|Major Depressive Disorder|major depressive disorder
397280|NCT01254266|morbid obesity|morbid obesity
397281|NCT01254266|adolescents|adolescents
397282|NCT01254266|inpatient treatment|inpatient treatment
397283|NCT01254253|percutaneous coronary intervention|percutaneous coronary intervention
397284|NCT01254253|chronic total occlusion|chronic total occlusion
397285|NCT01254253|coronary angiography|coronary angiography
397286|NCT01254253|single photon emission CT|single photon emission ct
397287|NCT01254253|Multislice coronary CT angiography|multislice coronary ct angiography
397288|NCT01254227|Cardiac iron overload,|cardiac iron overload,
397289|NCT01254227|deferasirox,|deferasirox,
397290|NCT01254227|deferoxamine|deferoxamine
397291|NCT01254214|Mindfulness|mindfulness
397292|NCT01254214|Quality of life|quality of life
397293|NCT01254214|Transplantation|transplantation
397294|NCT01254214|Renal disease|renal disease
397295|NCT01254188|Chronic myeloid leukemia,|chronic myeloid leukemia,
397296|NCT01254188|CML,|cml,
397297|NCT01254188|nilotinib,|nilotinib,
397298|NCT01254188|myelogenous,|myelogenous,
397299|NCT01254188|Philadelphia chromosome|philadelphia chromosome
397300|NCT01254162|Oily Skin|oily skin
397301|NCT01254162|Sebum|sebum
397302|NCT01254123|Glucagon Like Peptide-1|glucagon like peptide-1
397303|NCT01254123|Exenatide|exenatide
397304|NCT01254123|myocardial infarction|myocardial infarction
397305|NCT01254123|MRI|mri
397306|NCT01254123|PCI|pci
397307|NCT01254084|Herbal medicine; Type 2 diabetes; Gynostemma pentaphyllum Tea; Insulin sensitivity;|herbal medicine; type 2 diabetes; gynostemma pentaphyllum tea; insulin sensitivity;
397308|NCT01254071|GI198745|gi198745
397309|NCT01254071|Tamsulosin hydrochloride|tamsulosin hydrochloride
397310|NCT01254071|Dutasteride|dutasteride
397311|NCT01254071|food effect|food effect
397312|NCT01254071|healthy male subjects|healthy male subjects
397313|NCT01254071|north-east Asian ancestry|north-east asian ancestry
397314|NCT01254071|Bioequivalence|bioequivalence
397315|NCT01254071|cross-over design|cross-over design
397316|NCT01254071|Pilot bioequivalence|pilot bioequivalence
397317|NCT01254032|CAT|cat
397318|NCT01254032|COPD|copd
397319|NCT01254019|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
397320|NCT01254019|DMD|dmd
397321|NCT01254019|968|968
397322|NCT01254019|GSK|gsk
397323|NCT01254019|Duchenne|duchenne
397324|NCT01253993|Disruptive Behavior Disorders, Substance abuse,|disruptive behavior disorders, substance abuse,
397325|NCT01253993|Iowa Gambling Task, Decision Making.|iowa gambling task, decision making.
397326|NCT01253980|pneumonitis|pneumonitis
397327|NCT01253980|paraffin|paraffin
397328|NCT01253980|kerosene|kerosene
397329|NCT01253967|Gastroenteritis|gastroenteritis
397330|NCT01253967|Hospital surveillance|hospital surveillance
397331|NCT01253967|Rotavirus gastroenteritis|rotavirus gastroenteritis
397332|NCT01253954|invasive candida infection|invasive candida infection
8601|NCT03235635|microbiome|microbiome
8602|NCT03235635|preterm|preterm
397333|NCT01253941|COPD, Intensive Resistive Breathing, Cytokine IL6,|copd, intensive resistive breathing, cytokine il6,
397334|NCT01253928|body composition|body composition
397335|NCT01253928|insulin sensitivity|insulin sensitivity
397336|NCT01253928|protein metabolism|protein metabolism
397337|NCT01253928|pioglitazone|pioglitazone
397338|NCT01253889|Functional echocardiography|functional echocardiography
397339|NCT01253889|oral glucose|oral glucose
397340|NCT01253889|neonatal stress|neonatal stress
397341|NCT01253863|Clinical Examination, Accuracy, Hand, Tendon, Injury.|clinical examination, accuracy, hand, tendon, injury.
397342|NCT01253850|hiv|hiv
397343|NCT01253850|antiretroviral|antiretroviral
397344|NCT01253850|adherence|adherence
397345|NCT01253850|adolescent|adolescent
397346|NCT01253837|L19|l19
397347|NCT01253837|antibody|antibody
397348|NCT01253837|monoclonal|monoclonal
397349|NCT01253837|tumor targeting|tumor targeting
397350|NCT01253837|TNFa|tnfa
397351|NCT01253837|colorectal cancer|colorectal cancer
397352|NCT01253837|Phase I: Patients with relapsed or refractory locally advanced or metastatic solid tumors not amenable to standard systemic therapy.|phase i: patients with relapsed or refractory locally advanced or metastatic solid tumors not amenable to standard systemic therapy.
397353|NCT01253837|Phase II: Patients with relapsed or refractory locally advanced or metastatic colorectal cancer not amenable to standard systemic therapy.|phase ii: patients with relapsed or refractory locally advanced or metastatic colorectal cancer not amenable to standard systemic therapy.
397354|NCT01253824|NPC-01|npc-01
397355|NCT01253824|IKH-01|ikh-01
397356|NCT01253824|Pharmacodynamics|pharmacodynamics
397357|NCT01253824|Norethisterone|norethisterone
397358|NCT01253824|Ethinyl Estradiol|ethinyl estradiol
397359|NCT01253824|Estradiol|estradiol
397360|NCT01253824|Progesterone|progesterone
397361|NCT01253824|FSH|fsh
397362|NCT01253824|LH|lh
397363|NCT01253798|exercise|exercise
397364|NCT01253798|hydrotherapy|hydrotherapy
397365|NCT01253759|Transpupillary thermotherapy|transpupillary thermotherapy
397366|NCT01253759|Choroidal melanoma|choroidal melanoma
397367|NCT01253759|ICG-Photodynamic therapy|icg-photodynamic therapy
397368|NCT01253746|NTD|ntd
397369|NCT01253746|open NTD|open ntd
397370|NCT01253746|spina bifida|spina bifida
397371|NCT01253746|anencephaly|anencephaly
397372|NCT01253746|closed NTD|closed ntd
397373|NCT01253746|lipomeningocele|lipomeningocele
397374|NCT01253746|tethered cord.|tethered cord.
397375|NCT01253733|Cystic Fibrosis|cystic fibrosis
397376|NCT01253733|Inflammatory Bowel Disease|inflammatory bowel disease
397377|NCT01253733|Type 1 Diabetes|type 1 diabetes
397378|NCT01253733|Chronic Disease Management|chronic disease management
397380|NCT01253733|Text messages|text messages
397381|NCT01253733|Internet|internet
397382|NCT01253733|Healthcare Interactions|healthcare interactions
397383|NCT01253720|obesity|obesity
397384|NCT01253720|text messages|text messages
397385|NCT01253720|internet|internet
397386|NCT01253720|cancer|cancer
397387|NCT01253720|overweight|overweight
397388|NCT01253707|Solid Tumors|solid tumors
397389|NCT01253707|C-met inhibitor|c-met inhibitor
397390|NCT01253694|Diabetes|diabetes
397391|NCT01253694|edema|edema
397392|NCT01253694|ranibizumab|ranibizumab
397393|NCT01253694|bevacizumab|bevacizumab
397394|NCT01253694|refractory|refractory
397395|NCT01253681|AMG 386|amg 386
397396|NCT01253681|Ovarian Cancer|ovarian cancer
397397|NCT01253655|Healthy Volunteers|healthy volunteers
397398|NCT01253629|Fragile X Syndrome|fragile x syndrome
397399|NCT01253629|Martin-Bell Syndrome|martin-bell syndrome
397400|NCT01253629|Genetic Diseases|genetic diseases
397401|NCT01253629|X-Linked|x-linked
397402|NCT01253603|Asthma|asthma
397403|NCT01253590|atrial fibrillation|atrial fibrillation
397404|NCT01253590|ECG monitor|ecg monitor
397405|NCT01253590|Blood pressure device|blood pressure device
397406|NCT01253590|Remote Cardiac Monitoring|remote cardiac monitoring
397407|NCT01253551|VX-950HEP1001|vx-950hep1001
397408|NCT01253551|hepatitis|hepatitis
397409|NCT01253551|telaprevir|telaprevir
397410|NCT01253551|raltegravir|raltegravir
397411|NCT01253551|crossover|crossover
397412|NCT01253551|healthy volunteers|healthy volunteers
397413|NCT01253551|VX-950.|vx-950.
397414|NCT01253538|Mother-to-Child Transmission of HIV|mother-to-child transmission of hiv
397415|NCT01253538|HAART|haart
397416|NCT01253525|Adenocarcinoma|adenocarcinoma
397417|NCT01253525|Gastroesophageal Junction|gastroesophageal junction
397418|NCT01253512|Ischemic Stroke|ischemic stroke
397419|NCT01253512|Thrombolysis|thrombolysis
397420|NCT01253486|expressive writing|expressive writing
397421|NCT01253486|cardiac rehabilitation|cardiac rehabilitation
397422|NCT01253473|COPD|copd
397423|NCT01253460|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
397424|NCT01253460|CLL|cll
397425|NCT01253460|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
397426|NCT01253460|SLL|sll
397427|NCT01253460|Cyclophosphamide|cyclophosphamide
397428|NCT01253460|Rituximab|rituximab
397429|NCT01253460|Sapacitabine|sapacitabine
397430|NCT01253460|Cytoxan|cytoxan
397431|NCT01253460|Neosar|neosar
397432|NCT01253460|Rituxan|rituxan
397433|NCT01253434|Transdermal Administration|transdermal administration
397435|NCT01253421|Major Depressive Disorder|major depressive disorder
397436|NCT01253421|Amisulpride|amisulpride
397437|NCT01253408|anandamide|anandamide
397438|NCT01253408|cannabinoid|cannabinoid
397439|NCT01253408|fatty acid amide hydrolase|fatty acid amide hydrolase
397440|NCT01253408|gastric|gastric
397441|NCT01253408|motility|motility
397442|NCT01253408|small bowel|small bowel
397443|NCT01253395|Exercise|exercise
397444|NCT01253395|Pain|pain
397445|NCT01253369|pazopanib|pazopanib
397446|NCT01253317|Rett Syndrome|rett syndrome
397447|NCT01253317|IGF-1|igf-1
397448|NCT01253317|Increlex|increlex
397449|NCT01253317|Mecasermin|mecasermin
397450|NCT01253317|IGF1|igf1
397451|NCT01253317|MECP2|mecp2
397452|NCT01253317|RTT|rtt
397453|NCT01253252|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
397454|NCT01253252|Prosthesis|prosthesis
397455|NCT01253252|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
397456|NCT01253252|Positron-emission Tomography|positron-emission tomography
397457|NCT01253252|Spiral computed tomography|spiral computed tomography
397458|NCT01253252|Biological markers|biological markers
397459|NCT01253239|Visual outcomes|visual outcomes
397460|NCT01253239|Patient satisfaction|patient satisfaction
397461|NCT01253213|Prostate cancer|prostate cancer
397462|NCT01253213|Ultrasound molecular imaging|ultrasound molecular imaging
397463|NCT01253213|Contrast agent|contrast agent
397464|NCT01253213|BR55|br55
397465|NCT01253213|VEGFR2|vegfr2
397466|NCT01253200|Type 1 Atrial Flutter|type 1 atrial flutter
397467|NCT01253200|Typical Atrial Flutter|typical atrial flutter
397468|NCT01253200|Arrhythmias, Cardiac|arrhythmias, cardiac
397469|NCT01253200|Heart Diseases|heart diseases
397470|NCT01253200|Cardiovascular Diseases|cardiovascular diseases
397471|NCT01253161|advanced|advanced
397472|NCT01253161|metastatic|metastatic
397473|NCT01253161|unresectable|unresectable
397474|NCT01253161|carcinoma|carcinoma
397475|NCT01253161|gastrointestinal tract|gastrointestinal tract
397476|NCT01253161|lungs|lungs
397477|NCT01253161|colon|colon
397478|NCT01253161|liver|liver
397479|NCT01253161|rectum|rectum
397480|NCT01253161|small intestine|small intestine
397481|NCT01253161|stomach|stomach
397482|NCT01253161|pancreatic|pancreatic
397483|NCT01253148|Liver|liver
397484|NCT01253148|Bile Duct|bile duct
397485|NCT01253135|Fibrin, white petrolatum, wound healing|fibrin, white petrolatum, wound healing
397486|NCT01253096|Interleukin|interleukin
397487|NCT01253096|IL2|il2
397488|NCT01253096|monoclonal|monoclonal
397489|NCT01253096|antibody|antibody
397490|NCT01253096|cytokine|cytokine
397491|NCT01253096|metastatic|metastatic
397492|NCT01253096|melanoma|melanoma
397493|NCT01253096|tumor targeting|tumor targeting
397494|NCT01253096|intratumoral|intratumoral
397495|NCT01253096|Malignant melanoma with presence of injectable soft-tissue metastases either in clinical stage III or stage IV without visceral metastases.|malignant melanoma with presence of injectable soft-tissue metastases either in clinical stage iii or stage iv without visceral metastases.
397496|NCT01253083|Mobility|mobility
397497|NCT01253083|Developmental Delay|developmental delay
397498|NCT01253083|Cerebral Palsy|cerebral palsy
397499|NCT01253083|Early Walking|early walking
397500|NCT01253083|Postural Control|postural control
397501|NCT01253057|cleaning staff|cleaning staff
397502|NCT01253057|antineoplastic agents|antineoplastic agents
397503|NCT01253044|OEF/OIF|oef/oif
397504|NCT01253044|Veterans|veterans
397505|NCT01253044|Psychotherapy|psychotherapy
402075|NCT01233258|rFVIII|rfviii
397506|NCT01253031|hearing loss|hearing loss
397507|NCT01253031|aging|aging
397508|NCT01253031|short term memory|short term memory
397509|NCT01253031|attentional blink|attentional blink
397510|NCT01253018|stroke|stroke
397511|NCT01253018|robotics|robotics
397512|NCT01253018|upper extremity rehabilitation|upper extremity rehabilitation
397513|NCT01252992|Extrapulmonary|extrapulmonary
397514|NCT01252992|Tuberculosis|tuberculosis
397515|NCT01252992|Paradoxical reaction|paradoxical reaction
397516|NCT01252992|Risk factors|risk factors
397517|NCT01252992|Incidence|incidence
397518|NCT01252992|CT scan|ct scan
397519|NCT01252992|Natural history|natural history
397520|NCT01252992|Immune system phenomena|immune system phenomena
397521|NCT01252992|Immune markers|immune markers
397522|NCT01252992|Gene Expression Profiling|gene expression profiling
397523|NCT01252979|MELAS|melas
397524|NCT01252979|Ketones|ketones
397525|NCT01252979|Medium Chain Triglycerides|medium chain triglycerides
397526|NCT01252979|MCT oil|mct oil
397527|NCT01252979|Mitochondrial Disorder|mitochondrial disorder
397528|NCT01252979|Heteroplasmy|heteroplasmy
397529|NCT01252979|3243AG|3243ag
397530|NCT01252979|Subject is informed and given ample opportunity to consider his/her participation and has given his/her written consent.|subject is informed and given ample opportunity to consider his/her participation and has given his/her written consent.
397531|NCT01252979|Subject is willing and able to comply with all trial requirements.|subject is willing and able to comply with all trial requirements.
8603|NCT03235635|newborn|newborn
8660|NCT03235427|CAD|cad
8890|NCT03234036|tablet|tablet
397637|NCT01252576|FSFI|fsfi
397532|NCT01252979|Subject harbors the 3243 A>G mtDNA mutation at a level detectable in blood.|subject harbors the 3243 a>g mtdna mutation at a level detectable in blood.
397533|NCT01252979|Female subjects of child-bearing potential must not be pregnant.|female subjects of child-bearing potential must not be pregnant.
397534|NCT01252979|Subjects must not have Diabetes Mellitus.|subjects must not have diabetes mellitus.
397535|NCT01252966|Tobacco|tobacco
397536|NCT01252966|Smoking|smoking
397537|NCT01252966|Cognition|cognition
397538|NCT01252966|Behavioral Training|behavioral training
397539|NCT01252966|Relapse|relapse
397540|NCT01252953|vascular disease|vascular disease
397541|NCT01252953|lipids|lipids
397542|NCT01252953|cholesteryl ester transfer protein (CETP) inhibition|cholesteryl ester transfer protein (cetp) inhibition
397543|NCT01252953|anacetrapib|anacetrapib
397544|NCT01252940|HIV-1|hiv-1
397546|NCT01252940|Treatment Experienced|treatment experienced
397547|NCT01252914|Open angle|open angle
397548|NCT01252914|Glaucoma|glaucoma
397549|NCT01252914|Surgery|surgery
397550|NCT01252914|Ocular Hypertension|ocular hypertension
397551|NCT01252914|Eye Diseases|eye diseases
397552|NCT01252901|WT1|wt1
397553|NCT01252901|Wilms Tumor|wilms tumor
397554|NCT01252901|Denys-Drash Syndrome|denys-drash syndrome
397555|NCT01252901|Nephrotic Syndrome|nephrotic syndrome
397556|NCT01252901|Proteinuria|proteinuria
397557|NCT01252888|Open angle|open angle
397558|NCT01252888|Glaucoma|glaucoma
397559|NCT01252888|Surgery|surgery
397560|NCT01252888|Glaucoma Open-Angle|glaucoma open-angle
397561|NCT01252888|Ocular Hypertension|ocular hypertension
397562|NCT01252888|Eye Diseases|eye diseases
397563|NCT01252875|LDL-C|ldl-c
397564|NCT01252875|Cholesterol|cholesterol
397565|NCT01252875|Stroke|stroke
397566|NCT01252875|Transient ischemic attack|transient ischemic attack
397567|NCT01252875|Statin|statin
397568|NCT01252875|Lipid lowering therapy|lipid lowering therapy
397569|NCT01252862|Open angle|open angle
397570|NCT01252862|Glaucoma|glaucoma
397571|NCT01252862|Surgery|surgery
397572|NCT01252862|Ocular Hypertension|ocular hypertension
397573|NCT01252862|eye diseases|eye diseases
397574|NCT01252849|Open angle|open angle
397575|NCT01252849|Glaucoma|glaucoma
397576|NCT01252849|surgery|surgery
397577|NCT01252849|Glaucoma, Open-Angle|glaucoma, open-angle
397578|NCT01252849|Ocular Hypertension|ocular hypertension
397579|NCT01252849|Eye Diseases|eye diseases
397580|NCT01252823|Hemodialysis|hemodialysis
397581|NCT01252823|Cardiac Arrhythmia|cardiac arrhythmia
397582|NCT01252823|Cardiac Death|cardiac death
397583|NCT01252823|Implantable Loop Recorder|implantable loop recorder
397584|NCT01252810|CATH Catheterization|cath catheterization
397585|NCT01252810|CI-AKI Contrast-induced acute kidney injury|ci-aki contrast-induced acute kidney injury
397586|NCT01252810|DM Diabetes mellitus|dm diabetes mellitus
397587|NCT01252810|eGFR Estimated glomerular filtration rate|egfr estimated glomerular filtration rate
397588|NCT01252810|MDRD Modification of Diet in Renal Disease|mdrd modification of diet in renal disease
397589|NCT01252810|NYHA New York Heart Association|nyha new york heart association
397590|NCT01252810|PCI Percutaneous coronary intervention|pci percutaneous coronary intervention
397591|NCT01252810|SCr Serum creatinine|scr serum creatinine
397592|NCT01252797|brain metastases|brain metastases
397593|NCT01252784|higher risk MDS|higher risk mds
397594|NCT01252771|phosphorus|phosphorus
397595|NCT01252771|dialysis|dialysis
397596|NCT01252771|PhosLo|phoslo
397597|NCT01252732|ABSSSI|absssi
397598|NCT01252732|Skin Infection|skin infection
397599|NCT01252732|Abscess|abscess
397600|NCT01252719|ABSSSI|absssi
397601|NCT01252719|Skin Infection|skin infection
397602|NCT01252719|Abscess|abscess
397603|NCT01252706|brief intervention|brief intervention
397604|NCT01252706|alcohol|alcohol
397605|NCT01252706|nicotine|nicotine
397606|NCT01252706|drug abuse|drug abuse
397607|NCT01252654|Lasik|lasik
397608|NCT01252654|Femtosecond Laser|femtosecond laser
397609|NCT01252654|Visumax|visumax
397610|NCT01252654|IntraLase|intralase
397611|NCT01252654|Myopia|myopia
397612|NCT01252654|Myopic Patients undergoing LASIK|myopic patients undergoing lasik
397613|NCT01252641|HIV|hiv
397614|NCT01252628|CRC|crc
397615|NCT01252628|SCCHN|scchn
397616|NCT01252628|PX-866|px-866
397617|NCT01252628|Cetuximab|cetuximab
397618|NCT01252628|ERBITUX|erbitux
397619|NCT01252628|Colon|colon
397620|NCT01252628|Head and Neck|head and neck
397621|NCT01252628|Colorectal cancer|colorectal cancer
397622|NCT01252628|Squamous cell carcinoma|squamous cell carcinoma
397623|NCT01252628|PI-3K|pi-3k
397624|NCT01252628|PI3 kinase|pi3 kinase
397625|NCT01252628|PI3K|pi3k
397626|NCT01252615|ICD|icd
397627|NCT01252615|HF|hf
397628|NCT01252615|cardiac arrest|cardiac arrest
397629|NCT01252615|VF|vf
397630|NCT01252615|cardiac arrhythmias|cardiac arrhythmias
397631|NCT01252602|breastfeeding, EPDS, prenatal depression|breastfeeding, epds, prenatal depression
397632|NCT01252589|Chronic Myeloid Leukemia|chronic myeloid leukemia
397633|NCT01252589|Quality of Life|quality of life
397634|NCT01252589|Symptoms|symptoms
397635|NCT01252589|Patient-Reported outcomes|patient-reported outcomes
397638|NCT01252576|female sexual function|female sexual function
397639|NCT01252576|italian validation|italian validation
397640|NCT01252563|ENTER10|enter10
397641|NCT01252563|Hypertension|hypertension
397642|NCT01252563|Japanese|japanese
397643|NCT01252563|Norvasc 10mg|norvasc 10mg
397644|NCT01252563|Post Marketing surveillance|post marketing surveillance
397645|NCT01252550|IBS|ibs
397646|NCT01252550|GI|gi
397647|NCT01252550|QOL|qol
397648|NCT01252550|Pathophysiology|pathophysiology
397649|NCT01252550|Gut microbiota|gut microbiota
397650|NCT01252550|Danone|danone
397651|NCT01252550|Activia|activia
397652|NCT01252550|Probiotics|probiotics
397653|NCT01252537|HIV|hiv
397654|NCT01252537|Tuberculosis|tuberculosis
397655|NCT01252537|Immunosuppression|immunosuppression
397656|NCT01252537|ART|art
397657|NCT01252537|Ethiopia|ethiopia
397658|NCT01252537|Primary health care|primary health care
397659|NCT01252524|diabetes mellitus|diabetes mellitus
397660|NCT01252524|fiber|fiber
397661|NCT01252524|glycemic control|glycemic control
397662|NCT01252524|calcium polycarbophil|calcium polycarbophil
397663|NCT01252511|Malabsorption after RYGB|malabsorption after rygb
397664|NCT01252511|Fat Malabsorption and maldigestion|fat malabsorption and maldigestion
397665|NCT01252511|Obesity surgery|obesity surgery
397666|NCT01252511|Bariatric surgery|bariatric surgery
397667|NCT01252498|Cancer of the head and neck|cancer of the head and neck
397668|NCT01252498|Radiotherapy|radiotherapy
397669|NCT01252498|Prostaglandins|prostaglandins
397670|NCT01252485|AML|aml
397671|NCT01252485|Registry study|registry study
397672|NCT01252485|Biology and Outcome|biology and outcome
397673|NCT01252485|Higher Risk MDS|higher risk mds
397674|NCT01252472|Flomax|flomax
397675|NCT01252472|Floppy iris Syndrome|floppy iris syndrome
397676|NCT01252472|Tamsulosin|tamsulosin
397677|NCT01252459|AA-PET|aa-pet
397678|NCT01252459|T1-Gd-MRI|t1-gd-mri
397679|NCT01252459|re-irradiation|re-irradiation
397680|NCT01252459|recurrent glioma|recurrent glioma
397681|NCT01252446|ICD 10|icd 10
397682|NCT01252446|Attention-Deficit-Hyperactivity-Disorder (ADHD)|attention-deficit-hyperactivity-disorder (adhd)
397683|NCT01252446|Comorbidity|comorbidity
397684|NCT01252446|Social-demographic profile|social-demographic profile
397685|NCT01252420|Distal Vein Thrombosis|distal vein thrombosis
397686|NCT01252420|Proximal Vein Thrombosis|proximal vein thrombosis
397687|NCT01252420|Pulmonary Embolism|pulmonary embolism
397688|NCT01252420|Post-thrombotic syndrome|post-thrombotic syndrome
397689|NCT01252420|Limited duration treatment|limited duration treatment
397690|NCT01252407|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
397691|NCT01252407|Sympathetic nervous system|sympathetic nervous system
397692|NCT01252407|Parasympathetic nervous system|parasympathetic nervous system
397693|NCT01252407|heart rate|heart rate
397694|NCT01252342|Oxytocin|oxytocin
397695|NCT01252342|Intramyometrial|intramyometrial
397696|NCT01252329|high risk cutaneous squamous cell carcinoma|high risk cutaneous squamous cell carcinoma
397697|NCT01252329|selective neck dissection|selective neck dissection
397698|NCT01252329|elective lymph node management|elective lymph node management
397699|NCT01252329|clinical nodal observation|clinical nodal observation
397700|NCT01252303|Obesity, weight loss, meal replacements|obesity, weight loss, meal replacements
397701|NCT01252264|biorepository|biorepository
397702|NCT01252264|genetics|genetics
397703|NCT01252264|craniofacial|craniofacial
397704|NCT01252264|cleft lip|cleft lip
397705|NCT01252264|cleft palate|cleft palate
397706|NCT01252251|PASIREOTIDE (SOM230)|pasireotide (som230)
397707|NCT01252251|RAD001 (EVEROLIMUS)|rad001 (everolimus)
397709|NCT01252251|10-123|10-123
397710|NCT01252225|Chronic Cough|chronic cough
397711|NCT01252225|Lidocaine|lidocaine
397712|NCT01252212|HIV, antiretroviral, adherence, SMS, cell phone|hiv, antiretroviral, adherence, sms, cell phone
397713|NCT01252199|Shigamabs|shigamabs
397714|NCT01252199|Monoclonal|monoclonal
397715|NCT01252199|Antibodies|antibodies
397716|NCT01252199|Shiga|shiga
397717|NCT01252199|Toxin|toxin
397718|NCT01252199|E.coli|e.coli
397719|NCT01252199|HUS|hus
397720|NCT01252199|Bloody|bloody
397721|NCT01252199|Diarrhea|diarrhea
397722|NCT01252186|Contraception|contraception
397723|NCT01252186|Hemostasis|hemostasis
397724|NCT01252186|Blood Coagulation|blood coagulation
397725|NCT01252173|endotracheal|endotracheal
397726|NCT01252173|intubation|intubation
397727|NCT01252173|tracheal|tracheal
397728|NCT01252173|pressure|pressure
397729|NCT01252173|cufflator|cufflator
397730|NCT01252160|Neuralgia, Postherpetic|neuralgia, postherpetic
397731|NCT01252160|QUTENZA|qutenza
397732|NCT01252134|Soft Contact lens|soft contact lens
397733|NCT01252134|Multi-purpose solution|multi-purpose solution
397734|NCT01252134|Wettability|wettability
397735|NCT01252121|Dry Eye|dry eye
397736|NCT01252121|Ocular Retention Time|ocular retention time
397737|NCT01252108|Helicobacter pylori|helicobacter pylori
397738|NCT01252108|peptic ulcer disease|peptic ulcer disease
397739|NCT01252108|stomach ulcers|stomach ulcers
397740|NCT01252108|gastric cancer|gastric cancer
397741|NCT01252095|PG545|pg545
397742|NCT01252095|Phase I|phase i
397743|NCT01252095|Progen|progen
397744|NCT01252095|antimetastatic|antimetastatic
397745|NCT01252095|antiangiogenic|antiangiogenic
397746|NCT01252095|advanced cancer patients|advanced cancer patients
397747|NCT01252095|solid tumors|solid tumors
397748|NCT01252095|solid tumours|solid tumours
397749|NCT01252082|metabolic control|metabolic control
397750|NCT01252082|fasting plasma glucose|fasting plasma glucose
397751|NCT01252082|glycated hemoglobin|glycated hemoglobin
397752|NCT01252043|cholestasis|cholestasis
397753|NCT01252043|children|children
397754|NCT01252030|CAD, physical activity, rehabilitation, prevention|cad, physical activity, rehabilitation, prevention
397755|NCT01252004|Left ventricular ballooning|left ventricular ballooning
397756|NCT01251978|Choroidal melanoma|choroidal melanoma
397757|NCT01251978|Ranibizumab|ranibizumab
397758|NCT01251978|Transpupillary Thermotherapy|transpupillary thermotherapy
397759|NCT01251978|CSTIP|cstip
397760|NCT01251978|Indocyanine Green|indocyanine green
397761|NCT01251965|Relapsed Acute Leukemia|relapsed acute leukemia
397762|NCT01251965|Acute myeloid leukemia|acute myeloid leukemia
397763|NCT01251965|AML|aml
397764|NCT01251965|Acute lymphocytic leukemia|acute lymphocytic leukemia
397765|NCT01251965|ALL|all
397766|NCT01251965|Ruxolitinib|ruxolitinib
397767|NCT01251965|Jakafi|jakafi
397768|NCT01251965|INC424|inc424
397769|NCT01251965|INCB018424|incb018424
397770|NCT01251926|Bevacizumab|bevacizumab
397771|NCT01251926|Camptothecin|camptothecin
397772|NCT01251926|EZN-2208|ezn-2208
397773|NCT01251926|Anti-Angiogenesis|anti-angiogenesis
397774|NCT01251926|Advanced Cancer|advanced cancer
397775|NCT01251926|Cancer|cancer
397776|NCT01251926|Solid Tumor|solid tumor
397777|NCT01251913|Tissue Harvest|tissue harvest
397778|NCT01251913|Hospice|hospice
397779|NCT01251913|Autopsy|autopsy
397780|NCT01251913|Crainiotomy|crainiotomy
397781|NCT01251913|Brain Tumor|brain tumor
397783|NCT01251913|Astrocytoma|astrocytoma
397784|NCT01251900|Triple Negative Disease|triple negative disease
397785|NCT01251900|BRCA1|brca1
397786|NCT01251900|BRCA2|brca2
397787|NCT01251900|Hispanic/Latino|hispanic/latino
397788|NCT01251900|Breast Cancer|breast cancer
397789|NCT01251887|Lipids|lipids
397790|NCT01251887|Obesity|obesity
397791|NCT01251887|Omega-3 Fatty Acids|omega-3 fatty acids
397792|NCT01251887|Overweight|overweight
388528|NCT01291849|nasal surgery|nasal surgery
388529|NCT01291849|endoscopic sinus surgery|endoscopic sinus surgery
388530|NCT01291849|septoplasty|septoplasty
388531|NCT01291849|Cough|cough
388532|NCT01291836|Acute Kidney Injury (AKI)|acute kidney injury (aki)
388541|NCT01291797|AEEG|aeeg
397793|NCT01251848|Sitaxentan|sitaxentan
397794|NCT01251848|ritonavir|ritonavir
397795|NCT01251848|drug interaction|drug interaction
397796|NCT01251848|pharmacokinetics|pharmacokinetics
397797|NCT01251835|Sitaxsentan|sitaxsentan
397798|NCT01251835|Rifampin|rifampin
397799|NCT01251835|Drug Interaction|drug interaction
397800|NCT01251835|Pharmacokinetics|pharmacokinetics
397801|NCT01251809|Asparaginase|asparaginase
397802|NCT01251809|ALL|all
397803|NCT01251783|term babies|term babies
397804|NCT01251770|Hyponatremia|hyponatremia
397805|NCT01251770|Water-Electrolyte Imbalance|water-electrolyte imbalance
397806|NCT01251757|diabetes|diabetes
397807|NCT01251757|cardiovascular disease|cardiovascular disease
397808|NCT01251757|randomized clinical trial|randomized clinical trial
397809|NCT01251757|medication adherence|medication adherence
397810|NCT01251757|health information technology|health information technology
397811|NCT01251757|adult|adult
397812|NCT01251757|telephone calls|telephone calls
397814|NCT01251744|Pregnancy|pregnancy
397815|NCT01251744|Congenital|congenital
397816|NCT01251744|Cytomegalovirus infection|cytomegalovirus infection
397817|NCT01251718|Donepezil hydrochloride|donepezil hydrochloride
397818|NCT01251718|Alzheimer's Disease|alzheimer's disease
397819|NCT01251705|Cornea|cornea
397820|NCT01251705|SL OCT|sl oct
397821|NCT01251705|Spectral OCT Cornea modul|spectral oct cornea modul
397822|NCT01251705|ultrasound pachymetry|ultrasound pachymetry
397823|NCT01251705|Pentacam|pentacam
397824|NCT01251692|Corneal erosions|corneal erosions
397825|NCT01251692|PTK|ptk
397826|NCT01251679|handwashing|handwashing
397827|NCT01251679|masks|masks
397828|NCT01251679|infectious disease transmission|infectious disease transmission
397829|NCT01251666|Colorectal cancer|colorectal cancer
397830|NCT01251666|Screening|screening
397831|NCT01251666|Average-risk population|average-risk population
397832|NCT01251666|faecal occult blood tests|faecal occult blood tests
397833|NCT01251640|pancreatic cancer,|pancreatic cancer,
397834|NCT01251640|MEK-inhibitor|mek-inhibitor
397835|NCT01251627|Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Decitabine|myelodysplastic syndromes, chronic myelomonocytic leukemia, decitabine
397836|NCT01251614|Randomized|randomized
397837|NCT01251614|Double-blind|double-blind
397838|NCT01251614|Chronic plaque psoriasis|chronic plaque psoriasis
397839|NCT01251614|Pediatric|pediatric
397840|NCT01251588|Cartilage legions|cartilage legions
397841|NCT01251588|Symptomatic focal cartilage defects|symptomatic focal cartilage defects
397842|NCT01251588|Microfracture|microfracture
397843|NCT01251588|MACI|maci
397844|NCT01251588|Autologous chondrocyte|autologous chondrocyte
397845|NCT01251549|ReWalk|rewalk
397846|NCT01251549|Paraplegia|paraplegia
397847|NCT01251549|Spinal Cord Injuries (SCI)|spinal cord injuries (sci)
397848|NCT01251536|colorectal cancer|colorectal cancer
397849|NCT01251536|K-Ras wildtype|k-ras wildtype
397850|NCT01251536|first line metastatic|first line metastatic
397851|NCT01251536|standard cetuximab + FOLFIRI|standard cetuximab + folfiri
397852|NCT01251536|dose escalation cetuximab|dose escalation cetuximab
397853|NCT01251523|Asthma|asthma
397854|NCT01251471|major depressive disorder|major depressive disorder
397855|NCT01251471|MDD|mdd
397856|NCT01251471|imaging genetics|imaging genetics
397857|NCT01251471|pharmacoMRI|pharmacomri
397858|NCT01251432|otitis media|otitis media
397859|NCT01251432|Eustachian tube|eustachian tube
397860|NCT01251432|allergy|allergy
397861|NCT01251432|gastroesophageal reflux|gastroesophageal reflux
397862|NCT01251432|tympanostomy tube|tympanostomy tube
397863|NCT01251419|Generic Medication|generic medication
397864|NCT01251419|Brand Name Medication|brand name medication
397865|NCT01251419|Conversion Rates|conversion rates
397866|NCT01251419|Social Proximity|social proximity
397867|NCT01251419|Behavioral Economics|behavioral economics
397868|NCT01251406|Stable|stable
397869|NCT01251406|Chronic Heart Failure|chronic heart failure
397870|NCT01251406|Systolic|systolic
397871|NCT01251393|Cocaine|cocaine
397872|NCT01251393|crack|crack
397873|NCT01251393|treatment|treatment
397874|NCT01251393|dependence|dependence
397875|NCT01251393|biperiden|biperiden
397876|NCT01251341|inflammation|inflammation
397877|NCT01251341|immune system|immune system
397878|NCT01251341|cytokines|cytokines
397879|NCT01251341|meditation|meditation
397880|NCT01251341|compassion|compassion
397881|NCT01251341|attention|attention
397882|NCT01251315|Glutathione|glutathione
397883|NCT01251315|Antioxidant|antioxidant
485346|NCT00123695|outcome|outcome
397884|NCT01251315|Free radical|free radical
397885|NCT01251315|Oxidative stress|oxidative stress
397886|NCT01251315|N-Acetyl Cysteine|n-acetyl cysteine
397887|NCT01251315|Glutathione precursor|glutathione precursor
397888|NCT01251302|Coronary Artery Disease|coronary artery disease
397889|NCT01251302|Angina|angina
397890|NCT01251302|Molecular Genetics|molecular genetics
397891|NCT01251302|Atherosclerosis|atherosclerosis
397892|NCT01251263|headaches|headaches
397893|NCT01251263|migraines|migraines
397894|NCT01251263|breakthrough bleeding|breakthrough bleeding
397895|NCT01251263|breakthrough spotting|breakthrough spotting
397896|NCT01251263|menstrually associated migraines|menstrually associated migraines
397897|NCT01251263|breakthrough bleeding or breakthrough spotting|breakthrough bleeding or breakthrough spotting
397898|NCT01251224|asthma|asthma
397899|NCT01251224|mouse allergen|mouse allergen
397900|NCT01251224|environmental intervention|environmental intervention
397901|NCT01251211|BOTULINUM TOXIN|botulinum toxin
397902|NCT01251211|NEUROPATHIC PAIN|neuropathic pain
397903|NCT01251211|RANDOMIZED CONTROLLED TRIAL|randomized controlled trial
397904|NCT01251185|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
397905|NCT01251185|Heart Failure|heart failure
397906|NCT01251185|Congestive Heart Failure|congestive heart failure
397907|NCT01251185|Non-invasive|non-invasive
397908|NCT01251185|Device Trial|device trial
397909|NCT01251185|NYHA (New York Heart Association)|nyha (new york heart association)
397910|NCT01251185|Ischemic cardiomyopathy|ischemic cardiomyopathy
397911|NCT01251185|Ischemia|ischemia
397912|NCT01251185|Myocardial contractility|myocardial contractility
397913|NCT01251159|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
397914|NCT01251159|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
397915|NCT01251159|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
397916|NCT01251159|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
397917|NCT01251159|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
397918|NCT01251159|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
397919|NCT01251159|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
397920|NCT01251159|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
397921|NCT01251159|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
397922|NCT01251159|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
397923|NCT01251159|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
397924|NCT01251159|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
397925|NCT01251159|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
397926|NCT01251159|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
397927|NCT01251159|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
397928|NCT01251146|Hypertension|hypertension
397929|NCT01251146|Bisoprolol|bisoprolol
397930|NCT01251146|Atenolol|atenolol
398021|NCT01250678|SDMT|sdmt
397931|NCT01251133|Communicable Diseases|communicable diseases
397932|NCT01251133|Infection|infection
397933|NCT01251133|Influenza|influenza
8891|NCT03233984|bisphenol-A|bisphenol-a
397934|NCT01251133|Orthomyxoviridae Infections|orthomyxoviridae infections
397935|NCT01251133|RNA Virus Infections|rna virus infections
397936|NCT01251133|Virus Diseases|virus diseases
397937|NCT01251133|Respiratory Tract Infections|respiratory tract infections
397938|NCT01251133|Respiratory Tract Diseases|respiratory tract diseases
397939|NCT01251107|Hodgkin lymphoma|hodgkin lymphoma
397940|NCT01251107|ABVD|abvd
397941|NCT01251107|BEACOPP|beacopp
397942|NCT01251107|Salvage high dose chemotherapy|salvage high dose chemotherapy
397943|NCT01251094|Dementia|dementia
397944|NCT01251094|Parkinson's|parkinson's
397945|NCT01251094|impairment|impairment
397946|NCT01251094|Dementia Registry for Parkinson's Disease|dementia registry for parkinson's disease
397947|NCT01251081|high volume hemofiltration|high volume hemofiltration
397948|NCT01251081|sepsis|sepsis
397949|NCT01251081|acute kidney injury|acute kidney injury
397950|NCT01251081|survival|survival
397951|NCT01251068|anemic preterms, cerebral oxygenation,somatic oxygenation, blood transfusion|anemic preterms, cerebral oxygenation,somatic oxygenation, blood transfusion
397952|NCT01251055|N-methyl-D-aspartate receptor|n-methyl-d-aspartate receptor
397953|NCT01251055|glycine transporter|glycine transporter
397954|NCT01251055|schizophrenia|schizophrenia
397955|NCT01251016|Type 2 diabetes mellitus|type 2 diabetes mellitus
397956|NCT01251016|Y-Roux gastric bypass|y-roux gastric bypass
397957|NCT01251016|Gut hormones|gut hormones
397958|NCT01251016|Gene expression|gene expression
397959|NCT01251016|Surgery|surgery
397960|NCT01251003|Traumatic Brain Injury|traumatic brain injury
397962|NCT01251003|Pediatric|pediatric
397963|NCT01251003|Chronic|chronic
397964|NCT01250990|Niacin|niacin
397965|NCT01250990|HDL|hdl
397966|NCT01250990|Reverse cholesterol transport|reverse cholesterol transport
388724|NCT01291121|Age related macular degeneration|age related macular degeneration
388725|NCT01291121|Intravitreal ranibizumab|intravitreal ranibizumab
388726|NCT01291121|Intravitreal expansile gas injection|intravitreal expansile gas injection
388727|NCT01291082|Breast cancer|breast cancer
388728|NCT01291082|metastasis|metastasis
388729|NCT01291082|bone|bone
388730|NCT01291082|diffusion MRI|diffusion mri
397967|NCT01250977|Non-treatment seeking smokers, reporting consumption of at least|non-treatment seeking smokers, reporting consumption of at least
397968|NCT01250977|10 cigarettes per day for at least the past 6 months|10 cigarettes per day for at least the past 6 months
397969|NCT01250951|Iron Overload|iron overload
397970|NCT01250951|hemotranfusion|hemotranfusion
397971|NCT01250951|deferasirox|deferasirox
397972|NCT01250951|ferritin|ferritin
397973|NCT01250951|Rare anemia|rare anemia
397974|NCT01250951|Transfusional Iron Overload|transfusional iron overload
397975|NCT01250938|autism|autism
397976|NCT01250938|autism spectrum disorders|autism spectrum disorders
397977|NCT01250938|pervasive developmental disorders|pervasive developmental disorders
397978|NCT01250938|intervention|intervention
397979|NCT01250938|low-income|low-income
397980|NCT01250938|underserved populations|underserved populations
397981|NCT01250938|underrepresented populations|underrepresented populations
397982|NCT01250925|Contact lens|contact lens
397983|NCT01250925|Lens care|lens care
397984|NCT01250912|Ablation|ablation
397985|NCT01250912|Arrythmia|arrythmia
397986|NCT01250912|Imaging|imaging
397987|NCT01250899|HIV|hiv
397988|NCT01250899|Vitamin D|vitamin d
397989|NCT01250899|HAART|haart
397990|NCT01250860|Manual therapy|manual therapy
397991|NCT01250860|DoboMed exercise|dobomed exercise
397992|NCT01250860|Spirometric test|spirometric test
397993|NCT01250847|ARMS|arms
397994|NCT01250847|Ultra High Risk|ultra high risk
397995|NCT01250847|Quetiapine|quetiapine
397996|NCT01250847|Verbal memory|verbal memory
397997|NCT01250821|Infertility|infertility
397998|NCT01250821|Anovulation|anovulation
397999|NCT01250821|Ovulation induction|ovulation induction
398000|NCT01250795|Prevention|prevention
398001|NCT01250782|Glutamine, trauma patients, infections, mortality|glutamine, trauma patients, infections, mortality
398002|NCT01250769|dental|dental
398003|NCT01250769|dentist|dentist
398004|NCT01250769|plaque|plaque
398005|NCT01250769|IP Cleaning|ip cleaning
398006|NCT01250756|vaccine|vaccine
398007|NCT01250756|pneumococcal conjugate|pneumococcal conjugate
398008|NCT01250743|genotype 1|genotype 1
398009|NCT01250730|PK profile in Japanese healthy male volunteers|pk profile in japanese healthy male volunteers
398010|NCT01250717|prostatectomy|prostatectomy
398011|NCT01250717|docetaxel|docetaxel
398012|NCT01250704|Neuromyotonia, Isaac's syndrome; Peripheral nerve hyperexcitability; Myokymia; Potassium channelopathy|neuromyotonia, isaac's syndrome; peripheral nerve hyperexcitability; myokymia; potassium channelopathy
398013|NCT01250691|pneumonia|pneumonia
398015|NCT01250691|isolation room|isolation room
398016|NCT01250691|clinical epidemiology|clinical epidemiology
398017|NCT01250691|infection control|infection control
398018|NCT01250678|multiple sclerosis|multiple sclerosis
398019|NCT01250678|cognitive impairment|cognitive impairment
398020|NCT01250678|natalizumab|natalizumab
398022|NCT01250665|multiple sclerosis|multiple sclerosis
398023|NCT01250665|cognitive impairment|cognitive impairment
398024|NCT01250665|interferon-beta 1b|interferon-beta 1b
398025|NCT01250665|corpus callosum index|corpus callosum index
398026|NCT01250652|Chronic urticaria|chronic urticaria
398027|NCT01250652|Urticaria|urticaria
398028|NCT01250652|Antihistamine|antihistamine
398029|NCT01250639|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
398030|NCT01250639|non-aboriginal Taiwanese|non-aboriginal taiwanese
8892|NCT03233984|prevention|prevention
398031|NCT01250639|Genome-wide association study|genome-wide association study
398033|NCT01250626|childhood GFR formula|childhood gfr formula
398034|NCT01250587|Open label|open label
398035|NCT01250587|dose-finding Phase 1 study|dose-finding phase 1 study
398036|NCT01250574|CD64|cd64
398037|NCT01250574|Procalcitonin|procalcitonin
398038|NCT01250561|gabapentin|gabapentin
398039|NCT01250561|valacyclovir|valacyclovir
398040|NCT01250561|phn|phn
398041|NCT01250561|shingles|shingles
398042|NCT01250548|Rheumatoid arthritis|rheumatoid arthritis
398043|NCT01250548|RA|ra
398044|NCT01250548|Active rheumatoid arthritis|active rheumatoid arthritis
398045|NCT01250535|Drug drug interactions|drug drug interactions
398046|NCT01250535|Warfarin|warfarin
398047|NCT01250535|Anticoagulants|anticoagulants
398048|NCT01250535|Lovastatin|lovastatin
398049|NCT01250535|Statins|statins
398050|NCT01250535|CYP4F2|cyp4f2
398051|NCT01250535|Vitamin K|vitamin k
398052|NCT01250509|Obesity|obesity
398053|NCT01250509|Mindfulness based stress reduction|mindfulness based stress reduction
398054|NCT01250509|Mindful eating|mindful eating
398055|NCT01250509|Stress|stress
398056|NCT01250509|Overnutrition|overnutrition
398057|NCT01250509|Nutrition Disorders|nutrition disorders
398058|NCT01250509|Overweight|overweight
398059|NCT01250509|Body Weight|body weight
398060|NCT01250509|Signs and Symptoms|signs and symptoms
398061|NCT01250496|regadenoson|regadenoson
398062|NCT01250496|lexiscan|lexiscan
398063|NCT01250496|aminophylline|aminophylline
398064|NCT01250496|SPECT|spect
398065|NCT01250496|Myocardial Perfusion Imaging|myocardial perfusion imaging
398066|NCT01250496|pharmacologic stress test|pharmacologic stress test
398067|NCT01250483|prostate|prostate
398068|NCT01250483|prostate-specific antigen|prostate-specific antigen
398069|NCT01250483|benign prostatic hyperplasia|benign prostatic hyperplasia
398070|NCT01250483|adrenergic alpha-Antagonists|adrenergic alpha-antagonists
398071|NCT01250444|Inspiratory Muscle Training|inspiratory muscle training
398072|NCT01250444|Hypertension|hypertension
398073|NCT01250444|Breathing Exercises|breathing exercises
398074|NCT01250444|Cardiac Rehabilitation|cardiac rehabilitation
398075|NCT01250418|Bispectral Index|bispectral index
398076|NCT01250418|Ketamine|ketamine
398077|NCT01250392|Active choice|active choice
398078|NCT01250392|Nurse visits|nurse visits
398079|NCT01250392|Behavioral economics|behavioral economics
398080|NCT01250366|Safety and Pharmacokinetics|safety and pharmacokinetics
398081|NCT01250353|ocular surface reconstruction|ocular surface reconstruction
398082|NCT01250353|conjunctival healing|conjunctival healing
398083|NCT01250353|pterygium|pterygium
398084|NCT01250353|latex biomembrane|latex biomembrane
398085|NCT01250353|pterygium surgery|pterygium surgery
398086|NCT01250340|Diabetes|diabetes
398087|NCT01250340|Isoprostanes|isoprostanes
398088|NCT01250340|Thromboxane|thromboxane
398089|NCT01250340|Aspirin|aspirin
398090|NCT01250327|right ventricular outflow tract|right ventricular outflow tract
398091|NCT01250327|endovascular valve insertion|endovascular valve insertion
398092|NCT01250327|economic evaluation|economic evaluation
398093|NCT01250327|valved stent|valved stent
398094|NCT01250314|osteoporosis|osteoporosis
398095|NCT01250314|men|men
398096|NCT01250314|bone micro-architecture|bone micro-architecture
398097|NCT01250314|bone markers|bone markers
398098|NCT01250301|Smoking Cessation|smoking cessation
398099|NCT01250301|Tobacco Dependence|tobacco dependence
398100|NCT01250301|De-nicotinised cigarettes|de-nicotinised cigarettes
398101|NCT01250288|Health Information Technology|health information technology
398102|NCT01250288|Health Records, Personal|health records, personal
398103|NCT01250288|Hospital Information Systems|hospital information systems
398104|NCT01250288|Patient Access to Records|patient access to records
398105|NCT01250288|Medical Records|medical records
398106|NCT01250288|Medical Record Systems, Computerized|medical record systems, computerized
398107|NCT01250275|Canola Oil|canola oil
398108|NCT01250275|Peripheral Arterial Disease|peripheral arterial disease
398109|NCT01250275|Peripheral Vascular Disease|peripheral vascular disease
398110|NCT01250275|PAD|pad
398111|NCT01250262|low back pain|low back pain
398112|NCT01250262|obese|obese
398113|NCT01250262|fear avoidance|fear avoidance
398114|NCT01250262|disability and low back pain|disability and low back pain
398115|NCT01250262|chronic low back pain in obese older adults|chronic low back pain in obese older adults
398116|NCT01250249|To compare Safety and Reactogenecity of BCG vaccine of Green Signal Biopharma Private Limited with BCG vaccine of serum institute of India limited|to compare safety and reactogenecity of bcg vaccine of green signal biopharma private limited with bcg vaccine of serum institute of india limited
398117|NCT01250236|brimonidine|brimonidine
398118|NCT01250236|alpha-2 adrenoceptor|alpha-2 adrenoceptor
398119|NCT01250236|cornea|cornea
398120|NCT01250236|corneal thickness|corneal thickness
398121|NCT01250223|Lymphoma, Follicular|lymphoma, follicular
398122|NCT01250223|Prognosis|prognosis
398123|NCT01250223|Progression-Free Survival|progression-free survival
398124|NCT01250223|Outcome|outcome
398125|NCT01250223|International Cooperation|international cooperation
398127|NCT01250223|Prospective studies|prospective studies
398128|NCT01250223|Rare Diseases|rare diseases
398129|NCT01250210|contraception|contraception
398130|NCT01250210|pregnancy prevention|pregnancy prevention
398131|NCT01250197|Normal Volunteers|normal volunteers
398132|NCT01250184|Myofascial pain|myofascial pain
398133|NCT01250184|Trigger points.|trigger points.
398134|NCT01250184|Lidocaine injection.|lidocaine injection.
398135|NCT01250184|Physical therapy|physical therapy
398137|NCT01250171|IL17/ IL-1β|il17/ il-1β
398138|NCT01250171|Biologic|biologic
398139|NCT01250158|Liver Percutaneous Isolated Localized Perfusion|liver percutaneous isolated localized perfusion
398140|NCT01250158|PILP|pilp
398141|NCT01250158|Isolated Hepatic Perfusion|isolated hepatic perfusion
398142|NCT01250158|IHP|ihp
398143|NCT01250158|Liver metastases|liver metastases
398144|NCT01250158|Unresectable liver metastases of different etiologies|unresectable liver metastases of different etiologies
398145|NCT01250132|Traumatic brain injury|traumatic brain injury
398146|NCT01250132|Paediatrics|paediatrics
398147|NCT01250132|Hypopituitarism|hypopituitarism
398148|NCT01250106|probiotics|probiotics
398149|NCT01250106|prevention|prevention
398150|NCT01250106|dietary intervention|dietary intervention
398151|NCT01250106|insulin resistance|insulin resistance
398152|NCT01250106|obesity|obesity
398153|NCT01250106|type 2 diabetes|type 2 diabetes
398154|NCT01250015|colorectal cancer|colorectal cancer
398155|NCT01250015|consent|consent
398156|NCT01250015|screening|screening
398157|NCT01250002|Pain|pain
398158|NCT01250002|MQOR 40|mqor 40
398159|NCT01250002|Lidocaine|lidocaine
398160|NCT01250002|Gynecologic|gynecologic
398161|NCT01250002|Surgery|surgery
398162|NCT01250002|Laparoscopic|laparoscopic
398163|NCT01249989|Physical Activity|physical activity
398164|NCT01249989|Sedentary Lifestyle|sedentary lifestyle
398165|NCT01249989|Diet|diet
398166|NCT01249989|Health Behavior|health behavior
399029|NCT01245972|SCC|scc
398167|NCT01249976|blood culture|blood culture
398168|NCT01249976|central venous catheter|central venous catheter
398169|NCT01249976|acridine orange leucocyte cytospin test|acridine orange leucocyte cytospin test
398170|NCT01249976|semi-quantitative skin culture|semi-quantitative skin culture
398171|NCT01249963|acute pancreatitis|acute pancreatitis
398172|NCT01249963|enteral nutrition|enteral nutrition
398173|NCT01249963|nutritional status|nutritional status
398174|NCT01249963|pancreas|pancreas
398175|NCT01249963|T-Diet plus Atémpero|t-diet plus atémpero
398176|NCT01249950|Morbid obesity|morbid obesity
398177|NCT01249950|teenagers|teenagers
398178|NCT01249950|co-morbidities|co-morbidities
398179|NCT01249950|bariatric surgery|bariatric surgery
398180|NCT01249950|epidemiology|epidemiology
398181|NCT01249937|Macular Degeneration|macular degeneration
398182|NCT01249937|Age-related macular degeneration|age-related macular degeneration
398183|NCT01249937|Anti-inflammatory|anti-inflammatory
398184|NCT01249937|Anti-vascular endothelial growth factor (Anti-VEGF)|anti-vascular endothelial growth factor (anti-vegf)
398185|NCT01249937|Lucentis|lucentis
398186|NCT01249937|Ranibizumab|ranibizumab
398188|NCT01249937|Triamcinolone Acetonide|triamcinolone acetonide
398189|NCT01249937|Vision loss|vision loss
398190|NCT01249924|Obstructive sleep apnea (OSA), continuous positive airway pressure(CPAP), surgery, anesthesia|obstructive sleep apnea (osa), continuous positive airway pressure(cpap), surgery, anesthesia
398191|NCT01249911|Infants|infants
398192|NCT01249898|Fracture in the Scaphoid fractures|fracture in the scaphoid fractures
398193|NCT01249885|pacifier sucking|pacifier sucking
398194|NCT01249885|children|children
398195|NCT01249885|occlusion|occlusion
398196|NCT01249885|drooling|drooling
398197|NCT01249872|open gastric by-pass|open gastric by-pass
398198|NCT01249872|super morbidly obese patients|super morbidly obese patients
398199|NCT01249872|postoperative thoracic epidural analgesia|postoperative thoracic epidural analgesia
398200|NCT01249872|different drug regimens (morphine and levobupivacaine)|different drug regimens (morphine and levobupivacaine)
398201|NCT01249872|Lung function tests|lung function tests
398202|NCT01249872|Postoperative Bowel recovery|postoperative bowel recovery
398203|NCT01249872|Postoperative Ambulation|postoperative ambulation
398204|NCT01249859|stomach disease|stomach disease
398205|NCT01249859|signet ring cell carcinoma|signet ring cell carcinoma
398206|NCT01249859|chemotherapy|chemotherapy
398207|NCT01249859|Prognostic|prognostic
398208|NCT01249833|Influenza|influenza
398209|NCT01249833|Cognition|cognition
398210|NCT01249833|Attention|attention
398211|NCT01249833|Simple Reaction Time|simple reaction time
398212|NCT01249833|Alertness|alertness
398213|NCT01249833|Calmness|calmness
398214|NCT01249833|Contentment|contentment
398215|NCT01249833|Mood|mood
398216|NCT01249820|anidulafungin|anidulafungin
398217|NCT01249820|antifungal prophylaxis|antifungal prophylaxis
398218|NCT01249820|allogeneic haematopoietic stem cell transplant|allogeneic haematopoietic stem cell transplant
398219|NCT01249820|myeloablative chemotherapy|myeloablative chemotherapy
398220|NCT01249820|AML-MDS|aml-mds
398221|NCT01249820|pharmacokinetics|pharmacokinetics
398222|NCT01249807|Cancer Screening|cancer screening
398223|NCT01249807|health service utilization model|health service utilization model
398224|NCT01249807|quality of health life|quality of health life
398225|NCT01249794|NIV|niv
398226|NCT01249794|non invasive ventilation|non invasive ventilation
398227|NCT01249794|cardiac surgery|cardiac surgery
398228|NCT01249794|continuous positive airway pressure|continuous positive airway pressure
398229|NCT01249768|Prospective study|prospective study
398230|NCT01249768|diagnostic accuracy|diagnostic accuracy
398231|NCT01249768|CSF|csf
398232|NCT01249768|MRI|mri
398233|NCT01249742|diabetes mellitus|diabetes mellitus
398234|NCT01249742|adolescent|adolescent
398235|NCT01249742|online intervention|online intervention
398236|NCT01249742|psychosocial|psychosocial
398237|NCT01249742|quality of life|quality of life
398238|NCT01249729|Magnetic Resonance Imaging, 3D reconstructed image|magnetic resonance imaging, 3d reconstructed image
398239|NCT01249716|follow-up home visit|follow-up home visit
398240|NCT01249716|Geriatric Disorder|geriatric disorder
398241|NCT01249716|rehabilitation|rehabilitation
398242|NCT01249690|Bortezomib,Thalidomide,bone metabolites|bortezomib,thalidomide,bone metabolites
398243|NCT01249677|type 2 diabetes|type 2 diabetes
398244|NCT01249677|first phase insulin secretion|first phase insulin secretion
398245|NCT01249677|beta-cell rest|beta-cell rest
398246|NCT01249677|basal insulin|basal insulin
398247|NCT01249664|sham-controlled|sham-controlled
398248|NCT01249664|pathologic myopia|pathologic myopia
398249|NCT01249664|mCNV|mcnv
398250|NCT01249664|choroidal neovascularization|choroidal neovascularization
398251|NCT01249664|intravitreal injection|intravitreal injection
398252|NCT01249664|vision loss|vision loss
398253|NCT01249664|macular damage|macular damage
398254|NCT01249651|Patients, Single|patients, single
398255|NCT01249638|Bevacizumab|bevacizumab
398256|NCT01249638|Capecitabine|capecitabine
398257|NCT01249638|Irinotecan|irinotecan
398258|NCT01249638|mCRC|mcrc
398259|NCT01249625|Influenza|influenza
398260|NCT01249625|H1N1|h1n1
398261|NCT01249625|Respiratory protection|respiratory protection
398262|NCT01249625|N95 respirator|n95 respirator
398263|NCT01249625|Medical mask|medical mask
398264|NCT01249625|Personal protective equipment|personal protective equipment
398265|NCT01249625|Facial protective equipment|facial protective equipment
398266|NCT01249625|Pandemic planning|pandemic planning
398267|NCT01249612|Knee joint icing|knee joint icing
398268|NCT01249612|knee-extension strength|knee-extension strength
398269|NCT01249599|Takotsubo Syndrome|takotsubo syndrome
398270|NCT01249599|apical balooning syndrome|apical balooning syndrome
398271|NCT01249599|stress-cardiomyopathy|stress-cardiomyopathy
398272|NCT01249599|endothelial function|endothelial function
398273|NCT01249599|sympathetic nervous activity|sympathetic nervous activity
398274|NCT01249599|platelet adhesion|platelet adhesion
398275|NCT01249599|arterial compliance|arterial compliance
398276|NCT01249573|fascia therapy|fascia therapy
398277|NCT01249573|transcutaneous fibrolysis|transcutaneous fibrolysis
398278|NCT01249573|acute ankle distortion|acute ankle distortion
398279|NCT01249495|leg ulcer|leg ulcer
398280|NCT01249495|wound therapy|wound therapy
398281|NCT01249495|Pro-inflammatory interleukins|pro-inflammatory interleukins
398282|NCT01249482|Helicobacter pylori|helicobacter pylori
398283|NCT01249482|reflux|reflux
398284|NCT01249482|acid rebound|acid rebound
398285|NCT01249391|Hand|hand
398286|NCT01249391|osteoarthritis|osteoarthritis
398287|NCT01249391|splint|splint
398288|NCT01249391|pain|pain
398289|NCT01249391|deformity|deformity
398290|NCT01249391|function|function
398291|NCT01249378|Nutrition|nutrition
398292|NCT01249378|Lipid|lipid
398293|NCT01249378|Digestion|digestion
398294|NCT01249378|Endotoxemia|endotoxemia
398295|NCT01249378|Inflammation|inflammation
398296|NCT01249378|Metabolism|metabolism
398297|NCT01249378|Stable Isotope|stable isotope
398298|NCT01249378|Obesity|obesity
398299|NCT01249365|medically significant conditions|medically significant conditions
398300|NCT01249365|cervical neoplasia|cervical neoplasia
398301|NCT01249365|serious adverse events (SAEs)|serious adverse events (saes)
398302|NCT01249365|HPV vaccine|hpv vaccine
398303|NCT01249352|Esophageal Cancer|esophageal cancer
398304|NCT01249352|Nimotuzumab|nimotuzumab
398305|NCT01249352|EF024|ef024
398306|NCT01249352|EF024-201|ef024-201
398307|NCT01249339|smokeless tobacco|smokeless tobacco
398308|NCT01249339|Nicotine|nicotine
398309|NCT01249339|Cadmium|cadmium
398310|NCT01249339|lead|lead
398311|NCT01249339|Tobacco Specific Nitrosamines|tobacco specific nitrosamines
398312|NCT01249326|Morbid obesity,|morbid obesity,
398313|NCT01249326|Bariatric surgery, by-pass, sleeve gastrectomy,|bariatric surgery, by-pass, sleeve gastrectomy,
398314|NCT01249326|Nitrogen balance,|nitrogen balance,
398315|NCT01249326|Protein requirement,|protein requirement,
398316|NCT01249326|Weight loss|weight loss
398317|NCT01249326|Muscle wasting, muscle disability|muscle wasting, muscle disability
398318|NCT01249313|Risk|risk
398319|NCT01249313|outcome|outcome
398320|NCT01249300|Dysphagia caused by cerebral vascular accidents|dysphagia caused by cerebral vascular accidents
398321|NCT01249287|stroke|stroke
398322|NCT01249287|stem cell|stem cell
398323|NCT01249274|cocaine abuse|cocaine abuse
398324|NCT01249274|cocaine dependence|cocaine dependence
398325|NCT01249274|postpartum period|postpartum period
398326|NCT01249261|Postmenopausal Women|postmenopausal women
398327|NCT01249261|Osteoporosis|osteoporosis
398328|NCT01249248|Heart rate variability|heart rate variability
398329|NCT01249248|Autonomic dysfunction|autonomic dysfunction
398330|NCT01249248|Exercise|exercise
398331|NCT01249248|Sports|sports
398332|NCT01249248|Competition|competition
398333|NCT01249248|Athletes|athletes
398334|NCT01249209|obesity|obesity
398335|NCT01249209|adults|adults
398336|NCT01249209|lifestyle intervention|lifestyle intervention
398337|NCT01249209|effect after two years treatment for lifestyle change - morbid obesity adults|effect after two years treatment for lifestyle change - morbid obesity adults
398338|NCT01249183|Diphtheria|diphtheria
485962|NCT00125307|SLE|sle
389133|NCT01289457|Relapsed|relapsed
389134|NCT01289457|Refractory|refractory
389135|NCT01289457|Clofarabine|clofarabine
389136|NCT01289457|Clofarex|clofarex
389137|NCT01289457|Clolar|clolar
389138|NCT01289457|Idarubicin|idarubicin
389139|NCT01289457|Idamycin|idamycin
389140|NCT01289457|Cytarabine|cytarabine
389141|NCT01289457|Ara-C|ara-c
389142|NCT01289457|Cytosar|cytosar
389143|NCT01289457|DepoCyt|depocyt
389144|NCT01289457|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
390228|NCT01284920|MDV3100|mdv3100
389162|NCT01289418|H1N1|h1n1
389163|NCT01289418|vaccine safety|vaccine safety
389164|NCT01289418|adverse events|adverse events
389165|NCT01289418|health care workers|health care workers
389166|NCT01289405|obstructive sleep apnea|obstructive sleep apnea
389167|NCT01289405|oropharyngeal exercises|oropharyngeal exercises
398339|NCT01249183|Tetanus|tetanus
398340|NCT01249183|Pertussis (acellular, component)|pertussis (acellular, component)
398341|NCT01249183|Diphteria|diphteria
398342|NCT01249183|Biological / vaccine|biological / vaccine
398343|NCT01249170|Communication skills|communication skills
398344|NCT01249157|MRI|mri
398345|NCT01249157|PEM|pem
398346|NCT01249157|10-189|10-189
398347|NCT01249144|Intraocular Lens (IOL)|intraocular lens (iol)
398348|NCT01249144|Quarter Diopter|quarter diopter
398349|NCT01249144|Biaspheric|biaspheric
398350|NCT01249105|MK-2206|mk-2206
398351|NCT01249105|GBM|gbm
398352|NCT01249092|biliary cirrhosis|biliary cirrhosis
398353|NCT01249066|AMP-activated protein kinase|amp-activated protein kinase
398354|NCT01249066|lung adenocarcinomas|lung adenocarcinomas
398355|NCT01249066|Prognosis|prognosis
398356|NCT01249066|Observation study|observation study
398357|NCT01249053|OPA1|opa1
398358|NCT01249053|lung adenocarcinomas|lung adenocarcinomas
398359|NCT01249053|Prognosis|prognosis
398360|NCT01249053|Expression of optic atrophy type 1 (OPA1) protein in lung adenocarcinoma|expression of optic atrophy type 1 (opa1) protein in lung adenocarcinoma
398361|NCT01249040|Frozen shoulder|frozen shoulder
398362|NCT01249040|pain scale|pain scale
398363|NCT01249040|range of motion(ROM)|range of motion(rom)
398364|NCT01249040|muscle strength|muscle strength
398365|NCT01249040|shoulder arthrography|shoulder arthrography
398366|NCT01249027|Drug eluting stents|drug eluting stents
398367|NCT01249027|Stents|stents
398368|NCT01249027|China|china
398369|NCT01249027|DES|des
398370|NCT01249027|XIENCE V EECSS|xience v eecss
398371|NCT01249001|pediatrics|pediatrics
398372|NCT01249001|nausea|nausea
398373|NCT01249001|vomiting|vomiting
398374|NCT01249001|chemotherapy|chemotherapy
398375|NCT01249001|antiemetic|antiemetic
398376|NCT01248988|Pneumococcal vaccine|pneumococcal vaccine
398377|NCT01248988|Safety|safety
398378|NCT01248988|Synflorix|synflorix
398379|NCT01248988|Pneumococcal diseases|pneumococcal diseases
398380|NCT01248975|asthma|asthma
398381|NCT01248975|GSK2190915|gsk2190915
398382|NCT01248962|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
398383|NCT01248962|CARBOPLATIN|carboplatin
398384|NCT01248962|DEXAMETHASONE|dexamethasone
398385|NCT01248962|GEMCITABINE|gemcitabine
398386|NCT01248962|LIPODOX(LIPOSOMAL DOXORUBICIN)|lipodox(liposomal doxorubicin)
398387|NCT01248962|MONTELUKAST (SINGULAR)|montelukast (singular)
398388|NCT01248962|TAXOL (PACLITAXEL|taxol (paclitaxel
398389|NCT01248962|Fallopian Tubes|fallopian tubes
398390|NCT01248962|10-184|10-184
398391|NCT01248949|Advanced solid tumors|advanced solid tumors
398392|NCT01248949|Advanced recurrent ovarian tumors|advanced recurrent ovarian tumors
398393|NCT01248949|MEDI3617|medi3617
398394|NCT01248949|Ang2|ang2
398395|NCT01248949|Ovarian cancer|ovarian cancer
398396|NCT01248949|Malignant glioma|malignant glioma
398397|NCT01248923|relapsed multiple myeloma|relapsed multiple myeloma
398398|NCT01248923|plasma cell dyscrasia|plasma cell dyscrasia
398399|NCT01248923|plasmacytoma|plasmacytoma
398400|NCT01248923|kinesin spindle protein|kinesin spindle protein
398401|NCT01248923|anti-mitotic|anti-mitotic
398402|NCT01248884|combination vaccine|combination vaccine
398403|NCT01248884|Primary vaccination|primary vaccination
398404|NCT01248871|renal|renal
398405|NCT01248871|transplantation|transplantation
398406|NCT01248871|Volatile|volatile
398407|NCT01248871|anesthetic|anesthetic
398408|NCT01248845|Mechanical ventilation|mechanical ventilation
398409|NCT01248845|Electrical diaphragmatic activity|electrical diaphragmatic activity
398410|NCT01248832|tobacco cessation|tobacco cessation
398411|NCT01248832|smoking cessation|smoking cessation
398412|NCT01248832|telephone|telephone
398413|NCT01248832|self-help|self-help
398414|NCT01248832|smoking abstinence|smoking abstinence
398415|NCT01248832|tobacco use disorder|tobacco use disorder
398416|NCT01248832|disparity|disparity
398417|NCT01248819|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
398418|NCT01248819|Nebulization|nebulization
398419|NCT01248819|Ropivacaine|ropivacaine
398420|NCT01248806|Lung nodule|lung nodule
398421|NCT01248806|Screening|screening
398422|NCT01248806|Spiral low - dose computed tomography|spiral low - dose computed tomography
398423|NCT01248806|Lung cancer|lung cancer
398424|NCT01248793|Ankylosing Sponylitis, injection, golimumab, simponi|ankylosing sponylitis, injection, golimumab, simponi
398425|NCT01248780|Rheumatoid Arthritis|rheumatoid arthritis
398426|NCT01248780|injection|injection
398427|NCT01248780|golimumab|golimumab
398428|NCT01248780|simponi|simponi
398429|NCT01248767|Pathological gambling|pathological gambling
398430|NCT01248767|"at risk gambling"|"at risk gambling"
398431|NCT01248767|cohort|cohort
398432|NCT01248767|cognitive distortions|cognitive distortions
398433|NCT01248767|impulsivity|impulsivity
398434|NCT01248767|psychiatric comorbidities|psychiatric comorbidities
398435|NCT01248767|gambling trajectory|gambling trajectory
398436|NCT01248767|gambling practice evolution|gambling practice evolution
398437|NCT01248767|addiction|addiction
398438|NCT01248754|Neurosurgery|neurosurgery
398439|NCT01248754|Neuronavigation|neuronavigation
398440|NCT01248754|Positron emission tomography|positron emission tomography
398441|NCT01248754|FDOPA|fdopa
398442|NCT01248741|prostate cancer|prostate cancer
398443|NCT01248741|interstitial radiation,|interstitial radiation,
398444|NCT01248741|brachytherapy|brachytherapy
398445|NCT01248728|Autism Spectrum Disorder|autism spectrum disorder
398446|NCT01248728|Clinical Trial|clinical trial
398447|NCT01248728|Omega-3 Fatty Acids|omega-3 fatty acids
398448|NCT01248728|Toddlers|toddlers
398449|NCT01248715|pneumonia, bacterial|pneumonia, bacterial
398450|NCT01248715|pneumonia, viral|pneumonia, viral
398451|NCT01248715|respiratory tract infections|respiratory tract infections
398452|NCT01248715|oseltamivir, therapeutic use|oseltamivir, therapeutic use
398453|NCT01248702|Myocardial Infarction|myocardial infarction
398454|NCT01248702|Heart Failure|heart failure
398455|NCT01248702|Sudden Cardiac Death|sudden cardiac death
398456|NCT01248702|Critical Pathways|critical pathways
398457|NCT01248676|cancer radiation patient education|cancer radiation patient education
398458|NCT01248663|pancreatic cancer|pancreatic cancer
398459|NCT01248663|pylorus-preserving pancreaticoduodenectomy|pylorus-preserving pancreaticoduodenectomy
399030|NCT01245972|594nM laser|594nm laser
398460|NCT01248663|delayed gastric emptying|delayed gastric emptying
398461|NCT01248663|reconstruction|reconstruction
398462|NCT01248650|Safety evaluation|safety evaluation
398463|NCT01248650|Pharmacokinetic analysis|pharmacokinetic analysis
398464|NCT01248637|pancreas|pancreas
398465|NCT01248637|pancreatic cancer|pancreatic cancer
398466|NCT01248637|pancreatic tumor|pancreatic tumor
398467|NCT01248637|pimonidazole|pimonidazole
398468|NCT01248637|hypoxia|hypoxia
398469|NCT01248637|whipple's resection|whipple's resection
398470|NCT01248624|Palliative Care|palliative care
398471|NCT01248624|Quality of Life|quality of life
398472|NCT01248624|Satisfaction with Care|satisfaction with care
398473|NCT01248611|pain|pain
398474|NCT01248611|adverse effects|adverse effects
398475|NCT01248611|safety|safety
398476|NCT01248611|feasibility|feasibility
398477|NCT01248585|Symptom Control|symptom control
398478|NCT01248572|Cataract|cataract
398479|NCT01248572|Biaspheric intraocular lens|biaspheric intraocular lens
398480|NCT01248572|Uniplanar intraocular lens|uniplanar intraocular lens
398481|NCT01248572|Effective lens position|effective lens position
398482|NCT01248546|Breast cancer|breast cancer
398483|NCT01248546|Computer-aided detection|computer-aided detection
398484|NCT01248546|Mammography screening|mammography screening
398485|NCT01248546|Digital breast tomosynthesis|digital breast tomosynthesis
398486|NCT01248533|Abdominal aortic aneurysm, atherosclerosis|abdominal aortic aneurysm, atherosclerosis
398487|NCT01248520|Pregnancy|pregnancy
398488|NCT01248520|Influenza Vaccination|influenza vaccination
398489|NCT01248507|COPD|copd
398490|NCT01248481|Acarbose/Glucobay®|acarbose/glucobay®
398491|NCT01248481|Basal insulin|basal insulin
398492|NCT01248481|PPG (Postprandial Glycaemia)|ppg (postprandial glycaemia)
398493|NCT01248468|Pain, Migraine|pain, migraine
398494|NCT01248455|Monoclonal Antibody|monoclonal antibody
398495|NCT01248455|NK Cell Mediated Killing|nk cell mediated killing
398496|NCT01248455|Response Rate|response rate
398497|NCT01248455|Pharmacokinetics|pharmacokinetics
398498|NCT01248455|Biological Activity|biological activity
398499|NCT01248455|Smoldering Multiple Myeloma|smoldering multiple myeloma
398501|NCT01248442|Vitamin D Deficiency|vitamin d deficiency
398502|NCT01248442|Autoimmune disease|autoimmune disease
398503|NCT01248442|Diabetes|diabetes
398504|NCT01248429|thyrosine kinase inhibitor|thyrosine kinase inhibitor
398505|NCT01248429|phosphokinase creatinin|phosphokinase creatinin
398506|NCT01248429|myalgia|myalgia
398507|NCT01248416|Aromatase|aromatase
398508|NCT01248416|Growth|growth
398509|NCT01248416|Letrozole|letrozole
398510|NCT01248416|Anastrozole|anastrozole
398512|NCT01248416|Children|children
398513|NCT01248416|Puberty|puberty
398514|NCT01248403|RAD001|rad001
398515|NCT01248403|Paclitaxel|paclitaxel
398516|NCT01248403|gastric cancer|gastric cancer
398517|NCT01248403|advanced gastric or esophagogastric junction cancer|advanced gastric or esophagogastric junction cancer
398518|NCT01248390|traumatic brain injury|traumatic brain injury
398519|NCT01248390|post-concussion|post-concussion
398520|NCT01248377|Cephalosporins|cephalosporins
398522|NCT01248351|aspirin, clopidogrel, pharmacodynamics, platelet transfusion|aspirin, clopidogrel, pharmacodynamics, platelet transfusion
398523|NCT01248299|Chemotherapy|chemotherapy
398524|NCT01248299|Best Supportive Care|best supportive care
398525|NCT01248286|Diabetes|diabetes
398526|NCT01248286|Prediabetes|prediabetes
398527|NCT01248286|Prevention|prevention
398528|NCT01248286|Whole grain|whole grain
398529|NCT01248286|Advanced glycation end products|advanced glycation end products
398530|NCT01248286|Insulin sensitivity|insulin sensitivity
398531|NCT01248273|GLOBO H-KLH CONJUGATE|globo h-klh conjugate
398532|NCT01248273|MUC-1 KLH|muc-1 klh
398533|NCT01248273|QS-21|qs-21
398534|NCT01248273|TF(C)-KLH|tf(c)-klh
398535|NCT01248273|TN(C)-KLH|tn(c)-klh
398536|NCT01248273|Immunization|immunization
398537|NCT01248273|Vaccine|vaccine
398538|NCT01248273|09-184|09-184
398539|NCT01248260|Fetal body size|fetal body size
398540|NCT01248260|Fetal brain size|fetal brain size
398541|NCT01248260|Folic acid|folic acid
398542|NCT01248247|Non small cell lung cancer|non small cell lung cancer
398543|NCT01248247|Biopsy accessible tumor|biopsy accessible tumor
398544|NCT01248247|Stage IIIB non small cell lung cancer|stage iiib non small cell lung cancer
398545|NCT01248247|Stage IV non small cell lung cancer|stage iv non small cell lung cancer
398546|NCT01248234|elderly|elderly
398547|NCT01248234|hypertensive|hypertensive
398548|NCT01248234|anesthesia|anesthesia
398549|NCT01248221|Breath test|breath test
398550|NCT01248221|Dyspepsia|dyspepsia
398551|NCT01248221|Gastric Emptying|gastric emptying
398552|NCT01248221|Gastroparesis|gastroparesis
398553|NCT01248208|egg allergy|egg allergy
398554|NCT01248208|influenza vaccine|influenza vaccine
398555|NCT01248195|Schizophrenia|schizophrenia
398556|NCT01248195|Schizophreniform disorder|schizophreniform disorder
398557|NCT01248195|Schizoaffective disorder|schizoaffective disorder
398558|NCT01248195|Imaging|imaging
398559|NCT01248195|Prognosis|prognosis
398560|NCT01248195|Treatment guidelines|treatment guidelines
398561|NCT01248195|Pharmacogenetics|pharmacogenetics
398562|NCT01248182|acetabular fracture|acetabular fracture
398563|NCT01248182|pelvic ring injury|pelvic ring injury
398564|NCT01248143|Green Tea|green tea
398565|NCT01248143|Fermented papaya preparation|fermented papaya preparation
398566|NCT01248143|Diabetes|diabetes
398567|NCT01248143|Cardiovascular diseases|cardiovascular diseases
398568|NCT01248143|Atherosclerotic plaques|atherosclerotic plaques
398569|NCT01248143|Glucose|glucose
398570|NCT01248143|Dietary supplements and functional foods|dietary supplements and functional foods
398571|NCT01248130|Omega-3 Fatty Acid|omega-3 fatty acid
398572|NCT01248130|Autism Spectrum Disorders|autism spectrum disorders
398573|NCT01248130|Pervasive Developmental Disorders|pervasive developmental disorders
398574|NCT01248130|Children|children
398575|NCT01248130|Cognitive Functioning|cognitive functioning
398577|NCT01248117|polypoidal|polypoidal
398578|NCT01248117|choroidal|choroidal
398579|NCT01248117|vasculopathy|vasculopathy
398580|NCT01248104|Cardiac Surgery|cardiac surgery
398581|NCT01248104|Antifibrinolytic agents|antifibrinolytic agents
398582|NCT01248104|Blood transfusion|blood transfusion
398583|NCT01248104|epsilon aminocaproic acid|epsilon aminocaproic acid
398584|NCT01248104|tranexamic acid|tranexamic acid
398585|NCT01248091|IUD, Insertion, Decrease, Pain|iud, insertion, decrease, pain
398586|NCT01248078|elective cesarean section|elective cesarean section
398587|NCT01248078|antibiotic prophylaxis|antibiotic prophylaxis
398588|NCT01248078|cefazoline|cefazoline
398589|NCT01248078|wound infection|wound infection
398590|NCT01248065|Asthma|asthma
398591|NCT01248065|Vitamin D|vitamin d
398592|NCT01248065|Corticosteroids|corticosteroids
398593|NCT01248065|Treatment failure|treatment failure
398594|NCT01248039|Muscle strength, functional performance, joint replacement|muscle strength, functional performance, joint replacement
398595|NCT01248026|Cardiovascular disease|cardiovascular disease
398596|NCT01248026|Buttermilk|buttermilk
398597|NCT01248026|Blood lipids|blood lipids
398598|NCT01248026|Cholesterol absorption|cholesterol absorption
398599|NCT01248026|Cholesterol synthesis|cholesterol synthesis
398600|NCT01248000|Hodgkin lymphoma|hodgkin lymphoma
398601|NCT01248000|FDG-PET|fdg-pet
398602|NCT01248000|prognostic factor|prognostic factor
398603|NCT01248000|clinical trial|clinical trial
398604|NCT01247987|IVF, assisted reproduction, embryo transfer|ivf, assisted reproduction, embryo transfer
398605|NCT01247974|Coronary Artery Bypass Grafting|coronary artery bypass grafting
398606|NCT01247974|New Onset Postoperative Atrial Fibrillation|new onset postoperative atrial fibrillation
398607|NCT01247948|pedicle screw of fixation operation|pedicle screw of fixation operation
398608|NCT01247948|spine surgery|spine surgery
398609|NCT01247948|navigation assisted|navigation assisted
398610|NCT01247935|Pain|pain
398611|NCT01247935|Acupuncture|acupuncture
398612|NCT01247935|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
398613|NCT01247935|Colonoscopy|colonoscopy
398614|NCT01247922|Pediatric Ependymoma|pediatric ependymoma
398615|NCT01247922|Ependymoma|ependymoma
398616|NCT01247922|Erlotinib|erlotinib
398618|NCT01247883|Phase 1|phase 1
398619|NCT01247883|relative bioavailability|relative bioavailability
398620|NCT01247883|healthy volunteers|healthy volunteers
398621|NCT01247883|pharmacokinetics|pharmacokinetics
398622|NCT01247883|solution|solution
398623|NCT01247883|tablet|tablet
398624|NCT01247870|Chronic obstructive pulmonary disease, COPD, metformin|chronic obstructive pulmonary disease, copd, metformin
398625|NCT01247857|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
398626|NCT01247857|Nebulization|nebulization
398627|NCT01247857|Ropivacaine|ropivacaine
398628|NCT01247844|adult Males|adult males
398629|NCT01247844|circumcision|circumcision
398630|NCT01247844|HIV prevention|hiv prevention
398631|NCT01247844|device|device
398632|NCT01247831|glaucoma, selective laser trabeculoplasty, ocular rigidity|glaucoma, selective laser trabeculoplasty, ocular rigidity
398633|NCT01247805|Bioequivalence|bioequivalence
398634|NCT01247805|Powder for oral suspention|powder for oral suspention
398635|NCT01247792|sepsis|sepsis
398636|NCT01247792|organ failure|organ failure
398637|NCT01247792|end-of-life decisions|end-of-life decisions
398638|NCT01247792|patient-centered communication|patient-centered communication
398639|NCT01247779|gynecology|gynecology
398640|NCT01247779|oncology|oncology
398641|NCT01247779|coelioscopy|coelioscopy
398642|NCT01247779|robot|robot
398643|NCT01247779|morbidity|morbidity
398644|NCT01247727|Heart rate variability|heart rate variability
398645|NCT01247727|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
398646|NCT01247714|T-Diet plus Diabet NP|t-diet plus diabet np
398647|NCT01247714|Diabetic|diabetic
398648|NCT01247714|Enteral Nutrition|enteral nutrition
398649|NCT01247714|Glycaemic response|glycaemic response
398650|NCT01247714|Metabolic Syndrome|metabolic syndrome
398651|NCT01247714|Insulin resistance|insulin resistance
398652|NCT01247714|Lipidic profile|lipidic profile
398653|NCT01247701|UCB|ucb
398654|NCT01247701|Umbilical Cord Blood|umbilical cord blood
398655|NCT01247701|Transplant|transplant
398656|NCT01247701|Umbilical Cord Blood Transplant|umbilical cord blood transplant
398657|NCT01247701|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
398658|NCT01247701|Pediatric|pediatric
398659|NCT01247701|Myeloid Hematological Malignancies|myeloid hematological malignancies
398660|NCT01247701|Busulfan|busulfan
398661|NCT01247701|Cytoxan|cytoxan
398662|NCT01247701|Cyclophosphamide|cyclophosphamide
398663|NCT01247701|Fludarabine|fludarabine
398664|NCT01247688|Lymphoid|lymphoid
398665|NCT01247688|hematologic malignancy|hematologic malignancy
398666|NCT01247688|UCB|ucb
398667|NCT01247688|Umbilical Cord Blood Transplant|umbilical cord blood transplant
398668|NCT01247688|Total Body Irradiation|total body irradiation
398669|NCT01247688|Cytoxan|cytoxan
398670|NCT01247688|Cyclophosphamide|cyclophosphamide
398671|NCT01247688|Fludarabine|fludarabine
398672|NCT01247662|Autism spectrum disorder|autism spectrum disorder
398673|NCT01247662|Social Responsiveness Scale|social responsiveness scale
398674|NCT01247662|Childhood Asperger's Syndrome Test|childhood asperger's syndrome test
398675|NCT01247662|Adult Autism Spectrum Quotient|adult autism spectrum quotient
398676|NCT01247662|psychometric|psychometric
398677|NCT01247649|Continuous glucose monitoring system|continuous glucose monitoring system
398678|NCT01247649|Non invasive|non invasive
398679|NCT01247649|Type 1 diabetes|type 1 diabetes
398680|NCT01247649|Dielectric spectroscopy|dielectric spectroscopy
398681|NCT01247636|HLRQ|hlrq
398682|NCT01247636|Elderly|elderly
398683|NCT01247636|Balance|balance
398684|NCT01247636|Mobility|mobility
398685|NCT01247636|Fear of falling|fear of falling
398686|NCT01247623|Non-resectable, advanced malignant melanoma.|non-resectable, advanced malignant melanoma.
398687|NCT01247597|Thyroid Cancer|thyroid cancer
398688|NCT01247597|Germline DICER1 Mutation|germline dicer1 mutation
398689|NCT01247597|MicroRNA Biogenesis|microrna biogenesis
398690|NCT01247597|Pleuropulmonary Blastoma|pleuropulmonary blastoma
398691|NCT01247597|PPB|ppb
398692|NCT01247584|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
398693|NCT01247584|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
398694|NCT01247584|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
398695|NCT01247584|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
398696|NCT01247584|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
398697|NCT01247584|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
398698|NCT01247584|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
398699|NCT01247584|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
398700|NCT01247558|Metanx®|metanx®
398701|NCT01247558|diabetes|diabetes
398702|NCT01247558|neuropathy|neuropathy
398703|NCT01247558|peripheral neurological disorder|peripheral neurological disorder
398704|NCT01247558|peripheral circulation disorder|peripheral circulation disorder
398705|NCT01247558|folic acid|folic acid
398706|NCT01247558|folate|folate
398707|NCT01247558|L-methylfolate|l-methylfolate
398708|NCT01247558|vitamin B6|vitamin b6
398709|NCT01247558|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
398710|NCT01247558|vitamin B12|vitamin b12
398711|NCT01247558|methylcobalamin|methylcobalamin
398712|NCT01247545|Remote ischemic preconditioning|remote ischemic preconditioning
398713|NCT01247545|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
398714|NCT01247545|Cardioprotection|cardioprotection
398715|NCT01247545|Clinical Outcomes|clinical outcomes
398716|NCT01247532|Cancer|cancer
398717|NCT01247532|Fatigue|fatigue
398718|NCT01247532|Mindfulness|mindfulness
398719|NCT01247532|Meditation|meditation
398720|NCT01247532|Neoplasms|neoplasms
398721|NCT01247506|microRNA|microrna
398722|NCT01247493|fludarabine|fludarabine
398723|NCT01247493|AML|aml
398724|NCT01247493|Efficacy|efficacy
398725|NCT01247493|tolerability|tolerability
398726|NCT01247454|CVD|cvd
398727|NCT01247454|primary prevention|primary prevention
398728|NCT01247454|ASA|asa
398729|NCT01247454|physician behavioral change|physician behavioral change
398730|NCT01247454|Patient behavioral change|patient behavioral change
398731|NCT01247441|All breast cancer patients who were diagnosed or managed in NUH will be included into this registry|all breast cancer patients who were diagnosed or managed in nuh will be included into this registry
398732|NCT01247428|Coronary Artery Disease|coronary artery disease
398733|NCT01247428|Drug-eluting Stent|drug-eluting stent
398734|NCT01247428|Sirolimus|sirolimus
398735|NCT01247415|anaphylaxis|anaphylaxis
398736|NCT01247415|allergy|allergy
398737|NCT01247415|IgE mediated|ige mediated
398738|NCT01247415|ORS|ors
398739|NCT01247415|oculorespiratory syndrome|oculorespiratory syndrome
398740|NCT01247415|Allergic-like reactions|allergic-like reactions
398741|NCT01247415|H1N1|h1n1
398742|NCT01247415|Arepanrix|arepanrix
398743|NCT01247402|peripheral arterial disease|peripheral arterial disease
398744|NCT01247402|in-stent restenosis|in-stent restenosis
398745|NCT01247402|drug eluting balloon|drug eluting balloon
398746|NCT01247389|laparoscopy|laparoscopy
398747|NCT01247389|colon resection|colon resection
399517|NCT01243684|Spinal cord|spinal cord
398748|NCT01247389|incisional hernia|incisional hernia
398749|NCT01247376|inflammation|inflammation
398750|NCT01247376|arthroscopy|arthroscopy
398751|NCT01247376|knee|knee
398752|NCT01247376|microdialysis|microdialysis
398753|NCT01247363|Diabetes glucokinase safety|diabetes glucokinase safety
398754|NCT01247311|Vitamin D|vitamin d
398755|NCT01247311|pulse wave velocity|pulse wave velocity
398756|NCT01247298|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
398757|NCT01247298|Trans-Arterial Chemobolizaion (TACE)|trans-arterial chemobolizaion (tace)
398758|NCT01247298|Radiation Induced Liver Disease (RILD)|radiation induced liver disease (rild)
402076|NCT01233245|Multiple Sclerosis|multiple sclerosis
398759|NCT01247298|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
398760|NCT01247285|Bioequivalence|bioequivalence
398761|NCT01247285|Healthy Subjects|healthy subjects
398762|NCT01247272|Bioequivalence|bioequivalence
398763|NCT01247272|Healthy Subjects|healthy subjects
398764|NCT01247259|allergic rhinitis|allergic rhinitis
398765|NCT01247259|immunotherapy|immunotherapy
398766|NCT01247259|sublingual|sublingual
398767|NCT01247246|Oral Mucositis|oral mucositis
398768|NCT01247246|Head and Neck|head and neck
398769|NCT01247246|Head and Neck Neoplasms|head and neck neoplasms
398770|NCT01247246|Mucositis|mucositis
398771|NCT01247246|Stomatitis|stomatitis
398772|NCT01247246|Neoplasms by Site|neoplasms by site
398773|NCT01247246|Neoplasms|neoplasms
398774|NCT01247246|Gastroenteritis|gastroenteritis
398775|NCT01247246|Gastrointestinal Diseases|gastrointestinal diseases
398776|NCT01247246|Digestive System Diseases|digestive system diseases
398777|NCT01247246|Mouth Diseases|mouth diseases
398778|NCT01247246|Stomatognathic Diseases|stomatognathic diseases
398779|NCT01247246|SCV-07|scv-07
398780|NCT01247233|breast cancer|breast cancer
398781|NCT01247233|Accelerated Partial Breast Irradiation|accelerated partial breast irradiation
398782|NCT01247233|invasive cancer|invasive cancer
398783|NCT01247233|Hypofractionated Irradiation|hypofractionated irradiation
398784|NCT01247233|Lumpectomy|lumpectomy
398785|NCT01247220|Macular Edema|macular edema
398786|NCT01247220|Branch retinal vein occlusion|branch retinal vein occlusion
398787|NCT01247220|Ranibizumab|ranibizumab
398788|NCT01247207|Duchenne muscular dystrophy|duchenne muscular dystrophy
398789|NCT01247207|Becker muscular dystrophy|becker muscular dystrophy
398790|NCT01247207|Nonsense mutation|nonsense mutation
398791|NCT01247207|Premature stop codon|premature stop codon
398792|NCT01247207|DMD|dmd
398793|NCT01247207|BMD|bmd
398794|NCT01247207|nmDBMD|nmdbmd
398795|NCT01247207|DBMD|dbmd
398796|NCT01247207|Ataluren|ataluren
398797|NCT01247207|PTC124|ptc124
398798|NCT01247194|hepatitis C|hepatitis c
398799|NCT01247194|NS5A|ns5a
398800|NCT01247194|HCV RNA|hcv rna
398801|NCT01247181|compliance|compliance
398802|NCT01247181|observance|observance
398803|NCT01247181|mobile phone|mobile phone
398804|NCT01247181|SMS|sms
398805|NCT01247181|text message|text message
398806|NCT01247181|ARV|arv
398807|NCT01247181|HAART|haart
398809|NCT01247168|Refractory|refractory
398810|NCT01247168|Solid tumors|solid tumors
398811|NCT01247168|Cancer|cancer
398812|NCT01247142|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
398813|NCT01247142|exhaled breath condensate|exhaled breath condensate
398814|NCT01247129|Superficial inferior epigastric artery flap, delay phenomenon|superficial inferior epigastric artery flap, delay phenomenon
398815|NCT01247103|healthy volunteers|healthy volunteers
398816|NCT01247103|safety|safety
398817|NCT01247103|tolerability|tolerability
398818|NCT01247090|hypertension|hypertension
398819|NCT01247090|end stage renal disease|end stage renal disease
398820|NCT01247090|vasopressin|vasopressin
398821|NCT01247090|Arginine Vasopressin|arginine vasopressin
398822|NCT01247090|AVP|avp
398823|NCT01247090|Pitressin®|pitressin®
398824|NCT01247077|selenium|selenium
398825|NCT01247077|neuropsychological testing|neuropsychological testing
398826|NCT01247077|autoantibodies|autoantibodies
398827|NCT01247064|Bronchiolitis|bronchiolitis
398828|NCT01247064|Hypertonic Saline|hypertonic saline
398829|NCT01247051|priming|priming
398830|NCT01247051|cardiac surgery|cardiac surgery
398831|NCT01247051|cardio pulmonary bypass|cardio pulmonary bypass
398832|NCT01247051|precoating|precoating
398833|NCT01246999|Influenza|influenza
398834|NCT01246999|A/California/7/2009-like (2009 H1N1)|a/california/7/2009-like (2009 h1n1)
398835|NCT01246999|A/Perth/16/2009-like (H3N2)|a/perth/16/2009-like (h3n2)
398836|NCT01246999|B/Brisbane/60/2008-like (B/Victoria lineage)|b/brisbane/60/2008-like (b/victoria lineage)
398837|NCT01246973|Oral Curcumin|oral curcumin
398838|NCT01246973|Radiation Dermatitis|radiation dermatitis
398839|NCT01246973|Breast Cancer Patients|breast cancer patients
398840|NCT01246960|cancer|cancer
398841|NCT01246960|stomach|stomach
398842|NCT01246960|esophagus|esophagus
398843|NCT01246960|gastroesophageal|gastroesophageal
398844|NCT01246947|Moderate Tricuspid Valve Regurgitation|moderate tricuspid valve regurgitation
398845|NCT01246947|Tricuspid Valve Repair|tricuspid valve repair
398846|NCT01246947|Mitral Value Surgery|mitral value surgery
398931|NCT01246427|Adjuvant hormonal therapy|adjuvant hormonal therapy
398847|NCT01246921|Vitiligo, repigmentation, satisfaction|vitiligo, repigmentation, satisfaction
398848|NCT01246908|TRD|trd
398849|NCT01246895|Cartilage repair|cartilage repair
398850|NCT01246895|Cartilage|cartilage
398851|NCT01246895|Knee|knee
398852|NCT01246895|Knee Injuries|knee injuries
398853|NCT01246895|Knee Pain|knee pain
398854|NCT01246895|Microfracture|microfracture
398855|NCT01246895|Bone Marrow Stimulation|bone marrow stimulation
398856|NCT01246895|Arthroscopy|arthroscopy
398857|NCT01246882|Stroke, gait, walking, disability|stroke, gait, walking, disability
398858|NCT01246882|wireless inertial sensing|wireless inertial sensing
398859|NCT01246882|mobile health|mobile health
398860|NCT01246869|brain, cancer,glioblastoma multiforme, meningioma, glioma|brain, cancer,glioblastoma multiforme, meningioma, glioma
398861|NCT01246856|Cardiotoxicity|cardiotoxicity
398862|NCT01246856|Breast cancer treatment|breast cancer treatment
398863|NCT01246856|MIBG scintigraphy|mibg scintigraphy
398864|NCT01246856|Strain Echocardiography|strain echocardiography
398865|NCT01246856|patients who have been treated with TAC one year previously|patients who have been treated with tac one year previously
398866|NCT01246843|sunitinib|sunitinib
398867|NCT01246843|sorafenib|sorafenib
398868|NCT01246843|cognitive functioning|cognitive functioning
398869|NCT01246817|Carcinoma, Renal Cell|carcinoma, renal cell
398870|NCT01246817|temsirolimus|temsirolimus
398871|NCT01246817|FLT-PET|flt-pet
398872|NCT01246817|FDG-PET|fdg-pet
398873|NCT01246817|Adult patients with metastatic RCC (any histology and any MSKCC prognostic score), with documented|adult patients with metastatic rcc (any histology and any mskcc prognostic score), with documented
398874|NCT01246817|progressive disease after more than two prior systemic treatments with any of the following: cytokines (±|progressive disease after more than two prior systemic treatments with any of the following: cytokines (±
398875|NCT01246817|chemotherapy), sunitinib, sorafenib, or bevacizumab (± IFN).|chemotherapy), sunitinib, sorafenib, or bevacizumab (± ifn).
398876|NCT01246804|HIV infections|hiv infections
398877|NCT01246804|interaction|interaction
398878|NCT01246804|pharmacokinetics|pharmacokinetics
398879|NCT01246791|NPC-01|npc-01
398880|NCT01246791|Pharmacokinetics|pharmacokinetics
398881|NCT01246791|Healthy female volunteer|healthy female volunteer
398882|NCT01246791|Norethisterone|norethisterone
398883|NCT01246791|Ethinyl Estradiol|ethinyl estradiol
398884|NCT01246765|Atypical Antipsychotics and pregnancy|atypical antipsychotics and pregnancy
398885|NCT01246765|Pregnancy|pregnancy
398886|NCT01246765|Medication use during pregnancy|medication use during pregnancy
398887|NCT01246752|AML, Leukemia|aml, leukemia
398888|NCT01246752|Acute Myeloid Leukemia|acute myeloid leukemia
398889|NCT01246752|HSCT|hsct
398890|NCT01246752|Stem Cell Transplantation|stem cell transplantation
398891|NCT01246752|Tx|tx
398892|NCT01246752|Chemotherapy|chemotherapy
398893|NCT01246739|mild hypercortisolism|mild hypercortisolism
398894|NCT01246739|adrenal tumour|adrenal tumour
398895|NCT01246739|surgical procedures, elective|surgical procedures, elective
398896|NCT01246739|indication|indication
398897|NCT01246726|cancer, breast, radiotherapy, boost|cancer, breast, radiotherapy, boost
398898|NCT01246713|acetaminophen|acetaminophen
398899|NCT01246713|excipients|excipients
398900|NCT01246700|Parkinson's disease|parkinson's disease
398901|NCT01246700|Randomized single-blind crossover trial|randomized single-blind crossover trial
398902|NCT01246700|Sensory Attention Focused Exercise|sensory attention focused exercise
398903|NCT01246674|function, hip muscle strength, hip replacement, hip pain,|function, hip muscle strength, hip replacement, hip pain,
398904|NCT01246609|acid base balance|acid base balance
398905|NCT01246609|Percutaneous Lithotripsy|percutaneous lithotripsy
398906|NCT01246583|Multi Site|multi site
398907|NCT01246583|Randomized|randomized
398908|NCT01246583|Placebo Controlled|placebo controlled
398909|NCT01246583|Double Blind|double blind
398910|NCT01246583|Parallel Group|parallel group
398911|NCT01246583|chronic plaque psoriasis|chronic plaque psoriasis
398912|NCT01246583|topical treatment|topical treatment
398913|NCT01246583|skin diseases|skin diseases
398914|NCT01246583|papulosquamous|papulosquamous
398915|NCT01246570|exercise|exercise
398916|NCT01246570|heart|heart
398917|NCT01246570|coronary disease|coronary disease
398918|NCT01246570|rehabilitation|rehabilitation
398919|NCT01246557|Patients with Chronic Lymphatic Leukemia relapsing or resistant to treatment|patients with chronic lymphatic leukemia relapsing or resistant to treatment
398920|NCT01246544|Patient Safety|patient safety
398921|NCT01246544|The Helsinki Declaration on Patient Safety in Anaesthesiology|the helsinki declaration on patient safety in anaesthesiology
398922|NCT01246544|Helsinki Declaration on Patient Safety|helsinki declaration on patient safety
398923|NCT01246544|European Board of Anaesthesiology (EBA)|european board of anaesthesiology (eba)
398924|NCT01246544|European Society of Anaesthesiology (ESA)|european society of anaesthesiology (esa)
398925|NCT01246531|Urolithiasis|urolithiasis
398926|NCT01246531|Renal calculi|renal calculi
398927|NCT01246531|Aging|aging
398928|NCT01246531|Osteoporosis|osteoporosis
398929|NCT01246518|distal subungual onychomycosis|distal subungual onychomycosis
398930|NCT01246466|Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation, Ablation, catheter ablation|persistent atrial fibrillation, longstanding persistent atrial fibrillation, ablation, catheter ablation
399028|NCT01245972|BCC|bcc
398932|NCT01246427|Homeopathic treatment|homeopathic treatment
398933|NCT01246427|Hot flashes|hot flashes
398934|NCT01246427|Quality of life|quality of life
398935|NCT01246427|Hot flash score|hot flash score
398936|NCT01246414|Asthma|asthma
398937|NCT01246414|Exhaled breath condensates|exhaled breath condensates
398938|NCT01246414|Cytokines|cytokines
398939|NCT01246388|Fibrosis|fibrosis
398940|NCT01246388|Steatosis|steatosis
398941|NCT01246388|Liver biopsy|liver biopsy
398942|NCT01246388|Elastography|elastography
398944|NCT01246349|Motivational Interviewing|motivational interviewing
398945|NCT01246349|Child and Adolescent Self-Efficacy|child and adolescent self-efficacy
398946|NCT01246349|Health Behaviours|health behaviours
398947|NCT01246336|Parkinson's disease, Parkinsonism|parkinson's disease, parkinsonism
398948|NCT01246336|Biomarkers|biomarkers
398949|NCT01246336|Exhaled breath|exhaled breath
398950|NCT01246336|Nanothechnology|nanothechnology
398951|NCT01246323|Visual analogue scale|visual analogue scale
398952|NCT01246323|pain level|pain level
398953|NCT01246323|analgesia|analgesia
398954|NCT01246323|combined anesthesia|combined anesthesia
398955|NCT01246284|Alopecia areata|alopecia areata
398956|NCT01246284|Intralesional|intralesional
398957|NCT01246284|Triamcinolone acetonide|triamcinolone acetonide
398958|NCT01246284|Concentration|concentration
398959|NCT01246258|primary ciliary dyskinesia|primary ciliary dyskinesia
398960|NCT01246258|otolith|otolith
398961|NCT01246258|vestibular tests|vestibular tests
398962|NCT01246245|PIN SITE INFECTION AFTER EXTERNAL FIXATION|pin site infection after external fixation
398963|NCT01246219|Idiopathic Short stature|idiopathic short stature
398964|NCT01246219|Self Image|self image
398965|NCT01246219|GH therapy|gh therapy
398966|NCT01246219|Psychological distress|psychological distress
398967|NCT01246206|● Non-Hodgkin lymphoma,|● non-hodgkin lymphoma,
398968|NCT01246206|● Hodgkin disease,|● hodgkin disease,
398969|NCT01246206|● Acute Myelogenous or Acute Lymphocytic Leukemia|● acute myelogenous or acute lymphocytic leukemia
398970|NCT01246206|● Myelodysplastic Syndromes,|● myelodysplastic syndromes,
398971|NCT01246206|● Chronic Myelogenous Leukemia|● chronic myelogenous leukemia
398972|NCT01246206|● Multiple Myeloma|● multiple myeloma
398973|NCT01246206|● Chronic Lymphocytic Leukemia|● chronic lymphocytic leukemia
398974|NCT01246206|● Myelofibrosis and other myeloproliferative disorders;|● myelofibrosis and other myeloproliferative disorders;
398975|NCT01246193|CKD-828|ckd-828
398976|NCT01246193|Hypertension|hypertension
398977|NCT01246193|Primary Hypertension|primary hypertension
398978|NCT01246193|Healthy Volunteer|healthy volunteer
398979|NCT01246193|S-Amlodipine|s-amlodipine
398980|NCT01246193|Telmisartan|telmisartan
398981|NCT01246193|Amlodipine|amlodipine
398982|NCT01246193|Pharmacokinetic|pharmacokinetic
398983|NCT01246193|Phase 1|phase 1
398984|NCT01246180|Skin, microcirculation; ASIC, pressure ulcer|skin, microcirculation; asic, pressure ulcer
398985|NCT01246167|Proximal humerus fracture|proximal humerus fracture
398986|NCT01246167|conservative|conservative
398987|NCT01246167|locking plate|locking plate
398988|NCT01246167|Philos|philos
398989|NCT01246167|Hemiprosthesis|hemiprosthesis
398990|NCT01246154|ASTHMA|asthma
398991|NCT01246141|tricuspid valve regurgitation|tricuspid valve regurgitation
398992|NCT01246141|replacement|replacement
398993|NCT01246141|repair|repair
398994|NCT01246141|outcomes|outcomes
398995|NCT01246128|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
398996|NCT01246128|Schizophrenia Smokers|schizophrenia smokers
398997|NCT01246128|PET Imaging|pet imaging
398998|NCT01246102|Targeted Therapy|targeted therapy
398999|NCT01246102|HER2 Positive Cancer|her2 positive cancer
399000|NCT01246102|Cancer|cancer
399001|NCT01246102|Solid Tumor|solid tumor
399002|NCT01246102|Breast Cancer|breast cancer
399003|NCT01246089|Ranibizumab|ranibizumab
399004|NCT01246089|Myopia|myopia
399005|NCT01246089|Complications|complications
399006|NCT01246089|Neovascularization|neovascularization
399007|NCT01246089|OCT|oct
399008|NCT01246050|Heart Failure|heart failure
399009|NCT01246050|Outcome Assessment|outcome assessment
399010|NCT01246050|Congestive Heart Failure|congestive heart failure
399011|NCT01246037|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
399012|NCT01246037|Beta-blocker|beta-blocker
399013|NCT01246037|Adrenergic Receptor Antagonist|adrenergic receptor antagonist
399014|NCT01245998|Thrombophlebitis|thrombophlebitis
399015|NCT01245998|Venous thrombosis|venous thrombosis
399016|NCT01245998|Pulmonary embolism|pulmonary embolism
399017|NCT01245998|Anticoagulants|anticoagulants
399018|NCT01245998|Low-Molecular-Weight Heparin|low-molecular-weight heparin
399019|NCT01245985|SCCHN|scchn
399020|NCT01245985|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
399021|NCT01245985|oropharyngeal carcinoma|oropharyngeal carcinoma
399022|NCT01245985|hypopharyngeal carcinoma|hypopharyngeal carcinoma
399023|NCT01245985|laryngeal carcinoma|laryngeal carcinoma
399024|NCT01245972|pulsed dye laser|pulsed dye laser
399025|NCT01245972|PDL|pdl
399026|NCT01245972|basal cell carcinoma|basal cell carcinoma
399027|NCT01245972|squamous cell carcinoma|squamous cell carcinoma
399031|NCT01245959|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
399032|NCT01245959|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
399033|NCT01245959|Induction chemotherapy|induction chemotherapy
399034|NCT01245959|Clinical trial|clinical trial
399035|NCT01245946|Acne moderate|acne moderate
399036|NCT01245946|Photodynamic Therapy|photodynamic therapy
399037|NCT01245946|Topical retinoids|topical retinoids
399038|NCT01245946|Antimicrobial agents|antimicrobial agents
399039|NCT01245933|COPD|copd
399040|NCT01245933|register|register
399041|NCT01245933|comorbidities|comorbidities
399042|NCT01245933|systemic inflammation|systemic inflammation
399043|NCT01245920|Dental implant|dental implant
399044|NCT01245920|Alveolar bone|alveolar bone
399045|NCT01245920|Clinical attachment Level|clinical attachment level
399046|NCT01245907|Hot flashes|hot flashes
399047|NCT01245907|Menopause|menopause
399048|NCT01245907|HRQoL|hrqol
399049|NCT01245907|Applied relaxation|applied relaxation
399050|NCT01245907|Insomnia|insomnia
399051|NCT01245907|Women's knowledge|women's knowledge
399052|NCT01245894|Index of microcirculatory resistance|index of microcirculatory resistance
399053|NCT01245894|Fractional Flow Reserve|fractional flow reserve
399054|NCT01245881|controlled trial|controlled trial
399055|NCT01245881|fractional photothermolysis|fractional photothermolysis
399056|NCT01245881|laser surgery|laser surgery
399057|NCT01245881|melasma|melasma
399058|NCT01245881|pigment disorder|pigment disorder
399059|NCT01245868|Spinal anaesthesia|spinal anaesthesia
399060|NCT01245868|Bupivacaine|bupivacaine
399061|NCT01245868|Lidocaine|lidocaine
399062|NCT01245868|Duration of blockade|duration of blockade
399063|NCT01245855|Prostaglandin E1|prostaglandin e1
399064|NCT01245855|percutaneous coronary intervention|percutaneous coronary intervention
399065|NCT01245855|Cardiac troponin T|cardiac troponin t
399066|NCT01245855|Creatine kinase-MB|creatine kinase-mb
399067|NCT01245829|Cross Infection|cross infection
399068|NCT01245829|Nosocomial Infection|nosocomial infection
399069|NCT01245829|Healthcare Acquired Infection|healthcare acquired infection
399652|NCT01243125|SCI|sci
399070|NCT01245829|Hospital Paperwork|hospital paperwork
399071|NCT01245829|Observation Charts|observation charts
399072|NCT01245829|Critical Care|critical care
399073|NCT01245829|Contamination|contamination
399074|NCT01245816|colon polyps|colon polyps
399075|NCT01245803|rosuvastatin|rosuvastatin
399076|NCT01245803|angioplasty|angioplasty
399077|NCT01245803|acute coronary syndrome|acute coronary syndrome
399078|NCT01245790|Phase 1|phase 1
399079|NCT01245790|healthy volunteers|healthy volunteers
399080|NCT01245790|volunteers with renal impairment|volunteers with renal impairment
399081|NCT01245790|pharmacokinetics|pharmacokinetics
399082|NCT01245790|Rheumatoid arthritis|rheumatoid arthritis
399083|NCT01245790|RA|ra
399084|NCT01245790|fostamatinib|fostamatinib
399085|NCT01245790|Patients|patients
399086|NCT01245777|RLS|rls
399087|NCT01245777|Pregnancy|pregnancy
399088|NCT01245777|Iron Deficiency|iron deficiency
399089|NCT01245777|Anaemia|anaemia
399090|NCT01245764|Cervical cancer|cervical cancer
399091|NCT01245764|vulvar cancer|vulvar cancer
399092|NCT01245764|vaginal cancer|vaginal cancer
399093|NCT01245764|genital warts|genital warts
399094|NCT01245764|human papillomavirus|human papillomavirus
399095|NCT01245751|Shingles|shingles
399096|NCT01245751|Vaccine|vaccine
399097|NCT01245712|Adenocarcinoma of the breast|adenocarcinoma of the breast
399098|NCT01245712|Lumpectomy|lumpectomy
399099|NCT01245712|Stage 0 breast cancer|stage 0 breast cancer
399100|NCT01245712|Stage I breast cancer|stage i breast cancer
399101|NCT01245712|Stage II breast cancer|stage ii breast cancer
399102|NCT01245712|Accelerated partial breast irradiation|accelerated partial breast irradiation
399103|NCT01245712|APBI|apbi
399104|NCT01245699|Cardiac arrest, CPR, quality improvement|cardiac arrest, cpr, quality improvement
399105|NCT01245686|Diet interventions|diet interventions
399106|NCT01245686|Physical activity interventions|physical activity interventions
399107|NCT01245686|Medication adherence|medication adherence
399108|NCT01245686|Tailored interventions|tailored interventions
399109|NCT01245673|Advanced Disease|advanced disease
399110|NCT01245673|MAGE-A3 Immunizations with Hiltonol|mage-a3 immunizations with hiltonol
399111|NCT01245673|Vaccine-Primed Autologous T-Cells|vaccine-primed autologous t-cells
399112|NCT01245673|Lenalidomide Maintenance|lenalidomide maintenance
399113|NCT01245660|Phase 0|phase 0
399114|NCT01245660|Bladder carcinoma|bladder carcinoma
399115|NCT01245660|egf pathway|egf pathway
399116|NCT01245660|infiltrative bladder carcinoma|infiltrative bladder carcinoma
399117|NCT01245660|cystectomy|cystectomy
399118|NCT01245660|LAPATINIB|lapatinib
399119|NCT01245647|women|women
399120|NCT01245647|HIV|hiv
399121|NCT01245647|alcohol|alcohol
399122|NCT01245647|medication|medication
399123|NCT01245647|adherence|adherence
399124|NCT01245647|acceptability|acceptability
399125|NCT01245621|palliative care|palliative care
399126|NCT01245621|end of life care|end of life care
399127|NCT01245621|quality of life|quality of life
399128|NCT01245621|caregivers|caregivers
399129|NCT01245608|Atorvastatin|atorvastatin
399130|NCT01245608|Aspirin|aspirin
399131|NCT01245608|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
399132|NCT01245608|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
399133|NCT01245608|antihypertensive agents|antihypertensive agents
399134|NCT01245595|Acute Kidney Injury (AKI)|acute kidney injury (aki)
399135|NCT01245595|Cardiopulmonary bypass (CPB)|cardiopulmonary bypass (cpb)
399136|NCT01245530|Alzheimer disease|alzheimer disease
399137|NCT01245517|hyperphosphatemia or malnutrition|hyperphosphatemia or malnutrition
399138|NCT01245478|Surgical Procedures, Elective|surgical procedures, elective
399139|NCT01245452|Rheumatoid arthritis|rheumatoid arthritis
399140|NCT01245452|Tocilizumab|tocilizumab
399141|NCT01245452|Cardiorespiratory endurance|cardiorespiratory endurance
399142|NCT01245426|Asthma|asthma
399143|NCT01245426|GW870086|gw870086
399144|NCT01245426|Efficacy|efficacy
399145|NCT01245426|FEV1|fev1
399146|NCT01245413|Stoma|stoma
399147|NCT01245413|adhesive|adhesive
399148|NCT01245413|warm|warm
399149|NCT01245413|moist|moist
399150|NCT01245413|cycling|cycling
399151|NCT01245413|men|men
399152|NCT01245413|peel-value|peel-value
399153|NCT01245413|healthy men 50-70 years old|healthy men 50-70 years old
399154|NCT01245413|men with colostoma, above 18 years|men with colostoma, above 18 years
399155|NCT01245400|Z-Lig|z-lig
399156|NCT01245400|allograft|allograft
399157|NCT01245400|ACL|acl
399158|NCT01245400|Anterior Cruciate Ligament|anterior cruciate ligament
399159|NCT01245400|ACLR|aclr
399160|NCT01245400|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
399161|NCT01245400|EU|eu
399162|NCT01245400|European Union|european union
399163|NCT01245400|S. Africa|s. africa
399164|NCT01245400|Reconstruction of ruptured anterior cruciate ligaments|reconstruction of ruptured anterior cruciate ligaments
399165|NCT01245387|prospective|prospective
399166|NCT01245387|observational|observational
399167|NCT01245387|Phase 4|phase 4
399168|NCT01245387|non-interventional|non-interventional
399169|NCT01245387|open-label|open-label
399170|NCT01245361|Undifferentiated Arthritis|undifferentiated arthritis
399171|NCT01245361|Rheumatoid Arthritis|rheumatoid arthritis
399172|NCT01245361|Infliximab|infliximab
399173|NCT01245348|Schizophrenia|schizophrenia
399174|NCT01245348|Bipolar Disorder|bipolar disorder
399175|NCT01245348|atypical antipsychotic|atypical antipsychotic
399176|NCT01245348|adherence|adherence
399177|NCT01245348|cost effectiveness|cost effectiveness
399178|NCT01245348|pharmacogenetics|pharmacogenetics
399179|NCT01245348|mental illness|mental illness
399180|NCT01245348|SULT4A1|sult4a1
399181|NCT01245335|CLI|cli
399182|NCT01245335|Critical Limb Ischemia|critical limb ischemia
399183|NCT01245335|PAOD|paod
399184|NCT01245335|Peripheral Arterial Disease|peripheral arterial disease
399185|NCT01245335|Stem Cells|stem cells
399186|NCT01245335|Limb amputation|limb amputation
399187|NCT01245335|Leg ulcers|leg ulcers
399188|NCT01245322|treatment, lactobacilli|treatment, lactobacilli
399189|NCT01245296|Umbilical cord|umbilical cord
399190|NCT01245296|cord clamping|cord clamping
399191|NCT01245296|iron|iron
399192|NCT01245296|Ferritin|ferritin
399193|NCT01245296|newborn|newborn
399194|NCT01245296|jaundice|jaundice
399195|NCT01245296|infant|infant
399196|NCT01245296|development|development
399197|NCT01245296|infections|infections
399198|NCT01245283|knee|knee
399199|NCT01245283|osteoarthritis|osteoarthritis
399200|NCT01245283|pain|pain
399201|NCT01245283|function|function
399202|NCT01245283|impairment|impairment
399203|NCT01245270|anthocyanin|anthocyanin
399204|NCT01245270|blaeberries|blaeberries
399205|NCT01245270|bilberries|bilberries
399206|NCT01245270|blueberries|blueberries
399207|NCT01245270|mirtoselect|mirtoselect
399208|NCT01245270|glucose AUC|glucose auc
399209|NCT01245257|Inflammation|inflammation
399210|NCT01245257|Urea Synthesis|urea synthesis
399211|NCT01245257|Catabolism|catabolism
399212|NCT01245257|Nitrogen balance|nitrogen balance
399213|NCT01245231|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
399214|NCT01245179|sickle cell anemia|sickle cell anemia
399215|NCT01245179|sickle cell thalassemia|sickle cell thalassemia
399216|NCT01245179|HDAC inhibitor|hdac inhibitor
399217|NCT01245179|hemoglobin F|hemoglobin f
399218|NCT01245179|sickle beta thalassemia|sickle beta thalassemia
399219|NCT01245179|Fetal Hemoglobin|fetal hemoglobin
399220|NCT01245153|Urinary incontinence, Pelvic floor muscle training|urinary incontinence, pelvic floor muscle training
399221|NCT01245140|Palmo-Plantar Pustolosis|palmo-plantar pustolosis
399222|NCT01245127|Schnitzler syndrome|schnitzler syndrome
399223|NCT01245101|HIV raltegravir intensification replication activation|hiv raltegravir intensification replication activation
399224|NCT01245088|Crohn's disease|crohn's disease
399225|NCT01245088|chondroitin sulfate|chondroitin sulfate
399226|NCT01245062|MEK inhibitor|mek inhibitor
399227|NCT01245062|Cancer|cancer
399228|NCT01245062|Metastatic Melanoma|metastatic melanoma
399229|NCT01245062|BRAF mutant metastatic melanoma|braf mutant metastatic melanoma
399230|NCT01245062|GSK1120212|gsk1120212
399231|NCT01245049|MMR|mmr
399232|NCT01245049|dTpa-IPV|dtpa-ipv
399233|NCT01245049|Boostrix Polio|boostrix polio
399235|NCT01245049|Priorix|priorix
399236|NCT01245036|Sarcoidosis|sarcoidosis
399237|NCT01245036|Tuberculosis|tuberculosis
399238|NCT01245010|Metabolic Syndrome|metabolic syndrome
399239|NCT01245010|Water|water
399240|NCT01245010|Obesity|obesity
399241|NCT01245010|Clinical trial|clinical trial
399242|NCT01245010|Prevention|prevention
399243|NCT01244997|Partial edentulism|partial edentulism
399244|NCT01244997|Bone atrophy|bone atrophy
399245|NCT01244997|Bone healing|bone healing
399246|NCT01244984|asthma|asthma
399247|NCT01244984|Fluticasone furoate|fluticasone furoate
399248|NCT01244984|GW642444|gw642444
399249|NCT01244958|Active rheumatoid arthritis|active rheumatoid arthritis
399250|NCT01244958|leflunomide|leflunomide
399251|NCT01244958|rituximab|rituximab
399252|NCT01244958|inadequate clinical response to leflunomide|inadequate clinical response to leflunomide
399253|NCT01244945|Functional Constipation|functional constipation
399254|NCT01244945|Functional Foods|functional foods
399255|NCT01244945|Probiotics|probiotics
399256|NCT01244945|Lactobacillus reuteri|lactobacillus reuteri
399257|NCT01244906|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
399258|NCT01244906|Acute Myelogenous Leukemia|acute myelogenous leukemia
399259|NCT01244906|Myelodysplastic Syndrome|myelodysplastic syndrome
399260|NCT01244906|Myelofibrosis|myelofibrosis
399261|NCT01244906|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
399262|NCT01244906|Acute Lymphoblastic Lymphoma|acute lymphoblastic lymphoma
399263|NCT01244906|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
399264|NCT01244906|Prolymphocytic Leukemia|prolymphocytic leukemia
390196|NCT01285050|HIV|hiv
399265|NCT01244906|Low-grade non-Hodgkin's Lymphoma|low-grade non-hodgkin's lymphoma
399266|NCT01244906|Mantle Cell Lymphoma|mantle cell lymphoma
399267|NCT01244906|Hodgkin Lymphoma|hodgkin lymphoma
399268|NCT01244906|Myeloma|myeloma
399269|NCT01244880|PF-02545920|pf-02545920
399270|NCT01244880|ketamine|ketamine
399271|NCT01244880|fMRI|fmri
399272|NCT01244880|associative Learning|associative learning
399273|NCT01244854|chronic mental disorders|chronic mental disorders
399274|NCT01244854|cardiovascular disease|cardiovascular disease
399275|NCT01244854|behavior change|behavior change
399276|NCT01244841|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
399277|NCT01244841|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
399278|NCT01244841|Discharge|discharge
399279|NCT01244841|Health status|health status
399280|NCT01244841|Quality of care|quality of care
399281|NCT01244815|Bi-polar I disorder|bi-polar i disorder
399282|NCT01244815|antipsychotic|antipsychotic
399283|NCT01244815|serotonin|serotonin
399284|NCT01244815|dopamine|dopamine
399285|NCT01244815|noradrenalin|noradrenalin
399286|NCT01244815|histamine|histamine
399287|NCT01244815|pediatric|pediatric
399288|NCT01244802|yellow fever vaccine|yellow fever vaccine
399289|NCT01244789|endometrial cancer|endometrial cancer
399290|NCT01244789|chemotherapy|chemotherapy
399291|NCT01244789|carboplatin|carboplatin
399292|NCT01244789|paclitaxel|paclitaxel
399293|NCT01244789|Stage 1 & 2|stage 1 & 2
399294|NCT01244789|node-negative|node-negative
399295|NCT01244789|intermediate risk|intermediate risk
399296|NCT01244789|high risk|high risk
399297|NCT01244763|Kidney|kidney
399298|NCT01244763|Chronic Kidney Disease|chronic kidney disease
399299|NCT01244763|CKD|ckd
399300|NCT01244763|Renal|renal
399301|NCT01244763|Anemia|anemia
399302|NCT01244763|Oral anemia treatment|oral anemia treatment
399303|NCT01244763|Hemoglobin levels|hemoglobin levels
399304|NCT01244763|Erythropoietin|erythropoietin
399305|NCT01244763|Blood count|blood count
399306|NCT01244763|Predialysis|predialysis
399307|NCT01244763|Pre-dialysis|pre-dialysis
399308|NCT01244763|Hb|hb
399309|NCT01244763|Non-dialysis|non-dialysis
399310|NCT01244750|Chronic Phase - Chronic Myeloid Leukemia|chronic phase - chronic myeloid leukemia
399311|NCT01244737|Brain neoplasms|brain neoplasms
399312|NCT01244737|Children|children
399313|NCT01244737|Positron-Emission Tomography|positron-emission tomography
399314|NCT01244737|18F-FLT|18f-flt
399315|NCT01244711|Major Depression|major depression
399316|NCT01244711|Generalized Anxiety Disorder|generalized anxiety disorder
399317|NCT01244711|Benzodiazepine|benzodiazepine
399318|NCT01244711|Quetiapine|quetiapine
399319|NCT01244698|Surgical Site Infection, Breast Reconstruction, Antibiotics|surgical site infection, breast reconstruction, antibiotics
399320|NCT01244685|bowel resection|bowel resection
399321|NCT01244685|Deltex CardioQ Probe|deltex cardioq probe
399322|NCT01244685|fluid management|fluid management
399323|NCT01244672|Hemorrhoids|hemorrhoids
399324|NCT01244672|THD|thd
399325|NCT01244672|Ferguson|ferguson
399326|NCT01244659|Tacrolimus|tacrolimus
399327|NCT01244659|Immunosuppressive Agents|immunosuppressive agents
399328|NCT01244659|Kidney transplantation|kidney transplantation
399329|NCT01244646|Diabetes Mellitus|diabetes mellitus
399330|NCT01244646|Type 2|type 2
399331|NCT01244646|DMT2|dmt2
399332|NCT01244646|T2DM|t2dm
399333|NCT01244646|metformin|metformin
399334|NCT01244646|sulfonylurea|sulfonylurea
399335|NCT01244646|hypoglycemia|hypoglycemia
399336|NCT01244646|weight|weight
399337|NCT01244646|quality of life|quality of life
399338|NCT01244646|compliance|compliance
399339|NCT01244633|Tourette's|tourette's
399340|NCT01244633|Ecopipam|ecopipam
399341|NCT01244633|Dopamine receptors|dopamine receptors
399342|NCT01244633|Efficacy|efficacy
399343|NCT01244633|Safety|safety
399344|NCT01244633|Adults|adults
399345|NCT01244620|A pharmacokinetic drug-drug interaction study between sitaxsentan and tadalafil and between sitaxsentan and sildenafil at the steady-state|a pharmacokinetic drug-drug interaction study between sitaxsentan and tadalafil and between sitaxsentan and sildenafil at the steady-state
399346|NCT01244594|Spinal Cord Injury|spinal cord injury
399347|NCT01244594|Cycling|cycling
399348|NCT01244594|Functional Electrical Stimulation|functional electrical stimulation
399349|NCT01244581|middle ear effusion|middle ear effusion
399350|NCT01244581|amoxicillin-clavulanate|amoxicillin-clavulanate
399351|NCT01244581|tympanometry|tympanometry
399352|NCT01244568|Prostate Cancer|prostate cancer
399353|NCT01244568|Decision support interventions (DESI)|decision support interventions (desi)
399354|NCT01244568|Comparative Effectiveness Research (CER)|comparative effectiveness research (cer)
399355|NCT01244542|Schizophrenia|schizophrenia
399356|NCT01244542|DSM IV criteria|dsm iv criteria
399357|NCT01244542|Pain insensitivity|pain insensitivity
399358|NCT01244542|Painful perception|painful perception
399359|NCT01244542|Opioid receptors|opioid receptors
399360|NCT01244490|ADHD|adhd
399361|NCT01244477|Stress Disorders, Post Traumatic|stress disorders, post traumatic
399362|NCT01244477|Trust|trust
399363|NCT01244477|functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
399364|NCT01244464|Poliomyelitis|poliomyelitis
399365|NCT01244464|IMOVAX POLIO™|imovax polio™
399366|NCT01244464|Polio|polio
399367|NCT01244451|CLL|cll
399368|NCT01244451|relapsed|relapsed
399369|NCT01244451|refractory|refractory
399370|NCT01244451|Bendamustine|bendamustine
399371|NCT01244451|Ofatumumab|ofatumumab
400246|NCT01240642|core phase|core phase
399372|NCT01244438|endometrial cancer|endometrial cancer
399373|NCT01244438|FGFR2 mutations|fgfr2 mutations
399374|NCT01244412|Fundus photography|fundus photography
399375|NCT01244399|inositol|inositol
399376|NCT01244399|caffeine|caffeine
399377|NCT01244399|NTDs|ntds
399378|NCT01244386|Computed tomography|computed tomography
399379|NCT01244386|Iterative reconstruction|iterative reconstruction
399380|NCT01244386|Automatic tube current modulation|automatic tube current modulation
399381|NCT01244386|Crohn's disease|crohn's disease
399382|NCT01244386|Inflammatory bowel disease|inflammatory bowel disease
399383|NCT01244386|Radiation dose optimization|radiation dose optimization
399384|NCT01244386|C reactive protein|c reactive protein
399385|NCT01244373|Best-corrected visual acuity|best-corrected visual acuity
399386|NCT01244373|posterior capsule opacification|posterior capsule opacification
399387|NCT01244373|QUATRIX® Aspheric Evolutive pre-loaded|quatrix® aspheric evolutive pre-loaded
399388|NCT01244360|resveratrol|resveratrol
399389|NCT01244360|insulin|insulin
399390|NCT01244360|inflammation|inflammation
399391|NCT01244360|cognition|cognition
399392|NCT01244360|metabolism|metabolism
399393|NCT01244347|folic acid|folic acid
399394|NCT01244347|malformations|malformations
399395|NCT01244347|prevention|prevention
399396|NCT01244334|cataract surgery, vision, corneal edema, retinal thickness|cataract surgery, vision, corneal edema, retinal thickness
399397|NCT01244321|End stage heart failure|end stage heart failure
399398|NCT01244321|heart transplantation|heart transplantation
399399|NCT01244321|Ventricular assist device|ventricular assist device
399400|NCT01244321|Patients with end stage heart failure|patients with end stage heart failure
399401|NCT01244321|awaiting heart transplantation|awaiting heart transplantation
399402|NCT01244308|Phrenic nerve stimulation|phrenic nerve stimulation
399403|NCT01244308|LV pacing configuration|lv pacing configuration
399404|NCT01244308|CRT|crt
399405|NCT01244308|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
399406|NCT01244308|Heart failure|heart failure
399407|NCT01244295|Grief|grief
399408|NCT01244295|Bereavement|bereavement
399409|NCT01244295|Psychotherapy|psychotherapy
399410|NCT01244295|Randomized controlled trial|randomized controlled trial
399411|NCT01244295|Treatment study|treatment study
399412|NCT01244282|brain imaging|brain imaging
399413|NCT01244269|Parkinson's disease|parkinson's disease
399414|NCT01244269|Methylphenidate|methylphenidate
399415|NCT01244269|Non motor symptoms|non motor symptoms
399416|NCT01244269|Postural control|postural control
399417|NCT01244243|stroke|stroke
399418|NCT01244243|rehabilitation|rehabilitation
399419|NCT01244204|vitamin D deficiency|vitamin d deficiency
399420|NCT01244204|tuberculin sin test|tuberculin sin test
399421|NCT01244204|immunity|immunity
399422|NCT01244204|tuberculosis|tuberculosis
399423|NCT01244191|Non squamous, non-small-cell lung cancer|non squamous, non-small-cell lung cancer
399424|NCT01244191|Epidermal growth factor receptor, wild type|epidermal growth factor receptor, wild type
399425|NCT01244191|c-Met inhibitor|c-met inhibitor
399426|NCT01244178|Sepsis|sepsis
399427|NCT01244178|Insulin|insulin
399428|NCT01244139|BIIB033|biib033
399429|NCT01244139|Multiple Sclerosis|multiple sclerosis
399430|NCT01244139|anti-LINGO-1 antibody|anti-lingo-1 antibody
399431|NCT01244139|Relapsing Remitting MS|relapsing remitting ms
399432|NCT01244139|remyelination|remyelination
399433|NCT01244139|myelin repair|myelin repair
399434|NCT01244139|Multiple ascending dose|multiple ascending dose
399435|NCT01244139|Secondary progessive MS|secondary progessive ms
399436|NCT01244126|otitis media|otitis media
399437|NCT01244126|recurrent ear infections (otitis media)|recurrent ear infections (otitis media)
399438|NCT01244100|Food-effects PK study in healthy subjects.|food-effects pk study in healthy subjects.
399439|NCT01244087|Inquiry-based stress reduction|inquiry-based stress reduction
399440|NCT01244087|Quality of life|quality of life
399441|NCT01244087|breast cancer|breast cancer
399442|NCT01244048|n3 LC-PUFA, yoghurt, inflammatory markers|n3 lc-pufa, yoghurt, inflammatory markers
399443|NCT01244035|High blood pressure|high blood pressure
399444|NCT01244022|Colorectal cancer|colorectal cancer
399445|NCT01244022|Surgical stress response|surgical stress response
399446|NCT01244022|interleukins|interleukins
399447|NCT01244009|Poly (ADP-ribose) polymerase (PARP) inhibitor|poly (adp-ribose) polymerase (parp) inhibitor
399448|NCT01243996|Patent ductus arteriosus, ibuprofen, preterm infants|patent ductus arteriosus, ibuprofen, preterm infants
399449|NCT01243970|Spinal anaesthesia|spinal anaesthesia
399450|NCT01243970|phenylephrine|phenylephrine
399451|NCT01243970|ephedrine|ephedrine
399452|NCT01243970|ECG changes|ecg changes
487471|NCT00131807|HIV|hiv
399453|NCT01243970|Caesarean delivery|caesarean delivery
399454|NCT01243970|Myocardial ischaemia|myocardial ischaemia
399455|NCT01243970|Cardiac output|cardiac output
399456|NCT01243970|hypotension|hypotension
399457|NCT01243944|INCB018424|incb018424
399458|NCT01243931|Phototherapeutic keratectomy|phototherapeutic keratectomy
399459|NCT01243931|Optical coherence tomography|optical coherence tomography
399460|NCT01243931|Corneal opacity|corneal opacity
399461|NCT01243918|Acute respiratory failure|acute respiratory failure
399462|NCT01243918|Oxygen therapy delivery systems|oxygen therapy delivery systems
400441|NCT01239888|Estrogens|estrogens
399463|NCT01243918|Non invasive ventilation|non invasive ventilation
399464|NCT01243918|High concentration mask|high concentration mask
399465|NCT01243918|Hypoxemic pneumonia|hypoxemic pneumonia
399467|NCT01243879|starvation|starvation
399468|NCT01243879|calorie restriction|calorie restriction
399469|NCT01243879|fMRI|fmri
399470|NCT01243840|Central aortic pressure|central aortic pressure
399471|NCT01243840|Aortic pulse wave velocity|aortic pulse wave velocity
399472|NCT01243840|Aortic PWV using a single pressure recording|aortic pwv using a single pressure recording
399473|NCT01243840|Vascular aging|vascular aging
399474|NCT01243840|Left ventricular hypertrophy|left ventricular hypertrophy
399475|NCT01243840|Left ventricular diastolic function|left ventricular diastolic function
399476|NCT01243827|Hypertension, carvedilol, bisoprolol, central pulse pressure, pulse pressure amplification, reflection magnitude, LV mass index, LV diastolic function|hypertension, carvedilol, bisoprolol, central pulse pressure, pulse pressure amplification, reflection magnitude, lv mass index, lv diastolic function
399477|NCT01243814|hyaluronate|hyaluronate
399478|NCT01243814|hyaluronic acid|hyaluronic acid
399479|NCT01243814|viscosupplementation|viscosupplementation
399480|NCT01243801|chronic pain|chronic pain
399481|NCT01243801|persistent postsurgical pain|persistent postsurgical pain
399482|NCT01243801|hyperalgesia|hyperalgesia
399483|NCT01243801|ketamine|ketamine
399484|NCT01243801|quantitative sensory testing|quantitative sensory testing
399485|NCT01243788|COPD|copd
399486|NCT01243788|Seretide|seretide
399487|NCT01243788|Combivent|combivent
399488|NCT01243788|effect and safety|effect and safety
399489|NCT01243788|Twelve weeks|twelve weeks
399490|NCT01243775|NSCLC|nsclc
399491|NCT01243762|Colorectal cancer|colorectal cancer
399492|NCT01243762|Solid tumors|solid tumors
399493|NCT01243762|Ovarian cancer|ovarian cancer
399494|NCT01243762|Fallopian tube cancer|fallopian tube cancer
399495|NCT01243762|Primary peritoneal cancer|primary peritoneal cancer
399496|NCT01243749|Target Vessel Revascularization (TVR)|target vessel revascularization (tvr)
399497|NCT01243749|Target Lesion Revascularization (TLR)|target lesion revascularization (tlr)
399498|NCT01243749|Myocardial Infarction (MI)|myocardial infarction (mi)
399499|NCT01243749|Target Vessel Failure (TVF)|target vessel failure (tvf)
399500|NCT01243749|Target Lesion Failure (TLF)|target lesion failure (tlf)
399501|NCT01243749|Stent Thrombosis|stent thrombosis
399502|NCT01243749|Restenotic Lesion|restenotic lesion
399503|NCT01243749|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
399504|NCT01243749|Real-world|real-world
399505|NCT01243736|anemic|anemic
399506|NCT01243736|bleeding|bleeding
399507|NCT01243736|blood in stool|blood in stool
399508|NCT01243736|abdomen pain|abdomen pain
399509|NCT01243736|Gastrointestinal bleeding|gastrointestinal bleeding
399510|NCT01243736|capsule endoscopy (CE)|capsule endoscopy (ce)
399511|NCT01243723|Dyschesia treatment|dyschesia treatment
399512|NCT01243723|Inconfort related to dyschesia|inconfort related to dyschesia
399513|NCT01243723|Quality of life|quality of life
399514|NCT01243723|Bowel function index|bowel function index
399515|NCT01243697|Desogestrel|desogestrel
399516|NCT01243697|Chemosensitivity|chemosensitivity
399518|NCT01243684|cervical spondylosis|cervical spondylosis
399519|NCT01243684|myelopathy|myelopathy
399520|NCT01243671|Behçet's, intestinal|behçet's, intestinal
399521|NCT01243658|Oxytocin|oxytocin
399523|NCT01243658|Borderline|borderline
399524|NCT01243632|malignant pleural mesothelioma|malignant pleural mesothelioma
399525|NCT01243632|chemotherapy|chemotherapy
399526|NCT01243632|gemcitabine|gemcitabine
399527|NCT01243632|cisplatin|cisplatin
399528|NCT01243632|long infusion|long infusion
399529|NCT01243619|PET|pet
399530|NCT01243619|CT|ct
399531|NCT01243619|radiotherapy|radiotherapy
399532|NCT01243606|Anxiety|anxiety
399533|NCT01243606|Depression|depression
399534|NCT01243606|Obsessive Compulsive Disorder|obsessive compulsive disorder
399535|NCT01243606|Panic Disorder|panic disorder
399536|NCT01243606|Generalized Anxiety Disorder|generalized anxiety disorder
399537|NCT01243606|Social Anxiety Disorder|social anxiety disorder
399538|NCT01243606|Transdiagnostic Treatment|transdiagnostic treatment
399539|NCT01243606|CBT|cbt
399540|NCT01243593|pediatrics|pediatrics
399541|NCT01243593|anesthesia|anesthesia
399542|NCT01243593|pyeloplasty|pyeloplasty
399543|NCT01243593|Transversus Abdominis Plane Block|transversus abdominis plane block
399544|NCT01243593|Regional Anesthesia|regional anesthesia
399545|NCT01243580|PK and safety|pk and safety
399546|NCT01243580|Pharmacokinetic profile (PK) and safety|pharmacokinetic profile (pk) and safety
399547|NCT01243554|Exercise training|exercise training
399548|NCT01243554|Pregnancy|pregnancy
399549|NCT01243554|Obesity|obesity
399550|NCT01243528|Malnutrition|malnutrition
399551|NCT01243528|Infection|infection
399552|NCT01243528|Neurological|neurological
399553|NCT01243515|Central Venous Pressure|central venous pressure
399554|NCT01243515|Kidney Diseases|kidney diseases
399555|NCT01243515|Chronic Kidney Disease|chronic kidney disease
399556|NCT01243515|Healthy Subjects|healthy subjects
399557|NCT01243515|Non-Invasive Monitor|non-invasive monitor
399558|NCT01243489|CML|cml
399559|NCT01243489|compliance|compliance
399560|NCT01243489|compliance supporting measures|compliance supporting measures
399561|NCT01243489|complete cytogenetic response|complete cytogenetic response
399562|NCT01243489|mayor molecular remission|mayor molecular remission
399563|NCT01243489|Philadelphia chromosome|philadelphia chromosome
399564|NCT01243489|BCR-ABL|bcr-abl
399565|NCT01243489|Imatinib|imatinib
399566|NCT01243489|tyrosine kinase inhibitor|tyrosine kinase inhibitor
399567|NCT01243489|smart blister|smart blister
399568|NCT01243476|myelodysplastic syndrome|myelodysplastic syndrome
399569|NCT01243476|5q deletion|5q deletion
399570|NCT01243476|anemia|anemia
399571|NCT01243476|lenalidomide|lenalidomide
399572|NCT01243476|red blood cells transfusion|red blood cells transfusion
399573|NCT01243437|plague, ciprofloxacin|plague, ciprofloxacin
399574|NCT01243411|Peyronie's Disease, penile plaque, penile curvature|peyronie's disease, penile plaque, penile curvature
399575|NCT01243398|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
399576|NCT01243398|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
399577|NCT01243398|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
399578|NCT01243398|recurrent esophageal cancer|recurrent esophageal cancer
399579|NCT01243398|stage IA esophageal cancer|stage ia esophageal cancer
399580|NCT01243398|stage IB esophageal cancer|stage ib esophageal cancer
399581|NCT01243398|stage IIA esophageal cancer|stage iia esophageal cancer
399582|NCT01243398|stage IIB esophageal cancer|stage iib esophageal cancer
399583|NCT01243398|stage IIIA esophageal cancer|stage iiia esophageal cancer
399584|NCT01243398|stage IIIB esophageal cancer|stage iiib esophageal cancer
399585|NCT01243398|stage IIIC esophageal cancer|stage iiic esophageal cancer
399586|NCT01243398|stage IV esophageal cancer|stage iv esophageal cancer
399587|NCT01243385|adenocarcinoma of the prostate|adenocarcinoma of the prostate
399588|NCT01243385|hormone-resistant prostate cancer|hormone-resistant prostate cancer
399589|NCT01243385|stage III prostate cancer|stage iii prostate cancer
399590|NCT01243385|stage IV prostate cancer|stage iv prostate cancer
399591|NCT01243385|recurrent prostate cancer|recurrent prostate cancer
399592|NCT01243372|recurrent colon cancer|recurrent colon cancer
399593|NCT01243372|stage IIIA colon cancer|stage iiia colon cancer
399594|NCT01243372|stage IIIB colon cancer|stage iiib colon cancer
399595|NCT01243372|stage IIIC colon cancer|stage iiic colon cancer
399596|NCT01243372|stage IVA colon cancer|stage iva colon cancer
399597|NCT01243372|stage IVB colon cancer|stage ivb colon cancer
399598|NCT01243372|recurrent rectal cancer|recurrent rectal cancer
399599|NCT01243372|stage III rectal cancer|stage iii rectal cancer
399600|NCT01243372|stage IV rectal cancer|stage iv rectal cancer
399601|NCT01243346|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
399602|NCT01243346|PDGFR Inhibitor|pdgfr inhibitor
399603|NCT01243346|Crenolanib (CP-868,596)|crenolanib (cp-868,596)
399604|NCT01243333|cancer, imaging|cancer, imaging
399605|NCT01243281|hepatitis B|hepatitis b
399607|NCT01243281|pegylated interferon|pegylated interferon
399608|NCT01243281|entecavir|entecavir
399609|NCT01243255|hypercholesterolemia|hypercholesterolemia
399610|NCT01243255|low density lipoprotein|low density lipoprotein
399611|NCT01243255|undertreatment of hypercholesterolemia|undertreatment of hypercholesterolemia
399612|NCT01243242|ADHD,Adults,MG01CI,METADOXINE|adhd,adults,mg01ci,metadoxine
399613|NCT01243216|Pregnancy|pregnancy
399614|NCT01243216|Labor|labor
399615|NCT01243216|Epidural Analgesia|epidural analgesia
399616|NCT01243216|Epidural Anesthesia|epidural anesthesia
399617|NCT01243216|Spinal Anesthesia|spinal anesthesia
399618|NCT01243216|Ultrasound|ultrasound
399619|NCT01243216|Neuraxial Analgesia|neuraxial analgesia
399620|NCT01243216|Neuraxial Anesthesia|neuraxial anesthesia
399621|NCT01243216|Cesarean delivery|cesarean delivery
399622|NCT01243203|Smoking, surgery, Anesthesia, quit|smoking, surgery, anesthesia, quit
399623|NCT01243190|leukemia|leukemia
399624|NCT01243190|small lymphocytic leukemia|small lymphocytic leukemia
399625|NCT01243190|SLL|sll
399626|NCT01243190|CLL|cll
399627|NCT01243190|ofatumumab|ofatumumab
399628|NCT01243190|untreated|untreated
399629|NCT01243190|early stage|early stage
399630|NCT01243190|high-risk|high-risk
399631|NCT01243177|Lacosamide|lacosamide
399632|NCT01243177|Vimpat®|vimpat®
399633|NCT01243177|Epilepsy|epilepsy
399634|NCT01243177|Monotherapy|monotherapy
399635|NCT01243177|Velocity|velocity
399636|NCT01243164|confidence|confidence
399637|NCT01243164|wheelchair performance|wheelchair performance
390500|NCT01283516|NSCLC,|nsclc,
399638|NCT01243151|Hypercholesterolemia|hypercholesterolemia
399639|NCT01243151|Dyslipidemia|dyslipidemia
399640|NCT01243151|LDL|ldl
399641|NCT01243151|High Cholesterol|high cholesterol
399642|NCT01243151|Japanese Volunteers|japanese volunteers
399643|NCT01243151|PF-04950615|pf-04950615
399644|NCT01243151|RN316|rn316
399645|NCT01243138|Cross-sectional|cross-sectional
399646|NCT01243138|epidemiological study|epidemiological study
399647|NCT01243138|to evaluate the prevalence of CV risk factors in patients attending general practice in AfME region|to evaluate the prevalence of cv risk factors in patients attending general practice in afme region
399648|NCT01243125|Blockage|blockage
399649|NCT01243125|Encrustation|encrustation
399650|NCT01243125|Catheter|catheter
399651|NCT01243125|Spinal Cord Injury|spinal cord injury
399653|NCT01243086|Macular Degeneration|macular degeneration
399654|NCT01243086|Age-related macular degeneration|age-related macular degeneration
399655|NCT01243086|Anti-inflammatory|anti-inflammatory
399656|NCT01243086|Anti-vascular endothelial growth factor (Anti-VEGF)|anti-vascular endothelial growth factor (anti-vegf)
399657|NCT01243086|Lucentis|lucentis
399658|NCT01243086|Ranibizumab|ranibizumab
399659|NCT01243086|OZURDEX|ozurdex
399660|NCT01243086|Dexamethasone|dexamethasone
399661|NCT01243086|Vision loss|vision loss
399662|NCT01243073|imetelstat|imetelstat
399663|NCT01243073|imetelstat sodium|imetelstat sodium
399664|NCT01243073|GRN163L|grn163l
399665|NCT01243073|telomerase inhibitor|telomerase inhibitor
399666|NCT01243073|telomerase|telomerase
399667|NCT01243073|essential thrombocytosis|essential thrombocytosis
399668|NCT01243073|essential thrombocythemia|essential thrombocythemia
399669|NCT01243073|ET|et
399234|NCT01245049|Repevax|repevax
399670|NCT01243073|polycythemia vera|polycythemia vera
399671|NCT01243073|PV|pv
399672|NCT01243060|Sleep Aid|sleep aid
399673|NCT01243047|Second line treatment for metastatic colorectal cancer|second line treatment for metastatic colorectal cancer
399674|NCT01243008|Lyme disease|lyme disease
399675|NCT01243008|Borreliosis|borreliosis
399676|NCT01243008|Azithromycin|azithromycin
399677|NCT01242982|5. metacarpal fracture/fractures|5. metacarpal fracture/fractures
399678|NCT01242982|subcapital|subcapital
399679|NCT01242982|shaft|shaft
399680|NCT01242982|closed|closed
399681|NCT01242956|stroke|stroke
399682|NCT01242956|video-based training|video-based training
399683|NCT01242956|rehabilitation|rehabilitation
399684|NCT01242943|I131|i131
399685|NCT01242943|L19|l19
399686|NCT01242943|antibody|antibody
399687|NCT01242943|monoclonal|monoclonal
399688|NCT01242943|tumour targeting|tumour targeting
399689|NCT01242943|radioimmunotherapy|radioimmunotherapy
399690|NCT01242943|cancer|cancer
399691|NCT01242930|imetelstat|imetelstat
399692|NCT01242930|imetelstat sodium|imetelstat sodium
399693|NCT01242930|GRN163L|grn163l
399694|NCT01242930|telomerase inhibitor|telomerase inhibitor
399695|NCT01242930|telomerase inhibition|telomerase inhibition
399696|NCT01242930|multiple myeloma|multiple myeloma
399697|NCT01242930|myeloma|myeloma
399698|NCT01242930|myeloma progenitor cells|myeloma progenitor cells
399699|NCT01242904|dialysis solutions|dialysis solutions
399700|NCT01242904|renal replacement therapy|renal replacement therapy
399701|NCT01242904|peritoneal dialysis|peritoneal dialysis
399702|NCT01242904|bimodal solution|bimodal solution
399703|NCT01242904|glucose sparing therapy|glucose sparing therapy
399704|NCT01242891|Ventricular Assist Device|ventricular assist device
399705|NCT01242891|Pediatric Ventricular Assist Device|pediatric ventricular assist device
399706|NCT01242878|HbSS|hbss
399707|NCT01242878|Sickle cell anemia|sickle cell anemia
399708|NCT01242878|HbSC|hbsc
399709|NCT01242878|HbSbetathalassemia|hbsbetathalassemia
399710|NCT01242878|Hemoglobinopathy|hemoglobinopathy
399711|NCT01242878|Hemoglobinopathies|hemoglobinopathies
399713|NCT01242865|Anxiety|anxiety
399714|NCT01242865|Resilience|resilience
399715|NCT01242865|Mindfulness|mindfulness
399716|NCT01242865|Quality of Life|quality of life
399717|NCT01242865|Stress Management|stress management
399718|NCT01242852|Hysteroscopy|hysteroscopy
399719|NCT01242852|infertility|infertility
399720|NCT01242852|subfertility|subfertility
399721|NCT01242852|intrauterine abnormalities|intrauterine abnormalities
399722|NCT01242852|intracavitary pathology|intracavitary pathology
399723|NCT01242852|IVF|ivf
399724|NCT01242852|ICSI|icsi
399725|NCT01242852|in vitro fertilization|in vitro fertilization
399726|NCT01242852|intracytoplasmic sperm injection|intracytoplasmic sperm injection
399727|NCT01242839|CACICOL20|cacicol20
399728|NCT01242813|TNF-receptor associated periodic syndrome|tnf-receptor associated periodic syndrome
399729|NCT01242813|fevers|fevers
399730|NCT01242813|rashes|rashes
399731|NCT01242813|musculoskeletal and abdominal pain|musculoskeletal and abdominal pain
399732|NCT01242813|periorbital edema|periorbital edema
399733|NCT01242813|TNFR1|tnfr1
399734|NCT01242800|male breast cancer|male breast cancer
399735|NCT01242800|stage IV breast cancer|stage iv breast cancer
399736|NCT01242787|Chronic hepatitis B|chronic hepatitis b
399737|NCT01242787|LB80380|lb80380
399738|NCT01242787|treatment-naive|treatment-naive
399739|NCT01242787|entecavir|entecavir
399740|NCT01242787|Extension|extension
399741|NCT01242774|AML|aml
399742|NCT01242774|bone marrow|bone marrow
399743|NCT01242774|abnormal blast cells of myeloid|abnormal blast cells of myeloid
399744|NCT01242774|acute leukemia|acute leukemia
399745|NCT01242774|cytogenetic abnormalities|cytogenetic abnormalities
399746|NCT01242774|HDACi|hdaci
399747|NCT01242761|Accuracy of diagnostic ultrasound based in community or as part of a specialist hospital-based service|accuracy of diagnostic ultrasound based in community or as part of a specialist hospital-based service
399748|NCT01242735|Obsessive Compulsive Disorder|obsessive compulsive disorder
399749|NCT01242735|OCD|ocd
399750|NCT01242735|Exercise|exercise
399751|NCT01242735|Aerobic Exercise|aerobic exercise
399752|NCT01242722|Heart failure|heart failure
399753|NCT01242722|auto threshold|auto threshold
399754|NCT01242722|pacing|pacing
399755|NCT01242722|CRT-D recipients|crt-d recipients
399756|NCT01242722|Left Ventricular (LV) evoked response signals|left ventricular (lv) evoked response signals
399757|NCT01242696|Drug Eluting Stents|drug eluting stents
399758|NCT01242696|Observational|observational
399759|NCT01242696|All-Comers|all-comers
399760|NCT01242657|Tobacco Use Cessation|tobacco use cessation
399761|NCT01242657|Youth Tobacco Use|youth tobacco use
399762|NCT01242657|Physical Activity|physical activity
399763|NCT01242657|Smoking Cessation Intervention|smoking cessation intervention
399764|NCT01242618|nasal cartilage diseases|nasal cartilage diseases
399765|NCT01242605|unresectable|unresectable
399766|NCT01242605|advanced|advanced
399767|NCT01242566|Temozolomide|temozolomide
399768|NCT01242566|Elderly|elderly
399769|NCT01242566|Glioblastoma|glioblastoma
8893|NCT03233984|endocrine disruptors|endocrine disruptors
399770|NCT01242566|Karnofsky performance score (KPS)|karnofsky performance score (kps)
399772|NCT01242540|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
399773|NCT01242527|dyslipidemia|dyslipidemia
399774|NCT01242527|hyperlipidemia|hyperlipidemia
399775|NCT01242527|omega-3 carboxylic acid|omega-3 carboxylic acid
399776|NCT01242514|Rheumatoid Arthritis|rheumatoid arthritis
399777|NCT01242514|OSKIRA|oskira
399778|NCT01242514|Fostamatinib|fostamatinib
399779|NCT01242501|Prevention|prevention
399780|NCT01242501|Counseling|counseling
399781|NCT01242501|Behavioral interventions|behavioral interventions
399782|NCT01242501|HIV risk reduction|hiv risk reduction
399783|NCT01242488|Rheumatoid Arthritis|rheumatoid arthritis
399784|NCT01242488|CDP6038|cdp6038
399785|NCT01242488|Interleukin-6|interleukin-6
399786|NCT01242488|Tocilizumab|tocilizumab
399787|NCT01242475|tuberculosis|tuberculosis
399788|NCT01242475|rdESAT-6|rdesat-6
399789|NCT01242475|CFP-10|cfp-10
399790|NCT01242475|skin test|skin test
399791|NCT01242475|diagnostic test|diagnostic test
399792|NCT01242462|Conventional mechanical ventilation|conventional mechanical ventilation
399793|NCT01242462|Mid-frequency ventilation|mid-frequency ventilation
399794|NCT01242462|Respiratory Distress Syndrome|respiratory distress syndrome
399795|NCT01242462|Preterm Newborn Infant|preterm newborn infant
399796|NCT01242462|Mean Airway Pressure|mean airway pressure
399797|NCT01242462|Mean Arterial Pressure|mean arterial pressure
399798|NCT01242462|Mean Peak Inspiratory Pressure|mean peak inspiratory pressure
399799|NCT01242449|Breast cancer|breast cancer
399800|NCT01242449|Metastatic|metastatic
399801|NCT01242449|HER2 positive|her2 positive
399802|NCT01242449|vinorelbine|vinorelbine
399803|NCT01242436|Ovarian Cancer|ovarian cancer
399804|NCT01242436|Peritoneal Metastasis|peritoneal metastasis
402077|NCT01233245|Adherence|adherence
399805|NCT01242436|Whole body diffusion MRI|whole body diffusion mri
399806|NCT01242436|therapy|therapy
399807|NCT01242423|musculoskeletal shockwave therapy|musculoskeletal shockwave therapy
399808|NCT01242410|Short cervix|short cervix
399809|NCT01242410|Preterm birth|preterm birth
399810|NCT01242410|Cervical pessary|cervical pessary
399811|NCT01242410|Twins|twins
399812|NCT01242371|Schizophrenia|schizophrenia
399813|NCT01242371|Schizoaffective|schizoaffective
399814|NCT01242371|Probiotic supplements|probiotic supplements
399815|NCT01242371|Gliadin|gliadin
399816|NCT01242371|Casein|casein
399817|NCT01242358|hypoxaemia - capnography - integrated pulmonary index - PEG|hypoxaemia - capnography - integrated pulmonary index - peg
399818|NCT01242345|Hypoxemia|hypoxemia
399819|NCT01242345|Capnography|capnography
399820|NCT01242345|Integrated pulmonary index|integrated pulmonary index
399821|NCT01242345|Sedation|sedation
399822|NCT01242345|Propofol|propofol
399823|NCT01242345|Safety|safety
399824|NCT01242332|perioperative|perioperative
399825|NCT01242332|pregabalin|pregabalin
399826|NCT01242332|arthroscopic anterior cruciate ligament reconstruction|arthroscopic anterior cruciate ligament reconstruction
399827|NCT01242332|postoperative pain management|postoperative pain management
399828|NCT01242319|quality improvement|quality improvement
399829|NCT01242319|implementation trials|implementation trials
399830|NCT01242319|cholesterol guidelines|cholesterol guidelines
399831|NCT01242319|patient activation|patient activation
399832|NCT01242306|endothelial dysfunction acetylcholine bms ses|endothelial dysfunction acetylcholine bms ses
399833|NCT01242280|Acute variceal bleeding|acute variceal bleeding
399834|NCT01242280|Massive bleeding|massive bleeding
399835|NCT01242280|Liver Cirrhosis|liver cirrhosis
399836|NCT01242280|Esophageal tamponade|esophageal tamponade
399837|NCT01242280|Esophageal stent|esophageal stent
399838|NCT01242267|multiple myeloma|multiple myeloma
399839|NCT01242267|transplant|transplant
399840|NCT01242267|Multiple myeloma patients undergoing transplant|multiple myeloma patients undergoing transplant
399841|NCT01242254|KH902|kh902
399842|NCT01242254|age-related macular degeneration|age-related macular degeneration
399843|NCT01242254|choroidal neovascularization|choroidal neovascularization
399844|NCT01242254|intravitreal injection|intravitreal injection
399845|NCT01242254|multiple injections|multiple injections
399846|NCT01242241|Propofol|propofol
400442|NCT01239888|Tibolone|tibolone
399847|NCT01242241|Childhood obesity|childhood obesity
399848|NCT01242241|Pharmacodynamics|pharmacodynamics
399849|NCT01242228|ASP1941|asp1941
399850|NCT01242228|Diabetes mellitus|diabetes mellitus
399851|NCT01242228|Dipeptidyl peptidase-4 inhibitor|dipeptidyl peptidase-4 inhibitor
399852|NCT01242228|DPP-4 inhibitor|dpp-4 inhibitor
399853|NCT01242228|long-term safety|long-term safety
399854|NCT01242215|ASP1941|asp1941
399855|NCT01242215|Diabetes mellitus|diabetes mellitus
399856|NCT01242215|sulfonylurea|sulfonylurea
399857|NCT01242202|ASP1941|asp1941
399858|NCT01242202|Diabetes mellitus|diabetes mellitus
399859|NCT01242202|alpha glucosidase inhibitor|alpha glucosidase inhibitor
399860|NCT01242202|long-term safety|long-term safety
399861|NCT01242150|Acute Respiratory Failure|acute respiratory failure
399862|NCT01242150|Continuous Positive Airway Pressure|continuous positive airway pressure
399863|NCT01242150|Infants|infants
399864|NCT01242150|Helmet|helmet
399865|NCT01242111|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
399866|NCT01242111|MPS IV Type A|mps iv type a
399867|NCT01242111|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
399868|NCT01242111|MPS IVA|mps iva
399869|NCT01242111|Morquio A Syndrome|morquio a syndrome
399870|NCT01242111|Lysosomal Storage Disorder|lysosomal storage disorder
399872|NCT01242111|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
399873|NCT01242111|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
399874|NCT01242111|galactose-6-sulfatase|galactose-6-sulfatase
399875|NCT01242111|GALNS|galns
399876|NCT01242111|enzyme replacement therapy|enzyme replacement therapy
399878|NCT01242098|Asthma|asthma
399879|NCT01242098|Combination therapy|combination therapy
399880|NCT01242098|Primary care management|primary care management
399881|NCT01242098|Switch|switch
399882|NCT01242098|ICS/LABA|ics/laba
399883|NCT01242098|Fostair|fostair
399884|NCT01242098|Seretide|seretide
399885|NCT01242085|alignment|alignment
399886|NCT01242072|malignancy|malignancy
399887|NCT01242072|etoposide and carboplatin|etoposide and carboplatin
399888|NCT01242072|non small cell lung cancer|non small cell lung cancer
399889|NCT01242072|small cell lung cancer|small cell lung cancer
399890|NCT01242072|testicular cancer|testicular cancer
399891|NCT01242072|thymoma|thymoma
399892|NCT01242072|ovarian cancer|ovarian cancer
399893|NCT01242072|osteosarcoma|osteosarcoma
399894|NCT01242059|Obesity|obesity
399895|NCT01242059|Food intake regulation|food intake regulation
399896|NCT01242059|blood glucose regulation|blood glucose regulation
399897|NCT01242059|protein|protein
399898|NCT01242059|fiber|fiber
399899|NCT01242059|pulses|pulses
399900|NCT01242059|yellow peas|yellow peas
399901|NCT01242046|female sexual arousal|female sexual arousal
399902|NCT01242033|red raspberries|red raspberries
399903|NCT01242033|post-prandial|post-prandial
399904|NCT01242033|oxidative stress|oxidative stress
399905|NCT01242033|antioxidants|antioxidants
399906|NCT01242033|polyphenols|polyphenols
399907|NCT01242033|vitamin C|vitamin c
399908|NCT01242033|acute dietary intervention|acute dietary intervention
399909|NCT01242007|Myotonic dystrophy|myotonic dystrophy
399910|NCT01242007|Steinert's disease|steinert's disease
399911|NCT01241981|Breast|breast
399912|NCT01241981|Cancer|cancer
399913|NCT01241981|Digital|digital
399914|NCT01241981|Mammography|mammography
399915|NCT01241981|Tomosynthesis|tomosynthesis
399916|NCT01241968|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
399917|NCT01241968|Myocardial Ischemia|myocardial ischemia
399918|NCT01241968|Refractory Angina|refractory angina
399919|NCT01241955|CPR|cpr
399920|NCT01241942|Lung Transplant|lung transplant
399921|NCT01241942|Emphysema|emphysema
399922|NCT01241942|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
399923|NCT01241942|Cystic Fibrosis|cystic fibrosis
399924|NCT01241942|Pulmonary Fibrosis|pulmonary fibrosis
399925|NCT01241942|Bronchiectasis|bronchiectasis
399926|NCT01241942|Sarcoidosis|sarcoidosis
399927|NCT01241942|Pulmonary Hypertension|pulmonary hypertension
399928|NCT01241942|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
399929|NCT01241929|advanced cancer|advanced cancer
399930|NCT01241916|elbow, splint|elbow, splint
399931|NCT01241903|Platelet activation|platelet activation
399932|NCT01241903|platelet leukocyte aggregates|platelet leukocyte aggregates
399933|NCT01241890|Cystic Fibrosis|cystic fibrosis
399934|NCT01241890|Children|children
399935|NCT01241890|Exhaled Breath Condensate|exhaled breath condensate
399936|NCT01241890|Non-invasive Inflammatory Markers|non-invasive inflammatory markers
399937|NCT01241890|Volatile Organic Compounds|volatile organic compounds
399938|NCT01241890|Home monitoring|home monitoring
399939|NCT01241890|Quality of life|quality of life
399940|NCT01241838|Heart failure|heart failure
399941|NCT01241838|Left ventricular hypertrophy|left ventricular hypertrophy
399942|NCT01241838|Diastolic dysfunction|diastolic dysfunction
399943|NCT01241825|capsule endoscopy|capsule endoscopy
399944|NCT01241825|chewing gum|chewing gum
399945|NCT01241825|small bowel transit time|small bowel transit time
399946|NCT01241812|knee|knee
399947|NCT01241812|osteoarthritis|osteoarthritis
400630|NCT01238848|Hypertonic|hypertonic
399948|NCT01241799|endoscopic ultrasound guided fine needle aspiration (EUS-FNA)|endoscopic ultrasound guided fine needle aspiration (eus-fna)
399949|NCT01241799|pancreatic biopsy|pancreatic biopsy
399950|NCT01241799|randomized|randomized
399951|NCT01241799|single blind|single blind
399952|NCT01241799|fine needle aspiration (FNA) adequacy|fine needle aspiration (fna) adequacy
399953|NCT01241799|fine needle aspiration (FNA) accuracy|fine needle aspiration (fna) accuracy
399954|NCT01241786|chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
399955|NCT01241786|small lymphocytic lymphoma (SLL)|small lymphocytic lymphoma (sll)
399956|NCT01241773|TMC435-TiDP16-C123|tmc435-tidp16-c123
399957|NCT01241773|TMC435-C123|tmc435-c123
399958|NCT01241773|TMC435|tmc435
399959|NCT01241773|HCV|hcv
399960|NCT01241773|Hepatitis C|hepatitis c
399961|NCT01241760|Genotype 1 chronic hepatitis C|genotype 1 chronic hepatitis c
399522|NCT01243658|BPD|bpd
399962|NCT01241760|VX-950-C211|vx-950-c211
399963|NCT01241760|VX-950|vx-950
399964|NCT01241760|IL28B|il28b
399965|NCT01241760|Telaprevir|telaprevir
399966|NCT01241760|Hepatitis C|hepatitis c
399967|NCT01241760|BID|bid
399968|NCT01241760|Q8h|q8h
399969|NCT01241760|SOC|soc
399970|NCT01241734|Diffuse Large B cell Lymphoma|diffuse large b cell lymphoma
399971|NCT01241721|Breast Diseases|breast diseases
399972|NCT01241721|Breast Neoplasms|breast neoplasms
399973|NCT01241721|Neoplasms|neoplasms
399974|NCT01241695|Oral nutritional supplement, diabetes mellitus type 2, glycaemic control|oral nutritional supplement, diabetes mellitus type 2, glycaemic control
399975|NCT01241695|Oral nutritional supplement (Food for special medical purposes)|oral nutritional supplement (food for special medical purposes)
399976|NCT01241682|Mesothelioma|mesothelioma
399977|NCT01241682|Dendritic cells|dendritic cells
399978|NCT01241682|Cyclophosphamide|cyclophosphamide
399979|NCT01241682|Tumor lysate-loaded|tumor lysate-loaded
399980|NCT01241682|Immunotherapy|immunotherapy
399981|NCT01241656|Prostate cancer|prostate cancer
399982|NCT01241656|Decision support intervention (DESI)|decision support intervention (desi)
399983|NCT01241656|Shared medical appointments (SMA)|shared medical appointments (sma)
399984|NCT01241656|Comparative effectiveness research (CER)|comparative effectiveness research (cer)
399985|NCT01241643|interleukin-7|interleukin-7
399986|NCT01241643|immune-based therapies|immune-based therapies
399987|NCT01241643|HIV|hiv
399988|NCT01241643|infectious disease|infectious disease
399989|NCT01241643|immune non-responders|immune non-responders
399990|NCT01241630|Somato-sensory reflex arch|somato-sensory reflex arch
399991|NCT01241630|Spinal cord injury|spinal cord injury
399992|NCT01241630|Xiao Procedure|xiao procedure
399993|NCT01241617|Lung disease|lung disease
399994|NCT01241617|Lobectomy|lobectomy
399995|NCT01241617|Pulmonary resection|pulmonary resection
399996|NCT01241591|CP-690,550|cp-690,550
399997|NCT01241591|Etanercept|etanercept
399998|NCT01241591|Moderate|moderate
399999|NCT01241591|Severe|severe
400000|NCT01241591|Chronic|chronic
400001|NCT01241591|Plaque|plaque
400002|NCT01241591|Psoriasis|psoriasis
400003|NCT01241591|Efficacy|efficacy
400004|NCT01241591|Safety|safety
400005|NCT01241591|Tofacitinib|tofacitinib
400006|NCT01241591|Xeljanz|xeljanz
400007|NCT01241591|OPT Compare|opt compare
400008|NCT01241591|OPT|opt
400009|NCT01241591|head-to-head|head-to-head
400010|NCT01241591|non-inferiority|non-inferiority
400011|NCT01241591|Psoriasis vulgaris|psoriasis vulgaris
400012|NCT01241591|short-term|short-term
400013|NCT01241591|Itch|itch
400014|NCT01241591|Pruritus|pruritus
400015|NCT01241591|Plaque psoriasis|plaque psoriasis
400016|NCT01241591|DLQI|dlqi
400017|NCT01241578|Obesity|obesity
400018|NCT01241578|Behavior Therapy|behavior therapy
400019|NCT01241578|Lifestyle|lifestyle
400020|NCT01241578|Technology|technology
400021|NCT01241578|Cellular Phone|cellular phone
400022|NCT01241565|lung cancer|lung cancer
400023|NCT01241565|lobectomy|lobectomy
400024|NCT01241565|wedge resection|wedge resection
400025|NCT01241552|Clostridium difficile|clostridium difficile
400026|NCT01241552|recurrent Clostridium difficile|recurrent clostridium difficile
400027|NCT01241552|vancomycin|vancomycin
400028|NCT01241552|metronidazole|metronidazole
400029|NCT01241552|monoclonal antibody|monoclonal antibody
400030|NCT01241552|Clostridium difficile infection (CDI)|clostridium difficile infection (cdi)
400031|NCT01241526|COPD|copd
400032|NCT01241526|COMET|comet
400033|NCT01241526|Disease management|disease management
400034|NCT01241513|glutathione|glutathione
400035|NCT01241513|redox status|redox status
400036|NCT01241513|carotid body chemosensitivity|carotid body chemosensitivity
400037|NCT01241513|ventilation|ventilation
400038|NCT01241500|Myelodysplastic syndromes|myelodysplastic syndromes
400039|NCT01241500|MDS|mds
400040|NCT01241487|Hypertension, Valsartan/Amlodipine,|hypertension, valsartan/amlodipine,
400041|NCT01241461|Advanced Cancer|advanced cancer
400042|NCT01241461|Metastatic Cancer|metastatic cancer
400043|NCT01241461|p70s6 inhibitor|p70s6 inhibitor
400044|NCT01241448|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
400045|NCT01241422|Asthma|asthma
400046|NCT01241422|Mild asthma|mild asthma
400047|NCT01241422|Singulair|singulair
400048|NCT01241422|JNJ 40929837|jnj 40929837
400049|NCT01241422|Montelukast|montelukast
400050|NCT01241409|Healthy|healthy
400051|NCT01241409|Sprinkle Capsule Formulation|sprinkle capsule formulation
400052|NCT01241409|Rabeprazole sodium|rabeprazole sodium
400053|NCT01241409|Pharmacokinetics|pharmacokinetics
400054|NCT01241409|Bioequivalence|bioequivalence
400055|NCT01241409|Safety|safety
400056|NCT01241396|Multiple Myeloma|multiple myeloma
400057|NCT01241396|observational|observational
400058|NCT01241396|survey|survey
400059|NCT01241396|non-interventional|non-interventional
400060|NCT01241396|international|international
400061|NCT01241396|epidemiology|epidemiology
400062|NCT01241396|treatment|treatment
400063|NCT01241396|routine clinical practice|routine clinical practice
400064|NCT01241396|retrospective|retrospective
400065|NCT01241396|prospective|prospective
400066|NCT01241383|Scleroderma renal crisis|scleroderma renal crisis
400067|NCT01241383|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
400068|NCT01241383|bosentan|bosentan
400069|NCT01241383|endothelin receptor antagonist|endothelin receptor antagonist
400070|NCT01241370|Retinal endothelia dysfunction|retinal endothelia dysfunction
400071|NCT01241370|Type 2 diabetes mellitus|type 2 diabetes mellitus
400072|NCT01241370|Insulin-resistance|insulin-resistance
400073|NCT01241370|micro-lightguide spectrophotometry|micro-lightguide spectrophotometry
400074|NCT01241370|laserdopplerfluxmetry|laserdopplerfluxmetry
400076|NCT01241357|Iron overload|iron overload
400077|NCT01241357|Hepatic iron concentration|hepatic iron concentration
400078|NCT01241357|High-temperature superconductivity|high-temperature superconductivity
400079|NCT01241357|Magnetic susceptibility|magnetic susceptibility
400080|NCT01241357|Susceptometer|susceptometer
400081|NCT01241344|Adv|adv
400082|NCT01241344|Hematopoeitic Stem cell Transplant|hematopoeitic stem cell transplant
400083|NCT01241344|HSCT|hsct
400084|NCT01241331|moderate to severe facial acne vulgaris|moderate to severe facial acne vulgaris
400085|NCT01241318|neonate|neonate
400086|NCT01241318|omphalitis|omphalitis
400087|NCT01241318|neonatal mortality|neonatal mortality
400088|NCT01241318|maternal health|maternal health
400089|NCT01241318|umbilical cord infection|umbilical cord infection
400090|NCT01241305|Vasculitis|vasculitis
400091|NCT01241305|CSS|css
400092|NCT01241305|EGPA|egpa
400093|NCT01241305|GCA|gca
400094|NCT01241305|GPA|gpa
400095|NCT01241305|WG|wg
400096|NCT01241305|MPA|mpa
400097|NCT01241305|PAN|pan
400098|NCT01241305|TAK|tak
400099|NCT01241279|cataract surgery|cataract surgery
400100|NCT01241279|intraocular lens|intraocular lens
400101|NCT01241266|Peptic Ulcer Bleeding|peptic ulcer bleeding
400102|NCT01241266|high risk|high risk
400103|NCT01241266|None-Interventional Study|none-interventional study
400104|NCT01241266|he proportion of peptic ulcer bleeding patients who are at high risk (Forrest Ia-IIb)|he proportion of peptic ulcer bleeding patients who are at high risk (forrest ia-iib)
400105|NCT01241253|legumes|legumes
400106|NCT01241253|glycemic response|glycemic response
400107|NCT01241253|glucose|glucose
400108|NCT01241253|type 2 diabetes mellitus|type 2 diabetes mellitus
400109|NCT01241227|liver fibrosis|liver fibrosis
400110|NCT01241227|survival|survival
400111|NCT01241227|transient elastography|transient elastography
400112|NCT01241214|Seasonal allergic rhinitis|seasonal allergic rhinitis
400114|NCT01241214|Allergic rhinitis|allergic rhinitis
400115|NCT01241214|Allergies|allergies
400116|NCT01241201|intestinal health|intestinal health
400117|NCT01241201|probiotics|probiotics
400118|NCT01241201|inflammation|inflammation
400119|NCT01241201|biomarkers|biomarkers
400120|NCT01241188|tuberculosis|tuberculosis
400121|NCT01241188|rdESAT-6|rdesat-6
400122|NCT01241188|CFP-10|cfp-10
400123|NCT01241188|skin test|skin test
400124|NCT01241188|diagnostic test|diagnostic test
400125|NCT01241175|IOP|iop
400126|NCT01241175|ophthalmic anesthesia|ophthalmic anesthesia
400127|NCT01241175|magnesium sulfate|magnesium sulfate
400128|NCT01241162|Neuroblastoma|neuroblastoma
400129|NCT01241162|Ewings sarcoma|ewings sarcoma
400130|NCT01241162|osteogenic sarcoma|osteogenic sarcoma
400131|NCT01241162|rhabdomyosarcoma|rhabdomyosarcoma
400132|NCT01241162|synovial sarcoma|synovial sarcoma
400133|NCT01241162|high-risk|high-risk
400134|NCT01241162|relapsed|relapsed
400135|NCT01241162|children|children
400136|NCT01241149|Nissen fundoplication|nissen fundoplication
400137|NCT01241149|non-acid reflux disease|non-acid reflux disease
400138|NCT01241149|anti-reflux surgery|anti-reflux surgery
400139|NCT01241136|pilonidal disease, cystectomy, recurrence|pilonidal disease, cystectomy, recurrence
400140|NCT01241123|return of bowel function, post-operative, colon surgery|return of bowel function, post-operative, colon surgery
400141|NCT01241110|PID, Ofloxacin, Azitromicine, Metronidazole|pid, ofloxacin, azitromicine, metronidazole
400142|NCT01241097|endothelial function|endothelial function
400143|NCT01241097|statins|statins
400144|NCT01241097|ezetimibe|ezetimibe
400145|NCT01241097|pleiotropism|pleiotropism
400146|NCT01241084|asthmatic children|asthmatic children
400147|NCT01241071|Lumbar region|lumbar region
400148|NCT01241071|Pain|pain
400149|NCT01241071|Fascia|fascia
400150|NCT01241071|Electromyography|electromyography
400151|NCT01241071|Goniometry|goniometry
400152|NCT01241058|pediatrics, crohn's disease, disease course, therapy|pediatrics, crohn's disease, disease course, therapy
400153|NCT01241032|DA-8159|da-8159
400154|NCT01241032|Udenafil|udenafil
400155|NCT01241032|Alcohol|alcohol
400156|NCT01241019|asphyxia neonatorum, hypothermia, neuroprotection|asphyxia neonatorum, hypothermia, neuroprotection
400157|NCT01241006|Relapse|relapse
400158|NCT01241006|Corticosteroids|corticosteroids
400159|NCT01240993|parenting intervention|parenting intervention
400160|NCT01240993|mother-child relations|mother-child relations
400161|NCT01240993|substance abuse|substance abuse
400162|NCT01240993|attachment|attachment
400163|NCT01240993|child development|child development
400164|NCT01240967|Phase 1|phase 1
400166|NCT01240967|volunteers with renal impairment|volunteers with renal impairment
400167|NCT01240967|pharmacokinetics|pharmacokinetics
400168|NCT01240967|TC-5214|tc-5214
400169|NCT01240954|Rhinitis|rhinitis
400170|NCT01240954|Allergic|allergic
400171|NCT01240954|Immunotherapy|immunotherapy
400172|NCT01240915|safety efficacy MultiStem(r) moderate to severe Ulcerative Colitis|safety efficacy multistem(r) moderate to severe ulcerative colitis
400173|NCT01240902|Valvular Heart Disease|valvular heart disease
400174|NCT01240902|Critical Aortic Stenosis|critical aortic stenosis
400175|NCT01240902|Severe Aortic Stenosis|severe aortic stenosis
400176|NCT01240902|High Risk|high risk
400177|NCT01240902|Aortic Valve Replacement|aortic valve replacement
400178|NCT01240889|Ragweed allergies|ragweed allergies
400179|NCT01240889|acoustic rhinometry|acoustic rhinometry
400180|NCT01240889|nasal allergen challenge|nasal allergen challenge
400181|NCT01240876|Sciatica|sciatica
400182|NCT01240876|Pain|pain
400183|NCT01240863|osteoarthritis|osteoarthritis
400184|NCT01240863|low back pain|low back pain
400185|NCT01240863|Moderate to Severe Pain|moderate to severe pain
400186|NCT01240850|Retroperitoneal fibrosis|retroperitoneal fibrosis
400187|NCT01240850|Inflammatory aneurysms|inflammatory aneurysms
400188|NCT01240850|Methotrexate|methotrexate
400189|NCT01240850|Prednisone|prednisone
400190|NCT01240850|Aorta|aorta
400191|NCT01240837|glycaemic index|glycaemic index
400192|NCT01240837|arenga pinnata sugar|arenga pinnata sugar
400193|NCT01240837|palm sugar|palm sugar
400194|NCT01240837|diabetes|diabetes
400195|NCT01240824|bladder cancer|bladder cancer
400196|NCT01240824|urothelial carcinoma|urothelial carcinoma
400197|NCT01240824|transitional cell carcinoma bladder|transitional cell carcinoma bladder
400198|NCT01240824|ureter|ureter
400199|NCT01240811|intrauterine device|intrauterine device
400200|NCT01240811|IUD|iud
400201|NCT01240811|levonorgestrel|levonorgestrel
400202|NCT01240811|copper|copper
400203|NCT01240811|CD4|cd4
400204|NCT01240811|CCR5|ccr5
400205|NCT01240811|microflora|microflora
400206|NCT01240798|Depression|depression
400207|NCT01240798|Anxiety|anxiety
400588|NCT01239134|Solid tumor|solid tumor
400208|NCT01240798|Coronary disease|coronary disease
400209|NCT01240785|gestational diabetes|gestational diabetes
400210|NCT01240785|metformin|metformin
400211|NCT01240785|insulin|insulin
400212|NCT01240772|Haemorrhoids, Surgery, Cost-effectiveness, Morbidity, Risk assessment,RCT, Stapled haemorrhoidopexy, Doppler-guided, Haemorrhoidal artery ligation, Outcome|haemorrhoids, surgery, cost-effectiveness, morbidity, risk assessment,rct, stapled haemorrhoidopexy, doppler-guided, haemorrhoidal artery ligation, outcome
400213|NCT01240759|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
400214|NCT01240759|Metformin|metformin
400215|NCT01240746|Influenza|influenza
400216|NCT01240746|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
400217|NCT01240746|Trivalent Influenza Vaccine|trivalent influenza vaccine
400218|NCT01240746|Influenza viruses|influenza viruses
400219|NCT01240746|Fluzone®|fluzone®
400220|NCT01240720|I131|i131
400221|NCT01240720|F16|f16
400222|NCT01240720|antibody|antibody
400223|NCT01240720|monoclonal|monoclonal
400224|NCT01240720|tumor targeting|tumor targeting
400225|NCT01240720|radioimmunotherapy|radioimmunotherapy
400226|NCT01240720|lymphoma, breast and lung cancer|lymphoma, breast and lung cancer
400227|NCT01240720|Patients with different cancer types|patients with different cancer types
400228|NCT01240694|Lupus|lupus
400229|NCT01240694|SLE|sle
400230|NCT01240681|Locally Advanced Breast Cancer (LABC)|locally advanced breast cancer (labc)
400231|NCT01240681|neoadjuvant chemotherapy|neoadjuvant chemotherapy
400232|NCT01240681|Fluorothymidine Positron Emission Tomography (FLT PET)|fluorothymidine positron emission tomography (flt pet)
400233|NCT01240681|Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI)|blood oxygen level dependent magnetic resonance imaging (bold mri)
400234|NCT01240681|tumor response|tumor response
400235|NCT01240681|mastectomy|mastectomy
400236|NCT01240668|Hyponatremia|hyponatremia
400237|NCT01240668|Euvolemia|euvolemia
400238|NCT01240668|Hypervolemia|hypervolemia
400239|NCT01240668|Euvolemic|euvolemic
400240|NCT01240668|Hypervolemic|hypervolemic
400241|NCT01240655|LCL161|lcl161
400242|NCT01240655|solid tumors|solid tumors
400243|NCT01240655|paclitaxel|paclitaxel
400244|NCT01240642|Advanced or metastatic cancer|advanced or metastatic cancer
400245|NCT01240642|refractory|refractory
400247|NCT01240642|extension phase|extension phase
400248|NCT01240642|dose escalation|dose escalation
400249|NCT01240642|standard chemotherapy|standard chemotherapy
400250|NCT01240642|doctaxel|doctaxel
400251|NCT01240642|paclitaxel|paclitaxel
400252|NCT01240642|carboplatin|carboplatin
400253|NCT01240642|safety|safety
400254|NCT01240642|tolerability|tolerability
400255|NCT01240616|Nicotine|nicotine
400256|NCT01240616|Mecamylamine|mecamylamine
400257|NCT01240616|Attention|attention
400258|NCT01240616|fMRI|fmri
400259|NCT01240616|Default Network|default network
400260|NCT01240616|Healthy Volunteer|healthy volunteer
400261|NCT01240616|HV|hv
400262|NCT01240603|Artemisinin|artemisinin
400263|NCT01240603|Malaria|malaria
400264|NCT01240603|Drug Resistance|drug resistance
400265|NCT01240603|Hemoglobin E|hemoglobin e
400266|NCT01240590|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
400267|NCT01240590|Crolibulin|crolibulin
400268|NCT01240590|Solid Tumors|solid tumors
400269|NCT01240590|ATC|atc
400270|NCT01240577|IPdR|ipdr
400271|NCT01240577|Pharmacokinetics|pharmacokinetics
400272|NCT01240577|Early Phase I|early phase i
400273|NCT01240577|Cancer|cancer
400274|NCT01240577|Solid Tumor|solid tumor
400275|NCT01240577|Lymphoma|lymphoma
400276|NCT01240551|Imaging|imaging
400277|NCT01240551|Bone Metastasis|bone metastasis
400278|NCT01240551|Bone Scan|bone scan
400279|NCT01240551|Radiopharmaceutical|radiopharmaceutical
400280|NCT01240551|Pet Scan|pet scan
400281|NCT01240551|Prostate Cancer|prostate cancer
400282|NCT01240525|graft versus host disease|graft versus host disease
400283|NCT01240525|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
400284|NCT01240525|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
400285|NCT01240525|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
400286|NCT01240525|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
400287|NCT01240525|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
400288|NCT01240525|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
400289|NCT01240525|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
400290|NCT01240525|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
400291|NCT01240525|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
400292|NCT01240525|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
400293|NCT01240525|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
400294|NCT01240525|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
400295|NCT01240525|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
400296|NCT01240525|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
400297|NCT01240525|Hodgkin's lymphoma|hodgkin's lymphoma
400298|NCT01240525|Chronic (Pro-)lymphocytic leukaemia|chronic (pro-)lymphocytic leukaemia
400299|NCT01240525|Plasma cell myeloma|plasma cell myeloma
400797|NCT01238276|cefazolin|cefazolin
400300|NCT01240525|Acute myeloid leukaemia|acute myeloid leukaemia
400301|NCT01240525|Acute lymphoblastic leukaemia|acute lymphoblastic leukaemia
400302|NCT01240525|Myelodysplastic syndrome|myelodysplastic syndrome
400303|NCT01240525|Chronic myelomonocytic leukaemia|chronic myelomonocytic leukaemia
400304|NCT01240499|Weight management|weight management
400305|NCT01240499|New weight paradigm|new weight paradigm
400306|NCT01240499|Overweight women|overweight women
400307|NCT01240499|Eating behaviors|eating behaviors
400308|NCT01240499|Appetite ratings|appetite ratings
400309|NCT01240499|Blood lipids|blood lipids
400310|NCT01240486|IRIS|iris
400311|NCT01240486|HIV|hiv
400312|NCT01240486|Immune|immune
400313|NCT01240486|Reconstitution|reconstitution
400314|NCT01240486|Inflammatory|inflammatory
400315|NCT01240486|Syndrome|syndrome
400316|NCT01240473|kala azar|kala azar
400317|NCT01240473|visceral leishmaniasis|visceral leishmaniasis
400318|NCT01240473|diagnosis|diagnosis
400319|NCT01240473|drug resistance|drug resistance
400320|NCT01240473|Therapeutics|therapeutics
400321|NCT01240473|Capacity Building|capacity building
400322|NCT01240447|NSCLC|nsclc
400323|NCT01240447|lung cancer, small-cell|lung cancer, small-cell
400324|NCT01240447|advanced lung cancer|advanced lung cancer
400325|NCT01240434|trocar hernia closure laparoscopy|trocar hernia closure laparoscopy
400326|NCT01240421|Metastatic breast cancer with no other treatment options|metastatic breast cancer with no other treatment options
400327|NCT01240395|Multiple chemical sensitivities|multiple chemical sensitivities
400328|NCT01240395|MCS|mcs
400329|NCT01240395|Mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
400330|NCT01240395|MBCT|mbct
400331|NCT01240369|VEGFC|vegfc
400332|NCT01240369|CTTN|cttn
400333|NCT01240369|miR326|mir326
400334|NCT01240369|ESCC|escc
400335|NCT01240369|NSCLC|nsclc
400336|NCT01240356|transcranial doppler|transcranial doppler
400337|NCT01240356|sonothrombolysis|sonothrombolysis
400338|NCT01240356|ultrasound|ultrasound
400339|NCT01240356|stroke|stroke
400340|NCT01240343|Biobank|biobank
400341|NCT01240343|Genetics|genetics
400342|NCT01240330|Deep Vein Thrombosis|deep vein thrombosis
400631|NCT01238848|Saline|saline
400343|NCT01240330|Effects of compression therapy|effects of compression therapy
400344|NCT01240330|Peak Flow Velocity|peak flow velocity
400345|NCT01240317|expert system|expert system
400346|NCT01240317|decision support system|decision support system
400347|NCT01240317|human patient simulator|human patient simulator
400348|NCT01240317|anesthesia|anesthesia
400349|NCT01240291|glutamine|glutamine
400350|NCT01240291|trauma|trauma
400351|NCT01240291|alanyl-glutamine|alanyl-glutamine
400352|NCT01240265|Vitamin D deficiency|vitamin d deficiency
400353|NCT01240265|Rickets|rickets
400354|NCT01240265|Infant|infant
400355|NCT01240265|Nutrition|nutrition
400356|NCT01240252|diabetes|diabetes
400357|NCT01240252|insulin resistance|insulin resistance
400358|NCT01240239|Pre anesthesia consultation|pre anesthesia consultation
400359|NCT01240239|telemedicine|telemedicine
400360|NCT01240213|Vitamin D|vitamin d
400361|NCT01240213|lifestyle intervention|lifestyle intervention
400362|NCT01240213|postmenopausal women|postmenopausal women
400363|NCT01240200|diabetes|diabetes
400364|NCT01240200|elderly|elderly
400365|NCT01240200|insulin injections|insulin injections
400366|NCT01240187|epilepsy|epilepsy
400367|NCT01240174|Antibiotic|antibiotic
400368|NCT01240174|Antimicrobial|antimicrobial
400369|NCT01240174|Prescribing|prescribing
400370|NCT01240174|Cough|cough
400371|NCT01240174|Acute Bronchitis|acute bronchitis
400372|NCT01240161|Glioblastoma multiforme|glioblastoma multiforme
400374|NCT01240161|PET|pet
400375|NCT01240148|Allodynia|allodynia
400376|NCT01240148|hyperalgesia|hyperalgesia
400377|NCT01240148|paresthesia|paresthesia
400378|NCT01240135|Contact Lens Wear|contact lens wear
400379|NCT01240135|Contact Lens Solution|contact lens solution
400380|NCT01240135|Multi-purpose disinfecting solution|multi-purpose disinfecting solution
400381|NCT01240135|Myopia|myopia
400382|NCT01240122|Corneal staining and comfort evaluation in normal, habitual contact lens wearers.|corneal staining and comfort evaluation in normal, habitual contact lens wearers.
400383|NCT01240096|Functional dyspepsia|functional dyspepsia
400384|NCT01240096|Weight loss|weight loss
400385|NCT01240096|Mirtazapine|mirtazapine
400386|NCT01240083|Depression|depression
402078|NCT01233245|Interferon beta-1b|interferon beta-1b
400387|NCT01240083|Transcranial magnetic stimulation|transcranial magnetic stimulation
400388|NCT01240083|Thetaburst Stimulation|thetaburst stimulation
400389|NCT01240083|Alternative treatment methods|alternative treatment methods
400390|NCT01240070|diabetes,|diabetes,
400391|NCT01240070|cardiovascular|cardiovascular
400392|NCT01240070|risk factor|risk factor
400393|NCT01240070|cardiovascular event|cardiovascular event
400394|NCT01240070|intervention|intervention
400395|NCT01240057|Isolated Congenital Diaphragmatic Hernia|isolated congenital diaphragmatic hernia
400396|NCT01240057|Fetal Surgery|fetal surgery
400397|NCT01240057|Pulmonary Hypoplasia|pulmonary hypoplasia
400398|NCT01240044|Newborn Pain|newborn pain
400399|NCT01240044|Respiratory Physiotherapy|respiratory physiotherapy
400587|NCT01239134|Stage III or Stage IV|stage iii or stage iv
400400|NCT01240044|Neonatal intensive care unit|neonatal intensive care unit
400401|NCT01240031|Malnutrition|malnutrition
400402|NCT01240031|Nutritional Risk|nutritional risk
400403|NCT01240031|Intake|intake
400404|NCT01240031|Food sensory|food sensory
400405|NCT01240031|Nutritional therapy|nutritional therapy
400406|NCT01240031|Energy|energy
400407|NCT01240031|Protein|protein
400408|NCT01240031|Handgrip strength|handgrip strength
400409|NCT01240031|Reaction time|reaction time
400410|NCT01240031|Quality of Life|quality of life
400411|NCT01239979|coronary artery disease|coronary artery disease
400412|NCT01239966|Acute Respiratory Distress syndrome|acute respiratory distress syndrome
400413|NCT01239966|Acute renal Failure|acute renal failure
400414|NCT01239953|In-stent restenosis|in-stent restenosis
400415|NCT01239953|Drug-eluting balloon|drug-eluting balloon
400416|NCT01239953|Drug-eluting stent|drug-eluting stent
400417|NCT01239953|Angiography|angiography
400418|NCT01239953|Minimal lumen diameter|minimal lumen diameter
400419|NCT01239940|In-stent restenosis|in-stent restenosis
400420|NCT01239940|Drug-eluting balloon|drug-eluting balloon
400421|NCT01239940|Drug-eluting stent|drug-eluting stent
400422|NCT01239940|Angiography|angiography
400423|NCT01239940|Minimal lumen diameter|minimal lumen diameter
400424|NCT01239927|diverticulitis|diverticulitis
400425|NCT01239927|hartmann|hartmann
400426|NCT01239927|anastomosis|anastomosis
400427|NCT01239914|drug eluting stent|drug eluting stent
400428|NCT01239914|coronary artery disease|coronary artery disease
400429|NCT01239914|Korean registry|korean registry
400430|NCT01239901|sickle cell disease|sickle cell disease
400431|NCT01239901|sickle cell anemia|sickle cell anemia
400432|NCT01239901|sickled cells|sickled cells
400433|NCT01239901|blood vessel|blood vessel
400434|NCT01239901|iron overload|iron overload
400435|NCT01239888|Depression|depression
400436|NCT01239888|Treatment resistant depression|treatment resistant depression
400437|NCT01239888|Oxytocin|oxytocin
400438|NCT01239888|Estrogen Modulators|estrogen modulators
400439|NCT01239888|HPA axis|hpa axis
400440|NCT01239888|Mental Disorders|mental disorders
400443|NCT01239888|Estrogen Receptor Modulators|estrogen receptor modulators
400444|NCT01239888|Androgens|androgens
400445|NCT01239888|Hormones|hormones
400446|NCT01239888|Hormone Substitutes|hormone substitutes
400447|NCT01239888|Physiological Effects of Drugs|physiological effects of drugs
400448|NCT01239888|Pharmacologic Actions|pharmacologic actions
400449|NCT01239888|Hormone Antagonists|hormone antagonists
400450|NCT01239888|Bone Density Conservation Agents|bone density conservation agents
400451|NCT01239888|Estrogen Antagonists|estrogen antagonists
8894|NCT03233932|CKD-841|ckd-841
8895|NCT03233932|Leuplin|leuplin
400452|NCT01239862|pulmonary, silicosis, chronic and accelerated silicosis, autologous transplantation|pulmonary, silicosis, chronic and accelerated silicosis, autologous transplantation
400453|NCT01239862|bone marrow cells, stem cells, cell therapy|bone marrow cells, stem cells, cell therapy
400454|NCT01239849|Diabetes Mellitus, Hypercholesterolemia|diabetes mellitus, hypercholesterolemia
400455|NCT01239836|urinary incontinence, self-management, cost, self-efficacy, continence promotion|urinary incontinence, self-management, cost, self-efficacy, continence promotion
400456|NCT01239823|osteoarthritis|osteoarthritis
400457|NCT01239823|whole body vibration|whole body vibration
400458|NCT01239823|mobility|mobility
400459|NCT01239823|rehabilitation|rehabilitation
400460|NCT01239810|hyaluronic acid|hyaluronic acid
400461|NCT01239810|cartilage|cartilage
400462|NCT01239810|T2 mapping|t2 mapping
400463|NCT01239810|quantitative|quantitative
400465|NCT01239810|volume|volume
400466|NCT01239784|pediatrics|pediatrics
400467|NCT01239784|Heart Defects|heart defects
400468|NCT01239784|Neurodevelopmental deficit|neurodevelopmental deficit
400469|NCT01239784|Neurodevelopmental Rehabilitation|neurodevelopmental rehabilitation
400470|NCT01239771|Safety|safety
400471|NCT01239771|tolerability|tolerability
400472|NCT01239771|healthy|healthy
400473|NCT01239771|stable disease|stable disease
400474|NCT01239771|oral|oral
400475|NCT01239771|tablet|tablet
400595|NCT01239043|Meningococcal Infections|meningococcal infections
402079|NCT01233245|Coping Styles|coping styles
583402|NCT00511615|Loop Electrosurgical Excision Procedure|loop electrosurgical excision procedure
400476|NCT01239745|Hormone adjuvant treatment of early breast cancer with aromatase inhibitors following 2-3 years of tamoxifen|hormone adjuvant treatment of early breast cancer with aromatase inhibitors following 2-3 years of tamoxifen
400477|NCT01239719|Allergic dermatitis|allergic dermatitis
400478|NCT01239693|Stunting|stunting
400479|NCT01239693|Growth failure|growth failure
400480|NCT01239693|Malnutrition|malnutrition
400481|NCT01239693|Lipid based nutrient supplement|lipid based nutrient supplement
400483|NCT01239693|Prevention|prevention
400484|NCT01239693|Malawi|malawi
400485|NCT01239693|Sub-Saharan Africa|sub-saharan africa
400486|NCT01239693|Dietary supplementation|dietary supplementation
400487|NCT01239693|Efficacy|efficacy
400488|NCT01239693|Pregnancy|pregnancy
400489|NCT01239693|Infancy|infancy
400490|NCT01239693|Newborn|newborn
400491|NCT01239680|hemorrhagic shock|hemorrhagic shock
400492|NCT01239680|glutamine|glutamine
400493|NCT01239680|trauma resuscitation|trauma resuscitation
400494|NCT01239680|department of defense|department of defense
400495|NCT01239680|trauma|trauma
400496|NCT01239667|Health related quality of Life, Self Care behavior, activities of daily living|health related quality of life, self care behavior, activities of daily living
400497|NCT01239654|acute|acute
400498|NCT01239654|coronary|coronary
400499|NCT01239654|syndrome|syndrome
400500|NCT01239654|everolimus|everolimus
400501|NCT01239654|zotarolimus|zotarolimus
400502|NCT01239654|optical|optical
400503|NCT01239654|coherence|coherence
400504|NCT01239654|tomography|tomography
400505|NCT01239641|Uterine Fibroids|uterine fibroids
400506|NCT01239641|Myoectomy|myoectomy
400507|NCT01239641|High Intensity Focused Ultrasound|high intensity focused ultrasound
400508|NCT01239641|ablation|ablation
400509|NCT01239602|changes in cortical excitability in subjects with chronic stroke after stem cell therapy|changes in cortical excitability in subjects with chronic stroke after stem cell therapy
400510|NCT01239589|Patients admitted as for an acute bipolar manic episode|patients admitted as for an acute bipolar manic episode
400511|NCT01239589|Description of management patterns and hospital stay in patients admitted for acute bipolar manic episode and treated with either quetiapine IR or quetiapine XR|description of management patterns and hospital stay in patients admitted for acute bipolar manic episode and treated with either quetiapine ir or quetiapine xr
400512|NCT01239563|kidney transplantation|kidney transplantation
400513|NCT01239563|donation after cardiac death|donation after cardiac death
400514|NCT01239563|ischemia-reperfusion injury|ischemia-reperfusion injury
400515|NCT01239563|thymoglobulin|thymoglobulin
400516|NCT01239563|steroid avoidance|steroid avoidance
400517|NCT01239563|lymphocyte|lymphocyte
400518|NCT01239550|Insulin|insulin
400519|NCT01239550|Detemir|detemir
400520|NCT01239550|Dopamine, brain,neurotransmitter|dopamine, brain,neurotransmitter
400521|NCT01239550|Diabetes|diabetes
400522|NCT01239550|Obesity|obesity
400523|NCT01239550|Neurotransmitters|neurotransmitters
400524|NCT01239524|breast reconstruction, latissimus dorsi flap, thoracodorsal nerve, skeletal muscle disuse, breast MRI|breast reconstruction, latissimus dorsi flap, thoracodorsal nerve, skeletal muscle disuse, breast mri
400525|NCT01239485|Pediatric refractory or relapsed acute leukemia|pediatric refractory or relapsed acute leukemia
400526|NCT01239472|chronic allograft nephropathy|chronic allograft nephropathy
400527|NCT01239472|cytokines|cytokines
400528|NCT01239472|kidney transplant|kidney transplant
400529|NCT01239472|calcineurin inhibitors withdrawn|calcineurin inhibitors withdrawn
400530|NCT01239446|Hodgkin lymphoma|hodgkin lymphoma
400531|NCT01239446|mediastinal irradiation|mediastinal irradiation
400532|NCT01239446|Coronary Artery Disease|coronary artery disease
400533|NCT01239394|NHL|nhl
400534|NCT01239394|ofatumumab|ofatumumab
400535|NCT01239381|proton radiation|proton radiation
400536|NCT01239381|stereotactic body radiotherapy|stereotactic body radiotherapy
400537|NCT01239381|SBRT|sbrt
400538|NCT01239368|Multiple Myeloma|multiple myeloma
400539|NCT01239368|High Risk|high risk
400540|NCT01239368|Newly Diagnosed|newly diagnosed
400541|NCT01239368|Adoptive Immunotherapy|adoptive immunotherapy
400542|NCT01239368|Autologous|autologous
400543|NCT01239329|Complex multiple disabilities|complex multiple disabilities
400544|NCT01239329|Malnutrition|malnutrition
400545|NCT01239277|muscle|muscle
400546|NCT01239277|FSR|fsr
400547|NCT01239277|protein|protein
400548|NCT01239277|carbohydrate|carbohydrate
400549|NCT01239277|leucine|leucine
400550|NCT01239251|GlowCap|glowcap
400551|NCT01239251|adjuvant endocrine therapy|adjuvant endocrine therapy
400552|NCT01239238|asthma|asthma
400553|NCT01239238|children|children
400554|NCT01239238|home monitoring|home monitoring
400555|NCT01239238|exhaled breath condensate|exhaled breath condensate
400556|NCT01239238|non-invasive inflammatory markers|non-invasive inflammatory markers
400557|NCT01239238|volatile organic compounds|volatile organic compounds
400558|NCT01239225|Patients undergoing coronary angiography|patients undergoing coronary angiography
400559|NCT01239212|seizures|seizures
400560|NCT01239212|neonate|neonate
400561|NCT01239212|levetiracetam|levetiracetam
400562|NCT01239212|Epilepsy|epilepsy
400563|NCT01239212|central nervous system diseases|central nervous system diseases
400564|NCT01239212|anticonvulsants|anticonvulsants
400565|NCT01239199|Infants|infants
400566|NCT01239199|Exhaled Nitric Oxide|exhaled nitric oxide
400567|NCT01239199|Asthma|asthma
400568|NCT01239199|Tobacco smoke exposure|tobacco smoke exposure
400569|NCT01239199|environment|environment
400570|NCT01239186|methylation|methylation
400571|NCT01239186|micro array|micro array
400572|NCT01239186|locus H19|locus h19
400573|NCT01239186|male infertility|male infertility
400574|NCT01239173|Posttraumatic stress disorder|posttraumatic stress disorder
400575|NCT01239173|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
400576|NCT01239173|Amygdala|amygdala
400577|NCT01239173|emotion regulation|emotion regulation
400578|NCT01239173|memory|memory
400579|NCT01239160|lymphedema|lymphedema
400580|NCT01239160|pneumatic compression device|pneumatic compression device
400581|NCT01239160|randomised clinical trial|randomised clinical trial
400582|NCT01239160|volume reduction|volume reduction
400583|NCT01239147|weight maintenance|weight maintenance
400584|NCT01239134|Malignant melanoma|malignant melanoma
400585|NCT01239134|Metastatic|metastatic
400586|NCT01239134|Unresectable|unresectable
400589|NCT01239121|drug toxicity|drug toxicity
400590|NCT01239121|drug interactions|drug interactions
400591|NCT01239121|electronic health records|electronic health records
400592|NCT01239121|medical errors|medical errors
400593|NCT01239043|Meningitis|meningitis
400594|NCT01239043|Meningococcal Meningitis|meningococcal meningitis
400596|NCT01239043|Menactra®|menactra®
400597|NCT01239043|Menomune®|menomune®
400598|NCT01239043|Meningococcal vaccine|meningococcal vaccine
400599|NCT01239030|inattention|inattention
400600|NCT01239030|impulsivity|impulsivity
400601|NCT01239030|hyperactivity|hyperactivity
400602|NCT01239030|ADHD|adhd
400603|NCT01239004|dyslipidemia|dyslipidemia
400604|NCT01239004|hyperlipidemia|hyperlipidemia
400605|NCT01239004|hyperglycemia|hyperglycemia
400606|NCT01239004|impaired fasting glucose|impaired fasting glucose
400607|NCT01238978|Diabetes mellitus, vildagliptin, hypoglycemia, elderly|diabetes mellitus, vildagliptin, hypoglycemia, elderly
400608|NCT01238952|solid tumors|solid tumors
400609|NCT01238952|breast cancer|breast cancer
400610|NCT01238952|triple negative breast cancer|triple negative breast cancer
400611|NCT01238952|HER2 negative|her2 negative
400612|NCT01238952|ER negative|er negative
400613|NCT01238952|PR negative|pr negative
400614|NCT01238939|solid tumors|solid tumors
400615|NCT01238939|colorectal cancer|colorectal cancer
400616|NCT01238926|Oxidative stress|oxidative stress
400617|NCT01238926|Parkinson's disease|parkinson's disease
400618|NCT01238926|Homocysteine|homocysteine
400619|NCT01238926|Glutathione|glutathione
400620|NCT01238926|B vitamins|b vitamins
400621|NCT01238887|Satiety|satiety
400622|NCT01238887|Food Intake|food intake
400623|NCT01238887|Weight Loss|weight loss
400624|NCT01238887|Oxidative Stress|oxidative stress
400625|NCT01238887|botanicals|botanicals
400626|NCT01238887|Garcinia Cambogia-derived hydroxycitric acid|garcinia cambogia-derived hydroxycitric acid
400627|NCT01238861|Asthma|asthma
400628|NCT01238861|Benralizumab|benralizumab
400629|NCT01238861|MEDI-563|medi-563
400632|NCT01238848|Bronchiolitis|bronchiolitis
400633|NCT01238848|Efficacy|efficacy
400634|NCT01238835|Sapien XT Valve|sapien xt valve
400635|NCT01238835|Valvular Heart Disease|valvular heart disease
400636|NCT01238835|Aortic Stenosis|aortic stenosis
400637|NCT01238835|Heart Valve Therapy|heart valve therapy
400638|NCT01238835|Transapical|transapical
400639|NCT01238835|Transcatheter|transcatheter
400640|NCT01238809|Compliance|compliance
400641|NCT01238809|France|france
400642|NCT01238796|telavancin|telavancin
400643|NCT01238796|Pharmacokinetics|pharmacokinetics
400644|NCT01238796|Severe renal disease|severe renal disease
400645|NCT01238796|VIBATIV®|vibativ®
400646|NCT01238796|ASP9809|asp9809
400647|NCT01238770|Ovarian cancer|ovarian cancer
400648|NCT01238757|Prospective Studies|prospective studies
400649|NCT01238757|Humans, pediatric|humans, pediatric
400650|NCT01238757|Positive-Pressure Respiration/methods*|positive-pressure respiration/methods*
400651|NCT01238757|Respiration, Artificial/methods*|respiration, artificial/methods*
400652|NCT01238757|Intensive Care|intensive care
400653|NCT01238757|Intensive Care Units/statistics & numerical data*|intensive care units/statistics & numerical data*
400654|NCT01238757|Respiration, Artificial/statistics & numerical data*|respiration, artificial/statistics & numerical data*
400655|NCT01238757|Patients/statistics & numerical data*|patients/statistics & numerical data*
400656|NCT01238757|Prevalence|prevalence
400657|NCT01238757|Respiratory Muscles/innervation|respiratory muscles/innervation
400658|NCT01238757|Child|child
400659|NCT01238757|Child, Preschool|child, preschool
400660|NCT01238757|Infant|infant
400661|NCT01238757|Infant, Newborn|infant, newborn
400662|NCT01238757|Intensive Care Units, Pediatric|intensive care units, pediatric
400663|NCT01238757|Respiratory Rate*|respiratory rate*
400664|NCT01238731|Valve replacement|valve replacement
400665|NCT01238731|pulmonary hypertension|pulmonary hypertension
400666|NCT01238731|long term follow up|long term follow up
400667|NCT01238718|lidocaine|lidocaine
400668|NCT01238718|anesthetic depth|anesthetic depth
400669|NCT01238718|hemodynamics|hemodynamics
400670|NCT01238718|rapid sequence induction|rapid sequence induction
400671|NCT01238718|BIS|bis
400672|NCT01238705|Hypertension|hypertension
400673|NCT01238705|Antihypertensive Agents|antihypertensive agents
400674|NCT01238705|Combination|combination
400675|NCT01238705|Sexual Dysfunction|sexual dysfunction
400676|NCT01238705|Oxidative Stress|oxidative stress
400677|NCT01238692|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
400678|NCT01238692|DLBCL|dlbcl
400679|NCT01238692|Relapsed B-cell lymphoma|relapsed b-cell lymphoma
400680|NCT01238692|Refractory B-cell lymphoma|refractory b-cell lymphoma
400681|NCT01238692|B-cell Lymphoma|b-cell lymphoma
400682|NCT01238692|Panobinostat|panobinostat
400683|NCT01238692|LBH589|lbh589
400684|NCT01238692|Rituximab|rituximab
400685|NCT01238692|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
400686|NCT01238679|safety|safety
400687|NCT01238679|tolerability|tolerability
400688|NCT01238679|pharmacokinetics|pharmacokinetics
400798|NCT01238276|cephazolin|cephazolin
400689|NCT01238679|healthy volunteers|healthy volunteers
400690|NCT01238666|liver|liver
400691|NCT01238666|cancer|cancer
400692|NCT01238666|tumor|tumor
400693|NCT01238666|ablation|ablation
400694|NCT01238666|Pathfinder|pathfinder
400695|NCT01238653|liver|liver
400696|NCT01238653|cancer|cancer
400697|NCT01238653|tumor|tumor
400698|NCT01238653|Pathfinder|pathfinder
400699|NCT01238640|Smoking Cessation|smoking cessation
400700|NCT01238640|Nicotine|nicotine
400701|NCT01238627|Smoking Cessation|smoking cessation
400702|NCT01238627|Nicotine pharmacokinetics|nicotine pharmacokinetics
400703|NCT01238614|maternal depression|maternal depression
400704|NCT01238614|clinical decision support|clinical decision support
400705|NCT01238601|Breast augmentation|breast augmentation
400706|NCT01238575|Pervasive Developmental Disorders|pervasive developmental disorders
400707|NCT01238575|PDD|pdd
400708|NCT01238575|PDD-NOS|pdd-nos
400709|NCT01238575|Autistic Disorder|autistic disorder
400710|NCT01238575|Autism|autism
400711|NCT01238575|Asperger's Disorder|asperger's disorder
400712|NCT01238575|Hyperactivity|hyperactivity
400713|NCT01238575|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
400714|NCT01238575|ADHD|adhd
400715|NCT01238575|Medication|medication
400716|NCT01238575|Drug|drug
400717|NCT01238575|Guanfacine|guanfacine
400718|NCT01238575|Intuniv|intuniv
400719|NCT01238575|Placebo|placebo
400720|NCT01238575|Methylphenidate|methylphenidate
400721|NCT01238562|cancer patient|cancer patient
400722|NCT01238562|chemotherapy|chemotherapy
400723|NCT01238562|carboplatin|carboplatin
400724|NCT01238562|taxol|taxol
400725|NCT01238562|cyclophosphamide|cyclophosphamide
400726|NCT01238562|pharmorubicin|pharmorubicin
400727|NCT01238549|Spinal Cord Injuries|spinal cord injuries
400728|NCT01238549|Quality of Life|quality of life
400729|NCT01238536|Epidural Steroid Injection|epidural steroid injection
400730|NCT01238536|Low Back Pain|low back pain
400731|NCT01238536|Spinal Stenosis|spinal stenosis
400732|NCT01238536|Elderly|elderly
400733|NCT01238523|tibia|tibia
400734|NCT01238523|shaft|shaft
400735|NCT01238523|fracture|fracture
400736|NCT01238523|children|children
400737|NCT01238497|SAPIEN XT™|sapien xt™
400738|NCT01238497|Transfemoral|transfemoral
400739|NCT01238497|NovaFlex|novaflex
400740|NCT01238497|NovaFlex+|novaflex+
400741|NCT01238497|NF|nf
400742|NCT01238497|NF+|nf+
400743|NCT01238497|Transapical|transapical
400744|NCT01238497|Transaortic|transaortic
400745|NCT01238497|Ascendra2|ascendra2
400746|NCT01238497|Ascendra+|ascendra+
400747|NCT01238497|Asc+|asc+
400748|NCT01238497|aortic stenosis|aortic stenosis
400749|NCT01238497|aortic valve|aortic valve
400750|NCT01238497|Transcatheter Heart Valve|transcatheter heart valve
400751|NCT01238497|THV|thv
400752|NCT01238484|Ankle Equinus|ankle equinus
400753|NCT01238484|Ankle contracture|ankle contracture
400754|NCT01238484|Diabetes Mellitus|diabetes mellitus
400755|NCT01238484|Dynasplint|dynasplint
400756|NCT01238484|AFD|afd
400757|NCT01238471|retinopathy of prematurity|retinopathy of prematurity
400758|NCT01238471|Propranolol|propranolol
400759|NCT01238471|Vascular endothelial growth factor|vascular endothelial growth factor
400760|NCT01238471|premature infant|premature infant
400761|NCT01238458|[18F]AV-45 PET amyloid binding imaging|[18f]av-45 pet amyloid binding imaging
400762|NCT01238458|Alzheimer's disease|alzheimer's disease
400763|NCT01238458|mild cognitive impartment,|mild cognitive impartment,
400764|NCT01238445|Pediatric|pediatric
400765|NCT01238432|Pediatric|pediatric
400766|NCT01238432|Polymorphism, Genetic|polymorphism, genetic
400767|NCT01238432|Adrenergic beta-Agonists|adrenergic beta-agonists
602136|NCT00588562|PH1|ph1
400768|NCT01238406|Type 1 diabetes|type 1 diabetes
400769|NCT01238406|Closed loop|closed loop
400770|NCT01238406|Artificial Pancreas|artificial pancreas
400771|NCT01238380|Monogenic diabetes|monogenic diabetes
400772|NCT01238380|HNF1A|hnf1a
400773|NCT01238380|HNF4A|hnf4a
400774|NCT01238380|GCK|gck
400775|NCT01238380|genetic testing|genetic testing
400776|NCT01238380|health economic model|health economic model
400777|NCT01238354|Weight Loss|weight loss
400778|NCT01238354|Social support|social support
400779|NCT01238341|Pancreatobiliary disease in patients with altered gastric anatomy.|pancreatobiliary disease in patients with altered gastric anatomy.
400780|NCT01238328|Mucopolysaccharidosis|mucopolysaccharidosis
400781|NCT01238328|HSCT|hsct
400782|NCT01238315|Batten's disease|batten's disease
400783|NCT01238315|INCL|incl
400784|NCT01238315|LINCL|lincl
400785|NCT01238315|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
400786|NCT01238315|NCL|ncl
400787|NCT01238289|peer education|peer education
400788|NCT01238289|diabetes|diabetes
400789|NCT01238289|randomized|randomized
400790|NCT01238289|trial|trial
400791|NCT01238276|soft tissue infection|soft tissue infection
400792|NCT01238276|wound infection|wound infection
400793|NCT01238276|cellulitis|cellulitis
400794|NCT01238276|foot ulcer|foot ulcer
400795|NCT01238276|Diabetes|diabetes
400796|NCT01238276|antibiotics|antibiotics
400799|NCT01238276|Ancef|ancef
400800|NCT01238276|Kefzol|kefzol
400801|NCT01238276|subcutaneous fluid administration|subcutaneous fluid administration
400802|NCT01238276|ultrasound|ultrasound
400803|NCT01238276|MRSA|mrsa
400804|NCT01238276|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
400805|NCT01238263|Atopic dermatitis, autologous serum skin testing, IgE autoantibodies|atopic dermatitis, autologous serum skin testing, ige autoantibodies
400806|NCT01238250|16p11.2|16p11.2
400807|NCT01238250|16p11.2 del|16p11.2 del
400808|NCT01238250|16p11.2 deletion|16p11.2 deletion
400809|NCT01238250|16p11.2 dup|16p11.2 dup
400810|NCT01238250|16p11.2 duplication|16p11.2 duplication
400811|NCT01238250|chromosome 16|chromosome 16
400812|NCT01238250|chromosome 16p|chromosome 16p
400813|NCT01238250|chromosome 16p11|chromosome 16p11
400814|NCT01238250|chromosome 16p11.2|chromosome 16p11.2
400815|NCT01238250|1q21.1|1q21.1
400816|NCT01238250|1q21.1 del|1q21.1 del
400817|NCT01238250|1q21.1 deletion|1q21.1 deletion
400818|NCT01238250|1q21.1 dup|1q21.1 dup
400819|NCT01238250|1q21.1 duplication|1q21.1 duplication
400820|NCT01238250|chromosome 1|chromosome 1
400821|NCT01238250|chromosome 1q|chromosome 1q
400822|NCT01238250|chromosome 1q21|chromosome 1q21
400823|NCT01238250|chromosome 1q21.1|chromosome 1q21.1
400824|NCT01238250|genetic mutation|genetic mutation
400825|NCT01238250|genetic variant|genetic variant
400826|NCT01238250|gene variant|gene variant
400827|NCT01238250|autism|autism
400828|NCT01238250|ADNP|adnp
400829|NCT01238250|ANKRD1|ankrd1
400830|NCT01238250|ARID1B|arid1b
400831|NCT01238250|ASXL3|asxl3
400832|NCT01238250|BAF105|baf105
400833|NCT01238250|BAF180|baf180
400834|NCT01238250|BAF190|baf190
400835|NCT01238250|BAF35|baf35
400836|NCT01238250|BAF35b|baf35b
400837|NCT01238250|BCL11A|bcl11a
400838|NCT01238250|CHD2|chd2
400839|NCT01238250|CHD8|chd8
400840|NCT01238250|CTNNB1|ctnnb1
400841|NCT01238250|CUL3|cul3
400842|NCT01238250|DST|dst
400843|NCT01238250|DYRK1A|dyrk1a
400844|NCT01238250|FOXP1|foxp1
400845|NCT01238250|GRIN2B|grin2b
400846|NCT01238250|KDM6B|kdm6b
400847|NCT01238250|KMT2E|kmt2e
400848|NCT01238250|MBD5|mbd5
400849|NCT01238250|MED13L|med13l
400850|NCT01238250|PTEN|pten
400851|NCT01238250|REST|rest
400852|NCT01238250|SCN2A|scn2a
400853|NCT01238250|SMARCC1|smarcc1
400854|NCT01238250|SMARCC2|smarcc2
400855|NCT01238250|SYNGAP1|syngap1
400856|NCT01238250|HIVEP2|hivep2
400857|NCT01238250|HNRNPH2|hnrnph2
400858|NCT01238250|PPP2R5D|ppp2r5d
400859|NCT01238237|Glioblastoma Multiforme|glioblastoma multiforme
400860|NCT01238237|Anaplastic Astrocytoma|anaplastic astrocytoma
400861|NCT01238237|High Grade Glial Neoplasms|high grade glial neoplasms
400862|NCT01238237|Brain Tumor|brain tumor
400863|NCT01238237|EGFR|egfr
400864|NCT01238237|Epidermal Growth Factor Receptor|epidermal growth factor receptor
400865|NCT01238237|EGFRvIII|egfrviii
400866|NCT01238224|Insulin resistance|insulin resistance
400867|NCT01238224|Phosphodiesterase-5 inhibition|phosphodiesterase-5 inhibition
400868|NCT01238224|Microdialysis|microdialysis
400869|NCT01238224|Type 2 diabetes|type 2 diabetes
400870|NCT01238224|Endothelial dysfunction|endothelial dysfunction
400871|NCT01238224|Oral hypoglycaemic agents|oral hypoglycaemic agents
400872|NCT01238185|oral leukoplakia|oral leukoplakia
400873|NCT01238172|stage I prostate cancer|stage i prostate cancer
400874|NCT01238172|stage IIB prostate cancer|stage iib prostate cancer
400875|NCT01238172|stage IIA prostate cancer|stage iia prostate cancer
400876|NCT01238172|adenocarcinoma of the prostate|adenocarcinoma of the prostate
602137|NCT00588562|PH2|ph2
400877|NCT01238159|Natural killer cell|natural killer cell
400878|NCT01238159|T cell|t cell
400879|NCT01238159|Lymphoma|lymphoma
400880|NCT01238159|Radiation|radiation
400881|NCT01238159|Chemotherapy|chemotherapy
400882|NCT01238120|Cancer|cancer
400883|NCT01238120|Cognitive difficulties|cognitive difficulties
400884|NCT01238107|Cachexia|cachexia
400885|NCT01238107|Cancer|cancer
400886|NCT01238094|colorectal cancer|colorectal cancer
400887|NCT01238094|simvastatin|simvastatin
400888|NCT01238094|second-line chemotherapy|second-line chemotherapy
400889|NCT01238081|Cystic fibrosis|cystic fibrosis
400890|NCT01238055|advanced gastric cancer|advanced gastric cancer
400891|NCT01238055|sunitinib|sunitinib
400892|NCT01238055|docetaxel|docetaxel
400893|NCT01238055|fluoropyrimidine platinum based chemotherapy|fluoropyrimidine platinum based chemotherapy
400894|NCT01238029|Dose finding study|dose finding study
400895|NCT01238029|Combination|combination
400896|NCT01237990|liver|liver
400897|NCT01237990|cancer|cancer
400898|NCT01237990|tumor|tumor
400899|NCT01237951|Autologous Hematopoietic-Cell Support|autologous hematopoietic-cell support
400900|NCT01237951|Stem Cell Transplant|stem cell transplant
400901|NCT01237951|Busulfan|busulfan
400902|NCT01237951|Myleran|myleran
400903|NCT01237951|Busulfex|busulfex
400904|NCT01237951|Gemcitabine|gemcitabine
400905|NCT01237951|Gemzar|gemzar
400906|NCT01237951|Melphalan|melphalan
400907|NCT01237951|Alkeran|alkeran
400908|NCT01237951|Decadron|decadron
400909|NCT01237951|Dexamethasone|dexamethasone
400910|NCT01237951|G-CSF|g-csf
400911|NCT01237951|Filgrastim|filgrastim
400912|NCT01237951|Neupogen|neupogen
400913|NCT01237925|Sunburn|sunburn
400914|NCT01237925|Dexchlorpheniramine|dexchlorpheniramine
400915|NCT01237925|Gel|gel
400916|NCT01237925|Cream|cream
400917|NCT01237899|Kidney|kidney
400918|NCT01237899|Renal|renal
400919|NCT01237886|spontaneous breathing trial|spontaneous breathing trial
400920|NCT01237886|heart rate variability|heart rate variability
400921|NCT01237886|respiratory rate variability|respiratory rate variability
400922|NCT01237873|Aliskiren|aliskiren
400923|NCT01237873|Amlodipine|amlodipine
400924|NCT01237873|Essential hypertension|essential hypertension
400925|NCT01237873|Long term|long term
400926|NCT01237860|Foot drop|foot drop
400927|NCT01237860|Thigh muscle weakness|thigh muscle weakness
400928|NCT01237860|Upper Motor Neuron injury or disease|upper motor neuron injury or disease
400929|NCT01237847|inflammatory bowel disease|inflammatory bowel disease
400930|NCT01237847|IBD|ibd
400931|NCT01237847|Crohn's disease|crohn's disease
400932|NCT01237847|ulcerative colitis|ulcerative colitis
400933|NCT01237847|adolescent|adolescent
400934|NCT01237808|AML|aml
400935|NCT01237808|NPM1 Mutation|npm1 mutation
400936|NCT01237808|elderly patients (>60 years)|elderly patients (>60 years)
400937|NCT01237808|unfit for intensive chemotherapy|unfit for intensive chemotherapy
400938|NCT01237795|Chloramine T|chloramine t
400939|NCT01237795|Complete Denture|complete denture
400940|NCT01237795|Dental Plaque Index|dental plaque index
400941|NCT01237795|Dentifrice|dentifrice
400942|NCT01237795|Denture Bases|denture bases
400943|NCT01237795|Denture Cleansers|denture cleansers
400944|NCT01237795|Edentulous Mouth|edentulous mouth
400945|NCT01237795|Fluorosurfactant|fluorosurfactant
400946|NCT01237795|Oral Health|oral health
400947|NCT01237795|Toothpaste|toothpaste
400948|NCT01237782|Candida|candida
400949|NCT01237782|Complete Denture|complete denture
400950|NCT01237782|Dental Plaque Index|dental plaque index
400951|NCT01237782|Denture Bases|denture bases
400952|NCT01237782|Denture Cleansers|denture cleansers
400953|NCT01237782|Edentulous Mouth|edentulous mouth
400954|NCT01237782|Mutans Streptococci|mutans streptococci
400955|NCT01237782|Oral Health|oral health
400956|NCT01237782|Propolis|propolis
400957|NCT01237782|Streptococcus mutans|streptococcus mutans
400958|NCT01237769|vitamin D|vitamin d
400959|NCT01237769|Metabolic syndrome|metabolic syndrome
400960|NCT01237769|Hypertension|hypertension
400961|NCT01237769|Dyslipidemia|dyslipidemia
400962|NCT01237769|Dysglycemia|dysglycemia
400963|NCT01237769|Inflammation|inflammation
400964|NCT01237756|pediatric anesthesia|pediatric anesthesia
400965|NCT01237756|endotracheal tube|endotracheal tube
400966|NCT01237756|electrical impedance tomography|electrical impedance tomography
400967|NCT01237756|misplacement|misplacement
400968|NCT01237756|endobronchial|endobronchial
400969|NCT01237743|Embolism|embolism
400970|NCT01237743|Nervous system|nervous system
400972|NCT01237743|Valves|valves
400973|NCT01237743|Ultrasonics|ultrasonics
400974|NCT01237730|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
400975|NCT01237730|peristomal wound infection|peristomal wound infection
400976|NCT01237730|prophylactic antibiotics|prophylactic antibiotics
400977|NCT01237717|hypertension|hypertension
400978|NCT01237691|drug use|drug use
400979|NCT01237691|drug arrests|drug arrests
400980|NCT01237691|incarceration|incarceration
400981|NCT01237678|Immunogen|immunogen
400982|NCT01237678|Lung|lung
400983|NCT01237678|Small Cell Lung Cancer|small cell lung cancer
400984|NCT01237678|Carboplatin|carboplatin
400985|NCT01237678|ADC|adc
401111|NCT01237145|bird fancier|bird fancier
400986|NCT01237665|locally resectable advanced adenocarcinoma of the rectum|locally resectable advanced adenocarcinoma of the rectum
400987|NCT01237652|Isolated Systolic Hypertension|isolated systolic hypertension
400988|NCT01237652|Perioperative Myocardial Ischemia|perioperative myocardial ischemia
400989|NCT01237652|Perioperative Cardiovascular adverse events|perioperative cardiovascular adverse events
400990|NCT01237639|Red Cells|red cells
400991|NCT01237639|Transfusion|transfusion
400992|NCT01237639|Trigger|trigger
400993|NCT01237639|Threshold|threshold
400994|NCT01237639|Hematopoietic Stem cell Transplantation|hematopoietic stem cell transplantation
400995|NCT01237626|Driving|driving
400996|NCT01237626|Aging|aging
400997|NCT01237626|Older drivers|older drivers
400998|NCT01237626|Medical Fitness to drive|medical fitness to drive
400999|NCT01237626|Health Status|health status
401000|NCT01237626|At-fault collisions|at-fault collisions
401001|NCT01237613|Achilles|achilles
401002|NCT01237613|Rupture|rupture
401003|NCT01237613|Tendon|tendon
401004|NCT01237613|Artelon|artelon
401005|NCT01237600|Ocular surface damage|ocular surface damage
401006|NCT01237600|Limbal deficiency|limbal deficiency
401007|NCT01237600|Cultivated corneal epithelial stem cell transplantation|cultivated corneal epithelial stem cell transplantation
401008|NCT01237587|Adolescents|adolescents
401009|NCT01237587|Juvenile Primary Fibromyalgia Syndrome|juvenile primary fibromyalgia syndrome
401010|NCT01237574|Liver Diseases|liver diseases
401011|NCT01237574|Alcoholic|alcoholic
401012|NCT01237574|Metabolic Diseases|metabolic diseases
401013|NCT01237574|cohort|cohort
401014|NCT01237574|liver disease|liver disease
401015|NCT01237561|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
401016|NCT01237561|COPD Guidelines|copd guidelines
401017|NCT01237561|Patient Activation|patient activation
401018|NCT01237561|Lung Age|lung age
401019|NCT01237548|water pipe smoking|water pipe smoking
401020|NCT01237548|acute effect|acute effect
401021|NCT01237548|Endothelial|endothelial
401022|NCT01237548|healthy adults who smoke narghile|healthy adults who smoke narghile
401023|NCT01237535|Unexplained infertility|unexplained infertility
401024|NCT01237535|Insemination|insemination
401025|NCT01237535|Luteal phase support|luteal phase support
401026|NCT01237535|Ovarian stimulation|ovarian stimulation
401027|NCT01237522|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
401028|NCT01237522|Metabolic Clearance Rate|metabolic clearance rate
401029|NCT01237522|Pharmacokinetics|pharmacokinetics
401030|NCT01237522|Pharmacogenetics|pharmacogenetics
401031|NCT01237509|EEG|eeg
401032|NCT01237509|Sleep|sleep
401033|NCT01237509|device|device
401034|NCT01237509|diabetes|diabetes
401035|NCT01237509|hypoglycemia|hypoglycemia
401036|NCT01237483|reirradiation with Erbitux|reirradiation with erbitux
401037|NCT01237483|HNSCC|hnscc
401038|NCT01237483|local recurrent inoperable Squamous Cell Cancer of the Head and Neck|local recurrent inoperable squamous cell cancer of the head and neck
401039|NCT01237470|inguinal hernia|inguinal hernia
401040|NCT01237470|hernia recurrence|hernia recurrence
401041|NCT01237470|no mesh techniques|no mesh techniques
401042|NCT01237470|Desarda technique|desarda technique
401043|NCT01237444|Lopinavir/ritonavir plus 3TC as a dual therapy regimen.|lopinavir/ritonavir plus 3tc as a dual therapy regimen.
401044|NCT01237431|Water drinking|water drinking
401045|NCT01237431|osmoreceptors|osmoreceptors
401046|NCT01237431|autonomic failure|autonomic failure
401047|NCT01237431|syncope|syncope
401048|NCT01237431|blood pressure|blood pressure
401049|NCT01237431|liver transplant|liver transplant
401050|NCT01237405|osteoarthritis|osteoarthritis
401051|NCT01237405|nuclear medicine|nuclear medicine
401052|NCT01237405|macrophages|macrophages
401053|NCT01237392|wound debridement|wound debridement
401054|NCT01237392|requiring debridement|requiring debridement
401055|NCT01237366|HIV/AIDS|hiv/aids
401056|NCT01237366|Methamphetamine|methamphetamine
401057|NCT01237366|Trauma|trauma
401058|NCT01237340|Adult Growth Hormone Deficiency (AGHD)|adult growth hormone deficiency (aghd)
401059|NCT01237340|immunogenicity|immunogenicity
401060|NCT01237340|growth hormone|growth hormone
401061|NCT01237340|antibodies|antibodies
401062|NCT01237340|GH biomarkers|gh biomarkers
401063|NCT01237340|IGF-I|igf-i
401064|NCT01237327|Metastatic Breast Cancer|metastatic breast cancer
401065|NCT01237327|Advanced|advanced
401066|NCT01237327|Postmenopausal|postmenopausal
401067|NCT01237327|Exemestane vs Megestrol|exemestane vs megestrol
401068|NCT01237314|type 2 diabetes|type 2 diabetes
401069|NCT01237314|metformin|metformin
401070|NCT01237314|glargine|glargine
401071|NCT01237314|exenatide|exenatide
401072|NCT01237314|glycemic impact of food|glycemic impact of food
401073|NCT01237314|continuous glucose monitoring|continuous glucose monitoring
401074|NCT01237301|Type 2 Diabetes|type 2 diabetes
401075|NCT01237301|Continuous Glucose Monitoring|continuous glucose monitoring
401076|NCT01237275|Pharmacogenomics|pharmacogenomics
401077|NCT01237275|Prediction of Antidepressant Response|prediction of antidepressant response
401078|NCT01237275|Depressed Patients|depressed patients
401079|NCT01237262|psoriasis|psoriasis
401080|NCT01237262|immune infiltrate|immune infiltrate
401081|NCT01237262|dendritic cells|dendritic cells
401082|NCT01237262|cytokine expression|cytokine expression
401083|NCT01237249|Multiple Myeloma|multiple myeloma
401084|NCT01237249|Velcade|velcade
401085|NCT01237249|Revlimid|revlimid
401086|NCT01237236|Advanced solid tumor|advanced solid tumor
401087|NCT01237236|lymphoma|lymphoma
401088|NCT01237223|Aliskiren|aliskiren
401089|NCT01237223|Amlodipine|amlodipine
401090|NCT01237223|Essential hypertension|essential hypertension
401091|NCT01237210|Parkinson's Disease|parkinson's disease
401092|NCT01237210|PD|pd
401093|NCT01237210|magnetic resonance spectroscopy|magnetic resonance spectroscopy
401094|NCT01237184|initial dental implant stability|initial dental implant stability
401095|NCT01237184|maxillary sinus proximity|maxillary sinus proximity
401096|NCT01237184|bicortical fixation|bicortical fixation
401097|NCT01237171|Brachytherapy|brachytherapy
401098|NCT01237171|Lung Brachytherapy|lung brachytherapy
401099|NCT01237171|NSCLC|nsclc
401100|NCT01237171|Sub-lobar resection|sub-lobar resection
401101|NCT01237158|GAD1,|gad1,
401102|NCT01237158|GAD67,|gad67,
401103|NCT01237158|bipolar,|bipolar,
401104|NCT01237158|GABA,|gaba,
401105|NCT01237158|Glutamate,|glutamate,
401106|NCT01237158|Reelin,|reelin,
401107|NCT01237158|Rln,|rln,
401108|NCT01237158|Spectroscopy|spectroscopy
401109|NCT01237158|euthymic bipolar I patients|euthymic bipolar i patients
401110|NCT01237145|pigeon|pigeon
401112|NCT01237145|extrinsic allergic alveolitis|extrinsic allergic alveolitis
401113|NCT01237145|BAL|bal
401114|NCT01237145|broncho-alveolar lavage|broncho-alveolar lavage
401115|NCT01237145|elispot|elispot
401116|NCT01237145|antigen|antigen
401117|NCT01237106|PCOS|pcos
401118|NCT01237106|IVM|ivm
401119|NCT01237106|Polycystic ovarian syndrome|polycystic ovarian syndrome
401120|NCT01237106|In Vitro Maturation|in vitro maturation
401121|NCT01237106|IVF|ivf
401122|NCT01237093|Fish Diet|fish diet
401123|NCT01237093|Meat Diet|meat diet
401124|NCT01237093|Biomarkers|biomarkers
401125|NCT01237093|Stable Isotopes|stable isotopes
401126|NCT01237093|Dietary Intake|dietary intake
401127|NCT01237067|PARP inhibitor, womens's cancers, relapsed, recurrent|parp inhibitor, womens's cancers, relapsed, recurrent
401128|NCT01237067|Ovarian, breast, endometrial, cervical|ovarian, breast, endometrial, cervical
401129|NCT01237067|Carboplatin|carboplatin
401130|NCT01237067|BRCA 1 and BRCA 2|brca 1 and brca 2
401131|NCT01237067|Breast Cancer|breast cancer
401132|NCT01237067|Ovarian Cancer|ovarian cancer
401133|NCT01237067|Uterine Cancer|uterine cancer
401134|NCT01237067|Cervical Cancer|cervical cancer
401135|NCT01237067|Peritoneal Cancer|peritoneal cancer
401136|NCT01237067|Endometrial Cancer|endometrial cancer
401137|NCT01237067|Fallopian Tube Cancer|fallopian tube cancer
401138|NCT01237054|18-FDG PET/CT|18-fdg pet/ct
401139|NCT01237054|Abnormal Plasma Cells|abnormal plasma cells
401140|NCT01237054|Serum Free Light-Chain Abnormality|serum free light-chain abnormality
401141|NCT01237054|Serum M-Protein|serum m-protein
401142|NCT01237054|DCE-MRI|dce-mri
401143|NCT01237054|Multiple Myeloma|multiple myeloma
401144|NCT01237054|Smoldering Multiple Myeloma|smoldering multiple myeloma
401145|NCT01237054|SMM|smm
401146|NCT01237054|MM|mm
401147|NCT01237041|Child|child
401148|NCT01237041|Body Fat|body fat
401149|NCT01237041|Niacin|niacin
401150|NCT01237041|Growth Hormone|growth hormone
401151|NCT01237041|Obesity|obesity
401152|NCT01237041|Growth Hormones|growth hormones
401153|NCT01237041|Short Stature|short stature
401154|NCT01237041|Children|children
401155|NCT01237015|Neonate|neonate
401156|NCT01237015|Oral feeding|oral feeding
401157|NCT01237015|Nasal CPAP|nasal cpap
401158|NCT01237015|Sucking|sucking
401159|NCT01237015|Swallowing|swallowing
401160|NCT01237015|Breathing|breathing
401161|NCT01237002|Liver ischemia; Pringle time|liver ischemia; pringle time
401162|NCT01236989|anatomical resection|anatomical resection
401163|NCT01236989|non-anatomical resection|non-anatomical resection
401164|NCT01236989|IOUS-guided finger compression|ious-guided finger compression
401165|NCT01236963|Clinical trial|clinical trial
401166|NCT01236963|Prevention mouthrinse|prevention mouthrinse
401167|NCT01236963|Dental Floss|dental floss
401168|NCT01236950|Clinical Trial|clinical trial
401169|NCT01236950|Prevention Mouthrinse|prevention mouthrinse
401170|NCT01236937|CT, lung nodule biopsy, Respiration Gated, Lung Cancer|ct, lung nodule biopsy, respiration gated, lung cancer
401171|NCT01236911|Calcium , TBI,complications, days in hospital|calcium , tbi,complications, days in hospital
401172|NCT01236898|N-acetylneuraminic acid,|n-acetylneuraminic acid,
401173|NCT01236898|pharmacokinetics|pharmacokinetics
401174|NCT01236898|hIBM|hibm
401175|NCT01236872|Nitrate|nitrate
401176|NCT01236872|Nitrite|nitrite
401177|NCT01236872|Vegetable|vegetable
602138|NCT00588562|PH3|ph3
401178|NCT01236872|Aortic stiffness|aortic stiffness
401179|NCT01236859|Gabapentin|gabapentin
401180|NCT01236859|prophylaxis|prophylaxis
401181|NCT01236859|incidence of pruritus|incidence of pruritus
401182|NCT01236859|intrathecal morphine|intrathecal morphine
401183|NCT01236846|Vitamin D fortification|vitamin d fortification
401184|NCT01236846|Yogurt Drink|yogurt drink
401185|NCT01236846|Efficacy|efficacy
401186|NCT01236833|Lactated Ringer's Solution|lactated ringer's solution
401187|NCT01236833|Isotonic Solution|isotonic solution
401188|NCT01236833|Intestinal Disease|intestinal disease
401189|NCT01236833|Feeding Intolerance|feeding intolerance
401190|NCT01236833|Necrotizing Enterocolitis|necrotizing enterocolitis
401191|NCT01236833|Newborn|newborn
401192|NCT01236833|Premature Infant|premature infant
401193|NCT01236820|L5|l5
401194|NCT01236820|LDL|ldl
401195|NCT01236820|Cardiovascular disease|cardiovascular disease
401196|NCT01236820|Chronic kidney disease|chronic kidney disease
401197|NCT01236820|Hemodialysis|hemodialysis
401198|NCT01236807|Adenosine|adenosine
401199|NCT01236807|Magnetic Resonance Imaging|magnetic resonance imaging
401200|NCT01236807|MR perfusion|mr perfusion
401201|NCT01236807|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
401202|NCT01236807|FFR|ffr
401203|NCT01236807|Pressure wire|pressure wire
401204|NCT01236807|Coronary Disease|coronary disease
401205|NCT01236807|Heart Diseases|heart diseases
401206|NCT01236807|Cardiovascular Diseases|cardiovascular diseases
401207|NCT01236807|Arteriosclerosis|arteriosclerosis
401208|NCT01236781|breast cancer|breast cancer
401209|NCT01236781|screening|screening
401210|NCT01236781|diagnostics|diagnostics
401211|NCT01236781|diagnosis|diagnosis
401212|NCT01236781|high-risk|high-risk
401213|NCT01236781|breast neoplasms|breast neoplasms
401214|NCT01236781|digital mammography|digital mammography
401215|NCT01236781|mammography|mammography
401216|NCT01236781|tomosynthesis|tomosynthesis
401217|NCT01236781|dense breasts|dense breasts
401218|NCT01236781|radiation dose|radiation dose
401219|NCT01236781|comparison|comparison
401221|NCT01236781|Pennsylvania|pennsylvania
401222|NCT01236781|Philadelphia|philadelphia
401223|NCT01236781|breast study|breast study
401224|NCT01236781|mammo|mammo
401225|NCT01236781|tomo|tomo
401226|NCT01236781|mammary|mammary
401227|NCT01236768|Contraceptive|contraceptive
401228|NCT01236755|children|children
401229|NCT01236755|corneal reshaping|corneal reshaping
401230|NCT01236755|myopia|myopia
401231|NCT01236755|myopia progression|myopia progression
401232|NCT01236755|orthokeratology|orthokeratology
401233|NCT01236742|children|children
401234|NCT01236742|corneal reshaping|corneal reshaping
401235|NCT01236742|myopia|myopia
401236|NCT01236742|myopia progression|myopia progression
401237|NCT01236742|orthokeratology|orthokeratology
401238|NCT01236729|knee replacement|knee replacement
401239|NCT01236729|disability|disability
401240|NCT01236729|older people|older people
401241|NCT01236716|squamous cell carcinoma of lung|squamous cell carcinoma of lung
401242|NCT01236716|Albumin bound paclitaxel|albumin bound paclitaxel
401243|NCT01236716|chemotherapy|chemotherapy
401244|NCT01236703|SIRS|sirs
401245|NCT01236703|Sepsis|sepsis
401246|NCT01236703|hematological infection score|hematological infection score
401247|NCT01236690|Transcatheter arterial embolization|transcatheter arterial embolization
401248|NCT01236690|Cinobufacin injection|cinobufacin injection
401249|NCT01236690|hepatoma|hepatoma
401250|NCT01236677|Pathogen|pathogen
401251|NCT01236664|memory training|memory training
401252|NCT01236664|mnemonics|mnemonics
401253|NCT01236664|cognition|cognition
401254|NCT01236664|work|work
401255|NCT01236638|Primary Myelofibrosis|primary myelofibrosis
401256|NCT01236638|Post-Polycythemia Vera|post-polycythemia vera
401257|NCT01236638|Post-Essential Thrombocythemia|post-essential thrombocythemia
401258|NCT01236638|CYT387|cyt387
401259|NCT01236625|Tissue Adhesions|tissue adhesions
401260|NCT01236625|Adhesiolysis|adhesiolysis
401261|NCT01236625|Inadvertent enterotomy|inadvertent enterotomy
401262|NCT01236625|Prospective cohort study|prospective cohort study
401263|NCT01236625|Quality of life|quality of life
401264|NCT01236612|Plasmodium|plasmodium
401265|NCT01236612|falciparum|falciparum
401266|NCT01236612|malaria|malaria
401267|NCT01236612|chloroquine|chloroquine
401268|NCT01236612|immunity|immunity
401269|NCT01236599|preterm infant, thermoregulation, polyethylene bag|preterm infant, thermoregulation, polyethylene bag
401270|NCT01236586|Maximum Tolerated Dose|maximum tolerated dose
401271|NCT01236586|Toxicity|toxicity
401272|NCT01236586|Pharmacokinetics|pharmacokinetics
401273|NCT01236586|NOTCH Signaling Pathway|notch signaling pathway
401274|NCT01236586|Expression of JAGGED 1 and 2|expression of jagged 1 and 2
401275|NCT01236586|Cancer|cancer
401276|NCT01236586|Solid Tumor|solid tumor
401277|NCT01236586|Brain Tumor|brain tumor
401278|NCT01236586|Wilms Tumor|wilms tumor
401279|NCT01236586|Osteosarcoma|osteosarcoma
401280|NCT01236586|Lymphoma|lymphoma
401281|NCT01236573|Gene Therapy|gene therapy
401282|NCT01236573|Immunotherapy|immunotherapy
401283|NCT01236573|Adoptive Cell Therapy|adoptive cell therapy
401284|NCT01236573|Metastatic Melanoma|metastatic melanoma
401285|NCT01236534|Multiple Sclerosis|multiple sclerosis
401286|NCT01236534|Constipation|constipation
401287|NCT01236534|Multiple Sclerosis Associated Constipation|multiple sclerosis associated constipation
401288|NCT01236521|Back pain|back pain
401289|NCT01236521|Care Management|care management
401290|NCT01236521|Pain|pain
401291|NCT01236521|Patient outcomes|patient outcomes
401292|NCT01236521|Patient-center Care|patient-center care
401293|NCT01236521|Primary care|primary care
401294|NCT01236508|White Matter Hyperintensity|white matter hyperintensity
401295|NCT01236508|Stroke|stroke
401296|NCT01236508|Carotid Artery Plaque Inflammation|carotid artery plaque inflammation
401297|NCT01236508|FDG PET|fdg pet
401298|NCT01236508|MRI|mri
401299|NCT01236508|TIA|tia
401300|NCT01236495|thoracotomy|thoracotomy
401301|NCT01236495|postoperative pain|postoperative pain
401302|NCT01236495|spinal morphine|spinal morphine
401303|NCT01236482|Pregnancy|pregnancy
401304|NCT01236482|Postpartum hemorrhage|postpartum hemorrhage
401305|NCT01236482|Uterine tone|uterine tone
401306|NCT01236482|Oxytocin|oxytocin
401307|NCT01236482|Ergometrine|ergometrine
401308|NCT01236482|Pharmacokinetic-pharmacodynamic analysis|pharmacokinetic-pharmacodynamic analysis
401309|NCT01236469|Aortic Valve|aortic valve
401310|NCT01236456|chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy
401311|NCT01236456|cyclophosphamide|cyclophosphamide
401312|NCT01236456|autoimmune|autoimmune
401313|NCT01236430|Hyperlipidemia|hyperlipidemia
401314|NCT01236430|statin|statin
401315|NCT01236430|Ezetimibe|ezetimibe
401316|NCT01236430|Zetia|zetia
401317|NCT01236430|Atorvastatin|atorvastatin
401318|NCT01236430|Lipitor|lipitor
401319|NCT01236391|Pharmacyclics|pharmacyclics
401320|NCT01236391|Mantle|mantle
401321|NCT01236391|Mantle Cell|mantle cell
401322|NCT01236391|Lymphoma|lymphoma
401323|NCT01236391|Non-Hodgkins|non-hodgkins
401324|NCT01236391|Bortezomib|bortezomib
401325|NCT01236391|Velcade|velcade
401326|NCT01236391|Naive|naive
401327|NCT01236391|PCYC|pcyc
401328|NCT01236378|Organ Transplants|organ transplants
401329|NCT01236378|Anti-Rejection Therapy|anti-rejection therapy
401330|NCT01236378|Pharmacokinetics|pharmacokinetics
401331|NCT01236365|Type 1 diabetes|type 1 diabetes
401332|NCT01236365|Children|children
401333|NCT01236365|Statins|statins
401334|NCT01236365|Hypercholesterolemia|hypercholesterolemia
401335|NCT01236365|Lipoproteins|lipoproteins
401336|NCT01236365|C reactive protein|c reactive protein
401337|NCT01236365|Continuous glucose monitors|continuous glucose monitors
401338|NCT01236365|Adolescence|adolescence
401339|NCT01236365|Abdominal magnetic resonance imaging|abdominal magnetic resonance imaging
401340|NCT01236365|Toll like receptors|toll like receptors
401341|NCT01236365|Receptors of advanced glycation end products|receptors of advanced glycation end products
401342|NCT01236365|Nutrition|nutrition
401343|NCT01236352|Advanced Cancer, Various, NOS|advanced cancer, various, nos
401344|NCT01236313|TEE|tee
401345|NCT01236313|Cardiac Surgery|cardiac surgery
401346|NCT01236313|Pulse Pressure|pulse pressure
401347|NCT01236300|Pancreatic cysts|pancreatic cysts
401348|NCT01236274|Myocardial Infarction|myocardial infarction
401349|NCT01236274|Antipsychotic agents|antipsychotic agents
401350|NCT01236274|Self-controlled case series method|self-controlled case series method
401351|NCT01236274|General Practice Research Database|general practice research database
401352|NCT01236274|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
401353|NCT01236274|CALIBER|caliber
401459|NCT01235871|Safety|safety
401460|NCT01235871|Tolerability|tolerability
401354|NCT01236261|Fungemia, fungal infection, susceptibility, antifungal|fungemia, fungal infection, susceptibility, antifungal
401355|NCT01236248|drugs|drugs
401356|NCT01236248|youth|youth
401357|NCT01236248|parent|parent
401358|NCT01236248|computer|computer
401359|NCT01236248|prevention|prevention
401360|NCT01236222|commuter cycling|commuter cycling
401361|NCT01236222|fitness|fitness
401362|NCT01236222|metabolic syndrome|metabolic syndrome
401363|NCT01236222|children|children
401364|NCT01236196|pain|pain
401365|NCT01236196|chronic pain|chronic pain
401366|NCT01236196|cognitive therapy|cognitive therapy
401367|NCT01236196|telehealth|telehealth
401368|NCT01236183|manual skill|manual skill
401369|NCT01236183|anesthesia residents|anesthesia residents
401370|NCT01236170|Amputees|amputees
401371|NCT01236170|spinal cord injuries|spinal cord injuries
401372|NCT01236170|quality of life|quality of life
401373|NCT01236170|satisfaction|satisfaction
401374|NCT01236170|healthcare disparities|healthcare disparities
401375|NCT01236170|wheelchairs|wheelchairs
401376|NCT01236157|Cardiology|cardiology
401377|NCT01236144|Myeloid|myeloid
401378|NCT01236144|Leukaemia|leukaemia
401379|NCT01236144|Acute|acute
401380|NCT01236144|Myelodysplastic|myelodysplastic
401381|NCT01236144|Pilot|pilot
401382|NCT01236144|Cardiff|cardiff
401383|NCT01236144|Haematology|haematology
401384|NCT01236144|Burnett|burnett
401385|NCT01236144|AC220|ac220
401386|NCT01236144|Plerixafor|plerixafor
401387|NCT01236144|Ganetespib|ganetespib
401388|NCT01236092|resolution of low back pain|resolution of low back pain
401389|NCT01236092|show measurable improvement in disc measurement|show measurable improvement in disc measurement
401390|NCT01236092|conservative therapy vs. surgery in resolving low back pain|conservative therapy vs. surgery in resolving low back pain
401391|NCT01236066|Rotavirus Gastroenteritis|rotavirus gastroenteritis
401392|NCT01236066|Rotarix|rotarix
401393|NCT01236066|RotaTeq|rotateq
401394|NCT01236066|Gastroenteritis|gastroenteritis
401395|NCT01236053|renal cancer|renal cancer
401396|NCT01236053|pancreatic cancer|pancreatic cancer
401397|NCT01236053|epidemiology|epidemiology
401398|NCT01236053|renal cell carcinoma|renal cell carcinoma
401399|NCT01236053|nervous system cancer|nervous system cancer
401400|NCT01236053|lung cancer|lung cancer
401401|NCT01236053|breast cancer|breast cancer
401402|NCT01236053|case-control|case-control
401403|NCT01236053|GPRD|gprd
401404|NCT01236053|Gapabentin|gapabentin
401405|NCT01236053|cancer|cancer
401406|NCT01236053|anal cancer|anal cancer
401407|NCT01236053|bone and joint cancer|bone and joint cancer
401408|NCT01236053|renal pelvis cancer|renal pelvis cancer
401409|NCT01236053|penis cancer|penis cancer
401410|NCT01236053|stomach cancer|stomach cancer
401411|NCT01236053|bladder cancer|bladder cancer
401412|NCT01236040|H5N1|h5n1
401413|NCT01236040|Influenza|influenza
401414|NCT01236040|Pandemic|pandemic
401415|NCT01236001|Lacosamide|lacosamide
401416|NCT01236001|Vimpat®|vimpat®
401417|NCT01235975|Neisseria meningitidis|neisseria meningitidis
401418|NCT01235975|Meningococcal Vaccines|meningococcal vaccines
401419|NCT01235975|serogroups A,C, W-135 or Y|serogroups a,c, w-135 or y
401420|NCT01235975|meningococcal diseases|meningococcal diseases
401421|NCT01235975|meningococcal conjugate vaccine|meningococcal conjugate vaccine
401422|NCT01235975|Immunogenicity|immunogenicity
401423|NCT01235962|anti-angiogenic agent|anti-angiogenic agent
401424|NCT01235962|renal cell carcinoma|renal cell carcinoma
401425|NCT01235962|pazopanib|pazopanib
401426|NCT01235962|adjuvant therapy|adjuvant therapy
401427|NCT01235962|VEGFR inhibitor|vegfr inhibitor
401428|NCT01235949|Pneumococcal vaccine|pneumococcal vaccine
401429|NCT01235949|Immunogenicity|immunogenicity
401431|NCT01235949|Fever|fever
401432|NCT01235949|Primary vaccination|primary vaccination
401433|NCT01235949|Booster vaccination|booster vaccination
401434|NCT01235949|Pneumococcal disease|pneumococcal disease
401435|NCT01235949|Prophylactic antipyretic|prophylactic antipyretic
401436|NCT01235936|anemia|anemia
401437|NCT01235936|chronic kidney disease|chronic kidney disease
401438|NCT01235936|CKD|ckd
401439|NCT01235936|chronic renal insufficiency|chronic renal insufficiency
401440|NCT01235936|renal impairment|renal impairment
401441|NCT01235936|erythropoietin|erythropoietin
401442|NCT01235936|safety|safety
401443|NCT01235936|efficacy|efficacy
401444|NCT01235936|tolerability|tolerability
401445|NCT01235936|pharmacokinetics|pharmacokinetics
401446|NCT01235923|anemia|anemia
401447|NCT01235923|transfusions|transfusions
401448|NCT01235923|erythropoiesis|erythropoiesis
401449|NCT01235923|neonate|neonate
401450|NCT01235923|preterm|preterm
401451|NCT01235910|Hypertension|hypertension
401452|NCT01235910|Cardiac transplantation|cardiac transplantation
401453|NCT01235910|Aliskiren|aliskiren
401454|NCT01235910|Cyclosporine|cyclosporine
401455|NCT01235897|Neoplasms|neoplasms
401456|NCT01235897|Paclitaxel|paclitaxel
401457|NCT01235897|Trastuzumab|trastuzumab
401458|NCT01235884|gaseous colic, regurgitation and of constipation|gaseous colic, regurgitation and of constipation
401461|NCT01235871|SB1578|sb1578
401462|NCT01235858|Epidural analgesia|epidural analgesia
401463|NCT01235858|Epidural anesthesia labor|epidural anesthesia labor
401464|NCT01235858|Aseptic technique|aseptic technique
401465|NCT01235858|gown|gown
401466|NCT01235858|no gown|no gown
401467|NCT01235832|cholesterol|cholesterol
401468|NCT01235832|triglycerides|triglycerides
401469|NCT01235832|low-density lipoprotein|low-density lipoprotein
401470|NCT01235832|high-density lipoprotein|high-density lipoprotein
401471|NCT01235832|reverse cholesterol transport|reverse cholesterol transport
401472|NCT01235819|type 1 diabetes|type 1 diabetes
401473|NCT01235819|exenatide|exenatide
401474|NCT01235819|sitagliptin|sitagliptin
401475|NCT01235806|scaphoid|scaphoid
401476|NCT01235806|MRI|mri
401477|NCT01235806|ESAOTE|esaote
401478|NCT01235793|Relapsed|relapsed
401479|NCT01235793|Refractory|refractory
401480|NCT01235793|Primary Central Nervous System B-cell Lymphoma|primary central nervous system b-cell lymphoma
401481|NCT01235793|Autologous Stem Cell Transplant|autologous stem cell transplant
401482|NCT01235793|Temozolomide|temozolomide
401483|NCT01235793|B-Cell Lymphoma|b-cell lymphoma
401484|NCT01235793|RBEAM|rbeam
401485|NCT01235793|Conditioning Regimen|conditioning regimen
602139|NCT00588562|PHI|phi
401486|NCT01235780|corneal hysteresis, ocular response analyzer|corneal hysteresis, ocular response analyzer
401487|NCT01235767|birth weight|birth weight
401488|NCT01235767|prematurity|prematurity
401489|NCT01235767|gestational age|gestational age
401490|NCT01235767|low birth weight|low birth weight
401491|NCT01235767|pregnancy|pregnancy
401492|NCT01235767|nutrition|nutrition
401493|NCT01235767|Vietnam|vietnam
401494|NCT01235754|testosterone|testosterone
401495|NCT01235754|hypoactive sexual desire disorder|hypoactive sexual desire disorder
401496|NCT01235754|menopause|menopause
401497|NCT01235741|Pramlintide|pramlintide
401498|NCT01235741|Metreleptin|metreleptin
401499|NCT01235741|Obesity|obesity
401500|NCT01235741|Amylin|amylin
401501|NCT01235741|Takeda|takeda
401502|NCT01235715|osteoarthritis|osteoarthritis
401503|NCT01235715|total knee replacement|total knee replacement
401504|NCT01235702|high blood pressure, hypertension, African Americans, perceived stress|high blood pressure, hypertension, african americans, perceived stress
401505|NCT01235689|Efficacy and Safety of two treatment algorithms in Subjects with Moderate to Severe Crohn's Disease|efficacy and safety of two treatment algorithms in subjects with moderate to severe crohn's disease
401506|NCT01235676|obesity|obesity
401507|NCT01235676|lifestyle|lifestyle
401508|NCT01235676|pregnancy|pregnancy
401509|NCT01235676|newborn infant|newborn infant
401510|NCT01235663|obesity, insulin resistance|obesity, insulin resistance
401511|NCT01235637|COMFORT B score|comfort b score
401512|NCT01235637|Bis score|bis score
401513|NCT01235624|Autosomal dominant retinitis pigmentosa|autosomal dominant retinitis pigmentosa
401514|NCT01235624|Rare disease|rare disease
401515|NCT01235624|Genetics|genetics
401516|NCT01235598|Cimzia®|cimzia®
401517|NCT01235598|CDP870|cdp870
401519|NCT01235598|Certolizumab Pegol|certolizumab pegol
489921|NCT00135603|adult.|adult.
401520|NCT01235598|Rheumatoid Arthritis|rheumatoid arthritis
401521|NCT01235598|MRI|mri
401522|NCT01235572|Acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
401523|NCT01235572|Adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
401524|NCT01235572|Adult acute basophilic leukemia|adult acute basophilic leukemia
401525|NCT01235572|De|de
401526|NCT01235572|novo myelodysplastic syndromes|novo myelodysplastic syndromes
401527|NCT01235572|Secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
401528|NCT01235572|Untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
401529|NCT01235546|Pregnancy|pregnancy
401530|NCT01235546|Cesarean section|cesarean section
401531|NCT01235546|Antibiotic|antibiotic
401532|NCT01235546|Infections|infections
401533|NCT01235533|late-life depression|late-life depression
401534|NCT01235533|recurrence of depression|recurrence of depression
401535|NCT01235533|cognition|cognition
401536|NCT01235533|N-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
401537|NCT01235481|pulmonary rehabilitation|pulmonary rehabilitation
401538|NCT01235481|exercise therapy|exercise therapy
401539|NCT01235481|chronic lung disease|chronic lung disease
401540|NCT01235481|self-efficacy|self-efficacy
401541|NCT01235468|umbilical cord blood|umbilical cord blood
401542|NCT01235468|ex vivo expansion|ex vivo expansion
401543|NCT01235468|engraftment|engraftment
401544|NCT01235468|GVHD|gvhd
401545|NCT01235455|Multiple Sclerosis|multiple sclerosis
401546|NCT01235455|Adherence|adherence
401547|NCT01235455|Interferon beta-1b|interferon beta-1b
401548|NCT01235455|Coping styles|coping styles
401549|NCT01235442|Psoriasis|psoriasis
401550|NCT01235442|Topical|topical
401551|NCT01235442|etanercept|etanercept
401552|NCT01235442|clobetasol propionate|clobetasol propionate
401553|NCT01235429|Diabetes|diabetes
401554|NCT01235429|Behavioral intervention|behavioral intervention
401555|NCT01235429|diabetes self-management|diabetes self-management
401556|NCT01235429|Native Hawaiians|native hawaiians
401557|NCT01235429|health disparities|health disparities
401558|NCT01235403|Epilepsy treatment.|epilepsy treatment.
401559|NCT01235403|Anti-epileptic drugs|anti-epileptic drugs
401560|NCT01235403|Seizures|seizures
401561|NCT01235390|Postmenopausal women|postmenopausal women
401562|NCT01235390|walnuts|walnuts
401563|NCT01235377|prescribing patterns|prescribing patterns
401564|NCT01235377|thiazide|thiazide
401565|NCT01235377|chlorthalidone|chlorthalidone
401566|NCT01235377|hydrochlorothiazide|hydrochlorothiazide
401567|NCT01235377|target dose|target dose
401568|NCT01235377|cluster randomized trial|cluster randomized trial
401569|NCT01235364|Foley catheter|foley catheter
401570|NCT01235364|induction|induction
401572|NCT01235364|skin conductance|skin conductance
401573|NCT01235364|visual analogue scale|visual analogue scale
401574|NCT01235364|mechanical method|mechanical method
401575|NCT01235351|Myocardial infarction|myocardial infarction
401576|NCT01235351|Percutaneous coronary intervention|percutaneous coronary intervention
401577|NCT01235351|Clopidogrel|clopidogrel
401578|NCT01235351|Genetics|genetics
401579|NCT01235351|Platelet Function|platelet function
401580|NCT01235325|vitamin K|vitamin k
401581|NCT01235325|supplementation|supplementation
401582|NCT01235325|bone health indices|bone health indices
401583|NCT01235325|adult|adult
401584|NCT01235325|Crohn's disease|crohn's disease
401585|NCT01235286|remote ischemic preconditioning, free flap, microcirculation|remote ischemic preconditioning, free flap, microcirculation
401586|NCT01235260|REGRANEX (becaplermin)|regranex (becaplermin)
401587|NCT01235260|Platelet-derived growth factor BB|platelet-derived growth factor bb
401588|NCT01235260|Cancer|cancer
401589|NCT01235260|Cancer incidence|cancer incidence
401590|NCT01235260|Cancer mortality|cancer mortality
401591|NCT01235260|Lower Extremity Diabetic Neuropathic Ulcer|lower extremity diabetic neuropathic ulcer
401592|NCT01235234|Dry eye disease|dry eye disease
401593|NCT01235234|KCS|kcs
401594|NCT01235234|Aqueous Deficient Dry Eye|aqueous deficient dry eye
401595|NCT01235208|Overweight|overweight
401596|NCT01235208|Obesity|obesity
401597|NCT01235208|Metabolic syndrome|metabolic syndrome
401598|NCT01235208|Diet|diet
401599|NCT01235208|Carbohydrate|carbohydrate
401600|NCT01235208|Low glycemic index|low glycemic index
401601|NCT01235208|Eurodiet|eurodiet
401602|NCT01235195|bioequivalence study|bioequivalence study
401603|NCT01235195|sertraline 50 mg|sertraline 50 mg
401604|NCT01235195|capsules vs tablets|capsules vs tablets
401605|NCT01235182|acute dyspnea|acute dyspnea
401606|NCT01235182|prehospital emergency setting|prehospital emergency setting
401607|NCT01235182|differential diagnosis|differential diagnosis
401608|NCT01235182|ultrasound|ultrasound
401609|NCT01235182|NT-proBNP|nt-probnp
401610|NCT01235156|Premature ventricular contraction|premature ventricular contraction
403036|NCT01228435|Hsp90 inhibitor|hsp90 inhibitor
403037|NCT01228422|Will be studied 24 subjects divided Research and 2 parallel groups|will be studied 24 subjects divided research and 2 parallel groups
490055|NCT00136110|ALS|als
401611|NCT01235156|Frequent premature ventricular contraction, with or without a short array of non-sustained ventricular tachycardia|frequent premature ventricular contraction, with or without a short array of non-sustained ventricular tachycardia
401612|NCT01235143|incidence|incidence
401613|NCT01235143|emergence agitation|emergence agitation
401614|NCT01235143|sevoflurane|sevoflurane
401615|NCT01235143|desflurane|desflurane
401616|NCT01235143|ambulatory pediatric surgery|ambulatory pediatric surgery
401617|NCT01235117|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
401618|NCT01235091|HIV prevention|hiv prevention
401619|NCT01235091|substance abuse|substance abuse
401620|NCT01235091|high risk behaviors|high risk behaviors
401621|NCT01235091|peer intervention|peer intervention
401622|NCT01235065|airway management|airway management
401623|NCT01235065|trauma|trauma
401624|NCT01235065|intubation|intubation
401625|NCT01235052|Head and neck neoplasms|head and neck neoplasms
401626|NCT01235052|Positron Emission Tomography|positron emission tomography
401627|NCT01235052|F18 fluoromisonidazole|f18 fluoromisonidazole
401628|NCT01235026|Obesity|obesity
401629|NCT01235026|Type-2 Diabetes|type-2 diabetes
401630|NCT01235026|Metabolic syndrome|metabolic syndrome
401631|NCT01235026|Low grade inflammation|low grade inflammation
401632|NCT01235026|Metabolic endotoxinemia|metabolic endotoxinemia
401633|NCT01235026|Insulin resistance|insulin resistance
401634|NCT01235026|Lipopolysaccharide|lipopolysaccharide
401635|NCT01235026|LPS-binding protein|lps-binding protein
401636|NCT01235026|sCD14|scd14
401637|NCT01235026|Synbiotic|synbiotic
401638|NCT01235026|Oligofructose|oligofructose
401639|NCT01235026|Bifidobacterium animalis subsp. lactis Bb12|bifidobacterium animalis subsp. lactis bb12
401640|NCT01235026|probiotic|probiotic
401641|NCT01235026|Prebiotic|prebiotic
401642|NCT01235013|HIV-1 infection|hiv-1 infection
401643|NCT01235013|Maraviroc|maraviroc
401644|NCT01235013|CD4 lymphocyte count|cd4 lymphocyte count
401645|NCT01235000|Influenza vaccines|influenza vaccines
401646|NCT01235000|Infant|infant
401647|NCT01235000|Dose-Response relationship, immunologic|dose-response relationship, immunologic
401648|NCT01235000|Prime-boost response|prime-boost response
401649|NCT01234987|Cancer|cancer
401650|NCT01234987|Breast Cancer|breast cancer
401651|NCT01234987|Colon cancer|colon cancer
401652|NCT01234987|Lung Cancer|lung cancer
401653|NCT01234974|multiple myeloma|multiple myeloma
401654|NCT01234948|Halitosis|halitosis
401655|NCT01234948|VSC|vsc
401656|NCT01234948|Periodontitis|periodontitis
401657|NCT01234948|Gingivitis|gingivitis
401658|NCT01234948|Putative periodontal pathogens|putative periodontal pathogens
401659|NCT01234948|Real-time PCR|real-time pcr
401660|NCT01234909|Missed immunizations|missed immunizations
401661|NCT01234896|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
401662|NCT01234883|dehydration|dehydration
401663|NCT01234883|gastroenteritis|gastroenteritis
401664|NCT01234870|Myocardial Perfusion Imaging|myocardial perfusion imaging
401665|NCT01234870|Magnetic Resonance Imaging|magnetic resonance imaging
401666|NCT01234857|mTOR|mtor
401667|NCT01234857|breast cancer|breast cancer
401668|NCT01234857|estrogen receptor positive|estrogen receptor positive
401669|NCT01234844|pet-therapy|pet-therapy
401670|NCT01234844|guinea-pigs|guinea-pigs
401671|NCT01234844|rehabilitation|rehabilitation
401672|NCT01234844|elderly|elderly
401673|NCT01234831|MRSA|mrsa
401674|NCT01234831|colonization|colonization
401675|NCT01234831|nucleic acid amplification|nucleic acid amplification
401676|NCT01234831|chromogenic agar|chromogenic agar
401677|NCT01234818|Endometrial hyperplasia|endometrial hyperplasia
401678|NCT01234818|LNG-IUS|lng-ius
401679|NCT01234792|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
401680|NCT01234753|Adults with CHD|adults with chd
401681|NCT01234753|GUCH|guch
401682|NCT01234753|Congenital heart disease|congenital heart disease
401683|NCT01234753|Computer-based education|computer-based education
401684|NCT01234753|Nursing|nursing
401685|NCT01234740|Los Angeles|los angeles
401686|NCT01234727|diabetes, SMBG, glucose testing systems, accuracy|diabetes, smbg, glucose testing systems, accuracy
401687|NCT01234714|Fatty Liver|fatty liver
401688|NCT01234714|Liver|liver
401689|NCT01234714|Magnetic Resonance Imaging|magnetic resonance imaging
401690|NCT01234714|Surgery|surgery
401691|NCT01234701|Liver|liver
401692|NCT01234701|Neoplasms|neoplasms
401693|NCT01234701|Magnetic Resonance Imaging|magnetic resonance imaging
401694|NCT01234701|Surgery|surgery
401695|NCT01234701|Pathology|pathology
401696|NCT01234688|Exercise Tolerance|exercise tolerance
401697|NCT01234688|Physical Endurance|physical endurance
401698|NCT01234675|Fibromyalgia|fibromyalgia
401699|NCT01234675|Sleep disorders|sleep disorders
401700|NCT01234675|Forest Laboratories|forest laboratories
401701|NCT01234675|Milnacipran|milnacipran
401702|NCT01234662|Elective cesarean sections|elective cesarean sections
401703|NCT01234662|Postoperative pain level|postoperative pain level
401704|NCT01234662|Spinal anesthesia|spinal anesthesia
392544|NCT01274598|LGG|lgg
401705|NCT01234662|Combined spinal epidural anesthesia|combined spinal epidural anesthesia
401706|NCT01234662|Epidural catheter|epidural catheter
401707|NCT01234649|gestational diabetes mellitus|gestational diabetes mellitus
401708|NCT01234649|type 2 diabetes mellitus|type 2 diabetes mellitus
401709|NCT01234649|metabolic dysfunction|metabolic dysfunction
401710|NCT01234649|impaired fasting glucose|impaired fasting glucose
401711|NCT01234649|impaired glucose tolerance|impaired glucose tolerance
401712|NCT01234649|incretin mimetic|incretin mimetic
401713|NCT01234636|Platelets|platelets
401714|NCT01234636|Platelet aggregation|platelet aggregation
401715|NCT01234636|Platelet activation|platelet activation
401716|NCT01234636|Platelet function|platelet function
401717|NCT01234636|Light transmission aggregometry|light transmission aggregometry
401718|NCT01234636|Flow cytometry|flow cytometry
401719|NCT01234636|Platelet function analyzer-100 (PFA-100)|platelet function analyzer-100 (pfa-100)
401720|NCT01234636|Linoleic acid, conjugated|linoleic acid, conjugated
401721|NCT01234636|cis9, trans11 conjugated linoleic acid|cis9, trans11 conjugated linoleic acid
401722|NCT01234636|dietary supplement|dietary supplement
401723|NCT01234636|short-term intervention|short-term intervention
401724|NCT01234623|Umbilical cord serum, eyedrops, GVHD, SS-I, corneal healing|umbilical cord serum, eyedrops, gvhd, ss-i, corneal healing
401725|NCT01234610|Exercise|exercise
401726|NCT01234610|Aortic aneurysm|aortic aneurysm
401727|NCT01234610|Feasibility|feasibility
401728|NCT01234610|Vascular disease|vascular disease
401729|NCT01234571|Pulmonary hypertension|pulmonary hypertension
401730|NCT01234571|Remodulin (Treprostenil sodium)|remodulin (treprostenil sodium)
401731|NCT01234571|End-stage renal disease|end-stage renal disease
401732|NCT01234571|Hemo-dialysis|hemo-dialysis
401733|NCT01234558|depression|depression
401734|NCT01234558|NMDA antagonist|nmda antagonist
401735|NCT01234558|treatment resistant|treatment resistant
401736|NCT01234519|ureter cancer|ureter cancer
401737|NCT01234519|renal pelvis cancer|renal pelvis cancer
401738|NCT01234519|bladder cancer|bladder cancer
401739|NCT01234519|urethra|urethra
401740|NCT01234506|long term care|long term care
401741|NCT01234506|lignans|lignans
401742|NCT01234506|oxidative stress|oxidative stress
401743|NCT01234506|inflammation|inflammation
401744|NCT01234506|aging|aging
401745|NCT01234506|dementia|dementia
401746|NCT01234506|postural balance|postural balance
401747|NCT01234506|depression|depression
401748|NCT01234506|muscle weakness|muscle weakness
401749|NCT01234506|quality of life|quality of life
401750|NCT01234506|pain|pain
401751|NCT01234493|ankle; fracture; syndesmosis;|ankle; fracture; syndesmosis;
401752|NCT01232673|Critical Limb Ischemia|critical limb ischemia
401753|NCT01232673|Bone-Marrow Aspiration Concentrate|bone-marrow aspiration concentrate
401754|NCT01232673|Diabetes Mellitus|diabetes mellitus
401755|NCT01232673|Major Amputation|major amputation
401757|NCT01232647|vitamin K|vitamin k
401758|NCT01232647|BONE MINERAL DENSITY|bone mineral density
401759|NCT01232647|BIOCHEMICAL MARKERS OF BONE TURNOVER|biochemical markers of bone turnover
401760|NCT01234467|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
401761|NCT01234467|Elderly|elderly
401762|NCT01234467|Newly Diagnosed|newly diagnosed
401763|NCT01234467|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
401764|NCT01234467|University of North Carolina|university of north carolina
401765|NCT01234467|Bendamustine|bendamustine
401766|NCT01234467|Rituximab|rituximab
401767|NCT01234467|Rituxan|rituxan
401768|NCT01234467|Treanda|treanda
401769|NCT01234467|Phase 2|phase 2
401770|NCT01234467|Geriatric|geriatric
401771|NCT01234467|Lymphoma|lymphoma
401772|NCT01234428|laparoscopy|laparoscopy
401773|NCT01234428|adjustable gastric banding|adjustable gastric banding
401774|NCT01234428|morbid obesity|morbid obesity
401775|NCT01234428|esophageal motility|esophageal motility
401776|NCT01234428|esophageal dilatation|esophageal dilatation
401777|NCT01234415|nasal|nasal
401778|NCT01234415|septum|septum
401779|NCT01234415|reconstruction|reconstruction
401780|NCT01234402|Breast Cancer|breast cancer
401781|NCT01234363|Renal allograft|renal allograft
401782|NCT01234363|kidney|kidney
401783|NCT01234363|fibrosis|fibrosis
401784|NCT01234363|elastography|elastography
401785|NCT01234363|elasticity|elasticity
401786|NCT01234337|Breast Cancer|breast cancer
401787|NCT01234337|HER2-neu|her2-neu
401788|NCT01234324|Stomach Neoplasms|stomach neoplasms
401789|NCT01234324|Gastroesophageal Junction Neoplasms|gastroesophageal junction neoplasms
401790|NCT01234324|gastric cancer|gastric cancer
401791|NCT01234324|cancer of the gastroesophageal junction|cancer of the gastroesophageal junction
401792|NCT01234285|sepsis|sepsis
401793|NCT01234285|septic shock|septic shock
401794|NCT01234285|anticoagulation|anticoagulation
401795|NCT01234285|intensive care unit|intensive care unit
401796|NCT01234272|patients with|patients with
401797|NCT01234272|undergoing|undergoing
401798|NCT01234272|gastrectomy|gastrectomy
401799|NCT01234259|Wrinkles|wrinkles
401800|NCT01234259|rhytides|rhytides
490298|NCT00143052|insulin|insulin
401801|NCT01234259|Cellulite|cellulite
401802|NCT01234259|circumference reduction|circumference reduction
401803|NCT01234246|Colorectal cancer|colorectal cancer
401804|NCT01234246|Sexual function|sexual function
401805|NCT01234246|Sexual dysfunction|sexual dysfunction
401806|NCT01234246|Quality of (sexual) life|quality of (sexual) life
401807|NCT01234246|Partners|partners
401808|NCT01234246|Body image|body image
401809|NCT01234246|Anxiety (state and trait)|anxiety (state and trait)
401810|NCT01234246|Depressive symptoms|depressive symptoms
401811|NCT01234246|Personality|personality
401812|NCT01234233|hypothermia, accidental|hypothermia, accidental
401813|NCT01234233|prewarming|prewarming
401814|NCT01234233|body temperature monitoring|body temperature monitoring
401815|NCT01234233|preoperative warming|preoperative warming
401816|NCT01234233|sublingual temperature assessment|sublingual temperature assessment
401817|NCT01234233|tympanic temperature assessment|tympanic temperature assessment
401818|NCT01234220|Aldosterone|aldosterone
401819|NCT01234220|Primary Aldosteronism|primary aldosteronism
401820|NCT01234220|Aldosterone Producing Adenoma (APA)|aldosterone producing adenoma (apa)
401821|NCT01234220|Idiopathic Adrenal Hyperplasia (IHA)|idiopathic adrenal hyperplasia (iha)
401822|NCT01234220|Adrenal Venous Sampling|adrenal venous sampling
401823|NCT01234207|Progressive addition lenses|progressive addition lenses
401824|NCT01234207|Customized free-form|customized free-form
401825|NCT01234207|Presbyopia|presbyopia
401826|NCT01234207|Bifocals|bifocals
401827|NCT01234207|Subjective assessment|subjective assessment
401828|NCT01234207|Visual performance|visual performance
401829|NCT01234207|Visual acuity|visual acuity
401830|NCT01234207|Amsler grid|amsler grid
401831|NCT01234194|Composite Variability Index|composite variability index
401832|NCT01234194|Bispectral Index|bispectral index
401833|NCT01234194|Electromyography|electromyography
401834|NCT01234194|Nociception|nociception
401835|NCT01234194|Pain|pain
401836|NCT01234155|Exercise|exercise
401837|NCT01234155|Diabetes|diabetes
401838|NCT01234155|Obesity|obesity
401839|NCT01234155|Insulin Sensitivity|insulin sensitivity
401840|NCT01234155|Insulin Secretion|insulin secretion
401841|NCT01234155|Beta-cell Function|beta-cell function
401842|NCT01234155|Glycemic Control|glycemic control
401844|NCT01234155|GLP-1|glp-1
401935|NCT01233700|physical well-being|physical well-being
401936|NCT01233700|interpersonal relations|interpersonal relations
401845|NCT01234142|varenicline transdermal percutaneous transcutaneous transdermal delivery system patch|varenicline transdermal percutaneous transcutaneous transdermal delivery system patch
401846|NCT01234129|multiple myeloma|multiple myeloma
401847|NCT01234129|stem cell transplant|stem cell transplant
401848|NCT01234129|zoledronic acid|zoledronic acid
401849|NCT01234116|Post exposure prophylaxis|post exposure prophylaxis
401850|NCT01234116|Health Care Workers|health care workers
401851|NCT01234103|sexually transmitted infection|sexually transmitted infection
401852|NCT01234103|sexual risk|sexual risk
401853|NCT01234103|HIV|hiv
401854|NCT01234103|young adults|young adults
401855|NCT01234103|cognitive-behavioral intervention|cognitive-behavioral intervention
401856|NCT01234090|Aphasia|aphasia
401857|NCT01234090|Quality of Life|quality of life
401858|NCT01234077|scheduled for a polysomnogram (overnight sleep study)|scheduled for a polysomnogram (overnight sleep study)
401859|NCT01234064|Symptomatic Venous Thromboembolism|symptomatic venous thromboembolism
401860|NCT01234064|Graduated Compression Stockings|graduated compression stockings
401861|NCT01234064|Randomized Controlled Trial|randomized controlled trial
401862|NCT01234064|Noncardiac Surgery|noncardiac surgery
401863|NCT01234038|Non-small cell lung cancer|non-small cell lung cancer
401864|NCT01234025|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
401865|NCT01234012|melanoma|melanoma
401866|NCT01234012|breast cancer|breast cancer
401867|NCT01234012|ovarian cancer|ovarian cancer
401868|NCT01234012|prostate cancer|prostate cancer
401869|NCT01234012|esophageal cancer|esophageal cancer
401870|NCT01234012|uterine cancer|uterine cancer
401872|NCT01234012|NY-ESO-1|ny-eso-1
401873|NCT01233999|Scleroderma|scleroderma
401874|NCT01233999|Raynaud's Syndrome|raynaud's syndrome
401875|NCT01233986|Acute Ischemic Stroke|acute ischemic stroke
401876|NCT01233986|Atherosclerosis|atherosclerosis
401877|NCT01233986|Apolipoprotein B48|apolipoprotein b48
401878|NCT01233973|nursing home|nursing home
401879|NCT01233973|advance care planning|advance care planning
401880|NCT01233960|Crohn's Disease|crohn's disease
401881|NCT01233960|Adult Stem Cell Therapy|adult stem cell therapy
401882|NCT01233960|inflammation of the gastrointestinal tract|inflammation of the gastrointestinal tract
401883|NCT01233934|Insect bites|insect bites
401884|NCT01233934|Dexchlorpheniramine|dexchlorpheniramine
401885|NCT01233934|Gel|gel
401886|NCT01233934|Cream|cream
401887|NCT01233882|Renal impairment|renal impairment
401888|NCT01233882|healthy volunteers|healthy volunteers
401889|NCT01233869|Bosutinib|bosutinib
401890|NCT01233869|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
401891|NCT01233856|ADHD|adhd
401892|NCT01233843|induction chemotherapy|induction chemotherapy
403038|NCT01228422|The treatment is a dose of 3MUI of alpha interferon 2nd|the treatment is a dose of 3mui of alpha interferon 2nd
490450|NCT00144352|HIV|hiv
401893|NCT01233843|followed by irradiation and concurrent Erbitux, or radiochemotherapy|followed by irradiation and concurrent erbitux, or radiochemotherapy
401894|NCT01233830|safety, tolerability, pharmacokinetics, AZD2423, Japanese|safety, tolerability, pharmacokinetics, azd2423, japanese
401895|NCT01233817|Spinal muscular atrophy|spinal muscular atrophy
401896|NCT01233817|Neuromuscular disorder|neuromuscular disorder
401897|NCT01233817|Progressive strength training|progressive strength training
401898|NCT01233817|Children|children
401899|NCT01233804|influenza vaccination rates|influenza vaccination rates
401900|NCT01233791|high tone pelvic floor dysfunction|high tone pelvic floor dysfunction
401901|NCT01233791|levator pain|levator pain
401902|NCT01233791|dyspareunia|dyspareunia
401903|NCT01233778|Cardiovascular disease|cardiovascular disease
401904|NCT01233778|Omega-3 fatty acids|omega-3 fatty acids
401905|NCT01233778|Inflammation|inflammation
401906|NCT01233778|Endothelial function|endothelial function
401907|NCT01233778|Canola oil|canola oil
401908|NCT01233765|Periodontitis|periodontitis
401909|NCT01233765|Neutrophil|neutrophil
401910|NCT01233765|Inflammation|inflammation
401911|NCT01233752|systemic morphine analgesia|systemic morphine analgesia
401912|NCT01233752|pharmacogenetics|pharmacogenetics
401913|NCT01233752|pharmacokinetics|pharmacokinetics
401914|NCT01233739|rhizarthrosis|rhizarthrosis
401915|NCT01233739|Chondroitin sulfate|chondroitin sulfate
401916|NCT01233739|Placebo|placebo
401917|NCT01233726|Critical illness|critical illness
401918|NCT01233726|Hyperglycemia|hyperglycemia
401919|NCT01233726|Mechanical Ventilation|mechanical ventilation
401920|NCT01233726|Enteral nutrition|enteral nutrition
401921|NCT01233726|T-Diet plus Diabet IR|t-diet plus diabet ir
401922|NCT01233726|Malnutrition|malnutrition
401923|NCT01233726|Insulin resistance|insulin resistance
401924|NCT01233726|Metabolic stress|metabolic stress
401925|NCT01233713|Emergency Surgery|emergency surgery
401926|NCT01233713|Bowel perforation|bowel perforation
401927|NCT01233713|Diverticulitis|diverticulitis
401928|NCT01233713|Neoplasms|neoplasms
401929|NCT01233713|Postoperative Complications|postoperative complications
401930|NCT01233713|Randomized Controlled Trial|randomized controlled trial
401931|NCT01233700|living donation|living donation
401932|NCT01233700|organ donation|organ donation
401933|NCT01233700|psychological adaptation|psychological adaptation
401934|NCT01233700|mental health|mental health
402449|NCT01231347|metastatic|metastatic
401937|NCT01233700|quality of life|quality of life
401938|NCT01233700|psychosocial factors|psychosocial factors
401939|NCT01233687|Recurrent|recurrent
401940|NCT01233687|progressive|progressive
401941|NCT01233687|advanced|advanced
401942|NCT01232634|pediatrics|pediatrics
401943|NCT01232634|haemophilia|haemophilia
401944|NCT01232634|ultrasound|ultrasound
401946|NCT01232634|arthropathy|arthropathy
401947|NCT01232608|Coronary Artery Disease|coronary artery disease
401948|NCT01232608|Atherosclerosis.|atherosclerosis.
401949|NCT01232608|Diabetes Mellitus, type 2|diabetes mellitus, type 2
401950|NCT01232608|Exercise|exercise
401951|NCT01232608|HbA1c|hba1c
401952|NCT01232608|Carotid Atherosclerotic Disease|carotid atherosclerotic disease
401954|NCT01232595|Clostridium difficile,|clostridium difficile,
401955|NCT01232595|C. difficile,|c. difficile,
401956|NCT01232595|CDI,|cdi,
401957|NCT01232595|Clostridium difficile-associated disease,|clostridium difficile-associated disease,
401958|NCT01232595|CDAD,|cdad,
401959|NCT01232595|pseudomembranous colitis,|pseudomembranous colitis,
401960|NCT01232595|PMC,|pmc,
401961|NCT01232595|antibiotic-associated diarrhea|antibiotic-associated diarrhea
402080|NCT01233232|Chronic Obstructive Pulmonary Disease, Neutrophil, Respiratory Disease|chronic obstructive pulmonary disease, neutrophil, respiratory disease
402081|NCT01233219|systemic morphine analgesia|systemic morphine analgesia
402082|NCT01233219|pharmacogenetics|pharmacogenetics
402083|NCT01233219|pharmacokinetics|pharmacokinetics
402084|NCT01233206|PCOS|pcos
402085|NCT01233206|Polycystic ovary syndrome|polycystic ovary syndrome
402086|NCT01233206|Cancelled cycles|cancelled cycles
402087|NCT01233206|OHSS|ohss
402088|NCT01233206|Infertility|infertility
402089|NCT01233193|Home blood pressure measurement|home blood pressure measurement
402090|NCT01233193|Pharmaceutical Services|pharmaceutical services
402091|NCT01233193|Medication adherence|medication adherence
402092|NCT01233193|hypertension management|hypertension management
402093|NCT01233193|Blood Pressure|blood pressure
402094|NCT01233180|neck pain|neck pain
402095|NCT01233180|massage|massage
402096|NCT01233180|hyperthermia, induced|hyperthermia, induced
402097|NCT01233180|touch perception|touch perception
402098|NCT01233180|randomized controlled trial|randomized controlled trial
402099|NCT01233167|dual antiplatelet therapy|dual antiplatelet therapy
402100|NCT01233167|sirolimus drug-eluting stent|sirolimus drug-eluting stent
402101|NCT01233167|major adverse cardiac events|major adverse cardiac events
402102|NCT01233167|bleeding|bleeding
392849|NCT01273376|MDD|mdd
402103|NCT01233141|peripheral artery disease stage IV (Fontaine's classification) or stage 5 and 6 (Rutherford's classification|peripheral artery disease stage iv (fontaine's classification) or stage 5 and 6 (rutherford's classification
402104|NCT01233102|liver Cirrhosis|liver cirrhosis
402105|NCT01233102|Mesenchymal stem cells|mesenchymal stem cells
402106|NCT01233102|Hepatic artery infusion|hepatic artery infusion
402107|NCT01233102|Intravenous infusion|intravenous infusion
402108|NCT01233089|Myopia|myopia
402109|NCT01233089|contact lenses|contact lenses
402110|NCT01233089|children|children
402111|NCT01233063|behavior change|behavior change
402112|NCT01233063|physical activity|physical activity
402113|NCT01233063|nutrition|nutrition
402114|NCT01233063|fruits and vegetables|fruits and vegetables
402115|NCT01233063|saturated fat|saturated fat
402116|NCT01233063|trans fat|trans fat
402117|NCT01233063|added sugars|added sugars
402118|NCT01233063|email|email
402119|NCT01233063|web|web
402120|NCT01233063|obesity|obesity
402121|NCT01233063|aging|aging
402122|NCT01233050|undergoing elective colon and /or rectal surgical procedures involving an abdominal incision|undergoing elective colon and /or rectal surgical procedures involving an abdominal incision
402123|NCT01233024|Adult|adult
402124|NCT01233024|Women|women
402125|NCT01233024|Dietary Fiber|dietary fiber
402126|NCT01233024|Satiety Response|satiety response
402127|NCT01233024|Food Intake|food intake
402128|NCT01233011|Intubating laryngeal airway|intubating laryngeal airway
402129|NCT01233011|Pediatric|pediatric
402130|NCT01233011|Observational study|observational study
402131|NCT01232998|Patient Satisfaction|patient satisfaction
402132|NCT01232985|Atopic Dermatitis|atopic dermatitis
402133|NCT01232985|Pruritus|pruritus
402134|NCT01232972|vitrification|vitrification
402135|NCT01232972|egg freezing|egg freezing
402136|NCT01232972|oocyte cryopreservation|oocyte cryopreservation
402137|NCT01232972|female fertility potential|female fertility potential
402138|NCT01232972|fertility preservation|fertility preservation
402139|NCT01232972|Fertility preservation, female|fertility preservation, female
402140|NCT01232959|Gallbladder removal|gallbladder removal
402141|NCT01232946|Diabetes|diabetes
402142|NCT01232946|Myocardial metabolism|myocardial metabolism
402143|NCT01232933|PICC|picc
402144|NCT01232920|uveitis|uveitis
402145|NCT01232920|antimetabolite|antimetabolite
402146|NCT01232920|immunosuppressive|immunosuppressive
402147|NCT01232920|clinical trial|clinical trial
402148|NCT01232907|Spinal Cord Injury (SCI)|spinal cord injury (sci)
402149|NCT01232894|indacaterol|indacaterol
402150|NCT01232894|COPD|copd
402151|NCT01232894|Long-acting beta2-agonist (LABA)|long-acting beta2-agonist (laba)
402152|NCT01232868|Innate immunity|innate immunity
402153|NCT01232868|Adaptive immunity|adaptive immunity
402154|NCT01232868|Slu shot|slu shot
402155|NCT01232868|Elderly|elderly
402156|NCT01232855|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
402157|NCT01232855|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
402158|NCT01232855|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
402159|NCT01232855|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
402160|NCT01232855|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
402161|NCT01232855|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
402162|NCT01232855|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
402163|NCT01232842|adult acute myeloid leukemia|adult acute myeloid leukemia
402164|NCT01232842|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
402165|NCT01232803|Rectal Microbicides|rectal microbicides
402166|NCT01232803|Tenofovir|tenofovir
402167|NCT01232803|Rectal use|rectal use
402168|NCT01232803|Rectal mucosal damage|rectal mucosal damage
402169|NCT01232790|Schizophrenia|schizophrenia
402170|NCT01232790|working memory|working memory
402171|NCT01232790|N-Acetylcysteine|n-acetylcysteine
402172|NCT01232777|Retinopathy of Prematurity|retinopathy of prematurity
402173|NCT01232777|Bevacizumab|bevacizumab
402174|NCT01232777|Avastin|avastin
402175|NCT01232777|Vascular Endothelial Growth Factor|vascular endothelial growth factor
402176|NCT01232751|health|health
402177|NCT01232751|women|women
402178|NCT01232725|BSID III|bsid iii
402179|NCT01232725|Human Milk|human milk
402180|NCT01232725|Donor Human Milk|donor human milk
402181|NCT01232725|Preterm infant|preterm infant
402182|NCT01232725|Breastfeeding|breastfeeding
402183|NCT01232712|MUC1|muc1
402184|NCT01232712|ImMucin|immucin
402185|NCT01232712|Vaccine|vaccine
402186|NCT01232712|Multiple Myeloma|multiple myeloma
402187|NCT01232699|obesity|obesity
402188|NCT01232699|weight loss|weight loss
402189|NCT01232699|internet treatment|internet treatment
402190|NCT01232699|motivational interviewing|motivational interviewing
402191|NCT01232686|Communicable Diseases|communicable diseases
402192|NCT01232686|Epidemiology|epidemiology
402193|NCT01232686|Population surveillance|population surveillance
402194|NCT01232686|Computerized Medical Record|computerized medical record
402195|NCT01232686|Data collection|data collection
402196|NCT01232400|subarachnoid hemorrhage|subarachnoid hemorrhage
402197|NCT01232400|esmolol|esmolol
402198|NCT01232400|cardiac function|cardiac function
402199|NCT01232400|cardiac electrophysiology|cardiac electrophysiology
402200|NCT01232387|Fetomaternal hemorrhage|fetomaternal hemorrhage
402201|NCT01232387|neonatal anemia|neonatal anemia
402202|NCT01232387|perinatal epidemiology|perinatal epidemiology
402203|NCT01232387|Kleihauer-Betke|kleihauer-betke
402204|NCT01232387|flow cytometry|flow cytometry
402205|NCT01232374|Nimotuzumab|nimotuzumab
402206|NCT01232374|local advanced esophageal squamous cell carcinoma|local advanced esophageal squamous cell carcinoma
402207|NCT01232374|chemo-irradiation|chemo-irradiation
402208|NCT01232361|ADHD|adhd
402209|NCT01232361|HIV|hiv
402210|NCT01232361|Pharmacokinetics|pharmacokinetics
402211|NCT01232348|bronchial asthma|bronchial asthma
402212|NCT01232348|Symbicort|symbicort
402213|NCT01232335|bronchial asthma|bronchial asthma
402214|NCT01232335|Symbicort|symbicort
402215|NCT01232335|long term use,|long term use,
402216|NCT01232322|bronchial asthma|bronchial asthma
402217|NCT01232322|Pulmicort Respules|pulmicort respules
402218|NCT01232322|long term use|long term use
402219|NCT01232322|pediatrics|pediatrics
402220|NCT01232309|Arterial Health|arterial health
402221|NCT01232309|Fiber|fiber
402222|NCT01232309|Chitin-glucan|chitin-glucan
402223|NCT01232309|oxidized LDL|oxidized ldl
402224|NCT01232296|Hepatocellular Carcinoma|hepatocellular carcinoma
402225|NCT01232296|HCC|hcc
402226|NCT01232296|Liver cancer|liver cancer
402227|NCT01232296|Child Pugh A|child pugh a
402228|NCT01232296|HCC Stage C|hcc stage c
402229|NCT01232257|Chronic kidney disease|chronic kidney disease
402230|NCT01232257|Chronic kidney failure|chronic kidney failure
402231|NCT01232257|End stage kidney disease|end stage kidney disease
402232|NCT01232257|End stage renal disease|end stage renal disease
402233|NCT01232257|Hydrogen sulfide|hydrogen sulfide
402234|NCT01232257|N-acetylcysteine|n-acetylcysteine
402235|NCT01232257|Acetylcysteine|acetylcysteine
402236|NCT01232244|Incretin hormones|incretin hormones
402237|NCT01232244|Glucagon|glucagon
402238|NCT01232244|Satiety|satiety
402239|NCT01232244|Hunger|hunger
402240|NCT01232244|Energy expenditure|energy expenditure
402241|NCT01232231|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
402242|NCT01232231|decolonization|decolonization
402243|NCT01232231|random allocation|random allocation
402244|NCT01232231|outpatient|outpatient
402245|NCT01232218|Cerebral Vascular Accident|cerebral vascular accident
402246|NCT01232218|Stroke|stroke
402247|NCT01232218|Hemiplegic|hemiplegic
402248|NCT01232218|Shoulder pain|shoulder pain
402249|NCT01232218|range of motion|range of motion
402250|NCT01232218|scapula|scapula
402251|NCT01232218|mobilization|mobilization
402252|NCT01232205|antioxidant supplementation|antioxidant supplementation
402253|NCT01232205|preeclampsia|preeclampsia
402254|NCT01232153|chest tube|chest tube
402255|NCT01232153|preoxygenation|preoxygenation
402256|NCT01232153|NIV|niv
402257|NCT01232153|out-of-hospital|out-of-hospital
402258|NCT01232153|patients needing tracheal chest tube managed by Medical Mobile Emergency rescue services|patients needing tracheal chest tube managed by medical mobile emergency rescue services
402259|NCT01232140|COPD|copd
402260|NCT01232140|exacerbation|exacerbation
402261|NCT01232140|antibiotic treatment|antibiotic treatment
402262|NCT01232140|CRP|crp
402263|NCT01232140|sputum|sputum
402264|NCT01232140|inflammation|inflammation
402265|NCT01232101|covered, uncovered, palliative treatment, stent|covered, uncovered, palliative treatment, stent
402266|NCT01232088|drug labelling|drug labelling
402267|NCT01232088|standardized drug syringe labelling|standardized drug syringe labelling
402268|NCT01232088|European ICU|european icu
402269|NCT01232075|Letrozole ,Clomiphene citrate , IUI,unexplained infertility|letrozole ,clomiphene citrate , iui,unexplained infertility
402270|NCT01232062|breast neoplasm|breast neoplasm
402271|NCT01232062|Neoplasm Metastasis|neoplasm metastasis
402272|NCT01232062|Drug Therapy|drug therapy
402273|NCT01232049|healthy volunteers|healthy volunteers
402274|NCT01232036|healthy volunteers|healthy volunteers
402275|NCT01232023|Indobufen|indobufen
402276|NCT01232023|healthy volunteers|healthy volunteers
402277|NCT01232010|SK-3530|sk-3530
402278|NCT01232010|renal impairment|renal impairment
402279|NCT01232010|healthy volunteers|healthy volunteers
402280|NCT01231997|Udenafil|udenafil
402281|NCT01231997|DA-8159|da-8159
402282|NCT01231997|renal impairment|renal impairment
402283|NCT01231997|healthy volunteers|healthy volunteers
402284|NCT01231984|diabetes|diabetes
402285|NCT01231984|obesity|obesity
402286|NCT01231984|hypoglycemia|hypoglycemia
402287|NCT01231984|hyperglycemia|hyperglycemia
402288|NCT01231984|pen needle|pen needle
402289|NCT01231971|amyloid|amyloid
402290|NCT01231971|plaques|plaques
402772|NCT01229787|allergies|allergies
402291|NCT01231971|neuroimaging|neuroimaging
490820|NCT00140309|TB|tb
402292|NCT01231971|biomarkers|biomarkers
402293|NCT01231971|cognition disorder|cognition disorder
402294|NCT01231971|early detection|early detection
402295|NCT01231971|Amnestic MCI|amnestic mci
402296|NCT01231971|pre-dementia|pre-dementia
402297|NCT01231971|dementia|dementia
402298|NCT01231971|Alzheimer's disease|alzheimer's disease
402300|NCT01231958|Puerto Rican; CVD; Hispanic; health disparities; allostatic load; diet|puerto rican; cvd; hispanic; health disparities; allostatic load; diet
402301|NCT01231945|Cervical Cancer|cervical cancer
402302|NCT01231945|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
402303|NCT01231945|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
402304|NCT01231932|Fatigue|fatigue
402305|NCT01231932|Cancer|cancer
402306|NCT01231932|Cancer Therapy|cancer therapy
402307|NCT01231932|Cancer Treatment|cancer treatment
402308|NCT01231932|Gene Expression Patterns|gene expression patterns
402309|NCT01231893|human, spinal cord injury, olfactory ensheathing cells, transplantation|human, spinal cord injury, olfactory ensheathing cells, transplantation
402310|NCT01231880|Malaria|malaria
402311|NCT01231867|Coronary Heart Disease|coronary heart disease
402312|NCT01231867|Acute Coronary Syndrome|acute coronary syndrome
402313|NCT01231867|Drug interactions|drug interactions
402314|NCT01231867|Clopidogrel|clopidogrel
402315|NCT01231867|Proton Pump Inhibitors|proton pump inhibitors
402316|NCT01231867|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
402317|NCT01231854|atopic hand dermatitis|atopic hand dermatitis
402318|NCT01231854|Chronic hand dermatitis|chronic hand dermatitis
402319|NCT01231828|sleep|sleep
402320|NCT01231828|cirrhosis|cirrhosis
402321|NCT01231828|encephalopathy|encephalopathy
402322|NCT01231828|simulated driving|simulated driving
402323|NCT01231828|sleep disorders|sleep disorders
402324|NCT01231815|Heart transplantation|heart transplantation
402325|NCT01231789|cardiac surgery|cardiac surgery
402326|NCT01231789|RIPC|ripc
402327|NCT01231789|brain injury|brain injury
402328|NCT01231776|cardiopulmonary bypass|cardiopulmonary bypass
402329|NCT01231776|sleep|sleep
402330|NCT01231776|acupuncture|acupuncture
402331|NCT01231763|HIV prevention|hiv prevention
402332|NCT01231763|Vaginal film|vaginal film
402333|NCT01231763|Microbicide|microbicide
402334|NCT01231763|Administration, intravaginal|administration, intravaginal
402335|NCT01231737|Prophylasy|prophylasy
402336|NCT01231737|recurrent urinary tract infection|recurrent urinary tract infection
402337|NCT01231737|prulifloxacin|prulifloxacin
402338|NCT01231737|phosphomycin|phosphomycin
402339|NCT01231711|depression|depression
402340|NCT01231711|post traumatic stress syndrome|post traumatic stress syndrome
402341|NCT01231711|functional status|functional status
402342|NCT01231711|veteran|veteran
402343|NCT01231711|military|military
402344|NCT01231711|stigma|stigma
402345|NCT01231711|mental health self-efficacy|mental health self-efficacy
402346|NCT01231698|septic shock|septic shock
402347|NCT01231698|esmolol|esmolol
402348|NCT01231698|tachycardia|tachycardia
402349|NCT01231698|betablockers|betablockers
402350|NCT01231685|Liver fibrosis|liver fibrosis
402351|NCT01231685|HIV|hiv
402352|NCT01231685|Hepatitis C Virus|hepatitis c virus
402353|NCT01231685|Coinfection|coinfection
402354|NCT01231659|RAD001 (Everolimus)|rad001 (everolimus)
402355|NCT01231659|Letrozole|letrozole
402356|NCT01231659|Breast cancer|breast cancer
402357|NCT01231659|Metastatic Breast cancer|metastatic breast cancer
402358|NCT01231659|Estrogen receptor positive|estrogen receptor positive
402359|NCT01231659|Failure of Tamoxifen|failure of tamoxifen
402360|NCT01231659|Anastrozole or Examestane|anastrozole or examestane
402361|NCT01231646|Folate Receptor Autoantibodies|folate receptor autoantibodies
402362|NCT01231646|Epilepsy|epilepsy
402363|NCT01231646|Psychiatric conditions|psychiatric conditions
402364|NCT01231633|Macular Edema|macular edema
402365|NCT01231633|Central Retinal Vein Occlusion|central retinal vein occlusion
402366|NCT01231620|Seasonal Influenza|seasonal influenza
402367|NCT01231620|Pandemic|pandemic
402368|NCT01231620|Orthomyxoviridae Infections|orthomyxoviridae infections
402369|NCT01231620|Influenza|influenza
402370|NCT01231620|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
402371|NCT01231620|Enzyme Inhibitors|enzyme inhibitors
402372|NCT01231620|Influenza, seasonal|influenza, seasonal
402373|NCT01231620|Respiratory Tract Diseases|respiratory tract diseases
402374|NCT01231620|Zanamivir|zanamivir
402375|NCT01231620|Pharmacologic Actions|pharmacologic actions
402376|NCT01231620|Antiviral Agents|antiviral agents
402377|NCT01231620|Anti-Infective Agents|anti-infective agents
402378|NCT01231620|H1N1|h1n1
402379|NCT01231620|Neuraminidase inhibitor|neuraminidase inhibitor
402380|NCT01231620|Influenza B virus|influenza b virus
402381|NCT01231594|BRAF Inhibitor|braf inhibitor
402382|NCT01231594|Cancer|cancer
402383|NCT01231594|Safety|safety
402384|NCT01231594|GSK2118436|gsk2118436
402385|NCT01231594|BRAF mutation positive tumors|braf mutation positive tumors
402386|NCT01231568|particle size|particle size
402387|NCT01231568|food effect; high fat meal|food effect; high fat meal
402388|NCT01231568|GSK2118436|gsk2118436
402389|NCT01231568|pharmacokinetic|pharmacokinetic
402390|NCT01231568|BRAF inhibitor|braf inhibitor
402391|NCT01231568|BRAF positive tumor|braf positive tumor
402392|NCT01231555|antiretroviral|antiretroviral
402394|NCT01231555|NNRTI|nnrti
402395|NCT01231555|emtricitabine|emtricitabine
402396|NCT01231555|Sexually Transmitted Disease|sexually transmitted disease
402397|NCT01231555|antiretroviral therapy (ART)-naive adults|antiretroviral therapy (art)-naive adults
402398|NCT01231555|Immunologic Deficiency Syndrome|immunologic deficiency syndrome
402399|NCT01231555|tenofovir|tenofovir
402400|NCT01231555|abacavir|abacavir
402401|NCT01231555|Retroviridae Infections|retroviridae infections
402402|NCT01231555|GSK2248761|gsk2248761
402403|NCT01231555|lamivudine|lamivudine
402404|NCT01231555|Acquired ImmunoDeficiency Syndrome (AIDS)|acquired immunodeficiency syndrome (aids)
402405|NCT01231555|HIV infection|hiv infection
402406|NCT01231555|efavirenz|efavirenz
402407|NCT01231542|GSK1349572|gsk1349572
402408|NCT01231542|pharmacokinetics|pharmacokinetics
402409|NCT01231542|dolutegravir|dolutegravir
402410|NCT01231542|integrase|integrase
402411|NCT01231542|rifabutin|rifabutin
402412|NCT01231542|rifampin|rifampin
402413|NCT01231516|ART-experienced|art-experienced
402414|NCT01231516|Integrase inhibitor|integrase inhibitor
402415|NCT01231516|Raltegravir|raltegravir
402416|NCT01231516|GSK1349572|gsk1349572
402417|NCT01231516|Integrase inhibitor naive|integrase inhibitor naive
402418|NCT01231503|Africa|africa
402419|NCT01231503|malaria vaccine|malaria vaccine
402420|NCT01231503|schedule|schedule
402422|NCT01231503|Plasmodium falciparum|plasmodium falciparum
402423|NCT01231477|anaesthetic techniques, inhalation|anaesthetic techniques, inhalation
402424|NCT01231477|sevoflurane|sevoflurane
402425|NCT01231477|Cytokines|cytokines
402426|NCT01231477|Immune response|immune response
402427|NCT01231464|safety|safety
402428|NCT01231464|efficacy|efficacy
402429|NCT01231464|placebo|placebo
402430|NCT01231464|allergic rhinitis|allergic rhinitis
402431|NCT01231464|fluticasone furoate|fluticasone furoate
402432|NCT01231451|HIV Infection|hiv infection
402433|NCT01231438|Renal failure stage 3B|renal failure stage 3b
402434|NCT01231425|Back pain|back pain
402435|NCT01231425|cervicalgia|cervicalgia
402436|NCT01231425|dorsalgia|dorsalgia
402437|NCT01231425|lumbalgia|lumbalgia
402438|NCT01231425|acupuncture|acupuncture
402439|NCT01231386|Female Breast Cancer|female breast cancer
402440|NCT01231386|miRNA expression|mirna expression
402441|NCT01231386|Neoadjuvant/Adjuvant Treatment|neoadjuvant/adjuvant treatment
402442|NCT01231386|Locally and Inflammatory Breast Cancer|locally and inflammatory breast cancer
402443|NCT01231373|varicose veins|varicose veins
402444|NCT01231360|claudication|claudication
402445|NCT01231360|peripheral artery disease|peripheral artery disease
402446|NCT01231360|PAD|pad
402447|NCT01231347|pancreas|pancreas
402448|NCT01231347|gemcitabine|gemcitabine
402450|NCT01231347|jaundice|jaundice
402451|NCT01231321|Adalimumab added to inadequate standard anti-rheumatic therapy in patients with active Rheumatoid Arthritis|adalimumab added to inadequate standard anti-rheumatic therapy in patients with active rheumatoid arthritis
402452|NCT01231256|Quality of life|quality of life
402453|NCT01231256|preventive health consultation|preventive health consultation
402454|NCT01231256|General practice|general practice
402455|NCT01231256|resources|resources
402456|NCT01231256|life style|life style
8896|NCT03233932|Postmenopausal|postmenopausal
401945|NCT01232634|MRI|mri
402457|NCT01231243|tooth bleaching, bleaching agent, hydrogen peroxide|tooth bleaching, bleaching agent, hydrogen peroxide
402458|NCT01231230|asthma, corticosteroids, bronchodilator, airway blood flow|asthma, corticosteroids, bronchodilator, airway blood flow
402460|NCT01231204|Mastectomy|mastectomy
402461|NCT01231204|UCSD|ucsd
402462|NCT01231204|Surgery|surgery
402463|NCT01231204|PVB Catheter|pvb catheter
402464|NCT01231204|Paravertebral Catheter|paravertebral catheter
402465|NCT01231204|Breast Pain|breast pain
402466|NCT01231204|Mastectomy Pain|mastectomy pain
402467|NCT01231204|Postoperative Pain|postoperative pain
402468|NCT01231139|Brain Injury|brain injury
402469|NCT01231139|Temperature|temperature
402470|NCT01231139|Paracetamol|paracetamol
402471|NCT01231139|Phase 2|phase 2
402472|NCT01231139|TBI|tbi
402473|NCT01231126|Induced labor|induced labor
402474|NCT01231126|Misoprostol|misoprostol
402475|NCT01231126|Postpartum blood|postpartum blood
402476|NCT01231126|Erythrocyte indices|erythrocyte indices
402477|NCT01231126|Vaginal delivery|vaginal delivery
402478|NCT01231113|malaria,|malaria,
402479|NCT01231113|pregnancy,|pregnancy,
402480|NCT01231113|dihydroartemisinin-piperaquine,|dihydroartemisinin-piperaquine,
402481|NCT01231113|efficacy,|efficacy,
402482|NCT01231113|safety,|safety,
402484|NCT01231087|energy expenditure|energy expenditure
402485|NCT01231087|morbid obesity|morbid obesity
402486|NCT01231087|bariatric surgery|bariatric surgery
402487|NCT01231087|nutritional follow-up|nutritional follow-up
402488|NCT01231074|obesity|obesity
402489|NCT01231074|weight gain|weight gain
491049|NCT00149669|Cocaine|cocaine
402490|NCT01231074|metformin|metformin
402500|NCT01231022|Neoplasm Metastasis|neoplasm metastasis
402502|NCT01231022|Drug-Induced Liver Injury|drug-induced liver injury
402511|NCT01230983|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
402512|NCT01230983|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
402513|NCT01230983|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
402514|NCT01230983|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
402515|NCT01230983|cardiac toxicity|cardiac toxicity
402516|NCT01230957|Clostridium difficile infection|clostridium difficile infection
402517|NCT01230957|Diarrhea|diarrhea
402518|NCT01230957|Pseudomembranous colitis|pseudomembranous colitis
402519|NCT01230957|Clostridium Difficile Toxoid Vaccine|clostridium difficile toxoid vaccine
402520|NCT01230957|ACAM-CDIFF™ vaccine|acam-cdiff™ vaccine
402521|NCT01230944|GERD|gerd
402522|NCT01230944|LNF|lnf
402523|NCT01230944|CNF|cnf
402524|NCT01230944|Laparoscopic Nissen fundoplication|laparoscopic nissen fundoplication
402525|NCT01230944|Open Nissen fundoplication|open nissen fundoplication
402526|NCT01230944|Antireflux surgery|antireflux surgery
402527|NCT01230931|Acetabulum|acetabulum
402528|NCT01230931|Fracture|fracture
402529|NCT01230931|Hemostatis|hemostatis
402530|NCT01230931|Vitagel|vitagel
402531|NCT01230931|Fibrin sealant|fibrin sealant
402532|NCT01230918|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
402533|NCT01230918|Acute Coronary Syndrome|acute coronary syndrome
402534|NCT01230918|Myocardial Fibrosis|myocardial fibrosis
402535|NCT01230918|Fibrogenesis|fibrogenesis
402536|NCT01230918|Intimal Hyperplasia|intimal hyperplasia
402537|NCT01230918|Sudden Death|sudden death
402538|NCT01230918|avB3 Integrin Expression|avb3 integrin expression
402539|NCT01230905|Androgen Suppression Therapy|androgen suppression therapy
402540|NCT01230905|Hormonal Toxicity|hormonal toxicity
402541|NCT01230905|Quantitative PET|quantitative pet
402542|NCT01230905|Myocardial blood flow|myocardial blood flow
402543|NCT01230905|Coronary blood flow reserve|coronary blood flow reserve
402544|NCT01230905|Endothelial dysfunction|endothelial dysfunction
402545|NCT01230905|Coronary Artery Disease|coronary artery disease
402546|NCT01230879|Aging lung|aging lung
402547|NCT01230879|Airway remodeling|airway remodeling
402548|NCT01230879|Airway segmentation|airway segmentation
402549|NCT01230879|Chest CT|chest ct
402550|NCT01230866|Proton Radiation Prostate Cancer|proton radiation prostate cancer
402551|NCT01230840|fiber|fiber
402552|NCT01230840|calcium|calcium
402553|NCT01230840|magnesium|magnesium
402554|NCT01230827|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
402555|NCT01230827|golimumab|golimumab
402556|NCT01230827|juvenile arthritis|juvenile arthritis
402557|NCT01230827|GO KIDS|go kids
402558|NCT01230827|anti TNF alpha medications|anti tnf alpha medications
402559|NCT01230827|juvenile psoriatic arthritis|juvenile psoriatic arthritis
402655|NCT01230320|Edentulism|edentulism
402656|NCT01230320|Oral Health-Related Quality of Life|oral health-related quality of life
402560|NCT01230814|Bacterial vaginosis, metronidazole, miconazole, vulvovaginal candidiasis, trichomonas vaginalis, women, Kenya|bacterial vaginosis, metronidazole, miconazole, vulvovaginal candidiasis, trichomonas vaginalis, women, kenya
402561|NCT01230788|ALL|all
402562|NCT01230788|Leukemia|leukemia
402563|NCT01230788|Rituximab|rituximab
402564|NCT01230788|Pediatrics|pediatrics
402565|NCT01230762|Dapoxetine, Orgasmic disorder|dapoxetine, orgasmic disorder
402566|NCT01230762|Premature ejaculation|premature ejaculation
402567|NCT01230762|Sexual dysfunction|sexual dysfunction
402568|NCT01230762|Sexual intercourse|sexual intercourse
402569|NCT01230762|Ejaculation|ejaculation
402570|NCT01230762|Erectile Dysfunction|erectile dysfunction
402571|NCT01230749|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
402572|NCT01230749|Diabetes Mellitus|diabetes mellitus
402573|NCT01230749|Hyperglycemia|hyperglycemia
402574|NCT01230749|JNJ-41443532|jnj-41443532
402575|NCT01230749|Pioglitazone|pioglitazone
502819|NCT00211211|Spine|spine
402576|NCT01230749|Placebo|placebo
402577|NCT01230697|Advanced|advanced
402578|NCT01230697|hepatocarcinoma|hepatocarcinoma
402579|NCT01230684|CEUS, Abdominal Aortic Aneurysm, Endoleaks|ceus, abdominal aortic aneurysm, endoleaks
402580|NCT01230658|prophylactic enoxaparin|prophylactic enoxaparin
402581|NCT01230658|Roux en Y gastric bypass surgery|roux en y gastric bypass surgery
402582|NCT01230632|assisted reproduction technology|assisted reproduction technology
402583|NCT01230632|Metabolic risk factors|metabolic risk factors
402584|NCT01230632|In Vitro Fertilisation|in vitro fertilisation
402585|NCT01230606|Percutaneous Intervention|percutaneous intervention
402586|NCT01230606|Percutaneous Coronary Intervention|percutaneous coronary intervention
402587|NCT01230606|Catheterization|catheterization
402588|NCT01230606|Coronary Catheterization|coronary catheterization
402589|NCT01230606|Same day Discharge|same day discharge
402590|NCT01230606|Next Day Discharge|next day discharge
402591|NCT01230606|Patient Satisfaction|patient satisfaction
402592|NCT01230606|Multi-Center|multi-center
402593|NCT01230606|Randomized|randomized
402594|NCT01230606|Low-risk PCI|low-risk pci
402595|NCT01230606|BlindedClosure device|blindedclosure device
402596|NCT01230606|Vascular closure device|vascular closure device
402597|NCT01230580|Protease Inhibitors|protease inhibitors
402598|NCT01230580|RNA virus infections|rna virus infections
402599|NCT01230580|Virus diseases|virus diseases
402600|NCT01230580|Sexually Transmitted Diseases viral|sexually transmitted diseases viral
402601|NCT01230580|Immune system diseases|immune system diseases
402602|NCT01230580|Anti-infective Agents|anti-infective agents
402603|NCT01230580|Drug resistance|drug resistance
402604|NCT01230567|Problem wounds|problem wounds
402605|NCT01230567|Non healing wounds|non healing wounds
402606|NCT01230567|BCC|bcc
402607|NCT01230567|SCC|scc
402608|NCT01230567|Vasculitis|vasculitis
402609|NCT01230554|contact lens|contact lens
402610|NCT01230541|Semen characteristics|semen characteristics
402611|NCT01230541|Erectile Dysfunction|erectile dysfunction
402612|NCT01230515|Oncology Pain Management in outpatient hospice setting|oncology pain management in outpatient hospice setting
402613|NCT01230502|immunosuppression|immunosuppression
402614|NCT01230502|anti-rejection|anti-rejection
402615|NCT01230502|immune tolerance|immune tolerance
402616|NCT01230476|Locally advanced nasopharyngeal carcinoma|locally advanced nasopharyngeal carcinoma
402617|NCT01230476|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
402618|NCT01230476|Chemoradiation|chemoradiation
402619|NCT01230476|Cetuximab|cetuximab
402620|NCT01230463|Pain, Postoperative|pain, postoperative
402621|NCT01230463|Ketorolac|ketorolac
402622|NCT01230463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
402623|NCT01230463|Intraoperative Care|intraoperative care
402624|NCT01230450|urodynamic urinary incontinence, sub-urethral tape|urodynamic urinary incontinence, sub-urethral tape
402625|NCT01230437|montelukast|montelukast
402626|NCT01230437|asthma|asthma
402627|NCT01230437|allergic rhinitis|allergic rhinitis
402628|NCT01230437|nasal epithelial cells|nasal epithelial cells
402629|NCT01230437|inflammatory mediators|inflammatory mediators
402630|NCT01230424|OA|oa
402631|NCT01230424|Knee arthritis|knee arthritis
402632|NCT01230424|MRI|mri
402633|NCT01230424|Steroid|steroid
402634|NCT01230411|Episodic migraine|episodic migraine
402635|NCT01230385|lersivirine|lersivirine
402636|NCT01230385|UK-453|uk-453
402637|NCT01230385|061|061
402638|NCT01230385|safety|safety
402639|NCT01230385|tolerability|tolerability
402640|NCT01230385|pharmacokinetics|pharmacokinetics
402641|NCT01230385|HIV|hiv
402642|NCT01230385|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
402643|NCT01230385|NNRTI|nnrti
402644|NCT01230359|Autism|autism
402645|NCT01230359|Children|children
402646|NCT01230359|ASD|asd
402647|NCT01230359|Vitamin B6|vitamin b6
402648|NCT01230359|Magnesium|magnesium
402649|NCT01230320|Cost estimates|cost estimates
402650|NCT01230320|Complete Denture|complete denture
402651|NCT01230320|Dental Economics|dental economics
402652|NCT01230320|Dental Impression Technique|dental impression technique
402653|NCT01230320|Denture Retention|denture retention
402654|NCT01230320|Edentulous|edentulous
402657|NCT01230320|Patient Acceptance of Health Care|patient acceptance of health care
402658|NCT01230320|Patient Satisfaction|patient satisfaction
402659|NCT01230320|Quality of Health Care|quality of health care
402660|NCT01230320|Quality of Life|quality of life
402661|NCT01230307|Vitamin D|vitamin d
402662|NCT01230307|Systolic failure|systolic failure
402663|NCT01230307|Genomics|genomics
402664|NCT01230307|Biomarkers|biomarkers
402665|NCT01230307|Exercise|exercise
402666|NCT01230307|Quality of Life|quality of life
402667|NCT01230294|echocardiography of the right heart|echocardiography of the right heart
402668|NCT01230294|3D 4D echocardiography|3d 4d echocardiography
402669|NCT01230294|strain measurement|strain measurement
402670|NCT01230294|chronic heart failure|chronic heart failure
402671|NCT01230294|pulmonary hypertension|pulmonary hypertension
402672|NCT01230281|C3G|c3g
402673|NCT01230281|Oxidative stress|oxidative stress
402674|NCT01230281|Antioxidant|antioxidant
402675|NCT01230281|Black bean|black bean
402676|NCT01230268|C3G|c3g
402677|NCT01230268|Oxidative stress|oxidative stress
402678|NCT01230268|Antioxidant|antioxidant
402679|NCT01230268|Mulberry|mulberry
402680|NCT01230255|intra-abdominal pressure|intra-abdominal pressure
402681|NCT01230255|intra-abdominal hypertension|intra-abdominal hypertension
402682|NCT01230255|abdominal compartment syndrome|abdominal compartment syndrome
402683|NCT01230255|open abdomen|open abdomen
402684|NCT01230255|percutaneous|percutaneous
402685|NCT01230242|Mirena|mirena
402686|NCT01230242|postplacental intrauterine device|postplacental intrauterine device
402687|NCT01230242|postpartum insertion|postpartum insertion
402688|NCT01230229|Intermittent claudication|intermittent claudication
402689|NCT01230229|Superficial femoral artery|superficial femoral artery
402690|NCT01230229|Stenting|stenting
402691|NCT01230229|Medical treatment|medical treatment
402692|NCT01230229|Quality of life|quality of life
402693|NCT01230216|coronary artery disease|coronary artery disease
402694|NCT01230216|hypertension|hypertension
402695|NCT01230190|infants|infants
402696|NCT01230190|adaptive immunology|adaptive immunology
402697|NCT01230190|atopic dermatitis|atopic dermatitis
402698|NCT01230190|probiotics|probiotics
402699|NCT01230151|Deep Brain Stimulation|deep brain stimulation
402701|NCT01230151|Parkinson's disease|parkinson's disease
402702|NCT01230151|PD|pd
402703|NCT01230151|Patients who have a preexisting Deep Brain Stimulation (DBS) system for the treatment of Parkinson's disease (PD)|patients who have a preexisting deep brain stimulation (dbs) system for the treatment of parkinson's disease (pd)
402704|NCT01230125|Inflammation|inflammation
402705|NCT01230125|Pain|pain
402706|NCT01230125|Ocular surgery|ocular surgery
402707|NCT01230099|Critical Illness|critical illness
402708|NCT01230099|Mechanical Ventilation|mechanical ventilation
402709|NCT01230099|Palliative Care|palliative care
402710|NCT01230099|Caregivers|caregivers
402711|NCT01230086|ICD|icd
402712|NCT01230086|DFT-testing|dft-testing
402713|NCT01230073|ICD|icd
402714|NCT01230073|Home-Monitoring|home-monitoring
402715|NCT01230073|Quality of life|quality of life
402716|NCT01230060|ocular surgery|ocular surgery
402717|NCT01230060|phacoemulsification|phacoemulsification
402718|NCT01230047|depression|depression
402719|NCT01230047|anxiety|anxiety
402720|NCT01230047|psychoeducation|psychoeducation
402721|NCT01230047|self-help|self-help
402722|NCT01230047|psychosocial|psychosocial
402723|NCT01230034|Imidapril, Ramipril, Hypertension, Type 2 diabetes mellitus, Microalbuminuria|imidapril, ramipril, hypertension, type 2 diabetes mellitus, microalbuminuria
402724|NCT01230008|primary mediastinal lymphoma|primary mediastinal lymphoma
402725|NCT01230008|radiotherapy|radiotherapy
402726|NCT01230008|chemotherapy|chemotherapy
402727|NCT01230008|rituximab|rituximab
402728|NCT01229969|falls, balance problems, gaming systems, balance assessments|falls, balance problems, gaming systems, balance assessments
402729|NCT01229956|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
402730|NCT01229956|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
402731|NCT01229956|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
402732|NCT01229930|cervical adenocarcinoma|cervical adenocarcinoma
402733|NCT01229930|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
402734|NCT01229930|cervical squamous cell carcinoma|cervical squamous cell carcinoma
402735|NCT01229930|recurrent cervical cancer|recurrent cervical cancer
402736|NCT01229930|stage IVB cervical cancer|stage ivb cervical cancer
402737|NCT01229930|stage IVA cervical cancer|stage iva cervical cancer
402738|NCT01229891|vitamin D fortification|vitamin d fortification
402739|NCT01229891|yogurt drink|yogurt drink
402740|NCT01229891|type 2 diabetes|type 2 diabetes
402741|NCT01229891|efficacy|efficacy
402742|NCT01229852|Fibromyalgia|fibromyalgia
402743|NCT01229852|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
402744|NCT01229852|Pain|pain
402745|NCT01229839|Carcinoma,Hepatocellular|carcinoma,hepatocellular
402746|NCT01229839|Liver Neoplasms|liver neoplasms
402747|NCT01229839|Therapeutic|therapeutic
402748|NCT01229839|Chemoembolization,|chemoembolization,
402749|NCT01229839|TACE|tace
402750|NCT01229839|pharmacokinetics|pharmacokinetics
402751|NCT01229839|Iodized Oil/administration & dosage|iodized oil/administration & dosage
402752|NCT01229839|polyvinyl alcohol|polyvinyl alcohol
402753|NCT01229839|Humans|humans
402754|NCT01229826|Uterine fibroids|uterine fibroids
402755|NCT01229826|Uterine leiomyomas|uterine leiomyomas
402756|NCT01229826|MR Elastography|mr elastography
402757|NCT01229826|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
402758|NCT01229826|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
402760|NCT01229813|First line|first line
402761|NCT01229813|Chemotherapy|chemotherapy
402762|NCT01229813|Maintenance treatment|maintenance treatment
402763|NCT01229813|KRAS wt|kras wt
402764|NCT01229813|KRAS mutated|kras mutated
402765|NCT01229813|Anti-angiogenetic treatment|anti-angiogenetic treatment
402766|NCT01229813|Metronomic capecitabine|metronomic capecitabine
402767|NCT01229813|bevacizumab|bevacizumab
402768|NCT01229813|erlotinib|erlotinib
402769|NCT01229813|Translational research|translational research
402770|NCT01229800|Polyethylene Glycol, Sodium Phosphate, Bowel preparation, Efficacy|polyethylene glycol, sodium phosphate, bowel preparation, efficacy
402771|NCT01229787|asthma|asthma
402773|NCT01229787|obesity|obesity
402775|NCT01229761|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
402776|NCT01229761|Breast Feeding|breast feeding
402777|NCT01229761|Infant Mortality|infant mortality
402778|NCT01229761|Morbidity|morbidity
402779|NCT01229761|Botswana|botswana
402780|NCT01229761|Africa|africa
402781|NCT01229761|Infectious disease transmission, vertical|infectious disease transmission, vertical
402782|NCT01229761|adverse drug event|adverse drug event
402783|NCT01229735|levetiracetam|levetiracetam
402784|NCT01229735|topiramate|topiramate
402785|NCT01229735|epilepsy|epilepsy
402786|NCT01229735|partial seizures|partial seizures
402787|NCT01229722|adherence|adherence
491421|NCT00151671|Surgery|surgery
402788|NCT01229722|reminders|reminders
402789|NCT01229722|text messages|text messages
402790|NCT01229722|SMS|sms
402791|NCT01229722|mHealth|mhealth
402792|NCT01229709|Tinnitus|tinnitus
402793|NCT01229709|Mindfulness|mindfulness
402794|NCT01229709|MBSR|mbsr
402795|NCT01229709|Mindfulness Based Stress Reduction|mindfulness based stress reduction
402796|NCT01229709|MBTR|mbtr
402797|NCT01229696|Popliteal|popliteal
402798|NCT01229696|UCSD|ucsd
402799|NCT01229696|Postoperative pain|postoperative pain
402800|NCT01229696|Foot surgery|foot surgery
402801|NCT01229696|Ankle surgery|ankle surgery
402802|NCT01229696|Popliteal Catheter|popliteal catheter
402803|NCT01229696|Popliteal Nerve Block|popliteal nerve block
402804|NCT01229696|Lower extremity surgery|lower extremity surgery
402805|NCT01229696|Bifurcation|bifurcation
402806|NCT01229696|Catheter Insertion Site|catheter insertion site
402807|NCT01229683|UCSD|ucsd
402808|NCT01229683|Perineural Nerve Block|perineural nerve block
402809|NCT01229683|Shoulder Surgery|shoulder surgery
402810|NCT01229683|Pain|pain
402811|NCT01229683|Grip Strength|grip strength
402812|NCT01229683|Sensation|sensation
402813|NCT01229683|Interscalene Nerve Block|interscalene nerve block
402814|NCT01229670|Heart failure|heart failure
402815|NCT01229670|Hemorheology|hemorheology
402816|NCT01229670|Atherothrombosis|atherothrombosis
402817|NCT01229670|Angiogenesis|angiogenesis
402818|NCT01229657|Reopening of macular hole;|reopening of macular hole;
402819|NCT01229657|Visual acuity;|visual acuity;
402820|NCT01229657|Phacoemulsification cataract surgery;|phacoemulsification cataract surgery;
402821|NCT01229657|Vitrectomy|vitrectomy
402822|NCT01229644|Glioma|glioma
402823|NCT01229644|Brain Cancer|brain cancer
402824|NCT01229644|Recurrent glioma|recurrent glioma
402825|NCT01229644|Low grade glioma|low grade glioma
402826|NCT01229644|PDGFR Inhibitor|pdgfr inhibitor
402827|NCT01229644|Crenolanib (CP-868,596)|crenolanib (cp-868,596)
402828|NCT01229644|Neo-adjuvant Therapy|neo-adjuvant therapy
402829|NCT01229631|Periodontitis|periodontitis
402830|NCT01229631|Dietary supplementation|dietary supplementation
402831|NCT01229618|Prostate Cancer|prostate cancer
402832|NCT01229592|infection|infection
402833|NCT01229592|catheter|catheter
402834|NCT01229592|bacteriaemia|bacteriaemia
402835|NCT01229592|ethanol|ethanol
402836|NCT01229579|poliomyelitis|poliomyelitis
402837|NCT01229579|OPV|opv
402838|NCT01229579|zinc supplement|zinc supplement
402839|NCT01229579|diarrhea|diarrhea
402840|NCT01229579|placebo|placebo
402841|NCT01229579|double blind randomized control trial|double blind randomized control trial
402842|NCT01229579|elemental zinc|elemental zinc
402843|NCT01229579|seroconversion|seroconversion
402844|NCT01229579|bOPV|bopv
402845|NCT01229579|infants|infants
402846|NCT01229579|immunity|immunity
402847|NCT01229527|Colonoscopy|colonoscopy
402848|NCT01229527|Remifentanil|remifentanil
402849|NCT01229527|Sedation|sedation
402850|NCT01229514|Children|children
402851|NCT01229514|before|before
402852|NCT01229514|the age of 2 years|the age of 2 years
402853|NCT01229475|Atrial fibrillation|atrial fibrillation
402854|NCT01229475|recurrence|recurrence
402855|NCT01229475|repeat procedure|repeat procedure
402856|NCT01229475|linear ablation|linear ablation
402857|NCT01229475|stepwise approach|stepwise approach
402858|NCT01229449|Dental pain|dental pain
402859|NCT01229449|Ibuprofen|ibuprofen
402860|NCT01229449|Acetaminophen|acetaminophen
402861|NCT01229449|Nurofen Plus®|nurofen plus®
402862|NCT01229449|Panadeine® Extra|panadeine® extra
402863|NCT01229436|Dupuytren's|dupuytren's
402864|NCT01229436|treatment|treatment
402866|NCT01229436|recovery|recovery
402867|NCT01229436|health care resources|health care resources
402868|NCT01229397|Influenza|influenza
402869|NCT01229397|Virus|virus
402870|NCT01229397|Vaccination|vaccination
402871|NCT01229397|Immunisation|immunisation
402872|NCT01229371|Influenza|influenza
402873|NCT01229371|Virus|virus
402874|NCT01229371|Vaccination|vaccination
402875|NCT01229371|Immunisation|immunisation
402876|NCT01229358|vascular surgery|vascular surgery
402877|NCT01229358|wound infection|wound infection
402878|NCT01229358|wound complication|wound complication
402974|NCT01228799|canaloplasty,|canaloplasty,
402879|NCT01229332|Motor fluctuations levodopa pharmacokinetics carbidopa solution continuous|motor fluctuations levodopa pharmacokinetics carbidopa solution continuous
402880|NCT01229319|actinic keratosis, keratocytic lesion, keratoses, cryotherapy, imiquimod|actinic keratosis, keratocytic lesion, keratoses, cryotherapy, imiquimod
402881|NCT01229293|Mechanical muscle function|mechanical muscle function
402882|NCT01229293|Muscle strength|muscle strength
402883|NCT01229293|Hip replacement|hip replacement
402884|NCT01229293|Osteoarthritis|osteoarthritis
402885|NCT01229293|Hip arthroplasty|hip arthroplasty
402886|NCT01229280|Bioequivalence|bioequivalence
402887|NCT01229280|Darifenacin|darifenacin
402888|NCT01229280|Healthy volunteers|healthy volunteers
759837|NCT03271073|S1|s1
759944|NCT03261167|Safety|safety
761339|NCT01074970|Triple negative|triple negative
761340|NCT01062360|Sore Throat|sore throat
761341|NCT01062360|Upper Respiratory Tract Infections|upper respiratory tract infections
761342|NCT01062360|Nasal Congestion|nasal congestion
761343|NCT01000493|efficacy|efficacy
761344|NCT01000493|double-blind|double-blind
761345|NCT01000493|Clinician Administered PTSD Scale|clinician administered ptsd scale
761346|NCT01000493|placebo|placebo
761347|NCT01000493|Sleep|sleep
761348|NCT01000493|safety|safety
761349|NCT01000493|CAPS|caps
761350|NCT01000493|neurokinin-1 antagonist|neurokinin-1 antagonist
761351|NCT01000493|orvepitant|orvepitant
761352|NCT01000493|PTSD|ptsd
761353|NCT01000493|randomized|randomized
761354|NCT01000493|Post traumatic stress disorder|post traumatic stress disorder
761355|NCT01000493|Phase II|phase ii
761356|NCT00882037|Methamphetamine Dependence|methamphetamine dependence
761357|NCT00882037|Substance Abuse Treatment|substance abuse treatment
759819|NCT03269578|Pharmacodynamics|pharmacodynamics
759820|NCT03269578|Tissue Collection|tissue collection
759821|NCT03269578|Tissue Biopsies|tissue biopsies
759822|NCT03269578|Biospecimen|biospecimen
759823|NCT03269578|Assay Development|assay development
759824|NCT03270657|Deep Brain Stimulation|deep brain stimulation
759825|NCT03271125|Intervention|intervention
759826|NCT03271125|Multiple sclerosis|multiple sclerosis
759827|NCT03271125|Treadmill|treadmill
759828|NCT03271125|Mobility|mobility
759829|NCT03271099|survivorship; navigation|survivorship; navigation
759830|NCT03271086|Relaxation training|relaxation training
759831|NCT03271086|Pediatric clinic|pediatric clinic
759832|NCT03271086|Children 6-11 years|children 6-11 years
759833|NCT03271086|Text messaging|text messaging
759834|NCT03271073|gastric cancer|gastric cancer
759835|NCT03271073|gastroesophageal junction cancer|gastroesophageal junction cancer
759836|NCT03271073|Apatinib|apatinib
759838|NCT03271047|cancer|cancer
759839|NCT03270592|Service dogs|service dogs
759840|NCT03270592|Alert dogs|alert dogs
759841|NCT03270592|Costs|costs
759842|NCT03270592|Quality of Life|quality of life
759843|NCT03270592|Cost-effectiveness|cost-effectiveness
759844|NCT03270709|Vitamin D3|vitamin d3
759845|NCT03270709|Pulmonary disease|pulmonary disease
759846|NCT03270709|Immunosuppression|immunosuppression
759847|NCT03270709|HIV|hiv
759848|NCT03270709|Smoking|smoking
759849|NCT03270566|Water hardness|water hardness
759850|NCT03270566|Atopic eczema prevention|atopic eczema prevention
759851|NCT03270566|Skin barrier function|skin barrier function
759852|NCT03270566|Skin microbiome|skin microbiome
759853|NCT03270878|Glasdegib|glasdegib
759854|NCT03270878|PF-04449913|pf-04449913
759855|NCT03270878|Pharmacokinetics|pharmacokinetics
759856|NCT03270878|Bioavailability|bioavailability
759857|NCT03270215|Computed Tomography|computed tomography
759858|NCT03270215|Specificity|specificity
759859|NCT03270215|Sensitivity|sensitivity
759860|NCT03270384|early feasibility|early feasibility
759861|NCT03270384|non-randomized|non-randomized
759862|NCT03270982|Non Inflammatory Degenerative Joint Disease|non inflammatory degenerative joint disease
759863|NCT03270982|Rheumatoid Arthritis|rheumatoid arthritis
759864|NCT03270982|Revision where other devices have failed|revision where other devices have failed
759865|NCT03270982|Correction of functional deformity|correction of functional deformity
760579|NCT02685683|Mongersen|mongersen
759866|NCT03270982|Oncology Applications|oncology applications
759867|NCT03270982|Treatment of acute or Chronic fractures|treatment of acute or chronic fractures
759868|NCT03269604|Urological Surgery|urological surgery
759869|NCT03269604|Bacterial resistance|bacterial resistance
759870|NCT03271138|Celiac Disease|celiac disease
759871|NCT03271138|Gluten-Free Diet|gluten-free diet
759872|NCT03271138|Bifidobacterium infantis NLS super strain|bifidobacterium infantis nls super strain
759873|NCT03271138|gastrointestinal symptoms|gastrointestinal symptoms
759874|NCT03271138|quality of life|quality of life
759875|NCT03271138|microbiota|microbiota
759876|NCT03271138|IgA TTG|iga ttg
759877|NCT03271138|IgA DGP|iga dgp
759878|NCT03269071|Multiple Sclerosis|multiple sclerosis
759879|NCT03269071|Cell Therapy|cell therapy
759880|NCT03269071|Human Neural Stem Cells|human neural stem cells
759881|NCT03270228|Incidence of cancer|incidence of cancer
759882|NCT03270228|Survival|survival
759883|NCT03269591|Dysmenorrhea|dysmenorrhea
759884|NCT03269591|Pulsed electromagnetic field|pulsed electromagnetic field
759885|NCT03269591|Diclofenac|diclofenac
759886|NCT03270683|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
759887|NCT03270683|transcranial Doppler sonography|transcranial doppler sonography
759888|NCT03270683|cerebrovascular circulation|cerebrovascular circulation
759889|NCT03270683|prognosis|prognosis
759890|NCT03267277|Calcinosis|calcinosis
759891|NCT03267277|Dermatomyositis|dermatomyositis
759892|NCT03267277|Juvenile Dermatomyositis|juvenile dermatomyositis
759893|NCT03267277|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
759894|NCT03267277|Sodium Thiosulfate|sodium thiosulfate
759895|NCT03271034|Lipedema|lipedema
759896|NCT03271034|Metabolism|metabolism
759897|NCT03271034|Body Composition|body composition
759898|NCT03271034|Fat Distribution|fat distribution
759899|NCT03271034|Immunology|immunology
759900|NCT03268876|Epithelial ovarian cancer|epithelial ovarian cancer
759901|NCT03268876|Surgery|surgery
759902|NCT03268876|Quality of life|quality of life
759903|NCT03270280|Chronic Periodontitis|chronic periodontitis
759904|NCT03270280|Phytomedicines|phytomedicines
759905|NCT03270280|Nigella sativa|nigella sativa
759906|NCT03270917|Parenchymal preserving|parenchymal preserving
759907|NCT03270917|Postero-superior|postero-superior
759908|NCT03270917|Laparoscopy|laparoscopy
759909|NCT03267953|Stress management, e-Health, cardiovascular disease, adaptive design, lay coaching, motivational interviewing|stress management, e-health, cardiovascular disease, adaptive design, lay coaching, motivational interviewing
759910|NCT03269214|osteonecrosis|osteonecrosis
759911|NCT03269214|mandible|mandible
759912|NCT03270397|Self Esteem|self esteem
759913|NCT03270397|Body Image|body image
759914|NCT03270397|Eating disorders|eating disorders
759915|NCT03270020|treatment|treatment
759916|NCT03270020|denosumab|denosumab
759917|NCT03270020|Positron Emission Tomography (PET) CT scan|positron emission tomography (pet) ct scan
759918|NCT03263000|Belpharospasm|belpharospasm
759919|NCT03263000|Blink Reflex|blink reflex
759920|NCT03263000|Eyeblink|eyeblink
759921|NCT03263013|Functional (BOLD) MRI|functional (bold) mri
759922|NCT03267316|First-in-Human|first-in-human
759923|NCT03267316|Phase 1|phase 1
759924|NCT03267316|Phase 2|phase 2
759925|NCT03267316|Antibody, Monoclonal|antibody, monoclonal
759926|NCT03267316|IL1RAP|il1rap
759927|NCT03267316|Safety|safety
759928|NCT03267316|Tolerability|tolerability
759929|NCT03267316|Cancer|cancer
759930|NCT03267316|Solid tumor|solid tumor
759931|NCT03267316|Malignant|malignant
759932|NCT03267316|Dose escalation|dose escalation
759933|NCT03267316|Dose expansion|dose expansion
759934|NCT03267316|CAN04|can04
759935|NCT03267316|Immunoglobulin|immunoglobulin
759936|NCT03267316|Clinical Trial|clinical trial
759937|NCT03267316|Infusion|infusion
759938|NCT03267316|Antineoplastic|antineoplastic
759939|NCT03267316|Anticancer|anticancer
759940|NCT03268616|neural respiratory drive|neural respiratory drive
759941|NCT03268616|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
759942|NCT03268616|electromyography|electromyography
759943|NCT03261167|Botulinum toxin A|botulinum toxin a
759945|NCT03261167|post-stroke upper limb spasticity|post-stroke upper limb spasticity
759946|NCT03261167|Efficacy|efficacy
759947|NCT03261167|GSK1358820|gsk1358820
759948|NCT03261167|double blind|double blind
759949|NCT03270930|Operative duration|operative duration
759950|NCT03270930|Pediatric surgery|pediatric surgery
759951|NCT03270930|Emergency laparotomy|emergency laparotomy
759952|NCT03270930|Mortality rate|mortality rate
759953|NCT03270930|Survival|survival
759954|NCT03270930|Kaplan-Meier analysis|kaplan-meier analysis
759955|NCT03270930|ROC curve analysis|roc curve analysis
759956|NCT03270930|Senior resident|senior resident
759957|NCT03271177|transradial percutaneous coronary intervention|transradial percutaneous coronary intervention
759958|NCT03270410|neonates|neonates
759959|NCT03270410|non invasive monitoring|non invasive monitoring
759960|NCT03258580|Pain|pain
759961|NCT03258580|Visual Analogue Pain Scale|visual analogue pain scale
759962|NCT03258580|Healthy Volunteer|healthy volunteer
759963|NCT03258580|Social Cognition|social cognition
759964|NCT03258580|Eye Movement|eye movement
759965|NCT03258606|Research Participants|research participants
759966|NCT03258606|Retrospective Review|retrospective review
759967|NCT03258606|Capacity Assignment|capacity assignment
759968|NCT03258606|Cognitive Impairment|cognitive impairment
759969|NCT03258606|Assent|assent
759970|NCT03258567|Monoclonal Antibody|monoclonal antibody
759971|NCT03258593|Carcinoma-in-situ|carcinoma-in-situ
759972|NCT03258593|High-grade Ta or T1 disease|high-grade ta or t1 disease
759973|NCT03258593|Papillary Tumors|papillary tumors
759974|NCT03270449|fibromyalgia|fibromyalgia
759975|NCT03270449|community-based|community-based
759976|NCT03270449|multidisciplinary|multidisciplinary
759977|NCT03270137|Alzheimer Disease|alzheimer disease
759978|NCT03270137|rTMS|rtms
759979|NCT03270137|Cognition|cognition
759980|NCT03270137|Behavioral Symptoms|behavioral symptoms
759981|NCT03270137|Functionality|functionality
759982|NCT03263026|Lymphoma|lymphoma
759983|NCT03263026|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
759984|NCT03263026|enzastaurin|enzastaurin
759985|NCT03255031|Ketogenic Diet|ketogenic diet
759986|NCT03255031|Detoxification|detoxification
759987|NCT03255031|Functional MRI|functional mri
759988|NCT03255031|MRI/MRS|mri/mrs
759989|NCT03255031|Alcoholism|alcoholism
759990|NCT03255018|Monoclonal Antibody|monoclonal antibody
759991|NCT03255018|PD-1 Receptor|pd-1 receptor
759992|NCT03253705|Assay Development|assay development
759993|NCT03253705|Gene Expression|gene expression
759994|NCT03253705|Metabolomics|metabolomics
759995|NCT03253705|Induced Pluripotent Stem Cell (iPS)|induced pluripotent stem cell (ips)
759996|NCT03253705|PBMCs/DNA/RNA|pbmcs/dna/rna
759997|NCT03253744|Image Guidance|image guidance
759998|NCT03253744|Dose Escalation|dose escalation
759999|NCT03253744|Radiotherapy|radiotherapy
760000|NCT03253744|Re-irradiation|re-irradiation
760001|NCT03253744|Quality of Life|quality of life
760002|NCT03268642|Fulminant Myocarditis|fulminant myocarditis
760003|NCT03268642|Retrospective cohort study|retrospective cohort study
760004|NCT03253718|Healthy Volunteers|healthy volunteers
760005|NCT03253692|Cardiac Computed Tomography|cardiac computed tomography
760006|NCT03253692|Radiation|radiation
760007|NCT03253692|Iterative Reconstruction|iterative reconstruction
760008|NCT03253731|Brain Plasticity|brain plasticity
760009|NCT03253731|Healthy Volunteers|healthy volunteers
760010|NCT03251989|Brain Tumor|brain tumor
760011|NCT03251989|Central Nervous System|central nervous system
760012|NCT03251989|CNS|cns
760013|NCT03248622|Incidence|incidence
760014|NCT03248622|Hepatitis B Surface Antigen|hepatitis b surface antigen
760015|NCT03248622|Decompensation|decompensation
760016|NCT03248635|Survey|survey
760017|NCT03248635|Pre-Test|pre-test
760018|NCT03250741|Rotigotine|rotigotine
760019|NCT03250741|Dopamine|dopamine
760020|NCT03270163|Intensive care unit acquired muscle weakness|intensive care unit acquired muscle weakness
760021|NCT03270163|Transcutaneous electrical stimulation|transcutaneous electrical stimulation
760022|NCT03249077|Prevention|prevention
760023|NCT03249077|Medicare|medicare
760024|NCT03244670|Myopia|myopia
760025|NCT03239899|HIV|hiv
760026|NCT03239899|Brain|brain
760027|NCT03239899|Immunotherapy|immunotherapy
760028|NCT03239145|Advanced Solid Tumor|advanced solid tumor
760029|NCT03239145|Melanoma|melanoma
760030|NCT03239145|Ovarian Cancer|ovarian cancer
760031|NCT03239145|Renal Cancer|renal cancer
760032|NCT03239145|Colorectal Cancer|colorectal cancer
760033|NCT03233724|PD-L1|pd-l1
760034|NCT03233724|Demethylating Agents and Histone Deacetylase (HDAC) Inhibitors|demethylating agents and histone deacetylase (hdac) inhibitors
760035|NCT03233724|DNA Hypomethylating Agent|dna hypomethylating agent
760036|NCT03233724|Cytidine Deaminase|cytidine deaminase
760037|NCT03233724|Checkpoint Inhibitor|checkpoint inhibitor
760038|NCT03231943|FTIH|ftih
760039|NCT03231943|Healthy|healthy
760040|NCT03231943|Tolerability|tolerability
760041|NCT03231943|Dose-escalation|dose-escalation
760042|NCT03231943|HIV-1|hiv-1
760043|NCT03231943|Safety|safety
760044|NCT03231943|PK|pk
760045|NCT03231943|GSK3640254|gsk3640254
760046|NCT03231943|Maturation inhibitor|maturation inhibitor
760047|NCT03225183|TOPMed|topmed
760048|NCT03225183|Blood Pressure|blood pressure
760049|NCT03225183|Long Noncoding RNA|long noncoding rna
760050|NCT03225183|Gene Expression|gene expression
760051|NCT03225183|MicroRNA|microrna
760052|NCT03225144|Motor Neuron Disease|motor neuron disease
760053|NCT03225144|Frontotemporal Dementia|frontotemporal dementia
760054|NCT03225144|Corticobasal Syndrome|corticobasal syndrome
760055|NCT03225157|Audiogram|audiogram
760056|NCT03225157|Statins|statins
760057|NCT03225157|Drug Response|drug response
760058|NCT03225157|Cancer Treatment|cancer treatment
760059|NCT03225157|Head and Neck Cancer|head and neck cancer
760060|NCT03225170|BRCA1|brca1
760061|NCT03225170|BRCA2|brca2
760062|NCT03225170|Clinical Decision-Making|clinical decision-making
760063|NCT03225196|Extracellular RNA|extracellular rna
760064|NCT03225196|MicroRNA|microrna
760065|NCT03223636|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
760066|NCT03223636|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
760067|NCT03223636|Electroencephalogram (EEG)|electroencephalogram (eeg)
760068|NCT03223636|Magnetoencephalogram|magnetoencephalogram
760069|NCT03223636|Transcranial Electrical Stimulation (TES)|transcranial electrical stimulation (tes)
760070|NCT03223623|Complex Regional Pain Syndrome|complex regional pain syndrome
760071|NCT03223623|CRPS|crps
760072|NCT03223623|Dystonia|dystonia
760073|NCT03223610|Monoclonal Antibody|monoclonal antibody
760074|NCT03223610|Dose-Finding|dose-finding
760075|NCT03223662|Neoadjuvant Chemoradiotherapy (nCRT)|neoadjuvant chemoradiotherapy (ncrt)
760076|NCT03223662|Esophagectomy|esophagectomy
760077|NCT03223662|Tissue or serologic biomarkers|tissue or serologic biomarkers
760078|NCT03221192|Real-time data capture|real-time data capture
760079|NCT03221192|Concept elicitation|concept elicitation
760080|NCT03221192|Nasal polyps|nasal polyps
760081|NCT03221192|Cognitive debriefing|cognitive debriefing
760082|NCT03221192|Patient-reported outcomes|patient-reported outcomes
760083|NCT03221192|HRQoL|hrqol
760084|NCT03206060|Hypertension|hypertension
760085|NCT03206060|Catecholamine|catecholamine
760086|NCT03206060|Familial Syndromes|familial syndromes
760087|NCT03206060|Somatostatin|somatostatin
760088|NCT03206125|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
760089|NCT03206125|Case-Control Study|case-control study
760090|NCT03206125|Risk Factors|risk factors
760091|NCT03206125|Epidemiology|epidemiology
760092|NCT03206086|DNA Repair|dna repair
760093|NCT03206086|Bone Marrow|bone marrow
760094|NCT03206086|Hematopoiesis|hematopoiesis
760095|NCT03206086|Pancytopenia|pancytopenia
760096|NCT03206086|Thrombocytopenia|thrombocytopenia
760097|NCT03206112|Focal Dystonia|focal dystonia
760098|NCT03206112|Healthy Volunteers|healthy volunteers
760099|NCT03206112|Paired Associative Stimulation (PAS)|paired associative stimulation (pas)
760100|NCT03270813|Child|child
760101|NCT03270813|Adolescent|adolescent
760102|NCT03204188|BTK Inhibitor|btk inhibitor
760103|NCT03204188|Checkpoint Inhibitor|checkpoint inhibitor
760104|NCT03197025|HPV-16|hpv-16
760105|NCT03197025|premalignancy|premalignancy
760106|NCT03197025|T Cell Therapy|t cell therapy
760107|NCT03199170|Caesarean Section|caesarean section
760108|NCT03199170|Spinal anesthesia|spinal anesthesia
760109|NCT03199170|Quadratus lumborum block|quadratus lumborum block
760110|NCT03199170|Postoperative pain|postoperative pain
760111|NCT03199170|Intrathecal morphine|intrathecal morphine
760112|NCT03190967|Ado-trastuzumab Emtansine|ado-trastuzumab emtansine
760113|NCT03190967|Systemic Control of Disease|systemic control of disease
760114|NCT03190967|Maximum Tolerated Dose|maximum tolerated dose
760115|NCT03190967|Preventing the Formation of a Metastasis|preventing the formation of a metastasis
760116|NCT03190941|KRAS|kras
760117|NCT03190941|HRAS|hras
760118|NCT03190941|NRAS|nras
760119|NCT03190941|Cell Therapy|cell therapy
760120|NCT03190941|Immunotherapy|immunotherapy
760121|NCT03189121|Metabolism|metabolism
760122|NCT03189121|Macronutrients|macronutrients
760123|NCT03189121|Obesity|obesity
760124|NCT03189121|Energy Expenditure|energy expenditure
760125|NCT03189121|Glucose|glucose
760126|NCT03188406|Intestinal Metaplasia|intestinal metaplasia
760127|NCT03188406|Epidemiology|epidemiology
760128|NCT03188406|Risk Stratification|risk stratification
760129|NCT03188406|Helicobacter Pylori|helicobacter pylori
760130|NCT03188419|Prospective Donors|prospective donors
760131|NCT03188419|Immunodeficiency|immunodeficiency
760132|NCT03267537|Insomnia|insomnia
760133|NCT03267537|Sleep|sleep
760134|NCT03267537|Telemedicine|telemedicine
760135|NCT03186781|Flu Virus|flu virus
760136|NCT03186781|Flu Shot|flu shot
760137|NCT03186781|H2N2|h2n2
760138|NCT03186781|Protein|protein
760139|NCT03186781|Immune Response|immune response
760140|NCT03186794|Fatigue|fatigue
760141|NCT03184987|fluticasone furoate|fluticasone furoate
760142|NCT03184987|fixed dose combination|fixed dose combination
760143|NCT03184987|Japanese subjects|japanese subjects
760144|NCT03184987|vilanterol|vilanterol
760145|NCT03184987|asthma|asthma
760146|NCT03184987|umeclidinium bromide|umeclidinium bromide
760147|NCT03184987|closed triple therapy|closed triple therapy
760148|NCT03180034|Human Papillomavirus|human papillomavirus
760149|NCT03180034|Cervical Cancer|cervical cancer
760150|NCT03180034|Costa Rica|costa rica
760151|NCT03180034|Fewer Doses|fewer doses
760152|NCT03173963|Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor|sodium glucose co-transporter 2 (sglt2) inhibitor
760153|NCT03173963|Kidney Biopsy|kidney biopsy
760154|NCT03173963|Morphometry|morphometry
760155|NCT03173963|American Indians|american indians
760156|NCT03173963|Glomerular Filtration Rate|glomerular filtration rate
760157|NCT03170258|real-time fMRI|real-time fmri
760158|NCT03170258|reward|reward
760159|NCT03170258|motivation|motivation
760160|NCT03170258|dopamine|dopamine
760161|NCT03167450|CRISPR|crispr
760162|NCT03167450|Gene Editing|gene editing
760163|NCT03167450|Qualitative|qualitative
760164|NCT03167450|Participation Clinical Trials|participation clinical trials
760165|NCT03167450|Genetic Literacy|genetic literacy
760166|NCT03167437|Reduce Symptoms of Crohn's Disease|reduce symptoms of crohn's disease
760167|NCT03167437|HDAC Inhibitors|hdac inhibitors
760168|NCT03186300|bolus advisor|bolus advisor
760169|NCT03151811|Refractory Multiple Myeloma|refractory multiple myeloma
760170|NCT03151811|Relapsed Multiple Myeloma|relapsed multiple myeloma
760171|NCT03151811|Melflufen|melflufen
760172|NCT03151811|Pomalidomide|pomalidomide
760173|NCT03151811|Dexamethasone|dexamethasone
760174|NCT03196765|X-ALD|x-ald
760175|NCT03270046|Bowel preparation|bowel preparation
760176|NCT03270046|CRC screening|crc screening
760177|NCT03144518|Positive Affect|positive affect
760178|NCT03144518|Positive Mood|positive mood
760179|NCT03144518|Influenza Vaccination|influenza vaccination
760180|NCT03144518|Vaccination|vaccination
760181|NCT03144518|Randomised Controlled Trial|randomised controlled trial
760182|NCT03145272|Pharmacogenomics|pharmacogenomics
760183|NCT03145272|Pharmacokinetics|pharmacokinetics
760184|NCT03145272|Oxycodone|oxycodone
760185|NCT03126019|Follicular lymphoma|follicular lymphoma
760186|NCT03126019|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
760187|NCT03126019|phosphatidylinositol 3-kinase (PI3K) δ inhibitor|phosphatidylinositol 3-kinase (pi3k) δ inhibitor
760188|NCT03124459|CMT1 / CMTX|cmt1 / cmtx
760189|NCT03111745|Reactivation or Proliferation of Latent Viral Infections.|reactivation or proliferation of latent viral infections.
760190|NCT03111745|VIRAL INFECTION|viral infection
760191|NCT03111745|Lymphoproliferation|lymphoproliferation
760192|NCT03115359|Chronic Low Back Pain|chronic low back pain
760193|NCT03115359|Opioid Therapy|opioid therapy
760194|NCT03115359|Chronic Pain|chronic pain
760195|NCT03115359|Mindfulness Meditation|mindfulness meditation
760196|NCT03115359|Cognitive Behavioral Therapy|cognitive behavioral therapy
760197|NCT03115359|Opioid-treated Chronic Low Back Pain|opioid-treated chronic low back pain
760198|NCT03115359|CLBP|clbp
760199|NCT03109301|Mesenchymal Neoplasm|mesenchymal neoplasm
760200|NCT03109301|Neurofibromatosis 1|neurofibromatosis 1
760201|NCT03109301|Plexiform Neurofibromas|plexiform neurofibromas
760202|NCT03117595|Single Shot Spinal|single shot spinal
760203|NCT03117595|Intrathecal narcotics|intrathecal narcotics
760204|NCT03117595|Morphine|morphine
760205|NCT03117595|Fentanyl|fentanyl
760206|NCT03117595|Labour Analgesia|labour analgesia
760207|NCT03105492|Prenatal Testing|prenatal testing
760208|NCT03105492|Whole Genome Sequencing|whole genome sequencing
760209|NCT03104725|5-S-Cysteinyldopamine|5-s-cysteinyldopamine
760210|NCT03104725|Cerebrospinal Fluid|cerebrospinal fluid
760211|NCT03104725|PARKINSONS DISEASE|parkinsons disease
760212|NCT03104725|MONOAMINE OXIDASE INHIBITOR|monoamine oxidase inhibitor
760213|NCT03098862|Ebola Virus|ebola virus
760214|NCT03098862|Genome-Wide Association Study|genome-wide association study
760215|NCT03098862|Liberia|liberia
760216|NCT03098862|Ebola Survivors|ebola survivors
760217|NCT03098862|Ebola Contacts|ebola contacts
760218|NCT03103919|Parkinson´s Disease|parkinson´s disease
760219|NCT03103919|Kinesia-360™|kinesia-360™
760220|NCT03103919|Kinesia-ONE™|kinesia-one™
760221|NCT03103919|Biosensor|biosensor
760222|NCT03099304|Vitiligo|vitiligo
760223|NCT03099304|depigmenting disorder|depigmenting disorder
760224|NCT03099304|topical JAK inhibitor|topical jak inhibitor
760225|NCT03110224|Subchondroplasty|subchondroplasty
760226|NCT03110224|Bone Marrow Lesion|bone marrow lesion
760227|NCT03110224|Arthroscopy|arthroscopy
760228|NCT03110224|Bone Substitute Material|bone substitute material
760229|NCT03110224|AccuFill|accufill
760230|NCT03110224|Subchondral Bone Defect|subchondral bone defect
760231|NCT03112200|Subchondroplasty|subchondroplasty
760232|NCT03112200|Arthroscopy|arthroscopy
760233|NCT03112200|Bone Substitute Material|bone substitute material
760234|NCT03112200|Subchondral Bone Defect|subchondral bone defect
760235|NCT03112200|AccuFill|accufill
760236|NCT03112200|Bone Marrow Lesion|bone marrow lesion
760237|NCT03104348|COPD|copd
760238|NCT03104348|Primary care|primary care
760239|NCT03092687|Mental Illness|mental illness
760240|NCT03092687|Aging|aging
760241|NCT03092687|Normal Development|normal development
760242|NCT03092492|Age Related Macular Degeneration|age related macular degeneration
760243|NCT03092492|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
760244|NCT03092492|Reticular Pseudodrusen|reticular pseudodrusen
760245|NCT03092505|Herpes|herpes
760246|NCT03092505|Uganda|uganda
760247|NCT03092505|HSV|hsv
760248|NCT03092505|Sample|sample
760249|NCT03085797|SB240563|sb240563
760250|NCT03085797|Nasal Polyps|nasal polyps
760251|NCT03085797|Mepolizumab|mepolizumab
760252|NCT03085797|Phase 3|phase 3
760253|NCT03085797|Parallel group|parallel group
760254|NCT03085797|Efficacy|efficacy
760255|NCT03103490|PET/MR|pet/mr
760256|NCT03076567|Epidemiology|epidemiology
760257|NCT03076567|Cancer|cancer
760258|NCT03076567|Methylation|methylation
760259|NCT03076567|Genetics|genetics
760260|NCT03076567|Screening|screening
760261|NCT03077555|quick starting contraception|quick starting contraception
760262|NCT03068546|Oral Microbiota|oral microbiota
760263|NCT03061097|Autologous Fecal Microbiota Transplantation|autologous fecal microbiota transplantation
760264|NCT03056755|advanced breast cancer|advanced breast cancer
760265|NCT03056755|PIK3CA|pik3ca
760266|NCT03056755|CDK 4/6 inhibitor|cdk 4/6 inhibitor
760267|NCT03056755|fulvestrant|fulvestrant
760268|NCT03056755|letrozole|letrozole
760269|NCT03056755|HR+|hr+
760270|NCT03056755|HER-negative|her-negative
760271|NCT03056755|post menopausal|post menopausal
760272|NCT03070392|Melanoma|melanoma
760273|NCT03070392|Uveal Cancer|uveal cancer
760274|NCT03070392|IMCgp100|imcgp100
760275|NCT03070392|Immunotherapy|immunotherapy
760276|NCT03052751|UCB7665|ucb7665
760277|NCT03052751|Myasthenia Gravis|myasthenia gravis
760278|NCT03066570|Graded Exposure|graded exposure
760279|NCT03066570|Quality of Life|quality of life
760280|NCT03066570|Physical Activity|physical activity
760281|NCT03066570|Anxiety|anxiety
760282|NCT03046446|Osteoarthritis|osteoarthritis
760283|NCT03046446|Knee|knee
760284|NCT03046446|Pain|pain
760285|NCT03046446|Steroid|steroid
760286|NCT03046446|Intra-articular|intra-articular
760287|NCT03046446|Injection|injection
760288|NCT03070782|IONIS-APO(a)-LRx|ionis-apo(a)-lrx
760289|NCT03070782|AKCEA-APO(a)-LRx|akcea-apo(a)-lrx
760290|NCT03070782|Dyslipidemia|dyslipidemia
760291|NCT03070782|Dyslipoproteinemia|dyslipoproteinemia
760292|NCT03070782|Hyperlipidemia|hyperlipidemia
760293|NCT03070782|Hyperlipoproteinemia|hyperlipoproteinemia
760294|NCT03070782|Hyperlipoproteinemia(a)|hyperlipoproteinemia(a)
760295|NCT03070782|Hyperlipoproteinemia a|hyperlipoproteinemia a
760296|NCT03070782|Lipoprotein|lipoprotein
760297|NCT03070782|Lipoprotein(a)|lipoprotein(a)
760298|NCT03070782|Lipoprotein a|lipoprotein a
760299|NCT03070782|Lp(a)|lp(a)
760300|NCT03070782|Lp a|lp a
760301|NCT03039114|Follicular lymphoma|follicular lymphoma
760302|NCT03039114|relapsed|relapsed
760303|NCT03039114|refractory|refractory
760304|NCT03039114|non-Hodgkin lymphoma|non-hodgkin lymphoma
760305|NCT03039114|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
760306|NCT03041181|Nivolumab|nivolumab
760307|NCT03041181|BMS-936558-01|bms-936558-01
760308|NCT03041181|Anti-PD-1 Antibody|anti-pd-1 antibody
760309|NCT03041181|Docetaxel|docetaxel
760310|NCT03039101|allergen|allergen
760311|NCT03039101|neutrophils|neutrophils
760312|NCT03039101|allergy|allergy
760313|NCT03034915|Vilanterol|vilanterol
760314|NCT03034915|COPD|copd
760315|NCT03034915|HRQoL|hrqol
760316|NCT03034915|Salmeterol|salmeterol
760317|NCT03034915|Umeclidinium|umeclidinium
402889|NCT01229280|Postprandial|postprandial
760318|NCT03034811|Noninflammatory degenerative joint disease|noninflammatory degenerative joint disease
760319|NCT03034811|Osteoarthritis|osteoarthritis
760320|NCT03034811|Avascular necrosis|avascular necrosis
760321|NCT03034811|Traumatic arthritis|traumatic arthritis
760322|NCT03034811|Partial knee arthroplasty|partial knee arthroplasty
760323|NCT03034811|Unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
760324|NCT03034967|HCRU exacerbations|hcru exacerbations
760325|NCT03034967|SGRQ|sgrq
760326|NCT03034967|CXCR2 antagonist|cxcr2 antagonist
760327|NCT03034967|GSK1325756|gsk1325756
760328|NCT03034967|Danirixin|danirixin
760329|NCT03034967|COPD|copd
760330|NCT03085888|Cancer Screening|cancer screening
760331|NCT03085888|Next Generation Sequencing|next generation sequencing
760332|NCT03085888|Circulating cell-free nucleic acid|circulating cell-free nucleic acid
760333|NCT03085888|Circulating cell-free tumor DNA|circulating cell-free tumor dna
760334|NCT03085888|Deep sequencing|deep sequencing
760335|NCT03012061|Respiratory|respiratory
760336|NCT03012061|Efficacy|efficacy
760337|NCT03012061|Umeclidinium bromide|umeclidinium bromide
760338|NCT03012061|Parallel|parallel
760339|NCT03012061|Asthma|asthma
760340|NCT03012061|Dry powder inhaler|dry powder inhaler
760341|NCT03010527|Chronic plaque psoriasis|chronic plaque psoriasis
760342|NCT03010527|Psoriasis|psoriasis
760343|NCT03010527|Bimekizumab|bimekizumab
760344|NCT03002012|cryptococcal antigen|cryptococcal antigen
760345|NCT03002012|preemptive treatment|preemptive treatment
760346|NCT03002012|CRAG+|crag+
760347|NCT03002012|sertraline|sertraline
760348|NCT03002012|fluconazole|fluconazole
760349|NCT03002012|randomized clinical trial|randomized clinical trial
760350|NCT03002012|HIV|hiv
760351|NCT02991456|malignant glioma|malignant glioma
760352|NCT02991456|temozolomide|temozolomide
760353|NCT02991456|temodar|temodar
760354|NCT02991456|radiation|radiation
760355|NCT02991456|emesis|emesis
760356|NCT02991456|nausea|nausea
760357|NCT02991456|vomiting|vomiting
760358|NCT02991456|chemotherapy|chemotherapy
760359|NCT02991456|Affronti|affronti
760360|NCT02991456|Peters|peters
760361|NCT02991456|00076418|00076418
760362|NCT03051451|Hydrochloride of Metformin / Fluoxetine|hydrochloride of metformin / fluoxetine
760363|NCT03051451|Placebo|placebo
760364|NCT03051451|Obesity|obesity
760365|NCT02979574|acupuncture|acupuncture
760366|NCT02979574|pain|pain
760367|NCT02979574|chronic pain|chronic pain
760368|NCT02979574|pain management|pain management
760369|NCT02979574|16-1579|16-1579
760685|NCT02581878|Thorium-227|thorium-227
760370|NCT02974322|Crohn's Disease|crohn's disease
760371|NCT02974322|GED-0301|ged-0301
760372|NCT02974322|Mongersen|mongersen
760373|NCT02974322|Adolescent|adolescent
760374|NCT02974322|Pediatric|pediatric
760375|NCT02974322|Children|children
760376|NCT03145051|saline solution|saline solution
760377|NCT03145051|minerals|minerals
760378|NCT03145051|cystic fibrosis|cystic fibrosis
760379|NCT03145051|chronic rhinosinusitis|chronic rhinosinusitis
760380|NCT03145051|nasal irrigation|nasal irrigation
760381|NCT02965599|pharmacodynamics|pharmacodynamics
760382|NCT02965599|tolerability|tolerability
760383|NCT02965599|GSK3117391|gsk3117391
760384|NCT02965599|safety|safety
760385|NCT02965599|efficacy|efficacy
760386|NCT02965599|rheumatoid arthritis|rheumatoid arthritis
760387|NCT02965599|pharmacokinetics|pharmacokinetics
760388|NCT02964507|GSK525762|gsk525762
760389|NCT02964507|ER+ breast cancer|er+ breast cancer
760390|NCT02964507|mTPI|mtpi
760391|NCT02969525|Psoriatic Arthritis|psoriatic arthritis
760392|NCT02969525|PsA|psa
760393|NCT02969525|Bimekizumab|bimekizumab
760394|NCT02963909|Adjuvant|adjuvant
760395|NCT02963909|Alum|alum
760396|NCT02963909|Inactivated|inactivated
760397|NCT02963909|Purified|purified
760398|NCT02963909|Vaccine|vaccine
760399|NCT02963909|Virus|virus
760400|NCT02963909|Zika|zika
760401|NCT02963506|AS|as
760402|NCT02963506|Ankylosing Spondylitis|ankylosing spondylitis
760403|NCT02963506|Bimekizumab|bimekizumab
760404|NCT02959086|Epidemiology|epidemiology
760405|NCT02959086|Shanghai|shanghai
760406|NCT02959086|Cancer|cancer
760407|NCT02959086|Adolescents|adolescents
760408|NCT02959086|Children|children
760409|NCT02999100|oxytocin|oxytocin
760410|NCT02999100|non-pregnant|non-pregnant
760411|NCT02999100|pregnant|pregnant
760412|NCT02999100|Postpartum Hemorrhage|postpartum hemorrhage
760413|NCT02948244|fshd|fshd
760414|NCT02948244|creatine monohydrate|creatine monohydrate
760415|NCT02948244|children|children
760416|NCT02948244|pediatrics|pediatrics
760417|NCT02948244|Facio-Scapulo-Humeral Dystrophy|facio-scapulo-humeral dystrophy
760418|NCT02958527|Effexor|effexor
760419|NCT02958527|Depression|depression
760420|NCT02958527|Depressed state|depressed state
760421|NCT02936037|progressive multiple sclerosis|progressive multiple sclerosis
760422|NCT02936037|MS|ms
760423|NCT02936037|EDSS|edss
760424|NCT02936037|TW25|tw25
395326|NCT01262885|safety|safety
760425|NCT02936037|multiple sclerosis|multiple sclerosis
760426|NCT02927873|Safety|safety
760427|NCT02927873|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
760428|NCT02927873|Immunogenicity|immunogenicity
760429|NCT02927873|Reactogenicity|reactogenicity
760430|NCT02927873|Infants|infants
760431|NCT02927873|Vaccine|vaccine
760432|NCT02923726|Antitachycardia Pacing Therapy|antitachycardia pacing therapy
760433|NCT02923726|Shock Therapy|shock therapy
760434|NCT02923726|Primary Prevention|primary prevention
760435|NCT02923167|CP|cp
760436|NCT02923167|Cerebral Palsy|cerebral palsy
760437|NCT02923167|Robotic|robotic
760438|NCT02923167|Hand|hand
760439|NCT02907619|Duchenne muscular dystrophy, myostatin, open-label|duchenne muscular dystrophy, myostatin, open-label
760440|NCT02905006|Psoriasis|psoriasis
760441|NCT02905006|Chronic Plaque Psoriasis|chronic plaque psoriasis
760442|NCT02905006|Bimekizumab|bimekizumab
760443|NCT02924688|umeclidinium bromide|umeclidinium bromide
760444|NCT02924688|fluticasone furoate|fluticasone furoate
760445|NCT02924688|vilanterol|vilanterol
760446|NCT02924688|fixed dose combination|fixed dose combination
760447|NCT02924688|lung function|lung function
760448|NCT02924688|albuterol/salbutamol|albuterol/salbutamol
760449|NCT02924688|asthma|asthma
760450|NCT02924688|closed triple therapy|closed triple therapy
760451|NCT02891382|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
760452|NCT02891382|Weight Loss|weight loss
760453|NCT02891382|Financial Incentives|financial incentives
760454|NCT02891382|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
760455|NCT02877784|screening|screening
760456|NCT02877784|OPMD|opmd
760457|NCT02877784|dysphagia|dysphagia
760458|NCT02877784|dysarthria|dysarthria
760459|NCT02865187|Vitamin D|vitamin d
760460|NCT02865187|polycystic ovary syndrome|polycystic ovary syndrome
760461|NCT02865187|polycystic ovarian syndrome|polycystic ovarian syndrome
760462|NCT02865187|PCOS|pcos
760463|NCT02865187|sexual dysfunction|sexual dysfunction
760464|NCT02865187|female sexual dysfunction|female sexual dysfunction
760465|NCT02865187|low libido|low libido
760466|NCT02883413|Adolescents|adolescents
760467|NCT02883413|Cognitive Flexibility|cognitive flexibility
760468|NCT02883413|Behavioral Flexibility|behavioral flexibility
760469|NCT02847650|Early Parkinson Disease|early parkinson disease
760470|NCT02847650|Phase 2|phase 2
760471|NCT02844517|Artificial Pancreas|artificial pancreas
760472|NCT02844517|Closed Loop Control|closed loop control
760473|NCT02844517|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
760474|NCT02836496|Safety|safety
760475|NCT02836496|Mepolizumab|mepolizumab
760476|NCT02836496|Hypereosinophilic syndrome|hypereosinophilic syndrome
760477|NCT02836496|HES flare|hes flare
760478|NCT02836496|Efficacy|efficacy
760479|NCT02842671|autism|autism
760480|NCT02842671|ambassador|ambassador
760481|NCT02833610|Multiple Myeloma|multiple myeloma
760482|NCT02831673|safety|safety
760483|NCT02831673|treatment naïve|treatment naïve
760484|NCT02831673|HIV 1|hiv 1
760485|NCT02831673|dolutegravir plus lamivudine|dolutegravir plus lamivudine
760486|NCT02831673|non inferiority|non inferiority
760487|NCT02831673|tolerability|tolerability
760488|NCT02831673|dolutegravir plus tenofovir/emtricitabine|dolutegravir plus tenofovir/emtricitabine
760489|NCT02831673|efficacy|efficacy
760490|NCT02826473|Dementia|dementia
760491|NCT02826473|Dementia screening|dementia screening
760492|NCT02826473|General Hospital|general hospital
760493|NCT02826473|Inpatients|inpatients
760494|NCT02825589|BIA|bia
760495|NCT02825589|chronic hemodialysis|chronic hemodialysis
760496|NCT02825589|sleep quality|sleep quality
760497|NCT02844504|Fatigue|fatigue
760498|NCT02844504|Breast cancer|breast cancer
760499|NCT02844504|Force|force
760500|NCT02844504|Motor imagery|motor imagery
760501|NCT02844504|Cancer Treatment|cancer treatment
760502|NCT02810990|bosutinib|bosutinib
760503|NCT02810990|chronic myeloid leukemia|chronic myeloid leukemia
760504|NCT02813798|Renal Insufficiency|renal insufficiency
760505|NCT03097562|Cataract|cataract
760506|NCT03097562|Femtosecond laser|femtosecond laser
760507|NCT03097562|Cornea|cornea
760508|NCT03097562|Anatomy|anatomy
760509|NCT03097562|FSL|fsl
760510|NCT03097562|surgery|surgery
760511|NCT02798211|PsA, ACR, CASPAR|psa, acr, caspar
760512|NCT02795988|Secondary|secondary
760513|NCT02790632|Aneurysm, Ruptured|aneurysm, ruptured
760514|NCT02790632|Nimodipine|nimodipine
760515|NCT02790632|Subarachnoid Hemorrhage|subarachnoid hemorrhage
760516|NCT02756247|Buparlisib|buparlisib
760517|NCT02756247|BKM120|bkm120
760518|NCT02756247|Ibrutinib|ibrutinib
760519|NCT02756247|16-009|16-009
760520|NCT02757937|Medication Adherence|medication adherence
760521|NCT02757937|Self-efficacy|self-efficacy
760522|NCT02757937|Behavior|behavior
760523|NCT02757937|Diabetes|diabetes
760524|NCT02757937|Diabetes Mellitus|diabetes mellitus
760525|NCT02755597|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
760526|NCT02755597|refractory multiple myeloma|refractory multiple myeloma
760527|NCT02755597|multiple myeloma|multiple myeloma
760528|NCT02755597|relapsed multiple myeloma|relapsed multiple myeloma
760529|NCT02750995|myelodysplastic syndrome|myelodysplastic syndrome
760530|NCT02750995|acute myeloid leukemia|acute myeloid leukemia
760531|NCT02750995|azacitidine|azacitidine
760532|NCT02750995|peptide vaccine|peptide vaccine
760533|NCT02750995|cancer testis antigen|cancer testis antigen
760534|NCT02750995|cancer vaccine|cancer vaccine
760535|NCT02750995|immunotherapy|immunotherapy
760536|NCT02750995|combination therapy|combination therapy
760537|NCT02750995|NY-ESO-1|ny-eso-1
760538|NCT02750995|PRAME|prame
760539|NCT02750995|MAGE-A3|mage-a3
760540|NCT02750995|WT-1|wt-1
760541|NCT02750995|vaccine|vaccine
760542|NCT02748369|TCA cycle flux|tca cycle flux
760543|NCT02748369|in vivo measurements|in vivo measurements
760544|NCT02748369|Stable isotopes|stable isotopes
760545|NCT02748369|Arteriovenous balance|arteriovenous balance
760546|NCT02748369|Metabolome|metabolome
760547|NCT02748369|Proteome|proteome
760548|NCT02748369|Exosomes|exosomes
394053|NCT01268540|intraocular lens|intraocular lens
394054|NCT01268540|IOL|iol
394055|NCT01268540|cataract|cataract
760549|NCT02726958|aortic valve replacement|aortic valve replacement
760550|NCT02726958|percutaneous valve|percutaneous valve
760551|NCT02726958|blood glucose variability|blood glucose variability
760552|NCT02726958|TAVI|tavi
760553|NCT03270319|Measurement of cardiac output|measurement of cardiac output
760554|NCT03270995|breast cancer|breast cancer
760555|NCT03270995|gynecological cancer|gynecological cancer
760556|NCT03270995|fear of cancer recurrence|fear of cancer recurrence
760557|NCT03270995|clinical trial|clinical trial
760558|NCT03270995|randomized controlled trial|randomized controlled trial
760559|NCT03270995|group therapy|group therapy
760560|NCT03270995|intervention|intervention
760561|NCT03270995|cognitive-existential|cognitive-existential
760562|NCT02757339|neurobiology|neurobiology
760563|NCT02757339|PTSD|ptsd
760564|NCT02757339|DID|did
760565|NCT02794792|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
760566|NCT02794792|ASP1941|asp1941
760567|NCT02794792|Ipragliflozin|ipragliflozin
760568|NCT02718716|ITP|itp
760569|NCT02705313|neuroendocrine tumors|neuroendocrine tumors
760570|NCT02705313|177Lu-DOTA0-Tyr3-Octreotate|177lu-dota0-tyr3-octreotate
760571|NCT02705313|PRRT|prrt
760572|NCT02691260|obesity|obesity
760573|NCT02691260|behavioral intervention|behavioral intervention
760574|NCT02691260|diet|diet
760575|NCT02685683|Crohn's Disease|crohn's disease
760576|NCT02685683|GED-0301|ged-0301
760577|NCT02685683|Open-label|open-label
760578|NCT02685683|Pharmacodynamic|pharmacodynamic
760580|NCT02697773|osteoarthritis of the knee|osteoarthritis of the knee
760581|NCT02697773|osteoarthritis of the hip|osteoarthritis of the hip
760582|NCT02697773|nerve growth factor inhibitor|nerve growth factor inhibitor
760583|NCT02697773|tanezumab|tanezumab
760584|NCT02680574|vadadustat|vadadustat
760585|NCT02680574|AKB-6548|akb-6548
760586|NCT02680574|Chronic kidney disease|chronic kidney disease
760587|NCT02680574|anemia|anemia
760588|NCT02680574|CKD|ckd
760589|NCT02680574|chronic renal insufficiency|chronic renal insufficiency
760590|NCT02680574|renal impairment|renal impairment
760591|NCT02680574|erythropoietin|erythropoietin
760592|NCT02680574|kidney|kidney
760593|NCT02680574|renal|renal
760594|NCT02680574|oral anemia treatment|oral anemia treatment
760595|NCT02680574|hemoglobin|hemoglobin
760596|NCT02680574|hypoxia-inducible factor|hypoxia-inducible factor
760597|NCT02680574|HIF|hif
760598|NCT02680574|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
760599|NCT02680574|HIF-PHI|hif-phi
760600|NCT02680574|efficacy|efficacy
760601|NCT02680574|safety|safety
760602|NCT02680574|Phase 3|phase 3
760603|NCT02680574|cardiovascular|cardiovascular
760604|NCT02680574|NDD-CKD|ndd-ckd
760605|NCT02689934|hypercholesterolemia|hypercholesterolemia
760606|NCT02689934|bifidobacterium longum BB536|bifidobacterium longum bb536
760607|NCT02689934|red yeast rice|red yeast rice
760608|NCT02689934|monacolin K|monacolin k
760609|NCT02689934|lactoflorene colesterolo|lactoflorene colesterolo
760610|NCT02687542|Parkinson Disease|parkinson disease
760611|NCT02687542|Motor Fluctuation|motor fluctuation
760612|NCT02683785|Pain intensity|pain intensity
760613|NCT02683785|Hand Osteoarthritis|hand osteoarthritis
760614|NCT02683785|GSK3196165|gsk3196165
760615|NCT02683785|AUSCAN|auscan
760616|NCT02683785|GM-CSF|gm-csf
760617|NCT02683785|Numerical Rating Scale|numerical rating scale
760618|NCT02663700|Burkina Faso|burkina faso
760619|NCT02663700|healthy adults|healthy adults
760620|NCT02663700|Irradiated|irradiated
760621|NCT02663700|malaria|malaria
760622|NCT02663700|PfSPZ Vaccine|pfspz vaccine
760623|NCT02663700|Sanaria|sanaria
760624|NCT02663700|Sporozoite|sporozoite
760625|NCT02663700|Vaccine|vaccine
760626|NCT02659163|cardiometabolic risk|cardiometabolic risk
760627|NCT02659163|obesity|obesity
760628|NCT02659163|mHealth|mhealth
760629|NCT02659163|health behaviors|health behaviors
760630|NCT02648347|vadadustat|vadadustat
760631|NCT02648347|AKB-6548|akb-6548
760632|NCT02648347|Chronic kidney disease|chronic kidney disease
760633|NCT02648347|anemia|anemia
760634|NCT02648347|CKD|ckd
760635|NCT02648347|chronic renal insufficiency|chronic renal insufficiency
760636|NCT02648347|renal impairment|renal impairment
760637|NCT02648347|erythropoietin|erythropoietin
760638|NCT02648347|kidney|kidney
760639|NCT02648347|renal|renal
760640|NCT02648347|oral anemia treatment|oral anemia treatment
760641|NCT02648347|hemoglobin|hemoglobin
760642|NCT02648347|hypoxia-inducible factor|hypoxia-inducible factor
760643|NCT02648347|HIF|hif
760644|NCT02648347|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
760645|NCT02648347|HIF-PHI|hif-phi
760646|NCT02648347|efficacy|efficacy
760647|NCT02648347|safety|safety
760648|NCT02648347|Phase 3|phase 3
760649|NCT02648347|cardiovascular|cardiovascular
760650|NCT02648347|NDD-CKD|ndd-ckd
760651|NCT02641392|Crohn's Disease|crohn's disease
760652|NCT02641392|GED 0301|ged 0301
760653|NCT02641392|Mongersen|mongersen
760654|NCT02641392|Safety|safety
760655|NCT02641392|IBD|ibd
760656|NCT02635269|Ergometry|ergometry
760657|NCT02635269|Stable isotope tracers|stable isotope tracers
760658|NCT02663245|Type 2 diabetes mellitus|type 2 diabetes mellitus
760659|NCT02663245|glycemic control|glycemic control
760660|NCT02625090|Drug-resistance|drug-resistance
760661|NCT02625090|focal epilepsy|focal epilepsy
760662|NCT02625090|partial-onset seizures|partial-onset seizures
760663|NCT02716311|EGFR|egfr
760664|NCT02716311|Lung Cancer|lung cancer
760665|NCT02639091|Phase 1|phase 1
760666|NCT02639091|Solid tumors|solid tumors
760667|NCT02639091|Mesothelioma|mesothelioma
760668|NCT02639091|Lung cancer|lung cancer
760669|NCT02639091|Pemetrexed|pemetrexed
760670|NCT02639091|Cisplatin|cisplatin
760671|NCT02605122|pneumonia|pneumonia
760672|NCT02605122|macrolide|macrolide
760673|NCT02605122|pediatric|pediatric
760674|NCT02597036|Advanced, Angiopoietin|advanced, angiopoietin
760675|NCT02593994|Onyx|onyx
760676|NCT02593994|drug eluting stent|drug eluting stent
760677|NCT02593994|Routine Clinical Practice|routine clinical practice
760678|NCT02593994|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
760679|NCT02593994|Coronary Artery Disease|coronary artery disease
760680|NCT02592564|Magnetic Resonance Imaging|magnetic resonance imaging
760681|NCT02592564|Cognitive Behavior Therapy|cognitive behavior therapy
760682|NCT02592564|Telomerase|telomerase
760683|NCT02592564|Telomere Length, Mean Leukocyte|telomere length, mean leukocyte
760684|NCT02585687|Liver Perfusion MRI, Hepatocellular carcinoma|liver perfusion mri, hepatocellular carcinoma
760686|NCT02581878|BAY1862864 Injection|bay1862864 injection
760687|NCT02581878|Safety|safety
760688|NCT02581878|Pharmacokinetics|pharmacokinetics
760689|NCT02581878|CD22|cd22
760690|NCT02581878|Radioimmunotherapy|radioimmunotherapy
760691|NCT02578875|Sequence Technique|sequence technique
760692|NCT02578875|Infectious Disease|infectious disease
760693|NCT02578875|Pathogen Detection|pathogen detection
760694|NCT02578875|Diagnostic|diagnostic
760695|NCT02566369|Efficacy|efficacy
760696|NCT02566369|Safety|safety
760697|NCT02566369|Acne vulgaris|acne vulgaris
760698|NCT02559284|Saline Solution, Isotonic / Administration & dosage|saline solution, isotonic / administration & dosage
760699|NCT02559284|Therapeutic Irrigation / methods|therapeutic irrigation / methods
760700|NCT02559284|Postoperative Care / methods|postoperative care / methods
760701|NCT02559284|Quality of life|quality of life
760702|NCT02586987|Selumetinib|selumetinib
760703|NCT02586987|Tremelimumab|tremelimumab
760704|NCT02586987|MEDI4736|medi4736
760705|NCT02586987|Safety|safety
760706|NCT02586987|Tolerability|tolerability
760707|NCT02586987|Pharmacokinetics|pharmacokinetics
760708|NCT02586987|Patients with advanced solid tumours|patients with advanced solid tumours
760709|NCT02586987|Disease progression|disease progression
760710|NCT02556788|Efficacy|efficacy
760711|NCT02556788|Safety|safety
760712|NCT02556788|Acne vulgaris|acne vulgaris
760713|NCT02555371|Severe eosinophilic asthma|severe eosinophilic asthma
760714|NCT02555371|mepolizumab|mepolizumab
760715|NCT02555371|asthma exacerbation|asthma exacerbation
760716|NCT02502838|overactive bladder|overactive bladder
760717|NCT02502838|pelvic organ prolapse|pelvic organ prolapse
760718|NCT02502838|TVT|tvt
760719|NCT02617446|safety|safety
760720|NCT02617446|efficacy|efficacy
760721|NCT02617446|istaroxime|istaroxime
760722|NCT02545296|In-vitro Diagnostics|in-vitro diagnostics
760723|NCT02545296|paediatrics|paediatrics
760724|NCT02487953|Nicotine addiction|nicotine addiction
760725|NCT02487953|Cigarette smoking|cigarette smoking
760726|NCT02487953|Smoking cessation|smoking cessation
760727|NCT02487953|Nicotine patches|nicotine patches
760728|NCT02487953|E-cigarettes|e-cigarettes
760729|NCT02468648|Oral Therapy|oral therapy
760730|NCT02468648|Liver Biopsy|liver biopsy
760731|NCT02468648|Chronic Hepatitis C|chronic hepatitis c
760732|NCT02467920|exenatide|exenatide
760733|NCT02467920|glargine|glargine
760734|NCT02467920|aspart 30|aspart 30
760735|NCT02458833|Obesity|obesity
760736|NCT02458833|Nutrition|nutrition
760737|NCT02458833|Home Food Preparation|home food preparation
760738|NCT02458833|Home Food Environment|home food environment
760739|NCT02458833|Peer Mentoring|peer mentoring
760740|NCT02458833|Early Head Start|early head start
760741|NCT02458833|Cooking|cooking
760742|NCT02458833|Diet|diet
760743|NCT02449317|contrast induced acute kidney injury|contrast induced acute kidney injury
760744|NCT02449317|bioimpedance|bioimpedance
760745|NCT02481518|Cisplatin nephrotoxicity|cisplatin nephrotoxicity
760746|NCT02481518|Acute kidney injury|acute kidney injury
760747|NCT02477839|epilepsy, children, partial-onset seizures, Lacosamide, LCM, pediatric|epilepsy, children, partial-onset seizures, lacosamide, lcm, pediatric
760748|NCT02810834|Executive Function|executive function
760749|NCT02810834|Academic Performance|academic performance
760750|NCT02441673|Postanaesthetic shivering|postanaesthetic shivering
760751|NCT02441673|Subarachnoid block|subarachnoid block
760752|NCT02441673|Tramadol|tramadol
760753|NCT02441673|Nefopam|nefopam
760754|NCT02439008|liver metastases of colorectal cancer|liver metastases of colorectal cancer
760755|NCT02439008|metastases of melanoma or renal cancer|metastases of melanoma or renal cancer
760756|NCT02416622|XLRS|xlrs
760757|NCT02416622|maculoschisis|maculoschisis
760758|NCT02416622|retinal degeneration|retinal degeneration
760759|NCT02416622|RS1|rs1
760760|NCT02416622|adeno-associated virus|adeno-associated virus
760761|NCT02416622|gene therapy|gene therapy
760762|NCT02416622|AAV|aav
760763|NCT02413788|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
760764|NCT02413788|inflammatory markers|inflammatory markers
760765|NCT02413788|exercise|exercise
760766|NCT02408549|Lacosamide|lacosamide
760767|NCT02408549|Vimpat|vimpat
760768|NCT02408549|Epilepsy|epilepsy
760769|NCT02408549|Children|children
760770|NCT02408549|Primary Generalized Tonic Clonic seizures|primary generalized tonic clonic seizures
760771|NCT02408549|Idiopathic Generalized Epilepsy|idiopathic generalized epilepsy
760772|NCT02408549|Adults|adults
760773|NCT02408523|Lacosamide|lacosamide
760774|NCT02408523|Vimpat|vimpat
760775|NCT02408523|Epilepsy|epilepsy
760776|NCT02408523|Children|children
760777|NCT02408523|Primary Generalized Tonic Clonic seizures|primary generalized tonic clonic seizures
760778|NCT02408523|Idiopathic Generalized Epilepsy|idiopathic generalized epilepsy
760779|NCT02408523|Adults|adults
760780|NCT02388048|Leukemia|leukemia
760781|NCT02388048|Chronic|chronic
760782|NCT02388048|High-risk|high-risk
760783|NCT02388048|ofatumumab|ofatumumab
760784|NCT02388048|ibrutinib|ibrutinib
760785|NCT02388048|Lymphoblastic|lymphoblastic
760786|NCT02385669|vaccine|vaccine
760787|NCT02385669|peptide|peptide
760788|NCT02385669|ipilimumab|ipilimumab
760789|NCT02385669|Yervoy|yervoy
760790|NCT02385669|Montanide ISA-51|montanide isa-51
760791|NCT02382107|TB|tb
760792|NCT02382107|Tuberculosis|tuberculosis
760793|NCT02382107|Diagnostic study|diagnostic study
760794|NCT02392559|Hypercholesterolemia|hypercholesterolemia
760795|NCT02392559|Elevated Cholesterol|elevated cholesterol
760796|NCT02392559|High Cholesterol|high cholesterol
760797|NCT02392559|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
760798|NCT02392559|PCSK9 mutations|pcsk9 mutations
760799|NCT02392559|Paediatric|paediatric
760800|NCT02392559|pediatric|pediatric
760801|NCT02392559|Childhood Familial Hypercholesterolemia|childhood familial hypercholesterolemia
760802|NCT02367196|CC-90002|cc-90002
760803|NCT02367196|Monoclonal|monoclonal
760804|NCT02367196|Antibody|antibody
760805|NCT02367196|CD47|cd47
760806|NCT02367196|Advanced|advanced
760807|NCT02367196|Solid Cancers|solid cancers
760808|NCT02367196|Hematologic Cancers|hematologic cancers
760809|NCT02359994|hemostasis|hemostasis
760810|NCT02348437|Pronator quadratus|pronator quadratus
760811|NCT02348437|Distal radius fracture|distal radius fracture
760812|NCT02348437|Repair|repair
760813|NCT02348437|Volar plating|volar plating
760814|NCT02348437|PRWE|prwe
760815|NCT02343354|behavioural|behavioural
760816|NCT02343354|diabetes prevention|diabetes prevention
760817|NCT02343354|physical activity|physical activity
760818|NCT02343354|healthy eating|healthy eating
760819|NCT02343354|gestational diabetes|gestational diabetes
760820|NCT02337244|Osteoarthritis|osteoarthritis
760821|NCT02337244|Rheumatoid arthritis|rheumatoid arthritis
760822|NCT02337244|Traumatic arthritis|traumatic arthritis
760823|NCT02337244|Polyarthritis|polyarthritis
760824|NCT02337244|Total knee arthroplasty|total knee arthroplasty
760825|NCT02336672|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
760826|NCT02336672|Cryothermoablation|cryothermoablation
760827|NCT02318602|Lennox-Gastaut syndrome|lennox-gastaut syndrome
760828|NCT02318602|Dravet syndrome|dravet syndrome
760829|NCT02318602|Treatment-resistant seizures|treatment-resistant seizures
760830|NCT02318563|Treatment-resistant seizures|treatment-resistant seizures
760831|NCT02318537|Treatment-resistant seizures|treatment-resistant seizures
760832|NCT02311790|cis-C16:1n7 supplement|cis-c16:1n7 supplement
760833|NCT02311790|trans-C16:1n7 supplement|trans-c16:1n7 supplement
760834|NCT02311790|palmitoleic acid supplement|palmitoleic acid supplement
760835|NCT02305186|Immunotherapy|immunotherapy
760836|NCT02305186|Neoadjuvant|neoadjuvant
760837|NCT02305186|Resectable|resectable
760838|NCT02305186|Borderline resectable|borderline resectable
760839|NCT02293707|Castration-resistant prostate cancer|castration-resistant prostate cancer
760840|NCT02293707|Therapeutic vaccine|therapeutic vaccine
760841|NCT02293707|Telomerase vaccine|telomerase vaccine
760842|NCT02289417|Ulcerative Colitis|ulcerative colitis
760843|NCT02289417|Inflammatory Bowel Disease|inflammatory bowel disease
760844|NCT02432768|Anaplerotic diet|anaplerotic diet
760845|NCT02432768|McArdle Disease|mcardle disease
760846|NCT02432768|Glycogen Storage Disease|glycogen storage disease
760847|NCT02432768|Triheptanoin|triheptanoin
760848|NCT02290496|Insomnia|insomnia
760849|NCT02290496|Depression|depression
760850|NCT02290496|Teen|teen
760851|NCT02290496|SSRI|ssri
760852|NCT02290496|CBT|cbt
760853|NCT02290496|Youth|youth
760854|NCT02281084|myelodysplastic syndromes|myelodysplastic syndromes
760855|NCT02281084|MDS|mds
760856|NCT02281084|azacitidine|azacitidine
760857|NCT02281084|oral azacitidine (CC-486)|oral azacitidine (cc-486)
760858|NCT02281084|decitabine|decitabine
760859|NCT02281084|intermediate-1|intermediate-1
760860|NCT02281084|intermediate-2 and high risk myelodysplastic syndromes (MDS)|intermediate-2 and high risk myelodysplastic syndromes (mds)
760861|NCT02281084|proliferative chronic myelomonocytic leukemia (CMML)|proliferative chronic myelomonocytic leukemia (cmml)
760862|NCT02281084|Durvalumab|durvalumab
760863|NCT02281084|MEDI4736|medi4736
760864|NCT02281084|hronic, Durvalumab, MEDI4736|hronic, durvalumab, medi4736
760865|NCT02281084|iHMA (injectable hypomethylating agents)|ihma (injectable hypomethylating agents)
760866|NCT02281084|PD-L1|pd-l1
760867|NCT02275715|autism spectrum disorder (ASD)|autism spectrum disorder (asd)
760868|NCT02275715|feeding problems|feeding problems
760869|NCT02244632|Colorectal cancer|colorectal cancer
760870|NCT02244632|Colorectal carcinoma|colorectal carcinoma
760871|NCT02244632|Colorectal tumors|colorectal tumors
760872|NCT02244632|Intestinal Neoplasm|intestinal neoplasm
760873|NCT02244632|Gastrointestinal Neoplasm|gastrointestinal neoplasm
760874|NCT02244632|Gastrointestinal disease|gastrointestinal disease
760875|NCT02244632|5,10-methylenetetrahydrofolate|5,10-methylenetetrahydrofolate
760876|NCT02244632|Tetrahydrofolates|tetrahydrofolates
760877|NCT02244632|Therapeutic uses|therapeutic uses
760878|NCT02244632|Pharmacokinetics|pharmacokinetics
760879|NCT02244632|Pharmacodynamics|pharmacodynamics
760880|NCT02244632|Safety assessments|safety assessments
760881|NCT02234128|Ex Vivo Lung Perfusion|ex vivo lung perfusion
760882|NCT02234128|EVLP|evlp
760883|NCT02234128|Lung Transplant|lung transplant
760884|NCT02234128|Lung Transplantation|lung transplantation
760885|NCT02234128|Toronto EVLP System™|toronto evlp system™
760886|NCT02234128|PERFUSIX|perfusix
760887|NCT02232386|Chronic lymphocyte leukemia|chronic lymphocyte leukemia
760888|NCT02232386|Adults|adults
760889|NCT02232386|Ibrutinib|ibrutinib
760890|NCT02216214|Urinary Incontinence|urinary incontinence
760891|NCT02216214|Mirabegron|mirabegron
760892|NCT02216214|Overactive Bladder|overactive bladder
760893|NCT02234050|Grade 2 Chordoid meningioma|grade 2 chordoid meningioma
760894|NCT02234050|Grade 2 Clear cell meningioma|grade 2 clear cell meningioma
760895|NCT02234050|Grade 2 Atypical meningioma|grade 2 atypical meningioma
760896|NCT02234050|Grade 3 Papillary meningioma|grade 3 papillary meningioma
760897|NCT02234050|Grade 3 Rhabdoid meningioma|grade 3 rhabdoid meningioma
760898|NCT02234050|Grade 3 Anaplastic meningioma|grade 3 anaplastic meningioma
760899|NCT02234050|Grade 3 Malignant meningioma|grade 3 malignant meningioma
760900|NCT02208531|Early Childhood Development (ECD)|early childhood development (ecd)
760901|NCT02208531|Psychosocial stimulation|psychosocial stimulation
760902|NCT02208531|Malnutrition|malnutrition
760903|NCT02208531|Bangladesh|bangladesh
760904|NCT02208531|Scaling up ECD|scaling up ecd
760905|NCT02201485|Budd-Chiari syndrome|budd-chiari syndrome
760906|NCT02201485|percutaneous recanalization|percutaneous recanalization
760907|NCT02201485|treatment|treatment
760908|NCT02201485|reocclusion|reocclusion
760909|NCT02201485|patency|patency
760910|NCT02189278|Breast Cancer|breast cancer
760911|NCT02189278|Surveillance|surveillance
760912|NCT02189278|Mammography|mammography
760913|NCT02189278|Adherence|adherence
760914|NCT02185781|Phase I|phase i
760915|NCT02185781|Adoptive immunotherapy|adoptive immunotherapy
760916|NCT02185781|Enriched and expanded autologous natural killer (NK) cells|enriched and expanded autologous natural killer (nk) cells
760917|NCT02185781|Ph+ acute lymphoblastic leukemia|ph+ acute lymphoblastic leukemia
760918|NCT02185781|≥60 years|≥60 years
760919|NCT02185781|Not eligible for other post-CHR treatment modalities|not eligible for other post-chr treatment modalities
760920|NCT02184611|lung function|lung function
760921|NCT02184611|Umeclidinium|umeclidinium
760922|NCT02184611|GSK573719|gsk573719
760923|NCT02184611|anticholinergic|anticholinergic
760924|NCT02184611|novel dry powder inhaler|novel dry powder inhaler
760925|NCT02184611|long-acting muscarinic receptor antagonist|long-acting muscarinic receptor antagonist
760926|NCT02184611|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
760927|NCT02155660|Obstructive Lung Diseases|obstructive lung diseases
760928|NCT02155660|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
760929|NCT02155660|Lung Disease|lung disease
760930|NCT02155660|Bronchial Diseases|bronchial diseases
760931|NCT02155660|COPD Exacerbation|copd exacerbation
760932|NCT02155660|Respiratory Tract Diseases|respiratory tract diseases
760933|NCT02163694|Breast Cancer|breast cancer
760934|NCT02163694|Carboplatin|carboplatin
760935|NCT02163694|BRCA2|brca2
760936|NCT02163694|BRCA Mutation|brca mutation
760937|NCT02163694|BRCA1|brca1
760938|NCT02163694|ABT-888|abt-888
760939|NCT02163694|Paclitaxel|paclitaxel
760940|NCT02163694|Metastatic Breast Cancer|metastatic breast cancer
760941|NCT02163694|PARP|parp
760942|NCT02163694|Genetic breast cancer|genetic breast cancer
760943|NCT02163694|Veliparib|veliparib
760944|NCT02163694|Locally recurrent|locally recurrent
760945|NCT02163694|PARP Inhibitor|parp inhibitor
760946|NCT02163694|HER2-negative|her2-negative
760947|NCT02147938|France|france
760948|NCT02147938|Tacrolimus|tacrolimus
760949|NCT02147938|Prograf|prograf
760950|NCT02147938|Observational|observational
760951|NCT02147938|Advagraf|advagraf
760952|NCT02143479|France|france
760953|NCT02143479|Prograf|prograf
760954|NCT02143479|Pharmaco-epidemiology|pharmaco-epidemiology
760955|NCT02143479|Tacrolimus|tacrolimus
760956|NCT02143479|Observational|observational
760957|NCT02135692|Severe eosinophilic asthma|severe eosinophilic asthma
760958|NCT02135692|Extension study|extension study
760959|NCT02135692|Expanded access|expanded access
760960|NCT02135692|Safety|safety
760961|NCT02135692|Mepolizumab|mepolizumab
760962|NCT02135692|Eosinophils|eosinophils
760963|NCT02124772|v600-mutation|v600-mutation
760964|NCT02124772|neuroblastoma|neuroblastoma
760965|NCT02124772|Trametinib|trametinib
760966|NCT02124772|pediatrics|pediatrics
760967|NCT02124772|Langerhans Cell Histiocytosis|langerhans cell histiocytosis
760968|NCT02124772|low grade glioma plexiform neurofibromas|low grade glioma plexiform neurofibromas
760969|NCT02126579|melanoma|melanoma
760970|NCT02126579|neoplasms|neoplasms
760971|NCT02126579|Poly ICLC|poly iclc
760972|NCT02126579|Freund's Adjuvant|freund's adjuvant
760973|NCT02126579|Metastatic melanoma|metastatic melanoma
760974|NCT02126579|resiquimod|resiquimod
760975|NCT02126579|adjuvants|adjuvants
760976|NCT02126579|peptide vaccine|peptide vaccine
760977|NCT02099721|Sudden Cardiac Arrest (SCA)|sudden cardiac arrest (sca)
760978|NCT02099721|Syncope|syncope
760979|NCT02099721|NSVT|nsvt
760980|NCT02099721|PVC|pvc
760981|NCT02099721|LVEF|lvef
760982|NCT02099721|Primary Prevention|primary prevention
760983|NCT02099721|Secondary Prevention|secondary prevention
760984|NCT02099721|ATP|atp
760985|NCT02099721|shock|shock
760986|NCT02099721|appropriate therapy|appropriate therapy
760987|NCT02091960|Enzalutamide|enzalutamide
760988|NCT02091960|Trastuzumab|trastuzumab
760989|NCT02091960|Breast cancer|breast cancer
760990|NCT02091960|HER2|her2
760991|NCT02091960|Androgen receptor positive|androgen receptor positive
760992|NCT02091960|Xtandi|xtandi
760993|NCT02067143|Untreated philadelphia positive acute lymphoblastic leukemia|untreated philadelphia positive acute lymphoblastic leukemia
760994|NCT02067143|De novo|de novo
760995|NCT02067143|Secondary|secondary
760996|NCT02067143|Low-dose corticosteroids pretreatment|low-dose corticosteroids pretreatment
760997|NCT02067143|Pegylated asparaginase|pegylated asparaginase
760998|NCT02067143|Lineage-targeted risk and minimal residual disease|lineage-targeted risk and minimal residual disease
760999|NCT02064478|Bone anchored hearing implant|bone anchored hearing implant
761000|NCT02064478|Bone anchored hearing device|bone anchored hearing device
761001|NCT02021604|Congenital Hyperinsulinism|congenital hyperinsulinism
761002|NCT02021604|HI|hi
761003|NCT02021604|Hypoglycemia|hypoglycemia
761004|NCT02021604|FDOPA|fdopa
761005|NCT02021604|18F-DOPA|18f-dopa
761006|NCT02021604|Hyperinsulinism|hyperinsulinism
761007|NCT02039947|BRAF V600K mutation|braf v600k mutation
761008|NCT02039947|Metastatic Melanoma|metastatic melanoma
761009|NCT02039947|BRAF V600R mutation|braf v600r mutation
761010|NCT02039947|BRAF V600D mutation|braf v600d mutation
761011|NCT02039947|BRAF V600E mutation|braf v600e mutation
761012|NCT02039947|Brain metastases BRAF inhibitor|brain metastases braf inhibitor
761013|NCT02039947|Intracranial|intracranial
761014|NCT02016456|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
761015|NCT02016456|Neuronavigation|neuronavigation
761016|NCT02016456|Magnetic Resonance Imaging|magnetic resonance imaging
761017|NCT02034110|solid tumors|solid tumors
761018|NCT02034110|efficacy|efficacy
761019|NCT02034110|BRAF V600E mutation|braf v600e mutation
761020|NCT02034110|trametinib|trametinib
761021|NCT02034110|safety|safety
761022|NCT02034110|Dabrafenib|dabrafenib
761023|NCT01974713|CKD progression|ckd progression
761024|NCT01974713|Inflammation|inflammation
761025|NCT01974713|FGF23|fgf23
761026|NCT01974713|Genetic biomarkers|genetic biomarkers
761027|NCT01964430|Resectable pancreatic cancer|resectable pancreatic cancer
761028|NCT01964430|resected|resected
761029|NCT01964430|resectable PDA|resectable pda
761030|NCT01964430|adenocarcinoma|adenocarcinoma
761031|NCT01964430|surgically resected|surgically resected
761032|NCT01964430|adjuvant|adjuvant
761033|NCT01964430|Abraxane|abraxane
761034|NCT01964430|nab-paclitaxel|nab-paclitaxel
761035|NCT01964430|ABI-007|abi-007
761036|NCT01964430|gemcitabine|gemcitabine
761037|NCT01964430|Gemzar|gemzar
761038|NCT01964430|Phase 3|phase 3
761039|NCT01956929|Insulin Resistance|insulin resistance
761040|NCT01956929|Prediabetic State|prediabetic state
761041|NCT01956929|Metformin|metformin
761042|NCT01950442|malignant strictures|malignant strictures
761043|NCT01950442|esophageal staging|esophageal staging
761044|NCT01948570|acne,comedones, oily skin|acne,comedones, oily skin
761045|NCT01955317|Neonate|neonate
761046|NCT01955317|Bangladesh|bangladesh
761047|NCT01955317|Health behavior|health behavior
761048|NCT01955317|Handwashing|handwashing
761049|NCT01955317|Developing countries|developing countries
761050|NCT01955317|Infectious disease|infectious disease
761051|NCT01912612|Breast cancer|breast cancer
761052|NCT01912612|Pain sensitivity|pain sensitivity
761053|NCT01861106|Allogeneic Donors|allogeneic donors
761054|NCT01861106|Peripheral Blood Stem Cell|peripheral blood stem cell
761055|NCT01861106|Immunodeficiency|immunodeficiency
761056|NCT01861106|Myelodysplasia|myelodysplasia
761057|NCT01861106|Haploidentical|haploidentical
761058|NCT01855698|hematologic neoplasm, profhylaxis, arterial and venous thromboembolism|hematologic neoplasm, profhylaxis, arterial and venous thromboembolism
761059|NCT01819259|Nonsmoker|nonsmoker
761060|NCT01819259|ADHD|adhd
761061|NCT01819259|Nicotine|nicotine
761062|NCT01819259|Nicotine Nasal Spray|nicotine nasal spray
761063|NCT01819259|Nicotine Reinforcement|nicotine reinforcement
761064|NCT01815580|HIV|hiv
761065|NCT01815580|Treatment as Prevention|treatment as prevention
761066|NCT01815580|Seek, Test, Treat, Retain Strategies|seek, test, treat, retain strategies
761067|NCT01813539|malignancy|malignancy
761068|NCT01794403|Prostate Cancer|prostate cancer
761069|NCT01794403|Prostate|prostate
761070|NCT01794403|Radiation Therapy|radiation therapy
761071|NCT01794403|Hypofractionation Radiotherapy|hypofractionation radiotherapy
761072|NCT01794403|Extended Hypofractionation Radiotherapy|extended hypofractionation radiotherapy
761073|NCT01794403|Accelerated Hypofractionation Radiotherapy|accelerated hypofractionation radiotherapy
761074|NCT01794403|AHRT|ahrt
761075|NCT01794403|EHRT|ehrt
761076|NCT01793883|Influenza Laninamivir Octanoate|influenza laninamivir octanoate
761077|NCT01791101|Thrombocytopenia|thrombocytopenia
761078|NCT01791101|Eltrombopag|eltrombopag
761079|NCT01787682|CHF|chf
761080|NCT01787682|Protein digestion|protein digestion
761081|NCT01787682|Fat digestion|fat digestion
761082|NCT01787682|Gut function|gut function
761083|NCT01787682|Glucose absorption|glucose absorption
761084|NCT01787682|Muscle function|muscle function
761085|NCT01776424|Cardiovascular events|cardiovascular events
761086|NCT01776424|Rivaroxaban|rivaroxaban
761087|NCT01776424|Xarelto|xarelto
761088|NCT01776424|anticoagulant|anticoagulant
761089|NCT01776424|blood thinner|blood thinner
761090|NCT01776424|aspirin|aspirin
761091|NCT01776424|ASA|asa
761092|NCT01776424|CAD|cad
761093|NCT01776424|coronary disease|coronary disease
761094|NCT01776424|artery disease|artery disease
761095|NCT01776424|coronary artery bypass graft|coronary artery bypass graft
761096|NCT01776424|stroke|stroke
761097|NCT01776424|heart attack|heart attack
761098|NCT01776424|angina|angina
761099|NCT01776424|arterial vascular disease|arterial vascular disease
761100|NCT01776424|transient ischemic attack|transient ischemic attack
761101|NCT01776424|TIA|tia
761102|NCT01776424|heart disease|heart disease
761103|NCT01762202|CLL|cll
761104|NCT01762202|Fludarabine|fludarabine
761105|NCT01762202|Cyclophosphamide|cyclophosphamide
761106|NCT01762202|Ofatumumab|ofatumumab
761107|NCT01761890|Chronic Myeloid Leukemia|chronic myeloid leukemia
761108|NCT01761890|Early phase|early phase
761109|NCT01761890|CML|cml
761110|NCT01761890|Dasatinib|dasatinib
761111|NCT02007226|Coronary Heart Disease|coronary heart disease
761112|NCT02007226|spinal cord injury|spinal cord injury
761113|NCT02007226|risk factor|risk factor
761114|NCT02007226|postprandial lipemia|postprandial lipemia
761115|NCT01750918|MEK inhibitor|mek inhibitor
761116|NCT01750918|anti-EGFR antibody|anti-egfr antibody
761117|NCT01750918|colorectal cancer|colorectal cancer
761118|NCT01750918|BRAF inhibitor|braf inhibitor
761119|NCT01738490|Bone anchored hearing aid|bone anchored hearing aid
761120|NCT01738490|Bone anchored implant|bone anchored implant
761121|NCT01738490|Implant stability|implant stability
761122|NCT01738490|Wide diameter implant|wide diameter implant
761123|NCT01738490|Linear incision|linear incision
761124|NCT01738490|Ponto|ponto
761125|NCT01734928|Multiple Myeloma|multiple myeloma
761126|NCT01734928|Pomalidomide|pomalidomide
761127|NCT01757535|Maintenance therapy|maintenance therapy
761128|NCT01757535|AML|aml
761129|NCT01757535|Acute Myeloid Leukemia|acute myeloid leukemia
761130|NCT01757535|oral Azacitidine|oral azacitidine
761131|NCT01757535|best supportive care|best supportive care
761132|NCT01757535|complete remission|complete remission
761133|NCT01728714|Diabetes; compliance|diabetes; compliance
761134|NCT01730222|pancreatic adenocarcinoma|pancreatic adenocarcinoma
761135|NCT01730222|stage III disease|stage iii disease
761136|NCT01730222|stage IV disease|stage iv disease
761137|NCT01730222|chemotherapy|chemotherapy
761138|NCT01699217|Chronic Myeloid Leukaemia|chronic myeloid leukaemia
761139|NCT01699217|Philadelphia positive|philadelphia positive
761140|NCT01699217|BCR-ABL positive|bcr-abl positive
761141|NCT01677741|Children and Adolescents|children and adolescents
761142|NCT01677741|BRAF|braf
761143|NCT01677741|dabrafenib|dabrafenib
761144|NCT01677741|dose escalation|dose escalation
761145|NCT01677741|BRF116013|brf116013
761146|NCT01677741|V600-mutation positive|v600-mutation positive
761147|NCT01677741|BRF|brf
761148|NCT01641107|Ph+|ph+
761149|NCT01641107|BCR-ABL+|bcr-abl+
761150|NCT01641107|ALL|all
761151|NCT01641107|Ponatinib|ponatinib
761152|NCT01641107|stem cell transplantation|stem cell transplantation
761153|NCT01621893|bone marrow edema|bone marrow edema
761154|NCT01621893|bone marrow defects|bone marrow defects
761155|NCT01601301|Limb|limb
761156|NCT01601301|Lengthening|lengthening
761157|NCT01601301|PRECICE|precice
761158|NCT01601301|Ellipse|ellipse
761159|NCT01601301|Technologies|technologies
761160|NCT01601301|Distraction|distraction
761161|NCT01601301|Osteogenesis|osteogenesis
761162|NCT01601301|Femur|femur
761163|NCT01601301|Tibia|tibia
761164|NCT01601301|Intramedullary|intramedullary
761165|NCT01601301|Nail|nail
761166|NCT01601301|Device|device
761167|NCT01601301|Medical|medical
761168|NCT01601301|Orthopedic|orthopedic
761169|NCT01601301|Implant|implant
761170|NCT01594229|ABT-199|abt-199
761171|NCT01594229|Cancer|cancer
761172|NCT01594229|Preliminary Efficacy|preliminary efficacy
761173|NCT01594229|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
761174|NCT01594229|Rituximab|rituximab
761175|NCT01594229|Bendamustine|bendamustine
761176|NCT01594229|Pharmacokinetics|pharmacokinetics
761177|NCT01594229|Maximum Tolerated Dose|maximum tolerated dose
761178|NCT01594229|Safety|safety
761179|NCT01621646|lutein|lutein
761180|NCT01621646|eggs|eggs
761181|NCT01621646|mild cognitive impairment|mild cognitive impairment
761182|NCT01621646|elderly|elderly
761183|NCT01638936|Combination|combination
761184|NCT01638936|Multiple Myeloma|multiple myeloma
761185|NCT01535391|Chronic Myeloid Leukemia,|chronic myeloid leukemia,
761186|NCT01535391|Nilotinib,|nilotinib,
761187|NCT01535391|Philadelphia positive,|philadelphia positive,
761188|NCT01535391|BCR-ABL+|bcr-abl+
761189|NCT01535391|Early chronic phase|early chronic phase
761190|NCT02145936|fatty acid|fatty acid
761191|NCT01485042|Phase 1|phase 1
761192|NCT01485042|pazopanib|pazopanib
761193|NCT01485042|TH-302|th-302
761194|NCT01485042|advanced solid tumors|advanced solid tumors
761195|NCT01511913|Unresectable or metastatic cutaneous melanoma|unresectable or metastatic cutaneous melanoma
761196|NCT01475110|Imatinib|imatinib
761197|NCT01475110|Chronic Myeloid Leukaemia|chronic myeloid leukaemia
761198|NCT01475110|Nilotinib|nilotinib
761199|NCT01475110|Adult patients|adult patients
761200|NCT01475110|Imatinib resistant|imatinib resistant
761201|NCT01471249|esophageal stenting|esophageal stenting
761202|NCT01471249|palliative|palliative
761203|NCT01471249|dysphagia|dysphagia
761204|NCT01463306|safety|safety
761205|NCT01463306|partial onset seizures|partial onset seizures
761206|NCT01463306|primary generalized tonic-clonic seizures|primary generalized tonic-clonic seizures
761207|NCT01463306|pregabalin|pregabalin
761208|NCT01463306|pediatric|pediatric
761209|NCT01463306|adult|adult
761210|NCT01463306|open-label|open-label
761211|NCT01463306|long term|long term
761212|NCT01452646|acute myeloid leukemia|acute myeloid leukemia
761213|NCT01452646|risk-adapted therapy|risk-adapted therapy
761214|NCT01452646|MRD-directed therapy|mrd-directed therapy
761215|NCT01452646|young adults|young adults
761216|NCT01450033|kidney|kidney
761217|NCT01450033|renal|renal
761218|NCT01450033|transplant|transplant
761219|NCT01450033|transplantation|transplantation
761220|NCT01450033|adolescent|adolescent
761221|NCT01450033|pediatric|pediatric
761222|NCT01450033|mentor|mentor
761223|NCT01450033|mentoring|mentoring
761224|NCT01450033|medication|medication
761225|NCT01450033|adherence|adherence
761226|NCT01450033|immunosuppressant|immunosuppressant
761227|NCT01450033|heart|heart
761228|NCT01450033|liver|liver
761229|NCT01448395|Mass Balance|mass balance
761230|NCT01448395|Metabolite Identification and Profiling|metabolite identification and profiling
761231|NCT01448395|Metabolite profile and Identification of [14C]NXL104|metabolite profile and identification of [14c]nxl104
761232|NCT01448395|Mass Balance Recovery|mass balance recovery
761233|NCT01440244|mediastinoscopy|mediastinoscopy
761234|NCT01440244|pleural evaluation|pleural evaluation
761235|NCT01440244|pleural biopsy|pleural biopsy
761236|NCT01440244|pleurodesis|pleurodesis
761237|NCT01430910|Phase 1|phase 1
761238|NCT01430910|open label|open label
761239|NCT01430910|ceftazidime|ceftazidime
761240|NCT01430910|pharmacokinetics|pharmacokinetics
761241|NCT01430910|urinary tract infection|urinary tract infection
761242|NCT01430910|intra-abdominal infection|intra-abdominal infection
761243|NCT01411345|Prostate Cancer|prostate cancer
761244|NCT01411345|Prostate Adenocarcinoma|prostate adenocarcinoma
761245|NCT01395420|Phase 1|phase 1
761246|NCT01395420|open label|open label
761247|NCT01395420|healthy male and female (post menopausal) volunteers|healthy male and female (post menopausal) volunteers
761248|NCT01395420|Pharmacokinetics|pharmacokinetics
761249|NCT01395420|CAZ104|caz104
761250|NCT01395420|Avibactam|avibactam
761251|NCT01395420|Ceftazidime|ceftazidime
761252|NCT01395420|open label, at least 2 different regimens, concentration of investigational product (IP), CAZ104, Avibactam, Ceftazidime, Cmax, tmax|open label, at least 2 different regimens, concentration of investigational product (ip), caz104, avibactam, ceftazidime, cmax, tmax
761253|NCT01393483|esophagectomy|esophagectomy
761254|NCT01393483|endoscopy|endoscopy
761255|NCT01393483|biopsy|biopsy
761256|NCT01393483|Tissue mesothelin|tissue mesothelin
761257|NCT01393483|Serum mesothelin|serum mesothelin
761258|NCT01393483|11-037|11-037
761259|NCT01364597|Brivaracetam|brivaracetam
761260|NCT01364597|Epilepsy|epilepsy
761261|NCT01364597|Child|child
761262|NCT01364597|Infant|infant
761263|NCT01364597|Adolescents|adolescents
761264|NCT01362881|Early|early
761265|NCT01362881|Onset|onset
761266|NCT01362881|Scoliosis|scoliosis
761267|NCT01295944|Chemotherapy|chemotherapy
761268|NCT01295944|Brain Tumor|brain tumor
761269|NCT01295944|Spinal Cord Tumor|spinal cord tumor
761270|NCT01295944|Malignancy|malignancy
761271|NCT01295944|Neurologic|neurologic
761272|NCT01291602|NXL104|nxl104
761273|NCT01291602|ceftazidime|ceftazidime
761274|NCT01291602|CAZ104|caz104
761275|NCT01291602|Healthy Japanese volunteers|healthy japanese volunteers
761276|NCT01291602|Phase 1|phase 1
761277|NCT01291602|Single and Multiple Dose Study|single and multiple dose study
761278|NCT01290900|NXL104|nxl104
761279|NCT01290900|CAZ104|caz104
761280|NCT01290900|Ceftazidime|ceftazidime
761281|NCT01290900|CXL104|cxl104
761282|NCT01290900|Ceftaroline|ceftaroline
761283|NCT01290900|Healthy Male Volunteers|healthy male volunteers
761284|NCT01290900|Phase 1|phase 1
761285|NCT01290900|OT|ot
761286|NCT01290900|Single Dose Study|single dose study
761287|NCT01304836|Kidney|kidney
761288|NCT01304836|Diabetes Mellitus|diabetes mellitus
761289|NCT01304836|Transplant|transplant
761290|NCT01304836|Immunosuppression|immunosuppression
761291|NCT01289444|palliative care|palliative care
761292|NCT01289444|AIDS|aids
761293|NCT01289444|adolescents|adolescents
761294|NCT01289444|quality of life|quality of life
761295|NCT01289444|adherence|adherence
761296|NCT01289444|spiritual|spiritual
761297|NCT01289444|threat appraisal|threat appraisal
761298|NCT01289444|treatment congruence|treatment congruence
761299|NCT01289444|treatment preferences|treatment preferences
761300|NCT01289444|dialysis|dialysis
761301|NCT01289444|hospitalization|hospitalization
761302|NCT01289444|communication|communication
761303|NCT01289444|family intervention|family intervention
761304|NCT01289444|Family Centered Advance Care Planning|family centered advance care planning
761305|NCT01289444|decision making|decision making
761306|NCT01289444|advance care planning|advance care planning
761307|NCT01289444|end of life|end of life
761308|NCT01268553|pulmonary arterial hypertension|pulmonary arterial hypertension
761309|NCT01268553|inhaled prostacyclin|inhaled prostacyclin
761310|NCT01226316|Advanced solid malignancy,PIK3CA mutated,AKT1 mutated, PTEN mutation, PTEN alteration, metastatic,ER+,breast,ovarian,endometrial,AZD5363,AKT inhibitor,|advanced solid malignancy,pik3ca mutated,akt1 mutated, pten mutation, pten alteration, metastatic,er+,breast,ovarian,endometrial,azd5363,akt inhibitor,
761311|NCT01202864|Intracerebral Hemorrhage|intracerebral hemorrhage
761312|NCT01202864|ICH|ich
761313|NCT01202864|Stroke|stroke
761314|NCT01202864|Cerebrovascular accident|cerebrovascular accident
761315|NCT01156883|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
761316|NCT01156883|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
761317|NCT01156883|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
761318|NCT01156883|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
761319|NCT01150630|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
761320|NCT01150630|stage I pancreatic cancer|stage i pancreatic cancer
761321|NCT01150630|stage II pancreatic cancer|stage ii pancreatic cancer
761322|NCT01144338|exenatide once weekly|exenatide once weekly
761323|NCT01144338|cardiovascular|cardiovascular
761324|NCT01144338|Bydureon|bydureon
761325|NCT01144338|Amylin|amylin
761326|NCT01122368|mycoses|mycoses
761327|NCT01122368|Micafungin|micafungin
761328|NCT01122368|intra-abdominal surgery|intra-abdominal surgery
761329|NCT01122368|invasive fungal infection|invasive fungal infection
761330|NCT01122368|intra-abdominal infection|intra-abdominal infection
761331|NCT01076205|Work Productivity|work productivity
761332|NCT01076205|Long-term Observation|long-term observation
761333|NCT01076205|Humira|humira
761334|NCT01076205|Quality of Life|quality of life
761335|NCT01076205|Rheumatoid Arthritis|rheumatoid arthritis
761336|NCT01074970|PARP inhibition + breast cancer|parp inhibition + breast cancer
761337|NCT01074970|breast cancer|breast cancer
761338|NCT01074970|PARP inhibitor|parp inhibitor
761358|NCT00882037|Rural and Urban|rural and urban
761359|NCT00882037|Latino and Non-Latino|latino and non-latino
761360|NCT00810264|Long-term safety and reliability of a bipolar left ventricular lead on congestive heart failure patients|long-term safety and reliability of a bipolar left ventricular lead on congestive heart failure patients
761361|NCT00708045|Breast Cancer|breast cancer
761362|NCT00629642|Neurogenic bladder|neurogenic bladder
761363|NCT00629642|Vesicare|vesicare
761364|NCT00619710|skin infections|skin infections
761365|NCT00619710|MERREM|merrem
761366|NCT00619710|PRIMAXIN IV|primaxin iv
761367|NCT00619710|complex abscess|complex abscess
761368|NCT00619710|perirectal abscess|perirectal abscess
761369|NCT00619710|wound infections|wound infections
761370|NCT00619710|infected ischemic/diabetic ulcers|infected ischemic/diabetic ulcers
761371|NCT00619710|cellulitis|cellulitis
761372|NCT00619710|Meropenem|meropenem
761373|NCT00619710|Imipenem-cilastatin|imipenem-cilastatin
761374|NCT00494169|Idiopathic Hypogonadotropic Hypogonadism|idiopathic hypogonadotropic hypogonadism
761375|NCT00494169|Kallmann Syndrome|kallmann syndrome
761376|NCT00494169|Puberty|puberty
761377|NCT00494169|Pituitary Abnormalities|pituitary abnormalities
761378|NCT00494169|Hypothalamus|hypothalamus
761379|NCT00494169|anosmia|anosmia
761380|NCT00494169|GnRH deficiency|gnrh deficiency
761381|NCT00493961|Kallmann Syndrome|kallmann syndrome
761382|NCT00493961|Idiopathic Hypogonadotropic Hypogonadism|idiopathic hypogonadotropic hypogonadism
761383|NCT00493961|GnRH deficiency|gnrh deficiency
761384|NCT00475280|geriatric assessment adapted therapy|geriatric assessment adapted therapy
761385|NCT00475280|Leukemia, Lymphoblastic, Acute|leukemia, lymphoblastic, acute
761386|NCT00475280|Older patients|older patients
761387|NCT00475280|> 60 years old|> 60 years old
761388|NCT00475280|Ph negative|ph negative
761389|NCT00471978|non-small cell lung cancer|non-small cell lung cancer
761390|NCT00471978|small cell lung cancer|small cell lung cancer
761391|NCT00471978|pulmonary carcinoid tumor|pulmonary carcinoid tumor
761392|NCT00392756|Kallmann Syndrome|kallmann syndrome
761393|NCT00392756|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
761394|NCT00392756|GnRH deficiency|gnrh deficiency
761395|NCT00392756|Pulsatile GnRH|pulsatile gnrh
761396|NCT00356265|Blood Pressure Nitric Oxide|blood pressure nitric oxide
761397|NCT00356265|L-NMMA|l-nmma
761398|NCT00356265|Phenylephrine|phenylephrine
761399|NCT00356265|Vasoreactivity|vasoreactivity
761400|NCT00356265|Blood Pressure|blood pressure
761401|NCT00340132|Non-Insulin Dependent Diabetes|non-insulin dependent diabetes
761402|NCT00340132|Insulin Resistance|insulin resistance
761403|NCT00340132|Insulin Secretion|insulin secretion
761404|NCT00340132|Glucose Tolerance|glucose tolerance
761405|NCT00340132|Adipose Tissue|adipose tissue
761406|NCT00340132|Preadipocytes|preadipocytes
761407|NCT00318552|Antibiotic Therapy|antibiotic therapy
761408|NCT00318552|sepsis treatment|sepsis treatment
761409|NCT00318552|Meropenem|meropenem
761410|NCT00175916|Brivaracetam|brivaracetam
761411|NCT00175916|Epilepsy|epilepsy
761412|NCT00175916|long term|long term
761413|NCT00118274|stage II melanoma|stage ii melanoma
761414|NCT00118274|stage III melanoma|stage iii melanoma
761415|NCT00118274|stage IV melanoma|stage iv melanoma
761416|NCT00061438|non-infected necrotizing pancreatitis|non-infected necrotizing pancreatitis
761417|NCT00061438|pancreatic infection|pancreatic infection
761418|NCT00061438|peripancreatic infection|peripancreatic infection
761419|NCT00059033|6-[18F]Fluorodopamine|6-[18f]fluorodopamine
761420|NCT00059033|Autonomic Failure|autonomic failure
761421|NCT00059033|Parkinson's Disease|parkinson's disease
761422|NCT00059033|Multiple System Atrophy|multiple system atrophy
761423|NCT00059033|Pure Autonomic Failure|pure autonomic failure
761424|NCT00059033|Primary Chronic Autonomic Failure|primary chronic autonomic failure
761425|NCT00059033|CAF|caf
761426|NCT00050401|ventilator-associated|ventilator-associated
761427|NCT00050401|nosocomial|nosocomial
761428|NCT00004847|Neurofibromatosis|neurofibromatosis
761429|NCT00004847|Multiple Endocrine Neoplasia (MEN)|multiple endocrine neoplasia (men)
761430|NCT00004847|Von Hippel-Lindau Disease|von hippel-lindau disease
761431|NCT00004847|Norepinephrine|norepinephrine
761432|NCT00004847|Epinephrine|epinephrine
761433|NCT00004847|Metanephrines|metanephrines
761434|NCT00004847|PET|pet
394757|NCT01265498|FXR|fxr
761435|NCT00004847|Paraganglioma|paraganglioma
761436|NCT00004847|Pheochromocytoma|pheochromocytoma
756985|NCT03269721|Cognition, Pulmonary, COPD, Lung|cognition, pulmonary, copd, lung
756987|NCT03269747|brown adipose tissue|brown adipose tissue
756988|NCT03269747|cold induced thermogenesis|cold induced thermogenesis
3529|NCT03268434|CBT|cbt
3591|NCT03268057|SEMA4D|sema4d
757087|NCT03270345|Intensive care|intensive care
757088|NCT03269370|CBT|cbt
757089|NCT03269370|Self-Help|self-help
757090|NCT03269370|Family|family
757091|NCT03268304|Upper Limb Motor Function Deficit|upper limb motor function deficit
757092|NCT03268304|Neurorehabilitation|neurorehabilitation
757093|NCT03268304|Virtual Reality|virtual reality
757094|NCT03268304|Action Research Arm Test|action research arm test
757095|NCT03269942|Intracranial Aneurysm|intracranial aneurysm
757096|NCT03269942|Flow Diverter|flow diverter
757097|NCT03269942|Cerebral Revascularization|cerebral revascularization
757098|NCT03269851|neurological deficit|neurological deficit
757108|NCT03268967|intensive care|intensive care
757109|NCT03268967|crisis resource management|crisis resource management
757110|NCT03268967|simulation training|simulation training
757111|NCT03268967|before and after study|before and after study
757112|NCT03270241|Healthy|healthy
757113|NCT03270241|Healthy Adult|healthy adult
757114|NCT03270241|Vitiligo|vitiligo
757115|NCT03270241|Dermatology|dermatology
757116|NCT03270241|Johns Hopkins|johns hopkins
757117|NCT03270241|Compensation|compensation
757118|NCT03270241|Paid|paid
757119|NCT03270241|Phototherapy|phototherapy
757120|NCT03270241|NB-UVB|nb-uvb
757121|NCT03270241|Light treatment|light treatment
757122|NCT03269799|uncontrolled type 2 diabetes mellitus|uncontrolled type 2 diabetes mellitus
757123|NCT03269799|periodontitis|periodontitis
757124|NCT03269799|non surgical periodontal treatment|non surgical periodontal treatment
757125|NCT03269799|vitamin C|vitamin c
757126|NCT03266302|vasodilatory shock|vasodilatory shock
757127|NCT03266302|hemoadsorption|hemoadsorption
757154|NCT03268629|Tai Chi|tai chi
757155|NCT03268629|Inflammation|inflammation
757156|NCT03268629|NF-κB|nf-κb
757161|NCT03269357|LARC|larc
757162|NCT03269357|contraception|contraception
757163|NCT03269357|counselling|counselling
757164|NCT03269357|unplanned pregnancy|unplanned pregnancy
757165|NCT03268590|Hyperoxia|hyperoxia
757166|NCT03268590|Hypoxia, Brain|hypoxia, brain
757167|NCT03268928|Shared Book Reading|shared book reading
757168|NCT03268928|Language Development|language development
757170|NCT03268928|Vocabulary|vocabulary
757171|NCT03268928|Phonological Awareness|phonological awareness
757172|NCT03268928|Young Children|young children
757173|NCT03268928|Randomised Control Trial|randomised control trial
757174|NCT03268928|Language Intervention|language intervention
757178|NCT03269461|stent, DES, INSPIRON, OCT, tissue repair|stent, des, inspiron, oct, tissue repair
757179|NCT03263806|angina|angina
757180|NCT03263806|coronary artery disease|coronary artery disease
757181|NCT03263806|coronary artery catheterization|coronary artery catheterization
757182|NCT03263806|coronary CT angiography|coronary ct angiography
757183|NCT03263806|fractional flow reserve CT|fractional flow reserve ct
757184|NCT03263806|emergency department|emergency department
757185|NCT03270748|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
757186|NCT03270748|acute graft-versus-host disease|acute graft-versus-host disease
757187|NCT03270748|Unrelated donors|unrelated donors
757188|NCT03270748|Post-transplant cyclophosphamide|post-transplant cyclophosphamide
757189|NCT03270748|Myeloid Malignancies|myeloid malignancies
757190|NCT03270748|unrelated hematopoietic cell transplantation|unrelated hematopoietic cell transplantation
757191|NCT03270748|GITMO|gitmo
3786|NCT03266718|couples|couples
757506|NCT03191734|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
757507|NCT03191734|AQUABEAM|aquabeam
757508|NCT03191734|Aquablation|aquablation
757520|NCT03176628|Pharmacokinetics|pharmacokinetics
757521|NCT03176628|Pharmacodynamics|pharmacodynamics
757563|NCT03131635|Developmental|developmental
757574|NCT03127514|Randomized|randomized
757575|NCT03127514|Double-blind|double-blind
757576|NCT03127514|Placebo-controlled|placebo-controlled
757577|NCT03127514|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
757578|NCT03127514|Sodium Phenylbutyrate|sodium phenylbutyrate
757579|NCT03127514|Tauroursodeoxycholic Acid|tauroursodeoxycholic acid
757587|NCT03123250|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
757588|NCT03123250|AQUABEAM|aquabeam
757589|NCT03123250|Aquablation|aquablation
757590|NCT03123250|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
757599|NCT03132246|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
757600|NCT03132246|Infection|infection
757601|NCT03132246|Biofilm Assay|biofilm assay
757604|NCT03108612|diagnostic accuracy|diagnostic accuracy
757605|NCT03108612|upper limb|upper limb
757610|NCT03103542|ITI|iti
757611|NCT03103542|rFVIIIFc|rfviiifc
757612|NCT03103542|Immune Tolerance Induction|immune tolerance induction
4285|NCT03263559|Bone Marrow|bone marrow
757939|NCT02960334|OAC|oac
757940|NCT02960334|VKA|vka
495211|NCT00169000|bax|bax
757941|NCT02960334|NOAC|noac
757942|NCT02956382|Ibrutinib|ibrutinib
757943|NCT02956382|Venetoclax|venetoclax
757944|NCT02956382|Follicular|follicular
757945|NCT02956382|Refractory|refractory
757946|NCT02956382|Relapsed|relapsed
757947|NCT02956382|Lymphoma|lymphoma
757957|NCT02957942|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
757958|NCT02957942|Spasmodic dysphonia|spasmodic dysphonia
757959|NCT02957942|Dystonia|dystonia
757960|NCT02948257|Vessel closure|vessel closure
757961|NCT02948257|Antegrade access|antegrade access
757962|NCT02948257|Femoral arteriotomy|femoral arteriotomy
757963|NCT02948257|Peripheral endovascular interventions|peripheral endovascular interventions
757972|NCT03000205|Dextrose prolotherapy|dextrose prolotherapy
757973|NCT03000205|patients|patients
757974|NCT02930330|Exercise|exercise
757975|NCT02930330|Interval training|interval training
757976|NCT02930330|Blood platelets|blood platelets
757977|NCT02930330|Platelet function tests|platelet function tests
757978|NCT02930330|Physical fitness|physical fitness
757979|NCT02930330|Rehabilitation|rehabilitation
757986|NCT03269773|Atopic Dermatitis|atopic dermatitis
757987|NCT03269773|Stem cell|stem cell
757988|NCT03269773|Cell therapy|cell therapy
757989|NCT03269773|skin disease|skin disease
757990|NCT03269773|Umbilical cord Blood|umbilical cord blood
757991|NCT03269773|UCB-MSC|ucb-msc
757992|NCT03269773|hUCB-MSC|hucb-msc
757993|NCT03269773|AD|ad
757994|NCT03269773|furestem|furestem
758002|NCT02927171|Skilled Nursing Facility|skilled nursing facility
758003|NCT02927171|Post-Acute Care|post-acute care
758004|NCT02927171|Older Adults|older adults
758005|NCT02927171|Physical Function|physical function
758006|NCT02927171|Rehabilitation|rehabilitation
758007|NCT02921750|wound reduction wound healing, venous ulcers|wound reduction wound healing, venous ulcers
758008|NCT02919735|Alopecia|alopecia
758009|NCT02919735|Hair|hair
758010|NCT02919735|Chemotherapy|chemotherapy
758011|NCT02919735|Cancer|cancer
4688|NCT03260712|gemcitabine|gemcitabine
758284|NCT02693665|spiritual|spiritual
758285|NCT02693665|religion|religion
758286|NCT02693665|treatment congruence|treatment congruence
758287|NCT02693665|treatment preferences|treatment preferences
758288|NCT02693665|FAmily CEntered (FACE) Advance Care Planning|family centered (face) advance care planning
758289|NCT02687607|Endovascular|endovascular
758290|NCT02687607|Brain aneurysm|brain aneurysm
758291|NCT02687607|Ruptured aneurysm|ruptured aneurysm
758342|NCT02668653|Newly diagnosed Acute Myeloid Leukemia|newly diagnosed acute myeloid leukemia
758343|NCT02668653|FLT3-ITD positive|flt3-itd positive
758344|NCT02668653|Chemotherapy|chemotherapy
758345|NCT02668653|Induction chemotherapy|induction chemotherapy
758346|NCT02668653|Consolidation chemotherapy|consolidation chemotherapy
758347|NCT02668653|Maintenance chemotherapy|maintenance chemotherapy
758348|NCT02668653|Quizartinib|quizartinib
758349|NCT02668653|Receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
758350|NCT02668653|Feline McDonough sarcoma (FMS)-like tyrosine kinase 3|feline mcdonough sarcoma (fms)-like tyrosine kinase 3
758351|NCT02668653|AC220|ac220
758352|NCT02668653|FLT3-ITD|flt3-itd
758353|NCT02668653|AML|aml
758368|NCT02662621|personalized care|personalized care
758369|NCT02662621|early diagnosis|early diagnosis
758370|NCT02662621|ovarian cancer|ovarian cancer
758371|NCT02662621|breast cancer|breast cancer
758372|NCT02662621|lung cancer|lung cancer
758373|NCT02662621|Early Detection|early detection
758374|NCT02662621|Cancer [E01.390.500]|cancer [e01.390.500]
758379|NCT02654639|Metastatic Colorectal Cancer|metastatic colorectal cancer
758380|NCT02654639|Advanced Colorectal Cancer|advanced colorectal cancer
758381|NCT02743845|Rare|rare
758382|NCT02743845|Undiagnosed|undiagnosed
758383|NCT02743845|Orphan Disease|orphan disease
758384|NCT02743845|Genomic Sequencing|genomic sequencing
758429|NCT02628067|microsatellite instability|microsatellite instability
758430|NCT02628067|MMR|mmr
758431|NCT02628067|mismatch repair|mismatch repair
758432|NCT02628067|anal carcinoma|anal carcinoma
758434|NCT02628067|biliary adenocarcinoma|biliary adenocarcinoma
758435|NCT02628067|biliary cancer|biliary cancer
758436|NCT02628067|cholangiocarcinoma|cholangiocarcinoma
758437|NCT02628067|bile duct cancer|bile duct cancer
758438|NCT02628067|neuroendocrine tumor|neuroendocrine tumor
758439|NCT02628067|carcinoid tumor|carcinoid tumor
758440|NCT02628067|endometrial carcinoma|endometrial carcinoma
758441|NCT02628067|endometrial cancer|endometrial cancer
758442|NCT02628067|cervical carcinoma|cervical carcinoma
758443|NCT02628067|cervical cancer|cervical cancer
758444|NCT02628067|vulvar carcinoma|vulvar carcinoma
758445|NCT02628067|vulvar cancer|vulvar cancer
758446|NCT02628067|small cell lung carcinoma|small cell lung carcinoma
758447|NCT02628067|small cell lung cancer|small cell lung cancer
758448|NCT02628067|SCLC|sclc
758449|NCT02628067|mesothelioma|mesothelioma
758450|NCT02628067|thyroid carcinoma|thyroid carcinoma
758451|NCT02628067|thyroid cancer|thyroid cancer
758452|NCT02628067|salivary gland carcinoma|salivary gland carcinoma
758453|NCT02628067|salivary gland cancer|salivary gland cancer
758454|NCT02628067|salivary cancer|salivary cancer
758455|NCT02628067|parotid gland cancer|parotid gland cancer
758456|NCT02628067|advanced solid tumors|advanced solid tumors
758462|NCT02627508|Autism Spectrum Disorder|autism spectrum disorder
758463|NCT02627508|Autism|autism
758464|NCT02627508|Pregnenolone|pregnenolone
758473|NCT02641002|CC-90002|cc-90002
758474|NCT02641002|Monoclonal|monoclonal
758475|NCT02641002|Antibody|antibody
758476|NCT02641002|CD47|cd47
758477|NCT02641002|Hematologic Cancers|hematologic cancers
758478|NCT02641002|Acute Myeloid Leukemia|acute myeloid leukemia
758479|NCT02641002|AML|aml
758480|NCT02641002|Myelodysplastic syndrome|myelodysplastic syndrome
758481|NCT02641002|MDS|mds
758482|NCT02641002|Blood disorder|blood disorder
758486|NCT02600936|venous outflow obstruction|venous outflow obstruction
758487|NCT02600936|peripheral venous disease|peripheral venous disease
758488|NCT02600936|vein stent|vein stent
758489|NCT02600936|Wallstent|wallstent
758490|NCT02600936|registry|registry
758491|NCT02600936|May Thurner|may thurner
758493|NCT02606994|oral mucositis|oral mucositis
758494|NCT02606994|chemotherapy|chemotherapy
758495|NCT02606994|toothpaste|toothpaste
758560|NCT02572869|Fibula Osteomyocutaneous Free Flaps|fibula osteomyocutaneous free flaps
758561|NCT02572869|Quality of Life|quality of life
758562|NCT02572869|15-244|15-244
758584|NCT02552212|Axial Spondyloarthritis|axial spondyloarthritis
758585|NCT02552212|axSpA|axspa
758586|NCT02552212|Ankylosing Spondylitis|ankylosing spondylitis
758587|NCT02552212|Anti TNF-alpha|anti tnf-alpha
758588|NCT02552212|Certolizumab Pegol|certolizumab pegol
758589|NCT02552212|Nr-axSpA|nr-axspa
758590|NCT02552212|Non-radiographic|non-radiographic
758591|NCT02552212|Spondylarthropathies|spondylarthropathies
758592|NCT02552212|Arthritis|arthritis
758593|NCT02552212|Spinal Diseases|spinal diseases
758594|NCT02552212|Immunosuppressive Agents|immunosuppressive agents
759114|NCT01953016|CGD (Chronic Granulomatous Disease)|cgd (chronic granulomatous disease)
759121|NCT02091544|obesity|obesity
759122|NCT02091544|children|children
759123|NCT02091544|lifestyle intervention|lifestyle intervention
759124|NCT01943526|Ireland|ireland
759125|NCT01943526|Natalizumab|natalizumab
759126|NCT01946620|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
759127|NCT01946620|Exacerbations|exacerbations
759128|NCT01946620|FEV1 ≤ 50%|fev1 ≤ 50%
759130|NCT01938378|Octaplas|octaplas
759139|NCT01906255|HIV-1|hiv-1
759140|NCT01906255|Truvada|truvada
759141|NCT01906255|FTC/TDF|ftc/tdf
759142|NCT01906255|Pre-exposure prophylaxy|pre-exposure prophylaxy
759143|NCT01906255|PrEP|prep
759144|NCT01906255|Adherence|adherence
759145|NCT01906255|Resistance|resistance
759146|NCT01902472|HIV-1|hiv-1
759147|NCT01902472|Truvada|truvada
759148|NCT01902472|FTC/TDF|ftc/tdf
759149|NCT01902472|Pre-exposure prophylaxy|pre-exposure prophylaxy
759150|NCT01902472|PrEP|prep
759151|NCT01902472|Resistance|resistance
759152|NCT01878721|PET/CT|pet/ct
759153|NCT01878721|infection|infection
759154|NCT01878721|vasculitis|vasculitis
759155|NCT01864083|FACBC PET/PEM|facbc pet/pem
759156|NCT01864083|MR|mr
759157|NCT01864083|11-177|11-177
759163|NCT01857973|HCL|hcl
759164|NCT01857973|Type 1 Diabetes|type 1 diabetes
759165|NCT01857973|Sensor|sensor
759665|NCT00953992|gene polymorphism|gene polymorphism
759670|NCT00876369|urticaria|urticaria
759671|NCT00876369|angioedema|angioedema
759672|NCT00876369|vitamin D|vitamin d
759673|NCT00876369|allergy|allergy
759674|NCT00871637|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
759675|NCT00871637|Airway macrophages|airway macrophages
759676|NCT00871637|Sputum milieu|sputum milieu
759677|NCT00871637|Airway inflammation|airway inflammation
756813|NCT00331162|Renal Transplantation|renal transplantation
756828|NCT00281684|VR1|vr1
754386|NCT03268382|High Grade Serous Ovarian Cancer|high grade serous ovarian cancer
754472|NCT03262688|Children|children
754473|NCT03262688|Pediatric|pediatric
754474|NCT03262688|Inguinal hernia|inguinal hernia
754481|NCT03260218|postoperative delirium|postoperative delirium
754482|NCT03260218|elderly|elderly
754848|NCT03208543|thermotherapy|thermotherapy
754849|NCT03208543|Pakistan|pakistan
754857|NCT03167216|chronic pain|chronic pain
754858|NCT03167216|prostatitis|prostatitis
754859|NCT03167216|pelvic pain|pelvic pain
754860|NCT03165747|Probiotics|probiotics
754861|NCT03165747|Menopausal Osteoporosis|menopausal osteoporosis
754864|NCT03160677|Acute Stroke|acute stroke
754865|NCT03160677|Blood Pressure|blood pressure
754866|NCT03160677|Cerebral Hemorrhage|cerebral hemorrhage
754869|NCT03157336|Cassava|cassava
754870|NCT03157336|Konzo|konzo
754871|NCT03157336|Cyanide|cyanide
754872|NCT03157336|Cyanate|cyanate
754873|NCT03157336|Thiocyanate|thiocyanate
754874|NCT03157336|Carbamoylation|carbamoylation
754875|NCT03157336|Isoprostanes|isoprostanes
754876|NCT03157336|Oxidative Damage|oxidative damage
754877|NCT03152760|Alcoholism|alcoholism
754878|NCT03152760|Healthy Volunteers|healthy volunteers
754879|NCT03152760|Craving|craving
754880|NCT03152760|Gut|gut
754881|NCT03179540|Low Rectal Cancer|low rectal cancer
754882|NCT03179540|Complete Clinical Response|complete clinical response
6852|NCT03247088|AML|aml
754936|NCT03112226|estrogen|estrogen
754937|NCT03112226|functional MRI|functional mri
754938|NCT03112226|executive function|executive function
754939|NCT03112226|endothelial function|endothelial function
754940|NCT03112226|arterial stiffness|arterial stiffness
754956|NCT03266575|Frailty|frailty
754957|NCT03266575|Sarcopenia|sarcopenia
754958|NCT03266575|Pulmonary Rehabilitation|pulmonary rehabilitation
754964|NCT03110770|Flavivirus|flavivirus
754965|NCT03110770|Zika|zika
754966|NCT03110770|Vaccine|vaccine
754967|NCT03110770|Physiological Effects of Drugs|physiological effects of drugs
754968|NCT03110770|Immunologic Factors|immunologic factors
754969|NCT03110770|Virus-like Particles|virus-like particles
754970|NCT03110770|Zika vaccine|zika vaccine
754971|NCT03116971|M3814, Small Cell Lung Cancer (SCLC), Deoxyribonucleic acid-dependent protein kinase inhibitor, Chemotherapy|m3814, small cell lung cancer (sclc), deoxyribonucleic acid-dependent protein kinase inhibitor, chemotherapy
755058|NCT03066804|6 MWT|6 mwt
755059|NCT03066804|SF-36|sf-36
755060|NCT03066804|NYHA Class|nyha class
755061|NCT03066804|LCZ696|lcz696
755062|NCT03066804|Enalapril|enalapril
755063|NCT03066804|Valsartan|valsartan
4125|NCT03264313|TMS|tms
755064|NCT03066804|Angiotensin-Converting Enzyme Inhibitors (ACEi)|angiotensin-converting enzyme inhibitors (acei)
755065|NCT03066804|Angiotensin II Type 1 Receptor Blockers (ARB)|angiotensin ii type 1 receptor blockers (arb)
755066|NCT03066804|Renin Angiotensin System Inhibitors (RASi)|renin angiotensin system inhibitors (rasi)
755068|NCT03065088|Exercise|exercise
755069|NCT03065088|Feasibility Studies|feasibility studies
755152|NCT02994953|NHS-IL12|nhs-il12
755153|NCT02994953|Advanced Solid Tumors|advanced solid tumors
755154|NCT02991859|Dose-response|dose-response
755155|NCT02991859|AMP challenge|amp challenge
755156|NCT02991859|cortisol suppression|cortisol suppression
755157|NCT02991859|dose escalation|dose escalation
755158|NCT02991859|therapeutic index|therapeutic index
755163|NCT03070938|Chronic wounds|chronic wounds
755164|NCT03070938|Acute Wounds|acute wounds
755165|NCT03070938|PHMB|phmb
755166|NCT03070938|Wound Management|wound management
755167|NCT03070938|Bioburden|bioburden
755168|NCT03070938|Collagen|collagen
755169|NCT03010852|Bariatric Surgery|bariatric surgery
755170|NCT03010852|Spirometry Monitoring|spirometry monitoring
755245|NCT02981381|Depression|depression
755246|NCT02945618|cryotherapy|cryotherapy
755247|NCT02945618|physical therapy|physical therapy
755248|NCT02939963|weaning|weaning
755249|NCT02939963|mechanical ventilation|mechanical ventilation
755250|NCT02939963|work of breathing|work of breathing
755251|NCT02939963|automatic tube compensation|automatic tube compensation
755264|NCT02923570|proton-beam radiation therapy (PBRT)|proton-beam radiation therapy (pbrt)
755265|NCT02923570|intensity-modulated radiation therapy (IMRT)|intensity-modulated radiation therapy (imrt)
755267|NCT03002896|Cancer|cancer
755268|NCT03002896|Caregivers|caregivers
755269|NCT03002896|Pep-pal|pep-pal
755320|NCT02905435|synthetic|synthetic
755332|NCT02893683|Paris Visual Learning Test|paris visual learning test
755333|NCT02893683|visual memory|visual memory
755334|NCT02893683|criterion validity|criterion validity
755335|NCT02893800|assistive technology|assistive technology
755336|NCT02893800|dementia care|dementia care
755337|NCT02893800|tracking technology|tracking technology
755338|NCT02893800|locating systems|locating systems
755339|NCT02893800|user experience|user experience
755342|NCT02872792|cycloergometer|cycloergometer
755343|NCT02875301|Exercise|exercise
755344|NCT02875301|Brain Health|brain health
755345|NCT02875301|Dose Response|dose response
755346|NCT02875301|Cognition|cognition
755347|NCT02888067|Neuromuscular Blockade|neuromuscular blockade
755348|NCT02880397|Anti-inflammatory agents, antimicrobials, Periodontitis|anti-inflammatory agents, antimicrobials, periodontitis
755349|NCT02858310|HPV-16|hpv-16
755350|NCT02858310|E7 TCR|e7 tcr
755351|NCT02858310|Pembrolizumab|pembrolizumab
755352|NCT02858310|Immunotherapy|immunotherapy
755353|NCT02858310|Reproductive Cancers|reproductive cancers
755357|NCT03268083|Foot-and-Mouth Disease|foot-and-mouth disease
755358|NCT03268083|Vaccines|vaccines
755359|NCT03268083|Hand, Foot and Mouth Disease|hand, foot and mouth disease
755360|NCT03268083|EV71 vaccine|ev71 vaccine
755361|NCT02863445|Obesity|obesity
755362|NCT02863445|Body weight|body weight
755363|NCT02863445|Emergency contraception|emergency contraception
755364|NCT02863445|Levonogestrel|levonogestrel
755365|NCT02863445|Ulipristal acetate|ulipristal acetate
755366|NCT02859337|obesity|obesity
759678|NCT00871637|Occupational diseases|occupational diseases
755414|NCT02833402|Urinary incontinence|urinary incontinence
755415|NCT02833402|Urinary microbiome|urinary microbiome
755416|NCT02831686|Selinexor (KPT-330)|selinexor (kpt-330)
495621|NCT00163176|PET|pet
755417|NCT02831686|Ixazomib|ixazomib
755418|NCT02831686|dexamethasone|dexamethasone
755419|NCT02831686|15-310|15-310
755423|NCT02892903|Fractional flow reserve (FFR)|fractional flow reserve (ffr)
755424|NCT02892903|Pressure wire (PW)|pressure wire (pw)
755425|NCT02892903|Coronary angiography|coronary angiography
755426|NCT02964481|malignant|malignant
755427|NCT02964481|genetics|genetics
755428|NCT02964481|RYR1|ryr1
755429|NCT02964481|CAC-NA1S|cac-na1s
755430|NCT02964481|hyperthermia|hyperthermia
755431|NCT02872259|metastatic melanoma|metastatic melanoma
755432|NCT02872259|advanced Non-resectable melanoma|advanced non-resectable melanoma
755433|NCT02848001|CC-90009|cc-90009
755434|NCT02848001|Hematologic Cancers|hematologic cancers
755435|NCT02848001|Leukemia|leukemia
755436|NCT02848001|Acute Myeloid Leukemia|acute myeloid leukemia
755445|NCT02960997|epidermolysis bullosa simplex|epidermolysis bullosa simplex
755446|NCT02811029|neurological|neurological
755447|NCT02811029|difficulties|difficulties
755449|NCT02805660|MGCD0103|mgcd0103
755450|NCT02805660|MEDI4736|medi4736
755451|NCT02805660|Mocetinostat|mocetinostat
755452|NCT02805660|Durvalumab|durvalumab
755453|NCT02805660|HDAC Inhibitor|hdac inhibitor
755454|NCT02805660|PD-L1 Inhibitor|pd-l1 inhibitor
755455|NCT02805660|Phase 1|phase 1
755456|NCT02805660|Phase 2|phase 2
755457|NCT02805660|Metastatic Solid Tumor|metastatic solid tumor
755458|NCT02805660|Non-small cell lung cancer|non-small cell lung cancer
755459|NCT02805660|immunotherapy|immunotherapy
755460|NCT02805660|checkpoint inhibitor|checkpoint inhibitor
755461|NCT02806947|Acute GVHD|acute gvhd
755462|NCT02806947|Standard-Risk|standard-risk
755463|NCT02806947|Sirolimus|sirolimus
755464|NCT02806947|Refined Minnesota Risk Criteria|refined minnesota risk criteria
755465|NCT02806947|Ann Arbor|ann arbor
755466|NCT02806947|Biomarker|biomarker
759679|NCT00860782|Sickle Cell Disease|sickle cell disease
755487|NCT02798276|Cardiac surgery|cardiac surgery
755489|NCT02798354|Blood Pressure|blood pressure
755490|NCT02798354|Anemias, Iron-Deficiency|anemias, iron-deficiency
755491|NCT02798354|Streptococcal Infections|streptococcal infections
755492|NCT02798354|Sexually Transmitted Diseases|sexually transmitted diseases
755493|NCT02798354|Lead Poisoning, Nervous System, Childhood|lead poisoning, nervous system, childhood
755494|NCT02798354|Thyrotropin|thyrotropin
755496|NCT02797964|Advanced solid tumors|advanced solid tumors
755497|NCT02797964|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
755498|NCT02797964|Metastatic Colorectal Cancer|metastatic colorectal cancer
755499|NCT02797964|Platinum-Resistant Ovarian Cancer|platinum-resistant ovarian cancer
755500|NCT02797964|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
755501|NCT02797964|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
755502|NCT02797964|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
755504|NCT02797964|Dose escalation|dose escalation
755505|NCT02797964|Chk1 Inhibitor|chk1 inhibitor
755506|NCT02797964|Checkpoint kinase 1|checkpoint kinase 1
755507|NCT02797964|Synthetic lethality|synthetic lethality
755508|NCT02797964|Next-Generation Sequencing|next-generation sequencing
755509|NCT02797964|Genetic biomarkers|genetic biomarkers
755510|NCT02780479|Prednisone|prednisone
755511|NCT02780479|Dexamethasone|dexamethasone
755512|NCT02780479|Asthma exacerbation|asthma exacerbation
755513|NCT02780479|Hospitalized|hospitalized
755514|NCT02775435|PD1|pd1
755515|NCT02775435|PD-1|pd-1
755516|NCT02775435|PDL1|pdl1
755517|NCT02775435|PD-L1|pd-l1
755518|NCT02788851|Stimulant Medication|stimulant medication
755519|NCT02788851|Exercise|exercise
755520|NCT02788851|Functional Outcome|functional outcome
755521|NCT02788851|Effectiveness|effectiveness
755522|NCT02788851|Symptoms|symptoms
755523|NCT02772276|Glomerular Filtration Rate|glomerular filtration rate
755524|NCT02768363|Immunotherapy|immunotherapy
755525|NCT02768363|Tumor vaccine|tumor vaccine
755526|NCT02768363|Immuno-oncology|immuno-oncology
755527|NCT02768363|Cytotoxicity|cytotoxicity
755528|NCT02768363|Prostate cancer|prostate cancer
755529|NCT02768363|Active Surveillance|active surveillance
755530|NCT02766465|Sickle Cell Disease|sickle cell disease
755531|NCT02766465|Young Adults|young adults
755532|NCT02766465|Phase II Trial|phase ii trial
755533|NCT02766465|Hematopoietic Cell Transplantation (HCT)|hematopoietic cell transplantation (hct)
755534|NCT02766465|Human Leukocyte Antigen (HLA)|human leukocyte antigen (hla)
755546|NCT02761161|PTSD|ptsd
755547|NCT02761161|Sleep|sleep
755548|NCT02761161|Refugee|refugee
755549|NCT02761161|IRT|irt
755550|NCT02761161|Mianserin|mianserin
755551|NCT02745756|Children|children
755552|NCT02745756|Cancer|cancer
755553|NCT02745756|High-risk neuroblastoma|high-risk neuroblastoma
755554|NCT02754362|Poly-ICLC and bevacizumab|poly-iclc and bevacizumab
755555|NCT02754362|humanized monoclonal antibody|humanized monoclonal antibody
755837|NCT02553096|software application|software application
755838|NCT02519348|Hepatocellular Carcinoma|hepatocellular carcinoma
755839|NCT02519348|Immunotherapy|immunotherapy
755840|NCT02519348|Antibodies, Monoclonal|antibodies, monoclonal
755841|NCT02519348|Tremelimumab|tremelimumab
755842|NCT02519348|MEDI4736|medi4736
755843|NCT02519348|Durvalumab|durvalumab
755844|NCT02511015|Early Onset Parkinson's Disease|early onset parkinson's disease
755845|NCT02511015|Cellular Quality Control Programs|cellular quality control programs
755846|NCT02511015|Mitochondria|mitochondria
755847|NCT02511015|Neuroinflammation|neuroinflammation
755848|NCT02511015|Immunology|immunology
755853|NCT02515578|Primary Health Care|primary health care
755854|NCT02515578|Cardiovascular Diseases|cardiovascular diseases
755855|NCT02515578|Quality Improvement|quality improvement
755859|NCT02512913|Smoking Cessation|smoking cessation
755860|NCT02512913|Intervention|intervention
755861|NCT02512913|Pregnancy|pregnancy
755862|NCT02512913|Postnatal|postnatal
755906|NCT02464410|Self-efficacy|self-efficacy
755907|NCT02464410|Behavioral symptoms|behavioral symptoms
755908|NCT02464410|Injuries|injuries
755909|NCT02464410|Opioid Safety|opioid safety
755910|NCT02492360|Peripheral Neuropathies|peripheral neuropathies
755911|NCT02492360|Testicular Cancer|testicular cancer
755912|NCT02492360|Cisplatin|cisplatin
755913|NCT02492360|Pharmacogenomics|pharmacogenomics
755914|NCT02478775|obesity|obesity
755915|NCT02478775|fertility|fertility
755916|NCT02478775|infertility|infertility
755917|NCT02478775|reproductive hormones|reproductive hormones
755927|NCT02473926|Physical Activity|physical activity
755928|NCT02473926|Physical Function|physical function
755929|NCT02473926|Physical Impairment|physical impairment
755930|NCT02473926|Sedentary Lifestyle|sedentary lifestyle
755931|NCT02427594|Kidney Diseases|kidney diseases
755932|NCT02427594|Renal Insufficiency, Chronic|renal insufficiency, chronic
755933|NCT02427594|Dietary nonvolatile acid load|dietary nonvolatile acid load
755934|NCT02427594|Blood pressure|blood pressure
755935|NCT02427594|Urine net acid excretion|urine net acid excretion
755938|NCT02429466|testicular germ cell tumor|testicular germ cell tumor
755939|NCT02429466|ovarian germ cell tumor|ovarian germ cell tumor
755940|NCT02429466|platinum refractory|platinum refractory
755941|NCT02429466|cisplatin|cisplatin
755942|NCT02429466|SGI110|sgi110
755943|NCT02429466|Guadecitabine|guadecitabine
755944|NCT02444611|neonates|neonates
755945|NCT02444611|BCG|bcg
755946|NCT02444611|Hepatitis B vaccine|hepatitis b vaccine
755949|NCT02444611|immune response|immune response
755950|NCT02444611|Bacille- Calmette-Guerin|bacille- calmette-guerin
755956|NCT02412735|Chronic Lumbar Back Pain|chronic lumbar back pain
755957|NCT02412735|Low back pain|low back pain
755958|NCT02412735|Back pain|back pain
755959|NCT02412735|Degenerative Disc Disease|degenerative disc disease
755991|NCT02401542|second line therapy|second line therapy
755992|NCT02401542|monoclonal antibody|monoclonal antibody
755994|NCT02401542|combination therapy|combination therapy
755995|NCT02401542|Phase 1|phase 1
755996|NCT02379442|Graft-Versus-Host Disease|graft-versus-host disease
755997|NCT02379442|Corticosteroids|corticosteroids
755998|NCT02379442|Mesenchymal Stromal Cell|mesenchymal stromal cell
755999|NCT02379442|Adoptive Cellular Therapy|adoptive cellular therapy
756000|NCT02391519|Pregnancy|pregnancy
756001|NCT02391519|High altitude|high altitude
756002|NCT02391519|vasoreactivity|vasoreactivity
756003|NCT02391519|myometrial arteries|myometrial arteries
756004|NCT02382601|Pregnancy|pregnancy
756005|NCT02382601|IUGR|iugr
756006|NCT02382601|Small for gestational age|small for gestational age
756007|NCT02399449|iron|iron
756008|NCT02399449|pharmacokinetics|pharmacokinetics
756014|NCT02374541|Patient Navigation|patient navigation
756015|NCT02374541|Health Disparities|health disparities
756016|NCT02374541|Coordination of Services|coordination of services
756017|NCT02374541|Early Intervention (Education)|early intervention (education)
756018|NCT02374541|Health Services Accessibility|health services accessibility
756019|NCT02374541|Patient Advocacy|patient advocacy
756026|NCT02362594|PD1|pd1
756027|NCT02362594|PDL1|pdl1
756035|NCT02359890|Interventional|interventional
756036|NCT02359890|Radiofrequency ablation|radiofrequency ablation
756037|NCT02359890|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
756048|NCT02344251|Drug study|drug study
756049|NCT02344251|Medication compliance|medication compliance
756050|NCT02332369|Cataract|cataract
756080|NCT02285062|Diffuse Large B-Cell Lymphoma, T-cell / histiocyte-rich|diffuse large b-cell lymphoma, t-cell / histiocyte-rich
756084|NCT02337361|risky alcohol use|risky alcohol use
756085|NCT02337361|pregnancy|pregnancy
756086|NCT02284087|transcranial magnetic stimulation|transcranial magnetic stimulation
756087|NCT02284087|movement disorders|movement disorders
756088|NCT02282020|BRCA, ovarian, platinum, chemotherapy,|brca, ovarian, platinum, chemotherapy,
756089|NCT02266147|Low Grade B-cell Lymphoma|low grade b-cell lymphoma
756095|NCT02264288|Peripheral Arterial Disease|peripheral arterial disease
756096|NCT02264288|Diabetic Foot|diabetic foot
756097|NCT02261649|Cerebellar tumor|cerebellar tumor
756098|NCT02261649|Non-malignant low-grade cerebellar astrocytomas|non-malignant low-grade cerebellar astrocytomas
756100|NCT02241369|Aerodigestive Lesions and Malignancies|aerodigestive lesions and malignancies
756101|NCT02241369|Human Papillomavirus|human papillomavirus
756102|NCT02241369|Squamous Cell Carcinoma|squamous cell carcinoma
756103|NCT02237313|psychological support|psychological support
756104|NCT02237313|therapeutic education|therapeutic education
756105|NCT02237313|vulnerability of patients|vulnerability of patients
756106|NCT02232282|Painful Bladder Syndrome|painful bladder syndrome
756107|NCT02232282|Interstitial Cystitis|interstitial cystitis
756108|NCT02232282|Suprapubic Pain|suprapubic pain
756109|NCT02232282|Urinary Urgency|urinary urgency
756117|NCT02210728|cognitive behavioral therapy|cognitive behavioral therapy
756118|NCT02210728|stimulant medication|stimulant medication
756119|NCT02210728|efficacy|efficacy
756120|NCT02210728|symptoms|symptoms
756121|NCT02210728|functional outcomes|functional outcomes
756123|NCT02423603|Triple Negative Breast Cancer|triple negative breast cancer
756124|NCT02423603|Metastatic|metastatic
756125|NCT02423603|AKT Inhibitor|akt inhibitor
756126|NCT02423603|Advanced|advanced
756127|NCT02423603|AZD5363|azd5363
756128|NCT02423603|Paclitaxel|paclitaxel
756129|NCT02423603|PAKT|pakt
756134|NCT02186418|sickle cell disease|sickle cell disease
756135|NCT02186418|sickle cell anemia|sickle cell anemia
756136|NCT02186418|hemoglobinopathies|hemoglobinopathies
756137|NCT02186418|hematopoietic stem cell|hematopoietic stem cell
756138|NCT02186418|gene transfer|gene transfer
756139|NCT02186418|gene therapy|gene therapy
759680|NCT00860782|Educational Outcomes|educational outcomes
756175|NCT02116582|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
756176|NCT02116582|Enzalutamide|enzalutamide
756177|NCT02117934|HBV vaccine|hbv vaccine
756178|NCT02117934|HEPLISAV-B|heplisav-b
756179|NCT02117934|Hepatitis B vaccine|hepatitis b vaccine
756180|NCT02117934|Hepatitis B|hepatitis b
756181|NCT02117934|Hepatitis|hepatitis
756182|NCT02117934|Hepatitis B virus (HBV)|hepatitis b virus (hbv)
756183|NCT02117934|Prevention and Control|prevention and control
756185|NCT02117934|Healthy volunteers|healthy volunteers
756186|NCT02104713|Skin Burn Degree Second|skin burn degree second
756187|NCT02104713|Second degree Burn|second degree burn
756188|NCT02104713|Burn wound|burn wound
756191|NCT02098343|Ovarian cancer|ovarian cancer
756192|NCT02098343|Ovarian carcinoma|ovarian carcinoma
756193|NCT02098343|High Grade Serous Ovarian Cancer|high grade serous ovarian cancer
756194|NCT02098343|Recurrent Cancer|recurrent cancer
756195|NCT02098343|Resistant Cancer|resistant cancer
756197|NCT02094118|RBC|rbc
756198|NCT02094118|cardiac|cardiac
756199|NCT02094118|surgery|surgery
756200|NCT02094118|transfusion related acute lung injury (TRALI)|transfusion related acute lung injury (trali)
756201|NCT02094118|transfusion associated circulatory overload (TACO)|transfusion associated circulatory overload (taco)
756202|NCT02090361|collagen -elastin matrix|collagen -elastin matrix
756203|NCT02090361|skin graft|skin graft
756204|NCT02090361|loss of cutaneous substance|loss of cutaneous substance
756205|NCT02081846|transitions of care|transitions of care
756206|NCT02081846|reutilization|reutilization
756207|NCT02081846|home nurse visit|home nurse visit
756208|NCT02081846|focus groups|focus groups
756209|NCT02081846|quality improvement|quality improvement
756210|NCT02076204|Pregnancy|pregnancy
756211|NCT02076204|Postpartum programs|postpartum programs
756212|NCT02076204|Infant health services|infant health services
756213|NCT02075853|Cerebral palsy|cerebral palsy
756214|NCT02075853|Pes planus|pes planus
756215|NCT02075853|Calcaneal lengthening|calcaneal lengthening
756216|NCT02069782|Pregnancy|pregnancy
756217|NCT02069782|postpartum programs|postpartum programs
756218|NCT02069782|infant health services|infant health services
756224|NCT02060760|Prospective cohort study|prospective cohort study
756225|NCT02060760|Diagnostic accuracy|diagnostic accuracy
3830|NCT03266549|botulinum toxin|botulinum toxin
756226|NCT02060760|High sensitivity versus contemporary troponin I assay|high sensitivity versus contemporary troponin i assay
756227|NCT02060760|Gender|gender
756228|NCT02060760|Renal Function|renal function
756229|NCT02050035|Exercise Therapy|exercise therapy
756230|NCT02050035|Endothelium, vascular|endothelium, vascular
756231|NCT02050035|Blood Vessels|blood vessels
756240|NCT02121327|stroke, disease management programs, self-management|stroke, disease management programs, self-management
756241|NCT02029898|cesarean section|cesarean section
756242|NCT02029898|anesthesia|anesthesia
756243|NCT02029898|children|children
756274|NCT01997333|Estrogen|estrogen
756275|NCT01997333|Progesterone|progesterone
756276|NCT01997333|HER2 receptors|her2 receptors
756277|NCT01997333|Targeted treatment for breast cancer|targeted treatment for breast cancer
756278|NCT01997333|Antibody-drug-conjugate|antibody-drug-conjugate
756279|NCT01997333|Breast Neoplasms|breast neoplasms
756280|NCT01997333|CDX-011|cdx-011
756281|NCT01997333|gpNMB|gpnmb
756282|NCT01997333|METRIC|metric
756283|NCT01997333|Glembatumumab vedotin|glembatumumab vedotin
756284|NCT01997333|Triple Negative Breast Cancer|triple negative breast cancer
756285|NCT01997333|TNBC|tnbc
756290|NCT01984658|pancreatic cancer|pancreatic cancer
756296|NCT01960257|tuberculosis|tuberculosis
756297|NCT01960257|tuberculosis treatment|tuberculosis treatment
756298|NCT01960257|wirelessly observed therapy|wirelessly observed therapy
756299|NCT01960257|proteus digital health|proteus digital health
756300|NCT01960257|digital health feedback system|digital health feedback system
756301|NCT01962103|Neuroblastoma|neuroblastoma
756302|NCT01962103|Rhabdomyosarcoma|rhabdomyosarcoma
756303|NCT01962103|Soft Tissue|soft tissue
756304|NCT01962103|Pediatric Oncology|pediatric oncology
756305|NCT01962103|Abraxane|abraxane
756306|NCT01962103|albumin-bound paclitaxel|albumin-bound paclitaxel
756307|NCT01962103|nab-paclitaxel|nab-paclitaxel
756308|NCT01962103|ABI-007|abi-007
756309|NCT01962103|taxane|taxane
756310|NCT01962103|solid tumors|solid tumors
756316|NCT01951326|Crohn's Disease|crohn's disease
756317|NCT01951326|moderate to severe|moderate to severe
756318|NCT01951326|remission|remission
756319|NCT01951326|MAP|map
756320|NCT01951326|antibiotic|antibiotic
756321|NCT01951339|diabetes|diabetes
756322|NCT01951339|type 2 diabetes|type 2 diabetes
756323|NCT01951339|exercise|exercise
756324|NCT01951339|echo|echo
756325|NCT01951339|heart|heart
756326|NCT01951339|sitagliptin|sitagliptin
756327|NCT01951339|glimepiride|glimepiride
756328|NCT01951339|cardiovascular|cardiovascular
756333|NCT01946477|Multiple Myeloma, MM, cancer, oncology, hematology, plasma, neoplasm, plasmacytoma|multiple myeloma, mm, cancer, oncology, hematology, plasma, neoplasm, plasmacytoma
756421|NCT01771471|lumbar spine|lumbar spine
756422|NCT01762332|nociception|nociception
756423|NCT01762332|analgesia|analgesia
756424|NCT01762332|intraoperative monitoring|intraoperative monitoring
756441|NCT01793909|Type 2 Diabetes|type 2 diabetes
756442|NCT01793909|Exercise Impairment|exercise impairment
756694|NCT01005407|HBV|hbv
756695|NCT01005407|Prevention & Control|prevention & control
756696|NCT01005407|Healthy|healthy
756697|NCT01005407|Healthy volunteers|healthy volunteers
756703|NCT00945152|Elimination of MRSA in open wounds|elimination of mrsa in open wounds
756704|NCT00945152|MRSA infected open wounds|mrsa infected open wounds
756705|NCT00900419|non-small cell lung cancer|non-small cell lung cancer
756706|NCT00900419|small cell lung cancer|small cell lung cancer
756707|NCT00900419|squamous lung dysplasia|squamous lung dysplasia
756710|NCT00900419|lip and oral cavity cancer|lip and oral cavity cancer
756711|NCT00900419|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
756713|NCT00900419|oropharyngeal cancer|oropharyngeal cancer
756714|NCT00900419|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
756715|NCT00900419|salivary gland cancer|salivary gland cancer
756716|NCT00900419|esophageal cancer|esophageal cancer
756717|NCT00900419|pulmonary carcinoid tumor|pulmonary carcinoid tumor
756718|NCT00900419|tongue cancer|tongue cancer
756719|NCT00897364|non-small cell lung cancer|non-small cell lung cancer
756720|NCT00897364|small cell lung cancer|small cell lung cancer
756721|NCT00897364|squamous lung dysplasia|squamous lung dysplasia
756722|NCT01136447|Brachial plexus|brachial plexus
756723|NCT01136447|Ultrasound|ultrasound
756724|NCT00877903|Acute myocardial infarction|acute myocardial infarction
756725|NCT00877903|AMI|ami
756726|NCT00877903|Myocardial infarction|myocardial infarction
602140|NCT00588562|PHII|phii
756788|NCT00435812|HBV|hbv
756789|NCT00435812|Immunostimulatory sequence (ISS)|immunostimulatory sequence (iss)
756790|NCT00378482|Melanoma and other tumors|melanoma and other tumors
756791|NCT00368082|EBV-Positive Lymphoma|ebv-positive lymphoma
756792|NCT00368082|Hodgkin´s Disease (HD)|hodgkin´s disease (hd)
756793|NCT00368082|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
756794|NCT00368082|relapsed Hodgkin's disease|relapsed hodgkin's disease
756795|NCT00368082|relapsed non-Hodgkin's disease|relapsed non-hodgkin's disease
756796|NCT00368082|lymphoma|lymphoma
756797|NCT00368082|TGFbeta resistant LMP-specific CTLs|tgfbeta resistant lmp-specific ctls
756798|NCT00368082|cytotoxic T cells|cytotoxic t cells
756799|NCT00351390|congestive heart failure treatment|congestive heart failure treatment
756800|NCT00351390|congestive heart failure, prognosis|congestive heart failure, prognosis
756801|NCT00351390|NT-proBNP testing|nt-probnp testing
756802|NCT00340899|Perinatal Mortality|perinatal mortality
756803|NCT00340899|Perinatal Morbidity|perinatal morbidity
756804|NCT00340899|Preterm Birth|preterm birth
756805|NCT00340899|Pregnancy Complications|pregnancy complications
756806|NCT00340899|Pregnancy|pregnancy
756814|NCT00331162|Pancreas Transplantation|pancreas transplantation
756815|NCT00331162|Graft Rejection|graft rejection
756816|NCT00331162|Immunosuppression|immunosuppression
756817|NCT00331162|Kidney failure, chronic|kidney failure, chronic
756818|NCT00331162|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
756819|NCT00331162|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
756825|NCT00281684|Acute Pain|acute pain
756868|NCT00062868|CTL|ctl
756869|NCT00062868|EBV|ebv
756870|NCT00062868|Relapse|relapse
756905|NCT00001846|Volunteer Donor|volunteer donor
756906|NCT00001846|Research Samples|research samples
756907|NCT00001846|Leukapheresis|leukapheresis
756908|NCT00001846|Plateletpheresis|plateletpheresis
756909|NCT00001846|Plasmapheresis|plasmapheresis
756910|NCT00001846|Healthy Volunteer|healthy volunteer
756911|NCT00001846|Normal Volunteer|normal volunteer
756912|NCT00001208|Spasmodic Torticollis|spasmodic torticollis
756913|NCT00001208|Writer's Cramp|writer's cramp
756914|NCT00001208|Spasmodic Dysphonia|spasmodic dysphonia
756915|NCT00001208|Stuttering|stuttering
756916|NCT00001208|Oromandibular Dystonia|oromandibular dystonia
756917|NCT00001208|Palatal Myoclonus|palatal myoclonus
756918|NCT00001208|Dystonia|dystonia
756919|NCT00001208|Essential Tremor|essential tremor
756920|NCT00001208|Movement Disorders|movement disorders
6552|NCT03249246|ICU|icu
7467|NCT03242967|renal|renal
7597|NCT03241797|AIP|aip
8473|NCT03236337|Obesity|obesity
3720|NCT03265964|Veteran|veteran
3721|NCT03265964|Uridine|uridine
3722|NCT03265964|Neuroimaging|neuroimaging
3723|NCT03265951|sleep apnea, PTSD|sleep apnea, ptsd
3724|NCT03265938|Head and Neck cancer|head and neck cancer
3725|NCT03265938|Cancer of oral cavity|cancer of oral cavity
3726|NCT03265938|Ear, Nose and Throat|ear, nose and throat
3727|NCT03265938|Indirect laryngoscopy|indirect laryngoscopy
3728|NCT03265938|Awake intubation|awake intubation
3729|NCT03265938|Expected difficult intubation|expected difficult intubation
3730|NCT03267121|head and neck cancer|head and neck cancer
3731|NCT03267121|Apatinib|apatinib
3732|NCT03267121|Tegafur Gimeracil Oteracil|tegafur gimeracil oteracil
3733|NCT03267121|induction chemotherapy|induction chemotherapy
3734|NCT03267108|Pulmonary Fibrosis|pulmonary fibrosis
3735|NCT03267108|PF|pf
3736|NCT03267108|Pulmonary Hypertension|pulmonary hypertension
3737|NCT03267108|Inhaled Nitric Oxide|inhaled nitric oxide
3738|NCT03267108|iNO|ino
3739|NCT03267108|Long Term Oxygen Therapy|long term oxygen therapy
3740|NCT03267108|Oxygen|oxygen
3742|NCT03267043|preterm birth|preterm birth
3743|NCT03267043|NICU|nicu
3744|NCT03267043|neonatal|neonatal
3745|NCT03267043|skin to skin|skin to skin
3746|NCT03267043|kangaroo care|kangaroo care
3747|NCT03267043|separation stress|separation stress
3748|NCT03267043|family nurture|family nurture
3749|NCT03267043|maternal confidence|maternal confidence
3750|NCT03267043|maternal competence|maternal competence
3751|NCT03267043|calming cycle|calming cycle
3752|NCT03267043|infant neurodevelopment|infant neurodevelopment
3753|NCT03267043|infant psychological development|infant psychological development
3754|NCT03267043|mother-infant co-regulation|mother-infant co-regulation
3755|NCT03267043|postpartum depression|postpartum depression
3758|NCT03266965|Histamine|histamine
3768|NCT03266835|Chronic Total Occlusion|chronic total occlusion
3769|NCT03266835|Peripheral|peripheral
3770|NCT03266835|SoundBite™ Crossing System|soundbite™ crossing system
3771|NCT03266835|CTO|cto
3772|NCT03266835|intra-luminal|intra-luminal
3773|NCT03266835|Active wire|active wire
3774|NCT03266835|Device|device
3775|NCT03266835|Procedure|procedure
3778|NCT03266770|ureteral stent|ureteral stent
3783|NCT03266718|cancer survivor|cancer survivor
3784|NCT03266718|breast cancer|breast cancer
3805|NCT03266679|sense of self|sense of self
3806|NCT03266679|insight|insight
3807|NCT03266666|grocery|grocery
3808|NCT03266666|lifestyle|lifestyle
3809|NCT03266666|lifestyle change|lifestyle change
3810|NCT03266666|behavior|behavior
3811|NCT03266666|nutrition|nutrition
3812|NCT03266640|Cytomegalovirus|cytomegalovirus
3813|NCT03266640|CMV|cmv
3814|NCT03266640|cytotoxic t-lymphocytes|cytotoxic t-lymphocytes
3818|NCT03266614|Mental Illness|mental illness
3819|NCT03266614|Loneliness|loneliness
3820|NCT03266614|Hope|hope
3821|NCT03266614|Community|community
3822|NCT03266614|Social Media|social media
3823|NCT03266601|Aged 1-6 years old, within 72 hours of onset patients with herpangina|aged 1-6 years old, within 72 hours of onset patients with herpangina
3824|NCT03266588|migraine|migraine
3825|NCT03266588|acute|acute
3831|NCT03266549|infantile esotropia|infantile esotropia
3832|NCT03266536|Gut microbiota|gut microbiota
3833|NCT03266523|CT|ct
3834|NCT03266523|MRI|mri
3835|NCT03266523|Anxiety-state|anxiety-state
3836|NCT03266523|Anxiety State-Trait|anxiety state-trait
3837|NCT03266510|Inspiratory muscle strength training|inspiratory muscle strength training
3838|NCT03266497|diet quality|diet quality
3839|NCT03266497|health disparities|health disparities
3840|NCT03266497|immigrants|immigrants
3841|NCT03266497|foreign-born|foreign-born
3842|NCT03266497|Blacks/African Americans|blacks/african americans
3843|NCT03266497|place of birth/nativity|place of birth/nativity
3844|NCT03266497|length of residency|length of residency
3845|NCT03266497|NHANES|nhanes
3846|NCT03266497|acculturation|acculturation
3847|NCT03266484|Microbiome|microbiome
3848|NCT03266484|Fatigue|fatigue
3849|NCT03266484|Probiotics|probiotics
3852|NCT03266445|relapse|relapse
3853|NCT03266445|buprenorphine/naloxone|buprenorphine/naloxone
3854|NCT03266445|opioids|opioids
3855|NCT03266445|narcotics|narcotics
3856|NCT03266445|post-surgical pain|post-surgical pain
3857|NCT03266393|Envarsus XR|envarsus xr
3858|NCT03266393|Kidney transplantation|kidney transplantation
3859|NCT03266393|Grafting, Kidney|grafting, kidney
3860|NCT03266393|Tacrolimus|tacrolimus
3861|NCT03266393|Rejection|rejection
3862|NCT03266393|Adherence|adherence
3863|NCT03266393|Quality of Life|quality of life
3864|NCT03266393|post-transplant immunosuppression|post-transplant immunosuppression
3865|NCT03266354|Artisan|artisan
3871|NCT03266237|Influenza|influenza
3872|NCT03266237|Influenza Virus Vaccines|influenza virus vaccines
3873|NCT03266237|Vaxigrip|vaxigrip
3874|NCT03266237|Respiratory Tract Infections|respiratory tract infections
3875|NCT03266237|Orthomyxoviridae Infections|orthomyxoviridae infections
3876|NCT03266237|Frailty|frailty
3877|NCT03266237|Aging|aging
3878|NCT03266237|Safety|safety
3879|NCT03266237|Immunogenicity|immunogenicity
3885|NCT03266185|paclitaxel-containing chemotherapy|paclitaxel-containing chemotherapy
3886|NCT03266172|immediate release tablet|immediate release tablet
3887|NCT03266172|GSK2982772|gsk2982772
3888|NCT03266172|Modified release|modified release
3917|NCT03265847|risk for intimate partner homicide|risk for intimate partner homicide
3918|NCT03265821|Smoking|smoking
3919|NCT03265821|Periodontal treatment|periodontal treatment
3920|NCT03265821|Periodontal disease|periodontal disease
3921|NCT03265821|Healing|healing
3922|NCT03265808|stem cells|stem cells
3923|NCT03265782|efficacy|efficacy
3924|NCT03265782|safety|safety
3925|NCT03265782|paracetamol|paracetamol
3926|NCT03265782|ibuprofen|ibuprofen
3927|NCT03265782|PDA|pda
3928|NCT03265782|preterms|preterms
3932|NCT03265730|Outpatient clinics|outpatient clinics
3933|NCT03265730|oral antibiotics|oral antibiotics
3934|NCT03265730|diarrhea|diarrhea
3935|NCT03265704|Maternal PIH|maternal pih
7052|NCT03245853|CXL|cxl
3936|NCT03265704|Neonatal thrombocytopenia|neonatal thrombocytopenia
3937|NCT03265704|Neonatal neutropenia|neonatal neutropenia
3938|NCT03265691|Accidental Falls|accidental falls
3939|NCT03265691|Hyponatremia|hyponatremia
3940|NCT03265691|Elderly|elderly
3941|NCT03265691|Risk factors|risk factors
3942|NCT03265691|Nurse|nurse
3943|NCT03265665|walking|walking
3944|NCT03265665|African American women|african american women
3945|NCT03265665|community-based|community-based
3949|NCT03265587|Feng Shui|feng shui
3950|NCT03265587|Inner harmony|inner harmony
3951|NCT03265587|Chi|chi
3952|NCT03265522|Mediterranean diet|mediterranean diet
3953|NCT03265522|Lifestyle|lifestyle
3954|NCT03265483|Personalized prevention trial|personalized prevention trial
3955|NCT03265483|Magnesium|magnesium
3956|NCT03265483|Vitamin D metabolism and synthesis|vitamin d metabolism and synthesis
3957|NCT03265483|Magnesium-vitamin D interaction|magnesium-vitamin d interaction
3958|NCT03265444|MSA|msa
3971|NCT03265340|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
3972|NCT03265288|Inflammation|inflammation
3973|NCT03265288|Essential Fatty Acids|essential fatty acids
3974|NCT03265288|Inflammation resolution|inflammation resolution
3975|NCT03265288|Docosahexaenoic acid|docosahexaenoic acid
3976|NCT03265288|Lung function|lung function
3977|NCT03265275|Fast track|fast track
3986|NCT03265210|Middle-aged and Older Adults|middle-aged and older adults
3987|NCT03265210|Primary Care|primary care
3988|NCT03265197|Tinnitus|tinnitus
3997|NCT03265132|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
3998|NCT03265028|primary care|primary care
3999|NCT03265028|antibiotics|antibiotics
4000|NCT03265028|communication skills|communication skills
4001|NCT03265028|general practice|general practice
4002|NCT03265028|outpatient|outpatient
4003|NCT03265028|ambulatory care|ambulatory care
4004|NCT03265028|anti-bacterial agents|anti-bacterial agents
4005|NCT03265002|fibre|fibre
4006|NCT03265002|inulin|inulin
4007|NCT03265002|psyllium|psyllium
4008|NCT03265002|small bowel MRI|small bowel mri
4009|NCT03264989|Sickle cell disease|sickle cell disease
4010|NCT03264989|sickle cell anemia|sickle cell anemia
4011|NCT03264989|vaso-occlusive crisis|vaso-occlusive crisis
4012|NCT03264989|P-selectin|p-selectin
4013|NCT03264989|SEG101|seg101
4014|NCT03264989|crizanlizumab|crizanlizumab
4015|NCT03264989|monoclonal antibody|monoclonal antibody
4016|NCT03264989|Anemia, Sickle Cell|anemia, sickle cell
4017|NCT03264989|HbS Disease|hbs disease
4018|NCT03264989|Hemoglobin SC Disease|hemoglobin sc disease
4019|NCT03264989|Sickle Cell Disorders|sickle cell disorders
4020|NCT03264989|Sickling Disorder Due to Hemoglobin S|sickling disorder due to hemoglobin s
4021|NCT03264976|diabetic retinopathy|diabetic retinopathy
4022|NCT03264976|miRNA|mirna
4023|NCT03264976|serum exosomes|serum exosomes
4024|NCT03264976|prognostic biomarker|prognostic biomarker
4025|NCT03264963|Upper airway exercises|upper airway exercises
4026|NCT03264963|Smart phone application|smart phone application
4028|NCT03264937|INR|inr
4029|NCT03264937|Warfarin|warfarin
4030|NCT03264937|social software|social software
4034|NCT03264911|pharyngitis|pharyngitis
4035|NCT03264911|amoxicillin|amoxicillin
4036|NCT03264872|Motivational Interviewing|motivational interviewing
4037|NCT03264859|NGAL|ngal
4038|NCT03264859|STEMI|stemi
4039|NCT03264859|no-reflow|no-reflow
4040|NCT03264859|PCI (Percutaneous Coronary Intervention)|pci (percutaneous coronary intervention)
4041|NCT03264820|digital obstructive arterial disease, DOAD|digital obstructive arterial disease, doad
4042|NCT03264807|Lymph Node 14v|lymph node 14v
4043|NCT03264807|D2 lymphadenectomy|d2 lymphadenectomy
4050|NCT03264768|valves|valves
4051|NCT03264768|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4052|NCT03264768|endoscopic long volume reduction|endoscopic long volume reduction
4053|NCT03264742|ghreline, stroke|ghreline, stroke
4054|NCT03264729|plantar heel pain|plantar heel pain
4055|NCT03264716|TACE (transarterial chemoembolization)|tace (transarterial chemoembolization)
4056|NCT03264716|colorectal liver metastasis|colorectal liver metastasis
4057|NCT03264703|Joint pain|joint pain
4058|NCT03264703|Joint stiffness|joint stiffness
4059|NCT03264703|Joint redness|joint redness
4060|NCT03264703|Loss of joint function|loss of joint function
4061|NCT03264703|Swollen joints|swollen joints
4062|NCT03264690|Crohn's disease|crohn's disease
4063|NCT03264690|Ulcerative colitis|ulcerative colitis
4064|NCT03264677|8-week HUT|8-week hut
4065|NCT03264677|Hydro Boost|hydro boost
4066|NCT03264677|Skin healthy signs|skin healthy signs
4067|NCT03264677|Environmental aggressors|environmental aggressors
4068|NCT03264677|Cosmetic|cosmetic
4069|NCT03264664|E7386|e7386
4070|NCT03264664|dose escalation|dose escalation
4071|NCT03264664|advanced or recurrent neoplasms|advanced or recurrent neoplasms
4072|NCT03264651|Selective androgen receptor modulator|selective androgen receptor modulator
4073|NCT03264651|Aromatase inhibitor|aromatase inhibitor
4074|NCT03264638|PCOS|pcos
4075|NCT03264638|Dingkundan|dingkundan
4078|NCT03264625|Peritoneal dialysis|peritoneal dialysis
4079|NCT03264625|Peritonitis|peritonitis
4080|NCT03264573|Atrophic scar|atrophic scar
4081|NCT03264573|PRP|prp
4082|NCT03264573|ADSCs|adscs
4083|NCT03264560|Telepsychiatry|telepsychiatry
4084|NCT03264560|Synchronous|synchronous
4085|NCT03264560|Asynchronous|asynchronous
4086|NCT03264560|SNF|snf
4087|NCT03264521|Crowdsourcing|crowdsourcing
4088|NCT03264521|Patient Engagement|patient engagement
4089|NCT03264521|Chiropractic|chiropractic
4103|NCT03264404|metastatic pancreatic cancer|metastatic pancreatic cancer
4104|NCT03264404|first-line|first-line
4105|NCT03264391|OCT-A|oct-a
4106|NCT03264391|Retinal vasculitis|retinal vasculitis
4107|NCT03264391|Behcet's disease|behcet's disease
4108|NCT03264365|Health-related quality of life|health-related quality of life
4109|NCT03264365|Anxiety|anxiety
4110|NCT03264365|Depression|depression
4111|NCT03264365|Post-traumatic stress disorder|post-traumatic stress disorder
4112|NCT03264365|Recovery programme|recovery programme
4113|NCT03264365|Rehabilitation|rehabilitation
4114|NCT03264365|Follow-up programme|follow-up programme
4115|NCT03264365|Aftercare|aftercare
4116|NCT03264365|Randomized controlled Trial|randomized controlled trial
4117|NCT03264365|Multicentre|multicentre
4118|NCT03264339|Infant|infant
4119|NCT03264339|Hand/Growth & Development|hand/growth & development
4120|NCT03264339|Motor activity|motor activity
4121|NCT03264339|Exercise|exercise
4122|NCT03264339|Communication|communication
4123|NCT03264313|tobacco|tobacco
4124|NCT03264313|Smoking Cessation|smoking cessation
4126|NCT03264313|Neuromodulation|neuromodulation
4127|NCT03264313|transcranial magnetic stimulation|transcranial magnetic stimulation
4128|NCT03264300|brain tumor, MRI|brain tumor, mri
4129|NCT03264287|acne vulgaris|acne vulgaris
4130|NCT03264287|acupuncture|acupuncture
4131|NCT03264287|cupping|cupping
4132|NCT03264287|ear point tapping|ear point tapping
4133|NCT03264287|randomized controlled trial|randomized controlled trial
4139|NCT03264261|stroke, locomotion|stroke, locomotion
4140|NCT03264248|obesity|obesity
4141|NCT03264248|overweight|overweight
4142|NCT03264248|wheelchair|wheelchair
4143|NCT03264235|Powered-Knee Exoskeleton|powered-knee exoskeleton
4144|NCT03264235|Stair Training|stair training
4145|NCT03264235|Keeogo|keeogo
4146|NCT03264196|condylar hear|condylar hear
4147|NCT03264196|fracture|fracture
4148|NCT03264196|randomised controlled trial|randomised controlled trial
4153|NCT03264131|Brentuximab Vedotin|brentuximab vedotin
4154|NCT03264131|Adcetris|adcetris
4155|NCT03264131|Lymphoma|lymphoma
4156|NCT03264131|Leukemia|leukemia
4157|NCT03264131|CD30|cd30
4158|NCT03264118|Periodontal Guided Tissue Regeneration|periodontal guided tissue regeneration
4159|NCT03264118|Photochemotherapy|photochemotherapy
4160|NCT03264079|RTA 402|rta 402
4161|NCT03264079|Bardoxolone methyl|bardoxolone methyl
4162|NCT03264079|Itraconazole|itraconazole
397545|NCT01252940|HIV|hiv
4163|NCT03264079|Sporanox|sporanox
4164|NCT03264079|CYP3A4|cyp3a4
4165|NCT03264053|socket shield technique|socket shield technique
4166|NCT03264053|crestal bone loss|crestal bone loss
4167|NCT03264053|immediate implanation|immediate implanation
4168|NCT03264040|rounded eyebrows|rounded eyebrows
4169|NCT03264040|large head|large head
4170|NCT03264040|large ears|large ears
4171|NCT03264040|flattened bridge of the nose|flattened bridge of the nose
4172|NCT03264040|deformations of the bones in the spine (vertebrae)|deformations of the bones in the spine (vertebrae)
4173|NCT03263988|pulse contour analysis|pulse contour analysis
4174|NCT03263988|capton|capton
4175|NCT03263988|intraoperative monitoring|intraoperative monitoring
4176|NCT03263962|CHF|chf
4177|NCT03263962|Canrenone|canrenone
4178|NCT03263949|risk prediction|risk prediction
4179|NCT03263949|ventricular arrhythmia|ventricular arrhythmia
4180|NCT03263949|myocardial infarction|myocardial infarction
4181|NCT03263936|Relapse|relapse
4182|NCT03263936|Myelogenous|myelogenous
4183|NCT03263936|Leukemia|leukemia
4184|NCT03263936|Refractory|refractory
4185|NCT03263936|Acute|acute
4186|NCT03263936|Pediatric|pediatric
4187|NCT03263923|grandmother caregivers|grandmother caregivers
4188|NCT03263923|grandfamily|grandfamily
4189|NCT03263923|grandfamilies|grandfamilies
4190|NCT03263923|custodial grandparent|custodial grandparent
4191|NCT03263923|custodial grandmother|custodial grandmother
4192|NCT03263923|multigenerational family|multigenerational family
4193|NCT03263923|Grandmothers raising or living with grandchildren|grandmothers raising or living with grandchildren
4218|NCT03263767|allogenic transplantation|allogenic transplantation
4219|NCT03263767|RIC (reduced-intensity conditioning)|ric (reduced-intensity conditioning)
4221|NCT03263741|S-1|s-1
4222|NCT03263741|Oxaliplatin|oxaliplatin
4223|NCT03263741|Efficiency|efficiency
4224|NCT03263741|safety|safety
4225|NCT03263728|Stress Cardiac Magnetic Resonance|stress cardiac magnetic resonance
4226|NCT03263715|Polymyalgia Rheumatica|polymyalgia rheumatica
4227|NCT03263715|Tocilizumab|tocilizumab
4228|NCT03263715|Glucocorticoid|glucocorticoid
4229|NCT03263715|Glucocorticoid-Sparing|glucocorticoid-sparing
4230|NCT03263702|Persistent Atrial Fibrillation|persistent atrial fibrillation
4231|NCT03263702|mapping|mapping
4232|NCT03263663|colorectal cancer|colorectal cancer
4233|NCT03263663|adjuvant|adjuvant
4234|NCT03263650|prostate cancer|prostate cancer
4235|NCT03263650|genomic alterations|genomic alterations
4236|NCT03263650|DNA damage repair|dna damage repair
4237|NCT03263650|DDR pathway gene expression|ddr pathway gene expression
4238|NCT03263650|aggressive-variant prostate carcinomas|aggressive-variant prostate carcinomas
4239|NCT03263650|small cell prostate carcinoma|small cell prostate carcinoma
4240|NCT03263650|neuroendocrine prostate carcinoma|neuroendocrine prostate carcinoma
4241|NCT03263637|Relapsed or refractory haematological malignancies|relapsed or refractory haematological malignancies
4242|NCT03263637|AZD4573|azd4573
4243|NCT03263637|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4244|NCT03263637|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
4245|NCT03263637|Chronic lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
4246|NCT03263637|High risk Myelodysplastic syndrome (MDS)|high risk myelodysplastic syndrome (mds)
4247|NCT03263637|Chronic Myelomonocytic Leukemia (CML)|chronic myelomonocytic leukemia (cml)
4248|NCT03263637|Richter's syndrome|richter's syndrome
4249|NCT03263637|B-cell Non-Hodgkin Lymphoma (B-cell NHL)|b-cell non-hodgkin lymphoma (b-cell nhl)
4250|NCT03263637|T-cell Non-Hodgkin Lymphoma (T-cell NHL)|t-cell non-hodgkin lymphoma (t-cell nhl)
4251|NCT03263637|Small lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
4252|NCT03263637|Multiple Myeloma (MM)|multiple myeloma (mm)
4253|NCT03263624|psoriasis|psoriasis
4254|NCT03263624|laser|laser
4255|NCT03263624|nail|nail
4256|NCT03263611|disc degeneration|disc degeneration
4257|NCT03263598|liver cirrhosis|liver cirrhosis
4258|NCT03263598|ascites|ascites
4264|NCT03263572|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
4265|NCT03263572|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4266|NCT03263572|ALL|all
4267|NCT03263572|Philadelphia chromosome-positive acute lymphoblastic leukemia|philadelphia chromosome-positive acute lymphoblastic leukemia
4268|NCT03263572|Ph+ ALL|ph+ all
4269|NCT03263572|BCR-ABL-positive ALL|bcr-abl-positive all
4270|NCT03263572|ALL relapsed or refractory|all relapsed or refractory
4271|NCT03263572|Methotrexate|methotrexate
4272|NCT03263572|Cytarabine|cytarabine
4273|NCT03263572|Ara-C|ara-c
4274|NCT03263572|Cytosar|cytosar
4275|NCT03263572|DepoCyt|depocyt
4276|NCT03263572|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
4277|NCT03263572|Blinatumomab|blinatumomab
4278|NCT03263572|Dexamethasone|dexamethasone
4279|NCT03263572|Decadron|decadron
4280|NCT03263572|Ponatinib|ponatinib
4281|NCT03263572|Iclusig|iclusig
4282|NCT03263572|AP24534|ap24534
496657|NCT00176592|MRI|mri
4283|NCT03263559|Reduced Intensity Conditioning|reduced intensity conditioning
4297|NCT03263455|range of motion|range of motion
4298|NCT03263416|Metastatic solid tumor|metastatic solid tumor
4299|NCT03263416|Oral Targeted Therapy|oral targeted therapy
4300|NCT03263416|Treatment adherence|treatment adherence
4301|NCT03263403|Meningococcal Vaccine, Ingovax ACWY, adults, Bangladeshi, immunogenicity.|meningococcal vaccine, ingovax acwy, adults, bangladeshi, immunogenicity.
4302|NCT03263390|Obesity|obesity
4303|NCT03263390|Bariatric Surgery|bariatric surgery
4304|NCT03263390|Anti Obesity Medications|anti obesity medications
4305|NCT03263390|Weight Regulation|weight regulation
4306|NCT03263390|Pluripotent Stem Cells|pluripotent stem cells
4307|NCT03263377|School feeding|school feeding
4308|NCT03263377|Fortified Biscuits|fortified biscuits
4309|NCT03263377|Bangladesh|bangladesh
4313|NCT03263273|Minocycline|minocycline
4314|NCT03263273|Topical|topical
4315|NCT03263273|Tetracycline|tetracycline
4316|NCT03263273|Doxycycline|doxycycline
4317|NCT03263273|Rosacea|rosacea
4318|NCT03263273|Skin Disease|skin disease
4319|NCT03263273|Anti-Bacterial Agent|anti-bacterial agent
4320|NCT03263273|Anti-Inflammatory Agent|anti-inflammatory agent
4321|NCT03263260|stent, DES, Inspiron|stent, des, inspiron
4326|NCT03263182|childbirth|childbirth
4327|NCT03263182|delivery|delivery
4328|NCT03263169|e-health, community networks, pragmatic RCT|e-health, community networks, pragmatic rct
4333|NCT03263130|COPD, Emphysema, Asthma COPD Overlap|copd, emphysema, asthma copd overlap
4334|NCT03263117|Acute stroke|acute stroke
4335|NCT03263117|Cerebral Stroke|cerebral stroke
4336|NCT03263091|Myelodysplastic Syndromes|myelodysplastic syndromes
4337|NCT03263091|Anemia|anemia
4338|NCT03263091|Hemoglobin (Hb)|hemoglobin (hb)
4339|NCT03263091|Low Risk Myelodysplastic Syndrome|low risk myelodysplastic syndrome
4340|NCT03263091|Low Risk MDS|low risk mds
4341|NCT03263078|inhalation,intravenous anesthesia|inhalation,intravenous anesthesia
4342|NCT03263065|Nopal|nopal
4343|NCT03263065|Bran|bran
4344|NCT03263065|Psyllium|psyllium
4345|NCT03263052|kidney transplant|kidney transplant
4346|NCT03263052|immunosuppression|immunosuppression
4347|NCT03263052|tacrolimus XR|tacrolimus xr
4348|NCT03263052|elderly|elderly
4349|NCT03263052|quality of life|quality of life
4350|NCT03263052|neurological adverse events|neurological adverse events
4351|NCT03263039|Programmed Cell Death 1 Receptor|programmed cell death 1 receptor
4352|NCT03263039|Pembrolizumab|pembrolizumab
4353|NCT03263039|Keytruda|keytruda
4354|NCT03263039|MK-3475|mk-3475
4355|NCT03263039|Urothelial Carcinoma|urothelial carcinoma
4363|NCT03262974|Imatinib|imatinib
4364|NCT03262974|Pharmacogenetics|pharmacogenetics
4365|NCT03262974|CML|cml
4366|NCT03262974|Plasma level|plasma level
4367|NCT03262961|Mild pre-eclampsia Sildenafil Citrate|mild pre-eclampsia sildenafil citrate
4368|NCT03262922|systemic scleroderma|systemic scleroderma
4369|NCT03262922|environmental and professional toxics|environmental and professional toxics
4370|NCT03262896|Brain Death|brain death
4371|NCT03262896|Spinal Reflex|spinal reflex
4372|NCT03262896|Electromyography|electromyography
4373|NCT03262883|Prolonged akut mechanical ventilation|prolonged akut mechanical ventilation
4374|NCT03262883|Tracheotomy|tracheotomy
4375|NCT03262857|magnesium sulfate|magnesium sulfate
4376|NCT03262857|pulpitis|pulpitis
4377|NCT03262857|anesthesia|anesthesia
4378|NCT03262805|Knee OA|knee oa
4379|NCT03262805|Joint Pain|joint pain
4380|NCT03262805|Dietary supplement|dietary supplement
4381|NCT03262805|WOMAC|womac
4382|NCT03262805|Lequesne index|lequesne index
4383|NCT03262805|hs-CRP|hs-crp
4395|NCT03262675|Chronic Heat Failure|chronic heat failure
4396|NCT03262675|Cardiovascular diseases|cardiovascular diseases
4397|NCT03262675|Heart diseases|heart diseases
4399|NCT03262675|Tunisia|tunisia
4400|NCT03262597|fluid balance|fluid balance
4401|NCT03262597|dehydration|dehydration
4402|NCT03262597|rehydration|rehydration
4403|NCT03262597|electrolytes|electrolytes
4404|NCT03262597|urine|urine
4405|NCT03262571|Heart failure|heart failure
4406|NCT03262571|Lung ultrasound|lung ultrasound
4407|NCT03262571|B-lines|b-lines
4408|NCT03262558|staphylococcus aureus|staphylococcus aureus
4409|NCT03262558|nosocomial infection|nosocomial infection
4410|NCT03262532|Interactive web-base simulation|interactive web-base simulation
4411|NCT03262493|intubation, gastrointestinal|intubation, gastrointestinal
4412|NCT03262493|nursing|nursing
4413|NCT03262493|clinical trial|clinical trial
4414|NCT03262493|enteral nutrition|enteral nutrition
4415|NCT03262441|HIV|hiv
4416|NCT03262441|Antiretroviral treatment|antiretroviral treatment
4417|NCT03262441|Mycophenolate mofetil|mycophenolate mofetil
4418|NCT03262441|Cure|cure
4419|NCT03262441|Latency|latency
4420|NCT03262441|Reservoir|reservoir
4421|NCT03262441|CD4 T cell|cd4 t cell
4422|NCT03262441|Anti-proliferation|anti-proliferation
402890|NCT01229267|Herpes zoster|herpes zoster
4423|NCT03262415|LabPatch Continuous Glucose Monitoring (CGM)|labpatch continuous glucose monitoring (cgm)
4424|NCT03262402|Chronic periodontitis|chronic periodontitis
4425|NCT03262402|Candida spp|candida spp
4426|NCT03262402|Histatin-5|histatin-5
4427|NCT03262402|Lactoferrin|lactoferrin
4428|NCT03262389|positron emission tomography (PET)|positron emission tomography (pet)
4429|NCT03262389|computerized tomography (CT)|computerized tomography (ct)
4430|NCT03262389|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4431|NCT03262389|Fludeoxyglucose (F-18 FDG)|fludeoxyglucose (f-18 fdg)
4432|NCT03262389|C-11 acetate|c-11 acetate
4433|NCT03262376|Magnesium|magnesium
4434|NCT03262376|Stress|stress
4435|NCT03262376|Green tea|green tea
4436|NCT03262376|Rhodiola|rhodiola
4437|NCT03262376|Anxiety|anxiety
4438|NCT03262376|Cortisol|cortisol
4439|NCT03262363|nutrigenomics|nutrigenomics
4440|NCT03262363|Diet-gene interaction,|diet-gene interaction,
4441|NCT03262363|Curcumin,|curcumin,
4442|NCT03262363|Antioxidants,|antioxidants,
4443|NCT03262363|Human NFE2L2 protein,|human nfe2l2 protein,
4444|NCT03262363|Polymorphism,|polymorphism,
4445|NCT03262363|Diabetes,|diabetes,
4446|NCT03262363|Chronic kidney disease|chronic kidney disease
4447|NCT03262324|Foot and Ankle|foot and ankle
4448|NCT03262324|Disorders|disorders
4449|NCT03262324|Outcome Measure|outcome measure
4450|NCT03262298|CD22|cd22
4451|NCT03262298|CAR-T|car-t
4452|NCT03262298|Leukemia|leukemia
4453|NCT03262298|Lymphoma|lymphoma
4454|NCT03262220|Haematological malignancy|haematological malignancy
4455|NCT03262220|Total Marrow Irradiation|total marrow irradiation
4456|NCT03262220|Volumetric Arc Therapy|volumetric arc therapy
4457|NCT03262181|Exercise|exercise
4458|NCT03262181|Physical Activity|physical activity
4459|NCT03262181|Biomechanics|biomechanics
4460|NCT03262168|Exercise|exercise
4461|NCT03262168|Physical Activity|physical activity
4462|NCT03262142|COPD|copd
4463|NCT03262142|Pseudomonas Aeruginosa|pseudomonas aeruginosa
4464|NCT03262116|bionic pancreas|bionic pancreas
4465|NCT03262116|insulin|insulin
4466|NCT03262116|continuous glucose monitor|continuous glucose monitor
4468|NCT03262116|insulin pharmacokinetics|insulin pharmacokinetics
4469|NCT03262103|Prostate Cancer|prostate cancer
4470|NCT03262103|Gleason 8-10|gleason 8-10
4471|NCT03262103|Immunotherapy|immunotherapy
4472|NCT03262103|Neoadjuvant|neoadjuvant
4473|NCT03262090|Emergence Delirium|emergence delirium
4474|NCT03262090|desoflurane|desoflurane
4475|NCT03262090|general anesthesia|general anesthesia
4476|NCT03262077|photodynamic therapy|photodynamic therapy
4477|NCT03262077|periodontal disease|periodontal disease
4478|NCT03262077|dosimetry|dosimetry
4479|NCT03262077|methylene blue|methylene blue
4480|NCT03262051|cytochrome|cytochrome
4481|NCT03262051|chronic inflammation|chronic inflammation
4482|NCT03262051|genotyping|genotyping
4483|NCT03262051|phenotyping|phenotyping
4484|NCT03262051|acute inflammation|acute inflammation
4485|NCT03262051|rheumatoid arthritis|rheumatoid arthritis
4486|NCT03262038|intrathecal morphine|intrathecal morphine
4487|NCT03262025|Primary cecal pathology|primary cecal pathology
4687|NCT03260712|cisplatin|cisplatin
4488|NCT03262025|Emergency laparotomy|emergency laparotomy
4489|NCT03262025|Ruptured liver abscess|ruptured liver abscess
4490|NCT03262025|Right hemicolectomy|right hemicolectomy
4491|NCT03262025|Conservative colonic resection|conservative colonic resection
4492|NCT03262025|Fulminant amoebic colitis|fulminant amoebic colitis
4493|NCT03262025|Ileocecal resection|ileocecal resection
4494|NCT03262025|Ileoascending anastomosis|ileoascending anastomosis
4495|NCT03262025|Ileotransverse anastomosis|ileotransverse anastomosis
4496|NCT03262025|Cecal diverticulitis|cecal diverticulitis
4497|NCT03262025|Amoebic typhilitis|amoebic typhilitis
4498|NCT03262025|Idiopathic typhilitis|idiopathic typhilitis
4499|NCT03261999|Prostate Neoplasm Cancer Carcinoma|prostate neoplasm cancer carcinoma
4500|NCT03261986|Trident|trident
4502|NCT03261986|THA|tha
4503|NCT03261947|Drug therapy|drug therapy
4504|NCT03261934|Chronic Atrophic Gastritis|chronic atrophic gastritis
4505|NCT03261934|Malignant Transformation|malignant transformation
4506|NCT03261934|Risk Assessment|risk assessment
4507|NCT03261934|Syndrome Evolution|syndrome evolution
4621|NCT03261102|Crohn|crohn
4508|NCT03261934|Traditional Chinese Medicine|traditional chinese medicine
4509|NCT03261934|Registry Study|registry study
4510|NCT03261869|Ice pack therapy, third molar surgery, swelling, pain, trismus|ice pack therapy, third molar surgery, swelling, pain, trismus
4511|NCT03261856|Breath test|breath test
4512|NCT03261856|SIBO|sibo
4513|NCT03261856|GI|gi
4514|NCT03261843|platelet rich plasma , posterior lumbar interbody fusion|platelet rich plasma , posterior lumbar interbody fusion
4515|NCT03261830|Antibiotic|antibiotic
4516|NCT03261830|Pediatric|pediatric
4517|NCT03261817|web|web
4518|NCT03261817|brain imaging|brain imaging
4519|NCT03261817|heart rate variability|heart rate variability
4520|NCT03261817|circadian cycles|circadian cycles
397813|NCT01251757|IVR|ivr
4521|NCT03261817|cognition|cognition
4522|NCT03261817|well-being|well-being
4523|NCT03261817|hippocampus|hippocampus
4524|NCT03261817|N acetyl aspartate|n acetyl aspartate
4525|NCT03261817|white matter|white matter
4526|NCT03261817|physical activity|physical activity
4527|NCT03261791|hepatocellular carcinoma|hepatocellular carcinoma
4528|NCT03261791|apatinib|apatinib
4529|NCT03261791|portal vein invasion|portal vein invasion
4530|NCT03261791|adjuvant therapy|adjuvant therapy
4536|NCT03261713|rehabilitation|rehabilitation
4537|NCT03261713|telerehabilitation|telerehabilitation
4538|NCT03261713|feasibility studies|feasibility studies
4539|NCT03261713|virtual reality|virtual reality
4540|NCT03261700|women Veterans|women veterans
4541|NCT03261700|interpersonal violence|interpersonal violence
4542|NCT03261687|pregnancy|pregnancy
4543|NCT03261687|pelvic girdle pain|pelvic girdle pain
4544|NCT03261687|hydrotherapy|hydrotherapy
4545|NCT03261687|quality of life|quality of life
4546|NCT03261687|physical therapy|physical therapy
4547|NCT03261674|Insomnia|insomnia
4548|NCT03261674|Traumatic Brain Injury|traumatic brain injury
4549|NCT03261674|Cognitive Behavioral Therapy|cognitive behavioral therapy
4550|NCT03261674|Veterans|veterans
4551|NCT03261622|Sacral Nerve Stimulation|sacral nerve stimulation
4552|NCT03261622|Sacral Nerve Modulation|sacral nerve modulation
4553|NCT03261609|extremely preterm|extremely preterm
4554|NCT03261609|young adults|young adults
4555|NCT03261609|CVD risks factors|cvd risks factors
4556|NCT03261609|inflammation|inflammation
4557|NCT03261609|chronic health conditions|chronic health conditions
4558|NCT03261609|term|term
4559|NCT03261596|Soil-transmitted helminth|soil-transmitted helminth
4560|NCT03261596|hookworm|hookworm
4561|NCT03261596|hookworm infections|hookworm infections
4562|NCT03261596|necator americanus|necator americanus
4563|NCT03261596|ancylostoma duodenale|ancylostoma duodenale
4564|NCT03261570|Postural Orthostatic Tachycardia Syndrome (POTS)|postural orthostatic tachycardia syndrome (pots)
4565|NCT03261570|POTS|pots
4566|NCT03261570|Orthostatic Intolerance|orthostatic intolerance
4567|NCT03261570|Digoxin|digoxin
4568|NCT03261570|Pyridostigmine|pyridostigmine
4569|NCT03261570|Mestinon|mestinon
4570|NCT03261531|Overweight|overweight
4571|NCT03261531|Class I Obesity|class i obesity
4572|NCT03261518|ileus|ileus
4573|NCT03261518|Contrast-induced Nephropathy|contrast-induced nephropathy
4574|NCT03261518|vena cava inferior|vena cava inferior
4575|NCT03261505|fMRI|fmri
4576|NCT03261505|acupuncture|acupuncture
4577|NCT03261505|osteoarthritis|osteoarthritis
4578|NCT03261479|pneumonia|pneumonia
4579|NCT03261479|thermal imaging|thermal imaging
4580|NCT03261479|respiratory distress|respiratory distress
4581|NCT03261479|x-ray|x-ray
4582|NCT03261479|thermal|thermal
4583|NCT03261466|obesity|obesity
4584|NCT03261466|paediatric|paediatric
4585|NCT03261466|probiotic|probiotic
4586|NCT03261401|Healthy Subjects|healthy subjects
4587|NCT03261401|M5717|m5717
4588|NCT03261401|Malaria|malaria
4589|NCT03261401|Plasmodium falciparum|plasmodium falciparum
4590|NCT03261349|Follicular lymphoma|follicular lymphoma
4591|NCT03261349|MALT lymphoma|malt lymphoma
4592|NCT03261349|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
4593|NCT03261349|Hepatitis C virus|hepatitis c virus
4594|NCT03261323|Breast Reconstruction|breast reconstruction
4595|NCT03261323|Mastectomy|mastectomy
4596|NCT03261310|acetaminophen|acetaminophen
4597|NCT03261310|pain|pain
4598|NCT03261310|laminectomy|laminectomy
4599|NCT03261310|craniotomy|craniotomy
4600|NCT03261284|D-dimer|d-dimer
4601|NCT03261284|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
4602|NCT03261284|Direct thrombin inhibitor|direct thrombin inhibitor
4603|NCT03261284|INR|inr
4604|NCT03261193|quadratus lumborum block|quadratus lumborum block
4605|NCT03261193|post-operative pain|post-operative pain
4606|NCT03261193|cesarean section pain|cesarean section pain
4607|NCT03261193|analgesia|analgesia
4608|NCT03261193|nerve block|nerve block
4615|NCT03261154|Serum iPTH|serum ipth
4616|NCT03261154|Calcium|calcium
4617|NCT03261154|Phosphate|phosphate
4618|NCT03261128|cancer|cancer
4619|NCT03261128|chemotherapy|chemotherapy
4620|NCT03261102|IBD|ibd
4622|NCT03261102|adalimumab|adalimumab
4623|NCT03261102|ADAL|adal
4624|NCT03261089|coma, prognosis, cardiac arrest|coma, prognosis, cardiac arrest
4625|NCT03261076|Specific Learning Disorder|specific learning disorder
4626|NCT03261076|Learning Disorders|learning disorders
4627|NCT03261076|Neurodevelopmental Disorders|neurodevelopmental disorders
4628|NCT03261076|Mental Disorders|mental disorders
4629|NCT03261076|Developmental Reading Disability|developmental reading disability
4630|NCT03261076|Reading Disorder|reading disorder
4631|NCT03261076|Conduct Disorder|conduct disorder
4632|NCT03261050|Eating disorder|eating disorder
4633|NCT03261050|Counter attitudinal therapy|counter attitudinal therapy
4634|NCT03261050|fMRI|fmri
4635|NCT03261024|En-masse retraction , Class I bimaxillary protrusion|en-masse retraction , class i bimaxillary protrusion
4636|NCT03261011|immunotherapy|immunotherapy
4637|NCT03261011|immuno-oncology|immuno-oncology
4638|NCT03261011|advanced solid tumors|advanced solid tumors
4639|NCT03260920|oxytocin|oxytocin
4640|NCT03260920|frontotemporal dementia|frontotemporal dementia
4641|NCT03260920|apathy|apathy
4642|NCT03260920|empathy|empathy
4643|NCT03260907|Overactive bladder|overactive bladder
4644|NCT03260907|menopause|menopause
4645|NCT03260907|Postmenopausal overactive bladder|postmenopausal overactive bladder
4646|NCT03260907|Electroacupuncture|electroacupuncture
4647|NCT03260894|Renal cell carcinoma|renal cell carcinoma
4648|NCT03260894|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
4649|NCT03260894|indoleamine 2|indoleamine 2
4650|NCT03260894|3-deoxygenase 1 (IDO1) inhibitor|3-deoxygenase 1 (ido1) inhibitor
4651|NCT03260881|Epicardial Fat|epicardial fat
4652|NCT03260855|Lymphoma|lymphoma
4653|NCT03260855|Cancer survivorship|cancer survivorship
4654|NCT03260855|Fear|fear
4655|NCT03260842|early detection|early detection
4656|NCT03260842|biomarkers|biomarkers
4657|NCT03260842|pancreas cancer|pancreas cancer
4658|NCT03260829|vitamin C|vitamin c
4659|NCT03260829|palatally impacted canines|palatally impacted canines
4660|NCT03260829|intraepidermal injection|intraepidermal injection
4661|NCT03260816|Preschoolers|preschoolers
4662|NCT03260816|Developmental Delay|developmental delay
4663|NCT03260816|Disruptive Behavior|disruptive behavior
4664|NCT03260816|Early Intervention|early intervention
4665|NCT03260816|Parent-Child Interaction Therapy (PCIT)|parent-child interaction therapy (pcit)
4666|NCT03260816|Telehealth|telehealth
4667|NCT03260816|Telemental Health|telemental health
4668|NCT03260816|Telepsychiatry|telepsychiatry
4669|NCT03260803|osteopenia|osteopenia
4670|NCT03260803|oligopin|oligopin
4671|NCT03260803|postmenopause|postmenopause
4672|NCT03260803|antioxidant|antioxidant
4673|NCT03260803|bone|bone
4674|NCT03260790|Vaccine|vaccine
4675|NCT03260790|Pneumococcal|pneumococcal
4676|NCT03260790|Pneumonia|pneumonia
4677|NCT03260764|Multifocal Contact Lenses|multifocal contact lenses
4678|NCT03260764|Bifocal Spectacles|bifocal spectacles
4679|NCT03260764|Congenital Cataracts|congenital cataracts
4680|NCT03260738|Chronic Low Back Pain|chronic low back pain
4681|NCT03260738|Rehabilitation|rehabilitation
4682|NCT03260738|Robot Poppy|robot poppy
4683|NCT03260712|biliary tract cancer|biliary tract cancer
4684|NCT03260712|metastitic cancer|metastitic cancer
4685|NCT03260712|advanced cancer|advanced cancer
4686|NCT03260712|pembrolizumab|pembrolizumab
4697|NCT03260582|cardiac rehabilitation|cardiac rehabilitation
4699|NCT03260582|smartphone application|smartphone application
4700|NCT03260569|Mechanical ventilation|mechanical ventilation
4701|NCT03260569|Inhaled nitric oxide|inhaled nitric oxide
4702|NCT03260556|pulmonary fibrosis|pulmonary fibrosis
4703|NCT03260543|ginseng powder|ginseng powder
4704|NCT03260543|Fatty Liver|fatty liver
4705|NCT03260543|Clinical Trial|clinical trial
4706|NCT03260491|Oncology|oncology
4707|NCT03260491|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
4708|NCT03260491|Inoperable Non-small Cell Lung Cancer|inoperable non-small cell lung cancer
4709|NCT03260491|Metastatic|metastatic
4710|NCT03260491|Unresectable|unresectable
4711|NCT03260491|Epidermal growth factor receptor|epidermal growth factor receptor
4712|NCT03260491|EGFR|egfr
4713|NCT03260478|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
4714|NCT03260478|Red Blood Cells (RBC) Transfusion|red blood cells (rbc) transfusion
4715|NCT03260478|Intensive Care Unit (ICU)|intensive care unit (icu)
4716|NCT03260478|Transfusion Threshold|transfusion threshold
4717|NCT03260478|Anemia|anemia
4718|NCT03260478|Oxygen Delivery|oxygen delivery
4719|NCT03260478|Neurocritical Care|neurocritical care
4720|NCT03260478|Critical Care Neurology and Trauma|critical care neurology and trauma
4721|NCT03260465|total hip replacement|total hip replacement
4722|NCT03260465|roentgen stereophotogrammetric analysis|roentgen stereophotogrammetric analysis
4723|NCT03260452|Type 2 diabetes|type 2 diabetes
4724|NCT03260452|Adipose tissue|adipose tissue
4725|NCT03260452|Hematopoiesis|hematopoiesis
4726|NCT03260452|Inflammation|inflammation
4727|NCT03260452|Macrophages|macrophages
4838|NCT03259672|remifentanil|remifentanil
4728|NCT03260439|tramadol-penile block -circumcision surgery-anesthesia-child|tramadol-penile block -circumcision surgery-anesthesia-child
4730|NCT03260400|RPNI|rpni
4731|NCT03260400|Regenerative Peripheral Nerve Interface|regenerative peripheral nerve interface
4732|NCT03260335|Challenging behaviour|challenging behaviour
4733|NCT03260335|Biofeedback|biofeedback
4734|NCT03260335|Anxiety management|anxiety management
4735|NCT03260322|Oncology|oncology
4736|NCT03260322|Tumors|tumors
4737|NCT03260322|ASP8374|asp8374
398014|NCT01250691|ICU|icu
4738|NCT03260322|Locally advanced or metastatic solid tumor malignancies|locally advanced or metastatic solid tumor malignancies
4739|NCT03260296|smartphones addiction|smartphones addiction
4740|NCT03260283|pethidine|pethidine
4741|NCT03260257|Neurofeedback, Gamma band response|neurofeedback, gamma band response
4742|NCT03260244|atrial fibrillation|atrial fibrillation
4743|NCT03260244|atrial flutter|atrial flutter
4744|NCT03260244|supraventricular tachycardia|supraventricular tachycardia
4745|NCT03260244|ventricular tachycardia|ventricular tachycardia
4746|NCT03260244|premature ventricular contractions|premature ventricular contractions
4747|NCT03260244|cardiac mapping system|cardiac mapping system
4758|NCT03260192|circulating tumor DNA|circulating tumor dna
4759|NCT03260166|nicotinamide|nicotinamide
4760|NCT03260166|lupus-associated skin lesion|lupus-associated skin lesion
4761|NCT03260166|lupus erythematosus|lupus erythematosus
4762|NCT03260153|Intracerebral Hemorrhage|intracerebral hemorrhage
4763|NCT03260153|Perihematomal edema|perihematomal edema
4764|NCT03260153|Deproteinised Calf Blood Serum Injection|deproteinised calf blood serum injection
4765|NCT03260140|weight loss|weight loss
4766|NCT03260140|lifestyle|lifestyle
4767|NCT03260140|diet|diet
4768|NCT03260140|exercise|exercise
4769|NCT03260140|randomized controlled trial|randomized controlled trial
4770|NCT03260127|PTSD|ptsd
4771|NCT03260127|treatment|treatment
4772|NCT03260127|posttraumatic stress disorder|posttraumatic stress disorder
4773|NCT03260127|therapy|therapy
4774|NCT03260127|cognition|cognition
4775|NCT03260127|thinking|thinking
4776|NCT03260127|executive function|executive function
4777|NCT03260127|computer|computer
4778|NCT03260127|training|training
4779|NCT03260114|Physical activity|physical activity
4780|NCT03260114|Body weight|body weight
4781|NCT03260114|Obesity|obesity
4782|NCT03260062|cochlear implants|cochlear implants
4783|NCT03260062|language development|language development
4784|NCT03260062|parenting intervention|parenting intervention
4785|NCT03260062|maternal sensitivity|maternal sensitivity
4786|NCT03260062|facilitative language techniques|facilitative language techniques
4787|NCT03260036|Urea synthesis|urea synthesis
4788|NCT03260036|Ammonia|ammonia
4789|NCT03260036|Bariatric surgery|bariatric surgery
4790|NCT03260023|Avelumab|avelumab
4791|NCT03260023|Cancer|cancer
4792|NCT03260023|Anti PD-L1|anti pd-l1
4793|NCT03260023|Therapeutic Vaccine|therapeutic vaccine
4799|NCT03259919|Androgens|androgens
4800|NCT03259893|Proctor Conceptual Model of Implementation Research|proctor conceptual model of implementation research
4801|NCT03259893|Prevention|prevention
4802|NCT03259893|Safety net hospital|safety net hospital
4803|NCT03259893|Diverse inner city patients|diverse inner city patients
4804|NCT03259880|evaluation|evaluation
4805|NCT03259867|Hepatocellular carcinoma|hepatocellular carcinoma
4806|NCT03259867|colorectal cancer|colorectal cancer
4807|NCT03259867|checkpoint inhibitor|checkpoint inhibitor
4808|NCT03259828|Sigmoid colon cancer|sigmoid colon cancer
4809|NCT03259828|Internal organ motion|internal organ motion
4810|NCT03259828|Radiotherapy|radiotherapy
4811|NCT03259815|FFR Targeted PCI|ffr targeted pci
4812|NCT03259815|Post-PCI FFR|post-pci ffr
4813|NCT03259776|Intensive Care|intensive care
4814|NCT03259776|Patient- and Family-Centred Care|patient- and family-centred care
4815|NCT03259776|Patient and Public Involvement|patient and public involvement
4816|NCT03259776|South West London Major Trauma Network|south west london major trauma network
4817|NCT03259776|Service Improvement|service improvement
4818|NCT03259776|Survey Questionnaire|survey questionnaire
4819|NCT03259776|Visitor Experiences|visitor experiences
4820|NCT03259763|Gastroenterostomy|gastroenterostomy
4821|NCT03259763|Gastric Outlet Obstruction|gastric outlet obstruction
4822|NCT03259763|Cancer|cancer
4823|NCT03259763|Endosonography|endosonography
4824|NCT03259750|Self-reported outcome instrument|self-reported outcome instrument
4825|NCT03259750|Sport|sport
4826|NCT03259750|Ankle and foot|ankle and foot
4827|NCT03259750|Injury|injury
4828|NCT03259711|Cardiotoxicity|cardiotoxicity
4829|NCT03259711|selective estrogen receptor modulators|selective estrogen receptor modulators
4830|NCT03259711|aromatase inhibitors|aromatase inhibitors
4831|NCT03259711|hormone replacement therapy|hormone replacement therapy
4832|NCT03259711|estrogen|estrogen
4833|NCT03259685|Non-nutritive sweeteners|non-nutritive sweeteners
4834|NCT03259685|High Sugar Sweetened Beverages|high sugar sweetened beverages
4835|NCT03259685|Diet|diet
4836|NCT03259672|intubation|intubation
4837|NCT03259672|pharyngitis|pharyngitis
602141|NCT00588562|PHIII|phiii
4839|NCT03259633|Neurofibromatosis type1,|neurofibromatosis type1,
4840|NCT03259633|Plexiform Neurofibromas|plexiform neurofibromas
4841|NCT03259633|inoperable, progressive/symptomatic plexiform neurofibromas (PN) without any alternative therapeutic options|inoperable, progressive/symptomatic plexiform neurofibromas (pn) without any alternative therapeutic options
4842|NCT03259633|mutation in the NF1 gene|mutation in the nf1 gene
4843|NCT03259633|Selumetinib|selumetinib
4844|NCT03259633|Early Access|early access
4845|NCT03259633|Intermediate Access Protocol|intermediate access protocol
4846|NCT03259607|Bioequivalence|bioequivalence
4847|NCT03259594|Renal functional reserve|renal functional reserve
4848|NCT03259594|Simple renal cysts|simple renal cysts
4849|NCT03259594|Laparoscopic deroofing|laparoscopic deroofing
4850|NCT03259581|transarterial chemoembolization|transarterial chemoembolization
4851|NCT03259568|TMS|tms
4852|NCT03259555|Brexpiprazole|brexpiprazole
4853|NCT03259555|Bipolar|bipolar
4854|NCT03259555|Manic episode|manic episode
4855|NCT03259529|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
4856|NCT03259529|Nivolumab|nivolumab
4857|NCT03259529|Bendamustine Hydrochloride|bendamustine hydrochloride
4858|NCT03259529|Gemcitabine|gemcitabine
4859|NCT03259529|Rituximab|rituximab
4860|NCT03259516|myelodysplastic syndrome|myelodysplastic syndrome
4861|NCT03259516|nivolumab|nivolumab
4862|NCT03259516|5-azacitidine|5-azacitidine
4863|NCT03259516|cytarabine|cytarabine
4864|NCT03259516|melphalan|melphalan
4865|NCT03259516|all-trans retinoic acid|all-trans retinoic acid
4866|NCT03259516|lymphodepletion|lymphodepletion
4867|NCT03259503|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
4868|NCT03259503|Lymphoma|lymphoma
4869|NCT03259503|Refractory|refractory
4870|NCT03259503|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4871|NCT03259503|DLBCL|dlbcl
4872|NCT03259503|Palifermin|palifermin
4873|NCT03259503|Kepivance|kepivance
4874|NCT03259503|Olaparib|olaparib
4875|NCT03259503|Lynparza|lynparza
4876|NCT03259503|Vorinostat|vorinostat
4877|NCT03259503|SAHA|saha
4878|NCT03259503|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
4879|NCT03259503|MSK-390|msk-390
4880|NCT03259503|Zolinza|zolinza
4881|NCT03259503|Dexamethasone|dexamethasone
4882|NCT03259503|Decadron|decadron
7811|NCT03240510|Male|male
4886|NCT03259503|Melphalan|melphalan
4887|NCT03259503|Alkeran|alkeran
4888|NCT03259503|Evomela|evomela
4889|NCT03259503|Glutamine|glutamine
4890|NCT03259503|Enterex|enterex
4891|NCT03259503|Glutapak-10|glutapak-10
4892|NCT03259503|NutreStore|nutrestore
4893|NCT03259503|Resource|resource
4894|NCT03259503|GlutaSolve|glutasolve
4895|NCT03259503|Sympt-X G.I|sympt-x g.i
4896|NCT03259503|Sympt-X|sympt-x
4897|NCT03259503|Gemcitabine|gemcitabine
4898|NCT03259503|Gemcitabine Hydrochloride|gemcitabine hydrochloride
4899|NCT03259503|Gemzar|gemzar
4900|NCT03259503|Busulfan|busulfan
4901|NCT03259503|Busulfex|busulfex
4902|NCT03259503|Myleran|myleran
4903|NCT03259503|Pyridoxine|pyridoxine
4904|NCT03259503|Autologous Stem-Cell Transplant|autologous stem-cell transplant
4905|NCT03259503|ASCT|asct
4906|NCT03259503|G-CSF|g-csf
4907|NCT03259503|Filgrastim|filgrastim
4908|NCT03259503|Neupogen|neupogen
4909|NCT03259477|laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
4910|NCT03259477|precise segmental renal arterial clamping|precise segmental renal arterial clamping
4911|NCT03259477|renal cell carcinoma|renal cell carcinoma
4912|NCT03259477|renal functional reserve|renal functional reserve
4913|NCT03259438|Qigong|qigong
4914|NCT03259438|Comprehensive Health Improvement Program (CHIP)|comprehensive health improvement program (chip)
4915|NCT03259438|Pre-Train Injury Prevention Program|pre-train injury prevention program
4916|NCT03259438|Cancer Related Fatigue|cancer related fatigue
4917|NCT03259438|Cancer Survivorship|cancer survivorship
4918|NCT03259438|Inflammation|inflammation
4919|NCT03259438|Flowmetry|flowmetry
4920|NCT03259438|Corticomuscular coherence|corticomuscular coherence
4921|NCT03259438|Heart Rate Variability|heart rate variability
4922|NCT03259438|Neuroimmune Interactions|neuroimmune interactions
4923|NCT03259438|Complex Systems Analysis|complex systems analysis
4924|NCT03259438|Female|female
4925|NCT03259425|Resectable Stage IIIB, IIIC, and IVM1a|resectable stage iiib, iiic, and ivm1a
4926|NCT03259373|AF|af
4927|NCT03259373|AFib|afib
4928|NCT03259373|OAC|oac
4929|NCT03259373|Atrial fibrillation|atrial fibrillation
4930|NCT03259373|Oral anticoagulant|oral anticoagulant
4931|NCT03259373|Education|education
4932|NCT03259360|Tobacco|tobacco
4933|NCT03259360|Gender Identity Minority|gender identity minority
4934|NCT03259360|Sexual Identity Minority|sexual identity minority
4935|NCT03259360|Cessation|cessation
4936|NCT03259360|Intervention|intervention
4937|NCT03259360|Young Adults|young adults
4938|NCT03259360|Social Media|social media
4939|NCT03259360|Internet|internet
4940|NCT03259360|Cigarette|cigarette
4941|NCT03259321|Fish|fish
4942|NCT03259321|Polyunsaturated fatty acids|polyunsaturated fatty acids
4943|NCT03259321|CHNS|chns
4944|NCT03259295|skin tag|skin tag
402892|NCT01229267|herpes zoster-related complications|herpes zoster-related complications
4945|NCT03259243|Bupivacaine, Port site infiltration ,Postoperative pain ,Gynecologic laparoscopy|bupivacaine, port site infiltration ,postoperative pain ,gynecologic laparoscopy
4946|NCT03259230|Hemophagocytic Lymphohistiocytosis|hemophagocytic lymphohistiocytosis
4947|NCT03259230|Malignancy-Associated Hemophagocytic Lymphohistiocytosis|malignancy-associated hemophagocytic lymphohistiocytosis
4948|NCT03259230|M-HLH|m-hlh
4949|NCT03259230|Patients with known diagnosis of malignancy without HLH|patients with known diagnosis of malignancy without hlh
4950|NCT03259230|Interferon Gamma|interferon gamma
4951|NCT03259230|IFNγ|ifnγ
4952|NCT03259230|Biomarkers|biomarkers
4953|NCT03259230|Inflammatory Markers|inflammatory markers
4954|NCT03259230|Blood draws|blood draws
4955|NCT03259230|Data collection|data collection
4956|NCT03259204|Achilles tendon|achilles tendon
4957|NCT03259204|Microdialysis|microdialysis
4958|NCT03259204|Immobilization|immobilization
4959|NCT03259204|Wound healing|wound healing
4960|NCT03259204|Intermittent Pneumatic Compression|intermittent pneumatic compression
4961|NCT03259204|Ultrasonography|ultrasonography
4962|NCT03259191|Anti-reflux mucosectomy,refractory gastroesophageal reflux disease,safety,efficacy|anti-reflux mucosectomy,refractory gastroesophageal reflux disease,safety,efficacy
4963|NCT03259178|Binocular vision test|binocular vision test
4964|NCT03259165|Heart Failure|heart failure
4965|NCT03259165|Acute Heart Failure|acute heart failure
4966|NCT03259165|Pulmonary Edema|pulmonary edema
4967|NCT03259165|Lung Ultrasound|lung ultrasound
4968|NCT03259165|Extra vascular lung water|extra vascular lung water
4969|NCT03259165|B-lines|b-lines
4970|NCT03259165|Diuretics|diuretics
4971|NCT03259165|Nitrates|nitrates
4972|NCT03259152|Giant cell tumor of bone|giant cell tumor of bone
4973|NCT03259152|Denousmab|denousmab
4974|NCT03259152|Pathologic|pathologic
4975|NCT03259152|Clinical|clinical
4976|NCT03259152|Mechansim|mechansim
4981|NCT03259126|Transradial|transradial
4982|NCT03259126|Coronary|coronary
4983|NCT03259126|X-ray|x-ray
4984|NCT03259126|Radiation|radiation
4985|NCT03259126|Curtain|curtain
4986|NCT03259113|insertable cardiac monitor|insertable cardiac monitor
4987|NCT03259113|atrial fibrillation|atrial fibrillation
4988|NCT03259113|non-sustained ventricular tachycardia|non-sustained ventricular tachycardia
4989|NCT03259074|ankylosing spondylitis, AS, secukinumab, GP2017, adalimumab biosimilar, mSASSS, ASAS20|ankylosing spondylitis, as, secukinumab, gp2017, adalimumab biosimilar, msasss, asas20
4990|NCT03259009|colorectal cancer|colorectal cancer
4991|NCT03259009|anti-EGFR therapy|anti-egfr therapy
4992|NCT03259009|rechallenge|rechallenge
4993|NCT03259009|circulating tumor DNA|circulating tumor dna
4994|NCT03259009|biomarker|biomarker
4995|NCT03259009|RAS mutations|ras mutations
4996|NCT03258996|Gingival recession|gingival recession
4997|NCT03258996|Class III gingival recession|class iii gingival recession
4998|NCT03258996|Multiples gingival recessions|multiples gingival recessions
4999|NCT03258996|Periodontitis|periodontitis
5000|NCT03258996|Mucogingival surgery|mucogingival surgery
5001|NCT03258996|Modified vestibular incision subperiosteal tunnel access|modified vestibular incision subperiosteal tunnel access
5002|NCT03258996|Coronally advanced flap|coronally advanced flap
5003|NCT03258996|Connective tissue graft|connective tissue graft
5004|NCT03258996|Post-surgical pain|post-surgical pain
5005|NCT03258983|Alpha-linolenic acid|alpha-linolenic acid
5006|NCT03258983|Dietary intake|dietary intake
5007|NCT03258983|Adipose tissue|adipose tissue
5008|NCT03258983|Nutritional epidemiology|nutritional epidemiology
5009|NCT03258970|vitamin supplement|vitamin supplement
5010|NCT03258970|Vitamin C|vitamin c
5011|NCT03258970|Vitamin E|vitamin e
5012|NCT03258905|transition-age youth|transition-age youth
5013|NCT03258905|mobile app|mobile app
5014|NCT03258905|grounding|grounding
5015|NCT03258905|Seeking Safety|seeking safety
5016|NCT03258879|Combined spinal epidural analgesia, dural puncture epidural|combined spinal epidural analgesia, dural puncture epidural
5017|NCT03258866|thrombocytopenia|thrombocytopenia
5018|NCT03258866|Immune Thrombocytopenia|immune thrombocytopenia
5019|NCT03258866|purpura|purpura
5020|NCT03258853|cystic fibrosis|cystic fibrosis
5021|NCT03258853|insulin|insulin
5022|NCT03258853|glucagon|glucagon
5023|NCT03258853|continuous glucose monitor|continuous glucose monitor
5024|NCT03258853|bionic pancreas|bionic pancreas
5025|NCT03258840|EPA|epa
5026|NCT03258840|Paraoxonase 1|paraoxonase 1
5027|NCT03258840|Paraoxonase 2|paraoxonase 2
5028|NCT03258840|Type 2 diabetes|type 2 diabetes
5029|NCT03258827|elderly|elderly
5030|NCT03258827|sarcopenia|sarcopenia
5031|NCT03258827|strengthening exercise|strengthening exercise
5032|NCT03258814|health-related quality of life|health-related quality of life
5033|NCT03258814|physical training|physical training
5034|NCT03258814|disease activity|disease activity
5035|NCT03258814|active supervised training|active supervised training
5036|NCT03258814|workability|workability
5037|NCT03258814|spinal mobility|spinal mobility
5038|NCT03258814|psychosocial risk factors|psychosocial risk factors
5039|NCT03258814|adalimumab|adalimumab
5040|NCT03258814|Bath Ankylosing Spondylitis Metrology Index (BASMI)|bath ankylosing spondylitis metrology index (basmi)
5041|NCT03258814|physical function|physical function
5042|NCT03258814|physiotherapy|physiotherapy
5043|NCT03258814|axial spondyloarthritis|axial spondyloarthritis
5044|NCT03258814|pain|pain
5045|NCT03258775|RMR|rmr
5046|NCT03258775|hydration|hydration
5047|NCT03258775|substrate oxidation|substrate oxidation
5048|NCT03258762|Japanese|japanese
5049|NCT03258762|Caucasian|caucasian
5050|NCT03258762|pharmacokinetics|pharmacokinetics
5051|NCT03258762|pyrimethamine|pyrimethamine
5052|NCT03258762|toxoplasmosis|toxoplasmosis
5053|NCT03258749|COPD|copd
5054|NCT03258749|GOLD|gold
5055|NCT03258749|formoterol|formoterol
5056|NCT03258749|tiotropium|tiotropium
5057|NCT03258736|pediatric, inguinal hernia, caudal, ilioinguinal/ilioihypogastric|pediatric, inguinal hernia, caudal, ilioinguinal/ilioihypogastric
5058|NCT03258710|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
5059|NCT03258710|safety|safety
5060|NCT03258710|chronic hepatitis B|chronic hepatitis b
5061|NCT03258710|virological effect|virological effect
5062|NCT03258697|Local analgesia, Pharmacokinetics, Total joint replacement|local analgesia, pharmacokinetics, total joint replacement
5063|NCT03258684|corticosteroid|corticosteroid
5064|NCT03258684|hydrocortisone|hydrocortisone
5065|NCT03258684|septic shock|septic shock
5066|NCT03258684|thiamine|thiamine
5067|NCT03258684|vitamin C|vitamin c
5068|NCT03258658|Urethral Stricture|urethral stricture
5069|NCT03258632|Alcohol Use Disorder|alcohol use disorder
5269|NCT03257527|Happiness|happiness
5092|NCT03258385|Vitamin B12, Fortified milk, Immunity, Child development|vitamin b12, fortified milk, immunity, child development
5094|NCT03258346|Pomegranate Juice|pomegranate juice
5095|NCT03258346|Functional Tasks of Living|functional tasks of living
5096|NCT03258333|aortic stenosis, aortic valve replacement, pericardium|aortic stenosis, aortic valve replacement, pericardium
5098|NCT03258320|Docetaxel|docetaxel
5099|NCT03258320|Mitoxantrone|mitoxantrone
5102|NCT03258320|Prostate Cancer|prostate cancer
5103|NCT03258320|Localized|localized
5104|NCT03258320|High Risk|high risk
5105|NCT03258294|melatonin|melatonin
5106|NCT03258294|sleep disturbances|sleep disturbances
5107|NCT03258229|Angelica gigas N. extract|angelica gigas n. extract
5108|NCT03258229|Glucose|glucose
5109|NCT03258229|Clinical Trial|clinical trial
5110|NCT03258216|Upper gastrointestinal disorders|upper gastrointestinal disorders
5111|NCT03258216|Automatic tongue diagnosis system|automatic tongue diagnosis system
5112|NCT03258216|Panendoscopy|panendoscopy
5113|NCT03258190|Urolithaisis|urolithaisis
5114|NCT03258190|Recurrence|recurrence
5115|NCT03258190|Citrate|citrate
5116|NCT03258190|Antioxidants|antioxidants
5117|NCT03258190|Lime Powder Regimen|lime powder regimen
5118|NCT03258177|Virtual Visits|virtual visits
5119|NCT03258177|Telehealth|telehealth
5120|NCT03258138|Pragmatic|pragmatic
5121|NCT03258138|Pilot study|pilot study
5122|NCT03258138|Mixed methods|mixed methods
5123|NCT03258138|Randomized controlled trial|randomized controlled trial
5124|NCT03258138|Implementation research|implementation research
5125|NCT03258138|Person-centered care|person-centered care
5126|NCT03258138|Multidisciplinary|multidisciplinary
5127|NCT03258138|Ecological approach|ecological approach
5128|NCT03258073|maternal|maternal
5129|NCT03258073|newborn|newborn
5130|NCT03258073|resuscitation|resuscitation
5131|NCT03258073|emergencies|emergencies
5132|NCT03258073|medical simulation|medical simulation
5133|NCT03258060|Heart Failure|heart failure
5134|NCT03258060|Pacing|pacing
5135|NCT03258060|Resynchronization|resynchronization
5136|NCT03258060|Electrophysiology|electrophysiology
5137|NCT03258060|Imaging|imaging
5138|NCT03258060|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5139|NCT03258034|Conversion therapy|conversion therapy
5140|NCT03258021|Glioblastoma|glioblastoma
5141|NCT03258021|GBM|gbm
5142|NCT03258021|Tumor-treating fields|tumor-treating fields
5143|NCT03258021|TTFields|ttfields
5144|NCT03258008|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
5145|NCT03258008|Malignant neoplasms of ill-defined secondary and unspecified sites|malignant neoplasms of ill-defined secondary and unspecified sites
5146|NCT03258008|Oropharyngeal Cancer|oropharyngeal cancer
5147|NCT03258008|Oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
5148|NCT03258008|OPSCC|opscc
5149|NCT03258008|Human Papillomavirus - positive (HPV+)|human papillomavirus - positive (hpv+)
5150|NCT03258008|Utomilumab|utomilumab
5151|NCT03258008|PF-05082566|pf-05082566
5152|NCT03258008|Anti-CD137|anti-cd137
5153|NCT03258008|ISA101b|isa101b
5154|NCT03257995|asthma, asthma attack, difficulty breathing, bronchial diseases, lung, lung diseases, inhaled drugs, bronchodilator, inhaled corticosteriod|asthma, asthma attack, difficulty breathing, bronchial diseases, lung, lung diseases, inhaled drugs, bronchodilator, inhaled corticosteriod
5155|NCT03257982|Brain-computer interface|brain-computer interface
5156|NCT03257982|Functional electrical stimulation|functional electrical stimulation
5157|NCT03257969|Oral chemotherapy|oral chemotherapy
5158|NCT03257969|Health related program|health related program
5159|NCT03257969|Secured drug intake|secured drug intake
5160|NCT03257969|Pharmacist intervention|pharmacist intervention
5161|NCT03257969|Cancer outpatient|cancer outpatient
5162|NCT03257917|Financial Burden|financial burden
5163|NCT03257917|Out of Pocket expenses|out of pocket expenses
5164|NCT03257917|Time spent on Healthcare|time spent on healthcare
5178|NCT03257839|Abnormal Breast|abnormal breast
5179|NCT03257839|Normal Breast|normal breast
5180|NCT03257839|Breast Imaging|breast imaging
5181|NCT03257839|Breast Biopsy|breast biopsy
5182|NCT03257839|Mammography|mammography
5183|NCT03257839|Tomosynthesis|tomosynthesis
5184|NCT03257839|Automated Breast Ultrasound|automated breast ultrasound
5185|NCT03257839|Breast Cancer|breast cancer
5186|NCT03257839|Breast Carcinoma|breast carcinoma
5187|NCT03257839|Breast Tumors|breast tumors
5188|NCT03257839|Mammary Carcinoma|mammary carcinoma
5189|NCT03257839|Malignant Breast Tumor|malignant breast tumor
5190|NCT03257839|Mammary Neoplasm|mammary neoplasm
5191|NCT03257839|Mammary Cancer|mammary cancer
5193|NCT03257839|AWBUS|awbus
5194|NCT03257839|Breast Tomography|breast tomography
5195|NCT03257839|ATUS|atus
5196|NCT03257839|ABTUS|abtus
5197|NCT03257839|Mammogram|mammogram
5198|NCT03257839|3D Mammogram|3d mammogram
5199|NCT03257839|3D ABUS|3d abus
5200|NCT03257839|3D Breast Ultrasound|3d breast ultrasound
5201|NCT03257839|DBT|dbt
5202|NCT03257839|FFDM|ffdm
5203|NCT03257839|Digital Mammography|digital mammography
5204|NCT03257839|Breast Ultrasound|breast ultrasound
5205|NCT03257839|Dense Breasts|dense breasts
5206|NCT03257839|Breast Density|breast density
5207|NCT03257839|Dense Parenchyma|dense parenchyma
5208|NCT03257839|Asymptomatic|asymptomatic
5209|NCT03257839|Delphinus|delphinus
5210|NCT03257839|Delphinus Medical Technologies|delphinus medical technologies
5211|NCT03257839|Screening Breast Ultrasound|screening breast ultrasound
5212|NCT03257826|congenital pseudarthrosis of the tibia|congenital pseudarthrosis of the tibia
5213|NCT03257826|age of surgery|age of surgery
5214|NCT03257826|Percutaneous Kirschner wire|percutaneous kirschner wire
5215|NCT03257813|timolol|timolol
5216|NCT03257813|dorzolamide|dorzolamide
5217|NCT03257813|brimonidine|brimonidine
5218|NCT03257813|Glaucoma|glaucoma
5219|NCT03257813|Ocular hypertension|ocular hypertension
5220|NCT03257800|ketamine|ketamine
5221|NCT03257800|Propofol|propofol
5222|NCT03257800|laryngeal masks|laryngeal masks
5223|NCT03257800|anesthesia|anesthesia
5224|NCT03257800|child|child
5225|NCT03257722|Non Small Cell Lung Cancer|non small cell lung cancer
5226|NCT03257722|Metastasis|metastasis
5227|NCT03257722|Recurrence|recurrence
5228|NCT03257722|Immunotherapy|immunotherapy
5229|NCT03257670|Dyspareunia|dyspareunia
5230|NCT03257670|Laser|laser
5232|NCT03257670|Breast Cancer|breast cancer
5233|NCT03257670|Vaginal Atrophy|vaginal atrophy
5234|NCT03257670|Lidocaine|lidocaine
5235|NCT03257644|Atopic dermatitis|atopic dermatitis
5236|NCT03257644|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
5237|NCT03257644|pediatric|pediatric
5238|NCT03257644|inflammation|inflammation
5253|NCT03257605|Pharmacogenomics|pharmacogenomics
5254|NCT03257605|Medication Therapy Management|medication therapy management
5255|NCT03257579|Myocardial Infarction|myocardial infarction
5256|NCT03257579|Adherence|adherence
5257|NCT03257579|Medication|medication
5258|NCT03257540|bunion|bunion
5259|NCT03257540|early weight-bearing|early weight-bearing
5260|NCT03257540|Lapidus|lapidus
5261|NCT03257540|arthrodesis|arthrodesis
5262|NCT03257540|intramedullary nail|intramedullary nail
5263|NCT03257540|Hallux Valgus|hallux valgus
5264|NCT03257527|Well-being|well-being
5265|NCT03257527|Comparative Clinical Trial|comparative clinical trial
5266|NCT03257527|Positive Psychology Intervention|positive psychology intervention
5267|NCT03257527|Mindfulness Based Stress Reduction (MBSR)|mindfulness based stress reduction (mbsr)
5268|NCT03257527|Group Therapy|group therapy
5270|NCT03257527|Bibliotherapy|bibliotherapy
5271|NCT03257475|cervical cance|cervical cance
5272|NCT03257475|vaginal radiation injury|vaginal radiation injury
5274|NCT03257475|R-V|r-v
5275|NCT03257475|VRL|vrl
5276|NCT03257462|17-hydroxyprogesterone|17-hydroxyprogesterone
5277|NCT03257449|Body Weight|body weight
5278|NCT03257449|Weight loss|weight loss
5279|NCT03257449|BMI|bmi
5280|NCT03257449|Waist Circumference|waist circumference
5281|NCT03257449|Body Fat Percentage|body fat percentage
5282|NCT03257449|Viscofiber|viscofiber
5283|NCT03257449|Viscous Fibres|viscous fibres
5284|NCT03257449|supplement|supplement
5285|NCT03257436|Pacing|pacing
5286|NCT03257423|Uncomplicated acute appendicitis|uncomplicated acute appendicitis
5287|NCT03257423|Complicated acute appendicitis|complicated acute appendicitis
497726|NCT00179790|ECP|ecp
5288|NCT03257423|Antibiotic therapy|antibiotic therapy
5289|NCT03257423|Microbiological etiology|microbiological etiology
5290|NCT03257358|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5291|NCT03257358|RMS|rms
5292|NCT03257358|Relapsing Multiple Sclerosis (RMS)|relapsing multiple sclerosis (rms)
5293|NCT03257358|Multiple Sclerosis|multiple sclerosis
5294|NCT03257358|MS|ms
5295|NCT03257358|Multiple Sclerosis (MS)|multiple sclerosis (ms)
5296|NCT03257358|Fingolimod|fingolimod
5297|NCT03257358|FLUENT|fluent
5298|NCT03257358|Immune Phenotype|immune phenotype
5299|NCT03257345|Real world outcomes|real world outcomes
5300|NCT03257332|Rectum cancer|rectum cancer
5301|NCT03257332|Low Anterior Rectal Syndrome|low anterior rectal syndrome
5302|NCT03257332|Anorectal muscle function|anorectal muscle function
5303|NCT03257306|Urinary tract stone|urinary tract stone
5304|NCT03257306|ureter double-J stent|ureter double-j stent
5305|NCT03257254|GSV|gsv
5306|NCT03257254|AASV|aasv
5307|NCT03257254|Vein|vein
5308|NCT03257254|Venous|venous
5309|NCT03257254|Ulcer|ulcer
5310|NCT03257254|Vericose Vein|vericose vein
5311|NCT03257254|VLU|vlu
5312|NCT03257254|venous insufficiency|venous insufficiency
5313|NCT03257254|venous disease|venous disease
5314|NCT03257254|chronic VLU|chronic vlu
5315|NCT03257241|aml|aml
5316|NCT03257241|acute myeloid leukemia|acute myeloid leukemia
5317|NCT03257241|DAC|dac
5318|NCT03257241|DA-90|da-90
5319|NCT03257241|FLAG-IDA|flag-ida
5320|NCT03257241|CLAG-M|clag-m
5321|NCT03257241|Ara-C|ara-c
5322|NCT03257241|HiDAC|hidac
5323|NCT03257215|Vitamin D|vitamin d
5324|NCT03257202|Propionibacterium Acnes|propionibacterium acnes
5325|NCT03257202|Surgical Site Infection|surgical site infection
5326|NCT03257202|Shoulder|shoulder
5327|NCT03257137|sleep|sleep
5328|NCT03257137|macronutrients|macronutrients
5329|NCT03257137|dietary patterns|dietary patterns
5330|NCT03257137|sleep quality|sleep quality
5331|NCT03257137|diet quality|diet quality
5332|NCT03257137|polysomnography|polysomnography
5334|NCT03257137|mood|mood
5335|NCT03257137|hunger|hunger
5336|NCT03257111|rehabilitation outcomes|rehabilitation outcomes
5337|NCT03257111|activity level|activity level
5338|NCT03257098|Chronic Venous Ulcer|chronic venous ulcer
5339|NCT03257098|ABCB5|abcb5
5340|NCT03257098|Allogeneic|allogeneic
5341|NCT03257098|Mesenchymal stem cells|mesenchymal stem cells
5342|NCT03257098|varicose ulcer|varicose ulcer
5343|NCT03257098|skin ulcer|skin ulcer
5344|NCT03257098|advanced therapy medicinal product|advanced therapy medicinal product
5345|NCT03257098|somatic cell therapy|somatic cell therapy
5346|NCT03257098|phase I/IIa|phase i/iia
5347|NCT03257072|hookworm|hookworm
5348|NCT03257072|controlled human infection model|controlled human infection model
5349|NCT03257020|OCT|oct
5350|NCT03257020|RNFL|rnfl
5351|NCT03257020|BMO-MRW|bmo-mrw
5352|NCT03257020|Glaucoma|glaucoma
5353|NCT03256981|SBRT|sbrt
5354|NCT03256981|Oligoprogressive disease|oligoprogressive disease
5355|NCT03256981|NSCLC|nsclc
5356|NCT03256981|TKI|tki
5357|NCT03256955|Validation study for a neuromuscular monitoring device|validation study for a neuromuscular monitoring device
5358|NCT03256929|Personalized Diet|personalized diet
5359|NCT03256929|Microbiota|microbiota
5360|NCT03256929|Depression|depression
5361|NCT03256929|Elderly|elderly
5362|NCT03256929|Gut flora|gut flora
5363|NCT03256916|Cervical cancer|cervical cancer
5364|NCT03256903|Methoxyflurane|methoxyflurane
5365|NCT03256903|emergency|emergency
5366|NCT03256903|trauma pain|trauma pain
5367|NCT03256903|inhaled analgesia|inhaled analgesia
5368|NCT03256890|mindfulness|mindfulness
5369|NCT03256890|blood pressure|blood pressure
5370|NCT03256890|hypertension|hypertension
5371|NCT03256890|prehypertension|prehypertension
5372|NCT03256890|self regulation|self regulation
5373|NCT03256890|Science of Behavior Change|science of behavior change
5374|NCT03256890|attention control|attention control
5375|NCT03256890|self awareness|self awareness
5376|NCT03256890|emotion regulation|emotion regulation
5377|NCT03256838|Citric Acid|citric acid
5378|NCT03256838|Ferric Compounds|ferric compounds
5379|NCT03256838|Renal Insufficiency|renal insufficiency
5380|NCT03256838|Anticoagulants|anticoagulants
5381|NCT03256838|Calcium Chelating Agents|calcium chelating agents
5382|NCT03256838|Chelating Agents|chelating agents
5383|NCT03256838|Sequestering Agents|sequestering agents
5384|NCT03256838|Hemodialysis|hemodialysis
5385|NCT03256838|Dialysis|dialysis
5386|NCT03256838|Renal Failure|renal failure
5387|NCT03256838|Kidney Failure|kidney failure
5388|NCT03256838|Urologic Diseases|urologic diseases
5389|NCT03256838|Metabolic Disease|metabolic disease
5390|NCT03256838|Kidney Diseases|kidney diseases
5391|NCT03256838|Renal Insufficiency, Chronic|renal insufficiency, chronic
398576|NCT01248117|PCV|pcv
5392|NCT03256825|Diagnostic accuracy|diagnostic accuracy
5393|NCT03256825|Anti-bacterial agents|anti-bacterial agents
5394|NCT03256825|Decision support systems, clinical|decision support systems, clinical
5395|NCT03256812|Arrhythmias, Atrial Fibrillation|arrhythmias, atrial fibrillation
5396|NCT03256786|cesarean delivery with spinal anesthesia|cesarean delivery with spinal anesthesia
5397|NCT03256786|Hypothermia and shivering|hypothermia and shivering
5398|NCT03256786|Active warming|active warming
5399|NCT03256760|Insomnia, depression|insomnia, depression
5400|NCT03256747|Diabetes Mellitus|diabetes mellitus
5401|NCT03256747|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5402|NCT03256747|Glucose Metabolism Disorders|glucose metabolism disorders
5403|NCT03256747|Metabolic Diseases|metabolic diseases
5404|NCT03256747|Endocrine System Diseases|endocrine system diseases
5405|NCT03256721|apatinib docetaxel pemetrexed|apatinib docetaxel pemetrexed
5406|NCT03256708|antibiotic-associated diarrhea|antibiotic-associated diarrhea
5407|NCT03256708|probiotic|probiotic
5408|NCT03256708|prebiotic|prebiotic
5409|NCT03256708|placebo|placebo
5410|NCT03256708|synbiotic|synbiotic
5411|NCT03256682|Resilience|resilience
5412|NCT03256682|Mobile video counseling|mobile video counseling
5413|NCT03256682|Emotiona labor|emotiona labor
5414|NCT03256643|traumatic brain injury|traumatic brain injury
5415|NCT03256643|brain contusion|brain contusion
5416|NCT03256643|craniocerebral trauma|craniocerebral trauma
5417|NCT03256643|exercise therapy|exercise therapy
5418|NCT03256643|chronic brain injury|chronic brain injury
5419|NCT03256643|environment impact|environment impact
5420|NCT03256643|cognitive therapy|cognitive therapy
5421|NCT03256643|health facility environment|health facility environment
5422|NCT03256630|Active Surveillance|active surveillance
5423|NCT03256630|Radical Prostatectomy|radical prostatectomy
5424|NCT03256617|low back pain|low back pain
5425|NCT03256617|cognitive reassurance|cognitive reassurance
5426|NCT03256617|physical therapist training|physical therapist training
5427|NCT03256604|point of care, HGF, innate immunity|point of care, hgf, innate immunity
5428|NCT03256578|Resuscitation|resuscitation
5429|NCT03256578|Neonatal Prematurity|neonatal prematurity
5430|NCT03256578|Positive-Pressure Ventilation|positive-pressure ventilation
5431|NCT03256578|Respiratory Function Monitor|respiratory function monitor
5433|NCT03256461|lactate clearance|lactate clearance
5434|NCT03256461|protocolized resuscitation|protocolized resuscitation
5435|NCT03256422|Controlled, virological and therapeutic success, treatment discontinution, 4 days per week|controlled, virological and therapeutic success, treatment discontinution, 4 days per week
5436|NCT03256409|biomaterials|biomaterials
5437|NCT03256409|methacrylates|methacrylates
5438|NCT03256409|microbiology|microbiology
5439|NCT03256409|implant dentistry/implantology|implant dentistry/implantology
5440|NCT03256409|removable prosthodontics|removable prosthodontics
5441|NCT03256409|clinical studies/trials|clinical studies/trials
5442|NCT03256396|Intraoperative mechanical ventilation|intraoperative mechanical ventilation
5443|NCT03256396|Positive-end expiratory pressure|positive-end expiratory pressure
5444|NCT03256396|Esophageal pressure|esophageal pressure
5445|NCT03256396|Transpulmonary pressure|transpulmonary pressure
5446|NCT03256396|Laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
5447|NCT03256370|Allergic manifestation, Human milk oligosaccharides, Atopic mother's breast milk, Non-atopic mother's breast milk|allergic manifestation, human milk oligosaccharides, atopic mother's breast milk, non-atopic mother's breast milk
5448|NCT03256357|unilateral cerebral palsy|unilateral cerebral palsy
5449|NCT03256357|upper limb rehabilitation|upper limb rehabilitation
5450|NCT03256344|Liver Metastases|liver metastases
5451|NCT03256305|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5452|NCT03256279|Orthodontic Wires|orthodontic wires
5453|NCT03256279|Alloys/therapeutic use|alloys/therapeutic use
5454|NCT03256279|Orthodontics, corrective|orthodontics, corrective
5455|NCT03256253|alcohol use disorder|alcohol use disorder
5456|NCT03256253|alcohol abuse|alcohol abuse
5457|NCT03256253|treatment|treatment
5458|NCT03256253|lyrica|lyrica
5459|NCT03256240|Crohn's recurrence|crohn's recurrence
5460|NCT03256227|Posttraumatic Stress Disorder|posttraumatic stress disorder
5461|NCT03256227|family therapy|family therapy
5462|NCT03256227|patient adherence|patient adherence
5463|NCT03256227|Prolonged Exposure Therapy|prolonged exposure therapy
5464|NCT03256201|Cancer|cancer
5465|NCT03256201|prehabilitation|prehabilitation
5466|NCT03256201|sarcopenia|sarcopenia
5467|NCT03256188|classroom|classroom
5468|NCT03256188|prolonged sitting|prolonged sitting
5469|NCT03256188|sedentary time|sedentary time
5470|NCT03256188|time-on-task|time-on-task
5471|NCT03256188|children|children
11472|NCT03217747|XRT|xrt
5472|NCT03256175|Myocardial Protection|myocardial protection
5473|NCT03256175|Oxygen|oxygen
5474|NCT03256175|Exercise Test|exercise test
5475|NCT03256162|ketamine|ketamine
5476|NCT03256162|glutamate|glutamate
5477|NCT03256136|Lung Cancer|lung cancer
5478|NCT03256123|Vitamin A Deficiency|vitamin a deficiency
5479|NCT03256123|Iron Deficiency|iron deficiency
5480|NCT03256123|Parasite|parasite
5481|NCT03256123|Gut Microbiota|gut microbiota
5482|NCT03256123|Red palm oil|red palm oil
5483|NCT03256110|Advance Care Planning|advance care planning
5484|NCT03256110|Palliative Care|palliative care
5485|NCT03256110|Indians, North American|indians, north american
5486|NCT03256110|Alaska Natives|alaska natives
5487|NCT03256110|Health Communication|health communication
5488|NCT03256110|Primary Health Care|primary health care
5489|NCT03256097|Sound processing strategy|sound processing strategy
5490|NCT03256019|intubation|intubation
5491|NCT03256019|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5492|NCT03256006|sport exercise|sport exercise
5493|NCT03256006|ultra endurance|ultra endurance
5494|NCT03255954|Interpersonal Counseling|interpersonal counseling
5495|NCT03255941|LHV (Lady Health Visitor)|lhv (lady health visitor)
5496|NCT03255941|LHW (Lady Health Worker|lhw (lady health worker
5497|NCT03255941|DMPA (Depot medroxyprogesterone acetate or Depo Provera)|dmpa (depot medroxyprogesterone acetate or depo provera)
5498|NCT03255941|DMPA IM (Depo Provera intramuscular injection)|dmpa im (depo provera intramuscular injection)
5499|NCT03255941|SP (Sayana Press subcutaneous injection)|sp (sayana press subcutaneous injection)
5500|NCT03255941|Contraception|contraception
5501|NCT03255941|CBA2I (Community-based access to injectables)|cba2i (community-based access to injectables)
5502|NCT03255928|Platelet activation|platelet activation
5503|NCT03255928|Ventricular Assist Device|ventricular assist device
5504|NCT03255928|Thrombosis|thrombosis
5505|NCT03255928|Bleeding|bleeding
5506|NCT03255928|Antithrombotic Pharmacological Therapy|antithrombotic pharmacological therapy
5507|NCT03255928|Mechanical Circulatory Support|mechanical circulatory support
5508|NCT03255915|HIV Prevention|hiv prevention
5509|NCT03255915|Intravaginal Ring|intravaginal ring
5510|NCT03255915|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
5511|NCT03255915|Emtricitabine|emtricitabine
5512|NCT03255889|Safety|safety
5513|NCT03255889|Tolerability|tolerability
5514|NCT03255889|Pharmacokinetics|pharmacokinetics
5515|NCT03255889|Absorption|absorption
5516|NCT03255876|Polyphenols|polyphenols
5517|NCT03255876|Hyperglycemia|hyperglycemia
5518|NCT03255876|Postprandial|postprandial
5519|NCT03255876|Starch|starch
5520|NCT03255876|Alpha-amylase|alpha-amylase
5521|NCT03255863|Psychological Theory|psychological theory
5522|NCT03255850|adolescents|adolescents
5523|NCT03255850|quality of life|quality of life
5524|NCT03255850|psychological well-being|psychological well-being
5525|NCT03255837|Transcranial Stimulation|transcranial stimulation
5526|NCT03255837|Memory|memory
5527|NCT03255824|Oral Surgery|oral surgery
5528|NCT03255824|Third Molars|third molars
5529|NCT03255824|Intravenous Sedation|intravenous sedation
5530|NCT03255824|Dexmedetomidine|dexmedetomidine
5531|NCT03255811|Advanced gastric cancer apatinib Maintenance therapy|advanced gastric cancer apatinib maintenance therapy
5532|NCT03255772|Magnetocardiography|magnetocardiography
5533|NCT03255772|Chest pain|chest pain
5534|NCT03255733|Chronic Lateral Epicondylitis|chronic lateral epicondylitis
5535|NCT03255733|Tennis Elbow|tennis elbow
5536|NCT03255733|Intense Therapeutic Ultrasound (ITU)|intense therapeutic ultrasound (itu)
5537|NCT03255733|Guided Therapy Systems (GTS)|guided therapy systems (gts)
5538|NCT03255733|Ardent Sound, Inc.|ardent sound, inc.
5539|NCT03255733|Actisound|actisound
5540|NCT03255707|Amblyopia|amblyopia
5541|NCT03255707|Interactive Binocular Treatment|interactive binocular treatment
5542|NCT03255707|Dissociative Treatment|dissociative treatment
5543|NCT03255707|Occlusion|occlusion
5544|NCT03255707|Patching|patching
5545|NCT03255681|Cosmetics|cosmetics
5546|NCT03255681|Filler|filler
5547|NCT03255668|Mercaptopurine, acute lymphoblastic leukemia, hematotoxicity|mercaptopurine, acute lymphoblastic leukemia, hematotoxicity
5548|NCT03255655|Chronic Plantar Fasciitis|chronic plantar fasciitis
5549|NCT03255655|Plantar Fascia Pain|plantar fascia pain
5550|NCT03255655|Intense Therapeutic Ultrasound (ITU)|intense therapeutic ultrasound (itu)
5551|NCT03255655|Guided Therapy Systems (GTS)|guided therapy systems (gts)
5552|NCT03255655|Ardent Sound, Inc.|ardent sound, inc.
5553|NCT03255655|Actisound|actisound
5554|NCT03255642|Clonazepam|clonazepam
5555|NCT03255642|Melatonin|melatonin
5556|NCT03255642|Treatment|treatment
5557|NCT03255642|REM Sleep Behavior Disorder|rem sleep behavior disorder
6240|NCT03251014|Thrombosis|thrombosis
5561|NCT03255603|Gastrointestinal Tolerance|gastrointestinal tolerance
5562|NCT03255590|motor recovery|motor recovery
5563|NCT03255590|transcranial magnetic stimulation|transcranial magnetic stimulation
759681|NCT00860782|Neurodevelopmental Functioning|neurodevelopmental functioning
5564|NCT03255590|motor learning|motor learning
5565|NCT03255590|ischemic Stroke|ischemic stroke
5566|NCT03255577|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5567|NCT03255577|17-384|17-384
5568|NCT03255538|patellar tendon|patellar tendon
5569|NCT03255499|cognitive training|cognitive training
5570|NCT03255499|physical exercise|physical exercise
5571|NCT03255499|brain dynamics|brain dynamics
5572|NCT03255499|cognitive abilities|cognitive abilities
5573|NCT03255499|physiological markers|physiological markers
5574|NCT03255460|Multiple Sclerosis|multiple sclerosis
5575|NCT03255460|Fatigue|fatigue
5576|NCT03255460|Physical Activity|physical activity
5577|NCT03255460|Exercise|exercise
5578|NCT03255447|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
5579|NCT03255447|Primary Membranous Nephropathy|primary membranous nephropathy
5580|NCT03255447|Immunoadsorption|immunoadsorption
5581|NCT03255447|Apharesis|apharesis
5582|NCT03255421|urodynamic|urodynamic
5583|NCT03255421|backwards cystometry|backwards cystometry
5584|NCT03255421|reverse cystometry|reverse cystometry
5585|NCT03255421|follow-up|follow-up
5587|NCT03255395|Ultrasound|ultrasound
5588|NCT03255395|Phantom Limb Pain|phantom limb pain
5589|NCT03255395|Residual Limb Pain|residual limb pain
5590|NCT03255395|Neuroma|neuroma
5591|NCT03255382|BI 655066|bi 655066
5592|NCT03255382|ABBV-0066|abbv-0066
5593|NCT03255382|risankizumab|risankizumab
5594|NCT03255369|Zika virus|zika virus
5595|NCT03255369|Microcephaly|microcephaly
5596|NCT03255369|Child|child
5597|NCT03255369|pregnancy|pregnancy
5598|NCT03255356|Postoperative pulmonary complications|postoperative pulmonary complications
5599|NCT03255356|Protective mechanical ventilation|protective mechanical ventilation
5600|NCT03255356|Alveolar lung recruitment manoeuvres|alveolar lung recruitment manoeuvres
5601|NCT03255356|Cardiac Surgery Procedures|cardiac surgery procedures
5603|NCT03255278|Tuberculosis|tuberculosis
5604|NCT03255278|Recombinant vaccine|recombinant vaccine
5605|NCT03255278|Mycobacterium tuberculosis|mycobacterium tuberculosis
5606|NCT03255265|organ transplantation|organ transplantation
5607|NCT03255265|cfDNA|cfdna
5608|NCT03255265|microchimerism|microchimerism
5609|NCT03255265|acute rejection|acute rejection
5610|NCT03255239|ventral hernia|ventral hernia
5611|NCT03255239|Open mesh repair|open mesh repair
5612|NCT03255239|Polyester mesh|polyester mesh
5613|NCT03255239|Preperitoneal|preperitoneal
8505|NCT03236142|DS|ds
5617|NCT03255187|Oxidative stress|oxidative stress
5618|NCT03255187|Air pollution|air pollution
5619|NCT03255187|Cardiopulmonary system|cardiopulmonary system
5620|NCT03255174|Bleeding, hemostasis, re-bleeding, hemostatic|bleeding, hemostasis, re-bleeding, hemostatic
5621|NCT03255148|resting state|resting state
5622|NCT03255148|EEG|eeg
5623|NCT03255148|skin conductance|skin conductance
5624|NCT03255148|heart rate|heart rate
5625|NCT03255148|oxytocin|oxytocin
5626|NCT03255109|Lung|lung
5627|NCT03255109|acute|acute
5628|NCT03255109|respiratory|respiratory
5629|NCT03255109|distress|distress
5630|NCT03255109|weaning|weaning
5631|NCT03255109|mechanical ventilation|mechanical ventilation
5632|NCT03255109|respiratory infection|respiratory infection
5633|NCT03255083|Oncology|oncology
5634|NCT03255083|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
5635|NCT03255083|Inoperable Non-small Cell Lung Cancer|inoperable non-small cell lung cancer
5636|NCT03255083|Metastatic|metastatic
5637|NCT03255083|Non-resectable|non-resectable
5638|NCT03255083|Epidermal growth factor receptor|epidermal growth factor receptor
5639|NCT03255083|EGFR|egfr
5640|NCT03255070|HER2|her2
5641|NCT03255070|Breast Cancer|breast cancer
5642|NCT03255070|ADC|adc
5643|NCT03255070|antibody drug conjugate|antibody drug conjugate
5644|NCT03255070|elevated HER2 expression|elevated her2 expression
5645|NCT03255070|breast neoplasm|breast neoplasm
5646|NCT03255070|stomach neoplasm|stomach neoplasm
5647|NCT03255070|gastrointestinal neoplasm|gastrointestinal neoplasm
5648|NCT03255070|digestive system|digestive system
5649|NCT03255070|breast diseases|breast diseases
5650|NCT03255070|digestive system neoplasm|digestive system neoplasm
5651|NCT03255070|digestive system diseases|digestive system diseases
5652|NCT03255070|stomach diseases|stomach diseases
5653|NCT03255044|statin|statin
5654|NCT03255044|hydrophilic|hydrophilic
5655|NCT03255044|lipophilic|lipophilic
5669|NCT03254953|smartphone|smartphone
5670|NCT03254953|obesity|obesity
5671|NCT03254953|overweight|overweight
5672|NCT03254953|weight loss|weight loss
5673|NCT03254953|behavioral intervention|behavioral intervention
5674|NCT03254953|self-monitoring|self-monitoring
5675|NCT03254953|tracking|tracking
5676|NCT03254953|engagement|engagement
5677|NCT03254953|adherence|adherence
5678|NCT03254953|weight change|weight change
5679|NCT03254953|e-mail|e-mail
5680|NCT03254953|mobile application|mobile application
5681|NCT03254953|goal setting|goal setting
5682|NCT03254953|action plan|action plan
5683|NCT03254953|feedback|feedback
5684|NCT03254953|electronic health|electronic health
5685|NCT03254940|text message|text message
5686|NCT03254940|digital health|digital health
5687|NCT03254940|weight loss|weight loss
5688|NCT03254940|personalized|personalized
5689|NCT03254927|Erbitux|erbitux
5690|NCT03254914|Home Blood Pressure|home blood pressure
5691|NCT03254914|Fimasartan|fimasartan
5692|NCT03254875|Breast cancer, Psychosocial intervention|breast cancer, psychosocial intervention
5693|NCT03254862|Functional electrical stimulation|functional electrical stimulation
5694|NCT03254836|Actigraphy|actigraphy
5695|NCT03254836|Major Depression Inventory (MDI)|major depression inventory (mdi)
5696|NCT03254836|Insomnia Severity Index (ISI)|insomnia severity index (isi)
5697|NCT03254797|Rehabilitation|rehabilitation
5698|NCT03254797|Neurological condition|neurological condition
5699|NCT03254797|Walking ability|walking ability
5700|NCT03254797|Feedback|feedback
5701|NCT03254797|External information|external information
5702|NCT03254771|Knee ostheoartritis|knee ostheoartritis
5703|NCT03254771|Arthroplasty|arthroplasty
5704|NCT03254771|Clinical trial|clinical trial
5705|NCT03254771|Decision aids|decision aids
5706|NCT03254719|Low Back Pain|low back pain
5707|NCT03254719|Chiropractic|chiropractic
5708|NCT03254719|Veterans|veterans
5709|NCT03254719|PTSD|ptsd
5710|NCT03254719|Depression|depression
5711|NCT03254719|Anxiety|anxiety
5712|NCT03254706|Dentin adhesive; Non-carious cervical lesions; Longevity.|dentin adhesive; non-carious cervical lesions; longevity.
5713|NCT03254693|Non-carious cervical lesions; Universal system; Longevity.|non-carious cervical lesions; universal system; longevity.
5714|NCT03254680|Turmeric Oil|turmeric oil
5715|NCT03254680|antiseizure medications|antiseizure medications
5716|NCT03254680|ar-turmerone|ar-turmerone
5717|NCT03254615|Plain water|plain water
5718|NCT03254615|Educative strategies|educative strategies
5719|NCT03254615|Effectiveness|effectiveness
5720|NCT03254589|Methotrexate|methotrexate
5721|NCT03254589|Rheumatoid arthritis|rheumatoid arthritis
5722|NCT03254589|Blood pressure|blood pressure
5723|NCT03254589|Arterial stiffness|arterial stiffness
5724|NCT03254589|Cardiovascular risk|cardiovascular risk
5725|NCT03254576|Overweight|overweight
5726|NCT03254576|Obesity|obesity
5727|NCT03254576|Body Mass Index|body mass index
5728|NCT03254576|Weight|weight
5729|NCT03254576|Brain imaging|brain imaging
5730|NCT03254576|Child|child
5731|NCT03254576|Learning|learning
5732|NCT03254550|PrEP|prep
5733|NCT03254524|Epidemiology Research|epidemiology research
5734|NCT03254511|neoadjuvant chemoradiation|neoadjuvant chemoradiation
5735|NCT03254511|pathologic response|pathologic response
5736|NCT03254511|low molecular weight heparin|low molecular weight heparin
5737|NCT03254498|colonic adenoma|colonic adenoma
5738|NCT03254498|serrated polyps|serrated polyps
5739|NCT03254498|caecal intubation time|caecal intubation time
5740|NCT03254498|withdrawal time|withdrawal time
5741|NCT03254498|polyp miss rate|polyp miss rate
5742|NCT03254485|Heart Failure|heart failure
5743|NCT03254485|Cardiovascular|cardiovascular
5744|NCT03254485|HF|hf
5745|NCT03254485|HFpEF|hfpef
5746|NCT03254472|Biological markers|biological markers
5747|NCT03254472|Professional practice|professional practice
5748|NCT03254472|Big data analysis|big data analysis
5749|NCT03254472|Measured concentrations|measured concentrations
5750|NCT03254472|Cardiac markers|cardiac markers
5751|NCT03254472|Troponin|troponin
5752|NCT03254472|NTproBNP|ntprobnp
5753|NCT03254472|Creatinin|creatinin
5754|NCT03254472|INR|inr
5755|NCT03254472|Hemogram|hemogram
5756|NCT03254472|Lipid profile|lipid profile
5757|NCT03254446|Diabetes|diabetes
5758|NCT03254446|Hypertension|hypertension
5759|NCT03254446|Dyslipidemia|dyslipidemia
5760|NCT03254446|Cardiovascular Risk|cardiovascular risk
5764|NCT03254407|bioequivalent|bioequivalent
5765|NCT03254407|IV/PO switch|iv/po switch
5766|NCT03254407|appropriateness|appropriateness
5767|NCT03254407|clinical pharmacy|clinical pharmacy
5768|NCT03254394|Oxaliplatin|oxaliplatin
5769|NCT03254394|Cold hypersensitivity|cold hypersensitivity
5770|NCT03254394|Neuropathy|neuropathy
5771|NCT03254394|Colorectal cancer|colorectal cancer
5772|NCT03254394|CIPN|cipn
5773|NCT03254394|Neuropathic Pain|neuropathic pain
5774|NCT03254381|cognitive assessment|cognitive assessment
5775|NCT03254381|cognitive function|cognitive function
5776|NCT03254381|community dwelling older people|community dwelling older people
5777|NCT03254381|pre-diabetes|pre-diabetes
5778|NCT03254381|randomized control trial|randomized control trial
5779|NCT03254381|exercise|exercise
5780|NCT03254381|pilot study|pilot study
5781|NCT03254381|feasibility study|feasibility study
602240|NCT00589082|DaunoXome|daunoxome
5782|NCT03254368|Methionine Aminopeptidase 2 Inhibitor|methionine aminopeptidase 2 inhibitor
5783|NCT03254368|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5784|NCT03254368|Blood Glucose|blood glucose
5785|NCT03254368|Overweight|overweight
5786|NCT03254368|Obesity|obesity
5787|NCT03254355|avulsion injury|avulsion injury
5788|NCT03254355|urinary incontinence|urinary incontinence
398943|NCT01246388|MRI|mri
5789|NCT03254355|multimodal physiotherapy|multimodal physiotherapy
5790|NCT03254329|Breast milk|breast milk
5791|NCT03254329|Micronutrients|micronutrients
5792|NCT03254329|Lactation|lactation
5793|NCT03254329|Quality|quality
5794|NCT03254303|Sevoflurane, Catheterization, Anesthetics Inhalation, child|sevoflurane, catheterization, anesthetics inhalation, child
5795|NCT03254277|Broadly Neutralizing Antibody|broadly neutralizing antibody
5796|NCT03254277|3BNC117-LS|3bnc117-ls
5797|NCT03254277|First in Human|first in human
5798|NCT03254277|Dose Escalation|dose escalation
5799|NCT03254225|Hypertension|hypertension
5800|NCT03254225|Elderly|elderly
5801|NCT03254225|Resistance training|resistance training
5802|NCT03254225|Heart rate variability|heart rate variability
5803|NCT03254212|Heart failure|heart failure
5804|NCT03254212|Central sleep apnea|central sleep apnea
5805|NCT03254212|oxygen therapy|oxygen therapy
5806|NCT03254199|Charcot-Marie-Tooth|charcot-marie-tooth
5807|NCT03254199|CMT|cmt
5808|NCT03254199|Muscle Cramps|muscle cramps
5809|NCT03254199|Muscle Cramping|muscle cramping
5810|NCT03254199|FLX-787|flx-787
5811|NCT03254199|Hereditary Sensory and Motor Neuropathy|hereditary sensory and motor neuropathy
5812|NCT03254199|Neurogenetic disorder|neurogenetic disorder
5813|NCT03254199|Nervous System Malformations|nervous system malformations
5814|NCT03254199|Nervous System Diseases|nervous system diseases
5815|NCT03254199|Neurodegenerative Diseases|neurodegenerative diseases
5816|NCT03254199|Neuromuscular Diseases|neuromuscular diseases
5817|NCT03254186|Propranolol|propranolol
5818|NCT03254186|Safety|safety
5819|NCT03254186|Efficacy|efficacy
5820|NCT03254186|Tardive Dyskinesia treatment|tardive dyskinesia treatment
5821|NCT03254173|Mirtazapine|mirtazapine
5822|NCT03254173|Anorexia - Cachexia|anorexia - cachexia
5823|NCT03254173|Advanced Cancer|advanced cancer
5824|NCT03254173|Appetite|appetite
5828|NCT03254121|Sustained virological response|sustained virological response
5829|NCT03254121|Whole genome sequencing|whole genome sequencing
5830|NCT03254095|Skin temperature|skin temperature
5831|NCT03254095|Plantar pressure|plantar pressure
5832|NCT03254095|Diabetic foot|diabetic foot
5833|NCT03254095|Tissue hardness|tissue hardness
5834|NCT03254095|Neuropathy|neuropathy
5835|NCT03254095|Peripheral artery disease|peripheral artery disease
5836|NCT03254082|sorghum health|sorghum health
5837|NCT03254056|fascial closure device|fascial closure device
5838|NCT03254056|laparoscopic surgery|laparoscopic surgery
5839|NCT03254056|postoperative pain|postoperative pain
5840|NCT03254030|Adenoma|adenoma
5841|NCT03254030|Sessile serrated adenoma|sessile serrated adenoma
5842|NCT03254017|Bilateral Habeluna|bilateral habeluna
5843|NCT03254017|Remote Deep Brain Stimulation|remote deep brain stimulation
5844|NCT03254017|Treatment Resistant Major Depressive Disorder|treatment resistant major depressive disorder
5845|NCT03253900|wobble board|wobble board
5846|NCT03253900|slides|slides
5847|NCT03253900|rowing stroke|rowing stroke
5848|NCT03253900|rowing biomechanics|rowing biomechanics
5849|NCT03253900|power output|power output
5850|NCT03253887|Ethanol lock therapy|ethanol lock therapy
5851|NCT03253887|Pediatrics|pediatrics
5852|NCT03253887|Central Venous Catheter|central venous catheter
5853|NCT03253887|Bloodstream Infection|bloodstream infection
5854|NCT03253874|Pre-operative Testing|pre-operative testing
5855|NCT03253874|Cataract Surgery|cataract surgery
5856|NCT03253874|Health Service Research|health service research
5857|NCT03253874|Low-Value Care|low-value care
5858|NCT03253874|Safety-Net Hospital|safety-net hospital
5873|NCT03253861|Pancreatitis, Acute Necrotizing/surgery|pancreatitis, acute necrotizing/surgery
5874|NCT03253861|Pancreatitis, Acute Necrotizing/therapy|pancreatitis, acute necrotizing/therapy
5875|NCT03253822|Colorectal Neoplasms|colorectal neoplasms
5876|NCT03253822|Decision Support Techniques|decision support techniques
5877|NCT03253822|Early Detection of Cancer|early detection of cancer
5878|NCT03253822|Educational Status|educational status
5879|NCT03253822|Decision Making|decision making
5880|NCT03253822|Knowledge, Attitudes, Practice|knowledge, attitudes, practice
5881|NCT03253770|Cognitive Aid|cognitive aid
5882|NCT03253757|PrEP|prep
5900|NCT03253653|waterpipe|waterpipe
5901|NCT03253653|hookah|hookah
5902|NCT03253653|NNAL|nnal
5903|NCT03253653|SPMA|spma
5904|NCT03253653|1-HOP|1-hop
5905|NCT03253653|Furan-BDA-NAL|furan-bda-nal
5906|NCT03253653|Carbon monoxide|carbon monoxide
5907|NCT03253653|Pulmonary Function|pulmonary function
5908|NCT03253640|Costs and Cost Analysis|costs and cost analysis
5909|NCT03253640|Quality of Life|quality of life
5910|NCT03253640|Length of Stay|length of stay
5911|NCT03253640|Cohort study|cohort study
5912|NCT03253601|Rehabilitation|rehabilitation
5913|NCT03253601|Disability|disability
5914|NCT03253601|Mobile Health Technology|mobile health technology
5915|NCT03253575|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5916|NCT03253575|Breast Cancer|breast cancer
498460|NCT00171132|women|women
5917|NCT03253575|Non-Small Cell Lung Cancer|non-small cell lung cancer
5918|NCT03253575|Epithelial Ovarian Cancer|epithelial ovarian cancer
5919|NCT03253575|Colorectal Cancer|colorectal cancer
5920|NCT03253575|Local Recurrent Cancer|local recurrent cancer
5921|NCT03253575|Late Stage Cancer|late stage cancer
5922|NCT03253575|Clinical Utility|clinical utility
5923|NCT03253575|Outcomes Study|outcomes study
5924|NCT03253562|diabetes|diabetes
5925|NCT03253562|Metformin|metformin
5926|NCT03253562|vildagliptin|vildagliptin
5927|NCT03253562|hypertension|hypertension
5928|NCT03253562|cardiovascular risk|cardiovascular risk
5929|NCT03253549|remote automated monitoring|remote automated monitoring
5930|NCT03253549|hospital to home virtual care|hospital to home virtual care
5931|NCT03253549|cardiac surgery|cardiac surgery
5932|NCT03253549|major vascular surgery|major vascular surgery
5933|NCT03253549|self-management|self-management
5934|NCT03253536|Hepatocellular Cancer|hepatocellular cancer
5935|NCT03253536|Quality of Life|quality of life
5936|NCT03253536|stereotactic body radiation therapy|stereotactic body radiation therapy
5937|NCT03253536|observational|observational
5938|NCT03253497|chlorhexidine, benzidamine, laryngeal mask|chlorhexidine, benzidamine, laryngeal mask
5939|NCT03253484|scar NAFL laser|scar nafl laser
5940|NCT03253458|Optical coherence tomography|optical coherence tomography
5941|NCT03253458|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
5942|NCT03253458|Histology|histology
5943|NCT03253445|smoking cessation|smoking cessation
5944|NCT03253445|acceptance and commitment therapy|acceptance and commitment therapy
5945|NCT03253445|ACT|act
5946|NCT03253445|schizophrenic patients|schizophrenic patients
5947|NCT03253445|hostel setting|hostel setting
5948|NCT03253445|randomised controlled trial|randomised controlled trial
5949|NCT03253419|Falls|falls
5950|NCT03253419|Hip Replacement|hip replacement
5951|NCT03253419|Home Safety|home safety
5952|NCT03253367|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
5953|NCT03253341|exercise program|exercise program
5954|NCT03253341|lifestyle changes|lifestyle changes
5955|NCT03253341|fitness program|fitness program
5956|NCT03253341|lifestyle intervention|lifestyle intervention
5963|NCT03253237|Hypoglycemia|hypoglycemia
5964|NCT03253211|Co-management model of care|co-management model of care
5965|NCT03253211|Primary Care|primary care
5966|NCT03253211|Specialty Care|specialty care
5967|NCT03253211|Decision support tools|decision support tools
5968|NCT03253211|Emergency Department Clinicians|emergency department clinicians
5969|NCT03253211|Co-management|co-management
5970|NCT03253185|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
5971|NCT03253185|Cancer|cancer
5972|NCT03253185|Esophagogastric junction (EGJ) cancers|esophagogastric junction (egj) cancers
5973|NCT03253185|Maximum Tolerated Dose|maximum tolerated dose
5974|NCT03253185|Advanced cancer|advanced cancer
5975|NCT03253185|Pharmacokinetics|pharmacokinetics
5976|NCT03253146|Vimentin|vimentin
5977|NCT03253146|sepsis|sepsis
5978|NCT03253146|immune cells|immune cells
5979|NCT03253146|apoptosis|apoptosis
5980|NCT03253107|gastric cancer|gastric cancer
5981|NCT03253107|RNA sequencing|rna sequencing
5982|NCT03253107|chemotherapy response|chemotherapy response
5983|NCT03253107|miRNA sequencing|mirna sequencing
5984|NCT03253055|Physical Performance|physical performance
5985|NCT03253055|Bone|bone
5986|NCT03253055|Illness|illness
5987|NCT03253055|Injury|injury
5988|NCT03253042|Exercise|exercise
5989|NCT03253042|Vibration|vibration
5990|NCT03253042|Torque|torque
5991|NCT03253042|Aging|aging
5992|NCT03253029|oncology, cancer cachexia, cachexia anorexia,|oncology, cancer cachexia, cachexia anorexia,
5993|NCT03252977|fentanyl|fentanyl
5994|NCT03252977|Pain Threshold|pain threshold
5995|NCT03252977|predicted|predicted
5996|NCT03252938|solid tumor|solid tumor
5997|NCT03252938|peritoneal carcinomatosis|peritoneal carcinomatosis
5998|NCT03252886|intubation|intubation
5999|NCT03252886|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
6000|NCT03252886|neck injury|neck injury
6001|NCT03252873|adherence|adherence
6002|NCT03252873|pulmonary rehabilitation|pulmonary rehabilitation
6003|NCT03252873|copd|copd
6004|NCT03252847|XLRP RPGR|xlrp rpgr
6005|NCT03252808|Unresectable pancreatic cancer|unresectable pancreatic cancer
6006|NCT03252808|Metastatic pancreatic cancer|metastatic pancreatic cancer
6007|NCT03252808|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
6008|NCT03252808|TBI-1401(HF10)|tbi-1401(hf10)
6009|NCT03252808|HF10|hf10
6010|NCT03252808|Oncolytic virus|oncolytic virus
6011|NCT03252808|Oncolytic viral immunotherapy|oncolytic viral immunotherapy
6012|NCT03252808|Gemcitabine|gemcitabine
6013|NCT03252808|Nab-paclitaxel|nab-paclitaxel
6014|NCT03252808|Albumin-bound paclitaxel|albumin-bound paclitaxel
6015|NCT03252808|Abraxane|abraxane
6016|NCT03252795|Infertility, female|infertility, female
498559|NCT00176852|marrow|marrow
6017|NCT03252795|Mayer Rokitansky Kuster Hauser Syndrome|mayer rokitansky kuster hauser syndrome
6018|NCT03252795|Transplantation; Deceased donor|transplantation; deceased donor
6019|NCT03252782|Soft Tissue|soft tissue
6020|NCT03252782|Functional Appliance|functional appliance
6021|NCT03252782|Maxillary Molar Distalization|maxillary molar distalization
6022|NCT03252756|Cannabidiol|cannabidiol
6023|NCT03252756|Alcohol Use Disorder|alcohol use disorder
6024|NCT03252730|Dry scalp|dry scalp
6025|NCT03252730|Itchy scalp|itchy scalp
6026|NCT03252704|postprandial glucose insulin|postprandial glucose insulin
6027|NCT03252678|Advanced Care Planning|advanced care planning
6028|NCT03252665|STEMI|stemi
6768|NCT03247738|cangrelor|cangrelor
6029|NCT03252665|myocardial perfusion|myocardial perfusion
6030|NCT03252665|TMPFC|tmpfc
6031|NCT03252665|Nicorandil|nicorandil
6032|NCT03252665|Alprostadil|alprostadil
6033|NCT03252652|Cranial vessels|cranial vessels
6034|NCT03252652|Normal parameters|normal parameters
6035|NCT03252652|Carotid Duplex|carotid duplex
6036|NCT03252652|Egyptian|egyptian
6037|NCT03252639|Renal Artery Stenosis|renal artery stenosis
6038|NCT03252639|Renal Blood Perfusion|renal blood perfusion
6039|NCT03252613|septic cardiomyopathy|septic cardiomyopathy
6040|NCT03252613|cytokine|cytokine
6041|NCT03252613|iPSC|ipsc
6042|NCT03252613|Inducible pluripotent stem cell|inducible pluripotent stem cell
6043|NCT03252561|TAP block|tap block
6044|NCT03252561|Acute Appendicitis|acute appendicitis
6045|NCT03252561|Post-operative analgesia|post-operative analgesia
6046|NCT03252535|Huntington disease|huntington disease
6047|NCT03252535|Stem cell therapy|stem cell therapy
6048|NCT03252535|Dental pulp stem cell|dental pulp stem cell
6049|NCT03252509|interventional radiology, percutaneous radiologic gastrostomy, Head and Neck Neoplasms|interventional radiology, percutaneous radiologic gastrostomy, head and neck neoplasms
6433|NCT03249935|Urogenital|urogenital
6057|NCT03252444|EMG biofeedback training|emg biofeedback training
6058|NCT03252444|Intensive Scapula-focused intervention|intensive scapula-focused intervention
6060|NCT03252418|diode laser|diode laser
6061|NCT03252418|gingival hyperpigmentation|gingival hyperpigmentation
6062|NCT03252392|hearing and communication abnormalities|hearing and communication abnormalities
6063|NCT03252366|MAXILLARY SINUS ELEVATION ,Simultaneous implant placement|maxillary sinus elevation ,simultaneous implant placement
6064|NCT03252353|Octreotide Capsules, Acromegaly, OPTIMAL, MYCAPSSA|octreotide capsules, acromegaly, optimal, mycapssa
6066|NCT03252301|post operative|post operative
6067|NCT03252301|surgery|surgery
6068|NCT03252301|objective|objective
6069|NCT03252236|Stroke|stroke
6070|NCT03252236|Tai Chi|tai chi
6071|NCT03252236|Dual-tasking|dual-tasking
6072|NCT03252236|Arterial compliance|arterial compliance
6073|NCT03252236|Arterial stiffness|arterial stiffness
6074|NCT03252236|Autonomic nervous system|autonomic nervous system
6075|NCT03252236|Heart rate variability|heart rate variability
6076|NCT03252223|polycystic ovary syndrome|polycystic ovary syndrome
6077|NCT03252223|anovulation|anovulation
6078|NCT03252223|hyperandrogenism|hyperandrogenism
6079|NCT03252210|Preoperative localization|preoperative localization
6080|NCT03252210|Stereoscopic Localization|stereoscopic localization
6081|NCT03252210|Wedge Resection|wedge resection
6082|NCT03252210|Ground Glass Opacity|ground glass opacity
6083|NCT03252197|Ultrasound guided central venous cannulation|ultrasound guided central venous cannulation
6084|NCT03252197|new device|new device
6085|NCT03252197|first attempt success|first attempt success
6086|NCT03252184|Phototherapy|phototherapy
6087|NCT03252184|Laser Therapy|laser therapy
6088|NCT03252184|Endothelium-Dependent|endothelium-dependent
6089|NCT03252184|Vascular Endothelium|vascular endothelium
6090|NCT03252184|Low Intensity Light Therapy|low intensity light therapy
6091|NCT03252184|Relaxing Factors|relaxing factors
6092|NCT03252171|CAR-T cell immunotherapy|car-t cell immunotherapy
6093|NCT03252171|GD2|gd2
6094|NCT03252171|glioma|glioma
6095|NCT03252080|type 2 diabetes|type 2 diabetes
6096|NCT03252080|holistic management|holistic management
6097|NCT03252067|Azithromycin eyedrops, pharmacokinetics, tears|azithromycin eyedrops, pharmacokinetics, tears
6098|NCT03252041|PCS|pcs
6099|NCT03252028|Hepatocyte growth factor, Nosocomial infections, VAP, Meningitis, In vitro, point of care, rapid test|hepatocyte growth factor, nosocomial infections, vap, meningitis, in vitro, point of care, rapid test
6100|NCT03252002|Chronic kidney disease|chronic kidney disease
6104|NCT03251976|ovarian cancer|ovarian cancer
603821|NCT00597402|Brain tumor|brain tumor
6105|NCT03251976|cardiopulmonary resuscitation|cardiopulmonary resuscitation
6106|NCT03251976|end of life care|end of life care
6107|NCT03251976|endometrial cancer|endometrial cancer
6108|NCT03251976|cervical cancer|cervical cancer
6109|NCT03251950|Vegetable and fruit intake|vegetable and fruit intake
6110|NCT03251937|Chronic Pain|chronic pain
6111|NCT03251937|Back Pain|back pain
6112|NCT03251937|Leg Pain|leg pain
6113|NCT03251937|Pain|pain
6114|NCT03251937|Stimulation|stimulation
6115|NCT03251937|Spinal Cord Stimulator|spinal cord stimulator
6116|NCT03251937|Implantable Pulse Generator|implantable pulse generator
6117|NCT03251872|pulmonary arterial hypertension|pulmonary arterial hypertension
6118|NCT03251872|PAH|pah
6119|NCT03251872|poly (ADP-ribose) polymerases inhibition|poly (adp-ribose) polymerases inhibition
6120|NCT03251872|PARP-1 inhibition|parp-1 inhibition
6121|NCT03251872|DNA damage|dna damage
6122|NCT03251872|Early-phase clinical trial pilot study|early-phase clinical trial pilot study
6123|NCT03251872|Olaparib|olaparib
6124|NCT03251872|Safety and efficacy|safety and efficacy
6125|NCT03251859|platelet reactivity|platelet reactivity
6126|NCT03251859|ticagrelor|ticagrelor
6127|NCT03251859|myocardial infarction|myocardial infarction
6128|NCT03251859|pharmacodynamics|pharmacodynamics
6129|NCT03251859|antiplatelet therapy|antiplatelet therapy
6130|NCT03251846|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
6131|NCT03251846|self-monitoring blood glucose|self-monitoring blood glucose
6132|NCT03251846|diabetes mobile application|diabetes mobile application
6133|NCT03251846|diabetes management device|diabetes management device
6134|NCT03251820|electrical status epilepticus during slow wave sleep|electrical status epilepticus during slow wave sleep
6135|NCT03251820|seizure|seizure
6136|NCT03251820|cognition|cognition
6137|NCT03251820|continuous spikes and waves during sleep|continuous spikes and waves during sleep
6138|NCT03251807|Low-intensity pulsed ultrasound|low-intensity pulsed ultrasound
6139|NCT03251807|Twin-block|twin-block
6143|NCT03251781|Rehabilitation|rehabilitation
6144|NCT03251781|Disability Evaluation|disability evaluation
6145|NCT03251768|Chemotherapy|chemotherapy
6146|NCT03251768|Neutropenia|neutropenia
6147|NCT03251768|breast cancer|breast cancer
9000|NCT03233516|MxA|mxa
6148|NCT03251755|type 2 diabetes mellitus|type 2 diabetes mellitus
6149|NCT03251755|insomnia|insomnia
6151|NCT03251742|Fontan operation|fontan operation
6152|NCT03251742|Negative pressure ventilation|negative pressure ventilation
6153|NCT03251742|MRI|mri
6154|NCT03251729|cerclage, preterm birth, short cervix|cerclage, preterm birth, short cervix
6155|NCT03251716|Metabolic syndrome|metabolic syndrome
6156|NCT03251716|Schizophrenia|schizophrenia
6157|NCT03251716|Efficacy|efficacy
6158|NCT03251716|Female|female
6159|NCT03251716|Berberine|berberine
6160|NCT03251638|NHS( newborn hearing screening )|nhs( newborn hearing screening )
6161|NCT03251599|peak temperature|peak temperature
6162|NCT03251599|rewarming rate|rewarming rate
6163|NCT03251599|surgical outcomes|surgical outcomes
6164|NCT03251560|Fuke Qianjin capsule|fuke qianjin capsule
6165|NCT03251560|chronic pelvic pain|chronic pelvic pain
6166|NCT03251547|rFVIIa|rfviia
6167|NCT03251547|Massive Hemorrhage|massive hemorrhage
6168|NCT03251547|non-hemophilia|non-hemophilia
6169|NCT03251534|Eos imaging stereography|eos imaging stereography
6170|NCT03251534|Centromedullary nailing|centromedullary nailing
6171|NCT03251534|Quantification of malunions|quantification of malunions
6172|NCT03251521|pain|pain
6173|NCT03251521|spasticity|spasticity
6174|NCT03251521|stroke|stroke
6175|NCT03251521|injection|injection
6176|NCT03251521|botulinum toxin A|botulinum toxin a
6177|NCT03251508|Peanut|peanut
6182|NCT03251469|tranexamic acid|tranexamic acid
6183|NCT03251469|blood tranfusion|blood tranfusion
6184|NCT03251469|hip fractures|hip fractures
6185|NCT03251469|elderly|elderly
6186|NCT03251469|blood loss|blood loss
6187|NCT03251456|Visual Developmental Disorders|visual developmental disorders
6188|NCT03251456|Tertiary Care|tertiary care
6189|NCT03251456|Pre-school Children|pre-school children
6190|NCT03251417|Irinotecan|irinotecan
6191|NCT03251417|Apatinib|apatinib
6192|NCT03251391|revascularization|revascularization
6193|NCT03251391|blocked arteries|blocked arteries
6194|NCT03251391|leg arteries|leg arteries
6195|NCT03251391|leg pain|leg pain
6196|NCT03251365|Pancreatic cancer|pancreatic cancer
6197|NCT03251365|Gemcitabine|gemcitabine
6198|NCT03251365|Pancreatic carcinomatosis|pancreatic carcinomatosis
6199|NCT03251365|Intrabdominal hyperthermic chemotherapy|intrabdominal hyperthermic chemotherapy
6200|NCT03251352|TKI, CML, discontinuation|tki, cml, discontinuation
6201|NCT03251339|Healthy Subjects|healthy subjects
6202|NCT03251339|MSB11455|msb11455
6203|NCT03251274|bath machine|bath machine
6204|NCT03251274|sleep quality|sleep quality
6205|NCT03251274|nursing home|nursing home
6206|NCT03251274|heart rate variability|heart rate variability
6207|NCT03251248|MSB11455|msb11455
6209|NCT03251235|cognitive behaviour therapy|cognitive behaviour therapy
6210|NCT03251222|conscious sedation, vitroretinal procedures|conscious sedation, vitroretinal procedures
6212|NCT03251157|Adults|adults
6213|NCT03251157|Europe|europe
6214|NCT03251157|Lung function|lung function
6215|NCT03251157|Allergy|allergy
6216|NCT03251157|Atopy|atopy
6217|NCT03251157|IgE|ige
6218|NCT03251157|Sensitisation|sensitisation
6219|NCT03251157|Diet|diet
6220|NCT03251157|Dietary patterns|dietary patterns
6221|NCT03251157|Dietary antioxidants|dietary antioxidants
6222|NCT03251157|Flavonoids|flavonoids
6223|NCT03251157|Fruits and vegetables|fruits and vegetables
6224|NCT03251157|Food frequency questionnaire (FFQ)|food frequency questionnaire (ffq)
6225|NCT03251157|Fatty acids|fatty acids
6226|NCT03251144|HIV/AIDS|hiv/aids
6227|NCT03251144|Tenofovir disoproxil fumarate (TDF)|tenofovir disoproxil fumarate (tdf)
6228|NCT03251144|Tenofovir alafenamide (TAF)|tenofovir alafenamide (taf)
6229|NCT03251144|mitochondria|mitochondria
6230|NCT03251144|toxicity|toxicity
6231|NCT03251118|Crohn's Disease|crohn's disease
6232|NCT03251118|Ulcerative colitis|ulcerative colitis
6233|NCT03251118|Indeterminate colitis|indeterminate colitis
6234|NCT03251118|Digestive System Diseases|digestive system diseases
6235|NCT03251066|Nose Saline Solution Irrigation Nasal Spray|nose saline solution irrigation nasal spray
6236|NCT03251066|Sodium propionate Locke-Ringer Solution|sodium propionate locke-ringer solution
6237|NCT03251040|Esophagogastric anastomosis|esophagogastric anastomosis
6238|NCT03251040|Fibrin sealant|fibrin sealant
6239|NCT03251040|Sealing|sealing
6244|NCT03251014|Randomized crossover trial|randomized crossover trial
6246|NCT03251001|keratinized mucosa|keratinized mucosa
6247|NCT03251001|gingival graft|gingival graft
6248|NCT03250975|Intubation injury|intubation injury
6249|NCT03250975|Acute laryngeal injury|acute laryngeal injury
6250|NCT03250975|Chronic Laryngeal Injury|chronic laryngeal injury
6251|NCT03250962|Relapsed/Refractory; Hodgkin Lymphoma；Decitabine; SHR-1210|relapsed/refractory; hodgkin lymphoma；decitabine; shr-1210
6252|NCT03250936|trampoline|trampoline
6253|NCT03250910|hepatitis C virus|hepatitis c virus
6254|NCT03250910|human immunodeficiency virus|human immunodeficiency virus
6255|NCT03250910|Direct acting antiviral agent|direct acting antiviral agent
6261|NCT03250858|Personalised nutrition|personalised nutrition
6262|NCT03250858|Mobile web application|mobile web application
6264|NCT03250845|Immunoglobulin|immunoglobulin
6265|NCT03250845|Secondary immunodeficiency|secondary immunodeficiency
6266|NCT03250832|advanced solid tumors|advanced solid tumors
6267|NCT03250832|endometrioid ovarian cancer|endometrioid ovarian cancer
6268|NCT03250832|fallopian tube cancer|fallopian tube cancer
6269|NCT03250832|primary peritoneal cancer|primary peritoneal cancer
6270|NCT03250832|breast cancer|breast cancer
6271|NCT03250832|bladder cancer|bladder cancer
6272|NCT03250832|urothelial carcinoma|urothelial carcinoma
6273|NCT03250832|TNBC|tnbc
6274|NCT03250832|triple-negative breast cancer|triple-negative breast cancer
6275|NCT03250832|LAG-3|lag-3
6276|NCT03250806|aortic stenosis, auscultation, target echocardiography|aortic stenosis, auscultation, target echocardiography
6277|NCT03250793|Hernia, DIaphragmatic, Congenital|hernia, diaphragmatic, congenital
6278|NCT03250793|Respiration, Artificial|respiration, artificial
6279|NCT03250793|physiologic pilot study|physiologic pilot study
6280|NCT03250793|NAVA|nava
6281|NCT03250793|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
6282|NCT03250793|esophageal transducer|esophageal transducer
6283|NCT03250793|Work of Breathing|work of breathing
6284|NCT03250754|Acupuncture|acupuncture
6285|NCT03250754|Migraine|migraine
6286|NCT03250754|Tension-type headache|tension-type headache
6289|NCT03250728|CDG|cdg
6290|NCT03250728|Stroke-like|stroke-like
6291|NCT03250728|Endothelial progenitor cells (EPCs)|endothelial progenitor cells (epcs)
6292|NCT03250728|Protein C|protein c
6293|NCT03250702|Tanzania|tanzania
6294|NCT03250702|Observational|observational
6295|NCT03250702|Sub-Saharan Africa|sub-saharan africa
6296|NCT03250702|Treatment|treatment
6297|NCT03250689|Danirixin|danirixin
6298|NCT03250689|CXCR2|cxcr2
6299|NCT03250689|NETs|nets
6300|NCT03250689|GSK1325756|gsk1325756
6301|NCT03250689|COPD|copd
6302|NCT03250689|HBr|hbr
6307|NCT03250663|topical therapy, atopic dermatitis,|topical therapy, atopic dermatitis,
6308|NCT03250650|Overactive Bladder|overactive bladder
6309|NCT03250650|Electric Stimulation|electric stimulation
603822|NCT00597402|Glioma|glioma
6310|NCT03250650|Physical Therapy Modalities|physical therapy modalities
6311|NCT03250637|Gene-environment interaction|gene-environment interaction
6312|NCT03250637|Candidate gene|candidate gene
6313|NCT03250637|Western style diet|western style diet
6314|NCT03250637|Toll-like receptors|toll-like receptors
6315|NCT03250637|Prospective study|prospective study
6316|NCT03250637|Nested case-cohort|nested case-cohort
6317|NCT03250611|Occipital condyle|occipital condyle
6318|NCT03250611|Occipital condyle screw|occipital condyle screw
6319|NCT03250598|Healthy|healthy
6320|NCT03250598|Japanese|japanese
6321|NCT03250585|acute chest syndrome|acute chest syndrome
6322|NCT03250585|secretory phospholipases A2|secretory phospholipases a2
6323|NCT03250585|exhaled breath condensate|exhaled breath condensate
6324|NCT03250585|sickle cell disease|sickle cell disease
6325|NCT03250559|Stone disease|stone disease
6326|NCT03250533|Wound healing|wound healing
6327|NCT03250533|Phototherapy|phototherapy
6328|NCT03250533|Electrotherapy|electrotherapy
6329|NCT03250507|TAP block|tap block
6330|NCT03250507|Liposomal bupivicaine|liposomal bupivicaine
6331|NCT03250494|Duloxetine, Dexamethasone, Postoperative pain, side effects.|duloxetine, dexamethasone, postoperative pain, side effects.
6332|NCT03250481|Sedation, Responsiveness Index, Electromyogram|sedation, responsiveness index, electromyogram
6333|NCT03250390|Lung cancer|lung cancer
6334|NCT03250390|diagnosis|diagnosis
6335|NCT03250390|volatile organic compounds|volatile organic compounds
6337|NCT03250377|Epilepsy|epilepsy
6338|NCT03250377|Partial seizures with or without secondary generalization|partial seizures with or without secondary generalization
6339|NCT03250377|Asian subjects|asian subjects
6340|NCT03250325|Adoptive cell transfer|adoptive cell transfer
6341|NCT03250325|Cell therapy|cell therapy
6342|NCT03250325|Immunotherapy|immunotherapy
6343|NCT03250325|NY-ESO-1|ny-eso-1
6344|NCT03250325|T cell receptor gene therapy|t cell receptor gene therapy
6345|NCT03250325|Synovial sarcoma|synovial sarcoma
6721|NCT03248115|green tea catechins|green tea catechins
6769|NCT03247712|HNSCC|hnscc
6346|NCT03250312|Osteopathic manipulation|osteopathic manipulation
9176|NCT03232099|TMAO|tmao
6347|NCT03250312|low back pain|low back pain
6348|NCT03250312|immune cells|immune cells
6349|NCT03250273|Immunotherapy|immunotherapy
6350|NCT03250273|Nivolumab|nivolumab
6351|NCT03250273|Entinostat|entinostat
6352|NCT03250273|Adenocarcinoma|adenocarcinoma
6353|NCT03250273|Cholangiocarcinoma|cholangiocarcinoma
6354|NCT03250273|Unresectable|unresectable
6355|NCT03250273|Metastatic|metastatic
6356|NCT03250273|PD-1|pd-1
6357|NCT03250273|Antibody|antibody
6358|NCT03250260|3-dimensional imaging|3-dimensional imaging
6359|NCT03250260|Breast Conserving Treatment|breast conserving treatment
6360|NCT03250260|Simulation|simulation
6361|NCT03250247|deep vein thrombosis|deep vein thrombosis
6362|NCT03250247|superficial venous reflux|superficial venous reflux
6363|NCT03250247|blood clot|blood clot
6364|NCT03250247|post thrombotic syndrome|post thrombotic syndrome
6365|NCT03250247|iliac vein obstruction|iliac vein obstruction
6366|NCT03250234|microRNA, carbohydrate oxidation|microrna, carbohydrate oxidation
6367|NCT03250208|Microbiome|microbiome
6368|NCT03250208|Lactobacillus|lactobacillus
6369|NCT03250208|Probiotic|probiotic
6370|NCT03250208|Fem-Dophilus|fem-dophilus
6371|NCT03250156|Mindfulness|mindfulness
6372|NCT03250156|Attention|attention
6373|NCT03250156|Working Memory|working memory
6374|NCT03250156|Psychological Well-Being|psychological well-being
6375|NCT03250156|Proctored Practice|proctored practice
6376|NCT03250117|Parkinson Disease|parkinson disease
6377|NCT03250117|Dyskinesia|dyskinesia
6378|NCT03250117|ropinirole|ropinirole
6379|NCT03250117|implant|implant
6380|NCT03250117|ProNeura|proneura
6381|NCT03250117|movement disorders|movement disorders
6382|NCT03250117|dopamine agonist|dopamine agonist
6383|NCT03250117|extended-release|extended-release
6384|NCT03250117|Parkinsonian disorders|parkinsonian disorders
6385|NCT03250117|brain diseases|brain diseases
6386|NCT03250117|central nervous system diseases|central nervous system diseases
6387|NCT03250117|Neurodegenerative Diseases|neurodegenerative diseases
6388|NCT03250117|Antiparkinson agents|antiparkinson agents
6389|NCT03250117|Anti-dyskinesia agents|anti-dyskinesia agents
6390|NCT03250117|dopamine agents|dopamine agents
6391|NCT03250117|neurotransmitter agents|neurotransmitter agents
6392|NCT03250117|REQUIP|requip
6393|NCT03250117|subdermal|subdermal
6394|NCT03250104|antimicrobial stewardship|antimicrobial stewardship
6395|NCT03250104|infection control|infection control
6396|NCT03250104|nosocomial infection|nosocomial infection
6397|NCT03250104|clostridium difficile|clostridium difficile
6398|NCT03250104|MRGN bacteria|mrgn bacteria
6399|NCT03250104|health-care associated pathogens|health-care associated pathogens
6400|NCT03250104|VRE|vre
6401|NCT03250091|gastric precancerous lesions|gastric precancerous lesions
6402|NCT03250091|gastric cancer|gastric cancer
6403|NCT03250091|gastric intestinal Metaplasia|gastric intestinal metaplasia
6404|NCT03250091|gastric atrophy|gastric atrophy
6405|NCT03250091|gastric dysplasia|gastric dysplasia
6406|NCT03250078|Pancreas|pancreas
6407|NCT03250078|Cancer|cancer
6408|NCT03250078|Diabetes Mellitus|diabetes mellitus
6409|NCT03250078|MRI|mri
6410|NCT03250078|BRCA|brca
6411|NCT03250078|Early Detection|early detection
6412|NCT03250078|Genetics|genetics
6414|NCT03250039|Absorption, Metabolism, Excretion, Absolute Bioavailability|absorption, metabolism, excretion, absolute bioavailability
6415|NCT03250026|primary care|primary care
6416|NCT03250026|convergence dialogue|convergence dialogue
6417|NCT03250026|sick leave|sick leave
6418|NCT03250026|care manager|care manager
6419|NCT03249974|Enlite glucose monitoring|enlite glucose monitoring
6420|NCT03249974|accuracy|accuracy
6421|NCT03249974|usability|usability
6422|NCT03249974|skin reactions|skin reactions
6423|NCT03249974|type 1 diabetes mellitus|type 1 diabetes mellitus
6424|NCT03249961|motor|motor
402893|NCT01229267|immunocompromised|immunocompromised
499062|NCT00190450|graft|graft
6425|NCT03249961|transcranial direct current stimulation|transcranial direct current stimulation
6426|NCT03249961|transcranial magnetic stimulation|transcranial magnetic stimulation
6427|NCT03249935|Azithromycin|azithromycin
6428|NCT03249935|Chlamydia|chlamydia
6429|NCT03249935|Correctional|correctional
6430|NCT03249935|Facilities|facilities
6431|NCT03249935|Symptoms|symptoms
6432|NCT03249935|Urethral|urethral
6435|NCT03249922|spinal cord stimulation|spinal cord stimulation
6436|NCT03249896|Gestational Diabetes|gestational diabetes
6437|NCT03249896|RCT|rct
6438|NCT03249896|Lifestyle coaching program|lifestyle coaching program
6439|NCT03249896|Smartphone app|smartphone app
6440|NCT03249896|Gestational weight gain|gestational weight gain
6441|NCT03249883|prosthetic feet|prosthetic feet
6442|NCT03249883|double blind study|double blind study
6443|NCT03249883|limited ambulators|limited ambulators
6444|NCT03249883|SACH foot|sach foot
6445|NCT03249883|prosthetic components comparison|prosthetic components comparison
6446|NCT03249857|Bipolar affective disorders|bipolar affective disorders
6447|NCT03249857|Cognition|cognition
6448|NCT03249857|Emotion|emotion
6449|NCT03249857|Embodiment|embodiment
6451|NCT03249857|Simulation|simulation
6452|NCT03249844|arterial ischemic stroke|arterial ischemic stroke
6453|NCT03249844|children|children
6454|NCT03249844|steroids|steroids
6455|NCT03249844|aspirin|aspirin
6456|NCT03249844|Methylprednisolone|methylprednisolone
6457|NCT03249844|Prednisolone|prednisolone
6458|NCT03249831|Sickle Cell Disease|sickle cell disease
6459|NCT03249831|Sickle Cell Disorders|sickle cell disorders
6460|NCT03249831|Hemoglobinopathies|hemoglobinopathies
6461|NCT03249831|Thalassemia|thalassemia
6462|NCT03249831|Anemia, Sickle Cell|anemia, sickle cell
6463|NCT03249831|Haploidentical Transplant|haploidentical transplant
6464|NCT03249831|Nonmyeloablative Conditioning|nonmyeloablative conditioning
6465|NCT03249831|CD4+ T cell|cd4+ t cell
6466|NCT03249831|CD4+ T cell-depleted Hematopoietic Cell Transplant|cd4+ t cell-depleted hematopoietic cell transplant
6467|NCT03249831|Mixed Chimerism|mixed chimerism
6468|NCT03249805|LMIC|lmic
6469|NCT03249805|Medical device efficacy|medical device efficacy
6470|NCT03249740|Age-related macular degeneration|age-related macular degeneration
6471|NCT03249740|Choroidal neovascularization|choroidal neovascularization
6472|NCT03249727|natural killer cells|natural killer cells
6473|NCT03249727|natural killer cell activity|natural killer cell activity
6474|NCT03249714|double-blind, placebo controlled, ofatumumab, relapsing multiple sclerosis, Japanese patients|double-blind, placebo controlled, ofatumumab, relapsing multiple sclerosis, japanese patients
6475|NCT03249701|Transcutaneous Electrical Acupoint Stimulation|transcutaneous electrical acupoint stimulation
6476|NCT03249701|Safety|safety
6477|NCT03249701|Effectiveness|effectiveness
6478|NCT03249701|Postoperative Complications|postoperative complications
6479|NCT03249701|Peri-operation|peri-operation
6480|NCT03249688|Lifestyle intervention|lifestyle intervention
6481|NCT03249688|Medical food|medical food
6482|NCT03249688|Randomized controlled trial|randomized controlled trial
6483|NCT03249688|Prodromal Alzheimer's disease|prodromal alzheimer's disease
6484|NCT03249688|Prevention|prevention
6485|NCT03249688|Intervention|intervention
6486|NCT03249688|Multidomain|multidomain
6487|NCT03249688|Multimodal|multimodal
6488|NCT03249675|mild Traumatic Brain Injury|mild traumatic brain injury
6489|NCT03249675|Concussion|concussion
6490|NCT03249662|periarticular infiltration|periarticular infiltration
6491|NCT03249662|postoperative pain management|postoperative pain management
6492|NCT03249662|plasma level of bupivacaine|plasma level of bupivacaine
6493|NCT03249649|defibulation|defibulation
6494|NCT03249649|healthcare needs assessment|healthcare needs assessment
6495|NCT03249649|CBPR|cbpr
6496|NCT03249623|Weaning|weaning
6497|NCT03249623|Intensive Care|intensive care
6498|NCT03249623|Individualised Care|individualised care
6499|NCT03249623|Open-Loop Decision Support System|open-loop decision support system
6500|NCT03249623|Respiratory Failure|respiratory failure
6501|NCT03249623|Mechanical Ventilation|mechanical ventilation
6503|NCT03249623|Extubation|extubation
6504|NCT03249597|Sepsis|sepsis
6505|NCT03249597|Emergency Medical Services|emergency medical services
6506|NCT03249597|Prehospital|prehospital
6507|NCT03249597|Emergency Care|emergency care
6508|NCT03249597|Emergency Medicine|emergency medicine
6509|NCT03249571|exercise|exercise
6510|NCT03249571|flavonoids|flavonoids
6511|NCT03249571|gut permeability|gut permeability
6512|NCT03249571|gut-derived phenolics|gut-derived phenolics
6513|NCT03249558|Pain|pain
6514|NCT03249558|Pain Management|pain management
6515|NCT03249519|Radiation therapy|radiation therapy
6516|NCT03249519|Chemoradiation|chemoradiation
6517|NCT03249519|Brachytherapy|brachytherapy
6518|NCT03249519|Hyperthermia|hyperthermia
6519|NCT03249519|Cervical cancer|cervical cancer
6520|NCT03249519|Multimodality treatment of advanced cervical cancer|multimodality treatment of advanced cervical cancer
6522|NCT03249467|HAQ-II|haq-ii
6523|NCT03249467|Rheumatoid arthritis|rheumatoid arthritis
6524|NCT03249454|Incomplete SCI|incomplete sci
6525|NCT03249415|Platelet-Rich Plasma|platelet-rich plasma
6526|NCT03249415|Cell therapy|cell therapy
6527|NCT03249415|Regenerative factors|regenerative factors
6528|NCT03249415|Autologous treatment|autologous treatment
6536|NCT03249324|Overweight|overweight
6537|NCT03249324|Obesity|obesity
6538|NCT03249324|Prevention|prevention
6539|NCT03249324|Positive-gain counseling|positive-gain counseling
6540|NCT03249311|Levomilnacipran|levomilnacipran
6541|NCT03249311|Antidepressant|antidepressant
6542|NCT03249311|Ottawa|ottawa
6543|NCT03249311|Selective Norepinephrine Reuptake Inhibitor|selective norepinephrine reuptake inhibitor
6544|NCT03249311|Healthy males|healthy males
6545|NCT03249311|Tyramine response|tyramine response
6546|NCT03249311|Serotonin|serotonin
6547|NCT03249311|Norepinephrine|norepinephrine
6548|NCT03249285|hypertension|hypertension
6549|NCT03249285|pharmacogenomics|pharmacogenomics
6550|NCT03249285|anti-hypertensive therapy|anti-hypertensive therapy
6551|NCT03249246|Sepsis|sepsis
6553|NCT03249246|Point prevalence|point prevalence
6554|NCT03249207|Aneurysmal|aneurysmal
6555|NCT03249181|MTCT|mtct
6556|NCT03249181|Antiretroviral|antiretroviral
6557|NCT03249181|Pregnancy|pregnancy
6558|NCT03249181|Africa|africa
6559|NCT03249155|Freezing of Gait, Action Observation|freezing of gait, action observation
6560|NCT03249142|Ovarian Cancer|ovarian cancer
6561|NCT03249142|Anti-PD-L1|anti-pd-l1
6562|NCT03249142|Anti-CLA-4|anti-cla-4
6563|NCT03249142|Neo-adjuvant|neo-adjuvant
6564|NCT03249129|Trauma|trauma
6565|NCT03249129|spinal cord|spinal cord
6566|NCT03249129|autoimmunity|autoimmunity
6567|NCT03249129|antibody|antibody
6570|NCT03249103|Fibromyalgia|fibromyalgia
6573|NCT03249064|TREGS|tregs
6574|NCT03249064|CD91|cd91
6575|NCT03249064|LRP1|lrp1
6576|NCT03249025|lidocaine|lidocaine
6577|NCT03249025|ketamine|ketamine
6578|NCT03249025|infusion|infusion
6579|NCT03248999|multidrug resistance|multidrug resistance
6580|NCT03248999|nursing home|nursing home
6581|NCT03248999|ESBL|esbl
6583|NCT03248947|opioid use disorder|opioid use disorder
6584|NCT03248947|Medication-assisted treatment|medication-assisted treatment
6585|NCT03248947|Buprenorphine treatment|buprenorphine treatment
6586|NCT03248947|Collaborative care model|collaborative care model
6587|NCT03248908|pupillary reflex|pupillary reflex
6588|NCT03248908|nociception|nociception
6589|NCT03248908|heart rate|heart rate
6590|NCT03248908|intraoperative monitoring|intraoperative monitoring
6591|NCT03248895|Inhaler assessment|inhaler assessment
6592|NCT03248895|Direct observation of therapy|direct observation of therapy
6593|NCT03248882|PF-05221304|pf-05221304
6594|NCT03248882|NAFLD|nafld
6595|NCT03248882|NASH|nash
6596|NCT03248882|features of metabolic syndrome|features of metabolic syndrome
6597|NCT03248882|Dose-Ranging Study|dose-ranging study
6598|NCT03248869|asthma|asthma
6599|NCT03248869|mobile application|mobile application
6600|NCT03248869|mobile app|mobile app
6601|NCT03248869|mobile health applications|mobile health applications
6602|NCT03248869|asthma mobile health application|asthma mobile health application
6603|NCT03248843|KN035|kn035
6604|NCT03248843|Solid tumors|solid tumors
6605|NCT03248843|Phase 1|phase 1
6606|NCT03248804|Overweight|overweight
6607|NCT03248804|Obesity|obesity
6608|NCT03248804|Weight Loss|weight loss
6609|NCT03248778|disclosure|disclosure
6610|NCT03248752|Behavioural|behavioural
6611|NCT03248739|Catheter|catheter
6612|NCT03248739|Ventricular|ventricular
6613|NCT03248739|External Ventricular Drain Catheter|external ventricular drain catheter
6614|NCT03248739|EVD Catheter|evd catheter
6615|NCT03248739|Occlusion|occlusion
6616|NCT03248739|Ventriculostomy|ventriculostomy
6617|NCT03248739|Clear Bactiseal catheter|clear bactiseal catheter
6618|NCT03248739|Orange Bactiseal catheter|orange bactiseal catheter
6619|NCT03248739|Ventriculostomy Occlusion|ventriculostomy occlusion
6620|NCT03248739|Neurosurgery|neurosurgery
6621|NCT03248726|Polyethylene Glycol|polyethylene glycol
6622|NCT03248726|Bisacodyl|bisacodyl
6623|NCT03248726|Colonoscopy|colonoscopy
6624|NCT03248726|Bowel preparation|bowel preparation
6625|NCT03248726|Ottawa bowel preparation scale|ottawa bowel preparation scale
6631|NCT03248596|Extracorporeal Membrane Oxygenation (ECMO)|extracorporeal membrane oxygenation (ecmo)
6632|NCT03248596|Primary hemostasis|primary hemostasis
6633|NCT03248583|Proof-of-principle|proof-of-principle
6634|NCT03248583|Feasibility|feasibility
6635|NCT03248557|resuscitation|resuscitation
6636|NCT03248557|wavelet analysis|wavelet analysis
6637|NCT03248557|spectral analysis|spectral analysis
6638|NCT03248557|post-cardiac arrest syndrome|post-cardiac arrest syndrome
6639|NCT03248544|vitamin D|vitamin d
6640|NCT03248544|Brain Neoplasms|brain neoplasms
499313|NCT00194428|BMI|bmi
6641|NCT03248544|perioperative complications|perioperative complications
6642|NCT03248544|clinical outcomes|clinical outcomes
6643|NCT03248544|craniotomy|craniotomy
6644|NCT03248544|Immune System|immune system
6645|NCT03248531|Hidradenitis Suppurativa|hidradenitis suppurativa
6646|NCT03248531|Bimekizumab|bimekizumab
6647|NCT03248531|HS|hs
6648|NCT03248531|Moderate to Severe HS|moderate to severe hs
6649|NCT03248518|Inflammatory Rheumatic Disease|inflammatory rheumatic disease
6650|NCT03248518|Fatigue|fatigue
6651|NCT03248518|Exercise|exercise
6652|NCT03248518|Behavioural Intervention|behavioural intervention
6653|NCT03248518|Rheumatoid Arthritis|rheumatoid arthritis
6654|NCT03248518|Systemic Lupus Erythematosus|systemic lupus erythematosus
6655|NCT03248518|Axial Spondyloarthritis|axial spondyloarthritis
6656|NCT03248492|HER-2 positive breast cancer|her-2 positive breast cancer
6657|NCT03248492|Metastatic or Unresectable|metastatic or unresectable
6658|NCT03248492|Resistant or refractory to T-DM1|resistant or refractory to t-dm1
6659|NCT03248479|Hu5F9-G4|hu5f9-g4
6660|NCT03248479|CD47|cd47
6661|NCT03248479|azacitidine|azacitidine
6662|NCT03248466|platelet rich gel|platelet rich gel
6663|NCT03248466|BMMSCs|bmmscs
6664|NCT03248466|diabetic foot ulcer|diabetic foot ulcer
6665|NCT03248453|Simulated colonoscopy|simulated colonoscopy
6666|NCT03248453|Self-regulated learning|self-regulated learning
6667|NCT03248427|Breast Cancer|breast cancer
6668|NCT03248427|Neoadjuvant|neoadjuvant
6669|NCT03248427|Luminal B tumors|luminal b tumors
6670|NCT03248427|Ribociclib|ribociclib
6671|NCT03248375|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
6672|NCT03248375|Radioembolization|radioembolization
6673|NCT03248375|Radiation Segmentectomy|radiation segmentectomy
6674|NCT03248349|Critically ill children|critically ill children
6675|NCT03248349|Pharmacokinetics|pharmacokinetics
6676|NCT03248349|Anti-Bacterial agents|anti-bacterial agents
6677|NCT03248310|Quality of Life (QoL)|quality of life (qol)
6678|NCT03248310|17-377|17-377
6679|NCT03248271|Diabetes|diabetes
6680|NCT03248271|Sarcopenia|sarcopenia
6681|NCT03248271|Hypotension|hypotension
6682|NCT03248271|Tilt Table Test|tilt table test
6683|NCT03248258|Metastatic Breast Cancer|metastatic breast cancer
6684|NCT03248258|Treatment Decision Making|treatment decision making
6685|NCT03248258|Shared Decision Making|shared decision making
6686|NCT03248245|interprofessional team collaboration|interprofessional team collaboration
6687|NCT03248245|primary school|primary school
6688|NCT03248245|learning environment|learning environment
6689|NCT03248245|teacher's self-efficacy|teacher's self-efficacy
6690|NCT03248245|teachers working ours|teachers working ours
6691|NCT03248245|pupils learning outcome|pupils learning outcome
6692|NCT03248245|cluster-randomized|cluster-randomized
6693|NCT03248232|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
6694|NCT03248193|paclitaxel|paclitaxel
6695|NCT03248193|neuropathy|neuropathy
6696|NCT03248193|hypothermia|hypothermia
6697|NCT03248193|cryocompression|cryocompression
6698|NCT03248193|alopecia|alopecia
6699|NCT03248180|antipsychotic|antipsychotic
6700|NCT03248180|guided dose reduction|guided dose reduction
6701|NCT03248180|maintenance treatment|maintenance treatment
6702|NCT03248180|remitted psychosis|remitted psychosis
6703|NCT03248180|relapse|relapse
6704|NCT03248167|Cannabidiol|cannabidiol
6705|NCT03248154|Biofilm|biofilm
6706|NCT03248154|Procellera|procellera
6707|NCT03248141|Hemophilia A Factor VIII|hemophilia a factor viii
6708|NCT03248141|Hemophilia B Factor IX|hemophilia b factor ix
6709|NCT03248141|Cross-sectional|cross-sectional
6710|NCT03248141|Epidemiological|epidemiological
6711|NCT03248141|Clinical practice|clinical practice
6712|NCT03248141|United States|united states
6713|NCT03248128|Fluticasone furoate|fluticasone furoate
6714|NCT03248128|Efficacy|efficacy
6715|NCT03248128|Vilanterol|vilanterol
6716|NCT03248128|Asthma|asthma
6717|NCT03248128|Safety|safety
6718|NCT03248128|GW642444|gw642444
6719|NCT03248128|GW685698|gw685698
6720|NCT03248115|polyphenols|polyphenols
6722|NCT03248115|coffee caffeoylquinic acids|coffee caffeoylquinic acids
6723|NCT03248115|metabolism|metabolism
6724|NCT03248115|inter-individual variability|inter-individual variability
6725|NCT03248115|colonic microbiota|colonic microbiota
6726|NCT03248102|paediatric|paediatric
6727|NCT03248063|Staphylococcus aureus|staphylococcus aureus
6728|NCT03248063|bacteremia|bacteremia
6729|NCT03248063|cloxacillin|cloxacillin
6730|NCT03248063|cefazolin|cefazolin
6731|NCT03248024|Chronic Disease|chronic disease
6732|NCT03248024|Ulcerative Colitis|ulcerative colitis
6733|NCT03248011|hamstring|hamstring
6736|NCT03247998|Stroke|stroke
6737|NCT03247998|endovascular repair|endovascular repair
6738|NCT03247998|general anesthesia|general anesthesia
6739|NCT03247998|conscious sedation|conscious sedation
6740|NCT03247985|Mesh|mesh
6741|NCT03247985|Repair|repair
6742|NCT03247985|Peritoneal|peritoneal
6743|NCT03247959|oral health education, distraction, videogame|oral health education, distraction, videogame
6744|NCT03247946|infant|infant
6745|NCT03247946|feeding position|feeding position
6746|NCT03247946|respiratory|respiratory
6750|NCT03247920|Antibiotic switch therapy|antibiotic switch therapy
6751|NCT03247920|Amoxicillin/clavulanic acid|amoxicillin/clavulanic acid
6752|NCT03247894|Multiple sclerosis, anesthesia|multiple sclerosis, anesthesia
6753|NCT03247842|post mastectomy pain|post mastectomy pain
6754|NCT03247829|CardioMEMS|cardiomems
6755|NCT03247829|Left Ventricular Assist Device|left ventricular assist device
6756|NCT03247829|Hemodynamic Management|hemodynamic management
6757|NCT03247803|Air-Q® SP|air-q® sp
6758|NCT03247803|Williams Airway Intubator (WA)|williams airway intubator (wa)
6759|NCT03247803|Flexible Bronchoscopic intubation (FBI)|flexible bronchoscopic intubation (fbi)
6760|NCT03247803|Fiberoptic Intubation (FOI)|fiberoptic intubation (foi)
6761|NCT03247803|Fiberoptic Intubating Airway(FIA)|fiberoptic intubating airway(fia)
6762|NCT03247803|Laryngeal Mask Airway|laryngeal mask airway
6763|NCT03247777|golf|golf
6764|NCT03247777|strength training|strength training
6765|NCT03247777|physical performance tests|physical performance tests
6766|NCT03247777|body composition|body composition
6767|NCT03247738|ticagrelor|ticagrelor
6773|NCT03247712|immunotherapy|immunotherapy
6774|NCT03247712|nivolumab|nivolumab
6775|NCT03247712|antibodies|antibodies
6776|NCT03247673|safety|safety
6777|NCT03247673|Pharmacokinetics|pharmacokinetics
6778|NCT03247673|Immunogenicity|immunogenicity
6779|NCT03247647|Alcohol Intervention|alcohol intervention
6780|NCT03247647|College Students|college students
6781|NCT03247634|getting ahead|getting ahead
6782|NCT03247634|vulnerable population|vulnerable population
6783|NCT03247634|safety net practice network|safety net practice network
6784|NCT03247621|external eating, technology|external eating, technology
6785|NCT03247608|Ambio Health|ambio health
6786|NCT03247595|Colonoscopy preparation|colonoscopy preparation
6787|NCT03247595|Magnesium Citrate Capsules|magnesium citrate capsules
6788|NCT03247582|Real World Evidence|real world evidence
6789|NCT03247582|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
6790|NCT03247582|Observational Safety|observational safety
6791|NCT03247569|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
6792|NCT03247569|Real World Evidence|real world evidence
6793|NCT03247569|Observational Safety|observational safety
6794|NCT03247491|Mindfulness|mindfulness
6795|NCT03247491|Compassion|compassion
6796|NCT03247491|Depression during Pregnancy and Postpartum|depression during pregnancy and postpartum
6797|NCT03247491|Prevention|prevention
6798|NCT03247491|Stress|stress
6799|NCT03247478|Computed tomography (CT) reconstruction|computed tomography (ct) reconstruction
6800|NCT03247478|axillary lymph node status|axillary lymph node status
6801|NCT03247452|Low fiber diet|low fiber diet
6802|NCT03247452|Colonoscopy|colonoscopy
6803|NCT03247452|Bowel Cleansing|bowel cleansing
6804|NCT03247439|CMC Joint|cmc joint
6805|NCT03247439|Osteoarthritis|osteoarthritis
6806|NCT03247439|Cartilage Replacement|cartilage replacement
6807|NCT03247439|First CMC Joint Osteoarthritis|first cmc joint osteoarthritis
6808|NCT03247439|Damaged Articular Surface|damaged articular surface
6809|NCT03247439|LRTI|lrti
6810|NCT03247439|Ligament Reconstruction Tendon Interposition|ligament reconstruction tendon interposition
6811|NCT03247387|Wearable device|wearable device
6812|NCT03247387|Patient monitor|patient monitor
6813|NCT03247374|rehabilitation|rehabilitation
6814|NCT03247374|treatment|treatment
6815|NCT03247374|biofeedback|biofeedback
6816|NCT03247374|bio-feedback|bio-feedback
6817|NCT03247374|dysphagia|dysphagia
6818|NCT03247374|swallowing disorders|swallowing disorders
6819|NCT03247374|post-stroke|post-stroke
6820|NCT03247374|deglutition disorders|deglutition disorders
6821|NCT03247361|Heart Failure; Rehabilitation|heart failure; rehabilitation
6822|NCT03247322|Medication Safety|medication safety
6823|NCT03247322|Mobile Health Technology|mobile health technology
6824|NCT03247309|T-cell therapy|t-cell therapy
6825|NCT03247309|immunotherapy|immunotherapy
6826|NCT03247309|HLA-A*02:01|hla-a*02:01
6827|NCT03247309|adoptive cellular therapy|adoptive cellular therapy
6828|NCT03247309|T-Cell Receptor|t-cell receptor
6829|NCT03247296|Daclatasvir|daclatasvir
6830|NCT03247296|HCC|hcc
6831|NCT03247296|HCV|hcv
6832|NCT03247296|Sofosbuvir|sofosbuvir
6833|NCT03247244|Cannabis|cannabis
6834|NCT03247244|Tics|tics
6835|NCT03247244|Tourette Syndrome|tourette syndrome
6836|NCT03247231|SUBEPITHELIAL TUMORS|subepithelial tumors
6837|NCT03247231|SUBMUCOSAL TUMORS|submucosal tumors
6838|NCT03247231|ENDOSCOPIC BAND LIGATION|endoscopic band ligation
6839|NCT03247205|hip fracture|hip fracture
6840|NCT03247205|cognitive impairment|cognitive impairment
6841|NCT03247205|physical therapy|physical therapy
6842|NCT03247192|resistance training|resistance training
6843|NCT03247192|protein supplementation|protein supplementation
6844|NCT03247192|aging|aging
6845|NCT03247192|Randomized Controlled Trial|randomized controlled trial
6846|NCT03247127|hippocampal avoidance whole brain radiotherapy (HA-WBRT)|hippocampal avoidance whole brain radiotherapy (ha-wbrt)
6847|NCT03247127|brain metastases|brain metastases
6848|NCT03247127|memory preservation|memory preservation
6849|NCT03247127|neurocognitive function|neurocognitive function
6850|NCT03247088|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
6851|NCT03247088|Acute Myeloid Leukemia|acute myeloid leukemia
6853|NCT03247088|flt3 positive and negative|flt3 positive and negative
6854|NCT03247088|Stem cell transplant|stem cell transplant
6855|NCT03247088|Sorafenib|sorafenib
6856|NCT03247088|Nexavar|nexavar
6857|NCT03247088|BAY 43-9006|bay 43-9006
6858|NCT03247088|Busulfan|busulfan
6859|NCT03247088|Busulfex|busulfex
6860|NCT03247088|Myleran|myleran
6861|NCT03247088|Fludarabine|fludarabine
6862|NCT03247088|Fludarabine Phosphate|fludarabine phosphate
6863|NCT03247088|Fludara|fludara
6864|NCT03247088|Tacrolimus|tacrolimus
6865|NCT03247088|Prograf|prograf
6866|NCT03247088|Filgrastim|filgrastim
6867|NCT03247088|G-CSF|g-csf
6868|NCT03247088|Neupogen|neupogen
6869|NCT03247075|Social anxiety disorder|social anxiety disorder
6870|NCT03247075|Cognitive Behavior Therapy|cognitive behavior therapy
7598|NCT03241797|EUS-FNA|eus-fna
6871|NCT03247075|Internet-delivered treatments|internet-delivered treatments
6872|NCT03247075|Children and adolescents|children and adolescents
6873|NCT03247075|Randomized controlled trial|randomized controlled trial
6874|NCT03247062|agitation, sleep deprivation, bundle|agitation, sleep deprivation, bundle
6875|NCT03246997|Food Insecure|food insecure
6876|NCT03246958|Thyroid Cancer|thyroid cancer
6877|NCT03246932|peer expert or specialist|peer expert or specialist
6878|NCT03246932|psycho-education|psycho-education
6879|NCT03246932|schizophrenia|schizophrenia
6880|NCT03246932|outpatients|outpatients
6881|NCT03246893|Sepsis|sepsis
6882|NCT03246893|Septic shock|septic shock
6883|NCT03246893|Severe sepsis|severe sepsis
6884|NCT03246893|Extubation|extubation
6885|NCT03246893|Reintubation|reintubation
6886|NCT03246893|Noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
6887|NCT03246893|High flow oxygen nasal cannula|high flow oxygen nasal cannula
6888|NCT03246867|isolytic stretching|isolytic stretching
6889|NCT03246867|static stretching|static stretching
6890|NCT03246867|Glenohumeral Internal Rotation Deficit|glenohumeral internal rotation deficit
6891|NCT03246854|DBPR112|dbpr112
6892|NCT03246854|EGFR mutated NSCLC|egfr mutated nsclc
6893|NCT03246854|squamous cell cancer of head and neck|squamous cell cancer of head and neck
6894|NCT03246854|maximum tolerated dose|maximum tolerated dose
6895|NCT03246854|recommended Phase 2 dose|recommended phase 2 dose
6896|NCT03246841|Oncogeneticists|oncogeneticists
6897|NCT03246841|Mutations|mutations
6898|NCT03246841|Breast Cancer|breast cancer
6899|NCT03246841|Ovarian cancer|ovarian cancer
6900|NCT03246828|gliclazide|gliclazide
6901|NCT03246828|glucagon|glucagon
6902|NCT03246828|diabetes|diabetes
6903|NCT03246802|recurrent prostate cancer|recurrent prostate cancer
6904|NCT03246802|mpMRI|mpmri
6905|NCT03246802|salvage HDR brachytherapy|salvage hdr brachytherapy
6906|NCT03246763|childhood obesity|childhood obesity
6907|NCT03246750|Brentuximab Vedotin|brentuximab vedotin
6908|NCT03246724|Ocular surgery|ocular surgery
6909|NCT03246724|Intravenous sedation|intravenous sedation
6910|NCT03246724|Oral sedation|oral sedation
6911|NCT03246698|Stretching|stretching
6912|NCT03246698|Subacromial Impingement Syndrome|subacromial impingement syndrome
6913|NCT03246698|Glenohumeral Internal Rotation Deficit|glenohumeral internal rotation deficit
6914|NCT03246672|obesity, morbid|obesity, morbid
6915|NCT03246659|medullary thyroid carcinoma|medullary thyroid carcinoma
6917|NCT03246659|new gastrin analog|new gastrin analog
6918|NCT03246659|111In-CP04|111in-cp04
6919|NCT03246659|CP04 indium|cp04 indium
6920|NCT03246659|personalised diagnostics|personalised diagnostics
6921|NCT03246659|personalised therapy|personalised therapy
6922|NCT03246659|theranostics|theranostics
6923|NCT03246659|advanced MTC|advanced mtc
6924|NCT03246659|CCK-2/gastrin receptor|cck-2/gastrin receptor
6925|NCT03246646|Substance Abuse|substance abuse
6926|NCT03246646|Alcohol Abuse|alcohol abuse
6927|NCT03246620|emergency|emergency
6928|NCT03246620|emergency medicine|emergency medicine
6929|NCT03246620|sedation|sedation
6932|NCT03246594|esophageal probe|esophageal probe
6934|NCT03246581|inhalation|inhalation
6935|NCT03246581|anticholinergic|anticholinergic
6936|NCT03246568|Ablation|ablation
6937|NCT03246568|Renal Denervation|renal denervation
6938|NCT03246568|Cryoballoon|cryoballoon
6939|NCT03246477|maxillomandibular advancement osteotomy|maxillomandibular advancement osteotomy
6940|NCT03246477|long-term results|long-term results
6941|NCT03246477|quality of life|quality of life
499687|NCT00196417|HIT|hit
6942|NCT03246477|polysomnographic measurements|polysomnographic measurements
6943|NCT03246477|skeletal stability|skeletal stability
6947|NCT03246451|GLP-1|glp-1
6948|NCT03246451|glucagon-like peptide-1|glucagon-like peptide-1
6949|NCT03246451|Metformin|metformin
6950|NCT03246451|Exendin(9-39)|exendin(9-39)
6951|NCT03246399|SM04690|sm04690
6952|NCT03246399|Wnt pathway|wnt pathway
6953|NCT03246399|Samumed|samumed
6954|NCT03246373|cognitive impairment|cognitive impairment
6955|NCT03246334|Cohort study|cohort study
6956|NCT03246334|Critical Care|critical care
6957|NCT03246334|Follow-up study|follow-up study
6958|NCT03246334|Intensive care units|intensive care units
6959|NCT03246334|Long-term outcome|long-term outcome
6960|NCT03246334|Outcome assessment|outcome assessment
6961|NCT03246334|Quality of life|quality of life
6962|NCT03246321|Colorectal Neoplasms|colorectal neoplasms
6963|NCT03246321|Peritoneal Neoplasms|peritoneal neoplasms
6964|NCT03246321|Intraperitoneal Injections|intraperitoneal injections
6965|NCT03246321|Laparoscopy|laparoscopy
6966|NCT03246321|Aerosols|aerosols
6967|NCT03246321|Chemotherapy, Cancer, Regional Perfusion|chemotherapy, cancer, regional perfusion
6968|NCT03246321|Antineoplastic Agents|antineoplastic agents
6969|NCT03246321|Leucovorin|leucovorin
6971|NCT03246321|Platinum|platinum
6972|NCT03246321|Intraoperative Complications|intraoperative complications
6973|NCT03246321|Postoperative Complications|postoperative complications
7069|NCT03245749|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
6974|NCT03246321|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
6975|NCT03246321|Metabolic Side Effects of Drugs and Substances|metabolic side effects of drugs and substances
6976|NCT03246321|Disease-free survival|disease-free survival
6977|NCT03246321|Survival|survival
6978|NCT03246321|Mortality|mortality
6979|NCT03246321|Quality of Life|quality of life
6980|NCT03246321|Costs and Cost Analysis|costs and cost analysis
6981|NCT03246321|Translational Medical Research|translational medical research
6982|NCT03246321|Clinical Trials, Phase II as topic|clinical trials, phase ii as topic
6983|NCT03246321|PIPAC|pipac
6984|NCT03246321|Pressurized Intraperitoneal Aerosol Chemotherapy|pressurized intraperitoneal aerosol chemotherapy
6985|NCT03246321|Pressurised Intraperitoneal Aerosol Chemotherapy|pressurised intraperitoneal aerosol chemotherapy
6986|NCT03246321|Peritoneum|peritoneum
6987|NCT03246321|Cecal Neoplasms|cecal neoplasms
6988|NCT03246321|Clinical Trials, Phase I as topic|clinical trials, phase i as topic
6989|NCT03246295|Proteomics|proteomics
6990|NCT03246295|Metabolomics|metabolomics
6991|NCT03246256|acute|acute
6992|NCT03246256|informed consent|informed consent
6993|NCT03246256|thrombolysis|thrombolysis
6994|NCT03246243|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
6995|NCT03246243|Bottle Feeding|bottle feeding
6996|NCT03246230|newborn vaccine responses|newborn vaccine responses
6997|NCT03246178|Haploidentical|haploidentical
6998|NCT03246178|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
6999|NCT03246178|Severe aplastic anemia|severe aplastic anemia
7000|NCT03246152|Anti-VEGF safety|anti-vegf safety
7001|NCT03246152|Ischemic Maculopathy|ischemic maculopathy
7002|NCT03246152|Diabetic Macular Edema|diabetic macular edema
7003|NCT03246152|OCTA|octa
7004|NCT03246139|stroke|stroke
7005|NCT03246139|neurorehabilitation|neurorehabilitation
7006|NCT03246139|mirror neuron system|mirror neuron system
7007|NCT03246139|action observation|action observation
7008|NCT03246139|motor imagery|motor imagery
7009|NCT03246139|MEG|meg
7010|NCT03246113|GBM WHO Grade IV|gbm who grade iv
7011|NCT03246100|centralized reminder/recall|centralized reminder/recall
7012|NCT03246100|influenza vaccine reminders|influenza vaccine reminders
7013|NCT03246100|childhood influenza vaccines|childhood influenza vaccines
7014|NCT03246087|acupuncture|acupuncture
7015|NCT03246087|plantar fasiosis|plantar fasiosis
7016|NCT03246074|Phase I|phase i
7017|NCT03246074|Ovarian Cancer|ovarian cancer
7018|NCT03246074|Fostamatinib and Paclitaxel|fostamatinib and paclitaxel
7019|NCT03246035|Acute Decompensated Heart Failure|acute decompensated heart failure
7020|NCT03246035|Heart Failure|heart failure
7021|NCT03246035|Frailty|frailty
7022|NCT03246035|Geriatrics|geriatrics
7023|NCT03246035|Self-care|self-care
7024|NCT03246035|Emergency Medicine|emergency medicine
7025|NCT03246035|Cardiology|cardiology
7026|NCT03246035|Patient Oriented Research|patient oriented research
7027|NCT03246022|blood pressure fluctuation|blood pressure fluctuation
7028|NCT03246022|hypertension|hypertension
7029|NCT03246022|continuous positive airway pressure|continuous positive airway pressure
7030|NCT03246009|Neutropenia|neutropenia
7031|NCT03246009|Chemotherapy|chemotherapy
7032|NCT03246009|rHSA/GCSF|rhsa/gcsf
7033|NCT03245996|sick sinus syndrome|sick sinus syndrome
7034|NCT03245996|heart rate|heart rate
7035|NCT03245996|aortic blood pressure|aortic blood pressure
7036|NCT03245996|artificial pacemaker|artificial pacemaker
7037|NCT03245944|immature AVF|immature avf
400113|NCT01241214|SAR|sar
7038|NCT03245944|percutaneous intervention|percutaneous intervention
7039|NCT03245892|Nivolumab|nivolumab
7040|NCT03245892|Paclitaxel|paclitaxel
7041|NCT03245892|Carboplatin|carboplatin
7042|NCT03245892|17-182|17-182
7043|NCT03245866|Subarachnoid Hemorrhage|subarachnoid hemorrhage
7044|NCT03245866|Intracranial Aneurysm|intracranial aneurysm
7045|NCT03245866|Ruptured Intracranial Aneurysm|ruptured intracranial aneurysm
7046|NCT03245866|Neurosurgery|neurosurgery
7047|NCT03245866|Interventional Neuroradiology|interventional neuroradiology
7048|NCT03245866|Neurointensive Care Medicine|neurointensive care medicine
7049|NCT03245866|Switzerland|switzerland
7050|NCT03245853|Keratoconus|keratoconus
7051|NCT03245853|Corneal Crosslinking|corneal crosslinking
7053|NCT03245814|service dogs|service dogs
7054|NCT03245814|human-animal interaction|human-animal interaction
7055|NCT03245801|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
7056|NCT03245801|Canada|canada
7057|NCT03245801|Registry|registry
7058|NCT03245801|Clinical outcomes|clinical outcomes
7059|NCT03245801|Adverse events|adverse events
7060|NCT03245801|CAPRI|capri
7061|NCT03245788|Lay Navigator|lay navigator
7062|NCT03245788|Quality of Care|quality of care
7063|NCT03245788|High-Need Cancer Treatment Regimen|high-need cancer treatment regimen
7064|NCT03245775|health disparities|health disparities
7065|NCT03245775|community-based participatory research|community-based participatory research
7066|NCT03245749|omega-3 status|omega-3 status
7067|NCT03245749|blood lipids|blood lipids
7068|NCT03245749|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
7070|NCT03245723|premature adults|premature adults
7071|NCT03245723|premature|premature
7072|NCT03245723|premature lung function|premature lung function
7073|NCT03245723|premature cardiac function|premature cardiac function
7074|NCT03245723|MRI|mri
7075|NCT03245723|PET|pet
7076|NCT03245697|breast milk|breast milk
7077|NCT03245697|composition|composition
7078|NCT03245697|Galicia|galicia
7079|NCT03245697|diet|diet
7080|NCT03245697|lactation|lactation
7081|NCT03245684|ARDS|ards
7082|NCT03245684|Ventilator-induced Lung Injury|ventilator-induced lung injury
7083|NCT03245684|cytokines|cytokines
7084|NCT03245684|mechanical ventilation|mechanical ventilation
7085|NCT03245645|FODMAP|fodmap
7086|NCT03245645|IBS|ibs
7087|NCT03245645|Diet|diet
7088|NCT03245645|Re-introduction|re-introduction
7089|NCT03245645|Fructose|fructose
7090|NCT03245619|3-hydroxykynurenine|3-hydroxykynurenine
7091|NCT03245619|Acute pancreatitis|acute pancreatitis
7092|NCT03245619|Dose-escalation|dose-escalation
7093|NCT03245619|Healthy subjects|healthy subjects
7094|NCT03245619|GSK3335065|gsk3335065
7095|NCT03245606|NAFLD|nafld
7096|NCT03245606|steatosis|steatosis
7097|NCT03245606|fibrosis|fibrosis
7098|NCT03245606|transient elastography|transient elastography
7099|NCT03245554|Gastrointestinal Cancer|gastrointestinal cancer
7100|NCT03245554|Propranolol|propranolol
7101|NCT03245541|SBRT/SABR; Durvalumab; Locally advanced; Borderline resectable|sbrt/sabr; durvalumab; locally advanced; borderline resectable
7102|NCT03245450|eribulin mesilate|eribulin mesilate
7103|NCT03245450|irinotecan|irinotecan
7104|NCT03245450|combination therapy|combination therapy
7105|NCT03245450|children|children
7106|NCT03245437|Social Cognition|social cognition
7107|NCT03245437|Oxytocin|oxytocin
7108|NCT03245372|cardiac output|cardiac output
7109|NCT03245372|perioperative care|perioperative care
7110|NCT03245372|postoperative complications|postoperative complications
7111|NCT03245359|Total Knee Arthroplasty|total knee arthroplasty
7112|NCT03245359|Intra-articular Analgesia|intra-articular analgesia
7113|NCT03245359|Bupivacaine Hydrochloride|bupivacaine hydrochloride
7114|NCT03245294|cervical epidural space|cervical epidural space
7115|NCT03245294|abrupt pressure decrease|abrupt pressure decrease
7116|NCT03245281|Heart Failure|heart failure
7117|NCT03245268|Balloon pulmonary angioplasty|balloon pulmonary angioplasty
7118|NCT03245268|BPA|bpa
7119|NCT03245255|pressure measurements|pressure measurements
7120|NCT03245255|blood pressure|blood pressure
7121|NCT03245255|contrast echocardiography|contrast echocardiography
7122|NCT03245255|ventricular pressures|ventricular pressures
7123|NCT03245255|catheterization|catheterization
7124|NCT03245242|enhanced recovery after surgery|enhanced recovery after surgery
7125|NCT03245242|urologic reconstruction|urologic reconstruction
7126|NCT03245242|pediatric urology|pediatric urology
7127|NCT03245242|bladder augmentation|bladder augmentation
7128|NCT03245242|Mitrofanoff|mitrofanoff
7129|NCT03245242|Malone antegrade continence enema channel|malone antegrade continence enema channel
7130|NCT03245242|appendicovesicostomy|appendicovesicostomy
7131|NCT03245242|ileovesicostomy|ileovesicostomy
7132|NCT03245242|appendicocecostomy|appendicocecostomy
7133|NCT03245216|Parkinson's Disease|parkinson's disease
7134|NCT03245216|motor learning|motor learning
7135|NCT03245216|aerobic exercise|aerobic exercise
7136|NCT03245216|cardiovascular exercise|cardiovascular exercise
7137|NCT03245216|balance|balance
7138|NCT03245216|postural instability|postural instability
7139|NCT03245216|motor skill|motor skill
7140|NCT03245203|neoadjuvant chemotherapy|neoadjuvant chemotherapy
7141|NCT03245164|obese children|obese children
7142|NCT03245164|motor skills|motor skills
7143|NCT03245164|physiotherapy|physiotherapy
7144|NCT03245164|basketball|basketball
7145|NCT03245151|pediatrics|pediatrics
7146|NCT03245151|central nervous system tumors|central nervous system tumors
7147|NCT03245151|lenvatinib|lenvatinib
7148|NCT03245151|E7080|e7080
7149|NCT03245151|everolimus|everolimus
7150|NCT03245151|Ewing sarcoma/peripheral primitive neuroectodermal tumor|ewing sarcoma/peripheral primitive neuroectodermal tumor
7151|NCT03245151|rhabdomyosarcoma|rhabdomyosarcoma
7152|NCT03245151|high grade glioma|high grade glioma
7153|NCT03245151|solid tumors|solid tumors
7154|NCT03245138|endoscopic third ventriculostomy|endoscopic third ventriculostomy
7155|NCT03245138|ventricular peritoneal shunt|ventricular peritoneal shunt
7156|NCT03245138|communicating hydrocephalus|communicating hydrocephalus
7157|NCT03245060|psychosocial well-being|psychosocial well-being
7158|NCT03245060|solution focused brief therapy|solution focused brief therapy
7159|NCT03245034|Medical Residents|medical residents
7160|NCT03245034|Well-Being|well-being
7161|NCT03245034|Stress/Burnout in Medical Residents|stress/burnout in medical residents
7162|NCT03244995|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
7163|NCT03244995|High grade glioma|high grade glioma
7165|NCT03244995|Couple-based mind-body program|couple-based mind-body program
7166|NCT03244995|CBMB|cbmb
7167|NCT03244995|Waitlist Control Group|waitlist control group
7168|NCT03244995|Questionnaires|questionnaires
7169|NCT03244995|Surveys|surveys
7170|NCT03244995|Mind-Body Intervention|mind-body intervention
7171|NCT03244995|Compact Discs (CD's)|compact discs (cd's)
7172|NCT03244995|Printed Materials|printed materials
7173|NCT03244995|Phone calls|phone calls
7174|NCT03244982|fluorescein|fluorescein
7175|NCT03244982|angiography|angiography
7176|NCT03244969|Hematoma fracture, angiogenesis, bone formation|hematoma fracture, angiogenesis, bone formation
7177|NCT03244917|Nursing home|nursing home
7178|NCT03244917|Palliative Care|palliative care
7179|NCT03244917|Dementia|dementia
7180|NCT03244917|Infection|infection
7181|NCT03244917|Antimicrobials|antimicrobials
7182|NCT03244904|NGS,SCLC, ctDNA|ngs,sclc, ctdna
7183|NCT03244878|Cognitive Behavior Therapy|cognitive behavior therapy
7184|NCT03244852|OCD|ocd
7185|NCT03244852|deep brain stimulation|deep brain stimulation
7186|NCT03244852|treatment-resistant OCD|treatment-resistant ocd
7187|NCT03244826|Cancer|cancer
7188|NCT03244800|0382, T2DM|0382, t2dm
7189|NCT03244761|high flow tracheal oxygen|high flow tracheal oxygen
7190|NCT03244761|modified interface|modified interface
7191|NCT03244735|Ketogenic Diet|ketogenic diet
7192|NCT03244709|Giant cell arteritis,|giant cell arteritis,
7193|NCT03244709|Tocilizumab|tocilizumab
7194|NCT03244709|Aortitis|aortitis
7195|NCT03244709|Remission|remission
7196|NCT03244696|Multiple Sclerosis|multiple sclerosis
7197|NCT03244696|Sclerosis|sclerosis
7198|NCT03244696|Demyelinating Autoimmune Diseases, Central Nervous System|demyelinating autoimmune diseases, central nervous system
7199|NCT03244696|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
7200|NCT03244696|Nervous System Diseases|nervous system diseases
7201|NCT03244696|Demyelinating Diseases|demyelinating diseases
7202|NCT03244696|Immune System Diseases|immune system diseases
7203|NCT03244696|Physical Activity|physical activity
7204|NCT03244696|Walking|walking
7205|NCT03244696|Hydration|hydration
7206|NCT03244696|Lifestyle Intervention|lifestyle intervention
603823|NCT00597402|New GBM|new gbm
7207|NCT03244696|Health Behavior Tracking|health behavior tracking
7208|NCT03244696|Inflammatory Biomarkers|inflammatory biomarkers
7209|NCT03244696|Neurodegenerative Disease|neurodegenerative disease
7211|NCT03244644|C Difficile Colitis|c difficile colitis
7212|NCT03244644|Clostridium Difficile|clostridium difficile
7214|NCT03244644|C.Difficile Diarrhea|c.difficile diarrhea
7215|NCT03244644|Fecal Transplant|fecal transplant
7216|NCT03244644|Fecal Microbiota Transplant|fecal microbiota transplant
7217|NCT03244644|Microbiota Restoration Therapy|microbiota restoration therapy
7218|NCT03244644|Diarrhea|diarrhea
7219|NCT03244644|FMT|fmt
7222|NCT03244566|positron emission tomography|positron emission tomography
7223|NCT03244566|cervical lymphatic metastasis|cervical lymphatic metastasis
7224|NCT03244540|postoperative pain|postoperative pain
7225|NCT03244540|transversus abdominis plane block|transversus abdominis plane block
7226|NCT03244540|quadratus lumborum block|quadratus lumborum block
7227|NCT03244540|neuropathic pain|neuropathic pain
7231|NCT03244514|cardiac surgery|cardiac surgery
7232|NCT03244514|KDIGO-Guideline|kdigo-guideline
7233|NCT03244501|tSMS|tsms
7234|NCT03244501|Transcranial Static Magnetic Field Stimulation|transcranial static magnetic field stimulation
7235|NCT03244501|healthy control|healthy control
7236|NCT03244475|mild Traumatic Brain Injury|mild traumatic brain injury
7237|NCT03244475|transcranial electrical stimulation|transcranial electrical stimulation
7238|NCT03244475|neurofeedback|neurofeedback
7239|NCT03244475|magnetoencephalography|magnetoencephalography
7240|NCT03244475|post-traumatic stress disorder|post-traumatic stress disorder
7241|NCT03244449|biomarker|biomarker
7242|NCT03244449|insulin resistance|insulin resistance
7243|NCT03244449|myokine|myokine
7244|NCT03244449|clamp|clamp
7245|NCT03244423|Pediatric|pediatric
7246|NCT03244423|Cyanotic heart disease|cyanotic heart disease
7247|NCT03244423|Tranexamic acid|tranexamic acid
7248|NCT03244423|Postoperative|postoperative
7249|NCT03244423|Blood|blood
7250|NCT03244358|Triple Negative Breast Cancer|triple negative breast cancer
7251|NCT03244358|Epalrestat|epalrestat
7252|NCT03244306|leukemia|leukemia
7253|NCT03244306|CD 22|cd 22
7254|NCT03244306|CAR T cell|car t cell
7255|NCT03244306|pediatric|pediatric
7256|NCT03244306|young adult|young adult
7257|NCT03244306|chimeric antigen receptor|chimeric antigen receptor
7258|NCT03244267|Orthopedics|orthopedics
7259|NCT03244254|Celiac Disease|celiac disease
7260|NCT03244254|Children|children
7261|NCT03244254|I-FABP|i-fabp
7262|NCT03244241|Type 2 diabetes, inpatient diabetes management, basal-bolus insulin|type 2 diabetes, inpatient diabetes management, basal-bolus insulin
7267|NCT03244215|Corneal Confocal Microscopy|corneal confocal microscopy
7268|NCT03244215|High performance liquid chromatography,|high performance liquid chromatography,
7269|NCT03244215|Inflammatory biomarkers|inflammatory biomarkers
7270|NCT03244215|modified Rankin scale ( mRS)|modified rankin scale ( mrs)
7271|NCT03244202|Incidental Findings|incidental findings
7272|NCT03244202|Decision Aids|decision aids
7273|NCT03244202|Genomic Sequencing|genomic sequencing
7274|NCT03244202|Randomized Controlled Trail|randomized controlled trail
7275|NCT03244202|Genetic Counselling|genetic counselling
7276|NCT03244189|Urinary Stone Disease|urinary stone disease
7277|NCT03244189|Kidney Stone|kidney stone
7278|NCT03244189|Urinary Calculi|urinary calculi
7279|NCT03244176|DLBCL|dlbcl
7280|NCT03244163|Spyglass DS|spyglass ds
7281|NCT03244163|Laser lithotripsy|laser lithotripsy
7282|NCT03244163|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
7283|NCT03244150|Physical activity|physical activity
7284|NCT03244150|Obesity|obesity
7285|NCT03244150|Overweight|overweight
7286|NCT03244150|Lifestyle|lifestyle
7287|NCT03244150|Diet|diet
7288|NCT03244124|dentin bonding agents|dentin bonding agents
7289|NCT03244124|tooth sensitivity|tooth sensitivity
7290|NCT03244124|composite resin restoration|composite resin restoration
7291|NCT03244059|COPD|copd
7292|NCT03244059|belimumab|belimumab
7293|NCT03244059|biologic agent|biologic agent
7294|NCT03244059|GRP78|grp78
7295|NCT03244046|Low Back pain|low back pain
7296|NCT03244046|Pain|pain
7297|NCT03244046|Posttraumatic Stress Disorder|posttraumatic stress disorder
7298|NCT03244046|PTSD|ptsd
7299|NCT03244046|Somatic Experiencing|somatic experiencing
7300|NCT03244046|SE|se
7301|NCT03244033|context|context
7302|NCT03244033|contextual error|contextual error
7303|NCT03244033|contextual care|contextual care
7304|NCT03244033|electronic medical record|electronic medical record
7305|NCT03244033|clinical decision support|clinical decision support
7306|NCT03244007|macular hole|macular hole
7307|NCT03244007|lamellar macular hole|lamellar macular hole
7308|NCT03243994|Cor pulmonale|cor pulmonale
7309|NCT03243994|COPD|copd
7310|NCT03243994|Malabsorption|malabsorption
7311|NCT03243994|D-xylose|d-xylose
7312|NCT03243994|Zinc|zinc
7313|NCT03243955|acupuncture|acupuncture
7314|NCT03243955|TENS|tens
7315|NCT03243955|TEAS|teas
7316|NCT03243955|constipation|constipation
7317|NCT03243955|transcutaneous|transcutaneous
7318|NCT03243942|pressure measurements|pressure measurements
7319|NCT03243942|blood pressure|blood pressure
7320|NCT03243942|contrast echocardiography|contrast echocardiography
7321|NCT03243942|ventricular pressures|ventricular pressures
7322|NCT03243942|catheterization|catheterization
7323|NCT03243916|interventional therapy|interventional therapy
7324|NCT03243916|TACE|tace
7325|NCT03243916|Cyberknife|cyberknife
7326|NCT03243903|T2DM|t2dm
7327|NCT03243903|QS-M needle free injector|qs-m needle free injector
7328|NCT03243903|insulin pen|insulin pen
7329|NCT03243903|effective|effective
7330|NCT03243903|safety|safety
7331|NCT03243877|Screening|screening
7332|NCT03243877|Mammography|mammography
7333|NCT03243851|Glioblastoma|glioblastoma
7334|NCT03243838|Triple-Negative Breast Cancer|triple-negative breast cancer
7335|NCT03243838|apatinib|apatinib
7336|NCT03243838|pCR|pcr
7337|NCT03243838|OS|os
7338|NCT03243838|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
400464|NCT01239810|MRI|mri
7339|NCT03243825|neoadjuvant chemotherapy|neoadjuvant chemotherapy
7340|NCT03243825|brachytherapy|brachytherapy
7341|NCT03243825|radiotherapy|radiotherapy
7342|NCT03243812|Sickle Cell Disease|sickle cell disease
7343|NCT03243812|Muscle function|muscle function
7344|NCT03243812|Hemorheological disorders|hemorheological disorders
7345|NCT03243760|CCI15106|cci15106
7346|NCT03243760|pharmacokinetics|pharmacokinetics
7347|NCT03243760|BAL|bal
7348|NCT03243760|COPD|copd
7349|NCT03243734|spray cryotherapy|spray cryotherapy
7350|NCT03243734|quality of life|quality of life
7351|NCT03243734|symptom reduction|symptom reduction
7352|NCT03243734|esophageal malignancies|esophageal malignancies
7353|NCT03243734|liquid nitrogen|liquid nitrogen
7354|NCT03243734|ablation|ablation
7355|NCT03243721|multiple sclerosis|multiple sclerosis
7356|NCT03243721|thalamus|thalamus
7357|NCT03243721|high field MRI|high field mri
7358|NCT03243721|cognition|cognition
7359|NCT03243708|Venous Thromboembolism Risk Calculator|venous thromboembolism risk calculator
10180|NCT03225664|MK-3475|mk-3475
7370|NCT03243604|androgen antagonist|androgen antagonist
7371|NCT03243565|adenoid hypertrophy|adenoid hypertrophy
7372|NCT03243565|Adenoid Hyperplasia|adenoid hyperplasia
7374|NCT03243565|respiratory tract infection|respiratory tract infection
7375|NCT03243565|adenotonsillectomy|adenotonsillectomy
7376|NCT03243565|OM-85|om-85
7377|NCT03243539|lung protective ventilation|lung protective ventilation
7378|NCT03243500|atracurium|atracurium
7379|NCT03243500|high myopes|high myopes
7380|NCT03243500|percaruncular|percaruncular
7381|NCT03243500|phacoemulsification|phacoemulsification
7382|NCT03243500|medial canthal|medial canthal
7383|NCT03243500|ophthalmic regional anesthesia|ophthalmic regional anesthesia
7384|NCT03243461|Glioblastoma|glioblastoma
7385|NCT03243461|high grade glioma|high grade glioma
7386|NCT03243461|brain tumor|brain tumor
7387|NCT03243461|Anaplastic astrocytoma|anaplastic astrocytoma
7388|NCT03243461|DIPG|dipg
7389|NCT03243461|Gliomatosis cerebri|gliomatosis cerebri
7390|NCT03243461|Diffuse midline glioma|diffuse midline glioma
7391|NCT03243409|reversed shoulder arthroplasties|reversed shoulder arthroplasties
7392|NCT03243409|clinical complications|clinical complications
7393|NCT03243409|complex proximal humeral fractures|complex proximal humeral fractures
7394|NCT03243396|Mental health|mental health
7395|NCT03243396|Cognitive behavioral therapy|cognitive behavioral therapy
7396|NCT03243396|Task-shifting|task-shifting
7397|NCT03243396|Global health|global health
7398|NCT03243396|Teacher|teacher
7399|NCT03243396|Community health volunteer|community health volunteer
7400|NCT03243396|Children|children
7401|NCT03243396|Orphans|orphans
7402|NCT03243396|Abandoned children|abandoned children
7403|NCT03243396|TF-CBT|tf-cbt
7404|NCT03243396|Mental health policy|mental health policy
7405|NCT03243396|Ministry of Education|ministry of education
7406|NCT03243396|Ministry of Health|ministry of health
7407|NCT03243396|Delivery|delivery
605851|NCT00596310|screening|screening
7408|NCT03243396|Implementation science|implementation science
7409|NCT03243396|Qualitative comparative analysis|qualitative comparative analysis
7410|NCT03243396|Implementation practices and policies|implementation practices and policies
7411|NCT03243396|Youth|youth
7412|NCT03243396|Adoption|adoption
7413|NCT03243396|Fidelity|fidelity
7414|NCT03243396|Kenya|kenya
7415|NCT03243396|Bungoma|bungoma
7416|NCT03243396|Kanduyi|kanduyi
7417|NCT03243396|East Africa|east africa
7418|NCT03243396|Posttraumatic stress|posttraumatic stress
7419|NCT03243396|Childhood traumatic grief|childhood traumatic grief
7420|NCT03243396|Grief|grief
7421|NCT03243396|Trauma|trauma
7422|NCT03243383|readmission|readmission
7423|NCT03243370|Validate the Clock'nTest|validate the clock'ntest
7424|NCT03243357|Endodontics, molars, instrumentation, obturation, anatomy|endodontics, molars, instrumentation, obturation, anatomy
7425|NCT03243331|Breast Cancer|breast cancer
7426|NCT03243292|Bronchial Thermoplasty|bronchial thermoplasty
7427|NCT03243292|Alair|alair
7428|NCT03243292|Registry|registry
7429|NCT03243227|carpal tunnel syndrome, neurodynamics, median nerve gliding exercise|carpal tunnel syndrome, neurodynamics, median nerve gliding exercise
7430|NCT03243214|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
7431|NCT03243188|Palliative Care|palliative care
7432|NCT03243175|intracerebral hemorrhage|intracerebral hemorrhage
7433|NCT03243175|atrial fibrillation|atrial fibrillation
7434|NCT03243175|microhemorrhage|microhemorrhage
7435|NCT03243175|oral anticoagulation|oral anticoagulation
7436|NCT03243175|left atrial appendage closure|left atrial appendage closure
7437|NCT03243084|tACS|tacs
7438|NCT03243084|transcranial alternating current stimulation|transcranial alternating current stimulation
7439|NCT03243084|low back pain|low back pain
7440|NCT03243084|chronic pain|chronic pain
7441|NCT03243084|alpha oscillations|alpha oscillations
7442|NCT03243084|heart rate variability|heart rate variability
7443|NCT03243071|Medical Care|medical care
7444|NCT03243071|Racial Discrimination|racial discrimination
7445|NCT03243071|Poor Health Literacy|poor health literacy
7446|NCT03243071|Medical Care Disparities|medical care disparities
7447|NCT03243045|Arterial hypertension|arterial hypertension
7448|NCT03243045|Microcirculation|microcirculation
7449|NCT03243045|Sympathetic nervous system|sympathetic nervous system
7450|NCT03243019|cervico-facial|cervico-facial
7451|NCT03243019|rapamycin|rapamycin
7452|NCT03243006|acute pain|acute pain
7453|NCT03243006|emergency department|emergency department
7454|NCT03243006|opioid consumption|opioid consumption
7456|NCT03242980|Adherence|adherence
7457|NCT03242980|Viral re-suppression|viral re-suppression
7458|NCT03242980|Step-wedgged randomized trial|step-wedgged randomized trial
7459|NCT03242967|Anemia|anemia
7460|NCT03242967|hemoglobin|hemoglobin
7461|NCT03242967|darbepoetin alfa|darbepoetin alfa
7462|NCT03242967|TIW|tiw
7463|NCT03242967|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
7464|NCT03242967|HIF-PHI|hif-phi
7465|NCT03242967|AKB-6548|akb-6548
7466|NCT03242967|vadadustat|vadadustat
7468|NCT03242967|hypoxia-inducible factor|hypoxia-inducible factor
7469|NCT03242967|HIF|hif
7470|NCT03242967|dialysis-dependent chronic kidney disease|dialysis-dependent chronic kidney disease
7471|NCT03242967|CKD|ckd
7472|NCT03242967|DD-CKD|dd-ckd
7473|NCT03242967|kidney|kidney
7474|NCT03242967|erythropoiesis stimulating agent|erythropoiesis stimulating agent
7475|NCT03242967|ESA|esa
7476|NCT03242967|Trilogy|trilogy
7477|NCT03242928|Cocaine Use Disorder; cocaine dependence|cocaine use disorder; cocaine dependence
7478|NCT03242902|light therapy|light therapy
7479|NCT03242902|cancer related fatigue|cancer related fatigue
7480|NCT03242902|sleep quality|sleep quality
7481|NCT03242902|biological rhythms|biological rhythms
7482|NCT03242850|Reading|reading
7483|NCT03242850|Text Messages|text messages
7484|NCT03242850|Video|video
7485|NCT03242850|Cognitive Development|cognitive development
7486|NCT03242850|Child Development|child development
7487|NCT03242850|Infants|infants
7488|NCT03242811|Medical age assessment|medical age assessment
7489|NCT03242798|liver cirrhosis|liver cirrhosis
7490|NCT03242798|malnutrition|malnutrition
7491|NCT03242798|nutritional status|nutritional status
7492|NCT03242798|nutritional assessment|nutritional assessment
7493|NCT03242785|Self-monitoring|self-monitoring
7494|NCT03242785|Education|education
7495|NCT03242785|Self-titration|self-titration
7496|NCT03242785|antihypertensives|antihypertensives
7497|NCT03242746|LEEP|leep
7498|NCT03242746|Loop Electrosurgical Excision Procedure|loop electrosurgical excision procedure
7499|NCT03242746|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
7500|NCT03242746|pregnancy outcome|pregnancy outcome
7501|NCT03242733|Gastroparesis|gastroparesis
7502|NCT03242694|persistent atrial fibrillation|persistent atrial fibrillation
7503|NCT03242694|pulmonary vein isolation|pulmonary vein isolation
7504|NCT03242694|catheter ablation|catheter ablation
7505|NCT03242694|left atrial function|left atrial function
7506|NCT03242694|left atrial pressure|left atrial pressure
7507|NCT03242694|voltage map|voltage map
7508|NCT03242694|strain|strain
7509|NCT03242694|scar|scar
7510|NCT03242694|success|success
7511|NCT03242694|biomarker|biomarker
7512|NCT03242668|paravertebral block,PVC,PCA|paravertebral block,pvc,pca
7513|NCT03242629|pediatric ophthalmic examination|pediatric ophthalmic examination
7514|NCT03242629|chloral hydrate|chloral hydrate
7515|NCT03242629|Effects Comparison|effects comparison
7516|NCT03242603|Relapsed, Refractory, Neuroblastoma|relapsed, refractory, neuroblastoma
7517|NCT03242603|Anti-GD2|anti-gd2
7518|NCT03242603|Natural Killer (NK) Cells|natural killer (nk) cells
7519|NCT03242603|Immunotherapy|immunotherapy
7520|NCT03242538|Exercise|exercise
7522|NCT03242512|osteoporosis|osteoporosis
7523|NCT03242512|bone resorption|bone resorption
7524|NCT03242512|post-menopausal women|post-menopausal women
7525|NCT03242512|TK006|tk006
7526|NCT03242434|Mannitol|mannitol
7527|NCT03242434|Intestinal permeability|intestinal permeability
7528|NCT03242434|Thermal injury|thermal injury
7529|NCT03242434|HESTIA|hestia
7530|NCT03242434|Sucralose|sucralose
7531|NCT03242434|Lactulose|lactulose
7532|NCT03242421|test-retest reliability|test-retest reliability
7533|NCT03242421|Binocular vision tests|binocular vision tests
7534|NCT03242395|Neuroinflammation|neuroinflammation
7535|NCT03242395|fMRI|fmri
7536|NCT03242395|Post-operative cognitive dysfunction|post-operative cognitive dysfunction
7537|NCT03242395|Systemic inflammation|systemic inflammation
7538|NCT03242395|Severe burns|severe burns
7539|NCT03242382|advanced|advanced
7540|NCT03242382|sarcoma|sarcoma
7541|NCT03242382|cdk4|cdk4
7542|NCT03242369|colorectal neoplasia|colorectal neoplasia
10385|NCT03224468|pain|pain
500515|NCT00198978|ALL|all
7557|NCT03242200|young adult female|young adult female
7558|NCT03242200|mobile app|mobile app
7559|NCT03242200|questionnaire|questionnaire
7560|NCT03242200|health tracking|health tracking
7561|NCT03242187|Minimally invasive surgery|minimally invasive surgery
7562|NCT03242187|trans-anal total mesorectal excision|trans-anal total mesorectal excision
7563|NCT03242187|Laparoscopic total mesoretal excision|laparoscopic total mesoretal excision
7564|NCT03242070|Patient Portals|patient portals
7565|NCT03242070|Chronic Disease|chronic disease
7566|NCT03242070|Older Adults|older adults
7567|NCT03242057|NAVA|nava
7568|NCT03242057|Extubation|extubation
7569|NCT03242057|NIPPV|nippv
7570|NCT03241992|Inflammatory Bowel Disease|inflammatory bowel disease
7571|NCT03241992|IBD|ibd
7572|NCT03241992|Electronic Health Record|electronic health record
7573|NCT03241992|Patient Portal|patient portal
7574|NCT03241992|Quality of Life|quality of life
7575|NCT03241966|Parkinson's Disease|parkinson's disease
7576|NCT03241966|Online Study|online study
7577|NCT03241966|Quality of Life|quality of life
7578|NCT03241966|Activities of Daily Living|activities of daily living
7579|NCT03241966|Perception|perception
7580|NCT03241966|Cognition|cognition
7581|NCT03241966|Gait|gait
7582|NCT03241927|Pembrolizumab|pembrolizumab
7583|NCT03241927|NK Cell Exhaustion|nk cell exhaustion
7584|NCT03241927|PD-1|pd-1
7585|NCT03241927|Unresectable|unresectable
7586|NCT03241927|Stage III|stage iii
7587|NCT03241927|Stage IV|stage iv
7588|NCT03241901|Artemether-Lumefantrine, Primaquine|artemether-lumefantrine, primaquine
7589|NCT03241888|Levonorgestrel-releasing intrauterine system|levonorgestrel-releasing intrauterine system
7590|NCT03241888|megestrol acetate|megestrol acetate
7591|NCT03241888|Atypical Endometrial Hyperplasia|atypical endometrial hyperplasia
7592|NCT03241875|pregabalin|pregabalin
7593|NCT03241875|gabapentin|gabapentin
7594|NCT03241875|post operative pain|post operative pain
7595|NCT03241875|laparoscopic cholecystectomy|laparoscopic cholecystectomy
7596|NCT03241810|Breast Cancer, HER2 Negative, Hormone receptor positive, heregulin|breast cancer, her2 negative, hormone receptor positive, heregulin
7599|NCT03241784|ALS|als
7600|NCT03241784|T-Regulatory Cells|t-regulatory cells
7601|NCT03241745|Nivolumab|nivolumab
7602|NCT03241745|17-180|17-180
7603|NCT03241732|Traumatic Brain Injury|traumatic brain injury
7604|NCT03241732|TBI|tbi
7605|NCT03241732|Brain Trauma|brain trauma
7606|NCT03241732|N-acetyl cysteine|n-acetyl cysteine
7607|NCT03241732|Concussion|concussion
7608|NCT03241732|NAC|nac
7609|NCT03241732|Integrative Medicine|integrative medicine
7610|NCT03241732|EEG|eeg
7611|NCT03241732|electroencephalogram|electroencephalogram
7612|NCT03241732|Functional magnetic resonance imaging or functional MRI|functional magnetic resonance imaging or functional mri
7613|NCT03241732|fMRI|fmri
7614|NCT03241732|PET|pet
7615|NCT03241732|Positron emission tomography|positron emission tomography
7616|NCT03241732|MRI|mri
7617|NCT03241732|magnetic resonance imaging|magnetic resonance imaging
7618|NCT03241706|hypoglycemia|hypoglycemia
7619|NCT03241706|type 1 diabetes|type 1 diabetes
7620|NCT03241706|liver glucose metabolism|liver glucose metabolism
7621|NCT03241628|Skin blisters|skin blisters
7622|NCT03241628|Finger webbing|finger webbing
7623|NCT03241628|Finger contracture|finger contracture
7624|NCT03241628|Hand contracture|hand contracture
7625|NCT03241589|Teledermatology|teledermatology
7626|NCT03241589|Telehealth|telehealth
7627|NCT03241589|Dermatology|dermatology
7628|NCT03241589|Telemedicine|telemedicine
7629|NCT03241589|Mobile Application|mobile application
7630|NCT03241550|invasive fungal disease|invasive fungal disease
7631|NCT03241550|Cresemba®|cresemba®
7632|NCT03241550|Hematological malignancy|hematological malignancy
7633|NCT03241550|isavuconazonium sulfate|isavuconazonium sulfate
7635|NCT03241550|isavuconazole|isavuconazole
7636|NCT03241550|pediatric population|pediatric population
7637|NCT03241524|Pelvic Floor muscles|pelvic floor muscles
7638|NCT03241524|Physical Therapy|physical therapy
7639|NCT03241524|Sexual function evaluation|sexual function evaluation
7640|NCT03241498|Medicines optimisation|medicines optimisation
7641|NCT03241498|Healthcare resource utilisation|healthcare resource utilisation
7642|NCT03241498|HRQOL|hrqol
7643|NCT03241498|Pharmacist-led|pharmacist-led
7644|NCT03241498|GP based|gp based
7645|NCT03241459|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
7646|NCT03241459|PTA|pta
7647|NCT03241459|Peripheral Artery Disease|peripheral artery disease
7648|NCT03241459|PAD|pad
7649|NCT03241459|Paclitaxel|paclitaxel
7650|NCT03241433|Exercise|exercise
7651|NCT03241394|Monocyte subsets|monocyte subsets
7652|NCT03241394|Obesity|obesity
7653|NCT03241394|Metabolic Syndrome|metabolic syndrome
7654|NCT03241381|observational sample|observational sample
7655|NCT03241368|Irritable Bowel Disease|irritable bowel disease
500558|NCT00199095|ALL|all
7656|NCT03241368|IBD|ibd
7657|NCT03241368|Mucosal Disease|mucosal disease
7658|NCT03241329|Endometriosis|endometriosis
7659|NCT03241329|Metabolomics|metabolomics
7660|NCT03241329|Transcriptomics|transcriptomics
7661|NCT03241329|Follicular fluid|follicular fluid
7662|NCT03241329|Cumulus cells|cumulus cells
7663|NCT03241329|Oocyte quality|oocyte quality
7664|NCT03241316|qualitative and survey research|qualitative and survey research
7665|NCT03241303|Glp-1|glp-1
7666|NCT03241303|alpha-glucosidase inhibitor|alpha-glucosidase inhibitor
7667|NCT03241303|acarbose|acarbose
7668|NCT03241290|C-arm|c-arm
7669|NCT03241290|Medical Imaging Device|medical imaging device
7670|NCT03241290|Radiological|radiological
7671|NCT03241277|social phobia|social phobia
7672|NCT03241277|anxiety disorders|anxiety disorders
7673|NCT03241277|DSM-IV TR|dsm-iv tr
7674|NCT03241277|periodontal disease|periodontal disease
7675|NCT03241277|non surgical periodontal treatment|non surgical periodontal treatment
7676|NCT03241251|psychosocial risk|psychosocial risk
7677|NCT03241225|Elder abuse|elder abuse
7678|NCT03241225|Depression|depression
7679|NCT03241225|Mental health|mental health
7680|NCT03241212|adolescent|adolescent
7681|NCT03241212|young adult|young adult
7682|NCT03241212|knowledge|knowledge
7683|NCT03241212|self-care|self-care
7684|NCT03241186|Ipilimumab|ipilimumab
7685|NCT03241186|Nivolumab|nivolumab
7686|NCT03241186|OPDIVO|opdivo
7687|NCT03241186|IgG4 kappa immunoglobulin|igg4 kappa immunoglobulin
7688|NCT03241173|advanced or metastatic cervical cancer|advanced or metastatic cervical cancer
7689|NCT03241173|endometrial cancer|endometrial cancer
7690|NCT03241173|esophageal cancer|esophageal cancer
7691|NCT03241173|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
7692|NCT03241173|melanoma|melanoma
7693|NCT03241173|Merkel cell carcinoma|merkel cell carcinoma
7694|NCT03241173|mesothelioma|mesothelioma
7695|NCT03241173|microsatellite instability-high colorectal cancer|microsatellite instability-high colorectal cancer
7696|NCT03241173|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
7697|NCT03241173|ovarian cancer|ovarian cancer
7698|NCT03241173|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
608169|NCT00617617|isoflavones|isoflavones
7699|NCT03241173|small cell lung cancer (SLCL)|small cell lung cancer (slcl)
7700|NCT03241173|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
605852|NCT00596323|antenna|antenna
7701|NCT03241173|triple-negative breast cancer|triple-negative breast cancer
7702|NCT03241173|TNBC|tnbc
7703|NCT03241173|urothelial carcinoma|urothelial carcinoma
7704|NCT03241173|OX40 ligand (OX40)|ox40 ligand (ox40)
7705|NCT03241173|SCCHN|scchn
7706|NCT03241173|MSI-H CRC|msi-h crc
7707|NCT03241173|gastric cancer (including stomach and gastroesophageal junction [GEJ])|gastric cancer (including stomach and gastroesophageal junction [gej])
7708|NCT03241134|Dry needling|dry needling
7709|NCT03241134|Sham needling|sham needling
7710|NCT03241134|Office workers|office workers
7711|NCT03241134|Myofascial pain|myofascial pain
7712|NCT03241134|Surface electromyography|surface electromyography
7713|NCT03241121|Time Restricted Feeding|time restricted feeding
7714|NCT03241121|Eating patterns|eating patterns
8007|NCT03239431|asthma|asthma
7715|NCT03241095|Osteopathic Manipulation Treatment|osteopathic manipulation treatment
7716|NCT03241095|Golf|golf
7717|NCT03241069|bio-impedance|bio-impedance
7718|NCT03241069|BIOPAC system|biopac system
7719|NCT03241069|dyspnea|dyspnea
7720|NCT03241069|acute heart failure|acute heart failure
7721|NCT03241043|Pharmacokinetic study|pharmacokinetic study
7722|NCT03241043|Comparing Envarsus versus Advagraf|comparing envarsus versus advagraf
7723|NCT03241017|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
7724|NCT03241017|Double-hit Lymphomas|double-hit lymphomas
7725|NCT03241017|Grey Zone Lymphomas|grey zone lymphomas
7726|NCT03241017|Double or Triple Expressor Lymphomas|double or triple expressor lymphomas
7727|NCT03241017|Unclassifiable Aggressive Lymphoma types|unclassifiable aggressive lymphoma types
7728|NCT03241017|Aggressive Lymphomas|aggressive lymphomas
7729|NCT03240991|bradykinin-mediated angiodema|bradykinin-mediated angiodema
7730|NCT03240991|quality of life|quality of life
7731|NCT03240939|Dutasteride|dutasteride
7732|NCT03240939|Tadalafil|tadalafil
7733|NCT03240926|COPD|copd
7734|NCT03240926|COPD Exacerbation|copd exacerbation
7735|NCT03240926|COPD Asthma|copd asthma
7736|NCT03240926|COPD Bronchitis|copd bronchitis
7737|NCT03240926|COPD, Severe Early-Onset|copd, severe early-onset
7738|NCT03240887|Teen pregnancy prevention|teen pregnancy prevention
7739|NCT03240874|Gestational Diabetes|gestational diabetes
7740|NCT03240874|Diabetes Type 2 in Pregnancy|diabetes type 2 in pregnancy
7741|NCT03240861|T cells|t cells
7742|NCT03240861|stem cells|stem cells
7743|NCT03240861|gene therapy|gene therapy
7744|NCT03240861|NYESO|nyeso
7745|NCT03240848|congenital cataract|congenital cataract
7746|NCT03240848|artificial intelligent clinic|artificial intelligent clinic
7747|NCT03240835|pre-Albumin|pre-albumin
7748|NCT03240835|Retinol Conjugated Protein|retinol conjugated protein
7749|NCT03240835|Transferrin|transferrin
7750|NCT03240835|Locoregionally Advanced Nasopharyngeal Carcinoma|locoregionally advanced nasopharyngeal carcinoma
7751|NCT03240835|nutrition|nutrition
7752|NCT03240822|Penile Trauma|penile trauma
7753|NCT03240822|Allotransplantation|allotransplantation
7754|NCT03240822|Vascularized Composite Allotransplantation|vascularized composite allotransplantation
7755|NCT03240822|VCA|vca
7756|NCT03240822|Genital Trauma|genital trauma
7757|NCT03240822|Penile Transplantation|penile transplantation
7758|NCT03240822|Amputation|amputation
7759|NCT03240822|Penile Injury|penile injury
7760|NCT03240796|dense cataract|dense cataract
7761|NCT03240796|intraocular lens implantation|intraocular lens implantation
7762|NCT03240796|traditional cataract surgery|traditional cataract surgery
7763|NCT03240783|CT-Fluoroscopic Selective Transforaminal Epidural Steroid|ct-fluoroscopic selective transforaminal epidural steroid
7764|NCT03240783|Oral Dexamethasone|oral dexamethasone
7765|NCT03240783|Acute Lumbar Radiculopathy|acute lumbar radiculopathy
7766|NCT03240783|Sciatic Neuropathy|sciatic neuropathy
7767|NCT03240783|Betamethasone injectable|betamethasone injectable
7768|NCT03240783|Dexamethasone injectable|dexamethasone injectable
7769|NCT03240783|Acute Lumbar radicular pain|acute lumbar radicular pain
7770|NCT03240783|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
7771|NCT03240783|Comparative Effectiveness Controlled Trial|comparative effectiveness controlled trial
7772|NCT03240770|HFV|hfv
7773|NCT03240770|HFA|hfa
7774|NCT03240770|High Frequency Vibration|high frequency vibration
7775|NCT03240757|meal absorption|meal absorption
7776|NCT03240757|exercise|exercise
7777|NCT03240757|energy balance|energy balance
7778|NCT03240757|lipolysis|lipolysis
7779|NCT03240744|immunogenicity|immunogenicity
7780|NCT03240744|safety|safety
7781|NCT03240744|Hand, Foot and Mouth Disease (HFMD)|hand, foot and mouth disease (hfmd)
7782|NCT03240731|sickle cell disease|sickle cell disease
7783|NCT03240731|haploidentical|haploidentical
7784|NCT03240731|graft|graft
7785|NCT03240731|marrow|marrow
7786|NCT03240705|Stress|stress
7787|NCT03240705|Medical education|medical education
7788|NCT03240692|Major Depressive Disorder|major depressive disorder
7789|NCT03240692|Treatment Resistant Depression|treatment resistant depression
8118|NCT03238781|Prophylaxis|prophylaxis
7790|NCT03240692|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
7791|NCT03240692|Theta Burst|theta burst
7792|NCT03240679|Barrett's esophagus|barrett's esophagus
7793|NCT03240679|Endoscopic Mucosal Resection|endoscopic mucosal resection
7794|NCT03240640|Inspiratory muscle training|inspiratory muscle training
7795|NCT03240640|COPD|copd
7796|NCT03240640|Dyspnea|dyspnea
7797|NCT03240640|Balance|balance
7798|NCT03240562|serratus anterior plane block|serratus anterior plane block
7799|NCT03240562|paravertebral block|paravertebral block
7800|NCT03240562|ultrasound-guided|ultrasound-guided
7801|NCT03240562|regional anesthesia|regional anesthesia
7802|NCT03240562|thoracic surgery|thoracic surgery
7803|NCT03240562|postoperative pain|postoperative pain
7804|NCT03240549|advanced pulmonary adenocarcinoma|advanced pulmonary adenocarcinoma
7805|NCT03240549|Bevacizumab|bevacizumab
7806|NCT03240549|First line chemotherapy|first line chemotherapy
7807|NCT03240549|Stable disease|stable disease
7808|NCT03240536|Rheumatology Referral|rheumatology referral
7814|NCT03240471|Patient rated outcome (PRO)|patient rated outcome (pro)
7815|NCT03240419|Obesity|obesity
7816|NCT03240419|Inflammation|inflammation
7817|NCT03240419|Pregnancy|pregnancy
7818|NCT03240419|Programming|programming
7819|NCT03240393|Non Small Cell Lung Cancer|non small cell lung cancer
7820|NCT03240393|NSCLC|nsclc
7821|NCT03240393|INC280|inc280
7822|NCT03240393|EGFR wild-type (wt)|egfr wild-type (wt)
7823|NCT03240393|advanced non-small cell lung cancer|advanced non-small cell lung cancer
7824|NCT03240393|advanced/metastatic disease|advanced/metastatic disease
7825|NCT03240393|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
7826|NCT03240393|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
7828|NCT03240393|lung adenocarcinoma|lung adenocarcinoma
7829|NCT03240393|Non small cell lung carcinoma|non small cell lung carcinoma
7830|NCT03240393|Non-small cell lung cancer|non-small cell lung cancer
7831|NCT03240393|MET exon 14 deletion|met exon 14 deletion
7832|NCT03240393|MET exon 14 skipping|met exon 14 skipping
7833|NCT03240393|MET exon 14 mutation|met exon 14 mutation
7834|NCT03240393|MET mutation|met mutation
7835|NCT03240393|MET amplification|met amplification
7836|NCT03240393|MET inhibitor|met inhibitor
7837|NCT03240393|MET dysregulation|met dysregulation
7838|NCT03240393|MET activation|met activation
7839|NCT03240393|MET signaling|met signaling
7840|NCT03240393|MET pathway|met pathway
7841|NCT03240393|MET|met
7842|NCT03240393|cMET|cmet
7843|NCT03240328|CAR-T HIV therapy|car-t hiv therapy
7844|NCT03240250|VATS|vats
7845|NCT03240250|Pulmonary lobectomy|pulmonary lobectomy
7846|NCT03240250|Uniportal|uniportal
7847|NCT03240250|Postoperative pain|postoperative pain
7848|NCT03240250|Thoracic surgery|thoracic surgery
7849|NCT03240237|HFpEF|hfpef
7850|NCT03240224|Cancer ablation|cancer ablation
7851|NCT03240224|Life information rehabilitation therapy|life information rehabilitation therapy
7852|NCT03240211|Pembrolizumab|pembrolizumab
7853|NCT03240211|Decitabine|decitabine
7854|NCT03240211|Pralatrexate|pralatrexate
7855|NCT03240211|T-cell lymphoma|t-cell lymphoma
7859|NCT03240185|hemorrhoid|hemorrhoid
7860|NCT03240185|pain|pain
7861|NCT03240185|deep breathing|deep breathing
7862|NCT03240185|multimodal pain control|multimodal pain control
7863|NCT03240133|HAE|hae
7864|NCT03240133|hereditary angioedema|hereditary angioedema
7865|NCT03240133|kallikrein inhibitor|kallikrein inhibitor
7866|NCT03240133|plasma kallikrein|plasma kallikrein
7867|NCT03240107|levator resection|levator resection
7868|NCT03240107|levator tucking|levator tucking
7869|NCT03240107|Fair levator function|fair levator function
7870|NCT03240107|Eyelid contour|eyelid contour
7871|NCT03240094|Ehealth|ehealth
7872|NCT03240094|Older adults|older adults
7873|NCT03240094|Undernutrition|undernutrition
7874|NCT03240081|Post-menopause dyspareunia|post-menopause dyspareunia
7875|NCT03240081|Vulvar vestibular pain|vulvar vestibular pain
7876|NCT03240081|Genitourinary syndrome of menopause|genitourinary syndrome of menopause
7877|NCT03240081|Sexual pain|sexual pain
7878|NCT03240068|Renin-Angiotensin System|renin-angiotensin system
7879|NCT03240068|Inflammation|inflammation
7880|NCT03240068|Cardiovascular|cardiovascular
7881|NCT03240068|Atherosclerosis|atherosclerosis
7882|NCT03240055|spinal anesthesia|spinal anesthesia
7883|NCT03240055|etomidate|etomidate
7884|NCT03240055|median effective dose|median effective dose
7885|NCT03240055|BIS50|bis50
7886|NCT03240042|anterior cervical spine surgery|anterior cervical spine surgery
7887|NCT03240042|cuff pressure|cuff pressure
7888|NCT03240042|nasotracheal|nasotracheal
7889|NCT03240042|orotracheal|orotracheal
7890|NCT03240029|children|children
7891|NCT03240029|life quality|life quality
7892|NCT03240029|school reintegration|school reintegration
7896|NCT03239990|Children's mental health|children's mental health
7897|NCT03239990|Conduct disorders|conduct disorders
7898|NCT03239990|Conduct problems|conduct problems
7899|NCT03239990|Externalizing problems|externalizing problems
7900|NCT03239990|Parental Intervention|parental intervention
7901|NCT03239990|Groups based intervention|groups based intervention
7902|NCT03239990|Finland|finland
7903|NCT03239990|Social learning theory|social learning theory
7904|NCT03239990|Cognitive-behavioral theory|cognitive-behavioral theory
7905|NCT03239977|social intelligence|social intelligence
7906|NCT03239977|quality of life|quality of life
7907|NCT03239977|social competence|social competence
7908|NCT03239964|recurrent keloid|recurrent keloid
7911|NCT03239938|chronic whiplash associated disorders|chronic whiplash associated disorders
7912|NCT03239938|central sensitization|central sensitization
7913|NCT03239938|electroencephalography|electroencephalography
7914|NCT03239938|physiotherapy|physiotherapy
7915|NCT03239938|chronic pain|chronic pain
7916|NCT03239938|functionality|functionality
7917|NCT03239938|quality of life|quality of life
7918|NCT03239938|stress management|stress management
7919|NCT03239938|randomized controlled trial|randomized controlled trial
7920|NCT03239938|modern neuroscience approach|modern neuroscience approach
7921|NCT03239938|pain neuroscience education|pain neuroscience education
7922|NCT03239938|neck school|neck school
7923|NCT03239938|exercise therapy|exercise therapy
7924|NCT03239938|pain cognitions|pain cognitions
7925|NCT03239925|Cell phones, Electromagnetic Radiation|cell phones, electromagnetic radiation
7926|NCT03239912|Low-level laser|low-level laser
7927|NCT03239912|functional treatment|functional treatment
7928|NCT03239912|twin-block|twin-block
7929|NCT03239912|RCT|rct
7933|NCT03239860|Multiple Sclerosis|multiple sclerosis
7934|NCT03239860|Multiple Sclerosis Relapsing-Remitting|multiple sclerosis relapsing-remitting
7935|NCT03239860|GNbAC1|gnbac1
7936|NCT03239860|MRI|mri
7937|NCT03239860|Monoclonal antibody|monoclonal antibody
7938|NCT03239860|Multiple Sclerosis associated retrovirus MSRV|multiple sclerosis associated retrovirus msrv
7939|NCT03239860|MS|ms
7940|NCT03239860|RRMS|rrms
7941|NCT03239860|HERV-W|herv-w
7942|NCT03239808|haemodialysis (HD) and renal replacement therapy (RRT)|haemodialysis (hd) and renal replacement therapy (rrt)
7943|NCT03239795|Posters|posters
7944|NCT03239795|Pamphlets|pamphlets
7945|NCT03239795|Primary Health Care|primary health care
7946|NCT03239795|Health Facilities|health facilities
7947|NCT03239769|Thyroid surgery|thyroid surgery
7948|NCT03239769|Thyroidectomy|thyroidectomy
7949|NCT03239769|Minimally invasive access|minimally invasive access
7950|NCT03239769|Aesthetic principle|aesthetic principle
7951|NCT03239769|POSAS|posas
7952|NCT03239743|virtual reality|virtual reality
7953|NCT03239743|adenoidectomy|adenoidectomy
7954|NCT03239743|induction of anesthesia|induction of anesthesia
7955|NCT03239743|pre-operative anxiety|pre-operative anxiety
7956|NCT03239730|dyspnea|dyspnea
7957|NCT03239730|pH|ph
7958|NCT03239730|blood gas analysis|blood gas analysis
7959|NCT03239730|emergency department|emergency department
7960|NCT03239730|Intensive care unit|intensive care unit
7961|NCT03239704|Inflammatory Bowel Disease|inflammatory bowel disease
7962|NCT03239704|Ulcerative Colitis|ulcerative colitis
7963|NCT03239704|Crohn Disease|crohn disease
7964|NCT03239704|Quality Improvement|quality improvement
7965|NCT03239704|Telemedicine|telemedicine
7966|NCT03239678|Preoxygenation|preoxygenation
7967|NCT03239678|Oxygen Concentration|oxygen concentration
7968|NCT03239665|Vaccine|vaccine
7969|NCT03239665|Educational intervention|educational intervention
7970|NCT03239665|Senior Center Model of Care|senior center model of care
7971|NCT03239665|Older adults|older adults
7972|NCT03239652|Microsphere|microsphere
7973|NCT03239652|Transcatheter Arterial chemo-embolization|transcatheter arterial chemo-embolization
7974|NCT03239600|Anti-IL-7 Receptor-alpha Monoclonal Antibody|anti-il-7 receptor-alpha monoclonal antibody
7975|NCT03239600|Safety|safety
7976|NCT03239600|GSK2618960|gsk2618960
7977|NCT03239600|Primary Sjögren's Syndrome|primary sjögren's syndrome
7978|NCT03239587|Symptoms and signs involving cognition perception emotion & behaviour|symptoms and signs involving cognition perception emotion & behaviour
7979|NCT03239587|Abdominal cancer patients|abdominal cancer patients
7980|NCT03239587|Musical preop intervention|musical preop intervention
7981|NCT03239587|Surveys|surveys
7982|NCT03239587|Questionnaires|questionnaires
7983|NCT03239587|Blood draws|blood draws
7984|NCT03239548|Opinion,|opinion,
7985|NCT03239548|Doctors,|doctors,
7986|NCT03239548|Nurses,|nurses,
7987|NCT03239548|Key informants,|key informants,
7988|NCT03239548|Independent Nurse Midwifery Practitioner|independent nurse midwifery practitioner
7989|NCT03239522|GSK1278863|gsk1278863
7990|NCT03239522|pharmacokinetics|pharmacokinetics
7991|NCT03239522|mass balance|mass balance
7992|NCT03239522|daprodustat|daprodustat
7993|NCT03239509|long-term survival|long-term survival
7994|NCT03239509|bioprosthesis|bioprosthesis
7995|NCT03239509|complications|complications
7996|NCT03239509|anticoagulation|anticoagulation
7997|NCT03239509|mechanichal prosthesis|mechanichal prosthesis
7998|NCT03239470|autologous polyclonal regulatory T cell therapy|autologous polyclonal regulatory t cell therapy
8004|NCT03239444|Trans-septal|trans-septal
8119|NCT03238768|Nutrition|nutrition
8006|NCT03239444|Echocardiography|echocardiography
8008|NCT03239431|lung function|lung function
8009|NCT03239431|forced oscillometry technique|forced oscillometry technique
8010|NCT03239431|exacerbation|exacerbation
8011|NCT03239418|NMES|nmes
8012|NCT03239405|laparoscopic|laparoscopic
8013|NCT03239405|sleeve|sleeve
8014|NCT03239405|gastrectomy|gastrectomy
8015|NCT03239392|BNZ-1|bnz-1
8016|NCT03239392|Cytokine|cytokine
8017|NCT03239392|IL-2|il-2
8018|NCT03239392|IL-15|il-15
8019|NCT03239379|cytokine inhibitor|cytokine inhibitor
8020|NCT03239379|IL-2|il-2
8021|NCT03239379|IL-9|il-9
8022|NCT03239379|IL-15|il-15
8023|NCT03239366|T2D|t2d
8024|NCT03239340|EGFR, NSCLC, Lung Cancer, Biopsy, Molecular Profiling|egfr, nsclc, lung cancer, biopsy, molecular profiling
8025|NCT03239327|Misoprostol|misoprostol
8026|NCT03239327|neonatal|neonatal
8027|NCT03239327|respiratory distress|respiratory distress
8028|NCT03239327|cesarean section|cesarean section
8029|NCT03239288|Fiber|fiber
8030|NCT03239288|Postprandial glucose|postprandial glucose
8031|NCT03239288|Insulin|insulin
8032|NCT03239288|Resistant Starch Type 4|resistant starch type 4
8033|NCT03239275|en masse retraction|en masse retraction
8034|NCT03239275|biocreative therapy|biocreative therapy
8035|NCT03239275|class II|class ii
8036|NCT03239275|skeletal anchorage|skeletal anchorage
8037|NCT03239262|Atrial Fibrillation|atrial fibrillation
8038|NCT03239262|Left Atrial Cryoablation|left atrial cryoablation
8039|NCT03239262|Ganglionated Plexi|ganglionated plexi
8040|NCT03239262|Open-Heart Surgery|open-heart surgery
8041|NCT03239249|school dropout prevention|school dropout prevention
8042|NCT03239249|intervention study|intervention study
8043|NCT03239249|cluster-randomized|cluster-randomized
8044|NCT03239210|Brain Function|brain function
8045|NCT03239210|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
8046|NCT03239210|Sensory processing|sensory processing
8047|NCT03239210|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
8048|NCT03239210|OCD|ocd
8049|NCT03239184|Cancer ablation|cancer ablation
8050|NCT03239184|Life information rehabilitation therapy|life information rehabilitation therapy
8051|NCT03239171|Cancer ablation|cancer ablation
8052|NCT03239171|Life information rehabilitation therapy|life information rehabilitation therapy
8053|NCT03239158|Cancer ablation|cancer ablation
8054|NCT03239158|Life information rehabilitation therapy|life information rehabilitation therapy
8060|NCT03239119|rE-4|re-4
8061|NCT03239119|Exenatide|exenatide
8062|NCT03239119|Metformin|metformin
8063|NCT03239119|Sulfonylurea|sulfonylurea
8064|NCT03239106|itch|itch
8065|NCT03239106|pruritus|pruritus
8066|NCT03239106|CIP|cip
8067|NCT03239080|Rheumatoid Arthritis|rheumatoid arthritis
8068|NCT03239080|HR-pQCT|hr-pqct
8069|NCT03239080|erosion|erosion
8070|NCT03239080|denosumab|denosumab
8071|NCT03239067|Ticagrelor|ticagrelor
8072|NCT03239067|Clopidogrel|clopidogrel
8073|NCT03239067|Acute Coronary Syndrome|acute coronary syndrome
8074|NCT03239067|Percutaneous Coronary Intervention|percutaneous coronary intervention
8075|NCT03239028|diet quality|diet quality
8076|NCT03239028|pregnancy|pregnancy
8077|NCT03239028|adolescence|adolescence
8078|NCT03239028|longitudinal study|longitudinal study
8079|NCT03239028|food frequency questionnaire|food frequency questionnaire
8080|NCT03238989|Interstitial lung disease|interstitial lung disease
8081|NCT03238976|breast core biopsy|breast core biopsy
8082|NCT03238976|core needle biopsies|core needle biopsies
8083|NCT03238924|posttraumatic stress disorder|posttraumatic stress disorder
8084|NCT03238924|oxytocin|oxytocin
8085|NCT03238924|Prolonged Exposure|prolonged exposure
8086|NCT03238898|muscle cramps|muscle cramps
8087|NCT03238898|diabetic neuropathy|diabetic neuropathy
8088|NCT03238898|botulinum toxin|botulinum toxin
8089|NCT03238872|Anxiety|anxiety
8090|NCT03238872|Depression|depression
8091|NCT03238872|CBT|cbt
8092|NCT03238872|Outcome monitoring|outcome monitoring
8093|NCT03238872|Dissemination|dissemination
8094|NCT03238872|Routine services|routine services
8095|NCT03238833|In vitro fertilization|in vitro fertilization
8096|NCT03238833|Poor ovarian responder|poor ovarian responder
8097|NCT03238833|Luteal ovarian stimulation|luteal ovarian stimulation
8098|NCT03238833|Antagonist protocol|antagonist protocol
8099|NCT03238833|Cumulus cells|cumulus cells
8100|NCT03238820|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
8101|NCT03238820|Robot|robot
8102|NCT03238820|manual suture|manual suture
8103|NCT03238807|hCG|hcg
8104|NCT03238807|Intrauterine hCG|intrauterine hcg
8105|NCT03238807|IVF|ivf
8106|NCT03238807|ICSI|icsi
8107|NCT03238794|Body Mass Index|body mass index
8108|NCT03238794|gastric|gastric
8109|NCT03238794|bypass|bypass
8110|NCT03238794|bariatric surgery|bariatric surgery
8113|NCT03238794|diet|diet
8114|NCT03238794|low calorie|low calorie
8115|NCT03238781|Migraine|migraine
8116|NCT03238781|Headache|headache
8117|NCT03238781|Prevention|prevention
8120|NCT03238768|Body Composition|body composition
8121|NCT03238768|Preterm|preterm
8122|NCT03238768|Neonate|neonate
8123|NCT03238755|HIV|hiv
8124|NCT03238755|Diastolic Dysfunction|diastolic dysfunction
8125|NCT03238755|Myocardial fibrosis|myocardial fibrosis
8126|NCT03238755|Statin|statin
8127|NCT03238742|Xuebijing Injection, morality, sepsis|xuebijing injection, morality, sepsis
8128|NCT03238690|LVAD|lvad
8129|NCT03238690|Cardiac Recovery|cardiac recovery
8130|NCT03238677|speech sound disorder|speech sound disorder
8131|NCT03238651|Drug therapy|drug therapy
8132|NCT03238638|Epacadostat|epacadostat
8133|NCT03238638|Pembrolizumab|pembrolizumab
8134|NCT03238638|PD-1|pd-1
8135|NCT03238638|PD-L1|pd-l1
8136|NCT03238612|influenza|influenza
8137|NCT03238612|FFA|ffa
8138|NCT03238612|clarithromycin|clarithromycin
8139|NCT03238612|mortality|mortality
8140|NCT03238612|hospitalisation|hospitalisation
8141|NCT03238586|hiv|hiv
8142|NCT03238586|aids|aids
8143|NCT03238586|alcohol|alcohol
8144|NCT03238586|health|health
8145|NCT03238586|knowledge|knowledge
8146|NCT03238586|motivation|motivation
8147|NCT03238586|skills|skills
8148|NCT03238586|behavior|behavior
8149|NCT03238573|Colorectal Sessile Serrated Adenomas/Polyps optical enhancement endoscopy|colorectal sessile serrated adenomas/polyps optical enhancement endoscopy
8150|NCT03238508|Deferred stenting|deferred stenting
8151|NCT03238508|Microvascular dysfunction|microvascular dysfunction
8152|NCT03238495|Operable breast cancer|operable breast cancer
8153|NCT03238495|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
8154|NCT03238469|Microwave Ablation|microwave ablation
8155|NCT03238469|Hair Follicle|hair follicle
8156|NCT03238469|Sweat gland|sweat gland
8157|NCT03238456|Pacific Islander|pacific islander
8158|NCT03238456|Native Hawaiian|native hawaiian
8159|NCT03238456|NHPI|nhpi
8160|NCT03238456|Tobacco Health|tobacco health
8161|NCT03238456|Tobacco Use|tobacco use
8162|NCT03238456|Tobacco Smoking|tobacco smoking
8163|NCT03238456|Tobacco Use Cessation|tobacco use cessation
8164|NCT03238456|Smoking Cessation|smoking cessation
8165|NCT03238456|Smoking|smoking
8166|NCT03238456|Cigarette Use|cigarette use
8167|NCT03238456|Young Adult|young adult
8168|NCT03238443|DSA|dsa
8169|NCT03238417|women's health|women's health
8170|NCT03238417|primary health care|primary health care
8171|NCT03238417|mental health|mental health
8172|NCT03238417|Veterans|veterans
8173|NCT03238417|quality improvement|quality improvement
8174|NCT03238404|gastric cancer|gastric cancer
8175|NCT03238404|neoadjuvant chemotherapy|neoadjuvant chemotherapy
8176|NCT03238404|enhanced recovery after surgery|enhanced recovery after surgery
8177|NCT03238404|gastrectomy|gastrectomy
8178|NCT03238391|Contrast-induced nephropathy|contrast-induced nephropathy
8179|NCT03238391|Ischemic preconditioning|ischemic preconditioning
8180|NCT03238378|head and neck cancer|head and neck cancer
8181|NCT03238378|Locally recurrent head and neck cancer|locally recurrent head and neck cancer
8182|NCT03238378|Brachytherapy|brachytherapy
8183|NCT03238378|Hyperthermia|hyperthermia
8184|NCT03238339|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
8185|NCT03238339|Respiratory Insufficiency|respiratory insufficiency
8186|NCT03238339|Oxygen Inhalation Therapy|oxygen inhalation therapy
8187|NCT03238339|Noninvasive Ventilation|noninvasive ventilation
8190|NCT03238300|adolescent|adolescent
8191|NCT03238287|Emergency|emergency
8192|NCT03238287|Mechanical chest compression|mechanical chest compression
8193|NCT03238287|Cerebral oximetry|cerebral oximetry
8194|NCT03238222|Walking|walking
8195|NCT03238222|Six-Minute Walk Distance|six-minute walk distance
8196|NCT03238222|Illness Perceptions|illness perceptions
8197|NCT03238222|Theory of Planned Behaviour|theory of planned behaviour
8198|NCT03238209|neural respiratory drive|neural respiratory drive
8199|NCT03238209|transesophageal diaphragmatic EMG|transesophageal diaphragmatic emg
8200|NCT03238209|surface diaphragmatic EMG|surface diaphragmatic emg
8201|NCT03238209|surface sternocleidomastoid EMG|surface sternocleidomastoid emg
8202|NCT03238209|surface parasternal intercostal muscle EMG|surface parasternal intercostal muscle emg
8203|NCT03238196|FGFR inhibitor|fgfr inhibitor
8204|NCT03238196|ER+ metastatic breast cancer|er+ metastatic breast cancer
8205|NCT03238196|CDK4/6 inhibitor|cdk4/6 inhibitor
8206|NCT03238196|Endocrine therapy|endocrine therapy
8207|NCT03238183|knee osteoarthritis|knee osteoarthritis
8208|NCT03238183|hyaluronic acid|hyaluronic acid
8209|NCT03238183|dextrose|dextrose
8210|NCT03238183|therapeutic effects|therapeutic effects
8211|NCT03238118|irritability|irritability
8212|NCT03238118|severe mood dysregulation|severe mood dysregulation
8213|NCT03238118|disruptive mood dysregulation disorder|disruptive mood dysregulation disorder
8214|NCT03238105|Dark circles|dark circles
8215|NCT03238105|Periorbital hyperchromia|periorbital hyperchromia
8216|NCT03238105|Facial aesthetics|facial aesthetics
8217|NCT03238092|in vitro fertilization|in vitro fertilization
8218|NCT03238092|estradiol|estradiol
8219|NCT03238092|gnrh antagonist|gnrh antagonist
8220|NCT03238092|testosterone|testosterone
8221|NCT03238053|laser treatment, randomized trial, menopause, vaginal symptoms|laser treatment, randomized trial, menopause, vaginal symptoms
8222|NCT03238040|Critical illness|critical illness
8223|NCT03238040|PICU|picu
8224|NCT03238040|biomarkers|biomarkers
8225|NCT03238027|SNDX-6352|sndx-6352
8226|NCT03238027|CSF-1R inhibitor|csf-1r inhibitor
8227|NCT03238027|Colony Stimulating factor 1 receptor inhibitor|colony stimulating factor 1 receptor inhibitor
8228|NCT03238027|Solid Tumor|solid tumor
8229|NCT03238027|Recurrent locally advanced tumor|recurrent locally advanced tumor
8230|NCT03238027|unresectable solid tumor|unresectable solid tumor
8231|NCT03238027|Metastatic tumor|metastatic tumor
8232|NCT03237975|type 2 diabetes|type 2 diabetes
8233|NCT03237975|sense of coherence|sense of coherence
8234|NCT03237975|self-care|self-care
8235|NCT03237975|strengths-based intervention|strengths-based intervention
8236|NCT03237962|High flow nasal cannula|high flow nasal cannula
8237|NCT03237962|Pulmonary rehab|pulmonary rehab
8238|NCT03237962|Pulmonary rehabilitation|pulmonary rehabilitation
8239|NCT03237962|Nasal cannula|nasal cannula
8240|NCT03237962|Exercise endurance|exercise endurance
8241|NCT03237962|Oxygen Therapy|oxygen therapy
8242|NCT03237962|COPD|copd
8243|NCT03237962|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
8244|NCT03237949|Tobacco Use Disorder|tobacco use disorder
8245|NCT03237949|Hospitalized patients|hospitalized patients
8247|NCT03237949|Motivational Interview|motivational interview
8248|NCT03237949|Substance-Related Disorders|substance-related disorders
8249|NCT03237949|Behaviors and Mental Disorders|behaviors and mental disorders
8250|NCT03237923|fluid|fluid
8251|NCT03237910|amplitude spectrum area|amplitude spectrum area
8252|NCT03237910|defibrillation|defibrillation
8253|NCT03237910|waveform analysis|waveform analysis
8254|NCT03237910|cardiopulmonary resuscitation|cardiopulmonary resuscitation
8255|NCT03237910|cardiac arrest|cardiac arrest
8256|NCT03237897|ERAS|eras
8257|NCT03237897|Enhanced recovery after surgery|enhanced recovery after surgery
8258|NCT03237884|Palliative Care|palliative care
8259|NCT03237884|Oncology|oncology
8260|NCT03237884|advanced incurable cancer (any type)|advanced incurable cancer (any type)
8261|NCT03237884|integration|integration
8262|NCT03237884|development|development
8263|NCT03237884|palliative care interventions|palliative care interventions
8264|NCT03237884|process indicators|process indicators
8265|NCT03237884|Romania|romania
8266|NCT03237858|heart failure|heart failure
8267|NCT03237858|diagnostics|diagnostics
8268|NCT03237858|heart sounds|heart sounds
8269|NCT03237858|CRT-D|crt-d
8270|NCT03237858|ICD|icd
8271|NCT03237858|remote monitoring|remote monitoring
8272|NCT03237819|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
8273|NCT03237819|Intensive care|intensive care
8274|NCT03237806|ARDS,|ards,
8275|NCT03237806|Transpulmonary pressure,|transpulmonary pressure,
8276|NCT03237806|Sedation|sedation
8277|NCT03237754|migraine|migraine
8278|NCT03237754|neurostimulation|neurostimulation
8279|NCT03237754|neuroimaging|neuroimaging
8280|NCT03237754|tDCS|tdcs
8281|NCT03237754|MRI|mri
8282|NCT03237702|prostate cancer|prostate cancer
8283|NCT03237702|prostate biopsy|prostate biopsy
8284|NCT03237702|biomarkers|biomarkers
8285|NCT03237702|metabolomics|metabolomics
8286|NCT03237702|overtreatment|overtreatment
8287|NCT03237702|cancer screening|cancer screening
8288|NCT03237702|urine|urine
8289|NCT03237702|lycopene|lycopene
8290|NCT03237676|cognitive rehabilitation|cognitive rehabilitation
8291|NCT03237676|diffusion tensor imaging|diffusion tensor imaging
8292|NCT03237676|neuropsychology|neuropsychology
8293|NCT03237676|functional outcome|functional outcome
8294|NCT03237650|Painful cutaneous electrical stimulation|painful cutaneous electrical stimulation
8295|NCT03237650|Conditioned Pain Modulation|conditioned pain modulation
8296|NCT03237624|gingivitis|gingivitis
8297|NCT03237611|emesis|emesis
8298|NCT03237611|aprepitant|aprepitant
8299|NCT03237611|carboplatin|carboplatin
8300|NCT03237611|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
608170|NCT00617617|soy|soy
8301|NCT03237585|gender based violence|gender based violence
8302|NCT03237585|violence against women|violence against women
8303|NCT03237585|intimate partner violence|intimate partner violence
8304|NCT03237585|impact assessment|impact assessment
8305|NCT03237585|rural response system|rural response system
8306|NCT03237585|cluster randomised controlled trial|cluster randomised controlled trial
8307|NCT03237572|breast cancer|breast cancer
8308|NCT03237572|pembrolizumab|pembrolizumab
8309|NCT03237572|focused ultrasound|focused ultrasound
8310|NCT03237572|immunotherapy|immunotherapy
8311|NCT03237559|Eugenics|eugenics
8312|NCT03237559|Eligible Couples|eligible couples
8313|NCT03237559|Knowledge|knowledge
8314|NCT03237559|Attitude|attitude
8315|NCT03237559|Practice|practice
8316|NCT03237546|Robotic Cardiac Surgery|robotic cardiac surgery
8512|NCT03236129|Relapse|relapse
8317|NCT03237494|Peripheral Nervous System Diseases|peripheral nervous system diseases
8318|NCT03237494|Nervous System Diseases|nervous system diseases
8319|NCT03237494|Metabolism, Inborn Errors|metabolism, inborn errors
8320|NCT03237494|Genetic Diseases, Inborn|genetic diseases, inborn
8321|NCT03237468|concussion|concussion
8322|NCT03237468|football|football
8323|NCT03237468|student|student
8324|NCT03237468|athlete|athlete
8325|NCT03237468|sports|sports
8326|NCT03237429|bioimpedance spectroscopy|bioimpedance spectroscopy
8327|NCT03237429|arterial stiffness|arterial stiffness
8328|NCT03237416|Drug-drug interaction|drug-drug interaction
8329|NCT03237403|Sepsis|sepsis
8330|NCT03237403|Adults|adults
8331|NCT03237403|Pre hospital settings|pre hospital settings
8332|NCT03237403|Triage|triage
8333|NCT03237403|Hospital orientation|hospital orientation
8334|NCT03237403|Outcome|outcome
8335|NCT03237364|deployed in Iraq and/or Afghanistan|deployed in iraq and/or afghanistan
8336|NCT03237351|goal-directed fluid therapy|goal-directed fluid therapy
8337|NCT03237351|thoracic surgery, video-assisted|thoracic surgery, video-assisted
8338|NCT03237351|acute lung injury|acute lung injury
8339|NCT03237325|OM|om
11224|NCT03219047|MCL|mcl
8340|NCT03237325|Head and Neck Cancer|head and neck cancer
8341|NCT03237325|SGX942|sgx942
8342|NCT03237325|Dusquetide|dusquetide
8343|NCT03237325|Squamous Cell Carcinoma|squamous cell carcinoma
8344|NCT03237299|Pharyngitis|pharyngitis
8345|NCT03237299|case-control study|case-control study
8346|NCT03237299|loco-regional complications of pharyngitis|loco-regional complications of pharyngitis
8347|NCT03237286|depression|depression
8348|NCT03237286|ketamine|ketamine
8349|NCT03237286|neurocognitive|neurocognitive
8350|NCT03237286|fMRI|fmri
8351|NCT03237286|cognitive training|cognitive training
8352|NCT03237247|extrahepatic cholestasis, CBC|extrahepatic cholestasis, cbc
8353|NCT03237208|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
8354|NCT03237208|emergency medicine|emergency medicine
8355|NCT03237182|whole genome sequencing;|whole genome sequencing;
8356|NCT03237130|esophagus cancer; radiomics; computed tomograpy|esophagus cancer; radiomics; computed tomograpy
8357|NCT03237104|Adolescent|adolescent
8358|NCT03237104|Athlete|athlete
8359|NCT03237091|non-invasive brain stimulation|non-invasive brain stimulation
8360|NCT03237078|probiotics|probiotics
8361|NCT03237078|major depressive disorder|major depressive disorder
8362|NCT03237078|gut-brain axis|gut-brain axis
8363|NCT03237078|inflammation|inflammation
8364|NCT03237039|Roussouly type|roussouly type
8365|NCT03237039|spine alignment|spine alignment
8366|NCT03237039|fall-risk|fall-risk
8367|NCT03237039|gait cycle analysis|gait cycle analysis
8368|NCT03237026|prostate cancer, prostatectomy, prostate radiotherapy, chemotherapy, immunotherapy, biomarkers, metabolomics, urine|prostate cancer, prostatectomy, prostate radiotherapy, chemotherapy, immunotherapy, biomarkers, metabolomics, urine
8369|NCT03237013|Sunbathing|sunbathing
8370|NCT03237013|Indoor Tanning|indoor tanning
8371|NCT03237013|Facial Morphing|facial morphing
8372|NCT03237013|Skin Cancer Risk|skin cancer risk
8373|NCT03237000|Preeclampsia|preeclampsia
8374|NCT03237000|MgSO4|mgso4
8375|NCT03236987|MAC|mac
8376|NCT03236987|Clarithromycin|clarithromycin
8377|NCT03236987|Azithromycin|azithromycin
8378|NCT03236987|Efficacy|efficacy
8379|NCT03236987|Safety|safety
8380|NCT03236961|uncomplicated acute appendicitis|uncomplicated acute appendicitis
8381|NCT03236961|complicated acute appendicitis|complicated acute appendicitis
8382|NCT03236961|antibiotic therapy|antibiotic therapy
8383|NCT03236922|obstetric fistula, anti-incontinence techniques|obstetric fistula, anti-incontinence techniques
8384|NCT03236896|Menopause|menopause
8385|NCT03236896|Hot Flash|hot flash
8386|NCT03236896|MENQOL|menqol
8387|NCT03236896|Mobile exercise device|mobile exercise device
8388|NCT03236870|adalimumab|adalimumab
8389|NCT03236870|effectiveness|effectiveness
8390|NCT03236870|psoriasis|psoriasis
8391|NCT03236870|safety|safety
8392|NCT03236857|cancer|cancer
8393|NCT03236857|Venetoclax|venetoclax
8394|NCT03236857|pediatric|pediatric
8395|NCT03236831|Ventricular Assist Device|ventricular assist device
608171|NCT00617643|Nevirapine|nevirapine
8396|NCT03236818|pulmonary arterial hypertension|pulmonary arterial hypertension
8397|NCT03236818|right ventricle|right ventricle
8398|NCT03236818|MRI|mri
8399|NCT03236818|medical combination therapy|medical combination therapy
8400|NCT03236805|Morphine|morphine
8401|NCT03236805|Ketamine|ketamine
8402|NCT03236805|Acute pain|acute pain
8403|NCT03236805|prehospital|prehospital
8404|NCT03236792|Newly Diagnosed|newly diagnosed
8405|NCT03236792|AL Amyloidosis|al amyloidosis
8406|NCT03236792|Amyloid|amyloid
8407|NCT03236792|Light chain Amyloidosis|light chain amyloidosis
8408|NCT03236753|Thread-Embedding Acupuncture|thread-embedding acupuncture
8409|NCT03236753|Herniated Intervertebral Disc of Lumbar Spine|herniated intervertebral disc of lumbar spine
8410|NCT03236753|Low Back Pain|low back pain
8411|NCT03236753|Radiculopathy|radiculopathy
8511|NCT03236129|Hematological malignancies|hematological malignancies
8412|NCT03236727|Dexmedetomidine, spinal fusion, SSEP|dexmedetomidine, spinal fusion, ssep
8413|NCT03236701|hyperphosphatemia|hyperphosphatemia
8414|NCT03236701|hemodialysis|hemodialysis
8415|NCT03236701|dietary treatment|dietary treatment
8416|NCT03236701|egg white|egg white
8417|NCT03236701|protein energy wasting|protein energy wasting
8418|NCT03236662|BMD|bmd
8419|NCT03236662|Becker muscular dystrophy|becker muscular dystrophy
8420|NCT03236662|epicatechin|epicatechin
8421|NCT03236662|clinical trial|clinical trial
8422|NCT03236662|neuromuscular disease|neuromuscular disease
8423|NCT03236623|Surgical Patient|surgical patient
8424|NCT03236623|Menthol|menthol
8425|NCT03236623|Clinical Study|clinical study
8426|NCT03236571|Marfan syndrome|marfan syndrome
8427|NCT03236571|Personal Training Program|personal training program
8428|NCT03236571|Cardiorespiratory rehabilitation|cardiorespiratory rehabilitation
8429|NCT03236571|Muscular rehabilitation|muscular rehabilitation
8430|NCT03236558|Type 1 diabetes|type 1 diabetes
8431|NCT03236558|Juvenile diabetes|juvenile diabetes
8432|NCT03236558|Immune-tolerance|immune-tolerance
8433|NCT03236558|Regulatory T lymphocyte|regulatory t lymphocyte
8434|NCT03236558|Treg|treg
8435|NCT03236558|TCR|tcr
8436|NCT03236558|Repertoire|repertoire
8437|NCT03236532|HIV/AIDS; Resistance training, supplementation|hiv/aids; resistance training, supplementation
8439|NCT03236506|Injecting drug|injecting drug
8440|NCT03236467|Fibromyalgia and PTSD|fibromyalgia and ptsd
8441|NCT03236454|brain stimulation|brain stimulation
8442|NCT03236454|cognitive training|cognitive training
8443|NCT03236454|cognition|cognition
8444|NCT03236454|treatment|treatment
8445|NCT03236441|remote ischemic conditioning|remote ischemic conditioning
8446|NCT03236441|contrast-induced nephropathy|contrast-induced nephropathy
8447|NCT03236441|cardiac catheterization|cardiac catheterization
8448|NCT03236441|coronary artery disease|coronary artery disease
8449|NCT03236428|Smoldering Multiple Myeloma|smoldering multiple myeloma
8450|NCT03236428|Monoclonal Gammopathy|monoclonal gammopathy
8451|NCT03236402|Knowledge|knowledge
8452|NCT03236402|Opinion|opinion
8453|NCT03236402|Adoption|adoption
8454|NCT03236402|Adults|adults
8455|NCT03236402|Cross-Sectional|cross-sectional
8456|NCT03236363|Physical activity|physical activity
8457|NCT03236363|Obesity|obesity
8458|NCT03236363|Children|children
8459|NCT03236363|Cognitive function|cognitive function
8460|NCT03236363|Academic achievement|academic achievement
8461|NCT03236363|Cardiorespiratory fitness|cardiorespiratory fitness
8462|NCT03236363|Adiposity|adiposity
8463|NCT03236363|Cardiovascular fitness|cardiovascular fitness
8464|NCT03236363|Aerobic capacity|aerobic capacity
8465|NCT03236350|Chronic Kidney Disease|chronic kidney disease
8466|NCT03236350|Hypertension|hypertension
8467|NCT03236350|Cardiovascular Disease|cardiovascular disease
8468|NCT03236350|Central Aortic Systolic Pressure|central aortic systolic pressure
8469|NCT03236350|Proteinuria|proteinuria
8470|NCT03236350|Remote Ischemic Conditioning|remote ischemic conditioning
8471|NCT03236350|Left Ventricular Hypertrophy|left ventricular hypertrophy
8472|NCT03236337|Physical activity|physical activity
8474|NCT03236337|Children|children
8475|NCT03236337|Cognitive function|cognitive function
8476|NCT03236337|Academic achievement|academic achievement
8477|NCT03236337|Cardiorespiratory fitness|cardiorespiratory fitness
8478|NCT03236337|Adiposity|adiposity
8479|NCT03236337|Cardiovascular fitness|cardiovascular fitness
8480|NCT03236337|Atherosclerosis|atherosclerosis
8481|NCT03236337|Aerobic capacity|aerobic capacity
8482|NCT03236298|Epidural|epidural
8483|NCT03236298|Labor analgesia|labor analgesia
8484|NCT03236298|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
8485|NCT03236285|Obesity|obesity
8486|NCT03236285|Microcirculation|microcirculation
8487|NCT03236285|Endothelial function|endothelial function
8488|NCT03236285|Laser speckle imaging|laser speckle imaging
8489|NCT03236285|Capillary density|capillary density
8490|NCT03236272|Biomarkers|biomarkers
8491|NCT03236272|High-Throughput Screening Assays|high-throughput screening assays
608172|NCT00617643|Rifampicin|rifampicin
8492|NCT03236272|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
8493|NCT03236220|haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
8494|NCT03236220|poor graft function|poor graft function
8495|NCT03236220|prolonged isolated thrombocytopenia|prolonged isolated thrombocytopenia
8496|NCT03236220|bone marrow endothelial cells|bone marrow endothelial cells
8497|NCT03236220|N-acetyl-L-cysteine|n-acetyl-l-cysteine
8498|NCT03236220|Acute leukemia|acute leukemia
8499|NCT03236181|Energy Expenditure|energy expenditure
8500|NCT03236181|Appetite|appetite
8501|NCT03236181|Satiety|satiety
8502|NCT03236155|Opioids|opioids
8503|NCT03236142|bariatric|bariatric
8504|NCT03236142|duodenal switch|duodenal switch
8506|NCT03236142|weight loss surgery|weight loss surgery
8507|NCT03236142|SIPS|sips
8508|NCT03236142|Single Anastomosis|single anastomosis
8510|NCT03236129|Regulatory T cells depletion|regulatory t cells depletion
8513|NCT03236103|Ventricular assist device|ventricular assist device
8514|NCT03236090|Cirrhosis|cirrhosis
8515|NCT03236090|Probiotics|probiotics
8516|NCT03236090|Systemic inflammation|systemic inflammation
8517|NCT03236090|neuroinflammation|neuroinflammation
8518|NCT03236090|Cognitive function|cognitive function
8519|NCT03236090|Bacterial translocation|bacterial translocation
8520|NCT03236077|obesity, women, exercise, physical activity,|obesity, women, exercise, physical activity,
8521|NCT03236051|gastric cancer|gastric cancer
8522|NCT03236051|gastrectomy|gastrectomy
8523|NCT03236051|multimodal analgesia|multimodal analgesia
8524|NCT03236051|parecoxib|parecoxib
8525|NCT03236038|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
8526|NCT03236038|liver cirrhosis|liver cirrhosis
8527|NCT03236038|decompensated cirrhosis|decompensated cirrhosis
8528|NCT03236038|malnutrition|malnutrition
8529|NCT03236038|prevalence|prevalence
8530|NCT03236025|smoking cessation|smoking cessation
8531|NCT03236025|video|video
8532|NCT03236025|male smoker|male smoker
8533|NCT03235986|RDS|rds
8534|NCT03235973|refractory acute leukemia|refractory acute leukemia
8535|NCT03235973|refractory myelodysplastic syndrome|refractory myelodysplastic syndrome
8536|NCT03235973|cladribine dose escalation|cladribine dose escalation
8537|NCT03235947|Renal transplant|renal transplant
8538|NCT03235947|Antimicrobian prophylaxis|antimicrobian prophylaxis
8539|NCT03235947|Fosfomycin|fosfomycin
8540|NCT03235947|Urinary tract infection|urinary tract infection
8541|NCT03235947|Asymptomatic bacteriuria|asymptomatic bacteriuria
8542|NCT03235934|glucose monitoring|glucose monitoring
8543|NCT03235921|hemorrhagic shock|hemorrhagic shock
8544|NCT03235921|perfusion index|perfusion index
8545|NCT03235921|lactate|lactate
8546|NCT03235921|nitroglycerin|nitroglycerin
8547|NCT03235908|Copeptin|copeptin
8548|NCT03235908|Outcome prediction|outcome prediction
8549|NCT03235882|Lung surfactant|lung surfactant
8550|NCT03235882|Mid-infrared spectroscopy|mid-infrared spectroscopy
8551|NCT03235882|Prematurity|prematurity
8552|NCT03235882|Respiratory distress syndrome|respiratory distress syndrome
8553|NCT03235882|gastric aspirate|gastric aspirate
8554|NCT03235843|Chronotropic Incompetence|chronotropic incompetence
8555|NCT03235843|Rate Adaptive Pacing|rate adaptive pacing
8556|NCT03235843|Minute Ventilation Sensor|minute ventilation sensor
8557|NCT03235843|Primary Prevention ICD Therapy|primary prevention icd therapy
8558|NCT03235843|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
8559|NCT03235843|Heart Failure|heart failure
8560|NCT03235843|Exercise Intolerance|exercise intolerance
8561|NCT03235830|Healthcare utilization|healthcare utilization
8562|NCT03235830|Health literacy|health literacy
8563|NCT03235817|Proseal™ LMA|proseal™ lma
8564|NCT03235817|infants|infants
8565|NCT03235817|ventilation|ventilation
8566|NCT03235817|general anesthesia|general anesthesia
8567|NCT03235817|outpatient surgery|outpatient surgery
8568|NCT03235804|High-protein diet|high-protein diet
8569|NCT03235804|Inflammation|inflammation
8570|NCT03235804|Energy metabolism|energy metabolism
8571|NCT03235804|Body composition|body composition
8572|NCT03235804|Gut microbiome|gut microbiome
8573|NCT03235778|Tolerance; Pharmacokinetic characteristics|tolerance; pharmacokinetic characteristics
8574|NCT03235765|NSCLC|nsclc
8575|NCT03235765|Cancer panel|cancer panel
8576|NCT03235765|NGS|ngs
8577|NCT03235765|Actionable mutation|actionable mutation
8578|NCT03235765|Immune checkpoint inhibitor|immune checkpoint inhibitor
8579|NCT03235752|Randomized|randomized
8580|NCT03235752|Double-blind|double-blind
8581|NCT03235752|Placebo-controlled|placebo-controlled
8582|NCT03235752|Safety|safety
8583|NCT03235752|Efficacy|efficacy
8584|NCT03235752|Active Ulcerative Colitis|active ulcerative colitis
8585|NCT03235726|bystander|bystander
8586|NCT03235726|inhalation powder|inhalation powder
8587|NCT03235726|monodose device|monodose device
8588|NCT03235726|COPD|copd
8589|NCT03235726|pharmacokinetics|pharmacokinetics
8590|NCT03235726|safety|safety
8591|NCT03235726|Healthy|healthy
8592|NCT03235726|CCI15106|cci15106
8593|NCT03235726|tolerability|tolerability
8594|NCT03235713|Ecological momentary assessments|ecological momentary assessments
8595|NCT03235700|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
8596|NCT03235700|intermediate coronary stenosis|intermediate coronary stenosis
8597|NCT03235700|adenosine|adenosine
8598|NCT03235700|hyperemia|hyperemia
8599|NCT03235674|Cardiac rehabilitation|cardiac rehabilitation
8600|NCT03235674|interval exercise|interval exercise
8604|NCT03235635|gut microbiome|gut microbiome
8605|NCT03235635|allergic predisposition|allergic predisposition
8606|NCT03235596|executive functions|executive functions
8607|NCT03235596|tDCS|tdcs
8608|NCT03235583|Energy expenditure|energy expenditure
8609|NCT03235583|physical activity|physical activity
8610|NCT03235583|accelerometer|accelerometer
8611|NCT03235583|magnetometer|magnetometer
8612|NCT03235583|monitoring|monitoring
8613|NCT03235583|free-living conditions|free-living conditions
8614|NCT03235583|doubly labelled water|doubly labelled water
8615|NCT03235570|Solid tumor|solid tumor
8616|NCT03235570|malignancy|malignancy
8617|NCT03235570|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
8618|NCT03235570|fibroblast growth factor (FGF)/FGFR alteration|fibroblast growth factor (fgf)/fgfr alteration
8619|NCT03235557|prostate|prostate
8620|NCT03235557|cancer|cancer
8621|NCT03235557|radiation|radiation
8622|NCT03235557|stereotactic|stereotactic
8623|NCT03235557|CyberKnife|cyberknife
8624|NCT03235557|elderly|elderly
8625|NCT03235544|Mantle cell lymphoma|mantle cell lymphoma
8626|NCT03235544|non-Hodgkin lymphoma|non-hodgkin lymphoma
8627|NCT03235544|Bruton's tyrosine kinase (BTK)|bruton's tyrosine kinase (btk)
8628|NCT03235544|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
8629|NCT03235531|alcohol withdrawal syndrome|alcohol withdrawal syndrome
8630|NCT03235531|trauma|trauma
8631|NCT03235531|alcohol use disorder|alcohol use disorder
8632|NCT03235531|alcohol|alcohol
8633|NCT03235531|lorazepam|lorazepam
8634|NCT03235531|benzodiazepine|benzodiazepine
8635|NCT03235531|valproate|valproate
8636|NCT03235518|HIV Prevention|hiv prevention
8637|NCT03235518|Female sex workers|female sex workers
8638|NCT03235505|Smoking Cessation|smoking cessation
8639|NCT03235505|Electronic cigarette|electronic cigarette
8640|NCT03235505|Adults|adults
8644|NCT03235453|Parkinson|parkinson
8645|NCT03235453|Quality of Life|quality of life
8646|NCT03235453|Sleep Disorder|sleep disorder
8647|NCT03235453|Gait Disorders|gait disorders
8648|NCT03235453|Mobility|mobility
8649|NCT03235427|Coronary|coronary
8650|NCT03235427|Coronary Disease|coronary disease
8651|NCT03235427|Coronary Arteriosclerosis|coronary arteriosclerosis
8652|NCT03235427|Heart Disease|heart disease
8653|NCT03235427|Cardiotoxicity|cardiotoxicity
8654|NCT03235427|Breast Cancer|breast cancer
8655|NCT03235427|Carcinoma|carcinoma
8656|NCT03235427|Coronary Vessels|coronary vessels
8657|NCT03235427|Radiation|radiation
8658|NCT03235427|Radiation Therapy|radiation therapy
8659|NCT03235427|Coronary Artery Disease|coronary artery disease
8661|NCT03235427|RT|rt
8662|NCT03235427|CT|ct
8663|NCT03235427|Cardiac toxicity|cardiac toxicity
8664|NCT03235427|Cardiac calcium score|cardiac calcium score
8665|NCT03235427|Chest RT|chest rt
8666|NCT03235427|Lung Cancer|lung cancer
8667|NCT03235427|Lymphoma|lymphoma
8668|NCT03235427|Cardiac CT Scan|cardiac ct scan
8669|NCT03235427|Coronary Artery|coronary artery
8670|NCT03235427|Coronary arteries|coronary arteries
8671|NCT03235427|Cardiac Side Effect|cardiac side effect
8672|NCT03235427|Cardiac tissue|cardiac tissue
8673|NCT03235427|Cardiac|cardiac
8674|NCT03235401|Questionnaire|questionnaire
8675|NCT03235401|Disability assessment|disability assessment
8676|NCT03235401|Bothersomeness|bothersomeness
8677|NCT03235401|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
8678|NCT03235401|patient-reported outcome measure|patient-reported outcome measure
8679|NCT03235401|New York Heart Association (NYHA) functional class|new york heart association (nyha) functional class
8680|NCT03235388|Trauma|trauma
8681|NCT03235388|Injury|injury
8682|NCT03235388|Audit filter|audit filter
8683|NCT03235388|Quality improvement|quality improvement
8684|NCT03235388|India|india
8685|NCT03235375|Kidney Failure, Kidney Insufficiency, Renal Failure, Renal Insufficiency, MEDI0382|kidney failure, kidney insufficiency, renal failure, renal insufficiency, medi0382
8686|NCT03235349|Human Immunodeficiency Virus|human immunodeficiency virus
8687|NCT03235349|Cirrhosis|cirrhosis
8688|NCT03235349|Genotype 1 to 6|genotype 1 to 6
8689|NCT03235349|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
8690|NCT03235349|treatment-experienced|treatment-experienced
8693|NCT03235349|Compensated Cirrhosis|compensated cirrhosis
8694|NCT03235349|interferon|interferon
8695|NCT03235323|Vein Graft Failure|vein graft failure
8696|NCT03235323|Coronary Artery Bypass|coronary artery bypass
8697|NCT03235323|External Counterpulsation|external counterpulsation
8698|NCT03235310|HIV|hiv
8699|NCT03235310|Pregnancy|pregnancy
8700|NCT03235310|Prevention of mother-to-child transmission|prevention of mother-to-child transmission
8701|NCT03235297|Altitude|altitude
8702|NCT03235297|Diffusing capacity for carbon monoxide|diffusing capacity for carbon monoxide
8703|NCT03235297|COPD|copd
8704|NCT03235297|Pulmonary function testing|pulmonary function testing
8705|NCT03235258|HIV Infection|hiv infection
8706|NCT03235258|Adolescent|adolescent
8707|NCT03235245|cutaneous melanoma|cutaneous melanoma
8708|NCT03235245|mucosal melanoma|mucosal melanoma
8709|NCT03235245|BRAF mutation|braf mutation
8710|NCT03235206|Police Officers|police officers
8711|NCT03235154|HCV|hcv
8712|NCT03235154|suboxone|suboxone
8713|NCT03235154|epclusa|epclusa
8714|NCT03235154|psychiatrist|psychiatrist
8715|NCT03235141|Azithromycin eye drops|azithromycin eye drops
8716|NCT03235141|Local Pharmacokinetics|local pharmacokinetics
8717|NCT03235063|Dilated cardiomyopathy|dilated cardiomyopathy
8718|NCT03235063|registry|registry
8719|NCT03235063|heart failure|heart failure
8720|NCT03235063|pregnancy|pregnancy
8721|NCT03234959|Early Intervention|early intervention
8722|NCT03234959|Cerebral Palsy|cerebral palsy
8723|NCT03234959|CareToy Intervention|caretoy intervention
8724|NCT03234959|Infant Massage|infant massage
8725|NCT03234959|Information Communication Technology|information communication technology
8726|NCT03234946|Diabetes|diabetes
8727|NCT03234946|Family|family
8728|NCT03234946|Impaired fasting-glucose|impaired fasting-glucose
8729|NCT03234946|Carbohydrate intolerance|carbohydrate intolerance
8730|NCT03234933|Cancer|cancer
8731|NCT03234920|cirrhosis|cirrhosis
8732|NCT03234920|liver transplantation|liver transplantation
8733|NCT03234920|HMB|hmb
8734|NCT03234907|Drug therapy|drug therapy
8735|NCT03234881|Recurrent Binge Eating|recurrent binge eating
8736|NCT03234881|Cognitive Behavioral Therapist|cognitive behavioral therapist
8737|NCT03234881|Weight reduction|weight reduction
8738|NCT03234842|Esophagus|esophagus
8739|NCT03234842|Proton|proton
8740|NCT03234842|Radiation|radiation
8741|NCT03234829|arch lengths, space analysis, arch prediction|arch lengths, space analysis, arch prediction
8742|NCT03234790|Diesel Exhaust|diesel exhaust
8743|NCT03234790|Air Pollution|air pollution
8744|NCT03234790|Airway Responsiveness|airway responsiveness
8745|NCT03234790|Proteomics|proteomics
8746|NCT03234790|Urine PAH Metabolites|urine pah metabolites
8747|NCT03234764|IgE|ige
8748|NCT03234764|Allergy|allergy
8749|NCT03234764|Tolerance|tolerance
8750|NCT03234764|Immunotherapy|immunotherapy
8751|NCT03234764|Desensitization|desensitization
8752|NCT03234751|human B-type natriuretic peptide|human b-type natriuretic peptide
8753|NCT03234725|Blue light imaging|blue light imaging
8754|NCT03234725|Linked color imaging|linked color imaging
8755|NCT03234725|Optical histology|optical histology
8756|NCT03234725|Adenoma detection rate|adenoma detection rate
8757|NCT03234725|Variable stiffness|variable stiffness
8758|NCT03234725|Deep learning|deep learning
8759|NCT03234712|Advanced Solid Tumors|advanced solid tumors
8760|NCT03234712|EGFR ligands|egfr ligands
8761|NCT03234712|Squamous cell carcinoma of the head and neck (HNSCC)|squamous cell carcinoma of the head and neck (hnscc)
8762|NCT03234712|Glioblastoma (GBM)|glioblastoma (gbm)
8763|NCT03234712|Squamous non-small cell lung cancer (sqNSCLC)|squamous non-small cell lung cancer (sqnsclc)
8764|NCT03234712|Colorectal carcinoma (CRC)|colorectal carcinoma (crc)
8765|NCT03234712|Cancer|cancer
8766|NCT03234712|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
8767|NCT03234686|Dementia|dementia
8768|NCT03234686|Alzheimer's Disease|alzheimer's disease
8769|NCT03234621|protective ventilation strategy|protective ventilation strategy
8772|NCT03234595|Cerebraca wafer|cerebraca wafer
8773|NCT03234595|Recurrent high grade glioma|recurrent high grade glioma
8774|NCT03234595|anaplastic astrocytoma|anaplastic astrocytoma
8775|NCT03234595|glioblastoma multiforme|glioblastoma multiforme
8776|NCT03234569|sonohysterosalpingography|sonohysterosalpingography
8777|NCT03234569|hysterosalpingogagraphy|hysterosalpingogagraphy
8778|NCT03234543|Abdominal Surgery|abdominal surgery
8779|NCT03234543|Pre-conditioning|pre-conditioning
8780|NCT03234543|Remote Ischemic Conditioning|remote ischemic conditioning
8781|NCT03234543|Post-Operative Complications|post-operative complications
8782|NCT03234543|Acute Phase Response|acute phase response
8783|NCT03234530|albuminuria|albuminuria
8784|NCT03234530|sleep apnea|sleep apnea
8785|NCT03234530|particulate matter|particulate matter
8786|NCT03234530|renal injury|renal injury
8787|NCT03234491|Diabetes|diabetes
8788|NCT03234491|Insulin|insulin
8789|NCT03234478|deep brain stimulation|deep brain stimulation
8790|NCT03234478|cognition|cognition
8791|NCT03234478|young onset Parkinson disease|young onset parkinson disease
8792|NCT03234452|Lactoflorene plus|lactoflorene plus
8793|NCT03234452|Bifidobacterium animalis subsp. lactis, BB-12®|bifidobacterium animalis subsp. lactis, bb-12®
8794|NCT03234452|Lactobacillus acidophilus, LA-5®|lactobacillus acidophilus, la-5®
8795|NCT03234452|Lactobacillus paracasei subsp. paracasei, L. CASEI 431®|lactobacillus paracasei subsp. paracasei, l. casei 431®
8796|NCT03234452|Inflammation|inflammation
8797|NCT03234452|gut permeability|gut permeability
8798|NCT03234452|disbiosis|disbiosis
8799|NCT03234452|probiotic|probiotic
8800|NCT03234452|IgA|iga
8801|NCT03234452|IL10|il10
8802|NCT03234439|digital behavioral health|digital behavioral health
8803|NCT03234413|Botulinum Toxin-A|botulinum toxin-a
8804|NCT03234374|Pharmacokinetics|pharmacokinetics
8805|NCT03234374|Bioavailability|bioavailability
8806|NCT03234374|Safety|safety
8807|NCT03234374|Bupivacaine|bupivacaine
8808|NCT03234374|Collagen|collagen
8809|NCT03234374|Implant|implant
8810|NCT03234374|Marcaine|marcaine
8811|NCT03234374|Hernioplasty|hernioplasty
8812|NCT03234361|Hypertension|hypertension
8813|NCT03234361|High phosphorus diet|high phosphorus diet
8814|NCT03234361|FGF 23|fgf 23
8815|NCT03234361|24 hour ambulatory blood pressure|24 hour ambulatory blood pressure
8816|NCT03234361|Muscle sympathetic nerve|muscle sympathetic nerve
8817|NCT03234348|biodegradable stent|biodegradable stent
8818|NCT03234348|STEMI|stemi
8819|NCT03234348|Magnesium bioresorbable|magnesium bioresorbable
8820|NCT03234348|Vasomotion|vasomotion
8821|NCT03234335|Multiple Myeloma|multiple myeloma
8822|NCT03234335|Renal Failure|renal failure
8823|NCT03234335|Autologous Hematopoietic Stem Cell Transplantation (ASCT)|autologous hematopoietic stem cell transplantation (asct)
8824|NCT03234335|Melphalan|melphalan
8825|NCT03234322|prevention|prevention
8826|NCT03234322|risk score|risk score
8827|NCT03234322|behaviour|behaviour
8828|NCT03234322|physical activity|physical activity
8829|NCT03234296|uncomplicated acute appendicitis|uncomplicated acute appendicitis
8830|NCT03234296|complicated acute appendicitis|complicated acute appendicitis
8831|NCT03234296|antibiotic therapy|antibiotic therapy
8832|NCT03234296|spontaneous resolution|spontaneous resolution
8833|NCT03234283|Intubation|intubation
8834|NCT03234270|Heat stress, pilots|heat stress, pilots
8835|NCT03234257|Carotid stenosis|carotid stenosis
8841|NCT03234192|Therapeutic Ultrasound|therapeutic ultrasound
8842|NCT03234192|Astym Treatment Technique|astym treatment technique
8843|NCT03234192|Graston Treatment Technique|graston treatment technique
8844|NCT03234179|Non small cell lung cancer|non small cell lung cancer
8845|NCT03234179|Genetic study|genetic study
8846|NCT03234166|Acute necrotizing pancreatitis Acute pancreatitis Pancreas disease Sepsis Infection Drainage Catheters Antibiotics Multiresistant organism|acute necrotizing pancreatitis acute pancreatitis pancreas disease sepsis infection drainage catheters antibiotics multiresistant organism
8847|NCT03234153|Muscle-invasive Bladder Cancer|muscle-invasive bladder cancer
8848|NCT03234153|Ineligible for Cisplatin-based Chemotherapy|ineligible for cisplatin-based chemotherapy
8849|NCT03234153|Durvalumab|durvalumab
8850|NCT03234153|Tremelimumab|tremelimumab
502110|NCT00198042|ACL|acl
8851|NCT03234114|polymer-free drug eluting stent (DES)|polymer-free drug eluting stent (des)
8852|NCT03234114|triple antithrombotic therapy (TT)|triple antithrombotic therapy (tt)
8853|NCT03234101|Systematic review and meta-analysis|systematic review and meta-analysis
8854|NCT03234101|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
8855|NCT03234101|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
8856|NCT03234101|Clinical practice guidelines|clinical practice guidelines
8857|NCT03234101|Prospective cohort studies|prospective cohort studies
8858|NCT03234101|Low-risk lifestyle behaviours|low-risk lifestyle behaviours
8859|NCT03234101|Healthy Diet|healthy diet
8860|NCT03234101|Exercise|exercise
8861|NCT03234101|Physical activity|physical activity
8862|NCT03234101|Body weight|body weight
8863|NCT03234101|Sleep|sleep
8864|NCT03234101|alcohol|alcohol
8865|NCT03234101|Smoking|smoking
8866|NCT03234101|Cardiovascular disease|cardiovascular disease
8867|NCT03234101|Coronary heart disease|coronary heart disease
8868|NCT03234101|Stroke|stroke
8869|NCT03234101|Diabetes|diabetes
8870|NCT03234101|Cancer|cancer
8871|NCT03234101|Cardiovascular disease mortality|cardiovascular disease mortality
8872|NCT03234101|Coronary heart disease mortality|coronary heart disease mortality
8873|NCT03234101|Stroke mortality|stroke mortality
8874|NCT03234101|All-cause mortality|all-cause mortality
8875|NCT03234088|Congestive Heart Failure|congestive heart failure
8876|NCT03234088|Heart Failure|heart failure
8877|NCT03234088|Home telemonitoring|home telemonitoring
8878|NCT03234088|Telehealth|telehealth
8879|NCT03234088|HF Disease Management|hf disease management
8880|NCT03234088|Heart failure remote self management|heart failure remote self management
8881|NCT03234049|pediatric|pediatric
8882|NCT03234049|checklist|checklist
8883|NCT03234049|cognitive aid|cognitive aid
8884|NCT03234036|GSK2838232|gsk2838232
8885|NCT03234036|safety|safety
8886|NCT03234036|food effect|food effect
8887|NCT03234036|capsule|capsule
8888|NCT03234036|healthy|healthy
8889|NCT03234036|PK|pk
8898|NCT03233893|based dentin substitute|based dentin substitute
8899|NCT03233893|dentin bridge|dentin bridge
8900|NCT03233893|tertiary dentin|tertiary dentin
8901|NCT03233893|indirect pulp treatment|indirect pulp treatment
8902|NCT03233880|chlamydia|chlamydia
8903|NCT03233880|prevention|prevention
8904|NCT03233841|Natural History Study|natural history study
8905|NCT03233841|Observational Study|observational study
8906|NCT03233841|Prospective Study|prospective study
8907|NCT03233841|Retrospective Study|retrospective study
8908|NCT03233841|Farber Disease|farber disease
8909|NCT03233841|Farber's Disease|farber's disease
8910|NCT03233841|ASAH1|asah1
8911|NCT03233841|Subcutaneous Nodules|subcutaneous nodules
8912|NCT03233841|Lysosomal Storage Disease|lysosomal storage disease
8913|NCT03233841|Lysosomal Storage Disease, Nervous System|lysosomal storage disease, nervous system
8914|NCT03233841|Metabolic Diseases|metabolic diseases
8915|NCT03233841|Lipid Metabolism Disorders|lipid metabolism disorders
8916|NCT03233841|Lipidoses|lipidoses
8917|NCT03233841|Sphingolipidoses|sphingolipidoses
8918|NCT03233841|Genetic Disease, Inborn|genetic disease, inborn
8919|NCT03233841|Musculoskeletal Diseases|musculoskeletal diseases
8920|NCT03233841|Connective Tissue Diseases|connective tissue diseases
8921|NCT03233841|Central Nervous System Diseases|central nervous system diseases
8922|NCT03233841|Brain Diseases, Metabolic, Inborn|brain diseases, metabolic, inborn
8923|NCT03233841|Brain Diseases, Metabolic|brain diseases, metabolic
8924|NCT03233841|Brain Diseases, Inborn|brain diseases, inborn
8925|NCT03233841|Brain Diseases|brain diseases
8926|NCT03233841|Infant, Newborn Diseases|infant, newborn diseases
8927|NCT03233841|Inborn Errors of Metabolism|inborn errors of metabolism
8928|NCT03233841|Inherited Metabolic Disease|inherited metabolic disease
8929|NCT03233828|Intralesional Injection|intralesional injection
8930|NCT03233828|Immunotherapy|immunotherapy
8931|NCT03233828|Immune Response|immune response
8932|NCT03233828|Interleukin-2 (Aldesleukin)|interleukin-2 (aldesleukin)
8933|NCT03233828|Tumor Infiltration|tumor infiltration
8934|NCT03233828|Metastasis Prevention|metastasis prevention
8935|NCT03233815|Inhaled anesthesia|inhaled anesthesia
8936|NCT03233815|Total intravenous anesthesia|total intravenous anesthesia
8937|NCT03233802|Alcohol Use Disorder|alcohol use disorder
8938|NCT03233802|Treatment|treatment
8939|NCT03233802|Cognitive-Behavioral Treatment|cognitive-behavioral treatment
8940|NCT03233802|Individualized Treatment|individualized treatment
8941|NCT03233776|Anakinra|anakinra
8942|NCT03233776|Mucositis|mucositis
8943|NCT03233776|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
8944|NCT03233776|Febrile neutropenia|febrile neutropenia
8945|NCT03233737|local anesthesia|local anesthesia
8946|NCT03233737|pain tolerance|pain tolerance
8947|NCT03233737|experimental pain|experimental pain
8953|NCT03233685|Tennis|tennis
8954|NCT03233685|Reaction Time|reaction time
8955|NCT03233685|Visual training|visual training
502253|NCT00198718|HIV|hiv
403039|NCT01228422|There will be collection of blood at times: 0, 2, 4, 6, 8, 10, 12, 16, 24, 36, 48, 72 and 96 hours.|there will be collection of blood at times: 0, 2, 4, 6, 8, 10, 12, 16, 24, 36, 48, 72 and 96 hours.
403040|NCT01228422|The volunteers will be hospitalized 24 hours.|the volunteers will be hospitalized 24 hours.
402491|NCT01231074|psychotropic drugs|psychotropic drugs
403041|NCT01228422|Will be measured labels the AUC, Tmax, Cmax, neopterin and beta2-microglobulin|will be measured labels the auc, tmax, cmax, neopterin and beta2-microglobulin
403042|NCT01228409|Psoriasis|psoriasis
403043|NCT01228409|phototherapy|phototherapy
403044|NCT01228409|soriatane|soriatane
403045|NCT01228409|acitretin|acitretin
403046|NCT01228409|retinoid-related adverse events|retinoid-related adverse events
403047|NCT01228396|bladder|bladder
403048|NCT01228396|optic neuritis|optic neuritis
403049|NCT01228396|secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
403050|NCT01228396|AIMSPRO|aimspro
403051|NCT01228396|hyperimmune caprine serum|hyperimmune caprine serum
403052|NCT01228396|hyperimmune goat serum|hyperimmune goat serum
403053|NCT01228383|Monoclonal antibody|monoclonal antibody
403054|NCT01228383|Rabies|rabies
403055|NCT01228383|Post-exposure prophylaxis|post-exposure prophylaxis
403056|NCT01228370|sildosin|sildosin
403057|NCT01228370|neurogenic bladder|neurogenic bladder
403058|NCT01228370|voiding dysfunction|voiding dysfunction
403059|NCT01228357|Pharmacogenomics|pharmacogenomics
403060|NCT01228357|Depressed Patients|depressed patients
403061|NCT01228344|Artemether-lumefantrine|artemether-lumefantrine
403062|NCT01228344|demographics|demographics
403063|NCT01228344|malaria|malaria
403157|NCT01227889|Metastatic melanoma|metastatic melanoma
403064|NCT01228331|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
403065|NCT01228331|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
403066|NCT01228318|HAART|haart
403067|NCT01228318|Antiresorptive drugs|antiresorptive drugs
403068|NCT01228318|HIV/AIDS|hiv/aids
403069|NCT01228318|Bone loss|bone loss
403070|NCT01228305|ventricular septal defect|ventricular septal defect
403071|NCT01228305|atrioventricular septal defect|atrioventricular septal defect
403072|NCT01228305|oxidative stress|oxidative stress
403073|NCT01228305|cardiopulmonary bypass|cardiopulmonary bypass
403074|NCT01228305|acetaminophen|acetaminophen
403075|NCT01228305|hemolysis|hemolysis
403076|NCT01228305|acute kidney injury|acute kidney injury
403077|NCT01228305|Congenital heart disease undergoing cardiopulmonary bypass|congenital heart disease undergoing cardiopulmonary bypass
403078|NCT01228292|Anticoagulation|anticoagulation
403079|NCT01228292|Intensive Care Medicine|intensive care medicine
403080|NCT01228292|Hemodialysis|hemodialysis
403081|NCT01228292|Critical Ill Patients|critical ill patients
403082|NCT01228279|Peritoneal Dialysis|peritoneal dialysis
403083|NCT01228279|Dialysis Solutions|dialysis solutions
403084|NCT01228279|Artificial Kidney|artificial kidney
403085|NCT01228279|Renal Replacement Therapy|renal replacement therapy
403086|NCT01228279|Renal Dialysis|renal dialysis
403087|NCT01228279|Sympathetic Nervous System|sympathetic nervous system
403088|NCT01228279|Leptin|leptin
403089|NCT01228279|Icodextrin|icodextrin
403090|NCT01228266|Multiple Sclerosis|multiple sclerosis
403091|NCT01228240|Diabetes mellitus, type 2, Metformin, Generic, Efficacy|diabetes mellitus, type 2, metformin, generic, efficacy
403092|NCT01228227|Myonecrosis|myonecrosis
403093|NCT01228227|Percutaneous Angioplasty|percutaneous angioplasty
403094|NCT01228227|Myocardial Infarction|myocardial infarction
403095|NCT01228188|FTMH|ftmh
403096|NCT01228188|PPV|ppv
403097|NCT01228188|inverted ILM repositioning|inverted ilm repositioning
403098|NCT01228149|glaucoma|glaucoma
403099|NCT01228149|trabeculectomy|trabeculectomy
403100|NCT01228149|intraocular pressure|intraocular pressure
403101|NCT01228136|Adenotonsillectomy|adenotonsillectomy
403102|NCT01228136|Tranexamic acid|tranexamic acid
403103|NCT01228136|Blood loss|blood loss
403104|NCT01228136|Postoperative hemorrhage|postoperative hemorrhage
403105|NCT01228084|sulforaphane|sulforaphane
403106|NCT01228084|broccoli sprout extract (BSE)|broccoli sprout extract (bse)
403107|NCT01228084|prostate cancer|prostate cancer
403108|NCT01228084|recurrent prostate cancer|recurrent prostate cancer
403109|NCT01228084|phase II|phase ii
403110|NCT01228071|testosterone deficiency|testosterone deficiency
403111|NCT01228071|hypogonadism|hypogonadism
403112|NCT01228058|Trauma|trauma
403113|NCT01228058|Coagulopathy|coagulopathy
403114|NCT01228058|Coagulopathy in adult trauma patients|coagulopathy in adult trauma patients
403115|NCT01228045|Patients with histologically proved adenocarcinoma of advanced gastric cancer|patients with histologically proved adenocarcinoma of advanced gastric cancer
403116|NCT01228019|Usual practice re-examination|usual practice re-examination
403117|NCT01228006|Reduction of stress and fatigue|reduction of stress and fatigue
403118|NCT01227993|Central Serous Chorioretinopathy|central serous chorioretinopathy
403119|NCT01227993|Finasteride|finasteride
403120|NCT01227993|Proscar|proscar
403121|NCT01227993|Retinal Eye Disease|retinal eye disease
403122|NCT01227980|Addiction|addiction
403123|NCT01227980|Alcohol|alcohol
403124|NCT01227980|Alcohol Treatment|alcohol treatment
403125|NCT01227980|Alcoholics|alcoholics
403126|NCT01227980|Alcohol Dependence|alcohol dependence
403127|NCT01227980|Anxiety Disorder|anxiety disorder
403128|NCT01227980|Alcoholism|alcoholism
403129|NCT01227967|Adaptive Design|adaptive design
403130|NCT01227967|At Risk|at risk
403131|NCT01227967|H1N1|h1n1
403132|NCT01227967|Synergy|synergy
403133|NCT01227967|TCAD|tcad
403134|NCT01227954|cognitive/functional effects|cognitive/functional effects
403135|NCT01227954|tumors metastatic to brain|tumors metastatic to brain
403136|NCT01227954|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
403137|NCT01227941|advanced solid tumors|advanced solid tumors
403138|NCT01227941|ovarian cancer|ovarian cancer
403139|NCT01227941|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
403141|NCT01227941|Caelyx|caelyx
403142|NCT01227928|tyrosine kinase inhibitors|tyrosine kinase inhibitors
503567|NCT00214643|Malaria|malaria
403143|NCT01227928|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
403144|NCT01227928|primary peritoneal cancer|primary peritoneal cancer
403145|NCT01227928|ovarian cancer|ovarian cancer
403146|NCT01227928|Fallopian Tube Cancer|fallopian tube cancer
403147|NCT01227928|gynecologic cancer|gynecologic cancer
403148|NCT01227928|anti-angiogenesis|anti-angiogenesis
403149|NCT01227928|pazopanib|pazopanib
403150|NCT01227915|SIGNS AND SYMPTOMS OF ACUTE BACTERIAL CONJUNCTIVITIS|signs and symptoms of acute bacterial conjunctivitis
403151|NCT01227902|Seizures|seizures
403152|NCT01227902|retigabine IR|retigabine ir
403153|NCT01227902|GW582892|gw582892
403154|NCT01227902|Epilepsy|epilepsy
403155|NCT01227902|Open label, flexible dose|open label, flexible dose
403156|NCT01227902|Partial-onset seizures|partial-onset seizures
403158|NCT01227889|melanoma|melanoma
403159|NCT01227889|BRAF mutant|braf mutant
403160|NCT01227889|Advanced melanoma|advanced melanoma
403161|NCT01227876|Control of postoperative inflammation in cataract surgery by phacoemulsification|control of postoperative inflammation in cataract surgery by phacoemulsification
403162|NCT01227863|SIGNS AND SYMPTOMS OF ACUTE BACTERIAL CONJUNCTIVITIS|signs and symptoms of acute bacterial conjunctivitis
403163|NCT01227850|Leptin|leptin
403164|NCT01227850|IGF1|igf1
403165|NCT01227850|Refeeding Index|refeeding index
403166|NCT01227850|Hypophosphataemia|hypophosphataemia
403167|NCT01227850|Primary focus of the study was to detemine whether the 'Refeeding Index', could reliably predict,that the refeeding syndrome would occur|primary focus of the study was to detemine whether the 'refeeding index', could reliably predict,that the refeeding syndrome would occur
403168|NCT01227837|omega 3|omega 3
403169|NCT01227837|CRT_AICD|crt_aicd
403170|NCT01227837|congestive heart failure|congestive heart failure
403171|NCT01227837|CHF|chf
403172|NCT01227824|integrase inhibitor|integrase inhibitor
403173|NCT01227824|HIV Infection|hiv infection
403174|NCT01227824|raltegravir|raltegravir
403175|NCT01227824|GSK1349572|gsk1349572
403176|NCT01227811|Darifenacin|darifenacin
403177|NCT01227811|Bioequivalence|bioequivalence
403178|NCT01227811|Healthy volunteers|healthy volunteers
403179|NCT01227811|Postprandial|postprandial
403180|NCT01227798|influenza A, H1N1|influenza a, h1n1
403181|NCT01227772|gastric cancer vaccine|gastric cancer vaccine
403182|NCT01227772|OTSGC-A24|otsgc-a24
403183|NCT01227772|A Phase I/IIa study|a phase i/iia study
403184|NCT01227772|HLA-A24-positive|hla-a24-positive
403185|NCT01227746|Advanced gastro-intestinal stromal tumors|advanced gastro-intestinal stromal tumors
403186|NCT01227720|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
403187|NCT01227694|Cell therapy|cell therapy
403188|NCT01227694|Regenerative therapy|regenerative therapy
403189|NCT01227694|Advance therapy|advance therapy
403190|NCT01227694|Bone marrow|bone marrow
403191|NCT01227694|Mesenchymal stem cell|mesenchymal stem cell
403192|NCT01227694|Autologous|autologous
403193|NCT01227694|Interventional clinical trial|interventional clinical trial
403194|NCT01227694|Osteoarthrosis|osteoarthrosis
403195|NCT01227694|Osteoarthritis|osteoarthritis
403196|NCT01227694|Knee|knee
403197|NCT01227655|Parkinson|parkinson
403198|NCT01227655|PD|pd
403199|NCT01227655|Wearing-off|wearing-off
403200|NCT01227655|Levodopa/DDCI|levodopa/ddci
403201|NCT01227642|Prostate Cancer|prostate cancer
403202|NCT01227642|Prostate brachytherapy|prostate brachytherapy
403203|NCT01227642|Ultrasound treatment planning|ultrasound treatment planning
403204|NCT01227616|Iron deficiency anemia (IDA), Feraheme, ferumoxytol, chronic kidney disease (CKD), hemodialysis, magnetic resonance imaging (MRI)|iron deficiency anemia (ida), feraheme, ferumoxytol, chronic kidney disease (ckd), hemodialysis, magnetic resonance imaging (mri)
403205|NCT01227603|Bioequivalence|bioequivalence
403206|NCT01227603|Nifedipine|nifedipine
403207|NCT01227603|Candesartan|candesartan
403208|NCT01227603|FDC|fdc
403209|NCT01227590|Herbal medicine|herbal medicine
403210|NCT01227590|African Potato|african potato
403211|NCT01227590|Hypoxis obtusa|hypoxis obtusa
403212|NCT01227590|Drug interaction|drug interaction
403213|NCT01227590|HIV Infections|hiv infections
403214|NCT01227590|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
403215|NCT01227590|Healthy Subjects|healthy subjects
403216|NCT01227590|Anti-retroviral Agents|anti-retroviral agents
403217|NCT01227590|Lopinavir|lopinavir
403218|NCT01227590|Ritonavir|ritonavir
403219|NCT01227577|CML|cml
403220|NCT01227577|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
403221|NCT01227577|Leukemia|leukemia
403222|NCT01227577|CML-CP|cml-cp
403223|NCT01227577|Nilotinib|nilotinib
403224|NCT01227564|Early Alzheimer's disease|early alzheimer's disease
403225|NCT01227564|active immunization|active immunization
403226|NCT01227564|amyloid imaging|amyloid imaging
403227|NCT01227551|Melanoma|melanoma
403228|NCT01227551|CALM|calm
403229|NCT01227538|Beta cell reserve, urinary C peptide|beta cell reserve, urinary c peptide
403230|NCT01227512|Hyponatremia|hyponatremia
403231|NCT01227512|Dilutional Hyponatremia|dilutional hyponatremia
403232|NCT01227512|Euvolemic Hyponatremia|euvolemic hyponatremia
403233|NCT01227512|Hypervolemic Hyponatremia|hypervolemic hyponatremia
403234|NCT01227512|Fluid Restriction|fluid restriction
403235|NCT01227512|Tolvaptan|tolvaptan
403236|NCT01227486|Intubation, intratracheal|intubation, intratracheal
403237|NCT01227486|Ultrasonography|ultrasonography
403238|NCT01227486|Auscultation|auscultation
403239|NCT01227486|Capnography|capnography
403240|NCT01227486|Obesity|obesity
403241|NCT01227473|prediabetes|prediabetes
403242|NCT01227473|African Americans|african americans
403243|NCT01227473|mindfulness|mindfulness
403244|NCT01227473|behavioral|behavioral
403245|NCT01227473|diabetes|diabetes
403246|NCT01227460|Type 1 diabetes, Sitagliptin|type 1 diabetes, sitagliptin
403247|NCT01227434|Glioblastoma|glioblastoma
403248|NCT01227434|Gliosarcoma|gliosarcoma
403249|NCT01227434|Anaplastic astrocytoma|anaplastic astrocytoma
403250|NCT01227434|Malignant astrocytoma NOS|malignant astrocytoma nos
403251|NCT01227434|Malignant glioma|malignant glioma
403252|NCT01227434|GBM|gbm
403253|NCT01227421|influenza|influenza
403254|NCT01227408|Patients with confirmed breast cancer for neoadjuvant chemotherapy|patients with confirmed breast cancer for neoadjuvant chemotherapy
403255|NCT01227395|HIV|hiv
403256|NCT01227395|Post Marketing Surveillance|post marketing surveillance
403257|NCT01227369|Bisphosphonates|bisphosphonates
403258|NCT01227369|OPSAT-Q|opsat-q
403259|NCT01227356|Chronic myeloid leukemia, imatinib, interferon|chronic myeloid leukemia, imatinib, interferon
403260|NCT01227343|Gender differences|gender differences
403261|NCT01227343|nicotine|nicotine
403262|NCT01227343|cigarette smoking habits|cigarette smoking habits
403263|NCT01227343|behavior changes|behavior changes
403264|NCT01227317|Dyspnea|dyspnea
403265|NCT01227317|Mortality|mortality
403266|NCT01227291|Glaucoma|glaucoma
403267|NCT01227291|IOP|iop
403268|NCT01227291|siRNAs|sirnas
403269|NCT01227291|RNAi|rnai
403270|NCT01227291|beta inhibitor|beta inhibitor
403271|NCT01227278|Benralizumab|benralizumab
403272|NCT01227278|MEDI-563|medi-563
403273|NCT01227278|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
403274|NCT01227226|Dry eye|dry eye
403275|NCT01227187|Hemodialysis|hemodialysis
403276|NCT01227187|Anticoagulation|anticoagulation
403277|NCT01227187|Xigris|xigris
403278|NCT01227187|PTT|ptt
403279|NCT01227174|propofol only|propofol only
403280|NCT01227174|safety and efficacy|safety and efficacy
403281|NCT01227161|ASA I-II children between the age 0-7|asa i-ii children between the age 0-7
403282|NCT01227161|general anesthesia|general anesthesia
403283|NCT01227148|critical care, glycemic control, insulin, nitrogen balance|critical care, glycemic control, insulin, nitrogen balance
403284|NCT01227135|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
403285|NCT01227135|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
403286|NCT01227122|NGAL plasmatic level|ngal plasmatic level
403287|NCT01227122|Preoperative KIDNEY FAILURE, CHRONIC|preoperative kidney failure, chronic
403288|NCT01227122|Postoperative KIDNEY FAILURE, ACUTE|postoperative kidney failure, acute
403289|NCT01227122|Cardiac Surgery Procedures|cardiac surgery procedures
403290|NCT01227109|Infections|infections
403291|NCT01227109|Cancer|cancer
403292|NCT01227109|Procalcitonin|procalcitonin
403293|NCT01227109|C reactive protein|c reactive protein
403294|NCT01227096|electroacupuncture pediatric cardioprotection|electroacupuncture pediatric cardioprotection
403295|NCT01227083|AQLQ and cAQOL|aqlq and caqol
403296|NCT01227070|Asthma, hospitalization, children, exhaled nitric oxide, lung function, breath condensate, cysteinyl leukotrienes|asthma, hospitalization, children, exhaled nitric oxide, lung function, breath condensate, cysteinyl leukotrienes
403297|NCT01227057|exposure therapy|exposure therapy
403298|NCT01227057|case management|case management
403299|NCT01227057|older adults|older adults
403300|NCT01227057|cognitive rehabilitation|cognitive rehabilitation
403301|NCT01227044|Substance Abuse Counseling|substance abuse counseling
403302|NCT01227044|Adherence (medication)|adherence (medication)
403303|NCT01227044|Alcohol Abuse|alcohol abuse
403304|NCT01227044|Highly Active Antiretroviral Therapy (HAART)|highly active antiretroviral therapy (haart)
403305|NCT01227044|Naltrexone|naltrexone
403306|NCT01227044|Vivitrol|vivitrol
403307|NCT01227044|HIV|hiv
403308|NCT01227031|Genetic susceptibility of androgenetic alopecia|genetic susceptibility of androgenetic alopecia
403309|NCT01227031|Genetic difference in Finasteride response|genetic difference in finasteride response
403310|NCT01227005|Transfusion|transfusion
403311|NCT01227005|Whole Blood|whole blood
403312|NCT01227005|Trauma|trauma
403313|NCT01227005|Coagulopathy|coagulopathy
403314|NCT01227005|Component Therapy|component therapy
403315|NCT01227005|Civilian|civilian
403316|NCT01227005|Military|military
403317|NCT01226992|Clostridium difficile|clostridium difficile
403318|NCT01226992|Fecal Transplant|fecal transplant
403319|NCT01226992|Recurrent Diarrhea|recurrent diarrhea
403320|NCT01226992|Abdominal distension/bloating|abdominal distension/bloating
403322|NCT01226979|rectal cancer|rectal cancer
583277|NCT00511095|HBV|hbv
403323|NCT01226979|high dose endorectal brachytherapy|high dose endorectal brachytherapy
403324|NCT01226953|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
403325|NCT01226953|Vaccine|vaccine
403326|NCT01226953|Anti-PRP antibody|anti-prp antibody
403327|NCT01226914|EVICEL, Fibrin Sealant, Thyroidectomy|evicel, fibrin sealant, thyroidectomy
403328|NCT01226901|Poly (ADP-ribose) polymerase (PARP) inhibitor|poly (adp-ribose) polymerase (parp) inhibitor
403329|NCT01226901|tumor|tumor
403330|NCT01226901|cancer|cancer
403331|NCT01226888|brown adipose tissue|brown adipose tissue
403454|NCT01226472|MF|mf
403332|NCT01226888|androgen deprivation therapy|androgen deprivation therapy
403333|NCT01226875|SWL|swl
403334|NCT01226875|kidney stones|kidney stones
403335|NCT01226875|renal calculi|renal calculi
403336|NCT01226862|Stroke|stroke
403337|NCT01226862|Telemedicine|telemedicine
403338|NCT01226862|Telestroke|telestroke
403339|NCT01226849|diffuse large B-cell lymphoma relapse refractory|diffuse large b-cell lymphoma relapse refractory
403340|NCT01226836|Pulmonary Rehabilitation|pulmonary rehabilitation
403341|NCT01226823|cholestasis|cholestasis
403342|NCT01226823|pregnancy|pregnancy
403343|NCT01226823|ursodeoxycholic acid|ursodeoxycholic acid
403345|NCT01226797|Chronic HCV infection|chronic hcv infection
403346|NCT01226797|raised ALT|raised alt
403347|NCT01226797|transaminitis|transaminitis
403348|NCT01226797|HCV infection|hcv infection
403349|NCT01226771|hepatitis V virus|hepatitis v virus
403350|NCT01226771|genotype 1|genotype 1
403351|NCT01226771|ribavirin|ribavirin
403352|NCT01226771|interferon|interferon
403353|NCT01226771|Alternative ribavirin dosing|alternative ribavirin dosing
403354|NCT01226758|Safety|safety
403355|NCT01226758|Tolerability|tolerability
403356|NCT01226758|Efficacy|efficacy
403357|NCT01226758|Influenza|influenza
403358|NCT01226758|Flu|flu
403359|NCT01226758|Virus|virus
403360|NCT01226758|Vaccine|vaccine
403361|NCT01226745|Multiple sclerosis|multiple sclerosis
403362|NCT01226745|ONO-4641|ono-4641
403363|NCT01226745|MSC2430913A|msc2430913a
403364|NCT01226745|Efficacy|efficacy
403365|NCT01226732|Solid tumor|solid tumor
403366|NCT01226732|Capecitabine|capecitabine
403367|NCT01226732|Hsp90 inhibitor AUY922|hsp90 inhibitor auy922
403368|NCT01226719|liver-only metastatic KRAS wild-type colorectal cancer|liver-only metastatic kras wild-type colorectal cancer
403369|NCT01226719|Panitumumab|panitumumab
403370|NCT01226719|Oxaliplatin|oxaliplatin
403371|NCT01226719|Irinotecan|irinotecan
403372|NCT01226719|Leucovorin|leucovorin
403373|NCT01226719|5-Fluorouracil|5-fluorouracil
403374|NCT01226706|Urinary incontinence, urge|urinary incontinence, urge
403375|NCT01226706|detrusor hyperreflexia|detrusor hyperreflexia
403376|NCT01226706|detrusor instability|detrusor instability
403377|NCT01226706|non-neurogenic|non-neurogenic
403378|NCT01226706|Female Urogenital Diseases and Pregnancy Complications|female urogenital diseases and pregnancy complications
403379|NCT01226706|Female Urogenital Diseases|female urogenital diseases
403770|NCT01224847|Anesthesia|anesthesia
403380|NCT01226706|Urologic Diseases|urologic diseases
403381|NCT01226706|Urination Disorders|urination disorders
403382|NCT01226706|Urinary Incontinence|urinary incontinence
403383|NCT01226693|pharmacokinetic|pharmacokinetic
403384|NCT01226693|single dose bioequivalence study|single dose bioequivalence study
403385|NCT01226693|balanced incomplete block design|balanced incomplete block design
403386|NCT01226693|PH-797804|ph-797804
403387|NCT01226693|P38 kinase inhibitor|p38 kinase inhibitor
403388|NCT01226680|Dry Eye|dry eye
403389|NCT01226680|Schirmer test|schirmer test
403390|NCT01226680|corneal staining|corneal staining
403391|NCT01226680|OSDI|osdi
403392|NCT01226680|OCI|oci
403393|NCT01226667|fibromyalgia|fibromyalgia
403394|NCT01226667|lyrica|lyrica
403395|NCT01226667|pregabalin|pregabalin
403396|NCT01226654|Quantitative Imaging of Multiple Sclerosis|quantitative imaging of multiple sclerosis
403397|NCT01226641|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
403398|NCT01226641|SCORE|score
403399|NCT01226641|Telemedicine|telemedicine
403400|NCT01226641|Arterial blood pressure|arterial blood pressure
403401|NCT01226641|Daily physical activity|daily physical activity
403402|NCT01226628|Macular degeneration|macular degeneration
403403|NCT01226628|Age-related macular degeneration|age-related macular degeneration
403404|NCT01226628|Cell therapy|cell therapy
403405|NCT01226628|CNTO 2476|cnto 2476
403406|NCT01226628|Human umbilical tissue-derived cells|human umbilical tissue-derived cells
403407|NCT01226628|hUTC|hutc
403408|NCT01226628|Geographic Atrophy|geographic atrophy
403409|NCT01226628|Subretinal|subretinal
403410|NCT01226628|Visual Acuity|visual acuity
403411|NCT01226615|Chondroitin sulphate|chondroitin sulphate
403412|NCT01226615|Knee osteoarthritis|knee osteoarthritis
402891|NCT01229267|vaccine|vaccine
403413|NCT01226615|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
403415|NCT01226602|Healthy|healthy
403416|NCT01226602|Coronary flow velocity|coronary flow velocity
403417|NCT01226602|Adenosine|adenosine
403418|NCT01226589|Cancer cancer|cancer cancer
403419|NCT01226589|MRS|mrs
403423|NCT01226589|Karnofsky performance score is equal to or greater than 70.|karnofsky performance score is equal to or greater than 70.
403424|NCT01226589|No previously irradiated or recurrent breast.|no previously irradiated or recurrent breast.
403425|NCT01226589|No contraindication to MRS/MRI.|no contraindication to mrs/mri.
403427|NCT01226576|Prostate Cancer|prostate cancer
403428|NCT01226576|Low-Intermediate Risk Prostate Cancer|low-intermediate risk prostate cancer
403429|NCT01226576|Localized Prostate Cancer|localized prostate cancer
403430|NCT01226576|InSightec|insightec
403431|NCT01226576|ExAblate|exablate
403432|NCT01226563|STEMI|stemi
403433|NCT01226563|Acute Myocardial Infarction|acute myocardial infarction
403434|NCT01226563|Congestive Heart Failure|congestive heart failure
403435|NCT01226563|Left Ventricular Remodeling|left ventricular remodeling
403436|NCT01226563|Devices, Medical|devices, medical
403437|NCT01226550|hyperthermic intraoperative peritoneal chemotherapy (HIPEC)|hyperthermic intraoperative peritoneal chemotherapy (hipec)
403438|NCT01226550|Irinotecan|irinotecan
403439|NCT01226550|Pharmacokinetics|pharmacokinetics
403440|NCT01226550|peritoneal carcinomatosis (PC)|peritoneal carcinomatosis (pc)
403441|NCT01226537|Taurine,Diabetes mellitus,oxidative stress,glycemic control|taurine,diabetes mellitus,oxidative stress,glycemic control
403442|NCT01226498|Blood Transfusion, Autologous|blood transfusion, autologous
403443|NCT01226498|Blood Preservation/adverse effects|blood preservation/adverse effects
403444|NCT01226498|Blood Transfusion/adverse effects|blood transfusion/adverse effects
403445|NCT01226498|Endothelium, Vascular/physiopathology|endothelium, vascular/physiopathology
403446|NCT01226498|Inflammation Mediators|inflammation mediators
403447|NCT01226485|Cancer|cancer
403448|NCT01226485|Terminal|terminal
403449|NCT01226485|Solid Tumor|solid tumor
403450|NCT01226485|End Stage|end stage
403451|NCT01226485|Metastatic|metastatic
403452|NCT01226472|PTCL|ptcl
403453|NCT01226472|CTCL|ctcl
403455|NCT01226472|SS|ss
403456|NCT01226459|Female Pattern Baldness|female pattern baldness
403457|NCT01226433|AE adverse event|ae adverse event
403458|NCT01226433|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
403459|NCT01226433|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
403460|NCT01226433|ART antiretroviral therapy|art antiretroviral therapy
403461|NCT01226433|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
403462|NCT01226433|DCF data collection forms|dcf data collection forms
403463|NCT01226433|DMC Data Monitoring Committee|dmc data monitoring committee
403464|NCT01226433|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
403465|NCT01226433|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
403466|NCT01226433|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
403467|NCT01226433|ICH International Conference of Harmonisation|ich international conference of harmonisation
403468|NCT01226433|IND Investigational New Drug Application|ind investigational new drug application
403469|NCT01226433|IRB Institutional Review Board|irb institutional review board
403470|NCT01226433|IU International units|iu international units
403471|NCT01226433|mg milligram(s)|mg milligram(s)
403472|NCT01226433|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
404162|NCT01223274|Prematurity|prematurity
403473|NCT01226433|PCR polymerase chain reaction|pcr polymerase chain reaction
403474|NCT01226433|SAE serious adverse event|sae serious adverse event
403475|NCT01226433|µg microgram|µg microgram
403476|NCT01226433|ULN upper limit of the normal range|uln upper limit of the normal range
403477|NCT01226433|WB Western Blot|wb western blot
403478|NCT01226420|GVHD|gvhd
403479|NCT01226420|Alefacept|alefacept
403480|NCT01226420|Amevive|amevive
403481|NCT01226407|Solid Tumour|solid tumour
403482|NCT01226394|peritoneal carcinomatosis|peritoneal carcinomatosis
403483|NCT01226394|HIPEC|hipec
403484|NCT01226394|controlled clinical trial|controlled clinical trial
403485|NCT01226381|Paracetamol and setrons|paracetamol and setrons
403486|NCT01226381|No disease, healthy volunteers|no disease, healthy volunteers
403487|NCT01226368|HIV, HPV, cervical-vaginal smear|hiv, hpv, cervical-vaginal smear
403488|NCT01226342|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
403489|NCT01226329|Minority Groups|minority groups
403490|NCT01226329|Decision Making|decision making
403491|NCT01226329|Patient Participation|patient participation
403492|NCT01226329|Mental Health Services|mental health services
403493|NCT01226329|retention|retention
403494|NCT01226329|attendance|attendance
200947|NCT02112890|Seroprevalence|seroprevalence
403495|NCT01226329|patient activation|patient activation
403496|NCT01226329|Hispanic Americans|hispanic americans
403497|NCT01226329|patient-provider communication|patient-provider communication
403499|NCT01226290|uterine fibroid RF ablation|uterine fibroid rf ablation
403500|NCT01226290|intrauterine ultrasound|intrauterine ultrasound
504086|NCT00208156|PMD|pmd
403501|NCT01226290|VizAblate|vizablate
403502|NCT01226264|Uterine cervical cancer|uterine cervical cancer
403503|NCT01226264|diffusion-weighted MRI|diffusion-weighted mri
403504|NCT01226264|recurrence|recurrence
403505|NCT01226251|oral malodour|oral malodour
403506|NCT01226251|halitosis|halitosis
403507|NCT01226251|Subjects consulting a bad breath clinic|subjects consulting a bad breath clinic
403508|NCT01226225|Patients with recent coronary event|patients with recent coronary event
403509|NCT01226212|Older people|older people
403510|NCT01226212|Synbiotic|synbiotic
403511|NCT01226212|Prebiotic|prebiotic
403512|NCT01226212|Probiotic|probiotic
403513|NCT01226212|Bacteria|bacteria
403514|NCT01226212|Immune|immune
403515|NCT01226186|Knee replacement|knee replacement
403516|NCT01226186|Pain control|pain control
403517|NCT01226186|Self medication|self medication
403518|NCT01226173|Prospective screening of blood donors.|prospective screening of blood donors.
403519|NCT01226147|Lupus Nephritis|lupus nephritis
403521|NCT01226147|retinoid|retinoid
403522|NCT01226147|tamibarotene|tamibarotene
403523|NCT01226134|Functional Dyspepsia|functional dyspepsia
403524|NCT01226134|Itopride|itopride
403525|NCT01226134|Gastric Emptying|gastric emptying
403526|NCT01226134|Gastric Accommodation|gastric accommodation
403527|NCT01226134|Dyspeptic Symptoms|dyspeptic symptoms
403528|NCT01226121|dupuytren|dupuytren
403529|NCT01226121|dupuytren's|dupuytren's
403530|NCT01226095|Osteoarthritis|osteoarthritis
403531|NCT01226095|Pain|pain
403532|NCT01226095|Morning stiffness|morning stiffness
403533|NCT01226069|superficial phlebitis|superficial phlebitis
403534|NCT01226069|cannula-related vein inflammation|cannula-related vein inflammation
403535|NCT01226069|Glycerine magnesium sulphate|glycerine magnesium sulphate
403536|NCT01226069|Hirudoid cream|hirudoid cream
403537|NCT01226069|Nursing|nursing
403538|NCT01226056|advanced solid tumors|advanced solid tumors
403539|NCT01226056|Sorafenib (Nexavar®)|sorafenib (nexavar®)
403540|NCT01226056|RAD001 (everolimus)|rad001 (everolimus)
403541|NCT01226056|tumor molecular targets|tumor molecular targets
403542|NCT01226030|Advanced Solid Tumors|advanced solid tumors
403543|NCT01226017|Oxytocin|oxytocin
403544|NCT01226017|Animal Assisted therapy|animal assisted therapy
403545|NCT01226017|Farm animals|farm animals
403546|NCT01226017|Healthy nursing students|healthy nursing students
403547|NCT01226004|radiosurgery|radiosurgery
403548|NCT01226004|prostate|prostate
403549|NCT01226004|cancer|cancer
403550|NCT01226004|early|early
403551|NCT01226004|intermediate|intermediate
403552|NCT01226004|CyberKnife|cyberknife
403553|NCT01225991|Pain, Fatigue, Geriatric, Rheumatoid Arthritis, Milnacipran|pain, fatigue, geriatric, rheumatoid arthritis, milnacipran
403554|NCT01225978|Genetic Information|genetic information
403555|NCT01225978|Variant Updates|variant updates
403556|NCT01225978|Information Technology|information technology
403557|NCT01225978|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
403558|NCT01225978|Hearing Loss|hearing loss
403559|NCT01225978|Oncology|oncology
403560|NCT01225965|Particulate Matter induced inflammation of the lung|particulate matter induced inflammation of the lung
403561|NCT01225952|phacoemulsification|phacoemulsification
403562|NCT01225952|intraocular lens|intraocular lens
403563|NCT01225939|Type 2 diabetes mellitus|type 2 diabetes mellitus
403564|NCT01225939|Healthy|healthy
403565|NCT01225926|Intraocular Lens|intraocular lens
403566|NCT01225926|Toric|toric
403567|NCT01225913|asthma|asthma
403568|NCT01225913|lung function|lung function
403569|NCT01225913|inflammation|inflammation
403570|NCT01225874|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
403571|NCT01225874|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
403697|NCT01225146|Ischemic|ischemic
403572|NCT01225874|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
403573|NCT01225809|AD01 follow-up extension|ad01 follow-up extension
403574|NCT01225796|Bicarbonate|bicarbonate
403575|NCT01225796|Chronic allograft nephropathy|chronic allograft nephropathy
403576|NCT01225796|Urinary TGF-beta|urinary tgf-beta
403577|NCT01225796|Urinary acid excretion|urinary acid excretion
403578|NCT01225770|green tea|green tea
403579|NCT01225770|gargling|gargling
403580|NCT01225770|prophylaxis|prophylaxis
403581|NCT01225770|influenza|influenza
403582|NCT01225770|Respiratory Tract Infections|respiratory tract infections
403583|NCT01225770|high school students|high school students
403584|NCT01225757|Echocardiography|echocardiography
403585|NCT01225757|HIPEC|hipec
403586|NCT01225692|Brain Injury|brain injury
403587|NCT01225692|Head Trauma|head trauma
403588|NCT01225692|Trauma Systems|trauma systems
403589|NCT01225692|Head Injury Guideline|head injury guideline
403590|NCT01225692|Time to Tertiary Care|time to tertiary care
403591|NCT01225679|Congenital Central Hypoventilation Syndrome|congenital central hypoventilation syndrome
403592|NCT01225679|Phox2B gene|phox2b gene
403593|NCT01225679|invasive ventilation|invasive ventilation
403594|NCT01225679|genetics|genetics
403595|NCT01225679|late-onset|late-onset
403596|NCT01225679|sleep|sleep
403597|NCT01225679|central sleep apnea|central sleep apnea
403598|NCT01225666|MOD-4023|mod-4023
403599|NCT01225666|Growth Hormone Deficient Adults|growth hormone deficient adults
403600|NCT01225666|Phase II|phase ii
403601|NCT01225653|Latanoprost|latanoprost
403602|NCT01225653|vasodilation|vasodilation
403603|NCT01225653|diabetic retinopathy|diabetic retinopathy
403604|NCT01225640|Tuberculosis|tuberculosis
403605|NCT01225640|EBA|eba
403606|NCT01225640|WBA|wba
403607|NCT01225627|Chronic disease management|chronic disease management
403608|NCT01225627|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
403609|NCT01225627|Discharge planning|discharge planning
403610|NCT01225627|Discharge coordinator|discharge coordinator
403611|NCT01225614|Home ventilation|home ventilation
403612|NCT01225614|Myotonic dystrophy type 1 (DM1)|myotonic dystrophy type 1 (dm1)
403613|NCT01225575|large cartilage defects|large cartilage defects
403614|NCT01225575|knee joint|knee joint
403615|NCT01225575|femoral condyle, tibia, trochlear, retropatellar|femoral condyle, tibia, trochlear, retropatellar
403616|NCT01225562|Heart attack|heart attack
403617|NCT01225562|Heart Disease|heart disease
403618|NCT01225562|Acute coronary syndrome|acute coronary syndrome
403619|NCT01225562|ACS|acs
403620|NCT01225562|Cardiovascular Disease|cardiovascular disease
403621|NCT01225549|Allergen Challenge|allergen challenge
403622|NCT01225549|Asthma|asthma
403623|NCT01225549|Inhaled selective glucocorticoid receptor agonist (iSEGRA)|inhaled selective glucocorticoid receptor agonist (isegra)
403624|NCT01225536|BRAF mutations|braf mutations
403625|NCT01225510|recurrent glioblastoma multiforme (GBM)|recurrent glioblastoma multiforme (gbm)
403626|NCT01225510|CVX-060|cvx-060
403627|NCT01225510|PF-04856884|pf-04856884
403628|NCT01225510|phase 2|phase 2
403629|NCT01225510|open-label|open-label
403630|NCT01225510|bevacizumab|bevacizumab
403631|NCT01225510|anti-angiogenic|anti-angiogenic
403632|NCT01225497|Randomized|randomized
403633|NCT01225497|Pilot study|pilot study
403634|NCT01225497|VISA-A|visa-a
403635|NCT01225497|VAS|vas
403636|NCT01225484|Knee arthroplasty, perioperative analgesia|knee arthroplasty, perioperative analgesia
403637|NCT01225471|novel epitope peptide|novel epitope peptide
403638|NCT01225471|CTL|ctl
403639|NCT01225471|advanced prostate cancer|advanced prostate cancer
403640|NCT01225458|Elderly patients|elderly patients
403641|NCT01225458|renal insufficiency|renal insufficiency
403642|NCT01225458|systematized gerontologic evaluation|systematized gerontologic evaluation
403643|NCT01225419|Plerixafor|plerixafor
403644|NCT01225419|Hematopoietic Stem Cell Transplant mobilization|hematopoietic stem cell transplant mobilization
403645|NCT01225419|children|children
403646|NCT01225406|Third line ARV therapy|third line arv therapy
403647|NCT01225406|HIV RNA|hiv rna
403648|NCT01225406|Absolute CD4+ T cell count|absolute cd4+ t cell count
403649|NCT01225406|serious adverse events (SAEs)|serious adverse events (saes)
403650|NCT01225406|Drug resistance|drug resistance
403651|NCT01225380|Hepatitis C|hepatitis c
403652|NCT01225380|HCV|hcv
403653|NCT01225380|Rapid Virologic Response|rapid virologic response
403654|NCT01225380|Sustained Virologic Response|sustained virologic response
403655|NCT01225380|Direct Acting Antiviral|direct acting antiviral
403656|NCT01225380|Combination Therapy|combination therapy
403657|NCT01225380|HCV RNA|hcv rna
403658|NCT01225380|Polymerase inhibitor|polymerase inhibitor
403659|NCT01225380|Protease inhibitor|protease inhibitor
403660|NCT01225380|Treatment naïve|treatment naïve
403661|NCT01225380|GS-9190|gs-9190
403662|NCT01225380|GS-9256|gs-9256
403663|NCT01225354|Cheek|cheek
403664|NCT01225354|Cheek flattening|cheek flattening
403665|NCT01225354|Malar deficiency|malar deficiency
403666|NCT01225354|Filler|filler
403667|NCT01225341|HSV-1|hsv-1
403668|NCT01225341|Herpes labialis|herpes labialis
403669|NCT01225341|Cold sores|cold sores
403670|NCT01225341|Fever blisters|fever blisters
403671|NCT01225289|Multiple Sclerosis|multiple sclerosis
403672|NCT01225289|Vitamin A|vitamin a
403673|NCT01225289|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
403674|NCT01225289|Th1 Cells|th1 cells
403675|NCT01225289|Th2 Cells|th2 cells
403676|NCT01225276|CIDP|cidp
403677|NCT01225276|IVIG|ivig
403678|NCT01225263|Migraine disorders|migraine disorders
403679|NCT01225263|Headache|headache
403680|NCT01225263|Simvastatin|simvastatin
403681|NCT01225263|Vitamin D|vitamin d
403682|NCT01225250|Caudal septal extension graft|caudal septal extension graft
403683|NCT01225250|Primary rhinoplasty|primary rhinoplasty
403684|NCT01225250|Secondary rhinoplasty|secondary rhinoplasty
403685|NCT01225237|diarrhea|diarrhea
403686|NCT01225237|IBS|ibs
403687|NCT01225237|Colonic disease|colonic disease
403688|NCT01225237|YM060|ym060
403689|NCT01225224|ASP015K|asp015k
403690|NCT01225224|Ethnic difference|ethnic difference
403691|NCT01225198|Vitamins|vitamins
403692|NCT01225198|Minerals|minerals
745790|NCT01145963|nutrition|nutrition
403693|NCT01225185|neurological complications|neurological complications
403694|NCT01225185|brain blood flow autoregulation|brain blood flow autoregulation
403695|NCT01225159|tight glycemic control|tight glycemic control
403696|NCT01225159|cardiac surgery|cardiac surgery
403698|NCT01225146|Central|central
403699|NCT01225146|Retinal|retinal
403700|NCT01225146|Vein|vein
403701|NCT01225146|Occlusion|occlusion
403702|NCT01225146|Ranibizumab|ranibizumab
403703|NCT01225146|Lucentis|lucentis
403704|NCT01225146|CRVO|crvo
403705|NCT01225146|ISCRVO|iscrvo
403706|NCT01225133|Osteoarthritis, Osteoarthrosis, Arthritis, Arthrosis|osteoarthritis, osteoarthrosis, arthritis, arthrosis
403707|NCT01225107|Burns|burns
403708|NCT01225107|Infections|infections
403709|NCT01225107|Cranberry|cranberry
403710|NCT01225094|AAA|aaa
403711|NCT01225094|abdominal aortic aneurysm|abdominal aortic aneurysm
403712|NCT01225094|acute kidney injury|acute kidney injury
403713|NCT01225094|ischemia-reperfusion|ischemia-reperfusion
403714|NCT01225081|ASP1941|asp1941
403715|NCT01225081|Diabetes mellitus|diabetes mellitus
403716|NCT01225081|pioglitazone|pioglitazone
403717|NCT01225042|infectious diarrhea|infectious diarrhea
403718|NCT01225042|probiotics|probiotics
403719|NCT01225042|prevention|prevention
403720|NCT01225042|dietary intervention|dietary intervention
403721|NCT01225042|E. coli infection|e. coli infection
403722|NCT01225042|intestinal infection|intestinal infection
403723|NCT01225042|intestinal resistance|intestinal resistance
403724|NCT01225029|premature birth|premature birth
403823|NCT01224548|diabetes|diabetes
403725|NCT01225029|late preterm birth|late preterm birth
403726|NCT01225029|respiratory distress of the newborn|respiratory distress of the newborn
403727|NCT01225029|Transient tachypnea of the newborn|transient tachypnea of the newborn
403728|NCT01225003|gliomas|gliomas
403729|NCT01225003|magnetic resonance|magnetic resonance
403730|NCT01225003|diffusion kurtosis imaging|diffusion kurtosis imaging
403731|NCT01225003|MR spectroscopy|mr spectroscopy
403732|NCT01225003|grading|grading
403733|NCT01224990|gastro-intestinal tumor|gastro-intestinal tumor
403734|NCT01224990|accurate staging|accurate staging
403735|NCT01224990|whole-body diffusion weighted MRI|whole-body diffusion weighted mri
403736|NCT01224990|non-invasive|non-invasive
403737|NCT01224925|carious exposure|carious exposure
403738|NCT01224925|pulp capping|pulp capping
403740|NCT01224925|Dycal|dycal
403741|NCT01224912|Insomnia|insomnia
403742|NCT01224912|Intervention|intervention
403743|NCT01224912|Self-help|self-help
403744|NCT01224912|Internet|internet
403745|NCT01224899|Heart Failure|heart failure
403746|NCT01224899|Sympathetic Nervous System|sympathetic nervous system
403747|NCT01224899|Sympathectomy|sympathectomy
403748|NCT01224899|Adrenergic beta-Antagonists|adrenergic beta-antagonists
403749|NCT01224899|Ventricular Dysfunction, Left|ventricular dysfunction, left
403750|NCT01224886|Aging|aging
403751|NCT01224886|Insulin resistance|insulin resistance
403752|NCT01224886|Ectopic lipids|ectopic lipids
403753|NCT01224886|Obesity|obesity
403754|NCT01224886|Exercise|exercise
403755|NCT01224886|Physical activity|physical activity
403756|NCT01224886|Oxidative capacity|oxidative capacity
403757|NCT01224886|Diabetes|diabetes
403758|NCT01224886|Metabolic syndrome|metabolic syndrome
403759|NCT01224873|breast cancer|breast cancer
403760|NCT01224873|bone metastasis|bone metastasis
403761|NCT01224873|comparison of diagnostic methods|comparison of diagnostic methods
403762|NCT01224873|bone scintigraphy|bone scintigraphy
403763|NCT01224873|fluoride PET/CT|fluoride pet/ct
403764|NCT01224873|FDG-PET/CT|fdg-pet/ct
403765|NCT01224860|Telmisartan|telmisartan
403766|NCT01224860|Losartan|losartan
403767|NCT01224860|Renal transplant|renal transplant
403768|NCT01224847|AMD|amd
403769|NCT01224847|Intravitreal Injection|intravitreal injection
403771|NCT01224834|Ragweed, allergy, sublingual immunotherapy|ragweed, allergy, sublingual immunotherapy
403772|NCT01224821|iodine I 131 tositumomab|iodine i 131 tositumomab
403773|NCT01224821|anti-B1 Antibody|anti-b1 antibody
403774|NCT01224821|Bexxar|bexxar
403775|NCT01224821|radioimmunotherapy|radioimmunotherapy
403776|NCT01224821|tositumomab|tositumomab
403777|NCT01224808|von Willebrand Disease|von willebrand disease
403778|NCT01224795|uncomplicated influenza|uncomplicated influenza
403779|NCT01224782|Zemplar capsules|zemplar capsules
403780|NCT01224782|Chronic kidney disease (CKD) stage 3 or 4|chronic kidney disease (ckd) stage 3 or 4
403781|NCT01224782|Secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
403782|NCT01224782|Postmarketing observational study (PMOS)|postmarketing observational study (pmos)
403783|NCT01224756|Tonsillitis|tonsillitis
403784|NCT01224756|Pharyngitis|pharyngitis
403785|NCT01224756|Sore Throat|sore throat
403786|NCT01224756|Drug Therapy|drug therapy
403787|NCT01224717|Osteoporosis|osteoporosis
403788|NCT01224704|Hypertonic Saline Infusion|hypertonic saline infusion
403789|NCT01224704|Water Deprivation|water deprivation
403790|NCT01224704|Thirst|thirst
403791|NCT01224704|Water/Electrolytes Homeostasis|water/electrolytes homeostasis
403793|NCT01224691|Respiratory Syncytial Virus|respiratory syncytial virus
403794|NCT01224691|TGF Beta|tgf beta
403795|NCT01224691|RSV|rsv
403796|NCT01224691|Asthma|asthma
403797|NCT01224691|Healthy Volunteer|healthy volunteer
403798|NCT01224678|breast cancer|breast cancer
403799|NCT01224665|stage II bladder cancer|stage ii bladder cancer
403800|NCT01224665|stage III bladder cancer|stage iii bladder cancer
403801|NCT01224665|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
403802|NCT01224652|gastric cancer|gastric cancer
403803|NCT01224652|paclitaxel|paclitaxel
403804|NCT01224652|irinotecan|irinotecan
403805|NCT01224639|dengue fever|dengue fever
403806|NCT01224639|live attenuated tetravalent dengue vaccine|live attenuated tetravalent dengue vaccine
403808|NCT01224639|Drug therapy|drug therapy
403809|NCT01224626|VRE|vre
403810|NCT01224626|Japanese|japanese
403811|NCT01224626|Post Marketing Surveillance|post marketing surveillance
403812|NCT01224600|lower limbs|lower limbs
403813|NCT01224600|Arterial Diseases|arterial diseases
403814|NCT01224587|Imaging technique|imaging technique
403815|NCT01224587|gastric transport through the gut|gastric transport through the gut
403816|NCT01224574|atrial fribrillation, cardiovascular events, aging, D-dimer|atrial fribrillation, cardiovascular events, aging, d-dimer
403817|NCT01224561|Thinness|thinness
403818|NCT01224561|Leanness|leanness
403819|NCT01224561|healthy volunteers|healthy volunteers
403820|NCT01224561|Lipid metabolism disorder|lipid metabolism disorder
403821|NCT01224548|vegan|vegan
403822|NCT01224548|diet|diet
403824|NCT01224548|overweight|overweight
403825|NCT01224548|workplace|workplace
403826|NCT01224548|nutrition|nutrition
403827|NCT01224548|diabetes and/or overweight|diabetes and/or overweight
403828|NCT01224535|Complementary foods|complementary foods
403829|NCT01224535|Amaranth|amaranth
403830|NCT01224535|Food Based approaches|food based approaches
403831|NCT01224535|Iron Deficiency anemia|iron deficiency anemia
403832|NCT01224535|Arid Areas|arid areas
403833|NCT01224535|Africa|africa
403834|NCT01224522|Randomized Controlled Trial|randomized controlled trial
403835|NCT01224522|Total Knee Arthroplasty|total knee arthroplasty
403836|NCT01224522|Patient Matched Cutting Blocks|patient matched cutting blocks
403837|NCT01224509|Cervix|cervix
403838|NCT01224509|EP3 receptors|ep3 receptors
403839|NCT01224509|Mifepristone|mifepristone
403840|NCT01224509|Prostaglandin|prostaglandin
403841|NCT01224509|Receptors|receptors
403842|NCT01224509|Steroids|steroids
403843|NCT01224496|Chronic cytopenic haematological diseases|chronic cytopenic haematological diseases
403844|NCT01224496|Chinese herbal concoction|chinese herbal concoction
403845|NCT01224496|Supportive management|supportive management
403846|NCT01224444|colon polyps|colon polyps
403847|NCT01224444|adenoma resection|adenoma resection
403848|NCT01224444|colon cancer screening|colon cancer screening
403849|NCT01224444|colonoscopy|colonoscopy
403850|NCT01224431|pain|pain
403851|NCT01224431|lidocaine|lidocaine
403852|NCT01224431|lumbar puncture|lumbar puncture
403853|NCT01224431|j-tip|j-tip
403854|NCT01224418|Tacrolimus|tacrolimus
403855|NCT01224418|Prograf|prograf
403856|NCT01224418|Calcinurin inhibitor|calcinurin inhibitor
403857|NCT01224418|Rheumatoid arthritis(RA)|rheumatoid arthritis(ra)
403858|NCT01224392|colorectal cancer|colorectal cancer
403859|NCT01224392|colorectal neoplasms|colorectal neoplasms
403860|NCT01224392|radiotherapy|radiotherapy
403861|NCT01224392|chemoradiotherapy|chemoradiotherapy
403862|NCT01224392|T3-4 rectal cancer|t3-4 rectal cancer
403863|NCT01224379|Lumbar spine|lumbar spine
403864|NCT01224379|fusion|fusion
403865|NCT01224379|adjacent instability|adjacent instability
403866|NCT01224379|topping-off.|topping-off.
403867|NCT01224366|Add-on to insulin|add-on to insulin
403868|NCT01224327|Liver cirrhosis|liver cirrhosis
403869|NCT01224327|Radiology|radiology
403870|NCT01224327|Mesenchymal Stem Cells|mesenchymal stem cells
403871|NCT01224327|Umbilical Cord|umbilical cord
403872|NCT01224314|Haemodynamics|haemodynamics
403873|NCT01224314|Hypotension|hypotension
403874|NCT01224314|Potassium|potassium
403875|NCT01224314|Haemodialysis|haemodialysis
403876|NCT01224314|Dialysis fluids|dialysis fluids
403877|NCT01224301|seasonal influenza vaccine|seasonal influenza vaccine
403878|NCT01224301|school-based clinics|school-based clinics
403879|NCT01224301|economic analysis of school based influenza vaccine delivery|economic analysis of school based influenza vaccine delivery
403880|NCT01224301|pediatric influenza vaccine rates|pediatric influenza vaccine rates
403881|NCT01224301|Influenza vaccine information for parents|influenza vaccine information for parents
403882|NCT01224288|RCC|rcc
403883|NCT01224288|Kidney cancer|kidney cancer
200948|NCT02112890|Pertussis|pertussis
403884|NCT01224288|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
403885|NCT01224288|mRCC|mrcc
403886|NCT01224288|Dynamic contrast enhanced CT|dynamic contrast enhanced ct
403887|NCT01224288|DCE-CT|dce-ct
403888|NCT01224288|Tumor perfusion|tumor perfusion
403889|NCT01224275|group based care|group based care
403890|NCT01224275|antenatal care|antenatal care
403891|NCT01224275|parents satisfaction|parents satisfaction
403892|NCT01224275|Antenatal care´s organization and patient satisfaction|antenatal care´s organization and patient satisfaction
403893|NCT01224262|influenza vaccine|influenza vaccine
403894|NCT01224262|seasonal influenza|seasonal influenza
403895|NCT01224262|novel vaccine|novel vaccine
403896|NCT01224262|flu|flu
403897|NCT01224249|Selenium|selenium
403898|NCT01224249|Selenoprotein P|selenoprotein p
403899|NCT01224249|Fish|fish
403900|NCT01224249|Shellfish|shellfish
403344|NCT01226823|ICP|icp
403902|NCT01224223|asthma|asthma
403903|NCT01224210|portopulmonary hypertension|portopulmonary hypertension
403904|NCT01224210|portal hypertension|portal hypertension
403905|NCT01224210|esophageal or gastric varices|esophageal or gastric varices
403906|NCT01224210|right heart catheterization|right heart catheterization
403907|NCT01224210|transpulmonary gradient|transpulmonary gradient
403908|NCT01224210|Endothelin Receptor Antagonist|endothelin receptor antagonist
403909|NCT01224210|Ambrisentan|ambrisentan
403910|NCT01224210|Letairis|letairis
403911|NCT01224210|pulmonary hemodynamics|pulmonary hemodynamics
403912|NCT01224197|TMC435HPC1004|tmc435hpc1004
403913|NCT01224197|TMC435|tmc435
403914|NCT01224197|HCV|hcv
403915|NCT01224197|Hepatitis C|hepatitis c
403916|NCT01224197|Healthy Chinese volunteer|healthy chinese volunteer
403917|NCT01224184|HIV|hiv
403918|NCT01224184|Sexually Transmitted Diseases|sexually transmitted diseases
403919|NCT01224184|Substance Abuse Detection|substance abuse detection
403920|NCT01224184|Randomized Controlled Trial|randomized controlled trial
403921|NCT01222507|tinnitus|tinnitus
403922|NCT01222507|cognition|cognition
403923|NCT01222507|brain processing speed|brain processing speed
403924|NCT01222507|Brain Fitness Program|brain fitness program
403925|NCT01222507|Posit Science|posit science
403926|NCT01222494|Child Psychiatry|child psychiatry
403927|NCT01222494|Obesity|obesity
403928|NCT01222494|Antipsychotic|antipsychotic
403929|NCT01222481|Head and Neck Cancer|head and neck cancer
403930|NCT01222481|Functional Status|functional status
403931|NCT01222481|Cognitive Status|cognitive status
403932|NCT01222481|Neurocognitive Assessments|neurocognitive assessments
403933|NCT01222481|Performance-based Assessments|performance-based assessments
403934|NCT01222481|Cancer|cancer
403935|NCT01222481|Function|function
403936|NCT01222481|Cognition|cognition
403937|NCT01222481|Quality of Life|quality of life
403938|NCT01222468|Spasticity, Spinal Cord Injury|spasticity, spinal cord injury
403939|NCT01222455|Phase 1|phase 1
403940|NCT01222455|Healthy volunteers|healthy volunteers
403941|NCT01222455|Volunteers with hepatic impairment|volunteers with hepatic impairment
403942|NCT01222455|Pharmacokinetics|pharmacokinetics
403943|NCT01222455|Fostamatinib|fostamatinib
403944|NCT01222442|Respiratory disease|respiratory disease
403945|NCT01222442|Bronchiolitis|bronchiolitis
403946|NCT01222442|Emphysema|emphysema
403947|NCT01222442|Lung disease causing persistent narrowing of the airways|lung disease causing persistent narrowing of the airways
403948|NCT01224132|Atopic dermatitis, probiotic, SCORAD index, prick tests, cytokines|atopic dermatitis, probiotic, scorad index, prick tests, cytokines
403949|NCT01224119|foot ankle arthritis bone graft|foot ankle arthritis bone graft
403950|NCT01224054|Tolerance alimentary|tolerance alimentary
403951|NCT01224054|Morbid obesity|morbid obesity
403952|NCT01224054|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
403953|NCT01224041|Tacrolimus|tacrolimus
403954|NCT01224041|Prograf|prograf
403955|NCT01224041|Calcinurin inhibitor|calcinurin inhibitor
403956|NCT01224041|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
403957|NCT01224028|Tacrolimus|tacrolimus
403958|NCT01224028|Prograf|prograf
403959|NCT01224028|Calcinurin inhibitor|calcinurin inhibitor
403960|NCT01224028|Albuminurea|albuminurea
403961|NCT01224028|Proteinurea|proteinurea
403962|NCT01224028|FK506|fk506
403963|NCT01224002|Cross-Sectional|cross-sectional
403964|NCT01224002|Observational|observational
403965|NCT01224002|Comparative|comparative
403966|NCT01224002|Retrospective|retrospective
403967|NCT01224002|Feasibility|feasibility
403968|NCT01224002|Dental Decay|dental decay
403969|NCT01224002|Drug Abuse|drug abuse
403970|NCT01224002|Survey|survey
403971|NCT01223989|overweight|overweight
403972|NCT01223989|obesity|obesity
403973|NCT01223989|bread|bread
403974|NCT01223989|hypocaloric diet|hypocaloric diet
403975|NCT01223976|latent tuberculosis psoriasis arthritis TST QTF|latent tuberculosis psoriasis arthritis tst qtf
403976|NCT01223976|Screening of latent tuberculosis in psoriasis|screening of latent tuberculosis in psoriasis
403977|NCT01223963|Macrolane|macrolane
403978|NCT01223963|Retrospective|retrospective
403979|NCT01223924|cancer|cancer
403980|NCT01223898|CML,|cml,
403981|NCT01223898|nilotinib,|nilotinib,
403982|NCT01223898|midazolam|midazolam
403983|NCT01223859|Radiofrequency, ablation, RFA, RFTA, RFITT, soft palate.|radiofrequency, ablation, rfa, rfta, rfitt, soft palate.
403984|NCT01223833|breast cancer|breast cancer
403985|NCT01223833|postmenopausal|postmenopausal
403986|NCT01223833|aromatase inhibitors|aromatase inhibitors
403987|NCT01223833|tamoxifen|tamoxifen
403988|NCT01223833|arthralgia|arthralgia
403989|NCT01223833|IGF-I|igf-i
403990|NCT01223833|BMI|bmi
403991|NCT01223833|grip strength|grip strength
403992|NCT01223807|COPD, diaphragm, rehabilitation|copd, diaphragm, rehabilitation
403993|NCT01223794|Fall|fall
403994|NCT01223794|all in surgical & Medical in-patient|all in surgical & medical in-patient
403995|NCT01223781|Freezing|freezing
403996|NCT01223781|biofeedback|biofeedback
403997|NCT01223781|motor learning|motor learning
403998|NCT01223781|freezing of gait in PD|freezing of gait in pd
403999|NCT01223755|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
404000|NCT01223755|Sirolimus|sirolimus
404001|NCT01223755|Renal insufficiency|renal insufficiency
404002|NCT01223729|Acetyl-L-carnitine;|acetyl-l-carnitine;
404003|NCT01223729|Minimal hepatic encephalopathy;|minimal hepatic encephalopathy;
404004|NCT01223729|Quality of life;|quality of life;
404005|NCT01223729|Depression.|depression.
404006|NCT01223716|amblyopia treatment|amblyopia treatment
404007|NCT01223716|neural plasticity|neural plasticity
404008|NCT01223716|perceptual learning|perceptual learning
404009|NCT01223716|vision therapy|vision therapy
404010|NCT01223716|spatial vision|spatial vision
404011|NCT01223716|video games|video games
404012|NCT01223716|occlusion therapy|occlusion therapy
404013|NCT01223703|n-3 PUFAs|n-3 pufas
404014|NCT01223703|Heart Failure|heart failure
404015|NCT01223703|Dilated cardiomyopathy|dilated cardiomyopathy
404016|NCT01223703|Ejection Fraction|ejection fraction
404017|NCT01223703|Exercise Capacity|exercise capacity
404018|NCT01223690|sepsis|sepsis
404019|NCT01223690|infection|infection
404020|NCT01223690|bacteremia|bacteremia
404021|NCT01223690|clarithromycin|clarithromycin
404022|NCT01223664|ABMSC|abmsc
404023|NCT01223664|Allogenic bone marrow mesenchymal stem cells|allogenic bone marrow mesenchymal stem cells
404024|NCT01223664|Liver cirrhosis|liver cirrhosis
404025|NCT01223664|Transplantation|transplantation
404026|NCT01223651|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
404027|NCT01223651|Continuous Glucose Monitoring System|continuous glucose monitoring system
404028|NCT01223651|Accuracy|accuracy
404029|NCT01223651|Altitude|altitude
404030|NCT01223638|Congenital hypothyroidism(CH)|congenital hypothyroidism(ch)
404031|NCT01223638|Hearing loss among children with CH|hearing loss among children with ch
404032|NCT01223612|Diabetes Mellitus|diabetes mellitus
404033|NCT01223612|Diabetes Complications|diabetes complications
404034|NCT01223612|Retinal Diseases|retinal diseases
404035|NCT01223612|Edema|edema
404036|NCT01223612|Endothelial Growth Factors|endothelial growth factors
404037|NCT01223612|Monoclonal Antibodies|monoclonal antibodies
404038|NCT01223612|Ranibizumab|ranibizumab
404039|NCT01223612|Laser therapy|laser therapy
404040|NCT01223599|pilonidal disease|pilonidal disease
404041|NCT01223599|natal cleft|natal cleft
404042|NCT01223599|limberg flap|limberg flap
404043|NCT01222390|Breast Cancer Reconstruction|breast cancer reconstruction
404044|NCT01222390|Tissue Expander|tissue expander
404045|NCT01222390|3-D Camera|3-d camera
404046|NCT01222390|Breast Reconstruction|breast reconstruction
404047|NCT01222390|Crescentric|crescentric
404048|NCT01222390|Expander Profile|expander profile
404049|NCT01222390|Fill-Volume|fill-volume
404050|NCT01222390|Lower Pole|lower pole
404051|NCT01222390|Upper Pole|upper pole
404052|NCT01222390|Acellular Dermis|acellular dermis
404053|NCT01222390|3-D Imaging|3-d imaging
404054|NCT01222364|NICHD Neonatal Research Network|nichd neonatal research network
404055|NCT01222364|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
404056|NCT01222364|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
404057|NCT01222364|Prematurity|prematurity
404058|NCT01222351|Alzheimer's disease|alzheimer's disease
404059|NCT01222351|Positron emission tomography|positron emission tomography
404060|NCT01222351|Biomarker|biomarker
404061|NCT01222351|Plasma Aβ|plasma aβ
404062|NCT01222351|Brain amyloid plaque load|brain amyloid plaque load
404063|NCT01222338|Mycobacterium|mycobacterium
404064|NCT01222338|MDR-TB|mdr-tb
404065|NCT01222338|XDR-TB|xdr-tb
404067|NCT01222338|HCV|hcv
405151|NCT01219023|Sunitinib|sunitinib
404068|NCT01222325|kidney calculi|kidney calculi
404069|NCT01222325|urolithiasis|urolithiasis
404070|NCT01222325|urologic surgical procedures|urologic surgical procedures
404071|NCT01222325|extracorporeal shockwave lithotripsy|extracorporeal shockwave lithotripsy
404072|NCT01222312|advanced NSCLC|advanced nsclc
404073|NCT01222312|oxaliplatin|oxaliplatin
404074|NCT01222312|cisplatin|cisplatin
404075|NCT01222312|docetaxel|docetaxel
404076|NCT01222312|locally advanced or metastatic non small cell lung cancer (stage IIIB-IV)|locally advanced or metastatic non small cell lung cancer (stage iiib-iv)
200949|NCT02112890|Young adults|young adults
404077|NCT01222286|Smoldering Multiple Myeloma|smoldering multiple myeloma
404078|NCT01222273|cystic fibrosis|cystic fibrosis
404079|NCT01222273|Allergic bronchopulmonary aspergillosis|allergic bronchopulmonary aspergillosis
404080|NCT01222273|A. fumigatus|a. fumigatus
404081|NCT01222273|Immune response|immune response
404082|NCT01222260|Amyloidosis|amyloidosis
404083|NCT01222260|Dexamethasone|dexamethasone
404084|NCT01222260|Bendamustine|bendamustine
404085|NCT01222260|Relapsed AL Amyloidosis|relapsed al amyloidosis
404086|NCT01222247|Betamethasone|betamethasone
404087|NCT01222247|Celestone|celestone
404088|NCT01222247|Steroids|steroids
404089|NCT01222247|Perinatology|perinatology
404090|NCT01223560|Artificial pancreas|artificial pancreas
404091|NCT01223560|Model predictive control|model predictive control
404092|NCT01223560|Virtual patient|virtual patient
404093|NCT01223547|Carbohydrate counting|carbohydrate counting
404094|NCT01223547|Insulin bolus calculation|insulin bolus calculation
404095|NCT01223534|Tuberculosis|tuberculosis
404096|NCT01223534|Latent tuberculosis infection|latent tuberculosis infection
404097|NCT01223534|Tuberculin skin test|tuberculin skin test
404098|NCT01223534|Interferon-gamma release assays|interferon-gamma release assays
404099|NCT01223534|Contact-tracing study|contact-tracing study
404100|NCT01223521|Contraception|contraception
404101|NCT01223521|Abortion|abortion
404102|NCT01223521|First trimester|first trimester
404103|NCT01223521|Intrauterine device|intrauterine device
404104|NCT01223482|Miscarriage|miscarriage
404105|NCT01223482|Karyotyping|karyotyping
404106|NCT01223482|Genetic testing|genetic testing
404107|NCT01223469|Atrial Fibrillation|atrial fibrillation
404108|NCT01223469|Supraventricular Tachycardia|supraventricular tachycardia
404109|NCT01223469|Contact Force|contact force
404110|NCT01223469|RF Ablation|rf ablation
404111|NCT01223469|Radiofrequency|radiofrequency
404112|NCT01223469|Pulmonary Vein Isolation|pulmonary vein isolation
404113|NCT01223469|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
404114|NCT01223456|Saxagliptin|saxagliptin
404115|NCT01223456|type 2 diabetes|type 2 diabetes
404116|NCT01223456|clinical practice|clinical practice
404117|NCT01223443|Coronary Artery Bypass Grafting|coronary artery bypass grafting
404118|NCT01223443|Drug Eluting Stent|drug eluting stent
404119|NCT01223443|Saphenous Vein Graft|saphenous vein graft
404120|NCT01223430|septic shock|septic shock
404121|NCT01223430|shock reversal|shock reversal
404122|NCT01223430|ICU|icu
404123|NCT01223430|traditional Chinese medicine|traditional chinese medicine
404124|NCT01223404|nicotine|nicotine
404125|NCT01223404|mecamylamine|mecamylamine
404126|NCT01223404|attention|attention
404127|NCT01223404|default network|default network
404128|NCT01223404|fMRI|fmri
404129|NCT01223391|orthostatic|orthostatic
404130|NCT01223391|abdominal compression|abdominal compression
404131|NCT01223365|moderate to severe pain|moderate to severe pain
404132|NCT01223365|diabetic peripheral neuropathy|diabetic peripheral neuropathy
404133|NCT01223365|postherpetic neuralgia|postherpetic neuralgia
404134|NCT01223365|traumatic injury|traumatic injury
404135|NCT01223365|complex regional pain syndrome|complex regional pain syndrome
404136|NCT01223365|back pain|back pain
404137|NCT01223365|neck pain|neck pain
404138|NCT01223365|osteoarthritis|osteoarthritis
404139|NCT01223365|rheumatoid arthritis|rheumatoid arthritis
404140|NCT01223352|pulmonary arterial hypertension|pulmonary arterial hypertension
404141|NCT01223352|children|children
404142|NCT01223352|pediatric|pediatric
404143|NCT01223352|bosentan|bosentan
404144|NCT01223339|Ertugliflozin|ertugliflozin
404145|NCT01223339|Japanese and Western population|japanese and western population
404146|NCT01223339|pharmacokinetics|pharmacokinetics
404147|NCT01223339|pharmacodynamics|pharmacodynamics
404148|NCT01223326|Acetylcysteine|acetylcysteine
404149|NCT01223313|Contraception|contraception
404150|NCT01223313|Woman's Condom|woman's condom
404151|NCT01223313|Female Condom|female condom
404152|NCT01223313|Condom|condom
404153|NCT01223287|NICHD Neonatal Research Network|nichd neonatal research network
404154|NCT01223287|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
404155|NCT01223287|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
404156|NCT01223287|Prematurity|prematurity
404157|NCT01223287|Mechanical ventilation|mechanical ventilation
404158|NCT01223287|Chronic Lung Disease (CLD)|chronic lung disease (cld)
404159|NCT01223274|NICHD Neonatal Research Network|nichd neonatal research network
404160|NCT01223274|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
404161|NCT01223274|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
404163|NCT01223274|Mechanical ventilation|mechanical ventilation
404164|NCT01223274|Positive-Pressure Ventilation|positive-pressure ventilation
404165|NCT01223274|Surfactant|surfactant
404166|NCT01223274|Intubation|intubation
404167|NCT01223274|Pulse oximetry|pulse oximetry
404168|NCT01223274|Oxygen saturation|oxygen saturation
404169|NCT01223261|NICHD Neonatal Research Network|nichd neonatal research network
200950|NCT02112877|iliofemoral vein|iliofemoral vein
404170|NCT01223261|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
404171|NCT01223261|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
404172|NCT01223261|Prematurity|prematurity
404173|NCT01223261|Laparotomy|laparotomy
404174|NCT01223261|Drainage|drainage
404175|NCT01223261|Isolated intestinal perforation|isolated intestinal perforation
404176|NCT01223261|Focal intestinal performation|focal intestinal performation
404177|NCT01223248|radiation|radiation
404178|NCT01223248|Hypofractionated Image- Guided|hypofractionated image- guided
404179|NCT01223248|IGIMRT|igimrt
404180|NCT01223248|RT|rt
404181|NCT01223248|10-154|10-154
404182|NCT01223235|FALLOPIAN TUBE|fallopian tube
404183|NCT01223235|OVARY|ovary
404184|NCT01223235|PERITONEUM|peritoneum
404185|NCT01223235|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
404186|NCT01223235|GLOBO H-KLH CONJUGATE|globo h-klh conjugate
404187|NCT01223235|MUC-1 KLH|muc-1 klh
404188|NCT01223235|OPT-821|opt-821
404189|NCT01223235|TF (C) - KLH|tf (c) - klh
404190|NCT01223235|TN(C)-KLH|tn(c)-klh
404191|NCT01223235|10-099|10-099
404192|NCT01223222|Uncomplicated skin infections|uncomplicated skin infections
404193|NCT01223222|Impetigo|impetigo
404194|NCT01223222|Gram-negative|gram-negative
404319|NCT01222676|stage III bladder cancer|stage iii bladder cancer
404195|NCT01223222|Diagnosis of uncomplicated, Gram-positive, skin infection. This may include patients with mild eczema/dermatoses such as atopic dermatitis.|diagnosis of uncomplicated, gram-positive, skin infection. this may include patients with mild eczema/dermatoses such as atopic dermatitis.
404196|NCT01223222|Gram-positive organisms which in the opinion of the investigator are causative for infection of the lesion(s),|gram-positive organisms which in the opinion of the investigator are causative for infection of the lesion(s),
404197|NCT01223209|Cancer|cancer
404198|NCT01223209|Carcinoma|carcinoma
404199|NCT01223209|Curative surgery|curative surgery
404200|NCT01223209|Curative surgery for carcinoma at least three months and not more than 5 years prior to treatment start|curative surgery for carcinoma at least three months and not more than 5 years prior to treatment start
404201|NCT01223196|Type 2 Diabetes, Thiazolidinediones, TIMP-3, TACE, TNF-a,|type 2 diabetes, thiazolidinediones, timp-3, tace, tnf-a,
404202|NCT01223196|insulin resistance|insulin resistance
404203|NCT01223183|cystic fibrosis|cystic fibrosis
404204|NCT01223183|nuclear medicine|nuclear medicine
404205|NCT01223183|aerosol|aerosol
404206|NCT01223183|nebulizer|nebulizer
404213|NCT01223157|endocannabinoids|endocannabinoids
404214|NCT01223144|Cognition|cognition
404215|NCT01223144|orbitofrontal cortex|orbitofrontal cortex
404216|NCT01223144|Iowa Gambling Task|iowa gambling task
404217|NCT01223144|facial emotion recognition|facial emotion recognition
404218|NCT01223118|Oocyte|oocyte
404219|NCT01223118|vitrification|vitrification
404221|NCT01223118|PGD|pgd
404222|NCT01223118|embryo biopsy|embryo biopsy
404223|NCT01223105|slow freeze|slow freeze
404224|NCT01223105|cryopreservation|cryopreservation
404225|NCT01223105|vitrification|vitrification
404226|NCT01223105|oocyte preservation|oocyte preservation
404227|NCT01223092|IVF|ivf
404228|NCT01223092|infertility|infertility
404229|NCT01223092|DNA|dna
404230|NCT01223079|r-hFSH|r-hfsh
404231|NCT01223079|r-hLH|r-hlh
404232|NCT01223066|Macrolane|macrolane
404233|NCT01223053|Sprain|sprain
404234|NCT01223053|Strain|strain
404235|NCT01223053|Pain|pain
404236|NCT01223053|Ankle Pain|ankle pain
404237|NCT01223053|Knee Pain|knee pain
404238|NCT01223053|Wrist Pain|wrist pain
404239|NCT01223053|Hand Pain|hand pain
404240|NCT01223027|Dovitinib|dovitinib
404241|NCT01223027|TKI|tki
404242|NCT01223027|Renal cell cancer|renal cell cancer
404243|NCT01223027|RCC|rcc
404244|NCT01223027|mRCC|mrcc
404245|NCT01223014|Radioactive|radioactive
404246|NCT01223014|ADME|adme
404247|NCT01223014|Neuropathic pain|neuropathic pain
404248|NCT01223001|Depression|depression
404249|NCT01223001|Traumatic brain injury|traumatic brain injury
404250|NCT01223001|Duloxetine|duloxetine
404251|NCT01223001|Cymbalta|cymbalta
404252|NCT01223001|impaired cognitive function|impaired cognitive function
404253|NCT01222975|risperidone fasting study|risperidone fasting study
404254|NCT01222936|LBH581|lbh581
404255|NCT01222936|Panobinostat|panobinostat
404256|NCT01222936|Small Cell Lung Carcinoma|small cell lung carcinoma
404257|NCT01222923|Risperidone fed study|risperidone fed study
404258|NCT01222910|Valacyclovir hydrochloride fasting study|valacyclovir hydrochloride fasting study
404259|NCT01222897|Valacyclovir hydrochloride fed study|valacyclovir hydrochloride fed study
404260|NCT01222871|Treatment|treatment
404261|NCT01222858|Obesity|obesity
404262|NCT01222858|Primary Care|primary care
404263|NCT01222858|Internet|internet
404264|NCT01222858|Technology|technology
404265|NCT01222858|Behavior Modification|behavior modification
404266|NCT01222819|Febrile neutropenia|febrile neutropenia
404267|NCT01222819|growth factors|growth factors
404268|NCT01222819|leukemia|leukemia
88630|NCT02733341|Cardiovascular Magnetic Resonance (CMR)|cardiovascular magnetic resonance (cmr)
404269|NCT01222806|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
404270|NCT01222806|Cocaine|cocaine
404271|NCT01222806|Cue-Induced Craving|cue-induced craving
404272|NCT01222806|Repetitive TMS (rTMS)|repetitive tms (rtms)
404273|NCT01222806|Cocaine Craving|cocaine craving
404274|NCT01222793|High Weight Gain Liability (HWLA)|high weight gain liability (hwla)
404275|NCT01222793|Antipsychotic|antipsychotic
404276|NCT01222793|Obesity|obesity
404277|NCT01222793|Low Weight Gain|low weight gain
404278|NCT01222793|Schizophrenia|schizophrenia
404279|NCT01222793|Food Craving|food craving
404280|NCT01222780|Hematologic Malignancies|hematologic malignancies
404281|NCT01222780|Vincristine Sulfate|vincristine sulfate
404282|NCT01222780|Maximum Tolerated Dose|maximum tolerated dose
404283|NCT01222780|Pharmacokinetics|pharmacokinetics
404284|NCT01222780|Solid Tumors|solid tumors
404285|NCT01222780|Cancer|cancer
404286|NCT01222780|Pediatrics|pediatrics
404287|NCT01222780|Sarcoma|sarcoma
404288|NCT01222780|Wilms Tumor|wilms tumor
404289|NCT01222780|Leukemia|leukemia
404290|NCT01222780|Lymphoma|lymphoma
404291|NCT01222780|Brain Tumor|brain tumor
404292|NCT01222767|EFT|eft
404293|NCT01222767|PNET|pnet
404294|NCT01222767|EOE|eoe
404295|NCT01222754|Newly Diagnosed|newly diagnosed
404296|NCT01222754|DIPG|dipg
404297|NCT01222754|CC 5013|cc 5013
404298|NCT01222754|Radiation Therapy|radiation therapy
404299|NCT01222754|Lenalidomide|lenalidomide
404300|NCT01222754|XRT|xrt
404301|NCT01222754|Brain Tumor|brain tumor
404302|NCT01222754|Glioma|glioma
404303|NCT01222754|Pediatrics|pediatrics
404308|NCT01222728|PET Imaging|pet imaging
404309|NCT01222728|Vestibular Schwannoma|vestibular schwannoma
404310|NCT01222728|Neurofibromatosis|neurofibromatosis
404311|NCT01222728|Neurofibromatosis Type 2|neurofibromatosis type 2
404312|NCT01222728|NF2|nf2
404313|NCT01222702|CDIFF|cdiff
404314|NCT01222702|CDAD|cdad
404315|NCT01222702|CDI|cdi
404316|NCT01222702|Clostridium difficile infection|clostridium difficile infection
404317|NCT01222676|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
404318|NCT01222676|stage II bladder cancer|stage ii bladder cancer
404321|NCT01222663|peritonitis|peritonitis
404322|NCT01222663|septic shock|septic shock
404323|NCT01222663|hemoperfusion|hemoperfusion
404324|NCT01222663|Polymyxin B|polymyxin b
404325|NCT01222663|endotoxin|endotoxin
404326|NCT01222650|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
404327|NCT01222650|I-PSS|i-pss
404328|NCT01222650|α1A-AR antagonist|α1a-ar antagonist
404329|NCT01222637|advanced solid cancers|advanced solid cancers
404330|NCT01222637|metastatic solid cancers|metastatic solid cancers
404331|NCT01222624|advanced solid malignancies|advanced solid malignancies
404332|NCT01222611|HIV|hiv
404333|NCT01222611|HCV|hcv
404334|NCT01222611|HIV/HCV|hiv/hcv
404335|NCT01222611|Coinfection|coinfection
404336|NCT01222611|Fosamprenavir|fosamprenavir
404337|NCT01222585|Metronidazole|metronidazole
404338|NCT01222585|Neonate|neonate
404339|NCT01222585|Premature|premature
404340|NCT01222585|Sepsis|sepsis
404341|NCT01222585|Necrotizing enterocolitis|necrotizing enterocolitis
404342|NCT01222572|radiation therapy|radiation therapy
404343|NCT01222572|stereotactic radiotherapy|stereotactic radiotherapy
404344|NCT01222572|stereotactic boost|stereotactic boost
404345|NCT01222559|Cartilage defects|cartilage defects
404346|NCT01222559|Knee joint|knee joint
404347|NCT01222559|Femoral Condyle|femoral condyle
404348|NCT01222221|adult gliosarcoma|adult gliosarcoma
404349|NCT01222221|adult giant cell glioblastoma|adult giant cell glioblastoma
404350|NCT01222221|adult glioblastoma|adult glioblastoma
404351|NCT01222208|Bowel resection|bowel resection
404352|NCT01222195|Myelodysplastic Syndrome|myelodysplastic syndrome
404353|NCT01222195|Red cell transfusion independence|red cell transfusion independence
404354|NCT01222195|Darbepoetin alfa|darbepoetin alfa
404355|NCT01222195|Lenalidomide|lenalidomide
404356|NCT01222195|CC-5013|cc-5013
404357|NCT01222195|Revlimid|revlimid
404358|NCT01222195|Aranesp|aranesp
404359|NCT01222195|Erythropoietin|erythropoietin
404360|NCT01222195|Erythropoiesis Stimulating Protein|erythropoiesis stimulating protein
404361|NCT01222182|low density lipoprotein (LDL) cholesterol|low density lipoprotein (ldl) cholesterol
404362|NCT01222182|statin|statin
404363|NCT01222182|dose equivalent|dose equivalent
404364|NCT01222182|Hypercholesterolemia (defined by LDL guidelines)|hypercholesterolemia (defined by ldl guidelines)
404365|NCT01222169|Anesthesia|anesthesia
404366|NCT01222169|Children|children
404367|NCT01222169|Larynx|larynx
404368|NCT01222156|Cardiac arrhythmias|cardiac arrhythmias
404369|NCT01222156|Catheter ablation|catheter ablation
404370|NCT01222156|Electrophysiology|electrophysiology
404371|NCT01222156|Magnetic|magnetic
404372|NCT01222156|Mapping|mapping
404373|NCT01222156|Remote navigation|remote navigation
404374|NCT01222143|AML|aml
404375|NCT01222143|NOVE-HiDAC|nove-hidac
404376|NCT01222143|Nilotinib|nilotinib
404377|NCT01222130|HIV|hiv
404378|NCT01222130|Infant infection|infant infection
403420|NCT01226589|Treatment response|treatment response
403421|NCT01226589|Histologically confirmed diagnosed Breast cancer.|histologically confirmed diagnosed breast cancer.
403422|NCT01226589|Patient is 18 years or older.|patient is 18 years or older.
403426|NCT01226576|MRgFUS|mrgfus
404379|NCT01222130|Diagnosis|diagnosis
404380|NCT01222130|Non-virological algorithm|non-virological algorithm
404381|NCT01222117|Acute Limb Ischemia|acute limb ischemia
404382|NCT01222104|vascular closure|vascular closure
404383|NCT01222104|Angio-Seal|angio-seal
404384|NCT01222104|Interventional radiology|interventional radiology
404385|NCT01222104|femoral artery|femoral artery
404386|NCT01222078|newly diagnosed type 1 diabetes mellitus|newly diagnosed type 1 diabetes mellitus
404387|NCT01222078|re-treatment|re-treatment
404388|NCT01222078|intravenous otelixizumab|intravenous otelixizumab
404389|NCT01222078|beta-cell preservation|beta-cell preservation
404390|NCT01222065|Glaucoma|glaucoma
404391|NCT01222065|Neurotubules|neurotubules
404392|NCT01222065|Birefringence|birefringence
404393|NCT01222065|Retinal Nerve Fiber Layer (RNFL)|retinal nerve fiber layer (rnfl)
404394|NCT01222052|high risk breast cancer|high risk breast cancer
404395|NCT01222052|low risk breast cancer|low risk breast cancer
404396|NCT01222052|uPA|upa
404397|NCT01222052|urokinase-type plasminogen activator|urokinase-type plasminogen activator
404398|NCT01222052|PAI|pai
404399|NCT01222052|plasminogen activator inhibitor-type|plasminogen activator inhibitor-type
404400|NCT01222039|Graft versus host disease|graft versus host disease
404401|NCT01222039|Mesenchymal stem cell|mesenchymal stem cell
404402|NCT01222039|Allogeneic mesenchymal stem cell|allogeneic mesenchymal stem cell
404403|NCT01222039|Adipose tissue|adipose tissue
404404|NCT01222039|Allotransplant|allotransplant
404405|NCT01222039|Allogenic|allogenic
404406|NCT01222039|Mesenchymal Stem Cells|mesenchymal stem cells
404407|NCT01222039|Immune System Diseases|immune system diseases
404408|NCT01222039|Chronic|chronic
404409|NCT01222039|Expanded|expanded
404410|NCT01222026|Primary Hyperparathyroidism|primary hyperparathyroidism
404411|NCT01222026|Osteopenia|osteopenia
404412|NCT01222026|Osteoporosis|osteoporosis
404413|NCT01221987|Human papillomavirus|human papillomavirus
404414|NCT01221987|neoplasia|neoplasia
404415|NCT01221974|Hydrosalpinx or infertility|hydrosalpinx or infertility
404416|NCT01221961|Major spine surgery|major spine surgery
404417|NCT01221961|Hemoglobin|hemoglobin
404418|NCT01221961|Blood transfusion|blood transfusion
404419|NCT01221948|Deep Brain Stimulation|deep brain stimulation
404420|NCT01221948|Parkinson's Disease|parkinson's disease
404421|NCT01221935|retrospective chart review study|retrospective chart review study
404422|NCT01221935|desvenlafaxine utilization|desvenlafaxine utilization
404423|NCT01221935|psychiatrists and primary care physicians|psychiatrists and primary care physicians
404424|NCT01221935|treatment of major depressive disorder|treatment of major depressive disorder
404425|NCT01221909|bleeding|bleeding
404426|NCT01221909|dacryocystorhinostomy|dacryocystorhinostomy
404427|NCT01221909|operative duration|operative duration
404428|NCT01221896|Localization of a parathyroid adenoma in patients with primary hyperparathyroidism.|localization of a parathyroid adenoma in patients with primary hyperparathyroidism.
404429|NCT01221883|Posttraumatic Stress|posttraumatic stress
404430|NCT01221883|Prevention|prevention
404431|NCT01221883|Diazepam|diazepam
404432|NCT01221870|Metastatic breast cancer|metastatic breast cancer
404433|NCT01221870|First-line therapy|first-line therapy
404434|NCT01221870|Tesetaxel|tesetaxel
404435|NCT01221870|Oral taxane|oral taxane
404436|NCT01221857|Double Umbilical Cord Blood Stem Cell Transplantation|double umbilical cord blood stem cell transplantation
404437|NCT01221857|Hematological Malignancies|hematological malignancies
404438|NCT01221857|HLA Mismatched Donors|hla mismatched donors
404439|NCT01221857|Cord Blood Transplantation|cord blood transplantation
404440|NCT01221844|Lactoferrin|lactoferrin
404441|NCT01221844|Pregnancy|pregnancy
404442|NCT01221844|Hereditary Thrombophilia|hereditary thrombophilia
404443|NCT01221844|Iron deficiency|iron deficiency
404444|NCT01221844|Iron deficiency anemia|iron deficiency anemia
404445|NCT01221818|Inflammatory Bowel Disease|inflammatory bowel disease
404446|NCT01221805|deep venous thrombosis|deep venous thrombosis
404447|NCT01221805|pulmonary embolism|pulmonary embolism
404448|NCT01221805|venous thromboembolism|venous thromboembolism
404449|NCT01221805|D-dimer|d-dimer
404450|NCT01221805|Wells score|wells score
404451|NCT01221805|Wells clinical pretest probability|wells clinical pretest probability
404452|NCT01221792|PTSD|ptsd
404453|NCT01221792|Anxiety|anxiety
404454|NCT01221792|Trauma|trauma
404455|NCT01221792|Assault|assault
404456|NCT01221792|Victim|victim
404457|NCT01221792|Witness|witness
404458|NCT01221792|Post Traumatic Stress Disorder|post traumatic stress disorder
404459|NCT01221792|Combat veteran|combat veteran
404460|NCT01221792|Flashbacks|flashbacks
404461|NCT01221792|Nightmares|nightmares
200951|NCT02112877|venous|venous
405733|NCT01216449|Elderly|elderly
404462|NCT01221792|Sleep Disturbance|sleep disturbance
404463|NCT01221792|Hyperarousal|hyperarousal
404464|NCT01221792|Numbness|numbness
404465|NCT01221792|Avoidance|avoidance
404466|NCT01221779|Intensive language therapy|intensive language therapy
404467|NCT01221779|Anomia|anomia
404468|NCT01221779|Magnetic Resonance Imaging|magnetic resonance imaging
404469|NCT01221766|adnexal|adnexal
404470|NCT01221766|hair and nail|hair and nail
404471|NCT01221766|chronic graft vs host disease|chronic graft vs host disease
404472|NCT01221766|children|children
404473|NCT01221753|SSCHN|sschn
404475|NCT01221753|IMRT|imrt
404476|NCT01221740|To show that patients with greater pain sensitivity|to show that patients with greater pain sensitivity
404477|NCT01221740|will show greater improvement in their symptoms|will show greater improvement in their symptoms
404478|NCT01221740|(self-reported pain intensity, mood, sleep, and|(self-reported pain intensity, mood, sleep, and
404479|NCT01221740|quality of life) than those with lower pain|quality of life) than those with lower pain
404480|NCT01221740|sensitivity, based on QST, after taking milnacipran.|sensitivity, based on qst, after taking milnacipran.
404481|NCT01221740|To compare outcome differences|to compare outcome differences
404482|NCT01221740|(pain intensity, mood, activity interference,|(pain intensity, mood, activity interference,
404483|NCT01221740|sleep, and side effects) with those patients|sleep, and side effects) with those patients
404484|NCT01221740|who are either taking or not taking opioids for|who are either taking or not taking opioids for
404485|NCT01221740|their pain 10 weeks after being prescribed milnacipran.|their pain 10 weeks after being prescribed milnacipran.
404486|NCT01221740|To show that patients who are older, male,|to show that patients who are older, male,
404487|NCT01221740|with more medical comorbidities, greater disability,|with more medical comorbidities, greater disability,
404488|NCT01221740|and longer pain duration will report less improvement|and longer pain duration will report less improvement
404489|NCT01221740|(pain, mood, sleep, health-related quality of life)|(pain, mood, sleep, health-related quality of life)
8897|NCT03233919|Remote Ischemic Conditioning|remote ischemic conditioning
404490|NCT01221740|and treatment satisfaction while taking milnacipran|and treatment satisfaction while taking milnacipran
404491|NCT01221740|compared with others without such characteristics.|compared with others without such characteristics.
404492|NCT01221740|identify patients back or neck pain|identify patients back or neck pain
404493|NCT01221740|greater 6 months|greater 6 months
404495|NCT01221740|10 weeks|10 weeks
404496|NCT01221740|milnacipran|milnacipran
404497|NCT01221740|pain intensity|pain intensity
404498|NCT01221740|mood|mood
404499|NCT01221740|activity|activity
404500|NCT01221740|interference|interference
404501|NCT01221740|sleep|sleep
404502|NCT01221740|side effects|side effects
404503|NCT01221740|age|age
404504|NCT01221740|gender|gender
404505|NCT01221740|medical comorbidities|medical comorbidities
404506|NCT01221740|pain diagnosis|pain diagnosis
404507|NCT01221740|pain duration|pain duration
404508|NCT01221740|disability status|disability status
404509|NCT01221727|Amgen|amgen
404510|NCT01221727|Phase 1|phase 1
404511|NCT01221727|Postmenopausal|postmenopausal
404512|NCT01221727|Osteoporosis|osteoporosis
404513|NCT01221714|nutritional supplements|nutritional supplements
404514|NCT01221714|supplements|supplements
404515|NCT01221714|vitamins|vitamins
404516|NCT01221714|omega-3|omega-3
404517|NCT01221714|Amerisciences|amerisciences
404518|NCT01221714|Carlos Montesinos|carlos montesinos
404519|NCT01221701|depression|depression
404520|NCT01221701|psychological treatments|psychological treatments
404521|NCT01221701|Cognitive Behavioral Therapy|cognitive behavioral therapy
404522|NCT01221701|child social/emotional functioning|child social/emotional functioning
404523|NCT01221701|parenting|parenting
404524|NCT01221701|home visitation|home visitation
404525|NCT01221688|Sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
404526|NCT01221688|large operable breast cancer|large operable breast cancer
404527|NCT01221688|neoadjuvant chemotherapy|neoadjuvant chemotherapy
404528|NCT01221688|patients with large operable breast cancer after neoadjuvant chemotherapy (NAC)|patients with large operable breast cancer after neoadjuvant chemotherapy (nac)
404529|NCT01221675|Small Cell Lung Cancer or CEA-expressing Non Small Cell Lung Carcinoma (NSCLC)|small cell lung cancer or cea-expressing non small cell lung carcinoma (nsclc)
404530|NCT01221675|Radio Immunotherapy|radio immunotherapy
404531|NCT01221675|Lutetium|lutetium
404532|NCT01221675|patient ≥ 18 years of age with CEA-positive SCLC in partial response|patient ≥ 18 years of age with cea-positive sclc in partial response
404533|NCT01221675|or who failed at least two lines of standard radiation and/or chemotherapy|or who failed at least two lines of standard radiation and/or chemotherapy
404534|NCT01221675|or Patients with histologic diagnosis of NSCLC|or patients with histologic diagnosis of nsclc
404535|NCT01221662|Siwu tang|siwu tang
404536|NCT01221662|brain hypoperfusion|brain hypoperfusion
404537|NCT01221662|cognition function|cognition function
404538|NCT01221623|Peyronie's Disease|peyronie's disease
404539|NCT01221623|penile plaque|penile plaque
404540|NCT01221623|penile curvature|penile curvature
404541|NCT01221610|Stenosis|stenosis
404542|NCT01221610|Occlusions|occlusions
404543|NCT01221610|SFA|sfa
404544|NCT01221610|PTA|pta
404545|NCT01221610|POBA|poba
404546|NCT01221610|DRB|drb
404547|NCT01221597|Peyronie's Disease|peyronie's disease
404548|NCT01221597|penile plaque|penile plaque
404549|NCT01221597|penile curvature|penile curvature
404550|NCT01221584|Dyslipidaemia|dyslipidaemia
404551|NCT01221584|LDL-C goals|ldl-c goals
404552|NCT01221584|guidelines|guidelines
404553|NCT01221571|Phase I|phase i
404554|NCT01221571|Dose escalation|dose escalation
404555|NCT01221571|AFM 13|afm 13
404556|NCT01221571|Natural killer cell|natural killer cell
404557|NCT01221545|Diabetes Mellitus|diabetes mellitus
404558|NCT01221519|Phase I|phase i
404559|NCT01221519|Bioavailability|bioavailability
404560|NCT01221519|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
404561|NCT01221519|Diabetic treatment|diabetic treatment
404562|NCT01221519|Metformin|metformin
404563|NCT01221519|High blood sugar|high blood sugar
404564|NCT01221506|unresectable|unresectable
404565|NCT01221506|metastatic|metastatic
404566|NCT01221506|clear cell renal carcinoma|clear cell renal carcinoma
404567|NCT01221493|solitary pulmonary nodules|solitary pulmonary nodules
404568|NCT01221493|transbronchial lung biopsy|transbronchial lung biopsy
746489|NCT01148706|abdomen|abdomen
404569|NCT01221493|endobronchial ultrasound|endobronchial ultrasound
404570|NCT01221454|ABMSC|abmsc
404571|NCT01221454|Allogenic bone marrow mesenchymal stem cells|allogenic bone marrow mesenchymal stem cells
404572|NCT01221454|Liver Failure|liver failure
404573|NCT01221454|Transplantation|transplantation
404574|NCT01221441|Cartilage|cartilage
404575|NCT01221441|Knee|knee
404576|NCT01221441|Osteoarthritis|osteoarthritis
404577|NCT01221428|Ulcerative colitis|ulcerative colitis
404578|NCT01221428|Mesenchymal Stem Cells|mesenchymal stem cells
404579|NCT01221428|Umbilical Cord|umbilical cord
404580|NCT01221389|hemorrhage|hemorrhage
404581|NCT01221389|plasma|plasma
404582|NCT01221389|coagulopathy|coagulopathy
404583|NCT01221389|trauma|trauma
404584|NCT01221363|Life style disease|life style disease
404586|NCT01221363|Sedentary behaviour|sedentary behaviour
404587|NCT01221363|Cardiovascular biomarkers|cardiovascular biomarkers
404588|NCT01221350|Asthma|asthma
404589|NCT01221350|Allergic rhinitis|allergic rhinitis
404590|NCT01221350|Respiratory disease|respiratory disease
404591|NCT01221350|Allergy|allergy
404592|NCT01221350|Lipoic acid|lipoic acid
404593|NCT01221350|Thioctic acid|thioctic acid
404594|NCT01221350|Antioxidant|antioxidant
404595|NCT01221350|Oxidative stress|oxidative stress
404596|NCT01221311|stenosis|stenosis
404597|NCT01221311|bile duct|bile duct
404598|NCT01221311|chronic pancreatitis|chronic pancreatitis
404599|NCT01221311|postoperative|postoperative
404600|NCT01221311|post-liver transplant|post-liver transplant
404601|NCT01221285|Cockroach|cockroach
404602|NCT01221285|Immunotherapy|immunotherapy
404603|NCT01221285|Subcutaneous immunotherapy|subcutaneous immunotherapy
404604|NCT01221285|Inner city asthma|inner city asthma
404605|NCT01221272|SPECT MPI|spect mpi
404606|NCT01221246|Acute Middle Cerebral Artery Ischemic Stroke within 18 hours|acute middle cerebral artery ischemic stroke within 18 hours
404607|NCT01221207|diabetic foot ulcers|diabetic foot ulcers
404608|NCT01221207|casting|casting
404609|NCT01221207|wound care|wound care
404610|NCT01221194|diabetes|diabetes
404611|NCT01221194|foot ulcer prevention|foot ulcer prevention
404612|NCT01221194|therapeutic stockings|therapeutic stockings
404613|NCT01221181|Dense deposit disease|dense deposit disease
404614|NCT01221181|C3 nephropathy|c3 nephropathy
404615|NCT01221181|Eculizumab|eculizumab
404616|NCT01221168|prostate|prostate
404617|NCT01221168|cancer|cancer
404618|NCT01221168|genetic|genetic
404619|NCT01221168|epidemiology|epidemiology
404620|NCT01221168|susceptibility|susceptibility
404621|NCT01221155|Musculoskeletal|musculoskeletal
404622|NCT01221142|Hypothermia, ICH|hypothermia, ich
404623|NCT01221129|zinc|zinc
404624|NCT01221129|reticulocyte|reticulocyte
404625|NCT01221129|PBMC|pbmc
404626|NCT01221129|whole blood|whole blood
404627|NCT01221129|transcriptome|transcriptome
404628|NCT01221129|microarray|microarray
404629|NCT01221116|coronary artery disease,|coronary artery disease,
404630|NCT01221116|aortic stenosis,|aortic stenosis,
404631|NCT01221116|heart failure|heart failure
404632|NCT01221103|Dexamethasone|dexamethasone
404633|NCT01221103|Ofatumumab|ofatumumab
404634|NCT01221103|Bendamustine|bendamustine
404635|NCT01221103|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
404636|NCT01221103|Non-Hodgkin lymphoma|non-hodgkin lymphoma
404637|NCT01221090|Type 2 diabetes|type 2 diabetes
404638|NCT01221090|Health disparities|health disparities
404639|NCT01221090|Central Texas|central texas
404640|NCT01221090|PDA|pda
404641|NCT01221090|CDSMP|cdsmp
404642|NCT01221077|NSCLC|nsclc
404643|NCT01221077|Non-small cell lung cancer|non-small cell lung cancer
404644|NCT01221077|OSI-906|osi-906
404645|NCT01221077|IGF-IR|igf-ir
404646|NCT01221077|Tarceva|tarceva
404647|NCT01221077|Erlotinib|erlotinib
404648|NCT01221077|Epidermal Growth Factor Receptor|epidermal growth factor receptor
404649|NCT01221077|EGFR|egfr
404650|NCT01221077|Chemonaive|chemonaive
404651|NCT01221077|Activating mutations|activating mutations
404652|NCT01221064|Breast cancer|breast cancer
404653|NCT01221064|Axillary clearance|axillary clearance
404654|NCT01221064|lymphorrhoea|lymphorrhoea
404655|NCT01221051|third stage of labor,oxytocics, postpartum hemorrhage,|third stage of labor,oxytocics, postpartum hemorrhage,
404656|NCT01221025|Parecoxib;|parecoxib;
404657|NCT01221025|emergence delirium;|emergence delirium;
404658|NCT01221025|postoperative pain;|postoperative pain;
404659|NCT01221025|elderly patients;|elderly patients;
404660|NCT01221025|abdominal surgery|abdominal surgery
404661|NCT01221025|Parecoxib on emergence agitation and postoperative pain|parecoxib on emergence agitation and postoperative pain
404662|NCT01220999|Clinical trial|clinical trial
404663|NCT01220999|CS-1008 mAb|cs-1008 mab
404664|NCT01220999|monoclonal antibody CS-1008|monoclonal antibody cs-1008
404665|NCT01220999|Positron-Emission Tomography|positron-emission tomography
404666|NCT01220999|Pharmacokinetics|pharmacokinetics
404667|NCT01220999|Pharmacodynamics|pharmacodynamics
404668|NCT01220999|apoptosis|apoptosis
404669|NCT01220999|caspases|caspases
404670|NCT01220986|Liver regeneration|liver regeneration
404671|NCT01220986|Innate immune response|innate immune response
404672|NCT01220973|stage IV prostate cancer|stage iv prostate cancer
404673|NCT01220973|stage III prostate cancer|stage iii prostate cancer
404674|NCT01220973|recurrent prostate cancer|recurrent prostate cancer
404675|NCT01220973|stage IIB prostate cancer|stage iib prostate cancer
404676|NCT01220973|stage IIA prostate cancer|stage iia prostate cancer
404677|NCT01220960|art therapy|art therapy
404678|NCT01220960|breast cancer|breast cancer
404680|NCT01220960|young women|young women
404681|NCT01220960|older women|older women
404682|NCT01220960|quality of life|quality of life
404683|NCT01220960|meaning making|meaning making
404684|NCT01220960|support group|support group
404685|NCT01220960|art making|art making
404686|NCT01220960|art symbols|art symbols
404693|NCT01220895|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
404694|NCT01220882|Slipped capital femoral epiphysis|slipped capital femoral epiphysis
404695|NCT01220856|Islet transplantation|islet transplantation
404696|NCT01220856|Type 1 diabetes mellitus|type 1 diabetes mellitus
404697|NCT01220843|chronic renal failure|chronic renal failure
404699|NCT01220843|Sevelamer carbonate|sevelamer carbonate
404700|NCT01220830|Multiple sclerosis|multiple sclerosis
404701|NCT01220830|RFQMR|rfqmr
404702|NCT01220830|Cytotron|cytotron
404703|NCT01220830|EDSS|edss
404704|NCT01220830|QOL assessment with FAMS|qol assessment with fams
404705|NCT01220817|prostate|prostate
404706|NCT01220817|cancer|cancer
404708|NCT01220817|psadt|psadt
404709|NCT01220817|pomegranate|pomegranate
404710|NCT01220817|POMx|pomx
404711|NCT01220791|methylprednisolone|methylprednisolone
404712|NCT01220791|IVF|ivf
404713|NCT01220791|progesterone|progesterone
404714|NCT01220791|corticosteroid|corticosteroid
404715|NCT01220791|late follicular phase|late follicular phase
404716|NCT01220791|pregnancy rates|pregnancy rates
404717|NCT01220765|hypoxemia|hypoxemia
404718|NCT01220765|capnography|capnography
404719|NCT01220765|sedation|sedation
404720|NCT01220752|IMRT|imrt
404721|NCT01220752|carbon ion therapy|carbon ion therapy
404722|NCT01220752|paranasal sinus|paranasal sinus
404723|NCT01220752|nasal cavity|nasal cavity
404724|NCT01220752|adenocarcinoma|adenocarcinoma
404725|NCT01220752|squamous cell carcinoma|squamous cell carcinoma
404726|NCT01220739|ischemic stroke|ischemic stroke
404727|NCT01220739|transcranial laser|transcranial laser
404728|NCT01220739|tissue plasminogen activator|tissue plasminogen activator
404729|NCT01220739|therapy|therapy
404730|NCT01220726|OAB|oab
404731|NCT01220713|Traumatic Brain Injury|traumatic brain injury
404732|NCT01220713|Veterans|veterans
404733|NCT01220713|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
404734|NCT01220713|OEF/OIF|oef/oif
404735|NCT01220713|Post-Concussive Symptoms|post-concussive symptoms
404736|NCT01220713|Blast Exposure|blast exposure
404737|NCT01220687|Prematurity|prematurity
404738|NCT01220687|Oxygen exposure|oxygen exposure
404739|NCT01220687|Nitric Oxide|nitric oxide
404740|NCT01220674|neuropsychological assessment|neuropsychological assessment
404741|NCT01220674|cognitive impairment|cognitive impairment
404742|NCT01220674|computer-aided diagnostic tool|computer-aided diagnostic tool
404743|NCT01220661|Colorectal Surgery|colorectal surgery
404744|NCT01220661|Surgical Wound Infection|surgical wound infection
404745|NCT01220661|Laparoscopy|laparoscopy
404746|NCT01220661|Anti-Bacterial Agents|anti-bacterial agents
404747|NCT01220648|Chronic myeloid leukemia|chronic myeloid leukemia
404748|NCT01220648|interferon alfa|interferon alfa
404749|NCT01220648|nilotinib|nilotinib
404750|NCT01220648|combination|combination
404751|NCT01220648|CML|cml
88631|NCT02733341|Index of microvascular resistance (IMR)|index of microvascular resistance (imr)
403792|NCT01224704|Obesity|obesity
404752|NCT01220648|Philadelphia chromosome positive (Ph+) chronic myeloid leukemia patients in chronic phase (CML-CP) after switch from previous CML treatment|philadelphia chromosome positive (ph+) chronic myeloid leukemia patients in chronic phase (cml-cp) after switch from previous cml treatment
404753|NCT01220635|Depressive Symptoms|depressive symptoms
404754|NCT01220635|Depression prevention|depression prevention
404755|NCT01220635|Adolescents|adolescents
404756|NCT01220635|School-Based Services|school-based services
404757|NCT01220635|Health Behavior|health behavior
404758|NCT01220622|Stroke|stroke
404759|NCT01220622|Mild cognitive impairment|mild cognitive impairment
404760|NCT01220622|Nimodipine|nimodipine
404761|NCT01220583|stage I salivary gland cancer|stage i salivary gland cancer
404762|NCT01220583|stage II salivary gland cancer|stage ii salivary gland cancer
404763|NCT01220583|stage III salivary gland cancer|stage iii salivary gland cancer
404764|NCT01220583|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
404765|NCT01220583|salivary gland adenocarcinoma|salivary gland adenocarcinoma
404766|NCT01220583|stage IVA salivary gland cancer|stage iva salivary gland cancer
404767|NCT01220583|stage IVB salivary gland cancer|stage ivb salivary gland cancer
404768|NCT01220583|stage IVC salivary gland cancer|stage ivc salivary gland cancer
404769|NCT01220570|breast cancer|breast cancer
404770|NCT01220570|ridaforolimus|ridaforolimus
404771|NCT01220570|ridaforolimus/dalotuzumab combination therapy|ridaforolimus/dalotuzumab combination therapy
404772|NCT01220557|Diabetes mellitus, education, self management|diabetes mellitus, education, self management
404773|NCT01220531|DiGeorge Anomaly|digeorge anomaly
404207|NCT01223170|Tailoring|tailoring
404774|NCT01220531|Thymus Transplantation|thymus transplantation
404775|NCT01220531|DiGeorge Syndrome|digeorge syndrome
404776|NCT01220531|Athymia|athymia
404777|NCT01220531|Low T cell numbers|low t cell numbers
404778|NCT01220531|Immunoreconstitution|immunoreconstitution
404779|NCT01220531|Immunodeficiency|immunodeficiency
404780|NCT01220531|Complete DiGeorge|complete digeorge
404781|NCT01220531|Typical DiGeorge|typical digeorge
404782|NCT01220531|Atypical DiGeorge|atypical digeorge
404783|NCT01220531|Complete DiGeorge Anomaly|complete digeorge anomaly
404784|NCT01220505|scoliosis|scoliosis
404785|NCT01220505|kyphosis|kyphosis
404786|NCT01220505|spinal deformity|spinal deformity
404787|NCT01220505|curvature|curvature
404788|NCT01220505|lordosis|lordosis
404789|NCT01220492|liver cirrhosis|liver cirrhosis
404790|NCT01220492|mesenchymal stem cells|mesenchymal stem cells
404791|NCT01220492|ascites|ascites
404792|NCT01220492|serum albumin|serum albumin
404793|NCT01220479|Type 1 Diabetes, Bone mineral density, Growth|type 1 diabetes, bone mineral density, growth
404794|NCT01220479|Cardiovascular diseases, Exercise, Training,|cardiovascular diseases, exercise, training,
404795|NCT01220479|Child, Adolescent|child, adolescent
404796|NCT01220440|ADHD|adhd
404797|NCT01220440|Children|children
404798|NCT01220440|Methylphenidate|methylphenidate
404799|NCT01220440|Dextroamphetamine|dextroamphetamine
404800|NCT01220440|Placebo|placebo
404801|NCT01220440|Crossover|crossover
404802|NCT01220440|Double Blind|double blind
404803|NCT01220440|Neuropsychological tests|neuropsychological tests
404804|NCT01220440|Behavioural Questionnaires|behavioural questionnaires
404805|NCT01220427|high-risk prostate cancer|high-risk prostate cancer
404806|NCT01220427|radical prostatectomy|radical prostatectomy
404807|NCT01220427|micro-RNA|micro-rna
404808|NCT01220401|Nightmare|nightmare
404809|NCT01220401|PTSD|ptsd
404810|NCT01220401|Posttraumatic stress disorder|posttraumatic stress disorder
404811|NCT01220401|Suicide|suicide
404812|NCT01220401|Exposure Relaxation Rescription Therapy|exposure relaxation rescription therapy
404813|NCT01220401|Sleep|sleep
404814|NCT01220388|Aldosterone|aldosterone
404815|NCT01220388|L-lysine|l-lysine
404816|NCT01220388|Cortisol|cortisol
404817|NCT01220388|Adrenal glands|adrenal glands
404818|NCT01220375|Mobilization of autologous peripheral blood progenitor cells PBPC|mobilization of autologous peripheral blood progenitor cells pbpc
404819|NCT01220375|Autologous stem cell mobilization|autologous stem cell mobilization
404820|NCT01220375|Multiple Myeloma|multiple myeloma
404821|NCT01220375|Plerixafor|plerixafor
404822|NCT01220362|Analgesia, Epidural|analgesia, epidural
404823|NCT01220362|Urodynamics|urodynamics
404824|NCT01220362|Urinary Retention|urinary retention
404825|NCT01220284|solid tumors|solid tumors
404826|NCT01220284|oral treatment|oral treatment
404827|NCT01220284|platinum compound|platinum compound
404828|NCT01220284|vinca alkaloid|vinca alkaloid
404829|NCT01220284|drug combination|drug combination
404830|NCT01220271|Glioma|glioma
404831|NCT01220271|Glioblastoma|glioblastoma
404832|NCT01220245|endoluminal|endoluminal
404833|NCT01220245|surgical|surgical
404834|NCT01220245|bypass|bypass
404835|NCT01220245|patency|patency
404836|NCT01220245|quality of life|quality of life
404837|NCT01220245|multicentre|multicentre
404838|NCT01220245|RCT|rct
404839|NCT01220245|superficial femoral artery|superficial femoral artery
404840|NCT01220245|vascular patency|vascular patency
404841|NCT01220232|Lersivirine|lersivirine
404842|NCT01220232|UK-453|uk-453
404843|NCT01220232|061|061
404844|NCT01220232|NNRTI|nnrti
404845|NCT01220232|Abacavir|abacavir
404846|NCT01220232|Lamivudine|lamivudine
404847|NCT01220232|Combivir|combivir
404848|NCT01220232|Pharmacokinetics|pharmacokinetics
404849|NCT01220232|Drug Interaction|drug interaction
404850|NCT01220232|HIV|hiv
404851|NCT01220232|AIDS|aids
404852|NCT01220219|pregabalin|pregabalin
404853|NCT01220219|pharmacokinetics|pharmacokinetics
404854|NCT01220219|bioavailability|bioavailability
404855|NCT01220219|bioequivalence|bioequivalence
404856|NCT01220206|ED|ed
404857|NCT01220206|POMx|pomx
404858|NCT01220206|Pomegranate|pomegranate
404859|NCT01220206|Erectile dysfunction|erectile dysfunction
404860|NCT01220180|epilepsy|epilepsy
404861|NCT01220180|neuropathic pain|neuropathic pain
404862|NCT01220180|fibromyalgia|fibromyalgia
404863|NCT01220180|post-market surveillance|post-market surveillance
404864|NCT01220180|prospective observational|prospective observational
404865|NCT01220154|ovarian|ovarian
404866|NCT01220154|cancer|cancer
404867|NCT01220154|fallopian tube|fallopian tube
404868|NCT01220154|peritoneal|peritoneal
404869|NCT01220154|intraperitoneal|intraperitoneal
404870|NCT01220154|bevacizumab|bevacizumab
404871|NCT01220154|carboplatin|carboplatin
404872|NCT01220154|paclitaxel|paclitaxel
404873|NCT01220154|chemo-naive|chemo-naive
404874|NCT01220128|WT1|wt1
404875|NCT01220128|neoadjuvant|neoadjuvant
404876|NCT01220128|tumor antigen|tumor antigen
404877|NCT01220128|immunotherapy|immunotherapy
404878|NCT01220128|breast cancer|breast cancer
404880|NCT01220115|sickle cell disease|sickle cell disease
404881|NCT01220115|iron over load|iron over load
404882|NCT01220102|acne|acne
404883|NCT01220102|Epiduo|epiduo
404884|NCT01220102|adapalene/ benzoyl peroxide|adapalene/ benzoyl peroxide
404885|NCT01220089|obesity|obesity
404886|NCT01220089|weight loss|weight loss
404887|NCT01220076|Tamoxifen,|tamoxifen,
404888|NCT01220076|Breat Cancer|breat cancer
404889|NCT01220076|Pharmacogenetic|pharmacogenetic
404890|NCT01220076|non metastatic breast cancer, HR +|non metastatic breast cancer, hr +
404891|NCT01220063|RSHF|rshf
404892|NCT01220063|Irinotecan|irinotecan
404893|NCT01220063|Colorectal Cancer|colorectal cancer
404894|NCT01220063|metastases|metastases
404895|NCT01220050|Paricalcitol|paricalcitol
404896|NCT01220050|Renal transplant|renal transplant
404897|NCT01220050|Secondary Hyperparathyroidism|secondary hyperparathyroidism
404898|NCT01220011|Fetoscopic Laser surgery|fetoscopic laser surgery
404899|NCT01220011|Stage 1 Twin - twin transfusion syndrome|stage 1 twin - twin transfusion syndrome
404900|NCT01219998|Postoperative Complications|postoperative complications
404901|NCT01219998|Acute Kidney Failure|acute kidney failure
404902|NCT01219998|Peritoneal Dialysis|peritoneal dialysis
404904|NCT01219985|positron emission tomography / computed tomography|positron emission tomography / computed tomography
404905|NCT01219985|18F-fluoro-2-deoxyglucose|18f-fluoro-2-deoxyglucose
404906|NCT01219985|liver neoplasm|liver neoplasm
404907|NCT01219985|respiratory motion|respiratory motion
404908|NCT01219972|Bone marrow transplant|bone marrow transplant
404909|NCT01219972|Pulmonary complications|pulmonary complications
404910|NCT01219959|ESRD|esrd
404911|NCT01219959|Diabetes|diabetes
404912|NCT01219959|CAPD|capd
404913|NCT01219946|Chronic Obstructive Pulmonary Disease, symptoms|chronic obstructive pulmonary disease, symptoms
404914|NCT01219920|Metastatic colorectal cancer|metastatic colorectal cancer
404915|NCT01219920|Phase III|phase iii
404916|NCT01219920|FOLFOXIRI|folfoxiri
404917|NCT01219920|FOLFIRI|folfiri
404918|NCT01219894|Coronary Disease|coronary disease
404919|NCT01219894|Stent|stent
404920|NCT01219894|Healing|healing
404921|NCT01219894|Anti-platelet therapy|anti-platelet therapy
404922|NCT01219881|desflurane|desflurane
404923|NCT01219881|sevoflurane|sevoflurane
404924|NCT01219855|Parathyroid Diseases|parathyroid diseases
404925|NCT01219855|Renal Insufficiency|renal insufficiency
404926|NCT01219855|Kidney Failure, Chronic|kidney failure, chronic
404927|NCT01219855|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
404928|NCT01219855|Vitamin D|vitamin d
404929|NCT01219855|Hyperparathyroidism|hyperparathyroidism
404930|NCT01219855|Kidney Diseases|kidney diseases
404931|NCT01219855|Kidney Failure|kidney failure
404932|NCT01219855|Renal Insufficiency, Chronic|renal insufficiency, chronic
404933|NCT01219842|Intermittent claudication|intermittent claudication
404934|NCT01219842|Health Related Quality of Life|health related quality of life
404935|NCT01219842|Walking performance|walking performance
404936|NCT01219842|Daily walking capacity|daily walking capacity
404937|NCT01219829|Pancreatic intraepithelial neoplasia (PanIN)|pancreatic intraepithelial neoplasia (panin)
404938|NCT01219829|Pancreatic Cancer|pancreatic cancer
404939|NCT01219829|Recurrence of pancreatic cancer|recurrence of pancreatic cancer
404940|NCT01219829|Field Effect|field effect
404941|NCT01219829|Genetic mutations in pancreatic cancer|genetic mutations in pancreatic cancer
404942|NCT01219816|efficacy of Chemo-immunotherapy|efficacy of chemo-immunotherapy
404943|NCT01219803|Dose-Response Relationship, type 2 diabetes,TCM|dose-response relationship, type 2 diabetes,tcm
404944|NCT01219790|Patients with painful vertebral metastases with a prostate cancer with an indication of analgesic treatment.|patients with painful vertebral metastases with a prostate cancer with an indication of analgesic treatment.
404945|NCT01219777|bevacizumab|bevacizumab
404946|NCT01219777|paclitaxel|paclitaxel
404947|NCT01219777|carboplatin|carboplatin
404948|NCT01219777|ovarian|ovarian
404949|NCT01219777|cancer|cancer
404950|NCT01219777|fallopian tube|fallopian tube
404951|NCT01219777|primary peritoneal|primary peritoneal
404952|NCT01219764|Helicobacter pylori infection|helicobacter pylori infection
404953|NCT01219764|quadruple therapy|quadruple therapy
404954|NCT01219764|Amoxicillin|amoxicillin
404955|NCT01219764|Metronidazole|metronidazole
404956|NCT01219764|Clarithromycin|clarithromycin
404957|NCT01219764|Rabeprazole|rabeprazole
404958|NCT01219738|Asthma, airway blood flow, budesonide, glucocorticosteroid.|asthma, airway blood flow, budesonide, glucocorticosteroid.
404959|NCT01219725|Body composition|body composition
404960|NCT01219725|Endothelial function|endothelial function
404961|NCT01219725|Lipoprotein profile|lipoprotein profile
404962|NCT01219725|Inflammatory markers|inflammatory markers
404963|NCT01219725|Aerobic capacity|aerobic capacity
404964|NCT01219725|Thrombotic markers|thrombotic markers
404965|NCT01219725|Arterial stiffness|arterial stiffness
404966|NCT01219725|Cardiac function|cardiac function
404967|NCT01219725|Traditional and emerging cardiovascular disease risk factors|traditional and emerging cardiovascular disease risk factors
404968|NCT01219712|NT-proBNP|nt-probnp
404969|NCT01219712|non-cardiac surgery|non-cardiac surgery
404970|NCT01219712|left ventricular dysfunction|left ventricular dysfunction
404971|NCT01219712|cardiac complications|cardiac complications
404972|NCT01219699|advanced solid tumors|advanced solid tumors
404973|NCT01219699|mutation|mutation
404974|NCT01219699|amplification|amplification
404975|NCT01219699|wild type|wild type
404976|NCT01219699|PIK3CA gene|pik3ca gene
404977|NCT01219699|dose-escalation|dose-escalation
404978|NCT01219699|estrogen receptor positive breast cancer|estrogen receptor positive breast cancer
404979|NCT01219686|unipolar depression, escitalopram, pindolol|unipolar depression, escitalopram, pindolol
404980|NCT01219673|Epithelial carcinoma|epithelial carcinoma
404981|NCT01219673|Oropharynx|oropharynx
404982|NCT01219673|Larynx|larynx
404983|NCT01219673|Symptom-management|symptom-management
404984|NCT01219673|Chemoradiation|chemoradiation
404985|NCT01219673|Placebo|placebo
404986|NCT01219673|Armodafinil|armodafinil
404987|NCT01219673|Nuvigil|nuvigil
404988|NCT01219673|Bupropion|bupropion
404989|NCT01219673|Wellbutrin|wellbutrin
404990|NCT01219673|Wellbutrin SR|wellbutrin sr
404991|NCT01219673|Zyban|zyban
404992|NCT01219673|Minocycline|minocycline
404993|NCT01219673|Dynacin|dynacin
404994|NCT01219673|Minocin|minocin
404995|NCT01219673|Minocin PAC|minocin pac
404996|NCT01219673|Myrac|myrac
404997|NCT01219673|Solodyn|solodyn
404998|NCT01219660|sleep|sleep
404999|NCT01219660|apnea|apnea
405000|NCT01219647|Multiple Sclerosis|multiple sclerosis
405001|NCT01219647|Exercise|exercise
405002|NCT01219647|Cognition|cognition
405003|NCT01219621|Symphony DR 2550,|symphony dr 2550,
405004|NCT01219621|Dual Chamber Pacemaker,|dual chamber pacemaker,
405005|NCT01219621|Sorin,|sorin,
405006|NCT01219621|Ela Medical,|ela medical,
405007|NCT01219621|DDD Mode,|ddd mode,
405008|NCT01219621|AAIsafeR2 mode,|aaisafer2 mode,
405009|NCT01219621|AV-Conduction,|av-conduction,
405010|NCT01219621|Reducing Ventricular Pacing,|reducing ventricular pacing,
405011|NCT01219621|Congestive Heart Failure,|congestive heart failure,
405012|NCT01219621|Cardiac Function,|cardiac function,
405013|NCT01219621|Atrial Arrhythmia,|atrial arrhythmia,
405014|NCT01219621|Atrial Fibrillation,|atrial fibrillation,
405015|NCT01219621|Atrial and Ventricular Hemodynamics,|atrial and ventricular hemodynamics,
405016|NCT01219621|Long AV-delays.|long av-delays.
405017|NCT01219621|Ventricular Function,|ventricular function,
405018|NCT01219621|Implantation,|implantation,
405019|NCT01219595|Urinary Tract Infection|urinary tract infection
405021|NCT01219582|Diabetes Mellitus Type-2|diabetes mellitus type-2
405022|NCT01219582|Acarbose|acarbose
405023|NCT01219582|Metformin|metformin
405024|NCT01219582|Drug Therapy, Combination|drug therapy, combination
405025|NCT01219569|blindness|blindness
405026|NCT01219569|ischemic optic neuropathy|ischemic optic neuropathy
405027|NCT01219556|Hypertension|hypertension
405028|NCT01219556|Antihypertensive Agents|antihypertensive agents
405029|NCT01219556|Drug Therapy, Combination|drug therapy, combination
405030|NCT01219556|Olmesartan Medoxomil|olmesartan medoxomil
405031|NCT01219556|Hydrochlorothiazide|hydrochlorothiazide
405032|NCT01219543|Advanced solid malignancies|advanced solid malignancies
405033|NCT01219543|Child-Pugh A to B7 advanced hepatocellular carcinoma|child-pugh a to b7 advanced hepatocellular carcinoma
405034|NCT01219543|EGFR and/or ROS mutant NSCLC|egfr and/or ros mutant nsclc
405035|NCT01219543|Non-smokers with lung metastasis|non-smokers with lung metastasis
405036|NCT01219543|Gastric cancer|gastric cancer
405037|NCT01219543|Solid tumour|solid tumour
405038|NCT01219543|AZD1480|azd1480
405039|NCT01219543|JAK1/JAK2 kinase inhibitor|jak1/jak2 kinase inhibitor
405040|NCT01219530|gestational carrier|gestational carrier
405041|NCT01219530|intended parent|intended parent
405043|NCT01219517|embryo biopsy|embryo biopsy
405044|NCT01219517|DNA fingerprinting|dna fingerprinting
405045|NCT01219517|SNP|snp
405046|NCT01219504|PGD|pgd
405047|NCT01219504|IVF|ivf
405048|NCT01219491|egg donor|egg donor
405049|NCT01219491|recipients|recipients
405050|NCT01219491|donor characteristics|donor characteristics
405150|NCT01219023|chemotherapy|chemotherapy
405051|NCT01219478|To investigate the relationship between retinal thickness (RT) and metabolic risks (MRs) in patients without retinal lesion|to investigate the relationship between retinal thickness (rt) and metabolic risks (mrs) in patients without retinal lesion
405052|NCT01219465|Diabetes Mellitus|diabetes mellitus
405053|NCT01219465|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
405054|NCT01219465|mesenchymal stem cells|mesenchymal stem cells
405055|NCT01219465|Umbilical cord|umbilical cord
405056|NCT01219452|Dilated Cardiomyopathy|dilated cardiomyopathy
405057|NCT01219452|Umbilical cord|umbilical cord
405058|NCT01219452|Mesenchymal stem cells|mesenchymal stem cells
405059|NCT01219452|Children|children
405060|NCT01219439|discarded pathological specimens|discarded pathological specimens
405061|NCT01219439|discarded media|discarded media
405062|NCT01219439|IVF|ivf
405063|NCT01219426|Gambling|gambling
405064|NCT01219426|cognitive distortions|cognitive distortions
405065|NCT01219426|assessment tool|assessment tool
405066|NCT01219426|validation|validation
405067|NCT01219426|French|french
405068|NCT01219413|aliskiren|aliskiren
405069|NCT01219413|renin inhibitor|renin inhibitor
405070|NCT01219413|proteinuria|proteinuria
405071|NCT01219413|chronic kidney diseases|chronic kidney diseases
405072|NCT01219413|ACE inhibitor|ace inhibitor
405073|NCT01219400|DPP-4|dpp-4
405074|NCT01219400|GLP-1|glp-1
405075|NCT01219400|Glucagon|glucagon
405076|NCT01219400|Catecholamines|catecholamines
405077|NCT01219400|Counterregulation|counterregulation
405078|NCT01219400|Insulin-treatment|insulin-treatment
405079|NCT01219400|Type 2 diabetes|type 2 diabetes
405080|NCT01219387|AMH|amh
405081|NCT01219387|inhibin B|inhibin b
405082|NCT01219387|infertility|infertility
405083|NCT01219374|egg donor|egg donor
405084|NCT01219361|Donated embryos|donated embryos
405085|NCT01219348|IDO enzyme|ido enzyme
405086|NCT01219348|Vaccination trial|vaccination trial
405087|NCT01219348|Immunotherapy|immunotherapy
405088|NCT01219348|NSCLC, stage III_IV|nsclc, stage iii_iv
405089|NCT01219348|Indeolamine 2,3 dioxygenase = IDO|indeolamine 2,3 dioxygenase = ido
405090|NCT01219335|IVF|ivf
405091|NCT01219322|general endotracheal anesthesia|general endotracheal anesthesia
405092|NCT01219322|ASA I or II|asa i or ii
405093|NCT01219309|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
405094|NCT01219309|Omega 3/6 fatty acids|omega 3/6 fatty acids
405095|NCT01219309|Developmental coordination disorder|developmental coordination disorder
405096|NCT01219309|Reading/writing difficulties.|reading/writing difficulties.
405097|NCT01219296|infertility|infertility
405098|NCT01219296|IVF|ivf
405099|NCT01219283|PGD|pgd
405100|NCT01219283|IVF|ivf
405101|NCT01219270|Radiocontrast media,|radiocontrast media,
405102|NCT01219270|hyponatremia|hyponatremia
405103|NCT01219257|SpA|spa
405104|NCT01219257|Anti-TNF alpha treatment|anti-tnf alpha treatment
405105|NCT01219257|Ultrasonography|ultrasonography
405106|NCT01219257|Synovitis|synovitis
405107|NCT01219257|Enthesitis|enthesitis
405108|NCT01219244|memory|memory
405109|NCT01219244|diet|diet
405110|NCT01219244|elderly|elderly
405111|NCT01219244|cognition|cognition
405112|NCT01219244|prevention|prevention
405113|NCT01219244|lifestyle|lifestyle
405114|NCT01219231|Exercise|exercise
405115|NCT01219231|elderly|elderly
405116|NCT01219231|cognition|cognition
405117|NCT01219231|prevention|prevention
405118|NCT01219231|cognitive decline|cognitive decline
405119|NCT01219231|Lifestyle|lifestyle
405120|NCT01219218|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
405121|NCT01219218|Myocardial Ischemia|myocardial ischemia
405122|NCT01219218|Refractory Angina|refractory angina
405123|NCT01219205|macular edema secondary to retinal benous occlusion|macular edema secondary to retinal benous occlusion
405124|NCT01219179|Extremely Low Birth Weight Infants|extremely low birth weight infants
405125|NCT01219179|Hypernatremia|hypernatremia
405126|NCT01219179|Enteral Sterile Water Feeds|enteral sterile water feeds
405127|NCT01219153|Letrozole ,IVF, poor responders , GnRH antagonist|letrozole ,ivf, poor responders , gnrh antagonist
405128|NCT01219140|POMx|pomx
405129|NCT01219140|Osteopenia|osteopenia
405130|NCT01219140|postmenopausal women|postmenopausal women
405131|NCT01219140|Pomegranate|pomegranate
405132|NCT01219127|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
405133|NCT01219114|Daptomycin|daptomycin
405134|NCT01219114|endocarditis|endocarditis
405135|NCT01219114|complicated skin and skin structure infection|complicated skin and skin structure infection
405136|NCT01219101|Ethinyl estradiol|ethinyl estradiol
405137|NCT01219101|Polycystic ovary syndrome|polycystic ovary syndrome
405138|NCT01219101|Intrauterine insemination|intrauterine insemination
405139|NCT01219049|Diet|diet
405140|NCT01219049|Fibromyalgia|fibromyalgia
405141|NCT01219049|Pain|pain
405142|NCT01219049|Drug|drug
405143|NCT01219049|Amino-acid|amino-acid
405144|NCT01219049|Fatigue|fatigue
405145|NCT01219036|Asthma|asthma
405146|NCT01219036|Non-adherence|non-adherence
405147|NCT01219036|Fractional exhaled nitric oxide|fractional exhaled nitric oxide
405148|NCT01219023|Hand foot syndrome|hand foot syndrome
405149|NCT01219023|Palmar Plantar Erythrodysesthesia|palmar plantar erythrodysesthesia
405152|NCT01219023|Capecitebine|capecitebine
405153|NCT01219023|Sildenafil|sildenafil
584351|NCT00515489|Schizophreniform Disorders|schizophreniform disorders
405154|NCT01219010|Monoclonal Gammopathy of Undetermined Significance|monoclonal gammopathy of undetermined significance
405155|NCT01219010|Smoldering Multiple Myeloma|smoldering multiple myeloma
405156|NCT01219010|Indolent Multiple Myeloma|indolent multiple myeloma
405158|NCT01219010|Siltuximab|siltuximab
405159|NCT01219010|CNTO 328|cnto 328
405160|NCT01219010|IL-6|il-6
405161|NCT01219010|Monoclonal Antibody|monoclonal antibody
405162|NCT01218997|Alcoholism|alcoholism
405163|NCT01218997|Alcohol dependence|alcohol dependence
405164|NCT01218984|Opiate Dependence|opiate dependence
405165|NCT01218971|Alcohol Dependence|alcohol dependence
405166|NCT01218958|Alcoholism|alcoholism
405167|NCT01218932|primaquine|primaquine
405168|NCT01218932|chloroquine|chloroquine
405169|NCT01218932|pharmacokinetic|pharmacokinetic
405170|NCT01218932|interactions|interactions
405171|NCT01218906|Dengue Fever Fever Dengue Infection|dengue fever fever dengue infection
405172|NCT01218867|Clinical Response|clinical response
405174|NCT01218867|Immunotherapy|immunotherapy
405175|NCT01218867|Adoptive Cell Therapy|adoptive cell therapy
405176|NCT01218867|Metastatic Melanoma|metastatic melanoma
405177|NCT01218854|Biopsy|biopsy
405178|NCT01218854|Surgical Navigation|surgical navigation
405179|NCT01218854|Image-guided Therapy|image-guided therapy
405180|NCT01218854|CT- Guided Biopsy|ct- guided biopsy
405181|NCT01218854|Cancer|cancer
405182|NCT01218841|Fish oil|fish oil
405183|NCT01218841|Omega-3 fatty acids|omega-3 fatty acids
405184|NCT01218841|Parenteral lipid emulsions|parenteral lipid emulsions
405185|NCT01218841|Immune response|immune response
405186|NCT01218841|Surgery|surgery
405187|NCT01218828|Contrast|contrast
405188|NCT01218828|nephropathy|nephropathy
405189|NCT01218828|cardiac catheterization|cardiac catheterization
405190|NCT01218828|angiography|angiography
405191|NCT01218828|percutaneous coronary intervention is|percutaneous coronary intervention is
405192|NCT01218802|HIV|hiv
405193|NCT01218802|Heart Disease|heart disease
405194|NCT01218802|Bone Density|bone density
405195|NCT01218789|Blindness|blindness
405196|NCT01218789|Eye Diseases|eye diseases
405197|NCT01218789|Nap Disorders|nap disorders
405198|NCT01218789|Circadian Rhythm Disorders|circadian rhythm disorders
405199|NCT01218789|Sleep disorders|sleep disorders
405200|NCT01218789|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
405201|NCT01218789|Dyssomnias|dyssomnias
405202|NCT01218789|Nervous System Diseases|nervous system diseases
405203|NCT01218776|Acute Coronary Syndrome, Eastern Europe, Therapies|acute coronary syndrome, eastern europe, therapies
405204|NCT01218763|Cardiac Event recorder|cardiac event recorder
405205|NCT01218763|Sensitivity|sensitivity
405206|NCT01218763|Efficacy|efficacy
405207|NCT01218750|DDME, ppV, ILM peeling, bevacizumab injection|ddme, ppv, ilm peeling, bevacizumab injection
405208|NCT01218685|Immunocompromised patients|immunocompromised patients
405209|NCT01218685|Safety of pandemic influenza A (H1N1)vaccine|safety of pandemic influenza a (h1n1)vaccine
405210|NCT01218685|Immunogenicity of pandemic influenza A (H1N1)vaccine|immunogenicity of pandemic influenza a (h1n1)vaccine
405212|NCT01218672|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
405213|NCT01218659|Fabry Disease|fabry disease
405214|NCT01218646|Influenza|influenza
405215|NCT01218646|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
405216|NCT01218646|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
405217|NCT01218646|Influenza viruses|influenza viruses
405218|NCT01218607|Heart Septal Defects, Atrial|heart septal defects, atrial
405219|NCT01218607|Pulmonary Circulation|pulmonary circulation
405220|NCT01218607|Ventricular Function, Right|ventricular function, right
405221|NCT01218607|Echocardiography, Stress|echocardiography, stress
405222|NCT01218607|Ergometry|ergometry
405223|NCT01218607|Tissue Doppler Imaging|tissue doppler imaging
405224|NCT01218594|Stage III|stage iii
405225|NCT01218594|Unresectable|unresectable
405226|NCT01218594|Non-small cell lung cancer|non-small cell lung cancer
405227|NCT01218581|Adenomyosis, letrozole, GnRH-a|adenomyosis, letrozole, gnrh-a
405228|NCT01218555|kidney cancer|kidney cancer
405229|NCT01218555|adenoidcystic cancer|adenoidcystic cancer
405230|NCT01218542|Secondary brain malignancies|secondary brain malignancies
405231|NCT01218542|RapidArc|rapidarc
405232|NCT01218542|Volumetric modulated arc therapy|volumetric modulated arc therapy
405233|NCT01218529|Brain metastases from lung and breast tumors|brain metastases from lung and breast tumors
405234|NCT01218490|surgery|surgery
405235|NCT01218490|ovarian cancer|ovarian cancer
405236|NCT01218490|lymphadectomy|lymphadectomy
405237|NCT01218477|Leukemia|leukemia
405238|NCT01218477|(Chronic Myeloid Leukemia-Chronic Phase and Advanced)|(chronic myeloid leukemia-chronic phase and advanced)
405239|NCT01218464|Liver Failure|liver failure
405240|NCT01218464|Mesenchymal Stem Cells|mesenchymal stem cells
405241|NCT01218464|Model for End-Stage Liver Disease|model for end-stage liver disease
405242|NCT01218464|Ascite|ascite
405243|NCT01218464|Serum Albumin|serum albumin
405244|NCT01218425|dopamine|dopamine
405245|NCT01218425|EEG|eeg
405246|NCT01218425|episodic memory|episodic memory
405247|NCT01218425|contingent negative variation|contingent negative variation
405248|NCT01218425|response preparation|response preparation
405249|NCT01218425|levodopa|levodopa
405250|NCT01218425|methylphenidate|methylphenidate
405251|NCT01218412|Physical Activity|physical activity
405252|NCT01218412|Motivational Interviewing|motivational interviewing
405253|NCT01218412|Web-based|web-based
405254|NCT01218412|Physician Referral|physician referral
405255|NCT01218399|Asthma|asthma
405256|NCT01218386|ICSI|icsi
405257|NCT01218386|GnRH antagonists|gnrh antagonists
405258|NCT01218386|planning|planning
405259|NCT01218373|older people|older people
405260|NCT01218373|living independently at home|living independently at home
405261|NCT01218360|Crohn's disease|crohn's disease
405262|NCT01218360|standard-of-care|standard-of-care
405263|NCT01218360|Crohn Disease|crohn disease
405264|NCT01218360|Active Crohn's Disease|active crohn's disease
405265|NCT01218347|OATP1B1|oatp1b1
405266|NCT01218347|rosuvastatin|rosuvastatin
405267|NCT01218321|antiepileptic drugs|antiepileptic drugs
405268|NCT01218321|mitochondria|mitochondria
405270|NCT01218295|COPD|copd
405271|NCT01218295|inspiratory muscles training|inspiratory muscles training
405272|NCT01218282|COPD|copd
405273|NCT01218282|home exercise training|home exercise training
405274|NCT01218269|anastomoses|anastomoses
405275|NCT01218256|diabetes mellitus|diabetes mellitus
405276|NCT01218256|type 2 diabetes|type 2 diabetes
405277|NCT01218256|T2DM|t2dm
405278|NCT01218256|resistance training|resistance training
405279|NCT01218256|hypertrophy training|hypertrophy training
405280|NCT01218256|endurance training|endurance training
405281|NCT01218243|Acupuncture|acupuncture
405282|NCT01218243|Mild and moderate BPH|mild and moderate bph
405283|NCT01218230|Pegaptanib, myopic CNVM, intravitreal anti-VEGF|pegaptanib, myopic cnvm, intravitreal anti-vegf
405284|NCT01218217|TB|tb
405285|NCT01218217|Tuberculosis|tuberculosis
405286|NCT01218217|EBA|eba
405287|NCT01218217|Pulmonary|pulmonary
405288|NCT01218217|Early Bactericidal Activity|early bactericidal activity
405289|NCT01218204|Dyslipidemia|dyslipidemia
405290|NCT01218204|Tolerability|tolerability
405291|NCT01218204|Safety|safety
405292|NCT01218204|Ezetimibe|ezetimibe
405293|NCT01218204|Pharmacokinetics|pharmacokinetics
405294|NCT01218204|Lipids|lipids
405295|NCT01218204|Statin|statin
405296|NCT01218204|Atorvastatin|atorvastatin
405297|NCT01218204|Pharmacodynamics|pharmacodynamics
405298|NCT01218204|GSK1292263|gsk1292263
405299|NCT01218191|subarachnoid hemorrhage|subarachnoid hemorrhage
405300|NCT01218191|scintigraphy|scintigraphy
405301|NCT01218191|neurocardiogenic injury|neurocardiogenic injury
405302|NCT01218178|acute myocardial infarction|acute myocardial infarction
405303|NCT01218178|acute kidney injury|acute kidney injury
405304|NCT01218178|contrast induced nephropathy|contrast induced nephropathy
405305|NCT01218178|primary PCI|primary pci
405306|NCT01218178|sodium-bicarbonate|sodium-bicarbonate
405307|NCT01218178|N-acetylcysteine|n-acetylcysteine
405308|NCT01218165|Healthy Eldery People|healthy eldery people
405309|NCT01218152|NF1|nf1
405310|NCT01218152|MPNST|mpnst
405311|NCT01218152|plasma|plasma
405312|NCT01218152|microarray CGH|microarray cgh
405313|NCT01218139|neurofibroma|neurofibroma
405314|NCT01218139|MPNST|mpnst
405315|NCT01218139|array CGH|array cgh
405316|NCT01218139|sequencing|sequencing
405317|NCT01218113|Human Immunodeficiency Virus (HIV)-1|human immunodeficiency virus (hiv)-1
405318|NCT01218113|safety|safety
405319|NCT01218113|vaccine|vaccine
405320|NCT01218113|immunogenicity|immunogenicity
405321|NCT01218113|reactogenicity|reactogenicity
405322|NCT01218113|HIV infection|hiv infection
405323|NCT01218087|Positional Head Shape Deformity|positional head shape deformity
405324|NCT01218074|bleeding|bleeding
405325|NCT01218074|blood sparing procedure|blood sparing procedure
405326|NCT01218074|desmopressin|desmopressin
405327|NCT01218074|aggregometry|aggregometry
405328|NCT01218074|thromboelastography|thromboelastography
405329|NCT01218061|Pre-diabetes|pre-diabetes
405330|NCT01218061|Type 2 diabetes|type 2 diabetes
405331|NCT01218061|Biomarkers|biomarkers
405332|NCT01218061|Cohort|cohort
405333|NCT01218061|Diabetes Risk Score|diabetes risk score
405334|NCT01218048|Carcinoma|carcinoma
405335|NCT01218048|Head and Neck|head and neck
405336|NCT01218048|Cetuximab|cetuximab
405337|NCT01218048|Locally Advanced Head and Neck Squamous Cell Carcinoma|locally advanced head and neck squamous cell carcinoma
405338|NCT01218035|Hip osteoarthritis|hip osteoarthritis
405339|NCT01218035|Bisphophonate therapy|bisphophonate therapy
405340|NCT01218035|Zoledronic acid|zoledronic acid
405341|NCT01218035|Radiostereometric analysis|radiostereometric analysis
405342|NCT01218035|Osteoporosis|osteoporosis
405343|NCT01218009|asthma|asthma
405344|NCT01218009|dry powder inhaler|dry powder inhaler
405345|NCT01218009|short-acting beta2-agonist|short-acting beta2-agonist
405346|NCT01218009|SABA|saba
746880|NCT01143948|Insulin|insulin
405347|NCT01218009|bronchoconstriction|bronchoconstriction
405348|NCT01218009|bronchodilation|bronchodilation
405349|NCT01218009|bronchodilator|bronchodilator
405350|NCT01218009|metered dose inhaler|metered dose inhaler
405351|NCT01217996|working memory intervention|working memory intervention
405352|NCT01217996|memory impairment|memory impairment
405353|NCT01217996|cognitive late effects|cognitive late effects
405354|NCT01217996|Childhood Cancer Survivors|childhood cancer survivors
405355|NCT01217970|methamphetamine|methamphetamine
405356|NCT01217970|dependence|dependence
405357|NCT01217970|stimulant|stimulant
405358|NCT01217970|amphetamine|amphetamine
405359|NCT01217970|los angeles|los angeles
405360|NCT01217970|meth|meth
405361|NCT01217970|speed|speed
405362|NCT01217970|crank|crank
405363|NCT01217970|abuse|abuse
405364|NCT01217957|Drug therapy|drug therapy
405365|NCT01217944|Pathologic myopia|pathologic myopia
405366|NCT01217944|PM|pm
405367|NCT01217944|choroidal neovascularization|choroidal neovascularization
405368|NCT01217944|CNV|cnv
405369|NCT01217944|ranibizumab|ranibizumab
405371|NCT01217931|Renal Cell Carcinoma|renal cell carcinoma
405372|NCT01217931|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
405373|NCT01217931|Clear cell component|clear cell component
405374|NCT01217931|RCC|rcc
405375|NCT01217931|Bevacizumab|bevacizumab
405376|NCT01217931|Everolimus|everolimus
405377|NCT01217931|Pazopanib|pazopanib
405378|NCT01217931|GW786034|gw786034
405379|NCT01217931|Avastin|avastin
405380|NCT01217931|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
405381|NCT01217931|rhuMAb-VEGF|rhumab-vegf
405382|NCT01217931|Afinitor|afinitor
405383|NCT01217931|RAD001|rad001
405384|NCT01217918|PH-797804|ph-797804
405385|NCT01217918|Japanese|japanese
405386|NCT01217918|Phase 1|phase 1
405387|NCT01217918|multiple dose study|multiple dose study
405388|NCT01217905|Phase 1|phase 1
405389|NCT01217905|Type 2 diabetes|type 2 diabetes
405390|NCT01217905|obesity|obesity
405391|NCT01217905|Japanese healthy volunteer|japanese healthy volunteer
405392|NCT01217905|AZD7687|azd7687
405393|NCT01217892|Type 2 diabetes|type 2 diabetes
405394|NCT01217892|metformin treated|metformin treated
405395|NCT01217892|inadequate control|inadequate control
405396|NCT01217892|metformin treatment alone|metformin treatment alone
405397|NCT01217879|Cough|cough
405398|NCT01217879|Telmisartan|telmisartan
405399|NCT01217879|Bradykinin|bradykinin
405400|NCT01217879|Tolerability|tolerability
405401|NCT01217866|laparoscopic|laparoscopic
405402|NCT01217866|vaginal|vaginal
405403|NCT01217866|hysterectomy|hysterectomy
405404|NCT01217840|Adolescents, Vitamin D|adolescents, vitamin d
405405|NCT01217788|Generalized Social Phobia|generalized social phobia
405406|NCT01217788|Social Anxiety Disorder|social anxiety disorder
405407|NCT01217788|Social Phobia|social phobia
405408|NCT01217788|Phobic Disorders|phobic disorders
405409|NCT01217788|Phobias|phobias
405410|NCT01217775|PMDD, Premenstrual, Dysphoria, Mood Swings, Bloating.|pmdd, premenstrual, dysphoria, mood swings, bloating.
405411|NCT01217762|Oraya|oraya
405412|NCT01217762|Oraya Therapeutics, Inc.|oraya therapeutics, inc.
405413|NCT01217762|low voltage stereotactic radiosurgery|low voltage stereotactic radiosurgery
405414|NCT01217762|radiosurgery|radiosurgery
405415|NCT01217762|radiotherapy|radiotherapy
405416|NCT01217762|IRay|iray
405418|NCT01217762|Macular Degeneration|macular degeneration
405419|NCT01217762|Wet AMD|wet amd
405420|NCT01217762|xray|xray
405421|NCT01217762|radiation|radiation
405422|NCT01217762|x ray|x ray
405423|NCT01217762|external beam radiation|external beam radiation
405424|NCT01217762|Ranibizumab|ranibizumab
405425|NCT01217762|Lucentis|lucentis
405426|NCT01217723|Acute leukemia (myeloid,lymphoid,or biphenotypic)|acute leukemia (myeloid,lymphoid,or biphenotypic)
405427|NCT01217723|Chronic myeloid leukemia|chronic myeloid leukemia
405428|NCT01217723|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
405429|NCT01217723|Lymphoma|lymphoma
405430|NCT01217723|Myelodysplastic syndrome|myelodysplastic syndrome
405431|NCT01217723|Myeloproliferative disorder|myeloproliferative disorder
405432|NCT01217710|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
405433|NCT01217710|Physical Activity|physical activity
405434|NCT01217710|Self Management|self management
405435|NCT01217710|Exercise|exercise
405436|NCT01217710|Technology|technology
405437|NCT01217710|Motivational Interviewing|motivational interviewing
405438|NCT01217697|Metastatic Castration-Resistant Prostate Cancer (CRPC)|metastatic castration-resistant prostate cancer (crpc)
405439|NCT01217697|Abiraterone Acetate|abiraterone acetate
405440|NCT01216696|ipilimumab|ipilimumab
405441|NCT01216696|melanoma|melanoma
405442|NCT01216696|NY-ESO-1|ny-eso-1
405443|NCT01216683|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
405444|NCT01216683|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
405445|NCT01216683|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
584551|NCT00509431|adult glioblastoma|adult glioblastoma
405446|NCT01216683|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
405447|NCT01216683|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
405543|NCT01217502|Homes for the aged|homes for the aged
405448|NCT01216683|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
405449|NCT01216683|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
405450|NCT01216683|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
405451|NCT01216683|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
405452|NCT01216683|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
405453|NCT01216683|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
405454|NCT01216683|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
405455|NCT01216670|Reveal® XT|reveal® xt
405456|NCT01216670|Acute Heart Failure|acute heart failure
405457|NCT01216670|Low Ejection Fraction|low ejection fraction
405458|NCT01216670|Reveal® XT implanted|reveal® xt implanted
405459|NCT01216657|melanoma|melanoma
405460|NCT01216657|sunitinib|sunitinib
405461|NCT01216644|gastric cancer|gastric cancer
405462|NCT01216644|perioperative|perioperative
405463|NCT01216644|FLOT|flot
405464|NCT01216644|ECF|ecf
405465|NCT01216644|pathological complete remission|pathological complete remission
405466|NCT01216644|locally advanced resectable adenocarcinoma of the esophagogastric juction or the stomach|locally advanced resectable adenocarcinoma of the esophagogastric juction or the stomach
405467|NCT01216631|seronegative|seronegative
405468|NCT01216631|oligoarthritis|oligoarthritis
405469|NCT01216631|infliximab|infliximab
405470|NCT01216631|intraarticular|intraarticular
405471|NCT01216618|MiniMed paradigm insulin pumps|minimed paradigm insulin pumps
405472|NCT01216618|insulin Lispro|insulin lispro
405473|NCT01216618|Insulin Asprt.|insulin asprt.
405474|NCT01216592|COPD|copd
405475|NCT01216592|Airway inflammation|airway inflammation
405476|NCT01216592|Symptoms|symptoms
405477|NCT01216592|Lung function|lung function
405478|NCT01216592|Correlation|correlation
405479|NCT01216553|Bronchiolitis|bronchiolitis
405480|NCT01216553|Infants|infants
405481|NCT01216553|Nebulized Inhalation|nebulized inhalation
405482|NCT01216553|RSV|rsv
405483|NCT01216553|Oxygen|oxygen
405484|NCT01216540|vancomycin|vancomycin
405485|NCT01216540|nephrotoxicity|nephrotoxicity
405486|NCT01216540|length of stay|length of stay
405487|NCT01216540|costs|costs
405488|NCT01216527|Stage IIB or III squamous cell esophageal carcinoma.|stage iib or iii squamous cell esophageal carcinoma.
405489|NCT01216514|chronic inflammatory bowel diseases|chronic inflammatory bowel diseases
405490|NCT01216514|crohn disease|crohn disease
405491|NCT01216514|hemorrhagic rectocolitis|hemorrhagic rectocolitis
405492|NCT01216514|immunological markers|immunological markers
405493|NCT01216514|serological markers|serological markers
405494|NCT01216514|ANCA|anca
405495|NCT01216514|ASCA|asca
405496|NCT01216488|Forearm surgery|forearm surgery
405497|NCT01216488|Hand surgery|hand surgery
405498|NCT01216488|Anesthesia|anesthesia
405499|NCT01217671|Pulmonary, Emphysema|pulmonary, emphysema
405500|NCT01217671|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
405501|NCT01217658|Randomized Trial|randomized trial
405502|NCT01217658|Infant Colic|infant colic
405503|NCT01217658|Abusive Head Trauma|abusive head trauma
405504|NCT01217658|Shaken Baby Syndrome|shaken baby syndrome
405505|NCT01217645|Major depression disorder|major depression disorder
405506|NCT01217632|Connective tissue growth factor (CTGF)|connective tissue growth factor (ctgf)
405507|NCT01217632|human IgG1 monoclonal antibody|human igg1 monoclonal antibody
405508|NCT01217619|neoadjuvant treatment|neoadjuvant treatment
405509|NCT01217593|mastectomy|mastectomy
405510|NCT01217593|breast cancer|breast cancer
405511|NCT01217593|breast surgery|breast surgery
405512|NCT01217580|c-section|c-section
405513|NCT01217580|cesarean section|cesarean section
405514|NCT01217580|TAP block|tap block
405515|NCT01217580|pain|pain
405516|NCT01217580|pain after delivery|pain after delivery
405517|NCT01217580|pain after C-section|pain after c-section
405518|NCT01217580|pain after C-section delivery|pain after c-section delivery
405519|NCT01217580|pain after cesarean delivery|pain after cesarean delivery
405520|NCT01217580|pain after cesarean|pain after cesarean
405521|NCT01217567|cicatrix|cicatrix
405522|NCT01217567|cesarean section|cesarean section
405523|NCT01217567|sutures|sutures
405524|NCT01217567|surgical staples|surgical staples
405525|NCT01217567|postoperative pain|postoperative pain
405526|NCT01217567|Infection|infection
405527|NCT01217554|Low Back Pain|low back pain
405528|NCT01217554|Disability|disability
405529|NCT01217554|Kinematic measures|kinematic measures
405530|NCT01217541|Dementia|dementia
405531|NCT01217541|BPSD|bpsd
405532|NCT01217541|Quality of Life|quality of life
405533|NCT01217541|Person-centred care|person-centred care
405534|NCT01217541|Job satisfaction|job satisfaction
405535|NCT01217541|Nursing home|nursing home
405536|NCT01217541|Primary care|primary care
405537|NCT01217528|ICD|icd
405538|NCT01217528|CRTD|crtd
405539|NCT01217528|Sudden cardiac death|sudden cardiac death
405540|NCT01217528|Device settings|device settings
405541|NCT01217528|Patients who received ICD/CRTD for primary prevention of sudden cardiac death|patients who received icd/crtd for primary prevention of sudden cardiac death
405542|NCT01217502|Aged|aged
405544|NCT01217502|Self management|self management
405545|NCT01217502|Personal autonomy|personal autonomy
405546|NCT01217502|Disease management|disease management
405547|NCT01217502|Self efficacy|self efficacy
405548|NCT01217502|Participation|participation
405549|NCT01217489|breast|breast
405550|NCT01217489|cancer|cancer
405551|NCT01217489|diagnosis|diagnosis
405552|NCT01217489|electrical|electrical
405553|NCT01217489|non-invasive|non-invasive
405554|NCT01217489|mammography|mammography
405555|NCT01217476|Diabetic foot|diabetic foot
405556|NCT01217476|Neuropathic|neuropathic
405557|NCT01217476|Wound|wound
405558|NCT01217476|Growth factor|growth factor
405559|NCT01217463|Diabetic foot|diabetic foot
405560|NCT01217463|Neuropathic|neuropathic
405561|NCT01217463|Wound|wound
405562|NCT01217463|Growth factor|growth factor
405563|NCT01217424|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
405564|NCT01217424|pain|pain
405565|NCT01217424|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
405566|NCT01217398|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
405567|NCT01217398|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
405568|NCT01217398|iris melanoma|iris melanoma
405569|NCT01217398|metastatic intraocular melanoma|metastatic intraocular melanoma
405570|NCT01217398|stage IV intraocular melanoma|stage iv intraocular melanoma
405571|NCT01217385|stage IIIA breast cancer|stage iiia breast cancer
405572|NCT01217385|stage IIIB breast cancer|stage iiib breast cancer
405573|NCT01217385|stage IIIC breast cancer|stage iiic breast cancer
405574|NCT01217372|Recurrent idiopathic calcium oxalate nephrolithiasis.|recurrent idiopathic calcium oxalate nephrolithiasis.
405575|NCT01217333|Telephones|telephones
405576|NCT01217333|Community-Based Participatory Research|community-based participatory research
405577|NCT01217333|Participation, Patient|participation, patient
405578|NCT01217333|Rural health services|rural health services
405579|NCT01217320|rheumatology|rheumatology
405580|NCT01217320|creatine supplementation|creatine supplementation
405581|NCT01217320|quality of life|quality of life
405582|NCT01217320|strength|strength
405583|NCT01217320|juvenile systemic lupus erythematosus|juvenile systemic lupus erythematosus
405584|NCT01217320|juvenile dermatomyositis|juvenile dermatomyositis
405585|NCT01217307|Metformin|metformin
405586|NCT01217307|ST elevation myocardial infarction (STEMI)|st elevation myocardial infarction (stemi)
405587|NCT01217307|Coronary artery disease|coronary artery disease
405588|NCT01217307|Heart failure|heart failure
405589|NCT01217307|Diabetes|diabetes
405590|NCT01217294|anaesthetic techniques, regional|anaesthetic techniques, regional
405591|NCT01217294|analgesia, post-operative|analgesia, post-operative
405592|NCT01217294|fascia iliaca compartment block|fascia iliaca compartment block
405593|NCT01217294|ultrasound guided|ultrasound guided
405594|NCT01217294|surgery, orthopaedic|surgery, orthopaedic
405595|NCT01217281|CKD, Renal, Chronic Kidney Disease, Periodontitis, Perio|ckd, renal, chronic kidney disease, periodontitis, perio
405596|NCT01217255|Hemophilia|hemophilia
405597|NCT01217255|Burden of Illness|burden of illness
405598|NCT01217255|Pediatric|pediatric
405599|NCT01217255|Quality of Life|quality of life
405600|NCT01217255|Disability|disability
405601|NCT01217255|Participation|participation
405602|NCT01217242|cerebral palsy|cerebral palsy
405603|NCT01217242|walking activity|walking activity
405604|NCT01217242|physical activity|physical activity
405605|NCT01217242|participation|participation
405606|NCT01217242|activity performance|activity performance
405607|NCT01217242|activity capacity|activity capacity
405608|NCT01217229|Hodgkin Lymphoma|hodgkin lymphoma
405609|NCT01217216|Breast Cancer|breast cancer
405610|NCT01217216|Weight loss|weight loss
405611|NCT01217216|Group Intervention|group intervention
405612|NCT01217216|Telephone Intervention|telephone intervention
405613|NCT01217177|Cervical cancer,|cervical cancer,
405614|NCT01217177|radiotherapy,|radiotherapy,
405615|NCT01217177|chemotherapy,|chemotherapy,
404679|NCT01220960|women|women
405616|NCT01217177|rad001,|rad001,
405617|NCT01217177|everolimus|everolimus
405618|NCT01217164|nutrition|nutrition
405619|NCT01217164|very low birth weight|very low birth weight
405620|NCT01217164|premature|premature
405621|NCT01217151|Hemodynamic Monitoring|hemodynamic monitoring
405622|NCT01217151|Goal-Directed Therapy|goal-directed therapy
405623|NCT01217138|Anaphylaxis, autoinjector, design, epinephrine|anaphylaxis, autoinjector, design, epinephrine
405624|NCT01217125|tuberousclerosis, angiomyolipoma, rapamycin|tuberousclerosis, angiomyolipoma, rapamycin
405625|NCT01217112|Dyslipidemias|dyslipidemias
405626|NCT01217112|Diabetes|diabetes
405627|NCT01217112|Liver Fat|liver fat
405628|NCT01217112|Body Fat|body fat
746881|NCT01143948|Inpatient|inpatient
405629|NCT01217099|refractory mycoplasma pneumoniae pneumonia|refractory mycoplasma pneumoniae pneumonia
405630|NCT01217060|Adenocarcinoma|adenocarcinoma
405631|NCT01217060|Squamous cell carcinoma|squamous cell carcinoma
405632|NCT01217060|Thoracic esophagus|thoracic esophagus
405633|NCT01217060|Gastroesophageal junction|gastroesophageal junction
405634|NCT01217060|Chemoradiotherapy|chemoradiotherapy
405635|NCT01217060|Esophagectomy|esophagectomy
405636|NCT01217060|5-Fluorouracil|5-fluorouracil
405637|NCT01217060|Docetaxel|docetaxel
405638|NCT01217060|Radiation|radiation
405639|NCT01217060|Radiotherapy|radiotherapy
405640|NCT01217060|XRT|xrt
405641|NCT01217060|IMRT|imrt
405642|NCT01217060|Taxotere|taxotere
405643|NCT01217060|Adrucil|adrucil
405644|NCT01217060|Efudex|efudex
405645|NCT01217060|Dexamethasone|dexamethasone
405646|NCT01217060|Decadron|decadron
405647|NCT01217047|Spinal cord injury|spinal cord injury
405648|NCT01217047|Functional electrical stimulation|functional electrical stimulation
405649|NCT01217047|Rehabilitation|rehabilitation
405650|NCT01217047|Growth factors|growth factors
405651|NCT01217047|Cytokines|cytokines
405652|NCT01217034|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
405653|NCT01217034|TACE|tace
405654|NCT01217034|sorafenib|sorafenib
405655|NCT01217034|Time to untreatable progression|time to untreatable progression
405656|NCT01217034|TTUP|ttup
405657|NCT01217008|Spinal Cord Injury|spinal cord injury
405658|NCT01217008|GRNOPC1|grnopc1
405659|NCT01216995|Heart Attack|heart attack
405660|NCT01216995|Regenerative Cells|regenerative cells
405661|NCT01216995|Stem Cells|stem cells
405662|NCT01216982|Mood Disorders|mood disorders
405663|NCT01216982|Depression|depression
405664|NCT01216982|Combat Disorders|combat disorders
405665|NCT01216982|Stress Disorders|stress disorders
405666|NCT01216982|Fatty Acids, Omega-3|fatty acids, omega-3
405667|NCT01216982|Military Personnel|military personnel
405668|NCT01216982|Docosahexaenoic Acids/*therapeutic use|docosahexaenoic acids/*therapeutic use
405669|NCT01216982|Eicosapentaenoic Acid/*therapeutic use|eicosapentaenoic acid/*therapeutic use
405670|NCT01216956|extended release nicotinic acid|extended release nicotinic acid
405671|NCT01216956|non esterified fatty acid (NEFA)|non esterified fatty acid (nefa)
405672|NCT01216956|insulin resistance|insulin resistance
405673|NCT01216956|Cholesteryl ester transfer protein (CETP)|cholesteryl ester transfer protein (cetp)
405674|NCT01216956|High density lipoprotein cholesterol|high density lipoprotein cholesterol
405675|NCT01216891|Schizophrenia|schizophrenia
405676|NCT01216891|Schizoaffective Disorder|schizoaffective disorder
405677|NCT01216891|Schizophreniform Disorder|schizophreniform disorder
405678|NCT01216891|Delusional Disorder|delusional disorder
405679|NCT01216891|Psychosis|psychosis
405680|NCT01216891|First episode|first episode
405681|NCT01216865|Diabetic foot|diabetic foot
405682|NCT01216865|critical limb ischemia|critical limb ischemia
405683|NCT01216865|mesenchymal stem cells|mesenchymal stem cells
405684|NCT01216865|umbilical cord|umbilical cord
405685|NCT01216813|esophageal cancer|esophageal cancer
405686|NCT01216813|gastric cancer|gastric cancer
405687|NCT01216813|cervical cancer|cervical cancer
405688|NCT01216813|fallopian tube cancer|fallopian tube cancer
405689|NCT01216813|ovarian epithelial cancer|ovarian epithelial cancer
405690|NCT01216813|ovarian germ cell tumor|ovarian germ cell tumor
405691|NCT01216813|ovarian sarcoma|ovarian sarcoma
405692|NCT01216813|ovarian stromal cancer|ovarian stromal cancer
405693|NCT01216813|endometrial cancer|endometrial cancer
405694|NCT01216813|uterine sarcoma|uterine sarcoma
405695|NCT01216813|vaginal cancer|vaginal cancer
405696|NCT01216813|vulvar cancer|vulvar cancer
405697|NCT01216813|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
405698|NCT01216800|ototoxicity|ototoxicity
405699|NCT01216800|radiation toxicity|radiation toxicity
405700|NCT01216800|stage I salivary gland cancer|stage i salivary gland cancer
405701|NCT01216800|stage II salivary gland cancer|stage ii salivary gland cancer
405702|NCT01216800|stage III salivary gland cancer|stage iii salivary gland cancer
405703|NCT01216761|Bacteremia|bacteremia
405704|NCT01216761|Blood culture|blood culture
405705|NCT01216761|Contamination|contamination
405706|NCT01216761|Antiseptic agents|antiseptic agents
405707|NCT01216748|airway blood flow|airway blood flow
505744|NCT00215566|IBS|ibs
405708|NCT01216748|albuterol|albuterol
405709|NCT01216748|acidosis|acidosis
405710|NCT01216748|alkalosis|alkalosis
405711|NCT01216735|smokers|smokers
405712|NCT01216735|inhaled corticosteroids|inhaled corticosteroids
405713|NCT01216735|brachial flow|brachial flow
405714|NCT01216735|airway blood flow|airway blood flow
405715|NCT01216735|albuterol|albuterol
405716|NCT01216735|spirometry|spirometry
405717|NCT01216735|endothelial dysfunction|endothelial dysfunction
405718|NCT01216722|Muscle Wasting|muscle wasting
405719|NCT01216722|Strengthening|strengthening
405720|NCT01216722|Liver Disease|liver disease
405721|NCT01216722|Transplant|transplant
405722|NCT01216709|Infant|infant
405723|NCT01216709|Dietary Supplements|dietary supplements
405724|NCT01216709|Food, Fortified|food, fortified
405725|NCT01216709|Iron Absorption|iron absorption
405726|NCT01216462|Acute Coronary Syndrome|acute coronary syndrome
405727|NCT01216449|Citalopram|citalopram
405728|NCT01216449|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
405729|NCT01216449|fMRI|fmri
405730|NCT01216449|Pharmacokinetics|pharmacokinetics
405731|NCT01216449|Pharmacodynamics|pharmacodynamics
405732|NCT01216449|Amygdala|amygdala
405734|NCT01216436|melanoma|melanoma
405735|NCT01216436|immunotherapy|immunotherapy
405736|NCT01216436|dendritic cell|dendritic cell
405737|NCT01216436|GITR-ligand|gitr-ligand
405738|NCT01216436|CTLA-4|ctla-4
405739|NCT01216423|Patent Foramen Ovale|patent foramen ovale
405740|NCT01216423|Pulmonary embolism|pulmonary embolism
405741|NCT01216423|Stroke|stroke
405742|NCT01216410|Nausea|nausea
405743|NCT01216410|Vomiting|vomiting
405744|NCT01216371|carcinoma|carcinoma
405745|NCT01216371|metastases|metastases
405746|NCT01216371|renal|renal
405747|NCT01216371|lung|lung
405748|NCT01216358|Headache|headache
405749|NCT01216358|Contraception|contraception
405750|NCT01216319|Biodesign|biodesign
405751|NCT01216319|Nipple Reconstruction|nipple reconstruction
405211|NCT01218672|BPH|bph
405752|NCT01216319|Breast Cancer|breast cancer
405753|NCT01216319|Mastectomy|mastectomy
405754|NCT01216306|Obesity|obesity
405755|NCT01216306|Physical Activity|physical activity
405756|NCT01216306|Sedentary Activity|sedentary activity
405757|NCT01216306|Television viewing|television viewing
405758|NCT01216306|Latino|latino
405759|NCT01216306|Hispanic|hispanic
405760|NCT01216306|Preschool|preschool
405761|NCT01216306|School|school
405762|NCT01216306|Head Start|head start
405763|NCT01216293|Drug Therapy|drug therapy
405764|NCT01216280|Natura-alpha|natura-alpha
405765|NCT01216280|ulcerative colitis|ulcerative colitis
405766|NCT01216280|cytokines|cytokines
405767|NCT01216280|Th1|th1
405768|NCT01216280|Th17|th17
405769|NCT01216267|chromogranin A|chromogranin a
405770|NCT01216267|neuroendocrine|neuroendocrine
405771|NCT01216267|carcinoid|carcinoid
405772|NCT01216267|Proton Pump Inhibitor|proton pump inhibitor
405773|NCT01216254|breast cancer|breast cancer
405774|NCT01216254|stage 2|stage 2
405775|NCT01216254|breast conserving therapy|breast conserving therapy
405776|NCT01216254|sentinel lymph node dissection|sentinel lymph node dissection
405777|NCT01216254|high frequency electrocoagulation|high frequency electrocoagulation
405778|NCT01216202|Rectal cancer|rectal cancer
405779|NCT01216202|Preoperative radiotherapy|preoperative radiotherapy
405780|NCT01216202|Pelvic surgery|pelvic surgery
405781|NCT01216202|Sexual function|sexual function
405782|NCT01216202|Wellbeing|wellbeing
405783|NCT01216202|Hormone levels|hormone levels
405784|NCT01216202|Spermatogenesis|spermatogenesis
405785|NCT01216189|Rectal cancer|rectal cancer
405786|NCT01216189|Preoperative radiotherapy|preoperative radiotherapy
405787|NCT01216189|Pelvic surgery|pelvic surgery
405788|NCT01216189|Sexual function|sexual function
405789|NCT01216189|Wellbeing|wellbeing
405790|NCT01216189|Hormone levels|hormone levels
405791|NCT01216176|Breast Cancer|breast cancer
405792|NCT01216176|Postmenopausal|postmenopausal
405793|NCT01216176|Metastatic Phase I ONLY|metastatic phase i only
405794|NCT01216176|AZD0530|azd0530
405795|NCT01216176|Anastrozole|anastrozole
405796|NCT01216176|Phase I for metastatic disease|phase i for metastatic disease
405797|NCT01216176|Phase II for newly diagnosed breast cancer|phase ii for newly diagnosed breast cancer
405798|NCT01216176|Pharmacokinetic|pharmacokinetic
405799|NCT01216176|PK|pk
405800|NCT01216176|Hormone Receptor|hormone receptor
405801|NCT01216176|Estrogen Receptor|estrogen receptor
405802|NCT01216176|Progesterone Receptor|progesterone receptor
405803|NCT01216176|ER+|er+
405804|NCT01216176|PR+|pr+
405805|NCT01216176|HER negative|her negative
405806|NCT01216176|Aromatase Inhibitors|aromatase inhibitors
405807|NCT01216163|Pain following third molar extraction (wisdom tooth)|pain following third molar extraction (wisdom tooth)
405808|NCT01216150|antifibrinolytic drug|antifibrinolytic drug
405809|NCT01216150|coronary surgery|coronary surgery
405810|NCT01216150|hemorrhage|hemorrhage
405811|NCT01216150|aspirin|aspirin
405812|NCT01216150|clopidogrel|clopidogrel
405813|NCT01216137|Multiple Sclerosis|multiple sclerosis
405814|NCT01216137|Fatigue|fatigue
405815|NCT01216137|Balance|balance
405816|NCT01216137|Upright Postural Control|upright postural control
405817|NCT01216137|Dizziness|dizziness
405818|NCT01216124|triple negative local advanced breast cancer(TNLABC),neoadjuvant chemotherapy|triple negative local advanced breast cancer(tnlabc),neoadjuvant chemotherapy
405819|NCT01216111|triple negative breast cancer，local recurrence,distant metastasis|triple negative breast cancer，local recurrence,distant metastasis
405820|NCT01216098|Intrapartum|intrapartum
405821|NCT01216098|Clinical trial|clinical trial
405822|NCT01216098|Perinatal|perinatal
405823|NCT01216098|Doula|doula
405824|NCT01216098|VBAC|vbac
405825|NCT01216098|Perinatal Outcomes|perinatal outcomes
405826|NCT01216072|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
405827|NCT01216072|Disease Modifying Therapy|disease modifying therapy
405828|NCT01216072|fingolimod|fingolimod
405829|NCT01216072|Patient Reported Outcomes|patient reported outcomes
405830|NCT01216059|adherence|adherence
405831|NCT01216059|text message|text message
405832|NCT01216059|reminder|reminder
405833|NCT01216059|adolescents|adolescents
405834|NCT01216033|Breast cancer|breast cancer
405835|NCT01216033|Diagnostics|diagnostics
405836|NCT01216033|HER2|her2
405837|NCT01216033|Imaging|imaging
405838|NCT01216033|Metastases|metastases
405839|NCT01216033|SPECT|spect
405840|NCT01216033|Imaging of metastases|imaging of metastases
405841|NCT01216020|Head and Neck Cancer|head and neck cancer
405842|NCT01216020|Radiotherapy|radiotherapy
405843|NCT01216020|Cetuximab|cetuximab
405844|NCT01216020|Cisplatin|cisplatin
405845|NCT01216007|Plasma|plasma
405846|NCT01216007|bupivacaine|bupivacaine
405847|NCT01216007|concentration|concentration
405848|NCT01216007|caudal|caudal
405849|NCT01216007|epidural|epidural
405850|NCT01216007|TIVA|tiva
405851|NCT01216007|Inhalational|inhalational
405852|NCT01216007|anesthesia|anesthesia
405853|NCT01216007|Caudal epidural|caudal epidural
405854|NCT01215981|influenza vaccine|influenza vaccine
405855|NCT01215955|Type 2 Diabetes|type 2 diabetes
405856|NCT01215955|Insulin|insulin
405857|NCT01215955|Algorithms|algorithms
405858|NCT01215955|Blood glucose levels|blood glucose levels
405859|NCT01215942|Rheumatoid Arthritis|rheumatoid arthritis
405860|NCT01215929|methamphetamine withdrawal|methamphetamine withdrawal
405861|NCT01215929|mood|mood
405862|NCT01215929|retention|retention
405863|NCT01215929|sleep|sleep
405864|NCT01215916|Solid tumors|solid tumors
405865|NCT01215890|Crohn's disease|crohn's disease
405866|NCT01215890|Low bone mineral density|low bone mineral density
405867|NCT01215890|inflammatory bowel disease|inflammatory bowel disease
405868|NCT01215890|bisphosphonate|bisphosphonate
405869|NCT01215877|Bladder cancer|bladder cancer
405870|NCT01215877|Previously treated patients|previously treated patients
405871|NCT01215877|Tesetaxel|tesetaxel
405872|NCT01215877|Oral taxane|oral taxane
405873|NCT01215864|metastatic tumors|metastatic tumors
405874|NCT01215864|refractory tumors|refractory tumors
405875|NCT01215864|recurrent tumors|recurrent tumors
405876|NCT01215851|Tuberculosis|tuberculosis
405878|NCT01215851|TMC207|tmc207
405879|NCT01215851|pretomanid|pretomanid
405880|NCT01215851|Early Bactericidal Activity|early bactericidal activity
406270|NCT01214382|Sertraline|sertraline
405881|NCT01215851|Pulmonary Tuberculosis|pulmonary tuberculosis
405883|NCT01215851|bedaquiline|bedaquiline
405884|NCT01215851|pyrazinamide|pyrazinamide
405885|NCT01215851|moxifloxacin|moxifloxacin
405886|NCT01215851|ethambutol|ethambutol
405887|NCT01215851|rifafour|rifafour
405888|NCT01215838|HCC|hcc
405889|NCT01215838|hepatocellular carcinoma|hepatocellular carcinoma
405890|NCT01215838|Eovist|eovist
405891|NCT01215838|MR|mr
405892|NCT01215838|MRI|mri
405893|NCT01215838|magnetic resonance|magnetic resonance
405894|NCT01215825|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
405895|NCT01215825|systemic steroid|systemic steroid
405896|NCT01215799|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
405897|NCT01215799|HRPC|hrpc
405898|NCT01215760|peripheral nerve injury|peripheral nerve injury
405899|NCT01215760|sensory reeducation|sensory reeducation
405900|NCT01215760|brain plasticity|brain plasticity
405901|NCT01215760|training with a mirror|training with a mirror
405902|NCT01215760|rehabilitation|rehabilitation
405903|NCT01215747|Kiacta for AA amyloidosis|kiacta for aa amyloidosis
405904|NCT01215721|Incontinence|incontinence
405905|NCT01215721|Robotic Prostatectomy|robotic prostatectomy
405906|NCT01215721|Prostate Cancer|prostate cancer
405907|NCT01215708|Kidney calculi|kidney calculi
405908|NCT01215708|Lithotripsy|lithotripsy
405909|NCT01215708|Calcium channel blockers|calcium channel blockers
405910|NCT01215708|Adrenergic alpha-antagonists.|adrenergic alpha-antagonists.
405911|NCT01215695|Intubation, Endotracheal|intubation, endotracheal
405042|NCT01219517|IVF|ivf
405912|NCT01215695|Endotracheal Intubation, adverse events|endotracheal intubation, adverse events
405913|NCT01215682|infections|infections
405914|NCT01215682|immune system|immune system
405915|NCT01215682|vitamin D|vitamin d
405916|NCT01215682|sport|sport
405917|NCT01215682|children|children
405918|NCT01215669|Influenza|influenza
405919|NCT01215669|Influenza Virus Vaccines|influenza virus vaccines
405920|NCT01215669|Intradermal Injections|intradermal injections
405921|NCT01215643|Chronic hepatitis C genotype 2|chronic hepatitis c genotype 2
405922|NCT01215643|Chronic hepatitis C genotype 3|chronic hepatitis c genotype 3
405923|NCT01215643|Cyclophilin inhibitor|cyclophilin inhibitor
405924|NCT01215630|Veins|veins
405925|NCT01215630|Exercise tests|exercise tests
405926|NCT01215630|maximal oxygen uptake|maximal oxygen uptake
405927|NCT01215630|VO2max|vo2max
405928|NCT01215617|Randomized controlled study|randomized controlled study
405929|NCT01215617|Exercise training|exercise training
405930|NCT01215617|Lung function|lung function
405931|NCT01215617|Heart function|heart function
405932|NCT01215604|elderly patients|elderly patients
405933|NCT01215604|acute infection|acute infection
405934|NCT01215604|translation initiation factors|translation initiation factors
405935|NCT01215604|eIF4E|eif4e
405936|NCT01215604|eIF4G|eif4g
405937|NCT01215591|Neonatal|neonatal
405938|NCT01215591|Nasal CPAP|nasal cpap
405939|NCT01215591|Randomized controlled trial|randomized controlled trial
405940|NCT01215591|Weaning|weaning
405941|NCT01215578|Neuroendocrine Tumors|neuroendocrine tumors
405942|NCT01215578|Neuroectodermal Tumors|neuroectodermal tumors
405943|NCT01215578|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
405944|NCT01215578|Neoplasms by Histologic Type|neoplasms by histologic type
405945|NCT01215578|Neoplasms|neoplasms
405946|NCT01215578|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
405947|NCT01215578|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
405948|NCT01215578|Pancreatic Neoplasms|pancreatic neoplasms
405949|NCT01215578|Digestive System Neoplasms|digestive system neoplasms
405950|NCT01215578|Neoplasms by Site|neoplasms by site
405951|NCT01215578|Endocrine Gland Neoplasms|endocrine gland neoplasms
405952|NCT01215578|Adenoma, Islet Cell|adenoma, islet cell
405953|NCT01215578|Adenocarcinoma|adenocarcinoma
405954|NCT01215578|Carcinoma|carcinoma
405955|NCT01215578|Adenoma|adenoma
405956|NCT01215578|Digestive System Diseases|digestive system diseases
405957|NCT01215578|Pancreatic Diseases|pancreatic diseases
405958|NCT01215578|Endocrine System Diseases|endocrine system diseases
405959|NCT01215578|Sunitinib|sunitinib
405960|NCT01215578|Antineoplastic Agents|antineoplastic agents
405961|NCT01215578|Therapeutic Uses|therapeutic uses
405962|NCT01215578|Pharmacologic Actions|pharmacologic actions
405963|NCT01215578|Angiogenesis Inhibitors|angiogenesis inhibitors
405964|NCT01215578|Angiogenesis Modulating Agents|angiogenesis modulating agents
405965|NCT01215578|Growth Substances|growth substances
405966|NCT01215578|Physiological Effects of Drugs|physiological effects of drugs
405967|NCT01215578|Growth Inhibitors|growth inhibitors
405968|NCT01215565|Carcinoma, Hepatocellular|carcinoma, hepatocellular
405969|NCT01215565|Carcinoma|carcinoma
405970|NCT01215565|Fibrosis|fibrosis
405971|NCT01215565|Liver Neoplasms|liver neoplasms
405972|NCT01215565|Pathologic Processes|pathologic processes
405973|NCT01215565|Digestive System Neoplasms|digestive system neoplasms
405974|NCT01215565|Neoplasms by Site|neoplasms by site
405975|NCT01215565|Neoplasms|neoplasms
405976|NCT01215565|Liver Diseases|liver diseases
405977|NCT01215565|Adenocarcinoma|adenocarcinoma
405978|NCT01215565|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
405979|NCT01215565|Neoplasms by Histologic Type|neoplasms by histologic type
405980|NCT01215565|Sunitinib|sunitinib
405981|NCT01215565|Antineoplastic Agents|antineoplastic agents
405982|NCT01215565|Therapeutic Uses|therapeutic uses
405983|NCT01215565|Pharmacologic Actions|pharmacologic actions
405984|NCT01215565|Angiogenesis Inhibitors|angiogenesis inhibitors
405985|NCT01215565|Angiogenesis Modulating Agents|angiogenesis modulating agents
405986|NCT01215565|Growth Substances|growth substances
405987|NCT01215565|Physiological Effects of Drugs|physiological effects of drugs
405988|NCT01215565|Growth Inhibitors|growth inhibitors
405989|NCT01215500|solid tumor cancer|solid tumor cancer
405990|NCT01215500|epithelial carcinoma|epithelial carcinoma
405991|NCT01215487|CML Predictive Study|cml predictive study
405992|NCT01215461|Neonatal mortality|neonatal mortality
405993|NCT01215461|Preterm birth|preterm birth
405994|NCT01215461|Low gestational age|low gestational age
405995|NCT01215461|VLBW|vlbw
405996|NCT01215448|Fatigue|fatigue
405997|NCT01215448|Quality of life|quality of life
405998|NCT01215448|Lifestyle|lifestyle
405999|NCT01215448|Complementary medicine|complementary medicine
406000|NCT01215422|Surgical procedures|surgical procedures
406001|NCT01215422|Intubation|intubation
406002|NCT01215422|Anesthesiologist|anesthesiologist
406003|NCT01215422|Laryngoscope|laryngoscope
406004|NCT01215422|Videolaryngoscope|videolaryngoscope
406005|NCT01215409|Levitra|levitra
506087|NCT00227136|5HIAA|5hiaa
406006|NCT01215409|Erectile dysfunction|erectile dysfunction
406007|NCT01215409|Taiwan|taiwan
406008|NCT01215396|Branched Chain Amino Acids|branched chain amino acids
406009|NCT01215396|Mental Performance|mental performance
406010|NCT01215396|Muscular Performance|muscular performance
406011|NCT01215396|Central Fatigue Theory|central fatigue theory
406013|NCT01215383|psychiatric patients|psychiatric patients
406014|NCT01215383|psychiatric patients before and during antipsychotic therapy|psychiatric patients before and during antipsychotic therapy
406015|NCT01215357|Pathological Gambling|pathological gambling
406016|NCT01215357|ecopipam|ecopipam
406017|NCT01215357|Dopamine|dopamine
406018|NCT01215331|Gestational Diabetes Mellitus|gestational diabetes mellitus
406019|NCT01215331|Treatment|treatment
406020|NCT01215331|Insulin|insulin
406021|NCT01215331|Metformin|metformin
507333|NCT00231010|RP|rp
406022|NCT01215331|Glyburide|glyburide
406023|NCT01215305|Gastroesophageal Reflux Disease, extraesophageal symptoms|gastroesophageal reflux disease, extraesophageal symptoms
406024|NCT01215292|testosterone|testosterone
406025|NCT01215292|acyline|acyline
406026|NCT01215292|ketoconazole|ketoconazole
406027|NCT01215292|dutasteride|dutasteride
406028|NCT01215292|anastrazole|anastrazole
406029|NCT01215292|Intratesticular hormone concentration|intratesticular hormone concentration
406030|NCT01215279|Respiratory disease|respiratory disease
406031|NCT01215279|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
406032|NCT01215266|Bladder cancer|bladder cancer
406033|NCT01215266|Chemotherapy|chemotherapy
406034|NCT01215266|Urothelium cancer|urothelium cancer
406035|NCT01215253|Sudden Death|sudden death
406036|NCT01215253|Ranolazine|ranolazine
406037|NCT01215253|Heart failure|heart failure
406038|NCT01215253|Ventricular tachycardia|ventricular tachycardia
406039|NCT01215253|Ventricular fibrillation|ventricular fibrillation
406040|NCT01215253|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
406041|NCT01215214|metabolite profiles|metabolite profiles
406042|NCT01215214|pharmacokinetics|pharmacokinetics
406043|NCT01215214|CYP3A|cyp3a
406044|NCT01215214|metabolomics|metabolomics
406045|NCT01215201|Periodontal maintenance|periodontal maintenance
406046|NCT01215201|≥5mm probing depth|≥5mm probing depth
406047|NCT01215201|bleeding on probing and/or suppuration|bleeding on probing and/or suppuration
406048|NCT01215188|Invasive pneumococcal disease|invasive pneumococcal disease
406049|NCT01215188|Pneumonia|pneumonia
406050|NCT01215188|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
406051|NCT01215175|Pneumococcal disease|pneumococcal disease
406052|NCT01215149|HIV|hiv
406053|NCT01215110|Bedaquiline|bedaquiline
406054|NCT01215110|Sirturo|sirturo
406055|NCT01215110|Early Bactericidal Activity|early bactericidal activity
406056|NCT01215110|EBA|eba
406057|NCT01215110|Pulmonary Tuberculosis|pulmonary tuberculosis
406058|NCT01215110|TMC207|tmc207
406059|NCT01215084|Human Volunteers|human volunteers
406060|NCT01215071|Lymphadenectomy|lymphadenectomy
406061|NCT01215071|Extension|extension
406062|NCT01215071|Bladder cancer|bladder cancer
406063|NCT01215058|Compliance, France|compliance, france
406064|NCT01215058|Gastrointestinal bleeding ulcer or symptomatic ulcer with NSAID|gastrointestinal bleeding ulcer or symptomatic ulcer with nsaid
406065|NCT01215045|AcrySof ReSTOR Aspheric +4|acrysof restor aspheric +4
406066|NCT01215032|castration-resistant prostate cancer|castration-resistant prostate cancer
406067|NCT01215032|insulin levels|insulin levels
406068|NCT01215032|metformin|metformin
406069|NCT01215019|traumatic brain injury|traumatic brain injury
406070|NCT01214993|GSK1349572|gsk1349572
406071|NCT01214993|para-aminohippurate|para-aminohippurate
406072|NCT01214993|iohexol|iohexol
406073|NCT01214980|Low-frequency ultrasound|low-frequency ultrasound
406074|NCT01214980|Wound healing|wound healing
406075|NCT01214980|Split thickness wound healing|split thickness wound healing
406076|NCT01214980|Skin graft donor site healing|skin graft donor site healing
406077|NCT01214967|risk factors for maternal depression|risk factors for maternal depression
406078|NCT01214954|Total Hip Replacement|total hip replacement
406079|NCT01214954|Rehabilitation|rehabilitation
406080|NCT01214954|Resistance training|resistance training
406081|NCT01214928|vitamin D|vitamin d
406082|NCT01214928|cholecalciferol|cholecalciferol
406083|NCT01214928|hemodialysis|hemodialysis
406084|NCT01214928|randomized controlled trial|randomized controlled trial
406085|NCT01214928|pilot|pilot
406086|NCT01214889|Diphtheria|diphtheria
406087|NCT01214889|Tetanus|tetanus
406088|NCT01214889|Pertussis|pertussis
406089|NCT01214889|Haemophilus influenzae type B|haemophilus influenzae type b
406090|NCT01214889|Poliomyelitis|poliomyelitis
406091|NCT01214889|PENTAXIM™|pentaxim™
406092|NCT01214889|TETRAXIM™|tetraxim™
406093|NCT01214863|Toric Intraocular Lens (IOL)|toric intraocular lens (iol)
406094|NCT01214850|Meningococcal vaccines|meningococcal vaccines
406095|NCT01214850|Meningococcal B|meningococcal b
406096|NCT01214850|Meningococcal ACWY serogroups|meningococcal acwy serogroups
406097|NCT01214837|Meningococcal|meningococcal
405157|NCT01219010|QT|qt
406098|NCT01214837|ACWY|acwy
406099|NCT01214837|Conjugate Vaccine|conjugate vaccine
406100|NCT01214837|Meningitis|meningitis
406101|NCT01214837|Infants|infants
406102|NCT01214837|Persistence|persistence
406103|NCT01214824|Diabetes|diabetes
406104|NCT01214824|Continuous Glucose Monitoring|continuous glucose monitoring
406105|NCT01214811|The change in signs of inflammation/local infection|the change in signs of inflammation/local infection
406106|NCT01214811|To evaluate the comfort, conformability,|to evaluate the comfort, conformability,
406107|NCT01214811|Pain during wear|pain during wear
406108|NCT01213823|invasive candidiasis|invasive candidiasis
406109|NCT01213823|candidemia|candidemia
406110|NCT01213823|severe hepatic injury|severe hepatic injury
406111|NCT01213823|echinocandins|echinocandins
406112|NCT01213823|anidulafungin|anidulafungin
406113|NCT01213823|caspofungin|caspofungin
406114|NCT01213823|micafungin|micafungin
406116|NCT01213810|VZV (Varicella zoster Virus)|vzv (varicella zoster virus)
406117|NCT01213810|vaccine|vaccine
406118|NCT01213810|T cell|t cell
406119|NCT01213810|immunogenicity|immunogenicity
406120|NCT01213810|safety|safety
406121|NCT01213797|Suicide|suicide
406122|NCT01213771|Preoperative|preoperative
406123|NCT01213771|Intervention|intervention
406124|NCT01213771|Support|support
406125|NCT01213771|Care|care
406126|NCT01213758|liver function|liver function
406127|NCT01213758|galactose|galactose
406128|NCT01213758|18-F-deoxy-galactose|18-f-deoxy-galactose
406129|NCT01213758|PET/CT|pet/ct
406130|NCT01213758|stereotactic body radiation therapy|stereotactic body radiation therapy
406131|NCT01213758|SBRT|sbrt
406132|NCT01213745|lung|lung
406133|NCT01213745|cancer|cancer
406134|NCT01213745|quality of life|quality of life
406135|NCT01213732|L19, antibody, monoclonal, tumor targeting, TNFa, ILP, melanoma|l19, antibody, monoclonal, tumor targeting, tnfa, ilp, melanoma
406136|NCT01213719|betaine, creatine, strength|betaine, creatine, strength
406137|NCT01213706|airway blood flow|airway blood flow
406138|NCT01213706|albuterol|albuterol
406139|NCT01213706|Whole Body Periodic Acceleration (WBPA)|whole body periodic acceleration (wbpa)
406140|NCT01213706|Nitric Oxide|nitric oxide
406141|NCT01213706|Endothelial Dysfunction|endothelial dysfunction
406142|NCT01213693|COPD|copd
406143|NCT01213693|Bacteria|bacteria
406144|NCT01213693|Virus|virus
406145|NCT01213693|Inhaled Corticosteroids|inhaled corticosteroids
406146|NCT01213680|Inflammatory Bowel Disease, IBD|inflammatory bowel disease, ibd
406147|NCT01213654|Lung cancer|lung cancer
406148|NCT01213654|VATS Lobectomy|vats lobectomy
406149|NCT01213641|Cryopyrin-associated periodic syndromes(CAPS)|cryopyrin-associated periodic syndromes(caps)
406150|NCT01213641|CIAS1 protein|cias1 protein
406151|NCT01213641|NLRP3 protein|nlrp3 protein
406152|NCT01213641|human cryopyrin protein|human cryopyrin protein
406153|NCT01213641|Familial Cold Autoinflammatory Syndrome(FCAS)|familial cold autoinflammatory syndrome(fcas)
406154|NCT01213641|Muckle-Wells Syndrome(MWS)|muckle-wells syndrome(mws)
406155|NCT01213641|Neonatal Onset Multisystem Inflammatory disease(NOMID)|neonatal onset multisystem inflammatory disease(nomid)
406157|NCT01213641|canakinumab|canakinumab
406158|NCT01213641|Interleukin-1(IL-1)|interleukin-1(il-1)
406159|NCT01213628|abdominal surgery|abdominal surgery
406160|NCT01213628|hypothermia|hypothermia
406161|NCT01213628|wound desiccation|wound desiccation
406162|NCT01213628|warming|warming
406163|NCT01213602|Trauma patients|trauma patients
406164|NCT01213589|descending|descending
406165|NCT01213589|thoracic|thoracic
406166|NCT01213589|aortic|aortic
406167|NCT01213589|dissection|dissection
406168|NCT01213589|Valiant|valiant
406169|NCT01213589|Medtronic|medtronic
406170|NCT01213589|Type B|type b
406171|NCT01213589|VIRTUE|virtue
406172|NCT01213589|stent|stent
406271|NCT01214382|Zoloft|zoloft
406173|NCT01213576|Lymphatic filariasis|lymphatic filariasis
406174|NCT01213576|microfilaria|microfilaria
406175|NCT01213576|Albendazole|albendazole
406176|NCT01213576|ivermectin|ivermectin
406177|NCT01213576|human immunodeficiency|human immunodeficiency
406178|NCT01213563|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
406179|NCT01214798|sesamoid displacement,|sesamoid displacement,
406180|NCT01214798|metacarpophalangeal joint,|metacarpophalangeal joint,
406181|NCT01214798|radial condylar ridge of the metacarpal head.|radial condylar ridge of the metacarpal head.
406182|NCT01214772|pregnancy|pregnancy
406183|NCT01214772|heparin|heparin
406184|NCT01214772|fertilization|fertilization
406185|NCT01214759|HIV|hiv
406186|NCT01214759|prevention|prevention
406187|NCT01214759|prophylaxis|prophylaxis
406188|NCT01214759|Raltegravir|raltegravir
406189|NCT01214759|Truvada|truvada
406190|NCT01214746|Statin|statin
406191|NCT01214746|L-NMMA|l-nmma
406192|NCT01214746|Healthy subjects|healthy subjects
406193|NCT01214746|Nephrology|nephrology
406194|NCT01214707|Exercise/No active Treatment|exercise/no active treatment
406195|NCT01214694|TBI|tbi
406196|NCT01214694|intracranial edema|intracranial edema
406197|NCT01214694|brain edema|brain edema
406198|NCT01214694|craniocerebral trauma|craniocerebral trauma
506311|NCT00228202|CMV|cmv
406199|NCT01214694|head injury|head injury
406200|NCT01214694|brain hemorrhage, traumatic|brain hemorrhage, traumatic
406201|NCT01214694|subdural hematoma|subdural hematoma
406202|NCT01214694|brain concussion|brain concussion
406203|NCT01214694|head injuries, closed|head injuries, closed
406204|NCT01214694|epidural hematoma|epidural hematoma
406205|NCT01214694|extra-axial hemorrhage|extra-axial hemorrhage
406206|NCT01214694|cortical contusion|cortical contusion
406207|NCT01214694|Additional relevant MeSH terms:|additional relevant mesh terms:
406208|NCT01214694|Nervous System Diseases|nervous system diseases
406209|NCT01214694|Wounds and Injuries|wounds and injuries
406210|NCT01214694|Disorders of Environmental Origin|disorders of environmental origin
406211|NCT01214694|Central Nervous System Diseases|central nervous system diseases
406212|NCT01214694|Trauma, Nervous System|trauma, nervous system
747082|NCT01152021|pediatric|pediatric
406213|NCT01214694|Brain Diseases|brain diseases
406214|NCT01214694|Brain Injuries|brain injuries
406215|NCT01214681|Biomarkers|biomarkers
406216|NCT01214681|Colorectal cancer|colorectal cancer
406217|NCT01214681|Resistant starch|resistant starch
406218|NCT01214681|Polydextrose|polydextrose
406219|NCT01214681|Non-digestible carbohydrate|non-digestible carbohydrate
406220|NCT01214655|Acute Myelogenous Leukemia|acute myelogenous leukemia
406221|NCT01214655|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
406222|NCT01214655|Chronic Myelogenous Leukemia,Blast Crisis|chronic myelogenous leukemia,blast crisis
406223|NCT01214642|Advanced Cancer|advanced cancer
406224|NCT01214642|Cancer|cancer
406225|NCT01214629|Advanced Cancer|advanced cancer
406226|NCT01214629|Metastatic Cancer|metastatic cancer
406227|NCT01214629|Cancer|cancer
406329|NCT01214031|Confocal laser endomicroscope|confocal laser endomicroscope
406228|NCT01214603|Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute|acute myelogenous leukemia, acute myeloid leukemia, acute
406229|NCT01214603|Leukemia, Leukemia|leukemia, leukemia
406230|NCT01214577|PEP005|pep005
406231|NCT01214577|Peplin|peplin
406232|NCT01214577|Photo-damage|photo-damage
406233|NCT01214564|PEP005|pep005
406234|NCT01214564|Peplin|peplin
406235|NCT01214564|Seborrhoeic Keratosis|seborrhoeic keratosis
406236|NCT01214538|Vaccine pneumococcal natural history Acute otitis media|vaccine pneumococcal natural history acute otitis media
406237|NCT01214525|Meatal stenosis|meatal stenosis
406238|NCT01214525|Meatotomy|meatotomy
406239|NCT01214525|Uroflow|uroflow
406240|NCT01214525|Postvoid residual|postvoid residual
406241|NCT01214499|Refractory angina|refractory angina
406242|NCT01214499|Transmyocardial revascularization|transmyocardial revascularization
406243|NCT01214499|Stem cells|stem cells
9177|NCT03232099|Gut Microbiota|gut microbiota
406244|NCT01214499|Diffuse coronary disease not amenable to percutaneous coronary intervention, and angina, despite proper medical treatment|diffuse coronary disease not amenable to percutaneous coronary intervention, and angina, despite proper medical treatment
406245|NCT01214486|HIV|hiv
406246|NCT01214486|RAL|ral
406247|NCT01214486|Raltegravir|raltegravir
406248|NCT01214486|Isentress|isentress
406249|NCT01214486|Pharmacokinetics|pharmacokinetics
406250|NCT01214473|Clinical sepsis|clinical sepsis
406251|NCT01214473|Pneumonia|pneumonia
406252|NCT01214473|Diarrhea|diarrhea
406253|NCT01214473|Probiotics|probiotics
406254|NCT01214473|Synbiotics|synbiotics
406255|NCT01214460|MET|met
406256|NCT01214447|Hemodialysis|hemodialysis
406257|NCT01214447|Inflammation|inflammation
406258|NCT01214447|Malnutrition|malnutrition
406259|NCT01214447|Phase Angle|phase angle
406260|NCT01214434|Cradle Cap|cradle cap
406261|NCT01214434|Infantile seborrheic Dermatitis|infantile seborrheic dermatitis
406262|NCT01214421|Kidney Disease|kidney disease
406263|NCT01214421|ADPKD|adpkd
406264|NCT01214421|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
406265|NCT01214421|Adult Polycystic Kidney Disease|adult polycystic kidney disease
406266|NCT01214395|haemodialysis|haemodialysis
406267|NCT01214395|peritoneal dialysis|peritoneal dialysis
406268|NCT01214382|Gastric Bypass|gastric bypass
406269|NCT01214382|Bariatric Surgery|bariatric surgery
406272|NCT01214382|Pharmacokinetic|pharmacokinetic
406273|NCT01214369|intraosseous injection|intraosseous injection
406274|NCT01214369|X-tip|x-tip
406275|NCT01214369|PDL injection|pdl injection
406276|NCT01214369|Supplementary Injection|supplementary injection
406277|NCT01214356|diabetes|diabetes
406278|NCT01214356|kidney disease|kidney disease
406279|NCT01214356|vitamin D|vitamin d
406280|NCT01214343|sorafenib|sorafenib
406281|NCT01214343|Hepatic intraarterial infusion chemotherapy|hepatic intraarterial infusion chemotherapy
406282|NCT01214343|HAIC|haic
406283|NCT01214343|Low dose FP|low dose fp
406284|NCT01214343|cisplatin|cisplatin
406285|NCT01214343|fluorouracil|fluorouracil
406286|NCT01214330|cervical cancer|cervical cancer
406287|NCT01214317|multiple sclerosis|multiple sclerosis
406288|NCT01214317|mitoxantrone|mitoxantrone
406289|NCT01214317|plasmapheresis|plasmapheresis
406290|NCT01214317|induction therapy|induction therapy
406291|NCT01214304|Colposcopy|colposcopy
406292|NCT01214291|fractures|fractures
406293|NCT01214291|prostate cancer|prostate cancer
406294|NCT01214291|androgen deprivation therapy|androgen deprivation therapy
406295|NCT01214278|bioavailability|bioavailability
406296|NCT01214278|marine n-3 fatty acids|marine n-3 fatty acids
406297|NCT01214278|EPA|epa
406298|NCT01214278|DHA|dha
406299|NCT01214252|Repair of patients' abdominal wall defects|repair of patients' abdominal wall defects
406300|NCT01214187|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
406301|NCT01214187|IPF|ipf
406302|NCT01214187|pulmonary fibrosis|pulmonary fibrosis
406303|NCT01214187|carbon monoxide|carbon monoxide
406304|NCT01214174|cataract|cataract
406305|NCT01214174|inflammation|inflammation
406306|NCT01214161|IUD|iud
406307|NCT01214161|Lidocaine gel|lidocaine gel
406308|NCT01214135|Mental disorder|mental disorder
406309|NCT01214135|antipsychotic treatment|antipsychotic treatment
406310|NCT01214122|Phase 1|phase 1
406311|NCT01214122|Drug-Drug interaction|drug-drug interaction
406312|NCT01214122|warfarin|warfarin
406313|NCT01214122|AZD9668|azd9668
406314|NCT01214122|resulting from AZD9668 and Warfarin interaction|resulting from azd9668 and warfarin interaction
406315|NCT01214122|pharmacokinetics|pharmacokinetics
406316|NCT01214122|pharmacodynamics|pharmacodynamics
406317|NCT01214096|Chronic Heart failure|chronic heart failure
406319|NCT01214096|MRI|mri
406320|NCT01214083|N-acetylcysteine|n-acetylcysteine
406321|NCT01214083|naltrexone|naltrexone
406322|NCT01214070|Visual Perception|visual perception
406323|NCT01214070|Vision, Ocular|vision, ocular
406324|NCT01214070|Neuronal Plasticity|neuronal plasticity
406325|NCT01214057|chronic rhinosinusitis|chronic rhinosinusitis
406326|NCT01214057|endoscopic sinus surgery|endoscopic sinus surgery
406327|NCT01214057|TIVA|tiva
406328|NCT01214057|surgical field visualization|surgical field visualization
406428|NCT01213303|oxysterols|oxysterols
406330|NCT01214031|Adenomatous polyps|adenomatous polyps
406331|NCT01214031|Colonoscopy|colonoscopy
406332|NCT01214005|nicotine|nicotine
406333|NCT01214005|reinforcement|reinforcement
406334|NCT01214005|craving|craving
406335|NCT01214005|relapse|relapse
406336|NCT01213966|Acute uncomplicated Plasmodium Falciparum malaria|acute uncomplicated plasmodium falciparum malaria
406337|NCT01213966|Blood stage Plasmodium Vivax malaria|blood stage plasmodium vivax malaria
406338|NCT01213953|Vertebral disc, mesenchymal stem cell.|vertebral disc, mesenchymal stem cell.
406339|NCT01213914|Burns|burns
406340|NCT01213914|Hemofiltration|hemofiltration
406341|NCT01213914|Vasopressins|vasopressins
406342|NCT01213914|Kidney Failure Acute|kidney failure acute
406343|NCT01213914|Shock, Septic|shock, septic
406344|NCT01213901|Insulin absorption|insulin absorption
406345|NCT01213901|Insulin injection technique|insulin injection technique
406346|NCT01213888|Diabetic retinopathy|diabetic retinopathy
406347|NCT01213888|pan-retinal photocoagulation|pan-retinal photocoagulation
406348|NCT01213888|macular edema|macular edema
406349|NCT01213875|heart failure|heart failure
406351|NCT01213875|home based intervention|home based intervention
406352|NCT01213875|cost|cost
406353|NCT01213875|efficacy|efficacy
406354|NCT01213862|Home Based education|home based education
406355|NCT01213862|Knowledge of Disease|knowledge of disease
406356|NCT01213862|Self-Care Skills|self-care skills
406357|NCT01213862|Quality of Life|quality of life
406358|NCT01213862|Heart Failure|heart failure
406359|NCT01213862|Randomized Clinical Trial|randomized clinical trial
406360|NCT01213836|Stable schizophrenia|stable schizophrenia
406361|NCT01213836|cognitive functioning|cognitive functioning
406362|NCT01213537|Heart failure|heart failure
406363|NCT01213524|nicotine|nicotine
406364|NCT01213524|craving|craving
406365|NCT01213524|dual-diagnosis|dual-diagnosis
406366|NCT01213524|comorbidity|comorbidity
406367|NCT01213511|coronary artery disease; coronary artery bypass grafting; cardiopulmonary bypass; minimal extracorporeal circulation|coronary artery disease; coronary artery bypass grafting; cardiopulmonary bypass; minimal extracorporeal circulation
406368|NCT01213498|Nephrology|nephrology
406369|NCT01213498|Atorvastatin|atorvastatin
406370|NCT01213498|L-NMMA|l-nmma
406371|NCT01213498|NO|no
406372|NCT01213472|ASCI|asci
406373|NCT01213472|melanoma|melanoma
406374|NCT01213472|tumor antigen|tumor antigen
406375|NCT01213472|unresectable|unresectable
406376|NCT01213472|progressive|progressive
406377|NCT01213472|NY-ESO-1|ny-eso-1
406378|NCT01213472|adult|adult
406379|NCT01213472|cancer-testis antigen|cancer-testis antigen
406380|NCT01213472|Immunotherapy|immunotherapy
406381|NCT01213459|Human papillomavirus|human papillomavirus
406382|NCT01213446|Von Willebrand Disease|von willebrand disease
406383|NCT01213420|Donor sites after wound closure|donor sites after wound closure
406384|NCT01213407|Dendritic cell|dendritic cell
406385|NCT01213407|Cancer vaccine|cancer vaccine
406386|NCT01213407|Anti-tumor immune therapy|anti-tumor immune therapy
406387|NCT01213407|Interleukine-12|interleukine-12
406388|NCT01213407|Individualised autologous therapy|individualised autologous therapy
406389|NCT01213407|Brain cancer|brain cancer
406390|NCT01213407|Temozolomide|temozolomide
406391|NCT01213407|Radiotherapy|radiotherapy
406392|NCT01213407|Irradiation|irradiation
406393|NCT01213407|High-grade glioma|high-grade glioma
406394|NCT01213407|Advanced therapy medicinal product ATMP|advanced therapy medicinal product atmp
406395|NCT01213407|Somatic cell therapy|somatic cell therapy
406396|NCT01213407|Leukocyte apheresis|leukocyte apheresis
406397|NCT01213407|Neurosurgery|neurosurgery
406398|NCT01213407|Neurooncology|neurooncology
406399|NCT01213407|Neurology|neurology
406400|NCT01213407|Immunology|immunology
406401|NCT01213407|Tumor immunology|tumor immunology
406402|NCT01213407|Transfusion medicine|transfusion medicine
406403|NCT01213407|Monocyte|monocyte
406404|NCT01213407|Killer cell|killer cell
406405|NCT01213407|Cytotoxic T-cell|cytotoxic t-cell
406406|NCT01213407|Cytotoxic T-lymphocyte|cytotoxic t-lymphocyte
406407|NCT01213394|Framingham score|framingham score
406408|NCT01213394|kidney transplant|kidney transplant
406409|NCT01213394|immunosuppression|immunosuppression
406410|NCT01213394|cardiovascular disease|cardiovascular disease
406411|NCT01213394|CellCept|cellcept
406412|NCT01213394|mycophenolate mofetil|mycophenolate mofetil
406413|NCT01213355|Randomized|randomized
406414|NCT01213355|double-blind|double-blind
406415|NCT01213355|placebo-controlled|placebo-controlled
406416|NCT01213355|5-way crossover|5-way crossover
406417|NCT01213355|single oral administrations of PF 05212377|single oral administrations of pf 05212377
406418|NCT01213355|scopolamine induced deficits in healthy subjects|scopolamine induced deficits in healthy subjects
406419|NCT01213342|dry eye disease|dry eye disease
406421|NCT01213316|antiretroviral|antiretroviral
406422|NCT01213316|human immunodeficiency virus|human immunodeficiency virus
406423|NCT01213316|Raltegravir|raltegravir
406424|NCT01213316|Adults with HIV-1 infection|adults with hiv-1 infection
406425|NCT01213303|cardiovascular risk|cardiovascular risk
406426|NCT01213303|metabolic syndrome|metabolic syndrome
406427|NCT01213303|fatty acids|fatty acids
406429|NCT01213303|antioxidants|antioxidants
406430|NCT01213303|oxidative stress|oxidative stress
406431|NCT01213290|Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA)|endoscopic ultrasound-guided fine-needle aspiration (eus-fna)
406432|NCT01213290|Stylet|stylet
406433|NCT01213277|Diabetes Mellitus|diabetes mellitus
406434|NCT01213277|HbA1c|hba1c
406435|NCT01213277|Glycation Rate|glycation rate
406436|NCT01213277|Fructosamine|fructosamine
406437|NCT01213264|neuromuscular blockade, NMBA, sugammadex, Bridion, TOF,|neuromuscular blockade, nmba, sugammadex, bridion, tof,
406438|NCT01213238|Liver metastasis|liver metastasis
406439|NCT01213238|hepatic arterial infusion|hepatic arterial infusion
406441|NCT01213238|Eloxatin|eloxatin
406442|NCT01213238|Xeloda|xeloda
406443|NCT01213238|Avastin|avastin
406444|NCT01213238|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
406445|NCT01213238|rhuMAb-VEGF|rhumab-vegf
406446|NCT01213238|Oxaliplatin|oxaliplatin
406447|NCT01213238|Capecitabine|capecitabine
406448|NCT01213238|Bevacizumab|bevacizumab
406449|NCT01213225|Elderly|elderly
406450|NCT01213225|Hospitalization|hospitalization
406451|NCT01213225|Geriatrics|geriatrics
406452|NCT01213225|Mortality|mortality
406453|NCT01213225|Readmission|readmission
406454|NCT01213225|Length of Stay|length of stay
406455|NCT01213212|Caloric restriction|caloric restriction
406456|NCT01213212|type 2 diabetes|type 2 diabetes
406457|NCT01213212|abdominal obesity|abdominal obesity
406458|NCT01213212|renal disease|renal disease
406459|NCT01213186|stem cell|stem cell
406460|NCT01213186|hiv|hiv
406461|NCT01213186|CD4|cd4
406462|NCT01213186|immune activation|immune activation
406463|NCT01213173|angina pectoris|angina pectoris
406464|NCT01213173|chest pain|chest pain
406465|NCT01213173|heart rate|heart rate
406466|NCT01213160|Phase I|phase i
406467|NCT01213160|cancer|cancer
406468|NCT01213160|solid tumours|solid tumours
406469|NCT01213160|advanced solid malignancies|advanced solid malignancies
406470|NCT01213160|dose escalation|dose escalation
406471|NCT01213160|FGFR TKI|fgfr tki
406472|NCT01213160|Japanese|japanese
406473|NCT01213147|Pregnancy|pregnancy
406474|NCT01213147|Clomiphene Citrate|clomiphene citrate
406475|NCT01213147|Fertilization|fertilization
406476|NCT01213147|Buserelin|buserelin
406477|NCT01213134|Medical Education|medical education
406478|NCT01213134|Resident Training|resident training
406479|NCT01213134|Portfolio|portfolio
406480|NCT01213121|bipolar depression|bipolar depression
406481|NCT01213121|heart rate variability|heart rate variability
406482|NCT01213121|cardio-respiratory coupling|cardio-respiratory coupling
406483|NCT01213121|electroencephalography|electroencephalography
406484|NCT01213108|Örebro prevention program|örebro prevention program
406485|NCT01213108|Youth drinking|youth drinking
406486|NCT01213095|Lymphoma|lymphoma
406487|NCT01213095|B-Cell|b-cell
406488|NCT01213095|Marginal Zone|marginal zone
406489|NCT01213095|Rituximab|rituximab
406490|NCT01213082|Exudative Age-related Macular Degeneration|exudative age-related macular degeneration
406491|NCT01213082|Proton beam irradiation|proton beam irradiation
406492|NCT01213082|ranibizumab|ranibizumab
406493|NCT01213082|bevacizumab|bevacizumab
406494|NCT01213082|anti-VEGF therapy|anti-vegf therapy
406495|NCT01213056|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
406496|NCT01213056|Chronic Headache Pain|chronic headache pain
406497|NCT01213056|Randomized Controlled Trial.|randomized controlled trial.
406498|NCT01213043|emphysema|emphysema
406499|NCT01213043|alpha 1-antitrypsin|alpha 1-antitrypsin
406500|NCT01213043|alpha 1-antitrypsin deficiency (AATD)|alpha 1-antitrypsin deficiency (aatd)
406501|NCT01213043|alpha 1-proteinase inhibitor (Alpha-1 PI)|alpha 1-proteinase inhibitor (alpha-1 pi)
406502|NCT01213030|HX4|hx4
406503|NCT01213030|[F-18]HX4|[f-18]hx4
406504|NCT01213030|FMISO|fmiso
406505|NCT01213030|[F-18]FMISO|[f-18]fmiso
406506|NCT01213030|Solitary Tumor|solitary tumor
406507|NCT01213030|Hypoxia|hypoxia
406508|NCT01213017|Certolizumab pegol|certolizumab pegol
406509|NCT01213017|Magnetic Resonance Imaging|magnetic resonance imaging
406510|NCT01213017|Rheumatoid Arthritis|rheumatoid arthritis
406511|NCT01213017|RAPID 3|rapid 3
406512|NCT01213004|gastro-esophageal junction|gastro-esophageal junction
406513|NCT01213004|lung|lung
406514|NCT01213004|abdominal|abdominal
406515|NCT01213004|cone-beam CT (CBCT)|cone-beam ct (cbct)
406516|NCT01213004|10-146|10-146
406517|NCT01212991|Progressive Metastatic Prostate Cancer|progressive metastatic prostate cancer
406518|NCT01212978|Aging|aging
406519|NCT01212978|Endothelium,Vascular|endothelium,vascular
406520|NCT01212978|Arterial Remodeling|arterial remodeling
406521|NCT01212978|Ventricular Vascular Coupling|ventricular vascular coupling
406522|NCT01212978|Nitric Oxide|nitric oxide
406523|NCT01212978|Walking|walking
406524|NCT01212978|Software|software
406525|NCT01212965|Selenium|selenium
406526|NCT01212965|Lymphatic Malformations|lymphatic malformations
406527|NCT01212965|Adolescents|adolescents
406528|NCT01212939|Dead pulps and open root ends|dead pulps and open root ends
406529|NCT01212939|Patients who have teeth with dead pulp and open root ends|patients who have teeth with dead pulp and open root ends
406715|NCT01212211|Gait|gait
406530|NCT01212900|Atherosclerosis|atherosclerosis
406531|NCT01212900|Cardiovascular Disease|cardiovascular disease
406532|NCT01212900|Cardiac MRI|cardiac mri
406533|NCT01212900|Cardiac CT|cardiac ct
406534|NCT01212900|Cholesterol|cholesterol
406535|NCT01212887|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
406536|NCT01212887|recurrent colon cancer|recurrent colon cancer
406537|NCT01212887|stage IIIA colon cancer|stage iiia colon cancer
406538|NCT01212887|stage IIIB colon cancer|stage iiib colon cancer
406539|NCT01212887|stage IIIC colon cancer|stage iiic colon cancer
406540|NCT01212887|stage IV colon cancer|stage iv colon cancer
406541|NCT01212887|stage IVB colon cancer|stage ivb colon cancer
406542|NCT01212887|recurrent rectal cancer|recurrent rectal cancer
9178|NCT03232099|Gut Flora|gut flora
406543|NCT01212887|stage IIIA rectal cancer|stage iiia rectal cancer
406544|NCT01212887|stage IIIB rectal cancer|stage iiib rectal cancer
406545|NCT01212887|stage IIIC rectal cancer|stage iiic rectal cancer
406546|NCT01212887|stage IVA rectal cancer|stage iva rectal cancer
406547|NCT01212887|stage IVB rectal cancer|stage ivb rectal cancer
406548|NCT01212887|recurrent gastric cancer|recurrent gastric cancer
406549|NCT01212887|stage IV gastric cancer|stage iv gastric cancer
406550|NCT01212887|recurrent pancreatic cancer|recurrent pancreatic cancer
406551|NCT01212887|stage III pancreatic cancer|stage iii pancreatic cancer
406552|NCT01212887|stage IV pancreatic cancer|stage iv pancreatic cancer
406553|NCT01212887|recurrent breast cancer|recurrent breast cancer
406554|NCT01212887|stage IIIC breast cancer|stage iiic breast cancer
406555|NCT01212887|stage IV breast cancer|stage iv breast cancer
406556|NCT01212887|extensive stage small cell lung cancer|extensive stage small cell lung cancer
406557|NCT01212887|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
406558|NCT01212887|recurrent small cell lung cancer|recurrent small cell lung cancer
406559|NCT01212887|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
406560|NCT01212887|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
406561|NCT01212887|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
406562|NCT01212887|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
406563|NCT01212887|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
406864|NCT01211600|Staples|staples
406564|NCT01212887|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
406565|NCT01212887|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
406566|NCT01212887|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
406567|NCT01212887|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
406568|NCT01212887|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
406569|NCT01212887|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
406570|NCT01212887|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
406571|NCT01212887|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
406572|NCT01212848|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
406573|NCT01212848|Suicidal ideation|suicidal ideation
406574|NCT01212835|Obesity|obesity
406575|NCT01212835|gastroesophageal reflux disease|gastroesophageal reflux disease
506795|NCT00221182|Angina|angina
406576|NCT01212835|Morbid obesity|morbid obesity
406577|NCT01212835|esophagitis|esophagitis
406578|NCT01212835|GERD|gerd
406579|NCT01212835|silastic ring|silastic ring
406580|NCT01212835|Gastric bypass|gastric bypass
406581|NCT01212796|allogeneic stem cell transplantation|allogeneic stem cell transplantation
406582|NCT01212783|depression|depression
406583|NCT01212783|psychological treatments|psychological treatments
406584|NCT01212783|Cognitive Behavioral Therapy|cognitive behavioral therapy
406585|NCT01212783|child development|child development
406586|NCT01212783|parenting|parenting
406587|NCT01212783|home visitation|home visitation
406588|NCT01212770|Psoriatic Arthritis|psoriatic arthritis
406589|NCT01212770|Psoriasis|psoriasis
406590|NCT01212770|Arthritis|arthritis
406591|NCT01212770|inflammation|inflammation
406592|NCT01212770|skin condition|skin condition
406593|NCT01212770|inflammatory cells|inflammatory cells
406594|NCT01212770|apremilast|apremilast
406595|NCT01212770|CC-10004|cc-10004
406596|NCT01212770|phosphodiesterase type 4|phosphodiesterase type 4
406597|NCT01212757|Psoriasis|psoriasis
406598|NCT01212757|Arthritis|arthritis
406599|NCT01212757|Psoriatic Arthritis|psoriatic arthritis
406600|NCT01212757|inflammation|inflammation
406601|NCT01212757|skin condition|skin condition
406602|NCT01212757|inflammatory cells|inflammatory cells
406603|NCT01212757|apremilast|apremilast
406604|NCT01212757|CC-10004|cc-10004
406605|NCT01212757|phosphodiesterase type 4|phosphodiesterase type 4
406606|NCT01212744|PEG PAL; PKU; injection;|peg pal; pku; injection;
406607|NCT01212731|Patients with malignancies of the skull base or patients with low grade glioma who require radiotherapy.|patients with malignancies of the skull base or patients with low grade glioma who require radiotherapy.
406608|NCT01212718|Colorectal Cancer|colorectal cancer
406609|NCT01212718|non resectable metastasis|non resectable metastasis
406610|NCT01212718|reference lesion|reference lesion
406611|NCT01212718|biopsy|biopsy
406612|NCT01212718|thymidylate synthase quantitation|thymidylate synthase quantitation
406613|NCT01212679|nerve growth factor|nerve growth factor
406614|NCT01212679|traumatic brain injury|traumatic brain injury
406615|NCT01212679|intranasal|intranasal
406616|NCT01212679|prognosis|prognosis
406617|NCT01212679|neurological function|neurological function
406618|NCT01212666|Adductor Canal Block (ACB)|adductor canal block (acb)
406619|NCT01212666|Anterior Cruciate Ligament (ACL) Reconstruction|anterior cruciate ligament (acl) reconstruction
406620|NCT01212666|Saphenous nerve|saphenous nerve
406621|NCT01212666|Pain|pain
406622|NCT01212666|Ultrasound block|ultrasound block
406623|NCT01212653|Ankylosing Spondylitis|ankylosing spondylitis
406624|NCT01212653|Golimumab|golimumab
406625|NCT01212653|Simponi|simponi
406626|NCT01212653|Anti-TNF alpha|anti-tnf alpha
406627|NCT01212653|EPCs|epcs
406628|NCT01212653|Vascular stiffness|vascular stiffness
406629|NCT01212640|Transfusion, distress|transfusion, distress
406630|NCT01212627|Non-Small Cell Lung Cancer|non-small cell lung cancer
406631|NCT01212601|safety|safety
406632|NCT01212601|efficacy|efficacy
406633|NCT01212601|Chinese patients|chinese patients
406634|NCT01212601|practice|practice
406635|NCT01212588|BPD|bpd
406636|NCT01212588|Borderline|borderline
406637|NCT01212588|personality disorder|personality disorder
406638|NCT01212588|mifepristone|mifepristone
406639|NCT01212575|Mental disorder|mental disorder
406640|NCT01212575|Antipsychotic treatment|antipsychotic treatment
406641|NCT01212562|basal cell carcinoma|basal cell carcinoma
406642|NCT01212562|cryosurgery|cryosurgery
406643|NCT01212562|imiquimod|imiquimod
406644|NCT01212562|immunocryosurgery|immunocryosurgery
406645|NCT01212549|basal cell carcinoma|basal cell carcinoma
406646|NCT01212549|cryosurgery|cryosurgery
406647|NCT01212549|imiquimod|imiquimod
406648|NCT01212549|immunocryosurgery|immunocryosurgery
406649|NCT01212536|children|children
406650|NCT01212536|intubation|intubation
406651|NCT01212536|laryngoscope|laryngoscope
406652|NCT01212523|propofol|propofol
406653|NCT01212523|isoflurane|isoflurane
406654|NCT01212523|pulmonary hypertension|pulmonary hypertension
406655|NCT01212523|congenital heart disease|congenital heart disease
406656|NCT01212510|metastatic colorectal cancer|metastatic colorectal cancer
406657|NCT01212510|circulating tumor markers|circulating tumor markers
406865|NCT01211600|Sutures|sutures
406658|NCT01212510|circulating tumor cell|circulating tumor cell
406659|NCT01212510|circulating tumor DNA|circulating tumor dna
406660|NCT01212510|marker's kinetic|marker's kinetic
406661|NCT01212497|mindfulness|mindfulness
406662|NCT01212497|meditation|meditation
406663|NCT01212497|training|training
406664|NCT01212497|coaching|coaching
406665|NCT01212497|virtual coach|virtual coach
406666|NCT01212471|Sign and symptoms of dry eye disease|sign and symptoms of dry eye disease
406667|NCT01212458|gesunde Probanden|gesunde probanden
406668|NCT01212432|Gram positive infection and CRRT|gram positive infection and crrt
406669|NCT01212406|Organ rejection|organ rejection
506998|NCT00229476|EEG|eeg
406670|NCT01212406|Lung transplantation|lung transplantation
406671|NCT01212406|Bronchiolitis Obliterans|bronchiolitis obliterans
406672|NCT01212406|Vitamin D|vitamin d
406673|NCT01212406|Prevention|prevention
406674|NCT01212393|venous thromboembolism disease|venous thromboembolism disease
406675|NCT01212393|emergency|emergency
406676|NCT01212393|prevention|prevention
406677|NCT01212393|thromboprophylaxis|thromboprophylaxis
406678|NCT01212393|medical|medical
406679|NCT01212393|hosptitalization|hosptitalization
406680|NCT01212393|health care risks|health care risks
406681|NCT01212380|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
406682|NCT01212380|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
406683|NCT01212380|Prolymphocytic Leukemia|prolymphocytic leukemia
406684|NCT01212367|Gene transfer|gene transfer
406685|NCT01212367|Immunology|immunology
406686|NCT01212367|Cancer|cancer
406687|NCT01212354|intensity modulated radiotherapy|intensity modulated radiotherapy
406688|NCT01212354|selective dose escalation|selective dose escalation
406689|NCT01212354|hypoxia|hypoxia
406690|NCT01212354|head cancer|head cancer
406691|NCT01212354|neck cancer|neck cancer
406692|NCT01212341|Allogenetic NK cells|allogenetic nk cells
406693|NCT01212341|Lymphomas|lymphomas
406694|NCT01212341|Solid tumors|solid tumors
406695|NCT01212328|T2DM|t2dm
406696|NCT01212328|Decision support software|decision support software
406697|NCT01212328|care coordinator|care coordinator
406698|NCT01212315|Wound infection|wound infection
406699|NCT01212315|SSI|ssi
406700|NCT01212315|Suture|suture
406701|NCT01212302|Clopidogrel|clopidogrel
406702|NCT01212302|ASA|asa
406703|NCT01212302|Low Response|low response
406704|NCT01212302|Resistance|resistance
406705|NCT01212263|PCOS|pcos
406706|NCT01212263|Clomiphene resistance|clomiphene resistance
406707|NCT01212263|ovulation induction|ovulation induction
406708|NCT01212263|low dose uFSH|low dose ufsh
406709|NCT01212263|uFSH step-up protocol|ufsh step-up protocol
406710|NCT01212237|glioma|glioma
406711|NCT01212237|meningioma|meningioma
406712|NCT01212237|anaplastic astrocytoma|anaplastic astrocytoma
406713|NCT01212211|Hyponatremia; Sodium level|hyponatremia; sodium level
406714|NCT01212211|Falls|falls
406716|NCT01212211|elderly|elderly
406717|NCT01212185|oxytocin|oxytocin
406718|NCT01212185|alcohol withdrawal|alcohol withdrawal
406719|NCT01212185|lorazepam|lorazepam
406720|NCT01212185|alcoholism|alcoholism
406721|NCT01212185|intranasal administration|intranasal administration
406722|NCT01212185|CIWA-Ar|ciwa-ar
406723|NCT01212172|Hair removal|hair removal
406724|NCT01212172|Laser|laser
406725|NCT01212172|Diode laser|diode laser
406726|NCT01212159|Internet based monitoring system|internet based monitoring system
406727|NCT01212146|Artichokes|artichokes
406728|NCT01212146|Constipation|constipation
406729|NCT01212146|Functional Foods|functional foods
406730|NCT01212146|Prebiotics|prebiotics
406731|NCT01212146|Probiotics|probiotics
406732|NCT01212120|Diabetic foot|diabetic foot
406733|NCT01212107|Advanced cancer|advanced cancer
406734|NCT01212107|Metastatic cancer|metastatic cancer
406735|NCT01212107|Oncology|oncology
406736|NCT01212094|Rituximab|rituximab
406737|NCT01212094|Multiple Sclerosis|multiple sclerosis
406738|NCT01212094|Intrathecal|intrathecal
406740|NCT01212094|Secondary-Progressive Multiple Sclerosis|secondary-progressive multiple sclerosis
406741|NCT01212094|SP-MS|sp-ms
406742|NCT01212081|Virtual Reality|virtual reality
406743|NCT01212081|Schizophrenia|schizophrenia
406744|NCT01212081|Cannabis|cannabis
406745|NCT01212081|Assessment|assessment
406746|NCT01212081|Craving|craving
406747|NCT01212068|MEG|meg
406748|NCT01212068|Epilepsy|epilepsy
406749|NCT01212068|Brain Imaging|brain imaging
406750|NCT01212068|Brain Scan|brain scan
406751|NCT01212068|Auditory Processing|auditory processing
406752|NCT01212068|Auditory Perceptual Disorder|auditory perceptual disorder
406753|NCT01212055|PBSC Collection|pbsc collection
406754|NCT01212055|Immunodeficiency|immunodeficiency
406755|NCT01212055|Spectra Apheresis System|spectra apheresis system
406756|NCT01212055|Stem Cell Mobilization|stem cell mobilization
406757|NCT01212055|Leukapheresis|leukapheresis
406758|NCT01212042|Pneumonia|pneumonia
406759|NCT01212042|Pulmonary Pathogens|pulmonary pathogens
406760|NCT01212042|HIV|hiv
406761|NCT01212042|Immunocompromised Host|immunocompromised host
407159|NCT01210417|Trauma|trauma
406762|NCT01212042|Respiratory Infection|respiratory infection
406763|NCT01212042|Mycobacteria|mycobacteria
406764|NCT01212029|Near Infrared|near infrared
406765|NCT01212029|Optical Imaging|optical imaging
406766|NCT01212029|Brain Imaging|brain imaging
406767|NCT01212029|Healthy Volunteer|healthy volunteer
406768|NCT01212029|HV|hv
406769|NCT01212016|Eosinophilic Esophagitis|eosinophilic esophagitis
406770|NCT01212016|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
406771|NCT01212016|Peanut Allergy|peanut allergy
406772|NCT01212016|T Cell|t cell
406773|NCT01212016|IgE|ige
406774|NCT01212016|Food Allergy|food allergy
406775|NCT01212003|Mycobacterium Tuberculosis|mycobacterium tuberculosis
406776|NCT01212003|Active Tuberculosis|active tuberculosis
406777|NCT01212003|Latent Tuberculosis|latent tuberculosis
406778|NCT01212003|Tuberculosis|tuberculosis
406779|NCT01212003|TB|tb
406780|NCT01211990|Pediatric|pediatric
406781|NCT01211990|Children|children
406782|NCT01211990|Cancer|cancer
406783|NCT01211990|Bone Marrow Transplant|bone marrow transplant
406784|NCT01211977|Muckle Wells Syndrome|muckle wells syndrome
406785|NCT01211977|Autoinflammatory|autoinflammatory
406786|NCT01211977|Interleukin-1|interleukin-1
406787|NCT01211951|Dry eye syndromes|dry eye syndromes
406788|NCT01211951|Corneal diseases|corneal diseases
406789|NCT01211951|Conjunctival diseases|conjunctival diseases
406790|NCT01211938|phase II/III|phase ii/iii
406791|NCT01211938|upper aerodigestive tract carcinoma|upper aerodigestive tract carcinoma
406792|NCT01211938|re irradiation|re irradiation
747083|NCT01152021|children|children
406793|NCT01211938|Recurrent or second upper aerodigestive tract carcinoma|recurrent or second upper aerodigestive tract carcinoma
406794|NCT01211925|unreconstructable peripheral arterial disease|unreconstructable peripheral arterial disease
406795|NCT01211912|Fetal movement|fetal movement
406796|NCT01211912|Fetal breathing|fetal breathing
406797|NCT01211912|Acetaminophen|acetaminophen
406798|NCT01211899|polymorphism,|polymorphism,
406799|NCT01211899|plasminogen activator inhibitor,|plasminogen activator inhibitor,
406800|NCT01211899|disseminated intravascular coagulation,|disseminated intravascular coagulation,
406801|NCT01211886|Brain natriuretic peptide|brain natriuretic peptide
406802|NCT01211886|Cardio-renal syndrome|cardio-renal syndrome
406803|NCT01211873|CNS|cns
406804|NCT01211873|Contrast Agent|contrast agent
406805|NCT01211873|MRI|mri
406806|NCT01211873|Dotarem|dotarem
406807|NCT01211873|Magnevist|magnevist
406808|NCT01211860|DCCR|dccr
406809|NCT01211860|Diazoxide Chonline Controlled-Release Tablet = DCCR|diazoxide chonline controlled-release tablet = dccr
406810|NCT01211860|Hypertriglyceridemia|hypertriglyceridemia
406811|NCT01211860|Triglycerides|triglycerides
406812|NCT01211860|Pharmacokinetics|pharmacokinetics
406813|NCT01211847|triglycerides|triglycerides
406814|NCT01211847|Apo B|apo b
406815|NCT01211847|non-HDL|non-hdl
406816|NCT01211847|statin|statin
406817|NCT01211847|fenofibrate|fenofibrate
406818|NCT01211795|Migraine|migraine
406819|NCT01211795|Prevention|prevention
406820|NCT01211795|Treatment|treatment
406821|NCT01211795|Ketoprofen|ketoprofen
406822|NCT01211795|Trigeminal nerve|trigeminal nerve
406823|NCT01211782|Alzheimer's disease|alzheimer's disease
406824|NCT01211782|AD|ad
406825|NCT01211782|AC-1204|ac-1204
406826|NCT01211782|ketogenic|ketogenic
406827|NCT01211782|ketosis|ketosis
406828|NCT01211769|PUFAs|pufas
406829|NCT01211769|Alcoholism|alcoholism
406830|NCT01211769|Treatment|treatment
406831|NCT01211769|Effectiveness|effectiveness
406832|NCT01211743|SILS|sils
406833|NCT01211743|Oxidative Stress|oxidative stress
406834|NCT01211743|8-epiPGF2a|8-epipgf2a
406835|NCT01211743|SILS vs standard laparoscopic cholecystectomy|sils vs standard laparoscopic cholecystectomy
406836|NCT01211730|Liver|liver
406837|NCT01211730|transplantation|transplantation
406838|NCT01211730|Glucose|glucose
406839|NCT01211730|Hyperglycemia|hyperglycemia
406840|NCT01211730|Insulin|insulin
406841|NCT01211730|Rejection|rejection
406842|NCT01211730|Hypoglycemia|hypoglycemia
406843|NCT01211717|Branched Chained Amino Acids|branched chained amino acids
406844|NCT01211717|Delayed Onset Muscle Soreness|delayed onset muscle soreness
406845|NCT01211717|Diabetes|diabetes
406846|NCT01211717|Muscle Damage|muscle damage
406847|NCT01211704|Bipolar, Alcoholism|bipolar, alcoholism
406848|NCT01211691|Hematologic|hematologic
406849|NCT01211691|Leukemia|leukemia
406850|NCT01211691|Malignancies|malignancies
406851|NCT01211691|Myeloproliferative Neoplasms|myeloproliferative neoplasms
406852|NCT01211665|IVMP|ivmp
406853|NCT01211665|corticosteroids|corticosteroids
406854|NCT01211665|IRIS|iris
406855|NCT01211665|Progressive Multifocal Leukoencephalopathy|progressive multifocal leukoencephalopathy
406856|NCT01211665|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
406857|NCT01211665|PML|pml
406858|NCT01211652|Compliance|compliance
406859|NCT01211652|France|france
406860|NCT01211652|Self-administered questionnaire to patients|self-administered questionnaire to patients
406861|NCT01211613|Manipulation|manipulation
406862|NCT01211613|Chiropractic|chiropractic
406863|NCT01211613|Low Back Pain|low back pain
406866|NCT01211600|Wound infections|wound infections
406867|NCT01211600|Cosmesis|cosmesis
406868|NCT01211600|Aesthetic appearance of skin incision|aesthetic appearance of skin incision
406869|NCT01211587|Parkinson's Disease|parkinson's disease
406870|NCT01211587|Cognition|cognition
406871|NCT01211587|Safinamide|safinamide
406872|NCT01211587|Phase 2|phase 2
406873|NCT01211587|Non-demented patients|non-demented patients
406874|NCT01211587|Levodopa|levodopa
406875|NCT01211587|Dopamine agonist|dopamine agonist
406876|NCT01211535|Soft contact lenses|soft contact lenses
406877|NCT01211535|Multi-purpose Solution|multi-purpose solution
406878|NCT01211522|Delirium|delirium
406879|NCT01211522|Intensive care|intensive care
406880|NCT01211522|Mechanical ventilation|mechanical ventilation
406881|NCT01211522|Antipsychotic|antipsychotic
406882|NCT01211522|Haloperidol|haloperidol
406883|NCT01211522|Ziprasidone|ziprasidone
406884|NCT01211522|Randomized|randomized
406885|NCT01211522|Placebo|placebo
406886|NCT01211522|Sepsis|sepsis
406887|NCT01211522|Sedation|sedation
406888|NCT01211522|Long-term cognitive impairment|long-term cognitive impairment
406889|NCT01211509|montelukast|montelukast
406890|NCT01211509|cysteinyl leukotriene|cysteinyl leukotriene
406891|NCT01211509|lung transplantation|lung transplantation
406892|NCT01211509|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
406893|NCT01211496|functional testing|functional testing
406894|NCT01211496|resistance training|resistance training
406895|NCT01211496|velocity training|velocity training
406896|NCT01211496|elderly|elderly
406897|NCT01211496|geriatric|geriatric
406898|NCT01211496|knee|knee
406899|NCT01211496|leg|leg
406900|NCT01211496|leg strength|leg strength
406901|NCT01211483|Lung cancer|lung cancer
406902|NCT01211470|MRSA|mrsa
406903|NCT01211470|ABSSSI|absssi
406904|NCT01211470|Staphylococcus aureus|staphylococcus aureus
406905|NCT01211444|Obstructive Sleep Apnea|obstructive sleep apnea
406906|NCT01211444|OSA|osa
406907|NCT01211444|Hypoglossal nerve stimulation|hypoglossal nerve stimulation
406908|NCT01211444|Sleep apnea|sleep apnea
406909|NCT01211431|cesarean section|cesarean section
406910|NCT01211431|pain|pain
406911|NCT01211431|ropivacain|ropivacain
406912|NCT01211431|diclofena|diclofena
406913|NCT01211431|morphine|morphine
406914|NCT01211405|MDMA|mdma
406915|NCT01211405|Psychotherapy|psychotherapy
406916|NCT01211405|Veterans|veterans
406917|NCT01211405|Posttraumatic Stress Disorder|posttraumatic stress disorder
406918|NCT01211379|colorectal cancer screening|colorectal cancer screening
406919|NCT01211379|primary care|primary care
406920|NCT01211379|health disparities|health disparities
406921|NCT01211366|cell saver|cell saver
406922|NCT01211366|allogeneic RBCs|allogeneic rbcs
406923|NCT01211366|washed cells|washed cells
406924|NCT01211366|PRBC transfusion|prbc transfusion
406925|NCT01211353|Alcohol|alcohol
406926|NCT01211353|Brief Intervention|brief intervention
406927|NCT01211353|Personalized Feedback|personalized feedback
406928|NCT01211353|Veterans|veterans
406929|NCT01211340|Hospice|hospice
406930|NCT01211340|Caregivers|caregivers
406931|NCT01211340|Interdisciplinary Team|interdisciplinary team
406932|NCT01211340|Pain management|pain management
406933|NCT01211314|hypertension|hypertension
406934|NCT01211314|Fixed combination|fixed combination
406935|NCT01211314|lercanidipine|lercanidipine
406936|NCT01211314|enalapril|enalapril
406937|NCT01211314|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
406938|NCT01211301|obesity|obesity
406939|NCT01211301|overweight|overweight
406940|NCT01211301|weight loss|weight loss
406941|NCT01211301|randomized controlled trial|randomized controlled trial
406942|NCT01211301|Medifast|medifast
406943|NCT01211288|HIV|hiv
406944|NCT01211288|Implant|implant
406945|NCT01211288|Crown|crown
406946|NCT01211275|mesothelioma|mesothelioma
406947|NCT01211275|chemotherapy|chemotherapy
406948|NCT01211275|translational research|translational research
406949|NCT01211275|axitinib|axitinib
406950|NCT01211262|Melanoma|melanoma
406951|NCT01211262|Phase I|phase i
406952|NCT01211262|Biologic|biologic
406953|NCT01211249|Methotrexate-refractory|methotrexate-refractory
406954|NCT01211223|Chronic periodontitis|chronic periodontitis
406955|NCT01211223|Metronidazole plus Amoxicillin|metronidazole plus amoxicillin
406956|NCT01211223|Mechanical periodontal therapy|mechanical periodontal therapy
406957|NCT01211223|Scaling and Root Planning|scaling and root planning
406958|NCT01211223|Periodontal treatment|periodontal treatment
406959|NCT01211210|rectal cancer|rectal cancer
406960|NCT01211210|neoadjuvant therapy|neoadjuvant therapy
406961|NCT01211210|oxaliplatin|oxaliplatin
406962|NCT01211210|radiation|radiation
406963|NCT01211184|Hip surgery|hip surgery
406964|NCT01211184|Metabolism|metabolism
406965|NCT01211184|Glucose|glucose
406966|NCT01211184|Body fluids|body fluids
406967|NCT01211184|Complications|complications
406968|NCT01211171|Cough|cough
406969|NCT01211171|Telmisartan|telmisartan
406970|NCT01211171|Bradykinin|bradykinin
406971|NCT01211171|Tolerability|tolerability
406972|NCT01211158|emergency department|emergency department
406973|NCT01211158|procedural sedation|procedural sedation
406974|NCT01211158|ketofol|ketofol
406975|NCT01211158|ketamine|ketamine
406976|NCT01211158|propofol|propofol
406977|NCT01211158|conscious sedation|conscious sedation
406978|NCT01211145|Migraine|migraine
406979|NCT01211145|Headache|headache
406980|NCT01211145|Pain|pain
200952|NCT02112877|venous obstruction|venous obstruction
406981|NCT01211145|Efficacy|efficacy
406982|NCT01211145|Adolescents|adolescents
406983|NCT01211132|Colon polyps|colon polyps
406984|NCT01211132|Adenoma detection|adenoma detection
406985|NCT01211132|Cap|cap
406986|NCT01211132|Standard|standard
406987|NCT01211132|Colon Cancer|colon cancer
406988|NCT01211106|Treatment|treatment
406989|NCT01211106|PTSD|ptsd
406990|NCT01211106|Addiction|addiction
406991|NCT01211093|vibration|vibration
406992|NCT01211093|muscle|muscle
406993|NCT01211093|cerebrovascular accident|cerebrovascular accident
406994|NCT01211093|exercise|exercise
406995|NCT01211093|rehabilitation|rehabilitation
406996|NCT01211080|infancy hemangioma|infancy hemangioma
406997|NCT01211080|propranolol|propranolol
406998|NCT01211080|study design|study design
406999|NCT01211080|side effects|side effects
407000|NCT01211080|safety|safety
407001|NCT01211067|Inguinal hernia|inguinal hernia
407002|NCT01211067|Inguinal ring|inguinal ring
407003|NCT01211067|Histology|histology
407004|NCT01211067|Hernioplasty|hernioplasty
407005|NCT01211067|Lichtenstein|lichtenstein
407006|NCT01211041|Candida albicans, fungemia , prognostic factor|candida albicans, fungemia , prognostic factor
407007|NCT01211028|Critical leg ischemia|critical leg ischemia
407008|NCT01211028|Adipose derived Stroma/Stem Cells|adipose derived stroma/stem cells
407009|NCT01211028|Autologous|autologous
407010|NCT01211028|Angiogenesis|angiogenesis
407011|NCT01211002|Radiotherapy|radiotherapy
407012|NCT01211002|rh-endostatin|rh-endostatin
407013|NCT01211002|chemotherapy|chemotherapy
407014|NCT01211002|NSCLC|nsclc
407015|NCT01210976|levosimendan|levosimendan
407016|NCT01210976|CABG|cabg
407017|NCT01210976|AVR|avr
407018|NCT01210950|distraction|distraction
407019|NCT01210950|osteogenesis|osteogenesis
407020|NCT01210950|limb length discrepancy|limb length discrepancy
407021|NCT01210950|callus|callus
407022|NCT01210937|Internal Carotid Artery Stenosis|internal carotid artery stenosis
407023|NCT01210937|Carotid Endarterectomy|carotid endarterectomy
407024|NCT01210937|Stroke|stroke
407025|NCT01210937|Cerebrovascular|cerebrovascular
407026|NCT01210937|Atherosclerosis|atherosclerosis
407027|NCT01210924|children|children
407028|NCT01210924|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
407029|NCT01210924|antiretroviral therapy|antiretroviral therapy
407030|NCT01210924|China|china
407031|NCT01210924|Mortality|mortality
407032|NCT01210911|pancreatic cancer|pancreatic cancer
407033|NCT01210911|metformin|metformin
407034|NCT01210911|MAPK pathway|mapk pathway
407035|NCT01210911|PI3K/Akt pathway|pi3k/akt pathway
407036|NCT01210911|gemcitabine|gemcitabine
407037|NCT01210898|Influenza|influenza
407038|NCT01210898|Trivalent|trivalent
407039|NCT01210898|Adjuvanted|adjuvanted
407040|NCT01210898|Vaccine|vaccine
407041|NCT01210898|Children|children
407042|NCT01210885|Meningococcal Disease|meningococcal disease
407043|NCT01210885|Vaccines|vaccines
407044|NCT01210885|Adolescents|adolescents
407045|NCT01210872|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
9179|NCT03232099|Atherosclerosis|atherosclerosis
407046|NCT01210872|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
407047|NCT01210872|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
407048|NCT01210872|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
407049|NCT01210872|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
407050|NCT01210872|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
407051|NCT01210872|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
407052|NCT01210872|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
407053|NCT01210872|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
407054|NCT01210872|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
407055|NCT01210872|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
407056|NCT01210872|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
407057|NCT01210872|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
407058|NCT01210872|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
407059|NCT01210872|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
407060|NCT01210872|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
407061|NCT01210872|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
407062|NCT01210872|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
407063|NCT01210872|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
407064|NCT01210872|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
407065|NCT01210872|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
407066|NCT01210872|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
407067|NCT01210872|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
407068|NCT01210872|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
407069|NCT01210872|tongue cancer|tongue cancer
407070|NCT01210859|detrusitol|detrusitol
407071|NCT01210859|overactive|overactive
407072|NCT01210859|bladder|bladder
407073|NCT01210859|ureteral|ureteral
407074|NCT01210859|stents|stents
407075|NCT01210846|AV-951|av-951
407076|NCT01210846|tivozanib|tivozanib
407078|NCT01210846|advanced solid tumors|advanced solid tumors
407079|NCT01210846|pharmacokinetics|pharmacokinetics
407080|NCT01210833|Finger Fractures|finger fractures
407081|NCT01210833|Tendon Injuries|tendon injuries
407082|NCT01210833|Soft Tissue Injuries|soft tissue injuries
407083|NCT01210781|All indication for deep brain stimulation (DBS)|all indication for deep brain stimulation (dbs)
407084|NCT01210768|Phase II|phase ii
407085|NCT01210768|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
407086|NCT01210768|Adjuvant Chemotherapy|adjuvant chemotherapy
407087|NCT01210768|Breast Cancer|breast cancer
407088|NCT01210755|Antithrombotics|antithrombotics
407089|NCT01210755|Haemostatics|haemostatics
407090|NCT01210755|Antidote|antidote
407091|NCT01210729|stroke|stroke
407092|NCT01210729|mechanical recanalization|mechanical recanalization
407093|NCT01210729|self-expanding stent|self-expanding stent
407094|NCT01210729|Solitaire|solitaire
407095|NCT01210716|Therapeutic plasma exchange|therapeutic plasma exchange
407096|NCT01210716|Autoimmune diseases|autoimmune diseases
407097|NCT01210716|Kidney transplant|kidney transplant
407098|NCT01210716|Hematologic disorders|hematologic disorders
407099|NCT01210716|Monoclonal gammopathy|monoclonal gammopathy
407100|NCT01210716|Neurologic disorders|neurologic disorders
407101|NCT01210703|Acoustic Pharyngometry|acoustic pharyngometry
407102|NCT01210703|CPAP|cpap
407103|NCT01210703|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
407104|NCT01210690|Levetiracetam|levetiracetam
407105|NCT01210690|Keppra® Oral Solution|keppra® oral solution
407106|NCT01210690|Keppra® in Children|keppra® in children
407107|NCT01210677|Cardiac Sarcoidosis|cardiac sarcoidosis
407108|NCT01210677|Sarcoidosis|sarcoidosis
407109|NCT01210664|Diabetes|diabetes
407110|NCT01210664|Treg|treg
407111|NCT01210651|Yoga|yoga
407112|NCT01210651|Major Depression|major depression
407113|NCT01210651|Self-Efficacy|self-efficacy
407114|NCT01210651|Self-Esteem|self-esteem
407115|NCT01210651|Hatha yoga|hatha yoga
407116|NCT01210651|mind-body therapies|mind-body therapies
407117|NCT01210651|depression|depression
407118|NCT01210625|Constipation|constipation
407119|NCT01210599|Back Pain|back pain
407120|NCT01210599|Bisphosphonate|bisphosphonate
407121|NCT01210599|Pamidronate|pamidronate
407122|NCT01210599|Bone Pain|bone pain
407123|NCT01210573|Heart Failure|heart failure
407124|NCT01210573|Heart-Assist Devices|heart-assist devices
407125|NCT01210573|Left Ventricular Assist Device|left ventricular assist device
407126|NCT01210560|Kidney Disease|kidney disease
407127|NCT01210560|Polycystic Kidney Disease|polycystic kidney disease
407128|NCT01210521|Asthmatic Patients|asthmatic patients
407129|NCT01210521|Vitamin D|vitamin d
407130|NCT01210521|Steroid Resistant Asthmatic Patients|steroid resistant asthmatic patients
407131|NCT01210521|cholecalciferol|cholecalciferol
407132|NCT01210508|Cancer patients with metastases to the spinal column|cancer patients with metastases to the spinal column
407133|NCT01210495|Hepatocellular Carcinoma|hepatocellular carcinoma
407134|NCT01210482|Torisel|torisel
407135|NCT01210482|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
407136|NCT01210469|elderly|elderly
407137|NCT01210469|postural balance|postural balance
407138|NCT01210469|musculoskeletal equilibrium|musculoskeletal equilibrium
407139|NCT01210469|posture|posture
407140|NCT01210469|muscle strength|muscle strength
407141|NCT01210469|muscle stretching exercises|muscle stretching exercises
407142|NCT01210456|Chronic Kidney Disease|chronic kidney disease
407143|NCT01210456|Contrast Media|contrast media
407144|NCT01210456|Acute Kidney Injury|acute kidney injury
407145|NCT01210456|N-Acetylcysteine|n-acetylcysteine
407146|NCT01210456|Bicarbonate|bicarbonate
407147|NCT01210443|sitaxentan sodium pulmonary hypertension|sitaxentan sodium pulmonary hypertension
407148|NCT01210430|Postural Tachycardia Syndrome|postural tachycardia syndrome
407149|NCT01210430|Orthostatic Intolerance|orthostatic intolerance
407150|NCT01210430|Reactive Oxygen Species|reactive oxygen species
407151|NCT01210430|Oxidative Stress|oxidative stress
407152|NCT01210430|Angiotensin II|angiotensin ii
407153|NCT01210430|Nitric Oxide|nitric oxide
407154|NCT01210430|Blood Flow|blood flow
407155|NCT01210430|POTS|pots
407156|NCT01210430|Ascorbic Acid|ascorbic acid
407157|NCT01210430|Vitamin C|vitamin c
407158|NCT01210430|Losartan|losartan
407160|NCT01210417|Hypovolemia|hypovolemia
407161|NCT01210417|Hemorrhage|hemorrhage
407162|NCT01210417|Out of hospital trauma|out of hospital trauma
407163|NCT01210404|Drug interaction with methadone.|drug interaction with methadone.
407164|NCT01210378|NSCLC|nsclc
407165|NCT01210378|Nitroglycerin|nitroglycerin
407166|NCT01210378|Tumour perfusion|tumour perfusion
407167|NCT01210378|Hypoxia|hypoxia
407168|NCT01210378|Toxicity|toxicity
407169|NCT01210378|Phase II|phase ii
407171|NCT01210365|CHF functional class II|chf functional class ii
407172|NCT01210365|Patients with CHF|patients with chf
407173|NCT01210365|Patients with CHF functional class II (NYHA) of any etiology|patients with chf functional class ii (nyha) of any etiology
407174|NCT01210352|surgical pain|surgical pain
407175|NCT01210352|acute pain|acute pain
407176|NCT01210352|Acute Post Surgical Pain|acute post surgical pain
407177|NCT01210339|phase 1|phase 1
407178|NCT01210339|cross-over|cross-over
407179|NCT01210339|drug-drug Interaction|drug-drug interaction
407180|NCT01210339|esomeprazole|esomeprazole
407181|NCT01210339|acetylsalicylic acid|acetylsalicylic acid
407182|NCT01210339|clopidogrel|clopidogrel
407183|NCT01210339|healthy volunteers|healthy volunteers
747188|NCT01152385|Japanese|japanese
407184|NCT01210339|cardiovascular disease|cardiovascular disease
407185|NCT01210339|patients with acid associated gastrointestinal symptoms|patients with acid associated gastrointestinal symptoms
407186|NCT01210326|TESE|tese
407187|NCT01210326|TESA|tesa
407188|NCT01210326|non obstructive|non obstructive
407189|NCT01210326|azoospermi|azoospermi
407190|NCT01210313|physical activity|physical activity
407191|NCT01210300|caesarean section|caesarean section
407192|NCT01210300|vaginal birth after caesarean section|vaginal birth after caesarean section
407193|NCT01210300|repeat caesarean section|repeat caesarean section
407194|NCT01210300|childbirth expectation|childbirth expectation
407195|NCT01210300|childbirth experience|childbirth experience
407196|NCT01210287|hepatitis B virus reactivation|hepatitis b virus reactivation
407197|NCT01210287|HBsAg negative|hbsag negative
407198|NCT01210287|HBcAb positive|hbcab positive
407199|NCT01210287|lymphoma|lymphoma
407200|NCT01210287|rituximab|rituximab
407201|NCT01210261|OSA|osa
407202|NCT01210261|CPAP|cpap
407203|NCT01210261|APAP|apap
407204|NCT01210261|SPAP|spap
407205|NCT01210261|Obstructive Sleep Apnea|obstructive sleep apnea
407206|NCT01210261|Sleep Apnea|sleep apnea
407207|NCT01210235|colorectal cancer screening|colorectal cancer screening
407208|NCT01210235|preventive health|preventive health
407209|NCT01210235|primary care|primary care
407210|NCT01210209|Ewing sarcoma|ewing sarcoma
407211|NCT01210209|Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)|ewing sarcoma/peripheral primitive neuroectodermal tumor (pnet)
407212|NCT01210196|Fabry|fabry
407213|NCT01210183|Dextrose|dextrose
407214|NCT01210183|Cartilage|cartilage
407215|NCT01210183|Regeneration|regeneration
407216|NCT01210170|asthma,|asthma,
407217|NCT01210170|inhaled corticosteroids,|inhaled corticosteroids,
407218|NCT01210170|airway blood flow,|airway blood flow,
407219|NCT01210170|mometasone,|mometasone,
407220|NCT01210170|albuterol|albuterol
407221|NCT01210170|spirometry|spirometry
407222|NCT01210144|Infertility|infertility
407223|NCT01210144|Gonal-f|gonal-f
407224|NCT01210144|gene expression|gene expression
407225|NCT01210144|Assisted Reproductive Technologies|assisted reproductive technologies
407226|NCT01210144|Follitropin alfa|follitropin alfa
407227|NCT01210144|endometrium|endometrium
407228|NCT01210131|Toxicity|toxicity
407229|NCT01210131|Progression|progression
407230|NCT01210131|Survival|survival
407231|NCT01210131|SCLC|sclc
407232|NCT01210118|Pregnancy|pregnancy
407233|NCT01210118|Smoking cessation|smoking cessation
407234|NCT01210118|Cognitive-Behavioural interventions|cognitive-behavioural interventions
407235|NCT01210105|intubation|intubation
407236|NCT01210105|video laryngoscopes|video laryngoscopes
407237|NCT01210079|opioid-induced hyperalgesia|opioid-induced hyperalgesia
407238|NCT01210079|methadone|methadone
407239|NCT01210079|gabapentin|gabapentin
407240|NCT01210079|opioid addiction|opioid addiction
407241|NCT01210066|inflammation|inflammation
407242|NCT01210066|opioid-induced hyperalgesia|opioid-induced hyperalgesia
407243|NCT01210066|bupenorphine|bupenorphine
407244|NCT01210066|prescription opioid abuse|prescription opioid abuse
407245|NCT01210053|Non-Small Cell Lung Cancer|non-small cell lung cancer
407246|NCT01210040|Pregnancy|pregnancy
407247|NCT01210040|Iron deficiency|iron deficiency
407248|NCT01210040|Iron supplementation|iron supplementation
407249|NCT01210040|Burkina Faso|burkina faso
407250|NCT01210014|Recurrent aphthous stomatitis|recurrent aphthous stomatitis
407251|NCT01210014|treatment|treatment
407252|NCT01210014|zinc sulphate|zinc sulphate
407253|NCT01209975|blood flow|blood flow
407254|NCT01209975|glaucoma|glaucoma
407255|NCT01209975|SLT|slt
407256|NCT01209936|Body Fat|body fat
407257|NCT01209936|Total body water|total body water
407258|NCT01209923|Percent body fat|percent body fat
407259|NCT01209923|Body Composition|body composition
406318|NCT01214096|rhNRG-1|rhnrg-1
407260|NCT01209923|Stayhealthy|stayhealthy
407261|NCT01209897|Smoking|smoking
407262|NCT01209871|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
407263|NCT01209871|Recombinant DNA|recombinant dna
407264|NCT01209871|Fusion DNA Vaccine|fusion dna vaccine
407265|NCT01209871|Waldenström macroglobulinemia|waldenström macroglobulinemia
407266|NCT01209858|epilepsy|epilepsy
407267|NCT01209845|depression|depression
407268|NCT01209845|suicide ideation|suicide ideation
407269|NCT01209845|emergency department|emergency department
407270|NCT01209845|ketamine|ketamine
407271|NCT01209832|Metastatic Tumors|metastatic tumors
407272|NCT01209832|Lymphoma|lymphoma
407273|NCT01209819|Bone Mineral Density|bone mineral density
407274|NCT01209819|Adults|adults
407275|NCT01209780|seasonal influenza, vaccine|seasonal influenza, vaccine
407276|NCT01209767|Cellulite|cellulite
407277|NCT01209767|Cryolipolysis|cryolipolysis
407278|NCT01209767|Zeltiq|zeltiq
407279|NCT01209767|Subcision|subcision
407280|NCT01209754|Pregnancy|pregnancy
407281|NCT01209754|Chemoprophylactic Exposure|chemoprophylactic exposure
407282|NCT01209754|Mother|mother
407283|NCT01209754|Infant|infant
407284|NCT01209754|malformations|malformations
407285|NCT01209754|HIV|hiv
407286|NCT01209728|insomnia|insomnia
407287|NCT01209728|insomniacs|insomniacs
407288|NCT01209728|simulated driving|simulated driving
407289|NCT01209728|alcohol|alcohol
407290|NCT01209728|ethanol|ethanol
407291|NCT01209715|airway blood flow,|airway blood flow,
407292|NCT01209715|COPD,|copd,
407293|NCT01209715|endothelial dysfunction|endothelial dysfunction
407294|NCT01209715|inhaled corticosteroids|inhaled corticosteroids
407295|NCT01209676|melanoma, with advanced unresectable|melanoma, with advanced unresectable
407296|NCT01209663|General Surgery|general surgery
407297|NCT01209663|Emergency treatment|emergency treatment
407298|NCT01209663|Postoperative care|postoperative care
407299|NCT01209663|Intermediate care unit|intermediate care unit
407300|NCT01209663|High dependency unit|high dependency unit
407301|NCT01209663|Mortality|mortality
407302|NCT01209637|stable coronary artery disease|stable coronary artery disease
407303|NCT01209637|significant coronary stenosis|significant coronary stenosis
407304|NCT01209624|prospective|prospective
407305|NCT01209624|non-interventional|non-interventional
407306|NCT01209624|observational|observational
407307|NCT01209624|multi-center|multi-center
407308|NCT01209624|long-term|long-term
407309|NCT01209598|soft tissue|soft tissue
407310|NCT01209598|Palbociclib (PD0332991)|palbociclib (pd0332991)
407311|NCT01209598|10-094|10-094
407312|NCT01209572|energy expenditure|energy expenditure
407313|NCT01209572|heart rate|heart rate
407314|NCT01209572|accelerometry|accelerometry
407315|NCT01209572|body temperature|body temperature
407909|NCT01207089|overweight|overweight
407316|NCT01209572|heat flow galvanic response of skin|heat flow galvanic response of skin
407317|NCT01209546|Bronchiectasis|bronchiectasis
407318|NCT01209546|Pulmonary function|pulmonary function
407319|NCT01209546|Respiratory muscle strength|respiratory muscle strength
407320|NCT01209546|Respiratory secretions|respiratory secretions
407321|NCT01209533|Asthma|asthma
407322|NCT01209520|Lung Cancer|lung cancer
407323|NCT01209520|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
407324|NCT01209520|NSCLC|nsclc
407325|NCT01209520|Methylation Analysis|methylation analysis
407326|NCT01209520|Hypermethylation|hypermethylation
407327|NCT01209520|Targeted Genes|targeted genes
407328|NCT01209520|Tumorigenesis|tumorigenesis
407329|NCT01209520|Tumor Supressor Genes|tumor supressor genes
9180|NCT03232099|Wine|wine
407330|NCT01209507|Adrenal suppression|adrenal suppression
407331|NCT01209507|Chemotherapy fatigue|chemotherapy fatigue
407332|NCT01209507|Quality of life|quality of life
407333|NCT01209494|sudden cardiac death|sudden cardiac death
407334|NCT01209494|implantable cardioverter defibrillator|implantable cardioverter defibrillator
407335|NCT01209494|ventricular arrhythmias|ventricular arrhythmias
407336|NCT01209494|genetic syndromes|genetic syndromes
407337|NCT01209494|calcium metabolism|calcium metabolism
407338|NCT01209494|ventricular repolarization|ventricular repolarization
407339|NCT01209494|ECG|ecg
407340|NCT01209494|T wave|t wave
407341|NCT01209494|programmed electrical stimulation|programmed electrical stimulation
407342|NCT01209494|alternans|alternans
407343|NCT01209494|late potentials|late potentials
407344|NCT01209494|risk stratification|risk stratification
407345|NCT01209481|fruits|fruits
407346|NCT01209481|vegetables|vegetables
407347|NCT01209481|primary health care|primary health care
407348|NCT01209481|nutritional education|nutritional education
407349|NCT01209455|Acetylcysteine|acetylcysteine
407350|NCT01209455|Adverse effects|adverse effects
407351|NCT01209455|Acetaminophen|acetaminophen
407352|NCT01209455|Anaphylactoid reactions|anaphylactoid reactions
407353|NCT01209442|Glioblastoma|glioblastoma
407354|NCT01209442|Multiforme|multiforme
407355|NCT01209429|Calorie restriction|calorie restriction
407356|NCT01209429|GH/IGF-I axis|gh/igf-i axis
407357|NCT01209429|STATb5|statb5
406420|NCT01213316|HIV|hiv
407358|NCT01209429|SIRT1|sirt1
407359|NCT01209429|Intracellular signaling peptides and proteins|intracellular signaling peptides and proteins
407360|NCT01209429|Fasting|fasting
407361|NCT01209429|Growth hormone|growth hormone
407362|NCT01209429|IGF-1|igf-1
407363|NCT01209416|ghrelin|ghrelin
407364|NCT01209416|metabolism|metabolism
407365|NCT01209416|type 2 diabetes|type 2 diabetes
407366|NCT01209416|insulin resistance|insulin resistance
407367|NCT01209403|Dialysis|dialysis
407368|NCT01209403|Malnutrition|malnutrition
407369|NCT01209403|Insulin-Like Growth Factor I|insulin-like growth factor i
407370|NCT01209403|Insulin-Like Growth Factor Binding Protein 1|insulin-like growth factor binding protein 1
407371|NCT01209403|Inflammation|inflammation
407372|NCT01209390|osteochondral|osteochondral
407373|NCT01209390|regenerative|regenerative
407374|NCT01209390|repair|repair
407375|NCT01209390|cartilage lesion|cartilage lesion
407376|NCT01209377|standard|standard
407377|NCT01209377|fixed|fixed
407378|NCT01209377|no focus|no focus
407379|NCT01209377|EMDR treatment with bilateral stimulation via eye movement|emdr treatment with bilateral stimulation via eye movement
407380|NCT01209377|EMDR treatment with fixed eyes|emdr treatment with fixed eyes
407381|NCT01209377|Trauma exposition without external stimulus|trauma exposition without external stimulus
407382|NCT01209364|comparative|comparative
407383|NCT01209364|randomized|randomized
407384|NCT01209364|double-blind|double-blind
407385|NCT01209364|non-inferior|non-inferior
407386|NCT01209364|knee OA|knee oa
407387|NCT01209351|Pharmacokinetics|pharmacokinetics
407388|NCT01209351|Pharmacodynamics|pharmacodynamics
407389|NCT01209351|teduglutide|teduglutide
407390|NCT01209325|human papilloma virus infection|human papilloma virus infection
407391|NCT01209325|anal cancer|anal cancer
407392|NCT01209325|penile cancer|penile cancer
407393|NCT01209325|HIV infection|hiv infection
407394|NCT01209299|recurrent melanoma|recurrent melanoma
407395|NCT01209299|stage IIIC melanoma|stage iiic melanoma
407396|NCT01209299|stage IV melanoma|stage iv melanoma
407397|NCT01209286|Blinatumomab|blinatumomab
407398|NCT01209286|B-ALL|b-all
407399|NCT01209286|adult ALL|adult all
407400|NCT01209286|relapsed ALL|relapsed all
407401|NCT01209286|refractory ALL|refractory all
407402|NCT01209286|Leukemia|leukemia
407403|NCT01209286|ALL|all
407404|NCT01209286|Lymphatic diseases|lymphatic diseases
407405|NCT01209286|Lymphoproliferative disorders|lymphoproliferative disorders
407406|NCT01209286|bispecific antibody|bispecific antibody
407407|NCT01209286|anti-CD19|anti-cd19
407408|NCT01209286|Immunotherapeutic treatment|immunotherapeutic treatment
407409|NCT01209273|Quality of Life|quality of life
407410|NCT01209273|Automated Peritoneal Dialysis|automated peritoneal dialysis
407411|NCT01209273|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
407412|NCT01209273|End Stage Renal Disease|end stage renal disease
407413|NCT01209260|Transseptal Puncture|transseptal puncture
407414|NCT01209260|Radiofrequency Energy|radiofrequency energy
407415|NCT01209260|Left Atrium Access|left atrium access
407416|NCT01209260|Left Atrial Catheterization|left atrial catheterization
407417|NCT01209260|Ablation|ablation
407418|NCT01209260|Transseptal Catheterization|transseptal catheterization
407419|NCT01209260|Electrocautery|electrocautery
407420|NCT01209260|Catheter Ablation|catheter ablation
407421|NCT01209260|Atrial Fibrillation|atrial fibrillation
407422|NCT01209247|Fluoroquinolone -resistance|fluoroquinolone -resistance
407423|NCT01209247|Commensal flora|commensal flora
407424|NCT01209247|Emergence of resistance|emergence of resistance
407425|NCT01209234|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
407426|NCT01209234|MRSA|mrsa
407427|NCT01209195|Ovarian cancer|ovarian cancer
407428|NCT01209195|HER-2 negative breast cancer|her-2 negative breast cancer
407429|NCT01209195|Breast cancer|breast cancer
407430|NCT01209195|Fallopian tube cancer|fallopian tube cancer
407431|NCT01209169|Kidney Renal|kidney renal
407432|NCT01209117|formulation|formulation
407433|NCT01209117|bioavailability|bioavailability
407434|NCT01209117|pharmacokinetics|pharmacokinetics
407435|NCT01209117|GSK2248761|gsk2248761
407436|NCT01209104|omeprazole|omeprazole
407437|NCT01209104|proton pump inhibitor|proton pump inhibitor
407438|NCT01209104|COPD|copd
407439|NCT01209104|CXCR2 inhibitor|cxcr2 inhibitor
407440|NCT01209104|bioavailability|bioavailability
407441|NCT01209104|food-effect|food-effect
407442|NCT01209078|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
407443|NCT01209078|linezolid|linezolid
407444|NCT01209078|repeat dose|repeat dose
407445|NCT01209078|GSK1322322|gsk1322322
407446|NCT01209065|integrase|integrase
407447|NCT01209065|fosamprenavir|fosamprenavir
407448|NCT01209065|ritonavir|ritonavir
407449|NCT01209065|GSK1349572|gsk1349572
407450|NCT01209052|COPD|copd
407451|NCT01209052|CXCR2 inhibitor|cxcr2 inhibitor
407452|NCT01209039|Schizophrenia|schizophrenia
407453|NCT01209039|PET|pet
407454|NCT01209026|Fluticasone furoate (GW685698)|fluticasone furoate (gw685698)
407455|NCT01209026|moxifloxacin|moxifloxacin
407456|NCT01209026|QTc|qtc
407457|NCT01209026|GW642444|gw642444
407458|NCT01209026|pharmacokinetics|pharmacokinetics
407459|NCT01209013|PDT|pdt
407460|NCT01209013|porfimer sodium|porfimer sodium
407461|NCT01209013|BE|be
407462|NCT01209000|Focal and Segmental Glomerulosclerosis|focal and segmental glomerulosclerosis
407463|NCT01209000|Focal & Segmental Glomerulosclerosis|focal & segmental glomerulosclerosis
407464|NCT01209000|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
407466|NCT01209000|Minimal change disease|minimal change disease
407467|NCT01209000|MCD|mcd
407468|NCT01209000|Membranous Nephropathy|membranous nephropathy
407469|NCT01209000|MN|mn
407470|NCT01209000|Nephrotic Syndrome|nephrotic syndrome
407471|NCT01209000|Neph Syndrome|neph syndrome
407472|NCT01209000|NEPTUNE|neptune
407473|NCT01209000|NephCure|nephcure
407474|NCT01209000|Halpin|halpin
407475|NCT01208974|Breast Cancer|breast cancer
407476|NCT01208974|Nipple Area Complex|nipple area complex
407477|NCT01208974|Mastectomy|mastectomy
407478|NCT01208974|Radiation Therapy|radiation therapy
407479|NCT01208974|Nipple-Sparing|nipple-sparing
407480|NCT01208974|Breast Reconstruction|breast reconstruction
407481|NCT01208961|Eicosapentaenoic Acid|eicosapentaenoic acid
407482|NCT01208961|Docosahexaenoic Acid|docosahexaenoic acid
407483|NCT01208961|Hypertriglyceridemia|hypertriglyceridemia
407484|NCT01208961|Omega-3 acid ethyl esters|omega-3 acid ethyl esters
407485|NCT01208961|Omega-3 carboxylic acids|omega-3 carboxylic acids
407486|NCT01208961|Epanova|epanova
407487|NCT01208961|Lovaza|lovaza
407488|NCT01208961|bioavailability|bioavailability
407489|NCT01208961|pharmacokinetics|pharmacokinetics
407490|NCT01208961|low-fat meal|low-fat meal
407491|NCT01208961|high-fat meal|high-fat meal
407492|NCT01208948|macular edema|macular edema
407493|NCT01208948|diabetes mellitus|diabetes mellitus
407494|NCT01208948|prevention alpha lipoic acid|prevention alpha lipoic acid
407495|NCT01208935|Randomized|randomized
407496|NCT01208935|Double blind|double blind
407497|NCT01208935|double-dummy|double-dummy
407498|NCT01208935|placebo-controlled|placebo-controlled
407499|NCT01208896|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
407500|NCT01208896|Reduced-intensity conditioning|reduced-intensity conditioning
407501|NCT01208896|Chemosensitive relapsed follicular lymphoma|chemosensitive relapsed follicular lymphoma
407502|NCT01208883|Primary non-operated squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx.|primary non-operated squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx.
407503|NCT01208831|Advanced tumors|advanced tumors
407504|NCT01208831|hedgehog|hedgehog
407505|NCT01208831|smoothened inhibitor|smoothened inhibitor
407506|NCT01208792|Auto antibodies|auto antibodies
407507|NCT01208792|Target antigens|target antigens
407508|NCT01208792|2D-immunoblot|2d-immunoblot
407509|NCT01208792|Reactive oxygen species|reactive oxygen species
407510|NCT01208792|Pulmonary arterial hypertension|pulmonary arterial hypertension
407511|NCT01208792|Systemic sclerosis|systemic sclerosis
407512|NCT01208792|Human immunodeficiency virus infection|human immunodeficiency virus infection
407513|NCT01208792|Porto pulmonary hypertension|porto pulmonary hypertension
407514|NCT01208792|Congenital heart defect|congenital heart defect
407515|NCT01208792|Systemic lupus erythematosus|systemic lupus erythematosus
407516|NCT01208792|Mixed connective tissue disease|mixed connective tissue disease
407517|NCT01208792|Sjögren's syndrome|sjögren's syndrome
407518|NCT01208779|Compliance|compliance
407519|NCT01208779|HR+ breast cancer|hr+ breast cancer
407520|NCT01208779|epidemiology|epidemiology
407521|NCT01208766|Multiple Myeloma (Kahler's disease)|multiple myeloma (kahler's disease)
407522|NCT01208753|Safety|safety
407523|NCT01208753|Tolerability|tolerability
407524|NCT01208753|Pharmacokinetics|pharmacokinetics
407525|NCT01208740|Gonadotropins|gonadotropins
407526|NCT01208740|infertility|infertility
407528|NCT01208740|metformin|metformin
407529|NCT01208740|PCOS|pcos
407530|NCT01208740|poor prognosis|poor prognosis
407531|NCT01208740|poor responder|poor responder
407532|NCT01208727|Myocardial infarction|myocardial infarction
407533|NCT01208727|Postconditioning|postconditioning
407534|NCT01208727|Microvascular obstruction|microvascular obstruction
407535|NCT01208727|No reflow|no reflow
407536|NCT01208727|MRI|mri
407537|NCT01208714|Renal artery stenosis|renal artery stenosis
407538|NCT01208714|Atherosclerosis|atherosclerosis
407539|NCT01208714|Arterial hypertension|arterial hypertension
407540|NCT01208714|Percutaneous renal angioplasty|percutaneous renal angioplasty
407541|NCT01208714|Stenting|stenting
407542|NCT01208701|Atorvastatin|atorvastatin
407543|NCT01208701|L-NMMA|l-nmma
407544|NCT01208701|NO|no
407545|NCT01208701|Nephrology|nephrology
407546|NCT01208701|Diabetes Mellitus|diabetes mellitus
407547|NCT01208688|Spinal Cord Injuries|spinal cord injuries
407548|NCT01208662|Lenalidomide|lenalidomide
407549|NCT01208662|Bortezomib|bortezomib
407550|NCT01208662|Dexamethasone|dexamethasone
407551|NCT01208662|Stem Cell Transplant|stem cell transplant
407552|NCT01208662|Myeloma|myeloma
407553|NCT01208662|Multiple Myeloma|multiple myeloma
407554|NCT01208649|exenatide|exenatide
407555|NCT01208649|hepatic steatosis|hepatic steatosis
407556|NCT01208649|insulin resistance|insulin resistance
407557|NCT01208649|insulin sensitizers|insulin sensitizers
407558|NCT01208649|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
407559|NCT01208649|- GLP1-Analog|- glp1-analog
407560|NCT01208636|Vitamin D deficiency|vitamin d deficiency
407561|NCT01208636|Sun|sun
407562|NCT01208636|Genetics|genetics
407563|NCT01208584|functional MRI,primary motor cortex,spinal cord injury|functional mri,primary motor cortex,spinal cord injury
407564|NCT01208571|Harmful use|harmful use
407565|NCT01208571|Hazardous use|hazardous use
407566|NCT01208571|Dependence|dependence
407567|NCT01208558|Blood pressure|blood pressure
407568|NCT01208558|Cereals|cereals
407569|NCT01208558|Diet Therapy|diet therapy
407570|NCT01208558|Dietary carbohydrates|dietary carbohydrates
407571|NCT01208558|Dietary fiber|dietary fiber
407572|NCT01208558|Exercise Therapy|exercise therapy
407573|NCT01208558|Food|food
407574|NCT01208558|Glucose intolerance|glucose intolerance
407575|NCT01208558|Lifestyle|lifestyle
407576|NCT01208558|Physiotherapy|physiotherapy
407577|NCT01208558|Stroke|stroke
407578|NCT01208558|TIA|tia
747189|NCT01152385|phase 2|phase 2
407579|NCT01208558|Waist circumference|waist circumference
407580|NCT01208558|Weight loss|weight loss
407581|NCT01208545|taxol|taxol
407582|NCT01208545|vincristine|vincristine
407583|NCT01208545|oxaliplatin|oxaliplatin
407584|NCT01208545|chemotherapy|chemotherapy
407585|NCT01208545|nerve degeneration|nerve degeneration
407586|NCT01208545|nerve conduction|nerve conduction
407587|NCT01208545|cancer|cancer
407588|NCT01208545|nerve conduction studies|nerve conduction studies
407589|NCT01208519|Drug resistance, Microbial|drug resistance, microbial
407590|NCT01208519|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
407591|NCT01208519|ESBL|esbl
407592|NCT01208519|Colonisation|colonisation
407593|NCT01208519|Screening|screening
407594|NCT01208519|Gram-negative|gram-negative
407595|NCT01208493|prematurity|prematurity
407596|NCT01208493|enteral feeding|enteral feeding
407597|NCT01208493|proteins|proteins
407598|NCT01208493|formula|formula
407599|NCT01208480|stage II breast cancer|stage ii breast cancer
407600|NCT01208480|stage IIIA breast cancer|stage iiia breast cancer
407601|NCT01208480|stage IIIB breast cancer|stage iiib breast cancer
407602|NCT01208480|stage IIIC breast cancer|stage iiic breast cancer
407603|NCT01208480|triple-negative breast cancer|triple-negative breast cancer
407604|NCT01208428|Depression|depression
407605|NCT01208415|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
407606|NCT01208415|iliac aneurysm|iliac aneurysm
407607|NCT01208415|branch|branch
407608|NCT01208415|connections|connections
407609|NCT01208415|endovascular graft|endovascular graft
407610|NCT01208415|graft-iliac bifurcation|graft-iliac bifurcation
407611|NCT01208415|Aneurysm|aneurysm
407612|NCT01208415|Vascular Diseases|vascular diseases
407613|NCT01208415|Cardiovascular Diseases|cardiovascular diseases
407614|NCT01208363|Iron fortification|iron fortification
407615|NCT01208363|polyphenols|polyphenols
407616|NCT01208363|NaFeEDTA|nafeedta
407617|NCT01208363|cowpea|cowpea
407618|NCT01208363|school feeding program|school feeding program
407619|NCT01208350|Weight Loss|weight loss
407620|NCT01208350|Motivation|motivation
407621|NCT01208350|Workplace|workplace
407622|NCT01208350|Web platform|web platform
407623|NCT01208337|Rejection|rejection
407624|NCT01208324|Cognitive difficulties|cognitive difficulties
407625|NCT01208324|memory impairment|memory impairment
407626|NCT01208324|mood changes|mood changes
407627|NCT01208324|brain activation|brain activation
407628|NCT01208311|Alcoholic cirrhosis|alcoholic cirrhosis
407630|NCT01208311|cirrhosis|cirrhosis
407631|NCT01208298|Cold Sore Patch|cold sore patch
407632|NCT01208272|Body Mass Index|body mass index
407633|NCT01208272|Bulimia/therapy|bulimia/therapy
407634|NCT01208272|Comorbidity|comorbidity
407635|NCT01208272|Interpersonal Relations|interpersonal relations
407636|NCT01208272|Psychotherapy/methods|psychotherapy/methods
407637|NCT01208259|Body Mass Index|body mass index
407638|NCT01208259|Bulimia/therapy|bulimia/therapy
407639|NCT01208259|Comorbidity|comorbidity
407640|NCT01208259|Interpersonal Relations|interpersonal relations
407641|NCT01208259|Psychotherapy/methods|psychotherapy/methods
407642|NCT01208233|Phase 2 Ischemic stroke Safety and efficacy|phase 2 ischemic stroke safety and efficacy
407643|NCT01208220|Collagenase Santyl|collagenase santyl
407644|NCT01208220|Enzymatic debridement|enzymatic debridement
407645|NCT01208220|maintenance debridement|maintenance debridement
407646|NCT01208220|VAC|vac
407647|NCT01208220|NPWT|npwt
407648|NCT01208194|Advanced colorectal carcinoma|advanced colorectal carcinoma
407649|NCT01208194|Maintenance therapy|maintenance therapy
407650|NCT01208194|Immunomodulator|immunomodulator
407651|NCT01208168|toenail fungus|toenail fungus
407652|NCT01208168|onychomycosis|onychomycosis
407653|NCT01208168|nail infection|nail infection
407654|NCT01208155|Phase 1|phase 1
407655|NCT01208155|Healthy|healthy
407656|NCT01208155|pharmacokinetics|pharmacokinetics
407657|NCT01208155|Fostamatinib|fostamatinib
407658|NCT01208142|toe walker|toe walker
407659|NCT01208142|Pediatric toe walking|pediatric toe walking
407660|NCT01208142|ankle flexion|ankle flexion
407661|NCT01208129|toenail fungus|toenail fungus
407662|NCT01208129|onychomycosis|onychomycosis
407663|NCT01208129|nail infection|nail infection
407664|NCT01208116|Atherosclerosis|atherosclerosis
407665|NCT01208116|Prognosis|prognosis
407666|NCT01208116|Flow-mediated dilatation|flow-mediated dilatation
407667|NCT01208116|Brachial-ankle pulse wave velocity|brachial-ankle pulse wave velocity
407668|NCT01208116|Carotid Intimal-Medial Thickness|carotid intimal-medial thickness
407669|NCT01208116|coronary artery calcification score|coronary artery calcification score
407670|NCT01208116|Ankle-brachial index|ankle-brachial index
407671|NCT01208103|Cancer|cancer
407672|NCT01208103|Small bowel|small bowel
407673|NCT01208103|Ampulla of Vater|ampulla of vater
407674|NCT01208103|CAPOX Chemotherapy|capox chemotherapy
407675|NCT01208103|Bevacizumab|bevacizumab
407676|NCT01208103|Capecitabine|capecitabine
407677|NCT01208103|Oxaliplatin|oxaliplatin
407678|NCT01208103|Xeloda|xeloda
407679|NCT01208103|Eloxatin|eloxatin
407680|NCT01208103|Avastin|avastin
407681|NCT01208103|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
407682|NCT01208103|rhuMab-VEGF|rhumab-vegf
407683|NCT01208090|psoriasis|psoriasis
407684|NCT01208090|chronic plaque psoriasis|chronic plaque psoriasis
407685|NCT01208090|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
407686|NCT01208077|ED hemodynamic profiles|ed hemodynamic profiles
407687|NCT01208077|patients treated under current clinical standards|patients treated under current clinical standards
407688|NCT01208077|Acute CHF|acute chf
407689|NCT01208077|Stroke syndromes|stroke syndromes
407690|NCT01208077|Systemic infection|systemic infection
407691|NCT01208064|adenocarcinoma of the lung|adenocarcinoma of the lung
407692|NCT01208064|adenosquamous cell lung cancer|adenosquamous cell lung cancer
407693|NCT01208064|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
407694|NCT01208064|large cell lung cancer|large cell lung cancer
407695|NCT01208064|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
407696|NCT01208064|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
407697|NCT01208064|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
407698|NCT01208025|Plaque|plaque
407699|NCT01208025|Imaging|imaging
407700|NCT01208012|Diabetes Mellitus treatment Metformin|diabetes mellitus treatment metformin
407701|NCT01207999|Human papillomavirus|human papillomavirus
407702|NCT01207960|dental phobia|dental phobia
407703|NCT01207960|psychotherapy|psychotherapy
407704|NCT01207960|eye movement desensitization and reprocessing - EMDR|eye movement desensitization and reprocessing - emdr
407705|NCT01207960|efficacy|efficacy
407706|NCT01207960|wait-list control|wait-list control
407707|NCT01207947|Vardenafil|vardenafil
407708|NCT01207947|Erectile dysfunction|erectile dysfunction
407709|NCT01207947|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
407710|NCT01207947|Combination use with alpha-blockers|combination use with alpha-blockers
407711|NCT01207934|diabetes|diabetes
407712|NCT01207934|obesity|obesity
407713|NCT01207908|DMD|dmd
407714|NCT01207908|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
407715|NCT01207908|Insulin like growth factor|insulin like growth factor
407716|NCT01207908|6 minute walk test|6 minute walk test
407717|NCT01207869|Bronchopulmonary dysplasia (BPD)|bronchopulmonary dysplasia (bpd)
407718|NCT01207869|Extremely premature infant|extremely premature infant
407719|NCT01207869|Mesenchymal stem cells (MSCs)|mesenchymal stem cells (mscs)
407720|NCT01207869|umbilical cord|umbilical cord
407721|NCT01207856|Multiple sclerosis|multiple sclerosis
407722|NCT01207856|functional MRI|functional mri
407723|NCT01207856|cognitive rehabilitation|cognitive rehabilitation
407724|NCT01207856|ecological evaluation|ecological evaluation
407725|NCT01207856|neuroplasticity|neuroplasticity
407726|NCT01207843|Computed tomography|computed tomography
407727|NCT01207830|Obesity|obesity
407728|NCT01207817|a light flash in each eye for a total of 48 measurements|a light flash in each eye for a total of 48 measurements
407729|NCT01207804|Obesity|obesity
407730|NCT01207791|drug abuse|drug abuse
407731|NCT01207791|emergency department|emergency department
407732|NCT01207791|brief intervention|brief intervention
407733|NCT01207791|motivational interviewing|motivational interviewing
407734|NCT01207791|SBIRT|sbirt
407735|NCT01207778|brain|brain
407736|NCT01207778|development|development
407737|NCT01207778|erythropoietin|erythropoietin
407738|NCT01207778|neuroprotection|neuroprotection
407739|NCT01207778|MRI|mri
407740|NCT01207765|Multiple Myeloma|multiple myeloma
407741|NCT01207765|Zevalin|zevalin
407742|NCT01207752|dry eye, meibomian gland dysfunction, tear film break up time|dry eye, meibomian gland dysfunction, tear film break up time
407743|NCT01207739|Prolonged antibiotic treatment in Lyme disease|prolonged antibiotic treatment in lyme disease
407744|NCT01207739|Doxycycline|doxycycline
407745|NCT01207739|Clarithromycin|clarithromycin
407746|NCT01207739|Hydroxychloroquine|hydroxychloroquine
407747|NCT01207700|post discharge intervention|post discharge intervention
407748|NCT01207700|adherence|adherence
407749|NCT01207700|compliance|compliance
407750|NCT01207700|community health worker|community health worker
407751|NCT01207674|Pathological gambling|pathological gambling
407752|NCT01207674|"at risk gambling"|"at risk gambling"
407753|NCT01207674|gambling practice evolution|gambling practice evolution
407754|NCT01207674|psychiatric comorbidities|psychiatric comorbidities
407755|NCT01207674|gambling trajectory|gambling trajectory
407756|NCT01207674|cognitive distortions|cognitive distortions
407757|NCT01207674|ADHD|adhd
407758|NCT01207674|addiction|addiction
407759|NCT01207674|recourse to care|recourse to care
407760|NCT01207661|Mesenchymal cells|mesenchymal cells
407761|NCT01207661|osteoarthritis|osteoarthritis
407762|NCT01207661|intra articular injection|intra articular injection
407763|NCT01207648|Interferon beta 1a|interferon beta 1a
407764|NCT01207648|Autoimmune Diseases|autoimmune diseases
407765|NCT01207648|Demyelinating Diseases|demyelinating diseases
407766|NCT01207648|Immune System Diseases|immune system diseases
407767|NCT01207648|Immunologic Factors|immunologic factors
407768|NCT01207648|Nervous System Diseases|nervous system diseases
407769|NCT01207648|Physiological Effects of Drugs|physiological effects of drugs
407770|NCT01207648|Demyelinating Autoimmune Diseases, CNS|demyelinating autoimmune diseases, cns
407771|NCT01207648|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
407772|NCT01207648|Retrospective Cohort Study|retrospective cohort study
407773|NCT01207635|Cancer|cancer
407774|NCT01207635|Arimidex|arimidex
407775|NCT01207609|Obesity|obesity
407776|NCT01207609|Morbid Obesity|morbid obesity
407777|NCT01207609|Bariatric Surgery|bariatric surgery
407778|NCT01207609|Laparoscopic Gastric Plication|laparoscopic gastric plication
407779|NCT01207596|Pain|pain
407780|NCT01207596|Neuropathy|neuropathy
407781|NCT01207596|Neuropathic Pain|neuropathic pain
407782|NCT01207596|Hydromorphone|hydromorphone
407783|NCT01207583|vaccine|vaccine
407784|NCT01207583|infant|infant
407785|NCT01207583|healthy subjects|healthy subjects
407786|NCT01207570|flexibility|flexibility
407787|NCT01207570|muscle|muscle
407788|NCT01207570|stretching|stretching
407789|NCT01207570|cerebral palsy|cerebral palsy
407790|NCT01207570|developmental|developmental
407791|NCT01207557|Healthcare personnel|healthcare personnel
407792|NCT01207557|influenza|influenza
407793|NCT01207557|immunization|immunization
407795|NCT01207557|vaccine|vaccine
407796|NCT01207544|motor|motor
407797|NCT01207544|balance|balance
407798|NCT01207544|developmental|developmental
407799|NCT01207544|physiotherapy|physiotherapy
407800|NCT01207531|sepsis|sepsis
407801|NCT01207531|miRNA|mirna
407802|NCT01207518|influenza|influenza
407803|NCT01207518|immunization|immunization
407804|NCT01207518|healthcare personnel|healthcare personnel
407805|NCT01207505|bipolar disorder|bipolar disorder
407806|NCT01207505|depression|depression
407807|NCT01207505|mania|mania
407808|NCT01207505|emotion regulation|emotion regulation
407809|NCT01207505|dialectical behavior therapy|dialectical behavior therapy
407810|NCT01207505|group therapy|group therapy
407811|NCT01207505|mindfulness|mindfulness
407812|NCT01207492|nilotinib|nilotinib
407813|NCT01207453|Arthritis, Rheumatoid|arthritis, rheumatoid
407814|NCT01207453|Milnacipran|milnacipran
407815|NCT01207453|Pain|pain
407816|NCT01207440|CML|cml
407817|NCT01207440|ALL|all
407818|NCT01207440|PH|ph
407819|NCT01207440|ponatinib|ponatinib
407820|NCT01207440|Ph+ALL|ph+all
407821|NCT01207440|T315I mutation|t315i mutation
407822|NCT01207440|Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
407823|NCT01207427|opioid therapy|opioid therapy
407824|NCT01207427|constipation|constipation
407825|NCT01207427|chronic noncancer pain|chronic noncancer pain
407826|NCT01207427|mu opioid receptor antagonist|mu opioid receptor antagonist
407827|NCT01207427|ADL5945|adl5945
407828|NCT01207414|Schizophrenia|schizophrenia
407829|NCT01207414|iloperidone|iloperidone
407830|NCT01207414|switch|switch
407831|NCT01207414|gradual switch|gradual switch
407832|NCT01207414|immediate switch|immediate switch
407833|NCT01207401|intrauterine device|intrauterine device
407834|NCT01207401|local anesthetic|local anesthetic
407835|NCT01207388|Blinatumomab|blinatumomab
407837|NCT01207388|B-ALL|b-all
407838|NCT01207388|Minimal residual disease|minimal residual disease
407839|NCT01207388|adult ALL|adult all
407840|NCT01207388|Leukemia|leukemia
407841|NCT01207388|ALL|all
407842|NCT01207388|Lymphatic diseases|lymphatic diseases
407843|NCT01207388|Lymphoproliferative disorders|lymphoproliferative disorders
407844|NCT01207388|bispecific antibody|bispecific antibody
407845|NCT01207388|anti-CD19|anti-cd19
407846|NCT01207388|Immunotherapeutic treatment|immunotherapeutic treatment
407847|NCT01207375|memory|memory
407848|NCT01207375|learning|learning
407849|NCT01207375|Traumatic Brain Injury|traumatic brain injury
407850|NCT01207375|cognition|cognition
407851|NCT01207375|treatment|treatment
407852|NCT01207375|therapy|therapy
407853|NCT01207349|Type 2 diabetes|type 2 diabetes
407854|NCT01207349|Secondary prevention|secondary prevention
407855|NCT01207349|Physical activity|physical activity
407856|NCT01207349|Nutritional education|nutritional education
407857|NCT01207349|HbA1c|hba1c
407858|NCT01207349|Reunion island|reunion island
407859|NCT01207349|diabetic patients, both female and male, age >=18 years, able to practise a physical activity, in Saint Pierre (GHSR) and Saint Denis (CHD)|diabetic patients, both female and male, age >=18 years, able to practise a physical activity, in saint pierre (ghsr) and saint denis (chd)
407860|NCT01207336|stroke|stroke
407861|NCT01207336|rehabilitation|rehabilitation
407862|NCT01207336|transcranial direct current stimulation|transcranial direct current stimulation
407863|NCT01207336|nerve stimulation|nerve stimulation
407864|NCT01207310|smoking|smoking
407865|NCT01207310|smoking of 10 cigarettes per day|smoking of 10 cigarettes per day
407866|NCT01207297|Lupus nephritis|lupus nephritis
407867|NCT01207297|tacrolimus|tacrolimus
407868|NCT01207297|cyclophosphamide|cyclophosphamide
407869|NCT01207271|depression|depression
407870|NCT01207271|community mental health|community mental health
407871|NCT01207271|treatment|treatment
407872|NCT01207271|psychotherapy|psychotherapy
407873|NCT01207271|mediators|mediators
407874|NCT01207258|Motivational Interviewing|motivational interviewing
407875|NCT01207258|Brief Intervention|brief intervention
407876|NCT01207258|Intimate Partner Violence|intimate partner violence
407877|NCT01207258|Domestic Violence|domestic violence
407878|NCT01207258|Alcohol Abuse|alcohol abuse
407879|NCT01207245|Cystic fibrosis|cystic fibrosis
407880|NCT01207245|Tobramycin|tobramycin
407881|NCT01207245|Pharmacokinetics|pharmacokinetics
407882|NCT01207245|Toxicity|toxicity
407883|NCT01207232|seasonal influenza|seasonal influenza
407884|NCT01207232|behavioral economics|behavioral economics
407885|NCT01207232|implementation intentions|implementation intentions
407886|NCT01207232|planning prompt|planning prompt
407887|NCT01207232|nudge|nudge
407888|NCT01207219|psychosis|psychosis
407889|NCT01207219|yoga|yoga
407890|NCT01207219|aerobic exercise|aerobic exercise
407891|NCT01207219|memory|memory
407892|NCT01207219|attention|attention
407893|NCT01207219|neuro cognition|neuro cognition
407894|NCT01207206|Patient suffering from severe cancer pain despite the opioid treatment|patient suffering from severe cancer pain despite the opioid treatment
407895|NCT01207206|Opiate tolerance suspected on the basis of rapid escalation in opiate dose|opiate tolerance suspected on the basis of rapid escalation in opiate dose
407896|NCT01207206|Severe opiate side effects|severe opiate side effects
407897|NCT01207193|bone cyst bone defect mesenchymal cell|bone cyst bone defect mesenchymal cell
407898|NCT01207180|emergency medicine|emergency medicine
407899|NCT01207180|primary care physicians|primary care physicians
407900|NCT01207141|Liver Transplantation|liver transplantation
407901|NCT01207141|Thymoglobulin|thymoglobulin
407902|NCT01207141|Rejection|rejection
407903|NCT01207102|Breast cancer|breast cancer
407904|NCT01207102|Triple negative|triple negative
407905|NCT01207089|Safety|safety
407906|NCT01207089|tolerability|tolerability
407907|NCT01207089|PK|pk
407908|NCT01207089|healthy|healthy
407910|NCT01207089|obese|obese
407911|NCT01207076|CD45+ disease|cd45+ disease
407912|NCT01207063|Radiotherapy|radiotherapy
407913|NCT01207063|NSCLC|nsclc
407914|NCT01207063|Stage II-III non-small cell lung cancer|stage ii-iii non-small cell lung cancer
407915|NCT01207050|sleep disorders|sleep disorders
407916|NCT01207050|traumatic brain injury|traumatic brain injury
407917|NCT01207024|knee arthrosis|knee arthrosis
407918|NCT01207024|obesity|obesity
407919|NCT01207024|MRI|mri
407920|NCT01207024|bariatric surgery|bariatric surgery
407921|NCT01206998|preterm labor|preterm labor
407922|NCT01206998|progesterone|progesterone
407923|NCT01206998|tocolysis|tocolysis
407924|NCT01206998|cervical length|cervical length
407925|NCT01206985|Paracetamol|paracetamol
407926|NCT01206985|per-oral mucosa PMB|per-oral mucosa pmb
407927|NCT01206985|No disease, healthy volunteers|no disease, healthy volunteers
407928|NCT01206972|venous thromboembolism|venous thromboembolism
407929|NCT01206972|prevention|prevention
407930|NCT01206972|orthopaedic surgery|orthopaedic surgery
407931|NCT01205945|Aortic aneurysm, abdominal|aortic aneurysm, abdominal
407932|NCT01205945|Screening|screening
407933|NCT01205945|Mortality|mortality
407934|NCT01205932|venous thromboembolism|venous thromboembolism
407935|NCT01205932|prevention|prevention
407936|NCT01205932|othopaedic surgery|othopaedic surgery
407937|NCT01205919|Tinnitus|tinnitus
407938|NCT01205919|Internet Training|internet training
407939|NCT01205919|Cognitive-Behavior Therapy|cognitive-behavior therapy
407941|NCT01205906|Tinnitus|tinnitus
407942|NCT01205906|Internet Training|internet training
407943|NCT01205906|Cognitive-Behavior Therapy|cognitive-behavior therapy
407944|NCT01205906|CBT|cbt
407945|NCT01205880|combination treatment|combination treatment
407946|NCT01205880|topical corticosteroid|topical corticosteroid
407947|NCT01205880|vitamin D analogue|vitamin d analogue
407948|NCT01205880|clobex|clobex
407949|NCT01205880|vectical|vectical
407950|NCT01205880|clobetasol|clobetasol
407951|NCT01205880|calcitriol|calcitriol
407952|NCT01205867|Butyrylcholinesterase deficiency|butyrylcholinesterase deficiency
407953|NCT01205867|tolerability|tolerability
407954|NCT01205867|safety|safety
407955|NCT01205867|AZD8848|azd8848
407956|NCT01205867|pharmacokinetics|pharmacokinetics
407961|NCT01205854|remission|remission
407962|NCT01205854|imaging remission|imaging remission
407963|NCT01205854|tight control|tight control
407964|NCT01205854|treat to target|treat to target
407965|NCT01205841|Ottawa Ankle and Foot Rules|ottawa ankle and foot rules
407966|NCT01205841|Buffalo Rule|buffalo rule
407967|NCT01205841|Bernese Ankle Rules|bernese ankle rules
407968|NCT01205841|Low Risk Exam|low risk exam
407969|NCT01205841|Malleolar Zone Algorithm|malleolar zone algorithm
407970|NCT01205841|Clinical decision rule|clinical decision rule
407971|NCT01205841|Ankle injury|ankle injury
407972|NCT01205841|Ankle sprain|ankle sprain
407973|NCT01205841|Inversion trauma|inversion trauma
407974|NCT01205828|liver cancer|liver cancer
407975|NCT01205828|hepatocellular|hepatocellular
747190|NCT01152385|AZD1656|azd1656
509781|NCT00240994|MMF|mmf
407976|NCT01205828|temozolomide|temozolomide
407977|NCT01205828|veliparib|veliparib
407978|NCT01205802|patency, hepatic venous congestion, liver transplantation|patency, hepatic venous congestion, liver transplantation
407979|NCT01205789|Drug eluting stents|drug eluting stents
407980|NCT01205789|Stents|stents
407981|NCT01205789|Angioplasty|angioplasty
407982|NCT01205789|Left Main Coronary Artery Disease|left main coronary artery disease
407987|NCT01205737|DLBCL|dlbcl
407988|NCT01205737|pharmacokinetics|pharmacokinetics
407989|NCT01205737|pharmacodynamics|pharmacodynamics
407990|NCT01206959|BP|bp
407991|NCT01206946|Respiratory distress|respiratory distress
407992|NCT01206946|Antenatal steroids|antenatal steroids
407993|NCT01206946|late preterm|late preterm
407994|NCT01206933|HIV/HCV Coinfection|hiv/hcv coinfection
407995|NCT01206933|Tat Protein|tat protein
407996|NCT01206933|HCV|hcv
407997|NCT01206920|HIV|hiv
407998|NCT01206920|AIDS|aids
407999|NCT01206920|Co-morbidities|co-morbidities
408000|NCT01206907|sickle cell anemia|sickle cell anemia
408001|NCT01206907|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
408002|NCT01206907|burn victim|burn victim
408003|NCT01206907|cancer|cancer
408004|NCT01206907|Chronic pain of malignant or non-malignant etiology|chronic pain of malignant or non-malignant etiology
408005|NCT01206894|lung cancer|lung cancer
408006|NCT01206894|chest wall invasion|chest wall invasion
408007|NCT01206894|transthoracic ultrasound|transthoracic ultrasound
408008|NCT01206881|breast cancer|breast cancer
408009|NCT01206881|neoadjuvant|neoadjuvant
408010|NCT01206881|liposomal doxorubicin|liposomal doxorubicin
408011|NCT01206881|PET scan|pet scan
408012|NCT01206868|kidney, transplantation, surgery, complications, lymphocele, fluid collections.|kidney, transplantation, surgery, complications, lymphocele, fluid collections.
408013|NCT01206855|MIST Therapy|mist therapy
408014|NCT01206842|functional capacity|functional capacity
408015|NCT01206842|training|training
408016|NCT01206842|neurocognition|neurocognition
408017|NCT01206829|Hearing Impaired Persons|hearing impaired persons
408018|NCT01206829|Tinnitus|tinnitus
408019|NCT01206829|Life Change Events|life change events
408020|NCT01206829|Adaptation, Psychological|adaptation, psychological
408021|NCT01206829|Rehabilitation, Vocational|rehabilitation, vocational
408022|NCT01206829|Cognitive Therapy|cognitive therapy
408023|NCT01206829|Avoidance Learning|avoidance learning
408024|NCT01206829|Escape Reaction|escape reaction
408025|NCT01206803|ovarian stimulation|ovarian stimulation
408026|NCT01206803|recombinant FSH|recombinant fsh
408027|NCT01206803|GnRH-antagonist|gnrh-antagonist
408028|NCT01206803|corifollitropin alfa|corifollitropin alfa
408029|NCT01206790|PTSD|ptsd
408030|NCT01206790|Narrative Exposure Therapy|narrative exposure therapy
408031|NCT01206790|torture victims|torture victims
408032|NCT01206790|immune system|immune system
408033|NCT01206777|Hypersensitivity Reactions|hypersensitivity reactions
408034|NCT01206777|B-cell malignancies|b-cell malignancies
408035|NCT01206764|RCC,|rcc,
408036|NCT01206764|mTOR pathway,|mtor pathway,
408037|NCT01206764|angiogenesis,|angiogenesis,
408038|NCT01206764|PFS,|pfs,
408039|NCT01206764|partial response [PR] + complete response [CR])|partial response [pr] + complete response [cr])
408040|NCT01206764|metastatic recurrent renal cell carcinoma|metastatic recurrent renal cell carcinoma
408041|NCT01206764|metastatic unresectable renal cell carcinoma|metastatic unresectable renal cell carcinoma
408042|NCT01206725|Diabetes type 2|diabetes type 2
408043|NCT01206725|exercise|exercise
408044|NCT01206725|tissue Doppler velocity|tissue doppler velocity
408045|NCT01206712|Diabetes Mellitus Type 2|diabetes mellitus type 2
408046|NCT01206712|insulin glargine|insulin glargine
408047|NCT01206712|Metformin|metformin
408048|NCT01206686|seasonal influenza|seasonal influenza
408049|NCT01206686|behavioral economics|behavioral economics
408050|NCT01206686|nudge|nudge
408051|NCT01206686|implementations intentions|implementations intentions
408052|NCT01206686|vaccination|vaccination
408053|NCT01206621|dyspnea|dyspnea
408054|NCT01206621|COPD|copd
408055|NCT01206621|CHF|chf
408056|NCT01206621|asthma|asthma
408057|NCT01206608|Breast augmentation|breast augmentation
408058|NCT01206608|Pain|pain
408059|NCT01206608|Analgesia|analgesia
408060|NCT01206595|Postoperative Pain|postoperative pain
408061|NCT01206595|Bunionectomy|bunionectomy
408062|NCT01206595|Analgesia|analgesia
408063|NCT01206569|glomerulonephritis|glomerulonephritis
408064|NCT01206569|systemic lupus erythematosus|systemic lupus erythematosus
408065|NCT01206556|HUMAN PAPILLOMA VIRUS|human papilloma virus
408066|NCT01206556|HPV|hpv
408067|NCT01206543|Craniopharyngioma|craniopharyngioma
408068|NCT01206543|Surgery|surgery
408069|NCT01206543|Intraoperative imaging|intraoperative imaging
408070|NCT01206543|Rate of total removal|rate of total removal
408071|NCT01206530|histologically documented|histologically documented
408072|NCT01206530|advanced|advanced
408073|NCT01206530|metastatic|metastatic
408074|NCT01206530|adenocarcinoma|adenocarcinoma
408075|NCT01206530|colon|colon
408076|NCT01206530|rectum|rectum
408077|NCT01206517|asenapine|asenapine
408078|NCT01206517|pediatric schizophrenia|pediatric schizophrenia
408079|NCT01206517|bipolar I disorder|bipolar i disorder
408080|NCT01206504|West Nile virus|west nile virus
408081|NCT01206504|WNV|wnv
408082|NCT01206504|Encephalitis|encephalitis
408083|NCT01206504|Meningitis|meningitis
408084|NCT01206504|Acute Flaccid Paralysis|acute flaccid paralysis
408085|NCT01206504|Monoclonal Antibody|monoclonal antibody
408086|NCT01206504|WNND|wnnd
408087|NCT01206504|West Nile Neuroinvasive Disease|west nile neuroinvasive disease
408088|NCT01206504|Accidental Exposure to West Nile Virus|accidental exposure to west nile virus
408089|NCT01206452|Atrial Fibrillation; Ablation|atrial fibrillation; ablation
408090|NCT01206426|Urothelial, cancer, cisplatin, neoadjuvant, chemotherapy, germline|urothelial, cancer, cisplatin, neoadjuvant, chemotherapy, germline
408091|NCT01206413|overweight; treatment; women|overweight; treatment; women
408092|NCT01206400|eugonadal, testosterone|eugonadal, testosterone
408093|NCT01206374|Vitiligo Vulgaris|vitiligo vulgaris
408094|NCT01206361|Real world|real world
408095|NCT01206361|observational|observational
408096|NCT01206361|retrospective|retrospective
408097|NCT01206361|database analysis|database analysis
408098|NCT01206348|Acne|acne
408099|NCT01206335|Cancer Cachexia|cancer cachexia
408100|NCT01206335|Anorexia|anorexia
408101|NCT01206335|Advanced Malignancies|advanced malignancies
408102|NCT01206335|Weight Loss|weight loss
408103|NCT01206335|Fatigue|fatigue
408104|NCT01206335|Karnofsky|karnofsky
408105|NCT01206335|C-Reactive Protein|c-reactive protein
408106|NCT01206335|Simmonds Functional Assessment|simmonds functional assessment
408107|NCT01206322|diabetes, blood flow, brain perfusion, cognitive function|diabetes, blood flow, brain perfusion, cognitive function
408108|NCT01206309|Graft vs Host Disease|graft vs host disease
408109|NCT01206309|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
408110|NCT01206309|Bone Marrow Transplantation|bone marrow transplantation
408111|NCT01206309|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
408112|NCT01206309|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
408113|NCT01206296|Adjuvant|adjuvant
408114|NCT01206296|Intraperitoneal|intraperitoneal
408115|NCT01206296|Gemcitabine|gemcitabine
408116|NCT01206296|Pancreas|pancreas
408117|NCT01206296|Adenocarcinoma|adenocarcinoma
408118|NCT01206283|traumatic brain injury|traumatic brain injury
408119|NCT01206283|subarachnoid hemorrhage|subarachnoid hemorrhage
408120|NCT01206283|secondary brain ischemia|secondary brain ischemia
408121|NCT01206283|microdialysis|microdialysis
408122|NCT01206283|modified Lund concept|modified lund concept
9181|NCT03232099|Red Wine|red wine
408123|NCT01206283|cerebral perfusion pressure|cerebral perfusion pressure
408124|NCT01206283|intracranial pressure|intracranial pressure
408126|NCT01206270|Leydig|leydig
408127|NCT01206270|Testicular Tumor|testicular tumor
408128|NCT01206270|LH|lh
408129|NCT01206270|Infertility|infertility
408130|NCT01206257|Survey|survey
408131|NCT01206257|Angiography|angiography
408132|NCT01206257|ADR|adr
408133|NCT01206257|Image quality|image quality
408134|NCT01206244|dry eye|dry eye
408135|NCT01206244|tear meniscus|tear meniscus
408136|NCT01206244|tear osmolarity|tear osmolarity
408137|NCT01206231|Standard daily practice in managing patients with hypercholesterolemia|standard daily practice in managing patients with hypercholesterolemia
408138|NCT01206218|Gastric Cancer, BRCA1|gastric cancer, brca1
408139|NCT01206205|De novo Multiple Myeloma|de novo multiple myeloma
408140|NCT01206205|Bortezomib|bortezomib
408141|NCT01206205|Lenalidomide|lenalidomide
408142|NCT01206205|induction therapy|induction therapy
408143|NCT01206205|consolidation therapy|consolidation therapy
408144|NCT01206205|maintenance therapy|maintenance therapy
408145|NCT01206205|High dose therapy|high dose therapy
408146|NCT01206205|frontline therapy including new drugs and high dose therapy|frontline therapy including new drugs and high dose therapy
408147|NCT01206192|Intimate Terrorism|intimate terrorism
408148|NCT01206192|Situational couple violence|situational couple violence
408149|NCT01206192|Mental health|mental health
408150|NCT01206192|Chinese|chinese
408151|NCT01206192|Women|women
408152|NCT01206179|nonunion fracture bone formation pain relief|nonunion fracture bone formation pain relief
408153|NCT01206166|Randomized trial|randomized trial
408154|NCT01206166|Parental nutrition|parental nutrition
408155|NCT01206166|Enteral nutrition|enteral nutrition
408156|NCT01206166|Intensive care unit|intensive care unit
408157|NCT01206166|BMI < 25 or ≥ 35|bmi < 25 or ≥ 35
408158|NCT01206114|2009 H1N1 influenza|2009 h1n1 influenza
408159|NCT01206114|vaccination|vaccination
408160|NCT01206114|pandemic|pandemic
408161|NCT01206114|effectiveness|effectiveness
408162|NCT01206075|Beta Thalassemia Major|beta thalassemia major
408163|NCT01206075|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
408164|NCT01206075|Gene Transfer Techniques|gene transfer techniques
408165|NCT01206062|blood pressure|blood pressure
747191|NCT01152385|efficacy|efficacy
408166|NCT01206062|antihypertensive|antihypertensive
408167|NCT01206062|systolic|systolic
408168|NCT01206062|diastolic|diastolic
408169|NCT01206062|heart failure|heart failure
408170|NCT01206062|myocardial infarction|myocardial infarction
408171|NCT01206062|stroke|stroke
408172|NCT01206062|chronic kidney disease|chronic kidney disease
408173|NCT01206062|dementia|dementia
408174|NCT01206062|cognitive decline|cognitive decline
408175|NCT01206049|Cholangiocarcinoma|cholangiocarcinoma
408176|NCT01206049|Inoperable|inoperable
408177|NCT01206049|KRAS mutation|kras mutation
408178|NCT01206049|Biological treatment|biological treatment
408179|NCT01206049|Combination chemotherapy|combination chemotherapy
408180|NCT01206049|Monoclonal antibody|monoclonal antibody
408181|NCT01206036|castration|castration
408182|NCT01206036|prostate cancer|prostate cancer
408183|NCT01206036|castration resistant prostate cancer|castration resistant prostate cancer
408184|NCT01206036|PSA|psa
408185|NCT01206036|Docetaxel|docetaxel
408186|NCT01206036|Temsirolimus|temsirolimus
408187|NCT01206036|disease progression free survival|disease progression free survival
408188|NCT01206036|DPFS|dpfs
408189|NCT01206036|dose escalation|dose escalation
408190|NCT01206023|Multiple Sclerosis|multiple sclerosis
408191|NCT01206023|Breath|breath
408192|NCT01206023|Diagnosis|diagnosis
408193|NCT01206023|Discrimination MS/healthy subj. via exhaled breath samples|discrimination ms/healthy subj. via exhaled breath samples
408194|NCT01206010|Tobacco Dependence|tobacco dependence
408195|NCT01206010|Smoking cessation|smoking cessation
408196|NCT01206010|Varenicline|varenicline
408197|NCT01206010|Tailored dosing|tailored dosing
408198|NCT01205997|magnesium|magnesium
408199|NCT01205997|fentanyl|fentanyl
408200|NCT01205997|intrathecal|intrathecal
408201|NCT01205997|pain|pain
408202|NCT01205984|Chronic rhinosinusitis|chronic rhinosinusitis
408203|NCT01205984|Computed tomography scan|computed tomography scan
408204|NCT01205984|Methylprednisolone|methylprednisolone
408205|NCT01205958|Cervical pain|cervical pain
408206|NCT01205958|Neck pain|neck pain
408207|NCT01205958|western medicine|western medicine
408208|NCT01205958|oriental medicine|oriental medicine
408209|NCT01205958|acupuncture|acupuncture
408210|NCT01205958|needle|needle
408211|NCT01205711|recurrent colon cancer|recurrent colon cancer
408212|NCT01205711|stage IV colon cancer|stage iv colon cancer
408213|NCT01205711|recurrent rectal cancer|recurrent rectal cancer
408214|NCT01205711|stage IV rectal cancer|stage iv rectal cancer
408215|NCT01205672|Endometrium|endometrium
408216|NCT01205672|Gynecologic malignancy|gynecologic malignancy
408217|NCT01205672|Endometrial adenocarcinoma|endometrial adenocarcinoma
408218|NCT01205672|Insulin/glucose metabolism|insulin/glucose metabolism
408219|NCT01205672|Metformin|metformin
408220|NCT01205646|prostate cancer|prostate cancer
408221|NCT01205646|metastatic|metastatic
408222|NCT01205646|zoledronate|zoledronate
408223|NCT01205646|zometa|zometa
408224|NCT01205633|neurodegenerative disease|neurodegenerative disease
408225|NCT01205633|neurovascular disease|neurovascular disease
408226|NCT01205633|fatigue|fatigue
408227|NCT01205633|Hubbard Foundation|hubbard foundation
408228|NCT01205633|angioplasty|angioplasty
408229|NCT01205620|CABG|cabg
408230|NCT01205607|traumatic brain injury|traumatic brain injury
408231|NCT01205594|CABG surgery|cabg surgery
408232|NCT01205581|Fluzone|fluzone
408233|NCT01205581|Trivalent Influenza Vaccine|trivalent influenza vaccine
408234|NCT01205555|intra uterine insemination|intra uterine insemination
408235|NCT01205529|Atrial Fibrillation|atrial fibrillation
408236|NCT01205529|ST elevation|st elevation
408237|NCT01205529|Genotype|genotype
408238|NCT01205503|chemobrain|chemobrain
408239|NCT01205503|Oxidative Stress|oxidative stress
408240|NCT01205503|Mesna|mesna
508936|NCT00236977|CKD|ckd
408241|NCT01205477|Anserine bursitis|anserine bursitis
408242|NCT01205464|Persistent symptoms|persistent symptoms
408243|NCT01205464|Doxycycline|doxycycline
408244|NCT01205464|Placebo|placebo
408245|NCT01205464|Neuroborreliosis|neuroborreliosis
408246|NCT01205451|GSK1358820|gsk1358820
408247|NCT01205451|upper limb|upper limb
408248|NCT01205451|spasticity|spasticity
408249|NCT01205451|post-stroke|post-stroke
408250|NCT01205438|SLE|sle
408251|NCT01205438|Systemic Lupus Erythematosis|systemic lupus erythematosis
408252|NCT01205438|Lupus|lupus
408253|NCT01205438|autoimmune disease|autoimmune disease
408254|NCT01205438|LY2127399|ly2127399
408255|NCT01205438|Immune System Disease|immune system disease
408256|NCT01205425|Computed coronary angiography|computed coronary angiography
408257|NCT01205425|Stent implantation|stent implantation
408258|NCT01205425|IVUS|ivus
408259|NCT01205386|CTO|cto
408260|NCT01205386|peripheral artery occlusive disease|peripheral artery occlusive disease
408261|NCT01205386|PAOD|paod
408262|NCT01205386|SFA|sfa
408263|NCT01205386|superficial femoral artery|superficial femoral artery
408264|NCT01205360|Analgesia, labour;|analgesia, labour;
408265|NCT01205360|Analgesic techniques, epidural;|analgesic techniques, epidural;
408266|NCT01205360|Drug delivery, intermittent bolus;|drug delivery, intermittent bolus;
408267|NCT01205360|Anesthetics local, Bupivacaine;|anesthetics local, bupivacaine;
408268|NCT01205360|Analgesics opioid, Fentanyl;|analgesics opioid, fentanyl;
408269|NCT01205347|Statin|statin
408270|NCT01205347|Myocardial infarction|myocardial infarction
408271|NCT01205347|Insulin sensitivity|insulin sensitivity
408272|NCT01205334|Glioblastoma multiforme|glioblastoma multiforme
408273|NCT01205334|GBM|gbm
408274|NCT01205334|Brain Cancer|brain cancer
408275|NCT01205334|CTL|ctl
408276|NCT01205321|Neoplasm|neoplasm
408277|NCT01205321|PET/CT diagnosis|pet/ct diagnosis
408278|NCT01205321|PET tracer|pet tracer
408279|NCT01205308|Plant stanols|plant stanols
408280|NCT01205308|type 1 diabetes|type 1 diabetes
408281|NCT01205308|sterol metabolism|sterol metabolism
408282|NCT01205308|cholesterol|cholesterol
408283|NCT01205295|hip|hip
408284|NCT01205295|shoulder|shoulder
408285|NCT01205295|mental disorders|mental disorders
408286|NCT01205295|anxiety|anxiety
408287|NCT01205295|concern|concern
408288|NCT01205295|efficacy of treatment|efficacy of treatment
408289|NCT01205282|ASD|asd
408290|NCT01205269|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
408291|NCT01205269|safety|safety
408292|NCT01205269|inhalation|inhalation
408293|NCT01205269|long-acting muscarinic receptor antagonist (LAMA)|long-acting muscarinic receptor antagonist (lama)
408294|NCT01205256|Methadone pharmacokinetics in adolescents|methadone pharmacokinetics in adolescents
408295|NCT01205243|Abacavir|abacavir
408296|NCT01205243|post-marketing surveillance|post-marketing surveillance
408297|NCT01205230|Esomeprazole|esomeprazole
408298|NCT01205230|Pharmacogenetics|pharmacogenetics
408299|NCT01205230|Pharmacokinetics|pharmacokinetics
408300|NCT01205230|Ketoconazole|ketoconazole
408301|NCT01205230|Pazopanib|pazopanib
408302|NCT01205230|Drug Interaction|drug interaction
408303|NCT01205230|Safety|safety
408304|NCT01205230|Solid Tumors|solid tumors
408305|NCT01205217|lapatinib|lapatinib
408306|NCT01205217|epirubicin|epirubicin
408307|NCT01205217|cyclophosphamide|cyclophosphamide
408308|NCT01205217|trastuzumab|trastuzumab
408309|NCT01205217|paclitaxel|paclitaxel
408310|NCT01205217|neoadjuvant therapy|neoadjuvant therapy
408311|NCT01205217|Breast Cancer|breast cancer
408312|NCT01205204|Clonidine|clonidine
408313|NCT01205204|Fentanyl|fentanyl
408314|NCT01205204|Bupivacaine|bupivacaine
408315|NCT01205204|Spinal Anesthesia|spinal anesthesia
408316|NCT01205204|Lower Segment Caesarian Section|lower segment caesarian section
408317|NCT01205191|Cognitive behavioural therapy|cognitive behavioural therapy
408318|NCT01205191|Anxiety|anxiety
408319|NCT01205191|Primary care|primary care
408320|NCT01205191|Effectiveness trial|effectiveness trial
408321|NCT01205191|Cell-phone supported therapy|cell-phone supported therapy
408322|NCT01205152|Hypophosphatasia|hypophosphatasia
408323|NCT01205152|HPP|hpp
408324|NCT01205152|Bone Disease|bone disease
408325|NCT01205152|Soft Bones|soft bones
408326|NCT01205152|Low Alkaline Phosphatase|low alkaline phosphatase
408327|NCT01205152|genetic metabolic disorder|genetic metabolic disorder
408328|NCT01205152|alkaline phosphatase|alkaline phosphatase
408329|NCT01205152|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
408330|NCT01205152|rickets|rickets
408331|NCT01205152|osteomalacia|osteomalacia
408332|NCT01205139|TMC435-TiDP16-C114|tmc435-tidp16-c114
408333|NCT01205139|TMC435-C114|tmc435-c114
408334|NCT01205139|TMC435|tmc435
408335|NCT01205139|HCV|hcv
408336|NCT01205139|Hepatitis C|hepatitis c
408337|NCT01205126|Pain|pain
408338|NCT01205126|Hydromorphone hydrochloride|hydromorphone hydrochloride
408339|NCT01205126|Oxycodone hydrochloride|oxycodone hydrochloride
509062|NCT00237523|Cysts|cysts
408340|NCT01205100|Gastrointestinal Diseases|gastrointestinal diseases
408341|NCT01205100|Irritable Bowel Syndrome|irritable bowel syndrome
408342|NCT01205100|Behavioral Research|behavioral research
408343|NCT01205100|Biofeedback|biofeedback
408344|NCT01205074|Patients with chronic liver disease and cirrhosis|patients with chronic liver disease and cirrhosis
408345|NCT01205035|Idiopathic Parafoveal Telangiectasia|idiopathic parafoveal telangiectasia
408346|NCT01205035|Macular Telangiectasia|macular telangiectasia
408347|NCT01205035|Macula Lutea/pathology|macula lutea/pathology
408348|NCT01205035|Retinal Diseases/pathology|retinal diseases/pathology
408632|NCT01204086|fluoxetine|fluoxetine
408349|NCT01205035|Retinal Pigments/metabolism|retinal pigments/metabolism
408350|NCT01205035|Telangiectasis/metabolism|telangiectasis/metabolism
408351|NCT01205035|Telangiectasis/pathology|telangiectasis/pathology
408352|NCT01205009|in-vitro fertilization|in-vitro fertilization
408353|NCT01205009|poor responders|poor responders
408354|NCT01205009|human chorionic gonadotropin|human chorionic gonadotropin
408355|NCT01205009|Fertility Agents, Female|fertility agents, female
408356|NCT01204996|monoclonal antibody|monoclonal antibody
408357|NCT01204996|solid tumor|solid tumor
408358|NCT01204996|chemotherapy|chemotherapy
408359|NCT01204996|standard of care|standard of care
408360|NCT01204983|very low birth weight infant|very low birth weight infant
408361|NCT01204983|donor human milk|donor human milk
584552|NCT00509431|adult pilocytic astrocytoma|adult pilocytic astrocytoma
408362|NCT01204970|Confocal Laser Scanning Microendoscopy|confocal laser scanning microendoscopy
408363|NCT01204970|Small airways|small airways
408364|NCT01204970|COPD|copd
408365|NCT01204970|Lung transplantation|lung transplantation
408366|NCT01204957|Homocysteine|homocysteine
408367|NCT01204957|Insulin-like growth factor|insulin-like growth factor
408368|NCT01204957|Insulin-like growth factor binding protein|insulin-like growth factor binding protein
408369|NCT01204957|Serum estrogen|serum estrogen
408370|NCT01204957|Urinary phytoestrogens|urinary phytoestrogens
408371|NCT01204957|Thyroid hormones|thyroid hormones
408372|NCT01204931|reflux|reflux
408373|NCT01204931|gastroesophageal reflux disease|gastroesophageal reflux disease
408374|NCT01204931|GERD|gerd
408375|NCT01204918|MDD|mdd
408376|NCT01204918|Depression|depression
408377|NCT01204918|Treatment refractory|treatment refractory
408378|NCT01204918|Glutamate|glutamate
408379|NCT01204918|Riluzole|riluzole
408380|NCT01204918|Major depressive disorder|major depressive disorder
408381|NCT01204918|psychopharmacology|psychopharmacology
408382|NCT01204918|rilutek|rilutek
408383|NCT01204905|HIV-1|hiv-1
408384|NCT01204905|CD4|cd4
408385|NCT01204905|Viral Load|viral load
408386|NCT01204905|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
408387|NCT01204866|Allergic-Like Reaction|allergic-like reaction
408388|NCT01204866|Selected Formulation Components|selected formulation components
408389|NCT01204853|sitaxentan sodium hypertension|sitaxentan sodium hypertension
408390|NCT01204840|in vitro fertilization|in vitro fertilization
408391|NCT01204840|IVF|ivf
408392|NCT01204840|poor responder|poor responder
408393|NCT01204840|growth hormone|growth hormone
408394|NCT01204840|Poor responders to in vitro fertilization treatments|poor responders to in vitro fertilization treatments
408395|NCT01204827|Patients with chronic HBeAg negative hepatitis B virus infection treated with Sebivo (Telbivudine)|patients with chronic hbeag negative hepatitis b virus infection treated with sebivo (telbivudine)
408396|NCT01204814|HIV|hiv
408397|NCT01204814|Drug resistance|drug resistance
408398|NCT01204814|mutations|mutations
408399|NCT01204814|ARV's|arv's
408400|NCT01204801|Cancer|cancer
408401|NCT01204801|Breast Cancer|breast cancer
408402|NCT01204801|Breast Tumor|breast tumor
408403|NCT01204801|Breast Neoplasm|breast neoplasm
408404|NCT01204801|Neoplasms by Site|neoplasms by site
408405|NCT01204801|Neoplasms|neoplasms
408406|NCT01204801|Breast Diseases|breast diseases
408407|NCT01204801|Breast Conserving Surgery|breast conserving surgery
408408|NCT01204801|Breast Conservation|breast conservation
408409|NCT01204801|Partial Mastectomy|partial mastectomy
408410|NCT01204801|Lumpectomy|lumpectomy
408411|NCT01204801|Mastectomy|mastectomy
408412|NCT01204801|Surgery|surgery
408413|NCT01204801|Neoadjuvant Therapy|neoadjuvant therapy
408414|NCT01204801|Primary Therapy|primary therapy
408415|NCT01204801|Neoadjuvant Systemic Therapy|neoadjuvant systemic therapy
408421|NCT01204801|Hyperthermia, Local|hyperthermia, local
408422|NCT01204801|Hyperthermia, Induced|hyperthermia, induced
408423|NCT01204801|Therapeutic Hyperthermia|therapeutic hyperthermia
408424|NCT01204801|Microwave|microwave
408425|NCT01204801|Focused Microwave|focused microwave
408426|NCT01204801|Focused Microwave Thermotherapy|focused microwave thermotherapy
408427|NCT01204801|Minimally Invasive|minimally invasive
408428|NCT01204801|Doxorubicin|doxorubicin
408429|NCT01204801|Epirubicin|epirubicin
408430|NCT01204801|Epidoxirubicin|epidoxirubicin
408431|NCT01204801|Immunosuppresive Agent|immunosuppresive agent
408432|NCT01204801|Immunologic Factors|immunologic factors
408433|NCT01204801|Physiological Effects of Drugs|physiological effects of drugs
408434|NCT01204801|Chemotherapy|chemotherapy
408435|NCT01204801|Drug Therapy|drug therapy
408436|NCT01204801|Pharmalogic Actions|pharmalogic actions
408437|NCT01204801|Antirheumatic Agents|antirheumatic agents
408438|NCT01204801|Therapeutic Uses|therapeutic uses
408439|NCT01204801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
408440|NCT01204801|Alkylating Agents|alkylating agents
408441|NCT01204801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
408442|NCT01204801|Antineoplastic Agents|antineoplastic agents
408732|NCT01203709|lupus|lupus
408443|NCT01204801|Myeloblative Agonists|myeloblative agonists
408444|NCT01204801|Antibiotics, Antineoplastic|antibiotics, antineoplastic
408445|NCT01204801|Anthracycline Agents|anthracycline agents
408446|NCT01204788|Acute myelogenous leukemia|acute myelogenous leukemia
408447|NCT01204788|AML|aml
408448|NCT01204788|Undifferentiated and bi-phenotypic leukemia|undifferentiated and bi-phenotypic leukemia
408449|NCT01204788|High-risk myelodysplastic syndrome|high-risk myelodysplastic syndrome
408450|NCT01204788|Chronic myelogenous leukemia|chronic myelogenous leukemia
408451|NCT01204788|Infection|infection
584553|NCT00509431|adult diffuse astrocytoma|adult diffuse astrocytoma
408452|NCT01204788|Radiated Prophylactic White Cell Transfusions|radiated prophylactic white cell transfusions
408453|NCT01204788|Therapeutic Radiated White Cell Transfusion|therapeutic radiated white cell transfusion
408454|NCT01204788|prophylactic antibiotics|prophylactic antibiotics
408455|NCT01204749|AMGEN|amgen
408456|NCT01204749|AMG 386|amg 386
408457|NCT01204749|Angiogenesis Inhibitors|angiogenesis inhibitors
408458|NCT01204749|Fallopian Tube Cancer|fallopian tube cancer
408459|NCT01204749|Primary Peritoneal Cancer|primary peritoneal cancer
408460|NCT01204749|Paclitaxel|paclitaxel
408461|NCT01204749|Ovarian Cancer|ovarian cancer
408462|NCT01204749|TRINOVA-1|trinova-1
408463|NCT01204736|tendon transfer|tendon transfer
408464|NCT01204736|elbow|elbow
408465|NCT01204723|Marijuana Abuse|marijuana abuse
408466|NCT01204723|Nicotine Dependence|nicotine dependence
408467|NCT01204723|Nicotine Withdrawal|nicotine withdrawal
408468|NCT01204723|neurokinin Receptor|neurokinin receptor
408469|NCT01204723|NK1 Receptor antagonist|nk1 receptor antagonist
408470|NCT01204723|Substance P|substance p
408471|NCT01204723|Recurrence|recurrence
408472|NCT01204723|Substance Withdrawal Syndrome|substance withdrawal syndrome
408473|NCT01204723|Substance-Related Disorders|substance-related disorders
408474|NCT01204723|Disorders of Environmental Origin|disorders of environmental origin
408475|NCT01204723|Mental Disorders|mental disorders
408476|NCT01204723|Disease Attributes|disease attributes
408477|NCT01204723|Pathologic Processes|pathologic processes
408478|NCT01204723|Tetrahydrocannabinol|tetrahydrocannabinol
408479|NCT01204723|Therapeutic Uses|therapeutic uses
408480|NCT01204723|Psychotropic Drugs|psychotropic drugs
408481|NCT01204723|Analgesics, Non-Narcotic|analgesics, non-narcotic
408482|NCT01204723|Analgesics|analgesics
408483|NCT01204723|Sensory System Agents|sensory system agents
408484|NCT01204723|Peripheral Nervous System Agents|peripheral nervous system agents
408485|NCT01204723|Neurotransmitter Agents|neurotransmitter agents
408486|NCT01204723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
408487|NCT01204723|Narcotic Antagonists|narcotic antagonists
408488|NCT01204723|cannabis|cannabis
408489|NCT01204710|Prostate Cancer|prostate cancer
408490|NCT01204684|dendritic cells|dendritic cells
408491|NCT01204684|glioma|glioma
408492|NCT01204684|vaccine|vaccine
408493|NCT01204684|glioma of WHO Grade III or IV|glioma of who grade iii or iv
408494|NCT01204671|influenza infection|influenza infection
408495|NCT01204671|GSK Biologicals influenza vaccine GSK2321138A|gsk biologicals influenza vaccine gsk2321138a
408496|NCT01204658|Haemophilus influenzae|haemophilus influenzae
408497|NCT01204658|Streptococcus pneumoniae|streptococcus pneumoniae
408498|NCT01204658|immunogenicity|immunogenicity
408499|NCT01204658|Pneumococcal vaccine|pneumococcal vaccine
408500|NCT01204658|infants|infants
408501|NCT01204658|safety|safety
408502|NCT01204619|peritoneal dialysis|peritoneal dialysis
408503|NCT01204567|HLRQ|hlrq
408504|NCT01204567|elderly|elderly
408505|NCT01204567|aerobic fitness|aerobic fitness
408506|NCT01204567|cognitive capacity|cognitive capacity
408507|NCT01204554|perforator flaps|perforator flaps
408508|NCT01204541|Non-exudative age-related macular degeneration|non-exudative age-related macular degeneration
408509|NCT01204528|Dysfunction in CKD|dysfunction in ckd
408511|NCT01204515|irritable bowel syndrome|irritable bowel syndrome
408512|NCT01204515|abdominal pain|abdominal pain
408513|NCT01204515|urgency|urgency
408514|NCT01204515|bloating|bloating
408515|NCT01204515|diarrhea|diarrhea
408516|NCT01204515|constipation|constipation
408517|NCT01204502|Gene therapy|gene therapy
408518|NCT01204502|Haploidentical|haploidentical
408519|NCT01204502|Bone marrow transplant|bone marrow transplant
408520|NCT01204502|Graft versus host disease|graft versus host disease
408521|NCT01204502|haploidentical stem cell transplantation|haploidentical stem cell transplantation
408522|NCT01204502|T-cell suicide gene therapy|t-cell suicide gene therapy
408523|NCT01204450|recurrent childhood brain tumor|recurrent childhood brain tumor
408524|NCT01204450|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
408525|NCT01204450|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
408526|NCT01204450|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
408527|NCT01204450|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
408528|NCT01204450|recurrent neuroblastoma|recurrent neuroblastoma
408529|NCT01204450|recurrent osteosarcoma|recurrent osteosarcoma
408530|NCT01204450|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
408531|NCT01204437|adjuvant chemotherapy|adjuvant chemotherapy
408532|NCT01204437|primary carcinoma|primary carcinoma
408533|NCT01204437|elderly non frail patients|elderly non frail patients
408534|NCT01204437|EC|ec
408535|NCT01204437|CMF|cmf
408536|NCT01204437|Capecitabine|capecitabine
408537|NCT01204437|Nab-Paclitaxel|nab-paclitaxel
408538|NCT01204424|minimal invasive|minimal invasive
408539|NCT01204424|sinus floor augmentation|sinus floor augmentation
408540|NCT01204424|sinuslift|sinuslift
408541|NCT01204424|dental implants|dental implants
408542|NCT01204411|Efficacy|efficacy
408543|NCT01204411|Safety|safety
408544|NCT01204411|Artesunate-amodiaquine|artesunate-amodiaquine
408545|NCT01204411|Malaria|malaria
408546|NCT01204411|Plasmodium falciparum|plasmodium falciparum
408547|NCT01204411|Malnutrition|malnutrition
408548|NCT01204385|Non-typeable Haemophilus Influenzae|non-typeable haemophilus influenzae
408549|NCT01204385|Acute Otitis Media|acute otitis media
408550|NCT01204385|Streptococcus Pneumoniae|streptococcus pneumoniae
408551|NCT01204385|etiology|etiology
408552|NCT01204372|Metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
408553|NCT01204372|First-line chemotherapy|first-line chemotherapy
408554|NCT01204372|Combination chemotherapy|combination chemotherapy
408555|NCT01204372|Targeted agents|targeted agents
408556|NCT01204346|adolescents|adolescents
408557|NCT01204346|MBT|mbt
408558|NCT01204346|depression|depression
408559|NCT01204346|emerging personality disorder|emerging personality disorder
408560|NCT01204333|Cerebral venous and sinus thrombosis|cerebral venous and sinus thrombosis
408561|NCT01204333|Cerebral venous thrombosis|cerebral venous thrombosis
408562|NCT01204333|Sinus Thrombosis, Intracranial|sinus thrombosis, intracranial
408563|NCT01204333|Endovascular thrombolysis|endovascular thrombolysis
408564|NCT01204333|Thrombolysis|thrombolysis
408565|NCT01204333|Thrombectomy|thrombectomy
408566|NCT01204320|Restenosis|restenosis
408567|NCT01204320|POBA|poba
408568|NCT01204320|Stenting|stenting
408569|NCT01204320|Paclitaxel|paclitaxel
408570|NCT01204281|Proportional Assist Ventilation plus|proportional assist ventilation plus
408571|NCT01204281|Acute respiratory failure|acute respiratory failure
408572|NCT01204281|Mechanical ventilation|mechanical ventilation
408573|NCT01204268|cerebral ischemia|cerebral ischemia
408574|NCT01204268|sevoflurane preconditioning|sevoflurane preconditioning
408575|NCT01204268|intracranial aneurysm surgery|intracranial aneurysm surgery
408576|NCT01204255|healthy, no evidence of disease|healthy, no evidence of disease
408577|NCT01204242|Breast Cancer|breast cancer
408578|NCT01204229|Alcohol Consumption|alcohol consumption
408579|NCT01204229|Social Anxiety|social anxiety
408580|NCT01204229|Depression|depression
408581|NCT01204229|Brief Intervention|brief intervention
408582|NCT01204229|Motivational Interviewing|motivational interviewing
408583|NCT01204229|Cognitive Behavioral Therapy|cognitive behavioral therapy
408584|NCT01204229|Sub-Clinical Social Anxiety|sub-clinical social anxiety
408585|NCT01204229|Sub-Clinical Depression|sub-clinical depression
408586|NCT01204216|Hemoglobin A1c|hemoglobin a1c
408587|NCT01204216|HbA1c|hba1c
408588|NCT01204216|glycated serum proteins|glycated serum proteins
408589|NCT01204216|fructosamine|fructosamine
408590|NCT01204216|glycated albumin|glycated albumin
408591|NCT01204216|glycation gap|glycation gap
408592|NCT01204203|mesothelioma|mesothelioma
408593|NCT01204203|zoledronic acid|zoledronic acid
408594|NCT01204203|zometa|zometa
408595|NCT01204203|bisphosphonate therapy|bisphosphonate therapy
408596|NCT01204203|CT scan|ct scan
408597|NCT01204203|PET scan|pet scan
408598|NCT01204190|Administration|administration
408599|NCT01204190|Cutaneous|cutaneous
408600|NCT01204177|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
408601|NCT01204177|MEK inhibitor|mek inhibitor
408602|NCT01204177|Sorafenib|sorafenib
408603|NCT01204177|Disease control rate (DCR)|disease control rate (dcr)
408604|NCT01204177|Safety|safety
408605|NCT01204164|AML|aml
408606|NCT01204164|ALL|all
408607|NCT01204164|MDS|mds
408608|NCT01204164|CML in blast crisis|cml in blast crisis
408609|NCT01204164|Multiple Myeloma|multiple myeloma
408610|NCT01204164|Carfilzomib refractory|carfilzomib refractory
408611|NCT01204138|RA, treatment, TNF, cytokines|ra, treatment, tnf, cytokines
408612|NCT01204112|Drug-Drug Interaction|drug-drug interaction
408613|NCT01204112|Tasocitinib (CP-690|tasocitinib (cp-690
408614|NCT01204112|550)|550)
408615|NCT01204112|Rifampin|rifampin
408616|NCT01204112|Healthy Volunteers|healthy volunteers
408617|NCT01204099|PX-866|px-866
408618|NCT01204099|Non small cell lung cancer|non small cell lung cancer
408619|NCT01204099|solid tumors|solid tumors
408620|NCT01204099|Squamous cell cancer of the head and neck|squamous cell cancer of the head and neck
408621|NCT01204099|docetaxel|docetaxel
408622|NCT01204099|NSCLC|nsclc
408623|NCT01204099|taxotere|taxotere
408624|NCT01204099|SCCHN|scchn
408625|NCT01204099|PI-3K|pi-3k
408626|NCT01204099|PI3 kinase|pi3 kinase
408627|NCT01204099|PI3K|pi3k
408628|NCT01204086|Major Depressive Disorder|major depressive disorder
408629|NCT01204086|Antidepressants|antidepressants
408630|NCT01204086|Pharmacogenetics|pharmacogenetics
408631|NCT01204086|venlafaxine|venlafaxine
408633|NCT01204060|Nasal Allergen Lipopolysaccharide Inflammation Asthma|nasal allergen lipopolysaccharide inflammation asthma
408634|NCT01204034|COPD|copd
408635|NCT01204034|Formoterol|formoterol
408636|NCT01204034|Beclomethasone Dipropionate|beclomethasone dipropionate
408637|NCT01204034|Computational Fluid Dynamics|computational fluid dynamics
408638|NCT01204034|Functional Imaging|functional imaging
408639|NCT01204034|Central and Peripheral Airways|central and peripheral airways
408640|NCT01204034|BODE index|bode index
408641|NCT01204034|COPD Assessment Test (CAT)|copd assessment test (cat)
408642|NCT01204034|Borg CR10 scale|borg cr10 scale
408643|NCT01204021|Stress|stress
408644|NCT01204021|loneliness|loneliness
408645|NCT01204021|social isolation|social isolation
408646|NCT01204021|autonomic activity|autonomic activity
408647|NCT01204021|inflammation|inflammation
408648|NCT01204021|Perceived social isolation|perceived social isolation
408649|NCT01204021|Chronic stress|chronic stress
408650|NCT01203982|CIMT|cimt
408651|NCT01203982|IVUS-VH|ivus-vh
408652|NCT01203982|Coronary artery disease|coronary artery disease
408653|NCT01203956|AutoAdjust|autoadjust
408654|NCT01203956|SmartFlex|smartflex
408655|NCT01203956|Apnea Hypopnea Index|apnea hypopnea index
408656|NCT01203956|Patient reported outcomes|patient reported outcomes
408657|NCT01203943|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
408658|NCT01203943|Pulmonary Fibrosis|pulmonary fibrosis
408659|NCT01203943|Fibrosis|fibrosis
408660|NCT01203943|Interstitial Lung Disease|interstitial lung disease
408661|NCT01203943|Lung Diseases, Interstitial|lung diseases, interstitial
408662|NCT01203943|CC-930|cc-930
408663|NCT01203930|CLL|cll
408664|NCT01203930|SLL|sll
408665|NCT01203930|GS-1101|gs-1101
408666|NCT01203930|CAL-101|cal-101
408667|NCT01203930|Phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
408668|NCT01203930|Rituximab|rituximab
408669|NCT01203930|Rituxan|rituxan
408670|NCT01203917|Gefitinib|gefitinib
408671|NCT01203917|EGFR TKI|egfr tki
408672|NCT01203917|efficacy|efficacy
408673|NCT01203917|Caucasian patients|caucasian patients
408674|NCT01203917|EGFR mutation positive advanced NSCLC|egfr mutation positive advanced nsclc
408676|NCT01203904|bronchial asthma, Pulmicort, long term use, pediatrics|bronchial asthma, pulmicort, long term use, pediatrics
408677|NCT01203891|SPECT|spect
408678|NCT01203891|Imaging|imaging
408679|NCT01203891|Healthy brain|healthy brain
408680|NCT01203891|regional cerebral blood flow|regional cerebral blood flow
408681|NCT01203878|Imiquimod|imiquimod
408682|NCT01203878|Photodynamic therapy|photodynamic therapy
408683|NCT01203878|Actinic keratoses|actinic keratoses
408684|NCT01203878|Sequential therapy|sequential therapy
408685|NCT01203878|Therapeutic uses|therapeutic uses
408686|NCT01203865|Fibromyalgia|fibromyalgia
408687|NCT01203865|Fatigue|fatigue
408688|NCT01203852|hypertension|hypertension
408689|NCT01203852|antihypertensive drug|antihypertensive drug
408690|NCT01203852|pharmacogenetics|pharmacogenetics
408691|NCT01203852|genetics|genetics
408692|NCT01203852|blood pressure|blood pressure
408693|NCT01203852|glucose|glucose
408694|NCT01203839|stage 1 breast cancer|stage 1 breast cancer
408695|NCT01203839|invasive ductal breast|invasive ductal breast
408696|NCT01203839|Partial Breast Irradiation (PBI)|partial breast irradiation (pbi)
408697|NCT01203839|radiation|radiation
408698|NCT01203839|10-114|10-114
408699|NCT01203826|Hypophosphatasia|hypophosphatasia
408700|NCT01203826|HPP|hpp
408701|NCT01203826|Bone Disease|bone disease
408702|NCT01203826|Soft Bones|soft bones
408703|NCT01203826|Low Alkaline Phosphatase|low alkaline phosphatase
408704|NCT01203826|genetic metabolic disorder|genetic metabolic disorder
408705|NCT01203826|alkaline phosphatase|alkaline phosphatase
408706|NCT01203826|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
408707|NCT01203826|rickets|rickets
408708|NCT01203826|osteomalacia|osteomalacia
408709|NCT01203813|Chronic kidney disease|chronic kidney disease
408710|NCT01203813|Quality improvement|quality improvement
408711|NCT01203813|Self management support|self management support
408712|NCT01203813|Electronic health records|electronic health records
408713|NCT01203813|Clinical decision support|clinical decision support
408714|NCT01203813|Electronic reminders|electronic reminders
408715|NCT01203813|Patient outreach|patient outreach
408716|NCT01203787|Hepatocellular Carcinoma|hepatocellular carcinoma
408717|NCT01203787|HCC|hcc
408718|NCT01203787|Liver Cancer|liver cancer
407794|NCT01207557|flu|flu
408719|NCT01203774|Diabetes|diabetes
408720|NCT01203761|loneliness|loneliness
408721|NCT01203735|Non-small-cell lung cancer|non-small-cell lung cancer
408722|NCT01203735|Valproic acid|valproic acid
408723|NCT01203735|Chemotherapy|chemotherapy
408724|NCT01203735|Radiotherapy|radiotherapy
408725|NCT01203722|Reduced intensity|reduced intensity
408726|NCT01203722|partially HLA mismatched allogeneic BMT|partially hla mismatched allogeneic bmt
408727|NCT01203722|Acute leukemias|acute leukemias
408728|NCT01203722|Chronic leukemias|chronic leukemias
408729|NCT01203722|Myelodysplasia|myelodysplasia
408730|NCT01203722|Lymphomas|lymphomas
408731|NCT01203722|Unrelated or non-first-degree related donors|unrelated or non-first-degree related donors
408733|NCT01203709|nephritis|nephritis
408734|NCT01203709|glomerulonephritis|glomerulonephritis
408735|NCT01203709|nephropathy|nephropathy
408736|NCT01203709|refractory|refractory
408737|NCT01203696|Clopidogrel|clopidogrel
408738|NCT01203696|Platelet reactivity|platelet reactivity
408739|NCT01203696|Amlodipine|amlodipine
408740|NCT01203683|depression|depression
408741|NCT01203670|Glomerular filtration rate (GFR)|glomerular filtration rate (gfr)
408742|NCT01203670|Aspartate Amino Transferase (ASAT)|aspartate amino transferase (asat)
408743|NCT01203670|Alanine Amino transferase (ALAT)|alanine amino transferase (alat)
408744|NCT01203670|gamma Glutamyl transpeptidase (gamma GT)|gamma glutamyl transpeptidase (gamma gt)
408745|NCT01203670|Lipase|lipase
408746|NCT01203670|Amylase|amylase
408747|NCT01203657|exercise|exercise
408748|NCT01203657|physical activity|physical activity
408749|NCT01203657|tai chi|tai chi
408750|NCT01203644|Postoperative pain|postoperative pain
408751|NCT01203644|Analgesia|analgesia
408752|NCT01203618|Resectable, non-functioning pituitary adenoma|resectable, non-functioning pituitary adenoma
408753|NCT01203618|Pituitary tumor|pituitary tumor
408754|NCT01203618|Pituitary adenoma|pituitary adenoma
408755|NCT01203618|Pituitary macroadenoma|pituitary macroadenoma
408756|NCT01203605|Operative surgical procedures|operative surgical procedures
408757|NCT01203605|mortality|mortality
408758|NCT01203605|adverse effects|adverse effects
408759|NCT01203605|Postoperative complications|postoperative complications
408760|NCT01203605|Epidemiological Study|epidemiological study
408761|NCT01203592|Congenital myasthenic syndrome|congenital myasthenic syndrome
408762|NCT01203592|Albuterol|albuterol
408763|NCT01203592|Neuromuscular transmission|neuromuscular transmission
408764|NCT01203579|CDT-Lung,CT scan,lung cancer detection|cdt-lung,ct scan,lung cancer detection
408765|NCT01203566|Single incision laparoscopic surgery|single incision laparoscopic surgery
408766|NCT01203566|Single site access laparoscopic surgery|single site access laparoscopic surgery
408767|NCT01203566|SILS|sils
408768|NCT01203566|Single-port access|single-port access
408769|NCT01203566|Laparoendoscopic single site surgery|laparoendoscopic single site surgery
408770|NCT01203566|Appendectomy|appendectomy
408771|NCT01203553|Incisional hernias|incisional hernias
408772|NCT01203553|Prophylaxis|prophylaxis
408773|NCT01203553|Preperitoneal mesh|preperitoneal mesh
408774|NCT01203527|H1N1 influenza|h1n1 influenza
408775|NCT01203527|Swine flu|swine flu
408776|NCT01203527|Oseltamivir|oseltamivir
408777|NCT01203527|Tamiflu|tamiflu
408778|NCT01203527|Pregnancy|pregnancy
408779|NCT01203514|NICHD Neonatal Research Network|nichd neonatal research network
408780|NCT01203514|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
408781|NCT01203514|Prematurity|prematurity
408782|NCT01203514|Erythrocyte transfusions|erythrocyte transfusions
408783|NCT01203514|Erythropoietin (Epo)|erythropoietin (epo)
408784|NCT01203514|Blood loss|blood loss
408785|NCT01203514|Phlebotomy|phlebotomy
408786|NCT01203501|NICHD Neonatal Research Network|nichd neonatal research network
408787|NCT01203501|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
408788|NCT01203501|Prematurity|prematurity
408789|NCT01203501|Antenatal Magnesium sulfate|antenatal magnesium sulfate
408790|NCT01203488|NICHD Neonatal Research Network|nichd neonatal research network
408791|NCT01203488|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
408792|NCT01203488|Prematurity|prematurity
408793|NCT01203488|Vitamin A|vitamin a
408794|NCT01203488|Chronic Lung Disease|chronic lung disease
408795|NCT01203475|NICHD Neonatal Research Network|nichd neonatal research network
408796|NCT01203475|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
408797|NCT01203475|Prematurity|prematurity
408798|NCT01203475|Growth Curve|growth curve
408799|NCT01203475|Head Circumference|head circumference
408800|NCT01203475|Length|length
408801|NCT01203449|NICHD Neonatal Research Network|nichd neonatal research network
408802|NCT01203449|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
408803|NCT01203449|Prematurity|prematurity
408804|NCT01203449|Gestational Age|gestational age
408805|NCT01203436|NICHD Neonatal Research Network|nichd neonatal research network
408806|NCT01203436|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
408807|NCT01203436|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
408808|NCT01203436|Prematurity|prematurity
408809|NCT01203423|NICHD Neonatal Research Network|nichd neonatal research network
408810|NCT01203423|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
408811|NCT01203423|Prematurity|prematurity
408812|NCT01203423|Persistent Pulmonary Hypertension of Newborn (PPHN)|persistent pulmonary hypertension of newborn (pphn)
408813|NCT01203410|NICHD Neonatal Research Network|nichd neonatal research network
408814|NCT01203410|Term infant|term infant
408815|NCT01203410|Hyperbilirubinemia|hyperbilirubinemia
408816|NCT01203397|SUPERFICIAL VARICOSE VEINS|superficial varicose veins
408817|NCT01203371|naftopidil|naftopidil
408818|NCT01203371|symptoms of lower urinary tract|symptoms of lower urinary tract
408819|NCT01203371|benign prostate hyperplasia|benign prostate hyperplasia
408820|NCT01203371|LUTS|luts
408821|NCT01203358|NICHD Neonatal Research Network|nichd neonatal research network
408822|NCT01203358|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
408823|NCT01203358|Prematurity|prematurity
408824|NCT01203358|Respiratory distress syndrome|respiratory distress syndrome
408825|NCT01203358|Surfactant|surfactant
408826|NCT01203345|NICHD Neonatal Research Network|nichd neonatal research network
408827|NCT01203345|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
408828|NCT01203345|Prematurity|prematurity
408829|NCT01203345|Septicemia|septicemia
408830|NCT01203345|Meningitis|meningitis
748605|NCT01150955|STAT5|stat5
408831|NCT01203345|Urinary tract infection|urinary tract infection
408832|NCT01203345|Immune globulin|immune globulin
408833|NCT01203332|HIV testing|hiv testing
408835|NCT01203332|Latina|latina
408836|NCT01203332|Men who have sex with men|men who have sex with men
408837|NCT01203319|immunogenicity|immunogenicity
408838|NCT01203319|safety|safety
408839|NCT01203319|recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
408840|NCT01203319|nonresponders|nonresponders
408841|NCT01203306|bevacizumab|bevacizumab
408842|NCT01203306|somatostatin analogue|somatostatin analogue
408843|NCT01203306|metronomic capecitabine|metronomic capecitabine
408844|NCT01203306|neuroendocrine tumors|neuroendocrine tumors
408845|NCT01203280|icing|icing
408846|NCT01203280|boxer|boxer
408847|NCT01203280|balance|balance
408848|NCT01203280|neck range of motion|neck range of motion
408849|NCT01203280|neck isometric strength|neck isometric strength
408850|NCT01203280|balance performance|balance performance
408851|NCT01203267|Breast Neoplasms|breast neoplasms
408852|NCT01203267|Neoadjuvant|neoadjuvant
408853|NCT01203267|Chemotherapy|chemotherapy
408854|NCT01203267|Paclitaxel|paclitaxel
408855|NCT01203267|Carboplatin|carboplatin
408856|NCT01203267|Pathological Complete Remission|pathological complete remission
408857|NCT01203254|Colesevelam|colesevelam
408858|NCT01203254|IBD|ibd
408859|NCT01203254|Bile Acid Malabsorption|bile acid malabsorption
408860|NCT01203254|Crohns disease|crohns disease
408861|NCT01203228|Reduced Intensity conditioning|reduced intensity conditioning
408862|NCT01203228|Myeloablative conditionig|myeloablative conditionig
408863|NCT01203228|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
408864|NCT01203228|MUD|mud
408865|NCT01203215|exercise|exercise
408866|NCT01203215|physical activity|physical activity
408867|NCT01203215|women|women
408868|NCT01203215|community|community
408869|NCT01203202|PE|pe
408870|NCT01203202|IELT|ielt
408871|NCT01203202|DCIT|dcit
408872|NCT01203189|dandruff, flaky scalp|dandruff, flaky scalp
408873|NCT01203176|Endometrial polyp|endometrial polyp
408874|NCT01203176|Endometrial carcinoma|endometrial carcinoma
408875|NCT01203176|Endometrial hyperplasia|endometrial hyperplasia
408876|NCT01203176|Postmenopausal symptomatic women|postmenopausal symptomatic women
408877|NCT01203176|Postmenopausal asymptomatic women|postmenopausal asymptomatic women
408878|NCT01203163|PDT|pdt
408879|NCT01203163|porfimer sodium|porfimer sodium
408880|NCT01203163|esophageal cancer|esophageal cancer
408881|NCT01203163|NSCLC|nsclc
408882|NCT01203163|HGD in BE|hgd in be
408883|NCT01203137|tricuspid regurgitation, severe|tricuspid regurgitation, severe
408884|NCT01203124|Intranasal|intranasal
408885|NCT01203124|Biomarker|biomarker
408886|NCT01203124|Healthy|healthy
408887|NCT01203124|Effect of different doses and dosing regimens of AZD8848 on biomarkers|effect of different doses and dosing regimens of azd8848 on biomarkers
753322|NCT01176240|concentration|concentration
408888|NCT01203124|Effect different doses and dosing frequency of AZD8848 on biomarkers|effect different doses and dosing frequency of azd8848 on biomarkers
408890|NCT01203098|venous thromboembolism|venous thromboembolism
408891|NCT01203098|edoxaban|edoxaban
408892|NCT01203098|anticoagulants|anticoagulants
408893|NCT01203072|prevention|prevention
408894|NCT01203072|venous thromboembolism|venous thromboembolism
408895|NCT01203072|edoxaban|edoxaban
408896|NCT01203072|factor Xa|factor xa
408897|NCT01203046|DURATION OF THERAPY|duration of therapy
408898|NCT01203046|PENETRATING ABDOMINAL TRAUMA|penetrating abdominal trauma
408899|NCT01203033|acute myeloid leukemia|acute myeloid leukemia
408900|NCT01203033|single cell network profiling|single cell network profiling
408901|NCT01203033|AML|aml
408902|NCT01203033|SCNP|scnp
408903|NCT01203020|Hodgkin's|hodgkin's
408904|NCT01203020|non-Hodgkin's|non-hodgkin's
408905|NCT01203020|lymphomas|lymphomas
200953|NCT02112838|IGA Glomerulonephritis|iga glomerulonephritis
408906|NCT01203020|allogeneic hematopoietic progenitor cell transplant|allogeneic hematopoietic progenitor cell transplant
408907|NCT01203020|HPCT|hpct
408908|NCT01203020|busulfex|busulfex
408909|NCT01203020|fludarabine|fludarabine
408910|NCT01203020|reduced-toxicity conditioning|reduced-toxicity conditioning
408911|NCT01203020|reduced-intensity conditioning|reduced-intensity conditioning
408912|NCT01202994|Alzheimer's disease|alzheimer's disease
408913|NCT01202994|Mild cognitive impairment|mild cognitive impairment
408914|NCT01202994|PET|pet
408915|NCT01202994|Practice effects|practice effects
408916|NCT01202981|glistenings|glistenings
408917|NCT01202981|contrast sensitivity|contrast sensitivity
408918|NCT01202981|visual quality|visual quality
408919|NCT01202981|straylight|straylight
408920|NCT01202981|AcrySof IOL|acrysof iol
408921|NCT01202968|intubation electric stimulation deglutition disorder|intubation electric stimulation deglutition disorder
408922|NCT01202955|Smoking, Abstinence|smoking, abstinence
408923|NCT01202929|High Resolution Manometry|high resolution manometry
408924|NCT01202929|achalasia|achalasia
408925|NCT01202929|dysphagia|dysphagia
408926|NCT01202929|GERD|gerd
408927|NCT01202929|chest pain|chest pain
408928|NCT01202929|Post fundoplication|post fundoplication
748606|NCT01150955|IGF-I|igf-i
408932|NCT01202903|immunoglobulin E|immunoglobulin e
408934|NCT01202890|lenalidomide|lenalidomide
408935|NCT01202890|revlimid|revlimid
408936|NCT01202890|liposomal doxorubicin|liposomal doxorubicin
408937|NCT01202890|doxil|doxil
408938|NCT01202890|bevacizumab|bevacizumab
408939|NCT01202890|avastin|avastin
408940|NCT01202890|platinum resistant ovarian cancer|platinum resistant ovarian cancer
408941|NCT01202890|ovarian cancer|ovarian cancer
408942|NCT01202877|Myelodysplastic Syndrome|myelodysplastic syndrome
408943|NCT01202877|MDS|mds
408944|NCT01202877|Refractory acute leukemias|refractory acute leukemias
408945|NCT01202877|Relapsed acute leukemia|relapsed acute leukemia
408946|NCT01202877|Acute myeloid leukemia|acute myeloid leukemia
408947|NCT01202877|AML|aml
408948|NCT01202877|5-Azacytidine|5-azacytidine
408949|NCT01202877|Azacitidine|azacitidine
408950|NCT01202877|5-aza|5-aza
408951|NCT01202877|Vidaza|vidaza
408952|NCT01202877|5-AZC|5-azc
408953|NCT01202877|AZA-CR|aza-cr
408954|NCT01202877|Ladakamycin|ladakamycin
408955|NCT01202877|NSC-102816|nsc-102816
408956|NCT01202877|PKC412|pkc412
408961|NCT01202851|radiotherapy|radiotherapy
408962|NCT01202851|radiation therapy|radiation therapy
408963|NCT01202851|stretching|stretching
408964|NCT01202851|relaxation|relaxation
408965|NCT01202851|quality of life|quality of life
408966|NCT01202851|QOL|qol
408967|NCT01202851|fatigue|fatigue
408968|NCT01202851|sleep disturbances|sleep disturbances
408969|NCT01202851|mental health|mental health
408970|NCT01202851|cost-effectiveness analysis|cost-effectiveness analysis
408971|NCT01202851|work productivity|work productivity
408972|NCT01202851|home productivity|home productivity
408973|NCT01202851|cortisol rhythmicity|cortisol rhythmicity
408974|NCT01202838|Cranial bone reconstruction, composite|cranial bone reconstruction, composite
408975|NCT01202825|HCV genotype 1 infected patients|hcv genotype 1 infected patients
408976|NCT01202825|TMC647055HPC1001|tmc647055hpc1001
408977|NCT01202825|TMC647055|tmc647055
408978|NCT01202825|HPC|hpc
408979|NCT01202825|Hepatitis C|hepatitis c
408980|NCT01202825|Healthy volunteers|healthy volunteers
408981|NCT01202825|TMC435|tmc435
408982|NCT01202812|Sickle Cell Anemia|sickle cell anemia
408983|NCT01202812|Sickle Cell Disease|sickle cell disease
408984|NCT01202812|Hemoglobin SS Disease|hemoglobin ss disease
408985|NCT01202812|Hemoglobin S beta-0 Thalassemia|hemoglobin s beta-0 thalassemia
408986|NCT01202812|Inflammation|inflammation
408987|NCT01202812|Quality of Life|quality of life
408988|NCT01202812|Sickle Thalassemia|sickle thalassemia
408989|NCT01202812|C-Reative Protein|c-reative protein
408990|NCT01202812|Hemolytic Anemia|hemolytic anemia
408991|NCT01202812|Hemostasis|hemostasis
408992|NCT01202812|Biomarkers|biomarkers
408993|NCT01202812|Coagulation|coagulation
408994|NCT01202812|Omega-3 Fatty Acids|omega-3 fatty acids
408995|NCT01202812|Eicosapentaenoic Acid|eicosapentaenoic acid
408996|NCT01202812|Docosahexaenoic Acid|docosahexaenoic acid
408997|NCT01202812|Fish Oils|fish oils
408998|NCT01202812|Drug: Placebo|drug: placebo
408999|NCT01202812|Drug: LOVAZA|drug: lovaza
409000|NCT01202799|Pharmacokinetics|pharmacokinetics
409001|NCT01202799|Healthy volunteers|healthy volunteers
409002|NCT01202799|PENNSAID|pennsaid
409003|NCT01202799|Topical NSAID|topical nsaid
409004|NCT01202799|Diclofenac|diclofenac
409005|NCT01202786|Cancer of Unknown Primary Site (CUP)|cancer of unknown primary site (cup)
409006|NCT01202773|Rheumatoid Arthritis|rheumatoid arthritis
409007|NCT01202760|Rheumatoid Arthritis|rheumatoid arthritis
409008|NCT01202734|CONCERTA|concerta
409009|NCT01202734|Methylphenidate HCl|methylphenidate hcl
409010|NCT01202734|Pharmacokinetic|pharmacokinetic
409011|NCT01202734|Safety|safety
509855|NCT00241267|Primary|primary
409012|NCT01202734|Adult|adult
409013|NCT01202734|Men|men
409014|NCT01202734|Male|male
409015|NCT01202721|Congenital|congenital
409016|NCT01202721|Aortic Valve|aortic valve
409017|NCT01202721|Bicuspid|bicuspid
409018|NCT01202721|Aortopathy|aortopathy
409019|NCT01202721|bicuspid aortic valve aortopathy|bicuspid aortic valve aortopathy
409020|NCT01202708|chronic renal failure|chronic renal failure
409021|NCT01202708|hemodiafiltration|hemodiafiltration
409022|NCT01202682|Healthy subject exercise study|healthy subject exercise study
409023|NCT01202656|Fertility Agents, Female|fertility agents, female
409024|NCT01202656|In vitro fertilization|in vitro fertilization
409025|NCT01202643|Thin Endometrium|thin endometrium
409026|NCT01202643|Asherman's Syndrome|asherman's syndrome
409027|NCT01202643|Endometrial Scarring|endometrial scarring
409028|NCT01202630|Clostridium difficile|clostridium difficile
409029|NCT01202630|diarrhea|diarrhea
409030|NCT01202617|Seroquel XR|seroquel xr
409031|NCT01202617|schizophrenia|schizophrenia
409032|NCT01202617|relapse prevention|relapse prevention
409033|NCT01202604|Bipolar disorder I and II|bipolar disorder i and ii
409034|NCT01202604|mood event|mood event
409035|NCT01202604|manic or depressive|manic or depressive
409036|NCT01202604|Greece|greece
409037|NCT01202591|Breast Cancer|breast cancer
409038|NCT01202591|ER+|er+
409039|NCT01202591|FGFR1|fgfr1
409040|NCT01202591|Exemestane|exemestane
409041|NCT01202591|AZD4547|azd4547
409042|NCT01202591|Fulvestrant|fulvestrant
409043|NCT01202565|Post-marketing observational study (PMOS) Protocol|post-marketing observational study (pmos) protocol
409044|NCT01202565|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
409045|NCT01202565|Treatment of Scalp and Nail Affection|treatment of scalp and nail affection
409046|NCT01202565|Effectiveness of Adalimumab (HUMIRA®)|effectiveness of adalimumab (humira®)
409047|NCT01202552|influenza|influenza
409048|NCT01202552|aged|aged
409049|NCT01202552|intradermal injection|intradermal injection
409050|NCT01202526|Insulin resistance|insulin resistance
409051|NCT01202526|Gastric bypass|gastric bypass
409052|NCT01202513|Vitiligo|vitiligo
409053|NCT01202513|Repigmentation|repigmentation
409054|NCT01202487|Laceration|laceration
409055|NCT01202487|Lacerations|lacerations
409056|NCT01202487|LET|let
409057|NCT01202487|Lidocaine Epinephrine Tetracaine|lidocaine epinephrine tetracaine
409058|NCT01202487|LAT|lat
409059|NCT01202487|Lidocaine Adrenaline Tetracaine|lidocaine adrenaline tetracaine
409060|NCT01202487|Tissue Adhesive|tissue adhesive
409061|NCT01202487|Skin Glue|skin glue
409062|NCT01202487|Pre-Treatment with LET|pre-treatment with let
409063|NCT01202487|Pre-Treatment with LAT|pre-treatment with lat
409064|NCT01202487|Pre-Treatment with Lidocaine Epinephrine Tetracaine|pre-treatment with lidocaine epinephrine tetracaine
409065|NCT01202487|Pre-Treatment with Lidocaine Adrenaline Tetracaine|pre-treatment with lidocaine adrenaline tetracaine
409066|NCT01202487|Use of LET with Skin Glue|use of let with skin glue
409067|NCT01202487|Use of LET with Tissue Adhesive|use of let with tissue adhesive
409068|NCT01202487|Histoacryl|histoacryl
409069|NCT01202461|Diabetic macular edema|diabetic macular edema
409070|NCT01202461|Combination therapy for DME|combination therapy for dme
409071|NCT01202461|DME|dme
409072|NCT01202448|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
409073|NCT01202448|central nervous system|central nervous system
409074|NCT01202448|prognosis|prognosis
409075|NCT01202435|pregabalin|pregabalin
409076|NCT01202435|pharmacokinetics|pharmacokinetics
409077|NCT01202435|bioavailability|bioavailability
409078|NCT01202435|bioequivalence|bioequivalence
409079|NCT01202422|pregabalin|pregabalin
409080|NCT01202422|pharmacokinetics|pharmacokinetics
409081|NCT01202422|bioavailability|bioavailability
409082|NCT01202422|bioequivalence|bioequivalence
409083|NCT01202409|Ampulla of Vater|ampulla of vater
409084|NCT01202409|Adenocarcinoma of the small bowel|adenocarcinoma of the small bowel
409085|NCT01202409|Metastatic|metastatic
409086|NCT01202409|Kirsten rat sarcoma|kirsten rat sarcoma
409087|NCT01202409|KRAS|kras
409088|NCT01202409|Capecitabine|capecitabine
409089|NCT01202409|Xeloda|xeloda
409090|NCT01202409|Oxaliplatin|oxaliplatin
409091|NCT01202409|Eloxatin|eloxatin
409092|NCT01202409|CAPOX|capox
409093|NCT01202409|Panitumumab|panitumumab
409094|NCT01202409|Vectibix|vectibix
409095|NCT01202396|pouch|pouch
409096|NCT01202396|pouchitis|pouchitis
409097|NCT01202396|ulcerative colitis|ulcerative colitis
409098|NCT01202396|microbiota|microbiota
409099|NCT01202396|defensins|defensins
409100|NCT01202396|epithelial integrity|epithelial integrity
409101|NCT01202370|Cancer|cancer
409102|NCT01202370|Tumors|tumors
409103|NCT01202357|Psychotic Disorders|psychotic disorders
409104|NCT01202357|Psychosis|psychosis
409105|NCT01202344|Angioplasty|angioplasty
409106|NCT01202344|Stenosis|stenosis
409107|NCT01202344|Restenosis|restenosis
409108|NCT01202344|Elastic Recoil|elastic recoil
752627|NCT01173393|out of hospital cardiac arrest|out of hospital cardiac arrest
409109|NCT01202344|cheduled for percutaneous dilation of a peripheral artery|cheduled for percutaneous dilation of a peripheral artery
409110|NCT01202344|Target lesion in native artery|target lesion in native artery
409111|NCT01202344|Baseline lumen diameter greater than 4 mm|baseline lumen diameter greater than 4 mm
409112|NCT01202331|Bacterial Infections|bacterial infections
409113|NCT01202331|Chlamydia Infections|chlamydia infections
409114|NCT01202331|Eye Diseases|eye diseases
409115|NCT01202318|Cerebrovascular Accident|cerebrovascular accident
409116|NCT01202318|Stroke,Acute|stroke,acute
409117|NCT01202305|HIV|hiv
409118|NCT01202305|HIV persistence|hiv persistence
409119|NCT01202305|Lymph node fibrosis|lymph node fibrosis
409120|NCT01202292|overweight|overweight
409121|NCT01202292|obesity|obesity
409122|NCT01202292|motivational intervention|motivational intervention
409123|NCT01202279|Acute Upper Respiratory Track Infection Who Seek Treatment|acute upper respiratory track infection who seek treatment
409224|NCT01201811|Neoplasms|neoplasms
409124|NCT01202266|Multiple Ascending Dose|multiple ascending dose
409125|NCT01202266|Phase 1|phase 1
409126|NCT01202266|Safety and Tolerability|safety and tolerability
409127|NCT01202266|PK|pk
748804|NCT01157390|Term-infant|term-infant
409128|NCT01202266|Healthy Subjects|healthy subjects
409129|NCT01202253|Ecalta|ecalta
409130|NCT01202253|Eraxis|eraxis
409131|NCT01202253|Candida|candida
409132|NCT01202253|Candidemia|candidemia
409133|NCT01202253|Systemic Candidiasis|systemic candidiasis
409134|NCT01202253|ICU|icu
409135|NCT01202253|Intensive Care Unit|intensive care unit
409136|NCT01202253|Critical Care Unit|critical care unit
409137|NCT01202240|Drug-Drug Interaction|drug-drug interaction
409138|NCT01202240|Healthy Volunteers|healthy volunteers
409139|NCT01202240|Tasocitinib (CP-690|tasocitinib (cp-690
409140|NCT01202240|550)|550)
409141|NCT01202240|Ketoconazole|ketoconazole
409142|NCT01202227|Central Nervous System Diseases|central nervous system diseases
409143|NCT01202227|Therapeutic Uses|therapeutic uses
409144|NCT01202227|Wounds and Injuries|wounds and injuries
409145|NCT01202227|Trauma|trauma
409146|NCT01202227|Nervous System|nervous system
409147|NCT01202227|pregabalin|pregabalin
409148|NCT01202188|QVA149, COPD, combination bronchodilator, indacaterol, glycopyrronium bromide|qva149, copd, combination bronchodilator, indacaterol, glycopyrronium bromide
409149|NCT01202175|Genetic risk of hypertension|genetic risk of hypertension
409150|NCT01202162|Induction|induction
409151|NCT01202162|Coughing|coughing
409152|NCT01202162|Anesthesia|anesthesia
409153|NCT01202149|eczema|eczema
409154|NCT01202149|elidel|elidel
409155|NCT01202149|non-medicated device|non-medicated device
409156|NCT01202149|hylatopic plus|hylatopic plus
409157|NCT01202149|pimecrolimus|pimecrolimus
409158|NCT01202149|bilateral comparison study|bilateral comparison study
409159|NCT01202149|topical therapy|topical therapy
409160|NCT01202136|pancreatic cyst|pancreatic cyst
409161|NCT01202136|IPMN|ipmn
409162|NCT01202136|PAN INs|pan ins
409163|NCT01202136|Pancreatic cancer|pancreatic cancer
409164|NCT01202136|pancreatic neoplasia|pancreatic neoplasia
409165|NCT01202071|Rabeprazole|rabeprazole
409166|NCT01202071|proton pump inhibitor|proton pump inhibitor
409167|NCT01202071|pharmacokinetics|pharmacokinetics
409168|NCT01202071|pharmacodynamics|pharmacodynamics
409169|NCT01202071|healthy adult male Japanese subjects|healthy adult male japanese subjects
409170|NCT01202058|Coronary artery disease|coronary artery disease
409171|NCT01202058|Drug-eluting stents|drug-eluting stents
409172|NCT01202058|Reservoir technology|reservoir technology
409173|NCT01202045|Echocardiography, Stress|echocardiography, stress
409174|NCT01202045|right heart catheterization|right heart catheterization
409175|NCT01202032|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
409176|NCT01202032|Advanced solid tumors|advanced solid tumors
409177|NCT01202032|Dose escalation|dose escalation
409178|NCT01202032|Association Pazopanib-Bevacizumab|association pazopanib-bevacizumab
409179|NCT01202019|cardiovascular risk|cardiovascular risk
409180|NCT01202019|exercise|exercise
409181|NCT01202019|post-exercise diet supplementation|post-exercise diet supplementation
409182|NCT01202006|Heart failure|heart failure
409183|NCT01202006|Diagnosis|diagnosis
409184|NCT01202006|Treatment|treatment
409185|NCT01202006|Primary care|primary care
409186|NCT01201993|syncope|syncope
409187|NCT01201993|evaluation|evaluation
409188|NCT01201993|recurrence|recurrence
409189|NCT01201993|morbidity|morbidity
409190|NCT01201980|essential arterial hypertension|essential arterial hypertension
409191|NCT01201980|calcium antagonist|calcium antagonist
409192|NCT01201967|Collaborative care|collaborative care
409193|NCT01201967|Cardiovascular disease|cardiovascular disease
409194|NCT01201967|Depression|depression
409195|NCT01201967|Anxiety|anxiety
409196|NCT01201954|pain|pain
409197|NCT01201954|sucrose|sucrose
409198|NCT01201954|newborn|newborn
409199|NCT01201954|mechanical ventilation|mechanical ventilation
409200|NCT01201876|Dental Caries|dental caries
409201|NCT01201876|Assessments|assessments
409202|NCT01201876|dental materials|dental materials
409203|NCT01201863|Testosterone|testosterone
409204|NCT01201863|Traumatic Brain Injury|traumatic brain injury
409205|NCT01201863|Hypogonadism|hypogonadism
409206|NCT01201863|Endocrine Dysfunction|endocrine dysfunction
409207|NCT01201863|Low Testosterone in men with new Traumatic Brain Injury|low testosterone in men with new traumatic brain injury
409208|NCT01201850|radiation necrosis|radiation necrosis
409209|NCT01201850|Bevacizumab (Avastin®)|bevacizumab (avastin®)
409210|NCT01201850|Central Nervous System Tumors|central nervous system tumors
409211|NCT01201837|Acute coronary syndrome|acute coronary syndrome
409212|NCT01201837|HDL mimetic|hdl mimetic
409213|NCT01201837|ApoA-I|apoa-i
409214|NCT01201824|lung cancer|lung cancer
409215|NCT01201824|intracavitary ultrasound|intracavitary ultrasound
409216|NCT01201824|pulmonary nodules|pulmonary nodules
409217|NCT01201824|VATS procedures|vats procedures
409218|NCT01201811|Myelodysplastic Syndromes|myelodysplastic syndromes
409219|NCT01201811|Taiwan|taiwan
409220|NCT01201811|Azacitidine|azacitidine
409221|NCT01201811|Vidaza|vidaza
409222|NCT01201811|Celgene|celgene
409223|NCT01201811|Pathologic Processes|pathologic processes
409225|NCT01201811|Bone Marrow Diseases|bone marrow diseases
409226|NCT01201811|Hematologic Diseases|hematologic diseases
409227|NCT01201811|Antineoplastic Agents|antineoplastic agents
409228|NCT01201811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
409229|NCT01201811|Antimetabolites|antimetabolites
409230|NCT01201811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
409231|NCT01201811|Pharmacologic Actions|pharmacologic actions
409232|NCT01201811|Therapeutic Uses|therapeutic uses
409233|NCT01201811|Enzyme inhibitors|enzyme inhibitors
409234|NCT01201785|diabetes mellitus, coronary artery disease, aspirin therapy|diabetes mellitus, coronary artery disease, aspirin therapy
409235|NCT01201772|coronary artery disease|coronary artery disease
409236|NCT01201772|percutaneous coronary revascularization|percutaneous coronary revascularization
409237|NCT01201772|prasugrel therapy|prasugrel therapy
409238|NCT01201759|cardiovascular risk|cardiovascular risk
409239|NCT01201746|Non-surgical periodontal therapy|non-surgical periodontal therapy
409240|NCT01201746|Coronary heart disease (CHD)|coronary heart disease (chd)
409241|NCT01201746|periodontal Disease|periodontal disease
409242|NCT01201746|hsCRP|hscrp
409243|NCT01201746|Fibrinogen|fibrinogen
409244|NCT01201746|WBCs|wbcs
409245|NCT01201720|cirrhosis|cirrhosis
409246|NCT01201720|cirrhotic patients with acute on chronic liver failure|cirrhotic patients with acute on chronic liver failure
409247|NCT01201707|Multiple Sclerosis|multiple sclerosis
409248|NCT01201707|Angioplasty|angioplasty
409249|NCT01201707|Vein|vein
409250|NCT01201694|Advanced malignancies|advanced malignancies
409251|NCT01201694|Surface-controlled water soluble curcumin|surface-controlled water soluble curcumin
409252|NCT01201694|Turmeric|turmeric
409253|NCT01201694|Dietary supplements|dietary supplements
409254|NCT01201681|Post-operative pain|post-operative pain
409255|NCT01201681|intra-operative pain|intra-operative pain
409256|NCT01201681|root canal therapy|root canal therapy
409257|NCT01201681|feasibility|feasibility
409258|NCT01201681|post-surgical persistent pain|post-surgical persistent pain
409259|NCT01201668|post-operative pain|post-operative pain
409260|NCT01201668|root canal therapy|root canal therapy
409261|NCT01201668|feasibility|feasibility
409262|NCT01201668|post-surgical persistent pain|post-surgical persistent pain
409263|NCT01201655|Posthepatitic cirrhosis;|posthepatitic cirrhosis;
409264|NCT01201655|Hepatocarcinogenesis;|hepatocarcinogenesis;
409265|NCT01201655|Splenectomy;|splenectomy;
409266|NCT01201642|Bell's palsy|bell's palsy
409267|NCT01201642|Prednisolone|prednisolone
409268|NCT01201642|acupuncture|acupuncture
409269|NCT01201629|Ischemic Strokes|ischemic strokes
409270|NCT01201629|t DC stimulation|t dc stimulation
409271|NCT01201629|Functional recovery|functional recovery
409272|NCT01201616|Cognitive function|cognitive function
409273|NCT01201616|mood|mood
409274|NCT01201616|women|women
409275|NCT01201616|high fat diet|high fat diet
409276|NCT01201616|high carbohydrate diet|high carbohydrate diet
409277|NCT01201603|Women|women
409278|NCT01201603|Orange Juice|orange juice
409279|NCT01201603|Insulin Resistance|insulin resistance
409280|NCT01201603|Obesity|obesity
409281|NCT01201590|Insulin resistance|insulin resistance
409282|NCT01201590|obesity|obesity
409283|NCT01201590|cocoa|cocoa
409284|NCT01201590|women|women
409285|NCT01201577|Quorum sensing|quorum sensing
409286|NCT01201577|Prebiotics|prebiotics
409287|NCT01201577|Probiotics|probiotics
409288|NCT01201577|Sepsis|sepsis
409289|NCT01201564|umbilical hernia,|umbilical hernia,
409290|NCT01201564|wound complications,|wound complications,
409291|NCT01201564|mesh repair, IPOM,|mesh repair, ipom,
409292|NCT01201564|quality of life,|quality of life,
409293|NCT01201564|sublay mesh repair,|sublay mesh repair,
409294|NCT01201564|recurrence rate|recurrence rate
409296|NCT01201551|Xalatan|xalatan
409297|NCT01201551|corneal temperature|corneal temperature
409298|NCT01201551|primary vascular dysregulation|primary vascular dysregulation
409299|NCT01201512|TMJD pain|tmjd pain
409300|NCT01201512|feasibility|feasibility
409301|NCT01201486|Ultrasound|ultrasound
510282|NCT00243932|ALS|als
409302|NCT01201486|Pregnancy|pregnancy
409303|NCT01201486|Fetal heart defects|fetal heart defects
409304|NCT01201486|Color doppler|color doppler
409305|NCT01201473|effect of participation|effect of participation
409306|NCT01201473|effect of association|effect of association
409307|NCT01201460|glucose testing|glucose testing
409308|NCT01201447|Assessment|assessment
409309|NCT01201447|Questionable Caries|questionable caries
409310|NCT01201434|cystic fibrosis|cystic fibrosis
409311|NCT01201434|probiotics|probiotics
409312|NCT01201434|pulmonary|pulmonary
409313|NCT01201434|infections|infections
409314|NCT01201421|patient satisfaction|patient satisfaction
409315|NCT01201421|assessments|assessments
409316|NCT01201421|dental caries|dental caries
409317|NCT01201421|dental materials|dental materials
409318|NCT01201408|Dental Caries|dental caries
409319|NCT01201408|Assessments|assessments
409320|NCT01201408|dental materials|dental materials
409321|NCT01201395|Dental Caries|dental caries
409322|NCT01201395|Assessment|assessment
409323|NCT01201395|dental materials|dental materials
409324|NCT01201382|Depression|depression
409325|NCT01201382|Prevention|prevention
409326|NCT01201382|Adolescents|adolescents
409327|NCT01201369|Percutaneous Coronary Intervention|percutaneous coronary intervention
409328|NCT01201369|Coronary Artery Stenosis|coronary artery stenosis
409329|NCT01201369|Acute Myocardial Infarction|acute myocardial infarction
409330|NCT01201369|Coronary Artery Stent|coronary artery stent
409331|NCT01201369|Optical Coherence Tomography|optical coherence tomography
409332|NCT01201356|Fingolimod|fingolimod
409333|NCT01201356|FTY720|fty720
409334|NCT01201356|Relapsing forms of MS|relapsing forms of ms
409335|NCT01201356|Multiple Sclerosis|multiple sclerosis
409336|NCT01201356|Efficacy|efficacy
409337|NCT01201343|Multiple sclerosis, relapsing, remitting|multiple sclerosis, relapsing, remitting
409338|NCT01201343|Interferon-beta|interferon-beta
409339|NCT01201330|ONJ|onj
409340|NCT01201317|Analgesic effect|analgesic effect
409341|NCT01201304|Anxiety sensitivity|anxiety sensitivity
409342|NCT01201304|Panic|panic
409343|NCT01201291|TBI|tbi
409344|NCT01201291|Normobaric hyperoxia|normobaric hyperoxia
409345|NCT01201291|Outcome|outcome
409346|NCT01201291|GOS|gos
409347|NCT01201291|GOSE|gose
409348|NCT01201278|intranasal insulin|intranasal insulin
409349|NCT01201252|children|children
409350|NCT01201252|gastroenteritis|gastroenteritis
409351|NCT01201252|Rotavirus|rotavirus
409352|NCT01201239|raltegravir|raltegravir
409353|NCT01201239|HIV-1|hiv-1
409354|NCT01201239|drug resistance|drug resistance
409355|NCT01201226|Primordial ovarian follicles|primordial ovarian follicles
409356|NCT01201226|PTEN|pten
409357|NCT01201226|PI3K activating peptide|pi3k activating peptide
409358|NCT01201226|Low ovarian reserve|low ovarian reserve
409359|NCT01201226|Gonadotrophins|gonadotrophins
409360|NCT01201213|Bupivacaine|bupivacaine
409361|NCT01201213|levobupivacaine|levobupivacaine
409362|NCT01201213|ropivacaine|ropivacaine
409363|NCT01201200|Obstructive Sleep Apnea|obstructive sleep apnea
409364|NCT01201200|Right Ventricular Function|right ventricular function
409365|NCT01201200|Pulmonary Hypertension|pulmonary hypertension
409366|NCT01201187|ADHD(Attention Deficit Hyperactivity Disorder)|adhd(attention deficit hyperactivity disorder)
409367|NCT01201174|Hemolysis in Patients with Hereditary Spherocytosis|hemolysis in patients with hereditary spherocytosis
409368|NCT01201174|with documented family history of HS.|with documented family history of hs.
409369|NCT01201174|spherocyte morphology,|spherocyte morphology,
409370|NCT01201174|splenomegaly and non-immune mediated hemolysis.|splenomegaly and non-immune mediated hemolysis.
409371|NCT01201161|Diabetic Retinopathy|diabetic retinopathy
409372|NCT01201161|Retinal detachment|retinal detachment
409373|NCT01201161|Vitreous Hemorrhage|vitreous hemorrhage
409374|NCT01201161|Preoperative Ranibizumab|preoperative ranibizumab
409375|NCT01201161|pars plana vitrectomy|pars plana vitrectomy
409376|NCT01201148|depression|depression
409377|NCT01201148|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
409378|NCT01201148|random noise stimulation|random noise stimulation
409379|NCT01201148|oscillatory tDCS|oscillatory tdcs
409380|NCT01201148|intermittent tDCS|intermittent tdcs
409381|NCT01201122|Pediatric|pediatric
409382|NCT01201122|Ulcerative colitis|ulcerative colitis
409383|NCT01201122|5-ASA|5-asa
409384|NCT01201122|Mesalamine|mesalamine
409385|NCT01201122|Dosing|dosing
409386|NCT01201109|Carpal tunnel syndrome|carpal tunnel syndrome
409387|NCT01201109|Entrapment neuropathies|entrapment neuropathies
409388|NCT01201109|Diabetes|diabetes
409880|NCT01199302|Amgen|amgen
409389|NCT01201096|neuroendocrine tumor|neuroendocrine tumor
408834|NCT01203332|Latino|latino
409390|NCT01201096|liver metastasis|liver metastasis
409391|NCT01201096|peptide receptor therapy|peptide receptor therapy
409392|NCT01201096|gastro-entero-pancreatic system|gastro-entero-pancreatic system
409393|NCT01201057|SPL7013|spl7013
409394|NCT01201057|VivaGel|vivagel
409395|NCT01201057|bacterial vaginosis|bacterial vaginosis
409396|NCT01201057|BV|bv
409397|NCT01201044|BAI|bai
408510|NCT01204515|IBS|ibs
409398|NCT01201044|3DCRT|3dcrt
409399|NCT01201031|for the active surveillance of VRE colinization and infection|for the active surveillance of vre colinization and infection
409400|NCT01201018|Tumor|tumor
409401|NCT01201018|cancer|cancer
409402|NCT01201018|metastasis|metastasis
409403|NCT01200992|Urinary Bladder Neoplasms|urinary bladder neoplasms
409404|NCT01200992|Neoplasms|neoplasms
409405|NCT01200992|Urologic Neoplasms|urologic neoplasms
409406|NCT01200992|Urogenital Neoplasms|urogenital neoplasms
409407|NCT01200992|Neoplasms by Site|neoplasms by site
409408|NCT01200992|Urinary Bladder Diseases|urinary bladder diseases
409409|NCT01200992|Urologic Diseases|urologic diseases
409410|NCT01200992|Mycobacterial cell wall DNA complex|mycobacterial cell wall dna complex
409411|NCT01200992|Intravesical drug administration|intravesical drug administration
409412|NCT01200979|Cytokine|cytokine
409413|NCT01200979|Lymphocyte|lymphocyte
409414|NCT01200979|Toll-Like Receptor|toll-like receptor
409415|NCT01200979|NK Cell|nk cell
409416|NCT01200979|Innate Immunity|innate immunity
409417|NCT01200979|Pregnancy|pregnancy
409418|NCT01200979|Immune Function|immune function
409419|NCT01200966|Essential Tremor|essential tremor
409420|NCT01200966|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
409421|NCT01200966|Ethanol|ethanol
409422|NCT01200966|Alcohol|alcohol
409423|NCT01200966|Alcohol Clamp|alcohol clamp
409424|NCT01200966|ET|et
409425|NCT01200953|Select Agents|select agents
409426|NCT01200953|Biosafety|biosafety
409427|NCT01200953|Bioterrorism|bioterrorism
409428|NCT01200953|SCSU (Special Clinical Studies Unit)|scsu (special clinical studies unit)
409429|NCT01200953|Infectious Disease|infectious disease
409430|NCT01200953|Bioterrorism-Related Illness|bioterrorism-related illness
409431|NCT01200940|GLP-1|glp-1
409432|NCT01200940|Glucose Tolerance|glucose tolerance
409433|NCT01200940|Gut Hormones|gut hormones
409434|NCT01200940|Gastric Bypass|gastric bypass
409435|NCT01200940|Roux-en-Y|roux-en-y
409436|NCT01200940|Bariatric Surgery|bariatric surgery
409437|NCT01200927|infant|infant
409438|NCT01200927|sitting|sitting
409439|NCT01200927|postural control|postural control
409440|NCT01200914|Hemodialysis|hemodialysis
409441|NCT01200914|Fistula|fistula
409442|NCT01200914|Angiograph|angiograph
409443|NCT01200914|Angiogram|angiogram
409444|NCT01200901|depression|depression
409445|NCT01200901|healthy|healthy
409446|NCT01200875|PRP|prp
409447|NCT01200875|platelet rich plasma|platelet rich plasma
409448|NCT01200875|platelet|platelet
409449|NCT01200875|growth hormone|growth hormone
409450|NCT01200875|tendonitis|tendonitis
409451|NCT01200875|tendinosis|tendinosis
409452|NCT01200875|tendinopathy|tendinopathy
409453|NCT01200875|enthesopathy|enthesopathy
409454|NCT01200875|muscle|muscle
409455|NCT01200875|sport|sport
409456|NCT01200875|tendon|tendon
409457|NCT01200862|Obese|obese
409458|NCT01200862|obesity|obesity
409459|NCT01200862|hypogonadism|hypogonadism
409460|NCT01200862|hypogonadotropic|hypogonadotropic
409461|NCT01200862|hyperestrogenemic|hyperestrogenemic
409462|NCT01200862|testosterone|testosterone
409463|NCT01200862|hypogonadal|hypogonadal
409464|NCT01200836|Statins|statins
409465|NCT01200836|Immune Modulation|immune modulation
409466|NCT01200836|Healthy Volunteer|healthy volunteer
409467|NCT01200823|Laboratory Research|laboratory research
409468|NCT01200823|Biologic Samples|biologic samples
409469|NCT01200823|Tissue Collection|tissue collection
409470|NCT01200823|Tissue Procurement|tissue procurement
409471|NCT01200771|FDG-PET/CT|fdg-pet/ct
409472|NCT01200771|FUO|fuo
409473|NCT01200771|Chronic Inflammatory syndrome|chronic inflammatory syndrome
409474|NCT01200771|Fever of unknown origin|fever of unknown origin
409475|NCT01200745|neck pain|neck pain
409476|NCT01200745|capsaicin|capsaicin
409477|NCT01200745|dermal patch|dermal patch
409478|NCT01200732|Tadalafil|tadalafil
409479|NCT01200732|phosphodiesterase-5 inhibitor|phosphodiesterase-5 inhibitor
409480|NCT01200732|Eisenmenger syndrome|eisenmenger syndrome
409481|NCT01200719|brain electrical stimulation|brain electrical stimulation
409482|NCT01200719|sub-acute post-stroke|sub-acute post-stroke
409483|NCT01200719|rehabilitation|rehabilitation
409484|NCT01200706|children aged under 5 years|children aged under 5 years
409485|NCT01200706|Non-severe|non-severe
409486|NCT01200693|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
409487|NCT01200693|Drug-Eluting Stents|drug-eluting stents
409488|NCT01200680|Sporadic Chordoma|sporadic chordoma
409489|NCT01200680|Pediatric and Adult|pediatric and adult
409490|NCT01200680|Gene Identification|gene identification
409491|NCT01200680|Rare Bone Cancer|rare bone cancer
409492|NCT01200680|All Chordoma Sites|all chordoma sites
409493|NCT01200680|Bone Cancer|bone cancer
409494|NCT01200654|Population pharmacokinetics|population pharmacokinetics
409495|NCT01200654|Linezolid|linezolid
409496|NCT01200654|Monolix|monolix
409497|NCT01200654|nonlinear mixed effects models|nonlinear mixed effects models
409498|NCT01200641|melatonin|melatonin
409499|NCT01200641|gabapentin|gabapentin
409500|NCT01200641|anxiety|anxiety
409501|NCT01200641|pain|pain
409502|NCT01200641|retrobulbar block|retrobulbar block
409503|NCT01200628|posttraumatic stress disorder|posttraumatic stress disorder
409504|NCT01200628|acute PTSD|acute ptsd
409505|NCT01200628|PTSD|ptsd
409506|NCT01200628|motor vehicle accident|motor vehicle accident
409507|NCT01200615|nocebo side-effects SSRI informed consent|nocebo side-effects ssri informed consent
409508|NCT01200589|Randomized trial|randomized trial
409509|NCT01200589|Ofatumumab|ofatumumab
409510|NCT01200589|Rituximab|rituximab
409511|NCT01200589|Indolent B-Cell Non Hodgkin Lymphoma|indolent b-cell non hodgkin lymphoma
409512|NCT01200576|CRF: Case Report Form|crf: case report form
409513|NCT01200576|DM: Data Management|dm: data management
409514|NCT01200576|FHI: FHI (formerly known as Family Health International)|fhi: fhi (formerly known as family health international)
409515|NCT01200576|IRB: Institutional Review Board|irb: institutional review board
409516|NCT01200576|IUD: Intra-uterine Device|iud: intra-uterine device
409517|NCT01200576|LTPM: Long-term and Permanent Contraceptive Methods|ltpm: long-term and permanent contraceptive methods
409518|NCT01200576|MSI: Marie Stopes International|msi: marie stopes international
409519|NCT01200576|MSM: Marie Stopes Madagascar|msm: marie stopes madagascar
409520|NCT01200576|PHSC: Protection of Human Subjects Committee|phsc: protection of human subjects committee
409521|NCT01200576|PI: Principal Investigator|pi: principal investigator
409522|NCT01200576|SAE: Serious Adverse Event|sae: serious adverse event
409523|NCT01200576|Sino-Implant (II)|sino-implant (ii)
409524|NCT01200576|SOP: Standard Operating Procedure|sop: standard operating procedure
409525|NCT01200576|Zarin|zarin
409526|NCT01200563|MIST Therapy|mist therapy
409527|NCT01200563|Negative Pressure Wound Therapy|negative pressure wound therapy
409528|NCT01200563|Wound care in long-term acute care hospital|wound care in long-term acute care hospital
409529|NCT01200563|Wound care in skilled nursing facility setting|wound care in skilled nursing facility setting
409530|NCT01200550|Gastroesophageal reflux disease|gastroesophageal reflux disease
409531|NCT01200550|GERD Impact Scale|gerd impact scale
409532|NCT01200537|IVF|ivf
409533|NCT01200537|poor responders|poor responders
409534|NCT01200537|follicle synchrony|follicle synchrony
409535|NCT01200537|IVF response|ivf response
409536|NCT01200537|estrogen|estrogen
409537|NCT01200537|estradiol (E2)|estradiol (e2)
409538|NCT01200537|oral contraceptive pill (OCP)|oral contraceptive pill (ocp)
409539|NCT01200537|birth control pill (BCP)|birth control pill (bcp)
409540|NCT01200524|Analgesic effect|analgesic effect
409541|NCT01200511|intraocular lens|intraocular lens
409542|NCT01200511|multifocal|multifocal
409543|NCT01200511|toric|toric
409544|NCT01200498|Primary Polycythemia Vera|primary polycythemia vera
409545|NCT01200498|Post Polycythemia Vera|post polycythemia vera
409546|NCT01200498|Post Essential Thrombocythemia Myelofibrosis|post essential thrombocythemia myelofibrosis
409547|NCT01200498|SB939|sb939
409548|NCT01200498|PMF|pmf
409549|NCT01200498|post-PV MF|post-pv mf
409550|NCT01200498|post-ET MF|post-et mf
409551|NCT01200485|Supportive Care|supportive care
409552|NCT01200485|Recombinant urate oxidase|recombinant urate oxidase
409553|NCT01200485|Chemotherapy|chemotherapy
409554|NCT01200485|Tumor Lysis Syndrome (TLS)|tumor lysis syndrome (tls)
409555|NCT01200485|Hematologic malignancies|hematologic malignancies
409556|NCT01200485|Acute myeloid leukemia|acute myeloid leukemia
409557|NCT01200472|EHOA|ehoa
409558|NCT01200459|Obesity|obesity
409559|NCT01200459|Weight Loss|weight loss
409560|NCT01200459|Healthy Lifestyle|healthy lifestyle
409561|NCT01200459|Social|social
409562|NCT01200459|Mobile|mobile
409563|NCT01200459|Facebook|facebook
409564|NCT01200459|Text Messages|text messages
409565|NCT01200446|Asthma|asthma
409566|NCT01200446|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
409567|NCT01200446|Inflammation|inflammation
409568|NCT01200446|Airway|airway
409569|NCT01200446|Fish Oil|fish oil
409570|NCT01200446|Docosahexaenoic Acid|docosahexaenoic acid
409571|NCT01200446|DHA|dha
409572|NCT01200433|dexmedetomidine|dexmedetomidine
409573|NCT01200433|propofol|propofol
409574|NCT01200433|cerebral blood flow|cerebral blood flow
409575|NCT01200433|brain oxygenation|brain oxygenation
409576|NCT01200420|Antisense|antisense
409577|NCT01200420|miR-122 antagonist|mir-122 antagonist
409578|NCT01200420|host factor|host factor
409579|NCT01200420|CHC|chc
409580|NCT01200407|Hypertension|hypertension
409581|NCT01200407|fixed drug combination|fixed drug combination
409582|NCT01200407|Filipinos|filipinos
409583|NCT01200407|Amlodipine|amlodipine
409584|NCT01200407|Olmesartan medoxomil|olmesartan medoxomil
409585|NCT01200407|uncontrolled hypertension|uncontrolled hypertension
409881|NCT01199302|Crohn's|crohn's
409586|NCT01200407|difficult to treat hypertension|difficult to treat hypertension
409587|NCT01200394|Diabetic nephropathy|diabetic nephropathy
409588|NCT01200394|chronic kidney disease|chronic kidney disease
409589|NCT01200394|PF-00489791|pf-00489791
409590|NCT01200394|phosphodiesterase|phosphodiesterase
409591|NCT01200394|PDE5|pde5
409592|NCT01200381|ICD|icd
409593|NCT01200381|CRTD|crtd
409594|NCT01200381|Remote care|remote care
409595|NCT01200381|Remote monitoring|remote monitoring
409596|NCT01200381|Heart failure|heart failure
409597|NCT01200368|vaccine|vaccine
409598|NCT01200368|pneumococcal conjugate|pneumococcal conjugate
409599|NCT01200355|MICAFUNGIN|micafungin
409600|NCT01200355|POSACONAZOLE|posaconazole
409601|NCT01200355|antifungal|antifungal
409602|NCT01200355|prolonged neutropenia|prolonged neutropenia
409603|NCT01200355|10-038|10-038
409604|NCT01200342|Uveal melanoma|uveal melanoma
409605|NCT01200342|Carboplatin|carboplatin
409606|NCT01200342|Genasense|genasense
409607|NCT01200342|Paclitaxel|paclitaxel
409608|NCT01200342|oblimersen|oblimersen
409609|NCT01200342|GCP|gcp
409610|NCT01200329|Hodgkin's disease|hodgkin's disease
409611|NCT01200329|Relapsed|relapsed
409612|NCT01200329|Refractory|refractory
409613|NCT01200329|High-dose chemotherapy|high-dose chemotherapy
409614|NCT01200329|Busulfan|busulfan
409615|NCT01200329|Gemcitabine|gemcitabine
409616|NCT01200329|Melphalan|melphalan
409617|NCT01200316|Colon Cancer|colon cancer
409618|NCT01200316|Abdominal Surgery|abdominal surgery
409619|NCT01200316|Stress|stress
409620|NCT01200316|Rocking Motion|rocking motion
409621|NCT01200316|Salivary Cortisol|salivary cortisol
409622|NCT01200316|Postoperative Ileus|postoperative ileus
409623|NCT01200303|colon cancer|colon cancer
409624|NCT01200303|adenomatous colonic polyps|adenomatous colonic polyps
409625|NCT01200303|colon screening|colon screening
409626|NCT01200303|CT Colonography (Virtual Colonoscopy)|ct colonography (virtual colonoscopy)
409627|NCT01200303|Computer Aided Detection|computer aided detection
409628|NCT01200303|Electronic Cleansing|electronic cleansing
409629|NCT01200290|end stage renal disease|end stage renal disease
409630|NCT01200290|end stage kidney disease|end stage kidney disease
409631|NCT01200290|ESRD|esrd
409632|NCT01200290|Uremia|uremia
409633|NCT01200290|Renal Dialysis|renal dialysis
409634|NCT01200277|osteoporosis|osteoporosis
409635|NCT01200277|vertebral fracture|vertebral fracture
409636|NCT01200277|vertebroplasty|vertebroplasty
409637|NCT01200277|percutaneous|percutaneous
409638|NCT01200238|STA9090|sta9090
409639|NCT01200238|STA-9090|sta-9090
409640|NCT01200238|HSP90|hsp90
409641|NCT01200212|Palliative Therapy|palliative therapy
409642|NCT01200212|bevacizimab|bevacizimab
409643|NCT01200212|Avastin|avastin
409644|NCT01200212|Xeloda|xeloda
409645|NCT01200212|metastatic breast cancer|metastatic breast cancer
409646|NCT01200212|Progression Free Survival|progression free survival
409647|NCT01200212|Time to Progression|time to progression
409648|NCT01200212|Overall survival|overall survival
409649|NCT01200173|Probiotic - Lactobacillus casei DN-114 001 - dairy|probiotic - lactobacillus casei dn-114 001 - dairy
409650|NCT01200173|product - infections - children|product - infections - children
409651|NCT01200160|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
409652|NCT01200160|Hypertriglyceridemia|hypertriglyceridemia
409653|NCT01200160|Latin America|latin america
409654|NCT01200160|Cardiovascular Diseases|cardiovascular diseases
409655|NCT01200160|Cholesterol|cholesterol
409656|NCT01200160|Sedentary Lifestyle|sedentary lifestyle
409657|NCT01200160|High-Density Lipoprotein Cholesterol|high-density lipoprotein cholesterol
409658|NCT01200134|glioma patients : anaplasic glioma (grade III) and GBM (grade IV)|glioma patients : anaplasic glioma (grade iii) and gbm (grade iv)
409659|NCT01200121|Symptomatic malignant ascites due to advanced-stage gastrointestinal cancers|symptomatic malignant ascites due to advanced-stage gastrointestinal cancers
409660|NCT01200108|Severe Asthma, requiring chronic oral steroid use|severe asthma, requiring chronic oral steroid use
409661|NCT01200082|chronic hepatitis C/B|chronic hepatitis c/b
409662|NCT01200082|alcoholic liver disease|alcoholic liver disease
409663|NCT01200082|primary biliary cirrhosis|primary biliary cirrhosis
409664|NCT01200082|primary sclerosing cholangitis|primary sclerosing cholangitis
409665|NCT01200082|progressive familial intrahepatic cholestasis|progressive familial intrahepatic cholestasis
409666|NCT01200069|depression,myalgia|depression,myalgia
409667|NCT01200056|Volumetric virtual histology intravascular ultrasound.|volumetric virtual histology intravascular ultrasound.
409668|NCT01200056|Statin-naive patient.|statin-naive patient.
409669|NCT01200056|Varying doses atorvastatin.|varying doses atorvastatin.
409670|NCT01200056|Clinical outcomes.|clinical outcomes.
409671|NCT01200043|Childhood obesity|childhood obesity
409672|NCT01200043|metabolic syndrome|metabolic syndrome
409673|NCT01200043|insulin resistance|insulin resistance
409674|NCT01200043|intrahepatic fat|intrahepatic fat
409675|NCT01200043|hypertension|hypertension
409676|NCT01200030|Sitting balance|sitting balance
409677|NCT01200030|Stroke|stroke
409678|NCT01200017|T cell depleted|t cell depleted
409679|NCT01200017|Matched unrelated donors|matched unrelated donors
409680|NCT01200017|Haplocompatible donors|haplocompatible donors
409681|NCT01200017|Graft vs Host Disease|graft vs host disease
409682|NCT01200017|Hemoglobinopathies|hemoglobinopathies
409683|NCT01200017|Leukemia|leukemia
409684|NCT01200017|Leukemia, Lymphoid|leukemia, lymphoid
409685|NCT01200017|Precursor Cell Lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
409686|NCT01200017|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
409687|NCT01200017|Leukemia, Myeloid|leukemia, myeloid
409688|NCT01200017|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
409689|NCT01200017|Lymphoma|lymphoma
409690|NCT01200017|Myelodysplastic Syndromes|myelodysplastic syndromes
409691|NCT01200017|Preleukemia|preleukemia
409692|NCT01200017|Osteopetrosis|osteopetrosis
409693|NCT01200017|Pancytopenia|pancytopenia
409694|NCT01200017|Immune System Diseases|immune system diseases
409695|NCT01200017|Hematologic Diseases|hematologic diseases
409696|NCT01200017|Genetic Diseases, Inborn|genetic diseases, inborn
409697|NCT01200017|Neoplasms by Histologic Type|neoplasms by histologic type
409698|NCT01200017|Neoplasms|neoplasms
409699|NCT01200017|Lymphoproliferative Disorders|lymphoproliferative disorders
409700|NCT01200017|Lymphatic Diseases|lymphatic diseases
409701|NCT01200017|Immunoproliferative Disorders|immunoproliferative disorders
409702|NCT01200017|Myeloproliferative Disorders|myeloproliferative disorders
409703|NCT01200017|Bone Marrow Diseases|bone marrow diseases
409704|NCT01200017|Precancerous Conditions|precancerous conditions
409705|NCT01200017|Osteosclerosis|osteosclerosis
409706|NCT01200017|Osteochondrodysplasias|osteochondrodysplasias
409707|NCT01200017|Bone Diseases, Developmental|bone diseases, developmental
409708|NCT01200017|Bone Diseases|bone diseases
409709|NCT01200017|Musculoskeletal Diseases|musculoskeletal diseases
409710|NCT01200017|Severe acquired and congenital cytopenias|severe acquired and congenital cytopenias
409711|NCT01200017|White and red blood cell abnormalities|white and red blood cell abnormalities
409712|NCT01200004|Advanced solid tumor|advanced solid tumor
409713|NCT01200004|Azacitidine|azacitidine
409714|NCT01200004|Grifola frondosa|grifola frondosa
409715|NCT01200004|Basidiomycete fungus|basidiomycete fungus
409716|NCT01200004|Lenalidomide|lenalidomide
409717|NCT01199978|radiation|radiation
409718|NCT01199978|fractionated proton radiation|fractionated proton radiation
409719|NCT01199952|contraception|contraception
409720|NCT01199939|Human Immunodeficiency Virus|human immunodeficiency virus
409721|NCT01199939|HIV|hiv
409722|NCT01199939|Etravirine|etravirine
409723|NCT01199939|Darunavir|darunavir
409724|NCT01199939|Prezista|prezista
409725|NCT01199939|Intelence|intelence
409726|NCT01199939|Ritonavir|ritonavir
409727|NCT01199939|INROADS|inroads
409728|NCT01199926|25-hydroxyvitamin D|25-hydroxyvitamin d
409729|NCT01199926|Parathyroid hormone|parathyroid hormone
409730|NCT01199926|Lean mass|lean mass
409731|NCT01199926|Muscular strength|muscular strength
409732|NCT01199926|Glucose tolerance|glucose tolerance
409733|NCT01199913|problems with thinking after surgery;|problems with thinking after surgery;
409734|NCT01199900|Healthy People|healthy people
409735|NCT01199900|Glucocorticoids|glucocorticoids
409736|NCT01199900|Prednisone|prednisone
409737|NCT01199887|safety, biologic effects, IPF, autoimmune|safety, biologic effects, ipf, autoimmune
409738|NCT01199874|Rotavirus|rotavirus
409739|NCT01199874|Rotavirus vaccine|rotavirus vaccine
409740|NCT01199874|Dosing schedule|dosing schedule
409741|NCT01199874|Immunogenicity|immunogenicity
409742|NCT01199874|Breast feeding|breast feeding
409743|NCT01199874|Pakistan|pakistan
409744|NCT01199861|Relapsing multiple sclerosis|relapsing multiple sclerosis
409745|NCT01199861|MS|ms
409746|NCT01199861|Immune response|immune response
409747|NCT01199848|nutrition|nutrition
409748|NCT01199848|polyphenolic|polyphenolic
409749|NCT01199848|strawberry|strawberry
409750|NCT01199848|insulin resistance|insulin resistance
409751|NCT01199848|metabolic syndrome|metabolic syndrome
409752|NCT01199835|obesity|obesity
409753|NCT01199835|metabolic syndrome|metabolic syndrome
409754|NCT01199835|fecal fat excretion|fecal fat excretion
409755|NCT01199835|fecal calcium|fecal calcium
409756|NCT01199835|weight loss|weight loss
409757|NCT01199835|appetite regulation|appetite regulation
409758|NCT01199835|intestinal micro flora|intestinal micro flora
409759|NCT01199835|lipid profile|lipid profile
409760|NCT01199835|energy balance|energy balance
409761|NCT01199783|Diabetic Foot,MRSA,|diabetic foot,mrsa,
409762|NCT01199783|Complicated skin and skin structure infections|complicated skin and skin structure infections
409763|NCT01199783|Antimicrobial therapy|antimicrobial therapy
409764|NCT01199783|Daptomycin|daptomycin
409765|NCT01199770|pasta|pasta
409766|NCT01199770|appetite|appetite
409767|NCT01199770|hunger|hunger
409768|NCT01199770|satiety|satiety
409769|NCT01199770|nutrition|nutrition
409770|NCT01199770|metabolic|metabolic
409771|NCT01199770|gut peptide hormones|gut peptide hormones
409772|NCT01199770|psychological phenomena and processes|psychological phenomena and processes
409773|NCT01199757|ocular symptoms|ocular symptoms
409774|NCT01199757|nasal symptoms|nasal symptoms
409775|NCT01199757|Allergic Rhinitis|allergic rhinitis
409776|NCT01199757|Symptom Free Days|symptom free days
409777|NCT01199757|Quality of Life|quality of life
409778|NCT01199744|Influenza|influenza
409779|NCT01199744|Relenza®|relenza®
409781|NCT01199731|raltegravir|raltegravir
409782|NCT01199731|NNRTI|nnrti
409783|NCT01199731|ritonavir|ritonavir
409784|NCT01199731|darunavir|darunavir
409785|NCT01199731|HIV|hiv
409786|NCT01199731|GSK2248761|gsk2248761
409787|NCT01199731|antiretroviral|antiretroviral
409788|NCT01199731|HIV Infection|hiv infection
409789|NCT01199731|HAART|haart
409790|NCT01199718|Multiple myeloma|multiple myeloma
409791|NCT01199718|Plasmacytoma|plasmacytoma
409792|NCT01199705|Immune globulin subcutaneous|immune globulin subcutaneous
409793|NCT01199705|SCIG|scig
409794|NCT01199705|Primary immunodeficiency|primary immunodeficiency
409795|NCT01199705|PID|pid
409796|NCT01199679|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
409797|NCT01199679|Heartburn|heartburn
409798|NCT01199679|Regurgitation|regurgitation
409799|NCT01199679|Dyspepsia|dyspepsia
409800|NCT01199666|Underimmunization, text message, vaccination|underimmunization, text message, vaccination
409801|NCT01199666|Underimmunization|underimmunization
409802|NCT01199653|clavicle fractures|clavicle fractures
409803|NCT01199653|midshaft|midshaft
409804|NCT01199653|dislocated|dislocated
409805|NCT01199653|operative treatment|operative treatment
409806|NCT01199653|conservative treatment|conservative treatment
409807|NCT01199653|non-operative treatment|non-operative treatment
409808|NCT01199653|randomized controlled trial|randomized controlled trial
409809|NCT01199653|bone plates|bone plates
409810|NCT01199627|total hip replacement|total hip replacement
409811|NCT01199627|tranexamic acid|tranexamic acid
409812|NCT01199614|Hypoparathyroidism|hypoparathyroidism
409813|NCT01199614|Hypopara|hypopara
409815|NCT01199614|Hypocalcemia|hypocalcemia
409816|NCT01199614|Hypercalciuria|hypercalciuria
409817|NCT01199614|PTH|pth
409818|NCT01199614|PTH(1-84)|pth(1-84)
409819|NCT01199588|VLU|vlu
409820|NCT01199588|Venous Leg Ulcers|venous leg ulcers
409821|NCT01199588|Ulcers|ulcers
409822|NCT01199588|chronic wounds|chronic wounds
409823|NCT01199588|wounds|wounds
409824|NCT01199588|Nexagon|nexagon
409825|NCT01199588|CoDa|coda
409826|NCT01199575|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
409827|NCT01199575|CLL|cll
409828|NCT01199575|Relapsed or Refractory|relapsed or refractory
409829|NCT01199575|previously treated|previously treated
409830|NCT01199536|Helicobacter-positive duodenal ulcer|helicobacter-positive duodenal ulcer
409831|NCT01199523|YM178|ym178
409832|NCT01199523|Mirabegron|mirabegron
409833|NCT01199523|QT|qt
409834|NCT01199497|cough, acute rhinitis, nasal congestion, common cold, nasal symptoms, children.|cough, acute rhinitis, nasal congestion, common cold, nasal symptoms, children.
409835|NCT01199497|Nasal congestion and non-productive cough, with or without associate other nasal and extranasal symptoms.|nasal congestion and non-productive cough, with or without associate other nasal and extranasal symptoms.
409836|NCT01199484|Cow's milk allergy|cow's milk allergy
409837|NCT01199484|food allergy|food allergy
409838|NCT01199484|oral desensitization|oral desensitization
409839|NCT01199484|randomized trial|randomized trial
409840|NCT01199484|specific oral tolerance induction.|specific oral tolerance induction.
409841|NCT01199471|Sevoflurane|sevoflurane
409842|NCT01199471|Physician's Practice Patterns|physician's practice patterns
409843|NCT01199471|Economics, Pharmaceutical|economics, pharmaceutical
409844|NCT01199471|Chinese|chinese
409845|NCT01199458|Lower Esophageal Sphincter|lower esophageal sphincter
409846|NCT01199458|Barrier pressure|barrier pressure
409847|NCT01199445|vitamin A deficiency|vitamin a deficiency
409848|NCT01199432|Primary Breast Cancer|primary breast cancer
409849|NCT01199419|multivessel coronary artery disease|multivessel coronary artery disease
409850|NCT01199419|drug-eluting stent|drug-eluting stent
409851|NCT01199419|CABG|cabg
409852|NCT01199419|cost-effectiveness|cost-effectiveness
409853|NCT01199406|gallstone|gallstone
409854|NCT01199406|gallbladder|gallbladder
409855|NCT01199406|cholecystectomy|cholecystectomy
409856|NCT01199406|laparoscopic|laparoscopic
409857|NCT01199406|pain|pain
409858|NCT01199393|breast neoplasm|breast neoplasm
409859|NCT01199393|drug therapy|drug therapy
409860|NCT01199393|polymorphism|polymorphism
409861|NCT01199393|gene|gene
409862|NCT01199380|Smoking, Smoking Cessation|smoking, smoking cessation
409863|NCT01199367|advanced or metastatic breast cancer|advanced or metastatic breast cancer
409864|NCT01199354|Invasive breast carcinoma|invasive breast carcinoma
409865|NCT01199341|Phase 1|phase 1
409866|NCT01199341|Drug-Drug interaction|drug-drug interaction
409867|NCT01199341|warfarin|warfarin
409868|NCT01199341|AZD1981|azd1981
409869|NCT01199328|Nexium|nexium
409870|NCT01199328|aspirin|aspirin
409871|NCT01199328|peptic ulcers|peptic ulcers
409872|NCT01199328|pharmacodynamic (PD)|pharmacodynamic (pd)
409873|NCT01199328|Esomoeprazole|esomoeprazole
409874|NCT01199315|safety|safety
409875|NCT01199315|tolerability|tolerability
409876|NCT01199315|AZD1446|azd1446
409877|NCT01199315|AD|ad
409878|NCT01199315|ADHD|adhd
409879|NCT01199315|Japanese|japanese
409882|NCT01199302|Inflammatory Bowel Disease|inflammatory bowel disease
409883|NCT01199302|IBD|ibd
409884|NCT01199302|Irritable Bowel Syndrome|irritable bowel syndrome
409885|NCT01199302|IBS|ibs
408929|NCT01202916|children with congenital heart disease|children with congenital heart disease
408930|NCT01202903|omalizumab|omalizumab
408931|NCT01202903|asthma|asthma
408933|NCT01202903|IgE|ige
409886|NCT01199302|Inflammation|inflammation
409887|NCT01199302|bowel|bowel
409888|NCT01199302|colon|colon
409889|NCT01199302|gastrointestinal|gastrointestinal
409890|NCT01199289|Amgen|amgen
409891|NCT01199289|chronic inflammatory disease|chronic inflammatory disease
409892|NCT01199289|wheezing|wheezing
409893|NCT01199276|Delirium|delirium
409894|NCT01199276|Hip Fracture|hip fracture
409895|NCT01199276|Elderly|elderly
409896|NCT01199237|Reflex, Pharyngeal|reflex, pharyngeal
409897|NCT01199237|Anesthetics, Inhalation|anesthetics, inhalation
409898|NCT01199224|Solid Tumors|solid tumors
409899|NCT01199224|veliparib|veliparib
409900|NCT01199224|refractory|refractory
409901|NCT01199224|relapsed|relapsed
409902|NCT01199211|hypertrophy, exercise, HDL, lipids, cholesterol|hypertrophy, exercise, hdl, lipids, cholesterol
409903|NCT01199198|Hyponatremia|hyponatremia
409904|NCT01199198|Serum sodium|serum sodium
409905|NCT01199198|Tolvaptan|tolvaptan
409906|NCT01199198|Placebo|placebo
409907|NCT01199172|Student teachers with normal or mildly disordered voices|student teachers with normal or mildly disordered voices
409908|NCT01199159|misoprostol|misoprostol
409909|NCT01199159|hysterectomy|hysterectomy
409910|NCT01199159|operative blood loss|operative blood loss
409911|NCT01199159|total abdominal hysterectomy|total abdominal hysterectomy
409912|NCT01199146|Abiraterone acetate|abiraterone acetate
409913|NCT01199120|Omega-3|omega-3
409914|NCT01199120|Cognition|cognition
409915|NCT01199120|Malnourishment|malnourishment
409916|NCT01199107|PTSD|ptsd
409917|NCT01199107|Anxiety|anxiety
409918|NCT01199107|Behavior Therapy|behavior therapy
409919|NCT01199107|Prolonged Exposure|prolonged exposure
409920|NCT01199107|Exercise|exercise
409921|NCT01199107|Wellness|wellness
409922|NCT01199107|Posttraumatic|posttraumatic
409923|NCT01199107|Stress|stress
409924|NCT01199094|low density lipoprotein receptor 5|low density lipoprotein receptor 5
409925|NCT01199094|high bone mass|high bone mass
409926|NCT01199094|autosomal dominant osteopetrosis type I|autosomal dominant osteopetrosis type i
409927|NCT01199094|bone turnover markers|bone turnover markers
409928|NCT01199068|PPAR gamma agonist|ppar gamma agonist
409929|NCT01199068|Tumor|tumor
409930|NCT01199068|Cancer|cancer
409931|NCT01199068|Antineoplastic Agent|antineoplastic agent
409932|NCT01199068|Respiratory Tract Neoplasms|respiratory tract neoplasms
409933|NCT01199068|Erlotinib|erlotinib
409934|NCT01199068|Protein Kinase Inhibitors|protein kinase inhibitors
409935|NCT01199068|Neoplasms|neoplasms
409936|NCT01199055|PPAR gamma agonist|ppar gamma agonist
409937|NCT01199055|Tumor|tumor
409938|NCT01199055|Cancer|cancer
409939|NCT01199055|Antineoplastic Agent|antineoplastic agent
409940|NCT01199055|Respiratory Tract Neoplasms|respiratory tract neoplasms
409941|NCT01199055|Carboplatin|carboplatin
409942|NCT01199055|Paclitaxel|paclitaxel
409943|NCT01199055|Neoplasms|neoplasms
409944|NCT01199029|Healthy People|healthy people
409945|NCT01199029|Glucocorticoids|glucocorticoids
409946|NCT01199029|Prednisone|prednisone
409947|NCT01199016|Acute otitis media|acute otitis media
409948|NCT01199016|Prevnar 13|prevnar 13
409949|NCT01199016|Streptococcus pneumoniae|streptococcus pneumoniae
409950|NCT01199016|nasopharyngeal colonization.|nasopharyngeal colonization.
409951|NCT01198977|multiple sclerosis|multiple sclerosis
409952|NCT01198977|Fatigue|fatigue
409953|NCT01198977|exercise|exercise
409954|NCT01198977|telemedicine|telemedicine
409955|NCT01198977|motivational interviewing|motivational interviewing
409956|NCT01198977|counseling|counseling
409957|NCT01198977|depression|depression
409958|NCT01198977|physical activity|physical activity
409959|NCT01198964|ECoG|ecog
409960|NCT01198964|Epilepsy|epilepsy
409961|NCT01198964|cortical|cortical
409962|NCT01198964|stimulation|stimulation
409963|NCT01198964|Electrocorticography|electrocorticography
409964|NCT01198964|electrodes|electrodes
409965|NCT01198964|mapping|mapping
409966|NCT01198938|Cardiac surgery, delirium, melatonin|cardiac surgery, delirium, melatonin
409967|NCT01198925|Infectious disease|infectious disease
409968|NCT01198925|piperacillin|piperacillin
409969|NCT01198925|continuous infusion|continuous infusion
409970|NCT01198925|extended infusion|extended infusion
409971|NCT01198912|rhinosinusitis|rhinosinusitis
409972|NCT01198912|doxycycline|doxycycline
409973|NCT01198912|Chronic rhinosinusitis with or without nasal polyps|chronic rhinosinusitis with or without nasal polyps
409974|NCT01198899|Fabry-Anderson disease|fabry-anderson disease
409975|NCT01198899|gen mutation|gen mutation
409976|NCT01198899|left ventricular hypertrophy|left ventricular hypertrophy
409977|NCT01198886|Mobility disability|mobility disability
409978|NCT01198886|Older adults|older adults
409979|NCT01198886|Physical activity|physical activity
409980|NCT01198886|Nutritional status|nutritional status
409981|NCT01198860|HBsAg|hbsag
409982|NCT01198847|child overweight|child overweight
409983|NCT01198847|child obesity|child obesity
409984|NCT01198847|prevention|prevention
409985|NCT01198847|targeted intervention|targeted intervention
409986|NCT01198847|development of overweight|development of overweight
409987|NCT01198834|ankle sprains|ankle sprains
409988|NCT01198821|pancreas|pancreas
409989|NCT01198821|adenocarcinoma|adenocarcinoma
409990|NCT01198821|metastatic|metastatic
409991|NCT01198821|unresectable|unresectable
409992|NCT01198808|Bladder cancer|bladder cancer
409993|NCT01198808|chemotherapy|chemotherapy
409994|NCT01198808|T cells|t cells
409995|NCT01198808|Immunotherapy|immunotherapy
409996|NCT01198808|Tumor-specific immunity in bladder cancer|tumor-specific immunity in bladder cancer
409997|NCT01198795|depression|depression
409998|NCT01198795|major depressive disorder|major depressive disorder
409999|NCT01198795|escitalopram|escitalopram
410000|NCT01198795|Lexapro|lexapro
410001|NCT01198795|pediatric|pediatric
410002|NCT01198769|Human rotavirus vaccine|human rotavirus vaccine
410003|NCT01198756|Influenza|influenza
410004|NCT01198743|Genetics modifications|genetics modifications
410005|NCT01198743|colorectal cancer|colorectal cancer
410006|NCT01198743|prognosis aim|prognosis aim
410008|NCT01198743|Plasma|plasma
410009|NCT01198730|DM|dm
410010|NCT01198730|CAD|cad
410011|NCT01198730|Meal tolerance test|meal tolerance test
410012|NCT01198730|Acarbose|acarbose
410013|NCT01198704|Hepatocellular carcinoma|hepatocellular carcinoma
410014|NCT01198704|Cirrhosis|cirrhosis
410015|NCT01198704|Transplantation|transplantation
410016|NCT01198691|metallic staples|metallic staples
410017|NCT01198691|absorbable staples|absorbable staples
410018|NCT01198691|Cesarean Delivery|cesarean delivery
410019|NCT01198665|RAD001|rad001
410020|NCT01198665|chemotherpy|chemotherpy
410021|NCT01198665|T cell lymphoma|t cell lymphoma
410022|NCT01198626|community-acquired bacterial pneumonia|community-acquired bacterial pneumonia
410023|NCT01198626|CABP|cabp
410024|NCT01198626|CAP|cap
410025|NCT01198626|pneumonia|pneumonia
410026|NCT01198626|pneumonia, bacterial|pneumonia, bacterial
410027|NCT01198626|bacterial infections|bacterial infections
410028|NCT01198626|anti-bacterial agents|anti-bacterial agents
410029|NCT01198626|anti-infective agents|anti-infective agents
410030|NCT01198626|lung disease, interstitial|lung disease, interstitial
410031|NCT01198626|respiratory tract diseases|respiratory tract diseases
410032|NCT01198626|respiratory tract infections|respiratory tract infections
410033|NCT01198626|community-acquired infections|community-acquired infections
410034|NCT01198613|Ragweed allergy|ragweed allergy
410035|NCT01198613|Rhinoconjunctivitis|rhinoconjunctivitis
410036|NCT01198613|Exposure chamber|exposure chamber
410037|NCT01198613|Immunotherapy|immunotherapy
410038|NCT01198613|ToleroMune Ragweed|toleromune ragweed
410039|NCT01198587|Diarrhea|diarrhea
410040|NCT01198587|Gastroenteritis|gastroenteritis
410041|NCT01198587|Zinc Supplementation|zinc supplementation
410042|NCT01198574|anemia|anemia
410043|NCT01198574|iron supplementation|iron supplementation
410044|NCT01198574|sub-clinical inflammation|sub-clinical inflammation
410045|NCT01198574|adolescents|adolescents
410046|NCT01198561|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
410047|NCT01198561|Major Depressive Disorder|major depressive disorder
410048|NCT01198522|Interleukin, IL2, Gemcitabine, monoclonal, antibody, cytokine, tumour targeting, dose finding, fusion protein, Pancreatic cancer,|interleukin, il2, gemcitabine, monoclonal, antibody, cytokine, tumour targeting, dose finding, fusion protein, pancreatic cancer,
410049|NCT01198522|L19|l19
410050|NCT01198509|rheumatoid arthritis|rheumatoid arthritis
410051|NCT01198509|psoriatic arthritis|psoriatic arthritis
410052|NCT01198509|periodontitis|periodontitis
410053|NCT01198509|microbiota|microbiota
410054|NCT01198509|microbiome|microbiome
410055|NCT01198509|vancomycin|vancomycin
410056|NCT01198509|doxycycline|doxycycline
410057|NCT01198509|T cell|t cell
410058|NCT01198509|Th17|th17
410059|NCT01198496|hypertension|hypertension
410060|NCT01198496|stroke|stroke
410061|NCT01198496|blood pressure|blood pressure
410062|NCT01198483|refraction|refraction
410063|NCT01198483|refractive error|refractive error
410064|NCT01198483|combined surgery|combined surgery
410065|NCT01198483|microincision|microincision
410066|NCT01198483|smallincision|smallincision
410067|NCT01198483|cataract surgery|cataract surgery
410068|NCT01198483|vitrectomy|vitrectomy
410069|NCT01198470|Low back pain|low back pain
410070|NCT01198470|Leg pain|leg pain
410071|NCT01198470|Discogenic pain|discogenic pain
410072|NCT01198470|Degenerative Disc Disease (DDD)|degenerative disc disease (ddd)
410073|NCT01198470|Herniated disc|herniated disc
410074|NCT01198470|Radiculopathy|radiculopathy
410075|NCT01198457|Clodronate|clodronate
410076|NCT01198457|Compliance|compliance
410077|NCT01198444|Contraception|contraception
410078|NCT01198444|Compliance|compliance
410079|NCT01198431|Appetite regulation|appetite regulation
410080|NCT01198431|Physical activity|physical activity
410081|NCT01198431|Energy balance|energy balance
410082|NCT01198418|STI|sti
410083|NCT01198418|MSM|msm
410084|NCT01198418|HIV|hiv
410085|NCT01198418|Prevention|prevention
410086|NCT01198418|Men having sex with men|men having sex with men
410087|NCT01198405|coronary artery disease|coronary artery disease
410088|NCT01198405|enhanced external counterpulsation|enhanced external counterpulsation
410089|NCT01198392|gastric cancer|gastric cancer
410090|NCT01198379|aspirin|aspirin
410091|NCT01198379|aspirin resistance|aspirin resistance
410092|NCT01198379|hemodialysis|hemodialysis
410093|NCT01198379|cardiovascular|cardiovascular
410094|NCT01198379|Prevalence of aspirin resistance, cardiovascular events, and safety profile|prevalence of aspirin resistance, cardiovascular events, and safety profile
410095|NCT01198366|Tuberculosis|tuberculosis
410096|NCT01198366|Vaccine|vaccine
410097|NCT01198366|Immunogenicity|immunogenicity
410098|NCT01198366|Prevention of Tuberculosis|prevention of tuberculosis
410099|NCT01198353|Schizophrenia|schizophrenia
410100|NCT01198353|Schizoaffective Disorder|schizoaffective disorder
410101|NCT01198353|Ziprasidone|ziprasidone
410102|NCT01198353|Switch|switch
410103|NCT01198353|Metabolic syndrome|metabolic syndrome
410105|NCT01198327|CRVO|crvo
410106|NCT01198327|BRVO|brvo
410107|NCT01198327|Horizon|horizon
410108|NCT01198327|Bravo|bravo
410109|NCT01198327|Cruise|cruise
410110|NCT01198314|long term|long term
410111|NCT01198314|stable|stable
410112|NCT01198314|recipients|recipients
748980|NCT01158456|lung cancer|lung cancer
512324|NCT00251147|open|open
410113|NCT01198301|Metastatic Breast Neoplasms|metastatic breast neoplasms
410114|NCT01198301|Gene Expression Profiling|gene expression profiling
410115|NCT01198301|Drug Therapy|drug therapy
410116|NCT01198288|COPD|copd
410117|NCT01198288|Respiratory Physiotherapy|respiratory physiotherapy
410118|NCT01198275|PUFA atrial fibrillation|pufa atrial fibrillation
410119|NCT01198262|polymerase chain reaction|polymerase chain reaction
410120|NCT01198236|hematological malignancy|hematological malignancy
410121|NCT01198236|previous proven or probable invasive fungal infection|previous proven or probable invasive fungal infection
410122|NCT01198223|denture stomatitis|denture stomatitis
410123|NCT01198223|nystatin|nystatin
410124|NCT01198223|garlic|garlic
410125|NCT01198210|pain|pain
410126|NCT01198210|tonsillectomy|tonsillectomy
410127|NCT01198210|peritonsillar infiltration|peritonsillar infiltration
410128|NCT01198210|postoperative pain|postoperative pain
410129|NCT01198197|Nociceptin/Orphanin FQ Peptide (NOP)|nociceptin/orphanin fq peptide (nop)
410130|NCT01198197|PET Imaging|pet imaging
410131|NCT01198197|Brain Imaging|brain imaging
410132|NCT01198197|Healthy Volunteer|healthy volunteer
410134|NCT01198145|diarrhea|diarrhea
410135|NCT01198145|gastrointestinal complications|gastrointestinal complications
410136|NCT01198145|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
410137|NCT01198132|Multiple Sclerosis Relapsing-Remitting|multiple sclerosis relapsing-remitting
410138|NCT01198132|Relapsing Multiple Sclerosis (RMS)|relapsing multiple sclerosis (rms)
410139|NCT01198132|Rebif|rebif
410140|NCT01198132|Vitamin D3|vitamin d3
410141|NCT01198132|Cholecalciferol|cholecalciferol
410142|NCT01198119|oral cavity tumor|oral cavity tumor
410143|NCT01198119|narrow band imaging|narrow band imaging
410144|NCT01198119|subclinical cancer lesion|subclinical cancer lesion
410145|NCT01198106|simulator sickness|simulator sickness
410146|NCT01198106|scopolamine|scopolamine
410147|NCT01198106|cinnarizine|cinnarizine
410148|NCT01198093|Alzheimer's disease|alzheimer's disease
410149|NCT01198093|Mild Cognitive Impairment|mild cognitive impairment
410150|NCT01198093|cohort study|cohort study
410151|NCT01198080|Avascular osteonecrosis,CD133+,core decompression|avascular osteonecrosis,cd133+,core decompression
410152|NCT01198067|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
410153|NCT01198067|B-cell lymphoproliferative disorder|b-cell lymphoproliferative disorder
410154|NCT01198067|Bone marrow|bone marrow
410155|NCT01198067|Lymphoplasmacytic cells|lymphoplasmacytic cells
410156|NCT01198067|Monoclonal gammopathy|monoclonal gammopathy
410157|NCT01198067|Pomalidomide|pomalidomide
410158|NCT01198067|Actimid|actimid
410159|NCT01198067|CC-4047|cc-4047
410160|NCT01198054|AML|aml
410161|NCT01198054|Lenalidomide|lenalidomide
410162|NCT01198028|Squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
410163|NCT01198028|Cutaneous squamous cell carcinoma|cutaneous squamous cell carcinoma
410164|NCT01198028|CSCC|cscc
410165|NCT01198028|epidermal growth factor receptor|epidermal growth factor receptor
410166|NCT01198028|EGFR|egfr
410167|NCT01198028|tyrosine kinase inhibitor|tyrosine kinase inhibitor
410168|NCT01198028|recurrent|recurrent
410169|NCT01198028|Erlotinib|erlotinib
410170|NCT01198028|Erlotinib hydrochloride|erlotinib hydrochloride
410171|NCT01198028|OSI-774|osi-774
410172|NCT01198028|Tarceva|tarceva
410173|NCT01198015|Rett syndrome|rett syndrome
410174|NCT01198015|Nutritional status|nutritional status
410175|NCT01198015|Creatine metabolism|creatine metabolism
410176|NCT01198002|Rheumatoid Arthritis|rheumatoid arthritis
410177|NCT01197989|pustulosis|pustulosis
410178|NCT01197989|soles|soles
410179|NCT01197989|teflon|teflon
410180|NCT01197976|psoriasis|psoriasis
410181|NCT01197976|soles|soles
410182|NCT01197976|teflon|teflon
410183|NCT01197963|Type 2 diabetes mellitus|type 2 diabetes mellitus
410185|NCT01197950|labour|labour
410186|NCT01197950|pain|pain
410187|NCT01197950|pain relief|pain relief
410188|NCT01197950|complementary|complementary
410189|NCT01197924|child cancer brain|child cancer brain
410190|NCT01197898|Diabetic|diabetic
410191|NCT01197898|Foot|foot
410192|NCT01197898|Ulcers|ulcers
410193|NCT01197898|Wounds|wounds
410194|NCT01197833|varicose veins|varicose veins
410195|NCT01197833|Great saphenous vein|great saphenous vein
410196|NCT01197833|varicosities|varicosities
410197|NCT01197820|HIFU|hifu
410198|NCT01197820|mobile organs|mobile organs
410199|NCT01197820|thermometry|thermometry
410200|NCT01197820|MR|mr
410201|NCT01197820|liver|liver
410202|NCT01197820|kidney|kidney
410203|NCT01197820|cancer|cancer
410204|NCT01197820|Liver tumors, kidney carcinoma|liver tumors, kidney carcinoma
410205|NCT01197807|Suctioning|suctioning
410206|NCT01197807|Wiping|wiping
410207|NCT01197807|Neonate|neonate
410208|NCT01197807|Resuscitation|resuscitation
410209|NCT01197794|Efficacy|efficacy
410210|NCT01197794|safety|safety
410211|NCT01197794|tolerability|tolerability
410212|NCT01197794|dose finding|dose finding
410213|NCT01197794|asthma patients|asthma patients
410214|NCT01197781|Phase I|phase i
410215|NCT01197781|FosD|fosd
410216|NCT01197781|fostamatinib disodium|fostamatinib disodium
410217|NCT01197781|verapamil|verapamil
410218|NCT01197781|healthy volunteers|healthy volunteers
410219|NCT01197755|Rheumatoid Arthritis|rheumatoid arthritis
410220|NCT01197742|Diabetes|diabetes
410221|NCT01197742|STEMI|stemi
410222|NCT01197742|NSTEMI|nstemi
410223|NCT01197742|Myocardial infarction|myocardial infarction
410224|NCT01197729|Myocardial infarction|myocardial infarction
410225|NCT01197729|ST-Elevation myocardial infarction|st-elevation myocardial infarction
410226|NCT01197729|Non-ST-Elevation myocardial infarction|non-st-elevation myocardial infarction
410227|NCT01197729|Register|register
410228|NCT01197729|CARDS|cards
410229|NCT01197716|Chest Pain Unit|chest pain unit
410230|NCT01197716|Myocardial infarction|myocardial infarction
410231|NCT01197716|Register|register
410232|NCT01197716|Admission to a Chest Pain Unit for any reason|admission to a chest pain unit for any reason
410233|NCT01197703|Clinical Practice Cardiac CT|clinical practice cardiac ct
410234|NCT01197703|Clinical Implications Coronary CT Angiography|clinical implications coronary ct angiography
410235|NCT01197703|Radiation Exposure of Coronary CT Angiography|radiation exposure of coronary ct angiography
410236|NCT01197703|Registry|registry
410237|NCT01197690|Bronchial asthma|bronchial asthma
410238|NCT01197690|level of control of asthma|level of control of asthma
410239|NCT01197690|fractional exhaled nitric oxide (FeNO)|fractional exhaled nitric oxide (feno)
410240|NCT01197690|asthma control test (ACT)|asthma control test (act)
410242|NCT01197677|Register|register
410243|NCT01197677|CAD|cad
410244|NCT01197677|myocard scarring|myocard scarring
410245|NCT01197651|Aorta|aorta
410246|NCT01197651|Aorta-Stent-Graft|aorta-stent-graft
410247|NCT01197651|Surgical operation|surgical operation
410248|NCT01197651|Aortic dissection|aortic dissection
410249|NCT01197638|Cardiac arrhythmia|cardiac arrhythmia
410250|NCT01197638|Catheter ablation|catheter ablation
410251|NCT01197638|Register|register
410252|NCT01197625|Vaccination treatment, dendritic cells|vaccination treatment, dendritic cells
410253|NCT01197599|Healthy Control|healthy control
410254|NCT01197586|surfactant protein B|surfactant protein b
410255|NCT01197586|differential diagnostics|differential diagnostics
410256|NCT01197560|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
410257|NCT01197560|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
410258|NCT01197560|relapsed|relapsed
410259|NCT01197560|refractory|refractory
410260|NCT01197560|relapsed/refractory|relapsed/refractory
410261|NCT01197560|DLBCL|dlbcl
410262|NCT01197560|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
410263|NCT01197547|Menorrhagia|menorrhagia
410264|NCT01197534|Rheumatoid Arthritis|rheumatoid arthritis
410265|NCT01197521|Rheumatoid Arthritis|rheumatoid arthritis
410266|NCT01197508|Major Depressive Disorder, MDD, Depression|major depressive disorder, mdd, depression
410267|NCT01197482|asthma|asthma
410268|NCT01197482|inhalation|inhalation
410269|NCT01197469|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
410270|NCT01197456|Breast cancer|breast cancer
410271|NCT01197456|Ovarian insufficiency|ovarian insufficiency
410272|NCT01197456|Ovarian failure|ovarian failure
410273|NCT01197456|Reproduction|reproduction
410274|NCT01197443|obesity|obesity
410275|NCT01197443|overweight|overweight
410276|NCT01197443|overweight children|overweight children
410277|NCT01197443|overweight parents|overweight parents
410278|NCT01197443|families with overweight child|families with overweight child
410279|NCT01197443|body mass index|body mass index
410280|NCT01197443|BMI|bmi
410281|NCT01197443|weight|weight
410282|NCT01197443|childhood obesity|childhood obesity
410283|NCT01197443|diet|diet
410284|NCT01197443|treatment|treatment
410286|NCT01197443|traffic light diet|traffic light diet
410287|NCT01197443|stop light diet|stop light diet
410288|NCT01197430|volleyball|volleyball
410289|NCT01197430|neck vertical stability training|neck vertical stability training
410290|NCT01197430|eye-hand coordination|eye-hand coordination
410291|NCT01197417|Sickle Cell Disease|sickle cell disease
410292|NCT01197417|Magnesium Sulfate|magnesium sulfate
410293|NCT01197417|Pediatric|pediatric
410294|NCT01197404|HIV Prevention|hiv prevention
410295|NCT01197378|cystinosis|cystinosis
410296|NCT01197378|cysteamine|cysteamine
410297|NCT01197378|inheritable disease|inheritable disease
410298|NCT01197378|orphan disease|orphan disease
410299|NCT01197378|CTNS protein, human|ctns protein, human
410300|NCT01197378|metabolic disease|metabolic disease
410301|NCT01197378|nephropathic cystinosis|nephropathic cystinosis
410302|NCT01197365|Acidified milk|acidified milk
410303|NCT01197365|Beta-palmitate|beta-palmitate
410304|NCT01197365|Bifidobacteria|bifidobacteria
410305|NCT01197365|Infant formula|infant formula
410306|NCT01197365|Galacto-oligosaccharides|galacto-oligosaccharides
410307|NCT01197365|Growth|growth
410308|NCT01197365|Infants|infants
410309|NCT01197365|Prebiotics|prebiotics
410310|NCT01197352|Alcohol|alcohol
410311|NCT01197352|Abuse|abuse
410312|NCT01197352|Drinking|drinking
410313|NCT01197352|Behavior|behavior
410314|NCT01197352|Text|text
410315|NCT01197352|Computer|computer
410316|NCT01197339|acute phonotrauma|acute phonotrauma
410317|NCT01197339|computer modeling|computer modeling
410318|NCT01197339|resonant voice|resonant voice
410319|NCT01197339|breathy voice|breathy voice
410320|NCT01197339|voice rest|voice rest
410321|NCT01197339|relaxation|relaxation
410322|NCT01197326|patient deterioration|patient deterioration
410323|NCT01197326|unplanned ICU admissions|unplanned icu admissions
410324|NCT01197326|rapid response teams|rapid response teams
410325|NCT01197313|chronic heart failure (CHF); anxiety and depression; quality of life (QOL); exercise|chronic heart failure (chf); anxiety and depression; quality of life (qol); exercise
410326|NCT01197300|Osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, Duchenne muscular dystrophy, glucocorticoids|osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, duchenne muscular dystrophy, glucocorticoids
410327|NCT01197287|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
410328|NCT01197274|allergy|allergy
410329|NCT01197274|skin prick test|skin prick test
410330|NCT01197274|mite sensitivity|mite sensitivity
410331|NCT01197261|Severe pain|severe pain
410332|NCT01197261|Bladder Pain Syndrome|bladder pain syndrome
410333|NCT01197261|Interstitial Cystitis|interstitial cystitis
410334|NCT01197261|Painful Bladder Syndrome|painful bladder syndrome
410335|NCT01197261|Severe pain due to Bladder Pain Syndrome/Interstitial Cystitis/Painful Bladder Syndrome|severe pain due to bladder pain syndrome/interstitial cystitis/painful bladder syndrome
410336|NCT01197248|cystocele|cystocele
410337|NCT01197248|voiding|voiding
410338|NCT01197248|dysfunction|dysfunction
410339|NCT01197235|darbepoetin, chronic kidney disease, coronary angiography|darbepoetin, chronic kidney disease, coronary angiography
410340|NCT01197222|Laparoscopic|laparoscopic
410341|NCT01197222|EndoClear|endoclear
410342|NCT01197222|Lens Cleaning Device|lens cleaning device
410343|NCT01197209|Prostate Cancer|prostate cancer
410344|NCT01197209|Prostatectomy|prostatectomy
410345|NCT01197209|Postectomy|postectomy
410346|NCT01197209|Oncology|oncology
410347|NCT01197209|REIC|reic
410348|NCT01197209|Dikkoff|dikkoff
410349|NCT01197209|Apoptosis|apoptosis
410350|NCT01197196|Migraine|migraine
410351|NCT01197196|Obesity|obesity
410352|NCT01197196|Weight loss|weight loss
410353|NCT01197196|Lifestyle|lifestyle
410354|NCT01197196|Behavior|behavior
410355|NCT01197183|Hypothyroidism|hypothyroidism
410356|NCT01197183|Thyroid hormones|thyroid hormones
410357|NCT01197170|Hormonal therapies|hormonal therapies
410358|NCT01197170|Estrogen receptor|estrogen receptor
410359|NCT01197170|Progesterone receptor|progesterone receptor
410360|NCT01197170|Hormone blockade|hormone blockade
410361|NCT01197170|Hormone-positive tumors|hormone-positive tumors
410362|NCT01197170|Advanced cancer|advanced cancer
410363|NCT01197170|Metastatic cancer|metastatic cancer
410364|NCT01197170|Avastin|avastin
410365|NCT01197170|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
410366|NCT01197170|rhuMAB-VEGF|rhumab-vegf
410367|NCT01197170|Afinitor|afinitor
410368|NCT01197170|RAD001|rad001
410369|NCT01197170|Nexavar|nexavar
410370|NCT01197170|BAY43-9006|bay43-9006
410371|NCT01197170|OSI-774|osi-774
410372|NCT01197170|Tarceva|tarceva
410373|NCT01197157|chronic hepatitis C|chronic hepatitis c
410374|NCT01197157|genotype 4|genotype 4
410375|NCT01197157|treatment naive patients|treatment naive patients
410376|NCT01197157|Egypt|egypt
410377|NCT01197144|TNF|tnf
410378|NCT01197144|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
410379|NCT01197144|Autonomic|autonomic
410380|NCT01197144|Vagus|vagus
410381|NCT01197144|adalimumab|adalimumab
410382|NCT01197131|autism|autism
410574|NCT01196273|AIDS,|aids,
410383|NCT01197131|autism spectrum disorder|autism spectrum disorder
410384|NCT01197131|steroids|steroids
410385|NCT01197131|steroid metabolites|steroid metabolites
410386|NCT01197131|urinary steroid metabolites|urinary steroid metabolites
410387|NCT01197131|hormone formation|hormone formation
410388|NCT01197131|androgen precursor|androgen precursor
410389|NCT01197118|gastric cancer|gastric cancer
410390|NCT01197118|sequence chemoradiotherapy|sequence chemoradiotherapy
410391|NCT01197118|OLF regimen|olf regimen
410392|NCT01197118|survival rate|survival rate
410393|NCT01197105|gingivitis|gingivitis
410394|NCT01197105|schinus terebinthifolius|schinus terebinthifolius
410395|NCT01197105|natural products|natural products
410396|NCT01197092|Diabetes|diabetes
410397|NCT01197079|HPV|hpv
410398|NCT01197079|Vaccine|vaccine
410399|NCT01197079|Vaccine utilization|vaccine utilization
410400|NCT01197079|Disease awareness|disease awareness
410401|NCT01197053|Peanut Allergy|peanut allergy
410402|NCT01197053|Food Allergy|food allergy
410403|NCT01197053|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
410404|NCT01197053|Food Challenge|food challenge
410405|NCT01197040|Minimal Change Nephrotic Syndrome|minimal change nephrotic syndrome
410406|NCT01197040|Complete remission|complete remission
410407|NCT01197040|Myfortic|myfortic
410408|NCT01197040|Minimal Change Disease|minimal change disease
410409|NCT01197014|Amlodipine, Losartan|amlodipine, losartan
410410|NCT01197001|Amlodipine, Losartan|amlodipine, losartan
410411|NCT01196988|GSK Biologicals influenza vaccine GSK2321138A|gsk biologicals influenza vaccine gsk2321138a
410412|NCT01196988|influenza infection|influenza infection
410413|NCT01196975|Influenza|influenza
410414|NCT01196962|central venous catheter|central venous catheter
410415|NCT01196962|complications|complications
410416|NCT01196962|internal jugular vein|internal jugular vein
410417|NCT01196962|randomized trial|randomized trial
410418|NCT01196962|subclavian vein|subclavian vein
410419|NCT01196949|Ankle|ankle
410420|NCT01196949|Chronic|chronic
410421|NCT01196949|Instability|instability
410422|NCT01196949|Manipulative|manipulative
410423|NCT01196949|Rehabilitative|rehabilitative
410424|NCT01196949|Manipulation|manipulation
410425|NCT01196949|Rehabilitation|rehabilitation
410426|NCT01196936|Cancer survivors|cancer survivors
410427|NCT01196936|Low Dose Tamoxifen|low dose tamoxifen
410428|NCT01196936|Breast Cancer Risk Reduction|breast cancer risk reduction
410429|NCT01196897|Atrial fibrillation|atrial fibrillation
410430|NCT01196897|Stroke|stroke
410431|NCT01196897|Warfarin|warfarin
410432|NCT01196897|Coumadin|coumadin
410433|NCT01196897|TIA|tia
410434|NCT01196897|Trans Ischemic Attack|trans ischemic attack
410435|NCT01196884|Patients with primary Immune Thrombocytopenia (ITP)|patients with primary immune thrombocytopenia (itp)
410436|NCT01196871|Fabry disease|fabry disease
410437|NCT01196871|drug drug interaction|drug drug interaction
410438|NCT01196845|adipose tissue|adipose tissue
410439|NCT01196845|obese patients|obese patients
410440|NCT01196845|inflammation|inflammation
410441|NCT01196845|oxidative stress|oxidative stress
410442|NCT01196845|sleep apnea syndrome|sleep apnea syndrome
410443|NCT01196806|Non-Invasive Blood Pressure(NIBP)|non-invasive blood pressure(nibp)
410444|NCT01196793|Feverish illness in children|feverish illness in children
410445|NCT01196767|Sternotomy|sternotomy
410446|NCT01196767|Pain|pain
410447|NCT01196767|Respiratory function|respiratory function
410448|NCT01196767|Opiates|opiates
410449|NCT01196767|Patient-controlled|patient-controlled
410450|NCT01196767|Scheduled cardiac surgery under general anaesthesia without any locoregional anaesthesia protocol other than this presently studied|scheduled cardiac surgery under general anaesthesia without any locoregional anaesthesia protocol other than this presently studied
410451|NCT01196754|Pharmacokinetics|pharmacokinetics
410452|NCT01196754|Sevoflurane|sevoflurane
410453|NCT01196754|Fluorides|fluorides
410454|NCT01196754|Sedation|sedation
410455|NCT01196754|Adult patients with a predicted sedation more than 48 h|adult patients with a predicted sedation more than 48 h
410456|NCT01196754|Stable respiratory and hemodynamic conditions for SBT|stable respiratory and hemodynamic conditions for sbt
410457|NCT01196754|Consent of patients|consent of patients
410458|NCT01196754|Arterial line|arterial line
410459|NCT01196715|Quality of Life|quality of life
410460|NCT01196715|Erythroid response|erythroid response
410461|NCT01196715|disease progression|disease progression
410462|NCT01196715|survival|survival
410463|NCT01196715|Overall erythroid response at 24 weeks|overall erythroid response at 24 weeks
410464|NCT01196715|Quality of life at 24 weeks|quality of life at 24 weeks
410465|NCT01196715|Quality of life at 12, 36 and 52 weeks|quality of life at 12, 36 and 52 weeks
410466|NCT01196715|Overall erythroid response at 12 and 52 weeks|overall erythroid response at 12 and 52 weeks
410467|NCT01196715|Incidence of disease progression|incidence of disease progression
410468|NCT01196715|Overall Survival|overall survival
752628|NCT01173393|OHCA|ohca
410469|NCT01196702|common variable immunodeficiency|common variable immunodeficiency
410470|NCT01196702|granulomatous disease|granulomatous disease
410471|NCT01196702|crohns disease|crohns disease
410472|NCT01196702|bronchiectasis|bronchiectasis
410473|NCT01196702|immunoglobulin replacement or treatment|immunoglobulin replacement or treatment
410474|NCT01196702|B-cell immunophenotyping|b-cell immunophenotyping
410475|NCT01196689|Pharmacokinetics AZD1981|pharmacokinetics azd1981
410477|NCT01196676|AZD4451|azd4451
410478|NCT01196676|Bipolar|bipolar
410479|NCT01196676|depression|depression
410480|NCT01196663|TMS|tms
410481|NCT01196637|thoracic outlet syndrome|thoracic outlet syndrome
410482|NCT01196637|brachial plexopathy|brachial plexopathy
410483|NCT01196637|ultrasonography|ultrasonography
410484|NCT01196624|PTSD|ptsd
410485|NCT01196624|FLASHBACKS|flashbacks
410486|NCT01196624|TMS|tms
410487|NCT01196624|EXPOSURE|exposure
410488|NCT01196611|Voice disorders|voice disorders
410489|NCT01196611|Voice|voice
410490|NCT01196598|pelvic floor|pelvic floor
410491|NCT01196598|pelvic organ prolapse|pelvic organ prolapse
410492|NCT01196585|Pleura|pleura
410493|NCT01196585|biopsy|biopsy
410494|NCT01196585|diagnosis|diagnosis
410495|NCT01196585|CT|ct
410496|NCT01196585|ultrasonography|ultrasonography
410497|NCT01196572|stricture|stricture
410498|NCT01196572|urethra|urethra
410499|NCT01196572|laser|laser
410500|NCT01196572|urethrotomy|urethrotomy
410501|NCT01196572|holmium|holmium
410502|NCT01196572|bladder outlet obstruction|bladder outlet obstruction
410503|NCT01196559|ovarian cancer|ovarian cancer
410504|NCT01196546|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
410505|NCT01196546|vildagliptin|vildagliptin
410506|NCT01196546|metformin|metformin
410507|NCT01196533|Non Invasive, Invasive, optical, light source, color image sensor,|non invasive, invasive, optical, light source, color image sensor,
410508|NCT01196533|, Hemodynamic, Arterial Systolic, Arterial Diastolic, MAP, PA Systolic,|, hemodynamic, arterial systolic, arterial diastolic, map, pa systolic,
410509|NCT01196533|PA Diastolic, Heart rate, Stroke volume, CBC, WBC, RBC, Hgb, HCT ,Iron.|pa diastolic, heart rate, stroke volume, cbc, wbc, rbc, hgb, hct ,iron.
410510|NCT01196533|PLT, PH, PCO2, PO2, HCO3, SaO2 , Na, K, Cl, CO2, Bun, Cr, Gluc, HGB (A1C),|plt, ph, pco2, po2, hco3, sao2 , na, k, cl, co2, bun, cr, gluc, hgb (a1c),
410511|NCT01196533|TBiLi, LDL, HDL.|tbili, ldl, hdl.
410512|NCT01196520|Burkitt Lymphoma|burkitt lymphoma
410513|NCT01196520|Epstein-Barr Virus|epstein-barr virus
410514|NCT01196520|Malaria|malaria
410515|NCT01196494|Obstructive left-sided colonic cancer|obstructive left-sided colonic cancer
410516|NCT01196494|Colorectal stent|colorectal stent
410517|NCT01196494|Intraoperative colon lavage|intraoperative colon lavage
410518|NCT01196494|Lavage|lavage
410519|NCT01196494|Stent|stent
410520|NCT01196468|HIV|hiv
410521|NCT01196468|Testing|testing
410522|NCT01196468|Targeted|targeted
410523|NCT01196468|Indicator|indicator
410524|NCT01196468|Diseases|diseases
410525|NCT01196468|Anal dysplasia|anal dysplasia
410526|NCT01196468|Cervical dysplasia|cervical dysplasia
410527|NCT01196468|STI|sti
410528|NCT01196468|Lymphoma|lymphoma
410529|NCT01196468|Seborrhoeic dermatitis|seborrhoeic dermatitis
410530|NCT01196468|Exanthema|exanthema
410531|NCT01196468|Thrombocytpaenia|thrombocytpaenia
410532|NCT01196468|Lymphopaenia|lymphopaenia
410533|NCT01196468|Hypergammaglobulinaemia|hypergammaglobulinaemia
410534|NCT01196455|Metastatic breast cancer patients|metastatic breast cancer patients
410535|NCT01196403|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
410536|NCT01196403|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
410537|NCT01196403|adenocarcinoma of the bladder|adenocarcinoma of the bladder
410538|NCT01196403|stage I bladder cancer|stage i bladder cancer
410539|NCT01196403|stage II bladder cancer|stage ii bladder cancer
410540|NCT01196403|stage III bladder cancer|stage iii bladder cancer
410541|NCT01196377|Asthma|asthma
410542|NCT01196377|Acute asthma|acute asthma
410543|NCT01196377|Pediatrics|pediatrics
410544|NCT01196364|Girls|girls
410545|NCT01196351|boys|boys
410546|NCT01196351|obesity|obesity
410547|NCT01196351|physical activity|physical activity
410548|NCT01196351|exercise|exercise
410549|NCT01196338|Ankle fracture|ankle fracture
410550|NCT01196338|Return to work|return to work
410551|NCT01196338|Return to function|return to function
410552|NCT01196338|Rehabilitation|rehabilitation
410553|NCT01196338|Weight-bearing|weight-bearing
410554|NCT01196325|Diabetes|diabetes
410555|NCT01196325|Diabetic Macular Edema|diabetic macular edema
410556|NCT01196325|Laser|laser
410557|NCT01196325|Anti-VEGF|anti-vegf
410558|NCT01196325|Morphology|morphology
410559|NCT01196325|Blood Flow|blood flow
410560|NCT01196325|Vision|vision
410561|NCT01196312|anxiety sensitivity|anxiety sensitivity
410562|NCT01196312|heroin|heroin
410563|NCT01196299|diffusion tensor imaging|diffusion tensor imaging
410564|NCT01196299|magnetic resonance spectroscopy|magnetic resonance spectroscopy
410565|NCT01196299|traumatic brain injury|traumatic brain injury
410566|NCT01196299|Metabolite changes|metabolite changes
410567|NCT01196299|Cerebral perfusion|cerebral perfusion
752629|NCT01173393|EMS|ems
410568|NCT01196299|Hemorrhagic burden|hemorrhagic burden
410569|NCT01196286|First-episode psychosis|first-episode psychosis
410570|NCT01196286|cognitive remediation|cognitive remediation
410571|NCT01196286|family psychoeducation|family psychoeducation
410572|NCT01196273|Cardiac Diseases,|cardiac diseases,
410573|NCT01196273|HIV-Infection,|hiv-infection,
410575|NCT01196273|Antiretroviral Therapy,|antiretroviral therapy,
410576|NCT01196273|Cardiovascular Medication,|cardiovascular medication,
410577|NCT01196273|Risk Factors,|risk factors,
410578|NCT01196273|coronary heart disease,|coronary heart disease,
410579|NCT01196273|heart failure,|heart failure,
410580|NCT01196273|metabolic syndrome|metabolic syndrome
410581|NCT01196260|efficiency|efficiency
410582|NCT01196260|capecitabine|capecitabine
410583|NCT01196260|oxaliplatin|oxaliplatin
410584|NCT01196260|colorectal cancer|colorectal cancer
410585|NCT01196247|pancreatic cancer|pancreatic cancer
410586|NCT01196247|molecular profiling|molecular profiling
410587|NCT01196247|SU2C|su2c
410588|NCT01196247|Second line therapy|second line therapy
410589|NCT01196247|Stage 4|stage 4
410590|NCT01196208|Disease, Hodgkin|disease, hodgkin
410591|NCT01196208|Lymphoma|lymphoma
410592|NCT01196208|Monomethylauristatin E|monomethylauristatin e
410593|NCT01196208|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
410594|NCT01196208|Lymphoma, T-Cell, Cutaneous|lymphoma, t-cell, cutaneous
410595|NCT01196208|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
410596|NCT01196208|Antibodies, Monoclonal|antibodies, monoclonal
410597|NCT01196208|Antibody-Drug Conjugate|antibody-drug conjugate
410598|NCT01196208|Antigens, CD30|antigens, cd30
410599|NCT01196208|Hematologic Diseases|hematologic diseases
410600|NCT01196208|Immunotherapy|immunotherapy
410601|NCT01196195|antiretroviral therapy|antiretroviral therapy
410602|NCT01196195|child|child
410603|NCT01196195|HIV-1|hiv-1
410604|NCT01196169|daptomycin|daptomycin
410605|NCT01196169|vancomycin|vancomycin
410606|NCT01196169|perioperative|perioperative
410607|NCT01196169|prophylaxis|prophylaxis
410608|NCT01196169|arthroplasty|arthroplasty
410609|NCT01196169|prosthesis|prosthesis
410610|NCT01196169|preoperative|preoperative
410611|NCT01196156|Infant, Small for Gestational Age|infant, small for gestational age
410612|NCT01196156|Dwarfism Pituitary|dwarfism pituitary
410613|NCT01196156|Saizen|saizen
410614|NCT01196156|Somatropin; Growth Hormone|somatropin; growth hormone
410615|NCT01196156|Insulin resistance|insulin resistance
410616|NCT01196143|Ovulation induction|ovulation induction
410617|NCT01196143|Intrauterine insemination|intrauterine insemination
410618|NCT01196143|Gonal-f|gonal-f
410619|NCT01196143|Controlled ovarian stimulation|controlled ovarian stimulation
410620|NCT01196143|Female infertility|female infertility
410621|NCT01196130|Metastatic colorectal cancer|metastatic colorectal cancer
410623|NCT01196130|Colorectal adenocarcinoma|colorectal adenocarcinoma
410624|NCT01196130|Biomarker determination|biomarker determination
410625|NCT01196130|Tumor tissue|tumor tissue
410626|NCT01196130|Treatment protocols|treatment protocols
410627|NCT01196117|automatic positive airway pressure (APAP)|automatic positive airway pressure (apap)
410628|NCT01196117|continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
410629|NCT01196117|Salivary Cortisol|salivary cortisol
410630|NCT01196117|Apnea|apnea
410631|NCT01196117|Sleep Apnea and/or any Sleep Disordered Breathing|sleep apnea and/or any sleep disordered breathing
410632|NCT01196091|Lupus|lupus
410633|NCT01196091|SLE|sle
410634|NCT01196091|Systemic Lupus Erythematosis|systemic lupus erythematosis
410635|NCT01196091|autoimmune disease|autoimmune disease
410636|NCT01196091|LY2127399|ly2127399
410637|NCT01196091|Immune system disease|immune system disease
410638|NCT01196026|Influenza|influenza
410639|NCT01196026|H1N1|h1n1
410640|NCT01196026|Fluarix|fluarix
410641|NCT01196026|Pandemrix|pandemrix
410642|NCT01195987|Hepatitis C|hepatitis c
410643|NCT01195987|Arthritis|arthritis
410644|NCT01195974|oral contraceptive, drug interaction, pharmacokinetics|oral contraceptive, drug interaction, pharmacokinetics
410645|NCT01195961|Direct Current Stimulation|direct current stimulation
410646|NCT01195961|Learning|learning
410647|NCT01195961|Cognitive Enhancement|cognitive enhancement
410648|NCT01195961|Cognitive Tasks|cognitive tasks
410649|NCT01195961|Cognitive Training|cognitive training
410650|NCT01195961|Developmental Dyscalculia|developmental dyscalculia
410651|NCT01195961|Learning Disability|learning disability
410652|NCT01195961|Cognition Disorder|cognition disorder
410653|NCT01195948|Uveitis|uveitis
410654|NCT01195948|Oral Tolerance|oral tolerance
410655|NCT01195922|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
410656|NCT01195922|Oral Cancer|oral cancer
410657|NCT01195922|mTOR Inhibitors|mtor inhibitors
410658|NCT01195922|Targeted Therapies|targeted therapies
410659|NCT01195922|Signal Transduction Inhibitors|signal transduction inhibitors
410660|NCT01195922|Head and Neck Cancer|head and neck cancer
410661|NCT01195922|Squamous Cell Carcinoma|squamous cell carcinoma
410662|NCT01195922|Tongue Cancer|tongue cancer
410663|NCT01195883|IV fluid|iv fluid
410664|NCT01195883|recovery|recovery
410665|NCT01195883|goal directed fluid replacement|goal directed fluid replacement
410666|NCT01195883|improved patient recovery|improved patient recovery
410667|NCT01195870|Multiple sclerosis|multiple sclerosis
410668|NCT01195870|Rebif|rebif
410669|NCT01195870|Interferon beta-1a|interferon beta-1a
410670|NCT01195857|Multiple sclerosis|multiple sclerosis
410672|NCT01195857|Interferon beta-1a|interferon beta-1a
410871|NCT01194999|PVS|pvs
410673|NCT01195844|Pediatric gastroenteritis, rotavirus infection|pediatric gastroenteritis, rotavirus infection
410674|NCT01195818|Albuminuria, hyperfiltration, RAS inhibitors, ADMA|albuminuria, hyperfiltration, ras inhibitors, adma
410675|NCT01195805|Blood pressure, PWV, HRV, PWV, potassium|blood pressure, pwv, hrv, pwv, potassium
410676|NCT01195792|Opioid receptors|opioid receptors
410677|NCT01195792|Body weight|body weight
410678|NCT01195792|Over-eating behaviour|over-eating behaviour
410679|NCT01195792|Obesity|obesity
410680|NCT01195792|Fat mass|fat mass
410681|NCT01195779|immunogenicity|immunogenicity
410682|NCT01195779|safety|safety
410683|NCT01195779|Influenza|influenza
410684|NCT01195779|children|children
410685|NCT01195779|vaccine|vaccine
410686|NCT01195766|Hodgkin|hodgkin
410687|NCT01195766|Ofatumumab|ofatumumab
410688|NCT01195766|Lymphoma|lymphoma
410689|NCT01195753|Urea cycle Disorders|urea cycle disorders
410690|NCT01195740|Suicide Ideation|suicide ideation
410691|NCT01195740|Depression|depression
410692|NCT01195740|Family Conflict|family conflict
410693|NCT01195701|female sexual dysfunction|female sexual dysfunction
410694|NCT01195701|anorgasmia|anorgasmia
410695|NCT01195701|clitoral complex|clitoral complex
410696|NCT01195701|pelvic MRI|pelvic mri
410697|NCT01195701|testosterone|testosterone
410698|NCT01195662|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
410699|NCT01195662|Diabetes Mellitus|diabetes mellitus
410700|NCT01195662|Endocrine System Diseases|endocrine system diseases
410701|NCT01195662|Glucose Metabolism Disorders|glucose metabolism disorders
410702|NCT01195662|Metabolic Diseases|metabolic diseases
410703|NCT01195662|Angiotensin Receptor Inhibitors|angiotensin receptor inhibitors
410704|NCT01195662|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
410705|NCT01195662|Antihypertensive Agents|antihypertensive agents
410706|NCT01195662|Cardiovascular Agents|cardiovascular agents
410707|NCT01195662|Pharmacological Actions|pharmacological actions
410708|NCT01195636|Pain from Shingles, PHN, Postherpetic Neuralgia|pain from shingles, phn, postherpetic neuralgia
410709|NCT01195623|varicose veins|varicose veins
410710|NCT01195623|venous insufficiency|venous insufficiency
410711|NCT01195623|surgery|surgery
410712|NCT01195623|duplex|duplex
410713|NCT01195623|recurrence|recurrence
410714|NCT01195597|electronic cigarette|electronic cigarette
410715|NCT01195597|ENDD|endd
410716|NCT01195597|nicotine|nicotine
410717|NCT01195597|smoking cessation|smoking cessation
410718|NCT01195597|smoking reduction|smoking reduction
410719|NCT01195584|complication rate in 3 cohorts (BMI < 25, > 25 and > 30)|complication rate in 3 cohorts (bmi < 25, > 25 and > 30)
410720|NCT01195558|Non-24|non-24
410721|NCT01195558|N24HSWD|n24hswd
410722|NCT01195558|Blindness|blindness
410723|NCT01195558|Sleep|sleep
410724|NCT01195558|Wake|wake
410725|NCT01195558|Circadian Rhythm|circadian rhythm
410726|NCT01195558|Nap|nap
410727|NCT01195545|Veritas® Collagen Matrix, Hiatal hernia|veritas® collagen matrix, hiatal hernia
410728|NCT01195532|hypoglycemic drug|hypoglycemic drug
410729|NCT01195519|peritoneal dialysis|peritoneal dialysis
410730|NCT01195519|hemodialysis patients|hemodialysis patients
410731|NCT01195506|We Will Collect the Bone Marrow Specimens From AML Patients|we will collect the bone marrow specimens from aml patients
410732|NCT01195493|Chronic periodontitis|chronic periodontitis
410733|NCT01195480|Immunotherapy|immunotherapy
410734|NCT01195480|Gene Therapy|gene therapy
410735|NCT01195480|Paediatric|paediatric
410736|NCT01195480|B cell Acute Lymphoblastic Leukaemia|b cell acute lymphoblastic leukaemia
410737|NCT01195441|Preeclampsia|preeclampsia
410738|NCT01195441|Doppler ultrasound|doppler ultrasound
410739|NCT01195441|First trimester|first trimester
410740|NCT01195441|Acetylsalicylic acid|acetylsalicylic acid
410741|NCT01195402|COPD|copd
410742|NCT01195402|pulmonary rehabilitation|pulmonary rehabilitation
410743|NCT01195389|dementia|dementia
410744|NCT01195389|memory loss|memory loss
410745|NCT01195389|cognitive decline|cognitive decline
410746|NCT01195376|PI3K|pi3k
410747|NCT01195376|mTOR|mtor
410748|NCT01195376|Advanced solid tumor|advanced solid tumor
410749|NCT01195363|bipolar disorder, mania, depression|bipolar disorder, mania, depression
410750|NCT01195350|Ischemic Stroke|ischemic stroke
410751|NCT01195350|Hemorrhagic Stroke|hemorrhagic stroke
410752|NCT01195350|Blood pressure|blood pressure
410753|NCT01195350|Intensive care|intensive care
410754|NCT01195337|Sedentary minority adult|sedentary minority adult
410755|NCT01195337|Psychosocial factors|psychosocial factors
410756|NCT01195337|Environmental factors|environmental factors
410757|NCT01195337|Obesity|obesity
410758|NCT01195337|Physical Activity|physical activity
410759|NCT01195337|PA|pa
410760|NCT01195337|Cancer Risk|cancer risk
410761|NCT01195337|African Americans|african americans
410762|NCT01195337|Latino|latino
410763|NCT01195324|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
410764|NCT01195324|Warfarin|warfarin
410765|NCT01195324|Pharmacokinetic|pharmacokinetic
410241|NCT01197677|CMR|cmr
410766|NCT01195324|Pharmacodynamic|pharmacodynamic
410767|NCT01195324|Prothrombin time (PT)|prothrombin time (pt)
410768|NCT01195324|International normalized ratio (INR)|international normalized ratio (inr)
410769|NCT01195311|Refractory, Advanced malignancies|refractory, advanced malignancies
410770|NCT01195298|metastatic breast cancer|metastatic breast cancer
410771|NCT01195298|elderly patients|elderly patients
410772|NCT01195298|chemoimmunotherapy|chemoimmunotherapy
410773|NCT01195298|Triple negative metastatic breast cancer|triple negative metastatic breast cancer
410774|NCT01195285|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
410775|NCT01195285|Quality of life|quality of life
410776|NCT01195285|Biliary Cholic|biliary cholic
410777|NCT01195285|Chronic Cholecystitis|chronic cholecystitis
410778|NCT01195285|Symptomatic Cholelithiasis|symptomatic cholelithiasis
410779|NCT01195259|rosiglitazone|rosiglitazone
410780|NCT01195259|ADOPT|adopt
410781|NCT01195259|metformin|metformin
410782|NCT01195259|malignancy|malignancy
410783|NCT01195259|RECORD|record
410784|NCT01195246|end stage renal failure|end stage renal failure
410785|NCT01195246|renal failure|renal failure
410786|NCT01195246|kidney failure|kidney failure
410787|NCT01195246|kidney failure, chronic|kidney failure, chronic
410788|NCT01195246|chronic kidney failure|chronic kidney failure
410789|NCT01195246|hepatitis B virus (HBV) vaccine|hepatitis b virus (hbv) vaccine
410790|NCT01195246|hepatitis B vaccine|hepatitis b vaccine
410791|NCT01195246|hepatitis B|hepatitis b
410792|NCT01195246|hepatitis|hepatitis
410794|NCT01195246|prevention and control|prevention and control
410795|NCT01195246|dialysis|dialysis
410796|NCT01195233|Xerostomia|xerostomia
410797|NCT01195233|Radiotherapy of head and neck|radiotherapy of head and neck
410798|NCT01195233|BioXtra|bioxtra
410799|NCT01195220|STI screening|sti screening
410800|NCT01195220|Emergency Department|emergency department
410801|NCT01195220|Chlamydia|chlamydia
410802|NCT01195220|Gonorrhea|gonorrhea
410804|NCT01195220|behavior|behavior
410805|NCT01195220|teenagers|teenagers
410806|NCT01195220|intervention|intervention
410807|NCT01195207|CNTO 3157|cnto 3157
410808|NCT01195207|healthy volunteers|healthy volunteers
410809|NCT01195207|asthma|asthma
410810|NCT01195194|T-cell lymphocyte allo-recognition|t-cell lymphocyte allo-recognition
410811|NCT01195194|CNI-free immunosuppressive regimen|cni-free immunosuppressive regimen
410812|NCT01195194|Enzyme-linked immunospot (ELISPOT)|enzyme-linked immunospot (elispot)
410813|NCT01195181|peginterferon alfa 2a and 2b type|peginterferon alfa 2a and 2b type
410814|NCT01195181|ribavirin|ribavirin
410815|NCT01195181|chronic hepatitis C|chronic hepatitis c
410816|NCT01195181|antiviral therapy cost/efficacy|antiviral therapy cost/efficacy
410817|NCT01195181|viral kinetics|viral kinetics
410818|NCT01195168|PCOS|pcos
410819|NCT01195155|PCOS|pcos
410820|NCT01195142|PCOS|pcos
410821|NCT01195129|Stent|stent
410822|NCT01195129|cerebral aneursym|cerebral aneursym
410823|NCT01195129|neurology|neurology
410824|NCT01195129|radiology|radiology
410825|NCT01195116|Post-operative pain management|post-operative pain management
410826|NCT01195116|Pain Management|pain management
410827|NCT01195116|Painful bladder syndrome|painful bladder syndrome
410828|NCT01195116|frequency and urgency|frequency and urgency
410829|NCT01195116|Dexmedetomidine|dexmedetomidine
410830|NCT01195116|hydrodistension|hydrodistension
410831|NCT01195103|Procedural sedation|procedural sedation
410832|NCT01195103|Regional Anesthesia block|regional anesthesia block
410833|NCT01195103|Orthopedic surgery|orthopedic surgery
410834|NCT01195103|Lusedra|lusedra
410835|NCT01195103|Fospropofol disodium|fospropofol disodium
410836|NCT01195103|Midazolam|midazolam
410837|NCT01195090|sitagliptin|sitagliptin
410838|NCT01195090|pioglitazone|pioglitazone
410839|NCT01195090|type 2 diabetes|type 2 diabetes
410840|NCT01195077|HIV|hiv
410841|NCT01195077|Dietary intervention|dietary intervention
410842|NCT01195077|Algae|algae
410843|NCT01195077|HIV progression|hiv progression
410844|NCT01195077|Algae specific kind|algae specific kind
410845|NCT01195064|COPD patients|copd patients
410846|NCT01195064|OSAS patients|osas patients
410847|NCT01195064|cardiovascular surgery|cardiovascular surgery
410848|NCT01195064|Endothelial function|endothelial function
410849|NCT01195051|Medication Reconciliation|medication reconciliation
410850|NCT01195051|Inpatient|inpatient
410851|NCT01195051|Electronic Medical Records|electronic medical records
410852|NCT01195038|Avian influenza, H5N1, pandemic, recombinant HA vaccine|avian influenza, h5n1, pandemic, recombinant ha vaccine
410853|NCT01195025|Blood volume|blood volume
410854|NCT01195025|blood coagulation|blood coagulation
410855|NCT01195025|volume kinetics|volume kinetics
410856|NCT01195012|child|child
410857|NCT01195012|primary care|primary care
410858|NCT01195012|treatment|treatment
410859|NCT01195012|parenting|parenting
410007|NCT01198743|DNA|dna
410860|NCT01195012|lifestyle behaviors|lifestyle behaviors
410861|NCT01194999|OAB|oab
410862|NCT01194999|Urinary Bladder, Overactive|urinary bladder, overactive
410863|NCT01194999|Overactive Bladder Syndrome|overactive bladder syndrome
410864|NCT01194999|VESIcare|vesicare
410865|NCT01194999|Urgency|urgency
410866|NCT01194999|Nocturia|nocturia
410867|NCT01194999|Frequency|frequency
410868|NCT01194999|Urge Urinary Incontinence|urge urinary incontinence
410870|NCT01194999|Pubovaginal Sling|pubovaginal sling
410872|NCT01194999|Incontinence|incontinence
410873|NCT01194986|Receptor binding|receptor binding
410874|NCT01194986|Histamine H3 receptor|histamine h3 receptor
410875|NCT01194986|binding|binding
410876|NCT01194986|radioligand|radioligand
410877|NCT01194973|Atypical Hemolytic-Uremic Syndrome|atypical hemolytic-uremic syndrome
410878|NCT01194960|cancer of prostate|cancer of prostate
410879|NCT01194960|cancer of the prostate|cancer of the prostate
410880|NCT01194960|neoplasms prostate|neoplasms prostate
410881|NCT01194960|neoplasms prostatic|neoplasms prostatic
410882|NCT01194960|prostate cancer|prostate cancer
410883|NCT01194960|prostate neoplasms|prostate neoplasms
410884|NCT01194960|prostatic cancer|prostatic cancer
410885|NCT01194960|prostate specific antigen|prostate specific antigen
410886|NCT01194960|prostatic hyperplasia|prostatic hyperplasia
410887|NCT01194947|banal-appearing nevi|banal-appearing nevi
410888|NCT01194947|NEVUS|nevus
410889|NCT01194934|Stem Cell Transplantation|stem cell transplantation
410890|NCT01194934|SDF-1|sdf-1
410891|NCT01194934|L-oligonucleotide Aptamer|l-oligonucleotide aptamer
410892|NCT01194934|Spiegelmer|spiegelmer
410893|NCT01194934|Hematopoietic Stem Cells|hematopoietic stem cells
410894|NCT01194908|Breast Cancer|breast cancer
410895|NCT01194908|Breast Tumors|breast tumors
410896|NCT01194908|Breast Neoplasms|breast neoplasms
410897|NCT01194895|esophagectomy|esophagectomy
410898|NCT01194895|acute lung injury|acute lung injury
410899|NCT01194895|protective ventilation|protective ventilation
410900|NCT01194869|Breast Cancer|breast cancer
410901|NCT01194856|HIV|hiv
410902|NCT01194856|Lipoatrophy|lipoatrophy
410903|NCT01194856|mitochondrial dysfunction|mitochondrial dysfunction
410904|NCT01194817|total knee arthroplasty|total knee arthroplasty
410905|NCT01194817|total knee replacement|total knee replacement
410906|NCT01194817|cementless TKA|cementless tka
410907|NCT01194817|high flexion|high flexion
410908|NCT01194817|trabecular metal|trabecular metal
410909|NCT01194804|Hemolytic Paroxysmal Nocturnal Hemoglobinuria|hemolytic paroxysmal nocturnal hemoglobinuria
410910|NCT01194804|Eculizumab|eculizumab
410911|NCT01194804|PNH|pnh
410912|NCT01194791|Amyloidosis|amyloidosis
410913|NCT01194791|Lenalidomide|lenalidomide
410914|NCT01194141|Barth syndrome|barth syndrome
410915|NCT01194141|cardiomyopathy|cardiomyopathy
410916|NCT01194141|mitochondria|mitochondria
410917|NCT01194141|cardiolipin|cardiolipin
410918|NCT01194128|caregivers,|caregivers,
410919|NCT01194128|institutionalization,|institutionalization,
410920|NCT01194128|dementia patients,|dementia patients,
410921|NCT01194128|bereavement,|bereavement,
410923|NCT01194128|complicated grief|complicated grief
410924|NCT01194115|surgical site infection|surgical site infection
410925|NCT01194115|obesity|obesity
410926|NCT01194115|pregnancy|pregnancy
410927|NCT01194115|cesarean section|cesarean section
410928|NCT01194115|cesarean delivery|cesarean delivery
410929|NCT01194102|Stroke|stroke
410930|NCT01194102|Exercise|exercise
410931|NCT01194102|Physical function|physical function
410932|NCT01194102|Community program|community program
410933|NCT01194102|Patient education|patient education
410934|NCT01194102|Self-management|self-management
410935|NCT01194089|Nicotine|nicotine
410936|NCT01194089|Postoperative pain|postoperative pain
410937|NCT01194089|Bariatric surgery|bariatric surgery
410938|NCT01194076|cognitive behavior therapy|cognitive behavior therapy
410939|NCT01194076|exposure and response prevention|exposure and response prevention
410940|NCT01194076|pediatric|pediatric
410941|NCT01194076|obsessive compulsive disorder|obsessive compulsive disorder
410942|NCT01194076|child|child
410943|NCT01194076|anxiety|anxiety
410944|NCT01194076|intensive|intensive
410945|NCT01194076|OCD|ocd
410946|NCT01194076|CBT|cbt
410947|NCT01194063|short bowel syndrome|short bowel syndrome
410948|NCT01194063|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
410949|NCT01194063|pediatric|pediatric
410950|NCT01194037|Hepatitis C|hepatitis c
410951|NCT01194037|HCV|hcv
410952|NCT01194037|Interferon|interferon
410953|NCT01194037|Hanferon|hanferon
410954|NCT01194024|Inhalation Injury, Smoke|inhalation injury, smoke
410955|NCT01194024|Inhalation Injury, Acute|inhalation injury, acute
410956|NCT01194011|Health care quality, information openness, health care information website|health care quality, information openness, health care information website
410957|NCT01194713|Alzheimer Disease|alzheimer disease
410958|NCT01194713|Cerebrospinal fluid|cerebrospinal fluid
410959|NCT01194713|Sleep|sleep
410960|NCT01194713|Abeta|abeta
410961|NCT01194700|lung bioavailability|lung bioavailability
410962|NCT01194700|asthma|asthma
410963|NCT01194700|seretide|seretide
410964|NCT01194700|Spacer|spacer
410965|NCT01194687|Estrogens|estrogens
410966|NCT01194687|Fecal Microbiome|fecal microbiome
410967|NCT01194687|Fecal Occult Blood|fecal occult blood
410968|NCT01194674|Microplasmin|microplasmin
410969|NCT01194674|Macular Edema|macular edema
410971|NCT01194661|Inhibitory Control|inhibitory control
410972|NCT01194661|Executive Function|executive function
410973|NCT01194661|fMRI|fmri
410974|NCT01194661|TMS|tms
410975|NCT01194661|TBI|tbi
410976|NCT01194661|Traumatic Brain Injury|traumatic brain injury
410977|NCT01194661|Healthy Volunteer|healthy volunteer
410978|NCT01194661|HV|hv
410979|NCT01194648|urinary incontinence|urinary incontinence
410980|NCT01194648|male erectile disorder|male erectile disorder
410981|NCT01194648|therapy-related toxicity|therapy-related toxicity
410982|NCT01194648|stage I prostate cancer|stage i prostate cancer
410983|NCT01194648|stage IIB prostate cancer|stage iib prostate cancer
410984|NCT01194648|stage IIA prostate cancer|stage iia prostate cancer
584761|NCT00509730|stress urinary incontinence|stress urinary incontinence
513463|NCT00255411|PMD|pmd
410985|NCT01194635|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
410986|NCT01194635|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
410987|NCT01194635|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
410988|NCT01194635|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
410989|NCT01194635|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
410990|NCT01194635|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
410991|NCT01194635|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
410992|NCT01194609|Low dose radiation|low dose radiation
410993|NCT01194609|Adoptive immune cell therapy|adoptive immune cell therapy
410994|NCT01194609|Cervical cancer|cervical cancer
410995|NCT01194609|Pilot study|pilot study
410996|NCT01194596|smoking cessation advice|smoking cessation advice
410997|NCT01194596|spirometry|spirometry
410998|NCT01194596|primary health care|primary health care
411096|NCT01193933|adult ALL|adult all
410999|NCT01194583|electronic cigarette|electronic cigarette
411000|NCT01194583|nicotine|nicotine
411001|NCT01194583|smoking cessation|smoking cessation
411002|NCT01194583|smoking reduction|smoking reduction
411003|NCT01194557|history of fever|history of fever
411004|NCT01194557|measured fever|measured fever
411005|NCT01194557|appropriate treatment|appropriate treatment
411006|NCT01194557|appropriate referral|appropriate referral
411007|NCT01194531|Preimplantation Gentic Screening|preimplantation gentic screening
411008|NCT01194531|PGS|pgs
411009|NCT01194531|In Vitro Fertilization|in vitro fertilization
411010|NCT01194531|IVF|ivf
411011|NCT01194531|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
411012|NCT01194531|PGD|pgd
411013|NCT01194518|Life experience|life experience
411014|NCT01194518|Life style|life style
411015|NCT01194518|Health behavior|health behavior
411016|NCT01194518|Mixed method|mixed method
411017|NCT01194505|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
411018|NCT01194505|obturator nerve block|obturator nerve block
411019|NCT01194505|sciatic nerve block|sciatic nerve block
411020|NCT01194505|femoral nerve block|femoral nerve block
411021|NCT01194505|posterior lumbar plexus block|posterior lumbar plexus block
411022|NCT01194505|ultrasound guided nerve block|ultrasound guided nerve block
411023|NCT01194492|plasma albumin|plasma albumin
411024|NCT01194492|inflammatory reaction|inflammatory reaction
411025|NCT01194492|systemic inflammatory response syndrome|systemic inflammatory response syndrome
411026|NCT01194479|type 1 diabetes|type 1 diabetes
411027|NCT01194479|hypoglycemia|hypoglycemia
411028|NCT01194479|formoterol|formoterol
411029|NCT01194466|Head and Neck Cancer|head and neck cancer
411030|NCT01194466|Oral Cancer|oral cancer
411031|NCT01194466|Laryngeal Cancer|laryngeal cancer
411032|NCT01194466|Oropharyngeal Cancer|oropharyngeal cancer
411033|NCT01194466|Transcutaneous Electrical Nerve Stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
411034|NCT01194466|Oral Mucositis|oral mucositis
411035|NCT01194466|Pain|pain
411036|NCT01194466|Function|function
411037|NCT01194466|TENS|tens
411038|NCT01194466|Functional Pain|functional pain
411039|NCT01194466|Non-pharamcologic|non-pharamcologic
411040|NCT01194466|Quality of Life|quality of life
411041|NCT01194427|Preoperative|preoperative
411042|NCT01194427|Neoadjuvant|neoadjuvant
411043|NCT01194388|Patients presenting with an intracranial aneurysm|patients presenting with an intracranial aneurysm
411044|NCT01194362|aortic valve disease|aortic valve disease
411045|NCT01194362|gene expression|gene expression
411046|NCT01194349|S. pneumoniae|s. pneumoniae
411047|NCT01194349|thrombocytosis|thrombocytosis
411048|NCT01194349|pediatric patients|pediatric patients
200954|NCT02112838|Nephritis, IGA Type|nephritis, iga type
411049|NCT01194349|The study aimed to understand the diagnostic value of thrombocytosis in children with S. pneumoniae infection|the study aimed to understand the diagnostic value of thrombocytosis in children with s. pneumoniae infection
411050|NCT01194336|Central nervous system|central nervous system
411051|NCT01194336|Cholinesterase|cholinesterase
411052|NCT01194336|Neurocognitive performance testing|neurocognitive performance testing
411053|NCT01194323|esophageal erosion|esophageal erosion
411054|NCT01194323|abnormal pH monitoring|abnormal ph monitoring
411055|NCT01194310|glaucoma|glaucoma
411056|NCT01194310|cataract|cataract
411057|NCT01194297|influenza|influenza
411058|NCT01194297|premature infant|premature infant
411059|NCT01194297|very low birth weight infant|very low birth weight infant
411060|NCT01194297|immunization|immunization
411061|NCT01194297|vaccine|vaccine
411062|NCT01194271|Hormone Ablation|hormone ablation
411063|NCT01194271|Prostate adenocarcinoma|prostate adenocarcinoma
411064|NCT01194271|Radical prostatectomy|radical prostatectomy
411065|NCT01194271|Leuprolide Acetate|leuprolide acetate
411066|NCT01194271|Lupron Depot|lupron depot
411067|NCT01194271|Ipilimumab|ipilimumab
411068|NCT01194271|BMS-734016|bms-734016
411069|NCT01194271|MDX010|mdx010
411070|NCT01194258|Type 2 diabetes|type 2 diabetes
411071|NCT01194245|Type 1 diabetes|type 1 diabetes
411072|NCT01194232|Cystic Fibrosis|cystic fibrosis
411074|NCT01194232|CMRI|cmri
411075|NCT01194232|vascularization|vascularization
411076|NCT01194232|perfusion|perfusion
411077|NCT01194219|Plaque Psoriasis|plaque psoriasis
411078|NCT01194193|Cancer|cancer
411079|NCT01194193|Advanced solid tumours|advanced solid tumours
411080|NCT01194193|lymphomas|lymphomas
411081|NCT01194193|dose escalation|dose escalation
411082|NCT01194193|preliminary anti-tumour activity|preliminary anti-tumour activity
411083|NCT01194193|Tor kinase inhibitor|tor kinase inhibitor
411084|NCT01194193|oral administration|oral administration
411085|NCT01194193|intermittent dosing|intermittent dosing
411086|NCT01194180|Mycobacterium tuberculosis|mycobacterium tuberculosis
411087|NCT01194180|BCG|bcg
411088|NCT01194180|MVA85A|mva85a
411089|NCT01194167|Platelet refractory thrombocytopenia|platelet refractory thrombocytopenia
411090|NCT01193972|Smoking cessation|smoking cessation
411091|NCT01193972|Smoking|smoking
411092|NCT01193972|Tobacco|tobacco
411093|NCT01193946|Protein requirement|protein requirement
411094|NCT01193946|Elderly women|elderly women
411095|NCT01193946|Indicator amino acid oxidation|indicator amino acid oxidation
411097|NCT01193933|Ph-negative|ph-negative
411098|NCT01193933|dexamethasone|dexamethasone
411099|NCT01193933|L-asparaginase|l-asparaginase
411100|NCT01193920|Group B streptococcus|group b streptococcus
411101|NCT01193920|GBS|gbs
411102|NCT01193920|Vaccine|vaccine
411103|NCT01193920|Prevention of group B streptococcus infection|prevention of group b streptococcus infection
411104|NCT01193907|Typhoid fever|typhoid fever
411105|NCT01193907|Glycoconjugate vaccine|glycoconjugate vaccine
411106|NCT01193907|Vi polysaccharide|vi polysaccharide
411107|NCT01193907|Immunogenicity|immunogenicity
411108|NCT01193894|IBD|ibd
411109|NCT01193894|UC|uc
411110|NCT01193894|Profermin|profermin
411111|NCT01193894|Fresubin|fresubin
411112|NCT01193894|Probiotics|probiotics
411113|NCT01193894|Dietetic|dietetic
411114|NCT01193855|stage IIB prostate cancer|stage iib prostate cancer
411115|NCT01193855|stage IIA prostate cancer|stage iia prostate cancer
411116|NCT01193816|restlessness during mechanical ventilation weaning|restlessness during mechanical ventilation weaning
411117|NCT01193803|Prosthetic Joint Infections|prosthetic joint infections
411118|NCT01193803|Vertebral Osteomyelitis|vertebral osteomyelitis
411119|NCT01193803|Septic arthritis|septic arthritis
411120|NCT01193803|Molecular methods|molecular methods
411121|NCT01193790|chronic tonsillitis|chronic tonsillitis
411122|NCT01193790|radio-frequency coblation|radio-frequency coblation
411123|NCT01193790|radio-frequency coblation in chronic tonsillitis treatment|radio-frequency coblation in chronic tonsillitis treatment
411124|NCT01193777|Carnitine|carnitine
411125|NCT01193777|Shock|shock
411126|NCT01193777|Sepsis|sepsis
411127|NCT01193764|acne|acne
411128|NCT01193764|cocoa|cocoa
411129|NCT01193764|chocolate|chocolate
411130|NCT01193764|gelatin|gelatin
411131|NCT01193764|pustule|pustule
411132|NCT01193764|comedones|comedones
411133|NCT01193764|papules|papules
411134|NCT01193764|pustules|pustules
411135|NCT01193751|Birth Asphyxia|birth asphyxia
411136|NCT01193751|Newborn's Resuscitation|newborn's resuscitation
411137|NCT01193751|Death|death
411138|NCT01193751|Neurodevelopmental Impairment|neurodevelopmental impairment
411139|NCT01193738|osteopathy|osteopathy
411140|NCT01193725|Combat Disorders|combat disorders
411141|NCT01193725|Exposure Therapy|exposure therapy
411142|NCT01193725|Army Personnel|army personnel
411143|NCT01193712|Electrophysiologic Techniques, Cardiac|electrophysiologic techniques, cardiac
411144|NCT01193660|umbilical cord blood|umbilical cord blood
411145|NCT01193660|stem cell|stem cell
411146|NCT01193660|cerebral palsy|cerebral palsy
411147|NCT01193634|ICD VR 9250, DR 9550 and CRT 9750 - PARADYM RF ICD|icd vr 9250, dr 9550 and crt 9750 - paradym rf icd
411148|NCT01193621|early evaluation|early evaluation
411149|NCT01193621|pharmacokinetics|pharmacokinetics
411150|NCT01193621|pharmacodynamics|pharmacodynamics
411151|NCT01193621|Biodistribution|biodistribution
411152|NCT01193621|D2-receptor occupancy|d2-receptor occupancy
411153|NCT01193608|Randomized|randomized
411154|NCT01193608|Safety Study|safety study
411155|NCT01193608|Adaptive|adaptive
411156|NCT01193608|Double Blind|double blind
411157|NCT01193582|Prevenar|prevenar
411158|NCT01193582|catch-up|catch-up
411159|NCT01193582|pneumococcal|pneumococcal
411160|NCT01193582|pneumonia|pneumonia
411161|NCT01193556|Tonsillectomy|tonsillectomy
411162|NCT01193556|PlasmaBlade|plasmablade
411163|NCT01193556|Electrosurgery|electrosurgery
411164|NCT01193556|PEAK Surgical|peak surgical
411165|NCT01193556|Medtronic Advanced Energy|medtronic advanced energy
411166|NCT01193556|Medtronic|medtronic
411167|NCT01193530|Sleep Disturbances|sleep disturbances
411168|NCT01193530|Depression|depression
411170|NCT01193530|Fatigue|fatigue
411171|NCT01193530|Quality of life|quality of life
411172|NCT01193517|Refractory metastatic colorectal cancer|refractory metastatic colorectal cancer
411173|NCT01193517|CRC|crc
411174|NCT01193517|colorectal adenocarcinoma with metastatic disease|colorectal adenocarcinoma with metastatic disease
411175|NCT01193517|Azacitidine|azacitidine
411176|NCT01193517|5-Azacytidine|5-azacytidine
411177|NCT01193517|5-aza|5-aza
411178|NCT01193517|Vidaza|vidaza
411179|NCT01193517|5-AZC|5-azc
411180|NCT01193517|AZA-CR|aza-cr
411181|NCT01193517|Ladakamycin|ladakamycin
411182|NCT01193517|NSC-102816|nsc-102816
411183|NCT01193517|Capecitabine|capecitabine
411184|NCT01193517|Oxaliplatin|oxaliplatin
411185|NCT01193517|CAPOX|capox
411186|NCT01193517|Xeloda|xeloda
411187|NCT01193517|Eloxatin|eloxatin
411188|NCT01193517|Hypermethylation|hypermethylation
411189|NCT01193517|CpG island methylator phenotype|cpg island methylator phenotype
411190|NCT01193504|Prevention of Retinal Thickening and CME Following Phacoemulsification|prevention of retinal thickening and cme following phacoemulsification
411191|NCT01193504|Pseudophakia following cataract surgery|pseudophakia following cataract surgery
411192|NCT01193491|Phase 1|phase 1
411193|NCT01193491|AML|aml
411194|NCT01193491|CML|cml
411195|NCT01193491|MPD|mpd
411196|NCT01193491|Client Proteins|client proteins
411197|NCT01193491|Hsp90|hsp90
411198|NCT01193478|Hepatitis C|hepatitis c
411199|NCT01193478|HCV RNA|hcv rna
411200|NCT01193478|multiple ascending dose|multiple ascending dose
411202|NCT01193478|GS-5885|gs-5885
411203|NCT01193478|chronic genotype 1 HCV infection|chronic genotype 1 hcv infection
411204|NCT01193465|Humidity|humidity
411205|NCT01193465|Temperature|temperature
411206|NCT01193465|Low Flow Anesthesia|low flow anesthesia
411207|NCT01193452|elderly patients|elderly patients
411208|NCT01193452|advanced colorectal cancer|advanced colorectal cancer
411209|NCT01193452|chemotherapy|chemotherapy
411210|NCT01193452|S-1|s-1
411211|NCT01193452|5-fluorouracil|5-fluorouracil
411212|NCT01193452|leucovorin|leucovorin
411213|NCT01193439|thoracoscopy|thoracoscopy
411214|NCT01193439|pleural diseases|pleural diseases
411215|NCT01193439|complications|complications
411216|NCT01193439|safety|safety
411217|NCT01193426|Hepatic|hepatic
411218|NCT01193426|cirrhosis|cirrhosis
411219|NCT01193426|IL-6|il-6
411220|NCT01193426|IL-8|il-8
411221|NCT01193426|Leptine|leptine
411222|NCT01193413|acute pancreatitis|acute pancreatitis
411223|NCT01193413|Drainage|drainage
411224|NCT01193413|Pancreatic surgery|pancreatic surgery
411225|NCT01193413|Biological Markers/analysis|biological markers/analysis
411226|NCT01193413|Infection diagnosis|infection diagnosis
411227|NCT01193413|ROC Curve|roc curve
411228|NCT01193413|Sensitivity and Specificity|sensitivity and specificity
411229|NCT01193413|Endoscopic ultrasonography|endoscopic ultrasonography
411230|NCT01193400|Acute myelogenous leukemia|acute myelogenous leukemia
411231|NCT01193400|Clofarabine|clofarabine
411232|NCT01193400|Cytarabine|cytarabine
411233|NCT01193374|Childhood Obesity|childhood obesity
411234|NCT01193374|Primary Care|primary care
411235|NCT01193374|Counseling|counseling
411236|NCT01193374|Screening|screening
411237|NCT01193348|Atypical Hemolytic-Uremic Syndrome|atypical hemolytic-uremic syndrome
411238|NCT01193335|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
411239|NCT01193335|premature|premature
411240|NCT01193335|immunization|immunization
411241|NCT01193335|safety.|safety.
411242|NCT01193296|Diabetes mellitus, vildagliptin, continuous glucose monitoring|diabetes mellitus, vildagliptin, continuous glucose monitoring
411243|NCT01193283|Aplastic Anemia|aplastic anemia
411244|NCT01193283|Immunosuppression|immunosuppression
411245|NCT01193283|T-Cells|t-cells
411246|NCT01193283|Hematopoiesis|hematopoiesis
411247|NCT01193283|Autoimmunity|autoimmunity
411248|NCT01193283|Severe Aplastic Anemia|severe aplastic anemia
411249|NCT01193270|NICHD Neonatal Research Network|nichd neonatal research network
411250|NCT01193270|Intraventricular Hemorrhage (IVH)|intraventricular hemorrhage (ivh)
411251|NCT01193270|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
411252|NCT01193270|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
411253|NCT01193270|Prematurity|prematurity
411254|NCT01193231|Laser Vision Correction|laser vision correction
411255|NCT01193231|Photorefractive Keratectomy|photorefractive keratectomy
411256|NCT01193231|PRK|prk
411257|NCT01193231|Nearsighted|nearsighted
411258|NCT01193231|Myopia|myopia
411259|NCT01193205|Borderline Personality Disorder|borderline personality disorder
411260|NCT01193205|Skills Training|skills training
411261|NCT01193205|Dialectical Behavior Therapy|dialectical behavior therapy
411262|NCT01193205|Suicidal and parasuicidal behavior|suicidal and parasuicidal behavior
411264|NCT01193192|Neevo DHA|neevo dha
411265|NCT01193192|L-methylfolate|l-methylfolate
411266|NCT01193192|anemia during pregnancy|anemia during pregnancy
411267|NCT01193192|folic acid|folic acid
411268|NCT01193192|vitamin B12|vitamin b12
411269|NCT01193192|prenatal vitamins|prenatal vitamins
411270|NCT01193192|hemoglobin|hemoglobin
411271|NCT01193192|iron deficiency|iron deficiency
411272|NCT01193192|Pregnancy|pregnancy
411273|NCT01193166|Schizophrenia|schizophrenia
411274|NCT01193166|Risperidone|risperidone
411275|NCT01193166|Risperdal|risperdal
411276|NCT01193166|Paliperidone palmitate|paliperidone palmitate
411277|NCT01193166|Aripiprazole|aripiprazole
411278|NCT01193166|Haloperidol|haloperidol
411279|NCT01193166|Olanzapine|olanzapine
411280|NCT01193166|Paliperidone|paliperidone
411281|NCT01193166|Perphenazine|perphenazine
411282|NCT01193166|Quetiapine|quetiapine
411283|NCT01193153|schizoaffective disorder|schizoaffective disorder
411284|NCT01193153|paliperidone palmitate|paliperidone palmitate
411285|NCT01193153|INVEGA SUSTENNA|invega sustenna
411286|NCT01193153|schizoaffective disorder relapse prevention|schizoaffective disorder relapse prevention
411287|NCT01193140|veliparib|veliparib
411288|NCT01193140|relapsed and refractory tumors|relapsed and refractory tumors
411289|NCT01193140|Temodar|temodar
411290|NCT01193140|temozolomide|temozolomide
411291|NCT01193140|ABT-888|abt-888
411292|NCT01193140|Solid Tumors|solid tumors
411293|NCT01193114|substance abuse|substance abuse
411294|NCT01193114|homeless mothers|homeless mothers
411295|NCT01193101|hypertension|hypertension
411296|NCT01193101|blood pressure|blood pressure
411297|NCT01193101|LCZ696|lcz696
411298|NCT01193101|dual-acting|dual-acting
411299|NCT01193101|neprilysin|neprilysin
411300|NCT01193101|nep inhibitor|nep inhibitor
411301|NCT01193101|vasopeptidase|vasopeptidase
411302|NCT01193101|angiotensin receptor|angiotensin receptor
411303|NCT01193101|ARNi|arni
411304|NCT01193101|Essential hypertension|essential hypertension
411305|NCT01193088|CMT|cmt
411306|NCT01193088|CMT1A|cmt1a
411307|NCT01193075|Charcot Marie Tooth disease|charcot marie tooth disease
411308|NCT01193075|CMT|cmt
411309|NCT01193075|HMSN|hmsn
411310|NCT01193075|HMN|hmn
411311|NCT01193075|HSN|hsn
411312|NCT01193075|CMT1|cmt1
411313|NCT01193075|CMT2|cmt2
411314|NCT01193062|healthy volunteers|healthy volunteers
411315|NCT01193062|pharmacokinetics-pharmacodynamics|pharmacokinetics-pharmacodynamics
411316|NCT01193062|cerebrospinal fluid|cerebrospinal fluid
411317|NCT01193062|serial sampling|serial sampling
411318|NCT01193049|Nasal Allergen Challenge, Inhaled Allergen Challenge, Asthma|nasal allergen challenge, inhaled allergen challenge, asthma
411319|NCT01193036|Psychosocial|psychosocial
411320|NCT01193036|Skin Problems|skin problems
411321|NCT01193036|Supportive Care|supportive care
411322|NCT01193036|Melanoma|melanoma
411323|NCT01193036|Questionnaire|questionnaire
411324|NCT01193023|Prospective Studies|prospective studies
411325|NCT01193023|Humans, pediatric|humans, pediatric
411326|NCT01193023|Positive-Pressure Respiration/methods*|positive-pressure respiration/methods*
411327|NCT01193023|Respiration, Artificial/methods*|respiration, artificial/methods*
411328|NCT01193023|Intensive Care|intensive care
411329|NCT01193023|Intensive Care Units/statistics & numerical data*|intensive care units/statistics & numerical data*
411330|NCT01193023|Respiration, Artificial/statistics & numerical data*|respiration, artificial/statistics & numerical data*
411331|NCT01193023|Patients/statistics & numerical data*|patients/statistics & numerical data*
411332|NCT01193023|Prevalence|prevalence
411333|NCT01193023|Respiratory Muscles/innervation|respiratory muscles/innervation
411334|NCT01192997|Meningitis|meningitis
411335|NCT01192997|Meningococci|meningococci
411336|NCT01192997|Meningitis C|meningitis c
411337|NCT01192997|Meningitis A|meningitis a
411338|NCT01192997|Meningitis W135|meningitis w135
411339|NCT01192997|Meningitis Y|meningitis y
411340|NCT01192997|Antibody|antibody
411341|NCT01192971|hcc, apatinib, phase II, cancer|hcc, apatinib, phase ii, cancer
411342|NCT01192958|swine flu|swine flu
411343|NCT01192958|novel h1n1v|novel h1n1v
411344|NCT01192958|novel h1n1|novel h1n1
411345|NCT01192958|h1n1|h1n1
411346|NCT01192945|Azacitidin|azacitidin
411347|NCT01192945|Vidaza|vidaza
411348|NCT01192945|Piaza|piaza
411349|NCT01192945|myelodysplastic syndrome|myelodysplastic syndrome
411350|NCT01192945|MDS|mds
411351|NCT01192945|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
411352|NCT01192945|CMML|cmml
411353|NCT01192945|acute myeloid leukemia|acute myeloid leukemia
411354|NCT01192945|AML|aml
411355|NCT01192945|daily routine|daily routine
411356|NCT01192945|concomitant antiemetic therapy|concomitant antiemetic therapy
411357|NCT01192945|germany|germany
411358|NCT01192945|non-interventional study|non-interventional study
411359|NCT01192919|bronchial carcinoma|bronchial carcinoma
411360|NCT01192919|registry|registry
411361|NCT01192919|real life treatment|real life treatment
411362|NCT01192919|cohort study|cohort study
411364|NCT01192919|SCLC|sclc
411365|NCT01192919|Germany|germany
411366|NCT01192854|Clevudine|clevudine
411367|NCT01192854|efficacy|efficacy
411368|NCT01192854|safety|safety
411369|NCT01192854|chronic hepatitis B|chronic hepatitis b
411370|NCT01192841|physician uniform|physician uniform
411371|NCT01192841|MRSA|mrsa
411372|NCT01192841|bacterial contamination|bacterial contamination
411373|NCT01192828|cystathionine beta-synthase (CBS)|cystathionine beta-synthase (cbs)
411374|NCT01192802|albendazole|albendazole
411375|NCT01192802|ascaris|ascaris
411376|NCT01192802|trichiurus|trichiurus
411377|NCT01192802|hookworms|hookworms
411378|NCT01192789|Severe pneumonia|severe pneumonia
411379|NCT01192789|Pneumonia|pneumonia
411380|NCT01192789|Lady health workers|lady health workers
411381|NCT01192789|Amoxicillin|amoxicillin
411382|NCT01192789|Treatment failure|treatment failure
411383|NCT01192789|Injectable Antibiotics|injectable antibiotics
411384|NCT01192789|Referral treatment|referral treatment
411385|NCT01192789|Health Facility|health facility
411386|NCT01192789|Under five children|under five children
411387|NCT01192789|home based management|home based management
411388|NCT01192789|community case management|community case management
411389|NCT01192776|NICHD Neonatal Research Network|nichd neonatal research network
411390|NCT01192776|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
411391|NCT01192776|Hypothermia|hypothermia
411392|NCT01192776|Neonatal depression|neonatal depression
411393|NCT01192776|Perinatal asphyxia|perinatal asphyxia
411394|NCT01192776|Fetal acidosis|fetal acidosis
411395|NCT01192750|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
411396|NCT01192750|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
411397|NCT01192750|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
411486|NCT01192438|prostate|prostate
411398|NCT01192750|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
411399|NCT01192750|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
411400|NCT01192750|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
411401|NCT01192750|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
411402|NCT01192750|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
411403|NCT01192750|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
411404|NCT01192750|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
411405|NCT01192750|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
411406|NCT01192750|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
411407|NCT01192750|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
411408|NCT01192750|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
411533|NCT01192269|phospholipids|phospholipids
411409|NCT01192750|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
411410|NCT01192750|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
411411|NCT01192750|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
411412|NCT01192750|recurrent salivary gland cancer|recurrent salivary gland cancer
411413|NCT01192750|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
411414|NCT01192737|pandemic|pandemic
411415|NCT01192737|A/H1N1|a/h1n1
411416|NCT01192737|pregnancy|pregnancy
411417|NCT01192737|cohort|cohort
411418|NCT01192737|vaccine|vaccine
411419|NCT01192737|Influenza and Pregnancy|influenza and pregnancy
411420|NCT01192724|Antiplatelet|antiplatelet
411421|NCT01192724|Coronary artery diseae|coronary artery diseae
411422|NCT01192724|Percutaneous coronary intervention|percutaneous coronary intervention
411423|NCT01192711|diabetes|diabetes
411424|NCT01192711|telemedicine|telemedicine
411425|NCT01192711|self monitoring blood glucose|self monitoring blood glucose
411426|NCT01192698|cirrhosis|cirrhosis
411427|NCT01192698|hepatitis C|hepatitis c
411428|NCT01192685|Depression|depression
411429|NCT01192685|Depressed|depressed
411430|NCT01192685|TMS|tms
411431|NCT01192685|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
411432|NCT01192646|maternal health|maternal health
411433|NCT01192646|birth preparedness|birth preparedness
411434|NCT01192646|cost effectiveness|cost effectiveness
411435|NCT01192646|male involvement|male involvement
411436|NCT01192646|delivery at hospital|delivery at hospital
411437|NCT01192646|complication readiness|complication readiness
411438|NCT01192646|Health seeking behavior in pregnancy, labour and pregnancy complication|health seeking behavior in pregnancy, labour and pregnancy complication
411439|NCT01192633|Sarcoma|sarcoma
411440|NCT01192633|gemcitabine|gemcitabine
411441|NCT01192633|vincristine|vincristine
411442|NCT01192633|cisplatin|cisplatin
411443|NCT01192633|chemotherapy|chemotherapy
411444|NCT01192620|Pediatric Appendicitis|pediatric appendicitis
411445|NCT01192620|Pathway|pathway
411446|NCT01192594|symptom management|symptom management
411447|NCT01192594|empowerment|empowerment
411448|NCT01192594|medication adherence|medication adherence
411449|NCT01192594|recovery|recovery
411450|NCT01192594|schizophrenia|schizophrenia
411451|NCT01192594|post-psychotic adjustment process|post-psychotic adjustment process
411452|NCT01192594|psychological adjustment|psychological adjustment
411453|NCT01192594|psychiatric case managers|psychiatric case managers
411454|NCT01192594|psychosis|psychosis
411455|NCT01192594|insight|insight
411456|NCT01192594|cognitive function|cognitive function
411457|NCT01192581|brain hypoperfusion|brain hypoperfusion
411458|NCT01192581|Vuloven|vuloven
411459|NCT01192581|computed tomography perfusion|computed tomography perfusion
411460|NCT01192555|Neuroblastoma|neuroblastoma
411461|NCT01192555|Chemotherapy|chemotherapy
411462|NCT01192555|Pediatrics|pediatrics
411463|NCT01192555|Cytoxan|cytoxan
411464|NCT01192555|immunotherapy|immunotherapy
411465|NCT01192555|vaccine|vaccine
411466|NCT01192529|Senile|senile
411467|NCT01192529|Dementia|dementia
411468|NCT01192529|Neurodegenerative|neurodegenerative
411469|NCT01192529|Supressi|supressi
411470|NCT01192529|Specific diet|specific diet
411471|NCT01192529|Cognitive Status|cognitive status
411472|NCT01192529|Memory|memory
411473|NCT01192529|Malnutrition|malnutrition
411474|NCT01192529|Parkinson|parkinson
411475|NCT01192529|Alzheimer|alzheimer
411476|NCT01192516|Osteoarthritis|osteoarthritis
411477|NCT01192516|Activity Pacing|activity pacing
411478|NCT01192503|Restless Legs Syndrome|restless legs syndrome
411479|NCT01192503|rasagiline|rasagiline
411480|NCT01192503|futility|futility
411481|NCT01192477|Air pollution|air pollution
411482|NCT01192477|Ozone|ozone
411483|NCT01192477|Health effects of ozone exposure|health effects of ozone exposure
411484|NCT01192464|Hodgkin's Lymphoma|hodgkin's lymphoma
411485|NCT01192464|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
411487|NCT01192438|cancer|cancer
411488|NCT01192438|ablation|ablation
411489|NCT01192438|laser-induced|laser-induced
411490|NCT01192438|focal therapy|focal therapy
411491|NCT01192425|PNH clone cells|pnh clone cells
411492|NCT01192425|Aplastic Anemia|aplastic anemia
411493|NCT01192425|AA|aa
411494|NCT01192425|Myelodysplastic Syndromes|myelodysplastic syndromes
411495|NCT01192425|MDS|mds
411496|NCT01192425|bone marrow failure syndromes|bone marrow failure syndromes
411497|NCT01192425|FLAER|flaer
411498|NCT01192425|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
411499|NCT01192412|hypertension|hypertension
411500|NCT01192412|pregnancy|pregnancy
411501|NCT01192412|antihypertensive therapy|antihypertensive therapy
411502|NCT01192412|perinatal outcome|perinatal outcome
411503|NCT01192412|maternal outcome|maternal outcome
411504|NCT01192412|Non-severe, non-proteinuric pre-existing or gestational hypertension in pregnancy|non-severe, non-proteinuric pre-existing or gestational hypertension in pregnancy
411505|NCT01192399|Hemolytic Paroxysmal Nocturnal Hemoglobinuria|hemolytic paroxysmal nocturnal hemoglobinuria
411506|NCT01192399|Eculizumab|eculizumab
411507|NCT01192399|PNH|pnh
411508|NCT01192399|Japan|japan
411509|NCT01192360|pediatrics|pediatrics
411510|NCT01192360|Heart Disease|heart disease
411511|NCT01192360|Cystic Fibrosis|cystic fibrosis
411512|NCT01192360|Severe Asthma|severe asthma
411513|NCT01192360|Magnetic Resonance Imaging|magnetic resonance imaging
411514|NCT01192334|knee osteoarthritis arthroplasty postural balance|knee osteoarthritis arthroplasty postural balance
411515|NCT01192321|intraocular lens|intraocular lens
411516|NCT01192321|Toric|toric
411517|NCT01192308|Breast cancer|breast cancer
411518|NCT01192308|Tamoxifen|tamoxifen
411519|NCT01192308|Pharmacokinetics|pharmacokinetics
411520|NCT01192308|Pharmacogenetics|pharmacogenetics
411521|NCT01192308|CYP2D6|cyp2d6
411522|NCT01192295|Malignant pain|malignant pain
411523|NCT01192295|Nonmalignant pain|nonmalignant pain
411524|NCT01192295|Pediatric|pediatric
411525|NCT01192295|Opioid|opioid
411526|NCT01192295|Moderate to severe malignant or nonmalignant pain|moderate to severe malignant or nonmalignant pain
411527|NCT01192282|Female Genital Warts|female genital warts
411528|NCT01192282|HPV Typing|hpv typing
411529|NCT01192282|HIV Status|hiv status
411530|NCT01192282|Treatment Modalities and Recurrence|treatment modalities and recurrence
411531|NCT01192282|Socio-economic Burdens|socio-economic burdens
411532|NCT01192269|cheek cells|cheek cells
411534|NCT01192269|fatty acids|fatty acids
411535|NCT01192269|docosahexaenoic acid|docosahexaenoic acid
411536|NCT01192269|Buccal Cheek cells|buccal cheek cells
411537|NCT01192269|non invasive fatty acid status marker|non invasive fatty acid status marker
411539|NCT01192256|cessation|cessation
411540|NCT01192256|mortality|mortality
411541|NCT01192256|quality of life|quality of life
411542|NCT01192243|Objective response rate|objective response rate
411543|NCT01192243|Time to Progression|time to progression
411544|NCT01192243|Quality of Live|quality of live
411545|NCT01192230|Objective response rate|objective response rate
411546|NCT01192230|Disease control rate|disease control rate
411547|NCT01192230|Disease free survival|disease free survival
411548|NCT01192230|Overall survival|overall survival
411549|NCT01192230|Quality of Live|quality of live
411550|NCT01192230|Nonsmall cell lung cancer|nonsmall cell lung cancer
411552|NCT01192217|video-assisted thoracic surgery|video-assisted thoracic surgery
411553|NCT01192217|axillary mini-thoracotomy|axillary mini-thoracotomy
411554|NCT01192217|bullectomy|bullectomy
411555|NCT01192204|FBR, OSCC, chemoprevention|fbr, oscc, chemoprevention
411556|NCT01192191|GW642444|gw642444
411557|NCT01192191|COPD|copd
411558|NCT01192191|Fluticasone Furoate|fluticasone furoate
411559|NCT01192178|pediatric|pediatric
411560|NCT01192178|exacerbation|exacerbation
411561|NCT01192178|viral induced exacerbation|viral induced exacerbation
411562|NCT01192178|asthma|asthma
411563|NCT01192165|Taxotere|taxotere
411564|NCT01192165|Cisplatin|cisplatin
411565|NCT01192165|Carboplatin|carboplatin
411566|NCT01192165|Trametinib|trametinib
411567|NCT01192165|GSK1120212|gsk1120212
411568|NCT01192165|Tarceva|tarceva
411569|NCT01192165|KRAS|kras
411570|NCT01192165|Pemetrexed|pemetrexed
411571|NCT01192165|MEK inhibitor|mek inhibitor
411572|NCT01192165|nab-Paclitaxel|nab-paclitaxel
411573|NCT01192165|Docetaxel|docetaxel
411574|NCT01192165|Alimta|alimta
411575|NCT01192165|Abraxane|abraxane
411576|NCT01192165|Erlotinib|erlotinib
411577|NCT01192113|Mecobalamin|mecobalamin
411578|NCT01192113|peripheral neuropathy|peripheral neuropathy
411579|NCT01192113|diabetic neuropathy|diabetic neuropathy
411580|NCT01192100|Protein-rich breakfast|protein-rich breakfast
411581|NCT01192100|Breakfast Skipping|breakfast skipping
411582|NCT01192100|Adolescents|adolescents
411583|NCT01192100|Obesity|obesity
411584|NCT01192100|Increased dietary protein|increased dietary protein
411585|NCT01192100|Breakfast|breakfast
411586|NCT01192100|fMRI|fmri
411587|NCT01192100|Ghrelin|ghrelin
411588|NCT01192100|PYY|pyy
411589|NCT01192087|adenoid cystic carcinoma|adenoid cystic carcinoma
411590|NCT01192087|carbon ion therapy|carbon ion therapy
411591|NCT01192087|IMRT (intensity-modulated therapy)|imrt (intensity-modulated therapy)
411592|NCT01192087|radioimmunotherapy|radioimmunotherapy
411593|NCT01192087|Cetuximab|cetuximab
411594|NCT01192074|Obstetric|obstetric
411595|NCT01192074|Analgesia|analgesia
411596|NCT01192074|Anesthesia|anesthesia
411597|NCT01192074|Obstetric Anesthesia|obstetric anesthesia
411598|NCT01192074|Obstetric Analgesia|obstetric analgesia
411599|NCT01192074|ultrasound|ultrasound
411600|NCT01192074|ultrasonography|ultrasonography
411601|NCT01192074|epidural analgesia|epidural analgesia
411602|NCT01192074|epidural anesthesia|epidural anesthesia
411603|NCT01192074|spinal anesthesia|spinal anesthesia
411604|NCT01192074|neuraxial anesthesia|neuraxial anesthesia
411605|NCT01192074|neuraxial analgesia|neuraxial analgesia
411606|NCT01192074|pregnancy|pregnancy
411607|NCT01192074|labor|labor
411608|NCT01192074|cesarean delivery|cesarean delivery
411609|NCT01192074|cesarean section|cesarean section
411610|NCT01192061|autonomic nervous system|autonomic nervous system
411611|NCT01192061|heart rate variability|heart rate variability
411612|NCT01192061|blood pressure variability|blood pressure variability
411613|NCT01192061|retrobulbar hemodynamics|retrobulbar hemodynamics
411614|NCT01192061|vascular dysregulation|vascular dysregulation
411615|NCT01192048|Congenital Heart Disease|congenital heart disease
411616|NCT01192048|birth defect|birth defect
411617|NCT01192048|genetics|genetics
411618|NCT01192048|gene|gene
411619|NCT01192048|DNA|dna
411620|NCT01192048|direct sequencing|direct sequencing
411621|NCT01192048|microarray|microarray
411622|NCT01192048|single nucleotide polymorphism|single nucleotide polymorphism
411623|NCT01192048|whole genome array comparative genomic hybridization|whole genome array comparative genomic hybridization
411624|NCT01192048|chromosomal copy number change|chromosomal copy number change
411625|NCT01192048|nucleotide sequence variation|nucleotide sequence variation
411626|NCT01192048|exome sequencing|exome sequencing
411627|NCT01192048|whole exome sequencing|whole exome sequencing
411628|NCT01192035|Africa, Western|africa, western
411629|NCT01192035|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
411630|NCT01192022|Liver resection|liver resection
411631|NCT01192022|Liver transplantation|liver transplantation
411632|NCT01192022|Liver surgery|liver surgery
411633|NCT01192022|Secondary hemostasis|secondary hemostasis
411634|NCT01192009|Leucine|leucine
411635|NCT01192009|Skeletal Muscle Disuse|skeletal muscle disuse
411636|NCT01192009|Atrophy|atrophy
411637|NCT01192009|Proteolysis|proteolysis
411638|NCT01191996|SPMS|spms
411639|NCT01191996|PPMS|ppms
411640|NCT01191996|MS|ms
411641|NCT01191996|Multiple Sclerosis|multiple sclerosis
411642|NCT01191970|epidural|epidural
411643|NCT01191970|beta-endorphins|beta-endorphins
411644|NCT01191970|breast-feeding|breast-feeding
411645|NCT01191970|colostrum|colostrum
411646|NCT01191970|feeding|feeding
411647|NCT01191957|Acute Myeloid Leukemia|acute myeloid leukemia
411648|NCT01191957|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
411649|NCT01191918|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
411651|NCT01191918|bipolar disorder|bipolar disorder
411652|NCT01191918|mania|mania
411653|NCT01191918|lithium|lithium
411654|NCT01191892|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
411655|NCT01191892|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
411656|NCT01191892|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
411657|NCT01191892|stage III bladder cancer|stage iii bladder cancer
411658|NCT01191892|stage IV bladder cancer|stage iv bladder cancer
411659|NCT01191892|anterior urethral cancer|anterior urethral cancer
411660|NCT01191892|posterior urethral cancer|posterior urethral cancer
411661|NCT01191892|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
411662|NCT01191892|ureter cancer|ureter cancer
411663|NCT01191866|diabetes mellitus|diabetes mellitus
411664|NCT01191866|psychosocial|psychosocial
411665|NCT01191866|metabolic control|metabolic control
411666|NCT01191866|quality of life questionnaires|quality of life questionnaires
411667|NCT01191866|children|children
411668|NCT01191866|adolescents|adolescents
411669|NCT01191853|Post Swine Flu Blood Samples|post swine flu blood samples
411670|NCT01191853|Biologic Samples|biologic samples
411671|NCT01191853|Laboratory Research Samples|laboratory research samples
411672|NCT01191853|Swine Flu|swine flu
411673|NCT01191853|Immunization|immunization
411674|NCT01191853|Healthy Volunteer|healthy volunteer
411676|NCT01191840|staphylococci|staphylococci
411677|NCT01191814|pancreatic cancer|pancreatic cancer
411678|NCT01191814|obstructive jaundice|obstructive jaundice
411679|NCT01191814|Obstructive jaundice secondary to pancreatic cancer|obstructive jaundice secondary to pancreatic cancer
411680|NCT01191801|Leukemia|leukemia
411681|NCT01191801|Acute Myeloid Leukemia|acute myeloid leukemia
411682|NCT01191801|Hematologic|hematologic
411683|NCT01191801|Hematologic diseases|hematologic diseases
411684|NCT01191801|Blood|blood
411685|NCT01191801|Cancer|cancer
411686|NCT01191801|Malignancy|malignancy
411687|NCT01191801|Vosaroxin|vosaroxin
411688|NCT01191801|Cytarabine|cytarabine
411689|NCT01191801|First Relapsed AML|first relapsed aml
411690|NCT01191801|Refractory AML|refractory aml
411691|NCT01191801|VALOR|valor
411692|NCT01191801|Sunesis|sunesis
411693|NCT01191801|Voreloxin|voreloxin
411694|NCT01191801|SNS-595|sns-595
411695|NCT01191788|Depression|depression
411696|NCT01191788|Substance Use|substance use
411697|NCT01191788|Group Cognitive Behavioral Therapy|group cognitive behavioral therapy
411698|NCT01191775|Oligonucleotide|oligonucleotide
411699|NCT01191775|DNAi|dnai
411700|NCT01191775|Oncology|oncology
411701|NCT01191775|Antineoplastic agent|antineoplastic agent
411702|NCT01191775|Lymphoma|lymphoma
411703|NCT01191775|PNT2258|pnt2258
411704|NCT01191762|secondary hyperparathyroidism|secondary hyperparathyroidism
411705|NCT01191762|phosphate|phosphate
411706|NCT01191762|calcium|calcium
411707|NCT01191762|chronic kidney disease|chronic kidney disease
411708|NCT01191749|Hematologic Disorder|hematologic disorder
411709|NCT01191749|Aplastic Anemia|aplastic anemia
411710|NCT01191749|T - Cell Large Granular Lymphocytic Leukemia|t - cell large granular lymphocytic leukemia
411711|NCT01191749|T-LGL|t-lgl
411712|NCT01191749|Myelodysplastic Syndrome|myelodysplastic syndrome
411713|NCT01191749|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
411714|NCT01191749|CLL|cll
411715|NCT01191749|Chemotherapy|chemotherapy
411716|NCT01191749|Alemtuzumab|alemtuzumab
411717|NCT01191736|hands only|hands only
411718|NCT01191736|CPR|cpr
411719|NCT01191736|resuscitation|resuscitation
411720|NCT01191736|cardiac arrest|cardiac arrest
411721|NCT01191736|Education of general public regarding resuscitation methods|education of general public regarding resuscitation methods
411722|NCT01191723|Healthy Volunteers|healthy volunteers
411723|NCT01191710|progesterone|progesterone
411724|NCT01191697|HER2 positive|her2 positive
411725|NCT01191671|Child Development|child development
411726|NCT01191671|Child|child
411727|NCT01191671|Daycare centers|daycare centers
411728|NCT01191671|Language|language
410793|NCT01195246|HBV|hbv
411729|NCT01191645|Lower esophageal sphincter pressure|lower esophageal sphincter pressure
411730|NCT01191645|Esophageal motility|esophageal motility
411731|NCT01191645|Remifentanil|remifentanil
411732|NCT01191645|Metoclopramide|metoclopramide
411733|NCT01191645|Naloxone|naloxone
411734|NCT01191645|High resolution solid state manometry|high resolution solid state manometry
411735|NCT01191632|T cell|t cell
411736|NCT01191632|surgery|surgery
411737|NCT01191632|radiation|radiation
411738|NCT01191619|McIvor retractor|mcivor retractor
411739|NCT01191619|Proseal laryngeal mask airway|proseal laryngeal mask airway
411740|NCT01191606|pressure controlled|pressure controlled
411741|NCT01191606|volume controlled|volume controlled
411742|NCT01191606|arterial oxygenation|arterial oxygenation
411743|NCT01191606|one lung ventilation|one lung ventilation
411744|NCT01191593|Adductor-Canal-Blockade|adductor-canal-blockade
411745|NCT01191593|postoperative pain|postoperative pain
411746|NCT01191593|US-guided nerve block|us-guided nerve block
411747|NCT01191593|revision knee arthroplasty|revision knee arthroplasty
411748|NCT01191567|acute wounds|acute wounds
411749|NCT01191567|postoperative wounds|postoperative wounds
411750|NCT01191541|ara-c|ara-c
411751|NCT01191541|As2O3|as2o3
411752|NCT01191541|pediatric|pediatric
411753|NCT01191541|acute|acute
411754|NCT01191528|Adult|adult
411755|NCT01191528|Post|post
411756|NCT01191528|operative|operative
411757|NCT01191528|oximetry|oximetry
411758|NCT01191528|capnometry|capnometry
411759|NCT01191528|Integrated|integrated
411760|NCT01191528|Pulmonary|pulmonary
411761|NCT01191528|Index|index
411762|NCT01191528|End-tidal|end-tidal
411763|NCT01191528|Monitoring Respiratory status|monitoring respiratory status
411764|NCT01191528|post-operative|post-operative
411765|NCT01191515|Previous Cataract patients|previous cataract patients
411766|NCT01191515|Monofocal IOL implant|monofocal iol implant
411767|NCT01191515|Evaluation|evaluation
411768|NCT01191502|Patients who have had binocular implantation of the Tecnis Multifocal IOL or the Crystalens™ HD Accommodating IOL.|patients who have had binocular implantation of the tecnis multifocal iol or the crystalens™ hd accommodating iol.
411769|NCT01191476|Sevoflurane|sevoflurane
411770|NCT01191476|Propofol|propofol
411771|NCT01191476|Economics|economics
411772|NCT01191476|Pharmaceutical|pharmaceutical
411773|NCT01191476|Chinese|chinese
411774|NCT01191450|chlortalidone|chlortalidone
411775|NCT01191450|amiloride|amiloride
411776|NCT01191450|arterial hypertension|arterial hypertension
411777|NCT01191424|Asthma|asthma
411779|NCT01191424|Adolescents|adolescents
411780|NCT01191424|Adults|adults
411781|NCT01191411|colorectal neoplasms|colorectal neoplasms
411782|NCT01191411|screening|screening
411783|NCT01191398|Hypersalivation|hypersalivation
411784|NCT01191398|Conscious Sedation|conscious sedation
411785|NCT01191398|Procedural Sedation|procedural sedation
411786|NCT01191398|Ketamine|ketamine
411787|NCT01191398|Atropine|atropine
411788|NCT01191398|Glycopyrrolate|glycopyrrolate
411790|NCT01191385|Liver cancer|liver cancer
411791|NCT01191385|Cancer of liver|cancer of liver
411792|NCT01191385|Cancer, liver|cancer, liver
411793|NCT01191385|Hepatic cancer|hepatic cancer
411794|NCT01191385|Cancer, hepatic|cancer, hepatic
411795|NCT01191385|Carcinoma, hepatocellular|carcinoma, hepatocellular
411796|NCT01191372|Hemophilia A|hemophilia a
411797|NCT01191372|Hemophilia B|hemophilia b
411798|NCT01191372|pharmacokinetics|pharmacokinetics
411799|NCT01191372|pharmacodynamics|pharmacodynamics
411800|NCT01191372|Tissue Factor Pathway Inhibitor|tissue factor pathway inhibitor
411801|NCT01191333|Mood Disorder|mood disorder
411802|NCT01191333|Depression|depression
411803|NCT01191333|stress disorder, post-traumatic|stress disorder, post-traumatic
411804|NCT01191333|Depressive Disorder|depressive disorder
411805|NCT01191333|Stress Disorders, Traumatic|stress disorders, traumatic
411806|NCT01191333|substance related disorders|substance related disorders
411807|NCT01191333|Transcranial Magnetic Stimulation, repetitive|transcranial magnetic stimulation, repetitive
411808|NCT01191333|transcranial magnetic stimulation|transcranial magnetic stimulation
411809|NCT01191333|Veterans|veterans
411810|NCT01191333|mental health|mental health
411811|NCT01191320|Adult onset hypogonadotropic hypogonadism|adult onset hypogonadotropic hypogonadism
411812|NCT01191307|Primary dystonia|primary dystonia
411813|NCT01191307|Epilepsy|epilepsy
411814|NCT01191307|Hydrocephalus|hydrocephalus
411815|NCT01191307|Bladder Control|bladder control
411816|NCT01191307|Deaf or Hearing Impaired|deaf or hearing impaired
411817|NCT01191294|Melanoma|melanoma
411818|NCT01191294|Simulation Training|simulation training
411819|NCT01191294|Medical Students|medical students
411820|NCT01191281|food habits|food habits
411821|NCT01191281|nutrition requirements|nutrition requirements
411822|NCT01191281|antiretroviral therapy|antiretroviral therapy
411823|NCT01191255|ESRD|esrd
411824|NCT01191255|end-stage renal disease|end-stage renal disease
411825|NCT01191255|dialysis|dialysis
411826|NCT01191255|hemodialysis|hemodialysis
411827|NCT01191255|peritoneal dialysis|peritoneal dialysis
411828|NCT01191255|hemodialysis (HD)|hemodialysis (hd)
411829|NCT01191255|peritoneal dialysis (PD)|peritoneal dialysis (pd)
411830|NCT01191255|chronic renal insufficiency|chronic renal insufficiency
411831|NCT01191255|phosphate binder|phosphate binder
411832|NCT01191255|kidney failure|kidney failure
411833|NCT01191255|renal failure|renal failure
411834|NCT01191242|methadone|methadone
411835|NCT01191242|genetic|genetic
411836|NCT01191203|Acceptability and Adherence to methods|acceptability and adherence to methods
411837|NCT01191190|Leukemia|leukemia
411838|NCT01191190|Chronic leukemia|chronic leukemia
411839|NCT01191190|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
411840|NCT01191190|Relapsed|relapsed
411841|NCT01191190|Refractory|refractory
411842|NCT01191177|oral fish oil|oral fish oil
411843|NCT01191177|Lovaza|lovaza
411844|NCT01191177|Omega-3-acid supplementation|omega-3-acid supplementation
411845|NCT01191164|Brachytherapy, Partial Breast Irradiation, Breast Seed Implant, Palladium Seeds|brachytherapy, partial breast irradiation, breast seed implant, palladium seeds
411846|NCT01191151|Orthopedic surgery|orthopedic surgery
411847|NCT01191151|sports medicine|sports medicine
411848|NCT01191138|Delayed Gastric emptying|delayed gastric emptying
411849|NCT01191138|Gastric emptying scintigraphy|gastric emptying scintigraphy
411850|NCT01191138|Pancreatic fistula|pancreatic fistula
411851|NCT01191138|Pancreatic Neoplasms|pancreatic neoplasms
411852|NCT01191138|Whipple Operation|whipple operation
411853|NCT01191086|Epilepsy|epilepsy
411854|NCT01191086|partial onset seizure|partial onset seizure
411855|NCT01191086|adjunctive therapy|adjunctive therapy
411856|NCT01191073|edentulous|edentulous
584762|NCT00509730|urodynamics|urodynamics
411857|NCT01191060|Progression free survival prolongation|progression free survival prolongation
411858|NCT01191060|Disease Progression|disease progression
411859|NCT01191060|Overall survival|overall survival
411860|NCT01191021|breath|breath
411861|NCT01191021|propofol|propofol
411862|NCT01191021|general anesthesia|general anesthesia
411863|NCT01191008|Xalacom Regulatory post marketing commitment plan safety|xalacom regulatory post marketing commitment plan safety
411864|NCT01190995|Pain|pain
411865|NCT01190995|Neonate|neonate
411866|NCT01190995|Procedure|procedure
411867|NCT01190995|Neurobehavioural outcome|neurobehavioural outcome
411868|NCT01190969|Elderly|elderly
411869|NCT01190969|malnutrition|malnutrition
411870|NCT01190969|nutritional supplement|nutritional supplement
411871|NCT01190943|localized osteosarcoma|localized osteosarcoma
411872|NCT01190943|metastatic osteosarcoma|metastatic osteosarcoma
411873|NCT01190943|recurrent osteosarcoma|recurrent osteosarcoma
411874|NCT01190917|Autism|autism
411875|NCT01190917|Autism Spectrum Disorder|autism spectrum disorder
411876|NCT01190917|Disorder|disorder
411877|NCT01190917|Autistic|autistic
411878|NCT01190917|Asperger Syndrome|asperger syndrome
411879|NCT01190917|social skills group|social skills group
411880|NCT01190917|behavioral intervention|behavioral intervention
411881|NCT01190917|Imaging, Magnetic Resonance|imaging, magnetic resonance
411882|NCT01190917|fMRI|fmri
411883|NCT01190917|Functional MRI|functional mri
411884|NCT01190917|MRI, Functional|mri, functional
411885|NCT01190917|Magnetic Resonance Imaging|magnetic resonance imaging
411886|NCT01190917|Functional|functional
411887|NCT01190904|Androgen deficiency|androgen deficiency
411888|NCT01190904|Erectile dysfunction|erectile dysfunction
411889|NCT01190904|Coronary Artery Disease|coronary artery disease
411890|NCT01190904|Coronary Revascularization|coronary revascularization
411891|NCT01190904|Diabetes mellitus|diabetes mellitus
411892|NCT01190904|MI|mi
411893|NCT01190904|Stroke|stroke
411894|NCT01190904|MACCE|macce
411895|NCT01190904|DM|dm
411896|NCT01190904|ED|ed
411897|NCT01190904|CAD|cad
411898|NCT01190904|Development of predictive cardiovascular/cerebrovascular AE|development of predictive cardiovascular/cerebrovascular ae
411899|NCT01190891|Rotator cuff tendonitis|rotator cuff tendonitis
411900|NCT01190891|Shoulder pain|shoulder pain
411901|NCT01190891|Shoulder impingement|shoulder impingement
411902|NCT01190839|Crohn's Disease|crohn's disease
411903|NCT01190839|Inflammatory Bowel Disease|inflammatory bowel disease
411904|NCT01190839|infliximab|infliximab
411905|NCT01190839|TNF-alpha|tnf-alpha
411906|NCT01190826|Stable moderate asthma|stable moderate asthma
411907|NCT01190813|amblyopia, levodopa|amblyopia, levodopa
411908|NCT01190800|Alzheimer's Disease|alzheimer's disease
411909|NCT01190800|Capacity assessment|capacity assessment
411910|NCT01190800|Decision-making assessment|decision-making assessment
411911|NCT01190800|Capacity to consent to treatment|capacity to consent to treatment
411912|NCT01190800|Capacity to vote|capacity to vote
411913|NCT01190800|Capacity to appoint a proxy|capacity to appoint a proxy
411914|NCT01190787|Multiple Myeloma|multiple myeloma
411915|NCT01190787|Elderly Patients|elderly patients
411916|NCT01190787|Diagnosis|diagnosis
411917|NCT01190787|Velcade subcutaneous|velcade subcutaneous
411918|NCT01190787|Prednisone|prednisone
411919|NCT01190787|Melphalan|melphalan
411920|NCT01190787|Cyclophosphamide|cyclophosphamide
200955|NCT02112825|Exercise|exercise
411921|NCT01190774|dental anxiety|dental anxiety
411922|NCT01190774|state anxiety|state anxiety
411923|NCT01190774|randomised control trial|randomised control trial
411924|NCT01190774|psychological intervention|psychological intervention
411925|NCT01190761|Bioequivalence|bioequivalence
411926|NCT01190761|Galantamine|galantamine
411927|NCT01190761|Reminyl|reminyl
411928|NCT01190761|Galantamine hydrobromide|galantamine hydrobromide
411929|NCT01190761|Healthy subjects|healthy subjects
411930|NCT01190748|Bioequivalence|bioequivalence
411931|NCT01190748|Galantamine|galantamine
411932|NCT01190748|Reminyl|reminyl
411933|NCT01190748|Galantamine hydrobromide|galantamine hydrobromide
411934|NCT01190748|Healthy subjects|healthy subjects
411935|NCT01190735|Caffeine|caffeine
411936|NCT01190735|Parkinson's Disease|parkinson's disease
411937|NCT01190735|Parkinson Disease|parkinson disease
411938|NCT01190735|Parkinsonian Disorders|parkinsonian disorders
411939|NCT01190735|Basal Ganglia Diseases|basal ganglia diseases
411940|NCT01190735|Brain Diseases|brain diseases
411941|NCT01190735|Central Nervous System Diseases|central nervous system diseases
411942|NCT01190735|Nervous System Diseases|nervous system diseases
411943|NCT01190735|Movement Disorders|movement disorders
411944|NCT01190735|Neurodegenerative Diseases|neurodegenerative diseases
411945|NCT01190735|Caffeine citrate|caffeine citrate
411946|NCT01190735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
411947|NCT01190735|Pharmacologic Actions|pharmacologic actions
411948|NCT01190735|Central Nervous System Stimulants|central nervous system stimulants
411949|NCT01190735|Physiological Effects of Drugs|physiological effects of drugs
411950|NCT01190735|Central Nervous System Agents|central nervous system agents
749076|NCT01158937|meropenem|meropenem
411951|NCT01190735|Therapeutic Uses|therapeutic uses
411952|NCT01190722|Day case surgery|day case surgery
411953|NCT01190722|postoperative pain|postoperative pain
411954|NCT01190722|NSAIDs|nsaids
411955|NCT01190722|Coxibs|coxibs
411956|NCT01190709|Close Fracture|close fracture
411957|NCT01190709|Tibia|tibia
411958|NCT01190709|Unreamed Intramedullary Nailing|unreamed intramedullary nailing
411959|NCT01190709|Dynamic Compression Plate|dynamic compression plate
411960|NCT01190696|Spica Cast|spica cast
411961|NCT01190696|TEN|ten
411962|NCT01190696|Femoral Shaft Fracture|femoral shaft fracture
411963|NCT01190696|Children|children
411964|NCT01190670|ASP015K|asp015k
411965|NCT01190670|tacrolimus|tacrolimus
411966|NCT01190670|healthy volunteers|healthy volunteers
411967|NCT01190657|Teprenone|teprenone
411968|NCT01190657|safety|safety
411969|NCT01190657|efficacy|efficacy
411970|NCT01190657|acute gastric lesion|acute gastric lesion
411971|NCT01190657|chronic gastritis|chronic gastritis
411972|NCT01190644|Red Blood Cell Mass|red blood cell mass
411973|NCT01190644|Plasma Volume|plasma volume
411974|NCT01190644|Solid Tumors|solid tumors
411975|NCT01190631|intraocular lens|intraocular lens
411976|NCT01190631|cataracts|cataracts
411977|NCT01190631|total residual spherical aberration|total residual spherical aberration
411978|NCT01190631|high order aberrations|high order aberrations
411979|NCT01190605|HIV|hiv
411980|NCT01190605|postpartum|postpartum
411981|NCT01190605|postpartum entry into HIV care|postpartum entry into hiv care
411982|NCT01190592|Resistance training|resistance training
411983|NCT01190592|Body Composition|body composition
411984|NCT01190592|Cardiovascular Risk factors|cardiovascular risk factors
411985|NCT01190592|Dairy|dairy
411986|NCT01190579|Coronary Artery Disease|coronary artery disease
411987|NCT01190579|Chest Pain|chest pain
411988|NCT01190579|Computed Tomography|computed tomography
411989|NCT01190566|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
411990|NCT01190566|Tomography, Positron-Emission|tomography, positron-emission
411991|NCT01190566|chemotherapy|chemotherapy
411992|NCT01190553|amantadine|amantadine
411993|NCT01190553|parkinson disease|parkinson disease
411994|NCT01190553|dyskinesia|dyskinesia
411995|NCT01190540|On site support services.|on site support services.
411996|NCT01190540|mid level health professionals.|mid level health professionals.
411997|NCT01190540|cost effectiveness.|cost effectiveness.
411998|NCT01190540|infectious disease.|infectious disease.
411999|NCT01190540|capacity building.|capacity building.
412000|NCT01190514|DVS SR|dvs sr
412001|NCT01190514|healthy|healthy
412002|NCT01190514|Bioequivalence study|bioequivalence study
412003|NCT01190501|blood pressure|blood pressure
412004|NCT01190501|antihypertensive treatments|antihypertensive treatments
412005|NCT01190488|End of life decision making|end of life decision making
412006|NCT01190488|End of life decision aid|end of life decision aid
412007|NCT01190488|Palliative care decision making|palliative care decision making
412008|NCT01190488|Palliative care decision aid|palliative care decision aid
412009|NCT01190488|Advanced care planning|advanced care planning
412010|NCT01190488|Decision Aid|decision aid
412011|NCT01190475|Endometriosis|endometriosis
412012|NCT01190475|Infertility|infertility
412013|NCT01190475|Pain|pain
412014|NCT01190475|Vaginal Diseases|vaginal diseases
412015|NCT01190475|Uterine Diseases|uterine diseases
412016|NCT01190462|recurrent colon cancer|recurrent colon cancer
412017|NCT01190462|stage III colon cancer|stage iii colon cancer
412018|NCT01190462|stage IV colon cancer|stage iv colon cancer
412019|NCT01190462|recurrent rectal cancer|recurrent rectal cancer
412020|NCT01190462|stage III rectal cancer|stage iii rectal cancer
412021|NCT01190462|stage IV rectal cancer|stage iv rectal cancer
412022|NCT01190449|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
412023|NCT01190449|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
412024|NCT01190449|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
412025|NCT01190449|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
412026|NCT01190449|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
412027|NCT01190449|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
412028|NCT01190449|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
753323|NCT01176240|head & neck pain|head & neck pain
412029|NCT01190449|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
412030|NCT01190449|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
412031|NCT01190449|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
412032|NCT01190449|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
412033|NCT01190449|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
412034|NCT01190436|Hypertension|hypertension
412035|NCT01190436|Diabetes Mellitus|diabetes mellitus
412036|NCT01190436|Bisoprolol|bisoprolol
412037|NCT01190423|AN|an
412038|NCT01190410|Certolizumab Pegol|certolizumab pegol
412039|NCT01190410|Cimzia®|cimzia®
412040|NCT01190410|Crohn's Disease|crohn's disease
412041|NCT01190410|Children and Adolescents with Crohn's Disease|children and adolescents with crohn's disease
412042|NCT01190397|Warming goggles|warming goggles
412043|NCT01190384|Metabolic Syndrome|metabolic syndrome
412044|NCT01190384|Inflammation|inflammation
412045|NCT01190384|Antioxidants|antioxidants
412046|NCT01190384|Satiety|satiety
412047|NCT01190384|Fiber|fiber
412048|NCT01190371|Artemisinin tolerance|artemisinin tolerance
412049|NCT01190345|breast cancer|breast cancer
412050|NCT01190332|common bile duct stones|common bile duct stones
412051|NCT01190319|blood pressure|blood pressure
412052|NCT01190319|strawberry|strawberry
412053|NCT01190319|fruit phenolics|fruit phenolics
412054|NCT01190319|LDL oxidation|ldl oxidation
412055|NCT01190319|Flow mediated dilation (FMD)|flow mediated dilation (fmd)
412056|NCT01190254|Asenapine|asenapine
412057|NCT01190254|adolescents|adolescents
412058|NCT01190254|schizophrenia|schizophrenia
412059|NCT01190254|phase IIIb|phase iiib
412060|NCT01190254|placebo-controlled|placebo-controlled
412061|NCT01190241|targeted therapy|targeted therapy
412062|NCT01190241|individualized medicine|individualized medicine
412063|NCT01190241|tyrosine kinase inhibitor|tyrosine kinase inhibitor
412064|NCT01190241|kinome profiling|kinome profiling
412065|NCT01190241|Metastasized|metastasized
412066|NCT01190228|Japanese Encephalitis|japanese encephalitis
412067|NCT01190228|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
412068|NCT01190228|Varicella|varicella
412069|NCT01190228|Varicella vaccine|varicella vaccine
412070|NCT01190215|Influenza|influenza
412071|NCT01190215|Pandemrix|pandemrix
412072|NCT01190215|H1N1|h1n1
412073|NCT01190215|Fluarix|fluarix
412074|NCT01190202|Malaria|malaria
412075|NCT01190202|Plasmodium falciparum|plasmodium falciparum
412076|NCT01190189|Serious adverse events (SAEs)|serious adverse events (saes)
412077|NCT01190189|HPV vaccine|hpv vaccine
412078|NCT01190189|Medically significant conditions|medically significant conditions
412079|NCT01190189|Cervical neoplasia|cervical neoplasia
412080|NCT01190176|HPV|hpv
412081|NCT01190176|HPV vaccine|hpv vaccine
412082|NCT01190176|Cervical neoplasia|cervical neoplasia
412083|NCT01190176|Human papillomavirus|human papillomavirus
412084|NCT01190176|Papillomavirus|papillomavirus
412085|NCT01190176|Cervical cancer|cervical cancer
412086|NCT01190176|Human papillomavirus (HPV) type 16/18 infections|human papillomavirus (hpv) type 16/18 infections
412087|NCT01190163|Vaginal Birth delivery within 24 hours and C-section rate|vaginal birth delivery within 24 hours and c-section rate
412088|NCT01190150|Cyclic Heavy Menstrual Bleed|cyclic heavy menstrual bleed
412089|NCT01190150|Menorraghia|menorraghia
412090|NCT01190137|Optimal vitamin D status|optimal vitamin d status
412091|NCT01190137|25-hydroxy vitamin D|25-hydroxy vitamin d
412092|NCT01190137|Rickets and bone mineralization|rickets and bone mineralization
412093|NCT01190137|Breast fed infants|breast fed infants
412094|NCT01190137|Cholecalciferol and ergocalciferol|cholecalciferol and ergocalciferol
412095|NCT01190124|HIV infections|hiv infections
412096|NCT01190124|HIV-1|hiv-1
412097|NCT01190124|HIV-2|hiv-2
412098|NCT01190124|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
412099|NCT01190124|AIDS|aids
412100|NCT01190124|Anti-Retroviral Agents|anti-retroviral agents
412101|NCT01190124|Raltegravir|raltegravir
412102|NCT01190124|Integrase Inhibitors|integrase inhibitors
412103|NCT01190124|multiple-experienced HIV infected patients|multiple-experienced hiv infected patients
412104|NCT01190111|interleukin-7|interleukin-7
412105|NCT01190111|immune-based therapy|immune-based therapy
412106|NCT01190111|HIV|hiv
412107|NCT01190111|viral disease|viral disease
412108|NCT01190098|Partial epilepsy|partial epilepsy
412109|NCT01190098|Excessive daytime sleepiness|excessive daytime sleepiness
412110|NCT01190098|Epworth Sleepiness Scale|epworth sleepiness scale
412111|NCT01190098|Maintenance of Wakefulness Test|maintenance of wakefulness test
412112|NCT01190085|alcoholism|alcoholism
412113|NCT01190085|ghrelin|ghrelin
412114|NCT01190085|craving|craving
412115|NCT01190072|Blood lipids|blood lipids
412116|NCT01190072|percutaneous coronary intervention|percutaneous coronary intervention
412117|NCT01190072|lipid lowering treatment|lipid lowering treatment
412118|NCT01190059|Lung|lung
412119|NCT01190059|Transplantation|transplantation
412120|NCT01190059|Lung Transplantation|lung transplantation
412121|NCT01190059|Transplantation Lung|transplantation lung
412122|NCT01190046|elderly|elderly
412123|NCT01190046|muscle|muscle
412124|NCT01190046|disuse|disuse
412125|NCT01190046|osteoarthritis|osteoarthritis
412126|NCT01190046|exercise|exercise
412127|NCT01189994|Fibromyalgia|fibromyalgia
412128|NCT01189994|Acupuncture|acupuncture
412129|NCT01189994|Randomized Controlled Trial|randomized controlled trial
412130|NCT01189994|Pain|pain
412131|NCT01189994|Quality of Life|quality of life
412132|NCT01189968|Phase 1,|phase 1,
412133|NCT01189968|dose escalation,|dose escalation,
412134|NCT01189968|histologically|histologically
412135|NCT01189968|confirmed|confirmed
412136|NCT01189968|malignancy|malignancy
412137|NCT01189968|metastatic|metastatic
412138|NCT01189955|thyroidectomy|thyroidectomy
412139|NCT01189955|harmonic|harmonic
412140|NCT01189955|RLN|rln
412141|NCT01189942|Phase 1|phase 1
412142|NCT01189942|dose escalation|dose escalation
412143|NCT01189942|histologically|histologically
412144|NCT01189942|confirmed|confirmed
412145|NCT01189942|malignancy|malignancy
412146|NCT01189942|metastatic|metastatic
412147|NCT01189929|Phase 1,|phase 1,
412148|NCT01189929|dose escalation,|dose escalation,
412149|NCT01189929|histologically|histologically
412150|NCT01189929|cytologically|cytologically
412151|NCT01189929|confirmed|confirmed
412152|NCT01189929|malignancy|malignancy
412153|NCT01189929|metastatic|metastatic
412154|NCT01189890|Type 2 Diabetes Mellitus, Hemoglobin A1C, glucagon-like peptide 1 (GLP-1), gastric inhibitory polypeptide (GIP), dipeptidyl peptidase 4 inhibitor (DPP-4)|type 2 diabetes mellitus, hemoglobin a1c, glucagon-like peptide 1 (glp-1), gastric inhibitory polypeptide (gip), dipeptidyl peptidase 4 inhibitor (dpp-4)
412155|NCT01189877|Direct pO2 Measurements|direct po2 measurements
412156|NCT01189877|10-121|10-121
412157|NCT01189851|breast|breast
412158|NCT01189851|IORT|iort
412159|NCT01189851|electronic brachytherapy|electronic brachytherapy
412160|NCT01189838|Cancer|cancer
412161|NCT01189838|cysteine-rich 61|cysteine-rich 61
412162|NCT01189838|prognosis|prognosis
412163|NCT01189838|transitional cell carcinoma|transitional cell carcinoma
412164|NCT01189825|Physiological|physiological
412165|NCT01189825|Antidepressive Agents|antidepressive agents
412166|NCT01189812|hopelessness|hopelessness
412167|NCT01189812|alone|alone
412168|NCT01189812|sad|sad
412169|NCT01189812|troubled|troubled
412170|NCT01189812|depression|depression
412171|NCT01189799|Co-occurring Disorders|co-occurring disorders
412172|NCT01189799|Depression|depression
412173|NCT01189799|Substance Dependence|substance dependence
412174|NCT01189799|Motivational Therapy|motivational therapy
412175|NCT01189799|Aftercare|aftercare
412176|NCT01189799|Cognitive Behavioral Therapy|cognitive behavioral therapy
412177|NCT01189786|Haploidentical Stem Cell Transplant|haploidentical stem cell transplant
412178|NCT01189786|CD34+ Selection|cd34+ selection
412179|NCT01189786|CliniMACS CD34 Reagent system|clinimacs cd34 reagent system
412180|NCT01189773|pain control|pain control
412181|NCT01189773|limb trauma|limb trauma
412182|NCT01189734|common bile duct stones|common bile duct stones
412183|NCT01189734|laparoscopic common bile duct exploration|laparoscopic common bile duct exploration
412184|NCT01189734|intraoperative ercp|intraoperative ercp
412185|NCT01189734|Preoperatively diagnosed common bile duct stones|preoperatively diagnosed common bile duct stones
412186|NCT01189721|remifentanil|remifentanil
412187|NCT01189721|hyperalgesia|hyperalgesia
412188|NCT01189708|Abdominal aortic aneurysm|abdominal aortic aneurysm
412189|NCT01189708|Abdominal hernia|abdominal hernia
412190|NCT01189695|HIV or AIDS|hiv or aids
412191|NCT01189695|Lopinavir|lopinavir
412192|NCT01189695|Ritonavir|ritonavir
412193|NCT01189695|Anti-Retroviral Agents|anti-retroviral agents
412194|NCT01189695|treatment failure|treatment failure
412195|NCT01189695|treatment experienced|treatment experienced
412196|NCT01189695|NNRTI failure|nnrti failure
412197|NCT01189695|monotherapy|monotherapy
412198|NCT01189682|catheter|catheter
412199|NCT01189682|dressing|dressing
412200|NCT01189682|chlorhexidine|chlorhexidine
752630|NCT01173393|Emergency medical System|emergency medical system
412201|NCT01189682|Patient admitted in ICU with a CVC or art. catheter|patient admitted in icu with a cvc or art. catheter
412203|NCT01189656|Chronic hepatitis B patients|chronic hepatitis b patients
412204|NCT01189643|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
412205|NCT01189643|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
412206|NCT01189643|TEMOZOLOMIDE|temozolomide
412207|NCT01189643|DSRCT|dsrct
412208|NCT01189643|10-091|10-091
412209|NCT01189630|"Real World Electronic Database with clinical information"|"real world electronic database with clinical information"
412210|NCT01189630|related to Implantable Cardiac devices.|related to implantable cardiac devices.
412211|NCT01189617|Personal Lubricant|personal lubricant
412212|NCT01189604|propofol endoscopy sedation|propofol endoscopy sedation
412213|NCT01189578|Recreational|recreational
412214|NCT01189578|cocaine|cocaine
412215|NCT01189578|fMRI|fmri
412216|NCT01189578|neuroimaging|neuroimaging
412217|NCT01189578|craving|craving
412218|NCT01189578|impulsivity|impulsivity
412219|NCT01189565|Total Hip Replacement/Revision|total hip replacement/revision
412220|NCT01189526|Branch retinal vein occlusion|branch retinal vein occlusion
412222|NCT01189526|intravitreal injection|intravitreal injection
412223|NCT01189526|ranibizumab|ranibizumab
412224|NCT01189513|Recurrent Glioblastoma|recurrent glioblastoma
412225|NCT01189513|Gliosarcoma|gliosarcoma
412226|NCT01189513|SCH 900105|sch 900105
412227|NCT01189500|Pharmacokinetic|pharmacokinetic
412228|NCT01189500|safety and tolerability|safety and tolerability
412229|NCT01189500|genetic testing|genetic testing
412230|NCT01189500|CYP 2D6|cyp 2d6
412231|NCT01189487|ampicillin sodium/sulbactam sodium|ampicillin sodium/sulbactam sodium
412232|NCT01189487|Unasyn-S|unasyn-s
412233|NCT01189487|community acquired pneumonia|community acquired pneumonia
412234|NCT01189487|bacterial pneumonia|bacterial pneumonia
412527|NCT01188083|NASH|nash
412235|NCT01189474|Meibomian Gland Dysfunction|meibomian gland dysfunction
412236|NCT01189461|pegaptanib sodium|pegaptanib sodium
412237|NCT01189461|diabetic macular edema|diabetic macular edema
412238|NCT01189448|Congenital Toxoplasmosis,|congenital toxoplasmosis,
412239|NCT01189448|Pregnancy,|pregnancy,
412240|NCT01189448|prenatal diagnosis,|prenatal diagnosis,
412241|NCT01189448|mother-to-child transmission,|mother-to-child transmission,
412242|NCT01189448|prevention,|prevention,
412243|NCT01189448|spiramycine,|spiramycine,
412244|NCT01189448|pyrimethamine-sulfadiazine|pyrimethamine-sulfadiazine
412245|NCT01189435|OSI-774, TARCEVA (ERLOTINIB)|osi-774, tarceva (erlotinib)
412246|NCT01189435|Lung|lung
412247|NCT01189435|recurrent|recurrent
412248|NCT01189435|10-097|10-097
412249|NCT01189435|Gefitinib|gefitinib
412250|NCT01189422|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
412251|NCT01189422|T1DM|t1dm
412252|NCT01189409|Constipation|constipation
412253|NCT01189409|Opioids|opioids
412254|NCT01189409|Cancer|cancer
412255|NCT01189409|Polyethylene glycol|polyethylene glycol
412256|NCT01189409|Sennosides|sennosides
412257|NCT01189409|Opioid Therapy|opioid therapy
412258|NCT01189396|asthma|asthma
412259|NCT01189396|bronchospasm|bronchospasm
412260|NCT01189396|COPD|copd
412261|NCT01189396|reversibility|reversibility
412262|NCT01189396|efficacy|efficacy
412263|NCT01189383|Melanoma|melanoma
412264|NCT01189383|Vaccine|vaccine
412265|NCT01189383|Dendritic Cell|dendritic cell
412266|NCT01189383|Immune response|immune response
412267|NCT01189383|Safety|safety
412268|NCT01189383|Efficacy|efficacy
412269|NCT01189370|carcinoma, renal cell|carcinoma, renal cell
412270|NCT01189370|kidney|kidney
412271|NCT01189370|cancer|cancer
412272|NCT01189357|meniscal transplant|meniscal transplant
412273|NCT01189344|Obesity|obesity
412275|NCT01189344|Absorption|absorption
412276|NCT01189344|Thyroid function|thyroid function
412277|NCT01189331|Coronary artery disease|coronary artery disease
412278|NCT01189331|CT|ct
412279|NCT01189331|Computational flow dynamics|computational flow dynamics
412280|NCT01189305|Drug Abuse|drug abuse
412281|NCT01189305|Female Patients|female patients
412282|NCT01189292|postoperative nausea and vomitus|postoperative nausea and vomitus
412283|NCT01189292|PONV|ponv
412284|NCT01189292|thyroid surgery|thyroid surgery
412285|NCT01189253|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
412286|NCT01189253|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
412287|NCT01189253|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
412288|NCT01189253|adult angiosarcoma|adult angiosarcoma
412289|NCT01189253|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
412290|NCT01189253|adult epithelioid sarcoma|adult epithelioid sarcoma
412291|NCT01189253|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
412292|NCT01189253|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
412293|NCT01189253|adult fibrosarcoma|adult fibrosarcoma
412294|NCT01189253|adult leiomyosarcoma|adult leiomyosarcoma
412295|NCT01189253|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
412296|NCT01189253|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
412297|NCT01189253|adult malignant mesenchymoma|adult malignant mesenchymoma
412298|NCT01189253|adult neurofibrosarcoma|adult neurofibrosarcoma
412299|NCT01189253|adult synovial sarcoma|adult synovial sarcoma
412300|NCT01189227|stage IV colon cancer|stage iv colon cancer
412301|NCT01189227|adenocarcinoma of the colon|adenocarcinoma of the colon
412302|NCT01189227|stage IV rectal cancer|stage iv rectal cancer
412303|NCT01189227|adenocarcinoma of the rectum|adenocarcinoma of the rectum
412304|NCT01189227|liver metastases|liver metastases
412305|NCT01189162|Primary treatment of RDS and treatment of RDS post extubation|primary treatment of rds and treatment of rds post extubation
412306|NCT01189136|Voiding dysfunction|voiding dysfunction
412307|NCT01189123|influenza|influenza
412308|NCT01189123|vaccine|vaccine
412309|NCT01189123|cell mediated immunity|cell mediated immunity
412310|NCT01189123|elderly|elderly
412311|NCT01189123|high dose influenza vaccine|high dose influenza vaccine
412312|NCT01189110|smoking cessation|smoking cessation
412313|NCT01189110|veterans|veterans
412314|NCT01189110|auriculotherapy|auriculotherapy
412315|NCT01189084|Alzheimer's disease|alzheimer's disease
412316|NCT01189084|amyloid beta|amyloid beta
412317|NCT01189084|vaccine|vaccine
411789|NCT01191385|HCC|hcc
412318|NCT01189071|Stents [E07.695.750]|stents [e07.695.750]
412319|NCT01189071|Darifenacin (C101207)|darifenacin (c101207)
412320|NCT01189071|Kidney calculi|kidney calculi
412321|NCT01189058|Perinatal stroke|perinatal stroke
412322|NCT01189058|Periventricular venous infarction|periventricular venous infarction
412323|NCT01189058|Presumed perinatal stroke|presumed perinatal stroke
412324|NCT01189058|Neonatal stroke|neonatal stroke
412325|NCT01189058|Arterial ischemic stroke|arterial ischemic stroke
412326|NCT01189058|Fetal stroke|fetal stroke
412327|NCT01189058|Transcranial magnetic stimulation|transcranial magnetic stimulation
412328|NCT01189058|Constraint-induced movement therapy|constraint-induced movement therapy
412329|NCT01189058|CIMT|cimt
412330|NCT01189058|Cerebral palsy|cerebral palsy
412331|NCT01189058|Congenital hemiplegia|congenital hemiplegia
412332|NCT01189058|Hemiplegic cerebral palsy|hemiplegic cerebral palsy
412333|NCT01189058|Neuroplasticity|neuroplasticity
412334|NCT01189058|Developmental plasticity|developmental plasticity
412335|NCT01189045|Stroke|stroke
412336|NCT01189045|Exercise|exercise
412337|NCT01189045|Rehabilitation|rehabilitation
412338|NCT01189045|Risk factors|risk factors
412339|NCT01189019|ranibizumab|ranibizumab
412340|NCT01189019|Wet macular degeneration|wet macular degeneration
412341|NCT01189019|macular degeneration|macular degeneration
412343|NCT01189019|Retinal Pigment Epithelial Detachment|retinal pigment epithelial detachment
412344|NCT01188967|Drugs, Investigational|drugs, investigational
412345|NCT01188967|Nicotine Dependence|nicotine dependence
412346|NCT01188967|Therapies for Relapse to Nicotine|therapies for relapse to nicotine
412347|NCT01188967|Relapse Prevention|relapse prevention
412348|NCT01188967|Smoking Cessation|smoking cessation
412349|NCT01188967|Nicotine Cessation Therapies|nicotine cessation therapies
412350|NCT01188954|Seroma|seroma
412351|NCT01188954|Doxycycline|doxycycline
412352|NCT01188954|Cardiopulmonary By-Pass|cardiopulmonary by-pass
412353|NCT01188954|Femoral Artery/Vein Cannulation|femoral artery/vein cannulation
412354|NCT01188954|Prevent Seroma Formation|prevent seroma formation
412355|NCT01188915|Hodgkin disease|hodgkin disease
412356|NCT01188915|Breast cancer|breast cancer
412357|NCT01188889|Chronic Myeloid Leukemia|chronic myeloid leukemia
412358|NCT01188876|carboplatin|carboplatin
412359|NCT01188876|recurrent|recurrent
412360|NCT01188876|platinum sensitive|platinum sensitive
412361|NCT01188876|pralatrexate|pralatrexate
412362|NCT01188850|CIN 2 or 3|cin 2 or 3
412363|NCT01188850|cervical cancer|cervical cancer
412364|NCT01188850|Human Papillomavirus (HPV)|human papillomavirus (hpv)
412365|NCT01188837|Osteoarthritis, Knee|osteoarthritis, knee
412366|NCT01188837|Manipulation Therapy|manipulation therapy
412367|NCT01188811|Multiple Sclerosis|multiple sclerosis
412368|NCT01188811|Multiple sclerosis, chronic progressive|multiple sclerosis, chronic progressive
412369|NCT01188811|Neuroprotective agents|neuroprotective agents
412370|NCT01188811|Magnetic resonance imaging|magnetic resonance imaging
412371|NCT01188811|Optical coherence tomography|optical coherence tomography
412372|NCT01188811|Gait|gait
412373|NCT01188811|Thioctic acid|thioctic acid
412374|NCT01188811|Alpha-lipoic acid|alpha-lipoic acid
412375|NCT01188798|Allogeneic Bone Marrow Transplantation|allogeneic bone marrow transplantation
412376|NCT01188798|Graft versus host disease|graft versus host disease
412377|NCT01188798|Tacrolimus|tacrolimus
412378|NCT01188798|Sirolimus|sirolimus
412379|NCT01188798|Methotrexate|methotrexate
412380|NCT01188798|Pentostatin|pentostatin
412381|NCT01188785|siRNA|sirna
412382|NCT01188785|RNA interference (RNAi)|rna interference (rnai)
412383|NCT01188785|Cancer|cancer
412384|NCT01188785|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
412385|NCT01188785|Pancreatic cancer|pancreatic cancer
412386|NCT01188785|Solid tumor|solid tumor
412387|NCT01188785|Operable pancreatic ductal adenocarcinoma|operable pancreatic ductal adenocarcinoma
412388|NCT01188785|Non operable pancreatic ductal adenocarcinoma|non operable pancreatic ductal adenocarcinoma
412389|NCT01188772|Hepatitis C Virus|hepatitis c virus
412390|NCT01188772|HCV|hcv
412391|NCT01188772|hepatitis|hepatitis
412392|NCT01188772|Genotype 1|genotype 1
412393|NCT01188772|Genotype 2|genotype 2
412394|NCT01188772|Genotype 3|genotype 3
412395|NCT01188759|Aspergillosis|aspergillosis
412396|NCT01188759|Combination Therapy|combination therapy
412397|NCT01188759|Voriconazole|voriconazole
412398|NCT01188759|Anidulafungin|anidulafungin
412399|NCT01188746|catheter|catheter
412400|NCT01188746|palliative|palliative
412401|NCT01188746|quality of life|quality of life
412402|NCT01188746|10-059|10-059
412403|NCT01188733|portal hypertension|portal hypertension
412404|NCT01188733|varices|varices
412405|NCT01188733|cirrhosis|cirrhosis
412406|NCT01188733|octreotide|octreotide
412407|NCT01188733|somatostatin analog|somatostatin analog
412408|NCT01188733|Child Pugh Class A,B|child pugh class a,b
412409|NCT01188707|Non small cell lung cancer|non small cell lung cancer
412410|NCT01188707|Belinostat|belinostat
412411|NCT01188707|Erlotinib|erlotinib
412412|NCT01188707|HDAC inhibitor|hdac inhibitor
412413|NCT01188707|Phase I/II|phase i/ii
412415|NCT01188681|TRU-016|tru-016
753424|NCT01179217|Sickle Cell Pain Crises|sickle cell pain crises
412416|NCT01188681|chronic lymphocytic leukemia|chronic lymphocytic leukemia
412417|NCT01188681|relapsed CLL|relapsed cll
412418|NCT01188681|bendamustine|bendamustine
412419|NCT01188668|Pharmacokinetic|pharmacokinetic
412420|NCT01188668|safety and tolerability|safety and tolerability
412421|NCT01188668|genetic testing|genetic testing
412422|NCT01188668|CYP 2D6 and CYP 3A4|cyp 2d6 and cyp 3a4
412423|NCT01188655|Ankylosing Spondylitis|ankylosing spondylitis
412424|NCT01188642|childhood obesity|childhood obesity
412425|NCT01188642|adipocytokines|adipocytokines
412426|NCT01188642|physical exercise|physical exercise
412427|NCT01188642|nutrition education|nutrition education
412428|NCT01188629|Preventive Care|preventive care
412429|NCT01188629|Medication Management|medication management
412430|NCT01188629|Electronic Medical Records|electronic medical records
412431|NCT01188629|Automated Telephone System|automated telephone system
412432|NCT01188616|Childhood Obesity|childhood obesity
412433|NCT01188616|Obesity Intervention|obesity intervention
412434|NCT01188590|Post operative Respiratory insufficiency|post operative respiratory insufficiency
412436|NCT01188577|bronchospasm|bronchospasm
412437|NCT01188577|wheezing|wheezing
412438|NCT01188577|shortness of breath|shortness of breath
412439|NCT01188564|Hereditary Angioedema|hereditary angioedema
412440|NCT01188564|HAE|hae
412441|NCT01188564|Angioedema|angioedema
412442|NCT01188564|Recombinant C1 Inhibitor|recombinant c1 inhibitor
412443|NCT01188564|rhC1INH|rhc1inh
412444|NCT01188551|myringotomy|myringotomy
412445|NCT01188551|pressure equalization tubes|pressure equalization tubes
412446|NCT01188538|P. acnes, Acne vulgaris|p. acnes, acne vulgaris
412447|NCT01188525|pharmacokinetics|pharmacokinetics
412448|NCT01188525|enzymes|enzymes
412449|NCT01188525|metabolism prediction|metabolism prediction
412450|NCT01188512|Live nasal vaccine for prevention of pertussis|live nasal vaccine for prevention of pertussis
412451|NCT01188473|Status Asthmaticus|status asthmaticus
412452|NCT01188473|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
412453|NCT01188473|Asthma in Children|asthma in children
412454|NCT01188460|Insomnia|insomnia
412455|NCT01188460|Chronic pain|chronic pain
412456|NCT01188447|cervical-spine injuries|cervical-spine injuries
412457|NCT01188447|cervical-spine fractures|cervical-spine fractures
412458|NCT01188447|spinal cord injury|spinal cord injury
412459|NCT01188447|neck injury|neck injury
412460|NCT01188447|Canadian C-Spine Rule|canadian c-spine rule
412461|NCT01188447|paramedics|paramedics
412462|NCT01188447|emergency medical services|emergency medical services
412463|NCT01188434|Methamphetamine|methamphetamine
412464|NCT01188434|Substance Abuse|substance abuse
412465|NCT01188434|Child Neglect|child neglect
412466|NCT01188434|Child Welfare|child welfare
412467|NCT01188434|Evidence Based Practice|evidence based practice
412468|NCT01188382|Intracranial pressure|intracranial pressure
412469|NCT01188382|resistance|resistance
412470|NCT01188382|CSF outflow|csf outflow
412471|NCT01188382|elderly|elderly
412472|NCT01188382|reference value|reference value
412473|NCT01188369|levosimendan|levosimendan
412474|NCT01188369|heart failure|heart failure
412475|NCT01188369|inotropics|inotropics
412476|NCT01188369|diastolic dysfunction|diastolic dysfunction
412477|NCT01188369|left ventricular hypertrophy|left ventricular hypertrophy
412478|NCT01188369|aortic valve stenosis|aortic valve stenosis
412479|NCT01188356|Reply|reply
412480|NCT01188356|Symphony|symphony
412481|NCT01188356|Atrial arrhythmias|atrial arrhythmias
412482|NCT01188356|V pacing|v pacing
412483|NCT01188356|Evaluate the incidence and evolution over-time of co-morbidities|evaluate the incidence and evolution over-time of co-morbidities
412484|NCT01188343|Japanese Encephalitis|japanese encephalitis
412485|NCT01188343|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
412486|NCT01188343|Measles|measles
412487|NCT01188343|Mumps|mumps
412488|NCT01188343|Rubella|rubella
412489|NCT01188330|acute myeloid leukemia|acute myeloid leukemia
752631|NCT01173393|non-VF|non-vf
412490|NCT01188291|Optical Coherence Tomography|optical coherence tomography
412491|NCT01188291|Retinal Nerve Fiber Layer Thickness|retinal nerve fiber layer thickness
412492|NCT01188291|Obstructive Sleep Apnea|obstructive sleep apnea
412493|NCT01188291|Hypopnea syndrome|hypopnea syndrome
412494|NCT01188291|Glaucoma|glaucoma
412495|NCT01188252|Phase I|phase i
412496|NCT01188252|Dose escalation|dose escalation
412497|NCT01188252|Kinase inhibitor|kinase inhibitor
412498|NCT01188252|Cyclin-dependent kinases|cyclin-dependent kinases
412499|NCT01188239|electronic cigarette|electronic cigarette
412500|NCT01188239|nicotine|nicotine
412501|NCT01188239|smoking cessation|smoking cessation
412502|NCT01188239|smoking reduction|smoking reduction
412503|NCT01188187|custirsen sodium|custirsen sodium
412504|NCT01188187|prostate cancer|prostate cancer
412505|NCT01188187|overall survival|overall survival
412506|NCT01188187|Metastatic Castrate Resistant Prostate Cancer|metastatic castrate resistant prostate cancer
412507|NCT01188174|AML|aml
412508|NCT01188174|primary induction failure|primary induction failure
412509|NCT01188161|Posturography|posturography
412510|NCT01188161|Balance|balance
412511|NCT01188161|Falls|falls
412512|NCT01188161|Gyroscope|gyroscope
412513|NCT01188161|Rotational Chair|rotational chair
412514|NCT01188161|Vestibular|vestibular
412515|NCT01188161|Movement Disorders|movement disorders
412516|NCT01188135|depression|depression
412517|NCT01188135|interactive voice messaging|interactive voice messaging
412518|NCT01188135|patient persistence with antidepressant medication treatment|patient persistence with antidepressant medication treatment
412519|NCT01188122|VAP|vap
412520|NCT01188109|Pancreatic Neoplasms|pancreatic neoplasms
412521|NCT01188109|Pancreatic cancer|pancreatic cancer
412522|NCT01188096|glioma|glioma
412523|NCT01188096|pediatrics|pediatrics
412524|NCT01188096|cancer|cancer
412525|NCT01188096|brain tumor|brain tumor
412526|NCT01188096|low grade glioma|low grade glioma
412528|NCT01188083|non-alcoholic fatty-liver disease|non-alcoholic fatty-liver disease
412529|NCT01188083|Hispanic|hispanic
412530|NCT01188083|overweight|overweight
412531|NCT01188070|Behavioral/Social|behavioral/social
412532|NCT01188070|Cardiology|cardiology
412533|NCT01188070|Clinical Laboratory Methods|clinical laboratory methods
412534|NCT01188070|Congestive Heart Failure|congestive heart failure
412535|NCT01188070|Heart Disease|heart disease
412536|NCT01188070|Knowledge Dissemination|knowledge dissemination
412537|NCT01188070|Lipids|lipids
412538|NCT01188070|Nursing|nursing
412539|NCT01188070|Health Promotion|health promotion
412540|NCT01188070|Alzheimer's Disease/Dementia|alzheimer's disease/dementia
412541|NCT01188057|Bioequivalence|bioequivalence
412542|NCT01188057|ALPRAZOLAM|alprazolam
412543|NCT01188057|Healthy subjects|healthy subjects
412544|NCT01188044|Motor activity|motor activity
412545|NCT01188044|Infant|infant
412546|NCT01188044|Validation studies|validation studies
412547|NCT01188044|Malawi|malawi
412548|NCT01188044|Sub-Saharan Africa|sub-saharan africa
412549|NCT01188031|Bioequivalence|bioequivalence
412550|NCT01188031|ALPRAZOLAM|alprazolam
412551|NCT01188031|Healthy subjects|healthy subjects
412552|NCT01188018|Smoking|smoking
412553|NCT01188018|Smoking Cessation|smoking cessation
412554|NCT01188018|Nicotine Dependence|nicotine dependence
412555|NCT01188018|Tobacco Use Cessation|tobacco use cessation
412556|NCT01188018|Health Education|health education
412557|NCT01188018|Patient Education|patient education
412558|NCT01188005|OSAS|osas
412559|NCT01188005|Sleep Apnoea|sleep apnoea
412560|NCT01188005|IL6|il6
412561|NCT01188005|TNFα|tnfα
412562|NCT01188005|Oxidative Stress|oxidative stress
412563|NCT01188005|Antioxidants|antioxidants
412564|NCT01187992|Atorvastatin|atorvastatin
412565|NCT01187992|Acute coronary syndrome|acute coronary syndrome
412566|NCT01187992|Advanced coronary artery disease|advanced coronary artery disease
412567|NCT01187979|Cash incentive|cash incentive
412568|NCT01187979|HIV prevention|hiv prevention
412569|NCT01187979|Adolescents|adolescents
412570|NCT01187979|South Africa|south africa
412571|NCT01187979|HIV|hiv
412572|NCT01187966|Parkinson's Disease|parkinson's disease
412573|NCT01187966|PD|pd
412574|NCT01187966|Levodopa|levodopa
412575|NCT01187966|Patients with idiopathic Parkinson's disease with motor fluctuations|patients with idiopathic parkinson's disease with motor fluctuations
412576|NCT01187953|Tacrolimus|tacrolimus
412577|NCT01187953|Acute Rejection|acute rejection
412578|NCT01187953|Kidney|kidney
412579|NCT01187940|Autism Spectrum Disorder;|autism spectrum disorder;
412580|NCT01187940|Psychoeducation|psychoeducation
412581|NCT01187914|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
412582|NCT01187914|Radio-frequency Ablation|radio-frequency ablation
412583|NCT01187914|Ablation|ablation
412584|NCT01187914|Open irrigation cooled-tip|open irrigation cooled-tip
412585|NCT01187901|Familial Adenomatous Polyposis|familial adenomatous polyposis
412586|NCT01187901|Attenuated Familial Polyposis|attenuated familial polyposis
412587|NCT01187888|PSP|psp
412588|NCT01187888|Progressive Supranuclear Palsy|progressive supranuclear palsy
412589|NCT01187888|Rasagiline|rasagiline
412590|NCT01187888|Azilect|azilect
412591|NCT01187888|PROSPERA|prospera
412592|NCT01187875|satiety, dietary fiber|satiety, dietary fiber
412593|NCT01187823|Chronic heart failure|chronic heart failure
412594|NCT01187823|Central sleep apnea|central sleep apnea
412595|NCT01187823|Obstructive sleep apnea|obstructive sleep apnea
412596|NCT01187823|Adaptive servo ventilation|adaptive servo ventilation
412597|NCT01187810|leukemia,lymphoma|leukemia,lymphoma
412598|NCT01187758|antibiotic use|antibiotic use
412599|NCT01187758|antibiotic prescription|antibiotic prescription
412600|NCT01187758|antibiotic resistant S. pneumoniae|antibiotic resistant s. pneumoniae
412601|NCT01187758|MRSA|mrsa
412602|NCT01187745|renal calculi|renal calculi
412603|NCT01187732|skin damage|skin damage
412604|NCT01187732|intertrigo|intertrigo
412605|NCT01187732|dermatitis|dermatitis
412606|NCT01187732|erythema|erythema
412607|NCT01187732|aggression|aggression
412608|NCT01187732|body Wipes|body wipes
412609|NCT01187732|soaps|soaps
412610|NCT01187732|no rinse|no rinse
412611|NCT01187732|cost effectiveness|cost effectiveness
412612|NCT01187732|nursing home residents|nursing home residents
412613|NCT01187732|nurse|nurse
412614|NCT01187719|HIV|hiv
412616|NCT01187719|phenytoin|phenytoin
412617|NCT01187719|ARV prophylaxis|arv prophylaxis
412618|NCT01187719|nevirapine|nevirapine
412619|NCT01187706|gynecological cancer survivors|gynecological cancer survivors
412620|NCT01187706|quality of life|quality of life
412621|NCT01187680|Tissue adhesions|tissue adhesions
412622|NCT01187680|Laparoscopy|laparoscopy
412623|NCT01187667|delirium|delirium
412624|NCT01187667|prevention|prevention
412625|NCT01187667|critical care|critical care
412626|NCT01187667|haloperidol|haloperidol
412627|NCT01187654|myocardial infarction|myocardial infarction
412628|NCT01187654|bone marrow stem cell|bone marrow stem cell
412629|NCT01187654|AC133|ac133
412630|NCT01187654|mono nuclear cell|mono nuclear cell
412727|NCT01187225|Bleeding|bleeding
412631|NCT01187641|cancer, colon, MRI scan|cancer, colon, mri scan
412632|NCT01187628|Long-term study in Chronic Kidney Disease|long-term study in chronic kidney disease
412633|NCT01187628|Lanthanum Carbonate|lanthanum carbonate
412634|NCT01187615|Nonsquamous Non-small cell lung cancer|nonsquamous non-small cell lung cancer
412635|NCT01187615|Phase I|phase i
412636|NCT01187576|Physical activity|physical activity
412637|NCT01187576|Hypertension|hypertension
412638|NCT01187576|Diabetes mellitus|diabetes mellitus
412639|NCT01187576|Motivational interviewing|motivational interviewing
412640|NCT01187563|Rheumatoid arthritis, tocilizumab|rheumatoid arthritis, tocilizumab
412641|NCT01187550|Dwarfism, pituitary|dwarfism, pituitary
412642|NCT01187550|Growth hormone|growth hormone
412643|NCT01187537|Knee Replacement|knee replacement
412644|NCT01187537|Analgesia|analgesia
412645|NCT01187537|Analgesics|analgesics
412646|NCT01187537|Nerve blocks|nerve blocks
412647|NCT01187537|Recovery of functions|recovery of functions
412648|NCT01187537|Post operative analgesia|post operative analgesia
412649|NCT01187524|Patient Registry|patient registry
412650|NCT01187524|FMR1 Gene|fmr1 gene
412651|NCT01187524|Fragile X Syndrome|fragile x syndrome
412652|NCT01187524|Primary Ovarian Insufficiency|primary ovarian insufficiency
412653|NCT01187524|Premature Ovarian Failure|premature ovarian failure
412654|NCT01187524|Premature Ovarian Insufficiency|premature ovarian insufficiency
412655|NCT01187511|Addiction|addiction
412656|NCT01187511|Alcohol Dependence|alcohol dependence
412657|NCT01187511|Anxiety|anxiety
412658|NCT01187511|CRH Antagonist|crh antagonist
412659|NCT01187511|Stress Induced Craving|stress induced craving
412660|NCT01187498|Overactive bladder|overactive bladder
412661|NCT01187498|Behavioral treatment|behavioral treatment
412662|NCT01187498|Drug therapy|drug therapy
412663|NCT01187498|Lower urinary tract symptoms|lower urinary tract symptoms
412664|NCT01187498|Urinary incontinence|urinary incontinence
412665|NCT01187498|Clinical trial|clinical trial
412666|NCT01187485|Androderm®|androderm®
412667|NCT01187485|Testosterone|testosterone
412668|NCT01187485|refractory|refractory
412669|NCT01187485|prostate|prostate
412670|NCT01187485|cancer|cancer
412671|NCT01187485|"Patients with hormone refractory prostate cancer will be treated with a daily testosterone patch Androderm® applied every 24 hours to the skin"|"patients with hormone refractory prostate cancer will be treated with a daily testosterone patch androderm® applied every 24 hours to the skin"
412672|NCT01187472|Head|head
412673|NCT01187472|neck|neck
412674|NCT01187472|cancer|cancer
412675|NCT01187472|advanced|advanced
412676|NCT01187472|oral cavity|oral cavity
412677|NCT01187472|lip|lip
412678|NCT01187472|larynx|larynx
412679|NCT01187459|Vitamin D|vitamin d
412680|NCT01187459|Crohn's Disease|crohn's disease
412681|NCT01187459|Dose Response|dose response
412682|NCT01187446|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
412683|NCT01187433|Dengue|dengue
412684|NCT01187433|Dengue hemorrhagic fever|dengue hemorrhagic fever
412685|NCT01187433|CYD Dengue Vaccines|cyd dengue vaccines
412686|NCT01187420|Cerebral vasospasm|cerebral vasospasm
412687|NCT01187420|delayed cerebral ischemia (DCI)|delayed cerebral ischemia (dci)
412688|NCT01187420|subarachnoid hemorrhage (SAH) patients|subarachnoid hemorrhage (sah) patients
412689|NCT01187394|Frozen Plasma|frozen plasma
412690|NCT01187394|Fresh Frozen Plasma|fresh frozen plasma
412691|NCT01187394|Cardiac Surgery|cardiac surgery
412692|NCT01187394|Bleeding|bleeding
412693|NCT01187394|Knowledge Translation|knowledge translation
412694|NCT01187368|heart failure|heart failure
412695|NCT01187368|LVAS|lvas
412696|NCT01187368|LVAD|lvad
412697|NCT01187368|bridge-to-transplant|bridge-to-transplant
412698|NCT01187368|rotary pump|rotary pump
412699|NCT01187355|Symptomatic, Contact lens care|symptomatic, contact lens care
412700|NCT01187355|Multi-purpose solution|multi-purpose solution
412701|NCT01187342|Stroke|stroke
412702|NCT01187329|Hyperglycemia|hyperglycemia
412703|NCT01187329|open heart surgery|open heart surgery
412704|NCT01187329|bypass|bypass
412705|NCT01187316|Facial Pain|facial pain
412706|NCT01187316|Temporomandibular Joint Disorders|temporomandibular joint disorders
412707|NCT01187316|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
412708|NCT01187316|Adolescent|adolescent
412709|NCT01187290|Preoperative chemoradiotherapy|preoperative chemoradiotherapy
412710|NCT01187290|stage IIIA, N2|stage iiia, n2
412712|NCT01187277|rehabilitation|rehabilitation
412713|NCT01187277|gait training|gait training
412714|NCT01187277|robot-assisted therapy|robot-assisted therapy
412715|NCT01187251|tinnitus|tinnitus
412716|NCT01187251|mp3 players|mp3 players
412717|NCT01187251|noise induced hearing loss|noise induced hearing loss
412718|NCT01187251|high frequencies audiometry|high frequencies audiometry
412719|NCT01187251|acoustic otoemissions|acoustic otoemissions
412720|NCT01187238|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
412721|NCT01187238|Stage II|stage ii
412722|NCT01187238|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
412723|NCT01187238|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
412724|NCT01187238|Cisplatin|cisplatin
412725|NCT01187225|Cardiac surgical procedures|cardiac surgical procedures
412726|NCT01187225|Fibrinogen|fibrinogen
412728|NCT01187225|Cryoprecipitate|cryoprecipitate
412729|NCT01187212|First line chemotherapy in advanced gastric cancer|first line chemotherapy in advanced gastric cancer
412730|NCT01187199|Metastatic cancer|metastatic cancer
412731|NCT01187199|Chemotherapy|chemotherapy
412732|NCT01187199|Avastin|avastin
412733|NCT01187199|Carboplatin|carboplatin
412734|NCT01187199|Paclitaxel|paclitaxel
412735|NCT01187199|Sorafenib|sorafenib
412736|NCT01187199|Temsirolimus|temsirolimus
412737|NCT01187186|Liver disease|liver disease
412738|NCT01187186|ASP1941|asp1941
412739|NCT01187160|Obstructive sleep apnea|obstructive sleep apnea
412740|NCT01187147|Asthma, green tea, antioxidants|asthma, green tea, antioxidants
412741|NCT01187134|sepsis|sepsis
412742|NCT01187134|shock, septic|shock, septic
412743|NCT01187134|quality assurance, health care|quality assurance, health care
412744|NCT01187134|quality control|quality control
412745|NCT01187134|Survival Rate|survival rate
412746|NCT01187134|Follow-Up Studies|follow-up studies
412747|NCT01187134|Anti-Infective Agents/*therapeutic use|anti-infective agents/*therapeutic use
412748|NCT01187121|Graduated Sanctions|graduated sanctions
412749|NCT01187121|Probationary failure|probationary failure
412750|NCT01187121|recidivism|recidivism
412751|NCT01187121|drug relapse|drug relapse
412752|NCT01187121|criminal justice|criminal justice
412753|NCT01187108|Cobalt|cobalt
412754|NCT01187108|Excessive Erythrocytosis|excessive erythrocytosis
412755|NCT01187108|Monge's Disease|monge's disease
412756|NCT01187108|Acetazolamide|acetazolamide
412757|NCT01187108|N-acetylcysteine|n-acetylcysteine
412758|NCT01187108|Altitude Sickness|altitude sickness
412759|NCT01187108|Chronic Mountain Sickness|chronic mountain sickness
412760|NCT01187095|Involuntary childlessness|involuntary childlessness
412761|NCT01187095|Infertility|infertility
412762|NCT01187095|IVF|ivf
412763|NCT01187095|EWI|ewi
412764|NCT01187095|Couples in IVF treatment|couples in ivf treatment
412765|NCT01187095|Psychosocial intervention|psychosocial intervention
412766|NCT01187082|overactive bladder|overactive bladder
412767|NCT01187082|women|women
412768|NCT01187082|bladder training|bladder training
412769|NCT01187082|groups|groups
412770|NCT01187069|Motivation|motivation
412771|NCT01187069|patients with type 2 diabetes|patients with type 2 diabetes
412772|NCT01187069|practice nurses|practice nurses
412773|NCT01187069|general practice|general practice
412774|NCT01187069|Self-determination Theory|self-determination theory
412775|NCT01187056|Shared decision-making|shared decision-making
412776|NCT01187056|Risk information|risk information
412777|NCT01187056|Decision aids|decision aids
412778|NCT01187043|Liver Function|liver function
412779|NCT01187043|Steady State Exposure|steady state exposure
412780|NCT01187030|Frozen Plasma|frozen plasma
412781|NCT01187030|Fresh Frozen Plasma|fresh frozen plasma
412782|NCT01187030|Prothrombin Complex Concentrates|prothrombin complex concentrates
412783|NCT01187030|RAND UCLA|rand ucla
412784|NCT01187030|Modified Delphi Methodology|modified delphi methodology
412785|NCT01187030|Expert Panel|expert panel
412786|NCT01187030|Appropriateness Rating|appropriateness rating
412787|NCT01187017|Severe Aplastic Anemia|severe aplastic anemia
412788|NCT01187017|Aplastic Anemia|aplastic anemia
412789|NCT01187017|Immunosuppression|immunosuppression
412790|NCT01187017|Immunosuppressive Therapy|immunosuppressive therapy
412791|NCT01187017|T-Cells|t-cells
412792|NCT01186965|Diabetes|diabetes
412793|NCT01186965|Second Life|second life
412794|NCT01186965|virtual community|virtual community
412795|NCT01186965|diabetes education|diabetes education
412796|NCT01186965|diabetes support group|diabetes support group
412797|NCT01186952|overweight|overweight
412798|NCT01186952|obesity|obesity
412799|NCT01186952|type 2 diabetes|type 2 diabetes
412800|NCT01186952|caloric restriction|caloric restriction
412801|NCT01186952|exercise program|exercise program
412802|NCT01186952|epicardial fat|epicardial fat
412803|NCT01186939|Myelodysplastic Syndromes|myelodysplastic syndromes
412804|NCT01186939|MDS|mds
412805|NCT01186926|Obstructive sleep apnea|obstructive sleep apnea
412806|NCT01186926|OSA|osa
412807|NCT01186926|hypoglossal nerve stimulation|hypoglossal nerve stimulation
412808|NCT01186926|sleep apnea|sleep apnea
412809|NCT01186900|skin abscess|skin abscess
412810|NCT01186900|needle aspiration|needle aspiration
412811|NCT01186900|incision and drainage|incision and drainage
412812|NCT01186887|primary ACL reconstruction with a hamstring graft|primary acl reconstruction with a hamstring graft
412813|NCT01186861|NSCLC|nsclc
412814|NCT01186861|Erlotinib|erlotinib
412815|NCT01186861|OSI-906|osi-906
412816|NCT01186861|Placebo|placebo
412817|NCT01186861|Platinum-based chemotherapy|platinum-based chemotherapy
412818|NCT01186848|Stretch marks|stretch marks
412819|NCT01186848|Striae distensae|striae distensae
412820|NCT01186809|hematologic malignancies (excluding Chronic Myeloid Leukemia)|hematologic malignancies (excluding chronic myeloid leukemia)
412822|NCT01186796|Fulvestrant Study|fulvestrant study
412823|NCT01186796|Post Menopausal Women|post menopausal women
412824|NCT01186796|Hormones|hormones
412825|NCT01186796|Healthy Adult Women|healthy adult women
412826|NCT01186783|heart rate|heart rate
412827|NCT01186783|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
412828|NCT01186783|ivabradine|ivabradine
412829|NCT01186783|sepsis|sepsis
412830|NCT01186783|cardiogenic shock|cardiogenic shock
412831|NCT01186770|Treatment of Opioid-Induced Constipation in Subjects with Chronic, Non-Malignant Pain|treatment of opioid-induced constipation in subjects with chronic, non-malignant pain
412832|NCT01186744|OPT Retreatment|opt retreatment
412833|NCT01186744|OPT|opt
412834|NCT01186744|chronic|chronic
412835|NCT01186744|moderate|moderate
412836|NCT01186744|severe|severe
412837|NCT01186744|treatment|treatment
412838|NCT01186744|safety|safety
412839|NCT01186744|treatment withdrawal|treatment withdrawal
412840|NCT01186744|retreatment|retreatment
412841|NCT01186744|retreatment withdrawal|retreatment withdrawal
412842|NCT01186744|CP-690,550|cp-690,550
412843|NCT01186744|Psoriasis Vulgaris|psoriasis vulgaris
412844|NCT01186744|Plaque Psoriasis|plaque psoriasis
412845|NCT01186744|tofacitinib|tofacitinib
412846|NCT01186744|Xeljanz|xeljanz
412847|NCT01186744|nail psoriasis|nail psoriasis
412848|NCT01186744|Jak-inhibitor|jak-inhibitor
412849|NCT01186744|oral treatment|oral treatment
412850|NCT01186744|Pruritus|pruritus
412851|NCT01186744|Itch|itch
412852|NCT01186744|DLQI|dlqi
412853|NCT01186744|rebound|rebound
412854|NCT01186744|intermittent|intermittent
412855|NCT01186744|retreat|retreat
412856|NCT01186731|SPARC (secreted protein acid rich in cysteine)|sparc (secreted protein acid rich in cysteine)
412857|NCT01186731|serum Carbohydrate Antigen CA 19-9|serum carbohydrate antigen ca 19-9
412858|NCT01186718|Cervical, motions, kinematics|cervical, motions, kinematics
412859|NCT01186705|MK-2206|mk-2206
412860|NCT01186705|colon|colon
412861|NCT01186705|rectal|rectal
412862|NCT01186705|10-068|10-068
412863|NCT01186666|Atherosclerosis|atherosclerosis
412864|NCT01186666|Vulnerable plaque|vulnerable plaque
412865|NCT01186666|Intravascular ultrasound|intravascular ultrasound
412866|NCT01186666|Virtual histology|virtual histology
412867|NCT01186666|Fluorodeoxyglucose|fluorodeoxyglucose
412868|NCT01186666|Positron emission tomography|positron emission tomography
412869|NCT01186666|Multidetector computed tomography|multidetector computed tomography
412870|NCT01186640|T-PLL|t-pll
412871|NCT01186640|Polychemotherapy|polychemotherapy
412872|NCT01186640|Alemtuzumab|alemtuzumab
412873|NCT01186640|Efficacy|efficacy
412874|NCT01186627|Neurodevelopmental Impairment|neurodevelopmental impairment
412875|NCT01186627|Intraventricular hemorrhage|intraventricular hemorrhage
412876|NCT01186627|Retinopathy of prematurity|retinopathy of prematurity
412877|NCT01186627|Mortality|mortality
412878|NCT01186627|Apgar Score|apgar score
412879|NCT01186614|cardiac arrest|cardiac arrest
412880|NCT01186614|ECMO|ecmo
412881|NCT01186614|hypothermia|hypothermia
412882|NCT01186614|automated CPR|automated cpr
412883|NCT01186614|coronary intervention|coronary intervention
412884|NCT01186601|Prostatic Neoplasms|prostatic neoplasms
412885|NCT01186601|Colorectal Neoplasms|colorectal neoplasms
412886|NCT01186601|Head and Neck Neoplasms|head and neck neoplasms
412887|NCT01186601|Melanoma|melanoma
412888|NCT01186601|Neoplasm Metastasis|neoplasm metastasis
412889|NCT01186588|Canagliflozin|canagliflozin
412890|NCT01186588|JNJ-28431754|jnj-28431754
412891|NCT01186588|Liver diseases|liver diseases
412892|NCT01186588|Hepatic impairment|hepatic impairment
412893|NCT01186588|Pharmacokinetic|pharmacokinetic
412894|NCT01186588|Normal hepatic function|normal hepatic function
412895|NCT01186575|HIV Infections|hiv infections
413024|NCT01186159|PMNL|pmnl
412896|NCT01186575|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
412897|NCT01186575|Circumcision, Male|circumcision, male
412898|NCT01186575|Coitus|coitus
412899|NCT01186575|Patient Compliance|patient compliance
412900|NCT01186575|Cellular Phone|cellular phone
412901|NCT01186562|Pancreatitis|pancreatitis
412902|NCT01186562|Pancreatectomy|pancreatectomy
412903|NCT01186562|Islet autotransplant|islet autotransplant
412904|NCT01186562|Sitagliptin|sitagliptin
412905|NCT01186562|Diabetes|diabetes
412906|NCT01186549|propofol|propofol
412907|NCT01186549|ephedrine|ephedrine
412908|NCT01186549|pain|pain
412909|NCT01186536|Whey Protein|whey protein
412910|NCT01186536|Soy Protein|soy protein
412911|NCT01186536|Resistance training|resistance training
412912|NCT01186536|Weight Management|weight management
412913|NCT01186523|Obesity|obesity
412914|NCT01186523|Weight Management|weight management
412915|NCT01186523|Physical Activity|physical activity
412916|NCT01186497|Healthy|healthy
412917|NCT01186497|Rabeprazole sodium|rabeprazole sodium
412918|NCT01186497|Rabeprazole sprinkle capsule granule formulation|rabeprazole sprinkle capsule granule formulation
412919|NCT01186497|Pharmacokinetics|pharmacokinetics
412920|NCT01186497|Bioavailability|bioavailability
412921|NCT01186497|Safety|safety
412922|NCT01186497|Adult|adult
412923|NCT01186484|Castration-resistant prostate cancer|castration-resistant prostate cancer
412924|NCT01186484|Abiraterone acetate|abiraterone acetate
412925|NCT01186484|JNJ-212082|jnj-212082
412926|NCT01186471|Symptomatic treatment|symptomatic treatment
412927|NCT01186471|Cognition|cognition
412928|NCT01186471|Cognitive deficits|cognitive deficits
412929|NCT01186471|Schizophrenia|schizophrenia
412930|NCT01186445|Acute Myocardial Infarction|acute myocardial infarction
412931|NCT01186445|Cardioprotective effect|cardioprotective effect
412932|NCT01186445|Pharmacological postconditioning|pharmacological postconditioning
412933|NCT01186445|Morphine Chlorhydrate|morphine chlorhydrate
412934|NCT01186445|Cardiac MRI|cardiac mri
412935|NCT01186419|Beta-thalassemia|beta-thalassemia
412936|NCT01186419|Sickle cell anemia|sickle cell anemia
412937|NCT01186419|Transfusional iron overload|transfusional iron overload
412938|NCT01186419|Iron overload|iron overload
412939|NCT01186419|Iron chelation|iron chelation
412940|NCT01186406|glioblastoma multiforme|glioblastoma multiforme
412941|NCT01186406|gliosarcoma|gliosarcoma
412942|NCT01186406|malignant glioma|malignant glioma
412943|NCT01186406|glioma|glioma
412944|NCT01186406|Gliadel|gliadel
412945|NCT01186406|carmustine wafers|carmustine wafers
412946|NCT01186406|Avastin|avastin
412947|NCT01186406|bevacizumab|bevacizumab
412948|NCT01186406|Temodar|temodar
412949|NCT01186406|temozolomide|temozolomide
412950|NCT01186406|Pro00025180|pro00025180
412951|NCT01186406|Desjardins|desjardins
412952|NCT01186406|Duke|duke
412953|NCT01186406|Preston Robert Tisch Brain Tumor Center|preston robert tisch brain tumor center
412954|NCT01186393|Weight Loss|weight loss
412955|NCT01186393|Potatoes|potatoes
412956|NCT01186393|Dietary Meetings|dietary meetings
413453|NCT01184443|Pediatric|pediatric
412957|NCT01186393|Glycemic Control|glycemic control
412958|NCT01186380|TEE|tee
412959|NCT01186380|Transesophageal|transesophageal
412960|NCT01186380|Transducer|transducer
412961|NCT01186380|Esophagus|esophagus
412962|NCT01186380|Ease of passage and during transitioning into and down the esophagus to complete a normal TEE study|ease of passage and during transitioning into and down the esophagus to complete a normal tee study
412963|NCT01186367|breast cancer|breast cancer
412964|NCT01186367|Linear Versus Nonlinear Aerobic Training|linear versus nonlinear aerobic training
412965|NCT01186367|15-147|15-147
412966|NCT01186354|Type 2 diabetes|type 2 diabetes
412967|NCT01186354|health literacy|health literacy
412968|NCT01186354|genetic literacy|genetic literacy
412969|NCT01186354|genetic risk|genetic risk
412970|NCT01186341|Chronic Pain|chronic pain
412971|NCT01186328|Relapse|relapse
412972|NCT01186328|T cell|t cell
412973|NCT01186328|Lymphoblastic|lymphoblastic
412974|NCT01186328|Leukemia|leukemia
412975|NCT01186328|EZN3042|ezn3042
412976|NCT01186328|Refractory|refractory
412977|NCT01186328|Precursor B|precursor b
412978|NCT01186328|Pre B cell|pre b cell
412979|NCT01186328|Survivan|survivan
412980|NCT01186328|Acute|acute
412981|NCT01186328|Childhood|childhood
412982|NCT01186328|Pediatric|pediatric
412983|NCT01186315|Addiction|addiction
412984|NCT01186315|Posttraumatic Stress|posttraumatic stress
412985|NCT01186315|substance abuse and posttraumatic stress|substance abuse and posttraumatic stress
412986|NCT01186302|medical abortion|medical abortion
412987|NCT01186302|Nepal|nepal
412988|NCT01186302|midlevel providers|midlevel providers
412989|NCT01186289|Neurocognitive Dysfunction|neurocognitive dysfunction
412990|NCT01186263|liver metastases|liver metastases
412991|NCT01186263|MAA|maa
412992|NCT01186263|B20|b20
412993|NCT01186263|SIR spheres|sir spheres
412994|NCT01186263|SPECT|spect
412995|NCT01186263|intra-hepatic distribution|intra-hepatic distribution
412996|NCT01186250|cardiac allograft vasculopathy|cardiac allograft vasculopathy
412997|NCT01186250|pioglitazone|pioglitazone
412998|NCT01186250|insulin resistance|insulin resistance
412999|NCT01186250|heart transplant|heart transplant
413000|NCT01186237|Colon/Rectal Cancer Rectal Cancer|colon/rectal cancer rectal cancer
413001|NCT01186237|Quality of Life|quality of life
413002|NCT01186211|knee, joint|knee, joint
413003|NCT01186198|Coronary Dilatation Catheter|coronary dilatation catheter
413004|NCT01186198|Balloon Dilatation Catheter|balloon dilatation catheter
413005|NCT01186198|Predilatation Balloon|predilatation balloon
413006|NCT01186198|Angioplasty|angioplasty
413007|NCT01186198|Myocardial Ischemia|myocardial ischemia
413008|NCT01186198|Coronary Stenosis|coronary stenosis
413009|NCT01186198|PCI|pci
413010|NCT01186198|PTCA|ptca
413011|NCT01186198|CTO|cto
413013|NCT01186185|sensorineural|sensorineural
413014|NCT01186185|hearing loss|hearing loss
413015|NCT01186185|fludrocortisone|fludrocortisone
413016|NCT01186185|mineralocorticoid|mineralocorticoid
413017|NCT01186185|steroid|steroid
413018|NCT01186172|ethanol|ethanol
413019|NCT01186172|lock therapy|lock therapy
413020|NCT01186172|vascular access|vascular access
413021|NCT01186172|central venous catheter|central venous catheter
413022|NCT01186172|sepsis|sepsis
413023|NCT01186159|COX-2|cox-2
413025|NCT01186159|pain|pain
413026|NCT01186159|macrophages|macrophages
413027|NCT01186159|NSAIDs|nsaids
413028|NCT01186146|coronary disease|coronary disease
413029|NCT01186146|stents|stents
413030|NCT01186146|antiplatelet drugs|antiplatelet drugs
413031|NCT01186146|drug-eluting stents|drug-eluting stents
413032|NCT01186133|coronary disease|coronary disease
413033|NCT01186133|drug eluting stent|drug eluting stent
413034|NCT01186120|coronary disease|coronary disease
413035|NCT01186120|stent|stent
413036|NCT01186107|coronary disease|coronary disease
413037|NCT01186107|stent|stent
413038|NCT01186094|Coronary Artery Disease|coronary artery disease
413039|NCT01186094|Stent|stent
413040|NCT01186081|Rectal cancer|rectal cancer
413041|NCT01186081|Preoperative CCRT|preoperative ccrt
413042|NCT01186081|Postoperative CCRT|postoperative ccrt
413043|NCT01186081|Capecitabine|capecitabine
413044|NCT01186068|Rosacea, erythema|rosacea, erythema
413045|NCT01186055|Smoking Relapse|smoking relapse
413046|NCT01186055|Nicotine Abstinence|nicotine abstinence
413047|NCT01186042|HIV|hiv
413048|NCT01186042|Aging|aging
413049|NCT01186042|Neuropsychological function|neuropsychological function
413050|NCT01186042|Activity|activity
413051|NCT01186042|Sleep patterns|sleep patterns
413052|NCT01186042|Frailty|frailty
413053|NCT01186042|Emotional well-being|emotional well-being
413054|NCT01186042|Sexual health|sexual health
413055|NCT01186029|Looking at adding drug to already established treatment regimen for|looking at adding drug to already established treatment regimen for
413056|NCT01186029|Nausea and Vomiting|nausea and vomiting
413057|NCT01186016|Genetic Education|genetic education
413058|NCT01186016|Smoking Cessation|smoking cessation
413059|NCT01186016|Quitting Smoking|quitting smoking
413060|NCT01186016|Standard Smoking Cessation Program|standard smoking cessation program
413061|NCT01186016|Genetic Education for Smoking Cessation|genetic education for smoking cessation
413062|NCT01186003|Diabetes|diabetes
413063|NCT01185977|Major Depressive Disorder|major depressive disorder
413064|NCT01185977|Fluoxetine|fluoxetine
413065|NCT01185977|QEEG|qeeg
413066|NCT01185977|cordance|cordance
413067|NCT01185977|ATR|atr
413068|NCT01185964|Sarcoma, Soft Tissue|sarcoma, soft tissue
413069|NCT01185964|Advanced Soft Tissue Sarcoma|advanced soft tissue sarcoma
413070|NCT01185951|Achilles Tendon|achilles tendon
413071|NCT01185951|Patella|patella
413072|NCT01185951|Allergy|allergy
413073|NCT01185951|Necrosis|necrosis
413074|NCT01185951|Infection|infection
413075|NCT01185938|statin|statin
413076|NCT01185938|CIN|cin
413077|NCT01185938|periprocedural damage|periprocedural damage
413078|NCT01185925|PDE5-inhibition|pde5-inhibition
413079|NCT01185925|exercise ventilation|exercise ventilation
413080|NCT01185925|heart failure|heart failure
413081|NCT01185925|sildenafil|sildenafil
413082|NCT01185925|pulmonary hemodynamics|pulmonary hemodynamics
413083|NCT01185912|Cardiac MRI|cardiac mri
413084|NCT01185912|Cardiac ultrasound|cardiac ultrasound
413085|NCT01185912|Cardiac surgery|cardiac surgery
413086|NCT01185899|heart attack|heart attack
413087|NCT01185899|acute myocardial infarction|acute myocardial infarction
413088|NCT01185899|STEMI|stemi
413089|NCT01185899|NSTEMI|nstemi
413090|NCT01185899|Unstable Angina|unstable angina
413091|NCT01185899|suspected acute coronary syndrome|suspected acute coronary syndrome
413092|NCT01185899|Non-ischemic chest pain|non-ischemic chest pain
413093|NCT01185886|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
413094|NCT01185886|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
413095|NCT01185886|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
413096|NCT01185886|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
413097|NCT01185886|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
413098|NCT01185886|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
413099|NCT01185886|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
413100|NCT01185886|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
413101|NCT01185886|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
413102|NCT01185886|Philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia|philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia
413103|NCT01185821|Multiple Sclerosis|multiple sclerosis
413104|NCT01185821|Relapsing remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
413105|NCT01185821|Demyelinating Autoimmune Diseases|demyelinating autoimmune diseases
413106|NCT01185808|sinusitis|sinusitis
413107|NCT01185808|chronic sinusitis with polyps|chronic sinusitis with polyps
413108|NCT01185795|yogurt|yogurt
413109|NCT01185795|probiotic|probiotic
413110|NCT01185795|cholesterol|cholesterol
413111|NCT01185782|Infertility|infertility
413112|NCT01185782|Ovulation induction|ovulation induction
413113|NCT01185782|Gonalef® (Follitropin alfa)|gonalef® (follitropin alfa)
413114|NCT01185782|Purified pituitary gonadotropin (Fertinorm-P®)|purified pituitary gonadotropin (fertinorm-p®)
413115|NCT01185782|gonadotropin|gonadotropin
413116|NCT01185782|Reproductive technologies, assisted|reproductive technologies, assisted
413117|NCT01185782|Polycystic ovary syndrome|polycystic ovary syndrome
413118|NCT01185769|Vitamin E|vitamin e
413119|NCT01185769|Absorption|absorption
413120|NCT01185756|Heart failure|heart failure
413121|NCT01185756|Sudden death|sudden death
413122|NCT01185756|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
413123|NCT01185756|MIBG scintigraphy|mibg scintigraphy
413124|NCT01185743|healthy volunteers|healthy volunteers
413125|NCT01185743|antipsychotics|antipsychotics
413126|NCT01185743|gene expression|gene expression
413127|NCT01185730|Pulmonary hypertension|pulmonary hypertension
413128|NCT01185730|Prognostic factors|prognostic factors
413129|NCT01185730|Idiopathic pulmonary hypertension|idiopathic pulmonary hypertension
413130|NCT01185730|Family pulmonary hypertension|family pulmonary hypertension
413131|NCT01185730|use anorectics|use anorectics
413132|NCT01185704|Cetrorelix acetate; follitropin alfa; human chorionic-gonadotropin alfa; follicular maturation; pregnancy; ovarian stimulation|cetrorelix acetate; follitropin alfa; human chorionic-gonadotropin alfa; follicular maturation; pregnancy; ovarian stimulation
413133|NCT01185678|Contraception|contraception
413134|NCT01185678|Compliance|compliance
413135|NCT01185665|FBSS|fbss
413136|NCT01185652|Smoking|smoking
413137|NCT01185652|airflow obstruction|airflow obstruction
413138|NCT01185652|pulmonary function tests|pulmonary function tests
413139|NCT01185639|lung cancer|lung cancer
413140|NCT01185639|metastatic|metastatic
413141|NCT01185639|SBRT|sbrt
413142|NCT01185639|Stereotactic body radiation therapy|stereotactic body radiation therapy
413143|NCT01185639|liver|liver
413144|NCT01185639|spine|spine
413145|NCT01185639|adrenal|adrenal
413146|NCT01185639|bone cancer|bone cancer
413147|NCT01185639|Spinal Column|spinal column
413148|NCT01185626|patients|patients
413149|NCT01185600|transfusion complications|transfusion complications
413150|NCT01185600|washed RBC|washed rbc
413151|NCT01185600|microparticles|microparticles
413152|NCT01185600|storage lesion|storage lesion
413153|NCT01185587|SCN5A protein|scn5a protein
413154|NCT01185587|voltage-gated Na+ channel|voltage-gated na+ channel
413155|NCT01185561|Diabetes|diabetes
413156|NCT01185561|SWEEP|sweep
413157|NCT01185561|Dysphoria|dysphoria
413158|NCT01185548|Advanced or Metastatic Solid Tumors or Lymphoma|advanced or metastatic solid tumors or lymphoma
413159|NCT01185535|topical anesthesia|topical anesthesia
413160|NCT01185535|tracheal intubation|tracheal intubation
413161|NCT01185535|difficult airway|difficult airway
413162|NCT01185509|HER2 negative|her2 negative
413163|NCT01185509|HER2 positive|her2 positive
413164|NCT01185496|diabetes mellitus|diabetes mellitus
413165|NCT01185483|Endoscopic submucosal dissection|endoscopic submucosal dissection
413166|NCT01185483|Submucosal tumor|submucosal tumor
413167|NCT01185483|Minimal invasive|minimal invasive
413168|NCT01185483|Gastroscopy|gastroscopy
413169|NCT01185470|Chronic pain|chronic pain
413170|NCT01185470|Morphine Sufate|morphine sufate
413171|NCT01185470|Intrathecal|intrathecal
413172|NCT01185470|Implantable drug delivery pumps|implantable drug delivery pumps
413173|NCT01185457|Shoulder surgery|shoulder surgery
413174|NCT01185457|Beach chair position|beach chair position
413175|NCT01185457|Interscalene block|interscalene block
412274|NCT01189344|LT4|lt4
413177|NCT01185457|Autonomic nervous system|autonomic nervous system
413178|NCT01185444|Knee Balance|knee balance
413179|NCT01185444|Hyaluronate|hyaluronate
413180|NCT01185444|Osteoarthritis|osteoarthritis
413181|NCT01185444|Viscosupplementation|viscosupplementation
413182|NCT01185431|Ficus Carica|ficus carica
413183|NCT01185431|Functional Constipation|functional constipation
413184|NCT01185431|Dietary Supplement|dietary supplement
413185|NCT01185431|Fig Paste|fig paste
413186|NCT01185405|Voriconazole|voriconazole
413187|NCT01185405|Therapeutic drug monitoring|therapeutic drug monitoring
413188|NCT01185405|Intensive care unit|intensive care unit
413189|NCT01185392|Cardiac Resynchronisation Therapy in Heart Failure|cardiac resynchronisation therapy in heart failure
413190|NCT01185379|Docosahexaenoic acid|docosahexaenoic acid
413191|NCT01185379|omega 3|omega 3
413192|NCT01185379|cerebral blood flow|cerebral blood flow
413193|NCT01185379|Near Infrared spectroscopy|near infrared spectroscopy
413194|NCT01185379|cognitive function|cognitive function
413195|NCT01185379|mood|mood
413196|NCT01185366|Advanced non-clear cell renal cell cancer (RCC)|advanced non-clear cell renal cell cancer (rcc)
413197|NCT01185366|Clear-cell renal cell carcinoma|clear-cell renal cell carcinoma
413198|NCT01185366|Collecting duct carcinoma|collecting duct carcinoma
413199|NCT01185366|Translocation carcinoma|translocation carcinoma
413200|NCT01185366|Chromophobe|chromophobe
413201|NCT01185366|Everolimus|everolimus
413202|NCT01185366|Sunitinib|sunitinib
413203|NCT01185366|Afinitor|afinitor
413204|NCT01185366|RAD001|rad001
413205|NCT01185366|Sunitinib Malate|sunitinib malate
413206|NCT01185366|SUO11248|suo11248
413207|NCT01185366|Sutent|sutent
413208|NCT01185366|ESPN|espn
413209|NCT01185353|Rheumatoid Arthritis|rheumatoid arthritis
413211|NCT01185340|Depression|depression
413212|NCT01185340|MDD|mdd
413213|NCT01185327|Regurgitation|regurgitation
413214|NCT01185327|Infants to Israeli Ethiopian-origin mothers|infants to israeli ethiopian-origin mothers
413215|NCT01185314|NSCLC, EGFR mutation|nsclc, egfr mutation
413216|NCT01185301|Arthritis|arthritis
413217|NCT01185301|Erosion|erosion
413218|NCT01185301|Humira|humira
413219|NCT01185301|Adalimumab|adalimumab
413220|NCT01185301|Injection|injection
413221|NCT01185301|Rheumatoid|rheumatoid
413222|NCT01185301|Methotrexate|methotrexate
413223|NCT01185288|Rheumatoid Arthritis|rheumatoid arthritis
413224|NCT01185262|Recurrent and refractory chronic lymphocytic leukemia|recurrent and refractory chronic lymphocytic leukemia
413225|NCT01185249|CHF|chf
413226|NCT01185249|congestive heart failure|congestive heart failure
413227|NCT01185236|Diabetes mellitus|diabetes mellitus
413228|NCT01185223|Valganciclovir|valganciclovir
413229|NCT01185223|Ganciclovir|ganciclovir
413230|NCT01185223|Antiviral Drug|antiviral drug
413231|NCT01185223|CMV disease|cmv disease
413232|NCT01185197|Minimal Change Nephrotic Syndrome|minimal change nephrotic syndrome
413233|NCT01185197|Corticosteroid|corticosteroid
413234|NCT01185197|Mycophenolate|mycophenolate
413235|NCT01185197|Remission|remission
413236|NCT01185197|Safety|safety
413237|NCT01185184|Relative bioavailability|relative bioavailability
413238|NCT01185184|controlled release|controlled release
413239|NCT01185184|Phase 1|phase 1
413240|NCT01185184|CP-690|cp-690
413241|NCT01185184|550|550
413242|NCT01185171|Larynx|larynx
413243|NCT01185171|Lip|lip
413244|NCT01185171|Oral Cavity and Pharynx|oral cavity and pharynx
413245|NCT01185158|Larynx|larynx
413246|NCT01185158|Lip|lip
413247|NCT01185158|Oral Cavity and Pharynx|oral cavity and pharynx
413248|NCT01185145|breast-conservation|breast-conservation
413249|NCT01185145|accelerated partial breast irradiation|accelerated partial breast irradiation
413250|NCT01185145|APBI|apbi
413251|NCT01185145|IMRT|imrt
413252|NCT01185145|Intensity modulated radiotherapy|intensity modulated radiotherapy
413253|NCT01185145|breast brachytherapy|breast brachytherapy
413254|NCT01185145|lumpectomy|lumpectomy
413255|NCT01185145|early stage breast cancer|early stage breast cancer
413256|NCT01185145|DCIS|dcis
413257|NCT01185145|Mammosite|mammosite
413258|NCT01185132|breast-conservation|breast-conservation
413259|NCT01185132|adjuvant radiotherapy|adjuvant radiotherapy
413260|NCT01185132|breast cancer|breast cancer
413261|NCT01185132|early-stage breast cancer|early-stage breast cancer
413262|NCT01185132|DCIS|dcis
413263|NCT01185132|lumpectomy|lumpectomy
413264|NCT01185132|accelerated partial breast irradiation|accelerated partial breast irradiation
413265|NCT01185132|APBI|apbi
413266|NCT01185132|three dimensional conformal external radiotherapy|three dimensional conformal external radiotherapy
413267|NCT01185132|intensity modulated radiotherapy|intensity modulated radiotherapy
413268|NCT01185132|3D CRT|3d crt
413269|NCT01185132|IMRT|imrt
413270|NCT01185119|glucose uptake and metabolism in brain|glucose uptake and metabolism in brain
413271|NCT01185093|Cells|cells
413272|NCT01185093|Prevention|prevention
413273|NCT01185093|Cancer education|cancer education
413274|NCT01185093|Nutrition|nutrition
413275|NCT01185093|Healthy living|healthy living
412342|NCT01189019|PED|ped
413276|NCT01185093|Physical activity|physical activity
413277|NCT01185093|Dangers of tobacco|dangers of tobacco
413278|NCT01185093|Sun protection|sun protection
413279|NCT01185080|AZD8848|azd8848
413280|NCT01185080|allergic rhinitis|allergic rhinitis
413281|NCT01185080|efficacy|efficacy
413282|NCT01185080|tolerability|tolerability
413283|NCT01185080|safety|safety
413284|NCT01185080|nasal symptoms|nasal symptoms
413285|NCT01185067|Hypertension|hypertension
413286|NCT01185067|Endothelial function|endothelial function
413287|NCT01185067|Antioxidants|antioxidants
413288|NCT01185067|Oxidative stress|oxidative stress
413289|NCT01185067|Grapes|grapes
413290|NCT01185067|Polyphenols|polyphenols
413291|NCT01185067|Resveratrol|resveratrol
413292|NCT01185067|Quercetin|quercetin
413293|NCT01185067|Anthocyanins|anthocyanins
413294|NCT01185067|Flavanols|flavanols
413295|NCT01185067|Flavonols|flavonols
413296|NCT01185067|Congestive heart failure|congestive heart failure
413297|NCT01185067|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
413298|NCT01185067|Heart failure with preserved systolic function|heart failure with preserved systolic function
413299|NCT01185067|HFNEF|hfnef
413300|NCT01185067|HFPSF|hfpsf
413301|NCT01185067|HFPEF|hfpef
413302|NCT01185067|DHF|dhf
413303|NCT01185054|Pediatrics|pediatrics
413304|NCT01185054|Gastroenteritis|gastroenteritis
413305|NCT01185054|Oral Rehydration|oral rehydration
413306|NCT01185054|Electrolyte Maintenance Solution|electrolyte maintenance solution
413307|NCT01185041|Arterial Stiffness|arterial stiffness
413308|NCT01185041|Wave Reflection|wave reflection
413309|NCT01185041|Watermelon Supplementation|watermelon supplementation
413310|NCT01185041|Aortic Blood Pressure|aortic blood pressure
413311|NCT01185041|Obesity|obesity
413312|NCT01185028|Chronic HCV|chronic hcv
413313|NCT01185028|HCV Treatment Nonresponders|hcv treatment nonresponders
413314|NCT01185028|HCV Treatment Relapsers|hcv treatment relapsers
413315|NCT01185028|HIV-HCV Co-Infection|hiv-hcv co-infection
413316|NCT01185028|Nitazoxanide|nitazoxanide
413317|NCT01185028|Hepatitis C|hepatitis c
413318|NCT01185015|Angina Pectoris, Coronary disease|angina pectoris, coronary disease
413319|NCT01185002|CE|ce
413320|NCT01185002|colonoscopy|colonoscopy
413321|NCT01185002|colon|colon
413322|NCT01185002|Eligable for colon evaluation|eligable for colon evaluation
413323|NCT01184976|H5N1|h5n1
413324|NCT01184976|Avian Influenza|avian influenza
413325|NCT01184976|DNA Vaccine|dna vaccine
413326|NCT01184976|Electroporation|electroporation
413327|NCT01184976|Intramuscular (IM) Injection|intramuscular (im) injection
413328|NCT01184963|PCOS|pcos
413329|NCT01184963|High protein diet|high protein diet
413330|NCT01184924|Arthritis|arthritis
413331|NCT01184924|Tai Chi|tai chi
413332|NCT01184911|Malaria|malaria
413333|NCT01184911|Pregnancy|pregnancy
413334|NCT01184898|AML|aml
413335|NCT01184898|mTOR|mtor
413336|NCT01184898|rapamycin|rapamycin
413337|NCT01184885|hyperCVAD|hypercvad
413338|NCT01184885|rapamycin|rapamycin
413339|NCT01184885|lymphoid malignancies|lymphoid malignancies
413340|NCT01184885|lymphoblastic leukemia|lymphoblastic leukemia
413341|NCT01184885|B and T cell|b and t cell
413342|NCT01184885|philadelphia chromosome negative|philadelphia chromosome negative
413343|NCT01184885|burkitt lymphoma|burkitt lymphoma
413344|NCT01184885|burkitt-type lymphoma|burkitt-type lymphoma
413345|NCT01184885|lymphoblastic lymphoma|lymphoblastic lymphoma
413346|NCT01184885|mantle cell lymphoma|mantle cell lymphoma
413347|NCT01184885|adult t cell leukemia|adult t cell leukemia
413348|NCT01184885|adult t cell lymphoma|adult t cell lymphoma
413349|NCT01184872|Skin infection|skin infection
413350|NCT01184872|Daptomycin|daptomycin
413351|NCT01184872|Elderly|elderly
413352|NCT01184872|Gram positive|gram positive
413353|NCT01184872|Complicated skin and soft tissue infections|complicated skin and soft tissue infections
413354|NCT01184859|nocturia|nocturia
413355|NCT01184859|bladder function|bladder function
413356|NCT01184846|Chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy
413357|NCT01184846|CIDP|cidp
413358|NCT01184833|Multiple sclerosis|multiple sclerosis
413359|NCT01184833|Interferon beta-1b|interferon beta-1b
413360|NCT01184833|Compliance to treatment|compliance to treatment
413361|NCT01184833|Premature treatment discontinuation|premature treatment discontinuation
413362|NCT01184820|Pharmacokinetics|pharmacokinetics
413363|NCT01184820|Safety|safety
413364|NCT01184807|Advanced solid tumor|advanced solid tumor
413365|NCT01184794|Analgesia laparoscopy|analgesia laparoscopy
413366|NCT01184768|type 2 diabetes|type 2 diabetes
413367|NCT01184768|HbA1c|hba1c
413368|NCT01184768|vitamin D|vitamin d
413369|NCT01184768|diagnosis|diagnosis
413370|NCT01184755|Device-guided breathing|device-guided breathing
413371|NCT01184755|hypertension|hypertension
413372|NCT01184755|behavioral intervention|behavioral intervention
413373|NCT01184755|stress reduction|stress reduction
412435|NCT01188577|asthma|asthma
413374|NCT01184755|Heart Rate Variability (HRV) biofeedback|heart rate variability (hrv) biofeedback
413375|NCT01184729|aerobic capacity|aerobic capacity
413376|NCT01184716|Vitamin D status (serum 25-hydroxyvitamin D)|vitamin d status (serum 25-hydroxyvitamin d)
413377|NCT01184703|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
413378|NCT01184703|Glycemic Index Diet|glycemic index diet
413379|NCT01184703|HbA1c|hba1c
413380|NCT01184703|Lipids|lipids
413381|NCT01184690|double-balloon endoscopy|double-balloon endoscopy
413382|NCT01184690|diagnostic yield|diagnostic yield
413383|NCT01184664|Smoking cessation|smoking cessation
413384|NCT01184664|Tobacco dependence|tobacco dependence
413385|NCT01184664|Varenicline|varenicline
413386|NCT01184664|Nicotine Replacement Therapy|nicotine replacement therapy
413387|NCT01184664|Combination therapy|combination therapy
413388|NCT01184651|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
413389|NCT01184651|CAH|cah
413390|NCT01184651|sex differences|sex differences
413391|NCT01184651|adolescence|adolescence
413392|NCT01184651|androgen|androgen
413393|NCT01184651|behavior|behavior
413394|NCT01184651|gender development|gender development
413395|NCT01184638|Cognitive Disorders|cognitive disorders
413396|NCT01184638|General anesthesia|general anesthesia
413397|NCT01184638|Sevoflurane|sevoflurane
413398|NCT01184638|Propofol|propofol
413399|NCT01184638|Memory|memory
413400|NCT01184625|Myositis|myositis
413401|NCT01184625|Physical exercise|physical exercise
413402|NCT01184625|Disability|disability
413403|NCT01184612|Inmates with heavy use of alcohol or drugs|inmates with heavy use of alcohol or drugs
413404|NCT01184599|Aliskiren|aliskiren
413405|NCT01184599|Albuminuria|albuminuria
413406|NCT01184599|Angiotensinogen|angiotensinogen
413407|NCT01184599|collagen type IV|collagen type iv
413408|NCT01184599|Transforming Growth Factor beta|transforming growth factor beta
413409|NCT01184599|aldosterone|aldosterone
413410|NCT01184599|renin|renin
413411|NCT01184599|prorenin receptor|prorenin receptor
413412|NCT01184599|des-angiotensin I renin substrate|des-angiotensin i renin substrate
413413|NCT01184599|oxidative stress|oxidative stress
413414|NCT01184599|advanced glycosylation end-product receptor|advanced glycosylation end-product receptor
413415|NCT01184599|N,N-dimethylarginine|n,n-dimethylarginine
413416|NCT01184586|function|function
413417|NCT01184586|DASH|dash
413418|NCT01184586|MHQ|mhq
413419|NCT01184586|pain|pain
413420|NCT01184586|strength|strength
413421|NCT01184573|chronic pancreatitis|chronic pancreatitis
413422|NCT01184573|breath test|breath test
413423|NCT01184573|bicarbonate|bicarbonate
413424|NCT01184560|obesity|obesity
413425|NCT01184534|Lung Biopsy|lung biopsy
413426|NCT01184534|Multimedia patient education tool|multimedia patient education tool
413427|NCT01184534|Multimedia Education Tool|multimedia education tool
413428|NCT01184534|Computed tomography guided lung biopsy|computed tomography guided lung biopsy
413429|NCT01184534|Computerized Tomography|computerized tomography
413430|NCT01184534|CT|ct
413431|NCT01184534|Questionnaire|questionnaire
413432|NCT01184534|Lung nodules|lung nodules
413433|NCT01184508|classic with aura|classic with aura
413434|NCT01184508|common without aura|common without aura
413435|NCT01184508|migraine|migraine
413436|NCT01184508|headache|headache
413437|NCT01184495|Erythropoietin|erythropoietin
413438|NCT01184495|Chronic renal failure|chronic renal failure
413439|NCT01184495|Hemodialysis|hemodialysis
413440|NCT01184495|Anemia|anemia
413441|NCT01184482|recurrent colorectal cancer|recurrent colorectal cancer
413442|NCT01184482|recurrent head and neck cancer|recurrent head and neck cancer
413443|NCT01184482|recurrent lung cancer|recurrent lung cancer
413444|NCT01184482|cetuximab|cetuximab
413445|NCT01184482|lapatinib|lapatinib
413446|NCT01184456|AIDS|aids
413447|NCT01184456|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
413448|NCT01184456|HIV|hiv
413449|NCT01184456|Human Immunodeficiency Virus|human immunodeficiency virus
413450|NCT01184443|Anorexia Nervosa|anorexia nervosa
413451|NCT01184443|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
413452|NCT01184443|Olanzapine|olanzapine
413454|NCT01184430|advanced hemodynamic monitoring|advanced hemodynamic monitoring
413455|NCT01184430|goal-directed therapy|goal-directed therapy
413456|NCT01184430|cardiac surgery|cardiac surgery
413457|NCT01184430|hemodynamic monitoring|hemodynamic monitoring
413458|NCT01184404|Congenital heart disease|congenital heart disease
413459|NCT01184404|Cardiac surgery|cardiac surgery
413460|NCT01184404|Bosentan|bosentan
413461|NCT01184378|infant formula|infant formula
413462|NCT01184378|dairy fat|dairy fat
413463|NCT01184378|soluble milk protein|soluble milk protein
413464|NCT01184365|fatigue|fatigue
413465|NCT01184365|energy management|energy management
413466|NCT01184365|spinal cord injury|spinal cord injury
413467|NCT01184365|self-efficacy|self-efficacy
413468|NCT01184365|environment|environment
413469|NCT01184339|Staphylococcus|staphylococcus
413470|NCT01184339|aureus|aureus
413471|NCT01184339|methicillin|methicillin
413472|NCT01184339|resistant|resistant
413473|NCT01184339|MRSA|mrsa
413474|NCT01184339|MSSA|mssa
413475|NCT01184339|Blood Culture|blood culture
413476|NCT01184339|diagnostic|diagnostic
413477|NCT01184326|RAD001|rad001
413478|NCT01184326|pazopanib|pazopanib
413479|NCT01184326|everolimus|everolimus
413480|NCT01184326|advanced cancer|advanced cancer
413481|NCT01184313|aortic valve surgery|aortic valve surgery
413482|NCT01184313|CPB|cpb
413483|NCT01184313|lung injury|lung injury
413484|NCT01184300|CYP2C19*2|cyp2c19*2
413485|NCT01184300|Pharmacogenomics|pharmacogenomics
413486|NCT01184300|Clopidogrel|clopidogrel
413487|NCT01184300|Prasugrel|prasugrel
413488|NCT01184300|Percutaneous Coronary Intervention|percutaneous coronary intervention
413489|NCT01184287|Non Small Cell Lung Cancer, NSCLC, Lung Cancer|non small cell lung cancer, nsclc, lung cancer
413490|NCT01184287|Previously untreated Non-Squamous, Non-Small Cell Lung Cancer|previously untreated non-squamous, non-small cell lung cancer
413491|NCT01184235|Circadian Disorders|circadian disorders
413492|NCT01184235|Autism Spectrum Disorders|autism spectrum disorders
413493|NCT01184235|Mood Disorders|mood disorders
413494|NCT01184235|Executive Functioning|executive functioning
413495|NCT01184235|Pediatric Mood Disorders|pediatric mood disorders
413496|NCT01184196|knee replacement|knee replacement
413497|NCT01184196|knee arthroplasty|knee arthroplasty
413498|NCT01184196|total knee replacement|total knee replacement
413499|NCT01184196|arthroplasty, knee replacement|arthroplasty, knee replacement
413500|NCT01184183|Patch for Carotid Endarterectomy|patch for carotid endarterectomy
413501|NCT01184170|obesity|obesity
413502|NCT01184170|metabolism|metabolism
413503|NCT01184170|cardiovascular metabolic syndrome|cardiovascular metabolic syndrome
413504|NCT01184144|Endometriosis|endometriosis
750141|NCT01163903|Doxorubicin|doxorubicin
413505|NCT01184144|Peritoneal fluid|peritoneal fluid
413506|NCT01184144|Cytokines|cytokines
413507|NCT01184144|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
413508|NCT01184131|Mentor Training|mentor training
413509|NCT01184131|Randomized trial of mentoring effectiveness|randomized trial of mentoring effectiveness
413510|NCT01184131|Mentoring clinical researchers|mentoring clinical researchers
413511|NCT01184118|asthma|asthma
413512|NCT01184118|sleep apnea|sleep apnea
413513|NCT01184092|Bioequivalence|bioequivalence
413514|NCT01184092|healthy volunteer study|healthy volunteer study
413515|NCT01184092|Rheumatoid Arthritis|rheumatoid arthritis
413516|NCT01184079|human papillomavirus vaccine L1, type 6,11,16,18|human papillomavirus vaccine l1, type 6,11,16,18
413517|NCT01184079|HPV Vaccines|hpv vaccines
413518|NCT01184079|HPV L1 vaccine, quadrivalent 6,11,16,18|hpv l1 vaccine, quadrivalent 6,11,16,18
413519|NCT01184066|Chemotherapy|chemotherapy
413520|NCT01184066|Patient Adherence|patient adherence
413521|NCT01184066|African Americans|african americans
413522|NCT01184066|Cancer Survivor|cancer survivor
413523|NCT01184066|Decision Making|decision making
413524|NCT01184066|Communication|communication
413525|NCT01184066|Quality of Life|quality of life
413526|NCT01184066|Social Support|social support
413527|NCT01184066|Patient Education|patient education
413528|NCT01184053|endometrial|endometrial
413529|NCT01184053|carcinoma|carcinoma
413530|NCT01184053|recurrent|recurrent
413531|NCT01184053|metastatic|metastatic
413532|NCT01184053|Trisenox|trisenox
413533|NCT01184053|arsenic trioxide|arsenic trioxide
413534|NCT01184053|Phase II|phase ii
413535|NCT01184053|VEGF|vegf
413536|NCT01184053|gynecology|gynecology
413537|NCT01184053|Lineberger|lineberger
413538|NCT01184053|UNC|unc
413539|NCT01184053|vascular endothelial growth factor|vascular endothelial growth factor
413540|NCT01184053|University of North Carolina at Chapel Hill|university of north carolina at chapel hill
413541|NCT01184027|head and neck cancer|head and neck cancer
413542|NCT01184027|surgery|surgery
413543|NCT01184027|nutrition|nutrition
413544|NCT01184014|corticosteroid|corticosteroid
413545|NCT01184014|hyperglycemia|hyperglycemia
413546|NCT01184014|hospital|hospital
413547|NCT01184014|corticosteroid induced hyperglycemia in the hospital|corticosteroid induced hyperglycemia in the hospital
413548|NCT01184001|Healthy subjects|healthy subjects
413549|NCT01184001|Food Effect Study|food effect study
413550|NCT01183962|CAD|cad
413551|NCT01183962|Vitamin D|vitamin d
413552|NCT01183962|CVD|cvd
413553|NCT01183949|Neoplasms|neoplasms
413554|NCT01183949|Neoplasms, Plasma Cell|neoplasms, plasma cell
413555|NCT01183949|Neoplasms by Histologic Type|neoplasms by histologic type
413556|NCT01183949|Hemostatic Disorders|hemostatic disorders
413557|NCT01183949|Paraproteinemias|paraproteinemias
413558|NCT01183949|Blood Protein Disorders|blood protein disorders
413559|NCT01183949|Hematologic Diseases|hematologic diseases
413560|NCT01183949|Hemorrhagic Disorders|hemorrhagic disorders
413561|NCT01183949|Lymphoproliferative Disorders|lymphoproliferative disorders
413562|NCT01183949|Immunoproliferative Disorders|immunoproliferative disorders
413563|NCT01183949|Immune System Diseases|immune system diseases
413564|NCT01183949|Bortezomib|bortezomib
413565|NCT01183949|Antineoplastic Agents|antineoplastic agents
413566|NCT01183936|Melanoma/mortality/pathology/*surgery|melanoma/mortality/pathology/*surgery
413567|NCT01183936|Randomized Controlled Trials as Topic|randomized controlled trials as topic
413568|NCT01183936|Survival|survival
413569|NCT01183936|Disease-Free Survival|disease-free survival
413570|NCT01183923|asthma|asthma
413571|NCT01183923|dietary interventions|dietary interventions
413572|NCT01183923|mouse allergy|mouse allergy
413573|NCT01183910|PURPURA|purpura
413574|NCT01183910|SENILE PURPURA|senile purpura
413575|NCT01183910|BATEMAN'S PURPURA|bateman's purpura
413576|NCT01183897|GM-CSF|gm-csf
413577|NCT01183897|MAB 3F8|mab 3f8
413578|NCT01183897|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
413579|NCT01183897|09-161|09-161
413580|NCT01183884|GM-CSF|gm-csf
413581|NCT01183884|MAB 3F8|mab 3f8
413582|NCT01183884|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
413583|NCT01183884|09-160|09-160
413584|NCT01183871|Cerebral oxygenation|cerebral oxygenation
413585|NCT01183871|thoracotomy|thoracotomy
413586|NCT01183871|lung resection|lung resection
413587|NCT01183871|pulmonary dysfunction|pulmonary dysfunction
413588|NCT01183845|Crohn Disease|crohn disease
413589|NCT01183845|Crohn's Disease Endoscopy Index of Severity|crohn's disease endoscopy index of severity
413590|NCT01183845|Colon Capsule Endoscopy|colon capsule endoscopy
413591|NCT01183845|Crohn's Disease located in colon and/or ileum|crohn's disease located in colon and/or ileum
413592|NCT01183832|Breast cancer|breast cancer
413593|NCT01183832|radiotherapy|radiotherapy
413594|NCT01183832|hormonotherapy|hormonotherapy
413595|NCT01183819|cognitive function|cognitive function
413596|NCT01183819|fMRI|fmri
413597|NCT01183819|apoE|apoe
413598|NCT01183819|inflammatory markers|inflammatory markers
413599|NCT01183819|exercise|exercise
413600|NCT01183819|cognitive intervention|cognitive intervention
413601|NCT01183819|Space Fortress|space fortress
413602|NCT01183806|Alzheimer's disease|alzheimer's disease
413603|NCT01183806|Exercise|exercise
413604|NCT01183806|Rivastigmine|rivastigmine
413605|NCT01183806|Quality of life|quality of life
413606|NCT01183793|Gastrointestinal Tract [A03.556]|gastrointestinal tract [a03.556]
413607|NCT01183780|second line|second line
413608|NCT01183780|metastatic colorectal cancer|metastatic colorectal cancer
413610|NCT01183780|ramucirumab|ramucirumab
413611|NCT01183780|CRC|crc
413612|NCT01183780|mCRC|mcrc
413613|NCT01183767|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
413614|NCT01183767|Epigallocatechin-Gallate|epigallocatechin-gallate
413615|NCT01183767|Green tea extract|green tea extract
413616|NCT01183754|coronary disease|coronary disease
413617|NCT01183754|platelet reactivity|platelet reactivity
413618|NCT01183754|drug-eluting stent|drug-eluting stent
413619|NCT01183741|Hypertension|hypertension
413620|NCT01183741|Hypotension|hypotension
413621|NCT01183741|Blood pressure|blood pressure
413622|NCT01183728|Knee degenerative disease|knee degenerative disease
413623|NCT01183728|osteoarthritis|osteoarthritis
413624|NCT01183728|gonarthrosis|gonarthrosis
413625|NCT01183728|stem cell|stem cell
413626|NCT01183728|cellular therapy|cellular therapy
413627|NCT01183728|regenerative therapy|regenerative therapy
413628|NCT01183728|Mesenchymal stem cells|mesenchymal stem cells
413629|NCT01183728|Bone marrow|bone marrow
413630|NCT01183728|musculoskeletal Diseases|musculoskeletal diseases
413631|NCT01183715|Single Ascending Dose|single ascending dose
413632|NCT01183715|Phase 1|phase 1
413633|NCT01183715|Safety and Tolerability|safety and tolerability
413634|NCT01183715|PK|pk
413635|NCT01183715|Healthy Subjects|healthy subjects
413636|NCT01183702|LASIK vs. non-LASIK|lasik vs. non-lasik
413637|NCT01183663|Lenalidomide|lenalidomide
413638|NCT01183663|Bevacizumab|bevacizumab
413639|NCT01183663|Sorafenib|sorafenib
413640|NCT01183663|Temsirolimus|temsirolimus
413641|NCT01183663|5-Fluorouracil|5-fluorouracil
413642|NCT01183663|Leucovorin|leucovorin
413643|NCT01183663|Oxaliplatin|oxaliplatin
413644|NCT01183663|Avastin|avastin
413645|NCT01183663|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
413646|NCT01183663|rhuMAB-VEGF|rhumab-vegf
413647|NCT01183663|CC-5013|cc-5013
413648|NCT01183663|Revlimid|revlimid
413649|NCT01183663|Nexavar|nexavar
413650|NCT01183663|BAY 43-90006|bay 43-90006
413651|NCT01183663|Metastatic cancer|metastatic cancer
413748|NCT01183312|Flumazenil|flumazenil
413652|NCT01183663|Metastatic colorectal cancer|metastatic colorectal cancer
413653|NCT01183663|Advanced solid tumors|advanced solid tumors
413654|NCT01183663|Hematologic malignancies|hematologic malignancies
413655|NCT01183663|Colon cancer|colon cancer
413656|NCT01183663|Advanced colorectal cancer|advanced colorectal cancer
413657|NCT01183663|Breast cancer|breast cancer
413658|NCT01183663|Pancreatic cancer|pancreatic cancer
413659|NCT01183663|Gastric cancer|gastric cancer
413660|NCT01183663|Advanced renal cell carcinoma|advanced renal cell carcinoma
413661|NCT01183663|Prostate cancer|prostate cancer
413662|NCT01183663|Melanoma|melanoma
413663|NCT01183663|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
413664|NCT01183663|Renal cell carcinoma|renal cell carcinoma
413665|NCT01183663|Metastatic breast cancer|metastatic breast cancer
413666|NCT01183663|Glioblastoma|glioblastoma
413667|NCT01183663|Multiple myeloma|multiple myeloma
413668|NCT01183637|Cartilage|cartilage
413669|NCT01183637|Knee|knee
413670|NCT01183637|Osteochondral|osteochondral
413671|NCT01183624|Osteoarthritis|osteoarthritis
413672|NCT01183624|Pain|pain
413673|NCT01183624|Herbal medicine|herbal medicine
413674|NCT01183624|Topical administration|topical administration
413675|NCT01183611|safety|safety
413676|NCT01183611|immunogenicity|immunogenicity
413677|NCT01183611|HBV vaccine|hbv vaccine
413678|NCT01183611|perinatal transmission|perinatal transmission
413679|NCT01183572|multivitamins|multivitamins
413680|NCT01183572|folate|folate
413681|NCT01183572|iron|iron
413682|NCT01183572|periconception|periconception
413683|NCT01183546|rehabilitation|rehabilitation
413684|NCT01183546|spinal cord injury|spinal cord injury
413685|NCT01183546|wheelchairs|wheelchairs
413686|NCT01183533|Wake-Up Stroke|wake-up stroke
413687|NCT01183533|Ischemic stroke|ischemic stroke
413688|NCT01183533|ischemic stroke patients who wake-up with their symptoms|ischemic stroke patients who wake-up with their symptoms
413689|NCT01183481|nausea|nausea
413690|NCT01183481|vomiting|vomiting
413691|NCT01183481|antiemetics|antiemetics
413692|NCT01183481|radiotherapy|radiotherapy
413693|NCT01183481|Radiation-induced nausea and vomiting|radiation-induced nausea and vomiting
413694|NCT01183468|Diabetes Mellitus, Type 1 (new-onset)|diabetes mellitus, type 1 (new-onset)
413695|NCT01183468|Diabetes Mellitus, Insulin-Dependent (new-onset)|diabetes mellitus, insulin-dependent (new-onset)
413696|NCT01183468|new-onset T1DM|new-onset t1dm
413697|NCT01183468|new-onset T1D|new-onset t1d
413698|NCT01183468|Diabetes Mellitus, Juvenile-Onset|diabetes mellitus, juvenile-onset
413699|NCT01183468|Diabetes, Autoimmune|diabetes, autoimmune
413700|NCT01183468|Aralast NP|aralast np
413701|NCT01183468|Alpha-1 Antitrypsin|alpha-1 antitrypsin
413702|NCT01183468|AAT|aat
413703|NCT01183455|Diabetes Mellitus, Type 1 (new-onset)|diabetes mellitus, type 1 (new-onset)
413704|NCT01183455|T1DM (new-onset)|t1dm (new-onset)
413705|NCT01183455|T1D (new-onset)|t1d (new-onset)
413706|NCT01183455|Diabetes, Autoimmune|diabetes, autoimmune
413707|NCT01183455|Alpha1-Proteinase Inhibitor|alpha1-proteinase inhibitor
413708|NCT01183455|Alpha-1 Antitrypsin|alpha-1 antitrypsin
413709|NCT01183455|AAT|aat
413710|NCT01183442|endothelial function|endothelial function
413711|NCT01183442|insulin sensitivity|insulin sensitivity
413712|NCT01183429|MAB 3F8|mab 3f8
413713|NCT01183429|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
413714|NCT01183429|Bone Marrow|bone marrow
413715|NCT01183429|09-159|09-159
413716|NCT01183416|GM-CSF|gm-csf
413717|NCT01183416|MAB 3F8|mab 3f8
413718|NCT01183416|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
413719|NCT01183416|09-158|09-158
413720|NCT01183403|stricture|stricture
413721|NCT01183403|anti-TNF|anti-tnf
413722|NCT01183403|ileal Crohn'Disease|ileal crohn'disease
413723|NCT01183403|patients with ileal Crohn's disease complicated by|patients with ileal crohn's disease complicated by
413724|NCT01183403|symptomatic stricture after failure of corticosteroids|symptomatic stricture after failure of corticosteroids
413725|NCT01183403|and/or immunosuppressives|and/or immunosuppressives
413726|NCT01183390|Bioequivalence|bioequivalence
413727|NCT01183390|Healthy Subjects|healthy subjects
413728|NCT01183377|Female Athlete Triad syndrom|female athlete triad syndrom
413729|NCT01183377|Eating disorder|eating disorder
413730|NCT01183377|osteoprosis|osteoprosis
413731|NCT01183364|solid tumor malignancies|solid tumor malignancies
413732|NCT01183364|tumor|tumor
413733|NCT01183364|cancer|cancer
413734|NCT01183364|STA-9090|sta-9090
413735|NCT01183364|ganetespib|ganetespib
413736|NCT01183364|HSP90 inhibitor|hsp90 inhibitor
413737|NCT01183351|Dementia|dementia
413738|NCT01183351|Agitation|agitation
413739|NCT01183351|Challenging behaviour|challenging behaviour
413740|NCT01183351|Behavioural and psychological symptoms in dementia (BPSD)|behavioural and psychological symptoms in dementia (bpsd)
413741|NCT01183338|SpO2|spo2
413742|NCT01183338|Oxygen saturation|oxygen saturation
413743|NCT01183325|Umbilical and small ventral hernias less than 3cm diameter|umbilical and small ventral hernias less than 3cm diameter
413744|NCT01183312|Hypersomnia|hypersomnia
413745|NCT01183312|Primary Hypersomnia|primary hypersomnia
413746|NCT01183312|Idiopathic Hypersomnia|idiopathic hypersomnia
413747|NCT01183312|Narcolepsy without Cataplexy|narcolepsy without cataplexy
413749|NCT01183299|bone metabolism|bone metabolism
413750|NCT01183299|salt intake|salt intake
413751|NCT01183299|acid base balance|acid base balance
413752|NCT01183299|bed rest|bed rest
413753|NCT01183260|revision total hip arthroplasty|revision total hip arthroplasty
413754|NCT01183260|bone mineral density|bone mineral density
413755|NCT01183260|trabecular metal|trabecular metal
413756|NCT01183260|DEXA|dexa
413757|NCT01183247|Everolimus,|everolimus,
413758|NCT01183247|rapamycin,|rapamycin,
413759|NCT01183247|prednisone,|prednisone,
413760|NCT01183247|tacrolimus,|tacrolimus,
413761|NCT01183247|MMF,|mmf,
413762|NCT01183247|steroid-free,|steroid-free,
412821|NCT01186796|Women|women
413763|NCT01183247|protocol biopsy|protocol biopsy
413764|NCT01183182|Lung nodule|lung nodule
413765|NCT01183182|Lung lesion|lung lesion
413766|NCT01183169|Chronic hepatitis C|chronic hepatitis c
413767|NCT01183169|Cyclophilin inhibitor|cyclophilin inhibitor
413768|NCT01183156|Colorectal Cancer|colorectal cancer
413769|NCT01183156|Screening|screening
413770|NCT01183156|Colonoscopy|colonoscopy
413771|NCT01183156|Attendance|attendance
413772|NCT01183156|Participation|participation
413773|NCT01183143|Infertility|infertility
413774|NCT01183143|Ovulation induction|ovulation induction
413775|NCT01183143|Gonal-F|gonal-f
413776|NCT01183143|Follitropin alpha|follitropin alpha
413777|NCT01183143|Controlled ovarian stimulation.|controlled ovarian stimulation.
413778|NCT01183130|opiate dependence|opiate dependence
413779|NCT01183130|compliance monitoring|compliance monitoring
413780|NCT01183130|substitution treatment|substitution treatment
413781|NCT01183104|Type 2 Diabetes|type 2 diabetes
413782|NCT01183104|Sitagliptin|sitagliptin
413783|NCT01183104|Glimepiride|glimepiride
413784|NCT01183104|Elderly patients|elderly patients
413785|NCT01183104|Japanese|japanese
413786|NCT01183091|Atrial fibrillation|atrial fibrillation
413787|NCT01183091|Ablation|ablation
413788|NCT01183078|efficacy|efficacy
413789|NCT01183078|drill placement|drill placement
413790|NCT01183078|nail placement|nail placement
413791|NCT01183078|radiation|radiation
413792|NCT01183078|Operative time|operative time
413793|NCT01183078|Reduction in exposure to radiation|reduction in exposure to radiation
413794|NCT01183078|Accuracy for nail placement|accuracy for nail placement
413795|NCT01183065|Pralatrexate|pralatrexate
413796|NCT01183065|Vitamin B12|vitamin b12
413797|NCT01183065|Folic Acid|folic acid
413798|NCT01183065|10-112|10-112
413799|NCT01183052|COPD|copd
413800|NCT01183052|exercise tolerance|exercise tolerance
413801|NCT01183052|oxidative stress|oxidative stress
413802|NCT01183039|Sedentary|sedentary
9182|NCT03232086|Controlled Human Exposure Study|controlled human exposure study
413803|NCT01183000|Formation of adhesions assessed at subsequent cs|formation of adhesions assessed at subsequent cs
413804|NCT01182987|Quality improvement|quality improvement
413805|NCT01182987|Quality of care|quality of care
413806|NCT01182987|Health care utilization|health care utilization
413807|NCT01182987|Behavioral change|behavioral change
413808|NCT01182974|fever in severe sepsis|fever in severe sepsis
413809|NCT01182961|Gait|gait
413810|NCT01182961|Falls|falls
413811|NCT01182961|Virtual reality|virtual reality
413812|NCT01182948|aerobic training|aerobic training
413813|NCT01182948|resistance training|resistance training
413814|NCT01182948|type 2 diabetes|type 2 diabetes
413815|NCT01182948|therapy|therapy
413816|NCT01182935|vitamin D|vitamin d
413817|NCT01182935|triglycerides|triglycerides
413818|NCT01182935|type 2 diabetes|type 2 diabetes
413819|NCT01182922|Attendance|attendance
413820|NCT01182922|Colorectal cancer|colorectal cancer
413821|NCT01182922|Screening|screening
413822|NCT01182922|Invitation letter|invitation letter
413824|NCT01182909|Environmental and Genetic|environmental and genetic
413825|NCT01182909|evaluate putative environmental exposures and NPC|evaluate putative environmental exposures and npc
413826|NCT01182909|assess the effect of genetic factors|assess the effect of genetic factors
413827|NCT01182909|investigate gene-environment interactions|investigate gene-environment interactions
413828|NCT01182909|examine the natural history of EBV infection|examine the natural history of ebv infection
413829|NCT01182883|Maximum Tolerated Dose|maximum tolerated dose
413830|NCT01182883|Dose Escalation|dose escalation
413831|NCT01182883|Pharmacokinetics|pharmacokinetics
413832|NCT01182883|Antitumor Activity|antitumor activity
413833|NCT01182883|Biologic Activity|biologic activity
413834|NCT01182870|vitamin D|vitamin d
413835|NCT01182870|influenza|influenza
413836|NCT01182870|prevention|prevention
413837|NCT01182857|Quality of Life|quality of life
413838|NCT01182857|Gene Therapy|gene therapy
413839|NCT01182857|ADA-SCID|ada-scid
413840|NCT01182857|SCID-ADA|scid-ada
413841|NCT01182857|Severe Combined Immunodeficiency|severe combined immunodeficiency
413842|NCT01182844|metabolic syndrome, probiotic|metabolic syndrome, probiotic
413843|NCT01182831|carcinoma pancreas|carcinoma pancreas
413844|NCT01182831|percutaneous celiac plexus neurolysis|percutaneous celiac plexus neurolysis
413845|NCT01182831|endosonography guided celiac plexus neurolysis|endosonography guided celiac plexus neurolysis
413846|NCT01182818|Cerebrovascular Accident|cerebrovascular accident
413847|NCT01182818|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
413848|NCT01182818|Fabry Disease|fabry disease
413849|NCT01182818|Fabry´s Disease|fabry´s disease
413850|NCT01182818|Anderson-Fabry Disease|anderson-fabry disease
413851|NCT01182818|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
413852|NCT01182818|Stroke, Acute|stroke, acute
413853|NCT01182818|Cerebral Stroke|cerebral stroke
413854|NCT01182792|Endothelial Function|endothelial function
413855|NCT01182792|Chronic Hypoxia|chronic hypoxia
413856|NCT01182792|Oxidative Stress|oxidative stress
413857|NCT01182779|base of skull chordoma|base of skull chordoma
413858|NCT01182779|radiation|radiation
413859|NCT01182779|carbon ions|carbon ions
413861|NCT01182766|alcohol|alcohol
413862|NCT01182766|alcoholism|alcoholism
413863|NCT01182766|nicotine|nicotine
413864|NCT01182766|cigarette|cigarette
413865|NCT01182753|Chondrosarcoma|chondrosarcoma
413866|NCT01182753|Radiation|radiation
413867|NCT01182753|carbon ion|carbon ion
413868|NCT01182727|schizophrenia|schizophrenia
413869|NCT01182727|salsalate|salsalate
413870|NCT01182727|obesity|obesity
413871|NCT01182714|Hysterectomy|hysterectomy
413872|NCT01182714|Catheterisation|catheterisation
413873|NCT01182701|Type 2 Diabetes|type 2 diabetes
413874|NCT01182701|Asian Pacific Islanders|asian pacific islanders
413875|NCT01182701|Cognitive behavioral intervention|cognitive behavioral intervention
413876|NCT01182688|utilization of Procalcitonin in the cardiac setting|utilization of procalcitonin in the cardiac setting
413877|NCT01182675|SCID|scid
413878|NCT01182675|Transplant|transplant
413879|NCT01182675|Alemtuzumab|alemtuzumab
413880|NCT01182675|Plerixafor|plerixafor
413881|NCT01182662|Bone Marrow Disease|bone marrow disease
413882|NCT01182662|Aplastic Anemia|aplastic anemia
413883|NCT01182662|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
413884|NCT01182662|Transplantation|transplantation
413885|NCT01182649|Drug Eluting Stents|drug eluting stents
413886|NCT01182649|Everolimus Eluting Stent|everolimus eluting stent
413887|NCT01182649|Coronary Angioplasty|coronary angioplasty
413888|NCT01182636|Bioequivalence|bioequivalence
413889|NCT01182636|Acne Vulgaris|acne vulgaris
413890|NCT01182623|FICE|fice
413891|NCT01182623|Chromoendoscopy|chromoendoscopy
413892|NCT01182623|Colonic polyps|colonic polyps
413893|NCT01182623|Adenomas|adenomas
413894|NCT01182623|Hyperplastic polyps|hyperplastic polyps
414018|NCT01182051|anxiety|anxiety
414019|NCT01182051|pediatric headache and anxiety|pediatric headache and anxiety
9183|NCT03232086|Cardiovascular|cardiovascular
9379|NCT03230734|radium-223|radium-223
9588|NCT03229369|ACL|acl
9675|NCT03228641|skin laxity reduction|skin laxity reduction
413895|NCT01182597|Oral PPI treatment has similar benefit as proton pump inhibitor infusion in patient with bleeding ulcers after combined endoscopic hemostasis|oral ppi treatment has similar benefit as proton pump inhibitor infusion in patient with bleeding ulcers after combined endoscopic hemostasis
413896|NCT01182571|Heart Transplantation|heart transplantation
413897|NCT01182571|Symptom Distress|symptom distress
413898|NCT01182571|Fatigue|fatigue
413899|NCT01182571|Depression|depression
413900|NCT01182571|Quality Of Life.|quality of life.
413901|NCT01182558|Muscle|muscle
413902|NCT01182558|Activation|activation
413903|NCT01182558|Effect|effect
413904|NCT01182558|Compound muscle action potential|compound muscle action potential
413905|NCT01182545|Anaesthesia|anaesthesia
413906|NCT01182545|laparoscopic cholecystectomy|laparoscopic cholecystectomy
413907|NCT01182545|CO2 insufflation|co2 insufflation
413908|NCT01182545|hemodynamic|hemodynamic
413909|NCT01182545|hyperventilation|hyperventilation
413910|NCT01182532|Mild type of hand, foot and mouth disease|mild type of hand, foot and mouth disease
413911|NCT01182532|Traditional Chinese Medicine|traditional chinese medicine
413912|NCT01182532|Effectiveness|effectiveness
413913|NCT01182532|Safety|safety
413914|NCT01182519|lung inflammation|lung inflammation
413915|NCT01182519|lung metastases|lung metastases
413916|NCT01182519|10-115|10-115
413917|NCT01182506|Cogmed Working Memory Training (CWMT)|cogmed working memory training (cwmt)
413918|NCT01182506|cognitive|cognitive
413919|NCT01182506|10-105|10-105
413920|NCT01182506|Breast cancer survivor|breast cancer survivor
413921|NCT01182493|Diabetes Mellitus|diabetes mellitus
413922|NCT01182493|MDI|mdi
413923|NCT01182493|pump therapy|pump therapy
413924|NCT01182467|Inflammatory bowel disease, PET scan, Crohn's disease|inflammatory bowel disease, pet scan, crohn's disease
413925|NCT01182454|blood pressure|blood pressure
413926|NCT01182441|atrial fibrillation|atrial fibrillation
413927|NCT01182441|stroke|stroke
413928|NCT01182441|TIA|tia
413929|NCT01182441|trans ischemic attack|trans ischemic attack
413930|NCT01182441|warfarin|warfarin
413931|NCT01182441|Coumadin|coumadin
413932|NCT01182428|Stents|stents
413933|NCT01182428|Angioplasty|angioplasty
413934|NCT01182428|Total coronary occlusions|total coronary occlusions
413935|NCT01182428|Coronary restenosis|coronary restenosis
413936|NCT01182428|Stent thrombosis|stent thrombosis
413937|NCT01182428|Everolimus|everolimus
413938|NCT01182415|CNS involvement|cns involvement
413939|NCT01182402|opiate dependence|opiate dependence
413940|NCT01182402|substitution treatment|substitution treatment
413941|NCT01182402|unsupervised dosing|unsupervised dosing
413942|NCT01182402|monitoring|monitoring
413943|NCT01182389|Ventricular Tachycardia|ventricular tachycardia
413944|NCT01182389|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
413945|NCT01182389|Catheter Ablation|catheter ablation
413946|NCT01182389|Robotic|robotic
413947|NCT01182376|Multaq|multaq
413948|NCT01182376|dronedarone|dronedarone
413949|NCT01182376|Atrial Fibrillation|atrial fibrillation
515911|NCT00268138|qlf|qlf
413950|NCT01182363|maternal depression|maternal depression
413951|NCT01182363|prematurity|prematurity
413952|NCT01182363|early intervention|early intervention
413953|NCT01182363|developmental delay|developmental delay
413954|NCT01182350|Molecularly Determined Treatment|molecularly determined treatment
413955|NCT01182324|Expectations|expectations
413956|NCT01182324|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
413957|NCT01182324|Clinical Trial|clinical trial
413958|NCT01182324|Motivations|motivations
413959|NCT01182311|Hepatitis B Virus|hepatitis b virus
413960|NCT01182311|Hepatitis B Vaccine|hepatitis b vaccine
413961|NCT01182311|Immunity|immunity
413962|NCT01182311|B-Cell Response|b-cell response
413963|NCT01182311|T-Cell Response|t-cell response
413964|NCT01182311|Hepatitis B Immunity|hepatitis b immunity
413965|NCT01182311|Hepatitis B Virus Vaccine|hepatitis b virus vaccine
413966|NCT01182298|Latino|latino
413967|NCT01182298|HCV|hcv
413968|NCT01182298|pegIFN|pegifn
413969|NCT01182298|Viral Kinetics|viral kinetics
413970|NCT01182298|IL-28 Haplotype|il-28 haplotype
413971|NCT01182285|Depakote|depakote
413972|NCT01182285|Poorly Differentiated Thyroid Cancer|poorly differentiated thyroid cancer
413973|NCT01182285|RAI Uptake|rai uptake
413974|NCT01182285|Thyrogen|thyrogen
413975|NCT01182272|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
413976|NCT01182272|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
413977|NCT01182246|adenocarcinoma|adenocarcinoma
413978|NCT01182246|Pancreatic cancer|pancreatic cancer
413979|NCT01182233|Multiple Myeloma|multiple myeloma
413980|NCT01182233|Autologous Hematopoietic Stem Cell Transplant|autologous hematopoietic stem cell transplant
413981|NCT01182233|Total Skeletal Irradiation|total skeletal irradiation
413982|NCT01182233|High dose chemotherapy|high dose chemotherapy
413983|NCT01182220|epidural|epidural
413984|NCT01182220|labor pain|labor pain
413985|NCT01182220|ultrasound|ultrasound
413986|NCT01182207|Bioequivalence|bioequivalence
413987|NCT01182207|Healthy Subjects|healthy subjects
413988|NCT01182194|Bioequivalence|bioequivalence
413989|NCT01182194|Healthy Subjects|healthy subjects
413990|NCT01182181|Healthy Subjects|healthy subjects
413991|NCT01182181|Bioequivalence|bioequivalence
413992|NCT01182168|CISPLATIN|cisplatin
413993|NCT01182168|GEMCITABINE|gemcitabine
413994|NCT01182168|RAD001 (EVEROLIMUS)|rad001 (everolimus)
413995|NCT01182168|10-106|10-106
413996|NCT01182155|Lung Cancer Non-Small Cell Cancer (NSCLC)|lung cancer non-small cell cancer (nsclc)
413997|NCT01182155|Lung Cancer Small Cell Lung Cancer (SCLC)|lung cancer small cell lung cancer (sclc)
413998|NCT01182129|Nicotine Polacrilex chewing gum versus Swedish Snus|nicotine polacrilex chewing gum versus swedish snus
413999|NCT01182116|J pouch|j pouch
414000|NCT01182116|colorectal|colorectal
414001|NCT01182116|rectal cancer|rectal cancer
414002|NCT01182116|coloplasty|coloplasty
414003|NCT01182103|Major depression|major depression
414004|NCT01182103|BDNF|bdnf
414005|NCT01182103|DNA methylation|dna methylation
414308|NCT01180959|Bevacizumab|bevacizumab
414006|NCT01182103|Histone modification|histone modification
414007|NCT01182090|pelvic organ prolapse|pelvic organ prolapse
414008|NCT01182090|colposacropexy|colposacropexy
414009|NCT01182090|surgery|surgery
414010|NCT01182077|ASP015K|asp015k
414011|NCT01182077|midazolam|midazolam
414012|NCT01182077|healthy volunteers|healthy volunteers
414013|NCT01182064|Heart injuries|heart injuries
414014|NCT01182064|Posttraumatic myocardial infarction|posttraumatic myocardial infarction
414015|NCT01182064|Echocardiography|echocardiography
414016|NCT01182064|Coronary angiography|coronary angiography
414017|NCT01182051|headache|headache
414020|NCT01182038|birth seat|birth seat
414021|NCT01182038|childbirth|childbirth
414022|NCT01182038|instrumental delivery|instrumental delivery
414023|NCT01182038|upright position|upright position
414024|NCT01182025|Mild type of hand, foot and mouth disease|mild type of hand, foot and mouth disease
414025|NCT01182025|Xiyanping Injection|xiyanping injection
414026|NCT01182025|Effectiveness|effectiveness
414027|NCT01182025|Safety|safety
414028|NCT01182012|Cardiovascular risk factor|cardiovascular risk factor
414029|NCT01182012|Severe mental illness|severe mental illness
414030|NCT01182012|Drug appropriateness|drug appropriateness
414031|NCT01182012|Drug compliance|drug compliance
414032|NCT01182012|Lifestyle counseling|lifestyle counseling
414033|NCT01181999|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
414034|NCT01181999|elderly patients|elderly patients
414035|NCT01181999|rituximab augmentation|rituximab augmentation
414036|NCT01181986|Type 2 diabetes mellitus, Impaired glucose tolerance|type 2 diabetes mellitus, impaired glucose tolerance
414037|NCT01181973|Relative bioavailability|relative bioavailability
414038|NCT01181973|pegvisomant|pegvisomant
414039|NCT01181960|Risperidone long acting injectable|risperidone long acting injectable
414040|NCT01181960|Risperdal Consta|risperdal consta
414041|NCT01181960|Paliperidone Palmitate|paliperidone palmitate
414042|NCT01181960|Invega Sustenna|invega sustenna
414043|NCT01181947|Stent graft|stent graft
414044|NCT01181947|thoracic aorta|thoracic aorta
414045|NCT01181947|dissection|dissection
414046|NCT01181947|aneurysm|aneurysm
414047|NCT01181947|TEVAR|tevar
414048|NCT01181947|VALIANT|valiant
414049|NCT01181947|CAPTIVIA|captivia
414050|NCT01181947|endovascular|endovascular
414051|NCT01181934|symptomatic treatment|symptomatic treatment
414052|NCT01181934|cognition|cognition
414053|NCT01181934|cognitive deficits|cognitive deficits
414054|NCT01181934|Schizophrenia|schizophrenia
414055|NCT01181921|Alzheimer Disease|alzheimer disease
414056|NCT01181921|Dementia|dementia
414057|NCT01181921|Sleep Disorders|sleep disorders
414058|NCT01181921|Galantamine|galantamine
414059|NCT01181921|Reminyl|reminyl
414060|NCT01181908|alcohol|alcohol
414061|NCT01181908|drug interaction|drug interaction
414062|NCT01181908|pharmacodynamic|pharmacodynamic
414063|NCT01181895|asthma|asthma
414064|NCT01181882|Cardiovascular Disease|cardiovascular disease
414065|NCT01181882|Aspirin Resistance|aspirin resistance
414066|NCT01181882|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
414067|NCT01181882|Platelet Function|platelet function
414068|NCT01181882|Omega-3 Fatty Acids|omega-3 fatty acids
414069|NCT01181882|Aspirin|aspirin
414070|NCT01181882|Lysophospholipids|lysophospholipids
414071|NCT01181882|Lysophosphatidic Acid|lysophosphatidic acid
414072|NCT01181882|Lysophosphatidylcholine|lysophosphatidylcholine
414073|NCT01181869|respiratory failure|respiratory failure
414074|NCT01181869|oxygen|oxygen
414075|NCT01181869|sleep apnoea|sleep apnoea
414076|NCT01181869|ventilation|ventilation
414077|NCT01181856|Vaccine|vaccine
414078|NCT01181856|MVA 85A|mva 85a
414079|NCT01181843|postoperative pain management|postoperative pain management
414080|NCT01181843|respiratory depression|respiratory depression
414081|NCT01181843|capnography|capnography
414082|NCT01181843|duramorph|duramorph
414083|NCT01181830|magnesium|magnesium
414084|NCT01181830|metabolic syndrome|metabolic syndrome
414085|NCT01181830|diabetes|diabetes
414086|NCT01181830|family history|family history
414087|NCT01181817|FBSS|fbss
414088|NCT01181817|at least one prior spinal surgery|at least one prior spinal surgery
414089|NCT01181804|boceprevir|boceprevir
414090|NCT01181804|hepatitis C|hepatitis c
414091|NCT01181804|bioequivalence|bioequivalence
414092|NCT01181804|SCH 503034|sch 503034
414093|NCT01181791|probiotics|probiotics
414094|NCT01181791|premature infants|premature infants
414095|NCT01181791|feeding tolerance|feeding tolerance
414096|NCT01181778|hormonal contraceptive methods|hormonal contraceptive methods
414097|NCT01181778|combined hormonal contraceptive methods|combined hormonal contraceptive methods
414098|NCT01181778|physician counseling|physician counseling
414099|NCT01181765|Crohn's Disease|crohn's disease
414100|NCT01181765|infliximab|infliximab
414101|NCT01181765|capsule endoscopy|capsule endoscopy
414102|NCT01181752|proficiency|proficiency
414103|NCT01181752|eye drop instillation|eye drop instillation
414104|NCT01181752|postoperative cataract surgery|postoperative cataract surgery
414106|NCT01181739|Colonoscopy|colonoscopy
414107|NCT01181739|Virtual Colonoscopy|virtual colonoscopy
414108|NCT01181739|Colonography|colonography
414109|NCT01181739|Colorectal Cancer|colorectal cancer
414110|NCT01181739|Colonic Polyps|colonic polyps
414111|NCT01181739|Screening|screening
414112|NCT01181726|Bioequivalence|bioequivalence
414113|NCT01181726|Healthy Subjects|healthy subjects
414114|NCT01181687|COMFORT behavioral scale|comfort behavioral scale
414115|NCT01181687|pain assessment scale|pain assessment scale
414116|NCT01181687|child|child
414117|NCT01181687|validity|validity
414118|NCT01181687|reliability|reliability
414119|NCT01181674|Diabetes|diabetes
414120|NCT01181674|Insulin|insulin
414121|NCT01181674|Glargine|glargine
414122|NCT01181674|Metformin|metformin
414123|NCT01181674|Acarbose|acarbose
414124|NCT01181674|Diet|diet
414125|NCT01181674|Exercise|exercise
414126|NCT01181674|Lifestyle|lifestyle
414127|NCT01181661|Cigarette|cigarette
414128|NCT01181661|Smoking|smoking
414129|NCT01181661|Nicotine|nicotine
414130|NCT01181661|Contingency Management|contingency management
414131|NCT01181661|Voucher Reinforcement|voucher reinforcement
414132|NCT01181661|Smoking Abstinence|smoking abstinence
414133|NCT01181661|Internet|internet
414134|NCT01181661|Internet-based Treatment|internet-based treatment
414135|NCT01181661|Group Contingencies|group contingencies
414136|NCT01181648|Survivor|survivor
414137|NCT01181648|Human Papillomavirus (HPV)|human papillomavirus (hpv)
414138|NCT01181648|Quality of Life|quality of life
414139|NCT01181648|Surviving Oropharynx Cancer|surviving oropharynx cancer
414140|NCT01181648|10-111|10-111
414141|NCT01181596|neonates and infants, from the 23-week gestational (0.5 kg)|neonates and infants, from the 23-week gestational (0.5 kg)
414142|NCT01181596|up to a 6 month old born at term (7 kg), for whom the PIV,|up to a 6 month old born at term (7 kg), for whom the piv,
414143|NCT01181596|PAC, UAC, UVC or PICC catheter insertion is medically|pac, uac, uvc or picc catheter insertion is medically
414144|NCT01181596|indicated.|indicated.
414145|NCT01181570|psoriasis|psoriasis
414146|NCT01181570|adalimumab|adalimumab
414147|NCT01181570|obstructive sleep apnea|obstructive sleep apnea
413210|NCT01185353|RA|ra
414148|NCT01181570|obesity|obesity
414149|NCT01181557|quality of life|quality of life
414150|NCT01181544|Anticoagulation|anticoagulation
414151|NCT01181544|Heparin|heparin
414152|NCT01181544|Hemodialysis|hemodialysis
414153|NCT01181544|Dialysis|dialysis
414154|NCT01181544|Renal Dialysis|renal dialysis
414155|NCT01181531|Secondary Hyperthyroidism|secondary hyperthyroidism
414156|NCT01181531|Hemodialysis|hemodialysis
414157|NCT01181531|Parathyroid|parathyroid
414158|NCT01181531|PARADIGM|paradigm
414159|NCT01181518|Tamoxifen|tamoxifen
414160|NCT01181518|Pharmacogenomics|pharmacogenomics
414161|NCT01181518|Breast cancer|breast cancer
414162|NCT01181505|HNF4a|hnf4a
414163|NCT01181505|CYP2D6|cyp2d6
414164|NCT01181505|Toterodine|toterodine
414165|NCT01181505|Genetic polymorphism|genetic polymorphism
414166|NCT01181492|gene polymorphism|gene polymorphism
414167|NCT01181492|CYP3A4|cyp3a4
414168|NCT01181492|fentanyl|fentanyl
414169|NCT01181492|HPLC|hplc
414170|NCT01181492|Analgesics|analgesics
414171|NCT01181479|Contraceptive|contraceptive
414172|NCT01181466|PLVR|plvr
414173|NCT01181466|BLVR|blvr
414174|NCT01181466|AeriSeal|aeriseal
414175|NCT01181466|treatment|treatment
414176|NCT01181466|device|device
414177|NCT01181466|breathing|breathing
414178|NCT01181466|COPD|copd
414179|NCT01181466|emphysema|emphysema
414180|NCT01181466|polymeric lung volume reduction|polymeric lung volume reduction
414181|NCT01181466|biologic lung volume reduction|biologic lung volume reduction
414182|NCT01181466|heterogeneous|heterogeneous
414183|NCT01181466|homogeneous|homogeneous
414184|NCT01181466|Pathologic Processes|pathologic processes
414185|NCT01181466|Respiratory Tract Diseases|respiratory tract diseases
414186|NCT01181466|Lung Diseases|lung diseases
414187|NCT01181466|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
414188|NCT01181453|Diabetic foot ulcer|diabetic foot ulcer
414189|NCT01181453|Randomized trial|randomized trial
414190|NCT01181453|Clinical trial|clinical trial
414191|NCT01181453|Dermagraft|dermagraft
414192|NCT01181453|Standard care|standard care
414193|NCT01181440|Diabetic foot ulcer|diabetic foot ulcer
414194|NCT01181440|Randomized trial|randomized trial
414195|NCT01181440|Clinical trial|clinical trial
414197|NCT01181440|Conventional care|conventional care
414198|NCT01181414|Permanent Atrial Fibrillation|permanent atrial fibrillation
414199|NCT01181414|Resynchronization therapy|resynchronization therapy
414200|NCT01181414|Ablation|ablation
414201|NCT01181401|induction chemotherapy|induction chemotherapy
414202|NCT01181401|radiotherapy|radiotherapy
414203|NCT01181401|locally advanced head neck tumor|locally advanced head neck tumor
414204|NCT01181401|toxicity|toxicity
414205|NCT01181401|LA SCCHN|la scchn
414206|NCT01181401|Unresectable squamous cell cancer of the head and neck,|unresectable squamous cell cancer of the head and neck,
414207|NCT01181401|Stage IV (UICC)|stage iv (uicc)
414208|NCT01181375|cervical cancer|cervical cancer
414209|NCT01181375|assay|assay
414210|NCT01181375|hypoxia|hypoxia
414211|NCT01181362|Endoscopy|endoscopy
414212|NCT01181362|Head and Neck region|head and neck region
414213|NCT01181362|Scope|scope
414214|NCT01181349|neuromuscular blockade; general anesthesia|neuromuscular blockade; general anesthesia
414215|NCT01181336|Safety|safety
414216|NCT01181336|Tolerability|tolerability
414217|NCT01181336|Immunogenicity|immunogenicity
414218|NCT01181336|Influenza|influenza
414219|NCT01181336|Virus|virus
414220|NCT01181336|Vaccine|vaccine
414221|NCT01181323|influenza, vaccine, breastfeeding, post-partum women, infant, LAIV, TIV, parent protocol|influenza, vaccine, breastfeeding, post-partum women, infant, laiv, tiv, parent protocol
414222|NCT01181310|dementia, cognitive impairment, neurodegeneration, Alzheimer's, acetylcholine, AchE|dementia, cognitive impairment, neurodegeneration, alzheimer's, acetylcholine, ache
414223|NCT01181297|Confirmed milk allergy|confirmed milk allergy
414224|NCT01181284|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
414225|NCT01181271|Lymphoma|lymphoma
414226|NCT01181271|non-hodgkins lymphoma|non-hodgkins lymphoma
414227|NCT01181271|Hodgkin's lymphoma|hodgkin's lymphoma
414228|NCT01181271|Hodgkin's disease|hodgkin's disease
414229|NCT01181271|stem cell transplant|stem cell transplant
414230|NCT01181271|High-risk diffuse large B cell|high-risk diffuse large b cell
414231|NCT01181271|Transformed low grade lymphoma|transformed low grade lymphoma
414232|NCT01181271|T-cell non-Hodgkin's lymphoma|t-cell non-hodgkin's lymphoma
414233|NCT01181271|Mantle cell lymphoma at any time in therapy|mantle cell lymphoma at any time in therapy
414234|NCT01181271|"Double-hit lymphoma"|"double-hit lymphoma"
414235|NCT01181258|related HLA-haploidentical donor|related hla-haploidentical donor
414236|NCT01181245|Pancreatic Cancer|pancreatic cancer
414237|NCT01181232|insomnia|insomnia
414238|NCT01181232|zolpidem|zolpidem
414239|NCT01181206|Surgical site infections|surgical site infections
414240|NCT01181206|Covering the abdominal wound edge in laparotomies|covering the abdominal wound edge in laparotomies
414946|NCT00000371|Serotonin|serotonin
414241|NCT01181193|glioblastoma multiforme|glioblastoma multiforme
414242|NCT01181193|chemoradiotherapy|chemoradiotherapy
414243|NCT01181193|vitamin D|vitamin d
414244|NCT01181180|Ageing|ageing
414245|NCT01181180|Balance control|balance control
414246|NCT01181180|Falls|falls
414247|NCT01181180|dehydration|dehydration
414248|NCT01181167|Anticoagulants|anticoagulants
414249|NCT01181167|Venous thromboembolism|venous thromboembolism
414250|NCT01181167|Thromboembolism|thromboembolism
414251|NCT01181167|Thrombosis|thrombosis
414252|NCT01181167|enoxaparin sodium|enoxaparin sodium
414253|NCT01181167|Embolism|embolism
414254|NCT01181167|Deep vein thrombosis|deep vein thrombosis
414255|NCT01181167|DU-176b|du-176b
414256|NCT01181167|edoxaban|edoxaban
414257|NCT01181167|factor Xa|factor xa
414258|NCT01181167|total hip arthroplasty|total hip arthroplasty
414259|NCT01181154|Auto-Immune|auto-immune
414260|NCT01181154|Hemolytic|hemolytic
414261|NCT01181154|Anemia|anemia
414262|NCT01181154|AHA|aha
414263|NCT01181154|AIHA|aiha
414264|NCT01181154|Rituximab|rituximab
414265|NCT01181141|Anticoagulants|anticoagulants
414266|NCT01181141|Enoxaparin sodium|enoxaparin sodium
414267|NCT01181141|venous thromboembolism.|venous thromboembolism.
414268|NCT01181141|thromboembolism|thromboembolism
414269|NCT01181141|Thrombosis|thrombosis
414270|NCT01181141|deep vein thrombosis|deep vein thrombosis
414271|NCT01181141|DU-176b|du-176b
414272|NCT01181141|Edoxaban|edoxaban
414273|NCT01181141|factor Xa|factor xa
414274|NCT01181141|hip fracture surgery|hip fracture surgery
414275|NCT01181141|embolism|embolism
414276|NCT01181115|Chinese Patients|chinese patients
414277|NCT01181115|Relapsing MS|relapsing ms
414278|NCT01181115|Safety|safety
414279|NCT01181115|Avonex|avonex
414280|NCT01181115|Tolerability|tolerability
414281|NCT01181115|Gadolinium|gadolinium
414282|NCT01181115|Interferon Beta 1a|interferon beta 1a
414283|NCT01181102|anticoagulant|anticoagulant
414284|NCT01181102|venus thromboembolism|venus thromboembolism
414285|NCT01181102|thrombosis|thrombosis
414286|NCT01181102|thromboembolism|thromboembolism
414287|NCT01181102|embolism and thrombosis|embolism and thrombosis
414288|NCT01181102|deep vein thrombosis|deep vein thrombosis
414289|NCT01181102|DU-176b|du-176b
414290|NCT01181102|Edoxaban|edoxaban
414291|NCT01181102|factor Xa|factor xa
414292|NCT01181102|total knee arthroplasty|total knee arthroplasty
414294|NCT01181076|Stem cell transplantation|stem cell transplantation
414295|NCT01181076|Individualized Nutrition|individualized nutrition
414296|NCT01181076|Quality of life|quality of life
414297|NCT01181076|Oral Mucositis|oral mucositis
414298|NCT01181076|Adult|adult
414299|NCT01181063|Asthma|asthma
414300|NCT01181063|Easyhaler|easyhaler
414301|NCT01181037|Displaced subcapital femoral fracture|displaced subcapital femoral fracture
414302|NCT01181037|Bbipolar H.A.|bbipolar h.a.
414303|NCT01181037|CRIF with Ttrochanteric Antegrade Nail|crif with ttrochanteric antegrade nail
414304|NCT01180972|Obesity, diabetes, hispanic, physical activity, nutrition|obesity, diabetes, hispanic, physical activity, nutrition
414305|NCT01180959|Advanced Liver Cancer|advanced liver cancer
414306|NCT01180959|primary neoplasm of the liver|primary neoplasm of the liver
414307|NCT01180959|Erlotinib|erlotinib
414309|NCT01180959|Hepatocellular Carcinoma|hepatocellular carcinoma
414310|NCT01180959|HCC|hcc
414311|NCT01180959|Avastin|avastin
414312|NCT01180959|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
414313|NCT01180959|rhuMAb-VEGF|rhumab-vegf
414314|NCT01180959|OSI-774|osi-774
414315|NCT01180959|Tarceva|tarceva
414316|NCT01180946|FGF23|fgf23
414317|NCT01180946|FGF-23|fgf-23
414318|NCT01180946|vitamin D|vitamin d
414319|NCT01180946|vitamin D deficiency|vitamin d deficiency
414320|NCT01180946|insulin resistance|insulin resistance
414321|NCT01180946|Healthy volunteers|healthy volunteers
414322|NCT01180933|docosahexaenoic acid|docosahexaenoic acid
414323|NCT01180933|folate|folate
414324|NCT01180933|neurological development|neurological development
414325|NCT01180933|allergies|allergies
414326|NCT01180933|long term consequences for the offspring|long term consequences for the offspring
414327|NCT01180933|allergy risk|allergy risk
414328|NCT01180920|Dental|dental
414329|NCT01180920|Periodontal|periodontal
414330|NCT01180920|Surgery|surgery
414331|NCT01180920|Gums|gums
414332|NCT01180907|18F-FAC|18f-fac
414333|NCT01180907|imaging|imaging
414334|NCT01180907|cancer|cancer
414335|NCT01180907|inflammation|inflammation
414336|NCT01180907|PET|pet
414337|NCT01180894|Trauma|trauma
414338|NCT01180894|Anemia|anemia
414339|NCT01180894|Iron|iron
414340|NCT01180894|Erythropoeisis|erythropoeisis
414341|NCT01180881|Proton Radiation|proton radiation
414342|NCT01180881|CNS tumors|cns tumors
414343|NCT01180881|Brain Tumors|brain tumors
414344|NCT01180881|Neurobehavioral functioning|neurobehavioral functioning
414345|NCT01180868|imaging probe|imaging probe
414346|NCT01180868|cancer|cancer
414347|NCT01180868|inflammatory tissue|inflammatory tissue
414348|NCT01180868|inflammatory diseases|inflammatory diseases
414349|NCT01180855|Melatonin|melatonin
414350|NCT01180855|Cognitive Behavior Therapy|cognitive behavior therapy
414351|NCT01180842|CF|cf
414352|NCT01180816|GBM|gbm
414353|NCT01180816|AA|aa
414354|NCT01180816|AO|ao
414355|NCT01180816|Brain|brain
414356|NCT01180816|Tumors|tumors
414357|NCT01180816|Malignant|malignant
414358|NCT01180816|Glioblastoma|glioblastoma
414359|NCT01180816|Multiforme|multiforme
414360|NCT01180816|Anaplastic|anaplastic
414361|NCT01180816|Astrocytoma|astrocytoma
414362|NCT01180803|COPD - long term oxygenotherapy|copd - long term oxygenotherapy
414363|NCT01180803|COPD patients with respiratory failure|copd patients with respiratory failure
414364|NCT01180790|HCV|hcv
414365|NCT01180790|Hepatitis C Genotype 1|hepatitis c genotype 1
414366|NCT01180764|hypertriglyceridemia|hypertriglyceridemia
414367|NCT01180764|omega-3 acid ethyl esters|omega-3 acid ethyl esters
414368|NCT01180764|high-density lipoproteins|high-density lipoproteins
414369|NCT01180764|fish oil|fish oil
414370|NCT01180751|Positron Emission Tomography|positron emission tomography
414371|NCT01180751|Fluorodeoxyglucose|fluorodeoxyglucose
414372|NCT01180751|FDG (18F-Fluorodeoxyglucose)|fdg (18f-fluorodeoxyglucose)
414373|NCT01180751|Oncology|oncology
414374|NCT01180751|Neurology|neurology
414375|NCT01180738|chronic stroke|chronic stroke
414376|NCT01180738|walking training|walking training
414377|NCT01180738|rehabilitation|rehabilitation
414378|NCT01180738|body weight supported treadmill training|body weight supported treadmill training
414379|NCT01180738|physical therapy|physical therapy
414380|NCT01180738|balance|balance
414381|NCT01180725|To investigate and compare the effects of dried plums and psyllium on the overall relief of constipation symptoms|to investigate and compare the effects of dried plums and psyllium on the overall relief of constipation symptoms
414382|NCT01180725|To investigate and compare the taste of dried plums and psyllium|to investigate and compare the taste of dried plums and psyllium
414383|NCT01180725|To investigate and compare the quality of life of dried plums and psyllium|to investigate and compare the quality of life of dried plums and psyllium
414384|NCT01180712|anthocyanin|anthocyanin
414385|NCT01180712|blaeberries|blaeberries
414386|NCT01180712|bilberries|bilberries
414387|NCT01180712|blueberries|blueberries
414388|NCT01180712|mirtoselect|mirtoselect
414389|NCT01180712|type 2 diabetes|type 2 diabetes
414390|NCT01180712|insulin resistance|insulin resistance
414391|NCT01180712|Adipose tissue|adipose tissue
414392|NCT01180712|inflammation|inflammation
414393|NCT01180699|adult solid organ transplant patients|adult solid organ transplant patients
414394|NCT01180686|low back pain|low back pain
414395|NCT01180686|chiropractic|chiropractic
414396|NCT01180686|manipulation|manipulation
414397|NCT01180673|Hypertension|hypertension
414398|NCT01180673|Older Adults|older adults
414399|NCT01180673|Motivational Interviewing|motivational interviewing
414400|NCT01180673|Lifestyle Counseling|lifestyle counseling
414401|NCT01180673|Senior Centers|senior centers
414402|NCT01180660|Gastric Surgery|gastric surgery
414404|NCT01180660|Recovery|recovery
414405|NCT01180660|Laparoscopic Surgery|laparoscopic surgery
414406|NCT01180647|Extended-release naltrexone|extended-release naltrexone
414407|NCT01180647|Prisoners|prisoners
414408|NCT01180647|Opioid addiction prevention|opioid addiction prevention
414409|NCT01180647|Medication Treatment Alternatives|medication treatment alternatives
414410|NCT01180647|Prevention of Relapse to Opioid Addiction|prevention of relapse to opioid addiction
414411|NCT01180621|vaccine|vaccine
414412|NCT01180621|Seasonal Influenza Vaccine|seasonal influenza vaccine
414413|NCT01180621|Influenza Vaccine|influenza vaccine
414414|NCT01180621|Vaccine Safety|vaccine safety
414415|NCT01180621|Vaccine Immunogenicity|vaccine immunogenicity
414416|NCT01180621|Fluviral 2010-2011|fluviral 2010-2011
414417|NCT01180608|neuropathic pain|neuropathic pain
414418|NCT01180608|Diabetic Polyneuropathy|diabetic polyneuropathy
414419|NCT01180595|osteoarthritis|osteoarthritis
414420|NCT01180595|arthroplasty|arthroplasty
414421|NCT01180595|knee joint|knee joint
414422|NCT01180595|radiography|radiography
414423|NCT01180595|surgery|surgery
414424|NCT01180595|Bone Density|bone density
414425|NCT01180595|Outcome Assessment (Health Care)|outcome assessment (health care)
414426|NCT01180582|knee|knee
414427|NCT01180582|arthroplasty|arthroplasty
414428|NCT01180582|RSA|rsa
414429|NCT01180582|migration|migration
414430|NCT01180582|micromotion|micromotion
414431|NCT01180582|osteoarthritis|osteoarthritis
414432|NCT01180569|Lenalidomide|lenalidomide
414433|NCT01180569|10-022|10-022
414434|NCT01180556|childhood|childhood
414435|NCT01180556|abdominal pain|abdominal pain
414436|NCT01180556|probiotics|probiotics
414437|NCT01180517|Angioplasty Balloon|angioplasty balloon
414438|NCT01180504|ovarian cancer|ovarian cancer
414439|NCT01180504|whole-abdominal radiotherapy|whole-abdominal radiotherapy
414440|NCT01180504|consolidation treatment|consolidation treatment
414441|NCT01180504|helical tomotherapy|helical tomotherapy
414442|NCT01180491|Discoloured and deformed nails resulting from onychomycosis|discoloured and deformed nails resulting from onychomycosis
414443|NCT01180478|Bladder Cancer|bladder cancer
415227|NCT00000395|Folic acid|folic acid
414444|NCT01180478|Urothelial carcinoma|urothelial carcinoma
414445|NCT01180478|Stage pTa or pT1|stage pta or pt1
414446|NCT01180478|NMIBC Ta/T1|nmibc ta/t1
414447|NCT01180478|Narrow Band Imaging|narrow band imaging
414448|NCT01180478|White Light Cystoscopy|white light cystoscopy
414449|NCT01180478|Transurethral resection|transurethral resection
414450|NCT01180478|Superficial bladder tumor|superficial bladder tumor
414451|NCT01180478|Positive urine cytology|positive urine cytology
414452|NCT01180465|Treatment of abdominal adiposity|treatment of abdominal adiposity
414453|NCT01180452|Crohn disease|crohn disease
414454|NCT01180452|dysplasia|dysplasia
414455|NCT01180452|adenocarcinoma|adenocarcinoma
414456|NCT01180452|endoscopy|endoscopy
414457|NCT01180452|jejunum|jejunum
414458|NCT01180452|ileum|ileum
414459|NCT01180439|Non-invasive ventilation|non-invasive ventilation
414460|NCT01180439|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
414461|NCT01180439|Patient-ventilator synchronisation|patient-ventilator synchronisation
414462|NCT01180439|Sleep study|sleep study
414463|NCT01180439|Polysomnography|polysomnography
414464|NCT01180426|Relapse Refractory Acute Myeloid Leukemia|relapse refractory acute myeloid leukemia
414465|NCT01180413|Inward eutrophic remodelling|inward eutrophic remodelling
414466|NCT01180400|Major Depressive Disorder|major depressive disorder
414467|NCT01180400|MDD|mdd
414468|NCT01180400|Depression|depression
414469|NCT01180400|Safety|safety
414470|NCT01180400|add-on therapy|add-on therapy
414471|NCT01180374|Cannabis|cannabis
414472|NCT01180374|Marijuana|marijuana
414473|NCT01180374|Cannabidiol|cannabidiol
414474|NCT01180374|CBD|cbd
414475|NCT01180374|THC|thc
414476|NCT01180374|Psychotic Disorders|psychotic disorders
414477|NCT01180361|rheumatoid arthritis|rheumatoid arthritis
414478|NCT01180361|systemic lupus erythematosus|systemic lupus erythematosus
414479|NCT01180361|atherosclerosis|atherosclerosis
414480|NCT01180361|adenosine|adenosine
414481|NCT01180348|Wrinkles, glabellar, facial.|wrinkles, glabellar, facial.
414482|NCT01180335|Genomic driven chemotherapy|genomic driven chemotherapy
414483|NCT01180322|azacitidine|azacitidine
414484|NCT01180322|Acute myeloid Leukemia (AML)|acute myeloid leukemia (aml)
414485|NCT01180309|Tongue frenum|tongue frenum
414486|NCT01180309|Lingual frenum|lingual frenum
414487|NCT01180309|Audio Phonology|audio phonology
414488|NCT01180309|Speech disorders|speech disorders
414489|NCT01180296|Preterm birth, prevention, progesterone, oral|preterm birth, prevention, progesterone, oral
414490|NCT01180283|Erectile dysfunction|erectile dysfunction
414491|NCT01180283|Lodenafil carbonate|lodenafil carbonate
414492|NCT01180283|Diabetes|diabetes
414493|NCT01180270|Cervical dystonia|cervical dystonia
414494|NCT01180270|torticollis spasmodicus|torticollis spasmodicus
414495|NCT01180270|botulinum toxin|botulinum toxin
414496|NCT01180270|Subjective visual vertical (SVV)|subjective visual vertical (svv)
414498|NCT01180270|static graviceptive function|static graviceptive function
414499|NCT01180244|fibromyalgia|fibromyalgia
414500|NCT01180244|noninvasive|noninvasive
414501|NCT01180244|electrical|electrical
414502|NCT01180244|cortical|cortical
414503|NCT01180244|stimulation|stimulation
414504|NCT01180244|pain|pain
414505|NCT01180244|brain|brain
414506|NCT01180244|tender point|tender point
414604|NCT01179815|Cohort Studies|cohort studies
414605|NCT01179789|Healthy Elderly People|healthy elderly people
414507|NCT01180231|Overweight or obese young adults (18 to 30 years old) with no previous history of cardiovascular disease/psychiatric illness, and not on medications|overweight or obese young adults (18 to 30 years old) with no previous history of cardiovascular disease/psychiatric illness, and not on medications
414508|NCT01180218|myocardial revascularization|myocardial revascularization
414509|NCT01180218|myocardial infarction|myocardial infarction
414510|NCT01180205|FMD|fmd
414511|NCT01180205|hypertension|hypertension
414512|NCT01180205|Telmisartan|telmisartan
414513|NCT01180205|Amlodipine|amlodipine
414514|NCT01180192|blood loss|blood loss
414515|NCT01180192|oxygen inhalation|oxygen inhalation
414516|NCT01180179|H. pylori-negative idiopathic peptic ulcers|h. pylori-negative idiopathic peptic ulcers
414517|NCT01180179|Recurrent ulcer bleeding|recurrent ulcer bleeding
414518|NCT01180166|Gastric cancer|gastric cancer
414519|NCT01180166|concurrent chemoradiotherapy|concurrent chemoradiotherapy
414520|NCT01180166|target therapy|target therapy
414521|NCT01180153|40 S-1/L-OHP|40 s-1/l-ohp
414522|NCT01180153|biliary tract|biliary tract
414523|NCT01180153|ampullary carcinoma|ampullary carcinoma
414524|NCT01180140|Seamguard|seamguard
414525|NCT01180140|staple-line reinforcement|staple-line reinforcement
414526|NCT01180140|leak|leak
414527|NCT01180140|bleeding|bleeding
414528|NCT01180127|flavonol|flavonol
414529|NCT01180127|exercise|exercise
414530|NCT01180127|dentate gyrus|dentate gyrus
414531|NCT01180127|cerebral blood volume|cerebral blood volume
414532|NCT01180127|dentate gyrus CBV|dentate gyrus cbv
414533|NCT01180114|economic empowerment model,|economic empowerment model,
414534|NCT01180114|orphaned children and youth,|orphaned children and youth,
414535|NCT01180114|Uganda,|uganda,
414536|NCT01180114|sub-Saharan Africa|sub-saharan africa
414537|NCT01180101|Obesity|obesity
414538|NCT01180101|Chronic Kidney Disease|chronic kidney disease
414539|NCT01180088|LIVER TUMOURS|liver tumours
414540|NCT01180062|Latanoprost subconjunctival insert|latanoprost subconjunctival insert
414541|NCT01180049|Mantle Cell Lymphoma|mantle cell lymphoma
414542|NCT01180049|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
414543|NCT01180049|temsirolimus|temsirolimus
414544|NCT01180036|Membranous Nephropathy|membranous nephropathy
414545|NCT01180023|GBS|gbs
414546|NCT01180023|Membrane sweeping|membrane sweeping
414547|NCT01180010|Hodgkin's Lymphoma|hodgkin's lymphoma
414548|NCT01180010|Lung Cancer|lung cancer
414549|NCT01180010|Lung Nodule|lung nodule
414550|NCT01180010|CT scan|ct scan
414551|NCT01179971|n-3 fatty acids|n-3 fatty acids
414552|NCT01179971|n-6 fatty acids|n-6 fatty acids
414553|NCT01179971|anti-inflammatory action|anti-inflammatory action
414554|NCT01179971|clinical trial|clinical trial
414555|NCT01179971|randomized double-blinded|randomized double-blinded
414556|NCT01179971|incorporation of fatty acids|incorporation of fatty acids
414557|NCT01179958|cognitive function|cognitive function
414558|NCT01179958|fMRI|fmri
414559|NCT01179958|apoE|apoe
414560|NCT01179958|inflammatory markers|inflammatory markers
414561|NCT01179958|exercise|exercise
414562|NCT01179945|diabetes|diabetes
414563|NCT01179945|benzoic acid|benzoic acid
414564|NCT01179945|benzoate|benzoate
414565|NCT01179945|soda|soda
414566|NCT01179945|soft drink|soft drink
414567|NCT01179945|preservative|preservative
414568|NCT01179945|blood sugar|blood sugar
414569|NCT01179932|Pilot|pilot
414570|NCT01179932|Charting|charting
414571|NCT01179932|Anesthesia Record|anesthesia record
414572|NCT01179932|Cardiac surgical operating room|cardiac surgical operating room
414573|NCT01179932|Cardiac surgical intensive care unit|cardiac surgical intensive care unit
414574|NCT01179932|Electrophysiology lab|electrophysiology lab
414575|NCT01179919|Oseltamivir|oseltamivir
414576|NCT01179919|Obesity|obesity
414577|NCT01179919|Influenza|influenza
414578|NCT01179919|Pharmacokinetics in Obesity|pharmacokinetics in obesity
414579|NCT01179906|CKD|ckd
414580|NCT01179893|Myasthenia Gravis|myasthenia gravis
414581|NCT01179893|IVIG|ivig
414582|NCT01179893|PLEX|plex
414583|NCT01179880|Dermatitis|dermatitis
414584|NCT01179880|Atopic|atopic
414585|NCT01179867|Medication reconciliation|medication reconciliation
414586|NCT01179867|Adverse drug events|adverse drug events
414587|NCT01179867|Hospital readmission|hospital readmission
414588|NCT01179867|Medication management|medication management
414589|NCT01179841|Autism Spectrum Disorder|autism spectrum disorder
414590|NCT01179841|language|language
414591|NCT01179841|social|social
414592|NCT01179841|toddlers|toddlers
414593|NCT01179828|Quantitative sensory testing|quantitative sensory testing
414594|NCT01179828|Drug efficacy|drug efficacy
414595|NCT01179828|Low back pain syndrome|low back pain syndrome
414596|NCT01179828|Imipramine|imipramine
414597|NCT01179828|Oxycodone|oxycodone
414598|NCT01179828|Clobazam|clobazam
414599|NCT01179828|Tolterodine|tolterodine
414600|NCT01179815|Patients with type 1 or type 2 diabetes mellitus|patients with type 1 or type 2 diabetes mellitus
414601|NCT01179815|Monogenetic diabetes|monogenetic diabetes
414602|NCT01179815|Pancreatogenic diabetes,|pancreatogenic diabetes,
414603|NCT01179815|Drug-induced diabetes, other forms|drug-induced diabetes, other forms
414606|NCT01179776|ST-eleveation|st-eleveation
414607|NCT01179776|Myocardial infarct|myocardial infarct
414608|NCT01179776|Percutaneous coronary intervention|percutaneous coronary intervention
414609|NCT01179776|Myocardial infarct STEMI patients|myocardial infarct stemi patients
414610|NCT01179763|Amblyopia|amblyopia
414611|NCT01179763|Retinal layer thickness|retinal layer thickness
414612|NCT01179750|Ultrasonic coagulating shears in gastrectomy|ultrasonic coagulating shears in gastrectomy
414613|NCT01179737|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
414614|NCT01179737|Nilotinib|nilotinib
414615|NCT01179737|6MWD|6mwd
414616|NCT01179737|Pulmonary Hypertension|pulmonary hypertension
414617|NCT00000104|lead overburden|lead overburden
414618|NCT00000106|Rheumatoid Diseases|rheumatoid diseases
414619|NCT00000107|Cyanotic Congenital Heart Disease|cyanotic congenital heart disease
414620|NCT00000108|exercise|exercise
414621|NCT00000110|exercise|exercise
414622|NCT00000110|exertion|exertion
414623|NCT00000110|physical fitness|physical fitness
414624|NCT00000110|lipids|lipids
414625|NCT00000110|nutrition|nutrition
414626|NCT00000111|mouth mucosa|mouth mucosa
414627|NCT00000111|transplants|transplants
414628|NCT00000113|myopia|myopia
414629|NCT00000113|nearsightedness|nearsightedness
414630|NCT00000114|retinitis pigmentosa|retinitis pigmentosa
414631|NCT00000114|vitamin supplements|vitamin supplements
414632|NCT00000171|Alzheimer's disease|alzheimer's disease
414633|NCT00000171|Sleep disorders|sleep disorders
414634|NCT00000171|Melatonin|melatonin
414635|NCT00000172|Alzheimer's disease|alzheimer's disease
414636|NCT00000172|Cholinergic agents|cholinergic agents
414637|NCT00000172|Cholinergic agonists|cholinergic agonists
414638|NCT00000172|Cholinesterase inhibitors|cholinesterase inhibitors
415228|NCT00000396|Arthritis|arthritis
414639|NCT00000173|Mild cognitive impairment|mild cognitive impairment
414640|NCT00000173|Alzheimer's disease|alzheimer's disease
414641|NCT00000173|Memory|memory
414642|NCT00000173|Donepezil|donepezil
414643|NCT00000173|Vitamin E|vitamin e
414644|NCT00000173|Antioxidants|antioxidants
414645|NCT00000173|Cholinergic agents|cholinergic agents
414646|NCT00000173|Cholinesterase inhibitors|cholinesterase inhibitors
414647|NCT00000174|Mild cognitive impairment|mild cognitive impairment
414648|NCT00000174|Alzheimer's disease|alzheimer's disease
414649|NCT00000174|Memory|memory
414650|NCT00000174|Cholinergic agents|cholinergic agents
414651|NCT00000174|Cholinesterase inhibitors|cholinesterase inhibitors
414652|NCT00000175|Emotions|emotions
414653|NCT00000175|Cognition|cognition
414654|NCT00000175|Aging|aging
414655|NCT00000175|Memory|memory
414656|NCT00000176|Alzheimer's disease|alzheimer's disease
414657|NCT00000176|memory loss|memory loss
414658|NCT00000176|Estrogen|estrogen
414659|NCT00000177|Alzheimer's disease|alzheimer's disease
414660|NCT00000177|Estrogen|estrogen
414661|NCT00000178|Alzheimer's disease|alzheimer's disease
414662|NCT00000178|Prednisone|prednisone
414663|NCT00000178|Anti-inflammatory agents|anti-inflammatory agents
414664|NCT00000179|Alzheimer's disease|alzheimer's disease
414665|NCT00000179|Psychomotor agitation|psychomotor agitation
414666|NCT00000179|Behavioral symptoms|behavioral symptoms
414667|NCT00000179|Haloperidol|haloperidol
414668|NCT00000179|Trazodone|trazodone
414669|NCT00000179|Anti-psychotic agents|anti-psychotic agents
414670|NCT00000179|Anti-depressant agents|anti-depressant agents
414671|NCT00000180|Memory|memory
414672|NCT00000180|Mild cognitive impairment|mild cognitive impairment
414673|NCT00000180|Nerve growth factors|nerve growth factors
414674|NCT00000187|Cocaine Dependence|cocaine dependence
414675|NCT00000187|ritanserin|ritanserin
414676|NCT00000188|Cocaine Dependence|cocaine dependence
414677|NCT00000188|Selegiline|selegiline
414678|NCT00000189|Cocaine Dependence|cocaine dependence
414679|NCT00000189|Gepirone|gepirone
414680|NCT00000190|Cocaine Detection|cocaine detection
414681|NCT00000190|Parotid Saliva|parotid saliva
414682|NCT00000191|Cocaine Dependence|cocaine dependence
414683|NCT00000191|Carbamazepine|carbamazepine
414684|NCT00000192|opioid disorders|opioid disorders
414685|NCT00000193|Opioid disorders|opioid disorders
414686|NCT00000194|opioid disorders|opioid disorders
414687|NCT00000195|opioid disorders|opioid disorders
414688|NCT00000197|cocaine|cocaine
414689|NCT00000198|cocaine|cocaine
414690|NCT00000199|cocaine|cocaine
414691|NCT00000200|self-administration|self-administration
414692|NCT00000201|cocaine dependence|cocaine dependence
414693|NCT00000206|Opioid|opioid
414694|NCT00000207|Buprenorphine|buprenorphine
414695|NCT00000207|Opioid|opioid
414696|NCT00000210|opioid addiction|opioid addiction
414697|NCT00000210|cocaine addiction|cocaine addiction
414698|NCT00000212|crack cocaine|crack cocaine
414699|NCT00000213|intravenous abuse|intravenous abuse
414700|NCT00000214|intravenous abuse|intravenous abuse
414701|NCT00000215|cocaine dependence|cocaine dependence
414702|NCT00000217|drug abuse|drug abuse
414703|NCT00000218|cocaine dependence|cocaine dependence
414704|NCT00000241|methamphetamine dependence|methamphetamine dependence
414705|NCT00000242|Cocaine|cocaine
414706|NCT00000242|Substance Abuse|substance abuse
414707|NCT00000243|opioid dependence|opioid dependence
414708|NCT00000244|addiction|addiction
414709|NCT00000244|opiate|opiate
414710|NCT00000244|heroin|heroin
414711|NCT00000244|dynorphin|dynorphin
414712|NCT00000245|cocaine dependence|cocaine dependence
414713|NCT00000246|Substance-Related Disorders|substance-related disorders
414714|NCT00000249|nitrous oxide|nitrous oxide
414715|NCT00000249|subjective effects|subjective effects
414716|NCT00000249|healthy volunteer|healthy volunteer
414717|NCT00000250|nitrous oxide|nitrous oxide
414718|NCT00000250|choice|choice
414719|NCT00000250|subjective effects|subjective effects
414720|NCT00000250|pain|pain
414721|NCT00000250|analgesia|analgesia
414722|NCT00000250|reinforcer|reinforcer
414723|NCT00000250|healthy volunteer|healthy volunteer
414724|NCT00000251|nitrous oxide|nitrous oxide
414725|NCT00000251|isoflurane|isoflurane
414726|NCT00000251|subjective effects|subjective effects
414727|NCT00000251|psychomotor|psychomotor
414728|NCT00000251|healthy volunteer|healthy volunteer
414729|NCT00000251|drug interaction|drug interaction
414730|NCT00000252|nitrous oxide|nitrous oxide
414731|NCT00000252|acute tolerance|acute tolerance
414732|NCT00000252|subjective effects|subjective effects
414733|NCT00000252|psychomotor|psychomotor
414734|NCT00000252|analgesia|analgesia
414735|NCT00000252|healthy volunteer|healthy volunteer
414736|NCT00000253|nitrous oxide|nitrous oxide
414737|NCT00000253|inhalant|inhalant
414738|NCT00000253|subjective effects|subjective effects
414739|NCT00000253|healthy volunteer|healthy volunteer
414740|NCT00000254|isoflurane|isoflurane
414741|NCT00000254|general anesthetic|general anesthetic
414742|NCT00000254|inhalant|inhalant
414743|NCT00000254|subjective effects|subjective effects
414744|NCT00000254|healthy volunteer|healthy volunteer
414745|NCT00000255|nitrous oxide|nitrous oxide
414746|NCT00000255|acute tolerance|acute tolerance
414747|NCT00000255|subjective effects|subjective effects
414748|NCT00000255|analgesia|analgesia
414749|NCT00000255|psychomotor|psychomotor
414750|NCT00000255|healthy volunteer|healthy volunteer
414751|NCT00000256|nitrous oxide|nitrous oxide
414752|NCT00000256|reinforcer|reinforcer
414753|NCT00000256|subjective effects|subjective effects
414754|NCT00000256|healthy volunteer|healthy volunteer
414755|NCT00000257|nitrous oxide|nitrous oxide
414756|NCT00000257|subjective effects|subjective effects
414757|NCT00000257|ethanol|ethanol
414758|NCT00000257|healthy volunteer|healthy volunteer
414759|NCT00000258|nitrous oxide|nitrous oxide
414760|NCT00000258|instruction|instruction
414761|NCT00000258|subjective effects|subjective effects
414762|NCT00000258|reinforcer|reinforcer
414763|NCT00000258|healthy volunteer|healthy volunteer
414764|NCT00000259|sevoflurane|sevoflurane
414765|NCT00000259|nitrous oxide|nitrous oxide
414766|NCT00000259|subjective effects|subjective effects
414767|NCT00000259|healthy volunteer|healthy volunteer
414768|NCT00000260|nitrous oxide|nitrous oxide
414769|NCT00000260|subjective effects|subjective effects
414770|NCT00000260|reinforcer|reinforcer
414771|NCT00000260|inhalant|inhalant
414772|NCT00000260|healthy volunteer|healthy volunteer
414773|NCT00000261|nitrous oxide|nitrous oxide
414774|NCT00000261|sevoflurane|sevoflurane
414775|NCT00000261|ethanol|ethanol
414776|NCT00000261|subjective effects|subjective effects
414777|NCT00000261|healthy volunteer|healthy volunteer
414778|NCT00000262|nitrous oxide|nitrous oxide
414779|NCT00000262|sevoflurane|sevoflurane
414780|NCT00000262|drug interaction|drug interaction
414781|NCT00000262|subjective effects|subjective effects
414782|NCT00000262|analgesia|analgesia
414783|NCT00000262|healthy volunteers|healthy volunteers
414784|NCT00000263|nitrous oxide|nitrous oxide
414786|NCT00000263|drug interaction|drug interaction
414787|NCT00000263|subjective effects|subjective effects
414788|NCT00000263|healthy volunteer|healthy volunteer
414789|NCT00000264|nitrous oxide|nitrous oxide
414790|NCT00000264|inhalant|inhalant
414791|NCT00000264|ethanol|ethanol
414792|NCT00000264|subjective effects|subjective effects
414793|NCT00000264|psychomotor effects|psychomotor effects
414794|NCT00000264|healthy volunteer|healthy volunteer
414795|NCT00000265|nitrous oxide|nitrous oxide
414796|NCT00000265|anxiety|anxiety
414797|NCT00000265|subjective effects|subjective effects
414798|NCT00000265|dental|dental
414799|NCT00000265|patients|patients
414800|NCT00000266|cocaine dependence|cocaine dependence
414801|NCT00000267|cocaine dependence|cocaine dependence
414802|NCT00000268|cocaine dependence|cocaine dependence
414803|NCT00000269|cocaine dependence|cocaine dependence
414804|NCT00000270|cocaine|cocaine
414805|NCT00000271|Desipramine, cocaine, depression|desipramine, cocaine, depression
414806|NCT00000273|heroin, opioid disorders, substance related disorders|heroin, opioid disorders, substance related disorders
414807|NCT00000274|cocaine dependence|cocaine dependence
414808|NCT00000275|cocaine dependence|cocaine dependence
414809|NCT00000280|cocaine|cocaine
414810|NCT00000281|anti psychotic agents|anti psychotic agents
414811|NCT00000282|pemoline|pemoline
414812|NCT00000284|nicotine dependence|nicotine dependence
414813|NCT00000285|cocaine dependence|cocaine dependence
414814|NCT00000286|cocaine dependence|cocaine dependence
414815|NCT00000287|Cocaine-Related Disorders|cocaine-related disorders
414816|NCT00000288|nicotine dependence|nicotine dependence
414817|NCT00000290|cocaine dependence|cocaine dependence
414818|NCT00000291|cocaine dependence|cocaine dependence
414819|NCT00000293|cocaine dependence|cocaine dependence
414820|NCT00000296|nicotine dependence|nicotine dependence
414821|NCT00000299|Opioid-Related Disorders|opioid-related disorders
414822|NCT00000301|Amantadine|amantadine
414823|NCT00000301|Cocaine|cocaine
414824|NCT00000301|Pharmacotherapy|pharmacotherapy
414825|NCT00000301|Outpatient|outpatient
414826|NCT00000303|Cocaine dependence|cocaine dependence
414827|NCT00000304|cocaine dependence|cocaine dependence
414828|NCT00000306|cocaine dependence|cocaine dependence
414829|NCT00000307|alcohol dependence|alcohol dependence
414830|NCT00000308|cocaine dependence|cocaine dependence
414831|NCT00000309|cocaine abuse, cocaine addiction|cocaine abuse, cocaine addiction
414832|NCT00000310|cocaine dependence|cocaine dependence
414833|NCT00000313|cocaine dependence|cocaine dependence
414834|NCT00000314|cocaine dependence|cocaine dependence
414835|NCT00000315|cocaine dependence|cocaine dependence
414836|NCT00000316|cocaine dependence|cocaine dependence
414837|NCT00000317|Cocaine|cocaine
414838|NCT00000317|METHADONE PATIENTS|methadone patients
414839|NCT00000317|RISPERIDONE|risperidone
414840|NCT00000318|opioid dependence|opioid dependence
414841|NCT00000320|opioid dependence|opioid dependence
414842|NCT00000321|methamphetamine dependence|methamphetamine dependence
414843|NCT00000322|amphetamine dependence|amphetamine dependence
414844|NCT00000323|cocaine dependence|cocaine dependence
414845|NCT00000325|cocaine dependence|cocaine dependence
414846|NCT00000326|Heroin Dependence|heroin dependence
414847|NCT00000327|drug dependence|drug dependence
414848|NCT00000328|drug dependence|drug dependence
414849|NCT00000329|drug dependence|drug dependence
414850|NCT00000330|Heroin Dependence|heroin dependence
414851|NCT00000331|Heroin Dependence|heroin dependence
414852|NCT00000335|opioid dependence|opioid dependence
414853|NCT00000336|cocaine dependence|cocaine dependence
414854|NCT00000337|cocaine dependence|cocaine dependence
414855|NCT00000338|cocaine dependence|cocaine dependence
414856|NCT00000339|cocaine dependence|cocaine dependence
414857|NCT00000340|cocaine dependence|cocaine dependence
414858|NCT00000341|opioid dependence|opioid dependence
414859|NCT00000342|cocaine dependence|cocaine dependence
414860|NCT00000343|stimulant dependence|stimulant dependence
414861|NCT00000344|opioid dependence|opioid dependence
414862|NCT00000345|opioid dependence|opioid dependence
414863|NCT00000346|amphetamine dependence|amphetamine dependence
414864|NCT00000347|cocaine dependence|cocaine dependence
414865|NCT00000348|cocaine dependence|cocaine dependence
414866|NCT00000349|cocaine dependence|cocaine dependence
414867|NCT00000350|amphetamine dependence|amphetamine dependence
414868|NCT00000352|opiate dependence|opiate dependence
414869|NCT00000353|opiate dependence|opiate dependence
414870|NCT00000354|opiate dependence|opiate dependence
414871|NCT00000355|opiate dependence|opiate dependence
414872|NCT00000356|opiate dependence|opiate dependence
414873|NCT00000357|opiate dependence|opiate dependence
414874|NCT00000359|Physical Therapy|physical therapy
414875|NCT00000359|Vertigo|vertigo
414876|NCT00000359|rehabilitation|rehabilitation
414877|NCT00000359|occupational therapy|occupational therapy
414878|NCT00000361|Autoimmune Diseases|autoimmune diseases
414879|NCT00000361|Cyclophosphamide|cyclophosphamide
414880|NCT00000361|Hearing|hearing
414881|NCT00000361|Labyrinth Diseases|labyrinth diseases
414882|NCT00000361|Methotrexate|methotrexate
414883|NCT00000361|Prednisone|prednisone
414884|NCT00000362|Deglutition Disorders|deglutition disorders
414885|NCT00000362|Dementia|dementia
414886|NCT00000362|Parkinson Disease|parkinson disease
414887|NCT00000362|Pneumonia, Aspiration|pneumonia, aspiration
414888|NCT00000363|Antibiotics|antibiotics
414889|NCT00000363|Adrenal Cortex Hormones|adrenal cortex hormones
414890|NCT00000363|Histamine H1 Antagonists|histamine h1 antagonists
414891|NCT00000363|Infant|infant
414892|NCT00000363|Otitis Media|otitis media
414893|NCT00000367|Depression|depression
414894|NCT00000367|Family|family
414895|NCT00000367|Female|female
414896|NCT00000367|Human|human
414897|NCT00000367|Male|male
414898|NCT00000367|Practice Guidelines|practice guidelines
414899|NCT00000367|Education, Medical, Continuing|education, medical, continuing
414900|NCT00000367|Patient Education|patient education
414902|NCT00000368|Adult|adult
414903|NCT00000368|Cognitive Behavioral Therapy|cognitive behavioral therapy
414904|NCT00000368|Pharmacotherapy|pharmacotherapy
414905|NCT00000368|Long term treatment|long term treatment
414906|NCT00000368|Remission and relapse|remission and relapse
414907|NCT00000368|Male|male
414908|NCT00000368|Panic Disorder|panic disorder
414909|NCT00000368|Paroxetine|paroxetine
414910|NCT00000368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
414911|NCT00000368|Panic Disorder -- *therapy|panic disorder -- *therapy
414912|NCT00000368|Panic Disorder -- drug therapy|panic disorder -- drug therapy
414913|NCT00000368|Paroxetine -- *therapeutic use|paroxetine -- *therapeutic use
414914|NCT00000368|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
414915|NCT00000369|Adult|adult
414916|NCT00000369|Antidepressive Agents|antidepressive agents
414917|NCT00000369|Bipolar Disorder|bipolar disorder
414918|NCT00000369|Combined Modality Therapy|combined modality therapy
414919|NCT00000369|Female|female
414920|NCT00000369|Human|human
414921|NCT00000369|Lithium Carbonate|lithium carbonate
414922|NCT00000369|Male|male
414923|NCT00000369|Psychotherapy|psychotherapy
414924|NCT00000369|Antidepressive Agents -- *therapeutic use|antidepressive agents -- *therapeutic use
414925|NCT00000369|Bipolar Disorder -- *therapy|bipolar disorder -- *therapy
414926|NCT00000369|Bipolar Disorder -- drug therapy|bipolar disorder -- drug therapy
414927|NCT00000369|Lithium Carbonate -- *therapeutic use|lithium carbonate -- *therapeutic use
414928|NCT00000370|Cognitive Therapy|cognitive therapy
414929|NCT00000370|Cost of Illness|cost of illness
414930|NCT00000370|Female|female
414931|NCT00000370|Human|human
414932|NCT00000370|Male|male
414933|NCT00000370|Phobic Disorders|phobic disorders
414934|NCT00000370|Phobic Disorders -- *therapy|phobic disorders -- *therapy
414935|NCT00000370|Phobic Disorders -- pathology|phobic disorders -- pathology
414936|NCT00000371|Adult|adult
414937|NCT00000371|Cognition|cognition
414938|NCT00000371|Cycloserine|cycloserine
414939|NCT00000371|Dopamine|dopamine
414940|NCT00000371|Female|female
414941|NCT00000371|Glutamic Acid|glutamic acid
414942|NCT00000371|Human|human
414943|NCT00000371|Male|male
414944|NCT00000371|Receptors, N-Methyl-D-Aspartate|receptors, n-methyl-d-aspartate
414945|NCT00000371|Schizophrenia|schizophrenia
414947|NCT00000371|Quality of Life|quality of life
414948|NCT00000371|Cycloserine -- *therapeutic use|cycloserine -- *therapeutic use
414949|NCT00000371|Dopamine -- blood|dopamine -- blood
414950|NCT00000371|Dopamine -- cerebrospinal fluid|dopamine -- cerebrospinal fluid
414951|NCT00000371|Glutamic Acid -- blood|glutamic acid -- blood
414952|NCT00000371|Glutamic Acid -- cerebrospinal fluid|glutamic acid -- cerebrospinal fluid
414953|NCT00000371|Serotonin -- blood|serotonin -- blood
414954|NCT00000371|Serotonin -- cerebrospinal fluid|serotonin -- cerebrospinal fluid
414955|NCT00000372|Adult|adult
414956|NCT00000372|Amino Acids|amino acids
414957|NCT00000372|Cycloserine|cycloserine
414958|NCT00000372|Female|female
414959|NCT00000372|Glycine|glycine
414960|NCT00000372|Human|human
414961|NCT00000372|Male|male
414962|NCT00000372|N-Methylaspartate|n-methylaspartate
414963|NCT00000372|Placebos|placebos
414964|NCT00000372|Schizophrenia|schizophrenia
414965|NCT00000372|Amino Acids -- blood|amino acids -- blood
414966|NCT00000372|Cycloserine -- *therapeutic use|cycloserine -- *therapeutic use
414967|NCT00000372|Glycine -- *therapeutic use|glycine -- *therapeutic use
414968|NCT00000372|Schizophrenia -- *drug therapy|schizophrenia -- *drug therapy
414969|NCT00000372|Schizophrenia -- physiopathology|schizophrenia -- physiopathology
414970|NCT00000373|Adolescence|adolescence
414971|NCT00000373|Adult|adult
414972|NCT00000373|Antipsychotic Agents|antipsychotic agents
414973|NCT00000373|Dopamine Antagonists|dopamine antagonists
414974|NCT00000373|Female|female
414975|NCT00000373|Fluvoxamine|fluvoxamine
414976|NCT00000373|Haloperidol|haloperidol
414977|NCT00000373|Human|human
414978|NCT00000373|Male|male
414979|NCT00000373|Middle Age|middle age
414980|NCT00000373|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
414981|NCT00000373|Placebos|placebos
414982|NCT00000373|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
414983|NCT00000373|Tourette Syndrome|tourette syndrome
414984|NCT00000373|Tryptophan|tryptophan
414985|NCT00000373|Drug Combinations|drug combinations
414986|NCT00000373|Antipsychotic Agents -- *therapeutic use|antipsychotic agents -- *therapeutic use
414987|NCT00000373|Fluvoxamine -- *therapeutic use|fluvoxamine -- *therapeutic use
414988|NCT00000373|Haloperidol -- *therapeutic use|haloperidol -- *therapeutic use
9676|NCT03228628|Spinal puncture|spinal puncture
414989|NCT00000373|Obsessive-Compulsive Disorder -- *drug therapy|obsessive-compulsive disorder -- *drug therapy
414990|NCT00000373|Obsessive-Compulsive Disorder -- physiopathology|obsessive-compulsive disorder -- physiopathology
414991|NCT00000373|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
414992|NCT00000374|Adolescence|adolescence
414993|NCT00000374|Adult|adult
414994|NCT00000374|Antipsychotic Agents|antipsychotic agents
414995|NCT00000374|Female|female
414996|NCT00000374|Human|human
414997|NCT00000374|Male|male
414998|NCT00000374|olanzapine|olanzapine
414999|NCT00000374|Risperidone|risperidone
415000|NCT00000374|Schizophrenia|schizophrenia
415001|NCT00000374|Antipsychotic Agents -- *therapeutic use|antipsychotic agents -- *therapeutic use
415002|NCT00000374|olanzapine -- *therapeutic use|olanzapine -- *therapeutic use
415003|NCT00000374|Risperidone -- *therapeutic use|risperidone -- *therapeutic use
415004|NCT00000374|Schizophrenia -- *drug therapy|schizophrenia -- *drug therapy
415005|NCT00000375|Adult|adult
415006|NCT00000375|Antidepressive Agents|antidepressive agents
415007|NCT00000375|Depressive Disorder|depressive disorder
415752|NCT00000707|Lung|lung
415008|NCT00000375|Electroconvulsive Therapy|electroconvulsive therapy
415009|NCT00000375|Female|female
415010|NCT00000375|Human|human
415011|NCT00000375|Lithium|lithium
415012|NCT00000375|Male|male
415013|NCT00000375|Nortriptyline|nortriptyline
415014|NCT00000375|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
415015|NCT00000375|Antidepressive Agents -- *therapeutic use|antidepressive agents -- *therapeutic use
415016|NCT00000375|Antidepressive Agents -- adverse effects|antidepressive agents -- adverse effects
415017|NCT00000375|Lithium -- *therapeutic use|lithium -- *therapeutic use
415018|NCT00000375|Lithium -- adverse effects|lithium -- adverse effects
415019|NCT00000375|Nortriptyline -- *therapeutic use|nortriptyline -- *therapeutic use
415020|NCT00000375|Nortriptyline -- adverse effects|nortriptyline -- adverse effects
415021|NCT00000376|Adult|adult
415022|NCT00000376|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic
415023|NCT00000376|Anxiety Disorders|anxiety disorders
415024|NCT00000376|Cognitive Therapy|cognitive therapy
415025|NCT00000376|Combined Modality Therapy|combined modality therapy
415026|NCT00000376|Depression|depression
415027|NCT00000376|Desipramine|desipramine
415028|NCT00000376|Female|female
415029|NCT00000376|Human|human
415030|NCT00000376|Male|male
415031|NCT00000376|Personality Disorders|personality disorders
415032|NCT00000376|Pilot Projects|pilot projects
415033|NCT00000376|Patient Care Team|patient care team
415034|NCT00000376|Antidepressive Agents, Tricyclic -- *therapeutic use|antidepressive agents, tricyclic -- *therapeutic use
415035|NCT00000376|Depression -- *therapy|depression -- *therapy
415036|NCT00000376|Depression -- drug therapy|depression -- drug therapy
415037|NCT00000376|Desipramine -- *therapeutic use|desipramine -- *therapeutic use
415038|NCT00000377|Aged|aged
415039|NCT00000377|Antidepressive Agents|antidepressive agents
415040|NCT00000377|Depression|depression
415041|NCT00000377|Dose-Response Relationship, Drug|dose-response relationship, drug
415042|NCT00000377|Female|female
415043|NCT00000377|Human|human
415044|NCT00000377|Male|male
415045|NCT00000377|Middle Age|middle age
415046|NCT00000377|Nortriptyline|nortriptyline
415047|NCT00000377|Placebos|placebos
415048|NCT00000377|Recurrence|recurrence
415049|NCT00000377|Aged, 80 and over|aged, 80 and over
415050|NCT00000377|Antidepressive Agents -- *therapeutic use|antidepressive agents -- *therapeutic use
415051|NCT00000377|Antidepressive Agents -- administration & dosage|antidepressive agents -- administration & dosage
415052|NCT00000377|Depression -- *drug therapy|depression -- *drug therapy
415053|NCT00000377|Nortriptyline -- *therapeutic use|nortriptyline -- *therapeutic use
415054|NCT00000377|Nortriptyline -- administration & dosage|nortriptyline -- administration & dosage
415055|NCT00000378|Aged|aged
415056|NCT00000378|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic
415057|NCT00000378|Depression|depression
415058|NCT00000378|Female|female
415059|NCT00000378|Human|human
415060|NCT00000378|Male|male
415061|NCT00000378|Middle Age|middle age
415062|NCT00000378|Nortriptyline|nortriptyline
415063|NCT00000378|Sertraline|sertraline
415064|NCT00000378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
415065|NCT00000378|Antidepressive Agents, Tricyclic -- *therapeutic use|antidepressive agents, tricyclic -- *therapeutic use
415066|NCT00000378|Antidepressive Agents, Tricyclic -- adverse effects|antidepressive agents, tricyclic -- adverse effects
415067|NCT00000378|Depression -- *drug therapy|depression -- *drug therapy
415068|NCT00000378|Nortriptyline -- *therapeutic use|nortriptyline -- *therapeutic use
415069|NCT00000378|Nortriptyline -- adverse effects|nortriptyline -- adverse effects
415070|NCT00000378|Sertraline -- *therapeutic use|sertraline -- *therapeutic use
415071|NCT00000378|Sertraline -- adverse effects|sertraline -- adverse effects
415072|NCT00000378|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
415073|NCT00000378|Serotonin Uptake Inhibitors -- adverse effects|serotonin uptake inhibitors -- adverse effects
415074|NCT00000379|Adult|adult
415075|NCT00000379|Comparative Study|comparative study
415076|NCT00000379|Desensitization, Psychologic|desensitization, psychologic
415077|NCT00000379|Eye Movements|eye movements
415078|NCT00000379|Female|female
415079|NCT00000379|Fluoxetine|fluoxetine
415080|NCT00000379|Human|human
415081|NCT00000379|Male|male
415082|NCT00000379|Placebos|placebos
415083|NCT00000379|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
415084|NCT00000379|Treatment Outcome|treatment outcome
415085|NCT00000379|Desensitization, Psychologic -- *methods|desensitization, psychologic -- *methods
415086|NCT00000379|Fluoxetine -- *therapeutic use|fluoxetine -- *therapeutic use
415087|NCT00000379|Stress Disorders, Post-Traumatic -- *therapy|stress disorders, post-traumatic -- *therapy
415088|NCT00000379|Stress Disorders, Post-Traumatic -- drug therapy|stress disorders, post-traumatic -- drug therapy
415089|NCT00000380|Adult|adult
415090|NCT00000380|Estrogen Replacement Therapy|estrogen replacement therapy
415091|NCT00000380|Female|female
415092|NCT00000380|Hormone Replacement Therapy|hormone replacement therapy
415093|NCT00000380|Human|human
415094|NCT00000380|Insulin-Like Growth Factor I|insulin-like growth factor i
415095|NCT00000380|Male|male
415096|NCT00000380|Placebos|placebos
415097|NCT00000380|Sleep Disorders|sleep disorders
415098|NCT00000380|Somatotropin-Releasing Hormone|somatotropin-releasing hormone
415099|NCT00000380|Somatotropin|somatotropin
415100|NCT00000380|Insulin-Like Growth Factor I -- secretion|insulin-like growth factor i -- secretion
415101|NCT00000380|Sleep Disorders -- *drug therapy|sleep disorders -- *drug therapy
415102|NCT00000380|Somatotropin-Releasing Hormone -- *therapeutic use|somatotropin-releasing hormone -- *therapeutic use
415103|NCT00000380|Somatotropin -- secretion|somatotropin -- secretion
415104|NCT00000381|Adolescence|adolescence
415105|NCT00000381|Anxiety Disorders|anxiety disorders
415106|NCT00000381|Child|child
415107|NCT00000381|Female|female
415108|NCT00000381|Fluoxetine|fluoxetine
415109|NCT00000381|Male|male
415110|NCT00000381|Placebos|placebos
415111|NCT00000381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
415112|NCT00000381|Anxiety Disorders -- *drug therapy|anxiety disorders -- *drug therapy
415113|NCT00000381|Fluoxetine -- *therapeutic use|fluoxetine -- *therapeutic use
415114|NCT00000381|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
415115|NCT00000382|Child Abuse|child abuse
415116|NCT00000382|Female|female
415117|NCT00000382|Human|human
415118|NCT00000382|Infant|infant
415119|NCT00000382|Male|male
415120|NCT00000382|Caregivers|caregivers
415121|NCT00000382|Patient Education|patient education
415122|NCT00000382|Psychotherapy|psychotherapy
415123|NCT00000382|Child Abuse -- *prevention & control|child abuse -- *prevention & control
415124|NCT00000383|Adolescence|adolescence
415125|NCT00000383|Child|child
415126|NCT00000383|Cognitive Therapy|cognitive therapy
415127|NCT00000383|Comparative Study|comparative study
415128|NCT00000383|Female|female
415129|NCT00000383|Human|human
415130|NCT00000383|Male|male
415131|NCT00000383|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
415604|NCT00000682|Zidovudine|zidovudine
415132|NCT00000383|Child Abuse, Sexual|child abuse, sexual
415133|NCT00000383|Stress Disorders, Post-Traumatic -- *therapy|stress disorders, post-traumatic -- *therapy
415134|NCT00000383|Child Abuse, Sexual -- *psychology|child abuse, sexual -- *psychology
415135|NCT00000384|Adolescence|adolescence
415136|NCT00000384|Child|child
415137|NCT00000384|Cognitive Therapy|cognitive therapy
415138|NCT00000384|Combined Modality Therapy|combined modality therapy
415139|NCT00000384|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
415140|NCT00000384|Placebos|placebos
415141|NCT00000384|Sertraline|sertraline
415142|NCT00000384|Patient Education|patient education
415143|NCT00000384|Psychotherapy|psychotherapy
415144|NCT00000385|Aggressive conduct disorder|aggressive conduct disorder
415145|NCT00000385|Adolescence|adolescence
415146|NCT00000385|Child|child
415147|NCT00000385|Conduct Disorder|conduct disorder
415148|NCT00000385|Female|female
415149|NCT00000385|Lithium|lithium
415150|NCT00000385|Male|male
415151|NCT00000385|Placebos|placebos
415152|NCT00000385|Conduct Disorder -- *drug therapy|conduct disorder -- *drug therapy
415153|NCT00000385|Lithium -- *therapeutic use|lithium -- *therapeutic use
415154|NCT00000386|Adolescence|adolescence
415155|NCT00000386|Child|child
415156|NCT00000386|Comparative Study|comparative study
415157|NCT00000386|Family|family
415158|NCT00000386|Female|female
415159|NCT00000386|Human|human
415160|NCT00000386|Male|male
415161|NCT00000386|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
415162|NCT00000386|Relaxation Techniques|relaxation techniques
415163|NCT00000386|Obsessive-Compulsive Disorder -- *therapy|obsessive-compulsive disorder -- *therapy
415164|NCT00000387|Adolescence|adolescence
415165|NCT00000387|Family|family
415166|NCT00000387|Female|female
415167|NCT00000387|Human|human
415168|NCT00000387|Male|male
415169|NCT00000387|Schizophrenia|schizophrenia
415170|NCT00000387|Self Care|self care
415171|NCT00000387|Community Health Services|community health services
415172|NCT00000388|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
415173|NCT00000388|Adolescence|adolescence
415174|NCT00000388|Child|child
415175|NCT00000388|Cognition|cognition
415176|NCT00000388|Combined Modality Therapy|combined modality therapy
415177|NCT00000388|Female|female
415178|NCT00000388|Human|human
415179|NCT00000388|Male|male
415180|NCT00000388|Peer Group|peer group
415181|NCT00000388|Risk Factors|risk factors
415182|NCT00000388|Treatment Outcome|treatment outcome
415183|NCT00000388|Attention Deficit Disorder with Hyperactivity -- *therapy|attention deficit disorder with hyperactivity -- *therapy
415184|NCT00000388|Attention Deficit Disorder with Hyperactivity -- drug therapy|attention deficit disorder with hyperactivity -- drug therapy
415185|NCT00000388|Attention Deficit Disorder with Hyperactivity -- psychology|attention deficit disorder with hyperactivity -- psychology
415186|NCT00000389|Adolescence|adolescence
415187|NCT00000389|Anxiety Disorders|anxiety disorders
415188|NCT00000389|Child|child
415189|NCT00000389|Female|female
415190|NCT00000389|Fluvoxamine|fluvoxamine
415191|NCT00000389|Human|human
415192|NCT00000389|Male|male
415193|NCT00000389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
415194|NCT00000389|Anxiety Disorders -- *drug therapy|anxiety disorders -- *drug therapy
415195|NCT00000389|Fluvoxamine -- *therapeutic use|fluvoxamine -- *therapeutic use
415196|NCT00000389|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
415197|NCT00000390|Adult|adult
415198|NCT00000390|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415199|NCT00000390|Depression|depression
415200|NCT00000390|Female|female
415201|NCT00000390|Human|human
415202|NCT00000390|Imipramine|imipramine
415203|NCT00000390|Male|male
415204|NCT00000390|Middle Age|middle age
415205|NCT00000390|Acquired Immunodeficiency Syndrome -- *complications|acquired immunodeficiency syndrome -- *complications
415206|NCT00000390|Depression -- *drug therapy|depression -- *drug therapy
415207|NCT00000390|Depression -- etiology|depression -- etiology
415208|NCT00000390|Imipramine -- *therapeutic use|imipramine -- *therapeutic use
415209|NCT00000391|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415210|NCT00000391|AIDS-Related Complex|aids-related complex
415211|NCT00000392|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415212|NCT00000392|AIDS-Related Complex|aids-related complex
415213|NCT00000393|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415214|NCT00000394|Carpal tunnel syndrome|carpal tunnel syndrome
415215|NCT00000394|Acupuncture|acupuncture
415216|NCT00000394|Median nerve|median nerve
415217|NCT00000394|Single-blind mute methodology|single-blind mute methodology
415218|NCT00000395|Rheumatoid arthritis|rheumatoid arthritis
415219|NCT00000395|Lewis rat adjuvant arthritis|lewis rat adjuvant arthritis
415220|NCT00000395|Antifolate efficacy|antifolate efficacy
415221|NCT00000395|Autoimmunity|autoimmunity
415222|NCT00000395|Adenosine metabolism|adenosine metabolism
415223|NCT00000395|Methotrexate therapy|methotrexate therapy
415224|NCT00000395|Skeletal disorder|skeletal disorder
415225|NCT00000395|Dietary supplement|dietary supplement
415226|NCT00000395|Antiarthritic agent|antiarthritic agent
415229|NCT00000396|Arthritis education|arthritis education
415230|NCT00000396|African Americans|african americans
415231|NCT00000396|Self-help|self-help
415232|NCT00000396|Self-management|self-management
415233|NCT00000396|Cultural beliefs|cultural beliefs
415234|NCT00000397|Fibromyalgia|fibromyalgia
415235|NCT00000397|Insomnia|insomnia
415236|NCT00000397|Cognitive-behavioral therapy (CBT)|cognitive-behavioral therapy (cbt)
415237|NCT00000397|Behavioral insomnia therapy|behavioral insomnia therapy
415238|NCT00000398|Fibromyalgia|fibromyalgia
415239|NCT00000398|Pain|pain
415240|NCT00000398|Coping skills training|coping skills training
415241|NCT00000398|Physical exercise training|physical exercise training
415242|NCT00000398|Combined coping skills training and exercise training|combined coping skills training and exercise training
415243|NCT00000399|Estrogen|estrogen
415244|NCT00000399|Hormone therapy|hormone therapy
415245|NCT00000399|Strength training|strength training
415246|NCT00000399|Exercise|exercise
415247|NCT00000399|Postmenopause|postmenopause
415248|NCT00000399|Disorder prevention|disorder prevention
415249|NCT00000399|Osteoporosis|osteoporosis
415250|NCT00000399|Bone mineral density|bone mineral density
415251|NCT00000399|Bone mass|bone mass
415252|NCT00000399|Cholesterol|cholesterol
415253|NCT00000399|Body composition|body composition
415254|NCT00000620|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
415255|NCT00000623|chelator|chelator
415256|NCT00000623|iron|iron
415257|NCT00000623|transfusion|transfusion
415258|NCT00000623|anemia|anemia
415259|NCT00000623|thalassemia|thalassemia
415260|NCT00000625|Zalcitabine|zalcitabine
415261|NCT00000625|Didanosine|didanosine
415382|NCT00000641|Ciprofloxacin|ciprofloxacin
415262|NCT00000625|Drug Therapy, Combination|drug therapy, combination
415263|NCT00000625|AIDS-Related Complex|aids-related complex
415264|NCT00000625|Antiviral Agents|antiviral agents
415265|NCT00000625|Zidovudine|zidovudine
415266|NCT00000626|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
415267|NCT00000626|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
10177|NCT03225664|GSK1120212|gsk1120212
415268|NCT00000626|Antineoplastic Agents, Combined|antineoplastic agents, combined
415269|NCT00000626|AIDS-Related Complex|aids-related complex
415270|NCT00000626|Hodgkin Disease|hodgkin disease
415271|NCT00000626|ABVD protocol|abvd protocol
415272|NCT00000627|Pilot Projects|pilot projects
415273|NCT00000627|Histoplasmosis|histoplasmosis
415274|NCT00000627|Drug Evaluation|drug evaluation
415275|NCT00000627|Fluconazole|fluconazole
415276|NCT00000627|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415277|NCT00000627|Recurrence|recurrence
415278|NCT00000628|Drug Evaluation|drug evaluation
415279|NCT00000628|Drugs, Investigational|drugs, investigational
415280|NCT00000628|Drug Therapy, Combination|drug therapy, combination
415281|NCT00000628|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415282|NCT00000628|AIDS-Related Complex|aids-related complex
415283|NCT00000628|Antiviral Agents|antiviral agents
415284|NCT00000629|Valproic Acid|valproic acid
415285|NCT00000629|Zidovudine|zidovudine
415286|NCT00000630|Vaccines, Synthetic|vaccines, synthetic
415287|NCT00000630|Vaccinia Virus|vaccinia virus
415288|NCT00000630|Viral Envelope Proteins|viral envelope proteins
415289|NCT00000630|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415290|NCT00000630|AIDS Vaccines|aids vaccines
415291|NCT00000630|HIV Seronegativity|hiv seronegativity
415292|NCT00000630|HIV Preventive Vaccine|hiv preventive vaccine
415293|NCT00000631|Vaccines, Synthetic|vaccines, synthetic
415294|NCT00000631|Vaccinia Virus|vaccinia virus
415295|NCT00000631|Viral Envelope Proteins|viral envelope proteins
415296|NCT00000631|Viral Vaccines|viral vaccines
415297|NCT00000631|AIDS Vaccines|aids vaccines
415298|NCT00000631|HIV Seronegativity|hiv seronegativity
415299|NCT00000631|HIV Preventive Vaccine|hiv preventive vaccine
415300|NCT00000632|Vaccines, Synthetic|vaccines, synthetic
415301|NCT00000632|Drug Evaluation|drug evaluation
415302|NCT00000632|Adjuvants, Immunologic|adjuvants, immunologic
415303|NCT00000632|AIDS Vaccines|aids vaccines
415304|NCT00000632|HIV Preventive Vaccine|hiv preventive vaccine
415305|NCT00000633|Vaccines, Synthetic|vaccines, synthetic
415306|NCT00000633|Vaccinia Virus|vaccinia virus
415307|NCT00000633|Viral Vaccines|viral vaccines
415309|NCT00000633|HIV Envelope Protein gp160|hiv envelope protein gp160
415310|NCT00000633|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415311|NCT00000633|AIDS-Related Complex|aids-related complex
415312|NCT00000633|AIDS Vaccines|aids vaccines
415313|NCT00000633|HIV Therapeutic Vaccine|hiv therapeutic vaccine
415314|NCT00000634|Benzodiazepines|benzodiazepines
415315|NCT00000634|Drug Evaluation|drug evaluation
415316|NCT00000634|Drugs, Investigational|drugs, investigational
415317|NCT00000634|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415318|NCT00000634|Antiviral Agents|antiviral agents
415319|NCT00000635|Bacitracin|bacitracin
415320|NCT00000635|Polymyxin B|polymyxin b
415321|NCT00000635|Trifluridine|trifluridine
415322|NCT00000635|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415323|NCT00000635|Herpesviridae Infections|herpesviridae infections
415324|NCT00000635|Drug Evaluation|drug evaluation
415325|NCT00000635|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415326|NCT00000635|Anti-Infective Agents, Local|anti-infective agents, local
415327|NCT00000635|Antiviral Agents|antiviral agents
415328|NCT00000636|Tuberculosis|tuberculosis
415329|NCT00000636|Isoniazid|isoniazid
415330|NCT00000636|Pyrazinamide|pyrazinamide
415331|NCT00000636|Pyridoxine|pyridoxine
415332|NCT00000636|Rifampin|rifampin
415333|NCT00000636|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415334|NCT00000636|Drug Therapy, Combination|drug therapy, combination
415335|NCT00000636|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415336|NCT00000636|Antitubercular Agents|antitubercular agents
415337|NCT00000636|AIDS-Related Complex|aids-related complex
415338|NCT00000637|Didanosine|didanosine
415339|NCT00000637|Drug Evaluation|drug evaluation
415340|NCT00000637|Drug Therapy, Combination|drug therapy, combination
415341|NCT00000637|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415342|NCT00000637|AIDS-Related Complex|aids-related complex
415343|NCT00000637|Zidovudine|zidovudine
415344|NCT00000638|Tuberculosis|tuberculosis
415345|NCT00000638|Isoniazid|isoniazid
415346|NCT00000638|Mycobacterium tuberculosis|mycobacterium tuberculosis
415347|NCT00000638|Pyrazinamide|pyrazinamide
415348|NCT00000638|Pyridoxine|pyridoxine
415349|NCT00000638|Rifampin|rifampin
415350|NCT00000638|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415351|NCT00000638|Drug Therapy, Combination|drug therapy, combination
415352|NCT00000638|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415353|NCT00000638|Antitubercular Agents|antitubercular agents
415354|NCT00000638|AIDS-Related Complex|aids-related complex
415355|NCT00000639|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415356|NCT00000639|Meningitis|meningitis
415357|NCT00000639|Cryptococcosis|cryptococcosis
415358|NCT00000639|Drug Evaluation|drug evaluation
415359|NCT00000639|Drug Therapy, Combination|drug therapy, combination
415360|NCT00000639|Fluconazole|fluconazole
415362|NCT00000639|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415363|NCT00000639|Amphotericin B|amphotericin b
415364|NCT00000639|Brain Diseases|brain diseases
415365|NCT00000640|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
415366|NCT00000640|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
415367|NCT00000640|Primaquine|primaquine
415369|NCT00000640|Drug Therapy, Combination|drug therapy, combination
415370|NCT00000640|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415371|NCT00000640|Clindamycin|clindamycin
415372|NCT00000640|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
415373|NCT00000641|Rifampin|rifampin
415374|NCT00000641|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
415375|NCT00000641|Drug Evaluation|drug evaluation
415376|NCT00000641|Drug Therapy, Combination|drug therapy, combination
415377|NCT00000641|Ethambutol|ethambutol
415378|NCT00000641|Clofazimine|clofazimine
415379|NCT00000641|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415380|NCT00000641|Amikacin|amikacin
415381|NCT00000641|Azithromycin|azithromycin
415383|NCT00000642|Recombinant Proteins|recombinant proteins
415840|NCT00000719|Zidovudine|zidovudine
415384|NCT00000642|Pregnancy Trimester, Third|pregnancy trimester, third
415385|NCT00000642|Pregnancy|pregnancy
415386|NCT00000642|Pregnancy Complications, Infectious|pregnancy complications, infectious
415387|NCT00000642|IgG|igg
415388|NCT00000642|Drug Evaluation|drug evaluation
415389|NCT00000642|Antigens, CD4|antigens, cd4
415390|NCT00000642|AIDS-Related Complex|aids-related complex
415391|NCT00000642|Immunization, Passive|immunization, passive
415392|NCT00000643|Toxoplasmosis|toxoplasmosis
415393|NCT00000643|Pyrimethamine|pyrimethamine
415394|NCT00000643|Leucovorin|leucovorin
415395|NCT00000643|Drug Evaluation|drug evaluation
415396|NCT00000643|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415397|NCT00000643|AIDS-Related Complex|aids-related complex
415398|NCT00000643|Brain Diseases|brain diseases
415399|NCT00000644|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415400|NCT00000644|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
415401|NCT00000644|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415402|NCT00000644|Clarithromycin|clarithromycin
415403|NCT00000645|Drug Evaluation|drug evaluation
415404|NCT00000645|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415405|NCT00000645|AIDS-Related Complex|aids-related complex
415406|NCT00000645|Antiviral Agents|antiviral agents
415407|NCT00000646|Pentoxifylline|pentoxifylline
415408|NCT00000646|Virus Replication|virus replication
415409|NCT00000646|Tumor Necrosis Factor|tumor necrosis factor
415410|NCT00000646|Drug Evaluation|drug evaluation
415411|NCT00000646|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415412|NCT00000646|Cachexia|cachexia
415413|NCT00000646|Drug Synergism|drug synergism
415414|NCT00000647|Recombinant Proteins|recombinant proteins
415415|NCT00000647|IgG|igg
415416|NCT00000647|Drug Evaluation|drug evaluation
415417|NCT00000647|Drug Therapy, Combination|drug therapy, combination
415418|NCT00000647|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415419|NCT00000647|Antigens, CD4|antigens, cd4
415420|NCT00000647|Zidovudine|zidovudine
415421|NCT00000647|Carrier Proteins|carrier proteins
415422|NCT00000647|Interferon Type I|interferon type i
415423|NCT00000648|Penicillin G|penicillin g
415424|NCT00000648|Neurosyphilis|neurosyphilis
415425|NCT00000648|Drug Evaluation|drug evaluation
415426|NCT00000648|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415427|NCT00000648|AIDS-Related Complex|aids-related complex
415428|NCT00000648|Ceftriaxone|ceftriaxone
415429|NCT00000649|Drug Therapy, Combination|drug therapy, combination
415430|NCT00000649|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415431|NCT00000649|AIDS-Related Complex|aids-related complex
415432|NCT00000649|Zidovudine|zidovudine
415433|NCT00000649|Nevirapine|nevirapine
415434|NCT00000650|Drug Evaluation|drug evaluation
415435|NCT00000650|Ditiocarb|ditiocarb
415436|NCT00000650|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415437|NCT00000651|Zalcitabine|zalcitabine
415438|NCT00000651|Antiviral Agents|antiviral agents
415439|NCT00000651|Zidovudine|zidovudine
415440|NCT00000652|Didanosine|didanosine
415441|NCT00000652|Drug Evaluation|drug evaluation
415442|NCT00000652|Drug Therapy, Combination|drug therapy, combination
415443|NCT00000652|Zidovudine|zidovudine
415444|NCT00000653|Zalcitabine|zalcitabine
415445|NCT00000653|Drug Evaluation|drug evaluation
415446|NCT00000653|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415447|NCT00000653|AIDS-Related Complex|aids-related complex
415448|NCT00000654|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415449|NCT00000654|Pyrimidine Nucleosides|pyrimidine nucleosides
415450|NCT00000654|Herpesviridae Infections|herpesviridae infections
415451|NCT00000654|Drug Evaluation|drug evaluation
415452|NCT00000654|Antiviral Agents|antiviral agents
415453|NCT00000654|Hepatitis B|hepatitis b
415454|NCT00000655|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
415455|NCT00000655|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415456|NCT00000655|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
415457|NCT00000655|Naphthoquinones|naphthoquinones
415458|NCT00000655|Antifungal Agents|antifungal agents
415459|NCT00000655|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415460|NCT00000655|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
415461|NCT00000656|Didanosine|didanosine
415462|NCT00000656|Drug Therapy, Combination|drug therapy, combination
415463|NCT00000656|Zidovudine|zidovudine
415464|NCT00000657|Didanosine|didanosine
415465|NCT00000657|Drug Evaluation|drug evaluation
415466|NCT00000657|Drugs, Investigational|drugs, investigational
415467|NCT00000657|AIDS Dementia Complex|aids dementia complex
415468|NCT00000657|Zidovudine|zidovudine
415469|NCT00000658|M-BACOD protocol|m-bacod protocol
415470|NCT00000658|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
415471|NCT00000658|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415472|NCT00000658|Allopurinol|allopurinol
415473|NCT00000658|Antineoplastic Agents, Combined|antineoplastic agents, combined
415474|NCT00000659|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415475|NCT00000659|Antigens, CD4|antigens, cd4
415476|NCT00000659|AIDS-Related Complex|aids-related complex
415477|NCT00000659|Zidovudine|zidovudine
415478|NCT00000660|Sarcoma, Kaposi|sarcoma, kaposi
415479|NCT00000660|Drug Evaluation|drug evaluation
415480|NCT00000660|Etoposide|etoposide
415481|NCT00000660|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415482|NCT00000661|Oxazepam|oxazepam
415483|NCT00000661|Drug Evaluation|drug evaluation
415484|NCT00000661|Drug Interactions|drug interactions
415485|NCT00000661|Zidovudine|zidovudine
415486|NCT00000662|Drugs, Investigational|drugs, investigational
415487|NCT00000662|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415488|NCT00000662|AIDS-Related Complex|aids-related complex
415489|NCT00000662|Zidovudine|zidovudine
415490|NCT00000663|Recombinant Proteins|recombinant proteins
415491|NCT00000663|Injections, Intravenous|injections, intravenous
415492|NCT00000663|IgG|igg
415493|NCT00000663|Drug Evaluation|drug evaluation
415494|NCT00000663|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415495|NCT00000663|Antigens, CD4|antigens, cd4
517781|NCT00266396|THA|tha
415496|NCT00000663|Carrier Proteins|carrier proteins
415497|NCT00000664|Polyethylene Glycols|polyethylene glycols
415498|NCT00000664|Interleukin-2|interleukin-2
415499|NCT00000664|Drug Evaluation|drug evaluation
415500|NCT00000664|Zidovudine|zidovudine
415501|NCT00000665|Retinitis|retinitis
415502|NCT00000665|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415503|NCT00000665|Ganciclovir|ganciclovir
415504|NCT00000665|Foscarnet|foscarnet
415505|NCT00000665|Cytomegalovirus Infections|cytomegalovirus infections
415506|NCT00000665|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415507|NCT00000665|Antiviral Agents|antiviral agents
415508|NCT00000666|Toxoplasmosis|toxoplasmosis
415509|NCT00000666|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415510|NCT00000666|Pyrimethamine|pyrimethamine
415511|NCT00000666|Drug Evaluation|drug evaluation
415512|NCT00000666|Encephalitis|encephalitis
415513|NCT00000666|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415514|NCT00000667|Vaccines, Synthetic|vaccines, synthetic
415515|NCT00000667|Injections, Intradermal|injections, intradermal
415516|NCT00000667|HIV Antigens|hiv antigens
415517|NCT00000667|HIV Seropositivity|hiv seropositivity
415518|NCT00000667|HIV-1|hiv-1
415519|NCT00000667|Drug Evaluation|drug evaluation
415520|NCT00000667|Hypersensitivity, Delayed|hypersensitivity, delayed
415521|NCT00000667|AIDS Vaccines|aids vaccines
415522|NCT00000667|HIV Therapeutic Vaccine|hiv therapeutic vaccine
415523|NCT00000668|Retinitis|retinitis
415524|NCT00000668|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415525|NCT00000668|Ganciclovir|ganciclovir
415526|NCT00000668|Cytomegalovirus Infections|cytomegalovirus infections
415527|NCT00000668|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415528|NCT00000669|Didanosine|didanosine
415529|NCT00000669|Drug Evaluation|drug evaluation
415530|NCT00000669|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415531|NCT00000669|AIDS-Related Complex|aids-related complex
415532|NCT00000670|Probenecid|probenecid
415533|NCT00000670|Drug Evaluation|drug evaluation
415534|NCT00000670|Drug Interactions|drug interactions
415535|NCT00000670|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415536|NCT00000670|Zidovudine|zidovudine
415537|NCT00000671|Didanosine|didanosine
415538|NCT00000671|Zidovudine|zidovudine
415539|NCT00000672|Didanosine|didanosine
415540|NCT00000672|Zidovudine|zidovudine
415541|NCT00000673|Retinitis|retinitis
415542|NCT00000673|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415543|NCT00000673|Ganciclovir|ganciclovir
415544|NCT00000673|Cytomegalovirus Infections|cytomegalovirus infections
415545|NCT00000673|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415546|NCT00000674|Toxoplasmosis|toxoplasmosis
415547|NCT00000674|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415548|NCT00000674|Pyrimethamine|pyrimethamine
415549|NCT00000674|Leucovorin|leucovorin
415550|NCT00000674|Drug Evaluation|drug evaluation
415551|NCT00000674|Drug Therapy, Combination|drug therapy, combination
415552|NCT00000674|Encephalitis|encephalitis
415553|NCT00000674|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415554|NCT00000674|Clindamycin|clindamycin
415555|NCT00000675|Recombinant Proteins|recombinant proteins
415556|NCT00000675|IgG|igg
415557|NCT00000675|Drug Evaluation|drug evaluation
415558|NCT00000675|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415559|NCT00000675|Antigens, CD4|antigens, cd4
415560|NCT00000675|AIDS-Related Complex|aids-related complex
415561|NCT00000675|Carrier Proteins|carrier proteins
415562|NCT00000676|Mycoses|mycoses
415563|NCT00000676|Fluconazole|fluconazole
415564|NCT00000676|Clotrimazole|clotrimazole
415565|NCT00000676|Antifungal Agents|antifungal agents
415566|NCT00000676|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415567|NCT00000676|AIDS-Related Complex|aids-related complex
415568|NCT00000677|Sch 39304|sch 39304
415569|NCT00000677|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415570|NCT00000677|Meningitis|meningitis
415571|NCT00000677|Cryptococcosis|cryptococcosis
415572|NCT00000677|Drug Evaluation|drug evaluation
415573|NCT00000677|Antifungal Agents|antifungal agents
415574|NCT00000677|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415575|NCT00000678|Zalcitabine|zalcitabine
415576|NCT00000678|Drug Evaluation|drug evaluation
415577|NCT00000678|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415578|NCT00000678|AIDS-Related Complex|aids-related complex
415579|NCT00000678|Zidovudine|zidovudine
415580|NCT00000679|Zalcitabine|zalcitabine
415581|NCT00000679|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415582|NCT00000679|AIDS-Related Complex|aids-related complex
415583|NCT00000679|Zidovudine|zidovudine
415584|NCT00000680|T-Lymphocytes, Suppressor-Effector|t-lymphocytes, suppressor-effector
415585|NCT00000680|Indium Radioisotopes|indium radioisotopes
415586|NCT00000680|Leukapheresis|leukapheresis
415587|NCT00000680|Interleukin-2|interleukin-2
415588|NCT00000680|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415589|NCT00000680|AIDS-Related Complex|aids-related complex
415590|NCT00000680|Zidovudine|zidovudine
415591|NCT00000680|Immunization, Passive|immunization, passive
415592|NCT00000681|Vincristine|vincristine
415593|NCT00000681|Doxorubicin|doxorubicin
415594|NCT00000681|Drug Evaluation|drug evaluation
415595|NCT00000681|Drug Therapy, Combination|drug therapy, combination
415596|NCT00000681|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
415597|NCT00000681|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415598|NCT00000681|Zidovudine|zidovudine
415599|NCT00000681|Bleomycin|bleomycin
415600|NCT00000682|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415601|NCT00000682|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
415602|NCT00000682|Zalcitabine|zalcitabine
415603|NCT00000682|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415605|NCT00000683|Vaccines, Synthetic|vaccines, synthetic
415606|NCT00000683|Vaccinia Virus|vaccinia virus
415607|NCT00000683|Viral Envelope Proteins|viral envelope proteins
415608|NCT00000683|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415609|NCT00000683|AIDS Vaccines|aids vaccines
415610|NCT00000683|HIV Seronegativity|hiv seronegativity
415611|NCT00000683|HIV Preventive Vaccine|hiv preventive vaccine
415612|NCT00000684|Infusions, Intravenous|infusions, intravenous
415613|NCT00000684|Dextran Sulfate|dextran sulfate
415614|NCT00000684|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415615|NCT00000685|Kidney Diseases|kidney diseases
415616|NCT00000685|Drug Evaluation|drug evaluation
415617|NCT00000685|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415618|NCT00000685|Zidovudine|zidovudine
415619|NCT00000685|Renal Dialysis|renal dialysis
415620|NCT00000686|Drug Evaluation|drug evaluation
415621|NCT00000686|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415622|NCT00000686|AIDS-Related Complex|aids-related complex
415623|NCT00000686|Antiviral Agents|antiviral agents
415624|NCT00000686|Zidovudine|zidovudine
415625|NCT00000687|Interferon Alfa-2a|interferon alfa-2a
415626|NCT00000687|Drug Evaluation|drug evaluation
415627|NCT00000687|Drug Therapy, Combination|drug therapy, combination
584763|NCT00509730|randomized clinical trial|randomized clinical trial
415628|NCT00000687|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415629|NCT00000687|Zidovudine|zidovudine
415630|NCT00000688|Retinitis|retinitis
415631|NCT00000688|Injections, Intravenous|injections, intravenous
415632|NCT00000688|Ganciclovir|ganciclovir
415633|NCT00000688|Cytomegalovirus Infections|cytomegalovirus infections
415634|NCT00000688|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415635|NCT00000689|M-BACOD protocol|m-bacod protocol
415636|NCT00000689|Nervous System Neoplasms|nervous system neoplasms
415637|NCT00000689|Infusions, Intravenous|infusions, intravenous
415638|NCT00000689|Injections, Intravenous|injections, intravenous
415639|NCT00000689|Leucovorin|leucovorin
415640|NCT00000689|Cytarabine|cytarabine
415641|NCT00000689|Drug Evaluation|drug evaluation
415642|NCT00000689|Drug Therapy, Combination|drug therapy, combination
415643|NCT00000689|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
415644|NCT00000689|Administration, Oral|administration, oral
415645|NCT00000689|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415646|NCT00000689|Antineoplastic Agents, Combined|antineoplastic agents, combined
415647|NCT00000690|Reference Values|reference values
415648|NCT00000690|Infusions, Intravenous|infusions, intravenous
415649|NCT00000690|Intestinal Absorption|intestinal absorption
415650|NCT00000690|Dextran Sulfate|dextran sulfate
415651|NCT00000690|Administration, Oral|administration, oral
415652|NCT00000690|Blood Coagulation|blood coagulation
415653|NCT00000691|Retinitis|retinitis
415654|NCT00000691|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415655|NCT00000691|Ganciclovir|ganciclovir
415656|NCT00000691|Drug Evaluation|drug evaluation
415657|NCT00000691|Foscarnet|foscarnet
415658|NCT00000691|Cytomegalovirus Infections|cytomegalovirus infections
415659|NCT00000691|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415660|NCT00000691|Antiviral Agents|antiviral agents
415892|NCT00000722|Lung|lung
415661|NCT00000692|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415662|NCT00000692|AIDS-Related Complex|aids-related complex
415663|NCT00000692|Antiviral Agents|antiviral agents
415664|NCT00000692|Biological Availability|biological availability
415665|NCT00000692|1-Deoxynojirimycin|1-deoxynojirimycin
415666|NCT00000693|Retinitis|retinitis
415667|NCT00000693|Drug Evaluation|drug evaluation
415668|NCT00000693|Drug Therapy, Combination|drug therapy, combination
415669|NCT00000693|Cytomegalovirus Infections|cytomegalovirus infections
415670|NCT00000693|Acyclovir|acyclovir
415671|NCT00000693|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415672|NCT00000693|Zidovudine|zidovudine
415673|NCT00000694|Interferon Alfa-2b|interferon alfa-2b
415674|NCT00000694|Immune System|immune system
415675|NCT00000694|Drug Evaluation|drug evaluation
415676|NCT00000694|Drug Therapy, Combination|drug therapy, combination
414785|NCT00000263|ethanol|ethanol
415677|NCT00000694|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
415678|NCT00000694|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415679|NCT00000694|Zidovudine|zidovudine
415680|NCT00000695|Drug Evaluation|drug evaluation
415681|NCT00000695|Drug Therapy, Combination|drug therapy, combination
415682|NCT00000695|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415683|NCT00000695|Zidovudine|zidovudine
415684|NCT00000695|Interferon Type I|interferon type i
415685|NCT00000696|Interferon Alfa-2a|interferon alfa-2a
415686|NCT00000696|Drug Therapy, Combination|drug therapy, combination
415687|NCT00000696|AIDS-Related Complex|aids-related complex
415688|NCT00000696|Zidovudine|zidovudine
415689|NCT00000697|Retinitis|retinitis
415690|NCT00000697|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415691|NCT00000697|Bone Marrow|bone marrow
415692|NCT00000697|Ganciclovir|ganciclovir
415693|NCT00000697|Foscarnet|foscarnet
415694|NCT00000697|Cytomegalovirus Infections|cytomegalovirus infections
415695|NCT00000697|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415696|NCT00000697|Antiviral Agents|antiviral agents
415697|NCT00000698|Retinitis|retinitis
415698|NCT00000698|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415699|NCT00000698|Ganciclovir|ganciclovir
415700|NCT00000698|Cytomegalovirus Infections|cytomegalovirus infections
415701|NCT00000698|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415702|NCT00000699|Ribavirin|ribavirin
415703|NCT00000699|Inosine Pranobex|inosine pranobex
415704|NCT00000699|Dose-Response Relationship, Drug|dose-response relationship, drug
415705|NCT00000699|Drug Evaluation|drug evaluation
415706|NCT00000699|Drug Therapy, Combination|drug therapy, combination
415707|NCT00000699|AIDS-Related Complex|aids-related complex
415708|NCT00000700|United States|united states
415709|NCT00000700|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415710|NCT00000700|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
415711|NCT00000700|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415712|NCT00000700|Zidovudine|zidovudine
415713|NCT00000701|Drug Evaluation|drug evaluation
415714|NCT00000701|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415715|NCT00000701|AIDS-Related Complex|aids-related complex
415716|NCT00000701|Zidovudine|zidovudine
415717|NCT00000702|AIDS Dementia Complex|aids dementia complex
415718|NCT00000702|Zidovudine|zidovudine
415719|NCT00000703|Vincristine|vincristine
415720|NCT00000703|Lymphoma|lymphoma
415721|NCT00000703|Methotrexate|methotrexate
415722|NCT00000703|Cyclophosphamide|cyclophosphamide
415723|NCT00000703|Cytarabine|cytarabine
415724|NCT00000703|Dexamethasone|dexamethasone
415725|NCT00000703|Doxorubicin|doxorubicin
415726|NCT00000703|Drug Therapy, Combination|drug therapy, combination
415727|NCT00000703|Combined Modality Therapy|combined modality therapy
415728|NCT00000703|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415729|NCT00000703|Antineoplastic Agents, Combined|antineoplastic agents, combined
415730|NCT00000703|Zidovudine|zidovudine
415731|NCT00000703|Bleomycin|bleomycin
415732|NCT00000704|HIV Antigens|hiv antigens
415733|NCT00000704|Immunologic Surveillance|immunologic surveillance
415734|NCT00000704|Zalcitabine|zalcitabine
415735|NCT00000704|Dose-Response Relationship, Drug|dose-response relationship, drug
415736|NCT00000704|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415737|NCT00000704|AIDS-Related Complex|aids-related complex
415738|NCT00000704|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
415739|NCT00000705|Drug Evaluation|drug evaluation
415740|NCT00000705|Zidovudine|zidovudine
415741|NCT00000705|Hemophilia A|hemophilia a
415742|NCT00000706|Quinine|quinine
415743|NCT00000706|Probenecid|probenecid
415744|NCT00000706|Drug Therapy, Combination|drug therapy, combination
415745|NCT00000706|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415746|NCT00000706|AIDS-Related Complex|aids-related complex
415747|NCT00000706|Zidovudine|zidovudine
415748|NCT00000707|Respiratory Function Tests|respiratory function tests
415749|NCT00000707|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415750|NCT00000707|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
415751|NCT00000707|Pentamidine|pentamidine
415753|NCT00000707|HIV Seropositivity|hiv seropositivity
415754|NCT00000707|Drug Evaluation|drug evaluation
415755|NCT00000707|Administration, Inhalation|administration, inhalation
415756|NCT00000707|Aerosols|aerosols
415757|NCT00000707|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415758|NCT00000708|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415759|NCT00000708|Meningitis|meningitis
415760|NCT00000708|Injections, Intravenous|injections, intravenous
415761|NCT00000708|Cryptococcus neoformans|cryptococcus neoformans
415762|NCT00000708|Cryptococcosis|cryptococcosis
415763|NCT00000708|Drug Therapy, Combination|drug therapy, combination
415764|NCT00000708|Fluconazole|fluconazole
415765|NCT00000708|Administration, Oral|administration, oral
415766|NCT00000708|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415767|NCT00000708|Amphotericin B|amphotericin b
415768|NCT00000709|Neuropsychological Tests|neuropsychological tests
415769|NCT00000709|AIDS Dementia Complex|aids dementia complex
415770|NCT00000709|Zidovudine|zidovudine
415771|NCT00000709|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
415772|NCT00000710|Injections, Intravenous|injections, intravenous
415773|NCT00000710|Didanosine|didanosine
415774|NCT00000710|Dose-Response Relationship, Drug|dose-response relationship, drug
415775|NCT00000710|Drug Evaluation|drug evaluation
415776|NCT00000710|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415777|NCT00000710|AIDS-Related Complex|aids-related complex
415778|NCT00000711|Neutropenia|neutropenia
415779|NCT00000711|Drug Evaluation|drug evaluation
415780|NCT00000711|Drug Therapy, Combination|drug therapy, combination
415781|NCT00000711|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
415782|NCT00000711|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415783|NCT00000711|AIDS-Related Complex|aids-related complex
415784|NCT00000711|Zidovudine|zidovudine
415785|NCT00000712|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
416511|NCT00000846|HIV-1|hiv-1
415786|NCT00000712|Herpesviridae Infections|herpesviridae infections
415787|NCT00000712|Drug Evaluation|drug evaluation
415788|NCT00000712|Drug Therapy, Combination|drug therapy, combination
415789|NCT00000712|Herpesvirus 4, Human|herpesvirus 4, human
415790|NCT00000712|Cytomegalovirus Infections|cytomegalovirus infections
415791|NCT00000712|Acyclovir|acyclovir
415792|NCT00000712|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415793|NCT00000712|Antiviral Agents|antiviral agents
415794|NCT00000712|Zidovudine|zidovudine
415795|NCT00000713|Polyribonucleotides|polyribonucleotides
415796|NCT00000713|HIV Seropositivity|hiv seropositivity
415797|NCT00000713|Dose-Response Relationship, Drug|dose-response relationship, drug
415798|NCT00000713|Drug Evaluation|drug evaluation
415799|NCT00000713|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415800|NCT00000713|ampligen|ampligen
415801|NCT00000713|AIDS-Related Complex|aids-related complex
415802|NCT00000713|Antiviral Agents|antiviral agents
415803|NCT00000714|Trimetrexate|trimetrexate
415804|NCT00000714|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415805|NCT00000714|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
415806|NCT00000714|Leucovorin|leucovorin
415807|NCT00000714|Drug Evaluation|drug evaluation
415808|NCT00000714|Drug Therapy, Combination|drug therapy, combination
415809|NCT00000714|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415810|NCT00000714|Antiprotozoal Agents|antiprotozoal agents
415811|NCT00000715|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
415812|NCT00000715|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415813|NCT00000715|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
415814|NCT00000715|Pentamidine|pentamidine
415815|NCT00000715|Infusions, Intravenous|infusions, intravenous
415816|NCT00000715|Administration, Inhalation|administration, inhalation
415817|NCT00000715|Aerosols|aerosols
415818|NCT00000715|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415819|NCT00000715|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
415820|NCT00000716|Drug Evaluation|drug evaluation
415821|NCT00000716|Administration, Oral|administration, oral
415822|NCT00000716|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415823|NCT00000716|Zidovudine|zidovudine
415824|NCT00000717|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415825|NCT00000717|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
415826|NCT00000717|Primaquine|primaquine
415827|NCT00000717|Infusions, Intravenous|infusions, intravenous
415828|NCT00000717|Drug Evaluation|drug evaluation
415829|NCT00000717|Drug Therapy, Combination|drug therapy, combination
415830|NCT00000717|Administration, Oral|administration, oral
415831|NCT00000717|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415832|NCT00000717|Clindamycin|clindamycin
415833|NCT00000718|Zalcitabine|zalcitabine
415834|NCT00000718|Dose-Response Relationship, Drug|dose-response relationship, drug
415835|NCT00000718|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415836|NCT00000718|AIDS-Related Complex|aids-related complex
415837|NCT00000718|Zidovudine|zidovudine
415838|NCT00000719|Zalcitabine|zalcitabine
415839|NCT00000719|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415841|NCT00000720|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415842|NCT00000720|Placebos|placebos
415843|NCT00000720|Infusions, Intravenous|infusions, intravenous
415844|NCT00000720|Gamma-Globulins|gamma-globulins
415845|NCT00000720|Combined Modality Therapy|combined modality therapy
415846|NCT00000720|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415847|NCT00000720|Zidovudine|zidovudine
415848|NCT00000720|Bacterial Infections|bacterial infections
415849|NCT00000720|Immunization, Passive|immunization, passive
415850|NCT00000120|Neonatal Conjunctivitis|neonatal conjunctivitis
415851|NCT00000121|strabismus|strabismus
415852|NCT00000124|Choroidal Melanoma|choroidal melanoma
415853|NCT00000124|Ocular Melanoma|ocular melanoma
415854|NCT00000126|Non-arteritic Ischemic Optic Neuropathy|non-arteritic ischemic optic neuropathy
415855|NCT00000127|Non-arteritic Ischemic Optic Neuropathy|non-arteritic ischemic optic neuropathy
415856|NCT00000128|Near-point Esophoria|near-point esophoria
415857|NCT00000130|Bacterial Endophthalmitis|bacterial endophthalmitis
415858|NCT00000131|Central Vein Occlusion|central vein occlusion
415859|NCT00000131|Ischemic Retina|ischemic retina
415860|NCT00000138|Herpes Simplex Stromal Keratitis|herpes simplex stromal keratitis
415861|NCT00000139|Herpes Simplex Stromal Keratitis|herpes simplex stromal keratitis
415862|NCT00000145|Age-Related Macular Degeneration|age-related macular degeneration
415863|NCT00000150|Ocular Histoplasmosis Syndrome|ocular histoplasmosis syndrome
415864|NCT00000150|Idiopathic Choroidal Neovascularization|idiopathic choroidal neovascularization
415865|NCT00000152|Age-Related Macular Degeneration|age-related macular degeneration
415866|NCT00000153|Diabetic Disc Neovascularization|diabetic disc neovascularization
415867|NCT00000153|Optic Disk|optic disk
415868|NCT00000158|photocoagulation|photocoagulation
415869|NCT00000158|argon blue-green laser|argon blue-green laser
415870|NCT00000158|krypton red laser|krypton red laser
415871|NCT00000160|Vision Loss|vision loss
416608|NCT00000861|Viral Load|viral load
415872|NCT00000161|Age-Related Macular Degeneration|age-related macular degeneration
415873|NCT00000163|Congenital Esotropia|congenital esotropia
415874|NCT00000167|Age-Related Macular Degeneration|age-related macular degeneration
415875|NCT00000170|Amblyopia|amblyopia
415876|NCT00000170|patching|patching
415877|NCT00000170|atropine|atropine
415878|NCT00000721|Recombinant Proteins|recombinant proteins
415879|NCT00000721|Infusions, Intravenous|infusions, intravenous
415880|NCT00000721|Injections, Intramuscular|injections, intramuscular
415881|NCT00000721|Injections, Intravenous|injections, intravenous
415882|NCT00000721|Injections, Subcutaneous|injections, subcutaneous
415883|NCT00000721|Dose-Response Relationship, Drug|dose-response relationship, drug
415884|NCT00000721|Drug Evaluation|drug evaluation
415885|NCT00000721|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415886|NCT00000721|Antigens, CD4|antigens, cd4
415887|NCT00000721|AIDS-Related Complex|aids-related complex
584764|NCT00509730|surgery|surgery
415888|NCT00000722|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415889|NCT00000722|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
415890|NCT00000722|Pentamidine|pentamidine
415891|NCT00000722|Injections, Intravenous|injections, intravenous
415893|NCT00000722|Administration, Inhalation|administration, inhalation
415894|NCT00000722|Aerosols|aerosols
415895|NCT00000722|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415896|NCT00000723|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415897|NCT00000723|Lymphoma|lymphoma
415898|NCT00000723|Methotrexate|methotrexate
415899|NCT00000723|Leucovorin|leucovorin
415900|NCT00000723|Dexamethasone|dexamethasone
415901|NCT00000723|Drug Evaluation|drug evaluation
415902|NCT00000723|Drug Therapy, Combination|drug therapy, combination
415903|NCT00000723|Combined Modality Therapy|combined modality therapy
415904|NCT00000723|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415905|NCT00000723|Zidovudine|zidovudine
415906|NCT00000723|Brain Neoplasms|brain neoplasms
415907|NCT00000724|Trimetrexate|trimetrexate
415908|NCT00000724|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
415909|NCT00000724|Injections, Intravenous|injections, intravenous
415910|NCT00000724|Leucovorin|leucovorin
415911|NCT00000724|Drug Evaluation|drug evaluation
415912|NCT00000724|Drug Therapy, Combination|drug therapy, combination
415913|NCT00000724|Folic Acid Antagonists|folic acid antagonists
415914|NCT00000724|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415915|NCT00000724|Antiprotozoal Agents|antiprotozoal agents
415916|NCT00000725|Interferon Alfa-2a|interferon alfa-2a
415917|NCT00000725|Sarcoma, Kaposi|sarcoma, kaposi
415918|NCT00000725|Dose-Response Relationship, Drug|dose-response relationship, drug
415919|NCT00000725|Drug Therapy, Combination|drug therapy, combination
415920|NCT00000725|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415921|NCT00000725|Zidovudine|zidovudine
415922|NCT00000725|Interferon Type I|interferon type i
415923|NCT00000726|Retinitis|retinitis
415924|NCT00000726|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415925|NCT00000726|Foscarnet|foscarnet
415926|NCT00000726|Cytomegalovirus Infections|cytomegalovirus infections
415927|NCT00000726|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415928|NCT00000726|Antiviral Agents|antiviral agents
415929|NCT00000727|Sulfadoxine|sulfadoxine
415930|NCT00000727|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
415931|NCT00000727|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415932|NCT00000727|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
415933|NCT00000727|Pentamidine|pentamidine
415934|NCT00000727|Pyrimethamine|pyrimethamine
415935|NCT00000727|Drug Evaluation|drug evaluation
415936|NCT00000727|Administration, Inhalation|administration, inhalation
415937|NCT00000727|Administration, Oral|administration, oral
415938|NCT00000727|Aerosols|aerosols
415939|NCT00000727|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415940|NCT00000727|Zidovudine|zidovudine
415941|NCT00000728|Immune Tolerance|immune tolerance
415942|NCT00000728|Interleukin-2|interleukin-2
415943|NCT00000728|Drug Therapy, Combination|drug therapy, combination
415944|NCT00000728|AIDS-Related Complex|aids-related complex
415945|NCT00000728|Zidovudine|zidovudine
415946|NCT00000728|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
415947|NCT00000729|Virus Replication|virus replication
415948|NCT00000729|Infusions, Intravenous|infusions, intravenous
415949|NCT00000729|Dose-Response Relationship, Drug|dose-response relationship, drug
415950|NCT00000729|Foscarnet|foscarnet
415951|NCT00000729|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415952|NCT00000729|AIDS-Related Complex|aids-related complex
415953|NCT00000729|Antiviral Agents|antiviral agents
415954|NCT00000729|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
415955|NCT00000730|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
415956|NCT00000730|Trimetrexate|trimetrexate
415957|NCT00000730|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415958|NCT00000730|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
415959|NCT00000730|Leucovorin|leucovorin
415960|NCT00000730|Folic Acid Antagonists|folic acid antagonists
415961|NCT00000730|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415962|NCT00000730|Antiprotozoal Agents|antiprotozoal agents
415963|NCT00000730|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
415964|NCT00000731|Acetaminophen|acetaminophen
415965|NCT00000731|Drug Interactions|drug interactions
415966|NCT00000731|Drug Therapy, Combination|drug therapy, combination
415967|NCT00000731|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415968|NCT00000731|AIDS-Related Complex|aids-related complex
415969|NCT00000731|Zidovudine|zidovudine
415970|NCT00000732|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
415971|NCT00000732|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
415972|NCT00000732|Drug Interactions|drug interactions
415973|NCT00000732|Drug Therapy, Combination|drug therapy, combination
415974|NCT00000732|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415975|NCT00000732|AIDS-Related Complex|aids-related complex
415976|NCT00000732|Zidovudine|zidovudine
415977|NCT00000732|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
415978|NCT00000733|Ribavirin|ribavirin
415979|NCT00000733|T-Lymphocytes|t-lymphocytes
415980|NCT00000733|Infusions, Intravenous|infusions, intravenous
415981|NCT00000733|Immunologic Surveillance|immunologic surveillance
415982|NCT00000733|Administration, Oral|administration, oral
415983|NCT00000733|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415984|NCT00000734|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
415985|NCT00000734|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
415986|NCT00000734|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
415987|NCT00000734|Drug Interactions|drug interactions
415988|NCT00000734|Drug Therapy, Combination|drug therapy, combination
415989|NCT00000734|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415990|NCT00000734|AIDS-Related Complex|aids-related complex
415991|NCT00000734|Zidovudine|zidovudine
415992|NCT00000734|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
415993|NCT00000735|Virus Replication|virus replication
415994|NCT00000735|T-Lymphocytes|t-lymphocytes
415995|NCT00000735|Infusions, Intravenous|infusions, intravenous
415996|NCT00000735|Immunologic Surveillance|immunologic surveillance
415997|NCT00000735|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
415998|NCT00000735|ampligen|ampligen
415999|NCT00000735|AIDS-Related Complex|aids-related complex
416000|NCT00000735|Antiviral Agents|antiviral agents
416001|NCT00000736|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416002|NCT00000736|AIDS-Related Complex|aids-related complex
416003|NCT00000736|Zidovudine|zidovudine
416004|NCT00000737|Weight Loss|weight loss
416005|NCT00000737|Megestrol|megestrol
416006|NCT00000737|Cachexia|cachexia
416007|NCT00000737|Eating Disorders|eating disorders
416008|NCT00000737|Tetrahydrocannabinol|tetrahydrocannabinol
416009|NCT00000737|Appetite|appetite
416010|NCT00000738|Central Nervous System Diseases|central nervous system diseases
416011|NCT00000738|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416012|NCT00000738|AIDS Dementia Complex|aids dementia complex
416013|NCT00000738|AIDS-Related Complex|aids-related complex
416014|NCT00000738|Zidovudine|zidovudine
416015|NCT00000738|Nimodipine|nimodipine
416016|NCT00000739|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
416017|NCT00000739|Dapsone|dapsone
416018|NCT00000739|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416019|NCT00000739|AIDS-Related Complex|aids-related complex
416020|NCT00000739|Drug Administration Schedule|drug administration schedule
416021|NCT00000740|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
416022|NCT00000740|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416023|NCT00000740|AIDS-Related Complex|aids-related complex
416024|NCT00000740|WR 6026|wr 6026
416025|NCT00000741|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
416026|NCT00000741|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416027|NCT00000741|Methylprednisolone|methylprednisolone
416028|NCT00000742|Didanosine|didanosine
416029|NCT00000742|Drug Therapy, Combination|drug therapy, combination
416030|NCT00000742|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416031|NCT00000742|AIDS-Related Complex|aids-related complex
416032|NCT00000742|Antiviral Agents|antiviral agents
416033|NCT00000742|Zidovudine|zidovudine
416034|NCT00000743|Recombinant Proteins|recombinant proteins
416035|NCT00000743|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416036|NCT00000743|Antigens, CD4|antigens, cd4
416037|NCT00000743|AIDS-Related Complex|aids-related complex
416038|NCT00000743|Zidovudine|zidovudine
416039|NCT00000744|Fluconazole|fluconazole
416040|NCT00000744|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416041|NCT00000744|AIDS-Related Complex|aids-related complex
416042|NCT00000744|Candidiasis|candidiasis
416043|NCT00000745|Vaccines, Synthetic|vaccines, synthetic
416044|NCT00000745|Vaccinia Virus|vaccinia virus
416045|NCT00000745|Viral Vaccines|viral vaccines
416046|NCT00000745|HIV-1|hiv-1
416047|NCT00000745|HIV Envelope Protein gp160|hiv envelope protein gp160
416048|NCT00000745|AIDS Vaccines|aids vaccines
416049|NCT00000745|HIV Seronegativity|hiv seronegativity
416050|NCT00000745|HIV Preventive Vaccine|hiv preventive vaccine
416051|NCT00000746|Vaccines, Synthetic|vaccines, synthetic
416052|NCT00000746|Vaccinia Virus|vaccinia virus
416053|NCT00000746|Viral Vaccines|viral vaccines
416055|NCT00000746|HIV Envelope Protein gp160|hiv envelope protein gp160
416056|NCT00000746|HIV Envelope Protein gp120|hiv envelope protein gp120
416057|NCT00000746|AIDS Vaccines|aids vaccines
416058|NCT00000746|HIV Seronegativity|hiv seronegativity
416059|NCT00000746|HIV Preventive Vaccine|hiv preventive vaccine
416060|NCT00000764|Interferon Alfa-2a|interferon alfa-2a
416061|NCT00000764|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416062|NCT00000764|AIDS-Related Complex|aids-related complex
416063|NCT00000764|Anus Neoplasms|anus neoplasms
416064|NCT00000764|Papillomavirus, Human|papillomavirus, human
416065|NCT00000764|Papovaviridae Infections|papovaviridae infections
416066|NCT00000764|Tumor Virus Infections|tumor virus infections
416067|NCT00000764|Isotretinoin|isotretinoin
416068|NCT00000765|Zidovudine|zidovudine
416069|NCT00000766|Retinitis|retinitis
416070|NCT00000766|Ganciclovir|ganciclovir
416071|NCT00000766|Foscarnet|foscarnet
416072|NCT00000766|Cytomegalovirus Infections|cytomegalovirus infections
416073|NCT00000766|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416074|NCT00000767|Vaccines, Synthetic|vaccines, synthetic
416075|NCT00000767|Vaccinia Virus|vaccinia virus
416076|NCT00000767|Viral Vaccines|viral vaccines
416077|NCT00000767|Smallpox Vaccine|smallpox vaccine
416078|NCT00000767|HIV-1|hiv-1
416079|NCT00000767|AIDS Vaccines|aids vaccines
416080|NCT00000767|HIV Seronegativity|hiv seronegativity
416081|NCT00000767|HIV Preventive Vaccine|hiv preventive vaccine
416082|NCT00000768|Intestinal Absorption|intestinal absorption
416083|NCT00000768|Ganciclovir|ganciclovir
416084|NCT00000768|Drug Therapy, Combination|drug therapy, combination
416085|NCT00000768|Cytomegalovirus Infections|cytomegalovirus infections
416087|NCT00000768|Administration, Oral|administration, oral
416088|NCT00000768|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416089|NCT00000768|Biological Availability|biological availability
416090|NCT00000768|Glutamic Acid|glutamic acid
416091|NCT00000769|Sarcoma, Kaposi|sarcoma, kaposi
416092|NCT00000769|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416093|NCT00000769|Interleukin-4|interleukin-4
416094|NCT00000770|Didanosine|didanosine
416095|NCT00000770|Drug Therapy, Combination|drug therapy, combination
416096|NCT00000770|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416097|NCT00000770|AIDS-Related Complex|aids-related complex
416098|NCT00000770|Zidovudine|zidovudine
416099|NCT00000770|Nevirapine|nevirapine
416100|NCT00000771|Cryptosporidiosis|cryptosporidiosis
416101|NCT00000771|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416102|NCT00000771|Paromomycin|paromomycin
416103|NCT00000772|Ribavirin|ribavirin
416104|NCT00000772|Didanosine|didanosine
416105|NCT00000772|Drug Therapy, Combination|drug therapy, combination
416106|NCT00000772|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416107|NCT00000772|AIDS-Related Complex|aids-related complex
416108|NCT00000773|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
416109|NCT00000773|Antifungal Agents|antifungal agents
416964|NCT00000903|Nelfinavir|nelfinavir
416110|NCT00000773|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416111|NCT00000773|AIDS-Related Complex|aids-related complex
416112|NCT00000773|Biological Availability|biological availability
416113|NCT00000773|atovaquone|atovaquone
416114|NCT00000774|Vaccines, Synthetic|vaccines, synthetic
416115|NCT00000774|Virus Replication|virus replication
416116|NCT00000774|HIV Envelope Protein gp120|hiv envelope protein gp120
416117|NCT00000774|AIDS Vaccines|aids vaccines
416118|NCT00000774|HIV Preventive Vaccine|hiv preventive vaccine
416119|NCT00000774|HIV Therapeutic Vaccine|hiv therapeutic vaccine
416120|NCT00000775|Vaccines, Synthetic|vaccines, synthetic
416121|NCT00000775|HIV-1|hiv-1
416122|NCT00000775|HIV Envelope Protein gp120|hiv envelope protein gp120
416123|NCT00000775|AIDS Vaccines|aids vaccines
416124|NCT00000775|HIV Seronegativity|hiv seronegativity
416125|NCT00000775|HIV Preventive Vaccine|hiv preventive vaccine
416126|NCT00000776|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
416127|NCT00000776|Meningitis|meningitis
416128|NCT00000776|Cryptococcosis|cryptococcosis
416129|NCT00000776|Dexamethasone|dexamethasone
416130|NCT00000776|Drug Therapy, Combination|drug therapy, combination
416131|NCT00000776|Fluconazole|fluconazole
416132|NCT00000776|Flucytosine|flucytosine
416133|NCT00000776|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416134|NCT00000776|Amphotericin B|amphotericin b
416135|NCT00000776|Brain Diseases|brain diseases
416136|NCT00000777|Vaccines, Synthetic|vaccines, synthetic
416137|NCT00000777|Pregnancy|pregnancy
416138|NCT00000777|Pregnancy Complications, Infectious|pregnancy complications, infectious
416139|NCT00000777|HIV Envelope Protein gp160|hiv envelope protein gp160
416140|NCT00000777|AIDS Vaccines|aids vaccines
416141|NCT00000777|HIV Preventive Vaccine|hiv preventive vaccine
416142|NCT00000777|HIV Therapeutic Vaccine|hiv therapeutic vaccine
416143|NCT00000778|Isoniazid|isoniazid
416144|NCT00000778|Tuberculosis, Pulmonary|tuberculosis, pulmonary
416145|NCT00000778|Pyridoxine|pyridoxine
416146|NCT00000778|Ofloxacin|ofloxacin
416147|NCT00000778|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
416148|NCT00000778|Drug Evaluation|drug evaluation
416149|NCT00000778|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416151|NCT00000778|Colony Count, Microbial|colony count, microbial
416152|NCT00000779|Vaccines, Synthetic|vaccines, synthetic
416153|NCT00000779|HIV-1|hiv-1
416154|NCT00000779|Adjuvants, Immunologic|adjuvants, immunologic
416155|NCT00000779|AIDS-Related Complex|aids-related complex
750142|NCT01163903|PANTO IV|panto iv
416156|NCT00000779|HIV Envelope Protein gp120|hiv envelope protein gp120
416157|NCT00000779|AIDS Vaccines|aids vaccines
416158|NCT00000779|HIV Therapeutic Vaccine|hiv therapeutic vaccine
416159|NCT00000780|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416160|NCT00000780|AIDS-Related Complex|aids-related complex
416161|NCT00000780|Adolescent Behavior|adolescent behavior
416162|NCT00000781|Zalcitabine|zalcitabine
416163|NCT00000781|Didanosine|didanosine
416164|NCT00000781|Drug Therapy, Combination|drug therapy, combination
416165|NCT00000781|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416166|NCT00000781|Zidovudine|zidovudine
416167|NCT00000781|Nevirapine|nevirapine
416168|NCT00000782|Vaccines, Synthetic|vaccines, synthetic
416169|NCT00000782|Injections, Intradermal|injections, intradermal
416170|NCT00000782|HIV Antigens|hiv antigens
416171|NCT00000782|HIV-1|hiv-1
416172|NCT00000782|HIV Envelope Protein gp160|hiv envelope protein gp160
416173|NCT00000782|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416174|NCT00000782|AIDS-Related Complex|aids-related complex
416175|NCT00000782|Hypersensitivity, Delayed|hypersensitivity, delayed
416176|NCT00000782|AIDS Vaccines|aids vaccines
416177|NCT00000782|HIV Therapeutic Vaccine|hiv therapeutic vaccine
416178|NCT00000783|Sex Behavior|sex behavior
416179|NCT00000783|Sexual Partners|sexual partners
416180|NCT00000784|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416181|NCT00000784|AIDS-Related Complex|aids-related complex
416182|NCT00000785|Tuberculosis|tuberculosis
416183|NCT00000785|Mycobacterium tuberculosis|mycobacterium tuberculosis
416184|NCT00000785|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
416185|NCT00000785|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416186|NCT00000785|Drug Resistance, Microbial|drug resistance, microbial
416187|NCT00000787|Sex Behavior|sex behavior
416188|NCT00000788|Methadone|methadone
416189|NCT00000788|Drug Interactions|drug interactions
416190|NCT00000788|Drug Therapy, Combination|drug therapy, combination
416191|NCT00000788|Fluconazole|fluconazole
416192|NCT00000788|Antifungal Agents|antifungal agents
416193|NCT00000788|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416194|NCT00000788|AIDS-Related Complex|aids-related complex
416195|NCT00000789|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416196|NCT00000789|AIDS-Related Complex|aids-related complex
416197|NCT00000789|Zidovudine|zidovudine
416198|NCT00000789|Stavudine|stavudine
416199|NCT00000790|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416200|NCT00000790|AIDS-Related Complex|aids-related complex
416201|NCT00000790|Thalidomide|thalidomide
416965|NCT00000903|efavirenz|efavirenz
416202|NCT00000790|Stomatitis, Aphthous|stomatitis, aphthous
416203|NCT00000791|Drug Therapy, Combination|drug therapy, combination
416204|NCT00000791|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416205|NCT00000791|AIDS-Related Complex|aids-related complex
416206|NCT00000791|Antiviral Agents|antiviral agents
416207|NCT00000791|Zidovudine|zidovudine
416208|NCT00000792|Administration, Oral|administration, oral
415368|NCT00000640|Dapsone|dapsone
416209|NCT00000792|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416210|NCT00000792|AIDS-Related Complex|aids-related complex
416211|NCT00000792|Antiviral Agents|antiviral agents
416212|NCT00000793|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416213|NCT00000793|AIDS-Related Complex|aids-related complex
416214|NCT00000793|Peripheral Nervous System Diseases|peripheral nervous system diseases
416215|NCT00000793|Amitriptyline|amitriptyline
416216|NCT00000793|Pain|pain
416217|NCT00000793|Mexiletine|mexiletine
416218|NCT00000793|benzatropine methanesulfonate|benzatropine methanesulfonate
416219|NCT00000793|Parasympatholytics|parasympatholytics
416220|NCT00000794|Pyrimethamine|pyrimethamine
416221|NCT00000794|Leucovorin|leucovorin
416222|NCT00000794|Drug Therapy, Combination|drug therapy, combination
416223|NCT00000794|Encephalitis|encephalitis
416224|NCT00000794|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416225|NCT00000794|Antiprotozoal Agents|antiprotozoal agents
416226|NCT00000794|Clarithromycin|clarithromycin
416227|NCT00000794|atovaquone|atovaquone
416228|NCT00000794|Toxoplasmosis, Cerebral|toxoplasmosis, cerebral
416229|NCT00000794|Sulfadiazine|sulfadiazine
416230|NCT00000795|Vaccines, Synthetic|vaccines, synthetic
416231|NCT00000795|HIV-1|hiv-1
416232|NCT00000795|AIDS Vaccines|aids vaccines
416233|NCT00000795|HIV Seronegativity|hiv seronegativity
416234|NCT00000795|HIV Preventive Vaccine|hiv preventive vaccine
416235|NCT00000796|Isoniazid|isoniazid
416236|NCT00000796|Tuberculosis, Pulmonary|tuberculosis, pulmonary
416237|NCT00000796|Pyrazinamide|pyrazinamide
416238|NCT00000796|Pyridoxine|pyridoxine
416239|NCT00000796|Ofloxacin|ofloxacin
416240|NCT00000796|Rifampin|rifampin
416241|NCT00000796|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
416242|NCT00000796|Drug Therapy, Combination|drug therapy, combination
416243|NCT00000796|Ethambutol|ethambutol
416244|NCT00000796|Clofazimine|clofazimine
416245|NCT00000796|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416246|NCT00000796|Amikacin|amikacin
416247|NCT00000796|Drug Resistance, Microbial|drug resistance, microbial
416248|NCT00000796|Cycloserine|cycloserine
416249|NCT00000796|Capreomycin Sulfate|capreomycin sulfate
416250|NCT00000796|Ethionamide|ethionamide
416251|NCT00000796|Aminosalicylic Acids|aminosalicylic acids
416252|NCT00000796|Streptomycin|streptomycin
416253|NCT00000796|p-Aminosalicylic Acid|p-aminosalicylic acid
416254|NCT00000798|Vaccines, Synthetic|vaccines, synthetic
416255|NCT00000798|HIV-1|hiv-1
416256|NCT00000798|Administration, Oral|administration, oral
416257|NCT00000798|AIDS Vaccines|aids vaccines
416258|NCT00000798|HIV Seronegativity|hiv seronegativity
416259|NCT00000798|HIV Preventive Vaccine|hiv preventive vaccine
416260|NCT00000799|Retinitis|retinitis
416261|NCT00000799|Cytomegalovirus Infections|cytomegalovirus infections
416262|NCT00000799|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416263|NCT00000799|Antiviral Agents|antiviral agents
416264|NCT00000799|cidofovir|cidofovir
416265|NCT00000800|Methadone|methadone
416266|NCT00000800|Drug Interactions|drug interactions
416267|NCT00000800|Drug Therapy, Combination|drug therapy, combination
416268|NCT00000800|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416269|NCT00000800|AIDS-Related Complex|aids-related complex
416270|NCT00000800|Zidovudine|zidovudine
416271|NCT00000801|Vincristine|vincristine
416272|NCT00000801|Cyclophosphamide|cyclophosphamide
416274|NCT00000801|Dexamethasone|dexamethasone
416275|NCT00000801|Doxorubicin|doxorubicin
416276|NCT00000801|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
416277|NCT00000801|Combined Modality Therapy|combined modality therapy
416278|NCT00000801|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416279|NCT00000801|Antineoplastic Agents, Combined|antineoplastic agents, combined
416280|NCT00000801|Brain Neoplasms|brain neoplasms
416281|NCT00000801|Lymphoma, High-Grade|lymphoma, high-grade
416282|NCT00000801|Lymphoma, Intermediate-Grade|lymphoma, intermediate-grade
416283|NCT00000802|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
416284|NCT00000802|Dapsone|dapsone
416285|NCT00000802|Antifungal Agents|antifungal agents
416286|NCT00000802|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416287|NCT00000802|atovaquone|atovaquone
416288|NCT00000803|Didanosine|didanosine
416289|NCT00000803|Drug Therapy, Combination|drug therapy, combination
416290|NCT00000803|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416291|NCT00000803|AIDS-Related Complex|aids-related complex
416292|NCT00000803|Antiviral Agents|antiviral agents
416293|NCT00000803|Zidovudine|zidovudine
416294|NCT00000805|Ganciclovir|ganciclovir
416295|NCT00000805|Cytomegalovirus Infections|cytomegalovirus infections
416296|NCT00000805|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416297|NCT00000806|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416298|NCT00000806|AIDS-Related Complex|aids-related complex
416299|NCT00000806|HIV Protease Inhibitors|hiv protease inhibitors
416300|NCT00000807|Sarcoma, Kaposi|sarcoma, kaposi
416301|NCT00000807|Etoposide|etoposide
416302|NCT00000807|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416303|NCT00000808|Pregnancy|pregnancy
416304|NCT00000808|Pregnancy Complications, Infectious|pregnancy complications, infectious
416305|NCT00000808|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416306|NCT00000808|AIDS-Related Complex|aids-related complex
416307|NCT00000808|Nevirapine|nevirapine
416308|NCT00000809|HIV Preventive Vaccine|hiv preventive vaccine
416309|NCT00000809|HIV Therapeutic Vaccine|hiv therapeutic vaccine
416310|NCT00000810|Didanosine|didanosine
416311|NCT00000810|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416312|NCT00000810|AIDS-Related Complex|aids-related complex
416313|NCT00000810|Antiviral Agents|antiviral agents
416314|NCT00000810|Zidovudine|zidovudine
416315|NCT00000811|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
416316|NCT00000811|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
416317|NCT00000811|Drug Therapy, Combination|drug therapy, combination
416318|NCT00000811|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416319|NCT00000811|Antiprotozoal Agents|antiprotozoal agents
416320|NCT00000811|AIDS-Related Complex|aids-related complex
416321|NCT00000811|Azithromycin|azithromycin
416322|NCT00000811|Bacterial Infections|bacterial infections
416323|NCT00000811|atovaquone|atovaquone
416324|NCT00000812|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416325|NCT00000812|AIDS-Related Complex|aids-related complex
416326|NCT00000812|Thalidomide|thalidomide
416327|NCT00000813|Vaccines, Synthetic|vaccines, synthetic
416328|NCT00000813|HIV Envelope Protein gp160|hiv envelope protein gp160
416329|NCT00000813|HIV Envelope Protein gp120|hiv envelope protein gp120
416330|NCT00000813|AIDS Vaccines|aids vaccines
416331|NCT00000813|HIV Seronegativity|hiv seronegativity
416332|NCT00000813|Avipoxvirus|avipoxvirus
416333|NCT00000813|HIV Preventive Vaccine|hiv preventive vaccine
416334|NCT00000814|Didanosine|didanosine
416335|NCT00000814|Drug Therapy, Combination|drug therapy, combination
584765|NCT00509743|Adult volunteers|adult volunteers
416336|NCT00000814|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416337|NCT00000814|AIDS-Related Complex|aids-related complex
416338|NCT00000814|Zidovudine|zidovudine
416339|NCT00000814|Nevirapine|nevirapine
416340|NCT00000815|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416341|NCT00000815|AIDS-Related Complex|aids-related complex
416342|NCT00000815|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
416343|NCT00000815|Vaccines, Attenuated|vaccines, attenuated
416344|NCT00000815|Measles Vaccine|measles vaccine
416345|NCT00000815|Immunization Schedule|immunization schedule
416346|NCT00000815|Measles Virus|measles virus
416347|NCT00000815|Measles|measles
416348|NCT00000816|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
416349|NCT00000816|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
416350|NCT00000816|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416351|NCT00000816|AIDS-Related Complex|aids-related complex
416352|NCT00000816|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
416353|NCT00000817|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416354|NCT00000817|AIDS-Related Complex|aids-related complex
416355|NCT00000817|Peripheral Nervous System Diseases|peripheral nervous system diseases
416356|NCT00000817|Amitriptyline|amitriptyline
416357|NCT00000817|Pain|pain
416358|NCT00000817|Acupuncture Therapy|acupuncture therapy
416359|NCT00000818|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416360|NCT00000818|AIDS-Related Complex|aids-related complex
416361|NCT00000818|Zidovudine|zidovudine
416362|NCT00000818|Lymph Nodes|lymph nodes
416363|NCT00000818|Lymphoid Tissue|lymphoid tissue
416364|NCT00000819|AIDS-Related Complex|aids-related complex
416365|NCT00000819|Prednisone|prednisone
416366|NCT00000819|AIDS-Associated Nephropathy|aids-associated nephropathy
416367|NCT00000820|Interleukin-2|interleukin-2
416368|NCT00000820|Drug Therapy, Combination|drug therapy, combination
416369|NCT00000820|AIDS-Related Complex|aids-related complex
416370|NCT00000820|Antiviral Agents|antiviral agents
416371|NCT00000821|Interleukin-2|interleukin-2
416372|NCT00000821|AIDS-Related Complex|aids-related complex
416373|NCT00000822|Vaccines, Synthetic|vaccines, synthetic
416374|NCT00000822|Didanosine|didanosine
416375|NCT00000822|Drug Therapy, Combination|drug therapy, combination
416376|NCT00000822|HIV Envelope Protein gp160|hiv envelope protein gp160
416377|NCT00000822|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416378|NCT00000822|AIDS-Related Complex|aids-related complex
416379|NCT00000822|Stavudine|stavudine
416380|NCT00000822|HIV Protease Inhibitors|hiv protease inhibitors
416381|NCT00000822|AIDS Vaccines|aids vaccines
416382|NCT00000822|Ritonavir|ritonavir
416383|NCT00000822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
417834|NCT00001122|Stavudine|stavudine
416384|NCT00000822|HIV Therapeutic Vaccine|hiv therapeutic vaccine
416385|NCT00000823|Didanosine|didanosine
416386|NCT00000823|Drug Therapy, Combination|drug therapy, combination
416387|NCT00000823|Zidovudine|zidovudine
416388|NCT00000823|Drug Administration Schedule|drug administration schedule
416389|NCT00000824|Immunotherapy, Adoptive|immunotherapy, adoptive
416390|NCT00000824|T-Lymphocyte Subsets|t-lymphocyte subsets
416391|NCT00000824|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
416392|NCT00000824|Dendritic Cells|dendritic cells
416393|NCT00000825|HIV-1|hiv-1
416394|NCT00000825|Interleukin-2|interleukin-2
416395|NCT00000825|Dose-Response Relationship, Drug|dose-response relationship, drug
416396|NCT00000825|Antiviral Agents|antiviral agents
416397|NCT00000825|CD4 Lymphocyte Count|cd4 lymphocyte count
416398|NCT00000825|DNA, Viral|dna, viral
416399|NCT00000826|Rifabutin|rifabutin
416400|NCT00000826|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
416401|NCT00000826|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
416402|NCT00000826|Dapsone|dapsone
416403|NCT00000826|Drug Interactions|drug interactions
416404|NCT00000826|Fluconazole|fluconazole
416405|NCT00000826|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416406|NCT00000826|AIDS-Related Complex|aids-related complex
416407|NCT00000826|Clarithromycin|clarithromycin
416408|NCT00000826|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
416409|NCT00000827|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416410|NCT00000827|AIDS-Related Complex|aids-related complex
416411|NCT00000827|Immunoglobulins, Intravenous|immunoglobulins, intravenous
416412|NCT00000827|Immunization, Passive|immunization, passive
416413|NCT00000828|Pregnancy|pregnancy
416414|NCT00000828|Pregnancy Complications, Infectious|pregnancy complications, infectious
416415|NCT00000828|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416416|NCT00000828|AIDS-Related Complex|aids-related complex
416417|NCT00000828|Zidovudine|zidovudine
416418|NCT00000828|Drug Resistance, Microbial|drug resistance, microbial
416419|NCT00000828|Disease Transmission, Vertical|disease transmission, vertical
416420|NCT00000829|Vaccines, Synthetic|vaccines, synthetic
416421|NCT00000829|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
750143|NCT01163903|Adriamycin|adriamycin
416422|NCT00000829|AIDS-Related Complex|aids-related complex
416423|NCT00000829|Pneumococcal Infections|pneumococcal infections
416424|NCT00000829|Bacterial Vaccines|bacterial vaccines
416425|NCT00000831|Didanosine|didanosine
416426|NCT00000831|Drug Therapy, Combination|drug therapy, combination
416427|NCT00000831|AIDS-Related Complex|aids-related complex
416428|NCT00000831|Antiviral Agents|antiviral agents
416429|NCT00000831|Zidovudine|zidovudine
416430|NCT00000831|Stavudine|stavudine
416431|NCT00000831|Lamivudine|lamivudine
416432|NCT00000831|Drug Combinations|drug combinations
416433|NCT00000832|Vaccines, Synthetic|vaccines, synthetic
416434|NCT00000832|HIV-1|hiv-1
416435|NCT00000832|Adjuvants, Immunologic|adjuvants, immunologic
416436|NCT00000832|HIV Envelope Protein gp120|hiv envelope protein gp120
416437|NCT00000832|AIDS Vaccines|aids vaccines
416438|NCT00000832|HIV Seronegativity|hiv seronegativity
416439|NCT00000832|HIV Preventive Vaccine|hiv preventive vaccine
416440|NCT00000833|Ribavirin|ribavirin
416441|NCT00000833|Didanosine|didanosine
416442|NCT00000833|Drug Therapy, Combination|drug therapy, combination
416443|NCT00000833|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416444|NCT00000833|AIDS-Related Complex|aids-related complex
416445|NCT00000833|Antiviral Agents|antiviral agents
416446|NCT00000834|Methotrexate|methotrexate
416447|NCT00000834|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416448|NCT00000834|AIDS-Related Complex|aids-related complex
416449|NCT00000834|Zidovudine|zidovudine
416450|NCT00000834|Lamivudine|lamivudine
416451|NCT00000834|Disease Progression|disease progression
416453|NCT00000834|Anti-HIV Agents|anti-hiv agents
416454|NCT00000836|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
416455|NCT00000836|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416456|NCT00000836|Antibodies, Monoclonal|antibodies, monoclonal
416457|NCT00000836|Cytomegalovirus Retinitis|cytomegalovirus retinitis
416458|NCT00000837|Herpesvirus 3, Human|herpesvirus 3, human
416459|NCT00000837|Viral Vaccines|viral vaccines
416460|NCT00000837|AIDS-Related Complex|aids-related complex
416461|NCT00000837|Vaccines, Attenuated|vaccines, attenuated
416462|NCT00000837|Chickenpox|chickenpox
416463|NCT00000837|Chickenpox Vaccine|chickenpox vaccine
416464|NCT00000838|Didanosine|didanosine
416465|NCT00000838|Drug Therapy, Combination|drug therapy, combination
416466|NCT00000838|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416467|NCT00000838|AIDS-Related Complex|aids-related complex
416468|NCT00000838|Antiviral Agents|antiviral agents
416469|NCT00000838|Zidovudine|zidovudine
416470|NCT00000838|Stavudine|stavudine
416471|NCT00000838|Lamivudine|lamivudine
416472|NCT00000839|Pregnancy Trimester, Third|pregnancy trimester, third
416473|NCT00000839|Pregnancy|pregnancy
416474|NCT00000839|Pregnancy Complications, Infectious|pregnancy complications, infectious
416475|NCT00000839|Didanosine|didanosine
416476|NCT00000839|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416477|NCT00000839|AIDS-Related Complex|aids-related complex
416478|NCT00000840|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416479|NCT00000840|AIDS-Related Complex|aids-related complex
416480|NCT00000840|Antiviral Agents|antiviral agents
416481|NCT00000840|Zidovudine|zidovudine
416482|NCT00000840|Biological Markers|biological markers
416483|NCT00000840|Viremia|viremia
416484|NCT00000840|RNA, Viral|rna, viral
416485|NCT00000841|Drug Therapy, Combination|drug therapy, combination
416486|NCT00000841|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416487|NCT00000841|Antiviral Agents|antiviral agents
416488|NCT00000841|Zidovudine|zidovudine
416489|NCT00000841|Stavudine|stavudine
416490|NCT00000841|HIV Protease Inhibitors|hiv protease inhibitors
416491|NCT00000841|Lamivudine|lamivudine
416492|NCT00000841|Indinavir|indinavir
416493|NCT00000842|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416494|NCT00000842|AIDS-Related Complex|aids-related complex
416495|NCT00000842|Peripheral Nervous System Diseases|peripheral nervous system diseases
416496|NCT00000842|Nerve Growth Factors|nerve growth factors
416497|NCT00000842|Growth Substances|growth substances
416498|NCT00000843|Antiviral Agents|antiviral agents
416499|NCT00000843|Adenine|adenine
416500|NCT00000844|Drug Therapy, Combination|drug therapy, combination
416501|NCT00000844|Adjuvants, Immunologic|adjuvants, immunologic
416502|NCT00000844|Administration, Oral|administration, oral
416503|NCT00000844|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416504|NCT00000844|AIDS-Related Complex|aids-related complex
416505|NCT00000844|Interferon-alpha|interferon-alpha
416506|NCT00000845|Vaccines, Synthetic|vaccines, synthetic
416507|NCT00000845|AIDS Vaccines|aids vaccines
416508|NCT00000845|HIV Seronegativity|hiv seronegativity
416509|NCT00000845|HIV Preventive Vaccine|hiv preventive vaccine
416510|NCT00000846|Vaccines, Synthetic|vaccines, synthetic
416512|NCT00000846|AIDS Vaccines|aids vaccines
416513|NCT00000846|HIV Seronegativity|hiv seronegativity
416514|NCT00000846|HIV Preventive Vaccine|hiv preventive vaccine
416515|NCT00000847|Vaccines, Synthetic|vaccines, synthetic
416516|NCT00000847|HIV Envelope Protein gp120|hiv envelope protein gp120
416517|NCT00000847|AIDS Vaccines|aids vaccines
416518|NCT00000847|HIV Seronegativity|hiv seronegativity
416519|NCT00000847|Avipoxvirus|avipoxvirus
416520|NCT00000847|HIV Preventive Vaccine|hiv preventive vaccine
416521|NCT00000848|Administration, Oral|administration, oral
416522|NCT00000848|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416523|NCT00000848|AIDS-Related Complex|aids-related complex
416524|NCT00000848|Antiviral Agents|antiviral agents
416525|NCT00000848|HIV Protease Inhibitors|hiv protease inhibitors
416526|NCT00000848|Biological Markers|biological markers
416527|NCT00000848|Indinavir|indinavir
416529|NCT00000848|RNA, Viral|rna, viral
416530|NCT00000848|Saquinavir|saquinavir
416531|NCT00000849|Interleukin-2|interleukin-2
416532|NCT00000849|Immunity, Cellular|immunity, cellular
416533|NCT00000849|Dose-Response Relationship, Drug|dose-response relationship, drug
416534|NCT00000849|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416535|NCT00000849|AIDS-Related Complex|aids-related complex
416536|NCT00000849|Viral Load|viral load
416537|NCT00000850|HIV-1|hiv-1
416538|NCT00000850|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
416539|NCT00000850|RNA, Viral|rna, viral
416540|NCT00000850|Anti-HIV Agents|anti-hiv agents
416541|NCT00000850|Viral Load|viral load
416542|NCT00000850|Receptors, Chemokine|receptors, chemokine
416543|NCT00000851|Didanosine|didanosine
416544|NCT00000851|Drug Therapy, Combination|drug therapy, combination
416545|NCT00000851|Antiviral Agents|antiviral agents
416547|NCT00000852|T-Lymphocytes|t-lymphocytes
416548|NCT00000852|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416549|NCT00000852|Transplantation, Homologous|transplantation, homologous
416550|NCT00000852|Immunotherapy, Adoptive|immunotherapy, adoptive
416551|NCT00000853|Vaccines, Synthetic|vaccines, synthetic
416552|NCT00000853|HIV-1|hiv-1
416553|NCT00000853|HIV Envelope Protein gp120|hiv envelope protein gp120
416554|NCT00000853|AIDS Vaccines|aids vaccines
416555|NCT00000853|HIV Seronegativity|hiv seronegativity
416556|NCT00000853|HIV Preventive Vaccine|hiv preventive vaccine
416557|NCT00000854|Placebos|placebos
416558|NCT00000854|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416559|NCT00000854|AIDS-Related Complex|aids-related complex
416560|NCT00000854|Anabolic Steroids|anabolic steroids
416561|NCT00000854|HIV Wasting Syndrome|hiv wasting syndrome
416562|NCT00000854|nandrolone decanoate|nandrolone decanoate
416563|NCT00000855|Zidovudine|zidovudine
416564|NCT00000855|Anti-HIV Agents|anti-hiv agents
416565|NCT00000856|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
416566|NCT00000856|Ganciclovir|ganciclovir
416567|NCT00000856|Drug Therapy, Combination|drug therapy, combination
416568|NCT00000856|Encephalitis|encephalitis
416569|NCT00000856|Foscarnet|foscarnet
416570|NCT00000856|Cytomegalovirus Infections|cytomegalovirus infections
416571|NCT00000856|Antiviral Agents|antiviral agents
416572|NCT00000856|Radiculopathy|radiculopathy
416573|NCT00000857|Recombinant Proteins|recombinant proteins
416574|NCT00000857|T-Lymphocytes|t-lymphocytes
416575|NCT00000857|Dose-Response Relationship, Drug|dose-response relationship, drug
416576|NCT00000857|Mycobacterium avium Complex|mycobacterium avium complex
416577|NCT00000857|CD4 Lymphocyte Count|cd4 lymphocyte count
416578|NCT00000857|Interleukin-12|interleukin-12
416579|NCT00000857|Killer Cells, Natural|killer cells, natural
416580|NCT00000857|Th1 Cells|th1 cells
416581|NCT00000857|Interferon Type II|interferon type ii
416582|NCT00000858|HIV-1|hiv-1
416583|NCT00000858|Vagina|vagina
416584|NCT00000859|HIV-1|hiv-1
416585|NCT00000859|Drug Resistance|drug resistance
416586|NCT00000859|Drug Therapy, Combination|drug therapy, combination
416587|NCT00000859|HIV Protease Inhibitors|hiv protease inhibitors
416588|NCT00000859|CD4 Lymphocyte Count|cd4 lymphocyte count
416589|NCT00000859|Ritonavir|ritonavir
416590|NCT00000859|Indinavir|indinavir
416591|NCT00000859|Disease Progression|disease progression
416592|NCT00000859|RNA, Viral|rna, viral
416593|NCT00000859|Genotype|genotype
416594|NCT00000859|Nelfinavir|nelfinavir
416595|NCT00000859|Anti-HIV Agents|anti-hiv agents
416596|NCT00000859|Viral Load|viral load
416597|NCT00000860|Tumor Necrosis Factor|tumor necrosis factor
416598|NCT00000860|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
416599|NCT00000860|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
416600|NCT00000860|Drug Therapy, Combination|drug therapy, combination
416601|NCT00000860|Anti-HIV Agents|anti-hiv agents
416602|NCT00000861|Drug Administration Schedule|drug administration schedule
416603|NCT00000861|HIV Protease Inhibitors|hiv protease inhibitors
416604|NCT00000861|CD4 Lymphocyte Count|cd4 lymphocyte count
416605|NCT00000861|Indinavir|indinavir
416606|NCT00000861|RNA, Viral|rna, viral
416607|NCT00000861|Anti-HIV Agents|anti-hiv agents
416609|NCT00000862|Pregnancy|pregnancy
416610|NCT00000862|Pregnancy Complications, Infectious|pregnancy complications, infectious
416611|NCT00000862|Administration, Oral|administration, oral
416612|NCT00000862|Zidovudine|zidovudine
416613|NCT00000862|Delivery|delivery
416614|NCT00000862|Labor|labor
416615|NCT00000862|Anti-HIV Agents|anti-hiv agents
416616|NCT00000863|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
416617|NCT00000863|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
416618|NCT00000863|Administration, Oral|administration, oral
416619|NCT00000863|WR 6026|wr 6026
416620|NCT00000864|Pregnancy|pregnancy
416621|NCT00000864|Pregnancy Complications, Infectious|pregnancy complications, infectious
416622|NCT00000864|HIV-1|hiv-1
416623|NCT00000864|Drug Therapy, Combination|drug therapy, combination
416624|NCT00000864|Zidovudine|zidovudine
416625|NCT00000864|Drug Administration Schedule|drug administration schedule
416626|NCT00000864|Disease Transmission, Vertical|disease transmission, vertical
416627|NCT00000864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
416628|NCT00000864|Anti-HIV Agents|anti-hiv agents
416629|NCT00000865|Drug Therapy, Combination|drug therapy, combination
416630|NCT00000865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
416631|NCT00000865|Anti-HIV Agents|anti-hiv agents
416632|NCT00000866|Vaccines, Synthetic|vaccines, synthetic
416633|NCT00000866|Vaccinia Virus|vaccinia virus
416634|NCT00000866|Placebos|placebos
416635|NCT00000866|HIV-1|hiv-1
416636|NCT00000866|AIDS Vaccines|aids vaccines
416637|NCT00000866|HIV Seronegativity|hiv seronegativity
416638|NCT00000866|Genes, env|genes, env
416639|NCT00000866|Genes, pol|genes, pol
416640|NCT00000866|Genes, gag|genes, gag
416641|NCT00000866|HIV Preventive Vaccine|hiv preventive vaccine
416642|NCT00000867|Drug Therapy, Combination|drug therapy, combination
416643|NCT00000867|Administration, Oral|administration, oral
416644|NCT00000867|AIDS Dementia Complex|aids dementia complex
416645|NCT00000867|Zidovudine|zidovudine
416646|NCT00000867|Anti-HIV Agents|anti-hiv agents
416647|NCT00000867|Memantine|memantine
416648|NCT00000868|Vaccines, Synthetic|vaccines, synthetic
416649|NCT00000868|HIV-1|hiv-1
416650|NCT00000868|Administration, Oral|administration, oral
416651|NCT00000868|AIDS Vaccines|aids vaccines
416652|NCT00000868|HIV Seronegativity|hiv seronegativity
416653|NCT00000868|HIV Envelope Protein gp120|hiv envelope protein gp120
416654|NCT00000868|Recombination, Genetic|recombination, genetic
416655|NCT00000868|Salmonella typhi|salmonella typhi
416656|NCT00000868|HIV Preventive Vaccine|hiv preventive vaccine
416657|NCT00000869|Pregnancy Trimester, Third|pregnancy trimester, third
416658|NCT00000869|Placebos|placebos
416659|NCT00000869|Pregnancy|pregnancy
416660|NCT00000869|Pregnancy Complications, Infectious|pregnancy complications, infectious
416661|NCT00000869|Administration, Oral|administration, oral
416662|NCT00000869|Nevirapine|nevirapine
416663|NCT00000869|Disease Transmission, Vertical|disease transmission, vertical
416664|NCT00000869|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
416665|NCT00000869|Anti-HIV Agents|anti-hiv agents
416666|NCT00000870|Recombinant Proteins|recombinant proteins
416667|NCT00000870|Infusions, Intravenous|infusions, intravenous
416668|NCT00000870|Injections, Intravenous|injections, intravenous
416669|NCT00000870|Injections, Subcutaneous|injections, subcutaneous
416670|NCT00000870|Interleukin-2|interleukin-2
416671|NCT00000870|Drug Administration Schedule|drug administration schedule
416672|NCT00000870|CD4 Lymphocyte Count|cd4 lymphocyte count
416673|NCT00000870|Quality of Life|quality of life
416674|NCT00000870|Anti-HIV Agents|anti-hiv agents
416675|NCT00000871|Vaccines, Synthetic|vaccines, synthetic
416676|NCT00000871|AIDS Vaccines|aids vaccines
416677|NCT00000871|HIV Seronegativity|hiv seronegativity
416678|NCT00000871|Avipoxvirus|avipoxvirus
416679|NCT00000871|HIV Preventive Vaccine|hiv preventive vaccine
416680|NCT00000872|Virus Replication|virus replication
416681|NCT00000872|HIV-1|hiv-1
416682|NCT00000872|Drug Therapy, Combination|drug therapy, combination
416683|NCT00000872|Zidovudine|zidovudine
416684|NCT00000872|Nevirapine|nevirapine
416685|NCT00000872|Stavudine|stavudine
416686|NCT00000872|HIV Protease Inhibitors|hiv protease inhibitors
416687|NCT00000872|CD4 Lymphocyte Count|cd4 lymphocyte count
416688|NCT00000872|Lamivudine|lamivudine
416689|NCT00000872|RNA, Viral|rna, viral
416690|NCT00000872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
416691|NCT00000872|Anti-HIV Agents|anti-hiv agents
416692|NCT00000872|Viral Load|viral load
416693|NCT00000872|Nelfinavir|nelfinavir
416694|NCT00000873|Nutritional Status|nutritional status
416695|NCT00000873|HIV Seronegativity|hiv seronegativity
416696|NCT00000873|Infant Food|infant food
416697|NCT00000874|HIV-1|hiv-1
416698|NCT00000874|Drug Therapy, Combination|drug therapy, combination
416699|NCT00000874|Zidovudine|zidovudine
416700|NCT00000874|Stavudine|stavudine
416701|NCT00000874|Drug Resistance, Microbial|drug resistance, microbial
416702|NCT00000874|HIV Protease Inhibitors|hiv protease inhibitors
416703|NCT00000874|CD4 Lymphocyte Count|cd4 lymphocyte count
416704|NCT00000874|Ritonavir|ritonavir
416705|NCT00000874|Lamivudine|lamivudine
416706|NCT00000874|Indinavir|indinavir
416707|NCT00000874|RNA, Viral|rna, viral
416708|NCT00000874|Genotype|genotype
416709|NCT00000874|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
416710|NCT00000874|Anti-HIV Agents|anti-hiv agents
416711|NCT00000874|Viral Load|viral load
416712|NCT00000875|Drug Therapy, Combination|drug therapy, combination
416713|NCT00000875|Immunotherapy, Adoptive|immunotherapy, adoptive
416714|NCT00000875|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
416715|NCT00000875|Anti-HIV Agents|anti-hiv agents
416716|NCT00000875|Viral Load|viral load
416717|NCT00000876|Antiviral Agents|antiviral agents
416718|NCT00000876|CD4-IgG(2)|cd4-igg(2)
416719|NCT00000876|PRO 542|pro 542
416720|NCT00000877|Rifabutin|rifabutin
416721|NCT00000877|Drug Therapy, Combination|drug therapy, combination
416722|NCT00000877|HIV Protease Inhibitors|hiv protease inhibitors
416723|NCT00000877|Indinavir|indinavir
416724|NCT00000877|HIV Seronegativity|hiv seronegativity
416725|NCT00000877|Anti-HIV Agents|anti-hiv agents
416726|NCT00000878|Pregnancy|pregnancy
416727|NCT00000878|Pregnancy Complications, Infectious|pregnancy complications, infectious
416728|NCT00000878|Drug Therapy, Combination|drug therapy, combination
416729|NCT00000878|Stavudine|stavudine
416730|NCT00000878|Lamivudine|lamivudine
416731|NCT00000878|Disease Transmission, Vertical|disease transmission, vertical
416732|NCT00000878|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
416733|NCT00000878|Anti-HIV Agents|anti-hiv agents
416734|NCT00000878|Viral Load|viral load
416735|NCT00000879|Pregnancy|pregnancy
416736|NCT00000879|Pregnancy Complications, Infectious|pregnancy complications, infectious
416737|NCT00000879|AIDS Vaccines|aids vaccines
416738|NCT00000879|Disease Transmission, Vertical|disease transmission, vertical
416739|NCT00000879|Avipoxvirus|avipoxvirus
416740|NCT00000879|HIV Preventive Vaccine|hiv preventive vaccine
416741|NCT00000879|HIV Therapeutic Vaccine|hiv therapeutic vaccine
416742|NCT00000880|T-Lymphocytes|t-lymphocytes
416743|NCT00000880|Lymphocyte Transformation|lymphocyte transformation
416744|NCT00000880|HIV-1|hiv-1
416745|NCT00000880|Drug Therapy, Combination|drug therapy, combination
416746|NCT00000880|Immunosuppressive Agents|immunosuppressive agents
416747|NCT00000880|Apoptosis|apoptosis
416748|NCT00000880|Cyclosporine|cyclosporine
416749|NCT00000880|Anti-HIV Agents|anti-hiv agents
416750|NCT00000881|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
416751|NCT00000881|Cytomegalovirus Infections|cytomegalovirus infections
416752|NCT00000881|Antiviral Agents|antiviral agents
416753|NCT00000881|cidofovir|cidofovir
416754|NCT00000882|HIV-1|hiv-1
416755|NCT00000882|Drug Therapy, Combination|drug therapy, combination
416756|NCT00000882|Stavudine|stavudine
416757|NCT00000882|HIV Protease Inhibitors|hiv protease inhibitors
416758|NCT00000882|Lamivudine|lamivudine
416759|NCT00000882|Indinavir|indinavir
416760|NCT00000882|RNA, Viral|rna, viral
416761|NCT00000882|Delavirdine|delavirdine
416762|NCT00000882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
416763|NCT00000882|Anti-HIV Agents|anti-hiv agents
416764|NCT00000882|Viral Load|viral load
416765|NCT00000883|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
416766|NCT00000883|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
416767|NCT00000883|Antibiotics, Macrolide|antibiotics, macrolide
416768|NCT00000883|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416769|NCT00000883|Azithromycin|azithromycin
416770|NCT00000883|CD4 Lymphocyte Count|cd4 lymphocyte count
416771|NCT00000883|Anti-HIV Agents|anti-hiv agents
416772|NCT00000884|Vaccines, Synthetic|vaccines, synthetic
416773|NCT00000884|Injections, Intramuscular|injections, intramuscular
416774|NCT00000884|HIV-1|hiv-1
416775|NCT00000884|Immunity, Cellular|immunity, cellular
416776|NCT00000884|AIDS Vaccines|aids vaccines
416777|NCT00000884|HIV Seronegativity|hiv seronegativity
416778|NCT00000884|Mucous Membrane|mucous membrane
416779|NCT00000884|Antibodies, Viral|antibodies, viral
416780|NCT00000884|Avipoxvirus|avipoxvirus
416781|NCT00000884|Genetic Vectors|genetic vectors
416782|NCT00000884|HIV Envelope Protein gp120|hiv envelope protein gp120
416783|NCT00000884|Immunity, Mucosal|immunity, mucosal
416784|NCT00000884|Rabies Vaccines|rabies vaccines
416785|NCT00000884|HIV Preventive Vaccine|hiv preventive vaccine
416786|NCT00000885|HIV-1|hiv-1
416787|NCT00000885|Drug Therapy, Combination|drug therapy, combination
416788|NCT00000885|Zidovudine|zidovudine
416789|NCT00000885|HIV Protease Inhibitors|hiv protease inhibitors
416790|NCT00000885|Lamivudine|lamivudine
416791|NCT00000885|Indinavir|indinavir
416792|NCT00000885|RNA, Viral|rna, viral
416793|NCT00000885|Treatment Failure|treatment failure
416794|NCT00000885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
416795|NCT00000885|Anti-HIV Agents|anti-hiv agents
416796|NCT00000885|Viral Load|viral load
416797|NCT00000886|HIV Antibodies|hiv antibodies
416798|NCT00000886|HIV Envelope Protein gp120|hiv envelope protein gp120
416799|NCT00000886|Drug Carriers|drug carriers
416800|NCT00000886|Hypersensitivity, Delayed|hypersensitivity, delayed
416801|NCT00000886|AIDS Vaccines|aids vaccines
416802|NCT00000886|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
416803|NCT00000886|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
416804|NCT00000886|HIV Seronegativity|hiv seronegativity
416805|NCT00000886|Neutralization Tests|neutralization tests
416806|NCT00000886|Mineral Oil|mineral oil
416807|NCT00000886|Oleic Acids|oleic acids
416809|NCT00000886|HLA-B7 Antigen|hla-b7 antigen
416810|NCT00000886|HLA-A2 Antigen|hla-a2 antigen
416811|NCT00000886|HIV Preventive Vaccine|hiv preventive vaccine
416812|NCT00000887|Pregnancy|pregnancy
416813|NCT00000887|Pregnancy Complications, Infectious|pregnancy complications, infectious
416814|NCT00000887|Drug Therapy, Combination|drug therapy, combination
416815|NCT00000887|Zidovudine|zidovudine
416816|NCT00000887|HIV Protease Inhibitors|hiv protease inhibitors
416817|NCT00000887|Lamivudine|lamivudine
416818|NCT00000887|Disease Transmission, Vertical|disease transmission, vertical
416819|NCT00000887|Nelfinavir|nelfinavir
416820|NCT00000887|Anti-HIV Agents|anti-hiv agents
416821|NCT00000888|Pregnancy|pregnancy
416822|NCT00000888|Pregnancy Complications, Infectious|pregnancy complications, infectious
416823|NCT00000888|Drug Therapy, Combination|drug therapy, combination
416824|NCT00000888|Administration, Oral|administration, oral
416825|NCT00000888|Zidovudine|zidovudine
416826|NCT00000888|HIV Protease Inhibitors|hiv protease inhibitors
416827|NCT00000888|Ritonavir|ritonavir
416828|NCT00000888|Disease Transmission, Vertical|disease transmission, vertical
416829|NCT00000888|Anti-HIV Agents|anti-hiv agents
416830|NCT00000888|Fetal Blood|fetal blood
416831|NCT00000889|Interleukin-2|interleukin-2
416832|NCT00000889|CD4 Lymphocyte Count|cd4 lymphocyte count
416833|NCT00000889|Anti-HIV Agents|anti-hiv agents
416834|NCT00000890|HIV-1|hiv-1
416835|NCT00000890|Muscles|muscles
416836|NCT00000890|RNA, Viral|rna, viral
416837|NCT00000890|Body Composition|body composition
416838|NCT00000890|Anti-HIV Agents|anti-hiv agents
416839|NCT00000890|Viral Load|viral load
416840|NCT00000891|Drug Therapy, Combination|drug therapy, combination
416841|NCT00000891|Hypersensitivity, Delayed|hypersensitivity, delayed
416842|NCT00000891|Follow-Up Studies|follow-up studies
416843|NCT00000891|Anti-HIV Agents|anti-hiv agents
416844|NCT00000891|Viral Load|viral load
416845|NCT00000892|HIV-1|hiv-1
416846|NCT00000892|Drug Therapy, Combination|drug therapy, combination
416847|NCT00000892|HIV Protease Inhibitors|hiv protease inhibitors
416848|NCT00000892|Ritonavir|ritonavir
416849|NCT00000892|Indinavir|indinavir
416850|NCT00000892|RNA, Viral|rna, viral
416851|NCT00000892|Saquinavir|saquinavir
416852|NCT00000892|Delavirdine|delavirdine
416853|NCT00000892|Nelfinavir|nelfinavir
416854|NCT00000892|Adenine|adenine
416855|NCT00000892|Anti-HIV Agents|anti-hiv agents
416856|NCT00000892|Viral Load|viral load
416857|NCT00000893|Dose-Response Relationship, Drug|dose-response relationship, drug
416858|NCT00000893|Drug Therapy, Combination|drug therapy, combination
416859|NCT00000893|HIV Protease Inhibitors|hiv protease inhibitors
416860|NCT00000893|Nelfinavir|nelfinavir
416861|NCT00000893|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
416862|NCT00000893|Area Under Curve|area under curve
416863|NCT00000893|efavirenz|efavirenz
416864|NCT00000894|Infusions, Intravenous|infusions, intravenous
416865|NCT00000894|Ganciclovir|ganciclovir
416866|NCT00000894|Drug Therapy, Combination|drug therapy, combination
416867|NCT00000894|Administration, Oral|administration, oral
416868|NCT00000894|Antiviral Agents|antiviral agents
416869|NCT00000894|Drug Implants|drug implants
416870|NCT00000894|Cytomegalovirus Retinitis|cytomegalovirus retinitis
416871|NCT00000894|Eye|eye
416872|NCT00000894|cidofovir|cidofovir
416873|NCT00000895|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
416874|NCT00000895|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
416875|NCT00000895|HIV-1|hiv-1
416876|NCT00000895|Drug Therapy, Combination|drug therapy, combination
416877|NCT00000895|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416878|NCT00000895|Mycobacterium avium Complex|mycobacterium avium complex
416879|NCT00000895|Bacteremia|bacteremia
416880|NCT00000895|Nevirapine|nevirapine
416881|NCT00000895|HIV Protease Inhibitors|hiv protease inhibitors
416882|NCT00000895|Risk Factors|risk factors
416883|NCT00000895|RNA, Viral|rna, viral
416884|NCT00000895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
416885|NCT00000895|Nelfinavir|nelfinavir
416886|NCT00000896|HIV-1|hiv-1
416887|NCT00000896|Drug Therapy, Combination|drug therapy, combination
416888|NCT00000896|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
416889|NCT00000896|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
416890|NCT00000896|Zidovudine|zidovudine
416891|NCT00000896|Nevirapine|nevirapine
416892|NCT00000896|Stavudine|stavudine
416893|NCT00000896|HIV Protease Inhibitors|hiv protease inhibitors
416894|NCT00000896|Lamivudine|lamivudine
416895|NCT00000896|Indinavir|indinavir
416896|NCT00000896|Interleukin-12|interleukin-12
416897|NCT00000896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
416898|NCT00000897|Drug Interactions|drug interactions
416899|NCT00000897|Zidovudine|zidovudine
416900|NCT00000897|Sex Factors|sex factors
416901|NCT00000897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
416902|NCT00000897|Contraceptives, Oral|contraceptives, oral
416903|NCT00000897|Progestational Hormones, Synthetic|progestational hormones, synthetic
416904|NCT00000897|Anti-HIV Agents|anti-hiv agents
416905|NCT00000897|Viral Load|viral load
416906|NCT00000897|Estrogens|estrogens
416907|NCT00000898|Drug Interactions|drug interactions
416908|NCT00000898|Drug Therapy, Combination|drug therapy, combination
416909|NCT00000898|Saquinavir|saquinavir
416910|NCT00000898|HIV Protease Inhibitors|hiv protease inhibitors
416911|NCT00000898|Ritonavir|ritonavir
416912|NCT00000898|Nelfinavir|nelfinavir
416913|NCT00000899|Cyclophosphamide|cyclophosphamide
416914|NCT00000899|Dose-Response Relationship, Drug|dose-response relationship, drug
416915|NCT00000899|Drug Therapy, Combination|drug therapy, combination
416916|NCT00000899|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
416917|NCT00000899|Combined Modality Therapy|combined modality therapy
416918|NCT00000899|Antineoplastic Agents|antineoplastic agents
416919|NCT00000899|Lymph Nodes|lymph nodes
416920|NCT00000899|Stavudine|stavudine
416921|NCT00000899|HIV Protease Inhibitors|hiv protease inhibitors
416922|NCT00000899|Lamivudine|lamivudine
416923|NCT00000899|DNA, Viral|dna, viral
416924|NCT00000899|RNA, Viral|rna, viral
416925|NCT00000899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
416926|NCT00000899|Anti-HIV Agents|anti-hiv agents
416927|NCT00000899|Nelfinavir|nelfinavir
416928|NCT00000899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
416929|NCT00000900|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
416930|NCT00000900|HIV-1|hiv-1
416931|NCT00000900|Antiviral Agents|antiviral agents
416932|NCT00000900|CD4 Lymphocyte Count|cd4 lymphocyte count
416933|NCT00000900|Polymerase Chain Reaction|polymerase chain reaction
416934|NCT00000900|RNA, Viral|rna, viral
416935|NCT00000900|Fever|fever
416936|NCT00000900|Viral Load|viral load
416937|NCT00000901|Dose-Response Relationship, Drug|dose-response relationship, drug
416938|NCT00000901|Drug Therapy, Combination|drug therapy, combination
416939|NCT00000901|Stavudine|stavudine
416940|NCT00000901|HIV Protease Inhibitors|hiv protease inhibitors
416941|NCT00000901|Lamivudine|lamivudine
416942|NCT00000901|Indinavir|indinavir
416943|NCT00000901|RNA, Viral|rna, viral
416944|NCT00000901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
416945|NCT00000901|Viral Load|viral load
416946|NCT00000902|Zalcitabine|zalcitabine
416947|NCT00000902|Didanosine|didanosine
416948|NCT00000902|Drug Therapy, Combination|drug therapy, combination
416949|NCT00000902|Zidovudine|zidovudine
416950|NCT00000902|Nevirapine|nevirapine
416951|NCT00000902|Stavudine|stavudine
416952|NCT00000902|Ritonavir|ritonavir
416953|NCT00000902|Lamivudine|lamivudine
416954|NCT00000902|RNA, Viral|rna, viral
416955|NCT00000902|Anti-HIV Agents|anti-hiv agents
416956|NCT00000902|Nelfinavir|nelfinavir
416957|NCT00000903|Drug Therapy, Combination|drug therapy, combination
416958|NCT00000903|Zidovudine|zidovudine
416959|NCT00000903|HIV Protease Inhibitors|hiv protease inhibitors
416960|NCT00000903|Lamivudine|lamivudine
416961|NCT00000903|Indinavir|indinavir
416962|NCT00000903|RNA, Viral|rna, viral
416963|NCT00000903|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
416966|NCT00000904|Vaccines, Synthetic|vaccines, synthetic
416967|NCT00000904|Viral Vaccines|viral vaccines
416968|NCT00000904|HIV Antibodies|hiv antibodies
416969|NCT00000904|HIV Envelope Protein gp160|hiv envelope protein gp160
416970|NCT00000904|AIDS Vaccines|aids vaccines
416971|NCT00000904|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
416972|NCT00000904|HIV Seronegativity|hiv seronegativity
416973|NCT00000904|Antibody Formation|antibody formation
416974|NCT00000904|Risk-Taking|risk-taking
416975|NCT00000904|Avipoxvirus|avipoxvirus
416976|NCT00000904|Genetic Vectors|genetic vectors
416977|NCT00000904|Immunization|immunization
416978|NCT00000904|HIV Preventive Vaccine|hiv preventive vaccine
416979|NCT00000905|Immunity, Cellular|immunity, cellular
416980|NCT00000905|Disease Progression|disease progression
416981|NCT00000905|Cytomegalovirus Retinitis|cytomegalovirus retinitis
416982|NCT00000905|DNA, Viral|dna, viral
416983|NCT00000905|Prognosis|prognosis
416984|NCT00000906|Methadone|methadone
416985|NCT00000906|HIV-1|hiv-1
416986|NCT00000906|Dose-Response Relationship, Drug|dose-response relationship, drug
416987|NCT00000906|Drug Interactions|drug interactions
416988|NCT00000906|Drug Therapy, Combination|drug therapy, combination
416989|NCT00000906|Saquinavir|saquinavir
416990|NCT00000906|Adolescent Behavior|adolescent behavior
416991|NCT00000906|HIV Protease Inhibitors|hiv protease inhibitors
416992|NCT00000906|Ritonavir|ritonavir
416993|NCT00000906|Narcotics|narcotics
416994|NCT00000906|Substance-Related Disorders|substance-related disorders
416995|NCT00000907|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
416996|NCT00000907|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
416997|NCT00000907|Immunity, Cellular|immunity, cellular
417874|NCT00001132|RNA, Viral|rna, viral
416998|NCT00000907|Antibiotics, Macrolide|antibiotics, macrolide
416999|NCT00000907|Mycobacterium avium Complex|mycobacterium avium complex
417000|NCT00000907|CD4 Lymphocyte Count|cd4 lymphocyte count
417001|NCT00000907|Disease Progression|disease progression
417002|NCT00000907|Anti-HIV Agents|anti-hiv agents
417003|NCT00000908|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
417004|NCT00000908|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
417005|NCT00000908|Antiviral Agents|antiviral agents
417006|NCT00000908|CD4 Lymphocyte Count|cd4 lymphocyte count
417007|NCT00000908|RNA, Viral|rna, viral
417008|NCT00000909|Interleukin-2|interleukin-2
417009|NCT00000909|Dose-Response Relationship, Drug|dose-response relationship, drug
417010|NCT00000909|CD4 Lymphocyte Count|cd4 lymphocyte count
417011|NCT00000909|RNA, Viral|rna, viral
417012|NCT00000910|Pregnancy|pregnancy
417013|NCT00000910|Anti-HIV Agents|anti-hiv agents
417014|NCT00000911|Semen|semen
417015|NCT00000911|HIV-1|hiv-1
417016|NCT00000911|Immunity, Cellular|immunity, cellular
417017|NCT00000911|Lymph Nodes|lymph nodes
417018|NCT00000911|Viremia|viremia
417019|NCT00000911|Antibodies, Viral|antibodies, viral
417020|NCT00000911|Vagina|vagina
417021|NCT00000911|Viral Load|viral load
417022|NCT00000911|Acute Infection|acute infection
417023|NCT00000912|Placebos|placebos
417024|NCT00000912|Drug Therapy, Combination|drug therapy, combination
417025|NCT00000912|HIV Protease Inhibitors|hiv protease inhibitors
417026|NCT00000912|VX 478|vx 478
417027|NCT00000912|Anti-HIV Agents|anti-hiv agents
417028|NCT00000912|Viral Load|viral load
417029|NCT00000912|efavirenz|efavirenz
417030|NCT00000913|Saquinavir|saquinavir
417031|NCT00000913|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
417032|NCT00000913|Anti-HIV Agents|anti-hiv agents
417033|NCT00000913|Viral Load|viral load
417034|NCT00000914|Drug Therapy, Combination|drug therapy, combination
417035|NCT00000914|HIV Protease Inhibitors|hiv protease inhibitors
417036|NCT00000914|Ritonavir|ritonavir
417037|NCT00000914|Indinavir|indinavir
417038|NCT00000914|Saquinavir|saquinavir
417039|NCT00000914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
417040|NCT00000914|Viral Load|viral load
417041|NCT00000914|Nelfinavir|nelfinavir
417042|NCT00000915|AIDS Vaccines|aids vaccines
417043|NCT00000915|Incidence|incidence
417044|NCT00000915|Knowledge, Attitudes, Practice|knowledge, attitudes, practice
417045|NCT00000915|Risk-Taking|risk-taking
417046|NCT00000916|Drug Therapy, Combination|drug therapy, combination
417047|NCT00000916|HIV Protease Inhibitors|hiv protease inhibitors
417048|NCT00000916|Hydroxyurea|hydroxyurea
417049|NCT00000916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
417050|NCT00000916|Anti-HIV Agents|anti-hiv agents
417051|NCT00000916|Viral Load|viral load
417052|NCT00000917|Gene Therapy|gene therapy
417053|NCT00000917|Specimen Handling|specimen handling
417054|NCT00000917|Blood Banks|blood banks
417055|NCT00000917|Fetal Blood|fetal blood
417056|NCT00000918|Drug Therapy, Combination|drug therapy, combination
417057|NCT00000918|HIV Protease Inhibitors|hiv protease inhibitors
417182|NCT00000943|Cell Division|cell division
417058|NCT00000918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
417059|NCT00000918|Salvage Therapy|salvage therapy
417060|NCT00000918|Anti-HIV Agents|anti-hiv agents
417061|NCT00000918|Viral Load|viral load
417062|NCT00000919|HIV Protease Inhibitors|hiv protease inhibitors
417063|NCT00000919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
417064|NCT00000919|Anti-HIV Agents|anti-hiv agents
417065|NCT00000919|Viral Load|viral load
417066|NCT00000920|Pregnancy|pregnancy
417067|NCT00000920|Drug Therapy, Combination|drug therapy, combination
417068|NCT00000920|Zidovudine|zidovudine
417069|NCT00000920|Pregnancy Complications|pregnancy complications
417070|NCT00000920|Ritonavir|ritonavir
417071|NCT00000920|Lamivudine|lamivudine
417072|NCT00000920|Saquinavir|saquinavir
417073|NCT00000920|Anti-HIV Agents|anti-hiv agents
417074|NCT00000921|Drug Therapy, Combination|drug therapy, combination
417075|NCT00000921|Prednisone|prednisone
417076|NCT00000921|Anti-HIV Agents|anti-hiv agents
417077|NCT00000922|Drug Therapy, Combination|drug therapy, combination
417078|NCT00000922|HIV Protease Inhibitors|hiv protease inhibitors
417079|NCT00000922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
417080|NCT00000922|Anti-HIV Agents|anti-hiv agents
417081|NCT00000922|Treatment Naive|treatment naive
417082|NCT00000923|Interleukin-2|interleukin-2
417083|NCT00000923|Drug Therapy, Combination|drug therapy, combination
417084|NCT00000923|CD4 Lymphocyte Count|cd4 lymphocyte count
417085|NCT00000923|Anti-HIV Agents|anti-hiv agents
417086|NCT00000923|Viral Load|viral load
417087|NCT00000924|Drug Therapy, Combination|drug therapy, combination
417088|NCT00000924|HIV Protease Inhibitors|hiv protease inhibitors
750433|NCT01165801|Size of AMD|size of amd
417089|NCT00000924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
417090|NCT00000924|Anti-HIV Agents|anti-hiv agents
417091|NCT00000925|Dietary Proteins|dietary proteins
417092|NCT00000925|HIV Wasting Syndrome|hiv wasting syndrome
417093|NCT00000926|Nonoxynol|nonoxynol
417094|NCT00000927|Administration, Topical|administration, topical
417095|NCT00000927|Mucous Membrane|mucous membrane
417096|NCT00000927|Anti-Infective Agents|anti-infective agents
417097|NCT00000927|Cervix Uteri|cervix uteri
417098|NCT00000927|Vagina|vagina
417099|NCT00000927|Vulva|vulva
417100|NCT00000927|Buffers|buffers
417101|NCT00000928|Sexual Partners|sexual partners
417102|NCT00000928|Condoms|condoms
417103|NCT00000928|Counseling|counseling
417104|NCT00000929|Sexual Partners|sexual partners
417105|NCT00000929|Homosexuality, Male|homosexuality, male
417106|NCT00000929|Anti-Infective Agents|anti-infective agents
417107|NCT00000929|Patient Compliance|patient compliance
417108|NCT00000929|Nonoxynol|nonoxynol
417109|NCT00000929|Rectum|rectum
417110|NCT00000930|Sexual Partners|sexual partners
417111|NCT00000930|Drug Resistance, Microbial|drug resistance, microbial
417112|NCT00000930|Cohort Studies|cohort studies
417113|NCT00000930|Risk Factors|risk factors
417114|NCT00000930|Substance Abuse, Intravenous|substance abuse, intravenous
417115|NCT00000930|Disease Progression|disease progression
417116|NCT00000930|Homosexuality, Male|homosexuality, male
417117|NCT00000930|Genotype|genotype
417118|NCT00000930|Phenotype|phenotype
417119|NCT00000931|Homosexuality, Male|homosexuality, male
417120|NCT00000931|Risk-Taking|risk-taking
417121|NCT00000931|Behavior Therapy|behavior therapy
417122|NCT00000931|HIV Seronegativity|hiv seronegativity
417123|NCT00000932|Prospective Studies|prospective studies
417124|NCT00000932|HIV-1|hiv-1
417125|NCT00000932|Drug Therapy, Combination|drug therapy, combination
417126|NCT00000932|Drug Resistance, Microbial|drug resistance, microbial
417127|NCT00000932|CD4 Lymphocyte Count|cd4 lymphocyte count
417128|NCT00000932|Disease Progression|disease progression
417129|NCT00000932|Treatment Outcome|treatment outcome
417130|NCT00000932|Genotype|genotype
417131|NCT00000932|Anti-HIV Agents|anti-hiv agents
417133|NCT00000933|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
417134|NCT00000933|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
417135|NCT00000933|Antibiotics, Macrolide|antibiotics, macrolide
417136|NCT00000933|Azithromycin|azithromycin
417137|NCT00000933|Drug Administration Schedule|drug administration schedule
417138|NCT00000933|Drug Resistance, Microbial|drug resistance, microbial
417139|NCT00000933|Carrier State|carrier state
417140|NCT00000933|Streptococcus pneumoniae|streptococcus pneumoniae
417141|NCT00000939|Didanosine|didanosine
417142|NCT00000939|Drug Therapy, Combination|drug therapy, combination
417143|NCT00000939|Stavudine|stavudine
417144|NCT00000939|HIV Protease Inhibitors|hiv protease inhibitors
417145|NCT00000939|Hydroxyurea|hydroxyurea
417146|NCT00000939|RNA, Viral|rna, viral
417147|NCT00000939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
417148|NCT00000939|Anti-HIV Agents|anti-hiv agents
417149|NCT00000939|Viral Load|viral load
417150|NCT00000939|efavirenz|efavirenz
417151|NCT00000940|Drug Therapy, Combination|drug therapy, combination
417152|NCT00000940|Stavudine|stavudine
417153|NCT00000940|Amprenavir/Ritonavir|amprenavir/ritonavir
417154|NCT00000940|Protease Inhibitors|protease inhibitors
417155|NCT00000940|Lamivudine|lamivudine
417156|NCT00000940|VX 478|vx 478
417157|NCT00000940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
417158|NCT00000940|Anti-HIV Agents|anti-hiv agents
417159|NCT00000940|Viral Load|viral load
417160|NCT00000940|Abacavir Sulfate|abacavir sulfate
418039|NCT00001162|Giardia|giardia
417161|NCT00000940|Acute Infection|acute infection
417162|NCT00000940|Treatment Interruption|treatment interruption
417163|NCT00000941|Drug Interactions|drug interactions
417164|NCT00000941|HIV Protease Inhibitors|hiv protease inhibitors
417165|NCT00000941|Ritonavir|ritonavir
417166|NCT00000941|HIV Seronegativity|hiv seronegativity
417167|NCT00000941|Saquinavir|saquinavir
417168|NCT00000941|Nelfinavir|nelfinavir
417169|NCT00000941|Anticholesteremic Agents|anticholesteremic agents
417170|NCT00000942|Placebos|placebos
417171|NCT00000942|Pregnancy|pregnancy
417172|NCT00000942|Pregnancy Complications, Infectious|pregnancy complications, infectious
417173|NCT00000942|Nevirapine|nevirapine
417174|NCT00000942|Disease Transmission, Vertical|disease transmission, vertical
417175|NCT00000942|Labor|labor
417176|NCT00000942|Anti-HIV Agents|anti-hiv agents
417177|NCT00000943|Lymphocytes|lymphocytes
417178|NCT00000943|Interleukin-2|interleukin-2
417179|NCT00000943|Drug Therapy, Combination|drug therapy, combination
417180|NCT00000943|AIDS Vaccines|aids vaccines
417181|NCT00000943|CD4 Lymphocyte Count|cd4 lymphocyte count
417183|NCT00000943|HIV Core Protein p24|hiv core protein p24
417184|NCT00000943|Anti-HIV Agents|anti-hiv agents
417185|NCT00000943|HIV Therapeutic Vaccine|hiv therapeutic vaccine
417186|NCT00000944|Pregnancy|pregnancy
750533|NCT01166282|enthesitis|enthesitis
417187|NCT00000944|Pregnancy Complications, Infectious|pregnancy complications, infectious
417188|NCT00000944|Drug Therapy, Combination|drug therapy, combination
417189|NCT00000944|Zidovudine|zidovudine
417190|NCT00000944|HIV Protease Inhibitors|hiv protease inhibitors
417191|NCT00000944|Lamivudine|lamivudine
417192|NCT00000944|Indinavir|indinavir
417193|NCT00000944|Disease Transmission, Vertical|disease transmission, vertical
417194|NCT00000944|Anti-HIV Agents|anti-hiv agents
417288|NCT00000955|AIDS-Related Complex|aids-related complex
417195|NCT00000945|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
417196|NCT00000945|Probenecid|probenecid
417197|NCT00000945|HIV-1|hiv-1
417198|NCT00000945|Central Nervous System Diseases|central nervous system diseases
417199|NCT00000945|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417200|NCT00000945|DNA, Viral|dna, viral
417201|NCT00000945|cidofovir|cidofovir
417202|NCT00000945|Anti-HIV Agents|anti-hiv agents
417203|NCT00000945|Neurologic Examination|neurologic examination
417204|NCT00000945|Renal Agents|renal agents
417205|NCT00000946|Drug Evaluation|drug evaluation
417206|NCT00000946|Drug Therapy, Combination|drug therapy, combination
417207|NCT00000946|AIDS Vaccines|aids vaccines
417208|NCT00000946|HIV Seronegativity|hiv seronegativity
417209|NCT00000946|HIV Preventive Vaccine|hiv preventive vaccine
417210|NCT00000947|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
417211|NCT00000947|Placebos|placebos
417212|NCT00000947|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
417213|NCT00000947|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417214|NCT00000947|Antitubercular Agents|antitubercular agents
417215|NCT00000947|Azithromycin|azithromycin
417216|NCT00000947|Drug Resistance, Microbial|drug resistance, microbial
417217|NCT00000947|CD4 Lymphocyte Count|cd4 lymphocyte count
417218|NCT00000947|Antibiotics|antibiotics
417219|NCT00000947|Time Factors|time factors
417220|NCT00000947|Anti-HIV Agents|anti-hiv agents
417221|NCT00000947|Pneumonia, Bacterial|pneumonia, bacterial
417222|NCT00000947|Streptococcus pneumoniae|streptococcus pneumoniae
417223|NCT00000948|Injections, Subcutaneous|injections, subcutaneous
417224|NCT00000948|Interleukin-2|interleukin-2
417225|NCT00000948|Dose-Response Relationship, Drug|dose-response relationship, drug
417226|NCT00000948|Drug Therapy, Combination|drug therapy, combination
417227|NCT00000948|CD4 Lymphocyte Count|cd4 lymphocyte count
417228|NCT00000948|Anti-HIV Agents|anti-hiv agents
417229|NCT00000949|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
417230|NCT00000949|Interleukin-2|interleukin-2
417231|NCT00000949|Dose-Response Relationship, Drug|dose-response relationship, drug
417232|NCT00000949|Adolescent Behavior|adolescent behavior
417233|NCT00000949|CD4 Lymphocyte Count|cd4 lymphocyte count
417234|NCT00000949|RNA, Viral|rna, viral
417235|NCT00000949|Quality of Life|quality of life
417236|NCT00000949|Anti-HIV Agents|anti-hiv agents
417237|NCT00000949|Viral Load|viral load
417238|NCT00000950|Tuberculosis|tuberculosis
417239|NCT00000950|Isoniazid|isoniazid
417240|NCT00000950|Pyrazinamide|pyrazinamide
417241|NCT00000950|Pyridoxine|pyridoxine
417242|NCT00000950|Rifampin|rifampin
417243|NCT00000950|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
520066|NCT00275275|PD|pd
417244|NCT00000950|Drug Therapy, Combination|drug therapy, combination
417245|NCT00000950|Ethambutol|ethambutol
417246|NCT00000950|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417247|NCT00000950|Antitubercular Agents|antitubercular agents
417248|NCT00000951|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
417249|NCT00000951|Fluconazole|fluconazole
417250|NCT00000951|Antifungal Agents|antifungal agents
417251|NCT00000951|Candidiasis, Oral|candidiasis, oral
417252|NCT00000951|Drug Administration Schedule|drug administration schedule
417253|NCT00000951|Pharyngeal Diseases|pharyngeal diseases
417254|NCT00000952|Dose-Response Relationship, Drug|dose-response relationship, drug
417255|NCT00000952|Drug Therapy, Combination|drug therapy, combination
417256|NCT00000952|Zidovudine|zidovudine
417257|NCT00000952|HIV Protease Inhibitors|hiv protease inhibitors
417258|NCT00000952|Ritonavir|ritonavir
417259|NCT00000952|Lamivudine|lamivudine
417260|NCT00000952|Anti-HIV Agents|anti-hiv agents
417261|NCT00000953|Herpes Zoster|herpes zoster
417262|NCT00000953|Acyclovir|acyclovir
417263|NCT00000953|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417264|NCT00000953|AIDS-Related Complex|aids-related complex
417265|NCT00000953|Antiviral Agents|antiviral agents
417266|NCT00000953|sorivudine|sorivudine
417267|NCT00000954|Vincristine|vincristine
417268|NCT00000954|Sarcoma, Kaposi|sarcoma, kaposi
417269|NCT00000954|Zalcitabine|zalcitabine
417270|NCT00000954|Didanosine|didanosine
417271|NCT00000954|Doxorubicin|doxorubicin
417272|NCT00000954|Drug Evaluation|drug evaluation
417273|NCT00000954|Drug Interactions|drug interactions
417274|NCT00000954|Drug Therapy, Combination|drug therapy, combination
417275|NCT00000954|Combined Modality Therapy|combined modality therapy
417276|NCT00000954|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
750534|NCT01166282|arthritis|arthritis
417277|NCT00000954|Antineoplastic Agents|antineoplastic agents
417278|NCT00000954|Antineoplastic Agents, Combined|antineoplastic agents, combined
417279|NCT00000954|Antiviral Agents|antiviral agents
417280|NCT00000954|Bleomycin|bleomycin
417281|NCT00000955|Tuberculosis|tuberculosis
417282|NCT00000955|Immunologic Tests|immunologic tests
417283|NCT00000955|Tuberculin|tuberculin
417284|NCT00000955|Tuberculin Test|tuberculin test
417285|NCT00000955|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
417286|NCT00000955|Injections, Intradermal|injections, intradermal
417287|NCT00000955|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417289|NCT00000955|Hypersensitivity, Delayed|hypersensitivity, delayed
417290|NCT00000400|Osteoporosis|osteoporosis
417291|NCT00000400|Bone formation|bone formation
417292|NCT00000400|Bone resorption|bone resorption
417293|NCT00000400|Parathyroid hormone (PTH)|parathyroid hormone (pth)
417294|NCT00000400|Postmenopause|postmenopause
417295|NCT00000401|NSAIDs|nsaids
417296|NCT00000401|Oral Tolerance|oral tolerance
417297|NCT00000401|Drug Interaction|drug interaction
417298|NCT00000401|Oral Administration|oral administration
417299|NCT00000401|Interleukin 10|interleukin 10
417300|NCT00000401|Collagen|collagen
417301|NCT00000401|Chemotherapy|chemotherapy
417302|NCT00000401|Human Therapy Evaluation|human therapy evaluation
417303|NCT00000401|DMARDs|dmards
417305|NCT00000401|IL-10|il-10
417306|NCT00000402|Osteoporosis|osteoporosis
417307|NCT00000402|Dietary calcium|dietary calcium
417308|NCT00000402|Puberty|puberty
417309|NCT00000402|Bone density|bone density
417310|NCT00000402|Bone mass|bone mass
417311|NCT00000402|Primary prevention of osteoporosis|primary prevention of osteoporosis
417312|NCT00000403|Osteoarthritis (OA)|osteoarthritis (oa)
417313|NCT00000403|Knee|knee
417314|NCT00000403|Doxycycline|doxycycline
417315|NCT00000403|Skeletal disorder|skeletal disorder
417316|NCT00000403|Placebo|placebo
417317|NCT00000403|Urinalysis|urinalysis
417318|NCT00000403|NSAIDs|nsaids
417319|NCT00000403|Joint space narrowing (JSN)|joint space narrowing (jsn)
417320|NCT00000403|WOMAC|womac
417321|NCT00000404|Osteoarthritis (OA)|osteoarthritis (oa)
417322|NCT00000404|Knee|knee
417323|NCT00000404|HMO|hmo
417324|NCT00000404|Comprehensive care|comprehensive care
417325|NCT00000405|Osteoporosis|osteoporosis
417326|NCT00000405|Bone fractures|bone fractures
417327|NCT00000405|Bone mass|bone mass
417328|NCT00000405|Bone mineral density (BMD)|bone mineral density (bmd)
417329|NCT00000405|Ossification|ossification
417330|NCT00000405|Biomechanics|biomechanics
417331|NCT00000405|Exercise|exercise
417332|NCT00000405|Diet|diet
417333|NCT00000405|Spine|spine
417334|NCT00000405|Middle childhood (6-11)|middle childhood (6-11)
417335|NCT00000406|Osteoarthritis (OA)|osteoarthritis (oa)
417336|NCT00000406|Knee|knee
417337|NCT00000406|Radiographic OA|radiographic oa
417338|NCT00000406|Strength training|strength training
417339|NCT00000406|Physical therapy|physical therapy
417340|NCT00000406|Exercise|exercise
417341|NCT00000406|Body composition|body composition
417342|NCT00000406|Striated muscle|striated muscle
417343|NCT00000406|Depression|depression
417344|NCT00000406|Radiographic OA with knee pain|radiographic oa with knee pain
417345|NCT00000406|Radiographic OA without knee pain|radiographic oa without knee pain
417346|NCT00000406|Knee pain without radiographic OA|knee pain without radiographic oa
417347|NCT00000406|Normal elderly (no radiographic OA, no knee pain)|normal elderly (no radiographic oa, no knee pain)
417348|NCT00000407|Arthritis and related musculoskeletal disorders (ARMD)|arthritis and related musculoskeletal disorders (armd)
417349|NCT00000407|Vocational rehabilitation (VR)|vocational rehabilitation (vr)
417350|NCT00000407|Agency enhancement intervention|agency enhancement intervention
417351|NCT00000407|Health care service evaluation|health care service evaluation
417352|NCT00000407|Musculoskeletal disability|musculoskeletal disability
417353|NCT00000407|Return to work|return to work
417354|NCT00000407|Outcomes research|outcomes research
417355|NCT00000407|Unemployment|unemployment
417356|NCT00000407|Work disability|work disability
417357|NCT00000408|Health education|health education
417358|NCT00000408|Back injury|back injury
417359|NCT00000408|Chronic pain|chronic pain
417360|NCT00000408|Education/evaluation planning|education/evaluation planning
417361|NCT00000408|Outcomes research|outcomes research
417362|NCT00000409|Intervertebral disc herniation (IDH)|intervertebral disc herniation (idh)
417363|NCT00000409|Degenerative spondylolisthesis (DS)|degenerative spondylolisthesis (ds)
417364|NCT00000409|Spinal stenosis (SpS)|spinal stenosis (sps)
417365|NCT00000409|Low back pain (LBP)|low back pain (lbp)
417366|NCT00000409|Leg pain|leg pain
417367|NCT00000409|Surgical therapy|surgical therapy
417368|NCT00000409|Randomized study|randomized study
417369|NCT00000409|Multicenter|multicenter
417370|NCT00000409|MRI|mri
417371|NCT00000409|Nonsurgical therapy|nonsurgical therapy
417372|NCT00000410|Intervertebral disc herniation (IDH)|intervertebral disc herniation (idh)
417373|NCT00000410|Stenosis with degenerative spondylolisthesis (DS)|stenosis with degenerative spondylolisthesis (ds)
417374|NCT00000410|Spinal stenosis (SpS)|spinal stenosis (sps)
417375|NCT00000410|Low back pain (LBP)|low back pain (lbp)
417376|NCT00000410|Leg pain|leg pain
417377|NCT00000410|Surgical therapy|surgical therapy
417378|NCT00000410|Non-surgical therapy|non-surgical therapy
417379|NCT00000410|Randomized study|randomized study
417380|NCT00000410|Multicenter|multicenter
417381|NCT00000410|MRI|mri
417382|NCT00000411|Spinal stenosis (SpS)|spinal stenosis (sps)
417383|NCT00000411|Intervertebral disc herniation (IDH)|intervertebral disc herniation (idh)
417384|NCT00000411|Degenerative spondylolisthesis (DS)|degenerative spondylolisthesis (ds)
417385|NCT00000411|Low back pain (LBP)|low back pain (lbp)
417487|NCT00000424|Sham lavage|sham lavage
417386|NCT00000411|Surgical therapy|surgical therapy
417387|NCT00000411|Nonsurgical therapy|nonsurgical therapy
417388|NCT00000411|Randomized study|randomized study
417389|NCT00000411|Multicenter|multicenter
417391|NCT00000412|Osteoporosis|osteoporosis
417392|NCT00000412|Osteopenia|osteopenia
417393|NCT00000412|Heart transplant|heart transplant
417394|NCT00000412|Bone fracture|bone fracture
417395|NCT00000412|Bone density|bone density
417396|NCT00000412|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
417397|NCT00000413|Osteoporosis prevention|osteoporosis prevention
417398|NCT00000413|Behavioral/educational intervention|behavioral/educational intervention
417399|NCT00000413|Preadolescent|preadolescent
417400|NCT00000413|Calcium|calcium
417401|NCT00000413|Exercise|exercise
417402|NCT00000413|Peak bone mass|peak bone mass
417403|NCT00000413|Bone density|bone density
417404|NCT00000414|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
417405|NCT00000414|Osteoarthritis (OA)|osteoarthritis (oa)
417406|NCT00000414|Arthritis education|arthritis education
417407|NCT00000414|Health care service evaluation|health care service evaluation
417408|NCT00000414|Outcomes research|outcomes research
417409|NCT00000414|Arthritis Self-Management Program (ASMP)|arthritis self-management program (asmp)
417410|NCT00000414|Self-Managed Arthritis Relief Therapy (SMART) Program|self-managed arthritis relief therapy (smart) program
417411|NCT00000415|Calcium|calcium
417412|NCT00000415|Physical activity|physical activity
417413|NCT00000415|Children|children
417414|NCT00000415|Bone mass accretion|bone mass accretion
417415|NCT00000415|Bone mineral density (BMD)|bone mineral density (bmd)
417416|NCT00000415|Bone response to activity and calcium supplements|bone response to activity and calcium supplements
417418|NCT00000415|Bone growth|bone growth
417419|NCT00000416|Arthritis|arthritis
417420|NCT00000416|Rheumatic disorders|rheumatic disorders
417421|NCT00000416|Work-related disability|work-related disability
417422|NCT00000416|Vocational rehabilitation (VR)|vocational rehabilitation (vr)
417423|NCT00000416|Job retention services|job retention services
417424|NCT00000416|Work limitations|work limitations
417425|NCT00000416|Work instability|work instability
417426|NCT00000417|SLE|sle
417427|NCT00000417|Lupus|lupus
417428|NCT00000417|Educational intervention|educational intervention
417429|NCT00000417|Health education|health education
417430|NCT00000417|Social support network|social support network
417431|NCT00000417|Outcomes research|outcomes research
417432|NCT00000417|Self-help|self-help
416528|NCT00000848|Viremia|viremia
417433|NCT00000418|OA|oa
417434|NCT00000418|Patient education|patient education
417435|NCT00000418|Acute low back pain (ALBP)|acute low back pain (albp)
417436|NCT00000418|Social support systems|social support systems
417437|NCT00000419|SLE|sle
417438|NCT00000419|SELENA|selena
417439|NCT00000419|Estrogen Replacement Therapy (ERT)|estrogen replacement therapy (ert)
417440|NCT00000419|Postmenopause|postmenopause
417441|NCT00000419|Osteoporosis|osteoporosis
417442|NCT00000419|Estrogens|estrogens
417443|NCT00000419|Steroids|steroids
417444|NCT00000419|Progestin|progestin
417445|NCT00000419|Placebo|placebo
417446|NCT00000420|SLE|sle
417447|NCT00000420|SELENA|selena
417448|NCT00000420|Oral contraceptives|oral contraceptives
417449|NCT00000420|The pill|the pill
417450|NCT00000420|Birth control|birth control
417451|NCT00000420|Condom|condom
417452|NCT00000420|Diaphragm|diaphragm
417453|NCT00000420|Estrogen|estrogen
417454|NCT00000420|Lupus|lupus
417455|NCT00000420|Placebo|placebo
417456|NCT00000421|SLE|sle
417457|NCT00000421|Lupus|lupus
417458|NCT00000421|Anti-double-stranded DNA antibody|anti-double-stranded dna antibody
417459|NCT00000421|Corticosteroid treatment|corticosteroid treatment
417460|NCT00000421|Hormone therapy|hormone therapy
417461|NCT00000421|Complement|complement
417462|NCT00000421|Hypertension|hypertension
417463|NCT00000421|Estrogen|estrogen
417464|NCT00000421|SELENA|selena
417465|NCT00000422|Fibromyalgia Syndrome (FMS)|fibromyalgia syndrome (fms)
417466|NCT00000422|Physical therapy|physical therapy
417467|NCT00000422|Psychotherapy|psychotherapy
417468|NCT00000422|Group counseling|group counseling
417469|NCT00000422|Human therapy relations|human therapy relations
417470|NCT00000422|Interpersonal relations|interpersonal relations
417471|NCT00000422|Chronic pain|chronic pain
417472|NCT00000422|Cognition|cognition
417473|NCT00000422|Emotion|emotion
417474|NCT00000422|Memory|memory
417475|NCT00000422|Musculoskeletal disorder|musculoskeletal disorder
417476|NCT00000422|Psychological stressor|psychological stressor
417477|NCT00000422|Psychological adaptation|psychological adaptation
417478|NCT00000422|Outcomes research|outcomes research
417479|NCT00000423|Fibromyalgia|fibromyalgia
417480|NCT00000423|Health education|health education
417481|NCT00000423|Program evaluation|program evaluation
417482|NCT00000423|Social support|social support
417483|NCT00000423|Managed care|managed care
417484|NCT00000423|Quality of well-being|quality of well-being
417485|NCT00000424|Osteoarthritis (OA)|osteoarthritis (oa)
417486|NCT00000424|Knee|knee
417488|NCT00000424|Tidal lavage|tidal lavage
417489|NCT00000424|Lavage therapy|lavage therapy
417490|NCT00000424|Nonsteroidal anti-inflammatory drug (NSAID)|nonsteroidal anti-inflammatory drug (nsaid)
417491|NCT00000424|Placebo|placebo
417492|NCT00000424|Radiography|radiography
417493|NCT00000424|Human therapy evaluation|human therapy evaluation
417494|NCT00000424|WOMAC|womac
417495|NCT00000425|Osteoarthritis|osteoarthritis
417496|NCT00000425|Skeletal disorder|skeletal disorder
417497|NCT00000425|Chemotherapy|chemotherapy
417498|NCT00000425|Nonsteroidal anti-inflammatory drugs (NSAIDs)|nonsteroidal anti-inflammatory drugs (nsaids)
417499|NCT00000425|Arthroplasty|arthroplasty
417500|NCT00000425|Cartilage metabolism|cartilage metabolism
417501|NCT00000425|Hip|hip
417502|NCT00000425|Knee|knee
417503|NCT00000425|Outcomes research|outcomes research
417504|NCT00000426|Calcium deficiency|calcium deficiency
417505|NCT00000426|Dietary calcium|dietary calcium
417506|NCT00000426|Dietary protein|dietary protein
417507|NCT00000426|Osteoporosis|osteoporosis
417508|NCT00000426|Calcium supplement|calcium supplement
417509|NCT00000426|Bone density|bone density
417510|NCT00000426|Bone mass|bone mass
417511|NCT00000426|Bone mass accumulation|bone mass accumulation
417512|NCT00000427|Parathyroid Hormone (PTH)|parathyroid hormone (pth)
417513|NCT00000427|Alendronate|alendronate
417514|NCT00000427|Bone metabolism|bone metabolism
417515|NCT00000427|Bone mineral density (BMD)|bone mineral density (bmd)
417516|NCT00000427|Bone loss|bone loss
417517|NCT00000427|Postmenopausal osteoporosis|postmenopausal osteoporosis
417518|NCT00000427|Osteoporosis in men|osteoporosis in men
417519|NCT00000428|Fibromyalgia Syndrome (FMS)|fibromyalgia syndrome (fms)
417520|NCT00000428|Amitriptyline|amitriptyline
417521|NCT00000428|Fluoxetine|fluoxetine
417522|NCT00000429|JRA|jra
417523|NCT00000429|Osteopenia|osteopenia
417524|NCT00000429|Dietary calcium|dietary calcium
417525|NCT00000429|Diet therapy|diet therapy
417526|NCT00000429|Bone density|bone density
417527|NCT00000429|Ossification|ossification
417528|NCT00000429|Biomarker|biomarker
417529|NCT00000429|Dietary supplement|dietary supplement
417530|NCT00000430|Osteoporosis|osteoporosis
417531|NCT00000430|Osteopenia|osteopenia
417532|NCT00000430|Postmenopausal women|postmenopausal women
417533|NCT00000430|Hormone replacement therapy|hormone replacement therapy
417534|NCT00000430|Alendronate|alendronate
417535|NCT00000431|Venous leg ulcer|venous leg ulcer
417536|NCT00000431|Wound healing|wound healing
417537|NCT00000431|Somatic gene therapy|somatic gene therapy
417538|NCT00000431|PDGF-B|pdgf-b
417539|NCT00000432|Lyme disease|lyme disease
417540|NCT00000432|Education evaluation|education evaluation
417541|NCT00000432|Communicable disease control|communicable disease control
417542|NCT00000432|Outcomes research|outcomes research
417543|NCT00000432|Tick-transmitted diseases|tick-transmitted diseases
417544|NCT00000433|Spondylitis|spondylitis
417545|NCT00000433|Etanercept|etanercept
417546|NCT00000433|ENBREL|enbrel
417547|NCT00000433|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
417548|NCT00000434|Osteoarthritis|osteoarthritis
417549|NCT00000434|Health education|health education
417550|NCT00000434|Aerobic exercise|aerobic exercise
418040|NCT00001162|Helminth|helminth
417551|NCT00000434|Self-efficacy|self-efficacy
417552|NCT00000434|Muscle strength|muscle strength
417553|NCT00000434|Outcomes research|outcomes research
417554|NCT00000434|Longitudinal study|longitudinal study
417555|NCT00000435|RA|ra
417556|NCT00000435|Immune Modulation|immune modulation
417557|NCT00000435|Oral Tolerance|oral tolerance
417558|NCT00000435|Peptide|peptide
417559|NCT00000435|dnaJ|dnaj
417560|NCT00000436|Hip fracture|hip fracture
417561|NCT00000436|Self-efficacy|self-efficacy
417562|NCT00000436|Strength training|strength training
417563|NCT00000436|Rehabilitation|rehabilitation
417564|NCT00000436|Postoperative|postoperative
417565|NCT00000451|Alcoholism|alcoholism
417566|NCT00000451|Alcohol Dependence|alcohol dependence
417567|NCT00000456|Alcoholism|alcoholism
417568|NCT00000456|Alcohol Dependence|alcohol dependence
417569|NCT00000456|Naltrexone|naltrexone
417570|NCT00000456|Cognitive Behavioral Therapy|cognitive behavioral therapy
417571|NCT00000956|Vaccines, Synthetic|vaccines, synthetic
417572|NCT00000956|Vaccinia Virus|vaccinia virus
417573|NCT00000956|HIV-1|hiv-1
417574|NCT00000956|HIV Envelope Protein gp160|hiv envelope protein gp160
417575|NCT00000956|AIDS Vaccines|aids vaccines
417576|NCT00000956|HIV Seronegativity|hiv seronegativity
751306|NCT01169207|CD|cd
417577|NCT00000956|HIV Preventive Vaccine|hiv preventive vaccine
417578|NCT00000957|Vaccines, Synthetic|vaccines, synthetic
417579|NCT00000957|Vaccinia Virus|vaccinia virus
417580|NCT00000957|Viral Vaccines|viral vaccines
417581|NCT00000957|HIV-1|hiv-1
417582|NCT00000957|Drug Evaluation|drug evaluation
417583|NCT00000957|HIV Envelope Protein gp160|hiv envelope protein gp160
417584|NCT00000957|Drug Administration Schedule|drug administration schedule
417585|NCT00000957|AIDS Vaccines|aids vaccines
417586|NCT00000957|HIV Seronegativity|hiv seronegativity
417587|NCT00000957|HIV Preventive Vaccine|hiv preventive vaccine
417588|NCT00000958|Vaccines, Synthetic|vaccines, synthetic
417683|NCT00000974|Pentamidine|pentamidine
417589|NCT00000958|Recombinant Proteins|recombinant proteins
417590|NCT00000958|Adjuvants, Immunologic|adjuvants, immunologic
417591|NCT00000958|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417592|NCT00000958|HIV Envelope Protein gp120|hiv envelope protein gp120
417593|NCT00000958|AIDS Vaccines|aids vaccines
417594|NCT00000958|HIV Therapeutic Vaccine|hiv therapeutic vaccine
417595|NCT00000959|Tuberculosis|tuberculosis
417596|NCT00000959|Isoniazid|isoniazid
417597|NCT00000959|Pyridoxine|pyridoxine
417598|NCT00000959|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
417599|NCT00000959|Drug Evaluation|drug evaluation
417600|NCT00000959|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417601|NCT00000959|Antitubercular Agents|antitubercular agents
417602|NCT00000960|Pregnancy|pregnancy
417603|NCT00000960|Pregnancy Complications, Infectious|pregnancy complications, infectious
417604|NCT00000960|Prenatal Exposure Delayed Effects|prenatal exposure delayed effects
417605|NCT00000960|Administration, Oral|administration, oral
417606|NCT00000960|AIDS-Related Complex|aids-related complex
417607|NCT00000960|Zidovudine|zidovudine
417608|NCT00000961|Drug Therapy, Combination|drug therapy, combination
417609|NCT00000961|Zidovudine|zidovudine
417610|NCT00000962|Drug Evaluation|drug evaluation
417611|NCT00000962|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417612|NCT00000962|AIDS-Related Complex|aids-related complex
417613|NCT00000962|Nevirapine|nevirapine
417614|NCT00000963|Didanosine|didanosine
417615|NCT00000963|Drug Evaluation|drug evaluation
10178|NCT03225664|Pembrolizumab|pembrolizumab
417616|NCT00000963|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417617|NCT00000963|AIDS-Related Complex|aids-related complex
417618|NCT00000963|Zidovudine|zidovudine
417619|NCT00000964|Ranitidine|ranitidine
417620|NCT00000964|Phosphorus Acids|phosphorus acids
417621|NCT00000964|Drug Evaluation|drug evaluation
417622|NCT00000964|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417623|NCT00000965|Leukocytes, Mononuclear|leukocytes, mononuclear
417624|NCT00000965|Drug Evaluation|drug evaluation
417625|NCT00000965|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417626|NCT00000965|AIDS-Related Complex|aids-related complex
417627|NCT00000965|Zidovudine|zidovudine
417628|NCT00000965|Phosphorylation|phosphorylation
417629|NCT00000966|Toxoplasmosis|toxoplasmosis
417630|NCT00000966|Toxoplasma|toxoplasma
417631|NCT00000966|Pyrimethamine|pyrimethamine
417632|NCT00000966|Leucovorin|leucovorin
417633|NCT00000966|Drug Evaluation|drug evaluation
417634|NCT00000966|Drug Therapy, Combination|drug therapy, combination
417635|NCT00000966|Encephalitis|encephalitis
417636|NCT00000966|Administration, Oral|administration, oral
417637|NCT00000966|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417638|NCT00000966|Azithromycin|azithromycin
417639|NCT00000967|Drug Therapy, Combination|drug therapy, combination
417640|NCT00000967|AIDS-Related Complex|aids-related complex
417641|NCT00000967|Zidovudine|zidovudine
417642|NCT00000967|Interferon Type I|interferon type i
417643|NCT00000968|Vaccines, Synthetic|vaccines, synthetic
417644|NCT00000968|Drug Evaluation|drug evaluation
418240|NCT00001195|Development|development
417645|NCT00000968|HIV Envelope Protein gp160|hiv envelope protein gp160
417646|NCT00000968|AIDS Vaccines|aids vaccines
417647|NCT00000968|HIV Seronegativity|hiv seronegativity
417648|NCT00000968|HIV Preventive Vaccine|hiv preventive vaccine
417649|NCT00000969|Zalcitabine|zalcitabine
417650|NCT00000969|Didanosine|didanosine
417651|NCT00000969|Drug Evaluation|drug evaluation
417652|NCT00000969|Zidovudine|zidovudine
417653|NCT00000970|Retinitis|retinitis
417654|NCT00000970|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
417655|NCT00000970|Ganciclovir|ganciclovir
417656|NCT00000970|Drug Evaluation|drug evaluation
417657|NCT00000970|Drug Therapy, Combination|drug therapy, combination
417658|NCT00000970|Foscarnet|foscarnet
417659|NCT00000970|Cytomegalovirus Infections|cytomegalovirus infections
417660|NCT00000970|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417661|NCT00000971|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
417662|NCT00000971|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
417663|NCT00000971|Didanosine|didanosine
417664|NCT00000971|Drug Evaluation|drug evaluation
417665|NCT00000971|Drug Interactions|drug interactions
417666|NCT00000971|Drug Therapy, Combination|drug therapy, combination
417667|NCT00000971|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417668|NCT00000971|Zidovudine|zidovudine
417669|NCT00000972|Vaccines, Synthetic|vaccines, synthetic
417670|NCT00000972|Drug Evaluation|drug evaluation
417671|NCT00000972|Adjuvants, Immunologic|adjuvants, immunologic
417672|NCT00000972|AIDS Vaccines|aids vaccines
417673|NCT00000972|HIV Preventive Vaccine|hiv preventive vaccine
417674|NCT00000973|Toxoplasmosis|toxoplasmosis
417675|NCT00000973|Toxoplasma|toxoplasma
417676|NCT00000973|Pyrimethamine|pyrimethamine
417677|NCT00000973|Leucovorin|leucovorin
417678|NCT00000973|Drug Evaluation|drug evaluation
417679|NCT00000973|Encephalitis|encephalitis
417680|NCT00000973|Zidovudine|zidovudine
417681|NCT00000974|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
417682|NCT00000974|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
417684|NCT00000974|Injections, Intravenous|injections, intravenous
417685|NCT00000974|Drug Evaluation|drug evaluation
417686|NCT00000974|Aerosols|aerosols
417687|NCT00000974|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417688|NCT00000975|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
417689|NCT00000975|Histoplasmosis|histoplasmosis
417690|NCT00000975|Drug Evaluation|drug evaluation
417691|NCT00000975|Antifungal Agents|antifungal agents
417692|NCT00000975|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417693|NCT00000976|Recombinant Proteins|recombinant proteins
417694|NCT00000976|Injections, Intravenous|injections, intravenous
417696|NCT00000976|Drug Evaluation|drug evaluation
417697|NCT00000976|Administration, Oral|administration, oral
417698|NCT00000976|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417699|NCT00000976|Antigens, CD4|antigens, cd4
417700|NCT00000976|Zidovudine|zidovudine
417701|NCT00000976|Carrier Proteins|carrier proteins
417702|NCT00000977|Vaccines, Synthetic|vaccines, synthetic
417703|NCT00000977|HIV Seropositivity|hiv seropositivity
417704|NCT00000977|HIV-1|hiv-1
417705|NCT00000977|Drug Evaluation|drug evaluation
417706|NCT00000977|AIDS Vaccines|aids vaccines
417707|NCT00000977|HIV Therapeutic Vaccine|hiv therapeutic vaccine
417708|NCT00000978|Zalcitabine|zalcitabine
417709|NCT00000978|Drug Therapy, Combination|drug therapy, combination
417710|NCT00000978|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417711|NCT00000978|AIDS-Related Complex|aids-related complex
417712|NCT00000978|Zidovudine|zidovudine
417713|NCT00000979|Didanosine|didanosine
417714|NCT00000979|Zidovudine|zidovudine
417715|NCT00000980|Single-Blind Method|single-blind method
417716|NCT00000980|Spiramycin|spiramycin
417717|NCT00000980|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
417718|NCT00000980|Injections, Intravenous|injections, intravenous
417719|NCT00000980|Cryptosporidiosis|cryptosporidiosis
417720|NCT00000980|Diarrhea|diarrhea
417721|NCT00000980|Drug Evaluation|drug evaluation
417722|NCT00000980|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417723|NCT00000981|Retinitis|retinitis
520674|NCT00287755|S-1|s-1
417724|NCT00000981|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
417725|NCT00000981|Pyrimidine Nucleosides|pyrimidine nucleosides
417726|NCT00000981|Drug Evaluation|drug evaluation
417727|NCT00000981|fiacitabine|fiacitabine
417728|NCT00000981|Cytomegalovirus Infections|cytomegalovirus infections
417729|NCT00000981|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417730|NCT00000981|Antiviral Agents|antiviral agents
417731|NCT00001106|Pregnancy|pregnancy
417732|NCT00001106|Pregnancy Complications, Infectious|pregnancy complications, infectious
417733|NCT00001106|Prenatal Exposure Delayed Effects|prenatal exposure delayed effects
417734|NCT00001106|Drug Evaluation|drug evaluation
417735|NCT00001106|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417736|NCT00001106|Zidovudine|zidovudine
417737|NCT00001108|Dose-Response Relationship, Drug|dose-response relationship, drug
417738|NCT00001108|Drug Therapy, Combination|drug therapy, combination
417739|NCT00001108|HIV Protease Inhibitors|hiv protease inhibitors
417740|NCT00001108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
417741|NCT00001108|Salvage Therapy|salvage therapy
417742|NCT00001108|Anti-HIV Agents|anti-hiv agents
417743|NCT00001109|Monocytes|monocytes
417744|NCT00001109|Flow Cytometry|flow cytometry
417745|NCT00001109|HIV Seronegativity|hiv seronegativity
417746|NCT00001109|Phenotype|phenotype
417747|NCT00001109|Lymphocyte Subsets|lymphocyte subsets
417748|NCT00001110|Lung|lung
417749|NCT00001110|HIV-1|hiv-1
417750|NCT00001110|Viremia|viremia
417751|NCT00001110|Anti-HIV Agents|anti-hiv agents
417752|NCT00001110|Viral Load|viral load
417753|NCT00001110|Bronchoalveolar Lavage Fluid|bronchoalveolar lavage fluid
417754|NCT00001111|Drug Therapy, Combination|drug therapy, combination
417755|NCT00001111|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417756|NCT00001111|AIDS-Related Complex|aids-related complex
417757|NCT00001111|Antiviral Agents|antiviral agents
417758|NCT00001111|Zidovudine|zidovudine
417759|NCT00001111|Nevirapine|nevirapine
417760|NCT00001112|Monocytes|monocytes
417761|NCT00001112|Interferon-gamma, Recombinant|interferon-gamma, recombinant
417762|NCT00001112|Injections, Subcutaneous|injections, subcutaneous
417763|NCT00001112|Immune System|immune system
417764|NCT00001112|Drug Evaluation|drug evaluation
417765|NCT00001112|Drug Therapy, Combination|drug therapy, combination
417766|NCT00001112|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417767|NCT00001112|Zidovudine|zidovudine
417768|NCT00001112|Blood Bactericidal Activity|blood bactericidal activity
417769|NCT00001113|Interferon Alfa-2a|interferon alfa-2a
417770|NCT00001113|Sarcoma, Kaposi|sarcoma, kaposi
417771|NCT00001113|Dose-Response Relationship, Drug|dose-response relationship, drug
417772|NCT00001113|Drug Evaluation|drug evaluation
417773|NCT00001113|Drug Therapy, Combination|drug therapy, combination
417774|NCT00001113|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417775|NCT00001113|Zidovudine|zidovudine
417776|NCT00001113|Interferon Type I|interferon type i
417777|NCT00001114|Sarcoma, Kaposi|sarcoma, kaposi
417778|NCT00001114|Didanosine|didanosine
417779|NCT00001114|Drug Interactions|drug interactions
417780|NCT00001114|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417781|NCT00001114|Interferon-alpha|interferon-alpha
417782|NCT00001115|Herpes Simplex|herpes simplex
417783|NCT00001115|Acyclovir|acyclovir
417784|NCT00001115|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417785|NCT00001116|Tumor Necrosis Factor|tumor necrosis factor
417786|NCT00001116|Interleukin-2|interleukin-2
417787|NCT00001116|Immunity, Cellular|immunity, cellular
417788|NCT00001116|Antiviral Agents|antiviral agents
417789|NCT00001116|Interleukin-6|interleukin-6
417790|NCT00001116|Receptors, Tumor Necrosis Factor|receptors, tumor necrosis factor
417792|NCT00001117|Drug Therapy, Combination|drug therapy, combination
417793|NCT00001117|Hepatitis C|hepatitis c
417794|NCT00001117|RNA, Viral|rna, viral
417795|NCT00001117|Anti-HIV Agents|anti-hiv agents
417796|NCT00001118|Injections, Intravenous|injections, intravenous
417797|NCT00001118|Injections, Subcutaneous|injections, subcutaneous
417798|NCT00001118|Drug Therapy, Combination|drug therapy, combination
417799|NCT00001118|HIV Protease Inhibitors|hiv protease inhibitors
417800|NCT00001118|Membrane Fusion|membrane fusion
417801|NCT00001118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
417802|NCT00001118|Anti-HIV Agents|anti-hiv agents
417803|NCT00001118|Viral Load|viral load
417804|NCT00001118|peptide T20|peptide t20
417805|NCT00001119|Immunity, Cellular|immunity, cellular
10179|NCT03225664|Keytruda|keytruda
417806|NCT00001119|Drug Therapy, Combination|drug therapy, combination
417807|NCT00001119|HIV Protease Inhibitors|hiv protease inhibitors
417809|NCT00001119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
417810|NCT00001119|Anti-HIV Agents|anti-hiv agents
417811|NCT00001119|Viral Load|viral load
417812|NCT00001119|Tetanus Toxoid|tetanus toxoid
417813|NCT00001119|Case-Control Studies|case-control studies
417814|NCT00001119|Hepatitis B Surface Antigens|hepatitis b surface antigens
417815|NCT00001119|Acute Infection|acute infection
520821|NCT00278863|S-1|s-1
417816|NCT00001120|Prospective Studies|prospective studies
417817|NCT00001120|Sarcoma, Kaposi|sarcoma, kaposi
417818|NCT00001120|Herpesvirus 4, Human|herpesvirus 4, human
417819|NCT00001120|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417820|NCT00001120|Cohort Studies|cohort studies
417821|NCT00001120|Risk Factors|risk factors
417822|NCT00001120|Lymphoma, AIDS-Related|lymphoma, aids-related
417823|NCT00001120|Antibodies, Viral|antibodies, viral
417824|NCT00001120|Lymphoproliferative Disorders|lymphoproliferative disorders
417825|NCT00001120|Viral Load|viral load
417826|NCT00001120|Herpesvirus, Kaposi Sarcoma-Associated|herpesvirus, kaposi sarcoma-associated
417827|NCT00001120|Translocation (Genetics)|translocation (genetics)
417828|NCT00001121|Placebos|placebos
417829|NCT00001121|AIDS Vaccines|aids vaccines
417830|NCT00001121|Follow-Up Studies|follow-up studies
417831|NCT00001121|HIV Therapeutic Vaccine|hiv therapeutic vaccine
417832|NCT00001122|Didanosine|didanosine
417833|NCT00001122|Drug Therapy, Combination|drug therapy, combination
417835|NCT00001122|HIV Protease Inhibitors|hiv protease inhibitors
417836|NCT00001122|CD4 Lymphocyte Count|cd4 lymphocyte count
417837|NCT00001122|Nelfinavir|nelfinavir
417838|NCT00001122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
417839|NCT00001122|Self Care|self care
417840|NCT00001122|Anti-HIV Agents|anti-hiv agents
417841|NCT00001122|Viral Load|viral load
417842|NCT00001122|efavirenz|efavirenz
417843|NCT00001122|Treatment Naive|treatment naive
417844|NCT00001125|Antibodies, Viral|antibodies, viral
417845|NCT00001125|Chickenpox|chickenpox
417846|NCT00001125|Chickenpox Vaccine|chickenpox vaccine
417847|NCT00001128|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
417848|NCT00001128|Cryptosporidiosis|cryptosporidiosis
417849|NCT00001128|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
417850|NCT00001128|Azithromycin|azithromycin
417851|NCT00001128|Paromomycin|paromomycin
417852|NCT00001128|Interleukin-12|interleukin-12
417853|NCT00001129|Drug Therapy, Combination|drug therapy, combination
417854|NCT00001129|RNA, Viral|rna, viral
417855|NCT00001129|Patient Compliance|patient compliance
417856|NCT00001129|Anti-HIV Agents|anti-hiv agents
417857|NCT00001129|Viral Load|viral load
751307|NCT01169207|UC|uc
417858|NCT00001129|Reminder Systems|reminder systems
417859|NCT00001129|Treatment Experienced|treatment experienced
417860|NCT00001129|Treatment Naive|treatment naive
417861|NCT00001130|Questionnaires|questionnaires
417862|NCT00001130|Antibodies, Viral|antibodies, viral
417863|NCT00001130|Emergency Service, Hospital|emergency service, hospital
417864|NCT00001131|Interleukin-2|interleukin-2
417865|NCT00001131|Drug Therapy, Combination|drug therapy, combination
417866|NCT00001131|Drug Administration Schedule|drug administration schedule
417867|NCT00001131|Viremia|viremia
417868|NCT00001131|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
417869|NCT00001131|Anti-HIV Agents|anti-hiv agents
417870|NCT00001131|Treatment Experienced|treatment experienced
417871|NCT00001132|Placebos|placebos
417872|NCT00001132|HIV-1|hiv-1
417873|NCT00001132|Drug Therapy, Combination|drug therapy, combination
417875|NCT00001132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
417876|NCT00001132|Anti-HIV Agents|anti-hiv agents
417877|NCT00001132|Viral Load|viral load
417878|NCT00001132|abacavir|abacavir
417879|NCT00001133|Dose-Response Relationship, Drug|dose-response relationship, drug
417880|NCT00001133|Drug Therapy, Combination|drug therapy, combination
417881|NCT00001133|HIV Protease Inhibitors|hiv protease inhibitors
417882|NCT00001133|Ritonavir|ritonavir
417883|NCT00001133|Indinavir|indinavir
417884|NCT00001133|Anti-HIV Agents|anti-hiv agents
417885|NCT00001133|Pharmacokinetics|pharmacokinetics
417886|NCT00001133|Treatment Experienced|treatment experienced
417887|NCT00001135|Placebos|placebos
417888|NCT00001135|Pregnancy|pregnancy
417889|NCT00001135|Pregnancy Complications, Infectious|pregnancy complications, infectious
417890|NCT00001135|Nevirapine|nevirapine
417891|NCT00001135|Disease Transmission, Vertical|disease transmission, vertical
417892|NCT00001135|Labor|labor
417893|NCT00001135|Anti-HIV Agents|anti-hiv agents
417894|NCT00001136|Injections, Intramuscular|injections, intramuscular
417895|NCT00001136|HIV-1|hiv-1
417896|NCT00001136|AIDS Vaccines|aids vaccines
417897|NCT00001136|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
417898|NCT00001136|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
417899|NCT00001136|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
417900|NCT00001136|Gene Products, gag|gene products, gag
417901|NCT00001136|HIV Seronegativity|hiv seronegativity
417902|NCT00001136|Immunologic Memory|immunologic memory
417903|NCT00001136|Antibodies, Viral|antibodies, viral
417904|NCT00001136|Genetic Vectors|genetic vectors
417905|NCT00001136|Gene Products, env|gene products, env
417906|NCT00001136|Poxviridae|poxviridae
417907|NCT00001136|HIV Preventive Vaccine|hiv preventive vaccine
417908|NCT00001137|Treatment Experienced|treatment experienced
417909|NCT00001137|Treatment Naive|treatment naive
417910|NCT00001137|Virus Replication|virus replication
417911|NCT00001137|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
417912|NCT00001137|HIV-1|hiv-1
417913|NCT00001137|Risk Factors|risk factors
417914|NCT00001137|Incidence|incidence
417915|NCT00001137|RNA, Viral|rna, viral
417916|NCT00001137|Anti-HIV Agents|anti-hiv agents
417917|NCT00001137|Viral Load|viral load
417918|NCT00001137|Lipodystrophy|lipodystrophy
417919|NCT00001137|Nervous System|nervous system
417920|NCT00001137|Cardiovascular System|cardiovascular system
417921|NCT00001137|Neurologic Symptoms|neurologic symptoms
417922|NCT00001142|Body Fat|body fat
417923|NCT00001142|DXA|dxa
417924|NCT00001142|HAART|haart
417925|NCT00001142|Hyperlipidemia|hyperlipidemia
417926|NCT00001142|Insulin Resistance|insulin resistance
417927|NCT00001142|Lipodystrophy|lipodystrophy
417928|NCT00001142|MRI|mri
417929|NCT00001142|Protease Inhibitor|protease inhibitor
417930|NCT00001142|Side-Effects|side-effects
417931|NCT00001142|Visceral Fat|visceral fat
417932|NCT00001142|Chronic Infection|chronic infection
417933|NCT00001142|HIV|hiv
417934|NCT00001142|Healthy Volunteer|healthy volunteer
417935|NCT00001143|Eye Movements|eye movements
417936|NCT00001143|Strabismus|strabismus
417937|NCT00001143|Infants|infants
417938|NCT00001143|Development|development
417939|NCT00001143|Ocular Motor System|ocular motor system
417940|NCT00001144|Peripheral Blood Stem Cells|peripheral blood stem cells
417941|NCT00001144|Engraftment|engraftment
417942|NCT00001144|Graft vs. Host Disease|graft vs. host disease
417943|NCT00001144|Graft-Versus-Leukemia|graft-versus-leukemia
417944|NCT00001144|Graft-Versus-Tumor/Melanoma|graft-versus-tumor/melanoma
417945|NCT00001144|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
417946|NCT00001145|Primary Immunodeficiency|primary immunodeficiency
417947|NCT00001145|Gamma Globulin (IgG) Immunization|gamma globulin (igg) immunization
417948|NCT00001145|KLH|klh
417949|NCT00001145|Phi-X 174|phi-x 174
417950|NCT00001145|X-linked HyperIgM Syndrome|x-linked hyperigm syndrome
417951|NCT00001146|Bipolar Disorder|bipolar disorder
417952|NCT00001146|Clinical Trial|clinical trial
417953|NCT00001146|Eicosapentaenoic Ethyl Ester|eicosapentaenoic ethyl ester
417954|NCT00001146|Life Chart Methodology|life chart methodology
417955|NCT00001146|Mood Disorders|mood disorders
417956|NCT00001146|Omega-3 Fatty Acid|omega-3 fatty acid
417957|NCT00001146|Rapid Cycling|rapid cycling
417958|NCT00001146|Treatment|treatment
417959|NCT00001147|Dopamine|dopamine
417960|NCT00001147|Metanephrine|metanephrine
417961|NCT00001147|Norepinephrine|norepinephrine
417962|NCT00001147|Epinephrine|epinephrine
417963|NCT00001147|Catecholamines|catecholamines
417964|NCT00001147|Tyrosine Hydroxylase|tyrosine hydroxylase
417965|NCT00001147|Monoamine Oxidase|monoamine oxidase
417966|NCT00001147|Phenosulfotransferase|phenosulfotransferase
417967|NCT00001147|Sympathetic Nervous System|sympathetic nervous system
417968|NCT00001147|Normetanephrine|normetanephrine
417969|NCT00001148|Metastasis|metastasis
417970|NCT00001148|Glioma|glioma
417971|NCT00001148|Venous|venous
417972|NCT00001148|Sampling|sampling
417973|NCT00001148|p53 Mutation|p53 mutation
417974|NCT00001148|Glioblastoma Multiforme|glioblastoma multiforme
417975|NCT00001148|Circulating Tumor Cells|circulating tumor cells
417978|NCT00001149|Anticonvulsants|anticonvulsants
417979|NCT00001149|Intensive Monitoring|intensive monitoring
417981|NCT00001150|Blister Formation|blister formation
417982|NCT00001150|Inflammatory Mediator Assay|inflammatory mediator assay
417983|NCT00001150|Ultraviolet Radiation|ultraviolet radiation
417984|NCT00001151|Calciferol|calciferol
417985|NCT00001151|Hypocalcemia|hypocalcemia
417986|NCT00001151|Rickets|rickets
417987|NCT00001152|Aqueous Humor Dynamics|aqueous humor dynamics
417988|NCT00001152|Glaucoma|glaucoma
417989|NCT00001152|Ocular Hypertension|ocular hypertension
417990|NCT00001152|Pigment Dispersion Syndrome|pigment dispersion syndrome
417991|NCT00001152|Primary Open Angle Glaucoma|primary open angle glaucoma
417992|NCT00001152|Pseudo-Exfoliation of the Lens Capsule|pseudo-exfoliation of the lens capsule
417993|NCT00001153|Albinism|albinism
417994|NCT00001153|Ocular Albinism|ocular albinism
417995|NCT00001153|Oculocutaneous Albinism|oculocutaneous albinism
417996|NCT00001153|Tyrosinase Negative|tyrosinase negative
417997|NCT00001153|Tyrosinase Positive|tyrosinase positive
417998|NCT00001154|Cholesterol|cholesterol
417999|NCT00001154|Apolipoproteins|apolipoproteins
418000|NCT00001154|Kinetics|kinetics
418001|NCT00001155|Vasculitis|vasculitis
418002|NCT00001155|Prednisone|prednisone
418003|NCT00001155|Granuloma|granuloma
418004|NCT00001155|Wegener's Granulomatosis|wegener's granulomatosis
10181|NCT03225664|SCH-900475|sch-900475
418005|NCT00001155|Cyclophosphamide|cyclophosphamide
418006|NCT00001155|Renal Biopsy|renal biopsy
418007|NCT00001156|Immunogenetics|immunogenetics
418008|NCT00001156|Tropical Spastic Paraplegia|tropical spastic paraplegia
418010|NCT00001156|Epstein-Barr Virus|epstein-barr virus
418011|NCT00001156|HTLV-I|htlv-i
418012|NCT00001156|Vasculitis|vasculitis
418013|NCT00001156|Cerebrospinal Fluid|cerebrospinal fluid
418014|NCT00001156|Immunity to Viruses|immunity to viruses
418015|NCT00001156|Multiple Sclerosis|multiple sclerosis
418016|NCT00001156|Magnetic Resonance Imaging|magnetic resonance imaging
418017|NCT00001158|Cellular Immunity|cellular immunity
418018|NCT00001158|Humoral Immunity|humoral immunity
418019|NCT00001158|Immunodeficiency Disease|immunodeficiency disease
418020|NCT00001159|Hyperthyroidism|hyperthyroidism
418021|NCT00001159|Hypothyroidism|hypothyroidism
418022|NCT00001159|Thyroid-Stimulating Hormone Secreting Pituitary Adenomas|thyroid-stimulating hormone secreting pituitary adenomas
418026|NCT00001161|Irido Corneal Angle|irido corneal angle
418027|NCT00001161|Mesothelium|mesothelium
418028|NCT00001161|Congenital Anomalies|congenital anomalies
418029|NCT00001161|Neural Crest|neural crest
418030|NCT00001161|Increased Intraocular Pressure|increased intraocular pressure
418031|NCT00001161|Glaucoma|glaucoma
418032|NCT00001161|Axenfeld's Syndrome|axenfeld's syndrome
418033|NCT00001161|Rieger's Anomaly|rieger's anomaly
418034|NCT00001161|Peter's Anomaly|peter's anomaly
418035|NCT00001161|Iridocorneal Endothelial Syndrome|iridocorneal endothelial syndrome
418036|NCT00001161|Aniridia|aniridia
418037|NCT00001161|Pigment Dispersion Syndrome|pigment dispersion syndrome
418038|NCT00001161|Megalocornea|megalocornea
418041|NCT00001162|Cryptosporidium|cryptosporidium
418042|NCT00001162|Hookworms|hookworms
418043|NCT00001162|Trichuris|trichuris
418044|NCT00001162|Strongyloides|strongyloides
418045|NCT00001162|Protozoa|protozoa
418046|NCT00001162|Small Bowel Biopsy|small bowel biopsy
418047|NCT00001162|E. Histolytica|e. histolytica
418048|NCT00001162|Duodenal Aspiration|duodenal aspiration
418049|NCT00001162|Coccidiosis|coccidiosis
418050|NCT00001162|Clonorchis|clonorchis
418051|NCT00001162|Amebiasis|amebiasis
418052|NCT00001162|Parasitic Disease|parasitic disease
418053|NCT00001162|Tapeworm|tapeworm
418054|NCT00001162|Trichinosis|trichinosis
418055|NCT00001162|Gastrointestinal Trematodes|gastrointestinal trematodes
418056|NCT00001162|Opisthorchis|opisthorchis
418057|NCT00001162|Paragonimiasis|paragonimiasis
418058|NCT00001162|Echinococcus|echinococcus
418059|NCT00001163|Cancer|cancer
418060|NCT00001163|Genes/Genetics|genes/genetics
418061|NCT00001163|Hereditary Neoplasms|hereditary neoplasms
418062|NCT00001163|Environment|environment
418063|NCT00001164|Genetic Evaluation|genetic evaluation
418064|NCT00001164|Immunologic Evaluations|immunologic evaluations
418065|NCT00001164|Inflammatory Skin Disease|inflammatory skin disease
418066|NCT00001164|Muscular Dystrophies|muscular dystrophies
418067|NCT00001164|Neoplastic Skin Diseases|neoplastic skin diseases
418068|NCT00001164|Neuronal Degenerations|neuronal degenerations
418069|NCT00001164|Retinal Degenerations|retinal degenerations
418070|NCT00001164|Viral Diseases|viral diseases
418071|NCT00001165|Gastrinoma|gastrinoma
418072|NCT00001165|Acid Secretion|acid secretion
418073|NCT00001165|Toxicity|toxicity
418074|NCT00001166|Hyperornithinemia|hyperornithinemia
418075|NCT00001166|Ornithine-Aminotransferase (OAT)|ornithine-aminotransferase (oat)
418076|NCT00001166|Tissue Culture|tissue culture
418077|NCT00001166|Pyridoxine Hydrochloride|pyridoxine hydrochloride
418078|NCT00001166|Pyridoxal Phosphate|pyridoxal phosphate
418079|NCT00001166|Arginine|arginine
418080|NCT00001166|Skin Fibroblast|skin fibroblast
418081|NCT00001166|Gyrate Atrophy|gyrate atrophy
418082|NCT00001166|Autosomal Recessive Retinitis Pigmentosa|autosomal recessive retinitis pigmentosa
418083|NCT00001166|Bietti's Crystalline Retinopathy|bietti's crystalline retinopathy
418084|NCT00001166|Chorioretinal Degeneration|chorioretinal degeneration
418085|NCT00001167|Dysphagia|dysphagia
418086|NCT00001167|Dysarthria|dysarthria
418087|NCT00001167|Tongue Motion|tongue motion
418088|NCT00001167|Xerostomia|xerostomia
418089|NCT00001167|Swallowing|swallowing
418090|NCT00001167|Speech|speech
418091|NCT00001167|Polymyositis|polymyositis
418092|NCT00001167|Speech Disorders|speech disorders
418093|NCT00001167|Oral-Facial Paralysis|oral-facial paralysis
418094|NCT00001167|Ultrasound|ultrasound
418095|NCT00001168|Dyslipoproteinemia|dyslipoproteinemia
418096|NCT00001168|Hypercholesterolemia|hypercholesterolemia
418097|NCT00001168|Hypertriglyceridemia|hypertriglyceridemia
418098|NCT00001168|hypoalphalipoproteinemia|hypoalphalipoproteinemia
418099|NCT00001168|Atherosclerosis|atherosclerosis
418100|NCT00001168|Type III Hyperlipoproteinemia|type iii hyperlipoproteinemia
418101|NCT00001168|Plasma Lipoproteins|plasma lipoproteins
418102|NCT00001169|Chemotherapy|chemotherapy
418103|NCT00001169|Cytokines|cytokines
418104|NCT00001169|Immunology|immunology
418105|NCT00001169|Kala-Azar|kala-azar
418106|NCT00001169|Leishmaniasis|leishmaniasis
418107|NCT00001170|Parental Psychopathology|parental psychopathology
418108|NCT00001170|Child Rearing|child rearing
418109|NCT00001170|Depression|depression
418110|NCT00001170|Bipolar Affective Disorders|bipolar affective disorders
418111|NCT00001170|Manic-Depression|manic-depression
418112|NCT00001170|Social-Emotional Development|social-emotional development
418113|NCT00001170|Cognitive Development|cognitive development
418114|NCT00001170|Child Psychopathology|child psychopathology
418115|NCT00001170|Affective Disorder|affective disorder
418116|NCT00001170|Children at Risk|children at risk
418117|NCT00001171|Brain Tumors|brain tumors
418118|NCT00001171|Glioma|glioma
418119|NCT00001171|Glioblastoma Multiforme|glioblastoma multiforme
418120|NCT00001171|Pituitary Adenoma|pituitary adenoma
418121|NCT00001172|Vision|vision
418122|NCT00001172|Eye Movement|eye movement
418123|NCT00001172|Perception|perception
418124|NCT00001172|Healthy Volunteer|healthy volunteer
418125|NCT00001173|B Cells|b cells
418126|NCT00001173|Humoral Immunity|humoral immunity
418127|NCT00001173|Lymphocytes|lymphocytes
418128|NCT00001173|Tetanus Toxoid|tetanus toxoid
418129|NCT00001174|Bipolar Manic-Depressive Illness|bipolar manic-depressive illness
418130|NCT00001174|Affective Disorder|affective disorder
418131|NCT00001174|Depression|depression
418132|NCT00001174|Genetic|genetic
418133|NCT00001174|DNA|dna
418134|NCT00001174|Mania|mania
418135|NCT00001174|Affected Sibling Pairs|affected sibling pairs
418136|NCT00001174|Family Study|family study
418137|NCT00001174|Genome-Wide Scan|genome-wide scan
418138|NCT00001174|Lymphoblastoid Cell Lines|lymphoblastoid cell lines
418139|NCT00001174|Diagnostic Interview for Genetic Studies (DIGS)|diagnostic interview for genetic studies (digs)
418140|NCT00001174|Panic Disorder|panic disorder
418141|NCT00001174|Bipolar Disorder|bipolar disorder
418142|NCT00001176|Adrenergic Nervous System|adrenergic nervous system
418143|NCT00001176|Dopaminergic Nervous System|dopaminergic nervous system
418144|NCT00001176|Salt-Sensitive Hypertension|salt-sensitive hypertension
418145|NCT00001176|Hypertension|hypertension
418146|NCT00001176|Primary Aldosteronism|primary aldosteronism
418147|NCT00001177|Mood|mood
418148|NCT00001177|Depression|depression
418149|NCT00001177|Cognition|cognition
418150|NCT00001177|Menstrual|menstrual
418151|NCT00001177|Neuroendocrine|neuroendocrine
418152|NCT00001177|Genetics|genetics
418153|NCT00001177|PMDD|pmdd
418154|NCT00001177|PMS Premenstrual Syndrome|pms premenstrual syndrome
418155|NCT00001177|MRMD Menstrually Related Mood Disorder|mrmd menstrually related mood disorder
418156|NCT00001178|Alzheimer's Disease|alzheimer's disease
418157|NCT00001178|Cerebral Metabolism|cerebral metabolism
418158|NCT00001178|Cerebrospinal Fluid|cerebrospinal fluid
751308|NCT01169207|IC|ic
418159|NCT00001178|Dementia of the Alzheimer Type|dementia of the alzheimer type
418160|NCT00001178|18-F-Fluoro-2-Deoxy-D-Glucose (FDG)|18-f-fluoro-2-deoxy-d-glucose (fdg)
418161|NCT00001178|Magnetic Resonance Imaging|magnetic resonance imaging
418162|NCT00001178|Positron Emission Tomography|positron emission tomography
418163|NCT00001178|X-Ray Computed Tomography (CT)|x-ray computed tomography (ct)
418164|NCT00001178|Senile Dementia|senile dementia
418165|NCT00001178|Down Syndrome|down syndrome
418166|NCT00001178|Trisomy 21|trisomy 21
418167|NCT00001180|Corticotropin Releasing Hormone|corticotropin releasing hormone
418168|NCT00001180|Cushing Syndrome|cushing syndrome
418169|NCT00001180|Psychiatric Hypercortisolism|psychiatric hypercortisolism
418170|NCT00001180|Adrenal Insufficiency|adrenal insufficiency
418171|NCT00001180|Normal Volunteer|normal volunteer
418172|NCT00001181|McCune-Albright Syndrome|mccune-albright syndrome
418173|NCT00001181|Aromatase Inhibitor|aromatase inhibitor
418174|NCT00001181|Teslac|teslac
418175|NCT00001182|General Dental|general dental
418176|NCT00001182|Diagnostic|diagnostic
418177|NCT00001182|Therapeutic|therapeutic
418178|NCT00001183|Computed Tomography|computed tomography
418179|NCT00001183|Fiberoptic Bronchoscopy|fiberoptic bronchoscopy
418180|NCT00001183|Pulmonary Function Testing|pulmonary function testing
418181|NCT00001183|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
418182|NCT00001183|Allergen Skin Testing|allergen skin testing
418183|NCT00001183|Chronic Lung Disease|chronic lung disease
418184|NCT00001184|Inflammatory Bowel Disease|inflammatory bowel disease
418185|NCT00001184|Regional Enteritis|regional enteritis
418186|NCT00001184|Crohn's Disease|crohn's disease
418187|NCT00001184|Ulcerative Colitis|ulcerative colitis
418188|NCT00001184|IBD|ibd
418189|NCT00001185|Poliomyelitis|poliomyelitis
418190|NCT00001185|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
418191|NCT00001185|Motor Neurons|motor neurons
418192|NCT00001185|Late Viral Infection|late viral infection
418193|NCT00001185|Motor Neuron Firing|motor neuron firing
418194|NCT00001185|Immune Defects|immune defects
418195|NCT00001185|Post-polio Syndrome|post-polio syndrome
418196|NCT00001185|Post-polio Motor Neuron Disease|post-polio motor neuron disease
418197|NCT00001186|Psychosocial|psychosocial
418198|NCT00001186|Self Esteem|self esteem
418199|NCT00001186|Oncology|oncology
418200|NCT00001186|Well-Being|well-being
418201|NCT00001186|Pediatrics|pediatrics
418202|NCT00001188|Chemotherapy|chemotherapy
418203|NCT00001188|Radiation Therapy|radiation therapy
418205|NCT00001188|Surgery|surgery
418206|NCT00001189|Adjuvant Radiotherapy|adjuvant radiotherapy
418207|NCT00001189|Low-Grade Sarcoma|low-grade sarcoma
418208|NCT00001189|Radiotherapy|radiotherapy
418209|NCT00001189|Randomized Study|randomized study
418210|NCT00001189|Sarcoma|sarcoma
418211|NCT00001189|Surgery|surgery
418212|NCT00001190|Growth|growth
418213|NCT00001190|Adolescence|adolescence
418214|NCT00001190|Children|children
418215|NCT00001191|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
418216|NCT00001191|Gastrinoma|gastrinoma
418217|NCT00001191|Acid Hypersecretion|acid hypersecretion
418218|NCT00001191|H+-K+ ATPase Inhibitor|h+-k+ atpase inhibitor
418219|NCT00001192|Executive Functions|executive functions
418220|NCT00001192|Language|language
418221|NCT00001192|Attention|attention
418222|NCT00001192|Visual-Spatial Ability|visual-spatial ability
418223|NCT00001192|Memory|memory
418224|NCT00001192|Motor Behavior|motor behavior
418225|NCT00001192|Intelligence|intelligence
418226|NCT00001192|Personality|personality
418227|NCT00001192|Visual and Auditory Functioning|visual and auditory functioning
418228|NCT00001192|Hand and Eye Dominance|hand and eye dominance
418229|NCT00001192|Normal Volunteer|normal volunteer
418230|NCT00001192|Neuropsychiatric Disorders|neuropsychiatric disorders
418231|NCT00001193|Autologous|autologous
418232|NCT00001193|Melphalan|melphalan
418233|NCT00001193|Stage III|stage iii
418234|NCT00001193|Transplantation|transplantation
418235|NCT00001194|Helium Cryogen|helium cryogen
418236|NCT00001194|Magnetic Field|magnetic field
418237|NCT00001194|Multi-Institute|multi-institute
418238|NCT00001194|Nitrogen Cryogen|nitrogen cryogen
418239|NCT00001194|Radiofrequency|radiofrequency
418241|NCT00001195|Hormones|hormones
418242|NCT00001195|Growth|growth
418243|NCT00001195|Metabolism|metabolism
418244|NCT00001195|Eating Behavior|eating behavior
418245|NCT00001195|Body Composition|body composition
418246|NCT00001195|Normal Volunteer|normal volunteer
418247|NCT00001196|Salivary Function|salivary function
418248|NCT00001196|Salivary Gland|salivary gland
418249|NCT00001196|Sjogren's Syndrome|sjogren's syndrome
418250|NCT00001196|Dry Mouth|dry mouth
418251|NCT00001197|Gene Expression Therapy|gene expression therapy
418252|NCT00001197|Gamma Globin Gene|gamma globin gene
418253|NCT00001197|Hemoglobin Switching|hemoglobin switching
418254|NCT00001197|Bone Marrow|bone marrow
418255|NCT00001197|Sickle Cell Anemia|sickle cell anemia
418256|NCT00001198|Schizophrenia|schizophrenia
418257|NCT00001198|Observational|observational
418258|NCT00001201|Nerve Conduction Studies|nerve conduction studies
418259|NCT00001201|EMG|emg
418260|NCT00001201|Normal Volunteer|normal volunteer
418261|NCT00001201|Electrophysiology|electrophysiology
418262|NCT00001201|Peripheral Neuropathies|peripheral neuropathies
418263|NCT00001201|Myopathies|myopathies
418264|NCT00001202|Luteinizing Hormone|luteinizing hormone
418265|NCT00001202|High Serum Testosterone Levels|high serum testosterone levels
418266|NCT00001202|Low Baseline Gonadotropin|low baseline gonadotropin
418267|NCT00001202|LHRH|lhrh
418268|NCT00001202|Precocious Puberty|precocious puberty
418269|NCT00001202|Familial Isosexual Precocious Puberty|familial isosexual precocious puberty
418270|NCT00001203|Desferal|desferal
418271|NCT00001203|Thalassemia|thalassemia
418272|NCT00001203|Liver Iron Concentration|liver iron concentration
418273|NCT00001203|Endocrine Evaluation|endocrine evaluation
418274|NCT00001203|Diabetes Mellitus|diabetes mellitus
418283|NCT00001206|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
418284|NCT00001206|Disruptive Behavior Disorders|disruptive behavior disorders
418286|NCT00001206|Lumbar Puncture|lumbar puncture
418287|NCT00001206|CSF|csf
418288|NCT00001206|Longitudinal Prospective Follow-Up|longitudinal prospective follow-up
418289|NCT00001206|Psychosocial Functioning|psychosocial functioning
418290|NCT00001206|Risk Factors|risk factors
418291|NCT00001206|Genetics|genetics
418301|NCT00001209|Combined Chemotherapy|combined chemotherapy
418302|NCT00001209|Irradiation|irradiation
418303|NCT00001209|Unresectable|unresectable
418304|NCT00001210|Blood Donors|blood donors
418305|NCT00001210|Epitopes|epitopes
418306|NCT00001210|HIV|hiv
418307|NCT00001211|Ectodermal Dysplasia|ectodermal dysplasia
418308|NCT00001211|Edentulous|edentulous
418309|NCT00001211|Endosseous|endosseous
418310|NCT00001211|Implants|implants
418311|NCT00001211|Mandibular Atrophy|mandibular atrophy
418312|NCT00001211|Oral|oral
418313|NCT00001211|Titanium|titanium
418314|NCT00001212|Systemic Lupus Erythematosus|systemic lupus erythematosus
418315|NCT00001212|Nephrotic Syndrome|nephrotic syndrome
418316|NCT00001212|Immunosuppressive Drugs|immunosuppressive drugs
418317|NCT00001212|Prednisone|prednisone
418318|NCT00001212|Methylprednisolone|methylprednisolone
418319|NCT00001212|Cyclophosphamide|cyclophosphamide
418320|NCT00001212|Cyclosporine|cyclosporine
418321|NCT00001212|Cyclosporin A|cyclosporin a
10182|NCT03225664|Metastatic|metastatic
418322|NCT00001213|Cysteamine Eye Drops|cysteamine eye drops
418323|NCT00001213|Nephropathic Cystinosis|nephropathic cystinosis
418324|NCT00001213|Corneal Crystals|corneal crystals
418325|NCT00001213|Benzalkonium|benzalkonium
418326|NCT00001213|Toxicity|toxicity
418327|NCT00001213|Efficacy|efficacy
418328|NCT00001213|Cystinosis|cystinosis
418329|NCT00001214|Bone Marrow Failure|bone marrow failure
418330|NCT00001214|Lymphocytapheresis|lymphocytapheresis
418331|NCT00001214|Pancytopenia|pancytopenia
418332|NCT00001214|Aplastic Anemia|aplastic anemia
418333|NCT00001214|Hematosuppressive Disease|hematosuppressive disease
418334|NCT00001215|Lysosomal Storage Disorders|lysosomal storage disorders
418335|NCT00001215|Variants|variants
418336|NCT00001215|Chemical Phenotype|chemical phenotype
418337|NCT00001215|Proteins|proteins
418338|NCT00001215|Genes|genes
418339|NCT00001215|Phenotype|phenotype
418340|NCT00001215|Mutations|mutations
418341|NCT00001215|Parkinsonism|parkinsonism
418342|NCT00001216|Amputations|amputations
418343|NCT00001216|Brainstem Stimulation|brainstem stimulation
418344|NCT00001216|Cerebellar Stimulation|cerebellar stimulation
418345|NCT00001216|Cortical Motor Physiology|cortical motor physiology
418346|NCT00001216|Electrical Stimulation|electrical stimulation
418347|NCT00001216|Motor Cortex|motor cortex
418348|NCT00001216|Plasticity|plasticity
418349|NCT00001216|Spinal Cord Injury|spinal cord injury
418350|NCT00001216|Stroke|stroke
418351|NCT00001217|Non-Metastatic Osteosarcoma|non-metastatic osteosarcoma
418352|NCT00001217|Presurgical Chemotherapy|presurgical chemotherapy
418353|NCT00001218|Baseline Data|baseline data
418354|NCT00001218|Curve Averaging|curve averaging
418355|NCT00001218|Curve Fitting|curve fitting
418356|NCT00001218|Movement Patterns|movement patterns
418357|NCT00001218|Normative Data|normative data
418358|NCT00001218|Polar Distribution|polar distribution
418359|NCT00001218|Tongue|tongue
418360|NCT00001218|Tongue Shape|tongue shape
418361|NCT00001218|Ultrasound|ultrasound
418362|NCT00001219|Magnetic Resonance Imaging|magnetic resonance imaging
418363|NCT00001219|Pulse Sequences|pulse sequences
418364|NCT00001220|Swallowing Disorders|swallowing disorders
418365|NCT00001220|Neuromotor Dysfunction|neuromotor dysfunction
418366|NCT00001220|Aspiration|aspiration
418367|NCT00001220|Imaging|imaging
418368|NCT00001221|Growth|growth
418369|NCT00001221|Gonadal Dysgenesis|gonadal dysgenesis
418370|NCT00001221|Estrogen|estrogen
418371|NCT00001221|Somatotropin|somatotropin
418372|NCT00001221|Turner's Syndrome|turner's syndrome
418373|NCT00001221|Growth Hormone|growth hormone
418374|NCT00001223|Cystic Fibrosis|cystic fibrosis
751309|NCT01169220|Colonoscopy|colonoscopy
418375|NCT00001223|Pancreatic Insufficiency|pancreatic insufficiency
418376|NCT00001223|Bronchiectasis|bronchiectasis
418377|NCT00001224|Ocular Inflammatory Disease|ocular inflammatory disease
418378|NCT00001224|Cataracts|cataracts
418379|NCT00001224|Vitrectomy|vitrectomy
418380|NCT00001224|Extracapsular|extracapsular
418381|NCT00001224|Cataract Surgery|cataract surgery
418382|NCT00001224|Uveitis|uveitis
418383|NCT00001224|Lenticular Opacity|lenticular opacity
418384|NCT00001224|Vitreal Opacity|vitreal opacity
418385|NCT00001225|DNA Polymorphisms|dna polymorphisms
418386|NCT00001225|Echocardiography|echocardiography
418387|NCT00001225|Gene Mapping|gene mapping
418388|NCT00001225|Linkage Analysis|linkage analysis
418389|NCT00001225|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
418390|NCT00001226|Nonradioactive Isotopes|nonradioactive isotopes
418391|NCT00001226|Lipoprotein Kinetics|lipoprotein kinetics
418392|NCT00001226|Apolipoproteins|apolipoproteins
418393|NCT00001226|Dyslipoproteinemia|dyslipoproteinemia
418394|NCT00001226|Healthy Volunteers|healthy volunteers
418395|NCT00001228|Interferon|interferon
418396|NCT00001228|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
418397|NCT00001229|Calcium-Pentagastrin|calcium-pentagastrin
418398|NCT00001229|Clonidine|clonidine
418399|NCT00001229|Glucagon|glucagon
418400|NCT00001229|Pheochromocytoma|pheochromocytoma
418401|NCT00001230|Wuchereria Bancrofti|wuchereria bancrofti
418402|NCT00001230|Loa Loa|loa loa
418403|NCT00001230|Brugia Malayi|brugia malayi
418404|NCT00001230|Brugia Timori|brugia timori
418405|NCT00001230|Onchocerca Volvulus|onchocerca volvulus
418406|NCT00001230|Mansonella Perstans|mansonella perstans
418407|NCT00001230|Mansonella Ozzardi|mansonella ozzardi
418408|NCT00001230|Diethylcarbamazine (DEC)|diethylcarbamazine (dec)
418409|NCT00001230|Suramin|suramin
418410|NCT00001230|Ivermectin|ivermectin
418411|NCT00001230|Filarial Infection|filarial infection
418412|NCT00001231|Mood|mood
418413|NCT00001231|Behavior|behavior
418414|NCT00001231|Cognition|cognition
418415|NCT00001231|Climacteric|climacteric
418416|NCT00001231|Menopause|menopause
418417|NCT00001231|Perimenopause|perimenopause
418418|NCT00001231|Midlife|midlife
418419|NCT00001231|Depression|depression
418420|NCT00001232|Depression|depression
418421|NCT00001232|FSH|fsh
418422|NCT00001232|GnRH|gnrh
418423|NCT00001232|LH|lh
418424|NCT00001232|Menopause|menopause
418425|NCT00001232|Menstrual Cycle|menstrual cycle
418429|NCT00001233|Developmental Psychopathology|developmental psychopathology
418430|NCT00001233|Disruptive Behavior Disorders|disruptive behavior disorders
418431|NCT00001233|Early Onset Aggression|early onset aggression
418432|NCT00001233|Emotion Regulation|emotion regulation
418433|NCT00001233|Family Violence|family violence
418434|NCT00001233|Preschool Conduct Problems|preschool conduct problems
418435|NCT00001234|Bone Marrow|bone marrow
418436|NCT00001234|Retroviral-Mediated Gene Transfer|retroviral-mediated gene transfer
418437|NCT00001234|Hematopoietic Progenitor Cell|hematopoietic progenitor cell
418438|NCT00001235|Primary Neuronal Degeneration|primary neuronal degeneration
418439|NCT00001235|Genetics|genetics
418440|NCT00001235|Neurotransmitters|neurotransmitters
418441|NCT00001235|DNA|dna
418442|NCT00001235|Lymphoblasts|lymphoblasts
418443|NCT00001235|Skin Fibroblast|skin fibroblast
418444|NCT00001235|Alzheimer's Disease|alzheimer's disease
418445|NCT00001237|Burkitt's Lymphoma|burkitt's lymphoma
418446|NCT00001237|GM-CSF|gm-csf
418447|NCT00001237|High-Grade|high-grade
418448|NCT00001238|Urologic Malignant Disorders|urologic malignant disorders
418449|NCT00001238|Birt Hogg Dube|birt hogg dube
418450|NCT00001238|Von Hippel Lindau|von hippel lindau
418451|NCT00001238|Hereditary Papillary Renal Cancer/Renal Cell Acarcinoma|hereditary papillary renal cancer/renal cell acarcinoma
418452|NCT00001239|5-Fluorouracil|5-fluorouracil
418453|NCT00001239|Adriamycin|adriamycin
418454|NCT00001239|Breast Carcinoma|breast carcinoma
418455|NCT00001239|Leucovorin|leucovorin
418456|NCT00001239|Phase II|phase ii
418457|NCT00001240|Stomach|stomach
418458|NCT00001240|Hypersecretion|hypersecretion
418459|NCT00001240|Hyposecretion|hyposecretion
418460|NCT00001240|Gastrinoma|gastrinoma
418461|NCT00001240|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
418462|NCT00001241|Gastric Acid Secretion|gastric acid secretion
419586|NCT00001483|Depression|depression
418463|NCT00001241|Histamine H2-Receptor Antagonists|histamine h2-receptor antagonists
418464|NCT00001242|Calcium|calcium
418465|NCT00001242|Vitamin D|vitamin d
418466|NCT00001242|Calcitriol|calcitriol
418467|NCT00001242|Parathyroid|parathyroid
418468|NCT00001242|Cyclic AMP|cyclic amp
418469|NCT00001242|Rickets|rickets
418470|NCT00001243|AIDS|aids
418471|NCT00001243|Myeloid Progenitors|myeloid progenitors
418472|NCT00001243|Monocytes|monocytes
418473|NCT00001243|Plasmid Libraries|plasmid libraries
418474|NCT00001243|Cytokines|cytokines
418475|NCT00001244|Agammaglobulinemia|agammaglobulinemia
418476|NCT00001244|Primary Immune Deficiency|primary immune deficiency
418477|NCT00001244|Immune Response|immune response
418478|NCT00001245|Strongyloidiasis|strongyloidiasis
418479|NCT00001245|Immediate Hypersensitivity Skin Test|immediate hypersensitivity skin test
418480|NCT00001245|IgE|ige
418481|NCT00001245|Nematode|nematode
418482|NCT00001245|Immunosuppression|immunosuppression
418483|NCT00001245|Skin Test|skin test
418484|NCT00001245|Diagnosis|diagnosis
418485|NCT00001245|Intestinal Helminth|intestinal helminth
418486|NCT00001245|Immediate Hypersensitivity|immediate hypersensitivity
418487|NCT00001246|Cognitive|cognitive
418488|NCT00001246|Genetics|genetics
418489|NCT00001246|Development|development
418490|NCT00001246|Klinefelter Syndrome|klinefelter syndrome
418491|NCT00001246|Jacob Syndrome|jacob syndrome
418492|NCT00001246|Trisomy X|trisomy x
418493|NCT00001246|Healthy Volunteer|healthy volunteer
418494|NCT00001246|XXY|xxy
418495|NCT00001246|XXXY|xxxy
418496|NCT00001246|XXXXY|xxxxy
418497|NCT00001246|XYY|xyy
418498|NCT00001246|XXYY|xxyy
418499|NCT00001246|XO|xo
418500|NCT00001246|XXXX|xxxx
418501|NCT00001246|XXX|xxx
418502|NCT00001246|XXXXX|xxxxx
418503|NCT00001246|Triple X|triple x
418504|NCT00001246|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
418505|NCT00001246|Twin|twin
418506|NCT00001247|Schizophrenia|schizophrenia
418507|NCT00001247|Psychosis|psychosis
418508|NCT00001247|Neuroleptics|neuroleptics
418509|NCT00001247|Schizoaffective Disorder|schizoaffective disorder
418510|NCT00001248|Multiple Sclerosis|multiple sclerosis
418511|NCT00001248|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
418512|NCT00001249|Interleukin-2 Receptor|interleukin-2 receptor
418513|NCT00001250|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
418514|NCT00001250|Dose Intense Chemotherapy|dose intense chemotherapy
418515|NCT00001250|Stage II Breast Cancer|stage ii breast cancer
418516|NCT00001250|Early Stage Breast Cancer|early stage breast cancer
418517|NCT00001251|Meningeal Malignancy|meningeal malignancy
418518|NCT00001251|Pediatric|pediatric
418519|NCT00001251|Alkylating Agents|alkylating agents
418520|NCT00001252|Biomechanics|biomechanics
418521|NCT00001252|Kinesiology|kinesiology
418522|NCT00001252|Walking|walking
418523|NCT00001252|ACL|acl
418524|NCT00001252|Stroke|stroke
418525|NCT00001252|Leg Weakness|leg weakness
418526|NCT00001252|Paralysis|paralysis
418527|NCT00001252|Anterior Cruciate Ligament|anterior cruciate ligament
418528|NCT00001252|Gait Degicit|gait degicit
418529|NCT00001253|Turner's Syndrome|turner's syndrome
418530|NCT00001253|Estrogen|estrogen
418531|NCT00001253|Ethinyl estradiol|ethinyl estradiol
418532|NCT00001253|Learning|learning
418533|NCT00001253|Ovarian dysgenesis|ovarian dysgenesis
418534|NCT00001254|Islet Cell Tumors|islet cell tumors
418535|NCT00001255|Retroviral Vector|retroviral vector
418536|NCT00001255|Gene Therapy|gene therapy
418537|NCT00001255|PEG-ADA|peg-ada
418538|NCT00001255|Severe Combined Immunodeficiency (SCID)|severe combined immunodeficiency (scid)
418539|NCT00001255|Adenosine Deaminase Deficiency (ADA)|adenosine deaminase deficiency (ada)
418540|NCT00001256|Vasculitis|vasculitis
418541|NCT00001256|Cytotoxic Therapy|cytotoxic therapy
418542|NCT00001256|Inflammation|inflammation
418543|NCT00001256|Glomerulonephritis|glomerulonephritis
418544|NCT00001256|Inflammatory Sinusitis|inflammatory sinusitis
418545|NCT00001257|Lymphokines|lymphokines
418546|NCT00001257|LTB4|ltb4
418547|NCT00001257|Inflammation|inflammation
418548|NCT00001257|Normal Volunteer|normal volunteer
418549|NCT00001257|Abnormal Phagocyte Function|abnormal phagocyte function
418550|NCT00001258|Neuropsychology|neuropsychology
418551|NCT00001258|Cerebral Blood Flow|cerebral blood flow
418552|NCT00001258|Cognitive Disorders|cognitive disorders
418553|NCT00001258|Prefrontal Cortex|prefrontal cortex
418554|NCT00001258|Hormones|hormones
418555|NCT00001258|Psychosis|psychosis
418556|NCT00001258|Neuroimaging|neuroimaging
418557|NCT00001258|Brain Scan|brain scan
418558|NCT00001258|Healthy Volunteers|healthy volunteers
418559|NCT00001258|Schizophrenia|schizophrenia
418560|NCT00001259|Depression|depression
418561|NCT00001259|Menstrual Cycle|menstrual cycle
418562|NCT00001259|Gonadal Steroids|gonadal steroids
418563|NCT00001259|GnRH Agonist|gnrh agonist
418564|NCT00001259|Mood Disorders|mood disorders
418565|NCT00001260|Schizophrenia|schizophrenia
418566|NCT00001260|Neuropathology|neuropathology
418567|NCT00001260|Neurochemistry|neurochemistry
418568|NCT00001260|Substance Abuse|substance abuse
418569|NCT00001260|Bipolar Disorder|bipolar disorder
418570|NCT00001260|Aging|aging
418571|NCT00001260|Normal Development|normal development
418572|NCT00001260|Depression|depression
418573|NCT00001260|Anxiety Disorders|anxiety disorders
418574|NCT00001260|Suicide|suicide
418575|NCT00001260|Dementia|dementia
418576|NCT00001260|Neuropsychiatric Disorders|neuropsychiatric disorders
418577|NCT00001260|Tourette's Syndrome|tourette's syndrome
418578|NCT00001260|Normal Controls|normal controls
418579|NCT00001261|Polymyositis/Dermatomyositis|polymyositis/dermatomyositis
418580|NCT00001261|Muscle Immunopathology|muscle immunopathology
418581|NCT00001261|Intravenous High-Dose Immunoglobulin|intravenous high-dose immunoglobulin
418582|NCT00001261|Inclusion Body Myositis|inclusion body myositis
418583|NCT00001262|Menkes|menkes
418584|NCT00001262|Copper|copper
418585|NCT00001262|X-Linked|x-linked
418586|NCT00001262|Neurodegeneration|neurodegeneration
418587|NCT00001262|ATP7A|atp7a
418588|NCT00001265|Autoimmune Diseases|autoimmune diseases
418589|NCT00001265|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
418590|NCT00001265|Polymyositis|polymyositis
418591|NCT00001265|Dermatomyositis|dermatomyositis
418592|NCT00001265|Inclusion Body Myositis|inclusion body myositis
418593|NCT00001265|Pathogenesis|pathogenesis
418594|NCT00001265|Connective Tissue Diseases|connective tissue diseases
418595|NCT00001266|Bayesian|bayesian
418596|NCT00001266|Hydroxy-Flutamide|hydroxy-flutamide
418597|NCT00001266|Combined Androgen Ablation|combined androgen ablation
418598|NCT00001266|Prostate Specific Antigen|prostate specific antigen
418599|NCT00001267|Anti-Viral|anti-viral
418600|NCT00001267|Dideoxynucleosides|dideoxynucleosides
418601|NCT00001267|HIV|hiv
418602|NCT00001267|Retrovirus|retrovirus
418603|NCT00001269|Dose-Intensive Chemotherapy|dose-intensive chemotherapy
418604|NCT00001269|Hematopoietic Growth Factor|hematopoietic growth factor
418605|NCT00001269|Peripheral Blood Progenitor Cell|peripheral blood progenitor cell
418606|NCT00001270|Chemotherapy|chemotherapy
418607|NCT00001270|High Dose|high dose
418608|NCT00001270|Protection|protection
418609|NCT00001271|Antigen Modulation|antigen modulation
418610|NCT00001271|Pharmacokinetics|pharmacokinetics
418611|NCT00001271|Ricin A Chain|ricin a chain
418612|NCT00001272|Adult|adult
418613|NCT00001272|Cytotoxic Chemotherapy|cytotoxic chemotherapy
418614|NCT00001272|Hematopoietic Growth Factor|hematopoietic growth factor
418615|NCT00001275|Menopause|menopause
418616|NCT00001275|Estrogen|estrogen
418617|NCT00001275|Infertility|infertility
418618|NCT00001275|Ovulation|ovulation
418619|NCT00001275|Amenorrhea|amenorrhea
418620|NCT00001275|Hypergonadotropic Hypogonadism|hypergonadotropic hypogonadism
418621|NCT00001275|Young Women|young women
418622|NCT00001275|Gonadal Steroid Deficiency|gonadal steroid deficiency
418623|NCT00001275|Mineralocorticoid Deficiency|mineralocorticoid deficiency
418624|NCT00001275|Premature Ovarian Failure|premature ovarian failure
418625|NCT00001275|POF|pof
418626|NCT00001276|Hypoglycemia|hypoglycemia
418627|NCT00001276|Insulinoma|insulinoma
418628|NCT00001277|Hypoglycemia|hypoglycemia
418629|NCT00001277|Genetics|genetics
418630|NCT00001277|Hyperparathyroidism|hyperparathyroidism
418631|NCT00001278|Conjunctival Biopsy|conjunctival biopsy
418632|NCT00001278|Lacrimal Gland Biopsy|lacrimal gland biopsy
418633|NCT00001278|Sarcoid Uveitis|sarcoid uveitis
418634|NCT00001278|Sarcoidosis|sarcoidosis
418635|NCT00001278|Conjunctiva|conjunctiva
418636|NCT00001278|Inflammatory Eye Disease|inflammatory eye disease
418637|NCT00001280|Aspergillosis|aspergillosis
521759|NCT00282113|NEC|nec
418638|NCT00001280|Phagocyte Defect|phagocyte defect
418639|NCT00001280|Torulopsis|torulopsis
418640|NCT00001280|Chronic Granulomatous Disease|chronic granulomatous disease
418641|NCT00001281|Lymphocytes|lymphocytes
418642|NCT00001281|Venipuncture|venipuncture
418643|NCT00001281|Mononuclear Cells|mononuclear cells
418644|NCT00001282|HIV|hiv
418645|NCT00001282|Immunomodulator|immunomodulator
418646|NCT00001282|Anti-Viral|anti-viral
418647|NCT00001284|Cognition|cognition
418648|NCT00001284|Schizophrenia|schizophrenia
418649|NCT00001284|Magnetic Resonance Imaging|magnetic resonance imaging
418650|NCT00001284|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
418651|NCT00001284|Dopaminergic Mechanisms|dopaminergic mechanisms
418652|NCT00001285|Circadian Rhythms|circadian rhythms
418653|NCT00001285|Environmental Light|environmental light
418654|NCT00001285|Estrogen|estrogen
418655|NCT00001285|Melatonin|melatonin
418656|NCT00001285|Progesterone|progesterone
418657|NCT00001285|Rapid Cycling Bipolar Disorder|rapid cycling bipolar disorder
418658|NCT00001285|Sleep|sleep
418659|NCT00001285|Testosterone|testosterone
418660|NCT00001285|Depression|depression
418661|NCT00001285|Hypomania|hypomania
418662|NCT00001285|Mania|mania
418663|NCT00001287|Intravenous High-Dose Immunoglobulin|intravenous high-dose immunoglobulin
418664|NCT00001287|Monoclonal Gammopathies|monoclonal gammopathies
418665|NCT00001287|Peripheral Nerve Demyelination|peripheral nerve demyelination
418666|NCT00001287|CIDP|cidp
418781|NCT00001310|Ocular Disease|ocular disease
418667|NCT00001287|Chronic Inflammatory Demyelinating Polyneuropathy|chronic inflammatory demyelinating polyneuropathy
418668|NCT00001288|Positron Emission Tomography|positron emission tomography
418669|NCT00001288|Epilepsy|epilepsy
418670|NCT00001288|Stroke|stroke
418671|NCT00001289|Enzyme Replacement|enzyme replacement
418672|NCT00001289|Type 3 Gaucher's Disease|type 3 gaucher's disease
418673|NCT00001289|Lysosomal Storage|lysosomal storage
418674|NCT00001289|Supranuclear Gaze Palsy|supranuclear gaze palsy
418675|NCT00001289|Seizures|seizures
418676|NCT00001289|Mental Retardation|mental retardation
418677|NCT00001289|Gaucher Disease|gaucher disease
418678|NCT00001291|Osteoarthritis|osteoarthritis
418679|NCT00001291|Psoriatic Arthritis|psoriatic arthritis
418680|NCT00001291|Rheumatoid Arthritis|rheumatoid arthritis
522809|NCT00293787|ocular|ocular
418681|NCT00001291|Synovial Biopsy|synovial biopsy
418682|NCT00001291|Synovitis|synovitis
418683|NCT00001291|Synovium|synovium
418684|NCT00001292|DNA Markers|dna markers
418685|NCT00001292|Family Studies|family studies
418686|NCT00001292|Gene Mapping|gene mapping
418687|NCT00001292|Ichthyosis|ichthyosis
418689|NCT00001292|Linkage Analysis|linkage analysis
418690|NCT00001292|Scaling Disorders|scaling disorders
418691|NCT00001292|Skin|skin
418692|NCT00001294|Genetic Linkage|genetic linkage
418693|NCT00001294|Sex Behavior|sex behavior
418694|NCT00001294|AIDS|aids
418695|NCT00001294|Alcohol Dependence|alcohol dependence
418696|NCT00001294|HLA System|hla system
418697|NCT00001294|Cancer|cancer
418698|NCT00001295|Follow-Up|follow-up
418699|NCT00001295|Treatment|treatment
418700|NCT00001296|Interferon-Gamma|interferon-gamma
418701|NCT00001296|Isolated Limb Perfusion|isolated limb perfusion
418702|NCT00001296|Melanoma|melanoma
418703|NCT00001296|Melphalan|melphalan
418704|NCT00001296|TNF|tnf
418705|NCT00001298|Antibody|antibody
418706|NCT00001298|DAMPA|dampa
418707|NCT00001298|Enzyme|enzyme
418708|NCT00001298|Kidney|kidney
418709|NCT00001298|Pharmacokinetics|pharmacokinetics
418710|NCT00001298|Thymidine|thymidine
418711|NCT00001298|Toxicity|toxicity
418712|NCT00001300|Adjuvant Chemotherapy|adjuvant chemotherapy
418713|NCT00001300|Ifosfamide|ifosfamide
418714|NCT00001300|Randomized Study|randomized study
418715|NCT00001300|Soft Tissue Sarcoma|soft tissue sarcoma
418716|NCT00001301|Adverse Effects|adverse effects
418717|NCT00001301|Burkitt's Lymphoma|burkitt's lymphoma
418718|NCT00001301|Diffuse Large Cell Lymphoma|diffuse large cell lymphoma
418719|NCT00001301|Extended Remission|extended remission
418720|NCT00001301|Health Status|health status
418721|NCT00001301|Lymphoblastic Lymphoma|lymphoblastic lymphoma
418722|NCT00001301|Molecular Studies|molecular studies
418723|NCT00001302|Vinblastine|vinblastine
418724|NCT00001302|Multidrug Resistance|multidrug resistance
418725|NCT00001302|Resistance Reversal|resistance reversal
418726|NCT00001302|Pgp Blocker|pgp blocker
418727|NCT00001302|Pharmacokinetics|pharmacokinetics
418728|NCT00001302|Cyclosporine|cyclosporine
418729|NCT00001302|Drug Interactions|drug interactions
418730|NCT00001303|Hemodynamics|hemodynamics
418731|NCT00001303|Lung Permeability|lung permeability
418740|NCT00001304|PTH 1-34|pth 1-34
418741|NCT00001304|Bone|bone
418742|NCT00001305|Osteogenesis Imperfecta|osteogenesis imperfecta
418743|NCT00001306|Infertility|infertility
418744|NCT00001306|Ovulation|ovulation
418745|NCT00001306|Autoimmune|autoimmune
418746|NCT00001306|Follicle|follicle
418747|NCT00001306|Menopause|menopause
418748|NCT00001306|Biopsy|biopsy
418749|NCT00001306|Glucocorticoids|glucocorticoids
418750|NCT00001306|Premature Ovarian Failure|premature ovarian failure
418751|NCT00001306|Amenorrhea|amenorrhea
418752|NCT00001306|Ovarian Failure|ovarian failure
418753|NCT00001306|POF|pof
418754|NCT00001307|Analgesia|analgesia
418755|NCT00001307|PET|pet
418756|NCT00001307|Positron Emission|positron emission
418757|NCT00001307|Functional Brain Imaging|functional brain imaging
418758|NCT00001307|Allodynia|allodynia
418759|NCT00001307|Thalamus|thalamus
418760|NCT00001307|Somatosensory Cortex|somatosensory cortex
418761|NCT00001307|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
418762|NCT00001307|Normal Volunteer|normal volunteer
418763|NCT00001307|Chronic Pain|chronic pain
418764|NCT00001308|Stuttering|stuttering
418765|NCT00001308|Tourette's Syndrome|tourette's syndrome
418766|NCT00001308|Spasmodic Dysphonia|spasmodic dysphonia
418767|NCT00001308|Dysarthria|dysarthria
418768|NCT00001308|Parkinson's Disease|parkinson's disease
418769|NCT00001308|Verbal Dyspraxia|verbal dyspraxia
418770|NCT00001308|Aphasia|aphasia
418771|NCT00001308|Speech|speech
418772|NCT00001308|Motor Control|motor control
418773|NCT00001309|Pharmacokinetics|pharmacokinetics
418774|NCT00001309|Biodistribution|biodistribution
418775|NCT00001309|Ascorbic Acid|ascorbic acid
418776|NCT00001310|Retinal Disease|retinal disease
418777|NCT00001310|Diabetic Retinopathy|diabetic retinopathy
418778|NCT00001310|Uveitis|uveitis
418779|NCT00001310|Age-Related Macular Degeneration|age-related macular degeneration
418780|NCT00001310|Corneal Disease|corneal disease
418782|NCT00001311|Cell/Flare Meter|cell/flare meter
418783|NCT00001311|Heparin Coating|heparin coating
418784|NCT00001311|Inflammation|inflammation
418785|NCT00001311|Laser Cell Flare Photometry|laser cell flare photometry
418786|NCT00001311|Multicentric|multicentric
418787|NCT00001311|Polymethylmetacrylate|polymethylmetacrylate
418788|NCT00001311|Specular Micrography|specular micrography
418789|NCT00001311|Specular Microscopy|specular microscopy
418790|NCT00001313|Cardiac Diagnosis|cardiac diagnosis
418791|NCT00001313|Chest Pain|chest pain
418792|NCT00001313|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
418793|NCT00001313|Coronary Artery Disease|coronary artery disease
418794|NCT00001313|Microvascular Angina|microvascular angina
418795|NCT00001313|Cardiac Investigation|cardiac investigation
418796|NCT00001313|Follow-up|follow-up
418797|NCT00001313|Heart Disease|heart disease
418798|NCT00001314|Aortic Regurgitation|aortic regurgitation
418799|NCT00001314|Dobutamine Stress|dobutamine stress
418800|NCT00001314|Left Ventricular Function|left ventricular function
418801|NCT00001314|Mitral Regurgitation|mitral regurgitation
418802|NCT00001314|Myocardial Contractile Reserve|myocardial contractile reserve
418803|NCT00001314|Transesophageal Echocardiography|transesophageal echocardiography
418804|NCT00001316|Lymph Node|lymph node
418805|NCT00001316|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
418806|NCT00001316|In Situ Hybridization|in situ hybridization
418807|NCT00001316|AIDS|aids
418808|NCT00001316|Excisional Biopsy|excisional biopsy
418809|NCT00001317|Children|children
418810|NCT00001317|Gamma Interferon|gamma interferon
418811|NCT00001317|Hospitalizations|hospitalizations
418812|NCT00001317|Infection|infection
418813|NCT00001317|Chronic Granulomatous Disease|chronic granulomatous disease
418814|NCT00001318|Immune Adjuvant|immune adjuvant
418815|NCT00001318|Phagocytes|phagocytes
418816|NCT00001318|Non-tuberculous Mycobacterial Infection|non-tuberculous mycobacterial infection
418817|NCT00001319|HIV Negative|hiv negative
418818|NCT00001319|CD4 Deficiency|cd4 deficiency
418819|NCT00001319|Retrovirus|retrovirus
418820|NCT00001320|Parkinson's Disease|parkinson's disease
418821|NCT00001320|Schizophrenia|schizophrenia
418822|NCT00001320|Dopamine D2/D3 receptors|dopamine d2/d3 receptors
418823|NCT00001320|Brain Imaging|brain imaging
418824|NCT00001320|SPECT|spect
418825|NCT00001320|Equilibrium|equilibrium
418826|NCT00001320|Brain Scan|brain scan
418827|NCT00001320|Brain Research|brain research
418828|NCT00001320|Brain Disorders|brain disorders
418829|NCT00001320|Schizoaffective Disorder|schizoaffective disorder
418830|NCT00001320|Normal Volunteer|normal volunteer
418831|NCT00001322|Gonadal Steroids|gonadal steroids
418832|NCT00001322|Mood|mood
418833|NCT00001322|Menstrual Cycle|menstrual cycle
418834|NCT00001322|Neuropsychological Testing|neuropsychological testing
418835|NCT00001322|Estrogen|estrogen
418836|NCT00001322|Dexamethasone|dexamethasone
418837|NCT00001322|Progesterone|progesterone
418838|NCT00001322|Central Nervous System Function|central nervous system function
418839|NCT00001322|Estradiol|estradiol
418840|NCT00001322|GnRH Agonist|gnrh agonist
418841|NCT00001323|Cognition|cognition
418842|NCT00001323|Neuropsychology|neuropsychology
418843|NCT00001323|Neuropsychological Tests|neuropsychological tests
418844|NCT00001323|Neurological Exam|neurological exam
418845|NCT00001323|Psychiatric|psychiatric
418846|NCT00001323|Attention|attention
418847|NCT00001323|Schizophrenic|schizophrenic
418848|NCT00001323|Schizoaffective|schizoaffective
418849|NCT00001323|Working Memory|working memory
418850|NCT00001323|Memory|memory
418851|NCT00001324|Ataxia|ataxia
418852|NCT00001324|Brain|brain
418853|NCT00001324|Motor Learning|motor learning
418854|NCT00001324|Parkinson's Disease|parkinson's disease
418855|NCT00001324|Physiology|physiology
418856|NCT00001324|Positron Emission Tomography|positron emission tomography
418857|NCT00001324|Stroke|stroke
418858|NCT00001324|Tremor|tremor
418859|NCT00001324|Voluntary and Involuntary Movement Physiology|voluntary and involuntary movement physiology
418860|NCT00001324|Movement Disorders|movement disorders
418861|NCT00001324|Normal Volunteer|normal volunteer
418862|NCT00001325|Positron|positron
418863|NCT00001325|Tomography|tomography
418864|NCT00001325|Seizures|seizures
418865|NCT00001325|Epileptic Focus|epileptic focus
418866|NCT00001325|Electroencephalography|electroencephalography
418867|NCT00001325|Metabolism|metabolism
418868|NCT00001325|Glucose|glucose
418869|NCT00001325|Cerebral|cerebral
418870|NCT00001325|Positron Emission Tomography|positron emission tomography
418871|NCT00001325|Lennox Gastaut Syndrome|lennox gastaut syndrome
418872|NCT00001327|Syringomyelia|syringomyelia
418873|NCT00001327|Chiari Malformation|chiari malformation
418874|NCT00001327|Magnetic Resonance Imaging|magnetic resonance imaging
418875|NCT00001327|Intraoperative Ultrasonography|intraoperative ultrasonography
418876|NCT00001327|Hydrocephalus|hydrocephalus
418877|NCT00001327|Spinal Cord|spinal cord
418878|NCT00001327|Ventriculostomy|ventriculostomy
418879|NCT00001327|Lumbar Puncture|lumbar puncture
418880|NCT00001327|Pressure Measurement|pressure measurement
418881|NCT00000747|Drug Resistance|drug resistance
418882|NCT00000747|AIDS-Related Complex|aids-related complex
418883|NCT00000747|Antiviral Agents|antiviral agents
418884|NCT00000747|Nevirapine|nevirapine
418885|NCT00000748|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
418886|NCT00000748|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
418887|NCT00000748|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
418888|NCT00000748|AIDS-Related Complex|aids-related complex
418889|NCT00000748|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
418890|NCT00000749|Vaccines, Synthetic|vaccines, synthetic
418891|NCT00000749|HIV Envelope Protein gp120|hiv envelope protein gp120
418892|NCT00000749|AIDS Vaccines|aids vaccines
418893|NCT00000749|HIV Seronegativity|hiv seronegativity
418894|NCT00000749|HIV Preventive Vaccine|hiv preventive vaccine
418895|NCT00000750|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
418896|NCT00000750|AIDS-Related Complex|aids-related complex
418897|NCT00000750|Zidovudine|zidovudine
418898|NCT00000751|Pregnancy|pregnancy
418899|NCT00000751|Pregnancy Complications, Infectious|pregnancy complications, infectious
418900|NCT00000751|Drug Therapy, Combination|drug therapy, combination
418901|NCT00000751|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
418902|NCT00000751|AIDS-Related Complex|aids-related complex
418903|NCT00000751|Zidovudine|zidovudine
418904|NCT00000751|Immunoglobulins, Intravenous|immunoglobulins, intravenous
418905|NCT00000751|Immunization, Passive|immunization, passive
418906|NCT00000752|Drug Therapy, Combination|drug therapy, combination
418907|NCT00000752|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
418908|NCT00000752|AIDS-Related Complex|aids-related complex
418909|NCT00000752|cefuroxime axetil|cefuroxime axetil
418910|NCT00000752|Beclomethasone|beclomethasone
418911|NCT00000752|Guaiacol Glyceryl Ether|guaiacol glyceryl ether
418912|NCT00000752|Sinusitis|sinusitis
418913|NCT00000752|Ephedrine|ephedrine
418914|NCT00000753|Zalcitabine|zalcitabine
418915|NCT00000753|Didanosine|didanosine
418916|NCT00000753|Drug Therapy, Combination|drug therapy, combination
418917|NCT00000753|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
418918|NCT00000753|AIDS-Related Complex|aids-related complex
418919|NCT00000753|Antiviral Agents|antiviral agents
418921|NCT00000754|Zalcitabine|zalcitabine
418922|NCT00000754|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
418923|NCT00000754|AIDS-Related Complex|aids-related complex
418924|NCT00000754|Zidovudine|zidovudine
418925|NCT00000754|Interferon-alpha|interferon-alpha
418926|NCT00000755|Vaccines, Synthetic|vaccines, synthetic
418927|NCT00000755|HIV-1|hiv-1
418928|NCT00000755|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
418929|NCT00000755|AIDS-Related Complex|aids-related complex
418930|NCT00000755|Zidovudine|zidovudine
418931|NCT00000755|HIV Envelope Protein gp120|hiv envelope protein gp120
418932|NCT00000755|AIDS Vaccines|aids vaccines
418933|NCT00000755|HIV Therapeutic Vaccine|hiv therapeutic vaccine
418934|NCT00000756|T-Lymphocytes|t-lymphocytes
418935|NCT00000756|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
418936|NCT00000756|AIDS-Related Complex|aids-related complex
418937|NCT00000756|Immunotherapy, Adoptive|immunotherapy, adoptive
418938|NCT00000756|Transplantation, Autologous|transplantation, autologous
418939|NCT00000757|Vaccines, Synthetic|vaccines, synthetic
418940|NCT00000757|Vaccinia Virus|vaccinia virus
418941|NCT00000757|HIV-1|hiv-1
418942|NCT00000757|HIV Envelope Protein gp160|hiv envelope protein gp160
418943|NCT00000757|AIDS Vaccines|aids vaccines
418944|NCT00000757|HIV Seronegativity|hiv seronegativity
418945|NCT00000757|HIV Preventive Vaccine|hiv preventive vaccine
418946|NCT00000758|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
418947|NCT00000758|AIDS-Related Complex|aids-related complex
418948|NCT00000758|Fluorouracil|fluorouracil
418949|NCT00000758|Cervix Dysplasia|cervix dysplasia
418950|NCT00000758|Cervix Diseases|cervix diseases
418951|NCT00000759|Central Nervous System Diseases|central nervous system diseases
418952|NCT00000759|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
418953|NCT00000759|AIDS-Related Complex|aids-related complex
418954|NCT00000759|Peripheral Nervous System Diseases|peripheral nervous system diseases
418955|NCT00000760|Didanosine|didanosine
418956|NCT00000760|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
418957|NCT00000760|AIDS-Related Complex|aids-related complex
418958|NCT00000760|Antiviral Agents|antiviral agents
418959|NCT00000760|Zidovudine|zidovudine
418960|NCT00000760|Gene Products, tat|gene products, tat
418961|NCT00000761|Interferon-gamma, Recombinant|interferon-gamma, recombinant
418962|NCT00000761|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
418963|NCT00000761|AIDS-Related Complex|aids-related complex
418964|NCT00000762|Vaccines, Synthetic|vaccines, synthetic
418965|NCT00000762|HIV Envelope Protein gp160|hiv envelope protein gp160
418966|NCT00000762|HIV Envelope Protein gp120|hiv envelope protein gp120
418967|NCT00000762|AIDS Vaccines|aids vaccines
418968|NCT00000762|HIV Therapeutic Vaccine|hiv therapeutic vaccine
418969|NCT00000763|Sarcoma, Kaposi|sarcoma, kaposi
418970|NCT00000763|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
418971|NCT00000763|Antineoplastic Agents|antineoplastic agents
418972|NCT00001328|Cancer|cancer
418973|NCT00001328|Gene Transfer|gene transfer
418974|NCT00001328|Recurrent Tumors|recurrent tumors
418975|NCT00001328|Primary Tumors|primary tumors
418976|NCT00001328|Metastases|metastases
418977|NCT00001328|Anti-Viral Drugs|anti-viral drugs
418978|NCT00001328|Chemosensitization|chemosensitization
418979|NCT00001328|Brain Tumors|brain tumors
418980|NCT00001328|Gene Therapy|gene therapy
418981|NCT00001328|Ganciclovir|ganciclovir
418982|NCT00001329|Yohimbine|yohimbine
418983|NCT00001329|Catecholamines|catecholamines
418984|NCT00001329|Sympathoadrenal Response|sympathoadrenal response
418985|NCT00001329|Sympathetic Nervous System|sympathetic nervous system
418986|NCT00001329|Stress|stress
418987|NCT00001329|Hypertension|hypertension
418988|NCT00001329|Autonomic Failure|autonomic failure
418989|NCT00001330|Autoimmune Diseases|autoimmune diseases
418990|NCT00001330|Connective Tissue Disease|connective tissue disease
418991|NCT00001330|Scleroderma|scleroderma
418992|NCT00001330|Silicone Device Implants|silicone device implants
418993|NCT00001330|Silicone Injection|silicone injection
418994|NCT00001330|Idiopathic Scleroderma|idiopathic scleroderma
418995|NCT00001330|Myositis|myositis
418996|NCT00001330|Systemic Sclerosis|systemic sclerosis
418997|NCT00001331|Myopathy|myopathy
418998|NCT00001331|Phosphofructokinase|phosphofructokinase
418999|NCT00001331|Acid Maltase|acid maltase
419000|NCT00001331|Pompe|pompe
419001|NCT00001331|Muscle Diseases|muscle diseases
419002|NCT00001331|Genetic Muscle Diseases|genetic muscle diseases
419003|NCT00001332|Cancer Treatment|cancer treatment
419004|NCT00001332|Chemotherapy|chemotherapy
419005|NCT00001332|Regional Therapy|regional therapy
419006|NCT00001332|Surgery|surgery
419007|NCT00001333|Intraventricular|intraventricular
419008|NCT00001333|Meningeal Malignancy|meningeal malignancy
419009|NCT00001333|NSC 609699|nsc 609699
419010|NCT00001333|SKF 104864|skf 104864
419011|NCT00001333|Topoisomerase 1|topoisomerase 1
419012|NCT00001335|Peripheral Stem Cell Transfusion|peripheral stem cell transfusion
419013|NCT00001335|Up-Front Phase II Window|up-front phase ii window
419014|NCT00001335|Dose-Intensive Vincristine|dose-intensive vincristine
419015|NCT00001335|Dose-Intensive Doxorubicin|dose-intensive doxorubicin
419016|NCT00001335|Dose-Intensive Cyclophosphamide|dose-intensive cyclophosphamide
419017|NCT00001335|ADR-529 for Cardioprotection|adr-529 for cardioprotection
419018|NCT00001335|BID Radiation Therapy for Local Control|bid radiation therapy for local control
419019|NCT00001336|Transplantation|transplantation
419020|NCT00001336|Cancer|cancer
419021|NCT00001336|Cellular Immunity|cellular immunity
419022|NCT00001336|Stem Cell Function|stem cell function
419023|NCT00001336|Immunodeficiency|immunodeficiency
419024|NCT00001337|Primary Mediastinal B-Cell Lymphoma|primary mediastinal b-cell lymphoma
419025|NCT00001337|CD20 +|cd20 +
419026|NCT00001337|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
419027|NCT00001337|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
419028|NCT00001337|De Novo|de novo
419029|NCT00001338|Fusion Protein|fusion protein
419030|NCT00001339|Multidrug Resistance|multidrug resistance
419031|NCT00001339|Reversal of Drug Resistance|reversal of drug resistance
419032|NCT00001339|P-Glycoprotein|p-glycoprotein
419033|NCT00001339|MDR-1|mdr-1
419034|NCT00001341|Antifolate|antifolate
419035|NCT00001341|Inhibitor|inhibitor
419036|NCT00001341|Pharmacokinetics|pharmacokinetics
419037|NCT00001341|Thymidylate Synthetase|thymidylate synthetase
419038|NCT00001341|Toxicity|toxicity
419039|NCT00001342|Electrooculography|electrooculography
419040|NCT00001342|Electroretinogram|electroretinogram
419041|NCT00001342|Fluorescein Angiogram|fluorescein angiogram
419042|NCT00001342|Glycogen Storage Disease|glycogen storage disease
419043|NCT00001343|Turner's Syndrome|turner's syndrome
419044|NCT00001343|Short Stature|short stature
419045|NCT00001343|Cognitive Function|cognitive function
419046|NCT00001343|Sex Steroids|sex steroids
419047|NCT00001343|Turner Syndrome|turner syndrome
419048|NCT00001343|TS|ts
419049|NCT00001344|Diabetes Mellitus|diabetes mellitus
419050|NCT00001344|Diabetic Neuropathy|diabetic neuropathy
419051|NCT00001344|Memantine|memantine
419052|NCT00001344|NMDA Receptor Antagonists|nmda receptor antagonists
419053|NCT00001344|Neuropathic Pain|neuropathic pain
419054|NCT00001344|Neuropathy|neuropathy
419055|NCT00001344|Post-Herpetic Neuralgia|post-herpetic neuralgia
419056|NCT00001344|Shingles|shingles
419057|NCT00001345|Hypercalcemia|hypercalcemia
419058|NCT00001345|Multiple Endocrine Neoplasia (MEN)|multiple endocrine neoplasia (men)
419059|NCT00001345|Familial Hypocalciuric Hypercalcemia|familial hypocalciuric hypercalcemia
419060|NCT00001345|Hyperparathyroidism|hyperparathyroidism
419061|NCT00001345|Linkage Analysis|linkage analysis
419062|NCT00001346|Diabetic Macular Edema|diabetic macular edema
419063|NCT00001346|Diabetic Retinopathy|diabetic retinopathy
419064|NCT00001346|Macular Edema|macular edema
419065|NCT00001346|Photocoagulation|photocoagulation
751967|NCT01171365|Ciclesonide|ciclesonide
419066|NCT00001346|Psychophysical Testing|psychophysical testing
419067|NCT00001346|Stiles-Crawford Effect|stiles-crawford effect
419068|NCT00001347|Linkage Analysis|linkage analysis
419069|NCT00001347|Genomic DNA|genomic dna
419070|NCT00001347|Pedigree Analysis|pedigree analysis
419071|NCT00001347|Usher Syndrome|usher syndrome
419072|NCT00001347|Usher Syndrome Type 1|usher syndrome type 1
419073|NCT00001347|Usher Syndrome Type 2|usher syndrome type 2
419074|NCT00001349|Plasmapheresis|plasmapheresis
419075|NCT00001349|Lymphocytes|lymphocytes
419076|NCT00001349|Eosinophils|eosinophils
419077|NCT00001349|Neutrophils|neutrophils
419078|NCT00001350|Immunoregulation|immunoregulation
419079|NCT00001350|T Cell Receptor Alpha/Beta|t cell receptor alpha/beta
419080|NCT00001350|Lymphadenopathy|lymphadenopathy
419081|NCT00001350|ALPS|alps
419082|NCT00001350|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
419083|NCT00001351|Chronic Infection|chronic infection
419084|NCT00001351|Infectious Diseases|infectious diseases
419085|NCT00001351|Host Response|host response
419086|NCT00001351|Immunologic Disorders|immunologic disorders
419087|NCT00001351|Acute Infection|acute infection
419088|NCT00001352|Cryptococcus Neoformans|cryptococcus neoformans
419089|NCT00001352|Cryptococcosis|cryptococcosis
419090|NCT00001352|CD4|cd4
419091|NCT00001353|AIDS|aids
419092|NCT00001353|Immune Based Therapy|immune based therapy
419093|NCT00001353|Adoptive Immunotherapy|adoptive immunotherapy
419094|NCT00001353|Lymphapheresis|lymphapheresis
419095|NCT00001353|Ex Vivo Activation|ex vivo activation
419096|NCT00001353|HIV|hiv
419097|NCT00001353|Gene Therapy|gene therapy
419098|NCT00001353|Protease Inhibitor|protease inhibitor
419099|NCT00001353|Interleukin-2|interleukin-2
419100|NCT00001353|Indinavir|indinavir
419101|NCT00001354|AIDS|aids
419102|NCT00001354|Immunotherapy|immunotherapy
419103|NCT00001354|CD4 Cells|cd4 cells
419104|NCT00001354|Immunomodulator|immunomodulator
419105|NCT00001354|Cytokines|cytokines
419106|NCT00001355|Immunodeficiency|immunodeficiency
419107|NCT00001355|Infections|infections
419108|NCT00001355|Phagocytes|phagocytes
419109|NCT00001355|Cytokines|cytokines
419110|NCT00001355|Genetics|genetics
419111|NCT00001356|IL-3|il-3
419112|NCT00001356|Stem Cell Factor|stem cell factor
419114|NCT00001356|Cell Differentiation|cell differentiation
419115|NCT00001356|Receptors|receptors
419116|NCT00001356|Bone Marrow|bone marrow
419117|NCT00001356|Mastocytosis|mastocytosis
419118|NCT00001387|Paclitaxel|paclitaxel
419119|NCT00001387|Pediatric|pediatric
419120|NCT00001387|Pharmacokinetics|pharmacokinetics
419121|NCT00001387|Phase I|phase i
419122|NCT00001387|Toxicity|toxicity
419123|NCT00001390|Saliva|saliva
419124|NCT00001390|Parotid|parotid
419125|NCT00001390|Lip Biopsy|lip biopsy
419126|NCT00001390|Health|health
419127|NCT00001390|Exocrine|exocrine
419128|NCT00001390|Normal Volunteer|normal volunteer
419129|NCT00001391|Augmentation|augmentation
419130|NCT00001391|Osteogenesis|osteogenesis
419131|NCT00001391|Stem Cells|stem cells
419132|NCT00001391|Bone Formation|bone formation
419133|NCT00001391|Bone Induction|bone induction
419134|NCT00001392|Retrovirus|retrovirus
419135|NCT00001392|PCR|pcr
419136|NCT00001392|Renal Failure|renal failure
419137|NCT00001392|HIV|hiv
419138|NCT00001392|Rituximab|rituximab
419139|NCT00001393|Collapsing Glomerulopathy|collapsing glomerulopathy
419140|NCT00001393|Renal Disease|renal disease
419141|NCT00001393|HIV Associated Nephropathy|hiv associated nephropathy
419142|NCT00001394|Hyperparathyroidism|hyperparathyroidism
419143|NCT00001394|Arterial Stimulation|arterial stimulation
419144|NCT00001394|Venous Sampling|venous sampling
419145|NCT00001394|Parathyroid Adenoma|parathyroid adenoma
419146|NCT00001394|Parathyroid Hyperplasia|parathyroid hyperplasia
419147|NCT00001395|Cataracts|cataracts
419148|NCT00001395|Complications|complications
419149|NCT00001395|Rates of Progression|rates of progression
419150|NCT00001395|Diabetic Retinopathy|diabetic retinopathy
419151|NCT00001396|Pacemaker|pacemaker
419152|NCT00001396|Pediatric|pediatric
419153|NCT00001396|Obstructive HCM|obstructive hcm
419154|NCT00001397|Hematologic Malignancies|hematologic malignancies
419155|NCT00001398|Hematopoiesis|hematopoiesis
419156|NCT00001398|Stem Cell Cycling|stem cell cycling
419157|NCT00001398|Bone Marrow Failure|bone marrow failure
419158|NCT00001398|Acquired Aplastic Anemia|acquired aplastic anemia
419159|NCT00001399|Gene Therapy|gene therapy
419160|NCT00001399|Stem Cell Rescue|stem cell rescue
419161|NCT00001399|Bone Marrow Failure|bone marrow failure
419162|NCT00001399|Fanconi Anemia|fanconi anemia
419163|NCT00001400|Heart Disease|heart disease
419164|NCT00001400|Screening|screening
419165|NCT00001400|Follow-Up|follow-up
419166|NCT00001402|Dilated Cardiomyopathy|dilated cardiomyopathy
419167|NCT00001402|Hibernating Myocardium|hibernating myocardium
419168|NCT00001402|Ischemic Cardiomyopathy|ischemic cardiomyopathy
419169|NCT00001402|Metoprolol|metoprolol
419170|NCT00001402|Stress Thallium Scintigraphy|stress thallium scintigraphy
419171|NCT00001402|Congestive Cardiomyopathy|congestive cardiomyopathy
419172|NCT00001402|Congestive Heart Failure|congestive heart failure
419173|NCT00001402|Heart Failure|heart failure
419174|NCT00001403|Proteus Syndrome|proteus syndrome
419175|NCT00001403|Overgrowth|overgrowth
419176|NCT00001404|Abnormalities, Multiple|abnormalities, multiple
419177|NCT00001404|Hypothalamic Hamartoma|hypothalamic hamartoma
419178|NCT00001404|Polysyndactyly|polysyndactyly
419179|NCT00001404|Autosomal Dominant|autosomal dominant
419180|NCT00001404|Mutation|mutation
419181|NCT00001404|Gelastic|gelastic
419182|NCT00001404|Gelastic Seizure|gelastic seizure
419183|NCT00001404|Hypothalamic|hypothalamic
419184|NCT00001404|Malformations|malformations
419185|NCT00001404|Polydactyly|polydactyly
419186|NCT00001404|Pallister-Hall Syndrome|pallister-hall syndrome
419187|NCT00001405|Chronic Granulomatous Disease|chronic granulomatous disease
419188|NCT00001405|Apheresis|apheresis
419189|NCT00001405|CD34 Cells|cd34 cells
419190|NCT00001405|Infection|infection
419191|NCT00001405|Nadph Oxidase|nadph oxidase
419192|NCT00001405|Normal Volunteer|normal volunteer
419193|NCT00001406|Eosinophils|eosinophils
419194|NCT00001406|Helminth Parasites|helminth parasites
419195|NCT00001406|Hypereosinophilia|hypereosinophilia
419196|NCT00001406|Allergy|allergy
419197|NCT00001406|Asthma|asthma
419198|NCT00001407|Cytokines|cytokines
419199|NCT00001407|Mycobacteria|mycobacteria
419200|NCT00001407|Pneumonia|pneumonia
419201|NCT00001407|Multiple Drug Resistant Tuberculosis|multiple drug resistant tuberculosis
419202|NCT00001408|Lymphocytes|lymphocytes
419203|NCT00001408|Asthma|asthma
419204|NCT00001408|Cytokines|cytokines
419205|NCT00001408|Interleukin-5|interleukin-5
419206|NCT00001408|Late Phase Response|late phase response
419207|NCT00001409|AIDS|aids
419208|NCT00001409|Gene Therapy|gene therapy
419209|NCT00001409|T Cell Universal Receptor|t cell universal receptor
419210|NCT00001409|Ex Vivo Activation|ex vivo activation
419211|NCT00001410|Recombinant Production|recombinant production
419212|NCT00001410|Inherited Disease|inherited disease
419213|NCT00001410|Lysosomal Disorder|lysosomal disorder
419214|NCT00001410|Inborn Error of Metabolism|inborn error of metabolism
419215|NCT00001410|Enzyme Replacement Therapy|enzyme replacement therapy
419216|NCT00001410|Glucocerebrosidase|glucocerebrosidase
419217|NCT00001410|Polyethylene Glycol|polyethylene glycol
419218|NCT00001410|Gaucher Disease|gaucher disease
419219|NCT00001410|Recombinant Enzyme|recombinant enzyme
419220|NCT00001412|Gonadal Steroids|gonadal steroids
419221|NCT00001412|Central Nervous System Function|central nervous system function
419222|NCT00001412|GnRH Agonist|gnrh agonist
419223|NCT00001412|Testosterone|testosterone
419224|NCT00001412|Leuprolide Acetate|leuprolide acetate
419225|NCT00001412|Mood|mood
419226|NCT00001412|Behavior|behavior
419227|NCT00001412|Cognitive Function|cognitive function
419228|NCT00001413|Corticosteroids|corticosteroids
419229|NCT00001413|Osteoporosis|osteoporosis
419230|NCT00001413|Depression|depression
419231|NCT00001413|DEXA Scan|dexa scan
419232|NCT00001413|Body Mass|body mass
419233|NCT00001413|Dual X-Ray|dual x-ray
419234|NCT00001413|Energy Absorptiometry|energy absorptiometry
419235|NCT00001413|Normal Volunteer|normal volunteer
419236|NCT00001414|Behavior Genetics|behavior genetics
419237|NCT00001414|Normal Personality|normal personality
522404|NCT00293228|ELISPOT|elispot
419238|NCT00001414|Intelligence|intelligence
419239|NCT00001414|Siblings|siblings
419240|NCT00001414|Sixteen Personality Factor Questionnaire|sixteen personality factor questionnaire
419241|NCT00001414|NEO-Personality Inventory (Revised)|neo-personality inventory (revised)
419242|NCT00001414|X-Chromosome|x-chromosome
419243|NCT00001415|IL-1|il-1
419244|NCT00001415|IL-6|il-6
419245|NCT00001415|Immune Response|immune response
419246|NCT00001415|Inflammation|inflammation
419247|NCT00001415|Steroids|steroids
419248|NCT00001415|Chronic Fatigue Syndrome|chronic fatigue syndrome
419249|NCT00001415|Depression|depression
419250|NCT00001415|Fibromyalgia|fibromyalgia
419251|NCT00001415|Normal Volunteer|normal volunteer
419252|NCT00001416|Bone Disease|bone disease
419253|NCT00001416|Calcitriol|calcitriol
419254|NCT00001416|Enzyme Replacement Therapy|enzyme replacement therapy
419255|NCT00001416|Gaucher's Disease|gaucher's disease
419256|NCT00001416|Vitamin D|vitamin d
419257|NCT00001417|Needle Biopsy|needle biopsy
419258|NCT00001417|Computed Tomography|computed tomography
419259|NCT00001417|Magnetic Resonance Imaging|magnetic resonance imaging
419260|NCT00001417|Spinal Angiography|spinal angiography
419261|NCT00001417|Intratumoral Pressure|intratumoral pressure
419262|NCT00001417|Vertebral Hemangioma|vertebral hemangioma
419263|NCT00001417|Spinal Metastasis|spinal metastasis
419264|NCT00001417|Absolute Ethanol|absolute ethanol
419265|NCT00001417|Spinal Tumor|spinal tumor
419266|NCT00001417|Vertebral Tumor|vertebral tumor
419267|NCT00001418|Sympathetic Nervous System|sympathetic nervous system
419268|NCT00001418|Dysautonomias|dysautonomias
419269|NCT00001418|Postural Tachycardia Syndrome|postural tachycardia syndrome
419270|NCT00001418|Neurocardiogenic Syncope|neurocardiogenic syncope
419271|NCT00001418|Hypernoradrenergic Hypertension|hypernoradrenergic hypertension
419272|NCT00001418|Sympathectomy|sympathectomy
419273|NCT00001418|Fluorodopamine|fluorodopamine
419274|NCT00001418|Positron Emission Tomography|positron emission tomography
419275|NCT00001418|Norepinephrine|norepinephrine
419276|NCT00001418|Dopamine|dopamine
419277|NCT00001418|Neurocardiologic Disorder|neurocardiologic disorder
419278|NCT00001420|Lymphocytes|lymphocytes
419279|NCT00001420|Cytokines|cytokines
419280|NCT00001420|Apoptosis|apoptosis
419281|NCT00001420|Psoriasis|psoriasis
419282|NCT00001420|Genetics|genetics
419283|NCT00001420|Psoriatic Arthritis|psoriatic arthritis
419284|NCT00001421|Cytotoxicity|cytotoxicity
419285|NCT00001421|HLA Class I|hla class i
419286|NCT00001421|Lymphocytes|lymphocytes
419288|NCT00001421|Myositis|myositis
419289|NCT00001421|Thionamides|thionamides
419290|NCT00001421|Dermatomyositis|dermatomyositis
419291|NCT00001421|Polymyositis|polymyositis
419292|NCT00001422|Adenine Analogue|adenine analogue
419293|NCT00001422|Apoptosis|apoptosis
419294|NCT00001422|Cytokines|cytokines
419295|NCT00001422|Psoriasis|psoriasis
419296|NCT00001422|Synovium|synovium
419297|NCT00001422|Psoriatic Arthritis|psoriatic arthritis
419299|NCT00001424|Children|children
419300|NCT00001424|Human Immunodeficiency Virus|human immunodeficiency virus
419301|NCT00001426|Ovarian Cancer|ovarian cancer
419302|NCT00001426|Initial Therapy|initial therapy
419303|NCT00001426|Paclitaxel|paclitaxel
419304|NCT00001426|Cisplatin|cisplatin
419305|NCT00001426|Cyclophosphamide|cyclophosphamide
419306|NCT00001427|Pharmacodynamic Studies|pharmacodynamic studies
419307|NCT00001427|Pharmacokinetics|pharmacokinetics
419308|NCT00001428|Chemotherapy|chemotherapy
419309|NCT00001428|Cytokine|cytokine
419310|NCT00001428|Efficacy|efficacy
419311|NCT00001428|Palliation|palliation
419312|NCT00001428|Solid Tumor|solid tumor
419313|NCT00001430|IL-2|il-2
419314|NCT00001430|Drug Resistance|drug resistance
419315|NCT00001430|Continuous Infusion|continuous infusion
419316|NCT00001430|Peripheral Stem Cells|peripheral stem cells
419317|NCT00001430|MDR|mdr
419318|NCT00001431|Combined Modality|combined modality
419319|NCT00001431|GI Cancer|gi cancer
419320|NCT00001431|Pancreatic Cancer|pancreatic cancer
419321|NCT00001431|Radiotherapy|radiotherapy
419323|NCT00001432|Apheresis|apheresis
419324|NCT00001432|Long Term Culture|long term culture
419325|NCT00001432|T Cells|t cells
419326|NCT00001432|Stem Cell|stem cell
419327|NCT00001435|Anxiety|anxiety
419328|NCT00001435|Depression|depression
419329|NCT00001435|Family Functioning|family functioning
419330|NCT00001435|Psychosocial Adjustment|psychosocial adjustment
419331|NCT00001435|Social Support|social support
419332|NCT00001436|Hormone Interactions|hormone interactions
419333|NCT00001436|IGF-I|igf-i
419334|NCT00001436|Metastatic|metastatic
419335|NCT00001436|Pediatric|pediatric
419336|NCT00001436|Recurrent|recurrent
419337|NCT00001437|Cytokines|cytokines
419338|NCT00001437|Fibrosis Intensity|fibrosis intensity
419339|NCT00001437|Post-Radiation Fibrosis|post-radiation fibrosis
419340|NCT00001437|Radiation Injury|radiation injury
419341|NCT00001437|Trental|trental
419342|NCT00001438|HIV Infection|hiv infection
419343|NCT00001438|Immune Response|immune response
419344|NCT00001438|Pediatric|pediatric
419345|NCT00001438|Pharmacokinetics|pharmacokinetics
419346|NCT00001438|Toxicity|toxicity
419347|NCT00001439|Cancer|cancer
419348|NCT00001439|Immunotherapy|immunotherapy
419349|NCT00001440|p53|p53
419350|NCT00001440|Interleukin-2|interleukin-2
419351|NCT00001440|T-Cell Repopulation|t-cell repopulation
419352|NCT00001440|Apheresis|apheresis
419353|NCT00001440|RAS|ras
419354|NCT00001442|Taxol|taxol
419355|NCT00001442|Squamous Cell Carcinoma|squamous cell carcinoma
419356|NCT00001442|Radiosensitizer|radiosensitizer
419357|NCT00001442|Radiotherapy|radiotherapy
419358|NCT00001442|Tumor Potential Doubling Time (Tpot)|tumor potential doubling time (tpot)
419359|NCT00001443|AIDS|aids
419360|NCT00001443|Bioavailability|bioavailability
419361|NCT00001443|Immunologic Evaluations|immunologic evaluations
419362|NCT00001443|Pharmacokinetics|pharmacokinetics
419363|NCT00001443|Toxicity|toxicity
419364|NCT00001444|Pharmacokinetics|pharmacokinetics
419365|NCT00001444|Natural Products|natural products
419366|NCT00001444|Salvage Therapy|salvage therapy
419367|NCT00001444|Protein Kinase Antagonist|protein kinase antagonist
419368|NCT00001445|Adjuvant-Controlled Study|adjuvant-controlled study
419369|NCT00001445|Double Blind Randomization|double blind randomization
419370|NCT00001445|Env-Deleted Inactivated HIV-1|env-deleted inactivated hiv-1
419371|NCT00001445|Therapeutic HIV Vaccine|therapeutic hiv vaccine
419372|NCT00001446|Angiogenesis|angiogenesis
419373|NCT00001446|Malignancy|malignancy
419374|NCT00001446|Neuropathy|neuropathy
419375|NCT00001446|Pharmacokinetics|pharmacokinetics
419376|NCT00001446|Sedation|sedation
419377|NCT00001448|Antifungal Therapy|antifungal therapy
419378|NCT00001448|Articulation|articulation
419379|NCT00001448|Behavior|behavior
419380|NCT00001448|Expressive Language|expressive language
419381|NCT00001448|Thrush|thrush
419382|NCT00001449|Anti-Cancer Agents|anti-cancer agents
419383|NCT00001449|Antimetabolite|antimetabolite
419384|NCT00001449|Palliation|palliation
419385|NCT00001449|Pharmacodynamics|pharmacodynamics
419386|NCT00001449|Pharmacokinetics|pharmacokinetics
419387|NCT00001450|Chemotherapy|chemotherapy
419388|NCT00001450|In Vitro Testing|in vitro testing
419389|NCT00001450|Infusional|infusional
419390|NCT00001450|Lung Neoplasm|lung neoplasm
419391|NCT00001450|Pharmacokinetics|pharmacokinetics
419392|NCT00001451|Bone Marrow Transplantation|bone marrow transplantation
419393|NCT00001451|Bone Marrow Donor|bone marrow donor
419394|NCT00001451|Marrow Transplant|marrow transplant
419395|NCT00001451|National Marrow Donor Program (NMDP)|national marrow donor program (nmdp)
419396|NCT00001451|Unrelated Marrow Donor|unrelated marrow donor
419397|NCT00001451|Healthy Volunteer|healthy volunteer
419398|NCT00001452|Cushing Syndrome|cushing syndrome
419399|NCT00001452|Gene Mapping|gene mapping
419400|NCT00001452|Linkage|linkage
419401|NCT00001452|Oncogene|oncogene
419402|NCT00001452|Linkage Analysis|linkage analysis
419403|NCT00001452|Gene Identification|gene identification
419404|NCT00001452|Tumors|tumors
419405|NCT00001452|Familial Neoplasia|familial neoplasia
419406|NCT00001452|Adrenal Gland|adrenal gland
419407|NCT00001452|Lentigines|lentigines
419408|NCT00001452|Carney Complex|carney complex
419409|NCT00001453|Petrosal Sinus Sampling|petrosal sinus sampling
419410|NCT00001453|Corticotropin Releasing Hormone|corticotropin releasing hormone
419411|NCT00001453|Cushing Syndrome|cushing syndrome
419412|NCT00001453|Internal Jugular Vein Sampling|internal jugular vein sampling
419413|NCT00001453|Corticotropin Releasing Hormone Stimulation|corticotropin releasing hormone stimulation
419414|NCT00001454|Estrogen|estrogen
419415|NCT00001454|Progesterone|progesterone
419416|NCT00001454|Menses|menses
419417|NCT00001454|Endometrium|endometrium
419418|NCT00001454|Normal Volunteer|normal volunteer
419419|NCT00001455|Genetics|genetics
419420|NCT00001455|Hemochromatosis|hemochromatosis
419421|NCT00001455|Iron Metabolism|iron metabolism
419422|NCT00001455|Iron Storage Disorder|iron storage disorder
419423|NCT00001455|Pedigree|pedigree
419424|NCT00001455|Iron Overload|iron overload
419425|NCT00001456|Albinism|albinism
419426|NCT00001456|Platelet Storage Pool Deficiency|platelet storage pool deficiency
419427|NCT00001456|Metabolic Disease|metabolic disease
419428|NCT00001456|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
419429|NCT00001457|Nucleoside Analogues|nucleoside analogues
419430|NCT00001457|Delta Hepatitis|delta hepatitis
419431|NCT00001457|Glomerulonephritis|glomerulonephritis
419432|NCT00001457|Polyarteritis Nodosa|polyarteritis nodosa
419433|NCT00001457|Hepatitis Mutants|hepatitis mutants
419434|NCT00001457|3TC|3tc
419435|NCT00001457|Chronic Hepatitis B|chronic hepatitis b
419436|NCT00001457|Chronic Hepatitis D|chronic hepatitis d
419437|NCT00001457|Cirrhosis|cirrhosis
419438|NCT00001457|Lamivudine|lamivudine
419439|NCT00001458|Exercise Testing|exercise testing
419440|NCT00001458|Echocardiography|echocardiography
419441|NCT00001458|Cardiac Catheterization|cardiac catheterization
419442|NCT00001458|Radionuclide Stress Testing|radionuclide stress testing
419443|NCT00001458|Holter Monitoring|holter monitoring
419444|NCT00001458|Heart Disease|heart disease
419445|NCT00001458|Muscle Leg Pain|muscle leg pain
419446|NCT00001458|Leg Pain|leg pain
419447|NCT00001458|Circulation|circulation
419448|NCT00001458|Peripheral Arterial Disease|peripheral arterial disease
419449|NCT00001458|Intermittent Claudication|intermittent claudication
419450|NCT00001458|Renal Vascular Disease|renal vascular disease
419451|NCT00001458|Uncontrolled Hypertension|uncontrolled hypertension
419452|NCT00001459|Gated Blood Pool|gated blood pool
419453|NCT00001459|SPECT Scan|spect scan
419454|NCT00001459|Coronary Artery Disease|coronary artery disease
419455|NCT00001459|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
419456|NCT00001459|Microvascular Angina|microvascular angina
419457|NCT00001460|Training Protocol|training protocol
419458|NCT00001460|Cardiac Diagnosis|cardiac diagnosis
419459|NCT00001460|Congenital Heart Disease|congenital heart disease
419460|NCT00001460|Acquired Heart Disease|acquired heart disease
419461|NCT00001460|Arrhythmias|arrhythmias
419462|NCT00001461|Angiotensin Converting Enzyme|angiotensin converting enzyme
419463|NCT00001461|Angiotensin Converting Enzyme Inhibitors|angiotensin converting enzyme inhibitors
419464|NCT00001461|Bradykinin|bradykinin
419465|NCT00001461|Endothelial Function|endothelial function
419466|NCT00001461|Nitric Oxide|nitric oxide
419467|NCT00001461|Coronary Artery Disease|coronary artery disease
419468|NCT00001462|Alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
419469|NCT00001462|Emphysema|emphysema
419470|NCT00001462|Genetic Diseases|genetic diseases
419471|NCT00001462|Inflammation|inflammation
419472|NCT00001462|Nitric Oxide|nitric oxide
419473|NCT00001462|Protease|protease
419474|NCT00001464|Oxygen|oxygen
419475|NCT00001464|Bronchoalveolar Lavage|bronchoalveolar lavage
419476|NCT00001464|DNA Repair|dna repair
419477|NCT00001464|Carbonyl Groups|carbonyl groups
419478|NCT00001464|Serum|serum
419479|NCT00001464|ADP-ribosylation|adp-ribosylation
419480|NCT00001464|Defensin|defensin
419481|NCT00001464|Protein Oxidation|protein oxidation
419482|NCT00001464|Human Volunteers|human volunteers
419483|NCT00001465|Smooth Muscle Proliferation|smooth muscle proliferation
419484|NCT00001465|Bronchoscopy|bronchoscopy
419485|NCT00001465|Female|female
419486|NCT00001465|Pneumothorax|pneumothorax
419487|NCT00001465|Tuberous Sclerosis|tuberous sclerosis
419488|NCT00001465|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
420209|NCT00001618|Asthma|asthma
419489|NCT00001466|Clinical Genetics|clinical genetics
419490|NCT00001466|Etiology|etiology
419491|NCT00001466|Medical Screening|medical screening
419492|NCT00001466|Prognosis|prognosis
419493|NCT00001466|Genetic Disorders|genetic disorders
419494|NCT00001467|Primary Immunodeficiency Disorders|primary immunodeficiency disorders
419495|NCT00001467|Immunologic Disorders|immunologic disorders
419496|NCT00001468|Behavioral and Attitudinal Changes|behavioral and attitudinal changes
419497|NCT00001468|Breast Cancer|breast cancer
419498|NCT00001468|High Risk Families|high risk families
419499|NCT00001468|Inherited Susceptibility|inherited susceptibility
419500|NCT00001468|Psychological Responses to Risk|psychological responses to risk
419501|NCT00001469|Cancer Susceptibility Alleles|cancer susceptibility alleles
419502|NCT00001469|Prostate Cancer|prostate cancer
419503|NCT00001469|Cancer Genetics|cancer genetics
419504|NCT00001469|Cancer|cancer
419505|NCT00001469|Prostate Cancer (hereditary)|prostate cancer (hereditary)
419506|NCT00001471|AIDS|aids
419508|NCT00001471|Retrovirus|retrovirus
419509|NCT00001471|Therapy|therapy
419510|NCT00001471|Response|response
419511|NCT00001473|Vasculitis|vasculitis
419512|NCT00001473|Remission|remission
419513|NCT00001473|Relapse|relapse
419514|NCT00001473|Toxicity|toxicity
419515|NCT00001473|ANCA|anca
419516|NCT00001473|Wegener's Granulomatosis|wegener's granulomatosis
419517|NCT00001474|Cytokines|cytokines
419518|NCT00001474|Immunoregulation|immunoregulation
419519|NCT00001474|Infusion Duration|infusion duration
419520|NCT00001474|CD4 Cells|cd4 cells
419521|NCT00001475|AIDS|aids
419522|NCT00001475|Cytokines|cytokines
419523|NCT00001475|Thalidomide|thalidomide
419524|NCT00001475|Monoclonal Antibody|monoclonal antibody
419525|NCT00001475|Immunomodulator|immunomodulator
419526|NCT00001476|CD34+ Progenitor|cd34+ progenitor
419527|NCT00001476|Retrovirus|retrovirus
419528|NCT00001476|Leukapheresis|leukapheresis
419529|NCT00001476|Transduction|transduction
419530|NCT00001476|Granulocytes|granulocytes
419531|NCT00001476|Chronic Granulomatous Disease|chronic granulomatous disease
419532|NCT00001477|Communicable Infection|communicable infection
419533|NCT00001477|Monitoring|monitoring
419534|NCT00001477|Non-Invasive Tests|non-invasive tests
419535|NCT00001477|Opportunistic Infection|opportunistic infection
419536|NCT00001478|Bupropion|bupropion
419537|NCT00001478|Carbamazepine|carbamazepine
419538|NCT00001478|Cerebral Blood Flow|cerebral blood flow
419539|NCT00001478|Gabapentin|gabapentin
419540|NCT00001478|Lamotrigine|lamotrigine
419541|NCT00001478|Mood Disorders|mood disorders
419542|NCT00001478|Nimodipine|nimodipine
419543|NCT00001478|Oxygen-15|oxygen-15
419544|NCT00001478|Positron Emission Tomography|positron emission tomography
419545|NCT00001478|Venlafaxine|venlafaxine
419546|NCT00001479|ACTH|acth
419547|NCT00001479|Adrenocorticotropic Hormone|adrenocorticotropic hormone
419548|NCT00001479|Antidepressant Treatment|antidepressant treatment
419549|NCT00001479|Chaos Theory|chaos theory
419550|NCT00001479|Chronic Fatigue Syndrome|chronic fatigue syndrome
419551|NCT00001479|Major Depression|major depression
419552|NCT00001479|Normal Volunteer|normal volunteer
419553|NCT00001479|Primary Affective Disorder|primary affective disorder
419554|NCT00001480|Dementia|dementia
419555|NCT00001480|Alzheimer's Disease|alzheimer's disease
419556|NCT00001480|Cerebrospinal Fluid|cerebrospinal fluid
419557|NCT00001480|Diagnostic Test|diagnostic test
419558|NCT00001480|Cognitive Testing|cognitive testing
419559|NCT00001480|Memory Disorder|memory disorder
419560|NCT00001480|Normal Volunteer|normal volunteer
419561|NCT00001481|Postpartum Disorders|postpartum disorders
419562|NCT00001481|Depression|depression
419563|NCT00001481|Mood|mood
419564|NCT00001481|Postpartum Depression|postpartum depression
419565|NCT00001481|Hormones|hormones
419566|NCT00001481|Pregnancy|pregnancy
419567|NCT00001481|Estrogen|estrogen
419568|NCT00001481|Progesterone|progesterone
419569|NCT00001481|Gonadal Steroids|gonadal steroids
419570|NCT00001481|GnRH Agonist|gnrh agonist
419571|NCT00001481|Postpartum|postpartum
419572|NCT00001481|Mood Disorder|mood disorder
419573|NCT00001482|Anticonvulsants|anticonvulsants
419574|NCT00001482|Bipolar Disorder|bipolar disorder
419575|NCT00001482|Depression|depression
419576|NCT00001482|Gabapentin|gabapentin
419577|NCT00001482|Lamotrigine|lamotrigine
419578|NCT00001482|Mania|mania
419579|NCT00001482|Mood Disorders|mood disorders
419580|NCT00001483|Manic-Depressive Disorder|manic-depressive disorder
419581|NCT00001483|Antidepressants|antidepressants
419582|NCT00001483|Re-Randomization|re-randomization
419583|NCT00001483|Continuation|continuation
419584|NCT00001483|Ratings|ratings
419585|NCT00001483|Bipolar Illness|bipolar illness
419587|NCT00001483|Bupropion|bupropion
419588|NCT00001483|Sertraline|sertraline
419589|NCT00001485|Chemical Mediators|chemical mediators
419590|NCT00001485|Circadian Rhythms|circadian rhythms
419591|NCT00001485|Gender Differences|gender differences
419592|NCT00001485|Melatonin|melatonin
419593|NCT00001485|Photoperiodism|photoperiodism
419594|NCT00001485|Seasonal Changes|seasonal changes
419595|NCT00001486|Paranoia|paranoia
419596|NCT00001486|Schizophrenic Research|schizophrenic research
419597|NCT00001486|Hallucinations|hallucinations
419598|NCT00001486|Delusions|delusions
419599|NCT00001486|Brain Scans|brain scans
419600|NCT00001486|Negative Symptoms|negative symptoms
419601|NCT00001486|Symptoms of Schizophrenia|symptoms of schizophrenia
419602|NCT00001486|Causes of Schizophrenia|causes of schizophrenia
419603|NCT00001486|Psychosis and Schizophrenia|psychosis and schizophrenia
419604|NCT00001486|Compensation|compensation
419605|NCT00001486|Schizophrenia|schizophrenia
419606|NCT00001486|Schizoaffective Disorder|schizoaffective disorder
419607|NCT00001486|Psychosis|psychosis
419608|NCT00001486|Manic-Depression|manic-depression
419609|NCT00001487|Menopause|menopause
419610|NCT00001487|Andropause|andropause
419611|NCT00001487|Depression|depression
419612|NCT00001487|DHEA|dhea
419613|NCT00001487|Steroids|steroids
419614|NCT00001487|Mid-Life Depression|mid-life depression
419615|NCT00001487|Mid Life|mid life
419616|NCT00001487|Perimenopause|perimenopause
419617|NCT00001487|Climecteric-Related Mood Disorder|climecteric-related mood disorder
419618|NCT00001489|Cerebral Metabolism|cerebral metabolism
419619|NCT00001489|Complex Partial Seizures|complex partial seizures
419620|NCT00001489|Epilepsy|epilepsy
419621|NCT00001491|Ceramidetrihexosidase Deficiency|ceramidetrihexosidase deficiency
419622|NCT00001491|Sural Nerve Biopsy|sural nerve biopsy
419623|NCT00001491|Nerve Conduction Studies|nerve conduction studies
419624|NCT00001491|Quantitative Sensory Testing|quantitative sensory testing
419625|NCT00001491|PGP 9.5 Levels (Skin, Serum and CSF)|pgp 9.5 levels (skin, serum and csf)
419627|NCT00001491|Fabrys|fabrys
419628|NCT00001491|Fabry's|fabry's
419629|NCT00001493|Dose Intensity|dose intensity
419630|NCT00001493|Gene Therapy|gene therapy
419631|NCT00001493|Multidrug Resistance|multidrug resistance
419632|NCT00001495|Camptothecin|camptothecin
419633|NCT00001495|Cancer|cancer
419634|NCT00001495|Chemotherapy|chemotherapy
419635|NCT00001495|Natural Products|natural products
419636|NCT00001495|Neoplasms|neoplasms
419637|NCT00001496|BRCA-1|brca-1
419638|NCT00001496|Familial Breast Cancer|familial breast cancer
419639|NCT00001496|Breast Cell Culture|breast cell culture
419640|NCT00001496|High Risk|high risk
419641|NCT00001497|Brain Imaging|brain imaging
419642|NCT00001497|Encephalopathy|encephalopathy
419643|NCT00001497|Hyperactivity|hyperactivity
419644|NCT00001497|Neuroimmunology|neuroimmunology
419645|NCT00001497|Reaction Time Tasks|reaction time tasks
419646|NCT00001498|5-Fluorouracil|5-fluorouracil
419647|NCT00001498|Cyclophosphamide|cyclophosphamide
200956|NCT02112825|blood pressure|blood pressure
419648|NCT00001498|Methotrexate|methotrexate
419649|NCT00001498|Thiotepa|thiotepa
419650|NCT00001499|Carcinoma|carcinoma
419651|NCT00001499|Combination Chemotherapy|combination chemotherapy
419652|NCT00001499|Combined Modality Therapy|combined modality therapy
419653|NCT00001499|Infusion|infusion
419654|NCT00001499|Intravenous|intravenous
419655|NCT00001499|Lung Neoplasm|lung neoplasm
419656|NCT00001499|Non-Small Cell Lung Cancer|non-small cell lung cancer
419657|NCT00001500|Smoking|smoking
419658|NCT00001500|Alcohol|alcohol
419659|NCT00001500|HIV|hiv
419660|NCT00001500|AIDS|aids
419661|NCT00001500|DNA Markers|dna markers
419662|NCT00001500|Personality|personality
419663|NCT00001500|Healthy Volunteers|healthy volunteers
419664|NCT00001500|Normal Volunteer|normal volunteer
419665|NCT00001502|Blood-Brain Barrier|blood-brain barrier
419666|NCT00001502|Bradykinin|bradykinin
419667|NCT00001502|Children|children
419668|NCT00001502|Glioma|glioma
419669|NCT00001502|Medulloblastoma|medulloblastoma
419670|NCT00001503|Cancer|cancer
419671|NCT00001503|Late Effects|late effects
419672|NCT00001503|Survival|survival
419673|NCT00001503|Follow-Up|follow-up
419674|NCT00001504|Retinoids|retinoids
419675|NCT00001504|Biomarkers|biomarkers
419676|NCT00001505|Biopsy|biopsy
419677|NCT00001505|Research|research
419678|NCT00001505|Autoimmune|autoimmune
419679|NCT00001505|Blistering|blistering
419680|NCT00001505|Compensation|compensation
419681|NCT00001506|Training Protocol|training protocol
419682|NCT00001506|Natural History|natural history
419683|NCT00001506|Consultation|consultation
419684|NCT00001506|Standard Therapy|standard therapy
419685|NCT00001506|Standard Tests|standard tests
419686|NCT00001506|Training|training
419687|NCT00001507|T-cells|t-cells
419688|NCT00001507|CD34+ Selection|cd34+ selection
419689|NCT00001507|T-Cell Depletion|t-cell depletion
419690|NCT00001507|Apheresis|apheresis
419691|NCT00001507|Mobilization|mobilization
419692|NCT00001509|Differentiation|differentiation
419693|NCT00001509|N-myc Expression|n-myc expression
419694|NCT00001509|Retinoid|retinoid
419695|NCT00001509|Solid Tumor|solid tumor
419696|NCT00001509|Trk Expression|trk expression
419697|NCT00001512|ProMace Chemotherapy|promace chemotherapy
419698|NCT00001512|Indolent Lymphoma|indolent lymphoma
419699|NCT00001512|Anti-Idiotype Antibody|anti-idiotype antibody
419700|NCT00001512|GM-CSF|gm-csf
419701|NCT00001512|B-Cell Lymphoma|b-cell lymphoma
419702|NCT00001515|Wegener's Granulomatosis|wegener's granulomatosis
419703|NCT00001515|Computer Assisted Visualization|computer assisted visualization
419704|NCT00001515|Lung Cavities|lung cavities
419705|NCT00001515|Endobronchial Lesions|endobronchial lesions
419706|NCT00001515|Computed Tomography (CT)|computed tomography (ct)
419707|NCT00001515|Bronchogenic Carcinoma|bronchogenic carcinoma
419708|NCT00001516|Case Study Design|case study design
419709|NCT00001516|Rehabilitation|rehabilitation
419710|NCT00001516|Treatment Efficacy|treatment efficacy
419711|NCT00001516|Occupational Therapy Process|occupational therapy process
419712|NCT00001516|Reflection|reflection
419713|NCT00001516|Occupational Therapy|occupational therapy
419714|NCT00001518|Groshong Catheter|groshong catheter
419715|NCT00001518|Heparinized Flush Solution|heparinized flush solution
419716|NCT00001518|Intraluminal Clot|intraluminal clot
419717|NCT00001518|Urokinase|urokinase
419718|NCT00001518|Venous Access Device|venous access device
419719|NCT00001518|Withdrawal Occlusion|withdrawal occlusion
419720|NCT00001519|Exercise|exercise
419721|NCT00001519|Exercise Intensity|exercise intensity
419722|NCT00001519|Non-Linear Regression|non-linear regression
419723|NCT00001519|Oxygen Uptake|oxygen uptake
419724|NCT00001519|Recovery|recovery
419725|NCT00001519|Subject Comparison|subject comparison
419726|NCT00001519|Time Constant|time constant
419728|NCT00001520|Endotracheal Intubation|endotracheal intubation
419729|NCT00001520|Neuromuscular Blockade|neuromuscular blockade
419730|NCT00001520|Neuromuscular Blocking Agents|neuromuscular blocking agents
419732|NCT00001520|Reversal Agents|reversal agents
419733|NCT00001521|21-Hydroxylase Deficiency|21-hydroxylase deficiency
419734|NCT00001521|11-Hydroxylase Deficiency|11-hydroxylase deficiency
419735|NCT00001521|Antiandrogen|antiandrogen
419736|NCT00001521|Aromatase Inhibitor|aromatase inhibitor
419737|NCT00001521|Growth Disorder|growth disorder
419738|NCT00001521|Congenital Adrenal Hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
419739|NCT00001522|Insulin Resistance|insulin resistance
419740|NCT00001522|Race|race
419741|NCT00001522|Body Fat|body fat
419742|NCT00001522|Body Composition|body composition
419743|NCT00001522|Obesity|obesity
419744|NCT00001523|Cytology|cytology
419745|NCT00001523|Diagnostic Imaging|diagnostic imaging
419746|NCT00001523|Radiation Damage|radiation damage
419747|NCT00001523|Saliva|saliva
419748|NCT00001523|Serostomia|serostomia
419749|NCT00001523|Xerostomia|xerostomia
419750|NCT00001523|Head Cancer|head cancer
419751|NCT00001523|Neck Cancer|neck cancer
419752|NCT00001524|Thalidomide|thalidomide
419753|NCT00001524|Clinical Trial|clinical trial
419754|NCT00001524|Tumor Necrosis Factor|tumor necrosis factor
419755|NCT00001524|Delayed Healing|delayed healing
419756|NCT00001524|Painful Oral Lesions|painful oral lesions
419757|NCT00001524|HIV/AIDS|hiv/aids
419758|NCT00001524|Mouth Ulcers|mouth ulcers
419759|NCT00001524|Aphthous Ulcers|aphthous ulcers
419760|NCT00001524|Healing|healing
419761|NCT00001524|Cytokines|cytokines
419762|NCT00001526|Uveitis|uveitis
419763|NCT00001526|Interleukin 2 Receptor|interleukin 2 receptor
419764|NCT00001526|Daclizumab|daclizumab
419766|NCT00001526|Zenapax|zenapax
419767|NCT00001526|Interleukin 2|interleukin 2
419768|NCT00001527|BQ-123|bq-123
419769|NCT00001527|BQ-788|bq-788
419770|NCT00001527|Endothelin|endothelin
419771|NCT00001527|Endothelium|endothelium
419772|NCT00001527|Plethysmography|plethysmography
419773|NCT00001527|Essential Hypertension|essential hypertension
419774|NCT00001528|Coronary Artery Disease|coronary artery disease
419775|NCT00001528|Gated Blood Pool Tomography|gated blood pool tomography
419776|NCT00001528|Myocardial Blood Flow|myocardial blood flow
419777|NCT00001528|Myocardial Stunning|myocardial stunning
419778|NCT00001528|Positron Emission Tomography|positron emission tomography
419779|NCT00001529|G-CSF|g-csf
419780|NCT00001529|Donor Apheresis|donor apheresis
419781|NCT00001529|Graft vs. Host Disease|graft vs. host disease
419782|NCT00001529|Graft-Versus-Leukemia|graft-versus-leukemia
419783|NCT00001529|Dexamethasone|dexamethasone
419784|NCT00001529|Transient Lymphopenia|transient lymphopenia
419785|NCT00001529|Improved T-Cell Depletion|improved t-cell depletion
419786|NCT00001529|Normal Volunteer|normal volunteer
419787|NCT00001530|Cardiac Hypertrophy|cardiac hypertrophy
419788|NCT00001530|Drug-Refractory|drug-refractory
419789|NCT00001530|Hemodynamic Benefits|hemodynamic benefits
419790|NCT00001530|Obstruction|obstruction
419791|NCT00001530|Pacemaker Therapy|pacemaker therapy
419792|NCT00001530|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
419793|NCT00001531|Atherogenesis|atherogenesis
419794|NCT00001531|Cell Mediated Immunity|cell mediated immunity
419795|NCT00001531|Coronary Artery Disease|coronary artery disease
419796|NCT00001532|Genetic Polymorphism|genetic polymorphism
419797|NCT00001532|Nitric Oxide Synthase|nitric oxide synthase
419798|NCT00001532|Alpha 1-Antitrypsin|alpha 1-antitrypsin
419799|NCT00001532|Candidate Genes|candidate genes
419800|NCT00001532|Lung Pathology|lung pathology
419801|NCT00001532|Asthma|asthma
419802|NCT00001532|Lung Disease|lung disease
419803|NCT00001532|Cystic Fibrosis|cystic fibrosis
419804|NCT00001533|Anemia|anemia
419805|NCT00001533|Chronic T Cell Lymphocytosis with Neutropenia|chronic t cell lymphocytosis with neutropenia
419806|NCT00001533|Immunosuppression|immunosuppression
419807|NCT00001533|Neutropenia|neutropenia
419808|NCT00001533|T-LGL Leukemia|t-lgl leukemia
419809|NCT00001534|Genetics|genetics
419810|NCT00001534|Myocardial Ischemia|myocardial ischemia
419811|NCT00001534|Diastolic Dysfunction|diastolic dysfunction
419812|NCT00001534|Renin-Angiotensin System|renin-angiotensin system
419813|NCT00001534|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
419814|NCT00001534|Left Ventricular (LV) Hypertrophy|left ventricular (lv) hypertrophy
419815|NCT00001535|Intracellular Immunization|intracellular immunization
419816|NCT00001535|Immune Based Therapy|immune based therapy
419817|NCT00001535|Ex Vivo Cell Processing|ex vivo cell processing
419818|NCT00001535|Identical Twins|identical twins
419819|NCT00001535|HIV/AIDS|hiv/aids
419820|NCT00001535|Kaposi's Sarcoma|kaposi's sarcoma
419821|NCT00001536|Disability|disability
419822|NCT00001536|Dwarfism|dwarfism
419823|NCT00001536|Ethics in Genetic Counseling|ethics in genetic counseling
419824|NCT00001536|Quality of Life|quality of life
419825|NCT00001536|Reproductive Issues|reproductive issues
419826|NCT00001536|Support Groups|support groups
419827|NCT00001536|Achondroplasia|achondroplasia
419828|NCT00001538|AIDS|aids
419829|NCT00001538|DNA Vaccine|dna vaccine
419830|NCT00001538|Naked DNA|naked dna
419832|NCT00001538|gp 160|gp 160
419833|NCT00001539|Central Nervous System|central nervous system
419834|NCT00001539|Lyme Disease|lyme disease
419835|NCT00001539|Borrelia Burgdorferi|borrelia burgdorferi
419836|NCT00001539|Neuroborreliosis|neuroborreliosis
419837|NCT00001539|Chronic Symptoms|chronic symptoms
419838|NCT00001540|Diagnostic|diagnostic
419839|NCT00001540|Immune Function|immune function
419840|NCT00001540|Immunization|immunization
419841|NCT00001540|Immunodeficiency|immunodeficiency
419842|NCT00001540|Quantitative|quantitative
419843|NCT00001541|Vasculitis|vasculitis
419844|NCT00001541|Inflammation|inflammation
419845|NCT00001541|Bronchoscopy|bronchoscopy
419846|NCT00001541|Cytokines|cytokines
419847|NCT00001541|Inflammatory Mediators|inflammatory mediators
419848|NCT00001541|Wegener's Granulomatosis|wegener's granulomatosis
419849|NCT00001542|Candidiasis|candidiasis
419850|NCT00001542|Azole|azole
419851|NCT00001542|Resistance|resistance
419852|NCT00001542|Candida Albicans|candida albicans
523088|NCT00295100|MRI|mri
419853|NCT00001542|Oropharynx|oropharynx
419854|NCT00001543|Major Depression|major depression
419855|NCT00001543|Metabolic Clearance Rate|metabolic clearance rate
419856|NCT00001543|Pulsatility|pulsatility
419857|NCT00001543|Adrenocorticotropic Hormone|adrenocorticotropic hormone
419858|NCT00001543|Cortisol|cortisol
419859|NCT00001543|Corticotropin Releasing Hormone Binding Protein|corticotropin releasing hormone binding protein
419860|NCT00001543|Pharmacokinetics|pharmacokinetics
419861|NCT00001543|Half-Life|half-life
419862|NCT00001543|Bioavailability|bioavailability
419863|NCT00001543|Cushing's Syndrome|cushing's syndrome
419864|NCT00001544|DNA Probes|dna probes
419865|NCT00001544|Trinucleotide Repeats|trinucleotide repeats
419866|NCT00001544|Family Studies|family studies
419867|NCT00001544|Lymphoblast Cell Lines|lymphoblast cell lines
419868|NCT00001544|Genotyping|genotyping
419869|NCT00001544|Bipolar Affective Disorders|bipolar affective disorders
419870|NCT00001544|Schizophrenia|schizophrenia
419871|NCT00001544|Mental Retardation|mental retardation
419872|NCT00001544|Neuropsychiatric Disorders|neuropsychiatric disorders
419873|NCT00001545|Affective Disorders|affective disorders
419874|NCT00001545|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
419875|NCT00001545|Mania|mania
419876|NCT00001545|Bipolar Disorder|bipolar disorder
419877|NCT00001545|Depression|depression
419878|NCT00001545|Unipolar Disorder|unipolar disorder
419879|NCT00001545|Unipolar Depression|unipolar depression
419880|NCT00001546|Biochemical Screening|biochemical screening
419881|NCT00001546|Body Temperature|body temperature
419882|NCT00001546|Consent Form|consent form
419885|NCT00001546|Melatonin|melatonin
419886|NCT00001546|Mood|mood
419887|NCT00001546|Physical Examination|physical examination
419888|NCT00001546|Psychiatric Examination|psychiatric examination
419889|NCT00001546|Sleep Duration|sleep duration
419890|NCT00001546|Sleep Disorders|sleep disorders
419891|NCT00001547|Drug|drug
419892|NCT00001547|Imaging|imaging
419893|NCT00001547|Brain|brain
419894|NCT00001547|Metabolism|metabolism
419895|NCT00001547|Organic Mental Syndrome|organic mental syndrome
419896|NCT00001547|Magnetic Resonance Imaging|magnetic resonance imaging
419897|NCT00001547|Spectroscopy|spectroscopy
420575|NCT00001034|Ganciclovir|ganciclovir
419898|NCT00001547|Neuropsychiatric Disorders|neuropsychiatric disorders
419899|NCT00001547|Drug Effects|drug effects
419900|NCT00001547|Interferon-alpha|interferon-alpha
419901|NCT00001548|Genetic|genetic
419902|NCT00001548|Psychiatric Disorder|psychiatric disorder
419903|NCT00001548|Affected Sib Pairs|affected sib pairs
419904|NCT00001548|Obsessions|obsessions
419905|NCT00001548|Compulsions|compulsions
419906|NCT00001548|Family Study|family study
419907|NCT00001548|OCD Spectrum Disorders|ocd spectrum disorders
419908|NCT00001548|Trichotillomania|trichotillomania
419909|NCT00001548|Tourette's Syndrome|tourette's syndrome
419910|NCT00001549|Movement Disorders|movement disorders
419911|NCT00001549|Parkinson's|parkinson's
419912|NCT00001549|Alzheimer's|alzheimer's
419913|NCT00001549|Screening|screening
419914|NCT00001549|Diagnostic Puzzles|diagnostic puzzles
419915|NCT00001549|Alzheimer Disease|alzheimer disease
419916|NCT00001549|Progressive Supranuclear Palsy|progressive supranuclear palsy
419918|NCT00001549|Restless Leg Syndrome|restless leg syndrome
419919|NCT00001549|RLS|rls
419920|NCT00001549|Parkinsonism|parkinsonism
419921|NCT00001549|PD|pd
419922|NCT00001550|Immunotherapy|immunotherapy
419923|NCT00001550|Muscle Stiffness|muscle stiffness
419924|NCT00001550|Rigidity|rigidity
419925|NCT00001550|Anti-GAD Antibodies|anti-gad antibodies
419926|NCT00001550|Episodic Spasms|episodic spasms
419927|NCT00001550|Intravenous High-Dose Immunoglobulin|intravenous high-dose immunoglobulin
419928|NCT00001550|Stiff-man Syndrome|stiff-man syndrome
419929|NCT00001551|Stuttering|stuttering
419930|NCT00001551|Linkage|linkage
419931|NCT00001551|Pedigree|pedigree
419932|NCT00001551|Speech Articulation|speech articulation
419933|NCT00001551|Phonological Processing Disorders|phonological processing disorders
419934|NCT00001551|Speech Disorder|speech disorder
419935|NCT00001552|Spasmodic Dysphonia|spasmodic dysphonia
419936|NCT00001552|Pedigree|pedigree
419937|NCT00001552|Vocal Fold Paralysis|vocal fold paralysis
419938|NCT00001552|Voice Disorder|voice disorder
419939|NCT00001553|Plasticity|plasticity
419940|NCT00001553|Recovery|recovery
419941|NCT00001553|Stroke|stroke
419942|NCT00001553|Use|use
419943|NCT00001553|Cortico-subcortical Stroke|cortico-subcortical stroke
419944|NCT00001554|Cortical Localization|cortical localization
419945|NCT00001554|Optical Imaging|optical imaging
419946|NCT00001554|Thermal Imaging|thermal imaging
419947|NCT00001560|AIDS|aids
419948|NCT00001560|Multidisciplinary|multidisciplinary
419949|NCT00001560|Leukemia|leukemia
419950|NCT00001560|Lymphoma|lymphoma
419951|NCT00001560|Kaposi's Sarcoma|kaposi's sarcoma
419952|NCT00001561|Multiple Myeloma|multiple myeloma
419953|NCT00001561|Vaccine|vaccine
419954|NCT00001561|Idiotype-Specific Immunity|idiotype-specific immunity
419955|NCT00001561|Immune Transfer|immune transfer
419956|NCT00001561|Myeloma Immunoglobulin|myeloma immunoglobulin
419957|NCT00001563|Lymphomagenesis|lymphomagenesis
419958|NCT00001563|Molecular markers of drug resistance|molecular markers of drug resistance
419959|NCT00001563|Refractory, progressive, or relapsed HIV + NHL|refractory, progressive, or relapsed hiv + nhl
419960|NCT00001563|AIDS-related NHL|aids-related nhl
419961|NCT00001564|Rhabdomyosarcoma|rhabdomyosarcoma
419962|NCT00001564|Ewing's Sarcoma|ewing's sarcoma
419963|NCT00001564|Immunotherapy|immunotherapy
419964|NCT00001564|Tumor Vaccine|tumor vaccine
419965|NCT00001564|Fusion Protein|fusion protein
419966|NCT00001565|Brain Tumors|brain tumors
419967|NCT00001565|Differentiation|differentiation
419968|NCT00001565|Maximally Tolerated Dose|maximally tolerated dose
419969|NCT00001565|Neuroblastoma|neuroblastoma
419970|NCT00001565|Phenylacetate|phenylacetate
419971|NCT00001566|Rhabdomyosarcoma|rhabdomyosarcoma
419972|NCT00001566|Ewing's Sarcoma|ewing's sarcoma
419973|NCT00001566|Immunotherapy|immunotherapy
419974|NCT00001566|Tumor Vaccine|tumor vaccine
419975|NCT00001566|Interleukin-2|interleukin-2
419976|NCT00001567|Follow-Up Study|follow-up study
419977|NCT00001567|Relapse-Free Survival|relapse-free survival
419978|NCT00001567|Serum Soluble IL-2 Receptor|serum soluble il-2 receptor
419979|NCT00001567|Hematologic Malignancy|hematologic malignancy
419980|NCT00001567|Chronic Therapy|chronic therapy
419981|NCT00001568|Tumors|tumors
419982|NCT00001568|Detection|detection
419983|NCT00001568|Follow-Up|follow-up
419984|NCT00001568|Markers|markers
419985|NCT00001568|Radiolabeled|radiolabeled
419986|NCT00001569|Gastrointestinal|gastrointestinal
419987|NCT00001569|Adenocarcinoma|adenocarcinoma
419988|NCT00001569|Taxol|taxol
419989|NCT00001570|Cytochrome P 450|cytochrome p 450
419990|NCT00001570|Multi-Drug Resistance|multi-drug resistance
419991|NCT00001570|P-Glycoprotein|p-glycoprotein
419992|NCT00001570|Pharmacokinetics|pharmacokinetics
419993|NCT00001571|Cancer|cancer
419994|NCT00001571|DDT, PCB|ddt, pcb
419995|NCT00001571|Epidemiology|epidemiology
419996|NCT00001571|Pesticides|pesticides
419997|NCT00001571|Serum|serum
419998|NCT00001572|B-Cell Lymphoma|b-cell lymphoma
419999|NCT00001572|BCL- 2 Positive Tumor|bcl- 2 positive tumor
420000|NCT00001572|Immunization|immunization
420001|NCT00001572|Induction Chemotherapy|induction chemotherapy
420002|NCT00001572|Lymphoma Vaccine|lymphoma vaccine
420003|NCT00001572|Follicular Lymphoma|follicular lymphoma
420004|NCT00001572|Tumor-Derived Immunoglobulin Idiotype|tumor-derived immunoglobulin idiotype
420005|NCT00001573|Glioma|glioma
420006|NCT00001573|PDGF|pdgf
420007|NCT00001573|Pharmacokinetics|pharmacokinetics
420008|NCT00001573|Sarcoma|sarcoma
420009|NCT00001573|Toxicity|toxicity
420010|NCT00001574|Metabolites|metabolites
420011|NCT00001574|Proton Nuclear Magnetic Resonance Spectroscopic Imaging|proton nuclear magnetic resonance spectroscopic imaging
420012|NCT00001574|Scans|scans
420013|NCT00001575|Yttrium 90|yttrium 90
420014|NCT00001575|Radiolabeled|radiolabeled
420015|NCT00001575|Anti -Tac|anti -tac
420016|NCT00001575|Calcium DTPA|calcium dtpa
420017|NCT00001576|Regional Therapy|regional therapy
420018|NCT00001576|Organ Perfusion|organ perfusion
420019|NCT00001576|Metastases|metastases
420020|NCT00001576|Hyperthermia|hyperthermia
420021|NCT00001577|Chemotherapy|chemotherapy
420022|NCT00001577|Hyperthermia|hyperthermia
420023|NCT00001577|Isolation perfusion|isolation perfusion
420024|NCT00001577|Regional Therapy|regional therapy
420025|NCT00001579|Biochemical Modulation|biochemical modulation
420026|NCT00001579|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
420027|NCT00001579|Oral Administration|oral administration
420028|NCT00001579|Pharmacokinetics|pharmacokinetics
420029|NCT00001580|Molecular Diagnostics|molecular diagnostics
420030|NCT00001580|Ovary|ovary
420031|NCT00001580|Tissue Acquisition|tissue acquisition
420032|NCT00001580|cDNA Library|cdna library
420033|NCT00001580|CGAP|cgap
420034|NCT00001582|Autoimmune Disorder|autoimmune disorder
420035|NCT00001582|Immune System Evaluation|immune system evaluation
420036|NCT00001582|Human Response Investigation|human response investigation
420037|NCT00001582|Tissue Acquisition|tissue acquisition
420038|NCT00001584|Pathogenesis|pathogenesis
420039|NCT00001584|Resistance|resistance
420040|NCT00001584|Sanctuary Sites|sanctuary sites
420041|NCT00001584|Semen|semen
420042|NCT00001584|Sexual Transmission|sexual transmission
420043|NCT00001586|Genetics|genetics
420044|NCT00001586|Bone Marrow Transplantation|bone marrow transplantation
420045|NCT00001586|Immunosuppression|immunosuppression
420046|NCT00001586|T Lymphocytes|t lymphocytes
420047|NCT00001586|Marrow Purging|marrow purging
420048|NCT00001587|Hyperthermia|hyperthermia
420049|NCT00001587|Metastases|metastases
420050|NCT00001587|Organ Perfusion|organ perfusion
420051|NCT00001587|Regional Therapy|regional therapy
420052|NCT00001589|Ferritin|ferritin
420053|NCT00001589|Atherosclerosis|atherosclerosis
420054|NCT00001589|Myocardial Infarction|myocardial infarction
420055|NCT00001589|Blood Donors|blood donors
523367|NCT00295945|pain|pain
420056|NCT00001589|Low Density Lipoprotein|low density lipoprotein
420057|NCT00001589|Asymptomatic Carotid Atherosclerosis|asymptomatic carotid atherosclerosis
420058|NCT00001591|Central Nervous System|central nervous system
420059|NCT00001591|Technical Development|technical development
420060|NCT00001591|Activation Studies|activation studies
420061|NCT00001591|Pulse Sequences|pulse sequences
420062|NCT00001591|Metabolites|metabolites
420063|NCT00001591|Normal Volunteer|normal volunteer
420064|NCT00001594|Osteogenesis Imperfecta|osteogenesis imperfecta
420065|NCT00001594|Basilar Invagination|basilar invagination
420066|NCT00001595|Oncogenesis|oncogenesis
420067|NCT00001595|Adenoma|adenoma
420068|NCT00001595|Craniopharyngioma|craniopharyngioma
420069|NCT00001595|Cushing Syndrome|cushing syndrome
420070|NCT00001595|Homeobox-Containing Genes|homeobox-containing genes
420071|NCT00001595|Developmental Defect|developmental defect
420072|NCT00001595|Pituitary Gland|pituitary gland
420073|NCT00001596|Albinism|albinism
420074|NCT00001596|Platelet Storage Pool Deficiency|platelet storage pool deficiency
420075|NCT00001596|Pulmonary Fibrosis|pulmonary fibrosis
420076|NCT00001596|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
420077|NCT00001597|Psychophysics|psychophysics
420078|NCT00001597|Validation|validation
420079|NCT00001597|Fentanyl|fentanyl
420080|NCT00001597|Normal Volunteer|normal volunteer
420081|NCT00001597|Pain|pain
420082|NCT00001598|Xerostomia|xerostomia
420083|NCT00001598|Autoimmunity|autoimmunity
420084|NCT00001598|Salivary Glands|salivary glands
420085|NCT00001598|Androgen Therapy|androgen therapy
420086|NCT00001598|Lacrimal Function|lacrimal function
420087|NCT00001598|DHEA|dhea
420088|NCT00001598|Sjogren's Syndrome|sjogren's syndrome
420089|NCT00001598|Dehydroepiandrosterone|dehydroepiandrosterone
420090|NCT00001599|Xerostomia|xerostomia
420091|NCT00001599|Autoimmunity|autoimmunity
420092|NCT00001599|Salivary Glands|salivary glands
420093|NCT00001599|Lacrimal Function|lacrimal function
420094|NCT00001599|Immunomodulator|immunomodulator
420095|NCT00001599|Sjogren's Syndrome|sjogren's syndrome
420096|NCT00001599|Dry Mouth|dry mouth
420097|NCT00001600|Screening Protocol|screening protocol
420098|NCT00001600|Temporomandibular Disorders|temporomandibular disorders
420099|NCT00001600|Oral Surgery|oral surgery
420100|NCT00001600|Chronic Orofacial Pain|chronic orofacial pain
420101|NCT00001601|Oral Medicine|oral medicine
420102|NCT00001601|Clinical Experience|clinical experience
420103|NCT00001601|Therapy|therapy
420104|NCT00001601|Educational Training|educational training
420105|NCT00001601|Pathogenesis|pathogenesis
420106|NCT00001601|Oral Lesions|oral lesions
420107|NCT00001601|Aphthous Ulcers|aphthous ulcers
420108|NCT00001601|Lichen Planus|lichen planus
420109|NCT00001601|Burning Mouth|burning mouth
420110|NCT00001601|Temporomandibular Dysfunction (TMD)|temporomandibular dysfunction (tmd)
420111|NCT00001601|Oral Disease|oral disease
420112|NCT00001601|Oral Manifestations|oral manifestations
420113|NCT00001602|Dysfluency|dysfluency
420114|NCT00001602|Polymorphism|polymorphism
420115|NCT00001602|Stuttering|stuttering
420116|NCT00001602|Dopamine|dopamine
420117|NCT00001602|Family Studies|family studies
420118|NCT00001602|Receptors|receptors
420119|NCT00001602|Serotonin|serotonin
420120|NCT00001602|Enzymes|enzymes
420121|NCT00001602|Genetics|genetics
420122|NCT00001602|Linkage Analysis|linkage analysis
420123|NCT00001603|Cytokines|cytokines
420124|NCT00001603|Squamous Cell Carcinoma|squamous cell carcinoma
420125|NCT00001603|Papilloma|papilloma
420126|NCT00001603|Communication|communication
420127|NCT00001603|Immunity|immunity
420128|NCT00001603|Head|head
420129|NCT00001603|Neck|neck
420130|NCT00001603|Head and Neck Cancer|head and neck cancer
420131|NCT00001604|DNA Samples|dna samples
420132|NCT00001604|Buccal Swab|buccal swab
420133|NCT00001604|Genotyping|genotyping
420134|NCT00001604|Statistical Analysis|statistical analysis
420135|NCT00001604|Computers|computers
420136|NCT00001604|Stuttering|stuttering
420137|NCT00001605|Conjugate Vaccine|conjugate vaccine
420138|NCT00001605|Detoxified Lipooligosaccharide|detoxified lipooligosaccharide
420139|NCT00001605|Tetanus Toxoid|tetanus toxoid
420141|NCT00001606|Linkage Analysis|linkage analysis
420142|NCT00001606|Positional Cloning|positional cloning
420143|NCT00001606|Mutation Screening|mutation screening
420144|NCT00001606|Syndromic Hearing Impairment|syndromic hearing impairment
420145|NCT00001606|Non-Syndromic Hearing Impairment|non-syndromic hearing impairment
420146|NCT00001609|Linkage|linkage
420147|NCT00001609|Genetic Analysis|genetic analysis
420148|NCT00001609|Lens|lens
420149|NCT00001609|Opacity|opacity
420150|NCT00001609|Inherited|inherited
420151|NCT00001609|Linkage Analysis|linkage analysis
420152|NCT00001609|Genomic DNA|genomic dna
420153|NCT00001609|Risk Prediction|risk prediction
420154|NCT00001609|Pedigree Analysis|pedigree analysis
420155|NCT00001609|Congenital Cataracts|congenital cataracts
420156|NCT00001609|Hereditary Cataracts|hereditary cataracts
420157|NCT00001610|Standing Potential|standing potential
420158|NCT00001610|Fast Oscillation|fast oscillation
420159|NCT00001610|Slow Oscillation|slow oscillation
420160|NCT00001610|Retinal Pigment|retinal pigment
420161|NCT00001610|Epithelium|epithelium
420162|NCT00001610|Electro-oculogram|electro-oculogram
420163|NCT00001610|Cellular Immune Response|cellular immune response
420164|NCT00001610|Retinal Antigens|retinal antigens
420165|NCT00001610|IRBP|irbp
420166|NCT00001610|S-Antigen|s-antigen
420167|NCT00001610|Normal Volunteer|normal volunteer
420168|NCT00001611|AIDS|aids
420169|NCT00001611|Eye|eye
420170|NCT00001611|Treatment|treatment
420171|NCT00001611|Opportunistic Infection|opportunistic infection
420172|NCT00001611|Immunology|immunology
420173|NCT00001611|Retinitis|retinitis
420174|NCT00001612|Diabetic Retinopathy|diabetic retinopathy
420175|NCT00001612|Long-Term Visual Outcome|long-term visual outcome
420176|NCT00001612|Photocoagulation|photocoagulation
420177|NCT00001612|J. H. Wilmer Eye Institute|j. h. wilmer eye institute
420178|NCT00001613|Cataract Surgery|cataract surgery
420179|NCT00001613|Human Lens|human lens
420180|NCT00001613|Crystallins|crystallins
420181|NCT00001613|Post-Translational|post-translational
420182|NCT00001613|Protein Modification|protein modification
420183|NCT00001613|Nuclear Cataract|nuclear cataract
420184|NCT00001613|Cataract Extraction|cataract extraction
420185|NCT00001614|Eye|eye
420186|NCT00001614|Immunosuppression|immunosuppression
420187|NCT00001614|Inflammation|inflammation
420188|NCT00001614|Iritis|iritis
420189|NCT00001614|Joint|joint
420190|NCT00001614|Oral Tolerance|oral tolerance
420191|NCT00001614|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
420192|NCT00001614|Uveitis|uveitis
420193|NCT00001615|Age-Related Macular Degeneration|age-related macular degeneration
420194|NCT00001615|Choroidal Neovascularization|choroidal neovascularization
420195|NCT00001615|Disciform|disciform
420196|NCT00001615|Drusen|drusen
420197|NCT00001615|Natural History|natural history
420198|NCT00001615|Periocular|periocular
420199|NCT00001615|Quality of Life|quality of life
420200|NCT00001615|Steroids|steroids
420201|NCT00001615|Corticosteroid|corticosteroid
420202|NCT00001617|Aging|aging
420203|NCT00001617|Cataract|cataract
420204|NCT00001617|Eye|eye
420205|NCT00001617|Human Lens|human lens
420206|NCT00001617|Normal Volunteer|normal volunteer
420207|NCT00001618|Cystic Fibrosis|cystic fibrosis
420208|NCT00001618|Healthy Volunteers|healthy volunteers
420210|NCT00001618|Normal Volunteer|normal volunteer
420211|NCT00001618|Chronic Lung Disease|chronic lung disease
420212|NCT00001619|Imaging|imaging
420213|NCT00001619|Spectroscopy|spectroscopy
420214|NCT00001619|MRI|mri
420215|NCT00001619|Cardiovascular|cardiovascular
420216|NCT00001619|Technical Development|technical development
420217|NCT00001619|Heart|heart
420218|NCT00001619|Safety|safety
420219|NCT00001619|Toxicity|toxicity
420220|NCT00001619|Gadolinium|gadolinium
420221|NCT00001619|Adverse Events|adverse events
420222|NCT00001619|Normal Volunteer|normal volunteer
420223|NCT00001620|Thrombocytopenia|thrombocytopenia
420224|NCT00001620|Anemia|anemia
420225|NCT00001620|Neutropenia|neutropenia
420226|NCT00001620|Dysplasia|dysplasia
420227|NCT00001620|Cytopenia|cytopenia
420228|NCT00001620|Hematologic Malignancy|hematologic malignancy
420229|NCT00001621|Teaching|teaching
420230|NCT00001621|Pulmonary Disease|pulmonary disease
420231|NCT00001621|Routine Testing|routine testing
420232|NCT00001621|Medically Indicated|medically indicated
420233|NCT00001621|Pulmonary Function Test|pulmonary function test
420234|NCT00001622|Endothelium|endothelium
420235|NCT00001622|Hypercholesterolemia|hypercholesterolemia
420236|NCT00001622|Hypertension|hypertension
420237|NCT00001622|Microvessels|microvessels
420238|NCT00001622|Vasodilation|vasodilation
420239|NCT00001622|Normal Volunteer|normal volunteer
420240|NCT00000982|Central Nervous System Diseases|central nervous system diseases
420241|NCT00000982|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420242|NCT00000982|Zidovudine|zidovudine
420243|NCT00000983|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420244|NCT00000983|Zidovudine|zidovudine
420245|NCT00000984|Recombinant Proteins|recombinant proteins
420246|NCT00000984|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420247|NCT00000984|Antigens, CD4|antigens, cd4
420248|NCT00000984|Antiviral Agents|antiviral agents
420249|NCT00000985|Vidarabine|vidarabine
420250|NCT00000985|Phosphonoacetic Acid|phosphonoacetic acid
420251|NCT00000985|Herpes Simplex|herpes simplex
420252|NCT00000985|Foscarnet|foscarnet
420253|NCT00000985|Acyclovir|acyclovir
420254|NCT00000985|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420255|NCT00000986|Recombinant Proteins|recombinant proteins
420256|NCT00000986|Interleukin-2|interleukin-2
420257|NCT00000986|Drug Interactions|drug interactions
420258|NCT00000986|Drug Therapy, Combination|drug therapy, combination
420259|NCT00000986|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420260|NCT00000986|AIDS-Related Complex|aids-related complex
419298|NCT00001424|AIDS|aids
420261|NCT00000986|Zidovudine|zidovudine
420262|NCT00000987|Vincristine|vincristine
420263|NCT00000987|Doxorubicin|doxorubicin
420264|NCT00000987|Drug Therapy, Combination|drug therapy, combination
420265|NCT00000987|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420266|NCT00000987|Zidovudine|zidovudine
420267|NCT00000987|Bleomycin|bleomycin
420268|NCT00000988|Injections, Intravenous|injections, intravenous
420269|NCT00000988|Drug Evaluation|drug evaluation
420270|NCT00000988|Administration, Oral|administration, oral
420271|NCT00000988|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420272|NCT00000988|AIDS-Related Complex|aids-related complex
420273|NCT00000988|Antiviral Agents|antiviral agents
420274|NCT00000989|Retinitis|retinitis
420275|NCT00000989|Ganciclovir|ganciclovir
420276|NCT00000989|Drug Evaluation|drug evaluation
420277|NCT00000989|Drug Therapy, Combination|drug therapy, combination
420278|NCT00000989|Cytomegalovirus Infections|cytomegalovirus infections
420279|NCT00000989|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420280|NCT00000989|Zidovudine|zidovudine
420281|NCT00000990|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
420282|NCT00000990|Pulmonary Fibrosis|pulmonary fibrosis
420283|NCT00000990|Zidovudine|zidovudine
420284|NCT00000991|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
420285|NCT00000991|Toxoplasmosis|toxoplasmosis
420286|NCT00000991|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
420287|NCT00000991|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
420288|NCT00000991|Pentamidine|pentamidine
420289|NCT00000991|Dapsone|dapsone
420290|NCT00000991|Drug Evaluation|drug evaluation
420291|NCT00000991|Drug Therapy, Combination|drug therapy, combination
420292|NCT00000991|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420293|NCT00000991|Zidovudine|zidovudine
420294|NCT00000991|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
420295|NCT00000992|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
420296|NCT00000992|Ketoconazole|ketoconazole
420297|NCT00000992|Histoplasmosis|histoplasmosis
420298|NCT00000992|Drug Evaluation|drug evaluation
420299|NCT00000992|Antifungal Agents|antifungal agents
420300|NCT00000992|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420301|NCT00000993|HIV-1|hiv-1
420302|NCT00000993|Drug Evaluation|drug evaluation
420303|NCT00000993|Accidents|accidents
420954|NCT00001092|Vagina|vagina
420304|NCT00000993|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420305|NCT00000993|AIDS Serodiagnosis|aids serodiagnosis
420306|NCT00000993|Zidovudine|zidovudine
420307|NCT00000994|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
420308|NCT00000994|Sarcoma, Kaposi|sarcoma, kaposi
420309|NCT00000994|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420310|NCT00000994|Zidovudine|zidovudine
420311|NCT00000995|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
420312|NCT00000995|Ganciclovir|ganciclovir
420313|NCT00000995|Drug Evaluation|drug evaluation
420314|NCT00000995|Drug Therapy, Combination|drug therapy, combination
420315|NCT00000995|Cytomegalovirus Infections|cytomegalovirus infections
420316|NCT00000995|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420317|NCT00000995|Zidovudine|zidovudine
420318|NCT00000996|Doxorubicin|doxorubicin
420319|NCT00000996|Drug Evaluation|drug evaluation
420320|NCT00000996|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420321|NCT00000997|Zalcitabine|zalcitabine
420322|NCT00000997|Drug Evaluation|drug evaluation
420439|NCT00001013|Leucovorin|leucovorin
420323|NCT00000997|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420324|NCT00000997|AIDS-Related Complex|aids-related complex
420325|NCT00000997|Biological Availability|biological availability
420326|NCT00000998|Trimetrexate|trimetrexate
420327|NCT00000998|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
420328|NCT00000998|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
420329|NCT00000998|Injections, Intravenous|injections, intravenous
420330|NCT00000998|Leucovorin|leucovorin
420331|NCT00000998|Dose-Response Relationship, Drug|dose-response relationship, drug
420332|NCT00000998|Drug Therapy, Combination|drug therapy, combination
420334|NCT00000998|Administration, Oral|administration, oral
420335|NCT00000998|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420336|NCT00000998|Antineoplastic Agents|antineoplastic agents
420337|NCT00000999|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420338|NCT00000999|AIDS-Related Complex|aids-related complex
420339|NCT00000999|Zidovudine|zidovudine
420340|NCT00001000|Macrophage Activation|macrophage activation
420341|NCT00001000|Lymphocyte Transformation|lymphocyte transformation
420342|NCT00001000|Immunologic Surveillance|immunologic surveillance
420343|NCT00001000|ampligen|ampligen
420344|NCT00001000|Antiviral Agents|antiviral agents
420345|NCT00001001|Liver|liver
420346|NCT00001001|Liver Diseases|liver diseases
420347|NCT00001001|Liver Function Tests|liver function tests
420348|NCT00001001|HIV Seropositivity|hiv seropositivity
420349|NCT00001001|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420350|NCT00001001|Zidovudine|zidovudine
420351|NCT00001001|Biological Availability|biological availability
420352|NCT00001002|Drug Therapy, Combination|drug therapy, combination
420353|NCT00001002|Foscarnet|foscarnet
420354|NCT00001002|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420355|NCT00001002|AIDS-Related Complex|aids-related complex
420356|NCT00001002|Antiviral Agents|antiviral agents
420357|NCT00001002|Zidovudine|zidovudine
420358|NCT00001003|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
420359|NCT00001003|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
420360|NCT00001003|Pentamidine|pentamidine
420361|NCT00001003|Nebulizers and Vaporizers|nebulizers and vaporizers
420362|NCT00001003|Lung|lung
420363|NCT00001003|Administration, Inhalation|administration, inhalation
420364|NCT00001003|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420365|NCT00001003|Zidovudine|zidovudine
420366|NCT00001004|Tumor Necrosis Factor|tumor necrosis factor
420367|NCT00001004|Interferon-gamma, Recombinant|interferon-gamma, recombinant
420368|NCT00001004|HIV Antigens|hiv antigens
420369|NCT00001004|Immunologic Surveillance|immunologic surveillance
420370|NCT00001004|Drug Therapy, Combination|drug therapy, combination
420371|NCT00001004|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420372|NCT00001004|AIDS-Related Complex|aids-related complex
420373|NCT00001005|Recombinant Proteins|recombinant proteins
420374|NCT00001005|HIV Seropositivity|hiv seropositivity
420375|NCT00001005|Interleukin-2|interleukin-2
420376|NCT00001005|Drug Evaluation|drug evaluation
420377|NCT00001005|Drug Therapy, Combination|drug therapy, combination
420378|NCT00001005|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420379|NCT00001005|AIDS-Related Complex|aids-related complex
420380|NCT00001005|Zidovudine|zidovudine
420381|NCT00001006|Infusions, Intravenous|infusions, intravenous
420382|NCT00001006|Immunologic Surveillance|immunologic surveillance
420383|NCT00001006|Drug Evaluation|drug evaluation
420384|NCT00001006|Adjuvants, Immunologic|adjuvants, immunologic
420385|NCT00001006|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420386|NCT00001006|AIDS-Related Complex|aids-related complex
420387|NCT00001006|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
420388|NCT00001007|Pregnancy|pregnancy
420389|NCT00001007|Pregnancy Complications, Infectious|pregnancy complications, infectious
420390|NCT00001007|Infant, Newborn, Diseases|infant, newborn, diseases
420391|NCT00001007|Infusions, Intravenous|infusions, intravenous
420392|NCT00001007|Drug Evaluation|drug evaluation
420668|NCT00001048|Cytarabine|cytarabine
420393|NCT00001007|Administration, Oral|administration, oral
420394|NCT00001007|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420395|NCT00001007|Zidovudine|zidovudine
420396|NCT00001008|Substance Withdrawal Syndrome|substance withdrawal syndrome
420397|NCT00001008|Methadone|methadone
420398|NCT00001008|Opioid-Related Disorders|opioid-related disorders
420399|NCT00001008|Drug Evaluation|drug evaluation
420400|NCT00001008|Drug Interactions|drug interactions
420401|NCT00001008|Drug Therapy, Combination|drug therapy, combination
420402|NCT00001008|Administration, Oral|administration, oral
420403|NCT00001008|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420404|NCT00001008|AIDS-Related Complex|aids-related complex
420405|NCT00001008|Zidovudine|zidovudine
420406|NCT00001009|T-Lymphocytes|t-lymphocytes
420407|NCT00001009|HIV Antigens|hiv antigens
420408|NCT00001009|Dextran Sulfate|dextran sulfate
420409|NCT00001009|Dose-Response Relationship, Drug|dose-response relationship, drug
420410|NCT00001009|Drug Evaluation|drug evaluation
420411|NCT00001009|Drug Therapy, Combination|drug therapy, combination
420412|NCT00001009|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420413|NCT00001009|AIDS-Related Complex|aids-related complex
420414|NCT00001010|Immune Tolerance|immune tolerance
420415|NCT00001010|Dose-Response Relationship, Drug|dose-response relationship, drug
420416|NCT00001010|Drug Evaluation|drug evaluation
420417|NCT00001010|Drug Therapy, Combination|drug therapy, combination
420418|NCT00001010|Acyclovir|acyclovir
419917|NCT00001549|PSP|psp
420419|NCT00001010|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420420|NCT00001010|AIDS-Related Complex|aids-related complex
420421|NCT00001010|Zidovudine|zidovudine
420422|NCT00001011|Virus Replication|virus replication
420423|NCT00001011|AIDS-Related Complex|aids-related complex
420424|NCT00001011|Zidovudine|zidovudine
420425|NCT00001012|Virus Replication|virus replication
420426|NCT00001012|T-Lymphocytes|t-lymphocytes
420427|NCT00001012|Dose-Response Relationship, Drug|dose-response relationship, drug
420428|NCT00001012|Drug Evaluation|drug evaluation
420429|NCT00001012|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420430|NCT00001012|AL 721|al 721
420431|NCT00001012|AIDS-Related Complex|aids-related complex
420432|NCT00001012|Antiviral Agents|antiviral agents
420433|NCT00001013|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
420434|NCT00001013|Trimetrexate|trimetrexate
419507|NCT00001471|HIV|hiv
420435|NCT00001013|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
420436|NCT00001013|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
420437|NCT00001013|Pentamidine|pentamidine
420438|NCT00001013|Infusions, Intravenous|infusions, intravenous
420440|NCT00001013|Drug Therapy, Combination|drug therapy, combination
420441|NCT00001013|Folic Acid Antagonists|folic acid antagonists
420442|NCT00001013|Aerosols|aerosols
420443|NCT00001013|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420444|NCT00001013|Antiprotozoal Agents|antiprotozoal agents
420445|NCT00001013|AIDS-Related Complex|aids-related complex
420446|NCT00001013|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
420447|NCT00001014|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
420448|NCT00001014|Trimetrexate|trimetrexate
420449|NCT00001014|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
420450|NCT00001014|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
420451|NCT00001014|Infusions, Intravenous|infusions, intravenous
420452|NCT00001014|Leucovorin|leucovorin
420453|NCT00001014|Drug Therapy, Combination|drug therapy, combination
420454|NCT00001014|Administration, Oral|administration, oral
420455|NCT00001014|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420456|NCT00001014|Antiprotozoal Agents|antiprotozoal agents
420457|NCT00001014|AIDS-Related Complex|aids-related complex
420458|NCT00001014|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
420459|NCT00001015|Ribavirin|ribavirin
420460|NCT00001015|T-Lymphocytes|t-lymphocytes
420461|NCT00001015|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420462|NCT00001015|AIDS-Related Complex|aids-related complex
420463|NCT00001016|Trimetrexate|trimetrexate
420464|NCT00001016|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
420465|NCT00001016|Quinazolines|quinazolines
420466|NCT00001016|Infusions, Intravenous|infusions, intravenous
420467|NCT00001016|Injections, Intravenous|injections, intravenous
420468|NCT00001016|Leucovorin|leucovorin
420469|NCT00001016|Drug Evaluation|drug evaluation
420470|NCT00001016|Drug Therapy, Combination|drug therapy, combination
420471|NCT00001016|Administration, Oral|administration, oral
420472|NCT00001016|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420473|NCT00001016|Antiprotozoal Agents|antiprotozoal agents
420474|NCT00001016|AIDS-Related Complex|aids-related complex
420475|NCT00001017|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
420476|NCT00001017|Meningitis|meningitis
420477|NCT00001017|Injections, Intravenous|injections, intravenous
420478|NCT00001017|Cryptococcosis|cryptococcosis
420479|NCT00001017|Fluconazole|fluconazole
420480|NCT00001017|Administration, Oral|administration, oral
420481|NCT00001017|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420482|NCT00001017|Amphotericin B|amphotericin b
420483|NCT00001018|Cryptosporidiosis|cryptosporidiosis
420484|NCT00001018|Diarrhea|diarrhea
420485|NCT00001018|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420486|NCT00001018|Antiprotozoal Agents|antiprotozoal agents
420487|NCT00001018|Triazines|triazines
420488|NCT00001019|Vaccines, Synthetic|vaccines, synthetic
420489|NCT00001019|Adjuvants, Immunologic|adjuvants, immunologic
420490|NCT00001019|HIV Envelope Protein gp120|hiv envelope protein gp120
420491|NCT00001019|AIDS Vaccines|aids vaccines
420492|NCT00001019|HIV Seronegativity|hiv seronegativity
420493|NCT00001019|HIV Preventive Vaccine|hiv preventive vaccine
420494|NCT00001020|Vaccines, Synthetic|vaccines, synthetic
420495|NCT00001020|Viral Vaccines|viral vaccines
420496|NCT00001020|HIV-1|hiv-1
420497|NCT00001020|HIV Envelope Protein gp120|hiv envelope protein gp120
420498|NCT00001020|AIDS Vaccines|aids vaccines
420499|NCT00001020|HIV Seronegativity|hiv seronegativity
420500|NCT00001020|HIV Preventive Vaccine|hiv preventive vaccine
420501|NCT00001021|Vaccines, Synthetic|vaccines, synthetic
420502|NCT00001021|HIV-1|hiv-1
420503|NCT00001021|HIV Envelope Protein gp120|hiv envelope protein gp120
420504|NCT00001021|AIDS Vaccines|aids vaccines
420505|NCT00001021|HIV Seronegativity|hiv seronegativity
420506|NCT00001021|HIV Preventive Vaccine|hiv preventive vaccine
420507|NCT00001022|Zalcitabine|zalcitabine
420508|NCT00001022|Didanosine|didanosine
420509|NCT00001022|Drug Therapy, Combination|drug therapy, combination
420510|NCT00001022|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420511|NCT00001022|AIDS-Related Complex|aids-related complex
420513|NCT00001023|Rifabutin|rifabutin
420514|NCT00001023|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
420515|NCT00001023|Drug Interactions|drug interactions
420516|NCT00001023|Azithromycin|azithromycin
420517|NCT00001023|Clarithromycin|clarithromycin
420518|NCT00001024|Didanosine|didanosine
420519|NCT00001024|AIDS-Related Complex|aids-related complex
420520|NCT00001024|Zidovudine|zidovudine
420521|NCT00001024|Lymph Nodes|lymph nodes
420522|NCT00001024|Lymphoid Tissue|lymphoid tissue
420523|NCT00001025|Virus Replication|virus replication
420524|NCT00001025|Didanosine|didanosine
420525|NCT00001025|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420526|NCT00001025|AIDS-Related Complex|aids-related complex
420527|NCT00001025|Zidovudine|zidovudine
420528|NCT00001026|Vaccines, Synthetic|vaccines, synthetic
420529|NCT00001026|Vaccinia Virus|vaccinia virus
420530|NCT00001026|Viral Vaccines|viral vaccines
420531|NCT00001026|HIV Envelope Protein gp160|hiv envelope protein gp160
420532|NCT00001026|HIV Envelope Protein gp120|hiv envelope protein gp120
420533|NCT00001026|AIDS Vaccines|aids vaccines
420534|NCT00001026|HIV Seronegativity|hiv seronegativity
420535|NCT00001026|HIV Preventive Vaccine|hiv preventive vaccine
420536|NCT00001027|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
420537|NCT00001027|Pentamidine|pentamidine
420538|NCT00001027|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420539|NCT00001027|AIDS-Related Complex|aids-related complex
420540|NCT00001028|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
420541|NCT00001028|Pentamidine|pentamidine
420542|NCT00001028|Dapsone|dapsone
420543|NCT00001028|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420544|NCT00001028|AIDS-Related Complex|aids-related complex
420545|NCT00001029|Zalcitabine|zalcitabine
420546|NCT00001029|Didanosine|didanosine
420547|NCT00001029|Drug Therapy, Combination|drug therapy, combination
420548|NCT00001029|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420549|NCT00001029|Zidovudine|zidovudine
420550|NCT00001030|Rifabutin|rifabutin
420551|NCT00001030|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
751968|NCT01171365|Asthma|asthma
420552|NCT00001030|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420553|NCT00001030|Clarithromycin|clarithromycin
420554|NCT00001031|Vaccines, Synthetic|vaccines, synthetic
420555|NCT00001031|HIV-1|hiv-1
420556|NCT00001031|HIV Envelope Protein gp120|hiv envelope protein gp120
420557|NCT00001031|AIDS Vaccines|aids vaccines
420558|NCT00001031|HIV Seronegativity|hiv seronegativity
420559|NCT00001031|HIV Preventive Vaccine|hiv preventive vaccine
420560|NCT00001032|Zalcitabine|zalcitabine
420561|NCT00001032|Drug Therapy, Combination|drug therapy, combination
420562|NCT00001032|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420563|NCT00001032|AIDS-Related Complex|aids-related complex
420564|NCT00001032|Zidovudine|zidovudine
420565|NCT00001033|Isoniazid|isoniazid
420566|NCT00001033|Tuberculosis, Pulmonary|tuberculosis, pulmonary
420567|NCT00001033|Pyrazinamide|pyrazinamide
420568|NCT00001033|Pyridoxine|pyridoxine
420569|NCT00001033|Ofloxacin|ofloxacin
420570|NCT00001033|Rifampin|rifampin
420571|NCT00001033|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
420572|NCT00001033|Ethambutol|ethambutol
420573|NCT00001033|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420574|NCT00001034|Retinitis|retinitis
420576|NCT00001034|Cytomegalovirus Infections|cytomegalovirus infections
420577|NCT00001034|Administration, Oral|administration, oral
420578|NCT00001034|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420579|NCT00001034|Gastrointestinal System|gastrointestinal system
420580|NCT00001035|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
420581|NCT00001035|Interferon Alfa-2b|interferon alfa-2b
420582|NCT00001035|Zalcitabine|zalcitabine
420583|NCT00001035|Didanosine|didanosine
420584|NCT00001035|Drug Therapy, Combination|drug therapy, combination
420585|NCT00001035|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420586|NCT00001035|Zidovudine|zidovudine
420587|NCT00001035|Hepatitis C|hepatitis c
420588|NCT00001036|T-Lymphocytes|t-lymphocytes
420589|NCT00001036|Polyethylene Glycols|polyethylene glycols
420590|NCT00001036|Interleukin-2|interleukin-2
420591|NCT00001036|Drug Therapy, Combination|drug therapy, combination
420592|NCT00001036|Adjuvants, Immunologic|adjuvants, immunologic
420593|NCT00001036|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420594|NCT00001036|Zidovudine|zidovudine
420595|NCT00001036|thymosin alpha(1)|thymosin alpha(1)
420596|NCT00001037|Vaccines, Synthetic|vaccines, synthetic
420597|NCT00001037|HIV-1|hiv-1
420598|NCT00001037|HIV Envelope Protein gp160|hiv envelope protein gp160
420599|NCT00001037|AIDS Vaccines|aids vaccines
420600|NCT00001037|HIV Seronegativity|hiv seronegativity
420601|NCT00001037|HIV Preventive Vaccine|hiv preventive vaccine
420602|NCT00001038|Cytomegalovirus Infections|cytomegalovirus infections
420603|NCT00001038|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420604|NCT00001038|Antiviral Agents|antiviral agents
420605|NCT00001039|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
420606|NCT00001039|Drug Therapy, Combination|drug therapy, combination
420607|NCT00001039|Ethambutol|ethambutol
420608|NCT00001039|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420609|NCT00001039|Clarithromycin|clarithromycin
420610|NCT00001040|Zalcitabine|zalcitabine
420611|NCT00001040|Drug Therapy, Combination|drug therapy, combination
420612|NCT00001040|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420613|NCT00001040|AIDS-Related Complex|aids-related complex
420614|NCT00001040|Zidovudine|zidovudine
419765|NCT00001526|HAT|hat
420615|NCT00001040|Saquinavir|saquinavir
420616|NCT00001040|HIV Protease Inhibitors|hiv protease inhibitors
420617|NCT00001041|Vaccines, Synthetic|vaccines, synthetic
420618|NCT00001041|Pregnancy|pregnancy
420619|NCT00001041|Pregnancy Complications, Infectious|pregnancy complications, infectious
420620|NCT00001041|HIV Envelope Protein gp120|hiv envelope protein gp120
420621|NCT00001041|AIDS Vaccines|aids vaccines
420622|NCT00001041|HIV Therapeutic Vaccine|hiv therapeutic vaccine
420623|NCT00001042|Vaccines, Synthetic|vaccines, synthetic
420624|NCT00001042|Drug Therapy, Combination|drug therapy, combination
420625|NCT00001042|Adjuvants, Immunologic|adjuvants, immunologic
420626|NCT00001042|HIV Envelope Protein gp120|hiv envelope protein gp120
420627|NCT00001042|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine
420628|NCT00001042|monophosphoryl lipid A|monophosphoryl lipid a
420629|NCT00001042|AIDS Vaccines|aids vaccines
420630|NCT00001042|HIV Seronegativity|hiv seronegativity
420631|NCT00001042|HIV Preventive Vaccine|hiv preventive vaccine
420632|NCT00001043|Vaccines, Synthetic|vaccines, synthetic
420633|NCT00001043|Vaccinia Virus|vaccinia virus
420634|NCT00001043|Viral Vaccines|viral vaccines
420635|NCT00001043|Smallpox Vaccine|smallpox vaccine
420636|NCT00001043|HIV-1|hiv-1
420637|NCT00001043|HIV Envelope Protein gp160|hiv envelope protein gp160
420638|NCT00001043|AIDS Vaccines|aids vaccines
420639|NCT00001043|HIV Seronegativity|hiv seronegativity
420640|NCT00001043|HIV Preventive Vaccine|hiv preventive vaccine
420641|NCT00001044|Vaccines, Synthetic|vaccines, synthetic
420642|NCT00001044|Drug Therapy, Combination|drug therapy, combination
420643|NCT00001044|Adjuvants, Immunologic|adjuvants, immunologic
752073|NCT01171651|Pexa-Vec|pexa-vec
525120|NCT00302146|HV|hv
420644|NCT00001044|HIV Envelope Protein gp120|hiv envelope protein gp120
420645|NCT00001044|AIDS Vaccines|aids vaccines
420646|NCT00001044|HIV Seronegativity|hiv seronegativity
420647|NCT00001044|HIV Preventive Vaccine|hiv preventive vaccine
420648|NCT00001045|Didanosine|didanosine
420649|NCT00001045|Drug Therapy, Combination|drug therapy, combination
420650|NCT00001045|Zidovudine|zidovudine
420651|NCT00001045|Nevirapine|nevirapine
420652|NCT00001046|Vaccines, Synthetic|vaccines, synthetic
420653|NCT00001046|Pregnancy|pregnancy
420654|NCT00001046|Pregnancy Complications, Infectious|pregnancy complications, infectious
420655|NCT00001046|AIDS-Related Complex|aids-related complex
420656|NCT00001046|HIV Envelope Protein gp120|hiv envelope protein gp120
420657|NCT00001046|HIV Preventive Vaccine|hiv preventive vaccine
420658|NCT00001046|HIV Therapeutic Vaccine|hiv therapeutic vaccine
420659|NCT00001047|Rifabutin|rifabutin
420660|NCT00001047|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
420661|NCT00001047|Drug Therapy, Combination|drug therapy, combination
420662|NCT00001047|Ethambutol|ethambutol
420663|NCT00001047|Clofazimine|clofazimine
420664|NCT00001047|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420665|NCT00001047|Clarithromycin|clarithromycin
420666|NCT00001048|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
420667|NCT00001048|Infusions, Intravenous|infusions, intravenous
420669|NCT00001048|Zalcitabine|zalcitabine
420670|NCT00001048|Didanosine|didanosine
420671|NCT00001048|Drug Therapy, Combination|drug therapy, combination
420672|NCT00001048|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
420673|NCT00001048|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420674|NCT00001048|Zidovudine|zidovudine
420675|NCT00001048|Injections, Spinal|injections, spinal
420676|NCT00001049|Didanosine|didanosine
420677|NCT00001049|Drug Therapy, Combination|drug therapy, combination
420678|NCT00001049|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420679|NCT00001049|AIDS-Related Complex|aids-related complex
420680|NCT00001049|Zidovudine|zidovudine
420681|NCT00001052|Vaccines, Synthetic|vaccines, synthetic
420682|NCT00001052|Drug Therapy, Combination|drug therapy, combination
420683|NCT00001052|Adjuvants, Immunologic|adjuvants, immunologic
420684|NCT00001052|HIV Envelope Protein gp120|hiv envelope protein gp120
420685|NCT00001052|AIDS Vaccines|aids vaccines
420686|NCT00001052|HIV Seronegativity|hiv seronegativity
420687|NCT00001052|HIV Preventive Vaccine|hiv preventive vaccine
420688|NCT00001053|Vaccines, Synthetic|vaccines, synthetic
420689|NCT00001053|Recombinant Proteins|recombinant proteins
420691|NCT00001053|AIDS Vaccines|aids vaccines
420692|NCT00001053|HIV Core Protein p24|hiv core protein p24
420694|NCT00001053|Gene Products, gag|gene products, gag
420695|NCT00001053|HIV Seronegativity|hiv seronegativity
420696|NCT00001053|HIV Preventive Vaccine|hiv preventive vaccine
420697|NCT00001054|Herpes Zoster|herpes zoster
420698|NCT00001054|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
420699|NCT00001054|Herpes Simplex|herpes simplex
420700|NCT00001054|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420701|NCT00001054|AIDS-Related Complex|aids-related complex
420702|NCT00001054|valacyclovir|valacyclovir
420703|NCT00001054|Chickenpox|chickenpox
420704|NCT00001055|Vaccines, Synthetic|vaccines, synthetic
420705|NCT00001055|HIV Envelope Protein gp120|hiv envelope protein gp120
420706|NCT00001055|AIDS Vaccines|aids vaccines
420707|NCT00001055|HIV Seronegativity|hiv seronegativity
420708|NCT00001055|Avipoxvirus|avipoxvirus
420709|NCT00001055|HIV Preventive Vaccine|hiv preventive vaccine
420710|NCT00001056|Vaccines, Synthetic|vaccines, synthetic
420711|NCT00001056|Vaccinia Virus|vaccinia virus
420712|NCT00001056|Viral Vaccines|viral vaccines
420713|NCT00001056|HIV-1|hiv-1
420714|NCT00001056|HIV Envelope Protein gp160|hiv envelope protein gp160
420715|NCT00001056|AIDS Vaccines|aids vaccines
420716|NCT00001056|HIV Seronegativity|hiv seronegativity
420717|NCT00001056|HIV Preventive Vaccine|hiv preventive vaccine
420718|NCT00001057|Didanosine|didanosine
420719|NCT00001057|Drug Therapy, Combination|drug therapy, combination
420720|NCT00001057|Zidovudine|zidovudine
420721|NCT00001058|Rifabutin|rifabutin
420722|NCT00001058|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
420723|NCT00001058|Drug Therapy, Combination|drug therapy, combination
420724|NCT00001058|Ethambutol|ethambutol
420725|NCT00001058|Clofazimine|clofazimine
420726|NCT00001058|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420727|NCT00001058|Ciprofloxacin|ciprofloxacin
420728|NCT00001058|Clarithromycin|clarithromycin
420729|NCT00001059|Vincristine|vincristine
420730|NCT00001059|Sarcoma, Kaposi|sarcoma, kaposi
420731|NCT00001059|Liposomes|liposomes
420732|NCT00001059|Doxorubicin|doxorubicin
420733|NCT00001059|Drug Therapy, Combination|drug therapy, combination
420734|NCT00001059|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
420735|NCT00001059|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420736|NCT00001059|Bleomycin|bleomycin
420737|NCT00001059|Drug Carriers|drug carriers
420738|NCT00001060|Vaccines, Synthetic|vaccines, synthetic
420739|NCT00001060|HIV-1|hiv-1
420740|NCT00001060|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420741|NCT00001060|AIDS-Related Complex|aids-related complex
420742|NCT00001060|AIDS Vaccines|aids vaccines
420743|NCT00001060|HIV Therapeutic Vaccine|hiv therapeutic vaccine
420744|NCT00001061|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
420745|NCT00001061|Ganciclovir|ganciclovir
420746|NCT00001061|Foscarnet|foscarnet
420747|NCT00001061|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420748|NCT00001061|Antibodies, Monoclonal|antibodies, monoclonal
420749|NCT00001061|Cytomegalovirus Retinitis|cytomegalovirus retinitis
420750|NCT00001062|Infusions, Intravenous|infusions, intravenous
420751|NCT00001062|Ganciclovir|ganciclovir
420752|NCT00001062|Administration, Oral|administration, oral
420753|NCT00001062|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420754|NCT00001062|Antiviral Agents|antiviral agents
420755|NCT00001062|Cytomegalovirus Retinitis|cytomegalovirus retinitis
420756|NCT00001063|Didanosine|didanosine
420757|NCT00001063|Drug Therapy, Combination|drug therapy, combination
420758|NCT00001063|AIDS-Related Complex|aids-related complex
420759|NCT00001063|Zidovudine|zidovudine
420760|NCT00001063|Stavudine|stavudine
420761|NCT00001064|HIV Antigens|hiv antigens
420762|NCT00001064|Immunotherapy, Adoptive|immunotherapy, adoptive
420763|NCT00001064|Dendritic Cells|dendritic cells
420764|NCT00001065|Administration, Oral|administration, oral
420765|NCT00001065|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420766|NCT00001065|Amphotericin B|amphotericin b
420767|NCT00001065|AIDS-Related Complex|aids-related complex
420768|NCT00001065|Candidiasis, Oral|candidiasis, oral
420769|NCT00001065|Suspensions|suspensions
420770|NCT00001066|Didanosine|didanosine
420771|NCT00001066|Drug Therapy, Combination|drug therapy, combination
420772|NCT00001066|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420773|NCT00001066|AIDS-Related Complex|aids-related complex
420774|NCT00001066|Zidovudine|zidovudine
420775|NCT00001066|Lamivudine|lamivudine
420776|NCT00001067|Drug Therapy, Combination|drug therapy, combination
420777|NCT00001067|AIDS-Related Complex|aids-related complex
420778|NCT00001067|Zidovudine|zidovudine
420779|NCT00001067|Stavudine|stavudine
420780|NCT00001067|Lamivudine|lamivudine
420781|NCT00001068|Zalcitabine|zalcitabine
420782|NCT00001068|Didanosine|didanosine
420783|NCT00001068|Drug Therapy, Combination|drug therapy, combination
420784|NCT00001068|AIDS-Related Complex|aids-related complex
420785|NCT00001068|Antiviral Agents|antiviral agents
420786|NCT00001068|Zidovudine|zidovudine
420787|NCT00001068|Lamivudine|lamivudine
420788|NCT00001069|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420789|NCT00001069|AIDS-Related Complex|aids-related complex
420790|NCT00001069|Antiviral Agents|antiviral agents
420791|NCT00001069|Decision Making|decision making
420792|NCT00001069|Physician's Practice Patterns|physician's practice patterns
420793|NCT00001071|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
420794|NCT00001071|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420795|NCT00001071|AIDS-Related Complex|aids-related complex
420796|NCT00001071|Stem Cells|stem cells
420797|NCT00001072|Vaccines, Synthetic|vaccines, synthetic
419884|NCT00001546|EKG|ekg
420798|NCT00001072|HIV Envelope Protein gp120|hiv envelope protein gp120
420799|NCT00001072|AIDS Vaccines|aids vaccines
420800|NCT00001072|HIV Seronegativity|hiv seronegativity
420801|NCT00001072|Avipoxvirus|avipoxvirus
420802|NCT00001072|HIV Preventive Vaccine|hiv preventive vaccine
420803|NCT00001073|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420804|NCT00001073|AIDS-Related Complex|aids-related complex
420805|NCT00001073|Cervix Dysplasia|cervix dysplasia
420806|NCT00001073|Cervix Diseases|cervix diseases
420807|NCT00001073|Isotretinoin|isotretinoin
420808|NCT00001073|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
420809|NCT00001073|Cervix Neoplasms|cervix neoplasms
420810|NCT00001073|Keratolytic Agents|keratolytic agents
420811|NCT00001074|Didanosine|didanosine
420812|NCT00001074|Drug Therapy, Combination|drug therapy, combination
420813|NCT00001074|Antiviral Agents|antiviral agents
420814|NCT00001074|Hydroxyurea|hydroxyurea
420815|NCT00001075|Drug Therapy, Combination|drug therapy, combination
420816|NCT00001075|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420817|NCT00001075|AIDS-Related Complex|aids-related complex
420818|NCT00001075|Antiviral Agents|antiviral agents
420819|NCT00001075|Zidovudine|zidovudine
420820|NCT00001075|HIV Protease Inhibitors|hiv protease inhibitors
420821|NCT00001075|Ritonavir|ritonavir
420822|NCT00001075|Lamivudine|lamivudine
420823|NCT00001076|Vaccines, Synthetic|vaccines, synthetic
420824|NCT00001076|HIV Envelope Protein gp120|hiv envelope protein gp120
420825|NCT00001076|AIDS Vaccines|aids vaccines
420826|NCT00001076|HIV Seronegativity|hiv seronegativity
420827|NCT00001076|Avipoxvirus|avipoxvirus
752074|NCT01171664|Phase 2|phase 2
420828|NCT00001076|HIV Preventive Vaccine|hiv preventive vaccine
420829|NCT00001077|Weight Loss|weight loss
420830|NCT00001077|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420831|NCT00001077|Nutritional Support|nutritional support
420832|NCT00001078|Viral Vaccines|viral vaccines
420833|NCT00001078|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
420834|NCT00001078|Anti-HIV Agents|anti-hiv agents
420835|NCT00001078|Hepatitis A Virus, Human|hepatitis a virus, human
420836|NCT00001079|Placebos|placebos
420837|NCT00001079|Drug Therapy, Combination|drug therapy, combination
420838|NCT00001079|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420839|NCT00001079|AIDS-Related Complex|aids-related complex
420840|NCT00001079|HIV Wasting Syndrome|hiv wasting syndrome
420841|NCT00001079|Megestrol Acetate|megestrol acetate
420842|NCT00001079|dihydrotestosterone heptanoate|dihydrotestosterone heptanoate
420843|NCT00001080|Lymphocyte Transformation|lymphocyte transformation
420845|NCT00001080|Drug Resistance, Microbial|drug resistance, microbial
420846|NCT00001080|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
420847|NCT00001080|Lamivudine|lamivudine
420848|NCT00001080|Influenza Vaccine|influenza vaccine
420849|NCT00001080|RNA, Viral|rna, viral
420850|NCT00001080|Bacterial Vaccines|bacterial vaccines
420851|NCT00001080|Anti-HIV Agents|anti-hiv agents
420852|NCT00001080|Pneumonia, Pneumococcal|pneumonia, pneumococcal
420853|NCT00001080|Viral Load|viral load
420854|NCT00001081|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
420855|NCT00001081|Cryptosporidiosis|cryptosporidiosis
420856|NCT00001081|Antiprotozoal Agents|antiprotozoal agents
420857|NCT00001081|nitazoxanide|nitazoxanide
420858|NCT00001082|Cytomegalovirus Infections|cytomegalovirus infections
420859|NCT00001082|Antiviral Agents|antiviral agents
420860|NCT00001082|CD4 Lymphocyte Count|cd4 lymphocyte count
420861|NCT00001082|Prodrugs|prodrugs
420862|NCT00001082|Survival|survival
420863|NCT00001082|Adenine|adenine
420864|NCT00001083|HIV-1|hiv-1
420865|NCT00001083|Drug Therapy, Combination|drug therapy, combination
420866|NCT00001083|Zidovudine|zidovudine
420867|NCT00001083|Nevirapine|nevirapine
420868|NCT00001083|Stavudine|stavudine
420869|NCT00001083|HIV Protease Inhibitors|hiv protease inhibitors
420870|NCT00001083|Ritonavir|ritonavir
420871|NCT00001083|Lamivudine|lamivudine
420872|NCT00001083|Indinavir|indinavir
420873|NCT00001083|RNA, Viral|rna, viral
420874|NCT00001083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
420875|NCT00001083|Anti-HIV Agents|anti-hiv agents
420876|NCT00001084|Prospective Studies|prospective studies
420877|NCT00001084|Drug Therapy, Combination|drug therapy, combination
420878|NCT00001084|Zidovudine|zidovudine
420879|NCT00001084|HIV Protease Inhibitors|hiv protease inhibitors
420880|NCT00001084|Lamivudine|lamivudine
420881|NCT00001084|Indinavir|indinavir
420882|NCT00001084|RNA, Viral|rna, viral
420883|NCT00001084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
420884|NCT00001084|Anti-HIV Agents|anti-hiv agents
420885|NCT00001084|Viral Load|viral load
420886|NCT00001085|HIV-1|hiv-1
420887|NCT00001085|Drug Therapy, Combination|drug therapy, combination
420888|NCT00001085|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420889|NCT00001085|Zidovudine|zidovudine
420890|NCT00001085|HIV Protease Inhibitors|hiv protease inhibitors
420891|NCT00001085|Lamivudine|lamivudine
420892|NCT00001085|RNA, Viral|rna, viral
420893|NCT00001085|VX 478|vx 478
420894|NCT00001085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
420895|NCT00001085|Anti-HIV Agents|anti-hiv agents
420896|NCT00001085|Viral Load|viral load
420897|NCT00001086|Placebos|placebos
420898|NCT00001086|HIV-1|hiv-1
420899|NCT00001086|Drug Therapy, Combination|drug therapy, combination
420900|NCT00001086|HIV Protease Inhibitors|hiv protease inhibitors
420901|NCT00001086|Indinavir|indinavir
420902|NCT00001086|RNA, Viral|rna, viral
420903|NCT00001086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
420904|NCT00001086|Anti-HIV Agents|anti-hiv agents
420905|NCT00001086|Viral Load|viral load
420906|NCT00001086|efavirenz|efavirenz
420907|NCT00001087|Drug Therapy, Combination|drug therapy, combination
420908|NCT00001087|Antiviral Agents|antiviral agents
420909|NCT00001087|HIV Protease Inhibitors|hiv protease inhibitors
420910|NCT00001087|Ritonavir|ritonavir
420911|NCT00001087|Saquinavir|saquinavir
420912|NCT00001087|Nelfinavir|nelfinavir
420913|NCT00001087|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
420914|NCT00001087|Adenine|adenine
420915|NCT00001087|Anti-HIV Agents|anti-hiv agents
420916|NCT00001087|efavirenz|efavirenz
420917|NCT00001088|Injections, Intramuscular|injections, intramuscular
420918|NCT00001088|AIDS Vaccines|aids vaccines
420919|NCT00001088|HIV Seronegativity|hiv seronegativity
420920|NCT00001088|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
420921|NCT00001088|Fusion Proteins, gag-pol|fusion proteins, gag-pol
420922|NCT00001088|Vaccines, DNA|vaccines, dna
420923|NCT00001088|HIV Preventive Vaccine|hiv preventive vaccine
420924|NCT00001089|Prospective Studies|prospective studies
420926|NCT00001089|Cytomegalovirus|cytomegalovirus
420927|NCT00001089|Cytomegalovirus Infections|cytomegalovirus infections
420928|NCT00001089|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420929|NCT00001089|Anti-HIV Agents|anti-hiv agents
420930|NCT00001089|Viral Load|viral load
420931|NCT00001089|Multiple Organ Failure|multiple organ failure
420932|NCT00001090|Reference Values|reference values
420933|NCT00001090|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
420934|NCT00001090|AIDS Vaccines|aids vaccines
420935|NCT00001090|HIV Seronegativity|hiv seronegativity
420936|NCT00001090|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
420937|NCT00001090|HIV Preventive Vaccine|hiv preventive vaccine
420938|NCT00001091|Drug Therapy, Combination|drug therapy, combination
420939|NCT00001091|Nevirapine|nevirapine
420940|NCT00001091|Stavudine|stavudine
420941|NCT00001091|HIV Protease Inhibitors|hiv protease inhibitors
420942|NCT00001091|Ritonavir|ritonavir
420943|NCT00001091|Lamivudine|lamivudine
420944|NCT00001091|Nelfinavir|nelfinavir
420945|NCT00001091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
420946|NCT00001092|Semen|semen
420947|NCT00001092|HIV-1|hiv-1
420948|NCT00001092|Sexual Partners|sexual partners
420949|NCT00001092|Drug Resistance, Microbial|drug resistance, microbial
420950|NCT00001092|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
420951|NCT00001092|Saliva|saliva
420952|NCT00001092|Blood|blood
420953|NCT00001092|Cervix Uteri|cervix uteri
420955|NCT00001092|Acute Infection|acute infection
420956|NCT00001093|Immunity, Cellular|immunity, cellular
420957|NCT00001093|Sexual Partners|sexual partners
420958|NCT00001093|Treatment Outcome|treatment outcome
420959|NCT00001093|Anti-HIV Agents|anti-hiv agents
420960|NCT00001093|Viral Load|viral load
420961|NCT00001093|Acute Infection|acute infection
420962|NCT00001094|HIV-1|hiv-1
420963|NCT00001094|Drug Therapy, Combination|drug therapy, combination
420964|NCT00001094|Zidovudine|zidovudine
420965|NCT00001094|Lamivudine|lamivudine
420966|NCT00001094|RNA, Viral|rna, viral
420967|NCT00001094|Saquinavir|saquinavir
420968|NCT00001094|Delavirdine|delavirdine
420969|NCT00001094|Anti-HIV Agents|anti-hiv agents
420970|NCT00001094|Nelfinavir|nelfinavir
420971|NCT00001095|Drug Therapy, Combination|drug therapy, combination
420972|NCT00001095|Zidovudine|zidovudine
420973|NCT00001095|Nevirapine|nevirapine
420974|NCT00001095|Stavudine|stavudine
420975|NCT00001095|HIV Protease Inhibitors|hiv protease inhibitors
420976|NCT00001095|Lamivudine|lamivudine
420977|NCT00001095|VX 478|vx 478
420978|NCT00001095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
420979|NCT00001095|Anti-HIV Agents|anti-hiv agents
420980|NCT00001095|Viral Load|viral load
420981|NCT00001096|Vaccines, Synthetic|vaccines, synthetic
420982|NCT00001096|HIV Antibodies|hiv antibodies
420983|NCT00001096|HIV Antigens|hiv antigens
420985|NCT00001096|Adjuvants, Immunologic|adjuvants, immunologic
420986|NCT00001096|AIDS Vaccines|aids vaccines
420987|NCT00001096|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
420988|NCT00001096|HIV Seronegativity|hiv seronegativity
420989|NCT00001096|HIV Envelope Protein gp120|hiv envelope protein gp120
420990|NCT00001096|Alum Compounds|alum compounds
420991|NCT00001096|HIV Preventive Vaccine|hiv preventive vaccine
420992|NCT00001097|Drug Therapy, Combination|drug therapy, combination
420993|NCT00001097|HIV Protease Inhibitors|hiv protease inhibitors
420994|NCT00001097|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
420995|NCT00001097|Anti-HIV Agents|anti-hiv agents
420996|NCT00001102|Drug Therapy, Combination|drug therapy, combination
420997|NCT00001102|HIV Protease Inhibitors|hiv protease inhibitors
420998|NCT00001102|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
420999|NCT00001102|Body Composition|body composition
421000|NCT00001102|Anti-HIV Agents|anti-hiv agents
421001|NCT00001102|Cholesterol|cholesterol
421002|NCT00001102|Triglycerides|triglycerides
421003|NCT00001103|Neuropsychological Tests|neuropsychological tests
421004|NCT00001103|HIV-1|hiv-1
421005|NCT00001103|RNA, Viral|rna, viral
421006|NCT00001103|Anti-HIV Agents|anti-hiv agents
421007|NCT00001103|Viral Load|viral load
421008|NCT00001104|Sex Behavior|sex behavior
421009|NCT00001104|T-Lymphocytes|t-lymphocytes
421010|NCT00001104|HIV Antibodies|hiv antibodies
421011|NCT00001104|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421012|NCT00001104|AIDS-Related Complex|aids-related complex
421013|NCT00001104|Zidovudine|zidovudine
421014|NCT00001104|Hemophilia A|hemophilia a
421015|NCT00001105|Antibodies, Monoclonal|antibodies, monoclonal
421016|NCT00001105|AIDS-Related Complex|aids-related complex
421017|NCT00001105|Immunization, Passive|immunization, passive
421018|NCT00001623|Peripheral Blood Stem Cells|peripheral blood stem cells
421019|NCT00001623|Graft-Versus-Leukemia|graft-versus-leukemia
421020|NCT00001623|Graft vs. Host Disease|graft vs. host disease
421021|NCT00001623|Whole Body Irradiation|whole body irradiation
421022|NCT00001623|Donor Apheresis|donor apheresis
421023|NCT00001623|Cyclophosphamide|cyclophosphamide
421024|NCT00001623|Graft-Versus-Myeloma|graft-versus-myeloma
421025|NCT00001623|Leukemic Relapse|leukemic relapse
421026|NCT00001623|Multiple Myeloma|multiple myeloma
421027|NCT00001623|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
421028|NCT00001623|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
421029|NCT00001623|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
421030|NCT00001623|Myelodysplastic Syndromes|myelodysplastic syndromes
421031|NCT00001623|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
421032|NCT00001624|BQ-123|bq-123
421033|NCT00001624|Endothelin|endothelin
421034|NCT00001624|Insulin|insulin
421035|NCT00001624|Plethysmography|plethysmography
421036|NCT00001624|Vasoconstriction|vasoconstriction
421037|NCT00001624|Healthy Volunteer|healthy volunteer
421038|NCT00001625|Insulin Resistance|insulin resistance
421039|NCT00001625|Obesity|obesity
421040|NCT00001625|Hypertension|hypertension
421041|NCT00001625|Diabetes|diabetes
421042|NCT00001625|Mathematical Modeling|mathematical modeling
421043|NCT00001625|Normal Volunteer|normal volunteer
421044|NCT00001626|Cytopenia|cytopenia
421045|NCT00001626|Randomized|randomized
421046|NCT00001626|Immunosuppression|immunosuppression
421047|NCT00001626|Severe Aplastic Anemia|severe aplastic anemia
421048|NCT00001627|Bone Marrow|bone marrow
421049|NCT00001627|Hematopoiesis|hematopoiesis
421050|NCT00001627|DNA|dna
421051|NCT00001627|RNA|rna
421052|NCT00001627|Viruses|viruses
421053|NCT00001627|Normal Volunteer|normal volunteer
421054|NCT00001627|Aplastic Anemia|aplastic anemia
421055|NCT00001627|Myelodysplasia|myelodysplasia
421056|NCT00001627|Fanconi's Anemia|fanconi's anemia
421057|NCT00001627|Single Lineage Cytopenia|single lineage cytopenia
421058|NCT00001628|Angiotensin Receptor Antagonist|angiotensin receptor antagonist
421059|NCT00001628|Atherosclerosis|atherosclerosis
421060|NCT00001628|Blood Flow|blood flow
421061|NCT00001628|Endothelium|endothelium
421062|NCT00001628|Endothelial Dysfunction|endothelial dysfunction
421063|NCT00001629|Angiotensin AT-1 Receptor|angiotensin at-1 receptor
421064|NCT00001629|Angiotensin Receptor Antagonist|angiotensin receptor antagonist
421065|NCT00001629|Atherosclerosis|atherosclerosis
421066|NCT00001629|Blood Flow|blood flow
421067|NCT00001629|Cold Pressor Test|cold pressor test
421068|NCT00001629|Endothelium|endothelium
421069|NCT00001629|Exercise|exercise
421070|NCT00001629|Coronary Artery Disease|coronary artery disease
421071|NCT00001629|Heart Failure|heart failure
421072|NCT00001630|Immunosuppression|immunosuppression
421073|NCT00001630|Thrombocytopenia|thrombocytopenia
421074|NCT00001630|Autoimmune Disease|autoimmune disease
421075|NCT00001630|Evan's Syndrome|evan's syndrome
421076|NCT00001630|Autoimmune Hemolytic Anemia|autoimmune hemolytic anemia
421077|NCT00001630|Episodic Bleeding|episodic bleeding
421078|NCT00001631|Gadolinium|gadolinium
421079|NCT00001631|Ischemia|ischemia
421080|NCT00001631|Coronary Artery Disease|coronary artery disease
421081|NCT00001631|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
421082|NCT00001631|Dipyridamole|dipyridamole
421083|NCT00001632|Hypertrophy|hypertrophy
421084|NCT00001632|Integrated|integrated
421085|NCT00001632|Backscatter|backscatter
421086|NCT00001632|Cyclic|cyclic
421087|NCT00001632|Echocardiography|echocardiography
421088|NCT00001632|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
421089|NCT00001633|Contrast Media|contrast media
421090|NCT00001633|Coronary Artery Disease|coronary artery disease
421091|NCT00001633|Coronary Vessels|coronary vessels
421092|NCT00001633|Magnetic Resonance Angiography|magnetic resonance angiography
421093|NCT00001633|Magnetic Resonance Imaging|magnetic resonance imaging
421094|NCT00001637|Peripheral Blood Stem Cells|peripheral blood stem cells
421095|NCT00001637|Engraftment|engraftment
421096|NCT00001637|Fludarabine|fludarabine
421097|NCT00001637|Nonmyeloablative|nonmyeloablative
421098|NCT00001637|Graft-Versus-Leukemia|graft-versus-leukemia
421099|NCT00001637|Graft vs. Host Disease|graft vs. host disease
421100|NCT00001637|Cyclophosphamide|cyclophosphamide
421101|NCT00001637|Donor Apheresis|donor apheresis
421102|NCT00001637|Nonmyeloablative Bone Marrow Transplantation|nonmyeloablative bone marrow transplantation
421103|NCT00001637|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
421104|NCT00001637|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
421105|NCT00001637|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
421106|NCT00001637|Myelodysplastic Syndromes|myelodysplastic syndromes
421107|NCT00001637|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
421108|NCT00001637|Prolymphocytic Leukemia|prolymphocytic leukemia
421109|NCT00001638|Echocardiography|echocardiography
421110|NCT00001638|Heart|heart
421111|NCT00001638|Gadolinium|gadolinium
421112|NCT00001638|Dobutamine|dobutamine
421113|NCT00001638|Toxicity|toxicity
421114|NCT00001638|Adverse Events|adverse events
421115|NCT00001638|Myocardial Infarction|myocardial infarction
421116|NCT00001638|Myocardial Viability|myocardial viability
421117|NCT00001638|Myocardial Perfusion|myocardial perfusion
421118|NCT00001638|Myocardial Function|myocardial function
421119|NCT00001638|Cardiovascular Disease|cardiovascular disease
421120|NCT00001639|Gene Dosage|gene dosage
421121|NCT00001639|Haploinsufficiency|haploinsufficiency
421122|NCT00001639|Karyotype|karyotype
421123|NCT00001639|Malformations|malformations
421124|NCT00001639|Mental Retardation|mental retardation
421125|NCT00001640|Parkinson's Disease|parkinson's disease
421126|NCT00001641|Fibrillin|fibrillin
421127|NCT00001641|Collagen|collagen
421128|NCT00001641|Marfan Syndrome|marfan syndrome
421129|NCT00001641|Stickler Syndrome|stickler syndrome
421130|NCT00001641|Aortic Dissection|aortic dissection
421131|NCT00001641|Ehlers-Danlos|ehlers-danlos
421132|NCT00001641|Connective Tissue Disorders|connective tissue disorders
421133|NCT00001641|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
421134|NCT00001641|Nail-Patella Syndrome|nail-patella syndrome
421135|NCT00001642|Chromosomal Deletion|chromosomal deletion
421136|NCT00001642|Mutations|mutations
421137|NCT00001642|Paucity of Bile Ducts|paucity of bile ducts
421138|NCT00001642|Physical Map|physical map
421139|NCT00001642|Transcript Identification|transcript identification
421140|NCT00001642|Alagille Syndrome|alagille syndrome
421141|NCT00001642|Syndromic Bile Duct Paucity|syndromic bile duct paucity
421142|NCT00001643|Lewy Body|lewy body
421143|NCT00001643|Mutation|mutation
421144|NCT00001643|Hereditary|hereditary
421145|NCT00001643|Dominant|dominant
421146|NCT00001643|Sporadic|sporadic
421147|NCT00001643|Parkinson's Disease|parkinson's disease
421148|NCT00001644|Immunodeficiency|immunodeficiency
421149|NCT00001644|Latency|latency
421150|NCT00001644|T Cell Turnover|t cell turnover
421151|NCT00001644|Infected Cell Turnover|infected cell turnover
421152|NCT00001644|Follicular Dendritic Cells|follicular dendritic cells
421153|NCT00001645|Chagas' Disease|chagas' disease
421154|NCT00001645|Trypanosomiasis|trypanosomiasis
421155|NCT00001645|Malaria|malaria
421156|NCT00001645|Parasitic Infection|parasitic infection
421157|NCT00001646|Aspergillus|aspergillus
421158|NCT00001646|Azole|azole
421159|NCT00001646|Immunocompromise|immunocompromise
421160|NCT00001647|AIDS|aids
421161|NCT00001647|Immunotherapy|immunotherapy
421162|NCT00001647|Adoptive Cell Transfers|adoptive cell transfers
421163|NCT00001647|T Cell Repertoire|t cell repertoire
421164|NCT00001647|Identical Twins|identical twins
421165|NCT00001648|HVEM Gene|hvem gene
421166|NCT00001648|HSV|hsv
421167|NCT00001648|Herpes Simplex Virus|herpes simplex virus
421168|NCT00001649|Clinical Trial|clinical trial
421169|NCT00001649|Sexual Transmitted Disease|sexual transmitted disease
421170|NCT00001649|Phase III|phase iii
421171|NCT00001649|HSV|hsv
421172|NCT00001649|Valtrex|valtrex
421173|NCT00001649|Valaciclovir|valaciclovir
421174|NCT00001649|HS2A/B3009|hs2a/b3009
421175|NCT00001649|Herpes Simplex Virus Transmission|herpes simplex virus transmission
421176|NCT00001649|Heterosexual Couples|heterosexual couples
421177|NCT00001650|BrDU|brdu
421178|NCT00001650|HIV|hiv
421179|NCT00001650|Labeling|labeling
421180|NCT00001650|CD4 Cells|cd4 cells
421181|NCT00001650|Immunodeficiency|immunodeficiency
421182|NCT00001651|Deuterium|deuterium
421183|NCT00001651|HIV|hiv
421184|NCT00001651|Labeling|labeling
421185|NCT00001651|CD4 Cells|cd4 cells
421186|NCT00001651|Immunodeficiency|immunodeficiency
421187|NCT00002008|Leukopenia|leukopenia
421188|NCT00002008|Drug Evaluation|drug evaluation
421189|NCT00002008|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
421190|NCT00002009|Leukopenia|leukopenia
421191|NCT00002009|Drug Evaluation|drug evaluation
421192|NCT00002009|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
421193|NCT00002010|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421194|NCT00002010|Meningitis|meningitis
421195|NCT00002010|Fluconazole|fluconazole
421196|NCT00002010|Coccidioidin|coccidioidin
421197|NCT00002010|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421198|NCT00002010|Coccidioidomycosis|coccidioidomycosis
421199|NCT00002011|PUVA Therapy|puva therapy
421200|NCT00002011|Methoxsalen|methoxsalen
421201|NCT00002011|AIDS-Related Complex|aids-related complex
421202|NCT00002012|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421203|NCT00002012|AIDS-Related Complex|aids-related complex
421204|NCT00002012|Interferon Type I, Recombinant|interferon type i, recombinant
421205|NCT00002013|Drug Therapy, Combination|drug therapy, combination
421206|NCT00002013|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421207|NCT00002013|AIDS-Related Complex|aids-related complex
421208|NCT00002013|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
421209|NCT00002013|Zidovudine|zidovudine
421210|NCT00002014|Didanosine|didanosine
421211|NCT00002014|Drug Evaluation|drug evaluation
421212|NCT00002014|Zidovudine|zidovudine
421213|NCT00002015|Retinitis|retinitis
421214|NCT00002015|Ganciclovir|ganciclovir
421215|NCT00002015|Cytomegalovirus Infections|cytomegalovirus infections
421216|NCT00002015|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421217|NCT00002015|Immunocompromised Host|immunocompromised host
421218|NCT00002016|Retinitis|retinitis
421219|NCT00002016|Ganciclovir|ganciclovir
421220|NCT00002016|Cytomegalovirus|cytomegalovirus
421221|NCT00002016|Cytomegalovirus Infections|cytomegalovirus infections
421222|NCT00002016|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421223|NCT00002016|Antibodies, Monoclonal|antibodies, monoclonal
421224|NCT00002017|Polyethylene Glycols|polyethylene glycols
421225|NCT00002017|Interleukin-2|interleukin-2
421226|NCT00002018|Interferon Type I|interferon type i
421227|NCT00002019|Meningitis|meningitis
421228|NCT00002019|Liposomes|liposomes
421229|NCT00002019|Cryptococcosis|cryptococcosis
421230|NCT00002019|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421231|NCT00002019|Amphotericin B|amphotericin b
421232|NCT00002019|Chemistry, Pharmaceutical|chemistry, pharmaceutical
421233|NCT00002020|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421234|NCT00002020|AIDS-Related Complex|aids-related complex
421235|NCT00002020|Zidovudine|zidovudine
421236|NCT00002021|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421237|NCT00002021|Immune Tolerance|immune tolerance
421238|NCT00002021|Injections, Intravenous|injections, intravenous
421239|NCT00002021|Herpes Simplex|herpes simplex
421240|NCT00002021|Immunity, Cellular|immunity, cellular
421241|NCT00002021|Foscarnet|foscarnet
421242|NCT00002021|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421243|NCT00002021|Antiviral Agents|antiviral agents
421244|NCT00002022|Recombinant Proteins|recombinant proteins
421245|NCT00002022|Drugs, Investigational|drugs, investigational
421246|NCT00002022|Erythropoietin|erythropoietin
421247|NCT00002022|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421249|NCT00002022|Zidovudine|zidovudine
421334|NCT00002039|Zidovudine|zidovudine
421250|NCT00002023|Dose-Response Relationship, Drug|dose-response relationship, drug
421516|NCT00002074|Fluconazole|fluconazole
421251|NCT00002023|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421252|NCT00002023|AIDS-Related Complex|aids-related complex
421253|NCT00002023|Zidovudine|zidovudine
421254|NCT00002024|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421255|NCT00002024|Immune Tolerance|immune tolerance
421256|NCT00002024|Ganciclovir|ganciclovir
421257|NCT00002024|Drugs, Investigational|drugs, investigational
421258|NCT00002024|Cytomegalovirus Infections|cytomegalovirus infections
421259|NCT00002024|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421260|NCT00002025|Retinitis|retinitis
421261|NCT00002025|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421262|NCT00002025|Immune Tolerance|immune tolerance
421263|NCT00002025|Injections, Intravenous|injections, intravenous
421264|NCT00002025|Ganciclovir|ganciclovir
421265|NCT00002025|Cytomegalovirus Infections|cytomegalovirus infections
421266|NCT00002025|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421267|NCT00002026|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421268|NCT00002026|Leukoplakia, Oral|leukoplakia, oral
421269|NCT00002026|Herpesvirus 4, Human|herpesvirus 4, human
421270|NCT00002026|Acyclovir|acyclovir
421271|NCT00002026|AIDS-Related Complex|aids-related complex
421272|NCT00002027|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421273|NCT00002027|Cryptosporidiosis|cryptosporidiosis
421274|NCT00002027|Diarrhea|diarrhea
421275|NCT00002027|diclazuril|diclazuril
421276|NCT00002027|Coccidiostats|coccidiostats
421277|NCT00002027|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421278|NCT00002028|Didanosine|didanosine
524767|NCT00301197|obesity|obesity
421279|NCT00002028|Drugs, Investigational|drugs, investigational
421280|NCT00002028|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421281|NCT00002028|AIDS-Related Complex|aids-related complex
421282|NCT00002028|Zidovudine|zidovudine
421283|NCT00002029|Weight Loss|weight loss
421284|NCT00002029|Parenteral Nutrition, Total|parenteral nutrition, total
421285|NCT00002029|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421286|NCT00002029|Liposyn|liposyn
421287|NCT00002029|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421288|NCT00002030|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421289|NCT00002030|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
421290|NCT00002030|Pentamidine|pentamidine
421291|NCT00002030|Aerosols|aerosols
421292|NCT00002030|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421293|NCT00002031|Langerhans Cells|langerhans cells
421294|NCT00002031|Dinitrochlorobenzene|dinitrochlorobenzene
421295|NCT00002031|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421296|NCT00002031|AIDS-Related Complex|aids-related complex
421297|NCT00002032|Rifabutin|rifabutin
421298|NCT00002032|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421299|NCT00002032|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
421300|NCT00002032|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421301|NCT00002032|Antitubercular Agents|antitubercular agents
421302|NCT00002033|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421303|NCT00002033|AIDS-Related Complex|aids-related complex
421304|NCT00002033|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
421305|NCT00002033|Zidovudine|zidovudine
421306|NCT00002034|Retinitis|retinitis
421307|NCT00002034|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421308|NCT00002034|Ganciclovir|ganciclovir
421309|NCT00002034|Drug Interactions|drug interactions
421310|NCT00002034|Cytomegalovirus Infections|cytomegalovirus infections
421311|NCT00002034|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421312|NCT00002034|Zidovudine|zidovudine
421313|NCT00002035|Didanosine|didanosine
421314|NCT00002035|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421315|NCT00002035|AIDS-Related Complex|aids-related complex
421316|NCT00002035|Zidovudine|zidovudine
421317|NCT00002036|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421318|NCT00002036|AIDS-Related Complex|aids-related complex
421319|NCT00002036|Immunization, Passive|immunization, passive
421320|NCT00002037|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421321|NCT00002037|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
421322|NCT00002037|Interferon-gamma, Recombinant|interferon-gamma, recombinant
421323|NCT00002037|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421324|NCT00002038|Mycoses|mycoses
421325|NCT00002038|Drugs, Investigational|drugs, investigational
421326|NCT00002038|Fluconazole|fluconazole
421327|NCT00002039|Retinitis|retinitis
421328|NCT00002039|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421329|NCT00002039|Drug Therapy, Combination|drug therapy, combination
421330|NCT00002039|Foscarnet|foscarnet
421331|NCT00002039|Cytomegalovirus Infections|cytomegalovirus infections
421332|NCT00002039|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421333|NCT00002039|Antiviral Agents|antiviral agents
421335|NCT00002040|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421336|NCT00002040|Meningitis|meningitis
421337|NCT00002040|Injections, Intravenous|injections, intravenous
421338|NCT00002040|Cryptococcosis|cryptococcosis
421339|NCT00002040|Fluconazole|fluconazole
421340|NCT00002040|Administration, Oral|administration, oral
421341|NCT00002040|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421342|NCT00002041|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421343|NCT00002041|Esophagitis|esophagitis
421344|NCT00002041|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421345|NCT00002041|Amphotericin B|amphotericin b
421346|NCT00002041|Candidiasis, Oral|candidiasis, oral
421347|NCT00002042|Recombinant Proteins|recombinant proteins
421348|NCT00002042|Erythropoietin|erythropoietin
421349|NCT00002042|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421350|NCT00002042|Anemia|anemia
421351|NCT00002042|AIDS-Related Complex|aids-related complex
421352|NCT00002042|Zidovudine|zidovudine
421353|NCT00002043|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421354|NCT00002043|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
421355|NCT00002043|Leukoplakia, Oral|leukoplakia, oral
421356|NCT00002043|Dapsone|dapsone
421357|NCT00002043|AIDS-Related Complex|aids-related complex
421358|NCT00002043|Candidiasis, Oral|candidiasis, oral
421359|NCT00002044|Pilot Projects|pilot projects
421360|NCT00002044|Neuromuscular Diseases|neuromuscular diseases
421361|NCT00002044|Drug Evaluation|drug evaluation
421362|NCT00002044|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421363|NCT00002044|AIDS Dementia Complex|aids dementia complex
421364|NCT00002044|AIDS-Related Complex|aids-related complex
421365|NCT00002044|Zidovudine|zidovudine
421366|NCT00002045|Prospective Studies|prospective studies
421367|NCT00002045|Zidovudine|zidovudine
421368|NCT00002046|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421369|NCT00002046|AIDS-Related Complex|aids-related complex
421370|NCT00002046|Zidovudine|zidovudine
421371|NCT00002047|Kidney Failure, Chronic|kidney failure, chronic
421372|NCT00002047|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421373|NCT00002047|AIDS-Related Complex|aids-related complex
421374|NCT00002047|Zidovudine|zidovudine
421375|NCT00002047|Renal Dialysis|renal dialysis
421376|NCT00002048|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421377|NCT00002048|Zidovudine|zidovudine
421378|NCT00002049|Semen|semen
421379|NCT00002049|Thymopentin|thymopentin
421380|NCT00002049|Leukocytes, Mononuclear|leukocytes, mononuclear
421381|NCT00002049|HIV Seropositivity|hiv seropositivity
421382|NCT00002049|AIDS-Related Complex|aids-related complex
421383|NCT00002050|Semen|semen
421384|NCT00002050|Thymopentin|thymopentin
421385|NCT00002050|Leukocytes, Mononuclear|leukocytes, mononuclear
421386|NCT00002050|AIDS-Related Complex|aids-related complex
421387|NCT00002051|Thymopentin|thymopentin
421388|NCT00002051|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421389|NCT00002052|Salmonella Infections|salmonella infections
421390|NCT00002052|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421391|NCT00002052|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421392|NCT00002052|Amoxicillin|amoxicillin
421393|NCT00002052|Ceftriaxone|ceftriaxone
421394|NCT00002053|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421395|NCT00002053|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
421396|NCT00002053|Pentamidine|pentamidine
421397|NCT00002053|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421398|NCT00002054|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421399|NCT00002054|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
421400|NCT00002054|Pentamidine|pentamidine
421401|NCT00002054|Dose-Response Relationship, Drug|dose-response relationship, drug
421402|NCT00002054|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421403|NCT00002055|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421404|NCT00002055|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
421405|NCT00002055|Pentamidine|pentamidine
421406|NCT00002055|Dose-Response Relationship, Drug|dose-response relationship, drug
421407|NCT00002055|Aerosols|aerosols
421408|NCT00002055|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421409|NCT00002056|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
421410|NCT00002056|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421411|NCT00002056|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
421412|NCT00002056|Pentamidine|pentamidine
421413|NCT00002056|Injections, Intravenous|injections, intravenous
421414|NCT00002056|Administration, Oral|administration, oral
421415|NCT00002056|Aerosols|aerosols
421416|NCT00002056|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421417|NCT00002057|Nystatin|nystatin
421418|NCT00002057|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421419|NCT00002057|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421420|NCT00002057|AIDS-Related Complex|aids-related complex
421421|NCT00002057|Candidiasis, Oral|candidiasis, oral
421422|NCT00002058|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421423|NCT00002058|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
421424|NCT00002058|Clofazimine|clofazimine
421425|NCT00002058|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421426|NCT00002059|T-Lymphocytes, Suppressor-Effector|t-lymphocytes, suppressor-effector
421427|NCT00002059|Neoplasms|neoplasms
421428|NCT00002059|Inosine Pranobex|inosine pranobex
421429|NCT00002059|Killer Cells|killer cells
421430|NCT00002059|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
421431|NCT00002059|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421432|NCT00002059|AIDS-Related Complex|aids-related complex
421433|NCT00002060|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421434|NCT00002060|Inosine Pranobex|inosine pranobex
421435|NCT00002060|Homosexuality|homosexuality
421436|NCT00002060|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421437|NCT00002060|AIDS-Related Complex|aids-related complex
421438|NCT00002061|T-Lymphocytes|t-lymphocytes
421439|NCT00002061|Immune Tolerance|immune tolerance
421440|NCT00002061|Inosine Pranobex|inosine pranobex
421441|NCT00002061|Killer Cells|killer cells
421442|NCT00002061|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
421443|NCT00002061|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421444|NCT00002061|AIDS-Related Complex|aids-related complex
421445|NCT00002062|Spiramycin|spiramycin
421446|NCT00002062|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421447|NCT00002062|Immune Tolerance|immune tolerance
421448|NCT00002062|Cryptosporidiosis|cryptosporidiosis
421449|NCT00002062|Diarrhea|diarrhea
421450|NCT00002062|Drugs, Investigational|drugs, investigational
421451|NCT00002062|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421452|NCT00002063|Immune Tolerance|immune tolerance
421453|NCT00002063|AIDS-Related Complex|aids-related complex
421454|NCT00002063|Zidovudine|zidovudine
421455|NCT00002064|Sulfonamides|sulfonamides
421456|NCT00002064|Toxoplasmosis|toxoplasmosis
421457|NCT00002064|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421458|NCT00002064|Pyrimethamine|pyrimethamine
421459|NCT00002064|Drug Therapy, Combination|drug therapy, combination
421460|NCT00002064|Encephalitis|encephalitis
421461|NCT00002064|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421462|NCT00002064|Clindamycin|clindamycin
421463|NCT00002065|Delayed-Action Preparations|delayed-action preparations
421464|NCT00002065|Disulfiram|disulfiram
421465|NCT00002065|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421466|NCT00002065|AIDS-Related Complex|aids-related complex
421467|NCT00002066|Thymopentin|thymopentin
421468|NCT00002066|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421469|NCT00002067|Body Weight|body weight
421470|NCT00002067|T-Lymphocytes|t-lymphocytes
421471|NCT00002067|Nutritional Status|nutritional status
421472|NCT00002067|Megestrol|megestrol
421473|NCT00002067|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421474|NCT00002067|Anorexia|anorexia
421475|NCT00002067|Cachexia|cachexia
421476|NCT00002067|Energy Intake|energy intake
421477|NCT00002068|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421478|NCT00002068|Meningitis|meningitis
421479|NCT00002068|Cryptococcosis|cryptococcosis
421480|NCT00002068|Drug Therapy, Combination|drug therapy, combination
421481|NCT00002068|Fluconazole|fluconazole
421482|NCT00002068|Flucytosine|flucytosine
421483|NCT00002068|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421484|NCT00002068|Amphotericin B|amphotericin b
421485|NCT00002069|Ditiocarb|ditiocarb
421486|NCT00002069|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421487|NCT00002069|AIDS-Related Complex|aids-related complex
421488|NCT00002070|Recombinant Proteins|recombinant proteins
421489|NCT00002070|Retinitis|retinitis
421490|NCT00002070|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421491|NCT00002070|Neutropenia|neutropenia
421492|NCT00002070|Ganciclovir|ganciclovir
421493|NCT00002070|Drug Therapy, Combination|drug therapy, combination
421494|NCT00002070|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
421495|NCT00002070|Cytomegalovirus Infections|cytomegalovirus infections
421496|NCT00002070|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421497|NCT00002071|Recombinant Proteins|recombinant proteins
421498|NCT00002071|Erythropoietin|erythropoietin
421499|NCT00002071|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421500|NCT00002071|Anemia|anemia
421501|NCT00002071|Zidovudine|zidovudine
421502|NCT00002072|Recombinant Proteins|recombinant proteins
421503|NCT00002072|Erythropoietin|erythropoietin
421504|NCT00002072|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421505|NCT00002072|Anemia|anemia
421506|NCT00002072|Zidovudine|zidovudine
421507|NCT00002073|Recombinant Proteins|recombinant proteins
421508|NCT00002073|Injections, Subcutaneous|injections, subcutaneous
421509|NCT00002073|Erythropoietin|erythropoietin
421510|NCT00002073|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421511|NCT00002073|Anemia|anemia
421512|NCT00002073|Zidovudine|zidovudine
421694|NCT00002113|Fluconazole|fluconazole
421513|NCT00002074|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421514|NCT00002074|Meningitis|meningitis
421515|NCT00002074|Cryptococcosis|cryptococcosis
421517|NCT00002074|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421518|NCT00002074|Amphotericin B|amphotericin b
421519|NCT00002075|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421520|NCT00002075|Meningitis|meningitis
421521|NCT00002075|Cryptococcosis|cryptococcosis
421522|NCT00002075|Drug Therapy, Combination|drug therapy, combination
421523|NCT00002075|Fluconazole|fluconazole
421524|NCT00002075|Flucytosine|flucytosine
421525|NCT00002075|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421526|NCT00002075|Amphotericin B|amphotericin b
421527|NCT00002076|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421528|NCT00002076|Meningitis|meningitis
421529|NCT00002076|Cryptococcosis|cryptococcosis
421530|NCT00002076|Fluconazole|fluconazole
421531|NCT00002076|Administration, Oral|administration, oral
421532|NCT00002076|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421533|NCT00002077|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421534|NCT00002077|Meningitis|meningitis
421535|NCT00002077|Injections, Intravenous|injections, intravenous
421536|NCT00002077|Cryptococcosis|cryptococcosis
421537|NCT00002077|Fluconazole|fluconazole
421538|NCT00002077|Administration, Oral|administration, oral
421539|NCT00002077|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421540|NCT00002078|Drug Evaluation|drug evaluation
421541|NCT00002078|Interferon-alpha|interferon-alpha
200957|NCT02112825|chronic kidney disease|chronic kidney disease
421542|NCT00002079|Zidovudine|zidovudine
421543|NCT00002079|1-Deoxynojirimycin|1-deoxynojirimycin
421544|NCT00002080|Rifabutin|rifabutin
421545|NCT00002080|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421546|NCT00002080|AIDS-Related Complex|aids-related complex
421547|NCT00002080|Mycobacterium avium Complex|mycobacterium avium complex
421548|NCT00002080|Bacteremia|bacteremia
421549|NCT00002081|Zalcitabine|zalcitabine
421550|NCT00002081|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421551|NCT00002081|AIDS-Related Complex|aids-related complex
421552|NCT00002081|Zidovudine|zidovudine
421553|NCT00002082|Cryptosporidiosis|cryptosporidiosis
421554|NCT00002082|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421555|NCT00002082|Azithromycin|azithromycin
421556|NCT00002083|Peptide T|peptide t
421558|NCT00002083|Administration, Intranasal|administration, intranasal
421559|NCT00002083|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421560|NCT00002083|Peripheral Nervous System Diseases|peripheral nervous system diseases
421561|NCT00002084|Acyclovir|acyclovir
421562|NCT00002084|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421563|NCT00002084|AIDS-Related Complex|aids-related complex
421564|NCT00002084|Antiviral Agents|antiviral agents
421565|NCT00002084|Anus Diseases|anus diseases
421566|NCT00002084|Herpes Genitalis|herpes genitalis
584766|NCT00509756|healthy subjects|healthy subjects
421567|NCT00002085|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
421568|NCT00002085|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421569|NCT00002085|Azithromycin|azithromycin
421570|NCT00002085|Mycobacterium Infections, Atypical|mycobacterium infections, atypical
421571|NCT00002086|Zalcitabine|zalcitabine
421572|NCT00002086|Drug Therapy, Combination|drug therapy, combination
421573|NCT00002086|AIDS-Related Complex|aids-related complex
421574|NCT00002086|Zidovudine|zidovudine
421575|NCT00002086|Interferon-alpha|interferon-alpha
421576|NCT00002087|Recombinant Proteins|recombinant proteins
421577|NCT00002087|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421578|NCT00002087|Antigens, CD4|antigens, cd4
421579|NCT00002087|AIDS-Related Complex|aids-related complex
421580|NCT00002088|Diarrhea|diarrhea
421581|NCT00002088|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421582|NCT00002088|AIDS-Related Complex|aids-related complex
421583|NCT00002088|Saccharomyces|saccharomyces
421584|NCT00002089|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
421585|NCT00002089|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421586|NCT00002089|Azithromycin|azithromycin
421587|NCT00002090|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
421588|NCT00002090|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421589|NCT00002090|Azithromycin|azithromycin
421590|NCT00002091|Pentoxifylline|pentoxifylline
421591|NCT00002091|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421592|NCT00002091|AIDS-Related Complex|aids-related complex
421593|NCT00002092|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421594|NCT00002092|AIDS-Related Complex|aids-related complex
421595|NCT00002092|Cimetidine|cimetidine
421596|NCT00002093|Vincristine|vincristine
421597|NCT00002093|Sarcoma, Kaposi|sarcoma, kaposi
421598|NCT00002093|Liposomes|liposomes
421599|NCT00002093|Doxorubicin|doxorubicin
421600|NCT00002093|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421601|NCT00002093|Bleomycin|bleomycin
421602|NCT00002093|Daunorubicin|daunorubicin
421603|NCT00002093|Drug Carriers|drug carriers
421604|NCT00002094|Virus Replication|virus replication
421605|NCT00002094|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421606|NCT00002094|Antiviral Agents|antiviral agents
421607|NCT00002095|Ganciclovir|ganciclovir
421608|NCT00002095|Cytomegalovirus Infections|cytomegalovirus infections
421609|NCT00002095|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421610|NCT00002096|Didanosine|didanosine
421611|NCT00002096|Ganciclovir|ganciclovir
421612|NCT00002096|Drug Interactions|drug interactions
421613|NCT00002096|Cytomegalovirus Infections|cytomegalovirus infections
421614|NCT00002096|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421615|NCT00002096|Zidovudine|zidovudine
421616|NCT00002097|Nystatin|nystatin
421617|NCT00002097|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421618|NCT00002097|AIDS-Related Complex|aids-related complex
421619|NCT00002098|Didanosine|didanosine
421620|NCT00002098|Drug Therapy, Combination|drug therapy, combination
421621|NCT00002098|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421622|NCT00002098|AIDS-Related Complex|aids-related complex
421623|NCT00002098|Lentinan|lentinan
421624|NCT00002099|Didanosine|didanosine
421625|NCT00002099|Drug Therapy, Combination|drug therapy, combination
421626|NCT00002099|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421627|NCT00002099|AIDS-Related Complex|aids-related complex
421628|NCT00002099|Lentinan|lentinan
421629|NCT00002100|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421630|NCT00002100|AIDS-Related Complex|aids-related complex
421631|NCT00002100|curdlan sulfate|curdlan sulfate
421632|NCT00002101|Rifabutin|rifabutin
421633|NCT00002101|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
421634|NCT00002101|Drug Therapy, Combination|drug therapy, combination
421635|NCT00002101|Ethambutol|ethambutol
421636|NCT00002101|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421637|NCT00002101|Clarithromycin|clarithromycin
421638|NCT00002102|Trimetrexate|trimetrexate
421639|NCT00002102|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
421640|NCT00002102|Leucovorin|leucovorin
421641|NCT00002102|Drug Therapy, Combination|drug therapy, combination
421642|NCT00002102|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421643|NCT00002103|Trimetrexate|trimetrexate
421644|NCT00002103|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
421645|NCT00002103|Leucovorin|leucovorin
421646|NCT00002103|Drug Therapy, Combination|drug therapy, combination
421647|NCT00002103|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421648|NCT00002104|Mycobacterium tuberculosis|mycobacterium tuberculosis
421649|NCT00002104|Mycobacterium Infections|mycobacterium infections
421650|NCT00002104|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421651|NCT00002104|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
752076|NCT01171664|STAHIST|stahist
421652|NCT00002104|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421653|NCT00002104|AIDS-Related Complex|aids-related complex
421654|NCT00002104|Mycobacterium Infections, Atypical|mycobacterium infections, atypical
421655|NCT00002104|Thalidomide|thalidomide
421656|NCT00002105|Vincristine|vincristine
421657|NCT00002105|Sarcoma, Kaposi|sarcoma, kaposi
421658|NCT00002105|Liposomes|liposomes
421659|NCT00002105|Doxorubicin|doxorubicin
421660|NCT00002105|Drug Therapy, Combination|drug therapy, combination
421661|NCT00002105|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421662|NCT00002105|Bleomycin|bleomycin
421663|NCT00002105|Drug Carriers|drug carriers
421664|NCT00002106|Ranitidine|ranitidine
421665|NCT00002107|Interleukin-2|interleukin-2
421666|NCT00002107|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421667|NCT00002107|AIDS-Related Complex|aids-related complex
421668|NCT00002108|Drug Therapy, Combination|drug therapy, combination
421669|NCT00002108|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421670|NCT00002108|AIDS-Related Complex|aids-related complex
421671|NCT00002108|Antiviral Agents|antiviral agents
421672|NCT00002108|Zidovudine|zidovudine
421673|NCT00002109|Thymopentin|thymopentin
421674|NCT00002109|Zalcitabine|zalcitabine
421675|NCT00002109|Didanosine|didanosine
421676|NCT00002109|Drug Therapy, Combination|drug therapy, combination
421677|NCT00002109|Zidovudine|zidovudine
421678|NCT00002109|Stavudine|stavudine
421679|NCT00002110|Drug Therapy, Combination|drug therapy, combination
421680|NCT00002110|AIDS-Related Complex|aids-related complex
421681|NCT00002110|Zidovudine|zidovudine
421682|NCT00002110|Cysteamine|cysteamine
421683|NCT00002111|AIDS-Related Complex|aids-related complex
421684|NCT00002111|Saquinavir|saquinavir
421685|NCT00002111|HIV Protease Inhibitors|hiv protease inhibitors
421686|NCT00002112|Nystatin|nystatin
421687|NCT00002112|Fluconazole|fluconazole
421688|NCT00002112|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421689|NCT00002112|AIDS-Related Complex|aids-related complex
421690|NCT00002112|Candidiasis, Oral|candidiasis, oral
421691|NCT00002113|Meningitis|meningitis
421692|NCT00002113|Cryptococcosis|cryptococcosis
421693|NCT00002113|Drug Therapy, Combination|drug therapy, combination
421695|NCT00002113|Flucytosine|flucytosine
421696|NCT00002113|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421697|NCT00002115|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421698|NCT00002115|Antiviral Agents|antiviral agents
421700|NCT00002116|Herpes Simplex|herpes simplex
421701|NCT00002116|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421702|NCT00002116|Antiviral Agents|antiviral agents
421703|NCT00002116|cidofovir|cidofovir
421704|NCT00002117|Zalcitabine|zalcitabine
421705|NCT00002117|Drug Therapy, Combination|drug therapy, combination
421706|NCT00002117|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421707|NCT00002117|AIDS-Related Complex|aids-related complex
421708|NCT00002117|Zidovudine|zidovudine
421709|NCT00002118|Zalcitabine|zalcitabine
421710|NCT00002118|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421711|NCT00002118|AIDS-Related Complex|aids-related complex
421712|NCT00002119|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421713|NCT00002119|AIDS-Related Complex|aids-related complex
421714|NCT00002119|Antiviral Agents|antiviral agents
421715|NCT00002120|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
421717|NCT00002120|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
421718|NCT00002120|Leucovorin|leucovorin
421719|NCT00002120|Dapsone|dapsone
421720|NCT00002120|Drug Therapy, Combination|drug therapy, combination
421721|NCT00002120|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421722|NCT00002121|Antidiarrheals|antidiarrheals
421723|NCT00002121|Diarrhea|diarrhea
421724|NCT00002121|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421725|NCT00002121|AIDS-Related Complex|aids-related complex
421726|NCT00002121|N(1),N(14)-bis(ethyl)homospermine|n(1),n(14)-bis(ethyl)homospermine
421727|NCT00002122|Rifabutin|rifabutin
421728|NCT00002122|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
421729|NCT00002122|Mycoses|mycoses
421730|NCT00002122|Drug Therapy, Combination|drug therapy, combination
421731|NCT00002122|Fluconazole|fluconazole
421732|NCT00002122|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421733|NCT00002122|Azithromycin|azithromycin
421734|NCT00002123|Didanosine|didanosine
421735|NCT00002123|Drug Therapy, Combination|drug therapy, combination
421736|NCT00002123|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421737|NCT00002123|AIDS-Related Complex|aids-related complex
421738|NCT00002123|Antiviral Agents|antiviral agents
421739|NCT00002124|Drug Therapy, Combination|drug therapy, combination
421740|NCT00002124|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421741|NCT00002124|AIDS-Related Complex|aids-related complex
421742|NCT00002124|Antiviral Agents|antiviral agents
421743|NCT00002124|Zidovudine|zidovudine
421744|NCT00002125|Retinitis|retinitis
421745|NCT00002125|Infusions, Intravenous|infusions, intravenous
421746|NCT00002125|Foscarnet|foscarnet
421747|NCT00002125|Cytomegalovirus Infections|cytomegalovirus infections
421748|NCT00002125|Administration, Oral|administration, oral
421749|NCT00002125|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421750|NCT00002125|Fluid Therapy|fluid therapy
421751|NCT00002126|Neutropenia|neutropenia
421752|NCT00002126|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
421753|NCT00002126|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421754|NCT00002127|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421755|NCT00002127|Cachexia|cachexia
421756|NCT00002127|Thalidomide|thalidomide
421757|NCT00002128|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421758|NCT00002128|AIDS-Related Complex|aids-related complex
421759|NCT00002128|Antiviral Agents|antiviral agents
421760|NCT00002128|Adenine|adenine
421761|NCT00002129|vesnarinone|vesnarinone
421762|NCT00002130|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421763|NCT00002130|Antiviral Agents|antiviral agents
421764|NCT00002130|vesnarinone|vesnarinone
421765|NCT00002131|Sarcoma, Kaposi|sarcoma, kaposi
421766|NCT00002131|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421767|NCT00002131|Antiviral Agents|antiviral agents
421768|NCT00002131|vesnarinone|vesnarinone
421769|NCT00002132|Itraconazole|itraconazole
421770|NCT00002132|Fluconazole|fluconazole
421771|NCT00002132|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421772|NCT00002132|Candidiasis|candidiasis
421773|NCT00002132|Immunocompromised Host|immunocompromised host
421774|NCT00002133|Itraconazole|itraconazole
421775|NCT00002133|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421776|NCT00002133|AIDS-Related Complex|aids-related complex
421777|NCT00002133|Candidiasis, Oral|candidiasis, oral
421778|NCT00002134|Retinitis|retinitis
421779|NCT00002134|Ganciclovir|ganciclovir
421780|NCT00002134|Administration, Oral|administration, oral
421781|NCT00002134|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421782|NCT00002135|Retinitis|retinitis
421783|NCT00002135|Ganciclovir|ganciclovir
421784|NCT00002135|Administration, Oral|administration, oral
421785|NCT00002135|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421786|NCT00002136|Neoplasms|neoplasms
421787|NCT00002136|Sarcoma, Kaposi|sarcoma, kaposi
421788|NCT00002136|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421789|NCT00002136|Antineoplastic Agents|antineoplastic agents
421790|NCT00002136|tecogalan|tecogalan
421791|NCT00002137|Neoplasms|neoplasms
421792|NCT00002137|Sarcoma, Kaposi|sarcoma, kaposi
421793|NCT00002137|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421794|NCT00002137|Antineoplastic Agents|antineoplastic agents
421795|NCT00002137|tecogalan|tecogalan
421796|NCT00002138|Neoplasms|neoplasms
421797|NCT00002138|Sarcoma, Kaposi|sarcoma, kaposi
421798|NCT00002138|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421799|NCT00002138|Antineoplastic Agents|antineoplastic agents
421800|NCT00002138|tecogalan|tecogalan
421801|NCT00002139|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421802|NCT00002139|Azithromycin|azithromycin
421803|NCT00002139|Bacterial Infections|bacterial infections
421804|NCT00002140|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
421805|NCT00002140|Drug Therapy, Combination|drug therapy, combination
421806|NCT00002140|Ethambutol|ethambutol
421807|NCT00002140|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
420925|NCT00001089|HIV-1|hiv-1
421808|NCT00002140|Azithromycin|azithromycin
421809|NCT00002140|Clarithromycin|clarithromycin
421810|NCT00002141|Biological Availability|biological availability
421811|NCT00002141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
421812|NCT00002141|Food-Drug Interactions|food-drug interactions
421813|NCT00002141|abacavir|abacavir
421814|NCT00002142|Retinitis|retinitis
421815|NCT00002142|Probenecid|probenecid
421816|NCT00002142|Drug Therapy, Combination|drug therapy, combination
421817|NCT00002142|Cytomegalovirus Infections|cytomegalovirus infections
421818|NCT00002142|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421819|NCT00002142|Antiviral Agents|antiviral agents
421820|NCT00002142|cidofovir|cidofovir
421821|NCT00002143|Psoriasis|psoriasis
421822|NCT00002143|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421823|NCT00002143|AIDS-Related Complex|aids-related complex
421824|NCT00002143|Acitretin|acitretin
421825|NCT00002144|Herpes Simplex|herpes simplex
421826|NCT00002144|Foscarnet|foscarnet
421827|NCT00002144|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421828|NCT00002145|Foscarnet|foscarnet
421829|NCT00002145|Cytomegalovirus Infections|cytomegalovirus infections
421830|NCT00002145|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421831|NCT00002146|Infusions, Intravenous|infusions, intravenous
421832|NCT00002146|Foscarnet|foscarnet
421833|NCT00002146|Cytomegalovirus Infections|cytomegalovirus infections
421834|NCT00002146|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421835|NCT00002146|Magnesium Sulfate|magnesium sulfate
421836|NCT00002146|Magnesium Deficiency|magnesium deficiency
421837|NCT00002146|Hypocalcemia|hypocalcemia
421838|NCT00002147|Sarcoma, Kaposi|sarcoma, kaposi
421839|NCT00002147|Liposomes|liposomes
421840|NCT00002147|Doxorubicin|doxorubicin
421841|NCT00002147|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421842|NCT00002147|Drug Carriers|drug carriers
421843|NCT00002148|Cognition Disorders|cognition disorders
421844|NCT00002148|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421845|NCT00002148|AIDS-Related Complex|aids-related complex
421846|NCT00002148|Free Radical Scavengers|free radical scavengers
421847|NCT00002148|Antioxidants|antioxidants
421848|NCT00002148|OPC 14117|opc 14117
421849|NCT00002149|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421850|NCT00002149|Drug Therapy, Combination|drug therapy, combination
421851|NCT00002149|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421852|NCT00002149|AIDS-Related Complex|aids-related complex
421853|NCT00002149|Sinusitis|sinusitis
421854|NCT00002149|Ephedrine|ephedrine
421855|NCT00002149|Acupuncture Therapy|acupuncture therapy
421856|NCT00002149|Drugs, Chinese Herbal|drugs, chinese herbal
421857|NCT00002149|Medicine, Chinese Traditional|medicine, chinese traditional
421858|NCT00002149|Drug Combinations|drug combinations
421859|NCT00002149|Antibiotics, Combined|antibiotics, combined
421860|NCT00002149|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination
421861|NCT00002150|Drug Therapy, Combination|drug therapy, combination
421862|NCT00002150|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421863|NCT00002150|AIDS-Related Complex|aids-related complex
421864|NCT00002150|Zidovudine|zidovudine
421865|NCT00002150|MDL 28574|mdl 28574
421866|NCT00002151|Drug Therapy, Combination|drug therapy, combination
421867|NCT00002151|AIDS-Related Complex|aids-related complex
421868|NCT00002151|Zidovudine|zidovudine
421869|NCT00002151|MDL 28574|mdl 28574
421870|NCT00002152|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421871|NCT00002152|Antiviral Agents|antiviral agents
421872|NCT00002153|Skin Neoplasms|skin neoplasms
421873|NCT00002153|Sarcoma, Kaposi|sarcoma, kaposi
421874|NCT00002153|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421875|NCT00002153|Antineoplastic Agents|antineoplastic agents
421876|NCT00002154|Drug Therapy, Combination|drug therapy, combination
421877|NCT00002154|Cognition Disorders|cognition disorders
421878|NCT00002154|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421879|NCT00002154|AIDS-Related Complex|aids-related complex
421880|NCT00002154|Thioctic Acid|thioctic acid
421881|NCT00002154|Selegiline|selegiline
421882|NCT00002155|Drug Therapy, Combination|drug therapy, combination
421883|NCT00002155|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421884|NCT00002155|Antiviral Agents|antiviral agents
421885|NCT00002155|Zidovudine|zidovudine
421886|NCT00002155|HIV Protease Inhibitors|hiv protease inhibitors
421887|NCT00002155|Lamivudine|lamivudine
421888|NCT00002155|Indinavir|indinavir
421889|NCT00002156|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421890|NCT00002156|Ganciclovir|ganciclovir
421891|NCT00002156|Drug Therapy, Combination|drug therapy, combination
421892|NCT00002156|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421893|NCT00002156|Antiviral Agents|antiviral agents
421894|NCT00002156|Cytomegalovirus Retinitis|cytomegalovirus retinitis
421895|NCT00002156|Injections|injections
421896|NCT00002157|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421897|NCT00002157|Cachexia|cachexia
421898|NCT00002157|Thalidomide|thalidomide
421899|NCT00002158|Cryptosporidiosis|cryptosporidiosis
421900|NCT00002158|Diarrhea|diarrhea
421901|NCT00002158|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421902|NCT00002158|nitazoxanide|nitazoxanide
421903|NCT00002158|Antiparasitic Agents|antiparasitic agents
421904|NCT00002159|Itraconazole|itraconazole
421905|NCT00002159|Histoplasmosis|histoplasmosis
421906|NCT00002159|Antifungal Agents|antifungal agents
421907|NCT00002159|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421908|NCT00002159|Amphotericin B|amphotericin b
421909|NCT00002159|AIDS-Related Complex|aids-related complex
421910|NCT00002159|Blastomycosis|blastomycosis
421911|NCT00002159|Antibiotics, Antifungal|antibiotics, antifungal
421912|NCT00002160|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421913|NCT00002160|AIDS-Related Complex|aids-related complex
421915|NCT00002160|Palliative Care|palliative care
421916|NCT00002160|omega-conopeptide MVIIA|omega-conopeptide mviia
421917|NCT00002160|Calcium Channel Blockers|calcium channel blockers
421918|NCT00002161|Drug Therapy, Combination|drug therapy, combination
421919|NCT00002161|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421920|NCT00002161|AIDS-Related Complex|aids-related complex
421921|NCT00002161|Antiviral Agents|antiviral agents
421922|NCT00002161|Adenine|adenine
421923|NCT00002162|Drug Therapy, Combination|drug therapy, combination
421924|NCT00002162|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421925|NCT00002162|AIDS-Related Complex|aids-related complex
421926|NCT00002162|Antiviral Agents|antiviral agents
421927|NCT00002162|Saquinavir|saquinavir
421928|NCT00002163|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421929|NCT00002163|AIDS Dementia Complex|aids dementia complex
421930|NCT00002163|Antiviral Agents|antiviral agents
421931|NCT00002163|abacavir|abacavir
421932|NCT00002164|Biological Availability|biological availability
421933|NCT00002164|HIV Protease Inhibitors|hiv protease inhibitors
421934|NCT00002164|Dosage Forms|dosage forms
421935|NCT00002164|Nelfinavir|nelfinavir
421936|NCT00002165|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421937|NCT00002165|HIV Protease Inhibitors|hiv protease inhibitors
421938|NCT00002165|CD4 Lymphocyte Count|cd4 lymphocyte count
421939|NCT00002165|Nelfinavir|nelfinavir
421940|NCT00002165|Anti-HIV Agents|anti-hiv agents
421941|NCT00002166|Nevirapine|nevirapine
421942|NCT00002166|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
421943|NCT00002166|Anti-HIV Agents|anti-hiv agents
421944|NCT00002167|Skin Neoplasms|skin neoplasms
421945|NCT00002167|Sarcoma, Kaposi|sarcoma, kaposi
421946|NCT00002167|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421947|NCT00002167|Photochemotherapy|photochemotherapy
421948|NCT00002167|tin etiopurpurin|tin etiopurpurin
421949|NCT00002167|Radiation-Sensitizing Agents|radiation-sensitizing agents
421950|NCT00002168|Didanosine|didanosine
421951|NCT00002168|Drug Therapy, Combination|drug therapy, combination
421952|NCT00002168|Zidovudine|zidovudine
421953|NCT00002168|Stavudine|stavudine
421954|NCT00002168|HIV Protease Inhibitors|hiv protease inhibitors
421955|NCT00002168|CD4 Lymphocyte Count|cd4 lymphocyte count
421956|NCT00002168|Lamivudine|lamivudine
421957|NCT00002168|Indinavir|indinavir
421958|NCT00002168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
421959|NCT00002168|Anti-HIV Agents|anti-hiv agents
421960|NCT00002168|Viral Load|viral load
421961|NCT00002169|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421962|NCT00002169|Placebos|placebos
421963|NCT00002169|Antiviral Agents|antiviral agents
421964|NCT00002169|Cytomegalovirus Retinitis|cytomegalovirus retinitis
421965|NCT00002169|Treatment Outcome|treatment outcome
421966|NCT00002169|Nelfinavir|nelfinavir
421967|NCT00002170|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
421968|NCT00002170|Placebos|placebos
421969|NCT00002170|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
421970|NCT00002170|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421971|NCT00002170|HIV Protease Inhibitors|hiv protease inhibitors
421972|NCT00002170|Nelfinavir|nelfinavir
421973|NCT00002170|Anti-Infective Agents|anti-infective agents
421974|NCT00002170|Anti-HIV Agents|anti-hiv agents
421975|NCT00002171|Placebos|placebos
421976|NCT00002171|Drug Therapy, Combination|drug therapy, combination
421977|NCT00002171|Stavudine|stavudine
421978|NCT00002171|HIV Protease Inhibitors|hiv protease inhibitors
421979|NCT00002171|Lamivudine|lamivudine
421980|NCT00002171|Nelfinavir|nelfinavir
421981|NCT00002171|Anti-HIV Agents|anti-hiv agents
421982|NCT00002172|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421983|NCT00002172|AIDS Vaccines|aids vaccines
421984|NCT00002172|CD4 Lymphocyte Count|cd4 lymphocyte count
421985|NCT00002172|Salk HIV Immunogen|salk hiv immunogen
421986|NCT00002173|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421987|NCT00002173|AIDS Vaccines|aids vaccines
421988|NCT00002173|CD4 Lymphocyte Count|cd4 lymphocyte count
421989|NCT00002173|Salk HIV Immunogen|salk hiv immunogen
421990|NCT00002174|Adjuvants, Immunologic|adjuvants, immunologic
421991|NCT00002174|Thalidomide|thalidomide
421993|NCT00002174|Viral Load|viral load
421994|NCT00002175|Cohort Studies|cohort studies
421995|NCT00002175|RNA, Viral|rna, viral
421996|NCT00002175|Administration, Cutaneous|administration, cutaneous
421997|NCT00002175|Anti-HIV Agents|anti-hiv agents
421998|NCT00002175|Dinitrobenzenes|dinitrobenzenes
421999|NCT00002176|Pilot Projects|pilot projects
422000|NCT00002176|Didanosine|didanosine
422001|NCT00002176|Drug Therapy, Combination|drug therapy, combination
422002|NCT00002176|Stavudine|stavudine
422003|NCT00002176|Hydroxyurea|hydroxyurea
422004|NCT00002176|Nelfinavir|nelfinavir
422005|NCT00002176|Anti-HIV Agents|anti-hiv agents
422006|NCT00002176|Viral Load|viral load
422007|NCT00002177|Pilot Projects|pilot projects
422008|NCT00002177|HIV-1|hiv-1
422009|NCT00002177|Didanosine|didanosine
422010|NCT00002177|Drug Therapy, Combination|drug therapy, combination
422011|NCT00002177|Stavudine|stavudine
422012|NCT00002177|Hydroxyurea|hydroxyurea
422013|NCT00002177|RNA, Viral|rna, viral
422014|NCT00002177|Nelfinavir|nelfinavir
422015|NCT00002177|Anti-HIV Agents|anti-hiv agents
422016|NCT00002177|Viral Load|viral load
422017|NCT00002178|HIV-1|hiv-1
422018|NCT00002178|Drug Therapy, Combination|drug therapy, combination
422019|NCT00002178|HIV Protease Inhibitors|hiv protease inhibitors
422020|NCT00002178|RNA, Viral|rna, viral
422021|NCT00002178|Dosage Forms|dosage forms
422022|NCT00002178|Saquinavir|saquinavir
422023|NCT00002178|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422024|NCT00002178|Anti-HIV Agents|anti-hiv agents
422025|NCT00002178|Viral Load|viral load
422026|NCT00002179|Semen|semen
422027|NCT00002179|Monocytes|monocytes
422028|NCT00002179|HIV-1|hiv-1
422029|NCT00002179|Drug Therapy, Combination|drug therapy, combination
422030|NCT00002179|Zidovudine|zidovudine
422031|NCT00002179|Lymph Nodes|lymph nodes
422032|NCT00002179|HIV Protease Inhibitors|hiv protease inhibitors
422033|NCT00002179|Lamivudine|lamivudine
422034|NCT00002179|Indinavir|indinavir
422035|NCT00002179|RNA, Viral|rna, viral
422036|NCT00002179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422037|NCT00002179|Anti-HIV Agents|anti-hiv agents
422038|NCT00002179|Viral Load|viral load
422039|NCT00002180|Placebos|placebos
422040|NCT00002180|Anti-HIV Agents|anti-hiv agents
422041|NCT00002180|Adenine|adenine
422042|NCT00002181|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422043|NCT00002181|Herpes Simplex|herpes simplex
422044|NCT00002181|Acyclovir|acyclovir
422045|NCT00002181|Antiviral Agents|antiviral agents
422046|NCT00002181|Gels|gels
422047|NCT00002181|cidofovir|cidofovir
422048|NCT00002182|Placebos|placebos
422049|NCT00002182|Appetite Stimulants|appetite stimulants
422050|NCT00002182|Megestrol Acetate|megestrol acetate
422051|NCT00002182|Failure to Thrive|failure to thrive
422052|NCT00002183|Drug Therapy, Combination|drug therapy, combination
422053|NCT00002183|Drug Administration Schedule|drug administration schedule
422054|NCT00002183|HIV Protease Inhibitors|hiv protease inhibitors
422055|NCT00002183|VX 478|vx 478
422056|NCT00002183|Anti-HIV Agents|anti-hiv agents
422057|NCT00002184|HIV-1|hiv-1
422058|NCT00002184|Dose-Response Relationship, Drug|dose-response relationship, drug
422059|NCT00002184|Drug Therapy, Combination|drug therapy, combination
422060|NCT00002184|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422061|NCT00002184|Zidovudine|zidovudine
422062|NCT00002184|Stavudine|stavudine
422063|NCT00002184|HIV Protease Inhibitors|hiv protease inhibitors
422064|NCT00002184|CD4 Lymphocyte Count|cd4 lymphocyte count
422065|NCT00002184|Lamivudine|lamivudine
422066|NCT00002184|RNA, Viral|rna, viral
422067|NCT00002184|Saquinavir|saquinavir
422068|NCT00002184|Nelfinavir|nelfinavir
422069|NCT00002184|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422070|NCT00002184|Adenine|adenine
422071|NCT00002184|Anti-HIV Agents|anti-hiv agents
422072|NCT00002184|Viral Load|viral load
422073|NCT00002185|Skin Neoplasms|skin neoplasms
422269|NCT00001379|Immunosuppression|immunosuppression
422074|NCT00002185|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422169|NCT00001360|Vision|vision
422075|NCT00002185|Sarcoma, Kaposi|sarcoma, kaposi
422076|NCT00002185|Drug Therapy, Combination|drug therapy, combination
422077|NCT00002185|HIV Protease Inhibitors|hiv protease inhibitors
422078|NCT00002185|Mucous Membrane|mucous membrane
422079|NCT00002185|Nelfinavir|nelfinavir
422080|NCT00002185|Anti-HIV Agents|anti-hiv agents
422081|NCT00002186|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422082|NCT00002186|Herpes Simplex|herpes simplex
422083|NCT00002186|Drug Therapy, Combination|drug therapy, combination
422084|NCT00002186|Acyclovir|acyclovir
422085|NCT00002186|Antiviral Agents|antiviral agents
422086|NCT00002186|Gels|gels
422087|NCT00002186|SP 303|sp 303
422088|NCT00002187|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422089|NCT00002187|Antiviral Agents|antiviral agents
421248|NCT00002022|Anemia|anemia
422090|NCT00002187|Drug Administration Schedule|drug administration schedule
422091|NCT00002187|Cytomegalovirus Retinitis|cytomegalovirus retinitis
422092|NCT00002187|fomivirsen|fomivirsen
422093|NCT00002187|Vitreous Body|vitreous body
422094|NCT00002188|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422095|NCT00002188|Sarcoma, Kaposi|sarcoma, kaposi
422096|NCT00002188|Antineoplastic Agents|antineoplastic agents
422097|NCT00002189|Sarcoma, Kaposi|sarcoma, kaposi
422098|NCT00002189|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422100|NCT00002189|Treatment Outcome|treatment outcome
422101|NCT00002189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
422102|NCT00002190|Drug Therapy, Combination|drug therapy, combination
422103|NCT00002190|Zidovudine|zidovudine
422104|NCT00002190|HIV Protease Inhibitors|hiv protease inhibitors
422105|NCT00002190|Lamivudine|lamivudine
422106|NCT00002190|Saquinavir|saquinavir
422107|NCT00002190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422108|NCT00002190|Anti-HIV Agents|anti-hiv agents
422109|NCT00002191|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422110|NCT00002191|Placebos|placebos
422111|NCT00002191|Protozoan Infections|protozoan infections
422112|NCT00002191|Intestinal Diseases|intestinal diseases
422113|NCT00002191|Albendazole|albendazole
422114|NCT00002191|Microsporida|microsporida
422115|NCT00002191|Anthelmintics|anthelmintics
422116|NCT00002192|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422117|NCT00002192|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
422118|NCT00002192|Drug Therapy, Combination|drug therapy, combination
422119|NCT00002192|Antitubercular Agents|antitubercular agents
422120|NCT00002192|Azithromycin|azithromycin
422121|NCT00002192|Clarithromycin|clarithromycin
422122|NCT00002192|Bacteremia|bacteremia
422123|NCT00002192|rifapentine|rifapentine
422124|NCT00002193|HIV-1|hiv-1
422125|NCT00002193|Drug Therapy, Combination|drug therapy, combination
422126|NCT00002193|HIV Protease Inhibitors|hiv protease inhibitors
422127|NCT00002193|RNA, Viral|rna, viral
422128|NCT00002193|VX 478|vx 478
422129|NCT00002193|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422130|NCT00002193|Anti-HIV Agents|anti-hiv agents
422131|NCT00002193|Viral Load|viral load
422132|NCT00002194|Antibiotics, Macrolide|antibiotics, macrolide
422133|NCT00002194|Clarithromycin|clarithromycin
422134|NCT00002194|Nevirapine|nevirapine
422135|NCT00002194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422136|NCT00002194|Cytochrome P-450|cytochrome p-450
422137|NCT00002194|Anti-HIV Agents|anti-hiv agents
422138|NCT00002195|Drug Therapy, Combination|drug therapy, combination
422139|NCT00002195|Zidovudine|zidovudine
422140|NCT00002195|HIV Protease Inhibitors|hiv protease inhibitors
422141|NCT00002195|Lamivudine|lamivudine
422142|NCT00002195|VX 478|vx 478
422143|NCT00002195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422144|NCT00002195|Anti-HIV Agents|anti-hiv agents
422145|NCT00002195|Viral Load|viral load
422146|NCT00002196|Dose-Response Relationship, Drug|dose-response relationship, drug
422147|NCT00002196|Administration, Oral|administration, oral
422148|NCT00002196|Drug Administration Schedule|drug administration schedule
422149|NCT00002196|CD4 Lymphocyte Count|cd4 lymphocyte count
422150|NCT00002196|Anti-HIV Agents|anti-hiv agents
422151|NCT00002197|HIV-1|hiv-1
422152|NCT00002197|CD4 Lymphocyte Count|cd4 lymphocyte count
422153|NCT00002197|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422154|NCT00002197|Anti-HIV Agents|anti-hiv agents
422155|NCT00002197|Viral Load|viral load
422156|NCT00002197|abacavir|abacavir
422157|NCT00001357|Cytokines|cytokines
422158|NCT00001357|Immunoregulation|immunoregulation
422159|NCT00001357|CD4 Cells|cd4 cells
422160|NCT00001359|Obsessive Compulsive Disorder|obsessive compulsive disorder
422161|NCT00001359|PANDAS Associated with Streptococcal Infections|pandas associated with streptococcal infections
422162|NCT00001359|Adolescents|adolescents
422163|NCT00001359|Autoimmune Illness|autoimmune illness
422164|NCT00001359|Children|children
422165|NCT00001359|Tic Disorders|tic disorders
422166|NCT00001359|Streptococcal Infections|streptococcal infections
422270|NCT00001379|Lymphoma|lymphoma
422167|NCT00001359|Childhood Onset Neuropsychiatric Disorder|childhood onset neuropsychiatric disorder
422168|NCT00001360|Cognition|cognition
422170|NCT00001360|Cortex|cortex
422171|NCT00001360|Visual Processing|visual processing
422172|NCT00001360|Magnetic Resonance Imaging|magnetic resonance imaging
422173|NCT00001361|Movement Disorders|movement disorders
422174|NCT00001361|Sensory Processing|sensory processing
422175|NCT00001361|Stroke|stroke
422176|NCT00001361|Spinal Cord Injury|spinal cord injury
422177|NCT00001361|Blood Flow|blood flow
422178|NCT00001361|Blood Volume|blood volume
422179|NCT00001361|Cognitive Function|cognitive function
422180|NCT00001361|Neurobehavioral Deficits|neurobehavioral deficits
422181|NCT00001361|Neurological Disorders|neurological disorders
422182|NCT00001361|Magnetic Resonance Imaging|magnetic resonance imaging
422183|NCT00001361|Plasticity|plasticity
422184|NCT00001361|Normal Volunteer|normal volunteer
422185|NCT00001362|Magnetic Resonance Imaging|magnetic resonance imaging
422186|NCT00001362|Contrast Enhancement|contrast enhancement
422187|NCT00001362|Neuroanatomic Morphometry|neuroanatomic morphometry
422188|NCT00001362|Neurobehavioral Deficits|neurobehavioral deficits
422189|NCT00001362|Neurological Disorders|neurological disorders
422190|NCT00001362|Blood Flow|blood flow
422191|NCT00001362|Blood Volume|blood volume
422192|NCT00001362|Normal Volunteer|normal volunteer
422193|NCT00001363|Blood Flow|blood flow
422194|NCT00001363|Chess Play|chess play
422195|NCT00001363|Frontal Lobe|frontal lobe
422196|NCT00001363|Neurobehavioral Deficits|neurobehavioral deficits
422197|NCT00001363|Neuropsychology|neuropsychology
422198|NCT00001363|Positron Emission Tomography|positron emission tomography
422199|NCT00001363|Prefrontal Cortex|prefrontal cortex
422200|NCT00001364|Spinal Arteriovenous Malformations|spinal arteriovenous malformations
422201|NCT00001364|Spinal Dural Arteriovenous Fistulas|spinal dural arteriovenous fistulas
422202|NCT00001364|Surgery|surgery
422203|NCT00001364|Embolization|embolization
422204|NCT00001364|Spinal Arteriography|spinal arteriography
422205|NCT00001365|Dextromethorphan|dextromethorphan
422206|NCT00001365|Dextrorphan|dextrorphan
422207|NCT00001365|Glutamate Antagonist|glutamate antagonist
422208|NCT00001365|Parkinson's Disease|parkinson's disease
422209|NCT00001366|Neuroimaging|neuroimaging
422210|NCT00001366|Seizures|seizures
422211|NCT00001366|Cerebral Localization|cerebral localization
422212|NCT00001366|Partial Epilepsy|partial epilepsy
422213|NCT00001366|Epilepsy|epilepsy
422214|NCT00001367|Human|human
422215|NCT00001367|Movement|movement
422216|NCT00001367|Non-Investigational to Diagnostic Puzzle|non-investigational to diagnostic puzzle
422217|NCT00001367|Parkinson's|parkinson's
422218|NCT00001367|Dystonia|dystonia
422219|NCT00001367|Cerebellar|cerebellar
422220|NCT00001367|Puzzles|puzzles
422221|NCT00001367|Neurological Disorders|neurological disorders
422222|NCT00001367|Movement Disorders|movement disorders
422223|NCT00001368|Cerebral Ischemia|cerebral ischemia
422224|NCT00001368|Hypertension|hypertension
422225|NCT00001368|Immune Response|immune response
422226|NCT00001368|Carotid Stenosis|carotid stenosis
422227|NCT00001368|Atherosclerosis|atherosclerosis
422228|NCT00001371|Inflammation|inflammation
422229|NCT00001371|Lipocortin|lipocortin
422230|NCT00001371|Phospholipase A-2|phospholipase a-2
422231|NCT00001371|Skin|skin
422232|NCT00001371|Uteroglobin|uteroglobin
422233|NCT00001371|Psoriasis|psoriasis
422234|NCT00001372|Systemic Lupus Erythematosus|systemic lupus erythematosus
422235|NCT00001372|Natural History|natural history
422236|NCT00001372|Lupus Nephritis|lupus nephritis
422237|NCT00001372|Lupus|lupus
422238|NCT00001372|Systemic Lupus|systemic lupus
422239|NCT00001372|SLE|sle
422240|NCT00001373|Auto-Inflammation|auto-inflammation
422241|NCT00001373|Familial Mediterranean Fever|familial mediterranean fever
422242|NCT00001373|Genetics|genetics
422243|NCT00001373|Periodic Fever|periodic fever
422244|NCT00001375|Infection|infection
422245|NCT00001375|Reactive Arthritis|reactive arthritis
422246|NCT00001375|Rheumatoid Arthritis|rheumatoid arthritis
422247|NCT00001375|Synovial Biopsy|synovial biopsy
422248|NCT00001375|Synovial Fluid|synovial fluid
422249|NCT00001375|Synovitis|synovitis
422250|NCT00001376|Androgens|androgens
422251|NCT00001376|Female|female
422252|NCT00001376|Immunology|immunology
422253|NCT00001376|Neuroendocrine Axis|neuroendocrine axis
422254|NCT00001376|Rheumatoid Arthritis|rheumatoid arthritis
422255|NCT00001376|Postpartum|postpartum
422256|NCT00001376|Pregnancy|pregnancy
422257|NCT00001377|Familial|familial
422258|NCT00001377|Inherited Prostate Cancer|inherited prostate cancer
422259|NCT00001377|Linkage|linkage
422260|NCT00001377|Prostate Cancer|prostate cancer
422261|NCT00001378|4-Quadrant Fine Needle Aspiration|4-quadrant fine needle aspiration
422262|NCT00001378|Biomarkers|biomarkers
422263|NCT00001378|Chemoprevention|chemoprevention
422264|NCT00001378|Nipple Suction Aspirates|nipple suction aspirates
422265|NCT00001378|TGF Beta|tgf beta
422266|NCT00001379|Epstein-Barr Virus|epstein-barr virus
422267|NCT00001379|Lymphoproliferative Disorder|lymphoproliferative disorder
422268|NCT00001379|Viral|viral
422271|NCT00001381|Adult|adult
422272|NCT00001381|Intravesical Chemotherapy|intravesical chemotherapy
422273|NCT00001382|Immunotherapy|immunotherapy
422274|NCT00001382|Vaccine|vaccine
422275|NCT00001383|Cyclosporine Analogue|cyclosporine analogue
422276|NCT00001383|Multidrug Resistance|multidrug resistance
422277|NCT00001383|Pgp Blocker|pgp blocker
422278|NCT00001383|Pump Blocker|pump blocker
422279|NCT00001383|Taxol Over 90 Hours|taxol over 90 hours
422280|NCT00001384|14-Day Cycle|14-day cycle
422281|NCT00001384|Dose Intensity|dose intensity
422282|NCT00001384|Filgrastim|filgrastim
422283|NCT00001384|Lymph Node Positive|lymph node positive
422284|NCT00001384|Non-Cross Resistant|non-cross resistant
422285|NCT00001385|Cancer Diagnosis|cancer diagnosis
422286|NCT00001385|Cancer Metabolism|cancer metabolism
422287|NCT00001385|FDG|fdg
422288|NCT00001385|FDG Breast Imaging|fdg breast imaging
422289|NCT00001385|PET|pet
422290|NCT00001385|Positron Emission Mammography|positron emission mammography
422291|NCT00001385|Radiopharmaceutical|radiopharmaceutical
422292|NCT00001385|Scintimammography|scintimammography
422294|NCT00001386|Retrovirus|retrovirus
422295|NCT00001386|Therapeutic Vaccine|therapeutic vaccine
422296|NCT00001386|Vaccine|vaccine
422297|NCT00001386|Helper T Cells|helper t cells
422298|NCT00002198|Drug Interactions|drug interactions
422299|NCT00002198|Antiviral Agents|antiviral agents
422300|NCT00002198|Ethanol|ethanol
422301|NCT00002198|abacavir|abacavir
422302|NCT00002199|HIV-1|hiv-1
422303|NCT00002199|Drug Therapy, Combination|drug therapy, combination
422304|NCT00002199|Zidovudine|zidovudine
422305|NCT00002199|Drug Resistance, Microbial|drug resistance, microbial
422306|NCT00002199|HIV Protease Inhibitors|hiv protease inhibitors
422307|NCT00002199|Lamivudine|lamivudine
422308|NCT00002199|Indinavir|indinavir
422309|NCT00002199|Genotype|genotype
422310|NCT00002199|Phenotype|phenotype
422311|NCT00002199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422312|NCT00002199|Anti-HIV Agents|anti-hiv agents
422313|NCT00002199|abacavir|abacavir
422314|NCT00002200|HIV-1|hiv-1
422315|NCT00002200|Administration, Oral|administration, oral
422316|NCT00002200|CD4 Lymphocyte Count|cd4 lymphocyte count
422317|NCT00002200|RNA, Viral|rna, viral
422318|NCT00002200|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422319|NCT00002200|Anti-HIV Agents|anti-hiv agents
422320|NCT00002200|Viral Load|viral load
422321|NCT00002200|abacavir|abacavir
422322|NCT00002201|Drug Therapy, Combination|drug therapy, combination
422323|NCT00002201|HIV Protease Inhibitors|hiv protease inhibitors
422324|NCT00002201|Ritonavir|ritonavir
422325|NCT00002201|Nelfinavir|nelfinavir
422326|NCT00002201|Anti-HIV Agents|anti-hiv agents
422327|NCT00002202|HIV-1|hiv-1
422328|NCT00002202|Drug Therapy, Combination|drug therapy, combination
422329|NCT00002202|HIV Protease Inhibitors|hiv protease inhibitors
422330|NCT00002202|Indinavir|indinavir
422331|NCT00002202|RNA, Viral|rna, viral
422332|NCT00002202|VX 478|vx 478
422333|NCT00002202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422334|NCT00002202|Anti-HIV Agents|anti-hiv agents
422335|NCT00002202|Viral Load|viral load
422336|NCT00002203|Drug Therapy, Combination|drug therapy, combination
422337|NCT00002203|Zidovudine|zidovudine
422338|NCT00002203|HIV Protease Inhibitors|hiv protease inhibitors
422339|NCT00002203|CD4 Lymphocyte Count|cd4 lymphocyte count
422340|NCT00002203|CD4-CD8 Ratio|cd4-cd8 ratio
422341|NCT00002203|Lamivudine|lamivudine
422342|NCT00002203|Patient Compliance|patient compliance
422343|NCT00002203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422344|NCT00002203|Anti-HIV Agents|anti-hiv agents
422345|NCT00002203|Viral Load|viral load
422346|NCT00002204|Reference Values|reference values
422347|NCT00002204|Placebos|placebos
422348|NCT00002204|AIDS Vaccines|aids vaccines
422349|NCT00002204|HIV Core Protein p24|hiv core protein p24
422350|NCT00002204|HIV Seronegativity|hiv seronegativity
422351|NCT00002204|MF59 oil emulsion|mf59 oil emulsion
422352|NCT00002205|HIV Protease Inhibitors|hiv protease inhibitors
422353|NCT00002205|VX 478|vx 478
422354|NCT00002205|Anti-HIV Agents|anti-hiv agents
422355|NCT00002205|abacavir|abacavir
422356|NCT00002206|HIV-1|hiv-1
422357|NCT00002206|Adenine|adenine
422358|NCT00002206|Anti-HIV Agents|anti-hiv agents
422359|NCT00002207|Didanosine|didanosine
422360|NCT00002207|Drug Therapy, Combination|drug therapy, combination
422361|NCT00002207|Stavudine|stavudine
422362|NCT00002207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422363|NCT00002208|HIV-1|hiv-1
422364|NCT00002208|Drug Therapy, Combination|drug therapy, combination
422365|NCT00002208|Zidovudine|zidovudine
422366|NCT00002208|HIV Protease Inhibitors|hiv protease inhibitors
422367|NCT00002208|Lamivudine|lamivudine
422368|NCT00002208|Indinavir|indinavir
422369|NCT00002208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422370|NCT00002209|Dose-Response Relationship, Drug|dose-response relationship, drug
422371|NCT00002209|Drug Therapy, Combination|drug therapy, combination
422372|NCT00002209|AIDS Dementia Complex|aids dementia complex
422373|NCT00002209|Zidovudine|zidovudine
422374|NCT00002209|Lamivudine|lamivudine
422375|NCT00002209|Indinavir|indinavir
422376|NCT00002209|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422378|NCT00002210|Drug Therapy, Combination|drug therapy, combination
422379|NCT00002210|Delavirdine|delavirdine
422380|NCT00002210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422381|NCT00002211|HIV-1|hiv-1
422382|NCT00002211|Didanosine|didanosine
422383|NCT00002211|Stavudine|stavudine
422384|NCT00002211|HIV Protease Inhibitors|hiv protease inhibitors
422385|NCT00002211|RNA, Viral|rna, viral
422386|NCT00002211|Delavirdine|delavirdine
422387|NCT00002211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422388|NCT00002211|Viral Load|viral load
422389|NCT00002211|Nelfinavir|nelfinavir
422390|NCT00002212|Sarcoma, Kaposi|sarcoma, kaposi
422391|NCT00002212|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
421914|NCT00002160|Pain|pain
422392|NCT00002212|Anticarcinogenic Agents|anticarcinogenic agents
422393|NCT00002213|HIV-1|hiv-1
422394|NCT00002213|Drug Therapy, Combination|drug therapy, combination
422395|NCT00002213|Antiviral Agents|antiviral agents
422396|NCT00002213|HIV Protease Inhibitors|hiv protease inhibitors
422397|NCT00002213|RNA, Viral|rna, viral
422398|NCT00002213|VX 478|vx 478
422399|NCT00002213|Anti-HIV Agents|anti-hiv agents
422400|NCT00002213|abacavir|abacavir
422401|NCT00002213|efavirenz|efavirenz
422402|NCT00002214|Dose-Response Relationship, Drug|dose-response relationship, drug
422403|NCT00002214|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422404|NCT00002215|Drug Therapy, Combination|drug therapy, combination
422405|NCT00002215|HIV Protease Inhibitors|hiv protease inhibitors
422406|NCT00002215|RNA, Viral|rna, viral
422407|NCT00002215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422408|NCT00002215|Viral Load|viral load
422409|NCT00002215|Nelfinavir|nelfinavir
422410|NCT00002215|Uracil|uracil
752077|NCT01171677|addiction|addiction
422411|NCT00002216|Drug Therapy, Combination|drug therapy, combination
422412|NCT00002216|HIV Protease Inhibitors|hiv protease inhibitors
422413|NCT00002216|VX 478|vx 478
422414|NCT00002216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422415|NCT00002216|Anti-HIV Agents|anti-hiv agents
422416|NCT00002216|abacavir|abacavir
422417|NCT00002217|Drug Therapy, Combination|drug therapy, combination
422418|NCT00002217|Patient Compliance|patient compliance
422419|NCT00002217|Anti-HIV Agents|anti-hiv agents
422420|NCT00002217|abacavir|abacavir
422421|NCT00002218|HIV-1|hiv-1
422422|NCT00002218|Dose-Response Relationship, Drug|dose-response relationship, drug
422423|NCT00002218|Anti-HIV Agents|anti-hiv agents
422424|NCT00002219|Dose-Response Relationship, Drug|dose-response relationship, drug
422425|NCT00002219|Antiviral Agents|antiviral agents
422426|NCT00002219|HIV Protease Inhibitors|hiv protease inhibitors
422427|NCT00002219|Disease Progression|disease progression
422428|NCT00002219|RNA, Viral|rna, viral
422429|NCT00002219|Adenine|adenine
422430|NCT00002219|Viral Load|viral load
422431|NCT00002219|Age Factors|age factors
422432|NCT00002219|Nelfinavir|nelfinavir
422433|NCT00002220|Drug Resistance|drug resistance
422434|NCT00002220|Drug Therapy, Combination|drug therapy, combination
422435|NCT00002220|Antiviral Agents|antiviral agents
422436|NCT00002220|HIV Protease Inhibitors|hiv protease inhibitors
422437|NCT00002220|Indinavir|indinavir
422438|NCT00002220|RNA, Viral|rna, viral
422439|NCT00002220|Adenine|adenine
422440|NCT00002220|efavirenz|efavirenz
422441|NCT00002221|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
422442|NCT00002221|Bone Marrow|bone marrow
422443|NCT00002221|Lymphocyte Transformation|lymphocyte transformation
422444|NCT00002221|HIV-1|hiv-1
422445|NCT00002221|Retroviridae|retroviridae
422446|NCT00002221|Lymphoma, AIDS-Related|lymphoma, aids-related
422447|NCT00002221|Genetic Vectors|genetic vectors
422448|NCT00002221|Transduction, Genetic|transduction, genetic
422449|NCT00002221|Gene Transfer Techniques|gene transfer techniques
422450|NCT00002222|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422451|NCT00002222|Ganciclovir|ganciclovir
422452|NCT00002222|Antiviral Agents|antiviral agents
422453|NCT00002222|Drug Administration Schedule|drug administration schedule
422454|NCT00002222|Cytomegalovirus Retinitis|cytomegalovirus retinitis
422455|NCT00002222|Prodrugs|prodrugs
422456|NCT00002223|Drug Therapy, Combination|drug therapy, combination
422457|NCT00002223|Adolescent Behavior|adolescent behavior
422458|NCT00002223|HIV Protease Inhibitors|hiv protease inhibitors
422459|NCT00002223|Ritonavir|ritonavir
422460|NCT00002223|Indinavir|indinavir
422461|NCT00002224|Didanosine|didanosine
422462|NCT00002224|Drug Therapy, Combination|drug therapy, combination
422463|NCT00002224|Drug Administration Schedule|drug administration schedule
422464|NCT00002224|Stavudine|stavudine
422465|NCT00002224|HIV Protease Inhibitors|hiv protease inhibitors
422466|NCT00002224|Nelfinavir|nelfinavir
422467|NCT00002224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422468|NCT00002224|Anti-HIV Agents|anti-hiv agents
422469|NCT00002224|Viral Load|viral load
422470|NCT00002225|Didanosine|didanosine
422662|NCT00002263|Neutropenia|neutropenia
422471|NCT00002225|Drug Therapy, Combination|drug therapy, combination
422472|NCT00002225|Stavudine|stavudine
422473|NCT00002225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422474|NCT00002225|efavirenz|efavirenz
422475|NCT00002226|Skin Neoplasms|skin neoplasms
422476|NCT00002226|Sarcoma, Kaposi|sarcoma, kaposi
422477|NCT00002226|Antineoplastic Agents|antineoplastic agents
422478|NCT00002227|Drug Therapy, Combination|drug therapy, combination
422479|NCT00002227|Stavudine|stavudine
422480|NCT00002227|Lamivudine|lamivudine
422481|NCT00002227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422482|NCT00002227|efavirenz|efavirenz
422483|NCT00002228|Injections, Subcutaneous|injections, subcutaneous
422484|NCT00002228|HIV-1|hiv-1
422485|NCT00002228|Anti-HIV Agents|anti-hiv agents
422486|NCT00002228|peptide T20|peptide t20
422487|NCT00002229|Drug Therapy, Combination|drug therapy, combination
422488|NCT00002229|HIV Protease Inhibitors|hiv protease inhibitors
422489|NCT00002229|Dosage Forms|dosage forms
422490|NCT00002229|Saquinavir|saquinavir
422491|NCT00002229|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422492|NCT00002229|Anti-HIV Agents|anti-hiv agents
422493|NCT00002230|Didanosine|didanosine
422494|NCT00002230|Drug Therapy, Combination|drug therapy, combination
422495|NCT00002230|Stavudine|stavudine
422496|NCT00002230|Hydroxyurea|hydroxyurea
422497|NCT00002230|Anti-HIV Agents|anti-hiv agents
422498|NCT00002231|Injections, Intramuscular|injections, intramuscular
422499|NCT00002231|HIV Antibodies|hiv antibodies
422500|NCT00002231|Immunity, Cellular|immunity, cellular
422501|NCT00002231|AIDS Vaccines|aids vaccines
422502|NCT00002231|HIV Seronegativity|hiv seronegativity
422503|NCT00002231|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
422504|NCT00002231|Vaccines, DNA|vaccines, dna
422505|NCT00002232|Injections, Intradermal|injections, intradermal
422506|NCT00002232|Injections, Intramuscular|injections, intramuscular
422507|NCT00002232|HIV Antibodies|hiv antibodies
422508|NCT00002232|Immunity, Cellular|immunity, cellular
422509|NCT00002232|AIDS Vaccines|aids vaccines
422510|NCT00002232|HIV Seronegativity|hiv seronegativity
422511|NCT00002232|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
422512|NCT00002232|Vaccines, DNA|vaccines, dna
422513|NCT00002232|Immunity, Mucosal|immunity, mucosal
422514|NCT00002233|Drug Therapy, Combination|drug therapy, combination
422515|NCT00002233|HIV Protease Inhibitors|hiv protease inhibitors
422516|NCT00002233|CD4 Lymphocyte Count|cd4 lymphocyte count
422517|NCT00002233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422518|NCT00002233|Anti-HIV Agents|anti-hiv agents
422519|NCT00002233|Viral Load|viral load
422520|NCT00002234|Drug Therapy, Combination|drug therapy, combination
422521|NCT00002234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422522|NCT00002234|Anti-HIV Agents|anti-hiv agents
422523|NCT00002235|Drug Therapy, Combination|drug therapy, combination
422524|NCT00002235|HIV Protease Inhibitors|hiv protease inhibitors
422525|NCT00002235|Indinavir|indinavir
422526|NCT00002235|Nelfinavir|nelfinavir
422527|NCT00002235|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422528|NCT00002235|Anti-HIV Agents|anti-hiv agents
422529|NCT00002235|efavirenz|efavirenz
422530|NCT00002236|Drug Therapy, Combination|drug therapy, combination
422531|NCT00002236|Zidovudine|zidovudine
422532|NCT00002236|Drug Administration Schedule|drug administration schedule
422533|NCT00002236|HIV Protease Inhibitors|hiv protease inhibitors
422534|NCT00002236|CD4 Lymphocyte Count|cd4 lymphocyte count
422535|NCT00002236|Indinavir|indinavir
422536|NCT00002236|Delavirdine|delavirdine
422537|NCT00002236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422538|NCT00002236|Anti-HIV Agents|anti-hiv agents
422539|NCT00002236|Viral Load|viral load
422540|NCT00002237|Placebos|placebos
422541|NCT00002237|Administration, Oral|administration, oral
422542|NCT00002237|Anti-HIV Agents|anti-hiv agents
422543|NCT00002237|Viral Load|viral load
422544|NCT00002237|peldesine|peldesine
422545|NCT00002238|Drug Therapy, Combination|drug therapy, combination
422546|NCT00002238|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422547|NCT00002238|AIDS-Related Complex|aids-related complex
422548|NCT00002238|Zidovudine|zidovudine
422549|NCT00002238|Interferon Type I|interferon type i
422550|NCT00002239|HIV-1|hiv-1
422551|NCT00002239|Dose-Response Relationship, Drug|dose-response relationship, drug
422552|NCT00002239|Drug Therapy, Combination|drug therapy, combination
422553|NCT00002239|VX 478|vx 478
422554|NCT00002239|Anti-HIV Agents|anti-hiv agents
422555|NCT00002239|pentafuside|pentafuside
422556|NCT00002239|abacavir|abacavir
422557|NCT00002239|efavirenz|efavirenz
422558|NCT00002240|Didanosine|didanosine
422559|NCT00002240|Dose-Response Relationship, Drug|dose-response relationship, drug
422560|NCT00002240|Drug Therapy, Combination|drug therapy, combination
422561|NCT00002240|Stavudine|stavudine
422562|NCT00002240|HIV Protease Inhibitors|hiv protease inhibitors
422563|NCT00002240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422564|NCT00002240|Anti-HIV Agents|anti-hiv agents
422565|NCT00002240|Nelfinavir|nelfinavir
423623|NCT00001790|Candidiasis|candidiasis
422566|NCT00002241|Drug Therapy, Combination|drug therapy, combination
422567|NCT00002241|Stavudine|stavudine
422568|NCT00002241|HIV Protease Inhibitors|hiv protease inhibitors
422569|NCT00002241|Ritonavir|ritonavir
422570|NCT00002241|Lamivudine|lamivudine
422571|NCT00002241|Indinavir|indinavir
422572|NCT00002241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422573|NCT00002241|Anti-HIV Agents|anti-hiv agents
422574|NCT00002241|Viral Load|viral load
422575|NCT00002243|Anti-HIV Agents|anti-hiv agents
422576|NCT00002244|Placebos|placebos
422577|NCT00002244|Infusions, Intravenous|infusions, intravenous
422578|NCT00002244|Quality of Life|quality of life
422579|NCT00002244|Anti-HIV Agents|anti-hiv agents
422580|NCT00002244|tetrachlorodecaoxide|tetrachlorodecaoxide
422581|NCT00002245|Drug Therapy, Combination|drug therapy, combination
422582|NCT00002245|HIV Protease Inhibitors|hiv protease inhibitors
422583|NCT00002245|Lamivudine|lamivudine
422584|NCT00002245|Carbohydrates|carbohydrates
422585|NCT00002245|VX 478|vx 478
422586|NCT00002245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422587|NCT00002245|Anti-HIV Agents|anti-hiv agents
422588|NCT00002245|Lipids|lipids
422589|NCT00002245|Insulin Resistance|insulin resistance
422590|NCT00002245|abacavir|abacavir
422591|NCT00002246|AIDS Dementia Complex|aids dementia complex
422592|NCT00002246|Zidovudine|zidovudine
422593|NCT00002246|Stavudine|stavudine
422594|NCT00002246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
422595|NCT00002247|Retinitis|retinitis
422596|NCT00002247|Ganciclovir|ganciclovir
422597|NCT00002247|Cytomegalovirus Infections|cytomegalovirus infections
422598|NCT00002247|Administration, Oral|administration, oral
422599|NCT00002247|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422600|NCT00002248|Antidiarrheals|antidiarrheals
422601|NCT00002248|Cryptosporidiosis|cryptosporidiosis
422602|NCT00002248|Diarrhea|diarrhea
422603|NCT00002248|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422604|NCT00002248|Cryptosporidium|cryptosporidium
422605|NCT00002248|Immunization, Passive|immunization, passive
422606|NCT00002249|Anti-Infective Agents, Quinolone|anti-infective agents, quinolone
422607|NCT00002249|Ofloxacin|ofloxacin
422608|NCT00002249|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422609|NCT00002250|Recombinant Proteins|recombinant proteins
422611|NCT00002250|Drug Evaluation|drug evaluation
422612|NCT00002250|Antigens, CD4|antigens, cd4
422613|NCT00002251|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422614|NCT00002251|Ganciclovir|ganciclovir
422615|NCT00002251|Cytomegalovirus Infections|cytomegalovirus infections
422616|NCT00002251|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422617|NCT00002251|Biological Availability|biological availability
422618|NCT00002252|Octreotide|octreotide
422619|NCT00002252|Diarrhea|diarrhea
422620|NCT00002252|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422621|NCT00002252|AIDS-Related Complex|aids-related complex
422622|NCT00002253|Octreotide|octreotide
422623|NCT00002253|Diarrhea|diarrhea
422624|NCT00002253|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422625|NCT00002253|AIDS-Related Complex|aids-related complex
422626|NCT00002254|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422627|NCT00002255|Erythropoietin|erythropoietin
422628|NCT00002255|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
422629|NCT00002255|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422630|NCT00002255|AIDS-Related Complex|aids-related complex
422631|NCT00002255|Zidovudine|zidovudine
422632|NCT00002256|Zalcitabine|zalcitabine
422633|NCT00002256|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422634|NCT00002256|AIDS-Related Complex|aids-related complex
422635|NCT00002256|Zidovudine|zidovudine
422636|NCT00002257|Retinitis|retinitis
422637|NCT00002257|Ganciclovir|ganciclovir
422638|NCT00002257|Cytomegalovirus Infections|cytomegalovirus infections
422639|NCT00002257|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422640|NCT00002258|Interleukin-3|interleukin-3
422641|NCT00002258|Recombinant Proteins|recombinant proteins
422642|NCT00002258|Leukopenia|leukopenia
422643|NCT00002258|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422644|NCT00002258|AIDS-Related Complex|aids-related complex
422645|NCT00002258|Thrombocytopenia|thrombocytopenia
422646|NCT00002259|Mitoxantrone|mitoxantrone
422647|NCT00002259|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422648|NCT00002260|Biological Availability|biological availability
422649|NCT00002260|alovudine|alovudine
422651|NCT00002261|Vaccines, Synthetic|vaccines, synthetic
422652|NCT00002261|Vaccinia Virus|vaccinia virus
422653|NCT00002261|Viral Vaccines|viral vaccines
422654|NCT00002261|Smallpox Vaccine|smallpox vaccine
422655|NCT00002261|HIV-1|hiv-1
422656|NCT00002261|AIDS Vaccines|aids vaccines
422657|NCT00002261|HIV Seronegativity|hiv seronegativity
422658|NCT00002262|Skin Neoplasms|skin neoplasms
422659|NCT00002262|Tumor Necrosis Factor|tumor necrosis factor
422660|NCT00002262|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422661|NCT00002263|Pilot Projects|pilot projects
422663|NCT00002263|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
422664|NCT00002263|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422665|NCT00002263|Zidovudine|zidovudine
422666|NCT00002265|Zalcitabine|zalcitabine
422667|NCT00002265|Drug Evaluation|drug evaluation
422668|NCT00002265|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422669|NCT00002265|AIDS-Related Complex|aids-related complex
422670|NCT00002265|Zidovudine|zidovudine
526519|NCT00298246|HV|hv
422671|NCT00002266|Drug Therapy, Combination|drug therapy, combination
422672|NCT00002266|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422673|NCT00002266|AIDS-Related Complex|aids-related complex
422674|NCT00002266|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
422675|NCT00002267|Rifabutin|rifabutin
422676|NCT00002267|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422677|NCT00002267|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
422678|NCT00002267|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422679|NCT00002267|Antitubercular Agents|antitubercular agents
422680|NCT00002268|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422681|NCT00002268|Immunotherapy|immunotherapy
422682|NCT00002268|Drug Evaluation|drug evaluation
422683|NCT00002268|Cytomegalovirus Infections|cytomegalovirus infections
422684|NCT00002268|Antibodies, Monoclonal|antibodies, monoclonal
422685|NCT00002269|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422686|NCT00002269|ampligen|ampligen
422687|NCT00002269|AIDS-Related Complex|aids-related complex
422688|NCT00002269|Zidovudine|zidovudine
422689|NCT00002270|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
422690|NCT00002270|Interferon Alfa-2b|interferon alfa-2b
422691|NCT00002270|Drug Evaluation|drug evaluation
422692|NCT00002270|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422693|NCT00002270|Zidovudine|zidovudine
422694|NCT00002271|Thymidine|thymidine
422695|NCT00002271|Nucleosides|nucleosides
422696|NCT00002271|Antiviral Agents|antiviral agents
422697|NCT00002272|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422698|NCT00002272|Immune Tolerance|immune tolerance
422699|NCT00002272|Injections, Intravenous|injections, intravenous
422700|NCT00002272|Herpes Simplex|herpes simplex
422701|NCT00002272|Immunity, Cellular|immunity, cellular
422702|NCT00002272|Drug Resistance|drug resistance
422703|NCT00002272|Foscarnet|foscarnet
422704|NCT00002272|Acyclovir|acyclovir
422705|NCT00002272|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422706|NCT00002272|Antiviral Agents|antiviral agents
422707|NCT00002273|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422708|NCT00002273|Ganciclovir|ganciclovir
422709|NCT00002273|Cytomegalovirus Infections|cytomegalovirus infections
422711|NCT00002273|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422712|NCT00002274|Didanosine|didanosine
422713|NCT00002274|Drugs, Investigational|drugs, investigational
422714|NCT00002274|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422715|NCT00002274|Zidovudine|zidovudine
422716|NCT00002275|Weight Loss|weight loss
422717|NCT00002275|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
422718|NCT00002275|Parenteral Nutrition|parenteral nutrition
422719|NCT00002275|Liposyn|liposyn
422720|NCT00002275|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422721|NCT00002276|Blood Platelets|blood platelets
422722|NCT00002276|Ibuprofen|ibuprofen
422723|NCT00002276|Drug Interactions|drug interactions
422724|NCT00002276|Zidovudine|zidovudine
422725|NCT00002276|Hemophilia A|hemophilia a
422726|NCT00002277|Mycoses|mycoses
422727|NCT00002277|Neoplasms|neoplasms
422728|NCT00002277|Neutropenia|neutropenia
422729|NCT00002277|Fluconazole|fluconazole
422730|NCT00002277|Amphotericin B|amphotericin b
422731|NCT00002278|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422732|NCT00002278|Cryptosporidiosis|cryptosporidiosis
422733|NCT00002278|Diarrhea|diarrhea
422734|NCT00002278|diclazuril|diclazuril
422735|NCT00002278|Coccidiostats|coccidiostats
422736|NCT00002278|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422737|NCT00002279|Zalcitabine|zalcitabine
422738|NCT00002279|Didanosine|didanosine
422739|NCT00002279|Drugs, Investigational|drugs, investigational
422740|NCT00002279|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422741|NCT00002279|AIDS-Related Complex|aids-related complex
422742|NCT00002279|Zidovudine|zidovudine
422743|NCT00002280|Didanosine|didanosine
422744|NCT00002280|Drugs, Investigational|drugs, investigational
422745|NCT00002280|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422746|NCT00002280|Zidovudine|zidovudine
422747|NCT00002281|Injections, Subcutaneous|injections, subcutaneous
422748|NCT00002281|Erythropoietin|erythropoietin
422749|NCT00002281|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422750|NCT00002281|AIDS-Related Complex|aids-related complex
422751|NCT00002281|Zidovudine|zidovudine
422752|NCT00002282|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422753|NCT00002282|Fluconazole|fluconazole
422754|NCT00002282|Clotrimazole|clotrimazole
422755|NCT00002282|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422756|NCT00002282|Candidiasis, Oral|candidiasis, oral
422757|NCT00002283|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
422758|NCT00002283|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
526646|NCT00298857|Healthy|healthy
422759|NCT00002283|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
422760|NCT00002283|Dapsone|dapsone
422761|NCT00002283|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422762|NCT00002284|Lymphoma, Large-Cell|lymphoma, large-cell
422763|NCT00002284|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422764|NCT00002284|AIDS-Related Complex|aids-related complex
422765|NCT00002284|Zidovudine|zidovudine
422766|NCT00002284|Bone Marrow Transplantation|bone marrow transplantation
422767|NCT00002285|Virus Replication|virus replication
422768|NCT00002285|Pilot Projects|pilot projects
422769|NCT00002285|Immune Tolerance|immune tolerance
422770|NCT00002285|Lymphocytes|lymphocytes
422771|NCT00002285|Drug Evaluation|drug evaluation
422772|NCT00002285|Combined Modality Therapy|combined modality therapy
422773|NCT00002285|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422774|NCT00002285|Transplantation, Homologous|transplantation, homologous
422775|NCT00002285|Zidovudine|zidovudine
422776|NCT00002286|Pilot Projects|pilot projects
422777|NCT00002286|Psoriasis|psoriasis
422778|NCT00002286|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422779|NCT00002286|Zidovudine|zidovudine
422780|NCT00002287|Health Manpower|health manpower
422781|NCT00002287|Accidents, Occupational|accidents, occupational
422782|NCT00002287|Zidovudine|zidovudine
422783|NCT00002288|Neuropsychological Tests|neuropsychological tests
422784|NCT00002288|AIDS-Related Complex|aids-related complex
422785|NCT00002288|Zidovudine|zidovudine
422787|NCT00002289|Thymopentin|thymopentin
422788|NCT00002289|Leukocytes, Mononuclear|leukocytes, mononuclear
422789|NCT00002289|HIV Seropositivity|hiv seropositivity
422790|NCT00002289|AIDS-Related Complex|aids-related complex
422791|NCT00002290|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422792|NCT00002290|Drug Therapy, Combination|drug therapy, combination
422793|NCT00002290|Acyclovir|acyclovir
422794|NCT00002290|AIDS-Related Complex|aids-related complex
422795|NCT00002290|Zidovudine|zidovudine
422796|NCT00002291|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422797|NCT00002291|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
422798|NCT00002291|Pentamidine|pentamidine
422799|NCT00002291|Dose-Response Relationship, Drug|dose-response relationship, drug
422800|NCT00002291|Aerosols|aerosols
422801|NCT00002291|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422802|NCT00002292|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422803|NCT00002292|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
422804|NCT00002292|Pentamidine|pentamidine
422805|NCT00002292|Injections, Intravenous|injections, intravenous
422806|NCT00002292|Administration, Inhalation|administration, inhalation
422807|NCT00002292|Aerosols|aerosols
422808|NCT00002292|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422809|NCT00002293|Nystatin|nystatin
422810|NCT00002293|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422811|NCT00002293|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422812|NCT00002293|AIDS-Related Complex|aids-related complex
422813|NCT00002293|Candidiasis, Oral|candidiasis, oral
422814|NCT00002294|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422815|NCT00002294|Meningitis|meningitis
422816|NCT00002294|Cryptococcosis|cryptococcosis
422817|NCT00002294|Fluconazole|fluconazole
422818|NCT00002294|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422819|NCT00002295|Infusions, Intravenous|infusions, intravenous
422820|NCT00002295|Drug Evaluation|drug evaluation
422821|NCT00002295|Administration, Oral|administration, oral
422822|NCT00002295|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422823|NCT00002295|AIDS-Related Complex|aids-related complex
422824|NCT00002295|Zidovudine|zidovudine
422825|NCT00002295|Biological Availability|biological availability
422826|NCT00002296|T-Lymphocytes|t-lymphocytes
422827|NCT00002296|Immune Tolerance|immune tolerance
422828|NCT00002296|Inosine Pranobex|inosine pranobex
422829|NCT00002296|Killer Cells|killer cells
422830|NCT00002296|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
422831|NCT00002296|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422832|NCT00002296|AIDS-Related Complex|aids-related complex
422833|NCT00002297|Inosine Pranobex|inosine pranobex
422834|NCT00002297|AIDS-Related Complex|aids-related complex
422835|NCT00002298|Ribavirin|ribavirin
422836|NCT00002298|AIDS-Related Complex|aids-related complex
422837|NCT00002299|Retinitis|retinitis
422838|NCT00002299|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422839|NCT00002299|Ganciclovir|ganciclovir
422840|NCT00002299|Drug Therapy, Combination|drug therapy, combination
422841|NCT00002299|Cytomegalovirus Infections|cytomegalovirus infections
422842|NCT00002299|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422843|NCT00002299|Interferon Type I|interferon type i
422844|NCT00002300|T-Lymphocytes|t-lymphocytes
422845|NCT00002300|Megestrol|megestrol
422846|NCT00002300|Dose-Response Relationship, Drug|dose-response relationship, drug
422847|NCT00002300|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422848|NCT00002300|Anorexia|anorexia
422849|NCT00002300|Cachexia|cachexia
422850|NCT00002301|Retinitis|retinitis
422851|NCT00002301|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422852|NCT00002301|Ganciclovir|ganciclovir
422853|NCT00002301|Foscarnet|foscarnet
422854|NCT00002301|Cytomegalovirus Infections|cytomegalovirus infections
422855|NCT00002301|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422856|NCT00002301|Antiviral Agents|antiviral agents
422857|NCT00002302|Recombinant Proteins|recombinant proteins
422858|NCT00002302|Injections, Subcutaneous|injections, subcutaneous
422859|NCT00002302|Erythropoietin|erythropoietin
422377|NCT00002210|HIV-1|hiv-1
422860|NCT00002302|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422861|NCT00002302|Anemia|anemia
422862|NCT00002302|Zidovudine|zidovudine
422863|NCT00002303|Recombinant Proteins|recombinant proteins
422864|NCT00002303|Erythropoietin|erythropoietin
422865|NCT00002303|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422866|NCT00002303|Anemia|anemia
422867|NCT00002303|AIDS-Related Complex|aids-related complex
422868|NCT00002303|Zidovudine|zidovudine
422869|NCT00002304|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422870|NCT00002304|Immune Tolerance|immune tolerance
422871|NCT00002304|Ketoconazole|ketoconazole
422872|NCT00002304|Esophagitis|esophagitis
422873|NCT00002304|Fluconazole|fluconazole
422874|NCT00002304|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422875|NCT00002304|Candidiasis, Oral|candidiasis, oral
422876|NCT00002305|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422877|NCT00002305|Meningitis|meningitis
422878|NCT00002305|Cryptococcosis|cryptococcosis
422879|NCT00002305|Drug Therapy, Combination|drug therapy, combination
422880|NCT00002305|Fluconazole|fluconazole
422881|NCT00002305|Flucytosine|flucytosine
422882|NCT00002305|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422883|NCT00002305|Amphotericin B|amphotericin b
422884|NCT00002306|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422885|NCT00002306|Meningitis|meningitis
422886|NCT00002306|Cryptococcosis|cryptococcosis
422887|NCT00002306|Fluconazole|fluconazole
422888|NCT00002306|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422889|NCT00002306|Amphotericin B|amphotericin b
422890|NCT00002307|Zidovudine|zidovudine
422891|NCT00002307|Stavudine|stavudine
422892|NCT00002308|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422893|NCT00002308|AIDS-Related Complex|aids-related complex
422894|NCT00002308|Stavudine|stavudine
422895|NCT00002309|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
422896|NCT00002309|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422897|NCT00002309|AIDS-Related Complex|aids-related complex
422898|NCT00002309|Azithromycin|azithromycin
422899|NCT00002310|Herpes Simplex|herpes simplex
422900|NCT00002310|HIV-1|hiv-1
422901|NCT00002310|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422902|NCT00002310|Antiviral Agents|antiviral agents
422903|NCT00002310|Administration, Topical|administration, topical
422904|NCT00002311|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422905|NCT00002311|AIDS-Related Complex|aids-related complex
422906|NCT00002311|Wobenzym|wobenzym
422907|NCT00002311|Hydrolases|hydrolases
422908|NCT00002312|Drug Interactions|drug interactions
422909|NCT00002312|Antiviral Agents|antiviral agents
422910|NCT00002312|Zidovudine|zidovudine
422911|NCT00002313|Nystatin|nystatin
422912|NCT00002313|Didanosine|didanosine
422913|NCT00002313|Drug Therapy, Combination|drug therapy, combination
422914|NCT00002313|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422915|NCT00002313|AIDS-Related Complex|aids-related complex
422916|NCT00002314|Sarcoma, Kaposi|sarcoma, kaposi
422917|NCT00002314|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422918|NCT00002314|Antineoplastic Agents|antineoplastic agents
422919|NCT00002314|Gene Products, tat|gene products, tat
422920|NCT00002315|Herpes Zoster|herpes zoster
422921|NCT00002315|Acyclovir|acyclovir
422922|NCT00002315|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422923|NCT00002315|AIDS-Related Complex|aids-related complex
422924|NCT00002315|Antiviral Agents|antiviral agents
422925|NCT00002316|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422926|NCT00002316|Meningitis|meningitis
422927|NCT00002316|Drug Therapy, Combination|drug therapy, combination
422928|NCT00002316|Antifungal Agents|antifungal agents
422929|NCT00002316|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422930|NCT00002316|Amphotericin B|amphotericin b
422931|NCT00002317|Trimetrexate|trimetrexate
422932|NCT00002317|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
422933|NCT00002317|Leucovorin|leucovorin
422934|NCT00002317|Drug Therapy, Combination|drug therapy, combination
422935|NCT00002317|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422936|NCT00002318|Vincristine|vincristine
422937|NCT00002318|Sarcoma, Kaposi|sarcoma, kaposi
422938|NCT00002318|Liposomes|liposomes
422939|NCT00002318|Doxorubicin|doxorubicin
422940|NCT00002318|Drug Therapy, Combination|drug therapy, combination
422941|NCT00002318|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422942|NCT00002318|Bleomycin|bleomycin
422943|NCT00002318|Drug Carriers|drug carriers
422944|NCT00002319|Sarcoma, Kaposi|sarcoma, kaposi
422945|NCT00002319|Liposomes|liposomes
422946|NCT00002319|Doxorubicin|doxorubicin
422947|NCT00002319|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422948|NCT00002319|Drug Carriers|drug carriers
422949|NCT00002320|Drug Therapy, Combination|drug therapy, combination
422950|NCT00002320|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422951|NCT00002320|AIDS-Related Complex|aids-related complex
422952|NCT00002320|Antiviral Agents|antiviral agents
422953|NCT00002320|Zidovudine|zidovudine
422954|NCT00002321|Retinitis|retinitis
422955|NCT00002321|Interleukin-2|interleukin-2
422956|NCT00002321|Ganciclovir|ganciclovir
422957|NCT00002321|Drug Therapy, Combination|drug therapy, combination
422958|NCT00002321|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422959|NCT00002321|Antiviral Agents|antiviral agents
422960|NCT00002322|Drug Therapy, Combination|drug therapy, combination
422961|NCT00002322|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422962|NCT00002322|AIDS-Related Complex|aids-related complex
422963|NCT00002322|Antiviral Agents|antiviral agents
422964|NCT00002323|Drug Therapy, Combination|drug therapy, combination
422965|NCT00002323|Zidovudine|zidovudine
422966|NCT00002323|Nevirapine|nevirapine
422967|NCT00002324|Drug Therapy, Combination|drug therapy, combination
422968|NCT00002324|AIDS-Related Complex|aids-related complex
422969|NCT00002324|Zidovudine|zidovudine
422970|NCT00002324|Nevirapine|nevirapine
422972|NCT00002325|Fluconazole|fluconazole
422973|NCT00002325|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422974|NCT00002325|AIDS-Related Complex|aids-related complex
422975|NCT00002325|Coccidioidomycosis|coccidioidomycosis
422976|NCT00002326|Drug Therapy, Combination|drug therapy, combination
422977|NCT00002326|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422978|NCT00002326|AIDS-Related Complex|aids-related complex
422979|NCT00002326|Antiviral Agents|antiviral agents
422980|NCT00002326|Zidovudine|zidovudine
422981|NCT00002326|Adenine|adenine
422982|NCT00002327|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
422983|NCT00002327|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422984|NCT00002327|AIDS-Related Complex|aids-related complex
422985|NCT00002327|Antiviral Agents|antiviral agents
422986|NCT00002327|Condylomata Acuminata|condylomata acuminata
422987|NCT00002327|cidofovir|cidofovir
422988|NCT00002328|Antidiarrheals|antidiarrheals
422989|NCT00002328|Cryptosporidiosis|cryptosporidiosis
422990|NCT00002328|Diarrhea|diarrhea
422991|NCT00002328|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422992|NCT00002328|Azithromycin|azithromycin
422993|NCT00002329|MDL 28574|mdl 28574
422994|NCT00002330|Retinitis|retinitis
422995|NCT00002330|Ganciclovir|ganciclovir
422996|NCT00002330|Cytomegalovirus Infections|cytomegalovirus infections
422997|NCT00002330|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
422998|NCT00002331|Mycobacterium avium-intracellular Infection|mycobacterium avium-intracellular infection
422999|NCT00002331|Drug Therapy, Combination|drug therapy, combination
423000|NCT00002331|Ethambutol|ethambutol
423001|NCT00002331|Clofazimine|clofazimine
423002|NCT00002331|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423003|NCT00002331|Clarithromycin|clarithromycin
423004|NCT00002332|Thymopentin|thymopentin
423005|NCT00002332|AIDS-Related Complex|aids-related complex
423006|NCT00002333|Zalcitabine|zalcitabine
423007|NCT00002333|Drug Therapy, Combination|drug therapy, combination
423008|NCT00002333|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423009|NCT00002333|AIDS-Related Complex|aids-related complex
423010|NCT00002333|Saquinavir|saquinavir
423011|NCT00002333|HIV Protease Inhibitors|hiv protease inhibitors
423012|NCT00002334|Drug Therapy, Combination|drug therapy, combination
423013|NCT00002334|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423014|NCT00002334|AIDS-Related Complex|aids-related complex
423015|NCT00002334|Zidovudine|zidovudine
423016|NCT00002334|Saquinavir|saquinavir
423017|NCT00002334|HIV Protease Inhibitors|hiv protease inhibitors
423018|NCT00002335|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423019|NCT00002335|AIDS-Related Complex|aids-related complex
423020|NCT00002335|Antiviral Agents|antiviral agents
423021|NCT00002336|Mycobacterium avium-intracellular Infection|mycobacterium avium-intracellular infection
423022|NCT00002336|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423023|NCT00002336|Clarithromycin|clarithromycin
423024|NCT00002337|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423025|NCT00002337|Antiviral Agents|antiviral agents
423026|NCT00002337|vesnarinone|vesnarinone
423119|NCT00002359|Salk HIV Immunogen|salk hiv immunogen
423027|NCT00002338|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423028|NCT00002338|AIDS-Related Complex|aids-related complex
423029|NCT00002338|Antiviral Agents|antiviral agents
423030|NCT00002339|Esophagitis|esophagitis
423031|NCT00002339|Fluconazole|fluconazole
423032|NCT00002339|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423033|NCT00002339|Candidiasis|candidiasis
423034|NCT00002339|Immunocompromised Host|immunocompromised host
423035|NCT00002340|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
423036|NCT00002340|Pentamidine|pentamidine
423037|NCT00002340|Antifungal Agents|antifungal agents
423038|NCT00002340|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423039|NCT00002340|AIDS-Related Complex|aids-related complex
423040|NCT00002340|atovaquone|atovaquone
423041|NCT00002341|Itraconazole|itraconazole
423042|NCT00002341|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423043|NCT00002341|AIDS-Related Complex|aids-related complex
423044|NCT00002341|Candidiasis, Oral|candidiasis, oral
423045|NCT00002342|Neoplasms|neoplasms
423046|NCT00002342|Sarcoma, Kaposi|sarcoma, kaposi
423047|NCT00002342|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423048|NCT00002342|Antineoplastic Agents|antineoplastic agents
423049|NCT00002342|tecogalan|tecogalan
423050|NCT00002343|Rifabutin|rifabutin
423051|NCT00002343|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
423052|NCT00002343|Drug Therapy, Combination|drug therapy, combination
423053|NCT00002343|Ethambutol|ethambutol
423054|NCT00002343|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423055|NCT00002344|Azithromycin|azithromycin
423056|NCT00002344|Bacterial Infections|bacterial infections
423057|NCT00002345|Megestrol|megestrol
423058|NCT00002345|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423059|NCT00002345|Anorexia|anorexia
423060|NCT00002345|Cachexia|cachexia
423061|NCT00002345|Suspensions|suspensions
423062|NCT00002346|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423063|NCT00002346|AIDS-Related Complex|aids-related complex
423064|NCT00002346|Antiviral Agents|antiviral agents
423065|NCT00002346|Adenine|adenine
423066|NCT00002347|Zalcitabine|zalcitabine
423067|NCT00002347|Drug Therapy, Combination|drug therapy, combination
423068|NCT00002347|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423069|NCT00002347|AIDS-Related Complex|aids-related complex
423070|NCT00002347|Zidovudine|zidovudine
423071|NCT00002347|Nevirapine|nevirapine
423072|NCT00002347|Saquinavir|saquinavir
423073|NCT00002348|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
423074|NCT00002348|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423075|NCT00002348|Lymphoma, AIDS-Related|lymphoma, aids-related
423076|NCT00002348|Mitoguazone|mitoguazone
423077|NCT00002349|AIDS-Related Complex|aids-related complex
423078|NCT00002349|Stavudine|stavudine
423079|NCT00002350|Vaccines, Synthetic|vaccines, synthetic
423080|NCT00002350|AIDS Vaccines|aids vaccines
423081|NCT00002350|DNA, Viral|dna, viral
423082|NCT00002351|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423083|NCT00002351|AIDS-Related Complex|aids-related complex
423084|NCT00002351|HIV Protease Inhibitors|hiv protease inhibitors
423085|NCT00002351|Indinavir|indinavir
423086|NCT00002352|Cytomegalovirus Infections|cytomegalovirus infections
423087|NCT00002352|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423088|NCT00002352|Antiviral Agents|antiviral agents
423089|NCT00002353|Vaccines, Synthetic|vaccines, synthetic
423090|NCT00002353|AIDS Vaccines|aids vaccines
423091|NCT00002354|Drug Therapy, Combination|drug therapy, combination
423092|NCT00002354|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423093|NCT00002354|AIDS-Related Complex|aids-related complex
423094|NCT00002354|Stavudine|stavudine
423095|NCT00002354|HIV Protease Inhibitors|hiv protease inhibitors
423096|NCT00002354|Indinavir|indinavir
423097|NCT00002355|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
423098|NCT00002355|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423099|NCT00002355|Antiviral Agents|antiviral agents
423100|NCT00002355|Cytomegalovirus Retinitis|cytomegalovirus retinitis
423101|NCT00002356|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423102|NCT00002356|Antiviral Agents|antiviral agents
423103|NCT00002356|Cytomegalovirus Retinitis|cytomegalovirus retinitis
423104|NCT00002357|Drug Therapy, Combination|drug therapy, combination
423105|NCT00002357|AIDS-Related Complex|aids-related complex
423106|NCT00002357|Antiviral Agents|antiviral agents
423107|NCT00002357|Zidovudine|zidovudine
423108|NCT00002358|Herpes Zoster|herpes zoster
423109|NCT00002358|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423110|NCT00002358|AIDS-Related Complex|aids-related complex
423111|NCT00002358|Antiviral Agents|antiviral agents
423112|NCT00002358|sorivudine|sorivudine
423113|NCT00002358|Chickenpox|chickenpox
423114|NCT00002359|Vaccines, Synthetic|vaccines, synthetic
423115|NCT00002359|Viral Vaccines|viral vaccines
423116|NCT00002359|HIV-1|hiv-1
423117|NCT00002359|AIDS-Related Complex|aids-related complex
423118|NCT00002359|AIDS Vaccines|aids vaccines
423839|NCT00001861|Lazy Eye|lazy eye
423120|NCT00002360|Didanosine|didanosine
423121|NCT00002360|Tablets|tablets
423122|NCT00002360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
423123|NCT00002360|Anti-HIV Agents|anti-hiv agents
423124|NCT00002360|Therapeutic Equivalency|therapeutic equivalency
423125|NCT00002361|Drug Therapy, Combination|drug therapy, combination
423126|NCT00002361|HIV Protease Inhibitors|hiv protease inhibitors
423127|NCT00002361|Ritonavir|ritonavir
423128|NCT00002361|Indinavir|indinavir
423129|NCT00002361|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
423130|NCT00002361|Anti-HIV Agents|anti-hiv agents
423131|NCT00002361|Viral Load|viral load
423132|NCT00002362|Dideoxynucleosides|dideoxynucleosides
423133|NCT00002362|Drug Therapy, Combination|drug therapy, combination
423134|NCT00002362|Stavudine|stavudine
753425|NCT01179217|Painful Crises|painful crises
423135|NCT00002362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
423136|NCT00002362|abacavir|abacavir
423137|NCT00002362|efavirenz|efavirenz
423138|NCT00002363|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423139|NCT00002363|AIDS-Related Complex|aids-related complex
423140|NCT00002363|Antiviral Agents|antiviral agents
423141|NCT00002364|Drug Therapy, Combination|drug therapy, combination
423142|NCT00002364|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423143|NCT00002364|AIDS-Related Complex|aids-related complex
423144|NCT00002364|Antiviral Agents|antiviral agents
423145|NCT00002365|Dose-Response Relationship, Drug|dose-response relationship, drug
423146|NCT00002365|Administration, Oral|administration, oral
423147|NCT00002365|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423148|NCT00002365|Anti-HIV Agents|anti-hiv agents
423149|NCT00002366|Skin Neoplasms|skin neoplasms
423150|NCT00002366|Sarcoma, Kaposi|sarcoma, kaposi
423151|NCT00002366|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423152|NCT00002366|HIV Protease Inhibitors|hiv protease inhibitors
423153|NCT00002366|Ritonavir|ritonavir
423154|NCT00002367|Drug Therapy, Combination|drug therapy, combination
423155|NCT00002367|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423156|NCT00002367|Zidovudine|zidovudine
423157|NCT00002367|HIV Protease Inhibitors|hiv protease inhibitors
423158|NCT00002367|Lamivudine|lamivudine
423159|NCT00002367|Saquinavir|saquinavir
423160|NCT00002367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
423161|NCT00002367|Anti-HIV Agents|anti-hiv agents
423162|NCT00002368|Drug Therapy, Combination|drug therapy, combination
423163|NCT00002368|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423164|NCT00002368|Nevirapine|nevirapine
423165|NCT00002368|Lamivudine|lamivudine
423166|NCT00002368|Disease Progression|disease progression
423167|NCT00002368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
423168|NCT00002368|Anti-HIV Agents|anti-hiv agents
423169|NCT00002369|Drug Therapy, Combination|drug therapy, combination
423170|NCT00002369|Zidovudine|zidovudine
423171|NCT00002369|Stavudine|stavudine
423172|NCT00002369|HIV Protease Inhibitors|hiv protease inhibitors
423173|NCT00002369|CD4 Lymphocyte Count|cd4 lymphocyte count
423174|NCT00002369|Lamivudine|lamivudine
423175|NCT00002369|Indinavir|indinavir
423176|NCT00002369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
423177|NCT00002369|Anti-HIV Agents|anti-hiv agents
423178|NCT00002369|Viral Load|viral load
423179|NCT00002370|Itraconazole|itraconazole
423180|NCT00002370|Administration, Oral|administration, oral
423181|NCT00002370|Antifungal Agents|antifungal agents
423182|NCT00002370|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423183|NCT00002370|Drug Administration Schedule|drug administration schedule
423184|NCT00002371|HIV-1|hiv-1
423185|NCT00002371|Drug Therapy, Combination|drug therapy, combination
423186|NCT00002371|Stavudine|stavudine
423187|NCT00002371|Lamivudine|lamivudine
423188|NCT00002371|RNA, Viral|rna, viral
423189|NCT00002371|Anti-HIV Agents|anti-hiv agents
423190|NCT00002371|Viral Load|viral load
423191|NCT00002372|Drug Therapy, Combination|drug therapy, combination
423192|NCT00002372|Administration, Oral|administration, oral
423193|NCT00002372|HIV Protease Inhibitors|hiv protease inhibitors
423194|NCT00002372|Indinavir|indinavir
423195|NCT00002372|Saquinavir|saquinavir
423196|NCT00002372|Nelfinavir|nelfinavir
423197|NCT00002372|VX 478|vx 478
423198|NCT00002373|Cytomegalovirus|cytomegalovirus
423199|NCT00002373|Cytomegalovirus Infections|cytomegalovirus infections
423200|NCT00002373|Administration, Oral|administration, oral
423201|NCT00002373|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423202|NCT00002373|Antiviral Agents|antiviral agents
423203|NCT00002373|Virus Shedding|virus shedding
423204|NCT00002373|Viral Load|viral load
423205|NCT00002374|HIV-1|hiv-1
423206|NCT00002374|Drug Therapy, Combination|drug therapy, combination
423207|NCT00002374|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423208|NCT00002374|HIV Protease Inhibitors|hiv protease inhibitors
527344|NCT00308620|HIV|hiv
423209|NCT00002374|RNA, Viral|rna, viral
423210|NCT00002374|Saquinavir|saquinavir
423211|NCT00002374|Anti-HIV Agents|anti-hiv agents
423212|NCT00002374|Viral Load|viral load
424042|NCT00001893|Asthma|asthma
423213|NCT00002375|Drug Therapy, Combination|drug therapy, combination
423214|NCT00002375|HIV Protease Inhibitors|hiv protease inhibitors
423215|NCT00002375|Indinavir|indinavir
423216|NCT00002375|Nelfinavir|nelfinavir
423217|NCT00002375|Anti-HIV Agents|anti-hiv agents
423218|NCT00002376|HIV-1|hiv-1
423219|NCT00002376|CD4 Lymphocyte Count|cd4 lymphocyte count
423220|NCT00002376|RNA, Viral|rna, viral
423221|NCT00002376|Anti-HIV Agents|anti-hiv agents
423222|NCT00002376|Viral Load|viral load
423223|NCT00002378|HIV-1|hiv-1
423224|NCT00002378|Drug Therapy, Combination|drug therapy, combination
423225|NCT00002378|Zidovudine|zidovudine
423226|NCT00002378|Stavudine|stavudine
423227|NCT00002378|HIV Protease Inhibitors|hiv protease inhibitors
423228|NCT00002378|Lamivudine|lamivudine
423229|NCT00002378|RNA, Viral|rna, viral
423230|NCT00002378|Dosage Forms|dosage forms
423231|NCT00002378|Saquinavir|saquinavir
423232|NCT00002378|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
423234|NCT00002378|Viral Load|viral load
423235|NCT00002378|Nelfinavir|nelfinavir
423236|NCT00002379|HIV-1|hiv-1
423237|NCT00002379|Drug Therapy, Combination|drug therapy, combination
423238|NCT00002379|Administration, Oral|administration, oral
423239|NCT00002379|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423240|NCT00002379|Zidovudine|zidovudine
423241|NCT00002379|Stavudine|stavudine
423242|NCT00002379|HIV Protease Inhibitors|hiv protease inhibitors
423243|NCT00002379|CD4 Lymphocyte Count|cd4 lymphocyte count
423244|NCT00002379|Lamivudine|lamivudine
423245|NCT00002379|Indinavir|indinavir
423246|NCT00002379|RNA, Viral|rna, viral
423247|NCT00002379|Adenine|adenine
423248|NCT00002379|Anti-HIV Agents|anti-hiv agents
423249|NCT00002379|Viral Load|viral load
423250|NCT00002380|Drug Therapy, Combination|drug therapy, combination
423251|NCT00002380|HIV Protease Inhibitors|hiv protease inhibitors
423252|NCT00002380|Dosage Forms|dosage forms
423253|NCT00002380|Saquinavir|saquinavir
423254|NCT00002380|Nelfinavir|nelfinavir
423255|NCT00002380|Anti-HIV Agents|anti-hiv agents
423256|NCT00002381|HIV-1|hiv-1
423257|NCT00002381|Drug Therapy, Combination|drug therapy, combination
423258|NCT00002381|Nevirapine|nevirapine
423259|NCT00002381|Stavudine|stavudine
423260|NCT00002381|RNA, Viral|rna, viral
423261|NCT00002381|Nelfinavir|nelfinavir
423262|NCT00002381|Anti-HIV Agents|anti-hiv agents
423263|NCT00002381|Viral Load|viral load
423264|NCT00002382|Zalcitabine|zalcitabine
423265|NCT00002382|Didanosine|didanosine
423266|NCT00002382|Drug Therapy, Combination|drug therapy, combination
423267|NCT00002382|Zidovudine|zidovudine
423268|NCT00002382|HIV Protease Inhibitors|hiv protease inhibitors
423269|NCT00002382|Saquinavir|saquinavir
423270|NCT00002382|Patient Selection|patient selection
423271|NCT00002382|Anti-HIV Agents|anti-hiv agents
423272|NCT00002383|Drug Administration Schedule|drug administration schedule
423273|NCT00002383|HIV Protease Inhibitors|hiv protease inhibitors
423274|NCT00002383|Dosage Forms|dosage forms
423275|NCT00002383|Saquinavir|saquinavir
423276|NCT00002383|Anti-HIV Agents|anti-hiv agents
423277|NCT00002385|Dose-Response Relationship, Drug|dose-response relationship, drug
423278|NCT00002385|Cohort Studies|cohort studies
423279|NCT00002385|Anti-HIV Agents|anti-hiv agents
423280|NCT00002386|Drug Therapy, Combination|drug therapy, combination
423281|NCT00002386|HIV Protease Inhibitors|hiv protease inhibitors
423282|NCT00002386|Indinavir|indinavir
423283|NCT00002386|Factor VIII|factor viii
423284|NCT00002386|Factor IX|factor ix
423285|NCT00002386|Half-Life|half-life
423286|NCT00002386|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
423287|NCT00002386|Anti-HIV Agents|anti-hiv agents
423288|NCT00002386|Platelet Aggregation|platelet aggregation
423289|NCT00002386|Hemophilia A|hemophilia a
423290|NCT00002386|Hemophilia B|hemophilia b
423291|NCT00002387|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423292|NCT00002387|Drug Administration Schedule|drug administration schedule
423293|NCT00002387|HIV Protease Inhibitors|hiv protease inhibitors
423294|NCT00002387|Indinavir|indinavir
423295|NCT00002387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
423296|NCT00002387|Anti-HIV Agents|anti-hiv agents
423297|NCT00002387|efavirenz|efavirenz
423298|NCT00002388|HIV-1|hiv-1
423299|NCT00002388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
423300|NCT00002388|Anti-HIV Agents|anti-hiv agents
423301|NCT00002389|HIV-1|hiv-1
423302|NCT00002389|Drug Therapy, Combination|drug therapy, combination
423303|NCT00002389|Antiviral Agents|antiviral agents
423304|NCT00002389|Zidovudine|zidovudine
423305|NCT00002389|CD4 Lymphocyte Count|cd4 lymphocyte count
423306|NCT00002389|Lamivudine|lamivudine
423307|NCT00002389|RNA, Viral|rna, viral
423308|NCT00002389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
423309|NCT00002389|Anti-HIV Agents|anti-hiv agents
423310|NCT00002389|Viral Load|viral load
423311|NCT00002389|abacavir|abacavir
423312|NCT00002391|HIV-1|hiv-1
423313|NCT00002391|Drug Therapy, Combination|drug therapy, combination
423314|NCT00002391|Zidovudine|zidovudine
423315|NCT00002391|Lamivudine|lamivudine
423316|NCT00002391|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
423317|NCT00002391|Anti-HIV Agents|anti-hiv agents
423318|NCT00002391|Viral Load|viral load
423319|NCT00002391|Child Development|child development
423320|NCT00002391|abacavir|abacavir
423321|NCT00002392|Lymphocyte Transformation|lymphocyte transformation
423322|NCT00002392|Immunity, Cellular|immunity, cellular
423323|NCT00002392|Drug Therapy, Combination|drug therapy, combination
423324|NCT00002392|Adjuvants, Immunologic|adjuvants, immunologic
423325|NCT00002392|Thalidomide|thalidomide
423326|NCT00002392|Immunologic Memory|immunologic memory
423327|NCT00002392|Streptococcus pneumoniae|streptococcus pneumoniae
423328|NCT00002392|Tetanus Toxoid|tetanus toxoid
423329|NCT00002392|Pneumococcal Vaccines|pneumococcal vaccines
423330|NCT00002393|Placebos|placebos
423331|NCT00002393|Drug Therapy, Combination|drug therapy, combination
423332|NCT00002393|HIV Protease Inhibitors|hiv protease inhibitors
423333|NCT00002393|Indinavir|indinavir
423334|NCT00002393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
423335|NCT00002393|efavirenz|efavirenz
423336|NCT00002394|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
423337|NCT00002394|Dose-Response Relationship, Drug|dose-response relationship, drug
423338|NCT00002394|Fluconazole|fluconazole
423339|NCT00002394|Antifungal Agents|antifungal agents
423340|NCT00002394|Candidiasis, Oral|candidiasis, oral
423341|NCT00002394|Drug Administration Schedule|drug administration schedule
423342|NCT00002394|terbinafine|terbinafine
423343|NCT00002395|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
423344|NCT00002395|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
423345|NCT00002395|Infusions, Intravenous|infusions, intravenous
423346|NCT00002395|Drug Administration Schedule|drug administration schedule
423347|NCT00002395|Topotecan|topotecan
423348|NCT00002396|Dose-Response Relationship, Drug|dose-response relationship, drug
423349|NCT00002396|Adenine|adenine
423350|NCT00002396|Anti-HIV Agents|anti-hiv agents
423351|NCT00002397|Kidney Failure, Chronic|kidney failure, chronic
423352|NCT00002397|HIV-1|hiv-1
423353|NCT00002397|Drug Therapy, Combination|drug therapy, combination
423354|NCT00002397|Stavudine|stavudine
423355|NCT00002397|HIV Protease Inhibitors|hiv protease inhibitors
423356|NCT00002397|Lamivudine|lamivudine
423357|NCT00002397|Saquinavir|saquinavir
423358|NCT00002397|AIDS-Associated Nephropathy|aids-associated nephropathy
423359|NCT00002397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
423360|NCT00002397|Viral Load|viral load
423361|NCT00002397|Nelfinavir|nelfinavir
423362|NCT00002398|HIV-1|hiv-1
423363|NCT00002398|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423364|NCT00002398|Adenine|adenine
423365|NCT00002398|Anti-HIV Agents|anti-hiv agents
423366|NCT00002399|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
423367|NCT00002399|Fluconazole|fluconazole
423368|NCT00002399|Antifungal Agents|antifungal agents
423369|NCT00002399|Candidiasis|candidiasis
423370|NCT00002399|Triazoles|triazoles
423371|NCT00002400|HIV-1|hiv-1
423372|NCT00002400|Drug Therapy, Combination|drug therapy, combination
423373|NCT00002400|Zidovudine|zidovudine
423374|NCT00002400|HIV Protease Inhibitors|hiv protease inhibitors
423375|NCT00002400|Lamivudine|lamivudine
423376|NCT00002400|Indinavir|indinavir
423377|NCT00002400|RNA, Viral|rna, viral
423378|NCT00002400|Delavirdine|delavirdine
423379|NCT00002400|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
423380|NCT00002401|HIV-1|hiv-1
423381|NCT00002401|Zidovudine|zidovudine
423382|NCT00002401|HIV Protease Inhibitors|hiv protease inhibitors
423383|NCT00002401|Lamivudine|lamivudine
423384|NCT00002401|Indinavir|indinavir
423385|NCT00002401|RNA, Viral|rna, viral
423386|NCT00002401|Delavirdine|delavirdine
423387|NCT00002401|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
423388|NCT00002401|Viral Load|viral load
423389|NCT00002402|HIV-1|hiv-1
423390|NCT00002402|Dose-Response Relationship, Drug|dose-response relationship, drug
423391|NCT00002402|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423392|NCT00002402|AIDS Vaccines|aids vaccines
423393|NCT00002402|HIV Seronegativity|hiv seronegativity
423394|NCT00002402|Antigens, Viral|antigens, viral
423395|NCT00002402|Alum Compounds|alum compounds
423396|NCT00002403|HIV-1|hiv-1
423397|NCT00002403|Dose-Response Relationship, Drug|dose-response relationship, drug
423398|NCT00002403|HIV Integrase Inhibitors|hiv integrase inhibitors
423399|NCT00002403|HIV Integrase|hiv integrase
423400|NCT00002404|HIV-1|hiv-1
423401|NCT00002404|Antiviral Agents|antiviral agents
423402|NCT00002404|Herpes Genitalis|herpes genitalis
423403|NCT00002404|Recurrence|recurrence
423404|NCT00002404|DNA, Viral|dna, viral
423405|NCT00002404|RNA, Viral|rna, viral
423406|NCT00002404|valacyclovir|valacyclovir
423407|NCT00002404|Herpesvirus 2, Human|herpesvirus 2, human
423408|NCT00002405|Drug Therapy, Combination|drug therapy, combination
423409|NCT00002405|HIV Protease Inhibitors|hiv protease inhibitors
423410|NCT00002405|VX 478|vx 478
423411|NCT00002405|Anti-HIV Agents|anti-hiv agents
423412|NCT00002406|HIV-1|hiv-1
424043|NCT00001894|HCM|hcm
423413|NCT00002406|Dose-Response Relationship, Drug|dose-response relationship, drug
423414|NCT00002406|HIV Protease Inhibitors|hiv protease inhibitors
423415|NCT00002406|Indinavir|indinavir
423416|NCT00002406|RNA, Viral|rna, viral
423417|NCT00002406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
423418|NCT00002408|Diarrhea|diarrhea
423419|NCT00002408|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423420|NCT00002409|Drug Therapy, Combination|drug therapy, combination
423421|NCT00002409|Zidovudine|zidovudine
423422|NCT00002409|HIV Protease Inhibitors|hiv protease inhibitors
423423|NCT00002409|Lamivudine|lamivudine
423424|NCT00002409|Patient Education|patient education
423425|NCT00002409|Patient Compliance|patient compliance
423426|NCT00002409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
423427|NCT00002409|Anti-HIV Agents|anti-hiv agents
423428|NCT00002409|Viral Load|viral load
423429|NCT00002409|abacavir|abacavir
423430|NCT00002410|HIV-1|hiv-1
423431|NCT00002410|Drug Therapy, Combination|drug therapy, combination
423432|NCT00002410|Zidovudine|zidovudine
423433|NCT00002410|Drug Resistance, Microbial|drug resistance, microbial
423434|NCT00002410|HIV Protease Inhibitors|hiv protease inhibitors
423435|NCT00002410|Lamivudine|lamivudine
423436|NCT00002410|Indinavir|indinavir
423437|NCT00002410|Genotype|genotype
423438|NCT00002410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
423439|NCT00002410|efavirenz|efavirenz
423440|NCT00002411|HIV-1|hiv-1
423441|NCT00002411|Didanosine|didanosine
423442|NCT00002411|Drug Therapy, Combination|drug therapy, combination
423443|NCT00002411|Zidovudine|zidovudine
423444|NCT00002411|Stavudine|stavudine
423445|NCT00002411|Lamivudine|lamivudine
423446|NCT00002411|RNA, Viral|rna, viral
423447|NCT00002411|Nelfinavir|nelfinavir
423448|NCT00002411|Anti-HIV Agents|anti-hiv agents
423449|NCT00002411|Viral Load|viral load
423450|NCT00002412|Didanosine|didanosine
423451|NCT00002412|Drug Therapy, Combination|drug therapy, combination
423452|NCT00002412|Stavudine|stavudine
423453|NCT00002412|Hydroxyurea|hydroxyurea
423454|NCT00002412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
423455|NCT00002412|Anti-HIV Agents|anti-hiv agents
423456|NCT00002412|Viral Load|viral load
423457|NCT00002412|MKC 442|mkc 442
423458|NCT00002413|Anti-HIV Agents|anti-hiv agents
423459|NCT00002413|Viral Load|viral load
423460|NCT00002413|MKC 442|mkc 442
423461|NCT00002414|AIDS Dementia Complex|aids dementia complex
423462|NCT00002414|Anti-HIV Agents|anti-hiv agents
423463|NCT00001757|Azole|azole
423464|NCT00001757|Immunocompromised|immunocompromised
423465|NCT00001757|Mycosis|mycosis
423466|NCT00001757|Invasive Fungal Infection|invasive fungal infection
423467|NCT00001757|Systemic Fungal Infection|systemic fungal infection
423468|NCT00001758|Antiretroviral|antiretroviral
423469|NCT00001758|HIV-1|hiv-1
423470|NCT00001758|1592U89|1592u89
423471|NCT00001758|141W94|141w94
423472|NCT00001758|DMP 266|dmp 266
423473|NCT00001759|Allergy|allergy
423474|NCT00001759|Fluorodeoxyglucose|fluorodeoxyglucose
423475|NCT00001759|Imaging|imaging
423476|NCT00001759|PET|pet
423477|NCT00001759|Wegener's Granulomatosis|wegener's granulomatosis
423478|NCT00001759|Asthma|asthma
423479|NCT00001760|Stem Cell Factor|stem cell factor
423480|NCT00001760|Cytokine|cytokine
423481|NCT00001760|Chemokines|chemokines
423482|NCT00001760|Chemotaxis|chemotaxis
423483|NCT00001760|Mast Cells|mast cells
423484|NCT00001760|Normal Volunteer|normal volunteer
423485|NCT00001760|Systemic Mastocytosis|systemic mastocytosis
423486|NCT00001760|Atopic Dermatitis|atopic dermatitis
423487|NCT00001761|Autoimmunity|autoimmunity
423488|NCT00001761|Cytokine|cytokine
423489|NCT00001761|Inflammation|inflammation
423490|NCT00001761|Interleukin|interleukin
423491|NCT00001761|Vasculitis|vasculitis
423492|NCT00001761|Wegener's Granulomatosis|wegener's granulomatosis
423493|NCT00001762|Protease Inhibitor|protease inhibitor
423494|NCT00001762|HIV Infection|hiv infection
423495|NCT00001762|Appearance|appearance
423496|NCT00001762|Subcutaneous Fat|subcutaneous fat
423497|NCT00001762|Facial Wasting|facial wasting
423498|NCT00001763|AIDS|aids
423499|NCT00001763|Cell Mediated Immunity|cell mediated immunity
423500|NCT00001763|Cytokine|cytokine
423501|NCT00001763|MAC|mac
423502|NCT00001763|Thl Response|thl response
423503|NCT00001764|Alternative agent|alternative agent
423504|NCT00001764|Purine Antimetabolite|purine antimetabolite
423505|NCT00001764|Immunosuppressive|immunosuppressive
423506|NCT00001764|Previous relapse|previous relapse
423507|NCT00001764|Drug Intolerance|drug intolerance
422650|NCT00002260|Food|food
423508|NCT00001764|Wegener's Granulomatosis|wegener's granulomatosis
423509|NCT00001765|Engraftment|engraftment
423510|NCT00001765|Minitransplant|minitransplant
423511|NCT00001765|Fludarabine|fludarabine
423512|NCT00001765|Neutrophil|neutrophil
423513|NCT00001765|Allogenic|allogenic
423514|NCT00001765|Donor Apheresis|donor apheresis
423515|NCT00001765|Anti-Thymocyte Globin|anti-thymocyte globin
423516|NCT00001765|Cyclophosphamide|cyclophosphamide
423622|NCT00001790|Aspergillosis|aspergillosis
423517|NCT00001765|Nonmyeloablative Bone Marrow Transplantation|nonmyeloablative bone marrow transplantation
423518|NCT00001765|Graft-versus-host Disease|graft-versus-host disease
423519|NCT00001765|Chronic Granulomatous Disease|chronic granulomatous disease
423520|NCT00001766|Abacavir|abacavir
423521|NCT00001766|Salvage|salvage
423522|NCT00001766|Drug Interaction|drug interaction
423523|NCT00001766|Drug Levels|drug levels
423524|NCT00001766|Anti-Viral|anti-viral
423525|NCT00001766|HIV|hiv
423526|NCT00001768|Autoimmunity|autoimmunity
423527|NCT00001768|Childhood Onset Schizophrenia|childhood onset schizophrenia
423528|NCT00001768|Intravenous Gammaglobulin|intravenous gammaglobulin
423529|NCT00001770|Depression|depression
423530|NCT00001770|Estrogen|estrogen
423531|NCT00001770|Hormone Replacement Therapy|hormone replacement therapy
423532|NCT00001770|Mood|mood
423533|NCT00001770|Progestin|progestin
423534|NCT00001770|Progesterone|progesterone
423535|NCT00001770|Anxiety|anxiety
423536|NCT00001771|Receptors|receptors
423537|NCT00001771|Re-Uptake|re-uptake
423538|NCT00001771|Neurotransmitters|neurotransmitters
423539|NCT00001771|Neuroimaging|neuroimaging
423540|NCT00001771|Drug Abuse|drug abuse
423541|NCT00001771|Serotonin|serotonin
423542|NCT00001771|Brain Scan|brain scan
423543|NCT00001771|Tourette's Syndrome|tourette's syndrome
423544|NCT00001771|Obsessive Compulsive Disorder|obsessive compulsive disorder
423545|NCT00001771|Schizophrenia|schizophrenia
423546|NCT00001771|Normal Volunteer|normal volunteer
423547|NCT00001772|Bipolar Disorder|bipolar disorder
423548|NCT00001772|Rapid Cycling|rapid cycling
423549|NCT00001772|Screening|screening
423550|NCT00001774|Acetylcholine|acetylcholine
423551|NCT00001774|Blood Flow|blood flow
423552|NCT00001774|Blood vessel|blood vessel
423553|NCT00001774|Resistance|resistance
423554|NCT00001774|Sodium Nitroprusside|sodium nitroprusside
423555|NCT00001774|Fabry Disease|fabry disease
423556|NCT00001774|Normal Volunteer|normal volunteer
423557|NCT00001776|Magnetic Stimulation|magnetic stimulation
423558|NCT00001776|Plasticity|plasticity
423560|NCT00001776|Sequence|sequence
423561|NCT00001776|Implicit Memory|implicit memory
423562|NCT00001776|Explicit Memory|explicit memory
423563|NCT00001776|Memory|memory
423564|NCT00001776|Parkinson's Disease|parkinson's disease
423565|NCT00001776|Cerebellar Deficit|cerebellar deficit
423566|NCT00001776|Frontal Lobe Lesions|frontal lobe lesions
423567|NCT00001776|Frontal Lobe Dementia|frontal lobe dementia
423568|NCT00001776|Normal Volunteer|normal volunteer
423569|NCT00001777|Frontal Lobe Dementia|frontal lobe dementia
423570|NCT00001777|Serotonergic Transmission|serotonergic transmission
423571|NCT00001778|Immune Response|immune response
423572|NCT00001778|Sero-Indeterminant|sero-indeterminant
423573|NCT00001778|Transmission|transmission
423574|NCT00001778|Tropical Spastic Paraparesis|tropical spastic paraparesis
423575|NCT00001778|Viral Load|viral load
423576|NCT00001778|HTLV-I|htlv-i
423577|NCT00001778|HAM/TSP|ham/tsp
423578|NCT00001780|Myelopathy|myelopathy
423579|NCT00001780|Demyelination|demyelination
423580|NCT00001780|Leukodystrophy|leukodystrophy
423581|NCT00001780|Motor Neuron Disease|motor neuron disease
423582|NCT00001780|Movement Disorders|movement disorders
423583|NCT00001780|Normal Volunteer|normal volunteer
423584|NCT00001781|Multiple Sclerosis|multiple sclerosis
423585|NCT00001781|Immunology|immunology
423586|NCT00001781|Treatment|treatment
423587|NCT00001782|Deafness|deafness
423588|NCT00001782|Hemisphere Dominance|hemisphere dominance
423589|NCT00001782|Language|language
423590|NCT00001782|Plasticity|plasticity
423591|NCT00001782|Speech|speech
423592|NCT00001782|rTMS|rtms
423593|NCT00001783|Rehabilitation|rehabilitation
423594|NCT00001783|Plasticity|plasticity
423595|NCT00001783|Stroke|stroke
423596|NCT00001783|Amphetamine|amphetamine
423597|NCT00001783|Motor|motor
423598|NCT00001783|Hemiparetic|hemiparetic
423599|NCT00001783|Thromboembolic Non-Hemorrhagic Infarction|thromboembolic non-hemorrhagic infarction
423600|NCT00001784|Blepharospasm|blepharospasm
423601|NCT00001784|Writer's Cramp|writer's cramp
423602|NCT00001784|Muscle Spindle Afferents|muscle spindle afferents
423603|NCT00001784|Sodium Channels|sodium channels
423604|NCT00001784|Sensorimotor Integration|sensorimotor integration
423605|NCT00001784|Focal Dystonia|focal dystonia
423606|NCT00001785|HTLV-1-Associated Myelopathy|htlv-1-associated myelopathy
423607|NCT00001785|Virus|virus
423608|NCT00001785|Spontaneous Proliferation|spontaneous proliferation
423609|NCT00001788|Cytokine|cytokine
422710|NCT00002273|Colitis|colitis
423610|NCT00001788|Stat|stat
423611|NCT00001788|Jak|jak
423612|NCT00001788|IL-12|il-12
423613|NCT00001788|Mutation|mutation
423614|NCT00001788|Immunodeficiency|immunodeficiency
423615|NCT00001789|Autoantibody|autoantibody
423616|NCT00001789|Autoimmunity|autoimmunity
423617|NCT00001789|Inflammation|inflammation
423618|NCT00001789|Kidney|kidney
423619|NCT00001789|Lymphocyte|lymphocyte
423730|NCT00001837|Premenopause|premenopause
423620|NCT00001789|Proliferative Lupus Glomerulonephritis|proliferative lupus glomerulonephritis
423621|NCT00001789|SLE-GN|sle-gn
423624|NCT00001790|Empiric Therapy|empiric therapy
423625|NCT00001790|Fungal Infection|fungal infection
423626|NCT00001790|Fungemia|fungemia
423627|NCT00001797|Cytokines|cytokines
423628|NCT00001797|Immunomodulation|immunomodulation
423629|NCT00001797|Inflammation|inflammation
423630|NCT00001797|Skin|skin
423631|NCT00001797|Therapy|therapy
423632|NCT00001803|Gene-Environment Interaction|gene-environment interaction
423633|NCT00001803|Kidney Cancer|kidney cancer
423634|NCT00001803|VHL|vhl
423635|NCT00001803|Genetic Epidemiology|genetic epidemiology
423636|NCT00001805|Breast Cancer|breast cancer
423637|NCT00001805|Colon Cancer|colon cancer
423638|NCT00001805|Gastric Cancer|gastric cancer
423639|NCT00001805|Lung Cancer|lung cancer
423640|NCT00001805|Pancreatic Cancer|pancreatic cancer
423641|NCT00001806|Genetic Testing|genetic testing
423642|NCT00001806|Genetic Counseling|genetic counseling
423643|NCT00001806|BRCA1/BRCA2|brca1/brca2
423644|NCT00001806|Genetic Education|genetic education
423645|NCT00001806|Informed Consent|informed consent
423646|NCT00001806|Breast Cancer|breast cancer
423647|NCT00001806|Ovarian Cancer|ovarian cancer
423648|NCT00001806|Known Family Mutation|known family mutation
423649|NCT00001807|CNS directed therapy|cns directed therapy
423650|NCT00001807|Neurotoxicity|neurotoxicity
423651|NCT00001807|H-NMRS|h-nmrs
423652|NCT00001807|MRI|mri
423653|NCT00001810|Antifungal Agent|antifungal agent
423654|NCT00001810|Aspergillosis|aspergillosis
423655|NCT00001810|Candidiasis|candidiasis
423656|NCT00001810|Fungemia|fungemia
423657|NCT00001812|Mucositis|mucositis
423658|NCT00001812|Oral Candidiasis|oral candidiasis
423659|NCT00001812|Prophylaxis|prophylaxis
423660|NCT00001812|Stomatitis|stomatitis
423661|NCT00001812|Swish and Swallow|swish and swallow
423662|NCT00001813|Xeroderma Pigmentosum|xeroderma pigmentosum
423663|NCT00001813|Trichothiodystrophy|trichothiodystrophy
423664|NCT00001813|Cockayne Syndrome|cockayne syndrome
423665|NCT00001813|Skin Cancer|skin cancer
423666|NCT00001813|DNA Repair|dna repair
423667|NCT00001814|Hereditary|hereditary
423668|NCT00001814|Kidney|kidney
423669|NCT00001814|MET|met
423670|NCT00001814|Oncocytoma|oncocytoma
423671|NCT00001814|VHL|vhl
423672|NCT00001816|Anger|anger
423673|NCT00001816|Loneliness|loneliness
423674|NCT00001816|Mood|mood
423675|NCT00001816|Psychosocial|psychosocial
423676|NCT00001816|Virtual Network|virtual network
423677|NCT00001818|Antiretrovirals|antiretrovirals
423678|NCT00001818|Resistant Virus|resistant virus
423679|NCT00001818|T-cell activation|t-cell activation
423680|NCT00001818|Immune Suppression|immune suppression
423681|NCT00001818|Cytotoxic Agent|cytotoxic agent
423682|NCT00001823|Cancer|cancer
423683|NCT00001823|Gene Therapy|gene therapy
423684|NCT00001823|Immunotherapy|immunotherapy
423685|NCT00001823|Melanoma|melanoma
423686|NCT00001823|Clinical Trial|clinical trial
423687|NCT00001826|CD-4-Naive T Cells|cd-4-naive t cells
423688|NCT00001826|CD-4-Memory T Cells|cd-4-memory t cells
423689|NCT00001826|Antiviral Activity|antiviral activity
423690|NCT00001826|VB Repertoire|vb repertoire
423691|NCT00001826|Immunizations|immunizations
423692|NCT00001826|HIV|hiv
423693|NCT00001826|Treatment Experienced|treatment experienced
423694|NCT00001827|Immunotherapy|immunotherapy
423695|NCT00001827|Cancer|cancer
423696|NCT00001827|Oncogenes|oncogenes
423697|NCT00001827|T-cells|t-cells
423698|NCT00001827|Vaccine Therapy|vaccine therapy
423699|NCT00001827|p53 Peptide|p53 peptide
423700|NCT00001827|Ovarian Cancer|ovarian cancer
423701|NCT00001830|Bone Marrow Transplantation|bone marrow transplantation
423702|NCT00001830|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
423703|NCT00001830|Immunotherapy|immunotherapy
423704|NCT00001830|Lymphoma|lymphoma
423705|NCT00001830|Multiple Myeloma|multiple myeloma
423706|NCT00001830|Graft vs. Host Disease|graft vs. host disease
423707|NCT00001830|Lymphoid Malignancy|lymphoid malignancy
423708|NCT00001830|Leukemia|leukemia
423709|NCT00001832|Immunotherapy|immunotherapy
423710|NCT00001832|Adoptive Transfer|adoptive transfer
423711|NCT00001832|IL-2|il-2
423712|NCT00001832|Toxicity|toxicity
423713|NCT00001832|Clinical Response|clinical response
423714|NCT00001832|Breast Cancer|breast cancer
423715|NCT00001835|Renal Dysfunction|renal dysfunction
423716|NCT00001835|Pharmacokinetics|pharmacokinetics
423717|NCT00001835|Platinum Analogues|platinum analogues
423718|NCT00001835|Renal Cancer|renal cancer
423719|NCT00001835|Kidney Cancer|kidney cancer
423720|NCT00001836|Coronary Artery Disease|coronary artery disease
423722|NCT00001836|Volumetric Scan|volumetric scan
423723|NCT00001836|Coronary Artery Calcium|coronary artery calcium
423724|NCT00001836|Prospective Gating|prospective gating
423725|NCT00001837|Sonohysterography|sonohysterography
423726|NCT00001837|Color Doppler Sonography|color doppler sonography
423727|NCT00001837|Endometrium|endometrium
423728|NCT00001837|Gynecologic|gynecologic
423729|NCT00001837|Menstrual Cycle|menstrual cycle
423731|NCT00001839|Anemia|anemia
424044|NCT00001894|Alcohol|alcohol
423739|NCT00001840|MRI|mri
423740|NCT00001840|Natural History|natural history
423741|NCT00001840|Stroke|stroke
423742|NCT00001840|Treatment|treatment
423743|NCT00001840|Brain Stroke|brain stroke
423744|NCT00001841|Arteriosclerosis|arteriosclerosis
423745|NCT00001841|Imaging|imaging
423746|NCT00001841|MRA|mra
423747|NCT00001841|Narrowing of Vessels|narrowing of vessels
423748|NCT00001841|Hardening of Arteries|hardening of arteries
423749|NCT00001842|Granulocytes|granulocytes
423750|NCT00001842|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
423751|NCT00001842|Granulocyte Transfusion Factor|granulocyte transfusion factor
423752|NCT00001842|Apheresis|apheresis
423753|NCT00001842|Blood Donors|blood donors
423754|NCT00001842|Healthy Volunteer|healthy volunteer
423755|NCT00001844|MRI/MRS|mri/mrs
423756|NCT00001844|Functional MRI|functional mri
423757|NCT00001844|Metabolic Imaging|metabolic imaging
423758|NCT00001844|Brain|brain
423759|NCT00001844|Healthy Volunteer|healthy volunteer
423760|NCT00001845|MRI|mri
423761|NCT00001845|Cerebral Blood Flow|cerebral blood flow
423762|NCT00001845|CO2 Inhalation|co2 inhalation
423763|NCT00001845|Acetazolamide|acetazolamide
423764|NCT00001845|Perfusion|perfusion
423765|NCT00001845|Healthy Volunteer|healthy volunteer
423773|NCT00001848|Estrogen Receptor|estrogen receptor
423774|NCT00001848|Laparoscopy|laparoscopy
423775|NCT00001848|Surgical Excision|surgical excision
423776|NCT00001848|Raloxifene|raloxifene
423777|NCT00001848|Selective Estrogen Receptor Modulator|selective estrogen receptor modulator
423778|NCT00001848|Estrogen|estrogen
423779|NCT00001848|Endometriosis|endometriosis
423780|NCT00001848|Pelvic Pain|pelvic pain
423781|NCT00001849|PET|pet
423782|NCT00001849|(18F)-DOPA|(18f)-dopa
423783|NCT00001849|Pentetreotide|pentetreotide
423784|NCT00001849|ACTH|acth
423785|NCT00001849|Octreotide|octreotide
423786|NCT00001849|Cushing's Syndrome|cushing's syndrome
423787|NCT00001849|Ectopic Cushing Syndrome|ectopic cushing syndrome
423788|NCT00001850|Training|training
423789|NCT00001850|Reproduction|reproduction
423790|NCT00001850|Infertility|infertility
423791|NCT00001850|Women's Health|women's health
423792|NCT00001850|Hormone|hormone
423793|NCT00001851|Marrow|marrow
423794|NCT00001851|Grafting|grafting
423795|NCT00001851|Imaging|imaging
423796|NCT00001851|Injection|injection
423797|NCT00001851|Aspiration|aspiration
423798|NCT00001851|Bone Marrow Stromal Cells|bone marrow stromal cells
423799|NCT00001851|Bone Grafting|bone grafting
423800|NCT00001851|Bone Graft Substitutes|bone graft substitutes
423801|NCT00001851|Bio and Pharmacological Regulators of Bone Turnover|bio and pharmacological regulators of bone turnover
423802|NCT00001852|Xerostomia|xerostomia
423803|NCT00001852|Oral Dryness|oral dryness
423804|NCT00001852|Salivary Function|salivary function
423805|NCT00001853|Healthy Volunteers|healthy volunteers
423806|NCT00001853|Health Disparities|health disparities
423807|NCT00001853|Diabetes|diabetes
423808|NCT00001853|Cardiovascular Disease|cardiovascular disease
423809|NCT00001854|Ribavirin|ribavirin
423810|NCT00001854|Liver Disease|liver disease
423811|NCT00001854|Antiviral Agent|antiviral agent
423812|NCT00001854|Cirrhosis|cirrhosis
423813|NCT00001854|Chronic Hepatitis|chronic hepatitis
423814|NCT00001854|Iron|iron
423815|NCT00001854|Viral Hepatitis|viral hepatitis
423816|NCT00001854|Hepatitis C Virus|hepatitis c virus
423817|NCT00001854|Hemolytic Anemia|hemolytic anemia
423818|NCT00001854|Hemolysis|hemolysis
423819|NCT00001856|Living Donor|living donor
423820|NCT00001856|Transplantation|transplantation
423821|NCT00001856|Nephrectomy|nephrectomy
423822|NCT00001857|Costimulation|costimulation
423823|NCT00001857|Immunosuppression|immunosuppression
423824|NCT00001857|Tolerance|tolerance
423825|NCT00001858|Biopsy|biopsy
423826|NCT00001858|Immune System|immune system
423827|NCT00001858|Renal|renal
423828|NCT00001859|Evaluation|evaluation
423829|NCT00001859|Diabetes|diabetes
423830|NCT00001859|Renal Failure|renal failure
423831|NCT00001860|Growth Hormone|growth hormone
423832|NCT00001860|Somatostatin|somatostatin
423833|NCT00001860|Insulin-like Growth Factor-One|insulin-like growth factor-one
423834|NCT00001860|Acromegaly|acromegaly
423835|NCT00001860|Macroadenoma|macroadenoma
423836|NCT00001861|Eye Movements|eye movements
423837|NCT00001861|Amblyopia|amblyopia
423838|NCT00001861|Orthoptics|orthoptics
423840|NCT00001861|Eye Development|eye development
423841|NCT00001861|Nystagmus|nystagmus
423842|NCT00001861|Strabismus|strabismus
423843|NCT00001861|Screening Protocol|screening protocol
423844|NCT00001861|Eye Movement Disorders|eye movement disorders
423845|NCT00001862|Ocular Inflammation|ocular inflammation
423846|NCT00001862|Children|children
423847|NCT00001862|Immunotherapy|immunotherapy
423848|NCT00001862|Cytokine|cytokine
423849|NCT00001862|Clinical Trial|clinical trial
423850|NCT00001862|Uveitis|uveitis
423851|NCT00001862|Immunosuppression|immunosuppression
423852|NCT00001862|Joint|joint
423853|NCT00001862|Inflammation|inflammation
423854|NCT00001863|Immunosuppression|immunosuppression
423855|NCT00001863|Inflammation|inflammation
423856|NCT00001863|Eye|eye
423857|NCT00001863|Vision|vision
423858|NCT00001863|Medication|medication
423859|NCT00001863|Uveitis|uveitis
423860|NCT00001863|Leflunomide|leflunomide
423861|NCT00001863|Vitritis|vitritis
423862|NCT00001864|Lazy Eye|lazy eye
423863|NCT00001864|Atropine Penalization|atropine penalization
423864|NCT00001864|Patching|patching
423865|NCT00001864|Vision Loss|vision loss
423866|NCT00001864|Amblyopia|amblyopia
423867|NCT00001865|Behcet's|behcet's
423868|NCT00001865|Monoclonal Antibody|monoclonal antibody
423869|NCT00001865|Uveitis|uveitis
423870|NCT00001865|Interleukin 2|interleukin 2
423871|NCT00001865|Retinal Vasculitis|retinal vasculitis
423872|NCT00001865|Hyopyon|hyopyon
423873|NCT00001865|Interleukin 2 Receptor|interleukin 2 receptor
423874|NCT00001865|Bechet's Disease|bechet's disease
423875|NCT00001865|Ocular Disease|ocular disease
423876|NCT00001866|Eye Movements|eye movements
423877|NCT00001866|Eye Oscillations|eye oscillations
423878|NCT00001866|Extraocular Muscles|extraocular muscles
423879|NCT00001866|Eye Development|eye development
423880|NCT00001866|Pediatric Ophthalmology|pediatric ophthalmology
423881|NCT00001866|Congenital Nystagmus|congenital nystagmus
423882|NCT00001867|Cytokine|cytokine
423883|NCT00001867|Gestation|gestation
423884|NCT00001867|Postpartum|postpartum
423885|NCT00001867|Pregnancy|pregnancy
423886|NCT00001867|Th 1 Lymphocyte|th 1 lymphocyte
423887|NCT00001867|Th 2 Lymphocyte|th 2 lymphocyte
423888|NCT00001867|Uveitis|uveitis
423889|NCT00001869|Progesterone|progesterone
423890|NCT00001869|Pulmonary Function Tests|pulmonary function tests
423891|NCT00001869|Pneumothorax|pneumothorax
423892|NCT00001869|Oopherectomy|oopherectomy
423893|NCT00001869|High Resolution CT|high resolution ct
423894|NCT00001869|Tuberous Sclerosis Complex|tuberous sclerosis complex
423895|NCT00001869|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
423896|NCT00001870|Insulin Resistance|insulin resistance
423897|NCT00001870|Oxidative Stress|oxidative stress
423898|NCT00001870|Antioxidant|antioxidant
423899|NCT00001870|Endothelial Function|endothelial function
423900|NCT00001870|Glucose Clamp|glucose clamp
423901|NCT00001870|Type 2 Diabetes|type 2 diabetes
423902|NCT00001870|Vitamin C Deficiency|vitamin c deficiency
423903|NCT00001871|Genetic Mutations|genetic mutations
423904|NCT00001871|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
423905|NCT00001871|Oculopharyngeal Muscular Dystrophy|oculopharyngeal muscular dystrophy
423906|NCT00001872|Volunteer|volunteer
423907|NCT00001872|Leukocyte Donors|leukocyte donors
423908|NCT00001872|Family Members|family members
423909|NCT00001872|Leukocyte Collection|leukocyte collection
423910|NCT00001872|No Reimbursement|no reimbursement
423911|NCT00001873|Peripheral Blood Stem Cells|peripheral blood stem cells
423912|NCT00001873|Cyclosporine|cyclosporine
423913|NCT00001873|Cyclosphosphamide|cyclosphosphamide
423914|NCT00001873|Whole Body Irradiation|whole body irradiation
423915|NCT00001873|Donor Apheresis|donor apheresis
423916|NCT00001873|Leukemic Relapse|leukemic relapse
423917|NCT00001873|Graft vs. Host Disease|graft vs. host disease
423918|NCT00001873|Graft-Versus-Leukemia|graft-versus-leukemia
423919|NCT00001873|Graft-Versus-Myeloma|graft-versus-myeloma
423920|NCT00001873|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
423921|NCT00001873|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
423922|NCT00001873|Acute Myelogenous Leukemia|acute myelogenous leukemia
423923|NCT00001873|Myelodysplastic Syndromes|myelodysplastic syndromes
423924|NCT00001873|Multiple Myeloma|multiple myeloma
423925|NCT00001873|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
423926|NCT00001873|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
423927|NCT00001874|Imaging|imaging
423928|NCT00001874|Spectroscopy|spectroscopy
423929|NCT00001874|MRI|mri
423930|NCT00001874|Cardiovascular|cardiovascular
423931|NCT00001874|Technical Development|technical development
423932|NCT00001874|Safety|safety
423933|NCT00001874|Gadolinium|gadolinium
423934|NCT00001874|Heart|heart
423935|NCT00001874|Toxicity|toxicity
423936|NCT00001874|Adverse Events|adverse events
423937|NCT00001874|Normal Volunteer|normal volunteer
423938|NCT00001876|Interstitial Lung Disease|interstitial lung disease
423939|NCT00001876|Collagen Vascular Disease|collagen vascular disease
423940|NCT00001876|Extracellular Matrix|extracellular matrix
423941|NCT00001876|Pulmonary Function|pulmonary function
423942|NCT00001876|DTPA Lung Clearance Scan|dtpa lung clearance scan
423943|NCT00001876|Rheumatoid Arthritis|rheumatoid arthritis
423944|NCT00001876|Pulmonary Fibrosis|pulmonary fibrosis
423945|NCT00001876|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
423946|NCT00001877|Tumor Necrosis Factor|tumor necrosis factor
423947|NCT00001877|Corticosteroids|corticosteroids
423948|NCT00001877|Macrophages|macrophages
423949|NCT00001877|Phosphodiesterase|phosphodiesterase
423950|NCT00001877|Autoimmune|autoimmune
423951|NCT00001877|Pulmonary Sarcoidosis|pulmonary sarcoidosis
423952|NCT00001878|Growth Hormone|growth hormone
423953|NCT00001878|Cardiac Hypertrophy|cardiac hypertrophy
423954|NCT00001878|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
423955|NCT00001878|Sarcomeric Gene Mutations|sarcomeric gene mutations
423956|NCT00001879|Liver Disease|liver disease
423957|NCT00001879|Novel Agents|novel agents
423958|NCT00001879|Serum|serum
423959|NCT00001879|Viruses|viruses
423960|NCT00001879|non-A,G Hepatitis|non-a,g hepatitis
423961|NCT00001879|Seronegative Acute Hepatitis|seronegative acute hepatitis
423962|NCT00001880|Graft-Versus-Tumor|graft-versus-tumor
423963|NCT00001880|Peripheral Blood Stem Cells|peripheral blood stem cells
423964|NCT00001880|Non-Myeloablative Bone Marrow Transplantation|non-myeloablative bone marrow transplantation
423965|NCT00001880|Metastatic Solid Tumors|metastatic solid tumors
423966|NCT00001880|Engraftment|engraftment
423967|NCT00001880|Cyclophosphamide|cyclophosphamide
423968|NCT00001880|Fludarabine|fludarabine
423969|NCT00001880|Donor Apheresis|donor apheresis
423970|NCT00001880|Graft-Versus-Host Disease|graft-versus-host disease
423971|NCT00001880|Cancer|cancer
423972|NCT00001880|Tumor|tumor
423973|NCT00001881|Cardiac Hypertrophy|cardiac hypertrophy
423974|NCT00001881|Genetics|genetics
423975|NCT00001881|Phenotypes|phenotypes
423976|NCT00001881|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
423977|NCT00001883|Treadmill|treadmill
423978|NCT00001883|Bicycle|bicycle
423979|NCT00001883|Lung Function|lung function
423980|NCT00001883|Physiology|physiology
423981|NCT00001883|Quality Control|quality control
423982|NCT00001883|Normal Volunteers|normal volunteers
423983|NCT00001884|Bronchoscopy|bronchoscopy
423984|NCT00001884|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
423985|NCT00001884|Proteases|proteases
423986|NCT00001884|Fibroblast Proliferation|fibroblast proliferation
423987|NCT00001884|Reactive Proteins|reactive proteins
423988|NCT00001884|Rheumatoid Arthritis|rheumatoid arthritis
423989|NCT00001884|Pulmonary Fibrosis|pulmonary fibrosis
423990|NCT00001885|Interstitial Lung Disease|interstitial lung disease
423991|NCT00001885|Inherited Disease|inherited disease
423992|NCT00001885|Genetic Markers|genetic markers
423993|NCT00001885|Alpha 1 Protease Inhibitor|alpha 1 protease inhibitor
423994|NCT00001885|DNA Mutations|dna mutations
423995|NCT00001885|Rheumatoid Arthritis|rheumatoid arthritis
423996|NCT00001885|Pulmonary Fibrosis|pulmonary fibrosis
423997|NCT00001885|Normal Volunteer|normal volunteer
423998|NCT00001886|Coronary Artery Disease|coronary artery disease
423999|NCT00001886|Ischemia|ischemia
424000|NCT00001886|Ultrasound|ultrasound
424001|NCT00001886|Ventricular Function|ventricular function
424002|NCT00001886|Wall Motion|wall motion
424003|NCT00001887|Airway Inflammation|airway inflammation
424004|NCT00001887|Allergen Challenge|allergen challenge
424005|NCT00001887|Bronchoscopy|bronchoscopy
424006|NCT00001887|Cytokines|cytokines
424007|NCT00001887|Receptors|receptors
424008|NCT00001887|Asthma|asthma
424009|NCT00001887|Normal Volunteer|normal volunteer
424010|NCT00001888|Induced Sputum|induced sputum
424011|NCT00001888|Exhaled Breath Condensate|exhaled breath condensate
424012|NCT00001888|Fiberoptic Bronchoscopy|fiberoptic bronchoscopy
424013|NCT00001888|Bronchoscopy|bronchoscopy
424014|NCT00001888|mRNA|mrna
424015|NCT00001888|Asthma|asthma
424016|NCT00001888|Normal Volunteer|normal volunteer
424017|NCT00001889|Microbubbles|microbubbles
424018|NCT00001889|Myocardial Blood Flow|myocardial blood flow
424019|NCT00001889|Myocardial Ischemia|myocardial ischemia
424020|NCT00001889|Second Harmonics|second harmonics
424021|NCT00001889|Ultrasound|ultrasound
424022|NCT00001889|Coronary Artery Disease|coronary artery disease
424023|NCT00001890|Cellular Immunity|cellular immunity
424024|NCT00001890|Cytokines|cytokines
424025|NCT00001890|Estrogen|estrogen
424026|NCT00001890|Humoral Immunity|humoral immunity
424027|NCT00001890|Progesterone|progesterone
424028|NCT00001890|Chlamydia Pneumoniae|chlamydia pneumoniae
424029|NCT00001890|Human Cytomegalovirus|human cytomegalovirus
424030|NCT00001890|Postmenopause|postmenopause
424031|NCT00001891|CABG|cabg
424032|NCT00001891|Hibernation|hibernation
424033|NCT00001891|LV Function|lv function
424034|NCT00001891|Microbubbles|microbubbles
424035|NCT00001891|Revascularization|revascularization
424036|NCT00001891|Coronary Artery Disease|coronary artery disease
424037|NCT00001893|Bronchoprovocation|bronchoprovocation
424038|NCT00001893|Airway Inflammation|airway inflammation
424039|NCT00001893|Tumor Necrosis Factor|tumor necrosis factor
424040|NCT00001893|Bronchoalveolar Lavage|bronchoalveolar lavage
424041|NCT00001893|Pulmonary Function Test|pulmonary function test
424045|NCT00001894|Septal Ablation|septal ablation
424046|NCT00001894|Pacemaker|pacemaker
424047|NCT00001895|Electromechanical Mapping|electromechanical mapping
424048|NCT00001895|Myocardial Viability|myocardial viability
424049|NCT00001895|Myocardial Ischemia|myocardial ischemia
424050|NCT00001895|Positron Emission Tomography|positron emission tomography
424051|NCT00001895|Magnetic Resonance Imaging|magnetic resonance imaging
424052|NCT00001898|Melanoma|melanoma
424053|NCT00001898|Breast Cancer|breast cancer
424054|NCT00001898|Gene Expression|gene expression
424055|NCT00001898|DNA Chip Technology|dna chip technology
424056|NCT00001898|Expressed Sequence Tags|expressed sequence tags
424057|NCT00001899|Viral Suppression|viral suppression
424058|NCT00001899|Latency|latency
424059|NCT00001899|AIDS Therapy|aids therapy
424060|NCT00001899|Viral Relapse|viral relapse
424061|NCT00001899|Immunodeficiency|immunodeficiency
424062|NCT00001899|HIV|hiv
424063|NCT00001899|Treatment Interruption|treatment interruption
424064|NCT00001901|Vasculitis|vasculitis
424065|NCT00001901|Prednisone-sparing|prednisone-sparing
424066|NCT00001901|Methotrexate|methotrexate
424067|NCT00001901|Tumor Necrosis Factor|tumor necrosis factor
424068|NCT00001901|Remission|remission
424069|NCT00001901|Wegener's Granulomatosis|wegener's granulomatosis
424070|NCT00001903|Immunization|immunization
424071|NCT00001903|Immunocompromised|immunocompromised
424072|NCT00001903|Immunoglobulin|immunoglobulin
424073|NCT00001903|Prophylaxis|prophylaxis
424074|NCT00001903|Respiratory Virus|respiratory virus
424075|NCT00001903|Bone Marrow Transplantation|bone marrow transplantation
424076|NCT00001903|Mini-Transplantation|mini-transplantation
424077|NCT00001903|Peripheral Stem Cell Transplantation|peripheral stem cell transplantation
424078|NCT00001904|Atherosclerosis|atherosclerosis
424079|NCT00001904|Cardiovascular Disease|cardiovascular disease
424080|NCT00001904|Computerized Edge Reader|computerized edge reader
424081|NCT00001904|Myocardial Infarction|myocardial infarction
424082|NCT00001904|Risk Factor|risk factor
424083|NCT00001905|Neutrophil|neutrophil
424084|NCT00001905|Immunodeficiency|immunodeficiency
424085|NCT00001905|Cytokine|cytokine
424086|NCT00001905|Treatment|treatment
424087|NCT00001905|Trafficking|trafficking
424088|NCT00001905|Leukocyte Adhesion Deficiency Type I|leukocyte adhesion deficiency type i
424089|NCT00001905|LAD I|lad i
424090|NCT00001906|Alum|alum
424091|NCT00001906|Antigen|antigen
424092|NCT00001906|Cytokine|cytokine
424093|NCT00001906|Parasitic Infection|parasitic infection
424094|NCT00001906|Phase I|phase i
424095|NCT00001906|Cutaneous Leishmaniasis|cutaneous leishmaniasis
424096|NCT00001908|Allergy|allergy
424097|NCT00001908|Interleukin|interleukin
424098|NCT00001908|Immunomodulator|immunomodulator
424099|NCT00001908|Th2|th2
424100|NCT00001908|Inflammation|inflammation
424101|NCT00001908|Asthma|asthma
424102|NCT00001909|Allergy|allergy
424103|NCT00001909|Immunomodulator|immunomodulator
424104|NCT00001909|Inflammation|inflammation
424105|NCT00001909|Interleukin|interleukin
424106|NCT00001909|Th2|th2
424107|NCT00001909|Asthma|asthma
424108|NCT00001910|T Cells|t cells
424109|NCT00001910|Allergy|allergy
424110|NCT00001910|Asthma|asthma
424111|NCT00001910|Cytokine|cytokine
424112|NCT00001910|Vaccine|vaccine
424113|NCT00001911|Cytokine|cytokine
424114|NCT00001911|Interferon Gamma|interferon gamma
424115|NCT00001911|Pulmonary|pulmonary
424116|NCT00001911|Disseminated|disseminated
424117|NCT00001911|Refractory|refractory
424118|NCT00001911|Mycobacterial Infection|mycobacterial infection
424119|NCT00001911|Nontuberculosis Mycobacterial Infection|nontuberculosis mycobacterial infection
424120|NCT00001911|Pulmonary Nontuberculous Mycobacterial Infection|pulmonary nontuberculous mycobacterial infection
424121|NCT00001912|Cysticercosis|cysticercosis
424122|NCT00001912|T. Solium|t. solium
424123|NCT00001912|MRI|mri
424124|NCT00001912|Seizures|seizures
424125|NCT00001912|Calcified Cysts|calcified cysts
424126|NCT00001912|Taenia|taenia
424127|NCT00001913|Visual Processing|visual processing
424128|NCT00001913|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
424129|NCT00001913|Maternal Behavior|maternal behavior
424130|NCT00001913|Attachment|attachment
424131|NCT00001913|Bereavement|bereavement
424132|NCT00001915|Cortical Stimulation|cortical stimulation
424133|NCT00001915|Motor Control|motor control
424134|NCT00001915|Neuromotor Maturation|neuromotor maturation
424135|NCT00001915|Magnetic Stimulation|magnetic stimulation
424136|NCT00001915|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
424137|NCT00001915|Hearing Loss|hearing loss
424138|NCT00001915|Hearing Conservation|hearing conservation
424139|NCT00001915|Hearing Protective Devices|hearing protective devices
424140|NCT00001915|Safety Study|safety study
424141|NCT00001915|Noise Induced Hearing Loss|noise induced hearing loss
424142|NCT00001915|Normal Volunteer|normal volunteer
424143|NCT00001916|Bone Remodeling|bone remodeling
424144|NCT00001916|Corticosteroids|corticosteroids
424145|NCT00001916|Cytokine|cytokine
424146|NCT00001916|Depression|depression
424147|NCT00001916|Glucocorticoids|glucocorticoids
424148|NCT00001916|Osteopenia|osteopenia
424149|NCT00001916|Osteoporosis|osteoporosis
424150|NCT00001916|Primary Affective Disorder|primary affective disorder
424151|NCT00001917|Positron Emission Tomography|positron emission tomography
424152|NCT00001917|Physostigmine|physostigmine
424153|NCT00001917|Visual Stimulation|visual stimulation
424154|NCT00001917|Cholinergic Stimulation|cholinergic stimulation
424155|NCT00001917|[F-18] FP-TZIP|[f-18] fp-tzip
424156|NCT00001917|Aging|aging
424157|NCT00001917|Alzheimer's Disease|alzheimer's disease
424158|NCT00001917|Visual Activation|visual activation
424159|NCT00001918|Cognitive Function|cognitive function
424160|NCT00001918|Depression|depression
424161|NCT00001918|EMG|emg
424162|NCT00001918|Eosinophilia Myalgia Syndrome|eosinophilia myalgia syndrome
424163|NCT00001918|Impurities|impurities
424164|NCT00001918|L-5-HTP|l-5-htp
424165|NCT00001918|Memory Impairment|memory impairment
424166|NCT00001918|Nerve-Muscle Biopsy|nerve-muscle biopsy
424167|NCT00001918|Sleep Disorders|sleep disorders
424168|NCT00001919|Mechanism of Action|mechanism of action
424169|NCT00001919|BCIT-SPECT|bcit-spect
424170|NCT00001919|St. John's Wort|st. john's wort
424171|NCT00001919|Hypericum Perforatum|hypericum perforatum
424172|NCT00001919|Depression|depression
424173|NCT00001919|Serotonin|serotonin
424174|NCT00001919|Dopamine Transporter|dopamine transporter
424182|NCT00001920|Healthy Volunteer|healthy volunteer
424183|NCT00001921|Functional Connectivity|functional connectivity
424184|NCT00001921|Frontotemporal Interaction|frontotemporal interaction
424185|NCT00001921|Electrophysiology|electrophysiology
424186|NCT00001921|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
424187|NCT00001921|Healthy Subjects|healthy subjects
424188|NCT00001921|Schizophrenia|schizophrenia
424189|NCT00001921|MEG|meg
424190|NCT00001921|Neuroimaging|neuroimaging
424191|NCT00001921|EEG|eeg
424192|NCT00001921|MRI|mri
424193|NCT00001922|Evoked Response|evoked response
424194|NCT00001922|Spasmodic Dysphonia|spasmodic dysphonia
424195|NCT00001922|Aerodynamic|aerodynamic
424196|NCT00001922|Vibration|vibration
424197|NCT00001922|Laryngeal|laryngeal
424198|NCT00001922|Voice Disorders|voice disorders
424199|NCT00001922|Laryngeal Brainstem Evoked Responses|laryngeal brainstem evoked responses
424200|NCT00001922|Long-latency Responses|long-latency responses
424201|NCT00001922|Muscular Tension Dysphonia|muscular tension dysphonia
424202|NCT00001923|Pain|pain
424203|NCT00001923|Amputee|amputee
424204|NCT00001923|Phantom Limb|phantom limb
424205|NCT00001923|Amputation|amputation
424206|NCT00001923|Magnetic Stimulation|magnetic stimulation
424207|NCT00001923|Phantom|phantom
424208|NCT00001925|Inferior Olives|inferior olives
424209|NCT00001925|Calcium Channels|calcium channels
424210|NCT00001925|Accelerometry|accelerometry
424211|NCT00001925|Electromyography|electromyography
424212|NCT00001925|Palatal Tremor|palatal tremor
424213|NCT00001926|Plasticity|plasticity
424214|NCT00001926|Magnetic Stimulation|magnetic stimulation
424215|NCT00001926|PET|pet
424216|NCT00001926|Blind|blind
424217|NCT00001926|Braille|braille
424218|NCT00001926|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
424219|NCT00001927|Factor V Leiden|factor v leiden
424220|NCT00001927|Prothrombin Mutation|prothrombin mutation
424221|NCT00001927|Antiphospholipids|antiphospholipids
424222|NCT00001927|Cerebral Infarction|cerebral infarction
424223|NCT00001927|Thrombophilia|thrombophilia
424224|NCT00001927|Porencephaly|porencephaly
424225|NCT00001927|Perinatal Stroke|perinatal stroke
424226|NCT00001927|Healthy Mothers|healthy mothers
424227|NCT00001927|Healthy Children|healthy children
424228|NCT00001928|Diagnosis|diagnosis
424229|NCT00001928|Infusion|infusion
424230|NCT00001928|Parkinsonism|parkinsonism
424231|NCT00001929|Dyskinesias|dyskinesias
424232|NCT00001929|Glutamate Antagonist|glutamate antagonist
424233|NCT00001929|Levodopa|levodopa
424234|NCT00001930|Amantadine|amantadine
424235|NCT00001930|Chorea|chorea
424236|NCT00001930|Glutamate Antagonist|glutamate antagonist
424237|NCT00001931|Continuous Stimulation|continuous stimulation
424238|NCT00001931|Dose Finding|dose finding
424239|NCT00001931|Skin Patch|skin patch
424240|NCT00001932|Epilepsy|epilepsy
424241|NCT00001932|Temporal Lobe|temporal lobe
424242|NCT00001932|Blood Flow|blood flow
424243|NCT00001932|Metabolism|metabolism
424244|NCT00001932|Localization|localization
424245|NCT00001933|Acetylcholine|acetylcholine
424246|NCT00001933|Clinical Trial|clinical trial
424247|NCT00001933|GABA|gaba
424248|NCT00001933|Cognition|cognition
424249|NCT00001933|Nicotine|nicotine
424250|NCT00001934|Multiple Sclerosis|multiple sclerosis
424251|NCT00001934|Immunotherapy|immunotherapy
424252|NCT00001934|MRI|mri
424649|NCT00002425|Saquinavir|saquinavir
424253|NCT00001936|Neuromuscular Stimulation|neuromuscular stimulation
424254|NCT00001936|Laryngeal Elevation|laryngeal elevation
424255|NCT00001936|Dysphagia|dysphagia
424256|NCT00001936|Stroke|stroke
424257|NCT00001936|Neuroprosthesis|neuroprosthesis
424258|NCT00001936|Dysphonia|dysphonia
424259|NCT00001936|Aspiration|aspiration
424260|NCT00001936|Motor Control|motor control
424261|NCT00001936|Videofluoroscopy|videofluoroscopy
424262|NCT00001936|Upper Esophageal Sphincter|upper esophageal sphincter
424263|NCT00001936|Healthy Volunteer|healthy volunteer
424264|NCT00001936|Swallowing Disorders|swallowing disorders
424265|NCT00001937|Aspergillosis|aspergillosis
424266|NCT00001937|Candidiasis|candidiasis
424267|NCT00001937|Fungal Infections|fungal infections
424268|NCT00001937|Fungemia|fungemia
424269|NCT00001937|Prophylactic Antifungal Therapy|prophylactic antifungal therapy
424373|NCT00001961|Perfusion|perfusion
424270|NCT00001938|Ovarian Cancer|ovarian cancer
424271|NCT00001938|Proteomics|proteomics
423733|NCT00001839|Phase II Trial|phase ii trial
424272|NCT00001940|Antifungal Agent|antifungal agent
424273|NCT00001940|Aspergillosis|aspergillosis
424274|NCT00001940|Candidemia|candidemia
424275|NCT00001940|Fungemia|fungemia
752078|NCT01171677|exercise|exercise
424276|NCT00001941|Interleukin-2 Receptor alpha chain|interleukin-2 receptor alpha chain
424277|NCT00001941|Interleukin-2|interleukin-2
424278|NCT00001941|HTLV-I|htlv-i
424279|NCT00001941|Adult T-Cell Leukemia (ATL)|adult t-cell leukemia (atl)
424280|NCT00001941|Monoclonal Antibody (Daclizumab, Zenapax)|monoclonal antibody (daclizumab, zenapax)
424281|NCT00001944|Drug Resistance|drug resistance
424282|NCT00001944|MDR-1|mdr-1
424283|NCT00001944|P-Glycoprotein Blocker|p-glycoprotein blocker
424285|NCT00001944|Resistance Reversal|resistance reversal
424286|NCT00001946|Magnetic Resonance Angiography|magnetic resonance angiography
424287|NCT00001946|Gadolinium|gadolinium
424288|NCT00001946|Suburban Hospital|suburban hospital
424289|NCT00001946|Atherosclerosis|atherosclerosis
424290|NCT00001948|Human Immunodeficiency Virus|human immunodeficiency virus
424291|NCT00001948|Symptom Distress|symptom distress
424292|NCT00001948|Immune Function|immune function
424293|NCT00001948|Medication Trial|medication trial
424294|NCT00001948|Physical Symptoms|physical symptoms
424295|NCT00001950|Cognition|cognition
424296|NCT00001950|Infancy|infancy
424297|NCT00001950|Perception|perception
424298|NCT00001951|Bone|bone
424299|NCT00001951|Cognition|cognition
424300|NCT00001951|Estrogen|estrogen
424301|NCT00001951|Mood|mood
424302|NCT00001951|Testosterone|testosterone
424303|NCT00001951|Osteoporosis|osteoporosis
424304|NCT00001951|Ovarian Failure|ovarian failure
424305|NCT00001951|Hormone Replacement Therapy|hormone replacement therapy
424306|NCT00001951|POF|pof
424307|NCT00001951|Premature Ovarian Failure|premature ovarian failure
424308|NCT00001952|Fentanyl|fentanyl
424309|NCT00001952|Intraosseous-Anesthesia|intraosseous-anesthesia
424310|NCT00001952|Endodontics|endodontics
424311|NCT00001952|Denti Patch|denti patch
424312|NCT00001952|Pain|pain
424313|NCT00001952|Chronic Inflammation|chronic inflammation
424314|NCT00001953|Endocrine System|endocrine system
424315|NCT00001953|Autoimmunity|autoimmunity
424316|NCT00001953|Salivary Glands|salivary glands
424317|NCT00001953|Glucose Tolerance Test|glucose tolerance test
424318|NCT00001953|Growth Hormone|growth hormone
424319|NCT00001953|Somatostatin|somatostatin
424320|NCT00001953|Sjogren's Syndrome|sjogren's syndrome
424321|NCT00001954|Clinical Trial|clinical trial
424322|NCT00001954|Autoimmune|autoimmune
424323|NCT00001954|Disease Activity|disease activity
424324|NCT00001954|Cytokine|cytokine
424325|NCT00001954|Saliva|saliva
424326|NCT00001954|Xerostomia|xerostomia
424327|NCT00001954|Salivary Glands|salivary glands
424328|NCT00001954|Sjogren's Syndrome|sjogren's syndrome
424329|NCT00001955|Clinical Trial|clinical trial
424330|NCT00001955|Temporomandibular Joints|temporomandibular joints
424331|NCT00001955|Celecoxib|celecoxib
424332|NCT00001955|Etanercept|etanercept
424333|NCT00001955|Tumor Necrosis Factor|tumor necrosis factor
424334|NCT00001955|TMJ|tmj
424335|NCT00001955|TMD|tmd
424336|NCT00001956|Genetic Markers|genetic markers
424337|NCT00001956|Thermal Pain|thermal pain
424338|NCT00001956|Hyperalgesia|hyperalgesia
424339|NCT00001956|Oral Surgery|oral surgery
424340|NCT00001956|Cold Pain|cold pain
424341|NCT00001956|Peripheral Nerve|peripheral nerve
424342|NCT00001956|Allodynia|allodynia
424343|NCT00001956|Spinal Cord|spinal cord
424344|NCT00001956|Personality Traits|personality traits
424345|NCT00001956|Pain Ratings|pain ratings
424346|NCT00001957|Ostoacoustic Emission|ostoacoustic emission
424347|NCT00001957|Central Auditory Processing|central auditory processing
424348|NCT00001957|CAPD|capd
424349|NCT00001957|Medial Olivocochlear Bundle|medial olivocochlear bundle
424350|NCT00001957|Speech Impediment|speech impediment
424351|NCT00001958|Gamma Gene|gamma gene
424352|NCT00001958|Hemoglobin Switching|hemoglobin switching
424353|NCT00001958|Erythropoiesis|erythropoiesis
424354|NCT00001958|HbE Hemoglobin Chain Synthesis Imbalance|hbe hemoglobin chain synthesis imbalance
424355|NCT00001958|Cooley's Anemia|cooley's anemia
438003|NCT00004735|Enfuvirtide|enfuvirtide
424356|NCT00001958|Beta-Thalassemia Intermedia|beta-thalassemia intermedia
424357|NCT00001959|Fibrosis|fibrosis
424358|NCT00001959|Nephrotic Syndrome|nephrotic syndrome
424359|NCT00001959|Proteinuria|proteinuria
424360|NCT00001959|Renal Failure|renal failure
424361|NCT00001959|TGF-Beta|tgf-beta
424362|NCT00001959|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
424363|NCT00001959|FSGS|fsgs
424365|NCT00001960|Pediatric|pediatric
424366|NCT00001960|Pacemaker|pacemaker
424367|NCT00001960|Treatment|treatment
424368|NCT00001960|Symptoms|symptoms
424369|NCT00001961|Myocardial Infarction|myocardial infarction
424370|NCT00001961|Coronary Artery Disease|coronary artery disease
424371|NCT00001961|Adenosine|adenosine
424372|NCT00001961|Stress Testing|stress testing
424374|NCT00001962|Immunosuppression|immunosuppression
424376|NCT00001962|Hematopoiesis|hematopoiesis
424377|NCT00001962|Monoclonal Antibody Therapy|monoclonal antibody therapy
752342|NCT01172574|Posture|posture
424378|NCT00001962|Immunosuppressive Therapy|immunosuppressive therapy
424379|NCT00001962|Aplastic Anemia|aplastic anemia
424380|NCT00001963|Blood Flow|blood flow
424381|NCT00001963|Exercise|exercise
424382|NCT00001963|Microcirculation|microcirculation
424383|NCT00001963|S-nitrosohemoglobin|s-nitrosohemoglobin
424384|NCT00001963|Vasodilation|vasodilation
424385|NCT00001963|Healthy Volunteer|healthy volunteer
424386|NCT00001964|Hematopoiesis|hematopoiesis
424387|NCT00001964|Bone Marrow Failure|bone marrow failure
424388|NCT00001964|Aplastic Anemia|aplastic anemia
424389|NCT00001965|Calcineurin|calcineurin
424390|NCT00001965|Cardiac Hypertrophy|cardiac hypertrophy
424391|NCT00001965|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
424392|NCT00001966|Adjustment|adjustment
424393|NCT00001966|Alternative|alternative
424394|NCT00001966|Anxiety|anxiety
424395|NCT00001966|Guided-Imagery|guided-imagery
424396|NCT00001966|Meditation|meditation
424397|NCT00001966|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
424398|NCT00001967|HIV|hiv
424399|NCT00001967|HAART|haart
424400|NCT00001967|Immunity|immunity
424401|NCT00001967|Toxicity|toxicity
424402|NCT00001967|Resistance|resistance
424403|NCT00001967|Treatment Interruption|treatment interruption
424404|NCT00001968|AIDS|aids
424405|NCT00001968|Anti-Retroviral Therapy|anti-retroviral therapy
424406|NCT00001968|Drug Interactions|drug interactions
424407|NCT00001968|HIV|hiv
424408|NCT00001968|Protease Inhibitor|protease inhibitor
424409|NCT00001969|Cardiovascular Disease|cardiovascular disease
424410|NCT00001969|Glucose Clamp|glucose clamp
424411|NCT00001969|Hypercortisolism|hypercortisolism
424412|NCT00001969|Insulin Sensitivity|insulin sensitivity
424413|NCT00001969|Major Depression Disorder|major depression disorder
424414|NCT00001969|Inflammation|inflammation
424415|NCT00001969|Coagulation|coagulation
424416|NCT00001969|Metabolic|metabolic
424417|NCT00001969|Insulin|insulin
424418|NCT00001969|Cytokine|cytokine
424419|NCT00001969|Depression|depression
424420|NCT00001969|Volunteer|volunteer
424421|NCT00001969|Healthy Volunteer|healthy volunteer
424422|NCT00001971|Hepatitis B|hepatitis b
424423|NCT00001971|Hepatitis C|hepatitis c
424424|NCT00001971|Hepatitis D|hepatitis d
424425|NCT00001971|Chronic Cholestatic Syndromes|chronic cholestatic syndromes
424426|NCT00001971|Primary Biliary Cirrhosis|primary biliary cirrhosis
424427|NCT00001971|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
424428|NCT00001971|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
424429|NCT00001971|Wilson's Disease|wilson's disease
424430|NCT00001971|Hemochromatosis|hemochromatosis
424431|NCT00001971|Liver Biopsy|liver biopsy
424432|NCT00001971|Noncirrhotic Portal Hypertension|noncirrhotic portal hypertension
424433|NCT00001971|Liver Disease|liver disease
424434|NCT00001972|Alzheimer's Disease|alzheimer's disease
424435|NCT00001972|Positron Emission Tomography|positron emission tomography
424436|NCT00001972|Brain Phospholipid|brain phospholipid
424437|NCT00001972|Fatty Acids|fatty acids
424438|NCT00001972|11C Arachidonate|11c arachidonate
424439|NCT00001972|Signal Transduction|signal transduction
424440|NCT00001972|Brain|brain
424441|NCT00001973|G Protein Mutation|g protein mutation
424442|NCT00001973|McCune-Albright Syndrome|mccune-albright syndrome
424443|NCT00001973|Fibrous Dysplasia|fibrous dysplasia
424444|NCT00001973|Mutation|mutation
424445|NCT00001973|Pathology|pathology
424446|NCT00001973|Immunohistochemistry|immunohistochemistry
424447|NCT00001973|PCR|pcr
424448|NCT00001973|In Situ Hybridization|in situ hybridization
424449|NCT00001973|Juvenile Dermatomyositis|juvenile dermatomyositis
424450|NCT00001973|Calcinosis|calcinosis
424451|NCT00001975|Skin Biopsy|skin biopsy
424452|NCT00001975|Familial Tumor Syndrome|familial tumor syndrome
424453|NCT00001975|Cell Growth|cell growth
424454|NCT00001975|Loss of Heterozygosity|loss of heterozygosity
424455|NCT00001975|Cytokines|cytokines
424456|NCT00001975|Tuberous Sclerosis|tuberous sclerosis
424457|NCT00001976|CMV|cmv
424458|NCT00001976|Infection|infection
424459|NCT00001976|Comparison|comparison
528683|NCT00319930|CLL|cll
424460|NCT00001976|Observational|observational
424461|NCT00001976|Cytomegalovirus|cytomegalovirus
424462|NCT00001976|RT-PCR|rt-pcr
424463|NCT00001977|Alzheimer's Disease|alzheimer's disease
424464|NCT00001977|Attention|attention
424465|NCT00001977|Brain|brain
424466|NCT00001977|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
424467|NCT00001977|Physostigmine|physostigmine
424468|NCT00001977|Positron Emission Tomography|positron emission tomography
424469|NCT00001977|Working Memory|working memory
424470|NCT00001978|Kidney Disease|kidney disease
424471|NCT00001978|Kidney Function Tests|kidney function tests
424472|NCT00001978|Proteinuria|proteinuria
424473|NCT00001979|Kidney Disease|kidney disease
424474|NCT00001979|Autoimmune Diseases|autoimmune diseases
424475|NCT00001979|Nephrotic Syndrome|nephrotic syndrome
428856|NCT00002446|Fluconazole|fluconazole
424476|NCT00001981|Somatostatin Analogue|somatostatin analogue
424477|NCT00001981|Acromegaly|acromegaly
424478|NCT00001981|TSH Producing Tumor|tsh producing tumor
424479|NCT00001981|Islet Cell Tumor|islet cell tumor
424480|NCT00001981|Ursodeoxycholate|ursodeoxycholate
424481|NCT00001981|Pituitary|pituitary
424482|NCT00001981|Irradiation|irradiation
424483|NCT00001981|Treatment|treatment
424484|NCT00001982|Aminotransferases|aminotransferases
424485|NCT00001982|Anti-HCV|anti-hcv
424486|NCT00001982|Blood Donors|blood donors
424488|NCT00001982|Hepatitis C|hepatitis c
424489|NCT00001982|Liver Biopsy|liver biopsy
424490|NCT00001982|Serum Aminotransferases|serum aminotransferases
424491|NCT00001982|Transfusion|transfusion
424492|NCT00001983|Questionnaires|questionnaires
424493|NCT00001983|Eligibility|eligibility
424494|NCT00001983|History|history
424495|NCT00001983|Physical Examination|physical examination
424496|NCT00001983|Tests|tests
424497|NCT00001983|Fibromyalgia|fibromyalgia
424498|NCT00001984|Immunosuppression|immunosuppression
424499|NCT00001984|Tolerance|tolerance
424500|NCT00001984|DSG|dsg
424501|NCT00001984|Alemtuzumab|alemtuzumab
424502|NCT00001985|Diabetes|diabetes
424503|NCT00001985|Gene|gene
424504|NCT00001986|Alcohol|alcohol
424505|NCT00001986|Octanol|octanol
424506|NCT00001986|Treatment|treatment
424507|NCT00001986|Tremor|tremor
424508|NCT00001987|Diabetes Mellitus|diabetes mellitus
424509|NCT00001987|Severe Insulin Resistance|severe insulin resistance
424510|NCT00001987|Type B Insulin Resistance|type b insulin resistance
424511|NCT00001989|Trichosanthin|trichosanthin
424512|NCT00001989|Drug Evaluation|drug evaluation
424513|NCT00001989|Drug Therapy, Combination|drug therapy, combination
424514|NCT00001989|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424515|NCT00001989|AIDS-Related Complex|aids-related complex
424516|NCT00001989|Antiviral Agents|antiviral agents
424517|NCT00001989|Zidovudine|zidovudine
424518|NCT00001990|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
424519|NCT00001990|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
424520|NCT00001990|Pentamidine|pentamidine
424521|NCT00001990|Antifungal Agents|antifungal agents
424522|NCT00001990|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424523|NCT00001990|atovaquone|atovaquone
424524|NCT00001991|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
424525|NCT00001991|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
424526|NCT00001991|Antifungal Agents|antifungal agents
424527|NCT00001991|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424528|NCT00001991|atovaquone|atovaquone
424529|NCT00001992|Vaccines, Synthetic|vaccines, synthetic
424530|NCT00001992|Drug Evaluation|drug evaluation
424531|NCT00001992|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424532|NCT00001992|AIDS Vaccines|aids vaccines
424533|NCT00001993|Drug Therapy, Combination|drug therapy, combination
424534|NCT00001993|Zidovudine|zidovudine
424535|NCT00001994|Toxoplasmosis|toxoplasmosis
424536|NCT00001994|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
424537|NCT00001994|Naphthoquinones|naphthoquinones
424538|NCT00001994|Encephalitis|encephalitis
424539|NCT00001994|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424540|NCT00001995|Rifabutin|rifabutin
424541|NCT00001995|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
424542|NCT00001995|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424543|NCT00001996|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
424544|NCT00001996|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
424545|NCT00001996|Pentamidine|pentamidine
424546|NCT00001996|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424547|NCT00001996|atovaquone|atovaquone
424548|NCT00001997|Recombinant Proteins|recombinant proteins
424549|NCT00001997|Polyethylene Glycols|polyethylene glycols
424550|NCT00001997|Interleukin-2|interleukin-2
424551|NCT00001997|Didanosine|didanosine
424552|NCT00001997|Zidovudine|zidovudine
424553|NCT00001998|Nystatin|nystatin
424554|NCT00001998|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
423559|NCT00001776|SRTT|srtt
424555|NCT00001998|AIDS-Related Complex|aids-related complex
424556|NCT00001999|Retinitis|retinitis
438004|NCT00004735|T-20|t-20
424557|NCT00001999|Gamma-Globulins|gamma-globulins
424558|NCT00001999|Ganciclovir|ganciclovir
424559|NCT00001999|Drug Therapy, Combination|drug therapy, combination
424560|NCT00001999|Cytomegalovirus Infections|cytomegalovirus infections
424561|NCT00001999|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424562|NCT00001999|Immunization, Passive|immunization, passive
424563|NCT00002000|Acyclovir|acyclovir
424564|NCT00002000|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424565|NCT00002000|AIDS-Related Complex|aids-related complex
424566|NCT00002000|Antiviral Agents|antiviral agents
424567|NCT00002000|Anus Diseases|anus diseases
424568|NCT00002000|Herpes Genitalis|herpes genitalis
424569|NCT00002001|Zalcitabine|zalcitabine
424570|NCT00002001|Didanosine|didanosine
430471|NCT00003552|skin tumor|skin tumor
424571|NCT00002001|Drug Therapy, Combination|drug therapy, combination
753426|NCT01179217|Sickle Cell Pain|sickle cell pain
424572|NCT00002001|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424573|NCT00002001|Zidovudine|zidovudine
424574|NCT00002002|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
424575|NCT00002002|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
424576|NCT00002002|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
424577|NCT00002002|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424578|NCT00002003|Mitoxantrone|mitoxantrone
424579|NCT00002003|Lymphoma, Large-Cell|lymphoma, large-cell
424580|NCT00002003|Etoposide|etoposide
424581|NCT00002003|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424582|NCT00002004|Recombinant Proteins|recombinant proteins
424583|NCT00002004|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424584|NCT00002004|Antigens, CD4|antigens, cd4
424585|NCT00002004|AIDS-Related Complex|aids-related complex
424586|NCT00002005|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424587|NCT00002005|Antigens, CD4|antigens, cd4
424588|NCT00002005|AIDS-Related Complex|aids-related complex
424589|NCT00002006|Neutropenia|neutropenia
424590|NCT00002006|Drug Interactions|drug interactions
424591|NCT00002006|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
424592|NCT00002006|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424593|NCT00002006|Zidovudine|zidovudine
424594|NCT00002007|Leukopenia|leukopenia
424595|NCT00002007|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
424596|NCT00002007|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424597|NCT00002007|Zidovudine|zidovudine
424598|NCT00002415|Drug Therapy, Combination|drug therapy, combination
424599|NCT00002415|Prodrugs|prodrugs
424600|NCT00002415|Anti-HIV Agents|anti-hiv agents
424602|NCT00002416|Zalcitabine|zalcitabine
424603|NCT00002416|Zidovudine|zidovudine
424604|NCT00002416|Stavudine|stavudine
424605|NCT00002416|HIV Protease Inhibitors|hiv protease inhibitors
424606|NCT00002416|Lamivudine|lamivudine
424607|NCT00002416|RNA, Viral|rna, viral
424608|NCT00002416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
424609|NCT00002416|Anti-HIV Agents|anti-hiv agents
424610|NCT00002417|Drug Therapy, Combination|drug therapy, combination
424611|NCT00002417|HIV Protease Inhibitors|hiv protease inhibitors
424612|NCT00002417|VX 478|vx 478
424613|NCT00002417|Lipodystrophy|lipodystrophy
424614|NCT00002417|Hyperlipidemia|hyperlipidemia
424615|NCT00002418|Drug Therapy, Combination|drug therapy, combination
424616|NCT00002418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
424617|NCT00002418|Anti-HIV Agents|anti-hiv agents
424618|NCT00002418|Viral Load|viral load
424619|NCT00002419|Drug Therapy, Combination|drug therapy, combination
424620|NCT00002419|HIV Protease Inhibitors|hiv protease inhibitors
424621|NCT00002419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
424622|NCT00002419|Anti-HIV Agents|anti-hiv agents
424623|NCT00002420|Drug Therapy, Combination|drug therapy, combination
424624|NCT00002420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
424625|NCT00002420|Anti-HIV Agents|anti-hiv agents
424626|NCT00002422|Injections, Intramuscular|injections, intramuscular
424627|NCT00002422|Drug Interactions|drug interactions
424628|NCT00002422|Salvage Therapy|salvage therapy
424629|NCT00002422|Anti-HIV Agents|anti-hiv agents
424630|NCT00002423|Drug Therapy, Combination|drug therapy, combination
424631|NCT00002423|HIV Protease Inhibitors|hiv protease inhibitors
424632|NCT00002423|Lamivudine|lamivudine
424633|NCT00002423|Indinavir|indinavir
424634|NCT00002423|Nelfinavir|nelfinavir
424635|NCT00002423|VX 478|vx 478
424636|NCT00002423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
424637|NCT00002423|Anti-HIV Agents|anti-hiv agents
424638|NCT00002423|Viral Load|viral load
424639|NCT00002423|abacavir|abacavir
424640|NCT00002424|Drug Therapy, Combination|drug therapy, combination
424641|NCT00002424|Drug Administration Schedule|drug administration schedule
424642|NCT00002424|Stavudine|stavudine
528932|NCT00320918|Cancer|cancer
424643|NCT00002424|HIV Protease Inhibitors|hiv protease inhibitors
424644|NCT00002424|Lamivudine|lamivudine
424645|NCT00002424|Indinavir|indinavir
424646|NCT00002424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
424647|NCT00002424|Anti-HIV Agents|anti-hiv agents
424648|NCT00002425|Drug Therapy, Combination|drug therapy, combination
424650|NCT00002425|HIV Protease Inhibitors|hiv protease inhibitors
424651|NCT00002425|Dosage Forms|dosage forms
424652|NCT00002425|Anti-HIV Agents|anti-hiv agents
424653|NCT00002426|HIV-1|hiv-1
424654|NCT00002426|RNA, Viral|rna, viral
424655|NCT00002426|VX 478|vx 478
424656|NCT00002426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
424657|NCT00002426|Anti-HIV Agents|anti-hiv agents
424658|NCT00002426|Viral Load|viral load
424659|NCT00002427|Didanosine|didanosine
424660|NCT00002427|Dose-Response Relationship, Drug|dose-response relationship, drug
424661|NCT00002427|Drug Therapy, Combination|drug therapy, combination
424662|NCT00002427|Stavudine|stavudine
424663|NCT00002427|Hydroxyurea|hydroxyurea
424664|NCT00002427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
424666|NCT00002428|Vaccines, Synthetic|vaccines, synthetic
424667|NCT00002428|HIV-1|hiv-1
424668|NCT00002428|HIV Envelope Protein gp120|hiv envelope protein gp120
424669|NCT00002428|AIDS Vaccines|aids vaccines
424670|NCT00002428|HIV Seronegativity|hiv seronegativity
424671|NCT00002429|Didanosine|didanosine
424672|NCT00002429|Drug Therapy, Combination|drug therapy, combination
424673|NCT00002429|Stavudine|stavudine
424674|NCT00002429|RNA, Viral|rna, viral
424675|NCT00002429|Nelfinavir|nelfinavir
424676|NCT00002429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
424677|NCT00002429|Anti-HIV Agents|anti-hiv agents
424678|NCT00002430|Drug Therapy, Combination|drug therapy, combination
424679|NCT00002430|HIV Protease Inhibitors|hiv protease inhibitors
424680|NCT00002430|Lamivudine|lamivudine
424681|NCT00002430|Indinavir|indinavir
424682|NCT00002430|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
424683|NCT00002430|Anti-HIV Agents|anti-hiv agents
424684|NCT00002430|Nelfinavir|nelfinavir
424685|NCT00002431|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
424686|NCT00002431|chlorhexidine gluconate|chlorhexidine gluconate
424687|NCT00002431|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424688|NCT00002431|Anti-Infective Agents, Local|anti-infective agents, local
424689|NCT00002431|AIDS-Related Complex|aids-related complex
424690|NCT00002431|Candidiasis, Oral|candidiasis, oral
424691|NCT00002432|Retinitis|retinitis
424692|NCT00002432|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
424693|NCT00002432|Foscarnet|foscarnet
424694|NCT00002432|Cytomegalovirus Infections|cytomegalovirus infections
424695|NCT00002432|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424696|NCT00002433|Pulmonary Alveoli|pulmonary alveoli
424697|NCT00002433|Macrophage Activation|macrophage activation
424698|NCT00002433|Interferon-gamma, Recombinant|interferon-gamma, recombinant
424699|NCT00002433|Injections, Subcutaneous|injections, subcutaneous
424700|NCT00002433|Aerosols|aerosols
424701|NCT00002433|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424702|NCT00002434|Trimetrexate|trimetrexate
424703|NCT00002434|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
424704|NCT00002434|Leucovorin|leucovorin
424705|NCT00002434|Drug Therapy, Combination|drug therapy, combination
424706|NCT00002434|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424707|NCT00002435|Drug Therapy, Combination|drug therapy, combination
424708|NCT00002435|Antiviral Agents|antiviral agents
424709|NCT00002435|Zidovudine|zidovudine
424710|NCT00002435|thymic humoral factor gamma 2|thymic humoral factor gamma 2
424711|NCT00002436|Zalcitabine|zalcitabine
424712|NCT00002436|Drug Therapy, Combination|drug therapy, combination
424713|NCT00002436|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424714|NCT00002436|AIDS-Related Complex|aids-related complex
424715|NCT00002436|Antiviral Agents|antiviral agents
424716|NCT00002436|Zidovudine|zidovudine
424717|NCT00002437|Retinitis|retinitis
424718|NCT00002437|Probenecid|probenecid
424719|NCT00002437|Drug Therapy, Combination|drug therapy, combination
424720|NCT00002437|Cytomegalovirus Infections|cytomegalovirus infections
424721|NCT00002437|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424722|NCT00002437|Antiviral Agents|antiviral agents
424723|NCT00002437|cidofovir|cidofovir
424724|NCT00002438|Itraconazole|itraconazole
424725|NCT00002438|Histoplasmosis|histoplasmosis
424726|NCT00002438|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424727|NCT00002440|HIV-1|hiv-1
424728|NCT00002440|Drug Therapy, Combination|drug therapy, combination
424729|NCT00002440|HIV Protease Inhibitors|hiv protease inhibitors
424730|NCT00002440|Mutation|mutation
424731|NCT00002440|HIV-1 Reverse Transcriptase|hiv-1 reverse transcriptase
424732|NCT00002440|HIV Protease|hiv protease
424733|NCT00002440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
424734|NCT00002440|Anti-HIV Agents|anti-hiv agents
424735|NCT00002440|abacavir|abacavir
424736|NCT00002441|HIV-1|hiv-1
424737|NCT00002441|Dose-Response Relationship, Drug|dose-response relationship, drug
424738|NCT00002441|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
424739|NCT00002441|AIDS Vaccines|aids vaccines
424740|NCT00002441|Sexually Transmitted Diseases|sexually transmitted diseases
424741|NCT00002441|Risk Factors|risk factors
424742|NCT00002441|HIV Seronegativity|hiv seronegativity
424743|NCT00002441|Antigens, Viral|antigens, viral
424744|NCT00002441|Alum Compounds|alum compounds
424745|NCT00002451|Drug Therapy, Combination|drug therapy, combination
424746|NCT00002451|Stavudine|stavudine
424747|NCT00002451|HIV Protease Inhibitors|hiv protease inhibitors
424748|NCT00002451|CD4 Lymphocyte Count|cd4 lymphocyte count
424749|NCT00002451|Ritonavir|ritonavir
424750|NCT00002451|Lamivudine|lamivudine
424751|NCT00002451|Indinavir|indinavir
424752|NCT00002451|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
424753|NCT00002451|Anti-HIV Agents|anti-hiv agents
424754|NCT00002451|Viral Load|viral load
424755|NCT00002452|Drug Therapy, Combination|drug therapy, combination
424756|NCT00002452|HIV Protease Inhibitors|hiv protease inhibitors
424758|NCT00002452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
424759|NCT00002452|Anti-HIV Agents|anti-hiv agents
424761|NCT00002453|HIV-1|hiv-1
424762|NCT00002453|Drug Therapy, Combination|drug therapy, combination
424763|NCT00002453|Disease Progression|disease progression
424764|NCT00002453|Anti-HIV Agents|anti-hiv agents
424765|NCT00002454|lung papilloma|lung papilloma
424766|NCT00002455|stage I colon cancer|stage i colon cancer
424767|NCT00002455|stage II colon cancer|stage ii colon cancer
424768|NCT00002455|stage III colon cancer|stage iii colon cancer
424769|NCT00002455|stage I breast cancer|stage i breast cancer
424770|NCT00002455|stage II breast cancer|stage ii breast cancer
424771|NCT00002455|stage IIIA breast cancer|stage iiia breast cancer
424772|NCT00002455|recurrent breast cancer|recurrent breast cancer
424773|NCT00002455|recurrent colon cancer|recurrent colon cancer
424774|NCT00002455|stage I melanoma|stage i melanoma
424775|NCT00002455|stage II melanoma|stage ii melanoma
424776|NCT00002455|stage III melanoma|stage iii melanoma
424777|NCT00002455|recurrent melanoma|recurrent melanoma
424778|NCT00002456|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
424779|NCT00002456|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
424780|NCT00002456|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
424781|NCT00002456|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
424782|NCT00002456|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
424783|NCT00002456|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
424784|NCT00002456|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
424785|NCT00002456|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
424786|NCT00002456|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
424787|NCT00002456|graft versus host disease|graft versus host disease
424788|NCT00002458|disseminated neuroblastoma|disseminated neuroblastoma
424789|NCT00002458|recurrent neuroblastoma|recurrent neuroblastoma
424790|NCT00002459|stage I uterine sarcoma|stage i uterine sarcoma
424791|NCT00002459|stage II uterine sarcoma|stage ii uterine sarcoma
424792|NCT00002459|uterine carcinosarcoma|uterine carcinosarcoma
424793|NCT00002459|uterine leiomyosarcoma|uterine leiomyosarcoma
424794|NCT00002459|endometrial stromal sarcoma|endometrial stromal sarcoma
424795|NCT00002460|stage I breast cancer|stage i breast cancer
424796|NCT00002460|stage II breast cancer|stage ii breast cancer
424797|NCT00002460|stage IIIA breast cancer|stage iiia breast cancer
424798|NCT00002461|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
424799|NCT00002461|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
424800|NCT00002461|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
424801|NCT00002461|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
424802|NCT00002461|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
424803|NCT00002461|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
424804|NCT00002461|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
424805|NCT00002461|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
424806|NCT00002461|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
424807|NCT00002461|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
424808|NCT00002461|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
424809|NCT00002461|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
424810|NCT00002461|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
424811|NCT00002461|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
424812|NCT00002461|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
424813|NCT00002461|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
424814|NCT00002462|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
529184|NCT00321399|PET|pet
424815|NCT00002462|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
424816|NCT00002463|childhood infratentorial ependymoma|childhood infratentorial ependymoma
424817|NCT00002463|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
424818|NCT00002463|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
424819|NCT00002463|childhood supratentorial ependymoma|childhood supratentorial ependymoma
424820|NCT00002463|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
441511|NCT00005762|efavirenz|efavirenz
424821|NCT00002463|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
424822|NCT00002463|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
424823|NCT00002463|untreated childhood medulloblastoma|untreated childhood medulloblastoma
424824|NCT00002463|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
424825|NCT00002463|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
424826|NCT00002465|stage IV breast cancer|stage iv breast cancer
424827|NCT00002465|recurrent breast cancer|recurrent breast cancer
424828|NCT00002465|advanced malignant mesothelioma|advanced malignant mesothelioma
424829|NCT00002465|recurrent malignant mesothelioma|recurrent malignant mesothelioma
424830|NCT00002465|stage IV endometrial carcinoma|stage iv endometrial carcinoma
424831|NCT00002465|recurrent endometrial carcinoma|recurrent endometrial carcinoma
424833|NCT00002466|metastatic osteosarcoma|metastatic osteosarcoma
424834|NCT00002466|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
424835|NCT00002466|stage III Wilms tumor|stage iii wilms tumor
424836|NCT00002466|stage IV Wilms tumor|stage iv wilms tumor
424837|NCT00002466|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
424838|NCT00002466|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
424839|NCT00002466|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
424840|NCT00002466|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
424841|NCT00002466|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
424842|NCT00002466|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
424843|NCT00002466|Askin tumor|askin tumor
424844|NCT00002466|peripheral primitive neuroectodermal tumor|peripheral primitive neuroectodermal tumor
424845|NCT00002470|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
424846|NCT00002470|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
424847|NCT00002470|pulmonary carcinoid tumor|pulmonary carcinoid tumor
424848|NCT00002471|childhood Burkitt lymphoma|childhood burkitt lymphoma
424849|NCT00002471|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
424850|NCT00002471|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
424851|NCT00002471|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
424852|NCT00002471|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
424853|NCT00002471|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
424854|NCT00002471|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
424855|NCT00002471|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
424856|NCT00002471|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
424857|NCT00002471|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
424858|NCT00002471|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
424859|NCT00002471|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
424860|NCT00002471|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
424861|NCT00002471|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
424862|NCT00002471|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
424863|NCT00002471|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
424864|NCT00002471|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
424865|NCT00002471|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
424866|NCT00002471|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
424867|NCT00002471|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
424868|NCT00002471|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
424869|NCT00002471|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
424870|NCT00002472|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
424871|NCT00002472|extragonadal germ cell tumor|extragonadal germ cell tumor
424872|NCT00002472|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
424873|NCT00002472|childhood teratoma|childhood teratoma
424874|NCT00002472|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
424875|NCT00002472|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
424876|NCT00002472|childhood central nervous system germinoma|childhood central nervous system germinoma
424877|NCT00002472|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
424878|NCT00002472|childhood central nervous system teratoma|childhood central nervous system teratoma
424879|NCT00002472|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
424880|NCT00002473|stage I renal cell cancer|stage i renal cell cancer
424881|NCT00002473|stage II renal cell cancer|stage ii renal cell cancer
424882|NCT00002474|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
424883|NCT00002475|stage III colon cancer|stage iii colon cancer
424884|NCT00002475|stage IV colon cancer|stage iv colon cancer
424885|NCT00002475|stage IV breast cancer|stage iv breast cancer
424886|NCT00002475|stage IIIA breast cancer|stage iiia breast cancer
424887|NCT00002475|recurrent breast cancer|recurrent breast cancer
424888|NCT00002475|stage IIIB breast cancer|stage iiib breast cancer
424889|NCT00002475|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
424890|NCT00002475|stage II pancreatic cancer|stage ii pancreatic cancer
424891|NCT00002475|stage III pancreatic cancer|stage iii pancreatic cancer
424892|NCT00002475|recurrent pancreatic cancer|recurrent pancreatic cancer
424893|NCT00002475|recurrent colon cancer|recurrent colon cancer
424894|NCT00002475|stage III renal cell cancer|stage iii renal cell cancer
424895|NCT00002475|stage IV renal cell cancer|stage iv renal cell cancer
424896|NCT00002475|recurrent renal cell cancer|recurrent renal cell cancer
424897|NCT00002475|extensive stage small cell lung cancer|extensive stage small cell lung cancer
424898|NCT00002475|recurrent small cell lung cancer|recurrent small cell lung cancer
430472|NCT00003552|solid tumor|solid tumor
424899|NCT00002475|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
424900|NCT00002475|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
424901|NCT00002475|stage IIIC breast cancer|stage iiic breast cancer
424902|NCT00002475|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
424903|NCT00002475|pulmonary carcinoid tumor|pulmonary carcinoid tumor
424904|NCT00002475|recurrent malignant mesothelioma|recurrent malignant mesothelioma
424905|NCT00002475|stage IV pancreatic cancer|stage iv pancreatic cancer
424906|NCT00002476|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
424907|NCT00002476|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
424908|NCT00002476|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
424909|NCT00002476|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
424910|NCT00002476|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
424911|NCT00002476|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
424912|NCT00002476|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
424913|NCT00002476|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
424914|NCT00002476|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
424915|NCT00002476|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
424916|NCT00002476|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
424917|NCT00002476|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
424918|NCT00002476|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
424919|NCT00002476|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
424920|NCT00002476|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
424921|NCT00002476|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
424922|NCT00002476|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
424923|NCT00002476|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
424924|NCT00002476|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
424925|NCT00002476|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
424926|NCT00002476|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
424927|NCT00002476|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
424928|NCT00002476|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
424929|NCT00002476|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
424930|NCT00002477|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
424931|NCT00002477|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
424932|NCT00002478|recurrent cervical cancer|recurrent cervical cancer
424933|NCT00002478|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
424934|NCT00002479|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
424935|NCT00002479|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
424936|NCT00002479|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
424937|NCT00002479|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
529435|NCT00328094|control|control
424938|NCT00002480|adenocarcinoma of the prostate|adenocarcinoma of the prostate
424939|NCT00002480|stage IIB prostate cancer|stage iib prostate cancer
424940|NCT00002480|stage IIA prostate cancer|stage iia prostate cancer
424941|NCT00002480|stage III prostate cancer|stage iii prostate cancer
424942|NCT00002481|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
424943|NCT00002481|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
424944|NCT00002481|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
424945|NCT00002481|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
424946|NCT00002481|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
424947|NCT00002481|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
424948|NCT00002481|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
425756|NCT00002546|stage IV uterine sarcoma|stage iv uterine sarcoma
424949|NCT00002481|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
424950|NCT00002481|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
424951|NCT00002481|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
424952|NCT00002481|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
424953|NCT00002481|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
424954|NCT00002481|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
424955|NCT00002481|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
424956|NCT00002481|splenic marginal zone lymphoma|splenic marginal zone lymphoma
424957|NCT00002482|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
424958|NCT00002484|stage I non-small cell lung cancer|stage i non-small cell lung cancer
424959|NCT00002484|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
424960|NCT00002484|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
424961|NCT00002484|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
424962|NCT00002485|localized osteosarcoma|localized osteosarcoma
424963|NCT00002485|metastatic osteosarcoma|metastatic osteosarcoma
424964|NCT00002485|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
424965|NCT00002485|childhood infratentorial ependymoma|childhood infratentorial ependymoma
424966|NCT00002485|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
424967|NCT00002485|childhood supratentorial ependymoma|childhood supratentorial ependymoma
424968|NCT00002485|childhood craniopharyngioma|childhood craniopharyngioma
424969|NCT00002485|localized resectable neuroblastoma|localized resectable neuroblastoma
424970|NCT00002485|regional neuroblastoma|regional neuroblastoma
424971|NCT00002485|disseminated neuroblastoma|disseminated neuroblastoma
424972|NCT00002485|stage 4S neuroblastoma|stage 4s neuroblastoma
424973|NCT00002485|recurrent neuroblastoma|recurrent neuroblastoma
424974|NCT00002485|stage I childhood liver cancer|stage i childhood liver cancer
424975|NCT00002485|stage II childhood liver cancer|stage ii childhood liver cancer
424976|NCT00002485|stage III childhood liver cancer|stage iii childhood liver cancer
424977|NCT00002485|stage IV childhood liver cancer|stage iv childhood liver cancer
424978|NCT00002485|recurrent childhood liver cancer|recurrent childhood liver cancer
424979|NCT00002485|childhood hepatoblastoma|childhood hepatoblastoma
424980|NCT00002485|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
424981|NCT00002485|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
424982|NCT00002485|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
424983|NCT00002485|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
424984|NCT00002485|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
424985|NCT00002485|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
424986|NCT00002485|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
424987|NCT00002485|recurrent osteosarcoma|recurrent osteosarcoma
424988|NCT00002485|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
424989|NCT00002485|childhood germ cell tumor|childhood germ cell tumor
424990|NCT00002485|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
424991|NCT00002485|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
424992|NCT00002485|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
424993|NCT00002485|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
424994|NCT00002485|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
424995|NCT00002485|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
424996|NCT00002485|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
424997|NCT00002485|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
424998|NCT00002485|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
424999|NCT00002485|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
425000|NCT00002485|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
425001|NCT00002485|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
425002|NCT00002485|extragonadal germ cell tumor|extragonadal germ cell tumor
425003|NCT00002485|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
425004|NCT00002485|childhood oligodendroglioma|childhood oligodendroglioma
425005|NCT00002485|childhood choroid plexus tumor|childhood choroid plexus tumor
425006|NCT00002485|childhood meningioma|childhood meningioma
425007|NCT00002485|localized unresectable neuroblastoma|localized unresectable neuroblastoma
425008|NCT00002485|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
425009|NCT00002485|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
425010|NCT00002485|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
425011|NCT00002485|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
425012|NCT00002485|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
425013|NCT00002485|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
425014|NCT00002485|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
425015|NCT00002485|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
425016|NCT00002485|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
425017|NCT00002485|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
425018|NCT00002485|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
425019|NCT00002485|untreated childhood brain stem glioma|untreated childhood brain stem glioma
425020|NCT00002485|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
425021|NCT00002485|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
425022|NCT00002485|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
425023|NCT00002485|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
425024|NCT00002485|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
425025|NCT00002485|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
425026|NCT00002485|untreated childhood medulloblastoma|untreated childhood medulloblastoma
425027|NCT00002485|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
425028|NCT00002485|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
425029|NCT00002485|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
425030|NCT00002485|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
425031|NCT00002485|recurrent childhood ependymoma|recurrent childhood ependymoma
425033|NCT00002485|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
425034|NCT00002485|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
425035|NCT00002485|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
425036|NCT00002485|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
425037|NCT00002485|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
425038|NCT00002487|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
425039|NCT00002488|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
425040|NCT00002488|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
425041|NCT00002488|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
425042|NCT00002488|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
425043|NCT00002488|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
425044|NCT00002488|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
425045|NCT00002488|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
425046|NCT00002489|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
425047|NCT00002489|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
425048|NCT00002489|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
425049|NCT00002489|ovarian teratoma|ovarian teratoma
425050|NCT00002489|extragonadal germ cell tumor|extragonadal germ cell tumor
425051|NCT00002490|stage I bladder cancer|stage i bladder cancer
425052|NCT00002490|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
425053|NCT00002492|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
425054|NCT00002492|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
425055|NCT00002492|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
425056|NCT00002493|stage III endometrial carcinoma|stage iii endometrial carcinoma
425057|NCT00002493|stage IV endometrial carcinoma|stage iv endometrial carcinoma
425058|NCT00002493|endometrial adenocarcinoma|endometrial adenocarcinoma
425059|NCT00002493|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
425060|NCT00002493|endometrial adenoacanthoma|endometrial adenoacanthoma
425061|NCT00002493|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
425062|NCT00002493|endometrial clear cell carcinoma|endometrial clear cell carcinoma
425063|NCT00002493|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
425064|NCT00002494|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
425065|NCT00002494|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
425066|NCT00002494|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
425067|NCT00002494|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
425068|NCT00002494|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
425069|NCT00002494|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
425070|NCT00002494|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
425071|NCT00002494|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
425072|NCT00002495|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
425073|NCT00002495|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
425074|NCT00002496|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
425075|NCT00002496|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
425076|NCT00002498|stage IV breast cancer|stage iv breast cancer
425077|NCT00002498|recurrent breast cancer|recurrent breast cancer
425078|NCT00002499|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
425079|NCT00002501|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
425080|NCT00002501|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
425081|NCT00002501|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
425082|NCT00002501|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
425083|NCT00002502|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
425084|NCT00002502|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
425085|NCT00002502|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
425086|NCT00002502|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
425087|NCT00002502|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
425088|NCT00002502|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
425089|NCT00002502|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
430909|NCT00003601|melanoma|melanoma
425090|NCT00002502|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
425091|NCT00002502|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
425092|NCT00002502|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
425093|NCT00002502|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
425094|NCT00002502|childhood Burkitt lymphoma|childhood burkitt lymphoma
425095|NCT00002502|refractory multiple myeloma|refractory multiple myeloma
425096|NCT00002502|Waldenström macroglobulinemia|waldenström macroglobulinemia
425097|NCT00002502|stage I multiple myeloma|stage i multiple myeloma
425098|NCT00002502|stage II multiple myeloma|stage ii multiple myeloma
425099|NCT00002502|stage III multiple myeloma|stage iii multiple myeloma
425100|NCT00002502|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
425101|NCT00002502|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
425102|NCT00002502|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
425103|NCT00002502|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
425104|NCT00002502|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
425105|NCT00002502|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
425106|NCT00002502|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
425107|NCT00002502|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
425108|NCT00002502|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
425109|NCT00002502|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
425110|NCT00002502|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
425111|NCT00002502|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
426887|NCT00001658|Cytokines|cytokines
425112|NCT00002502|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
425113|NCT00002502|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
425114|NCT00002502|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
425115|NCT00002502|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
425116|NCT00002502|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
425117|NCT00002502|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
425118|NCT00002502|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
425119|NCT00002502|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
425120|NCT00002502|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
425121|NCT00002502|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
425122|NCT00002502|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
425123|NCT00002502|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
425124|NCT00002502|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
752632|NCT01173393|non-ventricular fibrillation|non-ventricular fibrillation
425125|NCT00002502|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
425126|NCT00002502|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
425127|NCT00002502|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
425128|NCT00002502|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
425129|NCT00002502|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
425130|NCT00002502|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
425131|NCT00002502|refractory anemia|refractory anemia
425132|NCT00002502|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
425133|NCT00002502|refractory anemia with excess blasts|refractory anemia with excess blasts
425134|NCT00002502|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
425135|NCT00002502|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
425136|NCT00002502|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
425137|NCT00002502|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
425138|NCT00002502|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
425139|NCT00002502|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
425140|NCT00002502|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
425141|NCT00002502|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
425142|NCT00002502|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
425143|NCT00002502|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
425144|NCT00002502|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
425145|NCT00002502|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
425146|NCT00002502|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
425147|NCT00002502|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
425148|NCT00002502|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
425149|NCT00002502|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
425150|NCT00002502|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
425151|NCT00002502|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
425152|NCT00002502|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
425153|NCT00002502|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
425154|NCT00002502|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
425155|NCT00002502|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
425156|NCT00002502|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
425157|NCT00002502|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
425158|NCT00002502|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
425159|NCT00002502|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
425160|NCT00002502|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
425161|NCT00002502|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
425162|NCT00002502|secondary acute myeloid leukemia|secondary acute myeloid leukemia
425163|NCT00002502|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
425164|NCT00002502|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
425165|NCT00002502|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
425166|NCT00002502|intraocular lymphoma|intraocular lymphoma
425167|NCT00002502|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
425168|NCT00002502|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
425169|NCT00002502|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
425170|NCT00002502|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
425171|NCT00002502|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
425172|NCT00002502|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
425173|NCT00002502|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
425174|NCT00002502|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
425175|NCT00002502|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
425176|NCT00002502|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
425177|NCT00002502|stage I mantle cell lymphoma|stage i mantle cell lymphoma
425178|NCT00002502|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
425179|NCT00002502|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
425180|NCT00002502|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
425181|NCT00002502|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
425182|NCT00002502|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
425183|NCT00002502|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
425184|NCT00002502|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
424487|NCT00001982|HCV RNA|hcv rna
425185|NCT00002502|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
425186|NCT00002502|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
425187|NCT00002502|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
425188|NCT00002502|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
425189|NCT00002502|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
425190|NCT00002502|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
425191|NCT00002502|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
425192|NCT00002502|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
425193|NCT00002502|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
425194|NCT00002502|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
425195|NCT00002502|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
425196|NCT00002502|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
425197|NCT00002502|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
425198|NCT00002502|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
425199|NCT00002502|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
425200|NCT00002502|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
425201|NCT00002502|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
425202|NCT00002502|anaplastic large cell lymphoma|anaplastic large cell lymphoma
425203|NCT00002502|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
425204|NCT00002502|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
425205|NCT00002502|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
425206|NCT00002502|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
425207|NCT00002502|stage I marginal zone lymphoma|stage i marginal zone lymphoma
425208|NCT00002502|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
425209|NCT00002502|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
425210|NCT00002502|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
425211|NCT00002502|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
425212|NCT00002502|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
425752|NCT00002545|adult gliosarcoma|adult gliosarcoma
425213|NCT00002502|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
425214|NCT00002502|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
425215|NCT00002502|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
425216|NCT00002502|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
425217|NCT00002502|splenic marginal zone lymphoma|splenic marginal zone lymphoma
425218|NCT00002502|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
425219|NCT00002503|recurrent prostate cancer|recurrent prostate cancer
425221|NCT00002504|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
425222|NCT00002504|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
425223|NCT00002504|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
425224|NCT00002504|isolated plasmacytoma of bone|isolated plasmacytoma of bone
425225|NCT00002504|extramedullary plasmacytoma|extramedullary plasmacytoma
425226|NCT00002504|refractory multiple myeloma|refractory multiple myeloma
425227|NCT00002504|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
425228|NCT00002504|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
425229|NCT00002504|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
425230|NCT00002504|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
425231|NCT00002504|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
425232|NCT00002504|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
425233|NCT00002504|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
425234|NCT00002504|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
425235|NCT00002504|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
425236|NCT00002504|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
425237|NCT00002504|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
425238|NCT00002504|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
425239|NCT00002504|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
425240|NCT00002504|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
425241|NCT00002504|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
425242|NCT00002504|polycythemia vera|polycythemia vera
425243|NCT00002504|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
425244|NCT00002504|essential thrombocythemia|essential thrombocythemia
425245|NCT00002504|untreated hairy cell leukemia|untreated hairy cell leukemia
424601|NCT00002416|HIV-1|hiv-1
425246|NCT00002504|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
425247|NCT00002504|refractory hairy cell leukemia|refractory hairy cell leukemia
425248|NCT00002504|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
425249|NCT00002504|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
425250|NCT00002504|acute undifferentiated leukemia|acute undifferentiated leukemia
425251|NCT00002504|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
425252|NCT00002504|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
425253|NCT00002504|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
425254|NCT00002504|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
425255|NCT00002504|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
425256|NCT00002504|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
425257|NCT00002504|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
425258|NCT00002504|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
425259|NCT00002504|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
425260|NCT00002504|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
425261|NCT00002504|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
425262|NCT00002504|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
425263|NCT00002504|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
425264|NCT00002504|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
425265|NCT00002504|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
425266|NCT00002504|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
425267|NCT00002504|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
425268|NCT00002504|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
425269|NCT00002504|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
425270|NCT00002504|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
425271|NCT00002504|secondary acute myeloid leukemia|secondary acute myeloid leukemia
425272|NCT00002504|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
425273|NCT00002504|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
425274|NCT00002504|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
425276|NCT00002504|primary systemic amyloidosis|primary systemic amyloidosis
425277|NCT00002504|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
425278|NCT00002504|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
425279|NCT00002504|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
425280|NCT00002504|anaplastic large cell lymphoma|anaplastic large cell lymphoma
425281|NCT00002504|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
425282|NCT00002504|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
425283|NCT00002504|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
425284|NCT00002504|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
425285|NCT00002504|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
425286|NCT00002504|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
425287|NCT00002504|splenic marginal zone lymphoma|splenic marginal zone lymphoma
425288|NCT00002505|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
425289|NCT00002506|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
425290|NCT00002506|recurrent esophageal cancer|recurrent esophageal cancer
425291|NCT00002506|recurrent cervical cancer|recurrent cervical cancer
425292|NCT00002506|squamous cell lung cancer|squamous cell lung cancer
425293|NCT00002506|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
425294|NCT00002506|recurrent penile cancer|recurrent penile cancer
425295|NCT00002506|recurrent skin cancer|recurrent skin cancer
425296|NCT00002506|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
425297|NCT00002506|cervical squamous cell carcinoma|cervical squamous cell carcinoma
425298|NCT00002506|penile squamous cell carcinoma|penile squamous cell carcinoma
425299|NCT00002506|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
425300|NCT00002506|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
425301|NCT00002506|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
425302|NCT00002506|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
425303|NCT00002506|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
425304|NCT00002506|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
425305|NCT00002507|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
425306|NCT00002507|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
752845|NCT01174433|Bifurcation coronary artery disease|bifurcation coronary artery disease
424665|NCT00002427|Anti-HIV Agents|anti-hiv agents
425307|NCT00002507|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
425308|NCT00002507|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
425309|NCT00002507|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
425310|NCT00002507|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
425311|NCT00002507|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
425312|NCT00002507|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
425313|NCT00002507|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
425314|NCT00002507|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
425315|NCT00002507|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
425316|NCT00002507|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
425317|NCT00002507|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
425318|NCT00002507|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
425319|NCT00002507|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
425320|NCT00002507|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
425321|NCT00002507|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
425322|NCT00002507|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
425323|NCT00002507|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
425324|NCT00002507|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
425325|NCT00002507|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
425326|NCT00002507|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
425327|NCT00002507|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
425328|NCT00002507|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
425329|NCT00002507|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
425330|NCT00002507|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
425331|NCT00002507|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
425332|NCT00002507|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
425333|NCT00002507|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
425334|NCT00002507|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
425335|NCT00002507|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
425513|NCT00002520|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
425336|NCT00002507|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
425337|NCT00002507|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
425338|NCT00002507|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
425339|NCT00002507|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
425340|NCT00002507|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
425341|NCT00002507|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
425342|NCT00002507|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
425343|NCT00002507|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
425344|NCT00002507|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
425345|NCT00002507|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
425346|NCT00002507|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
425347|NCT00002508|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
425348|NCT00002508|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
425349|NCT00002508|extragonadal germ cell tumor|extragonadal germ cell tumor
425350|NCT00002509|stage II breast cancer|stage ii breast cancer
425351|NCT00002509|stage IV breast cancer|stage iv breast cancer
425352|NCT00002509|stage IIIA breast cancer|stage iiia breast cancer
425353|NCT00002509|recurrent breast cancer|recurrent breast cancer
425354|NCT00002509|stage IIIB breast cancer|stage iiib breast cancer
425355|NCT00002510|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
425356|NCT00002510|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
425357|NCT00002510|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
425358|NCT00002510|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
425359|NCT00002510|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
425360|NCT00002511|adenocarcinoma of the prostate|adenocarcinoma of the prostate
425361|NCT00002511|stage I prostate cancer|stage i prostate cancer
425362|NCT00002511|stage IIB prostate cancer|stage iib prostate cancer
425363|NCT00002511|stage IIA prostate cancer|stage iia prostate cancer
424757|NCT00002452|Indinavir|indinavir
425364|NCT00002511|stage III prostate cancer|stage iii prostate cancer
425365|NCT00002514|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
425367|NCT00002515|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
425368|NCT00002515|stage IV childhood liver cancer|stage iv childhood liver cancer
425369|NCT00002515|recurrent neuroblastoma|recurrent neuroblastoma
425370|NCT00002515|recurrent childhood liver cancer|recurrent childhood liver cancer
425371|NCT00002515|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
425372|NCT00002515|stage IV Wilms tumor|stage iv wilms tumor
425373|NCT00002515|recurrent retinoblastoma|recurrent retinoblastoma
425374|NCT00002515|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
425375|NCT00002515|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
425376|NCT00002515|recurrent osteosarcoma|recurrent osteosarcoma
425377|NCT00002515|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
425378|NCT00002515|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
425379|NCT00002515|childhood germ cell tumor|childhood germ cell tumor
425380|NCT00002515|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
425381|NCT00002515|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
425382|NCT00002515|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
425383|NCT00002515|childhood fibrosarcoma|childhood fibrosarcoma
425384|NCT00002515|extragonadal germ cell tumor|extragonadal germ cell tumor
425385|NCT00002515|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
425386|NCT00002515|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
425387|NCT00002515|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
425388|NCT00002515|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
425389|NCT00002515|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
425390|NCT00002515|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
425391|NCT00002515|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
425392|NCT00002515|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
425393|NCT00002515|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
425394|NCT00002515|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
425395|NCT00002516|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
425396|NCT00002516|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
425397|NCT00002517|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
10290|NCT03225131|Age Related Macular Degeneration|age related macular degeneration
425398|NCT00002517|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
10291|NCT03225131|Dark Adaptation|dark adaptation
441124|NCT00004550|Comorbidity|comorbidity
425399|NCT00002517|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
425400|NCT00002517|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
425401|NCT00002517|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
425402|NCT00002517|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
425403|NCT00002517|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
425404|NCT00002517|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
425405|NCT00002517|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
425406|NCT00002517|refractory anemia with excess blasts|refractory anemia with excess blasts
425407|NCT00002517|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
425408|NCT00002517|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
425409|NCT00002517|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
425410|NCT00002517|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
425411|NCT00002519|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
425412|NCT00002519|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
425413|NCT00002520|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
425414|NCT00002520|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
425415|NCT00002520|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
425416|NCT00002520|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
425417|NCT00002520|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
425418|NCT00002520|stage I colon cancer|stage i colon cancer
425419|NCT00002520|stage II colon cancer|stage ii colon cancer
425420|NCT00002520|stage I breast cancer|stage i breast cancer
425421|NCT00002520|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
425422|NCT00002520|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
425423|NCT00002520|anaplastic large cell lymphoma|anaplastic large cell lymphoma
752846|NCT01174433|Percutaneous coronary intervention|percutaneous coronary intervention
530436|NCT00314275|PCI|pci
425424|NCT00002520|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
425425|NCT00002520|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
425426|NCT00002520|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
425427|NCT00002520|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
425428|NCT00002520|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
425429|NCT00002520|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
425430|NCT00002520|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
425431|NCT00002520|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
425432|NCT00002520|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
425433|NCT00002520|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
425434|NCT00002520|intraocular lymphoma|intraocular lymphoma
425435|NCT00002520|limited stage small cell lung cancer|limited stage small cell lung cancer
425436|NCT00002520|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
425437|NCT00002520|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
584767|NCT00509769|Trastuzumab emtansine|trastuzumab emtansine
425438|NCT00002520|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
425439|NCT00002520|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
425440|NCT00002520|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
425441|NCT00002520|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
425442|NCT00002520|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
425443|NCT00002520|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
425444|NCT00002520|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
425445|NCT00002520|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
425446|NCT00002520|primary central nervous system lymphoma|primary central nervous system lymphoma
425447|NCT00002520|tobacco use disorder|tobacco use disorder
425448|NCT00002520|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
425449|NCT00002520|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
425450|NCT00002520|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
425451|NCT00002520|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
425452|NCT00002520|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
425453|NCT00002520|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
425575|NCT00002521|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
425454|NCT00002520|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
425455|NCT00002520|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
425456|NCT00002520|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
425457|NCT00002520|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
425458|NCT00002520|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
425459|NCT00002520|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
425460|NCT00002520|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
425461|NCT00002520|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
425462|NCT00002520|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
425463|NCT00002520|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
425464|NCT00002520|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
425465|NCT00002520|stage I mantle cell lymphoma|stage i mantle cell lymphoma
425466|NCT00002520|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
425467|NCT00002520|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
425468|NCT00002520|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
425469|NCT00002520|stage I non-small cell lung cancer|stage i non-small cell lung cancer
425470|NCT00002520|stage I prostate cancer|stage i prostate cancer
425471|NCT00002520|stage I rectal cancer|stage i rectal cancer
425472|NCT00002520|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
425473|NCT00002520|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
425474|NCT00002520|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
425475|NCT00002520|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
425476|NCT00002520|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
752415|NCT01172912|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
425477|NCT00002520|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
425478|NCT00002520|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
425479|NCT00002520|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
425480|NCT00002520|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
425481|NCT00002520|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
425482|NCT00002520|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
425483|NCT00002520|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
425484|NCT00002520|stage II bladder cancer|stage ii bladder cancer
425485|NCT00002520|stage II breast cancer|stage ii breast cancer
425486|NCT00002520|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
425487|NCT00002520|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
425488|NCT00002520|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
425489|NCT00002520|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
425490|NCT00002520|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
425491|NCT00002520|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
425492|NCT00002520|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
425493|NCT00002520|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
425494|NCT00002520|stage I bladder cancer|stage i bladder cancer
425495|NCT00002520|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
425496|NCT00002520|stage II prostate cancer|stage ii prostate cancer
425497|NCT00002520|stage II rectal cancer|stage ii rectal cancer
425498|NCT00002520|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
425499|NCT00002520|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
425500|NCT00002520|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
425501|NCT00002520|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
425502|NCT00002520|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
425503|NCT00002520|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
425504|NCT00002520|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
425505|NCT00002520|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
425506|NCT00002520|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
425507|NCT00002520|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
425508|NCT00002520|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
425509|NCT00002520|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
425510|NCT00002520|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
425511|NCT00002520|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
425576|NCT00002521|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
425512|NCT00002520|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
425753|NCT00002546|stage I uterine sarcoma|stage i uterine sarcoma
425514|NCT00002520|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
425515|NCT00002520|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
425516|NCT00002520|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
425517|NCT00002520|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
425518|NCT00002520|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
425519|NCT00002520|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
425520|NCT00002520|stage III prostate cancer|stage iii prostate cancer
425521|NCT00002520|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
425522|NCT00002520|stage IIIA breast cancer|stage iiia breast cancer
425523|NCT00002520|stage IIIB breast cancer|stage iiib breast cancer
425524|NCT00002520|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
425525|NCT00002520|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
425526|NCT00002520|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
425527|NCT00002520|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
425528|NCT00002520|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
425529|NCT00002520|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
425530|NCT00002520|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
425531|NCT00002520|stage IV breast cancer|stage iv breast cancer
425532|NCT00002520|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
425533|NCT00002520|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
425534|NCT00002520|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
425535|NCT00002520|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
425536|NCT00002520|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
425537|NCT00002520|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
425538|NCT00002520|stage IV prostate cancer|stage iv prostate cancer
425539|NCT00002520|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
425540|NCT00002520|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
425541|NCT00002520|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
425542|NCT00002520|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
425543|NCT00002520|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
425544|NCT00002520|stage I marginal zone lymphoma|stage i marginal zone lymphoma
425545|NCT00002520|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
425546|NCT00002520|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
425547|NCT00002520|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
425548|NCT00002520|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
425549|NCT00002520|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
425550|NCT00002520|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
425551|NCT00002520|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
425552|NCT00002520|splenic marginal zone lymphoma|splenic marginal zone lymphoma
425553|NCT00002521|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
425554|NCT00002521|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
425555|NCT00002521|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
425556|NCT00002521|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
425557|NCT00002521|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
425558|NCT00002521|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
425559|NCT00002521|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
425560|NCT00002521|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
425561|NCT00002521|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
425562|NCT00002521|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
425563|NCT00002521|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
425564|NCT00002521|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
425565|NCT00002521|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
425566|NCT00002521|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
425567|NCT00002521|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
425568|NCT00002521|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
425569|NCT00002521|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
425570|NCT00002521|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
425571|NCT00002521|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
425572|NCT00002521|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
425573|NCT00002521|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
425574|NCT00002521|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
425577|NCT00002521|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
10292|NCT03225118|Rebound|rebound
425754|NCT00002546|stage II uterine sarcoma|stage ii uterine sarcoma
425578|NCT00002521|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
425579|NCT00002521|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
425580|NCT00002521|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
425581|NCT00002521|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
425582|NCT00002521|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
425583|NCT00002521|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
425584|NCT00002521|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
425585|NCT00002521|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
425586|NCT00002521|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
425587|NCT00002521|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
425588|NCT00002521|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
425589|NCT00002522|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
425590|NCT00002522|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
425591|NCT00002522|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
425592|NCT00002522|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
425593|NCT00002522|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
530817|NCT00315705|ALL|all
425594|NCT00002523|stage II rectal cancer|stage ii rectal cancer
425595|NCT00002523|stage III rectal cancer|stage iii rectal cancer
425596|NCT00002523|adenocarcinoma of the rectum|adenocarcinoma of the rectum
425597|NCT00002524|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
425598|NCT00002524|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
425599|NCT00002524|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
425600|NCT00002524|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
425601|NCT00002524|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
425602|NCT00002524|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
425603|NCT00002524|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
425604|NCT00002525|stage II colon cancer|stage ii colon cancer
425605|NCT00002525|stage III colon cancer|stage iii colon cancer
425606|NCT00002526|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
425607|NCT00002526|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
425608|NCT00002526|stage III uterine sarcoma|stage iii uterine sarcoma
425609|NCT00002526|stage IV uterine sarcoma|stage iv uterine sarcoma
425610|NCT00002526|recurrent uterine sarcoma|recurrent uterine sarcoma
425611|NCT00002526|ovarian sarcoma|ovarian sarcoma
425612|NCT00002526|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
425613|NCT00002527|colon cancer|colon cancer
425614|NCT00002527|rectal cancer|rectal cancer
425615|NCT00002528|stage I breast cancer|stage i breast cancer
425616|NCT00002528|stage II breast cancer|stage ii breast cancer
425617|NCT00002529|stage II breast cancer|stage ii breast cancer
425618|NCT00002529|stage IIIA breast cancer|stage iiia breast cancer
425619|NCT00002531|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
425620|NCT00002531|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
425621|NCT00002531|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
425622|NCT00002531|non-T, non-B adult acute lymphoblastic leukemia|non-t, non-b adult acute lymphoblastic leukemia
425623|NCT00002532|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
425624|NCT00002533|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
425625|NCT00002533|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
425626|NCT00002533|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
425627|NCT00002533|oral complications|oral complications
425628|NCT00002533|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
425629|NCT00002533|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
425630|NCT00002533|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
425631|NCT00002533|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
425632|NCT00002533|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
425633|NCT00002533|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
425634|NCT00002533|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
425635|NCT00002533|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
425636|NCT00002533|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
425637|NCT00002533|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
425638|NCT00002533|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
425755|NCT00002546|stage III uterine sarcoma|stage iii uterine sarcoma
10293|NCT03225118|Reinitiation|reinitiation
425639|NCT00002533|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
425640|NCT00002533|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
425641|NCT00002533|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
425642|NCT00002533|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
425643|NCT00002533|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
425644|NCT00002533|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
425645|NCT00002533|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
425646|NCT00002533|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
425647|NCT00002533|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
425648|NCT00002533|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
425649|NCT00002533|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
425650|NCT00002533|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
425651|NCT00002533|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
752847|NCT01174433|Tryton Stent|tryton stent
425652|NCT00002533|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
425653|NCT00002533|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
425654|NCT00002533|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
425655|NCT00002533|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
425656|NCT00002533|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
425657|NCT00002533|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
425658|NCT00002533|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
425659|NCT00002533|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
425660|NCT00002533|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
425661|NCT00002533|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
425662|NCT00002533|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
425663|NCT00002533|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
425664|NCT00002533|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
425665|NCT00002533|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
425666|NCT00002533|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
425667|NCT00002533|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
584769|NCT00509769|Breast cancer|breast cancer
425668|NCT00002533|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
425669|NCT00002533|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
425670|NCT00002533|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
425671|NCT00002533|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
425672|NCT00002533|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
425673|NCT00002533|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
425674|NCT00002533|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
425675|NCT00002533|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
425676|NCT00002533|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
425677|NCT00002533|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
425678|NCT00002533|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
425679|NCT00002533|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
425680|NCT00002533|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
425681|NCT00002533|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
425682|NCT00002533|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
425683|NCT00002533|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
425684|NCT00002533|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
425685|NCT00002533|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
425686|NCT00002533|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
425687|NCT00002533|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
425688|NCT00002533|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
425689|NCT00002533|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
425690|NCT00002533|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
425691|NCT00002533|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
425751|NCT00002545|adult giant cell glioblastoma|adult giant cell glioblastoma
425692|NCT00002533|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
425693|NCT00002533|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
425694|NCT00002533|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
425695|NCT00002533|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
425696|NCT00002533|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
425697|NCT00002533|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
425698|NCT00002533|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
425699|NCT00002533|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
425700|NCT00002533|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
752416|NCT01172912|testicular immature teratoma|testicular immature teratoma
441512|NCT00005764|HIV-1|hiv-1
425701|NCT00002533|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
425702|NCT00002533|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
425703|NCT00002533|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
425704|NCT00002533|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
425705|NCT00002533|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
425706|NCT00002533|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
425707|NCT00002533|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
425708|NCT00002533|infection|infection
425709|NCT00002534|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
425710|NCT00002534|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
425711|NCT00002534|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
425712|NCT00002534|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
425713|NCT00002534|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
425714|NCT00002534|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
425715|NCT00002534|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
425716|NCT00002534|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
425717|NCT00002534|acute undifferentiated leukemia|acute undifferentiated leukemia
425718|NCT00002535|stage III melanoma|stage iii melanoma
425719|NCT00002535|stage IV melanoma|stage iv melanoma
425720|NCT00002535|recurrent melanoma|recurrent melanoma
425721|NCT00002536|stage IB cervical cancer|stage ib cervical cancer
425722|NCT00002537|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
425723|NCT00002537|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
425724|NCT00002537|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
425725|NCT00002537|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
425726|NCT00002538|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
425727|NCT00002538|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
425728|NCT00002538|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
425729|NCT00002538|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
425730|NCT00002538|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
425731|NCT00002538|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
425732|NCT00002538|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
425733|NCT00002538|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
425734|NCT00002538|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
425735|NCT00002538|fallopian tube cancer|fallopian tube cancer
425736|NCT00002538|primary peritoneal cavity cancer|primary peritoneal cavity cancer
425737|NCT00002539|localized osteosarcoma|localized osteosarcoma
425738|NCT00002542|stage I breast cancer|stage i breast cancer
425739|NCT00002542|stage II breast cancer|stage ii breast cancer
425740|NCT00002542|stage IIIA breast cancer|stage iiia breast cancer
425741|NCT00002543|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
425742|NCT00002543|recurrent childhood brain tumor|recurrent childhood brain tumor
425743|NCT00002543|recurrent neuroblastoma|recurrent neuroblastoma
425744|NCT00002543|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
425745|NCT00002543|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
425746|NCT00002543|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
425747|NCT00002543|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
425748|NCT00002544|stage IV breast cancer|stage iv breast cancer
425749|NCT00002544|recurrent breast cancer|recurrent breast cancer
425750|NCT00002545|adult glioblastoma|adult glioblastoma
425758|NCT00002547|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
425759|NCT00002547|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
425760|NCT00002547|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
425761|NCT00002547|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
425762|NCT00002547|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
425763|NCT00002547|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
425764|NCT00002547|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
425765|NCT00002547|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
200958|NCT02112812|Parkinsons disease|parkinsons disease
425766|NCT00002547|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
425767|NCT00002547|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
425768|NCT00002547|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
425769|NCT00002547|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
425770|NCT00002547|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
425771|NCT00002547|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
425772|NCT00002547|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
425773|NCT00002547|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
425774|NCT00002547|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
425775|NCT00002547|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
425776|NCT00002547|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
425777|NCT00002547|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
425778|NCT00002547|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
425779|NCT00002547|refractory anemia with excess blasts|refractory anemia with excess blasts
425780|NCT00002547|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
425781|NCT00002547|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
425782|NCT00002547|secondary acute myeloid leukemia|secondary acute myeloid leukemia
425783|NCT00002547|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
425784|NCT00002547|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
425785|NCT00002547|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
425786|NCT00002548|stage I multiple myeloma|stage i multiple myeloma
425787|NCT00002548|stage II multiple myeloma|stage ii multiple myeloma
425788|NCT00002548|stage III multiple myeloma|stage iii multiple myeloma
425789|NCT00002549|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
425790|NCT00002549|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
425791|NCT00002549|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
425792|NCT00002549|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
425793|NCT00002549|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
425794|NCT00002549|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
425795|NCT00002549|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
425796|NCT00002549|secondary acute myeloid leukemia|secondary acute myeloid leukemia
425797|NCT00002549|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
425798|NCT00002550|squamous cell lung cancer|squamous cell lung cancer
425800|NCT00002550|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
425801|NCT00002550|adenocarcinoma of the lung|adenocarcinoma of the lung
425802|NCT00002550|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
425803|NCT00002551|stage II rectal cancer|stage ii rectal cancer
425804|NCT00002551|stage III rectal cancer|stage iii rectal cancer
425805|NCT00002551|adenocarcinoma of the rectum|adenocarcinoma of the rectum
425806|NCT00002552|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
425807|NCT00002552|refractory multiple myeloma|refractory multiple myeloma
425808|NCT00002552|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
425809|NCT00002552|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
425810|NCT00002552|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
425811|NCT00002552|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
425812|NCT00002552|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
425813|NCT00002552|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
425814|NCT00002552|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
425815|NCT00002552|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
425816|NCT00002552|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
425817|NCT00002552|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
425818|NCT00002552|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
425819|NCT00002552|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
425820|NCT00002552|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
10294|NCT03225118|ART|art
425821|NCT00002552|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
425822|NCT00002552|splenic marginal zone lymphoma|splenic marginal zone lymphoma
425823|NCT00002552|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
425824|NCT00002552|childhood unfavorable prognosis Hodgkin lymphoma|childhood unfavorable prognosis hodgkin lymphoma
425825|NCT00002553|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
425826|NCT00002553|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
425827|NCT00002553|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
425275|NCT00002504|prolymphocytic leukemia|prolymphocytic leukemia
425828|NCT00002553|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
425829|NCT00002553|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
425830|NCT00002553|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
425831|NCT00002553|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
425832|NCT00002553|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
425833|NCT00002553|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
425834|NCT00002553|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
425835|NCT00002553|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
425836|NCT00002553|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
425837|NCT00002553|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
425838|NCT00002553|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
425839|NCT00002553|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
425840|NCT00002553|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
425841|NCT00002553|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
425842|NCT00002553|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
425843|NCT00002553|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
425844|NCT00002553|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
425845|NCT00002553|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
425846|NCT00002553|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
532557|NCT00332878|HIV|hiv
425847|NCT00002553|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
425848|NCT00002553|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
425849|NCT00002553|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
425850|NCT00002553|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
425851|NCT00002553|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
425852|NCT00002553|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
425853|NCT00002553|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
425854|NCT00002553|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
425855|NCT00002553|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
425856|NCT00002553|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
425857|NCT00002553|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
425858|NCT00002553|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
425859|NCT00002553|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
425860|NCT00002553|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
425861|NCT00002553|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
425862|NCT00002553|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
425863|NCT00002553|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
425864|NCT00002553|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
425865|NCT00002553|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
425866|NCT00002553|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
425867|NCT00002553|splenic marginal zone lymphoma|splenic marginal zone lymphoma
425868|NCT00002554|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
425869|NCT00002554|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
425870|NCT00002555|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
425871|NCT00002555|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
425872|NCT00002555|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
425873|NCT00002555|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
425874|NCT00002555|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
425875|NCT00002555|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
425876|NCT00002555|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
425877|NCT00002555|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
425878|NCT00002557|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
425879|NCT00002557|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
425880|NCT00002557|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
425881|NCT00002558|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
425882|NCT00002558|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
425883|NCT00002558|extragonadal germ cell tumor|extragonadal germ cell tumor
752417|NCT01172925|NSCLC|nsclc
425366|NCT00002515|chondrosarcoma|chondrosarcoma
425884|NCT00002559|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
425885|NCT00002559|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
425886|NCT00002560|recurrent neuroblastoma|recurrent neuroblastoma
425887|NCT00002561|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
425888|NCT00002561|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
425889|NCT00002561|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
425890|NCT00002561|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
425891|NCT00002561|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
425892|NCT00002561|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
425893|NCT00002562|recurrent cervical cancer|recurrent cervical cancer
425894|NCT00002562|recurrent vaginal cancer|recurrent vaginal cancer
425895|NCT00002562|vaginal clear cell adenocarcinoma|vaginal clear cell adenocarcinoma
425896|NCT00002562|cervical adenocarcinoma|cervical adenocarcinoma
425897|NCT00002563|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
425898|NCT00002563|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
425899|NCT00002563|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
425900|NCT00002564|recurrent breast cancer|recurrent breast cancer
425901|NCT00002565|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
425902|NCT00002565|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
425903|NCT00002565|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
425904|NCT00002565|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
425905|NCT00002565|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
425906|NCT00002565|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
425907|NCT00002565|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
425908|NCT00002565|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
425909|NCT00002565|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
425910|NCT00002565|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
425911|NCT00002565|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
425912|NCT00002565|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
425913|NCT00002565|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
425914|NCT00002565|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
425915|NCT00002565|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
425916|NCT00002565|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
425917|NCT00002565|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
425918|NCT00002565|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
425919|NCT00002565|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
425920|NCT00002565|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
425921|NCT00002565|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
425922|NCT00002565|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
425923|NCT00002565|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
427021|NCT00001685|Immunotherapy|immunotherapy
425924|NCT00002565|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
425925|NCT00002566|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
425926|NCT00002566|extragonadal germ cell tumor|extragonadal germ cell tumor
425927|NCT00002567|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
425928|NCT00002567|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
425929|NCT00002567|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
425930|NCT00002567|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
425931|NCT00002567|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
425932|NCT00002567|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
425933|NCT00002567|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
425934|NCT00002567|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
425935|NCT00002567|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
425936|NCT00002567|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
425937|NCT00002567|bone marrow ablation|bone marrow ablation
425938|NCT00002567|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
425939|NCT00002568|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
425940|NCT00002568|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
425941|NCT00002568|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
752418|NCT01172925|dyspnea|dyspnea
425942|NCT00002568|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
425943|NCT00002568|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
425944|NCT00002568|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
425945|NCT00002568|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
425946|NCT00002568|Brenner tumor|brenner tumor
425947|NCT00002569|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
425948|NCT00002569|adult mixed glioma|adult mixed glioma
425949|NCT00002570|stage III colon cancer|stage iii colon cancer
425950|NCT00002570|stage IV colon cancer|stage iv colon cancer
425951|NCT00002570|stage III rectal cancer|stage iii rectal cancer
425952|NCT00002570|stage IV rectal cancer|stage iv rectal cancer
425953|NCT00002570|recurrent colon cancer|recurrent colon cancer
425954|NCT00002570|recurrent rectal cancer|recurrent rectal cancer
425955|NCT00002571|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
425956|NCT00002571|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
425957|NCT00002571|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
425958|NCT00002571|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
425959|NCT00002571|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
425960|NCT00002571|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
425961|NCT00002572|recurrent adult brain tumor|recurrent adult brain tumor
425962|NCT00002572|adult glioblastoma|adult glioblastoma
425963|NCT00002572|adult anaplastic astrocytoma|adult anaplastic astrocytoma
425964|NCT00002572|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
425965|NCT00002572|adult mixed glioma|adult mixed glioma
425966|NCT00002572|adult giant cell glioblastoma|adult giant cell glioblastoma
425967|NCT00002572|adult gliosarcoma|adult gliosarcoma
425968|NCT00002574|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
584770|NCT00509769|HER2-positive breast cancer|her2-positive breast cancer
425969|NCT00002574|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
425970|NCT00002575|stage I colon cancer|stage i colon cancer
425971|NCT00002575|stage II colon cancer|stage ii colon cancer
425972|NCT00002575|stage III colon cancer|stage iii colon cancer
425973|NCT00002575|adenocarcinoma of the colon|adenocarcinoma of the colon
425974|NCT00002576|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
425975|NCT00002576|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
425976|NCT00002576|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
425977|NCT00002576|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
425978|NCT00002576|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
425979|NCT00002576|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
425980|NCT00002576|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
425981|NCT00002576|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
425982|NCT00002576|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
425983|NCT00002576|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
425984|NCT00002576|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
425985|NCT00002576|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
425986|NCT00002576|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
425987|NCT00002576|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
425988|NCT00002576|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
425989|NCT00002576|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
425990|NCT00002576|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
425991|NCT00002576|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
425992|NCT00002576|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
425993|NCT00002576|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
425994|NCT00002576|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
425995|NCT00002576|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
425996|NCT00002576|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
425997|NCT00002576|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
425998|NCT00002576|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
425999|NCT00002576|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
426000|NCT00002576|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
426001|NCT00002576|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
426002|NCT00002576|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
426003|NCT00002576|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
426004|NCT00002577|stage I non-small cell lung cancer|stage i non-small cell lung cancer
426005|NCT00002577|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
426421|NCT00002647|adult pilocytic astrocytoma|adult pilocytic astrocytoma
426006|NCT00002577|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
426007|NCT00002577|squamous cell lung cancer|squamous cell lung cancer
426008|NCT00002577|large cell lung cancer|large cell lung cancer
426009|NCT00002577|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
426010|NCT00002577|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
426011|NCT00002577|adenocarcinoma of the lung|adenocarcinoma of the lung
426012|NCT00002578|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
426013|NCT00002578|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
426014|NCT00002578|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
426015|NCT00002578|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
426016|NCT00002578|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
426017|NCT00002578|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
426018|NCT00002578|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
426019|NCT00002579|stage I breast cancer|stage i breast cancer
426020|NCT00002579|stage II breast cancer|stage ii breast cancer
426021|NCT00002579|stage IIIA breast cancer|stage iiia breast cancer
426022|NCT00002580|stage I breast cancer|stage i breast cancer
426023|NCT00002580|stage II breast cancer|stage ii breast cancer
426024|NCT00002580|stage IIIA breast cancer|stage iiia breast cancer
426025|NCT00002581|stage I breast cancer|stage i breast cancer
426026|NCT00002581|stage II breast cancer|stage ii breast cancer
426027|NCT00002581|stage IIIA breast cancer|stage iiia breast cancer
426028|NCT00002582|stage I breast cancer|stage i breast cancer
426029|NCT00002582|stage II breast cancer|stage ii breast cancer
426030|NCT00002582|stage IIIA breast cancer|stage iiia breast cancer
426031|NCT00002583|stage I non-small cell lung cancer|stage i non-small cell lung cancer
426032|NCT00002583|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
426033|NCT00002585|stage IV breast cancer|stage iv breast cancer
426034|NCT00002585|recurrent breast cancer|recurrent breast cancer
426035|NCT00002586|non-small cell lung cancer|non-small cell lung cancer
426036|NCT00002586|small cell lung cancer|small cell lung cancer
426037|NCT00002586|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
426038|NCT00002587|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
426039|NCT00002588|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
426040|NCT00002588|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
426041|NCT00002588|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
426042|NCT00002588|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
426043|NCT00002588|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
426044|NCT00002588|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
426045|NCT00002588|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
426046|NCT00002588|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
426047|NCT00002588|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
426048|NCT00002588|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
426049|NCT00002588|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
426050|NCT00002588|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
426051|NCT00002588|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
426052|NCT00002588|secondary acute myeloid leukemia|secondary acute myeloid leukemia
426053|NCT00002588|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
426054|NCT00002588|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
426055|NCT00002589|stage III renal cell cancer|stage iii renal cell cancer
426056|NCT00002589|stage IV renal cell cancer|stage iv renal cell cancer
426057|NCT00002589|recurrent renal cell cancer|recurrent renal cell cancer
426058|NCT00002590|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
426059|NCT00002590|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
426060|NCT00002592|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
426061|NCT00002592|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
426062|NCT00002592|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
426063|NCT00002593|stage II colon cancer|stage ii colon cancer
426064|NCT00002593|stage III colon cancer|stage iii colon cancer
426065|NCT00002594|recurrent childhood brain tumor|recurrent childhood brain tumor
426066|NCT00002594|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
426067|NCT00002594|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
426068|NCT00002595|desmoid tumor|desmoid tumor
426069|NCT00002596|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
426070|NCT00002596|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
426071|NCT00002596|testicular seminoma|testicular seminoma
426072|NCT00002596|testicular embryonal carcinoma|testicular embryonal carcinoma
426073|NCT00002596|testicular choriocarcinoma|testicular choriocarcinoma
426074|NCT00002596|testicular teratoma|testicular teratoma
426075|NCT00002596|testicular yolk sac tumor|testicular yolk sac tumor
426733|NCT00002673|stage II multiple myeloma|stage ii multiple myeloma
426076|NCT00002596|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
10295|NCT03225118|Reservoirs|reservoirs
426077|NCT00002596|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
426078|NCT00002596|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
426079|NCT00002596|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
426080|NCT00002596|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
426081|NCT00002596|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
426082|NCT00002596|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
426083|NCT00002596|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
426084|NCT00002596|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
426085|NCT00002596|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
426086|NCT00002596|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
426087|NCT00002596|extragonadal germ cell tumor|extragonadal germ cell tumor
426088|NCT00002596|childhood teratoma|childhood teratoma
426089|NCT00002596|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
426090|NCT00002596|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
426091|NCT00002597|adenocarcinoma of the prostate|adenocarcinoma of the prostate
426092|NCT00002597|stage I prostate cancer|stage i prostate cancer
426093|NCT00002597|stage IIB prostate cancer|stage iib prostate cancer
426094|NCT00002597|stage IIA prostate cancer|stage iia prostate cancer
426095|NCT00002598|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
426096|NCT00002598|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
426097|NCT00002598|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
426098|NCT00002599|stage I multiple myeloma|stage i multiple myeloma
426099|NCT00002599|stage II multiple myeloma|stage ii multiple myeloma
426100|NCT00002599|stage III multiple myeloma|stage iii multiple myeloma
426101|NCT00002600|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
426102|NCT00002600|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
426103|NCT00002600|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
426104|NCT00002600|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
426105|NCT00002600|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
426106|NCT00002600|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
426107|NCT00002600|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
426108|NCT00002600|fallopian tube cancer|fallopian tube cancer
426109|NCT00002600|primary peritoneal cavity cancer|primary peritoneal cavity cancer
426110|NCT00002601|metastatic osteosarcoma|metastatic osteosarcoma
426111|NCT00002601|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
426112|NCT00002601|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
426113|NCT00002601|recurrent osteosarcoma|recurrent osteosarcoma
426114|NCT00002601|adult rhabdomyosarcoma|adult rhabdomyosarcoma
426115|NCT00002601|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
426116|NCT00002601|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
426117|NCT00002601|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
426118|NCT00002601|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
426119|NCT00002601|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
426120|NCT00002601|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
426121|NCT00002602|adenocarcinoma of the prostate|adenocarcinoma of the prostate
426122|NCT00002602|stage IIB prostate cancer|stage iib prostate cancer
426123|NCT00002602|stage IIA prostate cancer|stage iia prostate cancer
426124|NCT00002602|stage III prostate cancer|stage iii prostate cancer
426125|NCT00002604|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
426126|NCT00002608|childhood brain tumor|childhood brain tumor
426127|NCT00002608|childhood infratentorial ependymoma|childhood infratentorial ependymoma
426128|NCT00002608|childhood supratentorial ependymoma|childhood supratentorial ependymoma
426129|NCT00002608|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
426130|NCT00002608|recurrent childhood brain tumor|recurrent childhood brain tumor
426131|NCT00002608|childhood liver cancer|childhood liver cancer
426132|NCT00002608|stage IV childhood liver cancer|stage iv childhood liver cancer
426133|NCT00002608|recurrent childhood liver cancer|recurrent childhood liver cancer
426134|NCT00002608|advanced malignant mesothelioma|advanced malignant mesothelioma
426135|NCT00002608|recurrent malignant mesothelioma|recurrent malignant mesothelioma
426136|NCT00002608|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
426137|NCT00002608|advanced adult primary liver cancer|advanced adult primary liver cancer
426138|NCT00002608|recurrent adult primary liver cancer|recurrent adult primary liver cancer
441513|NCT00005764|Zalcitabine|zalcitabine
426139|NCT00002608|recurrent adult brain tumor|recurrent adult brain tumor
426140|NCT00002608|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
426141|NCT00002608|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
426734|NCT00002673|stage III multiple myeloma|stage iii multiple myeloma
426142|NCT00002608|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
426143|NCT00002608|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
426144|NCT00002608|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
426145|NCT00002608|anaplastic thyroid cancer|anaplastic thyroid cancer
426146|NCT00002608|recurrent thyroid cancer|recurrent thyroid cancer
426147|NCT00002608|adult brain stem glioma|adult brain stem glioma
426148|NCT00002608|adult medulloblastoma|adult medulloblastoma
426149|NCT00002608|adult glioblastoma|adult glioblastoma
426150|NCT00002608|metastatic pheochromocytoma|metastatic pheochromocytoma
426151|NCT00002608|recurrent pheochromocytoma|recurrent pheochromocytoma
426152|NCT00002608|childhood soft tissue sarcoma|childhood soft tissue sarcoma
426153|NCT00002608|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
426154|NCT00002608|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
426155|NCT00002608|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
426156|NCT00002608|childhood oligodendroglioma|childhood oligodendroglioma
426157|NCT00002608|adult anaplastic astrocytoma|adult anaplastic astrocytoma
426158|NCT00002608|adult myxopapillary ependymoma|adult myxopapillary ependymoma
426159|NCT00002608|adult anaplastic ependymoma|adult anaplastic ependymoma
426160|NCT00002608|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
426161|NCT00002608|adult mixed glioma|adult mixed glioma
426162|NCT00002608|adult pilocytic astrocytoma|adult pilocytic astrocytoma
426163|NCT00002608|adult subependymoma|adult subependymoma
426164|NCT00002608|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
426165|NCT00002608|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
426166|NCT00002608|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
426167|NCT00002608|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
426168|NCT00002608|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
426169|NCT00002608|recurrent childhood ependymoma|recurrent childhood ependymoma
426170|NCT00002608|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
426171|NCT00002608|adult oligodendroglioma|adult oligodendroglioma
426172|NCT00002608|adult giant cell glioblastoma|adult giant cell glioblastoma
426173|NCT00002608|adult gliosarcoma|adult gliosarcoma
426174|NCT00002608|adult diffuse astrocytoma|adult diffuse astrocytoma
426175|NCT00002609|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
426176|NCT00002609|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
426177|NCT00002609|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
426178|NCT00002609|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
426179|NCT00002610|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
426180|NCT00002610|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
426181|NCT00002610|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
426182|NCT00002611|stage I Wilms tumor|stage i wilms tumor
426183|NCT00002611|stage II Wilms tumor|stage ii wilms tumor
426184|NCT00002611|stage III Wilms tumor|stage iii wilms tumor
426185|NCT00002611|stage IV Wilms tumor|stage iv wilms tumor
426186|NCT00002611|stage V Wilms tumor|stage v wilms tumor
426187|NCT00002611|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
426188|NCT00002615|stage II gastric cancer|stage ii gastric cancer
426189|NCT00002615|stage III gastric cancer|stage iii gastric cancer
426190|NCT00002615|adenocarcinoma of the stomach|adenocarcinoma of the stomach
426191|NCT00002616|stage IV breast cancer|stage iv breast cancer
426192|NCT00002616|recurrent breast cancer|recurrent breast cancer
426193|NCT00002616|stage IIIB breast cancer|stage iiib breast cancer
426194|NCT00002616|inflammatory breast cancer|inflammatory breast cancer
426195|NCT00002618|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
426196|NCT00002618|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
426197|NCT00002618|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
426198|NCT00002618|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
426199|NCT00002618|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
426200|NCT00002618|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
426201|NCT00002618|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
426202|NCT00002618|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
426203|NCT00002619|adult brain stem glioma|adult brain stem glioma
426204|NCT00002619|adult glioblastoma|adult glioblastoma
426205|NCT00002619|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
426206|NCT00002619|untreated childhood brain stem glioma|untreated childhood brain stem glioma
426207|NCT00002619|adult giant cell glioblastoma|adult giant cell glioblastoma
426208|NCT00002619|adult gliosarcoma|adult gliosarcoma
752419|NCT01172925|phase II|phase ii
532067|NCT00330564|VHL|vhl
426209|NCT00002620|adult anaplastic astrocytoma|adult anaplastic astrocytoma
426210|NCT00002621|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
426211|NCT00002621|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
426212|NCT00002621|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
426979|NCT00001676|Renal Function|renal function
426213|NCT00002621|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
426214|NCT00002621|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
426215|NCT00002621|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
426216|NCT00002621|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
426217|NCT00002621|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
426218|NCT00002621|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
426219|NCT00002621|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
426220|NCT00002621|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
426221|NCT00002621|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
426222|NCT00002621|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
426223|NCT00002621|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
426224|NCT00002621|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
426225|NCT00002621|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
426226|NCT00002621|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
426227|NCT00002621|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
426228|NCT00002621|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
426229|NCT00002621|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
426230|NCT00002621|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
426231|NCT00002621|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
426232|NCT00002621|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
426233|NCT00002621|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
426234|NCT00002622|malignant pleural effusion|malignant pleural effusion
426235|NCT00002623|squamous cell lung cancer|squamous cell lung cancer
426236|NCT00002623|large cell lung cancer|large cell lung cancer
426237|NCT00002623|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
426238|NCT00002623|adenocarcinoma of the lung|adenocarcinoma of the lung
426239|NCT00002623|adenosquamous cell lung cancer|adenosquamous cell lung cancer
426240|NCT00002623|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
426241|NCT00002624|stage I non-small cell lung cancer|stage i non-small cell lung cancer
426242|NCT00002624|squamous cell lung cancer|squamous cell lung cancer
426243|NCT00002624|large cell lung cancer|large cell lung cancer
426244|NCT00002624|adenocarcinoma of the lung|adenocarcinoma of the lung
426245|NCT00002624|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
426246|NCT00002625|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
426247|NCT00002625|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
426248|NCT00002625|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
426249|NCT00002625|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
426250|NCT00002625|recurrent esophageal cancer|recurrent esophageal cancer
426251|NCT00002625|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
426252|NCT00002625|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
426253|NCT00002625|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
426254|NCT00002625|recurrent small cell lung cancer|recurrent small cell lung cancer
426255|NCT00002625|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
426256|NCT00002625|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
426257|NCT00002625|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
426258|NCT00002625|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
426259|NCT00002625|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
426260|NCT00002625|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
426261|NCT00002625|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
426262|NCT00002625|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
426263|NCT00002625|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
426264|NCT00002625|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
426265|NCT00002625|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
426266|NCT00002625|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
426267|NCT00002625|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
426268|NCT00002625|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
426269|NCT00002625|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
426270|NCT00002625|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
426271|NCT00002625|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
426272|NCT00002625|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
426273|NCT00002625|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
426274|NCT00002625|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
426275|NCT00002625|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
426276|NCT00002625|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
426277|NCT00002625|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
426278|NCT00002625|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
426279|NCT00002625|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
426280|NCT00002625|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
426281|NCT00002625|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
426282|NCT00002625|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
426358|NCT00002641|uterine leiomyosarcoma|uterine leiomyosarcoma
426283|NCT00002625|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
426284|NCT00002625|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
426285|NCT00002625|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
426286|NCT00002625|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
426287|NCT00002625|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
426288|NCT00002625|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
426289|NCT00002625|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
426290|NCT00002625|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
426291|NCT00002625|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
426292|NCT00002625|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
426293|NCT00002625|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
426294|NCT00002625|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
426295|NCT00002625|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
584771|NCT00509769|HER2|her2
426296|NCT00002625|splenic marginal zone lymphoma|splenic marginal zone lymphoma
426297|NCT00002627|stage II breast cancer|stage ii breast cancer
426298|NCT00002627|stage IIIA breast cancer|stage iiia breast cancer
426299|NCT00002627|stage IIIB breast cancer|stage iiib breast cancer
426300|NCT00002627|inflammatory breast cancer|inflammatory breast cancer
426301|NCT00002628|stage IV breast cancer|stage iv breast cancer
426302|NCT00002628|recurrent breast cancer|recurrent breast cancer
426303|NCT00002630|refractory multiple myeloma|refractory multiple myeloma
426304|NCT00002630|stage II multiple myeloma|stage ii multiple myeloma
426305|NCT00002630|stage III multiple myeloma|stage iii multiple myeloma
426306|NCT00002631|stage I esophageal cancer|stage i esophageal cancer
426307|NCT00002631|stage II esophageal cancer|stage ii esophageal cancer
426308|NCT00002631|stage III esophageal cancer|stage iii esophageal cancer
426309|NCT00002631|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
426310|NCT00002631|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
426311|NCT00002632|stage IV salivary gland cancer|stage iv salivary gland cancer
426312|NCT00002632|recurrent salivary gland cancer|recurrent salivary gland cancer
426313|NCT00002632|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
426314|NCT00002632|salivary gland adenocarcinoma|salivary gland adenocarcinoma
426315|NCT00002633|adenocarcinoma of the prostate|adenocarcinoma of the prostate
426316|NCT00002633|stage II prostate cancer|stage ii prostate cancer
426317|NCT00002633|stage III prostate cancer|stage iii prostate cancer
426318|NCT00002633|stage IV prostate cancer|stage iv prostate cancer
426319|NCT00002634|localized resectable neuroblastoma|localized resectable neuroblastoma
426320|NCT00002634|regional neuroblastoma|regional neuroblastoma
426321|NCT00002634|disseminated neuroblastoma|disseminated neuroblastoma
426322|NCT00002634|recurrent neuroblastoma|recurrent neuroblastoma
426323|NCT00002634|localized unresectable neuroblastoma|localized unresectable neuroblastoma
426324|NCT00002635|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
426325|NCT00002635|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
426326|NCT00002635|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
426327|NCT00002635|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
426328|NCT00002637|recurrent prostate cancer|recurrent prostate cancer
426329|NCT00002638|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
426330|NCT00002639|recurrent adult brain tumor|recurrent adult brain tumor
426331|NCT00002639|adult glioblastoma|adult glioblastoma
426332|NCT00002639|adult anaplastic astrocytoma|adult anaplastic astrocytoma
426333|NCT00002639|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
426334|NCT00002639|adult mixed glioma|adult mixed glioma
426335|NCT00002639|adult giant cell glioblastoma|adult giant cell glioblastoma
426336|NCT00002639|adult gliosarcoma|adult gliosarcoma
426337|NCT00002641|adult angiosarcoma|adult angiosarcoma
426338|NCT00002641|adult fibrosarcoma|adult fibrosarcoma
426339|NCT00002641|adult leiomyosarcoma|adult leiomyosarcoma
426340|NCT00002641|adult liposarcoma|adult liposarcoma
426341|NCT00002641|adult neurofibrosarcoma|adult neurofibrosarcoma
426342|NCT00002641|adult synovial sarcoma|adult synovial sarcoma
426343|NCT00002641|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
426344|NCT00002641|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
426345|NCT00002641|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
426346|NCT00002641|adult epithelioid sarcoma|adult epithelioid sarcoma
426347|NCT00002641|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
426980|NCT00001676|Infection|infection
426348|NCT00002641|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
426349|NCT00002641|adult malignant mesenchymoma|adult malignant mesenchymoma
426350|NCT00002641|adult rhabdomyosarcoma|adult rhabdomyosarcoma
426351|NCT00002641|localized benign pheochromocytoma|localized benign pheochromocytoma
426352|NCT00002641|regional pheochromocytoma|regional pheochromocytoma
426353|NCT00002641|recurrent pheochromocytoma|recurrent pheochromocytoma
426354|NCT00002641|stage II uterine sarcoma|stage ii uterine sarcoma
426355|NCT00002641|stage III uterine sarcoma|stage iii uterine sarcoma
426356|NCT00002641|recurrent uterine sarcoma|recurrent uterine sarcoma
426357|NCT00002641|uterine carcinosarcoma|uterine carcinosarcoma
426359|NCT00002641|endometrial stromal sarcoma|endometrial stromal sarcoma
426361|NCT00002641|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
426362|NCT00002641|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
426363|NCT00002642|squamous cell lung cancer|squamous cell lung cancer
426364|NCT00002642|large cell lung cancer|large cell lung cancer
426365|NCT00002642|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
426366|NCT00002642|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
426367|NCT00002642|adenocarcinoma of the lung|adenocarcinoma of the lung
426368|NCT00002642|adenosquamous cell lung cancer|adenosquamous cell lung cancer
426369|NCT00002643|neutropenia|neutropenia
426370|NCT00002643|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
426371|NCT00002644|breast cancer|breast cancer
426372|NCT00002646|stage II breast cancer|stage ii breast cancer
426373|NCT00002646|stage IIIA breast cancer|stage iiia breast cancer
426374|NCT00002647|recurrent adult brain tumor|recurrent adult brain tumor
426375|NCT00002647|tumors metastatic to brain|tumors metastatic to brain
426376|NCT00002647|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
426377|NCT00002647|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
426378|NCT00002647|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
426379|NCT00002647|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
426380|NCT00002647|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
426381|NCT00002647|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
426382|NCT00002647|recurrent childhood diffuse astrocytoma|recurrent childhood diffuse astrocytoma
426383|NCT00002647|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
426384|NCT00002647|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
426385|NCT00002647|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
426386|NCT00002647|recurrent childhood glioblastoma|recurrent childhood glioblastoma
426387|NCT00002647|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
426388|NCT00002647|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
426389|NCT00002647|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
426390|NCT00002647|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
426391|NCT00002647|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
426392|NCT00002647|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
426393|NCT00002647|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
426394|NCT00002647|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
426395|NCT00002647|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
426396|NCT00002647|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
426397|NCT00002647|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
426398|NCT00002647|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
426399|NCT00002647|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
426400|NCT00002647|recurrent childhood ependymoma|recurrent childhood ependymoma
426401|NCT00002647|recurrent childhood brain tumor|recurrent childhood brain tumor
426402|NCT00002647|adult anaplastic astrocytoma|adult anaplastic astrocytoma
426403|NCT00002647|adult anaplastic ependymoma|adult anaplastic ependymoma
426404|NCT00002647|adult anaplastic meningioma|adult anaplastic meningioma
426405|NCT00002647|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
426406|NCT00002647|adult brain stem glioma|adult brain stem glioma
426407|NCT00002647|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
426408|NCT00002647|adult choroid plexus tumor|adult choroid plexus tumor
425799|NCT00002550|large cell lung cancer|large cell lung cancer
426409|NCT00002647|adult craniopharyngioma|adult craniopharyngioma
426410|NCT00002647|adult diffuse astrocytoma|adult diffuse astrocytoma
426411|NCT00002647|adult ependymoblastoma|adult ependymoblastoma
426412|NCT00002647|adult ependymoma|adult ependymoma
426413|NCT00002647|adult giant cell glioblastoma|adult giant cell glioblastoma
426414|NCT00002647|adult glioblastoma|adult glioblastoma
426415|NCT00002647|adult gliosarcoma|adult gliosarcoma
426416|NCT00002647|adult medulloblastoma|adult medulloblastoma
426417|NCT00002647|meningeal melanocytoma|meningeal melanocytoma
426418|NCT00002647|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
426419|NCT00002647|adult oligodendroglioma|adult oligodendroglioma
426420|NCT00002647|adult papillary meningioma|adult papillary meningioma
426422|NCT00002647|adult pineal gland astrocytoma|adult pineal gland astrocytoma
426423|NCT00002647|adult pineoblastoma|adult pineoblastoma
426424|NCT00002647|adult pineocytoma|adult pineocytoma
426425|NCT00002647|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
426426|NCT00002647|adult subependymoma|adult subependymoma
426427|NCT00002647|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
426428|NCT00002647|childhood grade I meningioma|childhood grade i meningioma
426429|NCT00002647|childhood grade II meningioma|childhood grade ii meningioma
426430|NCT00002647|childhood grade III meningioma|childhood grade iii meningioma
426431|NCT00002647|adult grade III meningioma|adult grade iii meningioma
426432|NCT00002647|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
426433|NCT00002647|childhood choroid plexus tumor|childhood choroid plexus tumor
426434|NCT00002647|childhood craniopharyngioma|childhood craniopharyngioma
426435|NCT00002647|childhood infratentorial ependymoma|childhood infratentorial ependymoma
426436|NCT00002647|childhood supratentorial ependymoma|childhood supratentorial ependymoma
426437|NCT00002647|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
426438|NCT00002647|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
426439|NCT00002650|colon cancer|colon cancer
426440|NCT00002650|rectal cancer|rectal cancer
426441|NCT00002651|adenocarcinoma of the prostate|adenocarcinoma of the prostate
426442|NCT00002651|stage IV prostate cancer|stage iv prostate cancer
426443|NCT00002651|recurrent prostate cancer|recurrent prostate cancer
426444|NCT00002652|refractory multiple myeloma|refractory multiple myeloma
426445|NCT00002653|stage I multiple myeloma|stage i multiple myeloma
426446|NCT00002653|stage II multiple myeloma|stage ii multiple myeloma
426447|NCT00002653|stage III multiple myeloma|stage iii multiple myeloma
426448|NCT00002654|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
426449|NCT00002654|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
426450|NCT00002654|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
426451|NCT00002654|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
426452|NCT00002654|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
426453|NCT00002654|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
426454|NCT00002654|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
426455|NCT00002654|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
426456|NCT00002655|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
426457|NCT00002655|recurrent adult primary liver cancer|recurrent adult primary liver cancer
426458|NCT00002655|liver metastases|liver metastases
426459|NCT00002656|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
426460|NCT00002656|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
426461|NCT00002656|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
426462|NCT00002657|isolated plasmacytoma of bone|isolated plasmacytoma of bone
426463|NCT00002657|extramedullary plasmacytoma|extramedullary plasmacytoma
426464|NCT00002657|refractory multiple myeloma|refractory multiple myeloma
426465|NCT00002657|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
426466|NCT00002657|stage I multiple myeloma|stage i multiple myeloma
426467|NCT00002657|stage II multiple myeloma|stage ii multiple myeloma
426468|NCT00002657|stage III multiple myeloma|stage iii multiple myeloma
426469|NCT00002657|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
426470|NCT00002657|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
426471|NCT00002657|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
426472|NCT00002657|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
426473|NCT00002657|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
426474|NCT00002657|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
426475|NCT00002657|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
426476|NCT00002657|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
752420|NCT01172925|crossover|crossover
200959|NCT02112812|Helicobacter pylori|helicobacter pylori
426477|NCT00002657|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
426478|NCT00002657|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
426479|NCT00002657|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
426480|NCT00002657|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
426481|NCT00002657|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
426482|NCT00002657|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
426483|NCT00002657|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
426484|NCT00002657|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
426485|NCT00002657|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
426486|NCT00002657|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
426487|NCT00002657|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
426488|NCT00002657|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
426489|NCT00002657|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
426490|NCT00002657|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
426491|NCT00002657|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
426492|NCT00002657|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
426493|NCT00002657|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
426494|NCT00002657|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
426495|NCT00002657|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
426496|NCT00002657|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
426497|NCT00002657|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
426498|NCT00002657|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
426499|NCT00002657|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
426500|NCT00002657|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
426501|NCT00002657|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
426502|NCT00002657|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
583278|NCT00511108|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
426503|NCT00002657|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
426504|NCT00002657|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
426505|NCT00002657|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
426506|NCT00002657|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
426507|NCT00002657|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
426508|NCT00002657|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
426509|NCT00002657|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
426510|NCT00002657|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
426511|NCT00002657|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
426512|NCT00002657|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
426513|NCT00002657|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
426514|NCT00002657|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
426515|NCT00002657|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
426516|NCT00002657|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
426517|NCT00002657|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
426518|NCT00002657|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
426519|NCT00002657|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
426520|NCT00002657|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
426521|NCT00002657|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
426522|NCT00002657|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
426523|NCT00002657|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
426524|NCT00002657|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
426525|NCT00002657|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
426526|NCT00002657|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
426527|NCT00002657|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
426528|NCT00002657|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
426529|NCT00002657|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
426530|NCT00002657|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
426531|NCT00002657|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
752421|NCT01172925|tiotropium|tiotropium
426532|NCT00002657|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
426533|NCT00002657|stage I marginal zone lymphoma|stage i marginal zone lymphoma
426534|NCT00002657|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
426535|NCT00002657|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
426536|NCT00002657|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
426537|NCT00002657|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
426538|NCT00002657|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
426539|NCT00002657|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
426540|NCT00002657|splenic marginal zone lymphoma|splenic marginal zone lymphoma
426541|NCT00002658|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
426542|NCT00002658|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
426543|NCT00002658|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
426544|NCT00002658|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
426545|NCT00002658|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
426546|NCT00002658|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
426547|NCT00002658|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
426548|NCT00002658|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
426549|NCT00002658|secondary acute myeloid leukemia|secondary acute myeloid leukemia
426550|NCT00002658|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
426552|NCT00002658|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
426553|NCT00002659|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
426554|NCT00002659|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
426555|NCT00002659|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
426556|NCT00002659|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
426557|NCT00002659|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
583279|NCT00511121|chronic myeloid leukemia|chronic myeloid leukemia
426558|NCT00002659|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
426559|NCT00002662|stage IV breast cancer|stage iv breast cancer
426560|NCT00002662|stage IIIA breast cancer|stage iiia breast cancer
426561|NCT00002662|recurrent breast cancer|recurrent breast cancer
426562|NCT00002662|stage IIIB breast cancer|stage iiib breast cancer
426563|NCT00002662|stage IIIC breast cancer|stage iiic breast cancer
426564|NCT00002663|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
426565|NCT00002663|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
426566|NCT00002663|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
426567|NCT00002663|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
426568|NCT00002663|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
426569|NCT00002663|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
426570|NCT00002663|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
426571|NCT00002663|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
426572|NCT00002663|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
426573|NCT00002663|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
426574|NCT00002663|childhood Burkitt lymphoma|childhood burkitt lymphoma
426575|NCT00002663|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
426576|NCT00002663|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
426577|NCT00002663|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
426578|NCT00002663|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
426579|NCT00002663|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
426580|NCT00002663|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
426581|NCT00002663|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
426582|NCT00002663|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
426583|NCT00002663|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
426584|NCT00002663|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
426585|NCT00002663|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
426586|NCT00002663|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
426587|NCT00002663|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
426588|NCT00002663|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
426589|NCT00002663|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
426590|NCT00002663|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
426591|NCT00002663|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
426592|NCT00002663|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
752422|NCT01172938|Psoriatic Arthritis|psoriatic arthritis
426593|NCT00002663|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
426594|NCT00002663|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
426595|NCT00002663|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
426596|NCT00002663|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
426597|NCT00002663|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
426598|NCT00002663|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
426599|NCT00002663|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
426600|NCT00002663|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
426601|NCT00002663|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
426602|NCT00002663|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
426603|NCT00002663|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
426604|NCT00002663|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
426605|NCT00002663|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
426606|NCT00002663|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
426607|NCT00002663|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
426608|NCT00002663|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
426609|NCT00002663|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
426610|NCT00002663|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
426611|NCT00002663|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
426612|NCT00002663|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
426613|NCT00002663|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
426614|NCT00002663|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
426615|NCT00002663|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
426616|NCT00002663|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
426617|NCT00002663|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
426618|NCT00002663|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
426619|NCT00002663|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
583280|NCT00511121|tyrosine kinase|tyrosine kinase
426620|NCT00002663|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
426621|NCT00002663|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
426622|NCT00002663|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
426623|NCT00002663|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
426624|NCT00002663|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
426625|NCT00002663|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
426626|NCT00002663|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
426627|NCT00002663|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
426628|NCT00002663|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
426629|NCT00002663|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
426630|NCT00002663|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
426631|NCT00002663|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
426632|NCT00002663|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
426633|NCT00002663|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
426634|NCT00002663|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
426635|NCT00002663|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
426636|NCT00002663|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
426637|NCT00002663|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
426638|NCT00002663|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
426639|NCT00002663|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
426640|NCT00002663|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
426641|NCT00002663|stage I mantle cell lymphoma|stage i mantle cell lymphoma
426642|NCT00002663|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
426643|NCT00002663|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
426644|NCT00002663|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
426645|NCT00002663|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
426646|NCT00002663|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
426647|NCT00002663|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
426648|NCT00002663|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
426649|NCT00002663|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
426650|NCT00002663|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
752423|NCT01172938|Psoriasis|psoriasis
752424|NCT01172938|Arthritis|arthritis
426651|NCT00002663|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
426652|NCT00002663|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
426653|NCT00002663|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
426654|NCT00002663|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
426655|NCT00002663|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
426656|NCT00002663|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
426657|NCT00002663|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
426658|NCT00002663|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
426659|NCT00002663|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
426660|NCT00002663|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
426661|NCT00002663|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
426662|NCT00002663|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
426663|NCT00002663|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
426664|NCT00002663|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
426665|NCT00002663|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
426666|NCT00002663|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
426667|NCT00002663|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
426668|NCT00002663|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
426669|NCT00002663|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
426670|NCT00002663|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
426671|NCT00002663|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
426672|NCT00002663|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
426673|NCT00002663|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
426674|NCT00002663|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
426675|NCT00002663|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
426676|NCT00002663|splenic marginal zone lymphoma|splenic marginal zone lymphoma
426677|NCT00002663|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
426678|NCT00002663|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
426886|NCT00001658|Antibiotics|antibiotics
426679|NCT00002663|stage I marginal zone lymphoma|stage i marginal zone lymphoma
426680|NCT00002663|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
426681|NCT00002663|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
426682|NCT00002663|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
426683|NCT00002663|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
426684|NCT00002663|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
426685|NCT00002663|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
426686|NCT00002663|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
426687|NCT00002664|recurrent colon cancer|recurrent colon cancer
426688|NCT00002664|recurrent rectal cancer|recurrent rectal cancer
427023|NCT00001686|Leukemia|leukemia
426689|NCT00002665|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
426690|NCT00002665|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
426691|NCT00002665|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
426692|NCT00002665|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
426693|NCT00002665|neutropenia|neutropenia
426694|NCT00002665|thrombocytopenia|thrombocytopenia
426695|NCT00002667|stage I non-small cell lung cancer|stage i non-small cell lung cancer
426696|NCT00002668|stage IV breast cancer|stage iv breast cancer
426697|NCT00002668|recurrent breast cancer|recurrent breast cancer
426698|NCT00002668|stage IV prostate cancer|stage iv prostate cancer
426699|NCT00002668|recurrent prostate cancer|recurrent prostate cancer
426700|NCT00002668|pain|pain
426701|NCT00002669|stage IV melanoma|stage iv melanoma
426702|NCT00002669|recurrent melanoma|recurrent melanoma
426703|NCT00002670|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
426704|NCT00002670|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
426705|NCT00002670|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
426706|NCT00002670|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
426707|NCT00002670|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
426708|NCT00002670|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
426709|NCT00002670|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
426710|NCT00002670|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
426711|NCT00002670|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
426712|NCT00002670|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
426713|NCT00002670|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
426714|NCT00002670|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
426715|NCT00002671|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
426716|NCT00002671|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
426717|NCT00002671|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
426718|NCT00002673|stage IV breast cancer|stage iv breast cancer
426719|NCT00002673|stage IIIA breast cancer|stage iiia breast cancer
426720|NCT00002673|stage IIIB breast cancer|stage iiib breast cancer
426721|NCT00002673|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
426722|NCT00002673|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
426723|NCT00002673|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
426724|NCT00002673|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
426725|NCT00002673|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
426726|NCT00002673|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
426727|NCT00002673|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
426728|NCT00002673|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
426729|NCT00002673|disseminated neuroblastoma|disseminated neuroblastoma
426730|NCT00002673|recurrent neuroblastoma|recurrent neuroblastoma
426731|NCT00002673|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
426732|NCT00002673|stage I multiple myeloma|stage i multiple myeloma
441227|NCT00004579|HIV-1|hiv-1
426735|NCT00002673|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
426736|NCT00002673|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
426737|NCT00002673|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
426738|NCT00002673|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
426739|NCT00002673|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
426740|NCT00002673|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
426741|NCT00002673|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
426742|NCT00002673|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
426743|NCT00002673|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
426744|NCT00002673|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
426997|NCT00001679|Immunogenetics|immunogenetics
426745|NCT00002673|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
426746|NCT00002673|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
426747|NCT00002673|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
426748|NCT00002673|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
426749|NCT00002673|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
426750|NCT00002673|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
426751|NCT00002673|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
426752|NCT00002673|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
426753|NCT00002673|testicular embryonal carcinoma|testicular embryonal carcinoma
426754|NCT00002673|testicular choriocarcinoma|testicular choriocarcinoma
426755|NCT00002673|testicular teratoma|testicular teratoma
426756|NCT00002673|testicular yolk sac tumor|testicular yolk sac tumor
426757|NCT00002673|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
426758|NCT00002673|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
426759|NCT00002673|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
426760|NCT00002673|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
426761|NCT00002673|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
426762|NCT00002673|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
426763|NCT00002673|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
426764|NCT00002673|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
426765|NCT00002673|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
426766|NCT00002673|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
426767|NCT00002673|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
426768|NCT00002673|refractory hairy cell leukemia|refractory hairy cell leukemia
426769|NCT00002673|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
426770|NCT00002673|ovarian germ cell tumor|ovarian germ cell tumor
426771|NCT00002673|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
426772|NCT00002673|ovarian yolk sac tumor|ovarian yolk sac tumor
426773|NCT00002673|ovarian embryonal carcinoma|ovarian embryonal carcinoma
426774|NCT00002673|ovarian polyembryoma|ovarian polyembryoma
426775|NCT00002673|ovarian choriocarcinoma|ovarian choriocarcinoma
426776|NCT00002673|ovarian teratoma|ovarian teratoma
426777|NCT00002673|ovarian immature teratoma|ovarian immature teratoma
426778|NCT00002673|ovarian mature teratoma|ovarian mature teratoma
426779|NCT00002673|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
426780|NCT00002673|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
426781|NCT00002673|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
426782|NCT00002673|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
426783|NCT00002673|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
426784|NCT00002673|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
426785|NCT00002673|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
426786|NCT00002673|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
426787|NCT00002673|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
426788|NCT00002673|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
426789|NCT00002673|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
426790|NCT00002673|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
426791|NCT00002673|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
426792|NCT00002673|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
426793|NCT00002673|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
426794|NCT00002673|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
426795|NCT00002673|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
426796|NCT00002673|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
426797|NCT00002673|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
426798|NCT00002673|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
426799|NCT00002673|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
426800|NCT00002673|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
426801|NCT00002673|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
426802|NCT00002673|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
426803|NCT00002673|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
426804|NCT00002673|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
426805|NCT00002673|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
426806|NCT00002673|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
426807|NCT00002673|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
426808|NCT00002673|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
426888|NCT00001658|Group A beta-Hemolytic Strep Infections|group a beta-hemolytic strep infections
426809|NCT00002673|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
426810|NCT00002673|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
426811|NCT00002673|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
426812|NCT00002673|infection|infection
426813|NCT00002673|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
426814|NCT00002673|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
426815|NCT00002673|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
426816|NCT00002673|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
426817|NCT00002673|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
426818|NCT00002673|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
426819|NCT00002673|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
426820|NCT00002673|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
426821|NCT00002673|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
426822|NCT00002673|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
426823|NCT00002673|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
426824|NCT00002673|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
426825|NCT00002673|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
426826|NCT00002673|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
426827|NCT00002673|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
426828|NCT00002673|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
426829|NCT00002673|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
426830|NCT00002673|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
426831|NCT00002673|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
426832|NCT00002673|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
426833|NCT00002673|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
426834|NCT00002673|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
426835|NCT00002673|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
426836|NCT00002673|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
426837|NCT00002673|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
426838|NCT00002673|splenic marginal zone lymphoma|splenic marginal zone lymphoma
426839|NCT00002673|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
426840|NCT00002674|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
426841|NCT00002674|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
426842|NCT00002674|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
426843|NCT00002674|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
426844|NCT00002675|intraocular retinoblastoma|intraocular retinoblastoma
426845|NCT00002676|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
426846|NCT00001652|Life-Charting|life-charting
426847|NCT00001652|Cerebrospinal Fluid|cerebrospinal fluid
426848|NCT00001652|Diagnostic Tests|diagnostic tests
426849|NCT00001652|Cognitive Testing|cognitive testing
426850|NCT00001652|Course of Illness|course of illness
426851|NCT00001652|Bipolar Disorder|bipolar disorder
426852|NCT00001654|Adolescence|adolescence
426853|NCT00001654|Comorbid Disorders|comorbid disorders
426854|NCT00001654|Physiology|physiology
426855|NCT00001654|Socialization|socialization
426856|NCT00001654|Gender|gender
426857|NCT00001654|Conduct Problems|conduct problems
426858|NCT00001654|Anxiety|anxiety
426859|NCT00001654|Sadness|sadness
426860|NCT00001654|Emotion|emotion
426861|NCT00001654|Psychophysiology|psychophysiology
426862|NCT00001656|Clozapine|clozapine
426863|NCT00001656|Olanzapine|olanzapine
426864|NCT00001656|Drug Response|drug response
426865|NCT00001656|Safety|safety
426866|NCT00001656|Childhood Onset Schizophrenia|childhood onset schizophrenia
426867|NCT00001656|Schizoaffective Disorder|schizoaffective disorder
443438|NCT00005118|Indinavir|indinavir
426868|NCT00001656|Multidimensionally Impaired Syndrome|multidimensionally impaired syndrome
426869|NCT00001656|Phenomenology|phenomenology
426870|NCT00001656|Biochemical Correlates|biochemical correlates
426871|NCT00001656|Brain Imaging|brain imaging
426872|NCT00001656|Schizophrenia|schizophrenia
426873|NCT00001656|Childhood Schizophrenia|childhood schizophrenia
426874|NCT00001656|Psychosis|psychosis
426875|NCT00001657|15 O PET Scanning|15 o pet scanning
426876|NCT00001657|Anxiety|anxiety
426877|NCT00001657|Cerebral Blood Flow|cerebral blood flow
426878|NCT00001657|Depression|depression
426879|NCT00001657|Domestic Abuse|domestic abuse
426880|NCT00001657|Neuroendocrine|neuroendocrine
426881|NCT00001657|PET Scanning|pet scanning
426882|NCT00001657|Police Officers|police officers
426883|NCT00001657|Post Traumatic Stress Disorder|post traumatic stress disorder
426884|NCT00001657|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
426889|NCT00001658|Obsessive Compulsive Disorder|obsessive compulsive disorder
426890|NCT00001658|Streptococcal Infection|streptococcal infection
426891|NCT00001658|Tic Disorders|tic disorders
426892|NCT00001659|Bereavement|bereavement
426893|NCT00001659|Depression|depression
426894|NCT00001659|Suicide|suicide
426895|NCT00001659|Activity of Daily Living|activity of daily living
426896|NCT00001659|Immune Function|immune function
426897|NCT00001659|Occupational Performance|occupational performance
426898|NCT00001659|Sleep Disorders|sleep disorders
426899|NCT00001659|Mood Changes|mood changes
426900|NCT00001661|Plasticity|plasticity
426902|NCT00001661|Stroke|stroke
426903|NCT00001661|Spinal Cord Injury|spinal cord injury
426904|NCT00001661|Amputation|amputation
426905|NCT00001661|Intracortical Inhibition|intracortical inhibition
426906|NCT00001662|Dementia|dementia
426907|NCT00001662|Glutamate|glutamate
426908|NCT00001662|Clinical Trial|clinical trial
426909|NCT00001662|Neurotransmitter|neurotransmitter
426910|NCT00001662|Alzheimer's Disease|alzheimer's disease
426911|NCT00001663|Neurological Disorders|neurological disorders
426912|NCT00001663|Movement Disorders|movement disorders
426913|NCT00001663|Physiology|physiology
426914|NCT00001663|Noninvasive|noninvasive
426915|NCT00001663|Brain Stimulation|brain stimulation
426916|NCT00001663|Cortical Myoclonus|cortical myoclonus
426917|NCT00001664|Narcolepsy|narcolepsy
426918|NCT00001664|Polysomnography|polysomnography
426919|NCT00001664|Multiple Sleep Latency Test|multiple sleep latency test
426920|NCT00001664|Sleep Disorders|sleep disorders
426921|NCT00001664|Hypersomnia|hypersomnia
426922|NCT00001664|Periodic Leg Movements|periodic leg movements
426923|NCT00001665|Magnetic Stimulation|magnetic stimulation
426924|NCT00001665|Motor Skills|motor skills
426925|NCT00001665|Parkinson's Disease|parkinson's disease
426926|NCT00001665|rTMS|rtms
426927|NCT00001666|Seizures|seizures
426928|NCT00001666|Partial Epilepsy|partial epilepsy
426929|NCT00001666|Intractable|intractable
426930|NCT00001666|TMS|tms
426931|NCT00001667|Family Studies|family studies
426932|NCT00001667|Genetic|genetic
426933|NCT00001667|Myoclonus|myoclonus
426934|NCT00001667|Tics|tics
426935|NCT00001667|Tremor|tremor
426936|NCT00001667|Movement Disorders|movement disorders
426937|NCT00001667|Neurological Disease|neurological disease
426938|NCT00001668|Deafness|deafness
426939|NCT00001668|Hemangioblastoma|hemangioblastoma
426940|NCT00001668|Papillary Carcinoma|papillary carcinoma
426941|NCT00001668|VHL Gene|vhl gene
426942|NCT00001668|Vestibular Function|vestibular function
426943|NCT00001668|von Hippel-Lindau Disease|von hippel-lindau disease
426944|NCT00001669|EAE|eae
426945|NCT00001669|EDSS|edss
426946|NCT00001669|MRI|mri
426947|NCT00001669|SNRS|snrs
426948|NCT00001669|Multiple Sclerosis|multiple sclerosis
426949|NCT00001671|White Matter|white matter
426950|NCT00001671|Myelin|myelin
426951|NCT00001671|Degenerative Diseases|degenerative diseases
426952|NCT00001671|Genetic|genetic
426953|NCT00001671|Oligodendrocytes|oligodendrocytes
426954|NCT00001671|Leukodystrophy|leukodystrophy
426955|NCT00001672|Brain Mapping|brain mapping
426956|NCT00001672|Cognition|cognition
426957|NCT00001672|Noninvasive|noninvasive
426958|NCT00001672|Temporal Lobe|temporal lobe
426959|NCT00001672|Visual Naming|visual naming
426960|NCT00001673|Alcoholics|alcoholics
426961|NCT00001673|Screening|screening
426962|NCT00001673|Healthy Volunteers|healthy volunteers
426963|NCT00001673|Violent Abusers|violent abusers
426964|NCT00001673|Illicit Drug Testing|illicit drug testing
426965|NCT00001673|Blood Tests|blood tests
426966|NCT00001673|Normal Volunteer|normal volunteer
426967|NCT00001675|Brain Imaging|brain imaging
426968|NCT00001675|Affect|affect
426969|NCT00001675|Limbic System|limbic system
426970|NCT00001675|Cerebral Blood Volume|cerebral blood volume
426971|NCT00001675|Alcoholism|alcoholism
426972|NCT00001675|Emotion|emotion
426973|NCT00001675|Brain|brain
426974|NCT00001675|Operant|operant
426975|NCT00001675|Autonomic|autonomic
426976|NCT00001675|Relapse|relapse
426977|NCT00001675|Normal Volunteer|normal volunteer
426978|NCT00001676|Remission|remission
426981|NCT00001676|Germinal Center|germinal center
426982|NCT00001676|Immunoglobulin|immunoglobulin
426983|NCT00001676|Glomerulonephritis|glomerulonephritis
426984|NCT00001676|Systemic Lupus Erythematosus|systemic lupus erythematosus
426986|NCT00001677|Immunosuppression|immunosuppression
426987|NCT00001677|Lymphocytes|lymphocytes
426988|NCT00001677|Magnetic Resonance|magnetic resonance
426989|NCT00001677|Synovial Biopsy|synovial biopsy
426990|NCT00001677|Synovitis|synovitis
426991|NCT00001677|Rheumatoid Arthritis|rheumatoid arthritis
426992|NCT00001678|Autoimmunity|autoimmunity
426993|NCT00001678|Sibling Pairs|sibling pairs
426994|NCT00001678|Genes|genes
426995|NCT00001678|Rheumatoid Arthritis|rheumatoid arthritis
426996|NCT00001678|Bone Erosion|bone erosion
426998|NCT00001679|Joint Damage|joint damage
426999|NCT00001679|Reactive Arthritis|reactive arthritis
427000|NCT00001679|Rheumatoid Arthritis|rheumatoid arthritis
427001|NCT00001679|Synovium|synovium
427002|NCT00001679|Synovitis|synovitis
427003|NCT00001680|Double-masked|double-masked
427004|NCT00001680|Neuropathy|neuropathy
427005|NCT00001680|Occlusive Dressing|occlusive dressing
427006|NCT00001680|Pilot|pilot
427007|NCT00001680|Placebo|placebo
427008|NCT00001681|Cytokines|cytokines
427009|NCT00001681|Gene Regulation|gene regulation
427010|NCT00001681|Immunization|immunization
427011|NCT00001681|Influenza|influenza
427012|NCT00001681|Pathogenesis|pathogenesis
427013|NCT00001683|Collagen Breakdown|collagen breakdown
427014|NCT00001683|Pharmacokinetics|pharmacokinetics
427015|NCT00001683|Rapid Escalation Phase I|rapid escalation phase i
427016|NCT00001683|Angiogenesis|angiogenesis
427017|NCT00001683|Tissue Inhibitors of Metalloproteinase|tissue inhibitors of metalloproteinase
427018|NCT00001685|Cancer|cancer
427024|NCT00001686|Ewing's Sarcoma|ewing's sarcoma
427025|NCT00001686|Neuroectodermal Tumors|neuroectodermal tumors
427026|NCT00001686|Osteosarcoma Lymphoma|osteosarcoma lymphoma
427027|NCT00001686|Rhabdomyosarcoma Brain Tumors|rhabdomyosarcoma brain tumors
427028|NCT00001686|Lymphoma|lymphoma
427029|NCT00001686|Neoplasm|neoplasm
427030|NCT00001686|Sarcoma|sarcoma
427031|NCT00001688|CD4 Cells|cd4 cells
427032|NCT00001688|Cytokines|cytokines
427033|NCT00001688|Anti-Retroviral Activity|anti-retroviral activity
427034|NCT00001688|V Beta Repertoire|v beta repertoire
427035|NCT00001688|CD-4-Naive T Cells|cd-4-naive t cells
427036|NCT00001688|CD-4-Memory T Cells|cd-4-memory t cells
427037|NCT00001689|Neurotoxicity|neurotoxicity
427038|NCT00001689|A.L.L.|a.l.l.
427039|NCT00001689|Limited Sampling|limited sampling
427040|NCT00001689|Dose Individualization|dose individualization
427041|NCT00001689|Vinca Alkaloids|vinca alkaloids
427042|NCT00001693|Chemoprevention|chemoprevention
427043|NCT00001693|Biomarkers|biomarkers
427044|NCT00001693|Endoscopy|endoscopy
427045|NCT00001693|Colorectal|colorectal
427046|NCT00001693|Celecoxib|celecoxib
427047|NCT00001695|Complementary Medicine|complementary medicine
427048|NCT00001695|Unproven Treatments|unproven treatments
427049|NCT00001695|Herbal|herbal
427050|NCT00001696|Anti-metastatic|anti-metastatic
427051|NCT00001696|Chemoprevention|chemoprevention
427052|NCT00001696|Isoflavinoid|isoflavinoid
427053|NCT00001696|Prostate Cancer|prostate cancer
427054|NCT00001696|Signal Transduction|signal transduction
427055|NCT00001698|Chemoprevention|chemoprevention
427056|NCT00001698|Direct Epithelial Delivery|direct epithelial delivery
427057|NCT00001698|Tobacco-induced Cancer|tobacco-induced cancer
427058|NCT00001698|Field Cancerization|field cancerization
427059|NCT00001699|AIDS|aids
427060|NCT00001699|Compliance|compliance
427062|NCT00001699|Medication|medication
427063|NCT00001699|Perceived Threat|perceived threat
427064|NCT00001699|Teenagers|teenagers
427065|NCT00001701|Risk Factor|risk factor
427066|NCT00001701|Genetic|genetic
427067|NCT00001701|Variant Alleles|variant alleles
427068|NCT00001701|Cancer|cancer
427069|NCT00001701|Transplantation|transplantation
427070|NCT00001702|Genetic|genetic
427071|NCT00001702|Variant Alleles|variant alleles
427072|NCT00001702|Risk Factor|risk factor
427073|NCT00001702|Cancer|cancer
427074|NCT00001702|Transplantation|transplantation
427075|NCT00001703|Immunotherapy|immunotherapy
427076|NCT00001703|Kidney|kidney
427077|NCT00001703|Genes|genes
427078|NCT00001703|Vaccine Therapy|vaccine therapy
427079|NCT00001703|Renal Cell Carcinoma|renal cell carcinoma
427080|NCT00001705|Antigen|antigen
427081|NCT00001705|Cancer|cancer
427082|NCT00001705|Immunotherapy|immunotherapy
427083|NCT00001711|Magnetic Resonance Imaging|magnetic resonance imaging
427084|NCT00001711|Gadolinium|gadolinium
427085|NCT00001711|Magnetic Resonance Angiography|magnetic resonance angiography
427086|NCT00001711|Normal Volunteer|normal volunteer
427087|NCT00001712|Healthcare Worker|healthcare worker
427088|NCT00001712|Bloodborne Diseases|bloodborne diseases
427089|NCT00001712|Hepatitis B|hepatitis b
427090|NCT00001712|Hepatitis C|hepatitis c
427091|NCT00001712|Human Immunodeficiency Virus|human immunodeficiency virus
427092|NCT00001712|Parenteral Exposure|parenteral exposure
427093|NCT00001712|Non-Parenteral Exposure|non-parenteral exposure
427094|NCT00001712|Blood and Body Substances|blood and body substances
427095|NCT00001712|Universal Precautions|universal precautions
427096|NCT00001712|HIV Seronegativity|hiv seronegativity
427097|NCT00001713|rtPA|rtpa
427098|NCT00001713|Catheter Directed|catheter directed
427099|NCT00001713|Thrombolysis|thrombolysis
427100|NCT00001713|Anticoagulation|anticoagulation
427101|NCT00001713|Emboli|emboli
427102|NCT00001713|Acute Deep Venous Thrombosis|acute deep venous thrombosis
427103|NCT00001713|TPA|tpa
427104|NCT00001713|DVT|dvt
427105|NCT00001714|MRI|mri
427106|NCT00001714|Macromolecules|macromolecules
427107|NCT00001714|Magnetization Transfer|magnetization transfer
427108|NCT00001714|Metabolites|metabolites
427109|NCT00001714|Tissue Characterization|tissue characterization
427110|NCT00001714|Normal Volunteer|normal volunteer
427111|NCT00001715|Consultation|consultation
427112|NCT00001715|Training|training
427113|NCT00001715|Referral|referral
427114|NCT00001715|Fellowship Program|fellowship program
427115|NCT00001715|Outpatient|outpatient
427116|NCT00001715|Blood Disorder|blood disorder
427117|NCT00001716|Hemoglobin|hemoglobin
427119|NCT00001716|Microvascular|microvascular
427120|NCT00001716|Perfusion|perfusion
427121|NCT00001716|Magnetic Resonance Imaging|magnetic resonance imaging
427122|NCT00001716|Sickle Cell Anemia|sickle cell anemia
427123|NCT00001717|Compensation|compensation
427124|NCT00001717|Motivations|motivations
427125|NCT00001717|Volunteers|volunteers
427126|NCT00001717|HIV|hiv
427127|NCT00001718|Biofeedback|biofeedback
427128|NCT00001718|Swallowing|swallowing
427129|NCT00001718|Swallowing Therapy|swallowing therapy
427130|NCT00001718|Tongue/Palate|tongue/palate
427131|NCT00001718|Ultrasound|ultrasound
427132|NCT00001718|Dysphagia|dysphagia
427133|NCT00001719|Blood Flow|blood flow
427134|NCT00001719|Hepatic Disease|hepatic disease
427135|NCT00001719|Liver|liver
427136|NCT00001719|Modeling|modeling
427137|NCT00001719|Rheology|rheology
427138|NCT00001719|Normal Volunteer|normal volunteer
427139|NCT00001720|Glucocorticoids|glucocorticoids
427140|NCT00001720|Bone Mineral Density|bone mineral density
427141|NCT00001720|Bisphosphonates|bisphosphonates
427142|NCT00001720|Vertebral Fracture|vertebral fracture
427143|NCT00001720|Childhood Osteoporosis|childhood osteoporosis
427144|NCT00001721|Dysmorphology|dysmorphology
427145|NCT00001721|Cholesterol|cholesterol
427146|NCT00001721|Endocrine|endocrine
427147|NCT00001721|MRI|mri
427148|NCT00001721|Demyelination|demyelination
427149|NCT00001721|Smith-Lemli-Opitz Syndrome (SLO)|smith-lemli-opitz syndrome (slo)
427150|NCT00001722|Obesity|obesity
427151|NCT00001722|Sympathetic Nervous System|sympathetic nervous system
427152|NCT00001722|Fat Tissue|fat tissue
427153|NCT00001722|Metabolism|metabolism
427154|NCT00001722|Adipose Tissue|adipose tissue
427155|NCT00001722|Microdialysis|microdialysis
427156|NCT00001722|Leptin|leptin
427157|NCT00001722|Lipolysis|lipolysis
427158|NCT00001722|Normal Volunteer|normal volunteer
427159|NCT00001723|Dyslipidemia|dyslipidemia
427160|NCT00001723|Race|race
427161|NCT00001723|Body Fat|body fat
427162|NCT00001723|Visceral Fat|visceral fat
427163|NCT00001723|Sleep Apnea|sleep apnea
427164|NCT00001723|Fat-Soluble Vitamins|fat-soluble vitamins
427165|NCT00001723|Type 2 Diabetes|type 2 diabetes
427166|NCT00001723|Obesity|obesity
427167|NCT00001723|Childhood Obesity|childhood obesity
427168|NCT00001724|Pain|pain
427169|NCT00001724|Microencapsulated Drug|microencapsulated drug
427170|NCT00001724|NSAID|nsaid
427171|NCT00001724|Acute Inflammation|acute inflammation
427172|NCT00001724|Peripheral Administration|peripheral administration
427173|NCT00001724|Dose-Response|dose-response
427174|NCT00001724|Relative Potency Assay|relative potency assay
427175|NCT00001724|Pharmacokinetics|pharmacokinetics
427176|NCT00001725|Trigeminal Neuralgia|trigeminal neuralgia
427177|NCT00001725|Dextromethorphan|dextromethorphan
427178|NCT00001725|Topiramate|topiramate
427179|NCT00001725|Orofacial Pain|orofacial pain
427180|NCT00001725|Neuropathic Pain|neuropathic pain
427181|NCT00001725|Facial Neuralgia|facial neuralgia
427182|NCT00001726|Bacterial Colonization|bacterial colonization
427183|NCT00001726|Plaque|plaque
427184|NCT00001726|Mouth|mouth
427185|NCT00001726|Saliva|saliva
427186|NCT00001726|Adhesion|adhesion
427187|NCT00001726|Dental Plaque Formation|dental plaque formation
427188|NCT00001726|Dental Caries|dental caries
427189|NCT00001727|Fibrous Dysplasia (FD)|fibrous dysplasia (fd)
427190|NCT00001727|McCune-Albright Syndrome|mccune-albright syndrome
427191|NCT00001727|Polyostotic Fibrous Dysplasia|polyostotic fibrous dysplasia
427192|NCT00001728|Bone Marrow Stromal Cells|bone marrow stromal cells
427193|NCT00001728|Bone Turnover|bone turnover
427194|NCT00001728|Fibrous Dysplastic Lesion|fibrous dysplastic lesion
427195|NCT00001728|Polyostotic Fibrous Dysplasia|polyostotic fibrous dysplasia
427196|NCT00001728|McCune-Albright Syndrome|mccune-albright syndrome
427197|NCT00001729|Cirrhosis|cirrhosis
427198|NCT00001729|Liver Disease|liver disease
427199|NCT00001729|Hemolytic Anemia|hemolytic anemia
427200|NCT00001729|Liver Biopsy|liver biopsy
427201|NCT00001729|Ribavirin|ribavirin
427202|NCT00001729|Alpha Interferon|alpha interferon
427203|NCT00001729|Viral Hepatitis|viral hepatitis
427204|NCT00001729|Hepatitis C Virus|hepatitis c virus
427205|NCT00001729|Chronic Hepatitis|chronic hepatitis
427206|NCT00001729|Antiviral Agents|antiviral agents
427208|NCT00001730|Activity-Time Curves|activity-time curves
427209|NCT00001730|Iodine Biokinetics|iodine biokinetics
427210|NCT00001730|Thyroid Carcinoma|thyroid carcinoma
427211|NCT00001730|Thyroid Remnant|thyroid remnant
427212|NCT00001731|Conjunctiva|conjunctiva
427213|NCT00001731|Dry Eyes|dry eyes
427214|NCT00001731|Inflammation|inflammation
427215|NCT00001731|Lacrimal Gland|lacrimal gland
427216|NCT00001731|T Lymphocyte|t lymphocyte
427217|NCT00001731|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
427218|NCT00001732|Genetics|genetics
427219|NCT00001732|Diagnosis|diagnosis
427220|NCT00001732|Screening Protocol|screening protocol
427221|NCT00001732|Ophthalmic Genetic Diseases|ophthalmic genetic diseases
427222|NCT00001732|Genetic Testing|genetic testing
427223|NCT00001732|Family Studies|family studies
427224|NCT00001733|Diabetic Retinopathy|diabetic retinopathy
427225|NCT00001733|Age-Related Macular Degeneration|age-related macular degeneration
427226|NCT00001733|Neovascularization|neovascularization
427227|NCT00001733|Macular Degeneration|macular degeneration
427228|NCT00001733|Retinal Disease|retinal disease
427229|NCT00001733|Diabetes|diabetes
427231|NCT00001734|Conjunctivitis|conjunctivitis
427233|NCT00001734|Retinitis|retinitis
427234|NCT00001734|Keratitis|keratitis
427235|NCT00001734|Screening Protocol|screening protocol
427236|NCT00001734|Ocular Immunology|ocular immunology
427237|NCT00001734|Inflammation|inflammation
427238|NCT00001734|Eye Inflammation|eye inflammation
427239|NCT00001735|Gene Therapy|gene therapy
427240|NCT00001735|Graft|graft
427241|NCT00001735|Ornithine|ornithine
427242|NCT00001735|Retina|retina
427243|NCT00001735|Retinovirus|retinovirus
427244|NCT00001735|Retrovirus|retrovirus
427245|NCT00001735|Skin|skin
427246|NCT00001735|Gyrate Atrophy|gyrate atrophy
427247|NCT00001736|Corneal Crystals|corneal crystals
427248|NCT00001736|Cysteamine|cysteamine
427249|NCT00001736|Cystinosis|cystinosis
427250|NCT00001736|Eye|eye
427251|NCT00001737|Eye|eye
427252|NCT00001737|Immunosuppression|immunosuppression
427253|NCT00001737|Inflammation|inflammation
427254|NCT00001737|Therapy|therapy
427255|NCT00001737|Vitreous|vitreous
427256|NCT00001737|Uveitis|uveitis
427257|NCT00001738|Intermediate Uveitis|intermediate uveitis
427258|NCT00001738|Pars Planitis|pars planitis
200960|NCT02112812|Eradication|eradication
427259|NCT00001738|Retinal Vasculature|retinal vasculature
427260|NCT00001738|Uveitis|uveitis
427261|NCT00001738|Vascular Permeability|vascular permeability
427262|NCT00001738|Vitreous|vitreous
427263|NCT00001740|Cardiac|cardiac
427264|NCT00001740|Function|function
427265|NCT00001740|MRI|mri
427266|NCT00001740|Reconstruction|reconstruction
427267|NCT00001740|Ultrasound|ultrasound
427268|NCT00001740|Heart Disease (Cardiovascular Disease)|heart disease (cardiovascular disease)
427269|NCT00001741|Angiotensin II Receptor|angiotensin ii receptor
427270|NCT00001741|Polymorphism, Genetic|polymorphism, genetic
427271|NCT00001741|Vascular Tone|vascular tone
427272|NCT00001741|Angiotensin II|angiotensin ii
427273|NCT00001741|Losartan|losartan
427274|NCT00001742|Acetylcholine|acetylcholine
427275|NCT00001742|Aspirin|aspirin
427276|NCT00001742|Nitric Oxide|nitric oxide
427277|NCT00001742|Sodium Nitroprusside|sodium nitroprusside
427278|NCT00001742|Hypercholesterolemia|hypercholesterolemia
427279|NCT00001742|Hypertension|hypertension
427280|NCT00001746|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
427281|NCT00001746|HCM|hcm
427282|NCT00001746|Evaluation for Research|evaluation for research
427283|NCT00001746|Medical Advice|medical advice
427284|NCT00001747|Brachial Artery|brachial artery
427285|NCT00001747|Doppler|doppler
427286|NCT00001747|Endothelium|endothelium
427287|NCT00001747|Nitric Oxide|nitric oxide
427288|NCT00001747|Nitroglycerin|nitroglycerin
427289|NCT00001747|Normal Volunteer|normal volunteer
427290|NCT00001748|Cyclophosphamide|cyclophosphamide
427291|NCT00001748|Donor Apheresis|donor apheresis
427292|NCT00001748|Graft vs. Host Disease|graft vs. host disease
427293|NCT00001748|Graft-Versus-Leukemia|graft-versus-leukemia
427294|NCT00001748|Leukemic Relapse|leukemic relapse
427295|NCT00001748|Myeloma|myeloma
427296|NCT00001748|Peripheral Blood Stem Cells|peripheral blood stem cells
427297|NCT00001748|Whole Body Irradiation|whole body irradiation
427298|NCT00001748|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
427299|NCT00001748|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
427300|NCT00001748|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
427301|NCT00001748|Hematological Malignancies|hematological malignancies
427302|NCT00001748|Myelodysplastic Syndrome|myelodysplastic syndrome
427303|NCT00001748|Myeloproliferative Disorders|myeloproliferative disorders
427304|NCT00001749|Immune Suppression|immune suppression
427305|NCT00001749|Erythroid Hypoplasia|erythroid hypoplasia
427306|NCT00001749|Congenital Anemia|congenital anemia
427307|NCT00001749|Reticulocytopenia|reticulocytopenia
427308|NCT00001749|Diamond Blackfan Anemia|diamond blackfan anemia
427311|NCT00001750|Stem Cell|stem cell
427312|NCT00001750|Apheresis|apheresis
427313|NCT00001750|Melphalan|melphalan
427314|NCT00001750|Gene Transfer|gene transfer
427315|NCT00001750|Retroviral Receptor|retroviral receptor
427316|NCT00001750|Stem Cell Expansion|stem cell expansion
427317|NCT00001750|Multiple Myeloma|multiple myeloma
427318|NCT00001752|Adhesion Molecules|adhesion molecules
427319|NCT00001752|Endothelial Function|endothelial function
427320|NCT00001752|Inflammation|inflammation
427321|NCT00001752|Lipoproteins|lipoproteins
427322|NCT00001752|Nitric Oxide|nitric oxide
427323|NCT00001752|Hormone Therapy|hormone therapy
427324|NCT00001752|Postmenopausal Women|postmenopausal women
427325|NCT00001753|Exercise|exercise
427326|NCT00001753|MRI|mri
427327|NCT00001753|MRS|mrs
427328|NCT00001753|Normal Volunteer|normal volunteer
427329|NCT00001753|Tibialix Anterior|tibialix anterior
427330|NCT00001754|Dwarfism|dwarfism
427331|NCT00001754|Gene Mapping|gene mapping
427332|NCT00001754|Linkage|linkage
427333|NCT00001754|Mutation Analysis|mutation analysis
427334|NCT00001754|Skeletal Biology|skeletal biology
427335|NCT00001754|Brachydactyly Types C & E|brachydactyly types c & e
427336|NCT00001754|Cartilage-Hair Hypoplasia|cartilage-hair hypoplasia
427337|NCT00001754|Ellis Van Crevald|ellis van crevald
427338|NCT00001754|FgFR-3|fgfr-3
427339|NCT00001754|Proximal Symphalangism|proximal symphalangism
427340|NCT00001754|Pyknodysotosis|pyknodysotosis
427341|NCT00001754|Schmid Metaphyseal|schmid metaphyseal
427342|NCT00001754|Short Stature|short stature
427343|NCT00001754|Skeletal Dysplasia|skeletal dysplasia
427344|NCT00001754|Type II Collagen Disorder|type ii collagen disorder
427345|NCT00001756|Leukapheresis|leukapheresis
427346|NCT00001756|Mastocytosis|mastocytosis
427347|NCT00001756|G-CSF|g-csf
427348|NCT00001756|Mast Cells|mast cells
427349|NCT00001756|Normal Volunteer|normal volunteer
427350|NCT00001756|Systemic Mastocytosis|systemic mastocytosis
427351|NCT00002677|stage IV prostate cancer|stage iv prostate cancer
427352|NCT00002677|recurrent prostate cancer|recurrent prostate cancer
427353|NCT00002677|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
427354|NCT00002678|stage I multiple myeloma|stage i multiple myeloma
427355|NCT00002678|stage II multiple myeloma|stage ii multiple myeloma
427356|NCT00002678|stage III multiple myeloma|stage iii multiple myeloma
427357|NCT00002679|stage II breast cancer|stage ii breast cancer
427358|NCT00002679|stage IIIA breast cancer|stage iiia breast cancer
427359|NCT00002679|male breast cancer|male breast cancer
427360|NCT00002680|stage IV breast cancer|stage iv breast cancer
427361|NCT00002680|recurrent breast cancer|recurrent breast cancer
427362|NCT00002681|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
427363|NCT00002681|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
427364|NCT00002681|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
427365|NCT00002681|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
427366|NCT00002681|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
427367|NCT00002682|Antibiotic Treatment|antibiotic treatment
427368|NCT00002682|Gastric Malt Lymphoma|gastric malt lymphoma
427369|NCT00002682|stage I marginal zone lymphoma|stage i marginal zone lymphoma
427370|NCT00002682|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
427371|NCT00002684|stage III bladder cancer|stage iii bladder cancer
427372|NCT00002684|recurrent bladder cancer|recurrent bladder cancer
427373|NCT00002684|stage IV bladder cancer|stage iv bladder cancer
427374|NCT00002684|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
427375|NCT00002684|adenocarcinoma of the bladder|adenocarcinoma of the bladder
427376|NCT00002684|recurrent urethral cancer|recurrent urethral cancer
427377|NCT00002684|distal urethral cancer|distal urethral cancer
427378|NCT00002684|proximal urethral cancer|proximal urethral cancer
427379|NCT00002684|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
427380|NCT00002687|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
427381|NCT00002687|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
427382|NCT00002687|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
427383|NCT00002687|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
427384|NCT00002687|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
427385|NCT00002687|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
427386|NCT00002687|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
427387|NCT00002687|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
427388|NCT00002688|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
427389|NCT00002689|stage I pancreatic cancer|stage i pancreatic cancer
427390|NCT00002689|stage II pancreatic cancer|stage ii pancreatic cancer
427391|NCT00002689|stage III pancreatic cancer|stage iii pancreatic cancer
427392|NCT00002689|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
427393|NCT00002691|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
427394|NCT00002691|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
427395|NCT00002691|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
427396|NCT00002691|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
428069|NCT00002826|recurrent breast cancer|recurrent breast cancer
427397|NCT00002691|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
427398|NCT00002692|stage IV colon cancer|stage iv colon cancer
427399|NCT00002692|stage IV rectal cancer|stage iv rectal cancer
427400|NCT00002692|recurrent colon cancer|recurrent colon cancer
427401|NCT00002692|recurrent rectal cancer|recurrent rectal cancer
427402|NCT00002692|adenocarcinoma of the colon|adenocarcinoma of the colon
427403|NCT00002692|adenocarcinoma of the rectum|adenocarcinoma of the rectum
427404|NCT00002692|liver metastases|liver metastases
427405|NCT00002693|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
427406|NCT00002693|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
427407|NCT00002693|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
427408|NCT00002693|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
427409|NCT00002693|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
427410|NCT00002693|neutropenia|neutropenia
427411|NCT00002695|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
427412|NCT00002695|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
427413|NCT00002695|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
427414|NCT00002695|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
427415|NCT00002695|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
427416|NCT00002695|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
427417|NCT00002695|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
427418|NCT00002695|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
427419|NCT00002695|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
427420|NCT00002695|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
427421|NCT00002695|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
427422|NCT00002695|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
427423|NCT00002695|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
427424|NCT00002695|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
427425|NCT00002695|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
427426|NCT00002695|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
427427|NCT00002695|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
427428|NCT00002695|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
427429|NCT00002695|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
427430|NCT00002695|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
427431|NCT00002695|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
427432|NCT00002695|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
427433|NCT00002695|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
427434|NCT00002695|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
427435|NCT00002695|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
427436|NCT00002696|stage IIIA breast cancer|stage iiia breast cancer
427437|NCT00002696|stage IIIB breast cancer|stage iiib breast cancer
427438|NCT00002696|stage IIIC breast cancer|stage iiic breast cancer
427439|NCT00002697|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
427440|NCT00002697|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
427441|NCT00002697|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
427442|NCT00002697|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
427443|NCT00002697|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
427444|NCT00002697|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
427445|NCT00002697|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
427446|NCT00002697|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
427447|NCT00002697|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
427448|NCT00002697|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
427449|NCT00002697|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
427450|NCT00002697|splenic marginal zone lymphoma|splenic marginal zone lymphoma
427451|NCT00002700|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
427452|NCT00002700|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
427453|NCT00002700|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
427454|NCT00002700|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
427455|NCT00002700|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
427456|NCT00002700|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
427457|NCT00002701|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
427458|NCT00002701|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
427459|NCT00002702|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
427460|NCT00002702|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
427461|NCT00002702|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
427462|NCT00002702|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
427463|NCT00002702|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
427464|NCT00002702|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
427465|NCT00002702|tongue cancer|tongue cancer
427466|NCT00002703|adenocarcinoma of the prostate|adenocarcinoma of the prostate
427467|NCT00002703|stage I prostate cancer|stage i prostate cancer
427468|NCT00002703|stage IIB prostate cancer|stage iib prostate cancer
427469|NCT00002703|stage IIA prostate cancer|stage iia prostate cancer
427470|NCT00002704|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
427471|NCT00002704|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
427472|NCT00002704|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
427473|NCT00002704|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
427474|NCT00002705|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
427475|NCT00002705|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
427476|NCT00002705|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
427477|NCT00002707|stage I breast cancer|stage i breast cancer
427478|NCT00002707|stage II breast cancer|stage ii breast cancer
427479|NCT00002707|stage IIIA breast cancer|stage iiia breast cancer
427480|NCT00002708|tumors metastatic to brain|tumors metastatic to brain
427481|NCT00002711|stage I esophageal cancer|stage i esophageal cancer
427482|NCT00002711|stage II esophageal cancer|stage ii esophageal cancer
427483|NCT00002711|stage III esophageal cancer|stage iii esophageal cancer
427484|NCT00002711|recurrent esophageal cancer|recurrent esophageal cancer
427485|NCT00002711|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
427486|NCT00002711|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
427487|NCT00002717|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
427488|NCT00002717|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
427489|NCT00002717|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
427490|NCT00002717|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
427491|NCT00002717|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
427492|NCT00002717|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
427493|NCT00002717|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
427494|NCT00002717|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
427495|NCT00002717|primary peritoneal cavity cancer|primary peritoneal cavity cancer
427496|NCT00002717|Brenner tumor|brenner tumor
427497|NCT00002718|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
427498|NCT00002718|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
427499|NCT00002718|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
427500|NCT00002718|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
427501|NCT00002718|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
427502|NCT00002718|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
427503|NCT00002718|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
427504|NCT00002718|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
427505|NCT00002718|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
427506|NCT00002718|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
427507|NCT00002718|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
427508|NCT00002718|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
427118|NCT00001716|P50|p50
427509|NCT00002718|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
427510|NCT00002718|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
427511|NCT00002718|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
427512|NCT00002718|secondary acute myeloid leukemia|secondary acute myeloid leukemia
427513|NCT00002718|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
427514|NCT00002718|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
427515|NCT00002718|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
427516|NCT00002718|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
427517|NCT00002718|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
427518|NCT00002718|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
427519|NCT00002718|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
427520|NCT00002718|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
427521|NCT00002718|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
427522|NCT00002719|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
427523|NCT00002719|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
427524|NCT00002719|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
427525|NCT00002719|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
427526|NCT00002719|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
427527|NCT00002719|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
427528|NCT00002719|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
427529|NCT00002719|secondary acute myeloid leukemia|secondary acute myeloid leukemia
427530|NCT00002719|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
427531|NCT00002719|neutropenia|neutropenia
427532|NCT00002719|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
427533|NCT00002720|stage I breast cancer|stage i breast cancer
427534|NCT00002721|recurrent prostate cancer|recurrent prostate cancer
427535|NCT00002722|stage III gastric cancer|stage iii gastric cancer
427536|NCT00002722|stage IV gastric cancer|stage iv gastric cancer
427537|NCT00002723|adenocarcinoma of the prostate|adenocarcinoma of the prostate
427538|NCT00002723|stage III prostate cancer|stage iii prostate cancer
427539|NCT00002723|stage IV prostate cancer|stage iv prostate cancer
427540|NCT00002723|recurrent prostate cancer|recurrent prostate cancer
427541|NCT00002725|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
752425|NCT01172938|inflammation|inflammation
427542|NCT00002725|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
427543|NCT00002725|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
427544|NCT00002725|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
427545|NCT00002725|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
427546|NCT00002725|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
427547|NCT00002725|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
427548|NCT00002725|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
427549|NCT00002725|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
427550|NCT00002725|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
427551|NCT00002725|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
427552|NCT00002725|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
427553|NCT00002725|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
427554|NCT00002725|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
427555|NCT00002725|splenic marginal zone lymphoma|splenic marginal zone lymphoma
427556|NCT00002727|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
427557|NCT00002730|recurrent neuroblastoma|recurrent neuroblastoma
427558|NCT00002733|stage IV renal cell cancer|stage iv renal cell cancer
427559|NCT00002733|stage IV melanoma|stage iv melanoma
427560|NCT00002733|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
427561|NCT00002734|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
427562|NCT00002734|primary peritoneal cavity cancer|primary peritoneal cavity cancer
427563|NCT00002735|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
427564|NCT00002735|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
427565|NCT00002735|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
427566|NCT00002735|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
427567|NCT00002737|stage IV renal cell cancer|stage iv renal cell cancer
427568|NCT00002737|recurrent renal cell cancer|recurrent renal cell cancer
427569|NCT00002738|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
427570|NCT00002738|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
427571|NCT00002738|recurrent osteosarcoma|recurrent osteosarcoma
427572|NCT00002738|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
427573|NCT00002738|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
427574|NCT00002740|disseminated neuroblastoma|disseminated neuroblastoma
427575|NCT00002742|adult Hodgkin lymphoma|adult hodgkin lymphoma
427576|NCT00002742|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
427577|NCT00002742|leukemia|leukemia
427578|NCT00002742|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
427579|NCT00002742|chronic myeloproliferative disorders|chronic myeloproliferative disorders
427580|NCT00002742|myelodysplastic syndromes|myelodysplastic syndromes
427581|NCT00002742|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
427582|NCT00002742|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
427583|NCT00002742|infection|infection
427584|NCT00002742|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
427585|NCT00002742|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
427586|NCT00002744|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
427587|NCT00002744|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
428284|NCT00002864|stage III breast cancer|stage iii breast cancer
427588|NCT00002744|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
427589|NCT00002745|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
427590|NCT00002745|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
427591|NCT00002745|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
427592|NCT00002745|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
427593|NCT00002746|refractory anemia|refractory anemia
427594|NCT00002746|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
427595|NCT00002746|refractory anemia with excess blasts|refractory anemia with excess blasts
427596|NCT00002746|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
427597|NCT00002746|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
427598|NCT00002746|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
427599|NCT00002746|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
427600|NCT00002746|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
427601|NCT00002746|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
427602|NCT00002746|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
427603|NCT00002747|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
427604|NCT00002747|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
427605|NCT00002747|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
427606|NCT00002748|recurrent neuroblastoma|recurrent neuroblastoma
427607|NCT00002749|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
427608|NCT00002749|recurrent adult brain tumor|recurrent adult brain tumor
427609|NCT00002749|adult brain stem glioma|adult brain stem glioma
427610|NCT00002749|childhood oligodendroglioma|childhood oligodendroglioma
427611|NCT00002749|untreated childhood brain stem glioma|untreated childhood brain stem glioma
427612|NCT00002749|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
427613|NCT00002749|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
427614|NCT00002749|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
427615|NCT00002749|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
427616|NCT00002749|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
427617|NCT00002749|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
427618|NCT00002749|adult anaplastic astrocytoma|adult anaplastic astrocytoma
427619|NCT00002749|adult oligodendroglioma|adult oligodendroglioma
427620|NCT00002750|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
427621|NCT00002750|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
427622|NCT00002750|Waldenström macroglobulinemia|waldenström macroglobulinemia
427623|NCT00002750|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
427624|NCT00002750|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
427625|NCT00002750|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
427626|NCT00002750|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
427627|NCT00002750|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
427628|NCT00002750|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
427629|NCT00002750|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
427630|NCT00002750|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
427631|NCT00002750|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
427632|NCT00002750|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
427633|NCT00002750|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
427634|NCT00002750|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
427635|NCT00002750|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
427636|NCT00002750|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
427637|NCT00002750|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
427638|NCT00002750|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
427639|NCT00002750|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
427640|NCT00002750|extragonadal germ cell tumor|extragonadal germ cell tumor
427641|NCT00002750|leptomeningeal metastases|leptomeningeal metastases
427642|NCT00002750|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
427643|NCT00002750|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
427644|NCT00002750|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
427645|NCT00002750|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
427646|NCT00002750|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
427647|NCT00002750|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
427648|NCT00002750|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
427649|NCT00002750|splenic marginal zone lymphoma|splenic marginal zone lymphoma
427650|NCT00002751|leptomeningeal metastases|leptomeningeal metastases
427651|NCT00002752|childhood supratentorial ependymoma|childhood supratentorial ependymoma
428425|NCT00002901|recurrent breast cancer|recurrent breast cancer
427652|NCT00002752|recurrent childhood brain tumor|recurrent childhood brain tumor
427653|NCT00002752|recurrent adult brain tumor|recurrent adult brain tumor
427654|NCT00002752|adult medulloblastoma|adult medulloblastoma
427655|NCT00002752|adult glioblastoma|adult glioblastoma
427656|NCT00002752|tumors metastatic to brain|tumors metastatic to brain
427657|NCT00002752|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
427658|NCT00002752|adult anaplastic astrocytoma|adult anaplastic astrocytoma
427659|NCT00002752|adult myxopapillary ependymoma|adult myxopapillary ependymoma
427660|NCT00002752|adult anaplastic ependymoma|adult anaplastic ependymoma
427661|NCT00002752|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
427662|NCT00002752|adult mixed glioma|adult mixed glioma
427663|NCT00002752|adult pilocytic astrocytoma|adult pilocytic astrocytoma
427664|NCT00002752|adult subependymoma|adult subependymoma
427665|NCT00002752|adult ependymoblastoma|adult ependymoblastoma
427666|NCT00002752|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
427667|NCT00002752|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
427668|NCT00002752|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
427669|NCT00002752|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
427670|NCT00002752|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
427671|NCT00002752|recurrent childhood ependymoma|recurrent childhood ependymoma
427672|NCT00002752|adult oligodendroglioma|adult oligodendroglioma
427673|NCT00002752|adult giant cell glioblastoma|adult giant cell glioblastoma
427674|NCT00002752|adult gliosarcoma|adult gliosarcoma
427675|NCT00002753|childhood supratentorial ependymoma|childhood supratentorial ependymoma
427676|NCT00002753|recurrent childhood brain tumor|recurrent childhood brain tumor
427677|NCT00002753|recurrent adult brain tumor|recurrent adult brain tumor
427679|NCT00002753|adult anaplastic astrocytoma|adult anaplastic astrocytoma
427680|NCT00002753|adult myxopapillary ependymoma|adult myxopapillary ependymoma
427681|NCT00002753|adult anaplastic ependymoma|adult anaplastic ependymoma
427682|NCT00002753|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
427683|NCT00002753|adult mixed glioma|adult mixed glioma
427684|NCT00002753|adult ependymoblastoma|adult ependymoblastoma
427685|NCT00002753|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
427686|NCT00002753|recurrent childhood ependymoma|recurrent childhood ependymoma
427687|NCT00002753|adult giant cell glioblastoma|adult giant cell glioblastoma
427688|NCT00002753|adult gliosarcoma|adult gliosarcoma
427689|NCT00002754|recurrent adult brain tumor|recurrent adult brain tumor
427690|NCT00002754|adult glioblastoma|adult glioblastoma
427691|NCT00002754|stage IV melanoma|stage iv melanoma
427692|NCT00002754|tumors metastatic to brain|tumors metastatic to brain
427693|NCT00002754|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
427694|NCT00002754|adult anaplastic astrocytoma|adult anaplastic astrocytoma
427695|NCT00002754|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
427696|NCT00002754|adult mixed glioma|adult mixed glioma
427697|NCT00002754|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
427698|NCT00002754|adult giant cell glioblastoma|adult giant cell glioblastoma
427699|NCT00002754|adult gliosarcoma|adult gliosarcoma
427700|NCT00002755|stage II breast cancer|stage ii breast cancer
427701|NCT00002755|stage IIIA breast cancer|stage iiia breast cancer
427702|NCT00002756|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
427703|NCT00002756|acute undifferentiated leukemia|acute undifferentiated leukemia
427704|NCT00002757|childhood Burkitt lymphoma|childhood burkitt lymphoma
427705|NCT00002757|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
427706|NCT00002757|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
427707|NCT00002757|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
427708|NCT00002757|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
427709|NCT00002757|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
427710|NCT00002757|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
427711|NCT00002757|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
427712|NCT00002757|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
427713|NCT00002757|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
427714|NCT00002757|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
427715|NCT00002759|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
427716|NCT00002759|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
427717|NCT00002759|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
445068|NCT00006395|Interaction|interaction
427718|NCT00002759|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
427719|NCT00002759|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
427720|NCT00002759|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
427721|NCT00002759|small intestine lymphoma|small intestine lymphoma
427722|NCT00002759|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
427723|NCT00002759|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
427724|NCT00002759|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
427725|NCT00002759|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
427726|NCT00002759|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
427727|NCT00002759|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
427728|NCT00002759|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
427729|NCT00002759|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
427730|NCT00002759|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
427731|NCT00002759|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
427732|NCT00002759|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
427733|NCT00002759|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
427734|NCT00002759|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
427735|NCT00002759|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
427736|NCT00002759|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
427737|NCT00002759|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
752426|NCT01172938|skin condition|skin condition
426985|NCT00001676|Lupus Nephritis|lupus nephritis
427738|NCT00002759|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
427739|NCT00002759|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
427740|NCT00002759|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
427741|NCT00002759|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
427742|NCT00002759|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
427743|NCT00002759|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
427744|NCT00002759|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
427745|NCT00002759|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
427746|NCT00002759|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
427747|NCT00002759|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
427748|NCT00002759|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
427749|NCT00002759|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
427750|NCT00002759|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
427751|NCT00002759|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
427752|NCT00002759|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
427753|NCT00002759|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
427754|NCT00002759|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
427756|NCT00002759|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
427757|NCT00002759|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
427758|NCT00002759|intraocular lymphoma|intraocular lymphoma
427759|NCT00002759|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
427760|NCT00002759|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
427761|NCT00002759|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
427762|NCT00002759|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
427763|NCT00002759|anaplastic large cell lymphoma|anaplastic large cell lymphoma
427764|NCT00002759|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
427765|NCT00002759|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
427766|NCT00002759|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
427767|NCT00002759|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
427768|NCT00002759|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
427769|NCT00002759|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
427770|NCT00002759|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
427771|NCT00002759|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
427772|NCT00002759|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
427773|NCT00002759|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
427774|NCT00002759|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
427775|NCT00002759|splenic marginal zone lymphoma|splenic marginal zone lymphoma
427776|NCT00002760|adenocarcinoma of the prostate|adenocarcinoma of the prostate
427777|NCT00002760|recurrent prostate cancer|recurrent prostate cancer
427778|NCT00002761|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
427779|NCT00002761|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
427780|NCT00002761|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
427783|NCT00002762|perioperative/postoperative complications|perioperative/postoperative complications
427784|NCT00002763|stage III melanoma|stage iii melanoma
427785|NCT00002763|recurrent melanoma|recurrent melanoma
427786|NCT00002764|adult angiosarcoma|adult angiosarcoma
427787|NCT00002764|adult fibrosarcoma|adult fibrosarcoma
427788|NCT00002764|adult leiomyosarcoma|adult leiomyosarcoma
427789|NCT00002764|adult liposarcoma|adult liposarcoma
427790|NCT00002764|adult neurofibrosarcoma|adult neurofibrosarcoma
427791|NCT00002764|adult synovial sarcoma|adult synovial sarcoma
427792|NCT00002764|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
427793|NCT00002764|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
427794|NCT00002764|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
427795|NCT00002764|adult malignant mesenchymoma|adult malignant mesenchymoma
427796|NCT00002764|localized benign pheochromocytoma|localized benign pheochromocytoma
427797|NCT00002764|regional pheochromocytoma|regional pheochromocytoma
427798|NCT00002764|lung metastases|lung metastases
427799|NCT00002764|stage IV uterine sarcoma|stage iv uterine sarcoma
427800|NCT00002764|recurrent uterine sarcoma|recurrent uterine sarcoma
427801|NCT00002764|uterine leiomyosarcoma|uterine leiomyosarcoma
427802|NCT00002764|endometrial stromal sarcoma|endometrial stromal sarcoma
427803|NCT00002764|ovarian sarcoma|ovarian sarcoma
427804|NCT00002764|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
427805|NCT00002764|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
427806|NCT00002765|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
427807|NCT00002765|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
427808|NCT00002765|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
427809|NCT00002765|Waldenström macroglobulinemia|waldenström macroglobulinemia
427810|NCT00002765|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
427811|NCT00002765|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
427812|NCT00002765|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
427813|NCT00002765|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
427814|NCT00002765|refractory hairy cell leukemia|refractory hairy cell leukemia
427815|NCT00002765|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
427816|NCT00002765|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
427817|NCT00002765|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
427818|NCT00002765|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
427819|NCT00002765|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
427820|NCT00002765|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
427821|NCT00002765|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
427822|NCT00002765|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
427823|NCT00002765|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
427824|NCT00002765|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
427825|NCT00002765|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
427826|NCT00002765|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
427827|NCT00002765|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
427828|NCT00002765|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
427829|NCT00002765|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
427830|NCT00002765|prolymphocytic leukemia|prolymphocytic leukemia
427831|NCT00002765|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
427832|NCT00002765|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
427833|NCT00002765|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
427834|NCT00002765|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
427835|NCT00002765|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
427836|NCT00002765|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
427837|NCT00002765|splenic marginal zone lymphoma|splenic marginal zone lymphoma
427838|NCT00002766|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
427839|NCT00002766|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
427840|NCT00002766|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
427841|NCT00002766|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
427842|NCT00002766|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
427843|NCT00002766|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
427844|NCT00002766|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
427845|NCT00002766|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
427846|NCT00002766|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
427847|NCT00002766|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
427848|NCT00002766|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
427849|NCT00002767|stage IV melanoma|stage iv melanoma
427850|NCT00002767|recurrent melanoma|recurrent melanoma
427851|NCT00002768|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
427852|NCT00002768|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
444192|NCT00006289|Causalgia|causalgia
427853|NCT00002768|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
427854|NCT00002768|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
427855|NCT00002768|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
427856|NCT00002768|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
427857|NCT00002768|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
427858|NCT00002768|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
427859|NCT00002768|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
427860|NCT00002768|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
427861|NCT00002771|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
427862|NCT00002771|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
427863|NCT00002771|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
427864|NCT00002771|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
427865|NCT00002772|stage II breast cancer|stage ii breast cancer
427866|NCT00002772|stage IIIA breast cancer|stage iiia breast cancer
427867|NCT00002773|stage II pancreatic cancer|stage ii pancreatic cancer
427868|NCT00002773|stage III pancreatic cancer|stage iii pancreatic cancer
427869|NCT00002773|recurrent pancreatic cancer|recurrent pancreatic cancer
427870|NCT00002773|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
427232|NCT00001734|Iritis|iritis
427871|NCT00002773|stage IV pancreatic cancer|stage iv pancreatic cancer
427872|NCT00002774|stage III|stage iii
427873|NCT00002774|stage IV|stage iv
427874|NCT00002774|recurrent|recurrent
427875|NCT00002775|adenocarcinoma of the prostate|adenocarcinoma of the prostate
427876|NCT00002775|stage IV prostate cancer|stage iv prostate cancer
427877|NCT00002775|recurrent prostate cancer|recurrent prostate cancer
427878|NCT00002777|stage IV breast cancer|stage iv breast cancer
427879|NCT00002777|recurrent breast cancer|recurrent breast cancer
427880|NCT00002778|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
427881|NCT00002778|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
427882|NCT00002778|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
427883|NCT00002778|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
427884|NCT00002778|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
427885|NCT00002778|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
427886|NCT00002779|Waldenström macroglobulinemia|waldenström macroglobulinemia
427887|NCT00002779|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
427888|NCT00002779|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
427889|NCT00002779|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
427890|NCT00002779|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
427891|NCT00002779|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
427892|NCT00002779|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
427893|NCT00002779|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
427894|NCT00002780|stage IV breast cancer|stage iv breast cancer
427895|NCT00002780|recurrent breast cancer|recurrent breast cancer
427896|NCT00002780|stage IIIB breast cancer|stage iiib breast cancer
427897|NCT00002781|stage III melanoma|stage iii melanoma
427898|NCT00002781|recurrent melanoma|recurrent melanoma
427899|NCT00002783|stage II gastric cancer|stage ii gastric cancer
427900|NCT00002783|stage III gastric cancer|stage iii gastric cancer
427901|NCT00002783|stage IV gastric cancer|stage iv gastric cancer
427902|NCT00002783|adenocarcinoma of the stomach|adenocarcinoma of the stomach
427903|NCT00002784|stage II breast cancer|stage ii breast cancer
427904|NCT00002784|stage IIIA breast cancer|stage iiia breast cancer
427905|NCT00002785|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
427906|NCT00002786|stage IV melanoma|stage iv melanoma
427907|NCT00002786|recurrent melanoma|recurrent melanoma
427908|NCT00002788|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
427909|NCT00002788|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
427910|NCT00002788|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
427911|NCT00002788|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
427912|NCT00002789|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
427913|NCT00002789|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
10296|NCT03225118|Immune Exhaustion|immune exhaustion
427914|NCT00002789|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
427915|NCT00002790|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
427916|NCT00002790|chronic lymphocytic leukemia|chronic lymphocytic leukemia
427917|NCT00002790|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
427918|NCT00002790|adult acute myeloid leukemia|adult acute myeloid leukemia
427919|NCT00002790|chronic myelogenous leukemia|chronic myelogenous leukemia
427920|NCT00002790|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
427921|NCT00002790|myelodysplastic syndromes|myelodysplastic syndromes
427922|NCT00002790|graft versus host disease|graft versus host disease
427923|NCT00002790|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
427924|NCT00002791|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
427925|NCT00002791|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
427926|NCT00002791|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
427927|NCT00002792|polycythemia vera|polycythemia vera
427928|NCT00002792|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
427929|NCT00002792|essential thrombocythemia|essential thrombocythemia
427930|NCT00002792|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
427931|NCT00002792|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
427932|NCT00002793|stage IV colon cancer|stage iv colon cancer
427933|NCT00002793|stage IV rectal cancer|stage iv rectal cancer
427934|NCT00002793|recurrent colon cancer|recurrent colon cancer
427935|NCT00002793|recurrent rectal cancer|recurrent rectal cancer
427936|NCT00002793|liver metastases|liver metastases
427937|NCT00002794|intraocular retinoblastoma|intraocular retinoblastoma
427938|NCT00002800|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
427939|NCT00002800|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
427309|NCT00001750|G-CSF|g-csf
427940|NCT00002800|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
427941|NCT00002800|refractory anemia with excess blasts|refractory anemia with excess blasts
427942|NCT00002800|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
427943|NCT00002800|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
427944|NCT00002800|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
427945|NCT00002800|neutropenia|neutropenia
427946|NCT00002801|stage II colon cancer|stage ii colon cancer
427947|NCT00002801|stage III colon cancer|stage iii colon cancer
427948|NCT00002801|stage I rectal cancer|stage i rectal cancer
427949|NCT00002801|stage II rectal cancer|stage ii rectal cancer
427950|NCT00002801|stage III rectal cancer|stage iii rectal cancer
427951|NCT00002802|localized resectable neuroblastoma|localized resectable neuroblastoma
427952|NCT00002802|regional neuroblastoma|regional neuroblastoma
427953|NCT00002802|disseminated neuroblastoma|disseminated neuroblastoma
427954|NCT00002802|stage 4S neuroblastoma|stage 4s neuroblastoma
427955|NCT00002802|localized unresectable neuroblastoma|localized unresectable neuroblastoma
427956|NCT00002803|localized resectable neuroblastoma|localized resectable neuroblastoma
427957|NCT00002803|regional neuroblastoma|regional neuroblastoma
427958|NCT00002803|stage 4S neuroblastoma|stage 4s neuroblastoma
427959|NCT00002803|localized unresectable neuroblastoma|localized unresectable neuroblastoma
427960|NCT00002804|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
427961|NCT00002804|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
427962|NCT00002805|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
427963|NCT00002805|secondary acute myeloid leukemia|secondary acute myeloid leukemia
427964|NCT00002805|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
427965|NCT00002806|adult diffuse astrocytoma|adult diffuse astrocytoma
427966|NCT00002807|stage I endometrial carcinoma|stage i endometrial carcinoma
427967|NCT00002807|stage II endometrial carcinoma|stage ii endometrial carcinoma
427968|NCT00002807|endometrial adenocarcinoma|endometrial adenocarcinoma
427969|NCT00002807|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
427970|NCT00002807|endometrial papillary carcinoma|endometrial papillary carcinoma
427971|NCT00002807|endometrial clear cell carcinoma|endometrial clear cell carcinoma
427972|NCT00002809|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
427973|NCT00002809|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
428168|NCT00002844|Cyclophosphamide|cyclophosphamide
427974|NCT00002809|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
427975|NCT00002809|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
427976|NCT00002809|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
427977|NCT00002809|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
427978|NCT00002809|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
427979|NCT00002809|refractory anemia|refractory anemia
427980|NCT00002809|refractory anemia with excess blasts|refractory anemia with excess blasts
427981|NCT00002809|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
427982|NCT00002809|secondary acute myeloid leukemia|secondary acute myeloid leukemia
427983|NCT00002809|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
427984|NCT00002809|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
427985|NCT00002809|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
427986|NCT00002809|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
427987|NCT00002809|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
427988|NCT00002809|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
427989|NCT00002809|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
427990|NCT00002809|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
427991|NCT00002810|refractory multiple myeloma|refractory multiple myeloma
427992|NCT00002810|stage I multiple myeloma|stage i multiple myeloma
427993|NCT00002810|stage II multiple myeloma|stage ii multiple myeloma
427994|NCT00002810|stage III multiple myeloma|stage iii multiple myeloma
427995|NCT00002810|primary systemic amyloidosis|primary systemic amyloidosis
427996|NCT00002811|actinic keratosis|actinic keratosis
427997|NCT00002812|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
427998|NCT00002812|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
427999|NCT00002812|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
428000|NCT00002813|recurrent cervical cancer|recurrent cervical cancer
428001|NCT00002813|stage IVB cervical cancer|stage ivb cervical cancer
428002|NCT00002813|cervical squamous cell carcinoma|cervical squamous cell carcinoma
428003|NCT00002814|recurrent adult brain tumor|recurrent adult brain tumor
428004|NCT00002814|adult glioblastoma|adult glioblastoma
428005|NCT00002814|adult anaplastic astrocytoma|adult anaplastic astrocytoma
428006|NCT00002814|adult giant cell glioblastoma|adult giant cell glioblastoma
428007|NCT00002814|adult gliosarcoma|adult gliosarcoma
428008|NCT00002816|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
428009|NCT00002817|stage III melanoma|stage iii melanoma
428010|NCT00002817|stage IV melanoma|stage iv melanoma
428011|NCT00002817|recurrent melanoma|recurrent melanoma
428012|NCT00002818|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
428013|NCT00002818|refractory multiple myeloma|refractory multiple myeloma
428014|NCT00002818|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
428015|NCT00002818|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
428016|NCT00002818|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
428017|NCT00002818|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
428018|NCT00002818|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
428019|NCT00002818|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
428020|NCT00002818|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
428021|NCT00002818|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
428022|NCT00002818|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
428023|NCT00002818|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
428024|NCT00002818|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
428025|NCT00002818|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
428026|NCT00002818|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
428027|NCT00002818|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
428028|NCT00002818|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
428029|NCT00002818|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
428030|NCT00002818|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
428031|NCT00002818|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
428032|NCT00002818|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
428033|NCT00002818|splenic marginal zone lymphoma|splenic marginal zone lymphoma
428034|NCT00002819|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
428035|NCT00002819|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
428036|NCT00002819|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
428037|NCT00002819|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
428038|NCT00002819|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
428039|NCT00002819|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
428040|NCT00002819|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
428041|NCT00002819|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
428042|NCT00002819|Brenner tumor|brenner tumor
428043|NCT00002822|limited stage small cell lung cancer|limited stage small cell lung cancer
428044|NCT00002822|extensive stage small cell lung cancer|extensive stage small cell lung cancer
428045|NCT00002823|stage I non-small cell lung cancer|stage i non-small cell lung cancer
428046|NCT00002823|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
428047|NCT00002823|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
428048|NCT00002823|squamous cell lung cancer|squamous cell lung cancer
428049|NCT00002823|large cell lung cancer|large cell lung cancer
428050|NCT00002823|adenocarcinoma of the lung|adenocarcinoma of the lung
428051|NCT00002823|adenosquamous cell lung cancer|adenosquamous cell lung cancer
428052|NCT00002824|recurrent adult brain tumor|recurrent adult brain tumor
428054|NCT00002824|adult anaplastic astrocytoma|adult anaplastic astrocytoma
428055|NCT00002824|adult giant cell glioblastoma|adult giant cell glioblastoma
428056|NCT00002824|adult gliosarcoma|adult gliosarcoma
428057|NCT00002825|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
428058|NCT00002825|recurrent neuroblastoma|recurrent neuroblastoma
428059|NCT00002825|recurrent osteosarcoma|recurrent osteosarcoma
428060|NCT00002825|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
428061|NCT00002825|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
428062|NCT00002825|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
428063|NCT00002825|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
428064|NCT00002825|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
428065|NCT00002825|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
428066|NCT00002825|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
428067|NCT00002825|recurrent childhood ependymoma|recurrent childhood ependymoma
428068|NCT00002826|stage IV breast cancer|stage iv breast cancer
428070|NCT00002827|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
428071|NCT00002827|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
428072|NCT00002827|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
428073|NCT00002827|cardiac toxicity|cardiac toxicity
428074|NCT00002828|stage III colon cancer|stage iii colon cancer
428075|NCT00002828|stage IV colon cancer|stage iv colon cancer
428076|NCT00002828|stage III rectal cancer|stage iii rectal cancer
428077|NCT00002828|stage IV rectal cancer|stage iv rectal cancer
428078|NCT00002828|recurrent colon cancer|recurrent colon cancer
428079|NCT00002828|recurrent rectal cancer|recurrent rectal cancer
428080|NCT00002829|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
428081|NCT00002829|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
428082|NCT00002829|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
428083|NCT00002829|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
428084|NCT00002829|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
428085|NCT00002829|extranodal marginal zone B-cell lymphoma|extranodal marginal zone b-cell lymphoma
428086|NCT00002829|mucosa-associated lymphoid tissue|mucosa-associated lymphoid tissue
428087|NCT00002829|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
428088|NCT00002829|splenic marginal zone lymphoma|splenic marginal zone lymphoma
428089|NCT00002831|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
428090|NCT00002831|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
428091|NCT00002831|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
428092|NCT00002832|Decitabine|decitabine
428093|NCT00002832|Dacogen|dacogen
428094|NCT00002832|Filgrastim|filgrastim
428095|NCT00002832|G-CSF|g-csf
428096|NCT00002832|Neupogen|neupogen
428097|NCT00002832|Cyclosporine|cyclosporine
428098|NCT00002832|Sandimmune|sandimmune
428099|NCT00002832|CYA|cya
428100|NCT00002832|Cyclosporin A|cyclosporin a
428101|NCT00002832|Peripheral blood stem cells|peripheral blood stem cells
428102|NCT00002832|PBSC|pbsc
428103|NCT00002832|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
428104|NCT00002832|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
428105|NCT00002832|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
428106|NCT00002832|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
583282|NCT00511134|nicotine dependence|nicotine dependence
428107|NCT00002832|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
428108|NCT00002832|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
428109|NCT00002832|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
428110|NCT00002832|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
428111|NCT00002832|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
428112|NCT00002833|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
428113|NCT00002833|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
428114|NCT00002833|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
428115|NCT00002833|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
428116|NCT00002833|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
428117|NCT00002833|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
428118|NCT00002833|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
428119|NCT00002833|refractory anemia with excess blasts|refractory anemia with excess blasts
428120|NCT00002833|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
428121|NCT00002833|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
428122|NCT00002833|graft versus host disease|graft versus host disease
428123|NCT00002835|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
428124|NCT00002835|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
428125|NCT00002835|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
428126|NCT00002835|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
428127|NCT00002835|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
428128|NCT00002835|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
428129|NCT00002835|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
428130|NCT00002835|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
428131|NCT00002835|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
444193|NCT00006289|CRPS|crps
428132|NCT00002835|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
428133|NCT00002835|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
428134|NCT00002835|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
428135|NCT00002835|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
428136|NCT00002835|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
428137|NCT00002835|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
428138|NCT00002835|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
428215|NCT00002854|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
428139|NCT00002835|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
428140|NCT00002835|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
428141|NCT00002835|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
428142|NCT00002835|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
428143|NCT00002835|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
428144|NCT00002835|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
428145|NCT00002835|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
428146|NCT00002835|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
428147|NCT00002835|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
428148|NCT00002836|recurrent breast cancer|recurrent breast cancer
428149|NCT00002837|stage IV breast cancer|stage iv breast cancer
428150|NCT00002837|recurrent breast cancer|recurrent breast cancer
428151|NCT00002838|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
428152|NCT00002838|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
428153|NCT00002838|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
428154|NCT00002839|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
428155|NCT00002839|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
428156|NCT00002839|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
428157|NCT00002839|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
428158|NCT00002839|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
428159|NCT00002840|recurrent adult brain tumor|recurrent adult brain tumor
428160|NCT00002840|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
428161|NCT00002840|adult mixed glioma|adult mixed glioma
428162|NCT00002842|stage IV colon cancer|stage iv colon cancer
428163|NCT00002842|stage IV rectal cancer|stage iv rectal cancer
428164|NCT00002842|recurrent colon cancer|recurrent colon cancer
583283|NCT00511134|smoking|smoking
428165|NCT00002842|recurrent rectal cancer|recurrent rectal cancer
428166|NCT00002842|liver metastases|liver metastases
428167|NCT00002844|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
428171|NCT00002844|Bone Marrow Transplantation|bone marrow transplantation
428172|NCT00002844|total body irradiation|total body irradiation
428173|NCT00002844|chronic lymphocytic leukemia|chronic lymphocytic leukemia
428174|NCT00002844|allogeneic|allogeneic
428175|NCT00002844|autologous|autologous
428176|NCT00002845|stage IV melanoma|stage iv melanoma
428177|NCT00002845|recurrent melanoma|recurrent melanoma
428178|NCT00002846|stage IV renal cell cancer|stage iv renal cell cancer
428179|NCT00002846|recurrent renal cell cancer|recurrent renal cell cancer
428180|NCT00002847|stage IV renal cell cancer|stage iv renal cell cancer
428181|NCT00002847|recurrent renal cell cancer|recurrent renal cell cancer
428182|NCT00002848|stage I prostate cancer|stage i prostate cancer
428183|NCT00002848|stage IIB prostate cancer|stage iib prostate cancer
428184|NCT00002848|stage IIA prostate cancer|stage iia prostate cancer
428185|NCT00002848|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
428186|NCT00002849|primary systemic amyloidosis|primary systemic amyloidosis
428187|NCT00002850|stage I multiple myeloma|stage i multiple myeloma
428188|NCT00002850|stage II multiple myeloma|stage ii multiple myeloma
428189|NCT00002850|stage III multiple myeloma|stage iii multiple myeloma
428190|NCT00002850|infection|infection
428191|NCT00002851|stage I breast cancer|stage i breast cancer
428192|NCT00002851|stage II breast cancer|stage ii breast cancer
428193|NCT00002851|stage IIIA breast cancer|stage iiia breast cancer
428194|NCT00002854|stage IV colon cancer|stage iv colon cancer
428195|NCT00002854|stage II breast cancer|stage ii breast cancer
428196|NCT00002854|stage IV breast cancer|stage iv breast cancer
428197|NCT00002854|stage IIIA breast cancer|stage iiia breast cancer
428198|NCT00002854|recurrent breast cancer|recurrent breast cancer
428199|NCT00002854|stage IV gastric cancer|stage iv gastric cancer
428200|NCT00002854|recurrent gastric cancer|recurrent gastric cancer
428201|NCT00002854|localized osteosarcoma|localized osteosarcoma
428202|NCT00002854|metastatic osteosarcoma|metastatic osteosarcoma
428203|NCT00002854|stage IIIB breast cancer|stage iiib breast cancer
428204|NCT00002854|recurrent pancreatic cancer|recurrent pancreatic cancer
428205|NCT00002854|stage IV rectal cancer|stage iv rectal cancer
428206|NCT00002854|recurrent colon cancer|recurrent colon cancer
428207|NCT00002854|recurrent rectal cancer|recurrent rectal cancer
428208|NCT00002854|stage IV anal cancer|stage iv anal cancer
428209|NCT00002854|recurrent anal cancer|recurrent anal cancer
428210|NCT00002854|stage IV esophageal cancer|stage iv esophageal cancer
428211|NCT00002854|recurrent esophageal cancer|recurrent esophageal cancer
428212|NCT00002854|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
428213|NCT00002854|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
428214|NCT00002854|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
428216|NCT00002854|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
428217|NCT00002854|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
428218|NCT00002854|advanced adult primary liver cancer|advanced adult primary liver cancer
428219|NCT00002854|recurrent adult primary liver cancer|recurrent adult primary liver cancer
428220|NCT00002854|recurrent osteosarcoma|recurrent osteosarcoma
428221|NCT00002854|recurrent gallbladder cancer|recurrent gallbladder cancer
428222|NCT00002854|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
428223|NCT00002854|recurrent small intestine cancer|recurrent small intestine cancer
428224|NCT00002854|stage II melanoma|stage ii melanoma
428225|NCT00002854|stage III melanoma|stage iii melanoma
428226|NCT00002854|stage IV melanoma|stage iv melanoma
428227|NCT00002854|recurrent melanoma|recurrent melanoma
428228|NCT00002854|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
428229|NCT00002854|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
428230|NCT00002854|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
428231|NCT00002854|stage IV pancreatic cancer|stage iv pancreatic cancer
428232|NCT00002855|adenocarcinoma of the prostate|adenocarcinoma of the prostate
428233|NCT00002855|stage III prostate cancer|stage iii prostate cancer
428234|NCT00002855|stage IV prostate cancer|stage iv prostate cancer
428235|NCT00002855|recurrent prostate cancer|recurrent prostate cancer
428236|NCT00002858|limited stage small cell lung cancer|limited stage small cell lung cancer
428237|NCT00002860|stage IV melanoma|stage iv melanoma
428238|NCT00002860|recurrent melanoma|recurrent melanoma
428239|NCT00002862|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
428240|NCT00002862|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
428241|NCT00002862|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
428242|NCT00002862|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
428243|NCT00002862|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
428244|NCT00002862|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
428245|NCT00002862|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
428246|NCT00002862|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
428247|NCT00002862|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
428248|NCT00002862|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
428249|NCT00002862|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
428250|NCT00002862|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
428251|NCT00002862|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
428252|NCT00002862|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
428253|NCT00002862|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
428254|NCT00002862|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
428255|NCT00002862|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
428256|NCT00002862|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
428257|NCT00002862|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
428258|NCT00002862|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
428259|NCT00002862|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
428260|NCT00002862|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
428261|NCT00002862|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
428262|NCT00002862|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
428263|NCT00002862|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
428264|NCT00002862|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
428265|NCT00002862|anaplastic large cell lymphoma|anaplastic large cell lymphoma
428266|NCT00002862|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
428267|NCT00002862|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
428268|NCT00002862|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
428269|NCT00002862|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
428270|NCT00002862|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
428271|NCT00002862|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
428272|NCT00002862|splenic marginal zone lymphoma|splenic marginal zone lymphoma
428273|NCT00002863|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
428274|NCT00002863|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
428275|NCT00002863|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
428276|NCT00002863|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
428277|NCT00002863|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
428278|NCT00002863|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
428279|NCT00002863|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
428280|NCT00002863|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
428281|NCT00002863|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
428282|NCT00002864|stage I breast cancer|stage i breast cancer
428283|NCT00002864|stage II breast cancer|stage ii breast cancer
428285|NCT00002865|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
428286|NCT00002866|stage IV breast cancer|stage iv breast cancer
428287|NCT00002866|recurrent breast cancer|recurrent breast cancer
428289|NCT00002868|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
428290|NCT00002869|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
428291|NCT00002869|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
428292|NCT00002869|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
428293|NCT00002870|stage IV breast cancer|stage iv breast cancer
428294|NCT00002870|recurrent breast cancer|recurrent breast cancer
428295|NCT00002872|malignant pleural effusion|malignant pleural effusion
428296|NCT00002873|stage I breast cancer|stage i breast cancer
428297|NCT00002873|stage II breast cancer|stage ii breast cancer
428298|NCT00002873|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
428299|NCT00002873|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
428300|NCT00002873|invasive ductal breast carcinoma|invasive ductal breast carcinoma
428301|NCT00002873|papillary ductal breast carcinoma|papillary ductal breast carcinoma
428302|NCT00002873|tubular ductal breast carcinoma|tubular ductal breast carcinoma
428303|NCT00002874|stage IIB prostate cancer|stage iib prostate cancer
428304|NCT00002874|stage IIA prostate cancer|stage iia prostate cancer
428305|NCT00002874|stage III prostate cancer|stage iii prostate cancer
428306|NCT00002874|recurrent prostate cancer|recurrent prostate cancer
428307|NCT00002875|untreated childhood medulloblastoma|untreated childhood medulloblastoma
428308|NCT00002876|recurrent adult brain tumor|recurrent adult brain tumor
428309|NCT00002876|adult myxopapillary ependymoma|adult myxopapillary ependymoma
428310|NCT00002876|adult anaplastic ependymoma|adult anaplastic ependymoma
428311|NCT00002878|refractory multiple myeloma|refractory multiple myeloma
428312|NCT00002879|mantle cell lymphoma|mantle cell lymphoma
428313|NCT00002879|stage I mantle cell lymphoma|stage i mantle cell lymphoma
428314|NCT00002879|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
428315|NCT00002879|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
428316|NCT00002879|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
428317|NCT00002879|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
428318|NCT00002879|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
428319|NCT00002880|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
428320|NCT00002880|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
428321|NCT00002880|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
428322|NCT00002880|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
428323|NCT00002880|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
428324|NCT00002880|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
428325|NCT00002880|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
428326|NCT00002880|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
428327|NCT00002880|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
428328|NCT00002881|adenocarcinoma of the prostate|adenocarcinoma of the prostate
428329|NCT00002881|stage IV prostate cancer|stage iv prostate cancer
428330|NCT00002881|recurrent prostate cancer|recurrent prostate cancer
428331|NCT00002882|stage III melanoma|stage iii melanoma
428332|NCT00002883|stage I gastric cancer|stage i gastric cancer
428333|NCT00002883|stage II gastric cancer|stage ii gastric cancer
428334|NCT00002883|stage I esophageal cancer|stage i esophageal cancer
428335|NCT00002883|stage II esophageal cancer|stage ii esophageal cancer
428336|NCT00002883|adenocarcinoma of the stomach|adenocarcinoma of the stomach
428337|NCT00002883|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
428338|NCT00002884|stage I esophageal cancer|stage i esophageal cancer
428339|NCT00002884|stage II esophageal cancer|stage ii esophageal cancer
428340|NCT00002884|stage III esophageal cancer|stage iii esophageal cancer
428341|NCT00002884|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
428342|NCT00002884|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
428343|NCT00002887|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
428344|NCT00002888|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
428345|NCT00002888|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
428346|NCT00002888|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
446176|NCT00005673|NNRTI|nnrti
428347|NCT00002888|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
428348|NCT00002888|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
428349|NCT00002888|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
428350|NCT00002888|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
752427|NCT01172938|inflammatory cells|inflammatory cells
428351|NCT00002888|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
428352|NCT00002888|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
428353|NCT00002888|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
428354|NCT00002888|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
428355|NCT00002888|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
428356|NCT00002888|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
428357|NCT00002888|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
428358|NCT00002888|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
428359|NCT00002889|adenocarcinoma of the prostate|adenocarcinoma of the prostate
428360|NCT00002889|stage I prostate cancer|stage i prostate cancer
428361|NCT00002889|stage II prostate cancer|stage ii prostate cancer
428362|NCT00002889|stage III prostate cancer|stage iii prostate cancer
428363|NCT00002889|stage IV prostate cancer|stage iv prostate cancer
428364|NCT00002890|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
428365|NCT00002890|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
428366|NCT00002890|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
428367|NCT00002890|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
428368|NCT00002890|refractory anemia with excess blasts|refractory anemia with excess blasts
428369|NCT00002890|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
428370|NCT00002890|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
428371|NCT00002890|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
428372|NCT00002890|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
428373|NCT00002890|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
428374|NCT00002892|stage II melanoma|stage ii melanoma
428375|NCT00002892|stage III melanoma|stage iii melanoma
428376|NCT00002892|recurrent melanoma|recurrent melanoma
428377|NCT00002893|stage III colon cancer|stage iii colon cancer
428378|NCT00002893|stage IV colon cancer|stage iv colon cancer
428379|NCT00002893|stage III rectal cancer|stage iii rectal cancer
428380|NCT00002893|stage IV rectal cancer|stage iv rectal cancer
428381|NCT00002893|recurrent colon cancer|recurrent colon cancer
428382|NCT00002893|recurrent rectal cancer|recurrent rectal cancer
428383|NCT00002893|adenocarcinoma of the colon|adenocarcinoma of the colon
428384|NCT00002893|adenocarcinoma of the rectum|adenocarcinoma of the rectum
428385|NCT00002894|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
428386|NCT00002894|primary peritoneal cavity cancer|primary peritoneal cavity cancer
428387|NCT00002895|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
428388|NCT00002895|primary peritoneal cavity cancer|primary peritoneal cavity cancer
428389|NCT00002895|fallopian tube cancer|fallopian tube cancer
428390|NCT00002896|stage II rectal cancer|stage ii rectal cancer
428391|NCT00002896|stage III rectal cancer|stage iii rectal cancer
428392|NCT00002896|recurrent rectal cancer|recurrent rectal cancer
428393|NCT00002896|adenocarcinoma of the rectum|adenocarcinoma of the rectum
428394|NCT00002896|mucinous adenocarcinoma of the rectum|mucinous adenocarcinoma of the rectum
428395|NCT00002897|stage II esophageal cancer|stage ii esophageal cancer
428396|NCT00002897|stage III esophageal cancer|stage iii esophageal cancer
428397|NCT00002897|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
428398|NCT00002898|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
428399|NCT00002898|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
428400|NCT00002898|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
428401|NCT00002898|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
428402|NCT00002898|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
428403|NCT00002898|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
428404|NCT00002898|childhood fibrosarcoma|childhood fibrosarcoma
428405|NCT00002898|childhood synovial sarcoma|childhood synovial sarcoma
428406|NCT00002898|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
428407|NCT00002898|childhood liposarcoma|childhood liposarcoma
428408|NCT00002898|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
428409|NCT00002898|childhood leiomyosarcoma|childhood leiomyosarcoma
428410|NCT00002898|childhood neurofibrosarcoma|childhood neurofibrosarcoma
428411|NCT00002898|childhood angiosarcoma|childhood angiosarcoma
428412|NCT00002898|childhood epithelioid sarcoma|childhood epithelioid sarcoma
428413|NCT00002898|childhood malignant fibrous histiocytoma of bone|childhood malignant fibrous histiocytoma of bone
428414|NCT00002898|childhood malignant mesenchymoma|childhood malignant mesenchymoma
428415|NCT00002898|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
428416|NCT00002898|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
428417|NCT00002898|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
427781|NCT00002762|stage I breast cancer|stage i breast cancer
428418|NCT00002899|tumors metastatic to brain|tumors metastatic to brain
428419|NCT00002900|stage I breast cancer|stage i breast cancer
428420|NCT00002900|stage II breast cancer|stage ii breast cancer
428421|NCT00002900|ductal breast carcinoma|ductal breast carcinoma
428423|NCT00002901|stage IV breast cancer|stage iv breast cancer
428424|NCT00002901|stage IIIA breast cancer|stage iiia breast cancer
428426|NCT00002901|stage IIIB breast cancer|stage iiib breast cancer
428427|NCT00002901|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
428428|NCT00002901|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
428429|NCT00002901|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
428430|NCT00002901|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
428431|NCT00002901|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
428432|NCT00002901|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
428433|NCT00002901|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
428434|NCT00002901|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
428435|NCT00002901|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
428436|NCT00002901|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
428437|NCT00002901|ovarian stromal cancer|ovarian stromal cancer
428438|NCT00002901|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
428439|NCT00002901|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
428440|NCT00002901|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
428441|NCT00002901|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
428442|NCT00002901|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
428443|NCT00002901|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
428444|NCT00002901|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
428445|NCT00002901|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
428446|NCT00002901|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
428447|NCT00002901|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
428448|NCT00002901|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
428449|NCT00002901|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
428450|NCT00002901|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
428451|NCT00002901|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
428452|NCT00002901|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
428453|NCT00002901|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
428454|NCT00002901|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
428455|NCT00002901|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
428456|NCT00002901|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
428457|NCT00002901|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
428458|NCT00002901|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
428459|NCT00002901|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
428460|NCT00002901|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
428461|NCT00002901|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
428462|NCT00002901|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
428463|NCT00002901|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
428464|NCT00002901|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
430010|NCT00003484|adult meningioma|adult meningioma
428465|NCT00002901|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
428466|NCT00002901|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
428467|NCT00002901|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
428468|NCT00002901|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
428169|NCT00002844|Cytoxan|cytoxan
428469|NCT00002901|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
428470|NCT00002901|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
428471|NCT00002901|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
428472|NCT00002901|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
428473|NCT00002901|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
428474|NCT00002901|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
446286|NCT00006442|Lymphocytes|lymphocytes
428475|NCT00002901|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
200961|NCT02112812|Levodopa response|levodopa response
535963|NCT00344474|Anxiety|anxiety
428476|NCT00002901|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
428477|NCT00002901|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
428478|NCT00002901|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
428479|NCT00002901|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
428480|NCT00002901|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
428481|NCT00002901|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
428482|NCT00002901|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
428483|NCT00002901|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
428484|NCT00002901|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
428485|NCT00002901|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
428486|NCT00002901|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
428487|NCT00002901|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
428488|NCT00002901|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
428489|NCT00002901|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
428490|NCT00002901|ovarian sarcoma|ovarian sarcoma
428491|NCT00002902|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
428492|NCT00002903|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
428493|NCT00002903|testicular seminoma|testicular seminoma
428494|NCT00002903|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
428495|NCT00002903|extragonadal germ cell tumor|extragonadal germ cell tumor
428496|NCT00002904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
428497|NCT00002905|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
428498|NCT00002907|refractory multiple myeloma|refractory multiple myeloma
428499|NCT00002908|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
428500|NCT00002908|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
428501|NCT00002908|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
428502|NCT00002908|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
428503|NCT00002908|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
428504|NCT00002908|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
428505|NCT00002908|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
428506|NCT00002908|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
428507|NCT00002908|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
428508|NCT00002908|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
428509|NCT00002908|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
428510|NCT00002908|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
428511|NCT00002908|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
428512|NCT00002908|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
428513|NCT00002908|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
428514|NCT00002908|splenic marginal zone lymphoma|splenic marginal zone lymphoma
428515|NCT00002909|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
428516|NCT00002909|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
428517|NCT00002909|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
428518|NCT00002909|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
428519|NCT00002909|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
428520|NCT00002909|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
428521|NCT00002909|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
428522|NCT00002909|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
428523|NCT00002909|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
428524|NCT00002909|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
428525|NCT00002909|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
428526|NCT00002909|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
428527|NCT00002909|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
428528|NCT00002909|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
428529|NCT00002909|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
428530|NCT00002909|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
428531|NCT00002909|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
428532|NCT00002909|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
428533|NCT00002909|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
428534|NCT00002909|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
428535|NCT00002909|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
428536|NCT00002909|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
428537|NCT00002909|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
428538|NCT00002909|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
428539|NCT00002909|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
428540|NCT00002909|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
428541|NCT00002909|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
428542|NCT00002909|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
428543|NCT00002909|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
428544|NCT00002909|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
428545|NCT00002909|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
428546|NCT00002909|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
428547|NCT00002909|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
428548|NCT00002909|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
428549|NCT00002909|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
428550|NCT00002909|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
428551|NCT00002909|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
428552|NCT00002909|anaplastic large cell lymphoma|anaplastic large cell lymphoma
428553|NCT00002909|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
428554|NCT00002909|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
428555|NCT00002909|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
583284|NCT00511134|smoking cessation|smoking cessation
428556|NCT00002909|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
428557|NCT00002909|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
428558|NCT00002909|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
428559|NCT00002909|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
428560|NCT00002909|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
428561|NCT00002909|splenic marginal zone lymphoma|splenic marginal zone lymphoma
428562|NCT00002911|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
428563|NCT00002911|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
428564|NCT00002912|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
428565|NCT00002912|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
428566|NCT00002912|secondary acute myeloid leukemia|secondary acute myeloid leukemia
428567|NCT00002914|recurrent bladder cancer|recurrent bladder cancer
428568|NCT00002914|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
428569|NCT00002914|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
428570|NCT00002914|adenocarcinoma of the bladder|adenocarcinoma of the bladder
428571|NCT00002914|recurrent urethral cancer|recurrent urethral cancer
428572|NCT00002914|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
428573|NCT00002915|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
428574|NCT00002916|stage IB cervical cancer|stage ib cervical cancer
428575|NCT00002916|stage IIA cervical cancer|stage iia cervical cancer
428576|NCT00002916|cervical squamous cell carcinoma|cervical squamous cell carcinoma
428577|NCT00002916|cervical adenocarcinoma|cervical adenocarcinoma
428578|NCT00002916|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
428579|NCT00002917|stage 0 bladder cancer|stage 0 bladder cancer
428580|NCT00002917|stage I bladder cancer|stage i bladder cancer
428581|NCT00002917|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
428582|NCT00002919|stage II bladder cancer|stage ii bladder cancer
428583|NCT00002919|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
428584|NCT00002920|endometrial cancer|endometrial cancer
428585|NCT00002920|stage I breast cancer|stage i breast cancer
428586|NCT00002920|stage II breast cancer|stage ii breast cancer
428587|NCT00002920|ductal breast carcinoma in situ|ductal breast carcinoma in situ
428588|NCT00002920|lobular breast carcinoma in situ|lobular breast carcinoma in situ
428589|NCT00002920|Paget disease of the breast|paget disease of the breast
428590|NCT00002921|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
428591|NCT00002921|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
428592|NCT00002922|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
428593|NCT00002922|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
752428|NCT01172938|apremilast|apremilast
428594|NCT00002922|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
428595|NCT00002922|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
428596|NCT00002922|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
428597|NCT00002922|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
428598|NCT00002922|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
428599|NCT00002922|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
428600|NCT00002922|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
428601|NCT00002922|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
428602|NCT00002922|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
428603|NCT00002922|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
428604|NCT00002923|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
428605|NCT00002924|adenocarcinoma of the prostate|adenocarcinoma of the prostate
428606|NCT00002924|recurrent prostate cancer|recurrent prostate cancer
428607|NCT00002925|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
428608|NCT00002925|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
428609|NCT00002925|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
428610|NCT00002925|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
428611|NCT00002925|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
428612|NCT00002925|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
428613|NCT00002925|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
428614|NCT00002925|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
428615|NCT00002925|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
428616|NCT00002926|secondary acute myeloid leukemia|secondary acute myeloid leukemia
583285|NCT00511134|zyban|zyban
428617|NCT00002926|refractory anemia|refractory anemia
428618|NCT00002926|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
428619|NCT00002926|refractory anemia with excess blasts|refractory anemia with excess blasts
428620|NCT00002926|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
428621|NCT00002926|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
428622|NCT00002926|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
428623|NCT00002926|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
428624|NCT00002926|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
428625|NCT00002926|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
428626|NCT00002926|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
428627|NCT00002928|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
428628|NCT00002930|stage I non-small cell lung cancer|stage i non-small cell lung cancer
428629|NCT00002930|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
428630|NCT00002930|stage I esophageal cancer|stage i esophageal cancer
428631|NCT00002930|stage II esophageal cancer|stage ii esophageal cancer
428632|NCT00002930|stage III esophageal cancer|stage iii esophageal cancer
428633|NCT00002930|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
428634|NCT00002930|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
428635|NCT00002931|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
428636|NCT00002931|testicular seminoma|testicular seminoma
428637|NCT00002931|testicular embryonal carcinoma|testicular embryonal carcinoma
428638|NCT00002931|testicular choriocarcinoma|testicular choriocarcinoma
428639|NCT00002931|testicular yolk sac tumor|testicular yolk sac tumor
428640|NCT00002931|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
428641|NCT00002931|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
428642|NCT00002931|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
428643|NCT00002931|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
428644|NCT00002931|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
428645|NCT00002931|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
428646|NCT00002931|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
428647|NCT00002931|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
428648|NCT00002931|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
428649|NCT00002931|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
428650|NCT00002931|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
428651|NCT00002931|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
10297|NCT03225105|Solid Tumors|solid tumors
428652|NCT00002931|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
536322|NCT00346697|HIV|hiv
428653|NCT00002931|recurrent extragonadal seminoma|recurrent extragonadal seminoma
428654|NCT00002931|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
428655|NCT00002931|adult teratoma|adult teratoma
428656|NCT00002931|testicular immature teratoma|testicular immature teratoma
428657|NCT00002931|testicular mature teratoma|testicular mature teratoma
428658|NCT00002931|ovarian immature teratoma|ovarian immature teratoma
428659|NCT00002931|ovarian mature teratoma|ovarian mature teratoma
428660|NCT00002931|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
428661|NCT00002931|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
428662|NCT00002931|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
428663|NCT00002931|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
428664|NCT00002931|stage IV extragonadal seminoma|stage iv extragonadal seminoma
428665|NCT00002931|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
428666|NCT00002932|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
428667|NCT00002932|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
428668|NCT00002932|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
428669|NCT00002932|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
428670|NCT00002933|stage IV colon cancer|stage iv colon cancer
428671|NCT00002933|stage IV rectal cancer|stage iv rectal cancer
428672|NCT00002933|recurrent colon cancer|recurrent colon cancer
428673|NCT00002933|recurrent rectal cancer|recurrent rectal cancer
428674|NCT00002933|adenocarcinoma of the colon|adenocarcinoma of the colon
428675|NCT00002933|adenocarcinoma of the rectum|adenocarcinoma of the rectum
428676|NCT00002934|breast cancer in situ|breast cancer in situ
428677|NCT00002934|ductal breast carcinoma|ductal breast carcinoma
428678|NCT00002935|stage 0 esophageal cancer|stage 0 esophageal cancer
428679|NCT00002936|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
428680|NCT00002936|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
428681|NCT00002936|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
583286|NCT00511147|IVIG|ivig
428682|NCT00002937|recurrent breast cancer|recurrent breast cancer
428683|NCT00002938|recurrent prostate cancer|recurrent prostate cancer
428684|NCT00002939|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
428685|NCT00002940|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
428686|NCT00002941|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
428687|NCT00002941|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
428688|NCT00002941|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
428689|NCT00002941|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
428690|NCT00002941|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
428691|NCT00002941|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
428692|NCT00002942|stage II breast cancer|stage ii breast cancer
428693|NCT00002942|stage IV breast cancer|stage iv breast cancer
428694|NCT00002942|stage IIIA breast cancer|stage iiia breast cancer
428695|NCT00002942|stage IIIB breast cancer|stage iiib breast cancer
428696|NCT00002943|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
428697|NCT00002943|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
428698|NCT00002943|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
428699|NCT00002943|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
428700|NCT00002943|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
428701|NCT00002943|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
428702|NCT00002943|extragonadal germ cell tumor|extragonadal germ cell tumor
428703|NCT00002944|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
428704|NCT00002944|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
428705|NCT00002944|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
428706|NCT00002944|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
428707|NCT00002944|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
428708|NCT00002944|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
428709|NCT00002945|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
428710|NCT00002945|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
428711|NCT00002945|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
428712|NCT00002945|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
428713|NCT00002945|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
428714|NCT00002945|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
428715|NCT00002945|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
428716|NCT00002945|secondary acute myeloid leukemia|secondary acute myeloid leukemia
428717|NCT00002945|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
428718|NCT00002946|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
428719|NCT00002946|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
428720|NCT00002946|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
428721|NCT00002946|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
428722|NCT00002946|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
428723|NCT00002946|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
428724|NCT00002946|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
428725|NCT00002946|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
428726|NCT00002946|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
428727|NCT00002946|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
428728|NCT00002946|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
428729|NCT00002946|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
428730|NCT00002946|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
428731|NCT00002946|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
428732|NCT00002946|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
428733|NCT00002946|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
428734|NCT00002946|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
428735|NCT00002946|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
428736|NCT00002946|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
428737|NCT00002946|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
444247|NCT00006301|T Cell|t cell
428738|NCT00002946|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
428739|NCT00002946|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
430011|NCT00003484|adult glioblastoma|adult glioblastoma
428740|NCT00002946|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
428741|NCT00002946|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
428742|NCT00002946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
537720|NCT00341146|NPC|npc
428743|NCT00002946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
428744|NCT00002946|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
428745|NCT00002946|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
428746|NCT00002946|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
428747|NCT00002946|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
428748|NCT00002946|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
428749|NCT00002946|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
428750|NCT00002946|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
428751|NCT00002946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
428752|NCT00002946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
428753|NCT00002946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
428754|NCT00002946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
428755|NCT00002946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
428756|NCT00002946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
428757|NCT00002946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
428758|NCT00002946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
428759|NCT00002946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
428760|NCT00002946|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
428761|NCT00002946|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
428762|NCT00002946|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
428763|NCT00002946|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
428764|NCT00002946|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
428765|NCT00002946|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
428766|NCT00002946|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
428767|NCT00002946|stage I mantle cell lymphoma|stage i mantle cell lymphoma
428768|NCT00002946|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
428769|NCT00002946|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
428770|NCT00002946|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
428771|NCT00002946|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
428772|NCT00002946|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
428773|NCT00002946|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
428774|NCT00002946|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
428775|NCT00002946|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
428170|NCT00002844|Neosar|neosar
428776|NCT00002946|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
428777|NCT00002946|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
428778|NCT00002946|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
428779|NCT00002946|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
428780|NCT00002946|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
428781|NCT00002946|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
428782|NCT00002946|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
428855|NCT00002446|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
428783|NCT00002946|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
428784|NCT00002946|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
428785|NCT00002946|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
428786|NCT00002946|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
428787|NCT00002946|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
428788|NCT00002946|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
428789|NCT00002946|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
428790|NCT00002946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
428791|NCT00002946|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
428792|NCT00002946|anaplastic large cell lymphoma|anaplastic large cell lymphoma
428793|NCT00002946|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
428794|NCT00002946|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
428795|NCT00002946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
428796|NCT00002946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
428797|NCT00002946|stage I marginal zone lymphoma|stage i marginal zone lymphoma
428798|NCT00002946|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
428799|NCT00002946|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
583287|NCT00511147|ITP|itp
428800|NCT00002946|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
428801|NCT00002946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
428802|NCT00002946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
428803|NCT00002946|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
428804|NCT00002946|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
428805|NCT00002946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
428806|NCT00002946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
428807|NCT00002946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
428808|NCT00002947|stage IV renal cell cancer|stage iv renal cell cancer
428809|NCT00002947|recurrent renal cell cancer|recurrent renal cell cancer
428810|NCT00002947|extensive stage small cell lung cancer|extensive stage small cell lung cancer
428811|NCT00002947|recurrent small cell lung cancer|recurrent small cell lung cancer
428812|NCT00002947|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
428813|NCT00002947|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
428814|NCT00002947|gastrinoma|gastrinoma
428815|NCT00002947|insulinoma|insulinoma
428816|NCT00002947|recurrent islet cell carcinoma|recurrent islet cell carcinoma
428817|NCT00002947|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
428818|NCT00002947|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
428819|NCT00002947|iris melanoma|iris melanoma
428820|NCT00002947|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
428821|NCT00002947|extraocular extension melanoma|extraocular extension melanoma
428822|NCT00002947|recurrent intraocular melanoma|recurrent intraocular melanoma
428823|NCT00002947|stage IV melanoma|stage iv melanoma
428824|NCT00002947|recurrent melanoma|recurrent melanoma
428825|NCT00002947|WDHA syndrome|wdha syndrome
428826|NCT00002947|somatostatinoma|somatostatinoma
428827|NCT00002947|pancreatic polypeptide tumor|pancreatic polypeptide tumor
428828|NCT00002947|glucagonoma|glucagonoma
428829|NCT00002947|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
428830|NCT00002947|metastatic pheochromocytoma|metastatic pheochromocytoma
428831|NCT00002947|recurrent pheochromocytoma|recurrent pheochromocytoma
428832|NCT00002947|pulmonary carcinoid tumor|pulmonary carcinoid tumor
428833|NCT00002947|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
428834|NCT00002947|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
428835|NCT00002947|stage III neuroendocrine carcinoma of the skin|stage iii neuroendocrine carcinoma of the skin
428836|NCT00002947|recurrent neuroendocrine carcinoma of the skin|recurrent neuroendocrine carcinoma of the skin
428837|NCT00002948|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
428838|NCT00002442|Drug Therapy, Combination|drug therapy, combination
428288|NCT00002866|neutropenia|neutropenia
428839|NCT00002442|Zidovudine|zidovudine
428840|NCT00002442|Drug Administration Schedule|drug administration schedule
428841|NCT00002442|Stavudine|stavudine
428842|NCT00002442|HIV Protease Inhibitors|hiv protease inhibitors
428843|NCT00002442|Lamivudine|lamivudine
428844|NCT00002442|Indinavir|indinavir
428845|NCT00002442|Dosage Forms|dosage forms
428846|NCT00002442|Nelfinavir|nelfinavir
428847|NCT00002442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
10298|NCT03225105|M3541|m3541
428849|NCT00002445|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
428850|NCT00002445|Placebos|placebos
428851|NCT00002445|Sarcoma, Kaposi|sarcoma, kaposi
428852|NCT00002445|Antineoplastic Agents|antineoplastic agents
428853|NCT00002445|Treatment Outcome|treatment outcome
428854|NCT00002445|Quality of Life|quality of life
428857|NCT00002446|Administration, Oral|administration, oral
428858|NCT00002446|Antifungal Agents|antifungal agents
428859|NCT00002446|Candidiasis, Oral|candidiasis, oral
428860|NCT00002446|Pharyngeal Diseases|pharyngeal diseases
428861|NCT00002446|posaconazole|posaconazole
428862|NCT00002447|Drug Therapy, Combination|drug therapy, combination
428863|NCT00002447|Saquinavir|saquinavir
428864|NCT00002447|HIV Protease Inhibitors|hiv protease inhibitors
428865|NCT00002447|Ritonavir|ritonavir
428866|NCT00002447|Dosage Forms|dosage forms
428867|NCT00002447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
428868|NCT00002447|Anti-HIV Agents|anti-hiv agents
428869|NCT00002447|efavirenz|efavirenz
428870|NCT00002448|Drug Therapy, Combination|drug therapy, combination
428871|NCT00002448|HIV Protease Inhibitors|hiv protease inhibitors
428872|NCT00002448|Ritonavir|ritonavir
428873|NCT00002448|Dosage Forms|dosage forms
428874|NCT00002448|Saquinavir|saquinavir
428875|NCT00002448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
428876|NCT00002448|Anti-HIV Agents|anti-hiv agents
428877|NCT00002448|efavirenz|efavirenz
428878|NCT00002449|Recombinant Proteins|recombinant proteins
446256|NCT00006437|Adhesion|adhesion
583288|NCT00511160|myocarditis|myocarditis
428879|NCT00002449|Injections, Subcutaneous|injections, subcutaneous
428881|NCT00002449|Dose-Response Relationship, Drug|dose-response relationship, drug
428882|NCT00002449|CD4 Lymphocyte Count|cd4 lymphocyte count
428883|NCT00002449|Anti-HIV Agents|anti-hiv agents
428884|NCT00002449|Viral Load|viral load
428885|NCT00002449|Pharmacokinetics|pharmacokinetics
428886|NCT00002450|HIV-1|hiv-1
428887|NCT00002450|Drug Therapy, Combination|drug therapy, combination
428888|NCT00002450|Drug Administration Schedule|drug administration schedule
428889|NCT00002450|RNA, Viral|rna, viral
428890|NCT00002450|Anti-HIV Agents|anti-hiv agents
428891|NCT00002450|Viral Load|viral load
428892|NCT00002949|stage II cervical cancer|stage ii cervical cancer
428893|NCT00002949|stage III cervical cancer|stage iii cervical cancer
428894|NCT00002949|stage IV cervical cancer|stage iv cervical cancer
428895|NCT00002949|stage II vaginal cancer|stage ii vaginal cancer
428896|NCT00002949|stage III vaginal cancer|stage iii vaginal cancer
428897|NCT00002949|stage IVA vaginal cancer|stage iva vaginal cancer
428898|NCT00002949|stage IVB vaginal cancer|stage ivb vaginal cancer
428899|NCT00002949|stage II endometrial carcinoma|stage ii endometrial carcinoma
428900|NCT00002949|stage III endometrial carcinoma|stage iii endometrial carcinoma
428901|NCT00002949|stage IV endometrial carcinoma|stage iv endometrial carcinoma
428902|NCT00002949|stage II bladder cancer|stage ii bladder cancer
428903|NCT00002949|stage III bladder cancer|stage iii bladder cancer
428904|NCT00002949|stage IV bladder cancer|stage iv bladder cancer
428905|NCT00002950|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
428906|NCT00002951|stage II esophageal cancer|stage ii esophageal cancer
428907|NCT00002951|stage III esophageal cancer|stage iii esophageal cancer
428908|NCT00002951|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
428909|NCT00002951|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
428910|NCT00002951|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
428911|NCT00002951|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
428912|NCT00002951|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
428913|NCT00002951|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
428914|NCT00002951|stage II laryngeal cancer|stage ii laryngeal cancer
428915|NCT00002951|stage III laryngeal cancer|stage iii laryngeal cancer
428916|NCT00002951|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
428917|NCT00002951|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
428918|NCT00002951|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
428919|NCT00002951|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
428920|NCT00002952|stage IV melanoma|stage iv melanoma
428921|NCT00002952|recurrent melanoma|recurrent melanoma
428922|NCT00002953|stage IV breast cancer|stage iv breast cancer
428923|NCT00002955|stage IV pancreatic cancer|stage iv pancreatic cancer
536815|NCT00337636|NCL|ncl
428924|NCT00002956|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
428925|NCT00002956|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
428926|NCT00002956|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
428927|NCT00002956|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
428928|NCT00002956|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
428929|NCT00002956|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
428930|NCT00002956|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
428931|NCT00002956|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
428932|NCT00002956|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
428933|NCT00002956|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
428934|NCT00002956|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
428935|NCT00002956|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
428936|NCT00002956|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
428937|NCT00002956|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
428938|NCT00002956|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
428939|NCT00002956|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
428940|NCT00002956|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
428941|NCT00002956|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
428942|NCT00002956|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
428943|NCT00002956|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
428944|NCT00002956|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
428945|NCT00002956|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
428946|NCT00002956|splenic marginal zone lymphoma|splenic marginal zone lymphoma
428947|NCT00002960|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
428948|NCT00002960|malignant ascites|malignant ascites
428949|NCT00002960|fallopian tube cancer|fallopian tube cancer
428950|NCT00002960|primary peritoneal cavity cancer|primary peritoneal cavity cancer
428951|NCT00002961|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
429089|NCT00003397|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
428952|NCT00002961|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
428953|NCT00002963|basal cell carcinoma of the skin|basal cell carcinoma of the skin
428954|NCT00002963|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
428955|NCT00002964|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
428956|NCT00002964|stage 0 laryngeal cancer|stage 0 laryngeal cancer
428957|NCT00002964|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
428958|NCT00002964|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
428959|NCT00002964|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
428960|NCT00002964|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
428961|NCT00002964|stage I laryngeal cancer|stage i laryngeal cancer
428962|NCT00002964|stage I oropharyngeal cancer|stage i oropharyngeal cancer
428963|NCT00002965|recurrent adult brain tumor|recurrent adult brain tumor
428964|NCT00002967|stage I breast cancer|stage i breast cancer
428965|NCT00002967|stage II breast cancer|stage ii breast cancer
428966|NCT00002967|invasive ductal breast carcinoma|invasive ductal breast carcinoma
428967|NCT00002969|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
428968|NCT00002969|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
428969|NCT00002969|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
428970|NCT00002971|recurrent adult brain tumor|recurrent adult brain tumor
428971|NCT00002971|adult glioblastoma|adult glioblastoma
428972|NCT00002971|adult anaplastic astrocytoma|adult anaplastic astrocytoma
428973|NCT00002971|adult giant cell glioblastoma|adult giant cell glioblastoma
428974|NCT00002971|adult gliosarcoma|adult gliosarcoma
428975|NCT00002972|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
428976|NCT00002972|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
428977|NCT00002972|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
428978|NCT00002972|adenocarcinoma of the lung|adenocarcinoma of the lung
428979|NCT00002973|stage III melanoma|stage iii melanoma
428980|NCT00002973|stage IV melanoma|stage iv melanoma
428981|NCT00002973|recurrent melanoma|recurrent melanoma
428982|NCT00002974|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
428983|NCT00002974|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
428984|NCT00002975|basal cell carcinoma of the skin|basal cell carcinoma of the skin
428985|NCT00002975|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
428986|NCT00002975|actinic keratosis|actinic keratosis
428987|NCT00002976|stage I endometrial carcinoma|stage i endometrial carcinoma
428988|NCT00002976|stage II endometrial carcinoma|stage ii endometrial carcinoma
428989|NCT00002976|endometrial adenocarcinoma|endometrial adenocarcinoma
752429|NCT01172938|CC-10004|cc-10004
536988|NCT00339040|HPV|hpv
428990|NCT00002977|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
428991|NCT00002977|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
428992|NCT00002977|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
428993|NCT00002977|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
428994|NCT00002977|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
428995|NCT00002977|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
428996|NCT00002977|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
428997|NCT00002977|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
428998|NCT00002977|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
429000|NCT00002980|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
429001|NCT00002980|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
429002|NCT00002980|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
429003|NCT00002980|isolated plasmacytoma of bone|isolated plasmacytoma of bone
429004|NCT00002980|extramedullary plasmacytoma|extramedullary plasmacytoma
429005|NCT00002980|refractory multiple myeloma|refractory multiple myeloma
429006|NCT00002980|Waldenström macroglobulinemia|waldenström macroglobulinemia
429007|NCT00002980|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
429008|NCT00002980|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
429009|NCT00002980|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
429010|NCT00002980|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
429011|NCT00002980|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
429012|NCT00002980|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
429013|NCT00002980|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
429014|NCT00002980|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
429015|NCT00002980|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
429016|NCT00002980|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
429017|NCT00002980|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
583289|NCT00511160|parvovirus B19 (PVB19)|parvovirus b19 (pvb19)
538220|NCT00350662|L1|l1
429018|NCT00002980|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
429019|NCT00002980|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
429020|NCT00002980|polycythemia vera|polycythemia vera
429021|NCT00002980|primary myelofibrosis|primary myelofibrosis
429022|NCT00002980|essential thrombocythemia|essential thrombocythemia
429023|NCT00002980|untreated hairy cell leukemia|untreated hairy cell leukemia
429024|NCT00002980|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
429025|NCT00002980|refractory hairy cell leukemia|refractory hairy cell leukemia
429026|NCT00002980|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
429027|NCT00002980|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
429028|NCT00002980|acute undifferentiated leukemia|acute undifferentiated leukemia
429029|NCT00002980|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
429030|NCT00002980|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
429031|NCT00002980|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
429032|NCT00002980|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
429033|NCT00002980|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
429034|NCT00002980|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
429035|NCT00002980|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
429036|NCT00002980|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
429037|NCT00002980|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
429038|NCT00002980|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
429039|NCT00002980|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
429040|NCT00002980|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
429041|NCT00002980|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
429042|NCT00002980|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
429043|NCT00002980|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
429044|NCT00002980|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
429045|NCT00002980|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
429046|NCT00002980|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
429047|NCT00002980|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
429048|NCT00002980|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
429049|NCT00002980|secondary acute myeloid leukemia|secondary acute myeloid leukemia
429050|NCT00002980|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
429051|NCT00002980|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
429052|NCT00002980|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
429053|NCT00002980|prolymphocytic leukemia|prolymphocytic leukemia
429054|NCT00002980|primary systemic amyloidosis|primary systemic amyloidosis
429055|NCT00002980|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
429056|NCT00002980|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
429057|NCT00002980|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
429058|NCT00002980|anaplastic large cell lymphoma|anaplastic large cell lymphoma
429059|NCT00002980|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
429060|NCT00002980|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
429061|NCT00002980|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
429062|NCT00002980|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
429063|NCT00002980|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
429064|NCT00002980|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
429065|NCT00002980|splenic marginal zone lymphoma|splenic marginal zone lymphoma
429066|NCT00002981|adenocarcinoma of the prostate|adenocarcinoma of the prostate
429067|NCT00002981|stage IV prostate cancer|stage iv prostate cancer
429068|NCT00002981|recurrent prostate cancer|recurrent prostate cancer
429069|NCT00002982|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
429070|NCT00002982|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
429071|NCT00002982|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
583290|NCT00511160|human herpes virus 6 (HHV6)|human herpes virus 6 (hhv6)
429072|NCT00002982|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
429073|NCT00002982|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
429074|NCT00002982|anaplastic large cell lymphoma|anaplastic large cell lymphoma
429075|NCT00003397|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
429076|NCT00003397|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
429077|NCT00003397|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
429078|NCT00003397|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
429079|NCT00003397|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
429080|NCT00003397|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
429081|NCT00003397|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
429082|NCT00003397|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
429083|NCT00003397|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
429084|NCT00003397|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
429085|NCT00003397|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
429086|NCT00003397|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
429087|NCT00003397|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
429088|NCT00003397|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
429090|NCT00003397|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
429091|NCT00003397|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
429092|NCT00003397|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
429093|NCT00003397|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
429094|NCT00003397|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
429095|NCT00003397|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
429096|NCT00003397|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
429097|NCT00003397|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
429098|NCT00003397|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
429099|NCT00003397|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
429100|NCT00003397|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
429101|NCT00003397|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
429102|NCT00003397|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
429103|NCT00003397|stage I mantle cell lymphoma|stage i mantle cell lymphoma
429104|NCT00003397|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
429105|NCT00003397|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
429106|NCT00003397|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
429107|NCT00003397|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
429108|NCT00003397|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
429109|NCT00003397|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
429110|NCT00003397|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
429111|NCT00003397|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
429112|NCT00003397|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
429113|NCT00003397|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
429114|NCT00003397|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
429115|NCT00003397|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
429116|NCT00003397|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
429117|NCT00003397|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
429118|NCT00003397|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
429119|NCT00003397|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
429120|NCT00003397|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
429121|NCT00003397|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
429122|NCT00003397|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
429123|NCT00003398|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
429124|NCT00003398|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
429125|NCT00003398|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
429126|NCT00003398|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
429127|NCT00003398|Burkitt lymphoma|burkitt lymphoma
429128|NCT00003398|refractory multiple myeloma|refractory multiple myeloma
429129|NCT00003398|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
429130|NCT00003398|stage I multiple myeloma|stage i multiple myeloma
429131|NCT00003398|stage II multiple myeloma|stage ii multiple myeloma
429132|NCT00003398|stage III multiple myeloma|stage iii multiple myeloma
429133|NCT00003398|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
429134|NCT00003398|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
429135|NCT00003398|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
429136|NCT00003398|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
429137|NCT00003398|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
429138|NCT00003398|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
429139|NCT00003398|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
429140|NCT00003398|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
429141|NCT00003398|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
429142|NCT00003398|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
429143|NCT00003398|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
429144|NCT00003398|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
429145|NCT00003398|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
429146|NCT00003398|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
429147|NCT00003398|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
429148|NCT00003398|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
429149|NCT00003398|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
429150|NCT00003398|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
429151|NCT00003398|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
429152|NCT00003398|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
429153|NCT00003398|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
429154|NCT00003398|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
429155|NCT00003398|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
429156|NCT00003398|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
429157|NCT00003398|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
429158|NCT00003398|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
429159|NCT00003398|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
429160|NCT00003398|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
429161|NCT00003398|adult acute basophilic leukemia|adult acute basophilic leukemia
429162|NCT00003398|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
429163|NCT00003398|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
429164|NCT00003398|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
429165|NCT00003398|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
429166|NCT00003398|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
429167|NCT00003398|childhood acute basophilic leukemia|childhood acute basophilic leukemia
429168|NCT00003398|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
429169|NCT00003398|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
429170|NCT00003398|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
429171|NCT00003398|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
429172|NCT00003398|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
429173|NCT00003398|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
429174|NCT00003398|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
429175|NCT00003398|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
429176|NCT00003398|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
429177|NCT00003398|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
429178|NCT00003398|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
429179|NCT00003398|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
429180|NCT00003398|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
429181|NCT00003398|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
429182|NCT00003398|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
429183|NCT00003398|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
429184|NCT00003398|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
429185|NCT00003398|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
429186|NCT00003398|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
429187|NCT00003398|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
429188|NCT00003398|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
429189|NCT00003398|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
429190|NCT00003398|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
429191|NCT00003398|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
429192|NCT00003398|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
429193|NCT00003398|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
429194|NCT00003398|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
429195|NCT00003398|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
429196|NCT00003398|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
429197|NCT00003398|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
429198|NCT00003398|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
429199|NCT00003398|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
429200|NCT00003398|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
429201|NCT00003398|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
429202|NCT00003398|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
429203|NCT00003398|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
429204|NCT00003398|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
429205|NCT00003398|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
429206|NCT00003398|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
429207|NCT00003398|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
429208|NCT00003398|anemia|anemia
429209|NCT00003398|graft versus host disease|graft versus host disease
429210|NCT00003398|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
429211|NCT00003398|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
429212|NCT00003398|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
429213|NCT00003398|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
446257|NCT00006437|Migration|migration
429214|NCT00003398|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
429215|NCT00003398|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
429216|NCT00003398|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
429217|NCT00003398|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
429218|NCT00003398|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
429219|NCT00003398|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
429220|NCT00003398|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
429221|NCT00003398|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
429222|NCT00003398|stage I mantle cell lymphoma|stage i mantle cell lymphoma
429223|NCT00003398|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
429224|NCT00003398|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
429225|NCT00003398|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
429226|NCT00003398|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
429227|NCT00003398|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
429228|NCT00003398|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
429229|NCT00003398|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
429230|NCT00003398|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
429231|NCT00003398|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
429232|NCT00003398|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
429233|NCT00003398|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
429234|NCT00003398|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
429235|NCT00003398|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
429236|NCT00003398|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
429237|NCT00003398|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
429238|NCT00003398|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
429239|NCT00003398|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
429240|NCT00003398|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
429241|NCT00003398|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
429242|NCT00003398|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
429243|NCT00003398|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
429244|NCT00003398|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
429245|NCT00003398|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
429246|NCT00003398|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
429247|NCT00003398|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
10299|NCT03225105|Palliative radiotherapy|palliative radiotherapy
429248|NCT00003398|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
429249|NCT00003398|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
429250|NCT00003398|stage I marginal zone lymphoma|stage i marginal zone lymphoma
429251|NCT00003398|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
429252|NCT00003398|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
429253|NCT00003398|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
429254|NCT00003398|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
429255|NCT00003398|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
446287|NCT00006442|HIV-1|hiv-1
429256|NCT00003398|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
429257|NCT00003398|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
429258|NCT00003398|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
429259|NCT00003398|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
429260|NCT00003398|splenic marginal zone lymphoma|splenic marginal zone lymphoma
429261|NCT00003398|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
429262|NCT00003399|refractory multiple myeloma|refractory multiple myeloma
429263|NCT00003399|stage I multiple myeloma|stage i multiple myeloma
429264|NCT00003399|stage II multiple myeloma|stage ii multiple myeloma
429265|NCT00003399|stage III multiple myeloma|stage iii multiple myeloma
429266|NCT00003400|adenocarcinoma of the prostate|adenocarcinoma of the prostate
429267|NCT00003400|stage IV prostate cancer|stage iv prostate cancer
429268|NCT00003400|recurrent prostate cancer|recurrent prostate cancer
429269|NCT00003401|refractory multiple myeloma|refractory multiple myeloma
429270|NCT00003401|stage I multiple myeloma|stage i multiple myeloma
429271|NCT00003401|stage II multiple myeloma|stage ii multiple myeloma
429272|NCT00003401|stage III multiple myeloma|stage iii multiple myeloma
429273|NCT00003402|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
429274|NCT00003402|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
429275|NCT00003402|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
429276|NCT00003402|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
429277|NCT00003402|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
429278|NCT00003402|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
429279|NCT00003402|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
429280|NCT00003402|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
429281|NCT00003402|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
429282|NCT00003402|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
429283|NCT00003402|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
429284|NCT00003402|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
429285|NCT00003402|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
429286|NCT00003403|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
429287|NCT00003404|recurrent breast cancer|recurrent breast cancer
429288|NCT00003404|phyllodes tumor|phyllodes tumor
429289|NCT00003405|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
429290|NCT00003405|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
429291|NCT00003405|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
429292|NCT00003405|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
429293|NCT00003405|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
429294|NCT00003405|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
429295|NCT00003405|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
429296|NCT00003405|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
429297|NCT00003405|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
429298|NCT00003405|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
429299|NCT00003405|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
429300|NCT00003405|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
429301|NCT00003405|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
429302|NCT00003405|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
429303|NCT00003405|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
429304|NCT00003405|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
429305|NCT00003406|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
429306|NCT00003406|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
429307|NCT00003406|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
429308|NCT00003406|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
429309|NCT00003406|isolated plasmacytoma of bone|isolated plasmacytoma of bone
429310|NCT00003406|extramedullary plasmacytoma|extramedullary plasmacytoma
429311|NCT00003406|refractory multiple myeloma|refractory multiple myeloma
429312|NCT00003406|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
429313|NCT00003406|stage III multiple myeloma|stage iii multiple myeloma
429314|NCT00003406|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
429315|NCT00003406|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
429316|NCT00003406|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
429317|NCT00003406|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
429318|NCT00003406|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
429319|NCT00003406|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
429320|NCT00003406|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
429321|NCT00003406|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
429322|NCT00003406|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
429323|NCT00003406|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
429324|NCT00003406|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
429325|NCT00003406|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
429326|NCT00003406|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
429327|NCT00003406|polycythemia vera|polycythemia vera
429328|NCT00003406|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
429329|NCT00003406|essential thrombocythemia|essential thrombocythemia
429330|NCT00003406|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
429331|NCT00003406|refractory hairy cell leukemia|refractory hairy cell leukemia
429332|NCT00003406|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
429333|NCT00003406|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
429334|NCT00003406|acute undifferentiated leukemia|acute undifferentiated leukemia
429335|NCT00003406|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
429336|NCT00003406|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
429337|NCT00003406|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
429338|NCT00003406|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
429339|NCT00003406|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
429340|NCT00003406|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
429674|NCT00003427|recurrent esophageal cancer|recurrent esophageal cancer
429341|NCT00003406|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
429342|NCT00003406|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
429343|NCT00003406|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
429344|NCT00003406|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
429345|NCT00003406|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
429346|NCT00003406|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
429347|NCT00003406|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
429348|NCT00003406|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
429349|NCT00003406|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
429350|NCT00003406|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
429351|NCT00003406|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
429352|NCT00003406|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
429353|NCT00003406|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
429354|NCT00003406|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
429355|NCT00003406|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
200962|NCT02112812|Motor outcomes|motor outcomes
429356|NCT00003406|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
429357|NCT00003406|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
429358|NCT00003406|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
429359|NCT00003406|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
429360|NCT00003406|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
429361|NCT00003406|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
429362|NCT00003406|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
429363|NCT00003406|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
429364|NCT00003406|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
429365|NCT00003406|secondary acute myeloid leukemia|secondary acute myeloid leukemia
429366|NCT00003406|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
429367|NCT00003406|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
429368|NCT00003406|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
429369|NCT00003406|prolymphocytic leukemia|prolymphocytic leukemia
429370|NCT00003406|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
429371|NCT00003406|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
429372|NCT00003406|primary systemic amyloidosis|primary systemic amyloidosis
429373|NCT00003406|non-Hodgkin lymphoma during pregnancy|non-hodgkin lymphoma during pregnancy
429374|NCT00003406|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
429375|NCT00003406|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
429376|NCT00003406|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
429377|NCT00003406|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
429378|NCT00003406|anaplastic large cell lymphoma|anaplastic large cell lymphoma
429379|NCT00003406|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
429380|NCT00003406|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
429381|NCT00003406|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
429382|NCT00003406|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
429383|NCT00003406|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
429384|NCT00003406|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
429385|NCT00003406|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
429386|NCT00003406|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
429387|NCT00003406|splenic marginal zone lymphoma|splenic marginal zone lymphoma
429388|NCT00003406|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
429389|NCT00003407|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
429390|NCT00003407|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
429391|NCT00003407|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
429392|NCT00003407|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
429393|NCT00003407|secondary acute myeloid leukemia|secondary acute myeloid leukemia
429394|NCT00003407|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
429395|NCT00003407|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
429396|NCT00003407|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
429397|NCT00003407|neutropenia|neutropenia
429398|NCT00003408|stage IV breast cancer|stage iv breast cancer
429399|NCT00003408|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
429400|NCT00003408|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
429401|NCT00003408|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
429402|NCT00003408|refractory multiple myeloma|refractory multiple myeloma
429403|NCT00003408|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
429404|NCT00003408|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
429405|NCT00003408|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
429406|NCT00003408|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
429407|NCT00003408|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
429408|NCT00003408|disseminated neuroblastoma|disseminated neuroblastoma
429409|NCT00003408|recurrent neuroblastoma|recurrent neuroblastoma
429410|NCT00003408|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
429411|NCT00003408|stage I multiple myeloma|stage i multiple myeloma
429412|NCT00003408|stage II multiple myeloma|stage ii multiple myeloma
429413|NCT00003408|stage III multiple myeloma|stage iii multiple myeloma
429414|NCT00003408|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
429415|NCT00003408|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
429416|NCT00003408|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
429417|NCT00003408|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
429418|NCT00003408|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
429419|NCT00003408|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
429420|NCT00003408|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
429421|NCT00003408|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
429422|NCT00003408|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
429423|NCT00003408|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
429424|NCT00003408|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
429425|NCT00003408|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
429426|NCT00003408|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
429427|NCT00003408|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
429428|NCT00003408|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
429429|NCT00003408|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
429430|NCT00003408|testicular embryonal carcinoma|testicular embryonal carcinoma
429431|NCT00003408|testicular choriocarcinoma|testicular choriocarcinoma
429432|NCT00003408|testicular teratoma|testicular teratoma
429433|NCT00003408|testicular yolk sac tumor|testicular yolk sac tumor
429434|NCT00003408|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
429435|NCT00003408|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
429436|NCT00003408|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
429437|NCT00003408|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
429438|NCT00003408|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
429439|NCT00003408|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
429440|NCT00003408|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
429441|NCT00003408|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
429442|NCT00003408|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
429443|NCT00003408|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
429444|NCT00003408|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
429445|NCT00003408|refractory hairy cell leukemia|refractory hairy cell leukemia
429446|NCT00003408|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
429447|NCT00003408|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
429448|NCT00003408|ovarian yolk sac tumor|ovarian yolk sac tumor
429449|NCT00003408|ovarian embryonal carcinoma|ovarian embryonal carcinoma
429450|NCT00003408|ovarian polyembryoma|ovarian polyembryoma
429451|NCT00003408|ovarian choriocarcinoma|ovarian choriocarcinoma
429452|NCT00003408|ovarian immature teratoma|ovarian immature teratoma
429453|NCT00003408|ovarian mature teratoma|ovarian mature teratoma
429454|NCT00003408|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
429455|NCT00003408|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
429456|NCT00003408|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
429457|NCT00003408|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
429458|NCT00003408|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
429459|NCT00003408|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
429460|NCT00003408|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
429461|NCT00003408|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
429462|NCT00003408|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
429463|NCT00003408|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
429464|NCT00003408|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
429465|NCT00003408|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
429466|NCT00003408|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
429467|NCT00003408|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
429468|NCT00003408|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
429469|NCT00003408|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
429470|NCT00003408|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
429471|NCT00003408|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
429885|NCT00003457|Glioma|glioma
429472|NCT00003408|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
429473|NCT00003408|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
429474|NCT00003408|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
429475|NCT00003408|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
429476|NCT00003408|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
429477|NCT00003408|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
429478|NCT00003408|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
429479|NCT00003408|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
429480|NCT00003408|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
428880|NCT00002449|Interleukin-2|interleukin-2
429481|NCT00003408|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
429482|NCT00003408|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
429483|NCT00003408|secondary acute myeloid leukemia|secondary acute myeloid leukemia
429484|NCT00003408|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
429485|NCT00003408|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
429486|NCT00003408|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
429487|NCT00003408|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
429488|NCT00003408|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
429489|NCT00003408|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
429490|NCT00003408|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
429491|NCT00003408|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
429492|NCT00003408|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
429493|NCT00003408|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
429494|NCT00003408|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
429495|NCT00003408|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
429496|NCT00003408|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
429497|NCT00003408|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
429498|NCT00003408|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
429499|NCT00003408|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
429500|NCT00003408|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
429501|NCT00003408|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
429502|NCT00003408|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
429503|NCT00003408|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
429504|NCT00003408|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
753427|NCT01179217|Vaso-occlusive Crises|vaso-occlusive crises
429505|NCT00003408|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
429506|NCT00003408|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
429507|NCT00003408|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
429508|NCT00003408|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
584772|NCT00509782|Solid Tumors|solid tumors
429509|NCT00003408|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
429510|NCT00003408|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
429511|NCT00003408|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
429512|NCT00003408|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
429513|NCT00003408|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
429514|NCT00003408|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
429515|NCT00003408|splenic marginal zone lymphoma|splenic marginal zone lymphoma
429516|NCT00003408|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
429517|NCT00003409|adult glioblastoma|adult glioblastoma
429518|NCT00003409|adult giant cell glioblastoma|adult giant cell glioblastoma
429519|NCT00003409|adult gliosarcoma|adult gliosarcoma
429520|NCT00003410|adult glioblastoma|adult glioblastoma
429521|NCT00003410|adult giant cell glioblastoma|adult giant cell glioblastoma
429522|NCT00003410|adult gliosarcoma|adult gliosarcoma
429523|NCT00003411|stage II pancreatic cancer|stage ii pancreatic cancer
429524|NCT00003411|stage III pancreatic cancer|stage iii pancreatic cancer
429525|NCT00003411|unresectable gallbladder cancer|unresectable gallbladder cancer
429526|NCT00003411|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
429527|NCT00003411|stage IV pancreatic cancer|stage iv pancreatic cancer
429528|NCT00003412|stage IV breast cancer|stage iv breast cancer
429529|NCT00003412|recurrent breast cancer|recurrent breast cancer
429530|NCT00003413|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
429531|NCT00003413|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
429532|NCT00003413|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
429533|NCT00003414|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
429534|NCT00003414|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
429535|NCT00003414|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
429536|NCT00003414|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
429537|NCT00003414|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
429538|NCT00003414|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
429539|NCT00003414|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
429540|NCT00003414|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
752430|NCT01172938|phosphodiesterase type 4|phosphodiesterase type 4
538099|NCT00350129|glucose|glucose
429541|NCT00003414|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
429542|NCT00003414|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
429543|NCT00003414|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
429544|NCT00003414|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
429545|NCT00003414|graft versus host disease|graft versus host disease
429546|NCT00003414|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
429547|NCT00003414|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
429548|NCT00003414|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
429549|NCT00003414|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
429550|NCT00003414|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
429551|NCT00003414|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
429552|NCT00003414|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
429553|NCT00003414|splenic marginal zone lymphoma|splenic marginal zone lymphoma
429554|NCT00003415|refractory anemia with excess blasts|refractory anemia with excess blasts
429555|NCT00003415|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
429556|NCT00003415|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
429557|NCT00003415|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
429558|NCT00003415|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
429559|NCT00003416|Waldenström macroglobulinemia|waldenström macroglobulinemia
429560|NCT00003417|adult glioblastoma|adult glioblastoma
429561|NCT00003417|adult giant cell glioblastoma|adult giant cell glioblastoma
429562|NCT00003417|adult gliosarcoma|adult gliosarcoma
429563|NCT00003418|stage I breast cancer|stage i breast cancer
429564|NCT00003418|stage II breast cancer|stage ii breast cancer
429565|NCT00003418|stage III breast cancer|stage iii breast cancer
429566|NCT00003419|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
429567|NCT00003420|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
429568|NCT00003420|testicular teratoma|testicular teratoma
429569|NCT00003421|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
429570|NCT00003421|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
429571|NCT00003421|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
429572|NCT00003421|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
429573|NCT00003422|stage I rectal cancer|stage i rectal cancer
429574|NCT00003422|stage II rectal cancer|stage ii rectal cancer
429575|NCT00003422|stage III rectal cancer|stage iii rectal cancer
429576|NCT00003422|adenocarcinoma of the rectum|adenocarcinoma of the rectum
584773|NCT00509782|Anti-Tumor Effects|anti-tumor effects
429577|NCT00003423|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
429578|NCT00003423|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
429579|NCT00003423|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
446835|NCT00007475|Proteinuria|proteinuria
429580|NCT00003423|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
429581|NCT00003423|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
429582|NCT00003423|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
429583|NCT00003423|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
429584|NCT00003423|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
429585|NCT00003424|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
429586|NCT00003424|advanced adult primary liver cancer|advanced adult primary liver cancer
429587|NCT00003424|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
429588|NCT00003425|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
429589|NCT00003425|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
429590|NCT00003425|stage IV breast cancer|stage iv breast cancer
429591|NCT00003425|stage IIIA breast cancer|stage iiia breast cancer
429592|NCT00003425|recurrent breast cancer|recurrent breast cancer
429593|NCT00003425|stage IIIB breast cancer|stage iiib breast cancer
429594|NCT00003425|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
429595|NCT00003425|refractory multiple myeloma|refractory multiple myeloma
429596|NCT00003425|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
429597|NCT00003425|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
429598|NCT00003425|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
429599|NCT00003425|regional neuroblastoma|regional neuroblastoma
429600|NCT00003425|disseminated neuroblastoma|disseminated neuroblastoma
429601|NCT00003425|stage 4S neuroblastoma|stage 4s neuroblastoma
429602|NCT00003425|recurrent neuroblastoma|recurrent neuroblastoma
429603|NCT00003425|stage III multiple myeloma|stage iii multiple myeloma
429604|NCT00003425|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
429605|NCT00003425|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
429606|NCT00003425|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
429607|NCT00003425|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
200963|NCT02112812|Quality of Life|quality of life
429608|NCT00003425|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
429609|NCT00003425|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
429610|NCT00003425|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
429611|NCT00003425|ovarian stromal cancer|ovarian stromal cancer
429612|NCT00003425|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
429613|NCT00003425|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
429614|NCT00003425|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
429615|NCT00003425|acute undifferentiated leukemia|acute undifferentiated leukemia
429616|NCT00003425|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
429617|NCT00003425|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
429618|NCT00003425|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
429619|NCT00003425|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
429620|NCT00003425|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
429621|NCT00003425|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
429622|NCT00003425|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
429623|NCT00003425|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
429624|NCT00003425|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
429625|NCT00003425|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
429626|NCT00003425|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
429627|NCT00003425|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
429628|NCT00003425|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
429629|NCT00003425|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
429630|NCT00003425|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
429631|NCT00003425|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
429632|NCT00003425|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
429633|NCT00003425|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
429634|NCT00003425|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
429635|NCT00003425|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
429636|NCT00003425|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
429637|NCT00003425|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
429638|NCT00003425|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
429639|NCT00003425|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
429640|NCT00003425|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
584774|NCT00509782|ZIO-101|zio-101
429641|NCT00003425|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
429642|NCT00003425|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
429643|NCT00003425|secondary acute myeloid leukemia|secondary acute myeloid leukemia
429644|NCT00003425|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
429645|NCT00003425|ovarian sarcoma|ovarian sarcoma
429646|NCT00003425|localized unresectable neuroblastoma|localized unresectable neuroblastoma
429647|NCT00003425|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
429648|NCT00003425|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
429649|NCT00003425|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
429650|NCT00003425|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
429651|NCT00003425|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
429652|NCT00003425|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
429653|NCT00003425|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
429654|NCT00003425|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
429655|NCT00003425|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
429656|NCT00003425|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
429657|NCT00003425|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
429658|NCT00003425|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
429659|NCT00003425|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
429660|NCT00003425|splenic marginal zone lymphoma|splenic marginal zone lymphoma
429661|NCT00003426|stage II pancreatic cancer|stage ii pancreatic cancer
429662|NCT00003426|stage III pancreatic cancer|stage iii pancreatic cancer
429663|NCT00003426|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
429664|NCT00003427|stage IV colon cancer|stage iv colon cancer
429665|NCT00003427|stage IV gastric cancer|stage iv gastric cancer
429666|NCT00003427|recurrent gastric cancer|recurrent gastric cancer
429667|NCT00003427|recurrent pancreatic cancer|recurrent pancreatic cancer
429668|NCT00003427|stage IV rectal cancer|stage iv rectal cancer
429669|NCT00003427|recurrent colon cancer|recurrent colon cancer
429670|NCT00003427|recurrent rectal cancer|recurrent rectal cancer
429671|NCT00003427|stage IV anal cancer|stage iv anal cancer
429672|NCT00003427|recurrent anal cancer|recurrent anal cancer
429673|NCT00003427|stage IV esophageal cancer|stage iv esophageal cancer
429675|NCT00003427|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
429676|NCT00003427|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
429677|NCT00003427|advanced adult primary liver cancer|advanced adult primary liver cancer
429678|NCT00003427|recurrent adult primary liver cancer|recurrent adult primary liver cancer
429679|NCT00003427|unresectable gallbladder cancer|unresectable gallbladder cancer
429680|NCT00003427|recurrent gallbladder cancer|recurrent gallbladder cancer
429681|NCT00003427|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
429682|NCT00003427|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
429683|NCT00003427|recurrent small intestine cancer|recurrent small intestine cancer
429684|NCT00003427|stage IV pancreatic cancer|stage iv pancreatic cancer
429685|NCT00003428|stage IV breast cancer|stage iv breast cancer
429686|NCT00003428|recurrent breast cancer|recurrent breast cancer
429687|NCT00003429|stage I cervical cancer|stage i cervical cancer
429688|NCT00003429|stage II cervical cancer|stage ii cervical cancer
429689|NCT00003429|recurrent cervical cancer|recurrent cervical cancer
429690|NCT00003430|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
429691|NCT00003430|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
429692|NCT00003430|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
429693|NCT00003430|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
429694|NCT00003430|recurrent laryngeal cancer|recurrent laryngeal cancer
429695|NCT00003430|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
429696|NCT00003430|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
429697|NCT00003431|stage IV colon cancer|stage iv colon cancer
429698|NCT00003431|lung metastases|lung metastases
429699|NCT00003431|liver metastases|liver metastases
429700|NCT00003432|stage IV breast cancer|stage iv breast cancer
429701|NCT00003433|stage IV colon cancer|stage iv colon cancer
429702|NCT00003433|liver metastases|liver metastases
429703|NCT00003434|stage I pancreatic cancer|stage i pancreatic cancer
429704|NCT00003434|stage II pancreatic cancer|stage ii pancreatic cancer
429705|NCT00003434|stage III pancreatic cancer|stage iii pancreatic cancer
429706|NCT00003434|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
429707|NCT00003435|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
429708|NCT00003435|secondary acute myeloid leukemia|secondary acute myeloid leukemia
429709|NCT00003435|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
429710|NCT00003435|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
429711|NCT00003436|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
584775|NCT00509834|hLF1-11|hlf1-11
429712|NCT00003436|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
429713|NCT00003436|refractory anemia with excess blasts|refractory anemia with excess blasts
429714|NCT00003436|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
429715|NCT00003436|secondary acute myeloid leukemia|secondary acute myeloid leukemia
429716|NCT00003436|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
429717|NCT00003436|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
429718|NCT00003436|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
429719|NCT00003437|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
429720|NCT00003437|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
429721|NCT00003439|stage IV colon cancer|stage iv colon cancer
429722|NCT00003439|stage IV gastric cancer|stage iv gastric cancer
429723|NCT00003439|recurrent gastric cancer|recurrent gastric cancer
429724|NCT00003439|recurrent pancreatic cancer|recurrent pancreatic cancer
429725|NCT00003439|stage IV rectal cancer|stage iv rectal cancer
429726|NCT00003439|recurrent colon cancer|recurrent colon cancer
429727|NCT00003439|recurrent rectal cancer|recurrent rectal cancer
429728|NCT00003439|stage IV anal cancer|stage iv anal cancer
429729|NCT00003439|recurrent anal cancer|recurrent anal cancer
429730|NCT00003439|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
429731|NCT00003439|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
429732|NCT00003439|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
429733|NCT00003439|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
429734|NCT00003439|advanced adult primary liver cancer|advanced adult primary liver cancer
429735|NCT00003439|recurrent adult primary liver cancer|recurrent adult primary liver cancer
429736|NCT00003439|stage IV endometrial carcinoma|stage iv endometrial carcinoma
429737|NCT00003439|recurrent endometrial carcinoma|recurrent endometrial carcinoma
429738|NCT00003439|small intestine adenocarcinoma|small intestine adenocarcinoma
429739|NCT00003439|unresectable gallbladder cancer|unresectable gallbladder cancer
429740|NCT00003439|recurrent gallbladder cancer|recurrent gallbladder cancer
429741|NCT00003439|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
429742|NCT00003439|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
429743|NCT00003439|recurrent small intestine cancer|recurrent small intestine cancer
429744|NCT00003439|stage IV prostate cancer|stage iv prostate cancer
429745|NCT00003439|recurrent prostate cancer|recurrent prostate cancer
429746|NCT00003439|fallopian tube cancer|fallopian tube cancer
429886|NCT00003457|Neurocytoma|neurocytoma
429747|NCT00003439|primary peritoneal cavity cancer|primary peritoneal cavity cancer
429748|NCT00003439|stage IV pancreatic cancer|stage iv pancreatic cancer
429749|NCT00003441|stage IV colon cancer|stage iv colon cancer
429750|NCT00003441|stage IV rectal cancer|stage iv rectal cancer
429751|NCT00003441|recurrent colon cancer|recurrent colon cancer
429752|NCT00003441|recurrent rectal cancer|recurrent rectal cancer
429753|NCT00003441|adenocarcinoma of the colon|adenocarcinoma of the colon
429754|NCT00003441|adenocarcinoma of the rectum|adenocarcinoma of the rectum
429755|NCT00003441|6-hydroxymethylacylfulvene|6-hydroxymethylacylfulvene
429756|NCT00003441|MGI-114|mgi-114
429757|NCT00003441|Irofulven|irofulven
429758|NCT00003443|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
429759|NCT00003443|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
429760|NCT00003443|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
429761|NCT00003443|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
429762|NCT00003443|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
429763|NCT00003443|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
429764|NCT00003443|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
429765|NCT00003443|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
429766|NCT00003443|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
429767|NCT00003443|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
429768|NCT00003443|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
429769|NCT00003443|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
429770|NCT00003444|stage III melanoma|stage iii melanoma
429771|NCT00003444|stage IV melanoma|stage iv melanoma
429772|NCT00003444|recurrent melanoma|recurrent melanoma
429773|NCT00003445|stage III cervical cancer|stage iii cervical cancer
429774|NCT00003445|stage IIB cervical cancer|stage iib cervical cancer
429775|NCT00003445|stage IVA cervical cancer|stage iva cervical cancer
429776|NCT00003445|cervical squamous cell carcinoma|cervical squamous cell carcinoma
429777|NCT00003446|stage IV colon cancer|stage iv colon cancer
429778|NCT00003446|stage IV rectal cancer|stage iv rectal cancer
429779|NCT00003446|recurrent colon cancer|recurrent colon cancer
584776|NCT00509834|Candida|candida
429780|NCT00003446|recurrent rectal cancer|recurrent rectal cancer
429781|NCT00003447|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
429782|NCT00003447|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
429783|NCT00003449|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
429784|NCT00003450|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
429785|NCT00003450|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
429786|NCT00003450|peritoneal cavity cancer|peritoneal cavity cancer
429787|NCT00003451|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
449335|NCT00009243|Brain|brain
429788|NCT00003451|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
429789|NCT00003451|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
429790|NCT00003451|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
429791|NCT00003451|isolated plasmacytoma of bone|isolated plasmacytoma of bone
429792|NCT00003451|extramedullary plasmacytoma|extramedullary plasmacytoma
429793|NCT00003451|refractory multiple myeloma|refractory multiple myeloma
429794|NCT00003451|Waldenström macroglobulinemia|waldenström macroglobulinemia
429795|NCT00003451|stage III multiple myeloma|stage iii multiple myeloma
429796|NCT00003451|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
429797|NCT00003451|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
429798|NCT00003451|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
429799|NCT00003451|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
429800|NCT00003451|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
429801|NCT00003451|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
429802|NCT00003451|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
429803|NCT00003451|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
429804|NCT00003451|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
429805|NCT00003451|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
429806|NCT00003451|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
429807|NCT00003451|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
200964|NCT02112812|Open label|open label
429808|NCT00003451|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
429809|NCT00003451|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
429810|NCT00003451|polycythemia vera|polycythemia vera
429811|NCT00003451|primary myelofibrosis|primary myelofibrosis
429812|NCT00003451|essential thrombocythemia|essential thrombocythemia
429813|NCT00003451|untreated hairy cell leukemia|untreated hairy cell leukemia
429814|NCT00003451|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
429815|NCT00003451|refractory hairy cell leukemia|refractory hairy cell leukemia
429816|NCT00003451|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
429817|NCT00003451|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
429818|NCT00003451|acute undifferentiated leukemia|acute undifferentiated leukemia
429819|NCT00003451|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
429820|NCT00003451|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
429821|NCT00003451|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
429822|NCT00003451|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
429823|NCT00003451|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
429824|NCT00003451|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
429825|NCT00003451|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
429826|NCT00003451|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
429827|NCT00003451|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
429828|NCT00003451|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
429829|NCT00003451|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
429830|NCT00003451|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
429831|NCT00003451|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
429832|NCT00003451|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
429833|NCT00003451|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
429834|NCT00003451|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
429835|NCT00003451|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
429836|NCT00003451|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
429837|NCT00003451|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
429838|NCT00003451|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
429839|NCT00003451|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
429840|NCT00003451|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
429841|NCT00003451|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
429842|NCT00003451|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
429843|NCT00003451|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
429844|NCT00003451|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
429845|NCT00003451|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
753429|NCT01179230|chest pain|chest pain
429846|NCT00003451|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
429847|NCT00003451|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
429848|NCT00003451|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
429849|NCT00003451|secondary acute myeloid leukemia|secondary acute myeloid leukemia
429850|NCT00003451|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
429851|NCT00003451|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
429852|NCT00003451|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
429853|NCT00003451|prolymphocytic leukemia|prolymphocytic leukemia
429854|NCT00003451|primary systemic amyloidosis|primary systemic amyloidosis
429855|NCT00003451|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
429856|NCT00003451|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
429857|NCT00003451|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
429858|NCT00003451|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
429859|NCT00003451|anaplastic large cell lymphoma|anaplastic large cell lymphoma
429860|NCT00003451|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
429861|NCT00003451|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
429862|NCT00003451|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
429863|NCT00003451|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
429864|NCT00003451|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
429865|NCT00003451|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
429866|NCT00003451|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
429867|NCT00003451|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
429868|NCT00003451|splenic marginal zone lymphoma|splenic marginal zone lymphoma
429869|NCT00003451|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
429870|NCT00003452|recurrent bladder cancer|recurrent bladder cancer
429871|NCT00003452|stage IV bladder cancer|stage iv bladder cancer
429872|NCT00003453|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
429873|NCT00003453|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
429874|NCT00003454|stage IV breast cancer|stage iv breast cancer
429875|NCT00003454|recurrent breast cancer|recurrent breast cancer
429876|NCT00003456|adult glioblastoma|adult glioblastoma
429877|NCT00003456|adult giant cell glioblastoma|adult giant cell glioblastoma
429878|NCT00003456|adult gliosarcoma|adult gliosarcoma
429879|NCT00003457|Anaplastic astrocytoma|anaplastic astrocytoma
429880|NCT00003457|Anaplastic astrocytoma/Mixed|anaplastic astrocytoma/mixed
429881|NCT00003457|Astrocytoma|astrocytoma
429882|NCT00003457|Astrocytoma/Pilocytic|astrocytoma/pilocytic
429883|NCT00003457|Brainstem glioma|brainstem glioma
429884|NCT00003457|Glioblastoma multiforme|glioblastoma multiforme
429887|NCT00003457|Primitive neuroectodermal tumor|primitive neuroectodermal tumor
429888|NCT00003457|Tectal glioma|tectal glioma
429889|NCT00003458|Anaplastic astrocytoma|anaplastic astrocytoma
429890|NCT00003458|Anaplastic glioma|anaplastic glioma
429891|NCT00003458|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
429892|NCT00003458|Astrocytoma|astrocytoma
429893|NCT00003458|Astrocytoma pilocytic|astrocytoma pilocytic
429894|NCT00003458|Brain stem glioma|brain stem glioma
429895|NCT00003458|Craniopharyngioma|craniopharyngioma
429896|NCT00003458|Ganglioglioma|ganglioglioma
429897|NCT00003458|Glioblastoma multiforme|glioblastoma multiforme
429898|NCT00003458|Gliosarcoma|gliosarcoma
429899|NCT00003458|Medulloepithelioma|medulloepithelioma
429900|NCT00003458|Neurocytoma|neurocytoma
429901|NCT00003458|Oligodendroglioma|oligodendroglioma
429902|NCT00003458|Oligodendroglioma-brainstem|oligodendroglioma-brainstem
429903|NCT00003458|Primitive neuroectodermal tumor|primitive neuroectodermal tumor
429904|NCT00003459|recurrent adult brain stem glioma|recurrent adult brain stem glioma
429905|NCT00003459|untreated adult brain stem glioma|untreated adult brain stem glioma
429906|NCT00003459|untreated childhood brain stem glioma|untreated childhood brain stem glioma
429907|NCT00003459|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
429908|NCT00003460|Recurrent primitive neuroectodermal tumor|recurrent primitive neuroectodermal tumor
429909|NCT00003461|localized resectable neuroblastoma|localized resectable neuroblastoma
429910|NCT00003461|recurrent neuroblastoma|recurrent neuroblastoma
429911|NCT00003461|recurrent adult brain tumor|recurrent adult brain tumor
429912|NCT00003461|adult craniopharyngioma|adult craniopharyngioma
429913|NCT00003461|adult medulloblastoma|adult medulloblastoma
429914|NCT00003461|adult meningioma|adult meningioma
429915|NCT00003461|adult glioblastoma|adult glioblastoma
429916|NCT00003461|adult oligodendroglioma|adult oligodendroglioma
429917|NCT00003461|tumors metastatic to brain|tumors metastatic to brain
429918|NCT00003461|adult anaplastic astrocytoma|adult anaplastic astrocytoma
429919|NCT00003461|adult mixed glioma|adult mixed glioma
429920|NCT00003461|adult pineal parenchymal tumor|adult pineal parenchymal tumor
429921|NCT00003461|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
429922|NCT00003461|adult grade III meningioma|adult grade iii meningioma
539938|NCT00354913|Droxia|droxia
429923|NCT00003461|adult pilocytic astrocytoma|adult pilocytic astrocytoma
429924|NCT00003461|adult giant cell glioblastoma|adult giant cell glioblastoma
429925|NCT00003461|adult gliosarcoma|adult gliosarcoma
429926|NCT00003461|adult pineal gland astrocytoma|adult pineal gland astrocytoma
429927|NCT00003462|leptomeningeal metastases|leptomeningeal metastases
429928|NCT00003463|recurrent adult brain tumor|recurrent adult brain tumor
429929|NCT00003463|adult brain stem glioma|adult brain stem glioma
429930|NCT00003463|adult glioblastoma|adult glioblastoma
429931|NCT00003463|adult anaplastic astrocytoma|adult anaplastic astrocytoma
429932|NCT00003463|adult mixed glioma|adult mixed glioma
429933|NCT00003463|adult giant cell glioblastoma|adult giant cell glioblastoma
429934|NCT00003463|adult gliosarcoma|adult gliosarcoma
429935|NCT00003464|adult glioblastoma|adult glioblastoma
429936|NCT00003464|adult giant cell glioblastoma|adult giant cell glioblastoma
429937|NCT00003464|adult gliosarcoma|adult gliosarcoma
429938|NCT00003465|recurrent adult brain tumor|recurrent adult brain tumor
429939|NCT00003465|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
429940|NCT00003466|recurrent adult brain tumor|recurrent adult brain tumor
429941|NCT00003466|adult mixed glioma|adult mixed glioma
429942|NCT00003466|childhood mixed glioma|childhood mixed glioma
429943|NCT00003466|adult pilocytic astrocytoma|adult pilocytic astrocytoma
429944|NCT00003466|adult subependymoma|adult subependymoma
429945|NCT00003466|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
429946|NCT00003466|adult brain stem glioma|adult brain stem glioma
429947|NCT00003466|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
429948|NCT00003466|untreated childhood brain stem glioma|untreated childhood brain stem glioma
429949|NCT00003466|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
429950|NCT00003466|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
429951|NCT00003466|adult oligodendroglioma|adult oligodendroglioma
429952|NCT00003466|adult diffuse astrocytoma|adult diffuse astrocytoma
429953|NCT00003467|recurrent adult brain tumor|recurrent adult brain tumor
429954|NCT00003467|adult brain stem glioma|adult brain stem glioma
429955|NCT00003467|adult mixed glioma|adult mixed glioma
429956|NCT00003467|adult anaplastic astrocytoma|adult anaplastic astrocytoma
429957|NCT00003467|adult pilocytic astrocytoma|adult pilocytic astrocytoma
429958|NCT00003467|adult oligodendroglioma|adult oligodendroglioma
429959|NCT00003468|childhood low-grade astrocytoma|childhood low-grade astrocytoma
429960|NCT00003468|recurrent childhood astrocytoma|recurrent childhood astrocytoma
429961|NCT00003468|persistent childhood astrocytoma|persistent childhood astrocytoma
429962|NCT00003469|childhood rhabdoid tumor|childhood rhabdoid tumor
429963|NCT00003470|persistent anaplastic astrocytoma|persistent anaplastic astrocytoma
429964|NCT00003470|recurrent anaplastic astrocytoma|recurrent anaplastic astrocytoma
429965|NCT00003470|adult anaplastic astrocytoma|adult anaplastic astrocytoma
429966|NCT00003471|recurrent adult brain tumor|recurrent adult brain tumor
429967|NCT00003471|adult pilocytic astrocytoma|adult pilocytic astrocytoma
429968|NCT00003471|adult diffuse astrocytoma|adult diffuse astrocytoma
429969|NCT00003472|recurrent adult brain tumor|recurrent adult brain tumor
429970|NCT00003472|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
429971|NCT00003472|adult oligodendroglioma|adult oligodendroglioma
429972|NCT00003473|recurrent adult mixed glioma|recurrent adult mixed glioma
429973|NCT00003473|refractoy adult mixed glioma|refractoy adult mixed glioma
429974|NCT00003474|recurrent adult brain tumor|recurrent adult brain tumor
429975|NCT00003474|adult glioblastoma|adult glioblastoma
429976|NCT00003474|adult giant cell glioblastoma|adult giant cell glioblastoma
429977|NCT00003474|adult gliosarcoma|adult gliosarcoma
429978|NCT00003475|adult glioblastoma multiforme|adult glioblastoma multiforme
429979|NCT00003475|adult anaplastic astrocytoma|adult anaplastic astrocytoma
429980|NCT00003475|adult anaplastic astrocytoma/Mixed|adult anaplastic astrocytoma/mixed
429981|NCT00003476|childhood anaplastic astrocytoma|childhood anaplastic astrocytoma
429982|NCT00003476|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
429983|NCT00003476|childhood glioblastoma multiforme|childhood glioblastoma multiforme
429984|NCT00003476|recurrent childhood glioblastoma multiforme|recurrent childhood glioblastoma multiforme
429985|NCT00003476|childhood brainstem glioma|childhood brainstem glioma
429986|NCT00003476|recurrent childhood brainstem glioma|recurrent childhood brainstem glioma
429987|NCT00003476|childhood primitive neuroectodermal tumor|childhood primitive neuroectodermal tumor
429988|NCT00003476|recurrent childhood primitive neuroectodermal tumor|recurrent childhood primitive neuroectodermal tumor
429989|NCT00003477|visual pathway glioma not amenable to standard therapy|visual pathway glioma not amenable to standard therapy
429990|NCT00003477|visual pathway glioma not responding to standard therapy|visual pathway glioma not responding to standard therapy
429991|NCT00003478|recurrent adult brain tumor|recurrent adult brain tumor
429992|NCT00003478|adult brain stem glioma|adult brain stem glioma
429993|NCT00003478|adult medulloblastoma|adult medulloblastoma
429994|NCT00003478|adult glioblastoma|adult glioblastoma
429995|NCT00003478|adult anaplastic astrocytoma|adult anaplastic astrocytoma
429996|NCT00003478|adult anaplastic ependymoma|adult anaplastic ependymoma
429997|NCT00003478|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
429998|NCT00003478|adult mixed glioma|adult mixed glioma
429999|NCT00003478|adult ependymoblastoma|adult ependymoblastoma
430000|NCT00003478|adult giant cell glioblastoma|adult giant cell glioblastoma
430001|NCT00003478|adult gliosarcoma|adult gliosarcoma
430002|NCT00003479|Ependymoma|ependymoma
430003|NCT00003479|Anaplastic Ependymoma|anaplastic ependymoma
430005|NCT00003483|recurrent adult meningioma|recurrent adult meningioma
430006|NCT00003484|localized resectable neuroblastoma|localized resectable neuroblastoma
430007|NCT00003484|recurrent adult brain tumor|recurrent adult brain tumor
430008|NCT00003484|adult craniopharyngioma|adult craniopharyngioma
430009|NCT00003484|adult medulloblastoma|adult medulloblastoma
430012|NCT00003484|adult oligodendroglioma|adult oligodendroglioma
430013|NCT00003484|adult anaplastic astrocytoma|adult anaplastic astrocytoma
430014|NCT00003484|adult mixed glioma|adult mixed glioma
430015|NCT00003484|adult pineal parenchymal tumor|adult pineal parenchymal tumor
430016|NCT00003484|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
430017|NCT00003484|adult grade III meningioma|adult grade iii meningioma
430018|NCT00003484|adult pilocytic astrocytoma|adult pilocytic astrocytoma
430019|NCT00003484|adult giant cell glioblastoma|adult giant cell glioblastoma
430020|NCT00003484|adult gliosarcoma|adult gliosarcoma
430021|NCT00003485|stage IV colon cancer|stage iv colon cancer
430022|NCT00003485|recurrent colon cancer|recurrent colon cancer
430023|NCT00003485|adenocarcinoma of the colon|adenocarcinoma of the colon
430024|NCT00003487|stage IV esophageal cancer|stage iv esophageal cancer
430025|NCT00003487|recurrent esophageal cancer|recurrent esophageal cancer
430026|NCT00003487|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
430027|NCT00003489|stage IV salivary gland cancer|stage iv salivary gland cancer
430028|NCT00003489|recurrent salivary gland cancer|recurrent salivary gland cancer
430029|NCT00003489|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
430030|NCT00003489|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
200965|NCT02112799|Hepatitis B|hepatitis b
430031|NCT00003489|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
430032|NCT00003489|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
430033|NCT00003489|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
430034|NCT00003489|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
430035|NCT00003489|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
430036|NCT00003489|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
430037|NCT00003489|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
430038|NCT00003489|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
430039|NCT00003489|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
430040|NCT00003489|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
430041|NCT00003489|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
430042|NCT00003489|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
430043|NCT00003489|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
430044|NCT00003489|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
430045|NCT00003489|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
430046|NCT00003489|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
430047|NCT00003489|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
430048|NCT00003489|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
430049|NCT00003489|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
430050|NCT00003489|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
430051|NCT00003489|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
430052|NCT00003489|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
430053|NCT00003489|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
430054|NCT00003489|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
430055|NCT00003489|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
430056|NCT00003489|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
430057|NCT00003489|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
430058|NCT00003489|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
584777|NCT00509834|candidaemia|candidaemia
430059|NCT00003489|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
430060|NCT00003489|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
430061|NCT00003490|refractory multiple myeloma|refractory multiple myeloma
430062|NCT00003490|stage I multiple myeloma|stage i multiple myeloma
430063|NCT00003490|stage II multiple myeloma|stage ii multiple myeloma
430064|NCT00003490|stage III multiple myeloma|stage iii multiple myeloma
430065|NCT00003491|non-small cell adenocarcinoma of the lung|non-small cell adenocarcinoma of the lung
430066|NCT00003492|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
430067|NCT00003492|large cell lung cancer|large cell lung cancer
430068|NCT00003492|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
430069|NCT00003493|refractory multiple myeloma|refractory multiple myeloma
430070|NCT00003493|stage I multiple myeloma|stage i multiple myeloma
430071|NCT00003493|stage II multiple myeloma|stage ii multiple myeloma
430072|NCT00003493|stage III multiple myeloma|stage iii multiple myeloma
430073|NCT00003494|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
430074|NCT00003494|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
430075|NCT00003494|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
430076|NCT00003495|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
430077|NCT00003495|squamous cell lung cancer|squamous cell lung cancer
430078|NCT00003495|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
430079|NCT00003496|extensive stage small cell lung cancer|extensive stage small cell lung cancer
430080|NCT00003496|recurrent small cell lung cancer|recurrent small cell lung cancer
430081|NCT00003497|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
430082|NCT00003497|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
430083|NCT00003498|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
430084|NCT00003498|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
430085|NCT00003498|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
430086|NCT00003498|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
430087|NCT00003498|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
430088|NCT00003498|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
430089|NCT00003498|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
430090|NCT00003498|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
430091|NCT00003498|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
430092|NCT00003498|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
430093|NCT00003498|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
430094|NCT00003498|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
430095|NCT00003498|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
430096|NCT00003498|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
430097|NCT00003498|splenic marginal zone lymphoma|splenic marginal zone lymphoma
430098|NCT00003499|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
430099|NCT00003499|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
430100|NCT00003499|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
430101|NCT00003499|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
430102|NCT00003499|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
431345|NCT00003718|adult leiomyosarcoma|adult leiomyosarcoma
430103|NCT00003499|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
430104|NCT00003499|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
430105|NCT00003499|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
430106|NCT00003499|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
430107|NCT00003499|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
430108|NCT00003499|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
430109|NCT00003499|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
430110|NCT00003499|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
430111|NCT00003499|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
430112|NCT00003499|splenic marginal zone lymphoma|splenic marginal zone lymphoma
430113|NCT00003499|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
430114|NCT00003499|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
430115|NCT00003499|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
430116|NCT00003499|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
430117|NCT00003500|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
430118|NCT00003500|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
430119|NCT00003500|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
430120|NCT00003500|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
430121|NCT00003500|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
430122|NCT00003500|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
430123|NCT00003500|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
430124|NCT00003500|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
430125|NCT00003500|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
430126|NCT00003500|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
430127|NCT00003500|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
430128|NCT00003500|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
430129|NCT00003500|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
430130|NCT00003500|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
430131|NCT00003500|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
430132|NCT00003500|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
430133|NCT00003500|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
430200|NCT00003521|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
430134|NCT00003500|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
430135|NCT00003500|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
430136|NCT00003500|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
430137|NCT00003501|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
430138|NCT00003501|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
430139|NCT00003501|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
430140|NCT00003501|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
430141|NCT00003501|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
430142|NCT00003501|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
430143|NCT00003501|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
430144|NCT00003501|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
430145|NCT00003501|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
430146|NCT00003501|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
430147|NCT00003501|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
430148|NCT00003501|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
430149|NCT00003501|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
430150|NCT00003501|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
430151|NCT00003501|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
430152|NCT00003508|advanced malignant mesothelioma|advanced malignant mesothelioma
430153|NCT00003508|recurrent malignant mesothelioma|recurrent malignant mesothelioma
430154|NCT00003509|stage IV melanoma|stage iv melanoma
430155|NCT00003509|recurrent melanoma|recurrent melanoma
430156|NCT00003511|refractory multiple myeloma|refractory multiple myeloma
430157|NCT00003511|stage I multiple myeloma|stage i multiple myeloma
430158|NCT00003511|stage II multiple myeloma|stage ii multiple myeloma
430159|NCT00003511|stage III multiple myeloma|stage iii multiple myeloma
430160|NCT00003512|refractory multiple myeloma|refractory multiple myeloma
430161|NCT00003512|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
430162|NCT00003513|regional neuroblastoma|regional neuroblastoma
430163|NCT00003513|disseminated neuroblastoma|disseminated neuroblastoma
430164|NCT00003513|stage 4S neuroblastoma|stage 4s neuroblastoma
430165|NCT00003513|recurrent neuroblastoma|recurrent neuroblastoma
430166|NCT00003513|localized unresectable neuroblastoma|localized unresectable neuroblastoma
430167|NCT00003514|ACTH-producing pituitary tumor|acth-producing pituitary tumor
430168|NCT00003514|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
430169|NCT00003514|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
430170|NCT00003514|recurrent pituitary tumor|recurrent pituitary tumor
430171|NCT00003514|TSH producing pituitary tumor|tsh producing pituitary tumor
430172|NCT00003514|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
430173|NCT00003514|somatostatinoma|somatostatinoma
430174|NCT00003514|stage III Merkel cell carcinoma|stage iii merkel cell carcinoma
430175|NCT00003514|recurrent Merkel cell carcinoma|recurrent merkel cell carcinoma
430176|NCT00003514|neuroendocrine carcinoma|neuroendocrine carcinoma
430177|NCT00003515|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
430178|NCT00003515|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
430179|NCT00003515|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
430180|NCT00003515|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
430181|NCT00003516|adenocarcinoma of the prostate|adenocarcinoma of the prostate
430182|NCT00003516|stage III prostate cancer|stage iii prostate cancer
430183|NCT00003516|stage IV prostate cancer|stage iv prostate cancer
430184|NCT00003516|recurrent prostate cancer|recurrent prostate cancer
430185|NCT00003518|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
430186|NCT00003518|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
430187|NCT00003518|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
430188|NCT00003518|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
430189|NCT00003519|stage II breast cancer|stage ii breast cancer
430190|NCT00003519|stage IIIA breast cancer|stage iiia breast cancer
430191|NCT00003519|stage IIIB breast cancer|stage iiib breast cancer
430192|NCT00003520|stage IV renal cell cancer|stage iv renal cell cancer
430193|NCT00003520|recurrent renal cell cancer|recurrent renal cell cancer
10300|NCT03225105|Adenosine triphosphate-competitive inhibitor|adenosine triphosphate-competitive inhibitor
430194|NCT00003520|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
430195|NCT00003520|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
430196|NCT00003521|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
430197|NCT00003521|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
430198|NCT00003521|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
430199|NCT00003521|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
430201|NCT00003521|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
430202|NCT00003522|small intestine adenocarcinoma|small intestine adenocarcinoma
430203|NCT00003522|recurrent small intestine cancer|recurrent small intestine cancer
430204|NCT00003523|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
430205|NCT00003523|primary peritoneal cavity cancer|primary peritoneal cavity cancer
430206|NCT00003524|stage III gastric cancer|stage iii gastric cancer
430207|NCT00003524|stage IV gastric cancer|stage iv gastric cancer
430208|NCT00003524|recurrent gastric cancer|recurrent gastric cancer
430209|NCT00003524|adenocarcinoma of the stomach|adenocarcinoma of the stomach
430210|NCT00003525|stage IV cervical cancer|stage iv cervical cancer
430211|NCT00003525|recurrent cervical cancer|recurrent cervical cancer
430212|NCT00003525|stage IV vulvar cancer|stage iv vulvar cancer
430213|NCT00003525|recurrent vulvar cancer|recurrent vulvar cancer
430214|NCT00003526|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
430215|NCT00003526|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
430216|NCT00003530|stage IV childhood liver cancer|stage iv childhood liver cancer
430217|NCT00003530|recurrent childhood liver cancer|recurrent childhood liver cancer
430218|NCT00003530|advanced adult primary liver cancer|advanced adult primary liver cancer
430219|NCT00003530|recurrent adult primary liver cancer|recurrent adult primary liver cancer
430220|NCT00003531|recurrent pancreatic cancer|recurrent pancreatic cancer
430221|NCT00003531|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
430222|NCT00003531|stage IV pancreatic cancer|stage iv pancreatic cancer
430223|NCT00003532|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
430224|NCT00003532|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
430225|NCT00003532|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
430226|NCT00003532|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
430227|NCT00003532|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
430228|NCT00003532|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
430229|NCT00003533|adenocarcinoma of the prostate|adenocarcinoma of the prostate
430230|NCT00003533|stage IV prostate cancer|stage iv prostate cancer
430231|NCT00003533|recurrent prostate cancer|recurrent prostate cancer
430232|NCT00003534|adenocarcinoma of the prostate|adenocarcinoma of the prostate
430233|NCT00003534|stage IV prostate cancer|stage iv prostate cancer
430234|NCT00003534|recurrent prostate cancer|recurrent prostate cancer
430433|NCT00003548|stage IV cervical cancer|stage iv cervical cancer
430235|NCT00003535|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
430236|NCT00003535|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
430237|NCT00003535|childhood cerebral astrocytoma/malignant glioma|childhood cerebral astrocytoma/malignant glioma
430238|NCT00003537|adult anaplastic astrocytoma|adult anaplastic astrocytoma
430239|NCT00003538|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
430240|NCT00003538|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
430241|NCT00003538|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
430242|NCT00003538|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
430243|NCT00003538|stage IV breast cancer|stage iv breast cancer
430244|NCT00003538|stage IIIA breast cancer|stage iiia breast cancer
430245|NCT00003538|stage IIIB breast cancer|stage iiib breast cancer
430246|NCT00003538|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
430247|NCT00003538|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
430248|NCT00003538|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
430249|NCT00003538|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
430250|NCT00003538|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
584778|NCT00509834|lactoferrin|lactoferrin
430251|NCT00003538|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
430252|NCT00003538|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
430253|NCT00003538|disseminated neuroblastoma|disseminated neuroblastoma
430254|NCT00003538|recurrent neuroblastoma|recurrent neuroblastoma
430255|NCT00003538|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
430256|NCT00003538|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
430257|NCT00003538|stage I multiple myeloma|stage i multiple myeloma
430258|NCT00003538|stage II multiple myeloma|stage ii multiple myeloma
430259|NCT00003538|stage III multiple myeloma|stage iii multiple myeloma
430260|NCT00003538|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
430261|NCT00003538|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
430262|NCT00003538|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
10317|NCT03225001|SAVR|savr
430263|NCT00003538|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
430264|NCT00003538|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
430265|NCT00003538|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
430266|NCT00003538|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
430267|NCT00003538|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
430268|NCT00003538|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
430269|NCT00003538|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
430469|NCT00003552|melanoma|melanoma
430270|NCT00003538|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
430271|NCT00003538|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
430272|NCT00003538|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
430273|NCT00003538|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
430274|NCT00003538|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
430275|NCT00003538|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
430276|NCT00003538|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
430277|NCT00003538|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
430278|NCT00003538|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
430279|NCT00003538|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
430280|NCT00003538|myelodysplastic syndromes|myelodysplastic syndromes
430281|NCT00003538|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
430282|NCT00003538|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
430283|NCT00003538|untreated hairy cell leukemia|untreated hairy cell leukemia
430284|NCT00003538|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
430285|NCT00003538|refractory hairy cell leukemia|refractory hairy cell leukemia
430286|NCT00003538|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
430287|NCT00003538|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
430288|NCT00003538|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
430289|NCT00003538|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
430290|NCT00003538|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
430291|NCT00003538|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
430292|NCT00003538|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
430293|NCT00003538|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
430294|NCT00003538|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
430295|NCT00003538|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
430296|NCT00003538|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
430297|NCT00003538|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
430298|NCT00003538|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
430299|NCT00003538|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
446339|NCT00006490|HIV-1|hiv-1
430300|NCT00003538|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
430301|NCT00003538|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
430302|NCT00003538|acute undifferentiated leukemia|acute undifferentiated leukemia
430303|NCT00003538|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
430304|NCT00003538|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
430305|NCT00003538|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
430306|NCT00003538|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
430307|NCT00003538|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
430308|NCT00003538|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
430309|NCT00003538|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
430310|NCT00003538|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
430311|NCT00003538|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
430312|NCT00003538|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
430313|NCT00003538|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
430314|NCT00003538|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
430315|NCT00003538|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
430316|NCT00003538|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
430317|NCT00003538|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
430318|NCT00003538|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
430319|NCT00003538|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
430320|NCT00003538|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
430321|NCT00003538|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
430322|NCT00003538|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
430323|NCT00003538|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
430324|NCT00003538|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
10476|NCT03223987|16S rRNA|16s rrna
430325|NCT00003538|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
430326|NCT00003538|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
430327|NCT00003538|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
430328|NCT00003538|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
430329|NCT00003538|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
430330|NCT00003538|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
430331|NCT00003538|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
430332|NCT00003538|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
430333|NCT00003538|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
430334|NCT00003538|secondary acute myeloid leukemia|secondary acute myeloid leukemia
430335|NCT00003538|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
752431|NCT01172951|Post-prandial|post-prandial
430336|NCT00003538|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
430337|NCT00003538|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
430338|NCT00003538|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
430339|NCT00003538|anemia|anemia
430340|NCT00003538|graft versus host disease|graft versus host disease
430341|NCT00003538|prolymphocytic leukemia|prolymphocytic leukemia
430342|NCT00003538|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
430343|NCT00003538|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
430344|NCT00003538|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
430345|NCT00003538|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
430346|NCT00003538|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
430347|NCT00003538|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
430348|NCT00003538|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
430349|NCT00003538|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
430350|NCT00003538|non-Hodgkin lymphoma during pregnancy|non-hodgkin lymphoma during pregnancy
430351|NCT00003538|stage I mantle cell lymphoma|stage i mantle cell lymphoma
430352|NCT00003538|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
430353|NCT00003538|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
430354|NCT00003538|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
430355|NCT00003538|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
430356|NCT00003538|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
430357|NCT00003538|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
430358|NCT00003538|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
430359|NCT00003538|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
430360|NCT00003538|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
430361|NCT00003538|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
430362|NCT00003538|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
430363|NCT00003538|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
430364|NCT00003538|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
430365|NCT00003538|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
430366|NCT00003538|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
430367|NCT00003538|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
430368|NCT00003538|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
430369|NCT00003538|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
430370|NCT00003538|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
430371|NCT00003538|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
540790|NCT00359879|Amylin|amylin
430372|NCT00003538|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
430373|NCT00003538|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
430374|NCT00003538|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
430375|NCT00003538|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
430376|NCT00003538|anaplastic large cell lymphoma|anaplastic large cell lymphoma
430377|NCT00003538|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
430378|NCT00003538|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
430379|NCT00003538|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
430380|NCT00003538|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
430381|NCT00003538|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
430382|NCT00003538|stage I marginal zone lymphoma|stage i marginal zone lymphoma
430383|NCT00003538|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
430384|NCT00003538|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
430385|NCT00003538|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
430386|NCT00003538|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
430387|NCT00003538|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
430388|NCT00003538|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
430389|NCT00003538|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
430390|NCT00003538|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
430391|NCT00003538|splenic marginal zone lymphoma|splenic marginal zone lymphoma
430470|NCT00003552|recurrent melanoma|recurrent melanoma
430392|NCT00003538|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
430393|NCT00003539|stage IV breast cancer|stage iv breast cancer
430394|NCT00003539|recurrent breast cancer|recurrent breast cancer
430395|NCT00003540|stage IV breast cancer|stage iv breast cancer
430396|NCT00003540|recurrent breast cancer|recurrent breast cancer
430397|NCT00003541|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
430398|NCT00003541|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
430399|NCT00003542|stage III renal cell cancer|stage iii renal cell cancer
430400|NCT00003542|stage IV renal cell cancer|stage iv renal cell cancer
430401|NCT00003543|stage IV colon cancer|stage iv colon cancer
430402|NCT00003543|stage IV rectal cancer|stage iv rectal cancer
430403|NCT00003543|recurrent colon cancer|recurrent colon cancer
430404|NCT00003543|recurrent rectal cancer|recurrent rectal cancer
430405|NCT00003544|stage IV colon cancer|stage iv colon cancer
430406|NCT00003544|stage IV rectal cancer|stage iv rectal cancer
430407|NCT00003544|recurrent colon cancer|recurrent colon cancer
430408|NCT00003544|recurrent rectal cancer|recurrent rectal cancer
430409|NCT00003545|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
430410|NCT00003545|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
430411|NCT00003545|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
430412|NCT00003545|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
430413|NCT00003545|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
430414|NCT00003545|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
430415|NCT00003545|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
430416|NCT00003546|stage I pancreatic cancer|stage i pancreatic cancer
430417|NCT00003546|stage II pancreatic cancer|stage ii pancreatic cancer
430418|NCT00003546|stage III pancreatic cancer|stage iii pancreatic cancer
430419|NCT00003546|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
430420|NCT00003548|stage IV colon cancer|stage iv colon cancer
430421|NCT00003548|stage IV breast cancer|stage iv breast cancer
430422|NCT00003548|recurrent breast cancer|recurrent breast cancer
430423|NCT00003548|stage IV gastric cancer|stage iv gastric cancer
430424|NCT00003548|recurrent gastric cancer|recurrent gastric cancer
430425|NCT00003548|recurrent pancreatic cancer|recurrent pancreatic cancer
430426|NCT00003548|stage IV rectal cancer|stage iv rectal cancer
430427|NCT00003548|recurrent colon cancer|recurrent colon cancer
430428|NCT00003548|recurrent rectal cancer|recurrent rectal cancer
430429|NCT00003548|stage IV anal cancer|stage iv anal cancer
430430|NCT00003548|recurrent anal cancer|recurrent anal cancer
430431|NCT00003548|stage IV esophageal cancer|stage iv esophageal cancer
430432|NCT00003548|recurrent esophageal cancer|recurrent esophageal cancer
446703|NCT00007137|Ultrasound|ultrasound
430434|NCT00003548|recurrent cervical cancer|recurrent cervical cancer
430435|NCT00003548|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
430436|NCT00003548|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
430437|NCT00003548|stage IV vulvar cancer|stage iv vulvar cancer
430438|NCT00003548|recurrent vulvar cancer|recurrent vulvar cancer
430439|NCT00003548|stage IVA vaginal cancer|stage iva vaginal cancer
430440|NCT00003548|stage IVB vaginal cancer|stage ivb vaginal cancer
430441|NCT00003548|recurrent vaginal cancer|recurrent vaginal cancer
430442|NCT00003548|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
584779|NCT00509847|S. epidermidis|s. epidermidis
430443|NCT00003548|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
430444|NCT00003548|advanced adult primary liver cancer|advanced adult primary liver cancer
430445|NCT00003548|recurrent adult primary liver cancer|recurrent adult primary liver cancer
430446|NCT00003548|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
430447|NCT00003548|stage IV endometrial carcinoma|stage iv endometrial carcinoma
430448|NCT00003548|recurrent endometrial carcinoma|recurrent endometrial carcinoma
430449|NCT00003548|unresectable gallbladder cancer|unresectable gallbladder cancer
430450|NCT00003548|recurrent gallbladder cancer|recurrent gallbladder cancer
430451|NCT00003548|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
430452|NCT00003548|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
430453|NCT00003548|recurrent small intestine cancer|recurrent small intestine cancer
430454|NCT00003548|carcinoma of the appendix|carcinoma of the appendix
430455|NCT00003548|fallopian tube cancer|fallopian tube cancer
430456|NCT00003548|stage IV uterine sarcoma|stage iv uterine sarcoma
430457|NCT00003548|recurrent uterine sarcoma|recurrent uterine sarcoma
430458|NCT00003548|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
430459|NCT00003548|stage IV pancreatic cancer|stage iv pancreatic cancer
10477|NCT03223987|Microbiome|microbiome
430460|NCT00003549|stage II neuroendocrine carcinoma of the skin|stage ii neuroendocrine carcinoma of the skin
430461|NCT00003549|stage III neuroendocrine carcinoma of the skin|stage iii neuroendocrine carcinoma of the skin
430462|NCT00003549|recurrent neuroendocrine carcinoma of the skin|recurrent neuroendocrine carcinoma of the skin
430463|NCT00003551|stage III renal cell cancer|stage iii renal cell cancer
430464|NCT00003551|stage IV renal cell cancer|stage iv renal cell cancer
430465|NCT00003551|recurrent renal cell cancer|recurrent renal cell cancer
430467|NCT00003552|body system/site cancer|body system/site cancer
430473|NCT00003552|stage IV melanoma|stage iv melanoma
430474|NCT00003552|stage, melanoma|stage, melanoma
430475|NCT00003553|stage IV renal cell cancer|stage iv renal cell cancer
430476|NCT00003553|recurrent renal cell cancer|recurrent renal cell cancer
430477|NCT00003554|stage I multiple myeloma|stage i multiple myeloma
430478|NCT00003554|stage II multiple myeloma|stage ii multiple myeloma
430479|NCT00003554|stage III multiple myeloma|stage iii multiple myeloma
430480|NCT00003555|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
430481|NCT00003556|stage IV melanoma|stage iv melanoma
430482|NCT00003556|recurrent melanoma|recurrent melanoma
430483|NCT00003557|advanced adult primary liver cancer|advanced adult primary liver cancer
430484|NCT00003557|recurrent adult primary liver cancer|recurrent adult primary liver cancer
430485|NCT00003557|unresectable gallbladder cancer|unresectable gallbladder cancer
430486|NCT00003557|recurrent gallbladder cancer|recurrent gallbladder cancer
430487|NCT00003557|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
430488|NCT00003557|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
430489|NCT00003557|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
430490|NCT00003557|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
430491|NCT00003558|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
430492|NCT00003558|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
430493|NCT00003560|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
430494|NCT00003560|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
430495|NCT00003560|stage III endometrial carcinoma|stage iii endometrial carcinoma
430496|NCT00003560|stage IV endometrial carcinoma|stage iv endometrial carcinoma
430497|NCT00003560|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
430498|NCT00003560|fallopian tube cancer|fallopian tube cancer
430499|NCT00003560|primary peritoneal cavity cancer|primary peritoneal cavity cancer
430500|NCT00003561|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
430501|NCT00003561|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
430502|NCT00003561|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
430503|NCT00003562|squamous cell lung cancer|squamous cell lung cancer
430504|NCT00003562|large cell lung cancer|large cell lung cancer
430505|NCT00003562|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
430506|NCT00003562|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
430507|NCT00003562|adenocarcinoma of the lung|adenocarcinoma of the lung
430508|NCT00003563|tumors metastatic to brain|tumors metastatic to brain
430509|NCT00003564|recurrent adult brain tumor|recurrent adult brain tumor
430510|NCT00003564|adult glioblastoma|adult glioblastoma
430511|NCT00003564|adult anaplastic astrocytoma|adult anaplastic astrocytoma
430512|NCT00003564|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
430513|NCT00003564|adult mixed glioma|adult mixed glioma
430514|NCT00003564|adult giant cell glioblastoma|adult giant cell glioblastoma
430515|NCT00003564|adult gliosarcoma|adult gliosarcoma
430516|NCT00003565|stage IV breast cancer|stage iv breast cancer
430517|NCT00003565|stage IIIA breast cancer|stage iiia breast cancer
430518|NCT00003565|recurrent breast cancer|recurrent breast cancer
430519|NCT00003565|stage IIIB breast cancer|stage iiib breast cancer
430520|NCT00003565|stage IIIC breast cancer|stage iiic breast cancer
430521|NCT00003565|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
430522|NCT00003565|extensive stage small cell lung cancer|extensive stage small cell lung cancer
430523|NCT00003565|recurrent small cell lung cancer|recurrent small cell lung cancer
430524|NCT00003565|stage III bladder cancer|stage iii bladder cancer
430525|NCT00003565|recurrent bladder cancer|recurrent bladder cancer
430526|NCT00003565|stage IV bladder cancer|stage iv bladder cancer
430527|NCT00003565|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
430528|NCT00003565|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
430529|NCT00003565|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
430530|NCT00003565|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
430531|NCT00003565|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
430532|NCT00003565|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
430533|NCT00003565|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
430534|NCT00003565|pulmonary carcinoid tumor|pulmonary carcinoid tumor
753430|NCT01179230|acute coronary syndrome|acute coronary syndrome
430535|NCT00003565|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
430536|NCT00003565|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
430537|NCT00003565|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
430538|NCT00003565|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
430539|NCT00003565|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
200966|NCT02112786|Overactive Bladder|overactive bladder
430540|NCT00003565|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
449336|NCT00009243|Alteplase|alteplase
430541|NCT00003565|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
430542|NCT00003565|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
430543|NCT00003565|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
430544|NCT00003565|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
430545|NCT00003565|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
430546|NCT00003565|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
430547|NCT00003565|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
430548|NCT00003565|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
430549|NCT00003565|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
430550|NCT00003565|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
430551|NCT00003565|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
430552|NCT00003565|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
430553|NCT00003565|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
430554|NCT00003565|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
430555|NCT00003565|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
430556|NCT00003565|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
430557|NCT00003565|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
430558|NCT00003565|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
430559|NCT00003565|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
430560|NCT00003565|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
430561|NCT00003565|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
430562|NCT00003565|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
430563|NCT00003565|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
430564|NCT00003565|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
430565|NCT00003565|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
430566|NCT00003565|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
430567|NCT00003565|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
430568|NCT00003565|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
430569|NCT00003565|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
430631|NCT00003568|recurrent melanoma|recurrent melanoma
430570|NCT00003565|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
430571|NCT00003565|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
430572|NCT00003565|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
430573|NCT00003565|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
430574|NCT00003565|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
430575|NCT00003565|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
430576|NCT00003565|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
430577|NCT00003565|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
431346|NCT00003718|adult liposarcoma|adult liposarcoma
430578|NCT00003565|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
430579|NCT00003565|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
430580|NCT00003565|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
430581|NCT00003565|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
430582|NCT00003565|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
430583|NCT00003565|recurrent salivary gland cancer|recurrent salivary gland cancer
430584|NCT00003565|stage III salivary gland cancer|stage iii salivary gland cancer
430585|NCT00003565|stage IV salivary gland cancer|stage iv salivary gland cancer
430586|NCT00003566|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
430587|NCT00003567|recurrent adult brain tumor|recurrent adult brain tumor
430588|NCT00003567|adult brain stem glioma|adult brain stem glioma
430589|NCT00003567|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
430590|NCT00003567|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
430591|NCT00003567|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
430592|NCT00003567|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
430593|NCT00003567|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
430594|NCT00003567|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
430595|NCT00003567|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
430596|NCT00003567|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
430597|NCT00003567|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
430598|NCT00003567|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
430599|NCT00003567|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
430600|NCT00003567|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
430601|NCT00003567|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
430602|NCT00003567|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
430603|NCT00003567|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
430604|NCT00003567|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
430605|NCT00003567|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
430606|NCT00003567|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
430607|NCT00003567|adult mixed glioma|adult mixed glioma
430608|NCT00003567|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
430609|NCT00003567|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
430610|NCT00003567|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
430611|NCT00003567|adult anaplastic astrocytoma|adult anaplastic astrocytoma
430612|NCT00003567|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
430613|NCT00003567|adult glioblastoma|adult glioblastoma
430614|NCT00003567|adult pilocytic astrocytoma|adult pilocytic astrocytoma
430615|NCT00003567|adult subependymoma|adult subependymoma
430616|NCT00003567|adult anaplastic ependymoma|adult anaplastic ependymoma
430617|NCT00003567|adult myxopapillary ependymoma|adult myxopapillary ependymoma
430618|NCT00003567|adult ependymoblastoma|adult ependymoblastoma
430619|NCT00003567|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
430620|NCT00003567|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
430621|NCT00003567|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
430622|NCT00003567|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
430623|NCT00003567|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
430624|NCT00003567|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
430625|NCT00003567|splenic marginal zone lymphoma|splenic marginal zone lymphoma
430626|NCT00003567|adult oligodendroglioma|adult oligodendroglioma
430627|NCT00003567|adult giant cell glioblastoma|adult giant cell glioblastoma
430628|NCT00003567|adult gliosarcoma|adult gliosarcoma
430629|NCT00003567|adult diffuse astrocytoma|adult diffuse astrocytoma
430630|NCT00003568|stage IV melanoma|stage iv melanoma
446704|NCT00007137|Volume|volume
584780|NCT00509847|Staphylococcus|staphylococcus
430632|NCT00003569|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
430633|NCT00003569|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
430634|NCT00003569|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
430635|NCT00003569|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
430636|NCT00003569|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
430637|NCT00003569|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
430638|NCT00003569|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
430639|NCT00003569|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
430640|NCT00003569|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
430641|NCT00003569|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
430642|NCT00003569|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
430643|NCT00003569|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
430644|NCT00003569|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
430645|NCT00003569|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
430646|NCT00003569|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
430647|NCT00003569|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
430648|NCT00003569|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
430649|NCT00003569|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
430650|NCT00003569|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
430651|NCT00003569|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
430652|NCT00003569|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
430653|NCT00003569|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
430654|NCT00003569|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
430655|NCT00003569|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
430657|NCT00003569|recurrent salivary gland cancer|recurrent salivary gland cancer
430658|NCT00003569|stage IV salivary gland cancer|stage iv salivary gland cancer
430659|NCT00003569|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
430660|NCT00003569|stage III salivary gland cancer|stage iii salivary gland cancer
430661|NCT00003571|stage III colon cancer|stage iii colon cancer
430662|NCT00003571|adenocarcinoma of the colon|adenocarcinoma of the colon
430663|NCT00003572|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
430664|NCT00003572|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
430665|NCT00003572|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
430666|NCT00003572|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
430667|NCT00003572|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
430668|NCT00003572|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
430669|NCT00003572|stage I multiple myeloma|stage i multiple myeloma
430670|NCT00003572|stage II multiple myeloma|stage ii multiple myeloma
430671|NCT00003572|stage III multiple myeloma|stage iii multiple myeloma
430672|NCT00003572|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
430673|NCT00003572|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
430674|NCT00003572|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
430675|NCT00003572|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
430676|NCT00003572|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
430677|NCT00003572|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
430678|NCT00003572|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
430679|NCT00003572|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
430680|NCT00003572|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
430681|NCT00003572|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
430682|NCT00003572|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
430683|NCT00003572|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
430684|NCT00003572|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
430685|NCT00003572|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
430686|NCT00003572|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
430687|NCT00003572|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
430688|NCT00003572|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
430689|NCT00003572|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
430690|NCT00003572|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
430691|NCT00003572|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
430692|NCT00003572|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
430693|NCT00003572|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
430694|NCT00003572|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
430695|NCT00003572|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
430696|NCT00003572|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
430697|NCT00003572|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
430698|NCT00003572|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
430699|NCT00003572|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
430700|NCT00003572|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
430701|NCT00003572|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
430702|NCT00003572|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
430703|NCT00003572|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
430704|NCT00003572|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
430705|NCT00003572|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
430706|NCT00003572|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
430707|NCT00003572|stage I mantle cell lymphoma|stage i mantle cell lymphoma
430708|NCT00003572|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
430709|NCT00003572|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
430710|NCT00003572|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
430711|NCT00003572|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
430712|NCT00003572|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
430713|NCT00003572|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
752432|NCT01172951|Nutrigenomic|nutrigenomic
540300|NCT00358397|Sarcoma|sarcoma
430714|NCT00003572|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
430715|NCT00003572|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
430716|NCT00003572|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
430717|NCT00003572|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
430718|NCT00003572|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
430719|NCT00003572|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
430720|NCT00003572|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
430721|NCT00003572|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
430722|NCT00003572|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
430723|NCT00003572|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
430724|NCT00003572|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
430725|NCT00003572|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
430726|NCT00003572|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
430727|NCT00003572|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
430728|NCT00003572|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
430729|NCT00003572|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
430730|NCT00003572|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
430731|NCT00003572|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
430732|NCT00003572|stage I marginal zone lymphoma|stage i marginal zone lymphoma
430733|NCT00003572|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
430734|NCT00003572|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
430735|NCT00003572|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
430736|NCT00003572|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
430737|NCT00003572|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
430738|NCT00003572|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
430739|NCT00003572|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
430740|NCT00003572|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
430741|NCT00003572|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
430742|NCT00003572|splenic marginal zone lymphoma|splenic marginal zone lymphoma
430743|NCT00003573|untreated childhood medulloblastoma|untreated childhood medulloblastoma
430744|NCT00003574|recurrent adult brain tumor|recurrent adult brain tumor
430746|NCT00003574|adult anaplastic astrocytoma|adult anaplastic astrocytoma
430747|NCT00003574|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
430748|NCT00003574|adult giant cell glioblastoma|adult giant cell glioblastoma
430749|NCT00003574|adult gliosarcoma|adult gliosarcoma
430750|NCT00003575|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
430751|NCT00003575|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
430752|NCT00003575|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
430753|NCT00003575|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
430754|NCT00003576|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
446706|NCT00007137|Swallowing|swallowing
430755|NCT00003576|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
430756|NCT00003576|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
430757|NCT00003576|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
430758|NCT00003576|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
430759|NCT00003576|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
430760|NCT00003576|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
430761|NCT00003576|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
430762|NCT00003576|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
430763|NCT00003576|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
430764|NCT00003577|stage I breast cancer|stage i breast cancer
430765|NCT00003577|stage II breast cancer|stage ii breast cancer
430766|NCT00003578|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
430767|NCT00003578|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
430768|NCT00003578|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
430769|NCT00003578|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
430770|NCT00003578|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
540432|NCT00358865|ABI|abi
430771|NCT00003578|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
430772|NCT00003578|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
430773|NCT00003578|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
430774|NCT00003580|oral complications|oral complications
430775|NCT00003580|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
430776|NCT00003580|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
430777|NCT00003580|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
430778|NCT00003580|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
430779|NCT00003580|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
430780|NCT00003580|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
430781|NCT00003580|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
430782|NCT00003580|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
430783|NCT00003580|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
430784|NCT00003580|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
430785|NCT00003580|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
430786|NCT00003580|radiation toxicity|radiation toxicity
430787|NCT00003582|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
430788|NCT00003582|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
430789|NCT00003582|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
430790|NCT00003582|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
430791|NCT00003582|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
430792|NCT00003582|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
430793|NCT00003582|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
430794|NCT00003582|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
430795|NCT00003582|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
430796|NCT00003582|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
430797|NCT00003582|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
430798|NCT00003582|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
430799|NCT00003582|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
430800|NCT00003583|limited stage small cell lung cancer|limited stage small cell lung cancer
430801|NCT00003583|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
430802|NCT00003583|radiation toxicity|radiation toxicity
430803|NCT00003584|stage IV renal cell cancer|stage iv renal cell cancer
430804|NCT00003584|recurrent renal cell cancer|recurrent renal cell cancer
430805|NCT00003585|stage IV renal cell cancer|stage iv renal cell cancer
584781|NCT00509847|Lactoferrin|lactoferrin
430806|NCT00003585|recurrent renal cell cancer|recurrent renal cell cancer
430807|NCT00003587|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
430808|NCT00003587|squamous cell lung cancer|squamous cell lung cancer
430809|NCT00003587|large cell lung cancer|large cell lung cancer
430810|NCT00003587|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
430811|NCT00003587|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
430812|NCT00003587|adenocarcinoma of the lung|adenocarcinoma of the lung
430813|NCT00003588|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
430814|NCT00003588|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
430815|NCT00003589|recurrent small cell lung cancer|recurrent small cell lung cancer
430816|NCT00003589|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
430817|NCT00003589|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
430818|NCT00003590|recurrent adult brain tumor|recurrent adult brain tumor
430819|NCT00003590|adult grade I meningioma|adult grade i meningioma
430820|NCT00003591|stage I pancreatic cancer|stage i pancreatic cancer
430821|NCT00003591|stage II pancreatic cancer|stage ii pancreatic cancer
430822|NCT00003591|stage III pancreatic cancer|stage iii pancreatic cancer
430823|NCT00003591|recurrent pancreatic cancer|recurrent pancreatic cancer
430824|NCT00003591|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
430825|NCT00003592|stage IV salivary gland cancer|stage iv salivary gland cancer
430826|NCT00003592|recurrent salivary gland cancer|recurrent salivary gland cancer
430827|NCT00003592|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
430828|NCT00003592|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
430829|NCT00003592|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
752433|NCT01172951|Test meal|test meal
430830|NCT00003592|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
430831|NCT00003592|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
430832|NCT00003592|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
430833|NCT00003592|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
430834|NCT00003592|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
430835|NCT00003592|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
430836|NCT00003592|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
430837|NCT00003592|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
430838|NCT00003592|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
430839|NCT00003592|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
430840|NCT00003593|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
430910|NCT00003602|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
430841|NCT00003593|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
430842|NCT00003593|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
430843|NCT00003593|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
430844|NCT00003593|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
430845|NCT00003593|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
430846|NCT00003593|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
430847|NCT00003593|refractory anemia|refractory anemia
430848|NCT00003593|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
430849|NCT00003593|refractory anemia with excess blasts|refractory anemia with excess blasts
430850|NCT00003593|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
430851|NCT00003593|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
430852|NCT00003593|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
430853|NCT00003593|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
430854|NCT00003593|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
430855|NCT00003593|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
430856|NCT00003593|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
430857|NCT00003593|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
430858|NCT00003593|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
430859|NCT00003594|stage III colon cancer|stage iii colon cancer
430860|NCT00003594|stage IV colon cancer|stage iv colon cancer
430861|NCT00003594|stage III rectal cancer|stage iii rectal cancer
430862|NCT00003594|stage IV rectal cancer|stage iv rectal cancer
430863|NCT00003594|recurrent colon cancer|recurrent colon cancer
430864|NCT00003594|recurrent rectal cancer|recurrent rectal cancer
430865|NCT00003594|adenocarcinoma of the colon|adenocarcinoma of the colon
430866|NCT00003594|adenocarcinoma of the rectum|adenocarcinoma of the rectum
430867|NCT00003595|childhood Burkitt lymphoma|childhood burkitt lymphoma
430868|NCT00003595|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
430869|NCT00003595|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
430870|NCT00003595|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
430871|NCT00003595|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
430872|NCT00003596|stage II anal cancer|stage ii anal cancer
430873|NCT00003596|stage III anal cancer|stage iii anal cancer
430874|NCT00003596|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
430875|NCT00003596|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
430876|NCT00003596|basaloid carcinoma of the anus|basaloid carcinoma of the anus
430877|NCT00003597|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
430878|NCT00003597|recurrent renal cell cancer|recurrent renal cell cancer
430879|NCT00003597|recurrent neuroblastoma|recurrent neuroblastoma
430880|NCT00003597|recurrent childhood liver cancer|recurrent childhood liver cancer
430881|NCT00003597|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
430882|NCT00003597|recurrent retinoblastoma|recurrent retinoblastoma
430883|NCT00003597|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
430884|NCT00003597|recurrent osteosarcoma|recurrent osteosarcoma
430885|NCT00003597|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
430886|NCT00003597|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
430887|NCT00003597|recurrent intraocular melanoma|recurrent intraocular melanoma
430888|NCT00003597|recurrent melanoma|recurrent melanoma
430889|NCT00003597|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
430890|NCT00003597|childhood germ cell tumor|childhood germ cell tumor
430891|NCT00003597|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
430892|NCT00003597|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
430893|NCT00003597|extragonadal germ cell tumor|extragonadal germ cell tumor
430894|NCT00003597|recurrent uterine sarcoma|recurrent uterine sarcoma
430895|NCT00003597|neutropenia|neutropenia
430896|NCT00003597|thrombocytopenia|thrombocytopenia
430897|NCT00003597|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
430898|NCT00003597|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
430899|NCT00003597|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
430900|NCT00003597|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
430901|NCT00003597|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
430902|NCT00003597|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
430903|NCT00003597|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
430905|NCT00003598|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
430906|NCT00003598|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
430907|NCT00003599|non-small cell lung cancer|non-small cell lung cancer
430908|NCT00003599|small cell lung cancer|small cell lung cancer
430911|NCT00003602|refractory anemia with excess blasts|refractory anemia with excess blasts
430912|NCT00003602|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
430913|NCT00003602|secondary acute myeloid leukemia|secondary acute myeloid leukemia
430914|NCT00003602|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
430915|NCT00003602|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
430916|NCT00003603|refractory multiple myeloma|refractory multiple myeloma
430917|NCT00003603|stage I multiple myeloma|stage i multiple myeloma
430918|NCT00003603|stage II multiple myeloma|stage ii multiple myeloma
430919|NCT00003603|stage III multiple myeloma|stage iii multiple myeloma
430920|NCT00003604|stage III renal cell cancer|stage iii renal cell cancer
430921|NCT00003604|stage IV renal cell cancer|stage iv renal cell cancer
430922|NCT00003605|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
430923|NCT00003605|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
430924|NCT00003605|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
430925|NCT00003605|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
430926|NCT00003605|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
430927|NCT00003605|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
430928|NCT00003605|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
430929|NCT00003605|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
430930|NCT00003605|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
430931|NCT00003605|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
430932|NCT00003605|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
430933|NCT00003605|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
430934|NCT00003605|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
430935|NCT00003605|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
430936|NCT00003605|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
430937|NCT00003605|splenic marginal zone lymphoma|splenic marginal zone lymphoma
430938|NCT00003606|extensive stage small cell lung cancer|extensive stage small cell lung cancer
430939|NCT00003607|adenocarcinoma of the prostate|adenocarcinoma of the prostate
430940|NCT00003607|stage I prostate cancer|stage i prostate cancer
430941|NCT00003607|stage IIB prostate cancer|stage iib prostate cancer
430942|NCT00003607|stage IIA prostate cancer|stage iia prostate cancer
430943|NCT00003607|stage III prostate cancer|stage iii prostate cancer
430944|NCT00002714|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
430945|NCT00002714|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
430946|NCT00002715|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
430947|NCT00002715|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
430948|NCT00002715|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
430949|NCT00002715|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
430950|NCT00002715|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
430951|NCT00002715|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
430952|NCT00002715|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
430953|NCT00002715|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
430954|NCT00002716|stage IV colon cancer|stage iv colon cancer
430955|NCT00002716|stage IV rectal cancer|stage iv rectal cancer
430956|NCT00002716|recurrent colon cancer|recurrent colon cancer
430957|NCT00002716|recurrent rectal cancer|recurrent rectal cancer
430958|NCT00002716|adenocarcinoma of the colon|adenocarcinoma of the colon
430959|NCT00002716|adenocarcinoma of the rectum|adenocarcinoma of the rectum
430960|NCT00002716|liver metastases|liver metastases
752434|NCT01172951|Oral glucose tolerance test|oral glucose tolerance test
201008|NCT02112643|Thyroid orbitopathy|thyroid orbitopathy
430961|NCT00003611|basal cell carcinoma of the skin|basal cell carcinoma of the skin
430962|NCT00003611|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
430963|NCT00003612|stage IV breast cancer|stage iv breast cancer
430964|NCT00003612|recurrent breast cancer|recurrent breast cancer
430965|NCT00003614|adenocarcinoma of the prostate|adenocarcinoma of the prostate
430966|NCT00003614|stage IV prostate cancer|stage iv prostate cancer
430967|NCT00003614|recurrent prostate cancer|recurrent prostate cancer
430968|NCT00003615|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
430969|NCT00003615|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
430970|NCT00003615|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
430971|NCT00003615|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
430972|NCT00003615|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
430973|NCT00003615|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
430974|NCT00003615|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
430975|NCT00003615|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
430976|NCT00003615|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
430977|NCT00003615|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
430978|NCT00003615|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
430979|NCT00003615|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
430980|NCT00003615|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
430981|NCT00003615|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
430982|NCT00003615|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
430983|NCT00003615|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
430984|NCT00003615|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
430985|NCT00003615|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
430986|NCT00003615|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
430987|NCT00003615|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
430988|NCT00003615|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
430989|NCT00003615|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
430990|NCT00003615|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
430991|NCT00003615|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
430992|NCT00003615|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
430993|NCT00003615|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
430994|NCT00003615|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
430995|NCT00003615|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
430996|NCT00003615|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
430997|NCT00003615|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
430998|NCT00003615|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
430999|NCT00003615|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
431000|NCT00003615|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
431001|NCT00003615|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
431002|NCT00003615|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
431003|NCT00003615|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
431004|NCT00003615|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
431005|NCT00003615|splenic marginal zone lymphoma|splenic marginal zone lymphoma
431006|NCT00003616|recurrent adult brain tumor|recurrent adult brain tumor
431007|NCT00003616|adult brain stem glioma|adult brain stem glioma
431008|NCT00003616|adult oligodendroglioma|adult oligodendroglioma
431009|NCT00003616|adult mixed glioma|adult mixed glioma
431010|NCT00003616|adult diffuse astrocytoma|adult diffuse astrocytoma
431011|NCT00003617|stage I gastric cancer|stage i gastric cancer
431012|NCT00003619|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
431013|NCT00003619|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
431014|NCT00003619|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
431015|NCT00003619|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
431016|NCT00003619|polycythemia vera|polycythemia vera
431017|NCT00003619|primary myelofibrosis|primary myelofibrosis
431018|NCT00003619|refractory anemia|refractory anemia
431019|NCT00003619|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
431020|NCT00003619|refractory anemia with excess blasts|refractory anemia with excess blasts
431021|NCT00003619|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
431022|NCT00003619|secondary acute myeloid leukemia|secondary acute myeloid leukemia
431023|NCT00003619|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
430466|NCT00003552|adult solid tumor|adult solid tumor
431024|NCT00003619|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
431025|NCT00003619|thrombocytopenia|thrombocytopenia
431026|NCT00003621|adult anaplastic astrocytoma|adult anaplastic astrocytoma
431027|NCT00003622|adenocarcinoma of the prostate|adenocarcinoma of the prostate
431028|NCT00003622|stage IV prostate cancer|stage iv prostate cancer
431029|NCT00003622|recurrent prostate cancer|recurrent prostate cancer
431030|NCT00003623|recurrent bladder cancer|recurrent bladder cancer
431031|NCT00003624|stage I cervical cancer|stage i cervical cancer
431032|NCT00003624|stage II cervical cancer|stage ii cervical cancer
431033|NCT00003624|stage III cervical cancer|stage iii cervical cancer
431034|NCT00003624|stage IV cervical cancer|stage iv cervical cancer
431035|NCT00003624|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
431036|NCT00003624|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
431037|NCT00003624|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
431038|NCT00003624|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
431039|NCT00003624|stage I endometrial carcinoma|stage i endometrial carcinoma
431040|NCT00003624|stage II endometrial carcinoma|stage ii endometrial carcinoma
431041|NCT00003624|stage III endometrial carcinoma|stage iii endometrial carcinoma
431042|NCT00003624|stage IV endometrial carcinoma|stage iv endometrial carcinoma
431043|NCT00003624|endometrial adenocarcinoma|endometrial adenocarcinoma
431044|NCT00003624|fallopian tube cancer|fallopian tube cancer
431045|NCT00003624|primary peritoneal cavity cancer|primary peritoneal cavity cancer
431046|NCT00003624|stage I uterine sarcoma|stage i uterine sarcoma
431047|NCT00003624|stage II uterine sarcoma|stage ii uterine sarcoma
431048|NCT00003624|stage III uterine sarcoma|stage iii uterine sarcoma
431049|NCT00003624|stage IV uterine sarcoma|stage iv uterine sarcoma
431050|NCT00003624|neurotoxicity|neurotoxicity
431051|NCT00003625|untreated childhood brain stem glioma|untreated childhood brain stem glioma
431052|NCT00003626|stage IV prostate cancer|stage iv prostate cancer
431053|NCT00003626|recurrent prostate cancer|recurrent prostate cancer
431054|NCT00003627|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
431055|NCT00003627|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
431056|NCT00003627|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
431057|NCT00003627|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
431058|NCT00003630|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
431059|NCT00003630|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431060|NCT00003631|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
431061|NCT00003631|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
431062|NCT00003632|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
431063|NCT00003633|adenocarcinoma of the prostate|adenocarcinoma of the prostate
431064|NCT00003633|stage IV prostate cancer|stage iv prostate cancer
431065|NCT00003633|recurrent prostate cancer|recurrent prostate cancer
431066|NCT00003634|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
431067|NCT00003634|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
431068|NCT00003634|fallopian tube cancer|fallopian tube cancer
431069|NCT00003634|primary peritoneal cavity cancer|primary peritoneal cavity cancer
431070|NCT00003635|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
431071|NCT00003635|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
431072|NCT00003635|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
431073|NCT00003636|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
431074|NCT00003636|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
431075|NCT00003636|fallopian tube cancer|fallopian tube cancer
431076|NCT00003636|primary peritoneal cavity cancer|primary peritoneal cavity cancer
431077|NCT00003637|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
431078|NCT00003637|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
431079|NCT00003637|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
431080|NCT00003637|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
431081|NCT00003638|stage IV breast cancer|stage iv breast cancer
431082|NCT00003638|recurrent breast cancer|recurrent breast cancer
431083|NCT00003673|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
431084|NCT00003674|stage IV colon cancer|stage iv colon cancer
431085|NCT00003674|stage IV breast cancer|stage iv breast cancer
431086|NCT00003674|recurrent breast cancer|recurrent breast cancer
431087|NCT00003674|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
431088|NCT00003674|stage IV rectal cancer|stage iv rectal cancer
431089|NCT00003674|recurrent colon cancer|recurrent colon cancer
431090|NCT00003674|recurrent rectal cancer|recurrent rectal cancer
431091|NCT00003674|extensive stage small cell lung cancer|extensive stage small cell lung cancer
431092|NCT00003674|recurrent small cell lung cancer|recurrent small cell lung cancer
541068|NCT00363051|Tumor|tumor
431093|NCT00003674|stage IV prostate cancer|stage iv prostate cancer
431094|NCT00003674|recurrent prostate cancer|recurrent prostate cancer
431095|NCT00003674|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
431096|NCT00003674|veno-occlusive disease|veno-occlusive disease
431097|NCT00003675|refractory anemia|refractory anemia
431098|NCT00003675|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
431099|NCT00003675|refractory anemia with excess blasts|refractory anemia with excess blasts
431100|NCT00003675|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
431101|NCT00003675|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
431102|NCT00003675|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
431103|NCT00003675|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
431104|NCT00003675|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
431105|NCT00003675|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
431106|NCT00003677|recurrent pancreatic cancer|recurrent pancreatic cancer
431107|NCT00003677|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
431108|NCT00003677|stage IV pancreatic cancer|stage iv pancreatic cancer
431109|NCT00003678|stage I breast cancer|stage i breast cancer
431110|NCT00003678|stage II breast cancer|stage ii breast cancer
431111|NCT00003679|stage IIIA breast cancer|stage iiia breast cancer
431112|NCT00003679|stage IIIB breast cancer|stage iiib breast cancer
431113|NCT00003679|inflammatory breast cancer|inflammatory breast cancer
431114|NCT00003680|stage III breast cancer|stage iii breast cancer
431115|NCT00003680|inflammatory breast cancer|inflammatory breast cancer
431116|NCT00003681|refractory anemia|refractory anemia
431117|NCT00003681|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
431118|NCT00003681|refractory anemia with excess blasts|refractory anemia with excess blasts
431397|NCT00003730|stage IV breast cancer|stage iv breast cancer
431119|NCT00003681|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
431120|NCT00003681|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
431121|NCT00003681|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
431122|NCT00003681|anemia|anemia
431123|NCT00003682|stage IV prostate cancer|stage iv prostate cancer
431124|NCT00003682|recurrent prostate cancer|recurrent prostate cancer
431125|NCT00003683|stage IV renal cell cancer|stage iv renal cell cancer
431126|NCT00003684|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431127|NCT00003684|pulmonary complications|pulmonary complications
431128|NCT00003684|quality of life|quality of life
431129|NCT00003685|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
431130|NCT00003685|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
431131|NCT00003685|squamous cell lung cancer|squamous cell lung cancer
431132|NCT00003685|large cell lung cancer|large cell lung cancer
431133|NCT00003685|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
431134|NCT00003685|adenocarcinoma of the lung|adenocarcinoma of the lung
431135|NCT00003685|adenosquamous cell lung cancer|adenosquamous cell lung cancer
431136|NCT00003685|fatigue|fatigue
431137|NCT00003685|nausea and vomiting|nausea and vomiting
431138|NCT00003685|pain|pain
431139|NCT00003685|pulmonary complications|pulmonary complications
431140|NCT00003685|quality of life|quality of life
431141|NCT00003686|oral complications|oral complications
431142|NCT00003686|quality of life|quality of life
431143|NCT00003687|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
431144|NCT00003687|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
431145|NCT00003687|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
431146|NCT00003687|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
584782|NCT00509847|hLF1-11|hlf1-11
431147|NCT00003687|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
431148|NCT00003687|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
431149|NCT00003687|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
431150|NCT00003687|isolated plasmacytoma of bone|isolated plasmacytoma of bone
431151|NCT00003687|extramedullary plasmacytoma|extramedullary plasmacytoma
431152|NCT00003687|refractory multiple myeloma|refractory multiple myeloma
431153|NCT00003687|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
431154|NCT00003687|stage III multiple myeloma|stage iii multiple myeloma
431155|NCT00003687|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
431156|NCT00003687|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
431157|NCT00003687|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
431158|NCT00003687|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
431159|NCT00003687|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
431160|NCT00003687|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
431161|NCT00003687|small intestine lymphoma|small intestine lymphoma
431162|NCT00003687|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431163|NCT00003687|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
431164|NCT00003687|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
431165|NCT00003687|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
431166|NCT00003687|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
431167|NCT00003687|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
431168|NCT00003687|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
431169|NCT00003687|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
431170|NCT00003687|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
431171|NCT00003687|polycythemia vera|polycythemia vera
431172|NCT00003687|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
431173|NCT00003687|essential thrombocythemia|essential thrombocythemia
431174|NCT00003687|untreated hairy cell leukemia|untreated hairy cell leukemia
431175|NCT00003687|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
431176|NCT00003687|refractory hairy cell leukemia|refractory hairy cell leukemia
431177|NCT00003687|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
431178|NCT00003687|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
431179|NCT00003687|acute undifferentiated leukemia|acute undifferentiated leukemia
431180|NCT00003687|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
431181|NCT00003687|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
431182|NCT00003687|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
431183|NCT00003687|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
431184|NCT00003687|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
431185|NCT00003687|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
431186|NCT00003687|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
431187|NCT00003687|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
431188|NCT00003687|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
450382|NCT00016653|dystrophy|dystrophy
431189|NCT00003687|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
431190|NCT00003687|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
431191|NCT00003687|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
431192|NCT00003687|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
431193|NCT00003687|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
431194|NCT00003687|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
431195|NCT00003687|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
431196|NCT00003687|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
431197|NCT00003687|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
431198|NCT00003687|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
431199|NCT00003687|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
431200|NCT00003687|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
431201|NCT00003687|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
431202|NCT00003687|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
431203|NCT00003687|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
431204|NCT00003687|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
431205|NCT00003687|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
431206|NCT00003687|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
431207|NCT00003687|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
431208|NCT00003687|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
431209|NCT00003687|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
431210|NCT00003687|secondary acute myeloid leukemia|secondary acute myeloid leukemia
431211|NCT00003687|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
431212|NCT00003687|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
431213|NCT00003687|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
431214|NCT00003687|pain|pain
431215|NCT00003687|prolymphocytic leukemia|prolymphocytic leukemia
431216|NCT00003687|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
431217|NCT00003687|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
431218|NCT00003687|primary systemic amyloidosis|primary systemic amyloidosis
431219|NCT00003687|non-Hodgkin lymphoma during pregnancy|non-hodgkin lymphoma during pregnancy
431220|NCT00003687|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
431221|NCT00003687|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
431222|NCT00003687|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
431223|NCT00003687|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
431224|NCT00003687|anaplastic large cell lymphoma|anaplastic large cell lymphoma
431225|NCT00003687|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
431226|NCT00003687|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
431227|NCT00003687|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
431228|NCT00003687|chronic eosinophilic leukemia|chronic eosinophilic leukemia
431229|NCT00003687|chronic neutrophilic leukemia|chronic neutrophilic leukemia
431230|NCT00003687|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
431231|NCT00003687|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
431232|NCT00003687|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
431233|NCT00003687|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
431234|NCT00003687|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
431235|NCT00003687|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
431236|NCT00003687|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
431237|NCT00003687|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
431238|NCT00003687|splenic marginal zone lymphoma|splenic marginal zone lymphoma
431239|NCT00003687|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
431240|NCT00003688|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
431241|NCT00003688|nonmetastatic gestational trophoblastic tumor|nonmetastatic gestational trophoblastic tumor
431242|NCT00003688|low risk metastatic gestational trophoblastic tumor|low risk metastatic gestational trophoblastic tumor
431243|NCT00003690|stage IV breast cancer|stage iv breast cancer
431244|NCT00003690|recurrent breast cancer|recurrent breast cancer
431245|NCT00003690|stage IV prostate cancer|stage iv prostate cancer
431246|NCT00003690|recurrent prostate cancer|recurrent prostate cancer
431247|NCT00003690|stage IV melanoma|stage iv melanoma
431248|NCT00003690|recurrent melanoma|recurrent melanoma
431249|NCT00003690|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431250|NCT00003691|stage III endometrial carcinoma|stage iii endometrial carcinoma
431251|NCT00003691|stage IV endometrial carcinoma|stage iv endometrial carcinoma
431252|NCT00003691|recurrent endometrial carcinoma|recurrent endometrial carcinoma
431253|NCT00003692|occult non-small cell lung cancer|occult non-small cell lung cancer
431254|NCT00003692|stage I non-small cell lung cancer|stage i non-small cell lung cancer
431255|NCT00003692|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
431256|NCT00003693|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
431257|NCT00003693|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
431258|NCT00003693|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
431259|NCT00003693|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
431260|NCT00003693|refractory anemia with excess blasts|refractory anemia with excess blasts
431261|NCT00003693|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
431262|NCT00003693|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
431263|NCT00003693|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
431264|NCT00003693|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
431265|NCT00003695|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
431266|NCT00003695|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
431267|NCT00003696|extensive stage small cell lung cancer|extensive stage small cell lung cancer
431268|NCT00003697|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431269|NCT00003698|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431270|NCT00003700|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
431271|NCT00003700|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
431272|NCT00003700|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
431273|NCT00003701|stage III bladder cancer|stage iii bladder cancer
431274|NCT00003701|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
431275|NCT00003701|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
431276|NCT00003703|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431277|NCT00003704|stage III colon cancer|stage iii colon cancer
431278|NCT00003704|stage III rectal cancer|stage iii rectal cancer
431279|NCT00003704|recurrent colon cancer|recurrent colon cancer
431280|NCT00003704|recurrent rectal cancer|recurrent rectal cancer
431281|NCT00003704|recurrent anal cancer|recurrent anal cancer
431282|NCT00003704|stage IIIA anal cancer|stage iiia anal cancer
431283|NCT00003704|stage IIIB anal cancer|stage iiib anal cancer
431284|NCT00003704|stage III cervical cancer|stage iii cervical cancer
431285|NCT00003704|recurrent cervical cancer|recurrent cervical cancer
431286|NCT00003704|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
431287|NCT00003704|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
431288|NCT00003704|stage III vulvar cancer|stage iii vulvar cancer
431289|NCT00003704|recurrent vulvar cancer|recurrent vulvar cancer
431290|NCT00003704|stage III vaginal cancer|stage iii vaginal cancer
431291|NCT00003704|recurrent vaginal cancer|recurrent vaginal cancer
431292|NCT00003704|stage III penile cancer|stage iii penile cancer
431293|NCT00003704|recurrent penile cancer|recurrent penile cancer
431294|NCT00003704|stage III endometrial carcinoma|stage iii endometrial carcinoma
431295|NCT00003704|recurrent endometrial carcinoma|recurrent endometrial carcinoma
541404|NCT00355134|MS|ms
431296|NCT00003704|stage III bladder cancer|stage iii bladder cancer
431297|NCT00003704|recurrent bladder cancer|recurrent bladder cancer
431298|NCT00003704|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
431299|NCT00003704|stage III prostate cancer|stage iii prostate cancer
448424|NCT00006070|Etanercept|etanercept
431300|NCT00003704|recurrent prostate cancer|recurrent prostate cancer
431301|NCT00003704|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
431302|NCT00003704|ovarian stromal cancer|ovarian stromal cancer
431303|NCT00003704|recurrent urethral cancer|recurrent urethral cancer
431304|NCT00003704|distal urethral cancer|distal urethral cancer
431305|NCT00003704|proximal urethral cancer|proximal urethral cancer
431306|NCT00003704|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
431307|NCT00003704|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
431308|NCT00003704|fallopian tube cancer|fallopian tube cancer
431309|NCT00003704|primary peritoneal cavity cancer|primary peritoneal cavity cancer
431310|NCT00003704|stage III uterine sarcoma|stage iii uterine sarcoma
431311|NCT00003704|recurrent uterine sarcoma|recurrent uterine sarcoma
431312|NCT00003704|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
431313|NCT00003704|ovarian sarcoma|ovarian sarcoma
431314|NCT00003705|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431315|NCT00003706|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431316|NCT00003707|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431317|NCT00003708|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431318|NCT00003709|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431319|NCT00003710|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431320|NCT00003711|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431321|NCT00003712|recurrent adult brain tumor|recurrent adult brain tumor
431322|NCT00003712|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431323|NCT00003712|tumors metastatic to brain|tumors metastatic to brain
431324|NCT00003713|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431398|NCT00003730|recurrent breast cancer|recurrent breast cancer
431325|NCT00003714|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
431326|NCT00003714|advanced adult primary liver cancer|advanced adult primary liver cancer
431327|NCT00003714|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
431328|NCT00003714|liver metastases|liver metastases
431329|NCT00003715|stage III melanoma|stage iii melanoma
431330|NCT00003716|childhood Burkitt lymphoma|childhood burkitt lymphoma
431331|NCT00003716|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
431332|NCT00003716|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
431333|NCT00003716|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
431334|NCT00003716|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
431335|NCT00003716|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
431336|NCT00003716|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
431337|NCT00003716|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
431338|NCT00003716|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
431339|NCT00003716|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
431340|NCT00003717|adenocarcinoma of the prostate|adenocarcinoma of the prostate
431341|NCT00003717|stage IV prostate cancer|stage iv prostate cancer
431342|NCT00003717|recurrent prostate cancer|recurrent prostate cancer
431343|NCT00003718|adult angiosarcoma|adult angiosarcoma
431344|NCT00003718|adult fibrosarcoma|adult fibrosarcoma
431347|NCT00003718|adult neurofibrosarcoma|adult neurofibrosarcoma
431348|NCT00003718|adult synovial sarcoma|adult synovial sarcoma
431349|NCT00003718|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
431350|NCT00003718|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
431351|NCT00003718|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
431352|NCT00003718|adult epithelioid sarcoma|adult epithelioid sarcoma
431353|NCT00003718|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
431354|NCT00003718|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
431355|NCT00003718|adult malignant mesenchymoma|adult malignant mesenchymoma
431356|NCT00003718|adult rhabdomyosarcoma|adult rhabdomyosarcoma
431357|NCT00003718|stage IV uterine sarcoma|stage iv uterine sarcoma
431358|NCT00003718|recurrent uterine sarcoma|recurrent uterine sarcoma
431359|NCT00003718|uterine carcinosarcoma|uterine carcinosarcoma
431360|NCT00003718|uterine leiomyosarcoma|uterine leiomyosarcoma
431361|NCT00003718|endometrial stromal sarcoma|endometrial stromal sarcoma
431362|NCT00003718|ovarian sarcoma|ovarian sarcoma
431363|NCT00003718|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
431364|NCT00003719|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
431365|NCT00003719|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
431366|NCT00003720|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
431367|NCT00003720|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
431368|NCT00003721|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431369|NCT00003723|advanced malignant mesothelioma|advanced malignant mesothelioma
431370|NCT00003723|epithelial mesothelioma|epithelial mesothelioma
431371|NCT00003723|sarcomatous mesothelioma|sarcomatous mesothelioma
431372|NCT00003724|lung metastases|lung metastases
431373|NCT00003725|stage 0 bladder cancer|stage 0 bladder cancer
431374|NCT00003725|stage I bladder cancer|stage i bladder cancer
431375|NCT00003725|recurrent bladder cancer|recurrent bladder cancer
431376|NCT00003725|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
431377|NCT00003726|extensive stage small cell lung cancer|extensive stage small cell lung cancer
431378|NCT00003726|recurrent small cell lung cancer|recurrent small cell lung cancer
431379|NCT00003727|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
431380|NCT00003727|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
431381|NCT00003727|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
431382|NCT00003727|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
431383|NCT00003727|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
431384|NCT00003728|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
431385|NCT00003728|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
431386|NCT00003728|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
431387|NCT00003728|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
431388|NCT00003728|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
431389|NCT00003728|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
431390|NCT00003728|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
431391|NCT00003728|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
431392|NCT00003728|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
431393|NCT00003728|acute undifferentiated leukemia|acute undifferentiated leukemia
431394|NCT00003729|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
431395|NCT00003729|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
431396|NCT00003729|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
431399|NCT00003731|adult oligodendroglioma|adult oligodendroglioma
431400|NCT00003731|adult mixed glioma|adult mixed glioma
431401|NCT00003732|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
431402|NCT00003732|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
431403|NCT00003732|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
431404|NCT00003732|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
431405|NCT00003732|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
431406|NCT00003732|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
431407|NCT00003733|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
431408|NCT00003733|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
431409|NCT00003733|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
431410|NCT00003734|adenocarcinoma of the prostate|adenocarcinoma of the prostate
431411|NCT00003734|stage I prostate cancer|stage i prostate cancer
431412|NCT00003734|stage IIB prostate cancer|stage iib prostate cancer
431413|NCT00003734|stage IIA prostate cancer|stage iia prostate cancer
431414|NCT00003734|stage III prostate cancer|stage iii prostate cancer
431415|NCT00003734|stage IV prostate cancer|stage iv prostate cancer
431416|NCT00003735|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
431417|NCT00003735|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
431418|NCT00003735|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
431419|NCT00003736|breast cancer|breast cancer
431420|NCT00003737|recurrent neuroblastoma|recurrent neuroblastoma
431421|NCT00003739|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
431422|NCT00003739|fever, sweats, and hot flashes|fever, sweats, and hot flashes
431423|NCT00003739|neutropenia|neutropenia
431424|NCT00003740|stage IV prostate cancer|stage iv prostate cancer
431425|NCT00003740|recurrent prostate cancer|recurrent prostate cancer
431426|NCT00003741|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
431427|NCT00003741|anaplastic large cell lymphoma|anaplastic large cell lymphoma
431428|NCT00003742|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431429|NCT00003743|disseminated neuroblastoma|disseminated neuroblastoma
431430|NCT00003744|stage III salivary gland cancer|stage iii salivary gland cancer
431431|NCT00003744|stage IV salivary gland cancer|stage iv salivary gland cancer
431432|NCT00003744|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
431433|NCT00003744|salivary gland acinic cell tumor|salivary gland acinic cell tumor
431434|NCT00003744|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
431435|NCT00003744|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
431436|NCT00003744|salivary gland adenocarcinoma|salivary gland adenocarcinoma
431437|NCT00003744|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
431438|NCT00003744|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
431439|NCT00003744|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
431440|NCT00003744|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
431441|NCT00003745|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
431442|NCT00003745|recurrent osteosarcoma|recurrent osteosarcoma
431443|NCT00003745|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
431444|NCT00003745|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
431445|NCT00003745|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
431646|NCT00003793|localized osteosarcoma|localized osteosarcoma
431446|NCT00003745|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
431447|NCT00003745|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
431448|NCT00003746|untreated hairy cell leukemia|untreated hairy cell leukemia
431449|NCT00003746|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
431450|NCT00003746|prolymphocytic leukemia|prolymphocytic leukemia
431451|NCT00003747|stage IV melanoma|stage iv melanoma
431452|NCT00003747|recurrent melanoma|recurrent melanoma
431453|NCT00003748|stage I gastric cancer|stage i gastric cancer
431454|NCT00003748|stage II gastric cancer|stage ii gastric cancer
431455|NCT00003748|stage III gastric cancer|stage iii gastric cancer
431456|NCT00003748|stage IV gastric cancer|stage iv gastric cancer
431457|NCT00003748|recurrent gastric cancer|recurrent gastric cancer
431458|NCT00003748|stage I esophageal cancer|stage i esophageal cancer
431459|NCT00003748|stage II esophageal cancer|stage ii esophageal cancer
431460|NCT00003748|stage III esophageal cancer|stage iii esophageal cancer
431461|NCT00003748|stage IV esophageal cancer|stage iv esophageal cancer
431462|NCT00003748|recurrent esophageal cancer|recurrent esophageal cancer
431463|NCT00003748|adenocarcinoma of the stomach|adenocarcinoma of the stomach
431464|NCT00003748|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
431465|NCT00003749|stage I endometrial carcinoma|stage i endometrial carcinoma
431466|NCT00003749|stage II endometrial carcinoma|stage ii endometrial carcinoma
431467|NCT00003749|endometrial clear cell carcinoma|endometrial clear cell carcinoma
431468|NCT00003749|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
431469|NCT00003750|metastatic osteosarcoma|metastatic osteosarcoma
431470|NCT00003750|recurrent neuroblastoma|recurrent neuroblastoma
431471|NCT00003750|recurrent osteosarcoma|recurrent osteosarcoma
431472|NCT00003750|recurrent melanoma|recurrent melanoma
431473|NCT00003750|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
431474|NCT00003750|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
431475|NCT00003750|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
431476|NCT00003751|adult glioblastoma|adult glioblastoma
431477|NCT00003751|adult giant cell glioblastoma|adult giant cell glioblastoma
431478|NCT00003751|adult gliosarcoma|adult gliosarcoma
431479|NCT00003752|stage IV breast cancer|stage iv breast cancer
431480|NCT00003752|recurrent breast cancer|recurrent breast cancer
431481|NCT00003753|stage IV colon cancer|stage iv colon cancer
431482|NCT00003753|stage IV rectal cancer|stage iv rectal cancer
431483|NCT00003753|adenocarcinoma of the colon|adenocarcinoma of the colon
431484|NCT00003753|adenocarcinoma of the rectum|adenocarcinoma of the rectum
431485|NCT00003753|liver metastases|liver metastases
431486|NCT00003753|recurrent colon cancer|recurrent colon cancer
431487|NCT00003753|recurrent rectal cancer|recurrent rectal cancer
431488|NCT00003754|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
431489|NCT00003755|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431490|NCT00003757|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
431491|NCT00003757|refractory hairy cell leukemia|refractory hairy cell leukemia
431492|NCT00003758|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
431493|NCT00003758|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
431494|NCT00003758|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
431495|NCT00003758|childhood acute monoblastic leukemia and acute monocytic leukemia (M5)|childhood acute monoblastic leukemia and acute monocytic leukemia (m5)
431496|NCT00003758|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
431497|NCT00003758|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
431498|NCT00003758|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
431499|NCT00003758|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
431500|NCT00003758|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
431501|NCT00003758|adult acute basophilic leukemia|adult acute basophilic leukemia
431502|NCT00003758|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
431503|NCT00003758|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
431504|NCT00003758|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
431505|NCT00003758|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
431506|NCT00003758|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
431507|NCT00003758|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
431508|NCT00003758|childhood acute basophilic leukemia|childhood acute basophilic leukemia
431509|NCT00003758|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
431581|NCT00003777|recurrent laryngeal cancer|recurrent laryngeal cancer
431510|NCT00003758|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
431511|NCT00003758|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
431512|NCT00003759|stage 0 bladder cancer|stage 0 bladder cancer
431513|NCT00003759|stage I bladder cancer|stage i bladder cancer
431514|NCT00003759|recurrent bladder cancer|recurrent bladder cancer
431515|NCT00003760|stage III pancreatic cancer|stage iii pancreatic cancer
431516|NCT00003760|stage IV pancreatic cancer|stage iv pancreatic cancer
431517|NCT00003760|recurrent pancreatic cancer|recurrent pancreatic cancer
431518|NCT00003760|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
431519|NCT00003761|stage IV breast cancer|stage iv breast cancer
431520|NCT00003761|recurrent breast cancer|recurrent breast cancer
431521|NCT00003762|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
431522|NCT00003762|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
431523|NCT00003762|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
431524|NCT00003763|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
431525|NCT00003763|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
431526|NCT00003763|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
431527|NCT00003763|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
431528|NCT00003763|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
431529|NCT00003763|ovarian stromal cancer|ovarian stromal cancer
431530|NCT00003763|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
431531|NCT00003763|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
431532|NCT00003763|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
431533|NCT00003763|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
431534|NCT00003763|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
431535|NCT00003763|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
431536|NCT00003763|ovarian sarcoma|ovarian sarcoma
431537|NCT00003764|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
431538|NCT00003764|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
431539|NCT00003764|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
431540|NCT00003764|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
431541|NCT00003764|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
431542|NCT00003764|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
431543|NCT00003765|childhood craniopharyngioma|childhood craniopharyngioma
431544|NCT00003765|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
431545|NCT00003765|childhood oligodendroglioma|childhood oligodendroglioma
431546|NCT00003765|childhood choroid plexus tumor|childhood choroid plexus tumor
431547|NCT00003765|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
431548|NCT00003765|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
431549|NCT00003765|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
431550|NCT00003765|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
431551|NCT00003765|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
431552|NCT00003765|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
431553|NCT00003765|recurrent childhood ependymoma|recurrent childhood ependymoma
431554|NCT00003766|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431555|NCT00003768|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431556|NCT00003769|stage II pancreatic cancer|stage ii pancreatic cancer
431557|NCT00003769|stage III pancreatic cancer|stage iii pancreatic cancer
431558|NCT00003769|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
431559|NCT00003771|menopausal symptoms|menopausal symptoms
431560|NCT00003771|stage I breast cancer|stage i breast cancer
431561|NCT00003771|stage II breast cancer|stage ii breast cancer
431562|NCT00003771|breast cancer in situ|breast cancer in situ
431563|NCT00003772|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
431564|NCT00003772|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
431565|NCT00003772|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
431566|NCT00003772|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
448423|NCT00006070|TNF|tnf
431567|NCT00003772|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
431568|NCT00003773|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
431569|NCT00003775|recurrent adult brain tumor|recurrent adult brain tumor
431570|NCT00003775|adult anaplastic astrocytoma|adult anaplastic astrocytoma
431571|NCT00003775|adult mixed glioma|adult mixed glioma
431572|NCT00003776|metastatic osteosarcoma|metastatic osteosarcoma
431573|NCT00003777|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
431574|NCT00003777|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
431575|NCT00003777|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
431576|NCT00003777|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
431577|NCT00003777|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
431578|NCT00003777|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
431579|NCT00003777|stage III laryngeal cancer|stage iii laryngeal cancer
431580|NCT00003777|stage IV laryngeal cancer|stage iv laryngeal cancer
451834|NCT00019578|brain tumor|brain tumor
431582|NCT00003777|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
431583|NCT00003777|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
431584|NCT00003777|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
431585|NCT00003777|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
431586|NCT00003777|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
431587|NCT00003777|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
431588|NCT00003778|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
431589|NCT00003778|stage IV uterine sarcoma|stage iv uterine sarcoma
431590|NCT00003778|recurrent uterine sarcoma|recurrent uterine sarcoma
431591|NCT00003778|ovarian sarcoma|ovarian sarcoma
431592|NCT00003778|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
431593|NCT00003779|stage 0 bladder cancer|stage 0 bladder cancer
431594|NCT00003779|stage I bladder cancer|stage i bladder cancer
431595|NCT00003780|stage II pancreatic cancer|stage ii pancreatic cancer
431596|NCT00003780|stage III pancreatic cancer|stage iii pancreatic cancer
431597|NCT00003780|stage IV pancreatic cancer|stage iv pancreatic cancer
431598|NCT00003781|adenocarcinoma of the prostate|adenocarcinoma of the prostate
431599|NCT00003781|stage IV prostate cancer|stage iv prostate cancer
431600|NCT00003781|recurrent prostate cancer|recurrent prostate cancer
431601|NCT00003781|pain|pain
431602|NCT00003782|stage I breast cancer|stage i breast cancer
431603|NCT00003782|stage II breast cancer|stage ii breast cancer
431604|NCT00003782|stage IIIA breast cancer|stage iiia breast cancer
431605|NCT00003783|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
431606|NCT00003783|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
431607|NCT00003783|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
431608|NCT00003783|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
431609|NCT00003784|Waldenström macroglobulinemia|waldenström macroglobulinemia
431610|NCT00003784|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
431611|NCT00003784|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
431612|NCT00003784|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
431613|NCT00003784|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
431614|NCT00003784|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
431615|NCT00003784|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
431616|NCT00003784|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
431617|NCT00003784|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
431618|NCT00003784|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
431619|NCT00003784|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
431620|NCT00003784|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
431621|NCT00003784|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
431622|NCT00003786|stage IV colon cancer|stage iv colon cancer
431623|NCT00003786|stage IV rectal cancer|stage iv rectal cancer
431624|NCT00003786|recurrent colon cancer|recurrent colon cancer
431625|NCT00003786|recurrent rectal cancer|recurrent rectal cancer
431626|NCT00003786|adenocarcinoma of the colon|adenocarcinoma of the colon
431627|NCT00003786|adenocarcinoma of the rectum|adenocarcinoma of the rectum
431628|NCT00003787|stage I breast cancer|stage i breast cancer
431629|NCT00003787|stage II breast cancer|stage ii breast cancer
431630|NCT00003787|stage IIIA breast cancer|stage iiia breast cancer
431631|NCT00003787|recurrent breast cancer|recurrent breast cancer
431632|NCT00003788|recurrent adult brain tumor|recurrent adult brain tumor
431633|NCT00003788|adult glioblastoma|adult glioblastoma
431634|NCT00003788|adult anaplastic astrocytoma|adult anaplastic astrocytoma
431635|NCT00003788|adult giant cell glioblastoma|adult giant cell glioblastoma
431636|NCT00003788|adult gliosarcoma|adult gliosarcoma
431637|NCT00003790|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
752435|NCT01172951|Oral lipid tolerance test|oral lipid tolerance test
752436|NCT01172964|Los Angeles|los angeles
431638|NCT00003790|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
431639|NCT00003790|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
431640|NCT00003790|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
431641|NCT00003790|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
431642|NCT00003792|stage IV melanoma|stage iv melanoma
431643|NCT00003792|recurrent melanoma|recurrent melanoma
431644|NCT00003793|secondary acute myeloid leukemia|secondary acute myeloid leukemia
431645|NCT00003793|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
431647|NCT00003793|metastatic osteosarcoma|metastatic osteosarcoma
431648|NCT00003793|childhood soft tissue sarcoma|childhood soft tissue sarcoma
431649|NCT00003793|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
431650|NCT00003793|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
431651|NCT00003793|childhood fibrosarcoma|childhood fibrosarcoma
431652|NCT00003793|childhood synovial sarcoma|childhood synovial sarcoma
431653|NCT00003793|childhood neurofibrosarcoma|childhood neurofibrosarcoma
431654|NCT00003793|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
431655|NCT00003793|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
431656|NCT00003793|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
431657|NCT00003794|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
431658|NCT00003794|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
431659|NCT00003794|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
431660|NCT00003794|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
431661|NCT00003794|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
431662|NCT00003795|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
431663|NCT00003795|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
431664|NCT00003795|stage I endometrial carcinoma|stage i endometrial carcinoma
431665|NCT00003795|stage II endometrial carcinoma|stage ii endometrial carcinoma
431666|NCT00003796|stage IV breast cancer|stage iv breast cancer
431667|NCT00003796|recurrent breast cancer|recurrent breast cancer
431668|NCT00003796|male breast cancer|male breast cancer
431669|NCT00003797|recurrent pancreatic cancer|recurrent pancreatic cancer
431670|NCT00003797|stage IV pancreatic cancer|stage iv pancreatic cancer
431671|NCT00003798|stage II pancreatic cancer|stage ii pancreatic cancer
431672|NCT00003798|stage III pancreatic cancer|stage iii pancreatic cancer
431673|NCT00003798|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
431674|NCT00003800|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
431675|NCT00003800|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
431676|NCT00003800|testicular embryonal carcinoma|testicular embryonal carcinoma
431677|NCT00003800|testicular choriocarcinoma|testicular choriocarcinoma
431678|NCT00003800|testicular teratoma|testicular teratoma
431679|NCT00003800|testicular yolk sac tumor|testicular yolk sac tumor
431680|NCT00003800|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
431681|NCT00003800|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
431682|NCT00003800|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
431683|NCT00003800|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
431684|NCT00003800|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
431685|NCT00003800|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
431686|NCT00003801|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
431687|NCT00003801|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
431688|NCT00003802|iris melanoma|iris melanoma
431689|NCT00003802|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
431690|NCT00003802|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
431691|NCT00003802|extraocular extension melanoma|extraocular extension melanoma
431692|NCT00003802|recurrent intraocular melanoma|recurrent intraocular melanoma
431693|NCT00003802|stage IV melanoma|stage iv melanoma
431694|NCT00003802|recurrent melanoma|recurrent melanoma
431695|NCT00003803|stage I non-small cell lung cancer|stage i non-small cell lung cancer
431696|NCT00003803|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
431697|NCT00003803|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
431698|NCT00003804|stage I Wilms tumor|stage i wilms tumor
431699|NCT00003805|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
431700|NCT00003805|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
431701|NCT00003805|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
431702|NCT00003805|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
431703|NCT00003805|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
431704|NCT00003805|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
431705|NCT00003805|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
431706|NCT00003805|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
431707|NCT00003805|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
431708|NCT00003805|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
431709|NCT00003805|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
431710|NCT00003805|Burkitt lymphoma|burkitt lymphoma
431711|NCT00003805|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
431712|NCT00003805|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
431713|NCT00003805|stage I multiple myeloma|stage i multiple myeloma
431714|NCT00003805|stage II multiple myeloma|stage ii multiple myeloma
431715|NCT00003805|stage III multiple myeloma|stage iii multiple myeloma
431716|NCT00003805|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
431717|NCT00003805|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
431718|NCT00003805|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
431719|NCT00003805|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
431720|NCT00003805|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
431721|NCT00003805|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
431722|NCT00003805|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
431723|NCT00003805|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
431724|NCT00003805|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
431725|NCT00003805|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
431726|NCT00003805|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
431727|NCT00003805|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
431728|NCT00003805|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
431729|NCT00003805|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
431730|NCT00003805|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
431731|NCT00003805|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
431732|NCT00003805|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
431733|NCT00003805|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431734|NCT00003805|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
431735|NCT00003805|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
431736|NCT00003805|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
431737|NCT00003805|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
431738|NCT00003805|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
431739|NCT00003805|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
431740|NCT00003805|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
431741|NCT00003805|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
431742|NCT00003805|fever, sweats, and hot flashes|fever, sweats, and hot flashes
431743|NCT00003805|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
431744|NCT00003805|refractory hairy cell leukemia|refractory hairy cell leukemia
431745|NCT00003805|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
431746|NCT00003805|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
431747|NCT00003805|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
431748|NCT00003805|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
431749|NCT00003805|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
431750|NCT00003805|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
431751|NCT00003805|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
431752|NCT00003805|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
431753|NCT00003805|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
431754|NCT00003805|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
431755|NCT00003805|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
431756|NCT00003805|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
431757|NCT00003805|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
431758|NCT00003805|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
431759|NCT00003805|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
431760|NCT00003805|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
431761|NCT00003805|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
431762|NCT00003805|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
431763|NCT00003805|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
431764|NCT00003805|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
431765|NCT00003805|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
431766|NCT00003805|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
431767|NCT00003805|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
431768|NCT00003805|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
431769|NCT00003805|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
431770|NCT00003805|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
431771|NCT00003805|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
431772|NCT00003805|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
431773|NCT00003805|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
431774|NCT00003805|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
431775|NCT00003805|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
431776|NCT00003805|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
431777|NCT00003805|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
431778|NCT00003805|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
431779|NCT00003805|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
431780|NCT00003805|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
431781|NCT00003805|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
431782|NCT00003805|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
431783|NCT00003805|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
431784|NCT00003805|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
431785|NCT00003805|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
431786|NCT00003805|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
431787|NCT00003805|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
431788|NCT00003805|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
431789|NCT00003805|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
431790|NCT00003805|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
431791|NCT00003805|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
431792|NCT00003805|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
431794|NCT00003805|bone marrow suppression|bone marrow suppression
431795|NCT00003805|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
431796|NCT00003805|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
431797|NCT00003805|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
431798|NCT00003805|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
431799|NCT00003805|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
431800|NCT00003805|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
431801|NCT00003805|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
431802|NCT00003805|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
431803|NCT00003805|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
431804|NCT00003805|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
431805|NCT00003805|stage I mantle cell lymphoma|stage i mantle cell lymphoma
431806|NCT00003805|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
431807|NCT00003805|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
431808|NCT00003805|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
431925|NCT00003816|acute undifferentiated leukemia|acute undifferentiated leukemia
431809|NCT00003805|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
431810|NCT00003805|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
431811|NCT00003805|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
431812|NCT00003805|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
584784|NCT00509860|Advanced Sarcomas|advanced sarcomas
431813|NCT00003805|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
431814|NCT00003805|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
431815|NCT00003805|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
431816|NCT00003805|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
431817|NCT00003805|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
431818|NCT00003805|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
431819|NCT00003805|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
431820|NCT00003805|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
431821|NCT00003805|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
431822|NCT00003805|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
431823|NCT00003805|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
431824|NCT00003805|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
752437|NCT01172977|Diabetes mellitus|diabetes mellitus
431825|NCT00003805|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
431826|NCT00003805|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
431827|NCT00003805|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
431828|NCT00003805|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
431829|NCT00003805|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
431830|NCT00003805|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
431831|NCT00003805|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
431832|NCT00003805|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
431833|NCT00003805|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
431834|NCT00003805|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
431835|NCT00003805|stage I marginal zone lymphoma|stage i marginal zone lymphoma
431836|NCT00003805|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
431837|NCT00003805|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
431838|NCT00003805|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
431839|NCT00003805|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
431840|NCT00003805|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
431841|NCT00003805|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
431842|NCT00003805|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
431843|NCT00003805|splenic marginal zone lymphoma|splenic marginal zone lymphoma
431844|NCT00003805|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
431845|NCT00003808|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
431846|NCT00003808|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
431847|NCT00003808|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
431848|NCT00003808|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
431849|NCT00003809|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
431850|NCT00003809|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
431851|NCT00003809|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
431852|NCT00003809|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
431853|NCT00003809|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
431854|NCT00003809|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
431855|NCT00003809|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
431856|NCT00003809|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
431857|NCT00003809|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
431858|NCT00003809|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
431859|NCT00003809|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
431860|NCT00003809|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
431861|NCT00003809|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
431862|NCT00003809|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
431863|NCT00003809|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
431926|NCT00003816|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
431864|NCT00003809|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
431865|NCT00003809|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
431866|NCT00003810|stage III pancreatic cancer|stage iii pancreatic cancer
431867|NCT00003810|stage IV pancreatic cancer|stage iv pancreatic cancer
431868|NCT00003810|recurrent pancreatic cancer|recurrent pancreatic cancer
431869|NCT00003810|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
431870|NCT00003811|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
431871|NCT00003811|childhood teratoma|childhood teratoma
431872|NCT00003811|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
431873|NCT00003811|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
431874|NCT00003811|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
431875|NCT00003811|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
431876|NCT00003812|limited stage small cell lung cancer|limited stage small cell lung cancer
431877|NCT00003814|stage 0 bladder cancer|stage 0 bladder cancer
431878|NCT00003814|stage I bladder cancer|stage i bladder cancer
431879|NCT00003814|recurrent bladder cancer|recurrent bladder cancer
431880|NCT00003814|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
431881|NCT00003815|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
431882|NCT00003815|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
431883|NCT00003815|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
431884|NCT00003815|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
431885|NCT00003815|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
431886|NCT00003815|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
431887|NCT00003815|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
431888|NCT00003815|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
431889|NCT00003815|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
431890|NCT00003815|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
431891|NCT00003815|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
431892|NCT00003815|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
431893|NCT00003815|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
431894|NCT00003815|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
431895|NCT00003815|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
431896|NCT00003815|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
431897|NCT00003815|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
431898|NCT00003815|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
431899|NCT00003815|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
431900|NCT00003815|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
431901|NCT00003816|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
431902|NCT00003816|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
431903|NCT00003816|Burkitt lymphoma|burkitt lymphoma
431904|NCT00003816|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
431968|NCT00003819|stage I prostate cancer|stage i prostate cancer
431905|NCT00003816|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
431906|NCT00003816|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
431907|NCT00003816|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
431908|NCT00003816|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
431909|NCT00003816|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
431910|NCT00003816|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
431911|NCT00003816|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
431912|NCT00003816|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
431913|NCT00003816|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
431914|NCT00003816|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
431915|NCT00003816|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
431916|NCT00003816|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
431917|NCT00003816|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
431918|NCT00003816|polycythemia vera|polycythemia vera
431919|NCT00003816|essential thrombocythemia|essential thrombocythemia
431920|NCT00003816|refractory anemia|refractory anemia
431921|NCT00003816|refractory anemia with excess blasts|refractory anemia with excess blasts
433837|NCT00003331|primary myelofibrosis|primary myelofibrosis
431922|NCT00003816|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
431923|NCT00003816|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
431924|NCT00003816|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
431927|NCT00003816|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
431928|NCT00003816|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
431929|NCT00003816|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
431930|NCT00003816|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
431931|NCT00003816|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
431932|NCT00003816|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
431933|NCT00003816|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
431934|NCT00003816|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
431935|NCT00003816|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
431936|NCT00003816|secondary acute myeloid leukemia|secondary acute myeloid leukemia
431937|NCT00003816|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
431938|NCT00003816|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
431939|NCT00003816|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
431940|NCT00003816|prolymphocytic leukemia|prolymphocytic leukemia
431941|NCT00003816|intraocular lymphoma|intraocular lymphoma
431942|NCT00003816|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
431943|NCT00003816|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
431944|NCT00003816|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
431945|NCT00003816|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
431946|NCT00003816|anaplastic large cell lymphoma|anaplastic large cell lymphoma
431947|NCT00003816|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
431948|NCT00003816|primary myelofibrosis|primary myelofibrosis
431949|NCT00003816|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
431950|NCT00003816|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
431951|NCT00003816|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
431952|NCT00003816|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
431953|NCT00003816|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
431954|NCT00003816|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
431955|NCT00003816|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
431956|NCT00003816|splenic marginal zone lymphoma|splenic marginal zone lymphoma
431957|NCT00003816|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
431958|NCT00003816|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
431959|NCT00003816|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
431960|NCT00003816|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
431961|NCT00003816|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
431962|NCT00003816|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
431964|NCT00003816|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431965|NCT00003816|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
431966|NCT00003817|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431967|NCT00003817|nausea and vomiting|nausea and vomiting
453373|NCT00013663|RNA, Viral|rna, viral
431969|NCT00003819|stage IIB prostate cancer|stage iib prostate cancer
431970|NCT00003819|stage IIA prostate cancer|stage iia prostate cancer
431971|NCT00003819|stage III prostate cancer|stage iii prostate cancer
431972|NCT00003819|recurrent prostate cancer|recurrent prostate cancer
431973|NCT00003821|recurrent endometrial carcinoma|recurrent endometrial carcinoma
431974|NCT00003822|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
431975|NCT00003824|stage 0 bladder cancer|stage 0 bladder cancer
431976|NCT00003824|recurrent bladder cancer|recurrent bladder cancer
431977|NCT00003824|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
431978|NCT00003825|radiation enteritis|radiation enteritis
431979|NCT00003825|diarrhea|diarrhea
431980|NCT00003827|refractory anemia with excess blasts|refractory anemia with excess blasts
431981|NCT00003827|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
431982|NCT00003827|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
431983|NCT00003827|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
431984|NCT00003827|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
431985|NCT00003828|stage IV melanoma|stage iv melanoma
431986|NCT00003828|recurrent melanoma|recurrent melanoma
431987|NCT00003829|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
431988|NCT00003829|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
431989|NCT00003829|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
431990|NCT00003829|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
431991|NCT00003829|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
431992|NCT00003830|stage I breast cancer|stage i breast cancer
431993|NCT00003830|stage II breast cancer|stage ii breast cancer
431994|NCT00003831|stage I non-small cell lung cancer|stage i non-small cell lung cancer
433118|NCT00003212|adult synovial sarcoma|adult synovial sarcoma
431995|NCT00003831|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
431996|NCT00003831|squamous cell lung cancer|squamous cell lung cancer
431997|NCT00003831|large cell lung cancer|large cell lung cancer
431998|NCT00003831|adenocarcinoma of the lung|adenocarcinoma of the lung
431999|NCT00003833|stage II colon cancer|stage ii colon cancer
432000|NCT00003833|stage III colon cancer|stage iii colon cancer
432001|NCT00003833|adenocarcinoma of the colon|adenocarcinoma of the colon
432002|NCT00003834|stage IV colon cancer|stage iv colon cancer
432003|NCT00003834|stage IV rectal cancer|stage iv rectal cancer
432004|NCT00003834|recurrent colon cancer|recurrent colon cancer
432005|NCT00003834|recurrent rectal cancer|recurrent rectal cancer
432006|NCT00003834|adenocarcinoma of the colon|adenocarcinoma of the colon
432007|NCT00003834|adenocarcinoma of the rectum|adenocarcinoma of the rectum
432008|NCT00003834|liver metastases|liver metastases
432009|NCT00003837|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
432010|NCT00003837|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
432011|NCT00003837|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
432012|NCT00003838|Graft-Versus-Leukemia|graft-versus-leukemia
432013|NCT00003838|Peripheral Blood Stem Cells|peripheral blood stem cells
432014|NCT00003838|Engraftment|engraftment
432015|NCT00003838|Cyclophosphamide|cyclophosphamide
432016|NCT00003838|Fludarabine|fludarabine
432017|NCT00003838|Donor Apheresis|donor apheresis
432018|NCT00003838|Nonmyeloablative Bone Marrow Transplantation|nonmyeloablative bone marrow transplantation
432019|NCT00003838|Graft-Versus-Tumor|graft-versus-tumor
432020|NCT00003838|Graft-Versus-Host Disease|graft-versus-host disease
432021|NCT00003838|Multiple Myeloma|multiple myeloma
432022|NCT00003838|Extramedullary Plasmacytoma|extramedullary plasmacytoma
432023|NCT00003838|Chronic Disease|chronic disease
432024|NCT00003838|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
432025|NCT00003838|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
432026|NCT00003838|Acute Myelogenous Leukemia|acute myelogenous leukemia
432027|NCT00003838|Myeloproliferative Disease|myeloproliferative disease
432028|NCT00003838|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
432029|NCT00003838|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
432030|NCT00003838|Aplastic Anemia|aplastic anemia
432031|NCT00003838|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
432032|NCT00003838|Chronic Myelomoncytic Leukemia|chronic myelomoncytic leukemia
432033|NCT00003838|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
432034|NCT00003838|Hodgkin Disease|hodgkin disease
432035|NCT00003838|Pure Red Cell Aplasia|pure red cell aplasia
432036|NCT00003840|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
432037|NCT00003840|secondary acute myeloid leukemia|secondary acute myeloid leukemia
432038|NCT00003842|recurrent adult brain tumor|recurrent adult brain tumor
432039|NCT00003842|adult glioblastoma|adult glioblastoma
432040|NCT00003842|adult anaplastic astrocytoma|adult anaplastic astrocytoma
432041|NCT00003842|adult giant cell glioblastoma|adult giant cell glioblastoma
432042|NCT00003842|adult gliosarcoma|adult gliosarcoma
432043|NCT00003843|stage IV colon cancer|stage iv colon cancer
432044|NCT00003843|stage IV rectal cancer|stage iv rectal cancer
432045|NCT00003843|recurrent colon cancer|recurrent colon cancer
432046|NCT00003843|recurrent rectal cancer|recurrent rectal cancer
432047|NCT00003846|regional neuroblastoma|regional neuroblastoma
432048|NCT00003846|disseminated neuroblastoma|disseminated neuroblastoma
432049|NCT00003846|stage 4S neuroblastoma|stage 4s neuroblastoma
432050|NCT00003846|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
432051|NCT00003846|untreated childhood medulloblastoma|untreated childhood medulloblastoma
432052|NCT00003846|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
432053|NCT00003847|recurrent small cell lung cancer|recurrent small cell lung cancer
432054|NCT00003847|intermediate type small cell lung cancer|intermediate type small cell lung cancer
432055|NCT00003849|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
432056|NCT00003849|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
432057|NCT00003849|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
432058|NCT00003850|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
432059|NCT00003850|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
432060|NCT00003850|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
753529|NCT01173692|Head and Neck|head and neck
432061|NCT00003850|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
432062|NCT00003850|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
432063|NCT00003850|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
432064|NCT00003850|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
432065|NCT00003850|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
584785|NCT00509860|Irinotecan|irinotecan
432066|NCT00003850|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
432329|NCT00003883|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
432067|NCT00003850|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
432068|NCT00003850|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
432069|NCT00003850|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
432070|NCT00003850|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
432071|NCT00003850|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
432072|NCT00003851|malnutrition|malnutrition
432073|NCT00003851|stage II pancreatic cancer|stage ii pancreatic cancer
432074|NCT00003851|stage III pancreatic cancer|stage iii pancreatic cancer
432075|NCT00003851|stage IV pancreatic cancer|stage iv pancreatic cancer
432076|NCT00003851|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
432077|NCT00003852|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
432078|NCT00003852|childhood germ cell tumor|childhood germ cell tumor
432079|NCT00003852|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
752438|NCT01172977|Stroke|stroke
432080|NCT00003852|extragonadal germ cell tumor|extragonadal germ cell tumor
432081|NCT00003853|primary systemic amyloidosis|primary systemic amyloidosis
432082|NCT00003854|stage IA breast cancer|stage ia breast cancer
432083|NCT00003854|stage IB breast cancer|stage ib breast cancer
432084|NCT00003854|stage II breast cancer|stage ii breast cancer
432085|NCT00003855|stage IA breast cancer|stage ia breast cancer
432086|NCT00003855|stage IB breast cancer|stage ib breast cancer
432087|NCT00003855|stage II breast cancer|stage ii breast cancer
432088|NCT00003856|recurrent salivary gland cancer|recurrent salivary gland cancer
432089|NCT00003856|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
432090|NCT00003856|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
432091|NCT00003856|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
432092|NCT00003856|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
432093|NCT00003856|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
432094|NCT00003856|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
432095|NCT00003856|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
432096|NCT00003857|breast cancer in situ|breast cancer in situ
432097|NCT00003857|ductal breast carcinoma in situ|ductal breast carcinoma in situ
432098|NCT00003858|adenocarcinoma of the prostate|adenocarcinoma of the prostate
432099|NCT00003858|stage I prostate cancer|stage i prostate cancer
432100|NCT00003858|stage IIB prostate cancer|stage iib prostate cancer
432101|NCT00003858|stage IIA prostate cancer|stage iia prostate cancer
432102|NCT00003858|stage III prostate cancer|stage iii prostate cancer
432103|NCT00003858|stage IV prostate cancer|stage iv prostate cancer
432104|NCT00003859|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
432105|NCT00003859|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
432106|NCT00003860|extensive stage small cell lung cancer|extensive stage small cell lung cancer
432107|NCT00003862|stage I gastric cancer|stage i gastric cancer
432108|NCT00003862|stage II gastric cancer|stage ii gastric cancer
432109|NCT00003862|stage III gastric cancer|stage iii gastric cancer
432110|NCT00003862|stage IV gastric cancer|stage iv gastric cancer
432111|NCT00003862|adenocarcinoma of the stomach|adenocarcinoma of the stomach
432179|NCT00003867|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
432112|NCT00003863|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
432113|NCT00003863|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
432114|NCT00003863|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
432115|NCT00003863|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
432116|NCT00003863|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
432117|NCT00003863|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
432118|NCT00003863|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
432119|NCT00003863|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
432120|NCT00003863|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
432121|NCT00003863|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
432122|NCT00003863|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
753530|NCT01173705|Obesity|obesity
432123|NCT00003863|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
432124|NCT00003863|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
432125|NCT00003863|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
432126|NCT00003863|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
432127|NCT00003863|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
432128|NCT00003863|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
432129|NCT00003863|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
432130|NCT00003863|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
432131|NCT00003863|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
432132|NCT00003863|stage I mantle cell lymphoma|stage i mantle cell lymphoma
432133|NCT00003863|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
432134|NCT00003863|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
432135|NCT00003863|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
432136|NCT00003863|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
432137|NCT00003863|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
432138|NCT00003863|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
432139|NCT00003863|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
752439|NCT01172990|ST Depression|st depression
432140|NCT00003863|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
432141|NCT00003863|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
432142|NCT00003863|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
432143|NCT00003863|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
432144|NCT00003863|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
432145|NCT00003863|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
432146|NCT00003863|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
432147|NCT00003863|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
432148|NCT00003864|stage III esophageal cancer|stage iii esophageal cancer
432149|NCT00003864|stage IV esophageal cancer|stage iv esophageal cancer
432150|NCT00003864|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
432151|NCT00003865|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
432152|NCT00003865|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
432153|NCT00003867|stage III colon cancer|stage iii colon cancer
432154|NCT00003867|stage IV colon cancer|stage iv colon cancer
432155|NCT00003867|stage IV breast cancer|stage iv breast cancer
432156|NCT00003867|stage IIIA breast cancer|stage iiia breast cancer
432157|NCT00003867|recurrent breast cancer|recurrent breast cancer
432158|NCT00003867|stage III gastric cancer|stage iii gastric cancer
432159|NCT00003867|stage IV gastric cancer|stage iv gastric cancer
432160|NCT00003867|recurrent gastric cancer|recurrent gastric cancer
432161|NCT00003867|stage IIIB breast cancer|stage iiib breast cancer
432162|NCT00003867|stage II pancreatic cancer|stage ii pancreatic cancer
432163|NCT00003867|stage III pancreatic cancer|stage iii pancreatic cancer
432164|NCT00003867|recurrent pancreatic cancer|recurrent pancreatic cancer
432165|NCT00003867|stage III rectal cancer|stage iii rectal cancer
432166|NCT00003867|stage IV rectal cancer|stage iv rectal cancer
432167|NCT00003867|recurrent colon cancer|recurrent colon cancer
432168|NCT00003867|recurrent rectal cancer|recurrent rectal cancer
432169|NCT00003867|stage IV anal cancer|stage iv anal cancer
432170|NCT00003867|recurrent anal cancer|recurrent anal cancer
432171|NCT00003867|stage II esophageal cancer|stage ii esophageal cancer
432172|NCT00003867|stage III esophageal cancer|stage iii esophageal cancer
432173|NCT00003867|stage IV esophageal cancer|stage iv esophageal cancer
432174|NCT00003867|stage IIIA anal cancer|stage iiia anal cancer
432175|NCT00003867|stage IIIB anal cancer|stage iiib anal cancer
432176|NCT00003867|recurrent esophageal cancer|recurrent esophageal cancer
432177|NCT00003867|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
432178|NCT00003867|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
453374|NCT00013663|Avipoxvirus|avipoxvirus
432180|NCT00003867|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
432181|NCT00003867|advanced adult primary liver cancer|advanced adult primary liver cancer
432182|NCT00003867|recurrent adult primary liver cancer|recurrent adult primary liver cancer
432183|NCT00003867|small intestine adenocarcinoma|small intestine adenocarcinoma
432184|NCT00003867|small intestine lymphoma|small intestine lymphoma
432185|NCT00003867|small intestine leiomyosarcoma|small intestine leiomyosarcoma
432186|NCT00003867|unresectable gallbladder cancer|unresectable gallbladder cancer
432187|NCT00003867|recurrent gallbladder cancer|recurrent gallbladder cancer
432188|NCT00003867|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
432189|NCT00003867|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
432190|NCT00003867|recurrent small intestine cancer|recurrent small intestine cancer
432191|NCT00003867|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
432192|NCT00003867|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
432193|NCT00003867|carcinoma of the appendix|carcinoma of the appendix
432194|NCT00003867|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
432195|NCT00003867|stage IV pancreatic cancer|stage iv pancreatic cancer
432196|NCT00003868|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
432197|NCT00003868|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
432198|NCT00003868|secondary acute myeloid leukemia|secondary acute myeloid leukemia
432199|NCT00003868|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
432200|NCT00003868|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
432201|NCT00003868|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
432202|NCT00003868|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
432203|NCT00003868|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
432204|NCT00003870|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
432205|NCT00003870|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
432206|NCT00003870|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
432207|NCT00003870|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
432208|NCT00003871|stage IV prostate cancer|stage iv prostate cancer
432209|NCT00003871|recurrent prostate cancer|recurrent prostate cancer
432210|NCT00003874|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
432211|NCT00003874|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
432212|NCT00003874|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
432213|NCT00003874|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
432214|NCT00003874|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
432215|NCT00003874|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
432216|NCT00003874|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
432217|NCT00003874|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
432218|NCT00003874|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
432219|NCT00003874|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
432220|NCT00003874|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
432221|NCT00003874|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
432222|NCT00003874|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
432223|NCT00003874|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
432224|NCT00003874|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
432225|NCT00003874|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
432226|NCT00003874|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
432227|NCT00003874|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
432228|NCT00003874|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
432229|NCT00003874|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
432230|NCT00003874|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
432231|NCT00003874|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
432232|NCT00003874|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
432233|NCT00003874|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
432234|NCT00003874|splenic marginal zone lymphoma|splenic marginal zone lymphoma
432235|NCT00003876|recurrent adult brain tumor|recurrent adult brain tumor
432236|NCT00003876|adult brain stem glioma|adult brain stem glioma
432237|NCT00003876|adult glioblastoma|adult glioblastoma
432238|NCT00003876|adult anaplastic astrocytoma|adult anaplastic astrocytoma
432239|NCT00003876|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
432240|NCT00003876|adult mixed glioma|adult mixed glioma
432241|NCT00003876|adult giant cell glioblastoma|adult giant cell glioblastoma
432242|NCT00003876|adult gliosarcoma|adult gliosarcoma
432243|NCT00003877|stage IV breast cancer|stage iv breast cancer
432244|NCT00003877|recurrent breast cancer|recurrent breast cancer
432310|NCT00003883|ovarian yolk sac tumor|ovarian yolk sac tumor
432245|NCT00003878|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
432246|NCT00003878|tumors metastatic to brain|tumors metastatic to brain
432247|NCT00003880|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
432248|NCT00003880|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
432249|NCT00003880|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
432250|NCT00003880|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
432251|NCT00003880|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
432252|NCT00003880|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
432253|NCT00003880|primary peritoneal cavity cancer|primary peritoneal cavity cancer
432254|NCT00003881|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
432255|NCT00003881|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
753531|NCT01173705|Insulin Resistance|insulin resistance
432256|NCT00003881|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
432257|NCT00003882|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
432258|NCT00003883|stage IV breast cancer|stage iv breast cancer
432259|NCT00003883|stage IIIA breast cancer|stage iiia breast cancer
432260|NCT00003883|stage IIIB breast cancer|stage iiib breast cancer
432261|NCT00003883|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
432262|NCT00003883|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
432641|NCT00002993|recurrent uterine sarcoma|recurrent uterine sarcoma
432263|NCT00003883|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
432264|NCT00003883|refractory multiple myeloma|refractory multiple myeloma
432265|NCT00003883|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
432266|NCT00003883|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
432267|NCT00003883|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
432268|NCT00003883|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
432269|NCT00003883|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
432270|NCT00003883|disseminated neuroblastoma|disseminated neuroblastoma
432271|NCT00003883|recurrent neuroblastoma|recurrent neuroblastoma
432272|NCT00003883|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
432273|NCT00003883|stage I multiple myeloma|stage i multiple myeloma
432274|NCT00003883|stage II multiple myeloma|stage ii multiple myeloma
432275|NCT00003883|stage III multiple myeloma|stage iii multiple myeloma
432276|NCT00003883|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
432277|NCT00003883|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
432278|NCT00003883|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
432279|NCT00003883|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
432280|NCT00003883|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
432281|NCT00003883|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
432282|NCT00003883|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
432283|NCT00003883|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
432284|NCT00003883|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
432285|NCT00003883|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
432286|NCT00003883|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
432287|NCT00003883|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
432288|NCT00003883|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
432289|NCT00003883|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
432290|NCT00003883|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
432291|NCT00003883|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
432292|NCT00003883|testicular embryonal carcinoma|testicular embryonal carcinoma
432293|NCT00003883|testicular choriocarcinoma|testicular choriocarcinoma
432294|NCT00003883|testicular teratoma|testicular teratoma
432295|NCT00003883|testicular yolk sac tumor|testicular yolk sac tumor
432296|NCT00003883|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
432297|NCT00003883|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
432298|NCT00003883|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
432299|NCT00003883|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
432300|NCT00003883|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
432301|NCT00003883|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
432302|NCT00003883|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
432303|NCT00003883|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
432304|NCT00003883|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
432305|NCT00003883|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
432306|NCT00003883|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
432307|NCT00003883|refractory hairy cell leukemia|refractory hairy cell leukemia
432308|NCT00003883|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
434594|NCT00003897|recurrent melanoma|recurrent melanoma
432309|NCT00003883|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
432311|NCT00003883|ovarian embryonal carcinoma|ovarian embryonal carcinoma
432312|NCT00003883|ovarian polyembryoma|ovarian polyembryoma
432313|NCT00003883|ovarian choriocarcinoma|ovarian choriocarcinoma
432314|NCT00003883|ovarian immature teratoma|ovarian immature teratoma
432315|NCT00003883|ovarian mature teratoma|ovarian mature teratoma
432316|NCT00003883|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
432317|NCT00003883|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
432318|NCT00003883|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
432319|NCT00003883|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
432320|NCT00003883|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
432321|NCT00003883|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
432322|NCT00003883|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
432323|NCT00003883|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
432324|NCT00003883|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
432325|NCT00003883|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
432326|NCT00003883|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
432327|NCT00003883|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
432328|NCT00003883|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
432330|NCT00003883|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
432331|NCT00003883|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
432332|NCT00003883|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
432333|NCT00003883|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
432334|NCT00003883|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
432335|NCT00003883|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
432336|NCT00003883|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
432337|NCT00003883|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
432338|NCT00003883|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
432339|NCT00003883|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
432340|NCT00003883|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
432341|NCT00003883|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
432342|NCT00003883|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
432343|NCT00003883|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
432344|NCT00003883|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
432345|NCT00003883|secondary acute myeloid leukemia|secondary acute myeloid leukemia
432346|NCT00003883|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
432347|NCT00003883|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
432348|NCT00003883|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
432349|NCT00003883|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
432351|NCT00003883|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
432352|NCT00003883|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
432353|NCT00003883|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
432354|NCT00003883|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
432355|NCT00003883|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
432356|NCT00003883|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
432357|NCT00003883|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
432358|NCT00003883|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
432359|NCT00003883|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
432360|NCT00003883|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
432361|NCT00003883|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
432362|NCT00003883|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
432363|NCT00003883|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
432364|NCT00003883|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
432365|NCT00003883|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
432366|NCT00003883|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
432367|NCT00003883|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
432368|NCT00003883|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
432369|NCT00003883|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
432370|NCT00003883|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
432371|NCT00003883|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
432372|NCT00003883|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
432373|NCT00003883|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
432374|NCT00003883|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
432375|NCT00003883|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
432376|NCT00003883|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
432377|NCT00003883|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
432378|NCT00003883|splenic marginal zone lymphoma|splenic marginal zone lymphoma
432379|NCT00003883|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
432380|NCT00003884|hypercalcemia of malignancy|hypercalcemia of malignancy
432381|NCT00003884|pain|pain
432382|NCT00003884|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
432383|NCT00003884|recurrent small cell lung cancer|recurrent small cell lung cancer
432384|NCT00003884|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
432386|NCT00003885|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
432387|NCT00003885|stage I multiple myeloma|stage i multiple myeloma
432388|NCT00003885|stage II multiple myeloma|stage ii multiple myeloma
432389|NCT00003885|stage III multiple myeloma|stage iii multiple myeloma
432390|NCT00003885|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
432391|NCT00003885|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
432392|NCT00003885|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
432393|NCT00003885|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
450383|NCT00016653|treatment|treatment
432394|NCT00003885|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
432395|NCT00003885|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
432396|NCT00003885|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
432397|NCT00003885|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
432398|NCT00003885|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
752739|NCT01173978|Glucagon|glucagon
432399|NCT00003885|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
432400|NCT00003885|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
432401|NCT00003885|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
432402|NCT00003885|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
432403|NCT00003885|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
432404|NCT00003885|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
432405|NCT00003885|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
432406|NCT00003885|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
432407|NCT00003885|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
432408|NCT00003885|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
432409|NCT00003885|splenic marginal zone lymphoma|splenic marginal zone lymphoma
432410|NCT00003887|stage IV breast cancer|stage iv breast cancer
432411|NCT00003887|stage IIIA breast cancer|stage iiia breast cancer
432412|NCT00003887|stage IIIB breast cancer|stage iiib breast cancer
432413|NCT00003887|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
432414|NCT00003887|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
432415|NCT00003887|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
432416|NCT00003887|refractory multiple myeloma|refractory multiple myeloma
432417|NCT00003887|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
432418|NCT00003887|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
432419|NCT00003887|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
432420|NCT00003887|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
432421|NCT00003887|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
432422|NCT00003887|disseminated neuroblastoma|disseminated neuroblastoma
432423|NCT00003887|recurrent neuroblastoma|recurrent neuroblastoma
432424|NCT00003887|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
432425|NCT00003887|stage I multiple myeloma|stage i multiple myeloma
432426|NCT00003887|stage II multiple myeloma|stage ii multiple myeloma
432427|NCT00003887|stage III multiple myeloma|stage iii multiple myeloma
432428|NCT00003887|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
432429|NCT00003887|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
432430|NCT00003887|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
432431|NCT00003887|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
432432|NCT00003887|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
432433|NCT00003887|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
432434|NCT00003887|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
432435|NCT00003887|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
432436|NCT00003887|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
432437|NCT00003887|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
432438|NCT00003887|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
432439|NCT00003887|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
432773|NCT00003023|recurrent osteosarcoma|recurrent osteosarcoma
432440|NCT00003887|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
432441|NCT00003887|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
432442|NCT00003887|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
432443|NCT00003887|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
432444|NCT00003887|testicular embryonal carcinoma|testicular embryonal carcinoma
432445|NCT00003887|testicular choriocarcinoma|testicular choriocarcinoma
432446|NCT00003887|testicular teratoma|testicular teratoma
432447|NCT00003887|testicular yolk sac tumor|testicular yolk sac tumor
432448|NCT00003887|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
584786|NCT00509860|Camptosar|camptosar
432449|NCT00003887|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
432450|NCT00003887|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
432451|NCT00003887|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
432452|NCT00003887|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
432453|NCT00003887|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
432454|NCT00003887|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
432455|NCT00003887|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
432456|NCT00003887|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
432457|NCT00003887|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
432458|NCT00003887|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
432459|NCT00003887|refractory hairy cell leukemia|refractory hairy cell leukemia
432460|NCT00003887|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
543614|NCT00370526|CRT|crt
432461|NCT00003887|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
432462|NCT00003887|ovarian yolk sac tumor|ovarian yolk sac tumor
432463|NCT00003887|ovarian embryonal carcinoma|ovarian embryonal carcinoma
432464|NCT00003887|ovarian polyembryoma|ovarian polyembryoma
432465|NCT00003887|ovarian choriocarcinoma|ovarian choriocarcinoma
432466|NCT00003887|ovarian immature teratoma|ovarian immature teratoma
432467|NCT00003887|ovarian mature teratoma|ovarian mature teratoma
432468|NCT00003887|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
432469|NCT00003887|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
432470|NCT00003887|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
432471|NCT00003887|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
432472|NCT00003887|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
432473|NCT00003887|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
432474|NCT00003887|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
432475|NCT00003887|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
432476|NCT00003887|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
432477|NCT00003887|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
432478|NCT00003887|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
432479|NCT00003887|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
432480|NCT00003887|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
432481|NCT00003887|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
432482|NCT00003887|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
432483|NCT00003887|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
432484|NCT00003887|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
432485|NCT00003887|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
432486|NCT00003887|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
432487|NCT00003887|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
432488|NCT00003887|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
432489|NCT00003887|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
432490|NCT00003887|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
432491|NCT00003887|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
432492|NCT00003887|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
432493|NCT00003887|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
432494|NCT00003887|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
432495|NCT00003887|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
432496|NCT00003887|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
432497|NCT00003887|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
432498|NCT00003887|secondary acute myeloid leukemia|secondary acute myeloid leukemia
432499|NCT00003887|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
432500|NCT00003887|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
432501|NCT00003887|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
432502|NCT00003887|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
432503|NCT00003887|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
454267|NCT00025857|Depression|depression
432504|NCT00003887|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
432505|NCT00003887|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
432506|NCT00003887|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
432507|NCT00003887|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
432508|NCT00003887|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
432509|NCT00003887|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
10478|NCT03223987|Strath Herbal Yeast Preparation|strath herbal yeast preparation
432510|NCT00003887|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
432511|NCT00003887|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
432512|NCT00003887|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
432513|NCT00003887|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
432514|NCT00003887|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
432515|NCT00003887|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
432516|NCT00003887|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
432517|NCT00003887|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
450384|NCT00016666|Season|season
432518|NCT00003887|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
432519|NCT00003887|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
432520|NCT00003887|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
432521|NCT00003887|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
432522|NCT00003887|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
432523|NCT00003887|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
432524|NCT00003887|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
432525|NCT00003887|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
432526|NCT00003887|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
432527|NCT00003887|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
432528|NCT00003887|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
432529|NCT00003887|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
432530|NCT00003887|splenic marginal zone lymphoma|splenic marginal zone lymphoma
432531|NCT00003887|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
432532|NCT00003888|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
432533|NCT00003888|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
432534|NCT00003888|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
432535|NCT00003888|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
432536|NCT00003888|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
432537|NCT00003888|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
432538|NCT00003888|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
432539|NCT00003888|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
432540|NCT00003890|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
432541|NCT00002984|stage II esophageal cancer|stage ii esophageal cancer
432542|NCT00002984|stage III esophageal cancer|stage iii esophageal cancer
432543|NCT00002984|stage IV esophageal cancer|stage iv esophageal cancer
432544|NCT00002984|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
432545|NCT00002984|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
432546|NCT00002985|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
432547|NCT00002986|recurrent adult brain tumor|recurrent adult brain tumor
432548|NCT00002987|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
432549|NCT00002987|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
432550|NCT00002988|recurrent adult brain tumor|recurrent adult brain tumor
432551|NCT00002989|stage I multiple myeloma|stage i multiple myeloma
432552|NCT00002989|stage II multiple myeloma|stage ii multiple myeloma
432553|NCT00002989|stage III multiple myeloma|stage iii multiple myeloma
432554|NCT00002989|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
432555|NCT00002989|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
432556|NCT00002989|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
432557|NCT00002989|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
432558|NCT00002989|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
432559|NCT00002989|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
432560|NCT00002989|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
432561|NCT00002989|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
432562|NCT00002989|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
432563|NCT00002989|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
432564|NCT00002989|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
432565|NCT00002989|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
433097|NCT00003203|regional neuroblastoma|regional neuroblastoma
432566|NCT00002989|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
432567|NCT00002989|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
432568|NCT00002989|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
432569|NCT00002989|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
432570|NCT00002989|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
432571|NCT00002989|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
10479|NCT03223974|Angioplasty|angioplasty
432572|NCT00002989|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
432573|NCT00002989|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
432574|NCT00002989|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
432575|NCT00002989|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
432576|NCT00002989|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
432577|NCT00002989|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
432578|NCT00002989|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
432579|NCT00002989|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
432718|NCT00003022|childhood infratentorial ependymoma|childhood infratentorial ependymoma
432580|NCT00002989|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
432581|NCT00002989|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
432582|NCT00002989|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
432583|NCT00002989|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
432584|NCT00002989|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
432585|NCT00002989|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
432586|NCT00002989|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
432587|NCT00002989|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
432588|NCT00002989|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
432589|NCT00002989|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
432590|NCT00002989|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
432591|NCT00002989|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
432592|NCT00002989|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
432593|NCT00002989|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
432594|NCT00002989|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
432595|NCT00002989|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
432596|NCT00002989|stage I mantle cell lymphoma|stage i mantle cell lymphoma
432597|NCT00002989|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
432598|NCT00002989|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
432599|NCT00002989|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
432600|NCT00002989|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
432601|NCT00002989|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
432602|NCT00002989|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
432603|NCT00002989|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
432604|NCT00002989|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
432605|NCT00002989|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
432606|NCT00002989|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
432607|NCT00002989|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
432608|NCT00002989|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
432609|NCT00002989|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
432610|NCT00002989|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
432611|NCT00002989|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
432612|NCT00002989|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
432613|NCT00002989|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
432614|NCT00002989|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
432615|NCT00002989|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
432616|NCT00002989|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
432617|NCT00002989|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
432618|NCT00002989|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
432619|NCT00002989|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
432620|NCT00002989|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
432621|NCT00002989|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
432622|NCT00002989|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
432623|NCT00002989|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
432624|NCT00002989|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
432625|NCT00002989|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
545018|NCT00374361|lipids|lipids
432626|NCT00002989|stage I marginal zone lymphoma|stage i marginal zone lymphoma
432627|NCT00002989|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
432628|NCT00002989|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
432629|NCT00002989|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
432630|NCT00002989|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
432631|NCT00002989|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
432632|NCT00002989|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
432633|NCT00002989|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
432634|NCT00002989|splenic marginal zone lymphoma|splenic marginal zone lymphoma
432635|NCT00002989|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
432636|NCT00002990|stage 0 bladder cancer|stage 0 bladder cancer
432637|NCT00002990|stage I bladder cancer|stage i bladder cancer
432638|NCT00002990|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
432639|NCT00002993|stage III uterine sarcoma|stage iii uterine sarcoma
432640|NCT00002993|stage IV uterine sarcoma|stage iv uterine sarcoma
432642|NCT00002994|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
432643|NCT00002995|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
432644|NCT00002995|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
432645|NCT00002995|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
432646|NCT00002995|adult rhabdomyosarcoma|adult rhabdomyosarcoma
432647|NCT00002995|adult malignant mesenchymoma|adult malignant mesenchymoma
432648|NCT00002995|childhood malignant mesenchymoma|childhood malignant mesenchymoma
432649|NCT00002995|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
432650|NCT00002995|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
432651|NCT00002995|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
432652|NCT00002995|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
432654|NCT00002997|stage IV colon cancer|stage iv colon cancer
432655|NCT00002997|stage IV rectal cancer|stage iv rectal cancer
432656|NCT00002997|recurrent colon cancer|recurrent colon cancer
432657|NCT00002997|recurrent rectal cancer|recurrent rectal cancer
432658|NCT00002997|adenocarcinoma of the colon|adenocarcinoma of the colon
432659|NCT00002997|adenocarcinoma of the rectum|adenocarcinoma of the rectum
432660|NCT00002997|liver metastases|liver metastases
432661|NCT00002998|stage IV breast cancer|stage iv breast cancer
432662|NCT00002998|recurrent breast cancer|recurrent breast cancer
432663|NCT00002999|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
432664|NCT00002999|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
432665|NCT00003000|pain|pain
432666|NCT00003001|stage IV colon cancer|stage iv colon cancer
432667|NCT00003001|stage IV rectal cancer|stage iv rectal cancer
432668|NCT00003001|recurrent colon cancer|recurrent colon cancer
432669|NCT00003001|recurrent rectal cancer|recurrent rectal cancer
432670|NCT00003002|stage III breast cancer|stage iii breast cancer
432671|NCT00003002|stage IV breast cancer|stage iv breast cancer
432672|NCT00003002|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
432673|NCT00003002|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
432674|NCT00003002|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
432675|NCT00003002|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
432676|NCT00003002|adenocarcinoma of the lung|adenocarcinoma of the lung
432677|NCT00003003|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
432678|NCT00003003|secondary acute myeloid leukemia|secondary acute myeloid leukemia
432679|NCT00003004|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
432680|NCT00003005|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
432681|NCT00003005|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
432682|NCT00003005|TdT positive adult acute lymphoblastic leukemia|tdt positive adult acute lymphoblastic leukemia
432683|NCT00003006|stage I non-small cell lung cancer|stage i non-small cell lung cancer
432684|NCT00003007|refractory multiple myeloma|refractory multiple myeloma
432685|NCT00003007|stage III multiple myeloma|stage iii multiple myeloma
432686|NCT00003008|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
432687|NCT00003008|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
432688|NCT00003009|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
432689|NCT00003010|recurrent breast cancer|recurrent breast cancer
432690|NCT00003011|recurrent small cell lung cancer|recurrent small cell lung cancer
432691|NCT00003012|stage II breast cancer|stage ii breast cancer
432692|NCT00003012|stage IIIA breast cancer|stage iiia breast cancer
432693|NCT00003013|stage II breast cancer|stage ii breast cancer
432694|NCT00003013|stage IIIA breast cancer|stage iiia breast cancer
432695|NCT00003014|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
432696|NCT00003014|testicular seminoma|testicular seminoma
432697|NCT00003015|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
432698|NCT00003015|childhood oligodendroglioma|childhood oligodendroglioma
432699|NCT00003015|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
432700|NCT00003015|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
432701|NCT00003016|stage I breast cancer|stage i breast cancer
432702|NCT00003016|stage II breast cancer|stage ii breast cancer
432703|NCT00003016|stage IIIA breast cancer|stage iiia breast cancer
432704|NCT00003016|stage IIIB breast cancer|stage iiib breast cancer
432705|NCT00003016|stage IIIC breast cancer|stage iiic breast cancer
432706|NCT00003017|stage IV cervical cancer|stage iv cervical cancer
432707|NCT00003017|recurrent cervical cancer|recurrent cervical cancer
432708|NCT00003017|cervical squamous cell carcinoma|cervical squamous cell carcinoma
432709|NCT00003017|cervical adenocarcinoma|cervical adenocarcinoma
432710|NCT00003017|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
432711|NCT00003018|stage II pancreatic cancer|stage ii pancreatic cancer
432712|NCT00003018|stage III pancreatic cancer|stage iii pancreatic cancer
432713|NCT00003018|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
432715|NCT00003020|leptomeningeal metastases|leptomeningeal metastases
432716|NCT00003021|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
432717|NCT00003022|metastatic osteosarcoma|metastatic osteosarcoma
432794|NCT00003035|stage IIIB breast cancer|stage iiib breast cancer
432719|NCT00003022|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
432720|NCT00003022|childhood supratentorial ependymoma|childhood supratentorial ependymoma
432721|NCT00003022|regional neuroblastoma|regional neuroblastoma
432722|NCT00003022|disseminated neuroblastoma|disseminated neuroblastoma
432723|NCT00003022|stage 4S neuroblastoma|stage 4s neuroblastoma
432724|NCT00003022|recurrent neuroblastoma|recurrent neuroblastoma
432726|NCT00003022|intraocular retinoblastoma|intraocular retinoblastoma
432727|NCT00003022|extraocular retinoblastoma|extraocular retinoblastoma
432728|NCT00003022|recurrent retinoblastoma|recurrent retinoblastoma
432729|NCT00003022|extensive stage small cell lung cancer|extensive stage small cell lung cancer
432730|NCT00003022|recurrent small cell lung cancer|recurrent small cell lung cancer
432731|NCT00003022|recurrent osteosarcoma|recurrent osteosarcoma
432732|NCT00003022|recurrent adult brain tumor|recurrent adult brain tumor
432733|NCT00003022|iris melanoma|iris melanoma
432734|NCT00003022|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
432735|NCT00003022|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
432736|NCT00003022|extraocular extension melanoma|extraocular extension melanoma
432737|NCT00003022|recurrent intraocular melanoma|recurrent intraocular melanoma
432738|NCT00003022|adult brain stem glioma|adult brain stem glioma
432739|NCT00003022|adult medulloblastoma|adult medulloblastoma
432740|NCT00003022|stage IV melanoma|stage iv melanoma
432741|NCT00003022|recurrent melanoma|recurrent melanoma
432742|NCT00003022|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
432743|NCT00003022|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
432744|NCT00003022|adult myxopapillary ependymoma|adult myxopapillary ependymoma
432745|NCT00003022|adult anaplastic ependymoma|adult anaplastic ependymoma
432746|NCT00003022|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
432747|NCT00003022|adult mixed glioma|adult mixed glioma
432748|NCT00003022|localized unresectable neuroblastoma|localized unresectable neuroblastoma
432749|NCT00003022|adult ependymoblastoma|adult ependymoblastoma
432750|NCT00003022|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
432751|NCT00003022|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
432752|NCT00003022|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
432753|NCT00003022|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
432754|NCT00003022|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
432755|NCT00003022|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
432756|NCT00003022|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
432757|NCT00003022|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
432758|NCT00003022|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
432759|NCT00003022|recurrent childhood ependymoma|recurrent childhood ependymoma
432760|NCT00003022|adult oligodendroglioma|adult oligodendroglioma
432761|NCT00003022|adult anaplastic astrocytoma|adult anaplastic astrocytoma
432762|NCT00003022|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
432763|NCT00003022|adult diffuse astrocytoma|adult diffuse astrocytoma
432764|NCT00003022|adult pilocytic astrocytoma|adult pilocytic astrocytoma
432765|NCT00003022|adult giant cell glioblastoma|adult giant cell glioblastoma
432766|NCT00003022|adult glioblastoma|adult glioblastoma
545274|NCT00368849|ADD|add
432767|NCT00003022|adult gliosarcoma|adult gliosarcoma
432768|NCT00003023|metastatic osteosarcoma|metastatic osteosarcoma
432769|NCT00003023|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
432770|NCT00003023|disseminated neuroblastoma|disseminated neuroblastoma
432771|NCT00003023|stage 4S neuroblastoma|stage 4s neuroblastoma
432772|NCT00003023|recurrent neuroblastoma|recurrent neuroblastoma
454268|NCT00025857|PTSD|ptsd
432774|NCT00003023|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
432775|NCT00003023|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
432776|NCT00003023|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
432777|NCT00003025|stage I pancreatic cancer|stage i pancreatic cancer
432778|NCT00003025|stage II pancreatic cancer|stage ii pancreatic cancer
432779|NCT00003025|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
432780|NCT00003026|adenocarcinoma of the prostate|adenocarcinoma of the prostate
432782|NCT00003028|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
432783|NCT00003029|stage III pancreatic cancer|stage iii pancreatic cancer
432784|NCT00003029|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
432785|NCT00003029|stage IV pancreatic cancer|stage iv pancreatic cancer
432786|NCT00003031|infection|infection
432787|NCT00003031|pulmonary complications|pulmonary complications
432788|NCT00003032|stage IV breast cancer|stage iv breast cancer
432789|NCT00003032|recurrent breast cancer|recurrent breast cancer
432790|NCT00003034|localized malignant mesothelioma|localized malignant mesothelioma
432791|NCT00003034|advanced malignant mesothelioma|advanced malignant mesothelioma
432792|NCT00003034|recurrent malignant mesothelioma|recurrent malignant mesothelioma
432793|NCT00003035|stage IIIA breast cancer|stage iiia breast cancer
432795|NCT00003037|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
432796|NCT00003037|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
432797|NCT00003038|stage IV colon cancer|stage iv colon cancer
432798|NCT00003038|stage IV breast cancer|stage iv breast cancer
432799|NCT00003038|recurrent breast cancer|recurrent breast cancer
432800|NCT00003038|recurrent colon cancer|recurrent colon cancer
432801|NCT00003038|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
432802|NCT00003038|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
432803|NCT00003038|stage IV prostate cancer|stage iv prostate cancer
432804|NCT00003038|recurrent prostate cancer|recurrent prostate cancer
432805|NCT00003038|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
432806|NCT00003039|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
432807|NCT00003039|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
432808|NCT00003039|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
432809|NCT00003039|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
432810|NCT00003039|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
432811|NCT00003039|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
432812|NCT00003039|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
432813|NCT00003039|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
432814|NCT00003040|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
432815|NCT00003040|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
432816|NCT00003040|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
432817|NCT00003041|recurrent breast cancer|recurrent breast cancer
432818|NCT00003042|stage IIIB breast cancer|stage iiib breast cancer
432819|NCT00003042|inflammatory breast cancer|inflammatory breast cancer
432820|NCT00003044|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
432821|NCT00003045|adenocarcinoma of the prostate|adenocarcinoma of the prostate
432822|NCT00003045|stage II prostate cancer|stage ii prostate cancer
432823|NCT00003045|stage III prostate cancer|stage iii prostate cancer
432824|NCT00003162|stage IV breast cancer|stage iv breast cancer
432825|NCT00003162|recurrent breast cancer|recurrent breast cancer
432826|NCT00003162|stage IV prostate cancer|stage iv prostate cancer
432827|NCT00003162|recurrent prostate cancer|recurrent prostate cancer
432828|NCT00003162|bone metastases|bone metastases
432829|NCT00003162|pain|pain
432830|NCT00003163|refractory multiple myeloma|refractory multiple myeloma
432831|NCT00003163|Waldenström macroglobulinemia|waldenström macroglobulinemia
432832|NCT00003163|stage I multiple myeloma|stage i multiple myeloma
432833|NCT00003163|stage II multiple myeloma|stage ii multiple myeloma
432834|NCT00003163|stage III multiple myeloma|stage iii multiple myeloma
432835|NCT00003163|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
432836|NCT00003163|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
432837|NCT00003163|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
432838|NCT00003163|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
432839|NCT00003163|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
432840|NCT00003163|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
432841|NCT00003163|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
432842|NCT00003163|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
432843|NCT00003163|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
432844|NCT00003163|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
432845|NCT00003163|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
433098|NCT00003203|stage 4S neuroblastoma|stage 4s neuroblastoma
432846|NCT00003163|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
432847|NCT00003163|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
432848|NCT00003163|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
432849|NCT00003163|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
432850|NCT00003163|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
432851|NCT00003163|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
432852|NCT00003163|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
432853|NCT00003163|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
432854|NCT00003163|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
432855|NCT00003163|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
432856|NCT00003163|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
432857|NCT00003163|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
432858|NCT00003163|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
432859|NCT00003163|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
432860|NCT00003163|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
432861|NCT00003163|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
432862|NCT00003163|primary systemic amyloidosis|primary systemic amyloidosis
432863|NCT00003163|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
432864|NCT00003163|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
432865|NCT00003163|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
432866|NCT00003163|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
432867|NCT00003163|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
432868|NCT00003163|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
432869|NCT00003163|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
432870|NCT00003163|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
432871|NCT00003163|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
432872|NCT00003163|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
432873|NCT00003163|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
432874|NCT00003163|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
432875|NCT00003163|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
432876|NCT00003163|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
432877|NCT00003163|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
432878|NCT00003163|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
432879|NCT00003163|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
435172|NCT00004145|refractory anemia|refractory anemia
432880|NCT00003163|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
432881|NCT00003163|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
432882|NCT00003163|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
432883|NCT00003163|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
432884|NCT00003163|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
432885|NCT00003163|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
432886|NCT00003163|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
432887|NCT00003163|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
432888|NCT00003163|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
432889|NCT00003163|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
432890|NCT00003163|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
432891|NCT00003163|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
432892|NCT00003163|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
432893|NCT00003163|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
432894|NCT00003163|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
432895|NCT00003163|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
432896|NCT00003163|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
432897|NCT00003163|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
432898|NCT00003163|splenic marginal zone lymphoma|splenic marginal zone lymphoma
432899|NCT00003165|stage IV breast cancer|stage iv breast cancer
432900|NCT00003165|recurrent breast cancer|recurrent breast cancer
432901|NCT00003171|refractory anemia|refractory anemia
432902|NCT00003171|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
432903|NCT00003171|refractory anemia with excess blasts|refractory anemia with excess blasts
432904|NCT00003171|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
432905|NCT00003171|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
432906|NCT00003171|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
432907|NCT00003171|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
432908|NCT00003171|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
432909|NCT00003172|stage III gastric cancer|stage iii gastric cancer
432910|NCT00003172|stage IV gastric cancer|stage iv gastric cancer
432911|NCT00003172|recurrent gastric cancer|recurrent gastric cancer
432912|NCT00003173|intraocular retinoblastoma|intraocular retinoblastoma
432913|NCT00003173|recurrent retinoblastoma|recurrent retinoblastoma
752440|NCT01173003|Medical abortion|medical abortion
432914|NCT00003173|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
432915|NCT00003173|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
432916|NCT00003173|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
432917|NCT00003173|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
432918|NCT00003173|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
432919|NCT00003173|childhood germ cell tumor|childhood germ cell tumor
432920|NCT00003173|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
432921|NCT00003173|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
432922|NCT00003173|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
432923|NCT00003173|extragonadal germ cell tumor|extragonadal germ cell tumor
432924|NCT00003173|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
432925|NCT00003173|childhood teratoma|childhood teratoma
432926|NCT00003173|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
432927|NCT00003173|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
432928|NCT00003173|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
432929|NCT00003173|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
432930|NCT00003174|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
432931|NCT00003174|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
432932|NCT00003174|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
432933|NCT00003174|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
432934|NCT00003174|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
432935|NCT00003175|recurrent bladder cancer|recurrent bladder cancer
432936|NCT00003175|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
432937|NCT00003175|recurrent urethral cancer|recurrent urethral cancer
432938|NCT00003175|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
432939|NCT00003176|recurrent adult brain tumor|recurrent adult brain tumor
432940|NCT00003176|adult glioblastoma|adult glioblastoma
432941|NCT00003176|adult anaplastic astrocytoma|adult anaplastic astrocytoma
432942|NCT00003176|adult mixed glioma|adult mixed glioma
432943|NCT00003176|adult giant cell glioblastoma|adult giant cell glioblastoma
432944|NCT00003176|adult gliosarcoma|adult gliosarcoma
432945|NCT00003178|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
432946|NCT00003178|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
432947|NCT00003178|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
432948|NCT00003178|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
432949|NCT00003178|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
432950|NCT00003178|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
432951|NCT00003178|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
432952|NCT00003178|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
432953|NCT00003178|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
432954|NCT00003178|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
432955|NCT00003179|endometrial cancer|endometrial cancer
432956|NCT00003181|stage IV renal cell cancer|stage iv renal cell cancer
432957|NCT00003181|recurrent renal cell cancer|recurrent renal cell cancer
432958|NCT00003182|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
432959|NCT00003182|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
432960|NCT00003182|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
432961|NCT00003182|stage III salivary gland cancer|stage iii salivary gland cancer
432962|NCT00003182|stage IV salivary gland cancer|stage iv salivary gland cancer
432963|NCT00003182|recurrent salivary gland cancer|recurrent salivary gland cancer
432964|NCT00003182|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
432965|NCT00003182|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
432966|NCT00003182|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
432967|NCT00003182|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
432968|NCT00003182|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
432969|NCT00003182|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
432970|NCT00003182|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
432971|NCT00003182|stage III laryngeal cancer|stage iii laryngeal cancer
432972|NCT00003182|stage IV laryngeal cancer|stage iv laryngeal cancer
432973|NCT00003182|recurrent laryngeal cancer|recurrent laryngeal cancer
432974|NCT00003182|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
432975|NCT00003182|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
432976|NCT00003182|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
432977|NCT00003182|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
432978|NCT00003182|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
432979|NCT00003182|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
432980|NCT00003182|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
432981|NCT00003182|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
432982|NCT00003182|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
432983|NCT00003182|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
432984|NCT00003182|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
432985|NCT00003182|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
432986|NCT00003182|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
432987|NCT00003182|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
432988|NCT00003182|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
432989|NCT00003182|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
432990|NCT00003182|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
432991|NCT00003182|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
432992|NCT00003182|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
432993|NCT00003182|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
432994|NCT00003182|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
432995|NCT00003182|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
432996|NCT00003182|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
432997|NCT00003182|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
432998|NCT00003183|adenocarcinoma of the prostate|adenocarcinoma of the prostate
432999|NCT00003183|stage IV prostate cancer|stage iv prostate cancer
433000|NCT00003183|recurrent prostate cancer|recurrent prostate cancer
433001|NCT00003184|stage IV breast cancer|stage iv breast cancer
433002|NCT00003184|recurrent breast cancer|recurrent breast cancer
433003|NCT00003185|adult glioblastoma|adult glioblastoma
433004|NCT00003185|adult anaplastic astrocytoma|adult anaplastic astrocytoma
433005|NCT00003185|adult giant cell glioblastoma|adult giant cell glioblastoma
433006|NCT00003185|adult gliosarcoma|adult gliosarcoma
433007|NCT00003186|stage I colon cancer|stage i colon cancer
433008|NCT00003186|stage II colon cancer|stage ii colon cancer
433009|NCT00003186|stage III colon cancer|stage iii colon cancer
433010|NCT00003186|stage IV colon cancer|stage iv colon cancer
433011|NCT00003186|stage I rectal cancer|stage i rectal cancer
433012|NCT00003186|stage II rectal cancer|stage ii rectal cancer
433013|NCT00003186|stage III rectal cancer|stage iii rectal cancer
433014|NCT00003186|stage IV rectal cancer|stage iv rectal cancer
433015|NCT00003186|adenocarcinoma of the colon|adenocarcinoma of the colon
433016|NCT00003186|liver metastases|liver metastases
433017|NCT00003187|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
433018|NCT00003187|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
433019|NCT00003187|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
433020|NCT00003187|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
433021|NCT00003187|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
433022|NCT00003187|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
433023|NCT00003187|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
433024|NCT00003187|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
433025|NCT00003187|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
433026|NCT00003187|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
433027|NCT00003187|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
433028|NCT00003187|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
433029|NCT00003187|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
433030|NCT00003187|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
433031|NCT00003187|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
433032|NCT00003187|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
433033|NCT00003187|refractory anemia|refractory anemia
433034|NCT00003187|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
433035|NCT00003187|refractory anemia with excess blasts|refractory anemia with excess blasts
433096|NCT00003203|localized unresectable neuroblastoma|localized unresectable neuroblastoma
433036|NCT00003187|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
433037|NCT00003187|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
433038|NCT00003187|acute undifferentiated leukemia|acute undifferentiated leukemia
433039|NCT00003187|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
433040|NCT00003187|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
433041|NCT00003187|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
433042|NCT00003187|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
433043|NCT00003187|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
433044|NCT00003191|recurrent neuroblastoma|recurrent neuroblastoma
433045|NCT00003191|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
433046|NCT00003192|stage III gastric cancer|stage iii gastric cancer
433047|NCT00003192|stage IV gastric cancer|stage iv gastric cancer
433048|NCT00003192|recurrent gastric cancer|recurrent gastric cancer
433049|NCT00003192|stage III esophageal cancer|stage iii esophageal cancer
433050|NCT00003192|stage IV esophageal cancer|stage iv esophageal cancer
433051|NCT00003192|recurrent esophageal cancer|recurrent esophageal cancer
433052|NCT00003192|adenocarcinoma of the stomach|adenocarcinoma of the stomach
433053|NCT00003193|oral complications|oral complications
433054|NCT00003193|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
433055|NCT00003193|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
433056|NCT00003193|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
433057|NCT00003193|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
433058|NCT00003193|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
433059|NCT00003193|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
433060|NCT00003193|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
433061|NCT00003193|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
433062|NCT00003193|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
433063|NCT00003193|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
433064|NCT00003193|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
433065|NCT00003193|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
433066|NCT00003194|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
433067|NCT00003195|refractory multiple myeloma|refractory multiple myeloma
433068|NCT00003195|stage II multiple myeloma|stage ii multiple myeloma
433069|NCT00003195|stage III multiple myeloma|stage iii multiple myeloma
433070|NCT00003197|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
433071|NCT00003198|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
433072|NCT00003200|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
433073|NCT00003200|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
433074|NCT00003200|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
433075|NCT00003200|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
433076|NCT00003200|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
433077|NCT00003200|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
433078|NCT00003200|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
433079|NCT00003200|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
433080|NCT00003200|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
584788|NCT00509938|immunocompromized|immunocompromized
433081|NCT00003200|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
433082|NCT00003200|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
433083|NCT00003200|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
433084|NCT00003200|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
433085|NCT00003200|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
433086|NCT00003200|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
433087|NCT00003200|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
433088|NCT00003202|squamous cell lung cancer|squamous cell lung cancer
433089|NCT00003202|large cell lung cancer|large cell lung cancer
433090|NCT00003202|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
433091|NCT00003202|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
433092|NCT00003202|adenocarcinoma of the lung|adenocarcinoma of the lung
433093|NCT00003202|adenosquamous cell lung cancer|adenosquamous cell lung cancer
433094|NCT00003203|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
433095|NCT00003203|untreated childhood medulloblastoma|untreated childhood medulloblastoma
454712|NCT00026871|Fiberoptic|fiberoptic
544794|NCT00373542|RLS|rls
433099|NCT00003205|stage IV breast cancer|stage iv breast cancer
433100|NCT00003205|recurrent breast cancer|recurrent breast cancer
433101|NCT00003206|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
433102|NCT00003206|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
433103|NCT00003207|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
433104|NCT00003207|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
433105|NCT00003207|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
433106|NCT00003209|stage IB cervical cancer|stage ib cervical cancer
433107|NCT00003209|stage IIA cervical cancer|stage iia cervical cancer
433108|NCT00003209|cervical squamous cell carcinoma|cervical squamous cell carcinoma
433109|NCT00003209|cervical adenocarcinoma|cervical adenocarcinoma
433110|NCT00003209|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
433111|NCT00003211|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
433112|NCT00003211|untreated childhood medulloblastoma|untreated childhood medulloblastoma
433113|NCT00003212|adult angiosarcoma|adult angiosarcoma
433114|NCT00003212|adult fibrosarcoma|adult fibrosarcoma
433115|NCT00003212|adult leiomyosarcoma|adult leiomyosarcoma
433116|NCT00003212|adult liposarcoma|adult liposarcoma
433117|NCT00003212|adult neurofibrosarcoma|adult neurofibrosarcoma
433119|NCT00003212|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
433120|NCT00003212|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
433121|NCT00003212|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
433122|NCT00003212|adult rhabdomyosarcoma|adult rhabdomyosarcoma
433123|NCT00003212|stage IV uterine sarcoma|stage iv uterine sarcoma
433124|NCT00003212|recurrent uterine sarcoma|recurrent uterine sarcoma
433125|NCT00003212|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
433126|NCT00003213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
433127|NCT00003213|nausea and vomiting|nausea and vomiting
433128|NCT00003214|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
433129|NCT00003214|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
433130|NCT00003215|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
433131|NCT00003215|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
433132|NCT00003215|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
433133|NCT00003215|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
433134|NCT00003215|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
433135|NCT00003215|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
433136|NCT00003215|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
433137|NCT00003215|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
433138|NCT00003215|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
433139|NCT00003215|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
433140|NCT00003215|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
433141|NCT00003215|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
433142|NCT00003215|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
433143|NCT00003215|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
433144|NCT00003215|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
433145|NCT00003215|anaplastic large cell lymphoma|anaplastic large cell lymphoma
433146|NCT00003216|stage I pancreatic cancer|stage i pancreatic cancer
584789|NCT00509938|hLF1-11|hlf1-11
433147|NCT00003216|stage II pancreatic cancer|stage ii pancreatic cancer
433148|NCT00003216|stage III pancreatic cancer|stage iii pancreatic cancer
433149|NCT00003216|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
433150|NCT00003216|stage IV pancreatic cancer|stage iv pancreatic cancer
433151|NCT00003217|childhood Burkitt lymphoma|childhood burkitt lymphoma
433152|NCT00003217|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
433153|NCT00003217|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
433154|NCT00003217|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
433155|NCT00003217|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
433156|NCT00003219|stage IV breast cancer|stage iv breast cancer
433157|NCT00003219|recurrent breast cancer|recurrent breast cancer
433158|NCT00003220|stage IV colon cancer|stage iv colon cancer
433159|NCT00003220|stage IV rectal cancer|stage iv rectal cancer
433160|NCT00003220|recurrent colon cancer|recurrent colon cancer
433161|NCT00003220|recurrent rectal cancer|recurrent rectal cancer
433162|NCT00003220|adenocarcinoma of the colon|adenocarcinoma of the colon
433163|NCT00003220|adenocarcinoma of the rectum|adenocarcinoma of the rectum
433164|NCT00003222|stage III melanoma|stage iii melanoma
433165|NCT00003222|stage IV melanoma|stage iv melanoma
433166|NCT00003222|recurrent melanoma|recurrent melanoma
433167|NCT00003223|lip and oral cavity cancer|lip and oral cavity cancer
433168|NCT00003224|stage II melanoma|stage ii melanoma
433169|NCT00003224|stage III melanoma|stage iii melanoma
433170|NCT00003224|stage IV melanoma|stage iv melanoma
433171|NCT00003224|recurrent melanoma|recurrent melanoma
433172|NCT00003225|stage IV colon cancer|stage iv colon cancer
433173|NCT00003225|stage IV rectal cancer|stage iv rectal cancer
433174|NCT00003225|recurrent colon cancer|recurrent colon cancer
433175|NCT00003225|recurrent rectal cancer|recurrent rectal cancer
433176|NCT00003229|stage IV melanoma|stage iv melanoma
433177|NCT00003229|recurrent melanoma|recurrent melanoma
433178|NCT00003230|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
433179|NCT00003230|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
433180|NCT00003230|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
433181|NCT00003230|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
433182|NCT00003230|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
433183|NCT00003231|squamous cell lung cancer|squamous cell lung cancer
433184|NCT00003231|large cell lung cancer|large cell lung cancer
433185|NCT00003231|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
433186|NCT00003231|adenocarcinoma of the lung|adenocarcinoma of the lung
433187|NCT00003232|adenocarcinoma of the prostate|adenocarcinoma of the prostate
433188|NCT00003232|recurrent prostate cancer|recurrent prostate cancer
433190|NCT00003232|quality of life|quality of life
433191|NCT00003234|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
433192|NCT00003234|recurrent neuroblastoma|recurrent neuroblastoma
433193|NCT00003234|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
433194|NCT00003234|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
433195|NCT00003234|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
433196|NCT00003234|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
433197|NCT00003234|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
433198|NCT00003234|recurrent childhood ependymoma|recurrent childhood ependymoma
433199|NCT00003235|squamous cell lung cancer|squamous cell lung cancer
433200|NCT00003235|large cell lung cancer|large cell lung cancer
433201|NCT00003235|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
433202|NCT00003235|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
433203|NCT00003235|adenocarcinoma of the lung|adenocarcinoma of the lung
433204|NCT00003236|recurrent breast cancer|recurrent breast cancer
433205|NCT00003237|stage II gastric cancer|stage ii gastric cancer
433206|NCT00003237|stage III gastric cancer|stage iii gastric cancer
433207|NCT00003237|stage II esophageal cancer|stage ii esophageal cancer
433208|NCT00003237|stage III esophageal cancer|stage iii esophageal cancer
433209|NCT00003237|adenocarcinoma of the stomach|adenocarcinoma of the stomach
433210|NCT00003237|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
433211|NCT00003238|recurrent prostate cancer|recurrent prostate cancer
433212|NCT00003239|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
433213|NCT00003239|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
433214|NCT00003239|Homoharringtonine|homoharringtonine
433216|NCT00003239|cephalotaxus alkaloid|cephalotaxus alkaloid
433217|NCT00003239|cytarabine|cytarabine
433218|NCT00003239|Interferon Alpha 2-A|interferon alpha 2-a
433219|NCT00003239|Roferon-A|roferon-a
433220|NCT00003239|Ara-C|ara-c
433221|NCT00003239|DepotCyt|depotcyt
433222|NCT00003239|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
433223|NCT00003240|stage I non-small cell lung cancer|stage i non-small cell lung cancer
584790|NCT00509938|antimicrobial|antimicrobial
433224|NCT00003240|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
433225|NCT00003240|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
433226|NCT00003240|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
433227|NCT00003240|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
433228|NCT00003241|recurrent childhood brain tumor|recurrent childhood brain tumor
433229|NCT00003241|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
433230|NCT00003241|untreated childhood brain stem glioma|untreated childhood brain stem glioma
433231|NCT00003241|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
433232|NCT00003241|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
433233|NCT00003241|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
433234|NCT00003241|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
433235|NCT00003241|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
433236|NCT00003241|recurrent childhood ependymoma|recurrent childhood ependymoma
433237|NCT00003242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
433238|NCT00003243|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
201009|NCT02112643|Graves' orbitopathy|graves' orbitopathy
433239|NCT00003243|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
433240|NCT00003243|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
433241|NCT00003243|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
433242|NCT00003243|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
433243|NCT00003243|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
433244|NCT00003243|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
433245|NCT00003243|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
433246|NCT00003243|acute undifferentiated leukemia|acute undifferentiated leukemia
433247|NCT00003243|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
433248|NCT00003243|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
433249|NCT00003243|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
433250|NCT00003243|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
433251|NCT00003243|secondary acute myeloid leukemia|secondary acute myeloid leukemia
433252|NCT00003243|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
433253|NCT00003243|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
433254|NCT00003243|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
433255|NCT00003243|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
433256|NCT00003243|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
433257|NCT00003243|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
433258|NCT00003243|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
433259|NCT00003245|Waldenström macroglobulinemia|waldenström macroglobulinemia
433260|NCT00003245|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
433261|NCT00003245|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
433262|NCT00003245|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
433263|NCT00003245|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
433264|NCT00003245|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
433265|NCT00003245|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
433266|NCT00003245|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
433267|NCT00003245|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
433268|NCT00003245|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
433269|NCT00003245|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
433270|NCT00003245|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
433271|NCT00003245|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
433272|NCT00003245|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
433273|NCT00003245|splenic marginal zone lymphoma|splenic marginal zone lymphoma
433274|NCT00003248|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
433275|NCT00003248|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
433276|NCT00003248|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
433277|NCT00003248|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
433278|NCT00003248|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
433279|NCT00003249|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
433280|NCT00003250|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
433281|NCT00003251|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
433282|NCT00003251|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
433283|NCT00003251|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
433284|NCT00003251|stage III salivary gland cancer|stage iii salivary gland cancer
433285|NCT00003251|stage IV salivary gland cancer|stage iv salivary gland cancer
433286|NCT00003251|recurrent salivary gland cancer|recurrent salivary gland cancer
433287|NCT00003251|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
433288|NCT00003251|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
433289|NCT00003251|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
433290|NCT00003251|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
433291|NCT00003251|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
433292|NCT00003251|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
433293|NCT00003251|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
433294|NCT00003251|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
433295|NCT00003251|stage III laryngeal cancer|stage iii laryngeal cancer
433296|NCT00003251|stage IV laryngeal cancer|stage iv laryngeal cancer
433297|NCT00003251|recurrent laryngeal cancer|recurrent laryngeal cancer
433298|NCT00003251|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
433299|NCT00003251|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
752441|NCT01173003|mifepristone|mifepristone
432714|NCT00003019|desmoid tumor|desmoid tumor
433300|NCT00003251|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
433301|NCT00003251|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
433302|NCT00003251|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
433303|NCT00003251|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
433304|NCT00003251|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
433305|NCT00003251|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
433306|NCT00003251|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
434217|NCT00003351|stage IV breast cancer|stage iv breast cancer
10480|NCT03223974|drug-coated balloon|drug-coated balloon
433307|NCT00003251|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
433308|NCT00003251|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
433309|NCT00003251|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
433310|NCT00003251|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
433311|NCT00003251|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
433312|NCT00003251|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
433313|NCT00003251|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
433314|NCT00003251|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
433315|NCT00003251|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
433316|NCT00003251|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
433317|NCT00003251|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
433442|NCT00003269|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
433318|NCT00003251|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
433319|NCT00003251|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
433320|NCT00003251|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
433321|NCT00003251|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
433322|NCT00003251|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
433323|NCT00003251|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
433324|NCT00003251|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
433325|NCT00003251|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
433326|NCT00003251|radiation toxicity|radiation toxicity
433327|NCT00003252|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
433328|NCT00003252|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
433329|NCT00003253|stage IV breast cancer|stage iv breast cancer
433330|NCT00003253|recurrent breast cancer|recurrent breast cancer
433331|NCT00003253|male breast cancer|male breast cancer
433332|NCT00003254|stage IV colon cancer|stage iv colon cancer
433333|NCT00003254|stage IV rectal cancer|stage iv rectal cancer
433334|NCT00003254|recurrent colon cancer|recurrent colon cancer
433335|NCT00003254|recurrent rectal cancer|recurrent rectal cancer
433336|NCT00003255|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
433337|NCT00003255|secondary acute myeloid leukemia|secondary acute myeloid leukemia
433338|NCT00003256|adenocarcinoma of the prostate|adenocarcinoma of the prostate
433339|NCT00003256|stage IV prostate cancer|stage iv prostate cancer
433340|NCT00003257|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
433341|NCT00003257|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
433342|NCT00003257|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
433343|NCT00003257|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
433344|NCT00003257|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
584791|NCT00509938|peptide|peptide
433345|NCT00003257|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
433346|NCT00003257|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
433347|NCT00003259|stage IV prostate cancer|stage iv prostate cancer
433348|NCT00003260|stage IV colon cancer|stage iv colon cancer
433349|NCT00003260|stage IV rectal cancer|stage iv rectal cancer
433350|NCT00003260|recurrent colon cancer|recurrent colon cancer
433351|NCT00003260|recurrent rectal cancer|recurrent rectal cancer
433352|NCT00003260|adenocarcinoma of the colon|adenocarcinoma of the colon
433353|NCT00003260|adenocarcinoma of the rectum|adenocarcinoma of the rectum
433354|NCT00003261|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
433355|NCT00003262|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
433356|NCT00003262|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
201010|NCT02112643|Graves' ophthalmopathy|graves' ophthalmopathy
433357|NCT00003262|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
433358|NCT00003262|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
433359|NCT00003262|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
433360|NCT00003262|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
433361|NCT00003263|localized malignant mesothelioma|localized malignant mesothelioma
433362|NCT00003264|stage IV salivary gland cancer|stage iv salivary gland cancer
433363|NCT00003264|recurrent salivary gland cancer|recurrent salivary gland cancer
433364|NCT00003264|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
433365|NCT00003264|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
433366|NCT00003264|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
433367|NCT00003264|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
10481|NCT03223974|bifurcation|bifurcation
433432|NCT00003269|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
433368|NCT00003264|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
433369|NCT00003264|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
433370|NCT00003264|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
433371|NCT00003264|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
433372|NCT00003264|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
433373|NCT00003264|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
433374|NCT00003264|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
433375|NCT00003264|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
433376|NCT00003264|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
433443|NCT00003269|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
433377|NCT00003264|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
433378|NCT00003264|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
433379|NCT00003266|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
433381|NCT00003267|stage I cervical cancer|stage i cervical cancer
433382|NCT00003267|stage II cervical cancer|stage ii cervical cancer
433383|NCT00003267|stage I vaginal cancer|stage i vaginal cancer
433384|NCT00003267|stage II vaginal cancer|stage ii vaginal cancer
433385|NCT00003267|stage I endometrial carcinoma|stage i endometrial carcinoma
433386|NCT00003267|stage II endometrial carcinoma|stage ii endometrial carcinoma
433387|NCT00003267|infection|infection
433388|NCT00003267|perioperative/postoperative complications|perioperative/postoperative complications
433389|NCT00003268|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
433390|NCT00003268|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
433391|NCT00003268|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
433392|NCT00003268|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
433393|NCT00003268|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
433394|NCT00003268|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
433395|NCT00003268|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
433396|NCT00003268|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
433397|NCT00003268|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
433398|NCT00003269|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
433399|NCT00003269|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
433400|NCT00003269|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
433401|NCT00003269|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
433402|NCT00003269|stage I breast cancer|stage i breast cancer
433403|NCT00003269|stage II breast cancer|stage ii breast cancer
433404|NCT00003269|stage IV breast cancer|stage iv breast cancer
433405|NCT00003269|stage IIIA breast cancer|stage iiia breast cancer
433406|NCT00003269|stage I non-small cell lung cancer|stage i non-small cell lung cancer
433407|NCT00003269|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
433408|NCT00003269|stage IIIB breast cancer|stage iiib breast cancer
433409|NCT00003269|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
433410|NCT00003269|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
433411|NCT00003269|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
433412|NCT00003269|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
433413|NCT00003269|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
433414|NCT00003269|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
433415|NCT00003269|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
752442|NCT01173003|misoprostol|misoprostol
433416|NCT00003269|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
433417|NCT00003269|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
433418|NCT00003269|limited stage small cell lung cancer|limited stage small cell lung cancer
433419|NCT00003269|extensive stage small cell lung cancer|extensive stage small cell lung cancer
433420|NCT00003269|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
433421|NCT00003269|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
433422|NCT00003269|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
433423|NCT00003269|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
433424|NCT00003269|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
433425|NCT00003269|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
433426|NCT00003269|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
433427|NCT00003269|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
433428|NCT00003269|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
433429|NCT00003269|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
10482|NCT03223961|myelodysplastic syndrome|myelodysplastic syndrome
433430|NCT00003269|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
433431|NCT00003269|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
454713|NCT00026884|Serum|serum
433433|NCT00003269|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
433434|NCT00003269|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
433435|NCT00003269|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
433436|NCT00003269|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
433437|NCT00003269|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
433438|NCT00003269|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
433439|NCT00003269|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
433440|NCT00003269|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
433441|NCT00003269|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
434156|NCT00003341|anemia|anemia
433444|NCT00003269|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
433445|NCT00003269|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
433446|NCT00003269|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
433447|NCT00003269|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
433448|NCT00003269|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
435942|NCT00004232|Burkitt lymphoma|burkitt lymphoma
433449|NCT00003269|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
433450|NCT00003269|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
433451|NCT00003269|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
433452|NCT00003269|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
433453|NCT00003269|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
433454|NCT00003269|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
433455|NCT00003269|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
433456|NCT00003269|stage I mantle cell lymphoma|stage i mantle cell lymphoma
433457|NCT00003269|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
433458|NCT00003269|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
433459|NCT00003269|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
433460|NCT00003269|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
433461|NCT00003269|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
433462|NCT00003269|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
433463|NCT00003269|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
433464|NCT00003269|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
433465|NCT00003269|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
433466|NCT00003269|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
584792|NCT00509938|lactoferrin|lactoferrin
433467|NCT00003269|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
433468|NCT00003269|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
433469|NCT00003269|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
433470|NCT00003269|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
433471|NCT00003269|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
433472|NCT00003269|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
433473|NCT00003269|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
433474|NCT00003269|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
433475|NCT00003269|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
433476|NCT00003269|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
433477|NCT00003269|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
433478|NCT00003269|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
433479|NCT00003269|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
433480|NCT00003269|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
433481|NCT00003269|stage I marginal zone lymphoma|stage i marginal zone lymphoma
433482|NCT00003269|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
433483|NCT00003269|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
433484|NCT00003269|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
433485|NCT00003269|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
433486|NCT00003269|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
433487|NCT00003269|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
433488|NCT00003269|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
10483|NCT03223961|erythropoetin|erythropoetin
433489|NCT00003269|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
433490|NCT00003269|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
433491|NCT00003269|splenic marginal zone lymphoma|splenic marginal zone lymphoma
434218|NCT00003352|stage IV breast cancer|stage iv breast cancer
433492|NCT00003270|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
433493|NCT00003270|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
433494|NCT00003270|Burkitt lymphoma|burkitt lymphoma
433495|NCT00003270|refractory multiple myeloma|refractory multiple myeloma
433496|NCT00003270|stage I multiple myeloma|stage i multiple myeloma
433497|NCT00003270|stage II multiple myeloma|stage ii multiple myeloma
433498|NCT00003270|stage III multiple myeloma|stage iii multiple myeloma
433499|NCT00003270|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
433500|NCT00003270|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
433501|NCT00003270|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
433502|NCT00003270|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
433503|NCT00003270|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
433504|NCT00003270|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
433505|NCT00003270|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
433506|NCT00003270|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
433507|NCT00003270|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
433508|NCT00003270|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
433509|NCT00003270|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
433510|NCT00003270|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
433511|NCT00003270|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
433512|NCT00003270|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
433513|NCT00003270|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
433514|NCT00003270|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
433515|NCT00003270|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
433516|NCT00003270|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
433517|NCT00003270|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
433518|NCT00003270|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
433519|NCT00003270|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
433520|NCT00003270|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
433521|NCT00003270|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
433522|NCT00003270|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
433523|NCT00003270|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
433524|NCT00003270|secondary acute myeloid leukemia|secondary acute myeloid leukemia
433525|NCT00003270|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
433526|NCT00003270|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
433527|NCT00003270|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
433528|NCT00003270|graft versus host disease|graft versus host disease
433529|NCT00003270|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
433530|NCT00003270|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
433531|NCT00003270|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
433532|NCT00003270|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
433533|NCT00003270|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
752443|NCT01173003|Tunisia|tunisia
433534|NCT00003270|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
433535|NCT00003270|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
433536|NCT00003270|splenic marginal zone lymphoma|splenic marginal zone lymphoma
433537|NCT00003270|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
433538|NCT00003273|childhood infratentorial ependymoma|childhood infratentorial ependymoma
433539|NCT00003273|childhood supratentorial ependymoma|childhood supratentorial ependymoma
433540|NCT00003273|localized resectable neuroblastoma|localized resectable neuroblastoma
433541|NCT00003273|regional neuroblastoma|regional neuroblastoma
433542|NCT00003273|disseminated neuroblastoma|disseminated neuroblastoma
433543|NCT00003273|stage 4S neuroblastoma|stage 4s neuroblastoma
433544|NCT00003273|extraocular retinoblastoma|extraocular retinoblastoma
433545|NCT00003273|childhood choroid plexus tumor|childhood choroid plexus tumor
433546|NCT00003273|localized unresectable neuroblastoma|localized unresectable neuroblastoma
433547|NCT00003273|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
433548|NCT00003273|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
433549|NCT00003273|untreated childhood medulloblastoma|untreated childhood medulloblastoma
433550|NCT00003273|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
433551|NCT00003274|stage II melanoma|stage ii melanoma
433552|NCT00003276|unresectable gallbladder cancer|unresectable gallbladder cancer
433553|NCT00003276|recurrent gallbladder cancer|recurrent gallbladder cancer
433554|NCT00003278|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
433555|NCT00003278|intraocular lymphoma|intraocular lymphoma
433556|NCT00003279|limited stage small cell lung cancer|limited stage small cell lung cancer
433557|NCT00003280|stage I mantle cell lymphoma|stage i mantle cell lymphoma
433558|NCT00003280|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
433559|NCT00003280|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
433560|NCT00003280|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
433561|NCT00003280|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
433562|NCT00003280|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
433563|NCT00003281|recurrent small cell lung cancer|recurrent small cell lung cancer
433564|NCT00003283|invasive thymoma and thymic carcinoma|invasive thymoma and thymic carcinoma
433565|NCT00003283|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
433566|NCT00003284|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
433567|NCT00003284|limited stage small cell lung cancer|limited stage small cell lung cancer
450385|NCT00016666|Light|light
433568|NCT00003284|extensive stage small cell lung cancer|extensive stage small cell lung cancer
433569|NCT00003284|recurrent small cell lung cancer|recurrent small cell lung cancer
433570|NCT00003284|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
433571|NCT00003284|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
433572|NCT00003284|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
433573|NCT00003287|stage IV colon cancer|stage iv colon cancer
433574|NCT00003287|stage IV rectal cancer|stage iv rectal cancer
433575|NCT00003287|recurrent colon cancer|recurrent colon cancer
433576|NCT00003287|recurrent rectal cancer|recurrent rectal cancer
433577|NCT00003287|adenocarcinoma of the colon|adenocarcinoma of the colon
433578|NCT00003287|adenocarcinoma of the rectum|adenocarcinoma of the rectum
433579|NCT00003288|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
433580|NCT00003289|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
433581|NCT00003289|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
433582|NCT00003289|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
433583|NCT00003289|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
433584|NCT00003289|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
433585|NCT00003289|refractory hairy cell leukemia|refractory hairy cell leukemia
433586|NCT00003289|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
433587|NCT00003289|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
433588|NCT00003289|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
433589|NCT00003289|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
433590|NCT00003289|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
433591|NCT00003289|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
433592|NCT00003289|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
433593|NCT00003289|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
433594|NCT00003289|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
433595|NCT00003289|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
433596|NCT00003289|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
433597|NCT00003289|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
433598|NCT00003289|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
752848|NCT01174472|Dialysis access|dialysis access
433599|NCT00003289|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
433600|NCT00003289|prolymphocytic leukemia|prolymphocytic leukemia
433601|NCT00003289|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
433602|NCT00003289|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
433603|NCT00003289|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
433604|NCT00003289|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
433605|NCT00003289|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
433606|NCT00003289|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
433607|NCT00003289|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
433608|NCT00003289|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
433609|NCT00003289|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
433610|NCT00003289|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
433611|NCT00003289|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
433612|NCT00003289|splenic marginal zone lymphoma|splenic marginal zone lymphoma
433613|NCT00003290|stage IIB prostate cancer|stage iib prostate cancer
433614|NCT00003290|stage IIA prostate cancer|stage iia prostate cancer
433615|NCT00003290|stage III prostate cancer|stage iii prostate cancer
433616|NCT00003291|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
433617|NCT00003293|recurrent adult brain tumor|recurrent adult brain tumor
433618|NCT00003293|adult glioblastoma|adult glioblastoma
433619|NCT00003293|adult giant cell glioblastoma|adult giant cell glioblastoma
433620|NCT00003293|adult gliosarcoma|adult gliosarcoma
433621|NCT00003294|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
433622|NCT00003294|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
433623|NCT00003294|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
433624|NCT00003294|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
433625|NCT00003294|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
434219|NCT00003352|recurrent breast cancer|recurrent breast cancer
433626|NCT00003294|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
433627|NCT00003294|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
433628|NCT00003294|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
433629|NCT00003294|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
433630|NCT00003294|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
433631|NCT00003294|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
433632|NCT00003294|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
433633|NCT00003294|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
450386|NCT00016666|Propranolol|propranolol
433634|NCT00003294|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
433635|NCT00003294|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
433636|NCT00003294|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
433637|NCT00003294|untreated hairy cell leukemia|untreated hairy cell leukemia
433638|NCT00003294|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
433639|NCT00003294|refractory hairy cell leukemia|refractory hairy cell leukemia
433640|NCT00003294|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
433641|NCT00003294|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
433642|NCT00003294|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
433643|NCT00003294|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
433644|NCT00003294|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
433645|NCT00003294|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
433646|NCT00003294|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
433647|NCT00003294|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
433648|NCT00003294|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
433649|NCT00003294|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
433650|NCT00003294|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
433651|NCT00003294|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
433652|NCT00003294|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
433653|NCT00003294|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
433654|NCT00003294|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
433655|NCT00003294|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
433656|NCT00003294|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
433657|NCT00003294|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
433658|NCT00003294|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
433659|NCT00003294|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
433660|NCT00003294|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
433661|NCT00003294|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
433662|NCT00003294|prolymphocytic leukemia|prolymphocytic leukemia
433663|NCT00003294|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
433664|NCT00003294|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
433665|NCT00003294|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
433666|NCT00003294|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
433667|NCT00003294|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
433668|NCT00003294|anaplastic large cell lymphoma|anaplastic large cell lymphoma
433669|NCT00003294|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
433670|NCT00003294|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
433671|NCT00003294|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
433672|NCT00003294|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
433673|NCT00003294|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
433674|NCT00003294|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
433675|NCT00003294|splenic marginal zone lymphoma|splenic marginal zone lymphoma
433676|NCT00003296|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
433677|NCT00003296|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
433678|NCT00003296|advanced adult primary liver cancer|advanced adult primary liver cancer
433679|NCT00003296|recurrent adult primary liver cancer|recurrent adult primary liver cancer
433680|NCT00003296|localized gallbladder cancer|localized gallbladder cancer
433681|NCT00003296|unresectable gallbladder cancer|unresectable gallbladder cancer
433682|NCT00003296|recurrent gallbladder cancer|recurrent gallbladder cancer
433683|NCT00003296|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
433684|NCT00003296|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
433685|NCT00003296|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
433686|NCT00003296|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
433687|NCT00003296|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
433688|NCT00003296|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
433689|NCT00003296|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
455153|NCT00010985|Acupuncture|acupuncture
433690|NCT00003297|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
433691|NCT00003297|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
433692|NCT00003297|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
433693|NCT00003298|stage II gastric cancer|stage ii gastric cancer
433694|NCT00003298|stage III gastric cancer|stage iii gastric cancer
433695|NCT00003298|stage IV gastric cancer|stage iv gastric cancer
433696|NCT00003298|adenocarcinoma of the stomach|adenocarcinoma of the stomach
433697|NCT00003299|extensive stage small cell lung cancer|extensive stage small cell lung cancer
433698|NCT00003301|recurrent adult brain tumor|recurrent adult brain tumor
433699|NCT00003301|adult glioblastoma|adult glioblastoma
433700|NCT00003301|adult anaplastic astrocytoma|adult anaplastic astrocytoma
433701|NCT00003301|adult giant cell glioblastoma|adult giant cell glioblastoma
433702|NCT00003301|adult gliosarcoma|adult gliosarcoma
433703|NCT00003302|breast cancer|breast cancer
433704|NCT00003304|adult oligodendroglioma|adult oligodendroglioma
433705|NCT00003305|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
433706|NCT00003305|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
433707|NCT00003305|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
433708|NCT00003305|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
433709|NCT00003307|adenocarcinoma of the prostate|adenocarcinoma of the prostate
433710|NCT00003307|stage I prostate cancer|stage i prostate cancer
433711|NCT00003307|stage II prostate cancer|stage ii prostate cancer
433712|NCT00003307|stage III prostate cancer|stage iii prostate cancer
433713|NCT00003307|radiation toxicity|radiation toxicity
433714|NCT00003308|metastatic osteosarcoma|metastatic osteosarcoma
433715|NCT00003308|chondrosarcoma|chondrosarcoma
433716|NCT00003308|stage IV renal cell cancer|stage iv renal cell cancer
433717|NCT00003308|stage IV melanoma|stage iv melanoma
433718|NCT00003308|tumors metastatic to brain|tumors metastatic to brain
433719|NCT00003308|stage IV uterine sarcoma|stage iv uterine sarcoma
433720|NCT00003308|ovarian sarcoma|ovarian sarcoma
433721|NCT00003308|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
433722|NCT00003308|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
433723|NCT00003309|adult medulloblastoma|adult medulloblastoma
433724|NCT00003309|adult anaplastic ependymoma|adult anaplastic ependymoma
433725|NCT00003309|adult ependymoma|adult ependymoma
433726|NCT00003309|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
433727|NCT00003311|stage I mantle cell lymphoma|stage i mantle cell lymphoma
433728|NCT00003311|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
433729|NCT00003311|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
433730|NCT00003311|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
433731|NCT00003311|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
752849|NCT01174472|angioplasty|angioplasty
433732|NCT00003312|stage I prostate cancer|stage i prostate cancer
433733|NCT00003312|stage IIB prostate cancer|stage iib prostate cancer
433734|NCT00003312|stage IIA prostate cancer|stage iia prostate cancer
433735|NCT00003313|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
433736|NCT00003313|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
433737|NCT00003313|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
433738|NCT00003313|oral complications|oral complications
433739|NCT00003313|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
433740|NCT00003313|radiation toxicity|radiation toxicity
433741|NCT00003315|infection|infection
433742|NCT00003316|recurrent uterine sarcoma|recurrent uterine sarcoma
433743|NCT00003316|uterine leiomyosarcoma|uterine leiomyosarcoma
433744|NCT00003317|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
433745|NCT00003320|tumors metastatic to brain|tumors metastatic to brain
433746|NCT00003321|stage I esophageal cancer|stage i esophageal cancer
433747|NCT00003321|stage II esophageal cancer|stage ii esophageal cancer
433748|NCT00003321|stage III esophageal cancer|stage iii esophageal cancer
433749|NCT00003321|stage IV esophageal cancer|stage iv esophageal cancer
433750|NCT00003321|recurrent esophageal cancer|recurrent esophageal cancer
433751|NCT00003322|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
433752|NCT00003322|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
433753|NCT00003322|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
433754|NCT00003322|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
433755|NCT00003322|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
433756|NCT00003322|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
433757|NCT00003322|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
433758|NCT00003322|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
433759|NCT00003322|primary peritoneal cavity cancer|primary peritoneal cavity cancer
433760|NCT00003322|Brenner tumor|brenner tumor
433761|NCT00003323|adenocarcinoma of the prostate|adenocarcinoma of the prostate
433762|NCT00003323|recurrent prostate cancer|recurrent prostate cancer
433763|NCT00003323|sexual dysfunction and infertility|sexual dysfunction and infertility
433764|NCT00003324|tumors metastatic to brain|tumors metastatic to brain
433765|NCT00003325|stage I vulvar cancer|stage i vulvar cancer
433766|NCT00003325|stage II vulvar cancer|stage ii vulvar cancer
433767|NCT00003325|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
433768|NCT00003326|stage IV esophageal cancer|stage iv esophageal cancer
433769|NCT00003326|recurrent esophageal cancer|recurrent esophageal cancer
433770|NCT00003326|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
433771|NCT00003326|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
433772|NCT00003327|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
433773|NCT00003327|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
433774|NCT00003327|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
450387|NCT00016666|Photoperiod|photoperiod
433775|NCT00003327|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
433776|NCT00003327|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
433777|NCT00003327|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
433778|NCT00003327|stage IV laryngeal cancer|stage iv laryngeal cancer
433779|NCT00003327|recurrent laryngeal cancer|recurrent laryngeal cancer
433780|NCT00003327|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
433781|NCT00003327|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
433782|NCT00003327|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
433783|NCT00003327|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
433784|NCT00003328|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
433785|NCT00003328|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
433786|NCT00003328|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
433787|NCT00003328|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
433788|NCT00003328|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
433789|NCT00003328|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
433790|NCT00003328|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
433791|NCT00003328|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
433792|NCT00003329|stage I colon cancer|stage i colon cancer
433793|NCT00003329|stage II colon cancer|stage ii colon cancer
433794|NCT00003329|stage III colon cancer|stage iii colon cancer
433795|NCT00003329|stage IV colon cancer|stage iv colon cancer
433796|NCT00003329|stage I breast cancer|stage i breast cancer
433797|NCT00003329|stage II breast cancer|stage ii breast cancer
433798|NCT00003329|stage IIIA breast cancer|stage iiia breast cancer
433799|NCT00003329|stage IIIB breast cancer|stage iiib breast cancer
433800|NCT00003329|stage IIIC breast cancer|stage iiic breast cancer
433801|NCT00003329|stage IV breast cancer|stage iv breast cancer
433802|NCT00003329|stage I non-small cell lung cancer|stage i non-small cell lung cancer
433803|NCT00003329|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
433804|NCT00003329|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
433805|NCT00003329|limited stage small cell lung cancer|limited stage small cell lung cancer
433806|NCT00003329|extensive stage small cell lung cancer|extensive stage small cell lung cancer
433807|NCT00003329|stage I prostate cancer|stage i prostate cancer
433808|NCT00003329|stage II prostate cancer|stage ii prostate cancer
433809|NCT00003329|stage III prostate cancer|stage iii prostate cancer
433810|NCT00003329|stage IV prostate cancer|stage iv prostate cancer
433811|NCT00003329|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
433812|NCT00003330|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
433813|NCT00003331|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
433814|NCT00003331|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
433815|NCT00003331|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
433816|NCT00003331|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
433817|NCT00003331|isolated plasmacytoma of bone|isolated plasmacytoma of bone
433818|NCT00003331|extramedullary plasmacytoma|extramedullary plasmacytoma
433819|NCT00003331|refractory multiple myeloma|refractory multiple myeloma
433820|NCT00003331|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
433821|NCT00003331|stage III multiple myeloma|stage iii multiple myeloma
433822|NCT00003331|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
433823|NCT00003331|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
433824|NCT00003331|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
433825|NCT00003331|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
433826|NCT00003331|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
433827|NCT00003331|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
433828|NCT00003331|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
433829|NCT00003331|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
433830|NCT00003331|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
753532|NCT01173705|Inflammation|inflammation
433831|NCT00003331|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
433832|NCT00003331|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
433833|NCT00003331|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
433834|NCT00003331|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
457151|NCT00022958|Corixa|corixa
433835|NCT00003331|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
433836|NCT00003331|polycythemia vera|polycythemia vera
433838|NCT00003331|essential thrombocythemia|essential thrombocythemia
433839|NCT00003331|untreated hairy cell leukemia|untreated hairy cell leukemia
433840|NCT00003331|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
433841|NCT00003331|refractory hairy cell leukemia|refractory hairy cell leukemia
433842|NCT00003331|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
433843|NCT00003331|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
433844|NCT00003331|acute undifferentiated leukemia|acute undifferentiated leukemia
433845|NCT00003331|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
433846|NCT00003331|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
433847|NCT00003331|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
433848|NCT00003331|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
433849|NCT00003331|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
433850|NCT00003331|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
433851|NCT00003331|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
433852|NCT00003331|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
433853|NCT00003331|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
433854|NCT00003331|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
433855|NCT00003331|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
433856|NCT00003331|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
433857|NCT00003331|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
433858|NCT00003331|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
433859|NCT00003331|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
433860|NCT00003331|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
433861|NCT00003331|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
433862|NCT00003331|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
433863|NCT00003331|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
433864|NCT00003331|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
433865|NCT00003331|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
433866|NCT00003331|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
433867|NCT00003331|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
433868|NCT00003331|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
433869|NCT00003331|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
433870|NCT00003331|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
433871|NCT00003331|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
433872|NCT00003331|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
433873|NCT00003331|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
433874|NCT00003331|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
433875|NCT00003331|secondary acute myeloid leukemia|secondary acute myeloid leukemia
433876|NCT00003331|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
433877|NCT00003331|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
433878|NCT00003331|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
433879|NCT00003331|prolymphocytic leukemia|prolymphocytic leukemia
433880|NCT00003331|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
433881|NCT00003331|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
433882|NCT00003331|primary systemic amyloidosis|primary systemic amyloidosis
433883|NCT00003331|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
433884|NCT00003331|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
433885|NCT00003331|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
433886|NCT00003331|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
433887|NCT00003331|anaplastic large cell lymphoma|anaplastic large cell lymphoma
433888|NCT00003331|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
433889|NCT00003331|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
433890|NCT00003331|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
433891|NCT00003331|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
433892|NCT00003331|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
433893|NCT00003331|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
433894|NCT00003331|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
433895|NCT00003331|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
433896|NCT00003331|splenic marginal zone lymphoma|splenic marginal zone lymphoma
433897|NCT00003332|stage I pancreatic cancer|stage i pancreatic cancer
433898|NCT00003332|stage II pancreatic cancer|stage ii pancreatic cancer
433899|NCT00003332|stage III pancreatic cancer|stage iii pancreatic cancer
433900|NCT00003332|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
433901|NCT00003334|stage IV endometrial carcinoma|stage iv endometrial carcinoma
434220|NCT00003352|stage IIIB breast cancer|stage iiib breast cancer
433902|NCT00003334|recurrent endometrial carcinoma|recurrent endometrial carcinoma
433903|NCT00003334|fallopian tube cancer|fallopian tube cancer
433904|NCT00003334|stage IV uterine sarcoma|stage iv uterine sarcoma
433905|NCT00003334|recurrent uterine sarcoma|recurrent uterine sarcoma
433906|NCT00003334|uterine carcinosarcoma|uterine carcinosarcoma
433907|NCT00003334|uterine leiomyosarcoma|uterine leiomyosarcoma
433908|NCT00003334|endometrial stromal sarcoma|endometrial stromal sarcoma
433909|NCT00003334|ovarian sarcoma|ovarian sarcoma
433910|NCT00003334|ovarian carcinosarcoma|ovarian carcinosarcoma
433911|NCT00003335|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
433912|NCT00003335|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
433913|NCT00003335|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
433914|NCT00003335|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
433915|NCT00003335|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
433916|NCT00003335|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
433917|NCT00003335|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
433918|NCT00003335|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
433919|NCT00003335|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
433920|NCT00003335|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
433921|NCT00003335|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
433922|NCT00003335|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
433923|NCT00003335|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
433924|NCT00003335|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
433925|NCT00003335|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
433926|NCT00003335|refractory anemia with excess blasts|refractory anemia with excess blasts
433927|NCT00003335|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
433928|NCT00003335|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
433929|NCT00003335|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
433930|NCT00003335|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
433931|NCT00003335|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
433932|NCT00003335|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
433933|NCT00003335|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
433934|NCT00003335|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
433935|NCT00003335|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
433936|NCT00003335|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
433937|NCT00003335|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
433938|NCT00003335|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
433939|NCT00003335|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
433940|NCT00003335|graft versus host disease|graft versus host disease
433941|NCT00003335|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
433942|NCT00003335|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
433943|NCT00003335|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
433944|NCT00003335|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
433945|NCT00003335|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
433946|NCT00003335|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
433947|NCT00003335|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
433948|NCT00003335|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
433949|NCT00003335|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
433950|NCT00003335|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
433951|NCT00003335|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
433952|NCT00003335|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
433953|NCT00003335|splenic marginal zone lymphoma|splenic marginal zone lymphoma
433954|NCT00003335|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
433955|NCT00003335|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
433956|NCT00003335|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
433957|NCT00003335|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
433958|NCT00003335|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
433959|NCT00003335|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
433961|NCT00003336|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
433962|NCT00003336|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
433963|NCT00003336|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
433964|NCT00003336|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
434430|NCT00003387|large cell lung cancer|large cell lung cancer
433965|NCT00003336|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
433966|NCT00003336|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
433967|NCT00003336|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
433968|NCT00003337|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
433969|NCT00003337|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
433970|NCT00003337|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
434227|NCT00003354|stage 0 rectal cancer|stage 0 rectal cancer
433971|NCT00003337|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
433972|NCT00003337|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
433973|NCT00003337|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
433974|NCT00003337|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
433975|NCT00003337|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
433976|NCT00003337|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
433977|NCT00003337|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
433978|NCT00003337|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
433979|NCT00003337|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
433980|NCT00003337|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
433981|NCT00003337|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
433982|NCT00003337|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
433983|NCT00003337|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
433984|NCT00003337|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
433985|NCT00003337|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
433986|NCT00003337|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
433987|NCT00003337|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
433988|NCT00003337|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
433989|NCT00003337|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
433990|NCT00003337|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
433991|NCT00003337|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
433992|NCT00003337|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
433993|NCT00003337|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
433994|NCT00003337|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
433995|NCT00003337|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
433996|NCT00003337|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
433997|NCT00003337|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
433998|NCT00003337|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
433999|NCT00003337|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
434000|NCT00003337|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
434001|NCT00003337|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
434002|NCT00003337|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
434003|NCT00003337|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
434004|NCT00003337|stage I mantle cell lymphoma|stage i mantle cell lymphoma
434005|NCT00003337|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
434006|NCT00003337|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
434007|NCT00003337|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
434008|NCT00003337|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
434009|NCT00003337|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
434010|NCT00003337|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
434011|NCT00003337|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
434012|NCT00003337|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
434013|NCT00003337|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
434014|NCT00003337|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
434015|NCT00003337|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
434016|NCT00003337|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
434017|NCT00003337|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
434018|NCT00003337|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
434019|NCT00003337|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
434020|NCT00003337|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
434021|NCT00003337|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
434022|NCT00003337|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
434023|NCT00003337|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
434024|NCT00003337|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
434025|NCT00003337|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
434026|NCT00003337|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
434027|NCT00003337|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
434028|NCT00003337|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
434029|NCT00003337|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
434030|NCT00003337|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
434031|NCT00003337|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
434032|NCT00003337|stage I marginal zone lymphoma|stage i marginal zone lymphoma
434033|NCT00003337|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
434034|NCT00003337|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
434035|NCT00003337|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
434036|NCT00003337|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
434037|NCT00003337|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
434038|NCT00003337|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
434039|NCT00003337|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
434040|NCT00003337|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
434041|NCT00003337|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
434042|NCT00003337|splenic marginal zone lymphoma|splenic marginal zone lymphoma
434043|NCT00003338|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
434044|NCT00003338|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
434045|NCT00003338|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
434046|NCT00003338|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
434047|NCT00003338|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
434048|NCT00003338|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
434049|NCT00003338|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
434050|NCT00003338|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
434051|NCT00003338|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
434052|NCT00003338|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
434053|NCT00003338|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
434054|NCT00003338|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
434055|NCT00003338|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
434056|NCT00003338|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
434057|NCT00003338|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
434058|NCT00003338|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
434059|NCT00003338|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
434060|NCT00003338|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
434061|NCT00003338|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
434062|NCT00003338|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
434063|NCT00003338|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
434064|NCT00003338|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
434065|NCT00003338|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
434066|NCT00003338|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
434067|NCT00003338|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
434068|NCT00003338|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
434069|NCT00003338|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
434070|NCT00003338|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
434071|NCT00003338|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
434072|NCT00003338|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
434073|NCT00003338|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
434074|NCT00003338|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
434075|NCT00003338|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
434076|NCT00003338|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
434077|NCT00003338|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
434078|NCT00003338|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
434079|NCT00003338|stage I mantle cell lymphoma|stage i mantle cell lymphoma
434080|NCT00003338|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
753533|NCT01176682|NSAID-treated patients|nsaid-treated patients
434081|NCT00003338|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
434082|NCT00003338|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
434083|NCT00003338|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
434084|NCT00003338|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
434085|NCT00003338|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
434086|NCT00003338|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
434151|NCT00003341|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
434087|NCT00003338|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
434088|NCT00003338|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
434089|NCT00003338|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
434090|NCT00003338|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
434091|NCT00003338|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
434092|NCT00003338|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
434093|NCT00003338|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
434094|NCT00003338|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
434095|NCT00003338|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
434096|NCT00003338|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
434097|NCT00003338|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
434098|NCT00003338|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
434099|NCT00003338|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
434100|NCT00003338|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
434101|NCT00003338|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
434102|NCT00003338|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
434103|NCT00003338|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
434104|NCT00003338|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
434105|NCT00003338|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
434106|NCT00003338|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
434107|NCT00003338|stage I marginal zone lymphoma|stage i marginal zone lymphoma
434108|NCT00003338|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
434109|NCT00003338|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
434110|NCT00003338|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
434111|NCT00003338|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
434112|NCT00003338|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
434113|NCT00003338|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
434114|NCT00003338|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
434115|NCT00003338|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
434116|NCT00003338|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
434117|NCT00003338|splenic marginal zone lymphoma|splenic marginal zone lymphoma
434118|NCT00003339|recurrent intraocular melanoma|recurrent intraocular melanoma
434119|NCT00003339|stage III melanoma|stage iii melanoma
434120|NCT00003339|stage IV melanoma|stage iv melanoma
434121|NCT00003339|recurrent melanoma|recurrent melanoma
434122|NCT00003340|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
434123|NCT00003341|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
434124|NCT00003341|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
434125|NCT00003341|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
434126|NCT00003341|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
434127|NCT00003341|refractory multiple myeloma|refractory multiple myeloma
434128|NCT00003341|Waldenström macroglobulinemia|waldenström macroglobulinemia
434129|NCT00003341|stage II multiple myeloma|stage ii multiple myeloma
434130|NCT00003341|stage III multiple myeloma|stage iii multiple myeloma
434131|NCT00003341|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
434132|NCT00003341|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
434133|NCT00003341|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
434134|NCT00003341|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
434135|NCT00003341|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
434136|NCT00003341|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
434137|NCT00003341|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
434138|NCT00003341|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
434139|NCT00003341|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
434140|NCT00003341|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
434141|NCT00003341|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
434142|NCT00003341|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
434143|NCT00003341|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
434144|NCT00003341|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
434145|NCT00003341|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
434146|NCT00003341|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
434147|NCT00003341|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
434148|NCT00003341|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
434149|NCT00003341|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
434150|NCT00003341|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
434152|NCT00003341|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
434153|NCT00003341|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
434154|NCT00003341|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
434155|NCT00003341|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
434157|NCT00003341|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
434158|NCT00003341|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
434159|NCT00003341|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
434160|NCT00003341|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
434161|NCT00003341|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
434162|NCT00003341|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
434163|NCT00003341|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
434164|NCT00003341|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
434165|NCT00003341|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
434166|NCT00003341|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
434167|NCT00003341|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
434168|NCT00003341|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
434169|NCT00003341|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
434170|NCT00003341|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
434171|NCT00003341|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
434172|NCT00003341|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
434173|NCT00003341|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
434174|NCT00003341|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
434175|NCT00003341|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
434176|NCT00003341|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
434177|NCT00003341|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
434178|NCT00003341|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
434179|NCT00003341|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
434180|NCT00003341|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
434181|NCT00003341|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
434182|NCT00003341|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
434183|NCT00003341|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
434184|NCT00003341|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
434185|NCT00003341|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
434186|NCT00003341|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
434187|NCT00003341|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
434188|NCT00003341|splenic marginal zone lymphoma|splenic marginal zone lymphoma
434189|NCT00003342|stage III bladder cancer|stage iii bladder cancer
434190|NCT00003342|stage IV bladder cancer|stage iv bladder cancer
434191|NCT00003342|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
434192|NCT00003342|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
434193|NCT00003342|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
434194|NCT00003342|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
434195|NCT00003343|stage IV prostate cancer|stage iv prostate cancer
434196|NCT00003344|stage II colon cancer|stage ii colon cancer
434197|NCT00003344|stage III colon cancer|stage iii colon cancer
434198|NCT00003344|stage II rectal cancer|stage ii rectal cancer
434199|NCT00003344|stage III rectal cancer|stage iii rectal cancer
434200|NCT00003344|recurrent colon cancer|recurrent colon cancer
434201|NCT00003344|recurrent rectal cancer|recurrent rectal cancer
434202|NCT00003345|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
434203|NCT00003345|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
434204|NCT00003345|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
434205|NCT00003345|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
434206|NCT00003345|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
434207|NCT00003345|fallopian tube cancer|fallopian tube cancer
434208|NCT00003345|primary peritoneal cavity cancer|primary peritoneal cavity cancer
434209|NCT00003346|stage III melanoma|stage iii melanoma
434210|NCT00003346|stage IV melanoma|stage iv melanoma
434211|NCT00003346|recurrent melanoma|recurrent melanoma
434212|NCT00003348|recurrent adult brain tumor|recurrent adult brain tumor
434213|NCT00003348|adult glioblastoma|adult glioblastoma
434214|NCT00003348|adult anaplastic astrocytoma|adult anaplastic astrocytoma
434215|NCT00003348|adult giant cell glioblastoma|adult giant cell glioblastoma
434216|NCT00003348|adult gliosarcoma|adult gliosarcoma
434221|NCT00003353|primary systemic amyloidosis|primary systemic amyloidosis
434222|NCT00003354|stage I colon cancer|stage i colon cancer
434223|NCT00003354|stage II colon cancer|stage ii colon cancer
434224|NCT00003354|stage III colon cancer|stage iii colon cancer
434225|NCT00003354|stage IV colon cancer|stage iv colon cancer
434226|NCT00003354|stage 0 colon cancer|stage 0 colon cancer
458157|NCT00037830|PD|pd
434228|NCT00003354|stage I rectal cancer|stage i rectal cancer
434229|NCT00003354|stage II rectal cancer|stage ii rectal cancer
434230|NCT00003354|stage III rectal cancer|stage iii rectal cancer
434231|NCT00003354|stage IV rectal cancer|stage iv rectal cancer
434232|NCT00003356|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
434233|NCT00003356|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
434234|NCT00003356|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
434235|NCT00003356|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
584794|NCT00509951|Evidence-Based Treatment|evidence-based treatment
434236|NCT00003356|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
434237|NCT00003356|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
434238|NCT00003356|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
434239|NCT00003356|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
434240|NCT00003356|stage I mantle cell lymphoma|stage i mantle cell lymphoma
434241|NCT00003356|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
434242|NCT00003356|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
434243|NCT00003356|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
434244|NCT00003356|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
434245|NCT00003356|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
434246|NCT00003356|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
434247|NCT00003356|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
434248|NCT00003356|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
434249|NCT00003356|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
434250|NCT00003356|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
434251|NCT00003356|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
434252|NCT00003356|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
434253|NCT00003356|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
434254|NCT00003356|stage I marginal zone lymphoma|stage i marginal zone lymphoma
434255|NCT00003356|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
434256|NCT00003356|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
434257|NCT00003356|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
434258|NCT00003356|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
434259|NCT00003356|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
434260|NCT00003356|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
434261|NCT00003356|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
434262|NCT00003356|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
434263|NCT00003356|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
434264|NCT00003356|splenic marginal zone lymphoma|splenic marginal zone lymphoma
434266|NCT00003357|stage II breast cancer|stage ii breast cancer
434267|NCT00003357|stage III breast cancer|stage iii breast cancer
434268|NCT00003358|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
434269|NCT00003358|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
434270|NCT00003358|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
434271|NCT00003358|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
434272|NCT00003358|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
434273|NCT00003358|fallopian tube cancer|fallopian tube cancer
434274|NCT00003358|primary peritoneal cavity cancer|primary peritoneal cavity cancer
434275|NCT00003359|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
434276|NCT00003360|stage IV colon cancer|stage iv colon cancer
434277|NCT00003360|stage IV rectal cancer|stage iv rectal cancer
434278|NCT00003360|recurrent colon cancer|recurrent colon cancer
434279|NCT00003360|recurrent rectal cancer|recurrent rectal cancer
434280|NCT00003361|refractory anemia|refractory anemia
434281|NCT00003361|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
753534|NCT01176682|gastrointestinal events|gastrointestinal events
434282|NCT00003361|refractory anemia with excess blasts|refractory anemia with excess blasts
434283|NCT00003361|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
434284|NCT00003361|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
434285|NCT00003361|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
434286|NCT00003361|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
434287|NCT00003361|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
434288|NCT00003361|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
434289|NCT00003362|stage III melanoma|stage iii melanoma
434290|NCT00003362|stage IV melanoma|stage iv melanoma
434291|NCT00003362|recurrent melanoma|recurrent melanoma
434292|NCT00003364|limited stage small cell lung cancer|limited stage small cell lung cancer
434293|NCT00003365|colon cancer|colon cancer
434294|NCT00003367|adenocarcinoma of the prostate|adenocarcinoma of the prostate
434295|NCT00003367|stage I prostate cancer|stage i prostate cancer
434296|NCT00003367|stage IIB prostate cancer|stage iib prostate cancer
434297|NCT00003367|stage IIA prostate cancer|stage iia prostate cancer
434298|NCT00003367|stage III prostate cancer|stage iii prostate cancer
434299|NCT00003367|stage IV prostate cancer|stage iv prostate cancer
434300|NCT00003367|recurrent prostate cancer|recurrent prostate cancer
434301|NCT00003368|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
434302|NCT00003368|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
434303|NCT00003368|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
434304|NCT00003368|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
434305|NCT00003368|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
434306|NCT00003368|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
434307|NCT00003368|small intestine lymphoma|small intestine lymphoma
434308|NCT00003368|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
434309|NCT00003368|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
434310|NCT00003368|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
434311|NCT00003368|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
434312|NCT00003368|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
434313|NCT00003368|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
434314|NCT00003368|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
434315|NCT00003368|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
434316|NCT00003368|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
434317|NCT00003368|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
434318|NCT00003368|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
434319|NCT00003368|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
434320|NCT00003368|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
434321|NCT00003368|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
434322|NCT00003368|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
434323|NCT00003368|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
434324|NCT00003368|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
434325|NCT00003368|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
434326|NCT00003368|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
434327|NCT00003368|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
434328|NCT00003368|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
434329|NCT00003368|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
434330|NCT00003368|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
434331|NCT00003368|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
434332|NCT00003368|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
434333|NCT00003368|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
434334|NCT00003368|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
434335|NCT00003368|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
434336|NCT00003368|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
434337|NCT00003368|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
434338|NCT00003368|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
434339|NCT00003368|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
434340|NCT00003368|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
434341|NCT00003368|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
434342|NCT00003368|intraocular lymphoma|intraocular lymphoma
434343|NCT00003368|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
434344|NCT00003368|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
434345|NCT00003368|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
434346|NCT00003368|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
434347|NCT00003368|anaplastic large cell lymphoma|anaplastic large cell lymphoma
434348|NCT00003368|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
434349|NCT00003368|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
434350|NCT00003368|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
434351|NCT00003368|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
434352|NCT00003368|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
434353|NCT00003368|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
434354|NCT00003368|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
434355|NCT00003368|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
434356|NCT00003368|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
434357|NCT00003368|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
434358|NCT00003368|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
434359|NCT00003368|splenic marginal zone lymphoma|splenic marginal zone lymphoma
434360|NCT00003369|stage IV cervical cancer|stage iv cervical cancer
434361|NCT00003369|recurrent cervical cancer|recurrent cervical cancer
434362|NCT00003369|cervical squamous cell carcinoma|cervical squamous cell carcinoma
458975|NCT00041951|Epilepsy|epilepsy
434363|NCT00003369|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
434364|NCT00003370|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
434365|NCT00003372|recurrent adult brain tumor|recurrent adult brain tumor
584795|NCT00509951|Clinical Investigation|clinical investigation
434366|NCT00003372|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
434367|NCT00003372|adult mixed glioma|adult mixed glioma
434368|NCT00003375|adult oligodendroglioma|adult oligodendroglioma
434369|NCT00003375|adult diffuse astrocytoma|adult diffuse astrocytoma
434370|NCT00003375|adult pilocytic astrocytoma|adult pilocytic astrocytoma
434371|NCT00003376|stage III bladder cancer|stage iii bladder cancer
434372|NCT00003376|stage IV bladder cancer|stage iv bladder cancer
434373|NCT00003376|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
434374|NCT00003376|anterior urethral cancer|anterior urethral cancer
434375|NCT00003376|posterior urethral cancer|posterior urethral cancer
434376|NCT00003376|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
434377|NCT00003376|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
434378|NCT00003376|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
434379|NCT00003377|stage III cervical cancer|stage iii cervical cancer
434380|NCT00003377|stage IVA cervical cancer|stage iva cervical cancer
434381|NCT00003377|cervical squamous cell carcinoma|cervical squamous cell carcinoma
434382|NCT00003377|cervical adenocarcinoma|cervical adenocarcinoma
434383|NCT00003377|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
434384|NCT00003378|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
434385|NCT00003378|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
434386|NCT00003378|primary peritoneal cavity cancer|primary peritoneal cavity cancer
434387|NCT00003379|stage III cervical cancer|stage iii cervical cancer
434388|NCT00003379|stage IB cervical cancer|stage ib cervical cancer
434389|NCT00003379|stage IIB cervical cancer|stage iib cervical cancer
434390|NCT00003379|stage IIA cervical cancer|stage iia cervical cancer
434391|NCT00003379|stage IVA cervical cancer|stage iva cervical cancer
434392|NCT00003379|cervical squamous cell carcinoma|cervical squamous cell carcinoma
434393|NCT00003379|cervical adenocarcinoma|cervical adenocarcinoma
434394|NCT00003379|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
434395|NCT00003379|cervical small cell carcinoma|cervical small cell carcinoma
434396|NCT00003380|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
434397|NCT00003380|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
434398|NCT00003380|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
434399|NCT00003380|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
434400|NCT00003380|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
434401|NCT00003380|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
434402|NCT00003380|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
434403|NCT00003380|fallopian tube cancer|fallopian tube cancer
434404|NCT00003380|primary peritoneal cavity cancer|primary peritoneal cavity cancer
434405|NCT00003380|Brenner tumor|brenner tumor
434406|NCT00003382|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
434407|NCT00003382|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
434408|NCT00003382|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
434409|NCT00003382|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
434410|NCT00003382|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
434411|NCT00003382|fallopian tube cancer|fallopian tube cancer
434412|NCT00003382|primary peritoneal cavity cancer|primary peritoneal cavity cancer
434413|NCT00003385|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
434414|NCT00003385|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
434415|NCT00003385|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
434416|NCT00003385|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
434417|NCT00003385|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
434418|NCT00003385|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
434419|NCT00003385|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
434420|NCT00003385|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
434421|NCT00003385|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
434422|NCT00003385|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
434423|NCT00003385|fallopian tube cancer|fallopian tube cancer
434424|NCT00003385|primary peritoneal cavity cancer|primary peritoneal cavity cancer
434425|NCT00003385|Brenner tumor|brenner tumor
434426|NCT00003386|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
434427|NCT00003386|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
434428|NCT00003387|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
434429|NCT00003387|squamous cell lung cancer|squamous cell lung cancer
434431|NCT00003387|adenocarcinoma of the lung|adenocarcinoma of the lung
434432|NCT00003388|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
434433|NCT00003388|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
434434|NCT00003388|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
434435|NCT00003388|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
434436|NCT00003388|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
434437|NCT00003388|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
434438|NCT00003388|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
434439|NCT00003388|anaplastic large cell lymphoma|anaplastic large cell lymphoma
434440|NCT00003389|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
434441|NCT00003389|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
434442|NCT00003389|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
434443|NCT00003389|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
434444|NCT00003389|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
434445|NCT00003389|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
434446|NCT00003389|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
434447|NCT00003390|stage IV renal cell cancer|stage iv renal cell cancer
434448|NCT00003390|recurrent renal cell cancer|recurrent renal cell cancer
434449|NCT00003391|adenocarcinoma of the prostate|adenocarcinoma of the prostate
434450|NCT00003391|stage IV prostate cancer|stage iv prostate cancer
434451|NCT00003391|recurrent prostate cancer|recurrent prostate cancer
434452|NCT00003392|stage IV breast cancer|stage iv breast cancer
434453|NCT00003392|recurrent breast cancer|recurrent breast cancer
434454|NCT00003394|adenocarcinoma of the prostate|adenocarcinoma of the prostate
434455|NCT00003394|stage I prostate cancer|stage i prostate cancer
434456|NCT00003394|stage IIB prostate cancer|stage iib prostate cancer
434457|NCT00003394|stage IIA prostate cancer|stage iia prostate cancer
434458|NCT00003394|stage III prostate cancer|stage iii prostate cancer
434459|NCT00003394|stage IV prostate cancer|stage iv prostate cancer
434460|NCT00003394|recurrent prostate cancer|recurrent prostate cancer
434461|NCT00003395|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
434462|NCT00003395|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
434463|NCT00003395|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
434464|NCT00003395|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
434465|NCT00003395|refractory multiple myeloma|refractory multiple myeloma
434466|NCT00003395|Waldenström macroglobulinemia|waldenström macroglobulinemia
434467|NCT00003395|stage III multiple myeloma|stage iii multiple myeloma
434468|NCT00003395|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
434469|NCT00003395|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
434470|NCT00003395|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
434471|NCT00003395|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
434472|NCT00003395|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
434473|NCT00003395|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
434474|NCT00003395|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
434475|NCT00003395|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
434476|NCT00003395|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
434477|NCT00003395|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
434478|NCT00003395|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
434479|NCT00003395|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
434480|NCT00003395|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
434481|NCT00003395|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
434482|NCT00003395|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
434483|NCT00003395|adult acute basophilic leukemia|adult acute basophilic leukemia
434484|NCT00003395|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
434485|NCT00003395|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
434486|NCT00003395|refractory hairy cell leukemia|refractory hairy cell leukemia
434487|NCT00003395|acute undifferentiated leukemia|acute undifferentiated leukemia
434488|NCT00003395|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
434489|NCT00003395|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
434490|NCT00003395|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
434491|NCT00003395|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
434492|NCT00003395|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
434493|NCT00003395|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
434494|NCT00003395|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
434495|NCT00003395|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
434496|NCT00003395|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
434497|NCT00003395|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
434498|NCT00003395|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
434499|NCT00003395|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
434500|NCT00003395|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
584796|NCT00509951|Young Patients|young patients
434501|NCT00003395|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
434502|NCT00003395|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
434503|NCT00003395|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
434504|NCT00003395|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
434505|NCT00003395|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
434506|NCT00003395|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
434507|NCT00003395|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
434508|NCT00003395|secondary acute myeloid leukemia|secondary acute myeloid leukemia
434509|NCT00003395|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
434510|NCT00003395|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
434511|NCT00003395|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
434512|NCT00003395|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
434513|NCT00003395|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
434514|NCT00003395|intraocular lymphoma|intraocular lymphoma
434515|NCT00003395|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
434516|NCT00003395|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
434517|NCT00003395|anaplastic large cell lymphoma|anaplastic large cell lymphoma
434518|NCT00003395|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
434519|NCT00003395|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
434520|NCT00003395|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
434521|NCT00003395|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
434522|NCT00003395|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
434523|NCT00003395|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
434524|NCT00003395|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
434525|NCT00003395|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
434526|NCT00003395|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
434527|NCT00003395|splenic marginal zone lymphoma|splenic marginal zone lymphoma
434528|NCT00003396|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
434529|NCT00003396|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
434530|NCT00003396|refractory multiple myeloma|refractory multiple myeloma
434531|NCT00003396|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
434532|NCT00003396|stage I multiple myeloma|stage i multiple myeloma
434533|NCT00003396|stage II multiple myeloma|stage ii multiple myeloma
434534|NCT00003396|stage III multiple myeloma|stage iii multiple myeloma
434535|NCT00003396|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
434536|NCT00003396|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
434537|NCT00003396|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
434538|NCT00003396|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
434539|NCT00003396|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
434540|NCT00003396|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
434541|NCT00003396|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
434542|NCT00003396|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
434543|NCT00003396|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
434544|NCT00003396|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
434545|NCT00003396|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
434546|NCT00003396|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
434547|NCT00003396|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
434548|NCT00003396|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
434549|NCT00003396|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
434550|NCT00003396|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
434551|NCT00003396|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
434552|NCT00003396|adult acute basophilic leukemia|adult acute basophilic leukemia
434553|NCT00003396|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
434554|NCT00003396|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
434555|NCT00003396|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
434556|NCT00003396|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
434557|NCT00003396|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
434558|NCT00003396|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
434559|NCT00003396|childhood acute basophilic leukemia|childhood acute basophilic leukemia
434560|NCT00003396|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
434561|NCT00003396|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
434562|NCT00003396|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
434563|NCT00003396|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
434564|NCT00003396|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
434765|NCT00004097|stage IV laryngeal cancer|stage iv laryngeal cancer
434565|NCT00003396|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
434566|NCT00003396|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
434567|NCT00003396|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
434568|NCT00003396|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
434569|NCT00003396|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
434570|NCT00003396|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
434571|NCT00003396|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
434572|NCT00003396|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
434573|NCT00003396|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
434574|NCT00003396|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
434575|NCT00003396|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
434576|NCT00003396|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
434577|NCT00003396|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
434578|NCT00003396|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
434579|NCT00003396|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
434580|NCT00003396|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
434581|NCT00003396|splenic marginal zone lymphoma|splenic marginal zone lymphoma
434582|NCT00003396|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
434583|NCT00003891|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
434584|NCT00003892|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
434585|NCT00003892|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
434586|NCT00003893|stage I breast cancer|stage i breast cancer
434587|NCT00003894|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
434588|NCT00003894|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
434589|NCT00003894|graft versus host disease|graft versus host disease
434590|NCT00003896|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
434591|NCT00003896|peritoneal cavity cancer|peritoneal cavity cancer
434592|NCT00003896|fallopian tube cancer|fallopian tube cancer
434593|NCT00003897|stage IV melanoma|stage iv melanoma
434595|NCT00003898|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
434596|NCT00003898|oral complications|oral complications
434597|NCT00003899|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
434598|NCT00003900|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
434599|NCT00003900|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
434600|NCT00003901|stage I non-small cell lung cancer|stage i non-small cell lung cancer
434601|NCT00003901|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
434602|NCT00003901|squamous cell lung cancer|squamous cell lung cancer
434603|NCT00003901|large cell lung cancer|large cell lung cancer
434604|NCT00003901|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
434605|NCT00003901|adenocarcinoma of the lung|adenocarcinoma of the lung
434606|NCT00003902|stage IV breast cancer|stage iv breast cancer
434607|NCT00003903|stage I prostate cancer|stage i prostate cancer
434608|NCT00003903|stage IIB prostate cancer|stage iib prostate cancer
434609|NCT00003903|stage IIA prostate cancer|stage iia prostate cancer
434610|NCT00003903|stage III prostate cancer|stage iii prostate cancer
434611|NCT00003903|stage IV prostate cancer|stage iv prostate cancer
434612|NCT00003903|osteoporosis|osteoporosis
434613|NCT00003906|breast cancer|breast cancer
434614|NCT00003907|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
434615|NCT00003907|advanced adult primary liver cancer|advanced adult primary liver cancer
434616|NCT00003907|recurrent adult primary liver cancer|recurrent adult primary liver cancer
434617|NCT00003907|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
434618|NCT00003907|liver metastases|liver metastases
753628|NCT01176968|myocardial infarction|myocardial infarction
434619|NCT00003908|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
434620|NCT00003908|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
434621|NCT00003908|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
434622|NCT00003908|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
434623|NCT00003908|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
434624|NCT00003908|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
434625|NCT00003908|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
434626|NCT00003908|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
434627|NCT00003908|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
434628|NCT00003908|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
434629|NCT00003908|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
434630|NCT00003908|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
434631|NCT00003908|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
434632|NCT00003908|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
434633|NCT00003910|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
434634|NCT00003910|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
434635|NCT00003910|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
434636|NCT00003910|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
434637|NCT00003910|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
434638|NCT00003910|LGL clone|lgl clone
434639|NCT00003911|stage IV melanoma|stage iv melanoma
434640|NCT00003911|recurrent melanoma|recurrent melanoma
434641|NCT00003911|tumors metastatic to brain|tumors metastatic to brain
434642|NCT00003912|stage I childhood liver cancer|stage i childhood liver cancer
434643|NCT00003912|stage II childhood liver cancer|stage ii childhood liver cancer
434644|NCT00003912|stage III childhood liver cancer|stage iii childhood liver cancer
434645|NCT00003912|stage IV childhood liver cancer|stage iv childhood liver cancer
434646|NCT00003912|recurrent childhood liver cancer|recurrent childhood liver cancer
434647|NCT00003912|childhood hepatoblastoma|childhood hepatoblastoma
434648|NCT00003912|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
434649|NCT00003913|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
434650|NCT00003913|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
434651|NCT00003913|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
434652|NCT00003913|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
434653|NCT00003913|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
434654|NCT00003913|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
434655|NCT00003913|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
434656|NCT00003913|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
434657|NCT00003913|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
434658|NCT00003913|refractory anemia|refractory anemia
434659|NCT00003913|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
434660|NCT00003913|refractory anemia with excess blasts|refractory anemia with excess blasts
434661|NCT00003913|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
434662|NCT00003913|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
434663|NCT00003913|acute undifferentiated leukemia|acute undifferentiated leukemia
434664|NCT00003913|secondary acute myeloid leukemia|secondary acute myeloid leukemia
434665|NCT00003913|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
434666|NCT00003913|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
434667|NCT00003913|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
434668|NCT00003913|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
434669|NCT00003913|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
434670|NCT00003913|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
434671|NCT00003913|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
434672|NCT00003913|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
434673|NCT00003913|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
434674|NCT00003913|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
434675|NCT00003914|stage IV renal cell cancer|stage iv renal cell cancer
434676|NCT00003914|recurrent renal cell cancer|recurrent renal cell cancer
434677|NCT00003915|adenocarcinoma of the prostate|adenocarcinoma of the prostate
434678|NCT00003915|stage I prostate cancer|stage i prostate cancer
434679|NCT00003916|adult glioblastoma|adult glioblastoma
434680|NCT00003916|adult anaplastic astrocytoma|adult anaplastic astrocytoma
434681|NCT00003916|adult giant cell glioblastoma|adult giant cell glioblastoma
753629|NCT01176968|mortality|mortality
434682|NCT00003916|adult gliosarcoma|adult gliosarcoma
434683|NCT00003917|limited stage small cell lung cancer|limited stage small cell lung cancer
434684|NCT00003917|extensive stage small cell lung cancer|extensive stage small cell lung cancer
434685|NCT00003917|recurrent small cell lung cancer|recurrent small cell lung cancer
434686|NCT00003920|stage IV breast cancer|stage iv breast cancer
434687|NCT00003920|recurrent breast cancer|recurrent breast cancer
434688|NCT00004085|stage IV breast cancer|stage iv breast cancer
434689|NCT00004085|recurrent breast cancer|recurrent breast cancer
434690|NCT00004086|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
584797|NCT00509951|Phobic Disorders|phobic disorders
434691|NCT00004086|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
434692|NCT00004086|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
434693|NCT00004086|refractory hairy cell leukemia|refractory hairy cell leukemia
434694|NCT00004086|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
434695|NCT00004086|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
434696|NCT00004086|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
434697|NCT00004086|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
434698|NCT00004086|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
434699|NCT00004086|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
434700|NCT00004086|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
434701|NCT00004086|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
434702|NCT00004086|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
434703|NCT00004086|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
434704|NCT00004086|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
434705|NCT00004086|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
434706|NCT00004086|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
434707|NCT00004086|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
434708|NCT00004086|splenic marginal zone lymphoma|splenic marginal zone lymphoma
434709|NCT00004087|stage IV colon cancer|stage iv colon cancer
434710|NCT00004087|stage IV pancreatic cancer|stage iv pancreatic cancer
434711|NCT00004087|recurrent pancreatic cancer|recurrent pancreatic cancer
434712|NCT00004087|stage IV rectal cancer|stage iv rectal cancer
434713|NCT00004087|recurrent colon cancer|recurrent colon cancer
434714|NCT00004087|recurrent rectal cancer|recurrent rectal cancer
434715|NCT00004088|stage I multiple myeloma|stage i multiple myeloma
434716|NCT00004088|stage II multiple myeloma|stage ii multiple myeloma
434717|NCT00004088|stage III multiple myeloma|stage iii multiple myeloma
434718|NCT00004089|anaplastic thyroid cancer|anaplastic thyroid cancer
434719|NCT00004090|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
434720|NCT00004091|cervical cancer|cervical cancer
434721|NCT00004092|stage II breast cancer|stage ii breast cancer
434722|NCT00004092|stage IIIA breast cancer|stage iiia breast cancer
434723|NCT00004092|stage IIIB breast cancer|stage iiib breast cancer
434724|NCT00004093|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
434725|NCT00004093|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
434726|NCT00004094|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
434727|NCT00004094|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
434728|NCT00004094|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
434729|NCT00004094|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
434730|NCT00004094|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
434731|NCT00004094|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
434732|NCT00004094|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
434733|NCT00004094|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
434734|NCT00004094|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
434735|NCT00004095|stage IV colon cancer|stage iv colon cancer
434736|NCT00004095|stage IV breast cancer|stage iv breast cancer
434737|NCT00004095|recurrent breast cancer|recurrent breast cancer
434738|NCT00004095|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
434739|NCT00004095|recurrent pancreatic cancer|recurrent pancreatic cancer
434740|NCT00004095|stage IV rectal cancer|stage iv rectal cancer
434741|NCT00004095|recurrent colon cancer|recurrent colon cancer
434742|NCT00004095|recurrent rectal cancer|recurrent rectal cancer
434743|NCT00004095|stage IV renal cell cancer|stage iv renal cell cancer
434744|NCT00004095|recurrent renal cell cancer|recurrent renal cell cancer
434745|NCT00004095|extensive stage small cell lung cancer|extensive stage small cell lung cancer
434746|NCT00004095|recurrent small cell lung cancer|recurrent small cell lung cancer
434747|NCT00004095|recurrent bladder cancer|recurrent bladder cancer
434748|NCT00004095|stage IV bladder cancer|stage iv bladder cancer
434749|NCT00004095|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
434750|NCT00004095|stage IV pancreatic cancer|stage iv pancreatic cancer
434751|NCT00004096|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
434752|NCT00004096|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
434753|NCT00004097|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
434754|NCT00004097|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
434755|NCT00004097|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
434756|NCT00004097|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
583291|NCT00511160|cardiac magnetic resonance tomography (CMR)|cardiac magnetic resonance tomography (cmr)
434757|NCT00004097|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
434758|NCT00004097|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
434759|NCT00004097|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
434760|NCT00004097|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
434761|NCT00004097|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
434762|NCT00004097|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
434763|NCT00004097|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
434764|NCT00004097|stage III laryngeal cancer|stage iii laryngeal cancer
434766|NCT00004097|recurrent laryngeal cancer|recurrent laryngeal cancer
434767|NCT00004097|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
434768|NCT00004097|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
434769|NCT00004097|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
434770|NCT00004097|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
434771|NCT00004097|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
434772|NCT00004097|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
434773|NCT00004099|stage II gastric cancer|stage ii gastric cancer
434774|NCT00004099|stage III gastric cancer|stage iii gastric cancer
434775|NCT00004099|stage IV gastric cancer|stage iv gastric cancer
434776|NCT00004099|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
434777|NCT00004099|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
434778|NCT00004099|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
434779|NCT00004100|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
434780|NCT00004100|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
434781|NCT00004101|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
434782|NCT00004101|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
434783|NCT00004101|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
434784|NCT00004101|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
434785|NCT00004101|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
434786|NCT00004101|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
434787|NCT00004101|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
434788|NCT00004101|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
434789|NCT00004101|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
434790|NCT00004101|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
434791|NCT00004101|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
434792|NCT00004101|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
434793|NCT00004101|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
434794|NCT00004101|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
434795|NCT00004101|splenic marginal zone lymphoma|splenic marginal zone lymphoma
434796|NCT00004102|stage IV colon cancer|stage iv colon cancer
434797|NCT00004102|stage IV rectal cancer|stage iv rectal cancer
434798|NCT00004102|recurrent colon cancer|recurrent colon cancer
434799|NCT00004102|recurrent rectal cancer|recurrent rectal cancer
434800|NCT00004102|adenocarcinoma of the colon|adenocarcinoma of the colon
434801|NCT00004102|adenocarcinoma of the rectum|adenocarcinoma of the rectum
434802|NCT00004103|stage I gastric cancer|stage i gastric cancer
434803|NCT00004103|stage II gastric cancer|stage ii gastric cancer
434804|NCT00004103|stage III gastric cancer|stage iii gastric cancer
434805|NCT00004103|stage IV gastric cancer|stage iv gastric cancer
434806|NCT00004104|stage III melanoma|stage iii melanoma
434807|NCT00004105|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
434808|NCT00004105|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
434809|NCT00004105|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
434810|NCT00004105|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
434811|NCT00004105|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
434812|NCT00004105|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
434813|NCT00004105|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
434814|NCT00004105|childhood fibrosarcoma|childhood fibrosarcoma
434815|NCT00004105|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
434816|NCT00004105|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
434817|NCT00004105|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
434818|NCT00004105|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
434819|NCT00004105|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
434820|NCT00004105|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
434821|NCT00004105|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
434822|NCT00004105|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
584798|NCT00509951|Fear|fear
434823|NCT00004105|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
434824|NCT00004105|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
434825|NCT00004105|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
434826|NCT00004105|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
434827|NCT00004105|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
434828|NCT00004105|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
434829|NCT00004105|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
434265|NCT00003357|stage I breast cancer|stage i breast cancer
434830|NCT00004105|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
434831|NCT00004105|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
458976|NCT00041951|Seizures|seizures
434832|NCT00004105|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
434833|NCT00004105|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
434834|NCT00004105|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
434835|NCT00004105|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
434836|NCT00004105|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
434837|NCT00004105|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
434838|NCT00004105|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
434839|NCT00004105|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
434840|NCT00004105|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
434841|NCT00004105|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
434842|NCT00004105|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
434843|NCT00004105|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
434844|NCT00004105|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
434845|NCT00004105|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
434846|NCT00004105|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
434847|NCT00004105|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
434848|NCT00004105|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
434849|NCT00004105|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
434850|NCT00004105|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
434851|NCT00004105|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
434852|NCT00004105|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
434853|NCT00004105|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
434854|NCT00004105|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
434855|NCT00004105|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
434856|NCT00004105|splenic marginal zone lymphoma|splenic marginal zone lymphoma
434857|NCT00004106|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
434858|NCT00004106|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
434859|NCT00004106|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
434860|NCT00004106|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
434861|NCT00004106|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
434862|NCT00004106|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
434863|NCT00004106|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
434864|NCT00004106|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
434865|NCT00004106|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
434866|NCT00004106|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
434867|NCT00004107|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
434868|NCT00004107|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
434869|NCT00004107|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
434870|NCT00004107|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
434871|NCT00004107|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
434872|NCT00004107|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
434873|NCT00004107|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
434874|NCT00004107|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
434875|NCT00004107|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
434876|NCT00004107|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
434877|NCT00004107|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
434878|NCT00004107|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
434879|NCT00004107|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
434880|NCT00004107|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
434881|NCT00004107|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
434882|NCT00004107|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
583292|NCT00511173|mechanical valve|mechanical valve
434883|NCT00004107|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
434884|NCT00004107|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
434885|NCT00004107|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
434886|NCT00004107|splenic marginal zone lymphoma|splenic marginal zone lymphoma
434887|NCT00004108|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
434888|NCT00004108|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
434889|NCT00004108|advanced adult primary liver cancer|advanced adult primary liver cancer
434890|NCT00004108|recurrent adult primary liver cancer|recurrent adult primary liver cancer
434891|NCT00004108|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
434892|NCT00004109|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
434893|NCT00004109|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
434894|NCT00004109|Doxorubicin|doxorubicin
458977|NCT00041951|Genes|genes
434895|NCT00004109|External-Beam RT|external-beam rt
434896|NCT00004109|XRT|xrt
434897|NCT00004109|cancer|cancer
457263|NCT00023166|Phase I|phase i
434898|NCT00004109|PREOPERATIVE CONCURRENT CHEMORADIATION|preoperative concurrent chemoradiation
434899|NCT00004109|EXTREMITY SOFT TISSUE SARCOMAS|extremity soft tissue sarcomas
434900|NCT00004109|TRUNK SOFT TISSUE SARCOMAS|trunk soft tissue sarcomas
434901|NCT00004109|Concurrent Chemoradiation|concurrent chemoradiation
434902|NCT00004109|Surgical Resection|surgical resection
434903|NCT00004109|Localized Extremity Soft Tissue Sarcomas|localized extremity soft tissue sarcomas
434904|NCT00004109|Body Wall Soft Tissue Sarcomas|body wall soft tissue sarcomas
434905|NCT00004110|regional neuroblastoma|regional neuroblastoma
434906|NCT00004110|disseminated neuroblastoma|disseminated neuroblastoma
434907|NCT00004110|recurrent neuroblastoma|recurrent neuroblastoma
434908|NCT00004110|localized unresectable neuroblastoma|localized unresectable neuroblastoma
434909|NCT00004112|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
434910|NCT00004112|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
434911|NCT00004112|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
434912|NCT00004112|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
434913|NCT00004112|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
434914|NCT00004112|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
434915|NCT00004112|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
434916|NCT00004112|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
434917|NCT00004112|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
434918|NCT00004112|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
434919|NCT00004112|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
434920|NCT00004112|anaplastic large cell lymphoma|anaplastic large cell lymphoma
434921|NCT00004112|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
434922|NCT00004112|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
434923|NCT00004112|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
434924|NCT00004112|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
434925|NCT00004112|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
434926|NCT00004112|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
434927|NCT00004112|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
434928|NCT00004112|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
434929|NCT00004112|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
434930|NCT00004112|splenic marginal zone lymphoma|splenic marginal zone lymphoma
434931|NCT00004113|recurrent adult brain tumor|recurrent adult brain tumor
434932|NCT00004113|adult glioblastoma|adult glioblastoma
434933|NCT00004113|adult anaplastic astrocytoma|adult anaplastic astrocytoma
434934|NCT00004113|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
434935|NCT00004113|adult mixed glioma|adult mixed glioma
434936|NCT00004113|adult giant cell glioblastoma|adult giant cell glioblastoma
434937|NCT00004113|adult gliosarcoma|adult gliosarcoma
434938|NCT00004114|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
434939|NCT00004114|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
434940|NCT00004114|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
434941|NCT00004114|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
434942|NCT00004114|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
434943|NCT00004114|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
434944|NCT00004114|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
434945|NCT00004114|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
434946|NCT00004114|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
434947|NCT00004114|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
434948|NCT00004114|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
434949|NCT00004114|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
434950|NCT00004114|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
434951|NCT00004114|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
434952|NCT00004114|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
434953|NCT00004114|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
434954|NCT00004114|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
434955|NCT00004114|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
457152|NCT00022958|Bexxar|bexxar
434956|NCT00004114|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
434957|NCT00004114|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
434958|NCT00004114|anaplastic large cell lymphoma|anaplastic large cell lymphoma
434959|NCT00004114|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
434960|NCT00004114|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
434961|NCT00004114|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
434962|NCT00004114|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
434963|NCT00004114|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
434964|NCT00004114|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
434965|NCT00004114|splenic marginal zone lymphoma|splenic marginal zone lymphoma
434966|NCT00004115|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
434967|NCT00004115|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
434968|NCT00004115|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
434969|NCT00004115|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
434970|NCT00004115|primary peritoneal cavity cancer|primary peritoneal cavity cancer
434971|NCT00004122|stage I bladder cancer|stage i bladder cancer
434972|NCT00004122|recurrent bladder cancer|recurrent bladder cancer
434973|NCT00004122|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
434974|NCT00004123|adult leiomyosarcoma|adult leiomyosarcoma
434975|NCT00004123|adult liposarcoma|adult liposarcoma
434976|NCT00004123|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
434977|NCT00004123|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
434978|NCT00004123|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
434979|NCT00004124|adenocarcinoma of the prostate|adenocarcinoma of the prostate
434980|NCT00004124|stage I prostate cancer|stage i prostate cancer
434981|NCT00004124|stage II prostate cancer|stage ii prostate cancer
434982|NCT00004124|stage III prostate cancer|stage iii prostate cancer
434983|NCT00004125|stage II breast cancer|stage ii breast cancer
434984|NCT00004125|stage IIIA breast cancer|stage iiia breast cancer
434985|NCT00004126|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
434986|NCT00004126|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
434987|NCT00004126|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
434988|NCT00004127|stage IV gastric cancer|stage iv gastric cancer
434989|NCT00004127|recurrent gastric cancer|recurrent gastric cancer
434990|NCT00004127|stage IV esophageal cancer|stage iv esophageal cancer
434991|NCT00004127|recurrent esophageal cancer|recurrent esophageal cancer
434992|NCT00004127|adenocarcinoma of the stomach|adenocarcinoma of the stomach
434993|NCT00004127|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
434994|NCT00004128|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
434995|NCT00004128|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
434996|NCT00004128|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
434997|NCT00004128|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
434998|NCT00004128|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
434999|NCT00004128|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
435000|NCT00004128|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
435001|NCT00004128|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
435002|NCT00004128|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
435003|NCT00004128|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
435004|NCT00004128|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
435005|NCT00004128|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
435006|NCT00004128|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
435007|NCT00004129|recurrent adult brain tumor|recurrent adult brain tumor
435008|NCT00004129|adult glioblastoma|adult glioblastoma
435009|NCT00004129|adult giant cell glioblastoma|adult giant cell glioblastoma
435010|NCT00004129|adult gliosarcoma|adult gliosarcoma
435011|NCT00004132|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
435012|NCT00004132|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
435013|NCT00004132|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
435014|NCT00004132|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
435015|NCT00004132|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
435016|NCT00004132|childhood Burkitt lymphoma|childhood burkitt lymphoma
435017|NCT00004132|refractory multiple myeloma|refractory multiple myeloma
435018|NCT00004132|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
435019|NCT00004132|stage I multiple myeloma|stage i multiple myeloma
435020|NCT00004132|stage II multiple myeloma|stage ii multiple myeloma
435021|NCT00004132|stage III multiple myeloma|stage iii multiple myeloma
435022|NCT00004132|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
435023|NCT00004132|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
435024|NCT00004132|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
435025|NCT00004132|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
435026|NCT00004132|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
435027|NCT00004132|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
435028|NCT00004132|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
435029|NCT00004132|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
435030|NCT00004132|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
435031|NCT00004132|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
435032|NCT00004132|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
435033|NCT00004132|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
435034|NCT00004132|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
435035|NCT00004132|oral complications|oral complications
435036|NCT00004132|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
435037|NCT00004132|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
435038|NCT00004132|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
435039|NCT00004132|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
435040|NCT00004132|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
435041|NCT00004132|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
435042|NCT00004132|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
435043|NCT00004132|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
435044|NCT00004132|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
435045|NCT00004132|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
435046|NCT00004132|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
435047|NCT00004132|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
435048|NCT00004132|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
435049|NCT00004132|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
435050|NCT00004132|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
435051|NCT00004132|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
435052|NCT00004132|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
435053|NCT00004132|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
435054|NCT00004132|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
435055|NCT00004132|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
435056|NCT00004132|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
435057|NCT00004132|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
435058|NCT00004132|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
435059|NCT00004132|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
435060|NCT00004132|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
435061|NCT00004132|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
435062|NCT00004132|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
435063|NCT00004132|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
435064|NCT00004132|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
435065|NCT00004132|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
435066|NCT00004132|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
435067|NCT00004132|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
435068|NCT00004132|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
435069|NCT00004132|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
435070|NCT00004132|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
435071|NCT00004132|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
435072|NCT00004132|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
435073|NCT00004132|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
435074|NCT00004132|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
435075|NCT00004132|radiation toxicity|radiation toxicity
436036|NCT00004232|prolymphocytic leukemia|prolymphocytic leukemia
435076|NCT00004132|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
435077|NCT00004132|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
435078|NCT00004132|stage I mantle cell lymphoma|stage i mantle cell lymphoma
435079|NCT00004132|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
435080|NCT00004132|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
435081|NCT00004132|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
457262|NCT00023153|HIV|hiv
435082|NCT00004132|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
435083|NCT00004132|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
435084|NCT00004132|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
435085|NCT00004132|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
435086|NCT00004132|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
435087|NCT00004132|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
435088|NCT00004132|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
435089|NCT00004132|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
435090|NCT00004132|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
435091|NCT00004132|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
435092|NCT00004132|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
435093|NCT00004132|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
435508|NCT00004180|adult liposarcoma|adult liposarcoma
435094|NCT00004132|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
435095|NCT00004132|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
435096|NCT00004132|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
435097|NCT00004132|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
435098|NCT00004132|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
435099|NCT00004132|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
435100|NCT00004132|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
435101|NCT00004132|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
435102|NCT00004132|anaplastic large cell lymphoma|anaplastic large cell lymphoma
435103|NCT00004132|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
435104|NCT00004132|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
435105|NCT00004132|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
435106|NCT00004132|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
435107|NCT00004132|stage I marginal zone lymphoma|stage i marginal zone lymphoma
435108|NCT00004132|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
435109|NCT00004132|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
435110|NCT00004132|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
435111|NCT00004132|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
435112|NCT00004132|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
435113|NCT00004132|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
435114|NCT00004132|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
435115|NCT00004132|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
435116|NCT00004132|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
435117|NCT00004132|splenic marginal zone lymphoma|splenic marginal zone lymphoma
435118|NCT00004135|stage IV renal cell cancer|stage iv renal cell cancer
435119|NCT00004135|recurrent renal cell cancer|recurrent renal cell cancer
435120|NCT00004135|stage IV melanoma|stage iv melanoma
435121|NCT00004135|recurrent melanoma|recurrent melanoma
435122|NCT00004136|stage III childhood liver cancer|stage iii childhood liver cancer
435123|NCT00004136|stage IV childhood liver cancer|stage iv childhood liver cancer
435124|NCT00004136|recurrent childhood liver cancer|recurrent childhood liver cancer
435125|NCT00004136|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
435126|NCT00004136|advanced adult primary liver cancer|advanced adult primary liver cancer
435127|NCT00004136|recurrent adult primary liver cancer|recurrent adult primary liver cancer
435128|NCT00004136|liver metastases|liver metastases
435129|NCT00004137|extensive stage small cell lung cancer|extensive stage small cell lung cancer
435130|NCT00004138|stage I non-small cell lung cancer|stage i non-small cell lung cancer
435131|NCT00004138|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
435132|NCT00004138|squamous cell lung cancer|squamous cell lung cancer
435133|NCT00004138|large cell lung cancer|large cell lung cancer
435134|NCT00004138|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
435135|NCT00004138|adenocarcinoma of the lung|adenocarcinoma of the lung
435136|NCT00004138|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
435137|NCT00004139|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
435138|NCT00004139|squamous cell lung cancer|squamous cell lung cancer
435139|NCT00004139|large cell lung cancer|large cell lung cancer
435140|NCT00004139|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
435141|NCT00004139|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
435142|NCT00004139|adenocarcinoma of the lung|adenocarcinoma of the lung
548647|NCT00387283|WNV|wnv
435143|NCT00004139|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
435144|NCT00004141|stage III melanoma|stage iii melanoma
435145|NCT00004141|stage IV melanoma|stage iv melanoma
435146|NCT00004141|recurrent melanoma|recurrent melanoma
435147|NCT00004142|stage IV colon cancer|stage iv colon cancer
435148|NCT00004142|stage IV rectal cancer|stage iv rectal cancer
435149|NCT00004142|recurrent colon cancer|recurrent colon cancer
435150|NCT00004142|recurrent rectal cancer|recurrent rectal cancer
435151|NCT00004142|liver metastases|liver metastases
435152|NCT00004143|sickle cell anemia|sickle cell anemia
435153|NCT00004143|severe aplastic anemia|severe aplastic anemia
435154|NCT00004144|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
435155|NCT00004145|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
435156|NCT00004145|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
435157|NCT00004145|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
435158|NCT00004145|refractory multiple myeloma|refractory multiple myeloma
435159|NCT00004145|stage I multiple myeloma|stage i multiple myeloma
435160|NCT00004145|stage II multiple myeloma|stage ii multiple myeloma
458978|NCT00041951|Inheritance|inheritance
435161|NCT00004145|stage III multiple myeloma|stage iii multiple myeloma
435162|NCT00004145|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
435163|NCT00004145|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
435164|NCT00004145|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
435165|NCT00004145|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
435166|NCT00004145|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
435167|NCT00004145|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
435168|NCT00004145|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
435169|NCT00004145|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
435170|NCT00004145|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
435171|NCT00004145|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
435173|NCT00004145|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
435174|NCT00004145|refractory anemia with excess blasts|refractory anemia with excess blasts
435175|NCT00004145|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
435176|NCT00004145|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
435177|NCT00004145|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
435178|NCT00004145|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
435179|NCT00004145|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
435180|NCT00004145|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
435181|NCT00004145|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
435182|NCT00004145|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
435183|NCT00004145|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
435184|NCT00004145|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
435185|NCT00004145|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
435186|NCT00004145|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
435187|NCT00004145|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
435188|NCT00004145|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
435189|NCT00004145|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
435190|NCT00004145|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
435191|NCT00004145|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
435192|NCT00004145|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
435193|NCT00004145|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
435194|NCT00004145|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
435195|NCT00004145|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
435196|NCT00004145|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
435197|NCT00004145|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
435198|NCT00004145|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
435199|NCT00004145|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
435200|NCT00004145|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
435201|NCT00004145|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
435202|NCT00004145|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
435203|NCT00004145|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
435204|NCT00004145|secondary acute myeloid leukemia|secondary acute myeloid leukemia
435205|NCT00004145|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
435206|NCT00004145|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
435207|NCT00004145|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
435208|NCT00004145|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
435209|NCT00004145|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
435210|NCT00004145|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
435211|NCT00004145|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
435212|NCT00004145|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
435213|NCT00004145|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
435214|NCT00004145|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
435215|NCT00004145|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
435216|NCT00004145|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
435217|NCT00004145|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
435218|NCT00004145|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
435219|NCT00004145|splenic marginal zone lymphoma|splenic marginal zone lymphoma
435220|NCT00004147|recurrent adult brain tumor|recurrent adult brain tumor
435221|NCT00004147|adult glioblastoma|adult glioblastoma
435222|NCT00004147|adult anaplastic astrocytoma|adult anaplastic astrocytoma
435223|NCT00004147|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
435224|NCT00004147|adult giant cell glioblastoma|adult giant cell glioblastoma
435225|NCT00004147|adult gliosarcoma|adult gliosarcoma
435226|NCT00004148|stage III melanoma|stage iii melanoma
435227|NCT00004148|stage IV melanoma|stage iv melanoma
435228|NCT00004148|recurrent melanoma|recurrent melanoma
435229|NCT00004149|stage IV prostate cancer|stage iv prostate cancer
435230|NCT00004149|recurrent prostate cancer|recurrent prostate cancer
435231|NCT00004150|stage III colon cancer|stage iii colon cancer
435232|NCT00004150|adenocarcinoma of the colon|adenocarcinoma of the colon
435233|NCT00004150|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
435234|NCT00004151|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
435235|NCT00004151|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
435236|NCT00004151|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
435237|NCT00004151|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
435238|NCT00004152|stage III melanoma|stage iii melanoma
435239|NCT00004152|stage IV melanoma|stage iv melanoma
435240|NCT00004152|recurrent melanoma|recurrent melanoma
435241|NCT00004153|stage I melanoma|stage i melanoma
435242|NCT00004153|stage II melanoma|stage ii melanoma
435243|NCT00004153|stage III melanoma|stage iii melanoma
435244|NCT00004153|stage IV melanoma|stage iv melanoma
435245|NCT00004154|stage 0 bladder cancer|stage 0 bladder cancer
435246|NCT00004154|stage I bladder cancer|stage i bladder cancer
435247|NCT00004154|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
435248|NCT00004156|stage I breast cancer|stage i breast cancer
435249|NCT00004156|stage II breast cancer|stage ii breast cancer
435250|NCT00004156|stage IV breast cancer|stage iv breast cancer
435251|NCT00004156|stage IIIA breast cancer|stage iiia breast cancer
435252|NCT00004156|recurrent breast cancer|recurrent breast cancer
435253|NCT00004156|stage IIIB breast cancer|stage iiib breast cancer
435254|NCT00004157|stage IV breast cancer|stage iv breast cancer
435255|NCT00004157|stage IIIA breast cancer|stage iiia breast cancer
435256|NCT00004157|stage IIIB breast cancer|stage iiib breast cancer
435257|NCT00004157|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
435258|NCT00004157|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
435259|NCT00004157|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
435260|NCT00004157|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
435261|NCT00004157|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
435262|NCT00004157|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
435263|NCT00004157|disseminated neuroblastoma|disseminated neuroblastoma
435264|NCT00004157|recurrent neuroblastoma|recurrent neuroblastoma
435265|NCT00004157|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
435266|NCT00004157|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
435267|NCT00004157|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
435268|NCT00004157|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
435269|NCT00004157|testicular embryonal carcinoma|testicular embryonal carcinoma
435270|NCT00004157|testicular choriocarcinoma|testicular choriocarcinoma
435271|NCT00004157|testicular teratoma|testicular teratoma
435272|NCT00004157|testicular yolk sac tumor|testicular yolk sac tumor
435273|NCT00004157|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
435274|NCT00004157|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
435275|NCT00004157|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
435276|NCT00004157|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
435277|NCT00004157|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
435278|NCT00004157|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
435279|NCT00004157|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
752444|NCT01173016|mucopolysaccharide IH (MPS IH)|mucopolysaccharide ih (mps ih)
548923|NCT00381576|CNS|cns
435280|NCT00004157|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
435281|NCT00004157|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
435282|NCT00004157|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
435283|NCT00004157|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
435284|NCT00004157|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
435285|NCT00004157|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
435286|NCT00004157|ovarian yolk sac tumor|ovarian yolk sac tumor
435287|NCT00004157|ovarian embryonal carcinoma|ovarian embryonal carcinoma
435288|NCT00004157|ovarian polyembryoma|ovarian polyembryoma
435289|NCT00004157|ovarian choriocarcinoma|ovarian choriocarcinoma
435290|NCT00004157|ovarian immature teratoma|ovarian immature teratoma
435291|NCT00004157|ovarian mature teratoma|ovarian mature teratoma
435292|NCT00004157|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
435293|NCT00004157|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
435294|NCT00004157|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
435295|NCT00004157|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
435296|NCT00004157|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
435297|NCT00004157|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
435298|NCT00004157|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
435299|NCT00004157|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
435300|NCT00004157|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
435301|NCT00004157|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
435302|NCT00004157|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
435841|NCT00004230|testicular choriocarcinoma|testicular choriocarcinoma
435303|NCT00004157|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
435304|NCT00004157|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
435305|NCT00004157|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
435306|NCT00004157|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
435307|NCT00004157|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
435308|NCT00004157|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
435309|NCT00004157|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
435310|NCT00004157|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
435311|NCT00004157|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
435312|NCT00004157|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
435313|NCT00004157|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
435314|NCT00004157|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
435315|NCT00004157|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
435316|NCT00004157|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
435317|NCT00004157|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
435318|NCT00004157|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
435319|NCT00004157|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
435320|NCT00004157|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
435321|NCT00004157|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
435322|NCT00004157|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
435323|NCT00004157|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
435324|NCT00004157|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
435325|NCT00004157|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
435326|NCT00004157|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
435327|NCT00004157|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
435328|NCT00004157|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
435329|NCT00004157|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
435330|NCT00004157|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
435331|NCT00004157|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
435332|NCT00004157|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
435333|NCT00004157|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
435334|NCT00004157|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
435335|NCT00004157|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
435336|NCT00004157|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
583294|NCT00511186|Alkaline Phosphatase|alkaline phosphatase
435337|NCT00004157|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
435338|NCT00004157|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
435339|NCT00004157|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
435340|NCT00004157|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
435341|NCT00004157|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
435342|NCT00004157|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
435343|NCT00004157|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
435344|NCT00004157|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
435345|NCT00004157|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
435346|NCT00004157|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
435347|NCT00004157|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
435348|NCT00004157|splenic marginal zone lymphoma|splenic marginal zone lymphoma
435349|NCT00004158|refractory multiple myeloma|refractory multiple myeloma
435350|NCT00004158|stage I multiple myeloma|stage i multiple myeloma
435351|NCT00004158|stage II multiple myeloma|stage ii multiple myeloma
435352|NCT00004158|stage III multiple myeloma|stage iii multiple myeloma
435353|NCT00004159|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
435354|NCT00004159|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
435355|NCT00004160|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
435356|NCT00004160|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
435357|NCT00004161|lip and oral cavity cancer|lip and oral cavity cancer
435358|NCT00004162|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
435430|NCT00004178|stage III cervical cancer|stage iii cervical cancer
435359|NCT00004162|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
435360|NCT00004162|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
435361|NCT00004162|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
435362|NCT00004162|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
435363|NCT00004162|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
437602|NCT00003657|metastatic osteosarcoma|metastatic osteosarcoma
435364|NCT00004163|stage III salivary gland cancer|stage iii salivary gland cancer
435365|NCT00004163|stage IV salivary gland cancer|stage iv salivary gland cancer
435366|NCT00004163|recurrent salivary gland cancer|recurrent salivary gland cancer
435367|NCT00004163|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
435368|NCT00004163|salivary gland acinic cell tumor|salivary gland acinic cell tumor
435369|NCT00004163|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
435370|NCT00004163|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
435371|NCT00004163|salivary gland adenocarcinoma|salivary gland adenocarcinoma
435372|NCT00004163|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
435373|NCT00004163|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
435374|NCT00004163|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
435375|NCT00004164|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
435376|NCT00004164|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
435377|NCT00004164|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
435378|NCT00004165|refractory multiple myeloma|refractory multiple myeloma
435379|NCT00004165|stage I multiple myeloma|stage i multiple myeloma
435380|NCT00004165|stage II multiple myeloma|stage ii multiple myeloma
435381|NCT00004165|stage III multiple myeloma|stage iii multiple myeloma
435382|NCT00004165|primary systemic amyloidosis|primary systemic amyloidosis
435383|NCT00004166|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
435384|NCT00004166|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
435385|NCT00004166|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
435386|NCT00004166|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
435387|NCT00004166|quality of life|quality of life
435388|NCT00004169|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
435389|NCT00004169|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
435390|NCT00004171|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
435391|NCT00004171|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
435392|NCT00004171|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
435393|NCT00004171|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
435394|NCT00004171|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
435395|NCT00004171|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
435396|NCT00004171|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
435397|NCT00004171|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
435398|NCT00004172|stage IV breast cancer|stage iv breast cancer
435399|NCT00004172|stage IIIA breast cancer|stage iiia breast cancer
435400|NCT00004172|recurrent breast cancer|recurrent breast cancer
435401|NCT00004172|stage IIIB breast cancer|stage iiib breast cancer
435402|NCT00004173|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
549132|NCT00388128|PAD|pad
435403|NCT00004174|stage IV breast cancer|stage iv breast cancer
435404|NCT00004174|stage IIIA breast cancer|stage iiia breast cancer
435405|NCT00004174|recurrent breast cancer|recurrent breast cancer
435406|NCT00004174|stage IIIB breast cancer|stage iiib breast cancer
435407|NCT00004175|stage IIIA breast cancer|stage iiia breast cancer
435408|NCT00004175|stage IIIB breast cancer|stage iiib breast cancer
435409|NCT00004176|limited stage small cell lung cancer|limited stage small cell lung cancer
435410|NCT00004176|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
435411|NCT00004176|radiation toxicity|radiation toxicity
435412|NCT00004177|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
435413|NCT00004178|stage III colon cancer|stage iii colon cancer
435414|NCT00004178|stage IV colon cancer|stage iv colon cancer
435415|NCT00004178|stage III gastric cancer|stage iii gastric cancer
435416|NCT00004178|stage IV gastric cancer|stage iv gastric cancer
435417|NCT00004178|recurrent gastric cancer|recurrent gastric cancer
435418|NCT00004178|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
435419|NCT00004178|stage II pancreatic cancer|stage ii pancreatic cancer
435420|NCT00004178|stage III pancreatic cancer|stage iii pancreatic cancer
435421|NCT00004178|recurrent pancreatic cancer|recurrent pancreatic cancer
435422|NCT00004178|stage III rectal cancer|stage iii rectal cancer
435423|NCT00004178|stage IV rectal cancer|stage iv rectal cancer
435424|NCT00004178|recurrent colon cancer|recurrent colon cancer
435425|NCT00004178|recurrent rectal cancer|recurrent rectal cancer
435426|NCT00004178|stage II esophageal cancer|stage ii esophageal cancer
435427|NCT00004178|stage III esophageal cancer|stage iii esophageal cancer
435428|NCT00004178|stage IV esophageal cancer|stage iv esophageal cancer
435429|NCT00004178|recurrent esophageal cancer|recurrent esophageal cancer
435431|NCT00004178|recurrent cervical cancer|recurrent cervical cancer
435432|NCT00004178|stage IVB cervical cancer|stage ivb cervical cancer
435433|NCT00004178|stage IVA cervical cancer|stage iva cervical cancer
435434|NCT00004178|adenocarcinoma of the prostate|adenocarcinoma of the prostate
435435|NCT00004178|stage III renal cell cancer|stage iii renal cell cancer
435436|NCT00004178|stage IV renal cell cancer|stage iv renal cell cancer
435437|NCT00004178|recurrent renal cell cancer|recurrent renal cell cancer
435438|NCT00004178|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
435439|NCT00004178|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
435440|NCT00004178|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
435441|NCT00004178|adenocarcinoma of the stomach|adenocarcinoma of the stomach
435442|NCT00004178|extensive stage small cell lung cancer|extensive stage small cell lung cancer
435443|NCT00004178|recurrent small cell lung cancer|recurrent small cell lung cancer
435444|NCT00004178|stage III vaginal cancer|stage iii vaginal cancer
435445|NCT00004178|stage IVA vaginal cancer|stage iva vaginal cancer
435446|NCT00004178|stage IVB vaginal cancer|stage ivb vaginal cancer
435447|NCT00004178|recurrent vaginal cancer|recurrent vaginal cancer
435448|NCT00004178|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
435449|NCT00004178|advanced adult primary liver cancer|advanced adult primary liver cancer
435450|NCT00004178|recurrent adult primary liver cancer|recurrent adult primary liver cancer
435451|NCT00004178|stage III endometrial carcinoma|stage iii endometrial carcinoma
435452|NCT00004178|stage IV endometrial carcinoma|stage iv endometrial carcinoma
435453|NCT00004178|recurrent endometrial carcinoma|recurrent endometrial carcinoma
435454|NCT00004178|small intestine adenocarcinoma|small intestine adenocarcinoma
435455|NCT00004178|unresectable gallbladder cancer|unresectable gallbladder cancer
435456|NCT00004178|recurrent gallbladder cancer|recurrent gallbladder cancer
435457|NCT00004178|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
435458|NCT00004178|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
435459|NCT00004178|recurrent small intestine cancer|recurrent small intestine cancer
435460|NCT00004178|stage III bladder cancer|stage iii bladder cancer
435461|NCT00004178|recurrent bladder cancer|recurrent bladder cancer
435462|NCT00004178|stage IV bladder cancer|stage iv bladder cancer
435463|NCT00004178|stage III prostate cancer|stage iii prostate cancer
435464|NCT00004178|stage IV prostate cancer|stage iv prostate cancer
435465|NCT00004178|recurrent prostate cancer|recurrent prostate cancer
437895|NCT00004354|hyperaldosteronism|hyperaldosteronism
435466|NCT00004178|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
435467|NCT00004178|stage III salivary gland cancer|stage iii salivary gland cancer
435468|NCT00004178|stage IV salivary gland cancer|stage iv salivary gland cancer
435469|NCT00004178|recurrent salivary gland cancer|recurrent salivary gland cancer
435470|NCT00004178|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
435471|NCT00004178|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
435472|NCT00004178|adenocarcinoma of the lung|adenocarcinoma of the lung
435473|NCT00004178|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
435474|NCT00004178|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
435475|NCT00004178|adenocarcinoma of the colon|adenocarcinoma of the colon
435476|NCT00004178|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
435477|NCT00004178|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
435478|NCT00004178|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
435479|NCT00004178|signet ring adenocarcinoma of the colon|signet ring adenocarcinoma of the colon
435480|NCT00004178|adenocarcinoma of the rectum|adenocarcinoma of the rectum
435481|NCT00004178|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
435482|NCT00004178|mucinous adenocarcinoma of the rectum|mucinous adenocarcinoma of the rectum
435483|NCT00004178|signet ring adenocarcinoma of the rectum|signet ring adenocarcinoma of the rectum
435484|NCT00004178|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
435485|NCT00004178|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
435486|NCT00004178|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
435487|NCT00004178|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
435488|NCT00004178|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
435489|NCT00004178|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
435490|NCT00004178|vaginal adenocarcinoma|vaginal adenocarcinoma
435491|NCT00004178|vaginal clear cell adenocarcinoma|vaginal clear cell adenocarcinoma
435492|NCT00004178|endometrial adenocarcinoma|endometrial adenocarcinoma
435493|NCT00004178|cervical adenocarcinoma|cervical adenocarcinoma
435494|NCT00004178|adenocarcinoma of the bladder|adenocarcinoma of the bladder
435495|NCT00004178|salivary gland adenocarcinoma|salivary gland adenocarcinoma
435496|NCT00004178|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
435497|NCT00004178|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
435498|NCT00004178|stage IV pancreatic cancer|stage iv pancreatic cancer
435499|NCT00004179|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
435500|NCT00004179|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
435501|NCT00004179|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
458979|NCT00041951|Genetics|genetics
435502|NCT00004179|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
435503|NCT00004179|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
435504|NCT00004179|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
435505|NCT00004179|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
435506|NCT00004179|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
435507|NCT00004179|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
435509|NCT00004180|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
435510|NCT00004181|refractory multiple myeloma|refractory multiple myeloma
435511|NCT00004181|stage I multiple myeloma|stage i multiple myeloma
435512|NCT00004181|stage II multiple myeloma|stage ii multiple myeloma
435513|NCT00004181|stage III multiple myeloma|stage iii multiple myeloma
435514|NCT00004181|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
435515|NCT00004181|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
435516|NCT00004181|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
435517|NCT00004182|stage IV breast cancer|stage iv breast cancer
435518|NCT00004182|recurrent breast cancer|recurrent breast cancer
435519|NCT00004183|localized malignant mesothelioma|localized malignant mesothelioma
435520|NCT00004183|advanced malignant mesothelioma|advanced malignant mesothelioma
435521|NCT00004183|recurrent malignant mesothelioma|recurrent malignant mesothelioma
435522|NCT00004183|epithelial mesothelioma|epithelial mesothelioma
435523|NCT00004183|sarcomatous mesothelioma|sarcomatous mesothelioma
435524|NCT00004184|stage III melanoma|stage iii melanoma
435525|NCT00004184|stage IV melanoma|stage iv melanoma
435526|NCT00004184|recurrent melanoma|recurrent melanoma
435527|NCT00004186|limited stage small cell lung cancer|limited stage small cell lung cancer
435528|NCT00004186|extensive stage small cell lung cancer|extensive stage small cell lung cancer
435529|NCT00004186|recurrent small cell lung cancer|recurrent small cell lung cancer
435530|NCT00004187|stage III colon cancer|stage iii colon cancer
435531|NCT00004187|stage IV colon cancer|stage iv colon cancer
435532|NCT00004187|stage III rectal cancer|stage iii rectal cancer
435533|NCT00004187|stage IV rectal cancer|stage iv rectal cancer
435534|NCT00004187|recurrent colon cancer|recurrent colon cancer
435535|NCT00004187|recurrent rectal cancer|recurrent rectal cancer
435536|NCT00004188|localized resectable neuroblastoma|localized resectable neuroblastoma
435537|NCT00004188|regional neuroblastoma|regional neuroblastoma
435538|NCT00004188|disseminated neuroblastoma|disseminated neuroblastoma
435539|NCT00004188|stage 4S neuroblastoma|stage 4s neuroblastoma
435540|NCT00004188|localized unresectable neuroblastoma|localized unresectable neuroblastoma
435541|NCT00004189|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
435542|NCT00004189|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
435543|NCT00004189|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
435544|NCT00004189|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
435545|NCT00004189|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
435546|NCT00004189|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
435547|NCT00004189|small intestine lymphoma|small intestine lymphoma
435548|NCT00004189|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
435549|NCT00004189|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
435550|NCT00004189|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
435551|NCT00004189|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
435552|NCT00004189|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
435553|NCT00004189|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
435554|NCT00004189|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
435555|NCT00004189|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
435556|NCT00004189|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
435557|NCT00004189|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
435558|NCT00004189|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
435559|NCT00004189|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
435560|NCT00004189|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
435561|NCT00004189|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
753630|NCT01176968|morbidity|morbidity
435562|NCT00004189|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
435563|NCT00004189|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
435564|NCT00004189|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
437896|NCT00004354|rare disease|rare disease
435565|NCT00004189|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
435566|NCT00004189|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
435567|NCT00004189|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
435568|NCT00004189|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
435569|NCT00004189|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
435570|NCT00004189|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
459511|NCT00043810|Transplant|transplant
435571|NCT00004189|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
435572|NCT00004189|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
435573|NCT00004189|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
435574|NCT00004189|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
435575|NCT00004189|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
435576|NCT00004189|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
435842|NCT00004230|testicular teratoma|testicular teratoma
435577|NCT00004189|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
435578|NCT00004189|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
435579|NCT00004189|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
435580|NCT00004189|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
435581|NCT00004189|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
435582|NCT00004189|intraocular lymphoma|intraocular lymphoma
435583|NCT00004189|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
435584|NCT00004189|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
435585|NCT00004189|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
435586|NCT00004189|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
435587|NCT00004189|anaplastic large cell lymphoma|anaplastic large cell lymphoma
435588|NCT00004189|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
435589|NCT00004189|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
435590|NCT00004189|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
435591|NCT00004189|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
435592|NCT00004189|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
435593|NCT00004189|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
435594|NCT00004189|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
435595|NCT00004189|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
435596|NCT00004189|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
435597|NCT00004189|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
435598|NCT00004189|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
435599|NCT00004189|splenic marginal zone lymphoma|splenic marginal zone lymphoma
435600|NCT00004190|stage III pancreatic cancer|stage iii pancreatic cancer
435601|NCT00004190|recurrent pancreatic cancer|recurrent pancreatic cancer
435602|NCT00004190|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
435603|NCT00004190|stage IV pancreatic cancer|stage iv pancreatic cancer
435605|NCT00004192|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
435606|NCT00004192|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
435607|NCT00004192|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
435608|NCT00004192|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
435609|NCT00004192|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
435610|NCT00004192|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
435611|NCT00004192|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
435612|NCT00004192|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
435613|NCT00004192|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
435614|NCT00004192|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
435615|NCT00004192|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
435616|NCT00004192|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
435617|NCT00004192|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
435618|NCT00004192|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
435619|NCT00004192|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
435620|NCT00004192|splenic marginal zone lymphoma|splenic marginal zone lymphoma
435621|NCT00004193|stage IV colon cancer|stage iv colon cancer
435622|NCT00004193|stage IV rectal cancer|stage iv rectal cancer
435623|NCT00004193|recurrent colon cancer|recurrent colon cancer
435624|NCT00004193|recurrent rectal cancer|recurrent rectal cancer
435625|NCT00004193|adenocarcinoma of the colon|adenocarcinoma of the colon
435626|NCT00004193|adenocarcinoma of the rectum|adenocarcinoma of the rectum
435627|NCT00004194|graft versus host disease|graft versus host disease
435628|NCT00004195|stage I colon cancer|stage i colon cancer
435629|NCT00004195|stage II colon cancer|stage ii colon cancer
435630|NCT00004195|stage III colon cancer|stage iii colon cancer
435631|NCT00004195|stage IV colon cancer|stage iv colon cancer
435632|NCT00004195|stage I rectal cancer|stage i rectal cancer
435633|NCT00004195|stage II rectal cancer|stage ii rectal cancer
435634|NCT00004195|stage III rectal cancer|stage iii rectal cancer
435635|NCT00004195|stage IV rectal cancer|stage iv rectal cancer
435636|NCT00004195|recurrent colon cancer|recurrent colon cancer
435637|NCT00004195|recurrent rectal cancer|recurrent rectal cancer
435638|NCT00004196|stage I melanoma|stage i melanoma
435639|NCT00004196|stage II melanoma|stage ii melanoma
435640|NCT00004196|stage III melanoma|stage iii melanoma
435641|NCT00004197|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
435642|NCT00004197|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
435643|NCT00004197|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
435644|NCT00004197|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
435645|NCT00004197|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
435646|NCT00004197|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
435647|NCT00004197|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
435648|NCT00004197|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
435649|NCT00004197|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
435650|NCT00004197|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
435651|NCT00004197|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
435652|NCT00004197|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
435653|NCT00004197|stage I mantle cell lymphoma|stage i mantle cell lymphoma
435654|NCT00004197|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
435655|NCT00004197|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
435656|NCT00004197|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
435657|NCT00004197|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
435658|NCT00004197|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
435659|NCT00004197|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
435660|NCT00004197|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
435661|NCT00004197|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
435662|NCT00004197|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
435663|NCT00004197|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
435664|NCT00004197|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
435665|NCT00004197|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
435666|NCT00004198|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
435667|NCT00004198|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
435668|NCT00004198|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
435669|NCT00004198|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
435670|NCT00004199|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
435671|NCT00004199|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
435672|NCT00004200|adult glioblastoma|adult glioblastoma
435673|NCT00004200|adult giant cell glioblastoma|adult giant cell glioblastoma
435674|NCT00004200|adult gliosarcoma|adult gliosarcoma
435675|NCT00004201|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
435676|NCT00004201|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
435677|NCT00004201|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
435678|NCT00004202|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
435679|NCT00004202|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
435680|NCT00004202|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
435681|NCT00004203|recurrent bladder cancer|recurrent bladder cancer
435682|NCT00004203|stage IV bladder cancer|stage iv bladder cancer
435683|NCT00004203|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
435684|NCT00004203|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
435685|NCT00004203|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
435686|NCT00004204|recurrent adult brain tumor|recurrent adult brain tumor
435687|NCT00004204|adult anaplastic astrocytoma|adult anaplastic astrocytoma
435688|NCT00004204|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
435689|NCT00004205|stage I breast cancer|stage i breast cancer
435690|NCT00004205|stage II breast cancer|stage ii breast cancer
435691|NCT00004205|stage IIIA breast cancer|stage iiia breast cancer
435692|NCT00004205|breast cancer in situ|breast cancer in situ
435693|NCT00004205|recurrent breast cancer|recurrent breast cancer
435694|NCT00004205|ductal breast carcinoma|ductal breast carcinoma
435695|NCT00004205|lobular breast carcinoma in situ|lobular breast carcinoma in situ
753631|NCT01176981|pediatrics|pediatrics
435696|NCT00004206|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
435697|NCT00004207|stage IV breast cancer|stage iv breast cancer
435698|NCT00004207|recurrent breast cancer|recurrent breast cancer
435700|NCT00004208|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
435701|NCT00004208|refractory anemia with excess blasts|refractory anemia with excess blasts
435702|NCT00004208|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
435703|NCT00004208|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
435704|NCT00004208|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
435705|NCT00004209|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
435706|NCT00004209|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
435707|NCT00004210|colon cancer|colon cancer
435708|NCT00004210|rectal cancer|rectal cancer
435709|NCT00004211|stage IV prostate cancer|stage iv prostate cancer
435710|NCT00004211|recurrent prostate cancer|recurrent prostate cancer
435711|NCT00004212|childhood infratentorial ependymoma|childhood infratentorial ependymoma
435712|NCT00004212|childhood supratentorial ependymoma|childhood supratentorial ependymoma
435713|NCT00004212|childhood craniopharyngioma|childhood craniopharyngioma
435714|NCT00004212|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
435715|NCT00004212|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
435716|NCT00004212|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
435717|NCT00004212|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
435718|NCT00004212|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
435719|NCT00004212|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
435720|NCT00004212|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
435721|NCT00004212|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
435722|NCT00004212|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
435723|NCT00004212|childhood oligodendroglioma|childhood oligodendroglioma
435724|NCT00004212|childhood choroid plexus tumor|childhood choroid plexus tumor
435725|NCT00004212|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
435726|NCT00004212|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
435727|NCT00004212|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
435728|NCT00004212|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
435729|NCT00004212|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
435730|NCT00004212|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
435731|NCT00004212|untreated childhood brain stem glioma|untreated childhood brain stem glioma
435732|NCT00004212|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
435733|NCT00004212|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
435734|NCT00004212|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
435735|NCT00004212|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
435736|NCT00004212|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
435737|NCT00004212|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
435738|NCT00004212|untreated childhood medulloblastoma|untreated childhood medulloblastoma
435739|NCT00004212|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
752445|NCT01173029|Systemic arterial hypertension|systemic arterial hypertension
435740|NCT00004212|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
435741|NCT00004212|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
435742|NCT00004212|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
435743|NCT00004212|recurrent childhood ependymoma|recurrent childhood ependymoma
435744|NCT00004213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
435745|NCT00004215|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
435746|NCT00004215|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
435747|NCT00004215|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
435748|NCT00004215|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
435749|NCT00004215|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
435750|NCT00004215|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
435751|NCT00004215|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
435752|NCT00004215|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
435754|NCT00004215|neutropenia|neutropenia
435755|NCT00004215|thrombocytopenia|thrombocytopenia
435756|NCT00004215|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
435757|NCT00004216|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
435758|NCT00004217|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
435759|NCT00004217|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
435760|NCT00004217|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
435761|NCT00004217|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
435762|NCT00004217|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
435763|NCT00004217|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
435764|NCT00004217|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
435765|NCT00004217|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
435766|NCT00004217|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
435767|NCT00004218|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
435768|NCT00004218|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
435769|NCT00004218|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
435770|NCT00004218|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
459619|NCT00031083|Glioma|glioma
435771|NCT00004218|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
435772|NCT00004219|nausea and vomiting|nausea and vomiting
435773|NCT00004219|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
435774|NCT00004219|testicular seminoma|testicular seminoma
435775|NCT00004220|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
435776|NCT00004223|stage III bladder cancer|stage iii bladder cancer
435777|NCT00004223|recurrent bladder cancer|recurrent bladder cancer
435778|NCT00004223|stage IV bladder cancer|stage iv bladder cancer
435779|NCT00004223|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
435780|NCT00004223|posterior urethral cancer|posterior urethral cancer
435781|NCT00004223|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
435782|NCT00004223|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
435783|NCT00004224|childhood infratentorial ependymoma|childhood infratentorial ependymoma
435784|NCT00004224|childhood supratentorial ependymoma|childhood supratentorial ependymoma
435785|NCT00004224|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
435786|NCT00004225|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
435787|NCT00004226|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
435788|NCT00004226|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
435789|NCT00004226|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
435790|NCT00004226|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
435791|NCT00004226|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
435792|NCT00004226|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
435793|NCT00004227|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
435794|NCT00004227|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
435795|NCT00004227|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
435796|NCT00004227|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
435797|NCT00004227|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
435798|NCT00004227|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
583295|NCT00511186|inflammation|inflammation
435799|NCT00004227|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
435800|NCT00004227|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
435801|NCT00004227|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
435802|NCT00004228|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
435803|NCT00004228|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
435804|NCT00004229|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
435805|NCT00004230|pulmonary complications|pulmonary complications
435806|NCT00004230|stage IV breast cancer|stage iv breast cancer
435807|NCT00004230|stage IIIA breast cancer|stage iiia breast cancer
435808|NCT00004230|stage IIIB breast cancer|stage iiib breast cancer
435809|NCT00004230|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
435810|NCT00004230|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
435811|NCT00004230|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
435812|NCT00004230|refractory multiple myeloma|refractory multiple myeloma
435813|NCT00004230|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
435814|NCT00004230|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
435815|NCT00004230|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
435816|NCT00004230|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
435817|NCT00004230|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
435818|NCT00004230|disseminated neuroblastoma|disseminated neuroblastoma
435819|NCT00004230|recurrent neuroblastoma|recurrent neuroblastoma
435820|NCT00004230|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
435821|NCT00004230|stage I multiple myeloma|stage i multiple myeloma
435822|NCT00004230|stage II multiple myeloma|stage ii multiple myeloma
435823|NCT00004230|stage III multiple myeloma|stage iii multiple myeloma
753632|NCT01176981|Osteosarcoma|osteosarcoma
435824|NCT00004230|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
435825|NCT00004230|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
435826|NCT00004230|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
435827|NCT00004230|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
435828|NCT00004230|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
435829|NCT00004230|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
435830|NCT00004230|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
435831|NCT00004230|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
435832|NCT00004230|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
435833|NCT00004230|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
435834|NCT00004230|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
435835|NCT00004230|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
435836|NCT00004230|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
435837|NCT00004230|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
435838|NCT00004230|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
435839|NCT00004230|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
435840|NCT00004230|testicular embryonal carcinoma|testicular embryonal carcinoma
435843|NCT00004230|testicular yolk sac tumor|testicular yolk sac tumor
435844|NCT00004230|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
435845|NCT00004230|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
435846|NCT00004230|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
435847|NCT00004230|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
435848|NCT00004230|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
435849|NCT00004230|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
435850|NCT00004230|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
435851|NCT00004230|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
435852|NCT00004230|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
435853|NCT00004230|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
435854|NCT00004230|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
435855|NCT00004230|refractory hairy cell leukemia|refractory hairy cell leukemia
435856|NCT00004230|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
435857|NCT00004230|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
435858|NCT00004230|ovarian yolk sac tumor|ovarian yolk sac tumor
435859|NCT00004230|ovarian embryonal carcinoma|ovarian embryonal carcinoma
435860|NCT00004230|ovarian polyembryoma|ovarian polyembryoma
435861|NCT00004230|ovarian choriocarcinoma|ovarian choriocarcinoma
435862|NCT00004230|ovarian immature teratoma|ovarian immature teratoma
435863|NCT00004230|ovarian mature teratoma|ovarian mature teratoma
435864|NCT00004230|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
435865|NCT00004230|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
435866|NCT00004230|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
435867|NCT00004230|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
435868|NCT00004230|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
435869|NCT00004230|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
435870|NCT00004230|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
435871|NCT00004230|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
435872|NCT00004230|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
435873|NCT00004230|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
435874|NCT00004230|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
435875|NCT00004230|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
435876|NCT00004230|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
435877|NCT00004230|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
435878|NCT00004230|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
435879|NCT00004230|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
435880|NCT00004230|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
435881|NCT00004230|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
435882|NCT00004230|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
435883|NCT00004230|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
435884|NCT00004230|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
435885|NCT00004230|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
435886|NCT00004230|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
435887|NCT00004230|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
435888|NCT00004230|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
753633|NCT01176981|Methotrexate|methotrexate
435889|NCT00004230|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
435890|NCT00004230|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
435891|NCT00004230|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
435892|NCT00004230|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
435893|NCT00004230|secondary acute myeloid leukemia|secondary acute myeloid leukemia
435894|NCT00004230|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
435895|NCT00004230|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
435896|NCT00004230|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
435897|NCT00004230|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
435898|NCT00004230|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
435899|NCT00004230|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
435900|NCT00004230|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
435901|NCT00004230|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
435902|NCT00004230|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
435903|NCT00004230|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
435904|NCT00004230|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
436160|NCT00004239|polycythemia vera|polycythemia vera
435905|NCT00004230|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
435906|NCT00004230|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
435907|NCT00004230|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
435908|NCT00004230|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
435909|NCT00004230|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
435910|NCT00004230|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
435911|NCT00004230|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
435912|NCT00004230|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
435913|NCT00004230|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
435914|NCT00004230|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
435915|NCT00004230|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
435916|NCT00004230|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
435917|NCT00004230|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
435918|NCT00004230|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
435919|NCT00004230|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
435920|NCT00004230|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
435921|NCT00004230|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
457264|NCT00023166|Open label|open label
435922|NCT00004230|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
583297|NCT00511186|renal failure|renal failure
435923|NCT00004230|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
435924|NCT00004230|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
435925|NCT00004230|splenic marginal zone lymphoma|splenic marginal zone lymphoma
435926|NCT00004230|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
435927|NCT00004231|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
435928|NCT00004231|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
435929|NCT00004231|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
435930|NCT00004232|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
435931|NCT00004232|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
435932|NCT00004232|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
435933|NCT00004232|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
435934|NCT00004232|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
435935|NCT00004232|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
435936|NCT00004232|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
435937|NCT00004232|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
435938|NCT00004232|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
435939|NCT00004232|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
435940|NCT00004232|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
435941|NCT00004232|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
435943|NCT00004232|isolated plasmacytoma of bone|isolated plasmacytoma of bone
435944|NCT00004232|extramedullary plasmacytoma|extramedullary plasmacytoma
435945|NCT00004232|refractory multiple myeloma|refractory multiple myeloma
435946|NCT00004232|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
435947|NCT00004232|stage I multiple myeloma|stage i multiple myeloma
435948|NCT00004232|stage II multiple myeloma|stage ii multiple myeloma
435949|NCT00004232|stage III multiple myeloma|stage iii multiple myeloma
435950|NCT00004232|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
435951|NCT00004232|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
435952|NCT00004232|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
435953|NCT00004232|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
435954|NCT00004232|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
435955|NCT00004232|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
435956|NCT00004232|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
435957|NCT00004232|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
435958|NCT00004232|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
435959|NCT00004232|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
459620|NCT00031083|Brain Tumor|brain tumor
435960|NCT00004232|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
435961|NCT00004232|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
435962|NCT00004232|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
435963|NCT00004232|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
435964|NCT00004232|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
435965|NCT00004232|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
435966|NCT00004232|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
435967|NCT00004232|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
435968|NCT00004232|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
435969|NCT00004232|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
435970|NCT00004232|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
435971|NCT00004232|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
435972|NCT00004232|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
435973|NCT00004232|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
435974|NCT00004232|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
435975|NCT00004232|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
435976|NCT00004232|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
435977|NCT00004232|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
435978|NCT00004232|essential thrombocythemia|essential thrombocythemia
435979|NCT00004232|untreated hairy cell leukemia|untreated hairy cell leukemia
435980|NCT00004232|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
435981|NCT00004232|refractory hairy cell leukemia|refractory hairy cell leukemia
435982|NCT00004232|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
435983|NCT00004232|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
435984|NCT00004232|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
435985|NCT00004232|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
583298|NCT00511212|severe peritonitis|severe peritonitis
435986|NCT00004232|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
435987|NCT00004232|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
435988|NCT00004232|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
435989|NCT00004232|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
435990|NCT00004232|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
435991|NCT00004232|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
435992|NCT00004232|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
435993|NCT00004232|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
435994|NCT00004232|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
435995|NCT00004232|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
435996|NCT00004232|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
435997|NCT00004232|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
435998|NCT00004232|acute undifferentiated leukemia|acute undifferentiated leukemia
435999|NCT00004232|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
436000|NCT00004232|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
436001|NCT00004232|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
436002|NCT00004232|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
436003|NCT00004232|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
436004|NCT00004232|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
436005|NCT00004232|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
436006|NCT00004232|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
436007|NCT00004232|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
436008|NCT00004232|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
436009|NCT00004232|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
436010|NCT00004232|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
436011|NCT00004232|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
436012|NCT00004232|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
753634|NCT01176981|Outpatient|outpatient
436013|NCT00004232|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
436014|NCT00004232|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
436015|NCT00004232|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
436016|NCT00004232|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
436017|NCT00004232|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
436018|NCT00004232|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
436019|NCT00004232|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
436020|NCT00004232|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
436021|NCT00004232|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
436022|NCT00004232|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
436023|NCT00004232|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
436024|NCT00004232|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
436025|NCT00004232|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
436026|NCT00004232|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
436027|NCT00004232|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
436028|NCT00004232|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
436029|NCT00004232|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
436030|NCT00004232|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
436031|NCT00004232|secondary acute myeloid leukemia|secondary acute myeloid leukemia
436032|NCT00004232|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
458264|NCT00038272|Placebos|placebos
436033|NCT00004232|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
436034|NCT00004232|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
436035|NCT00004232|graft versus host disease|graft versus host disease
436037|NCT00004232|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
436038|NCT00004232|primary systemic amyloidosis|primary systemic amyloidosis
436039|NCT00004232|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
436040|NCT00004232|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
436041|NCT00004232|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
436042|NCT00004232|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
436043|NCT00004232|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
436044|NCT00004232|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
436045|NCT00004232|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
436046|NCT00004232|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
436047|NCT00004232|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
436048|NCT00004232|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
436049|NCT00004232|stage I mantle cell lymphoma|stage i mantle cell lymphoma
436050|NCT00004232|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
436051|NCT00004232|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
436052|NCT00004232|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
436053|NCT00004232|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
436054|NCT00004232|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
436055|NCT00004232|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
436056|NCT00004232|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
436057|NCT00004232|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
436058|NCT00004232|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
436059|NCT00004232|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
436060|NCT00004232|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
436061|NCT00004232|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
436062|NCT00004232|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
436063|NCT00004232|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
436064|NCT00004232|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
436065|NCT00004232|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
436066|NCT00004232|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
436067|NCT00004232|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
436068|NCT00004232|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
436069|NCT00004232|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
436070|NCT00004232|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
436071|NCT00004232|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
436072|NCT00004232|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
436073|NCT00004232|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
436074|NCT00004232|anaplastic large cell lymphoma|anaplastic large cell lymphoma
436075|NCT00004232|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
436076|NCT00004232|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
436077|NCT00004232|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
436078|NCT00004232|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
436079|NCT00004232|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
436080|NCT00004232|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
436081|NCT00004232|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
436082|NCT00004232|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
436083|NCT00004232|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
436084|NCT00004232|stage I marginal zone lymphoma|stage i marginal zone lymphoma
436085|NCT00004232|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
436086|NCT00004232|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
436087|NCT00004232|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
436088|NCT00004232|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
436089|NCT00004232|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
436090|NCT00004232|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
436091|NCT00004232|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
436092|NCT00004232|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
436093|NCT00004232|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
436094|NCT00004232|splenic marginal zone lymphoma|splenic marginal zone lymphoma
436095|NCT00004232|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
436096|NCT00004233|stage III gastric cancer|stage iii gastric cancer
436097|NCT00004233|stage IV gastric cancer|stage iv gastric cancer
436098|NCT00004233|recurrent gastric cancer|recurrent gastric cancer
436099|NCT00004233|stage III esophageal cancer|stage iii esophageal cancer
436100|NCT00004233|stage IV esophageal cancer|stage iv esophageal cancer
436101|NCT00004233|recurrent esophageal cancer|recurrent esophageal cancer
436102|NCT00004233|adenocarcinoma of the stomach|adenocarcinoma of the stomach
436103|NCT00004233|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
436105|NCT00004234|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
435604|NCT00004192|neutropenia|neutropenia
436106|NCT00004234|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
436107|NCT00004234|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
436108|NCT00004234|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
436109|NCT00004234|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
436110|NCT00004234|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
436111|NCT00004234|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
436112|NCT00004234|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
436113|NCT00004234|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
436114|NCT00004234|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
436115|NCT00004234|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
436116|NCT00004234|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
436117|NCT00004234|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
436118|NCT00004234|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
436119|NCT00004234|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
436120|NCT00004234|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
436121|NCT00004234|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
436122|NCT00004234|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
436123|NCT00004234|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
436124|NCT00004234|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
436125|NCT00004234|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
436126|NCT00004234|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
436127|NCT00004234|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
436128|NCT00004234|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
436129|NCT00004234|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
436130|NCT00004235|stage IV gastric cancer|stage iv gastric cancer
436131|NCT00004235|recurrent gastric cancer|recurrent gastric cancer
436132|NCT00004235|stage II esophageal cancer|stage ii esophageal cancer
436133|NCT00004235|stage III esophageal cancer|stage iii esophageal cancer
436134|NCT00004235|stage IV esophageal cancer|stage iv esophageal cancer
436135|NCT00004235|recurrent esophageal cancer|recurrent esophageal cancer
436136|NCT00004235|adenocarcinoma of the stomach|adenocarcinoma of the stomach
436137|NCT00004235|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
436138|NCT00004236|stage III gastric cancer|stage iii gastric cancer
436139|NCT00004236|stage IV gastric cancer|stage iv gastric cancer
436140|NCT00004236|recurrent gastric cancer|recurrent gastric cancer
436141|NCT00004236|stage III esophageal cancer|stage iii esophageal cancer
436142|NCT00004236|stage IV esophageal cancer|stage iv esophageal cancer
436143|NCT00004236|recurrent esophageal cancer|recurrent esophageal cancer
436144|NCT00004236|adenocarcinoma of the stomach|adenocarcinoma of the stomach
436145|NCT00004236|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
436146|NCT00004237|stage I breast cancer|stage i breast cancer
436147|NCT00004237|stage II breast cancer|stage ii breast cancer
459621|NCT00031083|Adenovirus|adenovirus
436148|NCT00004238|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
436149|NCT00004238|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
436150|NCT00004238|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
436151|NCT00004239|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
436152|NCT00004239|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
436153|NCT00004239|refractory multiple myeloma|refractory multiple myeloma
436154|NCT00004239|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
436155|NCT00004239|stage III multiple myeloma|stage iii multiple myeloma
436156|NCT00004239|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
436157|NCT00004239|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
436158|NCT00004239|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
436159|NCT00004239|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
436161|NCT00004239|primary myelofibrosis|primary myelofibrosis
436162|NCT00004239|essential thrombocythemia|essential thrombocythemia
436163|NCT00004239|refractory hairy cell leukemia|refractory hairy cell leukemia
436164|NCT00004239|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
436165|NCT00004239|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
436166|NCT00004239|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
436167|NCT00004239|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
752881|NCT01174589|Lower limb strength training|lower limb strength training
436168|NCT00004239|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
436169|NCT00004239|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
436170|NCT00004239|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
436171|NCT00004239|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
436172|NCT00004239|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
436173|NCT00004239|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
436174|NCT00004239|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
436175|NCT00004239|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
436176|NCT00004239|prolymphocytic leukemia|prolymphocytic leukemia
436177|NCT00004239|primary systemic amyloidosis|primary systemic amyloidosis
436178|NCT00004239|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
436179|NCT00004239|anaplastic large cell lymphoma|anaplastic large cell lymphoma
436180|NCT00004239|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
436181|NCT00004239|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
436182|NCT00004239|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
436183|NCT00004239|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
436184|NCT00004239|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
436185|NCT00004239|splenic marginal zone lymphoma|splenic marginal zone lymphoma
436186|NCT00004242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
436187|NCT00004243|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
436188|NCT00004244|stage IV renal cell cancer|stage iv renal cell cancer
436189|NCT00004244|recurrent renal cell cancer|recurrent renal cell cancer
436190|NCT00004244|stage IV melanoma|stage iv melanoma
436191|NCT00004244|recurrent melanoma|recurrent melanoma
436192|NCT00004245|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
436193|NCT00004245|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
436194|NCT00004245|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
436195|NCT00004245|refractory anemia with excess blasts|refractory anemia with excess blasts
436196|NCT00004245|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
436197|NCT00004245|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
436198|NCT00004245|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
436199|NCT00004245|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
436200|NCT00004245|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
436201|NCT00004245|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
436202|NCT00004245|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
436203|NCT00004245|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
753829|NCT01177865|stage I prostate cancer|stage i prostate cancer
436204|NCT00004245|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
436205|NCT00004245|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
436206|NCT00004246|Radiation Therapy|radiation therapy
436207|NCT00004246|RT|rt
436208|NCT00004246|Radiotherapy|radiotherapy
436209|NCT00004246|Fludarabine|fludarabine
436210|NCT00004246|Fludara|fludara
436211|NCT00004246|Fludarabine Phosphate|fludarabine phosphate
436212|NCT00004246|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
436213|NCT00004246|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
436214|NCT00004246|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
436215|NCT00004246|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
436216|NCT00004246|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
436217|NCT00004246|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
436218|NCT00004246|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
436219|NCT00004246|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
436220|NCT00004246|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
436221|NCT00004246|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
436222|NCT00004248|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
436223|NCT00004248|recurrent adult primary liver cancer|recurrent adult primary liver cancer
436224|NCT00004248|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
436492|NCT00004261|stage III laryngeal cancer|stage iii laryngeal cancer
436225|NCT00004249|limited stage small cell lung cancer|limited stage small cell lung cancer
436226|NCT00004250|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
436227|NCT00004250|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
435699|NCT00004208|refractory anemia|refractory anemia
436228|NCT00004250|stage III melanoma|stage iii melanoma
436229|NCT00004250|stage IV melanoma|stage iv melanoma
436230|NCT00004250|recurrent melanoma|recurrent melanoma
436231|NCT00004250|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
436232|NCT00004251|stage IV endometrial carcinoma|stage iv endometrial carcinoma
436233|NCT00004251|recurrent endometrial carcinoma|recurrent endometrial carcinoma
436234|NCT00004251|endometrial adenocarcinoma|endometrial adenocarcinoma
583299|NCT00511212|SSI|ssi
436235|NCT00004251|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
436236|NCT00004252|stage IV colon cancer|stage iv colon cancer
436237|NCT00004252|stage IV rectal cancer|stage iv rectal cancer
436238|NCT00004252|recurrent colon cancer|recurrent colon cancer
436239|NCT00004252|recurrent rectal cancer|recurrent rectal cancer
436240|NCT00004252|adenocarcinoma of the colon|adenocarcinoma of the colon
436241|NCT00004253|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
436242|NCT00004253|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
436243|NCT00004253|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
436244|NCT00004254|localized malignant mesothelioma|localized malignant mesothelioma
436245|NCT00004254|advanced malignant mesothelioma|advanced malignant mesothelioma
436246|NCT00004254|recurrent malignant mesothelioma|recurrent malignant mesothelioma
436247|NCT00004255|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
436248|NCT00004255|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
436249|NCT00004255|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
436250|NCT00004255|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
436251|NCT00004255|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
436252|NCT00004255|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
436253|NCT00004255|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
436254|NCT00004255|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
436255|NCT00004255|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
436256|NCT00004255|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
436257|NCT00004255|refractory anemia with excess blasts|refractory anemia with excess blasts
436258|NCT00004255|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
436259|NCT00004255|secondary acute myeloid leukemia|secondary acute myeloid leukemia
436260|NCT00004255|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
436261|NCT00004255|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
436262|NCT00004255|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
436263|NCT00004255|graft versus host disease|graft versus host disease
436264|NCT00004255|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
436265|NCT00004256|stage I laryngeal cancer|stage i laryngeal cancer
436266|NCT00004256|stage II laryngeal cancer|stage ii laryngeal cancer
436267|NCT00004256|recurrent laryngeal cancer|recurrent laryngeal cancer
436268|NCT00004256|oral complications|oral complications
436269|NCT00004256|radiation toxicity|radiation toxicity
436270|NCT00004257|stage I esophageal cancer|stage i esophageal cancer
754129|NCT01179100|elderly|elderly
436271|NCT00004257|stage II esophageal cancer|stage ii esophageal cancer
436272|NCT00004257|stage III esophageal cancer|stage iii esophageal cancer
436273|NCT00004257|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
436274|NCT00004257|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
436275|NCT00004258|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
436276|NCT00004258|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
436277|NCT00004258|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
436278|NCT00004258|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
460129|NCT00032721|Reiki|reiki
436279|NCT00004258|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
436280|NCT00004258|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
436281|NCT00004258|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
436282|NCT00004258|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
436283|NCT00004258|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
436284|NCT00004258|isolated plasmacytoma of bone|isolated plasmacytoma of bone
436285|NCT00004258|extramedullary plasmacytoma|extramedullary plasmacytoma
436286|NCT00004258|refractory multiple myeloma|refractory multiple myeloma
436287|NCT00004258|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
436288|NCT00004258|stage III multiple myeloma|stage iii multiple myeloma
436289|NCT00004258|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
436290|NCT00004258|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
436291|NCT00004258|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
436292|NCT00004258|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
436293|NCT00004258|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
436493|NCT00004261|stage IV laryngeal cancer|stage iv laryngeal cancer
436294|NCT00004258|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
436295|NCT00004258|small intestine lymphoma|small intestine lymphoma
436296|NCT00004258|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
436297|NCT00004258|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
436298|NCT00004258|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
436299|NCT00004258|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
436300|NCT00004258|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
436301|NCT00004258|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
436302|NCT00004258|polycythemia vera|polycythemia vera
436303|NCT00004258|essential thrombocythemia|essential thrombocythemia
436304|NCT00004258|untreated hairy cell leukemia|untreated hairy cell leukemia
436305|NCT00004258|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
436306|NCT00004258|refractory hairy cell leukemia|refractory hairy cell leukemia
436307|NCT00004258|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
436308|NCT00004258|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
436309|NCT00004258|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
436310|NCT00004258|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
436311|NCT00004258|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
436312|NCT00004258|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
436313|NCT00004258|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
436314|NCT00004258|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
436315|NCT00004258|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
436316|NCT00004258|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
436317|NCT00004258|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
436318|NCT00004258|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
436319|NCT00004258|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
436320|NCT00004258|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
436321|NCT00004258|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
436322|NCT00004258|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
436323|NCT00004258|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
436324|NCT00004258|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
436325|NCT00004258|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
436326|NCT00004258|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
436327|NCT00004258|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
436328|NCT00004258|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
436329|NCT00004258|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
436330|NCT00004258|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
436331|NCT00004258|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
436332|NCT00004258|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
436333|NCT00004258|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
436334|NCT00004258|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
436335|NCT00004258|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
436336|NCT00004258|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
436337|NCT00004258|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
436338|NCT00004258|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
436339|NCT00004258|secondary acute myeloid leukemia|secondary acute myeloid leukemia
436340|NCT00004258|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
436341|NCT00004258|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
436342|NCT00004258|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
436343|NCT00004258|prolymphocytic leukemia|prolymphocytic leukemia
436344|NCT00004258|primary systemic amyloidosis|primary systemic amyloidosis
436345|NCT00004258|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
436346|NCT00004258|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
436347|NCT00004258|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
436348|NCT00004258|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
436349|NCT00004258|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
436350|NCT00004258|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
436351|NCT00004258|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
436352|NCT00004258|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
436353|NCT00004258|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
436354|NCT00004258|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
436355|NCT00004258|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
436356|NCT00004258|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
436357|NCT00004258|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
436358|NCT00004258|splenic marginal zone lymphoma|splenic marginal zone lymphoma
458480|NCT00038844|Lymphoma|lymphoma
436359|NCT00004259|adult anaplastic astrocytoma|adult anaplastic astrocytoma
436360|NCT00004259|adult mixed glioma|adult mixed glioma
436361|NCT00004260|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
436362|NCT00004260|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
436363|NCT00004260|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
436364|NCT00004260|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
436365|NCT00004260|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
436366|NCT00004260|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
436367|NCT00004260|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
436368|NCT00004260|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
436369|NCT00004260|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
436370|NCT00004260|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
436371|NCT00004260|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
436372|NCT00004260|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
436373|NCT00004260|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
436374|NCT00004260|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
436375|NCT00004260|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
436376|NCT00004260|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
436377|NCT00004260|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
436378|NCT00004260|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
436379|NCT00004260|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
436380|NCT00004260|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
436381|NCT00004260|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
436382|NCT00004260|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
436383|NCT00004260|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
436384|NCT00004260|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
436385|NCT00004260|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
436386|NCT00004260|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
436387|NCT00004260|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
436388|NCT00004260|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
436389|NCT00004260|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
436390|NCT00004260|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
436391|NCT00004260|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
436392|NCT00004260|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
436393|NCT00004260|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
436394|NCT00004260|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
436395|NCT00004260|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
436396|NCT00004260|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
436397|NCT00004260|stage I mantle cell lymphoma|stage i mantle cell lymphoma
436398|NCT00004260|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
436399|NCT00004260|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
436400|NCT00004260|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
436401|NCT00004260|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
436402|NCT00004260|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
436403|NCT00004260|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
436404|NCT00004260|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
436405|NCT00004260|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
460130|NCT00032721|HIV/AIDS|hiv/aids
436406|NCT00004260|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
436407|NCT00004260|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
436408|NCT00004260|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
436409|NCT00004260|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
436410|NCT00004260|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
436411|NCT00004260|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
436412|NCT00004260|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
436413|NCT00004260|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
436414|NCT00004260|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
436415|NCT00004260|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
436416|NCT00004260|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
436417|NCT00004260|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
436418|NCT00004260|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
436419|NCT00004260|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
436420|NCT00004260|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
436421|NCT00004260|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
436422|NCT00004260|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
436423|NCT00004260|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
436424|NCT00004260|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
436425|NCT00004260|stage I marginal zone lymphoma|stage i marginal zone lymphoma
436426|NCT00004260|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
436427|NCT00004260|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
436428|NCT00004260|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
436429|NCT00004260|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
436430|NCT00004260|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
436431|NCT00004260|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
436432|NCT00004260|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
436433|NCT00004260|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
436434|NCT00004260|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
436435|NCT00004260|splenic marginal zone lymphoma|splenic marginal zone lymphoma
436436|NCT00004261|stage I breast cancer|stage i breast cancer
436437|NCT00004261|stage II breast cancer|stage ii breast cancer
436438|NCT00004261|stage IV breast cancer|stage iv breast cancer
436439|NCT00004261|stage IIIA breast cancer|stage iiia breast cancer
436440|NCT00004261|breast cancer in situ|breast cancer in situ
436441|NCT00004261|recurrent breast cancer|recurrent breast cancer
436442|NCT00004261|stage IIIB breast cancer|stage iiib breast cancer
436443|NCT00004261|stage 0 cervical cancer|stage 0 cervical cancer
436444|NCT00004261|stage III cervical cancer|stage iii cervical cancer
436445|NCT00004261|recurrent cervical cancer|recurrent cervical cancer
436446|NCT00004261|stage IB cervical cancer|stage ib cervical cancer
436447|NCT00004261|stage IIB cervical cancer|stage iib cervical cancer
436448|NCT00004261|stage IVB cervical cancer|stage ivb cervical cancer
436449|NCT00004261|stage IA cervical cancer|stage ia cervical cancer
436450|NCT00004261|stage IIA cervical cancer|stage iia cervical cancer
436451|NCT00004261|stage IVA cervical cancer|stage iva cervical cancer
436452|NCT00004261|inflammatory breast cancer|inflammatory breast cancer
436453|NCT00004261|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
436454|NCT00004261|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
436455|NCT00004261|stage I prostate cancer|stage i prostate cancer
436456|NCT00004261|stage IIB prostate cancer|stage iib prostate cancer
436457|NCT00004261|stage IIA prostate cancer|stage iia prostate cancer
436458|NCT00004261|stage III prostate cancer|stage iii prostate cancer
436459|NCT00004261|stage IV prostate cancer|stage iv prostate cancer
436460|NCT00004261|recurrent prostate cancer|recurrent prostate cancer
436461|NCT00004261|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
436462|NCT00004261|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
436463|NCT00004261|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
436464|NCT00004261|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
436465|NCT00004261|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
436466|NCT00004261|stage 0 paranasal sinus and nasal cavity cancer|stage 0 paranasal sinus and nasal cavity cancer
436467|NCT00004261|stage 0 nasopharyngeal cancer|stage 0 nasopharyngeal cancer
436468|NCT00004261|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
436469|NCT00004261|stage 0 laryngeal cancer|stage 0 laryngeal cancer
436470|NCT00004261|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
436471|NCT00004261|stage I salivary gland cancer|stage i salivary gland cancer
436472|NCT00004261|stage II salivary gland cancer|stage ii salivary gland cancer
436473|NCT00004261|stage III salivary gland cancer|stage iii salivary gland cancer
436474|NCT00004261|stage IV salivary gland cancer|stage iv salivary gland cancer
460231|NCT00033176|lipoic acid|lipoic acid
436475|NCT00004261|recurrent salivary gland cancer|recurrent salivary gland cancer
436476|NCT00004261|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
436477|NCT00004261|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
436478|NCT00004261|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
436479|NCT00004261|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
436480|NCT00004261|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
436481|NCT00004261|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
436482|NCT00004261|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
436483|NCT00004261|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
436484|NCT00004261|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
436485|NCT00004261|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
436486|NCT00004261|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
436487|NCT00004261|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
436488|NCT00004261|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
436489|NCT00004261|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
436490|NCT00004261|stage I laryngeal cancer|stage i laryngeal cancer
436491|NCT00004261|stage II laryngeal cancer|stage ii laryngeal cancer
436494|NCT00004261|recurrent laryngeal cancer|recurrent laryngeal cancer
436495|NCT00004261|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
436496|NCT00004261|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
436497|NCT00004261|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
436498|NCT00004261|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
436499|NCT00004261|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
436500|NCT00004261|stage I oropharyngeal cancer|stage i oropharyngeal cancer
436501|NCT00004261|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
436502|NCT00004261|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
436503|NCT00004261|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
436504|NCT00004261|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
436505|NCT00004261|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
436506|NCT00004261|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
436507|NCT00004263|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
436508|NCT00004263|refractory anemia with excess blasts|refractory anemia with excess blasts
436509|NCT00004263|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
436510|NCT00004263|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
436511|NCT00004263|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
436513|NCT00004263|Cytosar|cytosar
436514|NCT00004263|DepoCyt|depocyt
436515|NCT00004263|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
436516|NCT00004263|cytarabine|cytarabine
436517|NCT00004263|7-hydroxystaurosporine|7-hydroxystaurosporine
436518|NCT00004263|UCN-01|ucn-01
436519|NCT00004264|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
436520|NCT00004264|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
436521|NCT00004264|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
436522|NCT00004265|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
436523|NCT00004266|diabetic nephropathy|diabetic nephropathy
436524|NCT00004266|rare disease|rare disease
436525|NCT00004266|renal and genitourinary disorders|renal and genitourinary disorders
436526|NCT00004268|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
436527|NCT00004268|disease-related problem/condition|disease-related problem/condition
436528|NCT00004268|orthostatic hypotension|orthostatic hypotension
436529|NCT00004268|quality of life|quality of life
436530|NCT00004268|rare disease|rare disease
436531|NCT00004274|Turner's syndrome|turner's syndrome
436532|NCT00004274|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
436533|NCT00004274|rare disease|rare disease
436534|NCT00004275|Turner's syndrome|turner's syndrome
436535|NCT00004275|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
436536|NCT00004275|rare disease|rare disease
436537|NCT00004276|bacterial infection|bacterial infection
436538|NCT00004276|human immunodeficiency virus infection|human immunodeficiency virus infection
436539|NCT00004276|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
436540|NCT00004276|mycobacterium infection|mycobacterium infection
436541|NCT00004276|mycobacterium tuberculosis infection|mycobacterium tuberculosis infection
436542|NCT00004276|rare disease|rare disease
436543|NCT00004276|viral infection|viral infection
436544|NCT00004278|congenital cytomegalovirus infection|congenital cytomegalovirus infection
436545|NCT00004278|cytomegalovirus infection|cytomegalovirus infection
436546|NCT00004278|herpesvirus infection|herpesvirus infection
436547|NCT00004278|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
436548|NCT00004278|neonatal disorders|neonatal disorders
436549|NCT00004278|rare disease|rare disease
436550|NCT00004278|viral infection|viral infection
436551|NCT00004284|hypercalciuria|hypercalciuria
436552|NCT00004284|nephrolithiasis|nephrolithiasis
436553|NCT00004284|rare disease|rare disease
436554|NCT00004284|renal and genitourinary disorders|renal and genitourinary disorders
436555|NCT00004285|end stage renal disease|end stage renal disease
436556|NCT00004285|rare disease|rare disease
436557|NCT00004285|renal and genitourinary disorders|renal and genitourinary disorders
436558|NCT00004286|demyelinating neuropathy|demyelinating neuropathy
436559|NCT00004286|neurologic and psychiatric disorders|neurologic and psychiatric disorders
436560|NCT00004286|rare disease|rare disease
752882|NCT01174589|Randomized clinical trial|randomized clinical trial
436561|NCT00004287|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
436562|NCT00004287|cystic fibrosis|cystic fibrosis
436563|NCT00004287|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
436564|NCT00004287|rare disease|rare disease
436565|NCT00004288|ankylosing spondylitis|ankylosing spondylitis
436566|NCT00004288|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
436567|NCT00004288|rare disease|rare disease
436568|NCT00004293|Gaucher's disease|gaucher's disease
436569|NCT00004293|inborn errors of metabolism|inborn errors of metabolism
436570|NCT00004293|rare disease|rare disease
436571|NCT00004293|sphingolipidoses|sphingolipidoses
436572|NCT00004294|Gaucher's disease|gaucher's disease
458482|NCT00038844|Campath-1 H|campath-1 h
436573|NCT00004294|inborn errors of metabolism|inborn errors of metabolism
436574|NCT00004294|rare disease|rare disease
436575|NCT00004294|sphingolipidoses|sphingolipidoses
436576|NCT00004296|atypical mycobacterium infection|atypical mycobacterium infection
436577|NCT00004296|bacterial infection|bacterial infection
436578|NCT00004296|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
436579|NCT00004296|cystic fibrosis|cystic fibrosis
436580|NCT00004296|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
436581|NCT00004296|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
436582|NCT00004296|mycobacterium infection|mycobacterium infection
436583|NCT00004296|rare disease|rare disease
436584|NCT00004297|epilepsy|epilepsy
436585|NCT00004297|neurologic and psychiatric disorders|neurologic and psychiatric disorders
436586|NCT00004297|rare disease|rare disease
436587|NCT00004297|seizures|seizures
436588|NCT00004297|status epilepticus|status epilepticus
436589|NCT00004300|mental retardation|mental retardation
436590|NCT00004300|neurologic and psychiatric disorders|neurologic and psychiatric disorders
436591|NCT00004300|rare disease|rare disease
436592|NCT00004300|stereotyped behavior|stereotyped behavior
436593|NCT00004305|IgA glomerulonephritis|iga glomerulonephritis
436594|NCT00004305|rare disease|rare disease
436595|NCT00004305|renal and genitourinary disorders|renal and genitourinary disorders
436596|NCT00004306|hereditary ataxia|hereditary ataxia
436597|NCT00004306|neurologic and psychiatric disorders|neurologic and psychiatric disorders
436598|NCT00004306|rare disease|rare disease
436599|NCT00004307|inborn errors of metabolism|inborn errors of metabolism
436600|NCT00004307|rare disease|rare disease
436601|NCT00004307|urea cycle disorder|urea cycle disorder
436602|NCT00004310|anxiety disorder|anxiety disorder
436603|NCT00004310|disease-related problem/condition|disease-related problem/condition
436604|NCT00004310|neurologic and psychiatric disorders|neurologic and psychiatric disorders
436605|NCT00004310|obsessive compulsive disorder|obsessive compulsive disorder
436606|NCT00004310|oncologic disorders|oncologic disorders
436607|NCT00004310|rare disease|rare disease
436608|NCT00004311|acanthosis nigricans|acanthosis nigricans
436609|NCT00004311|dermatologic disorders|dermatologic disorders
436610|NCT00004311|endocrine disorders|endocrine disorders
436611|NCT00004311|polycystic ovarian syndrome|polycystic ovarian syndrome
436612|NCT00004311|rare disease|rare disease
436613|NCT00004312|cystinosis|cystinosis
436614|NCT00004312|rare disease|rare disease
436615|NCT00004312|renal and genitourinary disorders|renal and genitourinary disorders
436616|NCT00004313|Addison's disease|addison's disease
436617|NCT00004313|endocrine disorders|endocrine disorders
436618|NCT00004313|rare disease|rare disease
436619|NCT00004313|primary adrenal insufficiency|primary adrenal insufficiency
436620|NCT00004314|Lesch-Nyhan syndrome|lesch-nyhan syndrome
436621|NCT00004314|inborn errors of metabolism|inborn errors of metabolism
436622|NCT00004314|neurologic and psychiatric disorders|neurologic and psychiatric disorders
436623|NCT00004314|rare disease|rare disease
436624|NCT00004315|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
436625|NCT00004315|cholestasis|cholestasis
436626|NCT00004315|cystic fibrosis|cystic fibrosis
436627|NCT00004315|gastrointestinal disorders|gastrointestinal disorders
436628|NCT00004315|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
436629|NCT00004315|rare disease|rare disease
436630|NCT00004316|interstitial cystitis|interstitial cystitis
436631|NCT00004316|rare disease|rare disease
436632|NCT00004316|renal and genitourinary disorders|renal and genitourinary disorders
436633|NCT00004316|vulvar vestibulitis|vulvar vestibulitis
436634|NCT00004317|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
436635|NCT00004317|rare disease|rare disease
436636|NCT00004317|toxoplasmosis|toxoplasmosis
436637|NCT00004323|aplastic anemia|aplastic anemia
436638|NCT00004323|hematologic disorders|hematologic disorders
436639|NCT00004323|rare disease|rare disease
436640|NCT00004324|Tourette syndrome|tourette syndrome
436641|NCT00004324|anxiety disorder|anxiety disorder
436642|NCT00004324|disease-related problem/condition|disease-related problem/condition
436643|NCT00004324|neurologic and psychiatric disorders|neurologic and psychiatric disorders
436644|NCT00004324|obsessive compulsive disorder|obsessive compulsive disorder
436645|NCT00004324|oncologic disorders|oncologic disorders
436646|NCT00004324|rare disease|rare disease
436647|NCT00004325|Tourette syndrome|tourette syndrome
436648|NCT00004325|anxiety disorder|anxiety disorder
436649|NCT00004325|disease-related problem/condition|disease-related problem/condition
436650|NCT00004325|neurologic and psychiatric disorders|neurologic and psychiatric disorders
436651|NCT00004325|obsessive compulsive disorder|obsessive compulsive disorder
436652|NCT00004325|oncologic disorders|oncologic disorders
436653|NCT00004325|rare disease|rare disease
436654|NCT00004326|Cushing's syndrome|cushing's syndrome
436655|NCT00004326|endocrine disorders|endocrine disorders
436656|NCT00004326|rare disease|rare disease
436657|NCT00004327|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
436658|NCT00004327|hematologic disorders|hematologic disorders
436811|NCT00003078|stage IVA cervical cancer|stage iva cervical cancer
436659|NCT00004327|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
436660|NCT00004327|rare disease|rare disease
436661|NCT00004327|senile ectasia|senile ectasia
436662|NCT00003046|anal cancer|anal cancer
436663|NCT00003046|carcinoma of the appendix|carcinoma of the appendix
436664|NCT00003046|colorectal cancer|colorectal cancer
436665|NCT00003046|extrahepatic bile duct cancer|extrahepatic bile duct cancer
436666|NCT00003046|gallbladder cancer|gallbladder cancer
436667|NCT00003046|gastric cancer|gastric cancer
436668|NCT00003046|gastrointestinal carcinoid tumor|gastrointestinal carcinoid tumor
436669|NCT00003046|malignant mesothelioma|malignant mesothelioma
436670|NCT00003046|pancreatic cancer|pancreatic cancer
436671|NCT00003046|small intestine cancer|small intestine cancer
436672|NCT00003046|stage IV colon cancer|stage iv colon cancer
436673|NCT00003046|stage IV gastric cancer|stage iv gastric cancer
436674|NCT00003046|recurrent gastric cancer|recurrent gastric cancer
436675|NCT00003046|recurrent pancreatic cancer|recurrent pancreatic cancer
436676|NCT00003046|stage IV rectal cancer|stage iv rectal cancer
436677|NCT00003046|recurrent colon cancer|recurrent colon cancer
436678|NCT00003046|recurrent rectal cancer|recurrent rectal cancer
436679|NCT00003046|stage IV anal cancer|stage iv anal cancer
436680|NCT00003046|recurrent anal cancer|recurrent anal cancer
436681|NCT00003046|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
436682|NCT00003046|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
436683|NCT00003046|advanced malignant mesothelioma|advanced malignant mesothelioma
436684|NCT00003046|recurrent malignant mesothelioma|recurrent malignant mesothelioma
436685|NCT00003046|small intestine adenocarcinoma|small intestine adenocarcinoma
436686|NCT00003046|unresectable gallbladder cancer|unresectable gallbladder cancer
436687|NCT00003046|recurrent gallbladder cancer|recurrent gallbladder cancer
436688|NCT00003046|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
436689|NCT00003046|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
436690|NCT00003046|recurrent small intestine cancer|recurrent small intestine cancer
436691|NCT00003046|stage IV pancreatic cancer|stage iv pancreatic cancer
436692|NCT00003048|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
436693|NCT00003048|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
436694|NCT00003048|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
436695|NCT00003048|Amifostine|amifostine
436696|NCT00003048|Ethyol|ethyol
436697|NCT00003048|Ethiofos|ethiofos
436698|NCT00003048|Gammaphos|gammaphos
436699|NCT00003049|stage I pancreatic cancer|stage i pancreatic cancer
436700|NCT00003049|stage II pancreatic cancer|stage ii pancreatic cancer
436701|NCT00003049|stage III pancreatic cancer|stage iii pancreatic cancer
436702|NCT00003049|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
436703|NCT00003050|stage II breast cancer|stage ii breast cancer
436704|NCT00003050|stage IIIA breast cancer|stage iiia breast cancer
436705|NCT00003050|stage IIIB breast cancer|stage iiib breast cancer
436706|NCT00003052|adult angiosarcoma|adult angiosarcoma
436707|NCT00003052|adult fibrosarcoma|adult fibrosarcoma
436708|NCT00003052|adult leiomyosarcoma|adult leiomyosarcoma
436709|NCT00003052|adult liposarcoma|adult liposarcoma
436710|NCT00003052|adult neurofibrosarcoma|adult neurofibrosarcoma
436711|NCT00003052|adult synovial sarcoma|adult synovial sarcoma
436712|NCT00003052|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
436713|NCT00003052|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
436714|NCT00003052|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
436715|NCT00003052|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
436716|NCT00003052|adult rhabdomyosarcoma|adult rhabdomyosarcoma
436717|NCT00003052|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
436718|NCT00003052|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
436932|NCT00003088|stage IIIA breast cancer|stage iiia breast cancer
436719|NCT00003053|stage I non-small cell lung cancer|stage i non-small cell lung cancer
436720|NCT00003053|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
436721|NCT00003053|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
436722|NCT00003054|recurrent uterine sarcoma|recurrent uterine sarcoma
436723|NCT00003054|uterine leiomyosarcoma|uterine leiomyosarcoma
436724|NCT00003055|stage III gastric cancer|stage iii gastric cancer
436725|NCT00003055|stage IV gastric cancer|stage iv gastric cancer
436726|NCT00003055|recurrent gastric cancer|recurrent gastric cancer
436727|NCT00003055|stage III esophageal cancer|stage iii esophageal cancer
436728|NCT00003055|stage IV esophageal cancer|stage iv esophageal cancer
436729|NCT00003055|recurrent esophageal cancer|recurrent esophageal cancer
436730|NCT00003055|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
436731|NCT00003056|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
436732|NCT00003056|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
436733|NCT00003056|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
436734|NCT00003056|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
436735|NCT00003056|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
436736|NCT00003056|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
436737|NCT00003056|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
436738|NCT00003056|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
436739|NCT00003056|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
436740|NCT00003056|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
436741|NCT00003056|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
436742|NCT00003056|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
436743|NCT00003056|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
436744|NCT00003056|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
436745|NCT00003056|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
436746|NCT00003056|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
436747|NCT00003056|graft versus host disease|graft versus host disease
436748|NCT00003056|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
436749|NCT00003056|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
436750|NCT00003056|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
436751|NCT00003056|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
436752|NCT00003056|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
436753|NCT00003056|splenic marginal zone lymphoma|splenic marginal zone lymphoma
436755|NCT00003057|rectal cancer|rectal cancer
436756|NCT00003057|diarrhea|diarrhea
436757|NCT00003058|adult liposarcoma|adult liposarcoma
436758|NCT00003058|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
436759|NCT00003060|recurrent melanoma|recurrent melanoma
436760|NCT00003061|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
436761|NCT00003062|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
436762|NCT00003062|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
436763|NCT00003063|stage II colon cancer|stage ii colon cancer
436764|NCT00003063|stage III colon cancer|stage iii colon cancer
436765|NCT00003063|stage II rectal cancer|stage ii rectal cancer
436766|NCT00003063|stage III rectal cancer|stage iii rectal cancer
436767|NCT00003064|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
436768|NCT00003064|fallopian tube cancer|fallopian tube cancer
436769|NCT00003064|primary peritoneal cavity cancer|primary peritoneal cavity cancer
436770|NCT00003065|recurrent cervical cancer|recurrent cervical cancer
436771|NCT00003065|stage IVB cervical cancer|stage ivb cervical cancer
436772|NCT00003065|stage IVA cervical cancer|stage iva cervical cancer
436773|NCT00003065|cervical squamous cell carcinoma|cervical squamous cell carcinoma
436774|NCT00003065|cervical adenocarcinoma|cervical adenocarcinoma
436775|NCT00003066|stage IV breast cancer|stage iv breast cancer
436776|NCT00003066|recurrent breast cancer|recurrent breast cancer
436777|NCT00003067|recurrent adult brain tumor|recurrent adult brain tumor
436778|NCT00003067|adult glioblastoma|adult glioblastoma
436779|NCT00003067|adult anaplastic astrocytoma|adult anaplastic astrocytoma
436780|NCT00003067|adult mixed glioma|adult mixed glioma
436781|NCT00003067|adult giant cell glioblastoma|adult giant cell glioblastoma
436782|NCT00003067|adult gliosarcoma|adult gliosarcoma
436783|NCT00003068|stage IV breast cancer|stage iv breast cancer
436784|NCT00003068|stage IIIA breast cancer|stage iiia breast cancer
436785|NCT00003068|recurrent breast cancer|recurrent breast cancer
436786|NCT00003068|stage IIIB breast cancer|stage iiib breast cancer
436787|NCT00003068|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
436788|NCT00003070|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
436789|NCT00003070|cardiac toxicity|cardiac toxicity
436790|NCT00003072|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
436791|NCT00003072|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
436792|NCT00003072|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
436793|NCT00003072|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
436794|NCT00003072|neurotoxicity|neurotoxicity
436795|NCT00003073|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
436796|NCT00003073|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
436797|NCT00003073|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
436798|NCT00003073|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
436799|NCT00003073|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
436800|NCT00003073|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
436801|NCT00003073|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
436802|NCT00003073|leptomeningeal metastases|leptomeningeal metastases
436803|NCT00003073|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
436804|NCT00003073|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
436805|NCT00003075|cervical cancer|cervical cancer
436806|NCT00003075|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
436807|NCT00003075|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
436808|NCT00003076|esophageal cancer|esophageal cancer
436809|NCT00003078|stage III cervical cancer|stage iii cervical cancer
436810|NCT00003078|stage IIB cervical cancer|stage iib cervical cancer
436812|NCT00003078|cervical squamous cell carcinoma|cervical squamous cell carcinoma
436813|NCT00003078|cervical adenocarcinoma|cervical adenocarcinoma
436814|NCT00003078|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
436815|NCT00003079|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
436816|NCT00003079|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
436817|NCT00003079|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
436818|NCT00003079|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
436819|NCT00003080|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
436820|NCT00003080|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
436821|NCT00003080|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
436822|NCT00003081|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
436823|NCT00003081|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
436824|NCT00003081|adult rhabdomyosarcoma|adult rhabdomyosarcoma
436825|NCT00003081|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
436826|NCT00003082|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
436827|NCT00003082|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
436828|NCT00003082|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
436829|NCT00003082|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
436830|NCT00003082|isolated plasmacytoma of bone|isolated plasmacytoma of bone
436831|NCT00003082|extramedullary plasmacytoma|extramedullary plasmacytoma
436832|NCT00003082|refractory multiple myeloma|refractory multiple myeloma
436833|NCT00003082|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
436834|NCT00003082|stage III multiple myeloma|stage iii multiple myeloma
436835|NCT00003082|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
436836|NCT00003082|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
436837|NCT00003082|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
436838|NCT00003082|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
436839|NCT00003082|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
436840|NCT00003082|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
436841|NCT00003082|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
436842|NCT00003082|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
436843|NCT00003082|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
436844|NCT00003082|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
436845|NCT00003082|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
436846|NCT00003082|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
436847|NCT00003082|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
436848|NCT00003082|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
436849|NCT00003082|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
436850|NCT00003082|polycythemia vera|polycythemia vera
436851|NCT00003082|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
436852|NCT00003082|essential thrombocythemia|essential thrombocythemia
436853|NCT00003082|untreated hairy cell leukemia|untreated hairy cell leukemia
436854|NCT00003082|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
436855|NCT00003082|refractory hairy cell leukemia|refractory hairy cell leukemia
436856|NCT00003082|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
436857|NCT00003082|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
436858|NCT00003082|acute undifferentiated leukemia|acute undifferentiated leukemia
436859|NCT00003082|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
436860|NCT00003082|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
437387|NCT00003138|filgrastim|filgrastim
436861|NCT00003082|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
436862|NCT00003082|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
436863|NCT00003082|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
436864|NCT00003082|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
436865|NCT00003082|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
436866|NCT00003082|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
436867|NCT00003082|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
436868|NCT00003082|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
436869|NCT00003082|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
436870|NCT00003082|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
436871|NCT00003082|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
436872|NCT00003082|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
436873|NCT00003082|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
436874|NCT00003082|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
436875|NCT00003082|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
436876|NCT00003082|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
436877|NCT00003082|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
436878|NCT00003082|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
436879|NCT00003082|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
436880|NCT00003082|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
436881|NCT00003082|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
436882|NCT00003082|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
436883|NCT00003082|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
436884|NCT00003082|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
436885|NCT00003082|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
436886|NCT00003082|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
436887|NCT00003082|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
436888|NCT00003082|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
436889|NCT00003082|secondary acute myeloid leukemia|secondary acute myeloid leukemia
436890|NCT00003082|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
436891|NCT00003082|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
436892|NCT00003082|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
436893|NCT00003082|prolymphocytic leukemia|prolymphocytic leukemia
436894|NCT00003082|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
436895|NCT00003082|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
436896|NCT00003082|primary systemic amyloidosis|primary systemic amyloidosis
436897|NCT00003082|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
436898|NCT00003082|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
436899|NCT00003082|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
436900|NCT00003082|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
436901|NCT00003082|anaplastic large cell lymphoma|anaplastic large cell lymphoma
436902|NCT00003082|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
436903|NCT00003082|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
436904|NCT00003082|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
436905|NCT00003082|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
436906|NCT00003082|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
436907|NCT00003082|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
436908|NCT00003082|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
436909|NCT00003082|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
436910|NCT00003082|splenic marginal zone lymphoma|splenic marginal zone lymphoma
436911|NCT00003084|adenocarcinoma of the prostate|adenocarcinoma of the prostate
436912|NCT00003084|stage I prostate cancer|stage i prostate cancer
436913|NCT00003084|stage II prostate cancer|stage ii prostate cancer
436914|NCT00003084|stage III prostate cancer|stage iii prostate cancer
436915|NCT00003084|stage IV prostate cancer|stage iv prostate cancer
436916|NCT00003084|recurrent prostate cancer|recurrent prostate cancer
436917|NCT00003084|Chemotherapy|chemotherapy
436918|NCT00003084|Ketoconazole|ketoconazole
436919|NCT00003084|Estramustine|estramustine
436920|NCT00003084|Etoposide|etoposide
436921|NCT00003084|Paclitaxel|paclitaxel
436923|NCT00003084|Vinblastine|vinblastine
436924|NCT00003085|stage I pancreatic cancer|stage i pancreatic cancer
436925|NCT00003085|stage II pancreatic cancer|stage ii pancreatic cancer
436926|NCT00003086|stage IV breast cancer|stage iv breast cancer
436927|NCT00003087|stage II esophageal cancer|stage ii esophageal cancer
436928|NCT00003087|stage III esophageal cancer|stage iii esophageal cancer
436929|NCT00003087|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
436930|NCT00003087|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
436931|NCT00003088|stage II breast cancer|stage ii breast cancer
436933|NCT00003089|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
436934|NCT00003089|squamous cell lung cancer|squamous cell lung cancer
436935|NCT00003089|large cell lung cancer|large cell lung cancer
436936|NCT00003089|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
436937|NCT00003089|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
436938|NCT00003089|adenocarcinoma of the lung|adenocarcinoma of the lung
436939|NCT00003089|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
436940|NCT00003090|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
436941|NCT00003091|stage IV renal cell cancer|stage iv renal cell cancer
436942|NCT00003091|recurrent renal cell cancer|recurrent renal cell cancer
436943|NCT00003091|stage IV melanoma|stage iv melanoma
436944|NCT00003091|recurrent melanoma|recurrent melanoma
436945|NCT00003092|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
436946|NCT00003093|regional neuroblastoma|regional neuroblastoma
436947|NCT00003093|disseminated neuroblastoma|disseminated neuroblastoma
436948|NCT00003093|stage 4S neuroblastoma|stage 4s neuroblastoma
436949|NCT00003093|localized unresectable neuroblastoma|localized unresectable neuroblastoma
436950|NCT00003094|cervical cancer|cervical cancer
436951|NCT00003095|stage II breast cancer|stage ii breast cancer
436952|NCT00003095|stage III breast cancer|stage iii breast cancer
436953|NCT00003096|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
436954|NCT00003096|untreated childhood medulloblastoma|untreated childhood medulloblastoma
436955|NCT00003097|basal cell carcinoma of the skin|basal cell carcinoma of the skin
436956|NCT00003097|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
436957|NCT00003098|breast cancer|breast cancer
436958|NCT00003099|breast cancer|breast cancer
436959|NCT00003099|Tamoxifen|tamoxifen
436960|NCT00003099|Fenretinide|fenretinide
436961|NCT00003099|Chemoprevention Therapy|chemoprevention therapy
436962|NCT00003099|N-(4-hydroxyphenyl) Retinamide|n-(4-hydroxyphenyl) retinamide
436964|NCT00003099|Breast Neoplasia|breast neoplasia
436965|NCT00003099|Diagnostic Core Biopsy|diagnostic core biopsy
436966|NCT00003099|Surgery|surgery
436967|NCT00003100|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
436968|NCT00003101|adult oligodendroglioma|adult oligodendroglioma
436969|NCT00003101|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
436970|NCT00003102|stage IV renal cell cancer|stage iv renal cell cancer
436971|NCT00003102|recurrent renal cell cancer|recurrent renal cell cancer
436972|NCT00003103|stage III colon cancer|stage iii colon cancer
436973|NCT00003103|stage IV colon cancer|stage iv colon cancer
436974|NCT00003103|stage IV breast cancer|stage iv breast cancer
436975|NCT00003103|stage IIIA breast cancer|stage iiia breast cancer
436976|NCT00003103|recurrent breast cancer|recurrent breast cancer
436977|NCT00003103|stage IIIB breast cancer|stage iiib breast cancer
436978|NCT00003103|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
436979|NCT00003103|stage III rectal cancer|stage iii rectal cancer
436980|NCT00003103|stage IV rectal cancer|stage iv rectal cancer
436981|NCT00003103|recurrent colon cancer|recurrent colon cancer
436982|NCT00003103|recurrent rectal cancer|recurrent rectal cancer
436983|NCT00003103|stage II esophageal cancer|stage ii esophageal cancer
436984|NCT00003103|stage III esophageal cancer|stage iii esophageal cancer
436985|NCT00003103|stage IV esophageal cancer|stage iv esophageal cancer
436986|NCT00003103|recurrent esophageal cancer|recurrent esophageal cancer
436987|NCT00003103|stage III renal cell cancer|stage iii renal cell cancer
436988|NCT00003103|stage IV renal cell cancer|stage iv renal cell cancer
436989|NCT00003103|recurrent renal cell cancer|recurrent renal cell cancer
436990|NCT00003103|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
436991|NCT00003103|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
436992|NCT00003103|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
436993|NCT00003103|stage III Wilms tumor|stage iii wilms tumor
436994|NCT00003103|stage IV Wilms tumor|stage iv wilms tumor
436995|NCT00003103|stage V Wilms tumor|stage v wilms tumor
436996|NCT00003103|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
436997|NCT00003103|stage III bladder cancer|stage iii bladder cancer
436998|NCT00003103|recurrent bladder cancer|recurrent bladder cancer
436999|NCT00003103|stage IV bladder cancer|stage iv bladder cancer
437000|NCT00003103|stage III prostate cancer|stage iii prostate cancer
437001|NCT00003103|stage IV prostate cancer|stage iv prostate cancer
437002|NCT00003103|recurrent prostate cancer|recurrent prostate cancer
437003|NCT00003103|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
437004|NCT00003103|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
437005|NCT00003103|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
437006|NCT00003103|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
437007|NCT00003103|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
752883|NCT01174589|Patients with Hip fracture|patients with hip fracture
458481|NCT00038844|Leukemia|leukemia
437008|NCT00003103|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
437009|NCT00003103|ovarian stromal cancer|ovarian stromal cancer
437010|NCT00003103|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
437011|NCT00003103|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
437012|NCT00003103|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
584894|NCT00516542|stage IV breast cancer|stage iv breast cancer
437013|NCT00003103|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
437014|NCT00003103|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
437015|NCT00003103|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
437016|NCT00003103|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
437017|NCT00003103|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
437018|NCT00003103|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
437019|NCT00003103|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
437020|NCT00003103|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
437021|NCT00003103|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
437022|NCT00003103|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
437023|NCT00003103|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
437024|NCT00003103|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
437025|NCT00003103|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
437026|NCT00003103|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
437027|NCT00003103|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
437028|NCT00003103|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
437029|NCT00003103|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
437030|NCT00003103|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
437031|NCT00003103|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
437897|NCT00004356|homocystinuria|homocystinuria
437032|NCT00003103|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
437033|NCT00003103|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
437034|NCT00003103|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
437035|NCT00003103|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
437036|NCT00003103|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
437037|NCT00003103|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
437038|NCT00003103|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
437039|NCT00003103|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
437040|NCT00003103|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
437041|NCT00003103|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
437042|NCT00003103|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
437043|NCT00003103|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
437044|NCT00003103|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
437045|NCT00003103|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
437046|NCT00003103|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
437047|NCT00003103|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
437048|NCT00003103|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
437049|NCT00003103|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
437050|NCT00003103|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
437051|NCT00003103|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
437052|NCT00003103|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
437053|NCT00003103|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
437054|NCT00003103|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
437055|NCT00003103|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
437056|NCT00003103|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
752884|NCT01174589|6 vs. 12 weeks physical strength training|6 vs. 12 weeks physical strength training
437057|NCT00003103|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
437058|NCT00003103|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
437059|NCT00003103|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
437388|NCT00003139|oral complications|oral complications
437060|NCT00003103|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
437061|NCT00003103|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
437062|NCT00003103|ovarian sarcoma|ovarian sarcoma
437063|NCT00003103|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
437064|NCT00003103|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
437065|NCT00003104|adenocarcinoma of the prostate|adenocarcinoma of the prostate
437066|NCT00003104|stage IIB prostate cancer|stage iib prostate cancer
437067|NCT00003104|stage IIA prostate cancer|stage iia prostate cancer
437068|NCT00003105|stage III bladder cancer|stage iii bladder cancer
437069|NCT00003105|recurrent bladder cancer|recurrent bladder cancer
437070|NCT00003105|stage IV bladder cancer|stage iv bladder cancer
437071|NCT00003105|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
437072|NCT00003105|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
437073|NCT00003105|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
437074|NCT00003105|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
437075|NCT00003107|stage IV breast cancer|stage iv breast cancer
437076|NCT00003107|stage IIIA breast cancer|stage iiia breast cancer
437077|NCT00003107|stage IIIB breast cancer|stage iiib breast cancer
437078|NCT00003107|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
437079|NCT00003107|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
437080|NCT00003107|refractory multiple myeloma|refractory multiple myeloma
437081|NCT00003107|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
437082|NCT00003107|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
437083|NCT00003107|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
437084|NCT00003107|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
437085|NCT00003107|disseminated neuroblastoma|disseminated neuroblastoma
437086|NCT00003107|recurrent neuroblastoma|recurrent neuroblastoma
437087|NCT00003107|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
437088|NCT00003107|stage I multiple myeloma|stage i multiple myeloma
437089|NCT00003107|stage II multiple myeloma|stage ii multiple myeloma
437090|NCT00003107|stage III multiple myeloma|stage iii multiple myeloma
437091|NCT00003107|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
437092|NCT00003107|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
437093|NCT00003107|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
437094|NCT00003107|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
437095|NCT00003107|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
437096|NCT00003107|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
437097|NCT00003107|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
437098|NCT00003107|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
437099|NCT00003107|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
437100|NCT00003107|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
437101|NCT00003107|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
437102|NCT00003107|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
437103|NCT00003107|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
437104|NCT00003107|testicular embryonal carcinoma|testicular embryonal carcinoma
437105|NCT00003107|testicular choriocarcinoma|testicular choriocarcinoma
437106|NCT00003107|testicular teratoma|testicular teratoma
437107|NCT00003107|testicular yolk sac tumor|testicular yolk sac tumor
437108|NCT00003107|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
437109|NCT00003107|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
437110|NCT00003107|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
437111|NCT00003107|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
437112|NCT00003107|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
437113|NCT00003107|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
437114|NCT00003107|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
437115|NCT00003107|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
437116|NCT00003107|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
437117|NCT00003107|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
437118|NCT00003107|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
436512|NCT00004263|Ara-C|ara-c
437119|NCT00003107|refractory hairy cell leukemia|refractory hairy cell leukemia
437120|NCT00003107|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
437122|NCT00003107|ovarian embryonal carcinoma|ovarian embryonal carcinoma
437123|NCT00003107|ovarian polyembryoma|ovarian polyembryoma
437124|NCT00003107|ovarian choriocarcinoma|ovarian choriocarcinoma
437125|NCT00003107|ovarian immature teratoma|ovarian immature teratoma
437126|NCT00003107|ovarian mature teratoma|ovarian mature teratoma
437514|NCT00003640|stage III bladder cancer|stage iii bladder cancer
437127|NCT00003107|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
437128|NCT00003107|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
437129|NCT00003107|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
437130|NCT00003107|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
437131|NCT00003107|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
437132|NCT00003107|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
437133|NCT00003107|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
437134|NCT00003107|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
437135|NCT00003107|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
437136|NCT00003107|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
437137|NCT00003107|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
437138|NCT00003107|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
437139|NCT00003107|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
437140|NCT00003107|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
437141|NCT00003107|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
437142|NCT00003107|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
437143|NCT00003107|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
437144|NCT00003107|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
437145|NCT00003107|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
437146|NCT00003107|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
437147|NCT00003107|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
437148|NCT00003107|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
437149|NCT00003107|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
437150|NCT00003107|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
437151|NCT00003107|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
437152|NCT00003107|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
437153|NCT00003107|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
437154|NCT00003107|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
437155|NCT00003107|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
437156|NCT00003107|secondary acute myeloid leukemia|secondary acute myeloid leukemia
437157|NCT00003107|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
437158|NCT00003107|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
437159|NCT00003107|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
437160|NCT00003107|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
437161|NCT00003107|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
437162|NCT00003107|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
437163|NCT00003107|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
437164|NCT00003107|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
437165|NCT00003107|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
437166|NCT00003107|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
437167|NCT00003107|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
437168|NCT00003107|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
437169|NCT00003107|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
437170|NCT00003107|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
437171|NCT00003107|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
437172|NCT00003107|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
437173|NCT00003107|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
437174|NCT00003107|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
437175|NCT00003107|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
437176|NCT00003107|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
437177|NCT00003107|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
437178|NCT00003107|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
437179|NCT00003107|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
437180|NCT00003107|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
552396|NCT00395070|DTIC|dtic
436963|NCT00003099|4-HPR|4-hpr
437181|NCT00003107|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
437182|NCT00003107|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
437183|NCT00003107|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
437184|NCT00003107|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
437185|NCT00003107|splenic marginal zone lymphoma|splenic marginal zone lymphoma
437186|NCT00003108|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
437187|NCT00003109|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
437188|NCT00003110|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
437189|NCT00003110|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
437190|NCT00003110|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
437191|NCT00003110|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
437192|NCT00003110|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
437193|NCT00003110|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
437194|NCT00003110|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
437195|NCT00003110|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
437196|NCT00003110|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
437197|NCT00003110|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
437198|NCT00003110|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
437199|NCT00003110|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
437200|NCT00003110|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
437201|NCT00003110|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
437202|NCT00003110|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
437203|NCT00003110|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
437204|NCT00003110|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
437205|NCT00003110|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
437206|NCT00003111|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
437207|NCT00003113|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
437208|NCT00003113|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
437209|NCT00003113|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
437210|NCT00003113|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
437211|NCT00003113|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
437212|NCT00003113|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
437213|NCT00003113|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
437214|NCT00003113|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
437215|NCT00003113|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
437216|NCT00003113|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
437217|NCT00003113|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
437218|NCT00003113|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
437219|NCT00003113|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
437220|NCT00003113|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
437221|NCT00003113|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
437222|NCT00003113|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
437223|NCT00003113|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
437224|NCT00003113|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
437225|NCT00003113|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
437226|NCT00003113|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
437227|NCT00003113|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
437228|NCT00003113|stage I mantle cell lymphoma|stage i mantle cell lymphoma
437229|NCT00003113|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
437230|NCT00003113|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
437231|NCT00003113|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
437232|NCT00003113|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
437233|NCT00003113|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
437234|NCT00003113|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
437235|NCT00003113|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
437236|NCT00003113|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
437237|NCT00003113|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
437238|NCT00003113|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
437239|NCT00003113|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
437240|NCT00003113|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
437241|NCT00003113|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
437242|NCT00003113|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
437243|NCT00003113|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
584895|NCT00516542|recurrent breast cancer|recurrent breast cancer
437244|NCT00003113|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
437245|NCT00003113|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
437246|NCT00003113|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
437247|NCT00003113|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
437248|NCT00003114|AIDS-related lymphoma|aids-related lymphoma
437249|NCT00003114|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
437250|NCT00003115|prostate cancer|prostate cancer
437252|NCT00003116|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
437253|NCT00003116|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
437254|NCT00003116|refractory multiple myeloma|refractory multiple myeloma
437255|NCT00003116|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
437256|NCT00003116|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
437257|NCT00003116|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
437258|NCT00003116|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
437259|NCT00003116|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
437260|NCT00003116|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
437261|NCT00003116|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
437262|NCT00003116|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
437263|NCT00003116|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
437264|NCT00003116|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
437265|NCT00003116|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
437266|NCT00003116|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
437267|NCT00003116|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
437620|NCT00003657|classic Kaposi sarcoma|classic kaposi sarcoma
437268|NCT00003116|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
437269|NCT00003116|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
437270|NCT00003116|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
437271|NCT00003116|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
437272|NCT00003116|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
437273|NCT00003116|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
437274|NCT00003116|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
437275|NCT00003116|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
437276|NCT00003116|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
437277|NCT00003116|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
437278|NCT00003116|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
437279|NCT00003116|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
437280|NCT00003116|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
437281|NCT00003116|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
437282|NCT00003116|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
437283|NCT00003116|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
437284|NCT00003116|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
437285|NCT00003116|splenic marginal zone lymphoma|splenic marginal zone lymphoma
437286|NCT00003116|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
437287|NCT00003116|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
437288|NCT00003116|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
437289|NCT00003116|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
437290|NCT00003116|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
437291|NCT00003116|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
437292|NCT00003117|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
437293|NCT00003117|squamous cell lung cancer|squamous cell lung cancer
437294|NCT00003117|large cell lung cancer|large cell lung cancer
437295|NCT00003117|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
437296|NCT00003117|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
437297|NCT00003117|adenocarcinoma of the lung|adenocarcinoma of the lung
552662|NCT00396032|HD|hd
437298|NCT00003117|adenosquamous cell lung cancer|adenosquamous cell lung cancer
437299|NCT00003118|stage I esophageal cancer|stage i esophageal cancer
437300|NCT00003118|stage II esophageal cancer|stage ii esophageal cancer
437301|NCT00003118|stage III esophageal cancer|stage iii esophageal cancer
437302|NCT00003118|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
437303|NCT00003118|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
753830|NCT01177865|stage IIB prostate cancer|stage iib prostate cancer
437304|NCT00003119|localized resectable neuroblastoma|localized resectable neuroblastoma
437305|NCT00003119|stage 4S neuroblastoma|stage 4s neuroblastoma
437306|NCT00003120|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
437307|NCT00003120|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
437308|NCT00003120|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
437309|NCT00003120|fallopian tube cancer|fallopian tube cancer
437310|NCT00003120|peritoneal cavity cancer|peritoneal cavity cancer
437311|NCT00003122|localized resectable neuroblastoma|localized resectable neuroblastoma
437312|NCT00003122|localized unresectable neuroblastoma|localized unresectable neuroblastoma
437313|NCT00003123|refractory anemia|refractory anemia
437314|NCT00003123|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
437315|NCT00003123|refractory anemia with excess blasts|refractory anemia with excess blasts
437316|NCT00003123|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
437317|NCT00003124|adenocarcinoma of the prostate|adenocarcinoma of the prostate
437318|NCT00003124|stage I prostate cancer|stage i prostate cancer
437319|NCT00003124|stage IIB prostate cancer|stage iib prostate cancer
437320|NCT00003124|stage IIA prostate cancer|stage iia prostate cancer
437321|NCT00003124|stage III prostate cancer|stage iii prostate cancer
437322|NCT00003125|stage IV breast cancer|stage iv breast cancer
437323|NCT00003125|stage IIIA breast cancer|stage iiia breast cancer
437324|NCT00003125|stage III gastric cancer|stage iii gastric cancer
437325|NCT00003125|stage IV gastric cancer|stage iv gastric cancer
437326|NCT00003125|stage IIIB breast cancer|stage iiib breast cancer
437327|NCT00003125|stage II pancreatic cancer|stage ii pancreatic cancer
437328|NCT00003125|stage III pancreatic cancer|stage iii pancreatic cancer
437329|NCT00003125|stage II esophageal cancer|stage ii esophageal cancer
437330|NCT00003125|stage III esophageal cancer|stage iii esophageal cancer
437331|NCT00003125|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
437332|NCT00003125|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
437333|NCT00003125|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
437334|NCT00003125|stage IV pancreatic cancer|stage iv pancreatic cancer
437335|NCT00003126|renal cell cancer|renal cell cancer
437336|NCT00003126|renal cell carcinoma|renal cell carcinoma
437337|NCT00003126|interleukin-2|interleukin-2
437338|NCT00003127|stage IV endometrial carcinoma|stage iv endometrial carcinoma
437339|NCT00003127|recurrent endometrial carcinoma|recurrent endometrial carcinoma
437340|NCT00003127|endometrial adenocarcinoma|endometrial adenocarcinoma
437341|NCT00003127|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
437342|NCT00003127|endometrial clear cell carcinoma|endometrial clear cell carcinoma
437343|NCT00003128|stage III uterine sarcoma|stage iii uterine sarcoma
437344|NCT00003128|stage IV uterine sarcoma|stage iv uterine sarcoma
437345|NCT00003128|recurrent uterine sarcoma|recurrent uterine sarcoma
437346|NCT00003128|uterine carcinosarcoma|uterine carcinosarcoma
437347|NCT00003129|stage 0 bladder cancer|stage 0 bladder cancer
437348|NCT00003129|stage I bladder cancer|stage i bladder cancer
437349|NCT00003129|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
437350|NCT00003130|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
437351|NCT00003131|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
437352|NCT00003132|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
437353|NCT00003133|stage III bladder cancer|stage iii bladder cancer
437354|NCT00003133|stage IV bladder cancer|stage iv bladder cancer
437355|NCT00003133|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
437356|NCT00003133|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
437357|NCT00003133|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
437358|NCT00003134|recurrent adult brain tumor|recurrent adult brain tumor
437359|NCT00003134|adult brain stem glioma|adult brain stem glioma
437360|NCT00003134|adult oligodendroglioma|adult oligodendroglioma
437361|NCT00003134|adult mixed glioma|adult mixed glioma
437362|NCT00003134|adult diffuse astrocytoma|adult diffuse astrocytoma
437363|NCT00003135|stage IV breast cancer|stage iv breast cancer
437364|NCT00003135|recurrent breast cancer|recurrent breast cancer
437365|NCT00003135|recurrent cervical cancer|recurrent cervical cancer
437366|NCT00003135|stage IVB cervical cancer|stage ivb cervical cancer
437367|NCT00003135|stage IVA cervical cancer|stage iva cervical cancer
437368|NCT00003135|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
437369|NCT00003135|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
437370|NCT00003135|stage IV endometrial carcinoma|stage iv endometrial carcinoma
437371|NCT00003135|recurrent endometrial carcinoma|recurrent endometrial carcinoma
437372|NCT00003135|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
437373|NCT00003135|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
437374|NCT00003135|male breast cancer|male breast cancer
437375|NCT00003136|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
437376|NCT00003136|primary peritoneal cavity cancer|primary peritoneal cavity cancer
437377|NCT00003137|stage IV gastric cancer|stage iv gastric cancer
437378|NCT00003137|stage IV esophageal cancer|stage iv esophageal cancer
437379|NCT00003137|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
437380|NCT00003137|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
437381|NCT00003137|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
437382|NCT00003137|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
437384|NCT00003138|refractory anemia|refractory anemia
437385|NCT00003138|myelodysplastic syndromes|myelodysplastic syndromes
437386|NCT00003138|erythropoietin|erythropoietin
437389|NCT00003139|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
437390|NCT00003139|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
437391|NCT00003140|stage I breast cancer|stage i breast cancer
437392|NCT00003140|stage II breast cancer|stage ii breast cancer
437393|NCT00003140|stage IIIA breast cancer|stage iiia breast cancer
437394|NCT00003141|childhood infratentorial ependymoma|childhood infratentorial ependymoma
437395|NCT00003141|childhood supratentorial ependymoma|childhood supratentorial ependymoma
437396|NCT00003141|disseminated neuroblastoma|disseminated neuroblastoma
437397|NCT00003141|stage 4S neuroblastoma|stage 4s neuroblastoma
437398|NCT00003141|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
437399|NCT00003141|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
437400|NCT00003141|childhood choroid plexus tumor|childhood choroid plexus tumor
437401|NCT00003141|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
437402|NCT00003141|untreated childhood brain stem glioma|untreated childhood brain stem glioma
437403|NCT00003141|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
437404|NCT00003141|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
437405|NCT00003141|untreated childhood medulloblastoma|untreated childhood medulloblastoma
437406|NCT00003141|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
437407|NCT00003141|localized resectable neuroblastoma|localized resectable neuroblastoma
437408|NCT00003141|localized unresectable neuroblastoma|localized unresectable neuroblastoma
437409|NCT00003141|regional neuroblastoma|regional neuroblastoma
437410|NCT00003141|childhood spinal cord neoplasm|childhood spinal cord neoplasm
437892|NCT00004353|rare disease|rare disease
437411|NCT00003141|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
437412|NCT00003141|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
437413|NCT00003141|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
437414|NCT00003141|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
437415|NCT00003141|childhood central nervous system germinoma|childhood central nervous system germinoma
437416|NCT00003141|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
437417|NCT00003141|childhood central nervous system teratoma|childhood central nervous system teratoma
437418|NCT00003141|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
437419|NCT00003143|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
437420|NCT00003143|Waldenström macroglobulinemia|waldenström macroglobulinemia
437421|NCT00003143|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
437422|NCT00003143|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
437423|NCT00003143|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
437424|NCT00003143|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
437425|NCT00003143|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
437426|NCT00003143|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
437427|NCT00003143|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
437428|NCT00003143|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
437429|NCT00003143|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
437430|NCT00003143|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
437431|NCT00003143|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
437432|NCT00003143|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
437433|NCT00003143|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
437434|NCT00003143|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
437435|NCT00003143|splenic marginal zone lymphoma|splenic marginal zone lymphoma
552902|NCT00396942|PD|pd
437436|NCT00003144|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
437437|NCT00003144|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
437438|NCT00003146|stage I multiple myeloma|stage i multiple myeloma
437439|NCT00003146|stage II multiple myeloma|stage ii multiple myeloma
437440|NCT00003146|stage III multiple myeloma|stage iii multiple myeloma
437441|NCT00003147|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
437442|NCT00003147|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
437443|NCT00003148|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
437444|NCT00003149|stage I multiple myeloma|stage i multiple myeloma
437445|NCT00003149|stage II multiple myeloma|stage ii multiple myeloma
437446|NCT00003149|stage III multiple myeloma|stage iii multiple myeloma
437447|NCT00003150|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
437448|NCT00003150|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
437449|NCT00003150|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
437450|NCT00003150|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
437451|NCT00003150|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
437452|NCT00003150|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
460232|NCT00033176|dithiol|dithiol
437453|NCT00003150|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
437454|NCT00003150|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
437455|NCT00003150|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
437456|NCT00003150|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
437457|NCT00003150|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
437458|NCT00003150|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
437459|NCT00003150|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
437460|NCT00003150|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
437461|NCT00003150|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
437462|NCT00003151|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
437463|NCT00003151|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
437464|NCT00003151|stage I marginal zone lymphoma|stage i marginal zone lymphoma
437465|NCT00003151|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
437466|NCT00003151|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
437467|NCT00003152|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
437468|NCT00003152|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
437469|NCT00003152|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
437470|NCT00003152|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
437471|NCT00003152|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
458483|NCT00038844|Campath|campath
437472|NCT00003152|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
437473|NCT00003153|refractory multiple myeloma|refractory multiple myeloma
437474|NCT00003154|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
437475|NCT00003154|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
437476|NCT00003156|recurrent uterine sarcoma|recurrent uterine sarcoma
437477|NCT00003156|uterine carcinosarcoma|uterine carcinosarcoma
437478|NCT00003157|stage IV gastric cancer|stage iv gastric cancer
437479|NCT00003157|recurrent gastric cancer|recurrent gastric cancer
437480|NCT00003157|recurrent pancreatic cancer|recurrent pancreatic cancer
437481|NCT00003157|stage IV pancreatic cancer|stage iv pancreatic cancer
437482|NCT00003158|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
437483|NCT00003158|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
437484|NCT00003159|stage I non-small cell lung cancer|stage i non-small cell lung cancer
437485|NCT00003159|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
437486|NCT00003159|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
437487|NCT00003159|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
437488|NCT00003159|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
437489|NCT00003160|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
437490|NCT00003160|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
437491|NCT00003160|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
437492|NCT00003160|fallopian tube cancer|fallopian tube cancer
437493|NCT00003160|primary peritoneal cavity cancer|primary peritoneal cavity cancer
437494|NCT00003639|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
437495|NCT00003639|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
437496|NCT00003639|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
437497|NCT00003639|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
438027|NCT00004747|cystic fibrosis|cystic fibrosis
437498|NCT00003639|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
437499|NCT00003639|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
437500|NCT00003639|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
437501|NCT00003639|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
437502|NCT00003639|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
437503|NCT00003639|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
437504|NCT00003639|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
584896|NCT00516542|male breast cancer|male breast cancer
437505|NCT00003639|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
437506|NCT00003639|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
437507|NCT00003639|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
753831|NCT01177865|stage IIA prostate cancer|stage iia prostate cancer
437508|NCT00003639|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
437509|NCT00003639|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
437510|NCT00003639|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
437511|NCT00003639|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
437512|NCT00003639|splenic marginal zone lymphoma|splenic marginal zone lymphoma
437513|NCT00003640|stage II bladder cancer|stage ii bladder cancer
460233|NCT00033189|duchenne|duchenne
437515|NCT00003640|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
437516|NCT00003641|stage II melanoma|stage ii melanoma
437517|NCT00003641|stage III melanoma|stage iii melanoma
437518|NCT00003642|stage II bladder cancer|stage ii bladder cancer
437519|NCT00003642|stage III bladder cancer|stage iii bladder cancer
437520|NCT00003642|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
437521|NCT00003643|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
437522|NCT00003643|testicular seminoma|testicular seminoma
437523|NCT00003643|testicular embryonal carcinoma|testicular embryonal carcinoma
437524|NCT00003643|testicular choriocarcinoma|testicular choriocarcinoma
437525|NCT00003643|testicular yolk sac tumor|testicular yolk sac tumor
437526|NCT00003643|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
437527|NCT00003643|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
437528|NCT00003643|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
437529|NCT00003643|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
437530|NCT00003643|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
437531|NCT00003643|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
437532|NCT00003643|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
437533|NCT00003643|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
437534|NCT00003643|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
437535|NCT00003643|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
437536|NCT00003643|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
437537|NCT00003643|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
437538|NCT00003643|stage IV extragonadal seminoma|stage iv extragonadal seminoma
437539|NCT00003643|testicular immature teratoma|testicular immature teratoma
437540|NCT00003643|testicular mature teratoma|testicular mature teratoma
437542|NCT00003644|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
437543|NCT00003644|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
437544|NCT00003644|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
437545|NCT00003644|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
437546|NCT00003644|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
437547|NCT00003644|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
437548|NCT00003644|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
437549|NCT00003644|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
437550|NCT00003644|Brenner tumor|brenner tumor
437551|NCT00003645|stage I prostate cancer|stage i prostate cancer
437552|NCT00003645|stage II prostate cancer|stage ii prostate cancer
437553|NCT00003646|adult solid tumor|adult solid tumor
437554|NCT00003646|body system/site cancer|body system/site cancer
437555|NCT00003646|cancer|cancer
437556|NCT00003646|melanoma|melanoma
437557|NCT00003646|recurrent melanoma|recurrent melanoma
437558|NCT00003646|skin tumor|skin tumor
437559|NCT00003646|solid tumor|solid tumor
437560|NCT00003646|stage III melanoma|stage iii melanoma
437561|NCT00003646|stage IV melanoma|stage iv melanoma
437562|NCT00003646|stage, melanoma|stage, melanoma
437563|NCT00003647|adult solid tumor|adult solid tumor
437564|NCT00003647|body system/site cancer|body system/site cancer
437565|NCT00003647|cancer|cancer
437566|NCT00003647|melanoma|melanoma
437567|NCT00003647|recurrent melanoma|recurrent melanoma
437568|NCT00003647|skin tumor|skin tumor
437569|NCT00003647|solid tumor|solid tumor
437570|NCT00003647|stage III melanoma|stage iii melanoma
437571|NCT00003647|stage IV melanoma|stage iv melanoma
437572|NCT00003647|stage, melanoma|stage, melanoma
437573|NCT00003648|stage I colon cancer|stage i colon cancer
437574|NCT00003648|stage II colon cancer|stage ii colon cancer
437575|NCT00003648|stage III colon cancer|stage iii colon cancer
437576|NCT00003648|stage IV colon cancer|stage iv colon cancer
437577|NCT00003648|stage I rectal cancer|stage i rectal cancer
437578|NCT00003648|stage II rectal cancer|stage ii rectal cancer
437579|NCT00003648|stage III rectal cancer|stage iii rectal cancer
437580|NCT00003648|stage IV rectal cancer|stage iv rectal cancer
437581|NCT00003648|recurrent colon cancer|recurrent colon cancer
437582|NCT00003648|recurrent rectal cancer|recurrent rectal cancer
437583|NCT00003649|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
437584|NCT00003649|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
437585|NCT00003649|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
437586|NCT00003649|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
437587|NCT00003650|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
437588|NCT00003650|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
437589|NCT00003650|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
437590|NCT00003650|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
437591|NCT00003652|stage II anal cancer|stage ii anal cancer
437592|NCT00003652|stage III anal cancer|stage iii anal cancer
437593|NCT00003652|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
437594|NCT00003652|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
437595|NCT00003652|basaloid carcinoma of the anus|basaloid carcinoma of the anus
437596|NCT00003653|adenocarcinoma of the prostate|adenocarcinoma of the prostate
437597|NCT00003653|recurrent prostate cancer|recurrent prostate cancer
437598|NCT00003654|stage I breast cancer|stage i breast cancer
437599|NCT00003654|stage II breast cancer|stage ii breast cancer
437600|NCT00003656|stage IV renal cell cancer|stage iv renal cell cancer
437601|NCT00003656|recurrent renal cell cancer|recurrent renal cell cancer
437603|NCT00003657|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
437604|NCT00003657|chondrosarcoma|chondrosarcoma
437605|NCT00003657|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
437606|NCT00003657|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
437607|NCT00003657|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
437608|NCT00003657|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
437609|NCT00003657|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
437610|NCT00003657|extensive stage small cell lung cancer|extensive stage small cell lung cancer
437611|NCT00003657|recurrent small cell lung cancer|recurrent small cell lung cancer
437612|NCT00003657|recurrent osteosarcoma|recurrent osteosarcoma
437613|NCT00003657|stage III bladder cancer|stage iii bladder cancer
437614|NCT00003657|recurrent bladder cancer|recurrent bladder cancer
437615|NCT00003657|stage IV bladder cancer|stage iv bladder cancer
437616|NCT00003657|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
437617|NCT00003657|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
437618|NCT00003657|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
437619|NCT00003657|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
437621|NCT00003657|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
437622|NCT00003657|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
437623|NCT00003657|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
437624|NCT00003657|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
437625|NCT00003657|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
437626|NCT00003657|ovarian stromal cancer|ovarian stromal cancer
437627|NCT00003657|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
437628|NCT00003657|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
437629|NCT00003657|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
437630|NCT00003657|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
437631|NCT00003657|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
437632|NCT00003657|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
437633|NCT00003657|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
437634|NCT00003657|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
437635|NCT00003657|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
437636|NCT00003657|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
437637|NCT00003657|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
752994|NCT01175057|post stationary rehabilitation|post stationary rehabilitation
437638|NCT00003657|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
437639|NCT00003657|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
437640|NCT00003657|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
437641|NCT00003657|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
437642|NCT00003657|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
437643|NCT00003657|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
437644|NCT00003657|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
437645|NCT00003657|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
437646|NCT00003657|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
437647|NCT00003657|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
437648|NCT00003657|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
437649|NCT00003657|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
437650|NCT00003657|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
437651|NCT00003657|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
437652|NCT00003657|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
437653|NCT00003657|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
437654|NCT00003657|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
437655|NCT00003657|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
437656|NCT00003657|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
437715|NCT00003659|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
437657|NCT00003657|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
437658|NCT00003657|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
437659|NCT00003657|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
437660|NCT00003657|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
437661|NCT00003657|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
437662|NCT00003657|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
437663|NCT00003657|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
437664|NCT00003657|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
437665|NCT00003657|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
437666|NCT00003657|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
437667|NCT00003657|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
437668|NCT00003657|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
437669|NCT00003657|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
437670|NCT00003657|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
437671|NCT00003657|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
437672|NCT00003657|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
437673|NCT00003657|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
437674|NCT00003657|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
437675|NCT00003657|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
437676|NCT00003657|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
437677|NCT00003657|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
437678|NCT00003657|extragonadal germ cell tumor|extragonadal germ cell tumor
437679|NCT00003657|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
437680|NCT00003657|stage III uterine sarcoma|stage iii uterine sarcoma
437681|NCT00003657|stage IV uterine sarcoma|stage iv uterine sarcoma
437682|NCT00003657|recurrent uterine sarcoma|recurrent uterine sarcoma
437683|NCT00003657|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
437684|NCT00003657|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
437686|NCT00003657|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
437687|NCT00003657|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
437688|NCT00003657|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
437689|NCT00003657|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
437690|NCT00003657|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
437691|NCT00003658|Waldenström macroglobulinemia|waldenström macroglobulinemia
437692|NCT00003658|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
437693|NCT00003658|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
437694|NCT00003658|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
437695|NCT00003658|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
437696|NCT00003658|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
437697|NCT00003658|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
437698|NCT00003658|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
437699|NCT00003658|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
437700|NCT00003658|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
437701|NCT00003658|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
437702|NCT00003658|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
437703|NCT00003658|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
437704|NCT00003658|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
437705|NCT00003658|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
437706|NCT00003658|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
437707|NCT00003658|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
437708|NCT00003658|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
437709|NCT00003658|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
437710|NCT00003658|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
437711|NCT00003658|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
437712|NCT00003658|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
437713|NCT00003658|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
437714|NCT00003658|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
437716|NCT00003659|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
437717|NCT00003659|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
437718|NCT00003661|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
437719|NCT00003661|stage 4S neuroblastoma|stage 4s neuroblastoma
437720|NCT00003661|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
437721|NCT00003661|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
437722|NCT00003661|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
437723|NCT00003661|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
437724|NCT00003661|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
437725|NCT00003661|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
437726|NCT00003661|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
437727|NCT00003661|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
437728|NCT00003661|refractory anemia with excess blasts|refractory anemia with excess blasts
437729|NCT00003661|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
437730|NCT00003661|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
437731|NCT00003661|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
437732|NCT00003661|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
437733|NCT00003661|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
437734|NCT00003661|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
437735|NCT00003661|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
437736|NCT00003661|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
437737|NCT00003661|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
437738|NCT00003661|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
437739|NCT00003661|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
437740|NCT00003661|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
437741|NCT00003661|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
437742|NCT00003661|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
437743|NCT00003661|graft versus host disease|graft versus host disease
437744|NCT00003661|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
437745|NCT00003661|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
437746|NCT00003661|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
437747|NCT00003661|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
437748|NCT00003661|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
437749|NCT00003661|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
437750|NCT00003661|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
437751|NCT00003661|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
437752|NCT00003661|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
437753|NCT00003661|splenic marginal zone lymphoma|splenic marginal zone lymphoma
437754|NCT00003661|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
437755|NCT00003662|noninvasive thymoma and thymic carcinoma|noninvasive thymoma and thymic carcinoma
437756|NCT00003662|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
437757|NCT00003662|refractory anemia|refractory anemia
437758|NCT00003662|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
437759|NCT00003662|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
437760|NCT00003662|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
437761|NCT00003662|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
437762|NCT00003662|graft versus host disease|graft versus host disease
437763|NCT00003662|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
437764|NCT00003663|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
437765|NCT00003663|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
437766|NCT00003663|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
437767|NCT00003663|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
437768|NCT00003663|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
437769|NCT00003663|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
437770|NCT00003663|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
437771|NCT00003663|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
437772|NCT00003663|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
437773|NCT00003663|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
437774|NCT00003663|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
437775|NCT00003663|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
437776|NCT00003663|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
437777|NCT00003663|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
437778|NCT00003663|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
437779|NCT00003663|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
437780|NCT00003663|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
437781|NCT00003663|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
437782|NCT00003663|splenic marginal zone lymphoma|splenic marginal zone lymphoma
437783|NCT00003664|stage IV renal cell cancer|stage iv renal cell cancer
437784|NCT00003664|recurrent renal cell cancer|recurrent renal cell cancer
437785|NCT00003665|stage IV melanoma|stage iv melanoma
437786|NCT00003665|recurrent melanoma|recurrent melanoma
437787|NCT00003666|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
437788|NCT00003666|squamous cell lung cancer|squamous cell lung cancer
437789|NCT00003666|large cell lung cancer|large cell lung cancer
437790|NCT00003666|adenocarcinoma of the lung|adenocarcinoma of the lung
437791|NCT00003666|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
437792|NCT00003667|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
437793|NCT00003667|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
437794|NCT00003667|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
437795|NCT00003667|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
437796|NCT00003667|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
437797|NCT00003669|stage IV endometrial carcinoma|stage iv endometrial carcinoma
437798|NCT00003669|recurrent endometrial carcinoma|recurrent endometrial carcinoma
437799|NCT00003670|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
437800|NCT00003670|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
437801|NCT00003670|primary peritoneal cavity cancer|primary peritoneal cavity cancer
437893|NCT00004354|endocrine disorders|endocrine disorders
437802|NCT00003671|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
437803|NCT00003671|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
437804|NCT00004328|endocrine disorders|endocrine disorders
437805|NCT00004328|pseudohypoaldosteronism|pseudohypoaldosteronism
437806|NCT00004328|rare disease|rare disease
437807|NCT00004329|endocrine disorders|endocrine disorders
437808|NCT00004329|rare disease|rare disease
437809|NCT00004330|inborn errors of metabolism|inborn errors of metabolism
437810|NCT00004330|porphyria|porphyria
437811|NCT00004330|rare disease|rare disease
437812|NCT00004331|inborn errors of metabolism|inborn errors of metabolism
437813|NCT00004331|porphyria|porphyria
437814|NCT00004331|rare disease|rare disease
437815|NCT00004332|acromegaly|acromegaly
437816|NCT00004332|endocrine disorders|endocrine disorders
437817|NCT00004332|rare disease|rare disease
437818|NCT00004333|inborn errors of metabolism|inborn errors of metabolism
437819|NCT00004333|rare disease|rare disease
437251|NCT00003115|pain|pain
437820|NCT00004333|tyrosinemia I|tyrosinemia i
437821|NCT00004334|Cushing's syndrome|cushing's syndrome
437822|NCT00004334|endocrine disorders|endocrine disorders
437823|NCT00004334|rare disease|rare disease
437824|NCT00004335|endocrine disorders|endocrine disorders
437825|NCT00004335|growth hormone deficiency|growth hormone deficiency
437826|NCT00004335|hypogonadism|hypogonadism
437827|NCT00004335|precocious puberty|precocious puberty
437828|NCT00004335|rare disease|rare disease
437829|NCT00004336|Mondini dysplasia|mondini dysplasia
437830|NCT00004336|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
437831|NCT00004336|rare disease|rare disease
437832|NCT00004338|Wilson disease|wilson disease
437833|NCT00004338|inborn errors of metabolism|inborn errors of metabolism
437834|NCT00004338|rare disease|rare disease
437835|NCT00004339|Wilson disease|wilson disease
437836|NCT00004339|inborn errors of metabolism|inborn errors of metabolism
437837|NCT00004339|rare disease|rare disease
437838|NCT00004340|end stage renal disease|end stage renal disease
437839|NCT00004340|rare disease|rare disease
437840|NCT00004340|renal and genitourinary disorders|renal and genitourinary disorders
437841|NCT00004340|renal osteodystrophy|renal osteodystrophy
437842|NCT00004341|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
437843|NCT00004341|X-linked agammaglobulinemia|x-linked agammaglobulinemia
437844|NCT00004341|X-linked hyper IgM syndrome|x-linked hyper igm syndrome
437845|NCT00004341|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
437846|NCT00004341|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
437847|NCT00004341|leukocyte adhesion deficiency syndrome|leukocyte adhesion deficiency syndrome
753832|NCT01177865|stage III prostate cancer|stage iii prostate cancer
437848|NCT00004341|primary immunodeficiency disease|primary immunodeficiency disease
437849|NCT00004341|rare disease|rare disease
437850|NCT00004342|chronic neutropenia|chronic neutropenia
437851|NCT00004342|disease-related problem/condition|disease-related problem/condition
437852|NCT00004342|hematologic disorders|hematologic disorders
437853|NCT00004342|neutropenia|neutropenia
437854|NCT00004342|rare disease|rare disease
437855|NCT00004342|severe chronic neutropenia|severe chronic neutropenia
437856|NCT00004343|Cushing's syndrome|cushing's syndrome
437857|NCT00004343|endocrine disorders|endocrine disorders
437858|NCT00004343|rare disease|rare disease
437859|NCT00004344|endocrine disorders|endocrine disorders
437860|NCT00004344|precocious puberty|precocious puberty
437861|NCT00004344|rare disease|rare disease
437862|NCT00004345|Usher syndrome|usher syndrome
437863|NCT00004345|ophthalmologic disorders|ophthalmologic disorders
437864|NCT00004345|rare disease|rare disease
437865|NCT00004345|retinitis pigmentosa|retinitis pigmentosa
437866|NCT00004346|cerebrotendinous xanthomatosis|cerebrotendinous xanthomatosis
437867|NCT00004346|inborn errors of metabolism|inborn errors of metabolism
437868|NCT00004346|rare disease|rare disease
437869|NCT00004347|Smith-Lemli-Opitz syndrome|smith-lemli-opitz syndrome
437870|NCT00004347|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
437871|NCT00004347|rare disease|rare disease
437872|NCT00004348|beta-oxidation disorder|beta-oxidation disorder
437873|NCT00004348|inborn errors of metabolism|inborn errors of metabolism
437874|NCT00004348|rare disease|rare disease
437875|NCT00004350|Fanconi syndrome|fanconi syndrome
437876|NCT00004350|cystinosis|cystinosis
437877|NCT00004350|rare disease|rare disease
437878|NCT00004350|renal and genitourinary disorders|renal and genitourinary disorders
437879|NCT00004351|Angelman syndrome|angelman syndrome
437880|NCT00004351|DiGeorge syndrome|digeorge syndrome
437881|NCT00004351|Prader-Willi syndrome|prader-willi syndrome
437882|NCT00004351|Shprintzen syndrome|shprintzen syndrome
437883|NCT00004351|Smith-Magenis syndrome|smith-magenis syndrome
437884|NCT00004351|Williams syndrome|williams syndrome
437885|NCT00004351|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
437886|NCT00004351|neurologic and psychiatric disorders|neurologic and psychiatric disorders
437887|NCT00004351|rare disease|rare disease
437888|NCT00004353|MELAS syndrome|melas syndrome
437889|NCT00004353|inborn errors of metabolism|inborn errors of metabolism
437890|NCT00004353|lactic acidosis|lactic acidosis
437891|NCT00004353|mitochondrial myopathy|mitochondrial myopathy
437894|NCT00004354|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
437898|NCT00004356|inborn errors of metabolism|inborn errors of metabolism
437899|NCT00004356|rare disease|rare disease
437900|NCT00004357|Cardiovascular Disease|cardiovascular disease
437901|NCT00004357|Respiratory Disease|respiratory disease
437902|NCT00004357|Rare Diseases|rare diseases
437903|NCT00004357|Vasculitis|vasculitis
437904|NCT00004696|disease-related problem/condition|disease-related problem/condition
437905|NCT00004696|pain|pain
437906|NCT00004696|intraoperative/postoperative complications|intraoperative/postoperative complications
437907|NCT00004696|rare disease|rare disease
437908|NCT00004697|gastrointestinal disorders|gastrointestinal disorders
437909|NCT00004697|hepatic steatosis|hepatic steatosis
437910|NCT00004697|rare disease|rare disease
437911|NCT00004699|endocrine disorders|endocrine disorders
437912|NCT00004699|hyperinsulinism|hyperinsulinism
437913|NCT00004699|rare disease|rare disease
437914|NCT00004700|endocrine disorders|endocrine disorders
437915|NCT00004700|hyperinsulinism|hyperinsulinism
437916|NCT00004700|rare disease|rare disease
437917|NCT00004705|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
437918|NCT00004705|cystic fibrosis|cystic fibrosis
437919|NCT00004705|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
437920|NCT00004705|rare disease|rare disease
437921|NCT00004727|African American|african american
437922|NCT00004727|antiplatelet|antiplatelet
437923|NCT00004727|aspirin|aspirin
437925|NCT00004727|acetylsalicylic acid|acetylsalicylic acid
437926|NCT00004727|ticlopidine|ticlopidine
437927|NCT00004727|prevention|prevention
437928|NCT00004727|stroke|stroke
437929|NCT00004727|cerebral infarction|cerebral infarction
437930|NCT00004727|Chicago|chicago
437931|NCT00004727|non-cardioembolic ischemic stroke|non-cardioembolic ischemic stroke
437932|NCT00004728|stroke|stroke
437933|NCT00004728|cerebral infarction|cerebral infarction
437934|NCT00004728|warfarin|warfarin
437935|NCT00004728|coumadin|coumadin
437936|NCT00004728|aspirin|aspirin
437937|NCT00004728|ASA|asa
437938|NCT00004728|acetysalicylic acid|acetysalicylic acid
437939|NCT00004728|atherosclerosis|atherosclerosis
437940|NCT00004728|stenosis|stenosis
437941|NCT00004728|intracranial|intracranial
437942|NCT00004728|artery|artery
437943|NCT00004728|arteries|arteries
437944|NCT00004728|transient ischemic attack|transient ischemic attack
437945|NCT00004728|TIA|tia
437946|NCT00004728|minorities|minorities
437947|NCT00004729|child|child
437948|NCT00004729|children|children
437949|NCT00004729|epilepsy|epilepsy
437950|NCT00004729|seizure|seizure
437951|NCT00004729|ketogenic|ketogenic
437952|NCT00004729|diet|diet
437953|NCT00004729|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
437954|NCT00004729|LGS|lgs
437955|NCT00004730|head injury|head injury
437956|NCT00004730|traumatic brain injury|traumatic brain injury
437957|NCT00004730|concussion|concussion
437958|NCT00004730|magnesium sulfate|magnesium sulfate
437959|NCT00004730|neuroprotection|neuroprotection
437960|NCT00004731|Parkinson's disease|parkinson's disease
437961|NCT00004731|coenzyme Q10|coenzyme q10
437962|NCT00004732|angioplasty|angioplasty
460234|NCT00033189|dystrophy|dystrophy
437963|NCT00004732|asymptomatic|asymptomatic
437964|NCT00004732|atherosclerosis|atherosclerosis
437965|NCT00004732|carotid endarterectomy|carotid endarterectomy
437966|NCT00004732|carotid stenting|carotid stenting
437967|NCT00004732|CREST|crest
437968|NCT00004732|Cerebral Infarction|cerebral infarction
437969|NCT00004732|device|device
437970|NCT00004732|intervention|intervention
437971|NCT00004732|restenosis|restenosis
437972|NCT00004732|revascularization|revascularization
437973|NCT00004732|stenosis|stenosis
437974|NCT00004732|stent|stent
437975|NCT00004732|stroke|stroke
437976|NCT00004732|symptomatic|symptomatic
437977|NCT00004732|surgery|surgery
437978|NCT00004732|transient ischemic attack|transient ischemic attack
437979|NCT00004733|Parkinson's|parkinson's
437980|NCT00004733|ELLDOPA|elldopa
437981|NCT00004733|L-dopa|l-dopa
437982|NCT00004733|levodopa|levodopa
437983|NCT00004733|Sinemet|sinemet
437984|NCT00004733|tremor|tremor
437985|NCT00004734|stroke|stroke
437986|NCT00004734|cerebral infarction|cerebral infarction
437987|NCT00004734|homocysteine|homocysteine
437988|NCT00004734|vitamin|vitamin
437989|NCT00004734|folic acid|folic acid
437990|NCT00004734|pyridoxine|pyridoxine
437991|NCT00004734|vitamin B6|vitamin b6
437992|NCT00004734|cyanocobalamin|cyanocobalamin
437993|NCT00004734|vitamin B12|vitamin b12
437994|NCT00004734|multivitamin|multivitamin
437995|NCT00004735|Viral Vaccines|viral vaccines
437996|NCT00004735|Drug Therapy, Combination|drug therapy, combination
437997|NCT00004735|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
437998|NCT00004735|Immunologic Memory|immunologic memory
437999|NCT00004735|Antibody Formation|antibody formation
438000|NCT00004735|Anti-HIV Agents|anti-hiv agents
438001|NCT00004735|Tetanus Toxoid|tetanus toxoid
438002|NCT00004735|Hepatitis A Virus, Human|hepatitis a virus, human
438005|NCT00004735|Treatment Naive|treatment naive
438006|NCT00004735|Treatment Experienced|treatment experienced
438007|NCT00004736|Tuberculosis|tuberculosis
438008|NCT00004736|Rifabutin|rifabutin
438009|NCT00004736|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
438010|NCT00004736|Drug Therapy, Combination|drug therapy, combination
438011|NCT00004736|Antitubercular Agents|antitubercular agents
438012|NCT00004736|Anti-HIV Agents|anti-hiv agents
438013|NCT00004738|Arnold Chiari Malformation|arnold chiari malformation
438014|NCT00004738|Skeletal Dysplasia|skeletal dysplasia
438015|NCT00004738|Syringomyelia|syringomyelia
438016|NCT00004738|Genetics|genetics
438017|NCT00004738|Chiari I Malformation|chiari i malformation
438018|NCT00004739|Pediatric HIV infection|pediatric hiv infection
437383|NCT00003138|anemia|anemia
438019|NCT00004740|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
438020|NCT00004740|rare disease|rare disease
438021|NCT00004740|tuberculosis|tuberculosis
438022|NCT00004744|multiple sclerosis|multiple sclerosis
438023|NCT00004744|neurologic and psychiatric disorders|neurologic and psychiatric disorders
438024|NCT00004744|rare disease|rare disease
438025|NCT00004747|bacterial infections|bacterial infections
438026|NCT00004747|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
438028|NCT00004747|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
438029|NCT00004747|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
438030|NCT00004747|rare disease|rare disease
438031|NCT00004748|cirrhosis|cirrhosis
438032|NCT00004748|gastrointestinal disorders|gastrointestinal disorders
438033|NCT00004748|primary biliary cirrhosis|primary biliary cirrhosis
438034|NCT00004748|rare disease|rare disease
438035|NCT00004751|cerebral palsy|cerebral palsy
438036|NCT00004751|neurologic and psychiatric disorders|neurologic and psychiatric disorders
438037|NCT00004751|rare disease|rare disease
438038|NCT00004751|spastic diplegia|spastic diplegia
438039|NCT00004753|Huntington's disease|huntington's disease
438040|NCT00004753|neurologic and psychiatric disorders|neurologic and psychiatric disorders
438041|NCT00004753|rare disease|rare disease
438042|NCT00004754|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
438043|NCT00004754|hypertensive disorder|hypertensive disorder
438044|NCT00004754|primary pulmonary hypertension|primary pulmonary hypertension
438045|NCT00004754|rare disease|rare disease
438046|NCT00004755|dermatologic disorders|dermatologic disorders
438047|NCT00004755|environmental/toxic disorders|environmental/toxic disorders
438048|NCT00004755|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
438049|NCT00004755|leishmaniasis|leishmaniasis
438050|NCT00004755|rare disease|rare disease
438051|NCT00004756|arthritis & connective tissue diseases|arthritis & connective tissue diseases
438052|NCT00004756|disease-related problem/condition|disease-related problem/condition
438053|NCT00004756|educational needs|educational needs
438054|NCT00004756|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
438055|NCT00004756|rare disease|rare disease
438056|NCT00004756|systemic lupus erythematosus|systemic lupus erythematosus
438057|NCT00004757|herpes simplex virus infection|herpes simplex virus infection
438058|NCT00004757|herpesvirus infection|herpesvirus infection
460235|NCT00033189|DMD|dmd
438059|NCT00004757|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
438060|NCT00004757|rare disease|rare disease
438061|NCT00004757|viral infection|viral infection
438062|NCT00004758|infantile spasms|infantile spasms
438063|NCT00004758|epilepsy|epilepsy
438064|NCT00004758|neurologic and psychiatric disorders|neurologic and psychiatric disorders
438065|NCT00004758|rare disease|rare disease
438066|NCT00004758|seizures|seizures
438067|NCT00004759|environmental/toxic disorders|environmental/toxic disorders
438068|NCT00004759|neurologic and psychiatric disorders|neurologic and psychiatric disorders
438069|NCT00004759|rare disease|rare disease
438070|NCT00004759|spinal cord injury|spinal cord injury
438071|NCT00004760|Parkinson disease|parkinson disease
438072|NCT00004760|Neurologic and psychiatric disorders|neurologic and psychiatric disorders
438073|NCT00004760|Rare disease|rare disease
438074|NCT00004761|dermatologic disorders|dermatologic disorders
438075|NCT00004761|epidermolysis bullosa|epidermolysis bullosa
438076|NCT00004761|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
438077|NCT00004761|rare disease|rare disease
438078|NCT00004762|gastrointestinal disorders|gastrointestinal disorders
438079|NCT00004762|primary sclerosing cholangitis|primary sclerosing cholangitis
438080|NCT00004762|rare disease|rare disease
438081|NCT00004763|endocrine disorders|endocrine disorders
438082|NCT00004763|hyperandrogenism|hyperandrogenism
438083|NCT00004763|rare disease|rare disease
438084|NCT00004767|inborn errors of metabolism|inborn errors of metabolism
438085|NCT00004767|rare disease|rare disease
438086|NCT00004767|urea cycle disorder|urea cycle disorder
438087|NCT00004769|Genetic diseases|genetic diseases
438088|NCT00004769|Myotonic muscular dystrophy|myotonic muscular dystrophy
438089|NCT00004769|Facioscapulohumeral muscular dystrophy|facioscapulohumeral muscular dystrophy
438090|NCT00004769|CMT|cmt
438091|NCT00004769|Rare disease|rare disease
458484|NCT00038844|Alemtuzumab|alemtuzumab
438092|NCT00004770|inborn errors of metabolism|inborn errors of metabolism
438093|NCT00004770|mitochondrial myopathy|mitochondrial myopathy
438094|NCT00004770|rare disease|rare disease
438095|NCT00004771|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
438096|NCT00004771|motor neuron disease|motor neuron disease
438097|NCT00004771|neurologic and psychiatric disorders|neurologic and psychiatric disorders
438098|NCT00004771|rare disease|rare disease
438099|NCT00004771|spinal and bulbar muscular atrophy|spinal and bulbar muscular atrophy
438100|NCT00004771|spinal muscular atrophy|spinal muscular atrophy
438101|NCT00004771|Kennedy's Syndrome|kennedy's syndrome
438102|NCT00004772|demyelinating neuropathy|demyelinating neuropathy
438103|NCT00004772|neurologic and psychiatric disorders|neurologic and psychiatric disorders
438104|NCT00004772|rare disease|rare disease
438105|NCT00004773|Rett syndrome|rett syndrome
438106|NCT00004773|neurologic and psychiatric disorders|neurologic and psychiatric disorders
438107|NCT00004773|rare disease|rare disease
438108|NCT00004776|Lennox-Gastaut syndrome|lennox-gastaut syndrome
438109|NCT00004776|epilepsy|epilepsy
438110|NCT00004776|neurologic and psychiatric disorders|neurologic and psychiatric disorders
438111|NCT00004776|rare disease|rare disease
438112|NCT00004776|seizures|seizures
438113|NCT00004778|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
438114|NCT00004778|neonatal disorders|neonatal disorders
438115|NCT00004778|rare disease|rare disease
438116|NCT00004778|respiratory distress syndrome|respiratory distress syndrome
438117|NCT00004779|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
438118|NCT00004779|cystic fibrosis|cystic fibrosis
438119|NCT00004779|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
438120|NCT00004779|rare disease|rare disease
438121|NCT00004781|HIV-associated candidiasis|hiv-associated candidiasis
438122|NCT00004781|candidiasis|candidiasis
438123|NCT00004781|disease-related problem/condition|disease-related problem/condition
438124|NCT00004781|fungal infection|fungal infection
438125|NCT00004781|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
438126|NCT00004781|infection|infection
438127|NCT00004781|rare disease|rare disease
438128|NCT00004784|cirrhosis|cirrhosis
438129|NCT00004784|gastrointestinal disorders|gastrointestinal disorders
438130|NCT00004784|primary biliary cirrhosis|primary biliary cirrhosis
438131|NCT00004784|rare disease|rare disease
438132|NCT00004785|bronchopulmonary dysplasia|bronchopulmonary dysplasia
438133|NCT00004785|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
438134|NCT00004785|neonatal disorders|neonatal disorders
438135|NCT00004785|rare disease|rare disease
438136|NCT00004786|Raynaud's syndrome|raynaud's syndrome
438137|NCT00004786|arthritis & connective tissue diseases|arthritis & connective tissue diseases
438138|NCT00004786|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
438139|NCT00004786|rare disease|rare disease
438140|NCT00004786|systemic sclerosis|systemic sclerosis
438141|NCT00004787|Fanconi's anemia|fanconi's anemia
438142|NCT00004787|Shwachman syndrome|shwachman syndrome
438143|NCT00004787|aplastic anemia|aplastic anemia
438144|NCT00004787|dermatologic disorders|dermatologic disorders
438145|NCT00004787|dyskeratosis congenita|dyskeratosis congenita
438146|NCT00004787|hematologic disorders|hematologic disorders
438147|NCT00004787|rare disease|rare disease
438148|NCT00004787|thrombocytopenia|thrombocytopenia
438149|NCT00004788|inborn errors of metabolism|inborn errors of metabolism
438151|NCT00004788|rare disease|rare disease
438152|NCT00004789|inborn errors of metabolism|inborn errors of metabolism
438153|NCT00004789|acute porphyria|acute porphyria
438154|NCT00004789|rare disease|rare disease
438155|NCT00004791|dermatologic disorders|dermatologic disorders
438156|NCT00004791|epidermolysis bullosa|epidermolysis bullosa
438157|NCT00004791|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
438158|NCT00004791|rare disease|rare disease
438159|NCT00004793|constitutional growth delay|constitutional growth delay
438160|NCT00004793|endocrine disorders|endocrine disorders
438161|NCT00004793|rare disease|rare disease
438162|NCT00004794|cytomegalovirus retinitis|cytomegalovirus retinitis
438163|NCT00004794|ophthalmologic disorders|ophthalmologic disorders
438164|NCT00004794|rare disease|rare disease
438165|NCT00004795|arthritis & connective tissue diseases|arthritis & connective tissue diseases
438166|NCT00004795|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
438167|NCT00004795|rare disease|rare disease
438168|NCT00004795|systemic lupus erythematosus|systemic lupus erythematosus
438169|NCT00004796|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
438170|NCT00004796|cirrhosis|cirrhosis
438171|NCT00004796|gastrointestinal disorders|gastrointestinal disorders
438172|NCT00004796|hypertensive disorder|hypertensive disorder
438173|NCT00004796|portal hypertension|portal hypertension
438174|NCT00004796|rare disease|rare disease
438175|NCT00004797|disease-related problem/condition|disease-related problem/condition
438176|NCT00004797|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
438177|NCT00004797|hematologic disorders|hematologic disorders
438178|NCT00004797|pain|pain
438179|NCT00004797|rare disease|rare disease
438180|NCT00004797|sickle cell anemia|sickle cell anemia
438181|NCT00004799|bacterial infection|bacterial infection
438182|NCT00004799|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
438183|NCT00004799|pertussis|pertussis
438184|NCT00004799|rare disease|rare disease
438185|NCT00004800|bacterial infection|bacterial infection
438186|NCT00004800|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
438187|NCT00004800|pertussis|pertussis
437541|NCT00003643|adult teratoma|adult teratoma
438188|NCT00004800|rare disease|rare disease
438189|NCT00004801|hematologic disorders|hematologic disorders
438190|NCT00004801|rare disease|rare disease
438191|NCT00004802|neurologic and psychiatric disorders|neurologic and psychiatric disorders
438192|NCT00004802|periodic paralysis|periodic paralysis
438193|NCT00004802|rare disease|rare disease
438194|NCT00004804|hepatitis C|hepatitis c
438195|NCT00004804|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
438196|NCT00004804|rare disease|rare disease
438197|NCT00004804|viral infection|viral infection
438198|NCT00004805|bronchopulmonary dysplasia|bronchopulmonary dysplasia
438199|NCT00004805|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
438200|NCT00004805|disease-related problem/condition|disease-related problem/condition
438201|NCT00004805|educational needs|educational needs
438202|NCT00004805|hypertensive disorder|hypertensive disorder
438204|NCT00004805|primary pulmonary hypertension|primary pulmonary hypertension
438205|NCT00004805|rare disease|rare disease
438206|NCT00004805|respiratory distress syndrome|respiratory distress syndrome
438207|NCT00004806|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
438208|NCT00004806|cystic fibrosis|cystic fibrosis
438209|NCT00004806|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
438210|NCT00004806|rare disease|rare disease
438211|NCT00004807|Rett syndrome|rett syndrome
438212|NCT00004807|neurologic and psychiatric disorders|neurologic and psychiatric disorders
438213|NCT00004807|rare disease|rare disease
438214|NCT00004808|blastomycosis|blastomycosis
438215|NCT00004808|fungal infection|fungal infection
438216|NCT00004808|histoplasmosis|histoplasmosis
438217|NCT00004808|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
438218|NCT00004808|rare disease|rare disease
438219|NCT00004808|sporotrichosis|sporotrichosis
438220|NCT00004809|familial hypercholesterolemia|familial hypercholesterolemia
438221|NCT00004809|inborn errors of metabolism|inborn errors of metabolism
438222|NCT00004809|rare disease|rare disease
438223|NCT00004810|gastrointestinal disorders|gastrointestinal disorders
438224|NCT00004810|rare disease|rare disease
438225|NCT00004810|ulcerative colitis|ulcerative colitis
438226|NCT00004811|blastomycosis|blastomycosis
438227|NCT00004811|fungal infection|fungal infection
438228|NCT00004811|histoplasmosis|histoplasmosis
438229|NCT00004811|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
438230|NCT00004811|rare disease|rare disease
438231|NCT00004811|sporotrichosis|sporotrichosis
438232|NCT00004812|environmental/toxic disorders|environmental/toxic disorders
438233|NCT00004812|neurologic and psychiatric disorders|neurologic and psychiatric disorders
438234|NCT00004812|rare disease|rare disease
438235|NCT00004812|spinal cord injury|spinal cord injury
438236|NCT00004814|multiple sclerosis|multiple sclerosis
438237|NCT00004814|neurologic and psychiatric disorders|neurologic and psychiatric disorders
438238|NCT00004814|rare disease|rare disease
438239|NCT00004815|Werner's syndrome|werner's syndrome
438240|NCT00004815|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
438241|NCT00004815|rare disease|rare disease
438242|NCT00004816|multiple sclerosis|multiple sclerosis
438243|NCT00004816|neurologic and psychiatric disorders|neurologic and psychiatric disorders
438244|NCT00004816|rare disease|rare disease
438245|NCT00004817|neurologic and psychiatric disorders|neurologic and psychiatric disorders
438246|NCT00004817|rare disease|rare disease
438247|NCT00004817|seizures|seizures
438248|NCT00004825|endocrine disorders|endocrine disorders
438249|NCT00004825|hyperinsulinism|hyperinsulinism
438250|NCT00004825|rare disease|rare disease
438251|NCT00004826|Parkinson disease|parkinson disease
438252|NCT00004826|neurologic and psychiatric disorders|neurologic and psychiatric disorders
438253|NCT00004826|rare disease|rare disease
438254|NCT00004827|ophthalmologic disorders|ophthalmologic disorders
438255|NCT00004827|rare disease|rare disease
438256|NCT00004827|retinitis pigmentosa|retinitis pigmentosa
438257|NCT00004828|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
438258|NCT00004828|heart defects|heart defects
438259|NCT00004828|rare disease|rare disease
438260|NCT00004829|bacterial infection|bacterial infection
438261|NCT00004829|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
438262|NCT00004829|cystic fibrosis|cystic fibrosis
438263|NCT00004829|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
438264|NCT00004829|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
438265|NCT00004829|rare disease|rare disease
458485|NCT00038844|Fludarabine|fludarabine
438273|NCT00004833|Guillain-Barre syndrome|guillain-barre syndrome
438274|NCT00004833|demyelinating neuropathy|demyelinating neuropathy
438275|NCT00004833|neurologic and psychiatric disorders|neurologic and psychiatric disorders
438276|NCT00004833|rare disease|rare disease
438277|NCT00004834|anxiety disorder|anxiety disorder
438278|NCT00004834|disease-related problem/condition|disease-related problem/condition
438279|NCT00004834|neurologic and psychiatric disorders|neurologic and psychiatric disorders
438280|NCT00004834|panic disorder|panic disorder
438281|NCT00004834|rare disease|rare disease
438282|NCT00004838|environmental/toxic disorders|environmental/toxic disorders
438283|NCT00004838|lead poisoning|lead poisoning
438284|NCT00004838|rare disease|rare disease
438285|NCT00004840|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
438286|NCT00004840|neonatal disorders|neonatal disorders
438287|NCT00004840|rare disease|rare disease
438288|NCT00004840|respiratory distress syndrome|respiratory distress syndrome
438289|NCT00004842|cirrhosis|cirrhosis
438290|NCT00004842|gastrointestinal disorders|gastrointestinal disorders
438291|NCT00004842|primary biliary cirrhosis|primary biliary cirrhosis
438292|NCT00004842|primary sclerosing cholangitis|primary sclerosing cholangitis
438293|NCT00004842|rare disease|rare disease
555409|NCT00413400|TNF|tnf
438294|NCT00004843|disease-related problem/condition|disease-related problem/condition
438295|NCT00004843|endocrine disorders|endocrine disorders
438296|NCT00004843|hyperparathyroidism|hyperparathyroidism
438297|NCT00004843|quality of life|quality of life
438298|NCT00004843|rare disease|rare disease
438299|NCT00004844|Parkinson Disease|parkinson disease
438300|NCT00004844|neurologic and psychiatric disorders|neurologic and psychiatric disorders
438301|NCT00004844|rare disease|rare disease
438302|NCT00004845|Anti-inflammatory|anti-inflammatory
438303|NCT00004846|Viral Gene Amplification|viral gene amplification
438304|NCT00004846|Blood Transmitted Infections|blood transmitted infections
438305|NCT00004846|Transfusion Risks|transfusion risks
438306|NCT00004846|Transcription Mediated Analysis|transcription mediated analysis
438307|NCT00004846|Viral Detection Assays|viral detection assays
438308|NCT00004846|HIV Seronegativity|hiv seronegativity
438318|NCT00004848|AIDS|aids
438319|NCT00004848|Autologous Blood|autologous blood
438320|NCT00004848|Cardiac Surgery|cardiac surgery
438321|NCT00004848|HIV|hiv
438322|NCT00004848|Hepatocellular Inflammation|hepatocellular inflammation
438323|NCT00004848|Liver Biopsy|liver biopsy
438324|NCT00004848|Long Term Sera Storage|long term sera storage
438325|NCT00004848|Non-A Hepatitis|non-a hepatitis
438326|NCT00004848|Non-B Hepatitis|non-b hepatitis
438327|NCT00004850|Hepatitis C Virus|hepatitis c virus
438328|NCT00004850|Blood Donors|blood donors
438329|NCT00004850|Liver Biopsy|liver biopsy
438330|NCT00004850|ALT|alt
438331|NCT00004850|Natural History|natural history
438332|NCT00004851|HCV Antibody Library|hcv antibody library
438333|NCT00004852|HIV-1|hiv-1
438334|NCT00004852|Drug Therapy, Combination|drug therapy, combination
438335|NCT00004852|Zidovudine|zidovudine
438336|NCT00004852|Drug Administration Schedule|drug administration schedule
438337|NCT00004852|Lamivudine|lamivudine
438338|NCT00004852|Genotype|genotype
438339|NCT00004852|Phenotype|phenotype
438340|NCT00004852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
438341|NCT00004852|Anti-HIV Agents|anti-hiv agents
438342|NCT00004852|Viral Load|viral load
438343|NCT00004852|efavirenz|efavirenz
438344|NCT00004853|AMGEN|amgen
438345|NCT00004853|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
438346|NCT00004853|MPNST|mpnst
438347|NCT00004853|Randomized|randomized
438348|NCT00004853|Sarcoma|sarcoma
438349|NCT00004853|Tumor|tumor
438350|NCT00004854|moderate heart failure|moderate heart failure
438351|NCT00004855|Drug Therapy, Combination|drug therapy, combination
438352|NCT00004855|Nevirapine|nevirapine
438353|NCT00004855|Stavudine|stavudine
438354|NCT00004855|HIV Protease Inhibitors|hiv protease inhibitors
438355|NCT00004855|Ritonavir|ritonavir
438356|NCT00004855|Lamivudine|lamivudine
438357|NCT00004855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
438358|NCT00004855|Anti-HIV Agents|anti-hiv agents
438359|NCT00004855|ABT 378|abt 378
438360|NCT00004855|abacavir|abacavir
438361|NCT00004857|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
438362|NCT00004857|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
438363|NCT00004857|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
438364|NCT00004857|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
438365|NCT00004857|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
438366|NCT00004858|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
438367|NCT00004858|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
438368|NCT00004858|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
438369|NCT00004858|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
438370|NCT00004858|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
438371|NCT00004858|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
438372|NCT00004858|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
438373|NCT00004858|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
438374|NCT00004858|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
438375|NCT00004858|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
438376|NCT00004858|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
438377|NCT00004858|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
438378|NCT00004858|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
438379|NCT00004858|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
438380|NCT00004858|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
438381|NCT00004859|squamous cell lung cancer|squamous cell lung cancer
438382|NCT00004859|large cell lung cancer|large cell lung cancer
438383|NCT00004859|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
438384|NCT00004859|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
438385|NCT00004859|adenocarcinoma of the lung|adenocarcinoma of the lung
438386|NCT00004859|adenosquamous cell lung cancer|adenosquamous cell lung cancer
438387|NCT00004859|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
438388|NCT00004860|stage III colon cancer|stage iii colon cancer
438389|NCT00004860|stage IV colon cancer|stage iv colon cancer
438390|NCT00004860|stage III rectal cancer|stage iii rectal cancer
438391|NCT00004860|stage IV rectal cancer|stage iv rectal cancer
438392|NCT00004860|recurrent colon cancer|recurrent colon cancer
438393|NCT00004860|recurrent rectal cancer|recurrent rectal cancer
438394|NCT00004860|adenocarcinoma of the colon|adenocarcinoma of the colon
438395|NCT00004860|adenocarcinoma of the rectum|adenocarcinoma of the rectum
438396|NCT00004861|stage II pancreatic cancer|stage ii pancreatic cancer
438397|NCT00004861|stage III pancreatic cancer|stage iii pancreatic cancer
438398|NCT00004861|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
438399|NCT00004861|stage IV pancreatic cancer|stage iv pancreatic cancer
438400|NCT00004862|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
438401|NCT00004862|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
438402|NCT00004863|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
438403|NCT00004864|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
438404|NCT00004865|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
438405|NCT00004865|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
753932|NCT01178307|patient-reported outcomes|patient-reported outcomes
438406|NCT00004865|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
438407|NCT00004865|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
438408|NCT00004865|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
438409|NCT00004865|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
438410|NCT00004865|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
438411|NCT00004865|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
438412|NCT00004865|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
438413|NCT00004865|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
438414|NCT00004865|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
438415|NCT00004865|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
438416|NCT00004865|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
438417|NCT00004865|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
438418|NCT00004866|stage III cervical cancer|stage iii cervical cancer
438419|NCT00004866|stage IV cervical cancer|stage iv cervical cancer
438420|NCT00004866|recurrent cervical cancer|recurrent cervical cancer
438421|NCT00004866|cervical squamous cell carcinoma|cervical squamous cell carcinoma
438422|NCT00004867|stage I esophageal cancer|stage i esophageal cancer
438423|NCT00004867|stage II esophageal cancer|stage ii esophageal cancer
438424|NCT00004867|stage III esophageal cancer|stage iii esophageal cancer
438425|NCT00004867|stage IV esophageal cancer|stage iv esophageal cancer
438556|NCT00004879|recurrent prostate cancer|recurrent prostate cancer
438426|NCT00004867|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
438427|NCT00004867|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
438428|NCT00004868|recurrent adult brain tumor|recurrent adult brain tumor
438429|NCT00004868|adult meningioma|adult meningioma
438430|NCT00004868|adult glioblastoma|adult glioblastoma
438431|NCT00004868|adult anaplastic astrocytoma|adult anaplastic astrocytoma
438432|NCT00004868|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
438433|NCT00004868|adult mixed glioma|adult mixed glioma
438434|NCT00004868|adult grade III meningioma|adult grade iii meningioma
438435|NCT00004868|adult giant cell glioblastoma|adult giant cell glioblastoma
438436|NCT00004868|adult gliosarcoma|adult gliosarcoma
438437|NCT00004870|stage IV colon cancer|stage iv colon cancer
438438|NCT00004870|stage IV rectal cancer|stage iv rectal cancer
554511|NCT00410241|Genome|genome
438439|NCT00004870|recurrent colon cancer|recurrent colon cancer
438440|NCT00004870|recurrent rectal cancer|recurrent rectal cancer
438441|NCT00004870|adenocarcinoma of the colon|adenocarcinoma of the colon
438442|NCT00004870|adenocarcinoma of the rectum|adenocarcinoma of the rectum
438443|NCT00004871|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
438444|NCT00004871|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
438445|NCT00004871|refractory anemia|refractory anemia
438446|NCT00004871|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
438447|NCT00004871|refractory anemia with excess blasts|refractory anemia with excess blasts
438448|NCT00004871|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
438449|NCT00004871|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
438450|NCT00004871|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
438451|NCT00004871|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
438452|NCT00004871|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
438453|NCT00004871|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
438454|NCT00004871|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
438455|NCT00004872|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
438456|NCT00004873|stage III gastric cancer|stage iii gastric cancer
438457|NCT00004873|stage IV gastric cancer|stage iv gastric cancer
438458|NCT00004873|recurrent gastric cancer|recurrent gastric cancer
438459|NCT00004874|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
438460|NCT00004874|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
438461|NCT00004874|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
438462|NCT00004875|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
438463|NCT00004875|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
438464|NCT00004875|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
438465|NCT00004875|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
438466|NCT00004875|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
438467|NCT00004875|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
438468|NCT00004875|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
438469|NCT00004875|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
438470|NCT00004875|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
438471|NCT00004875|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
438477|NCT00004875|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
438478|NCT00004875|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
438479|NCT00004875|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
438480|NCT00004875|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
438481|NCT00004875|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
438482|NCT00004875|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
438483|NCT00004875|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
461321|NCT00046397|Vaccination|vaccination
438484|NCT00004875|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
438485|NCT00004875|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
438486|NCT00004875|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
438487|NCT00004875|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
438488|NCT00004875|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
438489|NCT00004875|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
438490|NCT00004875|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
438491|NCT00004875|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
438492|NCT00004875|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
438493|NCT00004875|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
438557|NCT00004879|recurrent colon cancer|recurrent colon cancer
438494|NCT00004875|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
438495|NCT00004875|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
438496|NCT00004875|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
438497|NCT00004875|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
438498|NCT00004875|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
438499|NCT00004875|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
438500|NCT00004875|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
438501|NCT00004875|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
438502|NCT00004875|stage I mantle cell lymphoma|stage i mantle cell lymphoma
438503|NCT00004875|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
438504|NCT00004875|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
438505|NCT00004875|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
438506|NCT00004875|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
438507|NCT00004875|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
438508|NCT00004875|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
438509|NCT00004875|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
438510|NCT00004875|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
438511|NCT00004875|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
438512|NCT00004875|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
438513|NCT00004875|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
438514|NCT00004875|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
438515|NCT00004875|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
438516|NCT00004875|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
438517|NCT00004875|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
438518|NCT00004875|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
438519|NCT00004875|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
438520|NCT00004875|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
438521|NCT00004875|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
438522|NCT00004875|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
438523|NCT00004875|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
438524|NCT00004875|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
438268|NCT00004831|porphyria|porphyria
438525|NCT00004875|anaplastic large cell lymphoma|anaplastic large cell lymphoma
438527|NCT00004875|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
438528|NCT00004875|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
438529|NCT00004875|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
438530|NCT00004875|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
438531|NCT00004875|stage I marginal zone lymphoma|stage i marginal zone lymphoma
438532|NCT00004875|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
438533|NCT00004875|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
438534|NCT00004875|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
438535|NCT00004875|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
438536|NCT00004875|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
438537|NCT00004875|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
438538|NCT00004875|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
438539|NCT00004875|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
438540|NCT00004875|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
438541|NCT00004875|splenic marginal zone lymphoma|splenic marginal zone lymphoma
438542|NCT00004876|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
438543|NCT00004876|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
438544|NCT00004876|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
438545|NCT00004876|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
438546|NCT00004876|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
438547|NCT00004876|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
438548|NCT00004876|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
438549|NCT00004876|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
438550|NCT00004877|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
438551|NCT00004878|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
438552|NCT00004878|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
438553|NCT00004878|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
438554|NCT00004878|graft versus host disease|graft versus host disease
438555|NCT00004879|recurrent renal cell cancer|recurrent renal cell cancer
438558|NCT00004879|recurrent rectal cancer|recurrent rectal cancer
438559|NCT00004879|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
438560|NCT00004879|recurrent pancreatic cancer|recurrent pancreatic cancer
438561|NCT00004879|recurrent esophageal cancer|recurrent esophageal cancer
438562|NCT00004880|stage IV renal cell cancer|stage iv renal cell cancer
438563|NCT00004880|recurrent renal cell cancer|recurrent renal cell cancer
438564|NCT00004881|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
438565|NCT00004884|stage III pancreatic cancer|stage iii pancreatic cancer
438566|NCT00004884|recurrent pancreatic cancer|recurrent pancreatic cancer
438567|NCT00004884|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
438568|NCT00004884|stage IV pancreatic cancer|stage iv pancreatic cancer
438569|NCT00004885|stage IV colon cancer|stage iv colon cancer
438570|NCT00004885|stage IV rectal cancer|stage iv rectal cancer
438571|NCT00004885|recurrent colon cancer|recurrent colon cancer
438572|NCT00004885|recurrent rectal cancer|recurrent rectal cancer
438573|NCT00004885|adenocarcinoma of the colon|adenocarcinoma of the colon
438574|NCT00004885|adenocarcinoma of the rectum|adenocarcinoma of the rectum
438575|NCT00004886|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
438576|NCT00004887|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
438577|NCT00004887|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
438578|NCT00004887|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
438579|NCT00004889|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
438580|NCT00004890|stage I renal cell cancer|stage i renal cell cancer
438581|NCT00004890|stage II renal cell cancer|stage ii renal cell cancer
438582|NCT00004890|stage III renal cell cancer|stage iii renal cell cancer
438583|NCT00004890|stage IV renal cell cancer|stage iv renal cell cancer
438584|NCT00004890|recurrent renal cell cancer|recurrent renal cell cancer
438585|NCT00004890|drug extravasation|drug extravasation
438586|NCT00004891|stage II rectal cancer|stage ii rectal cancer
438587|NCT00004891|stage III rectal cancer|stage iii rectal cancer
438588|NCT00004891|stage IV rectal cancer|stage iv rectal cancer
438589|NCT00004892|recurrent adult brain tumor|recurrent adult brain tumor
438590|NCT00004892|adult brain stem glioma|adult brain stem glioma
438591|NCT00004892|adult ependymoma|adult ependymoma
438592|NCT00004892|adult glioblastoma|adult glioblastoma
438593|NCT00004892|adult oligodendroglioma|adult oligodendroglioma
438594|NCT00004892|adult anaplastic astrocytoma|adult anaplastic astrocytoma
438595|NCT00004892|adult mixed glioma|adult mixed glioma
438596|NCT00004892|adult giant cell glioblastoma|adult giant cell glioblastoma
438597|NCT00004892|adult gliosarcoma|adult gliosarcoma
438598|NCT00004893|stage IV breast cancer|stage iv breast cancer
438599|NCT00004893|recurrent breast cancer|recurrent breast cancer
438600|NCT00004895|stage I colon cancer|stage i colon cancer
438601|NCT00004895|stage II colon cancer|stage ii colon cancer
438602|NCT00004895|stage III colon cancer|stage iii colon cancer
438603|NCT00004895|stage IV colon cancer|stage iv colon cancer
438604|NCT00004895|stage I gastric cancer|stage i gastric cancer
438605|NCT00004895|stage II gastric cancer|stage ii gastric cancer
438606|NCT00004895|stage III gastric cancer|stage iii gastric cancer
438607|NCT00004895|stage IV gastric cancer|stage iv gastric cancer
438608|NCT00004895|recurrent gastric cancer|recurrent gastric cancer
438609|NCT00004895|stage I pancreatic cancer|stage i pancreatic cancer
438610|NCT00004895|stage II pancreatic cancer|stage ii pancreatic cancer
438611|NCT00004895|stage III pancreatic cancer|stage iii pancreatic cancer
438612|NCT00004895|stage IV pancreatic cancer|stage iv pancreatic cancer
438613|NCT00004895|recurrent pancreatic cancer|recurrent pancreatic cancer
438614|NCT00004895|stage I rectal cancer|stage i rectal cancer
438615|NCT00004895|stage II rectal cancer|stage ii rectal cancer
438616|NCT00004895|stage III rectal cancer|stage iii rectal cancer
438617|NCT00004895|stage IV rectal cancer|stage iv rectal cancer
438618|NCT00004895|recurrent colon cancer|recurrent colon cancer
438619|NCT00004895|recurrent rectal cancer|recurrent rectal cancer
438620|NCT00004895|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
438621|NCT00004895|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
438622|NCT00004895|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
438623|NCT00004895|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
438624|NCT00004895|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
438625|NCT00004895|small intestine adenocarcinoma|small intestine adenocarcinoma
438626|NCT00004895|small intestine lymphoma|small intestine lymphoma
438627|NCT00004895|small intestine leiomyosarcoma|small intestine leiomyosarcoma
438628|NCT00004895|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
438629|NCT00004895|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
438630|NCT00004895|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
438631|NCT00004895|recurrent small intestine cancer|recurrent small intestine cancer
438632|NCT00004895|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
438633|NCT00004895|peritoneal cavity cancer|peritoneal cavity cancer
438634|NCT00004895|nausea and vomiting|nausea and vomiting
438635|NCT00004895|gastrointestinal stromal tumor|gastrointestinal stromal tumor
438636|NCT00004896|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
458987|NCT00041964|Viral Load|viral load
438637|NCT00004896|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
438638|NCT00004896|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
438639|NCT00004896|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
438640|NCT00004896|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
438641|NCT00004896|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
438642|NCT00004896|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
438643|NCT00004896|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
438644|NCT00004896|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
438645|NCT00004896|refractory anemia|refractory anemia
438646|NCT00004896|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
438647|NCT00004896|refractory anemia with excess blasts|refractory anemia with excess blasts
438648|NCT00004896|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
438649|NCT00004896|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
438650|NCT00004896|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
438651|NCT00004896|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
438652|NCT00004896|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
438653|NCT00004896|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
438654|NCT00004896|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
438655|NCT00004896|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
438656|NCT00004896|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
438657|NCT00004896|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
438658|NCT00004896|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
438659|NCT00004896|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
438660|NCT00004897|stage I esophageal cancer|stage i esophageal cancer
438661|NCT00004897|stage II esophageal cancer|stage ii esophageal cancer
438662|NCT00004897|stage III esophageal cancer|stage iii esophageal cancer
438663|NCT00004897|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
438664|NCT00004897|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
438665|NCT00004898|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
438666|NCT00004898|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
439165|NCT00003926|liver cancer|liver cancer
438667|NCT00004898|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
753933|NCT01178320|Magnetic Resonance Imaging|magnetic resonance imaging
438668|NCT00004898|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
438669|NCT00004898|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
438670|NCT00004898|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
438671|NCT00004898|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
438672|NCT00004898|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
438673|NCT00004898|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
438674|NCT00004898|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
438675|NCT00004898|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
438676|NCT00004898|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
438677|NCT00004898|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
438678|NCT00004898|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
438679|NCT00004898|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
438680|NCT00004898|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
438681|NCT00004898|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
438682|NCT00004898|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
438683|NCT00004898|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
438684|NCT00004898|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
438685|NCT00004898|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
438686|NCT00004898|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
438687|NCT00004898|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
438688|NCT00004898|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
438689|NCT00004898|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
438690|NCT00004898|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
438691|NCT00004898|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
438692|NCT00004898|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
438693|NCT00004898|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
438694|NCT00004898|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
438695|NCT00004898|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
438696|NCT00004898|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
438697|NCT00004898|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
458988|NCT00041964|puerperium|puerperium
438698|NCT00004898|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
438699|NCT00004899|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
438700|NCT00004899|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
438701|NCT00004899|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
438702|NCT00004899|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
438703|NCT00004899|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
438704|NCT00004899|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
554965|NCT00405106|stress|stress
438705|NCT00004899|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
438706|NCT00004899|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
438707|NCT00004899|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
438708|NCT00004899|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
438709|NCT00004899|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
438710|NCT00004899|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
438711|NCT00004899|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
438712|NCT00004899|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
438713|NCT00004899|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
438714|NCT00004899|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
438715|NCT00004899|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
438716|NCT00004899|secondary acute myeloid leukemia|secondary acute myeloid leukemia
438717|NCT00004899|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
438718|NCT00004899|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
438719|NCT00004899|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
438720|NCT00004899|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
438721|NCT00004899|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
438722|NCT00004899|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
438723|NCT00004899|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
438724|NCT00004899|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
438725|NCT00004899|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
438726|NCT00004899|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
438727|NCT00004900|stage IV breast cancer|stage iv breast cancer
438728|NCT00004900|recurrent breast cancer|recurrent breast cancer
438729|NCT00004900|stage IIIB breast cancer|stage iiib breast cancer
438730|NCT00004901|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
438731|NCT00004901|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
438732|NCT00004901|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
438733|NCT00004901|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
438734|NCT00004901|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
438735|NCT00004901|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
438736|NCT00004901|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
438737|NCT00004901|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
438738|NCT00004901|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
438739|NCT00004901|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
438740|NCT00004901|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
438741|NCT00004901|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
438742|NCT00004901|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
438743|NCT00004901|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
438744|NCT00004901|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
461322|NCT00046397|Variola|variola
438745|NCT00004901|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
438746|NCT00004901|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
438747|NCT00004901|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
438748|NCT00004901|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
438749|NCT00004901|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
438750|NCT00004901|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
438751|NCT00004901|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
438752|NCT00004901|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
438753|NCT00004901|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
438754|NCT00004902|refractory multiple myeloma|refractory multiple myeloma
438755|NCT00004902|stage I multiple myeloma|stage i multiple myeloma
438756|NCT00004902|stage II multiple myeloma|stage ii multiple myeloma
438757|NCT00004902|stage III multiple myeloma|stage iii multiple myeloma
438758|NCT00004903|refractory multiple myeloma|refractory multiple myeloma
438759|NCT00004903|stage I multiple myeloma|stage i multiple myeloma
438760|NCT00004903|stage II multiple myeloma|stage ii multiple myeloma
438761|NCT00004903|stage III multiple myeloma|stage iii multiple myeloma
438762|NCT00004904|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
555105|NCT00411645|CMV|cmv
438763|NCT00004904|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
438764|NCT00004904|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
438765|NCT00004904|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
438766|NCT00004904|isolated plasmacytoma of bone|isolated plasmacytoma of bone
438767|NCT00004904|extramedullary plasmacytoma|extramedullary plasmacytoma
438768|NCT00004904|refractory multiple myeloma|refractory multiple myeloma
438769|NCT00004904|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
438770|NCT00004904|stage III multiple myeloma|stage iii multiple myeloma
438771|NCT00004904|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
438772|NCT00004904|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
438773|NCT00004904|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
438774|NCT00004904|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
438775|NCT00004904|small intestine lymphoma|small intestine lymphoma
438776|NCT00004904|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
438777|NCT00004904|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
438778|NCT00004904|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
438779|NCT00004904|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
438780|NCT00004904|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
438781|NCT00004904|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
438783|NCT00004904|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
438784|NCT00004904|essential thrombocythemia|essential thrombocythemia
438785|NCT00004904|refractory hairy cell leukemia|refractory hairy cell leukemia
438786|NCT00004904|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
438787|NCT00004904|acute undifferentiated leukemia|acute undifferentiated leukemia
438788|NCT00004904|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
438789|NCT00004904|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
438790|NCT00004904|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
438791|NCT00004904|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
438792|NCT00004904|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
438793|NCT00004904|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
438794|NCT00004904|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
438795|NCT00004904|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
438796|NCT00004904|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
438797|NCT00004904|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
438798|NCT00004904|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
438799|NCT00004904|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
438800|NCT00004904|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
438801|NCT00004904|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
438802|NCT00004904|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
438803|NCT00004904|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
438804|NCT00004904|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
438805|NCT00004904|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
438806|NCT00004904|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
438807|NCT00004904|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
438808|NCT00004904|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
438809|NCT00004904|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
461323|NCT00046397|Adults|adults
438810|NCT00004904|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
438811|NCT00004904|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
438812|NCT00004904|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
438813|NCT00004904|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
438814|NCT00004904|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
438815|NCT00004904|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
438816|NCT00004904|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
438817|NCT00004904|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
438818|NCT00004904|secondary acute myeloid leukemia|secondary acute myeloid leukemia
438819|NCT00004904|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
438820|NCT00004904|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
438821|NCT00004904|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
438822|NCT00004904|graft versus host disease|graft versus host disease
438823|NCT00004904|primary systemic amyloidosis|primary systemic amyloidosis
438824|NCT00004904|intraocular lymphoma|intraocular lymphoma
438825|NCT00004904|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
438203|NCT00004805|neonatal disorders|neonatal disorders
438826|NCT00004904|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
438827|NCT00004904|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
438828|NCT00004904|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
438829|NCT00004904|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
438830|NCT00004904|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
438831|NCT00004904|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
438832|NCT00004904|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
438833|NCT00004904|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
438834|NCT00004904|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
438835|NCT00004904|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
438836|NCT00004904|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
438837|NCT00004904|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
438838|NCT00004904|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
438839|NCT00004904|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
438840|NCT00004904|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
438841|NCT00004904|splenic marginal zone lymphoma|splenic marginal zone lymphoma
438842|NCT00004904|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
438843|NCT00004905|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
438844|NCT00004905|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
438845|NCT00004905|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
438846|NCT00004905|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
438847|NCT00004905|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
438848|NCT00004905|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
438849|NCT00004906|stage IV breast cancer|stage iv breast cancer
438850|NCT00004906|recurrent breast cancer|recurrent breast cancer
438851|NCT00004907|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
438852|NCT00004907|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
438853|NCT00004907|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
438854|NCT00004907|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
438855|NCT00004907|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
438856|NCT00004907|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
438857|NCT00004907|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
438858|NCT00004907|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
438859|NCT00004907|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
438860|NCT00004907|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
438861|NCT00004907|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
438862|NCT00004907|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
438863|NCT00004907|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
438864|NCT00004907|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
438865|NCT00004907|splenic marginal zone lymphoma|splenic marginal zone lymphoma
438866|NCT00004908|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
438867|NCT00004908|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
438868|NCT00004908|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
438869|NCT00004908|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
438870|NCT00004908|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
438871|NCT00004908|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
438872|NCT00004908|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
438873|NCT00004908|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
438874|NCT00004908|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
438875|NCT00004908|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
438876|NCT00004908|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
438877|NCT00004908|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
438878|NCT00004908|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
438879|NCT00004908|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
438880|NCT00004908|splenic marginal zone lymphoma|splenic marginal zone lymphoma
438881|NCT00004909|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
438882|NCT00004909|peritoneal cavity cancer|peritoneal cavity cancer
438883|NCT00004909|quality of life|quality of life
438884|NCT00004910|stage I colon cancer|stage i colon cancer
438885|NCT00004910|stage II colon cancer|stage ii colon cancer
438886|NCT00004910|stage III colon cancer|stage iii colon cancer
438887|NCT00004910|stage IV colon cancer|stage iv colon cancer
201011|NCT02112630|Hepatitis C Infection|hepatitis c infection
438888|NCT00004910|stage I gastric cancer|stage i gastric cancer
438889|NCT00004910|stage II gastric cancer|stage ii gastric cancer
438890|NCT00004910|stage III gastric cancer|stage iii gastric cancer
438891|NCT00004910|stage IV gastric cancer|stage iv gastric cancer
438892|NCT00004910|recurrent gastric cancer|recurrent gastric cancer
438893|NCT00004910|stage I pancreatic cancer|stage i pancreatic cancer
438894|NCT00004910|stage II pancreatic cancer|stage ii pancreatic cancer
438895|NCT00004910|stage III pancreatic cancer|stage iii pancreatic cancer
438896|NCT00004910|recurrent pancreatic cancer|recurrent pancreatic cancer
438897|NCT00004910|recurrent colon cancer|recurrent colon cancer
584897|NCT00516555|Breech Presentation|breech presentation
438898|NCT00004910|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
438899|NCT00004910|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
438900|NCT00004910|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
438901|NCT00004910|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
438902|NCT00004910|small intestine adenocarcinoma|small intestine adenocarcinoma
438903|NCT00004910|small intestine lymphoma|small intestine lymphoma
438904|NCT00004910|small intestine leiomyosarcoma|small intestine leiomyosarcoma
438905|NCT00004910|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
438906|NCT00004910|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
438907|NCT00004910|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
438908|NCT00004910|recurrent small intestine cancer|recurrent small intestine cancer
438909|NCT00004910|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
438910|NCT00004910|quality of life|quality of life
438911|NCT00004910|gastrointestinal stromal tumor|gastrointestinal stromal tumor
438912|NCT00004910|stage IV pancreatic cancer|stage iv pancreatic cancer
438913|NCT00004911|stage I colon cancer|stage i colon cancer
438914|NCT00004911|stage II colon cancer|stage ii colon cancer
438915|NCT00004911|stage III colon cancer|stage iii colon cancer
438916|NCT00004911|stage IV colon cancer|stage iv colon cancer
438917|NCT00004911|stage I gastric cancer|stage i gastric cancer
438918|NCT00004911|stage II gastric cancer|stage ii gastric cancer
438919|NCT00004911|stage III gastric cancer|stage iii gastric cancer
438920|NCT00004911|stage IV gastric cancer|stage iv gastric cancer
438921|NCT00004911|recurrent gastric cancer|recurrent gastric cancer
438922|NCT00004911|stage I rectal cancer|stage i rectal cancer
438923|NCT00004911|stage II rectal cancer|stage ii rectal cancer
438924|NCT00004911|stage III rectal cancer|stage iii rectal cancer
438925|NCT00004911|stage IV rectal cancer|stage iv rectal cancer
438926|NCT00004911|recurrent colon cancer|recurrent colon cancer
438927|NCT00004911|recurrent rectal cancer|recurrent rectal cancer
438928|NCT00004911|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
438929|NCT00004911|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
438930|NCT00004911|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
438931|NCT00004911|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
438932|NCT00004911|small intestine adenocarcinoma|small intestine adenocarcinoma
438933|NCT00004911|small intestine lymphoma|small intestine lymphoma
438934|NCT00004911|small intestine leiomyosarcoma|small intestine leiomyosarcoma
438935|NCT00004911|recurrent small intestine cancer|recurrent small intestine cancer
438936|NCT00004911|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
438937|NCT00004911|quality of life|quality of life
438938|NCT00004911|gastrointestinal stromal tumor|gastrointestinal stromal tumor
438939|NCT00004912|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
438940|NCT00004912|fatigue|fatigue
438941|NCT00004912|cachexia|cachexia
438942|NCT00004913|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
438943|NCT00004914|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
438944|NCT00004914|anemia|anemia
438945|NCT00004914|fatigue|fatigue
438946|NCT00004915|recurrent endometrial carcinoma|recurrent endometrial carcinoma
438947|NCT00004916|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
438948|NCT00004916|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
438949|NCT00004916|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
438950|NCT00004916|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
438951|NCT00004916|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
438952|NCT00004917|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
438953|NCT00004917|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
438954|NCT00004917|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
438955|NCT00004917|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
438956|NCT00004917|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
555492|NCT00413621|MRI|mri
438957|NCT00004917|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
438958|NCT00004917|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
438959|NCT00004917|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
438960|NCT00004917|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
458989|NCT00041977|Rosacea|rosacea
438961|NCT00004917|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
438962|NCT00004917|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
438963|NCT00004917|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
438964|NCT00004917|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
438965|NCT00004917|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
438966|NCT00004917|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
438967|NCT00004917|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
438968|NCT00004917|anemia|anemia
438969|NCT00004920|localized malignant mesothelioma|localized malignant mesothelioma
438970|NCT00004920|advanced malignant mesothelioma|advanced malignant mesothelioma
438971|NCT00004920|recurrent malignant mesothelioma|recurrent malignant mesothelioma
438972|NCT00004921|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
438973|NCT00004921|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
438974|NCT00004922|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
438975|NCT00004922|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
438976|NCT00004922|stage III neuroendocrine carcinoma of the skin|stage iii neuroendocrine carcinoma of the skin
438977|NCT00004922|recurrent neuroendocrine carcinoma of the skin|recurrent neuroendocrine carcinoma of the skin
438978|NCT00004922|neuroendocrine carcinoma|neuroendocrine carcinoma
438979|NCT00004923|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
438980|NCT00004924|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
438981|NCT00004924|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
438982|NCT00004925|stage IV breast cancer|stage iv breast cancer
438983|NCT00004925|recurrent breast cancer|recurrent breast cancer
438984|NCT00004925|stage IIIB breast cancer|stage iiib breast cancer
438985|NCT00004925|inflammatory breast cancer|inflammatory breast cancer
438986|NCT00004926|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
438987|NCT00004927|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
438988|NCT00004928|adenocarcinoma of the prostate|adenocarcinoma of the prostate
438989|NCT00004928|stage I prostate cancer|stage i prostate cancer
438990|NCT00004928|stage IIB prostate cancer|stage iib prostate cancer
438991|NCT00004928|stage IIA prostate cancer|stage iia prostate cancer
438992|NCT00004928|stage III prostate cancer|stage iii prostate cancer
438993|NCT00004928|stage IV prostate cancer|stage iv prostate cancer
438994|NCT00004928|recurrent prostate cancer|recurrent prostate cancer
438995|NCT00004929|recurrent prostate cancer|recurrent prostate cancer
438996|NCT00004930|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
438997|NCT00004930|extensive stage small cell lung cancer|extensive stage small cell lung cancer
438998|NCT00004930|recurrent small cell lung cancer|recurrent small cell lung cancer
438999|NCT00004930|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
439000|NCT00004930|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
439001|NCT00004930|lung metastases|lung metastases
439002|NCT00004930|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
439003|NCT00004932|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
439004|NCT00004932|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
439005|NCT00004932|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
439006|NCT00004932|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
439007|NCT00004932|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
439008|NCT00004933|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
439009|NCT00004933|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
439010|NCT00004933|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
461701|NCT00047580|Spasticity|spasticity
439011|NCT00004934|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
439012|NCT00004934|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
439013|NCT00004934|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
439014|NCT00004934|fallopian tube cancer|fallopian tube cancer
439015|NCT00004934|primary peritoneal cavity cancer|primary peritoneal cavity cancer
439016|NCT00004935|stage IV breast cancer|stage iv breast cancer
439017|NCT00004935|recurrent breast cancer|recurrent breast cancer
439018|NCT00004936|stage III cervical cancer|stage iii cervical cancer
439019|NCT00004936|stage IB cervical cancer|stage ib cervical cancer
439020|NCT00004936|stage IIB cervical cancer|stage iib cervical cancer
439021|NCT00004936|stage IVB cervical cancer|stage ivb cervical cancer
439022|NCT00004936|stage IIA cervical cancer|stage iia cervical cancer
439023|NCT00004936|stage IVA cervical cancer|stage iva cervical cancer
439024|NCT00004936|cervical squamous cell carcinoma|cervical squamous cell carcinoma
439025|NCT00004936|cervical adenocarcinoma|cervical adenocarcinoma
439026|NCT00004936|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
439027|NCT00004937|recurrent adult brain tumor|recurrent adult brain tumor
439028|NCT00004937|adult glioblastoma|adult glioblastoma
439029|NCT00004937|adult giant cell glioblastoma|adult giant cell glioblastoma
439030|NCT00004937|adult gliosarcoma|adult gliosarcoma
439031|NCT00004938|fungal infection|fungal infection
439032|NCT00004938|rare disease|rare disease
439033|NCT00004938|sporotrichosis|sporotrichosis
439034|NCT00004939|demyelinating neuropathy|demyelinating neuropathy
439035|NCT00004939|neurologic and psychiatric disorders|neurologic and psychiatric disorders
439036|NCT00004939|rare disease|rare disease
439037|NCT00004940|erythropoietic protoporphyria|erythropoietic protoporphyria
439038|NCT00004940|inborn errors of metabolism|inborn errors of metabolism
439039|NCT00004940|porphyria|porphyria
439040|NCT00004940|rare disease|rare disease
439041|NCT00004941|Crohn's disease|crohn's disease
439042|NCT00004941|gastrointestinal disorders|gastrointestinal disorders
439043|NCT00004941|rare disease|rare disease
439044|NCT00004978|Recombinant Proteins|recombinant proteins
439045|NCT00004978|Injections, Subcutaneous|injections, subcutaneous
439046|NCT00004978|HIV-1|hiv-1
439047|NCT00004978|Interleukin-2|interleukin-2
439048|NCT00004978|Drug Therapy, Combination|drug therapy, combination
439049|NCT00004978|CD4 Lymphocyte Count|cd4 lymphocyte count
439050|NCT00004978|Disease Progression|disease progression
439051|NCT00004978|Follow-Up Studies|follow-up studies
439052|NCT00004978|Anti-HIV Agents|anti-hiv agents
439053|NCT00004979|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
439054|NCT00004980|neurologic and psychiatric disorders|neurologic and psychiatric disorders
439055|NCT00004980|rare disease|rare disease
439056|NCT00004980|schizophrenia|schizophrenia
439057|NCT00004981|Drug Therapy, Combination|drug therapy, combination
439058|NCT00004981|Zidovudine|zidovudine
439059|NCT00004981|Drug Administration Schedule|drug administration schedule
439060|NCT00004981|Lamivudine|lamivudine
439061|NCT00004981|RNA, Viral|rna, viral
439062|NCT00004981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
439063|NCT00004981|Anti-HIV Agents|anti-hiv agents
439064|NCT00004981|Viral Load|viral load
439065|NCT00004981|Combivir|combivir
439066|NCT00004981|abacavir|abacavir
439067|NCT00004982|chelation therapy|chelation therapy
439068|NCT00004982|combination chemotherapy|combination chemotherapy
439069|NCT00004982|iron poisoning|iron poisoning
439070|NCT00004982|thalassemia|thalassemia
439071|NCT00004982|chelating agent|chelating agent
439072|NCT00004982|deferoxamine|deferoxamine
439073|NCT00004982|drug screening /evaluation|drug screening /evaluation
439074|NCT00004982|therapy evaluation|therapy evaluation
439075|NCT00004983|diabetes mellitus, type 2|diabetes mellitus, type 2
439076|NCT00004983|diabetes self-management education|diabetes self-management education
439077|NCT00004983|diabetes self-care|diabetes self-care
439078|NCT00004983|blood glucose self-monitoring|blood glucose self-monitoring
439079|NCT00004983|health education|health education
439080|NCT00004983|patient education|patient education
439081|NCT00004984|diabetes|diabetes
439082|NCT00004984|insulin|insulin
439083|NCT00004984|prediction|prediction
439084|NCT00004984|prevention|prevention
439085|NCT00004984|C-peptide levels|c-peptide levels
439086|NCT00004984|insulin autoantibodies|insulin autoantibodies
439087|NCT00004984|pancreatic beta cell autoantibodies|pancreatic beta cell autoantibodies
439088|NCT00004984|cellular immune responses|cellular immune responses
439089|NCT00004984|prediction of type 1 diabetes|prediction of type 1 diabetes
439090|NCT00004985|HIV-1|hiv-1
439091|NCT00004985|Drug Therapy, Combination|drug therapy, combination
439092|NCT00004985|HIV Protease Inhibitors|hiv protease inhibitors
439093|NCT00004985|RNA, Viral|rna, viral
439094|NCT00004985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
439095|NCT00004985|Anti-HIV Agents|anti-hiv agents
439096|NCT00004985|Viral Load|viral load
439097|NCT00004985|Nelfinavir|nelfinavir
439098|NCT00004986|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
439099|NCT00004986|Cryptosporidiosis|cryptosporidiosis
439100|NCT00004986|Drug Evaluation|drug evaluation
439101|NCT00004986|Antiprotozoal Agents|antiprotozoal agents
439102|NCT00004986|Treatment Failure|treatment failure
439103|NCT00004986|nitazoxanide|nitazoxanide
439104|NCT00004987|Anti-HIV Agents|anti-hiv agents
439105|NCT00004987|Viral Load|viral load
439106|NCT00004987|dextrin 2-sulfate|dextrin 2-sulfate
439107|NCT00004987|Infusions, Parenteral|infusions, parenteral
439108|NCT00004988|Anti-Tumor Effects|anti-tumor effects
439109|NCT00004988|Maximum Tolerated Dose (MTD)|maximum tolerated dose (mtd)
439110|NCT00004988|Metastatic Cancer|metastatic cancer
439111|NCT00004988|Pharmacokinetics|pharmacokinetics
439112|NCT00004988|Solid Tumors|solid tumors
439113|NCT00004988|Tumor|tumor
439114|NCT00003923|stage I pancreatic cancer|stage i pancreatic cancer
439115|NCT00003923|stage II pancreatic cancer|stage ii pancreatic cancer
439116|NCT00003923|stage III pancreatic cancer|stage iii pancreatic cancer
439117|NCT00003923|stage IV pancreatic cancer|stage iv pancreatic cancer
439118|NCT00003923|recurrent pancreatic cancer|recurrent pancreatic cancer
439119|NCT00003923|unresectable gallbladder cancer|unresectable gallbladder cancer
439120|NCT00003923|recurrent gallbladder cancer|recurrent gallbladder cancer
439121|NCT00003923|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
439122|NCT00003923|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
439123|NCT00003923|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
439124|NCT00003923|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
439125|NCT00003923|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
439126|NCT00003924|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
439127|NCT00003924|Waldenström macroglobulinemia|waldenström macroglobulinemia
439128|NCT00003924|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
439129|NCT00003924|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
439130|NCT00003924|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
439131|NCT00003924|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
439132|NCT00003924|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
439133|NCT00003924|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
439134|NCT00003924|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
439135|NCT00003924|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
439136|NCT00003924|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
439137|NCT00003924|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
439138|NCT00003924|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
439139|NCT00003924|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
439140|NCT00003924|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
439141|NCT00003924|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
439142|NCT00003924|splenic marginal zone lymphoma|splenic marginal zone lymphoma
439143|NCT00003925|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
439145|NCT00003926|regional neuroblastoma|regional neuroblastoma
439146|NCT00003926|disseminated neuroblastoma|disseminated neuroblastoma
439147|NCT00003926|recurrent Wilms tumor|recurrent wilms tumor
439148|NCT00003926|recurrent retinoblastoma|recurrent retinoblastoma
439149|NCT00003926|recurrent adult brain tumor|recurrent adult brain tumor
439150|NCT00003926|adult rhabdomyosarcoma|adult rhabdomyosarcoma
439151|NCT00003926|ovarian germ cell tumor|ovarian germ cell tumor
439152|NCT00003926|chordoma|chordoma
439153|NCT00003926|ovarian sarcoma|ovarian sarcoma
439154|NCT00003926|unresectable neuroblastoma|unresectable neuroblastoma
439155|NCT00003926|desmoplastic small round cell tumor|desmoplastic small round cell tumor
439156|NCT00003926|rhabdomyosarcoma|rhabdomyosarcoma
439157|NCT00003926|Ewing sarcoma|ewing sarcoma
439158|NCT00003926|neuroectodermal tumor|neuroectodermal tumor
439160|NCT00003926|malignant testicular germ cell tumor|malignant testicular germ cell tumor
439161|NCT00003926|malignant ovarian germ cell tumor|malignant ovarian germ cell tumor
439162|NCT00003926|extragonadal germ cell tumor|extragonadal germ cell tumor
439163|NCT00003926|malignant germ cell tumor|malignant germ cell tumor
439164|NCT00003926|hepatoblastoma|hepatoblastoma
439166|NCT00003926|medulloblastoma|medulloblastoma
439167|NCT00003926|cerebellar astrocytoma|cerebellar astrocytoma
439168|NCT00003926|brain stem glioma|brain stem glioma
439169|NCT00003926|glioma|glioma
439170|NCT00003926|cerebral astrocytoma|cerebral astrocytoma
439171|NCT00003926|ependymoma|ependymoma
439172|NCT00003927|stage II breast cancer|stage ii breast cancer
439173|NCT00003927|stage IV breast cancer|stage iv breast cancer
439174|NCT00003927|stage IIIA breast cancer|stage iiia breast cancer
439175|NCT00003927|stage IIIB breast cancer|stage iiib breast cancer
439176|NCT00003928|stage IV renal cell cancer|stage iv renal cell cancer
439177|NCT00003928|recurrent renal cell cancer|recurrent renal cell cancer
439178|NCT00003929|primary central nervous system lymphoma|primary central nervous system lymphoma
439179|NCT00003929|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
439180|NCT00003930|stage II bladder cancer|stage ii bladder cancer
439181|NCT00003930|stage III bladder cancer|stage iii bladder cancer
439776|NCT00004006|intraocular retinoblastoma|intraocular retinoblastoma
439182|NCT00003931|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
439183|NCT00003931|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
439184|NCT00003933|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
439185|NCT00003935|untreated childhood brain stem glioma|untreated childhood brain stem glioma
439186|NCT00003936|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
439187|NCT00003937|localized osteosarcoma|localized osteosarcoma
439188|NCT00003937|cardiac toxicity|cardiac toxicity
439189|NCT00003938|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
439190|NCT00003938|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
439191|NCT00003938|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
439192|NCT00003938|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
439193|NCT00003938|stage IV breast cancer|stage iv breast cancer
439194|NCT00003938|stage IIIA breast cancer|stage iiia breast cancer
439195|NCT00003938|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
439196|NCT00003938|stage IIIB breast cancer|stage iiib breast cancer
439197|NCT00003938|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
439198|NCT00003938|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
439199|NCT00003938|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
439200|NCT00003938|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
439201|NCT00003938|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
439202|NCT00003938|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
439203|NCT00003938|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
439204|NCT00003938|isolated plasmacytoma of bone|isolated plasmacytoma of bone
439205|NCT00003938|extramedullary plasmacytoma|extramedullary plasmacytoma
439206|NCT00003938|refractory multiple myeloma|refractory multiple myeloma
439207|NCT00003938|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
439208|NCT00003938|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
439209|NCT00003938|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
439210|NCT00003938|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
439211|NCT00003938|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
439212|NCT00003938|disseminated neuroblastoma|disseminated neuroblastoma
439213|NCT00003938|recurrent neuroblastoma|recurrent neuroblastoma
439214|NCT00003938|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
439215|NCT00003938|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
439216|NCT00003938|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
439217|NCT00003938|stage I multiple myeloma|stage i multiple myeloma
439218|NCT00003938|stage II multiple myeloma|stage ii multiple myeloma
439219|NCT00003938|stage III multiple myeloma|stage iii multiple myeloma
439220|NCT00003938|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
439221|NCT00003938|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
439222|NCT00003938|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
439223|NCT00003938|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
439224|NCT00003938|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
439225|NCT00003938|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
439226|NCT00003938|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
439227|NCT00003938|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
439228|NCT00003938|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
439229|NCT00003938|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
439230|NCT00003938|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
439231|NCT00003938|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
439232|NCT00003938|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
439233|NCT00003938|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
439234|NCT00003938|small intestine lymphoma|small intestine lymphoma
439235|NCT00003938|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
439236|NCT00003938|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
439237|NCT00003938|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
439238|NCT00003938|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
439239|NCT00003938|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
439240|NCT00003938|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
439241|NCT00003938|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
439242|NCT00003938|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
439243|NCT00003938|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
439244|NCT00003938|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
439245|NCT00003938|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
439246|NCT00003938|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
439249|NCT00003938|essential thrombocythemia|essential thrombocythemia
439250|NCT00003938|fever, sweats, and hot flashes|fever, sweats, and hot flashes
439251|NCT00003938|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
439252|NCT00003938|testicular embryonal carcinoma|testicular embryonal carcinoma
439253|NCT00003938|testicular choriocarcinoma|testicular choriocarcinoma
439254|NCT00003938|testicular teratoma|testicular teratoma
439255|NCT00003938|testicular yolk sac tumor|testicular yolk sac tumor
439256|NCT00003938|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
439257|NCT00003938|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
439258|NCT00003938|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
439259|NCT00003938|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
439260|NCT00003938|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
439261|NCT00003938|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
439262|NCT00003938|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
439263|NCT00003938|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
439264|NCT00003938|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
439265|NCT00003938|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
439266|NCT00003938|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
439267|NCT00003938|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
439268|NCT00003938|refractory hairy cell leukemia|refractory hairy cell leukemia
439269|NCT00003938|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
439270|NCT00003938|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
439271|NCT00003938|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
439272|NCT00003938|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
439273|NCT00003938|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
439274|NCT00003938|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
439275|NCT00003938|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
439276|NCT00003938|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
439277|NCT00003938|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
439278|NCT00003938|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
439279|NCT00003938|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
439280|NCT00003938|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
439281|NCT00003938|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
439282|NCT00003938|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
439283|NCT00003938|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
439284|NCT00003938|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
439285|NCT00003938|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
439286|NCT00003938|ovarian yolk sac tumor|ovarian yolk sac tumor
439287|NCT00003938|ovarian embryonal carcinoma|ovarian embryonal carcinoma
439288|NCT00003938|ovarian polyembryoma|ovarian polyembryoma
439289|NCT00003938|ovarian choriocarcinoma|ovarian choriocarcinoma
439290|NCT00003938|ovarian immature teratoma|ovarian immature teratoma
439291|NCT00003938|ovarian mature teratoma|ovarian mature teratoma
439292|NCT00003938|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
439293|NCT00003938|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
439294|NCT00003938|acute undifferentiated leukemia|acute undifferentiated leukemia
439295|NCT00003938|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
439296|NCT00003938|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
439297|NCT00003938|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
439298|NCT00003938|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
439299|NCT00003938|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
439300|NCT00003938|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
439301|NCT00003938|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
439302|NCT00003938|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
439303|NCT00003938|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
439304|NCT00003938|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
439305|NCT00003938|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
439306|NCT00003938|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
439307|NCT00003938|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
439308|NCT00003938|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
439309|NCT00003938|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
439310|NCT00003938|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
439311|NCT00003938|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
439312|NCT00003938|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
439313|NCT00003938|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
439314|NCT00003938|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
439777|NCT00004006|extraocular retinoblastoma|extraocular retinoblastoma
439315|NCT00003938|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
439316|NCT00003938|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
439317|NCT00003938|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
439318|NCT00003938|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
439319|NCT00003938|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
439320|NCT00003938|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
439321|NCT00003938|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
439322|NCT00003938|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
439323|NCT00003938|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
439324|NCT00003938|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
439325|NCT00003938|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
439326|NCT00003938|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
439327|NCT00003938|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
439328|NCT00003938|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
460037|NCT00032227|Wrist MRI|wrist mri
439329|NCT00003938|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
439330|NCT00003938|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
439331|NCT00003938|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
439332|NCT00003938|neutropenia|neutropenia
439333|NCT00003938|infection|infection
439334|NCT00003938|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
439335|NCT00003938|prolymphocytic leukemia|prolymphocytic leukemia
439336|NCT00003938|primary systemic amyloidosis|primary systemic amyloidosis
439337|NCT00003938|intraocular lymphoma|intraocular lymphoma
439338|NCT00003938|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
439339|NCT00003938|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
439340|NCT00003938|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
439341|NCT00003938|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
439342|NCT00003938|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
439343|NCT00003938|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
439344|NCT00003938|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
439345|NCT00003938|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
439346|NCT00003938|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
439347|NCT00003938|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
439348|NCT00003938|stage I mantle cell lymphoma|stage i mantle cell lymphoma
439349|NCT00003938|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
439350|NCT00003938|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
439351|NCT00003938|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
439352|NCT00003938|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
439353|NCT00003938|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
439354|NCT00003938|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
439355|NCT00003938|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
439356|NCT00003938|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
439357|NCT00003938|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
439358|NCT00003938|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
439359|NCT00003938|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
439360|NCT00003938|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
439361|NCT00003938|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
439362|NCT00003938|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
439363|NCT00003938|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
439364|NCT00003938|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
439365|NCT00003938|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
439366|NCT00003938|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
439367|NCT00003938|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
439368|NCT00003938|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
439369|NCT00003938|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
439370|NCT00003938|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
439371|NCT00003938|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
439372|NCT00003938|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
439373|NCT00003938|anaplastic large cell lymphoma|anaplastic large cell lymphoma
439374|NCT00003938|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
439778|NCT00004006|recurrent retinoblastoma|recurrent retinoblastoma
439375|NCT00003938|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
439376|NCT00003938|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
439377|NCT00003938|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
439378|NCT00003938|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
439379|NCT00003938|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
439380|NCT00003938|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
439381|NCT00003938|chronic eosinophilic leukemia|chronic eosinophilic leukemia
584898|NCT00516555|External Cephalic version|external cephalic version
439382|NCT00003938|chronic neutrophilic leukemia|chronic neutrophilic leukemia
439383|NCT00003938|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
439384|NCT00003938|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
439385|NCT00003938|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
439386|NCT00003938|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
439387|NCT00003938|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
439388|NCT00003938|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
439389|NCT00003938|stage I marginal zone lymphoma|stage i marginal zone lymphoma
439390|NCT00003938|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
439391|NCT00003938|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
439392|NCT00003938|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
439393|NCT00003938|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
439394|NCT00003938|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
439395|NCT00003938|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
439396|NCT00003938|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
439397|NCT00003938|splenic marginal zone lymphoma|splenic marginal zone lymphoma
439398|NCT00003938|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
439399|NCT00003939|adult angiosarcoma|adult angiosarcoma
439400|NCT00003939|adult fibrosarcoma|adult fibrosarcoma
439401|NCT00003939|adult leiomyosarcoma|adult leiomyosarcoma
439402|NCT00003939|adult liposarcoma|adult liposarcoma
439403|NCT00003939|adult neurofibrosarcoma|adult neurofibrosarcoma
439404|NCT00003939|adult synovial sarcoma|adult synovial sarcoma
439405|NCT00003939|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
439406|NCT00003939|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
439407|NCT00003939|small intestine leiomyosarcoma|small intestine leiomyosarcoma
439408|NCT00003939|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
439409|NCT00003939|adult epithelioid sarcoma|adult epithelioid sarcoma
439410|NCT00003939|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
439411|NCT00003939|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
439412|NCT00003939|adult malignant mesenchymoma|adult malignant mesenchymoma
439413|NCT00003939|adult rhabdomyosarcoma|adult rhabdomyosarcoma
439414|NCT00003939|stage IV uterine sarcoma|stage iv uterine sarcoma
439415|NCT00003939|recurrent uterine sarcoma|recurrent uterine sarcoma
439416|NCT00003939|uterine carcinosarcoma|uterine carcinosarcoma
439417|NCT00003939|uterine leiomyosarcoma|uterine leiomyosarcoma
439418|NCT00003939|endometrial stromal sarcoma|endometrial stromal sarcoma
439420|NCT00003939|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
439421|NCT00003939|gastrointestinal stromal tumor|gastrointestinal stromal tumor
439422|NCT00003941|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
439423|NCT00003941|mediastinal cancer|mediastinal cancer
439424|NCT00003941|testicular embryonal carcinoma|testicular embryonal carcinoma
439425|NCT00003941|testicular choriocarcinoma|testicular choriocarcinoma
439426|NCT00003941|testicular teratoma|testicular teratoma
439427|NCT00003941|testicular yolk sac tumor|testicular yolk sac tumor
439428|NCT00003941|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
439429|NCT00003941|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
439430|NCT00003941|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
439431|NCT00003941|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
439432|NCT00003941|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
439433|NCT00003941|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
439434|NCT00003941|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
439435|NCT00003941|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
439436|NCT00003941|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
439437|NCT00003941|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
439438|NCT00003941|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
439439|NCT00003941|tumors metastatic to brain|tumors metastatic to brain
439440|NCT00003941|liver metastases|liver metastases
439441|NCT00003941|bone metastases|bone metastases
439442|NCT00003942|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
439443|NCT00003942|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
440674|NCT00005012|Virus Inhibitors|virus inhibitors
439444|NCT00003942|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
439445|NCT00003942|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
439446|NCT00003942|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
439447|NCT00003942|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
439448|NCT00003942|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
439449|NCT00003943|extensive stage small cell lung cancer|extensive stage small cell lung cancer
439450|NCT00003943|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
439451|NCT00003944|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
439452|NCT00003944|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
439453|NCT00003944|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
439454|NCT00003944|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
439455|NCT00003944|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
439456|NCT00003944|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
439457|NCT00003944|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
439458|NCT00003944|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
439459|NCT00003944|fallopian tube cancer|fallopian tube cancer
439460|NCT00003944|peritoneal cavity cancer|peritoneal cavity cancer
439461|NCT00003945|recurrent cervical cancer|recurrent cervical cancer
439462|NCT00003945|stage IVB cervical cancer|stage ivb cervical cancer
439463|NCT00003945|cervical squamous cell carcinoma|cervical squamous cell carcinoma
439464|NCT00003945|cervical adenocarcinoma|cervical adenocarcinoma
439465|NCT00003945|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
439466|NCT00003946|stage IV endometrial carcinoma|stage iv endometrial carcinoma
439467|NCT00003946|recurrent endometrial carcinoma|recurrent endometrial carcinoma
439468|NCT00003950|stage IV colon cancer|stage iv colon cancer
439469|NCT00003950|stage IV rectal cancer|stage iv rectal cancer
439470|NCT00003950|recurrent colon cancer|recurrent colon cancer
439471|NCT00003950|recurrent rectal cancer|recurrent rectal cancer
439472|NCT00003950|adenocarcinoma of the colon|adenocarcinoma of the colon
439473|NCT00003950|adenocarcinoma of the rectum|adenocarcinoma of the rectum
439474|NCT00003951|recurrent pancreatic cancer|recurrent pancreatic cancer
439475|NCT00003951|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
439476|NCT00003951|stage IV pancreatic cancer|stage iv pancreatic cancer
439477|NCT00003953|stage II breast cancer|stage ii breast cancer
439478|NCT00003953|stage IIIA breast cancer|stage iiia breast cancer
439479|NCT00003953|stage IIIB breast cancer|stage iiib breast cancer
439480|NCT00003955|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
439481|NCT00003955|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
439482|NCT00003955|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
439483|NCT00003955|childhood malignant mesenchymoma|childhood malignant mesenchymoma
439484|NCT00003955|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
439485|NCT00003955|adult rhabdomyosarcoma|adult rhabdomyosarcoma
439486|NCT00003955|adult malignant mesenchymoma|adult malignant mesenchymoma
439487|NCT00003955|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
439488|NCT00003956|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
439489|NCT00003956|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
439490|NCT00003956|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
439491|NCT00003956|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
439492|NCT00003956|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
439493|NCT00003956|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
439494|NCT00003956|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
439495|NCT00003956|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
439496|NCT00003956|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
439497|NCT00003956|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
439498|NCT00003956|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
439499|NCT00003956|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
439500|NCT00003956|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
439501|NCT00003956|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
439502|NCT00003956|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
439503|NCT00003956|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
439504|NCT00003956|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
439505|NCT00003956|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
439506|NCT00003956|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
439507|NCT00003956|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
439508|NCT00003956|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
439509|NCT00003956|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
439510|NCT00003956|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
439511|NCT00003956|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
556429|NCT00420147|wedge|wedge
439512|NCT00003956|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
439513|NCT00003956|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
439514|NCT00003956|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
439515|NCT00003956|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
439516|NCT00003956|anaplastic large cell lymphoma|anaplastic large cell lymphoma
439517|NCT00003956|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
439518|NCT00003956|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
439519|NCT00003956|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
439520|NCT00003956|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
439521|NCT00003956|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
439522|NCT00003956|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
439523|NCT00003956|splenic marginal zone lymphoma|splenic marginal zone lymphoma
439524|NCT00003957|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
439525|NCT00003957|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
439526|NCT00003957|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
439527|NCT00003957|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
439528|NCT00003959|refractory anemia|refractory anemia
439529|NCT00003959|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
439530|NCT00003959|refractory anemia with excess blasts|refractory anemia with excess blasts
439531|NCT00003959|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
439532|NCT00003959|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
439533|NCT00003959|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
439534|NCT00003959|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
439535|NCT00003960|refractory multiple myeloma|refractory multiple myeloma
439536|NCT00003960|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
439537|NCT00003960|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
439538|NCT00003960|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
439539|NCT00003960|refractory anemia with excess blasts|refractory anemia with excess blasts
439540|NCT00003960|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
439541|NCT00003960|acute undifferentiated leukemia|acute undifferentiated leukemia
439542|NCT00003960|secondary acute myeloid leukemia|secondary acute myeloid leukemia
439543|NCT00003960|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
439544|NCT00003960|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
439545|NCT00003960|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
439546|NCT00003961|refractory anemia with excess blasts|refractory anemia with excess blasts
439547|NCT00003961|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
439548|NCT00003961|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
439549|NCT00003961|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
439550|NCT00003961|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
439551|NCT00003961|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
439552|NCT00003961|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
439553|NCT00003961|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
439554|NCT00003961|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
439555|NCT00003962|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
439556|NCT00003962|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
439557|NCT00003962|refractory multiple myeloma|refractory multiple myeloma
439558|NCT00003962|stage I multiple myeloma|stage i multiple myeloma
439559|NCT00003962|stage II multiple myeloma|stage ii multiple myeloma
439560|NCT00003962|stage III multiple myeloma|stage iii multiple myeloma
439561|NCT00003962|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
439562|NCT00003962|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
439563|NCT00003962|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
439564|NCT00003962|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
439565|NCT00003962|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
439566|NCT00003962|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
439567|NCT00003962|acute undifferentiated leukemia|acute undifferentiated leukemia
439568|NCT00003962|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
439569|NCT00003962|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
439570|NCT00003962|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
439571|NCT00003962|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
439572|NCT00003962|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
439573|NCT00003962|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
556564|NCT00420797|placebo|placebo
439574|NCT00003962|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
439575|NCT00003962|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
439576|NCT00003962|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
439577|NCT00003962|secondary acute myeloid leukemia|secondary acute myeloid leukemia
439578|NCT00003962|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
439579|NCT00003962|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
439580|NCT00003962|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
439581|NCT00003962|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
439582|NCT00003962|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
439583|NCT00003962|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
439584|NCT00003962|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
439585|NCT00003962|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
439586|NCT00003962|splenic marginal zone lymphoma|splenic marginal zone lymphoma
439587|NCT00003963|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
439588|NCT00003963|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
439589|NCT00003963|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
439590|NCT00003963|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
439591|NCT00003963|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
439592|NCT00003963|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
460237|NCT00033189|CINRG|cinrg
439593|NCT00003963|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
439594|NCT00003963|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
439595|NCT00003963|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
439596|NCT00003963|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
439597|NCT00003963|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
439598|NCT00003963|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
439599|NCT00003963|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
439600|NCT00003963|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
439601|NCT00003963|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
439602|NCT00003963|splenic marginal zone lymphoma|splenic marginal zone lymphoma
439603|NCT00003966|veno-occlusive disease|veno-occlusive disease
439604|NCT00003967|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
439605|NCT00003967|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
439606|NCT00003967|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
439607|NCT00003967|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
439608|NCT00003967|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
439609|NCT00003967|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
439610|NCT00003967|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
439611|NCT00003967|fallopian tube cancer|fallopian tube cancer
439612|NCT00003967|primary peritoneal cavity cancer|primary peritoneal cavity cancer
439613|NCT00003967|Brenner tumor|brenner tumor
439614|NCT00003968|stage IV renal cell cancer|stage iv renal cell cancer
439615|NCT00003968|recurrent renal cell cancer|recurrent renal cell cancer
439616|NCT00003969|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
439617|NCT00003972|stage II breast cancer|stage ii breast cancer
439618|NCT00003972|stage IIIA breast cancer|stage iiia breast cancer
439619|NCT00003974|stage I non-small cell lung cancer|stage i non-small cell lung cancer
439620|NCT00003974|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
439621|NCT00003974|localized malignant mesothelioma|localized malignant mesothelioma
439622|NCT00003974|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
439623|NCT00003976|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
439624|NCT00003977|stage III cervical cancer|stage iii cervical cancer
439625|NCT00003977|recurrent cervical cancer|recurrent cervical cancer
439626|NCT00003977|stage IB cervical cancer|stage ib cervical cancer
439627|NCT00003977|stage IIB cervical cancer|stage iib cervical cancer
439628|NCT00003977|stage IVB cervical cancer|stage ivb cervical cancer
439629|NCT00003977|stage IA cervical cancer|stage ia cervical cancer
439630|NCT00003977|stage IIA cervical cancer|stage iia cervical cancer
439631|NCT00003977|stage IVA cervical cancer|stage iva cervical cancer
439632|NCT00003979|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
439633|NCT00003980|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
439634|NCT00003981|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
439635|NCT00003982|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
439636|NCT00003982|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
439637|NCT00003984|refractory anemia with excess blasts|refractory anemia with excess blasts
439638|NCT00003984|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
439639|NCT00003984|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
439640|NCT00003984|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
439641|NCT00003984|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
439642|NCT00003985|non-small cell lung cancer|non-small cell lung cancer
440732|NCT00004364|rare disease|rare disease
439643|NCT00003985|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
439644|NCT00003989|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
439645|NCT00003989|stage III melanoma|stage iii melanoma
439646|NCT00003989|stage IV melanoma|stage iv melanoma
439647|NCT00003989|recurrent melanoma|recurrent melanoma
439648|NCT00003989|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
439649|NCT00003989|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
439650|NCT00003989|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
439651|NCT00003991|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
439652|NCT00003992|stage II breast cancer|stage ii breast cancer
439653|NCT00003992|stage IIIA breast cancer|stage iiia breast cancer
439654|NCT00003993|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
439655|NCT00003993|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
439656|NCT00003993|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
439657|NCT00003993|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
439658|NCT00003993|small intestine lymphoma|small intestine lymphoma
439659|NCT00003993|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
439660|NCT00003993|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
439661|NCT00003993|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
439662|NCT00003993|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
439663|NCT00003993|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
439664|NCT00003993|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
439665|NCT00003993|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
439666|NCT00003993|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
439667|NCT00003993|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
439668|NCT00003993|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
439669|NCT00003993|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
439670|NCT00003993|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
439671|NCT00003993|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
439672|NCT00003993|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
439673|NCT00003993|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
439674|NCT00003993|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
439675|NCT00003993|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
439676|NCT00003993|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
439677|NCT00003993|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
439678|NCT00003993|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
439679|NCT00003993|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
439680|NCT00003993|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
439681|NCT00003993|intraocular lymphoma|intraocular lymphoma
439682|NCT00003993|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
439683|NCT00003993|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
439684|NCT00003993|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
439685|NCT00003993|anaplastic large cell lymphoma|anaplastic large cell lymphoma
439686|NCT00003993|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
439687|NCT00003993|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
439688|NCT00003993|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
439689|NCT00003993|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
439690|NCT00003993|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
439691|NCT00003993|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
439692|NCT00003993|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
439693|NCT00003993|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
439694|NCT00003993|splenic marginal zone lymphoma|splenic marginal zone lymphoma
439695|NCT00003995|stage IV colon cancer|stage iv colon cancer
439696|NCT00003995|stage IV rectal cancer|stage iv rectal cancer
439697|NCT00003995|recurrent colon cancer|recurrent colon cancer
439698|NCT00003995|recurrent rectal cancer|recurrent rectal cancer
439699|NCT00003996|adult glioblastoma|adult glioblastoma
439700|NCT00003996|adult giant cell glioblastoma|adult giant cell glioblastoma
439701|NCT00003996|adult gliosarcoma|adult gliosarcoma
439144|NCT00003926|soft tissue sarcoma|soft tissue sarcoma
439702|NCT00003997|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
439703|NCT00003997|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
439704|NCT00003997|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
439705|NCT00003997|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
439706|NCT00003997|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
439707|NCT00003998|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
439708|NCT00003998|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
439709|NCT00003998|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
439710|NCT00003998|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
439711|NCT00003998|primary peritoneal cavity cancer|primary peritoneal cavity cancer
439712|NCT00004001|adenocarcinoma of the prostate|adenocarcinoma of the prostate
439713|NCT00004001|stage IV prostate cancer|stage iv prostate cancer
439714|NCT00004001|recurrent prostate cancer|recurrent prostate cancer
439715|NCT00004002|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
439716|NCT00004002|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
439717|NCT00004002|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
439718|NCT00004002|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
439719|NCT00004002|small intestine lymphoma|small intestine lymphoma
439720|NCT00004002|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
439721|NCT00004002|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
439722|NCT00004002|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
439723|NCT00004002|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
439724|NCT00004002|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
439725|NCT00004002|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
439726|NCT00004002|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
439868|NCT00004031|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
439727|NCT00004002|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
439728|NCT00004002|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
439729|NCT00004002|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
439730|NCT00004002|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
439731|NCT00004002|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
439732|NCT00004002|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
439733|NCT00004002|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
439734|NCT00004002|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
439735|NCT00004002|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
439736|NCT00004002|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
439737|NCT00004002|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
439738|NCT00004002|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
439739|NCT00004002|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
439740|NCT00004002|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
439741|NCT00004002|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
439742|NCT00004002|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
439743|NCT00004002|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
439744|NCT00004002|intraocular lymphoma|intraocular lymphoma
439745|NCT00004002|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
439746|NCT00004002|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
439747|NCT00004002|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
439748|NCT00004002|anaplastic large cell lymphoma|anaplastic large cell lymphoma
439749|NCT00004002|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
439750|NCT00004002|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
439751|NCT00004002|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
439752|NCT00004002|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
439753|NCT00004002|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
439754|NCT00004002|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
439755|NCT00004002|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
439756|NCT00004002|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
439757|NCT00004002|splenic marginal zone lymphoma|splenic marginal zone lymphoma
439758|NCT00004003|stage III pancreatic cancer|stage iii pancreatic cancer
439759|NCT00004003|recurrent pancreatic cancer|recurrent pancreatic cancer
439760|NCT00004003|stage IV pancreatic cancer|stage iv pancreatic cancer
439761|NCT00004004|recurrent adult brain tumor|recurrent adult brain tumor
439762|NCT00004004|adult glioblastoma|adult glioblastoma
439763|NCT00004004|adult anaplastic astrocytoma|adult anaplastic astrocytoma
439247|NCT00003938|polycythemia vera|polycythemia vera
439764|NCT00004004|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
439765|NCT00004004|adult giant cell glioblastoma|adult giant cell glioblastoma
439766|NCT00004004|adult gliosarcoma|adult gliosarcoma
439767|NCT00004005|stage III colon cancer|stage iii colon cancer
439768|NCT00004005|stage IV colon cancer|stage iv colon cancer
439769|NCT00004005|stage III rectal cancer|stage iii rectal cancer
439770|NCT00004005|stage IV rectal cancer|stage iv rectal cancer
439771|NCT00004005|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
439772|NCT00004005|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
439773|NCT00004005|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
439774|NCT00004005|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
439775|NCT00004005|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
439779|NCT00004008|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
439780|NCT00004008|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
439781|NCT00004008|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
439782|NCT00004008|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
439783|NCT00004008|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
439784|NCT00004009|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
439785|NCT00004009|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
439786|NCT00004009|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
439787|NCT00004009|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
439788|NCT00004009|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
439789|NCT00004009|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
439790|NCT00004009|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
439791|NCT00004009|secondary acute myeloid leukemia|secondary acute myeloid leukemia
439792|NCT00004010|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
439793|NCT00004010|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
439794|NCT00004010|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
439795|NCT00004010|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
439796|NCT00004010|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
439797|NCT00004010|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
439798|NCT00004010|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
439799|NCT00004011|stage I non-small cell lung cancer|stage i non-small cell lung cancer
439800|NCT00004011|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
439801|NCT00004011|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
439802|NCT00004012|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
439803|NCT00004012|fallopian tube cancer|fallopian tube cancer
439804|NCT00004012|primary peritoneal cavity cancer|primary peritoneal cavity cancer
439805|NCT00004013|stage IV breast cancer|stage iv breast cancer
439806|NCT00004013|recurrent breast cancer|recurrent breast cancer
439807|NCT00004014|recurrent prostate cancer|recurrent prostate cancer
439808|NCT00004015|adult glioblastoma|adult glioblastoma
439809|NCT00004015|adult giant cell glioblastoma|adult giant cell glioblastoma
439810|NCT00004015|adult gliosarcoma|adult gliosarcoma
439811|NCT00004016|stage III melanoma|stage iii melanoma
439812|NCT00004016|stage IV melanoma|stage iv melanoma
439813|NCT00004016|recurrent melanoma|recurrent melanoma
439814|NCT00004016|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
439815|NCT00004017|recurrent adult brain tumor|recurrent adult brain tumor
439816|NCT00004017|adult glioblastoma|adult glioblastoma
439817|NCT00004017|adult anaplastic astrocytoma|adult anaplastic astrocytoma
439818|NCT00004017|adult giant cell glioblastoma|adult giant cell glioblastoma
439819|NCT00004017|adult gliosarcoma|adult gliosarcoma
439820|NCT00004022|stage III melanoma|stage iii melanoma
439821|NCT00004022|stage IV melanoma|stage iv melanoma
439822|NCT00004022|recurrent melanoma|recurrent melanoma
439823|NCT00004024|recurrent adult brain tumor|recurrent adult brain tumor
439824|NCT00004024|adult glioblastoma|adult glioblastoma
439825|NCT00004024|adult anaplastic astrocytoma|adult anaplastic astrocytoma
439826|NCT00004024|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
439827|NCT00004024|adult subependymoma|adult subependymoma
439829|NCT00004024|adult giant cell glioblastoma|adult giant cell glioblastoma
439830|NCT00004024|adult gliosarcoma|adult gliosarcoma
439831|NCT00004024|adult diffuse astrocytoma|adult diffuse astrocytoma
439832|NCT00004025|stage III melanoma|stage iii melanoma
439833|NCT00004025|stage IV melanoma|stage iv melanoma
439834|NCT00004025|recurrent melanoma|recurrent melanoma
439835|NCT00004026|adenocarcinoma of the prostate|adenocarcinoma of the prostate
439836|NCT00004026|stage IV prostate cancer|stage iv prostate cancer
439837|NCT00004026|recurrent prostate cancer|recurrent prostate cancer
439838|NCT00004028|recurrent adult brain tumor|recurrent adult brain tumor
439839|NCT00004028|adult glioblastoma|adult glioblastoma
439840|NCT00004028|adult anaplastic astrocytoma|adult anaplastic astrocytoma
439841|NCT00004028|adult anaplastic ependymoma|adult anaplastic ependymoma
439842|NCT00004028|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
439843|NCT00004028|adult mixed glioma|adult mixed glioma
439844|NCT00004028|adult ependymoblastoma|adult ependymoblastoma
439845|NCT00004028|adult giant cell glioblastoma|adult giant cell glioblastoma
439846|NCT00004028|adult gliosarcoma|adult gliosarcoma
439847|NCT00004029|adenocarcinoma of the prostate|adenocarcinoma of the prostate
439848|NCT00004029|stage IV prostate cancer|stage iv prostate cancer
439849|NCT00004029|recurrent prostate cancer|recurrent prostate cancer
439850|NCT00004030|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
439851|NCT00004031|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
439852|NCT00004031|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
439853|NCT00004031|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
439854|NCT00004031|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
439855|NCT00004031|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
439856|NCT00004031|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
439857|NCT00004031|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
439858|NCT00004031|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
439859|NCT00004031|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
439860|NCT00004031|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
439861|NCT00004031|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
439862|NCT00004031|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
439863|NCT00004031|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
439864|NCT00004031|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
439865|NCT00004031|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
439866|NCT00004031|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
439867|NCT00004031|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
460238|NCT00033202|Solid Tumor|solid tumor
439869|NCT00004031|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
439870|NCT00004031|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
439871|NCT00004031|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
439872|NCT00004031|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
439873|NCT00004031|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
439874|NCT00004031|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
439875|NCT00004033|localized malignant mesothelioma|localized malignant mesothelioma
439876|NCT00004033|advanced malignant mesothelioma|advanced malignant mesothelioma
439877|NCT00004033|recurrent malignant mesothelioma|recurrent malignant mesothelioma
439878|NCT00004036|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
439879|NCT00004036|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
439880|NCT00004036|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
439881|NCT00004036|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
439882|NCT00004036|isolated plasmacytoma of bone|isolated plasmacytoma of bone
439883|NCT00004036|extramedullary plasmacytoma|extramedullary plasmacytoma
439884|NCT00004036|refractory multiple myeloma|refractory multiple myeloma
439885|NCT00004036|Waldenström macroglobulinemia|waldenström macroglobulinemia
439886|NCT00004036|stage III multiple myeloma|stage iii multiple myeloma
439887|NCT00004036|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
439888|NCT00004036|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
439889|NCT00004036|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
439890|NCT00004036|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
439891|NCT00004036|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
439892|NCT00004036|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
439893|NCT00004036|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
439894|NCT00004036|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
439895|NCT00004036|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
439896|NCT00004036|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
439897|NCT00004036|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
439898|NCT00004036|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
439899|NCT00004036|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
439900|NCT00004036|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
439901|NCT00004036|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
439902|NCT00004036|polycythemia vera|polycythemia vera
439903|NCT00004036|primary myelofibrosis|primary myelofibrosis
439904|NCT00004036|essential thrombocythemia|essential thrombocythemia
439905|NCT00004036|untreated hairy cell leukemia|untreated hairy cell leukemia
439906|NCT00004036|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
439907|NCT00004036|refractory hairy cell leukemia|refractory hairy cell leukemia
439908|NCT00004036|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
439909|NCT00004036|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
439910|NCT00004036|acute undifferentiated leukemia|acute undifferentiated leukemia
439911|NCT00004036|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
439912|NCT00004036|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
584899|NCT00516555|Thyroid Function Tests|thyroid function tests
439913|NCT00004036|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
439914|NCT00004036|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
439915|NCT00004036|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
439916|NCT00004036|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
440675|NCT00005012|Anti-HIV Agents|anti-hiv agents
439917|NCT00004036|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
439918|NCT00004036|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
439919|NCT00004036|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
439920|NCT00004036|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
439921|NCT00004036|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
439922|NCT00004036|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
439923|NCT00004036|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
439924|NCT00004036|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
439925|NCT00004036|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
439926|NCT00004036|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
439927|NCT00004036|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
439928|NCT00004036|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
439929|NCT00004036|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
439930|NCT00004036|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
439931|NCT00004036|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
439932|NCT00004036|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
439933|NCT00004036|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
439934|NCT00004036|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
439935|NCT00004036|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
439936|NCT00004036|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
439937|NCT00004036|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
439938|NCT00004036|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
439939|NCT00004036|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
439940|NCT00004036|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
439941|NCT00004036|secondary acute myeloid leukemia|secondary acute myeloid leukemia
439942|NCT00004036|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
439943|NCT00004036|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
439944|NCT00004036|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
439945|NCT00004036|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
439946|NCT00004036|prolymphocytic leukemia|prolymphocytic leukemia
439947|NCT00004036|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
439948|NCT00004036|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
439949|NCT00004036|primary systemic amyloidosis|primary systemic amyloidosis
439950|NCT00004036|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
439951|NCT00004036|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
439952|NCT00004036|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
439953|NCT00004036|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
439954|NCT00004036|anaplastic large cell lymphoma|anaplastic large cell lymphoma
439955|NCT00004036|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
439956|NCT00004036|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
439957|NCT00004036|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
439958|NCT00004036|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
439959|NCT00004036|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
439960|NCT00004036|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
439961|NCT00004036|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
439962|NCT00004036|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
439963|NCT00004036|splenic marginal zone lymphoma|splenic marginal zone lymphoma
439964|NCT00004037|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
439965|NCT00004037|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
439966|NCT00004037|primary peritoneal cavity cancer|primary peritoneal cavity cancer
439967|NCT00004038|stage I breast cancer|stage i breast cancer
439968|NCT00004038|stage II breast cancer|stage ii breast cancer
439969|NCT00004038|stage IV breast cancer|stage iv breast cancer
439970|NCT00004038|stage IIIA breast cancer|stage iiia breast cancer
439971|NCT00004038|recurrent breast cancer|recurrent breast cancer
439972|NCT00004038|stage IIIB breast cancer|stage iiib breast cancer
439973|NCT00004039|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
439974|NCT00004039|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
439975|NCT00004039|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
439976|NCT00004039|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
439977|NCT00004039|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
439978|NCT00004039|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
439979|NCT00004039|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
439980|NCT00004039|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
439981|NCT00004039|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
439982|NCT00004039|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
440114|NCT00004058|primary systemic amyloidosis|primary systemic amyloidosis
439983|NCT00004039|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
439984|NCT00004039|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
439985|NCT00004039|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
439986|NCT00004039|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
439987|NCT00004039|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
439988|NCT00004039|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
439989|NCT00004039|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
439990|NCT00004039|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
439991|NCT00004039|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
439992|NCT00004039|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
439993|NCT00004039|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
439994|NCT00004039|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
439995|NCT00004039|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
439996|NCT00004039|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
439997|NCT00004039|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
439998|NCT00004040|stage I multiple myeloma|stage i multiple myeloma
439999|NCT00004040|stage II multiple myeloma|stage ii multiple myeloma
460404|NCT00033852|Depression|depression
440000|NCT00004040|stage III multiple myeloma|stage iii multiple myeloma
440001|NCT00004040|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
440002|NCT00004040|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
440003|NCT00004040|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
440004|NCT00004040|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
440005|NCT00004040|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
440006|NCT00004041|recurrent adult brain tumor|recurrent adult brain tumor
440007|NCT00004041|adult glioblastoma|adult glioblastoma
440008|NCT00004041|adult anaplastic astrocytoma|adult anaplastic astrocytoma
440009|NCT00004041|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
440010|NCT00004041|adult mixed glioma|adult mixed glioma
440011|NCT00004041|adult giant cell glioblastoma|adult giant cell glioblastoma
440012|NCT00004041|adult gliosarcoma|adult gliosarcoma
440013|NCT00004042|stage III colon cancer|stage iii colon cancer
440014|NCT00004042|stage IV colon cancer|stage iv colon cancer
440015|NCT00004042|stage III rectal cancer|stage iii rectal cancer
440016|NCT00004042|stage IV rectal cancer|stage iv rectal cancer
440017|NCT00004042|recurrent colon cancer|recurrent colon cancer
440018|NCT00004042|recurrent rectal cancer|recurrent rectal cancer
440019|NCT00004043|adenocarcinoma of the prostate|adenocarcinoma of the prostate
440020|NCT00004043|recurrent prostate cancer|recurrent prostate cancer
440021|NCT00004045|stage IV prostate cancer|stage iv prostate cancer
440022|NCT00004045|recurrent prostate cancer|recurrent prostate cancer
440023|NCT00004046|stage IV breast cancer|stage iv breast cancer
440024|NCT00004046|recurrent breast cancer|recurrent breast cancer
440025|NCT00004047|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
440026|NCT00004047|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
440027|NCT00004047|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
440028|NCT00004047|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
440029|NCT00004047|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
440030|NCT00004047|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
440031|NCT00004047|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
440032|NCT00004047|refractory anemia with excess blasts|refractory anemia with excess blasts
440033|NCT00004047|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
440034|NCT00004047|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
440035|NCT00004047|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
440036|NCT00004048|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
440037|NCT00004049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
440038|NCT00004050|stage IIB prostate cancer|stage iib prostate cancer
440039|NCT00004050|stage IIA prostate cancer|stage iia prostate cancer
440040|NCT00004050|stage III prostate cancer|stage iii prostate cancer
440041|NCT00004051|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
440042|NCT00004052|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
440043|NCT00004052|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
440044|NCT00004054|stage IIB prostate cancer|stage iib prostate cancer
440045|NCT00004054|stage IIA prostate cancer|stage iia prostate cancer
440046|NCT00004054|stage III prostate cancer|stage iii prostate cancer
440047|NCT00004054|stage IV prostate cancer|stage iv prostate cancer
440048|NCT00004055|extensive stage small cell lung cancer|extensive stage small cell lung cancer
440049|NCT00004056|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
440050|NCT00004056|childhood acute monoblastic leukemia and acute monocytic leukemia (M5)|childhood acute monoblastic leukemia and acute monocytic leukemia (m5)
440425|NCT00004081|peritoneal cavity cancer|peritoneal cavity cancer
440051|NCT00004056|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
440052|NCT00004056|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
440053|NCT00004056|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
440054|NCT00004056|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
440055|NCT00004056|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
440056|NCT00004056|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
440057|NCT00004057|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
440058|NCT00004057|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
440059|NCT00004057|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
440060|NCT00004057|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
440061|NCT00004057|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
440062|NCT00004057|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
440063|NCT00004057|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
440064|NCT00004057|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
440065|NCT00004057|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
440066|NCT00004057|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
460405|NCT00033852|HIV|hiv
440067|NCT00004057|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
440068|NCT00004057|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
440069|NCT00004057|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
440070|NCT00004057|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
440071|NCT00004057|anaplastic large cell lymphoma|anaplastic large cell lymphoma
440072|NCT00004057|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
440073|NCT00004057|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
440074|NCT00004057|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
440075|NCT00004057|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
440076|NCT00004057|splenic marginal zone lymphoma|splenic marginal zone lymphoma
440077|NCT00004058|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
440078|NCT00004058|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
440079|NCT00004058|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
440080|NCT00004058|isolated plasmacytoma of bone|isolated plasmacytoma of bone
440081|NCT00004058|extramedullary plasmacytoma|extramedullary plasmacytoma
440082|NCT00004058|refractory multiple myeloma|refractory multiple myeloma
440083|NCT00004058|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
440084|NCT00004058|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
440085|NCT00004058|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
440086|NCT00004058|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
440087|NCT00004058|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
440088|NCT00004058|polycythemia vera|polycythemia vera
440089|NCT00004058|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
440090|NCT00004058|essential thrombocythemia|essential thrombocythemia
440091|NCT00004058|refractory hairy cell leukemia|refractory hairy cell leukemia
440092|NCT00004058|refractory anemia|refractory anemia
440093|NCT00004058|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
440094|NCT00004058|refractory anemia with excess blasts|refractory anemia with excess blasts
557521|NCT00425984|HIV|hiv
440095|NCT00004058|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
440096|NCT00004058|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
440097|NCT00004058|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
440098|NCT00004058|acute undifferentiated leukemia|acute undifferentiated leukemia
440099|NCT00004058|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
440100|NCT00004058|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
440101|NCT00004058|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
440102|NCT00004058|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
440103|NCT00004058|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
440104|NCT00004058|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
584900|NCT00516581|Pneumocystis Pneumonia|pneumocystis pneumonia
440105|NCT00004058|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
440106|NCT00004058|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
440107|NCT00004058|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
440108|NCT00004058|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
440109|NCT00004058|secondary acute myeloid leukemia|secondary acute myeloid leukemia
440110|NCT00004058|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
440111|NCT00004058|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
440112|NCT00004058|primary central nervous system lymphoma|primary central nervous system lymphoma
440113|NCT00004058|prolymphocytic leukemia|prolymphocytic leukemia
440115|NCT00004058|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
440116|NCT00004058|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
440117|NCT00004058|anaplastic large cell lymphoma|anaplastic large cell lymphoma
440118|NCT00004058|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
440119|NCT00004058|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
440120|NCT00004058|chronic eosinophilic leukemia|chronic eosinophilic leukemia
440121|NCT00004058|chronic neutrophilic leukemia|chronic neutrophilic leukemia
440122|NCT00004058|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
440123|NCT00004058|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
440124|NCT00004058|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
440125|NCT00004058|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
440126|NCT00004058|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
440127|NCT00004058|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
440128|NCT00004058|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
440129|NCT00004059|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
440130|NCT00004060|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
440131|NCT00004060|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
461018|NCT00036491|anti-CD20|anti-cd20
440132|NCT00004060|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
440133|NCT00004060|fallopian tube cancer|fallopian tube cancer
440134|NCT00004060|primary peritoneal cavity cancer|primary peritoneal cavity cancer
440135|NCT00004061|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
440136|NCT00004061|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
440137|NCT00004061|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
440138|NCT00004061|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
440139|NCT00004061|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
440140|NCT00004061|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
440141|NCT00004061|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
440142|NCT00004061|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
440143|NCT00004061|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
440144|NCT00004061|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
440145|NCT00004061|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
440146|NCT00004061|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
440147|NCT00004061|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
440148|NCT00004061|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
440149|NCT00004061|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
440150|NCT00004061|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
440151|NCT00004061|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
440152|NCT00004061|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
440153|NCT00004061|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
440154|NCT00004061|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
440155|NCT00004061|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
440156|NCT00004061|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
440157|NCT00004061|oral complications|oral complications
440158|NCT00004061|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
440159|NCT00004061|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
440160|NCT00004061|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
440161|NCT00004061|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
440162|NCT00004061|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
440163|NCT00004061|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
440164|NCT00004061|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
440165|NCT00004061|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
440166|NCT00004061|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
440167|NCT00004061|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
440168|NCT00004061|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
440169|NCT00004061|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
440170|NCT00004061|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
440171|NCT00004061|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
440172|NCT00004061|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
440173|NCT00004061|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
440174|NCT00004061|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
440175|NCT00004061|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
440176|NCT00004061|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
440177|NCT00004061|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
440178|NCT00004061|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
440179|NCT00004061|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
440180|NCT00004061|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
440181|NCT00004061|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
440182|NCT00004061|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
440183|NCT00004061|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
440184|NCT00004061|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
440185|NCT00004061|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
440186|NCT00004061|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
440187|NCT00004061|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
440188|NCT00004061|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
440189|NCT00004061|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
440190|NCT00004061|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
440191|NCT00004061|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
440192|NCT00004061|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
440193|NCT00004061|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
440194|NCT00004061|secondary acute myeloid leukemia|secondary acute myeloid leukemia
440195|NCT00004061|stage I mantle cell lymphoma|stage i mantle cell lymphoma
440196|NCT00004061|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
440197|NCT00004061|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
440198|NCT00004061|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
440199|NCT00004061|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
440200|NCT00004061|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
440201|NCT00004061|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
440202|NCT00004061|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
440203|NCT00004061|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
440204|NCT00004061|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
440205|NCT00004061|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
440206|NCT00004061|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
440207|NCT00004061|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
440208|NCT00004061|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
440209|NCT00004061|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
440210|NCT00004061|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
440211|NCT00004061|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
440212|NCT00004061|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
440213|NCT00004061|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
440214|NCT00004061|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
440215|NCT00004061|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
440216|NCT00004061|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
440217|NCT00004061|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
440218|NCT00004061|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
440219|NCT00004061|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
440220|NCT00004061|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
440221|NCT00004061|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
440222|NCT00004061|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
440223|NCT00004061|stage I marginal zone lymphoma|stage i marginal zone lymphoma
440224|NCT00004061|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
440225|NCT00004061|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
440226|NCT00004061|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
440227|NCT00004061|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
440228|NCT00004061|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
440229|NCT00004061|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
440230|NCT00004061|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
440231|NCT00004061|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
440232|NCT00004061|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
440233|NCT00004061|splenic marginal zone lymphoma|splenic marginal zone lymphoma
440234|NCT00004062|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
440235|NCT00004062|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
440236|NCT00004062|recurrent thyroid cancer|recurrent thyroid cancer
440237|NCT00004063|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
440238|NCT00004064|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
440239|NCT00004064|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
440240|NCT00004064|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
440241|NCT00004064|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
440242|NCT00004064|fallopian tube cancer|fallopian tube cancer
440243|NCT00004064|primary peritoneal cavity cancer|primary peritoneal cavity cancer
440244|NCT00004065|stage III colon cancer|stage iii colon cancer
440245|NCT00004065|stage IV colon cancer|stage iv colon cancer
440246|NCT00004065|stage IV breast cancer|stage iv breast cancer
440247|NCT00004065|stage IIIA breast cancer|stage iiia breast cancer
440248|NCT00004065|recurrent breast cancer|recurrent breast cancer
440249|NCT00004065|stage III gastric cancer|stage iii gastric cancer
440250|NCT00004065|stage IV gastric cancer|stage iv gastric cancer
440251|NCT00004065|recurrent gastric cancer|recurrent gastric cancer
440252|NCT00004065|stage IIIB breast cancer|stage iiib breast cancer
440253|NCT00004065|stage IIIC breast cancer|stage iiic breast cancer
440254|NCT00004065|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
440255|NCT00004065|recurrent colon cancer|recurrent colon cancer
440256|NCT00004065|stage III renal cell cancer|stage iii renal cell cancer
440257|NCT00004065|stage IV renal cell cancer|stage iv renal cell cancer
440258|NCT00004065|recurrent renal cell cancer|recurrent renal cell cancer
440259|NCT00004065|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
440260|NCT00004065|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
440261|NCT00004065|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
461019|NCT00036491|rituximab|rituximab
440262|NCT00004065|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
440263|NCT00004065|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
440264|NCT00004065|stage III bladder cancer|stage iii bladder cancer
440265|NCT00004065|recurrent bladder cancer|recurrent bladder cancer
440266|NCT00004065|stage IV bladder cancer|stage iv bladder cancer
440267|NCT00004065|stage III prostate cancer|stage iii prostate cancer
440268|NCT00004065|stage IV prostate cancer|stage iv prostate cancer
440269|NCT00004065|recurrent prostate cancer|recurrent prostate cancer
440270|NCT00004065|stage III melanoma|stage iii melanoma
440271|NCT00004065|stage IV melanoma|stage iv melanoma
440272|NCT00004065|recurrent melanoma|recurrent melanoma
440273|NCT00004065|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
440274|NCT00004065|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
440275|NCT00004065|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
440276|NCT00004065|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
440277|NCT00004065|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
440278|NCT00004065|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
440279|NCT00004065|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
440280|NCT00004065|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
440281|NCT00004065|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
440282|NCT00004065|ovarian stromal cancer|ovarian stromal cancer
440283|NCT00004065|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
440284|NCT00004065|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
440285|NCT00004065|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
440286|NCT00004065|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
440287|NCT00004065|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
440288|NCT00004065|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
440289|NCT00004065|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
440290|NCT00004065|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
440291|NCT00004065|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
440292|NCT00004065|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
440293|NCT00004065|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
440294|NCT00004065|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
440295|NCT00004065|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
440296|NCT00004065|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
440297|NCT00004065|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
440298|NCT00004065|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
440299|NCT00004065|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
440300|NCT00004065|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
440301|NCT00004065|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
440302|NCT00004065|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
440303|NCT00004065|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
440304|NCT00004065|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
440305|NCT00004065|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
440306|NCT00004065|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
440307|NCT00004065|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
440308|NCT00004065|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
440309|NCT00004065|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
440733|NCT00004365|endocrine disorders|endocrine disorders
440310|NCT00004065|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
440311|NCT00004065|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
440312|NCT00004065|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
440313|NCT00004065|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
440314|NCT00004065|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
440315|NCT00004065|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
440316|NCT00004065|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
440317|NCT00004065|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
440318|NCT00004065|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
440319|NCT00004065|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
440320|NCT00004065|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
440377|NCT00004072|refractory multiple myeloma|refractory multiple myeloma
440321|NCT00004065|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
440322|NCT00004065|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
440323|NCT00004065|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
440324|NCT00004065|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
440325|NCT00004065|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
440326|NCT00004065|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
440327|NCT00004065|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
440328|NCT00004065|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
440329|NCT00004065|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
440330|NCT00004065|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
752995|NCT01175057|patients with myocardial infarction|patients with myocardial infarction
440331|NCT00004065|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
440332|NCT00004065|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
440333|NCT00004065|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
440335|NCT00004065|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
440336|NCT00004065|recurrent salivary gland cancer|recurrent salivary gland cancer
440337|NCT00004065|stage IV salivary gland cancer|stage iv salivary gland cancer
440338|NCT00004065|stage III salivary gland cancer|stage iii salivary gland cancer
440339|NCT00004066|adult leiomyosarcoma|adult leiomyosarcoma
440340|NCT00004066|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
440341|NCT00004066|small intestine leiomyosarcoma|small intestine leiomyosarcoma
440342|NCT00004066|stage IV uterine sarcoma|stage iv uterine sarcoma
440343|NCT00004066|recurrent uterine sarcoma|recurrent uterine sarcoma
440344|NCT00004066|uterine leiomyosarcoma|uterine leiomyosarcoma
440345|NCT00004066|ovarian sarcoma|ovarian sarcoma
440346|NCT00004066|recurrent small intestine cancer|recurrent small intestine cancer
440347|NCT00004066|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
440348|NCT00004067|stage II breast cancer|stage ii breast cancer
440349|NCT00004067|stage IIIA breast cancer|stage iiia breast cancer
440350|NCT00004068|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
440351|NCT00004068|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
440352|NCT00004068|childhood oligodendroglioma|childhood oligodendroglioma
440353|NCT00004068|untreated childhood brain stem glioma|untreated childhood brain stem glioma
440354|NCT00004068|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
440355|NCT00004070|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
440356|NCT00004070|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
440357|NCT00004070|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
440358|NCT00004070|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
440359|NCT00004070|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
440360|NCT00004070|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
440361|NCT00004070|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
440362|NCT00004070|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
440363|NCT00004070|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
440364|NCT00004070|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
440365|NCT00004070|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
440366|NCT00004070|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
440367|NCT00004070|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
440368|NCT00004070|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
440369|NCT00004070|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
440370|NCT00004070|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
440371|NCT00004070|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
440372|NCT00004070|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
440373|NCT00004070|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
440374|NCT00004070|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
440375|NCT00004071|stage IV prostate cancer|stage iv prostate cancer
440376|NCT00004071|recurrent prostate cancer|recurrent prostate cancer
440378|NCT00004072|stage I multiple myeloma|stage i multiple myeloma
440379|NCT00004072|stage II multiple myeloma|stage ii multiple myeloma
440380|NCT00004072|stage III multiple myeloma|stage iii multiple myeloma
440381|NCT00004073|adult glioblastoma|adult glioblastoma
440382|NCT00004073|adult giant cell glioblastoma|adult giant cell glioblastoma
440383|NCT00004073|adult gliosarcoma|adult gliosarcoma
440384|NCT00004075|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
440385|NCT00004075|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
440386|NCT00004075|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
440387|NCT00004075|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
440388|NCT00004075|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
440389|NCT00004075|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
440390|NCT00004075|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
440391|NCT00004075|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
440392|NCT00004075|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
440393|NCT00004075|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
440394|NCT00004075|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
440395|NCT00004075|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
440396|NCT00004075|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
440397|NCT00004075|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
440398|NCT00004075|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
440399|NCT00004075|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
440400|NCT00004075|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
440401|NCT00004075|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
440402|NCT00004075|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
440403|NCT00004075|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
440404|NCT00004075|splenic marginal zone lymphoma|splenic marginal zone lymphoma
440405|NCT00004076|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
440406|NCT00004077|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
440407|NCT00004077|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
440408|NCT00004077|testicular embryonal carcinoma|testicular embryonal carcinoma
440409|NCT00004077|testicular choriocarcinoma|testicular choriocarcinoma
440410|NCT00004077|testicular teratoma|testicular teratoma
440411|NCT00004077|testicular yolk sac tumor|testicular yolk sac tumor
440412|NCT00004077|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
440413|NCT00004077|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
440414|NCT00004077|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
440415|NCT00004077|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
440416|NCT00004077|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
440417|NCT00004077|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
440418|NCT00004080|recurrent adult brain tumor|recurrent adult brain tumor
440419|NCT00004080|adult glioblastoma|adult glioblastoma
440420|NCT00004080|adult anaplastic astrocytoma|adult anaplastic astrocytoma
440421|NCT00004080|adult mixed glioma|adult mixed glioma
440422|NCT00004080|adult giant cell glioblastoma|adult giant cell glioblastoma
440423|NCT00004080|adult gliosarcoma|adult gliosarcoma
440424|NCT00004081|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
440676|NCT00005012|Viral Load|viral load
440426|NCT00004082|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
440427|NCT00004082|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
440428|NCT00004082|stage III endometrial carcinoma|stage iii endometrial carcinoma
440429|NCT00004082|stage IV endometrial carcinoma|stage iv endometrial carcinoma
440430|NCT00004082|endometrial adenocarcinoma|endometrial adenocarcinoma
440431|NCT00004082|fallopian tube cancer|fallopian tube cancer
440432|NCT00004082|primary peritoneal cavity cancer|primary peritoneal cavity cancer
440433|NCT00004083|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
440434|NCT00004083|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
440435|NCT00004084|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
440436|NCT00004084|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
440437|NCT00004084|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
440438|NCT00004084|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
440439|NCT00004084|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
440440|NCT00004084|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
440441|NCT00004084|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
440442|NCT00004084|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
440443|NCT00004084|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
440444|NCT00004084|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
440445|NCT00004084|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
440446|NCT00004084|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
440447|NCT00004084|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
440448|NCT00004084|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
440449|NCT00004084|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
440450|NCT00004084|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
440451|NCT00004084|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
440452|NCT00004084|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
440453|NCT00004084|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
440454|NCT00004084|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
440455|NCT00004084|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
440456|NCT00004084|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
440457|NCT00004084|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
558154|NCT00417365|BV|bv
440458|NCT00004084|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
440459|NCT00004084|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
440460|NCT00004084|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
440461|NCT00004084|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
440462|NCT00004084|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
440463|NCT00004084|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
440464|NCT00004084|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
440465|NCT00004084|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
440466|NCT00004084|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
440467|NCT00004084|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
440468|NCT00004084|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
440469|NCT00004084|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
440470|NCT00004084|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
440471|NCT00004084|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
440472|NCT00004084|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
440473|NCT00004084|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
440474|NCT00004084|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
440475|NCT00004084|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
440476|NCT00004084|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
440477|NCT00004084|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
440478|NCT00004084|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
440479|NCT00004084|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
440480|NCT00004084|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
440481|NCT00004084|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
440482|NCT00004084|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
440483|NCT00004084|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
440484|NCT00004084|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
440485|NCT00004084|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
440486|NCT00004084|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
440487|NCT00004084|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
461049|NCT00036569|Interferon|interferon
440488|NCT00004084|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
440850|NCT00004404|rare disease|rare disease
440489|NCT00004084|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
440490|NCT00004084|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
440491|NCT00004084|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
440492|NCT00004084|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
440493|NCT00004084|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
440494|NCT00004084|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
440495|NCT00004084|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
440496|NCT00004084|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
440497|NCT00004084|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
440498|NCT00004084|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
440499|NCT00004084|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
440500|NCT00004084|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
440501|NCT00004084|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
440502|NCT00004084|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
440503|NCT00004084|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
440504|NCT00004084|stage I marginal zone lymphoma|stage i marginal zone lymphoma
441509|NCT00005762|Nelfinavir|nelfinavir
440505|NCT00004084|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
440506|NCT00004084|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
440507|NCT00004084|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
440508|NCT00004084|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
440509|NCT00004084|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
440510|NCT00004084|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
440511|NCT00004084|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
440512|NCT00004084|splenic marginal zone lymphoma|splenic marginal zone lymphoma
440513|NCT00004990|Nephrotic Syndrome|nephrotic syndrome
440514|NCT00004990|Steroids|steroids
440515|NCT00004990|Osteoporosis|osteoporosis
440516|NCT00004990|Adrenal Suppression|adrenal suppression
440517|NCT00004990|Proteinuria|proteinuria
440518|NCT00004990|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
440519|NCT00004991|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
440520|NCT00004991|Stuttering|stuttering
440521|NCT00004991|Speech Perception|speech perception
440522|NCT00004991|Speech Production|speech production
440523|NCT00004991|Phonology|phonology
440524|NCT00004991|Development|development
440525|NCT00004991|Motor Control|motor control
440526|NCT00004991|Neural Networks|neural networks
440527|NCT00004991|Phonological Disorders|phonological disorders
440528|NCT00004992|clinical trial|clinical trial
440529|NCT00004992|multi-center|multi-center
440530|NCT00004992|NIDDM|niddm
440532|NCT00004992|DPP|dpp
440533|NCT00004992|diabetes risk factors|diabetes risk factors
440534|NCT00004992|diabetes|diabetes
440535|NCT00004992|glycemia|glycemia
440536|NCT00004992|cardiovascular risk factors|cardiovascular risk factors
440537|NCT00004992|quality of life|quality of life
440538|NCT00004992|physical activity and nutrition|physical activity and nutrition
440539|NCT00004992|occurrence of adverse events|occurrence of adverse events
440540|NCT00004992|insulin secretion and sensitivity|insulin secretion and sensitivity
440541|NCT00004992|prevention|prevention
440542|NCT00004992|abnormal glucose metabolism|abnormal glucose metabolism
440543|NCT00004992|lifestyle intervention|lifestyle intervention
440544|NCT00004992|drug intervention|drug intervention
440545|NCT00004993|Parathyroid hormone (1-34)|parathyroid hormone (1-34)
440546|NCT00004993|Glucocorticoid-induced osteoporosis|glucocorticoid-induced osteoporosis
440547|NCT00004993|Postmenopausal women|postmenopausal women
440548|NCT00004993|osteoporotic fractures|osteoporotic fractures
440549|NCT00004994|Allogeneic Transplant|allogeneic transplant
440550|NCT00004994|Function|function
440551|NCT00004994|Mini-Transplant|mini-transplant
440552|NCT00004994|Physical Symptoms|physical symptoms
440553|NCT00004994|Symptom Distress|symptom distress
440554|NCT00004996|Antigen Presentation|antigen presentation
440555|NCT00004996|Cytokines|cytokines
440556|NCT00004996|Helminth|helminth
440557|NCT00004996|Healthy Volunteer|healthy volunteer
440558|NCT00004996|Cross-Over Study|cross-over study
440559|NCT00004996|Helminth Infection|helminth infection
440560|NCT00004997|Hematopoietic|hematopoietic
440561|NCT00004997|DHFR Enzyme|dhfr enzyme
440563|NCT00004997|Folic Acid|folic acid
440564|NCT00004997|MDS|mds
440565|NCT00004997|Myelodysplasia|myelodysplasia
440566|NCT00004997|Myelodysplastic|myelodysplastic
440567|NCT00004998|Drug Therapy, Combination|drug therapy, combination
440568|NCT00004998|Zidovudine|zidovudine
440569|NCT00004998|HIV Protease Inhibitors|hiv protease inhibitors
440570|NCT00004998|Lamivudine|lamivudine
461705|NCT00047593|open-angle|open-angle
440571|NCT00004998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
440572|NCT00004998|Anti-HIV Agents|anti-hiv agents
440573|NCT00004998|Nelfinavir|nelfinavir
440574|NCT00004998|Combivir|combivir
440575|NCT00004999|Drug Therapy, Combination|drug therapy, combination
440576|NCT00004999|Zidovudine|zidovudine
440577|NCT00004999|HIV Protease Inhibitors|hiv protease inhibitors
440578|NCT00004999|Lamivudine|lamivudine
440579|NCT00004999|Disease Progression|disease progression
440580|NCT00004999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
440581|NCT00004999|Anti-HIV Agents|anti-hiv agents
440582|NCT00004999|Viral Load|viral load
440583|NCT00004999|Nelfinavir|nelfinavir
440584|NCT00004999|Combivir|combivir
440585|NCT00005000|HIV-1|hiv-1
440586|NCT00005000|Drug Therapy, Combination|drug therapy, combination
440587|NCT00005000|Lymphoid Tissue|lymphoid tissue
440588|NCT00005000|HIV Protease Inhibitors|hiv protease inhibitors
440589|NCT00005000|Genotype|genotype
440590|NCT00005000|Phenotype|phenotype
440591|NCT00005000|Nelfinavir|nelfinavir
440592|NCT00005000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
440593|NCT00005000|Anti-HIV Agents|anti-hiv agents
440594|NCT00005000|Viral Load|viral load
440595|NCT00005000|Adipose Tissue|adipose tissue
440596|NCT00005000|Glucose|glucose
440597|NCT00005000|Lipids|lipids
440598|NCT00005000|Immunophenotyping|immunophenotyping
440599|NCT00005000|efavirenz|efavirenz
440600|NCT00005001|HIV-1|hiv-1
461693|NCT00047554|glaucoma|glaucoma
440601|NCT00005001|Drug Therapy, Combination|drug therapy, combination
440602|NCT00005001|RNA, Viral|rna, viral
440603|NCT00005001|Anti-HIV Agents|anti-hiv agents
440604|NCT00005001|Viral Load|viral load
440605|NCT00005001|remune|remune
440607|NCT00005002|Drug Therapy, Combination|drug therapy, combination
440608|NCT00005002|HIV Protease Inhibitors|hiv protease inhibitors
440609|NCT00005002|CD4 Lymphocyte Count|cd4 lymphocyte count
440610|NCT00005002|Nelfinavir|nelfinavir
440611|NCT00005002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
440612|NCT00005002|Anti-HIV Agents|anti-hiv agents
440613|NCT00005002|Viral Load|viral load
440614|NCT00005002|remune|remune
440615|NCT00005002|Combivir|combivir
440616|NCT00005003|Handedness|handedness
440617|NCT00005003|Laterality|laterality
440618|NCT00005003|Linkage|linkage
440619|NCT00005003|VNTR/Dinucleotide|vntr/dinucleotide
440620|NCT00005003|Dinucleotide|dinucleotide
440621|NCT00005003|High-Frequency-Trait Analysis|high-frequency-trait analysis
440622|NCT00005004|Cognitive Processes|cognitive processes
440623|NCT00005004|Inferential Ambiguities|inferential ambiguities
440624|NCT00005004|Language Processes|language processes
440625|NCT00005004|Lexical Ambiguities|lexical ambiguities
440626|NCT00005004|Suppression Mechanism|suppression mechanism
440627|NCT00005004|Discourse Processes|discourse processes
440628|NCT00005004|Discourse Production Analysis|discourse production analysis
440629|NCT00005004|Magnetic Resonance Imaging|magnetic resonance imaging
440630|NCT00005004|Prefrontal Cortex Function|prefrontal cortex function
440631|NCT00005004|Aging Effects|aging effects
440632|NCT00005004|Garden Path Phenomena|garden path phenomena
440633|NCT00005004|Text Integration|text integration
440634|NCT00005005|PTH|pth
440635|NCT00005005|Alendronate|alendronate
440636|NCT00005005|Parathyroid hormone|parathyroid hormone
440637|NCT00005005|Osteoporosis|osteoporosis
440638|NCT00005005|Postmenopausal|postmenopausal
440639|NCT00005006|Anabolic agent|anabolic agent
440640|NCT00005006|hPTH|hpth
440641|NCT00005006|PTH|pth
440642|NCT00005006|Parathyroid hormone|parathyroid hormone
440643|NCT00005006|Bone mass|bone mass
440644|NCT00005006|Bone turnover|bone turnover
440645|NCT00005006|Bone formation|bone formation
440646|NCT00005006|Alendronate|alendronate
440647|NCT00005006|Osteoporosis|osteoporosis
440648|NCT00005006|Cyclical therapy|cyclical therapy
440649|NCT00005007|Wegener's granulomatosis|wegener's granulomatosis
440650|NCT00005007|Vasculitis|vasculitis
440651|NCT00005007|Etanercept|etanercept
440652|NCT00005007|Tumor necrosis factor|tumor necrosis factor
440653|NCT00005009|pediatric renal transplant recipients|pediatric renal transplant recipients
440654|NCT00005009|varicella zoster virus (VZV) vaccine|varicella zoster virus (vzv) vaccine
440655|NCT00005009|herpes zoster vaccine|herpes zoster vaccine
440656|NCT00005009|VZV susceptible|vzv susceptible
440657|NCT00005009|safety|safety
440658|NCT00005009|immunogenicity|immunogenicity
440659|NCT00005011|Depression|depression
440660|NCT00005011|Menstrual Cycle|menstrual cycle
440661|NCT00005011|Gonadal Steroids|gonadal steroids
440662|NCT00005011|GnRH Agonist|gnrh agonist
440663|NCT00005011|PMS|pms
440664|NCT00005011|Estradiol|estradiol
440665|NCT00005011|Progesterone|progesterone
440666|NCT00005011|Mood|mood
440667|NCT00005011|MRMD|mrmd
440668|NCT00005011|PMDD|pmdd
440669|NCT00005011|Menstrually Related Mood Disorders|menstrually related mood disorders
440670|NCT00005012|Interferon Alfa-2b|interferon alfa-2b
440671|NCT00005012|Lymphocyte Transformation|lymphocyte transformation
440672|NCT00005012|CD4 Lymphocyte Count|cd4 lymphocyte count
440673|NCT00005012|RNA, Viral|rna, viral
440677|NCT00005013|Antidepressive Agents|antidepressive agents
440678|NCT00005013|Depression|depression
440679|NCT00005013|Depressive Disorder|depressive disorder
440680|NCT00005013|Herbs|herbs
440681|NCT00005013|Hypericum|hypericum
440682|NCT00005013|Medicine, Herbal|medicine, herbal
440683|NCT00005013|Plant Extracts|plant extracts
440684|NCT00005013|Alternative Medicine|alternative medicine
440685|NCT00005014|Autistic Disorder|autistic disorder
440686|NCT00005014|Risperidone|risperidone
440687|NCT00005015|Bipolar Disorder|bipolar disorder
440688|NCT00005015|Depression|depression
440689|NCT00005015|Fluoxetine|fluoxetine
440690|NCT00005016|Fetal Anomaly|fetal anomaly
440691|NCT00005016|Genetic Counseling|genetic counseling
440692|NCT00005016|Prenatal Diagnosis|prenatal diagnosis
440693|NCT00005016|Psychosocial Issues|psychosocial issues
440694|NCT00005016|Qualitative|qualitative
440695|NCT00005016|HPE|hpe
440696|NCT00005016|Holoprosencephaly|holoprosencephaly
440697|NCT00005017|HIV-1|hiv-1
440698|NCT00005017|Drug Therapy, Combination|drug therapy, combination
440699|NCT00005017|Stavudine|stavudine
440700|NCT00005017|HIV Protease Inhibitors|hiv protease inhibitors
440701|NCT00005017|Ritonavir|ritonavir
440702|NCT00005017|Lamivudine|lamivudine
440703|NCT00005017|VX 478|vx 478
440704|NCT00005017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
440705|NCT00005017|Anti-HIV Agents|anti-hiv agents
440706|NCT00005017|abacavir|abacavir
440707|NCT00005017|efavirenz|efavirenz
440708|NCT00004358|arthritis & connective tissue diseases|arthritis & connective tissue diseases
440709|NCT00004358|rare disease|rare disease
440710|NCT00004358|tumoral calcinosis|tumoral calcinosis
440711|NCT00004359|dermatologic disorders|dermatologic disorders
440712|NCT00004359|epidermolysis bullosa|epidermolysis bullosa
440713|NCT00004359|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
440714|NCT00004359|rare disease|rare disease
440715|NCT00004360|diabetes insipidus|diabetes insipidus
440716|NCT00004360|endocrine disorders|endocrine disorders
558522|NCT00426829|PT|pt
440717|NCT00004360|rare disease|rare disease
440718|NCT00004361|DiGeorge syndrome|digeorge syndrome
440719|NCT00004361|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
440720|NCT00004361|conotruncal cardiac defects|conotruncal cardiac defects
440721|NCT00004361|endocrine disorders|endocrine disorders
440722|NCT00004361|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
440723|NCT00004361|hypoparathyroidism|hypoparathyroidism
440724|NCT00004361|pulmonary valve stenosis|pulmonary valve stenosis
440725|NCT00004361|rare disease|rare disease
440726|NCT00004361|tetralogy of Fallot|tetralogy of fallot
440727|NCT00004363|diabetes insipidus|diabetes insipidus
440728|NCT00004363|endocrine disorders|endocrine disorders
440729|NCT00004363|rare disease|rare disease
440730|NCT00004364|diabetes insipidus|diabetes insipidus
440731|NCT00004364|endocrine disorders|endocrine disorders
440734|NCT00004365|growth hormone deficiency|growth hormone deficiency
440735|NCT00004365|rare disease|rare disease
440736|NCT00004366|agoraphobia|agoraphobia
440737|NCT00004366|anxiety disorder|anxiety disorder
440738|NCT00004366|disease-related problem/condition|disease-related problem/condition
440739|NCT00004366|neurologic and psychiatric disorders|neurologic and psychiatric disorders
440740|NCT00004366|panic disorder|panic disorder
440741|NCT00004366|rare disease|rare disease
440742|NCT00004366|vestibular diseases|vestibular diseases
440743|NCT00004367|anxiety disorder|anxiety disorder
440744|NCT00004367|disease-related problem/condition|disease-related problem/condition
440745|NCT00004367|neurologic and psychiatric disorders|neurologic and psychiatric disorders
440746|NCT00004367|panic disorder|panic disorder
440747|NCT00004367|rare disease|rare disease
440748|NCT00004368|hepatic cirrhosis|hepatic cirrhosis
440749|NCT00004368|gastrointestinal disorders|gastrointestinal disorders
440750|NCT00004368|rare disease|rare disease
440751|NCT00004373|anxiety disorder|anxiety disorder
440752|NCT00004373|disease-related problem/condition|disease-related problem/condition
440753|NCT00004373|neurologic and psychiatric disorders|neurologic and psychiatric disorders
440754|NCT00004373|panic disorder|panic disorder
440755|NCT00004373|rare disease|rare disease
440756|NCT00004374|amyloidosis|amyloidosis
440757|NCT00004374|arthritis & connective tissue diseases|arthritis & connective tissue diseases
440758|NCT00004374|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
440759|NCT00004374|rare disease|rare disease
440760|NCT00004375|arthritis & connective tissue diseases|arthritis & connective tissue diseases
440761|NCT00004375|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
440762|NCT00004375|rare disease|rare disease
440763|NCT00004375|systemic lupus erythematosus|systemic lupus erythematosus
440764|NCT00004376|Tourette syndrome|tourette syndrome
440765|NCT00004376|neurologic and psychiatric disorders|neurologic and psychiatric disorders
440766|NCT00004376|rare disease|rare disease
440767|NCT00004378|Fanconi's anemia|fanconi's anemia
440768|NCT00004378|amegakaryocytic thrombocytopenia|amegakaryocytic thrombocytopenia
440769|NCT00004378|aplastic anemia|aplastic anemia
440770|NCT00004378|congenital pure red cell aplasia|congenital pure red cell aplasia
440771|NCT00004378|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
440772|NCT00004378|hematologic disorders|hematologic disorders
440773|NCT00004378|inborn errors of metabolism|inborn errors of metabolism
440774|NCT00004378|metachromatic leukodystrophy|metachromatic leukodystrophy
440775|NCT00004378|pure red cell aplasia|pure red cell aplasia
440776|NCT00004378|rare disease|rare disease
440777|NCT00004378|sphingolipidoses|sphingolipidoses
440778|NCT00004378|thalassemia major|thalassemia major
440779|NCT00004380|arthritis & connective tissue diseases|arthritis & connective tissue diseases
440780|NCT00004380|rare disease|rare disease
440781|NCT00004380|systemic sclerosis|systemic sclerosis
440782|NCT00004381|glucose-6-phosphate dehydrogenase deficiency|glucose-6-phosphate dehydrogenase deficiency
440783|NCT00004381|hematologic disorders|hematologic disorders
440784|NCT00004381|hemolytic disease|hemolytic disease
440785|NCT00004381|hyperbilirubinemia|hyperbilirubinemia
440786|NCT00004381|neonatal disorders|neonatal disorders
440787|NCT00004381|rare disease|rare disease
440788|NCT00004382|hematologic disorders|hematologic disorders
440789|NCT00004382|hyperbilirubinemia|hyperbilirubinemia
440790|NCT00004382|rare disease|rare disease
440791|NCT00004386|inborn errors of metabolism|inborn errors of metabolism
440792|NCT00004386|rare disease|rare disease
440793|NCT00004386|urea cycle disorder|urea cycle disorder
440794|NCT00004387|Parkinson disease|parkinson disease
440795|NCT00004387|neurologic and psychiatric disorders|neurologic and psychiatric disorders
440796|NCT00004387|rare disease|rare disease
440797|NCT00004390|disease-related problem/condition|disease-related problem/condition
440798|NCT00004390|herpes zoster infection|herpes zoster infection
440799|NCT00004390|herpesvirus infection|herpesvirus infection
440800|NCT00004390|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
440801|NCT00004390|pain|pain
440802|NCT00004390|rare disease|rare disease
440803|NCT00004390|viral infection|viral infection
440804|NCT00004392|apnea|apnea
440805|NCT00004392|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
440806|NCT00004392|neurologic and psychiatric disorders|neurologic and psychiatric disorders
440807|NCT00004392|rare disease|rare disease
440808|NCT00004392|sudden infant death syndrome|sudden infant death syndrome
440809|NCT00004393|Tourette syndrome|tourette syndrome
440810|NCT00004393|neurologic and psychiatric disorders|neurologic and psychiatric disorders
440811|NCT00004393|rare disease|rare disease
440812|NCT00004396|inborn errors of metabolism|inborn errors of metabolism
440813|NCT00004396|porphyria|porphyria
440814|NCT00004396|rare disease|rare disease
440815|NCT00004397|inborn errors of metabolism|inborn errors of metabolism
440816|NCT00004397|porphyria|porphyria
440817|NCT00004397|rare disease|rare disease
440818|NCT00004398|inborn errors of metabolism|inborn errors of metabolism
440819|NCT00004398|porphyria|porphyria
440820|NCT00004398|rare disease|rare disease
440821|NCT00004399|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
440822|NCT00004399|hypertensive disorder|hypertensive disorder
440823|NCT00004399|pre-eclampsia|pre-eclampsia
440824|NCT00004399|rare disease|rare disease
440825|NCT00004400|cachexia|cachexia
440826|NCT00004400|disease-related problem/condition|disease-related problem/condition
440827|NCT00004400|human immunodeficiency virus infection|human immunodeficiency virus infection
440828|NCT00004400|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
440829|NCT00004400|nutrition|nutrition
440830|NCT00004400|quality of life|quality of life
440831|NCT00004400|rare disease|rare disease
440832|NCT00004400|viral infection|viral infection
440833|NCT00004401|bacterial infection|bacterial infection
440834|NCT00004401|clostridium infection|clostridium infection
440835|NCT00004401|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
440836|NCT00004401|infant botulism|infant botulism
440837|NCT00004401|rare disease|rare disease
440838|NCT00004402|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
440839|NCT00004402|osteopetrosis|osteopetrosis
440840|NCT00004402|rare disease|rare disease
440841|NCT00004403|cysticercosis|cysticercosis
440842|NCT00004403|epilepsy|epilepsy
440843|NCT00004403|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
440844|NCT00004403|neurologic and psychiatric disorders|neurologic and psychiatric disorders
440845|NCT00004403|parasitic infection|parasitic infection
440846|NCT00004403|rare disease|rare disease
440847|NCT00004403|seizures|seizures
440848|NCT00004404|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
440849|NCT00004404|hematologic disorders|hematologic disorders
440851|NCT00004404|sickle cell anemia|sickle cell anemia
440852|NCT00004406|disease-related problem/condition|disease-related problem/condition
440853|NCT00004406|osteoporosis|osteoporosis
440854|NCT00004406|rare disease|rare disease
440855|NCT00004407|diabetic amyotrophy|diabetic amyotrophy
440856|NCT00004407|diabetic lumbosacral radiculoplexus neuropathy|diabetic lumbosacral radiculoplexus neuropathy
440857|NCT00004407|diabetic neuropathy|diabetic neuropathy
440858|NCT00004407|diabetic proximal neuropathy|diabetic proximal neuropathy
441121|NCT00004550|Longitudinal|longitudinal
440859|NCT00004407|neurologic and psychiatric disorders|neurologic and psychiatric disorders
440860|NCT00004407|rare disease|rare disease
440861|NCT00004408|disease-related problem/condition|disease-related problem/condition
440862|NCT00004408|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
440863|NCT00004408|hematologic disorders|hematologic disorders
440864|NCT00004408|pain|pain
440865|NCT00004408|rare disease|rare disease
440866|NCT00004408|sickle cell anemia|sickle cell anemia
440867|NCT00004409|Dupuytren's disease|dupuytren's disease
440868|NCT00004409|arthritis & connective tissue diseases|arthritis & connective tissue diseases
440869|NCT00004409|rare disease|rare disease
440870|NCT00004410|cholestasis|cholestasis
440871|NCT00004410|gastrointestinal disorders|gastrointestinal disorders
440872|NCT00004410|rare disease|rare disease
440873|NCT00004412|dermatologic disorders|dermatologic disorders
440874|NCT00004412|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
440875|NCT00004412|hematologic disorders|hematologic disorders
440876|NCT00004412|rare disease|rare disease
440877|NCT00004412|sickle cell anemia|sickle cell anemia
440878|NCT00004412|skin ulcers|skin ulcers
440879|NCT00004412|thalassemia major|thalassemia major
440880|NCT00004414|cholestasis|cholestasis
440881|NCT00004414|gastrointestinal disorders|gastrointestinal disorders
440882|NCT00004414|rare disease|rare disease
440883|NCT00004415|environmental/toxic disorders|environmental/toxic disorders
440884|NCT00004415|neurologic and psychiatric disorders|neurologic and psychiatric disorders
440885|NCT00004415|rare disease|rare disease
440886|NCT00004415|spinal cord injury|spinal cord injury
440887|NCT00004416|achalasia|achalasia
440888|NCT00004416|gastrointestinal disorders|gastrointestinal disorders
440889|NCT00004416|rare disease|rare disease
440890|NCT00004418|adrenoleukodystrophy|adrenoleukodystrophy
440891|NCT00004418|inborn errors of metabolism|inborn errors of metabolism
440892|NCT00004418|rare disease|rare disease
440893|NCT00004418|sphingolipidoses|sphingolipidoses
440894|NCT00004419|endocrine disorders|endocrine disorders
440895|NCT00004419|insulin resistance|insulin resistance
440896|NCT00004419|rare disease|rare disease
440897|NCT00004420|arthritis & connective tissue diseases|arthritis & connective tissue diseases
440898|NCT00004420|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
440899|NCT00004420|rare disease|rare disease
440900|NCT00004421|dystonia|dystonia
440901|NCT00004421|neurologic and psychiatric disorders|neurologic and psychiatric disorders
440902|NCT00004421|rare disease|rare disease
440903|NCT00004422|bacterial infection|bacterial infection
440904|NCT00004422|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
440905|NCT00004422|pertussis|pertussis
440906|NCT00004422|rare disease|rare disease
440907|NCT00004423|Crohn's disease|crohn's disease
440908|NCT00004423|gastrointestinal disorders|gastrointestinal disorders
440909|NCT00004423|rare disease|rare disease
440910|NCT00004424|disease-related problem/condition|disease-related problem/condition
440911|NCT00004424|oncologic disorders|oncologic disorders
440912|NCT00004424|pulmonary complications|pulmonary complications
440913|NCT00004424|rare disease|rare disease
440914|NCT00004424|Respiration, Artificial|respiration, artificial
440915|NCT00004426|endocrine disorders|endocrine disorders
440917|NCT00004426|rare disease|rare disease
440918|NCT00004428|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
440919|NCT00004428|cystic fibrosis|cystic fibrosis
440920|NCT00004428|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
440921|NCT00004428|rare disease|rare disease
440922|NCT00004429|end stage renal disease|end stage renal disease
440923|NCT00004429|rare disease|rare disease
440924|NCT00004429|renal and genitourinary disorders|renal and genitourinary disorders
440925|NCT00004430|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
440926|NCT00004430|corneal neovascularization|corneal neovascularization
440927|NCT00004430|rare disease|rare disease
440928|NCT00004431|neurologic and psychiatric disorders|neurologic and psychiatric disorders
440929|NCT00004431|rare disease|rare disease
440930|NCT00004431|trigeminal neuralgia|trigeminal neuralgia
440931|NCT00004433|Tourette syndrome|tourette syndrome
440932|NCT00004433|neurologic and psychiatric disorders|neurologic and psychiatric disorders
440933|NCT00004433|rare disease|rare disease
440934|NCT00004436|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
440935|NCT00004436|hemangioma|hemangioma
440936|NCT00004436|rare disease|rare disease
440937|NCT00004437|acoustic neuroma|acoustic neuroma
440938|NCT00004437|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
440939|NCT00004437|hearing loss|hearing loss
440940|NCT00004437|neurofibromatosis|neurofibromatosis
440941|NCT00004437|neurologic and psychiatric disorders|neurologic and psychiatric disorders
440942|NCT00004437|rare disease|rare disease
440943|NCT00004438|endocrine disorders|endocrine disorders
440944|NCT00004438|hypogonadism|hypogonadism
440945|NCT00004438|rare disease|rare disease
440946|NCT00004440|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
440947|NCT00004440|cystic fibrosis|cystic fibrosis
441122|NCT00004550|Transition|transition
440948|NCT00004440|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
440949|NCT00004440|rare disease|rare disease
440950|NCT00004441|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
440951|NCT00004441|cystic fibrosis|cystic fibrosis
440952|NCT00004441|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
440953|NCT00004441|rare disease|rare disease
440954|NCT00004442|Zellweger syndrome|zellweger syndrome
440955|NCT00004442|adrenoleukodystrophy|adrenoleukodystrophy
440956|NCT00004442|bifunctional enzyme deficiency|bifunctional enzyme deficiency
440957|NCT00004442|inborn errors of metabolism|inborn errors of metabolism
440958|NCT00004442|infantile Refsum's disease|infantile refsum's disease
440959|NCT00004442|peroxisomal disorders|peroxisomal disorders
440960|NCT00004442|pseudo-Zellweger syndrome|pseudo-zellweger syndrome
440961|NCT00004442|rare disease|rare disease
440962|NCT00004442|sphingolipidoses|sphingolipidoses
440963|NCT00004443|inborn errors of metabolism|inborn errors of metabolism
440964|NCT00004443|rare disease|rare disease
440965|NCT00004443|tyrosinemia I|tyrosinemia i
440966|NCT00004444|bacterial infection|bacterial infection
441083|NCT00004494|rare disease|rare disease
440967|NCT00004444|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
440968|NCT00004444|mycobacterium infection|mycobacterium infection
440969|NCT00004444|mycobacterium tuberculosis infection|mycobacterium tuberculosis infection
440970|NCT00004444|rare disease|rare disease
440971|NCT00004445|environmental/toxic disorders|environmental/toxic disorders
440972|NCT00004445|neurologic and psychiatric disorders|neurologic and psychiatric disorders
440973|NCT00004445|rare disease|rare disease
440974|NCT00004445|spinal cord injury|spinal cord injury
440975|NCT00004446|depersonalization disorder|depersonalization disorder
558883|NCT00428233|CLL|cll
440976|NCT00004446|neurologic and psychiatric disorders|neurologic and psychiatric disorders
440977|NCT00004446|rare disease|rare disease
440978|NCT00004448|IgA glomerulonephritis|iga glomerulonephritis
440979|NCT00004448|rare disease|rare disease
440980|NCT00004448|renal and genitourinary disorders|renal and genitourinary disorders
440981|NCT00004449|autism|autism
440982|NCT00004449|neurologic and psychiatric disorders|neurologic and psychiatric disorders
440983|NCT00004449|rare disease|rare disease
440984|NCT00004450|adrenoleukodystrophy|adrenoleukodystrophy
440985|NCT00004450|inborn errors of metabolism|inborn errors of metabolism
440986|NCT00004450|rare disease|rare disease
440987|NCT00004450|sphingolipidoses|sphingolipidoses
440988|NCT00004451|Parkinson disease|parkinson disease
440989|NCT00004451|neurologic and psychiatric disorders|neurologic and psychiatric disorders
440990|NCT00004451|rare disease|rare disease
440991|NCT00004454|inborn errors of metabolism|inborn errors of metabolism
440992|NCT00004454|mucopolysaccharidosis|mucopolysaccharidosis
440993|NCT00004454|mucopolysaccharidosis II|mucopolysaccharidosis ii
440994|NCT00004454|rare disease|rare disease
440995|NCT00004457|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
440996|NCT00004457|motor neuron disease|motor neuron disease
440997|NCT00004457|neurologic and psychiatric disorders|neurologic and psychiatric disorders
440998|NCT00004457|rare disease|rare disease
440999|NCT00004458|autism|autism
441000|NCT00004458|childhood disintegrative disorder|childhood disintegrative disorder
441001|NCT00004458|neurologic and psychiatric disorders|neurologic and psychiatric disorders
441002|NCT00004458|rare disease|rare disease
441003|NCT00004464|aplastic anemia|aplastic anemia
441004|NCT00004464|hematologic disorders|hematologic disorders
441005|NCT00004464|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
441006|NCT00004464|rare disease|rare disease
441007|NCT00004465|E. coli infection|e. coli infection
441008|NCT00004465|bacterial infection|bacterial infection
441009|NCT00004465|hemolytic uremic syndrome|hemolytic uremic syndrome
441010|NCT00004465|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
441011|NCT00004465|rare disease|rare disease
441012|NCT00004465|renal and genitourinary disorders|renal and genitourinary disorders
441013|NCT00004466|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
441014|NCT00004466|hyperlipidemia|hyperlipidemia
441015|NCT00004466|nephrotic syndrome|nephrotic syndrome
441016|NCT00004466|rare disease|rare disease
441017|NCT00004466|renal and genitourinary disorders|renal and genitourinary disorders
441018|NCT00004467|acute liver failure|acute liver failure
441019|NCT00004467|gastrointestinal disorders|gastrointestinal disorders
441020|NCT00004467|rare disease|rare disease
441021|NCT00004468|dermatologic disorders|dermatologic disorders
441022|NCT00004468|psoriasis|psoriasis
441023|NCT00004468|rare disease|rare disease
441024|NCT00004471|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
441025|NCT00004471|cystic fibrosis|cystic fibrosis
441026|NCT00004471|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
441027|NCT00004471|rare disease|rare disease
441028|NCT00004474|Hematologic Disorders|hematologic disorders
441029|NCT00004474|Rare Disease|rare disease
441030|NCT00004478|Shy-Drager Syndrome|shy-drager syndrome
441031|NCT00004478|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
441123|NCT00004550|Treatment|treatment
441032|NCT00004478|neurologic and psychiatric disorders|neurologic and psychiatric disorders
441033|NCT00004478|orthostatic hypotension|orthostatic hypotension
441034|NCT00004478|rare disease|rare disease
441035|NCT00004479|neurologic and psychiatric disorders|neurologic and psychiatric disorders
441036|NCT00004479|rare disease|rare disease
441037|NCT00004479|syncope|syncope
441038|NCT00004480|dermatologic disorders|dermatologic disorders
441039|NCT00004480|hyperhidrosis|hyperhidrosis
441040|NCT00004480|rare disease|rare disease
441041|NCT00004481|endocrine disorders|endocrine disorders
441042|NCT00004481|inborn errors of metabolism|inborn errors of metabolism
441043|NCT00004481|rare disease|rare disease
441044|NCT00004481|sitosterolemia|sitosterolemia
441045|NCT00004482|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
441046|NCT00004482|giant cell myocarditis|giant cell myocarditis
441047|NCT00004482|rare disease|rare disease
441048|NCT00004485|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
441049|NCT00004485|hematologic disorders|hematologic disorders
441050|NCT00004485|rare disease|rare disease
441051|NCT00004485|sickle cell anemia|sickle cell anemia
441052|NCT00004486|autism|autism
441053|NCT00004486|neurologic and psychiatric disorders|neurologic and psychiatric disorders
441054|NCT00004486|rare disease|rare disease
441055|NCT00004487|rare disease|rare disease
441056|NCT00004487|renal and genitourinary disorders|renal and genitourinary disorders
441057|NCT00004487|vesicoureteral reflux|vesicoureteral reflux
441058|NCT00004488|Gaucher's disease|gaucher's disease
441059|NCT00004488|inborn errors of metabolism|inborn errors of metabolism
441060|NCT00004488|rare disease|rare disease
559053|NCT00428909|CML|cml
441061|NCT00004488|sphingolipidoses|sphingolipidoses
441062|NCT00004489|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
441063|NCT00004489|cystic fibrosis|cystic fibrosis
441064|NCT00004489|disease-related problem/condition|disease-related problem/condition
441065|NCT00004489|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
441066|NCT00004489|osteoporosis|osteoporosis
441067|NCT00004489|rare disease|rare disease
441068|NCT00004490|disease-related problem/condition|disease-related problem/condition
441069|NCT00004490|inborn errors of metabolism|inborn errors of metabolism
441070|NCT00004490|lactic acidosis|lactic acidosis
441071|NCT00004490|quality of life|quality of life
441072|NCT00004490|rare disease|rare disease
441073|NCT00004492|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
441074|NCT00004492|hematologic disorders|hematologic disorders
441075|NCT00004492|rare disease|rare disease
441076|NCT00004492|sickle cell anemia|sickle cell anemia
441077|NCT00004493|inborn errors of metabolism|inborn errors of metabolism
441079|NCT00004493|rare disease|rare disease
441080|NCT00004494|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
441081|NCT00004494|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
441082|NCT00004494|neonatal disorders|neonatal disorders
441084|NCT00004494|respiratory distress syndrome|respiratory distress syndrome
441085|NCT00004494|sepsis|sepsis
441086|NCT00004495|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
441087|NCT00004495|end stage renal disease|end stage renal disease
441088|NCT00004495|hyperhomocysteinemia|hyperhomocysteinemia
441089|NCT00004495|rare disease|rare disease
441090|NCT00004495|renal and genitourinary disorders|renal and genitourinary disorders
441091|NCT00004496|acute renal failure|acute renal failure
441092|NCT00004496|rare disease|rare disease
441093|NCT00004496|renal and genitourinary disorders|renal and genitourinary disorders
441094|NCT00004497|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
441095|NCT00004497|hypertensive disorder|hypertensive disorder
441096|NCT00004497|primary pulmonary hypertension|primary pulmonary hypertension
441097|NCT00004497|rare disease|rare disease
441098|NCT00004498|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
441099|NCT00004498|inborn errors of metabolism|inborn errors of metabolism
441100|NCT00004498|ornithine transcarbamylase deficiency|ornithine transcarbamylase deficiency
441101|NCT00004498|rare disease|rare disease
441102|NCT00004498|urea cycle disorder|urea cycle disorder
441103|NCT00004500|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
441104|NCT00004500|meconium aspiration syndrome|meconium aspiration syndrome
441105|NCT00004500|rare disease|rare disease
441106|NCT00004533|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
441107|NCT00004533|cystic fibrosis|cystic fibrosis
441108|NCT00004533|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
441109|NCT00004533|rare disease|rare disease
441110|NCT00004547|Surgery|surgery
441111|NCT00004547|Mesothelioma|mesothelioma
441112|NCT00004547|Pseudomyxoma|pseudomyxoma
441113|NCT00004547|Colon Cancer|colon cancer
441114|NCT00004547|Chemotherapy|chemotherapy
441115|NCT00004549|Atherosclerosis|atherosclerosis
441116|NCT00004549|Endothelium|endothelium
441117|NCT00004549|Peripheral Vascular Disease|peripheral vascular disease
441118|NCT00004549|Markers of Inflammation|markers of inflammation
441119|NCT00004549|Claudication|claudication
441120|NCT00004550|Screening|screening
441125|NCT00004550|Obsessive Compulsive Disorder|obsessive compulsive disorder
441126|NCT00004550|Evaluation|evaluation
441127|NCT00004550|Follow-Up|follow-up
441128|NCT00004550|OC Spectrum Disorders|oc spectrum disorders
441129|NCT00004550|OCD|ocd
441130|NCT00004553|Single Fiber EMG|single fiber emg
441131|NCT00004553|Macro-EMG|macro-emg
441132|NCT00004553|Myasthenia|myasthenia
441133|NCT00004553|Post-Polio Syndrome|post-polio syndrome
441134|NCT00004553|Neuromuscular Transmission|neuromuscular transmission
441135|NCT00004553|Motor Dysfunction|motor dysfunction
441136|NCT00004553|Neuromuscular Disorder|neuromuscular disorder
441137|NCT00004556|Stimulants|stimulants
441138|NCT00004556|Affect|affect
441139|NCT00004556|Cognition|cognition
441140|NCT00004556|Brain Physiology|brain physiology
441141|NCT00004556|Brain Metabolism|brain metabolism
441142|NCT00004556|Catecholamines|catecholamines
441143|NCT00004556|Brain Imaging|brain imaging
441144|NCT00004556|Cognitive Efficiency|cognitive efficiency
441145|NCT00004556|Dopamine Genes|dopamine genes
441146|NCT00004557|Attention|attention
441147|NCT00004557|Cognition|cognition
441148|NCT00004557|Dementia|dementia
441149|NCT00004557|Memory|memory
441150|NCT00004557|Object Recognition|object recognition
441151|NCT00004557|Spatial Processes|spatial processes
441152|NCT00004563|Lung Diseases|lung diseases
441153|NCT00004563|Pulmonary Fibrosis|pulmonary fibrosis
441154|NCT00004563|Systemic Scleroderma|systemic scleroderma
441155|NCT00004563|Scleroderma, systemic|scleroderma, systemic
441156|NCT00004564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
441157|NCT00004564|Cerebrovascular accident|cerebrovascular accident
441158|NCT00004565|Breast Cancer|breast cancer
441159|NCT00004565|Genetics|genetics
441160|NCT00004565|High Risk|high risk
441161|NCT00004565|Polymorphisms|polymorphisms
441162|NCT00004565|Susceptibility|susceptibility
441163|NCT00004565|Biomarkers|biomarkers
441164|NCT00004565|Estrogen|estrogen
441165|NCT00004565|Genes|genes
441166|NCT00004566|3D Imaging|3d imaging
441167|NCT00004566|Swallowing|swallowing
441168|NCT00004566|Fetal Development|fetal development
441169|NCT00004566|High-Risk Pregnancy|high-risk pregnancy
441170|NCT00004566|Ultrasound|ultrasound
441171|NCT00004567|Relapse|relapse
441172|NCT00004567|Immunosuppressive|immunosuppressive
441173|NCT00004567|Toxicity|toxicity
441174|NCT00004567|Purineantimetabolite|purineantimetabolite
441175|NCT00004567|Alternative Agents|alternative agents
441176|NCT00004567|Wegener's Granulomatosis|wegener's granulomatosis
441177|NCT00004567|Wegener's Disease|wegener's disease
441178|NCT00004567|Blood Vessel Disorder|blood vessel disorder
441179|NCT00004567|Systemic Vasculitis|systemic vasculitis
441180|NCT00004568|Peripheral Neuropathies|peripheral neuropathies
441181|NCT00004568|Myopathy|myopathy
441182|NCT00004568|Muscular Dystrophy|muscular dystrophy
441183|NCT00004568|Motor Neuron Disease|motor neuron disease
441184|NCT00004568|Spinocerebellar Degeneration|spinocerebellar degeneration
441185|NCT00004568|Neurological Disorders|neurological disorders
441186|NCT00004570|Temporal Processing|temporal processing
441187|NCT00004570|Language Impairment|language impairment
441188|NCT00004570|Linkage Analysis|linkage analysis
441189|NCT00004570|Inheritance|inheritance
441190|NCT00004570|Language Delay|language delay
441192|NCT00004570|Auditory Temporal Processing Disorder|auditory temporal processing disorder
441193|NCT00004570|Speech Impediment|speech impediment
441194|NCT00004571|Magnetic Resonance Imaging|magnetic resonance imaging
441195|NCT00004571|Brain Metabolism|brain metabolism
441196|NCT00004571|Brain Physiology|brain physiology
441197|NCT00004571|Neuropsychiatric Disorders|neuropsychiatric disorders
441198|NCT00004571|Cognitition|cognitition
441199|NCT00004572|Type 2 Diabetes|type 2 diabetes
441200|NCT00004573|cytomegalovirus viremia|cytomegalovirus viremia
441201|NCT00004574|Abetalipoproteinemia|abetalipoproteinemia
441202|NCT00004574|Ataxia|ataxia
441203|NCT00004574|Retinitis Pigmentosa|retinitis pigmentosa
441204|NCT00004574|Vitamin A|vitamin a
441205|NCT00004574|Vitamin E|vitamin e
441206|NCT00004575|Endothelium|endothelium
441207|NCT00004575|Vasodilation|vasodilation
441208|NCT00004575|Vascular Biology|vascular biology
441209|NCT00004575|Venous Occlusion Plethysmography|venous occlusion plethysmography
441210|NCT00004576|Dyskinesias|dyskinesias
441211|NCT00004576|Glutamate|glutamate
441212|NCT00004576|Levodopa|levodopa
441213|NCT00004576|Parkinson's Disease|parkinson's disease
441214|NCT00004577|BOLD Effect|bold effect
441215|NCT00004577|Cerebral Blood Flow|cerebral blood flow
441216|NCT00004577|Cerebral Blood Volume|cerebral blood volume
441217|NCT00004577|Functional Imaging|functional imaging
441218|NCT00004577|Magnetic Resonance Imaging|magnetic resonance imaging
441219|NCT00004577|Technical Developments|technical developments
441220|NCT00004578|Stavudine|stavudine
441221|NCT00004578|HIV Protease Inhibitors|hiv protease inhibitors
441222|NCT00004578|Ritonavir|ritonavir
441223|NCT00004578|Lamivudine|lamivudine
441224|NCT00004578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
441225|NCT00004579|Vaccines, Synthetic|vaccines, synthetic
441226|NCT00004579|Viral Vaccines|viral vaccines
441228|NCT00004579|Dose-Response Relationship, Drug|dose-response relationship, drug
441229|NCT00004579|HIV Envelope Protein gp160|hiv envelope protein gp160
441230|NCT00004579|AIDS Vaccines|aids vaccines
441231|NCT00004579|HIV Seronegativity|hiv seronegativity
441232|NCT00004579|Avipoxvirus|avipoxvirus
441233|NCT00004579|Immunization|immunization
441234|NCT00004579|HIV Envelope Protein gp120|hiv envelope protein gp120
441235|NCT00004579|Recombination, Genetic|recombination, genetic
441236|NCT00004580|Drug Therapy, Combination|drug therapy, combination
441237|NCT00004580|Nevirapine|nevirapine
441238|NCT00004580|HIV Protease Inhibitors|hiv protease inhibitors
441239|NCT00004580|Ritonavir|ritonavir
441240|NCT00004580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
441241|NCT00004581|Drug Therapy, Combination|drug therapy, combination
441242|NCT00004581|Nevirapine|nevirapine
441243|NCT00004581|HIV Protease Inhibitors|hiv protease inhibitors
441244|NCT00004581|Ritonavir|ritonavir
441245|NCT00004581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
441246|NCT00004581|Anti-HIV Agents|anti-hiv agents
441247|NCT00004581|ABT 378|abt 378
441248|NCT00004582|HIV Protease Inhibitors|hiv protease inhibitors
441249|NCT00004582|Ritonavir|ritonavir
441250|NCT00004582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
441251|NCT00004582|Anti-HIV Agents|anti-hiv agents
441252|NCT00004582|Viral Load|viral load
441253|NCT00004582|ABT 378|abt 378
441254|NCT00004582|efavirenz|efavirenz
441255|NCT00004583|Drug Therapy, Combination|drug therapy, combination
441256|NCT00004583|Administration, Oral|administration, oral
441257|NCT00004583|Stavudine|stavudine
441258|NCT00004583|HIV Protease Inhibitors|hiv protease inhibitors
441259|NCT00004583|Lamivudine|lamivudine
441260|NCT00004583|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
441261|NCT00004583|Anti-HIV Agents|anti-hiv agents
441262|NCT00004583|Nelfinavir|nelfinavir
441263|NCT00004583|ABT 378|abt 378
441264|NCT00004584|Dose-Response Relationship, Drug|dose-response relationship, drug
441265|NCT00004584|Drug Therapy, Combination|drug therapy, combination
441266|NCT00004584|HIV Protease Inhibitors|hiv protease inhibitors
441267|NCT00004584|Ritonavir|ritonavir
441268|NCT00004584|Saquinavir|saquinavir
441269|NCT00004584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
441270|NCT00004584|Anti-HIV Agents|anti-hiv agents
441271|NCT00004585|Drug Therapy, Combination|drug therapy, combination
441272|NCT00004585|Zidovudine|zidovudine
441273|NCT00004585|Lamivudine|lamivudine
441274|NCT00004585|RNA, Viral|rna, viral
441275|NCT00004585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
441276|NCT00004585|Anti-HIV Agents|anti-hiv agents
441277|NCT00004585|Viral Load|viral load
441278|NCT00004585|abacavir|abacavir
441279|NCT00004585|efavirenz|efavirenz
441280|NCT00004604|stage IV colon cancer|stage iv colon cancer
441281|NCT00004604|stage IV breast cancer|stage iv breast cancer
441282|NCT00004604|recurrent breast cancer|recurrent breast cancer
441283|NCT00004604|stage IV gastric cancer|stage iv gastric cancer
441284|NCT00004604|recurrent gastric cancer|recurrent gastric cancer
441285|NCT00004604|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
441286|NCT00004604|recurrent pancreatic cancer|recurrent pancreatic cancer
441287|NCT00004604|stage IV rectal cancer|stage iv rectal cancer
441288|NCT00004604|recurrent colon cancer|recurrent colon cancer
441289|NCT00004604|recurrent rectal cancer|recurrent rectal cancer
441290|NCT00004604|inflammatory breast cancer|inflammatory breast cancer
441291|NCT00004604|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
441292|NCT00004604|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
441293|NCT00004604|extensive stage small cell lung cancer|extensive stage small cell lung cancer
441294|NCT00004604|recurrent small cell lung cancer|recurrent small cell lung cancer
441295|NCT00004604|unresectable gallbladder cancer|unresectable gallbladder cancer
441296|NCT00004604|recurrent gallbladder cancer|recurrent gallbladder cancer
441297|NCT00004604|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
441298|NCT00004604|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
441299|NCT00004604|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
441300|NCT00004604|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
441301|NCT00004604|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
441302|NCT00004604|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
441303|NCT00004604|stage IV salivary gland cancer|stage iv salivary gland cancer
441304|NCT00004604|recurrent salivary gland cancer|recurrent salivary gland cancer
441305|NCT00004604|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
441306|NCT00004604|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
441307|NCT00004604|testicular yolk sac tumor|testicular yolk sac tumor
441308|NCT00004604|lung metastases|lung metastases
441309|NCT00004604|liver metastases|liver metastases
441310|NCT00004604|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
441311|NCT00004604|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
441312|NCT00004604|male breast cancer|male breast cancer
441313|NCT00004604|stage IV pancreatic cancer|stage iv pancreatic cancer
441314|NCT00004635|Angiogenesis|angiogenesis
441315|NCT00004635|Cancer|cancer
441316|NCT00004635|Hormonal Therapy|hormonal therapy
441317|NCT00004635|Prostate|prostate
441318|NCT00004635|Thalidomide|thalidomide
441319|NCT00004635|Prostate Cancer|prostate cancer
441320|NCT00004638|chronic sinusitis|chronic sinusitis
441321|NCT00004639|cleft lip and palate|cleft lip and palate
441322|NCT00004639|children|children
441323|NCT00004639|speech|speech
441324|NCT00004639|velopharyngeal function|velopharyngeal function
441325|NCT00004639|congenital facial malformation|congenital facial malformation
441326|NCT00004639|von Langenbeck procedure|von langenbeck procedure
441327|NCT00004639|Furlow procedure|furlow procedure
441328|NCT00004639|cleft lip and palate repair|cleft lip and palate repair
441329|NCT00004639|Unilateral cleft lip and palate|unilateral cleft lip and palate
441330|NCT00004640|Aging|aging
441331|NCT00004640|Elderly|elderly
441332|NCT00004640|Periodontal Disease|periodontal disease
441333|NCT00004640|Dental Caries|dental caries
441334|NCT00004640|Fluoride|fluoride
441335|NCT00004640|Antibacterial rinse|antibacterial rinse
440531|NCT00004992|NIDDK|niddk
441336|NCT00004640|Chlorhexidine|chlorhexidine
441337|NCT00004640|Tooth Mortality|tooth mortality
441338|NCT00004642|congenital cytomegalovirus infection|congenital cytomegalovirus infection
441339|NCT00004642|cytomegalovirus infection|cytomegalovirus infection
441340|NCT00004642|herpesvirus infection|herpesvirus infection
441341|NCT00004642|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
441342|NCT00004642|neonatal disorders|neonatal disorders
441343|NCT00004642|rare disease|rare disease
441344|NCT00004642|viral infection|viral infection
441345|NCT00004643|arthritis & connective tissue diseases|arthritis & connective tissue diseases
441346|NCT00004643|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
441347|NCT00004643|rare disease|rare disease
441348|NCT00004643|systemic lupus erythematosus|systemic lupus erythematosus
441349|NCT00004644|herpes simplex virus infection|herpes simplex virus infection
441350|NCT00004644|herpesvirus infection|herpesvirus infection
441351|NCT00004644|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
441353|NCT00004644|viral infection|viral infection
441354|NCT00004645|Balo's concentric sclerosis|balo's concentric sclerosis
441355|NCT00004645|Devic's syndrome|devic's syndrome
441356|NCT00004645|Marburg's variant of multiple sclerosis|marburg's variant of multiple sclerosis
441357|NCT00004645|acute disseminated encephalomyelitis|acute disseminated encephalomyelitis
441358|NCT00004645|acute transverse myelitis|acute transverse myelitis
441359|NCT00004645|multiple sclerosis|multiple sclerosis
441360|NCT00004645|neurologic and psychiatric disorders|neurologic and psychiatric disorders
441361|NCT00004645|rare disease|rare disease
441362|NCT00004646|Duchenne muscular dystrophy|duchenne muscular dystrophy
441363|NCT00004646|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
441364|NCT00004646|muscular dystrophy|muscular dystrophy
441365|NCT00004646|neurologic and psychiatric disorders|neurologic and psychiatric disorders
441366|NCT00004646|rare disease|rare disease
441367|NCT00004647|diabetic neuropathy|diabetic neuropathy
441368|NCT00004647|disease-related problem/condition|disease-related problem/condition
441369|NCT00004647|neurologic and psychiatric disorders|neurologic and psychiatric disorders
441371|NCT00004647|rare disease|rare disease
441372|NCT00004648|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
441373|NCT00004648|hematologic disorders|hematologic disorders
441374|NCT00004648|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
441375|NCT00004648|rare disease|rare disease
441376|NCT00004648|Osler-Rendu-Weber disease|osler-rendu-weber disease
441377|NCT00004649|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
441378|NCT00004649|hematologic disorders|hematologic disorders
441379|NCT00004649|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
441380|NCT00004649|rare disease|rare disease
441381|NCT00004650|disease-related problem/condition|disease-related problem/condition
441382|NCT00004650|osteoporosis|osteoporosis
441383|NCT00004650|rare disease|rare disease
441384|NCT00004652|Tourette syndrome|tourette syndrome
441385|NCT00004652|neurologic and psychiatric disorders|neurologic and psychiatric disorders
441386|NCT00004652|rare disease|rare disease
441387|NCT00004654|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
441388|NCT00004654|hematologic disorders|hematologic disorders
441389|NCT00004654|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
441390|NCT00004654|rare disease|rare disease
441391|NCT00004656|Rett syndrome|rett syndrome
441392|NCT00004656|neurologic and psychiatric disorders|neurologic and psychiatric disorders
441393|NCT00004656|rare disease|rare disease
441394|NCT00004658|5'-nucleotidase syndrome|5'-nucleotidase syndrome
441395|NCT00004658|inborn errors of metabolism|inborn errors of metabolism
441396|NCT00004658|rare disease|rare disease
441397|NCT00004659|adult brain tumor|adult brain tumor
441398|NCT00004659|brain tumor|brain tumor
441399|NCT00004659|childhood brain tumor|childhood brain tumor
441400|NCT00004659|genetic condition|genetic condition
441401|NCT00004659|nervous tissue tumors|nervous tissue tumors
441402|NCT00004659|oncologic disorders|oncologic disorders
441403|NCT00004659|rare disease|rare disease
441404|NCT00004660|Graves' disease|graves' disease
441405|NCT00004660|thyroid disease|thyroid disease
441406|NCT00004660|endocrine disorders|endocrine disorders
441407|NCT00004660|rare disease|rare disease
441408|NCT00004661|endocrine disorders|endocrine disorders
441409|NCT00004661|pseudohypoparathyroidism|pseudohypoparathyroidism
441410|NCT00004661|rare disease|rare disease
441411|NCT00004662|arthritis & connective tissue diseases|arthritis & connective tissue diseases
441412|NCT00004662|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
441413|NCT00004662|rare disease|rare disease
441414|NCT00004662|systemic lupus erythematosus|systemic lupus erythematosus
441415|NCT00004663|arthritis & connective tissue diseases|arthritis & connective tissue diseases
441416|NCT00004663|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
441417|NCT00004663|rare disease|rare disease
559537|NCT00422500|DRC|drc
441418|NCT00004663|systemic lupus erythematosus|systemic lupus erythematosus
441419|NCT00004664|disease-related problem/condition|disease-related problem/condition
441420|NCT00004664|human immunodeficiency virus infection|human immunodeficiency virus infection
441510|NCT00005762|Pharmacokinetics|pharmacokinetics
441421|NCT00004664|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
441422|NCT00004664|nutrition|nutrition
441423|NCT00004664|rare disease|rare disease
441424|NCT00004664|viral infection|viral infection
441425|NCT00004665|arthritis & connective tissue diseases|arthritis & connective tissue diseases
441426|NCT00004665|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
441427|NCT00004665|rare disease|rare disease
441428|NCT00004665|systemic lupus erythematosus|systemic lupus erythematosus
441429|NCT00004667|hematologic disorders|hematologic disorders
441430|NCT00004667|rare disease|rare disease
441431|NCT00004667|von Willebrand's disease|von willebrand's disease
441432|NCT00004669|bronchopulmonary dysplasia|bronchopulmonary dysplasia
441433|NCT00004669|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
441434|NCT00004669|neonatal disorders|neonatal disorders
441435|NCT00004669|rare disease|rare disease
441436|NCT00004670|Parkinson disease|parkinson disease
441437|NCT00004670|neurologic and psychiatric disorders|neurologic and psychiatric disorders
441438|NCT00004670|rare disease|rare disease
441439|NCT00004682|myasthenia gravis|myasthenia gravis
441440|NCT00004682|neurologic and psychiatric disorders|neurologic and psychiatric disorders
441441|NCT00004682|rare disease|rare disease
441442|NCT00004685|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
441443|NCT00004685|muscular dystrophy|muscular dystrophy
441444|NCT00004685|neurologic and psychiatric disorders|neurologic and psychiatric disorders
441445|NCT00004685|rare disease|rare disease
441446|NCT00004686|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
441447|NCT00004686|giant cell arteritis|giant cell arteritis
441448|NCT00004686|rare disease|rare disease
441449|NCT00004688|adult anaplastic astrocytoma|adult anaplastic astrocytoma
441450|NCT00004688|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
441451|NCT00004688|adult brain stem glioma|adult brain stem glioma
441452|NCT00004688|adult brain tumor|adult brain tumor
441453|NCT00004688|adult glioblastoma multiforme|adult glioblastoma multiforme
441454|NCT00004688|adult infiltrating astrocytoma|adult infiltrating astrocytoma
441455|NCT00004688|brain tumor|brain tumor
441456|NCT00004688|genetic condition|genetic condition
441457|NCT00004688|miscellaneous sites/terms|miscellaneous sites/terms
441458|NCT00004688|mixed gliomas|mixed gliomas
441459|NCT00004688|nervous tissue tumors|nervous tissue tumors
441460|NCT00004688|oncologic disorders|oncologic disorders
441461|NCT00004688|rare disease|rare disease
441462|NCT00004688|recurrent adult brain tumor|recurrent adult brain tumor
441463|NCT00004689|bacterial infection|bacterial infection
441464|NCT00004689|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
441465|NCT00004689|mycobacterium avium infection|mycobacterium avium infection
441466|NCT00004689|mycobacterium infection|mycobacterium infection
441467|NCT00004689|rare disease|rare disease
441468|NCT00004690|dermatologic disorders|dermatologic disorders
441469|NCT00004690|ichthyosis|ichthyosis
441470|NCT00004690|rare disease|rare disease
441471|NCT00004694|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
441472|NCT00004694|hereditary angioedema|hereditary angioedema
441473|NCT00004694|rare disease|rare disease
441474|NCT00004695|common variable immunodeficiency|common variable immunodeficiency
441475|NCT00004695|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
441476|NCT00004695|primary immunodeficiency disease|primary immunodeficiency disease
441477|NCT00004695|rare disease|rare disease
441478|NCT00005758|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
441479|NCT00005758|Combined Modality Therapy|combined modality therapy
441480|NCT00005758|HIV Envelope Protein gp120|hiv envelope protein gp120
441481|NCT00005758|AIDS Vaccines|aids vaccines
441482|NCT00005758|RNA, Viral|rna, viral
441483|NCT00005758|HIV Core Protein p24|hiv core protein p24
441484|NCT00005758|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
441485|NCT00005758|Anti-HIV Agents|anti-hiv agents
441486|NCT00005758|Viral Load|viral load
441487|NCT00005758|HIV Therapeutic Vaccine|hiv therapeutic vaccine
441488|NCT00005760|Dyslipidemia|dyslipidemia
441489|NCT00005760|Hypertension|hypertension
441490|NCT00005760|Metabolic Syndrome X|metabolic syndrome x
441492|NCT00005760|Subcutaneous Adipose Tissue|subcutaneous adipose tissue
441493|NCT00005760|Visceral Abdominal Adipose Tissue|visceral abdominal adipose tissue
441494|NCT00005761|Types 1 & 2 Diabetes|types 1 & 2 diabetes
441495|NCT00005761|Cell Adhesion Molecules|cell adhesion molecules
441496|NCT00005761|Chemokines|chemokines
441497|NCT00005761|Vascular Endothelial Growth Factor|vascular endothelial growth factor
441498|NCT00005761|Cross-Sectional|cross-sectional
441499|NCT00005761|Serum Levels|serum levels
441500|NCT00005761|Diabetic Retinopathy|diabetic retinopathy
441501|NCT00005762|Drug Interactions|drug interactions
441502|NCT00005762|Drug Therapy, Combination|drug therapy, combination
441503|NCT00005762|HIV Protease Inhibitors|hiv protease inhibitors
441504|NCT00005762|Ritonavir|ritonavir
441505|NCT00005762|Dosage Forms|dosage forms
441506|NCT00005762|Saquinavir|saquinavir
441507|NCT00005762|VX 478|vx 478
441508|NCT00005762|Anti-HIV Agents|anti-hiv agents
441515|NCT00005764|Drug Therapy, Combination|drug therapy, combination
441516|NCT00005764|Zidovudine|zidovudine
441517|NCT00005764|Stavudine|stavudine
441518|NCT00005764|Lamivudine|lamivudine
441519|NCT00005764|Blood|blood
441520|NCT00005764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
441521|NCT00005764|Anti-HIV Agents|anti-hiv agents
441522|NCT00005764|Lipodystrophy|lipodystrophy
441523|NCT00005764|Combivir|combivir
441524|NCT00005764|Lactic Acid|lactic acid
441527|NCT00005767|Amino Acid Metabolism|amino acid metabolism
441528|NCT00005770|elastic property of skin|elastic property of skin
441529|NCT00005771|Abdominal Hollowing Exercises|abdominal hollowing exercises
441530|NCT00005772|NICHD Neonatal Research Network|nichd neonatal research network
441531|NCT00005772|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
441532|NCT00005772|Hypothermia|hypothermia
441533|NCT00005772|Neonatal depression|neonatal depression
441534|NCT00005772|Perinatal asphyxia|perinatal asphyxia
441535|NCT00005773|NICHD Neonatal Research Network|nichd neonatal research network
441536|NCT00005773|Hypertension, pulmonary|hypertension, pulmonary
441537|NCT00005773|Hypoxic respiratory failure|hypoxic respiratory failure
441538|NCT00005773|Meconium aspiration|meconium aspiration
441539|NCT00005773|Methemoglobinemia|methemoglobinemia
441540|NCT00005773|Nitric oxide|nitric oxide
441541|NCT00005773|Oxygen inhalation therapy|oxygen inhalation therapy
441542|NCT00005773|Persistent Fetal Circulation Syndrome|persistent fetal circulation syndrome
441543|NCT00005773|Pneumonia, aspiration|pneumonia, aspiration
441544|NCT00005773|Respiratory distress syndrome|respiratory distress syndrome
441545|NCT00005773|Respiratory insufficiency|respiratory insufficiency
441546|NCT00005773|Severe respiratory failure|severe respiratory failure
441547|NCT00005774|NICHD Neonatal Research Network|nichd neonatal research network
441548|NCT00005774|Pulmonary ventilation|pulmonary ventilation
441549|NCT00005774|Respiratory distress syndrome|respiratory distress syndrome
441550|NCT00005774|Respiratory insufficiency|respiratory insufficiency
441551|NCT00005774|Surfactant, pulmonary|surfactant, pulmonary
441552|NCT00005774|Mechanical Ventilation|mechanical ventilation
441553|NCT00005774|Survanta|survanta
441554|NCT00005775|NICHD Neonatal Research Network|nichd neonatal research network
441555|NCT00005775|Extremely Low Birth Weight (ELBW) infants|extremely low birth weight (elbw) infants
441556|NCT00005775|Prematurity|prematurity
441557|NCT00005775|Glutamine|glutamine
441558|NCT00005775|Total parenteral nutrition|total parenteral nutrition
441559|NCT00005775|Nutrition|nutrition
441560|NCT00005775|Very low birth weight (VLBW) infants|very low birth weight (vlbw) infants
441561|NCT00005776|NICHD Neonatal Research Network|nichd neonatal research network
441562|NCT00005776|Hypertension, pulmonary|hypertension, pulmonary
441563|NCT00005776|Hypoxic respiratory failure|hypoxic respiratory failure
441564|NCT00005776|Meconium aspiration|meconium aspiration
441565|NCT00005776|Methemoglobinemia|methemoglobinemia
441566|NCT00005776|Nitric oxide|nitric oxide
441567|NCT00005776|Oxygen inhalation therapy|oxygen inhalation therapy
441568|NCT00005776|Persistent Fetal Circulation Syndrome|persistent fetal circulation syndrome
441569|NCT00005776|Pneumonia, aspiration|pneumonia, aspiration
441570|NCT00005776|Respiratory distress syndrome|respiratory distress syndrome
441571|NCT00005776|Respiratory insufficiency|respiratory insufficiency
441572|NCT00005776|Severe respiratory failure|severe respiratory failure
441573|NCT00005777|NICHD Neonatal Research Network|nichd neonatal research network
441574|NCT00005777|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
441575|NCT00005777|Prematurity|prematurity
441576|NCT00005777|Chronic Lung Disease (CLD)|chronic lung disease (cld)
441577|NCT00005777|Dexamethasone|dexamethasone
441578|NCT00005777|Glucocorticoids|glucocorticoids
441579|NCT00005777|Respiration, Artificial|respiration, artificial
441580|NCT00005777|Mechanical ventilation|mechanical ventilation
441581|NCT00005777|Respiratory Insufficiency|respiratory insufficiency
441582|NCT00005778|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
441583|NCT00005778|Cytoxan|cytoxan
441584|NCT00005778|Cyclophosphamide|cyclophosphamide
441585|NCT00005778|High-dose immunoablative therapy|high-dose immunoablative therapy
441586|NCT00005779|Virus Replication|virus replication
441587|NCT00005779|HIV-1|hiv-1
441588|NCT00005779|AIDS Vaccines|aids vaccines
441589|NCT00005779|CD4 Lymphocyte Count|cd4 lymphocyte count
441590|NCT00005779|Cohort Studies|cohort studies
441591|NCT00005779|Interleukin-12|interleukin-12
441592|NCT00005779|HIV Therapeutic Vaccine|hiv therapeutic vaccine
441593|NCT00005780|Lymphoma Vaccines|lymphoma vaccines
441594|NCT00005780|Immune Response Against Lymphoma|immune response against lymphoma
441595|NCT00005780|Molecular Complete Remissions|molecular complete remissions
441596|NCT00005780|Novel Treatment Approach|novel treatment approach
441597|NCT00005780|Mantle Cell Lymphoma|mantle cell lymphoma
441598|NCT00005781|Epidemiology|epidemiology
441599|NCT00005781|NHANES|nhanes
441600|NCT00005781|Photography|photography
441601|NCT00005781|Prevalence|prevalence
441602|NCT00005781|Skin Disease|skin disease
441603|NCT00005781|Healthy Volunteer|healthy volunteer
441604|NCT00005782|Donor Apheresis|donor apheresis
461694|NCT00047554|ocular|ocular
441605|NCT00005782|Sickle Cell Trait|sickle cell trait
441606|NCT00005782|Red Cell Alloimmunization|red cell alloimmunization
441607|NCT00005783|Fetal Hemoglobin|fetal hemoglobin
441608|NCT00005783|Hematopoietic Growth Factor|hematopoietic growth factor
441609|NCT00005783|Peripheral Blood CD34 Cells|peripheral blood cd34 cells
441610|NCT00005783|Vasoocclusive Crisis|vasoocclusive crisis
441611|NCT00005783|Sickle Cell Anemia|sickle cell anemia
441612|NCT00005783|Sickle Cell Disease|sickle cell disease
441613|NCT00005783|Sickle Cell Disorder|sickle cell disorder
441614|NCT00005784|Macular Degeneration|macular degeneration
441615|NCT00005784|Diabetic Retinopathy|diabetic retinopathy
441616|NCT00005784|Vascular Occlusive Disease|vascular occlusive disease
441617|NCT00005784|Central Serous Retinopathy|central serous retinopathy
441618|NCT00005784|Rare/Unknown Retinal Disease|rare/unknown retinal disease
441619|NCT00005784|Retinal Disease|retinal disease
441620|NCT00005784|Age-Related Macular Degeneration|age-related macular degeneration
441621|NCT00005785|Peripheral Blood Stem Cells|peripheral blood stem cells
441622|NCT00005785|Engraftment|engraftment
441623|NCT00005785|Graft vs. Host Disease|graft vs. host disease
441624|NCT00005785|Graft-Versus-Leukemia|graft-versus-leukemia
441625|NCT00005785|Donor Apheresis|donor apheresis
441626|NCT00005785|Cyclophosphamide|cyclophosphamide
441627|NCT00005785|Fludarabine|fludarabine
441629|NCT00005785|AIDS|aids
441630|NCT00005785|Gene Therapy|gene therapy
441631|NCT00005785|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
441632|NCT00005785|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
441633|NCT00005785|Acute Myelogenous Leukemia|acute myelogenous leukemia
441634|NCT00005785|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
441635|NCT00005787|neutropenia|neutropenia
441636|NCT00005787|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
441637|NCT00005787|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
441638|NCT00005787|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
441639|NCT00005787|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
441640|NCT00005787|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
441641|NCT00005787|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
441642|NCT00005787|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
441643|NCT00005787|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
441644|NCT00005787|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
441645|NCT00005787|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
441646|NCT00005787|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
441647|NCT00005787|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
441648|NCT00005787|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
441649|NCT00005787|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
441650|NCT00005787|splenic marginal zone lymphoma|splenic marginal zone lymphoma
441651|NCT00005788|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
441652|NCT00005788|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
441653|NCT00005788|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
441654|NCT00005788|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
441655|NCT00005788|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
441656|NCT00005788|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
441657|NCT00005788|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
441658|NCT00005788|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
441659|NCT00005788|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
441660|NCT00005788|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
441661|NCT00005790|adult brain stem glioma|adult brain stem glioma
441662|NCT00005790|adult ependymoma|adult ependymoma
441663|NCT00005790|adult craniopharyngioma|adult craniopharyngioma
441664|NCT00005790|adult medulloblastoma|adult medulloblastoma
441665|NCT00005790|adult meningioma|adult meningioma
441666|NCT00005790|adult glioblastoma|adult glioblastoma
441667|NCT00005790|adult oligodendroglioma|adult oligodendroglioma
441668|NCT00005790|adult anaplastic astrocytoma|adult anaplastic astrocytoma
441669|NCT00005790|adult myxopapillary ependymoma|adult myxopapillary ependymoma
441670|NCT00005790|adult anaplastic ependymoma|adult anaplastic ependymoma
441671|NCT00005790|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
441672|NCT00005790|adult mixed glioma|adult mixed glioma
441673|NCT00005790|adult pineal parenchymal tumor|adult pineal parenchymal tumor
752996|NCT01175070|diabetic macular oedema|diabetic macular oedema
441674|NCT00005790|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
441675|NCT00005790|adult pilocytic astrocytoma|adult pilocytic astrocytoma
441676|NCT00005790|adult subependymoma|adult subependymoma
441677|NCT00005790|adult diffuse astrocytoma|adult diffuse astrocytoma
441678|NCT00005790|adult ependymoblastoma|adult ependymoblastoma
441679|NCT00005790|adult pineocytoma|adult pineocytoma
441680|NCT00005790|adult pineoblastoma|adult pineoblastoma
441681|NCT00005790|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
441682|NCT00005790|adult choroid plexus tumor|adult choroid plexus tumor
441683|NCT00005790|adult grade III meningioma|adult grade iii meningioma
441684|NCT00005790|adult giant cell glioblastoma|adult giant cell glioblastoma
441685|NCT00005790|adult gliosarcoma|adult gliosarcoma
441686|NCT00005791|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
441687|NCT00005792|refractory multiple myeloma|refractory multiple myeloma
441688|NCT00005792|stage I multiple myeloma|stage i multiple myeloma
441689|NCT00005792|stage II multiple myeloma|stage ii multiple myeloma
441690|NCT00005792|stage III multiple myeloma|stage iii multiple myeloma
441691|NCT00005793|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
441692|NCT00005793|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
441693|NCT00005793|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
441694|NCT00005793|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
441695|NCT00005793|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
441696|NCT00005793|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
441697|NCT00005793|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
441698|NCT00005793|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
441699|NCT00005793|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
441700|NCT00005793|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
441701|NCT00005793|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
441702|NCT00005793|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
441703|NCT00005793|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
441704|NCT00005794|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
441705|NCT00005795|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
441706|NCT00005795|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
441707|NCT00005795|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
441708|NCT00005795|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
441709|NCT00005795|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
441710|NCT00005795|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
441711|NCT00005795|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
441712|NCT00005795|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
441713|NCT00005795|secondary acute myeloid leukemia|secondary acute myeloid leukemia
441714|NCT00005795|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
441715|NCT00005795|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
441716|NCT00005796|recurrent adult brain tumor|recurrent adult brain tumor
441717|NCT00005796|adult brain stem glioma|adult brain stem glioma
441719|NCT00005796|adult medulloblastoma|adult medulloblastoma
441720|NCT00005796|adult glioblastoma|adult glioblastoma
441721|NCT00005796|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
441722|NCT00005796|childhood oligodendroglioma|childhood oligodendroglioma
441723|NCT00005796|adult anaplastic astrocytoma|adult anaplastic astrocytoma
441724|NCT00005796|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
441725|NCT00005796|adult mixed glioma|adult mixed glioma
441726|NCT00005796|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
441727|NCT00005796|bone marrow suppression|bone marrow suppression
441728|NCT00005796|untreated childhood brain stem glioma|untreated childhood brain stem glioma
441729|NCT00005796|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
441730|NCT00005796|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
441731|NCT00005796|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
441732|NCT00005796|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
441733|NCT00005796|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
441734|NCT00005796|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
441735|NCT00005796|recurrent childhood ependymoma|recurrent childhood ependymoma
441736|NCT00005796|adult giant cell glioblastoma|adult giant cell glioblastoma
441737|NCT00005796|adult gliosarcoma|adult gliosarcoma
441738|NCT00005797|refractory multiple myeloma|refractory multiple myeloma
441739|NCT00005797|stage II multiple myeloma|stage ii multiple myeloma
441740|NCT00005797|stage III multiple myeloma|stage iii multiple myeloma
441741|NCT00005797|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
752997|NCT01175070|ischaemia|ischaemia
441742|NCT00005797|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
441743|NCT00005797|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
441744|NCT00005797|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
441745|NCT00005797|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
441746|NCT00005797|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
441747|NCT00005797|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
441748|NCT00005797|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
441749|NCT00005797|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
441750|NCT00005797|polycythemia vera|polycythemia vera
441751|NCT00005797|primary myelofibrosis|primary myelofibrosis
441752|NCT00005797|essential thrombocythemia|essential thrombocythemia
441754|NCT00005797|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
441755|NCT00005797|refractory anemia with excess blasts|refractory anemia with excess blasts
441756|NCT00005797|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
441757|NCT00005797|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
441758|NCT00005797|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
441759|NCT00005797|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
441760|NCT00005797|chronic eosinophilic leukemia|chronic eosinophilic leukemia
441761|NCT00005797|chronic neutrophilic leukemia|chronic neutrophilic leukemia
441762|NCT00005797|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
441763|NCT00005797|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
441764|NCT00005797|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
441765|NCT00005797|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
441766|NCT00005797|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
441767|NCT00005797|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
441768|NCT00005797|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
441769|NCT00005797|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
441771|NCT00005798|stage IV breast cancer|stage iv breast cancer
441772|NCT00005798|stage IIIA breast cancer|stage iiia breast cancer
441773|NCT00005798|recurrent breast cancer|recurrent breast cancer
441774|NCT00005798|stage IIIB breast cancer|stage iiib breast cancer
441775|NCT00005798|inflammatory breast cancer|inflammatory breast cancer
441776|NCT00005800|stage IIIA breast cancer|stage iiia breast cancer
441777|NCT00005800|stage IIIB breast cancer|stage iiib breast cancer
441778|NCT00005800|inflammatory breast cancer|inflammatory breast cancer
441779|NCT00005801|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
441780|NCT00005801|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
441781|NCT00005801|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
441782|NCT00005801|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
441783|NCT00005801|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
441784|NCT00005801|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
441785|NCT00005801|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
441786|NCT00005801|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
441787|NCT00005802|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
441788|NCT00005802|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
441789|NCT00005802|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
441790|NCT00005802|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
441791|NCT00005802|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
441792|NCT00005802|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
441793|NCT00005802|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
441794|NCT00005802|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
441795|NCT00005802|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
441796|NCT00005804|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
441797|NCT00005804|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
441798|NCT00005804|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
442196|NCT00005842|stage IV renal cell cancer|stage iv renal cell cancer
441799|NCT00005804|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
441800|NCT00005804|Burkitt lymphoma|burkitt lymphoma
441801|NCT00005804|isolated plasmacytoma of bone|isolated plasmacytoma of bone
441802|NCT00005804|extramedullary plasmacytoma|extramedullary plasmacytoma
441803|NCT00005804|refractory multiple myeloma|refractory multiple myeloma
441804|NCT00005804|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
441805|NCT00005804|stage III multiple myeloma|stage iii multiple myeloma
441806|NCT00005804|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
441078|NCT00004493|lactic acidosis|lactic acidosis
441807|NCT00005804|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
441808|NCT00005804|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
441809|NCT00005804|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
441810|NCT00005804|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
441811|NCT00005804|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
441812|NCT00005804|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
441813|NCT00005804|small intestine lymphoma|small intestine lymphoma
441814|NCT00005804|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
441815|NCT00005804|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
441816|NCT00005804|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
441817|NCT00005804|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
441818|NCT00005804|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
441819|NCT00005804|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
441820|NCT00005804|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
441821|NCT00005804|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
441822|NCT00005804|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
441823|NCT00005804|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
441824|NCT00005804|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
441825|NCT00005804|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
441826|NCT00005804|polycythemia vera|polycythemia vera
441827|NCT00005804|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
441828|NCT00005804|essential thrombocythemia|essential thrombocythemia
441829|NCT00005804|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
441830|NCT00005804|refractory hairy cell leukemia|refractory hairy cell leukemia
441831|NCT00005804|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
441832|NCT00005804|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
441628|NCT00005785|HIV|hiv
441833|NCT00005804|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
441834|NCT00005804|acute undifferentiated leukemia|acute undifferentiated leukemia
441835|NCT00005804|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
441836|NCT00005804|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
441837|NCT00005804|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
441838|NCT00005804|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
441839|NCT00005804|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
441840|NCT00005804|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
441841|NCT00005804|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
441842|NCT00005804|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
441843|NCT00005804|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
441844|NCT00005804|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
441845|NCT00005804|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
441846|NCT00005804|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
441847|NCT00005804|secondary acute myeloid leukemia|secondary acute myeloid leukemia
441848|NCT00005804|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
441849|NCT00005804|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
441850|NCT00005804|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
441851|NCT00005804|prolymphocytic leukemia|prolymphocytic leukemia
441852|NCT00005804|primary systemic amyloidosis|primary systemic amyloidosis
441853|NCT00005804|intraocular lymphoma|intraocular lymphoma
441854|NCT00005804|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
441855|NCT00005804|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
441856|NCT00005804|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
442044|NCT00005807|male breast cancer|male breast cancer
441857|NCT00005804|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
441858|NCT00005804|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
441859|NCT00005804|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
441860|NCT00005804|anaplastic large cell lymphoma|anaplastic large cell lymphoma
441861|NCT00005804|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
461706|NCT00047593|glaucoma|glaucoma
441862|NCT00005804|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
441863|NCT00005804|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
441864|NCT00005804|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
441865|NCT00005804|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
441866|NCT00005804|splenic marginal zone lymphoma|splenic marginal zone lymphoma
441191|NCT00004570|Healthy|healthy
441867|NCT00005804|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
441868|NCT00005805|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
441869|NCT00005805|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
441870|NCT00005805|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
441871|NCT00005805|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
441872|NCT00005805|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
441873|NCT00005805|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
441874|NCT00005805|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
441875|NCT00005805|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
441876|NCT00005805|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
441877|NCT00005805|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
441878|NCT00005805|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
441879|NCT00005805|childhood Burkitt lymphoma|childhood burkitt lymphoma
441880|NCT00005805|isolated plasmacytoma of bone|isolated plasmacytoma of bone
441881|NCT00005805|extramedullary plasmacytoma|extramedullary plasmacytoma
441882|NCT00005805|refractory multiple myeloma|refractory multiple myeloma
441883|NCT00005805|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
441884|NCT00005805|Waldenström macroglobulinemia|waldenström macroglobulinemia
441885|NCT00005805|stage I multiple myeloma|stage i multiple myeloma
441886|NCT00005805|stage II multiple myeloma|stage ii multiple myeloma
441887|NCT00005805|stage III multiple myeloma|stage iii multiple myeloma
441888|NCT00005805|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
441889|NCT00005805|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
441890|NCT00005805|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
441891|NCT00005805|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
441892|NCT00005805|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
441893|NCT00005805|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
441894|NCT00005805|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
441895|NCT00005805|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
441896|NCT00005805|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
441897|NCT00005805|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
441898|NCT00005805|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
441899|NCT00005805|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
441900|NCT00005805|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
441901|NCT00005805|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
441902|NCT00005805|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
441903|NCT00005805|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
441904|NCT00005805|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
441905|NCT00005805|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
441906|NCT00005805|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
441908|NCT00005805|primary myelofibrosis|primary myelofibrosis
441909|NCT00005805|essential thrombocythemia|essential thrombocythemia
441910|NCT00005805|untreated hairy cell leukemia|untreated hairy cell leukemia
441911|NCT00005805|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
441912|NCT00005805|refractory hairy cell leukemia|refractory hairy cell leukemia
441913|NCT00005805|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
441914|NCT00005805|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
441915|NCT00005805|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
441916|NCT00005805|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
441917|NCT00005805|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
441918|NCT00005805|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
441919|NCT00005805|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
441920|NCT00005805|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
441921|NCT00005805|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
441922|NCT00005805|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
441923|NCT00005805|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
441924|NCT00005805|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
441925|NCT00005805|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
441926|NCT00005805|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
441927|NCT00005805|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
441928|NCT00005805|stage I adult non-Hodgkin lymphoma|stage i adult non-hodgkin lymphoma
441929|NCT00005805|stage II adult non-Hodgkin lymphoma|stage ii adult non-hodgkin lymphoma
441930|NCT00005805|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
441931|NCT00005805|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
441932|NCT00005805|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
441933|NCT00005805|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
441934|NCT00005805|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
441935|NCT00005805|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
441936|NCT00005805|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
441937|NCT00005805|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
441938|NCT00005805|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
441939|NCT00005805|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
441940|NCT00005805|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
441941|NCT00005805|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
441942|NCT00005805|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
441943|NCT00005805|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
441944|NCT00005805|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
441945|NCT00005805|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
441946|NCT00005805|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
441947|NCT00005805|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
441948|NCT00005805|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
441949|NCT00005805|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
441950|NCT00005805|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
441951|NCT00005805|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
441952|NCT00005805|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
441953|NCT00005805|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
441954|NCT00005805|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
441955|NCT00005805|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
441956|NCT00005805|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
441957|NCT00005805|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
441958|NCT00005805|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
441959|NCT00005805|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
441960|NCT00005805|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
441961|NCT00005805|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
441962|NCT00005805|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
441963|NCT00005805|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
441964|NCT00005805|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
441965|NCT00005805|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
441966|NCT00005805|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
441967|NCT00005805|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
441968|NCT00005805|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
441969|NCT00005805|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
441970|NCT00005805|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
441971|NCT00005805|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
441972|NCT00005805|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
441973|NCT00005805|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
441974|NCT00005805|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
441975|NCT00005805|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
441976|NCT00005805|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
441977|NCT00005805|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
441978|NCT00005805|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
441979|NCT00005805|fatigue|fatigue
441980|NCT00005805|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
441981|NCT00005805|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
441982|NCT00005805|primary systemic amyloidosis|primary systemic amyloidosis
441983|NCT00005805|intraocular lymphoma|intraocular lymphoma
441984|NCT00005805|stage I mantle cell lymphoma|stage i mantle cell lymphoma
441985|NCT00005805|contiguous stage II adult non-Hodgkin lymphoma|contiguous stage ii adult non-hodgkin lymphoma
441986|NCT00005805|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
441987|NCT00005805|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
441988|NCT00005805|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
441989|NCT00005805|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
441990|NCT00005805|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
442116|NCT00005824|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
441991|NCT00005805|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
752998|NCT01175070|anti VEGF|anti vegf
441352|NCT00004644|rare disease|rare disease
441992|NCT00005805|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
441993|NCT00005805|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
441994|NCT00005805|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
441995|NCT00005805|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
441996|NCT00005805|noncontiguous stage II adult non-Hodgkin lymphoma|noncontiguous stage ii adult non-hodgkin lymphoma
441997|NCT00005805|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
584999|NCT00518050|Health Behaviors|health behaviors
441998|NCT00005805|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
441999|NCT00005805|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
442000|NCT00005805|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
442001|NCT00005805|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
442002|NCT00005805|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
442003|NCT00005805|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
442004|NCT00005805|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
442005|NCT00005805|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
442006|NCT00005805|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
442007|NCT00005805|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
442008|NCT00005805|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
442009|NCT00005805|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
442010|NCT00005805|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
442011|NCT00005805|anaplastic large cell lymphoma|anaplastic large cell lymphoma
442012|NCT00005805|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
442013|NCT00005805|multiple myeloma|multiple myeloma
442014|NCT00005805|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
442015|NCT00005805|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
442016|NCT00005805|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
442017|NCT00005805|stage I marginal zone lymphoma|stage i marginal zone lymphoma
442018|NCT00005805|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
442019|NCT00005805|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
442020|NCT00005805|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
442021|NCT00005805|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
442022|NCT00005805|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
442023|NCT00005805|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
442024|NCT00005805|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
442025|NCT00005805|splenic marginal zone lymphoma|splenic marginal zone lymphoma
442026|NCT00005806|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
442027|NCT00005806|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
442028|NCT00005806|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
442029|NCT00005806|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
442030|NCT00005807|stage IV breast cancer|stage iv breast cancer
442031|NCT00005807|stage IIIA breast cancer|stage iiia breast cancer
442032|NCT00005807|recurrent breast cancer|recurrent breast cancer
442033|NCT00005807|stage IIIB breast cancer|stage iiib breast cancer
442034|NCT00005807|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
442035|NCT00005807|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
442036|NCT00005807|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
442037|NCT00005807|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
442038|NCT00005807|ovarian stromal cancer|ovarian stromal cancer
442039|NCT00005807|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
442040|NCT00005807|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
442041|NCT00005807|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
442042|NCT00005807|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
442043|NCT00005807|ovarian sarcoma|ovarian sarcoma
442045|NCT00005809|colon cancer|colon cancer
442046|NCT00005809|rectal cancer|rectal cancer
442047|NCT00005810|adenocarcinoma of the prostate|adenocarcinoma of the prostate
442048|NCT00005810|stage IV prostate cancer|stage iv prostate cancer
442049|NCT00005810|recurrent prostate cancer|recurrent prostate cancer
442050|NCT00005812|leptomeningeal metastases|leptomeningeal metastases
442051|NCT00005812|temozolomide|temozolomide
442052|NCT00005813|adult glioblastoma|adult glioblastoma
442053|NCT00005813|adult giant cell glioblastoma|adult giant cell glioblastoma
442054|NCT00005813|adult gliosarcoma|adult gliosarcoma
442055|NCT00005814|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
441491|NCT00005760|Obesity|obesity
442056|NCT00005814|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
442057|NCT00005814|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
442058|NCT00005814|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
442059|NCT00005814|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
442060|NCT00005814|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
442061|NCT00005814|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
442062|NCT00005814|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
442063|NCT00005814|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
442064|NCT00005814|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
442065|NCT00005814|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
442066|NCT00005814|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
442067|NCT00005814|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
442068|NCT00005814|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
442069|NCT00005814|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
462121|NCT00039780|Weekly|weekly
442070|NCT00005815|iris melanoma|iris melanoma
442071|NCT00005815|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
442072|NCT00005815|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
442073|NCT00005815|extraocular extension melanoma|extraocular extension melanoma
442074|NCT00005815|recurrent intraocular melanoma|recurrent intraocular melanoma
442075|NCT00005815|stage III melanoma|stage iii melanoma
442076|NCT00005815|stage IV melanoma|stage iv melanoma
442077|NCT00005815|recurrent melanoma|recurrent melanoma
442078|NCT00005816|stage III renal cell cancer|stage iii renal cell cancer
442079|NCT00005816|stage IV renal cell cancer|stage iv renal cell cancer
442080|NCT00005819|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
442081|NCT00005820|adenocarcinoma of the prostate|adenocarcinoma of the prostate
442082|NCT00005820|stage IV prostate cancer|stage iv prostate cancer
442083|NCT00005820|recurrent prostate cancer|recurrent prostate cancer
442084|NCT00005821|stage I breast cancer|stage i breast cancer
442085|NCT00005821|stage II breast cancer|stage ii breast cancer
442086|NCT00005822|stage IV breast cancer|stage iv breast cancer
442087|NCT00005822|recurrent breast cancer|recurrent breast cancer
442088|NCT00005822|stage IIIB breast cancer|stage iiib breast cancer
442089|NCT00005822|inflammatory breast cancer|inflammatory breast cancer
442090|NCT00005822|male breast cancer|male breast cancer
442091|NCT00005823|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
442092|NCT00005823|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
10484|NCT03223922|whole brain radiation therapy|whole brain radiation therapy
442093|NCT00005823|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
442094|NCT00005823|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
442095|NCT00005823|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
442096|NCT00005823|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
442097|NCT00005823|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
442098|NCT00005823|refractory anemia with excess blasts|refractory anemia with excess blasts
442099|NCT00005823|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
442100|NCT00005823|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
442101|NCT00005823|secondary acute myeloid leukemia|secondary acute myeloid leukemia
442102|NCT00005823|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
442103|NCT00005823|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
442104|NCT00005823|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
442105|NCT00005823|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
442106|NCT00005823|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
442107|NCT00005823|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
442108|NCT00005823|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
442109|NCT00005823|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
442110|NCT00005823|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
442111|NCT00005823|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
442112|NCT00005824|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
442113|NCT00005824|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
441525|NCT00005764|abacavir|abacavir
442114|NCT00005824|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
442115|NCT00005824|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
442195|NCT00005842|stage III renal cell cancer|stage iii renal cell cancer
442117|NCT00005824|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
442118|NCT00005824|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
442119|NCT00005824|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
442120|NCT00005825|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
442121|NCT00005825|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
442122|NCT00005826|adult glioblastoma|adult glioblastoma
442123|NCT00005826|adult giant cell glioblastoma|adult giant cell glioblastoma
442124|NCT00005826|adult gliosarcoma|adult gliosarcoma
442125|NCT00005827|adenocarcinoma of the prostate|adenocarcinoma of the prostate
442126|NCT00005827|stage II prostate cancer|stage ii prostate cancer
442127|NCT00005827|stage III prostate cancer|stage iii prostate cancer
442128|NCT00005827|stage IV prostate cancer|stage iv prostate cancer
442129|NCT00005827|recurrent prostate cancer|recurrent prostate cancer
442130|NCT00005828|stage IV prostate cancer|stage iv prostate cancer
442131|NCT00005828|recurrent prostate cancer|recurrent prostate cancer
442132|NCT00005829|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
442133|NCT00005829|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
442134|NCT00005832|stage II pancreatic cancer|stage ii pancreatic cancer
442135|NCT00005832|stage III pancreatic cancer|stage iii pancreatic cancer
442136|NCT00005832|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
442137|NCT00005832|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
442138|NCT00005832|stage IV pancreatic cancer|stage iv pancreatic cancer
462122|NCT00039780|BNP7787|bnp7787
442139|NCT00005833|stage IV colon cancer|stage iv colon cancer
442140|NCT00005833|stage IV rectal cancer|stage iv rectal cancer
442141|NCT00005833|recurrent colon cancer|recurrent colon cancer
442142|NCT00005833|recurrent rectal cancer|recurrent rectal cancer
442143|NCT00005833|adenocarcinoma of the colon|adenocarcinoma of the colon
442144|NCT00005833|adenocarcinoma of the rectum|adenocarcinoma of the rectum
442145|NCT00005834|refractory multiple myeloma|refractory multiple myeloma
442146|NCT00005834|stage I multiple myeloma|stage i multiple myeloma
442147|NCT00005834|stage II multiple myeloma|stage ii multiple myeloma
442148|NCT00005834|stage III multiple myeloma|stage iii multiple myeloma
442149|NCT00005835|regional neuroblastoma|regional neuroblastoma
442150|NCT00005835|disseminated neuroblastoma|disseminated neuroblastoma
442151|NCT00005835|recurrent neuroblastoma|recurrent neuroblastoma
442152|NCT00005835|localized unresectable neuroblastoma|localized unresectable neuroblastoma
442153|NCT00005836|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
442154|NCT00005836|primary peritoneal cavity cancer|primary peritoneal cavity cancer
442155|NCT00005837|recurrent cervical cancer|recurrent cervical cancer
442156|NCT00005837|cervical squamous cell carcinoma|cervical squamous cell carcinoma
442157|NCT00005839|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
442158|NCT00005841|iris melanoma|iris melanoma
442159|NCT00005841|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
442160|NCT00005841|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
442161|NCT00005841|extraocular extension melanoma|extraocular extension melanoma
442162|NCT00005841|recurrent intraocular melanoma|recurrent intraocular melanoma
442163|NCT00005841|stage III melanoma|stage iii melanoma
442164|NCT00005841|stage IV melanoma|stage iv melanoma
442165|NCT00005841|recurrent melanoma|recurrent melanoma
442166|NCT00005842|stage III colon cancer|stage iii colon cancer
442167|NCT00005842|stage IV colon cancer|stage iv colon cancer
442168|NCT00005842|stage IV breast cancer|stage iv breast cancer
442169|NCT00005842|stage IIIA breast cancer|stage iiia breast cancer
442170|NCT00005842|recurrent breast cancer|recurrent breast cancer
442171|NCT00005842|stage III gastric cancer|stage iii gastric cancer
442172|NCT00005842|stage IV gastric cancer|stage iv gastric cancer
442173|NCT00005842|recurrent gastric cancer|recurrent gastric cancer
442174|NCT00005842|occult non-small cell lung cancer|occult non-small cell lung cancer
442175|NCT00005842|stage IIIB breast cancer|stage iiib breast cancer
442176|NCT00005842|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
442177|NCT00005842|stage III pancreatic cancer|stage iii pancreatic cancer
442178|NCT00005842|recurrent pancreatic cancer|recurrent pancreatic cancer
442179|NCT00005842|stage III rectal cancer|stage iii rectal cancer
442180|NCT00005842|stage IV rectal cancer|stage iv rectal cancer
442181|NCT00005842|recurrent colon cancer|recurrent colon cancer
442182|NCT00005842|recurrent rectal cancer|recurrent rectal cancer
442183|NCT00005842|stage IV anal cancer|stage iv anal cancer
442184|NCT00005842|recurrent anal cancer|recurrent anal cancer
442185|NCT00005842|stage III esophageal cancer|stage iii esophageal cancer
442186|NCT00005842|stage IV esophageal cancer|stage iv esophageal cancer
442187|NCT00005842|stage IIIA anal cancer|stage iiia anal cancer
442188|NCT00005842|stage IIIB anal cancer|stage iiib anal cancer
442189|NCT00005842|recurrent esophageal cancer|recurrent esophageal cancer
442190|NCT00005842|stage III cervical cancer|stage iii cervical cancer
442191|NCT00005842|recurrent cervical cancer|recurrent cervical cancer
442192|NCT00005842|stage IVB cervical cancer|stage ivb cervical cancer
442193|NCT00005842|stage IVA cervical cancer|stage iva cervical cancer
442194|NCT00005842|inflammatory breast cancer|inflammatory breast cancer
442197|NCT00005842|recurrent renal cell cancer|recurrent renal cell cancer
442198|NCT00005842|metastatic parathyroid cancer|metastatic parathyroid cancer
442199|NCT00005842|recurrent parathyroid cancer|recurrent parathyroid cancer
442200|NCT00005842|stage III vulvar cancer|stage iii vulvar cancer
442201|NCT00005842|stage IVB vulvar cancer|stage ivb vulvar cancer
442202|NCT00005842|recurrent vulvar cancer|recurrent vulvar cancer
442203|NCT00005842|stage III vaginal cancer|stage iii vaginal cancer
442204|NCT00005842|stage IVA vaginal cancer|stage iva vaginal cancer
442205|NCT00005842|stage IVB vaginal cancer|stage ivb vaginal cancer
442206|NCT00005842|recurrent vaginal cancer|recurrent vaginal cancer
442207|NCT00005842|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
442208|NCT00005842|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
442209|NCT00005842|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
442210|NCT00005842|advanced adult primary liver cancer|advanced adult primary liver cancer
442211|NCT00005842|recurrent adult primary liver cancer|recurrent adult primary liver cancer
442213|NCT00005842|stage III endometrial carcinoma|stage iii endometrial carcinoma
442214|NCT00005842|stage IV endometrial carcinoma|stage iv endometrial carcinoma
442215|NCT00005842|recurrent endometrial carcinoma|recurrent endometrial carcinoma
442216|NCT00005842|small intestine adenocarcinoma|small intestine adenocarcinoma
442217|NCT00005842|unresectable gallbladder cancer|unresectable gallbladder cancer
442218|NCT00005842|recurrent gallbladder cancer|recurrent gallbladder cancer
442219|NCT00005842|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
442220|NCT00005842|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
442221|NCT00005842|recurrent small intestine cancer|recurrent small intestine cancer
442222|NCT00005842|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
442223|NCT00005842|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
442224|NCT00005842|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
442225|NCT00005842|stage III bladder cancer|stage iii bladder cancer
442226|NCT00005842|recurrent bladder cancer|recurrent bladder cancer
442227|NCT00005842|stage IV bladder cancer|stage iv bladder cancer
442228|NCT00005842|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
442229|NCT00005842|stage III prostate cancer|stage iii prostate cancer
442230|NCT00005842|stage IV prostate cancer|stage iv prostate cancer
442231|NCT00005842|recurrent prostate cancer|recurrent prostate cancer
442232|NCT00005842|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
442233|NCT00005842|insulinoma|insulinoma
442234|NCT00005842|recurrent islet cell carcinoma|recurrent islet cell carcinoma
442235|NCT00005842|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
442236|NCT00005842|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
442237|NCT00005842|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
442238|NCT00005842|anaplastic thyroid cancer|anaplastic thyroid cancer
442239|NCT00005842|recurrent thyroid cancer|recurrent thyroid cancer
442240|NCT00005842|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
442241|NCT00005842|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
442242|NCT00005842|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
442243|NCT00005842|stage III salivary gland cancer|stage iii salivary gland cancer
442244|NCT00005842|stage IV salivary gland cancer|stage iv salivary gland cancer
442245|NCT00005842|recurrent salivary gland cancer|recurrent salivary gland cancer
442246|NCT00005842|WDHA syndrome|wdha syndrome
442247|NCT00005842|somatostatinoma|somatostatinoma
442248|NCT00005842|pancreatic polypeptide tumor|pancreatic polypeptide tumor
442249|NCT00005842|glucagonoma|glucagonoma
442250|NCT00005842|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
442251|NCT00005842|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
442252|NCT00005842|recurrent urethral cancer|recurrent urethral cancer
442253|NCT00005842|distal urethral cancer|distal urethral cancer
442254|NCT00005842|proximal urethral cancer|proximal urethral cancer
442255|NCT00005842|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
442256|NCT00005842|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
442257|NCT00005842|pulmonary carcinoid tumor|pulmonary carcinoid tumor
442258|NCT00005842|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
442259|NCT00005842|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
442260|NCT00005842|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
752999|NCT01175070|pegaptanib|pegaptanib
442261|NCT00005842|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
442262|NCT00005842|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
442263|NCT00005842|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
442264|NCT00005842|tumors metastatic to brain|tumors metastatic to brain
442265|NCT00005842|lung metastases|lung metastases
442266|NCT00005842|liver metastases|liver metastases
442267|NCT00005842|bone metastases|bone metastases
442268|NCT00005842|skin metastases|skin metastases
442269|NCT00005842|leptomeningeal metastases|leptomeningeal metastases
461707|NCT00047593|ocular|ocular
442270|NCT00005842|malignant pericardial effusion|malignant pericardial effusion
442271|NCT00005842|malignant pleural effusion|malignant pleural effusion
442272|NCT00005842|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
442273|NCT00005842|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
442274|NCT00005842|carcinoma of the appendix|carcinoma of the appendix
442275|NCT00005842|primary peritoneal cavity cancer|primary peritoneal cavity cancer
442276|NCT00005842|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
442277|NCT00005842|male breast cancer|male breast cancer
442278|NCT00005842|stage IV pancreatic cancer|stage iv pancreatic cancer
442279|NCT00005843|recurrent pancreatic cancer|recurrent pancreatic cancer
442280|NCT00005843|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
442281|NCT00005843|stage IV pancreatic cancer|stage iv pancreatic cancer
442282|NCT00005844|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
442283|NCT00005846|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
442284|NCT00005846|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
442285|NCT00005846|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
442286|NCT00005846|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
442287|NCT00005846|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
462123|NCT00039780|7787|7787
442288|NCT00005846|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
442289|NCT00005846|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
442290|NCT00005846|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
442291|NCT00005847|adenocarcinoma of the prostate|adenocarcinoma of the prostate
442292|NCT00005847|stage IV prostate cancer|stage iv prostate cancer
442293|NCT00005847|recurrent prostate cancer|recurrent prostate cancer
442294|NCT00005848|adenocarcinoma of the prostate|adenocarcinoma of the prostate
442295|NCT00005848|stage IV prostate cancer|stage iv prostate cancer
442296|NCT00005848|recurrent prostate cancer|recurrent prostate cancer
442297|NCT00005849|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
442298|NCT00005849|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
442299|NCT00005849|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
442300|NCT00005850|stage I non-small cell lung cancer|stage i non-small cell lung cancer
442301|NCT00005850|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
442302|NCT00005850|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
442303|NCT00005850|squamous cell lung cancer|squamous cell lung cancer
442304|NCT00005850|large cell lung cancer|large cell lung cancer
442305|NCT00005850|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
442306|NCT00005850|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
442307|NCT00005850|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
442308|NCT00005850|adenocarcinoma of the lung|adenocarcinoma of the lung
442309|NCT00005850|adenosquamous cell lung cancer|adenosquamous cell lung cancer
442310|NCT00005850|fatigue|fatigue
442311|NCT00005850|anxiety disorder|anxiety disorder
442312|NCT00005850|depression|depression
442313|NCT00005852|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
442314|NCT00005852|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
442315|NCT00005852|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
442316|NCT00005852|refractory multiple myeloma|refractory multiple myeloma
442317|NCT00005852|stage I multiple myeloma|stage i multiple myeloma
442318|NCT00005852|stage II multiple myeloma|stage ii multiple myeloma
442319|NCT00005852|stage III multiple myeloma|stage iii multiple myeloma
442320|NCT00005852|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
442321|NCT00005852|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
442322|NCT00005852|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
442323|NCT00005852|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
442324|NCT00005852|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
442325|NCT00005852|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
442326|NCT00005852|primary myelofibrosis|primary myelofibrosis
442327|NCT00005852|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
442328|NCT00005852|refractory hairy cell leukemia|refractory hairy cell leukemia
441753|NCT00005797|refractory anemia|refractory anemia
442329|NCT00005852|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
442330|NCT00005852|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
442331|NCT00005852|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
442332|NCT00005852|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
442333|NCT00005852|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
442334|NCT00005852|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
442335|NCT00005852|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
442336|NCT00005852|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
461925|NCT00048737|Fludarabine|fludarabine
442337|NCT00005852|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
442338|NCT00005852|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
442339|NCT00005852|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
442340|NCT00005852|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
442341|NCT00005852|graft versus host disease|graft versus host disease
442342|NCT00005852|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
442343|NCT00005852|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
442344|NCT00005852|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
442345|NCT00005852|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
442346|NCT00005852|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
442347|NCT00005852|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
442348|NCT00005852|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
442349|NCT00005852|splenic marginal zone lymphoma|splenic marginal zone lymphoma
442350|NCT00005852|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
442351|NCT00005853|refractory anemia|refractory anemia
442352|NCT00005853|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
442353|NCT00005853|refractory anemia with excess blasts|refractory anemia with excess blasts
442354|NCT00005853|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
442355|NCT00005853|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
462124|NCT00039780|Tavocept|tavocept
442356|NCT00005853|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
442357|NCT00005853|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
442358|NCT00005853|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
442359|NCT00005853|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
442360|NCT00005854|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
442361|NCT00005854|refractory multiple myeloma|refractory multiple myeloma
442362|NCT00005854|stage I multiple myeloma|stage i multiple myeloma
442363|NCT00005854|stage II multiple myeloma|stage ii multiple myeloma
442364|NCT00005854|stage III multiple myeloma|stage iii multiple myeloma
442365|NCT00005854|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
442366|NCT00005854|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
442367|NCT00005854|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
442368|NCT00005854|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
442369|NCT00005854|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
442370|NCT00005854|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
442371|NCT00005854|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
442372|NCT00005854|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
442373|NCT00005854|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
442374|NCT00005854|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
442375|NCT00005854|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
442376|NCT00005854|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
442377|NCT00005854|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
442378|NCT00005854|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
442379|NCT00005854|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
442380|NCT00005854|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
442381|NCT00005854|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
442382|NCT00005854|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
442383|NCT00005854|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
442384|NCT00005854|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
442385|NCT00005854|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
442386|NCT00005854|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
442387|NCT00005854|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
442388|NCT00005854|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
442389|NCT00005854|secondary acute myeloid leukemia|secondary acute myeloid leukemia
442390|NCT00005854|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
442391|NCT00005854|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
442392|NCT00005854|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
442393|NCT00005854|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
442394|NCT00005854|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
442395|NCT00005854|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
442396|NCT00005854|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
442397|NCT00005854|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
562315|NCT00431080|FEC|fec
442398|NCT00005854|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
442399|NCT00005854|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
442400|NCT00005854|splenic marginal zone lymphoma|splenic marginal zone lymphoma
442401|NCT00005854|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
442402|NCT00005855|adult glioblastoma|adult glioblastoma
442403|NCT00005855|adult anaplastic astrocytoma|adult anaplastic astrocytoma
442404|NCT00005855|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
442405|NCT00005855|recurrent adult brain tumor|recurrent adult brain tumor
442406|NCT00005855|adult giant cell glioblastoma|adult giant cell glioblastoma
442407|NCT00005855|adult gliosarcoma|adult gliosarcoma
442408|NCT00005857|stage IV prostate cancer|stage iv prostate cancer
442409|NCT00005857|recurrent prostate cancer|recurrent prostate cancer
442410|NCT00005858|stage III colon cancer|stage iii colon cancer
442411|NCT00005858|stage IV colon cancer|stage iv colon cancer
442412|NCT00005858|stage IV breast cancer|stage iv breast cancer
442413|NCT00005858|stage IIIA breast cancer|stage iiia breast cancer
442414|NCT00005858|recurrent breast cancer|recurrent breast cancer
442415|NCT00005858|stage IIIB breast cancer|stage iiib breast cancer
442416|NCT00005858|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
442417|NCT00005858|stage II pancreatic cancer|stage ii pancreatic cancer
442418|NCT00005858|stage III pancreatic cancer|stage iii pancreatic cancer
442419|NCT00005858|recurrent pancreatic cancer|recurrent pancreatic cancer
442420|NCT00005858|recurrent colon cancer|recurrent colon cancer
442421|NCT00005858|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
442422|NCT00005858|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
442423|NCT00005858|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
442424|NCT00005858|stage III bladder cancer|stage iii bladder cancer
442425|NCT00005858|recurrent bladder cancer|recurrent bladder cancer
442426|NCT00005858|stage IV bladder cancer|stage iv bladder cancer
442427|NCT00005858|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
442428|NCT00005858|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
442429|NCT00005858|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
442430|NCT00005858|ovarian stromal cancer|ovarian stromal cancer
442431|NCT00005858|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
442432|NCT00005858|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
442433|NCT00005858|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
442434|NCT00005858|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
442435|NCT00005858|ovarian sarcoma|ovarian sarcoma
442436|NCT00005858|male breast cancer|male breast cancer
442437|NCT00005858|stage IV pancreatic cancer|stage iv pancreatic cancer
442438|NCT00005859|recurrent adult brain tumor|recurrent adult brain tumor
442439|NCT00005859|adult glioblastoma|adult glioblastoma
442440|NCT00005859|adult giant cell glioblastoma|adult giant cell glioblastoma
442441|NCT00005859|adult gliosarcoma|adult gliosarcoma
442442|NCT00005860|stage IV colon cancer|stage iv colon cancer
442443|NCT00005860|stage IV gastric cancer|stage iv gastric cancer
442444|NCT00005860|recurrent gastric cancer|recurrent gastric cancer
442445|NCT00005860|recurrent pancreatic cancer|recurrent pancreatic cancer
442446|NCT00005860|recurrent colon cancer|recurrent colon cancer
442448|NCT00005860|stage 4S neuroblastoma|stage 4s neuroblastoma
442449|NCT00005860|recurrent neuroblastoma|recurrent neuroblastoma
442450|NCT00005860|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
442451|NCT00005860|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
442452|NCT00005860|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
442453|NCT00005860|advanced adult primary liver cancer|advanced adult primary liver cancer
442454|NCT00005860|recurrent adult primary liver cancer|recurrent adult primary liver cancer
442455|NCT00005860|gastrinoma|gastrinoma
442456|NCT00005860|small intestine adenocarcinoma|small intestine adenocarcinoma
442457|NCT00005860|small intestine lymphoma|small intestine lymphoma
442458|NCT00005860|small intestine leiomyosarcoma|small intestine leiomyosarcoma
442459|NCT00005860|unresectable gallbladder cancer|unresectable gallbladder cancer
442460|NCT00005860|recurrent gallbladder cancer|recurrent gallbladder cancer
442461|NCT00005860|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
442462|NCT00005860|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
442463|NCT00005860|recurrent small intestine cancer|recurrent small intestine cancer
441907|NCT00005805|polycythemia vera|polycythemia vera
442464|NCT00005860|insulinoma|insulinoma
442465|NCT00005860|recurrent islet cell carcinoma|recurrent islet cell carcinoma
442466|NCT00005860|WDHA syndrome|wdha syndrome
442467|NCT00005860|somatostatinoma|somatostatinoma
442468|NCT00005860|pancreatic polypeptide tumor|pancreatic polypeptide tumor
442469|NCT00005860|glucagonoma|glucagonoma
442470|NCT00005860|regional pheochromocytoma|regional pheochromocytoma
442471|NCT00005860|metastatic pheochromocytoma|metastatic pheochromocytoma
442472|NCT00005860|recurrent pheochromocytoma|recurrent pheochromocytoma
562368|NCT00431301|Genetic|genetic
442473|NCT00005860|extragonadal germ cell tumor|extragonadal germ cell tumor
442474|NCT00005860|liver metastases|liver metastases
442475|NCT00005860|malignant ascites|malignant ascites
442476|NCT00005860|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
442477|NCT00005860|carcinoma of the appendix|carcinoma of the appendix
442478|NCT00005860|pseudomyxoma peritonei|pseudomyxoma peritonei
442479|NCT00005860|fallopian tube cancer|fallopian tube cancer
442480|NCT00005860|primary peritoneal cavity cancer|primary peritoneal cavity cancer
442481|NCT00005860|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
442482|NCT00005860|gastrointestinal stromal tumor|gastrointestinal stromal tumor
442483|NCT00005860|stage IV pancreatic cancer|stage iv pancreatic cancer
442484|NCT00005861|stage III endometrial carcinoma|stage iii endometrial carcinoma
442485|NCT00005861|stage IV endometrial carcinoma|stage iv endometrial carcinoma
442486|NCT00005861|recurrent endometrial carcinoma|recurrent endometrial carcinoma
442487|NCT00005862|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
442488|NCT00005862|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
442489|NCT00005862|gastrointestinal stromal tumor|gastrointestinal stromal tumor
442490|NCT00005862|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
442491|NCT00005863|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
442492|NCT00005863|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
442493|NCT00005863|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
442494|NCT00005863|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
442495|NCT00005863|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
442496|NCT00005863|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
442497|NCT00005863|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
442498|NCT00005863|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
442632|NCT00005886|breast cancer in situ|breast cancer in situ
442499|NCT00005863|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
442500|NCT00005863|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
442501|NCT00005863|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
442502|NCT00005863|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
442503|NCT00005863|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
442504|NCT00005863|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
442505|NCT00005863|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
442506|NCT00005863|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
442507|NCT00005863|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
442508|NCT00005863|secondary acute myeloid leukemia|secondary acute myeloid leukemia
442509|NCT00005863|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
442510|NCT00005863|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
442511|NCT00005863|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
442512|NCT00005863|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
442513|NCT00005863|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
442514|NCT00005863|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
442515|NCT00005863|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
442516|NCT00005863|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
442517|NCT00005863|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
442518|NCT00005863|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
442519|NCT00005863|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
442520|NCT00005863|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
442521|NCT00005863|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
442522|NCT00005864|stage IV colon cancer|stage iv colon cancer
442523|NCT00005864|stage IV rectal cancer|stage iv rectal cancer
442524|NCT00005864|recurrent colon cancer|recurrent colon cancer
442525|NCT00005864|recurrent rectal cancer|recurrent rectal cancer
442526|NCT00005865|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
561382|NCT00434278|CF|cf
442527|NCT00005865|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
442528|NCT00005866|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
442529|NCT00005866|refractory anemia with excess blasts|refractory anemia with excess blasts
442530|NCT00005866|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
442531|NCT00005866|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
442532|NCT00005866|secondary acute myeloid leukemia|secondary acute myeloid leukemia
442533|NCT00005866|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
442534|NCT00005866|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
442535|NCT00005866|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
442536|NCT00005867|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
442537|NCT00005867|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
442538|NCT00005867|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
442539|NCT00005867|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
442540|NCT00005867|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
442690|NCT00005896|hematologic disorders|hematologic disorders
442541|NCT00005867|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
442542|NCT00005867|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
442543|NCT00005867|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
442544|NCT00005867|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
442545|NCT00005867|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
442546|NCT00005867|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
442547|NCT00005867|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
442548|NCT00005867|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
442549|NCT00005867|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
442550|NCT00005867|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
442551|NCT00005867|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
442552|NCT00005867|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
442553|NCT00005867|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
442554|NCT00005867|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
442555|NCT00005867|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
442556|NCT00005868|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
442557|NCT00005869|stage II pancreatic cancer|stage ii pancreatic cancer
442558|NCT00005869|stage III pancreatic cancer|stage iii pancreatic cancer
442559|NCT00005869|recurrent pancreatic cancer|recurrent pancreatic cancer
442560|NCT00005869|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
442561|NCT00005869|stage IV pancreatic cancer|stage iv pancreatic cancer
442562|NCT00005870|recurrent pancreatic cancer|recurrent pancreatic cancer
442563|NCT00005870|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
442564|NCT00005871|recurrent pancreatic cancer|recurrent pancreatic cancer
442565|NCT00005871|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
442566|NCT00005872|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
442567|NCT00005873|stage IV breast cancer|stage iv breast cancer
442568|NCT00005873|recurrent breast cancer|recurrent breast cancer
442569|NCT00005874|adult leiomyosarcoma|adult leiomyosarcoma
442570|NCT00005874|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
442571|NCT00005874|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
442572|NCT00005874|small intestine leiomyosarcoma|small intestine leiomyosarcoma
442573|NCT00005874|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
442574|NCT00005874|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
442575|NCT00005874|childhood leiomyosarcoma|childhood leiomyosarcoma
442576|NCT00005874|gastrointestinal stromal tumor|gastrointestinal stromal tumor
442577|NCT00005874|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
442578|NCT00005875|stage IV melanoma|stage iv melanoma
442579|NCT00005875|recurrent melanoma|recurrent melanoma
442580|NCT00005876|stage III gastric cancer|stage iii gastric cancer
442581|NCT00005876|stage IV gastric cancer|stage iv gastric cancer
442582|NCT00005876|recurrent gastric cancer|recurrent gastric cancer
442583|NCT00005876|stage III esophageal cancer|stage iii esophageal cancer
442584|NCT00005876|stage IV esophageal cancer|stage iv esophageal cancer
442585|NCT00005876|recurrent esophageal cancer|recurrent esophageal cancer
442586|NCT00005876|adenocarcinoma of the stomach|adenocarcinoma of the stomach
442587|NCT00005876|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
442588|NCT00005877|stage III colon cancer|stage iii colon cancer
442589|NCT00005877|stage IV colon cancer|stage iv colon cancer
442590|NCT00005877|stage III rectal cancer|stage iii rectal cancer
442591|NCT00005877|stage IV rectal cancer|stage iv rectal cancer
442592|NCT00005877|recurrent colon cancer|recurrent colon cancer
201012|NCT02112630|HCV, genotype 1|hcv, genotype 1
561512|NCT00435331|PPH|pph
442593|NCT00005877|recurrent rectal cancer|recurrent rectal cancer
442595|NCT00005879|breast cancer|breast cancer
442596|NCT00005880|non-small cell lung cancer|non-small cell lung cancer
442597|NCT00005880|small cell lung cancer|small cell lung cancer
442598|NCT00005881|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
442599|NCT00005881|childhood Burkitt lymphoma|childhood burkitt lymphoma
442600|NCT00005881|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
442601|NCT00005881|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
442602|NCT00005881|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
442603|NCT00005881|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
442604|NCT00005881|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
442605|NCT00005881|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
442606|NCT00005881|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
442607|NCT00005881|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
442608|NCT00005881|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
442609|NCT00005881|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
462348|NCT00040651|Stem Cell|stem cell
442610|NCT00005881|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
442611|NCT00005881|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
442612|NCT00005881|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
442613|NCT00005881|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
442614|NCT00005881|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
442615|NCT00005881|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
442616|NCT00005881|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
442617|NCT00005881|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
442618|NCT00005881|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
442619|NCT00005881|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
442620|NCT00005881|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
442621|NCT00005881|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
442622|NCT00005881|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
442623|NCT00005881|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
442624|NCT00005881|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
442625|NCT00005883|non-small cell lung cancer|non-small cell lung cancer
442626|NCT00005883|small cell lung cancer|small cell lung cancer
442627|NCT00005884|basal cell carcinoma of the skin|basal cell carcinoma of the skin
442628|NCT00005884|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
442629|NCT00005886|stage I breast cancer|stage i breast cancer
442630|NCT00005886|stage II breast cancer|stage ii breast cancer
442631|NCT00005886|ductal breast carcinoma in situ|ductal breast carcinoma in situ
442633|NCT00005887|tumors metastatic to brain|tumors metastatic to brain
442634|NCT00005888|gastrointestinal disorders|gastrointestinal disorders
442635|NCT00005888|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
442636|NCT00005888|low birth weight|low birth weight
442637|NCT00005888|necrotizing enterocolitis|necrotizing enterocolitis
442638|NCT00005888|neonatal disorders|neonatal disorders
442639|NCT00005888|rare disease|rare disease
442640|NCT00005888|sepsis|sepsis
442641|NCT00005889|endocrine disorders|endocrine disorders
442642|NCT00005889|hyperglycemia|hyperglycemia
442643|NCT00005889|low birth weight|low birth weight
442644|NCT00005889|neonatal disorders|neonatal disorders
442645|NCT00005889|rare disease|rare disease
442646|NCT00005890|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
442647|NCT00005890|rare disease|rare disease
442648|NCT00005890|sepsis|sepsis
442649|NCT00005890|septic shock|septic shock
442650|NCT00005891|Fanconi's Anemia|fanconi's anemia
442651|NCT00005891|aplastic anemia|aplastic anemia
442652|NCT00005891|hematologic disorders|hematologic disorders
442653|NCT00005891|rare disease|rare disease
442654|NCT00005892|Fanconi's anemia|fanconi's anemia
442655|NCT00005892|acute leukemia|acute leukemia
442656|NCT00005892|acute lymphocytic leukemia|acute lymphocytic leukemia
442657|NCT00005892|acute myeloid leukemia|acute myeloid leukemia
442658|NCT00005892|acute undifferentiated leukemia|acute undifferentiated leukemia
442659|NCT00005892|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
442660|NCT00005892|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
442661|NCT00005892|adult acute myeloid leukemia|adult acute myeloid leukemia
442662|NCT00005892|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
442663|NCT00005892|aplastic anemia|aplastic anemia
442664|NCT00005892|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
442665|NCT00005892|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
442666|NCT00005892|childhood acute myeloid leukemia|childhood acute myeloid leukemia
442667|NCT00005892|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
442668|NCT00005892|de novo myelodysplastic syndrome|de novo myelodysplastic syndrome
442669|NCT00005892|hematologic disorders|hematologic disorders
442670|NCT00005892|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
442672|NCT00005892|myelodysplastic syndrome|myelodysplastic syndrome
442673|NCT00005892|oncologic disorders|oncologic disorders
442674|NCT00005892|previously treated myelodysplastic syndrome|previously treated myelodysplastic syndrome
442675|NCT00005892|rare disease|rare disease
442676|NCT00005892|secondary myelodysplastic syndrome|secondary myelodysplastic syndrome
442677|NCT00005893|chronic congenital neutropenia|chronic congenital neutropenia
442678|NCT00005893|chronic neutropenia|chronic neutropenia
442679|NCT00005893|congenital pure red cell aplasia|congenital pure red cell aplasia
442680|NCT00005893|disease-related problem/condition|disease-related problem/condition
442681|NCT00005893|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
442682|NCT00005893|hematologic disorders|hematologic disorders
442683|NCT00005893|neutropenia|neutropenia
442684|NCT00005893|pure red cell aplasia|pure red cell aplasia
442685|NCT00005893|rare disease|rare disease
442686|NCT00005893|sickle cell anemia|sickle cell anemia
442687|NCT00005893|thalassemia major|thalassemia major
442688|NCT00005896|Fanconi's anemia|fanconi's anemia
442689|NCT00005896|aplastic anemia|aplastic anemia
442691|NCT00005896|rare disease|rare disease
442692|NCT00005900|Gaucher's disease|gaucher's disease
442693|NCT00005900|I cell disease|i cell disease
442694|NCT00005900|Niemann-Pick disease|niemann-pick disease
442695|NCT00005900|Wolman disease|wolman disease
442696|NCT00005900|adrenoleukodystrophy|adrenoleukodystrophy
442697|NCT00005900|disease-related problem/condition|disease-related problem/condition
442698|NCT00005900|fucosidosis|fucosidosis
442699|NCT00005900|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
442700|NCT00005900|globoid cell leukodystrophy|globoid cell leukodystrophy
442701|NCT00005900|inborn errors of metabolism|inborn errors of metabolism
442702|NCT00005900|mannosidosis|mannosidosis
442703|NCT00005900|metachromatic leukodystrophy|metachromatic leukodystrophy
442704|NCT00005900|mucopolysaccharidosis|mucopolysaccharidosis
442705|NCT00005900|mucopolysaccharidosis I|mucopolysaccharidosis i
442706|NCT00005900|mucopolysaccharidosis VI|mucopolysaccharidosis vi
442707|NCT00005900|oncologic disorders|oncologic disorders
442708|NCT00005900|pulmonary complications|pulmonary complications
442709|NCT00005900|rare disease|rare disease
442710|NCT00005900|sphingolipidoses|sphingolipidoses
442711|NCT00005901|Bisphosphonates|bisphosphonates
442712|NCT00005901|Growth Hormone|growth hormone
442713|NCT00005901|Bone Density|bone density
442714|NCT00005901|Osteogenesis Imperfecta|osteogenesis imperfecta
442715|NCT00005902|Brain|brain
442716|NCT00005902|Brainstem|brainstem
442717|NCT00005902|Cyst|cyst
442718|NCT00005902|Magnetic Resonance Imaging|magnetic resonance imaging
442719|NCT00005902|Spinal Cord|spinal cord
442720|NCT00005902|von Hippel-Lindau|von hippel-lindau
442721|NCT00005903|Parkinsonism|parkinsonism
442722|NCT00005903|Trophic Factor|trophic factor
442723|NCT00005903|Neurodegenerative Disorder|neurodegenerative disorder
442724|NCT00005903|Progressive Supranuclear Palsy|progressive supranuclear palsy
442725|NCT00005905|Adipocyte - Development|adipocyte - development
442726|NCT00005905|Insulin Resistance|insulin resistance
442727|NCT00005905|Dyslipidemia|dyslipidemia
442728|NCT00005905|Diabetes Mellitus|diabetes mellitus
442729|NCT00005905|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
442730|NCT00005905|Leptin Replacement|leptin replacement
442731|NCT00005906|Chylous Ascites|chylous ascites
442732|NCT00005906|Chylous Pleural Effusion|chylous pleural effusion
442733|NCT00005906|Inhibitory Effects|inhibitory effects
442734|NCT00005906|Lymphangioleiomyoma|lymphangioleiomyoma
442735|NCT00005906|Somatostatin|somatostatin
442736|NCT00005906|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
442737|NCT00005907|B Cell|b cell
442738|NCT00005907|Reconstitution|reconstitution
442739|NCT00005907|T Cell|t cell
442740|NCT00005907|Transplant|transplant
442741|NCT00005907|Vaccine|vaccine
442742|NCT00005908|cDNA Microarray|cdna microarray
442743|NCT00005908|Stage II and Stage III Breast Cancer|stage ii and stage iii breast cancer
442744|NCT00005908|Biological Response|biological response
442745|NCT00005908|Molecular Profiling|molecular profiling
442746|NCT00005908|Fine Needle Aspirate|fine needle aspirate
442747|NCT00005908|Breast Cancer|breast cancer
442748|NCT00005909|Homogentisic Acid|homogentisic acid
442749|NCT00005909|Ochronosis|ochronosis
442750|NCT00005909|Inborn Error of Metabolism|inborn error of metabolism
442751|NCT00005909|Arthritis|arthritis
442752|NCT00005909|Enzyme Defect|enzyme defect
442753|NCT00005909|Alkaptonuria|alkaptonuria
442754|NCT00005909|Homogentisic Acid Oxidase|homogentisic acid oxidase
561796|NCT00436462|IVF|ivf
442755|NCT00005910|Islet Cell Tumors|islet cell tumors
442756|NCT00005910|Surgery|surgery
442757|NCT00005910|Ultrasound|ultrasound
442758|NCT00005910|Insulin|insulin
442759|NCT00005910|Rapid Assay|rapid assay
442760|NCT00005910|Arteriogram|arteriogram
442761|NCT00005910|Pancreas|pancreas
442762|NCT00005910|Laparoscopy|laparoscopy
442763|NCT00005910|Insulinoma|insulinoma
442764|NCT00005910|Localization|localization
442765|NCT00005910|Hypoglycemia|hypoglycemia
442766|NCT00005911|Magnetic Resonance Imaging|magnetic resonance imaging
442767|NCT00005911|Human Eye|human eye
442768|NCT00005911|Lens|lens
442769|NCT00005911|Normal Volunteers|normal volunteers
442770|NCT00005911|Cataract|cataract
442771|NCT00005911|Human Lens|human lens
442772|NCT00005911|Healthy Volunteer|healthy volunteer
442773|NCT00005912|Aspergillosis|aspergillosis
442774|NCT00005912|Candidiasis|candidiasis
442775|NCT00005912|Fungal Infections|fungal infections
442776|NCT00005912|Fungemia|fungemia
442777|NCT00005912|Prophylactic Antifungal Therapy|prophylactic antifungal therapy
442778|NCT00005912|Pediatric Fungal Infection|pediatric fungal infection
442779|NCT00005914|Depression|depression
442780|NCT00005914|Depressive Disorder|depressive disorder
442781|NCT00005914|Family|family
442782|NCT00005914|Genes|genes
442783|NCT00005914|Genetic Techniques|genetic techniques
442784|NCT00005914|Genetics|genetics
442785|NCT00005914|Linkage (Genetics)|linkage (genetics)
442786|NCT00005914|Nuclear Family|nuclear family
442787|NCT00005914|Recurrence|recurrence
442788|NCT00005914|Severity of Illness Index|severity of illness index
442789|NCT00005915|HIV-1|hiv-1
462349|NCT00040651|T-Cell|t-cell
442790|NCT00005915|Drug Administration Schedule|drug administration schedule
442791|NCT00005915|Drug Resistance, Microbial|drug resistance, microbial
442792|NCT00005915|Disease Progression|disease progression
442793|NCT00005915|Genotype|genotype
442794|NCT00005915|Phenotype|phenotype
442795|NCT00005915|Drug Resistance, Multiple|drug resistance, multiple
442796|NCT00005915|Anti-HIV Agents|anti-hiv agents
442797|NCT00005915|Treatment Experienced|treatment experienced
442798|NCT00005916|Immunotherapy|immunotherapy
442799|NCT00005916|Radiation|radiation
442800|NCT00005916|Immunology|immunology
442801|NCT00005916|Prostvac|prostvac
442802|NCT00005916|Prostate Cancer|prostate cancer
442803|NCT00005917|Albinism|albinism
442804|NCT00005917|Giant Granules|giant granules
442805|NCT00005917|Infection|infection
442806|NCT00005917|Melanosomes|melanosomes
442807|NCT00005917|Platelet Storage Pool Defect|platelet storage pool defect
442808|NCT00005918|Drug Therapy, Combination|drug therapy, combination
442809|NCT00005918|Stavudine|stavudine
442810|NCT00005918|Lamivudine|lamivudine
442811|NCT00005918|RNA, Viral|rna, viral
442812|NCT00005918|Dosage Forms|dosage forms
442813|NCT00005918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
442814|NCT00005918|Anti-HIV Agents|anti-hiv agents
442815|NCT00005918|Viral Load|viral load
442816|NCT00005918|efavirenz|efavirenz
442817|NCT00005919|Pigment Dispersion|pigment dispersion
442818|NCT00005919|Ocular Hypertension|ocular hypertension
442819|NCT00005919|Glaucoma|glaucoma
442820|NCT00005919|Pupil Reaction|pupil reaction
442821|NCT00005919|Natural History|natural history
442822|NCT00005919|Pigment Dispersion Syndrome|pigment dispersion syndrome
462125|NCT00039780|Prevention|prevention
442823|NCT00005919|Gene Mutation|gene mutation
442824|NCT00005920|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
442825|NCT00005920|Dose-Response Relationship, Drug|dose-response relationship, drug
442826|NCT00005920|Fluconazole|fluconazole
442827|NCT00005920|Antifungal Agents|antifungal agents
442828|NCT00005920|Candidiasis, Oral|candidiasis, oral
442829|NCT00005920|Pharyngeal Diseases|pharyngeal diseases
442831|NCT00005921|Dose-Response Relationship, Drug|dose-response relationship, drug
442832|NCT00005921|Antifungal Agents|antifungal agents
442833|NCT00005921|Candidiasis|candidiasis
442834|NCT00005921|Esophageal Diseases|esophageal diseases
442835|NCT00005921|MK 0991|mk 0991
442836|NCT00005922|Conditioning|conditioning
442837|NCT00005922|Corticosteroid|corticosteroid
442838|NCT00005922|Lesions|lesions
442839|NCT00005922|Pharmacotherapy|pharmacotherapy
442840|NCT00005922|Placebo effect|placebo effect
442841|NCT00005922|Psoriasis|psoriasis
442842|NCT00005922|Psychoneuroimmunology|psychoneuroimmunology
442843|NCT00005923|Joint Instability|joint instability
442844|NCT00005924|B Cell|b cell
442845|NCT00005924|Epstein-Barr Virus|epstein-barr virus
442846|NCT00005925|Video-EEG|video-eeg
442847|NCT00005925|Muscimol|muscimol
442848|NCT00005925|Depth Electrode|depth electrode
442850|NCT00005925|Pharmacology|pharmacology
442851|NCT00005925|Epilepsy|epilepsy
442852|NCT00005925|Infusion|infusion
442853|NCT00005925|Magnetic Resonance Imaging|magnetic resonance imaging
442854|NCT00005926|Cancer|cancer
442855|NCT00005926|Gemzar|gemzar
442856|NCT00005926|Her-2/Neu|her-2/neu
442857|NCT00005926|Pancreatic|pancreatic
442858|NCT00005926|Radiotherapy|radiotherapy
442212|NCT00005842|gastrinoma|gastrinoma
442859|NCT00005926|Pancreatic Cancer|pancreatic cancer
442860|NCT00005927|Adrenal Adenoma|adrenal adenoma
442861|NCT00005927|Adrenal Cancer|adrenal cancer
442862|NCT00005927|Macronodular Adrenals|macronodular adrenals
442863|NCT00005927|Ectopic Receptors|ectopic receptors
442864|NCT00005927|Gene Profiling|gene profiling
442865|NCT00005927|Adrenocortical Carcinoma|adrenocortical carcinoma
442866|NCT00005927|Cushing Syndrome|cushing syndrome
442867|NCT00005927|Virilizing Adrenal Tumor|virilizing adrenal tumor
442868|NCT00005927|Feminizing Adrenal Tumor|feminizing adrenal tumor
442869|NCT00005927|Massive Macronodular Adrenocortical Disease|massive macronodular adrenocortical disease
442870|NCT00005927|Adrenal Gland Tumor|adrenal gland tumor
442871|NCT00005928|ACE Inhibitor|ace inhibitor
442872|NCT00005928|Vascular Inflammation|vascular inflammation
442873|NCT00005928|Vascular Compliance|vascular compliance
442874|NCT00005928|Cell Adhesion Molecules|cell adhesion molecules
442875|NCT00005928|Coronary Artery Disease|coronary artery disease
442876|NCT00005931|Skin Neoplasms|skin neoplasms
442877|NCT00005931|Sarcoma, Kaposi|sarcoma, kaposi
442878|NCT00005931|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
442879|NCT00005931|Antineoplastic Agents|antineoplastic agents
442880|NCT00005931|Enzyme Inhibitors|enzyme inhibitors
442881|NCT00005931|SU 5416|su 5416
442882|NCT00005931|Protein-Tyrosine Kinase|protein-tyrosine kinase
442883|NCT00005933|Chronic Disease|chronic disease
442884|NCT00005933|Pediatric|pediatric
442885|NCT00005933|Pulmonary|pulmonary
442886|NCT00005933|Intelligence|intelligence
442887|NCT00005933|Coping|coping
442888|NCT00005933|Chronic Illness|chronic illness
442889|NCT00005933|Learning|learning
442890|NCT00005934|Fetal Hemoglobin|fetal hemoglobin
442891|NCT00005934|5-Azacytidine|5-azacytidine
442892|NCT00005934|Phenylbutyrate|phenylbutyrate
442893|NCT00005934|Thalassemia|thalassemia
442894|NCT00005934|Hemoglobin|hemoglobin
442895|NCT00005934|Anemia|anemia
442896|NCT00005934|Blood|blood
442897|NCT00005934|Thalassemia Major|thalassemia major
442898|NCT00005934|Beta Thalassemia|beta thalassemia
442899|NCT00005935|Immunosuppression|immunosuppression
442900|NCT00005935|T Cells|t cells
442901|NCT00005935|Autoimmunity|autoimmunity
442902|NCT00005935|Bone Marrow Failure|bone marrow failure
442903|NCT00005935|Hematopoiesis|hematopoiesis
442904|NCT00005935|Relapsing Aplastic Anemia|relapsing aplastic anemia
442905|NCT00005936|Fulminant Hepatitis|fulminant hepatitis
442906|NCT00005936|Parvovirus|parvovirus
442907|NCT00005936|Hepatitis|hepatitis
442908|NCT00005936|Biopsy|biopsy
442909|NCT00005936|Control|control
442910|NCT00005936|Liver Biopsy|liver biopsy
442912|NCT00005937|Immunosuppression|immunosuppression
442913|NCT00005937|ATG|atg
442914|NCT00005937|Cyclosporine|cyclosporine
442915|NCT00005937|Myelodysplastic Syndrome|myelodysplastic syndrome
442916|NCT00005938|localized gallbladder cancer|localized gallbladder cancer
442917|NCT00005938|unresectable gallbladder cancer|unresectable gallbladder cancer
442918|NCT00005938|recurrent gallbladder cancer|recurrent gallbladder cancer
442919|NCT00005938|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
442920|NCT00005938|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
442921|NCT00005938|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
442922|NCT00005938|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
442923|NCT00005938|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
442924|NCT00005938|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
442925|NCT00005938|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
442926|NCT00005939|stage I prostate cancer|stage i prostate cancer
442927|NCT00005939|stage IIB prostate cancer|stage iib prostate cancer
442928|NCT00005939|stage IIA prostate cancer|stage iia prostate cancer
442929|NCT00005939|stage III prostate cancer|stage iii prostate cancer
442930|NCT00005939|recurrent prostate cancer|recurrent prostate cancer
442931|NCT00005941|stage III cervical cancer|stage iii cervical cancer
442932|NCT00005941|recurrent cervical cancer|recurrent cervical cancer
442933|NCT00005941|stage IVB cervical cancer|stage ivb cervical cancer
442934|NCT00005941|stage IVA cervical cancer|stage iva cervical cancer
442935|NCT00005941|stage III vaginal cancer|stage iii vaginal cancer
442936|NCT00005941|stage IVA vaginal cancer|stage iva vaginal cancer
442937|NCT00005941|stage IVB vaginal cancer|stage ivb vaginal cancer
442938|NCT00005941|recurrent vaginal cancer|recurrent vaginal cancer
442939|NCT00005943|stage IV melanoma|stage iv melanoma
442940|NCT00005943|recurrent melanoma|recurrent melanoma
442941|NCT00005944|recurrent colon cancer|recurrent colon cancer
442942|NCT00005944|recurrent rectal cancer|recurrent rectal cancer
442943|NCT00005944|adenocarcinoma of the colon|adenocarcinoma of the colon
442944|NCT00005944|adenocarcinoma of the rectum|adenocarcinoma of the rectum
442945|NCT00005944|liver metastases|liver metastases
442946|NCT00005944|primary peritoneal cavity cancer|primary peritoneal cavity cancer
753000|NCT01175070|Ischaemic diabetic macular oedema|ischaemic diabetic macular oedema
562007|NCT00437164|D2O|d2o
442947|NCT00005945|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
442948|NCT00005945|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
442949|NCT00005945|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
442950|NCT00005945|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
442951|NCT00005946|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
442952|NCT00005946|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
442953|NCT00005946|refractory multiple myeloma|refractory multiple myeloma
442954|NCT00005946|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
442955|NCT00005946|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
442956|NCT00005946|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
442957|NCT00005946|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
442958|NCT00005946|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
442959|NCT00005946|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
442960|NCT00005946|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
442961|NCT00005946|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
442962|NCT00005946|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
442963|NCT00005946|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
442964|NCT00005946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
442965|NCT00005946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
442966|NCT00005946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
442967|NCT00005946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
442968|NCT00005946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
442969|NCT00005946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
442970|NCT00005946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
442971|NCT00005946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
442972|NCT00005946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
442973|NCT00005946|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
442974|NCT00005946|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
442975|NCT00005946|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
442976|NCT00005946|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
442977|NCT00005946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
442978|NCT00005946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
442979|NCT00005946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
442980|NCT00005946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
442981|NCT00005946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
442982|NCT00005946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
442983|NCT00005946|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
442984|NCT00005947|adenocarcinoma of the prostate|adenocarcinoma of the prostate
442985|NCT00005947|stage IV prostate cancer|stage iv prostate cancer
442986|NCT00005947|recurrent prostate cancer|recurrent prostate cancer
442987|NCT00005948|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
442988|NCT00005948|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
442989|NCT00005948|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
442990|NCT00005951|recurrent adult brain tumor|recurrent adult brain tumor
442991|NCT00005951|adult glioblastoma|adult glioblastoma
442992|NCT00005951|adult anaplastic astrocytoma|adult anaplastic astrocytoma
442993|NCT00005951|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
442994|NCT00005951|adult mixed glioma|adult mixed glioma
442995|NCT00005951|adult giant cell glioblastoma|adult giant cell glioblastoma
442996|NCT00005951|adult gliosarcoma|adult gliosarcoma
442997|NCT00005952|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
442998|NCT00005952|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
442999|NCT00005952|childhood craniopharyngioma|childhood craniopharyngioma
443000|NCT00005952|disseminated neuroblastoma|disseminated neuroblastoma
443001|NCT00005952|stage 4S neuroblastoma|stage 4s neuroblastoma
443002|NCT00005952|recurrent neuroblastoma|recurrent neuroblastoma
443003|NCT00005952|stage IV Wilms tumor|stage iv wilms tumor
443004|NCT00005952|stage V Wilms tumor|stage v wilms tumor
443005|NCT00005952|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
443006|NCT00005952|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
443007|NCT00005952|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
443008|NCT00005952|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
443009|NCT00005952|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
562111|NCT00430313|CINV|cinv
443010|NCT00005952|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
443011|NCT00005952|childhood germ cell tumor|childhood germ cell tumor
443012|NCT00005952|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
443013|NCT00005952|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
443014|NCT00005952|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
443015|NCT00005952|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
443016|NCT00005952|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
443017|NCT00005952|childhood oligodendroglioma|childhood oligodendroglioma
443018|NCT00005952|childhood choroid plexus tumor|childhood choroid plexus tumor
443019|NCT00005952|untreated childhood brain stem glioma|untreated childhood brain stem glioma
443020|NCT00005952|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
443021|NCT00005952|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
443022|NCT00005952|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
443023|NCT00005952|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
443024|NCT00005952|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
443025|NCT00005952|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
443026|NCT00005952|untreated childhood medulloblastoma|untreated childhood medulloblastoma
443027|NCT00005952|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
443028|NCT00005952|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
443029|NCT00005952|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
443030|NCT00005952|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
443031|NCT00005952|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
443032|NCT00005952|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
443033|NCT00005952|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
443034|NCT00005952|recurrent childhood ependymoma|recurrent childhood ependymoma
443035|NCT00005954|adult tumors metastatic to brain|adult tumors metastatic to brain
443036|NCT00005955|childhood infratentorial ependymoma|childhood infratentorial ependymoma
443037|NCT00005955|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
443038|NCT00005955|childhood supratentorial ependymoma|childhood supratentorial ependymoma
443039|NCT00005955|childhood craniopharyngioma|childhood craniopharyngioma
443040|NCT00005955|localized resectable neuroblastoma|localized resectable neuroblastoma
443041|NCT00005955|regional neuroblastoma|regional neuroblastoma
443042|NCT00005955|disseminated neuroblastoma|disseminated neuroblastoma
443043|NCT00005955|stage 4S neuroblastoma|stage 4s neuroblastoma
443044|NCT00005955|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
443045|NCT00005955|childhood oligodendroglioma|childhood oligodendroglioma
443046|NCT00005955|childhood choroid plexus tumor|childhood choroid plexus tumor
443047|NCT00005955|childhood grade I meningioma|childhood grade i meningioma
443048|NCT00005955|childhood grade II meningioma|childhood grade ii meningioma
443049|NCT00005955|childhood grade III meningioma|childhood grade iii meningioma
443050|NCT00005955|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
443051|NCT00005955|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
443052|NCT00005955|untreated childhood medulloblastoma|untreated childhood medulloblastoma
443053|NCT00005955|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
443054|NCT00005955|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
443055|NCT00005955|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
443056|NCT00005955|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
443057|NCT00005955|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
443058|NCT00005955|childhood central nervous system teratoma|childhood central nervous system teratoma
443059|NCT00005955|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
443060|NCT00005956|stage II breast cancer|stage ii breast cancer
443061|NCT00005956|stage IV breast cancer|stage iv breast cancer
443062|NCT00005956|stage IIIA breast cancer|stage iiia breast cancer
443063|NCT00005956|stage II gastric cancer|stage ii gastric cancer
443064|NCT00005956|stage III gastric cancer|stage iii gastric cancer
443065|NCT00005956|stage IV gastric cancer|stage iv gastric cancer
443066|NCT00005956|stage IIIB breast cancer|stage iiib breast cancer
443067|NCT00005956|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
443068|NCT00005956|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
443069|NCT00005957|stage I breast cancer|stage i breast cancer
443070|NCT00005957|stage II breast cancer|stage ii breast cancer
443071|NCT00005958|stage III bladder cancer|stage iii bladder cancer
443072|NCT00005958|recurrent bladder cancer|recurrent bladder cancer
443073|NCT00005958|stage IV bladder cancer|stage iv bladder cancer
201013|NCT02112630|End Stage Renal Disease|end stage renal disease
443074|NCT00005958|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
443075|NCT00005958|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
443076|NCT00005958|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
443077|NCT00005958|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
443078|NCT00005959|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
443079|NCT00005959|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
443080|NCT00005959|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
443081|NCT00005959|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
443082|NCT00005959|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
443083|NCT00005959|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
585000|NCT00518050|Surveillance|surveillance
443084|NCT00005959|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
443085|NCT00005959|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
443086|NCT00005959|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
443087|NCT00005959|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
443088|NCT00005959|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
443089|NCT00005959|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
443090|NCT00005959|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
443091|NCT00005959|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
443092|NCT00005959|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
443093|NCT00005959|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
443094|NCT00005959|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
443095|NCT00005959|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
443096|NCT00005959|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
443171|NCT00005082|adult ependymoblastoma|adult ependymoblastoma
443097|NCT00005959|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
443098|NCT00005959|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
443099|NCT00005959|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
443100|NCT00005959|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
443101|NCT00005959|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
443102|NCT00005960|adenocarcinoma of the prostate|adenocarcinoma of the prostate
443103|NCT00005960|stage I prostate cancer|stage i prostate cancer
443104|NCT00005960|stage IIB prostate cancer|stage iib prostate cancer
443105|NCT00005960|stage IIA prostate cancer|stage iia prostate cancer
443106|NCT00005960|stage III prostate cancer|stage iii prostate cancer
443107|NCT00005960|stage IV prostate cancer|stage iv prostate cancer
443108|NCT00005960|recurrent prostate cancer|recurrent prostate cancer
443109|NCT00005960|pain|pain
443110|NCT00005060|stage II gastric cancer|stage ii gastric cancer
443111|NCT00005060|stage III gastric cancer|stage iii gastric cancer
443112|NCT00005061|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
443113|NCT00005062|limited stage small cell lung cancer|limited stage small cell lung cancer
443114|NCT00005066|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
443115|NCT00005066|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
443116|NCT00005068|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
443117|NCT00005069|stage IV renal cell cancer|stage iv renal cell cancer
443118|NCT00005069|recurrent renal cell cancer|recurrent renal cell cancer
443119|NCT00005070|recurrent cervical cancer|recurrent cervical cancer
443120|NCT00005070|stage IVB cervical cancer|stage ivb cervical cancer
443121|NCT00005070|cervical squamous cell carcinoma|cervical squamous cell carcinoma
443122|NCT00005070|cervical adenocarcinoma|cervical adenocarcinoma
443123|NCT00005070|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
443124|NCT00005071|stage I non-small cell lung cancer|stage i non-small cell lung cancer
443125|NCT00005071|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
443126|NCT00005071|limited stage small cell lung cancer|limited stage small cell lung cancer
443127|NCT00005072|stage I prostate cancer|stage i prostate cancer
443128|NCT00005072|stage IIB prostate cancer|stage iib prostate cancer
443129|NCT00005072|stage IIA prostate cancer|stage iia prostate cancer
443130|NCT00005072|recurrent prostate cancer|recurrent prostate cancer
443131|NCT00005073|stage I prostate cancer|stage i prostate cancer
443132|NCT00005073|stage IIB prostate cancer|stage iib prostate cancer
443133|NCT00005073|stage IIA prostate cancer|stage iia prostate cancer
443134|NCT00005073|stage III prostate cancer|stage iii prostate cancer
201014|NCT02112630|ESRD|esrd
201015|NCT02112630|Boceprevir|boceprevir
443135|NCT00005073|recurrent prostate cancer|recurrent prostate cancer
443136|NCT00005074|stage I mantle cell lymphoma|stage i mantle cell lymphoma
443137|NCT00005074|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
443138|NCT00005074|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
443139|NCT00005074|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
443140|NCT00005074|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
443141|NCT00005075|stage I prostate cancer|stage i prostate cancer
443142|NCT00005075|stage II prostate cancer|stage ii prostate cancer
443143|NCT00005075|recurrent prostate cancer|recurrent prostate cancer
443144|NCT00005076|stage III colon cancer|stage iii colon cancer
443145|NCT00005076|stage IV colon cancer|stage iv colon cancer
443146|NCT00005076|stage III rectal cancer|stage iii rectal cancer
443147|NCT00005076|stage IV rectal cancer|stage iv rectal cancer
443148|NCT00005076|recurrent colon cancer|recurrent colon cancer
443149|NCT00005076|recurrent rectal cancer|recurrent rectal cancer
443150|NCT00005077|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
583300|NCT00511212|lower digestive tract surgery|lower digestive tract surgery
443151|NCT00005078|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
443152|NCT00005079|stage I breast cancer|stage i breast cancer
443153|NCT00005079|stage II breast cancer|stage ii breast cancer
443154|NCT00005079|stage IIIA breast cancer|stage iiia breast cancer
443155|NCT00005079|stage IIIB breast cancer|stage iiib breast cancer
443156|NCT00005081|recurrent adult brain tumor|recurrent adult brain tumor
443157|NCT00005081|adult glioblastoma|adult glioblastoma
443158|NCT00005081|adult anaplastic astrocytoma|adult anaplastic astrocytoma
443159|NCT00005081|adult mixed glioma|adult mixed glioma
443160|NCT00005081|adult giant cell glioblastoma|adult giant cell glioblastoma
443161|NCT00005081|adult gliosarcoma|adult gliosarcoma
443162|NCT00005082|adult medulloblastoma|adult medulloblastoma
443163|NCT00005082|adult glioblastoma|adult glioblastoma
443164|NCT00005082|adult anaplastic astrocytoma|adult anaplastic astrocytoma
443165|NCT00005082|adult myxopapillary ependymoma|adult myxopapillary ependymoma
443166|NCT00005082|adult anaplastic ependymoma|adult anaplastic ependymoma
443167|NCT00005082|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
443168|NCT00005082|adult mixed glioma|adult mixed glioma
443169|NCT00005082|adult pilocytic astrocytoma|adult pilocytic astrocytoma
443170|NCT00005082|adult subependymoma|adult subependymoma
443172|NCT00005082|adult oligodendroglioma|adult oligodendroglioma
443173|NCT00005082|adult giant cell glioblastoma|adult giant cell glioblastoma
443174|NCT00005082|adult gliosarcoma|adult gliosarcoma
443175|NCT00005083|adult glioblastoma|adult glioblastoma
443176|NCT00005083|adult anaplastic astrocytoma|adult anaplastic astrocytoma
443177|NCT00005083|adult myxopapillary ependymoma|adult myxopapillary ependymoma
443178|NCT00005083|adult anaplastic ependymoma|adult anaplastic ependymoma
443179|NCT00005083|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
443180|NCT00005083|adult mixed glioma|adult mixed glioma
443181|NCT00005083|adult pilocytic astrocytoma|adult pilocytic astrocytoma
443182|NCT00005083|adult subependymoma|adult subependymoma
443183|NCT00005083|adult ependymoblastoma|adult ependymoblastoma
443184|NCT00005083|adult oligodendroglioma|adult oligodendroglioma
443185|NCT00005083|adult giant cell glioblastoma|adult giant cell glioblastoma
443186|NCT00005083|adult gliosarcoma|adult gliosarcoma
443187|NCT00005084|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
443188|NCT00005084|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
443189|NCT00005084|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
443190|NCT00005085|stage IV colon cancer|stage iv colon cancer
443191|NCT00005085|stage IV rectal cancer|stage iv rectal cancer
443192|NCT00005085|recurrent colon cancer|recurrent colon cancer
443193|NCT00005085|recurrent rectal cancer|recurrent rectal cancer
443194|NCT00005085|adenocarcinoma of the colon|adenocarcinoma of the colon
443195|NCT00005085|adenocarcinoma of the rectum|adenocarcinoma of the rectum
443196|NCT00005086|stage IV bladder cancer|stage iv bladder cancer
443197|NCT00005086|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
443198|NCT00005087|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
443199|NCT00005087|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
443200|NCT00005087|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
443316|NCT00005092|acute undifferentiated leukemia|acute undifferentiated leukemia
443201|NCT00005087|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
443202|NCT00005087|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
443203|NCT00005087|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
753001|NCT01175083|Catch-up vaccination|catch-up vaccination
201016|NCT02112630|Pegylated Interferon|pegylated interferon
443204|NCT00005087|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
443205|NCT00005087|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
443206|NCT00005087|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
443207|NCT00005087|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
443208|NCT00005087|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
443209|NCT00005087|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
10485|NCT03223922|genu of corpus callosum|genu of corpus callosum
443210|NCT00005087|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
443211|NCT00005087|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
443212|NCT00005087|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
443213|NCT00005087|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
443214|NCT00005087|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
443215|NCT00005087|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
443216|NCT00005087|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
583561|NCT00512213|preoperative Immunonutrition|preoperative immunonutrition
443217|NCT00005087|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
443218|NCT00005087|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
443219|NCT00005087|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
443220|NCT00005088|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
443221|NCT00005088|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
443222|NCT00005088|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
443223|NCT00005088|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
443224|NCT00005088|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
443225|NCT00005088|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
443226|NCT00005088|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
443227|NCT00005088|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
443228|NCT00005089|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
443229|NCT00005089|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
443230|NCT00005089|stage I mantle cell lymphoma|stage i mantle cell lymphoma
443231|NCT00005089|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
443232|NCT00005089|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
443233|NCT00005089|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
443234|NCT00005089|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
443235|NCT00005089|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
443236|NCT00005089|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
443237|NCT00005090|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
443238|NCT00005090|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
443239|NCT00005091|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
443240|NCT00005091|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
443241|NCT00005091|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
443242|NCT00005092|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
443243|NCT00005092|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
443244|NCT00005092|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
443245|NCT00005092|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
443246|NCT00005092|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
443247|NCT00005092|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
443248|NCT00005092|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
443249|NCT00005092|refractory multiple myeloma|refractory multiple myeloma
443250|NCT00005092|stage III multiple myeloma|stage iii multiple myeloma
443251|NCT00005092|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
443252|NCT00005092|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
443253|NCT00005092|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
443254|NCT00005092|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
443255|NCT00005092|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
443256|NCT00005092|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
443257|NCT00005092|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
443812|NCT00006225|recurrent breast cancer|recurrent breast cancer
443258|NCT00005092|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
443259|NCT00005092|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
443260|NCT00005092|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
443261|NCT00005092|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
443262|NCT00005092|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
443263|NCT00005092|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
443264|NCT00005092|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
443265|NCT00005092|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
443266|NCT00005092|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
10486|NCT03223922|cognitive function|cognitive function
443267|NCT00005092|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
443268|NCT00005092|childhood acute monoblastic leukemia and acute monocytic leukemia (M5)|childhood acute monoblastic leukemia and acute monocytic leukemia (m5)
443269|NCT00005092|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
443270|NCT00005092|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
443271|NCT00005092|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
443272|NCT00005092|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
443273|NCT00005092|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
443274|NCT00005092|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
443275|NCT00005092|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
443276|NCT00005092|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
443277|NCT00005092|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
443278|NCT00005092|non-T, non-B childhood acute lymphoblastic leukemia|non-t, non-b childhood acute lymphoblastic leukemia
443279|NCT00005092|non-T, non-B, cALLa positive childhood acute lymphoblastic leukemia|non-t, non-b, calla positive childhood acute lymphoblastic leukemia
443280|NCT00005092|non-T, non-B, cALLa negative childhood acute lymphoblastic leukemia|non-t, non-b, calla negative childhood acute lymphoblastic leukemia
443281|NCT00005092|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
443282|NCT00005092|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
443283|NCT00005092|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
443284|NCT00005092|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
443285|NCT00005092|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
443286|NCT00005092|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
443287|NCT00005092|non-T, non-B adult acute lymphoblastic leukemia|non-t, non-b adult acute lymphoblastic leukemia
443436|NCT00005118|HIV Protease Inhibitors|hiv protease inhibitors
443288|NCT00005092|non-T, non-B, cALLa positive adult acute lymphoblastic leukemia|non-t, non-b, calla positive adult acute lymphoblastic leukemia
443289|NCT00005092|non-T, non-B, cALLa positive, pre-B adult acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b adult acute lymphoblastic leukemia
443290|NCT00005092|non-T, non-B, cALLa negative adult acute lymphoblastic leukemia|non-t, non-b, calla negative adult acute lymphoblastic leukemia
443291|NCT00005092|TdT positive adult acute lymphoblastic leukemia|tdt positive adult acute lymphoblastic leukemia
443292|NCT00005092|TdT negative adult acute lymphoblastic leukemia|tdt negative adult acute lymphoblastic leukemia
443293|NCT00005092|TdT negative childhood acute lymphoblastic leukemia|tdt negative childhood acute lymphoblastic leukemia
443294|NCT00005092|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
443295|NCT00005092|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
443296|NCT00005092|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
443297|NCT00005092|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
443298|NCT00005092|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
443299|NCT00005092|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
443300|NCT00005092|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
443301|NCT00005092|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
443302|NCT00005092|adult acute basophilic leukemia|adult acute basophilic leukemia
443303|NCT00005092|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
443304|NCT00005092|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
443305|NCT00005092|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
443306|NCT00005092|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
443307|NCT00005092|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
443308|NCT00005092|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
443309|NCT00005092|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
443310|NCT00005092|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
443311|NCT00005092|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
443312|NCT00005092|childhood acute basophilic leukemia|childhood acute basophilic leukemia
443313|NCT00005092|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
443314|NCT00005092|untreated hairy cell leukemia|untreated hairy cell leukemia
443315|NCT00005092|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
443317|NCT00005092|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
443318|NCT00005092|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
443319|NCT00005092|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
443320|NCT00005092|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
443321|NCT00005092|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
443322|NCT00005092|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
443323|NCT00005092|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
443324|NCT00005092|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
443325|NCT00005092|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
443326|NCT00005092|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
443327|NCT00005092|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
443328|NCT00005092|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
443329|NCT00005092|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
443330|NCT00005092|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
585001|NCT00518050|06-128|06-128
443331|NCT00005092|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
443332|NCT00005092|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
443333|NCT00005092|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
443334|NCT00005092|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
443335|NCT00005092|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
443336|NCT00005092|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
443337|NCT00005092|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
443338|NCT00005092|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
443339|NCT00005092|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
443340|NCT00005092|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
443341|NCT00005092|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
443342|NCT00005092|secondary acute myeloid leukemia|secondary acute myeloid leukemia
443343|NCT00005092|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
443344|NCT00005092|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
443345|NCT00005092|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
443346|NCT00005092|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
443347|NCT00005092|prolymphocytic leukemia|prolymphocytic leukemia
443348|NCT00005092|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
443437|NCT00005118|Ritonavir|ritonavir
443349|NCT00005092|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
443350|NCT00005092|intraocular lymphoma|intraocular lymphoma
443351|NCT00005092|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
443352|NCT00005092|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
443353|NCT00005092|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
443354|NCT00005092|childhood large cell lymphoma|childhood large cell lymphoma
443355|NCT00005092|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
443356|NCT00005092|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
443357|NCT00005092|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
443358|NCT00005092|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
443359|NCT00005092|anaplastic large cell lymphoma|anaplastic large cell lymphoma
443360|NCT00005092|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
443361|NCT00005092|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
443362|NCT00005092|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
443363|NCT00005092|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
443364|NCT00005093|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
443365|NCT00005093|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
443366|NCT00005093|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
443367|NCT00005093|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
443368|NCT00005095|ovarian epithelial cancer|ovarian epithelial cancer
443369|NCT00005095|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
443370|NCT00005095|fallopian tube cancer|fallopian tube cancer
443371|NCT00005095|ovarian germ cell tumor|ovarian germ cell tumor
443372|NCT00005095|ovarian sarcoma|ovarian sarcoma
443373|NCT00005095|ovarian stromal cancer|ovarian stromal cancer
443374|NCT00005095|endometrial cancer|endometrial cancer
443375|NCT00005095|uterine sarcoma|uterine sarcoma
443376|NCT00005095|vaginal cancer|vaginal cancer
443377|NCT00005095|cervical cancer|cervical cancer
443378|NCT00005095|vulvar cancer|vulvar cancer
443379|NCT00005095|uterine leiomyomata|uterine leiomyomata
443380|NCT00005096|adenocarcinoma of the prostate|adenocarcinoma of the prostate
443381|NCT00005096|stage II prostate cancer|stage ii prostate cancer
443382|NCT00005096|stage III prostate cancer|stage iii prostate cancer
443383|NCT00005097|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
443384|NCT00005098|alpha 1-antitrypsin deficiency|alpha 1-antitrypsin deficiency
443813|NCT00006225|stage IIIB breast cancer|stage iiib breast cancer
443385|NCT00005098|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
443386|NCT00005098|rare disease|rare disease
443387|NCT00005100|acromegaly|acromegaly
443388|NCT00005100|endocrine disorders|endocrine disorders
443389|NCT00005100|rare disease|rare disease
443390|NCT00005101|disease-related problem/condition|disease-related problem/condition
443391|NCT00005101|osteoporosis|osteoporosis
443392|NCT00005101|rare disease|rare disease
443393|NCT00005102|DiGeorge syndrome|digeorge syndrome
443394|NCT00005102|Shprintzen syndrome|shprintzen syndrome
443395|NCT00005102|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
443396|NCT00005102|conotruncal cardiac defects|conotruncal cardiac defects
443397|NCT00005102|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
443398|NCT00005102|rare disease|rare disease
443399|NCT00005103|inborn errors of metabolism|inborn errors of metabolism
443400|NCT00005103|porphyria|porphyria
443401|NCT00005103|porphyria cutanea tarda|porphyria cutanea tarda
443402|NCT00005103|rare disease|rare disease
443403|NCT00005104|endocrine disorders|endocrine disorders
443404|NCT00005104|hyperinsulinism|hyperinsulinism
443405|NCT00005104|polycystic ovarian syndrome|polycystic ovarian syndrome
443406|NCT00005104|rare disease|rare disease
443407|NCT00005105|endocrine disorders|endocrine disorders
443408|NCT00005105|intrauterine growth retardation|intrauterine growth retardation
443409|NCT00005105|rare disease|rare disease
443410|NCT00005106|Drug Therapy, Combination|drug therapy, combination
443411|NCT00005106|Zidovudine|zidovudine
443412|NCT00005106|Stavudine|stavudine
443413|NCT00005106|HIV Protease Inhibitors|hiv protease inhibitors
443414|NCT00005106|Lamivudine|lamivudine
443415|NCT00005106|Nelfinavir|nelfinavir
443416|NCT00005106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
443417|NCT00005106|Anti-HIV Agents|anti-hiv agents
443418|NCT00005106|Adipose Tissue|adipose tissue
443419|NCT00005106|Lipodystrophy|lipodystrophy
443420|NCT00005106|abacavir|abacavir
443421|NCT00005108|Menopause|menopause
443422|NCT00005108|Atherosclerosis|atherosclerosis
443423|NCT00005108|Estrogen|estrogen
443425|NCT00005108|Ultrasound|ultrasound
443426|NCT00005111|Blood Flow|blood flow
443427|NCT00005111|Glucose|glucose
443428|NCT00005111|Lysosomal Disease|lysosomal disease
443429|NCT00005111|Metabolic|metabolic
443430|NCT00005111|Uptake|uptake
443431|NCT00005111|Fabry Disease|fabry disease
443432|NCT00005116|depression|depression
443433|NCT00005117|endothelial dysfunction|endothelial dysfunction
443434|NCT00005118|HIV-1|hiv-1
443435|NCT00005118|Drug Therapy, Combination|drug therapy, combination
443439|NCT00005118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
443440|NCT00005118|Anti-HIV Agents|anti-hiv agents
443441|NCT00005118|Viral Load|viral load
443442|NCT00005118|Nelfinavir|nelfinavir
443443|NCT00005119|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
443444|NCT00005119|Severe Premenstrual Syndrome|severe premenstrual syndrome
443445|NCT00005119|Calcium metabolism|calcium metabolism
443446|NCT00005119|Vitamin D|vitamin d
443447|NCT00005119|Bone Markers|bone markers
443448|NCT00005119|Premenopausal|premenopausal
443449|NCT00005119|Menstrual Cycle|menstrual cycle
443450|NCT00005120|CD4 Lymphocyte Count|cd4 lymphocyte count
443451|NCT00005120|Biological Markers|biological markers
443452|NCT00005120|Anti-HIV Agents|anti-hiv agents
443453|NCT00005120|Viral Load|viral load
443454|NCT00005120|Pharmacokinetics|pharmacokinetics
443455|NCT00005120|calanolide A|calanolide a
443456|NCT00005961|stage III melanoma|stage iii melanoma
443457|NCT00005961|stage IV melanoma|stage iv melanoma
443458|NCT00005961|recurrent melanoma|recurrent melanoma
443459|NCT00005962|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
443460|NCT00005962|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
443461|NCT00005962|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
443462|NCT00005962|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
443463|NCT00005962|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
443464|NCT00005962|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
443465|NCT00005962|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
443466|NCT00005962|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
753002|NCT01175083|Pneumococcal vaccine|pneumococcal vaccine
443467|NCT00005962|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
443468|NCT00005962|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
443469|NCT00005963|stage IV breast cancer|stage iv breast cancer
443470|NCT00005963|recurrent breast cancer|recurrent breast cancer
443471|NCT00005964|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
443472|NCT00005964|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
443473|NCT00005964|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
443474|NCT00005964|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
469431|NCT00067444|Elderly|elderly
443475|NCT00005964|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
443476|NCT00005964|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
443477|NCT00005964|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
443478|NCT00005964|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
443479|NCT00005964|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
443480|NCT00005964|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
10487|NCT03223909|dry eye|dry eye
443481|NCT00005964|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
443482|NCT00005964|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
443483|NCT00005965|stage III cervical cancer|stage iii cervical cancer
443484|NCT00005965|recurrent cervical cancer|recurrent cervical cancer
443485|NCT00005965|stage IVB cervical cancer|stage ivb cervical cancer
443486|NCT00005965|stage IVA cervical cancer|stage iva cervical cancer
443487|NCT00005965|cervical squamous cell carcinoma|cervical squamous cell carcinoma
443488|NCT00005965|cervical adenocarcinoma|cervical adenocarcinoma
443489|NCT00005965|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
443490|NCT00005966|stage III renal cell cancer|stage iii renal cell cancer
443491|NCT00005966|stage IV renal cell cancer|stage iv renal cell cancer
443492|NCT00005967|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
443493|NCT00005967|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
443494|NCT00005967|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
443495|NCT00005967|refractory multiple myeloma|refractory multiple myeloma
443496|NCT00005967|stage III multiple myeloma|stage iii multiple myeloma
443497|NCT00005967|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
443498|NCT00005967|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
443499|NCT00005967|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
443500|NCT00005967|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
443501|NCT00005967|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
443502|NCT00005967|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
443503|NCT00005967|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
443504|NCT00005967|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
443505|NCT00005967|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
443506|NCT00005967|refractory anemia with excess blasts|refractory anemia with excess blasts
443507|NCT00005967|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
465082|NCT00057629|Rape|rape
443508|NCT00005967|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
443509|NCT00005967|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
443510|NCT00005967|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
443511|NCT00005967|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
443512|NCT00005967|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
443513|NCT00005967|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
443514|NCT00005967|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
443515|NCT00005967|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
443516|NCT00005967|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
443517|NCT00005967|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
443518|NCT00005967|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
443519|NCT00005967|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
443520|NCT00005967|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
443521|NCT00005967|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
443522|NCT00005967|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
443523|NCT00005967|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
443524|NCT00005967|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
443525|NCT00005967|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
443526|NCT00005967|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
443527|NCT00005967|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
443528|NCT00005967|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
443529|NCT00005967|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
443530|NCT00005967|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
443531|NCT00005967|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
443532|NCT00005967|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
443533|NCT00005967|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
443534|NCT00005967|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
443535|NCT00005967|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
443536|NCT00005967|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
443537|NCT00005967|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
443538|NCT00005967|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
443539|NCT00005967|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
443540|NCT00005967|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
443541|NCT00005967|polycythemia vera|polycythemia vera
443542|NCT00005967|primary myelofibrosis|primary myelofibrosis
443543|NCT00005967|essential thrombocythemia|essential thrombocythemia
443544|NCT00005967|chronic eosinophilic leukemia|chronic eosinophilic leukemia
443545|NCT00005967|chronic neutrophilic leukemia|chronic neutrophilic leukemia
443546|NCT00005967|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
443547|NCT00005967|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
443548|NCT00005967|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
443549|NCT00005967|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
443550|NCT00005967|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
443551|NCT00005967|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
583562|NCT00512213|major abdominal surgery|major abdominal surgery
443552|NCT00005967|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
443553|NCT00005967|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
443554|NCT00005967|splenic marginal zone lymphoma|splenic marginal zone lymphoma
443555|NCT00005968|stage IV melanoma|stage iv melanoma
443556|NCT00005969|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
443557|NCT00005969|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
443558|NCT00005971|stage IV melanoma|stage iv melanoma
443559|NCT00005972|recurrent small cell lung cancer|recurrent small cell lung cancer
443560|NCT00005974|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
443561|NCT00005974|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
443562|NCT00005975|stage I breast cancer|stage i breast cancer
443563|NCT00005975|stage II breast cancer|stage ii breast cancer
443565|NCT00005976|recurrent adult brain tumor|recurrent adult brain tumor
443566|NCT00005976|adult glioblastoma|adult glioblastoma
443567|NCT00005976|adult anaplastic astrocytoma|adult anaplastic astrocytoma
443568|NCT00005976|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
443569|NCT00005976|adult mixed glioma|adult mixed glioma
443570|NCT00005976|adult oligodendroglioma|adult oligodendroglioma
443571|NCT00005976|adult giant cell glioblastoma|adult giant cell glioblastoma
443572|NCT00005976|adult gliosarcoma|adult gliosarcoma
443573|NCT00005977|childhood Burkitt lymphoma|childhood burkitt lymphoma
443574|NCT00005977|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
443575|NCT00005977|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
443576|NCT00005977|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
443577|NCT00005977|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
443578|NCT00005977|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
443579|NCT00005977|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
443580|NCT00005977|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
443581|NCT00005977|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
443582|NCT00005978|localized resectable neuroblastoma|localized resectable neuroblastoma
443583|NCT00005978|regional neuroblastoma|regional neuroblastoma
443584|NCT00005978|disseminated neuroblastoma|disseminated neuroblastoma
443585|NCT00005978|stage 4S neuroblastoma|stage 4s neuroblastoma
443586|NCT00005978|recurrent neuroblastoma|recurrent neuroblastoma
443587|NCT00005978|localized unresectable neuroblastoma|localized unresectable neuroblastoma
443588|NCT00005979|stage III colon cancer|stage iii colon cancer
443589|NCT00005979|adenocarcinoma of the colon|adenocarcinoma of the colon
443590|NCT00005980|stage IV breast cancer|stage iv breast cancer
443591|NCT00005980|recurrent breast cancer|recurrent breast cancer
443592|NCT00005981|stage IV colon cancer|stage iv colon cancer
443593|NCT00005981|stage IV rectal cancer|stage iv rectal cancer
443594|NCT00005981|recurrent colon cancer|recurrent colon cancer
443595|NCT00005981|recurrent rectal cancer|recurrent rectal cancer
443596|NCT00005983|stage II breast cancer|stage ii breast cancer
443597|NCT00005984|chronic phase myelogenous leukemia|chronic phase myelogenous leukemia
443598|NCT00005984|accelerated phase myelogenous leukemia|accelerated phase myelogenous leukemia
443599|NCT00005985|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
443600|NCT00005985|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
443601|NCT00005985|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
443602|NCT00005985|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
443603|NCT00005985|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
443604|NCT00005985|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
443605|NCT00005985|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
443606|NCT00005985|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
443607|NCT00005985|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
443608|NCT00005985|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
443609|NCT00005985|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
443610|NCT00005985|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
443611|NCT00005985|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
443612|NCT00005985|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
443613|NCT00005985|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
443614|NCT00005985|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
443615|NCT00005985|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
443616|NCT00005985|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
443617|NCT00005985|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
10488|NCT03223909|Chondroitin sulfate|chondroitin sulfate
443618|NCT00005985|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
443619|NCT00005985|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
443620|NCT00005985|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
443621|NCT00005985|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
443622|NCT00005985|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
443623|NCT00005985|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
443624|NCT00005985|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
443625|NCT00005985|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
443626|NCT00005985|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
443627|NCT00005985|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
443628|NCT00005985|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
443629|NCT00005985|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
443630|NCT00005985|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
443631|NCT00005985|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
443632|NCT00005985|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
443633|NCT00005985|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
443634|NCT00005985|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
443635|NCT00005985|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
443636|NCT00005985|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
443637|NCT00005985|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
443638|NCT00005985|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
443639|NCT00005985|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
443640|NCT00005985|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
443641|NCT00005985|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
443642|NCT00005985|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
443643|NCT00005985|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
443644|NCT00005985|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
443645|NCT00005985|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
443646|NCT00005985|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
443647|NCT00005985|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
443648|NCT00005985|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
443649|NCT00005985|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
443650|NCT00005985|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
443651|NCT00005985|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
443652|NCT00005985|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
443653|NCT00005985|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
443654|NCT00005985|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
443655|NCT00005985|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
443656|NCT00005985|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
443657|NCT00005985|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
443658|NCT00005985|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
443659|NCT00005985|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
443660|NCT00005985|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
443661|NCT00005985|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
443662|NCT00005985|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
443663|NCT00005985|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
443664|NCT00005985|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
443665|NCT00005985|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
443666|NCT00005985|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
443667|NCT00005985|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
443668|NCT00005985|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
443669|NCT00005986|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
443670|NCT00005986|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
443814|NCT00006225|stage IIIC breast cancer|stage iiic breast cancer
443671|NCT00005986|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
443672|NCT00006207|HIV Seropositivity|hiv seropositivity
443673|NCT00006207|Dose-Response Relationship, Drug|dose-response relationship, drug
443674|NCT00006207|HIV Seronegativity|hiv seronegativity
443676|NCT00006207|Ulcer|ulcer
443677|NCT00006207|Vagina|vagina
443678|NCT00006207|Anti-HIV Agents|anti-hiv agents
443679|NCT00006207|Sexual Abstinence|sexual abstinence
443680|NCT00006207|Irritants|irritants
443681|NCT00006207|PRO 2000|pro 2000
443682|NCT00006208|HIV-1|hiv-1
443683|NCT00006208|Didanosine|didanosine
443684|NCT00006208|Drug Therapy, Combination|drug therapy, combination
443685|NCT00006208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
443686|NCT00006208|Anti-HIV Agents|anti-hiv agents
443687|NCT00006208|Deoxycytidine|deoxycytidine
443688|NCT00006208|efavirenz|efavirenz
443689|NCT00006209|HIV-1|hiv-1
443690|NCT00006209|Immunity, Cellular|immunity, cellular
443691|NCT00006209|Drug Therapy, Combination|drug therapy, combination
443692|NCT00006209|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
443693|NCT00006209|Antigens|antigens
443694|NCT00006209|Anti-HIV Agents|anti-hiv agents
443695|NCT00006209|Viral Load|viral load
443696|NCT00006209|tucaresol|tucaresol
443697|NCT00006211|Drug Therapy, Combination|drug therapy, combination
443698|NCT00006211|HIV Protease Inhibitors|hiv protease inhibitors
443699|NCT00006211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
443700|NCT00006211|Anti-HIV Agents|anti-hiv agents
443701|NCT00006211|Viral Load|viral load
443702|NCT00006211|Nelfinavir|nelfinavir
443703|NCT00006212|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
443704|NCT00006212|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
443705|NCT00006212|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
443706|NCT00006214|prostate cancer|prostate cancer
443707|NCT00006215|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
443708|NCT00006215|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
443709|NCT00006216|stage IA malignant mesothelioma|stage ia malignant mesothelioma
443710|NCT00006216|stage IB malignant mesothelioma|stage ib malignant mesothelioma
443711|NCT00006216|stage II malignant mesothelioma|stage ii malignant mesothelioma
443712|NCT00006216|stage III malignant mesothelioma|stage iii malignant mesothelioma
443713|NCT00006218|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
443714|NCT00006219|multiple myeloma|multiple myeloma
443715|NCT00006220|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
465706|NCT00049946|psychosis|psychosis
443716|NCT00006220|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
443717|NCT00006220|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
443718|NCT00006220|refractory multiple myeloma|refractory multiple myeloma
443719|NCT00006220|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
443720|NCT00006220|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
443721|NCT00006220|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
443722|NCT00006220|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
443723|NCT00006220|refractory anemia with excess blasts|refractory anemia with excess blasts
443724|NCT00006220|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
443725|NCT00006220|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
443726|NCT00006220|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
443727|NCT00006220|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
443728|NCT00006220|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
753003|NCT01175083|Sickle cell disease|sickle cell disease
443729|NCT00006220|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
443730|NCT00006220|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
443731|NCT00006220|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
443732|NCT00006220|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
443733|NCT00006220|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
443734|NCT00006220|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
443735|NCT00006220|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
443736|NCT00006220|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
443737|NCT00006220|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
443738|NCT00006220|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
443739|NCT00006220|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
443740|NCT00006220|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
443741|NCT00006220|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
443742|NCT00006220|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
443743|NCT00006220|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
443744|NCT00006220|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
443745|NCT00006220|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
443746|NCT00006220|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
443747|NCT00006220|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
443748|NCT00006220|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
443749|NCT00006220|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
443750|NCT00006220|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
443751|NCT00006221|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
443752|NCT00006221|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
443753|NCT00006221|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
443754|NCT00006221|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
443755|NCT00006221|small intestine lymphoma|small intestine lymphoma
443756|NCT00006221|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
443757|NCT00006221|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
443758|NCT00006221|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
443759|NCT00006221|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
443760|NCT00006221|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
443761|NCT00006221|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
443762|NCT00006221|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
443763|NCT00006221|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
443764|NCT00006221|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
443765|NCT00006221|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
443766|NCT00006221|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
443767|NCT00006221|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
443768|NCT00006221|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
443769|NCT00006221|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
443770|NCT00006221|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
445385|NCT00005572|Immunocompetence|immunocompetence
443771|NCT00006221|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
443772|NCT00006221|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
443773|NCT00006221|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
443774|NCT00006221|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
443775|NCT00006221|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
443776|NCT00006221|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
443777|NCT00006221|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
443778|NCT00006221|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
443779|NCT00006221|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
443780|NCT00006221|intraocular lymphoma|intraocular lymphoma
443781|NCT00006221|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
443782|NCT00006221|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
443783|NCT00006221|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
443784|NCT00006221|anaplastic large cell lymphoma|anaplastic large cell lymphoma
443785|NCT00006221|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
443786|NCT00006221|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
443787|NCT00006221|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
443788|NCT00006221|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
443789|NCT00006221|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
443790|NCT00006221|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
443791|NCT00006221|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
443792|NCT00006221|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
443793|NCT00006221|splenic marginal zone lymphoma|splenic marginal zone lymphoma
443794|NCT00006222|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
443795|NCT00006222|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
443796|NCT00006223|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
443797|NCT00006223|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
443798|NCT00006223|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
443799|NCT00006223|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
443800|NCT00006223|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
443801|NCT00006223|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
443802|NCT00006223|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
443803|NCT00006223|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
443804|NCT00006223|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
443805|NCT00006223|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
443806|NCT00006224|recurrent cervical cancer|recurrent cervical cancer
443807|NCT00006224|cervical adenocarcinoma|cervical adenocarcinoma
443808|NCT00006224|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
443809|NCT00006225|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
443810|NCT00006225|stage IV breast cancer|stage iv breast cancer
443811|NCT00006225|stage IIIA breast cancer|stage iiia breast cancer
443815|NCT00006225|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
443816|NCT00006225|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
443817|NCT00006225|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
443818|NCT00006225|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
443819|NCT00006225|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
443820|NCT00006225|isolated plasmacytoma of bone|isolated plasmacytoma of bone
443821|NCT00006225|extramedullary plasmacytoma|extramedullary plasmacytoma
443822|NCT00006225|refractory multiple myeloma|refractory multiple myeloma
443823|NCT00006225|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
443824|NCT00006225|stage I multiple myeloma|stage i multiple myeloma
443825|NCT00006225|stage II multiple myeloma|stage ii multiple myeloma
443826|NCT00006225|stage III multiple myeloma|stage iii multiple myeloma
443827|NCT00006225|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
443828|NCT00006225|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
443829|NCT00006225|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
443830|NCT00006225|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
443831|NCT00006225|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
443832|NCT00006225|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
443833|NCT00006225|acute undifferentiated leukemia|acute undifferentiated leukemia
443834|NCT00006225|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
443835|NCT00006225|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
443836|NCT00006225|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
443837|NCT00006225|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
443838|NCT00006225|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
443839|NCT00006225|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
443840|NCT00006225|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
443841|NCT00006225|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
443842|NCT00006225|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
443843|NCT00006225|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
443844|NCT00006225|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
443845|NCT00006225|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
443846|NCT00006225|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
443847|NCT00006225|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
443848|NCT00006225|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
443849|NCT00006225|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
443850|NCT00006225|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
443851|NCT00006225|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
443852|NCT00006225|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
443853|NCT00006225|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
443854|NCT00006225|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
443855|NCT00006225|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
443856|NCT00006225|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
443857|NCT00006225|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
443858|NCT00006225|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
443859|NCT00006225|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
443860|NCT00006225|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
443861|NCT00006225|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
443862|NCT00006225|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
443863|NCT00006225|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
443864|NCT00006225|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
443865|NCT00006225|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
443866|NCT00006225|primary central nervous system lymphoma|primary central nervous system lymphoma
443867|NCT00006225|male breast cancer|male breast cancer
443868|NCT00006225|intraocular lymphoma|intraocular lymphoma
443869|NCT00006225|stage I mantle cell lymphoma|stage i mantle cell lymphoma
443870|NCT00006225|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
443871|NCT00006225|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
443872|NCT00006225|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
443873|NCT00006225|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
443874|NCT00006225|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
443875|NCT00006225|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
443876|NCT00006225|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
443877|NCT00006225|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
443878|NCT00006225|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
443879|NCT00006225|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
443880|NCT00006225|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
443881|NCT00006225|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
443882|NCT00006225|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
443883|NCT00006225|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
443884|NCT00006225|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
443885|NCT00006225|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
443886|NCT00006225|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
443887|NCT00006225|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
443888|NCT00006225|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
443889|NCT00006225|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
443890|NCT00006225|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
443891|NCT00006225|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
443892|NCT00006225|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
443893|NCT00006225|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
443894|NCT00006225|anaplastic large cell lymphoma|anaplastic large cell lymphoma
443895|NCT00006225|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
443896|NCT00006225|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
443897|NCT00006225|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
443898|NCT00006225|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
443899|NCT00006225|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
443900|NCT00006225|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
443901|NCT00006225|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
443902|NCT00006225|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
443903|NCT00006225|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
443904|NCT00006225|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
443905|NCT00006225|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
443906|NCT00006225|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
443907|NCT00006225|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
443908|NCT00006225|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
443909|NCT00006225|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
443910|NCT00006225|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
443911|NCT00006225|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
443912|NCT00006225|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
443913|NCT00006225|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
443914|NCT00006225|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
443915|NCT00006225|splenic marginal zone lymphoma|splenic marginal zone lymphoma
753004|NCT01175083|Booster vaccination|booster vaccination
443916|NCT00006229|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
443917|NCT00006229|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
443918|NCT00006230|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
443919|NCT00006230|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
443920|NCT00006230|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
443921|NCT00006231|localized malignant mesothelioma|localized malignant mesothelioma
443922|NCT00006231|advanced malignant mesothelioma|advanced malignant mesothelioma
443923|NCT00006231|perioperative/postoperative complications|perioperative/postoperative complications
443924|NCT00006232|stage II multiple myeloma|stage ii multiple myeloma
443925|NCT00006232|stage III multiple myeloma|stage iii multiple myeloma
443926|NCT00006233|stage IV melanoma|stage iv melanoma
443927|NCT00006233|recurrent melanoma|recurrent melanoma
443928|NCT00006234|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
443929|NCT00006234|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
443930|NCT00006234|adult rhabdomyosarcoma|adult rhabdomyosarcoma
443931|NCT00006234|bone metastases|bone metastases
443932|NCT00006234|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
443933|NCT00006234|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
443934|NCT00006234|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
443935|NCT00006234|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
443936|NCT00006235|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
443937|NCT00006235|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
443938|NCT00006235|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
443939|NCT00006235|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
443940|NCT00006235|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
443941|NCT00006235|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
443942|NCT00006235|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
443943|NCT00006235|fallopian tube cancer|fallopian tube cancer
443944|NCT00006235|primary peritoneal cavity cancer|primary peritoneal cavity cancer
443945|NCT00006235|Brenner tumor|brenner tumor
443946|NCT00006237|stage III melanoma|stage iii melanoma
443947|NCT00006237|recurrent melanoma|recurrent melanoma
443948|NCT00006239|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
443949|NCT00006239|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
443950|NCT00006239|refractory anemia|refractory anemia
443951|NCT00006239|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
443952|NCT00006239|refractory anemia with excess blasts|refractory anemia with excess blasts
443953|NCT00006239|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
443954|NCT00006239|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
443955|NCT00006239|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
443956|NCT00006239|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
443957|NCT00006239|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
443958|NCT00006239|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
443959|NCT00006239|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
443960|NCT00006239|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
443961|NCT00006239|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
443962|NCT00006239|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
443963|NCT00006240|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
443964|NCT00006241|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
443965|NCT00006241|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
443966|NCT00006241|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
443967|NCT00006241|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
443968|NCT00006241|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
443969|NCT00006241|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
443970|NCT00006241|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
443971|NCT00006241|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
443972|NCT00006241|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
444034|NCT00006250|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
443973|NCT00006241|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
443974|NCT00006241|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
443975|NCT00006241|splenic marginal zone lymphoma|splenic marginal zone lymphoma
443976|NCT00006245|stage III esophageal cancer|stage iii esophageal cancer
443977|NCT00006245|stage IV esophageal cancer|stage iv esophageal cancer
443978|NCT00006245|recurrent esophageal cancer|recurrent esophageal cancer
443979|NCT00006245|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
443980|NCT00006245|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
443981|NCT00006246|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
201017|NCT02112630|Ribavirin|ribavirin
443982|NCT00006246|childhood infratentorial ependymoma|childhood infratentorial ependymoma
443983|NCT00006246|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
443984|NCT00006246|recurrent childhood brain tumor|recurrent childhood brain tumor
443985|NCT00006246|recurrent retinoblastoma|recurrent retinoblastoma
443986|NCT00006246|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
443987|NCT00006246|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
443988|NCT00006246|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
443989|NCT00006246|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
443990|NCT00006246|leptomeningeal metastases|leptomeningeal metastases
443991|NCT00006246|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
443992|NCT00006246|childhood oligodendroglioma|childhood oligodendroglioma
443993|NCT00006246|childhood choroid plexus tumor|childhood choroid plexus tumor
443994|NCT00006246|childhood grade I meningioma|childhood grade i meningioma
443995|NCT00006246|childhood grade II meningioma|childhood grade ii meningioma
443996|NCT00006246|childhood grade III meningioma|childhood grade iii meningioma
443997|NCT00006246|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
443998|NCT00006246|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
443999|NCT00006246|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
444000|NCT00006246|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
444001|NCT00006246|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
444002|NCT00006246|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
444003|NCT00006246|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
444004|NCT00006246|recurrent childhood ependymoma|recurrent childhood ependymoma
583564|NCT00512226|Sickle Cell Anemia|sickle cell anemia
444005|NCT00006246|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
444006|NCT00006247|childhood craniopharyngioma|childhood craniopharyngioma
444007|NCT00006247|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
444008|NCT00006247|childhood oligodendroglioma|childhood oligodendroglioma
444009|NCT00006247|childhood choroid plexus tumor|childhood choroid plexus tumor
444010|NCT00006247|childhood grade I meningioma|childhood grade i meningioma
444011|NCT00006247|childhood grade II meningioma|childhood grade ii meningioma
444012|NCT00006247|childhood grade III meningioma|childhood grade iii meningioma
444013|NCT00006247|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
444014|NCT00006247|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
444015|NCT00006247|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
444016|NCT00006247|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
444017|NCT00006247|recurrent childhood ependymoma|recurrent childhood ependymoma
444018|NCT00006248|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
444019|NCT00006248|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
444020|NCT00006248|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
444021|NCT00006248|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
444022|NCT00006248|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
444023|NCT00006248|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
444024|NCT00006248|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
444025|NCT00006248|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
444026|NCT00006248|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
444027|NCT00006248|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
444028|NCT00006248|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
444029|NCT00006248|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
444030|NCT00006249|stage III melanoma|stage iii melanoma
444031|NCT00006250|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
444032|NCT00006250|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
444033|NCT00006250|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
444191|NCT00006289|Analgesia|analgesia
444035|NCT00006250|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
444036|NCT00006250|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
444037|NCT00006252|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
444038|NCT00006252|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
444039|NCT00006252|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
444040|NCT00006252|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
444041|NCT00006252|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
444042|NCT00006252|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
444043|NCT00006252|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
444044|NCT00006252|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
444045|NCT00006252|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
444046|NCT00006252|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
444047|NCT00006252|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
444048|NCT00006252|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
444049|NCT00006252|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
444050|NCT00006252|prolymphocytic leukemia|prolymphocytic leukemia
444051|NCT00006252|stage I mantle cell lymphoma|stage i mantle cell lymphoma
444052|NCT00006252|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
444053|NCT00006252|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
444054|NCT00006252|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
444055|NCT00006252|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
444056|NCT00006252|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
444057|NCT00006252|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
444058|NCT00006252|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
444059|NCT00006252|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
444060|NCT00006252|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
444061|NCT00006252|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
444062|NCT00006252|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
444063|NCT00006252|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
444064|NCT00006252|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
444065|NCT00006252|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
444066|NCT00006252|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
444144|NCT00006272|rare disease|rare disease
444067|NCT00006252|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
444068|NCT00006252|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
444069|NCT00006252|splenic marginal zone lymphoma|splenic marginal zone lymphoma
444070|NCT00006252|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
444071|NCT00006252|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
444072|NCT00006252|stage I marginal zone lymphoma|stage i marginal zone lymphoma
444073|NCT00006252|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
444074|NCT00006252|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
444075|NCT00006252|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
444076|NCT00006252|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
444077|NCT00006252|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
444078|NCT00006253|symptom management|symptom management
444080|NCT00006253|chemotherapy treatment|chemotherapy treatment
444081|NCT00006253|Behavioral Research|behavioral research
444082|NCT00006253|Physiological Effects of Drugs|physiological effects of drugs
444083|NCT00006253|Clinical Trial, Phase II|clinical trial, phase ii
444084|NCT00006254|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
444085|NCT00006255|stage III renal cell cancer|stage iii renal cell cancer
444086|NCT00006255|stage IV renal cell cancer|stage iv renal cell cancer
444087|NCT00006255|recurrent renal cell cancer|recurrent renal cell cancer
444088|NCT00006255|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
444089|NCT00006255|liver metastases|liver metastases
444090|NCT00006256|stage II breast cancer|stage ii breast cancer
444091|NCT00006256|stage IIIA breast cancer|stage iiia breast cancer
444092|NCT00006256|stage IIIB breast cancer|stage iiib breast cancer
444093|NCT00006256|stage IIIC breast cancer|stage iiic breast cancer
444094|NCT00006257|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
444095|NCT00006258|childhood infratentorial ependymoma|childhood infratentorial ependymoma
444096|NCT00006258|childhood supratentorial ependymoma|childhood supratentorial ependymoma
444097|NCT00006258|adult medulloblastoma|adult medulloblastoma
444098|NCT00006258|adult myxopapillary ependymoma|adult myxopapillary ependymoma
444099|NCT00006258|adult anaplastic ependymoma|adult anaplastic ependymoma
444100|NCT00006258|adult ependymoblastoma|adult ependymoblastoma
444101|NCT00006258|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
444102|NCT00006258|untreated childhood medulloblastoma|untreated childhood medulloblastoma
444103|NCT00006258|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
444104|NCT00006258|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
444105|NCT00006259|tumors metastatic to brain|tumors metastatic to brain
444106|NCT00006260|stage IV breast cancer|stage iv breast cancer
444107|NCT00006260|recurrent breast cancer|recurrent breast cancer
753005|NCT01175083|Safety|safety
443564|NCT00005975|hot flashes|hot flashes
444108|NCT00006261|stage IV breast cancer|stage iv breast cancer
444109|NCT00006261|recurrent breast cancer|recurrent breast cancer
444110|NCT00006262|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
444111|NCT00006262|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
444112|NCT00006262|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
444113|NCT00006263|adult brain stem glioma|adult brain stem glioma
444114|NCT00006263|adult glioblastoma|adult glioblastoma
444115|NCT00006263|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
444116|NCT00006263|adult anaplastic astrocytoma|adult anaplastic astrocytoma
444117|NCT00006263|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
444118|NCT00006263|adult giant cell glioblastoma|adult giant cell glioblastoma
444119|NCT00006263|adult gliosarcoma|adult gliosarcoma
444120|NCT00006264|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
444121|NCT00006265|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
444122|NCT00006267|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
444123|NCT00006267|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
444124|NCT00006267|primary peritoneal cavity cancer|primary peritoneal cavity cancer
444125|NCT00006268|recurrent adult brain tumor|recurrent adult brain tumor
444126|NCT00006268|adult glioblastoma|adult glioblastoma
444127|NCT00006268|adult anaplastic astrocytoma|adult anaplastic astrocytoma
444128|NCT00006268|adult mixed glioma|adult mixed glioma
444129|NCT00006268|adult giant cell glioblastoma|adult giant cell glioblastoma
444130|NCT00006268|adult gliosarcoma|adult gliosarcoma
444131|NCT00006269|stage IV colon cancer|stage iv colon cancer
444132|NCT00006269|stage IV rectal cancer|stage iv rectal cancer
444133|NCT00006269|recurrent colon cancer|recurrent colon cancer
444134|NCT00006269|recurrent rectal cancer|recurrent rectal cancer
444135|NCT00006269|diarrhea|diarrhea
444136|NCT00006270|brain injury|brain injury
444137|NCT00006270|neurologic and psychiatric disorders|neurologic and psychiatric disorders
444138|NCT00006270|rare disease|rare disease
444139|NCT00006271|brain injury|brain injury
444140|NCT00006271|neurologic and psychiatric disorders|neurologic and psychiatric disorders
444141|NCT00006271|rare disease|rare disease
444142|NCT00006272|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
444145|NCT00006273|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
444146|NCT00006273|cystic fibrosis|cystic fibrosis
444147|NCT00006273|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
444148|NCT00006273|rare disease|rare disease
444149|NCT00006274|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
444150|NCT00006274|neonatal disorders|neonatal disorders
444151|NCT00006274|rare disease|rare disease
444152|NCT00006274|respiratory distress syndrome|respiratory distress syndrome
444153|NCT00006275|dermatologic disorders|dermatologic disorders
444154|NCT00006275|psoriasis|psoriasis
444155|NCT00006275|rare disease|rare disease
444156|NCT00006276|Angiogenesis Inhibition|angiogenesis inhibition
444157|NCT00006276|Skin Disease|skin disease
444158|NCT00006276|Blood Vessels|blood vessels
444159|NCT00006276|Cytokines|cytokines
444160|NCT00006276|Autoimmune Disease|autoimmune disease
444161|NCT00006278|Cushing's Syndrome|cushing's syndrome
444162|NCT00006278|Adrenal Glands|adrenal glands
444163|NCT00006278|Proteomics|proteomics
444164|NCT00006278|Cortisol|cortisol
444165|NCT00006279|Pregnancy Complications, Infectious|pregnancy complications, infectious
444166|NCT00006279|Dose-Response Relationship, Drug|dose-response relationship, drug
444167|NCT00006279|Drug Administration Schedule|drug administration schedule
444168|NCT00006279|Nevirapine|nevirapine
444169|NCT00006279|Disease Transmission, Vertical|disease transmission, vertical
444170|NCT00006279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
444171|NCT00006279|Anti-HIV Agents|anti-hiv agents
444172|NCT00006279|Breast Feeding|breast feeding
444173|NCT00006280|Cystic Fibrosis|cystic fibrosis
444174|NCT00006285|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
444175|NCT00006285|Parietal Lobe|parietal lobe
444177|NCT00006285|Cognition|cognition
444178|NCT00006285|Perception|perception
444179|NCT00006285|Cortical Stimulation|cortical stimulation
444180|NCT00006285|Spatial Attention|spatial attention
444181|NCT00006286|Depression|depression
444182|NCT00006286|Major Depressive Disorder|major depressive disorder
444183|NCT00006286|Fluoxetine|fluoxetine
444184|NCT00006286|Prozac|prozac
444185|NCT00006286|SSRI|ssri
444186|NCT00006286|Psychotherapy|psychotherapy
444187|NCT00006286|CBT|cbt
444188|NCT00006286|Teenagers|teenagers
444189|NCT00006286|Adolescents|adolescents
444190|NCT00006286|Teens|teens
444194|NCT00006289|Neuropathic Pain|neuropathic pain
444195|NCT00006289|Oral Surgery|oral surgery
444196|NCT00006289|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
444197|NCT00006289|Sympathetic Nervous System|sympathetic nervous system
444198|NCT00006289|Chronic Regional Pain Syndrome|chronic regional pain syndrome
443675|NCT00006207|Mucous Membrane|mucous membrane
444199|NCT00006290|Drug Therapy, Combination|drug therapy, combination
444200|NCT00006290|Questionnaires|questionnaires
444201|NCT00006290|Quality of Life|quality of life
444202|NCT00006290|Patient Compliance|patient compliance
444203|NCT00006290|Body Composition|body composition
444204|NCT00006290|Anti-HIV Agents|anti-hiv agents
444205|NCT00006290|Adipose Tissue|adipose tissue
444206|NCT00006290|Body Image|body image
444207|NCT00006291|Virus Replication|virus replication
444208|NCT00006291|T-Lymphocytes|t-lymphocytes
444209|NCT00006291|Lymphocyte Transformation|lymphocyte transformation
444210|NCT00006291|AIDS Vaccines|aids vaccines
444211|NCT00006291|Anti-HIV Agents|anti-hiv agents
444212|NCT00006291|Viral Load|viral load
444213|NCT00006291|Aldesleukin|aldesleukin
444214|NCT00006291|HIV Therapeutic Vaccine|hiv therapeutic vaccine
444215|NCT00006292|Biologic Therapy|biologic therapy
444216|NCT00006292|Bone Erosion|bone erosion
444217|NCT00006292|CT|ct
444218|NCT00006292|MRI|mri
444219|NCT00006292|Rheumatoid Arthritis|rheumatoid arthritis
444220|NCT00006292|RA|ra
444221|NCT00006298|HIV Antibodies|hiv antibodies
444222|NCT00006298|HIV-1|hiv-1
444223|NCT00006298|CD4 Lymphocyte Count|cd4 lymphocyte count
444224|NCT00006298|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
444225|NCT00006298|Genotype|genotype
444226|NCT00006298|Species Specificity|species specificity
444227|NCT00006298|Neutralization Tests|neutralization tests
444228|NCT00006298|Viral Load|viral load
444229|NCT00006298|Alleles|alleles
444230|NCT00006298|HLA Antigens|hla antigens
444231|NCT00006298|Cross Reactions|cross reactions
444232|NCT00006298|Immunodominant Epitopes|immunodominant epitopes
444233|NCT00006298|Haplotypes|haplotypes
444234|NCT00006299|Celecoxib|celecoxib
444235|NCT00006299|Thromboxane B2|thromboxane b2
565312|NCT00448396|Cancer|cancer
444236|NCT00006299|Prostaglandin E2|prostaglandin e2
444237|NCT00006299|Microdialysis|microdialysis
444238|NCT00006299|Ibuprofen|ibuprofen
444239|NCT00006300|Immunosuppression|immunosuppression
444240|NCT00006300|Treatment Recommendations|treatment recommendations
444241|NCT00006300|Pancytopenia|pancytopenia
444242|NCT00006300|Schizophrenia|schizophrenia
444243|NCT00006300|Inpatient Population|inpatient population
444244|NCT00006301|Hepatitis C|hepatitis c
444245|NCT00006301|Viral Sequence|viral sequence
444248|NCT00006301|Seroconversion|seroconversion
444249|NCT00006301|Cytokines|cytokines
444250|NCT00006304|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
444251|NCT00006304|AIDS-Related Complex|aids-related complex
444252|NCT00006316|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
444253|NCT00006316|Histoplasmosis|histoplasmosis
444254|NCT00006316|Antifungal Agents|antifungal agents
444255|NCT00006316|Recurrence|recurrence
444256|NCT00006316|Anti-HIV Agents|anti-hiv agents
444257|NCT00006318|Cerebral Blood Flow|cerebral blood flow
444258|NCT00006318|CO2 Inhalation|co2 inhalation
444259|NCT00006318|Imaging|imaging
444261|NCT00006318|Perfusion|perfusion
444262|NCT00006318|Functional Activation|functional activation
444263|NCT00006319|X-Linked Agammagloblinemia|x-linked agammagloblinemia
444264|NCT00006319|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
444265|NCT00006319|Jak-3 SCID|jak-3 scid
444266|NCT00006319|X-Linked SCID|x-linked scid
444267|NCT00006319|X-Linked Hyper-IgM Syndrome|x-linked hyper-igm syndrome
444268|NCT00006319|Primary Immunodeficiencies|primary immunodeficiencies
444269|NCT00006319|ADA-SCID|ada-scid
444270|NCT00006319|CVID|cvid
444271|NCT00006320|Reverse Transcriptase Inhibitor|reverse transcriptase inhibitor
444272|NCT00006320|Protease Inhibitor|protease inhibitor
444273|NCT00006324|HIV Seronegativity|hiv seronegativity
444274|NCT00006324|Delayed-Action Preparations|delayed-action preparations
444275|NCT00006324|Risk Factors|risk factors
444276|NCT00006324|Prevalence|prevalence
444277|NCT00006324|Contraceptive Agents, Female|contraceptive agents, female
444278|NCT00006324|Contraceptives, Oral, Combined|contraceptives, oral, combined
444279|NCT00006324|Medroxyprogesterone 17-Acetate|medroxyprogesterone 17-acetate
444280|NCT00006325|Polyethylene Glycols|polyethylene glycols
444281|NCT00006325|Interferon Alfa-2b|interferon alfa-2b
444282|NCT00006325|HIV-1|hiv-1
444283|NCT00006325|Dose-Response Relationship, Drug|dose-response relationship, drug
444284|NCT00006325|Drug Therapy, Combination|drug therapy, combination
444285|NCT00006325|Virus Inhibitors|virus inhibitors
444286|NCT00006325|Anti-HIV Agents|anti-hiv agents
444287|NCT00006325|Pharmacokinetics|pharmacokinetics
444288|NCT00006326|Drug Therapy, Combination|drug therapy, combination
444289|NCT00006326|HIV Protease Inhibitors|hiv protease inhibitors
444290|NCT00006326|Ritonavir|ritonavir
444291|NCT00006326|Indinavir|indinavir
444292|NCT00006326|Delavirdine|delavirdine
444293|NCT00006326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
444294|NCT00006326|Salvage Therapy|salvage therapy
444295|NCT00006326|Anti-HIV Agents|anti-hiv agents
444296|NCT00006326|Viral Load|viral load
444297|NCT00006326|Nelfinavir|nelfinavir
444298|NCT00006327|Recombinant Proteins|recombinant proteins
444299|NCT00006327|HIV-1|hiv-1
444300|NCT00006327|AIDS Serodiagnosis|aids serodiagnosis
444301|NCT00006327|Substance Abuse, Intravenous|substance abuse, intravenous
444302|NCT00006327|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
444303|NCT00006327|Blotting, Western|blotting, western
444304|NCT00006327|HIV Envelope Protein gp120|hiv envelope protein gp120
444305|NCT00006327|AIDSVAX|aidsvax
444306|NCT00006328|Chronic Allograft Nephropathy (CAN)|chronic allograft nephropathy (can)
444307|NCT00006328|Transplantation immunology|transplantation immunology
444308|NCT00006328|Genetics|genetics
444309|NCT00006328|Graft Rejection|graft rejection
444310|NCT00006329|Radionuclide imaging|radionuclide imaging
444311|NCT00006329|Surgery|surgery
444312|NCT00006330|Digoxin|digoxin
444313|NCT00006330|Effect modifiers (Epidemiology)|effect modifiers (epidemiology)
444314|NCT00006330|Rosales|rosales
444315|NCT00006330|Drug Interaction|drug interaction
444316|NCT00006331|Kidney transplantation|kidney transplantation
444317|NCT00006331|Immunology|immunology
444318|NCT00006332|Molybdenum|molybdenum
444319|NCT00006333|Rheumatoid Arthritis|rheumatoid arthritis
444320|NCT00006333|Inflammation|inflammation
444321|NCT00006333|Synovitis|synovitis
444322|NCT00006333|Genetics|genetics
444323|NCT00006333|Synovial Biopsy|synovial biopsy
444324|NCT00006333|Arthritis|arthritis
444325|NCT00006333|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
444326|NCT00006333|JRA|jra
444327|NCT00006334|Genes|genes
444328|NCT00006334|X-Chromosome|x-chromosome
444329|NCT00006334|Osteoporosis|osteoporosis
444330|NCT00006334|Ovarian Failure|ovarian failure
444331|NCT00006334|Imprinting|imprinting
444332|NCT00006334|Turner's|turner's
444333|NCT00006334|Turner|turner
444334|NCT00006334|TS|ts
444335|NCT00006335|Genetic|genetic
444336|NCT00006335|Analysis|analysis
444337|NCT00006335|Immune|immune
444338|NCT00006335|Teenage|teenage
444339|NCT00006335|Girls|girls
444340|NCT00006335|Severe Combined Immune Deficiency (SCID)|severe combined immune deficiency (scid)
444341|NCT00006335|XSCID|xscid
444342|NCT00006335|Carrier Testing|carrier testing
444343|NCT00006335|X-Linked Disease|x-linked disease
444344|NCT00006335|Adolescent|adolescent
444345|NCT00006336|Gap Detection Test|gap detection test
444346|NCT00006336|Fahn-Scale|fahn-scale
444347|NCT00006336|Visual Analog and Verbal Scale|visual analog and verbal scale
444348|NCT00006336|Writing Standard Paragraph|writing standard paragraph
444349|NCT00006336|Braille Reading Grade I|braille reading grade i
444350|NCT00006337|Clinical Trial|clinical trial
444351|NCT00006337|Dyskinesias|dyskinesias
444352|NCT00006337|Levodopa Infusion|levodopa infusion
444353|NCT00006339|Prospective Studies|prospective studies
444354|NCT00006339|HIV-1|hiv-1
444355|NCT00006339|Didanosine|didanosine
444356|NCT00006339|Drug Therapy, Combination|drug therapy, combination
444358|NCT00006339|HIV Protease Inhibitors|hiv protease inhibitors
444359|NCT00006339|Hydroxyurea|hydroxyurea
444360|NCT00006339|Ritonavir|ritonavir
444361|NCT00006339|Indinavir|indinavir
444362|NCT00006339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
444363|NCT00006339|Anti-HIV Agents|anti-hiv agents
444364|NCT00006339|Viral Load|viral load
444365|NCT00006339|Reverse Transcriptase Polymerase Chain Reaction|reverse transcriptase polymerase chain reaction
444366|NCT00006340|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
444367|NCT00006340|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
444368|NCT00006340|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
444369|NCT00006340|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
444370|NCT00006340|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
444371|NCT00006340|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
444372|NCT00006340|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
444373|NCT00006340|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
444374|NCT00006340|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
444375|NCT00006340|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
444376|NCT00006340|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
444377|NCT00006340|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
444378|NCT00006340|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
444379|NCT00006340|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
444380|NCT00006340|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
444381|NCT00006340|small intestine lymphoma|small intestine lymphoma
444382|NCT00006340|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
444383|NCT00006340|grade I lymphomatoid granulomatosis|grade i lymphomatoid granulomatosis
444384|NCT00006340|grade II lymphomatoid granulomatosis|grade ii lymphomatoid granulomatosis
444385|NCT00006340|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
444386|NCT00006340|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
444387|NCT00006340|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
444388|NCT00006340|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
444389|NCT00006340|recurrent grade I lymphomatoid granulomatosis|recurrent grade i lymphomatoid granulomatosis
444390|NCT00006340|recurrent grade II lymphomatoid granulomatosis|recurrent grade ii lymphomatoid granulomatosis
444391|NCT00006340|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
444392|NCT00006340|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
444393|NCT00006340|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
444394|NCT00006340|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
444395|NCT00006340|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
444396|NCT00006340|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
444397|NCT00006340|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
444398|NCT00006340|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
444399|NCT00006340|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
444400|NCT00006340|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
444401|NCT00006340|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
444402|NCT00006340|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
444403|NCT00006340|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
444404|NCT00006340|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
444405|NCT00006340|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
444406|NCT00006340|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
444407|NCT00006340|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
444408|NCT00006340|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
444409|NCT00006340|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
444410|NCT00006340|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
444411|NCT00006340|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
444412|NCT00006340|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
444413|NCT00006340|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
444414|NCT00006340|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
444415|NCT00006340|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
444416|NCT00006340|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
444417|NCT00006340|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
444418|NCT00006340|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
444419|NCT00006340|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
444420|NCT00006340|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
444421|NCT00006340|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
444422|NCT00006340|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
444423|NCT00006340|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
444424|NCT00006340|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
444425|NCT00006340|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
444426|NCT00006340|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
444427|NCT00006340|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
444428|NCT00006340|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
444429|NCT00006340|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
444430|NCT00006340|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
444431|NCT00006340|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
444432|NCT00006340|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
444433|NCT00006340|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
444434|NCT00006340|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
444435|NCT00006340|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
444436|NCT00006340|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
444437|NCT00006340|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
444438|NCT00006340|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
444439|NCT00006340|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
444440|NCT00006340|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
444441|NCT00006340|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
444442|NCT00006340|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
444443|NCT00006340|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
444444|NCT00006340|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
444445|NCT00006340|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
444446|NCT00006340|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
444447|NCT00006340|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
445038|NCT00006387|recurrent rectal cancer|recurrent rectal cancer
444448|NCT00006340|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
444449|NCT00006340|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
444450|NCT00006340|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
444451|NCT00006340|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
444452|NCT00006340|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
444453|NCT00006340|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
444454|NCT00006340|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
444455|NCT00006340|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
444456|NCT00006340|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
444457|NCT00006340|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
444458|NCT00006340|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
444459|NCT00006340|stage I mantle cell lymphoma|stage i mantle cell lymphoma
444460|NCT00006340|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
444461|NCT00006340|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
444462|NCT00006340|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
444463|NCT00006340|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
444464|NCT00006340|anaplastic large cell lymphoma|anaplastic large cell lymphoma
444465|NCT00006340|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
444466|NCT00006340|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
444467|NCT00006340|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
444468|NCT00006340|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
444469|NCT00006340|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
444470|NCT00006340|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
583565|NCT00512226|Sickle Cell Thalassemia|sickle cell thalassemia
444471|NCT00006340|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
444472|NCT00006340|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
444473|NCT00006340|stage I marginal zone lymphoma|stage i marginal zone lymphoma
444474|NCT00006340|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
444475|NCT00006340|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
444476|NCT00006340|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
444477|NCT00006340|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
444478|NCT00006340|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
444479|NCT00006340|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
444480|NCT00006340|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
444481|NCT00006340|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
444482|NCT00006340|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
444483|NCT00006340|splenic marginal zone lymphoma|splenic marginal zone lymphoma
444484|NCT00006341|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
444485|NCT00006341|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
444486|NCT00006341|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
444487|NCT00006342|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
444488|NCT00006342|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
444489|NCT00006342|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
444490|NCT00006342|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
444491|NCT00006342|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
444492|NCT00006342|childhood infratentorial ependymoma|childhood infratentorial ependymoma
444493|NCT00006342|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
444494|NCT00006342|childhood supratentorial ependymoma|childhood supratentorial ependymoma
444495|NCT00006342|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
444496|NCT00006342|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
444497|NCT00006342|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
444498|NCT00006342|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
444499|NCT00006342|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
444500|NCT00006342|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
444501|NCT00006342|untreated childhood brain stem glioma|untreated childhood brain stem glioma
444502|NCT00006342|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
444503|NCT00006342|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
444504|NCT00006342|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
444505|NCT00006342|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
444506|NCT00006342|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
444507|NCT00006342|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
444508|NCT00006342|untreated childhood medulloblastoma|untreated childhood medulloblastoma
444509|NCT00006342|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
444510|NCT00006342|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
444511|NCT00006342|recurrent childhood ependymoma|recurrent childhood ependymoma
445039|NCT00006387|adenocarcinoma of the colon|adenocarcinoma of the colon
444512|NCT00006343|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
444513|NCT00006343|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
444514|NCT00006344|limited stage small cell lung cancer|limited stage small cell lung cancer
444515|NCT00006344|extensive stage small cell lung cancer|extensive stage small cell lung cancer
444516|NCT00006345|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
444517|NCT00006345|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
444518|NCT00006345|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
444519|NCT00006346|stage II breast cancer|stage ii breast cancer
444520|NCT00006346|stage IV breast cancer|stage iv breast cancer
444521|NCT00006346|stage IIIA breast cancer|stage iiia breast cancer
444522|NCT00006346|stage IIIB breast cancer|stage iiib breast cancer
444523|NCT00006346|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
444524|NCT00006347|recurrent small cell lung cancer|recurrent small cell lung cancer
444525|NCT00006348|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
444526|NCT00006348|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
444527|NCT00006348|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
444528|NCT00006348|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
444529|NCT00006348|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
444530|NCT00006348|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
444531|NCT00006348|isolated plasmacytoma of bone|isolated plasmacytoma of bone
444532|NCT00006348|extramedullary plasmacytoma|extramedullary plasmacytoma
444533|NCT00006348|refractory multiple myeloma|refractory multiple myeloma
444534|NCT00006348|Waldenström macroglobulinemia|waldenström macroglobulinemia
444535|NCT00006348|stage III multiple myeloma|stage iii multiple myeloma
444536|NCT00006348|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
444537|NCT00006348|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
444538|NCT00006348|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
444539|NCT00006348|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
444540|NCT00006348|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
444541|NCT00006348|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
444542|NCT00006348|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
444543|NCT00006348|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
444544|NCT00006348|small intestine lymphoma|small intestine lymphoma
444545|NCT00006348|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
444546|NCT00006348|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
444547|NCT00006348|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
10489|NCT03223909|Ocular lubricants|ocular lubricants
444548|NCT00006348|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
444549|NCT00006348|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
444550|NCT00006348|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
444551|NCT00006348|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
444552|NCT00006348|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
444553|NCT00006348|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
444554|NCT00006348|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
444555|NCT00006348|polycythemia vera|polycythemia vera
444556|NCT00006348|primary myelofibrosis|primary myelofibrosis
444557|NCT00006348|essential thrombocythemia|essential thrombocythemia
444558|NCT00006348|untreated hairy cell leukemia|untreated hairy cell leukemia
444559|NCT00006348|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
444560|NCT00006348|refractory hairy cell leukemia|refractory hairy cell leukemia
444561|NCT00006348|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
444562|NCT00006348|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
444563|NCT00006348|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
444564|NCT00006348|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
444565|NCT00006348|acute undifferentiated leukemia|acute undifferentiated leukemia
444566|NCT00006348|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
444567|NCT00006348|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
444568|NCT00006348|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
444569|NCT00006348|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
444570|NCT00006348|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
444571|NCT00006348|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
444572|NCT00006348|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
753006|NCT01175083|Immunogenicity|immunogenicity
444573|NCT00006348|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
444574|NCT00006348|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
444575|NCT00006348|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
444576|NCT00006348|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
444577|NCT00006348|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
444578|NCT00006348|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
444579|NCT00006348|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
444580|NCT00006348|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
445768|NCT00005615|recurrent melanoma|recurrent melanoma
444581|NCT00006348|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
444582|NCT00006348|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
444583|NCT00006348|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
444584|NCT00006348|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
444585|NCT00006348|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
444586|NCT00006348|secondary acute myeloid leukemia|secondary acute myeloid leukemia
444587|NCT00006348|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
444588|NCT00006348|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
444589|NCT00006348|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
444590|NCT00006348|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
444591|NCT00006348|nausea and vomiting|nausea and vomiting
444592|NCT00006348|prolymphocytic leukemia|prolymphocytic leukemia
444593|NCT00006348|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
444594|NCT00006348|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
444595|NCT00006348|primary systemic amyloidosis|primary systemic amyloidosis
444596|NCT00006348|intraocular lymphoma|intraocular lymphoma
444597|NCT00006348|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
444598|NCT00006348|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
444599|NCT00006348|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
444600|NCT00006348|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
444601|NCT00006348|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
444602|NCT00006348|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
444603|NCT00006348|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
444604|NCT00006348|anaplastic large cell lymphoma|anaplastic large cell lymphoma
444605|NCT00006348|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
444606|NCT00006348|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
444607|NCT00006348|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
444608|NCT00006348|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
444609|NCT00006348|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
444610|NCT00006348|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
444611|NCT00006348|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
469535|NCT00067821|Children|children
444612|NCT00006348|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
444613|NCT00006348|splenic marginal zone lymphoma|splenic marginal zone lymphoma
444614|NCT00006348|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
444615|NCT00006349|depression|depression
444616|NCT00006349|delirium|delirium
444617|NCT00006349|cognitive/functional effects|cognitive/functional effects
444618|NCT00006349|radiation toxicity|radiation toxicity
444619|NCT00006349|limited stage small cell lung cancer|limited stage small cell lung cancer
444620|NCT00006349|extensive stage small cell lung cancer|extensive stage small cell lung cancer
444621|NCT00006349|recurrent small cell lung cancer|recurrent small cell lung cancer
444622|NCT00006350|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
444623|NCT00006350|refractory multiple myeloma|refractory multiple myeloma
444624|NCT00006350|stage I multiple myeloma|stage i multiple myeloma
444625|NCT00006350|stage II multiple myeloma|stage ii multiple myeloma
444626|NCT00006350|stage III multiple myeloma|stage iii multiple myeloma
444627|NCT00006350|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
444628|NCT00006350|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
444629|NCT00006350|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
444630|NCT00006350|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
444631|NCT00006350|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
444632|NCT00006350|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
444633|NCT00006350|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
444634|NCT00006350|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
444635|NCT00006350|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
444636|NCT00006350|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
753007|NCT01175083|Pneumococcal disease|pneumococcal disease
444143|NCT00006272|heart defects|heart defects
444637|NCT00006350|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
444638|NCT00006350|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
444639|NCT00006350|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
444640|NCT00006350|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
444641|NCT00006350|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
444642|NCT00006350|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
444643|NCT00006350|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
444644|NCT00006350|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
444645|NCT00006350|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
444646|NCT00006350|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
444647|NCT00006350|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
444648|NCT00006350|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
444649|NCT00006350|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
444650|NCT00006350|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
444651|NCT00006350|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
444652|NCT00006350|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
444653|NCT00006350|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
444654|NCT00006350|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
444655|NCT00006350|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
444656|NCT00006350|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
444657|NCT00006350|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
444658|NCT00006350|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
444659|NCT00006350|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
583566|NCT00512226|Iron Overload|iron overload
444660|NCT00006350|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
444661|NCT00006350|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
444662|NCT00006350|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
444663|NCT00006350|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
444664|NCT00006350|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
444665|NCT00006350|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
444666|NCT00006350|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
444667|NCT00006350|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
444668|NCT00006350|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
444669|NCT00006350|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
444670|NCT00006350|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
444671|NCT00006350|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
444672|NCT00006350|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
444673|NCT00006350|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
444674|NCT00006350|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
444675|NCT00006350|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
444745|NCT00006359|stage II prostate cancer|stage ii prostate cancer
444676|NCT00006350|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
444677|NCT00006350|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
444678|NCT00006350|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
444679|NCT00006350|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
444680|NCT00006350|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
444681|NCT00006350|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
444682|NCT00006350|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
444683|NCT00006350|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
444684|NCT00006350|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
444685|NCT00006350|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
444686|NCT00006350|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
444687|NCT00006350|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
444688|NCT00006350|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
444689|NCT00006350|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
444690|NCT00006350|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
444691|NCT00006350|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
444692|NCT00006350|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
444693|NCT00006350|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
444694|NCT00006350|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
444695|NCT00006350|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
444696|NCT00006350|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
444697|NCT00006350|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
444698|NCT00006350|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
444699|NCT00006350|splenic marginal zone lymphoma|splenic marginal zone lymphoma
444700|NCT00006351|recurrent bladder cancer|recurrent bladder cancer
444701|NCT00006351|stage IV bladder cancer|stage iv bladder cancer
444702|NCT00006351|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
444703|NCT00006351|recurrent urethral cancer|recurrent urethral cancer
444704|NCT00006351|anterior urethral cancer|anterior urethral cancer
444705|NCT00006351|posterior urethral cancer|posterior urethral cancer
444706|NCT00006351|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
444707|NCT00006351|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
444708|NCT00006351|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
444709|NCT00006352|limited stage small cell lung cancer|limited stage small cell lung cancer
444710|NCT00006353|adult glioblastoma|adult glioblastoma
444711|NCT00006353|adult giant cell glioblastoma|adult giant cell glioblastoma
444712|NCT00006353|adult gliosarcoma|adult gliosarcoma
444713|NCT00006354|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
444714|NCT00006355|adult glioblastoma|adult glioblastoma
444715|NCT00006355|adult giant cell glioblastoma|adult giant cell glioblastoma
444716|NCT00006355|adult gliosarcoma|adult gliosarcoma
444717|NCT00006356|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
444718|NCT00006357|adult angiosarcoma|adult angiosarcoma
583567|NCT00512226|MRI|mri
444720|NCT00006357|adult leiomyosarcoma|adult leiomyosarcoma
444721|NCT00006357|adult liposarcoma|adult liposarcoma
444722|NCT00006357|adult neurofibrosarcoma|adult neurofibrosarcoma
444723|NCT00006357|adult synovial sarcoma|adult synovial sarcoma
444724|NCT00006357|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
444725|NCT00006357|small intestine leiomyosarcoma|small intestine leiomyosarcoma
444726|NCT00006357|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
444727|NCT00006357|adult epithelioid sarcoma|adult epithelioid sarcoma
444728|NCT00006357|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
444729|NCT00006357|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
444730|NCT00006357|adult malignant mesenchymoma|adult malignant mesenchymoma
444731|NCT00006357|adult rhabdomyosarcoma|adult rhabdomyosarcoma
444732|NCT00006357|ovarian stromal cancer|ovarian stromal cancer
444733|NCT00006357|recurrent uterine sarcoma|recurrent uterine sarcoma
444734|NCT00006357|uterine carcinosarcoma|uterine carcinosarcoma
444735|NCT00006357|uterine leiomyosarcoma|uterine leiomyosarcoma
444736|NCT00006357|endometrial stromal sarcoma|endometrial stromal sarcoma
444737|NCT00006357|ovarian sarcoma|ovarian sarcoma
444738|NCT00006357|gastrointestinal stromal tumor|gastrointestinal stromal tumor
444739|NCT00006358|recurrent adult brain tumor|recurrent adult brain tumor
444740|NCT00006358|adult glioblastoma|adult glioblastoma
444741|NCT00006358|adult giant cell glioblastoma|adult giant cell glioblastoma
444742|NCT00006358|adult gliosarcoma|adult gliosarcoma
444743|NCT00006359|adenocarcinoma of the prostate|adenocarcinoma of the prostate
444744|NCT00006359|stage I prostate cancer|stage i prostate cancer
469536|NCT00067821|Metabolic|metabolic
444746|NCT00006359|stage III prostate cancer|stage iii prostate cancer
444747|NCT00006360|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
444748|NCT00006360|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
444749|NCT00006360|radiation toxicity|radiation toxicity
444750|NCT00006361|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
444751|NCT00006361|recurrent skin cancer|recurrent skin cancer
444752|NCT00006361|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
444753|NCT00006361|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
444754|NCT00006361|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
444755|NCT00006361|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
444756|NCT00006361|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
444757|NCT00006361|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
444758|NCT00006361|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
444759|NCT00006361|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
444760|NCT00006361|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
444761|NCT00006361|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
444176|NCT00006285|fMRI|fmri
444762|NCT00006361|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
444763|NCT00006361|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
444764|NCT00006361|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
444765|NCT00006361|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
444766|NCT00006361|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
444767|NCT00006361|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
444768|NCT00006361|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
444769|NCT00006362|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
444770|NCT00006362|isolated plasmacytoma of bone|isolated plasmacytoma of bone
444771|NCT00006362|extramedullary plasmacytoma|extramedullary plasmacytoma
444772|NCT00006362|refractory multiple myeloma|refractory multiple myeloma
444773|NCT00006362|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
444774|NCT00006362|stage III multiple myeloma|stage iii multiple myeloma
444775|NCT00006362|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
444776|NCT00006362|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
444777|NCT00006362|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
444778|NCT00006362|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
444779|NCT00006362|untreated hairy cell leukemia|untreated hairy cell leukemia
444780|NCT00006362|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
444781|NCT00006362|refractory hairy cell leukemia|refractory hairy cell leukemia
444782|NCT00006362|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
444783|NCT00006362|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
444784|NCT00006362|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
444785|NCT00006362|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
444786|NCT00006362|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
444787|NCT00006362|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
444788|NCT00006362|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
444789|NCT00006362|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
444790|NCT00006362|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
444791|NCT00006362|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
444792|NCT00006362|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
444793|NCT00006362|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
444794|NCT00006362|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
444795|NCT00006362|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
444796|NCT00006362|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
444797|NCT00006362|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
444798|NCT00006362|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
444799|NCT00006362|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
444800|NCT00006362|primary systemic amyloidosis|primary systemic amyloidosis
444801|NCT00006362|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
444802|NCT00006362|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
444803|NCT00006362|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
444804|NCT00006362|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
444805|NCT00006362|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
444806|NCT00006362|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
10490|NCT03223896|antagonist|antagonist
444881|NCT00006368|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
444807|NCT00006362|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
444808|NCT00006362|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
444809|NCT00006362|splenic marginal zone lymphoma|splenic marginal zone lymphoma
444810|NCT00006365|adenocarcinoma of the prostate|adenocarcinoma of the prostate
444811|NCT00006365|stage I prostate cancer|stage i prostate cancer
444812|NCT00006365|stage IIB prostate cancer|stage iib prostate cancer
444813|NCT00006365|stage IIA prostate cancer|stage iia prostate cancer
444814|NCT00006366|stage II rectal cancer|stage ii rectal cancer
444815|NCT00006366|stage III rectal cancer|stage iii rectal cancer
444816|NCT00006366|adenocarcinoma of the rectum|adenocarcinoma of the rectum
444817|NCT00006367|polycythemia vera|polycythemia vera
444818|NCT00006367|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
444819|NCT00006367|essential thrombocythemia|essential thrombocythemia
444820|NCT00006368|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
444821|NCT00006368|stage IV breast cancer|stage iv breast cancer
444822|NCT00006368|recurrent breast cancer|recurrent breast cancer
444823|NCT00006368|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
444824|NCT00006368|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
201018|NCT02112617|Neuroblastoma|neuroblastoma
444825|NCT00006368|extensive stage small cell lung cancer|extensive stage small cell lung cancer
444826|NCT00006368|recurrent small cell lung cancer|recurrent small cell lung cancer
444827|NCT00006368|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
444828|NCT00006368|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
444829|NCT00006368|gastrinoma|gastrinoma
444830|NCT00006368|recurrent adult brain tumor|recurrent adult brain tumor
444831|NCT00006368|insulinoma|insulinoma
444832|NCT00006368|recurrent islet cell carcinoma|recurrent islet cell carcinoma
444833|NCT00006368|ACTH-producing pituitary tumor|acth-producing pituitary tumor
444834|NCT00006368|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
445341|NCT00005057|stage IV melanoma|stage iv melanoma
444835|NCT00006368|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
444836|NCT00006368|recurrent pituitary tumor|recurrent pituitary tumor
444837|NCT00006368|TSH producing pituitary tumor|tsh producing pituitary tumor
444838|NCT00006368|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
444839|NCT00006368|adult brain stem glioma|adult brain stem glioma
444840|NCT00006368|adult craniopharyngioma|adult craniopharyngioma
444841|NCT00006368|adult medulloblastoma|adult medulloblastoma
444842|NCT00006368|adult meningioma|adult meningioma
444843|NCT00006368|adult glioblastoma|adult glioblastoma
444844|NCT00006368|stage IV melanoma|stage iv melanoma
444845|NCT00006368|recurrent melanoma|recurrent melanoma
444846|NCT00006368|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
444847|NCT00006368|WDHA syndrome|wdha syndrome
444848|NCT00006368|somatostatinoma|somatostatinoma
444849|NCT00006368|pancreatic polypeptide tumor|pancreatic polypeptide tumor
444850|NCT00006368|glucagonoma|glucagonoma
444851|NCT00006368|pulmonary carcinoid tumor|pulmonary carcinoid tumor
444852|NCT00006368|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
444853|NCT00006368|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
444854|NCT00006368|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
583568|NCT00512239|Early Rheumatoid Arthritis|early rheumatoid arthritis
444855|NCT00006368|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
444856|NCT00006368|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
444857|NCT00006368|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
444858|NCT00006368|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
444859|NCT00006368|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
444860|NCT00006368|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
444861|NCT00006368|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
444862|NCT00006368|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
444863|NCT00006368|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
444864|NCT00006368|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
444865|NCT00006368|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
444866|NCT00006368|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
444867|NCT00006368|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
444868|NCT00006368|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
444869|NCT00006368|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
444870|NCT00006368|adult anaplastic astrocytoma|adult anaplastic astrocytoma
444871|NCT00006368|adult myxopapillary ependymoma|adult myxopapillary ependymoma
444872|NCT00006368|adult anaplastic ependymoma|adult anaplastic ependymoma
444873|NCT00006368|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
444874|NCT00006368|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
444875|NCT00006368|adult pilocytic astrocytoma|adult pilocytic astrocytoma
444876|NCT00006368|adult subependymoma|adult subependymoma
444877|NCT00006368|adult ependymoblastoma|adult ependymoblastoma
444878|NCT00006368|adult pineocytoma|adult pineocytoma
444879|NCT00006368|adult pineoblastoma|adult pineoblastoma
444880|NCT00006368|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
446144|NCT00005660|Psoriasis|psoriasis
444882|NCT00006368|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
444883|NCT00006368|adult choroid plexus tumor|adult choroid plexus tumor
444884|NCT00006368|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
444885|NCT00006368|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
444886|NCT00006368|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
444887|NCT00006368|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
444888|NCT00006368|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
444889|NCT00006368|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
444890|NCT00006368|splenic marginal zone lymphoma|splenic marginal zone lymphoma
444891|NCT00006368|adult grade III meningioma|adult grade iii meningioma
444892|NCT00006368|adult giant cell glioblastoma|adult giant cell glioblastoma
444893|NCT00006368|adult gliosarcoma|adult gliosarcoma
444894|NCT00006369|stage IV breast cancer|stage iv breast cancer
444895|NCT00006369|recurrent breast cancer|recurrent breast cancer
444896|NCT00006370|stage IV breast cancer|stage iv breast cancer
444897|NCT00006370|recurrent breast cancer|recurrent breast cancer
444898|NCT00006370|recurrent small cell lung cancer|recurrent small cell lung cancer
444899|NCT00006370|male breast cancer|male breast cancer
444900|NCT00006371|adenocarcinoma of the prostate|adenocarcinoma of the prostate
444901|NCT00006371|stage IV prostate cancer|stage iv prostate cancer
444902|NCT00006371|recurrent prostate cancer|recurrent prostate cancer
444903|NCT00006372|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
444904|NCT00006373|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
444905|NCT00006373|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
444906|NCT00006373|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
444907|NCT00006373|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
444908|NCT00006373|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
444909|NCT00006373|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
444910|NCT00006373|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
444911|NCT00006373|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
444912|NCT00006373|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
444913|NCT00006373|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
444914|NCT00006373|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
444915|NCT00006373|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
444916|NCT00006373|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
444917|NCT00006373|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
444918|NCT00006373|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
444919|NCT00006373|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
444920|NCT00006373|splenic marginal zone lymphoma|splenic marginal zone lymphoma
444921|NCT00006374|extensive stage small cell lung cancer|extensive stage small cell lung cancer
585101|NCT00518518|Sublingual immunotherapy|sublingual immunotherapy
444922|NCT00006374|recurrent small cell lung cancer|recurrent small cell lung cancer
444923|NCT00006375|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
444924|NCT00006376|stage II bladder cancer|stage ii bladder cancer
444925|NCT00006376|stage III bladder cancer|stage iii bladder cancer
444926|NCT00006376|recurrent bladder cancer|recurrent bladder cancer
444927|NCT00006376|stage IV bladder cancer|stage iv bladder cancer
444928|NCT00006376|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
444929|NCT00006376|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
444930|NCT00006376|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
444931|NCT00006376|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
444932|NCT00006377|stage III endometrial carcinoma|stage iii endometrial carcinoma
444933|NCT00006377|stage IV endometrial carcinoma|stage iv endometrial carcinoma
444934|NCT00006377|recurrent endometrial carcinoma|recurrent endometrial carcinoma
444935|NCT00006378|squamous cell lung cancer|squamous cell lung cancer
444936|NCT00006378|large cell lung cancer|large cell lung cancer
444937|NCT00006378|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
444938|NCT00006378|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
444939|NCT00006378|adenocarcinoma of the lung|adenocarcinoma of the lung
444940|NCT00006378|adenosquamous cell lung cancer|adenosquamous cell lung cancer
444941|NCT00006378|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
444942|NCT00006379|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
444943|NCT00006379|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
444944|NCT00006379|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
444945|NCT00006379|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
444946|NCT00006379|isolated plasmacytoma of bone|isolated plasmacytoma of bone
444947|NCT00006379|extramedullary plasmacytoma|extramedullary plasmacytoma
444948|NCT00006379|refractory multiple myeloma|refractory multiple myeloma
444949|NCT00006379|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
444950|NCT00006379|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
444951|NCT00006379|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
444952|NCT00006379|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
444953|NCT00006379|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
444954|NCT00006379|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
444955|NCT00006379|small intestine lymphoma|small intestine lymphoma
444956|NCT00006379|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
444957|NCT00006379|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
444958|NCT00006379|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
444959|NCT00006379|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
753008|NCT01175096|neuroendocrine tumors|neuroendocrine tumors
444960|NCT00006379|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
444961|NCT00006379|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
444962|NCT00006379|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
444963|NCT00006379|polycythemia vera|polycythemia vera
444964|NCT00006379|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
444965|NCT00006379|essential thrombocythemia|essential thrombocythemia
444966|NCT00006379|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
444967|NCT00006379|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
444968|NCT00006379|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
444969|NCT00006379|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
444970|NCT00006379|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
445342|NCT00005057|recurrent melanoma|recurrent melanoma
444971|NCT00006379|refractory anemia with excess blasts|refractory anemia with excess blasts
444972|NCT00006379|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
444973|NCT00006379|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
444974|NCT00006379|acute undifferentiated leukemia|acute undifferentiated leukemia
444975|NCT00006379|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
444976|NCT00006379|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
444977|NCT00006379|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
444978|NCT00006379|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
444979|NCT00006379|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
444980|NCT00006379|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
444981|NCT00006379|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
444982|NCT00006379|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
444983|NCT00006379|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
444984|NCT00006379|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
566673|NCT00453102|MZL|mzl
444985|NCT00006379|secondary acute myeloid leukemia|secondary acute myeloid leukemia
444986|NCT00006379|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
444987|NCT00006379|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
444988|NCT00006379|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
444989|NCT00006379|prolymphocytic leukemia|prolymphocytic leukemia
444990|NCT00006379|primary systemic amyloidosis|primary systemic amyloidosis
444991|NCT00006379|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
444992|NCT00006379|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
444993|NCT00006379|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
444994|NCT00006379|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
444995|NCT00006379|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
444996|NCT00006379|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
444997|NCT00006379|anaplastic large cell lymphoma|anaplastic large cell lymphoma
444998|NCT00006379|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
444999|NCT00006379|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
445000|NCT00006379|chronic eosinophilic leukemia|chronic eosinophilic leukemia
445001|NCT00006379|chronic neutrophilic leukemia|chronic neutrophilic leukemia
445002|NCT00006379|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
445003|NCT00006379|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
445004|NCT00006379|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
445005|NCT00006379|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
445006|NCT00006379|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
445007|NCT00006379|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
445008|NCT00006379|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
445009|NCT00006379|splenic marginal zone lymphoma|splenic marginal zone lymphoma
445010|NCT00006379|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
445011|NCT00006379|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
445012|NCT00006379|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
445013|NCT00006379|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
445014|NCT00006379|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
445015|NCT00006379|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
445016|NCT00006380|stage III prostate cancer|stage iii prostate cancer
445017|NCT00006380|stage IV prostate cancer|stage iv prostate cancer
445018|NCT00006380|recurrent prostate cancer|recurrent prostate cancer
445019|NCT00006381|stage IV breast cancer|stage iv breast cancer
445020|NCT00006381|recurrent breast cancer|recurrent breast cancer
445021|NCT00006382|non-small cell lung cancer|non-small cell lung cancer
445022|NCT00006382|small cell lung cancer|small cell lung cancer
445023|NCT00006383|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
445024|NCT00006383|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
445025|NCT00006383|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
445026|NCT00006383|anaplastic large cell lymphoma|anaplastic large cell lymphoma
445027|NCT00006384|stage IV renal cell cancer|stage iv renal cell cancer
445028|NCT00006384|recurrent renal cell cancer|recurrent renal cell cancer
445029|NCT00006385|stage IV melanoma|stage iv melanoma
445030|NCT00006385|recurrent melanoma|recurrent melanoma
445031|NCT00006386|adult glioblastoma|adult glioblastoma
445032|NCT00006386|adult giant cell glioblastoma|adult giant cell glioblastoma
445033|NCT00006386|adult gliosarcoma|adult gliosarcoma
445034|NCT00006387|stage IV colon cancer|stage iv colon cancer
445035|NCT00006387|recurrent pancreatic cancer|recurrent pancreatic cancer
445036|NCT00006387|stage IV rectal cancer|stage iv rectal cancer
445037|NCT00006387|recurrent colon cancer|recurrent colon cancer
445040|NCT00006387|adenocarcinoma of the rectum|adenocarcinoma of the rectum
445041|NCT00006387|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
445042|NCT00006387|stage IV pancreatic cancer|stage iv pancreatic cancer
445043|NCT00006388|adult glioblastoma|adult glioblastoma
445044|NCT00006388|adult giant cell glioblastoma|adult giant cell glioblastoma
445045|NCT00006388|adult gliosarcoma|adult gliosarcoma
445046|NCT00006390|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
445047|NCT00006390|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
445048|NCT00006390|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
445049|NCT00006390|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
445050|NCT00006390|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
445051|NCT00006391|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
445052|NCT00006391|fallopian tube cancer|fallopian tube cancer
445053|NCT00006391|peritoneal cavity cancer|peritoneal cavity cancer
445054|NCT00006392|prostate cancer|prostate cancer
445055|NCT00006393|arthritis & connective tissue diseases|arthritis & connective tissue diseases
445056|NCT00006393|rare disease|rare disease
445057|NCT00006393|systemic sclerosis|systemic sclerosis
445058|NCT00006394|disease-related problem/condition|disease-related problem/condition
445059|NCT00006394|endocrine disorders|endocrine disorders
445060|NCT00006394|growth hormone deficiency|growth hormone deficiency
445061|NCT00006394|osteoporosis|osteoporosis
445062|NCT00006394|quality of life|quality of life
445063|NCT00006394|rare disease|rare disease
445064|NCT00006395|Antiepileptic|antiepileptic
445065|NCT00006395|CYP3A4|cyp3a4
445066|NCT00006395|Herbal|herbal
445067|NCT00006395|Induction|induction
445069|NCT00006396|Pregnancy Complications, Infectious|pregnancy complications, infectious
445070|NCT00006396|HIV-1|hiv-1
445071|NCT00006396|Administration, Oral|administration, oral
445072|NCT00006396|Zidovudine|zidovudine
445073|NCT00006396|Nevirapine|nevirapine
445074|NCT00006396|RNA, Viral|rna, viral
445075|NCT00006396|Disease Transmission, Vertical|disease transmission, vertical
445076|NCT00006396|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
445077|NCT00006396|Blotting, Western|blotting, western
445078|NCT00006396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
445079|NCT00006396|Anti-HIV Agents|anti-hiv agents
445080|NCT00006396|Viral Load|viral load
445081|NCT00006396|HIV Seronegativity|hiv seronegativity
445082|NCT00006397|Didanosine|didanosine
445083|NCT00006397|Drug Therapy, Combination|drug therapy, combination
445084|NCT00006397|Stavudine|stavudine
445085|NCT00006397|HIV Protease Inhibitors|hiv protease inhibitors
445086|NCT00006397|Sex Factors|sex factors
445087|NCT00006397|Ritonavir|ritonavir
445088|NCT00006397|Indinavir|indinavir
445089|NCT00006397|Dosage Forms|dosage forms
445090|NCT00006397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
445091|NCT00006397|Anti-HIV Agents|anti-hiv agents
445092|NCT00006398|cirrhosis|cirrhosis
445093|NCT00006398|esophageal varices|esophageal varices
445094|NCT00006398|variceal hemorrhage|variceal hemorrhage
445095|NCT00006398|beta-adrenergic blocker|beta-adrenergic blocker
445096|NCT00006399|Alzheimer disease|alzheimer disease
445097|NCT00006399|Estrogen therapy|estrogen therapy
445098|NCT00006399|Post-menopausal women|post-menopausal women
445099|NCT00006400|Blood Diseases|blood diseases
469875|NCT00069082|EC|ec
445100|NCT00006400|Sickle Cell Anemia|sickle cell anemia
445101|NCT00006411|cornea transplant|cornea transplant
445102|NCT00006411|corneal endothelial cell density|corneal endothelial cell density
445103|NCT00006411|moderate risk corneal diseases requiring corneal transplantation|moderate risk corneal diseases requiring corneal transplantation
445104|NCT00006411|corneal transplantation|corneal transplantation
445105|NCT00006412|Hyperlipidemia|hyperlipidemia
445106|NCT00006412|Procetofen|procetofen
445107|NCT00006412|Pravastatin|pravastatin
445108|NCT00006412|Antilipemic Agents|antilipemic agents
445109|NCT00006413|Peripheral Blood Stem Cells|peripheral blood stem cells
445110|NCT00006413|Non-Myeloablative Bone Marrow Transplantation|non-myeloablative bone marrow transplantation
445111|NCT00006413|Engraftment|engraftment
445112|NCT00006413|Graft-versus-host Disease|graft-versus-host disease
445113|NCT00006413|Graft-Versus-Leukemia|graft-versus-leukemia
445114|NCT00006413|Graft-Versus-Mast Cell|graft-versus-mast cell
445115|NCT00006413|Cyclophosphamide|cyclophosphamide
445116|NCT00006413|Fludarabine|fludarabine
445117|NCT00006413|Donor Apheresis|donor apheresis
445118|NCT00006413|Mast Cells|mast cells
445119|NCT00006414|Anesthesia|anesthesia
445120|NCT00006414|Magnetic Stimulation|magnetic stimulation
445121|NCT00006414|Motor|motor
445122|NCT00006414|Neuroplasticity|neuroplasticity
445123|NCT00006414|Practice|practice
445124|NCT00006414|Rehabilitation|rehabilitation
445125|NCT00006414|Stroke|stroke
445126|NCT00005018|HIV-1|hiv-1
445127|NCT00005018|Didanosine|didanosine
445128|NCT00005018|Drug Therapy, Combination|drug therapy, combination
445129|NCT00005018|Zidovudine|zidovudine
445130|NCT00005018|Stavudine|stavudine
445131|NCT00005018|HIV Protease Inhibitors|hiv protease inhibitors
445132|NCT00005018|Hydroxyurea|hydroxyurea
445133|NCT00005018|RNA, Viral|rna, viral
445134|NCT00005018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
445135|NCT00005018|Anti-HIV Agents|anti-hiv agents
445136|NCT00005018|Viral Load|viral load
445137|NCT00005018|abacavir|abacavir
445138|NCT00005018|efavirenz|efavirenz
445139|NCT00005020|CD4 Lymphocyte Count|cd4 lymphocyte count
445140|NCT00005020|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
445141|NCT00005020|Phenotype|phenotype
445142|NCT00005020|Viral Load|viral load
445143|NCT00005020|Acute Infection|acute infection
445144|NCT00005021|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
445145|NCT00005021|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
445146|NCT00005021|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
445147|NCT00005021|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
585102|NCT00518518|Children|children
445148|NCT00005021|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
445149|NCT00005021|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
445150|NCT00005021|small intestine lymphoma|small intestine lymphoma
445151|NCT00005021|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
445152|NCT00005021|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
445153|NCT00005021|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
445154|NCT00005021|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
445155|NCT00005021|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
445156|NCT00005021|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
445157|NCT00005021|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
445158|NCT00005021|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
445159|NCT00005021|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
445160|NCT00005021|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
445161|NCT00005021|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
445162|NCT00005021|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
445163|NCT00005021|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
445164|NCT00005021|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
445165|NCT00005021|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
445166|NCT00005021|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
445167|NCT00005021|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
445168|NCT00005021|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
445169|NCT00005021|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
445170|NCT00005021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
445171|NCT00005021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
445172|NCT00005021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
445173|NCT00005021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
445174|NCT00005021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
445175|NCT00005021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
445176|NCT00005021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
445177|NCT00005021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
445178|NCT00005021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
445179|NCT00005021|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
445180|NCT00005021|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
445181|NCT00005021|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
445182|NCT00005021|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
445183|NCT00005021|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
445184|NCT00005021|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
445186|NCT00005021|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
445187|NCT00005021|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
445188|NCT00005021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
445189|NCT00005021|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
445190|NCT00005021|anaplastic large cell lymphoma|anaplastic large cell lymphoma
445191|NCT00005021|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
445192|NCT00005021|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
445193|NCT00005021|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
445194|NCT00005021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
445195|NCT00005021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
445196|NCT00005021|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
445197|NCT00005021|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
445198|NCT00005021|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
445199|NCT00005021|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
445200|NCT00005021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
445201|NCT00005021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
445202|NCT00005021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
445203|NCT00005022|limited stage small cell lung cancer|limited stage small cell lung cancer
445204|NCT00005023|stage IV breast cancer|stage iv breast cancer
445205|NCT00005023|stage IIIA breast cancer|stage iiia breast cancer
445206|NCT00005023|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
445207|NCT00005023|stage IIIB breast cancer|stage iiib breast cancer
445208|NCT00005023|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
445209|NCT00005023|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
445210|NCT00005023|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
445211|NCT00005023|adenocarcinoma of the lung|adenocarcinoma of the lung
445212|NCT00005024|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
445213|NCT00005025|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
445214|NCT00005025|fallopian tube cancer|fallopian tube cancer
445215|NCT00005025|primary peritoneal cavity cancer|primary peritoneal cavity cancer
445216|NCT00005026|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
445217|NCT00005026|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
445218|NCT00005026|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
445219|NCT00005026|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
445220|NCT00005026|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
445221|NCT00005026|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
445222|NCT00005026|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
445223|NCT00005026|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
445224|NCT00005026|primary peritoneal cavity cancer|primary peritoneal cavity cancer
445225|NCT00005026|Brenner tumor|brenner tumor
445226|NCT00005027|stage III renal cell cancer|stage iii renal cell cancer
445227|NCT00005027|stage IV renal cell cancer|stage iv renal cell cancer
445228|NCT00005027|recurrent renal cell cancer|recurrent renal cell cancer
445229|NCT00005028|adenocarcinoma of the prostate|adenocarcinoma of the prostate
445230|NCT00005028|stage IV prostate cancer|stage iv prostate cancer
445231|NCT00005028|recurrent prostate cancer|recurrent prostate cancer
445232|NCT00005029|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
445233|NCT00005029|primary peritoneal cavity cancer|primary peritoneal cavity cancer
445234|NCT00005030|stage IV colon cancer|stage iv colon cancer
445235|NCT00005030|stage IV rectal cancer|stage iv rectal cancer
445236|NCT00005030|recurrent colon cancer|recurrent colon cancer
445237|NCT00005030|recurrent rectal cancer|recurrent rectal cancer
445238|NCT00005030|liver metastases|liver metastases
445239|NCT00005031|recurrent endometrial carcinoma|recurrent endometrial carcinoma
445240|NCT00005032|recurrent small cell lung cancer|recurrent small cell lung cancer
445241|NCT00005033|recurrent osteosarcoma|recurrent osteosarcoma
445242|NCT00005035|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
445243|NCT00005035|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
445244|NCT00005035|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
445245|NCT00005035|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
445246|NCT00005035|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
445247|NCT00005035|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
445248|NCT00005035|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
445249|NCT00005035|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
445250|NCT00005035|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
445251|NCT00005035|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
445252|NCT00005035|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
445253|NCT00005035|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
445254|NCT00005035|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
445255|NCT00005035|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
445256|NCT00005035|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
445257|NCT00005035|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
445258|NCT00005035|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
445259|NCT00005035|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
445260|NCT00005035|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
445261|NCT00005037|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
445262|NCT00005037|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
445263|NCT00005037|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
445264|NCT00005038|stage IV renal cell cancer|stage iv renal cell cancer
445265|NCT00005038|recurrent renal cell cancer|recurrent renal cell cancer
445266|NCT00005040|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
445267|NCT00005040|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
445268|NCT00005040|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
445269|NCT00005040|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
445270|NCT00005040|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
445271|NCT00005040|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
445272|NCT00005040|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
445273|NCT00005040|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
445274|NCT00005040|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
445275|NCT00005040|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
445276|NCT00005040|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
445277|NCT00005040|anaplastic large cell lymphoma|anaplastic large cell lymphoma
445278|NCT00005041|extensive stage small cell lung cancer|extensive stage small cell lung cancer
445279|NCT00005041|recurrent small cell lung cancer|recurrent small cell lung cancer
445280|NCT00005042|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
445281|NCT00005042|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
445282|NCT00005044|adenocarcinoma of the prostate|adenocarcinoma of the prostate
445283|NCT00005044|stage IIB prostate cancer|stage iib prostate cancer
445284|NCT00005044|stage IIA prostate cancer|stage iia prostate cancer
445285|NCT00005044|stage III prostate cancer|stage iii prostate cancer
445286|NCT00005045|stage III renal cell cancer|stage iii renal cell cancer
445287|NCT00005045|stage IV renal cell cancer|stage iv renal cell cancer
445288|NCT00005045|recurrent renal cell cancer|recurrent renal cell cancer
445289|NCT00005046|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
445290|NCT00005046|primary peritoneal cavity cancer|primary peritoneal cavity cancer
445291|NCT00005047|stage I bladder cancer|stage i bladder cancer
445292|NCT00005047|stage II bladder cancer|stage ii bladder cancer
445293|NCT00005047|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
445294|NCT00005048|adenocarcinoma of the prostate|adenocarcinoma of the prostate
445295|NCT00005048|recurrent prostate cancer|recurrent prostate cancer
445296|NCT00005049|stage II colon cancer|stage ii colon cancer
445297|NCT00005049|stage III colon cancer|stage iii colon cancer
445298|NCT00005049|stage II gastric cancer|stage ii gastric cancer
445299|NCT00005049|stage III gastric cancer|stage iii gastric cancer
445300|NCT00005049|recurrent gastric cancer|recurrent gastric cancer
445301|NCT00005049|stage II rectal cancer|stage ii rectal cancer
445302|NCT00005049|stage III rectal cancer|stage iii rectal cancer
445303|NCT00005049|recurrent colon cancer|recurrent colon cancer
445304|NCT00005049|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
445305|NCT00005049|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
445306|NCT00005049|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
11770|NCT03215511|NTRK2 fusion|ntrk2 fusion
445307|NCT00005049|small intestine adenocarcinoma|small intestine adenocarcinoma
445308|NCT00005049|small intestine lymphoma|small intestine lymphoma
445309|NCT00005049|small intestine leiomyosarcoma|small intestine leiomyosarcoma
445310|NCT00005049|recurrent small intestine cancer|recurrent small intestine cancer
445311|NCT00005049|peritoneal cavity cancer|peritoneal cavity cancer
445312|NCT00005049|gastrointestinal stromal tumor|gastrointestinal stromal tumor
445313|NCT00005050|stage III colon cancer|stage iii colon cancer
445314|NCT00005050|stage IV colon cancer|stage iv colon cancer
445315|NCT00005050|stage III rectal cancer|stage iii rectal cancer
444719|NCT00006357|adult fibrosarcoma|adult fibrosarcoma
445316|NCT00005050|stage IV rectal cancer|stage iv rectal cancer
445317|NCT00005050|recurrent colon cancer|recurrent colon cancer
445318|NCT00005050|recurrent rectal cancer|recurrent rectal cancer
445319|NCT00005051|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
445320|NCT00005051|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
445321|NCT00005051|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
445322|NCT00005051|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
445323|NCT00005052|stage II melanoma|stage ii melanoma
445324|NCT00005053|stage III pancreatic cancer|stage iii pancreatic cancer
445325|NCT00005053|recurrent pancreatic cancer|recurrent pancreatic cancer
445326|NCT00005053|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
445327|NCT00005053|stage IV pancreatic cancer|stage iv pancreatic cancer
445328|NCT00005054|stage IV breast cancer|stage iv breast cancer
445329|NCT00005054|stage IIIA breast cancer|stage iiia breast cancer
445330|NCT00005054|recurrent breast cancer|recurrent breast cancer
445331|NCT00005054|stage IIIB breast cancer|stage iiib breast cancer
445332|NCT00005055|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
445333|NCT00005055|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
445334|NCT00005055|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
445335|NCT00005055|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
445336|NCT00005056|stage I renal cell cancer|stage i renal cell cancer
445337|NCT00005056|stage II renal cell cancer|stage ii renal cell cancer
445338|NCT00005056|stage III renal cell cancer|stage iii renal cell cancer
445339|NCT00005056|stage IV renal cell cancer|stage iv renal cell cancer
445340|NCT00005056|recurrent renal cell cancer|recurrent renal cell cancer
466452|NCT00061022|Ischemia|ischemia
445343|NCT00005057|lentigo maligna malignant melanoma|lentigo maligna malignant melanoma
445344|NCT00005057|superficial spreading malignant melanoma|superficial spreading malignant melanoma
445345|NCT00005057|acral lentiginous malignant melanoma|acral lentiginous malignant melanoma
445346|NCT00005057|nodular malignant melanoma|nodular malignant melanoma
445347|NCT00005058|stage I breast cancer|stage i breast cancer
445348|NCT00005058|stage II breast cancer|stage ii breast cancer
445349|NCT00005058|stage IIIA breast cancer|stage iiia breast cancer
445350|NCT00005058|stage IIIB breast cancer|stage iiib breast cancer
445351|NCT00005058|inflammatory breast cancer|inflammatory breast cancer
445352|NCT00005059|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
445353|NCT00005059|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
445354|NCT00005487|Coronary Arteriosclerosis|coronary arteriosclerosis
445355|NCT00005487|Cerebrovascular Accident|cerebrovascular accident
445356|NCT00005487|Heart Failure, Congestive|heart failure, congestive
445357|NCT00005487|Diabetes Mellitus, Non-Insulin Dependent|diabetes mellitus, non-insulin dependent
445358|NCT00005566|Suicide|suicide
445359|NCT00005569|Elastase|elastase
445360|NCT00005569|Inflammation|inflammation
445361|NCT00005569|Age|age
445362|NCT00005569|Gender|gender
445363|NCT00005569|Cytokine|cytokine
445364|NCT00005569|Healthy Volunteer|healthy volunteer
445365|NCT00005570|Bleeding|bleeding
445366|NCT00005570|Cytokines|cytokines
445367|NCT00005570|Immune Response|immune response
445368|NCT00005570|Pharmacogenomic|pharmacogenomic
445369|NCT00005570|Serum Antibodies|serum antibodies
445370|NCT00005570|ITP|itp
445371|NCT00005570|Immune Thrombocytopenia Purpura|immune thrombocytopenia purpura
445372|NCT00005571|Skin|skin
445373|NCT00005571|Humoral Immunity|humoral immunity
445374|NCT00005571|Myositis|myositis
445375|NCT00005571|Complement|complement
445376|NCT00005571|Antibody|antibody
445377|NCT00005571|Dermatomyositis|dermatomyositis
445378|NCT00005572|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
445379|NCT00005572|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
445380|NCT00005572|Lymphocytes|lymphocytes
445381|NCT00005572|Histoplasmosis|histoplasmosis
445382|NCT00005572|Recurrence|recurrence
445383|NCT00005572|Cytomegalovirus Retinitis|cytomegalovirus retinitis
445384|NCT00005572|Cell Division|cell division
445387|NCT00005574|Becker Muscular Dystrophy|becker muscular dystrophy
445388|NCT00005574|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
445389|NCT00005574|Muscle Disease|muscle disease
445390|NCT00005574|Myopathy|myopathy
445391|NCT00005575|Imipramine|imipramine
445392|NCT00005575|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
445393|NCT00005577|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
445394|NCT00005578|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
445395|NCT00005578|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
445396|NCT00005578|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
445397|NCT00005578|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
445398|NCT00005578|cardiac toxicity|cardiac toxicity
445399|NCT00005579|Waldenström macroglobulinemia|waldenström macroglobulinemia
445400|NCT00005579|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
445401|NCT00005579|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
445402|NCT00005579|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
445403|NCT00005579|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
445404|NCT00005579|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
445405|NCT00005579|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
445406|NCT00005579|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
445407|NCT00005579|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
445408|NCT00005579|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
445409|NCT00005579|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
445410|NCT00005579|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
445411|NCT00005579|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
445412|NCT00005579|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
445413|NCT00005579|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
445414|NCT00005579|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
445415|NCT00005579|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
445416|NCT00005579|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
445417|NCT00005580|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
445418|NCT00005580|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
445419|NCT00005580|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
445420|NCT00005580|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
445421|NCT00005580|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
445422|NCT00005580|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
445423|NCT00005580|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
585104|NCT00518531|low bone mineral density|low bone mineral density
445424|NCT00005580|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
445425|NCT00005580|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
445426|NCT00005580|refractory hairy cell leukemia|refractory hairy cell leukemia
445427|NCT00005580|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
445428|NCT00005580|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
585103|NCT00518531|osteoporosis|osteoporosis
445429|NCT00005580|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
445430|NCT00005580|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
445431|NCT00005580|prolymphocytic leukemia|prolymphocytic leukemia
445432|NCT00005580|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
445433|NCT00005580|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
445434|NCT00005580|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
445435|NCT00005580|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
445436|NCT00005580|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
445437|NCT00005580|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
445438|NCT00005580|splenic marginal zone lymphoma|splenic marginal zone lymphoma
445439|NCT00005581|stage II breast cancer|stage ii breast cancer
445440|NCT00005581|stage IIIA breast cancer|stage iiia breast cancer
445441|NCT00005581|stage IIIB breast cancer|stage iiib breast cancer
445442|NCT00005583|stage I endometrial carcinoma|stage i endometrial carcinoma
445443|NCT00005583|stage II endometrial carcinoma|stage ii endometrial carcinoma
445444|NCT00005583|endometrial adenocarcinoma|endometrial adenocarcinoma
445445|NCT00005583|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
445446|NCT00005583|endometrial clear cell carcinoma|endometrial clear cell carcinoma
445447|NCT00005584|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
445448|NCT00005584|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
445449|NCT00005584|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
445450|NCT00005585|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
445451|NCT00005585|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
445452|NCT00005586|stage II colon cancer|stage ii colon cancer
445453|NCT00005586|stage III colon cancer|stage iii colon cancer
445454|NCT00005586|stage II rectal cancer|stage ii rectal cancer
445455|NCT00005586|stage III rectal cancer|stage iii rectal cancer
445456|NCT00005587|stage I breast cancer|stage i breast cancer
445457|NCT00005587|stage II breast cancer|stage ii breast cancer
445458|NCT00005587|stage IIIA breast cancer|stage iiia breast cancer
445459|NCT00005588|stage I breast cancer|stage i breast cancer
445460|NCT00005588|stage II breast cancer|stage ii breast cancer
445461|NCT00005588|stage IIIA breast cancer|stage iiia breast cancer
445462|NCT00005589|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
445463|NCT00005589|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
445464|NCT00005589|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
445465|NCT00005590|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
445466|NCT00005590|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
445467|NCT00005590|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
445468|NCT00005590|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
445469|NCT00005590|recurrent breast cancer|recurrent breast cancer
445470|NCT00005590|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
445471|NCT00005590|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
445472|NCT00005590|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
445473|NCT00005590|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
445474|NCT00005590|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
445475|NCT00005590|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
445476|NCT00005590|limited stage small cell lung cancer|limited stage small cell lung cancer
445477|NCT00005590|extensive stage small cell lung cancer|extensive stage small cell lung cancer
445478|NCT00005590|recurrent small cell lung cancer|recurrent small cell lung cancer
445479|NCT00005590|small intestine lymphoma|small intestine lymphoma
445480|NCT00005590|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
445481|NCT00005590|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
445482|NCT00005590|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
445483|NCT00005590|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
445484|NCT00005590|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
445485|NCT00005590|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
445486|NCT00005590|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
445487|NCT00005590|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
445488|NCT00005590|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
445489|NCT00005590|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
445490|NCT00005590|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
445491|NCT00005590|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
445492|NCT00005590|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
445493|NCT00005590|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
445494|NCT00005590|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
445495|NCT00005590|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
445496|NCT00005590|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
445497|NCT00005590|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
445498|NCT00005590|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
445499|NCT00005590|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
445500|NCT00005590|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
445501|NCT00005590|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
445502|NCT00005590|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
445503|NCT00005590|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
445504|NCT00005590|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
445505|NCT00005590|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
445506|NCT00005590|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
445507|NCT00005590|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
445508|NCT00005590|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
445509|NCT00005590|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
445510|NCT00005590|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
445511|NCT00005590|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
445512|NCT00005590|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
445513|NCT00005590|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
445514|NCT00005590|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
445515|NCT00005590|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
445516|NCT00005590|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
445517|NCT00005590|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
445518|NCT00005590|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
445519|NCT00005590|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
445520|NCT00005590|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
445521|NCT00005590|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
445522|NCT00005590|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
445523|NCT00005590|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
445524|NCT00005590|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
445525|NCT00005590|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
445526|NCT00005590|extragonadal germ cell tumor|extragonadal germ cell tumor
445527|NCT00005590|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
445528|NCT00005590|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
445530|NCT00005590|intraocular lymphoma|intraocular lymphoma
445531|NCT00005590|stage I mantle cell lymphoma|stage i mantle cell lymphoma
445532|NCT00005590|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
445533|NCT00005590|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
445534|NCT00005590|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
446145|NCT00005660|Basal cell carcinoma|basal cell carcinoma
445535|NCT00005590|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
445536|NCT00005590|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
445537|NCT00005590|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
445538|NCT00005590|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
445539|NCT00005590|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
445540|NCT00005590|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
445541|NCT00005590|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
445542|NCT00005590|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
445543|NCT00005590|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
445544|NCT00005590|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
445545|NCT00005590|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
445546|NCT00005590|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
445547|NCT00005590|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
445548|NCT00005590|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
445549|NCT00005590|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
445550|NCT00005590|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
445551|NCT00005590|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
466453|NCT00061022|Hemorrhage|hemorrhage
445552|NCT00005590|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
445553|NCT00005590|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
445554|NCT00005590|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
445555|NCT00005590|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
445556|NCT00005590|anaplastic large cell lymphoma|anaplastic large cell lymphoma
445557|NCT00005590|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
445558|NCT00005590|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
445559|NCT00005590|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
445560|NCT00005590|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
445561|NCT00005590|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
445562|NCT00005590|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
445563|NCT00005590|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
445564|NCT00005590|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
445565|NCT00005590|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
445566|NCT00005590|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
445567|NCT00005590|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
445568|NCT00005590|stage I marginal zone lymphoma|stage i marginal zone lymphoma
445569|NCT00005590|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
445570|NCT00005590|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
445571|NCT00005590|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
445572|NCT00005590|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
445573|NCT00005590|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
445574|NCT00005590|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
445575|NCT00005590|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
445576|NCT00005590|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
445577|NCT00005590|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
445578|NCT00005590|splenic marginal zone lymphoma|splenic marginal zone lymphoma
445579|NCT00005591|stage III pancreatic cancer|stage iii pancreatic cancer
445580|NCT00005591|recurrent pancreatic cancer|recurrent pancreatic cancer
445581|NCT00005591|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
445582|NCT00005591|stage IV pancreatic cancer|stage iv pancreatic cancer
445583|NCT00005592|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
445584|NCT00005592|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
445585|NCT00005592|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
445586|NCT00005592|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
445587|NCT00005592|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
201019|NCT02112617|Childhood neuroblastoma|childhood neuroblastoma
445588|NCT00005592|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
445589|NCT00005592|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
445590|NCT00005592|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
445591|NCT00005592|splenic marginal zone lymphoma|splenic marginal zone lymphoma
445592|NCT00005593|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
445593|NCT00005593|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
445594|NCT00005593|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
445595|NCT00005593|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
446146|NCT00005660|Skin Cancer|skin cancer
445596|NCT00005593|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
445597|NCT00005593|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
445598|NCT00005593|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
445599|NCT00005593|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
445600|NCT00005593|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
445601|NCT00005593|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
445602|NCT00005593|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
445603|NCT00005593|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
445604|NCT00005593|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
445605|NCT00005593|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
445606|NCT00005593|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
445607|NCT00005593|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
445608|NCT00005593|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
445609|NCT00005593|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
445610|NCT00005593|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
445611|NCT00005593|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
445612|NCT00005593|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
445613|NCT00005593|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
445614|NCT00005593|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
445615|NCT00005593|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
445616|NCT00005593|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
445617|NCT00005593|refractory anemia with excess blasts|refractory anemia with excess blasts
445618|NCT00005593|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
445619|NCT00005593|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
445620|NCT00005593|secondary acute myeloid leukemia|secondary acute myeloid leukemia
445621|NCT00005593|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
445622|NCT00005593|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
445623|NCT00005593|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
445624|NCT00005593|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
445625|NCT00005593|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
445626|NCT00005593|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
445627|NCT00005594|stage III pancreatic cancer|stage iii pancreatic cancer
445628|NCT00005594|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
445629|NCT00005594|stage IV pancreatic cancer|stage iv pancreatic cancer
445630|NCT00005595|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
445631|NCT00005596|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
445632|NCT00005597|gastrointestinal stromal tumor|gastrointestinal stromal tumor
445633|NCT00005598|refractory anemia|refractory anemia
445634|NCT00005598|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
445635|NCT00005598|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
445636|NCT00005598|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
445637|NCT00005599|stage III gastric cancer|stage iii gastric cancer
445638|NCT00005599|stage IV gastric cancer|stage iv gastric cancer
445639|NCT00005599|recurrent gastric cancer|recurrent gastric cancer
445640|NCT00005599|stage III esophageal cancer|stage iii esophageal cancer
445641|NCT00005599|stage IV esophageal cancer|stage iv esophageal cancer
445642|NCT00005599|recurrent esophageal cancer|recurrent esophageal cancer
445643|NCT00005599|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
445644|NCT00005599|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
445645|NCT00005600|stage I breast cancer|stage i breast cancer
445646|NCT00005600|stage II breast cancer|stage ii breast cancer
445647|NCT00005600|lymphedema|lymphedema
753009|NCT01175096|carcinoid tumor|carcinoid tumor
445648|NCT00005600|perioperative/postoperative complications|perioperative/postoperative complications
445649|NCT00005601|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
445650|NCT00005601|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
445651|NCT00005601|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
445652|NCT00005601|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
445653|NCT00005601|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
445654|NCT00005601|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
445655|NCT00005601|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
445656|NCT00005601|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
445657|NCT00005601|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
445658|NCT00005601|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
445659|NCT00005601|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
445660|NCT00005601|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
446147|NCT00005663|Herpes Simplex|herpes simplex
445661|NCT00005601|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
445662|NCT00005601|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
445663|NCT00005601|splenic marginal zone lymphoma|splenic marginal zone lymphoma
445664|NCT00005602|untreated childhood brain stem glioma|untreated childhood brain stem glioma
445665|NCT00005603|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
445666|NCT00005603|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
445667|NCT00005605|osteoporosis|osteoporosis
445668|NCT00005605|stage I breast cancer|stage i breast cancer
445669|NCT00005605|stage II breast cancer|stage ii breast cancer
445670|NCT00005606|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
445671|NCT00005606|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
445672|NCT00005606|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
445673|NCT00005606|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
445674|NCT00005606|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
445675|NCT00005606|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
445676|NCT00005606|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
445677|NCT00005606|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
583569|NCT00512239|Early inflammatory arthritis|early inflammatory arthritis
445678|NCT00005606|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
466454|NCT00061022|TIA|tia
445679|NCT00005606|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
445680|NCT00005606|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
445681|NCT00005606|isolated plasmacytoma of bone|isolated plasmacytoma of bone
445682|NCT00005606|extramedullary plasmacytoma|extramedullary plasmacytoma
445683|NCT00005606|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
445684|NCT00005606|stage I multiple myeloma|stage i multiple myeloma
445685|NCT00005606|stage II multiple myeloma|stage ii multiple myeloma
445686|NCT00005606|stage III multiple myeloma|stage iii multiple myeloma
445687|NCT00005606|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
445688|NCT00005606|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
445689|NCT00005606|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
445690|NCT00005606|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
445691|NCT00005606|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
445692|NCT00005606|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
445693|NCT00005606|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
445694|NCT00005606|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
445695|NCT00005606|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
445696|NCT00005606|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
445697|NCT00005606|untreated hairy cell leukemia|untreated hairy cell leukemia
445698|NCT00005606|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
445699|NCT00005606|refractory hairy cell leukemia|refractory hairy cell leukemia
445700|NCT00005606|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
445701|NCT00005606|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
445702|NCT00005606|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
445703|NCT00005606|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
445704|NCT00005606|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
445705|NCT00005606|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
445706|NCT00005606|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
445707|NCT00005606|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
445708|NCT00005606|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
445709|NCT00005606|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
445710|NCT00005606|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
445711|NCT00005606|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
445712|NCT00005606|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
445713|NCT00005606|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
11771|NCT03215511|NTRK3 fusion|ntrk3 fusion
445714|NCT00005606|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
445715|NCT00005606|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
445716|NCT00005606|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
445717|NCT00005606|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
445718|NCT00005606|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
445719|NCT00005606|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
445720|NCT00005606|stage I marginal zone lymphoma|stage i marginal zone lymphoma
445721|NCT00005606|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
445722|NCT00005606|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
445723|NCT00005606|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
445724|NCT00005606|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
445725|NCT00005606|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
446253|NCT00006436|Monoclonal|monoclonal
445726|NCT00005606|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
445727|NCT00005606|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
445728|NCT00005606|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
445729|NCT00005606|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
445730|NCT00005606|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
445731|NCT00005606|splenic marginal zone lymphoma|splenic marginal zone lymphoma
445732|NCT00005607|stage IV gastric cancer|stage iv gastric cancer
445733|NCT00005607|recurrent gastric cancer|recurrent gastric cancer
445734|NCT00005607|stage IV esophageal cancer|stage iv esophageal cancer
445735|NCT00005607|recurrent esophageal cancer|recurrent esophageal cancer
445736|NCT00005607|adenocarcinoma of the stomach|adenocarcinoma of the stomach
445737|NCT00005607|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
445738|NCT00005608|stage IV breast cancer|stage iv breast cancer
445739|NCT00005608|recurrent breast cancer|recurrent breast cancer
445740|NCT00005609|Waldenström macroglobulinemia|waldenström macroglobulinemia
445741|NCT00005610|stage IV melanoma|stage iv melanoma
445742|NCT00005610|recurrent melanoma|recurrent melanoma
445743|NCT00005610|lung metastases|lung metastases
445744|NCT00005611|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
467376|NCT00054743|HIV|hiv
445745|NCT00005612|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
445746|NCT00005612|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
445747|NCT00005612|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
445748|NCT00005613|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
445749|NCT00005613|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
445750|NCT00005613|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
445751|NCT00005613|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
445752|NCT00005613|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
445753|NCT00005613|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
445754|NCT00005613|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
445755|NCT00005613|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
445756|NCT00005613|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
445757|NCT00005613|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
445758|NCT00005613|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
445759|NCT00005613|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
445760|NCT00005613|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
445761|NCT00005613|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
445762|NCT00005613|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
445763|NCT00005613|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
445764|NCT00005613|splenic marginal zone lymphoma|splenic marginal zone lymphoma
445765|NCT00005614|stage IV breast cancer|stage iv breast cancer
445766|NCT00005614|recurrent breast cancer|recurrent breast cancer
445767|NCT00005615|stage III melanoma|stage iii melanoma
445769|NCT00005616|stage I colon cancer|stage i colon cancer
445770|NCT00005616|stage II colon cancer|stage ii colon cancer
445771|NCT00005616|stage III colon cancer|stage iii colon cancer
445772|NCT00005616|stage IV colon cancer|stage iv colon cancer
445773|NCT00005616|stage I rectal cancer|stage i rectal cancer
445774|NCT00005616|stage II rectal cancer|stage ii rectal cancer
445775|NCT00005616|stage III rectal cancer|stage iii rectal cancer
445776|NCT00005616|stage IV rectal cancer|stage iv rectal cancer
445777|NCT00005616|recurrent colon cancer|recurrent colon cancer
445778|NCT00005616|recurrent rectal cancer|recurrent rectal cancer
445779|NCT00005616|liver metastases|liver metastases
445780|NCT00005617|stage IV melanoma|stage iv melanoma
445781|NCT00005617|recurrent melanoma|recurrent melanoma
445782|NCT00005618|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
445783|NCT00005618|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
445784|NCT00005618|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
445785|NCT00005618|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
445786|NCT00005619|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
445787|NCT00005619|refractory hairy cell leukemia|refractory hairy cell leukemia
445788|NCT00005622|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
445789|NCT00005622|refractory multiple myeloma|refractory multiple myeloma
445790|NCT00005622|stage I multiple myeloma|stage i multiple myeloma
445791|NCT00005622|stage II multiple myeloma|stage ii multiple myeloma
445792|NCT00005622|stage III multiple myeloma|stage iii multiple myeloma
445793|NCT00005622|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
445794|NCT00005622|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
445795|NCT00005622|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
445796|NCT00005622|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
445797|NCT00005622|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
445798|NCT00005622|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
445799|NCT00005622|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
445800|NCT00005622|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
445801|NCT00005622|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
445802|NCT00005622|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
445803|NCT00005622|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
445804|NCT00005622|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
445805|NCT00005622|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
445806|NCT00005622|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
445807|NCT00005622|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
445808|NCT00005622|polycythemia vera|polycythemia vera
445809|NCT00005622|primary myelofibrosis|primary myelofibrosis
445810|NCT00005622|essential thrombocythemia|essential thrombocythemia
445811|NCT00005622|refractory anemia|refractory anemia
445812|NCT00005622|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
445813|NCT00005622|refractory anemia with excess blasts|refractory anemia with excess blasts
445814|NCT00005622|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
445815|NCT00005622|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
445816|NCT00005622|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
445817|NCT00005622|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
445818|NCT00005622|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
445819|NCT00005622|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
445820|NCT00005622|chronic eosinophilic leukemia|chronic eosinophilic leukemia
445821|NCT00005622|chronic neutrophilic leukemia|chronic neutrophilic leukemia
445822|NCT00005622|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
445823|NCT00005622|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
445824|NCT00005622|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
445825|NCT00005622|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
445826|NCT00005622|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
445827|NCT00005622|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
445828|NCT00005622|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
445829|NCT00005622|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
445830|NCT00005623|stage IV prostate cancer|stage iv prostate cancer
445831|NCT00005623|recurrent prostate cancer|recurrent prostate cancer
445832|NCT00005623|hot flashes|hot flashes
445833|NCT00005624|refractory multiple myeloma|refractory multiple myeloma
445834|NCT00005624|stage II multiple myeloma|stage ii multiple myeloma
445835|NCT00005624|stage III multiple myeloma|stage iii multiple myeloma
445836|NCT00005624|plasma cell neoplasm|plasma cell neoplasm
445837|NCT00005625|metastatic osteosarcoma|metastatic osteosarcoma
445838|NCT00005625|recurrent osteosarcoma|recurrent osteosarcoma
445839|NCT00005626|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
445840|NCT00005626|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
445841|NCT00005626|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
445842|NCT00005626|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
445843|NCT00005626|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
445844|NCT00005626|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
445845|NCT00005626|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
445846|NCT00005626|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
445847|NCT00005626|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
445848|NCT00005626|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
445849|NCT00005626|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
445850|NCT00005626|prolymphocytic leukemia|prolymphocytic leukemia
445851|NCT00005626|stage I mantle cell lymphoma|stage i mantle cell lymphoma
445852|NCT00005626|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
445853|NCT00005626|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
445854|NCT00005626|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
445855|NCT00005626|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
445856|NCT00005626|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
445857|NCT00005626|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
445858|NCT00005626|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
445859|NCT00005626|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
445860|NCT00005626|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
445861|NCT00005626|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
445862|NCT00005626|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
445863|NCT00005626|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
445864|NCT00005626|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
445865|NCT00005626|stage I marginal zone lymphoma|stage i marginal zone lymphoma
445866|NCT00005626|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
445867|NCT00005626|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
445868|NCT00005626|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
445869|NCT00005626|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
445870|NCT00005626|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
445871|NCT00005626|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
445872|NCT00005626|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
445873|NCT00005626|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
445874|NCT00005626|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
445875|NCT00005626|splenic marginal zone lymphoma|splenic marginal zone lymphoma
445876|NCT00005627|adenocarcinoma of the prostate|adenocarcinoma of the prostate
445877|NCT00005627|recurrent prostate cancer|recurrent prostate cancer
445878|NCT00005628|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
445879|NCT00005628|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
445880|NCT00005629|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
445881|NCT00005629|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
445882|NCT00005629|advanced adult primary liver cancer|advanced adult primary liver cancer
445883|NCT00005629|recurrent adult primary liver cancer|recurrent adult primary liver cancer
445884|NCT00005629|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
445885|NCT00005630|stage I non-small cell lung cancer|stage i non-small cell lung cancer
445886|NCT00005630|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
445887|NCT00005630|large cell lung cancer|large cell lung cancer
445888|NCT00005630|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
445889|NCT00005630|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
445890|NCT00005630|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
445891|NCT00005630|adenocarcinoma of the lung|adenocarcinoma of the lung
445892|NCT00005630|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
445893|NCT00005631|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
445894|NCT00005631|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
445895|NCT00005631|anaplastic large cell lymphoma|anaplastic large cell lymphoma
445896|NCT00005632|recurrent prostate cancer|recurrent prostate cancer
445897|NCT00005633|stage III melanoma|stage iii melanoma
445898|NCT00005633|stage IV melanoma|stage iv melanoma
445899|NCT00005633|recurrent melanoma|recurrent melanoma
445900|NCT00005634|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
445901|NCT00005634|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
445902|NCT00005634|isolated plasmacytoma of bone|isolated plasmacytoma of bone
445903|NCT00005634|extramedullary plasmacytoma|extramedullary plasmacytoma
445904|NCT00005634|refractory multiple myeloma|refractory multiple myeloma
445905|NCT00005634|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
445906|NCT00005634|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
445907|NCT00005634|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
445908|NCT00005634|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
445909|NCT00005634|small intestine lymphoma|small intestine lymphoma
445910|NCT00005634|recurrent prostate cancer|recurrent prostate cancer
445911|NCT00005634|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
445912|NCT00005634|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
445913|NCT00005634|refractory hairy cell leukemia|refractory hairy cell leukemia
445914|NCT00005634|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
445915|NCT00005634|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
445916|NCT00005634|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
445917|NCT00005634|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
445918|NCT00005634|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
445919|NCT00005634|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
445920|NCT00005634|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
445921|NCT00005634|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
445922|NCT00005634|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
445923|NCT00005634|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
445924|NCT00005634|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
445925|NCT00005634|secondary acute myeloid leukemia|secondary acute myeloid leukemia
445926|NCT00005634|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
445927|NCT00005634|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
445928|NCT00005634|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
445929|NCT00005634|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
445930|NCT00005634|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
445931|NCT00005634|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
445932|NCT00005634|splenic marginal zone lymphoma|splenic marginal zone lymphoma
445933|NCT00005635|stage IV breast cancer|stage iv breast cancer
445934|NCT00005635|recurrent breast cancer|recurrent breast cancer
445935|NCT00005636|localized malignant mesothelioma|localized malignant mesothelioma
445936|NCT00005636|advanced malignant mesothelioma|advanced malignant mesothelioma
445937|NCT00005636|recurrent malignant mesothelioma|recurrent malignant mesothelioma
445938|NCT00005637|adult glioblastoma|adult glioblastoma
445939|NCT00005637|adult anaplastic astrocytoma|adult anaplastic astrocytoma
445940|NCT00005637|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
445941|NCT00005637|adult mixed glioma|adult mixed glioma
445942|NCT00005637|adult giant cell glioblastoma|adult giant cell glioblastoma
445943|NCT00005637|adult gliosarcoma|adult gliosarcoma
445944|NCT00005637|adult anaplastic ependymoma|adult anaplastic ependymoma
445945|NCT00005638|stage II gastric cancer|stage ii gastric cancer
445946|NCT00005638|stage III gastric cancer|stage iii gastric cancer
445947|NCT00005638|stage II esophageal cancer|stage ii esophageal cancer
445948|NCT00005638|stage III esophageal cancer|stage iii esophageal cancer
445949|NCT00005638|adenocarcinoma of the stomach|adenocarcinoma of the stomach
445950|NCT00005638|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
445951|NCT00005638|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
446016|NCT00005641|refractory multiple myeloma|refractory multiple myeloma
445952|NCT00005639|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
445953|NCT00005639|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
445954|NCT00005639|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
445955|NCT00005639|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
445956|NCT00005639|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
445957|NCT00005639|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
445958|NCT00005639|small intestine lymphoma|small intestine lymphoma
445959|NCT00005639|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
445960|NCT00005639|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
445961|NCT00005639|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
445962|NCT00005639|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
445963|NCT00005639|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
446169|NCT00005671|Heart Failure|heart failure
445964|NCT00005639|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
445965|NCT00005639|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
445966|NCT00005639|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
445967|NCT00005639|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
445968|NCT00005639|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
445969|NCT00005639|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
445970|NCT00005639|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
445971|NCT00005639|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
445972|NCT00005639|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
445973|NCT00005639|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
445974|NCT00005639|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
445975|NCT00005639|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
445976|NCT00005639|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
445977|NCT00005639|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
445978|NCT00005639|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
445979|NCT00005639|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
445980|NCT00005639|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
445981|NCT00005639|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
445982|NCT00005639|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
445983|NCT00005639|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
445984|NCT00005639|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
445985|NCT00005639|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
11772|NCT03215511|ETV6-NTRK3|etv6-ntrk3
445986|NCT00005639|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
445987|NCT00005639|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
445988|NCT00005639|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
445989|NCT00005639|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
445990|NCT00005639|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
445991|NCT00005639|intraocular lymphoma|intraocular lymphoma
445992|NCT00005639|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
445993|NCT00005639|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
445994|NCT00005639|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
445995|NCT00005639|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
445996|NCT00005639|anaplastic large cell lymphoma|anaplastic large cell lymphoma
445997|NCT00005639|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
445998|NCT00005639|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
446254|NCT00006437|MMP|mmp
445999|NCT00005639|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
446000|NCT00005639|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
446001|NCT00005639|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
446002|NCT00005639|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
446003|NCT00005639|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
446004|NCT00005639|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
446005|NCT00005639|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
446006|NCT00005639|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
446007|NCT00005639|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
446008|NCT00005639|splenic marginal zone lymphoma|splenic marginal zone lymphoma
446009|NCT00005640|stage I colon cancer|stage i colon cancer
446010|NCT00005640|stage II colon cancer|stage ii colon cancer
446011|NCT00005640|stage III colon cancer|stage iii colon cancer
446012|NCT00005640|stage I rectal cancer|stage i rectal cancer
446013|NCT00005640|stage II rectal cancer|stage ii rectal cancer
446014|NCT00005640|stage III rectal cancer|stage iii rectal cancer
446015|NCT00005641|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
446017|NCT00005641|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
446018|NCT00005641|stage I multiple myeloma|stage i multiple myeloma
446019|NCT00005641|stage II multiple myeloma|stage ii multiple myeloma
446020|NCT00005641|stage III multiple myeloma|stage iii multiple myeloma
446021|NCT00005641|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
446022|NCT00005641|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
446023|NCT00005641|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
446024|NCT00005641|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
446025|NCT00005641|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
446026|NCT00005641|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
446027|NCT00005641|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
446028|NCT00005641|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
446029|NCT00005641|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
446030|NCT00005641|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
446031|NCT00005641|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
446032|NCT00005641|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
446033|NCT00005641|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
446034|NCT00005641|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
446035|NCT00005641|polycythemia vera|polycythemia vera
446036|NCT00005641|primary myelofibrosis|primary myelofibrosis
446037|NCT00005641|essential thrombocythemia|essential thrombocythemia
446038|NCT00005641|refractory anemia|refractory anemia
446039|NCT00005641|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
446040|NCT00005641|refractory anemia with excess blasts|refractory anemia with excess blasts
446041|NCT00005641|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
446042|NCT00005641|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
446043|NCT00005641|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
446044|NCT00005641|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
446045|NCT00005641|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
446046|NCT00005641|graft versus host disease|graft versus host disease
446047|NCT00005641|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
446048|NCT00005641|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
446049|NCT00005642|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
446050|NCT00005643|stage IV uterine sarcoma|stage iv uterine sarcoma
446051|NCT00005643|recurrent uterine sarcoma|recurrent uterine sarcoma
446052|NCT00005643|uterine carcinosarcoma|uterine carcinosarcoma
446053|NCT00005643|uterine leiomyosarcoma|uterine leiomyosarcoma
446054|NCT00005643|endometrial stromal sarcoma|endometrial stromal sarcoma
446055|NCT00005644|stage III bladder cancer|stage iii bladder cancer
446056|NCT00005644|recurrent bladder cancer|recurrent bladder cancer
446057|NCT00005644|stage IV bladder cancer|stage iv bladder cancer
446058|NCT00005644|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
446059|NCT00005644|recurrent urethral cancer|recurrent urethral cancer
446060|NCT00005644|distal urethral cancer|distal urethral cancer
446061|NCT00005644|proximal urethral cancer|proximal urethral cancer
446062|NCT00005644|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
446063|NCT00005644|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
446064|NCT00005644|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
446065|NCT00005644|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
446066|NCT00005645|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
446255|NCT00006437|Proteases|proteases
446067|NCT00005645|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
446068|NCT00005645|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
446069|NCT00005645|liver metastases|liver metastases
446070|NCT00005645|malignant pericardial effusion|malignant pericardial effusion
446071|NCT00005645|malignant pleural effusion|malignant pleural effusion
446072|NCT00005645|malignant ascites|malignant ascites
446073|NCT00005645|fallopian tube cancer|fallopian tube cancer
446074|NCT00005645|primary peritoneal cavity cancer|primary peritoneal cavity cancer
446075|NCT00005646|extensive stage small cell lung cancer|extensive stage small cell lung cancer
446076|NCT00005647|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
446077|NCT00005647|anaplastic thyroid cancer|anaplastic thyroid cancer
446078|NCT00005647|recurrent thyroid cancer|recurrent thyroid cancer
446079|NCT00005647|recurrent salivary gland cancer|recurrent salivary gland cancer
446080|NCT00005647|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
446081|NCT00005647|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
446082|NCT00005647|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
446083|NCT00005647|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
446175|NCT00005673|Antiretroviral|antiretroviral
446084|NCT00005647|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
446085|NCT00005647|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
446086|NCT00005647|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
446087|NCT00005647|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
446088|NCT00005647|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
446089|NCT00005647|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
446090|NCT00005647|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
446091|NCT00005647|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
446092|NCT00005647|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
446093|NCT00005647|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
446094|NCT00005647|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
446095|NCT00005647|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
446096|NCT00005647|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
446097|NCT00005647|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
446098|NCT00005647|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
446099|NCT00005648|Stage II pancreatic cancer|stage ii pancreatic cancer
446100|NCT00005648|Stage III pancreatic cancer|stage iii pancreatic cancer
446101|NCT00005648|Recurrent pancreatic cancer|recurrent pancreatic cancer
446102|NCT00005648|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
446103|NCT00005648|Stage IV pancreatic cancer|stage iv pancreatic cancer
446104|NCT00005649|stage IV breast cancer|stage iv breast cancer
446105|NCT00005649|recurrent breast cancer|recurrent breast cancer
446106|NCT00005650|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
446107|NCT00005650|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
446108|NCT00005650|primary ciliary dyskinesia|primary ciliary dyskinesia
446109|NCT00005650|rare disease|rare disease
446110|NCT00005652|hematologic disorders|hematologic disorders
446111|NCT00005652|immune thrombocytopenic purpura|immune thrombocytopenic purpura
446112|NCT00005652|rare disease|rare disease
446113|NCT00005654|endocrine disorders|endocrine disorders
446114|NCT00005654|hyperinsulinism|hyperinsulinism
446115|NCT00005654|polycystic ovarian syndrome|polycystic ovarian syndrome
446116|NCT00005654|rare disease|rare disease
446117|NCT00005655|Gene Expression|gene expression
446118|NCT00005655|Neovascularization|neovascularization
446119|NCT00005655|antiangiogenic therapy|antiangiogenic therapy
446120|NCT00005655|immunomodulatory therapy|immunomodulatory therapy
446121|NCT00005655|Immunotherapy|immunotherapy
446122|NCT00005655|Tumor|tumor
446123|NCT00005657|Cytokines|cytokines
446124|NCT00005657|Treatment|treatment
446125|NCT00005657|Genetic Polymorphism|genetic polymorphism
446126|NCT00005657|Chronic Hepatitis C|chronic hepatitis c
446127|NCT00005657|Mononuclear Cells|mononuclear cells
446128|NCT00005658|Biochemical|biochemical
446129|NCT00005658|Schizophrenia|schizophrenia
446130|NCT00005658|NMDA|nmda
446131|NCT00005658|Adolescence|adolescence
446132|NCT00005658|Psychosis|psychosis
446133|NCT00005658|Child Psychosis|child psychosis
446134|NCT00005658|Biochemical Correlates|biochemical correlates
446135|NCT00005658|Brain Imaging|brain imaging
446136|NCT00005658|Glycine|glycine
446137|NCT00005658|Adjunctive Glycine Therapy|adjunctive glycine therapy
446138|NCT00005660|Hypertriglyceridemia|hypertriglyceridemia
446139|NCT00005660|Teratogenicity|teratogenicity
446140|NCT00005660|Ichthyosis|ichthyosis
446141|NCT00005660|Darier's Disease|darier's disease
446142|NCT00005660|Retinoids|retinoids
446143|NCT00005660|Skin|skin
446148|NCT00005663|Antiviral Agents|antiviral agents
446149|NCT00005663|Anus Diseases|anus diseases
446150|NCT00005663|Herpes Genitalis|herpes genitalis
446151|NCT00005663|Recurrence|recurrence
446152|NCT00005663|valacyclovir|valacyclovir
446153|NCT00005664|Healthy Volunteers|healthy volunteers
446154|NCT00005664|Endocrine Related Conditions|endocrine related conditions
446155|NCT00005664|Endocrine Dysfunction|endocrine dysfunction
446156|NCT00005664|Early Pubertal Development|early pubertal development
446157|NCT00005666|Diagnostic imaging|diagnostic imaging
446158|NCT00005667|liver transplantation|liver transplantation
446159|NCT00005667|vancomycin resistance|vancomycin resistance
446161|NCT00005669|Body Fat|body fat
446162|NCT00005669|Food Intake|food intake
446163|NCT00005669|Diabetes Mellitus|diabetes mellitus
446164|NCT00005669|Dyslipidemia|dyslipidemia
446165|NCT00005669|Vitamin B12|vitamin b12
446166|NCT00005669|Childhood Obesity|childhood obesity
446167|NCT00005671|Angina|angina
446168|NCT00005671|Condition Specific|condition specific
446170|NCT00005671|Symptom Distress|symptom distress
446171|NCT00005671|Revascularization|revascularization
446172|NCT00005671|Coronary Artery Disease|coronary artery disease
446173|NCT00005671|Ischemic Heart Disease|ischemic heart disease
446177|NCT00005675|Systemic Scleroderma (SSc)|systemic scleroderma (ssc)
446178|NCT00005675|Bovine Type I Collagen (CI)|bovine type i collagen (ci)
446179|NCT00005675|Multicenter|multicenter
446180|NCT00005727|Nutrition|nutrition
446181|NCT00005727|Education|education
446182|NCT00006415|Virus Replication|virus replication
446183|NCT00006415|HIV-1|hiv-1
446184|NCT00006415|Polymerase Chain Reaction|polymerase chain reaction
446185|NCT00006415|DNA, Viral|dna, viral
446186|NCT00006415|RNA, Viral|rna, viral
446187|NCT00006415|Sensitivity and Specificity|sensitivity and specificity
446188|NCT00006415|Anti-HIV Agents|anti-hiv agents
446189|NCT00006415|Viral Load|viral load
446190|NCT00006415|Proviruses|proviruses
446191|NCT00006415|Acute Infection|acute infection
446192|NCT00006417|Fludarabine|fludarabine
446193|NCT00006417|Non-Myeloablative BMT|non-myeloablative bmt
446194|NCT00006417|Immunodeficiency|immunodeficiency
446195|NCT00006417|Neutrophils|neutrophils
446196|NCT00006417|Oxidase|oxidase
446197|NCT00006417|Engraftment|engraftment
446198|NCT00006417|Graft-versus-host Disease|graft-versus-host disease
446199|NCT00006417|Cyclophosphamide|cyclophosphamide
446200|NCT00006417|Donor Apheresis|donor apheresis
446201|NCT00006417|Peripheral Blood Stem Cells|peripheral blood stem cells
446202|NCT00006417|Therapy|therapy
446203|NCT00006418|Schizophrenia|schizophrenia
446204|NCT00006418|Genetics|genetics
446205|NCT00006421|Breast MRI|breast mri
446206|NCT00006421|Nipple Aspirate Fluid|nipple aspirate fluid
446207|NCT00006421|Transvaginal ultrasound|transvaginal ultrasound
446208|NCT00006421|Ductal lavage|ductal lavage
446209|NCT00006422|Lazy Eye|lazy eye
446210|NCT00006422|Amblyopia|amblyopia
446211|NCT00006422|Nystagmus|nystagmus
446212|NCT00006422|Eye Movements|eye movements
446213|NCT00006422|Child Vision|child vision
446214|NCT00006424|Plasticity|plasticity
446215|NCT00006424|Motor|motor
446216|NCT00006424|Stroke|stroke
446217|NCT00006424|Amphetamine|amphetamine
446218|NCT00006424|fMRI|fmri
446219|NCT00006424|Cortical Reorganization|cortical reorganization
446220|NCT00006424|Spectroscopy|spectroscopy
446221|NCT00006425|Breast MRI|breast mri
446222|NCT00006425|Ductal lavage|ductal lavage
446223|NCT00006425|Nipple Aspirate Fluid|nipple aspirate fluid
446224|NCT00006425|Transvaginal ultrasound|transvaginal ultrasound
446225|NCT00006425|Healthy Volunteer|healthy volunteer
446226|NCT00006426|Foot ulcers|foot ulcers
446227|NCT00006426|Diabetes|diabetes
446228|NCT00006426|Peripheral neuropathy|peripheral neuropathy
446229|NCT00006426|Casting|casting
446230|NCT00006426|Achilles Lengthening|achilles lengthening
446231|NCT00006426|Ambulatory surgery|ambulatory surgery
446232|NCT00006426|Foot deformity|foot deformity
446233|NCT00006427|Amputation|amputation
446234|NCT00006427|Chronic Pain|chronic pain
446235|NCT00006427|Amitriptyline|amitriptyline
446236|NCT00006428|Spinal Cord injury (SCI)|spinal cord injury (sci)
446237|NCT00006428|Chronic Pain|chronic pain
446238|NCT00006428|Amitriptyline|amitriptyline
446239|NCT00006429|Spinal Cord Injury|spinal cord injury
446240|NCT00006429|Body Weight Supported Ambulation Training|body weight supported ambulation training
446241|NCT00006429|Treadmill Training|treadmill training
446242|NCT00006429|Physical therapy|physical therapy
446243|NCT00006429|Gait|gait
446244|NCT00006429|Assisted Ambulation|assisted ambulation
446245|NCT00006434|Dendritic cells|dendritic cells
446246|NCT00006435|Tissue Repository|tissue repository
446247|NCT00006435|Growth Rate|growth rate
446248|NCT00006435|Volumetric MRI|volumetric mri
446249|NCT00006436|AIDS|aids
446250|NCT00006436|Malignancy|malignancy
446251|NCT00006436|Antiretroviral|antiretroviral
446252|NCT00006436|Chemotherapy|chemotherapy
446258|NCT00006437|Extracellular Matrix|extracellular matrix
446259|NCT00006438|Rocker sole|rocker sole
446260|NCT00006438|Plantar pressure|plantar pressure
446261|NCT00006438|Diabetic feet|diabetic feet
446262|NCT00006438|Insensate feet|insensate feet
446263|NCT00006438|gait analysis|gait analysis
446264|NCT00006438|Pedorthics|pedorthics
446265|NCT00006438|Gait abnormalities|gait abnormalities
446267|NCT00006440|Risk Factors|risk factors
446268|NCT00006440|Behavior Therapy|behavior therapy
446269|NCT00006440|Substance-Related Disorders|substance-related disorders
446270|NCT00006440|Feasibility Studies|feasibility studies
446271|NCT00006441|Virus Replication|virus replication
446272|NCT00006441|HIV-1|hiv-1
446273|NCT00006441|Interleukin-2|interleukin-2
446274|NCT00006441|Drug Therapy, Combination|drug therapy, combination
446275|NCT00006441|Zidovudine|zidovudine
446276|NCT00006441|HIV Protease Inhibitors|hiv protease inhibitors
446277|NCT00006441|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
446278|NCT00006441|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
446279|NCT00006441|Biological Markers|biological markers
446280|NCT00006441|Lamivudine|lamivudine
446281|NCT00006441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
446282|NCT00006441|Anti-HIV Agents|anti-hiv agents
446283|NCT00006441|Nelfinavir|nelfinavir
446284|NCT00006441|Cytotoxicity, Immunologic|cytotoxicity, immunologic
446285|NCT00006441|Acute Infection|acute infection
446288|NCT00006442|Lymphoid Tissue|lymphoid tissue
446289|NCT00006442|Blood|blood
446290|NCT00006442|Anti-HIV Agents|anti-hiv agents
446291|NCT00006442|Viral Load|viral load
446292|NCT00006475|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
446293|NCT00006475|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
446294|NCT00006475|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
446295|NCT00006475|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
446296|NCT00006476|stage 0 bladder cancer|stage 0 bladder cancer
446297|NCT00006476|stage I bladder cancer|stage i bladder cancer
446298|NCT00006476|recurrent bladder cancer|recurrent bladder cancer
446299|NCT00006477|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
446300|NCT00006478|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
446301|NCT00006478|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
446302|NCT00006478|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
446303|NCT00006479|stage IV colon cancer|stage iv colon cancer
446304|NCT00006479|stage IV rectal cancer|stage iv rectal cancer
446305|NCT00006479|recurrent colon cancer|recurrent colon cancer
446306|NCT00006479|recurrent rectal cancer|recurrent rectal cancer
446307|NCT00006479|liver metastases|liver metastases
446308|NCT00006480|disseminated neuroblastoma|disseminated neuroblastoma
446309|NCT00006480|recurrent neuroblastoma|recurrent neuroblastoma
446310|NCT00006481|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
446311|NCT00006481|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
446312|NCT00006481|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
446313|NCT00006481|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
446314|NCT00006481|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
446315|NCT00006481|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
446316|NCT00006481|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
446317|NCT00006481|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
446318|NCT00006481|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
446319|NCT00006482|recurrent cervical cancer|recurrent cervical cancer
446320|NCT00006482|stage IVB cervical cancer|stage ivb cervical cancer
446321|NCT00006482|stage IVA cervical cancer|stage iva cervical cancer
446322|NCT00006482|cervical squamous cell carcinoma|cervical squamous cell carcinoma
446323|NCT00006483|stage IV renal cell cancer|stage iv renal cell cancer
446324|NCT00006483|recurrent renal cell cancer|recurrent renal cell cancer
446325|NCT00006483|lung metastases|lung metastases
446326|NCT00006484|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
446327|NCT00006484|squamous cell lung cancer|squamous cell lung cancer
446328|NCT00006484|large cell lung cancer|large cell lung cancer
446329|NCT00006484|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
446330|NCT00006484|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
446331|NCT00006484|adenocarcinoma of the lung|adenocarcinoma of the lung
446332|NCT00006485|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
446333|NCT00006487|limited stage small cell lung cancer|limited stage small cell lung cancer
446334|NCT00006489|Alcoholism|alcoholism
446335|NCT00006489|Alcohol Dependence|alcohol dependence
446336|NCT00006489|Post-Traumatic Stress Disorder|post-traumatic stress disorder
446337|NCT00006489|Naltrexone|naltrexone
446338|NCT00006489|Cognitive Behavior Therapy|cognitive behavior therapy
446340|NCT00006490|Drug Resistance, Microbial|drug resistance, microbial
446341|NCT00006490|Sequence Analysis, DNA|sequence analysis, dna
446342|NCT00006490|Microbial Sensitivity Tests|microbial sensitivity tests
446343|NCT00006490|Genotype|genotype
446344|NCT00006490|Phenotype|phenotype
446345|NCT00006490|Anti-HIV Agents|anti-hiv agents
446346|NCT00006492|Celiac Disease|celiac disease
446347|NCT00006492|Cerebellar Ataxia|cerebellar ataxia
446348|NCT00006492|Gluten-Free Diet|gluten-free diet
446349|NCT00006493|HIV-associated hyperlipidemia|hiv-associated hyperlipidemia
446351|NCT00006494|Antiretroviral Therapy|antiretroviral therapy
446352|NCT00006494|Drug Resistance|drug resistance
446353|NCT00006494|Phenotype|phenotype
446354|NCT00006494|HIV|hiv
446355|NCT00006494|Genotype|genotype
446356|NCT00006494|Treatment Experienced|treatment experienced
446357|NCT00006495|Placebos|placebos
446358|NCT00006495|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
446359|NCT00006495|AIDS Vaccines|aids vaccines
446360|NCT00006495|RNA, Viral|rna, viral
446361|NCT00006495|HIV Core Protein p24|hiv core protein p24
446362|NCT00006495|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
446363|NCT00006495|Anti-HIV Agents|anti-hiv agents
446364|NCT00006495|HIV Therapeutic Vaccine|hiv therapeutic vaccine
446365|NCT00006505|Islet Isolation|islet isolation
446366|NCT00006505|Diabetes|diabetes
446367|NCT00006507|Sensory integration|sensory integration
446368|NCT00006507|Occupational therapy|occupational therapy
446369|NCT00006507|Sensory Modulation Dysfunction (SMD)|sensory modulation dysfunction (smd)
446370|NCT00006509|Recombinant Proteins|recombinant proteins
446371|NCT00006509|HIV Envelope Protein gp160|hiv envelope protein gp160
446372|NCT00006509|AIDS Vaccines|aids vaccines
446373|NCT00006509|Anti-HIV Agents|anti-hiv agents
446374|NCT00006509|Treatment Experienced|treatment experienced
446375|NCT00006509|HIV Therapeutic Vaccine|hiv therapeutic vaccine
446376|NCT00006515|Pediatric|pediatric
446377|NCT00006515|Sarcoma|sarcoma
446378|NCT00006515|Effects|effects
446379|NCT00006515|Survivors|survivors
446380|NCT00006515|Pilot|pilot
446381|NCT00006516|Neonatal brain injury|neonatal brain injury
446382|NCT00006516|Brain Hypoxia|brain hypoxia
446383|NCT00006516|Cerebral Hypoxia|cerebral hypoxia
446384|NCT00006516|Brain Hypoxia-Ischemia|brain hypoxia-ischemia
446385|NCT00006516|Brain Ischemia-Hypoxia|brain ischemia-hypoxia
446386|NCT00006516|Cerebral Hypoxia-Ischemia|cerebral hypoxia-ischemia
446387|NCT00006516|Cerebral Ischemia-Hypoxia|cerebral ischemia-hypoxia
446388|NCT00006516|Environmental enrichment|environmental enrichment
446389|NCT00006516|Cognitive/sensorimotor stimulation|cognitive/sensorimotor stimulation
446390|NCT00006516|Parent-infant interactions|parent-infant interactions
446391|NCT00006516|Prenatal hypoxia|prenatal hypoxia
446392|NCT00006517|Seasonal Affective Disorder (SAD)|seasonal affective disorder (sad)
446393|NCT00006517|Winter Depression|winter depression
446394|NCT00006517|Mood disorders|mood disorders
446395|NCT00006517|Bipolar I and II disorders|bipolar i and ii disorders
446396|NCT00006517|Major Depressive Disorder, Recurrent|major depressive disorder, recurrent
446397|NCT00006517|Light therapy|light therapy
446398|NCT00006517|Phototherapy|phototherapy
446399|NCT00006517|Dawn Simulation therapy|dawn simulation therapy
446400|NCT00006517|Negative air ionization therapy|negative air ionization therapy
446401|NCT00006517|Chronobiology|chronobiology
446402|NCT00006517|Biological rhythms|biological rhythms
446403|NCT00006518|Tumor|tumor
446404|NCT00006518|Viruses|viruses
446405|NCT00006518|HIV|hiv
446406|NCT00006518|KSHV|kshv
446407|NCT00006518|AIDS|aids
446408|NCT00006519|Pharmacokinetic|pharmacokinetic
446409|NCT00006519|Pediatric AIDS|pediatric aids
446410|NCT00006519|Resistance Testing|resistance testing
446411|NCT00006519|Combination Therapy|combination therapy
446412|NCT00006519|Viral Drug Dynamics|viral drug dynamics
446413|NCT00006519|Treatment Experienced|treatment experienced
446414|NCT00006565|asthma|asthma
446415|NCT00006565|HEPA|hepa
446416|NCT00006565|ETS|ets
446417|NCT00006578|Drug Therapy, Combination|drug therapy, combination
446418|NCT00006578|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
446419|NCT00006578|HIV Protease Inhibitors|hiv protease inhibitors
446174|NCT00005673|HIV|hiv
446420|NCT00006578|Ritonavir|ritonavir
446421|NCT00006578|Lamivudine|lamivudine
446422|NCT00006578|Stem Cells|stem cells
446423|NCT00006578|VX 478|vx 478
446424|NCT00006578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
446425|NCT00006578|Anti-HIV Agents|anti-hiv agents
446426|NCT00006578|Antigens, CD34|antigens, cd34
446427|NCT00006578|abacavir|abacavir
446428|NCT00006578|Treatment Naive|treatment naive
446429|NCT00006591|Drug Therapy, Combination|drug therapy, combination
446430|NCT00006591|HIV Protease Inhibitors|hiv protease inhibitors
446431|NCT00006591|Ritonavir|ritonavir
446432|NCT00006591|VX 478|vx 478
446433|NCT00006591|Salvage Therapy|salvage therapy
446434|NCT00006591|Anti-HIV Agents|anti-hiv agents
446435|NCT00006591|Drug Monitoring|drug monitoring
446436|NCT00006591|Nelfinavir|nelfinavir
446437|NCT00006591|Treatment Experienced|treatment experienced
446438|NCT00006604|Dose-Response Relationship, Drug|dose-response relationship, drug
446439|NCT00006604|Drug Therapy, Combination|drug therapy, combination
446440|NCT00006604|Drug Administration Schedule|drug administration schedule
446441|NCT00006604|HIV Protease Inhibitors|hiv protease inhibitors
583570|NCT00512239|Biomarkers|biomarkers
446442|NCT00006604|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
446443|NCT00006604|Anti-HIV Agents|anti-hiv agents
446444|NCT00006604|Pharmacokinetics|pharmacokinetics
446445|NCT00006604|Treatment Experienced|treatment experienced
446446|NCT00006604|Treatment Naive|treatment naive
446447|NCT00006617|HIV-1|hiv-1
446448|NCT00006617|Drug Therapy, Combination|drug therapy, combination
446449|NCT00006617|Zidovudine|zidovudine
446450|NCT00006617|Lymphoid Tissue|lymphoid tissue
446451|NCT00006617|Gastrointestinal System|gastrointestinal system
446452|NCT00006617|HIV Protease Inhibitors|hiv protease inhibitors
446453|NCT00006617|Lamivudine|lamivudine
446454|NCT00006617|Lymphocyte Subsets|lymphocyte subsets
446455|NCT00006617|VX 478|vx 478
446456|NCT00006617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
446457|NCT00006617|Anti-HIV Agents|anti-hiv agents
446458|NCT00006617|Viral Load|viral load
446459|NCT00006617|Cerebrospinal Fluid|cerebrospinal fluid
446460|NCT00006617|abacavir|abacavir
446461|NCT00006630|Smallpox Vaccine|smallpox vaccine
446462|NCT00006630|Injections, Intramuscular|injections, intramuscular
446463|NCT00006630|Immunoglobulins|immunoglobulins
446464|NCT00006630|Orthopoxvirus|orthopoxvirus
446465|NCT00006643|Liver|liver
446466|NCT00006643|Hepatitis C|hepatitis c
446467|NCT00006643|Biopsy|biopsy
446468|NCT00006643|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
446469|NCT00006656|recurrent adult brain tumor|recurrent adult brain tumor
446470|NCT00006656|adult glioblastoma|adult glioblastoma
446471|NCT00006656|adult giant cell glioblastoma|adult giant cell glioblastoma
446472|NCT00006656|adult gliosarcoma|adult gliosarcoma
446473|NCT00006669|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
446474|NCT00006669|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
446475|NCT00006669|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
446476|NCT00006669|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
446477|NCT00006682|stage IV breast cancer|stage iv breast cancer
446478|NCT00006682|recurrent breast cancer|recurrent breast cancer
446479|NCT00006695|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
446480|NCT00006695|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
446481|NCT00006695|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
446482|NCT00006708|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
446483|NCT00006708|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
446484|NCT00006721|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
446485|NCT00006721|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
446486|NCT00006721|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
446487|NCT00006721|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
446488|NCT00006721|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
446489|NCT00006721|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
446490|NCT00006721|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
446491|NCT00006721|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
446492|NCT00006721|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
446493|NCT00006721|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
446494|NCT00006721|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
446495|NCT00006721|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
446496|NCT00006734|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
446497|NCT00006747|graft versus host disease|graft versus host disease
446498|NCT00006747|stage I mantle cell lymphoma|stage i mantle cell lymphoma
446499|NCT00006747|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
446500|NCT00006747|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
446501|NCT00006747|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
446502|NCT00006747|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
446503|NCT00006747|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
446504|NCT00006760|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
446505|NCT00006760|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
446506|NCT00006760|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
446507|NCT00006760|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
446508|NCT00006760|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
446509|NCT00006786|stage IV colon cancer|stage iv colon cancer
446510|NCT00006786|stage IV rectal cancer|stage iv rectal cancer
446511|NCT00006786|recurrent colon cancer|recurrent colon cancer
446512|NCT00006786|recurrent rectal cancer|recurrent rectal cancer
446513|NCT00006786|adenocarcinoma of the colon|adenocarcinoma of the colon
446514|NCT00006786|adenocarcinoma of the rectum|adenocarcinoma of the rectum
583571|NCT00512239|Autoantibodies|autoantibodies
446515|NCT00006799|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
446516|NCT00006799|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
446517|NCT00006799|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
446518|NCT00006799|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
446519|NCT00006799|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
446520|NCT00006799|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
446521|NCT00006799|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
446522|NCT00006799|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
446523|NCT00006799|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
446524|NCT00006799|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
446525|NCT00006799|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
446526|NCT00006799|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
446527|NCT00006799|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
446528|NCT00006799|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
446529|NCT00006799|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
446530|NCT00006799|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
446531|NCT00006799|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
446532|NCT00006799|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
446533|NCT00006799|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
446534|NCT00006799|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
446535|NCT00006799|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
446536|NCT00006799|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
446537|NCT00006799|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
446538|NCT00006799|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
446539|NCT00006799|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
446540|NCT00006799|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
446541|NCT00006799|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
446542|NCT00006799|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
446543|NCT00006799|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
446544|NCT00006799|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
446545|NCT00006799|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
446546|NCT00006799|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
446547|NCT00006799|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
446548|NCT00006799|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
446549|NCT00006799|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
446550|NCT00006799|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
446551|NCT00006799|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
446552|NCT00006799|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
446553|NCT00006799|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
446554|NCT00006799|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
446555|NCT00006799|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
446556|NCT00006799|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
446557|NCT00006799|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
446558|NCT00006799|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
446559|NCT00006799|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
446560|NCT00006799|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
446561|NCT00006799|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
446562|NCT00006799|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
446563|NCT00006799|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
446564|NCT00006799|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
446565|NCT00006799|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
446566|NCT00006799|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
583572|NCT00512239|Anti-Sa antibodies|anti-sa antibodies
585105|NCT00518531|alendronate|alendronate
446567|NCT00006799|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
446568|NCT00006799|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
470238|NCT00063661|Dual-Task|dual-task
446569|NCT00006799|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
446570|NCT00006799|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
446571|NCT00006799|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
446572|NCT00006799|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
446573|NCT00006799|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
446574|NCT00006799|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
446575|NCT00006799|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
446576|NCT00006799|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
446577|NCT00006799|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
446578|NCT00006799|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
446579|NCT00006799|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
446580|NCT00006799|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
446581|NCT00006799|anorexia|anorexia
446582|NCT00006799|cachexia|cachexia
446583|NCT00006799|quality of life|quality of life
446584|NCT00006812|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
446585|NCT00006812|primary peritoneal cavity cancer|primary peritoneal cavity cancer
446586|NCT00006825|stage IV breast cancer|stage iv breast cancer
446587|NCT00006825|recurrent breast cancer|recurrent breast cancer
446588|NCT00006864|stage IV renal cell cancer|stage iv renal cell cancer
446589|NCT00006864|recurrent renal cell cancer|recurrent renal cell cancer
446590|NCT00006864|clear cell renal cell carcinoma|clear cell renal cell carcinoma
446591|NCT00006877|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
446592|NCT00006877|squamous cell lung cancer|squamous cell lung cancer
446593|NCT00006877|large cell lung cancer|large cell lung cancer
446594|NCT00006877|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
446595|NCT00006877|adenocarcinoma of the lung|adenocarcinoma of the lung
446596|NCT00006890|refractory multiple myeloma|refractory multiple myeloma
446597|NCT00006890|stage I multiple myeloma|stage i multiple myeloma
446598|NCT00006890|stage II multiple myeloma|stage ii multiple myeloma
446599|NCT00006890|stage III multiple myeloma|stage iii multiple myeloma
446600|NCT00006916|adult glioblastoma|adult glioblastoma
446601|NCT00006916|adult giant cell glioblastoma|adult giant cell glioblastoma
446602|NCT00006916|adult gliosarcoma|adult gliosarcoma
446603|NCT00006968|stage III renal cell cancer|stage iii renal cell cancer
446604|NCT00006968|stage IV renal cell cancer|stage iv renal cell cancer
446605|NCT00006968|recurrent renal cell cancer|recurrent renal cell cancer
446606|NCT00006981|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
446607|NCT00006981|stage III cervical cancer|stage iii cervical cancer
446608|NCT00006981|recurrent cervical cancer|recurrent cervical cancer
446609|NCT00006981|stage IVB cervical cancer|stage ivb cervical cancer
446610|NCT00006981|stage IVA cervical cancer|stage iva cervical cancer
446611|NCT00006981|squamous cell lung cancer|squamous cell lung cancer
446612|NCT00006981|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
446613|NCT00006981|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
446614|NCT00006981|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
446615|NCT00006981|advanced malignant mesothelioma|advanced malignant mesothelioma
446616|NCT00006981|recurrent malignant mesothelioma|recurrent malignant mesothelioma
446617|NCT00006981|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
446618|NCT00006981|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
446619|NCT00006981|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
446620|NCT00006981|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
446621|NCT00006981|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
446622|NCT00006981|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
446623|NCT00006981|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
446624|NCT00006981|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
446625|NCT00006981|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
446626|NCT00006981|cervical squamous cell carcinoma|cervical squamous cell carcinoma
446627|NCT00006981|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
585106|NCT00518531|denosumab|denosumab
446628|NCT00006981|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
446629|NCT00006981|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
446630|NCT00006981|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
446631|NCT00006981|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
446705|NCT00007137|Healthy Volunteer|healthy volunteer
446632|NCT00006981|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
446633|NCT00006981|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
446634|NCT00006981|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
446635|NCT00006981|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
446636|NCT00006981|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
446637|NCT00006981|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
446638|NCT00006981|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
446639|NCT00006981|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
446640|NCT00006981|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
446641|NCT00006981|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
446642|NCT00006981|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
446643|NCT00006981|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
446644|NCT00006981|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
446645|NCT00006981|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
446646|NCT00006981|fallopian tube cancer|fallopian tube cancer
446647|NCT00006981|primary peritoneal cavity cancer|primary peritoneal cavity cancer
446648|NCT00006981|ovarian carcinosarcoma|ovarian carcinosarcoma
446649|NCT00006981|Brenner tumor|brenner tumor
446650|NCT00006981|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
446651|NCT00006981|recurrent salivary gland cancer|recurrent salivary gland cancer
446652|NCT00006981|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
446653|NCT00006981|stage III salivary gland cancer|stage iii salivary gland cancer
446654|NCT00006981|stage IV salivary gland cancer|stage iv salivary gland cancer
446655|NCT00006981|recurrent pancreatic cancer|recurrent pancreatic cancer
446656|NCT00006981|stage II pancreatic cancer|stage ii pancreatic cancer
446657|NCT00006981|stage III pancreatic cancer|stage iii pancreatic cancer
446658|NCT00006981|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
446659|NCT00006981|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
446660|NCT00006981|ovarian sarcoma|ovarian sarcoma
446661|NCT00006981|ovarian stromal cancer|ovarian stromal cancer
446662|NCT00006981|stage IV pancreatic cancer|stage iv pancreatic cancer
446663|NCT00006994|oral complications of radiation therapy|oral complications of radiation therapy
446664|NCT00006994|pain|pain
446665|NCT00006994|radiation toxicity|radiation toxicity
446666|NCT00006994|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
446667|NCT00006994|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
446668|NCT00006994|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
446669|NCT00006994|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
446670|NCT00006994|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
446671|NCT00006994|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
446672|NCT00006994|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
446673|NCT00006994|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
446674|NCT00007007|tumors metastatic to brain|tumors metastatic to brain
446675|NCT00007007|radiation toxicity|radiation toxicity
446676|NCT00007007|cognitive/functional effects|cognitive/functional effects
446677|NCT00007033|Alagille syndrome|alagille syndrome
446678|NCT00007033|biliary atresia|biliary atresia
446679|NCT00007033|cholestasis|cholestasis
446680|NCT00007033|gastrointestinal disorders|gastrointestinal disorders
446681|NCT00007033|rare disease|rare disease
446682|NCT00007046|arthritis & connective tissue diseases|arthritis & connective tissue diseases
446683|NCT00007046|bone cancer|bone cancer
446684|NCT00007046|diaphyseal medullary stenosis|diaphyseal medullary stenosis
446685|NCT00007046|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
446686|NCT00007046|malignant fibrous histiocytoma of bone|malignant fibrous histiocytoma of bone
446687|NCT00007046|musculoskeletal/mesodermal cancer|musculoskeletal/mesodermal cancer
446688|NCT00007046|oncologic disorders|oncologic disorders
446689|NCT00007046|rare disease|rare disease
585107|NCT00518531|adherence|adherence
446690|NCT00007059|disease-related problem/condition|disease-related problem/condition
446691|NCT00007059|graft versus host disease|graft versus host disease
446692|NCT00007059|rare disease|rare disease
446693|NCT00007124|Myoclonus|myoclonus
446694|NCT00007124|Epilepsy|epilepsy
446695|NCT00007124|Dementia|dementia
446696|NCT00007124|Polyglucosan|polyglucosan
446697|NCT00007124|Insulin|insulin
446698|NCT00007124|Lafora Disease|lafora disease
446699|NCT00007124|Restrictive Carbohydrate Diet|restrictive carbohydrate diet
446700|NCT00007137|3D MRI|3d mri
446701|NCT00007137|Diffusion Tensor|diffusion tensor
446702|NCT00007137|Tongue|tongue
446707|NCT00007137|Tongue Weakness|tongue weakness
446708|NCT00007137|Tongue Movement Coordination Problem|tongue movement coordination problem
446709|NCT00007150|Phlebotomy Therapy|phlebotomy therapy
446710|NCT00007150|Hemochromatosis|hemochromatosis
446711|NCT00007150|Iron Overload|iron overload
446712|NCT00007150|Hereditary Hemochromatosis|hereditary hemochromatosis
446713|NCT00007150|Blood Donation|blood donation
446714|NCT00007163|Immunosuppression|immunosuppression
446715|NCT00007163|Recombinant IgG1|recombinant igg1
446716|NCT00007163|Apoptosis|apoptosis
446717|NCT00007163|Interferon Gamma|interferon gamma
446718|NCT00007163|Colonoscopy|colonoscopy
446719|NCT00007163|Crohn's Disease|crohn's disease
446720|NCT00007163|Immunotherapy|immunotherapy
446722|NCT00007189|Alzheimer disease|alzheimer disease
446723|NCT00007189|Anti-inflammatory drugs|anti-inflammatory drugs
446724|NCT00007202|Virus Replication|virus replication
446725|NCT00007202|HIV-1|hiv-1
446726|NCT00007202|Didanosine|didanosine
446727|NCT00007202|Drug Therapy, Combination|drug therapy, combination
446728|NCT00007202|Stavudine|stavudine
446729|NCT00007202|HIV Protease Inhibitors|hiv protease inhibitors
446730|NCT00007202|Sensitivity and Specificity|sensitivity and specificity
446834|NCT00007475|Cyclophosphamide|cyclophosphamide
446731|NCT00007202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
446732|NCT00007202|Anti-HIV Agents|anti-hiv agents
446733|NCT00007202|Viral Load|viral load
446734|NCT00007202|Reverse Transcriptase Polymerase Chain Reaction|reverse transcriptase polymerase chain reaction
446735|NCT00007202|Acute Infection|acute infection
446736|NCT00007215|Cataract|cataract
446737|NCT00007215|Early Lens Changes|early lens changes
446738|NCT00007215|Protein Aggregation|protein aggregation
446739|NCT00007215|Blindness|blindness
446740|NCT00007215|Vision|vision
446741|NCT00007215|Dynamic Laser Scattering (DLS)|dynamic laser scattering (dls)
446742|NCT00007215|Age-Related Changes|age-related changes
446743|NCT00007215|Test Re-test Reproducibility|test re-test reproducibility
446744|NCT00007215|Normal Volunteers|normal volunteers
446745|NCT00007215|Lens|lens
446746|NCT00007215|Healthy Volunteer|healthy volunteer
446747|NCT00007228|Chorea|chorea
446749|NCT00007228|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
446750|NCT00007228|Sudden Death|sudden death
446751|NCT00007228|Neuroacanthocytosis|neuroacanthocytosis
446752|NCT00007241|Osteoarthritis|osteoarthritis
446753|NCT00007241|Knee|knee
446755|NCT00007241|Isometric|isometric
446756|NCT00007241|Exercise|exercise
446757|NCT00007241|Strengthening|strengthening
446758|NCT00007241|Joint-related pain|joint-related pain
446759|NCT00007254|Analgesia|analgesia
446760|NCT00007254|Bedsore|bedsore
446761|NCT00007254|Morphine gel|morphine gel
446762|NCT00007254|Pressure ulcer|pressure ulcer
446763|NCT00007254|Pain|pain
446764|NCT00007254|Ulcer|ulcer
446765|NCT00007267|Scleroderma|scleroderma
446766|NCT00007267|Systemic sclerosis|systemic sclerosis
446767|NCT00007267|Depression|depression
446768|NCT00007267|Pain|pain
446769|NCT00007267|Disfigurement|disfigurement
446770|NCT00007267|Body image dissatisfaction|body image dissatisfaction
446771|NCT00007267|Cognitive-behavioral therapy|cognitive-behavioral therapy
446772|NCT00007267|Self-help|self-help
446773|NCT00007267|Psychological intervention|psychological intervention
446774|NCT00007280|Bioengineered skin|bioengineered skin
446775|NCT00007280|Venous leg ulcer|venous leg ulcer
446776|NCT00007293|Phototherapy|phototherapy
446777|NCT00007293|Psoriasis|psoriasis
446778|NCT00007293|Scalp psoriasis|scalp psoriasis
446779|NCT00007293|Fiber optic|fiber optic
446780|NCT00007293|Light comb|light comb
446781|NCT00007293|UV source|uv source
446782|NCT00007306|Parathyroid hormone|parathyroid hormone
446783|NCT00007306|Psoriasis|psoriasis
446784|NCT00007306|Lesions|lesions
446785|NCT00007306|Topical medications|topical medications
446786|NCT00007306|Ointment|ointment
446787|NCT00007306|Calcium metabolism|calcium metabolism
446788|NCT00007306|Skin biopsy|skin biopsy
446789|NCT00007319|HIV Protease Inhibitors|hiv protease inhibitors
446790|NCT00007319|Risk Factors|risk factors
446791|NCT00007319|HIV Seronegativity|hiv seronegativity
446792|NCT00007319|Anti-HIV Agents|anti-hiv agents
446793|NCT00007319|Carotid Artery|carotid artery
446794|NCT00007319|Tunica Intima|tunica intima
446795|NCT00007319|Atherosclerosis|atherosclerosis
446796|NCT00007332|Drug Therapy, Combination|drug therapy, combination
585108|NCT00518531|preference|preference
446797|NCT00007332|HIV Envelope Protein gp120|hiv envelope protein gp120
446798|NCT00007332|AIDS Vaccines|aids vaccines
446799|NCT00007332|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
446800|NCT00007332|HIV Seronegativity|hiv seronegativity
446801|NCT00007332|AIDSVAX|aidsvax
446802|NCT00007332|HIV Preventive Vaccine|hiv preventive vaccine
446803|NCT00007345|Histone Acetylase|histone acetylase
446804|NCT00007345|Differentiation|differentiation
446805|NCT00007345|Sezary Syndrome|sezary syndrome
446806|NCT00007345|Mycosis Fungoides|mycosis fungoides
446807|NCT00007345|CD 30 Lymphoma|cd 30 lymphoma
446808|NCT00007358|Dexamethasone|dexamethasone
446809|NCT00007358|Anti-SSA/Ro antibodies|anti-ssa/ro antibodies
446810|NCT00007358|Anti-SSB/La antibodies|anti-ssb/la antibodies
446811|NCT00007358|Ultrasound|ultrasound
446812|NCT00007358|Atrioventricular (AV) nodal dysfunction|atrioventricular (av) nodal dysfunction
446813|NCT00007358|Echocardiograms|echocardiograms
446814|NCT00007358|Mothers|mothers
446815|NCT00007423|HIV Antibodies|hiv antibodies
446816|NCT00007423|HIV-1|hiv-1
446817|NCT00007423|AIDS Vaccines|aids vaccines
446818|NCT00007423|HIV Seronegativity|hiv seronegativity
446819|NCT00007423|Uganda|uganda
446820|NCT00007423|Cross Reactions|cross reactions
446821|NCT00007423|HIV Preventive Vaccine|hiv preventive vaccine
446822|NCT00007436|HIV-1|hiv-1
446823|NCT00007436|Drug Therapy, Combination|drug therapy, combination
446824|NCT00007436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
446825|NCT00007436|Anti-HIV Agents|anti-hiv agents
446826|NCT00007436|9-(2-phosphonylmethoxypropyl)adenine|9-(2-phosphonylmethoxypropyl)adenine
446827|NCT00007449|HIV-1|hiv-1
446828|NCT00007449|Drug Therapy, Combination|drug therapy, combination
446829|NCT00007449|RNA, Viral|rna, viral
446830|NCT00007449|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
446831|NCT00007449|Anti-HIV Agents|anti-hiv agents
446832|NCT00007449|Viral Load|viral load
446833|NCT00007475|Plasma Exchange|plasma exchange
446836|NCT00007475|Hemodialysis|hemodialysis
446837|NCT00007475|Expression Profiling|expression profiling
446839|NCT00007488|Lymphoid Tissue|lymphoid tissue
446840|NCT00007488|Viremia|viremia
446841|NCT00007488|RNA, Viral|rna, viral
446842|NCT00007488|Saliva|saliva
446843|NCT00007488|Anti-HIV Agents|anti-hiv agents
446844|NCT00007488|Viral Load|viral load
446845|NCT00007488|Genitalia, Female|genitalia, female
446846|NCT00007488|Genitalia, Male|genitalia, male
446160|NCT00005669|Child|child
446847|NCT00007501|varicella-zoster vaccine|varicella-zoster vaccine
446848|NCT00007514|olfactory functioning|olfactory functioning
446849|NCT00007514|neurotoxic exposure|neurotoxic exposure
446850|NCT00007514|Gulf War-era veterans|gulf war-era veterans
446851|NCT00007527|buprenorphine and naloxone|buprenorphine and naloxone
446852|NCT00007527|opiate dependence|opiate dependence
446853|NCT00007527|narcotic treatment|narcotic treatment
446854|NCT00007540|Prostate cancer|prostate cancer
446855|NCT00007540|CAG repeat sequence|cag repeat sequence
446856|NCT00007579|prostate cancer|prostate cancer
446857|NCT00007592|Hypertension|hypertension
446858|NCT00007592|national data base on the treatment of hypertension|national data base on the treatment of hypertension
446859|NCT00007592|cost of different antihypertensive regimens|cost of different antihypertensive regimens
446860|NCT00007605|amiodarone|amiodarone
446861|NCT00007605|atrial fibrillation converted to sinus rhythm|atrial fibrillation converted to sinus rhythm
446862|NCT00007605|cardiac mortality|cardiac mortality
446863|NCT00007605|major and minor bleeds|major and minor bleeds
446864|NCT00007605|sinus rhythm|sinus rhythm
446865|NCT00007605|sotalol|sotalol
446866|NCT00007618|colorectal cancer|colorectal cancer
446867|NCT00007631|NMSC|nmsc
446868|NCT00007631|nonmelanoma skin cancer|nonmelanoma skin cancer
446869|NCT00007631|topical tretinoin cream|topical tretinoin cream
446870|NCT00007644|cancer of the prostate (CAP)|cancer of the prostate (cap)
446871|NCT00007644|cancer treatment|cancer treatment
446872|NCT00007644|chronic diseases|chronic diseases
446873|NCT00007644|expectant management|expectant management
446874|NCT00007644|genitourinary|genitourinary
446875|NCT00007644|prostate|prostate
446876|NCT00007644|prostate specific cancer mortality|prostate specific cancer mortality
446877|NCT00007644|radical prostatectomy|radical prostatectomy
446878|NCT00007657|PCI plus intensive medical therapy|pci plus intensive medical therapy
446879|NCT00007670|gabapentin|gabapentin
446880|NCT00007670|lamotrigine|lamotrigine
11773|NCT03215511|ETV6 fusion|etv6 fusion
446881|NCT00007670|seizures in the elderly|seizures in the elderly
446883|NCT00007683|aspirin|aspirin
446884|NCT00007683|clopidogrel|clopidogrel
446885|NCT00007683|embolic events|embolic events
446886|NCT00007683|Left ventricular ejection fraction less than or eq|left ventricular ejection fraction less than or eq
446887|NCT00007683|NYHA Class II, III or IV CHF|nyha class ii, iii or iv chf
446888|NCT00007683|symptomatic CHF|symptomatic chf
446889|NCT00007683|warfarin|warfarin
446890|NCT00007696|Diabetes Mellitus,DM,glycemic control|diabetes mellitus,dm,glycemic control
446891|NCT00007709|Hepatitis C|hepatitis c
446892|NCT00007709|HIV|hiv
446893|NCT00007709|severe mental illness (SMI)|severe mental illness (smi)
446895|NCT00007722|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
446896|NCT00007722|Gulf War Veterans|gulf war veterans
446897|NCT00007735|antibiotic treatment|antibiotic treatment
446898|NCT00007735|mycoplasma species|mycoplasma species
446899|NCT00007735|Gulf War Veterans' Illnesses (GWI)|gulf war veterans' illnesses (gwi)
446900|NCT00007735|mycoplasma positive|mycoplasma positive
446901|NCT00007735|Gulf War Syndrome|gulf war syndrome
446902|NCT00007748|aerobic exercise|aerobic exercise
446903|NCT00007748|cognitive behavioral therapy|cognitive behavioral therapy
446904|NCT00007748|CBT|cbt
446905|NCT00007748|Gulf War Illnesses|gulf war illnesses
446906|NCT00007748|GWI|gwi
446907|NCT00007761|Bipolar Disease Program intervention|bipolar disease program intervention
446908|NCT00007774|Olanzapine, haloperidol, schizophrenia, schisoaffe|olanzapine, haloperidol, schizophrenia, schisoaffe
446909|NCT00007800|obesity treatment|obesity treatment
446910|NCT00007800|non insulin dependent diabetes|non insulin dependent diabetes
446911|NCT00007800|type 2 diabetes|type 2 diabetes
446912|NCT00007800|behavioral weight control|behavioral weight control
446913|NCT00007800|motivational interviewing|motivational interviewing
446914|NCT00007800|motivational enhancement|motivational enhancement
446915|NCT00007813|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
446916|NCT00007813|childhood craniopharyngioma|childhood craniopharyngioma
446917|NCT00007813|recurrent childhood brain tumor|recurrent childhood brain tumor
446918|NCT00007813|disseminated neuroblastoma|disseminated neuroblastoma
446919|NCT00007813|stage 4S neuroblastoma|stage 4s neuroblastoma
446920|NCT00007813|recurrent neuroblastoma|recurrent neuroblastoma
446921|NCT00007813|stage IV childhood liver cancer|stage iv childhood liver cancer
446922|NCT00007813|recurrent childhood liver cancer|recurrent childhood liver cancer
446923|NCT00007813|childhood hepatoblastoma|childhood hepatoblastoma
446924|NCT00007813|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
446925|NCT00007813|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
447056|NCT00007995|stage II multiple myeloma|stage ii multiple myeloma
446926|NCT00007813|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
446927|NCT00007813|childhood germ cell tumor|childhood germ cell tumor
446928|NCT00007813|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
446929|NCT00007813|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
446930|NCT00007813|extragonadal germ cell tumor|extragonadal germ cell tumor
446931|NCT00007813|childhood oligodendroglioma|childhood oligodendroglioma
446932|NCT00007813|childhood choroid plexus tumor|childhood choroid plexus tumor
446933|NCT00007813|childhood grade III meningioma|childhood grade iii meningioma
446934|NCT00007813|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
446935|NCT00007813|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
446936|NCT00007813|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
446937|NCT00007813|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
446938|NCT00007813|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
446939|NCT00007813|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
446940|NCT00007813|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
446941|NCT00007813|recurrent childhood ependymoma|recurrent childhood ependymoma
446942|NCT00007813|childhood teratoma|childhood teratoma
446943|NCT00007813|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
446944|NCT00007813|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
446945|NCT00007813|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
446946|NCT00007813|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
446947|NCT00007813|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
446948|NCT00007826|stage II colon cancer|stage ii colon cancer
446949|NCT00007826|stage III colon cancer|stage iii colon cancer
446950|NCT00007826|stage IV colon cancer|stage iv colon cancer
446951|NCT00007826|stage II rectal cancer|stage ii rectal cancer
446952|NCT00007826|stage III rectal cancer|stage iii rectal cancer
446953|NCT00007826|stage IV rectal cancer|stage iv rectal cancer
446954|NCT00007826|adenocarcinoma of the colon|adenocarcinoma of the colon
446955|NCT00007826|adenocarcinoma of the rectum|adenocarcinoma of the rectum
446956|NCT00007839|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
11774|NCT03215511|Metastatic cancer|metastatic cancer
446957|NCT00007839|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
446958|NCT00007839|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
446959|NCT00007839|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
446960|NCT00007839|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
446961|NCT00007839|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
446962|NCT00007839|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
446963|NCT00007839|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
583573|NCT00512239|Anti-CCP antibodies|anti-ccp antibodies
446964|NCT00007839|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
446965|NCT00007839|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
446966|NCT00007839|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
446967|NCT00007839|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
446968|NCT00007839|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
446969|NCT00007839|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
446970|NCT00007839|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
446971|NCT00007839|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
446972|NCT00007839|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
446973|NCT00007839|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
446974|NCT00007839|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
446975|NCT00007839|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
446976|NCT00007839|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
446977|NCT00007839|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
446978|NCT00007839|stage I marginal zone lymphoma|stage i marginal zone lymphoma
446979|NCT00007839|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
446980|NCT00007839|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
446981|NCT00007839|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
446982|NCT00007839|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
446983|NCT00007839|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
446984|NCT00007839|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
446985|NCT00007839|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
446986|NCT00007839|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
446987|NCT00007839|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
446988|NCT00007839|splenic marginal zone lymphoma|splenic marginal zone lymphoma
446989|NCT00007852|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
446990|NCT00007852|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
446991|NCT00007852|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
446992|NCT00007852|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
446993|NCT00007852|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
446994|NCT00007852|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
446995|NCT00007852|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
446996|NCT00007852|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
446997|NCT00007852|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
446998|NCT00007852|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
446999|NCT00007852|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
447000|NCT00007852|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
447001|NCT00007852|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
447002|NCT00007852|splenic marginal zone lymphoma|splenic marginal zone lymphoma
447003|NCT00007865|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
447004|NCT00007865|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
447005|NCT00007865|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
447006|NCT00007865|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
447007|NCT00007865|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
447008|NCT00007865|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
447009|NCT00007865|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
447010|NCT00007865|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
447011|NCT00007865|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
447012|NCT00007865|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
447013|NCT00007865|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
447014|NCT00007865|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
447015|NCT00007865|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
11776|NCT03215485|adolescent|adolescent
447016|NCT00007865|splenic marginal zone lymphoma|splenic marginal zone lymphoma
447017|NCT00007891|stage IV breast cancer|stage iv breast cancer
447018|NCT00007891|recurrent breast cancer|recurrent breast cancer
447019|NCT00007891|male breast cancer|male breast cancer
447020|NCT00007904|stage II breast cancer|stage ii breast cancer
447021|NCT00007904|stage IIIA breast cancer|stage iiia breast cancer
447022|NCT00007904|male breast cancer|male breast cancer
447023|NCT00007917|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
583574|NCT00512252|Plerixafor|plerixafor
447024|NCT00007930|stage I rectal cancer|stage i rectal cancer
447025|NCT00007930|stage II rectal cancer|stage ii rectal cancer
447026|NCT00007930|stage III rectal cancer|stage iii rectal cancer
447027|NCT00007943|stage III colon cancer|stage iii colon cancer
447028|NCT00007943|stage IV colon cancer|stage iv colon cancer
447029|NCT00007943|stage III rectal cancer|stage iii rectal cancer
447030|NCT00007943|stage IV rectal cancer|stage iv rectal cancer
447031|NCT00007943|recurrent colon cancer|recurrent colon cancer
447032|NCT00007943|recurrent rectal cancer|recurrent rectal cancer
447033|NCT00007956|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
447034|NCT00007956|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
447035|NCT00007956|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
447036|NCT00007956|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
447037|NCT00007956|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
447038|NCT00007956|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
447792|NCT00008463|Hepatitis C, Chronic|hepatitis c, chronic
447039|NCT00007956|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
447040|NCT00007956|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
447041|NCT00007956|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
447042|NCT00007956|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
447043|NCT00007969|stage III melanoma|stage iii melanoma
447044|NCT00007969|stage IV melanoma|stage iv melanoma
447045|NCT00007969|recurrent melanoma|recurrent melanoma
447046|NCT00007982|recurrent adult brain tumor|recurrent adult brain tumor
447047|NCT00007982|adult medulloblastoma|adult medulloblastoma
447048|NCT00007982|adult oligodendroglioma|adult oligodendroglioma
447049|NCT00007982|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
447050|NCT00007982|adult anaplastic astrocytoma|adult anaplastic astrocytoma
447051|NCT00007982|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
447052|NCT00007982|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
447053|NCT00007982|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
447054|NCT00007995|refractory multiple myeloma|refractory multiple myeloma
447055|NCT00007995|stage I multiple myeloma|stage i multiple myeloma
447057|NCT00007995|stage III multiple myeloma|stage iii multiple myeloma
447058|NCT00007995|primary systemic amyloidosis|primary systemic amyloidosis
447059|NCT00008008|childhood infratentorial ependymoma|childhood infratentorial ependymoma
447060|NCT00008008|childhood supratentorial ependymoma|childhood supratentorial ependymoma
447061|NCT00008008|recurrent adult brain tumor|recurrent adult brain tumor
447062|NCT00008008|adult medulloblastoma|adult medulloblastoma
447063|NCT00008008|adult glioblastoma|adult glioblastoma
447064|NCT00008008|adult oligodendroglioma|adult oligodendroglioma
447065|NCT00008008|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
447066|NCT00008008|childhood oligodendroglioma|childhood oligodendroglioma
447067|NCT00008008|adult anaplastic astrocytoma|adult anaplastic astrocytoma
447068|NCT00008008|adult anaplastic ependymoma|adult anaplastic ependymoma
447069|NCT00008008|adult mixed glioma|adult mixed glioma
447070|NCT00008008|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
447071|NCT00008008|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
447072|NCT00008008|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
447073|NCT00008008|recurrent childhood ependymoma|recurrent childhood ependymoma
447074|NCT00008008|adult giant cell glioblastoma|adult giant cell glioblastoma
447075|NCT00008008|adult gliosarcoma|adult gliosarcoma
447076|NCT00008008|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
447077|NCT00008021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
447078|NCT00008021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
447079|NCT00008021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
447080|NCT00008021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
447081|NCT00008021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
447082|NCT00008021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
447083|NCT00008021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
447084|NCT00008021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
447085|NCT00008021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
447086|NCT00008021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
447087|NCT00008021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
447088|NCT00008021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
447089|NCT00008021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
447090|NCT00008021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
447091|NCT00008021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
447093|NCT00008034|stage IIIA breast cancer|stage iiia breast cancer
447094|NCT00008034|stage IIIB breast cancer|stage iiib breast cancer
447095|NCT00008034|inflammatory breast cancer|inflammatory breast cancer
447096|NCT00008047|stage II esophageal cancer|stage ii esophageal cancer
447097|NCT00008047|stage III esophageal cancer|stage iii esophageal cancer
447098|NCT00008060|stage IV colon cancer|stage iv colon cancer
447099|NCT00008060|stage IV rectal cancer|stage iv rectal cancer
447100|NCT00008060|recurrent colon cancer|recurrent colon cancer
447101|NCT00008060|recurrent rectal cancer|recurrent rectal cancer
447102|NCT00008060|adenocarcinoma of the colon|adenocarcinoma of the colon
447103|NCT00008060|adenocarcinoma of the rectum|adenocarcinoma of the rectum
447104|NCT00008073|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
447105|NCT00008086|recurrent adult brain tumor|recurrent adult brain tumor
447106|NCT00008086|adult brain stem glioma|adult brain stem glioma
447107|NCT00008086|adult craniopharyngioma|adult craniopharyngioma
447108|NCT00008086|adult medulloblastoma|adult medulloblastoma
447109|NCT00008086|adult meningioma|adult meningioma
447110|NCT00008086|adult glioblastoma|adult glioblastoma
447111|NCT00008086|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
470239|NCT00063661|Mechanism|mechanism
447112|NCT00008086|adult anaplastic astrocytoma|adult anaplastic astrocytoma
447113|NCT00008086|adult myxopapillary ependymoma|adult myxopapillary ependymoma
447114|NCT00008086|adult anaplastic ependymoma|adult anaplastic ependymoma
447115|NCT00008086|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
447116|NCT00008086|adult mixed glioma|adult mixed glioma
447117|NCT00008086|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
447118|NCT00008086|adult pilocytic astrocytoma|adult pilocytic astrocytoma
447119|NCT00008086|adult subependymoma|adult subependymoma
447120|NCT00008086|adult ependymoblastoma|adult ependymoblastoma
447121|NCT00008086|adult pineocytoma|adult pineocytoma
447122|NCT00008086|adult pineoblastoma|adult pineoblastoma
447123|NCT00008086|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
447124|NCT00008086|adult choroid plexus tumor|adult choroid plexus tumor
447125|NCT00008086|adult grade III meningioma|adult grade iii meningioma
447126|NCT00008086|adult oligodendroglioma|adult oligodendroglioma
447127|NCT00008086|adult giant cell glioblastoma|adult giant cell glioblastoma
447128|NCT00008086|adult gliosarcoma|adult gliosarcoma
447129|NCT00008099|stage I pancreatic cancer|stage i pancreatic cancer
447130|NCT00008099|stage II pancreatic cancer|stage ii pancreatic cancer
467579|NCT00055302|MAS|mas
447131|NCT00008099|stage III pancreatic cancer|stage iii pancreatic cancer
447132|NCT00008099|stage IV pancreatic cancer|stage iv pancreatic cancer
447133|NCT00008112|stage III cervical cancer|stage iii cervical cancer
447134|NCT00008112|stage IIB cervical cancer|stage iib cervical cancer
447135|NCT00008112|stage IVA cervical cancer|stage iva cervical cancer
447136|NCT00008112|cervical squamous cell carcinoma|cervical squamous cell carcinoma
447137|NCT00008112|cervical adenocarcinoma|cervical adenocarcinoma
447138|NCT00008112|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
447139|NCT00008125|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
447140|NCT00008138|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
447141|NCT00008138|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
447142|NCT00008138|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
447143|NCT00008138|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
447144|NCT00008138|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
447145|NCT00008138|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
447146|NCT00008138|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
447147|NCT00008138|fallopian tube cancer|fallopian tube cancer
447148|NCT00008138|peritoneal cavity cancer|peritoneal cavity cancer
447149|NCT00008151|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
447150|NCT00008151|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
447151|NCT00008151|refractory anemia with excess blasts|refractory anemia with excess blasts
447152|NCT00008151|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
447153|NCT00008151|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
447154|NCT00008151|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
447155|NCT00008151|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
447156|NCT00008151|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
447157|NCT00008164|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
447158|NCT00008164|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
447159|NCT00008164|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
447160|NCT00008164|refractory multiple myeloma|refractory multiple myeloma
447161|NCT00008164|stage I multiple myeloma|stage i multiple myeloma
447162|NCT00008164|stage II multiple myeloma|stage ii multiple myeloma
447163|NCT00008164|stage III multiple myeloma|stage iii multiple myeloma
447164|NCT00008164|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
447165|NCT00008164|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
447166|NCT00008164|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
447167|NCT00008164|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
447168|NCT00008164|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
447169|NCT00008164|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
447170|NCT00008164|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
447171|NCT00008164|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
447172|NCT00008164|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
447173|NCT00008164|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
447174|NCT00008164|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
447175|NCT00008164|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
447176|NCT00008164|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
447177|NCT00008164|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
447178|NCT00008164|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
447179|NCT00008164|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
447180|NCT00008164|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
447181|NCT00008164|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
447182|NCT00008164|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
447183|NCT00008164|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
447184|NCT00008164|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
447185|NCT00008164|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
447186|NCT00008164|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
447187|NCT00008164|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
447188|NCT00008164|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
447189|NCT00008164|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
447190|NCT00008164|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
447191|NCT00008164|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
447192|NCT00008164|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
447193|NCT00008164|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
447194|NCT00008164|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
447195|NCT00008164|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
467840|NCT00063193|creatine|creatine
447196|NCT00008164|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
447197|NCT00008164|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
447198|NCT00008164|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
447199|NCT00008164|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
447200|NCT00008164|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
447201|NCT00008164|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
447202|NCT00008164|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
447203|NCT00008164|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
447204|NCT00008164|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
447205|NCT00008164|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
447206|NCT00008164|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
447207|NCT00008164|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
447208|NCT00008164|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
447209|NCT00008164|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
447210|NCT00008164|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
447211|NCT00008164|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
447212|NCT00008164|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
447213|NCT00008164|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
447214|NCT00008164|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
447215|NCT00008164|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
447216|NCT00008164|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
447217|NCT00008164|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
447218|NCT00008164|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
447219|NCT00008164|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
447220|NCT00008164|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
447221|NCT00008164|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
447222|NCT00008164|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
447223|NCT00008164|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
447224|NCT00008164|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
447225|NCT00008164|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
447226|NCT00008164|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
447227|NCT00008164|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
447228|NCT00008164|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
447229|NCT00008164|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
447230|NCT00008164|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
447231|NCT00008164|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
447232|NCT00008164|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
447233|NCT00008164|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
447234|NCT00008164|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
447235|NCT00008164|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
447236|NCT00008164|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
447237|NCT00008164|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
447238|NCT00008164|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
447239|NCT00008164|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
447240|NCT00008164|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
447241|NCT00008164|splenic marginal zone lymphoma|splenic marginal zone lymphoma
448425|NCT00006071|Brachial Reactivity|brachial reactivity
447242|NCT00008164|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
447243|NCT00008164|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
447244|NCT00008164|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
447245|NCT00008164|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
447246|NCT00008164|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
447247|NCT00008164|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
447248|NCT00008190|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
447249|NCT00008190|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
447250|NCT00008190|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
447251|NCT00008190|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
447252|NCT00008190|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
447253|NCT00008190|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
447254|NCT00008190|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
447255|NCT00008190|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
447256|NCT00008190|secondary acute myeloid leukemia|secondary acute myeloid leukemia
447257|NCT00008203|stage II breast cancer|stage ii breast cancer
447258|NCT00008203|stage IIIA breast cancer|stage iiia breast cancer
447259|NCT00008203|stage IIIB breast cancer|stage iiib breast cancer
447260|NCT00008216|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
447261|NCT00008216|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
447262|NCT00008216|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
447263|NCT00008216|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
447264|NCT00008216|refractory multiple myeloma|refractory multiple myeloma
447265|NCT00008216|stage I multiple myeloma|stage i multiple myeloma
447266|NCT00008216|stage II multiple myeloma|stage ii multiple myeloma
447267|NCT00008216|stage III multiple myeloma|stage iii multiple myeloma
447268|NCT00008216|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
447269|NCT00008216|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
447270|NCT00008216|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
447271|NCT00008216|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
447272|NCT00008216|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
447273|NCT00008216|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
447274|NCT00008216|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
447275|NCT00008216|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
447276|NCT00008216|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
447277|NCT00008216|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
447278|NCT00008216|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
447279|NCT00008216|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
447280|NCT00008216|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
447281|NCT00008216|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
447282|NCT00008216|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
447283|NCT00008216|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
447284|NCT00008216|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
447285|NCT00008216|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
447286|NCT00008216|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
447287|NCT00008216|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
447288|NCT00008216|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
447289|NCT00008216|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
447290|NCT00008216|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
447291|NCT00008216|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
447292|NCT00008216|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
447293|NCT00008216|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
447294|NCT00008216|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
447295|NCT00008216|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
447296|NCT00008216|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
447297|NCT00008216|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
447298|NCT00008216|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
447299|NCT00008216|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
447300|NCT00008216|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
447301|NCT00008216|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
447302|NCT00008216|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
447303|NCT00008216|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
447304|NCT00008216|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
447305|NCT00008216|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
447306|NCT00008216|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
447307|NCT00008216|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
447308|NCT00008216|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
447309|NCT00008216|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
447310|NCT00008216|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
447311|NCT00008216|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
447312|NCT00008216|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
447313|NCT00008216|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
447314|NCT00008216|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
447315|NCT00008216|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
447316|NCT00008216|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
447377|NCT00008216|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
447317|NCT00008216|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
447318|NCT00008216|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
447319|NCT00008216|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
447320|NCT00008216|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
447321|NCT00008216|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
447322|NCT00008216|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
447323|NCT00008216|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
447324|NCT00008216|secondary acute myeloid leukemia|secondary acute myeloid leukemia
447325|NCT00008216|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
447326|NCT00008216|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
447327|NCT00008216|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
447328|NCT00008216|intraocular lymphoma|intraocular lymphoma
447329|NCT00008216|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
447330|NCT00008216|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
447331|NCT00008216|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
447332|NCT00008216|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
447333|NCT00008216|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
447334|NCT00008216|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
447335|NCT00008216|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
447336|NCT00008216|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
447337|NCT00008216|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
447338|NCT00008216|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
447339|NCT00008216|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
447340|NCT00008216|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
447341|NCT00008216|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
447342|NCT00008216|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
447343|NCT00008216|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
447344|NCT00008216|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
447345|NCT00008216|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
447346|NCT00008216|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
447347|NCT00008216|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
447348|NCT00008216|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
447349|NCT00008216|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
447350|NCT00008216|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
447351|NCT00008216|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
447352|NCT00008216|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
447353|NCT00008216|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
447354|NCT00008216|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
447355|NCT00008216|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
447356|NCT00008216|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
447357|NCT00008216|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
447358|NCT00008216|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
447359|NCT00008216|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
447360|NCT00008216|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
447361|NCT00008216|anaplastic large cell lymphoma|anaplastic large cell lymphoma
447362|NCT00008216|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
447363|NCT00008216|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
447364|NCT00008216|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
447365|NCT00008216|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
447366|NCT00008216|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
447367|NCT00008216|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
447368|NCT00008216|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
447369|NCT00008216|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
447370|NCT00008216|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
447371|NCT00008216|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
447372|NCT00008216|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
447373|NCT00008216|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
447374|NCT00008216|splenic marginal zone lymphoma|splenic marginal zone lymphoma
447375|NCT00008216|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
447376|NCT00008216|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
447378|NCT00008216|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
447379|NCT00008216|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
447380|NCT00008216|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
447381|NCT00008216|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
447382|NCT00008216|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
447383|NCT00008216|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
447384|NCT00008216|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
447385|NCT00008216|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
447386|NCT00008216|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
447387|NCT00008216|adult Langerhans cell histiocytosis|adult langerhans cell histiocytosis
447388|NCT00008229|stage I multiple myeloma|stage i multiple myeloma
447389|NCT00008229|stage II multiple myeloma|stage ii multiple myeloma
447390|NCT00008229|stage III multiple myeloma|stage iii multiple myeloma
447391|NCT00008242|stage II multiple myeloma|stage ii multiple myeloma
447392|NCT00008242|stage III multiple myeloma|stage iii multiple myeloma
447393|NCT00008255|non-small cell lung cancer|non-small cell lung cancer
447394|NCT00008255|small cell lung cancer|small cell lung cancer
447395|NCT00008268|stage I multiple myeloma|stage i multiple myeloma
447396|NCT00008268|stage II multiple myeloma|stage ii multiple myeloma
447397|NCT00008268|stage III multiple myeloma|stage iii multiple myeloma
447398|NCT00008281|stage IV colon cancer|stage iv colon cancer
447399|NCT00008281|stage IV rectal cancer|stage iv rectal cancer
447400|NCT00008281|recurrent colon cancer|recurrent colon cancer
447401|NCT00008281|recurrent rectal cancer|recurrent rectal cancer
447402|NCT00008281|adenocarcinoma of the colon|adenocarcinoma of the colon
447403|NCT00008281|adenocarcinoma of the rectum|adenocarcinoma of the rectum
447404|NCT00008294|stage IV colon cancer|stage iv colon cancer
447405|NCT00008294|stage IV rectal cancer|stage iv rectal cancer
447406|NCT00008294|adenocarcinoma of the colon|adenocarcinoma of the colon
447407|NCT00008294|adenocarcinoma of the rectum|adenocarcinoma of the rectum
447408|NCT00008294|liver metastases|liver metastases
447409|NCT00008294|recurrent colon cancer|recurrent colon cancer
447410|NCT00008294|recurrent rectal cancer|recurrent rectal cancer
447411|NCT00008307|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
447412|NCT00008307|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
447413|NCT00008307|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
447414|NCT00008307|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
447415|NCT00008307|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
447416|NCT00008307|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
447417|NCT00008307|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
447418|NCT00008307|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
447419|NCT00008307|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
447420|NCT00008307|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
447421|NCT00008307|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
447422|NCT00008307|refractory multiple myeloma|refractory multiple myeloma
447423|NCT00008307|stage I multiple myeloma|stage i multiple myeloma
447424|NCT00008307|stage II multiple myeloma|stage ii multiple myeloma
447425|NCT00008307|stage III multiple myeloma|stage iii multiple myeloma
447426|NCT00008307|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
447427|NCT00008307|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
447428|NCT00008307|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
447429|NCT00008307|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
447430|NCT00008307|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
447431|NCT00008307|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
448426|NCT00006071|Endothelial Function|endothelial function
447432|NCT00008307|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
447433|NCT00008307|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
446894|NCT00007722|ALS|als
447434|NCT00008307|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
447435|NCT00008307|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
447436|NCT00008307|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
447437|NCT00008307|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
447438|NCT00008307|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
447439|NCT00008307|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
447440|NCT00008307|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
447441|NCT00008307|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
447442|NCT00008307|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
447443|NCT00008307|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
447444|NCT00008307|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
468909|NCT00059631|LDP-341|ldp-341
447445|NCT00008307|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
447446|NCT00008307|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
447447|NCT00008307|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
447448|NCT00008307|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
447449|NCT00008307|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
447450|NCT00008307|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
447451|NCT00008307|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
447452|NCT00008307|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
447453|NCT00008307|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
447454|NCT00008307|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
447455|NCT00008307|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
447456|NCT00008307|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
447457|NCT00008307|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
447458|NCT00008307|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
447459|NCT00008307|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
447460|NCT00008307|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
447461|NCT00008307|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
447462|NCT00008307|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
447463|NCT00008307|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
447464|NCT00008307|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
447465|NCT00008307|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
447466|NCT00008307|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
447467|NCT00008307|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
447468|NCT00008307|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
447469|NCT00008307|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
447470|NCT00008307|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
447471|NCT00008307|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
447472|NCT00008307|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
447473|NCT00008307|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
447474|NCT00008307|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
447475|NCT00008307|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
447476|NCT00008307|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
447477|NCT00008307|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
447478|NCT00008307|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
447479|NCT00008307|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
447480|NCT00008307|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
447481|NCT00008307|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
447482|NCT00008307|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
447483|NCT00008307|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
447484|NCT00008307|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
447485|NCT00008307|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
447486|NCT00008307|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
447487|NCT00008307|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
447488|NCT00008307|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
447489|NCT00008307|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
447490|NCT00008307|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
447491|NCT00008307|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
447492|NCT00008307|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
569852|NCT00463333|EEG|eeg
447493|NCT00008307|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
447494|NCT00008307|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
447495|NCT00008307|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
447496|NCT00008307|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
447497|NCT00008307|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
447498|NCT00008307|intraocular lymphoma|intraocular lymphoma
447499|NCT00008307|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
447500|NCT00008307|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
447501|NCT00008307|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
447502|NCT00008307|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
447503|NCT00008307|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
447504|NCT00008307|stage I mantle cell lymphoma|stage i mantle cell lymphoma
447505|NCT00008307|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
447506|NCT00008307|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
447507|NCT00008307|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
447601|NCT00008359|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
447508|NCT00008307|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
447509|NCT00008307|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
447510|NCT00008307|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
447511|NCT00008307|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
447512|NCT00008307|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
447513|NCT00008307|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
447514|NCT00008307|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
447515|NCT00008307|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
447516|NCT00008307|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
447517|NCT00008307|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
447518|NCT00008307|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
447519|NCT00008307|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
447520|NCT00008307|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
447521|NCT00008307|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
583576|NCT00512252|Chemosensitization|chemosensitization
447522|NCT00008307|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
447523|NCT00008307|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
447524|NCT00008307|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
447525|NCT00008307|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
447526|NCT00008307|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
447527|NCT00008307|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
447528|NCT00008307|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
447529|NCT00008307|anaplastic large cell lymphoma|anaplastic large cell lymphoma
447530|NCT00008307|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
447531|NCT00008307|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
447532|NCT00008307|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
447533|NCT00008307|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
447534|NCT00008307|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
447535|NCT00008307|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
447536|NCT00008307|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
447537|NCT00008307|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
447538|NCT00008307|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
447539|NCT00008307|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
447540|NCT00008307|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
447541|NCT00008307|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
447542|NCT00008307|splenic marginal zone lymphoma|splenic marginal zone lymphoma
447543|NCT00008307|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
447544|NCT00008307|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
447545|NCT00008307|stage I marginal zone lymphoma|stage i marginal zone lymphoma
447546|NCT00008307|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
447547|NCT00008307|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
447548|NCT00008307|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
447549|NCT00008307|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
447550|NCT00008307|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
447551|NCT00008307|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
447552|NCT00008307|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
447622|NCT00008359|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
447553|NCT00008307|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
447554|NCT00008307|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
447555|NCT00008307|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
447556|NCT00008307|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
447557|NCT00008320|stage IV breast cancer|stage iv breast cancer
447558|NCT00008320|recurrent breast cancer|recurrent breast cancer
447559|NCT00008333|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
447560|NCT00008333|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
447561|NCT00008346|breast cancer|breast cancer
447562|NCT00008359|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
447563|NCT00008359|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
447564|NCT00008359|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
447565|NCT00008359|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
447566|NCT00008359|stage IV breast cancer|stage iv breast cancer
447567|NCT00008359|stage IIIA breast cancer|stage iiia breast cancer
447568|NCT00008359|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
447569|NCT00008359|stage IIIB breast cancer|stage iiib breast cancer
447570|NCT00008359|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
447571|NCT00008359|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
447572|NCT00008359|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
447573|NCT00008359|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
447574|NCT00008359|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
447575|NCT00008359|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
447576|NCT00008359|isolated plasmacytoma of bone|isolated plasmacytoma of bone
447577|NCT00008359|extramedullary plasmacytoma|extramedullary plasmacytoma
447578|NCT00008359|refractory multiple myeloma|refractory multiple myeloma
447579|NCT00008359|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
447580|NCT00008359|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
447581|NCT00008359|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
447582|NCT00008359|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
447583|NCT00008359|disseminated neuroblastoma|disseminated neuroblastoma
447584|NCT00008359|recurrent neuroblastoma|recurrent neuroblastoma
447585|NCT00008359|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
447586|NCT00008359|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
447587|NCT00008359|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
447588|NCT00008359|stage I multiple myeloma|stage i multiple myeloma
447589|NCT00008359|stage II multiple myeloma|stage ii multiple myeloma
447590|NCT00008359|stage III multiple myeloma|stage iii multiple myeloma
447591|NCT00008359|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
447592|NCT00008359|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
447593|NCT00008359|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
447594|NCT00008359|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
447595|NCT00008359|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
447596|NCT00008359|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
447597|NCT00008359|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
447598|NCT00008359|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
447599|NCT00008359|small intestine lymphoma|small intestine lymphoma
447600|NCT00008359|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
447602|NCT00008359|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
447603|NCT00008359|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
447604|NCT00008359|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
447605|NCT00008359|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
447606|NCT00008359|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
447607|NCT00008359|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
447608|NCT00008359|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
447609|NCT00008359|polycythemia vera|polycythemia vera
447610|NCT00008359|primary myelofibrosis|primary myelofibrosis
447611|NCT00008359|essential thrombocythemia|essential thrombocythemia
447612|NCT00008359|fever, sweats, and hot flashes|fever, sweats, and hot flashes
447613|NCT00008359|testicular embryonal carcinoma|testicular embryonal carcinoma
447614|NCT00008359|testicular choriocarcinoma|testicular choriocarcinoma
447615|NCT00008359|testicular teratoma|testicular teratoma
447616|NCT00008359|testicular yolk sac tumor|testicular yolk sac tumor
447617|NCT00008359|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
447618|NCT00008359|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
447619|NCT00008359|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
447620|NCT00008359|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
447621|NCT00008359|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
447623|NCT00008359|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
447624|NCT00008359|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
447625|NCT00008359|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
447626|NCT00008359|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
447627|NCT00008359|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
447628|NCT00008359|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
447629|NCT00008359|refractory hairy cell leukemia|refractory hairy cell leukemia
447630|NCT00008359|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
447631|NCT00008359|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
447632|NCT00008359|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
447633|NCT00008359|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
447634|NCT00008359|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
447635|NCT00008359|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
447636|NCT00008359|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
447637|NCT00008359|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
447638|NCT00008359|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
447639|NCT00008359|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
447640|NCT00008359|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
447641|NCT00008359|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
447642|NCT00008359|ovarian yolk sac tumor|ovarian yolk sac tumor
447643|NCT00008359|ovarian embryonal carcinoma|ovarian embryonal carcinoma
447644|NCT00008359|ovarian polyembryoma|ovarian polyembryoma
447645|NCT00008359|ovarian choriocarcinoma|ovarian choriocarcinoma
447646|NCT00008359|ovarian immature teratoma|ovarian immature teratoma
447647|NCT00008359|ovarian mature teratoma|ovarian mature teratoma
447648|NCT00008359|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
447649|NCT00008359|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
447650|NCT00008359|acute undifferentiated leukemia|acute undifferentiated leukemia
447651|NCT00008359|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
447652|NCT00008359|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
447653|NCT00008359|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
447654|NCT00008359|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
447655|NCT00008359|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
447656|NCT00008359|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
447657|NCT00008359|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
447658|NCT00008359|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
447659|NCT00008359|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
447660|NCT00008359|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
447661|NCT00008359|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
447662|NCT00008359|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
447663|NCT00008359|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
447664|NCT00008359|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
447665|NCT00008359|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
447666|NCT00008359|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
447667|NCT00008359|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
447668|NCT00008359|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
447669|NCT00008359|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
447670|NCT00008359|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
447671|NCT00008359|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
447672|NCT00008359|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
447673|NCT00008359|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
447674|NCT00008359|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
447675|NCT00008359|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
447676|NCT00008359|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
447677|NCT00008359|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
447678|NCT00008359|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
447679|NCT00008359|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
447680|NCT00008359|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
447681|NCT00008359|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
447682|NCT00008359|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
447683|NCT00008359|secondary acute myeloid leukemia|secondary acute myeloid leukemia
447684|NCT00008359|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
447685|NCT00008359|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
447686|NCT00008359|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
447687|NCT00008359|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
447688|NCT00008359|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
447689|NCT00008359|neutropenia|neutropenia
447690|NCT00008359|infection|infection
447691|NCT00008359|prolymphocytic leukemia|prolymphocytic leukemia
447692|NCT00008359|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
447693|NCT00008359|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
447694|NCT00008359|primary systemic amyloidosis|primary systemic amyloidosis
447695|NCT00008359|intraocular lymphoma|intraocular lymphoma
447696|NCT00008359|stage I mantle cell lymphoma|stage i mantle cell lymphoma
447697|NCT00008359|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
447698|NCT00008359|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
447699|NCT00008359|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
447700|NCT00008359|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
447701|NCT00008359|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
447702|NCT00008359|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
447703|NCT00008359|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
447704|NCT00008359|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
447705|NCT00008359|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
447706|NCT00008359|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
447707|NCT00008359|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
447708|NCT00008359|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
447709|NCT00008359|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
447710|NCT00008359|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
447711|NCT00008359|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
447712|NCT00008359|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
447713|NCT00008359|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
447714|NCT00008359|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
447715|NCT00008359|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
447716|NCT00008359|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
447717|NCT00008359|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
447718|NCT00008359|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
447719|NCT00008359|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
447720|NCT00008359|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
447721|NCT00008359|anaplastic large cell lymphoma|anaplastic large cell lymphoma
447722|NCT00008359|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
447723|NCT00008359|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
11975|NCT03214302|Postpartum hepatitis|postpartum hepatitis
447724|NCT00008359|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
447725|NCT00008359|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
447726|NCT00008359|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
447727|NCT00008359|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
447728|NCT00008359|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
447729|NCT00008359|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
447730|NCT00008359|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
447731|NCT00008359|stage I marginal zone lymphoma|stage i marginal zone lymphoma
447732|NCT00008359|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
447733|NCT00008359|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
447734|NCT00008359|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
447735|NCT00008359|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
447736|NCT00008359|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
447737|NCT00008359|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
583575|NCT00512252|CXCR4|cxcr4
447738|NCT00008359|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
447739|NCT00008359|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
447740|NCT00008359|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
447741|NCT00008359|splenic marginal zone lymphoma|splenic marginal zone lymphoma
447742|NCT00008359|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
447743|NCT00008372|extensive stage small cell lung cancer|extensive stage small cell lung cancer
447744|NCT00008372|recurrent small cell lung cancer|recurrent small cell lung cancer
447745|NCT00008385|stage I non-small cell lung cancer|stage i non-small cell lung cancer
447746|NCT00008398|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
447747|NCT00008398|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
447748|NCT00008398|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
447749|NCT00008398|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
447750|NCT00008398|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
470243|NCT00063674|eating|eating
447751|NCT00008398|stage 0 paranasal sinus and nasal cavity cancer|stage 0 paranasal sinus and nasal cavity cancer
447752|NCT00008398|stage 0 nasopharyngeal cancer|stage 0 nasopharyngeal cancer
447753|NCT00008398|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
447754|NCT00008398|stage 0 laryngeal cancer|stage 0 laryngeal cancer
447755|NCT00008398|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
447756|NCT00008398|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
447757|NCT00008398|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
447758|NCT00008398|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
447759|NCT00008398|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
447760|NCT00008398|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
447761|NCT00008398|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
447762|NCT00008398|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
447763|NCT00008398|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
447764|NCT00008398|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
447765|NCT00008398|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
447766|NCT00008398|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
447767|NCT00008398|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
447768|NCT00008398|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
447769|NCT00008398|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
447770|NCT00008398|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
447771|NCT00008398|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
447772|NCT00008398|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
447773|NCT00008398|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
447774|NCT00008398|stage I oropharyngeal cancer|stage i oropharyngeal cancer
447775|NCT00008398|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
447776|NCT00008398|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
447777|NCT00008398|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
447778|NCT00008398|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
447779|NCT00008398|oral complications|oral complications
447780|NCT00008398|radiation toxicity|radiation toxicity
447781|NCT00008411|stage IV breast cancer|stage iv breast cancer
447782|NCT00008411|recurrent breast cancer|recurrent breast cancer
447783|NCT00008424|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
447784|NCT00008437|stage I breast cancer|stage i breast cancer
447785|NCT00008437|stage II breast cancer|stage ii breast cancer
447786|NCT00008437|stage IIIA breast cancer|stage iiia breast cancer
447787|NCT00008463|Ribavirin|ribavirin
447788|NCT00008463|Polyethylene Glycols|polyethylene glycols
447789|NCT00008463|Interferon Alfa-2a|interferon alfa-2a
447790|NCT00008463|HIV-1|hiv-1
447791|NCT00008463|Antiviral Agents|antiviral agents
447793|NCT00008476|Preemptive Analgesia|preemptive analgesia
447794|NCT00008476|Vanilloid|vanilloid
447795|NCT00008476|Vanilloid Receptor (VR)|vanilloid receptor (vr)
447797|NCT00008476|Acute Pain|acute pain
447798|NCT00008476|Orofacial|orofacial
447799|NCT00008476|Visual Analog Scale (VAS)|visual analog scale (vas)
447800|NCT00008476|Resiniferatoxin|resiniferatoxin
447801|NCT00008476|Healthy Volunteer|healthy volunteer
447802|NCT00008476|Wisdom Teeth|wisdom teeth
447803|NCT00008476|Pain|pain
447804|NCT00008489|Didanosine|didanosine
447805|NCT00008489|Gastrointestinal System|gastrointestinal system
447806|NCT00008489|Tablets|tablets
447807|NCT00008489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
447808|NCT00008489|Anti-HIV Agents|anti-hiv agents
447809|NCT00008489|Capsules|capsules
447810|NCT00008502|Genetics|genetics
447811|NCT00008502|African Americans|african americans
447812|NCT00008502|Skin|skin
447813|NCT00008502|Keloids|keloids
201020|NCT02112617|Ganglioneuroblastoma|ganglioneuroblastoma
447814|NCT00008502|Familial Disposition|familial disposition
447815|NCT00008515|Steroids|steroids
447816|NCT00008515|Age-Related Macular Degeneration|age-related macular degeneration
447817|NCT00008515|Implant|implant
447818|NCT00008515|Choroidal Neovascularization|choroidal neovascularization
447819|NCT00008515|Sustained Release Implant|sustained release implant
447820|NCT00008528|HIV-1|hiv-1
447821|NCT00008528|Drug Therapy, Combination|drug therapy, combination
447822|NCT00008528|Drug Resistance, Microbial|drug resistance, microbial
447823|NCT00008528|RNA, Viral|rna, viral
447824|NCT00008528|Membrane Fusion|membrane fusion
447825|NCT00008528|Anti-HIV Agents|anti-hiv agents
447826|NCT00008528|Viral Load|viral load
447827|NCT00005520|Hypertension|hypertension
447828|NCT00005520|Pharmacogenetics|pharmacogenetics
447829|NCT00005520|Hydrochlorothiazide|hydrochlorothiazide
447830|NCT00005520|Candesartan|candesartan
447831|NCT00005987|stage I multiple myeloma|stage i multiple myeloma
447832|NCT00005987|stage II multiple myeloma|stage ii multiple myeloma
447833|NCT00005987|stage III multiple myeloma|stage iii multiple myeloma
447834|NCT00005988|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
448427|NCT00006071|Endothelial Markers|endothelial markers
447835|NCT00005988|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
447836|NCT00005988|refractory multiple myeloma|refractory multiple myeloma
447837|NCT00005988|stage I multiple myeloma|stage i multiple myeloma
447838|NCT00005988|stage II multiple myeloma|stage ii multiple myeloma
447839|NCT00005988|stage III multiple myeloma|stage iii multiple myeloma
447840|NCT00005988|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
447841|NCT00005988|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
447842|NCT00005988|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
447843|NCT00005988|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
447844|NCT00005988|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
447845|NCT00005988|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
447846|NCT00005988|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
447847|NCT00005988|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
447848|NCT00005988|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
447849|NCT00005988|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
447850|NCT00005988|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
447851|NCT00005988|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
447852|NCT00005988|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
447853|NCT00005988|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
447854|NCT00005988|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
447855|NCT00005988|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
447856|NCT00005988|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
447857|NCT00005988|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
447858|NCT00005988|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
447859|NCT00005988|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
447860|NCT00005988|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
447861|NCT00005988|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
447862|NCT00005988|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
447863|NCT00005988|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
447864|NCT00005988|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
447865|NCT00005988|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
447866|NCT00005988|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
447867|NCT00005988|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
447868|NCT00005988|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
447869|NCT00005988|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
447870|NCT00005988|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
447871|NCT00005988|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
447872|NCT00005988|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
447873|NCT00005988|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
447874|NCT00005988|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
447875|NCT00005988|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
447876|NCT00005988|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
447877|NCT00005988|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
447878|NCT00005988|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
447879|NCT00005988|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
447880|NCT00005988|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
447881|NCT00005988|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
447882|NCT00005988|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
447883|NCT00005988|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
447884|NCT00005988|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
447885|NCT00005988|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
447886|NCT00005988|graft versus host disease|graft versus host disease
447887|NCT00005988|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
447888|NCT00005988|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
447889|NCT00005988|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
447890|NCT00005988|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
447891|NCT00005988|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
447892|NCT00005988|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
447893|NCT00005988|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
447894|NCT00005988|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
447895|NCT00005988|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
447896|NCT00005988|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
448428|NCT00006071|Forearm Flow|forearm flow
447897|NCT00005988|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
447898|NCT00005988|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
447899|NCT00005988|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
447900|NCT00005988|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
447901|NCT00005988|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
447902|NCT00005988|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
447903|NCT00005988|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
447904|NCT00005988|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
447905|NCT00005988|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
447906|NCT00005988|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
447907|NCT00005988|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
447908|NCT00005988|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
447909|NCT00005988|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
447910|NCT00005988|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
447911|NCT00005988|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
447912|NCT00005988|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
447913|NCT00005989|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
447914|NCT00005989|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
447915|NCT00005990|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
447916|NCT00005991|stage IV breast cancer|stage iv breast cancer
447917|NCT00005991|recurrent breast cancer|recurrent breast cancer
447918|NCT00006004|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
447919|NCT00006004|squamous cell lung cancer|squamous cell lung cancer
447920|NCT00006004|large cell lung cancer|large cell lung cancer
447921|NCT00006004|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
447922|NCT00006004|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
447923|NCT00006004|adenocarcinoma of the lung|adenocarcinoma of the lung
447924|NCT00006004|adenosquamous cell lung cancer|adenosquamous cell lung cancer
447925|NCT00006004|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
447926|NCT00006005|stage I uterine sarcoma|stage i uterine sarcoma
447927|NCT00006005|stage II uterine sarcoma|stage ii uterine sarcoma
447928|NCT00006005|stage III uterine sarcoma|stage iii uterine sarcoma
447929|NCT00006005|stage IV uterine sarcoma|stage iv uterine sarcoma
447930|NCT00006005|recurrent uterine sarcoma|recurrent uterine sarcoma
447931|NCT00006005|uterine carcinosarcoma|uterine carcinosarcoma
447932|NCT00006005|uterine leiomyosarcoma|uterine leiomyosarcoma
447933|NCT00006005|endometrial stromal sarcoma|endometrial stromal sarcoma
447934|NCT00006006|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
447935|NCT00006006|advanced adult primary liver cancer|advanced adult primary liver cancer
447936|NCT00006006|recurrent adult primary liver cancer|recurrent adult primary liver cancer
447937|NCT00006006|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
447938|NCT00006007|stage IV breast cancer|stage iv breast cancer
447939|NCT00006007|recurrent breast cancer|recurrent breast cancer
447940|NCT00006008|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
447941|NCT00006008|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
447942|NCT00006008|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
447943|NCT00006008|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
447944|NCT00006009|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
447945|NCT00006009|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
447946|NCT00006009|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
447947|NCT00006009|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
447948|NCT00006009|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
447949|NCT00006009|small intestine lymphoma|small intestine lymphoma
447950|NCT00006009|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
447951|NCT00006009|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
447952|NCT00006009|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
447953|NCT00006009|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
447954|NCT00006009|anaplastic large cell lymphoma|anaplastic large cell lymphoma
447955|NCT00006009|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
447956|NCT00006009|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
447957|NCT00006009|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
447958|NCT00006009|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
447959|NCT00006009|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
447960|NCT00006010|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
447961|NCT00006010|advanced adult primary liver cancer|advanced adult primary liver cancer
447962|NCT00006010|recurrent adult primary liver cancer|recurrent adult primary liver cancer
447963|NCT00006010|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
447964|NCT00006012|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
447965|NCT00006012|radiation toxicity|radiation toxicity
447966|NCT00006012|limited stage small cell lung cancer|limited stage small cell lung cancer
447967|NCT00006013|refractory multiple myeloma|refractory multiple myeloma
447968|NCT00006014|advanced malignant mesothelioma|advanced malignant mesothelioma
447969|NCT00006014|recurrent malignant mesothelioma|recurrent malignant mesothelioma
447970|NCT00006014|epithelial mesothelioma|epithelial mesothelioma
447971|NCT00006014|sarcomatous mesothelioma|sarcomatous mesothelioma
447972|NCT00006015|stage IV colon cancer|stage iv colon cancer
447973|NCT00006015|stage IV rectal cancer|stage iv rectal cancer
468910|NCT00059631|MLN341|mln341
447974|NCT00006015|recurrent colon cancer|recurrent colon cancer
447975|NCT00006015|recurrent rectal cancer|recurrent rectal cancer
447976|NCT00006015|adenocarcinoma of the colon|adenocarcinoma of the colon
447977|NCT00006015|adenocarcinoma of the rectum|adenocarcinoma of the rectum
447978|NCT00006017|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
447979|NCT00006017|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
447980|NCT00006017|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
447981|NCT00006018|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
447982|NCT00006019|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
447983|NCT00006019|refractory multiple myeloma|refractory multiple myeloma
447984|NCT00006019|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
447985|NCT00006019|recurrent prostate cancer|recurrent prostate cancer
447986|NCT00006019|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
447987|NCT00006019|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
447988|NCT00006019|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
447989|NCT00006019|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
447990|NCT00006019|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
447991|NCT00006019|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
447992|NCT00006019|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
447993|NCT00006019|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
447994|NCT00006019|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
447995|NCT00006019|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
447996|NCT00006019|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
447997|NCT00006019|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
447998|NCT00006019|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
447999|NCT00006019|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
448000|NCT00006019|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
448001|NCT00006019|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
448002|NCT00006019|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
448003|NCT00006019|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
448004|NCT00006019|splenic marginal zone lymphoma|splenic marginal zone lymphoma
448005|NCT00006020|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
448006|NCT00006020|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
448007|NCT00006020|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
448008|NCT00006020|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
448009|NCT00006020|non-T, non-B adult acute lymphoblastic leukemia|non-t, non-b adult acute lymphoblastic leukemia
448010|NCT00006021|refractory multiple myeloma|refractory multiple myeloma
448011|NCT00006021|stage II multiple myeloma|stage ii multiple myeloma
448012|NCT00006021|stage III multiple myeloma|stage iii multiple myeloma
448013|NCT00006022|stage III renal cell cancer|stage iii renal cell cancer
448014|NCT00006022|stage IV renal cell cancer|stage iv renal cell cancer
448015|NCT00006022|recurrent renal cell cancer|recurrent renal cell cancer
448016|NCT00006022|stage III melanoma|stage iii melanoma
448017|NCT00006022|stage IV melanoma|stage iv melanoma
448018|NCT00006022|recurrent melanoma|recurrent melanoma
448019|NCT00006023|stage IV prostate cancer|stage iv prostate cancer
448020|NCT00006023|recurrent prostate cancer|recurrent prostate cancer
448021|NCT00006024|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
448022|NCT00006025|recurrent adult brain tumor|recurrent adult brain tumor
448023|NCT00006025|adult glioblastoma|adult glioblastoma
448024|NCT00006025|adult anaplastic astrocytoma|adult anaplastic astrocytoma
448025|NCT00006025|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
448026|NCT00006025|adult mixed glioma|adult mixed glioma
448027|NCT00006025|adult giant cell glioblastoma|adult giant cell glioblastoma
448028|NCT00006025|adult gliosarcoma|adult gliosarcoma
448029|NCT00006026|recurrent bladder cancer|recurrent bladder cancer
448030|NCT00006026|stage IV bladder cancer|stage iv bladder cancer
448031|NCT00006026|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
448032|NCT00006026|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
448033|NCT00006026|adenocarcinoma of the bladder|adenocarcinoma of the bladder
448034|NCT00006026|recurrent urethral cancer|recurrent urethral cancer
448035|NCT00006026|anterior urethral cancer|anterior urethral cancer
448036|NCT00006026|posterior urethral cancer|posterior urethral cancer
448037|NCT00006026|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
448038|NCT00006026|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
448039|NCT00006026|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
448040|NCT00006026|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
448041|NCT00006027|stage I endometrial carcinoma|stage i endometrial carcinoma
469922|NCT00069238|Lymphoma|lymphoma
448042|NCT00006027|stage II endometrial carcinoma|stage ii endometrial carcinoma
448043|NCT00006027|endometrial adenocarcinoma|endometrial adenocarcinoma
448044|NCT00006027|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
448045|NCT00006027|endometrial adenoacanthoma|endometrial adenoacanthoma
448046|NCT00006027|endometrial clear cell carcinoma|endometrial clear cell carcinoma
448047|NCT00006027|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
448048|NCT00006028|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
448049|NCT00006028|primary peritoneal cavity cancer|primary peritoneal cavity cancer
448050|NCT00006029|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
571926|NCT00475189|PMS|pms
448051|NCT00006029|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
448052|NCT00006030|stage I breast cancer|stage i breast cancer
448053|NCT00006031|biopsy|biopsy
448054|NCT00006031|radioactive seed|radioactive seed
448055|NCT00006031|nonpalpable lesions|nonpalpable lesions
448056|NCT00006032|stage IV breast cancer|stage iv breast cancer
448057|NCT00006032|recurrent breast cancer|recurrent breast cancer
448058|NCT00006033|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
448059|NCT00006033|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
448060|NCT00006033|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
448061|NCT00006033|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
448062|NCT00006033|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
448063|NCT00006033|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
448064|NCT00006033|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
448065|NCT00006033|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
448066|NCT00006033|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
448067|NCT00006033|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
448068|NCT00006033|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
448069|NCT00006033|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
448070|NCT00006033|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
448071|NCT00006033|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
448072|NCT00006033|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
448073|NCT00006033|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
448074|NCT00006033|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
448075|NCT00006033|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
448076|NCT00006033|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
448078|NCT00006034|recurrent bladder cancer|recurrent bladder cancer
448079|NCT00006035|stage III melanoma|stage iii melanoma
448080|NCT00006035|stage IV melanoma|stage iv melanoma
448081|NCT00006035|recurrent melanoma|recurrent melanoma
448082|NCT00006036|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
448083|NCT00006036|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
448084|NCT00006036|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
448085|NCT00006036|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
448086|NCT00006036|extensive stage small cell lung cancer|extensive stage small cell lung cancer
448087|NCT00006036|recurrent small cell lung cancer|recurrent small cell lung cancer
448088|NCT00006036|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
448089|NCT00006036|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
448090|NCT00006036|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
448091|NCT00006036|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
448092|NCT00006036|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
448093|NCT00006036|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
448273|NCT00006043|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
448094|NCT00006036|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
448095|NCT00006036|ovarian stromal cancer|ovarian stromal cancer
448096|NCT00006036|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
448097|NCT00006036|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
448098|NCT00006036|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
448099|NCT00006036|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
448100|NCT00006036|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
448101|NCT00006036|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
448102|NCT00006036|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
448103|NCT00006036|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
448104|NCT00006036|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
448105|NCT00006036|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
448106|NCT00006036|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
448107|NCT00006036|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
448108|NCT00006036|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
448109|NCT00006036|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
448110|NCT00006036|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
448111|NCT00006036|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
448112|NCT00006036|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
448113|NCT00006036|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
448114|NCT00006036|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
448115|NCT00006036|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
448116|NCT00006036|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
448117|NCT00006036|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
448118|NCT00006036|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
448119|NCT00006036|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
448120|NCT00006036|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
448121|NCT00006036|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
448122|NCT00006036|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
448123|NCT00006036|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
448124|NCT00006036|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
448125|NCT00006036|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
448126|NCT00006036|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
448127|NCT00006036|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
448128|NCT00006036|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
448129|NCT00006036|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
448130|NCT00006036|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
448131|NCT00006036|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
448132|NCT00006036|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
448133|NCT00006036|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
448134|NCT00006036|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
448135|NCT00006036|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
448136|NCT00006036|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
448137|NCT00006036|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
448138|NCT00006036|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
448139|NCT00006036|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
448140|NCT00006036|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
448141|NCT00006036|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
448142|NCT00006036|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
448143|NCT00006036|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
448144|NCT00006036|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
448145|NCT00006036|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
448274|NCT00006044|stage IV prostate cancer|stage iv prostate cancer
448146|NCT00006036|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
448147|NCT00006036|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
448148|NCT00006036|ovarian sarcoma|ovarian sarcoma
448149|NCT00006037|stage IV colon cancer|stage iv colon cancer
448150|NCT00006037|stage IV rectal cancer|stage iv rectal cancer
448151|NCT00006037|recurrent colon cancer|recurrent colon cancer
448152|NCT00006037|recurrent rectal cancer|recurrent rectal cancer
448153|NCT00006037|adenocarcinoma of the colon|adenocarcinoma of the colon
448154|NCT00006037|adenocarcinoma of the rectum|adenocarcinoma of the rectum
448155|NCT00006038|stage II gastric cancer|stage ii gastric cancer
448156|NCT00006038|stage III gastric cancer|stage iii gastric cancer
448157|NCT00006038|stage IV gastric cancer|stage iv gastric cancer
448158|NCT00006038|stage II esophageal cancer|stage ii esophageal cancer
448159|NCT00006038|stage III esophageal cancer|stage iii esophageal cancer
448160|NCT00006038|adenocarcinoma of the stomach|adenocarcinoma of the stomach
448161|NCT00006038|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
448162|NCT00006039|small intestine lymphoma|small intestine lymphoma
448163|NCT00006039|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
448164|NCT00006039|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
448165|NCT00006039|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
448166|NCT00006039|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
448167|NCT00006039|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
448168|NCT00006039|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
448169|NCT00006039|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
448170|NCT00006039|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
448171|NCT00006039|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
448172|NCT00006039|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
448173|NCT00006039|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
448174|NCT00006039|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
448175|NCT00006039|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
448176|NCT00006039|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
448177|NCT00006039|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
448178|NCT00006039|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
448179|NCT00006039|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
448180|NCT00006039|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
448181|NCT00006039|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
448182|NCT00006039|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
11976|NCT03214289|Fecal Microbiota Transplantation|fecal microbiota transplantation
448183|NCT00006039|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
448184|NCT00006039|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
448185|NCT00006039|splenic marginal zone lymphoma|splenic marginal zone lymphoma
448186|NCT00006040|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
448187|NCT00006040|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
448188|NCT00006040|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
448189|NCT00006040|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
448190|NCT00006040|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
448191|NCT00006040|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
448192|NCT00006040|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
448193|NCT00006040|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
448194|NCT00006041|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
448195|NCT00006041|fallopian tube cancer|fallopian tube cancer
448196|NCT00006041|primary peritoneal cavity cancer|primary peritoneal cavity cancer
448197|NCT00006042|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
448198|NCT00006042|Burkitt lymphoma|burkitt lymphoma
448199|NCT00006042|refractory multiple myeloma|refractory multiple myeloma
448200|NCT00006042|stage II multiple myeloma|stage ii multiple myeloma
448201|NCT00006042|stage III multiple myeloma|stage iii multiple myeloma
448202|NCT00006042|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
448203|NCT00006042|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
448204|NCT00006042|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
448205|NCT00006042|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
448206|NCT00006042|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
448207|NCT00006042|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
448208|NCT00006042|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
448209|NCT00006042|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
448210|NCT00006042|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
448211|NCT00006042|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
448275|NCT00006044|recurrent prostate cancer|recurrent prostate cancer
448212|NCT00006042|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
448213|NCT00006042|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
448214|NCT00006042|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
448215|NCT00006042|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
448216|NCT00006042|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
448217|NCT00006042|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
448218|NCT00006042|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
448219|NCT00006042|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
448220|NCT00006042|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
470572|NCT00071877|Children|children
448221|NCT00006042|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
448222|NCT00006042|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
448223|NCT00006042|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
448224|NCT00006042|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
448225|NCT00006042|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
448226|NCT00006042|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
448227|NCT00006042|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
448228|NCT00006042|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
448229|NCT00006042|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
448230|NCT00006042|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
448231|NCT00006042|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
448232|NCT00006042|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
448233|NCT00006042|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
448234|NCT00006042|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
448235|NCT00006042|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
448236|NCT00006042|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
448237|NCT00006042|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
448238|NCT00006042|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
448239|NCT00006042|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
448240|NCT00006042|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
448241|NCT00006042|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
448242|NCT00006042|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
448243|NCT00006042|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
753010|NCT01175096|RAD001 (everolimus, Afinitor®)|rad001 (everolimus, afinitor®)
448244|NCT00006042|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
448245|NCT00006042|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
448246|NCT00006042|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
448247|NCT00006042|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
448248|NCT00006042|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
448249|NCT00006042|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
448250|NCT00006042|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
448251|NCT00006042|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
448252|NCT00006042|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
448253|NCT00006042|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
448254|NCT00006042|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
448255|NCT00006042|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
448256|NCT00006042|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
448257|NCT00006042|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
448258|NCT00006042|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
448259|NCT00006042|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
448260|NCT00006042|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
448261|NCT00006042|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
448262|NCT00006042|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
448263|NCT00006042|splenic marginal zone lymphoma|splenic marginal zone lymphoma
448264|NCT00006042|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
448265|NCT00006042|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
448266|NCT00006042|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
448267|NCT00006042|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
448268|NCT00006042|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
448269|NCT00006042|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
448270|NCT00006043|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
448271|NCT00006043|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
448272|NCT00006043|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
448276|NCT00006045|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
448277|NCT00006045|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
448278|NCT00006045|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
448279|NCT00006045|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
448280|NCT00006045|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
448281|NCT00006045|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
448282|NCT00006045|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
448283|NCT00006045|secondary acute myeloid leukemia|secondary acute myeloid leukemia
583577|NCT00512265|n-acetylcysteine|n-acetylcysteine
448284|NCT00006045|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
448285|NCT00006045|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
448286|NCT00006046|stage IV colon cancer|stage iv colon cancer
448287|NCT00006046|stage IV rectal cancer|stage iv rectal cancer
448288|NCT00006046|recurrent colon cancer|recurrent colon cancer
448289|NCT00006046|recurrent rectal cancer|recurrent rectal cancer
448290|NCT00006047|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
448291|NCT00006048|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
448292|NCT00006048|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
448293|NCT00006048|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
448294|NCT00006049|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
448295|NCT00006049|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
448296|NCT00006049|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
448297|NCT00006050|stage IV colon cancer|stage iv colon cancer
448298|NCT00006050|stage IV rectal cancer|stage iv rectal cancer
448299|NCT00006050|liver metastases|liver metastases
448300|NCT00006051|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
448301|NCT00006051|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
448302|NCT00006051|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
448303|NCT00006051|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
448304|NCT00006051|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
448305|NCT00006051|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
753011|NCT01175109|Chordoma|chordoma
448306|NCT00006051|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
448307|NCT00006051|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
12167|NCT03213106|TMS|tms
448308|NCT00006051|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
448309|NCT00006051|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
448310|NCT00006051|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
448311|NCT00006051|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
448312|NCT00006051|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
448313|NCT00006051|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
448314|NCT00006051|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
448315|NCT00006051|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
448316|NCT00006052|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
448317|NCT00006052|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
448318|NCT00006052|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
448319|NCT00006053|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
448320|NCT00006053|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
448321|NCT00006053|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
448322|NCT00006053|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
448323|NCT00006054|Chediak-Higashi syndrome|chediak-higashi syndrome
448324|NCT00006054|Langerhans cell histiocytosis|langerhans cell histiocytosis
448325|NCT00006054|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
448326|NCT00006054|X-linked agammaglobulinemia|x-linked agammaglobulinemia
448327|NCT00006054|X-linked hyper IgM syndrome|x-linked hyper igm syndrome
448328|NCT00006054|X-linked lymphoproliferative syndrome|x-linked lymphoproliferative syndrome
448329|NCT00006054|chronic granulomatous disease|chronic granulomatous disease
448330|NCT00006054|common variable immunodeficiency|common variable immunodeficiency
448331|NCT00006054|complement deficiency|complement deficiency
448332|NCT00006054|disease-related problem/condition|disease-related problem/condition
448333|NCT00006054|familial erythrophagocytic lymphohistiocytosis|familial erythrophagocytic lymphohistiocytosis
448334|NCT00006054|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
448335|NCT00006054|graft versus host disease|graft versus host disease
448336|NCT00006054|hematologic disorders|hematologic disorders
448337|NCT00006054|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
448338|NCT00006054|histiocytosis|histiocytosis
448339|NCT00006054|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
448340|NCT00006054|leukocyte adhesion deficiency syndrome|leukocyte adhesion deficiency syndrome
448341|NCT00006054|primary immunodeficiency disease|primary immunodeficiency disease
448342|NCT00006054|rare disease|rare disease
448343|NCT00006054|severe combined immunodeficiency|severe combined immunodeficiency
448344|NCT00006054|virus-associated hemophagocytic syndrome|virus-associated hemophagocytic syndrome
448345|NCT00006055|Churg-Strauss syndrome|churg-strauss syndrome
448346|NCT00006055|Schonlein-Henoch purpura|schonlein-henoch purpura
448347|NCT00006055|Takayasu arteritis|takayasu arteritis
448348|NCT00006055|Wegener's granulomatosis|wegener's granulomatosis
448349|NCT00006055|arthritis & connective tissue diseases|arthritis & connective tissue diseases
448350|NCT00006055|autoimmune hemolytic anemia|autoimmune hemolytic anemia
448351|NCT00006055|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
448352|NCT00006055|disease-related problem/condition|disease-related problem/condition
448353|NCT00006055|giant cell arteritis|giant cell arteritis
448354|NCT00006055|graft versus host disease|graft versus host disease
448355|NCT00006055|hematologic disorders|hematologic disorders
448356|NCT00006055|hypersensitivity vasculitis|hypersensitivity vasculitis
448357|NCT00006055|immune thrombocytopenic purpura|immune thrombocytopenic purpura
449085|NCT00006165|Diabetes Mellitus|diabetes mellitus
448358|NCT00006055|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
448359|NCT00006055|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
448360|NCT00006055|polyarteritis nodosa|polyarteritis nodosa
448361|NCT00006055|pure red cell aplasia|pure red cell aplasia
448362|NCT00006055|rare disease|rare disease
448363|NCT00006055|rheumatoid arthritis|rheumatoid arthritis
448364|NCT00006055|systemic lupus erythematosus|systemic lupus erythematosus
448365|NCT00006055|vasculitis|vasculitis
448366|NCT00006056|Chediak-Higashi syndrome|chediak-higashi syndrome
448367|NCT00006056|X-linked lymphoproliferative syndrome|x-linked lymphoproliferative syndrome
448368|NCT00006056|disease-related problem/condition|disease-related problem/condition
448369|NCT00006056|familial erythrophagocytic lymphohistiocytosis|familial erythrophagocytic lymphohistiocytosis
448370|NCT00006056|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
448371|NCT00006056|graft versus host disease|graft versus host disease
448372|NCT00006056|hematologic disorders|hematologic disorders
448373|NCT00006056|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
448374|NCT00006056|histiocytosis|histiocytosis
448375|NCT00006056|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
448376|NCT00006056|primary immunodeficiency disease|primary immunodeficiency disease
448377|NCT00006056|rare disease|rare disease
448378|NCT00006056|virus-associated hemophagocytic syndrome|virus-associated hemophagocytic syndrome
448379|NCT00006058|bronchopulmonary dysplasia|bronchopulmonary dysplasia
448380|NCT00006058|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
448381|NCT00006058|neonatal disorders|neonatal disorders
448382|NCT00006058|rare disease|rare disease
448383|NCT00006058|respiratory distress syndrome|respiratory distress syndrome
448384|NCT00006059|epilepsy|epilepsy
448385|NCT00006059|neurologic and psychiatric disorders|neurologic and psychiatric disorders
448386|NCT00006059|rare disease|rare disease
448387|NCT00006059|seizures|seizures
448388|NCT00006060|multiple sclerosis|multiple sclerosis
448389|NCT00006060|neurologic and psychiatric disorders|neurologic and psychiatric disorders
448390|NCT00006060|rare disease|rare disease
448391|NCT00006061|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
448392|NCT00006061|inborn errors of metabolism|inborn errors of metabolism
448393|NCT00006061|methionine adenosyltransferase deficiency|methionine adenosyltransferase deficiency
448394|NCT00006061|rare disease|rare disease
448395|NCT00006062|Liver Impairment|liver impairment
448396|NCT00006062|Pharmacokinetics|pharmacokinetics
448397|NCT00006062|Platinum Analogues|platinum analogues
448398|NCT00006063|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
448399|NCT00006063|cystic fibrosis|cystic fibrosis
448400|NCT00006063|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
448401|NCT00006063|rare disease|rare disease
448402|NCT00006064|Tumor Necrosis Factor|tumor necrosis factor
448403|NCT00006064|CD4 Lymphocyte Count|cd4 lymphocyte count
448404|NCT00006064|Polymerase Chain Reaction|polymerase chain reaction
448405|NCT00006064|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
448406|NCT00006064|RNA, Messenger|rna, messenger
448407|NCT00006064|Interleukin-1|interleukin-1
448408|NCT00006064|Body Composition|body composition
448409|NCT00006064|Anti-HIV Agents|anti-hiv agents
448410|NCT00006064|Viral Load|viral load
448411|NCT00006064|Age Factors|age factors
448412|NCT00006064|Anthropometry|anthropometry
448413|NCT00006066|Injections, Subcutaneous|injections, subcutaneous
448414|NCT00006066|Interleukin-2|interleukin-2
448415|NCT00006066|Dose-Response Relationship, Drug|dose-response relationship, drug
448416|NCT00006066|Drug Therapy, Combination|drug therapy, combination
448417|NCT00006066|Immunocompromised Host|immunocompromised host
448418|NCT00006066|CD4 Lymphocyte Count|cd4 lymphocyte count
448419|NCT00006066|Anti-HIV Agents|anti-hiv agents
448420|NCT00006070|Oral Surgery|oral surgery
448421|NCT00006070|Swelling|swelling
448429|NCT00006071|Insulin Resistance|insulin resistance
448430|NCT00006071|Elevated Cholesterol|elevated cholesterol
448431|NCT00006071|Hypertension|hypertension
448432|NCT00006073|Evaluation|evaluation
448433|NCT00006073|Endocrinology|endocrinology
448434|NCT00006073|Hormones|hormones
448435|NCT00006073|Metabolism|metabolism
448436|NCT00006073|Teaching|teaching
448437|NCT00006073|Endocrine Disorder|endocrine disorder
448438|NCT00006075|Pregnancy Complications, Infectious|pregnancy complications, infectious
448439|NCT00006075|Dose-Response Relationship, Drug|dose-response relationship, drug
448440|NCT00006075|Polymerase Chain Reaction|polymerase chain reaction
448441|NCT00006075|Disease Transmission, Vertical|disease transmission, vertical
448442|NCT00006075|Labor|labor
448443|NCT00006075|Disinfectants|disinfectants
448444|NCT00006075|Vagina|vagina
448445|NCT00006075|Chlorhexidine|chlorhexidine
448446|NCT00006075|Irrigation|irrigation
448447|NCT00006076|Hearing|hearing
448448|NCT00006076|Auditory Processing|auditory processing
448449|NCT00006076|Pitch Recognition|pitch recognition
448450|NCT00006076|Tone Deafness|tone deafness
448451|NCT00006076|Tune Deafness|tune deafness
448452|NCT00006076|HV|hv
448453|NCT00006076|Deafness|deafness
448454|NCT00006076|Congenital Amusia|congenital amusia
448455|NCT00006076|Healthy Volunteer|healthy volunteer
448456|NCT00006077|Clinical Trial|clinical trial
448457|NCT00006077|Dyskinesias|dyskinesias
448458|NCT00006077|Levodopa Infusion|levodopa infusion
448459|NCT00006077|Parkinson's Disease|parkinson's disease
448460|NCT00006078|prostate cancer|prostate cancer
448461|NCT00006079|cervical cancer|cervical cancer
448462|NCT00006079|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
448463|NCT00006079|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
448464|NCT00006079|Eflornithine|eflornithine
448465|NCT00006080|recurrent adult brain tumor|recurrent adult brain tumor
448466|NCT00006080|adult anaplastic astrocytoma|adult anaplastic astrocytoma
448467|NCT00006080|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
448468|NCT00006080|adult mixed glioma|adult mixed glioma
448469|NCT00006081|stage III gastric cancer|stage iii gastric cancer
448470|NCT00006081|stage IV gastric cancer|stage iv gastric cancer
448471|NCT00006081|stage III esophageal cancer|stage iii esophageal cancer
448472|NCT00006081|stage IV esophageal cancer|stage iv esophageal cancer
448473|NCT00006081|adenocarcinoma of the stomach|adenocarcinoma of the stomach
448474|NCT00006081|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
448475|NCT00006082|extensive stage small cell lung cancer|extensive stage small cell lung cancer
448476|NCT00006082|recurrent small cell lung cancer|recurrent small cell lung cancer
448477|NCT00006083|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
448478|NCT00006083|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
448479|NCT00006083|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
448480|NCT00006083|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
448481|NCT00006083|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
448482|NCT00006083|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
448483|NCT00006083|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
448484|NCT00006083|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
448485|NCT00006083|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
448486|NCT00006083|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
448487|NCT00006083|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
448488|NCT00006083|stage IB cervical cancer|stage ib cervical cancer
448489|NCT00006083|Burkitt lymphoma|burkitt lymphoma
448490|NCT00006083|isolated plasmacytoma of bone|isolated plasmacytoma of bone
448491|NCT00006083|extramedullary plasmacytoma|extramedullary plasmacytoma
448492|NCT00006083|refractory multiple myeloma|refractory multiple myeloma
448493|NCT00006083|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
448494|NCT00006083|stage I multiple myeloma|stage i multiple myeloma
448495|NCT00006083|stage II multiple myeloma|stage ii multiple myeloma
448496|NCT00006083|stage III multiple myeloma|stage iii multiple myeloma
448497|NCT00006083|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
448498|NCT00006083|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
448499|NCT00006083|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
448500|NCT00006083|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
448501|NCT00006083|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
448502|NCT00006083|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
448503|NCT00006083|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
448504|NCT00006083|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
448505|NCT00006083|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
448506|NCT00006083|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
448507|NCT00006083|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
448508|NCT00006083|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
448509|NCT00006083|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
448510|NCT00006083|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
448511|NCT00006083|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
583578|NCT00512265|esophagectomy|esophagectomy
448512|NCT00006083|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
448513|NCT00006083|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
448514|NCT00006083|essential thrombocythemia|essential thrombocythemia
448515|NCT00006083|untreated hairy cell leukemia|untreated hairy cell leukemia
471022|NCT00073801|Neuroimmune|neuroimmune
448516|NCT00006083|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
448517|NCT00006083|refractory hairy cell leukemia|refractory hairy cell leukemia
448518|NCT00006083|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
448519|NCT00006083|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
448520|NCT00006083|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
448521|NCT00006083|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
448522|NCT00006083|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
448523|NCT00006083|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
448524|NCT00006083|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
448525|NCT00006083|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
448526|NCT00006083|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
448527|NCT00006083|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
448528|NCT00006083|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
448529|NCT00006083|acute undifferentiated leukemia|acute undifferentiated leukemia
448530|NCT00006083|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
448531|NCT00006083|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
448532|NCT00006083|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
448533|NCT00006083|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
448534|NCT00006083|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
448535|NCT00006083|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
448536|NCT00006083|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
448537|NCT00006083|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
448538|NCT00006083|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
448539|NCT00006083|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
448540|NCT00006083|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
448541|NCT00006083|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
448542|NCT00006083|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
448543|NCT00006083|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
448544|NCT00006083|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
448545|NCT00006083|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
448546|NCT00006083|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
448547|NCT00006083|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
448548|NCT00006083|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
448549|NCT00006083|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
448550|NCT00006083|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
448551|NCT00006083|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
448552|NCT00006083|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
448553|NCT00006083|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
448554|NCT00006083|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
448555|NCT00006083|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
448556|NCT00006083|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
448557|NCT00006083|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
448558|NCT00006083|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
448559|NCT00006083|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
448560|NCT00006083|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
448561|NCT00006083|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
448562|NCT00006083|secondary acute myeloid leukemia|secondary acute myeloid leukemia
448563|NCT00006083|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
448564|NCT00006083|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
448565|NCT00006083|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
448566|NCT00006083|primary central nervous system lymphoma|primary central nervous system lymphoma
448567|NCT00006083|prolymphocytic leukemia|prolymphocytic leukemia
448568|NCT00006083|primary systemic amyloidosis|primary systemic amyloidosis
448569|NCT00006083|veno-occlusive disease|veno-occlusive disease
448570|NCT00006083|stage I mantle cell lymphoma|stage i mantle cell lymphoma
448571|NCT00006083|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
448572|NCT00006083|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
448633|NCT00006092|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
583579|NCT00512265|inflammatory reaction|inflammatory reaction
448573|NCT00006083|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
448574|NCT00006083|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
448575|NCT00006083|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
448576|NCT00006083|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
448577|NCT00006083|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
448578|NCT00006083|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
448579|NCT00006083|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
448580|NCT00006083|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
448581|NCT00006083|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
448582|NCT00006083|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
448583|NCT00006083|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
448584|NCT00006083|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
448585|NCT00006083|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
448586|NCT00006083|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
448587|NCT00006083|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
448588|NCT00006083|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
448589|NCT00006083|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
201021|NCT02112617|Pediatric neuroblastoma|pediatric neuroblastoma
448590|NCT00006083|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
448591|NCT00006083|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
448592|NCT00006083|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
448593|NCT00006083|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
448594|NCT00006083|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
448595|NCT00006083|anaplastic large cell lymphoma|anaplastic large cell lymphoma
448596|NCT00006083|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
448597|NCT00006083|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
448598|NCT00006083|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
448599|NCT00006083|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
448600|NCT00006083|stage I marginal zone lymphoma|stage i marginal zone lymphoma
448601|NCT00006083|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
448602|NCT00006083|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
448603|NCT00006083|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
448604|NCT00006083|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
448605|NCT00006083|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
448606|NCT00006083|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
448607|NCT00006083|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
448608|NCT00006083|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
448609|NCT00006083|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
448610|NCT00006083|splenic marginal zone lymphoma|splenic marginal zone lymphoma
448611|NCT00006084|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
448612|NCT00006084|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
448613|NCT00006084|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
448614|NCT00006084|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
448615|NCT00006084|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
448616|NCT00006084|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
448617|NCT00006084|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
448618|NCT00006084|secondary acute myeloid leukemia|secondary acute myeloid leukemia
448619|NCT00006084|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
448620|NCT00006084|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
448621|NCT00006085|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
448622|NCT00006086|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
448623|NCT00006087|non-small cell lung cancer|non-small cell lung cancer
448624|NCT00006087|small cell lung cancer|small cell lung cancer
448625|NCT00006088|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
448626|NCT00006090|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
448627|NCT00006090|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
448628|NCT00006091|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
448629|NCT00006091|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
448630|NCT00006091|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
448631|NCT00006092|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
448632|NCT00006092|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
448634|NCT00006092|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
448635|NCT00006092|lymphoid leukemia|lymphoid leukemia
448636|NCT00006092|myeloid and monocytic leukemia|myeloid and monocytic leukemia
448637|NCT00006093|recurrent adult brain tumor|recurrent adult brain tumor
448638|NCT00006093|adult glioblastoma|adult glioblastoma
448639|NCT00006093|adult anaplastic astrocytoma|adult anaplastic astrocytoma
448640|NCT00006093|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
448641|NCT00006093|adult giant cell glioblastoma|adult giant cell glioblastoma
448642|NCT00006093|adult gliosarcoma|adult gliosarcoma
448643|NCT00006095|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
448644|NCT00006096|stage I vulvar cancer|stage i vulvar cancer
448645|NCT00006096|stage II vulvar cancer|stage ii vulvar cancer
448646|NCT00006096|stage III vulvar cancer|stage iii vulvar cancer
448647|NCT00006096|stage IVB vulvar cancer|stage ivb vulvar cancer
448648|NCT00006096|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
448649|NCT00006097|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
448650|NCT00006097|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
448651|NCT00006098|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
448652|NCT00006098|refractory multiple myeloma|refractory multiple myeloma
448653|NCT00006098|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
448654|NCT00006098|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
448655|NCT00006098|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
448656|NCT00006098|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
448657|NCT00006098|refractory anemia with excess blasts|refractory anemia with excess blasts
448658|NCT00006098|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
448659|NCT00006098|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
448660|NCT00006098|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
448661|NCT00006098|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
449086|NCT00006165|Lifestyle Intervention|lifestyle intervention
448662|NCT00006098|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
448663|NCT00006098|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
448664|NCT00006098|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
448665|NCT00006098|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
448666|NCT00006098|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
448667|NCT00006098|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
448668|NCT00006098|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
448669|NCT00006098|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
448670|NCT00006098|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
448671|NCT00006098|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
448672|NCT00006098|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
448673|NCT00006098|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
448674|NCT00006098|splenic marginal zone lymphoma|splenic marginal zone lymphoma
448675|NCT00006099|ovarian epithelial cancer|ovarian epithelial cancer
448676|NCT00006100|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
448677|NCT00006101|stage I prostate cancer|stage i prostate cancer
448678|NCT00006102|childhood infratentorial ependymoma|childhood infratentorial ependymoma
448679|NCT00006102|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
448680|NCT00006102|childhood supratentorial ependymoma|childhood supratentorial ependymoma
448681|NCT00006102|childhood craniopharyngioma|childhood craniopharyngioma
448682|NCT00006102|disseminated neuroblastoma|disseminated neuroblastoma
448683|NCT00006102|recurrent neuroblastoma|recurrent neuroblastoma
448684|NCT00006102|intraocular retinoblastoma|intraocular retinoblastoma
448685|NCT00006102|extraocular retinoblastoma|extraocular retinoblastoma
448686|NCT00006102|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
448687|NCT00006102|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
448688|NCT00006102|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
448689|NCT00006102|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
448690|NCT00006102|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
448691|NCT00006102|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
448692|NCT00006102|childhood oligodendroglioma|childhood oligodendroglioma
448693|NCT00006102|childhood choroid plexus tumor|childhood choroid plexus tumor
448694|NCT00006102|childhood grade I meningioma|childhood grade i meningioma
448695|NCT00006102|childhood grade II meningioma|childhood grade ii meningioma
448696|NCT00006102|childhood grade III meningioma|childhood grade iii meningioma
448697|NCT00006102|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
448698|NCT00006102|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
448699|NCT00006102|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
448700|NCT00006102|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
449298|NCT00009035|Brain|brain
448701|NCT00006102|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
448702|NCT00006102|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
448703|NCT00006102|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
448704|NCT00006102|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
448705|NCT00006102|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
471264|NCT00067028|DepoCyt|depocyt
448706|NCT00006102|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
448707|NCT00006102|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
448708|NCT00006102|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
448709|NCT00006102|recurrent childhood ependymoma|recurrent childhood ependymoma
448710|NCT00006102|recurrent retinoblastoma|recurrent retinoblastoma
448711|NCT00006103|stage III colon cancer|stage iii colon cancer
448712|NCT00006103|stage IV colon cancer|stage iv colon cancer
448713|NCT00006103|stage III rectal cancer|stage iii rectal cancer
448714|NCT00006103|stage IV rectal cancer|stage iv rectal cancer
448715|NCT00006103|recurrent colon cancer|recurrent colon cancer
448716|NCT00006103|recurrent rectal cancer|recurrent rectal cancer
448717|NCT00006103|adenocarcinoma of the colon|adenocarcinoma of the colon
448718|NCT00006103|adenocarcinoma of the rectum|adenocarcinoma of the rectum
448719|NCT00006104|stage IV breast cancer|stage iv breast cancer
448720|NCT00006104|recurrent breast cancer|recurrent breast cancer
448721|NCT00006105|stage II bladder cancer|stage ii bladder cancer
448722|NCT00006105|stage III bladder cancer|stage iii bladder cancer
448723|NCT00006105|stage IV bladder cancer|stage iv bladder cancer
448724|NCT00006105|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
448725|NCT00006106|adult solid tumor|adult solid tumor
448726|NCT00006106|body system/site cancer|body system/site cancer
448727|NCT00006106|cancer|cancer
448728|NCT00006106|cellular diagnosis, hypopharyngeal cancer|cellular diagnosis, hypopharyngeal cancer
448729|NCT00006106|cellular diagnosis, laryngeal cancer|cellular diagnosis, laryngeal cancer
448730|NCT00006106|cellular diagnosis, lip and oral cavity cancer|cellular diagnosis, lip and oral cavity cancer
448731|NCT00006106|cellular diagnosis, nasopharyngeal cancer|cellular diagnosis, nasopharyngeal cancer
448732|NCT00006106|cellular diagnosis, oropharyngeal cancer|cellular diagnosis, oropharyngeal cancer
448733|NCT00006106|cellular diagnosis, paranasal sinus and nasal cavity cancer|cellular diagnosis, paranasal sinus and nasal cavity cancer
448734|NCT00006106|head and neck cancer|head and neck cancer
448735|NCT00006106|hypopharyngeal cancer|hypopharyngeal cancer
448736|NCT00006106|hypopharyngeal squamous cell carcinoma|hypopharyngeal squamous cell carcinoma
448737|NCT00006106|laryngeal cancer|laryngeal cancer
448738|NCT00006106|laryngeal squamous cell carcinoma|laryngeal squamous cell carcinoma
448739|NCT00006106|lip and oral cavity cancer|lip and oral cavity cancer
448740|NCT00006106|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
448741|NCT00006106|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
448742|NCT00006106|nasopharyngeal cancer|nasopharyngeal cancer
448743|NCT00006106|nasopharyngeal squamous cell carcinoma|nasopharyngeal squamous cell carcinoma
448744|NCT00006106|oropharyngeal cancer|oropharyngeal cancer
448745|NCT00006106|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
448746|NCT00006106|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
448747|NCT00006106|paranasal sinus and nasal cavity squamous cell carcinoma|paranasal sinus and nasal cavity squamous cell carcinoma
448748|NCT00006106|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
448749|NCT00006106|recurrent laryngeal cancer|recurrent laryngeal cancer
448750|NCT00006106|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
448751|NCT00006106|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
448752|NCT00006106|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
448753|NCT00006106|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
448754|NCT00006106|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
448755|NCT00006106|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
448756|NCT00006106|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
448757|NCT00006106|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
448758|NCT00006106|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
448759|NCT00006106|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
448760|NCT00006106|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
448762|NCT00006106|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
448763|NCT00006106|stage III laryngeal cancer|stage iii laryngeal cancer
448764|NCT00006106|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
448765|NCT00006106|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
448766|NCT00006106|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
448767|NCT00006106|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
448768|NCT00006106|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
449299|NCT00009035|Tumor|tumor
448769|NCT00006106|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
448770|NCT00006106|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
448771|NCT00006106|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
448772|NCT00006106|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
448832|NCT00006111|stage III bladder cancer|stage iii bladder cancer
448773|NCT00006106|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
448774|NCT00006106|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
448775|NCT00006106|stage IV laryngeal cancer|stage iv laryngeal cancer
448776|NCT00006106|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
448777|NCT00006106|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
448778|NCT00006106|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
448779|NCT00006106|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
448780|NCT00006106|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
448781|NCT00006106|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
448782|NCT00006106|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
448783|NCT00006106|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
448784|NCT00006106|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
448785|NCT00006106|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
448786|NCT00006106|stage, hypopharyngeal cancer|stage, hypopharyngeal cancer
448787|NCT00006106|stage, laryngeal cancer|stage, laryngeal cancer
448788|NCT00006106|stage, lip and oral cavity cancer|stage, lip and oral cavity cancer
448789|NCT00006106|stage, metastatic squamous neck cancer with occult primary|stage, metastatic squamous neck cancer with occult primary
448790|NCT00006106|stage, nasopharyngeal cancer|stage, nasopharyngeal cancer
448791|NCT00006106|stage, oropharyngeal cancer|stage, oropharyngeal cancer
448792|NCT00006106|stage, paranasal sinus and nasal cavity cancer|stage, paranasal sinus and nasal cavity cancer
448793|NCT00006107|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
448794|NCT00006107|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
751941|NCT01171287|Task Performance and Analysis|task performance and analysis
448795|NCT00006107|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
448796|NCT00006107|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
448797|NCT00006107|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
448798|NCT00006107|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
448799|NCT00006107|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
448800|NCT00006107|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
448801|NCT00006107|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
448802|NCT00006107|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
448803|NCT00006107|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
448804|NCT00006107|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
448805|NCT00006107|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
448806|NCT00006107|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
448807|NCT00006107|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
448808|NCT00006107|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
448809|NCT00006107|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
448810|NCT00006107|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
448811|NCT00006107|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
448812|NCT00006107|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
448813|NCT00006107|recurrent salivary gland cancer|recurrent salivary gland cancer
448814|NCT00006107|stage III salivary gland cancer|stage iii salivary gland cancer
448815|NCT00006107|stage IV salivary gland cancer|stage iv salivary gland cancer
448816|NCT00006107|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
448817|NCT00006107|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
448818|NCT00006107|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
448819|NCT00006107|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
448820|NCT00006107|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
448821|NCT00006107|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
448822|NCT00006107|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
448824|NCT00006108|recurrent breast cancer|recurrent breast cancer
448825|NCT00006110|stage II breast cancer|stage ii breast cancer
470523|NCT00071682|bleeding|bleeding
448826|NCT00006110|stage IV breast cancer|stage iv breast cancer
448827|NCT00006110|stage IIIA breast cancer|stage iiia breast cancer
448828|NCT00006110|stage IIIB breast cancer|stage iiib breast cancer
448829|NCT00006110|stage IIIC breast cancer|stage iiic breast cancer
448830|NCT00006110|inflammatory breast cancer|inflammatory breast cancer
448831|NCT00006111|stage II bladder cancer|stage ii bladder cancer
448833|NCT00006111|stage IV bladder cancer|stage iv bladder cancer
448834|NCT00006111|anterior urethral cancer|anterior urethral cancer
448835|NCT00006111|posterior urethral cancer|posterior urethral cancer
448836|NCT00006111|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
448837|NCT00006111|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
448838|NCT00006111|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
448839|NCT00006112|stage IV colon cancer|stage iv colon cancer
448840|NCT00006112|stage IV rectal cancer|stage iv rectal cancer
448841|NCT00006112|adenocarcinoma of the colon|adenocarcinoma of the colon
448842|NCT00006112|adenocarcinoma of the rectum|adenocarcinoma of the rectum
448843|NCT00006112|carcinoma of the appendix|carcinoma of the appendix
448844|NCT00006112|primary peritoneal cavity cancer|primary peritoneal cavity cancer
448845|NCT00006113|stage III melanoma|stage iii melanoma
448846|NCT00006113|stage IV melanoma|stage iv melanoma
448847|NCT00006113|recurrent melanoma|recurrent melanoma
448848|NCT00006114|adenocarcinoma of the prostate|adenocarcinoma of the prostate
448849|NCT00006114|stage IV prostate cancer|stage iv prostate cancer
448850|NCT00006114|recurrent prostate cancer|recurrent prostate cancer
448851|NCT00006115|stage IV colon cancer|stage iv colon cancer
448852|NCT00006115|stage IV rectal cancer|stage iv rectal cancer
448853|NCT00006115|recurrent colon cancer|recurrent colon cancer
448854|NCT00006115|recurrent rectal cancer|recurrent rectal cancer
448855|NCT00006115|adenocarcinoma of the colon|adenocarcinoma of the colon
448856|NCT00006115|adenocarcinoma of the rectum|adenocarcinoma of the rectum
448857|NCT00006116|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
448858|NCT00006116|squamous cell lung cancer|squamous cell lung cancer
448859|NCT00006116|large cell lung cancer|large cell lung cancer
448860|NCT00006116|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
448861|NCT00006116|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
448862|NCT00006116|adenocarcinoma of the lung|adenocarcinoma of the lung
448863|NCT00006117|stage III pancreatic cancer|stage iii pancreatic cancer
448864|NCT00006117|stage IV pancreatic cancer|stage iv pancreatic cancer
448865|NCT00006117|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
448866|NCT00006118|stage III bladder cancer|stage iii bladder cancer
448867|NCT00006118|stage IV bladder cancer|stage iv bladder cancer
448868|NCT00006118|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
448869|NCT00006119|recurrent adult brain tumor|recurrent adult brain tumor
448870|NCT00006119|adult grade III meningioma|adult grade iii meningioma
448871|NCT00006119|adult grade I meningioma|adult grade i meningioma
448872|NCT00006119|adult grade II meningioma|adult grade ii meningioma
448873|NCT00006120|stage IV breast cancer|stage iv breast cancer
448874|NCT00006120|stage IIIA breast cancer|stage iiia breast cancer
448875|NCT00006120|recurrent breast cancer|recurrent breast cancer
448876|NCT00006120|stage IIIB breast cancer|stage iiib breast cancer
448877|NCT00006121|stage III breast cancer|stage iii breast cancer
448878|NCT00006121|stage IV breast cancer|stage iv breast cancer
448879|NCT00006121|recurrent breast cancer|recurrent breast cancer
448880|NCT00006122|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
448881|NCT00006122|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
448882|NCT00006122|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
448883|NCT00006122|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
448884|NCT00006122|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
448885|NCT00006122|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
448886|NCT00006122|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
448887|NCT00006122|secondary acute myeloid leukemia|secondary acute myeloid leukemia
448888|NCT00006122|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
448889|NCT00006122|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
448890|NCT00006123|stage IV breast cancer|stage iv breast cancer
448891|NCT00006125|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
448892|NCT00006125|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
448893|NCT00006125|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
448894|NCT00006125|anaplastic large cell lymphoma|anaplastic large cell lymphoma
448895|NCT00006126|stage IV breast cancer|stage iv breast cancer
448896|NCT00006126|recurrent breast cancer|recurrent breast cancer
448897|NCT00006126|stage IV renal cell cancer|stage iv renal cell cancer
448898|NCT00006126|recurrent renal cell cancer|recurrent renal cell cancer
448899|NCT00006126|extensive stage small cell lung cancer|extensive stage small cell lung cancer
448900|NCT00006126|recurrent small cell lung cancer|recurrent small cell lung cancer
448901|NCT00006126|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
448902|NCT00006126|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
448903|NCT00006126|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
448905|NCT00006126|recurrent melanoma|recurrent melanoma
448906|NCT00006127|Fanconi's anemia|fanconi's anemia
448907|NCT00006127|aplastic anemia|aplastic anemia
448908|NCT00006127|hematologic disorders|hematologic disorders
448909|NCT00006127|rare disease|rare disease
448910|NCT00006128|neurologic and psychiatric disorders|neurologic and psychiatric disorders
448911|NCT00006128|rare disease|rare disease
448912|NCT00006129|burns|burns
448913|NCT00006129|dermatologic disorders|dermatologic disorders
448914|NCT00006129|rare disease|rare disease
448915|NCT00006130|arthritis & connective tissue diseases|arthritis & connective tissue diseases
448916|NCT00006130|avascular necrosis|avascular necrosis
448917|NCT00006130|disease-related problem/condition|disease-related problem/condition
448918|NCT00006130|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
448919|NCT00006130|hematologic disorders|hematologic disorders
448920|NCT00006130|pain|pain
448921|NCT00006130|rare disease|rare disease
448922|NCT00006130|sickle cell anemia|sickle cell anemia
448923|NCT00006132|herpes simplex virus infection|herpes simplex virus infection
448924|NCT00006132|herpes virus infection|herpes virus infection
448925|NCT00006132|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
448926|NCT00006132|rare disease|rare disease
448927|NCT00006132|viral infection|viral infection
448928|NCT00006133|arthritis & connective tissue diseases|arthritis & connective tissue diseases
448929|NCT00006133|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
448930|NCT00006133|rare disease|rare disease
448931|NCT00006133|systemic lupus erythematosus|systemic lupus erythematosus
448932|NCT00006134|arthritis & connective tissue diseases|arthritis & connective tissue diseases
448933|NCT00006134|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
448934|NCT00006134|rare disease|rare disease
448935|NCT00006134|systemic lupus erythematosus|systemic lupus erythematosus
448936|NCT00006135|herpes simplex virus infection|herpes simplex virus infection
448937|NCT00006135|herpesvirus infection|herpesvirus infection
448938|NCT00006135|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
448939|NCT00006135|rare disease|rare disease
448940|NCT00006135|viral infection|viral infection
448941|NCT00006136|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
448942|NCT00006136|hematologic disorders|hematologic disorders
448943|NCT00006136|rare disease|rare disease
448944|NCT00006136|thalassemia intermedia|thalassemia intermedia
448945|NCT00006137|IgA glomerulonephritis|iga glomerulonephritis
448946|NCT00006137|rare disease|rare disease
448947|NCT00006137|renal and genitourinary disorders|renal and genitourinary disorders
448948|NCT00006138|disease-related problem/condition|disease-related problem/condition
448949|NCT00006138|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
448950|NCT00006138|hematologic disorders|hematologic disorders
448951|NCT00006138|osteoporosis|osteoporosis
448952|NCT00006138|rare disease|rare disease
448953|NCT00006138|thalassemia major|thalassemia major
448954|NCT00006142|inborn errors of metabolism|inborn errors of metabolism
448955|NCT00006142|phenylketonuria|phenylketonuria
448956|NCT00006142|rare disease|rare disease
448957|NCT00006143|Treatment Outcome|treatment outcome
448959|NCT00006143|Developmental Disabilities|developmental disabilities
448960|NCT00006144|Drug Therapy, Combination|drug therapy, combination
448961|NCT00006144|Stavudine|stavudine
448962|NCT00006144|HIV Protease Inhibitors|hiv protease inhibitors
448963|NCT00006144|Cohort Studies|cohort studies
448964|NCT00006144|Ritonavir|ritonavir
448965|NCT00006144|Disease Progression|disease progression
448966|NCT00006144|Antigens, CD|antigens, cd
448967|NCT00006144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
448968|NCT00006144|Anti-HIV Agents|anti-hiv agents
448969|NCT00006144|Immunophenotyping|immunophenotyping
448970|NCT00006144|Deoxycytidine|deoxycytidine
448971|NCT00006145|Ganciclovir|ganciclovir
448972|NCT00006145|Cytomegalovirus|cytomegalovirus
448973|NCT00006145|Cytomegalovirus Infections|cytomegalovirus infections
448974|NCT00006145|Administration, Oral|administration, oral
448975|NCT00006145|Antiviral Agents|antiviral agents
448976|NCT00006145|Polymerase Chain Reaction|polymerase chain reaction
448977|NCT00006145|Viremia|viremia
448978|NCT00006145|DNA, Viral|dna, viral
448979|NCT00006148|Granulocyte Colony - Stimulation Factor|granulocyte colony - stimulation factor
448980|NCT00006148|Peripheral Blood Stem Cells|peripheral blood stem cells
448981|NCT00006148|Splenomegaly|splenomegaly
448983|NCT00006150|Fractures|fractures
448984|NCT00006150|Pneumonia|pneumonia
448985|NCT00006150|Scoliosis|scoliosis
448986|NCT00006150|Eczema|eczema
448987|NCT00006150|Job's Syndrome|job's syndrome
448988|NCT00006150|Hyperimmunologobulin E Syndrome|hyperimmunologobulin e syndrome
448989|NCT00006150|HIE Syndrome|hie syndrome
448990|NCT00006151|nicotine fading|nicotine fading
448991|NCT00006151|Accu Drop|accu drop
448992|NCT00006151|cigarette tapering|cigarette tapering
448993|NCT00006151|smoking cessation|smoking cessation
448994|NCT00006151|motivational interviewing|motivational interviewing
448995|NCT00006152|Drug Therapy, Combination|drug therapy, combination
448996|NCT00006152|HIV Protease Inhibitors|hiv protease inhibitors
448997|NCT00006152|Ritonavir|ritonavir
448998|NCT00006152|VX 478|vx 478
448999|NCT00006152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
449000|NCT00006152|Anti-HIV Agents|anti-hiv agents
449001|NCT00006152|Viral Load|viral load
449002|NCT00006152|abacavir|abacavir
449003|NCT00006153|HIV Antibodies|hiv antibodies
449004|NCT00006153|Immunity, Cellular|immunity, cellular
449005|NCT00006153|Drug Therapy, Combination|drug therapy, combination
449006|NCT00006153|Anti-HIV Agents|anti-hiv agents
449007|NCT00006153|remune|remune
449008|NCT00006153|HIV Therapeutic Vaccine|hiv therapeutic vaccine
449009|NCT00006154|Interleukin-2|interleukin-2
449010|NCT00006154|Didanosine|didanosine
449011|NCT00006154|Drug Therapy, Combination|drug therapy, combination
449012|NCT00006154|Stavudine|stavudine
449013|NCT00006154|HIV Protease Inhibitors|hiv protease inhibitors
449014|NCT00006154|Ritonavir|ritonavir
449015|NCT00006154|Indinavir|indinavir
449016|NCT00006154|Virus Latency|virus latency
449017|NCT00006154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
449018|NCT00006154|Anti-HIV Agents|anti-hiv agents
449019|NCT00006154|abacavir|abacavir
449020|NCT00006154|efavirenz|efavirenz
449021|NCT00006154|Acute Infection|acute infection
449022|NCT00006155|DNA Damage|dna damage
449023|NCT00006155|DNA Repair|dna repair
449024|NCT00006155|FLK-1|flk-1
449025|NCT00006155|Pharmacokinetics|pharmacokinetics
449026|NCT00006155|VEGF|vegf
449027|NCT00006155|Fallopian Tube Cancer|fallopian tube cancer
449028|NCT00006155|Ovarian Cancer|ovarian cancer
449029|NCT00006155|Platinum-Refractory Disease|platinum-refractory disease
449030|NCT00006156|Ovarian Failure|ovarian failure
449031|NCT00006156|Ovary|ovary
449032|NCT00006156|Aging|aging
449033|NCT00006156|Healthy Volunteer|healthy volunteer
449034|NCT00006156|Primary Ovarian Insufficiency(POI)|primary ovarian insufficiency(poi)
449035|NCT00006156|Premature Menopause|premature menopause
449036|NCT00006156|Premature Ovarian Failure (POF)|premature ovarian failure (pof)
449037|NCT00006157|Functional bowel disorder|functional bowel disorder
449038|NCT00006157|Irritable bowel syndrome|irritable bowel syndrome
449039|NCT00006157|Painful constipation|painful constipation
449040|NCT00006157|Unspecified functional bowel disorder|unspecified functional bowel disorder
449041|NCT00006157|Chronic functional abdominal pain|chronic functional abdominal pain
449042|NCT00006157|Cognitive-behavioral psychological treatment|cognitive-behavioral psychological treatment
449044|NCT00006157|CFAP|cfap
449045|NCT00006158|AIDS|aids
449046|NCT00006158|HIV|hiv
449047|NCT00006158|weight loss|weight loss
449048|NCT00006158|Wasting Syndrome|wasting syndrome
449049|NCT00006158|testosterone|testosterone
449050|NCT00006158|androgen levels|androgen levels
449051|NCT00006158|hormones|hormones
449052|NCT00006159|diabetes|diabetes
449053|NCT00006159|lifestyle intervention|lifestyle intervention
449054|NCT00006159|Native American|native american
449055|NCT00006159|community intervention|community intervention
449056|NCT00006159|diet|diet
449057|NCT00006159|exercise|exercise
449058|NCT00006161|TIPS|tips
449059|NCT00006161|DSRS|dsrs
449060|NCT00006161|Varices|varices
449061|NCT00006161|Variceal bleeding|variceal bleeding
449062|NCT00006161|Splenorenal Shunt|splenorenal shunt
449063|NCT00006161|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
449064|NCT00006161|Cirrhosis|cirrhosis
449065|NCT00006161|Portal hypertension|portal hypertension
449066|NCT00006161|Liver disease|liver disease
449067|NCT00006162|low fat diet|low fat diet
449068|NCT00006162|aerobic exercise|aerobic exercise
449069|NCT00006162|impaired glucose tolerance|impaired glucose tolerance
449070|NCT00006162|Japanese Americans|japanese americans
449071|NCT00006162|metabolic risk factors|metabolic risk factors
449072|NCT00006163|diabetes|diabetes
449073|NCT00006163|self-management|self-management
449074|NCT00006163|randomized trial|randomized trial
449075|NCT00006163|RE-AIM evaluation|re-aim evaluation
449076|NCT00006163|participation|participation
449077|NCT00006163|maintenance|maintenance
449078|NCT00006163|community resources|community resources
449079|NCT00006163|dietary change|dietary change
449080|NCT00006164|liver disease|liver disease
449081|NCT00006164|hepatitis c virus|hepatitis c virus
449082|NCT00006164|antiviral agent|antiviral agent
449083|NCT00006164|cirrhosis|cirrhosis
449084|NCT00006165|Native Hawaiian|native hawaiian
449087|NCT00006165|Family Support|family support
449088|NCT00006165|Diabetes Mellitus, at-risk|diabetes mellitus, at-risk
449089|NCT00006166|refractory ascites|refractory ascites
449090|NCT00006166|paracenteses|paracenteses
449091|NCT00006167|oxandrolone|oxandrolone
449092|NCT00006167|AIDS wasting|aids wasting
449100|NCT00006168|MTX|mtx
449101|NCT00006168|Hepatology|hepatology
449102|NCT00006168|methotrexate|methotrexate
449103|NCT00006168|liver|liver
449104|NCT00006169|Nutrition|nutrition
449105|NCT00006169|Behavior Therapy|behavior therapy
449106|NCT00006169|Cystic Fibrosis|cystic fibrosis
449107|NCT00006170|smoking cessation|smoking cessation
449108|NCT00006170|Women|women
449109|NCT00006170|bupropion|bupropion
449110|NCT00006170|weight concerns|weight concerns
449111|NCT00006170|weight|weight
449112|NCT00006171|HHV-8|hhv-8
449113|NCT00006171|Pathophysiology|pathophysiology
449114|NCT00006171|AIDS|aids
449115|NCT00006171|Cancer|cancer
449116|NCT00006171|Anti-Retroviral|anti-retroviral
449117|NCT00006171|Kaposi's Sarcoma|kaposi's sarcoma
449118|NCT00006171|HIV|hiv
449119|NCT00006172|Antidepressive Agents|antidepressive agents
449120|NCT00006172|Chronobiology|chronobiology
449121|NCT00006172|Chronotherapy|chronotherapy
449122|NCT00006172|Circadian rhythms|circadian rhythms
449123|NCT00006172|Depressive Disorder|depressive disorder
449124|NCT00006172|Ions|ions
449125|NCT00006172|Light|light
449126|NCT00006172|Lighting|lighting
449127|NCT00006172|Mood disorders|mood disorders
449128|NCT00006172|Phototherapy.|phototherapy.
449129|NCT00006173|Atherosclerosis|atherosclerosis
449130|NCT00006173|Hypertension|hypertension
449131|NCT00006173|Magnetic Resonance Angiography|magnetic resonance angiography
449132|NCT00006174|Precocious Puberty|precocious puberty
449133|NCT00006174|Polyostotic|polyostotic
449134|NCT00006174|Fibrous Dysplasia|fibrous dysplasia
449135|NCT00006174|PFD|pfd
449136|NCT00006174|McCune-Albright Syndrome (MAS)|mccune-albright syndrome (mas)
449137|NCT00006175|Cyclooxygenase|cyclooxygenase
449138|NCT00006175|COX-1|cox-1
449139|NCT00006175|COX-2|cox-2
449140|NCT00006175|Prostanoids|prostanoids
449141|NCT00006175|P.C.R.|p.c.r.
449142|NCT00006175|Healthy Volunteer|healthy volunteer
449143|NCT00006176|FENIB|fenib
449144|NCT00006176|Presenile Dementia|presenile dementia
449145|NCT00006176|Progressive Myoclonic Epilepsy|progressive myoclonic epilepsy
449146|NCT00006176|Dementia|dementia
449147|NCT00006176|Early Onset Progressive Dementia|early onset progressive dementia
449148|NCT00006176|Familial Presenile Dementia|familial presenile dementia
449149|NCT00006176|FDNIB|fdnib
449150|NCT00006176|familial encephalopathy with neuroserpin inclusion bodies|familial encephalopathy with neuroserpin inclusion bodies
449151|NCT00006176|Heredodegenerative Disorders, Nervous System|heredodegenerative disorders, nervous system
449160|NCT00006178|Renal Failure|renal failure
449161|NCT00006178|Anti-rejection|anti-rejection
449162|NCT00006178|Apoptosis|apoptosis
449163|NCT00006178|Polyclonal Antibody|polyclonal antibody
449164|NCT00006178|Kidney Transplant|kidney transplant
449165|NCT00006180|Preventive Medicine|preventive medicine
449166|NCT00006180|Women's Health|women's health
449167|NCT00006180|Bone Formation|bone formation
449168|NCT00006180|Mood Disorders|mood disorders
449169|NCT00006180|Bone Resorption|bone resorption
449170|NCT00006180|Major Depression|major depression
449171|NCT00006180|Osteopenia|osteopenia
449172|NCT00006180|Osteoporosis|osteoporosis
449173|NCT00006180|Bone Fracture|bone fracture
449174|NCT00006180|Bisphosphonate|bisphosphonate
449175|NCT00006180|Depression|depression
449176|NCT00006180|Bone Density|bone density
449177|NCT00006180|Healthy Volunteer|healthy volunteer
449178|NCT00006180|HV|hv
449179|NCT00006180|Normal Control|normal control
449180|NCT00006181|Health behavior change|health behavior change
449181|NCT00006181|Motivational interviewing|motivational interviewing
449182|NCT00006181|Motivational enhancement|motivational enhancement
449183|NCT00006181|Health counseling|health counseling
449184|NCT00006181|Team intervention|team intervention
449185|NCT00006181|One-on-one intervention|one-on-one intervention
449186|NCT00006181|Physical activity|physical activity
449187|NCT00006181|Exercise|exercise
449188|NCT00006181|Nutrition|nutrition
449189|NCT00006181|Health assessments|health assessments
449190|NCT00006181|Strength|strength
449191|NCT00006181|Flexibility|flexibility
449192|NCT00006181|Percent body fat|percent body fat
449193|NCT00006181|Social-learning theory|social-learning theory
449194|NCT00006181|PHLAME|phlame
449195|NCT00006181|Fire fighters|fire fighters
449196|NCT00006181|Fire stations|fire stations
449198|NCT00006181|Cardiovascular diseases|cardiovascular diseases
449199|NCT00006184|Immunoablative|immunoablative
449200|NCT00006184|Mobilization|mobilization
449201|NCT00006184|Apheresis|apheresis
449202|NCT00006184|Multiple Myeloma|multiple myeloma
449203|NCT00006184|IgG Multiple Myeloma|igg multiple myeloma
449204|NCT00006184|IgA Multiple Myeloma|iga multiple myeloma
449205|NCT00006185|peripheral fat wasting|peripheral fat wasting
449206|NCT00006185|truncal adiposity|truncal adiposity
449207|NCT00006185|fat biopsy|fat biopsy
449208|NCT00006185|muscle biopsy|muscle biopsy
449209|NCT00006185|intravenous lines|intravenous lines
449210|NCT00006185|blood draws|blood draws
449211|NCT00006185|insulin administration|insulin administration
449212|NCT00006185|sugar water|sugar water
449213|NCT00006185|screening|screening
449214|NCT00006186|dilutional coagulopathy|dilutional coagulopathy
449215|NCT00006187|Investigational Drug|investigational drug
449216|NCT00006188|Behcet's Disease|behcet's disease
449217|NCT00006188|Sarcoidosis|sarcoidosis
449218|NCT00006188|Iritis|iritis
449219|NCT00006188|Choroiditis|choroiditis
449220|NCT00006188|Iridocyclitis|iridocyclitis
449221|NCT00006188|Retinal Disease|retinal disease
449222|NCT00006188|Cystoid Macular Edema|cystoid macular edema
449223|NCT00006188|Uveitis|uveitis
449224|NCT00006188|Intraocular Inflammation|intraocular inflammation
449225|NCT00006188|Inflammatory Eye DIsease|inflammatory eye disease
449226|NCT00006190|Lipoproteins|lipoproteins
449227|NCT00006190|Insulin resistance|insulin resistance
449228|NCT00006190|Adipose tissue|adipose tissue
449229|NCT00006191|Antiepileptic Drugs|antiepileptic drugs
449230|NCT00006191|Motor Cortex|motor cortex
449231|NCT00006191|Myoclonus|myoclonus
449232|NCT00006191|Healthy Volunteer|healthy volunteer
449233|NCT00006194|sarcopenia|sarcopenia
449234|NCT00006196|Vitamin D resistance|vitamin d resistance
449235|NCT00006199|solid tumor|solid tumor
449236|NCT00006202|Serum levels of Lutein|serum levels of lutein
449237|NCT00006202|Age-Related Macular Degeneration|age-related macular degeneration
449238|NCT00006202|Safety|safety
449239|NCT00006202|Toxicity|toxicity
449240|NCT00006204|Alcoholism|alcoholism
449241|NCT00006204|Alcohol Dependence|alcohol dependence
449242|NCT00006204|Depression|depression
449243|NCT00006204|Naltrexone|naltrexone
449244|NCT00006204|Fluoxetine|fluoxetine
449245|NCT00006205|alcoholism|alcoholism
449246|NCT00006205|alcohol addiction|alcohol addiction
449247|NCT00008541|Keratitis|keratitis
449248|NCT00008541|Conjunctivitis|conjunctivitis
449249|NCT00008541|Meibomitis|meibomitis
449250|NCT00008541|Corneal Infiltrates|corneal infiltrates
449251|NCT00008541|Dacryocystitis|dacryocystitis
449252|NCT00008541|Blepharitis|blepharitis
449253|NCT00008541|Dacryoadenitis|dacryoadenitis
449254|NCT00008541|Corneal Eye Disease|corneal eye disease
449255|NCT00008554|HIV-1|hiv-1
449256|NCT00008554|Drug Therapy, Combination|drug therapy, combination
449257|NCT00008554|HIV Protease Inhibitors|hiv protease inhibitors
449258|NCT00008554|Lamivudine|lamivudine
449259|NCT00008554|Nelfinavir|nelfinavir
449265|NCT00008697|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
449266|NCT00008697|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
449268|NCT00008736|Infant, premature|infant, premature
449269|NCT00008814|Cognition|cognition
449270|NCT00008814|Infant Development|infant development
449271|NCT00008814|MRI, Functional|mri, functional
449272|NCT00008827|Obesity|obesity
449273|NCT00008827|Behavioral weight control|behavioral weight control
449274|NCT00008827|Internet|internet
449275|NCT00008853|Clinical Evaluation|clinical evaluation
449276|NCT00008866|HIV-1|hiv-1
449277|NCT00008866|Didanosine|didanosine
449278|NCT00008866|Drug Therapy, Combination|drug therapy, combination
449279|NCT00008866|Drug Administration Schedule|drug administration schedule
449280|NCT00008866|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
449281|NCT00008866|Hydroxyurea|hydroxyurea
449282|NCT00008866|RNA, Viral|rna, viral
449283|NCT00008866|Genotype|genotype
449284|NCT00008866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
449285|NCT00008866|Anti-HIV Agents|anti-hiv agents
449286|NCT00008866|Viral Load|viral load
449287|NCT00008892|Magnetic Resonance Imaging|magnetic resonance imaging
449288|NCT00008892|Diffusion Tensor Imaging|diffusion tensor imaging
449289|NCT00008892|Twin Study|twin study
449290|NCT00008892|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
449291|NCT00008892|Normal Volunteers|normal volunteers
449292|NCT00009009|Immune System|immune system
449293|NCT00009009|Biopsy|biopsy
449294|NCT00009009|AIDS|aids
449295|NCT00009009|HIV|hiv
449296|NCT00009009|End Stage Renal Disease|end stage renal disease
449297|NCT00009009|Kidney Transplant|kidney transplant
449300|NCT00009035|Chemotherapy|chemotherapy
449301|NCT00009035|Antiangiogenesis|antiangiogenesis
449302|NCT00009035|Radiation|radiation
449303|NCT00009035|CNS Tumor|cns tumor
449304|NCT00009035|Glioma|glioma
449305|NCT00009035|Medulloblastoma|medulloblastoma
449306|NCT00009035|Astrocytoma|astrocytoma
449307|NCT00009035|Glioblastoma|glioblastoma
449308|NCT00009048|Dyskinesias|dyskinesias
449309|NCT00009048|L-Dopa Infusion|l-dopa infusion
449310|NCT00009048|Clinical Trial|clinical trial
449311|NCT00009048|Motor Function|motor function
449312|NCT00009048|Psychosis|psychosis
449313|NCT00009048|Parkinson's Disease|parkinson's disease
449314|NCT00009061|HIV-1|hiv-1
449315|NCT00009061|Drug Therapy, Combination|drug therapy, combination
449316|NCT00009061|HIV Protease Inhibitors|hiv protease inhibitors
449317|NCT00009061|Ritonavir|ritonavir
449318|NCT00009061|Lamivudine|lamivudine
449319|NCT00009061|Nelfinavir|nelfinavir
449320|NCT00009061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
449321|NCT00009061|Anti-HIV Agents|anti-hiv agents
449322|NCT00009061|abacavir|abacavir
449323|NCT00009178|Primary Care|primary care
449324|NCT00009178|Fluoxetine|fluoxetine
449325|NCT00009204|Behavioral problems|behavioral problems
449326|NCT00009204|Agitation|agitation
449327|NCT00009217|Alzheimer's disease|alzheimer's disease
449328|NCT00009217|psychosis|psychosis
449329|NCT00009217|agitation|agitation
449330|NCT00009217|haloperidol|haloperidol
449331|NCT00009230|Age associated memory impairment|age associated memory impairment
449332|NCT00009230|Mild cognitive impairment|mild cognitive impairment
449333|NCT00009243|Brain Scans|brain scans
449197|NCT00006181|Cancer|cancer
449334|NCT00009243|Brain Imaging|brain imaging
449337|NCT00009243|Acute Stroke|acute stroke
449338|NCT00009243|Stroke|stroke
449339|NCT00009243|TIA|tia
449340|NCT00009256|Quasispecies Variation|quasispecies variation
449341|NCT00009256|Genotyping|genotyping
449342|NCT00009256|Phenotyping|phenotyping
449343|NCT00009256|Antiretroviral Therapy|antiretroviral therapy
449344|NCT00009256|Drug Naive Patients|drug naive patients
449345|NCT00009256|HIV|hiv
449346|NCT00009256|Treatment Naive|treatment naive
449347|NCT00014248|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
449348|NCT00014248|cachexia|cachexia
449349|NCT00014261|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
449350|NCT00014274|stage III bladder cancer|stage iii bladder cancer
449351|NCT00014274|stage IV bladder cancer|stage iv bladder cancer
449352|NCT00014274|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
449353|NCT00014274|anterior urethral cancer|anterior urethral cancer
449354|NCT00014274|posterior urethral cancer|posterior urethral cancer
449355|NCT00014274|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
449356|NCT00014274|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
449357|NCT00014274|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
449358|NCT00014287|stage 0 bladder cancer|stage 0 bladder cancer
449359|NCT00014287|stage I bladder cancer|stage i bladder cancer
449360|NCT00014287|recurrent bladder cancer|recurrent bladder cancer
449361|NCT00014300|recurrent adult brain tumor|recurrent adult brain tumor
449363|NCT00014300|adult giant cell glioblastoma|adult giant cell glioblastoma
449364|NCT00014300|adult gliosarcoma|adult gliosarcoma
449365|NCT00014313|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
449366|NCT00014326|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
449367|NCT00014326|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
449368|NCT00014326|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
449369|NCT00014326|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
449370|NCT00014326|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
449371|NCT00014326|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
449372|NCT00014326|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
449373|NCT00014326|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
449374|NCT00014326|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
449375|NCT00014326|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
449376|NCT00014326|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
449377|NCT00014326|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
449378|NCT00014326|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
449379|NCT00014326|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
449380|NCT00014326|stage I marginal zone lymphoma|stage i marginal zone lymphoma
449381|NCT00014326|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
449382|NCT00014339|stage II multiple myeloma|stage ii multiple myeloma
449383|NCT00014339|stage III multiple myeloma|stage iii multiple myeloma
470524|NCT00071682|clotting|clotting
449384|NCT00014352|stage III prostate cancer|stage iii prostate cancer
449385|NCT00014352|stage IV prostate cancer|stage iv prostate cancer
449386|NCT00014352|recurrent prostate cancer|recurrent prostate cancer
449387|NCT00014352|thromboembolism|thromboembolism
449388|NCT00014365|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
449389|NCT00014378|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
449390|NCT00014391|stage IV breast cancer|stage iv breast cancer
449391|NCT00014391|stage IIIA breast cancer|stage iiia breast cancer
449392|NCT00014391|stage IIIB breast cancer|stage iiib breast cancer
449393|NCT00014391|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
449394|NCT00014391|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
449395|NCT00014391|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
449396|NCT00014391|refractory multiple myeloma|refractory multiple myeloma
449397|NCT00014391|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
449398|NCT00014391|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
449399|NCT00014391|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
449400|NCT00014391|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
449401|NCT00014391|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
449402|NCT00014391|disseminated neuroblastoma|disseminated neuroblastoma
449403|NCT00014391|recurrent neuroblastoma|recurrent neuroblastoma
753012|NCT01175135|schizophrenia|schizophrenia
573120|NCT00477165|IBS|ibs
449404|NCT00014391|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
449405|NCT00014391|stage I multiple myeloma|stage i multiple myeloma
449406|NCT00014391|stage II multiple myeloma|stage ii multiple myeloma
449407|NCT00014391|stage III multiple myeloma|stage iii multiple myeloma
471459|NCT00074763|Transfusion|transfusion
449408|NCT00014391|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
449409|NCT00014391|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
449410|NCT00014391|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
449411|NCT00014391|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
449412|NCT00014391|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
449413|NCT00014391|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
449414|NCT00014391|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
449415|NCT00014391|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
449416|NCT00014391|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
449417|NCT00014391|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
449418|NCT00014391|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
449419|NCT00014391|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
449420|NCT00014391|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
449421|NCT00014391|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
449422|NCT00014391|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
449423|NCT00014391|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
449424|NCT00014391|testicular embryonal carcinoma|testicular embryonal carcinoma
449425|NCT00014391|testicular choriocarcinoma|testicular choriocarcinoma
449426|NCT00014391|testicular teratoma|testicular teratoma
449427|NCT00014391|testicular yolk sac tumor|testicular yolk sac tumor
449428|NCT00014391|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
449429|NCT00014391|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
449430|NCT00014391|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
449431|NCT00014391|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
449432|NCT00014391|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
449433|NCT00014391|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
449434|NCT00014391|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
449435|NCT00014391|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
449436|NCT00014391|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
449437|NCT00014391|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
449438|NCT00014391|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
449439|NCT00014391|refractory hairy cell leukemia|refractory hairy cell leukemia
449440|NCT00014391|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
449441|NCT00014391|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
449442|NCT00014391|ovarian yolk sac tumor|ovarian yolk sac tumor
449443|NCT00014391|ovarian embryonal carcinoma|ovarian embryonal carcinoma
449444|NCT00014391|ovarian polyembryoma|ovarian polyembryoma
449445|NCT00014391|ovarian choriocarcinoma|ovarian choriocarcinoma
449446|NCT00014391|ovarian immature teratoma|ovarian immature teratoma
449447|NCT00014391|ovarian mature teratoma|ovarian mature teratoma
449448|NCT00014391|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
449449|NCT00014391|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
449450|NCT00014391|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
449513|NCT00014430|stage IV breast cancer|stage iv breast cancer
449451|NCT00014391|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
449452|NCT00014391|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
449453|NCT00014391|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
449454|NCT00014391|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
449455|NCT00014391|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
449456|NCT00014391|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
449457|NCT00014391|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
449458|NCT00014391|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
449459|NCT00014391|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
449460|NCT00014391|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
449461|NCT00014391|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
449462|NCT00014391|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
449463|NCT00014391|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
449464|NCT00014391|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
448761|NCT00006106|solid tumor|solid tumor
449465|NCT00014391|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
449466|NCT00014391|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
449467|NCT00014391|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
449468|NCT00014391|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
449469|NCT00014391|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
449470|NCT00014391|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
471460|NCT00074763|Thrombosol|thrombosol
449471|NCT00014391|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
449472|NCT00014391|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
449473|NCT00014391|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
449474|NCT00014391|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
449475|NCT00014391|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
449476|NCT00014391|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
449477|NCT00014391|secondary acute myeloid leukemia|secondary acute myeloid leukemia
449478|NCT00014391|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
449479|NCT00014391|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
449480|NCT00014391|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
449481|NCT00014391|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
449483|NCT00014391|pulmonary complications|pulmonary complications
449484|NCT00014391|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
449485|NCT00014391|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
449486|NCT00014391|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
449487|NCT00014391|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
449488|NCT00014391|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
449489|NCT00014391|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
449490|NCT00014391|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
449491|NCT00014391|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
449492|NCT00014391|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
449493|NCT00014391|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
449494|NCT00014391|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
449495|NCT00014391|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
449496|NCT00014391|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
449497|NCT00014391|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
449498|NCT00014391|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
449499|NCT00014391|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
449500|NCT00014391|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
583580|NCT00512265|pulmonary morbidity|pulmonary morbidity
449501|NCT00014391|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
449502|NCT00014391|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
449503|NCT00014391|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
449504|NCT00014391|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
449505|NCT00014391|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
449506|NCT00014391|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
449507|NCT00014391|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
449508|NCT00014391|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
449509|NCT00014391|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
449510|NCT00014391|splenic marginal zone lymphoma|splenic marginal zone lymphoma
449511|NCT00014391|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
449512|NCT00014404|lip and oral cavity cancer|lip and oral cavity cancer
449514|NCT00014430|stage IIIA breast cancer|stage iiia breast cancer
449515|NCT00014430|recurrent breast cancer|recurrent breast cancer
449516|NCT00014430|stage IIIB breast cancer|stage iiib breast cancer
449517|NCT00014443|recurrent adult brain tumor|recurrent adult brain tumor
449518|NCT00014443|adult glioblastoma|adult glioblastoma
449519|NCT00014443|adult anaplastic astrocytoma|adult anaplastic astrocytoma
449520|NCT00014443|adult giant cell glioblastoma|adult giant cell glioblastoma
449521|NCT00014443|adult gliosarcoma|adult gliosarcoma
449522|NCT00014456|stage IV breast cancer|stage iv breast cancer
449523|NCT00014456|recurrent breast cancer|recurrent breast cancer
449524|NCT00014456|stage IV gastric cancer|stage iv gastric cancer
449525|NCT00014456|recurrent gastric cancer|recurrent gastric cancer
449526|NCT00014456|metastatic osteosarcoma|metastatic osteosarcoma
449527|NCT00014456|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
449528|NCT00014456|stage II pancreatic cancer|stage ii pancreatic cancer
449529|NCT00014456|stage III pancreatic cancer|stage iii pancreatic cancer
449530|NCT00014456|recurrent pancreatic cancer|recurrent pancreatic cancer
449531|NCT00014456|stage II esophageal cancer|stage ii esophageal cancer
449532|NCT00014456|stage III esophageal cancer|stage iii esophageal cancer
449533|NCT00014456|stage IV esophageal cancer|stage iv esophageal cancer
449534|NCT00014456|recurrent esophageal cancer|recurrent esophageal cancer
449535|NCT00014456|chondrosarcoma|chondrosarcoma
449536|NCT00014456|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
449537|NCT00014456|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
449538|NCT00014456|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
449539|NCT00014456|extensive stage small cell lung cancer|extensive stage small cell lung cancer
449540|NCT00014456|recurrent small cell lung cancer|recurrent small cell lung cancer
449541|NCT00014456|recurrent osteosarcoma|recurrent osteosarcoma
449542|NCT00014456|recurrent bladder cancer|recurrent bladder cancer
449543|NCT00014456|stage IV bladder cancer|stage iv bladder cancer
449544|NCT00014456|stage IV prostate cancer|stage iv prostate cancer
449545|NCT00014456|recurrent prostate cancer|recurrent prostate cancer
449546|NCT00014456|stage IV melanoma|stage iv melanoma
449547|NCT00014456|recurrent melanoma|recurrent melanoma
449548|NCT00014456|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
449549|NCT00014456|stage IV salivary gland cancer|stage iv salivary gland cancer
449550|NCT00014456|recurrent salivary gland cancer|recurrent salivary gland cancer
449551|NCT00014456|classic Kaposi sarcoma|classic kaposi sarcoma
449552|NCT00014456|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
449553|NCT00014456|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
449554|NCT00014456|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
449555|NCT00014456|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
449556|NCT00014456|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
449557|NCT00014456|stage IV uterine sarcoma|stage iv uterine sarcoma
449558|NCT00014456|recurrent uterine sarcoma|recurrent uterine sarcoma
449559|NCT00014456|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
449560|NCT00014456|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
449562|NCT00014456|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
449563|NCT00014456|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
449564|NCT00014456|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
449565|NCT00014456|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
449566|NCT00014456|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
449567|NCT00014456|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
449568|NCT00014456|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
449569|NCT00014456|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
449570|NCT00014456|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
449571|NCT00014456|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
449572|NCT00014456|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
449573|NCT00014456|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
449574|NCT00014456|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
449575|NCT00014456|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
449576|NCT00014456|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
449577|NCT00014456|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
449578|NCT00014456|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
449579|NCT00014456|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
449580|NCT00014456|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
449581|NCT00014456|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
449771|NCT00014599|stage IV vulvar cancer|stage iv vulvar cancer
449582|NCT00014456|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
449583|NCT00014456|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
449584|NCT00014456|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
449585|NCT00014456|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
449586|NCT00014456|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
449587|NCT00014456|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
449588|NCT00014456|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
449589|NCT00014456|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
449590|NCT00014456|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
449591|NCT00014456|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
449592|NCT00014456|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
449593|NCT00014456|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
449594|NCT00014456|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
449595|NCT00014456|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
449596|NCT00014456|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
449597|NCT00014456|stage IV pancreatic cancer|stage iv pancreatic cancer
449598|NCT00014469|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
449599|NCT00014469|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
449600|NCT00014469|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
449601|NCT00014469|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
449602|NCT00014469|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
449603|NCT00014469|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
449604|NCT00014469|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
449605|NCT00014469|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
449606|NCT00014469|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
449607|NCT00014469|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
449608|NCT00014469|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
449609|NCT00014469|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
449610|NCT00014469|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
449611|NCT00014469|refractory anemia with excess blasts|refractory anemia with excess blasts
449612|NCT00014469|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
449613|NCT00014469|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
449614|NCT00014469|acute undifferentiated leukemia|acute undifferentiated leukemia
449615|NCT00014469|secondary acute myeloid leukemia|secondary acute myeloid leukemia
449616|NCT00014469|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
449617|NCT00014469|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
449618|NCT00014469|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
449619|NCT00014469|graft versus host disease|graft versus host disease
449620|NCT00014469|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
449621|NCT00014469|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
449622|NCT00014469|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
449623|NCT00014469|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
449624|NCT00014469|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
583581|NCT00512278|Hepatitis|hepatitis
583582|NCT00512278|HCV|hcv
449625|NCT00014469|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
449626|NCT00014469|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
449627|NCT00014469|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
449628|NCT00014469|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
449629|NCT00014469|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
449630|NCT00014482|anxiety disorder|anxiety disorder
449631|NCT00014482|depression|depression
449633|NCT00014482|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
449634|NCT00014482|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
449635|NCT00014482|refractory multiple myeloma|refractory multiple myeloma
449636|NCT00014482|stage I multiple myeloma|stage i multiple myeloma
449637|NCT00014482|stage II multiple myeloma|stage ii multiple myeloma
449638|NCT00014482|stage III multiple myeloma|stage iii multiple myeloma
449639|NCT00014482|primary myelofibrosis|primary myelofibrosis
449640|NCT00014482|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
449641|NCT00014482|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
449642|NCT00014482|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
449643|NCT00014482|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
449644|NCT00014482|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
449645|NCT00014482|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
449646|NCT00014482|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
449647|NCT00014482|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
449648|NCT00014482|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
449649|NCT00014482|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
448982|NCT00006150|IgE|ige
449650|NCT00014482|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
449651|NCT00014482|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
449652|NCT00014482|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
449653|NCT00014482|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
449654|NCT00014482|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
449655|NCT00014482|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
449656|NCT00014482|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
449657|NCT00014482|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
449658|NCT00014482|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
449659|NCT00014482|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
449660|NCT00014482|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
449661|NCT00014482|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
473069|NCT00079573|Overweight|overweight
449662|NCT00014482|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
449663|NCT00014482|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
449664|NCT00014482|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
449665|NCT00014482|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
449666|NCT00014482|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
449667|NCT00014482|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
449668|NCT00014482|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
449669|NCT00014482|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
449670|NCT00014482|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
449671|NCT00014482|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
449672|NCT00014482|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
449673|NCT00014482|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
449674|NCT00014482|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
449675|NCT00014482|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
449676|NCT00014482|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
449677|NCT00014482|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
449678|NCT00014482|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
449679|NCT00014482|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
449680|NCT00014482|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
449681|NCT00014482|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
449682|NCT00014482|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
449683|NCT00014482|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
449684|NCT00014482|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
449685|NCT00014482|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
449686|NCT00014482|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
449687|NCT00014482|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
449688|NCT00014482|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
449689|NCT00014482|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
449690|NCT00014482|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
449691|NCT00014482|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
449692|NCT00014482|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
449693|NCT00014482|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
449694|NCT00014482|splenic marginal zone lymphoma|splenic marginal zone lymphoma
449695|NCT00014495|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
449696|NCT00014495|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
449697|NCT00014495|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
449698|NCT00014495|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
449699|NCT00014495|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
449700|NCT00014495|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
449701|NCT00014495|refractory anemia with excess blasts|refractory anemia with excess blasts
449772|NCT00014599|recurrent vulvar cancer|recurrent vulvar cancer
449702|NCT00014495|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
449703|NCT00014495|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
449704|NCT00014495|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
449705|NCT00014495|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
449706|NCT00014495|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
449707|NCT00014495|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
449708|NCT00014495|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
449709|NCT00014495|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
449710|NCT00014495|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
449711|NCT00014495|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
449712|NCT00014495|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
449713|NCT00014495|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
449714|NCT00014495|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
449715|NCT00014508|refractory multiple myeloma|refractory multiple myeloma
449716|NCT00014508|stage I multiple myeloma|stage i multiple myeloma
449717|NCT00014508|stage II multiple myeloma|stage ii multiple myeloma
449718|NCT00014508|stage III multiple myeloma|stage iii multiple myeloma
449719|NCT00014521|recurrent adult brain tumor|recurrent adult brain tumor
449720|NCT00014521|adult glioblastoma|adult glioblastoma
449721|NCT00014521|adult anaplastic astrocytoma|adult anaplastic astrocytoma
449722|NCT00014521|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
449723|NCT00014521|adult giant cell glioblastoma|adult giant cell glioblastoma
449724|NCT00014521|adult gliosarcoma|adult gliosarcoma
449725|NCT00014534|stage III bladder cancer|stage iii bladder cancer
449726|NCT00014534|stage IV bladder cancer|stage iv bladder cancer
449727|NCT00014534|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
449728|NCT00014547|extensive stage small cell lung cancer|extensive stage small cell lung cancer
449729|NCT00014547|recurrent small cell lung cancer|recurrent small cell lung cancer
449730|NCT00014560|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
449731|NCT00014560|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
449732|NCT00014560|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
449733|NCT00014560|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
449734|NCT00014560|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
449735|NCT00014560|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
449736|NCT00014560|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
449737|NCT00014560|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
449738|NCT00014560|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
449739|NCT00014560|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
449740|NCT00014560|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
449741|NCT00014560|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
449742|NCT00014573|childhood infratentorial ependymoma|childhood infratentorial ependymoma
449743|NCT00014573|childhood supratentorial ependymoma|childhood supratentorial ependymoma
449744|NCT00014573|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
449745|NCT00014573|recurrent adult brain tumor|recurrent adult brain tumor
449746|NCT00014573|adult brain stem glioma|adult brain stem glioma
449747|NCT00014573|adult medulloblastoma|adult medulloblastoma
449748|NCT00014573|adult glioblastoma|adult glioblastoma
449749|NCT00014573|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
449750|NCT00014573|adult anaplastic astrocytoma|adult anaplastic astrocytoma
449751|NCT00014573|childhood choroid plexus tumor|childhood choroid plexus tumor
449752|NCT00014573|childhood grade III meningioma|childhood grade iii meningioma
449753|NCT00014573|adult anaplastic ependymoma|adult anaplastic ependymoma
449754|NCT00014573|adult mixed glioma|adult mixed glioma
449755|NCT00014573|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
449756|NCT00014573|adult ependymoblastoma|adult ependymoblastoma
449757|NCT00014573|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
449758|NCT00014573|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
449759|NCT00014573|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
449760|NCT00014573|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
449761|NCT00014573|adult choroid plexus tumor|adult choroid plexus tumor
449762|NCT00014573|recurrent childhood ependymoma|recurrent childhood ependymoma
449763|NCT00014573|adult grade III meningioma|adult grade iii meningioma
449764|NCT00014573|adult giant cell glioblastoma|adult giant cell glioblastoma
449765|NCT00014573|adult gliosarcoma|adult gliosarcoma
449766|NCT00014586|stage I prostate cancer|stage i prostate cancer
449767|NCT00014586|stage IIB prostate cancer|stage iib prostate cancer
449768|NCT00014586|stage IIA prostate cancer|stage iia prostate cancer
449769|NCT00014586|stage III prostate cancer|stage iii prostate cancer
449770|NCT00014599|stage III vulvar cancer|stage iii vulvar cancer
449865|NCT00014950|growth|growth
449773|NCT00014599|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
449774|NCT00014612|stage IA breast cancer|stage ia breast cancer
449775|NCT00014612|stage IB breast cancer|stage ib breast cancer
449776|NCT00014612|stage II breast cancer|stage ii breast cancer
449777|NCT00014625|stage IV melanoma|stage iv melanoma
449778|NCT00014625|recurrent melanoma|recurrent melanoma
449779|NCT00014638|stage IV breast cancer|stage iv breast cancer
449780|NCT00014638|recurrent breast cancer|recurrent breast cancer
449781|NCT00014651|perioperative/postoperative complications|perioperative/postoperative complications
449782|NCT00014651|stage I pancreatic cancer|stage i pancreatic cancer
449783|NCT00014664|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
449784|NCT00014664|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
449785|NCT00014664|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
449786|NCT00014664|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
449787|NCT00014664|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
449788|NCT00014664|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
449789|NCT00014677|recurrent adult brain tumor|recurrent adult brain tumor
449790|NCT00014677|adult glioblastoma|adult glioblastoma
449791|NCT00014677|adult giant cell glioblastoma|adult giant cell glioblastoma
449792|NCT00014677|adult gliosarcoma|adult gliosarcoma
449793|NCT00014690|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
449794|NCT00014690|fallopian tube cancer|fallopian tube cancer
449795|NCT00014690|primary peritoneal cavity cancer|primary peritoneal cavity cancer
449796|NCT00014729|dermatologic disorders|dermatologic disorders
473172|NCT00079937|atopic|atopic
449797|NCT00014729|epidermolysis bullosa|epidermolysis bullosa
449798|NCT00014729|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
449799|NCT00014729|rare disease|rare disease
449800|NCT00014742|Dupuytren's disease|dupuytren's disease
449801|NCT00014742|arthritis & connective tissue diseases|arthritis & connective tissue diseases
449802|NCT00014742|rare disease|rare disease
449803|NCT00014755|multiple sclerosis|multiple sclerosis
449804|NCT00014755|neurologic and psychiatric disorders|neurologic and psychiatric disorders
449805|NCT00014755|rare disease|rare disease
449806|NCT00014768|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
449807|NCT00014768|cystic fibrosis|cystic fibrosis
449808|NCT00014768|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
449809|NCT00014768|rare disease|rare disease
449810|NCT00014781|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
449811|NCT00014781|cystic fibrosis|cystic fibrosis
449812|NCT00014781|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
449813|NCT00014781|rare disease|rare disease
449814|NCT00014794|Arthritis|arthritis
449815|NCT00014794|Vascularity|vascularity
449816|NCT00014794|Angiogenesis|angiogenesis
449817|NCT00014794|Imaging|imaging
449818|NCT00014794|MRI|mri
449819|NCT00014794|Rheumatoid Arthritis|rheumatoid arthritis
449821|NCT00014794|Synovitis|synovitis
449822|NCT00014807|Pesticide exposure|pesticide exposure
449823|NCT00014807|Organophosphate|organophosphate
449824|NCT00014807|Biomarkers of exposure|biomarkers of exposure
449825|NCT00014807|Poisoning|poisoning
449826|NCT00014807|Occupational Health|occupational health
449827|NCT00014859|Pulmonary surfactant|pulmonary surfactant
449828|NCT00014859|Surfactant protein B|surfactant protein b
449829|NCT00014859|Surfactant protein C|surfactant protein c
449830|NCT00014859|ABCA3|abca3
449831|NCT00014859|NKX2-1|nkx2-1
449832|NCT00014885|Lead exposure|lead exposure
449833|NCT00014885|Bone lead|bone lead
449834|NCT00014885|Cognitive function|cognitive function
449835|NCT00014885|Academic achievement|academic achievement
449836|NCT00014885|Neurobehavior|neurobehavior
449837|NCT00014898|Lead exposure|lead exposure
449838|NCT00014898|Bone lead|bone lead
449839|NCT00014898|Attention deficit|attention deficit
449840|NCT00014937|HIV-1|hiv-1
449841|NCT00014937|Didanosine|didanosine
449842|NCT00014937|Drug Therapy, Combination|drug therapy, combination
449843|NCT00014937|Zidovudine|zidovudine
449844|NCT00014937|Nevirapine|nevirapine
449845|NCT00014937|Stavudine|stavudine
449846|NCT00014937|HIV Protease Inhibitors|hiv protease inhibitors
449847|NCT00014937|Ritonavir|ritonavir
449848|NCT00014937|Lamivudine|lamivudine
449849|NCT00014937|RNA, Viral|rna, viral
449850|NCT00014937|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
449851|NCT00014937|Anti-HIV Agents|anti-hiv agents
449852|NCT00014937|Viral Load|viral load
449853|NCT00014937|ABT 378|abt 378
449854|NCT00014937|Combivir|combivir
449855|NCT00014937|Efavirenz|efavirenz
449856|NCT00014937|Treatment Experienced|treatment experienced
449857|NCT00014950|Cystic Fibrosis|cystic fibrosis
449858|NCT00014950|Immunoreactive trypsinogen|immunoreactive trypsinogen
449859|NCT00014950|deltaF508- CFTR gene|deltaf508- cftr gene
449860|NCT00014950|newborn screening|newborn screening
449861|NCT00014950|Pseudomonas aeruginosa infection|pseudomonas aeruginosa infection
449862|NCT00014950|nutrition|nutrition
449863|NCT00014950|pulmonary status|pulmonary status
449864|NCT00014950|meconium ileus|meconium ileus
449866|NCT00014950|Genetic counseling|genetic counseling
449867|NCT00014950|risk communication|risk communication
449868|NCT00014963|benzene|benzene
449869|NCT00014963|biomarkers|biomarkers
449870|NCT00014963|air pollution|air pollution
449871|NCT00014963|muconic acid|muconic acid
449872|NCT00014963|phenylmercapturic acid|phenylmercapturic acid
449873|NCT00014976|Pyramidal Tract|pyramidal tract
449874|NCT00014976|Primary Lateral Sclerosis|primary lateral sclerosis
449875|NCT00014976|Spastic Paraparesis|spastic paraparesis
449876|NCT00014976|EMG|emg
449877|NCT00014976|Magnetic Stimulation|magnetic stimulation
449878|NCT00014976|Muscle Spasticity|muscle spasticity
449879|NCT00014976|Healthy Volunteer|healthy volunteer
449880|NCT00014989|Preterm delivery|preterm delivery
449881|NCT00014989|Cerebral palsy|cerebral palsy
449882|NCT00014989|Magnesium sulfate|magnesium sulfate
449883|NCT00015002|Antenatal corticosteroids|antenatal corticosteroids
449884|NCT00015002|Preterm delivery|preterm delivery
449885|NCT00015015|Dichloroacetate|dichloroacetate
449886|NCT00015015|Chlorinated hydrocarbons|chlorinated hydrocarbons
449887|NCT00015015|Genetic disease|genetic disease
449888|NCT00015015|Toxicology|toxicology
449889|NCT00015015|Biotransformation|biotransformation
449890|NCT00015028|opioid dependence|opioid dependence
449891|NCT00015041|opiate dependence|opiate dependence
449892|NCT00015054|cocaine dependence|cocaine dependence
449893|NCT00015080|cocaine dependence|cocaine dependence
449894|NCT00015106|cocaine dependence|cocaine dependence
449895|NCT00015132|cocaine dependence|cocaine dependence
449896|NCT00015171|opioid dependence|opioid dependence
473173|NCT00079937|omalizumab|omalizumab
449897|NCT00015210|Cocaine Use Disorders Dependence Depression|cocaine use disorders dependence depression
449898|NCT00015249|cocaine dependence|cocaine dependence
449899|NCT00015340|Opioid Dependence|opioid dependence
449900|NCT00015431|Malabsorption|malabsorption
449901|NCT00015431|Endoscopy|endoscopy
449902|NCT00015431|Cytokine|cytokine
449903|NCT00015431|Immunophenotype|immunophenotype
449904|NCT00015431|Lymphocyte|lymphocyte
449905|NCT00015431|Common Variable Immunodeficiency|common variable immunodeficiency
449906|NCT00015431|Gastrointestinal|gastrointestinal
449907|NCT00015444|Apparently Sporadic Spastic Paraplegia|apparently sporadic spastic paraplegia
449908|NCT00015444|Spasticity|spasticity
449909|NCT00015444|Motor Neuron Disease|motor neuron disease
449910|NCT00015444|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
449911|NCT00015444|Primary Lateral Sclerosis|primary lateral sclerosis
449912|NCT00015444|Muscle Stiffness|muscle stiffness
449913|NCT00015444|Involuntary Muscle Contraction|involuntary muscle contraction
449915|NCT00015457|Writer's Cramp|writer's cramp
449916|NCT00015457|Calcium Channel Antagonists|calcium channel antagonists
449917|NCT00015457|Torticollis|torticollis
449918|NCT00015457|Chemodenervation|chemodenervation
449919|NCT00015470|Myopathy|myopathy
449920|NCT00015470|Dystrophy|dystrophy
449921|NCT00015470|Neuropathy|neuropathy
449922|NCT00015470|Muscle Weakness|muscle weakness
449923|NCT00015470|Muscle Cramps and Pains|muscle cramps and pains
449924|NCT00015470|Neuromuscular Disorders|neuromuscular disorders
449925|NCT00015483|Hematotoxicity|hematotoxicity
449926|NCT00015483|Benzene|benzene
449927|NCT00015483|Bone Marrow|bone marrow
449928|NCT00015548|antipsychotic treatment|antipsychotic treatment
449929|NCT00015548|Alzheimer's disease|alzheimer's disease
449930|NCT00015548|agitation|agitation
449931|NCT00015548|dementia|dementia
449932|NCT00015548|psychosis|psychosis
449933|NCT00015548|behavioral symptoms|behavioral symptoms
449934|NCT00015548|hallucinations|hallucinations
449935|NCT00015548|delusions|delusions
449936|NCT00015561|population studies|population studies
449937|NCT00015561|laboratory evaluation|laboratory evaluation
449938|NCT00015561|hormone analysis|hormone analysis
449939|NCT00015561|semen analysis|semen analysis
449940|NCT00015561|chromosome studies|chromosome studies
449941|NCT00015574|arrhythmia|arrhythmia
449942|NCT00015574|cardiac|cardiac
449943|NCT00015574|air pollution|air pollution
449944|NCT00015574|time series|time series
449945|NCT00015587|Molecular Epidemiology|molecular epidemiology
449946|NCT00015587|Case Control|case control
449947|NCT00015600|Pesticide|pesticide
449948|NCT00015600|Farmworker|farmworker
449949|NCT00015600|Occupational health|occupational health
449950|NCT00015613|Hispanics|hispanics
449951|NCT00015613|Acculturation|acculturation
449952|NCT00015613|Maternal Exposure|maternal exposure
449953|NCT00015613|Infant, Low Birth Weight|infant, low birth weight
449954|NCT00015613|Infant, Premature|infant, premature
449955|NCT00015613|Organophosphates|organophosphates
449956|NCT00015613|Pesticides|pesticides
449957|NCT00015613|Stress|stress
449958|NCT00015613|Nutrition|nutrition
449959|NCT00015639|Blood Donors|blood donors
449960|NCT00015639|Employees|employees
449961|NCT00015639|Heparin|heparin
449962|NCT00015639|Histidine-Rich Glycoprotein|histidine-rich glycoprotein
449963|NCT00015639|Membrane|membrane
449964|NCT00015639|Healthy Volunteer|healthy volunteer
449965|NCT00015652|Ribavirin|ribavirin
449966|NCT00015652|Polyethylene Glycols|polyethylene glycols
449967|NCT00015652|Interferon Alfa-2b|interferon alfa-2b
449968|NCT00015652|Dose-Response Relationship, Drug|dose-response relationship, drug
449969|NCT00015652|Drug Therapy, Combination|drug therapy, combination
449970|NCT00015652|Antiviral Agents|antiviral agents
449971|NCT00015652|Hepatitis C|hepatitis c
449972|NCT00015652|Aldesleukin|aldesleukin
449973|NCT00015652|Peginterferon|peginterferon
449974|NCT00015665|Fungal|fungal
449975|NCT00015665|Immunodeficiency|immunodeficiency
449976|NCT00015665|Infection|infection
449977|NCT00015665|Refractory|refractory
449978|NCT00015665|Severe|severe
449979|NCT00015665|Fungal Infections|fungal infections
449980|NCT00015678|Motor Cortex|motor cortex
449981|NCT00015678|Drug|drug
449982|NCT00015678|GABA|gaba
449983|NCT00015678|Cortical Modulation|cortical modulation
449984|NCT00015678|Magnetic Stimulation|magnetic stimulation
449985|NCT00015678|Healthy Volunteer|healthy volunteer
449986|NCT00015691|Drug Therapy, Combination|drug therapy, combination
449987|NCT00015691|Adipose Tissue|adipose tissue
449988|NCT00015691|Area Under Curve|area under curve
449989|NCT00015691|Hypoglycemic Agents|hypoglycemic agents
449990|NCT00015691|Anthropometry|anthropometry
449991|NCT00015691|Hyperinsulinemia|hyperinsulinemia
449992|NCT00015691|Metformin|metformin
449993|NCT00015691|BRL 49653|brl 49653
449994|NCT00015691|Insulin|insulin
449995|NCT00015691|Glucose Tolerance Test|glucose tolerance test
449996|NCT00015704|Treatment Experienced|treatment experienced
449997|NCT00015704|Treatment Interruption|treatment interruption
449998|NCT00015704|Drug Administration Schedule|drug administration schedule
473379|NCT00080587|Cholesterol|cholesterol
449999|NCT00015704|CD4 Lymphocyte Count|cd4 lymphocyte count
450000|NCT00015704|Anti-HIV Agents|anti-hiv agents
450001|NCT00015704|Tetanus Toxoid|tetanus toxoid
450002|NCT00015704|Aldesleukin|aldesleukin
450003|NCT00015704|Diphtheria Toxoid|diphtheria toxoid
450004|NCT00015717|Imaging|imaging
450005|NCT00015717|Complications|complications
450006|NCT00015717|Stenosis|stenosis
450007|NCT00015717|Treatment|treatment
450008|NCT00015717|Strokes|strokes
450009|NCT00015717|Cerebral Ischemia|cerebral ischemia
450010|NCT00015717|Cranial Cervical Angioplasty|cranial cervical angioplasty
450011|NCT00015756|Apheresis|apheresis
450012|NCT00015756|Transplantation|transplantation
450013|NCT00015756|Type III Secretion Pathway|type iii secretion pathway
450014|NCT00015756|Exotoxins|exotoxins
450015|NCT00015756|Pseudomonas Aeruginosa|pseudomonas aeruginosa
450016|NCT00015756|Cystic Fibrosis|cystic fibrosis
450017|NCT00015756|CF|cf
450018|NCT00015769|Mania|mania
450019|NCT00015769|Depression|depression
450020|NCT00015769|Anticonvulsants|anticonvulsants
450021|NCT00015769|Mood Stabilizers|mood stabilizers
450022|NCT00015769|Bipolar|bipolar
450023|NCT00015769|Mood Stabilizer|mood stabilizer
450024|NCT00015782|Metabolic|metabolic
450025|NCT00015782|Genetic|genetic
450026|NCT00015782|Storage|storage
450027|NCT00015782|Retinal Disease|retinal disease
450028|NCT00015782|Degenerative|degenerative
450029|NCT00015782|Mucolipidosis Type IV|mucolipidosis type iv
450030|NCT00015782|ML-IV|ml-iv
450031|NCT00015795|Pressure|pressure
450032|NCT00015795|Botulinum Toxin|botulinum toxin
450033|NCT00015795|Voice|voice
450034|NCT00015795|Dystonia|dystonia
450035|NCT00015795|Pathophysiology|pathophysiology
450036|NCT00015795|Healthy Volunteer|healthy volunteer
450038|NCT00015795|ABSD|absd
450039|NCT00015795|Spasmodic Dysphonia|spasmodic dysphonia
450040|NCT00015795|Abductor Spasmodic Dysphonia|abductor spasmodic dysphonia
450041|NCT00015808|Neurodegeneration|neurodegeneration
450042|NCT00015808|Anti-Oxidant|anti-oxidant
450043|NCT00015808|Neuropathy|neuropathy
450044|NCT00015808|Hereditary|hereditary
450045|NCT00015808|Spinocerebellar|spinocerebellar
450046|NCT00015808|Friedreich's Ataxia|friedreich's ataxia
450047|NCT00015808|Friedreich Ataxia|friedreich ataxia
450048|NCT00015808|FRDA|frda
450049|NCT00015847|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
450050|NCT00015847|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
450051|NCT00015847|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
450052|NCT00015860|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
450053|NCT00015860|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
450054|NCT00015860|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
450055|NCT00015873|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
450056|NCT00015886|stage IV breast cancer|stage iv breast cancer
450057|NCT00015886|recurrent breast cancer|recurrent breast cancer
450058|NCT00015886|stage IIIB breast cancer|stage iiib breast cancer
450059|NCT00015899|childhood craniopharyngioma|childhood craniopharyngioma
450060|NCT00015899|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
450061|NCT00015899|childhood oligodendroglioma|childhood oligodendroglioma
450062|NCT00015899|childhood choroid plexus tumor|childhood choroid plexus tumor
450063|NCT00015899|childhood grade I meningioma|childhood grade i meningioma
450681|NCT00006450|Children|children
450064|NCT00015899|childhood grade II meningioma|childhood grade ii meningioma
450065|NCT00015899|childhood grade III meningioma|childhood grade iii meningioma
450066|NCT00015899|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
450067|NCT00015899|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
450068|NCT00015899|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
450069|NCT00015899|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
450070|NCT00015899|recurrent childhood ependymoma|recurrent childhood ependymoma
450071|NCT00015899|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
450072|NCT00015899|childhood spinal cord neoplasm|childhood spinal cord neoplasm
450073|NCT00015925|refractory multiple myeloma|refractory multiple myeloma
450074|NCT00015925|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
450075|NCT00015925|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
450076|NCT00015925|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
450077|NCT00015925|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
450078|NCT00015925|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
450079|NCT00015925|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
450080|NCT00015925|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
450081|NCT00015925|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
450082|NCT00015925|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
450083|NCT00015925|refractory anemia with excess blasts|refractory anemia with excess blasts
450286|NCT00016380|testicular seminoma|testicular seminoma
450084|NCT00015925|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
450085|NCT00015925|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
450086|NCT00015925|secondary acute myeloid leukemia|secondary acute myeloid leukemia
450087|NCT00015925|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
450088|NCT00015925|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
450089|NCT00015925|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
450090|NCT00015925|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
450091|NCT00015925|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
450092|NCT00015925|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
450093|NCT00015925|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
450094|NCT00015925|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
450095|NCT00015925|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
450096|NCT00015938|stage IV breast cancer|stage iv breast cancer
450097|NCT00015938|recurrent breast cancer|recurrent breast cancer
450098|NCT00015951|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
450099|NCT00015951|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
450100|NCT00015951|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
583583|NCT00512278|Hepatitis C|hepatitis c
450101|NCT00015951|refractory anemia with excess blasts|refractory anemia with excess blasts
450102|NCT00015951|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
450103|NCT00015951|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
450104|NCT00015951|secondary acute myeloid leukemia|secondary acute myeloid leukemia
450105|NCT00015951|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
450106|NCT00015951|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
450107|NCT00015964|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
450108|NCT00015964|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
450109|NCT00015964|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
450110|NCT00015964|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
450111|NCT00015964|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
450112|NCT00015964|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
450113|NCT00015964|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
450114|NCT00015964|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
450115|NCT00015964|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
450116|NCT00015964|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
450117|NCT00015964|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
450118|NCT00015964|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
450119|NCT00015964|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
450120|NCT00015964|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
450121|NCT00015977|adenocarcinoma of the prostate|adenocarcinoma of the prostate
450122|NCT00015977|stage IV prostate cancer|stage iv prostate cancer
450123|NCT00015977|recurrent prostate cancer|recurrent prostate cancer
450682|NCT00006450|Brain|brain
450124|NCT00016029|colon cancer|colon cancer
450125|NCT00016029|rectal cancer|rectal cancer
450126|NCT00016042|stage IV colon cancer|stage iv colon cancer
450127|NCT00016042|stage IV rectal cancer|stage iv rectal cancer
450128|NCT00016042|recurrent colon cancer|recurrent colon cancer
450129|NCT00016042|recurrent rectal cancer|recurrent rectal cancer
450130|NCT00016042|stage IV renal cell cancer|stage iv renal cell cancer
450131|NCT00016042|recurrent renal cell cancer|recurrent renal cell cancer
450132|NCT00016055|stage IV melanoma|stage iv melanoma
450133|NCT00016055|recurrent melanoma|recurrent melanoma
450134|NCT00016068|infection|infection
450135|NCT00016081|infection|infection
450136|NCT00016133|stage II colon cancer|stage ii colon cancer
450137|NCT00016133|stage III colon cancer|stage iii colon cancer
450138|NCT00016133|adenocarcinoma of the colon|adenocarcinoma of the colon
450139|NCT00016146|recurrent prostate cancer|recurrent prostate cancer
450140|NCT00016159|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
450141|NCT00016159|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
450142|NCT00016159|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
450143|NCT00016159|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
450144|NCT00016159|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
450145|NCT00016172|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
450146|NCT00016172|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
450147|NCT00016172|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
450148|NCT00016172|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
450149|NCT00016172|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
450150|NCT00016172|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
450151|NCT00016172|small intestine lymphoma|small intestine lymphoma
450152|NCT00016172|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
450153|NCT00016172|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
450154|NCT00016172|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
450155|NCT00016172|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
450156|NCT00016172|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
450157|NCT00016172|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
450158|NCT00016172|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
450159|NCT00016172|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
450160|NCT00016172|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
450161|NCT00016172|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
450162|NCT00016172|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
450705|NCT00006454|fallopian tube cancer|fallopian tube cancer
450163|NCT00016172|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
450164|NCT00016172|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
450165|NCT00016172|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
450166|NCT00016172|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
450167|NCT00016172|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
450168|NCT00016172|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
450169|NCT00016172|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
450170|NCT00016172|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
450171|NCT00016172|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
450172|NCT00016172|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
450173|NCT00016172|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
450174|NCT00016172|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
450175|NCT00016172|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
450176|NCT00016172|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
450177|NCT00016172|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
450178|NCT00016172|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
450179|NCT00016172|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
450180|NCT00016172|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
450181|NCT00016172|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
450182|NCT00016172|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
450183|NCT00016172|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
450184|NCT00016172|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
450185|NCT00016172|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
450186|NCT00016172|intraocular lymphoma|intraocular lymphoma
450187|NCT00016172|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
450188|NCT00016172|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
450189|NCT00016172|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
450190|NCT00016172|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
450191|NCT00016172|anaplastic large cell lymphoma|anaplastic large cell lymphoma
450192|NCT00016172|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
450193|NCT00016172|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
450194|NCT00016172|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
450195|NCT00016172|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
450196|NCT00016172|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
450197|NCT00016172|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
450198|NCT00016172|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
450199|NCT00016172|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
450200|NCT00016172|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
450201|NCT00016172|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
450202|NCT00016172|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
450203|NCT00016172|splenic marginal zone lymphoma|splenic marginal zone lymphoma
450204|NCT00016185|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
450205|NCT00016198|stage IV colon cancer|stage iv colon cancer
450206|NCT00016198|stage IV rectal cancer|stage iv rectal cancer
450207|NCT00016198|recurrent colon cancer|recurrent colon cancer
450208|NCT00016198|recurrent rectal cancer|recurrent rectal cancer
450209|NCT00016198|adenocarcinoma of the colon|adenocarcinoma of the colon
450210|NCT00016198|adenocarcinoma of the rectum|adenocarcinoma of the rectum
450211|NCT00016211|extensive stage small cell lung cancer|extensive stage small cell lung cancer
450287|NCT00016380|carcinoma of the appendix|carcinoma of the appendix
450212|NCT00016224|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
450213|NCT00016237|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
450214|NCT00016237|squamous cell lung cancer|squamous cell lung cancer
450215|NCT00016237|stage IV renal cell cancer|stage iv renal cell cancer
450216|NCT00016237|recurrent renal cell cancer|recurrent renal cell cancer
450217|NCT00016237|extensive stage small cell lung cancer|extensive stage small cell lung cancer
450218|NCT00016237|recurrent small cell lung cancer|recurrent small cell lung cancer
450219|NCT00016237|recurrent bladder cancer|recurrent bladder cancer
450220|NCT00016237|stage IV bladder cancer|stage iv bladder cancer
450221|NCT00016237|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
450222|NCT00016237|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
450223|NCT00016237|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
450224|NCT00016250|stage IV colon cancer|stage iv colon cancer
450225|NCT00016250|stage IV rectal cancer|stage iv rectal cancer
450226|NCT00016250|recurrent colon cancer|recurrent colon cancer
450227|NCT00016250|recurrent rectal cancer|recurrent rectal cancer
450228|NCT00016250|adenocarcinoma of the colon|adenocarcinoma of the colon
450229|NCT00016250|adenocarcinoma of the rectum|adenocarcinoma of the rectum
450231|NCT00016263|stage IV melanoma|stage iv melanoma
450232|NCT00016263|recurrent melanoma|recurrent melanoma
450233|NCT00016315|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
450234|NCT00016315|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
450235|NCT00016341|stage III endometrial carcinoma|stage iii endometrial carcinoma
450236|NCT00016341|stage IV endometrial carcinoma|stage iv endometrial carcinoma
450237|NCT00016341|recurrent endometrial carcinoma|recurrent endometrial carcinoma
450238|NCT00016354|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
450239|NCT00016367|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
450240|NCT00016367|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
450241|NCT00016380|nausea and vomiting|nausea and vomiting
450242|NCT00016380|stage I colon cancer|stage i colon cancer
450243|NCT00016380|stage II colon cancer|stage ii colon cancer
450244|NCT00016380|stage III colon cancer|stage iii colon cancer
450245|NCT00016380|stage IV colon cancer|stage iv colon cancer
450246|NCT00016380|stage I gastric cancer|stage i gastric cancer
450247|NCT00016380|stage II gastric cancer|stage ii gastric cancer
450248|NCT00016380|stage III gastric cancer|stage iii gastric cancer
450249|NCT00016380|stage IV gastric cancer|stage iv gastric cancer
450250|NCT00016380|recurrent gastric cancer|recurrent gastric cancer
450251|NCT00016380|stage I pancreatic cancer|stage i pancreatic cancer
450252|NCT00016380|stage II pancreatic cancer|stage ii pancreatic cancer
450253|NCT00016380|stage III pancreatic cancer|stage iii pancreatic cancer
450254|NCT00016380|recurrent pancreatic cancer|recurrent pancreatic cancer
450255|NCT00016380|recurrent colon cancer|recurrent colon cancer
450256|NCT00016380|recurrent cervical cancer|recurrent cervical cancer
450257|NCT00016380|stage IB cervical cancer|stage ib cervical cancer
450258|NCT00016380|stage IIB cervical cancer|stage iib cervical cancer
450259|NCT00016380|stage IVB cervical cancer|stage ivb cervical cancer
450260|NCT00016380|stage IA cervical cancer|stage ia cervical cancer
450261|NCT00016380|stage IIA cervical cancer|stage iia cervical cancer
450262|NCT00016380|stage IVA cervical cancer|stage iva cervical cancer
574607|NCT00484315|DES|des
449632|NCT00014482|pain|pain
450263|NCT00016380|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
450264|NCT00016380|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
450265|NCT00016380|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
450266|NCT00016380|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
450683|NCT00006450|Maturation|maturation
450267|NCT00016380|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
450268|NCT00016380|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
450269|NCT00016380|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
450270|NCT00016380|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
450271|NCT00016380|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
450272|NCT00016380|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
450273|NCT00016380|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
450274|NCT00016380|advanced adult primary liver cancer|advanced adult primary liver cancer
450275|NCT00016380|recurrent adult primary liver cancer|recurrent adult primary liver cancer
450276|NCT00016380|small intestine adenocarcinoma|small intestine adenocarcinoma
450277|NCT00016380|small intestine lymphoma|small intestine lymphoma
450278|NCT00016380|small intestine leiomyosarcoma|small intestine leiomyosarcoma
450279|NCT00016380|localized gallbladder cancer|localized gallbladder cancer
450280|NCT00016380|unresectable gallbladder cancer|unresectable gallbladder cancer
450281|NCT00016380|recurrent gallbladder cancer|recurrent gallbladder cancer
450282|NCT00016380|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
450283|NCT00016380|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
450284|NCT00016380|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
450285|NCT00016380|recurrent small intestine cancer|recurrent small intestine cancer
450288|NCT00016380|quality of life|quality of life
450289|NCT00016380|stage IV pancreatic cancer|stage iv pancreatic cancer
450290|NCT00016393|adenocarcinoma of the prostate|adenocarcinoma of the prostate
450291|NCT00016393|stage IV prostate cancer|stage iv prostate cancer
450292|NCT00016393|recurrent prostate cancer|recurrent prostate cancer
450293|NCT00016406|stage II breast cancer|stage ii breast cancer
450294|NCT00016406|stage IIIA breast cancer|stage iiia breast cancer
450295|NCT00016406|stage IIIB breast cancer|stage iiib breast cancer
450296|NCT00016406|stage IIIC breast cancer|stage iiic breast cancer
450297|NCT00016406|inflammatory breast cancer|inflammatory breast cancer
450298|NCT00016419|refractory anemia|refractory anemia
450299|NCT00016419|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
450300|NCT00016419|refractory anemia with excess blasts|refractory anemia with excess blasts
450301|NCT00016419|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
450302|NCT00016419|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
450303|NCT00016419|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
450304|NCT00016432|stage I breast cancer|stage i breast cancer
450305|NCT00016432|stage II breast cancer|stage ii breast cancer
450306|NCT00016432|stage IIIA breast cancer|stage iiia breast cancer
450307|NCT00016445|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
450308|NCT00016445|cystic fibrosis|cystic fibrosis
450309|NCT00016445|disease-related problem/condition|disease-related problem/condition
450310|NCT00016445|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
450311|NCT00016445|quality of life|quality of life
450312|NCT00016445|rare disease|rare disease
450313|NCT00016458|arthritis & connective tissue diseases|arthritis & connective tissue diseases
450314|NCT00016458|rare disease|rare disease
450315|NCT00016458|systemic sclerosis|systemic sclerosis
450316|NCT00016497|otitis media with effusion|otitis media with effusion
450317|NCT00016497|children|children
450318|NCT00016497|tympanostomy tubes|tympanostomy tubes
450319|NCT00016497|adenoidectomy|adenoidectomy
450320|NCT00016510|Bilingualism|bilingualism
450321|NCT00016510|Fluency|fluency
450322|NCT00016510|Age at Acquisition|age at acquisition
450323|NCT00016510|Words and Sentences|words and sentences
450324|NCT00016510|Cortical Area|cortical area
450325|NCT00016510|Healthy Volunteer|healthy volunteer
450326|NCT00016510|HV|hv
450327|NCT00016510|Bilingual|bilingual
450328|NCT00016510|Second Language|second language
450329|NCT00016523|NICHD Neonatal Research Network|nichd neonatal research network
450330|NCT00016523|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
450331|NCT00016523|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
450332|NCT00016523|Prematurity|prematurity
450333|NCT00016523|Inhaled nitric oxide|inhaled nitric oxide
450334|NCT00016523|Aspiration syndrome|aspiration syndrome
450335|NCT00016523|Idiopathic pulmonary hypertension|idiopathic pulmonary hypertension
450336|NCT00016523|Pulmonary hypoplasia|pulmonary hypoplasia
450337|NCT00016536|Antiviral Agents|antiviral agents
450338|NCT00016536|Mucous Membrane|mucous membrane
450339|NCT00016536|Spermatocidal Agents|spermatocidal agents
450340|NCT00016536|Penis|penis
450341|NCT00016536|Epithelium|epithelium
450342|NCT00016536|PRO 2000|pro 2000
450343|NCT00016536|Urethra|urethra
450344|NCT00016536|HIV Seronegativity|hiv seronegativity
450345|NCT00016549|Endothelial Proliferation|endothelial proliferation
450346|NCT00016549|Endothelial Apoptosis|endothelial apoptosis
450347|NCT00016549|VEGF|vegf
450348|NCT00016549|Magnetic Resonance Imaging|magnetic resonance imaging
450349|NCT00016549|Molecular Targets|molecular targets
450350|NCT00016549|Breast Cancer|breast cancer
450351|NCT00016549|Inflammatory Breast Cancer|inflammatory breast cancer
450353|NCT00016562|Genetic|genetic
450354|NCT00016562|Degenerative|degenerative
450355|NCT00016562|Lysosomal|lysosomal
450356|NCT00016562|Brain|brain
450357|NCT00016562|Mental Retardation|mental retardation
450358|NCT00016562|Neurodegenerative Disorder|neurodegenerative disorder
450359|NCT00016562|Neurometabolic|neurometabolic
450360|NCT00016562|Metabolic Neurological Disorder|metabolic neurological disorder
450361|NCT00016562|Abnormal Metabolism|abnormal metabolism
450362|NCT00016588|HIV-1|hiv-1
450363|NCT00016588|Adenine|adenine
450364|NCT00016588|Anti-HIV Agents|anti-hiv agents
450365|NCT00016588|Viral Load|viral load
450366|NCT00016588|Organophosphorus Compounds|organophosphorus compounds
450367|NCT00016601|Delayed-Action Preparations|delayed-action preparations
450368|NCT00016601|Drug Interactions|drug interactions
450369|NCT00016601|Drug Therapy, Combination|drug therapy, combination
450370|NCT00016601|Nevirapine|nevirapine
450371|NCT00016601|HIV Protease Inhibitors|hiv protease inhibitors
450372|NCT00016601|Ritonavir|ritonavir
450373|NCT00016601|Indinavir|indinavir
450374|NCT00016601|Nelfinavir|nelfinavir
450375|NCT00016601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
450376|NCT00016601|Anti-HIV Agents|anti-hiv agents
450377|NCT00016601|Pharmacokinetics|pharmacokinetics
450378|NCT00016601|Medroxyprogesterone 17-Acetate|medroxyprogesterone 17-acetate
450379|NCT00016601|efavirenz|efavirenz
450380|NCT00016653|Duchenne|duchenne
450381|NCT00016653|muscular|muscular
450388|NCT00016666|Pharmacokinetics|pharmacokinetics
450389|NCT00016666|Circadian Rhythm|circadian rhythm
450390|NCT00016666|Seasonal Rhythm|seasonal rhythm
450391|NCT00016666|Seasonal Affective Disorder|seasonal affective disorder
450392|NCT00016666|Pineal Gland|pineal gland
450393|NCT00016666|Suprachiasmatic Nucleus|suprachiasmatic nucleus
450394|NCT00016666|Healthy Volunteer|healthy volunteer
450396|NCT00016666|Winter Depression|winter depression
450397|NCT00016666|SAD|sad
450398|NCT00016679|Pharmacokinetics|pharmacokinetics
450399|NCT00016679|Metabolism|metabolism
450400|NCT00016679|Toxicity|toxicity
450401|NCT00016679|Side Effects|side effects
450402|NCT00016679|Essential Tremor|essential tremor
450403|NCT00016679|Tremor|tremor
450404|NCT00016679|Movement Disorder|movement disorder
450405|NCT00016692|Drug tolerance|drug tolerance
450406|NCT00016692|Acute Infection|acute infection
450407|NCT00016718|Didanosine|didanosine
450408|NCT00016718|Drug Therapy, Combination|drug therapy, combination
450409|NCT00016718|Drug Administration Schedule|drug administration schedule
450410|NCT00016718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
450411|NCT00016718|Anti-HIV Agents|anti-hiv agents
450412|NCT00016718|Pharmacokinetics|pharmacokinetics
450413|NCT00016718|Deoxycytidine|deoxycytidine
450414|NCT00016718|Efavirenz|efavirenz
450415|NCT00016718|Treatment Naive|treatment naive
450416|NCT00016731|Depression|depression
450417|NCT00016731|Anxiety|anxiety
450418|NCT00016731|CAH|cah
450419|NCT00016731|Adults|adults
450420|NCT00016731|FMPP|fmpp
450421|NCT00016731|Emotion|emotion
450422|NCT00016731|Cushing's Syndrome|cushing's syndrome
450423|NCT00016731|Adolescence|adolescence
450424|NCT00016731|Magnetic Resonance Imaging|magnetic resonance imaging
450425|NCT00016731|fMRI|fmri
450426|NCT00016731|Healthy Volunteer|healthy volunteer
450427|NCT00016731|HV|hv
450428|NCT00016731|MRI|mri
450429|NCT00016783|Drug Therapy, Combination|drug therapy, combination
450430|NCT00016783|Drug Administration Schedule|drug administration schedule
450431|NCT00016783|HIV Protease Inhibitors|hiv protease inhibitors
450432|NCT00016783|CD4 Lymphocyte Count|cd4 lymphocyte count
450433|NCT00016783|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
450434|NCT00016783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
450435|NCT00016783|Anti-HIV Agents|anti-hiv agents
450436|NCT00016783|Viral Load|viral load
450437|NCT00016783|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
450438|NCT00016783|Treatment Experienced|treatment experienced
450439|NCT00016783|Treatment Interruption|treatment interruption
450440|NCT00016796|Reading|reading
450441|NCT00016796|Naming|naming
574856|NCT00485277|Vaccine|vaccine
450442|NCT00016835|Type 2 diabetes mellitus|type 2 diabetes mellitus
450443|NCT00016835|Glycemic control|glycemic control
450444|NCT00016835|Periodontal therapy|periodontal therapy
450445|NCT00016848|Obesity|obesity
450446|NCT00016848|Endocrine|endocrine
450447|NCT00016848|Diet|diet
450448|NCT00016848|Metabolism|metabolism
450449|NCT00016848|Macronutrients|macronutrients
450450|NCT00016861|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
450451|NCT00016874|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
450452|NCT00016887|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
450453|NCT00016887|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
450454|NCT00016900|stage III esophageal cancer|stage iii esophageal cancer
450455|NCT00016900|stage IV esophageal cancer|stage iv esophageal cancer
450456|NCT00016900|recurrent esophageal cancer|recurrent esophageal cancer
450457|NCT00016900|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
450458|NCT00016900|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
450459|NCT00016913|adenocarcinoma of the prostate|adenocarcinoma of the prostate
450460|NCT00016913|stage III prostate cancer|stage iii prostate cancer
450461|NCT00016926|stage III cervical cancer|stage iii cervical cancer
450462|NCT00016926|recurrent cervical cancer|recurrent cervical cancer
450463|NCT00016926|stage IVB cervical cancer|stage ivb cervical cancer
450464|NCT00016926|stage IVA cervical cancer|stage iva cervical cancer
450465|NCT00016926|cervical squamous cell carcinoma|cervical squamous cell carcinoma
450466|NCT00016939|stage III renal cell cancer|stage iii renal cell cancer
450467|NCT00016939|stage IV renal cell cancer|stage iv renal cell cancer
450468|NCT00016939|recurrent renal cell cancer|recurrent renal cell cancer
450469|NCT00016952|stage IV colon cancer|stage iv colon cancer
450470|NCT00016952|stage IV rectal cancer|stage iv rectal cancer
450471|NCT00016952|recurrent colon cancer|recurrent colon cancer
450472|NCT00016952|recurrent rectal cancer|recurrent rectal cancer
450473|NCT00016952|adenocarcinoma of the colon|adenocarcinoma of the colon
450474|NCT00016952|adenocarcinoma of the rectum|adenocarcinoma of the rectum
450475|NCT00016965|stage II pancreatic cancer|stage ii pancreatic cancer
450476|NCT00016965|stage III pancreatic cancer|stage iii pancreatic cancer
450477|NCT00016965|recurrent pancreatic cancer|recurrent pancreatic cancer
450478|NCT00016965|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
450479|NCT00016965|stage IV pancreatic cancer|stage iv pancreatic cancer
450480|NCT00016978|stage IV colon cancer|stage iv colon cancer
450481|NCT00016978|stage IV rectal cancer|stage iv rectal cancer
450482|NCT00016978|recurrent colon cancer|recurrent colon cancer
450483|NCT00016978|recurrent rectal cancer|recurrent rectal cancer
450484|NCT00016978|adenocarcinoma of the colon|adenocarcinoma of the colon
450485|NCT00016978|adenocarcinoma of the rectum|adenocarcinoma of the rectum
450486|NCT00016991|recurrent adult brain tumor|recurrent adult brain tumor
450487|NCT00016991|adult glioblastoma|adult glioblastoma
450488|NCT00016991|adult giant cell glioblastoma|adult giant cell glioblastoma
450489|NCT00016991|adult gliosarcoma|adult gliosarcoma
583584|NCT00512291|Advanced Cancer|advanced cancer
450490|NCT00017017|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
450491|NCT00017017|fallopian tube cancer|fallopian tube cancer
450492|NCT00017017|primary peritoneal cavity cancer|primary peritoneal cavity cancer
450493|NCT00017030|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
450494|NCT00017030|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
450495|NCT00017030|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
450496|NCT00017043|stage IV gastric cancer|stage iv gastric cancer
450497|NCT00017043|recurrent gastric cancer|recurrent gastric cancer
450498|NCT00017043|stage IV esophageal cancer|stage iv esophageal cancer
450499|NCT00017043|recurrent esophageal cancer|recurrent esophageal cancer
450500|NCT00017043|adenocarcinoma of the stomach|adenocarcinoma of the stomach
450501|NCT00017043|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
450502|NCT00017056|stage IV gastric cancer|stage iv gastric cancer
450503|NCT00017056|recurrent gastric cancer|recurrent gastric cancer
450504|NCT00017056|stage IV esophageal cancer|stage iv esophageal cancer
450505|NCT00017056|recurrent esophageal cancer|recurrent esophageal cancer
450506|NCT00017056|adenocarcinoma of the stomach|adenocarcinoma of the stomach
450507|NCT00017056|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
450508|NCT00017069|refractory multiple myeloma|refractory multiple myeloma
450509|NCT00017069|stage II multiple myeloma|stage ii multiple myeloma
450510|NCT00017069|stage III multiple myeloma|stage iii multiple myeloma
450511|NCT00017082|stage IV colon cancer|stage iv colon cancer
450512|NCT00017082|stage IV rectal cancer|stage iv rectal cancer
450513|NCT00017082|recurrent colon cancer|recurrent colon cancer
450514|NCT00017082|recurrent rectal cancer|recurrent rectal cancer
450515|NCT00017082|adenocarcinoma of the colon|adenocarcinoma of the colon
450516|NCT00017082|adenocarcinoma of the rectum|adenocarcinoma of the rectum
450517|NCT00017095|stage II breast cancer|stage ii breast cancer
450518|NCT00017095|stage IIIA breast cancer|stage iiia breast cancer
450519|NCT00017095|stage IIIB breast cancer|stage iiib breast cancer
450520|NCT00017095|stage IIIC breast cancer|stage iiic breast cancer
450521|NCT00017095|inflammatory breast cancer|inflammatory breast cancer
450522|NCT00017108|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
450523|NCT00017108|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
450524|NCT00017108|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
450525|NCT00017121|stage IV melanoma|stage iv melanoma
450526|NCT00017121|recurrent melanoma|recurrent melanoma
450527|NCT00017121|lung metastases|lung metastases
450528|NCT00017134|ovarian epithelial cancer|ovarian epithelial cancer
450529|NCT00017147|adult glioblastoma|adult glioblastoma
450530|NCT00017147|adult giant cell glioblastoma|adult giant cell glioblastoma
450531|NCT00017147|adult gliosarcoma|adult gliosarcoma
450684|NCT00006450|Phenylacetate|phenylacetate
450532|NCT00017173|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
450533|NCT00017173|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
450534|NCT00017173|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
450535|NCT00017173|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
450536|NCT00017173|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
450537|NCT00017173|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
450538|NCT00017173|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
450539|NCT00017173|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
450540|NCT00005992|stage IV prostate cancer|stage iv prostate cancer
450541|NCT00005992|recurrent prostate cancer|recurrent prostate cancer
450542|NCT00005993|stage IV breast cancer|stage iv breast cancer
450543|NCT00005993|stage IIIA breast cancer|stage iiia breast cancer
450544|NCT00005993|recurrent breast cancer|recurrent breast cancer
450545|NCT00005993|stage IIIB breast cancer|stage iiib breast cancer
450546|NCT00005993|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
450547|NCT00005993|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
450548|NCT00005993|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
450549|NCT00005993|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
450550|NCT00005993|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
450551|NCT00005993|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
450552|NCT00005993|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
450553|NCT00005993|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
450617|NCT00006001|stage III colon cancer|stage iii colon cancer
450554|NCT00005993|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
450555|NCT00005993|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
450556|NCT00005993|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
450557|NCT00005993|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
450558|NCT00005993|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
450559|NCT00005993|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
450560|NCT00005993|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
450561|NCT00005993|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
450562|NCT00005993|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
450563|NCT00005993|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
450564|NCT00005993|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
450565|NCT00005993|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
450566|NCT00005993|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
450567|NCT00005993|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
450568|NCT00005993|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
450569|NCT00005993|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
450570|NCT00005993|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
450571|NCT00005993|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
450572|NCT00005993|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
450573|NCT00005993|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
450574|NCT00005993|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
450575|NCT00005993|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
450576|NCT00005993|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
450577|NCT00005993|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
450578|NCT00005993|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
450579|NCT00005993|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
450580|NCT00005993|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
450581|NCT00005993|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
450582|NCT00005993|splenic marginal zone lymphoma|splenic marginal zone lymphoma
450583|NCT00005994|nausea and vomiting|nausea and vomiting
450584|NCT00005994|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
450585|NCT00005995|stage IV renal cell cancer|stage iv renal cell cancer
450586|NCT00005995|recurrent renal cell cancer|recurrent renal cell cancer
450587|NCT00005996|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
450588|NCT00005997|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
450589|NCT00005997|advanced adult primary liver cancer|advanced adult primary liver cancer
450590|NCT00005997|unresectable gallbladder cancer|unresectable gallbladder cancer
450591|NCT00005997|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
450592|NCT00005997|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
450593|NCT00005997|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
450594|NCT00005997|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
450595|NCT00005997|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
450596|NCT00005998|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
450597|NCT00005998|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
450598|NCT00005998|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
450599|NCT00005998|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
450600|NCT00005998|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
450601|NCT00005998|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
450602|NCT00005998|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
450603|NCT00005998|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
450604|NCT00005998|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
450605|NCT00005998|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
450606|NCT00005998|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
450607|NCT00005998|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
450608|NCT00005998|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
450609|NCT00005998|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
450610|NCT00005998|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
450611|NCT00005998|splenic marginal zone lymphoma|splenic marginal zone lymphoma
450612|NCT00005999|recurrent cervical cancer|recurrent cervical cancer
450613|NCT00005999|stage IVB cervical cancer|stage ivb cervical cancer
450614|NCT00005999|cervical squamous cell carcinoma|cervical squamous cell carcinoma
450615|NCT00005999|cervical adenocarcinoma|cervical adenocarcinoma
450616|NCT00006000|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
450618|NCT00006001|stage IV colon cancer|stage iv colon cancer
450619|NCT00006001|stage III rectal cancer|stage iii rectal cancer
450620|NCT00006001|stage IV rectal cancer|stage iv rectal cancer
450621|NCT00006001|recurrent colon cancer|recurrent colon cancer
450622|NCT00006001|recurrent rectal cancer|recurrent rectal cancer
450623|NCT00006001|adenocarcinoma of the colon|adenocarcinoma of the colon
450624|NCT00006001|adenocarcinoma of the rectum|adenocarcinoma of the rectum
450625|NCT00006002|stage IV prostate cancer|stage iv prostate cancer
450626|NCT00006002|recurrent prostate cancer|recurrent prostate cancer
450629|NCT00006443|Lymphoid Tissue|lymphoid tissue
450630|NCT00006443|Stavudine|stavudine
450631|NCT00006443|HIV Protease Inhibitors|hiv protease inhibitors
450632|NCT00006443|Polymerase Chain Reaction|polymerase chain reaction
450633|NCT00006443|Biological Markers|biological markers
450634|NCT00006443|Lamivudine|lamivudine
450635|NCT00006443|Indinavir|indinavir
450636|NCT00006443|RNA, Viral|rna, viral
450637|NCT00006443|Genotype|genotype
450638|NCT00006443|Phenotype|phenotype
450639|NCT00006443|Cytokines|cytokines
450640|NCT00006443|Nelfinavir|nelfinavir
450641|NCT00006443|Macrophages|macrophages
450642|NCT00006443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
450643|NCT00006443|In Situ Hybridization|in situ hybridization
450644|NCT00006443|Anti-HIV Agents|anti-hiv agents
450645|NCT00006443|Viral Load|viral load
450646|NCT00006443|Cell Membrane|cell membrane
450647|NCT00006443|Acute Infection|acute infection
450648|NCT00006443|Treatment Naive|treatment naive
450649|NCT00006444|Drug Therapy, Combination|drug therapy, combination
450650|NCT00006444|Papillomavirus, Human|papillomavirus, human
450651|NCT00006444|DNA, Viral|dna, viral
450652|NCT00006444|Anti-HIV Agent|anti-hiv agent
450653|NCT00006444|Treatment Naive|treatment naive
450654|NCT00006445|Pregnancy|pregnancy
450655|NCT00006445|Ultrasound|ultrasound
450656|NCT00006445|Serum screen|serum screen
450657|NCT00006445|Pregnancy associated plasma protein-A (PAPP-A)|pregnancy associated plasma protein-a (papp-a)
450658|NCT00006445|Free-beta human chorionic gonadotropin (FbhCG)|free-beta human chorionic gonadotropin (fbhcg)
450659|NCT00006445|Alpha fetoprotein|alpha fetoprotein
450660|NCT00006445|Unconjugated estriol|unconjugated estriol
450037|NCT00015795|HV|hv
450661|NCT00006445|Inhibin-A|inhibin-a
450662|NCT00006445|Down syndrome|down syndrome
450663|NCT00006445|Aneuploidy|aneuploidy
450664|NCT00006446|Behavioral disorders|behavioral disorders
450665|NCT00006446|Parenting skills and communication|parenting skills and communication
450666|NCT00006446|Parent-child interactions|parent-child interactions
450667|NCT00006446|At-risk preschooler|at-risk preschooler
450668|NCT00006446|Head Start|head start
450669|NCT00006447|Brain Injuries|brain injuries
450670|NCT00006447|Trauma|trauma
450671|NCT00006447|Caregivers|caregivers
450672|NCT00006447|Burden and Dependency|burden and dependency
450673|NCT00006447|Rehabilitation|rehabilitation
450674|NCT00006447|Support, social|support, social
450675|NCT00006447|Information System|information system
450676|NCT00006447|Information Resources (PT)|information resources (pt)
450677|NCT00006447|Disability, persons with|disability, persons with
450678|NCT00006448|Spinal cord injury|spinal cord injury
450679|NCT00006448|Amputation|amputation
450680|NCT00006448|Pain management|pain management
450685|NCT00006450|Differentiation|differentiation
450686|NCT00006451|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
450687|NCT00006451|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
450688|NCT00006451|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
450689|NCT00006451|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
450690|NCT00006451|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
450691|NCT00006451|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
450692|NCT00006451|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
450693|NCT00006451|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
450694|NCT00006451|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
450695|NCT00006451|acute undifferentiated leukemia|acute undifferentiated leukemia
450696|NCT00006451|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
450697|NCT00006451|graft versus host disease|graft versus host disease
450698|NCT00006452|adult glioblastoma|adult glioblastoma
450699|NCT00006452|adult giant cell glioblastoma|adult giant cell glioblastoma
450700|NCT00006452|adult gliosarcoma|adult gliosarcoma
450701|NCT00006453|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
450702|NCT00006454|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
450703|NCT00006454|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
450704|NCT00006454|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
450706|NCT00006455|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
450707|NCT00006455|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
450708|NCT00006455|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
450709|NCT00006455|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
450710|NCT00006455|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
450711|NCT00006456|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
450712|NCT00006456|lung metastases|lung metastases
450713|NCT00006456|liver metastases|liver metastases
450714|NCT00006457|non-small cell lung cancer|non-small cell lung cancer
450715|NCT00006457|small cell lung cancer|small cell lung cancer
450716|NCT00006458|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
450717|NCT00006458|squamous cell lung cancer|squamous cell lung cancer
450718|NCT00006458|large cell lung cancer|large cell lung cancer
450719|NCT00006458|adenocarcinoma of the lung|adenocarcinoma of the lung
450720|NCT00006458|adenosquamous cell lung cancer|adenosquamous cell lung cancer
450721|NCT00006459|stage IV breast cancer|stage iv breast cancer
450722|NCT00006459|stage IIIA breast cancer|stage iiia breast cancer
450723|NCT00006459|recurrent breast cancer|recurrent breast cancer
450724|NCT00006459|stage IIIB breast cancer|stage iiib breast cancer
450725|NCT00006460|adult glioblastoma|adult glioblastoma
450726|NCT00006460|adult giant cell glioblastoma|adult giant cell glioblastoma
450727|NCT00006460|adult gliosarcoma|adult gliosarcoma
450728|NCT00006462|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
450729|NCT00006462|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
450730|NCT00006463|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
450731|NCT00006464|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
450732|NCT00006465|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
450733|NCT00006466|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
450734|NCT00006466|isolated plasmacytoma of bone|isolated plasmacytoma of bone
450735|NCT00006466|extramedullary plasmacytoma|extramedullary plasmacytoma
450736|NCT00006466|refractory multiple myeloma|refractory multiple myeloma
450737|NCT00006466|stage I multiple myeloma|stage i multiple myeloma
450738|NCT00006466|stage II multiple myeloma|stage ii multiple myeloma
450739|NCT00006466|stage III multiple myeloma|stage iii multiple myeloma
450740|NCT00006467|stage III pancreatic cancer|stage iii pancreatic cancer
450741|NCT00006467|recurrent pancreatic cancer|recurrent pancreatic cancer
450742|NCT00006467|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
450743|NCT00006467|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
450744|NCT00006467|stage IV pancreatic cancer|stage iv pancreatic cancer
450745|NCT00006468|stage IV colon cancer|stage iv colon cancer
450746|NCT00006468|stage IV rectal cancer|stage iv rectal cancer
450747|NCT00006468|recurrent colon cancer|recurrent colon cancer
450748|NCT00006468|recurrent rectal cancer|recurrent rectal cancer
450749|NCT00006468|adenocarcinoma of the colon|adenocarcinoma of the colon
450750|NCT00006468|adenocarcinoma of the rectum|adenocarcinoma of the rectum
450751|NCT00006469|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
450752|NCT00006469|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
450753|NCT00006470|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
450754|NCT00006470|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
450755|NCT00006471|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
451010|NCT00017966|Healthy Volunteer|healthy volunteer
450756|NCT00006471|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
450757|NCT00006471|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
450758|NCT00006471|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
450759|NCT00006471|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
450760|NCT00006471|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
450761|NCT00006471|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
450762|NCT00006471|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
450763|NCT00006471|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
450764|NCT00006471|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
450765|NCT00006471|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
450766|NCT00006471|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
450767|NCT00006471|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
450768|NCT00006471|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
450769|NCT00006471|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
450770|NCT00006472|stage I esophageal cancer|stage i esophageal cancer
450771|NCT00006472|stage II esophageal cancer|stage ii esophageal cancer
450772|NCT00006472|stage III esophageal cancer|stage iii esophageal cancer
450773|NCT00006472|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
450774|NCT00006472|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
450775|NCT00006474|recurrent adult brain tumor|recurrent adult brain tumor
451160|NCT00018642|quetiapine|quetiapine
450776|NCT00006474|adult glioblastoma|adult glioblastoma
450777|NCT00006474|adult anaplastic astrocytoma|adult anaplastic astrocytoma
450778|NCT00006474|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
450779|NCT00006474|adult mixed glioma|adult mixed glioma
450780|NCT00006474|adult oligodendroglioma|adult oligodendroglioma
450781|NCT00006474|adult giant cell glioblastoma|adult giant cell glioblastoma
450782|NCT00006474|adult gliosarcoma|adult gliosarcoma
450783|NCT00017186|localized malignant mesothelioma|localized malignant mesothelioma
450784|NCT00017186|advanced malignant mesothelioma|advanced malignant mesothelioma
450785|NCT00017186|recurrent malignant mesothelioma|recurrent malignant mesothelioma
450786|NCT00017199|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
450787|NCT00017199|gastrinoma|gastrinoma
450788|NCT00017199|insulinoma|insulinoma
450789|NCT00017199|somatostatinoma|somatostatinoma
450790|NCT00017199|glucagonoma|glucagonoma
450791|NCT00017212|stage III gastric cancer|stage iii gastric cancer
450792|NCT00017212|stage IV gastric cancer|stage iv gastric cancer
450793|NCT00017212|recurrent gastric cancer|recurrent gastric cancer
450794|NCT00017212|stage III esophageal cancer|stage iii esophageal cancer
450795|NCT00017212|stage IV esophageal cancer|stage iv esophageal cancer
450796|NCT00017212|recurrent esophageal cancer|recurrent esophageal cancer
450797|NCT00017212|adenocarcinoma of the stomach|adenocarcinoma of the stomach
450798|NCT00017212|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
450799|NCT00017225|localized resectable neuroblastoma|localized resectable neuroblastoma
450800|NCT00017225|regional neuroblastoma|regional neuroblastoma
450801|NCT00017225|disseminated neuroblastoma|disseminated neuroblastoma
450802|NCT00017225|stage 4S neuroblastoma|stage 4s neuroblastoma
450803|NCT00017225|recurrent neuroblastoma|recurrent neuroblastoma
450804|NCT00017225|localized unresectable neuroblastoma|localized unresectable neuroblastoma
450805|NCT00017264|recurrent adult brain tumor|recurrent adult brain tumor
450806|NCT00017264|adult glioblastoma|adult glioblastoma
450807|NCT00017264|adult anaplastic astrocytoma|adult anaplastic astrocytoma
450808|NCT00017264|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
450809|NCT00017264|adult giant cell glioblastoma|adult giant cell glioblastoma
450810|NCT00017264|adult gliosarcoma|adult gliosarcoma
450811|NCT00017277|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
450812|NCT00017277|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
450813|NCT00017277|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
450814|NCT00017277|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
450815|NCT00017277|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
450816|NCT00017277|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
450817|NCT00017277|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
450818|NCT00017277|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
450819|NCT00017277|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
450820|NCT00017277|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
450821|NCT00017277|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
470764|NCT00072631|EGFR|egfr
450822|NCT00017277|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
450823|NCT00017277|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
450824|NCT00017277|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
450825|NCT00017277|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
450826|NCT00017277|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
450827|NCT00017290|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
450828|NCT00017290|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
450829|NCT00017290|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
450830|NCT00017290|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
450831|NCT00017290|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
450832|NCT00017290|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
450833|NCT00017303|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
450834|NCT00017303|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
450835|NCT00017303|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
450836|NCT00017303|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
450837|NCT00017303|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
450838|NCT00017303|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
450839|NCT00017303|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
450840|NCT00017303|primary peritoneal cavity cancer|primary peritoneal cavity cancer
450841|NCT00017303|Brenner tumor|brenner tumor
450842|NCT00017316|stage IV melanoma|stage iv melanoma
450843|NCT00017316|recurrent melanoma|recurrent melanoma
450844|NCT00017329|stage IV renal cell cancer|stage iv renal cell cancer
450845|NCT00017342|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
473888|NCT00082303|Anxiety|anxiety
450846|NCT00017342|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
450847|NCT00017342|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
450848|NCT00017342|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
450849|NCT00017342|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
450850|NCT00017342|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
450852|NCT00017355|recurrent melanoma|recurrent melanoma
450853|NCT00017368|regional neuroblastoma|regional neuroblastoma
450854|NCT00017368|disseminated neuroblastoma|disseminated neuroblastoma
450855|NCT00017368|localized unresectable neuroblastoma|localized unresectable neuroblastoma
450856|NCT00017368|stage 4S neuroblastoma|stage 4s neuroblastoma
450857|NCT00017407|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
450858|NCT00017407|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
450859|NCT00017407|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
450860|NCT00017433|refractory multiple myeloma|refractory multiple myeloma
450861|NCT00017433|stage II multiple myeloma|stage ii multiple myeloma
450862|NCT00017433|stage III multiple myeloma|stage iii multiple myeloma
450863|NCT00017446|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
450864|NCT00017446|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
450865|NCT00017446|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
450866|NCT00017459|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
450867|NCT00017459|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
450868|NCT00017459|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
450869|NCT00017485|basal cell carcinoma of the skin|basal cell carcinoma of the skin
450870|NCT00017485|recurrent skin cancer|recurrent skin cancer
450871|NCT00017498|stage IV salivary gland cancer|stage iv salivary gland cancer
450872|NCT00017498|recurrent salivary gland cancer|recurrent salivary gland cancer
450873|NCT00017498|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
450874|NCT00017498|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
450875|NCT00017498|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
450876|NCT00017511|stage I salivary gland cancer|stage i salivary gland cancer
450877|NCT00017511|stage II salivary gland cancer|stage ii salivary gland cancer
450878|NCT00017511|stage III salivary gland cancer|stage iii salivary gland cancer
450879|NCT00017511|stage IV salivary gland cancer|stage iv salivary gland cancer
450880|NCT00017511|recurrent salivary gland cancer|recurrent salivary gland cancer
450881|NCT00017511|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
450882|NCT00017511|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
450883|NCT00017511|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
450884|NCT00017511|oral complications|oral complications
450885|NCT00017511|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
450886|NCT00017511|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
450887|NCT00017511|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
451011|NCT00017966|Normal Control|normal control
450888|NCT00017511|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
450889|NCT00017511|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
450890|NCT00017511|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
450891|NCT00017511|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
450892|NCT00017511|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
450893|NCT00017511|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
450894|NCT00017511|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
450895|NCT00017511|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
450896|NCT00017511|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
450897|NCT00017511|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
450898|NCT00017511|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
450899|NCT00017511|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
450900|NCT00017511|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
450901|NCT00017511|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
583586|NCT00512291|Mixed Delirium|mixed delirium
450902|NCT00017511|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
450903|NCT00017511|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
450904|NCT00017511|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
751942|NCT01171287|Time Factors|time factors
450905|NCT00017511|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
450906|NCT00017511|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
450907|NCT00017511|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
450908|NCT00017511|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
450909|NCT00017511|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
450910|NCT00017511|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
450911|NCT00017511|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
450912|NCT00017511|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
450913|NCT00017511|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
450914|NCT00017511|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
450915|NCT00017511|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
450916|NCT00017511|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
450917|NCT00017511|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
450918|NCT00017511|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
450919|NCT00017511|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
450920|NCT00017511|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
450921|NCT00017511|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
450922|NCT00017511|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
450923|NCT00017511|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
450924|NCT00017511|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
450925|NCT00017511|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
450926|NCT00017511|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
450927|NCT00017511|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
450928|NCT00017511|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
450929|NCT00017511|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
450930|NCT00017511|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
450931|NCT00017511|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
450932|NCT00017511|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
450933|NCT00017511|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
450934|NCT00017511|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
450935|NCT00017511|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
450936|NCT00017511|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
450937|NCT00017511|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
450938|NCT00017511|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
450939|NCT00017511|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
450940|NCT00017511|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
450941|NCT00017511|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
450942|NCT00017511|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
450943|NCT00017511|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
450944|NCT00017511|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
450945|NCT00017511|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
450946|NCT00017511|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
450947|NCT00017511|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
450948|NCT00017511|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
450949|NCT00017511|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
450950|NCT00017511|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
450951|NCT00017511|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
450952|NCT00017511|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
583587|NCT00512291|Olanzapine|olanzapine
450953|NCT00017511|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
450954|NCT00017511|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
450955|NCT00017511|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
12263|NCT03212508|Continuous positive airway pressure, preterm|continuous positive airway pressure, preterm
450956|NCT00017511|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
450957|NCT00017511|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
450958|NCT00017511|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
450959|NCT00017511|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
450960|NCT00017511|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
450961|NCT00017511|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
450962|NCT00017511|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
450963|NCT00017511|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
450964|NCT00017511|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
450965|NCT00017511|radiation toxicity|radiation toxicity
450966|NCT00017524|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
450967|NCT00017862|Eosinophils|eosinophils
450968|NCT00017862|Monoclonal Antibody|monoclonal antibody
450969|NCT00017862|Hypereosinophilia|hypereosinophilia
450970|NCT00017862|Biologicals|biologicals
450971|NCT00017862|Hypereosinophilic Syndrome|hypereosinophilic syndrome
450972|NCT00017875|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
450973|NCT00017875|Intracortical Inhibition|intracortical inhibition
450974|NCT00017875|Dystonia|dystonia
450975|NCT00017875|Focal Dystonia|focal dystonia
450976|NCT00017875|Dystonic Disorder|dystonic disorder
450977|NCT00017875|DYTI Dystonia|dyti dystonia
450978|NCT00017875|Movement Disorder|movement disorder
450979|NCT00017875|Generalized Dystonia|generalized dystonia
450980|NCT00017875|Healthy Control|healthy control
450981|NCT00017875|Normal Volunteer|normal volunteer
451109|NCT00018291|Dementia|dementia
450982|NCT00017914|Adult and Pediatric Disease|adult and pediatric disease
450983|NCT00017914|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
450984|NCT00017914|Autoimmunity Pathogenesis|autoimmunity pathogenesis
450985|NCT00017914|Disease Assessment|disease assessment
450986|NCT00017914|Genetic and Environmental Risk Factors|genetic and environmental risk factors
450987|NCT00017914|Idiopathic Inflammatory Myopathy|idiopathic inflammatory myopathy
450988|NCT00017927|Acromegaly|acromegaly
450989|NCT00017927|McCune-Albright Syndrome|mccune-albright syndrome
450991|NCT00017927|Adenoma|adenoma
450992|NCT00017927|Hyperplasia|hyperplasia
450993|NCT00017927|MAS|mas
450994|NCT00017927|Polyostotic Fibrous Dysplasia|polyostotic fibrous dysplasia
450995|NCT00017927|PFD|pfd
450996|NCT00017940|Gene Therapy|gene therapy
450997|NCT00017953|Diabetes|diabetes
450998|NCT00017953|Weight loss|weight loss
450999|NCT00017953|Heart Attack|heart attack
451000|NCT00017953|Heart disease|heart disease
451001|NCT00017953|Lifestyle Intervention|lifestyle intervention
451002|NCT00017953|Physical Fitness/Physical Activity|physical fitness/physical activity
451003|NCT00017953|Psychosocial outcomes (e.g., depression, eating disorders)|psychosocial outcomes (e.g., depression, eating disorders)
451004|NCT00017953|Bone Density|bone density
451005|NCT00017966|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
451006|NCT00017966|Motor Cortex|motor cortex
451007|NCT00017966|Cerebral Inhibition|cerebral inhibition
451008|NCT00017966|Corpus Callosum|corpus callosum
451009|NCT00017966|Evoked Potential|evoked potential
451119|NCT00018330|Genetics|genetics
451012|NCT00017979|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
451013|NCT00017979|Motor Cortex|motor cortex
451014|NCT00017979|Motor Imagery|motor imagery
451015|NCT00017979|Reaction Time|reaction time
451016|NCT00017979|Cerebral Inhibition|cerebral inhibition
451017|NCT00017979|Healthy Volunteer|healthy volunteer
451018|NCT00017979|Normal Control|normal control
451019|NCT00017992|HIV-1|hiv-1
451020|NCT00017992|Drug Administration Schedule|drug administration schedule
451021|NCT00017992|Stavudine|stavudine
451022|NCT00017992|HIV Protease Inhibitors|hiv protease inhibitors
451023|NCT00017992|Ritonavir|ritonavir
451024|NCT00017992|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
451025|NCT00017992|Anti-HIV Agents|anti-hiv agents
451026|NCT00017992|Pharmacokinetics|pharmacokinetics
451027|NCT00017992|ABT 378|abt 378
451028|NCT00017992|emtricitabine|emtricitabine
451029|NCT00018005|Heart Failure|heart failure
451030|NCT00018005|Self-Management|self-management
451031|NCT00018005|Behavioral Clinical Trial|behavioral clinical trial
451032|NCT00018018|Gene Therapy|gene therapy
451033|NCT00018018|ADA-SCID|ada-scid
451034|NCT00018018|Stem Cells|stem cells
451035|NCT00018018|Retroviruses|retroviruses
451036|NCT00018018|Immune Deficiency Disease|immune deficiency disease
451037|NCT00018018|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
451038|NCT00018018|ADA-Deficiency|ada-deficiency
451039|NCT00018018|Retroviral Vectors|retroviral vectors
451040|NCT00018018|Hematopoietic Progenitors|hematopoietic progenitors
451041|NCT00018018|Severe Combined Immunodeficiency|severe combined immunodeficiency
451042|NCT00018018|SCID|scid
451043|NCT00018018|Immune Deficiency|immune deficiency
451044|NCT00018031|Liver Disease|liver disease
473889|NCT00082303|Depression|depression
451045|NCT00018031|Virologic Response|virologic response
451046|NCT00018031|Immune Mechanisms|immune mechanisms
451047|NCT00018031|Cirrhosis|cirrhosis
451048|NCT00018031|Eradication|eradication
451050|NCT00018031|Hepatitis C|hepatitis c
451051|NCT00018044|Morphotype|morphotype
451052|NCT00018044|Pulmonary|pulmonary
451053|NCT00018044|Infection|infection
451054|NCT00018044|Mycobacterium|mycobacterium
451055|NCT00018044|Nontuberculous|nontuberculous
451056|NCT00018044|Mycobacterial Infection|mycobacterial infection
451057|NCT00018044|Nontuberculous Mycobacterial Infection|nontuberculous mycobacterial infection
451059|NCT00018044|Job's Syndrome|job's syndrome
451060|NCT00018044|Job Syndrome|job syndrome
451061|NCT00018044|Cystic Fibrosis|cystic fibrosis
451062|NCT00018044|CF|cf
451063|NCT00018057|fMRI|fmri
451064|NCT00018057|SSRI|ssri
451065|NCT00018057|Neuropsychological|neuropsychological
451066|NCT00018057|Evaluative Learning|evaluative learning
451067|NCT00018057|Adolescent|adolescent
451068|NCT00018057|Normal Volunteers|normal volunteers
451069|NCT00018057|Magnetic Resonance Imaging|magnetic resonance imaging
451070|NCT00018057|CBT|cbt
451071|NCT00018057|IPT|ipt
451072|NCT00018057|Anxiety|anxiety
451073|NCT00018057|Anxiety Disorder|anxiety disorder
451074|NCT00018057|Mood Disorder|mood disorder
451075|NCT00018057|Depression|depression
451076|NCT00018057|Healthy Volunteer|healthy volunteer
451077|NCT00018057|Normal Control|normal control
451078|NCT00018070|Age-Related Macular Degeneration|age-related macular degeneration
451079|NCT00018070|Choroid|choroid
451080|NCT00018070|Blood Vessels|blood vessels
451081|NCT00018070|Choroidal Neovascularization|choroidal neovascularization
451082|NCT00018070|Laser|laser
451083|NCT00018070|Macular Degeneration|macular degeneration
451084|NCT00018070|AMD|amd
451085|NCT00018096|Genetics|genetics
451086|NCT00018096|Lipopolysaccharide|lipopolysaccharide
451087|NCT00018122|Islet cell transplant|islet cell transplant
451088|NCT00018135|high iPTH levels|high ipth levels
451089|NCT00018148|smoking cessation|smoking cessation
451090|NCT00018161|Nicotine|nicotine
451091|NCT00018161|addiction|addiction
451092|NCT00018161|cigarette smoking|cigarette smoking
451093|NCT00018174|Depression|depression
451094|NCT00018174|Fluoxetine|fluoxetine
451095|NCT00018174|Nicotine dependence|nicotine dependence
451096|NCT00018187|smoking cessation|smoking cessation
451097|NCT00018187|bupropion|bupropion
451098|NCT00018187|mecamylamine|mecamylamine
451099|NCT00018187|nicotine|nicotine
451100|NCT00018200|analgesia|analgesia
451101|NCT00018200|Back pain|back pain
451102|NCT00018200|sciatica|sciatica
451103|NCT00018213|Naltrexone|naltrexone
451104|NCT00018213|Nicotine patch|nicotine patch
451105|NCT00018213|Tobacco dependence|tobacco dependence
451106|NCT00018265|Rehabilitation|rehabilitation
451107|NCT00018265|exercise test|exercise test
451108|NCT00018265|aging|aging
451110|NCT00018291|Agitated Behavior|agitated behavior
451111|NCT00018291|Behavioral disturbance|behavioral disturbance
451112|NCT00018304|blood pressure|blood pressure
451113|NCT00018304|insulin sensitivity|insulin sensitivity
451114|NCT00018304|blood flow|blood flow
451115|NCT00018317|Diet|diet
451116|NCT00018317|exercise|exercise
451117|NCT00018330|Behavioral|behavioral
451120|NCT00018330|Lipoprotein lipase|lipoprotein lipase
451121|NCT00018330|Visceral fat|visceral fat
451122|NCT00018330|Lipoprotein|lipoprotein
451123|NCT00018356|Aging|aging
451124|NCT00018356|nutrition|nutrition
451125|NCT00018356|rehabilitation|rehabilitation
451126|NCT00018369|Aging|aging
451127|NCT00018369|Hydrocortisone Corticotropin Feedback|hydrocortisone corticotropin feedback
451128|NCT00018395|Calcium Metabolism|calcium metabolism
451129|NCT00018408|COPD|copd
451130|NCT00018408|Smoking|smoking
451131|NCT00018421|Cerebrovascular Disorders|cerebrovascular disorders
451132|NCT00018421|Exercise|exercise
451133|NCT00018421|Rehabilitation|rehabilitation
451134|NCT00018434|Infection|infection
451135|NCT00018447|osteoporosis|osteoporosis
451136|NCT00018460|geriatrics|geriatrics
451137|NCT00018460|vitamin B complex|vitamin b complex
451138|NCT00018460|thrombomodulin|thrombomodulin
451139|NCT00018460|anticoagulants|anticoagulants
451140|NCT00018473|Risk Factors|risk factors
451141|NCT00018473|Genes|genes
451142|NCT00018473|Epidemiology|epidemiology
451144|NCT00018473|Alzheimer's Disease|alzheimer's disease
451145|NCT00018499|Traumatic Brain Injury|traumatic brain injury
451146|NCT00018512|dental implant|dental implant
451147|NCT00018538|vitamin D|vitamin d
451148|NCT00018538|prostatic neoplasms|prostatic neoplasms
451149|NCT00018538|neoplasm recurrence|neoplasm recurrence
451150|NCT00018590|Vascular Diseases|vascular diseases
451151|NCT00018603|PTSD|ptsd
451153|NCT00018616|MEMS|mems
451154|NCT00018616|metformin|metformin
451155|NCT00018629|Aging|aging
451156|NCT00018629|Neuropsychology|neuropsychology
451157|NCT00018629|Psychotherapy|psychotherapy
451158|NCT00018629|Rehabilitation|rehabilitation
451159|NCT00018629|Schizophrenia|schizophrenia
451161|NCT00018642|haloperidol decanoate|haloperidol decanoate
451162|NCT00018655|Mood Disorders|mood disorders
451163|NCT00018655|Substance-Related Disorders|substance-related disorders
451164|NCT00018668|Antipsychotics|antipsychotics
451165|NCT00018668|schizophrenia|schizophrenia
451166|NCT00018668|motor retardation|motor retardation
451167|NCT00018668|bradykinesia|bradykinesia
451168|NCT00018694|bile acid synthesis|bile acid synthesis
451169|NCT00018694|chenodeoxycholic acid|chenodeoxycholic acid
451170|NCT00018694|sterol 27-hydroxylase|sterol 27-hydroxylase
451171|NCT00018720|triglyceride|triglyceride
451172|NCT00018720|bile acids|bile acids
451173|NCT00018720|cholelithias|cholelithias
451174|NCT00018733|Depression|depression
451175|NCT00018759|Serotonin, Hypertension, Depression|serotonin, hypertension, depression
451176|NCT00018772|coagulation|coagulation
451177|NCT00018772|thrombosis genetic markers|thrombosis genetic markers
451178|NCT00018785|kidney transplantation|kidney transplantation
451179|NCT00018785|immunosuppression|immunosuppression
451180|NCT00018785|bone marrow|bone marrow
451181|NCT00018798|Combat-Related PTSD, Vietnam Veterans|combat-related ptsd, vietnam veterans
451182|NCT00018811|Relaxation Techniques|relaxation techniques
451183|NCT00018811|Behavior Therapy Feedback|behavior therapy feedback
451184|NCT00018811|Psychophysiology|psychophysiology
451185|NCT00018850|schizophrenia|schizophrenia
451186|NCT00018850|ondansetron|ondansetron
451187|NCT00018850|nicotine|nicotine
451188|NCT00018850|haloperidol|haloperidol
451189|NCT00018863|ADHD|adhd
451190|NCT00018876|Epidural fibrosis|epidural fibrosis
451191|NCT00018876|Failed back surgery syndrome|failed back surgery syndrome
451192|NCT00018876|Postlaminectomy syndrome|postlaminectomy syndrome
451193|NCT00018876|Lumbar laminectomy|lumbar laminectomy
451194|NCT00018876|Radiotherapy|radiotherapy
451195|NCT00018876|Radiation|radiation
451196|NCT00018876|Perineural scar formation|perineural scar formation
451197|NCT00018876|Peridural fibrosis|peridural fibrosis
451198|NCT00018876|Back surgery|back surgery
451199|NCT00018889|Clinical Evaluation|clinical evaluation
451200|NCT00018889|Genetic Study|genetic study
451201|NCT00018889|Essential Tremor|essential tremor
451202|NCT00018889|Familial Myoclonus|familial myoclonus
451203|NCT00018889|Hereditary Ataxia|hereditary ataxia
451204|NCT00018889|Movement Disorder|movement disorder
451205|NCT00018889|Inherited Movement Disorder|inherited movement disorder
451206|NCT00018902|Depressive Disorder|depressive disorder
451207|NCT00018902|Adolescents|adolescents
451208|NCT00018902|Teenagers|teenagers
451209|NCT00018902|Teens|teens
451210|NCT00018902|Cognitive Behavior Therapy|cognitive behavior therapy
451211|NCT00018941|stage IV renal cell cancer|stage iv renal cell cancer
451212|NCT00018941|recurrent renal cell cancer|recurrent renal cell cancer
451213|NCT00018954|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
451214|NCT00018954|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
451215|NCT00018954|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
451216|NCT00018954|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
451217|NCT00018954|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
470766|NCT00072644|HIV|hiv
451218|NCT00018954|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
451219|NCT00018954|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
451220|NCT00018954|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
451221|NCT00018954|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
451222|NCT00018954|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
451223|NCT00018954|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
451224|NCT00018954|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
451225|NCT00018954|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
451226|NCT00018954|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
451227|NCT00018954|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
451228|NCT00018954|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
451229|NCT00018954|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
451230|NCT00018954|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
451231|NCT00018954|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
451232|NCT00018954|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
451233|NCT00018954|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
451234|NCT00018954|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
451235|NCT00018954|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
451236|NCT00018954|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
451237|NCT00018954|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
451238|NCT00018954|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
451239|NCT00018954|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
451240|NCT00018954|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
451241|NCT00018954|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
451242|NCT00018954|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
451243|NCT00018954|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
451244|NCT00018954|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
451245|NCT00018954|stage I mantle cell lymphoma|stage i mantle cell lymphoma
451246|NCT00018954|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
451247|NCT00018954|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
451248|NCT00018954|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
451249|NCT00018954|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
451250|NCT00018954|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
451251|NCT00018954|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
753013|NCT01175135|acute exacerbation|acute exacerbation
451252|NCT00018954|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
451253|NCT00018954|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
451254|NCT00018954|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
451255|NCT00018954|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
451256|NCT00018954|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
451257|NCT00018954|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
451258|NCT00018954|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
451259|NCT00018954|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
451260|NCT00018954|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
451261|NCT00018954|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
451262|NCT00018954|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
451263|NCT00018954|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
451264|NCT00018954|stage I marginal zone lymphoma|stage i marginal zone lymphoma
451265|NCT00018954|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
451266|NCT00018954|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
451267|NCT00018954|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
451268|NCT00018954|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
451269|NCT00018954|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
451270|NCT00018954|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
451271|NCT00018954|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
451272|NCT00018954|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
451273|NCT00018954|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
451274|NCT00018954|splenic marginal zone lymphoma|splenic marginal zone lymphoma
451275|NCT00018967|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
451276|NCT00018967|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
451277|NCT00018967|neurotoxicity|neurotoxicity
451278|NCT00019006|adult solid tumor|adult solid tumor
451279|NCT00019006|body system/site cancer|body system/site cancer
451280|NCT00019006|cancer|cancer
451281|NCT00019006|colon cancer|colon cancer
451282|NCT00019006|colorectal cancer|colorectal cancer
451283|NCT00019006|extensive stage small cell lung cancer|extensive stage small cell lung cancer
451284|NCT00019006|gastrointestinal cancer|gastrointestinal cancer
451285|NCT00019006|genetic condition|genetic condition
451286|NCT00019006|limited stage small cell lung cancer|limited stage small cell lung cancer
451287|NCT00019006|lung cancer|lung cancer
451288|NCT00019006|non-small cell lung cancer|non-small cell lung cancer
451289|NCT00019006|pancreatic cancer|pancreatic cancer
451290|NCT00019006|rectal cancer|rectal cancer
451291|NCT00019006|recurrent colon cancer|recurrent colon cancer
451292|NCT00019006|recurrent pancreatic cancer|recurrent pancreatic cancer
451293|NCT00019006|recurrent rectal cancer|recurrent rectal cancer
451294|NCT00019006|small cell lung cancer|small cell lung cancer
451295|NCT00019006|solid tumor|solid tumor
451296|NCT00019006|stage I pancreatic cancer|stage i pancreatic cancer
451297|NCT00019006|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
451298|NCT00019006|stage II pancreatic cancer|stage ii pancreatic cancer
451299|NCT00019006|stage III colon cancer|stage iii colon cancer
451300|NCT00019006|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
451301|NCT00019006|stage III pancreatic cancer|stage iii pancreatic cancer
451302|NCT00019006|stage III rectal cancer|stage iii rectal cancer
451303|NCT00019006|stage IV pancreatic cancer|stage iv pancreatic cancer
451304|NCT00019006|stage IVA pancreatic cancer|stage iva pancreatic cancer
451305|NCT00019006|stage IVB pancreatic cancer|stage ivb pancreatic cancer
451306|NCT00019006|stage, colon cancer|stage, colon cancer
451307|NCT00019006|stage, non-small cell lung cancer|stage, non-small cell lung cancer
451308|NCT00019006|stage, pancreatic cancer|stage, pancreatic cancer
474439|NCT00083512|Urine|urine
451309|NCT00019006|stage, rectal cancer|stage, rectal cancer
451310|NCT00019006|stage, small cell lung cancer|stage, small cell lung cancer
451311|NCT00019006|thorax/respiratory cancer|thorax/respiratory cancer
451312|NCT00019019|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
451313|NCT00019019|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
451314|NCT00019019|stage IV breast cancer|stage iv breast cancer
451315|NCT00019019|stage IIIA breast cancer|stage iiia breast cancer
451316|NCT00019019|recurrent breast cancer|recurrent breast cancer
451317|NCT00019019|stage IIIB breast cancer|stage iiib breast cancer
451318|NCT00019019|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
451319|NCT00019019|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
451320|NCT00019019|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
451321|NCT00019019|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
753014|NCT01175135|inpatient|inpatient
451322|NCT00019019|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
451323|NCT00019019|stage III renal cell cancer|stage iii renal cell cancer
451324|NCT00019019|stage IV renal cell cancer|stage iv renal cell cancer
451325|NCT00019019|recurrent renal cell cancer|recurrent renal cell cancer
451326|NCT00019019|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
451327|NCT00019019|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
451328|NCT00019019|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
451329|NCT00019019|recurrent adult brain tumor|recurrent adult brain tumor
451330|NCT00019019|small intestine lymphoma|small intestine lymphoma
451331|NCT00019019|adult brain stem glioma|adult brain stem glioma
451332|NCT00019019|adult craniopharyngioma|adult craniopharyngioma
451333|NCT00019019|adult medulloblastoma|adult medulloblastoma
451334|NCT00019019|adult meningioma|adult meningioma
451335|NCT00019019|adult glioblastoma|adult glioblastoma
451336|NCT00019019|stage III melanoma|stage iii melanoma
451337|NCT00019019|stage IV melanoma|stage iv melanoma
451338|NCT00019019|recurrent melanoma|recurrent melanoma
451339|NCT00019019|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
451340|NCT00019019|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
451341|NCT00019019|stage IIIC breast cancer|stage iiic breast cancer
451342|NCT00019019|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
451343|NCT00019019|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
451344|NCT00019019|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
451345|NCT00019019|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
451346|NCT00019019|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
451347|NCT00019019|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
451348|NCT00019019|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
451349|NCT00019019|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
451350|NCT00019019|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
451351|NCT00019019|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
451352|NCT00019019|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
451353|NCT00019019|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
451354|NCT00019019|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
451426|NCT00019084|recurrent colon cancer|recurrent colon cancer
451355|NCT00019019|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
451356|NCT00019019|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
451357|NCT00019019|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
451358|NCT00019019|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
451359|NCT00019019|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
451360|NCT00019019|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
451361|NCT00019019|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
451362|NCT00019019|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
451363|NCT00019019|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
451364|NCT00019019|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
451365|NCT00019019|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
451366|NCT00019019|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
451367|NCT00019019|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
451368|NCT00019019|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
451369|NCT00019019|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
451370|NCT00019019|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
451371|NCT00019019|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
451372|NCT00019019|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
451373|NCT00019019|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
451374|NCT00019019|adult anaplastic astrocytoma|adult anaplastic astrocytoma
451375|NCT00019019|adult myxopapillary ependymoma|adult myxopapillary ependymoma
451376|NCT00019019|adult anaplastic ependymoma|adult anaplastic ependymoma
474440|NCT00083512|GBM|gbm
451377|NCT00019019|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
451378|NCT00019019|adult mixed glioma|adult mixed glioma
451379|NCT00019019|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
451380|NCT00019019|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
451381|NCT00019019|adult pilocytic astrocytoma|adult pilocytic astrocytoma
451382|NCT00019019|adult subependymoma|adult subependymoma
451383|NCT00019019|adult ependymoblastoma|adult ependymoblastoma
451384|NCT00019019|adult pineocytoma|adult pineocytoma
451385|NCT00019019|adult pineoblastoma|adult pineoblastoma
451386|NCT00019019|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
451387|NCT00019019|intraocular lymphoma|intraocular lymphoma
451388|NCT00019019|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
753015|NCT01175148|HSCT|hsct
576502|NCT00481390|HIV|hiv
451389|NCT00019019|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
451390|NCT00019019|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
451391|NCT00019019|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
451392|NCT00019019|anaplastic large cell lymphoma|anaplastic large cell lymphoma
451393|NCT00019019|adult choroid plexus tumor|adult choroid plexus tumor
451394|NCT00019019|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
451395|NCT00019019|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
451396|NCT00019019|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
451397|NCT00019019|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
451398|NCT00019019|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
451399|NCT00019019|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
451400|NCT00019019|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
451401|NCT00019019|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
451402|NCT00019019|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
451403|NCT00019019|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
451404|NCT00019019|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
451405|NCT00019019|splenic marginal zone lymphoma|splenic marginal zone lymphoma
451406|NCT00019019|adult grade III meningioma|adult grade iii meningioma
451407|NCT00019019|adult oligodendroglioma|adult oligodendroglioma
451408|NCT00019019|adult giant cell glioblastoma|adult giant cell glioblastoma
451409|NCT00019019|adult gliosarcoma|adult gliosarcoma
451410|NCT00019032|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
451411|NCT00019032|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
451412|NCT00019058|adult glioblastoma|adult glioblastoma
451413|NCT00019058|adult giant cell glioblastoma|adult giant cell glioblastoma
451414|NCT00019058|adult gliosarcoma|adult gliosarcoma
451415|NCT00019071|adult glioblastoma|adult glioblastoma
451416|NCT00019071|adult anaplastic astrocytoma|adult anaplastic astrocytoma
451417|NCT00019071|adult giant cell glioblastoma|adult giant cell glioblastoma
451418|NCT00019071|adult gliosarcoma|adult gliosarcoma
451419|NCT00019084|stage IV colon cancer|stage iv colon cancer
451420|NCT00019084|stage IV breast cancer|stage iv breast cancer
451421|NCT00019084|recurrent breast cancer|recurrent breast cancer
451422|NCT00019084|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
451423|NCT00019084|stage II pancreatic cancer|stage ii pancreatic cancer
451424|NCT00019084|stage III pancreatic cancer|stage iii pancreatic cancer
451425|NCT00019084|recurrent pancreatic cancer|recurrent pancreatic cancer
451427|NCT00019084|recurrent cervical cancer|recurrent cervical cancer
451518|NCT00019175|recurrent melanoma|recurrent melanoma
451428|NCT00019084|stage IVB cervical cancer|stage ivb cervical cancer
451429|NCT00019084|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
451430|NCT00019084|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
451431|NCT00019084|extensive stage small cell lung cancer|extensive stage small cell lung cancer
451432|NCT00019084|recurrent small cell lung cancer|recurrent small cell lung cancer
583588|NCT00512317|partial onset epilepsy|partial onset epilepsy
451433|NCT00019084|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
451434|NCT00019084|stage IV pancreatic cancer|stage iv pancreatic cancer
451435|NCT00019097|body system/site cancer|body system/site cancer
451437|NCT00019097|genetic condition|genetic condition
451438|NCT00019097|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
451439|NCT00019097|multiple myeloma|multiple myeloma
451440|NCT00019097|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
451441|NCT00019097|plasma cell neoplasm|plasma cell neoplasm
451442|NCT00019097|refractory plasma cell neoplasm|refractory plasma cell neoplasm
451443|NCT00019097|stage II multiple myeloma|stage ii multiple myeloma
451444|NCT00019097|stage III multiple myeloma|stage iii multiple myeloma
451445|NCT00019097|stage, plasma cell neoplasm|stage, plasma cell neoplasm
451446|NCT00019110|stage IV anal cancer|stage iv anal cancer
451447|NCT00019110|recurrent anal cancer|recurrent anal cancer
451448|NCT00019110|stage II esophageal cancer|stage ii esophageal cancer
451449|NCT00019110|stage III esophageal cancer|stage iii esophageal cancer
451450|NCT00019110|stage IV esophageal cancer|stage iv esophageal cancer
451451|NCT00019110|stage IIIA anal cancer|stage iiia anal cancer
474441|NCT00083512|Radiation|radiation
451452|NCT00019110|stage IIIB anal cancer|stage iiib anal cancer
451453|NCT00019110|recurrent esophageal cancer|recurrent esophageal cancer
451454|NCT00019110|stage III cervical cancer|stage iii cervical cancer
451455|NCT00019110|stage IV cervical cancer|stage iv cervical cancer
451456|NCT00019110|recurrent cervical cancer|recurrent cervical cancer
451457|NCT00019110|stage III vulvar cancer|stage iii vulvar cancer
451458|NCT00019110|stage IVB vulvar cancer|stage ivb vulvar cancer
451459|NCT00019110|recurrent vulvar cancer|recurrent vulvar cancer
451460|NCT00019110|stage III penile cancer|stage iii penile cancer
451461|NCT00019110|stage IV penile cancer|stage iv penile cancer
451462|NCT00019110|recurrent penile cancer|recurrent penile cancer
753016|NCT01175148|HPC|hpc
470765|NCT00072631|OSI-774|osi-774
451463|NCT00019110|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
451464|NCT00019110|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
451465|NCT00019110|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
451466|NCT00019110|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
451467|NCT00019110|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
451468|NCT00019110|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
451469|NCT00019110|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
451470|NCT00019110|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
451471|NCT00019110|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
451472|NCT00019110|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
451473|NCT00019110|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
451474|NCT00019110|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
451475|NCT00019110|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
451476|NCT00019110|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
451477|NCT00019110|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
451478|NCT00019110|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
451479|NCT00019110|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
451480|NCT00019110|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
451481|NCT00019110|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
451482|NCT00019110|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
451483|NCT00019110|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
451484|NCT00019110|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
451485|NCT00019110|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
451486|NCT00019110|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
451487|NCT00019110|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
451488|NCT00019110|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
451489|NCT00019110|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
451490|NCT00019110|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
451491|NCT00019110|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
451557|NCT00019227|radiation toxicity|radiation toxicity
451492|NCT00019110|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
451493|NCT00019110|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
583589|NCT00512317|adult epilepsy|adult epilepsy
451494|NCT00019110|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
451495|NCT00019110|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
451496|NCT00019110|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
451497|NCT00019110|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
451498|NCT00019110|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
451499|NCT00019110|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
451500|NCT00019110|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
451501|NCT00019110|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
451502|NCT00019110|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
451503|NCT00019110|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
451504|NCT00019110|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
451505|NCT00019110|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
451506|NCT00019110|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
451507|NCT00019110|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
451508|NCT00019110|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
451509|NCT00019110|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
752446|NCT01173029|Hypertension Resistant to Conventional Therapy|hypertension resistant to conventional therapy
451118|NCT00018330|Weight Loss|weight loss
451510|NCT00019110|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
451511|NCT00019110|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
451512|NCT00019110|recurrent salivary gland cancer|recurrent salivary gland cancer
451513|NCT00019110|stage IV salivary gland cancer|stage iv salivary gland cancer
451514|NCT00019110|stage III salivary gland cancer|stage iii salivary gland cancer
451515|NCT00019123|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
451516|NCT00019136|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
451517|NCT00019175|stage IV melanoma|stage iv melanoma
451519|NCT00019188|AIDS-related malignancies|aids-related malignancies
451520|NCT00019188|Kaposi's sarcoma|kaposi's sarcoma
451521|NCT00019188|adult solid tumor|adult solid tumor
451522|NCT00019188|body system/site cancer|body system/site cancer
451523|NCT00019188|cancer|cancer
451524|NCT00019188|epidemic Kaposi's sarcoma|epidemic kaposi's sarcoma
451525|NCT00019188|recurrent Kaposi's sarcoma|recurrent kaposi's sarcoma
451526|NCT00019188|skin tumor|skin tumor
451527|NCT00019188|solid tumor|solid tumor
451528|NCT00019188|stage, Kaposi's sarcoma|stage, kaposi's sarcoma
451529|NCT00019201|stage I non-small cell lung cancer|stage i non-small cell lung cancer
451530|NCT00019201|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
451531|NCT00019201|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
451532|NCT00019201|limited stage small cell lung cancer|limited stage small cell lung cancer
451533|NCT00019201|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
451534|NCT00019201|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
451535|NCT00019201|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
451536|NCT00019201|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
451537|NCT00019201|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
451538|NCT00019201|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
451539|NCT00019201|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
451540|NCT00019201|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
451541|NCT00019201|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
451542|NCT00019201|stage I laryngeal cancer|stage i laryngeal cancer
451543|NCT00019201|stage II laryngeal cancer|stage ii laryngeal cancer
451544|NCT00019201|stage III laryngeal cancer|stage iii laryngeal cancer
451545|NCT00019201|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
451546|NCT00019201|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
451547|NCT00019201|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
451548|NCT00019201|stage I oropharyngeal cancer|stage i oropharyngeal cancer
451549|NCT00019201|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
451550|NCT00019201|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
451551|NCT00019214|recurrent melanoma|recurrent melanoma
451552|NCT00019227|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
451553|NCT00019227|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
451554|NCT00019227|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
451555|NCT00019227|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
583590|NCT00512317|partial seizures|partial seizures
451556|NCT00019227|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
451558|NCT00019240|classic Kaposi sarcoma|classic kaposi sarcoma
451559|NCT00019240|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
451560|NCT00019240|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
451561|NCT00019318|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
451562|NCT00019318|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
451563|NCT00019318|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
451564|NCT00019318|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
451565|NCT00019318|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
451566|NCT00019318|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
451567|NCT00019331|stage IV colon cancer|stage iv colon cancer
451568|NCT00019331|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
451569|NCT00019331|stage II pancreatic cancer|stage ii pancreatic cancer
451570|NCT00019331|stage III pancreatic cancer|stage iii pancreatic cancer
451571|NCT00019331|recurrent pancreatic cancer|recurrent pancreatic cancer
451572|NCT00019331|recurrent colon cancer|recurrent colon cancer
12264|NCT03212495|knee arthroscopy|knee arthroscopy
451573|NCT00019331|extensive stage small cell lung cancer|extensive stage small cell lung cancer
451574|NCT00019331|recurrent small cell lung cancer|recurrent small cell lung cancer
451575|NCT00019331|advanced adult primary liver cancer|advanced adult primary liver cancer
451576|NCT00019331|recurrent adult primary liver cancer|recurrent adult primary liver cancer
451577|NCT00019331|stage IV endometrial carcinoma|stage iv endometrial carcinoma
451578|NCT00019331|recurrent endometrial carcinoma|recurrent endometrial carcinoma
451579|NCT00019331|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
451580|NCT00019331|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
451581|NCT00019331|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
451582|NCT00019331|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
451583|NCT00019331|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
451584|NCT00019331|anaplastic thyroid cancer|anaplastic thyroid cancer
451585|NCT00019331|recurrent thyroid cancer|recurrent thyroid cancer
451587|NCT00019331|recurrent melanoma|recurrent melanoma
451588|NCT00019331|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
451589|NCT00019331|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
451590|NCT00019331|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
451591|NCT00019331|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
451592|NCT00019331|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
451593|NCT00019331|pulmonary carcinoid tumor|pulmonary carcinoid tumor
451594|NCT00019331|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
451595|NCT00019331|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
451596|NCT00019331|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
451597|NCT00019331|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
451598|NCT00019331|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
451599|NCT00019331|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
451600|NCT00019331|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
451601|NCT00019331|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
451602|NCT00019331|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
451603|NCT00019331|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
451604|NCT00019331|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
451605|NCT00019331|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
451606|NCT00019331|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
451607|NCT00019331|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
451608|NCT00019331|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
451609|NCT00019331|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
451610|NCT00019331|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
451611|NCT00019331|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
451612|NCT00019331|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
451613|NCT00019331|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
451614|NCT00019331|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
451811|NCT00019539|renal cell cancer|renal cell cancer
451615|NCT00019331|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
451616|NCT00019331|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
451617|NCT00019331|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
451618|NCT00019331|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
451686|NCT00019396|stage IV renal cell cancer|stage iv renal cell cancer
451619|NCT00019331|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
451620|NCT00019331|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
451621|NCT00019331|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
451622|NCT00019331|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
451623|NCT00019331|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
451624|NCT00019331|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
451625|NCT00019331|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
451626|NCT00019331|insular thyroid cancer|insular thyroid cancer
451627|NCT00019331|recurrent salivary gland cancer|recurrent salivary gland cancer
451628|NCT00019331|stage IV salivary gland cancer|stage iv salivary gland cancer
451629|NCT00019331|stage IV pancreatic cancer|stage iv pancreatic cancer
451630|NCT00019344|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
451631|NCT00019344|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
451632|NCT00019344|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
474553|NCT00083876|Thalidomide|thalidomide
451633|NCT00019344|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
451634|NCT00019344|small intestine lymphoma|small intestine lymphoma
451635|NCT00019344|stage IV prostate cancer|stage iv prostate cancer
753017|NCT01175148|HCT|hct
451636|NCT00019344|recurrent prostate cancer|recurrent prostate cancer
451637|NCT00019344|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
451638|NCT00019344|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
451639|NCT00019344|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
451640|NCT00019344|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
451641|NCT00019344|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
451642|NCT00019344|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
451643|NCT00019344|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
451644|NCT00019344|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
451645|NCT00019344|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
451646|NCT00019344|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
451647|NCT00019344|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
451648|NCT00019344|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
451649|NCT00019344|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
451650|NCT00019344|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
451651|NCT00019344|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
451652|NCT00019344|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
451653|NCT00019344|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
451654|NCT00019344|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
451655|NCT00019344|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
451656|NCT00019344|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
451657|NCT00019344|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
451658|NCT00019344|intraocular lymphoma|intraocular lymphoma
451659|NCT00019344|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
451660|NCT00019344|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
451661|NCT00019344|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
451662|NCT00019344|anaplastic large cell lymphoma|anaplastic large cell lymphoma
451663|NCT00019344|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
451664|NCT00019344|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
451665|NCT00019344|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
451666|NCT00019344|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
451667|NCT00019344|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
451668|NCT00019344|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
451669|NCT00019344|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
451670|NCT00019344|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
451671|NCT00019344|splenic marginal zone lymphoma|splenic marginal zone lymphoma
451672|NCT00019357|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
451673|NCT00019383|recurrent melanoma|recurrent melanoma
451674|NCT00019396|adult solid tumor|adult solid tumor
451675|NCT00019396|body system/site cancer|body system/site cancer
451676|NCT00019396|cancer|cancer
451677|NCT00019396|kidney tumor|kidney tumor
451678|NCT00019396|kidney/urinary cancer|kidney/urinary cancer
451679|NCT00019396|melanoma|melanoma
451680|NCT00019396|recurrent melanoma|recurrent melanoma
451681|NCT00019396|recurrent renal cell cancer|recurrent renal cell cancer
451682|NCT00019396|renal cell cancer|renal cell cancer
451683|NCT00019396|skin tumor|skin tumor
451684|NCT00019396|solid tumor|solid tumor
451685|NCT00019396|stage IV melanoma|stage iv melanoma
451687|NCT00019396|stage, melanoma|stage, melanoma
451688|NCT00019396|stage, renal cell cancer|stage, renal cell cancer
451689|NCT00019409|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
451690|NCT00019409|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
451691|NCT00019409|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
451692|NCT00019409|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
451693|NCT00019422|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
451694|NCT00019422|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
451695|NCT00019422|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
451696|NCT00019422|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
451697|NCT00019422|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
451698|NCT00019422|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
12265|NCT03212495|dexmedetomidine|dexmedetomidine
12266|NCT03212495|neostigmine|neostigmine
451699|NCT00019422|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
451700|NCT00019422|recurrent childhood ependymoma|recurrent childhood ependymoma
451701|NCT00019435|stage IV colon cancer|stage iv colon cancer
451702|NCT00019435|stage IV breast cancer|stage iv breast cancer
451143|NCT00018473|Apolipoproteins E|apolipoproteins e
451703|NCT00019435|recurrent breast cancer|recurrent breast cancer
451704|NCT00019435|stage IV gastric cancer|stage iv gastric cancer
451705|NCT00019435|recurrent gastric cancer|recurrent gastric cancer
451706|NCT00019435|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
451707|NCT00019435|recurrent pancreatic cancer|recurrent pancreatic cancer
451708|NCT00019435|recurrent colon cancer|recurrent colon cancer
451709|NCT00019435|stage IV esophageal cancer|stage iv esophageal cancer
451710|NCT00019435|recurrent esophageal cancer|recurrent esophageal cancer
451711|NCT00019435|recurrent bladder cancer|recurrent bladder cancer
451712|NCT00019435|stage IV bladder cancer|stage iv bladder cancer
451713|NCT00019435|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
451714|NCT00019435|stage IV pancreatic cancer|stage iv pancreatic cancer
451716|NCT00019448|body system/site cancer|body system/site cancer
451717|NCT00019448|cancer|cancer
451718|NCT00019448|melanoma|melanoma
451719|NCT00019448|recurrent melanoma|recurrent melanoma
451720|NCT00019448|skin tumor|skin tumor
451721|NCT00019448|solid tumor|solid tumor
451722|NCT00019448|stage IV melanoma|stage iv melanoma
451723|NCT00019448|stage, melanoma|stage, melanoma
451724|NCT00019461|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
451725|NCT00019461|fallopian tube cancer|fallopian tube cancer
451726|NCT00019461|primary peritoneal cavity cancer|primary peritoneal cavity cancer
451727|NCT00019474|stage III gastric cancer|stage iii gastric cancer
451728|NCT00019474|stage IV gastric cancer|stage iv gastric cancer
451729|NCT00019474|recurrent gastric cancer|recurrent gastric cancer
451730|NCT00019474|stage II pancreatic cancer|stage ii pancreatic cancer
451731|NCT00019474|stage III pancreatic cancer|stage iii pancreatic cancer
451732|NCT00019474|recurrent pancreatic cancer|recurrent pancreatic cancer
451733|NCT00019474|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
451734|NCT00019474|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
451735|NCT00019474|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
451736|NCT00019474|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
451737|NCT00019474|advanced adult primary liver cancer|advanced adult primary liver cancer
451738|NCT00019474|recurrent adult primary liver cancer|recurrent adult primary liver cancer
451739|NCT00019474|small intestine adenocarcinoma|small intestine adenocarcinoma
451740|NCT00019474|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
451741|NCT00019474|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
451742|NCT00019474|recurrent small intestine cancer|recurrent small intestine cancer
451743|NCT00019474|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
451744|NCT00019474|stage IV pancreatic cancer|stage iv pancreatic cancer
451745|NCT00019487|stage IV melanoma|stage iv melanoma
451746|NCT00019487|recurrent melanoma|recurrent melanoma
451747|NCT00019500|breast cancer|breast cancer
451748|NCT00019513|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
451749|NCT00019513|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
451750|NCT00019513|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
451751|NCT00019513|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
451752|NCT00019513|small intestine lymphoma|small intestine lymphoma
451753|NCT00019513|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
451754|NCT00019513|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
451755|NCT00019513|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
451756|NCT00019513|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
451757|NCT00019513|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
451758|NCT00019513|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
451759|NCT00019513|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
451760|NCT00019513|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
451761|NCT00019513|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
451762|NCT00019513|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
451763|NCT00019513|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
451764|NCT00019513|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
451765|NCT00019513|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
451766|NCT00019513|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
451767|NCT00019513|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
451768|NCT00019513|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
451769|NCT00019513|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
451770|NCT00019513|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
451771|NCT00019513|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
451772|NCT00019513|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
752447|NCT01173029|Genetic polymorphisms|genetic polymorphisms
451773|NCT00019513|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
451774|NCT00019513|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
451775|NCT00019513|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
451776|NCT00019513|anaplastic large cell lymphoma|anaplastic large cell lymphoma
451777|NCT00019513|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
451778|NCT00019513|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
451779|NCT00019513|recurrent adult primary liver cancer|recurrent adult primary liver cancer
451780|NCT00019513|advanced adult primary liver cancer|advanced adult primary liver cancer
451781|NCT00019513|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
451782|NCT00019513|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
451783|NCT00019513|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
451784|NCT00019513|extensive stage small cell lung cancer|extensive stage small cell lung cancer
451785|NCT00019513|recurrent small cell lung cancer|recurrent small cell lung cancer
451786|NCT00019513|recurrent pancreatic cancer|recurrent pancreatic cancer
451787|NCT00019513|stage IV esophageal cancer|stage iv esophageal cancer
451788|NCT00019513|recurrent esophageal cancer|recurrent esophageal cancer
451789|NCT00019513|recurrent colon cancer|recurrent colon cancer
451790|NCT00019513|stage IV colon cancer|stage iv colon cancer
451791|NCT00019513|recurrent gallbladder cancer|recurrent gallbladder cancer
451792|NCT00019513|unresectable gallbladder cancer|unresectable gallbladder cancer
451793|NCT00019513|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
451794|NCT00019513|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
451795|NCT00019513|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
451796|NCT00019513|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
451797|NCT00019513|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
451798|NCT00019513|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
451799|NCT00019513|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
451800|NCT00019513|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
451801|NCT00019513|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
451802|NCT00019513|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
451803|NCT00019513|splenic marginal zone lymphoma|splenic marginal zone lymphoma
451804|NCT00019513|stage IV pancreatic cancer|stage iv pancreatic cancer
451806|NCT00019539|body system/site cancer|body system/site cancer
451808|NCT00019539|kidney tumor|kidney tumor
451809|NCT00019539|kidney/urinary cancer|kidney/urinary cancer
451810|NCT00019539|recurrent renal cell cancer|recurrent renal cell cancer
451812|NCT00019539|solid tumor|solid tumor
451813|NCT00019539|stage IV renal cell cancer|stage iv renal cell cancer
451814|NCT00019539|stage, renal cell cancer|stage, renal cell cancer
451815|NCT00019552|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
451816|NCT00019552|fallopian tube cancer|fallopian tube cancer
451817|NCT00019552|primary peritoneal cavity cancer|primary peritoneal cavity cancer
451818|NCT00019565|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
451819|NCT00019578|adult brain stem glioma|adult brain stem glioma
451820|NCT00019578|adult brain tumor|adult brain tumor
451821|NCT00019578|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
451822|NCT00019578|adult craniopharyngioma|adult craniopharyngioma
451823|NCT00019578|adult ependymoma|adult ependymoma
451824|NCT00019578|adult infiltrating astrocytoma|adult infiltrating astrocytoma
451825|NCT00019578|adult malignant meningioma|adult malignant meningioma
451826|NCT00019578|adult medulloblastoma|adult medulloblastoma
451827|NCT00019578|adult meningioma|adult meningioma
451828|NCT00019578|adult noninfiltrating astrocytoma|adult noninfiltrating astrocytoma
451829|NCT00019578|adult oligodendroglioma|adult oligodendroglioma
451830|NCT00019578|adult pineal parenchymal tumor|adult pineal parenchymal tumor
451831|NCT00019578|adult solid tumor|adult solid tumor
451832|NCT00019578|body system/site cancer|body system/site cancer
451833|NCT00019578|brain metastases|brain metastases
451836|NCT00019578|central nervous system cancer|central nervous system cancer
451837|NCT00019578|genetic condition|genetic condition
451838|NCT00019578|metastatic cancer|metastatic cancer
451839|NCT00019578|mixed gliomas|mixed gliomas
451840|NCT00019578|site, metastatic cancer|site, metastatic cancer
451841|NCT00019578|solid tumor|solid tumor
451842|NCT00019578|stage IV peripheral primitive neuroectodermal tumor|stage iv peripheral primitive neuroectodermal tumor
451843|NCT00019578|stage/type, adult brain tumor|stage/type, adult brain tumor
451844|NCT00019578|unclassified/other cancer|unclassified/other cancer
451845|NCT00019591|stage III colon cancer|stage iii colon cancer
451846|NCT00019591|stage IV colon cancer|stage iv colon cancer
451847|NCT00019591|stage III rectal cancer|stage iii rectal cancer
451848|NCT00019591|stage IV rectal cancer|stage iv rectal cancer
451849|NCT00019591|recurrent colon cancer|recurrent colon cancer
451850|NCT00019591|recurrent rectal cancer|recurrent rectal cancer
451851|NCT00019604|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
451852|NCT00019604|recurrent adult primary liver cancer|recurrent adult primary liver cancer
451853|NCT00019604|liver metastases|liver metastases
451854|NCT00019604|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
451855|NCT00019630|Ewing's family of tumors|ewing's family of tumors
451856|NCT00019630|Wilms' tumor|wilms' tumor
451857|NCT00019630|adult solid tumor|adult solid tumor
451858|NCT00019630|body system/site cancer|body system/site cancer
451859|NCT00019630|bone cancer|bone cancer
451860|NCT00019630|brain tumor|brain tumor
451861|NCT00019630|cancer|cancer
451862|NCT00019630|central nervous system cancer|central nervous system cancer
451863|NCT00019630|childhood brain stem glioma|childhood brain stem glioma
451864|NCT00019630|childhood brain tumor|childhood brain tumor
451865|NCT00019630|childhood cancer|childhood cancer
451866|NCT00019630|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
451867|NCT00019630|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
451868|NCT00019630|childhood cerebral astrocytoma|childhood cerebral astrocytoma
451869|NCT00019630|childhood choroid plexus tumor|childhood choroid plexus tumor
451870|NCT00019630|childhood craniopharyngioma|childhood craniopharyngioma
451871|NCT00019630|childhood ependymoma|childhood ependymoma
451872|NCT00019630|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
451873|NCT00019630|childhood extragonadal malignant germ cell tumor|childhood extragonadal malignant germ cell tumor
451874|NCT00019630|childhood liver cancer|childhood liver cancer
451875|NCT00019630|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
451876|NCT00019630|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
451877|NCT00019630|childhood mature and immature teratomas|childhood mature and immature teratomas
451878|NCT00019630|childhood medulloblastoma|childhood medulloblastoma
451879|NCT00019630|childhood meningioma|childhood meningioma
451880|NCT00019630|childhood oligodendroglioma|childhood oligodendroglioma
451881|NCT00019630|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
451882|NCT00019630|childhood soft tissue sarcoma|childhood soft tissue sarcoma
451883|NCT00019630|childhood solid tumor|childhood solid tumor
451884|NCT00019630|childhood supratentorial primitive neuroectodermal and pineal tumors|childhood supratentorial primitive neuroectodermal and pineal tumors
451885|NCT00019630|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
451886|NCT00019630|endocrine cancer|endocrine cancer
451887|NCT00019630|gastrointestinal cancer|gastrointestinal cancer
451888|NCT00019630|genetic condition|genetic condition
451889|NCT00019630|kidney tumor|kidney tumor
451890|NCT00019630|kidney/urinary cancer|kidney/urinary cancer
451891|NCT00019630|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
451892|NCT00019630|muscle cancer|muscle cancer
451893|NCT00019630|musculoskeletal cancer|musculoskeletal cancer
451894|NCT00019630|neuroblastoma|neuroblastoma
451895|NCT00019630|osteosarcoma|osteosarcoma
451896|NCT00019630|osteosarcoma/malignant fibrous histiocytoma of bone|osteosarcoma/malignant fibrous histiocytoma of bone
451897|NCT00019630|pediatric germ cell tumor|pediatric germ cell tumor
451898|NCT00019630|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
451899|NCT00019630|recurrent Wilms' tumor|recurrent wilms' tumor
451900|NCT00019630|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
451901|NCT00019630|recurrent childhood brain tumor|recurrent childhood brain tumor
451902|NCT00019630|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
451903|NCT00019630|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
451904|NCT00019630|recurrent childhood ependymoma|recurrent childhood ependymoma
451905|NCT00019630|recurrent childhood liver cancer|recurrent childhood liver cancer
451906|NCT00019630|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
451907|NCT00019630|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
451908|NCT00019630|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
451909|NCT00019630|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
451910|NCT00019630|recurrent childhood supratentorial primitive neuroectodermal and pineal tumors|recurrent childhood supratentorial primitive neuroectodermal and pineal tumors
451911|NCT00019630|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
451912|NCT00019630|recurrent neuroblastoma|recurrent neuroblastoma
451913|NCT00019630|recurrent osteosarcoma|recurrent osteosarcoma
451914|NCT00019630|recurrent tumors of the Ewing's family|recurrent tumors of the ewing's family
451915|NCT00019630|solid tumor|solid tumor
451916|NCT00019630|stage, Ewing's family of tumors|stage, ewing's family of tumors
451917|NCT00019630|stage, Wilms' tumor|stage, wilms' tumor
451918|NCT00019630|stage, childhood extracranial germ cell tumor|stage, childhood extracranial germ cell tumor
451919|NCT00019630|stage, childhood liver cancer|stage, childhood liver cancer
451920|NCT00019630|stage, childhood medulloblastoma|stage, childhood medulloblastoma
451921|NCT00019630|stage, childhood rhabdomyosarcoma|stage, childhood rhabdomyosarcoma
451922|NCT00019630|stage, childhood soft tissue sarcoma|stage, childhood soft tissue sarcoma
451923|NCT00019630|stage, neuroblastoma|stage, neuroblastoma
451924|NCT00019630|stage, osteosarcoma|stage, osteosarcoma
451925|NCT00019630|stage/type, childhood brain tumor|stage/type, childhood brain tumor
12268|NCT03212456|general anesthesia|general anesthesia
451926|NCT00019630|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
451927|NCT00019643|adult solid tumor|adult solid tumor
451928|NCT00019643|body system/site cancer|body system/site cancer
451929|NCT00019643|breast cancer|breast cancer
451931|NCT00019643|cancer-related problem/condition|cancer-related problem/condition
451932|NCT00019643|depression|depression
451933|NCT00019643|depression and suicide|depression and suicide
451934|NCT00019643|nutrition|nutrition
451935|NCT00019643|psychosocial effects/treatment|psychosocial effects/treatment
451936|NCT00019643|quality of life|quality of life
451937|NCT00019643|solid tumor|solid tumor
451938|NCT00019643|stage I breast cancer|stage i breast cancer
451939|NCT00019643|stage I, II, and IIIA breast cancer|stage i, ii, and iiia breast cancer
451940|NCT00019643|stage II breast cancer|stage ii breast cancer
451941|NCT00019643|stage III breast cancer|stage iii breast cancer
451942|NCT00019643|stage IIIA breast cancer|stage iiia breast cancer
451943|NCT00019643|stage IIIB, IV, recurrent, and metastatic breast cancer|stage iiib, iv, recurrent, and metastatic breast cancer
451944|NCT00019643|stage, breast cancer|stage, breast cancer
451945|NCT00019656|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
451946|NCT00019656|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
451947|NCT00019656|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
451948|NCT00019656|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
451949|NCT00019656|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
451950|NCT00019656|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
451951|NCT00019656|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
451952|NCT00019656|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
451953|NCT00019656|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
451954|NCT00019656|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
451955|NCT00019656|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
451956|NCT00019656|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
451957|NCT00019656|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
451958|NCT00019656|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
451959|NCT00019656|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
451960|NCT00019656|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
451961|NCT00019656|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
451962|NCT00019656|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
451963|NCT00019656|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
451964|NCT00019656|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
451965|NCT00019656|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
451966|NCT00019656|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
451967|NCT00019656|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
451968|NCT00019656|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
451969|NCT00019656|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
451970|NCT00019656|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
451971|NCT00019656|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
451972|NCT00019656|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
451973|NCT00019656|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
451974|NCT00019656|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
451975|NCT00019656|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
451976|NCT00019656|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
451977|NCT00019656|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
451978|NCT00019656|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
451979|NCT00019656|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
451980|NCT00019656|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
451981|NCT00019656|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
451982|NCT00019656|splenic marginal zone lymphoma|splenic marginal zone lymphoma
451983|NCT00019669|stage IV melanoma|stage iv melanoma
451984|NCT00019669|recurrent melanoma|recurrent melanoma
451985|NCT00019695|adenocarcinoma of the prostate|adenocarcinoma of the prostate
451986|NCT00019695|adult solid tumor|adult solid tumor
451987|NCT00019695|body system/site cancer|body system/site cancer
451989|NCT00019695|cancer|cancer
451990|NCT00019695|cellular diagnosis, prostate cancer|cellular diagnosis, prostate cancer
451991|NCT00019695|genetic condition|genetic condition
451992|NCT00019695|male reproductive cancer|male reproductive cancer
451993|NCT00019695|metastatic cancer|metastatic cancer
451994|NCT00019695|prostate cancer|prostate cancer
451995|NCT00019695|recurrent prostate cancer|recurrent prostate cancer
577578|NCT00492245|PTK|ptk
451436|NCT00019097|cancer|cancer
451996|NCT00019695|site, metastatic cancer|site, metastatic cancer
451997|NCT00019695|solid tumor|solid tumor
451998|NCT00019695|stage IV prostate cancer|stage iv prostate cancer
451999|NCT00019695|stage, prostate cancer|stage, prostate cancer
452000|NCT00019695|unclassified/other cancer|unclassified/other cancer
452001|NCT00019721|stage IV melanoma|stage iv melanoma
452002|NCT00019721|recurrent melanoma|recurrent melanoma
452003|NCT00019734|stage IV melanoma|stage iv melanoma
452004|NCT00019734|recurrent melanoma|recurrent melanoma
452005|NCT00019747|stage IV colon cancer|stage iv colon cancer
452006|NCT00019747|stage IV rectal cancer|stage iv rectal cancer
452007|NCT00019747|recurrent colon cancer|recurrent colon cancer
452008|NCT00019747|recurrent rectal cancer|recurrent rectal cancer
452009|NCT00019760|adult solid tumor|adult solid tumor
452010|NCT00019760|body system/site cancer|body system/site cancer
452011|NCT00019760|cancer|cancer
452012|NCT00019760|colon cancer|colon cancer
452013|NCT00019760|colorectal cancer|colorectal cancer
452014|NCT00019760|gastrointestinal cancer|gastrointestinal cancer
452015|NCT00019760|genetic condition|genetic condition
452016|NCT00019760|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
452017|NCT00019760|liver metastases|liver metastases
452018|NCT00019760|metastatic cancer|metastatic cancer
452019|NCT00019760|rectal cancer|rectal cancer
452020|NCT00019760|recurrent colon cancer|recurrent colon cancer
452021|NCT00019760|recurrent rectal cancer|recurrent rectal cancer
452022|NCT00019760|site, metastatic cancer|site, metastatic cancer
452023|NCT00019760|solid tumor|solid tumor
452024|NCT00019760|stage IV colon cancer|stage iv colon cancer
452025|NCT00019760|stage IV rectal cancer|stage iv rectal cancer
452026|NCT00019760|stage, colon cancer|stage, colon cancer
452027|NCT00019760|stage, rectal cancer|stage, rectal cancer
452028|NCT00019760|unclassified/other cancer|unclassified/other cancer
452029|NCT00019773|stage I colon cancer|stage i colon cancer
452030|NCT00019773|stage II colon cancer|stage ii colon cancer
452031|NCT00019773|stage III colon cancer|stage iii colon cancer
452032|NCT00019773|stage IV colon cancer|stage iv colon cancer
452033|NCT00019773|stage 0 colon cancer|stage 0 colon cancer
452034|NCT00019773|stage 0 rectal cancer|stage 0 rectal cancer
452035|NCT00019773|stage I rectal cancer|stage i rectal cancer
452036|NCT00019773|stage II rectal cancer|stage ii rectal cancer
452037|NCT00019773|stage III rectal cancer|stage iii rectal cancer
452038|NCT00019773|stage IV rectal cancer|stage iv rectal cancer
452039|NCT00019773|recurrent colon cancer|recurrent colon cancer
452040|NCT00019773|recurrent rectal cancer|recurrent rectal cancer
452041|NCT00019773|small intestine adenocarcinoma|small intestine adenocarcinoma
452042|NCT00019773|small intestine lymphoma|small intestine lymphoma
452043|NCT00019773|small intestine leiomyosarcoma|small intestine leiomyosarcoma
452044|NCT00019773|recurrent small intestine cancer|recurrent small intestine cancer
452045|NCT00019773|carcinoma of the appendix|carcinoma of the appendix
452046|NCT00019786|stage IV colon cancer|stage iv colon cancer
452047|NCT00019786|stage IV rectal cancer|stage iv rectal cancer
452048|NCT00019786|recurrent colon cancer|recurrent colon cancer
452049|NCT00019786|recurrent rectal cancer|recurrent rectal cancer
452050|NCT00019786|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
452051|NCT00019786|recurrent adult primary liver cancer|recurrent adult primary liver cancer
452052|NCT00019786|recurrent islet cell carcinoma|recurrent islet cell carcinoma
452053|NCT00019786|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
452054|NCT00019786|adenocarcinoma of the colon|adenocarcinoma of the colon
452055|NCT00019786|adenocarcinoma of the rectum|adenocarcinoma of the rectum
452056|NCT00019786|liver metastases|liver metastases
452057|NCT00019786|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
452058|NCT00019786|advanced adult primary liver cancer|advanced adult primary liver cancer
452059|NCT00019786|recurrent childhood liver cancer|recurrent childhood liver cancer
452060|NCT00019786|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
452061|NCT00019786|stage III childhood liver cancer|stage iii childhood liver cancer
452062|NCT00019786|stage IV childhood liver cancer|stage iv childhood liver cancer
452063|NCT00019786|neuroendocrine carcinoma|neuroendocrine carcinoma
452064|NCT00019812|stage IV breast cancer|stage iv breast cancer
452065|NCT00019812|male breast cancer|male breast cancer
452066|NCT00019825|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
452067|NCT00019825|stage II esophageal cancer|stage ii esophageal cancer
452068|NCT00019825|stage III esophageal cancer|stage iii esophageal cancer
452069|NCT00019825|stage IV esophageal cancer|stage iv esophageal cancer
452070|NCT00019825|recurrent esophageal cancer|recurrent esophageal cancer
452071|NCT00019825|extensive stage small cell lung cancer|extensive stage small cell lung cancer
452072|NCT00019825|recurrent small cell lung cancer|recurrent small cell lung cancer
452073|NCT00019825|advanced malignant mesothelioma|advanced malignant mesothelioma
452074|NCT00019825|recurrent malignant mesothelioma|recurrent malignant mesothelioma
753018|NCT01175148|BMT|bmt
577753|NCT00492882|FSH|fsh
452075|NCT00019825|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
452076|NCT00019825|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
452077|NCT00019825|malignant pleural effusion|malignant pleural effusion
452078|NCT00019838|Waldenström macroglobulinemia|waldenström macroglobulinemia
452079|NCT00019838|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
452080|NCT00019838|refractory hairy cell leukemia|refractory hairy cell leukemia
452081|NCT00019838|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
452082|NCT00019838|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
452083|NCT00019838|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
452084|NCT00019838|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
452085|NCT00019838|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
452086|NCT00019838|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
452087|NCT00019838|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
452088|NCT00019838|splenic marginal zone lymphoma|splenic marginal zone lymphoma
452089|NCT00019864|cardiac toxicity|cardiac toxicity
452090|NCT00019864|localized osteosarcoma|localized osteosarcoma
452091|NCT00019864|metastatic osteosarcoma|metastatic osteosarcoma
452092|NCT00019864|recurrent osteosarcoma|recurrent osteosarcoma
452093|NCT00019890|adult solid tumor|adult solid tumor
452094|NCT00019890|body system/site cancer|body system/site cancer
452095|NCT00019890|cancer|cancer
452096|NCT00019890|melanoma|melanoma
452097|NCT00019890|recurrent melanoma|recurrent melanoma
452098|NCT00019890|skin tumor|skin tumor
452099|NCT00019890|solid tumor|solid tumor
452100|NCT00019890|stage III melanoma|stage iii melanoma
452101|NCT00019890|stage IV melanoma|stage iv melanoma
452102|NCT00019890|stage, melanoma|stage, melanoma
452103|NCT00019916|stage IV breast cancer|stage iv breast cancer
452104|NCT00019916|recurrent breast cancer|recurrent breast cancer
452105|NCT00019916|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
452106|NCT00019916|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
452107|NCT00019929|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
452108|NCT00019929|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
452109|NCT00019955|stage I renal cell cancer|stage i renal cell cancer
452110|NCT00019955|stage II renal cell cancer|stage ii renal cell cancer
452111|NCT00019968|adult soft tissue sarcoma|adult soft tissue sarcoma
452112|NCT00019968|adult solid tumor|adult solid tumor
452113|NCT00019968|body system/site cancer|body system/site cancer
452114|NCT00019968|cancer|cancer
452115|NCT00019968|muscle cancer|muscle cancer
452116|NCT00019968|musculoskeletal cancer|musculoskeletal cancer
452117|NCT00019968|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
452118|NCT00019968|solid tumor|solid tumor
452119|NCT00019968|stage IA, IB, and IIA adult soft tissue sarcoma|stage ia, ib, and iia adult soft tissue sarcoma
452120|NCT00019968|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
452121|NCT00019968|stage IIB adult soft tissue sarcoma|stage iib adult soft tissue sarcoma
452122|NCT00019968|stage IIB, IIC, and III adult soft tissue sarcoma|stage iib, iic, and iii adult soft tissue sarcoma
583591|NCT00512317|anticonvulsant|anticonvulsant
452123|NCT00019968|stage IIC adult soft tissue sarcoma|stage iic adult soft tissue sarcoma
452124|NCT00019968|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
452125|NCT00019968|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
452126|NCT00019968|stage IVA adult soft tissue sarcoma|stage iva adult soft tissue sarcoma
452127|NCT00019968|stage IVB adult soft tissue sarcoma|stage ivb adult soft tissue sarcoma
452128|NCT00019968|stage, adult soft tissue sarcoma|stage, adult soft tissue sarcoma
452130|NCT00019994|recurrent melanoma|recurrent melanoma
452131|NCT00020007|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
452132|NCT00020007|limited stage small cell lung cancer|limited stage small cell lung cancer
452231|NCT00020202|small cell lung cancer|small cell lung cancer
452133|NCT00020007|extensive stage small cell lung cancer|extensive stage small cell lung cancer
452134|NCT00020007|recurrent small cell lung cancer|recurrent small cell lung cancer
452135|NCT00020007|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
452136|NCT00020007|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
452137|NCT00020007|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
452138|NCT00020007|lung metastases|lung metastases
452139|NCT00020007|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
452140|NCT00020007|pulmonary carcinoid tumor|pulmonary carcinoid tumor
452141|NCT00020046|adenocarcinoma of the prostate|adenocarcinoma of the prostate
452142|NCT00020046|adult solid tumor|adult solid tumor
452143|NCT00020046|body system/site cancer|body system/site cancer
452144|NCT00020046|cancer|cancer
452145|NCT00020046|cellular diagnosis, prostate cancer|cellular diagnosis, prostate cancer
452146|NCT00020046|genetic condition|genetic condition
452147|NCT00020046|male reproductive cancer|male reproductive cancer
452148|NCT00020046|prostate cancer|prostate cancer
452149|NCT00020046|recurrent prostate cancer|recurrent prostate cancer
451586|NCT00019331|stage IV melanoma|stage iv melanoma
452150|NCT00020046|solid tumor|solid tumor
452151|NCT00020046|stage IV prostate cancer|stage iv prostate cancer
452152|NCT00020046|stage, prostate cancer|stage, prostate cancer
452153|NCT00020072|cutaneous T-cell non-Hodgkin lymphoma|cutaneous t-cell non-hodgkin lymphoma
452154|NCT00020072|mycosis fungoides/Sezary syndrome|mycosis fungoides/sezary syndrome
452155|NCT00020098|breast cancer|breast cancer
452156|NCT00020111|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
452157|NCT00020111|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
452158|NCT00020111|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
452159|NCT00020111|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
452160|NCT00020111|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
452161|NCT00020111|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
452162|NCT00020111|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
452163|NCT00020111|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
452164|NCT00020111|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
452165|NCT00020124|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
452166|NCT00020124|extensive stage small cell lung cancer|extensive stage small cell lung cancer
452167|NCT00020124|recurrent small cell lung cancer|recurrent small cell lung cancer
452168|NCT00020124|advanced malignant mesothelioma|advanced malignant mesothelioma
452169|NCT00020124|recurrent malignant mesothelioma|recurrent malignant mesothelioma
452170|NCT00020124|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
452171|NCT00020124|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
452172|NCT00020124|pulmonary carcinoid tumor|pulmonary carcinoid tumor
452173|NCT00020124|lung metastases|lung metastases
452174|NCT00020150|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
452175|NCT00020150|childhood craniopharyngioma|childhood craniopharyngioma
452176|NCT00020150|recurrent childhood brain tumor|recurrent childhood brain tumor
452177|NCT00020150|recurrent neuroblastoma|recurrent neuroblastoma
452178|NCT00020150|recurrent childhood liver cancer|recurrent childhood liver cancer
452179|NCT00020150|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
452180|NCT00020150|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
452181|NCT00020150|recurrent osteosarcoma|recurrent osteosarcoma
452182|NCT00020150|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
452183|NCT00020150|childhood germ cell tumor|childhood germ cell tumor
452184|NCT00020150|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
452185|NCT00020150|childhood oligodendroglioma|childhood oligodendroglioma
452186|NCT00020150|childhood choroid plexus tumor|childhood choroid plexus tumor
452187|NCT00020150|childhood grade I meningioma|childhood grade i meningioma
452188|NCT00020150|childhood grade II meningioma|childhood grade ii meningioma
452189|NCT00020150|childhood grade III meningioma|childhood grade iii meningioma
452190|NCT00020150|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
452191|NCT00020150|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
452192|NCT00020150|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
452193|NCT00020150|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
452194|NCT00020150|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
452195|NCT00020150|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
452196|NCT00020150|recurrent childhood ependymoma|recurrent childhood ependymoma
452197|NCT00020150|childhood teratoma|childhood teratoma
452198|NCT00020150|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
452199|NCT00020150|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
452200|NCT00020150|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
452201|NCT00020150|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
452202|NCT00020176|stage IV breast cancer|stage iv breast cancer
452203|NCT00020176|recurrent breast cancer|recurrent breast cancer
452204|NCT00020176|male breast cancer|male breast cancer
452205|NCT00020189|thromboembolism|thromboembolism
452206|NCT00020189|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
452207|NCT00020189|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
452208|NCT00020189|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
452209|NCT00020189|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
452210|NCT00020189|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
452211|NCT00020189|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
452212|NCT00020189|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
452213|NCT00020189|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
452214|NCT00020189|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
452215|NCT00020189|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
452216|NCT00020189|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
452217|NCT00020189|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
452218|NCT00020189|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
452219|NCT00020189|recurrent salivary gland cancer|recurrent salivary gland cancer
452220|NCT00020189|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
452221|NCT00020189|stage IV salivary gland cancer|stage iv salivary gland cancer
452222|NCT00020202|adult solid tumor|adult solid tumor
452223|NCT00020202|body system/site cancer|body system/site cancer
452224|NCT00020202|cancer|cancer
474661|NCT00084279|Pegasys|pegasys
452225|NCT00020202|extensive stage small cell lung cancer|extensive stage small cell lung cancer
452226|NCT00020202|genetic condition|genetic condition
452227|NCT00020202|lung cancer|lung cancer
452228|NCT00020202|non-small cell lung cancer|non-small cell lung cancer
452229|NCT00020202|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
452230|NCT00020202|recurrent small cell lung cancer|recurrent small cell lung cancer
452232|NCT00020202|solid tumor|solid tumor
452233|NCT00020202|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
452234|NCT00020202|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
452235|NCT00020202|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
452236|NCT00020202|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
452237|NCT00020202|stage, non-small cell lung cancer|stage, non-small cell lung cancer
452238|NCT00020202|stage, small cell lung cancer|stage, small cell lung cancer
452239|NCT00020202|thorax/respiratory cancer|thorax/respiratory cancer
452240|NCT00020254|adenocarcinoma of the prostate|adenocarcinoma of the prostate
452241|NCT00020254|recurrent prostate cancer|recurrent prostate cancer
452242|NCT00020267|Ewing's family of tumors|ewing's family of tumors
452243|NCT00020267|adult soft tissue sarcoma|adult soft tissue sarcoma
452244|NCT00020267|adult solid tumor|adult solid tumor
452245|NCT00020267|body system/site cancer|body system/site cancer
452246|NCT00020267|bone cancer|bone cancer
452247|NCT00020267|breast cancer|breast cancer
452248|NCT00020267|cancer|cancer
452249|NCT00020267|childhood cancer|childhood cancer
452250|NCT00020267|childhood solid tumor|childhood solid tumor
452251|NCT00020267|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
452252|NCT00020267|colon cancer|colon cancer
452253|NCT00020267|colorectal cancer|colorectal cancer
452254|NCT00020267|extraocular extension melanoma|extraocular extension melanoma
452255|NCT00020267|eye cancer|eye cancer
452256|NCT00020267|female reproductive cancer|female reproductive cancer
452257|NCT00020267|gastrointestinal cancer|gastrointestinal cancer
452258|NCT00020267|genetic condition|genetic condition
452259|NCT00020267|intraocular melanoma|intraocular melanoma
452260|NCT00020267|lung cancer|lung cancer
452261|NCT00020267|male breast cancer|male breast cancer
452262|NCT00020267|melanoma|melanoma
452263|NCT00020267|metastatic osteosarcoma|metastatic osteosarcoma
452264|NCT00020267|metastatic tumors of the Ewing's family|metastatic tumors of the ewing's family
452265|NCT00020267|muscle cancer|muscle cancer
452266|NCT00020267|musculoskeletal cancer|musculoskeletal cancer
452267|NCT00020267|non-small cell lung cancer|non-small cell lung cancer
452268|NCT00020267|osteosarcoma|osteosarcoma
452269|NCT00020267|osteosarcoma/malignant fibrous histiocytoma of bone|osteosarcoma/malignant fibrous histiocytoma of bone
452270|NCT00020267|ovarian sarcoma|ovarian sarcoma
452271|NCT00020267|rectal cancer|rectal cancer
452272|NCT00020267|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
452273|NCT00020267|recurrent breast cancer|recurrent breast cancer
452274|NCT00020267|recurrent colon cancer|recurrent colon cancer
452275|NCT00020267|recurrent intraocular melanoma|recurrent intraocular melanoma
452276|NCT00020267|recurrent melanoma|recurrent melanoma
452277|NCT00020267|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
452278|NCT00020267|recurrent osteosarcoma|recurrent osteosarcoma
452279|NCT00020267|recurrent rectal cancer|recurrent rectal cancer
452280|NCT00020267|recurrent tumors of the Ewing's family|recurrent tumors of the ewing's family
452281|NCT00020267|recurrent uterine sarcoma|recurrent uterine sarcoma
452282|NCT00020267|skin tumor|skin tumor
452283|NCT00020267|solid tumor|solid tumor
452284|NCT00020267|stage IIIB, IV, recurrent, and metastatic breast cancer|stage iiib, iv, recurrent, and metastatic breast cancer
452285|NCT00020267|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
452286|NCT00020267|stage IV breast cancer|stage iv breast cancer
452287|NCT00020267|stage IV colon cancer|stage iv colon cancer
452288|NCT00020267|stage IV melanoma|stage iv melanoma
452289|NCT00020267|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
452290|NCT00020267|stage IV rectal cancer|stage iv rectal cancer
452291|NCT00020267|stage IV uterine sarcoma|stage iv uterine sarcoma
452292|NCT00020267|stage IVA adult soft tissue sarcoma|stage iva adult soft tissue sarcoma
470873|NCT00073008|lapatinib|lapatinib
452293|NCT00020267|stage IVB adult soft tissue sarcoma|stage ivb adult soft tissue sarcoma
452294|NCT00020267|stage, Ewing's family of tumors|stage, ewing's family of tumors
452295|NCT00020267|stage, adult soft tissue sarcoma|stage, adult soft tissue sarcoma
452296|NCT00020267|stage, breast cancer|stage, breast cancer
452297|NCT00020267|stage, colon cancer|stage, colon cancer
452298|NCT00020267|stage, intraocular melanoma|stage, intraocular melanoma
452299|NCT00020267|stage, melanoma|stage, melanoma
452300|NCT00020267|stage, non-small cell lung cancer|stage, non-small cell lung cancer
452301|NCT00020267|stage, osteosarcoma|stage, osteosarcoma
452302|NCT00020267|stage, rectal cancer|stage, rectal cancer
452303|NCT00020267|stage, uterine sarcoma|stage, uterine sarcoma
452304|NCT00020267|thorax/respiratory cancer|thorax/respiratory cancer
452305|NCT00020267|uterine sarcoma|uterine sarcoma
452306|NCT00020332|stage IV breast cancer|stage iv breast cancer
452307|NCT00020332|stage IIIA breast cancer|stage iiia breast cancer
452308|NCT00020332|recurrent breast cancer|recurrent breast cancer
452309|NCT00020332|stage IIIB breast cancer|stage iiib breast cancer
452310|NCT00020332|male breast cancer|male breast cancer
452311|NCT00020345|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
452312|NCT00020345|adult solid tumor|adult solid tumor
452313|NCT00020345|body system/site cancer|body system/site cancer
452314|NCT00020345|cancer|cancer
452315|NCT00020345|cellular diagnosis, pancreatic cancer|cellular diagnosis, pancreatic cancer
452316|NCT00020345|gastrointestinal cancer|gastrointestinal cancer
452317|NCT00020345|pancreatic cancer|pancreatic cancer
452318|NCT00020345|solid tumor|solid tumor
452319|NCT00020345|stage III pancreatic cancer|stage iii pancreatic cancer
452320|NCT00020345|stage IV pancreatic cancer|stage iv pancreatic cancer
452321|NCT00020345|stage IVA pancreatic cancer|stage iva pancreatic cancer
452322|NCT00020345|stage, pancreatic cancer|stage, pancreatic cancer
452323|NCT00020358|stage I melanoma|stage i melanoma
452324|NCT00020358|stage II melanoma|stage ii melanoma
452325|NCT00020358|stage III melanoma|stage iii melanoma
452326|NCT00020358|stage IV melanoma|stage iv melanoma
452327|NCT00020358|recurrent melanoma|recurrent melanoma
452328|NCT00020371|adult solid tumor|adult solid tumor
452329|NCT00020371|bone marrow suppression|bone marrow suppression
452330|NCT00020371|cancer|cancer
452331|NCT00020371|cancer-related problem/condition|cancer-related problem/condition
452332|NCT00020371|neutropenia|neutropenia
452333|NCT00020371|solid tumor|solid tumor
452334|NCT00020371|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
452335|NCT00020397|recurrent melanoma|recurrent melanoma
452336|NCT00020397|stage IV melanoma|stage iv melanoma
452337|NCT00020410|stage IV breast cancer|stage iv breast cancer
452338|NCT00020410|recurrent breast cancer|recurrent breast cancer
452339|NCT00020410|male breast cancer|male breast cancer
452340|NCT00020449|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
452341|NCT00020449|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
452342|NCT00020462|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
452343|NCT00020462|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
452344|NCT00020462|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
452345|NCT00020462|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
452346|NCT00020462|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
452347|NCT00020462|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
452348|NCT00020462|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
452349|NCT00020462|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
452350|NCT00020462|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
452351|NCT00020475|adult solid tumor|adult solid tumor
452352|NCT00020475|body system/site cancer|body system/site cancer
452354|NCT00020475|extraocular extension melanoma|extraocular extension melanoma
452355|NCT00020475|eye cancer|eye cancer
452356|NCT00020475|intraocular melanoma|intraocular melanoma
452357|NCT00020475|recurrent intraocular melanoma|recurrent intraocular melanoma
452358|NCT00020475|solid tumor|solid tumor
452359|NCT00020475|stage, intraocular melanoma|stage, intraocular melanoma
452360|NCT00020488|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
452361|NCT00020501|stage IV colon cancer|stage iv colon cancer
452362|NCT00020501|stage IV rectal cancer|stage iv rectal cancer
452363|NCT00020501|recurrent colon cancer|recurrent colon cancer
452364|NCT00020501|recurrent rectal cancer|recurrent rectal cancer
452365|NCT00020501|liver metastases|liver metastases
452366|NCT00020527|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
452367|NCT00020527|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
452368|NCT00020527|disseminated neuroblastoma|disseminated neuroblastoma
452369|NCT00020527|recurrent neuroblastoma|recurrent neuroblastoma
452370|NCT00020527|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
452371|NCT00020527|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
753019|NCT01175148|lipitor|lipitor
451805|NCT00019539|adult solid tumor|adult solid tumor
452372|NCT00020527|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
452373|NCT00020527|fever, sweats, and hot flashes|fever, sweats, and hot flashes
452374|NCT00020527|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
452375|NCT00020527|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
452376|NCT00020527|neutropenia|neutropenia
452377|NCT00020527|infection|infection
452378|NCT00020527|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
452379|NCT00020527|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
452380|NCT00020527|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
452381|NCT00020540|stage IV renal cell cancer|stage iv renal cell cancer
452382|NCT00020540|recurrent renal cell cancer|recurrent renal cell cancer
452383|NCT00020540|stage IV melanoma|stage iv melanoma
452384|NCT00020540|recurrent melanoma|recurrent melanoma
452385|NCT00020553|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
452386|NCT00020566|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
474662|NCT00084279|PegIntron|pegintron
452387|NCT00020566|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
452388|NCT00020579|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
452389|NCT00020579|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
452390|NCT00020579|small intestine lymphoma|small intestine lymphoma
452391|NCT00020579|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
452392|NCT00020579|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
452393|NCT00020579|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
452394|NCT00020579|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
452395|NCT00020579|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
452396|NCT00020579|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
452397|NCT00020579|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
452398|NCT00020579|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
452399|NCT00020579|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
452400|NCT00020579|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
452401|NCT00020579|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
452402|NCT00020579|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
452403|NCT00020579|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
452404|NCT00020579|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
452405|NCT00020579|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
452406|NCT00020579|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
452407|NCT00020579|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
452408|NCT00020579|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
452409|NCT00020579|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
452410|NCT00020579|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
583592|NCT00512317|catamenial epilepsy|catamenial epilepsy
579338|NCT00500864|COPD|copd
452411|NCT00020579|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
452412|NCT00020579|intraocular lymphoma|intraocular lymphoma
452413|NCT00020579|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
452414|NCT00020579|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
452415|NCT00020579|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
452416|NCT00020579|anaplastic large cell lymphoma|anaplastic large cell lymphoma
452417|NCT00020579|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
452418|NCT00020579|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
452419|NCT00020579|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
452420|NCT00020579|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
452421|NCT00020579|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
452422|NCT00020579|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
452423|NCT00020579|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
452424|NCT00020579|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
452425|NCT00020579|splenic marginal zone lymphoma|splenic marginal zone lymphoma
452426|NCT00020579|male breast cancer|male breast cancer
452427|NCT00020579|stage IIIA breast cancer|stage iiia breast cancer
452428|NCT00020579|stage IIIB breast cancer|stage iiib breast cancer
452429|NCT00020579|stage IIIC breast cancer|stage iiic breast cancer
452430|NCT00020579|stage IV breast cancer|stage iv breast cancer
452431|NCT00020579|recurrent pancreatic cancer|recurrent pancreatic cancer
452432|NCT00020579|stage III pancreatic cancer|stage iii pancreatic cancer
452433|NCT00020579|recurrent colon cancer|recurrent colon cancer
578363|NCT00495638|SCD|scd
452434|NCT00020579|stage III colon cancer|stage iii colon cancer
452435|NCT00020579|stage IV colon cancer|stage iv colon cancer
452436|NCT00020579|recurrent rectal cancer|recurrent rectal cancer
452437|NCT00020579|stage III rectal cancer|stage iii rectal cancer
452438|NCT00020579|stage IV rectal cancer|stage iv rectal cancer
452439|NCT00020579|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
452440|NCT00020579|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
452441|NCT00020579|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
452442|NCT00020579|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
452863|NCT00009750|recurrent prostate cancer|recurrent prostate cancer
452443|NCT00020579|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
452638|NCT00020761|stage IV gastric cancer|stage iv gastric cancer
452444|NCT00020579|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
452445|NCT00020579|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
452446|NCT00020579|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
452447|NCT00020579|recurrent cervical cancer|recurrent cervical cancer
452448|NCT00020579|stage III cervical cancer|stage iii cervical cancer
452449|NCT00020579|stage IVA cervical cancer|stage iva cervical cancer
452450|NCT00020579|stage IVB cervical cancer|stage ivb cervical cancer
452451|NCT00020579|recurrent endometrial carcinoma|recurrent endometrial carcinoma
474663|NCT00084292|Ischemia|ischemia
452452|NCT00020579|stage III endometrial carcinoma|stage iii endometrial carcinoma
452453|NCT00020579|stage IV endometrial carcinoma|stage iv endometrial carcinoma
452454|NCT00020579|fallopian tube cancer|fallopian tube cancer
452455|NCT00020579|primary peritoneal cavity cancer|primary peritoneal cavity cancer
452456|NCT00020579|recurrent uterine sarcoma|recurrent uterine sarcoma
452457|NCT00020579|stage III uterine sarcoma|stage iii uterine sarcoma
452458|NCT00020579|stage IV uterine sarcoma|stage iv uterine sarcoma
452459|NCT00020579|recurrent vaginal cancer|recurrent vaginal cancer
452460|NCT00020579|stage III vaginal cancer|stage iii vaginal cancer
452461|NCT00020579|stage IVA vaginal cancer|stage iva vaginal cancer
452462|NCT00020579|stage IVB vaginal cancer|stage ivb vaginal cancer
452463|NCT00020579|recurrent vulvar cancer|recurrent vulvar cancer
452464|NCT00020579|stage III vulvar cancer|stage iii vulvar cancer
452465|NCT00020579|stage IV vulvar cancer|stage iv vulvar cancer
452466|NCT00020579|recurrent anal cancer|recurrent anal cancer
452467|NCT00020579|stage IIIA anal cancer|stage iiia anal cancer
452468|NCT00020579|stage IIIB anal cancer|stage iiib anal cancer
452469|NCT00020579|stage IV anal cancer|stage iv anal cancer
452470|NCT00020579|recurrent esophageal cancer|recurrent esophageal cancer
452471|NCT00020579|stage III esophageal cancer|stage iii esophageal cancer
452472|NCT00020579|stage IV esophageal cancer|stage iv esophageal cancer
452473|NCT00020579|recurrent gastric cancer|recurrent gastric cancer
452474|NCT00020579|stage III gastric cancer|stage iii gastric cancer
452475|NCT00020579|stage IV gastric cancer|stage iv gastric cancer
452476|NCT00020579|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
452477|NCT00020579|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
452478|NCT00020579|advanced adult primary liver cancer|advanced adult primary liver cancer
452479|NCT00020579|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
452480|NCT00020579|recurrent adult primary liver cancer|recurrent adult primary liver cancer
452481|NCT00020579|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
452482|NCT00020579|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
452483|NCT00020579|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
452484|NCT00020579|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
452485|NCT00020579|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
452486|NCT00020579|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
452487|NCT00020579|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
452488|NCT00020579|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
452489|NCT00020579|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
452490|NCT00020579|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
452491|NCT00020579|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
452492|NCT00020579|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
452493|NCT00020579|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
452494|NCT00020579|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
452495|NCT00020579|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
452496|NCT00020579|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
452497|NCT00020579|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
452498|NCT00020579|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
578452|NCT00495976|flu|flu
451930|NCT00019643|cancer|cancer
452499|NCT00020579|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
452500|NCT00020579|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
452501|NCT00020579|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
452502|NCT00020579|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
452503|NCT00020579|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
452504|NCT00020579|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
452505|NCT00020579|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
452506|NCT00020579|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
452507|NCT00020579|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
452508|NCT00020579|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
452509|NCT00020579|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
452510|NCT00020579|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
452511|NCT00020579|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
452512|NCT00020579|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
452513|NCT00020579|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
12463|NCT03211143|Nexium|nexium
12558|NCT03210506|hepatitis B virus|hepatitis b virus
452514|NCT00020579|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
452515|NCT00020579|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
452516|NCT00020579|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
452517|NCT00020579|metastatic parathyroid cancer|metastatic parathyroid cancer
452518|NCT00020579|recurrent parathyroid cancer|recurrent parathyroid cancer
452519|NCT00020579|recurrent salivary gland cancer|recurrent salivary gland cancer
452520|NCT00020579|stage III salivary gland cancer|stage iii salivary gland cancer
452521|NCT00020579|stage IV salivary gland cancer|stage iv salivary gland cancer
452522|NCT00020579|recurrent bladder cancer|recurrent bladder cancer
452523|NCT00020579|recurrent gallbladder cancer|recurrent gallbladder cancer
452524|NCT00020579|stage III bladder cancer|stage iii bladder cancer
452525|NCT00020579|stage IV bladder cancer|stage iv bladder cancer
452526|NCT00020579|unresectable gallbladder cancer|unresectable gallbladder cancer
452527|NCT00020579|recurrent renal cell cancer|recurrent renal cell cancer
452528|NCT00020579|stage III renal cell cancer|stage iii renal cell cancer
452529|NCT00020579|stage IV renal cell cancer|stage iv renal cell cancer
452530|NCT00020579|stage III Wilms tumor|stage iii wilms tumor
452531|NCT00020579|stage IV Wilms tumor|stage iv wilms tumor
452532|NCT00020579|stage V Wilms tumor|stage v wilms tumor
452533|NCT00020579|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
452534|NCT00020579|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
583593|NCT00512317|adult partial onset epilepsy|adult partial onset epilepsy
452535|NCT00020579|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
452536|NCT00020579|anterior urethral cancer|anterior urethral cancer
452537|NCT00020579|posterior urethral cancer|posterior urethral cancer
452538|NCT00020579|recurrent urethral cancer|recurrent urethral cancer
452539|NCT00020579|recurrent penile cancer|recurrent penile cancer
452540|NCT00020579|stage III penile cancer|stage iii penile cancer
452541|NCT00020579|stage IV penile cancer|stage iv penile cancer
452542|NCT00020579|recurrent prostate cancer|recurrent prostate cancer
452543|NCT00020579|stage III prostate cancer|stage iii prostate cancer
452544|NCT00020579|stage IV prostate cancer|stage iv prostate cancer
452545|NCT00020579|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
452546|NCT00020579|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
452547|NCT00020579|metastatic osteosarcoma|metastatic osteosarcoma
452548|NCT00020579|recurrent osteosarcoma|recurrent osteosarcoma
452549|NCT00020579|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
452550|NCT00020579|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
452551|NCT00020579|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
452552|NCT00020579|classic Kaposi sarcoma|classic kaposi sarcoma
452553|NCT00020579|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
452554|NCT00020579|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
578574|NCT00496522|CNS|cns
451988|NCT00019695|bone metastases|bone metastases
452555|NCT00020579|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
452556|NCT00020579|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
452557|NCT00020579|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
452558|NCT00020579|extraocular extension melanoma|extraocular extension melanoma
452559|NCT00020579|iris melanoma|iris melanoma
452560|NCT00020579|recurrent intraocular melanoma|recurrent intraocular melanoma
452561|NCT00020579|recurrent melanoma|recurrent melanoma
452562|NCT00020579|stage III melanoma|stage iii melanoma
452563|NCT00020579|stage IV melanoma|stage iv melanoma
452564|NCT00020579|extensive stage small cell lung cancer|extensive stage small cell lung cancer
452565|NCT00020579|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
452566|NCT00020579|recurrent small cell lung cancer|recurrent small cell lung cancer
452567|NCT00020579|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
452568|NCT00020579|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
452569|NCT00020579|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
452570|NCT00020579|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
452571|NCT00020579|advanced malignant mesothelioma|advanced malignant mesothelioma
452572|NCT00020579|recurrent malignant mesothelioma|recurrent malignant mesothelioma
452573|NCT00020579|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
452574|NCT00020579|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
452575|NCT00020579|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
452576|NCT00020579|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
452577|NCT00020579|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
452578|NCT00020579|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
452579|NCT00020579|desmoid tumor|desmoid tumor
452580|NCT00020579|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
452581|NCT00020579|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
452582|NCT00020579|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
452583|NCT00020579|carcinoma of the appendix|carcinoma of the appendix
452584|NCT00020579|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
452585|NCT00020579|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
452586|NCT00020579|recurrent pituitary tumor|recurrent pituitary tumor
452587|NCT00020579|adult anaplastic astrocytoma|adult anaplastic astrocytoma
452588|NCT00020579|adult astrocytic tumors|adult astrocytic tumors
452589|NCT00020579|adult diffuse astrocytoma|adult diffuse astrocytoma
452590|NCT00020579|adult pilocytic astrocytoma|adult pilocytic astrocytoma
452591|NCT00020579|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
452592|NCT00020579|adult brain stem glioma|adult brain stem glioma
452593|NCT00020579|adult oligodendroglioma|adult oligodendroglioma
452594|NCT00020579|adult mixed glioma|adult mixed glioma
452595|NCT00020579|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
452596|NCT00020579|adult choroid plexus tumor|adult choroid plexus tumor
452597|NCT00020579|adult craniopharyngioma|adult craniopharyngioma
452598|NCT00020579|adult anaplastic ependymoma|adult anaplastic ependymoma
452599|NCT00020579|adult subependymoma|adult subependymoma
452600|NCT00020579|adult medulloblastoma|adult medulloblastoma
452601|NCT00020579|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
452602|NCT00020579|adult ependymoblastoma|adult ependymoblastoma
452603|NCT00020579|adult ependymoma|adult ependymoma
579802|NCT00493506|HIV|hiv
452604|NCT00020579|adult myxopapillary ependymoma|adult myxopapillary ependymoma
452605|NCT00020579|adult anaplastic meningioma|adult anaplastic meningioma
452606|NCT00020579|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
452607|NCT00020579|adult meningioma|adult meningioma
452608|NCT00020579|adult papillary meningioma|adult papillary meningioma
452609|NCT00020579|adult grade I meningioma|adult grade i meningioma
452610|NCT00020579|adult grade II meningioma|adult grade ii meningioma
452611|NCT00020579|adult grade III meningioma|adult grade iii meningioma
452612|NCT00020579|adult pineal parenchymal tumor|adult pineal parenchymal tumor
452613|NCT00020579|recurrent adult brain tumor|recurrent adult brain tumor
452614|NCT00020579|stage IV pancreatic cancer|stage iv pancreatic cancer
452615|NCT00020579|stage III thymoma|stage iii thymoma
452616|NCT00020579|stage IVA thymoma|stage iva thymoma
452617|NCT00020579|stage IVB thymoma|stage ivb thymoma
452618|NCT00020605|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
452619|NCT00020605|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
452620|NCT00020618|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
452621|NCT00020618|pain|pain
452622|NCT00020631|radiation fibrosis|radiation fibrosis
753020|NCT01175148|atorvastatin|atorvastatin
452623|NCT00020644|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
452624|NCT00020657|nausea and vomiting|nausea and vomiting
452625|NCT00020657|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
452626|NCT00020670|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
452627|NCT00020670|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
452628|NCT00020670|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
452629|NCT00020670|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
452630|NCT00020696|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
452631|NCT00020696|primary peritoneal cavity cancer|primary peritoneal cavity cancer
452632|NCT00020722|stage IV breast cancer|stage iv breast cancer
452633|NCT00020722|recurrent breast cancer|recurrent breast cancer
452634|NCT00020735|adenocarcinoma of the prostate|adenocarcinoma of the prostate
452635|NCT00020735|stage I prostate cancer|stage i prostate cancer
452636|NCT00020735|stage II prostate cancer|stage ii prostate cancer
452637|NCT00020748|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
452639|NCT00020761|recurrent gastric cancer|recurrent gastric cancer
452640|NCT00020761|stage IV esophageal cancer|stage iv esophageal cancer
452641|NCT00020761|recurrent esophageal cancer|recurrent esophageal cancer
452642|NCT00020761|adenocarcinoma of the stomach|adenocarcinoma of the stomach
452643|NCT00020761|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
452644|NCT00020774|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
452645|NCT00020774|recurrent adult primary liver cancer|recurrent adult primary liver cancer
452646|NCT00020774|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
452864|NCT00009763|stage IV breast cancer|stage iv breast cancer
452647|NCT00020774|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
452648|NCT00020787|stage IV gastric cancer|stage iv gastric cancer
452649|NCT00020787|recurrent gastric cancer|recurrent gastric cancer
452650|NCT00020787|stage IV esophageal cancer|stage iv esophageal cancer
452651|NCT00020787|recurrent esophageal cancer|recurrent esophageal cancer
452652|NCT00020787|adenocarcinoma of the stomach|adenocarcinoma of the stomach
452653|NCT00020787|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
452654|NCT00020800|Waldenström macroglobulinemia|waldenström macroglobulinemia
12560|NCT03210506|Pegylated Interferon α-2a|pegylated interferon α-2a
452655|NCT00020826|adenocarcinoma of the stomach|adenocarcinoma of the stomach
452656|NCT00020839|stage IV melanoma|stage iv melanoma
452657|NCT00020839|recurrent melanoma|recurrent melanoma
452658|NCT00020839|tumors metastatic to brain|tumors metastatic to brain
452659|NCT00020852|stage I breast cancer|stage i breast cancer
452660|NCT00020852|stage II breast cancer|stage ii breast cancer
452661|NCT00020865|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
452662|NCT00020865|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
452663|NCT00020865|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
452664|NCT00020865|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
452665|NCT00020865|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
452666|NCT00020865|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
452667|NCT00020865|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
452668|NCT00020865|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
452669|NCT00020865|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
452670|NCT00020865|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
452671|NCT00020865|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
452672|NCT00020865|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
452673|NCT00020865|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
452674|NCT00020865|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
452675|NCT00020865|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
452676|NCT00020865|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
452677|NCT00020865|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
452678|NCT00020865|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
452679|NCT00020865|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
452680|NCT00020865|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
452681|NCT00020865|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
452682|NCT00020865|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
452683|NCT00020865|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
452684|NCT00020865|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
452685|NCT00020865|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
452686|NCT00020865|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
452687|NCT00020865|fever, sweats, and hot flashes|fever, sweats, and hot flashes
452688|NCT00020865|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
452129|NCT00019994|stage IV melanoma|stage iv melanoma
452689|NCT00020865|refractory hairy cell leukemia|refractory hairy cell leukemia
452690|NCT00020865|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
452691|NCT00020865|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
452692|NCT00020865|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
452693|NCT00020865|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
452694|NCT00020865|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
452695|NCT00020865|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
452696|NCT00020865|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
452697|NCT00020865|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
452698|NCT00020865|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
452699|NCT00020865|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
452700|NCT00020865|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
452701|NCT00020865|acute undifferentiated leukemia|acute undifferentiated leukemia
452702|NCT00020865|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
452703|NCT00020865|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
452704|NCT00020865|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
452705|NCT00020865|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
452706|NCT00020865|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
452707|NCT00020865|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
452708|NCT00020865|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
452709|NCT00020865|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
452710|NCT00020865|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
452711|NCT00020865|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
452712|NCT00020865|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
452713|NCT00020865|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
452714|NCT00020865|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
452715|NCT00020865|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
474664|NCT00084292|Pediatric|pediatric
452716|NCT00020865|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
452717|NCT00020865|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
452718|NCT00020865|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
452719|NCT00020865|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
452720|NCT00020865|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
452721|NCT00020865|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
452722|NCT00020865|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
452723|NCT00020865|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
452724|NCT00020865|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
452725|NCT00020865|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
452726|NCT00020865|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
452727|NCT00020865|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
452728|NCT00020865|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
452729|NCT00020865|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
452730|NCT00020865|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
452731|NCT00020865|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
452732|NCT00020865|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
452733|NCT00020865|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
452734|NCT00020865|secondary acute myeloid leukemia|secondary acute myeloid leukemia
583594|NCT00512330|childhood|childhood
452735|NCT00020865|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
452736|NCT00020865|neutropenia|neutropenia
452737|NCT00020865|infection|infection
452738|NCT00020865|prolymphocytic leukemia|prolymphocytic leukemia
452739|NCT00020865|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
452740|NCT00020865|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
452741|NCT00020865|intraocular lymphoma|intraocular lymphoma
452742|NCT00020865|stage I mantle cell lymphoma|stage i mantle cell lymphoma
452743|NCT00020865|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
452744|NCT00020865|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
452745|NCT00020865|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
452746|NCT00020865|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
452747|NCT00020865|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
452748|NCT00020865|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
753021|NCT01175148|HMG-CoA Reductase Inhibitor|hmg-coa reductase inhibitor
452749|NCT00020865|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
452750|NCT00020865|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
452751|NCT00020865|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
452752|NCT00020865|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
452753|NCT00020865|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
452754|NCT00020865|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
452755|NCT00020865|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
452756|NCT00020865|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
452757|NCT00020865|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
452758|NCT00020865|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
452759|NCT00020865|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
452760|NCT00020865|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
452761|NCT00020865|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
452762|NCT00020865|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
452763|NCT00020865|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
452764|NCT00020865|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
452765|NCT00020865|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
452766|NCT00020865|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
452767|NCT00020865|anaplastic large cell lymphoma|anaplastic large cell lymphoma
452768|NCT00020865|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
452769|NCT00020865|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
452770|NCT00020865|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
452771|NCT00020865|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
452772|NCT00020865|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
452773|NCT00020865|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
452774|NCT00020865|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
452865|NCT00009763|recurrent breast cancer|recurrent breast cancer
452775|NCT00020865|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
452776|NCT00020865|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
452777|NCT00020865|stage I marginal zone lymphoma|stage i marginal zone lymphoma
452778|NCT00020865|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
452779|NCT00020865|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
452780|NCT00020865|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
452781|NCT00020865|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
452782|NCT00020865|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
452783|NCT00020865|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
452784|NCT00020865|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
452785|NCT00020865|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
452786|NCT00020865|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
452787|NCT00020865|splenic marginal zone lymphoma|splenic marginal zone lymphoma
452789|NCT00009542|Cytochrome P 450|cytochrome p 450
452790|NCT00009542|Dextromethorphan|dextromethorphan
452791|NCT00009542|Herbal|herbal
452792|NCT00009542|Interactions|interactions
452793|NCT00009542|Alternative Therapy|alternative therapy
452794|NCT00009542|Healthy Volunteer|healthy volunteer
452795|NCT00009542|Kava|kava
452796|NCT00009555|Testosterone|testosterone
452797|NCT00009555|Anthropometry|anthropometry
452798|NCT00009555|Obesity|obesity
452799|NCT00009555|Abdomen|abdomen
452800|NCT00009568|Antidepressants|antidepressants
452801|NCT00009568|Platelet Function|platelet function
452802|NCT00009568|SSRI|ssri
452803|NCT00009568|Depression|depression
452804|NCT00009568|Bleeding Time|bleeding time
452805|NCT00009581|Endothelial Function|endothelial function
452806|NCT00009581|Hydroxyurea|hydroxyurea
452807|NCT00009581|Leukocyte Gene Expression|leukocyte gene expression
452808|NCT00009581|Nitrosylated Hemoglobin|nitrosylated hemoglobin
452809|NCT00009581|Sickle Cell Anemia|sickle cell anemia
452810|NCT00009581|Nitric Oxide|nitric oxide
452811|NCT00009620|NICHD Neonatal Research Network|nichd neonatal research network
452812|NCT00009620|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
452813|NCT00009620|Prematurity|prematurity
452814|NCT00009620|Cerebral hemorrhage|cerebral hemorrhage
452815|NCT00009620|Phenobarbital|phenobarbital
452816|NCT00009620|Pregnancy|pregnancy
452817|NCT00009620|Prenatal care|prenatal care
452818|NCT00009620|Intraventricular hemorrhage|intraventricular hemorrhage
452819|NCT00009620|Periventricular leukomalacia|periventricular leukomalacia
452820|NCT00009620|Brain injury|brain injury
452821|NCT00009620|Brain hemorrhage|brain hemorrhage
452822|NCT00009633|NICHD Neonatal Research Network|nichd neonatal research network
452823|NCT00009633|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
452824|NCT00009633|Prematurity|prematurity
452825|NCT00009633|Neurodevelopmental Outcome|neurodevelopmental outcome
452826|NCT00009633|Follow up studies|follow up studies
452827|NCT00009646|Chronic lung disease|chronic lung disease
452828|NCT00009646|Indocin|indocin
452829|NCT00009646|Indomethacin|indomethacin
452830|NCT00009646|Infants, very low birth weight|infants, very low birth weight
452831|NCT00009646|Intraventricular hemorrhage|intraventricular hemorrhage
452832|NCT00009646|Necrotizing enterocolitis|necrotizing enterocolitis
452833|NCT00009646|Patent ductus arteriosus|patent ductus arteriosus
452834|NCT00009646|Pulmonary hemorrhage|pulmonary hemorrhage
452835|NCT00009659|Endometrium|endometrium
452836|NCT00009659|Estrogen|estrogen
452837|NCT00009659|Antihormone|antihormone
452838|NCT00009659|Menopause|menopause
452839|NCT00009659|Progesterone|progesterone
452840|NCT00009659|Postmenopausal Women|postmenopausal women
452841|NCT00009659|Hormone Replacement|hormone replacement
452842|NCT00009672|Low Back Pain|low back pain
452843|NCT00009672|Opioid|opioid
452844|NCT00009672|Antidepressant|antidepressant
452845|NCT00009672|Randomized Controlled Trial|randomized controlled trial
452846|NCT00009672|Analgesic|analgesic
452847|NCT00009672|Sciatica|sciatica
452848|NCT00009685|Vaccine|vaccine
452849|NCT00009685|HIV|hiv
452850|NCT00009685|Codon-Optimized|codon-optimized
452851|NCT00009685|HIV Vaccine|hiv vaccine
452852|NCT00009685|Healthy Volunteer|healthy volunteer
452853|NCT00009685|HIV-1 DNA Vaccine|hiv-1 dna vaccine
452854|NCT00009685|HIV Seronegativity|hiv seronegativity
452855|NCT00009685|HIV Preventive Vaccine|hiv preventive vaccine
452856|NCT00009698|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
452857|NCT00009698|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
452858|NCT00009698|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
452859|NCT00009698|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
452860|NCT00009711|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
452861|NCT00009711|pulmonary complications|pulmonary complications
452862|NCT00009750|stage IV prostate cancer|stage iv prostate cancer
470874|NCT00073008|Her-2/neu|her-2/neu
452866|NCT00009776|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
474665|NCT00084292|Etiology|etiology
452867|NCT00009776|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
452868|NCT00009776|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
452869|NCT00009776|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
452870|NCT00009776|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
452871|NCT00009776|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
452872|NCT00009776|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
452873|NCT00009776|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
452874|NCT00009776|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
452875|NCT00009776|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
452876|NCT00009776|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
452877|NCT00009776|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
452878|NCT00009776|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
452879|NCT00009776|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
452880|NCT00009776|splenic marginal zone lymphoma|splenic marginal zone lymphoma
452881|NCT00009789|stage I non-small cell lung cancer|stage i non-small cell lung cancer
452882|NCT00009789|squamous cell lung cancer|squamous cell lung cancer
452883|NCT00009789|large cell lung cancer|large cell lung cancer
452884|NCT00009789|adenocarcinoma of the lung|adenocarcinoma of the lung
452885|NCT00009789|adenosquamous cell lung cancer|adenosquamous cell lung cancer
452886|NCT00009789|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
452887|NCT00009802|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
452888|NCT00009815|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
452889|NCT00009828|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
452890|NCT00009841|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
452891|NCT00009841|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
452892|NCT00009841|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
452893|NCT00009841|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
452894|NCT00009841|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
753022|NCT01175148|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
452353|NCT00020475|cancer|cancer
452895|NCT00009841|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
452896|NCT00009841|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
452897|NCT00009841|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
452898|NCT00009841|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
452899|NCT00009841|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
452900|NCT00009841|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
452901|NCT00009841|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
452902|NCT00009841|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
452903|NCT00009841|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
452904|NCT00009841|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
452906|NCT00009854|tumors metastatic to brain|tumors metastatic to brain
452907|NCT00009854|adult anaplastic astrocytoma|adult anaplastic astrocytoma
452908|NCT00009854|adult anaplastic ependymoma|adult anaplastic ependymoma
452909|NCT00009854|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
452910|NCT00009854|adult giant cell glioblastoma|adult giant cell glioblastoma
452911|NCT00009854|adult gliosarcoma|adult gliosarcoma
452912|NCT00009880|stage I gastric cancer|stage i gastric cancer
452913|NCT00009880|stage II gastric cancer|stage ii gastric cancer
452914|NCT00009880|stage III gastric cancer|stage iii gastric cancer
452915|NCT00009880|stage I esophageal cancer|stage i esophageal cancer
452916|NCT00009880|stage II esophageal cancer|stage ii esophageal cancer
452917|NCT00009880|stage III esophageal cancer|stage iii esophageal cancer
452918|NCT00009880|adenocarcinoma of the stomach|adenocarcinoma of the stomach
452919|NCT00009880|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
452920|NCT00009880|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
452921|NCT00009893|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
452922|NCT00009893|advanced adult primary liver cancer|advanced adult primary liver cancer
452923|NCT00009893|recurrent adult primary liver cancer|recurrent adult primary liver cancer
452924|NCT00009893|unresectable gallbladder cancer|unresectable gallbladder cancer
452925|NCT00009893|recurrent gallbladder cancer|recurrent gallbladder cancer
452926|NCT00009893|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
452927|NCT00009893|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
452928|NCT00009932|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
474747|NCT00077961|CAMPATH|campath
452929|NCT00009945|stage I breast cancer|stage i breast cancer
452930|NCT00009945|stage II breast cancer|stage ii breast cancer
452931|NCT00011583|Cerebrovascular|cerebrovascular
452932|NCT00011583|Hemiplegia|hemiplegia
452933|NCT00011583|Robotics|robotics
452934|NCT00011596|Hemiplegia, gait, electric stimulation|hemiplegia, gait, electric stimulation
452935|NCT00011609|Robotics; Activities of Daily Living; Spinal Cord Injuries|robotics; activities of daily living; spinal cord injuries
452936|NCT00011635|Caffeine|caffeine
452937|NCT00011635|Cytochrome P 450|cytochrome p 450
452938|NCT00011635|Dextromethorphan|dextromethorphan
452939|NCT00011635|Drug Interaction|drug interaction
452940|NCT00011635|Metabolism|metabolism
452941|NCT00011635|Drug Metabolism|drug metabolism
452942|NCT00011635|Healthy Volunteer|healthy volunteer
452943|NCT00011635|Milk Thistle|milk thistle
452944|NCT00011648|Echocardiogram|echocardiogram
452945|NCT00011648|Morbidity|morbidity
452946|NCT00011648|Mortality|mortality
452947|NCT00011648|Sickle Cell Anemia|sickle cell anemia
452948|NCT00011648|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
452949|NCT00011661|Lead poisoning|lead poisoning
452950|NCT00011661|Native Americans|native americans
452951|NCT00011674|Lead|lead
452952|NCT00011674|Prenatal|prenatal
452953|NCT00011674|Development|development
452954|NCT00011674|Children|children
452955|NCT00011674|Psychology|psychology
452956|NCT00011674|Toxicology|toxicology
452957|NCT00011674|Teratology|teratology
452958|NCT00011687|Fertility|fertility
452959|NCT00011687|Hormones|hormones
452960|NCT00011687|Semen|semen
452961|NCT00011687|Reproductive Health|reproductive health
452962|NCT00011700|idiopathic pulmonary hemorrhage in infants,|idiopathic pulmonary hemorrhage in infants,
452963|NCT00011700|toxigenic mold exposure|toxigenic mold exposure
452964|NCT00011713|Semen|semen
452965|NCT00011713|Infertility|infertility
452966|NCT00011713|ART - Assisted Reproduction Technology|art - assisted reproduction technology
452967|NCT00011713|Phthalates|phthalates
452968|NCT00011713|Bisphenol A|bisphenol a
452969|NCT00011726|Pregnancy|pregnancy
452970|NCT00011726|Lead Exposure|lead exposure
452971|NCT00011726|Lactation|lactation
452972|NCT00011726|Bone Mineralization|bone mineralization
452973|NCT00011726|Maternal-Fetal Exchange|maternal-fetal exchange
753023|NCT01175148|allogeneic transplant|allogeneic transplant
201022|NCT02112604|critically ill, OSA, mechanical ventilation|critically ill, osa, mechanical ventilation
452974|NCT00011739|Low back pain, Magnetic resonance imaging (MRI),|low back pain, magnetic resonance imaging (mri),
452975|NCT00011752|Serotonin Reuptake|serotonin reuptake
452976|NCT00011752|Large Neutral Amino Acids|large neutral amino acids
452977|NCT00011752|5-Hydroxyindoleacetic Acid|5-hydroxyindoleacetic acid
452978|NCT00011752|Alcoholism|alcoholism
452979|NCT00011752|PET|pet
452980|NCT00011752|TRP|trp
452981|NCT00011752|Tryptophan Depletion|tryptophan depletion
452982|NCT00011752|Healthy Volunteer|healthy volunteer
452983|NCT00011765|Aggression|aggression
452984|NCT00011765|Serotonin Reuptake Inhibitors (SSRI)|serotonin reuptake inhibitors (ssri)
452985|NCT00011765|Rage|rage
452986|NCT00011765|Fear|fear
452987|NCT00011765|Violence|violence
452988|NCT00011765|Domestic Violence|domestic violence
452989|NCT00011765|Physical Aggression|physical aggression
452990|NCT00011765|Serotonin Reuptake Inhibitor|serotonin reuptake inhibitor
452991|NCT00011778|Cell Cycle|cell cycle
452992|NCT00011778|NFKB|nfkb
452993|NCT00011778|Combined Modality|combined modality
452994|NCT00011778|Radiosensitizer|radiosensitizer
452995|NCT00011778|Ubiquitin|ubiquitin
452996|NCT00011778|Head and Neck Cancer|head and neck cancer
452997|NCT00011778|Squamous Cell Carcinoma|squamous cell carcinoma
452998|NCT00011778|Radiation Therapy|radiation therapy
452999|NCT00011778|Protease Inhibitor|protease inhibitor
453000|NCT00011791|CAH|cah
453001|NCT00011791|Catecholamines|catecholamines
453002|NCT00011791|Adrenal Medulla|adrenal medulla
453003|NCT00011791|Endocrine|endocrine
453004|NCT00011791|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
453005|NCT00011791|Exercise|exercise
453006|NCT00011791|Healthy Volunteer|healthy volunteer
453007|NCT00011804|Low Back Pain|low back pain
453008|NCT00011804|Lumbar Radiculopathy|lumbar radiculopathy
453009|NCT00011804|Anticonvulsants|anticonvulsants
453010|NCT00011804|Neuropathic Pain|neuropathic pain
453011|NCT00011804|Analgesia|analgesia
453012|NCT00011804|Sciatica|sciatica
453013|NCT00011817|Evaluation and Treatment|evaluation and treatment
453014|NCT00011817|Ophthalmic Genetic Diseases|ophthalmic genetic diseases
453015|NCT00011817|Genetic Testing|genetic testing
453016|NCT00011817|Genetic Eye Diseases|genetic eye diseases
453017|NCT00011817|Evaluation|evaluation
453018|NCT00011830|Stem Cell Cryopreservation|stem cell cryopreservation
453019|NCT00011830|Leukapheresis|leukapheresis
453020|NCT00011843|X-Linked|x-linked
453021|NCT00011843|Heterogeneous|heterogeneous
453022|NCT00011843|Embryologic Development|embryologic development
453023|NCT00011843|Mental Retardation|mental retardation
453024|NCT00011843|Brain Development|brain development
453025|NCT00011843|Microphthalmia|microphthalmia
453026|NCT00011843|Anophthalmia|anophthalmia
453027|NCT00011843|Malformations|malformations
453028|NCT00011843|Lenz Dysplasia|lenz dysplasia
470977|NCT00073580|CABG|cabg
453029|NCT00011843|Microphthalmia/Anophthalmia|microphthalmia/anophthalmia
453030|NCT00011843|Mutation Screening|mutation screening
453031|NCT00011843|Gene Characterization|gene characterization
453032|NCT00011856|Intracranial Aneurysms|intracranial aneurysms
453033|NCT00011856|Cerebral|cerebral
453034|NCT00011856|Loci|loci
453035|NCT00011856|Susceptibility Genes|susceptibility genes
453036|NCT00011856|Cerebral Aneurysm|cerebral aneurysm
453037|NCT00011856|Familial Cerebral Aneurysm|familial cerebral aneurysm
453039|NCT00011895|HIV-1|hiv-1
453040|NCT00011895|Drug Therapy, Combination|drug therapy, combination
453041|NCT00011895|Zidovudine|zidovudine
453042|NCT00011895|Lamivudine|lamivudine
453043|NCT00011895|Drug Combinations|drug combinations
453044|NCT00011895|RNA, Viral|rna, viral
453045|NCT00011895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
453046|NCT00011895|Anti-HIV Agents|anti-hiv agents
453047|NCT00011895|Viral Load|viral load
453048|NCT00011895|abacavir|abacavir
453049|NCT00011895|efavirenz|efavirenz
453050|NCT00011908|Safety|safety
453051|NCT00011908|B-Lymphocyte Depletion|b-lymphocyte depletion
453052|NCT00011908|Anti-CD22|anti-cd22
453053|NCT00011908|Response|response
453054|NCT00011908|Efficacy|efficacy
453055|NCT00011908|Lupus|lupus
453056|NCT00011908|Immunotherapy|immunotherapy
453057|NCT00011921|limited stage small cell lung cancer|limited stage small cell lung cancer
453058|NCT00011921|extensive stage small cell lung cancer|extensive stage small cell lung cancer
453059|NCT00011934|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
453060|NCT00011934|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
453061|NCT00011934|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
453062|NCT00011934|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
453063|NCT00011960|stage I gastric cancer|stage i gastric cancer
453064|NCT00011960|stage II gastric cancer|stage ii gastric cancer
453065|NCT00011960|stage III gastric cancer|stage iii gastric cancer
453066|NCT00011960|stage I esophageal cancer|stage i esophageal cancer
453067|NCT00011960|stage II esophageal cancer|stage ii esophageal cancer
453068|NCT00011960|stage III esophageal cancer|stage iii esophageal cancer
453069|NCT00011960|adenocarcinoma of the stomach|adenocarcinoma of the stomach
453070|NCT00011960|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
453071|NCT00011973|stage III renal cell cancer|stage iii renal cell cancer
453072|NCT00011973|stage IV renal cell cancer|stage iv renal cell cancer
453073|NCT00011973|recurrent renal cell cancer|recurrent renal cell cancer
453074|NCT00011999|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
453075|NCT00011999|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
453076|NCT00011999|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
453077|NCT00011999|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
453078|NCT00011999|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
453079|NCT00011999|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
453080|NCT00011999|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
453081|NCT00011999|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
453082|NCT00012012|radiation toxicity|radiation toxicity
453083|NCT00012012|stage III cervical cancer|stage iii cervical cancer
453084|NCT00012012|stage IVA cervical cancer|stage iva cervical cancer
453085|NCT00012012|cervical squamous cell carcinoma|cervical squamous cell carcinoma
453086|NCT00012012|cervical adenocarcinoma|cervical adenocarcinoma
453087|NCT00012012|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
453088|NCT00012025|stage IV breast cancer|stage iv breast cancer
453089|NCT00012025|recurrent breast cancer|recurrent breast cancer
453090|NCT00012025|stage IIIB breast cancer|stage iiib breast cancer
453091|NCT00012025|stage IIIC breast cancer|stage iiic breast cancer
453092|NCT00012038|recurrent adult brain tumor|recurrent adult brain tumor
453093|NCT00012038|adult glioblastoma|adult glioblastoma
453094|NCT00012038|adult anaplastic astrocytoma|adult anaplastic astrocytoma
453095|NCT00012038|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
453096|NCT00012038|adult giant cell glioblastoma|adult giant cell glioblastoma
453097|NCT00012038|adult gliosarcoma|adult gliosarcoma
453098|NCT00012051|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
453099|NCT00012051|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
453100|NCT00012064|stage IV melanoma|stage iv melanoma
453101|NCT00012064|recurrent melanoma|recurrent melanoma
453102|NCT00012090|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
453103|NCT00012090|fallopian tube cancer|fallopian tube cancer
453104|NCT00012090|primary peritoneal cavity cancer|primary peritoneal cavity cancer
453105|NCT00012103|non-small cell lung cancer|non-small cell lung cancer
453106|NCT00012103|small cell lung cancer|small cell lung cancer
453107|NCT00012116|tumors metastatic to brain|tumors metastatic to brain
453108|NCT00012129|stage IV breast cancer|stage iv breast cancer
471325|NCT00067275|Stroke|stroke
453109|NCT00012129|stage IIIA breast cancer|stage iiia breast cancer
453110|NCT00012129|recurrent breast cancer|recurrent breast cancer
453111|NCT00012129|stage IIIB breast cancer|stage iiib breast cancer
453112|NCT00012129|male breast cancer|male breast cancer
453113|NCT00012142|stage IV prostate cancer|stage iv prostate cancer
453114|NCT00012155|stage IV colon cancer|stage iv colon cancer
453115|NCT00012155|recurrent colon cancer|recurrent colon cancer
453116|NCT00012155|adenocarcinoma of the colon|adenocarcinoma of the colon
453117|NCT00012155|liver metastases|liver metastases
453118|NCT00012168|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
453119|NCT00012168|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
453120|NCT00012168|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
453121|NCT00012168|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
453122|NCT00012168|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
453123|NCT00012168|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
453124|NCT00012168|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
583595|NCT00512330|tuberculosis|tuberculosis
453125|NCT00012168|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
453126|NCT00012168|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
453127|NCT00012168|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
453128|NCT00012207|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
453129|NCT00012207|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
453130|NCT00012207|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
453131|NCT00012207|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
453132|NCT00012207|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
753024|NCT01175148|GVHD|gvhd
675916|NCT00878540|metabolism|metabolism
453133|NCT00012207|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
453134|NCT00012207|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
453135|NCT00012220|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
453136|NCT00012220|stage IV pancreatic cancer|stage iv pancreatic cancer
453137|NCT00012246|stage II colon cancer|stage ii colon cancer
453138|NCT00012246|stage III colon cancer|stage iii colon cancer
453139|NCT00012246|stage IV colon cancer|stage iv colon cancer
453140|NCT00012246|stage II gastric cancer|stage ii gastric cancer
453141|NCT00012246|stage III gastric cancer|stage iii gastric cancer
453142|NCT00012246|stage IV gastric cancer|stage iv gastric cancer
453143|NCT00012246|recurrent gastric cancer|recurrent gastric cancer
453144|NCT00012246|stage II pancreatic cancer|stage ii pancreatic cancer
453145|NCT00012246|stage III pancreatic cancer|stage iii pancreatic cancer
453146|NCT00012246|recurrent pancreatic cancer|recurrent pancreatic cancer
453147|NCT00012246|stage II rectal cancer|stage ii rectal cancer
453148|NCT00012246|stage III rectal cancer|stage iii rectal cancer
453149|NCT00012246|stage IV rectal cancer|stage iv rectal cancer
453150|NCT00012246|recurrent colon cancer|recurrent colon cancer
453151|NCT00012246|recurrent rectal cancer|recurrent rectal cancer
453152|NCT00012246|stage II esophageal cancer|stage ii esophageal cancer
453153|NCT00012246|stage III esophageal cancer|stage iii esophageal cancer
453154|NCT00012246|stage IV esophageal cancer|stage iv esophageal cancer
453155|NCT00012246|recurrent esophageal cancer|recurrent esophageal cancer
453156|NCT00012246|adenocarcinoma of the stomach|adenocarcinoma of the stomach
453157|NCT00012246|small intestine adenocarcinoma|small intestine adenocarcinoma
453158|NCT00012246|localized gallbladder cancer|localized gallbladder cancer
453159|NCT00012246|unresectable gallbladder cancer|unresectable gallbladder cancer
453160|NCT00012246|recurrent gallbladder cancer|recurrent gallbladder cancer
453161|NCT00012246|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
453162|NCT00012246|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
453163|NCT00012246|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
453164|NCT00012246|recurrent small intestine cancer|recurrent small intestine cancer
453165|NCT00012246|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
453166|NCT00012246|adenocarcinoma of the colon|adenocarcinoma of the colon
453167|NCT00012246|adenocarcinoma of the rectum|adenocarcinoma of the rectum
453168|NCT00012246|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
453169|NCT00012246|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
453170|NCT00012246|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
453171|NCT00012246|stage IV pancreatic cancer|stage iv pancreatic cancer
453172|NCT00012259|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
453173|NCT00012259|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
453174|NCT00012259|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
453175|NCT00012311|stage IV breast cancer|stage iv breast cancer
453176|NCT00012311|recurrent breast cancer|recurrent breast cancer
453177|NCT00012324|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
474748|NCT00077961|alemtuzumab|alemtuzumab
453178|NCT00012324|advanced adult primary liver cancer|advanced adult primary liver cancer
453179|NCT00012324|recurrent adult primary liver cancer|recurrent adult primary liver cancer
453180|NCT00012324|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
453181|NCT00012337|stage IV renal cell cancer|stage iv renal cell cancer
453182|NCT00012337|recurrent renal cell cancer|recurrent renal cell cancer
453183|NCT00012350|refractory multiple myeloma|refractory multiple myeloma
453184|NCT00012350|stage II multiple myeloma|stage ii multiple myeloma
453185|NCT00012350|stage III multiple myeloma|stage iii multiple myeloma
453186|NCT00012350|plasma cell neoplasm|plasma cell neoplasm
453187|NCT00012363|stage IV gastric cancer|stage iv gastric cancer
453188|NCT00012363|recurrent gastric cancer|recurrent gastric cancer
453189|NCT00012363|stage IV esophageal cancer|stage iv esophageal cancer
453190|NCT00012363|recurrent esophageal cancer|recurrent esophageal cancer
453191|NCT00012363|adenocarcinoma of the stomach|adenocarcinoma of the stomach
453192|NCT00012363|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
453193|NCT00012363|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
453194|NCT00012389|stage IV colon cancer|stage iv colon cancer
453195|NCT00012389|stage IV rectal cancer|stage iv rectal cancer
453196|NCT00012389|recurrent colon cancer|recurrent colon cancer
453197|NCT00012389|recurrent rectal cancer|recurrent rectal cancer
453198|NCT00012428|Cognitive development|cognitive development
453200|NCT00012428|PCBs|pcbs
453201|NCT00012441|Renal Dialysis|renal dialysis
453202|NCT00012454|Transforming Growth Factor-Beta|transforming growth factor-beta
453203|NCT00012454|Stroke|stroke
453204|NCT00012454|Prevention|prevention
453205|NCT00012454|Mucosal Tolerance|mucosal tolerance
453206|NCT00012454|E-selectin|e-selectin
453207|NCT00012467|Interferon-gamma, Recombinant|interferon-gamma, recombinant
453208|NCT00012467|Injections, Subcutaneous|injections, subcutaneous
453209|NCT00012467|Itraconazole|itraconazole
201023|NCT02112591|Stress urinary incontinence|stress urinary incontinence
453210|NCT00012467|Dose-Response Relationship, Drug|dose-response relationship, drug
453211|NCT00012467|Fluconazole|fluconazole
453212|NCT00012467|Flucytosine|flucytosine
453213|NCT00012467|Antifungal Agents|antifungal agents
453214|NCT00012467|Amphotericin B|amphotericin b
453215|NCT00012467|Meningitis, Cryptococcal|meningitis, cryptococcal
453216|NCT00012480|Lead|lead
453217|NCT00012480|Male infertility|male infertility
453218|NCT00012480|Gene expression|gene expression
453219|NCT00012480|Economics, Medical|economics, medical
453220|NCT00012493|Cardiac event|cardiac event
453221|NCT00012493|Heart disease|heart disease
453222|NCT00012493|Particulate Matter|particulate matter
453223|NCT00012519|Dose-Response Relationship, Drug|dose-response relationship, drug
453224|NCT00012519|Drug Therapy, Combination|drug therapy, combination
453225|NCT00012519|HIV Protease Inhibitors|hiv protease inhibitors
453226|NCT00012519|Ritonavir|ritonavir
453227|NCT00012519|Indinavir|indinavir
453228|NCT00012519|Anti-HIV Agents|anti-hiv agents
453229|NCT00012519|Viral Load|viral load
453230|NCT00012519|Pharmacokinetics|pharmacokinetics
453231|NCT00012519|Treatment Experienced|treatment experienced
453232|NCT00012545|Stem Cells|stem cells
453233|NCT00012545|Sickle Cell Disease|sickle cell disease
453234|NCT00012545|Umbilical Cord Blood|umbilical cord blood
453235|NCT00012558|Psychotic Disorders|psychotic disorders
453236|NCT00012558|Mood Disorders|mood disorders
453237|NCT00012558|Manic-Depressive Illness|manic-depressive illness
453238|NCT00012558|Hypomania|hypomania
453239|NCT00012558|Mania|mania
453240|NCT00012558|Mood Stabilizer|mood stabilizer
453241|NCT00012779|Health Care Education|health care education
453242|NCT00012779|Health Care Cost|health care cost
453243|NCT00012844|Musculoskeletal Disorders|musculoskeletal disorders
453244|NCT00012844|Patient Lifting|patient lifting
453245|NCT00012844|Occupational Accidents|occupational accidents
453246|NCT00013026|Congestive Heart Failure|congestive heart failure
453247|NCT00013195|Telephone|telephone
453248|NCT00013260|Case management|case management
453249|NCT00013260|Nurse intervention|nurse intervention
453250|NCT00013273|Venous insufficiency, plethysmography, hypertension|venous insufficiency, plethysmography, hypertension
453251|NCT00013286|Diabetes mellitus, foot ulcer, endothelium|diabetes mellitus, foot ulcer, endothelium
453252|NCT00013299|Foot ulcers, amputation prevention, diabetes, footwear, insoles|foot ulcers, amputation prevention, diabetes, footwear, insoles
453253|NCT00013312|Spinal cord injury, gastrointestinal motility, gastrointestinal transit|spinal cord injury, gastrointestinal motility, gastrointestinal transit
453254|NCT00013325|Spinal cord injury, heart disease, electrocardiography|spinal cord injury, heart disease, electrocardiography
453255|NCT00013338|Spinal cord injury, ambulation, treadmill|spinal cord injury, ambulation, treadmill
453256|NCT00013351|Aging adult, attention, falls, vision|aging adult, attention, falls, vision
453257|NCT00013364|Hearing loss, speech recognition|hearing loss, speech recognition
453258|NCT00013377|Low vision, Driving rehabilitation|low vision, driving rehabilitation
453259|NCT00013390|Auditory, tinnitus|auditory, tinnitus
453260|NCT00013403|Vision, quality of life|vision, quality of life
453261|NCT00013416|Hearing loss, hearing aid, amplification|hearing loss, hearing aid, amplification
453262|NCT00013429|Vision, Opthalmology, blindness, aging|vision, opthalmology, blindness, aging
474749|NCT00078013|AMI|ami
453263|NCT00013442|Aphasia, auditory evoked, aging|aphasia, auditory evoked, aging
453264|NCT00013455|Hearing aid, hearing impaired|hearing aid, hearing impaired
453265|NCT00013468|Hearing loss, ear, steroids, auditory|hearing loss, ear, steroids, auditory
453372|NCT00013663|AIDS Vaccines|aids vaccines
453266|NCT00013481|stroke, hemiparesis, CNS, motor coordination|stroke, hemiparesis, cns, motor coordination
453267|NCT00013494|Hemiplegia|hemiplegia
453269|NCT00013494|Video|video
453270|NCT00013494|F-PAT,Functional Performance|f-pat,functional performance
453271|NCT00013494|digitized videoclips|digitized videoclips
453272|NCT00013507|Frail|frail
453274|NCT00013507|transfer|transfer
453275|NCT00013507|continence|continence
453276|NCT00013507|ambulation|ambulation
453277|NCT00013507|balance|balance
453278|NCT00013507|fall risk|fall risk
453279|NCT00013507|strength,endurance|strength,endurance
453280|NCT00013520|HIV-1|hiv-1
453281|NCT00013520|Didanosine|didanosine
453282|NCT00013520|Drug Therapy, Combination|drug therapy, combination
453283|NCT00013520|Zidovudine|zidovudine
453284|NCT00013520|Nevirapine|nevirapine
453285|NCT00013520|Stavudine|stavudine
453286|NCT00013520|Lamivudine|lamivudine
453287|NCT00013520|RNA, Viral|rna, viral
453288|NCT00013520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
453289|NCT00013520|Anti-HIV Agents|anti-hiv agents
453290|NCT00013520|Viral Load|viral load
453291|NCT00013520|Combivir|combivir
453292|NCT00013520|BMS 232632|bms 232632
453293|NCT00013520|Efavirenz|efavirenz
453294|NCT00013520|Treatment Naive|treatment naive
453295|NCT00013533|Leukemia|leukemia
453296|NCT00013533|Myelodysplastic Syndrome|myelodysplastic syndrome
453297|NCT00013533|Bone Marrow Transplant|bone marrow transplant
453298|NCT00013533|Pediatric Oncology|pediatric oncology
453299|NCT00013533|Lymphoma|lymphoma
453300|NCT00013533|Efficacy|efficacy
453301|NCT00013533|Safety|safety
453302|NCT00013533|Childhood Cancer|childhood cancer
453303|NCT00013546|Osteoporosis|osteoporosis
453304|NCT00013546|Body Composition|body composition
453305|NCT00013546|Estrogen|estrogen
453306|NCT00013546|Androgen|androgen
453307|NCT00013546|Ovarian Failure|ovarian failure
453308|NCT00013546|Turner's Syndrome|turner's syndrome
453309|NCT00013546|Hormone Replacement|hormone replacement
453310|NCT00013546|Turners|turners
453311|NCT00013546|Turner's|turner's
453313|NCT00013559|Sleep Disturbance|sleep disturbance
453314|NCT00013559|Developmental Delay/ MR|developmental delay/ mr
453315|NCT00013559|Deletion 17p11.2|deletion 17p11.2
453316|NCT00013559|Chromosomal Abnormalities|chromosomal abnormalities
453317|NCT00013559|Behavioral Phenotype|behavioral phenotype
453318|NCT00013559|Smith-Magenis Syndrome|smith-magenis syndrome
453319|NCT00013559|Genetics|genetics
453320|NCT00013572|Injections, Intramuscular|injections, intramuscular
453321|NCT00013572|Injections, Intradermal|injections, intradermal
453322|NCT00013572|Injections, Subcutaneous|injections, subcutaneous
453323|NCT00013572|HIV-1|hiv-1
453324|NCT00013572|AIDS Vaccines|aids vaccines
453325|NCT00013572|Dendritic Cells|dendritic cells
453326|NCT00013572|HIV Seronegativity|hiv seronegativity
453327|NCT00013572|Genes, env|genes, env
453328|NCT00013572|Genes, pol|genes, pol
453329|NCT00013572|Genes, gag|genes, gag
453330|NCT00013572|Transfection|transfection
453331|NCT00013572|HIV Preventive Vaccine|hiv preventive vaccine
453332|NCT00013585|Cognitive Disorders|cognitive disorders
453333|NCT00013585|AIDS Dementia Complex|aids dementia complex
453334|NCT00013585|Selegiline|selegiline
453335|NCT00013585|Administration, Cutaneous|administration, cutaneous
453336|NCT00013585|Neuroprotective Agents|neuroprotective agents
453337|NCT00013598|Insulin Resistance|insulin resistance
453338|NCT00013598|Obesity|obesity
453339|NCT00013598|Diabetes|diabetes
453340|NCT00013598|Fatty Liver|fatty liver
453341|NCT00013598|Cirrhosis|cirrhosis
453342|NCT00013598|Thiazolidinediones|thiazolidinediones
453343|NCT00013598|Peroxisome Proliferator-Activated Receptor Gamma|peroxisome proliferator-activated receptor gamma
453344|NCT00013598|PPARgamma|ppargamma
453345|NCT00013598|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
453346|NCT00013598|Pioglitazone|pioglitazone
453347|NCT00013598|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
453348|NCT00013598|Liver Biopsy|liver biopsy
453349|NCT00013598|Pharmacotherapy|pharmacotherapy
453351|NCT00013611|Proleukin|proleukin
453352|NCT00013611|IL-2|il-2
453353|NCT00013611|Adult|adult
453354|NCT00013611|HAART|haart
453355|NCT00013611|Treatment Experienced|treatment experienced
453356|NCT00013624|Riluzole|riluzole
453357|NCT00013624|Dyskinesias|dyskinesias
453358|NCT00013624|L-Dopa Infusion|l-dopa infusion
453359|NCT00013624|Parkinson's Disease|parkinson's disease
453360|NCT00013637|Osteoporosis|osteoporosis
453361|NCT00013637|Lead|lead
453362|NCT00013650|Alzheimer's Disease|alzheimer's disease
453363|NCT00013650|Immunomodulatory|immunomodulatory
453364|NCT00013650|Antiinflammatory|antiinflammatory
453365|NCT00013650|Cyclophosphamide|cyclophosphamide
453366|NCT00013650|Non-steroidal|non-steroidal
453367|NCT00013650|Complement|complement
453368|NCT00013650|Immune Function|immune function
453369|NCT00013650|Immunotherapy|immunotherapy
453370|NCT00013663|Virus Replication|virus replication
453371|NCT00013663|HIV-1|hiv-1
453375|NCT00013663|Genetic Vectors|genetic vectors
453376|NCT00013663|Viral Load|viral load
453377|NCT00013663|aldesleukin|aldesleukin
453378|NCT00013663|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
453380|NCT00013663|Treatment Interruption|treatment interruption
453381|NCT00013689|Lymphadenopathy|lymphadenopathy
453382|NCT00013689|Splenomegaly|splenomegaly
453383|NCT00013689|Children|children
453384|NCT00013689|Tomography|tomography
453385|NCT00013689|Autoimmune Lymphoproliferative Syndrome (ALPS)|autoimmune lymphoproliferative syndrome (alps)
453386|NCT00013702|Immunology|immunology
453387|NCT00013702|Cirrhosis|cirrhosis
453388|NCT00013702|Ascites|ascites
453389|NCT00013702|Open-Label|open-label
453390|NCT00013702|Chronic|chronic
453391|NCT00013702|HIV|hiv
453392|NCT00013702|Hepatitis B|hepatitis b
453393|NCT00013715|Asthma|asthma
453394|NCT00013715|Rhinovirus|rhinovirus
453396|NCT00013728|asthma|asthma
453397|NCT00013728|particulate matter|particulate matter
453398|NCT00013741|Acute Myocardial Infarction|acute myocardial infarction
453399|NCT00013741|Diabetes Mellitus|diabetes mellitus
453400|NCT00013741|Renal Dialysis|renal dialysis
453401|NCT00013741|Heart Attack|heart attack
453402|NCT00013741|Coronary Heart Disease|coronary heart disease
453403|NCT00013754|pesticide|pesticide
453404|NCT00013754|insecticide|insecticide
453405|NCT00013754|organophosphate|organophosphate
453406|NCT00013754|exposure|exposure
453407|NCT00013754|child health|child health
453408|NCT00013767|Pesticide|pesticide
453409|NCT00013767|Insecticide|insecticide
453410|NCT00013767|Organophosphate|organophosphate
453411|NCT00013767|Child Health|child health
453412|NCT00013767|Exposure Prevention|exposure prevention
453413|NCT00013780|ozone uptake|ozone uptake
453414|NCT00013780|inhalation toxicology|inhalation toxicology
453415|NCT00013780|nasal cavities|nasal cavities
453416|NCT00013780|antioxidants|antioxidants
453417|NCT00013806|Relapsed and refractory neuroblastoma|relapsed and refractory neuroblastoma
453418|NCT00013819|lead poisoning|lead poisoning
453419|NCT00013819|central nervous system|central nervous system
453420|NCT00013819|peripheral nervous system|peripheral nervous system
453421|NCT00013819|occupational health|occupational health
453422|NCT00013819|genetic susceptibility|genetic susceptibility
453423|NCT00013832|Pressure|pressure
453424|NCT00013832|Swallowing|swallowing
453425|NCT00013832|Tongue|tongue
453426|NCT00013832|Healthy Volunteer|healthy volunteer
453427|NCT00013832|Dysphagia|dysphagia
453428|NCT00013845|Seizures|seizures
453429|NCT00013845|Anti-Epileptic Drugs|anti-epileptic drugs
453430|NCT00013845|Pharmacotherapy|pharmacotherapy
453431|NCT00013845|Neuropsychology|neuropsychology
453432|NCT00013845|Temporal Lobe Epilepsy|temporal lobe epilepsy
453433|NCT00013845|Frontal Lobe Epilepsy|frontal lobe epilepsy
453434|NCT00013845|Complex Partial Seizures|complex partial seizures
453435|NCT00013845|Grand Mal Seizures|grand mal seizures
453436|NCT00013845|Generalized Seizures|generalized seizures
453437|NCT00013845|Epilepsy|epilepsy
453438|NCT00013858|methylmercury|methylmercury
453439|NCT00013858|PCBs|pcbs
453440|NCT00013858|lead|lead
453441|NCT00013858|fish consumption|fish consumption
453442|NCT00013858|breast-feeding|breast-feeding
453443|NCT00013871|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
453444|NCT00013871|Antibodies, Viral|antibodies, viral
453445|NCT00013871|Hepatitis B Vaccines|hepatitis b vaccines
453446|NCT00013871|Immunization, Secondary|immunization, secondary
453447|NCT00013871|Pneumococcal Vaccines|pneumococcal vaccines
453448|NCT00013871|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
453449|NCT00013871|Diphtheria-Tetanus-acellular Pertussis Vaccines|diphtheria-tetanus-acellular pertussis vaccines
453450|NCT00013884|HIV|hiv
453451|NCT00013884|T20|t20
453452|NCT00013884|HAART|haart
453453|NCT00013884|Interruption|interruption
453454|NCT00013884|Therapy|therapy
453455|NCT00013884|Fusion Inhibitor T20|fusion inhibitor t20
453456|NCT00013884|Treatment Interuption|treatment interuption
453457|NCT00013897|Placebos|placebos
453458|NCT00013897|Drug Therapy, Combination|drug therapy, combination
453459|NCT00013897|Zidovudine|zidovudine
453460|NCT00013897|HIV Protease Inhibitors|hiv protease inhibitors
453461|NCT00013897|Lamivudine|lamivudine
453462|NCT00013897|RNA, Viral|rna, viral
453463|NCT00013897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
453464|NCT00013897|Anti-HIV Agents|anti-hiv agents
453465|NCT00013897|Viral Load|viral load
453466|NCT00013897|BMS 232632|bms 232632
453467|NCT00013897|efavirenz|efavirenz
453468|NCT00013910|glucagon-like peptide 1|glucagon-like peptide 1
453469|NCT00013923|Nutritional Supplement|nutritional supplement
453470|NCT00013936|Instrument Development|instrument development
453471|NCT00013936|Psychophysical Methods|psychophysical methods
453472|NCT00013936|ETDRS|etdrs
453473|NCT00013936|Computer-Based Methods|computer-based methods
453474|NCT00013936|Validation Study|validation study
453475|NCT00013936|Visual Acuity|visual acuity
453563|NCT00014196|adenocarcinoma of the lung|adenocarcinoma of the lung
453476|NCT00013936|Vision Tests/Instrumentation|vision tests/instrumentation
453477|NCT00013936|Psychophysics|psychophysics
453478|NCT00013936|Modified Binary Search|modified binary search
453479|NCT00013936|Visual Acuity Test|visual acuity test
453480|NCT00013949|Holter monitoring|holter monitoring
453483|NCT00013949|particulate exposure|particulate exposure
453484|NCT00013975|Framingham Risk Scoring|framingham risk scoring
453485|NCT00013975|Brachial Artery Reactivity|brachial artery reactivity
453486|NCT00013975|EPC Colony Assay|epc colony assay
453487|NCT00013975|Healthy Volunteer|healthy volunteer
453488|NCT00013975|Atherosclerosis Risk Factors|atherosclerosis risk factors
453489|NCT00013975|Cholesterol|cholesterol
453490|NCT00013975|Hypertension|hypertension
453491|NCT00013975|Smoking|smoking
453492|NCT00013975|Diabetes|diabetes
453493|NCT00013975|Postmenopausal|postmenopausal
453494|NCT00013975|Heart Disease Risk Factors|heart disease risk factors
453495|NCT00013975|Risk Factors|risk factors
453496|NCT00014001|Antipsychotic Treatment|antipsychotic treatment
453497|NCT00014001|Effectiveness|effectiveness
453498|NCT00014014|Zidovudine|zidovudine
453499|NCT00014014|Phosphorylation|phosphorylation
453500|NCT00014014|Drug Administration Schedule|drug administration schedule
453501|NCT00014014|Lamivudine|lamivudine
453502|NCT00014014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
453503|NCT00014014|Anti-HIV Agents|anti-hiv agents
453504|NCT00014014|Pharmacokinetics|pharmacokinetics
453505|NCT00014014|Combivir|combivir
453506|NCT00014027|Omega-3 Fatty Acids|omega-3 fatty acids
453507|NCT00014027|Cerebrospinal Fluid|cerebrospinal fluid
453508|NCT00014027|Neurotransmitters|neurotransmitters
453509|NCT00014027|Cardiovascular|cardiovascular
453510|NCT00014027|Reactivity|reactivity
453511|NCT00014027|Healthy Volunteer|healthy volunteer
453512|NCT00014027|Lumbar Puncture|lumbar puncture
453513|NCT00014027|MRI|mri
453514|NCT00014040|Angina Pectoris|angina pectoris
453515|NCT00014040|Endothelium|endothelium
453516|NCT00014040|Platelets|platelets
453517|NCT00014040|Inflammation|inflammation
453518|NCT00014040|Atherosclerosis|atherosclerosis
453519|NCT00014040|Coronary Artery Disease|coronary artery disease
453520|NCT00014040|Chest Pain|chest pain
453521|NCT00014040|Nitrous Oxide Inhalation|nitrous oxide inhalation
453522|NCT00014040|Treadmill Exercise|treadmill exercise
453523|NCT00014053|Reference Values|reference values
453524|NCT00014053|HIV Seropositivity|hiv seropositivity
453525|NCT00014053|Immune System|immune system
453526|NCT00014053|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
453527|NCT00014053|HIV Seronegativity|hiv seronegativity
453528|NCT00014053|Antigens, CD|antigens, cd
453529|NCT00014066|stage I non-small cell lung cancer|stage i non-small cell lung cancer
453530|NCT00014066|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
453531|NCT00014066|limited stage small cell lung cancer|limited stage small cell lung cancer
453532|NCT00014066|recurrent small cell lung cancer|recurrent small cell lung cancer
453533|NCT00014066|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
453534|NCT00014079|colon cancer|colon cancer
453535|NCT00014079|rectal cancer|rectal cancer
453536|NCT00014092|stage IV melanoma|stage iv melanoma
453537|NCT00014092|recurrent melanoma|recurrent melanoma
453538|NCT00014105|recurrent adult brain tumor|recurrent adult brain tumor
453539|NCT00014105|adult glioblastoma|adult glioblastoma
453540|NCT00014105|adult giant cell glioblastoma|adult giant cell glioblastoma
453541|NCT00014105|adult gliosarcoma|adult gliosarcoma
453542|NCT00014118|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
453543|NCT00014118|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
453544|NCT00014118|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
453545|NCT00014118|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
453546|NCT00014131|stage III renal cell cancer|stage iii renal cell cancer
453547|NCT00014131|stage IV renal cell cancer|stage iv renal cell cancer
453548|NCT00014131|recurrent renal cell cancer|recurrent renal cell cancer
453549|NCT00014144|recurrent bladder cancer|recurrent bladder cancer
453550|NCT00014144|stage IV bladder cancer|stage iv bladder cancer
453551|NCT00014144|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
453552|NCT00014144|recurrent urethral cancer|recurrent urethral cancer
453553|NCT00014144|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
453554|NCT00014144|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
453555|NCT00014144|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
453556|NCT00014144|anterior urethral cancer|anterior urethral cancer
453557|NCT00014144|posterior urethral cancer|posterior urethral cancer
453558|NCT00014183|stage IV renal cell cancer|stage iv renal cell cancer
453559|NCT00014183|recurrent renal cell cancer|recurrent renal cell cancer
453560|NCT00014196|squamous cell lung cancer|squamous cell lung cancer
453561|NCT00014196|large cell lung cancer|large cell lung cancer
453835|NCT00024570|catheter, stereotaxic|catheter, stereotaxic
453562|NCT00014196|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
453564|NCT00014209|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
453565|NCT00014209|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
453566|NCT00014209|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
453567|NCT00014209|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
453568|NCT00014209|anaplastic large cell lymphoma|anaplastic large cell lymphoma
453569|NCT00014222|stage I breast cancer|stage i breast cancer
453570|NCT00014222|stage II breast cancer|stage ii breast cancer
453571|NCT00014222|stage IIIA breast cancer|stage iiia breast cancer
453572|NCT00014222|stage IIIB breast cancer|stage iiib breast cancer
453573|NCT00020878|non-small cell lung cancer|non-small cell lung cancer
453574|NCT00020891|stage I prostate cancer|stage i prostate cancer
453575|NCT00020891|stage IIB prostate cancer|stage iib prostate cancer
453576|NCT00020891|stage IIA prostate cancer|stage iia prostate cancer
453577|NCT00020891|stage III prostate cancer|stage iii prostate cancer
453578|NCT00020891|stage IV prostate cancer|stage iv prostate cancer
453579|NCT00020891|recurrent prostate cancer|recurrent prostate cancer
453580|NCT00020904|stage IV breast cancer|stage iv breast cancer
453581|NCT00020904|recurrent breast cancer|recurrent breast cancer
453582|NCT00020917|stage IV colon cancer|stage iv colon cancer
453583|NCT00020917|stage IV rectal cancer|stage iv rectal cancer
453584|NCT00020930|stage IV colon cancer|stage iv colon cancer
453585|NCT00020930|stage IV rectal cancer|stage iv rectal cancer
453586|NCT00020930|recurrent colon cancer|recurrent colon cancer
453587|NCT00020930|recurrent rectal cancer|recurrent rectal cancer
453588|NCT00020943|stage I mantle cell lymphoma|stage i mantle cell lymphoma
453589|NCT00020943|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
453590|NCT00020943|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
453591|NCT00020943|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
453592|NCT00020943|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
453593|NCT00020969|refractory anemia|refractory anemia
453594|NCT00020969|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
453595|NCT00020969|refractory anemia with excess blasts|refractory anemia with excess blasts
453596|NCT00020969|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
453597|NCT00020969|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
453598|NCT00020969|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
453599|NCT00020969|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
453600|NCT00020969|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
453601|NCT00020969|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
453602|NCT00020969|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
453603|NCT00020995|adenocarcinoma of the prostate|adenocarcinoma of the prostate
453604|NCT00020995|stage I prostate cancer|stage i prostate cancer
453605|NCT00020995|stage IIB prostate cancer|stage iib prostate cancer
453606|NCT00020995|stage IIA prostate cancer|stage iia prostate cancer
453607|NCT00020995|stage III prostate cancer|stage iii prostate cancer
453608|NCT00020995|stage IV prostate cancer|stage iv prostate cancer
453609|NCT00021008|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
453610|NCT00021008|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
453611|NCT00021008|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
453612|NCT00021021|stage IV renal cell cancer|stage iv renal cell cancer
453613|NCT00021021|clear cell renal cell carcinoma|clear cell renal cell carcinoma
453614|NCT00021034|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
453615|NCT00021034|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
453616|NCT00021034|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
453617|NCT00021034|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
453618|NCT00021034|fallopian tube cancer|fallopian tube cancer
453619|NCT00021034|primary peritoneal cavity cancer|primary peritoneal cavity cancer
453620|NCT00021047|stage IV gastric cancer|stage iv gastric cancer
453621|NCT00021047|recurrent gastric cancer|recurrent gastric cancer
453622|NCT00021047|stage II esophageal cancer|stage ii esophageal cancer
453623|NCT00021047|stage III esophageal cancer|stage iii esophageal cancer
453624|NCT00021047|stage IV esophageal cancer|stage iv esophageal cancer
453625|NCT00021047|recurrent esophageal cancer|recurrent esophageal cancer
453626|NCT00021047|advanced adult primary liver cancer|advanced adult primary liver cancer
453627|NCT00021047|recurrent adult primary liver cancer|recurrent adult primary liver cancer
453628|NCT00021047|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
453629|NCT00021047|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
453630|NCT00021047|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
453631|NCT00021047|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
453632|NCT00021047|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
453633|NCT00021047|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
453836|NCT00024570|intratumoral therapy|intratumoral therapy
453634|NCT00021047|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
453759|NCT00024258|childhood teratoma|childhood teratoma
453635|NCT00021047|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
453636|NCT00021047|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
453637|NCT00021047|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
453638|NCT00021047|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
453639|NCT00021047|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
453640|NCT00021047|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
583596|NCT00512330|diagnostic|diagnostic
581314|NCT00498667|PET/CT|pet/ct
453641|NCT00021047|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
453642|NCT00021047|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
453643|NCT00021047|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
453644|NCT00021047|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
453645|NCT00021047|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
453646|NCT00021047|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
453647|NCT00021047|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
453648|NCT00021047|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
453649|NCT00021047|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
453650|NCT00021047|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
453651|NCT00021047|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
453652|NCT00021047|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
453653|NCT00021047|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
453654|NCT00021047|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
453655|NCT00021047|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
453656|NCT00021047|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
453657|NCT00021047|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
453658|NCT00021047|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
453659|NCT00021047|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
453660|NCT00021047|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
453661|NCT00021047|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
453662|NCT00021047|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
453663|NCT00021047|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
453664|NCT00021047|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
453665|NCT00021047|recurrent salivary gland cancer|recurrent salivary gland cancer
453666|NCT00021047|stage IV salivary gland cancer|stage iv salivary gland cancer
453667|NCT00021112|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
453668|NCT00021125|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
453669|NCT00021125|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
453670|NCT00021125|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
453671|NCT00021125|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
453672|NCT00021125|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
453673|NCT00021125|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
453674|NCT00021125|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
453675|NCT00021125|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
453676|NCT00021125|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
453677|NCT00021125|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
453678|NCT00021125|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
453679|NCT00021125|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
453680|NCT00021125|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
453681|NCT00021125|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
453682|NCT00021125|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
453683|NCT00021125|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
453684|NCT00021125|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
453685|NCT00021125|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
453686|NCT00021125|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
453842|NCT00024622|18F-Fluoro-L-dopa|18f-fluoro-l-dopa
453687|NCT00021125|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
453688|NCT00021125|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
453689|NCT00021125|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
453690|NCT00021125|stage I salivary gland cancer|stage i salivary gland cancer
453691|NCT00021125|stage II salivary gland cancer|stage ii salivary gland cancer
453692|NCT00021125|stage III salivary gland cancer|stage iii salivary gland cancer
453693|NCT00021125|stage IV salivary gland cancer|stage iv salivary gland cancer
453694|NCT00021138|non-small cell lung cancer|non-small cell lung cancer
453695|NCT00021138|small cell lung cancer|small cell lung cancer
453696|NCT00021138|esophageal cancer|esophageal cancer
453697|NCT00021138|hypopharyngeal cancer|hypopharyngeal cancer
453698|NCT00021138|laryngeal cancer|laryngeal cancer
453699|NCT00021138|nasopharyngeal cancer|nasopharyngeal cancer
453700|NCT00021138|oropharyngeal cancer|oropharyngeal cancer
453701|NCT00021138|lip and oral cavity cancer|lip and oral cavity cancer
453702|NCT00021138|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
453703|NCT00021138|tongue cancer|tongue cancer
453704|NCT00021151|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
453705|NCT00021151|prolymphocytic leukemia|prolymphocytic leukemia
453706|NCT00021164|stage IV melanoma|stage iv melanoma
453707|NCT00021164|recurrent melanoma|recurrent melanoma
453708|NCT00021164|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
453709|NCT00021229|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
453710|NCT00021229|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
453711|NCT00021229|untreated childhood brain stem glioma|untreated childhood brain stem glioma
453712|NCT00021229|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
453713|NCT00021229|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
453714|NCT00021242|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
453715|NCT00021242|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
453716|NCT00021242|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
453717|NCT00021268|stage IV colon cancer|stage iv colon cancer
453718|NCT00021268|stage IV rectal cancer|stage iv rectal cancer
453719|NCT00021268|recurrent colon cancer|recurrent colon cancer
453720|NCT00021268|recurrent rectal cancer|recurrent rectal cancer
453721|NCT00021281|stage IV colon cancer|stage iv colon cancer
453722|NCT00021281|stage IV rectal cancer|stage iv rectal cancer
453723|NCT00021281|recurrent colon cancer|recurrent colon cancer
453724|NCT00021281|recurrent rectal cancer|recurrent rectal cancer
453725|NCT00021281|adenocarcinoma of the colon|adenocarcinoma of the colon
453726|NCT00021281|adenocarcinoma of the rectum|adenocarcinoma of the rectum
453727|NCT00024232|stage IV prostate cancer|stage iv prostate cancer
453728|NCT00024232|recurrent prostate cancer|recurrent prostate cancer
453729|NCT00024245|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
453730|NCT00024258|metastatic osteosarcoma|metastatic osteosarcoma
453731|NCT00024258|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
453732|NCT00024258|regional neuroblastoma|regional neuroblastoma
453733|NCT00024258|disseminated neuroblastoma|disseminated neuroblastoma
453734|NCT00024258|stage 4S neuroblastoma|stage 4s neuroblastoma
453735|NCT00024258|recurrent neuroblastoma|recurrent neuroblastoma
453736|NCT00024258|stage III childhood liver cancer|stage iii childhood liver cancer
453737|NCT00024258|stage IV childhood liver cancer|stage iv childhood liver cancer
453738|NCT00024258|recurrent childhood liver cancer|recurrent childhood liver cancer
453739|NCT00024258|childhood hepatoblastoma|childhood hepatoblastoma
453740|NCT00024258|stage III Wilms tumor|stage iii wilms tumor
453741|NCT00024258|stage IV Wilms tumor|stage iv wilms tumor
453742|NCT00024258|stage V Wilms tumor|stage v wilms tumor
453743|NCT00024258|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
453744|NCT00024258|intraocular retinoblastoma|intraocular retinoblastoma
453745|NCT00024258|extraocular retinoblastoma|extraocular retinoblastoma
453746|NCT00024258|recurrent retinoblastoma|recurrent retinoblastoma
453747|NCT00024258|recurrent osteosarcoma|recurrent osteosarcoma
453748|NCT00024258|childhood germ cell tumor|childhood germ cell tumor
453749|NCT00024258|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
453750|NCT00024258|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
453751|NCT00024258|localized unresectable neuroblastoma|localized unresectable neuroblastoma
453752|NCT00024258|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
453753|NCT00024258|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
453754|NCT00024258|untreated childhood medulloblastoma|untreated childhood medulloblastoma
453755|NCT00024258|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
453756|NCT00024258|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
454009|NCT00025142|recurrent rectal cancer|recurrent rectal cancer
453757|NCT00024258|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
12561|NCT03210506|Nucleoside Analogues|nucleoside analogues
453758|NCT00024258|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
453760|NCT00024258|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
453761|NCT00024258|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
453762|NCT00024258|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
453763|NCT00024258|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
453764|NCT00024271|localized malignant mesothelioma|localized malignant mesothelioma
453765|NCT00024271|advanced malignant mesothelioma|advanced malignant mesothelioma
453766|NCT00024271|recurrent malignant mesothelioma|recurrent malignant mesothelioma
453767|NCT00024284|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
453768|NCT00024297|thromboembolism|thromboembolism
453769|NCT00024310|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
453770|NCT00024310|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
753025|NCT01175148|graft-versus-host-disease|graft-versus-host-disease
453771|NCT00024323|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
453772|NCT00024336|untreated childhood brain stem glioma|untreated childhood brain stem glioma
453773|NCT00024349|stage II bladder cancer|stage ii bladder cancer
453774|NCT00024349|stage III bladder cancer|stage iii bladder cancer
453775|NCT00024349|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
453776|NCT00024349|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
453777|NCT00024349|adenocarcinoma of the bladder|adenocarcinoma of the bladder
453778|NCT00024362|stage III pancreatic cancer|stage iii pancreatic cancer
453779|NCT00024362|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
453780|NCT00024362|stage IV pancreatic cancer|stage iv pancreatic cancer
453781|NCT00024375|recurrent pancreatic cancer|recurrent pancreatic cancer
453782|NCT00024375|stage IV pancreatic cancer|stage iv pancreatic cancer
453783|NCT00024388|stage III renal cell cancer|stage iii renal cell cancer
453784|NCT00024388|stage IV renal cell cancer|stage iv renal cell cancer
453785|NCT00024388|recurrent renal cell cancer|recurrent renal cell cancer
453786|NCT00024401|stage IV colon cancer|stage iv colon cancer
453787|NCT00024401|stage IV rectal cancer|stage iv rectal cancer
453788|NCT00024401|recurrent colon cancer|recurrent colon cancer
453789|NCT00024401|recurrent rectal cancer|recurrent rectal cancer
453790|NCT00024414|adenocarcinoma of the prostate|adenocarcinoma of the prostate
453791|NCT00024414|stage IV prostate cancer|stage iv prostate cancer
453792|NCT00024414|recurrent prostate cancer|recurrent prostate cancer
453793|NCT00024427|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
453794|NCT00024427|stage II pancreatic cancer|stage ii pancreatic cancer
453795|NCT00024427|stage III pancreatic cancer|stage iii pancreatic cancer
453796|NCT00024427|recurrent pancreatic cancer|recurrent pancreatic cancer
453797|NCT00024427|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
453798|NCT00024427|stage IV pancreatic cancer|stage iv pancreatic cancer
453799|NCT00024440|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
453800|NCT00024440|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
453801|NCT00024453|infection|infection
453802|NCT00024466|stage I multiple myeloma|stage i multiple myeloma
453803|NCT00024466|stage II multiple myeloma|stage ii multiple myeloma
453804|NCT00024466|stage III multiple myeloma|stage iii multiple myeloma
453805|NCT00024479|Minorities|minorities
453806|NCT00024479|Rheumatic Disease|rheumatic disease
453807|NCT00024479|Community Based|community based
453808|NCT00024479|Ethnicity|ethnicity
453809|NCT00024479|Health Disparities|health disparities
453810|NCT00024492|Liposome Encapsulated Mitoxantrone (LEM)|liposome encapsulated mitoxantrone (lem)
453811|NCT00024492|solid tumors|solid tumors
453812|NCT00024518|Diabetes|diabetes
453813|NCT00024518|Immunotherapy|immunotherapy
453814|NCT00024518|Study Drug|study drug
453815|NCT00024518|Insulin Dependent Diabetes|insulin dependent diabetes
453816|NCT00024518|Diabetes Mellitus|diabetes mellitus
453817|NCT00024518|TIBM|tibm
453818|NCT00024531|Alzheimer disease|alzheimer disease
453819|NCT00024531|Cholesterol-lowering drugs|cholesterol-lowering drugs
453820|NCT00024544|asthma|asthma
453821|NCT00024544|anti-IL-4 monoclonal antibody|anti-il-4 monoclonal antibody
453822|NCT00024544|pascolizumab|pascolizumab
453823|NCT00024557|neurosurgery, craniotomy|neurosurgery, craniotomy
453824|NCT00024557|convection-enhanced delivery|convection-enhanced delivery
453825|NCT00024557|CNS interstitial infusion|cns interstitial infusion
453826|NCT00024557|recombinant toxins|recombinant toxins
453827|NCT00024557|malignant glioma, recurrent|malignant glioma, recurrent
453828|NCT00024557|intratumoral therapy|intratumoral therapy
453829|NCT00024557|positive pressure microinfusion|positive pressure microinfusion
453830|NCT00024570|neurosurgery, craniotomy|neurosurgery, craniotomy
453831|NCT00024570|convection-enhanced delivery|convection-enhanced delivery
453832|NCT00024570|CNS interstitial infusion|cns interstitial infusion
453833|NCT00024570|recombinant toxins|recombinant toxins
453834|NCT00024570|malignant glioma, recurrent|malignant glioma, recurrent
453837|NCT00024570|positive pressure microinfusion|positive pressure microinfusion
453838|NCT00024622|Familial|familial
453840|NCT00024622|Symptomatic|symptomatic
453841|NCT00024622|Equivocally Affected|equivocally affected
453843|NCT00024622|O-15 Labelled Water|o-15 labelled water
453844|NCT00024622|Carbidopa|carbidopa
453845|NCT00024622|Adult|adult
453846|NCT00024622|Schizophrenia|schizophrenia
453847|NCT00024622|Parkinson's Disease|parkinson's disease
453848|NCT00024622|PD|pd
453849|NCT00024622|Parkinson|parkinson
453850|NCT00024622|Healthy Control|healthy control
453851|NCT00024622|HV|hv
453852|NCT00024622|Normal Control|normal control
453853|NCT00024635|Screening|screening
453854|NCT00024635|Psychiatric History|psychiatric history
453855|NCT00024635|Medical History|medical history
453856|NCT00024635|Diagnostic Evaluation|diagnostic evaluation
453857|NCT00024635|Natural History|natural history
453858|NCT00024635|Anxiety|anxiety
453859|NCT00024635|HV|hv
580719|NCT00504907|RSV|rsv
453860|NCT00024635|Healthy Volunteer|healthy volunteer
453861|NCT00024635|Normal Control|normal control
453862|NCT00024635|Mood Disorder|mood disorder
453863|NCT00024635|PTSD|ptsd
453864|NCT00024635|Post-Traumatic Stress Disorder|post-traumatic stress disorder
453865|NCT00024648|advanced malignancy|advanced malignancy
453866|NCT00024648|liposomes containing AON to c-raf messenger RNA|liposomes containing aon to c-raf messenger rna
453867|NCT00024648|antisense oligodeoxynucleotide (AON)|antisense oligodeoxynucleotide (aon)
453868|NCT00024648|LErafAON|lerafaon
453869|NCT00024661|recurrent solid tumors|recurrent solid tumors
453870|NCT00024661|liposomes containing AON to c-raf protein (LErafAON)|liposomes containing aon to c-raf protein (lerafaon)
453871|NCT00024674|SS1(dsFv)-PE38|ss1(dsfv)-pe38
453872|NCT00024674|SS1P|ss1p
453873|NCT00024674|anti-mesothelin immunotoxin|anti-mesothelin immunotoxin
453874|NCT00024674|advanced malignancy|advanced malignancy
453875|NCT00024687|SS1(dsFv)-PE38 Anti-Mesothelin Immunotoxin|ss1(dsfv)-pe38 anti-mesothelin immunotoxin
453876|NCT00024687|advanced malignancy|advanced malignancy
453877|NCT00024791|Cerebral Palsy|cerebral palsy
453878|NCT00024791|Pediatric|pediatric
453879|NCT00024791|Cognition|cognition
453880|NCT00024791|Motor Learning|motor learning
453881|NCT00024791|Visuomotor Integration|visuomotor integration
453882|NCT00024791|Corticospinal Tracts|corticospinal tracts
453883|NCT00024791|Cortical Re-Organization|cortical re-organization
453884|NCT00024791|Spastic Hemiplegia|spastic hemiplegia
453885|NCT00024791|Spastic Diplegia|spastic diplegia
453886|NCT00024791|Functional Outcome|functional outcome
453887|NCT00024791|Children|children
453888|NCT00024791|Healthy Volunteer|healthy volunteer
453889|NCT00024791|HV|hv
453890|NCT00024791|Normal Control|normal control
453891|NCT00024804|SKELETAL DISEASE|skeletal disease
453892|NCT00024804|Osteoporosis|osteoporosis
453893|NCT00024804|Dysplasia|dysplasia
453894|NCT00024804|Osteomalacia|osteomalacia
453895|NCT00024804|Bone Diseases|bone diseases
453896|NCT00024908|Cognition|cognition
453897|NCT00024908|Frontal Lobes|frontal lobes
453898|NCT00024908|Frontotemporal Dementia|frontotemporal dementia
453899|NCT00024908|Focal Lesions|focal lesions
453900|NCT00024908|Executive Functions|executive functions
453901|NCT00024908|Frontotemporal Lobe Dementia|frontotemporal lobe dementia
453902|NCT00024908|Frontal Lobe|frontal lobe
453903|NCT00024908|Frontal Lobe Dementia|frontal lobe dementia
453904|NCT00024908|Healthy Volunteer|healthy volunteer
453905|NCT00024908|HV|hv
453906|NCT00024908|Normal Control|normal control
453907|NCT00024934|Immunodeficiency|immunodeficiency
453908|NCT00024934|Primary|primary
453909|NCT00024934|Cancer|cancer
453910|NCT00024934|Genetics|genetics
453911|NCT00024934|IGA Deficiency|iga deficiency
453912|NCT00024934|Immune Deficiency|immune deficiency
453913|NCT00024960|Speech|speech
453914|NCT00024960|Motor Control|motor control
453915|NCT00024960|Phenotype|phenotype
453916|NCT00024960|Dysfluency|dysfluency
453917|NCT00024960|Fluency|fluency
453918|NCT00024960|Stuttering|stuttering
453919|NCT00024960|Healthy Volunteer|healthy volunteer
453920|NCT00024960|HV|hv
453921|NCT00024960|Normal Control|normal control
453922|NCT00024986|HAART|haart
453923|NCT00024986|Genotypic Resistance|genotypic resistance
453924|NCT00024986|Phenotypic Resistance|phenotypic resistance
453925|NCT00024986|Immune Reconstitution|immune reconstitution
453926|NCT00024986|Bone Density|bone density
453927|NCT00024986|HIV|hiv
453928|NCT00024986|Children|children
453929|NCT00024986|Pediatric HIV Infection|pediatric hiv infection
453930|NCT00024999|Movement|movement
453931|NCT00024999|Coordination|coordination
453932|NCT00024999|Correlation|correlation
453933|NCT00024999|Coherence|coherence
453934|NCT00024999|Parietofrontal Circuitry|parietofrontal circuitry
453935|NCT00024999|Apraxia|apraxia
453936|NCT00024999|Ideomotor Apraxia|ideomotor apraxia
453937|NCT00024999|Healthy Volunteer|healthy volunteer
453938|NCT00024999|HV|hv
453939|NCT00024999|Normal Control|normal control
453940|NCT00025012|basal cell carcinoma of the skin|basal cell carcinoma of the skin
454372|NCT00026052|Riluzole|riluzole
453941|NCT00025012|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
453942|NCT00025012|melanoma|melanoma
453943|NCT00025025|colon cancer|colon cancer
453944|NCT00025025|rectal cancer|rectal cancer
453945|NCT00025051|basal cell carcinoma of the skin|basal cell carcinoma of the skin
453946|NCT00025051|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
453947|NCT00025064|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
453948|NCT00025064|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
453949|NCT00025064|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
453950|NCT00025064|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
453951|NCT00025064|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
453952|NCT00025077|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
453953|NCT00025077|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
453954|NCT00025090|stage I anal cancer|stage i anal cancer
453955|NCT00025090|stage II anal cancer|stage ii anal cancer
453956|NCT00025090|stage IIIA anal cancer|stage iiia anal cancer
453957|NCT00025090|stage IIIB anal cancer|stage iiib anal cancer
453958|NCT00025090|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
453959|NCT00025090|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
453960|NCT00025090|basaloid carcinoma of the anus|basaloid carcinoma of the anus
453961|NCT00025103|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
453962|NCT00025103|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
453963|NCT00025116|adenocarcinoma of the prostate|adenocarcinoma of the prostate
453964|NCT00025116|recurrent prostate cancer|recurrent prostate cancer
453965|NCT00025129|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
453966|NCT00025129|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
453967|NCT00025129|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
453968|NCT00025129|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
453969|NCT00025129|small intestine lymphoma|small intestine lymphoma
453970|NCT00025129|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
453971|NCT00025129|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
453972|NCT00025129|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
453973|NCT00025129|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
453974|NCT00025129|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
453975|NCT00025129|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
453976|NCT00025129|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
453977|NCT00025129|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
453978|NCT00025129|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
453979|NCT00025129|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
453980|NCT00025129|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
453981|NCT00025129|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
453982|NCT00025129|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
453983|NCT00025129|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
453984|NCT00025129|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
453985|NCT00025129|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
453986|NCT00025129|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
453987|NCT00025129|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
453988|NCT00025129|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
453989|NCT00025129|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
453990|NCT00025129|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
453991|NCT00025129|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
453992|NCT00025129|intraocular lymphoma|intraocular lymphoma
453993|NCT00025129|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
453994|NCT00025129|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
453995|NCT00025129|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
453996|NCT00025129|anaplastic large cell lymphoma|anaplastic large cell lymphoma
453997|NCT00025129|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
453998|NCT00025129|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
453999|NCT00025129|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
454000|NCT00025129|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
454001|NCT00025129|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
454002|NCT00025129|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
454003|NCT00025129|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
454004|NCT00025129|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
454005|NCT00025129|splenic marginal zone lymphoma|splenic marginal zone lymphoma
454006|NCT00025142|stage IV colon cancer|stage iv colon cancer
454007|NCT00025142|stage IV rectal cancer|stage iv rectal cancer
454008|NCT00025142|recurrent colon cancer|recurrent colon cancer
454010|NCT00025142|adenocarcinoma of the colon|adenocarcinoma of the colon
454011|NCT00025142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
454012|NCT00025168|stage III pancreatic cancer|stage iii pancreatic cancer
454013|NCT00025181|iris melanoma|iris melanoma
454014|NCT00025181|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
454015|NCT00025181|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
454016|NCT00025181|extraocular extension melanoma|extraocular extension melanoma
454017|NCT00025181|recurrent intraocular melanoma|recurrent intraocular melanoma
454018|NCT00025181|stage III melanoma|stage iii melanoma
454019|NCT00025181|stage IV melanoma|stage iv melanoma
453395|NCT00013715|Ozone|ozone
454020|NCT00025181|recurrent melanoma|recurrent melanoma
454021|NCT00025194|adenocarcinoma of the prostate|adenocarcinoma of the prostate
454022|NCT00025194|stage IV prostate cancer|stage iv prostate cancer
454023|NCT00025194|recurrent prostate cancer|recurrent prostate cancer
454024|NCT00025272|extensive stage small cell lung cancer|extensive stage small cell lung cancer
454025|NCT00025285|squamous cell lung cancer|squamous cell lung cancer
454026|NCT00025285|large cell lung cancer|large cell lung cancer
454027|NCT00025285|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
454028|NCT00025285|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
454029|NCT00025285|adenocarcinoma of the lung|adenocarcinoma of the lung
454030|NCT00025285|adenosquamous cell lung cancer|adenosquamous cell lung cancer
454031|NCT00025285|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
454032|NCT00025298|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
454033|NCT00025298|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
454034|NCT00025298|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
454035|NCT00025298|oral complications|oral complications
454036|NCT00025298|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
454037|NCT00025298|radiation toxicity|radiation toxicity
454038|NCT00025311|leptomeningeal metastases|leptomeningeal metastases
454039|NCT00025324|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
454040|NCT00025324|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
454041|NCT00025350|stage IV colon cancer|stage iv colon cancer
454042|NCT00025350|stage IV rectal cancer|stage iv rectal cancer
454043|NCT00025350|recurrent colon cancer|recurrent colon cancer
454044|NCT00025350|recurrent rectal cancer|recurrent rectal cancer
454045|NCT00025350|adenocarcinoma of the colon|adenocarcinoma of the colon
454046|NCT00025350|adenocarcinoma of the rectum|adenocarcinoma of the rectum
454047|NCT00025376|stage IV renal cell cancer|stage iv renal cell cancer
454048|NCT00025376|recurrent renal cell cancer|recurrent renal cell cancer
454049|NCT00025389|stage I non-small cell lung cancer|stage i non-small cell lung cancer
454050|NCT00025389|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
454051|NCT00025389|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
454052|NCT00025402|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
454053|NCT00025402|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
454054|NCT00025402|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
454055|NCT00025402|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
454056|NCT00025402|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
454057|NCT00025428|localized unresectable neuroblastoma|localized unresectable neuroblastoma
454058|NCT00025441|chondrosarcoma|chondrosarcoma
454059|NCT00025441|small intestine leiomyosarcoma|small intestine leiomyosarcoma
454060|NCT00025441|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
454061|NCT00025441|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
454062|NCT00025441|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
454063|NCT00025441|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
454064|NCT00025441|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
454065|NCT00025441|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
454066|NCT00025441|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
454067|NCT00025441|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
454068|NCT00025441|childhood fibrosarcoma|childhood fibrosarcoma
454069|NCT00025441|childhood synovial sarcoma|childhood synovial sarcoma
454070|NCT00025441|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
454071|NCT00025441|childhood liposarcoma|childhood liposarcoma
454072|NCT00025441|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
454073|NCT00025441|childhood leiomyosarcoma|childhood leiomyosarcoma
454074|NCT00025441|childhood angiosarcoma|childhood angiosarcoma
454075|NCT00025441|childhood epithelioid sarcoma|childhood epithelioid sarcoma
454076|NCT00025441|childhood malignant mesenchymoma|childhood malignant mesenchymoma
454077|NCT00025441|stage IV uterine sarcoma|stage iv uterine sarcoma
454078|NCT00025441|uterine leiomyosarcoma|uterine leiomyosarcoma
454079|NCT00025441|ovarian sarcoma|ovarian sarcoma
454080|NCT00025441|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
454081|NCT00025441|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
454725|NCT00026923|Laparoscopy|laparoscopy
12562|NCT03210493|chronic hepatitis B|chronic hepatitis b
454082|NCT00025454|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
454083|NCT00025480|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
454084|NCT00025480|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
454085|NCT00025493|stage IV breast cancer|stage iv breast cancer
454086|NCT00025493|recurrent breast cancer|recurrent breast cancer
454087|NCT00025519|stage IV renal cell cancer|stage iv renal cell cancer
454088|NCT00025519|recurrent renal cell cancer|recurrent renal cell cancer
454089|NCT00025519|clear cell renal cell carcinoma|clear cell renal cell carcinoma
454090|NCT00025532|stage III colon cancer|stage iii colon cancer
454091|NCT00025532|stage IV colon cancer|stage iv colon cancer
454092|NCT00025532|stage III gastric cancer|stage iii gastric cancer
454093|NCT00025532|stage IV gastric cancer|stage iv gastric cancer
454094|NCT00025532|recurrent gastric cancer|recurrent gastric cancer
454095|NCT00025532|stage III pancreatic cancer|stage iii pancreatic cancer
454096|NCT00025532|recurrent pancreatic cancer|recurrent pancreatic cancer
454097|NCT00025532|stage III rectal cancer|stage iii rectal cancer
454098|NCT00025532|stage IV rectal cancer|stage iv rectal cancer
454099|NCT00025532|recurrent colon cancer|recurrent colon cancer
454100|NCT00025532|recurrent rectal cancer|recurrent rectal cancer
454101|NCT00025532|stage III esophageal cancer|stage iii esophageal cancer
454102|NCT00025532|stage IV esophageal cancer|stage iv esophageal cancer
454103|NCT00025532|recurrent esophageal cancer|recurrent esophageal cancer
454104|NCT00025532|adenocarcinoma of the stomach|adenocarcinoma of the stomach
454105|NCT00025532|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
454106|NCT00025532|adenocarcinoma of the colon|adenocarcinoma of the colon
454107|NCT00025532|adenocarcinoma of the rectum|adenocarcinoma of the rectum
454108|NCT00025532|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
454109|NCT00025532|stage IV pancreatic cancer|stage iv pancreatic cancer
454110|NCT00025545|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
454111|NCT00025545|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
454112|NCT00025545|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
454113|NCT00025545|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
454114|NCT00025545|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
454115|NCT00025545|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
454116|NCT00025545|acute undifferentiated leukemia|acute undifferentiated leukemia
454117|NCT00025545|secondary acute myeloid leukemia|secondary acute myeloid leukemia
454118|NCT00025558|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
454119|NCT00025558|recurrent adult brain tumor|recurrent adult brain tumor
454120|NCT00025558|adult medulloblastoma|adult medulloblastoma
454122|NCT00025558|adult anaplastic astrocytoma|adult anaplastic astrocytoma
454123|NCT00025558|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
454124|NCT00025558|adult mixed glioma|adult mixed glioma
454125|NCT00025558|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
454126|NCT00025558|adult pineoblastoma|adult pineoblastoma
454127|NCT00025558|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
454128|NCT00025558|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
454129|NCT00025558|recurrent childhood ependymoma|recurrent childhood ependymoma
454130|NCT00025558|adult giant cell glioblastoma|adult giant cell glioblastoma
454131|NCT00025558|adult gliosarcoma|adult gliosarcoma
454132|NCT00025558|adult anaplastic ependymoma|adult anaplastic ependymoma
454133|NCT00025558|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
454134|NCT00025571|squamous cell lung cancer|squamous cell lung cancer
454135|NCT00025571|large cell lung cancer|large cell lung cancer
454136|NCT00025571|adenocarcinoma of the lung|adenocarcinoma of the lung
454137|NCT00025571|stage I non-small cell lung cancer|stage i non-small cell lung cancer
454138|NCT00025571|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
454139|NCT00025597|localized unresectable neuroblastoma|localized unresectable neuroblastoma
454140|NCT00025610|disseminated neuroblastoma|disseminated neuroblastoma
454141|NCT00025610|stage 4S neuroblastoma|stage 4s neuroblastoma
454142|NCT00025623|disseminated neuroblastoma|disseminated neuroblastoma
454143|NCT00025636|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
454144|NCT00025649|localized resectable neuroblastoma|localized resectable neuroblastoma
454145|NCT00025649|regional neuroblastoma|regional neuroblastoma
454146|NCT00025649|disseminated neuroblastoma|disseminated neuroblastoma
454147|NCT00025649|stage 4S neuroblastoma|stage 4s neuroblastoma
454148|NCT00025649|localized unresectable neuroblastoma|localized unresectable neuroblastoma
454149|NCT00025662|Peripheral Blood Stem Cell|peripheral blood stem cell
454150|NCT00025662|Melphalan|melphalan
454151|NCT00025662|Fludarabine|fludarabine
454152|NCT00025662|Donor Apheresis|donor apheresis
454153|NCT00025662|Non-Myeloablative|non-myeloablative
454154|NCT00025662|MDS|mds
454155|NCT00025662|Chronic Myeloid Leukemia|chronic myeloid leukemia
454156|NCT00025662|CML|cml
454157|NCT00025662|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
454158|NCT00025662|CLL|cll
454159|NCT00025662|Lymphoma|lymphoma
454160|NCT00025662|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
454161|NCT00025662|Hodgkin's Disease|hodgkin's disease
454162|NCT00025662|Mantle Cell Lymphoma|mantle cell lymphoma
454163|NCT00025662|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
454164|NCT00025662|Chronic Myeloid Leukemia (CML)|chronic myeloid leukemia (cml)
454165|NCT00025662|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
454166|NCT00025662|Myelodysplasia (MDS)|myelodysplasia (mds)
454167|NCT00025662|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
454168|NCT00025662|Bone Marrow Transplant|bone marrow transplant
454169|NCT00025675|recurrent adult brain tumor|recurrent adult brain tumor
454170|NCT00025675|adult meningioma|adult meningioma
454171|NCT00025675|adult glioblastoma|adult glioblastoma
454172|NCT00025675|adult anaplastic astrocytoma|adult anaplastic astrocytoma
454173|NCT00025675|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
454174|NCT00025675|adult pilocytic astrocytoma|adult pilocytic astrocytoma
454175|NCT00025675|adult subependymoma|adult subependymoma
454176|NCT00025675|adult mixed glioma|adult mixed glioma
454177|NCT00025675|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
454178|NCT00025675|adult grade III meningioma|adult grade iii meningioma
454179|NCT00025675|adult giant cell glioblastoma|adult giant cell glioblastoma
454180|NCT00025675|adult gliosarcoma|adult gliosarcoma
454181|NCT00025675|adult grade I meningioma|adult grade i meningioma
454182|NCT00025675|adult grade II meningioma|adult grade ii meningioma
454183|NCT00025688|stage IV breast cancer|stage iv breast cancer
454184|NCT00025688|recurrent breast cancer|recurrent breast cancer
454187|NCT00025701|Motor Control|motor control
454188|NCT00025701|Event-Related Synchronization|event-related synchronization
454189|NCT00025701|Event-Related Desynchronization|event-related desynchronization
454190|NCT00025701|Focal Hand Dystonia|focal hand dystonia
454191|NCT00025701|Focal Dystonia|focal dystonia
454192|NCT00025701|Dystonia|dystonia
454193|NCT00025701|Hand|hand
454194|NCT00025701|Healthy Volunteer|healthy volunteer
454195|NCT00025701|HV|hv
454196|NCT00025714|Serotonin Receptor|serotonin receptor
454197|NCT00025714|Cell Culture|cell culture
454198|NCT00025714|Temporal Lobe|temporal lobe
454199|NCT00025714|Endothelial Cells|endothelial cells
454200|NCT00025714|Superficial Temporal Artery|superficial temporal artery
454201|NCT00025714|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
454202|NCT00025714|Epilepsy|epilepsy
454203|NCT00025714|Intractable Epilepsy|intractable epilepsy
454204|NCT00025727|HIV-1|hiv-1
454205|NCT00025727|HIV Protease Inhibitors|hiv protease inhibitors
454206|NCT00025727|Ritonavir|ritonavir
454207|NCT00025727|RNA, Viral|rna, viral
454208|NCT00025727|Anti-HIV Agents|anti-hiv agents
454209|NCT00025727|Viral Load|viral load
454210|NCT00025727|ABT 378|abt 378
454211|NCT00025727|VX-175|vx-175
454212|NCT00025740|SSRI (paroxetine)|ssri (paroxetine)
454213|NCT00025740|Benzodiazepine (clonazepam)|benzodiazepine (clonazepam)
454214|NCT00025740|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
454215|NCT00025740|Combined Treatment|combined treatment
454216|NCT00025740|Rapid Treatment|rapid treatment
454217|NCT00025740|Post-Traumatic Stress Disorder|post-traumatic stress disorder
454218|NCT00025740|PTSD|ptsd
454219|NCT00025779|Hyperactivity|hyperactivity
454220|NCT00025779|Distractibility|distractibility
454221|NCT00025779|Impulsiveness|impulsiveness
454222|NCT00025779|Pervasive Development Disorders|pervasive development disorders
454223|NCT00025792|Pramipexole|pramipexole
454224|NCT00025792|Neuroprotective|neuroprotective
454225|NCT00025792|Placebo Controlled|placebo controlled
454226|NCT00025792|Depression|depression
454227|NCT00025792|Brain Imaging|brain imaging
454228|NCT00025792|Antidepressant|antidepressant
454229|NCT00025792|Bipolar Disorder|bipolar disorder
454230|NCT00025792|Bipolar|bipolar
454231|NCT00025792|BPD|bpd
454232|NCT00025792|Bipolar Depression|bipolar depression
454233|NCT00025805|Cytokines|cytokines
454234|NCT00025805|Th1 Th2 Response|th1 th2 response
454235|NCT00025805|Inflammatory Bowel Dx|inflammatory bowel dx
454236|NCT00025805|Lymphocyte|lymphocyte
454237|NCT00025805|Colonoscopy|colonoscopy
454238|NCT00025805|Crohn's Disease|crohn's disease
454239|NCT00025805|Crohn's|crohn's
454240|NCT00025818|dry eyes|dry eyes
454241|NCT00025818|rheumatoid arthritis|rheumatoid arthritis
454242|NCT00025818|Lupus|lupus
454243|NCT00025818|Sjogren's syndrome|sjogren's syndrome
454244|NCT00025818|myositis|myositis
454245|NCT00025818|scleroderma|scleroderma
454246|NCT00025818|autoimmune disorder|autoimmune disorder
454247|NCT00025831|Buccal|buccal
454248|NCT00025831|DNA|dna
454249|NCT00025831|Pooling|pooling
454250|NCT00025831|Genotyping|genotyping
454251|NCT00025831|Mouthwash|mouthwash
454252|NCT00025831|Healthy Volunteer|healthy volunteer
454253|NCT00025831|HV|hv
454254|NCT00025831|Normal Control|normal control
454255|NCT00025844|Stress|stress
454256|NCT00025844|Anxiety|anxiety
454257|NCT00025844|Adults|adults
454258|NCT00025844|Fear Conditioning|fear conditioning
454259|NCT00025844|Normal Volunteers|normal volunteers
454260|NCT00025844|Associative Learning|associative learning
454261|NCT00025844|Virtual Reality|virtual reality
454262|NCT00025844|Context Conditioning|context conditioning
454263|NCT00025844|Healthy Volunteer|healthy volunteer
454265|NCT00025844|Normal Control|normal control
201024|NCT02112591|mesh|mesh
454270|NCT00025857|Magnetic Resonance Imaging|magnetic resonance imaging
454271|NCT00025857|Anxiety|anxiety
454272|NCT00025857|Normal Volunteers|normal volunteers
454273|NCT00025857|Adolescence|adolescence
454274|NCT00025857|Memory|memory
454275|NCT00025857|Physical/Sexual Abuse History|physical/sexual abuse history
454276|NCT00025857|Post-Traumatic Stress Disorder|post-traumatic stress disorder
454277|NCT00025857|Adolescent|adolescent
454278|NCT00025857|Healthy Volunteer|healthy volunteer
454279|NCT00025857|HV|hv
454280|NCT00025857|Normal Control|normal control
454281|NCT00025870|Genetics|genetics
454282|NCT00025870|Metabolic|metabolic
454283|NCT00025870|Dysmorphology|dysmorphology
454284|NCT00025870|Training|training
454285|NCT00025870|DNA|dna
454286|NCT00025870|DNA Testing|dna testing
454287|NCT00025870|Dysmorphic Syndromes|dysmorphic syndromes
454288|NCT00025870|Developmental Delay|developmental delay
454289|NCT00025870|Genetic Counseling|genetic counseling
454290|NCT00025870|Molecular Genetics|molecular genetics
454291|NCT00025883|Lipoatrophic Diabetes|lipoatrophic diabetes
454292|NCT00025883|Diabetes Mellitus|diabetes mellitus
454293|NCT00025883|Hypertriglyceridemia|hypertriglyceridemia
454294|NCT00025883|NASH|nash
454295|NCT00025883|Lipodystrophy|lipodystrophy
454296|NCT00025883|Leptin|leptin
454297|NCT00025883|Diabetes|diabetes
454298|NCT00025909|Therapy|therapy
454299|NCT00025909|Antiretrovirals|antiretrovirals
454300|NCT00025909|Interruption|interruption
454301|NCT00025909|CD4+ T Cell|cd4+ t cell
454302|NCT00025909|Plasma Viremia|plasma viremia
454303|NCT00025909|HIV|hiv
454304|NCT00025909|Treatment Experienced|treatment experienced
454305|NCT00025909|Treatment Interuption|treatment interuption
454306|NCT00025922|Immunization|immunization
454307|NCT00025922|Titers|titers
454308|NCT00025922|Immune Activation|immune activation
454309|NCT00025922|Antibody|antibody
454310|NCT00025922|CD4 Cell Count|cd4 cell count
454311|NCT00025922|HIV|hiv
454312|NCT00025935|Mood Disorders|mood disorders
454313|NCT00025935|Bipolar Disorder|bipolar disorder
454314|NCT00025935|Neuroimaging|neuroimaging
454315|NCT00025935|Psychophysiology|psychophysiology
454316|NCT00025935|Frustration|frustration
454317|NCT00025935|Emotional Dysregulation|emotional dysregulation
454318|NCT00025935|Lithium|lithium
454319|NCT00025935|Conduct Disorder|conduct disorder
454320|NCT00025935|Children and Adolescents|children and adolescents
454321|NCT00025935|Affective Neuroscience|affective neuroscience
454322|NCT00025935|Behavioral Dysregulation|behavioral dysregulation
454323|NCT00025935|Mood Disorder|mood disorder
454324|NCT00025935|Behavior|behavior
454325|NCT00025935|Children|children
454326|NCT00025935|Adolescent|adolescent
454327|NCT00025935|Healthy Volunteer|healthy volunteer
454328|NCT00025935|HV|hv
454329|NCT00025935|Normal Control|normal control
454330|NCT00025974|PET|pet
454331|NCT00025974|5-HT1A Receptors|5-ht1a receptors
454332|NCT00025974|Benzodiazepine Receptors|benzodiazepine receptors
454333|NCT00025974|Panic Disorder|panic disorder
454334|NCT00025974|PTSD|ptsd
454335|NCT00025974|Serotonin Type 1A Receptors|serotonin type 1a receptors
454336|NCT00025974|Post-Traumatic Stress Disorder|post-traumatic stress disorder
454337|NCT00025974|Major Depression|major depression
454338|NCT00025974|Anxiety|anxiety
454339|NCT00025974|Depression|depression
454340|NCT00025974|Healthy Volunteer|healthy volunteer
454341|NCT00025974|HV|hv
454342|NCT00025974|Normal Control|normal control
454343|NCT00025987|Brain|brain
454344|NCT00025987|Temperature|temperature
454345|NCT00025987|Lower|lower
454346|NCT00025987|Tympanic|tympanic
454347|NCT00025987|Rectal|rectal
454348|NCT00025987|Cooling of the Head and Neck|cooling of the head and neck
454349|NCT00025987|Control|control
454350|NCT00025987|Epilepsy|epilepsy
454351|NCT00025987|Healthy Volunteer|healthy volunteer
454352|NCT00025987|HV|hv
454353|NCT00026000|Voluntary Movement|voluntary movement
454354|NCT00026000|Basal Ganglia|basal ganglia
454355|NCT00026000|Frontal Lobe|frontal lobe
454356|NCT00026000|Motor Cortex|motor cortex
454357|NCT00026000|Motor Tic Disorder|motor tic disorder
454358|NCT00026000|Tourette's Syndrome|tourette's syndrome
454359|NCT00026000|Vocal Tic Disorder|vocal tic disorder
454360|NCT00026000|Tic|tic
454361|NCT00026000|Healthy Volunteer|healthy volunteer
454362|NCT00026000|HV|hv
454363|NCT00026000|Normal Control|normal control
454364|NCT00026013|contraception|contraception
454365|NCT00026013|hormonal contraception|hormonal contraception
454366|NCT00026013|herbal remedies|herbal remedies
454367|NCT00026013|hypericum perforatum|hypericum perforatum
454368|NCT00026013|contraceptive effectiveness|contraceptive effectiveness
454369|NCT00026026|Human tooth agenesis|human tooth agenesis
454370|NCT00026039|stroke|stroke
454371|NCT00026039|estrogen|estrogen
454373|NCT00026052|Neuroprotective|neuroprotective
454374|NCT00026052|Open-Label Study|open-label study
454375|NCT00026052|Glutamate Dysfunction|glutamate dysfunction
454376|NCT00026052|Unipolar Depression|unipolar depression
454377|NCT00026052|Antidepressant|antidepressant
454378|NCT00026052|Depression|depression
454379|NCT00026052|Major Depression|major depression
454380|NCT00026065|Hypertension|hypertension
454381|NCT00026065|BIofeedback|biofeedback
454382|NCT00026065|Non-pharmacological treatment|non-pharmacological treatment
454383|NCT00026065|Prediction|prediction
454384|NCT00026078|stage IV breast cancer|stage iv breast cancer
454385|NCT00026078|recurrent breast cancer|recurrent breast cancer
454386|NCT00026117|stage IV colon cancer|stage iv colon cancer
454387|NCT00026117|stage IV breast cancer|stage iv breast cancer
454388|NCT00026117|recurrent breast cancer|recurrent breast cancer
454389|NCT00026117|stage IV rectal cancer|stage iv rectal cancer
454390|NCT00026117|recurrent colon cancer|recurrent colon cancer
454391|NCT00026117|recurrent rectal cancer|recurrent rectal cancer
454392|NCT00026117|male breast cancer|male breast cancer
454393|NCT00026130|stage II pancreatic cancer|stage ii pancreatic cancer
454394|NCT00026130|stage III pancreatic cancer|stage iii pancreatic cancer
454395|NCT00026130|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
454396|NCT00026156|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
454397|NCT00026156|squamous cell lung cancer|squamous cell lung cancer
454398|NCT00026156|large cell lung cancer|large cell lung cancer
454399|NCT00026156|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
454400|NCT00026156|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
454401|NCT00026156|adenocarcinoma of the lung|adenocarcinoma of the lung
454402|NCT00026195|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
454403|NCT00026247|bone metastases|bone metastases
454404|NCT00026247|pain|pain
454405|NCT00026247|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
454406|NCT00026260|recurrent cervical cancer|recurrent cervical cancer
454616|NCT00026663|Assays|assays
454407|NCT00026260|cervical squamous cell carcinoma|cervical squamous cell carcinoma
454408|NCT00026273|stage III colon cancer|stage iii colon cancer
454409|NCT00026273|stage III rectal cancer|stage iii rectal cancer
454410|NCT00026273|adenocarcinoma of the colon|adenocarcinoma of the colon
454411|NCT00026273|adenocarcinoma of the rectum|adenocarcinoma of the rectum
454412|NCT00026286|stage I breast cancer|stage i breast cancer
454413|NCT00026286|stage II breast cancer|stage ii breast cancer
454414|NCT00026286|breast cancer in situ|breast cancer in situ
454415|NCT00026286|ductal breast carcinoma|ductal breast carcinoma
454416|NCT00026286|hot flashes|hot flashes
454417|NCT00026286|menopausal symptoms|menopausal symptoms
454418|NCT00026299|stage IV colon cancer|stage iv colon cancer
454419|NCT00026299|stage IV rectal cancer|stage iv rectal cancer
454420|NCT00026299|recurrent colon cancer|recurrent colon cancer
454421|NCT00026299|recurrent rectal cancer|recurrent rectal cancer
454422|NCT00026299|adenocarcinoma of the colon|adenocarcinoma of the colon
454423|NCT00026299|adenocarcinoma of the rectum|adenocarcinoma of the rectum
454424|NCT00026338|stage III pancreatic cancer|stage iii pancreatic cancer
454425|NCT00026338|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
454426|NCT00026338|stage IV pancreatic cancer|stage iv pancreatic cancer
454427|NCT00026351|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
454428|NCT00026351|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
454429|NCT00026351|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
454430|NCT00026351|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
454431|NCT00026351|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
454432|NCT00026351|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
454433|NCT00026351|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
454434|NCT00026351|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
454435|NCT00026351|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
454436|NCT00026351|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
454437|NCT00026351|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
454438|NCT00026351|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
454439|NCT00026351|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
454440|NCT00026351|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
454441|NCT00026351|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
454442|NCT00026351|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
454443|NCT00026351|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
454444|NCT00026351|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
454445|NCT00026351|prolymphocytic leukemia|prolymphocytic leukemia
583597|NCT00512330|lipoarabinomannan|lipoarabinomannan
454446|NCT00026351|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
454447|NCT00026351|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
454448|NCT00026351|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
454449|NCT00026351|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
454450|NCT00026351|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
454451|NCT00026351|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
454452|NCT00026351|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
454453|NCT00026351|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
454454|NCT00026351|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
454455|NCT00026351|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
454456|NCT00026351|stage I marginal zone lymphoma|stage i marginal zone lymphoma
454457|NCT00026351|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
454458|NCT00026351|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
454459|NCT00026351|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
454460|NCT00026351|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
454461|NCT00026351|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
454462|NCT00026351|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
454463|NCT00026351|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
454464|NCT00026351|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
454465|NCT00026364|stage IV colon cancer|stage iv colon cancer
454466|NCT00026364|stage IV rectal cancer|stage iv rectal cancer
454467|NCT00026364|recurrent colon cancer|recurrent colon cancer
454468|NCT00026364|recurrent rectal cancer|recurrent rectal cancer
454469|NCT00026364|adenocarcinoma of the colon|adenocarcinoma of the colon
454470|NCT00026364|adenocarcinoma of the rectum|adenocarcinoma of the rectum
454471|NCT00026377|adenocarcinoma of the prostate|adenocarcinoma of the prostate
454472|NCT00026377|stage IIB prostate cancer|stage iib prostate cancer
454473|NCT00026377|stage IIA prostate cancer|stage iia prostate cancer
454474|NCT00026377|stage III prostate cancer|stage iii prostate cancer
454475|NCT00026377|stage IV prostate cancer|stage iv prostate cancer
454476|NCT00026403|stage III pancreatic cancer|stage iii pancreatic cancer
454477|NCT00026403|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
454478|NCT00026403|stage IV pancreatic cancer|stage iv pancreatic cancer
454479|NCT00026416|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
454480|NCT00026416|localized osteosarcoma|localized osteosarcoma
454481|NCT00026416|metastatic osteosarcoma|metastatic osteosarcoma
454482|NCT00026416|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
454483|NCT00026416|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
454484|NCT00026429|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
454485|NCT00026429|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
454486|NCT00026429|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
454487|NCT00026429|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
454488|NCT00026429|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
454489|NCT00026429|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
454490|NCT00026429|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
454491|NCT00026429|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
454492|NCT00026429|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
454493|NCT00026429|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
454494|NCT00026429|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
454495|NCT00026429|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
454496|NCT00026429|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
454497|NCT00026429|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
454498|NCT00026429|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
454499|NCT00026429|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
454500|NCT00026429|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
454501|NCT00026429|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
454502|NCT00026429|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
454503|NCT00026429|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
454504|NCT00026429|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
454505|NCT00026429|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
454617|NCT00026663|Resistance|resistance
454506|NCT00026429|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
454507|NCT00026429|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
454508|NCT00026429|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
454509|NCT00026429|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
454510|NCT00026429|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
454511|NCT00026429|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
454512|NCT00026429|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
454513|NCT00026429|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
454514|NCT00026429|stage I mantle cell lymphoma|stage i mantle cell lymphoma
201025|NCT02112591|tape|tape
454515|NCT00026429|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
454516|NCT00026429|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
454517|NCT00026429|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
454518|NCT00026429|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
454519|NCT00026429|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
454520|NCT00026429|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
454521|NCT00026429|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
454522|NCT00026429|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
454523|NCT00026429|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
454524|NCT00026429|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
454525|NCT00026429|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
454526|NCT00026429|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
454527|NCT00026429|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
454528|NCT00026429|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
454529|NCT00026429|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
454530|NCT00026429|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
454531|NCT00026429|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
454532|NCT00026429|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
454533|NCT00026429|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
454534|NCT00026429|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
454535|NCT00026429|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
454536|NCT00026429|stage I marginal zone lymphoma|stage i marginal zone lymphoma
454537|NCT00026429|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
454538|NCT00026429|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
454539|NCT00026429|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
454540|NCT00026429|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
454541|NCT00026429|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
454542|NCT00026429|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
454543|NCT00026429|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
454544|NCT00026429|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
454545|NCT00026442|stage IV breast cancer|stage iv breast cancer
454546|NCT00026442|stage IIIA breast cancer|stage iiia breast cancer
454547|NCT00026442|stage IIIB breast cancer|stage iiib breast cancer
454548|NCT00026442|stage IIIC breast cancer|stage iiic breast cancer
454549|NCT00026468|colon cancer|colon cancer
454550|NCT00026468|rectal cancer|rectal cancer
454551|NCT00026468|small intestine cancer|small intestine cancer
454552|NCT00026494|tumors metastatic to brain|tumors metastatic to brain
454553|NCT00026520|stage IV melanoma|stage iv melanoma
454554|NCT00026520|recurrent melanoma|recurrent melanoma
454555|NCT00026533|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
454556|NCT00026533|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
454557|NCT00026533|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
454558|NCT00026533|recurrent thyroid cancer|recurrent thyroid cancer
454559|NCT00026533|insular thyroid cancer|insular thyroid cancer
454560|NCT00026546|Stop Task|stop task
454561|NCT00026546|Functional (BOLD) MRI|functional (bold) mri
454562|NCT00026546|Developmental|developmental
454563|NCT00026546|Inhibitory Control|inhibitory control
454564|NCT00026546|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
454565|NCT00026546|ADHD|adhd
454566|NCT00026546|Impulsivity|impulsivity
454567|NCT00026546|Healthy Volunteer|healthy volunteer
454568|NCT00026546|Normal Volunteer|normal volunteer
454569|NCT00026546|HV|hv
454570|NCT00026559|Classical Conditioning|classical conditioning
454571|NCT00026559|Fear Conditioning|fear conditioning
454572|NCT00026559|Stress|stress
454573|NCT00026559|Anxiety|anxiety
454574|NCT00026559|Learning|learning
454575|NCT00026559|Normal Volunteers|normal volunteers
454576|NCT00026559|Adults|adults
454577|NCT00026559|Healthy Volunteer|healthy volunteer
454578|NCT00026559|Normal Control|normal control
583598|NCT00512330|ELISA|elisa
454579|NCT00026585|Bipolar Disorder|bipolar disorder
454580|NCT00026585|Antimanic|antimanic
454581|NCT00026585|Placebo Controlled|placebo controlled
454582|NCT00026585|Randomized|randomized
454583|NCT00026585|Cytochrome P450|cytochrome p450
454584|NCT00026585|Mania|mania
454585|NCT00026585|PKC Inhibitor|pkc inhibitor
454586|NCT00026585|Tamoxifen|tamoxifen
454587|NCT00026585|Bipolar|bipolar
454588|NCT00026585|Manic|manic
454589|NCT00026585|BPD|bpd
454590|NCT00026598|Basal Ganglia|basal ganglia
454591|NCT00026598|Cerebral Cortex|cerebral cortex
454592|NCT00026598|Functional Neuroanatomy|functional neuroanatomy
454593|NCT00026598|Bradykinesia|bradykinesia
454594|NCT00026598|Bradyphrenia|bradyphrenia
454595|NCT00026598|Parkinson's Disease|parkinson's disease
454596|NCT00026598|Parkinson Disease|parkinson disease
454597|NCT00026598|PD|pd
454598|NCT00026598|Healthy Volunteer|healthy volunteer
454599|NCT00026598|HV|hv
454600|NCT00026598|Normal Control|normal control
454601|NCT00026611|Vaccine prophylaxis|vaccine prophylaxis
454607|NCT00026624|Adoptive Transfer|adoptive transfer
454608|NCT00026624|Keyhole-Limpet Hemocyanin|keyhole-limpet hemocyanin
454609|NCT00026624|HIV Therapeutic Vaccine|hiv therapeutic vaccine
454611|NCT00026637|epilepsy|epilepsy
454612|NCT00026637|seizures|seizures
454613|NCT00026650|Late Effects|late effects
454614|NCT00026650|Radiation Therapy|radiation therapy
454615|NCT00026650|Cancer|cancer
454618|NCT00026663|Biopsy Samples|biopsy samples
454619|NCT00026663|Specimen Acquisition|specimen acquisition
454620|NCT00026663|Cancer Cells|cancer cells
454621|NCT00026676|Surrogate Markers|surrogate markers
454622|NCT00026676|Genotypic Resistance|genotypic resistance
454623|NCT00026676|Phenotypic Resistance|phenotypic resistance
454624|NCT00026676|Selenium|selenium
454625|NCT00026689|Evaluation|evaluation
454626|NCT00026689|Screening|screening
454627|NCT00026689|Cancer|cancer
454628|NCT00026689|Radiation|radiation
454629|NCT00026689|Eligibility|eligibility
454630|NCT00026702|Acute Renal Failure|acute renal failure
454631|NCT00026702|Biomarkers|biomarkers
454632|NCT00026715|Renal Function|renal function
454633|NCT00026715|Iothalamate|iothalamate
454634|NCT00026728|Human Herpesvirus B|human herpesvirus b
454635|NCT00026728|NHANES|nhanes
454636|NCT00026728|Epidemiology|epidemiology
454637|NCT00026728|Population-Based Study|population-based study
454638|NCT00026728|Kaposi's Sarcoma Herpes Virus|kaposi's sarcoma herpes virus
454639|NCT00026741|Cytokine|cytokine
454640|NCT00026741|Inflammation|inflammation
454641|NCT00026741|Lymphocyte|lymphocyte
454642|NCT00026741|T Cell|t cell
454643|NCT00026741|Migration|migration
454644|NCT00026741|Healthy Volunteer|healthy volunteer
454645|NCT00026741|Skin Biopsy|skin biopsy
454653|NCT00026767|Risk Factors|risk factors
454654|NCT00026767|Epidemiology|epidemiology
454655|NCT00026767|BMT/SCT|bmt/sct
454656|NCT00026767|Fungal Infection|fungal infection
454657|NCT00026767|Bone Marrow Stem Cell Transplant|bone marrow stem cell transplant
454658|NCT00026767|Organ Transplant|organ transplant
454659|NCT00026780|CT Scan|ct scan
454660|NCT00026780|MRI Scan|mri scan
454661|NCT00026780|Childhood Cancer|childhood cancer
454662|NCT00026780|Eligibility Screening|eligibility screening
454663|NCT00026780|Tissue Procurement|tissue procurement
454664|NCT00026780|Pediatric|pediatric
454665|NCT00026780|Children|children
454666|NCT00026780|Screening|screening
454667|NCT00026793|Kaposi Sarcoma|kaposi sarcoma
454668|NCT00026793|Doppler|doppler
454669|NCT00026793|Infrared|infrared
454670|NCT00026793|HIV|hiv
454671|NCT00026793|Imaging|imaging
454672|NCT00026793|Kaposi's Sarcoma|kaposi's sarcoma
454673|NCT00026793|Laser Imaging|laser imaging
454674|NCT00026793|Infrared Imaging|infrared imaging
454675|NCT00026806|HIV Infection|hiv infection
454676|NCT00026806|Mental Health|mental health
454677|NCT00026806|Risk Behaviors|risk behaviors
454678|NCT00026806|Post-Traumatic Stress Disorder|post-traumatic stress disorder
454679|NCT00026806|Youth|youth
454680|NCT00026806|HIV|hiv
454681|NCT00026806|Long Term Survivor|long term survivor
454682|NCT00026819|NSAID|nsaid
454683|NCT00026819|Acute Pain Model|acute pain model
454684|NCT00026819|Hyperalgesia|hyperalgesia
454685|NCT00026819|Central Sensitization|central sensitization
454686|NCT00026819|Wisdom Teeth|wisdom teeth
454687|NCT00026819|Wisdom Teeth Extraction|wisdom teeth extraction
454688|NCT00026819|Third Molar|third molar
454689|NCT00026832|PET|pet
454690|NCT00026832|Major Depression|major depression
454691|NCT00026832|MRI|mri
454692|NCT00026832|Cerebral Blood Flow|cerebral blood flow
454693|NCT00026832|Neuroendocrine|neuroendocrine
454694|NCT00026832|Bipolar Disorder|bipolar disorder
454695|NCT00026832|Serotonin1A|serotonin1a
454696|NCT00026832|Mood Disorder|mood disorder
454697|NCT00026832|Major Depressive Disorder|major depressive disorder
454698|NCT00026832|MDD|mdd
454699|NCT00026832|Depression|depression
454700|NCT00026832|Healthy Volunteer|healthy volunteer
454701|NCT00026832|HV|hv
454702|NCT00026832|Normal Control|normal control
454703|NCT00026858|Bone Marrow Transplantation|bone marrow transplantation
454704|NCT00026858|Leukemia|leukemia
454705|NCT00026858|Breast Cancer|breast cancer
454706|NCT00026858|Multiple Myeloma|multiple myeloma
454707|NCT00026858|Total Body Irradiation|total body irradiation
454708|NCT00026871|Non-Therapeutic|non-therapeutic
454709|NCT00026871|Radiation Therapy|radiation therapy
454710|NCT00026871|Dosimetry|dosimetry
454711|NCT00026871|Dose-Rate|dose-rate
454714|NCT00026884|Collection of Tissue|collection of tissue
454715|NCT00026884|Malignant Disease|malignant disease
454722|NCT00026910|Cell-Cycle|cell-cycle
454723|NCT00026910|Apoptosis|apoptosis
454724|NCT00026910|Molecular Prognosis|molecular prognosis
454726|NCT00026923|Telemedicine|telemedicine
454727|NCT00026923|Surgery|surgery
454728|NCT00026923|Endoscopy|endoscopy
454729|NCT00026936|External Beam Radiotherapy|external beam radiotherapy
454730|NCT00026936|TCP|tcp
454731|NCT00026936|DVH|dvh
454732|NCT00026936|NTCP|ntcp
454733|NCT00026936|3-D Programming|3-d programming
454734|NCT00026949|Etoposide|etoposide
454735|NCT00026949|Breast Cancer|breast cancer
454736|NCT00026949|Pharmacokinetics|pharmacokinetics
454737|NCT00026962|Breast|breast
454738|NCT00026962|Hormones|hormones
454739|NCT00026962|Prevention|prevention
454740|NCT00026962|Saliva|saliva
454741|NCT00026962|Serum|serum
454742|NCT00026975|Laryngeal Cancer|laryngeal cancer
454743|NCT00026975|Laryngectomy|laryngectomy
454744|NCT00026975|Tissue Oxygenation|tissue oxygenation
454745|NCT00026975|Irradiated Tissue|irradiated tissue
454746|NCT00026975|Hyperbaric Oxygen|hyperbaric oxygen
454747|NCT00026975|Angiogenesis|angiogenesis
454748|NCT00026975|EF5|ef5
454749|NCT00026988|Huntington's disease|huntington's disease
454750|NCT00026988|creatine|creatine
454751|NCT00026988|energy depletion|energy depletion
454752|NCT00009971|limited stage small cell lung cancer|limited stage small cell lung cancer
454753|NCT00009971|extensive stage small cell lung cancer|extensive stage small cell lung cancer
454754|NCT00009971|recurrent small cell lung cancer|recurrent small cell lung cancer
454755|NCT00009997|stage II breast cancer|stage ii breast cancer
454756|NCT00009997|stage IIIA breast cancer|stage iiia breast cancer
454757|NCT00009997|stage IIIB breast cancer|stage iiib breast cancer
454758|NCT00010010|stage IV breast cancer|stage iv breast cancer
454759|NCT00010010|recurrent breast cancer|recurrent breast cancer
454760|NCT00010023|stage IV breast cancer|stage iv breast cancer
454761|NCT00010023|stage IIIA breast cancer|stage iiia breast cancer
454762|NCT00010023|recurrent breast cancer|recurrent breast cancer
454763|NCT00010023|stage III gastric cancer|stage iii gastric cancer
454764|NCT00010023|stage IV gastric cancer|stage iv gastric cancer
454765|NCT00010023|recurrent gastric cancer|recurrent gastric cancer
454766|NCT00010023|stage IIIB breast cancer|stage iiib breast cancer
454767|NCT00010023|stage IIIC breast cancer|stage iiic breast cancer
454768|NCT00010023|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
454769|NCT00010023|stage III pancreatic cancer|stage iii pancreatic cancer
454770|NCT00010023|recurrent pancreatic cancer|recurrent pancreatic cancer
454771|NCT00010023|stage III esophageal cancer|stage iii esophageal cancer
454772|NCT00010023|stage IV esophageal cancer|stage iv esophageal cancer
454773|NCT00010023|recurrent esophageal cancer|recurrent esophageal cancer
454774|NCT00010023|extensive stage small cell lung cancer|extensive stage small cell lung cancer
454775|NCT00010023|recurrent small cell lung cancer|recurrent small cell lung cancer
454776|NCT00010023|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
454777|NCT00010023|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
454778|NCT00010023|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
454779|NCT00010023|advanced adult primary liver cancer|advanced adult primary liver cancer
454780|NCT00010023|recurrent adult primary liver cancer|recurrent adult primary liver cancer
454781|NCT00010023|small intestine adenocarcinoma|small intestine adenocarcinoma
454782|NCT00010023|unresectable gallbladder cancer|unresectable gallbladder cancer
454783|NCT00010023|recurrent gallbladder cancer|recurrent gallbladder cancer
454784|NCT00010023|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
454785|NCT00010023|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
454786|NCT00010023|recurrent small intestine cancer|recurrent small intestine cancer
454787|NCT00010023|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
454788|NCT00010023|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
454789|NCT00010023|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
583599|NCT00512330|Tuberculosis in Childhood|tuberculosis in childhood
454790|NCT00010023|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
454791|NCT00010023|pulmonary carcinoid tumor|pulmonary carcinoid tumor
454792|NCT00010023|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
12563|NCT03210493|hepatitis B virus|hepatitis b virus
454793|NCT00010023|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
454794|NCT00010023|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
454795|NCT00010023|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
454796|NCT00010023|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
454797|NCT00010023|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
454121|NCT00025558|adult glioblastoma|adult glioblastoma
454798|NCT00010023|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
454799|NCT00010023|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
454800|NCT00010023|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
454856|NCT00010049|adult mixed glioma|adult mixed glioma
474750|NCT00078013|STEMI|stemi
454801|NCT00010023|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
454802|NCT00010023|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
454803|NCT00010023|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
454804|NCT00010023|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
454805|NCT00010023|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
454806|NCT00010023|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
454807|NCT00010023|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
454808|NCT00010023|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
454809|NCT00010023|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
454810|NCT00010023|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
454811|NCT00010023|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
454812|NCT00010023|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
454813|NCT00010023|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
454814|NCT00010023|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
454815|NCT00010023|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
454816|NCT00010023|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
454817|NCT00010023|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
454818|NCT00010023|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
454819|NCT00010023|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
454820|NCT00010023|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
454821|NCT00010023|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
454822|NCT00010023|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
454823|NCT00010023|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
454824|NCT00010023|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
454825|NCT00010023|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
454826|NCT00010023|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
454827|NCT00010023|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
454828|NCT00010023|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
454829|NCT00010023|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
454830|NCT00010023|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
454831|NCT00010023|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
454832|NCT00010023|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
454833|NCT00010023|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
454834|NCT00010023|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
454835|NCT00010023|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
454836|NCT00010023|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
454837|NCT00010023|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
454943|NCT00010283|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
454838|NCT00010023|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
454839|NCT00010023|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
454840|NCT00010023|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
454841|NCT00010023|carcinoma of the appendix|carcinoma of the appendix
454842|NCT00010023|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
454843|NCT00010023|gastrointestinal stromal tumor|gastrointestinal stromal tumor
454844|NCT00010023|recurrent salivary gland cancer|recurrent salivary gland cancer
454845|NCT00010023|stage III salivary gland cancer|stage iii salivary gland cancer
454846|NCT00010023|stage IV salivary gland cancer|stage iv salivary gland cancer
454185|NCT00025701|Cortex|cortex
454847|NCT00010023|stage IV pancreatic cancer|stage iv pancreatic cancer
454848|NCT00010036|adult glioblastoma|adult glioblastoma
454849|NCT00010036|adult giant cell glioblastoma|adult giant cell glioblastoma
454850|NCT00010036|adult gliosarcoma|adult gliosarcoma
454851|NCT00010049|recurrent adult brain tumor|recurrent adult brain tumor
454852|NCT00010049|adult meningioma|adult meningioma
454853|NCT00010049|adult glioblastoma|adult glioblastoma
454854|NCT00010049|adult anaplastic astrocytoma|adult anaplastic astrocytoma
454855|NCT00010049|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
455544|NCT00027274|Hereditary|hereditary
454857|NCT00010049|adult pilocytic astrocytoma|adult pilocytic astrocytoma
454858|NCT00010049|adult subependymoma|adult subependymoma
454859|NCT00010049|adult grade III meningioma|adult grade iii meningioma
454860|NCT00010049|adult giant cell glioblastoma|adult giant cell glioblastoma
454861|NCT00010049|adult gliosarcoma|adult gliosarcoma
454862|NCT00010062|stage I pancreatic cancer|stage i pancreatic cancer
454863|NCT00010062|stage II pancreatic cancer|stage ii pancreatic cancer
454864|NCT00010062|stage III pancreatic cancer|stage iii pancreatic cancer
454865|NCT00010062|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
454866|NCT00010062|stage IV pancreatic cancer|stage iv pancreatic cancer
454867|NCT00010075|stage IV breast cancer|stage iv breast cancer
454868|NCT00010075|recurrent breast cancer|recurrent breast cancer
454869|NCT00010088|stage II pancreatic cancer|stage ii pancreatic cancer
454870|NCT00010088|stage III pancreatic cancer|stage iii pancreatic cancer
454871|NCT00010088|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
454872|NCT00010088|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
454873|NCT00010088|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
454874|NCT00010088|stage IV pancreatic cancer|stage iv pancreatic cancer
454875|NCT00010101|childhood choroid plexus tumor|childhood choroid plexus tumor
454876|NCT00010101|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
454877|NCT00010101|untreated childhood medulloblastoma|untreated childhood medulloblastoma
454878|NCT00010101|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
454879|NCT00010114|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
454880|NCT00010114|childhood choroid plexus tumor|childhood choroid plexus tumor
454881|NCT00010114|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
454882|NCT00010114|untreated childhood medulloblastoma|untreated childhood medulloblastoma
454883|NCT00010114|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
454884|NCT00010127|adenocarcinoma of the prostate|adenocarcinoma of the prostate
454885|NCT00010127|stage IV prostate cancer|stage iv prostate cancer
454886|NCT00010140|stage II breast cancer|stage ii breast cancer
454887|NCT00010140|stage IIIA breast cancer|stage iiia breast cancer
454888|NCT00010140|stage IIIB breast cancer|stage iiib breast cancer
454889|NCT00010140|stage IIIC breast cancer|stage iiic breast cancer
454890|NCT00010153|stage I breast cancer|stage i breast cancer
454891|NCT00010153|stage II breast cancer|stage ii breast cancer
454892|NCT00010166|stage I pancreatic cancer|stage i pancreatic cancer
454893|NCT00010166|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
454894|NCT00010179|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
454895|NCT00010179|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
454896|NCT00010179|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
454897|NCT00010179|fallopian tube cancer|fallopian tube cancer
454898|NCT00010179|peritoneal cavity cancer|peritoneal cavity cancer
454899|NCT00010218|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
454900|NCT00010218|squamous cell lung cancer|squamous cell lung cancer
454901|NCT00010218|large cell lung cancer|large cell lung cancer
454902|NCT00010218|adenocarcinoma of the lung|adenocarcinoma of the lung
454903|NCT00010218|adenosquamous cell lung cancer|adenosquamous cell lung cancer
454904|NCT00010218|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
454905|NCT00010231|adenocarcinoma of the prostate|adenocarcinoma of the prostate
454906|NCT00010231|stage III prostate cancer|stage iii prostate cancer
454907|NCT00010231|stage IV prostate cancer|stage iv prostate cancer
454908|NCT00010231|recurrent prostate cancer|recurrent prostate cancer
454909|NCT00010244|stage IIB prostate cancer|stage iib prostate cancer
454910|NCT00010244|stage IIA prostate cancer|stage iia prostate cancer
454911|NCT00010244|stage III prostate cancer|stage iii prostate cancer
454912|NCT00010257|thymoma|thymoma
454913|NCT00010257|thymic carcinoma|thymic carcinoma
454914|NCT00010270|stage IV colon cancer|stage iv colon cancer
454915|NCT00010270|stage IV rectal cancer|stage iv rectal cancer
454916|NCT00010270|recurrent colon cancer|recurrent colon cancer
454917|NCT00010270|recurrent rectal cancer|recurrent rectal cancer
454918|NCT00010270|adenocarcinoma of the colon|adenocarcinoma of the colon
454919|NCT00010270|stage III pancreatic cancer|stage iii pancreatic cancer
454920|NCT00010270|stage II pancreatic cancer|stage ii pancreatic cancer
454921|NCT00010270|recurrent pancreatic cancer|recurrent pancreatic cancer
454922|NCT00010270|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
454923|NCT00010270|stage IV gastric cancer|stage iv gastric cancer
454924|NCT00010270|adenocarcinoma of the stomach|adenocarcinoma of the stomach
454925|NCT00010270|recurrent gastric cancer|recurrent gastric cancer
454926|NCT00010270|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
454927|NCT00010270|stage IV esophageal cancer|stage iv esophageal cancer
454928|NCT00010270|stage III esophageal cancer|stage iii esophageal cancer
454929|NCT00010270|recurrent esophageal cancer|recurrent esophageal cancer
454930|NCT00010270|stage II esophageal cancer|stage ii esophageal cancer
454931|NCT00010270|adenocarcinoma of the rectum|adenocarcinoma of the rectum
454932|NCT00010270|stage III colon cancer|stage iii colon cancer
454933|NCT00010270|stage III rectal cancer|stage iii rectal cancer
454934|NCT00010270|stage III gastric cancer|stage iii gastric cancer
454935|NCT00010270|stage IV pancreatic cancer|stage iv pancreatic cancer
454936|NCT00010283|stage III breast cancer|stage iii breast cancer
454937|NCT00010283|stage IV breast cancer|stage iv breast cancer
454938|NCT00010283|stage IIIA breast cancer|stage iiia breast cancer
454939|NCT00010283|stage IIIB breast cancer|stage iiib breast cancer
454940|NCT00010283|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
454941|NCT00010283|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
454942|NCT00010283|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
454944|NCT00010283|Burkitt lymphoma|burkitt lymphoma
454945|NCT00010283|extramedullary plasmacytoma|extramedullary plasmacytoma
454946|NCT00010283|refractory multiple myeloma|refractory multiple myeloma
454947|NCT00010283|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
454948|NCT00010283|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
454949|NCT00010283|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
454950|NCT00010283|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
454951|NCT00010283|disseminated neuroblastoma|disseminated neuroblastoma
454952|NCT00010283|recurrent neuroblastoma|recurrent neuroblastoma
454953|NCT00010283|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
454954|NCT00010283|stage I multiple myeloma|stage i multiple myeloma
454955|NCT00010283|stage II multiple myeloma|stage ii multiple myeloma
454956|NCT00010283|stage III multiple myeloma|stage iii multiple myeloma
454957|NCT00010283|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
454958|NCT00010283|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
454959|NCT00010283|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
454960|NCT00010283|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
454961|NCT00010283|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
454962|NCT00010283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
454963|NCT00010283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
454964|NCT00010283|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
454965|NCT00010283|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
454966|NCT00010283|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
454967|NCT00010283|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
454968|NCT00010283|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
454969|NCT00010283|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
454970|NCT00010283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
454971|NCT00010283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
454972|NCT00010283|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
454973|NCT00010283|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
454974|NCT00010283|essential thrombocythemia|essential thrombocythemia
454975|NCT00010283|testicular embryonal carcinoma|testicular embryonal carcinoma
454976|NCT00010283|testicular choriocarcinoma|testicular choriocarcinoma
454977|NCT00010283|testicular teratoma|testicular teratoma
454978|NCT00010283|testicular yolk sac tumor|testicular yolk sac tumor
454979|NCT00010283|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
454980|NCT00010283|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
454981|NCT00010283|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
454982|NCT00010283|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
454983|NCT00010283|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
454984|NCT00010283|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
454985|NCT00010283|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
454986|NCT00010283|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
454987|NCT00010283|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
454988|NCT00010283|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
454989|NCT00010283|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
454990|NCT00010283|refractory hairy cell leukemia|refractory hairy cell leukemia
454991|NCT00010283|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
454992|NCT00010283|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
454993|NCT00010283|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
454994|NCT00010283|ovarian yolk sac tumor|ovarian yolk sac tumor
454995|NCT00010283|ovarian embryonal carcinoma|ovarian embryonal carcinoma
454996|NCT00010283|ovarian polyembryoma|ovarian polyembryoma
454997|NCT00010283|ovarian choriocarcinoma|ovarian choriocarcinoma
454998|NCT00010283|ovarian immature teratoma|ovarian immature teratoma
471896|NCT00076427|Hepatitis C|hepatitis c
454999|NCT00010283|ovarian mature teratoma|ovarian mature teratoma
455000|NCT00010283|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
455001|NCT00010283|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
455002|NCT00010283|acute undifferentiated leukemia|acute undifferentiated leukemia
455003|NCT00010283|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
455004|NCT00010283|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
455005|NCT00010283|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
455006|NCT00010283|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
455007|NCT00010283|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
455008|NCT00010283|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
455009|NCT00010283|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
455010|NCT00010283|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
455011|NCT00010283|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
455012|NCT00010283|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
455013|NCT00010283|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
455014|NCT00010283|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
455015|NCT00010283|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
455016|NCT00010283|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
455017|NCT00010283|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
455018|NCT00010283|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
455019|NCT00010283|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
455020|NCT00010283|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
455021|NCT00010283|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
455022|NCT00010283|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
455023|NCT00010283|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
455024|NCT00010283|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
455025|NCT00010283|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
455026|NCT00010283|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
455027|NCT00010283|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
455028|NCT00010283|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
455029|NCT00010283|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
455030|NCT00010283|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
455031|NCT00010283|secondary acute myeloid leukemia|secondary acute myeloid leukemia
455032|NCT00010283|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
455033|NCT00010283|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
455034|NCT00010283|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
455035|NCT00010283|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
455036|NCT00010283|graft versus host disease|graft versus host disease
455037|NCT00010283|prolymphocytic leukemia|prolymphocytic leukemia
455038|NCT00010283|primary systemic amyloidosis|primary systemic amyloidosis
455039|NCT00010283|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
455040|NCT00010283|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
455041|NCT00010283|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
455042|NCT00010283|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
455043|NCT00010283|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
455044|NCT00010283|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
455045|NCT00010283|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
455046|NCT00010283|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
455047|NCT00010283|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
455048|NCT00010283|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
455049|NCT00010283|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
455050|NCT00010283|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
455051|NCT00010283|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
455052|NCT00010283|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
455053|NCT00010283|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
455054|NCT00010283|anaplastic large cell lymphoma|anaplastic large cell lymphoma
12564|NCT03210493|Treg Cells|treg cells
455055|NCT00010283|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
455056|NCT00010283|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
455057|NCT00010283|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
455058|NCT00010283|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
455059|NCT00010283|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
455060|NCT00010283|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
471897|NCT00076427|HCV|hcv
455061|NCT00010283|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
455062|NCT00010283|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
455063|NCT00010283|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
455064|NCT00010283|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
455545|NCT00027274|Bone Marrow|bone marrow
455065|NCT00010283|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
455066|NCT00010283|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
455067|NCT00010283|splenic marginal zone lymphoma|splenic marginal zone lymphoma
455068|NCT00010283|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
455069|NCT00010309|stage II melanoma|stage ii melanoma
455070|NCT00010309|stage III melanoma|stage iii melanoma
455071|NCT00010309|stage IV melanoma|stage iv melanoma
455072|NCT00010322|stage IV breast cancer|stage iv breast cancer
455073|NCT00010322|recurrent breast cancer|recurrent breast cancer
455074|NCT00010335|arthritis & connective tissue diseases|arthritis & connective tissue diseases
455075|NCT00010335|dermatomyositis|dermatomyositis
455076|NCT00010335|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
455077|NCT00010335|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
455078|NCT00010335|rare disease|rare disease
455079|NCT00010335|systemic lupus erythematosus|systemic lupus erythematosus
455080|NCT00010335|systemic sclerosis|systemic sclerosis
455081|NCT00010374|Diaphragm for Ventilatory Assist|diaphragm for ventilatory assist
455082|NCT00010374|environmental/toxic disorders|environmental/toxic disorders
455083|NCT00010374|neurologic and psychiatric disorders|neurologic and psychiatric disorders
455084|NCT00010374|rare disease|rare disease
455085|NCT00010374|spinal cord injury|spinal cord injury
455086|NCT00010387|Felty syndrome|felty syndrome
455087|NCT00010387|autoimmune hemolytic anemia|autoimmune hemolytic anemia
455088|NCT00010387|autoimmune neutropenia|autoimmune neutropenia
455089|NCT00010387|hematologic disorders|hematologic disorders
455090|NCT00010387|immune thrombocytopenic purpura|immune thrombocytopenic purpura
455091|NCT00010387|rare disease|rare disease
455092|NCT00010400|antiphospholipid antibody syndrome|antiphospholipid antibody syndrome
455093|NCT00010400|arthritis & connective tissue diseases|arthritis & connective tissue diseases
455094|NCT00010400|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
455095|NCT00010400|rare disease|rare disease
455096|NCT00010400|systemic lupus erythematosus|systemic lupus erythematosus
455097|NCT00010413|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
455098|NCT00010413|pemphigus|pemphigus
455099|NCT00010413|rare disease|rare disease
455100|NCT00010426|cystinosis|cystinosis
455101|NCT00010426|rare disease|rare disease
455102|NCT00010426|renal and genitourinary disorders|renal and genitourinary disorders
455103|NCT00010439|arthritis & connective tissue diseases|arthritis & connective tissue diseases
455104|NCT00010439|idiopathic juvenile osteoporosis|idiopathic juvenile osteoporosis
455105|NCT00010439|rare disease|rare disease
455106|NCT00010452|cystic hygroma|cystic hygroma
455107|NCT00010452|lymphangiomas|lymphangiomas
455108|NCT00010452|lymphatic malformations|lymphatic malformations
455109|NCT00010491|Diarrhea|diarrhea
455110|NCT00010491|complementary therapies|complementary therapies
455111|NCT00010504|acupuncture|acupuncture
455112|NCT00010504|fibromyalgia|fibromyalgia
455113|NCT00010504|pain|pain
455114|NCT00010504|analgesia|analgesia
455115|NCT00010530|CVD|cvd
455116|NCT00010608|CVD|cvd
455117|NCT00010699|cvd|cvd
455118|NCT00010712|Menopause|menopause
455119|NCT00010712|Hot Flashes|hot flashes
455120|NCT00010712|Osteoporosis|osteoporosis
455121|NCT00010712|Postmenopausal|postmenopausal
455122|NCT00010725|CVD|cvd
455123|NCT00010829|Cardiovascular Diseases|cardiovascular diseases
455124|NCT00010829|Osteoporosis|osteoporosis
455125|NCT00010829|Breast Cancer|breast cancer
455126|NCT00010829|Endometrial Cancer|endometrial cancer
455127|NCT00010855|hypnosis|hypnosis
455128|NCT00010855|relaxation|relaxation
455129|NCT00010855|invasive medical procedures|invasive medical procedures
455130|NCT00010855|interventional radiology|interventional radiology
455131|NCT00010855|conscious sedation|conscious sedation
455132|NCT00010855|anesthesia|anesthesia
582635|NCT00508820|TPO|tpo
455133|NCT00010855|complications|complications
455134|NCT00010855|cost analysis|cost analysis
455135|NCT00010855|Interventional procedures, complications|interventional procedures, complications
455136|NCT00010855|Angiography|angiography
455137|NCT00010855|Nephrostomy|nephrostomy
455138|NCT00010855|Hepatic chemoembolization|hepatic chemoembolization
455139|NCT00010855|Fibroid Embolization|fibroid embolization
455140|NCT00010868|bipolar disorder|bipolar disorder
455141|NCT00010868|omega-3 fatty acids|omega-3 fatty acids
455142|NCT00010868|eicosapentaenoic acid|eicosapentaenoic acid
455143|NCT00010868|docosahexaenoic acid|docosahexaenoic acid
455144|NCT00010946|acupuncture|acupuncture
455145|NCT00010946|osteoarthritis|osteoarthritis
455146|NCT00010946|elderly|elderly
455147|NCT00010959|menopause|menopause
455148|NCT00010959|hot flashes|hot flashes
455149|NCT00010959|botanicals|botanicals
455150|NCT00010985|Backpain|backpain
455152|NCT00010985|Alternative Medicine|alternative medicine
455154|NCT00010985|Chiropractic|chiropractic
455155|NCT00010985|Massage Therapy|massage therapy
455156|NCT00010998|Multiple Sclerosis|multiple sclerosis
455157|NCT00010998|Yoga|yoga
455158|NCT00011011|HIV-1|hiv-1
456020|NCT00028314|Ritonavir|ritonavir
455159|NCT00011011|Drug Administration Schedule|drug administration schedule
455160|NCT00011011|AIDS Vaccines|aids vaccines
455161|NCT00011011|CD4 Lymphocyte Count|cd4 lymphocyte count
455162|NCT00011011|RNA, Viral|rna, viral
455163|NCT00011011|Anti-HIV Agents|anti-hiv agents
455164|NCT00011011|Viral Load|viral load
455165|NCT00011011|HIV Therapeutic Vaccine|hiv therapeutic vaccine
455166|NCT00011011|Treatment Interruption|treatment interruption
455167|NCT00011037|HIV Antibodies|hiv antibodies
455168|NCT00011037|HIV Antigens|hiv antigens
455169|NCT00011037|HIV Envelope Protein gp120|hiv envelope protein gp120
455170|NCT00011037|AIDS Vaccines|aids vaccines
455171|NCT00011037|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
455172|NCT00011037|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
455173|NCT00011037|Neutralization Tests|neutralization tests
455174|NCT00011037|Haiti|haiti
455175|NCT00011037|Brazil|brazil
455176|NCT00011037|Cytotoxicity, Immunologic|cytotoxicity, immunologic
455177|NCT00011037|Epitopes|epitopes
455178|NCT00011037|Viral Proteins|viral proteins
455179|NCT00011037|Trinidad and Tobago|trinidad and tobago
455180|NCT00011037|Peru|peru
455181|NCT00011037|HIV Preventive Vaccine|hiv preventive vaccine
455182|NCT00011037|HIV Seronegativity|hiv seronegativity
455183|NCT00011050|Specimen Handling|specimen handling
455184|NCT00011050|Blood|blood
455185|NCT00011050|Cryopreservation|cryopreservation
455186|NCT00011050|Lactic Acid|lactic acid
455187|NCT00011050|Sodium Fluoride|sodium fluoride
455188|NCT00011050|Oxalates|oxalates
455189|NCT00011063|Anti-Epileptic|anti-epileptic
455190|NCT00011063|CYP2C9|cyp2c9
455191|NCT00011063|Herbal|herbal
455192|NCT00011063|Interaction|interaction
455193|NCT00011063|Metabolism|metabolism
455194|NCT00011063|Drug Interaction|drug interaction
455195|NCT00011063|Drug Metabolism|drug metabolism
455196|NCT00011063|Ginko Biloba|ginko biloba
455197|NCT00011063|Healthy Volunteer|healthy volunteer
455198|NCT00011076|Deskar|deskar
455199|NCT00011076|Fibrosis|fibrosis
455200|NCT00011076|Myocardium|myocardium
455201|NCT00011076|Scarring|scarring
455202|NCT00011076|Arrhythmia|arrhythmia
455203|NCT00011076|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
455204|NCT00011076|Left Ventricular Diastolic Dysfunction|left ventricular diastolic dysfunction
455205|NCT00011076|Myocardial Fibrosis|myocardial fibrosis
455206|NCT00011089|HIV-1|hiv-1
455207|NCT00011089|Disease Progression|disease progression
455208|NCT00011089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
455209|NCT00011089|Anti-HIV Agents|anti-hiv agents
455210|NCT00011089|9-(2-phosphonylmethoxypropyl)adenine|9-(2-phosphonylmethoxypropyl)adenine
455211|NCT00011102|weight gain|weight gain
455212|NCT00011115|overweight|overweight
455213|NCT00011128|HIV-1|hiv-1
455214|NCT00011128|Drug Resistance, Microbial|drug resistance, microbial
455215|NCT00011128|Microbial Sensitivity Tests|microbial sensitivity tests
455216|NCT00011128|Salvage Therapy|salvage therapy
455217|NCT00011128|Anti-HIV Agents|anti-hiv agents
455218|NCT00011128|Viral Load|viral load
455219|NCT00011128|Treatment Experienced|treatment experienced
455220|NCT00011141|Immune-mediated diabetes mellitus|immune-mediated diabetes mellitus
455221|NCT00011180|Venous thromboembolism (VTE)|venous thromboembolism (vte)
455222|NCT00011180|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
455223|NCT00011180|Pulmonary embolism (PE)|pulmonary embolism (pe)
455224|NCT00011193|Cardiovascular Diseases|cardiovascular diseases
455225|NCT00011193|Hypertension|hypertension
455226|NCT00011193|Postmenopausal|postmenopausal
455227|NCT00011193|Overweight or Obese|overweight or obese
455228|NCT00011193|Women|women
455229|NCT00011193|Sedentary|sedentary
455230|NCT00011245|Arachnoiditis|arachnoiditis
455231|NCT00011245|Myelography|myelography
455232|NCT00011245|Intraoperative Ultrasonography|intraoperative ultrasonography
455233|NCT00011245|Magnetic Resonance|magnetic resonance
455234|NCT00011245|CSF Pressure|csf pressure
455235|NCT00011245|Trauma|trauma
455236|NCT00011245|Meningitis|meningitis
455237|NCT00011245|Paralysis|paralysis
455238|NCT00011245|Spondylosis|spondylosis
455239|NCT00011245|Spinal Syringomyelia|spinal syringomyelia
455240|NCT00011245|Presyringomyelia|presyringomyelia
455241|NCT00011245|Spinal Cord Edema|spinal cord edema
455242|NCT00011245|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
455243|NCT00011245|Intraoperative Radiation|intraoperative radiation
455244|NCT00011245|Ultrasonography|ultrasonography
455245|NCT00011258|Atherosclerosis of the carotid arteries|atherosclerosis of the carotid arteries
455247|NCT00011258|lipoprotein metabolism|lipoprotein metabolism
455248|NCT00011258|paraoxonase|paraoxonase
455249|NCT00011284|Liver|liver
455250|NCT00011284|Inflammation|inflammation
455251|NCT00011284|Endotoxin|endotoxin
455252|NCT00011284|Neutrophils|neutrophils
455253|NCT00011284|Hepatocytes|hepatocytes
455254|NCT00011310|Particulates|particulates
455255|NCT00011310|Air Pollution|air pollution
455256|NCT00011310|Cardiopulmonary Disease|cardiopulmonary disease
455257|NCT00011310|Lung|lung
455258|NCT00011310|Inflammation|inflammation
455259|NCT00011323|osteoporosis,smoking, alcohol, caffeine|osteoporosis,smoking, alcohol, caffeine
455260|NCT00011336|SCI|sci
455261|NCT00011336|chronic respiratory symptoms|chronic respiratory symptoms
455262|NCT00011336|measures of pulmonary function|measures of pulmonary function
455263|NCT00011336|respiratory illness|respiratory illness
455264|NCT00011349|Prostate Cancer|prostate cancer
455265|NCT00011362|NICHD Neonatal Research Network|nichd neonatal research network
455266|NCT00011362|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
455267|NCT00011362|Prematurity|prematurity
455268|NCT00011362|Dexamethasone|dexamethasone
455269|NCT00011362|Glucocorticoids|glucocorticoids
455270|NCT00011362|Respiratory Distress Syndrome|respiratory distress syndrome
455271|NCT00011362|Respiratory insufficiency|respiratory insufficiency
455272|NCT00011362|Steroids|steroids
455273|NCT00011375|Phosphodiesterase Inhibitor|phosphodiesterase inhibitor
455274|NCT00011375|Immunology|immunology
455275|NCT00011375|Immunomodulation|immunomodulation
455276|NCT00011375|Antidepressant|antidepressant
455277|NCT00011375|Therapy|therapy
455278|NCT00011375|Multiple Sclerosis|multiple sclerosis
455279|NCT00011375|Immunotherapy|immunotherapy
455280|NCT00011388|Organochlorine compounds|organochlorine compounds
455281|NCT00011388|Endocrine disruptors|endocrine disruptors
455282|NCT00011388|Sex Hormones|sex hormones
455283|NCT00011388|Reproductive function|reproductive function
455284|NCT00011388|Menstrual Disturbances|menstrual disturbances
455285|NCT00011414|Drug Resistance|drug resistance
455286|NCT00011414|PEDIATRIC SOLID TUMORS|pediatric solid tumors
455287|NCT00011414|Chemotherapy|chemotherapy
455288|NCT00011414|p-glycoprotien|p-glycoprotien
455289|NCT00011414|Brain Tumors|brain tumors
455290|NCT00011414|Childhood Cancer|childhood cancer
455291|NCT00011414|Brain Tumor|brain tumor
455292|NCT00011440|Allergy|allergy
455293|NCT00011440|Air pollution|air pollution
455294|NCT00011440|Lung function|lung function
455295|NCT00011440|Inflammation|inflammation
455296|NCT00011453|NQO1|nqo1
455297|NCT00011453|DT-diaphorase|dt-diaphorase
455298|NCT00011453|Benzene|benzene
455299|NCT00011453|Leukemia|leukemia
455300|NCT00011453|Aplastic anemia|aplastic anemia
455301|NCT00011466|ADHD|adhd
455302|NCT00011466|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
455303|NCT00011466|Carbohydrate Craving|carbohydrate craving
455304|NCT00011479|Administration, Oral|administration, oral
455305|NCT00011479|Drug Administration Schedule|drug administration schedule
455306|NCT00011479|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
455307|NCT00011479|Anti-HIV Agents|anti-hiv agents
455308|NCT00011479|Pharmacokinetics|pharmacokinetics
455309|NCT00011479|abacavir|abacavir
455310|NCT00011492|Oral Cancer|oral cancer
455311|NCT00011492|Squamous Cell Cancer|squamous cell cancer
455312|NCT00011492|Head and Neck Cancer|head and neck cancer
455313|NCT00011492|Laryngeal Cancer|laryngeal cancer
455314|NCT00011492|Pharnygeal Cancer|pharnygeal cancer
455315|NCT00011492|Squamous Cell Carcinoma|squamous cell carcinoma
455316|NCT00011505|G-CSF|g-csf
455317|NCT00011505|Leukapheresis|leukapheresis
455318|NCT00011505|Stem Cell Cryopreservation|stem cell cryopreservation
455319|NCT00011505|Central Line Placement|central line placement
455320|NCT00011505|G-CSF Administration|g-csf administration
455321|NCT00011505|Stem Cell Preservation|stem cell preservation
455322|NCT00011505|Diamond Blackfan Anemia|diamond blackfan anemia
455323|NCT00011505|Healthy Volunteer|healthy volunteer
455324|NCT00011518|Arsenic|arsenic
455325|NCT00011518|Bladder Cancer|bladder cancer
455326|NCT00011518|Drinking Water|drinking water
455327|NCT00011531|Decubitus Ulcers|decubitus ulcers
455328|NCT00011531|dehiscence|dehiscence
455330|NCT00011531|wound healing|wound healing
753026|NCT01175148|Graft vs Host Disease|graft vs host disease
455331|NCT00011544|wheelchair, biomechanics, aging, functional outcome, disability|wheelchair, biomechanics, aging, functional outcome, disability
455332|NCT00011557|Bladder, electromagnetic fields, Spinal cord injury|bladder, electromagnetic fields, spinal cord injury
455333|NCT00011570|defecation|defecation
455334|NCT00011570|electrical stimulation|electrical stimulation
455335|NCT00011570|penile erection|penile erection
455336|NCT00011570|Spinal cord injury|spinal cord injury
455337|NCT00011570|urology|urology
455338|NCT00017537|stage IV breast cancer|stage iv breast cancer
455339|NCT00017537|recurrent breast cancer|recurrent breast cancer
455340|NCT00017537|stage IV gastric cancer|stage iv gastric cancer
455341|NCT00017537|recurrent gastric cancer|recurrent gastric cancer
455342|NCT00017537|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
455343|NCT00017537|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
455344|NCT00017537|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
455345|NCT00017537|adenocarcinoma of the stomach|adenocarcinoma of the stomach
455346|NCT00017537|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
455347|NCT00017537|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
455348|NCT00017550|refractory anemia|refractory anemia
455349|NCT00017550|refractory anemia with excess blasts|refractory anemia with excess blasts
455350|NCT00017550|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
455351|NCT00017550|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
456021|NCT00028314|RNA, Viral|rna, viral
455352|NCT00017563|adenocarcinoma of the prostate|adenocarcinoma of the prostate
455353|NCT00017563|stage II prostate cancer|stage ii prostate cancer
455354|NCT00017563|stage III prostate cancer|stage iii prostate cancer
455355|NCT00017576|adenocarcinoma of the prostate|adenocarcinoma of the prostate
455356|NCT00017576|stage IV prostate cancer|stage iv prostate cancer
455357|NCT00017576|recurrent prostate cancer|recurrent prostate cancer
455358|NCT00017589|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
455359|NCT00017602|refractory multiple myeloma|refractory multiple myeloma
455360|NCT00017602|stage I multiple myeloma|stage i multiple myeloma
455361|NCT00017602|stage II multiple myeloma|stage ii multiple myeloma
455362|NCT00017602|stage III multiple myeloma|stage iii multiple myeloma
455363|NCT00017628|multiple sclerosis|multiple sclerosis
455364|NCT00017628|neurologic and psychiatric disorders|neurologic and psychiatric disorders
455365|NCT00017628|rare disease|rare disease
455366|NCT00017641|arthritis & connective tissue diseases|arthritis & connective tissue diseases
455367|NCT00017641|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
455368|NCT00017641|rare disease|rare disease
455369|NCT00017641|systemic lupus erythematosus|systemic lupus erythematosus
455370|NCT00017654|aplastic anemia|aplastic anemia
455371|NCT00017654|disease-related problem/condition|disease-related problem/condition
455372|NCT00017654|graft versus host disease|graft versus host disease
455373|NCT00017654|hematologic disorders|hematologic disorders
455374|NCT00017654|rare disease|rare disease
455375|NCT00017680|amyloidosis|amyloidosis
455376|NCT00017680|arthritis & connective tissue diseases|arthritis & connective tissue diseases
455377|NCT00017680|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
455378|NCT00017680|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
455379|NCT00017680|oncologic disorders|oncologic disorders
455380|NCT00017680|plasma cell neoplasm|plasma cell neoplasm
455381|NCT00017680|primary systemic amyloidosis|primary systemic amyloidosis
455382|NCT00017680|rare disease|rare disease
455383|NCT00017693|Recombinant Proteins|recombinant proteins
455384|NCT00017693|Aerosols|aerosols
455385|NCT00017693|Asthma|asthma
455386|NCT00017693|Receptors, Interleukin-4|receptors, interleukin-4
455387|NCT00017693|Forced Expiratory Volume|forced expiratory volume
455388|NCT00017706|physician education|physician education
455389|NCT00017706|behavioral weight control|behavioral weight control
455390|NCT00017706|physician intervention|physician intervention
455391|NCT00017706|obesity counseling|obesity counseling
455392|NCT00017719|Pregnancy Complications, Infectious|pregnancy complications, infectious
455393|NCT00017719|HIV Protease Inhibitors|hiv protease inhibitors
455394|NCT00017719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
455395|NCT00017719|Anti-HIV Agents|anti-hiv agents
455396|NCT00017719|Viral Load|viral load
455397|NCT00017719|Combivir|combivir
455398|NCT00017719|Treatment Naive|treatment naive
455399|NCT00017732|Malformations|malformations
455400|NCT00017732|Ethnicity|ethnicity
455401|NCT00017732|Mutations|mutations
455402|NCT00017732|Cholesterol|cholesterol
455403|NCT00017732|Metabolism|metabolism
455404|NCT00017732|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
455405|NCT00017732|SLOS|slos
455406|NCT00017732|Cholesterol Metabolism|cholesterol metabolism
455407|NCT00017745|DNA|dna
455408|NCT00017745|Hereditary Myopathies|hereditary myopathies
455409|NCT00017745|Intermediate Filaments|intermediate filaments
455410|NCT00017745|Cardiomyopathies|cardiomyopathies
455411|NCT00017745|Genetic Testing|genetic testing
455412|NCT00017745|Myopathy|myopathy
455413|NCT00017745|Inherited Neuromuscular Disorder|inherited neuromuscular disorder
455414|NCT00017758|Drug Interactions|drug interactions
455415|NCT00017758|Nelfinavir|nelfinavir
455416|NCT00017758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
455417|NCT00017758|Anti-HIV Agents|anti-hiv agents
455418|NCT00017758|Pharmacokinetics|pharmacokinetics
455419|NCT00017758|Pravastatin|pravastatin
455420|NCT00017758|efavirenz|efavirenz
455421|NCT00017758|Simvastatin|simvastatin
455422|NCT00017758|atorvastatin|atorvastatin
455423|NCT00017758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
455424|NCT00017771|HIV-1|hiv-1
455425|NCT00017771|CD4 Lymphocyte Count|cd4 lymphocyte count
455426|NCT00017771|Risk Factors|risk factors
455427|NCT00017771|Hydroxyurea|hydroxyurea
455428|NCT00017771|Disease Progression|disease progression
455429|NCT00017771|Alcohol Drinking|alcohol drinking
455430|NCT00017771|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
455431|NCT00017771|Anti-HIV Agents|anti-hiv agents
455433|NCT00017771|Polyneuropathies|polyneuropathies
455434|NCT00017771|Treatment Experienced|treatment experienced
455435|NCT00017784|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
455436|NCT00017784|Infusions, Intravenous|infusions, intravenous
455437|NCT00017784|Antiviral Agents|antiviral agents
455438|NCT00017784|Cytomegalovirus Retinitis|cytomegalovirus retinitis
473737|NCT00081874|Leukemia|leukemia
455439|NCT00017784|valganciclovir|valganciclovir
455440|NCT00017797|Pregnancy Complications, Infectious|pregnancy complications, infectious
455441|NCT00017797|HIV-1|hiv-1
474751|NCT00078013|Infarct|infarct
455442|NCT00017797|HIV Protease Inhibitors|hiv protease inhibitors
455443|NCT00017797|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
455444|NCT00017797|Anti-HIV Agents|anti-hiv agents
455445|NCT00017797|Glucose Intolerance|glucose intolerance
455446|NCT00017810|complementary therapies|complementary therapies
455447|NCT00017810|Behavior Therapy|behavior therapy
455448|NCT00017810|Diarrhea|diarrhea
455449|NCT00017810|Diet Therapy|diet therapy
455450|NCT00017810|Food|food
455451|NCT00017810|HIV Seropositivity|hiv seropositivity
455452|NCT00017823|complementary therapies|complementary therapies
455453|NCT00017823|Acupressure|acupressure
455454|NCT00017823|HIV Infections|hiv infections
455455|NCT00017823|Nausea|nausea
455456|NCT00017823|Vomiting|vomiting
455457|NCT00027001|Qigong, exercise, circulatory assist devices|qigong, exercise, circulatory assist devices
455458|NCT00027014|opioid|opioid
455459|NCT00027014|St. John's wort|st. john's wort
455460|NCT00027014|analgesia|analgesia
455461|NCT00027014|metabolism|metabolism
455462|NCT00027014|transporter|transporter
455463|NCT00027040|AIDS Dementia Complex|aids dementia complex
455464|NCT00027040|Selegiline|selegiline
455465|NCT00027040|Oxidative Stress|oxidative stress
455466|NCT00027040|Cognition|cognition
455467|NCT00027040|Neuroprotective Agents|neuroprotective agents
455468|NCT00027040|Brain Injuries|brain injuries
455469|NCT00027040|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
455470|NCT00027040|Protons|protons
455471|NCT00027053|alcoholism|alcoholism
455472|NCT00027053|alcohol dependence|alcohol dependence
455473|NCT00027053|trazadone|trazadone
455474|NCT00027053|sleep|sleep
455475|NCT00027066|stroke|stroke
455476|NCT00027066|aspirin|aspirin
455477|NCT00027066|warfarin|warfarin
455478|NCT00027092|Infusions, Intravenous|infusions, intravenous
455479|NCT00027092|Testosterone|testosterone
455480|NCT00027092|Insulin Resistance|insulin resistance
455481|NCT00027092|Hormone Replacement Therapy|hormone replacement therapy
455482|NCT00027092|Glucose Tolerance Test|glucose tolerance test
455483|NCT00027105|Fatigue|fatigue
455484|NCT00027105|Shoulder function|shoulder function
455485|NCT00027105|Lymphedema|lymphedema
455486|NCT00027105|Breast Cancer|breast cancer
455487|NCT00027105|Breast Cancer Surgery|breast cancer surgery
455488|NCT00027105|Quality of Life|quality of life
455489|NCT00027118|Shoulder|shoulder
455490|NCT00027118|Breast Cancer|breast cancer
455491|NCT00027118|Physical Therapy|physical therapy
455492|NCT00027118|Lymphedema|lymphedema
455493|NCT00027118|Quality of Life|quality of life
455494|NCT00027118|Breast Cancer Surgery|breast cancer surgery
455495|NCT00027118|Healthy Volunteer|healthy volunteer
455496|NCT00027118|HV|hv
455497|NCT00027118|Normal Control|normal control
455498|NCT00027131|vaccine|vaccine
455499|NCT00027131|immunotherapy|immunotherapy
455500|NCT00027144|Leukemia|leukemia
455501|NCT00027144|Vaccine|vaccine
455502|NCT00027157|Coronary Spasm|coronary spasm
455503|NCT00027157|Endothelial-Derived-Relaxation Factor|endothelial-derived-relaxation factor
455504|NCT00027157|Nitric Oxide Synthase|nitric oxide synthase
455505|NCT00027157|Susceptibility Genes|susceptibility genes
455506|NCT00027157|Tetrahydrobiopterin|tetrahydrobiopterin
455507|NCT00027170|Myocardial Infarction|myocardial infarction
455508|NCT00027170|Myocardial Viability|myocardial viability
455509|NCT00027170|Myocardial Perfusion|myocardial perfusion
455510|NCT00027170|Myocardial Ischemia|myocardial ischemia
455511|NCT00027170|Atherosclerosis|atherosclerosis
455512|NCT00027170|Cardiovascular Disease|cardiovascular disease
455513|NCT00027170|Coronary Artery Disease|coronary artery disease
455514|NCT00027183|Cystic Fibrosis|cystic fibrosis
455515|NCT00027183|Effector Proteins|effector proteins
455516|NCT00027183|Cytotoxin|cytotoxin
455517|NCT00027183|Lung Injury|lung injury
455518|NCT00027183|Genetic Screen|genetic screen
455519|NCT00027196|Genetics|genetics
455520|NCT00027196|Cardiac Diseases|cardiac diseases
455521|NCT00027196|Cardiac Hypertrophy|cardiac hypertrophy
455522|NCT00027196|Sudden Death|sudden death
455523|NCT00027196|Arrhythmias|arrhythmias
455524|NCT00027209|seizures|seizures
455525|NCT00027209|epilepsy|epilepsy
455526|NCT00027209|menopause|menopause
455527|NCT00027248|central venous catheter|central venous catheter
455528|NCT00027248|bloodstream infection|bloodstream infection
455530|NCT00027248|catheter colonization|catheter colonization
455531|NCT00027248|local catheter site infection|local catheter site infection
455532|NCT00027261|Vaccines, Synthetic|vaccines, synthetic
455534|NCT00027261|AIDS Vaccines|aids vaccines
455535|NCT00027261|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
455536|NCT00027261|HIV Seronegativity|hiv seronegativity
455537|NCT00027261|Avipoxvirus|avipoxvirus
455538|NCT00027261|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
455539|NCT00027261|HIV Preventive Vaccine|hiv preventive vaccine
455540|NCT00027274|Fanconi's Anemia|fanconi's anemia
474391|NCT00083382|Pamidronate|pamidronate
455541|NCT00027274|Diamond Blackfan Anemia|diamond blackfan anemia
455542|NCT00027274|Dyskeratosis Congenita|dyskeratosis congenita
455543|NCT00027274|Shwachman-Diamond Syndrome|shwachman-diamond syndrome
455546|NCT00027274|Inherited Bone Marrow Failure Syndromes|inherited bone marrow failure syndromes
455547|NCT00027274|IBMFS|ibmfs
455548|NCT00027274|Familial Cancer|familial cancer
455549|NCT00027287|Type I Diabetes|type i diabetes
455550|NCT00027287|Type 2 Diabetes|type 2 diabetes
455551|NCT00027287|Diode Laser Photocoagulation|diode laser photocoagulation
455552|NCT00027287|Vitamin E|vitamin e
455553|NCT00027287|Elevated Low-Density Lipoprotein (LDL-C) Cholesterol|elevated low-density lipoprotein (ldl-c) cholesterol
455554|NCT00027287|Diabetic Retinopathy|diabetic retinopathy
455555|NCT00027287|Macular Edema|macular edema
455556|NCT00027287|Type II Diabetes|type ii diabetes
455557|NCT00027300|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
455558|NCT00027326|Blood|blood
455559|NCT00027326|Samples|samples
455560|NCT00027326|Radiation|radiation
455561|NCT00027326|Urine|urine
455562|NCT00027326|Cancer|cancer
455563|NCT00027326|Radiation Therapy|radiation therapy
455564|NCT00027339|HIV-1|hiv-1
455565|NCT00027339|HIV Protease Inhibitors|hiv protease inhibitors
455566|NCT00027339|RNA, Viral|rna, viral
455567|NCT00027339|Phenotype|phenotype
455568|NCT00027339|Viral Load|viral load
455569|NCT00027339|Pharmacokinetics|pharmacokinetics
455570|NCT00027339|Treatment Experienced|treatment experienced
455571|NCT00027469|Atheroembolism|atheroembolism
455572|NCT00027469|Atherosclerosis|atherosclerosis
455573|NCT00027469|MRI|mri
455574|NCT00027469|Renal Artery Stenosis|renal artery stenosis
455575|NCT00027469|Renovascular Hypertension|renovascular hypertension
455576|NCT00027469|ARAS|aras
455577|NCT00027469|Renovascular Disease|renovascular disease
455578|NCT00027469|Renal Artery Stenting|renal artery stenting
455579|NCT00027469|PTRAS|ptras
455580|NCT00027482|T Cell|t cell
455581|NCT00027482|B Cell|b cell
455582|NCT00027482|Flow Cytometry|flow cytometry
455583|NCT00027482|Cell-Mediated Immunity|cell-mediated immunity
455584|NCT00027482|Thymus|thymus
455585|NCT00027482|HIV|hiv
455586|NCT00027482|Immunity|immunity
455587|NCT00027482|Lymphocytes|lymphocytes
455588|NCT00027482|Monocytes|monocytes
455589|NCT00027482|Healthy Volunteer|healthy volunteer
455590|NCT00027482|HV|hv
455591|NCT00027482|Normal Control|normal control
455592|NCT00027495|colon cancer|colon cancer
455593|NCT00027508|advanced malignant mesothelioma|advanced malignant mesothelioma
455594|NCT00027508|recurrent malignant mesothelioma|recurrent malignant mesothelioma
455595|NCT00027521|stage III pancreatic cancer|stage iii pancreatic cancer
455596|NCT00027521|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
455597|NCT00027534|recurrent colon cancer|recurrent colon cancer
455598|NCT00027534|stage III colon cancer|stage iii colon cancer
455599|NCT00027534|stage IV colon cancer|stage iv colon cancer
455600|NCT00027534|recurrent breast cancer|recurrent breast cancer
455601|NCT00027534|stage IIIA breast cancer|stage iiia breast cancer
455602|NCT00027534|stage IIIB breast cancer|stage iiib breast cancer
455603|NCT00027534|stage IIIC breast cancer|stage iiic breast cancer
455604|NCT00027534|stage IV breast cancer|stage iv breast cancer
455605|NCT00027534|recurrent gastric cancer|recurrent gastric cancer
455606|NCT00027534|stage III gastric cancer|stage iii gastric cancer
455607|NCT00027534|stage IV gastric cancer|stage iv gastric cancer
455608|NCT00027534|recurrent pancreatic cancer|recurrent pancreatic cancer
455609|NCT00027534|stage II pancreatic cancer|stage ii pancreatic cancer
455610|NCT00027534|stage III pancreatic cancer|stage iii pancreatic cancer
455611|NCT00027534|recurrent rectal cancer|recurrent rectal cancer
455612|NCT00027534|stage III rectal cancer|stage iii rectal cancer
455613|NCT00027534|stage IV rectal cancer|stage iv rectal cancer
455614|NCT00027534|advanced adult primary liver cancer|advanced adult primary liver cancer
455615|NCT00027534|recurrent adult primary liver cancer|recurrent adult primary liver cancer
455616|NCT00027534|recurrent gallbladder cancer|recurrent gallbladder cancer
455617|NCT00027534|unresectable gallbladder cancer|unresectable gallbladder cancer
455618|NCT00027534|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
455619|NCT00027534|recurrent salivary gland cancer|recurrent salivary gland cancer
455620|NCT00027534|stage III salivary gland cancer|stage iii salivary gland cancer
455621|NCT00027534|stage IV salivary gland cancer|stage iv salivary gland cancer
455622|NCT00027534|Paget disease of the breast with intraductal carcinoma|paget disease of the breast with intraductal carcinoma
455623|NCT00027534|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
455624|NCT00027534|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
455625|NCT00027534|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
455626|NCT00027534|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
455627|NCT00027534|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
455628|NCT00027534|adenocarcinoma of the colon|adenocarcinoma of the colon
455629|NCT00027534|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
455630|NCT00027534|adenocarcinoma of the rectum|adenocarcinoma of the rectum
455631|NCT00027534|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
455632|NCT00027534|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
455633|NCT00027534|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
455635|NCT00027534|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
455636|NCT00027534|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
455637|NCT00027534|salivary gland adenocarcinoma|salivary gland adenocarcinoma
455638|NCT00027534|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
455639|NCT00027534|stage IV pancreatic cancer|stage iv pancreatic cancer
455640|NCT00027547|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
455641|NCT00027547|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
455642|NCT00027560|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
455643|NCT00027560|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
455644|NCT00027560|refractory multiple myeloma|refractory multiple myeloma
455645|NCT00027560|stage II multiple myeloma|stage ii multiple myeloma
455646|NCT00027560|stage III multiple myeloma|stage iii multiple myeloma
455647|NCT00027560|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
455648|NCT00027560|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
455649|NCT00027560|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
455650|NCT00027560|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
455651|NCT00027560|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
455652|NCT00027560|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
455653|NCT00027560|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
455654|NCT00027560|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
455655|NCT00027560|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
455656|NCT00027560|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
455657|NCT00027560|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
455658|NCT00027560|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
455659|NCT00027560|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
455660|NCT00027560|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
455661|NCT00027560|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
455662|NCT00027560|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
455663|NCT00027560|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
455664|NCT00027560|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
455665|NCT00027560|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
455666|NCT00027560|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
455667|NCT00027560|Waldenström macroglobulinemia|waldenström macroglobulinemia
455668|NCT00027560|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
455669|NCT00027560|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
455670|NCT00027560|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
455671|NCT00027560|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
455672|NCT00027560|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
455673|NCT00027560|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
455674|NCT00027560|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
583373|NCT00511524|PET|pet
455675|NCT00027560|splenic marginal zone lymphoma|splenic marginal zone lymphoma
455676|NCT00027560|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
455677|NCT00027560|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
455678|NCT00027573|stage IV renal cell cancer|stage iv renal cell cancer
455679|NCT00027573|recurrent renal cell cancer|recurrent renal cell cancer
455680|NCT00027573|clear cell renal cell carcinoma|clear cell renal cell carcinoma
455681|NCT00027573|papillary renal cell carcinoma|papillary renal cell carcinoma
455682|NCT00027586|stage IV melanoma|stage iv melanoma
455683|NCT00027586|recurrent melanoma|recurrent melanoma
455684|NCT00027586|Imatinib Mesylate|imatinib mesylate
455686|NCT00027586|protein tyrosine kinases|protein tyrosine kinases
455687|NCT00027586|PTK|ptk
455688|NCT00027586|Gleevec targets|gleevec targets
455689|NCT00027586|metastatic melanoma|metastatic melanoma
455690|NCT00027599|adenocarcinoma of the prostate|adenocarcinoma of the prostate
455691|NCT00027599|stage I prostate cancer|stage i prostate cancer
455692|NCT00027599|stage IIB prostate cancer|stage iib prostate cancer
455693|NCT00027599|stage IIA prostate cancer|stage iia prostate cancer
455694|NCT00027599|stage III prostate cancer|stage iii prostate cancer
455695|NCT00027599|stage IV prostate cancer|stage iv prostate cancer
455696|NCT00027599|recurrent prostate cancer|recurrent prostate cancer
455697|NCT00027612|adult glioblastoma|adult glioblastoma
455698|NCT00027612|adult giant cell glioblastoma|adult giant cell glioblastoma
455699|NCT00027612|adult gliosarcoma|adult gliosarcoma
455700|NCT00027625|recurrent adult brain tumor|recurrent adult brain tumor
455701|NCT00027625|adult glioblastoma|adult glioblastoma
455702|NCT00027625|adult anaplastic astrocytoma|adult anaplastic astrocytoma
455703|NCT00027625|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
455704|NCT00027625|adult mixed glioma|adult mixed glioma
455705|NCT00027625|adult giant cell glioblastoma|adult giant cell glioblastoma
455706|NCT00027625|adult gliosarcoma|adult gliosarcoma
455707|NCT00027638|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
455708|NCT00027638|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
455709|NCT00027638|gastrinoma|gastrinoma
455710|NCT00027638|insulinoma|insulinoma
455711|NCT00027638|recurrent islet cell carcinoma|recurrent islet cell carcinoma
455712|NCT00027638|WDHA syndrome|wdha syndrome
455713|NCT00027638|somatostatinoma|somatostatinoma
455714|NCT00027638|pancreatic polypeptide tumor|pancreatic polypeptide tumor
455715|NCT00027638|glucagonoma|glucagonoma
455716|NCT00027638|pulmonary carcinoid tumor|pulmonary carcinoid tumor
455717|NCT00027664|stage IV renal cell cancer|stage iv renal cell cancer
455718|NCT00027677|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
455719|NCT00027716|metastatic osteosarcoma|metastatic osteosarcoma
455720|NCT00027716|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
455721|NCT00027716|recurrent osteosarcoma|recurrent osteosarcoma
455722|NCT00027716|adult rhabdomyosarcoma|adult rhabdomyosarcoma
455723|NCT00027716|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
455724|NCT00027716|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
455725|NCT00027716|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
455726|NCT00027729|recurrent colon cancer|recurrent colon cancer
455727|NCT00027729|recurrent rectal cancer|recurrent rectal cancer
455728|NCT00027742|iris melanoma|iris melanoma
455729|NCT00027742|extraocular extension melanoma|extraocular extension melanoma
455730|NCT00027742|recurrent intraocular melanoma|recurrent intraocular melanoma
455731|NCT00027742|stage III melanoma|stage iii melanoma
455732|NCT00027742|stage IV melanoma|stage iv melanoma
455733|NCT00027742|recurrent melanoma|recurrent melanoma
455734|NCT00027768|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
455735|NCT00027768|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
455736|NCT00027781|adenocarcinoma of the prostate|adenocarcinoma of the prostate
455737|NCT00027781|recurrent prostate cancer|recurrent prostate cancer
455738|NCT00027794|adenocarcinoma of the prostate|adenocarcinoma of the prostate
455739|NCT00027794|stage III prostate cancer|stage iii prostate cancer
455740|NCT00027807|stage IV breast cancer|stage iv breast cancer
455741|NCT00027807|recurrent breast cancer|recurrent breast cancer
455742|NCT00027807|ductal breast carcinoma|ductal breast carcinoma
455743|NCT00027833|stage IV colon cancer|stage iv colon cancer
455744|NCT00027833|stage IV rectal cancer|stage iv rectal cancer
455745|NCT00027833|adenocarcinoma of the colon|adenocarcinoma of the colon
455746|NCT00027833|adenocarcinoma of the rectum|adenocarcinoma of the rectum
455747|NCT00027846|childhood supratentorial ependymoma|childhood supratentorial ependymoma
455748|NCT00027846|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
455749|NCT00027846|childhood infratentorial ependymoma|childhood infratentorial ependymoma
455750|NCT00027859|adenocarcinoma of the prostate|adenocarcinoma of the prostate
455751|NCT00027859|stage III prostate cancer|stage iii prostate cancer
455752|NCT00027885|stage IV breast cancer|stage iv breast cancer
455753|NCT00027885|stage IIIA breast cancer|stage iiia breast cancer
455754|NCT00027885|stage IIIB breast cancer|stage iiib breast cancer
455755|NCT00027885|stage IIIC breast cancer|stage iiic breast cancer
455757|NCT00027911|adult synovial sarcoma|adult synovial sarcoma
455758|NCT00027911|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
455759|NCT00027911|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
455760|NCT00027911|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
455761|NCT00027911|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
455762|NCT00027924|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
455763|NCT00027924|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
455764|NCT00027924|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
455765|NCT00027924|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
455766|NCT00027924|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
455767|NCT00027924|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
455768|NCT00027924|refractory anemia|refractory anemia
455769|NCT00027924|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
455770|NCT00027924|refractory anemia with excess blasts|refractory anemia with excess blasts
455771|NCT00027924|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
455772|NCT00027924|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
455773|NCT00027924|secondary acute myeloid leukemia|secondary acute myeloid leukemia
455774|NCT00027924|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
455775|NCT00027924|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
455776|NCT00027924|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
455777|NCT00027924|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
455778|NCT00027937|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
455779|NCT00027937|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
455780|NCT00027937|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
475066|NCT00085852|emphysema|emphysema
455781|NCT00027937|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
455782|NCT00027937|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
455783|NCT00027937|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
455784|NCT00027937|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
455785|NCT00027937|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
455786|NCT00027937|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
455787|NCT00027937|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
455788|NCT00027937|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
455789|NCT00027937|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
455790|NCT00027937|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
455791|NCT00027937|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
455792|NCT00027937|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
455793|NCT00027937|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
455794|NCT00027937|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
455795|NCT00027937|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
455796|NCT00027937|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
455797|NCT00027937|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
455798|NCT00027937|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
455799|NCT00027937|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
455800|NCT00027937|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
455801|NCT00027937|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
455802|NCT00027937|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
455803|NCT00027937|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
455804|NCT00027937|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
455805|NCT00027937|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
455806|NCT00027937|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
455807|NCT00027937|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
455808|NCT00027937|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
455809|NCT00027937|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
455810|NCT00027937|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
455811|NCT00027937|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
455812|NCT00027937|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
455813|NCT00027937|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
455814|NCT00027937|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
455815|NCT00027937|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
455816|NCT00027937|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
583649|NCT00512551|DNA|dna
455817|NCT00027937|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
455818|NCT00027937|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
455819|NCT00027937|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
455820|NCT00027937|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
455821|NCT00027937|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
455822|NCT00027937|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
455823|NCT00027937|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
455824|NCT00027937|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
455825|NCT00027937|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
455826|NCT00027937|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
455827|NCT00027937|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
455828|NCT00027937|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
455829|NCT00027937|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
455830|NCT00027937|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
12565|NCT03210493|Pegylated Interferon α-2a|pegylated interferon α-2a
455831|NCT00027937|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
455832|NCT00027937|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
455833|NCT00027937|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
455834|NCT00027937|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
455835|NCT00027937|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
455836|NCT00027937|stage I mantle cell lymphoma|stage i mantle cell lymphoma
455837|NCT00027937|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
455838|NCT00027937|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
455839|NCT00027937|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
455840|NCT00027937|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
455841|NCT00027937|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
455842|NCT00027937|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
455843|NCT00027937|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
455844|NCT00027937|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
455845|NCT00027937|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
455846|NCT00027937|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
455847|NCT00027937|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
455848|NCT00027937|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
455849|NCT00027937|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
455850|NCT00027937|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
455851|NCT00027937|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
455852|NCT00027937|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
455853|NCT00027937|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
455854|NCT00027937|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
455855|NCT00027937|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
455856|NCT00027937|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
455857|NCT00027937|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
455858|NCT00027937|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
455859|NCT00027937|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
455860|NCT00027937|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
455861|NCT00027937|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
455862|NCT00027937|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
455863|NCT00027937|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
455864|NCT00027937|stage I marginal zone lymphoma|stage i marginal zone lymphoma
455865|NCT00027937|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
455866|NCT00027937|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
455867|NCT00027937|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
455868|NCT00027937|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
455869|NCT00027937|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
455870|NCT00027937|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
455871|NCT00027937|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
455872|NCT00027937|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
455873|NCT00027937|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
455874|NCT00027937|splenic marginal zone lymphoma|splenic marginal zone lymphoma
455875|NCT00027963|neurotoxicity|neurotoxicity
455876|NCT00027963|pain|pain
455877|NCT00027976|actinic keratosis|actinic keratosis
455878|NCT00027989|stage IV breast cancer|stage iv breast cancer
455879|NCT00028015|stage IV colon cancer|stage iv colon cancer
455880|NCT00028015|stage IV rectal cancer|stage iv rectal cancer
455881|NCT00028015|recurrent colon cancer|recurrent colon cancer
455882|NCT00028015|recurrent rectal cancer|recurrent rectal cancer
455883|NCT00028067|Drug Therapy, Combination|drug therapy, combination
455884|NCT00028067|HIV Protease Inhibitors|hiv protease inhibitors
455885|NCT00028067|RNA, Viral|rna, viral
455886|NCT00028067|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
455887|NCT00028067|Viral Load|viral load
455888|NCT00028067|BMS 232632|bms 232632
455889|NCT00028080|Borrelia Burgdorferi|borrelia burgdorferi
455890|NCT00028080|Lyme Disease|lyme disease
455891|NCT00028080|Infection|infection
455892|NCT00028080|Therapy|therapy
455893|NCT00028080|Lyme|lyme
455894|NCT00028093|Chronic Hepatitis|chronic hepatitis
455895|NCT00028093|Cirrhosis|cirrhosis
455896|NCT00028093|Hepatitis C Virus|hepatitis c virus
455897|NCT00028093|Hemolysis|hemolysis
455898|NCT00028093|Ribavirin|ribavirin
455899|NCT00028093|Alpha Interferon|alpha interferon
455900|NCT00028093|Peginterferon|peginterferon
455901|NCT00028093|Antiviral Agents|antiviral agents
455902|NCT00028093|Viral Hepatitis|viral hepatitis
455903|NCT00028093|Hemolytic Anemia|hemolytic anemia
455904|NCT00028093|Renal Failure|renal failure
455905|NCT00028093|Renal Dialysis|renal dialysis
455906|NCT00028093|Hepatitis|hepatitis
455907|NCT00028093|Hepatitis C|hepatitis c
455908|NCT00028106|Cancer|cancer
455909|NCT00028106|Metastasis|metastasis
455910|NCT00028106|Fluorodopamine|fluorodopamine
455911|NCT00028106|PET|pet
455912|NCT00028106|Methylprednisolone|methylprednisolone
455913|NCT00028106|Catecholamines|catecholamines
455914|NCT00028106|Metanephrines|metanephrines
475220|NCT00086463|inhalation|inhalation
455915|NCT00028106|Alpha-Methyl-Para-Tyrosine|alpha-methyl-para-tyrosine
455916|NCT00028106|Retinoic Acid|retinoic acid
455917|NCT00028106|Carbidopa|carbidopa
455918|NCT00028119|Clinical Trials|clinical trials
455919|NCT00028119|Sexual Partners|sexual partners
455920|NCT00028119|Risk Factors|risk factors
455921|NCT00028119|Incidence|incidence
455922|NCT00028119|HIV Seronegativity|hiv seronegativity
455923|NCT00028119|India|india
455924|NCT00028119|Patient Compliance|patient compliance
455925|NCT00028119|Preventive Health Services|preventive health services
455926|NCT00028132|Risk Factors|risk factors
455927|NCT00028132|Mucous Membrane|mucous membrane
455928|NCT00028132|Anti-Infective Agents|anti-infective agents
455929|NCT00028132|Cervix Uteri|cervix uteri
455930|NCT00028132|Vagina|vagina
455931|NCT00028132|Anti-HIV Agents|anti-hiv agents
455932|NCT00028132|Pharmacokinetics|pharmacokinetics
455933|NCT00028132|Vulva|vulva
455934|NCT00028132|9-(2-phosphonylmethoxypropyl)adenine|9-(2-phosphonylmethoxypropyl)adenine
455935|NCT00028132|HIV Seronegativity|hiv seronegativity
455936|NCT00028145|Women's Health|women's health
455937|NCT00028145|Disease Transmission, Vertical|disease transmission, vertical
455938|NCT00028145|Preventive Medicine|preventive medicine
455939|NCT00028145|Treatment Experienced|treatment experienced
455940|NCT00028158|Antineoplastic agents|antineoplastic agents
455941|NCT00028158|Herpes virus|herpes virus
455942|NCT00028158|Brain tumor|brain tumor
455943|NCT00028158|Oncolytic virs|oncolytic virs
455944|NCT00028184|Chronic Stroke|chronic stroke
455945|NCT00028184|Ipsilateral Motor Cortex|ipsilateral motor cortex
455946|NCT00028184|Motor Control|motor control
455947|NCT00028184|Motor Recovery|motor recovery
455948|NCT00028184|Stroke|stroke
455949|NCT00028184|Healthy Volunteer|healthy volunteer
455950|NCT00028184|HV|hv
455951|NCT00028184|Healthy Control|healthy control
455952|NCT00028197|Voluntary Movement|voluntary movement
455953|NCT00028197|Functional MRI|functional mri
455954|NCT00028197|Sensorimotor Integration|sensorimotor integration
455955|NCT00028197|Superior Parietal Lobe|superior parietal lobe
455956|NCT00028197|Supplementary Motor Area|supplementary motor area
455957|NCT00028197|Normal Control|normal control
455958|NCT00028197|HV|hv
455959|NCT00028197|Healthy Volunteer|healthy volunteer
455960|NCT00028210|Amputee|amputee
455961|NCT00028210|Plasticity|plasticity
455962|NCT00028210|Somatosensory|somatosensory
455963|NCT00028210|Upper Limb Amputation|upper limb amputation
455964|NCT00028210|Tactile Performance|tactile performance
455965|NCT00028210|Cortical Reorganization|cortical reorganization
455966|NCT00028210|Healthy Volunteer|healthy volunteer
455968|NCT00028210|Normal Control|normal control
455969|NCT00028236|Peripheral Blood Stem Cells|peripheral blood stem cells
455970|NCT00028236|Common Gamma Chain (GC)|common gamma chain (gc)
455971|NCT00028236|Immune Reconstitution|immune reconstitution
455972|NCT00028236|T Lymphocytes|t lymphocytes
455973|NCT00028236|B Lymphocytes|b lymphocytes
455974|NCT00028236|X-Linked Severe Combined Immune Deficiency (XSCID)|x-linked severe combined immune deficiency (xscid)
455975|NCT00028236|Gene Therapy|gene therapy
455976|NCT00028236|NK Cell|nk cell
455977|NCT00028236|Bone Marrow Transplantation|bone marrow transplantation
455978|NCT00028236|Engraftment|engraftment
455979|NCT00028236|XSCID|xscid
455980|NCT00028236|Immune Deficiency|immune deficiency
455981|NCT00028236|Immune System|immune system
455982|NCT00028249|Patient Satisfaction|patient satisfaction
455983|NCT00028249|Self Efficacy|self efficacy
455984|NCT00028249|Social Support|social support
455985|NCT00028249|Symptom Management|symptom management
455986|NCT00028249|Advanced Malignancies|advanced malignancies
455987|NCT00028249|Pain Intervention|pain intervention
455988|NCT00028262|Palmitoyl-Protein Thioesterase|palmitoyl-protein thioesterase
455989|NCT00028262|Lysosomes|lysosomes
455990|NCT00028262|Batten Disease|batten disease
455991|NCT00028262|Encephalopathy|encephalopathy
455992|NCT00028262|Progressive Neurodegeneration|progressive neurodegeneration
455993|NCT00028262|CLN 1|cln 1
455994|NCT00028262|Infantile Neuronal Ceroid Lipofuscinosis|infantile neuronal ceroid lipofuscinosis
455995|NCT00028262|Cystagon|cystagon
455996|NCT00028275|Hepatitis C Virus|hepatitis c virus
455997|NCT00028275|Cirrhosis|cirrhosis
455998|NCT00028275|Antiviral Agents|antiviral agents
455999|NCT00028275|Viral Resistance|viral resistance
456000|NCT00028275|Alpha Interferon|alpha interferon
456001|NCT00028275|Hepatitis C|hepatitis c
456002|NCT00028275|Hepatitis|hepatitis
456003|NCT00028288|Asthma|asthma
456004|NCT00028288|Daclizumab|daclizumab
456005|NCT00028288|anti-Tac monoclonal antibody|anti-tac monoclonal antibody
456006|NCT00028288|anti-IL-2|anti-il-2
456007|NCT00028288|Zenapax|zenapax
456008|NCT00028301|HIV Protease Inhibitors|hiv protease inhibitors
456009|NCT00028301|RNA, Viral|rna, viral
456010|NCT00028301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
456011|NCT00028301|Anti-HIV Agents|anti-hiv agents
456012|NCT00028301|Viral Load|viral load
456013|NCT00028301|Lipids|lipids
456014|NCT00028301|ABT 378|abt 378
456111|NCT00028574|recurrent prostate cancer|recurrent prostate cancer
456015|NCT00028301|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
456016|NCT00028301|Lipoproteins, LDL Cholesterol|lipoproteins, ldl cholesterol
456017|NCT00028314|HIV-1|hiv-1
456018|NCT00028314|Abacavir|abacavir
456019|NCT00028314|Nevirapine|nevirapine
456022|NCT00028314|HIV Protease Inhibitors|hiv protease inhibitors
456023|NCT00028314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
456024|NCT00028314|Anti-HIV Agents|anti-hiv agents
456025|NCT00028314|Viral Load|viral load
456026|NCT00028314|HIV Wasting Syndrome|hiv wasting syndrome
456027|NCT00028314|ABT 378|abt 378
456028|NCT00028314|Treatment Experienced|treatment experienced
456029|NCT00028327|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
456030|NCT00028327|Zidovudine|zidovudine
456031|NCT00028327|HIV Protease Inhibitors|hiv protease inhibitors
456032|NCT00028327|CD4 Lymphocyte Count|cd4 lymphocyte count
456033|NCT00028327|Lamivudine|lamivudine
456034|NCT00028327|Pneumonia|pneumonia
456035|NCT00028327|Nelfinavir|nelfinavir
456036|NCT00028327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
456037|NCT00028327|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
456038|NCT00028327|Efavirenz|efavirenz
456039|NCT00028327|Intensive Care Units|intensive care units
456040|NCT00028327|Sepsis|sepsis
456041|NCT00028340|Breast Cancer|breast cancer
456042|NCT00028340|Post Menopausal|post menopausal
456043|NCT00028340|Breast Duct|breast duct
456044|NCT00028340|Healthy Volunteer|healthy volunteer
456045|NCT00028340|HV|hv
456046|NCT00028340|Normal Control|normal control
456047|NCT00028353|PIN|pin
456048|NCT00028353|High Grade Prostate Intraepithelial Neoplasia (PIN)|high grade prostate intraepithelial neoplasia (pin)
456049|NCT00028366|HIV-1|hiv-1
456050|NCT00028366|Drug Therapy, Combination|drug therapy, combination
456051|NCT00028366|HIV Protease Inhibitors|hiv protease inhibitors
456052|NCT00028366|Ritonavir|ritonavir
456053|NCT00028366|RNA, Viral|rna, viral
456054|NCT00028366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
456055|NCT00028366|Viral Load|viral load
456056|NCT00028366|ABT 378|abt 378
456057|NCT00028366|tenofovir disoproxil|tenofovir disoproxil
456058|NCT00028366|VX-175|vx-175
456059|NCT00028366|Treatment Experienced|treatment experienced
456060|NCT00028379|Plasticity|plasticity
456061|NCT00028379|Motor Cortex|motor cortex
456062|NCT00028379|Stroke|stroke
456063|NCT00028379|Somatosensory|somatosensory
456064|NCT00028379|Hemiparesis|hemiparesis
456065|NCT00028405|Photodynamic Therapy|photodynamic therapy
456066|NCT00028405|Bulky Tumor|bulky tumor
456067|NCT00028405|Refractory Tumor|refractory tumor
456068|NCT00028405|Head and Neck Cancer|head and neck cancer
456069|NCT00028405|Breast Cancer|breast cancer
456070|NCT00028405|Pelvic Tumors|pelvic tumors
456071|NCT00028405|Liver Metastasis|liver metastasis
456072|NCT00028405|Colorectal Cancer|colorectal cancer
456073|NCT00028405|Sarcoma|sarcoma
456074|NCT00028405|Anal Cancer|anal cancer
456075|NCT00028405|Oral Cancer|oral cancer
456076|NCT00028405|Recurrent|recurrent
456077|NCT00028405|Lymphadenopathy|lymphadenopathy
456078|NCT00028405|Ovarian Cancer|ovarian cancer
456079|NCT00028405|Cervical Cancer|cervical cancer
456080|NCT00028418|Acute Leukemia|acute leukemia
456081|NCT00028418|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
456082|NCT00028418|Antineoplastic Agents|antineoplastic agents
456083|NCT00028418|Nucleosides|nucleosides
456084|NCT00028418|Dose-Response Relationship, Drug|dose-response relationship, drug
456085|NCT00028418|Cladribine|cladribine
456086|NCT00028418|Fludarabine|fludarabine
456087|NCT00028431|Stage III melanoma|stage iii melanoma
456088|NCT00028431|Stage IV melanoma|stage iv melanoma
456089|NCT00028431|Interleukin-12|interleukin-12
456090|NCT00028431|Cancer Vaccines|cancer vaccines
456091|NCT00028431|Antineoplastic Agents, Combined|antineoplastic agents, combined
456092|NCT00028431|Incomplete Freund's adjuvant|incomplete freund's adjuvant
456093|NCT00028431|Monophenol Monooxygenase|monophenol monooxygenase
456094|NCT00028431|Mannitol|mannitol
456095|NCT00028431|Adjuvants, Immunologic|adjuvants, immunologic
456096|NCT00028431|Melan-A Protein|melan-a protein
456097|NCT00028431|Antigens, Neoplasm|antigens, neoplasm
456098|NCT00028431|Antibodies|antibodies
456099|NCT00028431|Melanocyte lineage-specific antigen gp100|melanocyte lineage-specific antigen gp100
456100|NCT00028431|CTLA-4|ctla-4
456101|NCT00028483|stage IV breast cancer|stage iv breast cancer
456102|NCT00028483|recurrent breast cancer|recurrent breast cancer
456103|NCT00028509|neurotoxicity|neurotoxicity
456104|NCT00028509|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
456105|NCT00028548|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
456106|NCT00028574|stage I prostate cancer|stage i prostate cancer
456107|NCT00028574|stage IIB prostate cancer|stage iib prostate cancer
456108|NCT00028574|stage IIA prostate cancer|stage iia prostate cancer
456109|NCT00028574|stage III prostate cancer|stage iii prostate cancer
456110|NCT00028574|stage IV prostate cancer|stage iv prostate cancer
456113|NCT00028600|refractory multiple myeloma|refractory multiple myeloma
456114|NCT00028600|stage I multiple myeloma|stage i multiple myeloma
456115|NCT00028600|stage II multiple myeloma|stage ii multiple myeloma
456116|NCT00028600|stage III multiple myeloma|stage iii multiple myeloma
456117|NCT00028613|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
456118|NCT00028626|liver metastases|liver metastases
456119|NCT00028626|adenocarcinoma of the colon|adenocarcinoma of the colon
456120|NCT00028626|recurrent colon cancer|recurrent colon cancer
456121|NCT00028626|stage IV colon cancer|stage iv colon cancer
456122|NCT00028626|adenocarcinoma of the rectum|adenocarcinoma of the rectum
456123|NCT00028626|recurrent rectal cancer|recurrent rectal cancer
456124|NCT00028626|stage IV rectal cancer|stage iv rectal cancer
456125|NCT00028639|stage IV breast cancer|stage iv breast cancer
456126|NCT00028639|recurrent breast cancer|recurrent breast cancer
456127|NCT00028652|skin metastases|skin metastases
456128|NCT00028665|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
456129|NCT00028665|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
456130|NCT00028665|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
456131|NCT00028665|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
456132|NCT00028665|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
456133|NCT00028665|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
456134|NCT00028665|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
456135|NCT00028665|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
456136|NCT00028665|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
456137|NCT00028665|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
456138|NCT00028665|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
456139|NCT00028665|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
456140|NCT00028665|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
456141|NCT00028665|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
456142|NCT00028665|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
456143|NCT00028665|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
456144|NCT00028665|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
456145|NCT00028665|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
456146|NCT00028665|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
456147|NCT00028665|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
456148|NCT00028665|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
456149|NCT00028665|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
753027|NCT01175161|Postpartum Contraception|postpartum contraception
456150|NCT00028665|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
456151|NCT00028665|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
456152|NCT00028665|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
456153|NCT00028665|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
456154|NCT00028678|adult glioblastoma|adult glioblastoma
456155|NCT00028678|adult giant cell glioblastoma|adult giant cell glioblastoma
456156|NCT00028678|adult gliosarcoma|adult gliosarcoma
456157|NCT00028691|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
456158|NCT00028691|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
456159|NCT00028691|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
456160|NCT00028691|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
456161|NCT00028691|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
456162|NCT00028691|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
456163|NCT00028704|stage II breast cancer|stage ii breast cancer
456164|NCT00028704|stage IIIA breast cancer|stage iiia breast cancer
456165|NCT00028704|stage IIIB breast cancer|stage iiib breast cancer
456166|NCT00028704|inflammatory breast cancer|inflammatory breast cancer
456167|NCT00028717|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
456168|NCT00028717|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
456169|NCT00028717|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
456170|NCT00028717|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
456171|NCT00028717|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
456172|NCT00028717|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
456173|NCT00028717|stage I mantle cell lymphoma|stage i mantle cell lymphoma
456174|NCT00028717|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
456175|NCT00028717|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
456176|NCT00028717|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
456177|NCT00028717|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
456178|NCT00028717|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
456179|NCT00028717|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
456180|NCT00028717|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
456181|NCT00028717|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
456182|NCT00028730|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
456183|NCT00028730|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
456184|NCT00028730|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
475752|NCT00090545|VEGFR|vegfr
456185|NCT00028730|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
456186|NCT00028730|secondary acute myeloid leukemia|secondary acute myeloid leukemia
456187|NCT00028730|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
456188|NCT00028730|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
456189|NCT00028730|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
456190|NCT00028730|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
456191|NCT00028730|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
456192|NCT00028730|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
456193|NCT00028743|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
456194|NCT00028743|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
456195|NCT00028743|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
456196|NCT00028743|fallopian tube cancer|fallopian tube cancer
456197|NCT00028743|peritoneal cavity cancer|peritoneal cavity cancer
456198|NCT00028769|adenocarcinoma of the prostate|adenocarcinoma of the prostate
456199|NCT00028769|stage IV prostate cancer|stage iv prostate cancer
456200|NCT00028769|recurrent prostate cancer|recurrent prostate cancer
456201|NCT00028795|childhood brain stem glioma|childhood brain stem glioma
456202|NCT00028795|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
456203|NCT00028795|childhood spinal cord neoplasm|childhood spinal cord neoplasm
456204|NCT00028795|untreated childhood brain stem glioma|untreated childhood brain stem glioma
456205|NCT00028847|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
456206|NCT00028847|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
456207|NCT00028860|stage III bladder cancer|stage iii bladder cancer
456208|NCT00028860|stage IV bladder cancer|stage iv bladder cancer
456209|NCT00028860|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
456210|NCT00028860|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
456211|NCT00028860|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
456212|NCT00028873|stage IV breast cancer|stage iv breast cancer
456213|NCT00028873|recurrent breast cancer|recurrent breast cancer
456214|NCT00028886|stage II multiple myeloma|stage ii multiple myeloma
455634|NCT00027534|male breast cancer|male breast cancer
456215|NCT00028886|stage III multiple myeloma|stage iii multiple myeloma
456216|NCT00028899|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
456217|NCT00028899|secondary acute myeloid leukemia|secondary acute myeloid leukemia
456218|NCT00028899|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
456219|NCT00028912|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
456220|NCT00028912|primary peritoneal cavity cancer|primary peritoneal cavity cancer
456221|NCT00028912|fallopian tube cancer|fallopian tube cancer
456222|NCT00028925|extensive stage small cell lung cancer|extensive stage small cell lung cancer
456223|NCT00028938|squamous cell lung cancer|squamous cell lung cancer
456224|NCT00028938|large cell lung cancer|large cell lung cancer
456225|NCT00028938|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
456226|NCT00028938|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
456227|NCT00028938|adenocarcinoma of the lung|adenocarcinoma of the lung
456228|NCT00028938|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
456230|NCT00028951|perioperative/postoperative complications|perioperative/postoperative complications
456231|NCT00028951|stage I vulvar cancer|stage i vulvar cancer
456232|NCT00028951|stage II vulvar cancer|stage ii vulvar cancer
456233|NCT00028951|stage III vulvar cancer|stage iii vulvar cancer
456234|NCT00028951|stage IVB vulvar cancer|stage ivb vulvar cancer
456235|NCT00028964|stage I breast cancer|stage i breast cancer
456236|NCT00028964|stage II breast cancer|stage ii breast cancer
456237|NCT00028964|stage IIIA breast cancer|stage iiia breast cancer
456238|NCT00028964|recurrent breast cancer|recurrent breast cancer
456239|NCT00028964|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
456240|NCT00028977|stage IV breast cancer|stage iv breast cancer
456241|NCT00028977|recurrent breast cancer|recurrent breast cancer
456242|NCT00028990|stage IV breast cancer|stage iv breast cancer
456243|NCT00028990|recurrent breast cancer|recurrent breast cancer
456244|NCT00028990|male breast cancer|male breast cancer
456247|NCT00029042|MRI|mri
456248|NCT00029042|Inflammation|inflammation
456249|NCT00029042|Joint Disability|joint disability
456250|NCT00029042|Imaging|imaging
456251|NCT00029042|Biologic Therapy|biologic therapy
456252|NCT00029042|Rheumatoid Arthritis|rheumatoid arthritis
456253|NCT00029042|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
456254|NCT00029042|JRA|jra
456255|NCT00029042|Children|children
456256|NCT00029042|Joints|joints
456257|NCT00029042|Joint Inflammation|joint inflammation
456258|NCT00029068|Neurophysiology|neurophysiology
456259|NCT00029068|Tourette Syndrome|tourette syndrome
456260|NCT00029068|Anorexia|anorexia
456261|NCT00029068|SRIs|sris
456262|NCT00029068|Personality|personality
456263|NCT00029068|Obsessive-Compulsive Disorder (OCD)|obsessive-compulsive disorder (ocd)
456264|NCT00029068|Cortical Excitability|cortical excitability
456265|NCT00029068|Motor Cortex|motor cortex
456266|NCT00029068|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
456267|NCT00029068|OCD Spectrum Disorders|ocd spectrum disorders
456268|NCT00029068|Obsessive Compulsive|obsessive compulsive
456269|NCT00029068|OCD|ocd
456270|NCT00029068|Healthy Volunteer|healthy volunteer
456271|NCT00029068|Normal Control|normal control
456272|NCT00029068|HV|hv
456273|NCT00029107|Hepatitis|hepatitis
456274|NCT00029107|Vasculitis|vasculitis
456275|NCT00029107|Rituximab|rituximab
456276|NCT00029107|Cryoglobulinemia|cryoglobulinemia
456277|NCT00029107|Hepatitis C|hepatitis c
456278|NCT00029107|HcV-cV|hcv-cv
456279|NCT00029107|Cryoglobulinemic Vasculitis|cryoglobulinemic vasculitis
456280|NCT00029120|Alzheimer's Disease|alzheimer's disease
456281|NCT00029120|Spectroscopy|spectroscopy
456282|NCT00029120|Longitudinal|longitudinal
456283|NCT00029120|Perfusion|perfusion
456284|NCT00029120|Hippocampus|hippocampus
456285|NCT00029120|N-acetylaspartic Acid|n-acetylaspartic acid
456286|NCT00029120|Cerebral Blood Flow|cerebral blood flow
456287|NCT00029120|Aging|aging
456288|NCT00029120|Dementia|dementia
456289|NCT00029120|Alzheimer's|alzheimer's
456290|NCT00029120|Memory Disorder|memory disorder
456291|NCT00029120|Memory|memory
456292|NCT00029120|Healthy Volunteer|healthy volunteer
456293|NCT00029120|HV|hv
456294|NCT00029120|Normal Control|normal control
456295|NCT00029133|aneurysm|aneurysm
456296|NCT00029133|hypothermia|hypothermia
456297|NCT00029133|subarachnoid intracranial hemorrhage|subarachnoid intracranial hemorrhage
456298|NCT00029146|stroke|stroke
456299|NCT00029146|transient ischemic attack (TIA)|transient ischemic attack (tia)
456300|NCT00029146|carotid arteries|carotid arteries
456301|NCT00029146|cerebral infarction|cerebral infarction
456302|NCT00029159|Turner syndrome|turner syndrome
456303|NCT00029159|estrogen|estrogen
456304|NCT00029159|androgen|androgen
456305|NCT00029159|growth hormone|growth hormone
456306|NCT00029172|stroke|stroke
456307|NCT00029172|depression|depression
456308|NCT00029185|Corneal Erosion|corneal erosion
456309|NCT00029185|Dextrans|dextrans
455685|NCT00027586|Gleevec|gleevec
456310|NCT00029185|Administration, Topical|administration, topical
456311|NCT00029185|Ophthalmic Solutions|ophthalmic solutions
456312|NCT00029185|Thimerosal|thimerosal
456313|NCT00029198|Massage Therapy|massage therapy
456314|NCT00029198|Preterm Infants|preterm infants
456315|NCT00029198|Weight Gain|weight gain
456316|NCT00029198|Vagal Tone|vagal tone
456317|NCT00029198|IGF-1|igf-1
456318|NCT00029198|Oxytocin|oxytocin
456319|NCT00029198|Brazelton|brazelton
456320|NCT00029224|bone lesions|bone lesions
456321|NCT00029224|breast cancer|breast cancer
456322|NCT00029224|multiple myeloma|multiple myeloma
456323|NCT00029224|prostate cancer|prostate cancer
456324|NCT00029224|bone metastases|bone metastases
456325|NCT00029224|pain|pain
456326|NCT00029237|Behavioral intervention|behavioral intervention
456327|NCT00029237|Psychoneuroimmunology|psychoneuroimmunology
456328|NCT00029237|Complementary therapy|complementary therapy
456329|NCT00029237|Stress and coping|stress and coping
456330|NCT00029237|complementary therapies|complementary therapies
456331|NCT00029250|complementary therapies|complementary therapies
456332|NCT00029250|garlic|garlic
456333|NCT00029250|Allium sativum|allium sativum
456334|NCT00029250|metabolic diseases|metabolic diseases
456335|NCT00029250|HAART|haart
456336|NCT00029250|Protease inhibitors|protease inhibitors
456337|NCT00029276|Parkinson's|parkinson's
456338|NCT00029276|Depression|depression
456339|NCT00029276|Magnetic Stimulation|magnetic stimulation
456340|NCT00029302|fMRI|fmri
456341|NCT00029302|Voluntary Movement|voluntary movement
456342|NCT00029302|Healthy Volunteer|healthy volunteer
456343|NCT00029302|HV|hv
456344|NCT00029302|Normal Control|normal control
456345|NCT00029315|Intraventricular hemorrhage|intraventricular hemorrhage
456346|NCT00029315|Subarachnoid hemorrhage|subarachnoid hemorrhage
456347|NCT00029315|Intracerebral hemorrhage|intracerebral hemorrhage
456348|NCT00029315|Pharmacokinetics|pharmacokinetics
456349|NCT00029315|Recombinant Proteins|recombinant proteins
456350|NCT00029315|Anticoagulants|anticoagulants
456351|NCT00029315|Tissue Plasminogen Activator|tissue plasminogen activator
456352|NCT00029315|Pharmacology|pharmacology
456353|NCT00029315|Catheters, Indwelling|catheters, indwelling
456354|NCT00029315|Cerebral Ventricles|cerebral ventricles
456355|NCT00029328|TNFR-Fc fusion protein|tnfr-fc fusion protein
456356|NCT00029328|Stem Cell Transplantation|stem cell transplantation
456357|NCT00029328|Transplantation, Homologous|transplantation, homologous
456358|NCT00029328|Respiratory Function Tests|respiratory function tests
456359|NCT00029341|Drug Therapy, Combination|drug therapy, combination
456360|NCT00029341|Drug Administration Schedule|drug administration schedule
456361|NCT00029341|Drug Resistance, Microbial|drug resistance, microbial
456363|NCT00029341|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
456364|NCT00029341|Anti-HIV Agents|anti-hiv agents
456365|NCT00029341|Viral Load|viral load
456366|NCT00029341|Pharmacokinetics|pharmacokinetics
456367|NCT00029341|Efavirenz|efavirenz
456368|NCT00029341|Treatment Interruption|treatment interruption
456369|NCT00029445|HLA B5701|hla b5701
456370|NCT00029445|LTNP|ltnp
456371|NCT00029445|Neutralizing Antibodies|neutralizing antibodies
456372|NCT00029445|CTL|ctl
456373|NCT00029445|Virus Restriction|virus restriction
456374|NCT00029445|HIV|hiv
456375|NCT00029445|HIV-Infected Long Term Nonprogressors|hiv-infected long term nonprogressors
456376|NCT00029458|Placebo Controlled|placebo controlled
456377|NCT00029458|Atypical Anti-Psychotic|atypical anti-psychotic
456378|NCT00029458|Bipolar Mood Disorder|bipolar mood disorder
456379|NCT00029458|Positron Emission Tomography|positron emission tomography
456380|NCT00029458|Dopamine Receptor Blockade|dopamine receptor blockade
456381|NCT00029458|Antimanic|antimanic
456382|NCT00029458|Mania|mania
456383|NCT00029458|Pathophysiology|pathophysiology
456384|NCT00029458|Treatment-Resistant|treatment-resistant
456385|NCT00029458|Mood Disorder|mood disorder
456386|NCT00029458|BPD|bpd
456387|NCT00029458|Bipolar|bipolar
456388|NCT00029523|neoplastic|neoplastic
456389|NCT00029523|meningitis|meningitis
456390|NCT00029523|cerebrospinal fluid|cerebrospinal fluid
456391|NCT00029523|CSF|csf
456392|NCT00029523|meningeal|meningeal
456393|NCT00029523|meninges|meninges
456394|NCT00029523|CNS|cns
456395|NCT00029523|Leptomeningeal Neoplasms|leptomeningeal neoplasms
456396|NCT00029536|Epilepsy|epilepsy
456397|NCT00029536|Seizure|seizure
456398|NCT00029536|Hormone|hormone
456399|NCT00029536|Progesterone|progesterone
456400|NCT00029536|Catamenial|catamenial
456401|NCT00029575|Atherosclerotic|atherosclerotic
456403|NCT00029575|Resolution|resolution
456404|NCT00029575|Adventitia|adventitia
456405|NCT00029575|Ultrasound|ultrasound
456406|NCT00029575|Cardiac Catheterization|cardiac catheterization
456407|NCT00029575|Arteriosclerosis|arteriosclerosis
456408|NCT00029575|Coronary Artery Disease|coronary artery disease
456409|NCT00029588|fMRI|fmri
456410|NCT00029588|Adolescents and Adults|adolescents and adults
456411|NCT00029588|Depression|depression
455756|NCT00027885|male breast cancer|male breast cancer
456412|NCT00029588|Anxiety|anxiety
456413|NCT00029588|Anxiety Disorder|anxiety disorder
456414|NCT00029588|GAD|gad
456415|NCT00029588|Adolescents|adolescents
456416|NCT00029588|Healthy Volunteer|healthy volunteer
456417|NCT00029588|HV|hv
456418|NCT00029588|Normal Control|normal control
456419|NCT00029601|Magnetic Stimulation|magnetic stimulation
456420|NCT00029601|Intracortical Inhibition|intracortical inhibition
456421|NCT00029601|Intracortical Facilitation|intracortical facilitation
456422|NCT00029601|Motor Evoked Potential|motor evoked potential
456423|NCT00029601|Reaction Time|reaction time
456424|NCT00029601|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
456425|NCT00029601|Dystonia|dystonia
456426|NCT00029601|Focal Dystonia|focal dystonia
456427|NCT00029601|Healthy Volunteer|healthy volunteer
456428|NCT00029601|HV|hv
456429|NCT00029601|Normal Control|normal control
456430|NCT00029614|ADHD|adhd
456431|NCT00029614|Substance Use|substance use
456432|NCT00029627|Alpha2-Adrenoreceptors|alpha2-adrenoreceptors
456433|NCT00029627|Polymorphisms|polymorphisms
456434|NCT00029627|Challenge Study|challenge study
456435|NCT00029627|Yohimbine|yohimbine
456436|NCT00029627|Clonidine|clonidine
456437|NCT00029627|Subtypes|subtypes
456438|NCT00029627|Normal Control|normal control
456439|NCT00029627|HV|hv
456440|NCT00029627|Healthy Volunteer|healthy volunteer
456441|NCT00029640|MRI|mri
456442|NCT00029640|MRS|mrs
456443|NCT00029640|SSRI|ssri
456444|NCT00029640|Children|children
456445|NCT00029640|Depression|depression
456446|NCT00029640|Augmentation|augmentation
456447|NCT00029640|Magnetic Resonance Imaging|magnetic resonance imaging
456448|NCT00029640|Major Depression|major depression
456449|NCT00029640|MDD|mdd
456450|NCT00029653|Frontal Lobe|frontal lobe
456451|NCT00029653|Reaction Time|reaction time
456452|NCT00029653|Movement Preparation|movement preparation
456453|NCT00029653|Motor Threshold|motor threshold
456454|NCT00029653|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
456455|NCT00029653|Motor Cortex|motor cortex
456456|NCT00029653|Healthy Volunteer|healthy volunteer
456457|NCT00029653|Normal Control|normal control
456458|NCT00029653|HV|hv
456459|NCT00029666|Motor Cortex|motor cortex
456460|NCT00029666|Sham Stimulation|sham stimulation
456461|NCT00029666|Prefrontal Cortex|prefrontal cortex
456462|NCT00029666|Brain Stimulation|brain stimulation
456463|NCT00029666|Gait|gait
456464|NCT00029666|Parkinson|parkinson
456465|NCT00029666|Parkinson's|parkinson's
456466|NCT00029666|PD|pd
456467|NCT00029718|Chronic Stroke|chronic stroke
456468|NCT00029718|Transcallosal Inhibition|transcallosal inhibition
456469|NCT00029718|Motor Cortex|motor cortex
456470|NCT00029718|Motor Control|motor control
456471|NCT00029718|Motor Recovery|motor recovery
456472|NCT00029718|Healthy Volunteer|healthy volunteer
456473|NCT00029718|HV|hv
456474|NCT00029718|Normal Control|normal control
456475|NCT00029731|Nitric Oxide|nitric oxide
456476|NCT00029731|Administration, Oral|administration, oral
456477|NCT00029744|AIDS Vaccines|aids vaccines
456478|NCT00029744|Clinical Protocols|clinical protocols
456479|NCT00029744|HIV Seronegativity|hiv seronegativity
456480|NCT00029744|Patient Selection|patient selection
456481|NCT00029744|Patient Acceptance of Health Care|patient acceptance of health care
456482|NCT00029744|Demography|demography
456483|NCT00029744|HIV Preventive Vaccine|hiv preventive vaccine
456484|NCT00029757|Surgical menopause|surgical menopause
456485|NCT00029783|Glioblastoma|glioblastoma
456486|NCT00029783|Brain tumor|brain tumor
456487|NCT00029783|Distant healing|distant healing
456488|NCT00029783|Distance healing|distance healing
456489|NCT00029809|Parkinsons Disease|parkinsons disease
456490|NCT00029809|Chinese exercise|chinese exercise
456491|NCT00029822|Acute Urinary Retention|acute urinary retention
456492|NCT00029822|AUR|aur
456493|NCT00029822|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
456494|NCT00029822|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
456495|NCT00029822|BPH|bph
456496|NCT00029822|Enlarged Prostate|enlarged prostate
456497|NCT00029835|Obesity|obesity
456498|NCT00029848|Diabetes|diabetes
456499|NCT00029848|Obesity|obesity
456500|NCT00029861|Weight Loss|weight loss
456501|NCT00029861|Obesity|obesity
456502|NCT00029861|Weight Reduction|weight reduction
456503|NCT00029861|Overweight|overweight
456504|NCT00029874|Tetracyclines|tetracyclines
456505|NCT00029874|Dose-Response Relationship, Drug|dose-response relationship, drug
456506|NCT00029900|Dose-Response Relationship, Drug|dose-response relationship, drug
456507|NCT00029900|Polyethylene Glycol|polyethylene glycol
456508|NCT00029900|Arginine Deiminase|arginine deiminase
456509|NCT00029913|Placebos|placebos
456510|NCT00029913|AIDS Vaccines|aids vaccines
456511|NCT00029913|CD4 Lymphocyte Count|cd4 lymphocyte count
456512|NCT00029913|Disease Progression|disease progression
456513|NCT00029913|Viral Load|viral load
201026|NCT02112591|micturition dysfunction|micturition dysfunction
584624|NCT00509678|Rituxan|rituxan
456514|NCT00029913|HIV Preventive Vaccine|hiv preventive vaccine
456515|NCT00029926|Imaging|imaging
456516|NCT00029926|Immune System|immune system
456517|NCT00029926|Autoimmune Disease|autoimmune disease
456518|NCT00029926|Lymphonodes|lymphonodes
456519|NCT00029926|Spleen|spleen
456520|NCT00029926|Systemic Lupus Erythematosus|systemic lupus erythematosus
456521|NCT00029926|Lupus|lupus
456522|NCT00029926|SLE|sle
456523|NCT00029939|Preparation|preparation
456524|NCT00029939|Subconscious|subconscious
456525|NCT00029939|Healthy Volunteer|healthy volunteer
456526|NCT00029939|HV|hv
456527|NCT00029939|Normal Control|normal control
456528|NCT00029952|Cortisol|cortisol
456529|NCT00029952|Bone Density|bone density
456530|NCT00029952|Cushing Syndrome|cushing syndrome
456531|NCT00029952|Postoperative|postoperative
456532|NCT00029965|Tay-Sachs|tay-sachs
456533|NCT00029965|Lysosomal Storage Disease|lysosomal storage disease
456534|NCT00029965|Sandhoff|sandhoff
456535|NCT00029965|GM1 Gangliosidosis|gm1 gangliosidosis
456536|NCT00029965|GM2 Gangliosidosis|gm2 gangliosidosis
456537|NCT00029965|Lysosomal Storage Disorder|lysosomal storage disorder
456538|NCT00029965|Gaucher|gaucher
456539|NCT00029991|Leg pain|leg pain
456540|NCT00029991|Peripheral angiopathies|peripheral angiopathies
456541|NCT00029991|Vascular Diseases, peripheral|vascular diseases, peripheral
456542|NCT00030043|Electric Stimulation|electric stimulation
456543|NCT00030043|Implants, Artificial|implants, artificial
456544|NCT00030043|Brainstem|brainstem
456545|NCT00030043|Electrodes|electrodes
456546|NCT00030043|Speech Perception|speech perception
456547|NCT00030056|Sargramostim|sargramostim
456548|NCT00030056|Injections, Subcutaneous|injections, subcutaneous
456549|NCT00030069|Hematopoiesis|hematopoiesis
456550|NCT00030069|Apoptosis|apoptosis
456551|NCT00030069|Cell Differentiation|cell differentiation
456552|NCT00030069|Bone Marrow Cells|bone marrow cells
456553|NCT00030082|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
456554|NCT00030082|advanced adult primary liver cancer|advanced adult primary liver cancer
456555|NCT00030082|recurrent adult primary liver cancer|recurrent adult primary liver cancer
456556|NCT00030082|liver metastases|liver metastases
456557|NCT00030095|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
456558|NCT00030108|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
456559|NCT00030108|childhood craniopharyngioma|childhood craniopharyngioma
456560|NCT00030108|recurrent neuroblastoma|recurrent neuroblastoma
456561|NCT00030108|recurrent childhood liver cancer|recurrent childhood liver cancer
456562|NCT00030108|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
456563|NCT00030108|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
456564|NCT00030108|recurrent osteosarcoma|recurrent osteosarcoma
476825|NCT00097214|Non-small|non-small
456565|NCT00030108|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
456566|NCT00030108|childhood germ cell tumor|childhood germ cell tumor
456645|NCT00030212|Inflammatory Myopathy|inflammatory myopathy
456567|NCT00030108|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
456568|NCT00030108|childhood oligodendroglioma|childhood oligodendroglioma
456569|NCT00030108|childhood choroid plexus tumor|childhood choroid plexus tumor
456570|NCT00030108|childhood grade I meningioma|childhood grade i meningioma
456571|NCT00030108|childhood grade II meningioma|childhood grade ii meningioma
456572|NCT00030108|childhood grade III meningioma|childhood grade iii meningioma
456573|NCT00030108|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
456574|NCT00030108|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
456575|NCT00030108|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
456576|NCT00030108|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
456577|NCT00030108|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
456578|NCT00030108|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
456579|NCT00030108|recurrent childhood ependymoma|recurrent childhood ependymoma
456580|NCT00030108|childhood teratoma|childhood teratoma
456581|NCT00030108|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
456582|NCT00030108|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
456583|NCT00030108|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
456584|NCT00030108|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
456585|NCT00030108|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
456586|NCT00030108|childhood acute basophilic leukemia|childhood acute basophilic leukemia
456587|NCT00030108|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
456588|NCT00030108|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
456589|NCT00030108|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
753028|NCT01175161|Intrauterine device|intrauterine device
456590|NCT00030108|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
456591|NCT00030108|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
456592|NCT00030108|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
456593|NCT00030108|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
456594|NCT00030108|non-T, non-B, cALLa negative childhood acute lymphoblastic leukemia|non-t, non-b, calla negative childhood acute lymphoblastic leukemia
456595|NCT00030108|non-T, non-B, cALLa positive childhood acute lymphoblastic leukemia|non-t, non-b, calla positive childhood acute lymphoblastic leukemia
456596|NCT00030108|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
456597|NCT00030108|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
456598|NCT00030108|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
456599|NCT00030108|TdT negative childhood acute lymphoblastic leukemia|tdt negative childhood acute lymphoblastic leukemia
456600|NCT00030108|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
456601|NCT00030108|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
456602|NCT00030108|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
456603|NCT00030121|Acute Respiratory Distress|acute respiratory distress
456604|NCT00030121|Acute Lung Injury|acute lung injury
456605|NCT00030134|Natural History|natural history
456606|NCT00030134|Female Carrier|female carrier
456607|NCT00030134|Alpha-Galactosidase|alpha-galactosidase
456608|NCT00030134|Lysosomal Disease|lysosomal disease
456609|NCT00030134|X-Linked|x-linked
456610|NCT00030134|Fabry|fabry
456611|NCT00030134|Fabry Disease|fabry disease
456612|NCT00030147|Gonadal Steroids|gonadal steroids
456613|NCT00030147|Estrogen Receptor|estrogen receptor
456614|NCT00030147|Mood Disorders|mood disorders
456615|NCT00030147|Perimenopause|perimenopause
456616|NCT00030147|Estradiol|estradiol
456617|NCT00030147|Depression|depression
456618|NCT00030147|Estrogen Response Element|estrogen response element
456619|NCT00030147|Perimenopausal|perimenopausal
456620|NCT00030147|Perimenopausal Depression|perimenopausal depression
456621|NCT00030160|Obesity|obesity
456622|NCT00030160|Prevention|prevention
456624|NCT00030173|Epothilone D|epothilone d
456625|NCT00030173|tubulin polymerization|tubulin polymerization
456627|NCT00030186|FLT-3 mutation|flt-3 mutation
456628|NCT00030199|Transcranial Magnetic Stimuli|transcranial magnetic stimuli
456629|NCT00030199|Eletromyography|eletromyography
456630|NCT00030199|Needle Electrode|needle electrode
456631|NCT00030199|Facial Muscles|facial muscles
456632|NCT00030199|Blink Reflex|blink reflex
456633|NCT00030199|Motor Cortex|motor cortex
456634|NCT00030199|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
456635|NCT00030199|Healthy Volunteer|healthy volunteer
456636|NCT00030199|HV|hv
456637|NCT00030199|Normal Control|normal control
456638|NCT00030212|T Cell|t cell
456639|NCT00030212|IBM|ibm
456640|NCT00030212|Inflammatory Myopathies|inflammatory myopathies
456641|NCT00030212|Antigenic Epitopes|antigenic epitopes
456642|NCT00030212|Endomysial T Lymphocytes|endomysial t lymphocytes
456643|NCT00030212|Myositis|myositis
456644|NCT00030212|Inclusion Body Myositis|inclusion body myositis
457266|NCT00023166|Lymphomas|lymphomas
456646|NCT00030225|Fulminant Hepatic Failure|fulminant hepatic failure
456647|NCT00030238|Body Fat|body fat
456648|NCT00030238|Weight Gain|weight gain
456649|NCT00030238|Adult|adult
456650|NCT00030238|Hypertension|hypertension
456651|NCT00030238|Dietary Supplements|dietary supplements
456652|NCT00030238|Healthy Volunteer|healthy volunteer
456653|NCT00030238|HIV|hiv
456654|NCT00030238|Body Weight|body weight
456655|NCT00030264|plexiform neurofibroma|plexiform neurofibroma
456656|NCT00030264|neurofibromatosis type 1|neurofibromatosis type 1
456657|NCT00021554|HIV-1|hiv-1
456658|NCT00021554|Drug Therapy, Combination|drug therapy, combination
456659|NCT00021554|HIV Protease Inhibitors|hiv protease inhibitors
456660|NCT00021554|RNA, Viral|rna, viral
456661|NCT00021554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
456662|NCT00021554|Anti-HIV Agents|anti-hiv agents
456663|NCT00021554|Viral Load|viral load
456664|NCT00021554|pentafuside|pentafuside
456665|NCT00021567|Pneumonia|pneumonia
456666|NCT00021567|Cytokine|cytokine
456667|NCT00021567|Aerosol|aerosol
456668|NCT00021567|Therapy|therapy
456669|NCT00021567|Mycobacteria|mycobacteria
456670|NCT00021567|Mycobacterium Avium Complex|mycobacterium avium complex
456671|NCT00021567|MAC|mac
456672|NCT00021567|Pulmonary Infection|pulmonary infection
456673|NCT00021567|Lung Infection|lung infection
456674|NCT00021632|Ribavirin|ribavirin
456675|NCT00021632|Drug Interactions|drug interactions
456676|NCT00021632|Drug Therapy, Combination|drug therapy, combination
456677|NCT00021632|Zidovudine|zidovudine
456678|NCT00021632|Stavudine|stavudine
456679|NCT00021632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
456680|NCT00021632|Anti-HIV Agents|anti-hiv agents
456681|NCT00021632|Pharmacokinetics|pharmacokinetics
456682|NCT00021632|Area Under Curve|area under curve
455967|NCT00028210|HV|hv
456683|NCT00021645|Corticosteroids|corticosteroids
456684|NCT00021645|Immunosuppressives|immunosuppressives
456685|NCT00021645|Intraocular Inflammatory Disease|intraocular inflammatory disease
456686|NCT00021645|Uveitis|uveitis
456687|NCT00021645|Macular Edema|macular edema
456688|NCT00021658|Epidemiology|epidemiology
456689|NCT00021658|pesticide|pesticide
456690|NCT00021658|asthma|asthma
456691|NCT00021658|children|children
456692|NCT00021658|exposure|exposure
456693|NCT00021671|Drug Therapy, Combination|drug therapy, combination
456694|NCT00021671|Ampicillin|ampicillin
456695|NCT00021671|Nevirapine|nevirapine
456696|NCT00021671|Disease Transmission, Vertical|disease transmission, vertical
456697|NCT00021671|Anti-Infective Agents|anti-infective agents
456698|NCT00021671|Erythromycin|erythromycin
456699|NCT00021671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
456700|NCT00021671|Metronidazole|metronidazole
456701|NCT00021671|Anti-HIV Agents|anti-hiv agents
456702|NCT00021671|Chorioamnionitis|chorioamnionitis
456703|NCT00021671|HIV Seronegativity|hiv seronegativity
456704|NCT00021697|AVP-923|avp-923
456705|NCT00021697|Dextromethorphan|dextromethorphan
456706|NCT00021697|Quinidine|quinidine
456707|NCT00021697|Pseudobulbar Affect|pseudobulbar affect
456708|NCT00021710|Stroke|stroke
456709|NCT00021710|Learning|learning
456710|NCT00021710|Plasticity|plasticity
456711|NCT00021710|Motor|motor
456712|NCT00021710|Rehabilitation|rehabilitation
456713|NCT00021710|Premotor|premotor
456714|NCT00021710|Normal Control|normal control
456715|NCT00021710|Healthy Volunteer|healthy volunteer
456716|NCT00021710|HV|hv
456717|NCT00021710|Motor Learning|motor learning
456718|NCT00021723|Alzheimer's|alzheimer's
456719|NCT00021723|AN-1792|an-1792
456720|NCT00021723|AIP-001|aip-001
456721|NCT00021736|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
456722|NCT00021736|subretinal neovascularization|subretinal neovascularization
456723|NCT00021749|CLL|cll
456724|NCT00021749|Leukemia|leukemia
456725|NCT00021749|Chronic|chronic
456726|NCT00021749|Cancer|cancer
456727|NCT00021749|Adult|adult
456728|NCT00021749|Lymphocytic|lymphocytic
456729|NCT00021749|Genasense|genasense
456730|NCT00021749|G3139|g3139
456731|NCT00021749|Genta|genta
456732|NCT00021749|Bcl-2|bcl-2
456733|NCT00021749|Antisense|antisense
456734|NCT00021749|Oligonucleotide|oligonucleotide
456735|NCT00021749|oblimerson|oblimerson
456736|NCT00021762|Virus Replication|virus replication
456737|NCT00021762|HIV-1|hiv-1
456738|NCT00021762|Drug Administration Schedule|drug administration schedule
456739|NCT00021762|AIDS Vaccines|aids vaccines
456740|NCT00021762|RNA, Viral|rna, viral
456741|NCT00021762|Viral Load|viral load
456742|NCT00021762|HIV-1 immunogen, incomplete Freund's adjuvant|hiv-1 immunogen, incomplete freund's adjuvant
456743|NCT00021762|Treatment Interruption|treatment interruption
456744|NCT00021762|HIV Therapeutic Vaccine|hiv therapeutic vaccine
456745|NCT00021775|Risk Factors|risk factors
456746|NCT00021775|Incidence|incidence
476826|NCT00097214|Lung|lung
456747|NCT00021775|Patient Selection|patient selection
456748|NCT00021775|HIV Seronegativity|hiv seronegativity
456749|NCT00021788|Type I Diabetes Mellitus|type i diabetes mellitus
456750|NCT00021788|Immunosuppression|immunosuppression
456751|NCT00021788|Islet Cell Transplantation|islet cell transplantation
456752|NCT00021788|PercutaneousTranshepaticPortalVein Catheterization|percutaneoustranshepaticportalvein catheterization
456753|NCT00021801|Type I Diabetes Mellitus|type i diabetes mellitus
456754|NCT00021801|Immunosuppression|immunosuppression
456755|NCT00021801|Islet Cell Transplant|islet cell transplant
456756|NCT00021801|Percutaneous Transhepatic Portal|percutaneous transhepatic portal
456757|NCT00021814|BPH progression|bph progression
456758|NCT00021814|Medical Therapy|medical therapy
456759|NCT00021814|Finasteride|finasteride
456760|NCT00021814|Doxazosin|doxazosin
456761|NCT00021814|Randomized|randomized
456762|NCT00021814|Multi-center|multi-center
456763|NCT00021814|Clinical Trial|clinical trial
456764|NCT00021814|Proscar|proscar
456765|NCT00021814|Cardura|cardura
456766|NCT00021827|parathyroid hormone-related protein|parathyroid hormone-related protein
456767|NCT00021827|parathyroid hormone|parathyroid hormone
456768|NCT00021827|anabolic skeletal therapy|anabolic skeletal therapy
456769|NCT00021827|postmenopausal women|postmenopausal women
456770|NCT00021853|Individualized|individualized
456771|NCT00021853|Finger|finger
456772|NCT00021853|Training|training
456773|NCT00021853|Splinting|splinting
456774|NCT00021853|TMS|tms
456775|NCT00021853|Dystonia|dystonia
456776|NCT00021853|Focal Dystonia|focal dystonia
456777|NCT00021853|Movement Disorder|movement disorder
456778|NCT00021853|Focal Hand Dystonia|focal hand dystonia
456779|NCT00021853|Writer's Cramp|writer's cramp
456780|NCT00021866|epilepsy|epilepsy
456781|NCT00021866|seizure|seizure
456782|NCT00021866|pregnancy|pregnancy
456783|NCT00021866|antiepileptic|antiepileptic
456784|NCT00021866|AED|aed
456785|NCT00021866|carbamazepine|carbamazepine
456786|NCT00021866|phenytoin|phenytoin
456787|NCT00021866|valproate|valproate
456788|NCT00021866|lamotrigine|lamotrigine
456789|NCT00021866|child|child
456790|NCT00021866|behavior|behavior
456791|NCT00021983|refractory hairy cell leukemia|refractory hairy cell leukemia
456792|NCT00021996|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
456793|NCT00021996|pain|pain
456794|NCT00022009|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
456795|NCT00022009|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
456796|NCT00022009|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
456797|NCT00022022|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
456798|NCT00022022|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
456799|NCT00022022|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
456800|NCT00022035|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
456801|NCT00022035|infection|infection
456802|NCT00022048|refractory anemia|refractory anemia
456803|NCT00022048|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
456804|NCT00022048|refractory anemia with excess blasts|refractory anemia with excess blasts
456805|NCT00022048|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
456806|NCT00022048|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
456807|NCT00022048|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
456808|NCT00022048|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
456809|NCT00022048|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
456810|NCT00022048|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
456811|NCT00022074|stage I breast cancer|stage i breast cancer
456812|NCT00022074|stage II breast cancer|stage ii breast cancer
456813|NCT00022074|stage IV breast cancer|stage iv breast cancer
456814|NCT00022074|stage IIIA breast cancer|stage iiia breast cancer
456815|NCT00022074|recurrent breast cancer|recurrent breast cancer
456816|NCT00022074|stage IIIB breast cancer|stage iiib breast cancer
456817|NCT00022074|stage IIIC breast cancer|stage iiic breast cancer
456818|NCT00022074|anxiety disorder|anxiety disorder
456819|NCT00022074|depression|depression
456820|NCT00022074|hot flashes|hot flashes
456821|NCT00022087|osteoporosis|osteoporosis
456822|NCT00022087|stage I breast cancer|stage i breast cancer
456823|NCT00022087|stage II breast cancer|stage ii breast cancer
456824|NCT00022087|stage IV breast cancer|stage iv breast cancer
456825|NCT00022087|stage IIIA breast cancer|stage iiia breast cancer
456826|NCT00022087|stage IIIB breast cancer|stage iiib breast cancer
456827|NCT00022087|stage IIIC breast cancer|stage iiic breast cancer
456828|NCT00022126|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
456829|NCT00022126|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
456830|NCT00022126|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
456831|NCT00022126|acute undifferentiated leukemia|acute undifferentiated leukemia
456832|NCT00022139|stage III gastric cancer|stage iii gastric cancer
456833|NCT00022139|stage II esophageal cancer|stage ii esophageal cancer
456834|NCT00022139|stage III esophageal cancer|stage iii esophageal cancer
456835|NCT00022139|adenocarcinoma of the stomach|adenocarcinoma of the stomach
476300|NCT00095459|Solid Tumor|solid tumor
456836|NCT00022139|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
456837|NCT00022139|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
456838|NCT00022152|stage IV breast cancer|stage iv breast cancer
456839|NCT00022152|recurrent breast cancer|recurrent breast cancer
456840|NCT00022165|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
456841|NCT00022178|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
456842|NCT00022178|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
456843|NCT00022178|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
456844|NCT00022178|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
456845|NCT00022191|stage IV bladder cancer|stage iv bladder cancer
456846|NCT00022191|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
456847|NCT00022191|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
456848|NCT00022191|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
456849|NCT00022191|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
456850|NCT00022204|stage I breast cancer|stage i breast cancer
456851|NCT00022204|stage II breast cancer|stage ii breast cancer
456852|NCT00022204|stage IIIA breast cancer|stage iiia breast cancer
456853|NCT00022204|lymphedema|lymphedema
456854|NCT00022204|male breast cancer|male breast cancer
456855|NCT00022217|recurrent salivary gland cancer|recurrent salivary gland cancer
456856|NCT00022217|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
456857|NCT00022217|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
457045|NCT00022776|Orthopedics|orthopedics
456858|NCT00022217|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
456859|NCT00022217|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
456860|NCT00022217|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
456861|NCT00022217|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
456862|NCT00022217|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
456863|NCT00022217|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
456864|NCT00022217|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
456865|NCT00022217|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
456866|NCT00022217|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
456867|NCT00022217|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
456868|NCT00022230|stage II breast cancer|stage ii breast cancer
456869|NCT00022230|stage IIIA breast cancer|stage iiia breast cancer
456870|NCT00022230|stage IIIB breast cancer|stage iiib breast cancer
456871|NCT00022230|stage IIIC breast cancer|stage iiic breast cancer
456872|NCT00022243|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
456873|NCT00022243|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
456874|NCT00022243|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
456875|NCT00022243|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
456876|NCT00022256|adult glioblastoma|adult glioblastoma
456877|NCT00022256|adult giant cell glioblastoma|adult giant cell glioblastoma
456878|NCT00022256|adult gliosarcoma|adult gliosarcoma
456879|NCT00022282|refractory multiple myeloma|refractory multiple myeloma
456880|NCT00022295|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
456881|NCT00022308|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
456882|NCT00022308|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
456883|NCT00022308|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
456884|NCT00022308|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
456885|NCT00022321|refractory anemia|refractory anemia
456886|NCT00022321|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
456887|NCT00022321|refractory anemia with excess blasts|refractory anemia with excess blasts
456888|NCT00022321|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
456889|NCT00022321|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
456890|NCT00022334|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
456891|NCT00022334|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
456892|NCT00022334|advanced adult primary liver cancer|advanced adult primary liver cancer
456893|NCT00022334|recurrent adult primary liver cancer|recurrent adult primary liver cancer
456894|NCT00022334|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
456895|NCT00022347|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
456896|NCT00022347|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
456897|NCT00022347|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
456898|NCT00022347|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
456899|NCT00022347|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
456900|NCT00022347|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
476985|NCT00088309|Osteopenia|osteopenia
456901|NCT00022347|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
456902|NCT00022347|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
456903|NCT00022347|fallopian tube cancer|fallopian tube cancer
456904|NCT00022347|primary peritoneal cavity cancer|primary peritoneal cavity cancer
456905|NCT00022360|recurrent adult brain tumor|recurrent adult brain tumor
456906|NCT00022360|adult glioblastoma|adult glioblastoma
456907|NCT00022360|adult anaplastic astrocytoma|adult anaplastic astrocytoma
456908|NCT00022360|adult giant cell glioblastoma|adult giant cell glioblastoma
456909|NCT00022360|adult gliosarcoma|adult gliosarcoma
456910|NCT00022373|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
456911|NCT00022373|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
456912|NCT00022373|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
456913|NCT00022373|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
456914|NCT00022373|stage I salivary gland cancer|stage i salivary gland cancer
456915|NCT00022373|stage II salivary gland cancer|stage ii salivary gland cancer
456916|NCT00022373|stage III salivary gland cancer|stage iii salivary gland cancer
456917|NCT00022373|stage IV salivary gland cancer|stage iv salivary gland cancer
456918|NCT00022373|recurrent salivary gland cancer|recurrent salivary gland cancer
456919|NCT00022373|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
456920|NCT00022373|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
456921|NCT00022373|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
456922|NCT00022373|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
456923|NCT00022373|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
456924|NCT00022373|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
456925|NCT00022373|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
456926|NCT00022373|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
456927|NCT00022373|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
456928|NCT00022373|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
456929|NCT00022373|stage I oropharyngeal cancer|stage i oropharyngeal cancer
456930|NCT00022373|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
456931|NCT00022373|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
456932|NCT00022373|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
456933|NCT00022373|radiation toxicity|radiation toxicity
456934|NCT00022373|oral complications of radiation therapy|oral complications of radiation therapy
456935|NCT00022386|stage I breast cancer|stage i breast cancer
456936|NCT00022386|stage II breast cancer|stage ii breast cancer
456937|NCT00022386|stage IIIA breast cancer|stage iiia breast cancer
456938|NCT00022386|stage IIIB breast cancer|stage iiib breast cancer
456939|NCT00022386|anemia|anemia
456940|NCT00022386|fatigue|fatigue
456941|NCT00022399|stage I prostate cancer|stage i prostate cancer
456942|NCT00022399|stage IIB prostate cancer|stage iib prostate cancer
456943|NCT00022399|stage IIA prostate cancer|stage iia prostate cancer
456944|NCT00022399|adenocarcinoma of the prostate|adenocarcinoma of the prostate
456945|NCT00022412|adenocarcinoma of the prostate|adenocarcinoma of the prostate
456946|NCT00022412|stage I prostate cancer|stage i prostate cancer
456947|NCT00022412|stage II prostate cancer|stage ii prostate cancer
456948|NCT00022425|recurrent breast cancer|recurrent breast cancer
456949|NCT00022438|stage IV melanoma|stage iv melanoma
456950|NCT00022438|recurrent melanoma|recurrent melanoma
456951|NCT00022451|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
456952|NCT00022451|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
456953|NCT00022451|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
456954|NCT00022451|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
456955|NCT00022451|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
456956|NCT00022451|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
456957|NCT00022451|acute undifferentiated leukemia|acute undifferentiated leukemia
456958|NCT00022451|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
456959|NCT00022451|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
456960|NCT00022464|stage IV melanoma|stage iv melanoma
456961|NCT00022464|recurrent melanoma|recurrent melanoma
456962|NCT00022477|stage IV colon cancer|stage iv colon cancer
456963|NCT00022477|stage IV rectal cancer|stage iv rectal cancer
456964|NCT00022477|recurrent colon cancer|recurrent colon cancer
456965|NCT00022477|recurrent rectal cancer|recurrent rectal cancer
456966|NCT00022477|adenocarcinoma of the colon|adenocarcinoma of the colon
456967|NCT00022477|adenocarcinoma of the rectum|adenocarcinoma of the rectum
456968|NCT00022490|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
456969|NCT00022490|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
456970|NCT00022516|stage IA breast cancer|stage ia breast cancer
456971|NCT00022516|stage II breast cancer|stage ii breast cancer
456972|NCT00022516|stage IIIA breast cancer|stage iiia breast cancer
456973|NCT00022516|stage IIIB breast cancer|stage iiib breast cancer
456974|NCT00022516|stage IB breast cancer|stage ib breast cancer
457046|NCT00022776|Physical therapy|physical therapy
456975|NCT00022516|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
456976|NCT00022516|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
456977|NCT00022516|triple-negative breast cancer|triple-negative breast cancer
456978|NCT00022516|low-dose maintenance chemotherapy|low-dose maintenance chemotherapy
456980|NCT00022516|angiogenesis|angiogenesis
456981|NCT00022568|stage IV melanoma|stage iv melanoma
456982|NCT00022568|recurrent melanoma|recurrent melanoma
456983|NCT00022594|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
456984|NCT00022594|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
456985|NCT00022594|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
456986|NCT00022594|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
456987|NCT00022594|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
456988|NCT00022594|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
456989|NCT00022594|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
456990|NCT00022594|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
456991|NCT00022594|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
753029|NCT01175161|feasibility|feasibility
456992|NCT00022594|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
456993|NCT00022594|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
456994|NCT00022594|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
456995|NCT00022594|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
456996|NCT00022594|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
456997|NCT00022607|refractory multiple myeloma|refractory multiple myeloma
456998|NCT00022607|stage I multiple myeloma|stage i multiple myeloma
456999|NCT00022607|stage II multiple myeloma|stage ii multiple myeloma
457000|NCT00022607|stage III multiple myeloma|stage iii multiple myeloma
457001|NCT00022620|recurrent endometrial carcinoma|recurrent endometrial carcinoma
457002|NCT00022620|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
457003|NCT00022633|recurrent bladder cancer|recurrent bladder cancer
457004|NCT00022633|stage IV bladder cancer|stage iv bladder cancer
457005|NCT00022633|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
457006|NCT00022633|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
457007|NCT00022633|adenocarcinoma of the bladder|adenocarcinoma of the bladder
457008|NCT00022633|recurrent urethral cancer|recurrent urethral cancer
457009|NCT00022633|anterior urethral cancer|anterior urethral cancer
457010|NCT00022633|posterior urethral cancer|posterior urethral cancer
457011|NCT00022633|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
457012|NCT00022633|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
457013|NCT00022633|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
457014|NCT00022633|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
457015|NCT00022646|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
457016|NCT00022646|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
457017|NCT00022685|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
457018|NCT00022685|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
457019|NCT00022698|stage III colon cancer|stage iii colon cancer
457020|NCT00022698|stage IV colon cancer|stage iv colon cancer
457021|NCT00022698|stage III rectal cancer|stage iii rectal cancer
457022|NCT00022698|stage IV rectal cancer|stage iv rectal cancer
457023|NCT00022698|recurrent colon cancer|recurrent colon cancer
457024|NCT00022698|recurrent rectal cancer|recurrent rectal cancer
457025|NCT00022698|adenocarcinoma of the colon|adenocarcinoma of the colon
457026|NCT00022698|adenocarcinoma of the rectum|adenocarcinoma of the rectum
457027|NCT00022711|recurrent small cell lung cancer|recurrent small cell lung cancer
457028|NCT00022711|intermediate type small cell lung cancer|intermediate type small cell lung cancer
457029|NCT00022724|recurrent adult brain tumor|recurrent adult brain tumor
457030|NCT00022724|adult glioblastoma|adult glioblastoma
457031|NCT00022724|adult anaplastic astrocytoma|adult anaplastic astrocytoma
457032|NCT00022724|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
457033|NCT00022724|adult mixed glioma|adult mixed glioma
457034|NCT00022724|adult giant cell glioblastoma|adult giant cell glioblastoma
457035|NCT00022724|adult gliosarcoma|adult gliosarcoma
457036|NCT00022750|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
457037|NCT00022750|Nurse Case Manager|nurse case manager
457038|NCT00022750|Community Health Worker|community health worker
457039|NCT00022750|Behavioral Interventions|behavioral interventions
457040|NCT00022750|Cost-effectiveness|cost-effectiveness
457041|NCT00022750|Randomized trial|randomized trial
457042|NCT00022763|Anti-HIV Agents|anti-hiv agents
457043|NCT00022763|pentafuside|pentafuside
457044|NCT00022776|Human therapy evaluation|human therapy evaluation
457047|NCT00022776|Nonsurgical treatment|nonsurgical treatment
457048|NCT00022776|Surgical decompression|surgical decompression
457050|NCT00022776|Lumbar|lumbar
457051|NCT00022776|Spine disorder|spine disorder
457052|NCT00022776|Spinal stenosis|spinal stenosis
457053|NCT00022776|Gender difference|gender difference
457054|NCT00022776|Medical rehabilitation|medical rehabilitation
457055|NCT00022789|Sleep-Disordered Breathing|sleep-disordered breathing
457056|NCT00022802|Biomedical equipment development|biomedical equipment development
457057|NCT00022802|Computer assisted patient care|computer assisted patient care
457058|NCT00022802|Digital imaging|digital imaging
457059|NCT00022802|Hip surgery|hip surgery
457060|NCT00022802|Orthopedics|orthopedics
457061|NCT00022802|Trauma|trauma
457062|NCT00022802|Radiography|radiography
457063|NCT00022802|Biomedical imaging|biomedical imaging
457064|NCT00022815|Compartment syndrome|compartment syndrome
457065|NCT00022815|Tissue ultrafiltration|tissue ultrafiltration
457066|NCT00022815|Reperfusion injury|reperfusion injury
457067|NCT00022815|Ischemia|ischemia
457068|NCT00022828|Laser|laser
457069|NCT00022828|Cervical|cervical
457070|NCT00022828|Spinal|spinal
457071|NCT00022828|Spine|spine
457072|NCT00022828|Neck|neck
457073|NCT00022828|Illinois|illinois
753030|NCT01175161|IUD|iud
456402|NCT00029575|Plaque|plaque
457074|NCT00022841|Bone mineral density (BMD)|bone mineral density (bmd)
457075|NCT00022841|Children|children
457076|NCT00022841|Glucocorticoids|glucocorticoids
457077|NCT00022841|Osteoporosis|osteoporosis
457078|NCT00022841|Pediatric|pediatric
457079|NCT00022841|Pamidronate|pamidronate
457080|NCT00022841|Steroids|steroids
457081|NCT00022854|ACL|acl
457082|NCT00022854|Nerve block|nerve block
457083|NCT00022854|Knee|knee
457084|NCT00022854|Outcome survey|outcome survey
457085|NCT00022854|Anesthesia|anesthesia
457086|NCT00022854|Analgesia|analgesia
457087|NCT00022854|Pain|pain
457088|NCT00022867|Bone growth|bone growth
457089|NCT00022867|Calcium|calcium
457090|NCT00022867|Children|children
457091|NCT00022867|Diet|diet
457092|NCT00022867|Puberty|puberty
457093|NCT00022880|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
457094|NCT00022880|Dose-Escalation|dose-escalation
457095|NCT00022880|Radioimmunotherapy|radioimmunotherapy
457096|NCT00022880|Monoclonal Antibody|monoclonal antibody
457097|NCT00022880|Corixa|corixa
457098|NCT00022880|Bexxar|bexxar
457099|NCT00022880|Anti-B1 Antibody|anti-b1 antibody
457100|NCT00022880|Tositumomab|tositumomab
457101|NCT00022880|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
457102|NCT00022880|Iodine I 131 Tositumomab|iodine i 131 tositumomab
457103|NCT00022893|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
457104|NCT00022893|Radioimmunotherapy|radioimmunotherapy
457105|NCT00022893|Monoclonal Antibody|monoclonal antibody
457106|NCT00022893|Corixa|corixa
457107|NCT00022893|Bexxar|bexxar
457108|NCT00022893|Anti-B1 Antibody|anti-b1 antibody
457109|NCT00022893|Tositumomab|tositumomab
457110|NCT00022893|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
457111|NCT00022893|Iodine I 131 Tositumomab|iodine i 131 tositumomab
457112|NCT00022906|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
457113|NCT00022906|Radioimmunotherapy|radioimmunotherapy
457114|NCT00022906|Monoclonal Antibody|monoclonal antibody
457115|NCT00022906|Corixa|corixa
457116|NCT00022906|Bexxar|bexxar
457117|NCT00022906|Anti-B1 Antibody|anti-b1 antibody
457118|NCT00022906|Tositumomab|tositumomab
457119|NCT00022906|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
457120|NCT00022906|Iodine I 131 Tositumomab|iodine i 131 tositumomab
457121|NCT00022919|Microdissection|microdissection
457122|NCT00022919|Chromosome|chromosome
457123|NCT00022919|Karyotype|karyotype
457124|NCT00022919|Tumor|tumor
457125|NCT00022919|Malignancy|malignancy
457126|NCT00022919|Prostate Adenocarcinoma|prostate adenocarcinoma
457127|NCT00022919|Prostate Intraepithelial Neoplasia|prostate intraepithelial neoplasia
457128|NCT00022919|Prostate Cancer|prostate cancer
457129|NCT00022919|Prostate|prostate
457130|NCT00022932|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
457131|NCT00022932|Radioimmunotherapy|radioimmunotherapy
457132|NCT00022932|Monoclonal Antibody|monoclonal antibody
457133|NCT00022932|Corixa|corixa
457134|NCT00022932|Bexxar|bexxar
457135|NCT00022932|Anti-B1 Antibody|anti-b1 antibody
457136|NCT00022932|Tositumomab|tositumomab
457137|NCT00022932|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
457138|NCT00022932|Iodine I 131 Tositumomab|iodine i 131 tositumomab
457139|NCT00022945|Mantle Cell Lymphoma|mantle cell lymphoma
457140|NCT00022945|Radioimmunotherapy|radioimmunotherapy
457141|NCT00022945|Monoclonal Antibody|monoclonal antibody
457142|NCT00022945|Corixa|corixa
457143|NCT00022945|Bexxar|bexxar
457144|NCT00022945|Anti-B1 Antibody|anti-b1 antibody
457145|NCT00022945|Tositumomab|tositumomab
457146|NCT00022945|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
457147|NCT00022945|Iodine I 131 Tositumomab|iodine i 131 tositumomab
457148|NCT00022958|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
457149|NCT00022958|Radioimmunotherapy|radioimmunotherapy
457150|NCT00022958|Monoclonal Antibody|monoclonal antibody
476986|NCT00088309|Pediatric|pediatric
457153|NCT00022958|Anti-B1 Antibody|anti-b1 antibody
457154|NCT00022958|Tositumomab|tositumomab
457155|NCT00022958|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
457156|NCT00022958|Iodine I 131 Tositumomab|iodine i 131 tositumomab
457157|NCT00022971|Monoclonal Antibody|monoclonal antibody
457158|NCT00022971|Lymphoma|lymphoma
457159|NCT00022971|Rituximab|rituximab
457160|NCT00022971|Hu1D10|hu1d10
457161|NCT00022971|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
457162|NCT00022971|NHL|nhl
457163|NCT00022971|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
457164|NCT00022971|CLL|cll
457165|NCT00022971|Leukemia|leukemia
457166|NCT00022984|Attitudes Towards Technology|attitudes towards technology
457167|NCT00022984|Cardiovascular Disease|cardiovascular disease
457168|NCT00022984|Illness Representation|illness representation
457169|NCT00022984|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
457170|NCT00022984|Symptom Distress|symptom distress
457171|NCT00022984|Heart Disease|heart disease
457173|NCT00022997|Phenylthiocarbamide|phenylthiocarbamide
457174|NCT00022997|Phlebotomy|phlebotomy
457175|NCT00022997|Chemoreceptors|chemoreceptors
457176|NCT00022997|Population Associations|population associations
457177|NCT00022997|Non-Tasters|non-tasters
457178|NCT00022997|Taste|taste
457179|NCT00022997|Healthy Volunteer|healthy volunteer
457180|NCT00022997|HV|hv
457181|NCT00022997|Normal Control|normal control
457182|NCT00023010|CD18|cd18
457183|NCT00023010|Retrovirus|retrovirus
457184|NCT00023010|RCR|rcr
457185|NCT00023010|Stem Cell|stem cell
457186|NCT00023010|Gene Transfer|gene transfer
457187|NCT00023010|Leukocyte Adhesion Deficiency|leukocyte adhesion deficiency
457188|NCT00023010|LAD|lad
457189|NCT00023023|Hepatitis|hepatitis
457190|NCT00023023|Blood Bank|blood bank
457191|NCT00023023|Viruses|viruses
457192|NCT00023023|Blood Donors|blood donors
457193|NCT00023023|Blood Recipients|blood recipients
457194|NCT00023036|Genetics|genetics
457195|NCT00023036|Deafness|deafness
457196|NCT00023036|EVA|eva
457197|NCT00023036|Pendred|pendred
457198|NCT00023036|Hearing|hearing
457199|NCT00023036|Hearing Impairment|hearing impairment
457200|NCT00023036|Nonsyndromic Hereditary Hearing Impairment|nonsyndromic hereditary hearing impairment
457201|NCT00023036|SNHL|snhl
457202|NCT00023036|Inner Ear|inner ear
457203|NCT00023036|Enlarged Vestibular Aqueducts|enlarged vestibular aqueducts
457204|NCT00023049|Deafness|deafness
457205|NCT00023049|Genes|genes
457206|NCT00023049|Impairment|impairment
457207|NCT00023049|Auditory|auditory
457208|NCT00023049|Vestibular|vestibular
457209|NCT00023049|Hereditary Hearing Disorder|hereditary hearing disorder
457210|NCT00023049|Hearing Impairment|hearing impairment
457211|NCT00023049|Sensorineural Hearing Loss|sensorineural hearing loss
457212|NCT00023049|Vestibular Dysfunction|vestibular dysfunction
457213|NCT00023049|SNHL|snhl
457214|NCT00023062|Natural History|natural history
457215|NCT00023062|Motor Cortex|motor cortex
457216|NCT00023062|Behavior|behavior
457217|NCT00023062|Healthy Volunteers|healthy volunteers
457218|NCT00023062|Motor Control|motor control
457219|NCT00023062|Parkinson Disease|parkinson disease
457220|NCT00023062|Parkinson's|parkinson's
457221|NCT00023062|Healthy Volunteer|healthy volunteer
457222|NCT00023062|HV|hv
457223|NCT00023062|Normal Control|normal control
457224|NCT00023075|MRI|mri
457225|NCT00023075|Neuromuscular Disease|neuromuscular disease
457226|NCT00023075|N-Acetyl Aspartate|n-acetyl aspartate
457227|NCT00023075|Choline|choline
457228|NCT00023075|Creatine|creatine
457229|NCT00023075|Spasms|spasms
457230|NCT00023075|Spasticity|spasticity
457231|NCT00023075|Primary Lateral Sclerosis|primary lateral sclerosis
457232|NCT00023075|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
457233|NCT00023075|Spastic Paraparesis|spastic paraparesis
457234|NCT00023075|Healthy Volunteer|healthy volunteer
457235|NCT00023075|HV|hv
457236|NCT00023075|Normal Control|normal control
457237|NCT00023088|Rehabilitation|rehabilitation
457239|NCT00023088|Activity of Daily Living|activity of daily living
457240|NCT00023088|Mobility|mobility
457241|NCT00023088|Normal Volunteer|normal volunteer
457242|NCT00023101|lead|lead
457243|NCT00023101|endocrine dysfunction|endocrine dysfunction
457244|NCT00023114|lung function|lung function
457245|NCT00023114|smoking|smoking
457246|NCT00023114|metabolism|metabolism
457247|NCT00023127|Asthma|asthma
457248|NCT00023127|Allergen|allergen
457249|NCT00023127|Cockroach|cockroach
457250|NCT00023140|biomarkers|biomarkers
457251|NCT00023140|exposure|exposure
457252|NCT00023140|adducts|adducts
457253|NCT00023140|metabolites|metabolites
457254|NCT00023140|butadiene|butadiene
457255|NCT00023153|Drug Resistance|drug resistance
457256|NCT00023153|Viral Load|viral load
457257|NCT00023153|Liver|liver
457258|NCT00023153|Immunology|immunology
457259|NCT00023153|Liver Histology|liver histology
457260|NCT00023153|Hepatitis B|hepatitis b
457261|NCT00023153|HBV|hbv
457265|NCT00023166|Safety/efficacy|safety/efficacy
457267|NCT00023166|Advanced primary and/or metastatic solid tumors|advanced primary and/or metastatic solid tumors
457268|NCT00023166|Neoplasms|neoplasms
457269|NCT00023166|Neoplasm metastasis|neoplasm metastasis
457270|NCT00023192|Campath 1-H|campath 1-h
457271|NCT00023192|T-Cell Depletion|t-cell depletion
457272|NCT00023192|Therapy|therapy
457273|NCT00023192|Stem Cell Transplantation|stem cell transplantation
457274|NCT00023192|Chronic Granulomatous Disease|chronic granulomatous disease
457275|NCT00023192|CGD|cgd
457276|NCT00023205|Arthritis|arthritis
457277|NCT00023205|Health literacy|health literacy
457278|NCT00023205|Patient education|patient education
457279|NCT00023205|Self-efficacy|self-efficacy
457280|NCT00023218|Liver|liver
457281|NCT00023218|HIV-1|hiv-1
457282|NCT00023218|HIV Protease Inhibitors|hiv protease inhibitors
457284|NCT00023218|Biopsy|biopsy
457285|NCT00023218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
457286|NCT00023218|Anti-HIV Agents|anti-hiv agents
457287|NCT00023218|ABT 378|abt 378
457288|NCT00023218|Acidosis, Lactic|acidosis, lactic
457289|NCT00023218|efavirenz|efavirenz
457290|NCT00023218|Alanine Transaminase|alanine transaminase
457291|NCT00023296|Acute Chest Syndrome|acute chest syndrome
457292|NCT00023296|Blood Flow|blood flow
457293|NCT00023296|Nitric Oxide|nitric oxide
457294|NCT00023296|NO Therapy|no therapy
457295|NCT00023296|Vaso-Occlusive Crisis|vaso-occlusive crisis
457296|NCT00023296|Sickle Cell Anemia|sickle cell anemia
457297|NCT00023296|Sickle Cell|sickle cell
457298|NCT00023296|ACS|acs
457299|NCT00023296|Pulmonary Hypertension|pulmonary hypertension
457300|NCT00023309|Adefovir Dipivoxil|adefovir dipivoxil
457301|NCT00023309|Lamivudine|lamivudine
457302|NCT00023309|Nucleoside/Nucleotide Analogue|nucleoside/nucleotide analogue
457303|NCT00023309|Chronic Hepatitis B|chronic hepatitis b
457304|NCT00023309|Hepatitis B Mutants|hepatitis b mutants
457305|NCT00023309|Liver Biopsy|liver biopsy
457306|NCT00023309|Hepatitis B|hepatitis b
457307|NCT00023309|Hepatitis|hepatitis
457308|NCT00023309|HBV|hbv
457309|NCT00023309|Liver|liver
457310|NCT00023322|Cirrhosis|cirrhosis
457311|NCT00023322|Chronic Hepatitis|chronic hepatitis
457312|NCT00023322|Alpha Interferon|alpha interferon
457313|NCT00023322|Hepatitis D Virus|hepatitis d virus
457314|NCT00023322|Delta Hepatitis|delta hepatitis
457315|NCT00023322|Viral Hepatitis|viral hepatitis
457316|NCT00023322|Antiviral Agents|antiviral agents
457317|NCT00023322|Hepatitis D|hepatitis d
457318|NCT00023322|HDV|hdv
457319|NCT00023322|Liver|liver
457320|NCT00023322|Hepatitis|hepatitis
457321|NCT00023348|Tuberculosis|tuberculosis
457322|NCT00023348|TB|tb
457323|NCT00023361|tuberculosis|tuberculosis
457324|NCT00023361|TB|tb
457325|NCT00023374|tuberculosis|tuberculosis
457326|NCT00023374|TB|tb
457327|NCT00023374|isoniazid resistance|isoniazid resistance
457328|NCT00023374|isoniazid intolerance|isoniazid intolerance
457329|NCT00023374|treatment|treatment
457330|NCT00023374|efficacy|efficacy
457331|NCT00023374|toxicity|toxicity
457332|NCT00023400|tuberculosis|tuberculosis
457333|NCT00023400|TB|tb
457334|NCT00023413|tuberculosis|tuberculosis
457335|NCT00023413|TB|tb
457336|NCT00023426|tuberculosis|tuberculosis
457337|NCT00023426|tb|tb
457338|NCT00023426|rifapentine|rifapentine
457339|NCT00023426|safety|safety
457340|NCT00023426|dose|dose
457341|NCT00023439|tuberculosis|tuberculosis
457342|NCT00023439|TB|tb
457343|NCT00023452|Latent TB infection|latent tb infection
457344|NCT00023491|Sjogren's Syndrome|sjogren's syndrome
457345|NCT00023491|Peripheral Blood Stem Cell|peripheral blood stem cell
457346|NCT00023491|Tissue Regeneration|tissue regeneration
457347|NCT00023491|Graft-versus-host Disease|graft-versus-host disease
457348|NCT00023491|Head and Neck Cancer|head and neck cancer
457349|NCT00023491|Salivary Gland|salivary gland
457350|NCT00023491|Saliva Gland|saliva gland
457351|NCT00023491|Salivary Gland Dysfunction|salivary gland dysfunction
457352|NCT00023504|Immunization|immunization
457353|NCT00023504|Antibody|antibody
457354|NCT00023504|Immunodeficiency|immunodeficiency
457355|NCT00023504|Pneumococcal Vaccines|pneumococcal vaccines
457356|NCT00023504|Phi-X 174|phi-x 174
457357|NCT00023504|Primary Immune Disorders|primary immune disorders
457359|NCT00023569|Conjoint Movement|conjoint movement
457360|NCT00023569|Chronic Hemiplegia|chronic hemiplegia
457361|NCT00023569|Brain Plasticity|brain plasticity
457362|NCT00023569|Electrical Stimulation|electrical stimulation
457363|NCT00023569|Stroke|stroke
457364|NCT00023569|CVA|cva
457365|NCT00023582|Syphilis|syphilis
457366|NCT00023582|Herpes Genitalis|herpes genitalis
457367|NCT00023582|Risk Factors|risk factors
457368|NCT00023582|Incidence|incidence
457369|NCT00023582|Prevalence|prevalence
457370|NCT00023582|Homosexuality, Male|homosexuality, male
457371|NCT00023582|Informed Consent|informed consent
457372|NCT00023582|Peru|peru
476827|NCT00097214|IIIB|iiib
457373|NCT00023582|HIV Seronegativity|hiv seronegativity
457374|NCT00023621|basal cell carcinoma of the skin|basal cell carcinoma of the skin
457375|NCT00023634|stage II gastric cancer|stage ii gastric cancer
457376|NCT00023634|stage III gastric cancer|stage iii gastric cancer
457377|NCT00023634|stage IV gastric cancer|stage iv gastric cancer
457378|NCT00023634|recurrent gastric cancer|recurrent gastric cancer
457379|NCT00023634|adenocarcinoma of the prostate|adenocarcinoma of the prostate
457380|NCT00023634|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
457381|NCT00023634|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
457382|NCT00023634|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
457383|NCT00023634|recurrent adult brain tumor|recurrent adult brain tumor
457384|NCT00023634|stage IV prostate cancer|stage iv prostate cancer
457385|NCT00023634|recurrent prostate cancer|recurrent prostate cancer
457386|NCT00023634|adult anaplastic astrocytoma|adult anaplastic astrocytoma
457387|NCT00023647|stage IV melanoma|stage iv melanoma
457388|NCT00023647|recurrent melanoma|recurrent melanoma
457389|NCT00023660|stage III cervical cancer|stage iii cervical cancer
457390|NCT00023660|stage IB cervical cancer|stage ib cervical cancer
457391|NCT00023660|stage IIB cervical cancer|stage iib cervical cancer
457392|NCT00023660|stage IIA cervical cancer|stage iia cervical cancer
457393|NCT00023660|stage IVA cervical cancer|stage iva cervical cancer
457394|NCT00023660|cervical squamous cell carcinoma|cervical squamous cell carcinoma
457395|NCT00023660|cervical adenocarcinoma|cervical adenocarcinoma
457396|NCT00023660|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
457397|NCT00023673|squamous cell lung cancer|squamous cell lung cancer
457398|NCT00023673|large cell lung cancer|large cell lung cancer
457399|NCT00023673|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
457400|NCT00023673|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
457401|NCT00023673|adenocarcinoma of the lung|adenocarcinoma of the lung
457402|NCT00023673|adenosquamous cell lung cancer|adenosquamous cell lung cancer
457403|NCT00023686|adenocarcinoma of the prostate|adenocarcinoma of the prostate
457404|NCT00023686|stage IIB prostate cancer|stage iib prostate cancer
457405|NCT00023686|stage IIA prostate cancer|stage iia prostate cancer
457406|NCT00023699|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
457407|NCT00023699|primary peritoneal cavity cancer|primary peritoneal cavity cancer
457408|NCT00023725|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
457409|NCT00023738|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
457410|NCT00023738|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
457411|NCT00023738|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
457412|NCT00023751|stage I rectal cancer|stage i rectal cancer
457413|NCT00023751|adenocarcinoma of the rectum|adenocarcinoma of the rectum
457414|NCT00023777|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
457415|NCT00023777|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
457416|NCT00023777|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
457417|NCT00023777|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
457418|NCT00023777|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
457419|NCT00023777|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
457420|NCT00023777|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
457421|NCT00023777|adult acute basophilic leukemia|adult acute basophilic leukemia
457422|NCT00023777|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
457423|NCT00023777|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
457424|NCT00023777|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
457425|NCT00023790|stage IV breast cancer|stage iv breast cancer
457426|NCT00023790|recurrent breast cancer|recurrent breast cancer
457427|NCT00023790|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
457428|NCT00023790|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
12566|NCT03210493|Nucleoside Analogues|nucleoside analogues
457429|NCT00023790|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
457430|NCT00023790|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
457431|NCT00023790|basal cell carcinoma of the skin|basal cell carcinoma of the skin
457432|NCT00023790|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
457433|NCT00023790|recurrent skin cancer|recurrent skin cancer
457434|NCT00023790|classic Kaposi sarcoma|classic kaposi sarcoma
457435|NCT00023790|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
457436|NCT00023790|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
457437|NCT00023790|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
457438|NCT00023790|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
457439|NCT00023790|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
457440|NCT00023790|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
457441|NCT00023790|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
457442|NCT00023790|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
457500|NCT00023816|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
457574|NCT00024063|stage III prostate cancer|stage iii prostate cancer
457443|NCT00023790|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
457444|NCT00023790|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
457445|NCT00023790|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
457446|NCT00023790|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
457447|NCT00023790|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
457448|NCT00023790|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
583600|NCT00512343|Synovial Fluid|synovial fluid
457449|NCT00023790|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
457450|NCT00023790|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
457451|NCT00023790|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
457452|NCT00023790|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
457453|NCT00023790|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
457454|NCT00023790|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
457455|NCT00023790|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
457456|NCT00023790|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
457457|NCT00023790|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
457458|NCT00023790|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
457459|NCT00023790|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
457460|NCT00023790|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
457461|NCT00023790|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
457462|NCT00023790|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
457463|NCT00023790|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
457464|NCT00023790|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
457465|NCT00023790|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
457466|NCT00023790|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
457467|NCT00023790|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
457468|NCT00023790|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
457469|NCT00023790|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
457470|NCT00023790|skin metastases|skin metastases
457471|NCT00023790|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
457472|NCT00023790|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
457473|NCT00023790|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
457474|NCT00023790|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
457475|NCT00023790|male breast cancer|male breast cancer
457476|NCT00023816|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
457477|NCT00023816|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
457478|NCT00023816|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
457479|NCT00023816|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
457480|NCT00023816|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
457481|NCT00023816|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
457482|NCT00023816|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
457483|NCT00023816|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
12567|NCT03210480|Lithium Sulphate|lithium sulphate
457484|NCT00023816|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
457485|NCT00023816|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
457486|NCT00023816|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
457487|NCT00023816|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
457488|NCT00023816|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
457489|NCT00023816|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
457490|NCT00023816|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
457491|NCT00023816|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
457492|NCT00023816|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
457493|NCT00023816|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
457494|NCT00023816|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
457495|NCT00023816|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
457496|NCT00023816|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
457497|NCT00023816|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
457498|NCT00023816|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
457499|NCT00023816|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
458052|NCT00037063|Lactic Acid|lactic acid
457501|NCT00023816|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
457502|NCT00023816|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
457503|NCT00023816|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
457504|NCT00023816|intraocular lymphoma|intraocular lymphoma
457505|NCT00023816|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
457506|NCT00023816|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
457507|NCT00023816|anaplastic large cell lymphoma|anaplastic large cell lymphoma
457508|NCT00023816|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
457509|NCT00023816|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
457510|NCT00023816|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
457511|NCT00023816|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
457512|NCT00023816|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
457513|NCT00023816|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
457514|NCT00023816|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
457515|NCT00023816|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
457516|NCT00023816|splenic marginal zone lymphoma|splenic marginal zone lymphoma
457517|NCT00023829|stage III prostate cancer|stage iii prostate cancer
457518|NCT00023829|stage IIB prostate cancer|stage iib prostate cancer
457519|NCT00023829|stage IIA prostate cancer|stage iia prostate cancer
457520|NCT00023842|stage 0 bladder cancer|stage 0 bladder cancer
457521|NCT00023842|recurrent bladder cancer|recurrent bladder cancer
457522|NCT00023842|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
457523|NCT00023855|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
457524|NCT00023868|stage IV colon cancer|stage iv colon cancer
457525|NCT00023868|stage IV rectal cancer|stage iv rectal cancer
457526|NCT00023868|recurrent colon cancer|recurrent colon cancer
457527|NCT00023868|recurrent rectal cancer|recurrent rectal cancer
457528|NCT00023868|adenocarcinoma of the colon|adenocarcinoma of the colon
457529|NCT00023868|adenocarcinoma of the rectum|adenocarcinoma of the rectum
457530|NCT00023868|liver metastases|liver metastases
457531|NCT00023881|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
457532|NCT00023881|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
457533|NCT00023881|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
457534|NCT00023881|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
457535|NCT00023894|recurrent endometrial carcinoma|recurrent endometrial carcinoma
457536|NCT00023907|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
457537|NCT00023907|primary peritoneal cavity cancer|primary peritoneal cavity cancer
457538|NCT00023972|stage III pancreatic cancer|stage iii pancreatic cancer
457539|NCT00023972|stage IV pancreatic cancer|stage iv pancreatic cancer
457540|NCT00023985|stage I non-small cell lung cancer|stage i non-small cell lung cancer
457541|NCT00023985|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
457542|NCT00023985|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
457543|NCT00024024|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
457544|NCT00024024|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
457545|NCT00024037|oral complications|oral complications
457546|NCT00024050|refractory anemia|refractory anemia
457547|NCT00024050|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
457548|NCT00024050|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
457549|NCT00024050|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
457550|NCT00024050|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
457551|NCT00024050|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
457552|NCT00024063|stage III colon cancer|stage iii colon cancer
457553|NCT00024063|stage IV colon cancer|stage iv colon cancer
457554|NCT00024063|stage IV breast cancer|stage iv breast cancer
457555|NCT00024063|stage IIIA breast cancer|stage iiia breast cancer
457556|NCT00024063|recurrent breast cancer|recurrent breast cancer
457557|NCT00024063|stage III gastric cancer|stage iii gastric cancer
457558|NCT00024063|stage IV gastric cancer|stage iv gastric cancer
457559|NCT00024063|recurrent gastric cancer|recurrent gastric cancer
457560|NCT00024063|stage IIIB breast cancer|stage iiib breast cancer
457561|NCT00024063|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
457562|NCT00024063|stage II pancreatic cancer|stage ii pancreatic cancer
457563|NCT00024063|stage III pancreatic cancer|stage iii pancreatic cancer
457564|NCT00024063|recurrent pancreatic cancer|recurrent pancreatic cancer
457565|NCT00024063|stage III rectal cancer|stage iii rectal cancer
457566|NCT00024063|stage IV rectal cancer|stage iv rectal cancer
457567|NCT00024063|recurrent colon cancer|recurrent colon cancer
457568|NCT00024063|recurrent rectal cancer|recurrent rectal cancer
457569|NCT00024063|refractory multiple myeloma|refractory multiple myeloma
457570|NCT00024063|stage III renal cell cancer|stage iii renal cell cancer
457571|NCT00024063|stage IV renal cell cancer|stage iv renal cell cancer
457572|NCT00024063|recurrent renal cell cancer|recurrent renal cell cancer
457573|NCT00024063|stage III multiple myeloma|stage iii multiple myeloma
457575|NCT00024063|stage IV prostate cancer|stage iv prostate cancer
457576|NCT00024063|recurrent prostate cancer|recurrent prostate cancer
457577|NCT00024063|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
457578|NCT00024063|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
457579|NCT00024063|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
457580|NCT00024063|male breast cancer|male breast cancer
457581|NCT00024063|stage IV pancreatic cancer|stage iv pancreatic cancer
457582|NCT00024076|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
201027|NCT02112591|urinary obstruction|urinary obstruction
201028|NCT02112591|TOT|tot
457583|NCT00024076|recurrent small cell lung cancer|recurrent small cell lung cancer
457584|NCT00024076|recurrent malignant mesothelioma|recurrent malignant mesothelioma
457585|NCT00024076|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
457586|NCT00024076|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
457587|NCT00024076|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
457588|NCT00024076|pulmonary carcinoid tumor|pulmonary carcinoid tumor
457589|NCT00024076|lung metastases|lung metastases
457590|NCT00024089|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
457591|NCT00024089|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
457592|NCT00024089|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
457593|NCT00024089|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
457594|NCT00024089|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
457595|NCT00024089|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
457596|NCT00024089|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
457597|NCT00024089|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
457598|NCT00024089|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
457599|NCT00024089|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
457600|NCT00024089|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
457601|NCT00024089|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
457602|NCT00024089|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
457603|NCT00024089|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
457604|NCT00024089|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
457605|NCT00024102|stage I breast cancer|stage i breast cancer
457606|NCT00024102|stage II breast cancer|stage ii breast cancer
457607|NCT00024102|stage IIIA breast cancer|stage iiia breast cancer
457608|NCT00024102|stage IIIB breast cancer|stage iiib breast cancer
457609|NCT00024102|stage IIIC breast cancer|stage iiic breast cancer
457610|NCT00024115|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
457611|NCT00024115|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
457612|NCT00024115|stage III grade I follicular small cleaved cell lymphoma|stage iii grade i follicular small cleaved cell lymphoma
457613|NCT00024115|stage III grade II follicular mixed cell lymphoma|stage iii grade ii follicular mixed cell lymphoma
457614|NCT00024115|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
457615|NCT00024115|stage IV grade I follicular small cleaved cell lymphoma|stage iv grade i follicular small cleaved cell lymphoma
457616|NCT00024115|stage IV grade II follicular mixed cell lymphoma|stage iv grade ii follicular mixed cell lymphoma
457617|NCT00024115|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
457618|NCT00024115|recurrent grade I follicular small cleaved cell lymphoma|recurrent grade i follicular small cleaved cell lymphoma
457619|NCT00024115|recurrent grade II follicular mixed cell lymphoma|recurrent grade ii follicular mixed cell lymphoma
457620|NCT00024115|recurrent grade III follicular large cell lymphoma|recurrent grade iii follicular large cell lymphoma
457621|NCT00024115|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
457622|NCT00024115|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
457623|NCT00024115|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
457624|NCT00024115|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
457625|NCT00024115|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
457626|NCT00024115|recurrent adult diffuse small noncleaved cell/Burkitt's lymphoma|recurrent adult diffuse small noncleaved cell/burkitt's lymphoma
457627|NCT00024115|prolymphocytic leukemia|prolymphocytic leukemia
457628|NCT00024115|contiguous stage II grade I follicular small cleaved cell lymphoma|contiguous stage ii grade i follicular small cleaved cell lymphoma
457629|NCT00024115|contiguous stage II grade II follicular mixed cell lymphoma|contiguous stage ii grade ii follicular mixed cell lymphoma
457630|NCT00024115|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
457631|NCT00024115|noncontiguous stage II grade I follicular small cleaved cell lymphoma|noncontiguous stage ii grade i follicular small cleaved cell lymphoma
457632|NCT00024115|noncontiguous stage II grade II follicular mixed cell lymphoma|noncontiguous stage ii grade ii follicular mixed cell lymphoma
457633|NCT00024115|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
457634|NCT00024115|stage III diffuse small lymphocytic/marginal zone lymphoma|stage iii diffuse small lymphocytic/marginal zone lymphoma
752448|NCT01173029|Renin-angiotensin-aldosterone system genetic polymorphism|renin-angiotensin-aldosterone system genetic polymorphism
457049|NCT00022776|Surgery|surgery
457635|NCT00024115|contiguous stage II diffuse small lymphocytic/marginal zone lymphoma|contiguous stage ii diffuse small lymphocytic/marginal zone lymphoma
457636|NCT00024115|noncontiguous stage II diffuse small lymphocytic/marginal zone lymphoma|noncontiguous stage ii diffuse small lymphocytic/marginal zone lymphoma
457637|NCT00024115|stage IV diffuse small lymphocytic/marginal zone lymphoma|stage iv diffuse small lymphocytic/marginal zone lymphoma
457638|NCT00024115|recurrent diffuse small lymphocytic/marginal zone lymphoma|recurrent diffuse small lymphocytic/marginal zone lymphoma
457639|NCT00024115|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
457640|NCT00024128|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
457641|NCT00024128|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
457936|NCT00036894|adult ependymoblastoma|adult ependymoblastoma
457642|NCT00024141|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
457643|NCT00024167|adenocarcinoma of the prostate|adenocarcinoma of the prostate
457644|NCT00024167|stage IV prostate cancer|stage iv prostate cancer
457645|NCT00024167|recurrent prostate cancer|recurrent prostate cancer
457646|NCT00024167|Strontium-89|strontium-89
457647|NCT00024167|Induction Chemotherapy|induction chemotherapy
457648|NCT00024167|Androgen-Independent Prostate Cancer|androgen-independent prostate cancer
457649|NCT00024180|Waldenström macroglobulinemia|waldenström macroglobulinemia
457650|NCT00024180|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
457651|NCT00024180|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
457652|NCT00024180|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
457653|NCT00024180|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
457654|NCT00024180|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
457655|NCT00024180|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
457656|NCT00024193|stage 4S neuroblastoma|stage 4s neuroblastoma
457657|NCT00030277|stage I prostate cancer|stage i prostate cancer
457658|NCT00030277|stage IIB prostate cancer|stage iib prostate cancer
457659|NCT00030277|stage IIA prostate cancer|stage iia prostate cancer
457660|NCT00030277|recurrent prostate cancer|recurrent prostate cancer
457661|NCT00030290|stage I prostate cancer|stage i prostate cancer
457662|NCT00030290|stage IIB prostate cancer|stage iib prostate cancer
457663|NCT00030290|stage IIA prostate cancer|stage iia prostate cancer
457664|NCT00030303|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
457665|NCT00030303|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
457666|NCT00030342|stage IV colon cancer|stage iv colon cancer
457667|NCT00030342|stage IV rectal cancer|stage iv rectal cancer
457668|NCT00030342|recurrent colon cancer|recurrent colon cancer
457669|NCT00030342|recurrent rectal cancer|recurrent rectal cancer
457670|NCT00030342|stage IV renal cell cancer|stage iv renal cell cancer
457671|NCT00030342|recurrent renal cell cancer|recurrent renal cell cancer
457672|NCT00030355|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
457673|NCT00030355|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
457674|NCT00030355|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
457675|NCT00030355|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
457676|NCT00030355|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
457677|NCT00030407|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
457678|NCT00030407|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
457679|NCT00030420|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
457680|NCT00030420|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
457681|NCT00030420|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
457682|NCT00030420|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
457683|NCT00030433|extensive stage small cell lung cancer|extensive stage small cell lung cancer
457684|NCT00030446|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
457685|NCT00030446|fallopian tube cancer|fallopian tube cancer
457686|NCT00030446|peritoneal cavity cancer|peritoneal cavity cancer
457687|NCT00030459|localized malignant mesothelioma|localized malignant mesothelioma
457688|NCT00030459|advanced malignant mesothelioma|advanced malignant mesothelioma
457689|NCT00030459|recurrent malignant mesothelioma|recurrent malignant mesothelioma
457690|NCT00030472|recurrent cervical cancer|recurrent cervical cancer
457691|NCT00030472|stage IVB cervical cancer|stage ivb cervical cancer
457692|NCT00030472|cervical squamous cell carcinoma|cervical squamous cell carcinoma
457693|NCT00030485|stage IV endometrial carcinoma|stage iv endometrial carcinoma
457694|NCT00030485|recurrent endometrial carcinoma|recurrent endometrial carcinoma
457695|NCT00030485|endometrial adenocarcinoma|endometrial adenocarcinoma
457696|NCT00030485|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
457697|NCT00030511|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
457698|NCT00030511|recurrent adult primary liver cancer|recurrent adult primary liver cancer
457699|NCT00030511|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
752449|NCT01173029|Risk markers|risk markers
457700|NCT00030511|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
457701|NCT00030524|stage III colon cancer|stage iii colon cancer
457702|NCT00030524|stage IV colon cancer|stage iv colon cancer
457703|NCT00030524|stage III rectal cancer|stage iii rectal cancer
457704|NCT00030524|stage IV rectal cancer|stage iv rectal cancer
457705|NCT00030524|recurrent colon cancer|recurrent colon cancer
457706|NCT00030524|recurrent rectal cancer|recurrent rectal cancer
457707|NCT00030524|adenocarcinoma of the colon|adenocarcinoma of the colon
457708|NCT00030524|adenocarcinoma of the rectum|adenocarcinoma of the rectum
457709|NCT00030537|stage IV breast cancer|stage iv breast cancer
457710|NCT00030537|recurrent breast cancer|recurrent breast cancer
457711|NCT00030537|stage IIIB breast cancer|stage iiib breast cancer
457712|NCT00030537|male breast cancer|male breast cancer
457713|NCT00030550|refractory anemia|refractory anemia
457714|NCT00030550|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
457715|NCT00030550|refractory anemia with excess blasts|refractory anemia with excess blasts
457716|NCT00030550|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
457717|NCT00030550|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
457718|NCT00030550|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
457719|NCT00030550|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
457720|NCT00030550|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
457721|NCT00030563|liver metastases|liver metastases
457722|NCT00030563|stage IV colon cancer|stage iv colon cancer
457723|NCT00030563|stage IV rectal cancer|stage iv rectal cancer
457724|NCT00030563|adenocarcinoma of the colon|adenocarcinoma of the colon
457725|NCT00030563|adenocarcinoma of the rectum|adenocarcinoma of the rectum
457726|NCT00030563|recurrent colon cancer|recurrent colon cancer
457727|NCT00030563|recurrent rectal cancer|recurrent rectal cancer
457728|NCT00030576|recurrent metastatic squamous neck cancer occult primary|recurrent metastatic squamous neck cancer occult primary
457729|NCT00030576|neck cancer with occult primary squamous carcinoma|neck cancer with occult primary squamous carcinoma
457730|NCT00030576|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
457731|NCT00030576|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
457732|NCT00030576|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
457733|NCT00030576|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
457734|NCT00030576|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
457735|NCT00030576|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
457736|NCT00030576|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
457737|NCT00030576|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
457738|NCT00030576|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
457739|NCT00030576|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
457740|NCT00030576|squamous cell carcinoma of paranasal sinus and nasal cavity|squamous cell carcinoma of paranasal sinus and nasal cavity
458037|NCT00037024|malnutrition|malnutrition
457741|NCT00030576|recurrent squamous cell carcinoma of sinus and nasal cavity|recurrent squamous cell carcinoma of sinus and nasal cavity
457742|NCT00030589|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
457743|NCT00030589|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
457744|NCT00030589|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
457745|NCT00030589|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
457746|NCT00030589|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
457747|NCT00030589|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
457748|NCT00030602|adenocarcinoma of the prostate|adenocarcinoma of the prostate
457749|NCT00030602|recurrent prostate cancer|recurrent prostate cancer
457750|NCT00030628|tumors metastatic to brain|tumors metastatic to brain
457751|NCT00036634|treatment naive|treatment naive
457752|NCT00036647|Non-Small Cell Lung Cancer|non-small cell lung cancer
457753|NCT00036647|Tarceva|tarceva
457754|NCT00036647|EGFR|egfr
457755|NCT00036647|erlotinib|erlotinib
457756|NCT00036660|recurrent adult brain tumor|recurrent adult brain tumor
457757|NCT00036660|adult glioblastoma|adult glioblastoma
457758|NCT00036660|adult anaplastic astrocytoma|adult anaplastic astrocytoma
457759|NCT00036660|adult giant cell glioblastoma|adult giant cell glioblastoma
457760|NCT00036660|adult gliosarcoma|adult gliosarcoma
457761|NCT00036686|stage I breast cancer|stage i breast cancer
457762|NCT00036686|stage II breast cancer|stage ii breast cancer
457763|NCT00036686|stage IIIA breast cancer|stage iiia breast cancer
457764|NCT00036686|stage IIIB breast cancer|stage iiib breast cancer
457765|NCT00036686|stage IIIC breast cancer|stage iiic breast cancer
457766|NCT00036686|recurrent breast cancer|recurrent breast cancer
457767|NCT00036686|stage IV breast cancer|stage iv breast cancer
752450|NCT01173029|Adverse events|adverse events
457172|NCT00022984|ICD|icd
457768|NCT00036712|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
457769|NCT00036712|refractory multiple myeloma|refractory multiple myeloma
457770|NCT00036712|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
457771|NCT00036712|disseminated neuroblastoma|disseminated neuroblastoma
457772|NCT00036712|recurrent neuroblastoma|recurrent neuroblastoma
457773|NCT00036712|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
457774|NCT00036712|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
457775|NCT00036712|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
457776|NCT00036712|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
457777|NCT00036712|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
457778|NCT00036712|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
457779|NCT00036712|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
457780|NCT00036712|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
457781|NCT00036712|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
457782|NCT00036712|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
457783|NCT00036712|primary myelofibrosis|primary myelofibrosis
457784|NCT00036712|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
457785|NCT00036712|refractory hairy cell leukemia|refractory hairy cell leukemia
457786|NCT00036712|oral complications|oral complications
457787|NCT00036712|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
457788|NCT00036712|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
457789|NCT00036712|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
457790|NCT00036712|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
457791|NCT00036712|pain|pain
457792|NCT00036712|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
457793|NCT00036712|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
457794|NCT00036712|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
457795|NCT00036712|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
457796|NCT00036712|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
457797|NCT00036712|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
457798|NCT00036712|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
457799|NCT00036712|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
457800|NCT00036790|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
457801|NCT00036790|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
457802|NCT00036790|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
457803|NCT00036790|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
457804|NCT00036790|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
457805|NCT00036790|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
457806|NCT00036790|isolated plasmacytoma of bone|isolated plasmacytoma of bone
457807|NCT00036790|extramedullary plasmacytoma|extramedullary plasmacytoma
457808|NCT00036790|refractory multiple myeloma|refractory multiple myeloma
457809|NCT00036790|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
457810|NCT00036790|stage III multiple myeloma|stage iii multiple myeloma
457811|NCT00036790|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
457812|NCT00036790|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
457813|NCT00036790|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
457814|NCT00036790|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
457815|NCT00036790|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
457816|NCT00036790|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
457817|NCT00036790|small intestine lymphoma|small intestine lymphoma
457818|NCT00036790|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
457819|NCT00036790|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
457820|NCT00036790|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
457821|NCT00036790|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
457822|NCT00036790|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
457823|NCT00036790|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
457824|NCT00036790|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
457825|NCT00036790|refractory hairy cell leukemia|refractory hairy cell leukemia
457826|NCT00036790|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
457827|NCT00036790|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
457828|NCT00036790|acute undifferentiated leukemia|acute undifferentiated leukemia
457829|NCT00036790|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
457830|NCT00036790|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
752451|NCT01173029|Acute myocardial infarction|acute myocardial infarction
457283|NCT00023218|Ritonavir|ritonavir
457831|NCT00036790|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
458040|NCT00037037|stage III melanoma|stage iii melanoma
457832|NCT00036790|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
457833|NCT00036790|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
457834|NCT00036790|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
457835|NCT00036790|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
457836|NCT00036790|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
457837|NCT00036790|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
457838|NCT00036790|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
457839|NCT00036790|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
457840|NCT00036790|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
457841|NCT00036790|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
457842|NCT00036790|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
457843|NCT00036790|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
457844|NCT00036790|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
457845|NCT00036790|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
457846|NCT00036790|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
457847|NCT00036790|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
457848|NCT00036790|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
457849|NCT00036790|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
457850|NCT00036790|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
457851|NCT00036790|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
457852|NCT00036790|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
457853|NCT00036790|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
457854|NCT00036790|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
457855|NCT00036790|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
457856|NCT00036790|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
457857|NCT00036790|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
457858|NCT00036790|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
457859|NCT00036790|secondary acute myeloid leukemia|secondary acute myeloid leukemia
457860|NCT00036790|prolymphocytic leukemia|prolymphocytic leukemia
457861|NCT00036790|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
457862|NCT00036790|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
457863|NCT00036790|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
457864|NCT00036790|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
457865|NCT00036790|anaplastic large cell lymphoma|anaplastic large cell lymphoma
457866|NCT00036790|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
457867|NCT00036790|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
457868|NCT00036790|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
457869|NCT00036790|chronic eosinophilic leukemia|chronic eosinophilic leukemia
457870|NCT00036790|chronic neutrophilic leukemia|chronic neutrophilic leukemia
457871|NCT00036790|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
457872|NCT00036790|recurrent small cell lung cancer|recurrent small cell lung cancer
457873|NCT00036790|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
457874|NCT00036790|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
457875|NCT00036790|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
457876|NCT00036790|extensive stage small cell lung cancer|extensive stage small cell lung cancer
457877|NCT00036790|limited stage small cell lung cancer|limited stage small cell lung cancer
457878|NCT00036790|recurrent breast cancer|recurrent breast cancer
457879|NCT00036790|stage IIIA breast cancer|stage iiia breast cancer
457880|NCT00036790|stage IIIB breast cancer|stage iiib breast cancer
457881|NCT00036790|stage IIIC breast cancer|stage iiic breast cancer
457882|NCT00036790|stage IV breast cancer|stage iv breast cancer
457883|NCT00036790|recurrent colon cancer|recurrent colon cancer
457884|NCT00036790|stage III colon cancer|stage iii colon cancer
457885|NCT00036790|stage IV colon cancer|stage iv colon cancer
457886|NCT00036790|recurrent prostate cancer|recurrent prostate cancer
457887|NCT00036790|stage III prostate cancer|stage iii prostate cancer
457888|NCT00036790|stage IV prostate cancer|stage iv prostate cancer
457889|NCT00036790|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
457890|NCT00036790|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
457891|NCT00036790|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
457892|NCT00036790|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
457893|NCT00036790|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
457894|NCT00036790|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
457895|NCT00036790|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
457896|NCT00036790|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
457897|NCT00036790|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
583601|NCT00512343|Arthritis|arthritis
458041|NCT00037037|stage IV melanoma|stage iv melanoma
457898|NCT00036790|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
457899|NCT00036790|recurrent laryngeal cancer|recurrent laryngeal cancer
457900|NCT00036790|stage III laryngeal cancer|stage iii laryngeal cancer
457901|NCT00036790|stage IV laryngeal cancer|stage iv laryngeal cancer
457902|NCT00036790|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
457903|NCT00036790|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
457904|NCT00036790|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
457905|NCT00036790|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
457906|NCT00036790|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
457907|NCT00036790|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
457908|NCT00036790|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
457909|NCT00036790|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
457910|NCT00036790|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
457911|NCT00036790|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
457912|NCT00036790|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
457913|NCT00036790|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
457914|NCT00036790|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
457915|NCT00036790|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
457916|NCT00036790|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
457917|NCT00036790|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
457918|NCT00036790|splenic marginal zone lymphoma|splenic marginal zone lymphoma
457919|NCT00036790|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
457920|NCT00036790|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
457921|NCT00036790|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
457922|NCT00036790|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
457923|NCT00036790|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
457924|NCT00036816|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
457925|NCT00036829|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
457927|NCT00036842|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
457928|NCT00036842|extragonadal germ cell tumor|extragonadal germ cell tumor
457929|NCT00036868|stage IV breast cancer|stage iv breast cancer
457930|NCT00036868|recurrent breast cancer|recurrent breast cancer
457931|NCT00036894|recurrent adult brain tumor|recurrent adult brain tumor
457932|NCT00036894|adult glioblastoma|adult glioblastoma
457933|NCT00036894|adult anaplastic astrocytoma|adult anaplastic astrocytoma
457934|NCT00036894|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
457935|NCT00036894|adult mixed glioma|adult mixed glioma
457937|NCT00036894|adult anaplastic ependymoma|adult anaplastic ependymoma
457938|NCT00036894|adult myxopapillary ependymoma|adult myxopapillary ependymoma
457939|NCT00036894|adult meningioma|adult meningioma
457940|NCT00036894|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
457941|NCT00036894|adult brain stem glioma|adult brain stem glioma
457942|NCT00036894|adult grade III meningioma|adult grade iii meningioma
457943|NCT00036894|adult giant cell glioblastoma|adult giant cell glioblastoma
457944|NCT00036894|adult gliosarcoma|adult gliosarcoma
457945|NCT00036920|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
457946|NCT00036920|squamous cell lung cancer|squamous cell lung cancer
457947|NCT00036920|large cell lung cancer|large cell lung cancer
457948|NCT00036920|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
457949|NCT00036920|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
457950|NCT00036920|adenocarcinoma of the lung|adenocarcinoma of the lung
457951|NCT00036920|adenosquamous cell lung cancer|adenosquamous cell lung cancer
457952|NCT00036920|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
457953|NCT00036933|stage III prostate cancer|stage iii prostate cancer
457954|NCT00036933|recurrent prostate cancer|recurrent prostate cancer
457955|NCT00036946|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
457956|NCT00036946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
457957|NCT00036946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
457958|NCT00036946|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
457959|NCT00036946|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
457960|NCT00036946|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
457961|NCT00036946|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
457962|NCT00036946|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
752453|NCT01173042|Overweight|overweight
586907|NCT00530153|Eating|eating
457963|NCT00036946|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
457964|NCT00036946|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
457965|NCT00036946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
457966|NCT00036946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
457967|NCT00036946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
457968|NCT00036946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
457969|NCT00036946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
457970|NCT00036946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
457971|NCT00036946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
457972|NCT00036946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
457973|NCT00036946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
457974|NCT00036946|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
457975|NCT00036946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
457976|NCT00036946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
457977|NCT00036946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
457978|NCT00036946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
457979|NCT00036946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
457980|NCT00036946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
457981|NCT00036946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
457982|NCT00036946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
457983|NCT00036959|metastatic osteosarcoma|metastatic osteosarcoma
457984|NCT00036959|childhood infratentorial ependymoma|childhood infratentorial ependymoma
457985|NCT00036959|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
457986|NCT00036959|childhood supratentorial ependymoma|childhood supratentorial ependymoma
457987|NCT00036959|childhood craniopharyngioma|childhood craniopharyngioma
457988|NCT00036959|disseminated neuroblastoma|disseminated neuroblastoma
457989|NCT00036959|recurrent neuroblastoma|recurrent neuroblastoma
457990|NCT00036959|recurrent childhood liver cancer|recurrent childhood liver cancer
457991|NCT00036959|stage IV childhood liver cancer|stage iv childhood liver cancer
457992|NCT00036959|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
457993|NCT00036959|stage IV Wilms tumor|stage iv wilms tumor
457994|NCT00036959|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
457995|NCT00036959|recurrent osteosarcoma|recurrent osteosarcoma
457996|NCT00036959|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
457997|NCT00036959|childhood germ cell tumor|childhood germ cell tumor
457998|NCT00036959|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
457999|NCT00036959|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
458000|NCT00036959|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
458001|NCT00036959|childhood oligodendroglioma|childhood oligodendroglioma
458002|NCT00036959|childhood choroid plexus tumor|childhood choroid plexus tumor
458003|NCT00036959|childhood grade I meningioma|childhood grade i meningioma
458004|NCT00036959|childhood grade II meningioma|childhood grade ii meningioma
458005|NCT00036959|childhood grade III meningioma|childhood grade iii meningioma
458006|NCT00036959|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
458007|NCT00036959|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
458008|NCT00036959|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
458009|NCT00036959|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
458010|NCT00036959|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
458011|NCT00036959|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
458012|NCT00036959|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
458013|NCT00036959|recurrent childhood ependymoma|recurrent childhood ependymoma
458014|NCT00036959|childhood teratoma|childhood teratoma
458015|NCT00036959|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
458016|NCT00036959|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
458017|NCT00036959|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
458018|NCT00036959|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
458019|NCT00036972|recurrent adult brain tumor|recurrent adult brain tumor
458020|NCT00036972|adult glioblastoma|adult glioblastoma
458021|NCT00036972|adult anaplastic astrocytoma|adult anaplastic astrocytoma
458022|NCT00036972|adult mixed glioma|adult mixed glioma
458023|NCT00036972|adult giant cell glioblastoma|adult giant cell glioblastoma
458024|NCT00036972|adult gliosarcoma|adult gliosarcoma
458025|NCT00036985|stage IIIA breast cancer|stage iiia breast cancer
458026|NCT00036998|stage I breast cancer|stage i breast cancer
458027|NCT00036998|stage II breast cancer|stage ii breast cancer
458028|NCT00037011|disseminated neuroblastoma|disseminated neuroblastoma
752454|NCT01173042|Obese|obese
458029|NCT00037011|recurrent neuroblastoma|recurrent neuroblastoma
458030|NCT00037024|stage I breast cancer|stage i breast cancer
458031|NCT00037024|stage II breast cancer|stage ii breast cancer
458032|NCT00037024|stage I prostate cancer|stage i prostate cancer
458033|NCT00037024|stage II B prostate cancer|stage ii b prostate cancer
458034|NCT00037024|stage II A prostate cancer|stage ii a prostate cancer
458036|NCT00037024|fatigue|fatigue
458038|NCT00037024|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
458039|NCT00037024|depression|depression
458042|NCT00037037|recurrent melanoma|recurrent melanoma
458043|NCT00037063|Pilot Projects|pilot projects
458044|NCT00037063|Recurrence|recurrence
458045|NCT00037063|Antioxidants|antioxidants
458046|NCT00037063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
458047|NCT00037063|Anti-HIV Agents|anti-hiv agents
458048|NCT00037063|Ascorbic Acid|ascorbic acid
458049|NCT00037063|Alpha-Tocopherol|alpha-tocopherol
458050|NCT00037063|Riboflavin|riboflavin
458051|NCT00037063|Thiamine|thiamine
458053|NCT00037076|HIV Seropositivity|hiv seropositivity
458054|NCT00037076|Hepatitis C|hepatitis c
458055|NCT00037076|Polymerase Chain Reaction|polymerase chain reaction
458056|NCT00037076|RNA, Viral|rna, viral
458057|NCT00037076|Prevalence|prevalence
458058|NCT00037076|Disease Transmission, Vertical|disease transmission, vertical
458059|NCT00037076|Hepacivirus|hepacivirus
458060|NCT00037076|Enzyme Immunoassay|enzyme immunoassay
458061|NCT00037076|GB virus C|gb virus c
458062|NCT00037102|Multiple Sclerosis|multiple sclerosis
458063|NCT00037102|Relapsing|relapsing
458064|NCT00037102|Methotrexate|methotrexate
458065|NCT00037102|AVONEX|avonex
458066|NCT00037102|interferon beta 1a|interferon beta 1a
458067|NCT00037102|demyelinating|demyelinating
458068|NCT00037102|autoimmune|autoimmune
458069|NCT00037115|Demyelinating|demyelinating
458070|NCT00037115|Multiple Sclerosis|multiple sclerosis
458071|NCT00037115|Myelitis|myelitis
458072|NCT00037115|Neuritis|neuritis
458073|NCT00037115|Optic Neuritis|optic neuritis
458074|NCT00037115|AVONEX|avonex
458075|NCT00037115|methotrexate|methotrexate
458076|NCT00037115|methylprednisolone|methylprednisolone
458077|NCT00037115|interferon beta 1a|interferon beta 1a
458078|NCT00037115|demyelination|demyelination
458079|NCT00037115|central nervous system|central nervous system
458080|NCT00037115|brain|brain
458081|NCT00037115|nerve|nerve
458082|NCT00037115|lesions|lesions
458083|NCT00037115|enhancement|enhancement
458084|NCT00037115|enhancing|enhancing
458085|NCT00037128|Lupus|lupus
458086|NCT00037128|SLE|sle
458087|NCT00037128|DHEA|dhea
458088|NCT00037128|GL701|gl701
458089|NCT00037141|Prostate|prostate
458090|NCT00037141|BPH|bph
458091|NCT00037141|Prostatitis|prostatitis
458092|NCT00037154|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
458093|NCT00037154|Herbal Therapies|herbal therapies
458094|NCT00037154|Complementary and Alternative Medicine|complementary and alternative medicine
458095|NCT00037154|Men's Health|men's health
458096|NCT00037167|Fall-Prevention|fall-prevention
458097|NCT00037167|Balance|balance
458098|NCT00037167|Musculoskeletal Systems|musculoskeletal systems
458099|NCT00037167|Protective Devices|protective devices
458100|NCT00037167|Gait|gait
458101|NCT00037167|Equilibrium|equilibrium
458102|NCT00037167|Accidental Falls|accidental falls
458103|NCT00037167|Frail Elderly|frail elderly
458104|NCT00037206|Invasive Aspergillosis|invasive aspergillosis
458105|NCT00037219|Anidulafungin|anidulafungin
458106|NCT00037219|Candidemia|candidemia
458107|NCT00037219|Invasive Candidiasis|invasive candidiasis
458108|NCT00037479|neurologic Lyme disease|neurologic lyme disease
458109|NCT00037479|Lyme disease|lyme disease
458110|NCT00037479|ceftriaxone|ceftriaxone
458111|NCT00037479|Rocephin|rocephin
458112|NCT00037479|PET scans|pet scans
458113|NCT00037479|Lyme encephalopathy|lyme encephalopathy
458114|NCT00037479|neuroborreliosis|neuroborreliosis
458115|NCT00037479|borreliosis|borreliosis
458116|NCT00037492|stroke|stroke
458117|NCT00037492|recovery|recovery
458118|NCT00037518|Severe primary hyperparathyroidism|severe primary hyperparathyroidism
458119|NCT00037518|Parathyroid carcinoma|parathyroid carcinoma
458120|NCT00037531|Transplant|transplant
458121|NCT00037531|Kidney|kidney
458122|NCT00037544|Severe|severe
458123|NCT00037544|Hemophilia|hemophilia
458124|NCT00037544|A|a
458125|NCT00037557|Hemophilia B|hemophilia b
458126|NCT00037570|Peptic|peptic
458127|NCT00037570|Ulcer|ulcer
458128|NCT00037570|Hemorrhage|hemorrhage
458129|NCT00037583|Acute|acute
458130|NCT00037583|Myeloid|myeloid
458131|NCT00037583|Leukemia|leukemia
458132|NCT00037609|Metastatic breast cancer|metastatic breast cancer
12749|NCT03209193|tissue oxygen saturation|tissue oxygen saturation
88632|NCT02733341|Vasodilator stimulated phosphoprotein phosphorylation (VASP)|vasodilator stimulated phosphoprotein phosphorylation (vasp)
88633|NCT02733341|Pharmacodynamic|pharmacodynamic
458133|NCT00037622|E-antigen positive, treatment naïve chronic HBV infected, lamivudine resistant chronic Hepatitis B, Achillion|e-antigen positive, treatment naïve chronic hbv infected, lamivudine resistant chronic hepatitis b, achillion
458134|NCT00037661|dry eye|dry eye
458135|NCT00037674|Bipolar Disorder|bipolar disorder
458136|NCT00037674|Bipolar|bipolar
458137|NCT00037674|Mania|mania
458138|NCT00037674|Topiramate|topiramate
458139|NCT00037674|Lithium|lithium
458140|NCT00037687|Severe sepsis|severe sepsis
458141|NCT00037687|Platelet-activating factor acetylhydrolase|platelet-activating factor acetylhydrolase
458142|NCT00037713|LD Small Cell Lung Cancer|ld small cell lung cancer
458143|NCT00037713|BEC2, vaccine|bec2, vaccine
458144|NCT00037713|adjuvant, monoclonal antibody|adjuvant, monoclonal antibody
458145|NCT00037713|LD Small Cell Lung Cancer (VA Classification, Zelen, 1973)|ld small cell lung cancer (va classification, zelen, 1973)
458146|NCT00037804|Pharmacia|pharmacia
458147|NCT00037817|Toxicity Evaluation|toxicity evaluation
458148|NCT00037817|Pharmacokinetics|pharmacokinetics
458149|NCT00037817|Apoptosis|apoptosis
458150|NCT00037817|Gene Induction|gene induction
458151|NCT00037817|Gene Expression|gene expression
458152|NCT00037817|Lung Cancer|lung cancer
458153|NCT00037817|Small Cell Lung Cancer|small cell lung cancer
458154|NCT00037817|Non-Small Cell Lung Cancer|non-small cell lung cancer
458155|NCT00037817|Pleural Mesothelioma|pleural mesothelioma
458156|NCT00037830|Parkinson's disease|parkinson's disease
458158|NCT00037830|GM1 Ganglioside|gm1 ganglioside
458159|NCT00037830|Sygen|sygen
458160|NCT00037843|adrenal diseases|adrenal diseases
458161|NCT00037869|Metastatic neuroendocrine tumors|metastatic neuroendocrine tumors
458162|NCT00037882|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
458163|NCT00037882|Interferon alpha|interferon alpha
458164|NCT00037882|Roferon|roferon
458165|NCT00037882|Intron|intron
458166|NCT00037882|Chronic Myelogenous Leukemia-Philadelphia positive|chronic myelogenous leukemia-philadelphia positive
458167|NCT00037895|Stroke|stroke
458168|NCT00037895|Ambulation Training|ambulation training
458169|NCT00037895|Rehabilitation|rehabilitation
458170|NCT00037895|Treadmill|treadmill
458171|NCT00037908|Stroke|stroke
458172|NCT00037908|Hemiparesis|hemiparesis
458173|NCT00037908|Upper limb function|upper limb function
458174|NCT00037908|Strength training|strength training
458175|NCT00037921|SCI|sci
458176|NCT00037921|UTI|uti
458177|NCT00037934|Robot|robot
458178|NCT00037934|Stroke|stroke
458179|NCT00037934|Upper Extremity|upper extremity
458180|NCT00037947|Multiple Sclerosis|multiple sclerosis
458181|NCT00037947|MS|ms
458182|NCT00037947|Hearing|hearing
458183|NCT00037960|Constrained Induced|constrained induced
458184|NCT00037960|CI therapy|ci therapy
458185|NCT00037960|CVA|cva
458186|NCT00037960|Strokes|strokes
458187|NCT00037973|COPD|copd
458188|NCT00037973|Ventilation|ventilation
458189|NCT00037986|Audiology|audiology
458190|NCT00037986|Hearing|hearing
458191|NCT00037986|Hearing Aids|hearing aids
458192|NCT00037986|Quality of Life|quality of life
458193|NCT00037999|Muscle strength|muscle strength
458194|NCT00037999|Testosterone|testosterone
458195|NCT00037999|Rehabilitation|rehabilitation
458196|NCT00037999|Impaired muscle strength|impaired muscle strength
458197|NCT00038012|Dose-intensified carboplatin|dose-intensified carboplatin
458198|NCT00038012|autologous cryopreserved platelets|autologous cryopreserved platelets
458199|NCT00038012|thrombopoietin|thrombopoietin
458200|NCT00038012|Gynecologic malignancy|gynecologic malignancy
458201|NCT00038025|Mycosis Fungoides|mycosis fungoides
458202|NCT00038025|Lymphoma|lymphoma
458203|NCT00038025|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
458204|NCT00038025|Deoxycoformycin|deoxycoformycin
458205|NCT00038025|Pentostatin|pentostatin
458206|NCT00038025|All other lymphomas|all other lymphomas
458207|NCT00038025|Nucleoside analogue|nucleoside analogue
458208|NCT00038025|Adenosine deaminase inhibitor|adenosine deaminase inhibitor
458209|NCT00038025|T-cells|t-cells
458210|NCT00038038|Squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
458211|NCT00038051|Acute Myeloid Leukemia|acute myeloid leukemia
458212|NCT00038051|AML|aml
458213|NCT00038051|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
458214|NCT00038051|CMML|cmml
458215|NCT00038051|Myeloproliferative Disorders|myeloproliferative disorders
458216|NCT00038051|Refractory Anemia with Excess of Blasts|refractory anemia with excess of blasts
458217|NCT00038051|RAEB-t|raeb-t
458218|NCT00038051|RAEB|raeb
458219|NCT00038051|Hum-195/rGel|hum-195/rgel
458220|NCT00038064|anemia of cancer/chemotherapy|anemia of cancer/chemotherapy
458221|NCT00038064|non-myeloid malignancies|non-myeloid malignancies
458222|NCT00038064|Drug Therapy|drug therapy
458223|NCT00038090|Myeloma|myeloma
458224|NCT00038090|Thalidomide|thalidomide
458225|NCT00038090|Thalomid|thalomid
458226|NCT00038090|Dexamethasone|dexamethasone
458227|NCT00038090|Decadron|decadron
458228|NCT00038116|Parkinson's disease|parkinson's disease
458229|NCT00038116|PD|pd
458230|NCT00038116|dopamine|dopamine
458231|NCT00038116|embryonic dopamine cell implant surgery|embryonic dopamine cell implant surgery
587239|NCT00531258|TBI|tbi
458232|NCT00038116|tissue implants|tissue implants
458234|NCT00038142|Vincristine|vincristine
458235|NCT00038142|Doxorubicin|doxorubicin
458236|NCT00038142|Adriamycin|adriamycin
458237|NCT00038142|Rubex|rubex
458238|NCT00038142|Cyclophosphamide|cyclophosphamide
458239|NCT00038142|Dexrazoxane|dexrazoxane
458240|NCT00038142|Zinecard|zinecard
458241|NCT00038142|VACdxr|vacdxr
458242|NCT00038142|ImmTher|immther
458243|NCT00038155|Ambulation|ambulation
458244|NCT00038155|Difficulties in ambulation|difficulties in ambulation
458245|NCT00038155|Geriatric|geriatric
458246|NCT00038155|Rehabilitation|rehabilitation
458247|NCT00038168|Prostate Cancer|prostate cancer
458248|NCT00038181|Prostate Cancer|prostate cancer
458249|NCT00038194|Prostate Cancer|prostate cancer
458250|NCT00038194|bone metastasis|bone metastasis
458251|NCT00038207|soft tissue sarcoma|soft tissue sarcoma
458252|NCT00038207|Bone sarcomas|bone sarcomas
458253|NCT00038220|HIV|hiv
458254|NCT00038233|myeloma|myeloma
458255|NCT00038246|Prostate Cancer|prostate cancer
458256|NCT00038259|Interleukin-2|interleukin-2
458257|NCT00038259|Drug Administration Schedule|drug administration schedule
458258|NCT00038259|CD4 Lymphocyte Count|cd4 lymphocyte count
458259|NCT00038259|Anti-HIV Agents|anti-hiv agents
458260|NCT00038259|Viral Load|viral load
458261|NCT00038259|Treatment Interruption|treatment interruption
458262|NCT00038259|Treatment Experienced|treatment experienced
458265|NCT00038272|Drug Therapy, Combination|drug therapy, combination
458266|NCT00038272|Anti-HIV Agents|anti-hiv agents
458267|NCT00038272|Mycophenolate Mofetil|mycophenolate mofetil
458268|NCT00038272|2,6-diaminopurine dioxolane|2,6-diaminopurine dioxolane
458269|NCT00038272|Treatment Experienced|treatment experienced
458270|NCT00038272|DAPD|dapd
458272|NCT00038285|Amputation|amputation
458273|NCT00038285|Cardiovascular Disease|cardiovascular disease
458274|NCT00038285|PVD|pvd
458275|NCT00038337|Health Literacy|health literacy
458276|NCT00038337|Visual|visual
458277|NCT00038337|Cognitive|cognitive
458278|NCT00038350|Age|age
458279|NCT00038350|Dysphagia|dysphagia
458280|NCT00038350|Swallowing|swallowing
458281|NCT00038363|Frail|frail
458282|NCT00038363|Disable|disable
458283|NCT00038363|Disabled Persons|disabled persons
458284|NCT00038363|Physically disabled|physically disabled
458285|NCT00038363|Elderly|elderly
458286|NCT00038363|Rehabilitation|rehabilitation
458287|NCT00038363|Subacute care|subacute care
458288|NCT00038376|T-cell lymphoma|t-cell lymphoma
458289|NCT00038376|accutane|accutane
458290|NCT00038376|isotretinoin|isotretinoin
458291|NCT00038376|mycosis fungoides|mycosis fungoides
458292|NCT00038376|T-cell malignancies|t-cell malignancies
458293|NCT00038389|Brain Stem Tumor|brain stem tumor
458294|NCT00038402|Breast Cancer|breast cancer
458295|NCT00038402|Non-Inflammatory Breast Cancer|non-inflammatory breast cancer
458296|NCT00038402|Operable Breast Cancer|operable breast cancer
458297|NCT00038402|Herceptin|herceptin
458298|NCT00038402|Taxol|taxol
458299|NCT00038402|FEC|fec
458300|NCT00038402|Fluorouracil|fluorouracil
458301|NCT00038402|Cyclophosphamide|cyclophosphamide
458302|NCT00038402|Epirubicin|epirubicin
458303|NCT00038402|Trastuzumab|trastuzumab
458304|NCT00038402|Paclitaxel|paclitaxel
458305|NCT00038402|Neosar|neosar
458306|NCT00038415|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
458307|NCT00038415|CLL|cll
458308|NCT00038415|Binet Stage A|binet stage a
458309|NCT00038415|Vaccination|vaccination
458310|NCT00038415|Idiotypic|idiotypic
458311|NCT00038415|Genetic|genetic
458312|NCT00038415|Deoxyribonucleic acid|deoxyribonucleic acid
458313|NCT00038415|DNA|dna
458314|NCT00038441|Malignant Glioma|malignant glioma
458315|NCT00038454|Oxygen Therapeutics|oxygen therapeutics
458316|NCT00038454|CABG|cabg
458317|NCT00038454|Transfusion|transfusion
458318|NCT00038480|Lopinavir|lopinavir
458319|NCT00038480|HIV-1|hiv-1
458320|NCT00038480|Drug Therapy, Combination|drug therapy, combination
458321|NCT00038480|HIV Protease Inhibitors|hiv protease inhibitors
458322|NCT00038480|Ritonavir|ritonavir
458323|NCT00038480|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
458324|NCT00038493|GBM|gbm
458325|NCT00038493|Glioma|glioma
458326|NCT00038493|Brain Tumor|brain tumor
458327|NCT00038506|HIV-1 TRIZIVIR Tenofovir|hiv-1 trizivir tenofovir
458328|NCT00038519|treatment experienced|treatment experienced
458329|NCT00038519|HIV|hiv
458330|NCT00038532|treatment experienced|treatment experienced
458331|NCT00038532|HIV|hiv
458332|NCT00038545|LYMPHOMA|lymphoma
458333|NCT00038545|NON-HODGKINS|non-hodgkins
458334|NCT00038545|AGGRESSIVE|aggressive
458335|NCT00038545|RELAPSED AND REFRACTORY|relapsed and refractory
458336|NCT00038558|Hodgkin's lymphoma|hodgkin's lymphoma
458337|NCT00038558|Dacarbazine|dacarbazine
458338|NCT00038558|DTIC|dtic
458339|NCT00038558|DTIC-Dome|dtic-dome
458340|NCT00038558|Vinblastine|vinblastine
458341|NCT00038558|Velban|velban
458342|NCT00038558|Bleomycin sulfate|bleomycin sulfate
458263|NCT00038259|STI|sti
458343|NCT00038558|Blenoxane|blenoxane
458344|NCT00038558|BLM|blm
458345|NCT00038558|Doxorubicin Hydrochloride|doxorubicin hydrochloride
458347|NCT00038558|Filgrastim|filgrastim
458348|NCT00038558|G-CSF|g-csf
458349|NCT00038558|Neupogen|neupogen
458350|NCT00038558|Pegfilgrastim|pegfilgrastim
458351|NCT00038558|granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
458352|NCT00038571|Cancer|cancer
458353|NCT00038571|Relapsed|relapsed
458354|NCT00038571|Refractory|refractory
458355|NCT00038571|B cell lymphoma|b cell lymphoma
458356|NCT00038571|Proteasome Inhibitor|proteasome inhibitor
458357|NCT00038571|PS-341|ps-341
458358|NCT00038597|Philadelphia chromosome positive CML|philadelphia chromosome positive cml
458359|NCT00038597|Myelogenous Leukemia, Chronic, Chronic Phase|myelogenous leukemia, chronic, chronic phase
458360|NCT00038597|Myelogenous Leukemia, Chronic, Accelerated Phase|myelogenous leukemia, chronic, accelerated phase
458361|NCT00038610|Leukemia|leukemia
458362|NCT00038610|Lymphoblastic|lymphoblastic
458363|NCT00038610|Acute|acute
458364|NCT00038610|Philadelphia-Positive|philadelphia-positive
458365|NCT00038610|Imatinib Mesylate|imatinib mesylate
458366|NCT00038610|Gleevec|gleevec
458367|NCT00038610|Glivec|glivec
458368|NCT00038610|Imatinib|imatinib
458369|NCT00038610|STI571|sti571
458370|NCT00038610|STI-571|sti-571
458371|NCT00038610|CGP-57148B|cgp-57148b
458372|NCT00038610|NSC-716051|nsc-716051
458373|NCT00038610|Cyclophosphamide|cyclophosphamide
458374|NCT00038610|Cytoxan®,|cytoxan®,
458375|NCT00038610|Neosar®|neosar®
458376|NCT00038610|Doxorubicin|doxorubicin
458377|NCT00038610|Adriamycin ®|adriamycin ®
458378|NCT00038610|Rubex ®|rubex ®
458379|NCT00038610|Adriamycin PFS|adriamycin pfs
458380|NCT00038610|Adriamycin RDF|adriamycin rdf
458381|NCT00038610|Vincristine|vincristine
458382|NCT00038610|Dexamethasone|dexamethasone
458383|NCT00038610|Decadron|decadron
458384|NCT00038610|Methotrexate|methotrexate
458385|NCT00038610|Cytarabine|cytarabine
458386|NCT00038610|Ara-C|ara-c
458387|NCT00038610|Cytosar|cytosar
458388|NCT00038610|DepoCyt|depocyt
458389|NCT00038610|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
458390|NCT00038610|Mesna|mesna
458391|NCT00038610|Mesnex|mesnex
458392|NCT00038610|G-CSF|g-csf
458393|NCT00038610|Filgrastim|filgrastim
458394|NCT00038610|Neupogen|neupogen
458395|NCT00038623|Relapsed/Refractory Mantle Cell Lymphoma|relapsed/refractory mantle cell lymphoma
458396|NCT00038623|Yttrium-Ibritumomab|yttrium-ibritumomab
458397|NCT00038623|Zevalin|zevalin
458398|NCT00038636|HIV|hiv
458399|NCT00038649|Philadelphia chromosome positive|philadelphia chromosome positive
458400|NCT00038649|early chronic phase (diagnosis < 12 months)|early chronic phase (diagnosis < 12 months)
458401|NCT00038649|Chronic Myelogenous Leukemia, Chronic Phase|chronic myelogenous leukemia, chronic phase
458402|NCT00038649|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
458403|NCT00038649|CML|cml
458404|NCT00038649|Gleevec|gleevec
458405|NCT00038649|STI571|sti571
458406|NCT00038675|Leukemia|leukemia
458407|NCT00038675|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
458408|NCT00038675|Chronic Myeloid Leukemia|chronic myeloid leukemia
458409|NCT00038675|Polycythemia Vera|polycythemia vera
458410|NCT00038675|Hypereosinophilic Syndrome|hypereosinophilic syndrome
458411|NCT00038675|Mastocytosis|mastocytosis
458412|NCT00038675|Imatinib Mesylate|imatinib mesylate
458413|NCT00038675|Gleevec|gleevec
458414|NCT00038688|Health Education|health education
458415|NCT00038688|Substance Abuse, Intravenous|substance abuse, intravenous
458416|NCT00038688|Program Evaluation|program evaluation
458417|NCT00038688|Peer Group|peer group
458418|NCT00038688|Risk-Taking|risk-taking
458419|NCT00038688|HIV Seronegativity|hiv seronegativity
458420|NCT00038688|Substance-related Disorders|substance-related disorders
458421|NCT00038701|Metastatic Pancreas Cancer|metastatic pancreas cancer
458422|NCT00038714|HPV|hpv
458423|NCT00038714|Papilloma|papilloma
458424|NCT00038727|DPP|dpp
458425|NCT00038727|IGT|igt
458426|NCT00038727|Prediabetes|prediabetes
458427|NCT00038727|Type 2 diabetes|type 2 diabetes
458428|NCT00038727|Macrovascular disease|macrovascular disease
458429|NCT00038727|Microvascular disease|microvascular disease
458430|NCT00038753|vision screening|vision screening
458431|NCT00038766|Inflammatory Bowel Disease|inflammatory bowel disease
458432|NCT00038779|Lymphoma|lymphoma
458433|NCT00038779|CML|cml
458434|NCT00038779|CLL|cll
458435|NCT00038779|AML|aml
458436|NCT00038779|ALL|all
458437|NCT00038779|MDS|mds
458438|NCT00038779|AA|aa
458439|NCT00038792|Acute Graft Versus Host Disease|acute graft versus host disease
458440|NCT00038792|Refractory|refractory
458441|NCT00038805|High Risk Acute Myeloid Leukemia|high risk acute myeloid leukemia
458442|NCT00038805|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
458443|NCT00038805|Chronic Myeloid Leukemia|chronic myeloid leukemia
458444|NCT00038805|Myelodysplastic Syndrome|myelodysplastic syndrome
458445|NCT00038805|ALL|all
458446|NCT00038805|AML|aml
458447|NCT00038805|MDS|mds
458448|NCT00038805|CML|cml
458450|NCT00038805|Nonmyeloablative Preparative Regimen|nonmyeloablative preparative regimen
458451|NCT00038805|Mylotarg|mylotarg
458452|NCT00038805|CMA-676|cma-676
458453|NCT00038818|CML|cml
458454|NCT00038818|MM|mm
458455|NCT00038818|NHL|nhl
458456|NCT00038818|HD|hd
458457|NCT00038818|CLL|cll
458458|NCT00038818|CD8 Depleted|cd8 depleted
458459|NCT00038818|Donor Lymphocyte|donor lymphocyte
458460|NCT00038831|Acute Myelogenous leukemia|acute myelogenous leukemia
458462|NCT00038831|Myelodysplastic Syndrome|myelodysplastic syndrome
458463|NCT00038831|MDS|mds
458464|NCT00038831|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
458465|NCT00038831|CML|cml
458466|NCT00038831|Mylotarg|mylotarg
458467|NCT00038831|Gemtuzumab|gemtuzumab
458468|NCT00038831|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
458469|NCT00038831|Melphalan|melphalan
458470|NCT00038831|Alkeran|alkeran
458471|NCT00038831|Fludarabine Phosphate|fludarabine phosphate
458472|NCT00038831|Fludarabine|fludarabine
458473|NCT00038831|Fludara|fludara
458474|NCT00038831|Anti-thymocyte globulin|anti-thymocyte globulin
458475|NCT00038831|ATG|atg
458476|NCT00038831|Allogeneic Bone Marrow|allogeneic bone marrow
458477|NCT00038831|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
458478|NCT00038831|Allo PBSCT|allo pbsct
458479|NCT00038831|Allogeneic transplantation|allogeneic transplantation
458486|NCT00038844|Fludarabine Phosphate|fludarabine phosphate
458487|NCT00038844|Fludara|fludara
458488|NCT00038844|Cyclophosphamide|cyclophosphamide
458489|NCT00038844|Cytoxan|cytoxan
458490|NCT00038844|Neosar|neosar
458491|NCT00038844|Rituxan|rituxan
458492|NCT00038844|Rituximab|rituximab
458493|NCT00038857|Acute Myelogenous Leukemia|acute myelogenous leukemia
458494|NCT00038857|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
458495|NCT00038857|Myelodysplastic Syndrome|myelodysplastic syndrome
458496|NCT00038857|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
458497|NCT00038857|Leukemia|leukemia
458498|NCT00038857|Lymphoma|lymphoma
458499|NCT00038857|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
458500|NCT00038857|T cell depletion|t cell depletion
458501|NCT00038857|CD34 selected progenitors cell|cd34 selected progenitors cell
458502|NCT00038857|GVHD|gvhd
458503|NCT00038870|AML|aml
458504|NCT00038870|CML|cml
458505|NCT00038870|Dendritic Cells|dendritic cells
458506|NCT00038883|Lymphoid Malignancies|lymphoid malignancies
458507|NCT00038883|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
458508|NCT00038883|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
458509|NCT00038883|Low grade Lymphoma|low grade lymphoma
458510|NCT00038883|B and T cell Lymphoma of the intermediate and high grade|b and t cell lymphoma of the intermediate and high grade
458511|NCT00038896|Panic|panic
458512|NCT00038896|Disorder|disorder
458513|NCT00038922|Left-Sided|left-sided
458514|NCT00038922|Ulcerative|ulcerative
458515|NCT00038922|Colitis|colitis
458516|NCT00038935|Hemophilia|hemophilia
458517|NCT00038948|Renal|renal
458518|NCT00038948|Allograft|allograft
458519|NCT00038948|Recipients|recipients
458520|NCT00038961|fondaparinux sodium|fondaparinux sodium
458521|NCT00038961|DVT Prevention|dvt prevention
458522|NCT00038961|abdominal surgery|abdominal surgery
458523|NCT00038961|VTE prevention|vte prevention
458524|NCT00038961|venous thromboembolism|venous thromboembolism
458525|NCT00038961|pulmonary embolism|pulmonary embolism
458526|NCT00038974|Hepatitis C|hepatitis c
458527|NCT00038974|Interferon|interferon
458528|NCT00038974|Ribavirin|ribavirin
458529|NCT00038974|Efficacy|efficacy
458530|NCT00038974|Viral load|viral load
458531|NCT00038974|Genetics|genetics
458532|NCT00038974|Cytokines|cytokines
458533|NCT00038974|Immunology|immunology
458534|NCT00038987|Smallpox|smallpox
458535|NCT00038987|APSV|apsv
458536|NCT00038987|Aventis Pasteur Smallpox Vaccine|aventis pasteur smallpox vaccine
458537|NCT00038987|vaccinia-naive|vaccinia-naive
458538|NCT00039000|Immunotherapy, Cancer, Melanoma, Skin Cancer, tumor|immunotherapy, cancer, melanoma, skin cancer, tumor
458539|NCT00039026|Type 2 Diabetes Mellitis|type 2 diabetes mellitis
458540|NCT00039039|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
458541|NCT00039039|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
458542|NCT00039039|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
458543|NCT00039052|stage IV breast cancer|stage iv breast cancer
458544|NCT00039052|recurrent breast cancer|recurrent breast cancer
458545|NCT00039052|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
458546|NCT00039052|stage IV renal cell cancer|stage iv renal cell cancer
458547|NCT00039052|recurrent renal cell cancer|recurrent renal cell cancer
458548|NCT00039052|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
458549|NCT00039052|male breast cancer|male breast cancer
458550|NCT00039078|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
458551|NCT00039078|recurrent adult primary liver cancer|recurrent adult primary liver cancer
458552|NCT00039078|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
458553|NCT00039130|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
458554|NCT00039130|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
458555|NCT00039130|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
458556|NCT00039130|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
458557|NCT00039130|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
458558|NCT00039130|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
458559|NCT00039130|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
458560|NCT00039156|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
458561|NCT00039156|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
458562|NCT00039156|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
458563|NCT00039156|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
458564|NCT00039156|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
458565|NCT00039156|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
458566|NCT00039156|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
458567|NCT00039169|stage III renal cell cancer|stage iii renal cell cancer
458568|NCT00039169|stage IV renal cell cancer|stage iv renal cell cancer
458569|NCT00039169|recurrent renal cell cancer|recurrent renal cell cancer
458570|NCT00039195|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
458571|NCT00039195|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
476828|NCT00097214|IV|iv
458572|NCT00039195|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
458573|NCT00039195|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
458574|NCT00039195|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
458575|NCT00039208|stage III colon cancer|stage iii colon cancer
458576|NCT00039208|stage IV colon cancer|stage iv colon cancer
458577|NCT00039208|stage III rectal cancer|stage iii rectal cancer
458578|NCT00039208|stage IV rectal cancer|stage iv rectal cancer
458579|NCT00039208|recurrent colon cancer|recurrent colon cancer
458580|NCT00039208|recurrent rectal cancer|recurrent rectal cancer
458581|NCT00039234|stage IV melanoma|stage iv melanoma
458582|NCT00039234|recurrent melanoma|recurrent melanoma
458583|NCT00039234|liver metastases|liver metastases
458584|NCT00021294|basal cell carcinoma of the skin|basal cell carcinoma of the skin
458585|NCT00021294|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
458586|NCT00021294|actinic keratosis|actinic keratosis
458587|NCT00021307|recurrent adult brain tumor|recurrent adult brain tumor
458588|NCT00021307|adult glioblastoma|adult glioblastoma
458589|NCT00021307|adult giant cell glioblastoma|adult giant cell glioblastoma
458590|NCT00021307|adult gliosarcoma|adult gliosarcoma
458591|NCT00021320|stage 0 esophageal cancer|stage 0 esophageal cancer
458592|NCT00021320|stage I esophageal cancer|stage i esophageal cancer
458593|NCT00021320|stage II esophageal cancer|stage ii esophageal cancer
458594|NCT00021320|stage III esophageal cancer|stage iii esophageal cancer
458595|NCT00021320|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
458596|NCT00021320|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
458597|NCT00021333|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
458598|NCT00021333|recurrent small cell lung cancer|recurrent small cell lung cancer
458599|NCT00021333|recurrent thyroid cancer|recurrent thyroid cancer
458600|NCT00021333|recurrent salivary gland cancer|recurrent salivary gland cancer
458601|NCT00021333|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
458602|NCT00021333|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
458603|NCT00021333|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
458604|NCT00021333|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
458605|NCT00021333|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
458606|NCT00021333|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
458607|NCT00021333|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
458608|NCT00021333|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
458609|NCT00021333|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
458610|NCT00021333|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
458611|NCT00021333|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
458612|NCT00021333|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
458613|NCT00021333|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
458614|NCT00021333|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
458615|NCT00021333|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
457926|NCT00036829|pain|pain
458616|NCT00021333|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
12850|NCT03208504|Thoracic Aortic Disease|thoracic aortic disease
458617|NCT00021346|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
458618|NCT00021359|stage I multiple myeloma|stage i multiple myeloma
458619|NCT00021359|stage II multiple myeloma|stage ii multiple myeloma
458620|NCT00021359|stage III multiple myeloma|stage iii multiple myeloma
458621|NCT00021372|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
458622|NCT00021372|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
458623|NCT00021372|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
458624|NCT00021372|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
458625|NCT00021372|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
458626|NCT00021372|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
458627|NCT00021372|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
458973|NCT00041951|CAE|cae
458628|NCT00021372|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
458629|NCT00021372|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
458630|NCT00021372|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
458631|NCT00021372|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
458632|NCT00021372|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
458633|NCT00021372|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
458634|NCT00021372|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
458635|NCT00021372|splenic marginal zone lymphoma|splenic marginal zone lymphoma
458636|NCT00021385|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
476829|NCT00097214|Carboplatin|carboplatin
458637|NCT00021385|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
458638|NCT00021385|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
458639|NCT00021385|ovarian stromal cancer|ovarian stromal cancer
458640|NCT00021385|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
458641|NCT00021385|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
458642|NCT00021385|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
458643|NCT00021385|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
458644|NCT00021385|ovarian sarcoma|ovarian sarcoma
458645|NCT00021398|stage II rectal cancer|stage ii rectal cancer
458646|NCT00021398|stage III rectal cancer|stage iii rectal cancer
458647|NCT00021398|adenocarcinoma of the rectum|adenocarcinoma of the rectum
458760|NCT00039468|adult gliosarcoma|adult gliosarcoma
458648|NCT00021424|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
458649|NCT00021424|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
458650|NCT00021424|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
458651|NCT00021424|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
458652|NCT00021424|skin metastases|skin metastases
458653|NCT00021437|Bloom syndrome protein|bloom syndrome protein
458654|NCT00021450|stage IIB prostate cancer|stage iib prostate cancer
458655|NCT00021450|stage IIA prostate cancer|stage iia prostate cancer
458656|NCT00021463|Nevirapine|nevirapine
458657|NCT00021463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
458658|NCT00021463|Anti-HIV Agents|anti-hiv agents
458659|NCT00021463|Triglycerides|triglycerides
458660|NCT00021463|abacavir|abacavir
458661|NCT00021463|efavirenz|efavirenz
458662|NCT00021463|Lipoproteins, LDL Cholesterol|lipoproteins, ldl cholesterol
458663|NCT00021476|Whiplash|whiplash
458664|NCT00021476|Chronic pain|chronic pain
458665|NCT00021476|Motor vehicle accidents|motor vehicle accidents
458666|NCT00021489|Placebos|placebos
458667|NCT00021489|Drug Therapy, Combination|drug therapy, combination
458668|NCT00021489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
458669|NCT00021489|Anti-HIV Agents|anti-hiv agents
458670|NCT00021489|abacavir|abacavir
458671|NCT00021489|mycophenolate mofetil|mycophenolate mofetil
458672|NCT00021502|Pyridoxalated hemoglobin polyoxyethylene conjugate (PHP)|pyridoxalated hemoglobin polyoxyethylene conjugate (php)
458673|NCT00021502|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
458674|NCT00021502|Nitric oxide (NO)|nitric oxide (no)
458675|NCT00021502|Shock|shock
458676|NCT00021528|Sequential Treatment|sequential treatment
458677|NCT00021528|Major Depression|major depression
458678|NCT00021528|Treatment Resistant Depression|treatment resistant depression
458679|NCT00021541|Surrogate Markers|surrogate markers
458680|NCT00021541|3-Dimensional Magnetic Resonance Imaging (MRI)|3-dimensional magnetic resonance imaging (mri)
458681|NCT00021541|Natural History of Neurofibromatosis Type 1 (NF1)|natural history of neurofibromatosis type 1 (nf1)
458682|NCT00021541|Tumor Tissue Bank|tumor tissue bank
458683|NCT00021541|Neurofibromatosis|neurofibromatosis
458685|NCT00021541|Neurofibromatosis Type 1|neurofibromatosis type 1
458686|NCT00021541|Plexiform Neurofibroma|plexiform neurofibroma
458687|NCT00021541|Neurofibroma|neurofibroma
458688|NCT00027352|Physician's Practice Patterns|physician's practice patterns
458689|NCT00027352|Anti-HIV Agents|anti-hiv agents
458690|NCT00027365|HIV Seronegativity|hiv seronegativity
458691|NCT00027365|HIV Preventive Vaccine|hiv preventive vaccine
12957|NCT03207685|EMU|emu
458692|NCT00027365|Injections, Intramuscular|injections, intramuscular
458693|NCT00027365|HIV Antibodies|hiv antibodies
458694|NCT00027365|HIV-1|hiv-1
458695|NCT00027365|HIV Envelope Protein gp120|hiv envelope protein gp120
458696|NCT00027365|Gene Products, tat|gene products, tat
458698|NCT00027365|Neutralization Tests|neutralization tests
458699|NCT00027365|Vaccines, Combined|vaccines, combined
458700|NCT00027365|AIDS Seronegativity|aids seronegativity
458701|NCT00027365|Gene Products, nef|gene products, nef
458702|NCT00027378|fluoxetine,|fluoxetine,
458703|NCT00027378|adolescents,|adolescents,
458704|NCT00027378|alcohol dependence,|alcohol dependence,
458705|NCT00027378|major depression|major depression
458706|NCT00027378|Alcoholism|alcoholism
458707|NCT00027391|Muscle Weakness, Muscular Dystrophy|muscle weakness, muscular dystrophy
458708|NCT00027404|Adult, Autism|adult, autism
458974|NCT00041951|Petit Mal|petit mal
458709|NCT00027417|Congenital heart defects|congenital heart defects
458710|NCT00027417|Hypoplastic left heart syndrome|hypoplastic left heart syndrome
458711|NCT00027417|Complete atrioventricular canal defect|complete atrioventricular canal defect
458712|NCT00027417|Triostat|triostat
458713|NCT00027417|Cardiac surgery|cardiac surgery
458714|NCT00027443|Giant Cell Myocarditis|giant cell myocarditis
458715|NCT00027456|Insulin Resistance|insulin resistance
458716|NCT00027456|Diabetes Mellitus|diabetes mellitus
458717|NCT00027456|Adipocytes|adipocytes
458718|NCT00027456|Rabson Mendenhall Syndrome|rabson mendenhall syndrome
458719|NCT00027456|Leprechaunism|leprechaunism
458720|NCT00027456|Leptin|leptin
458721|NCT00039273|stage IV colon cancer|stage iv colon cancer
458722|NCT00039273|stage IV rectal cancer|stage iv rectal cancer
458723|NCT00039273|recurrent colon cancer|recurrent colon cancer
458724|NCT00039273|recurrent rectal cancer|recurrent rectal cancer
458725|NCT00039286|stage II breast cancer|stage ii breast cancer
458726|NCT00039286|stage IIIA breast cancer|stage iiia breast cancer
458727|NCT00039286|recurrent breast cancer|recurrent breast cancer
458728|NCT00039299|adenocarcinoma of the prostate|adenocarcinoma of the prostate
458729|NCT00039299|recurrent prostate cancer|recurrent prostate cancer
458730|NCT00039312|cervical cancer|cervical cancer
458731|NCT00039325|stage IV melanoma|stage iv melanoma
458732|NCT00039325|recurrent melanoma|recurrent melanoma
458733|NCT00039338|stage IB cervical cancer|stage ib cervical cancer
458734|NCT00039338|stage IIB cervical cancer|stage iib cervical cancer
458735|NCT00039338|stage IIA cervical cancer|stage iia cervical cancer
458736|NCT00039338|cervical squamous cell carcinoma|cervical squamous cell carcinoma
458737|NCT00039338|cervical adenocarcinoma|cervical adenocarcinoma
458738|NCT00039338|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
458739|NCT00039351|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
458740|NCT00039351|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
458741|NCT00039351|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
458742|NCT00039351|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
458743|NCT00039351|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
458744|NCT00039351|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
458745|NCT00039364|recurrent adult brain tumor|recurrent adult brain tumor
458746|NCT00039364|adult glioblastoma|adult glioblastoma
458747|NCT00039364|adult anaplastic astrocytoma|adult anaplastic astrocytoma
458748|NCT00039364|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
458749|NCT00039364|adult mixed glioma|adult mixed glioma
458750|NCT00039364|adult pilocytic astrocytoma|adult pilocytic astrocytoma
458751|NCT00039364|adult subependymoma|adult subependymoma
458752|NCT00039364|adult giant cell glioblastoma|adult giant cell glioblastoma
458753|NCT00039364|adult gliosarcoma|adult gliosarcoma
458754|NCT00039364|adult diffuse astrocytoma|adult diffuse astrocytoma
458755|NCT00039429|stage IV renal cell cancer|stage iv renal cell cancer
458756|NCT00039429|recurrent renal cell cancer|recurrent renal cell cancer
458757|NCT00039468|adult glioblastoma|adult glioblastoma
458758|NCT00039468|recurrent adult brain tumor|recurrent adult brain tumor
458759|NCT00039468|adult giant cell glioblastoma|adult giant cell glioblastoma
458761|NCT00039507|stage I non-small cell lung cancer|stage i non-small cell lung cancer
458762|NCT00039507|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
458763|NCT00039520|stage IV breast cancer|stage iv breast cancer
458764|NCT00039520|recurrent breast cancer|recurrent breast cancer
458765|NCT00039546|stage I breast cancer|stage i breast cancer
458766|NCT00039546|stage II breast cancer|stage ii breast cancer
458767|NCT00039559|ovarian epithelial cancer|ovarian epithelial cancer
458768|NCT00039572|adult glioblastoma|adult glioblastoma
458769|NCT00039572|stage IV melanoma|stage iv melanoma
458770|NCT00039572|tumors metastatic to brain|tumors metastatic to brain
458771|NCT00039572|adult giant cell glioblastoma|adult giant cell glioblastoma
458035|NCT00037024|male breast cancer|male breast cancer
458772|NCT00039572|adult gliosarcoma|adult gliosarcoma
458773|NCT00039585|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
458774|NCT00039585|fallopian tube cancer|fallopian tube cancer
458775|NCT00039585|primary peritoneal cavity cancer|primary peritoneal cavity cancer
458776|NCT00039585|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
458777|NCT00039611|stage III colon cancer|stage iii colon cancer
458779|NCT00039611|stage III rectal cancer|stage iii rectal cancer
458780|NCT00039611|stage IV rectal cancer|stage iv rectal cancer
458781|NCT00039611|recurrent colon cancer|recurrent colon cancer
458782|NCT00039611|recurrent rectal cancer|recurrent rectal cancer
458783|NCT00039624|Radiation Therapy|radiation therapy
458784|NCT00039624|Prostate|prostate
458786|NCT00039624|Brachytherapy|brachytherapy
458787|NCT00039624|Phase II|phase ii
458788|NCT00039624|Prostate Cancer|prostate cancer
458789|NCT00041223|radiation fibrosis|radiation fibrosis
458790|NCT00041223|stage I breast cancer|stage i breast cancer
458791|NCT00041223|stage II breast cancer|stage ii breast cancer
458792|NCT00041223|stage IIIA breast cancer|stage iiia breast cancer
458793|NCT00041236|adult angiosarcoma|adult angiosarcoma
458794|NCT00041236|adult fibrosarcoma|adult fibrosarcoma
458795|NCT00041236|adult leiomyosarcoma|adult leiomyosarcoma
458796|NCT00041236|adult liposarcoma|adult liposarcoma
458797|NCT00041236|adult neurofibrosarcoma|adult neurofibrosarcoma
458798|NCT00041236|adult synovial sarcoma|adult synovial sarcoma
458799|NCT00041236|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
458800|NCT00041236|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
458801|NCT00041236|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
458802|NCT00041236|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
458803|NCT00041236|adult rhabdomyosarcoma|adult rhabdomyosarcoma
458804|NCT00041236|stage IV uterine sarcoma|stage iv uterine sarcoma
458805|NCT00041236|recurrent uterine sarcoma|recurrent uterine sarcoma
458806|NCT00041236|uterine leiomyosarcoma|uterine leiomyosarcoma
458807|NCT00041249|adult angiosarcoma|adult angiosarcoma
458808|NCT00041249|adult fibrosarcoma|adult fibrosarcoma
458809|NCT00041249|adult leiomyosarcoma|adult leiomyosarcoma
458810|NCT00041249|adult liposarcoma|adult liposarcoma
458811|NCT00041249|adult neurofibrosarcoma|adult neurofibrosarcoma
458812|NCT00041249|adult synovial sarcoma|adult synovial sarcoma
458813|NCT00041249|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
458814|NCT00041249|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
458815|NCT00041249|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
458816|NCT00041249|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
458817|NCT00041249|adult rhabdomyosarcoma|adult rhabdomyosarcoma
458818|NCT00041249|gastrointestinal stromal tumor|gastrointestinal stromal tumor
458819|NCT00041249|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
458820|NCT00041262|stage IIB esophageal cancer|stage iib esophageal cancer
458821|NCT00041262|stage IIIA esophageal cancer|stage iiia esophageal cancer
458822|NCT00041262|stage IIIB esophageal cancer|stage iiib esophageal cancer
458823|NCT00041262|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
458824|NCT00041275|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
458825|NCT00041275|advanced adult primary liver cancer|advanced adult primary liver cancer
458826|NCT00041275|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
458827|NCT00041288|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
458828|NCT00041288|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
458829|NCT00041288|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
458830|NCT00041288|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
458831|NCT00041288|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
458832|NCT00041288|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
458833|NCT00041301|stage I prostate cancer|stage i prostate cancer
458834|NCT00041301|stage IIB prostate cancer|stage iib prostate cancer
458835|NCT00041301|stage IIA prostate cancer|stage iia prostate cancer
458836|NCT00041301|stage III prostate cancer|stage iii prostate cancer
458837|NCT00041301|stage IV prostate cancer|stage iv prostate cancer
458838|NCT00041314|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
458839|NCT00041314|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
458840|NCT00041314|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
458841|NCT00041327|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
458842|NCT00041327|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
458843|NCT00041327|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
458844|NCT00041327|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
458845|NCT00041353|ductal breast carcinoma in situ|ductal breast carcinoma in situ
458846|NCT00041353|lobular breast carcinoma in situ|lobular breast carcinoma in situ
458847|NCT00041379|Waldenström macroglobulinemia|waldenström macroglobulinemia
458848|NCT00041483|AMD|amd
458849|NCT00041483|age-related macular degeneration|age-related macular degeneration
458850|NCT00041483|Anecortave|anecortave
458851|NCT00041483|Acetate|acetate
458852|NCT00041483|Wet form of age-related macular degeneration|wet form of age-related macular degeneration
458853|NCT00041496|symptomatic atrial fibrillation|symptomatic atrial fibrillation
458854|NCT00041496|persistent atrial fibrillation|persistent atrial fibrillation
458855|NCT00041509|venous thromboembolism|venous thromboembolism
458856|NCT00041509|thromboembolism|thromboembolism
458857|NCT00041509|pulmonary embolism|pulmonary embolism
458858|NCT00041509|deep vein thrombosis|deep vein thrombosis
458859|NCT00041535|Eye Movements|eye movements
458860|NCT00041535|Saccades|saccades
458861|NCT00041535|Metabolic|metabolic
458862|NCT00041535|Lysosomal|lysosomal
458863|NCT00041535|Myoclonus|myoclonus
458864|NCT00041535|Gaucher Disease|gaucher disease
458865|NCT00041535|Neuronopathic Gaucher Disease|neuronopathic gaucher disease
458866|NCT00041561|Acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
458867|NCT00041587|Cancer|cancer
458868|NCT00041587|Recurrent resectable supratentorial malignant glioma|recurrent resectable supratentorial malignant glioma
458869|NCT00041600|epilepsy|epilepsy
458870|NCT00041600|seizures|seizures
458997|NCT00041990|STI 571|sti 571
458871|NCT00041600|disorders of human cognition|disorders of human cognition
458872|NCT00041600|neuronal migration|neuronal migration
458873|NCT00041600|neuronal migration disorders|neuronal migration disorders
458874|NCT00041600|lissencephaly|lissencephaly
458875|NCT00041600|schizencephaly|schizencephaly
458876|NCT00041600|polymicrogyria|polymicrogyria
458877|NCT00041600|agenesis of the corpus callosum|agenesis of the corpus callosum
458878|NCT00041600|heterotopia|heterotopia
458879|NCT00041613|Refractory Squamous Cell Carcinoma of the Head and Neck|refractory squamous cell carcinoma of the head and neck
458880|NCT00041626|Recurrent Squamous Cell Carcinoma of the Head and Neck|recurrent squamous cell carcinoma of the head and neck
458881|NCT00041639|Pancreatic Cancer|pancreatic cancer
458882|NCT00041639|Pancreatic Carcinoma|pancreatic carcinoma
458883|NCT00041639|Pancreatic Neoplasms|pancreatic neoplasms
458884|NCT00041639|Pancreas Cancer|pancreas cancer
458885|NCT00041639|Pancreatic Tumor|pancreatic tumor
458886|NCT00041652|Colorectal Cancer|colorectal cancer
458887|NCT00041652|Colon Cancer|colon cancer
458888|NCT00041652|Rectal Cancer|rectal cancer
458889|NCT00041652|Colorectal Neoplasms|colorectal neoplasms
458890|NCT00041652|Colorectal Carcinoma|colorectal carcinoma
458891|NCT00041652|Breast Cancer|breast cancer
458892|NCT00041652|Breast Neoplasms|breast neoplasms
458893|NCT00041678|Psychosis Associated with Dementia of the Alzheimer's Type|psychosis associated with dementia of the alzheimer's type
458894|NCT00041691|Colorectal Cancer|colorectal cancer
458895|NCT00041691|Colon Cancer|colon cancer
458896|NCT00041691|Rectal Cancer|rectal cancer
458897|NCT00041691|Colorectal Neoplasms|colorectal neoplasms
458898|NCT00041691|Colorectal Carcinoma|colorectal carcinoma
458899|NCT00041691|Colorectal Tumor|colorectal tumor
458900|NCT00041704|Azole-Refractory Mucosal Candidiasis|azole-refractory mucosal candidiasis
458901|NCT00041704|Mucosal Candidiasis|mucosal candidiasis
458902|NCT00041717|spinal cord injury|spinal cord injury
458903|NCT00041717|muscle spasticity|muscle spasticity
458904|NCT00041730|lymphoma|lymphoma
458905|NCT00041730|vaccine|vaccine
458906|NCT00041730|idiotype|idiotype
458908|NCT00041730|GM-CSF|gm-csf
458909|NCT00041730|FavId|favid
458910|NCT00041756|Primary Disease: Knee Primary Osteoarthritis|primary disease: knee primary osteoarthritis
458911|NCT00041769|Drug Therapy, Combination|drug therapy, combination
458912|NCT00041769|HIV Protease Inhibitors|hiv protease inhibitors
458913|NCT00041769|Salvage Therapy|salvage therapy
458914|NCT00041769|Viral Load|viral load
458915|NCT00041769|Treatment Experienced|treatment experienced
458916|NCT00041782|Deep Vein Thrombosis|deep vein thrombosis
458917|NCT00041808|Metastatic liver cancer|metastatic liver cancer
458918|NCT00041808|Cholangiocarcinoma|cholangiocarcinoma
458919|NCT00041808|colorectal cancer|colorectal cancer
458920|NCT00041808|esophageal cancer|esophageal cancer
458921|NCT00041808|gastric cancer|gastric cancer
458922|NCT00041808|pancreatic cancer|pancreatic cancer
458923|NCT00041808|breast cancer|breast cancer
458924|NCT00041808|malignant melanoma|malignant melanoma
458925|NCT00041808|sarcoma|sarcoma
458926|NCT00041808|GIST|gist
458927|NCT00041808|gastrointestinal stromal tumor|gastrointestinal stromal tumor
458928|NCT00041808|lung cancer|lung cancer
458929|NCT00041808|liver cancer|liver cancer
458930|NCT00041821|rhinitis|rhinitis
458931|NCT00041821|irritation|irritation
458932|NCT00041821|trigeminal|trigeminal
458933|NCT00041834|childhood asthma|childhood asthma
458934|NCT00041834|traffic|traffic
458935|NCT00041847|gene|gene
458936|NCT00041847|environment|environment
458937|NCT00041847|occupation|occupation
458938|NCT00041847|diet|diet
458939|NCT00041847|interaction|interaction
458940|NCT00041860|Benzene|benzene
458941|NCT00041860|Air pollution|air pollution
458942|NCT00041886|Minimally Invasive Surgery|minimally invasive surgery
458943|NCT00041886|Percutaneous|percutaneous
458944|NCT00041886|Radiofrequency Ablation|radiofrequency ablation
458945|NCT00041886|Soft Tissue Metastases|soft tissue metastases
458946|NCT00041886|Thermal Ablation|thermal ablation
458947|NCT00041886|Soft Tissue Neoplasm|soft tissue neoplasm
458948|NCT00041886|Tumor|tumor
458949|NCT00041899|Progesterone|progesterone
458950|NCT00041899|Cortisol|cortisol
458951|NCT00041899|Menstrual Cycle|menstrual cycle
458952|NCT00041899|Formulation|formulation
458953|NCT00041899|Endometrium|endometrium
458954|NCT00041899|Estrogen|estrogen
13047|NCT03207165|Inotropes|inotropes
458955|NCT00041925|atherosclerotic vascular disease|atherosclerotic vascular disease
458956|NCT00041925|chronic critical limb ischemia|chronic critical limb ischemia
458958|NCT00041925|peripheral vein bypass|peripheral vein bypass
458959|NCT00041925|infra-inguinal bypass grafting surgery|infra-inguinal bypass grafting surgery
458960|NCT00041925|graft stenosis|graft stenosis
458961|NCT00041925|occluded grafts|occluded grafts
458962|NCT00041938|heart disease|heart disease
458963|NCT00041938|stroke|stroke
458964|NCT00041938|ischemic heart disease|ischemic heart disease
458965|NCT00041938|myocardial infarction|myocardial infarction
458966|NCT00041938|atrial fibrillation|atrial fibrillation
458967|NCT00041938|low ejection fraction|low ejection fraction
458968|NCT00041938|cardiac failure|cardiac failure
458969|NCT00041938|aspirin|aspirin
458970|NCT00041938|Warfarin|warfarin
458971|NCT00041938|anticoagulant|anticoagulant
458972|NCT00041951|Childhood Absence Epilepsy|childhood absence epilepsy
458980|NCT00041951|Genetic Linkage|genetic linkage
458981|NCT00041964|Lopinavir|lopinavir
458982|NCT00041964|Pregnancy Trimester, Third|pregnancy trimester, third
458983|NCT00041964|Pregnancy Complications, Infectious|pregnancy complications, infectious
458984|NCT00041964|HIV Protease Inhibitors|hiv protease inhibitors
458985|NCT00041964|Ritonavir|ritonavir
458986|NCT00041964|Nelfinavir|nelfinavir
458990|NCT00041990|Chronic myelogenous leukemia|chronic myelogenous leukemia
458991|NCT00041990|CML|cml
458992|NCT00041990|CML-AP|cml-ap
458993|NCT00041990|Accelerated phase|accelerated phase
458994|NCT00041990|Decitabine|decitabine
458995|NCT00041990|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
458996|NCT00041990|Methylation|methylation
458998|NCT00041990|Imatinib mesylate|imatinib mesylate
459000|NCT00041990|BCR/ABL|bcr/abl
459001|NCT00042003|Chronic myelogenous leukemia|chronic myelogenous leukemia
459002|NCT00042003|CML|cml
459003|NCT00042003|CML-BP|cml-bp
459004|NCT00042003|Blast phase|blast phase
459005|NCT00042003|Decitabine|decitabine
459006|NCT00042003|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
459007|NCT00042003|Methylation|methylation
459008|NCT00042003|STI 571|sti 571
459009|NCT00042003|Imatinib mesylate|imatinib mesylate
459010|NCT00042003|Gleevec|gleevec
459011|NCT00042003|BCR/ABL|bcr/abl
459012|NCT00042016|Chronic myelogenous leukemia|chronic myelogenous leukemia
459013|NCT00042016|CML|cml
459014|NCT00042016|CML-CP|cml-cp
459015|NCT00042016|Chronic phase|chronic phase
459016|NCT00042016|Decitabine|decitabine
459017|NCT00042016|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
459018|NCT00042016|Methylation|methylation
459019|NCT00042016|STI 571|sti 571
459020|NCT00042016|Imatinib mesylate|imatinib mesylate
459021|NCT00042016|Gleevec|gleevec
459022|NCT00042016|BCR/ABL|bcr/abl
459023|NCT00042055|Crohn's Disease|crohn's disease
459024|NCT00042055|Inflammatory Bowel Disease|inflammatory bowel disease
459025|NCT00042081|CABG|cabg
459026|NCT00042081|coronary artery bypass surgery|coronary artery bypass surgery
459027|NCT00042081|coronary artery disease|coronary artery disease
459028|NCT00042081|coronary arteriosclerosis|coronary arteriosclerosis
459029|NCT00042081|coronary stenosis|coronary stenosis
459030|NCT00042081|coronary occlusion|coronary occlusion
459031|NCT00042094|Smallpox|smallpox
459032|NCT00042094|Smallpox Vaccine|smallpox vaccine
459033|NCT00042094|Vaccinia|vaccinia
459034|NCT00042107|Parkinson Disease|parkinson disease
459035|NCT00042107|Neurodegenerative|neurodegenerative
459036|NCT00042120|Parkinson's disease|parkinson's disease
459037|NCT00042120|Movement Disorders|movement disorders
459038|NCT00042120|Epidemiological Study|epidemiological study
459039|NCT00042133|aging|aging
459040|NCT00042133|disability|disability
459041|NCT00042133|longitudinal studies|longitudinal studies
459042|NCT00042133|neighborhood factors|neighborhood factors
459043|NCT00042133|socio-economic status|socio-economic status
459044|NCT00042133|race|race
459045|NCT00042146|Insomnia|insomnia
459046|NCT00042146|Sleep Disorders|sleep disorders
459047|NCT00042146|Sleep Deprivation|sleep deprivation
459048|NCT00042159|Auditory hallucinations (voices)|auditory hallucinations (voices)
459049|NCT00042172|Cognition|cognition
459050|NCT00042172|Memory|memory
459051|NCT00042185|Adolescence|adolescence
459052|NCT00042185|Prevention and Control|prevention and control
459053|NCT00042185|Bulimia|bulimia
459054|NCT00042198|Cognitive therapy|cognitive therapy
459055|NCT00042198|Relaxation techniques|relaxation techniques
459056|NCT00042211|Depressive Disorder|depressive disorder
459057|NCT00042211|Blindness|blindness
459058|NCT00042211|Aged|aged
459059|NCT00042224|Electroconvulsive Therapy|electroconvulsive therapy
459060|NCT00042237|Child Abuse, Sexual|child abuse, sexual
459061|NCT00042250|Cell Cycle Interphase|cell cycle interphase
459062|NCT00042250|G0|g0
459064|NCT00042250|G2|g2
459065|NCT00042250|S Phase|s phase
459066|NCT00042263|health disparities|health disparities
459067|NCT00042263|social environment|social environment
459068|NCT00042263|physical environment|physical environment
459069|NCT00042263|racial health disparities|racial health disparities
459070|NCT00042276|Pressure Pain Threshold|pressure pain threshold
459071|NCT00042276|MTrP|mtrp
459072|NCT00042276|Musculoskeletal Pain|musculoskeletal pain
459073|NCT00042276|Soft Tissue Pain|soft tissue pain
459074|NCT00042276|Pathophysiology|pathophysiology
459075|NCT00042276|Myofascial Pain|myofascial pain
459076|NCT00042276|Microdialysis|microdialysis
459077|NCT00042276|Myofascial Trigger Points|myofascial trigger points
459078|NCT00042276|Rehabilitation|rehabilitation
459079|NCT00042276|Muscle Pain|muscle pain
459080|NCT00042276|Neck Pain|neck pain
459081|NCT00042276|Healthy Volunteer|healthy volunteer
459082|NCT00042276|HV|hv
459083|NCT00042276|Normal Control|normal control
459084|NCT00042289|Pregnancy|pregnancy
459085|NCT00042289|Pharmacokinetics|pharmacokinetics
459086|NCT00042289|Treatment Experienced|treatment experienced
459087|NCT00042328|Cancer|cancer
459088|NCT00042341|CLO212|clo212
459089|NCT00042341|clolar|clolar
459090|NCT00042341|pediatric ALL|pediatric all
459091|NCT00042341|Leukemia, Lymphoblastic, Acute - pediatric|leukemia, lymphoblastic, acute - pediatric
459092|NCT00042354|CLO222|clo222
459093|NCT00042354|clolar|clolar
459094|NCT00042354|Pediatric Acute Myelogenous Leukemia|pediatric acute myelogenous leukemia
459095|NCT00042380|Antidepressant|antidepressant
459096|NCT00042380|Anxiety|anxiety
459097|NCT00042380|Dopamine|dopamine
459098|NCT00042380|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
459099|NCT00042380|Affective Disorder|affective disorder
459100|NCT00042380|Phytoestrogen|phytoestrogen
459101|NCT00042380|Genistein|genistein
459102|NCT00042380|Major Depression|major depression
459103|NCT00042380|Depression|depression
459104|NCT00042393|Hepatitis B, Chronic|hepatitis b, chronic
459105|NCT00042419|Industrial Injuries|industrial injuries
459106|NCT00042419|Tendonitis|tendonitis
459107|NCT00042419|Assembly Line|assembly line
459108|NCT00042445|Neoplasm|neoplasm
459109|NCT00042445|Petrochemical|petrochemical
459110|NCT00042445|Leukemia|leukemia
459111|NCT00042445|Taiwan|taiwan
459112|NCT00042484|Asthma|asthma
459113|NCT00042484|Children's Health|children's health
459114|NCT00042484|Community Based Research|community based research
459115|NCT00042510|Gastroesophageal cancer|gastroesophageal cancer
459116|NCT00042510|Gastric cancer|gastric cancer
459117|NCT00042523|Autoantibody|autoantibody
459118|NCT00042523|Anti-DNA Antibody|anti-dna antibody
459119|NCT00042523|Cross-Reactivity|cross-reactivity
459120|NCT00042523|Neuron Loss|neuron loss
459121|NCT00042523|Imaging|imaging
459122|NCT00042523|Lupus|lupus
459123|NCT00042523|SLE|sle
459124|NCT00042523|Systemic Lupus Erythematosus|systemic lupus erythematosus
459125|NCT00042536|Yohimbine|yohimbine
459126|NCT00042536|Naltrexone|naltrexone
459127|NCT00042536|Sexual Function|sexual function
459128|NCT00042536|Erectile Dysfunction|erectile dysfunction
459129|NCT00042536|Alpha-2 Adrenoreceptor|alpha-2 adrenoreceptor
459130|NCT00042536|Opiate Receptor|opiate receptor
459131|NCT00042536|Male Impotence|male impotence
459132|NCT00042536|ED|ed
459133|NCT00042536|Healthy Volunteer|healthy volunteer
459134|NCT00042536|HV|hv
459135|NCT00042536|Normal Control|normal control
459136|NCT00042549|Gallstones|gallstones
459137|NCT00042549|Gallstone|gallstone
459138|NCT00042549|Biliary stones|biliary stones
459139|NCT00042549|Gallbladder stones|gallbladder stones
459140|NCT00042549|Gallbladder|gallbladder
459141|NCT00042549|Lithotripsy|lithotripsy
459142|NCT00042549|Cholelithiasis|cholelithiasis
459143|NCT00042549|ESWL|eswl
459144|NCT00042549|Shock wave|shock wave
459145|NCT00042549|Shock waves|shock waves
459146|NCT00042549|shockwaves|shockwaves
459147|NCT00042549|shockwave|shockwave
459148|NCT00042562|Depressed|depressed
459149|NCT00042562|blues|blues
459150|NCT00042562|sadness|sadness
459151|NCT00042562|feelings of guilt|feelings of guilt
459152|NCT00042562|hopelessness|hopelessness
459153|NCT00042562|lack of energy|lack of energy
459154|NCT00042575|Sad, blue, lack of energy, depressed, hopelessness, guilt|sad, blue, lack of energy, depressed, hopelessness, guilt
459155|NCT00042588|Safety and Efficacy|safety and efficacy
459156|NCT00042588|Community-Acquired Pneumonia, Sepsis|community-acquired pneumonia, sepsis
458461|NCT00038831|AML|aml
459157|NCT00042614|Genes|genes
459158|NCT00042614|Heart|heart
459159|NCT00042614|Lymphocytes|lymphocytes
459160|NCT00042614|Proteomics|proteomics
459161|NCT00042614|Transplant|transplant
459162|NCT00042614|Heart Transplant|heart transplant
459163|NCT00042614|Healthy Volunteer|healthy volunteer
459164|NCT00042614|HV|hv
459165|NCT00042614|Normal Control|normal control
459167|NCT00042627|Granulocytapheresis|granulocytapheresis
459168|NCT00042627|Granulocyte Donors|granulocyte donors
459169|NCT00042679|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
459171|NCT00042679|Carcinoma Squamous|carcinoma squamous
459172|NCT00042679|Adult Lung Cancer|adult lung cancer
459173|NCT00042692|catechol thioethers|catechol thioethers
459174|NCT00042692|Parkinson's disease|parkinson's disease
459175|NCT00042692|neurodegenerative disease|neurodegenerative disease
459176|NCT00042705|asthma|asthma
459177|NCT00042705|indoor allergens|indoor allergens
459178|NCT00042718|Chronic Bronchitis|chronic bronchitis
459179|NCT00042718|Acute Bacterial Exacerbation of Chronic Bronchitis|acute bacterial exacerbation of chronic bronchitis
459180|NCT00042731|stage I prostate cancer|stage i prostate cancer
459181|NCT00042731|stage IIB prostate cancer|stage iib prostate cancer
459182|NCT00042731|stage IIA prostate cancer|stage iia prostate cancer
459183|NCT00042770|malignant pleural effusion|malignant pleural effusion
459184|NCT00042770|pulmonary complications|pulmonary complications
459185|NCT00042783|stage IV melanoma|stage iv melanoma
459186|NCT00042783|recurrent melanoma|recurrent melanoma
459187|NCT00042822|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
459188|NCT00042822|refractory anemia with excess blasts|refractory anemia with excess blasts
459189|NCT00042822|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
459190|NCT00042822|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
459191|NCT00042822|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
459192|NCT00042822|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
459193|NCT00042822|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
459194|NCT00042822|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
459195|NCT00042822|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
459196|NCT00042822|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
459197|NCT00042822|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
459198|NCT00042822|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
459199|NCT00042822|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
459200|NCT00042822|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
459201|NCT00042822|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
459202|NCT00042822|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
459203|NCT00042822|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
459204|NCT00042822|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
459205|NCT00042822|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
459206|NCT00042822|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
459208|NCT00042848|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
459209|NCT00042861|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
459210|NCT00042887|stage 0 bladder cancer|stage 0 bladder cancer
459211|NCT00042887|stage I bladder cancer|stage i bladder cancer
459212|NCT00042887|recurrent bladder cancer|recurrent bladder cancer
459213|NCT00042887|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
459214|NCT00042900|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
459215|NCT00042900|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
459216|NCT00042900|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
459217|NCT00042900|Waldenström macroglobulinemia|waldenström macroglobulinemia
459218|NCT00042900|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
459219|NCT00042900|acute undifferentiated leukemia|acute undifferentiated leukemia
459220|NCT00042900|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
459221|NCT00042900|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
459222|NCT00042900|primary myelofibrosis|primary myelofibrosis
459223|NCT00042900|anaplastic large cell lymphoma|anaplastic large cell lymphoma
459224|NCT00042900|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
459225|NCT00042900|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
459226|NCT00042900|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
459227|NCT00042900|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
459228|NCT00042900|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
459229|NCT00042900|essential thrombocythemia|essential thrombocythemia
459230|NCT00042900|extramedullary plasmacytoma|extramedullary plasmacytoma
459231|NCT00042900|intraocular lymphoma|intraocular lymphoma
459232|NCT00042900|isolated plasmacytoma of bone|isolated plasmacytoma of bone
459233|NCT00042900|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
459234|NCT00042900|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
459235|NCT00042900|polycythemia vera|polycythemia vera
459236|NCT00042900|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
459237|NCT00042900|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
459238|NCT00042900|primary systemic amyloidosis|primary systemic amyloidosis
459239|NCT00042900|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
459240|NCT00042900|prolymphocytic leukemia|prolymphocytic leukemia
459241|NCT00042900|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
459242|NCT00042900|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
459243|NCT00042900|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
459244|NCT00042900|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
459245|NCT00042900|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
459246|NCT00042900|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
459247|NCT00042900|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
459248|NCT00042900|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
459249|NCT00042900|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
459250|NCT00042900|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
459251|NCT00042900|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
459252|NCT00042900|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
459253|NCT00042900|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
459254|NCT00042900|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
459255|NCT00042900|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
459256|NCT00042900|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
476987|NCT00088309|HIV|hiv
459257|NCT00042900|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
459258|NCT00042900|refractory hairy cell leukemia|refractory hairy cell leukemia
459259|NCT00042900|refractory multiple myeloma|refractory multiple myeloma
459260|NCT00042900|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
459261|NCT00042900|secondary acute myeloid leukemia|secondary acute myeloid leukemia
459262|NCT00042900|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
459263|NCT00042900|small intestine lymphoma|small intestine lymphoma
459264|NCT00042900|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
459265|NCT00042900|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
459266|NCT00042900|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
459267|NCT00042900|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
459268|NCT00042900|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
459269|NCT00042900|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
459270|NCT00042900|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
459271|NCT00042900|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
459272|NCT00042900|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
459273|NCT00042900|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
459274|NCT00042900|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
459275|NCT00042900|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
459276|NCT00042900|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
459277|NCT00042900|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
459278|NCT00042900|stage III multiple myeloma|stage iii multiple myeloma
459279|NCT00042900|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
459280|NCT00042900|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
459281|NCT00042900|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
459282|NCT00042900|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
459283|NCT00042900|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
459284|NCT00042900|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
459285|NCT00042900|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
459286|NCT00042900|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
459287|NCT00042900|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
459288|NCT00042900|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
459289|NCT00042900|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
459290|NCT00042900|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
459291|NCT00042900|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
459292|NCT00042900|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
459293|NCT00042900|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
752455|NCT01173068|Ertapenem|ertapenem
459294|NCT00042900|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
459295|NCT00042900|untreated hairy cell leukemia|untreated hairy cell leukemia
459296|NCT00042900|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
459297|NCT00042900|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
583602|NCT00512343|Paired serum/synovial fluid samples|paired serum/synovial fluid samples
459298|NCT00042900|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
459299|NCT00042900|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
459300|NCT00042900|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
459301|NCT00042900|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
459302|NCT00042900|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
459303|NCT00042900|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
459304|NCT00042900|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
459305|NCT00042900|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
459306|NCT00042900|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
459307|NCT00042900|splenic marginal zone lymphoma|splenic marginal zone lymphoma
459308|NCT00042913|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
459309|NCT00042926|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
459310|NCT00042926|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
459311|NCT00042939|pancreatic cancer|pancreatic cancer
459312|NCT00042939|metastatic pancreatic cancer|metastatic pancreatic cancer
459313|NCT00042939|EGF-r|egf-r
459314|NCT00042939|irinotecan|irinotecan
459315|NCT00042939|docetaxel|docetaxel
459316|NCT00042939|cetuximab|cetuximab
459317|NCT00042965|recurrent renal cell cancer|recurrent renal cell cancer
459318|NCT00042965|stage IV renal cell cancer|stage iv renal cell cancer
459319|NCT00043004|liver metastases|liver metastases
459320|NCT00043004|stage IV colon cancer|stage iv colon cancer
459321|NCT00043004|stage IV rectal cancer|stage iv rectal cancer
459322|NCT00043017|stage IIIA breast cancer|stage iiia breast cancer
459323|NCT00043017|stage IIIB breast cancer|stage iiib breast cancer
459324|NCT00043017|stage IIIC breast cancer|stage iiic breast cancer
459325|NCT00043030|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
459326|NCT00043030|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
459327|NCT00043043|colorectal cancer|colorectal cancer
459328|NCT00043069|osteoporosis|osteoporosis
459329|NCT00043069|stage I prostate cancer|stage i prostate cancer
459330|NCT00043069|stage IIB prostate cancer|stage iib prostate cancer
459331|NCT00043069|stage IIA prostate cancer|stage iia prostate cancer
459332|NCT00043069|stage III prostate cancer|stage iii prostate cancer
459333|NCT00043082|peritoneal cavity cancer|peritoneal cavity cancer
459334|NCT00043082|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
459335|NCT00043082|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
459336|NCT00043082|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
459337|NCT00043095|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
459338|NCT00043108|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
459339|NCT00043108|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
459340|NCT00043108|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
459341|NCT00043134|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
459342|NCT00043134|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
459343|NCT00043134|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
459344|NCT00043134|refractory anemia|refractory anemia
459345|NCT00043134|refractory anemia with excess blasts|refractory anemia with excess blasts
459346|NCT00043134|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
459347|NCT00043134|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
459348|NCT00043134|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
459349|NCT00043134|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
459350|NCT00043134|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
459351|NCT00043134|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
459352|NCT00043147|graft versus host disease|graft versus host disease
459353|NCT00043186|bone loss|bone loss
459354|NCT00043186|osteoporosis|osteoporosis
459355|NCT00043199|Colorectal Neoplasms|colorectal neoplasms
459356|NCT00043199|Colorectal Cancer|colorectal cancer
459357|NCT00043199|Colorectal Carcinoma|colorectal carcinoma
459358|NCT00043199|Colorectal Tumor|colorectal tumor
459359|NCT00043199|Neoplasms, Colorectal|neoplasms, colorectal
459360|NCT00043199|Unresectable|unresectable
459361|NCT00043199|Metastatic|metastatic
459362|NCT00043199|Refractory|refractory
459363|NCT00043212|prostate cancer|prostate cancer
459364|NCT00043212|oncology|oncology
459365|NCT00043212|urology|urology
588819|NCT00525655|FAP|fap
458697|NCT00027365|AIDS Vaccines|aids vaccines
459366|NCT00043212|hormone refractory prostate cancer|hormone refractory prostate cancer
459367|NCT00043225|Type III Secretion Pathways|type iii secretion pathways
459368|NCT00043225|Exotoxin A Polymorphisms|exotoxin a polymorphisms
459369|NCT00043225|Cystic Fibrosis and Pseudomonas Aeruginosa|cystic fibrosis and pseudomonas aeruginosa
459370|NCT00043225|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
583603|NCT00512369|Metabolic pathways|metabolic pathways
459371|NCT00043225|Severe Combined Immune Deficiency|severe combined immune deficiency
459372|NCT00043225|SCID|scid
459373|NCT00043225|ADA-SCID|ada-scid
459374|NCT00043225|Immune Deficiency|immune deficiency
459375|NCT00043238|PCBs|pcbs
459376|NCT00043238|Thyroid|thyroid
459377|NCT00043238|Hyperactivity|hyperactivity
459378|NCT00043238|School Performance|school performance
459379|NCT00043238|Mohawk Tribe|mohawk tribe
459380|NCT00043277|neonates|neonates
459381|NCT00043277|thrombosis|thrombosis
459382|NCT00043277|bivalirudin|bivalirudin
459383|NCT00043277|direct thrombin inhibitor|direct thrombin inhibitor
459384|NCT00043303|hepatitis C|hepatitis c
459385|NCT00043303|liver fibrosis|liver fibrosis
459386|NCT00043303|liver cirrhosis|liver cirrhosis
459387|NCT00043316|cystic fibrosis|cystic fibrosis
459388|NCT00043316|pulmonary impairment|pulmonary impairment
459389|NCT00043329|Registry|registry
459390|NCT00043329|Actimmune|actimmune
459391|NCT00043329|osteopetrosis|osteopetrosis
459392|NCT00043342|cystic fibrosis|cystic fibrosis
459393|NCT00043342|pulmonary impairment|pulmonary impairment
459394|NCT00043355|pulmonary|pulmonary
459395|NCT00043355|mycobacterium avium complex infection|mycobacterium avium complex infection
459396|NCT00043355|MAC|mac
459397|NCT00043355|nontuberculous|nontuberculous
459398|NCT00043355|mycobacteria|mycobacteria
459399|NCT00043355|lung|lung
459400|NCT00043368|CPG 7909 continuation study|cpg 7909 continuation study
459401|NCT00043381|myelodysplastic syndrome|myelodysplastic syndrome
459402|NCT00043381|MDS|mds
459403|NCT00043381|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
459404|NCT00043381|CMML|cmml
459405|NCT00043381|decitabine|decitabine
459406|NCT00043381|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
459512|NCT00043810|Peripheral Stem Cell|peripheral stem cell
476988|NCT00088309|Pediatrics|pediatrics
459407|NCT00043394|CpG 7909 subcutaneous injection combination with Herceptin® metastatic breast cancer.|cpg 7909 subcutaneous injection combination with herceptin® metastatic breast cancer.
459408|NCT00043407|Renal Cell Carcinoma, Phase I, Phase II, Immunotherapy|renal cell carcinoma, phase i, phase ii, immunotherapy
459409|NCT00043420|immunotherapy, lymphoma|immunotherapy, lymphoma
459410|NCT00043433|HCC|hcc
459411|NCT00043459|NHL|nhl
459412|NCT00043472|Screening|screening
459413|NCT00043472|Oophorectomy|oophorectomy
459414|NCT00043472|Hereditary|hereditary
459415|NCT00043472|Genetics|genetics
459416|NCT00043472|Cancer|cancer
459417|NCT00043472|Ovarian Cancer|ovarian cancer
459418|NCT00043472|Ovarian Cancer Risk|ovarian cancer risk
459419|NCT00043498|Pollutants|pollutants
459420|NCT00043511|Injections, Intramuscular|injections, intramuscular
459421|NCT00043511|HIV Seronegativity|hiv seronegativity
459422|NCT00043511|Plasmids|plasmids
459423|NCT00043511|Vaccines, DNA|vaccines, dna
459424|NCT00043511|HIV Preventive Vaccine|hiv preventive vaccine
459425|NCT00043537|Phobic Disorders|phobic disorders
459426|NCT00043537|Mutism|mutism
459427|NCT00043550|Major Depressive Disorder|major depressive disorder
459428|NCT00043563|Cognitive-behavior Therapy|cognitive-behavior therapy
459429|NCT00043563|Minimal Attention Control|minimal attention control
459430|NCT00043576|Prostate Cancer|prostate cancer
459431|NCT00043576|Androgen Independent Prostate Cancer|androgen independent prostate cancer
459432|NCT00043589|Memory|memory
459433|NCT00043615|Angiogenesis|angiogenesis
459434|NCT00043615|Drug Resistance|drug resistance
459435|NCT00043615|Signal Transduction|signal transduction
459436|NCT00043615|EGFR|egfr
459437|NCT00043615|Survival Factors|survival factors
459438|NCT00043615|Malignancy|malignancy
459439|NCT00043615|Pre-Cancer Condition|pre-cancer condition
459440|NCT00043615|Cancer Risk|cancer risk
459441|NCT00043628|Progenitor Cells|progenitor cells
459442|NCT00043628|MRI|mri
459443|NCT00043628|Coronary Blood Flow|coronary blood flow
459444|NCT00043628|Hematopoiesis|hematopoiesis
459445|NCT00043628|Myocardial Contractility|myocardial contractility
459446|NCT00043628|Coronary Artery Disease|coronary artery disease
459447|NCT00043628|CAD|cad
459448|NCT00043628|Heart Disease|heart disease
459449|NCT00043641|RT PCR|rt pcr
459450|NCT00043641|Antiretrovial Therapy|antiretrovial therapy
459451|NCT00043641|Drug Intensification|drug intensification
459452|NCT00043641|Ultra-low|ultra-low
459453|NCT00043641|Sequence|sequence
459454|NCT00043641|HIV|hiv
459455|NCT00043641|Treatment Experienced|treatment experienced
459456|NCT00043654|Antidepressant|antidepressant
459457|NCT00043654|Manic-Depressive Disorder|manic-depressive disorder
459458|NCT00043654|Cortisol|cortisol
459459|NCT00043654|Neuroendocrine|neuroendocrine
459460|NCT00043654|Cognition|cognition
459461|NCT00043654|Bipolar|bipolar
459462|NCT00043654|Bipolar Disorder|bipolar disorder
459463|NCT00043654|BPD|bpd
459464|NCT00043654|HV|hv
459465|NCT00043667|Interleukin 2|interleukin 2
459466|NCT00043667|IL-2 Receptor|il-2 receptor
459467|NCT00043667|Anti-CD25|anti-cd25
459468|NCT00043667|Anti-Tac|anti-tac
459469|NCT00043667|Anti-IL-2R|anti-il-2r
459470|NCT00043667|Uveitis|uveitis
459471|NCT00043667|Daclizumab|daclizumab
459472|NCT00043667|Inflammatory Eye DIsease|inflammatory eye disease
459473|NCT00043680|Classic|classic
459474|NCT00043680|Occult|occult
459475|NCT00043680|Neovascular|neovascular
459476|NCT00043680|Celecoxib|celecoxib
459477|NCT00043680|Age-Related Macular Degeneration|age-related macular degeneration
459478|NCT00043680|Photodynamic Therapy|photodynamic therapy
459479|NCT00043680|Choroidal Neovascularization|choroidal neovascularization
459480|NCT00043680|Cyclooxygenase 2|cyclooxygenase 2
459481|NCT00043680|Macular Degeneration|macular degeneration
459482|NCT00043680|AMD|amd
459483|NCT00043680|Age Related Macular Degeneration|age related macular degeneration
459484|NCT00043693|Psychotic Disorders|psychotic disorders
459485|NCT00043693|Schizoaffective Disorder|schizoaffective disorder
459486|NCT00043693|Substance Abuse|substance abuse
459487|NCT00043719|Human Female|human female
459488|NCT00043719|Osteoporosis|osteoporosis
459489|NCT00043719|Postmenopausal|postmenopausal
459490|NCT00043719|Nitric Oxide|nitric oxide
459491|NCT00043719|Nitroglycerin|nitroglycerin
459492|NCT00043719|Calcium|calcium
459493|NCT00043719|Vitamin D|vitamin d
459494|NCT00043732|Rheumatoid arthritis|rheumatoid arthritis
459495|NCT00043732|Scio-469|scio-469
459496|NCT00043745|soy|soy
459497|NCT00043745|isoflavones|isoflavones
459498|NCT00043745|alternative hormone therapy|alternative hormone therapy
459499|NCT00043745|bone loss|bone loss
459500|NCT00043758|CHF|chf
459501|NCT00043771|CHF|chf
459502|NCT00043784|Acute coronary syndromes|acute coronary syndromes
459503|NCT00043784|non-ST-segment elevation|non-st-segment elevation
459504|NCT00043797|ARI|ari
459505|NCT00043797|Diabetic polyneuropathy|diabetic polyneuropathy
459506|NCT00043797|Diabetic complications|diabetic complications
459507|NCT00043810|AML|aml
459508|NCT00043810|MDS|mds
459509|NCT00043810|Gelonin|gelonin
459510|NCT00043810|Purging|purging
459513|NCT00043823|Non-Small Cell Lung Cancer|non-small cell lung cancer
459514|NCT00043823|NSCLC|nsclc
459515|NCT00043823|Lung Cancer|lung cancer
459516|NCT00043823|Avastin|avastin
459517|NCT00043823|Bevacizumab|bevacizumab
459518|NCT00043823|rhuMAb VEGF|rhumab vegf
459519|NCT00043823|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
459520|NCT00043823|Tarceva|tarceva
459521|NCT00043823|OSI-774|osi-774
459522|NCT00043823|Erlotinib Hydrocholoride|erlotinib hydrocholoride
459523|NCT00043836|ejection fraction|ejection fraction
459524|NCT00043836|exercise tolerance|exercise tolerance
459525|NCT00043836|heart failure, congestive|heart failure, congestive
459526|NCT00043836|quality of life|quality of life
459527|NCT00043849|Psychosis|psychosis
459528|NCT00043849|Agitation, Psychomotor|agitation, psychomotor
459529|NCT00043862|Hycamtin|hycamtin
459530|NCT00043862|oral|oral
459531|NCT00043862|Radiation Sensitization|radiation sensitization
459532|NCT00043862|Small Cell Lung Cancer|small cell lung cancer
459533|NCT00043862|newly diagnosed|newly diagnosed
459534|NCT00043862|limited stage|limited stage
459535|NCT00043862|topotecan|topotecan
459536|NCT00030888|stage III renal cell cancer|stage iii renal cell cancer
459537|NCT00030888|stage IV renal cell cancer|stage iv renal cell cancer
459538|NCT00030888|recurrent renal cell cancer|recurrent renal cell cancer
459539|NCT00030901|prostate cancer|prostate cancer
459540|NCT00030901|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
459541|NCT00030914|hot flashes|hot flashes
459542|NCT00030940|Antigenic Epitopes|antigenic epitopes
459543|NCT00030940|Glutamic Acid Decarboxylase (GAD)|glutamic acid decarboxylase (gad)
459544|NCT00030940|Auto-antibodies|auto-antibodies
459545|NCT00030940|Stiffness Index|stiffness index
459546|NCT00030940|SPS|sps
459547|NCT00030940|Anti-GAD|anti-gad
459548|NCT00030940|MR Spectroscopy|mr spectroscopy
459549|NCT00030940|GAD|gad
459550|NCT00030940|Stiff Person Syndrome|stiff person syndrome
459551|NCT00030953|Tourette's Syndrome|tourette's syndrome
459552|NCT00030953|GABA|gaba
459553|NCT00030953|NAA|naa
459554|NCT00030953|Choline|choline
459555|NCT00030953|Creatine|creatine
459556|NCT00030953|Tourette Syndrome|tourette syndrome
459557|NCT00030953|Healthy Volunteer|healthy volunteer
459558|NCT00030953|HV|hv
459559|NCT00030953|Normal Control|normal control
459560|NCT00030966|Multiple Sclerosis|multiple sclerosis
459561|NCT00030966|MS|ms
459562|NCT00030979|Mild Dementia|mild dementia
459563|NCT00030979|Acetylcholine|acetylcholine
459564|NCT00030979|Memory|memory
459565|NCT00030979|Hallucinations|hallucinations
459566|NCT00030979|Washout|washout
459567|NCT00030979|Parkinson Disease|parkinson disease
459568|NCT00030979|Parkinson's Disease|parkinson's disease
459569|NCT00030979|PD|pd
459570|NCT00030979|Dementia|dementia
459571|NCT00030992|Epothilone B|epothilone b
459572|NCT00030992|Ixabepilone|ixabepilone
459573|NCT00030992|Renal Cell Carcinoma|renal cell carcinoma
459574|NCT00030992|Kidney Cancer|kidney cancer
459575|NCT00031005|Non-Myeloablative|non-myeloablative
459576|NCT00031005|Campath 1-H|campath 1-h
459577|NCT00031005|Fludarabine|fludarabine
459578|NCT00031005|Immunodeficiency|immunodeficiency
459579|NCT00031005|Infection|infection
459580|NCT00031005|Leukocyte Adhesion Deficiency|leukocyte adhesion deficiency
459581|NCT00031005|LAD|lad
459582|NCT00031018|Inflammation|inflammation
459583|NCT00031018|immunosenescence|immunosenescence
459584|NCT00031018|autoimmunity|autoimmunity
459585|NCT00031018|atherosclerosis|atherosclerosis
459586|NCT00031018|pro-inflammatory cytokines|pro-inflammatory cytokines
459587|NCT00031018|Hayflick phenomenon|hayflick phenomenon
459588|NCT00031031|MTD|mtd
459589|NCT00031031|Safety|safety
459590|NCT00031031|Pharmacokinetics|pharmacokinetics
459591|NCT00031031|Efficacy|efficacy
459592|NCT00031044|HIV-1|hiv-1
459593|NCT00031044|Drug Therapy, Combination|drug therapy, combination
459594|NCT00031044|RNA, Viral|rna, viral
459595|NCT00031044|Salvage Therapy|salvage therapy
459596|NCT00031044|Anti-HIV Agents|anti-hiv agents
459597|NCT00031044|Viral Load|viral load
459598|NCT00031044|Purines|purines
459599|NCT00031044|T-20 Peptide|t-20 peptide
459600|NCT00031044|ABT 378|abt 378
459601|NCT00031044|Treatment Experienced|treatment experienced
459602|NCT00031057|Administration, Oral|administration, oral
459603|NCT00031057|Blood|blood
459604|NCT00031057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
459605|NCT00031057|Riboflavin|riboflavin
459606|NCT00031057|Thiamine|thiamine
459607|NCT00031057|Vitamin B Complex|vitamin b complex
459608|NCT00031057|Lactic Acid|lactic acid
459609|NCT00031070|Zidovudine|zidovudine
459610|NCT00031070|CD4 Lymphocyte Count|cd4 lymphocyte count
459611|NCT00031070|Lamivudine|lamivudine
459612|NCT00031070|Cyclosporine|cyclosporine
459613|NCT00031070|Hepatitis A Vaccine|hepatitis a vaccine
459614|NCT00031070|Rabies Vaccine|rabies vaccine
459615|NCT00031070|abacavir|abacavir
459616|NCT00031070|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
459617|NCT00031070|efavirenz|efavirenz
459618|NCT00031070|Treatment Naive|treatment naive
459622|NCT00031083|Gene Therapy|gene therapy
459623|NCT00031083|Biogen|biogen
459624|NCT00031096|Acne Vulgaris|acne vulgaris
459625|NCT00031096|Propionibacterium acnes|propionibacterium acnes
459626|NCT00031109|HIV Antibodies|hiv antibodies
459627|NCT00031109|HIV-1|hiv-1
459628|NCT00031109|HIV Envelope Protein gp160|hiv envelope protein gp160
459629|NCT00031109|Adjuvants, Immunologic|adjuvants, immunologic
459630|NCT00031109|AIDS Vaccines|aids vaccines
459631|NCT00031109|CD4 Lymphocyte Count|cd4 lymphocyte count
459632|NCT00031109|Disease Models, Animal|disease models, animal
459633|NCT00031109|Antibody Formation|antibody formation
459634|NCT00031109|Macaca|macaca
459635|NCT00031109|Neutralization Tests|neutralization tests
459636|NCT00031109|Viral Load|viral load
459637|NCT00031109|aluminum hydroxide|aluminum hydroxide
459638|NCT00031109|HIV Preventive Vaccine|hiv preventive vaccine
459639|NCT00031122|Genetic Predisposition to Disease|genetic predisposition to disease
459640|NCT00031122|Environmental Exposure|environmental exposure
459641|NCT00031122|Chromosome Mapping|chromosome mapping
459642|NCT00031122|Data Collection|data collection
459643|NCT00031135|Parenteral Nutrition, Total|parenteral nutrition, total
459644|NCT00031135|Lipotropic Agents|lipotropic agents
459645|NCT00031135|Choline|choline
459646|NCT00031148|Keratinocyte growth factor|keratinocyte growth factor
459647|NCT00031148|Bone Marrow Transplantation|bone marrow transplantation
459648|NCT00031148|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
459649|NCT00031148|HLA Antigens|hla antigens
459650|NCT00031148|Transplantation, Homologous|transplantation, homologous
459651|NCT00031148|Recombinant Proteins|recombinant proteins
459652|NCT00031161|Tyrosine|tyrosine
459653|NCT00031161|Diet|diet
459654|NCT00031161|2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione|2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione
459655|NCT00031161|4-Hydroxyphenylpyruvate Dioxygenase|4-hydroxyphenylpyruvate dioxygenase
459656|NCT00031161|Enzyme Inhibitors|enzyme inhibitors
459657|NCT00031174|Apheresis|apheresis
459658|NCT00031174|Healthy Volunteer|healthy volunteer
459659|NCT00031174|Rheumatoid Disease|rheumatoid disease
459660|NCT00031174|Rheumatic Disease|rheumatic disease
459661|NCT00031174|Lupus|lupus
459662|NCT00031174|Rheumatoid Arthritis|rheumatoid arthritis
459663|NCT00031174|Myositis|myositis
459664|NCT00031174|HV|hv
459665|NCT00031174|Normal Control|normal control
459666|NCT00031187|Prostate|prostate
459667|NCT00031187|Lewis Blood-Group System|lewis blood-group system
589199|NCT00526721|Crestor|crestor
459668|NCT00031187|Antibodies, Monoclonal|antibodies, monoclonal
459669|NCT00031187|Antigens, Neoplasm|antigens, neoplasm
459670|NCT00031187|Antineoplastic Agents|antineoplastic agents
459671|NCT00031265|stroke|stroke
459672|NCT00031265|telephone|telephone
459673|NCT00031265|intervention|intervention
459674|NCT00031278|Metastatic|metastatic
459675|NCT00031278|Breast|breast
459676|NCT00031278|Cancer|cancer
459677|NCT00031278|immunotherapy|immunotherapy
459678|NCT00031278|CPG 7909|cpg 7909
459679|NCT00031291|Anthrax|anthrax
459680|NCT00031291|Immune Globulin|immune globulin
459681|NCT00031291|Plasmapheresis|plasmapheresis
459682|NCT00031291|Vaccine|vaccine
459683|NCT00031304|HIV|hiv
459684|NCT00031304|AIDS|aids
459685|NCT00031304|Vaccine|vaccine
459686|NCT00031304|Screening|screening
459687|NCT00031304|Prevention|prevention
459688|NCT00031304|HV|hv
459689|NCT00031304|Healthy Volunteer|healthy volunteer
459690|NCT00031304|Volunteer|volunteer
459691|NCT00031304|HIV Seronegativity|hiv seronegativity
459692|NCT00031304|HIV Preventive Vaccine|hiv preventive vaccine
459694|NCT00031317|Treatment|treatment
459695|NCT00031317|Antidepressant|antidepressant
459696|NCT00031317|Benzodiazepine (clonazepam)|benzodiazepine (clonazepam)
459697|NCT00031317|SSRI (paroxetine)|ssri (paroxetine)
459698|NCT00031317|Combined Treatment|combined treatment
459699|NCT00031317|Panic Disorder (PD)|panic disorder (pd)
459700|NCT00031317|Panic Disorder|panic disorder
459701|NCT00031317|PD|pd
459702|NCT00031343|Liver Disease|liver disease
459703|NCT00031343|Virologic Response|virologic response
459704|NCT00031343|Immune Mechanisms|immune mechanisms
459705|NCT00031343|Eradication|eradication
459706|NCT00031343|Antiviral Therapy|antiviral therapy
459707|NCT00031343|HIV|hiv
459708|NCT00031343|Hepatitis C|hepatitis c
459709|NCT00031343|HCV|hcv
459710|NCT00031343|Coinfection|coinfection
459711|NCT00031369|MRI|mri
459712|NCT00031369|Writer's Cramp|writer's cramp
459713|NCT00031369|Movement Disorder|movement disorder
459714|NCT00031369|Gray Matter|gray matter
459715|NCT00031369|Brain Morphology|brain morphology
459716|NCT00031369|Dystonia|dystonia
459717|NCT00031369|Focal Hand Dystonia|focal hand dystonia
459718|NCT00031369|Healthy Volunteer|healthy volunteer
459719|NCT00031369|HV|hv
459720|NCT00031369|Normal Control|normal control
459721|NCT00031382|Functional MRI|functional mri
459722|NCT00031382|Dual Task|dual task
459723|NCT00031382|Neural Activation|neural activation
459724|NCT00031382|Basal Ganglia|basal ganglia
459725|NCT00031382|Cerebellum|cerebellum
477098|NCT00088686|Orofacial|orofacial
459726|NCT00031382|Healthy Volunteer|healthy volunteer
459727|NCT00031382|HV|hv
459728|NCT00031382|Normal Control|normal control
459729|NCT00031395|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
459730|NCT00031395|ADHD|adhd
459731|NCT00031395|clonidine|clonidine
459732|NCT00031395|methylphenidate|methylphenidate
459733|NCT00031395|MPH|mph
459734|NCT00031408|Specimen Handling|specimen handling
459736|NCT00031408|Informed Consent|informed consent
459737|NCT00031408|Genetic Screening|genetic screening
459738|NCT00031421|CMV, cytomegalovirus, children, ganciclovir|cmv, cytomegalovirus, children, ganciclovir
459739|NCT00031434|Valganciclovir, congenital cytomegalovirus, ganciclovir|valganciclovir, congenital cytomegalovirus, ganciclovir
459740|NCT00031447|Herpes Simplex, Acyclovir, Infants|herpes simplex, acyclovir, infants
459741|NCT00031460|acyclovir, central nervous system, Herpes Simplex Virus|acyclovir, central nervous system, herpes simplex virus
459742|NCT00031473|Ribavirin|ribavirin
459743|NCT00031473|RSV|rsv
459744|NCT00031486|encephalitis, herpes simplex, valacyclovir|encephalitis, herpes simplex, valacyclovir
459745|NCT00031499|Azithromycin, Syphilis, Penicillin|azithromycin, syphilis, penicillin
459746|NCT00031512|enterovirus, enteroviral sepsis, Pleconaril, infants|enterovirus, enteroviral sepsis, pleconaril, infants
459747|NCT00031538|Brain Tumor|brain tumor
459748|NCT00031538|Surgery|surgery
459749|NCT00031538|Molecular|molecular
459750|NCT00031538|Glioma|glioma
459751|NCT00031538|Intraoperative|intraoperative
459752|NCT00031538|Gliomas|gliomas
459753|NCT00031551|Stomatitis|stomatitis
459754|NCT00031551|Oropharyngeal pain|oropharyngeal pain
459755|NCT00031551|TNF|tnf
459756|NCT00031551|Etanercept|etanercept
459757|NCT00031551|Bone marrow transplantation|bone marrow transplantation
459758|NCT00031551|Chemotherapy|chemotherapy
459759|NCT00031551|Cancer|cancer
459760|NCT00031551|Oral cavity|oral cavity
459761|NCT00031551|Oral mucous membranes|oral mucous membranes
459762|NCT00031551|Randomized controlled clinical trial|randomized controlled clinical trial
459763|NCT00031551|Inflammation|inflammation
459764|NCT00031564|stage IV|stage iv
459765|NCT00031564|renal cell carcinoma|renal cell carcinoma
459766|NCT00031577|untreated childhood brain stem glioma|untreated childhood brain stem glioma
459767|NCT00031590|untreated childhood medulloblastoma|untreated childhood medulloblastoma
459768|NCT00031590|PNET|pnet
459769|NCT00031590|craniospinal radiotherapy|craniospinal radiotherapy
459770|NCT00031616|stage IV colon cancer|stage iv colon cancer
459771|NCT00031616|stage IV rectal cancer|stage iv rectal cancer
459772|NCT00031616|recurrent colon cancer|recurrent colon cancer
459773|NCT00031616|recurrent rectal cancer|recurrent rectal cancer
459774|NCT00031616|adenocarcinoma of the colon|adenocarcinoma of the colon
459775|NCT00031616|adenocarcinoma of the rectum|adenocarcinoma of the rectum
459776|NCT00031642|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
459777|NCT00031642|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
459778|NCT00031642|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
459779|NCT00031642|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
459780|NCT00031642|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
459781|NCT00031642|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
459782|NCT00031642|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
459783|NCT00031642|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
459784|NCT00031642|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
459785|NCT00031642|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
459786|NCT00031642|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
459787|NCT00031642|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
459788|NCT00031642|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
459789|NCT00031642|splenic marginal zone lymphoma|splenic marginal zone lymphoma
459790|NCT00031668|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
459791|NCT00031668|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
459792|NCT00031668|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
459793|NCT00031668|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
459794|NCT00031668|anaplastic large cell lymphoma|anaplastic large cell lymphoma
459795|NCT00031707|anorexia|anorexia
459796|NCT00031707|cachexia|cachexia
459797|NCT00031720|lobular breast carcinoma in situ|lobular breast carcinoma in situ
459798|NCT00031720|stage I breast cancer|stage i breast cancer
459799|NCT00031720|stage II breast cancer|stage ii breast cancer
459800|NCT00031720|stage IIIA breast cancer|stage iiia breast cancer
459801|NCT00031720|recurrent breast cancer|recurrent breast cancer
459802|NCT00031720|ductal breast carcinoma in situ|ductal breast carcinoma in situ
459803|NCT00031720|hot flashes|hot flashes
459804|NCT00031733|iris melanoma|iris melanoma
459805|NCT00031733|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
459806|NCT00031733|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
459807|NCT00031733|extraocular extension melanoma|extraocular extension melanoma
459808|NCT00031733|recurrent intraocular melanoma|recurrent intraocular melanoma
459809|NCT00031733|stage II melanoma|stage ii melanoma
459810|NCT00031733|stage III melanoma|stage iii melanoma
459811|NCT00031733|stage IV melanoma|stage iv melanoma
459812|NCT00031733|recurrent melanoma|recurrent melanoma
459813|NCT00031746|prostate cancer|prostate cancer
459814|NCT00031759|cervical cancer|cervical cancer
459815|NCT00031759|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
476830|NCT00097214|Cetuximab|cetuximab
459816|NCT00031759|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
459817|NCT00031759|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
459818|NCT00031772|recurrent breast cancer|recurrent breast cancer
459819|NCT00031772|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
459820|NCT00031785|stage I non-small cell lung cancer|stage i non-small cell lung cancer
459821|NCT00031785|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
459822|NCT00031785|limited stage small cell lung cancer|limited stage small cell lung cancer
459823|NCT00031785|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
459824|NCT00031785|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
459825|NCT00031785|anorexia|anorexia
459826|NCT00031785|cachexia|cachexia
459828|NCT00031798|depression|depression
459829|NCT00031798|quality of life|quality of life
459830|NCT00031798|cognitive/functional effects|cognitive/functional effects
459831|NCT00031798|recurrent adult brain tumor|recurrent adult brain tumor
459832|NCT00031798|adult brain stem glioma|adult brain stem glioma
459833|NCT00031798|adult glioblastoma|adult glioblastoma
459834|NCT00031798|adult tumors metastatic to brain|adult tumors metastatic to brain
459835|NCT00031798|adult anaplastic astrocytoma|adult anaplastic astrocytoma
459836|NCT00031798|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
459837|NCT00031798|adult mixed glioma|adult mixed glioma
459838|NCT00031798|adult meningioma|adult meningioma
459839|NCT00031798|adult anaplastic ependymoma|adult anaplastic ependymoma
459840|NCT00031798|adult myxopapillary ependymoma|adult myxopapillary ependymoma
459841|NCT00031798|adult ependymoblastoma|adult ependymoblastoma
459842|NCT00031798|adult pilocytic astrocytoma|adult pilocytic astrocytoma
459843|NCT00031798|adult subependymoma|adult subependymoma
459844|NCT00031798|adult grade III meningioma|adult grade iii meningioma
459166|NCT00042627|Cataracts|cataracts
459845|NCT00031798|adult giant cell glioblastoma|adult giant cell glioblastoma
459846|NCT00031798|adult gliosarcoma|adult gliosarcoma
459847|NCT00031798|adult grade II meningioma|adult grade ii meningioma
459848|NCT00031811|stage I breast cancer|stage i breast cancer
459849|NCT00031811|stage II breast cancer|stage ii breast cancer
459850|NCT00031811|stage IIIA breast cancer|stage iiia breast cancer
459851|NCT00031811|stage IIIB breast cancer|stage iiib breast cancer
459852|NCT00031811|osteoporosis|osteoporosis
459853|NCT00031811|menopausal symptoms|menopausal symptoms
459854|NCT00031824|graft versus host disease|graft versus host disease
459855|NCT00031837|thromboembolism|thromboembolism
459856|NCT00031837|stage III pancreatic cancer|stage iii pancreatic cancer
459857|NCT00031837|recurrent pancreatic cancer|recurrent pancreatic cancer
459858|NCT00031837|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
459859|NCT00031837|stage IV pancreatic cancer|stage iv pancreatic cancer
459860|NCT00031850|breast cancer|breast cancer
459861|NCT00031863|stage II colon cancer|stage ii colon cancer
459862|NCT00031863|stage III colon cancer|stage iii colon cancer
459863|NCT00031863|stage II rectal cancer|stage ii rectal cancer
459864|NCT00031863|stage III rectal cancer|stage iii rectal cancer
459865|NCT00031876|stage IV breast cancer|stage iv breast cancer
459866|NCT00031876|recurrent breast cancer|recurrent breast cancer
459867|NCT00031889|adenocarcinoma of the prostate|adenocarcinoma of the prostate
459868|NCT00031889|stage IV prostate cancer|stage iv prostate cancer
459869|NCT00031889|recurrent prostate cancer|recurrent prostate cancer
459870|NCT00031902|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
459871|NCT00031902|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
459872|NCT00031902|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
459873|NCT00031902|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
459874|NCT00031902|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
459875|NCT00031902|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
459876|NCT00031902|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
459878|NCT00031915|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
459879|NCT00031915|recurrent osteosarcoma|recurrent osteosarcoma
459880|NCT00031915|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
459881|NCT00031915|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
459882|NCT00031915|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
459883|NCT00031915|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
459884|NCT00031915|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
459885|NCT00031915|childhood fibrosarcoma|childhood fibrosarcoma
459886|NCT00031915|childhood synovial sarcoma|childhood synovial sarcoma
459887|NCT00031915|childhood liposarcoma|childhood liposarcoma
459888|NCT00031915|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
459889|NCT00031915|childhood neurofibrosarcoma|childhood neurofibrosarcoma
459890|NCT00031915|childhood angiosarcoma|childhood angiosarcoma
459891|NCT00031915|childhood malignant fibrous histiocytoma of bone|childhood malignant fibrous histiocytoma of bone
459892|NCT00031915|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
459893|NCT00031915|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
459894|NCT00031915|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
459895|NCT00031915|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
459896|NCT00031928|leptomeningeal metastases|leptomeningeal metastases
459897|NCT00031941|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
459898|NCT00031941|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
459899|NCT00031941|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
459900|NCT00031941|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
459901|NCT00031941|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
459902|NCT00031941|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
459903|NCT00031941|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
459904|NCT00031941|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
459905|NCT00031941|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
459906|NCT00031941|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
459907|NCT00031941|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
459908|NCT00031941|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
459909|NCT00031941|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
459910|NCT00031941|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
459911|NCT00031941|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
459912|NCT00031941|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
459913|NCT00031941|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
459914|NCT00031941|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
459915|NCT00031941|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
459916|NCT00031941|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
459917|NCT00031941|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
459918|NCT00031941|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
459919|NCT00031941|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
459920|NCT00031941|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
459921|NCT00031941|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
459922|NCT00031941|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
459923|NCT00031941|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
459924|NCT00031941|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
459925|NCT00031941|anaplastic large cell lymphoma|anaplastic large cell lymphoma
459926|NCT00031941|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
459927|NCT00031941|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
459928|NCT00031941|small intestine lymphoma|small intestine lymphoma
459929|NCT00031941|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
459930|NCT00031941|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
459931|NCT00031941|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
459932|NCT00031941|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
459933|NCT00031941|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
459934|NCT00031941|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
459935|NCT00031941|splenic marginal zone lymphoma|splenic marginal zone lymphoma
459936|NCT00031954|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
459937|NCT00031954|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
459938|NCT00031954|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
459939|NCT00031954|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
459941|NCT00031954|primary peritoneal cavity cancer|primary peritoneal cavity cancer
459942|NCT00031967|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
459943|NCT00031967|tumors metastatic to brain|tumors metastatic to brain
459944|NCT00031967|radiation toxicity|radiation toxicity
459945|NCT00031980|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
459946|NCT00031980|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
459947|NCT00031980|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
459948|NCT00031980|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
459949|NCT00031980|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
459950|NCT00031980|anemia|anemia
459951|NCT00031980|neutropenia|neutropenia
459952|NCT00031980|thrombocytopenia|thrombocytopenia
459953|NCT00032006|adenocarcinoma of the prostate|adenocarcinoma of the prostate
459954|NCT00032006|stage I prostate cancer|stage i prostate cancer
459955|NCT00032006|stage IIB prostate cancer|stage iib prostate cancer
459956|NCT00032006|stage IIA prostate cancer|stage iia prostate cancer
459957|NCT00032006|recurrent prostate cancer|recurrent prostate cancer
459958|NCT00032019|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
459959|NCT00032019|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
459960|NCT00032019|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
477876|NCT00100672|NeoPharm|neopharm
459961|NCT00032019|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
459962|NCT00032019|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
459963|NCT00032019|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
459964|NCT00032019|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
459965|NCT00032019|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
459966|NCT00032032|stage I non-small cell lung cancer|stage i non-small cell lung cancer
459967|NCT00032032|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
459968|NCT00032032|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
459969|NCT00032032|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
459970|NCT00032045|iris melanoma|iris melanoma
459971|NCT00032045|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
459972|NCT00032045|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
459973|NCT00032045|extraocular extension melanoma|extraocular extension melanoma
459974|NCT00032045|recurrent intraocular melanoma|recurrent intraocular melanoma
459975|NCT00032045|stage IV melanoma|stage iv melanoma
459976|NCT00032045|recurrent melanoma|recurrent melanoma
459977|NCT00032058|adenocarcinoma of the prostate|adenocarcinoma of the prostate
459978|NCT00032058|stage I prostate cancer|stage i prostate cancer
459979|NCT00032058|stage IIB prostate cancer|stage iib prostate cancer
459980|NCT00032058|stage IIA prostate cancer|stage iia prostate cancer
459981|NCT00032084|non-small cell lung cancer|non-small cell lung cancer
459982|NCT00032084|stage I non-small cell lung cancer|stage i non-small cell lung cancer
459983|NCT00032084|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
459984|NCT00032097|adult glioblastoma|adult glioblastoma
459985|NCT00032097|adult giant cell glioblastoma|adult giant cell glioblastoma
459986|NCT00032097|adult gliosarcoma|adult gliosarcoma
459987|NCT00032123|stage IV gastric cancer|stage iv gastric cancer
459988|NCT00032123|stage IV esophageal cancer|stage iv esophageal cancer
459989|NCT00032123|adenocarcinoma of the stomach|adenocarcinoma of the stomach
459990|NCT00032123|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
459991|NCT00032123|recurrent esophageal cancer|recurrent esophageal cancer
459992|NCT00032123|recurrent gastric cancer|recurrent gastric cancer
459993|NCT00032136|stage I breast cancer|stage i breast cancer
459994|NCT00032136|stage II breast cancer|stage ii breast cancer
459995|NCT00032149|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
459996|NCT00032149|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
459997|NCT00032149|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
459998|NCT00032149|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
459999|NCT00032149|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
460000|NCT00032149|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
460001|NCT00032149|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
460002|NCT00032149|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
460003|NCT00032162|stage III cervical cancer|stage iii cervical cancer
460004|NCT00032162|recurrent cervical cancer|recurrent cervical cancer
460005|NCT00032162|stage IB cervical cancer|stage ib cervical cancer
460006|NCT00032162|stage IIB cervical cancer|stage iib cervical cancer
460007|NCT00032162|stage IVB cervical cancer|stage ivb cervical cancer
460008|NCT00032162|stage IA cervical cancer|stage ia cervical cancer
460009|NCT00032162|stage IIA cervical cancer|stage iia cervical cancer
460010|NCT00032162|stage IVA cervical cancer|stage iva cervical cancer
460011|NCT00032162|stage I endometrial carcinoma|stage i endometrial carcinoma
460012|NCT00032162|stage II endometrial carcinoma|stage ii endometrial carcinoma
460013|NCT00032162|stage III endometrial carcinoma|stage iii endometrial carcinoma
460014|NCT00032162|stage IV endometrial carcinoma|stage iv endometrial carcinoma
460015|NCT00032162|recurrent endometrial carcinoma|recurrent endometrial carcinoma
460016|NCT00032162|fallopian tube cancer|fallopian tube cancer
460017|NCT00032162|stage I uterine sarcoma|stage i uterine sarcoma
460018|NCT00032162|stage II uterine sarcoma|stage ii uterine sarcoma
460019|NCT00032162|stage III uterine sarcoma|stage iii uterine sarcoma
460020|NCT00032162|stage IV uterine sarcoma|stage iv uterine sarcoma
460021|NCT00032162|recurrent uterine sarcoma|recurrent uterine sarcoma
460022|NCT00032162|ovarian sarcoma|ovarian sarcoma
460023|NCT00032162|ovarian carcinosarcoma|ovarian carcinosarcoma
460024|NCT00032175|stage III pancreatic cancer|stage iii pancreatic cancer
460025|NCT00032175|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
460026|NCT00032175|stage IV pancreatic cancer|stage iv pancreatic cancer
460028|NCT00032201|Tissue Sample|tissue sample
460029|NCT00032201|Gene Expression Profiling|gene expression profiling
460236|NCT00033189|clinical trial|clinical trial
460030|NCT00032201|Tissue Array Gene Expression|tissue array gene expression
460031|NCT00032201|Comparative Genomic Hybridization|comparative genomic hybridization
460032|NCT00032201|Breast Cancer|breast cancer
460033|NCT00032201|Breast Cancer Risk|breast cancer risk
460034|NCT00032201|Breast|breast
460035|NCT00032227|Carpal Tunnel Release|carpal tunnel release
460036|NCT00032227|MR Nerve Imaging|mr nerve imaging
460038|NCT00032240|Biomechanics|biomechanics
460039|NCT00032305|Colitis|colitis
460040|NCT00032305|Gastrointestinal Disease|gastrointestinal disease
460041|NCT00032305|Digestive System Disease|digestive system disease
460042|NCT00032305|Intestinal Disease|intestinal disease
460043|NCT00032305|Colonic Disease|colonic disease
460044|NCT00032331|PET imaging, benign and malignant solitary pulmonary nodules|pet imaging, benign and malignant solitary pulmonary nodules
460045|NCT00032344|large (>1 cm) adenomas|large (>1 cm) adenomas
460046|NCT00032357|Ferritin reduction|ferritin reduction
460047|NCT00032357|Peripheral Vascular Disease (PVD)|peripheral vascular disease (pvd)
460048|NCT00032357|phlebotomy|phlebotomy
460049|NCT00032357|Reduction of Total Body Iron Storage(TBIS)|reduction of total body iron storage(tbis)
460050|NCT00032357|Total Body Iron Storage(TBIS)|total body iron storage(tbis)
460051|NCT00032370|myocardial infarction|myocardial infarction
460052|NCT00032370|Prophylactic coronary artery revascularization|prophylactic coronary artery revascularization
460053|NCT00032383|Rehabilitation|rehabilitation
460054|NCT00032383|Tai Chi|tai chi
460055|NCT00032396|AMD|amd
460056|NCT00032396|ARMD|armd
460057|NCT00032396|Age-Related Macular Degeneration|age-related macular degeneration
460058|NCT00032396|Subfoveal Choroidal Neovascularization|subfoveal choroidal neovascularization
460059|NCT00032396|CNV|cnv
460060|NCT00032409|Music Therapy|music therapy
460061|NCT00032409|Relaxation Therapy|relaxation therapy
460062|NCT00032409|Stress Reduction|stress reduction
460063|NCT00032409|Bone Marrow Transplantation|bone marrow transplantation
460064|NCT00032409|Stem Cell Transplantation|stem cell transplantation
460065|NCT00032422|Acupuncture|acupuncture
460066|NCT00032422|Heart Failure|heart failure
460067|NCT00032422|Autonomic nervous system|autonomic nervous system
460068|NCT00032435|folate|folate
460069|NCT00032435|pyridoxine|pyridoxine
460070|NCT00032435|vitamin B6|vitamin b6
460071|NCT00032435|cyanocobalamin|cyanocobalamin
460072|NCT00032435|homoc|homoc
460073|NCT00032448|Hernia|hernia
460074|NCT00032448|laparoscopic herniorrhaphy|laparoscopic herniorrhaphy
460075|NCT00032448|tension-free herniorrhaphy|tension-free herniorrhaphy
460076|NCT00032461|chronic fatigue syndrome|chronic fatigue syndrome
460077|NCT00032461|fibromyalgia|fibromyalgia
460078|NCT00032461|post-traumatic stress disorder|post-traumatic stress disorder
460079|NCT00032461|neurologic abnormalities|neurologic abnormalities
460080|NCT00032474|Ginkgo biloba|ginkgo biloba
460081|NCT00032474|type 2 diabetes|type 2 diabetes
460082|NCT00032474|platelet function|platelet function
460083|NCT00032474|antioxidant|antioxidant
460084|NCT00032487|DM|dm
460085|NCT00032487|glycemic control|glycemic control
460086|NCT00032487|insulin|insulin
460087|NCT00032487|type 2 diabetes mellitus|type 2 diabetes mellitus
460088|NCT00032500|common cold|common cold
460089|NCT00032500|Echinacea|echinacea
460090|NCT00032513|Herpesvirus|herpesvirus
460091|NCT00032513|Hemophagocytosis|hemophagocytosis
460092|NCT00032513|Lymphoproliferative|lymphoproliferative
460093|NCT00032513|Epstein-Barr|epstein-barr
460094|NCT00032513|Mononucleosis|mononucleosis
460095|NCT00032513|EBV|ebv
460096|NCT00032513|CAEBV|caebv
460097|NCT00032513|Chronic Active Epstein-Barr Virus|chronic active epstein-barr virus
460099|NCT00032539|Informed Consent|informed consent
460100|NCT00032591|AF|af
460101|NCT00032591|Mechanical heart valve (MHV)|mechanical heart valve (mhv)
460102|NCT00032617|PTSD|ptsd
460103|NCT00032617|Stress Disorder|stress disorder
460104|NCT00032617|Trauma|trauma
460105|NCT00032656|Adolescents|adolescents
460106|NCT00032656|Alternative and complimentary medication use|alternative and complimentary medication use
460107|NCT00032656|Health services utilization|health services utilization
460108|NCT00032656|Communication|communication
460109|NCT00032656|Quality of care|quality of care
460110|NCT00032669|Antiretrovirals|antiretrovirals
460111|NCT00032669|Adherence|adherence
460112|NCT00032669|Dose Adjustments|dose adjustments
460113|NCT00032669|Genotypic Resistance|genotypic resistance
460114|NCT00032669|Phenotypic Resistance|phenotypic resistance
460115|NCT00032682|Bowel Movement|bowel movement
460116|NCT00032682|Children|children
460117|NCT00032682|Stool|stool
460118|NCT00032682|Symptom Management|symptom management
460119|NCT00032682|Cancer|cancer
460120|NCT00032682|Constipation|constipation
460121|NCT00032695|myelopathy|myelopathy
460122|NCT00032695|AIDS-myelopathy|aids-myelopathy
460123|NCT00032695|AIDS vacuolar myelopathy|aids vacuolar myelopathy
460124|NCT00032695|methionine|methionine
460125|NCT00032721|complementary therapies|complementary therapies
460126|NCT00032721|Alternative medicine|alternative medicine
460127|NCT00032721|Complementary and alternative medicine|complementary and alternative medicine
460128|NCT00032721|Subtle energy therapy|subtle energy therapy
460131|NCT00032734|Low Blood Sodium (Hyponatremia)|low blood sodium (hyponatremia)
460132|NCT00032734|SIADH|siadh
460133|NCT00032734|Inappropriate ADH Syndrome|inappropriate adh syndrome
460134|NCT00032747|Chronic Heart Failure|chronic heart failure
460135|NCT00032747|Heart Disease|heart disease
460136|NCT00032760|binge eating disorder|binge eating disorder
460137|NCT00032760|human therapy evaluation|human therapy evaluation
460138|NCT00032760|meditation|meditation
460139|NCT00032760|obesity|obesity
460140|NCT00032760|nutrition education|nutrition education
460141|NCT00032760|psychotherapy|psychotherapy
460142|NCT00032760|racial /ethnic difference|racial /ethnic difference
460143|NCT00032760|adult human|adult human
460144|NCT00032760|alternative medicine|alternative medicine
460145|NCT00032760|patient oriented research|patient oriented research
460146|NCT00032773|acute graft versus host disease|acute graft versus host disease
460147|NCT00032773|aGVHD|agvhd
460148|NCT00032773|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
460149|NCT00032773|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
460150|NCT00032773|cord blood transplant|cord blood transplant
460151|NCT00032773|pentostatin|pentostatin
460152|NCT00032773|Nipent|nipent
460153|NCT00032773|deoxycoformycin|deoxycoformycin
460154|NCT00032812|Motor Learning|motor learning
460155|NCT00032812|Sequencing|sequencing
460156|NCT00032812|Functional Imaging|functional imaging
460157|NCT00032812|Raclopride|raclopride
460158|NCT00032812|Connectivity|connectivity
460159|NCT00032812|Parkinson Disease|parkinson disease
460160|NCT00032812|Parkinson's Disease|parkinson's disease
460161|NCT00032812|PD|pd
460162|NCT00032812|Healthy Volunteer|healthy volunteer
460163|NCT00032812|HV|hv
460164|NCT00032812|Normal Control|normal control
460165|NCT00032825|Combination|combination
460166|NCT00032825|Microtubule|microtubule
460167|NCT00032825|Hormonal|hormonal
460168|NCT00032825|Chemotherapy|chemotherapy
460169|NCT00032825|Pharmacokinetics|pharmacokinetics
460170|NCT00032825|Prostate Cancer|prostate cancer
460171|NCT00032825|Prostate|prostate
460172|NCT00032838|Hydrocortisone|hydrocortisone
460173|NCT00032838|Yohimbine|yohimbine
460174|NCT00032838|Cognition|cognition
460175|NCT00032838|Norepinephrine|norepinephrine
460176|NCT00032838|Cortisol|cortisol
460177|NCT00032838|Emotion|emotion
460178|NCT00032838|Healthy Volunteer|healthy volunteer
460179|NCT00032838|HV|hv
460180|NCT00032838|Normal Control|normal control
460181|NCT00032864|amputations, diabetes,|amputations, diabetes,
460182|NCT00032877|Linkage Study|linkage study
460183|NCT00032877|Gene Identification Study|gene identification study
460184|NCT00032877|Diaphragmatic Hernia|diaphragmatic hernia
460185|NCT00032877|Fraser Syndrome|fraser syndrome
460186|NCT00032877|Cryptophthalmos|cryptophthalmos
460187|NCT00032877|Fryns Syndrome|fryns syndrome
460188|NCT00032877|Hydrolethalus Syndrome|hydrolethalus syndrome
460189|NCT00032877|Positional Cloning|positional cloning
460190|NCT00032890|osteoarthritis|osteoarthritis
460191|NCT00032890|knee pain|knee pain
460192|NCT00032903|Malignant Glioma, Camptothecin, Pharmacokinetics|malignant glioma, camptothecin, pharmacokinetics
460193|NCT00032929|Cocaine Dependence|cocaine dependence
460194|NCT00032942|opiate dependence|opiate dependence
460195|NCT00032955|opiate addiction|opiate addiction
460196|NCT00032955|morphine addiction|morphine addiction
460197|NCT00032968|opiate dependence|opiate dependence
460198|NCT00032981|substance use disorder|substance use disorder
460199|NCT00032994|substance use disorders|substance use disorders
460200|NCT00033007|substance use disorders|substance use disorders
460201|NCT00033020|substance use disorders|substance use disorders
460202|NCT00033033|cocaine dependence|cocaine dependence
460203|NCT00033085|cocaine dependence|cocaine dependence
460204|NCT00033137|Pneumothorax|pneumothorax
460205|NCT00033137|Kidney|kidney
460206|NCT00033137|Fibrofolliculoma|fibrofolliculoma
460207|NCT00033137|BHD|bhd
460208|NCT00033137|Neoplasms|neoplasms
460209|NCT00033137|Kidney Cancer|kidney cancer
460210|NCT00033137|Birt Hogg Dube Syndrome|birt hogg dube syndrome
460211|NCT00033137|Skin Papules|skin papules
460212|NCT00033150|Specific Language Impairment|specific language impairment
460213|NCT00033150|Fast ForWord|fast forword
460214|NCT00033150|Language therapy|language therapy
460215|NCT00033150|Auditory processing|auditory processing
460216|NCT00033163|Antiviral Agents|antiviral agents
460217|NCT00033163|Hepatitis B|hepatitis b
460218|NCT00033163|Drug Resistance, Microbial|drug resistance, microbial
460219|NCT00033163|Lamivudine|lamivudine
460220|NCT00033163|DNA, Viral|dna, viral
460221|NCT00033163|Hepatitis B Virus|hepatitis b virus
460222|NCT00033163|Adefovir dipivoxil|adefovir dipivoxil
460223|NCT00033163|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
460224|NCT00033163|Treatment Experienced|treatment experienced
460225|NCT00033176|complementary therapies|complementary therapies
460226|NCT00033176|Immune restoration|immune restoration
460227|NCT00033176|HIV infection|hiv infection
460228|NCT00033176|AIDS|aids
460229|NCT00033176|HAART non-responsiveness|haart non-responsiveness
460230|NCT00033176|glutathione restoration|glutathione restoration
460239|NCT00033202|Camptothecin|camptothecin
460240|NCT00033202|Pharmacokinetics|pharmacokinetics
460241|NCT00033215|neovascularization|neovascularization
460242|NCT00033215|matrix metalloproteinases|matrix metalloproteinases
460243|NCT00033215|antiangiogenesis|antiangiogenesis
460244|NCT00033215|type IV collagenases|type iv collagenases
460245|NCT00033228|stage IV melanoma|stage iv melanoma
460246|NCT00033228|recurrent melanoma|recurrent melanoma
460247|NCT00033241|stage II pancreatic cancer|stage ii pancreatic cancer
460248|NCT00033241|stage III pancreatic cancer|stage iii pancreatic cancer
460249|NCT00033241|recurrent pancreatic cancer|recurrent pancreatic cancer
460250|NCT00033241|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
460251|NCT00033241|stage IV pancreatic cancer|stage iv pancreatic cancer
460252|NCT00033280|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
460253|NCT00033280|adult mixed glioma|adult mixed glioma
460254|NCT00033306|stage IV colon cancer|stage iv colon cancer
460255|NCT00033306|stage IV rectal cancer|stage iv rectal cancer
460256|NCT00033306|recurrent colon cancer|recurrent colon cancer
460257|NCT00033306|recurrent rectal cancer|recurrent rectal cancer
460258|NCT00033306|adenocarcinoma of the colon|adenocarcinoma of the colon
460259|NCT00033306|adenocarcinoma of the rectum|adenocarcinoma of the rectum
460260|NCT00033319|colon cancer|colon cancer
460261|NCT00033319|rectal cancer|rectal cancer
460262|NCT00033332|stage I multiple myeloma|stage i multiple myeloma
460263|NCT00033332|stage II multiple myeloma|stage ii multiple myeloma
460264|NCT00033332|stage III multiple myeloma|stage iii multiple myeloma
460265|NCT00033345|breast cancer|breast cancer
460266|NCT00033384|stage III colon cancer|stage iii colon cancer
460267|NCT00033384|stage IV colon cancer|stage iv colon cancer
460268|NCT00033384|stage IV breast cancer|stage iv breast cancer
460269|NCT00033384|stage IIIA breast cancer|stage iiia breast cancer
460270|NCT00033384|recurrent breast cancer|recurrent breast cancer
460271|NCT00033384|stage IIIB breast cancer|stage iiib breast cancer
460272|NCT00033384|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
460273|NCT00033384|stage II pancreatic cancer|stage ii pancreatic cancer
460274|NCT00033384|stage III pancreatic cancer|stage iii pancreatic cancer
460381|NCT00033787|Tryptophan Depletion|tryptophan depletion
460275|NCT00033384|recurrent pancreatic cancer|recurrent pancreatic cancer
460276|NCT00033384|recurrent colon cancer|recurrent colon cancer
460277|NCT00033384|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
460278|NCT00033384|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
460279|NCT00033384|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
460280|NCT00033384|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
460281|NCT00033384|stage IV pancreatic cancer|stage iv pancreatic cancer
460282|NCT00033397|stage II breast cancer|stage ii breast cancer
460283|NCT00033397|stage IV breast cancer|stage iv breast cancer
460284|NCT00033397|stage IIIA breast cancer|stage iiia breast cancer
460285|NCT00033397|stage IIIB breast cancer|stage iiib breast cancer
460286|NCT00033397|stage IIIC breast cancer|stage iiic breast cancer
460287|NCT00033397|inflammatory breast cancer|inflammatory breast cancer
460288|NCT00033410|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
460289|NCT00033410|squamous cell lung cancer|squamous cell lung cancer
460290|NCT00033410|large cell lung cancer|large cell lung cancer
460291|NCT00033410|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
460292|NCT00033410|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
460293|NCT00033410|adenocarcinoma of the lung|adenocarcinoma of the lung
460294|NCT00033423|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
460295|NCT00033423|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
460296|NCT00033423|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
460297|NCT00033423|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
460298|NCT00033423|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
460299|NCT00033423|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
460300|NCT00033423|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
460301|NCT00033423|splenic marginal zone lymphoma|splenic marginal zone lymphoma
460302|NCT00033436|stage I bladder cancer|stage i bladder cancer
460303|NCT00033436|stage II bladder cancer|stage ii bladder cancer
460304|NCT00033436|stage III bladder cancer|stage iii bladder cancer
460305|NCT00033436|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
460306|NCT00033475|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
460307|NCT00033488|ovarian epithelial cancer|ovarian epithelial cancer
460308|NCT00033514|stage IV breast cancer|stage iv breast cancer
460309|NCT00033514|recurrent breast cancer|recurrent breast cancer
460310|NCT00033527|non-small cell lung cancer|non-small cell lung cancer
460311|NCT00033527|small cell lung cancer|small cell lung cancer
460312|NCT00033540|unresectable gallbladder cancer|unresectable gallbladder cancer
460313|NCT00033540|recurrent gallbladder cancer|recurrent gallbladder cancer
460314|NCT00033540|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
460315|NCT00033540|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
477877|NCT00100672|Liposomes|liposomes
460316|NCT00033540|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
460317|NCT00033540|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
460318|NCT00033540|squamous cell carcinoma of the gallbladder|squamous cell carcinoma of the gallbladder
460319|NCT00033540|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
460320|NCT00033540|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
460321|NCT00033540|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
460322|NCT00033553|squamous cell lung cancer|squamous cell lung cancer
460323|NCT00033553|large cell lung cancer|large cell lung cancer
460324|NCT00033553|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
460325|NCT00033553|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
460326|NCT00033553|adenocarcinoma of the lung|adenocarcinoma of the lung
460327|NCT00033553|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
460328|NCT00033566|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
460329|NCT00033592|non-small cell lung cancer|non-small cell lung cancer
460330|NCT00033592|small cell lung cancer|small cell lung cancer
460331|NCT00033631|adenocarcinoma of the prostate|adenocarcinoma of the prostate
460332|NCT00033631|stage IIB prostate cancer|stage iib prostate cancer
460333|NCT00033631|stage IIA prostate cancer|stage iia prostate cancer
460334|NCT00033644|stage IV uterine sarcoma|stage iv uterine sarcoma
460335|NCT00033644|recurrent uterine sarcoma|recurrent uterine sarcoma
460336|NCT00033644|uterine leiomyosarcoma|uterine leiomyosarcoma
460337|NCT00033657|stage I gastric cancer|stage i gastric cancer
460338|NCT00033657|stage II gastric cancer|stage ii gastric cancer
460339|NCT00033657|stage III gastric cancer|stage iii gastric cancer
460340|NCT00033657|stage IV gastric cancer|stage iv gastric cancer
460341|NCT00033657|stage I esophageal cancer|stage i esophageal cancer
460342|NCT00033657|stage II esophageal cancer|stage ii esophageal cancer
460343|NCT00033657|stage III esophageal cancer|stage iii esophageal cancer
460344|NCT00033657|stage IV esophageal cancer|stage iv esophageal cancer
460345|NCT00033657|adenocarcinoma of the stomach|adenocarcinoma of the stomach
460346|NCT00033657|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
460347|NCT00033683|stage I breast cancer|stage i breast cancer
460348|NCT00033683|stage II breast cancer|stage ii breast cancer
460349|NCT00033696|limited stage small cell lung cancer|limited stage small cell lung cancer
460350|NCT00033709|adult leiomyosarcoma|adult leiomyosarcoma
460351|NCT00033709|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
460352|NCT00033709|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
460353|NCT00033709|stage III uterine sarcoma|stage iii uterine sarcoma
460354|NCT00033709|stage IV uterine sarcoma|stage iv uterine sarcoma
460355|NCT00033709|recurrent uterine sarcoma|recurrent uterine sarcoma
460356|NCT00033709|uterine leiomyosarcoma|uterine leiomyosarcoma
460357|NCT00033709|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
460358|NCT00033722|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
460359|NCT00033722|squamous cell lung cancer|squamous cell lung cancer
460360|NCT00033722|large cell lung cancer|large cell lung cancer
460361|NCT00033722|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
460362|NCT00033722|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
460363|NCT00033722|adenocarcinoma of the lung|adenocarcinoma of the lung
460364|NCT00033722|adenosquamous cell lung cancer|adenosquamous cell lung cancer
460365|NCT00033735|recurrent pancreatic cancer|recurrent pancreatic cancer
460366|NCT00033735|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
460367|NCT00033748|stage IV colon cancer|stage iv colon cancer
460368|NCT00033748|stage IV rectal cancer|stage iv rectal cancer
460369|NCT00033748|recurrent colon cancer|recurrent colon cancer
460370|NCT00033748|recurrent rectal cancer|recurrent rectal cancer
460371|NCT00033748|liver metastases|liver metastases
460372|NCT00033774|Leukapheresis|leukapheresis
460373|NCT00033774|G-CSF|g-csf
460374|NCT00033774|Mobilization|mobilization
460375|NCT00033774|Stem Cells|stem cells
460376|NCT00033774|Adult|adult
460377|NCT00033774|Healthy Volunteer|healthy volunteer
460379|NCT00033774|Normal Control|normal control
460380|NCT00033787|Depression|depression
460382|NCT00033787|PET|pet
460383|NCT00033787|Serotonin|serotonin
460384|NCT00033787|Pathophysiology|pathophysiology
460385|NCT00033787|Emotional Stimuli|emotional stimuli
460386|NCT00033787|GABA MRS|gaba mrs
460387|NCT00033787|MDD|mdd
460388|NCT00033787|Healthy Volunteer|healthy volunteer
460389|NCT00033787|HV|hv
460390|NCT00033787|Normal Control|normal control
460391|NCT00033813|Duchenne|duchenne
460392|NCT00033813|muscular|muscular
460393|NCT00033813|dystrophy|dystrophy
460394|NCT00033813|controlled clinical trial|controlled clinical trial
460395|NCT00033813|CINRG|cinrg
460396|NCT00033826|Vitamin D|vitamin d
460397|NCT00033826|Adipose tissue|adipose tissue
460398|NCT00033826|Metabolism|metabolism
460399|NCT00033839|Headache|headache
460400|NCT00033839|Cluster|cluster
460401|NCT00033839|EC|ec
460402|NCT00033839|Episodic Cluster|episodic cluster
460403|NCT00033852|complementary therapies|complementary therapies
460406|NCT00033852|Massage Therapy|massage therapy
460407|NCT00033852|Alternative Treatments|alternative treatments
460408|NCT00033865|Insomnia|insomnia
460409|NCT00033865|Yoga|yoga
460410|NCT00033865|Meditation|meditation
460411|NCT00033865|Behavioral treatment|behavioral treatment
460412|NCT00033878|Advanced Cancer|advanced cancer
460413|NCT00033891|Muscle Weakness|muscle weakness
460414|NCT00033891|Muscle Biopsy|muscle biopsy
460415|NCT00033891|Gene Expression Profiling|gene expression profiling
460416|NCT00033891|MRI|mri
460417|NCT00033891|Inflammation|inflammation
460418|NCT00033891|Polymyositis|polymyositis
460419|NCT00033891|Dermatomyositis|dermatomyositis
460420|NCT00033904|Kidney Cancer, renal, immunotherapy, tumor,|kidney cancer, renal, immunotherapy, tumor,
460421|NCT00034034|Advanced colorectal cancer|advanced colorectal cancer
460422|NCT00034034|acupressure /acupuncture|acupressure /acupuncture
460423|NCT00034034|anxiety|anxiety
460424|NCT00034034|colorectal neoplasm|colorectal neoplasm
460425|NCT00034034|human therapy evaluation|human therapy evaluation
460426|NCT00034034|neoplasm /cancer palliative treatment|neoplasm /cancer palliative treatment
460427|NCT00034034|quality of life|quality of life
460428|NCT00034034|terminal patient care|terminal patient care
460429|NCT00034034|hypothalamic pituitary adrenal axis|hypothalamic pituitary adrenal axis
460430|NCT00034034|pain|pain
460431|NCT00034034|psychological aspect of cancer|psychological aspect of cancer
460432|NCT00034034|stress management|stress management
460433|NCT00034034|alternative medicine|alternative medicine
460434|NCT00034034|behavioral /social science research tag|behavioral /social science research tag
460435|NCT00034034|human subject|human subject
460436|NCT00034034|patient oriented research|patient oriented research
460437|NCT00034047|Endometriosis|endometriosis
460438|NCT00034047|Pelvic pain|pelvic pain
460439|NCT00034047|Acupuncture|acupuncture
460440|NCT00034047|Chinese herbs|chinese herbs
460441|NCT00034047|Hormone therapy|hormone therapy
460442|NCT00034047|Nafarelin|nafarelin
460443|NCT00034060|Cytokines|cytokines
460444|NCT00034060|Exanercept|exanercept
460445|NCT00034060|Cachexia|cachexia
460446|NCT00034060|Body Composition|body composition
460447|NCT00034060|Vascular Endothelial System|vascular endothelial system
460448|NCT00034060|Rheumatoid Arthritis|rheumatoid arthritis
460449|NCT00034060|RA|ra
460450|NCT00034060|Women|women
460451|NCT00034060|Healthy Volunteer|healthy volunteer
460452|NCT00034060|HV|hv
460453|NCT00034060|Normal Control|normal control
460454|NCT00034073|Imaging|imaging
460455|NCT00034073|Pediatrics|pediatrics
460456|NCT00034073|Brain|brain
460457|NCT00034073|Mapping|mapping
460458|NCT00034073|Development|development
460459|NCT00034073|Healthy Volunteer|healthy volunteer
460460|NCT00034073|HV|hv
460461|NCT00034073|Normal Control|normal control
460462|NCT00034086|Lopinavir|lopinavir
460463|NCT00034086|OspA Protein|ospa protein
460464|NCT00034086|HIV-1|hiv-1
460465|NCT00034086|HIV Protease Inhibitors|hiv protease inhibitors
460466|NCT00034086|CD4 Lymphocyte Count|cd4 lymphocyte count
460467|NCT00034086|Ritonavir|ritonavir
460468|NCT00034086|Haemophilus Vaccines|haemophilus vaccines
460469|NCT00034086|HAART|haart
460470|NCT00034086|Pneumococcal Vaccines|pneumococcal vaccines
460471|NCT00034086|tenofovir disoproxil|tenofovir disoproxil
460472|NCT00034112|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
460473|NCT00034112|combination therapy,|combination therapy,
460474|NCT00034112|emphysema|emphysema
460475|NCT00034112|exercise|exercise
460476|NCT00034112|human therapy evaluation|human therapy evaluation
460477|NCT00034112|rehabilitation|rehabilitation
460478|NCT00034112|respiratory disease /disorder therapy|respiratory disease /disorder therapy
460479|NCT00034112|respiratory function|respiratory function
460480|NCT00034112|biomechanics|biomechanics
460481|NCT00034112|body movement|body movement
460482|NCT00034112|diaphragm|diaphragm
460483|NCT00034112|dyspnea|dyspnea
460484|NCT00034112|muscle tension|muscle tension
460485|NCT00034112|musculoskeletal system|musculoskeletal system
460486|NCT00034112|outcomes research|outcomes research
460487|NCT00034112|quality of life|quality of life
460488|NCT00034112|somatic reflex|somatic reflex
460489|NCT00034125|cancer|cancer
460490|NCT00034125|metastatic breast cancer|metastatic breast cancer
460491|NCT00034125|hormonal therapy|hormonal therapy
460492|NCT00034138|immunotherapy|immunotherapy
460493|NCT00034138|monoclonal|monoclonal
460494|NCT00034138|antibody|antibody
460495|NCT00034138|Stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
460496|NCT00034138|Stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
460497|NCT00034177|Locally Advanced, Metastatic, or Recurrent Transitional Cell Carcinoma of the Urothelium|locally advanced, metastatic, or recurrent transitional cell carcinoma of the urothelium
460498|NCT00034216|Suppressor Cells|suppressor cells
460499|NCT00034216|T-cells|t-cells
460500|NCT00034216|CD4+/CD25+ Cells|cd4+/cd25+ cells
460501|NCT00034216|Cancer|cancer
460502|NCT00034216|Malignancy|malignancy
460503|NCT00034216|Blood Sample|blood sample
460504|NCT00034229|Antidepressant|antidepressant
477878|NCT00100672|Antisense|antisense
460505|NCT00034229|Anti-Glutamatergic|anti-glutamatergic
460506|NCT00034229|Bipolar Disorder|bipolar disorder
460507|NCT00034229|Depression|depression
460508|NCT00034229|Treatment Refractory|treatment refractory
460509|NCT00034229|Felbamate|felbamate
460510|NCT00034229|Glutamate|glutamate
460511|NCT00034229|Treatment-Resistant|treatment-resistant
460512|NCT00034229|Bipolar|bipolar
460514|NCT00034229|Bipolar Depression|bipolar depression
460515|NCT00034242|Ataxia|ataxia
460516|NCT00034242|Treatment|treatment
460517|NCT00034242|IVIG|ivig
460518|NCT00034242|SCA|sca
460519|NCT00034242|Cerebellar Degeneration|cerebellar degeneration
460520|NCT00034242|Cerebellar Ataxia|cerebellar ataxia
460521|NCT00034242|Cerebellum|cerebellum
460522|NCT00034268|non-small cell lung cancer|non-small cell lung cancer
460523|NCT00034268|Stage IIIB or IV non-small cell lung cancer (NSCLC)|stage iiib or iv non-small cell lung cancer (nsclc)
460524|NCT00034281|Gene, HER2|gene, her2
460525|NCT00034281|Clinical Trial, Phase I|clinical trial, phase i
460526|NCT00034281|Breast neoplasm|breast neoplasm
460527|NCT00034281|Pancreatic neoplasm|pancreatic neoplasm
460528|NCT00034281|Ovarian neoplasm|ovarian neoplasm
460529|NCT00034281|Colorectal neoplasm|colorectal neoplasm
460530|NCT00034281|Renal neoplasm|renal neoplasm
460531|NCT00034281|Prostate neoplasm|prostate neoplasm
590372|NCT00538889|Adult|adult
460532|NCT00034281|Cancer|cancer
460533|NCT00034294|C. difficile-associated diarrhea|c. difficile-associated diarrhea
460534|NCT00034294|CDAD|cdad
460535|NCT00034294|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
460536|NCT00034294|Clostridium enterocolitis|clostridium enterocolitis
460537|NCT00034294|antibiotic-associated diarrhea|antibiotic-associated diarrhea
460538|NCT00034294|clostridium difficile colitis|clostridium difficile colitis
460539|NCT00034294|infectious diarrhea|infectious diarrhea
460540|NCT00034294|chronic diarrhea|chronic diarrhea
460541|NCT00034294|antibiotic-associated colitis|antibiotic-associated colitis
460542|NCT00034333|Hepatoma|hepatoma
460543|NCT00034333|Unresectable adult primary liver cancer|unresectable adult primary liver cancer
460544|NCT00034333|liver cancer|liver cancer
460546|NCT00034333|Hepatocellular Carcinoma|hepatocellular carcinoma
460547|NCT00034346|Advanced|advanced
460548|NCT00034346|Non-Small-Cell|non-small-cell
460549|NCT00034346|Lung|lung
460550|NCT00034346|Cancer|cancer
460551|NCT00034346|NSCLC|nsclc
460552|NCT00034346|Carcinoma|carcinoma
460553|NCT00034346|Advanced Non-Small-Cell Lung Cancer (NSCLC)|advanced non-small-cell lung cancer (nsclc)
460554|NCT00034359|E-antigen positive|e-antigen positive
460555|NCT00034359|Treatment Naive Chronic Hepatitis B, Achillion|treatment naive chronic hepatitis b, achillion
460556|NCT00034372|immunotherapy|immunotherapy
460557|NCT00034372|monoclonal|monoclonal
460558|NCT00034372|antibody|antibody
460559|NCT00034372|Stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
460560|NCT00034372|Stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
460561|NCT00034385|Cytomegalovirus|cytomegalovirus
460562|NCT00034385|Prophylaxis|prophylaxis
460563|NCT00034385|Renal Transplant|renal transplant
460564|NCT00034385|Valcyte|valcyte
460565|NCT00034385|Kidney Transplant|kidney transplant
460566|NCT00034398|Basal Ganglia|basal ganglia
460567|NCT00034398|Neuroimaging|neuroimaging
460568|NCT00034398|Inhibitory Neurons|inhibitory neurons
460569|NCT00034398|Disinhibition|disinhibition
460570|NCT00034398|Tics|tics
460571|NCT00034398|Tourette's Syndrome|tourette's syndrome
460572|NCT00034398|Tourette Syndrome|tourette syndrome
460573|NCT00034398|Healthy Volunteer|healthy volunteer
460575|NCT00034398|Normal Control|normal control
460576|NCT00034424|Genetics|genetics
460577|NCT00034424|Hereditary|hereditary
460578|NCT00034424|Screening|screening
460579|NCT00034424|Behavioral|behavioral
460580|NCT00034424|Familial Testicular Germ Cell Tumor|familial testicular germ cell tumor
460581|NCT00034424|Testicular Cancer|testicular cancer
460582|NCT00034437|Normal Volunteer|normal volunteer
460583|NCT00034437|Phlebotomy|phlebotomy
460584|NCT00034437|Cytomegalovirus|cytomegalovirus
460585|NCT00034437|CMV|cmv
460586|NCT00034437|CMV Seropositve|cmv seropositve
460587|NCT00034450|Terminal Cancer|terminal cancer
460588|NCT00034463|metastatic cancer|metastatic cancer
460589|NCT00034463|chemotherapy|chemotherapy
460590|NCT00034476|Sepsis, sPLA2 Inhibitor|sepsis, spla2 inhibitor
460591|NCT00034489|metastatic breast cancer|metastatic breast cancer
460592|NCT00034489|combination therapy|combination therapy
460593|NCT00034489|Alimta|alimta
460594|NCT00034541|cetuximab|cetuximab
460595|NCT00034541|epidermal growth factor receptor|epidermal growth factor receptor
460596|NCT00034541|antibody|antibody
460597|NCT00034541|non-small cell lung cancer|non-small cell lung cancer
460598|NCT00034541|carboplatin|carboplatin
460599|NCT00034541|paclitaxel|paclitaxel
460600|NCT00034554|AJCC stage III or stage IV malignant melanoma|ajcc stage iii or stage iv malignant melanoma
460601|NCT00034554|melanoma|melanoma
460602|NCT00034554|gp75|gp75
460603|NCT00034554|DNA vaccine|dna vaccine
460604|NCT00034567|Prevention|prevention
460605|NCT00034580|Bipolar I Disorder|bipolar i disorder
478523|NCT00102934|HIV|hiv
460606|NCT00034593|Bladder cancer|bladder cancer
460607|NCT00034593|metastatic|metastatic
460608|NCT00034593|transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
460609|NCT00034606|Lung cancer|lung cancer
460610|NCT00034606|cancer|cancer
460611|NCT00034606|neoplasm|neoplasm
460612|NCT00034606|non-small|non-small
460613|NCT00034606|chemotherapy|chemotherapy
460614|NCT00034632|Aspergillosis, Candidiasis, Cryptococcosis, Phaeohyphomycosis|aspergillosis, candidiasis, cryptococcosis, phaeohyphomycosis
460615|NCT00034632|Invasive Fungal Infections|invasive fungal infections
460616|NCT00034645|Allogenic Stem cell transplantation|allogenic stem cell transplantation
460617|NCT00034645|Fungal infections|fungal infections
460618|NCT00034658|Aspergillosis, Candidiasis, Cryptococcosis,|aspergillosis, candidiasis, cryptococcosis,
460619|NCT00034671|Aspergillosis, Candidiasis, Mucormycosis, Cryptococcosis|aspergillosis, candidiasis, mucormycosis, cryptococcosis
460620|NCT00034671|Invasive Fungal Infections|invasive fungal infections
460621|NCT00034684|Leukemia|leukemia
460622|NCT00034684|Myelodysplastic Syndromes|myelodysplastic syndromes
460623|NCT00034684|Leukemia, Myeloid|leukemia, myeloid
460624|NCT00034684|Leukemia, Lymphocytic|leukemia, lymphocytic
460625|NCT00034697|Brain mets|brain mets
460626|NCT00034697|non-small cell lung cancer|non-small cell lung cancer
459940|NCT00031954|fallopian tube cancer|fallopian tube cancer
460627|NCT00034710|Analgesics/*therapeutic use|analgesics/*therapeutic use
460628|NCT00034710|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
460629|NCT00034710|Herpes Zoster/*complications/drug therapy|herpes zoster/*complications/drug therapy
460630|NCT00034710|Neuralgia/*drug therapy/etiology|neuralgia/*drug therapy/etiology
460631|NCT00034710|Pain|pain
460632|NCT00034710|Capsicum|capsicum
460633|NCT00034710|Pepper|pepper
460634|NCT00034710|Dermal assessment|dermal assessment
460635|NCT00034710|Pain measurement|pain measurement
460636|NCT00034710|Diary|diary
460637|NCT00034710|PHN|phn
460638|NCT00034710|Postherpetic Neuralgia|postherpetic neuralgia
460639|NCT00034710|allodynia|allodynia
460640|NCT00034710|hyperalgesia|hyperalgesia
460641|NCT00034710|shingles|shingles
460642|NCT00034710|varicella|varicella
460643|NCT00034723|DTI|dti
460644|NCT00034723|MRSI|mrsi
460645|NCT00034723|MTR|mtr
460646|NCT00034723|NAWN|nawn
460647|NCT00034723|Fiber-Tract|fiber-tract
460648|NCT00034723|Normal Control|normal control
460649|NCT00034723|Healthy Volunteer|healthy volunteer
460650|NCT00034723|HV|hv
460651|NCT00034723|HTLV-1 Associated Myelopathy|htlv-1 associated myelopathy
460652|NCT00034723|Tropical Spastic Paraparesis|tropical spastic paraparesis
460653|NCT00034723|HAM/TSP|ham/tsp
460654|NCT00034736|Pneumonia|pneumonia
460655|NCT00034736|Bacterial pneumonia|bacterial pneumonia
460656|NCT00034736|Community acquired pneumonia|community acquired pneumonia
460657|NCT00034736|Lung Inflammation|lung inflammation
460658|NCT00034736|Quinolones|quinolones
460659|NCT00034736|Levofloxacin|levofloxacin
460660|NCT00034736|Ceftriaxone|ceftriaxone
460661|NCT00034736|Erythromycin|erythromycin
460662|NCT00034736|Clarithromycin|clarithromycin
460663|NCT00034749|Adolescents|adolescents
460665|NCT00034749|risperidone|risperidone
460666|NCT00034762|Alzheimer's disease|alzheimer's disease
460667|NCT00034762|psychosis|psychosis
460668|NCT00034762|elderly|elderly
460669|NCT00034762|dementia|dementia
460670|NCT00034762|risperidone|risperidone
460671|NCT00034762|antipsychotic agents|antipsychotic agents
460672|NCT00034775|Schizophrenia|schizophrenia
460673|NCT00034775|intramuscular injection|intramuscular injection
460674|NCT00034775|antipsychotic agents|antipsychotic agents
460675|NCT00034775|risperidone|risperidone
460676|NCT00034788|Regranex|regranex
460677|NCT00034788|Foot ulcers|foot ulcers
460678|NCT00034788|Diabetes|diabetes
460679|NCT00034788|Diabetes mellitus|diabetes mellitus
460680|NCT00034788|Diabetic foot|diabetic foot
460681|NCT00034801|Depression|depression
460682|NCT00034801|Comorbid Depression|comorbid depression
460683|NCT00034801|Schizophrenia|schizophrenia
460684|NCT00034801|Schizoaffective Disorder|schizoaffective disorder
460685|NCT00034840|hypertension|hypertension
460686|NCT00034840|telmisartan|telmisartan
460687|NCT00034840|valsartan|valsartan
460688|NCT00034840|boehringer|boehringer
460689|NCT00034866|HIV|hiv
460690|NCT00034866|treatment experienced|treatment experienced
460691|NCT00034866|Boehringer|boehringer
460692|NCT00034866|tipranavir|tipranavir
460693|NCT00034866|ritonavir|ritonavir
460694|NCT00034879|Locally advanced and/or metastatic non-operable|locally advanced and/or metastatic non-operable
460695|NCT00034879|non-small cell lung cancer (stage III or IV)|non-small cell lung cancer (stage iii or iv)
460696|NCT00034879|patients who have failed standard therapy.|patients who have failed standard therapy.
460697|NCT00034918|Metastatic breast cancer|metastatic breast cancer
460698|NCT00034957|Pharmacia|pharmacia
460699|NCT00034970|alternative medicine|alternative medicine
460700|NCT00034970|art|art
460701|NCT00034970|cancer|cancer
460702|NCT00034970|combination cancer therapy|combination cancer therapy
477879|NCT00100672|Anti-cancer|anti-cancer
461320|NCT00046397|Vaccine|vaccine
460703|NCT00034970|creative-expression|creative-expression
460704|NCT00034970|group therapy|group therapy
460705|NCT00034970|holistic|holistic
460706|NCT00034970|human therapy evaluation|human therapy evaluation
460707|NCT00034970|meditation|meditation
460708|NCT00034970|neoplasm /cancer chemotherapy|neoplasm /cancer chemotherapy
460709|NCT00034970|coping|coping
460710|NCT00034970|gender difference|gender difference
460711|NCT00034970|outcomes research|outcomes research
460712|NCT00034970|psychological aspect of cancer|psychological aspect of cancer
460713|NCT00034970|psychological stressor|psychological stressor
460714|NCT00034970|quality of life|quality of life
460715|NCT00034970|racial /ethnic difference|racial /ethnic difference
460716|NCT00034970|stress management|stress management
460717|NCT00034970|support|support
460718|NCT00034970|behavioral /social science research|behavioral /social science research
460719|NCT00034970|patient oriented research|patient oriented research
460720|NCT00035022|Leukemia, Lymphoma, T-Cell|leukemia, lymphoma, t-cell
460721|NCT00035035|Pancreas|pancreas
460722|NCT00035035|Cancer|cancer
460723|NCT00035035|Unresectable or Metastatic Cancer of the Pancreas|unresectable or metastatic cancer of the pancreas
460027|NCT00032201|Surgery|surgery
460724|NCT00035035|Alimta|alimta
460725|NCT00035061|Bladder Cancer|bladder cancer
460726|NCT00035061|Metastatic|metastatic
460727|NCT00035061|Recurrent|recurrent
460728|NCT00035061|Transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
460729|NCT00035087|colon|colon
460730|NCT00035087|rectum|rectum
460731|NCT00035087|colorectal|colorectal
460732|NCT00035087|rectal|rectal
460733|NCT00035087|cancer|cancer
460734|NCT00035087|tumor|tumor
460735|NCT00035087|tumour|tumour
460736|NCT00035087|neoplasm|neoplasm
460737|NCT00035087|carcinoma|carcinoma
460738|NCT00035087|intravenous|intravenous
460739|NCT00035087|epothilone|epothilone
460740|NCT00035100|ovarian|ovarian
460741|NCT00035100|ovary|ovary
460742|NCT00035100|peritoneal cancer|peritoneal cancer
460743|NCT00035100|fallopian cancer|fallopian cancer
460744|NCT00035100|cancer|cancer
460745|NCT00035100|tumor|tumor
460746|NCT00035100|tumour|tumour
460747|NCT00035100|neoplasm|neoplasm
460748|NCT00035100|carcinoma|carcinoma
460749|NCT00035100|intravenous|intravenous
460750|NCT00035100|epothilone|epothilone
460751|NCT00035113|prostate cancer|prostate cancer
460752|NCT00035113|prostate|prostate
460753|NCT00035113|androgen independent|androgen independent
460754|NCT00035113|cancer|cancer
460755|NCT00035113|tumor|tumor
460756|NCT00035113|tumour|tumour
460757|NCT00035113|neoplasm|neoplasm
460758|NCT00035113|carcinoma|carcinoma
460759|NCT00035113|intravenous|intravenous
460760|NCT00035113|epothilone|epothilone
460761|NCT00035126|breast|breast
460762|NCT00035126|cancer|cancer
460763|NCT00035126|tumor|tumor
460764|NCT00035126|tumour|tumour
460765|NCT00035126|intravenous|intravenous
460766|NCT00035126|epothilone|epothilone
460767|NCT00035126|taxane|taxane
460768|NCT00035126|anthracycline|anthracycline
460769|NCT00035139|pediatric traumatic brain injury|pediatric traumatic brain injury
460770|NCT00035165|melanoma|melanoma
460771|NCT00035165|cancer|cancer
460772|NCT00035165|tumor|tumor
460773|NCT00035165|tumour|tumour
460774|NCT00035165|malignant|malignant
460775|NCT00035165|metastatic|metastatic
460776|NCT00035165|intravenous|intravenous
460777|NCT00035165|epothilone|epothilone
460778|NCT00035178|ESRD|esrd
460779|NCT00035178|End-stage renal disease|end-stage renal disease
460780|NCT00035178|Hemodialysis|hemodialysis
460781|NCT00035191|Dementia|dementia
460782|NCT00035191|vascular dementia|vascular dementia
460783|NCT00035191|cerebral vascular disease|cerebral vascular disease
460784|NCT00035204|Donepezil|donepezil
460785|NCT00035204|Alzheimer's|alzheimer's
460786|NCT00035204|Dementia|dementia
460787|NCT00035204|Cognitive impairment|cognitive impairment
460788|NCT00035204|Aricept|aricept
460789|NCT00035204|Alzheimer's disease|alzheimer's disease
460790|NCT00035204|Razadyne|razadyne
460791|NCT00035204|Galantamine|galantamine
460792|NCT00035230|Bipolar disorders|bipolar disorders
460793|NCT00035230|Bipolar|bipolar
460794|NCT00035230|mania|mania
460795|NCT00035230|Topiramate|topiramate
460796|NCT00035230|Lithium|lithium
460797|NCT00035243|kidney cancer|kidney cancer
460798|NCT00035243|renal cancer|renal cancer
460799|NCT00035243|cancer|cancer
460800|NCT00035243|tumor|tumor
460801|NCT00035243|tumour|tumour
460802|NCT00035243|neoplasm|neoplasm
460803|NCT00035243|carcinoma|carcinoma
460804|NCT00035243|clear cell|clear cell
460805|NCT00035243|sarcomatoid|sarcomatoid
460806|NCT00035243|papillary|papillary
460807|NCT00035243|medullary|medullary
460808|NCT00035243|collecting duct|collecting duct
460809|NCT00035243|chromophobe|chromophobe
460810|NCT00035243|intravenous|intravenous
460811|NCT00035243|epothilone|epothilone
460812|NCT00035269|Pharmacia|pharmacia
460813|NCT00035308|Immunologic Diseases|immunologic diseases
460814|NCT00035308|Autoimmune Diseases|autoimmune diseases
460815|NCT00035308|Systemic Lupus Erythematosus|systemic lupus erythematosus
460816|NCT00035308|SLE|sle
460817|NCT00035308|Lupus Nephritis|lupus nephritis
460818|NCT00035308|Lupus Glomerulonephritis|lupus glomerulonephritis
460819|NCT00035334|Familial Mediterranean Fever|familial mediterranean fever
460820|NCT00035334|Amyloidosis|amyloidosis
460821|NCT00035334|Secondary (AA) Amyloidosis|secondary (aa) amyloidosis
460822|NCT00035334|Nephrotic Syndrome|nephrotic syndrome
460823|NCT00035360|PEG-Intron|peg-intron
460824|NCT00035360|treatment experienced|treatment experienced
460825|NCT00035373|Tumor|tumor
460826|NCT00035373|Brain|brain
460827|NCT00035373|Chemotherapy|chemotherapy
460828|NCT00035373|Anti-Angiogenesis|anti-angiogenesis
460829|NCT00035373|Radiation Therapy|radiation therapy
460830|NCT00035373|CNS Tumor|cns tumor
460831|NCT00035386|Outflow Obstruction|outflow obstruction
460832|NCT00035386|ICE|ice
460833|NCT00035386|HCM|hcm
460834|NCT00035386|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
460835|NCT00035386|OHC|ohc
460836|NCT00035386|Obstructive HCM|obstructive hcm
460837|NCT00035386|Cardiomyopathy|cardiomyopathy
460838|NCT00035399|acupressure /acupuncture|acupressure /acupuncture
460839|NCT00035399|alternative medicine|alternative medicine
460840|NCT00035399|arthritis therapy|arthritis therapy
460841|NCT00035399|combination therapy|combination therapy
460842|NCT00035399|human therapy evaluation|human therapy evaluation
460843|NCT00035399|knee|knee
460844|NCT00035399|osteoarthritis|osteoarthritis
460845|NCT00035399|physical therapy|physical therapy
460846|NCT00035399|chronic pain|chronic pain
460847|NCT00035399|clinical trial|clinical trial
460848|NCT00035399|functional ability|functional ability
460849|NCT00035412|Social phobia|social phobia
460850|NCT00035412|Social anxiety|social anxiety
460851|NCT00035412|Anxiety|anxiety
460852|NCT00035412|St. John’ Wort|st. john’ wort
460853|NCT00035412|Wisconsin|wisconsin
460854|NCT00035412|Psychiatric|psychiatric
460855|NCT00035412|Mental health|mental health
460856|NCT00035438|obsessive compulsive disorder|obsessive compulsive disorder
460858|NCT00035438|Anxiety|anxiety
460859|NCT00035438|St. John’s Wort|st. john’s wort
460860|NCT00035438|Wisconsin|wisconsin
460861|NCT00035438|Psychiatric|psychiatric
460862|NCT00035438|Mental health|mental health
460863|NCT00035529|MS|ms
460864|NCT00035542|Diabetes Mellitus, Type II|diabetes mellitus, type ii
460865|NCT00035555|kidney|kidney
460866|NCT00035555|transplant|transplant
460867|NCT00035555|rejection|rejection
460868|NCT00035568|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
460869|NCT00035581|treatment experienced|treatment experienced
460870|NCT00035581|HIV Infections|hiv infections
460871|NCT00035581|HIV|hiv
460872|NCT00035581|HAART|haart
460873|NCT00035581|early virologic failure|early virologic failure
460874|NCT00035594|Breast cancer|breast cancer
460875|NCT00035594|Neutropenia|neutropenia
460876|NCT00035594|Chemotherapy|chemotherapy
460877|NCT00035620|Bone cancer|bone cancer
460878|NCT00035620|Sarcoma|sarcoma
460879|NCT00035620|Neutropenia|neutropenia
460880|NCT00035620|Chemotherapy|chemotherapy
460881|NCT00035802|Bipolar|bipolar
460882|NCT00035802|Mania|mania
460883|NCT00035802|Pediatric|pediatric
460884|NCT00035802|Children|children
460885|NCT00035802|Adolescent|adolescent
460886|NCT00035802|Topiramate|topiramate
460887|NCT00035802|Anticonvulsants|anticonvulsants
460888|NCT00035802|Central Nervous System Agents|central nervous system agents
460889|NCT00035802|Protective Agents|protective agents
460890|NCT00035802|Neuroprotectiive Agents|neuroprotectiive agents
460891|NCT00035815|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
460892|NCT00035815|ALS|als
460893|NCT00035815|progressive weakness|progressive weakness
460894|NCT00035815|insulin-like growth factor-1|insulin-like growth factor-1
460895|NCT00035815|IGF-I|igf-i
460896|NCT00035815|Myotrophin|myotrophin
460897|NCT00035828|COPD|copd
460898|NCT00035828|Chronic bronchitis|chronic bronchitis
460899|NCT00035828|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
460900|NCT00035828|Shortness of breath|shortness of breath
460901|NCT00035828|Dyspnea|dyspnea
460902|NCT00035828|Bronchitis|bronchitis
460903|NCT00035854|Pharmacia|pharmacia
460904|NCT00035854|Drug Resistance, Microbial|drug resistance, microbial
460905|NCT00035880|Acute graft versus host disease|acute graft versus host disease
460906|NCT00035880|Stem Cell Transplantation|stem cell transplantation
460907|NCT00035893|treatment interruption|treatment interruption
460908|NCT00035893|HIV Infections|hiv infections
460909|NCT00035906|Diabetes|diabetes
460910|NCT00035906|Macular Edema|macular edema
460911|NCT00035906|Diabetic Macular Edema|diabetic macular edema
460912|NCT00035906|Diabetic Retinopathy|diabetic retinopathy
460913|NCT00035906|Cystoid Macular Edema|cystoid macular edema
460914|NCT00035906|Uveitis|uveitis
460915|NCT00035906|Vision|vision
460916|NCT00035906|Eye|eye
460917|NCT00035906|Retina|retina
460918|NCT00035906|Retinal Vein Occlusion|retinal vein occlusion
460919|NCT00035906|Irvine-Gass Syndrome|irvine-gass syndrome
460920|NCT00035919|Colon cancer|colon cancer
460921|NCT00035919|Targeted Injectable Vector|targeted injectable vector
460922|NCT00035919|Gene Transfer|gene transfer
460923|NCT00035919|Gene Therapy|gene therapy
460924|NCT00035919|Retroviral vector|retroviral vector
460925|NCT00035958|Juvenile Dermatomyositis|juvenile dermatomyositis
460926|NCT00035958|Pediatric|pediatric
460927|NCT00035958|Randomized Clinical Trial|randomized clinical trial
460928|NCT00035958|Pediatric Rheumatology|pediatric rheumatology
460929|NCT00035984|Type 2 Diabetes Mellitis|type 2 diabetes mellitis
460930|NCT00035997|Hormone-sensitive Prostate Cancer|hormone-sensitive prostate cancer
460931|NCT00035997|Prostate Cancer|prostate cancer
460932|NCT00035997|Bone Metastasis|bone metastasis
460933|NCT00036036|renal|renal
460934|NCT00036036|renal cell cancer|renal cell cancer
460935|NCT00036036|renal cell carcinoma|renal cell carcinoma
460936|NCT00036036|kidney cancer|kidney cancer
460937|NCT00036062|Sivelestat|sivelestat
460938|NCT00036062|acute lung injury|acute lung injury
460939|NCT00036075|prostate cancer|prostate cancer
460940|NCT00036075|prostate|prostate
460941|NCT00036101|Bipolar I Disorder|bipolar i disorder
460942|NCT00036114|Psychosis associated with dementia of the Alzheimer's type|psychosis associated with dementia of the alzheimer's type
460943|NCT00036127|agitated schizophrenic patients|agitated schizophrenic patients
460944|NCT00036140|Pharmacia|pharmacia
460945|NCT00036153|Tacrolimus, Prograf®, FK506|tacrolimus, prograf®, fk506
460946|NCT00036166|Aspergillus|aspergillus
460947|NCT00036166|Anti-Fungal|anti-fungal
460948|NCT00036179|Candidemia|candidemia
460949|NCT00036179|Anti-Fungal|anti-fungal
460950|NCT00036257|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
460951|NCT00036257|Leukemia|leukemia
460953|NCT00036296|Involuntary Movements|involuntary movements
460954|NCT00036296|Abnormal Movements|abnormal movements
460955|NCT00036296|Advanced Parkinson's disease|advanced parkinson's disease
460956|NCT00036296|Levodopa induced dyskinesia|levodopa induced dyskinesia
460957|NCT00036309|Major Depressive Disorder|major depressive disorder
460958|NCT00036309|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition-defined major depressive disorder without psychotic features|diagnostic and statistical manual of mental disorders fourth edition-defined major depressive disorder without psychotic features
460959|NCT00036335|depression|depression
460960|NCT00036335|pain|pain
460961|NCT00036335|blues|blues
460962|NCT00036335|sadness|sadness
460963|NCT00036335|aches|aches
460964|NCT00036348|Bipolar I disorder|bipolar i disorder
460965|NCT00036374|Juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
460966|NCT00036374|Infliximab|infliximab
460967|NCT00036374|Methotrexate|methotrexate
460968|NCT00036374|remicade|remicade
460969|NCT00036387|Rheumatoid arthritis|rheumatoid arthritis
460970|NCT00036387|infliximab|infliximab
460971|NCT00036387|anti-TNF|anti-tnf
460972|NCT00036387|methotrexate|methotrexate
460973|NCT00036387|safety and efficacy|safety and efficacy
460974|NCT00036387|Remicade|remicade
460975|NCT00036400|Anemia|anemia
460976|NCT00036400|Gastric Cancer|gastric cancer
460978|NCT00036400|Epoetin Alfa|epoetin alfa
460979|NCT00036413|(ALS)|(als)
460980|NCT00036426|lymphoma|lymphoma
460981|NCT00036426|vaccine|vaccine
460982|NCT00036426|idiotype|idiotype
460983|NCT00036426|KLH|klh
460984|NCT00036426|GM-CSF|gm-csf
460985|NCT00036439|ulcerative colitis|ulcerative colitis
460986|NCT00036439|infliximab|infliximab
460987|NCT00036439|Remicade|remicade
460988|NCT00036439|infusion|infusion
460989|NCT00036452|Lopinavir|lopinavir
460990|NCT00036452|HIV-1|hiv-1
460991|NCT00036452|Drug Administration Schedule|drug administration schedule
460992|NCT00036452|Stavudine|stavudine
460993|NCT00036452|HIV Protease Inhibitors|hiv protease inhibitors
460994|NCT00036452|Ritonavir|ritonavir
460995|NCT00036452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
460996|NCT00036452|Self Care|self care
460997|NCT00036452|Viral Load|viral load
460998|NCT00036452|Emtricitabine|emtricitabine
460999|NCT00036452|Directly Observed Therapy|directly observed therapy
461000|NCT00036452|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
461001|NCT00036452|Treatment Naive|treatment naive
461002|NCT00036465|Pilot Projects|pilot projects
461003|NCT00036465|HIV-1|hiv-1
461004|NCT00036465|RNA, Viral|rna, viral
461005|NCT00036465|Genotype|genotype
461006|NCT00036465|Viral Load|viral load
461007|NCT00036465|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
461008|NCT00036465|Treatment Experienced|treatment experienced
461009|NCT00036478|Pilot Projects|pilot projects
461010|NCT00036478|Exercise|exercise
461011|NCT00036478|Phosphorus Isotopes|phosphorus isotopes
461012|NCT00036478|Mitochondria|mitochondria
461013|NCT00036478|Lactates|lactates
461014|NCT00036478|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
461015|NCT00036491|Systemic Lupus Erythematosus|systemic lupus erythematosus
461016|NCT00036491|SLE|sle
461017|NCT00036491|B-Lymphocytes|b-lymphocytes
461265|NCT00044200|Neurotransmission|neurotransmission
461020|NCT00036504|Diabetes mellitus, insulin deficiency, hyperglycemia|diabetes mellitus, insulin deficiency, hyperglycemia
461021|NCT00036517|Stage III and Stage IV colorectal cancer|stage iii and stage iv colorectal cancer
461022|NCT00036517|diarrhea|diarrhea
461023|NCT00036517|reduce|reduce
461024|NCT00036517|alleviate|alleviate
461025|NCT00036517|modulate|modulate
461026|NCT00036517|Saltz regimen|saltz regimen
461027|NCT00036517|CPT-11|cpt-11
461028|NCT00036517|irinotecan|irinotecan
461029|NCT00036517|camptosar|camptosar
461030|NCT00036517|5-fluorouracil|5-fluorouracil
461031|NCT00036517|leucovorin|leucovorin
461032|NCT00036517|5-FU|5-fu
461033|NCT00036517|LV|lv
461034|NCT00036517|chemotherapy|chemotherapy
461035|NCT00036517|side effect|side effect
461036|NCT00036517|toxicity|toxicity
461037|NCT00036517|botanical drug|botanical drug
461038|NCT00036517|herbal medicine|herbal medicine
461039|NCT00036517|chinese herbal medicine|chinese herbal medicine
461040|NCT00036517|traditional chinese medicine|traditional chinese medicine
461041|NCT00036517|TCM|tcm
461042|NCT00036517|oral dose|oral dose
461043|NCT00036517|oral administration|oral administration
461044|NCT00036517|concomitant use|concomitant use
461045|NCT00036543|Hormone-Refractory, Prostate Cancer|hormone-refractory, prostate cancer
461046|NCT00036556|Hormone-Refractory Prostate Cancer|hormone-refractory prostate cancer
461047|NCT00036569|Brainstem Glioma|brainstem glioma
461048|NCT00036569|Pediatric|pediatric
461050|NCT00036569|MR Imaging|mr imaging
461051|NCT00036569|Angiogenesis|angiogenesis
461052|NCT00036569|Brain Tumor|brain tumor
461053|NCT00036569|Glioma|glioma
461054|NCT00036569|Pediatric Brain Tumor|pediatric brain tumor
461055|NCT00036582|Psychophysiology|psychophysiology
461056|NCT00036582|Structural MRI|structural mri
461057|NCT00036582|Genetics|genetics
461058|NCT00036582|Bipolar Disorder|bipolar disorder
461059|NCT00036582|Children and Adolescents|children and adolescents
461060|NCT00036582|Clozapine|clozapine
461061|NCT00036582|Placebo|placebo
461062|NCT00036582|Treatment-Refractory|treatment-refractory
461063|NCT00036582|Bipolar|bipolar
461064|NCT00036582|Healthy Volunteer|healthy volunteer
461065|NCT00036582|HV|hv
461066|NCT00036582|BPD|bpd
461067|NCT00036582|Normal Control|normal control
461068|NCT00036595|Subdural|subdural
461069|NCT00036595|Epilepsy|epilepsy
461070|NCT00036595|Motor Function|motor function
461071|NCT00036595|Desynchronization|desynchronization
461072|NCT00036595|Coherence|coherence
461073|NCT00036595|Motor Control|motor control
461074|NCT00030641|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
461075|NCT00030641|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
461076|NCT00030641|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
461077|NCT00030654|adenocarcinoma of the prostate|adenocarcinoma of the prostate
461078|NCT00030654|stage IIB prostate cancer|stage iib prostate cancer
461079|NCT00030654|stage IIA prostate cancer|stage iia prostate cancer
461080|NCT00030654|stage III prostate cancer|stage iii prostate cancer
461081|NCT00030654|stage IV prostate cancer|stage iv prostate cancer
461082|NCT00030654|recurrent prostate cancer|recurrent prostate cancer
461083|NCT00030680|desmoid tumor|desmoid tumor
461084|NCT00030706|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
461085|NCT00030706|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
461086|NCT00030706|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
461087|NCT00030706|peritoneal cavity cancer|peritoneal cavity cancer
461088|NCT00030719|regional neuroblastoma|regional neuroblastoma
461089|NCT00030719|disseminated neuroblastoma|disseminated neuroblastoma
461090|NCT00030719|stage 4S neuroblastoma|stage 4s neuroblastoma
461091|NCT00030719|localized unresectable neuroblastoma|localized unresectable neuroblastoma
461092|NCT00030732|stage III pancreatic cancer|stage iii pancreatic cancer
461093|NCT00030732|recurrent pancreatic cancer|recurrent pancreatic cancer
461094|NCT00030732|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
461095|NCT00030732|stage IV pancreatic cancer|stage iv pancreatic cancer
461096|NCT00030745|stage IA malignant mesothelioma|stage ia malignant mesothelioma
461097|NCT00030745|stage IB malignant mesothelioma|stage ib malignant mesothelioma
461098|NCT00030745|stage II malignant mesothelioma|stage ii malignant mesothelioma
461099|NCT00030745|stage III malignant mesothelioma|stage iii malignant mesothelioma
461100|NCT00030758|neutropenia|neutropenia
461101|NCT00030758|stage I breast cancer|stage i breast cancer
461102|NCT00030758|stage II breast cancer|stage ii breast cancer
461103|NCT00030771|squamous cell lung cancer|squamous cell lung cancer
461104|NCT00030771|large cell lung cancer|large cell lung cancer
461105|NCT00030771|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
461106|NCT00030771|adenosquamous cell lung cancer|adenosquamous cell lung cancer
461107|NCT00030784|adult angiosarcoma|adult angiosarcoma
461108|NCT00030784|adult fibrosarcoma|adult fibrosarcoma
461109|NCT00030784|adult leiomyosarcoma|adult leiomyosarcoma
461110|NCT00030784|adult liposarcoma|adult liposarcoma
461111|NCT00030784|adult neurofibrosarcoma|adult neurofibrosarcoma
479736|NCT00105638|Caregivers|caregivers
461112|NCT00030784|adult synovial sarcoma|adult synovial sarcoma
461113|NCT00030784|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
461114|NCT00030784|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
461115|NCT00030784|adult epithelioid sarcoma|adult epithelioid sarcoma
461116|NCT00030784|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
461117|NCT00030784|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
461118|NCT00030784|adult malignant mesenchymoma|adult malignant mesenchymoma
461119|NCT00030784|adult rhabdomyosarcoma|adult rhabdomyosarcoma
461120|NCT00030784|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
461121|NCT00030797|stage III colon cancer|stage iii colon cancer
461122|NCT00030797|stage IV colon cancer|stage iv colon cancer
461123|NCT00030797|stage III rectal cancer|stage iii rectal cancer
461124|NCT00030797|stage IV rectal cancer|stage iv rectal cancer
461125|NCT00030810|squamous cell lung cancer|squamous cell lung cancer
461126|NCT00030810|large cell lung cancer|large cell lung cancer
461127|NCT00030810|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
460378|NCT00033774|HV|hv
461128|NCT00030810|adenosquamous cell lung cancer|adenosquamous cell lung cancer
461129|NCT00030823|stage I breast cancer|stage i breast cancer
461130|NCT00030823|stage II breast cancer|stage ii breast cancer
461131|NCT00030823|stage IV breast cancer|stage iv breast cancer
461132|NCT00030823|stage IIIA breast cancer|stage iiia breast cancer
461133|NCT00030823|recurrent breast cancer|recurrent breast cancer
461134|NCT00030823|stage IIIB breast cancer|stage iiib breast cancer
461135|NCT00030823|stage IIIC breast cancer|stage iiic breast cancer
461136|NCT00030823|male breast cancer|male breast cancer
461137|NCT00030849|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
461138|NCT00030849|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
461139|NCT00030849|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
461140|NCT00030849|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
461141|NCT00030849|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
461142|NCT00030862|stage II esophageal cancer|stage ii esophageal cancer
461143|NCT00030862|stage III esophageal cancer|stage iii esophageal cancer
461144|NCT00030862|stage IV esophageal cancer|stage iv esophageal cancer
461145|NCT00030862|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
461146|NCT00030862|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
461147|NCT00030875|stage I mantle cell lymphoma|stage i mantle cell lymphoma
461148|NCT00030875|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
461149|NCT00030875|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
461150|NCT00030875|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
461151|NCT00030875|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
461152|NCT00030875|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
461153|NCT00043875|partial seizures|partial seizures
461154|NCT00043875|pediatric|pediatric
461155|NCT00043875|epilepsy|epilepsy
461156|NCT00043888|fosamprenavir|fosamprenavir
461157|NCT00043888|ritonavir|ritonavir
461158|NCT00043888|COMBIVIR|combivir
461159|NCT00043888|TRIZIVIR|trizivir
461160|NCT00043888|abacavir|abacavir
461161|NCT00043888|lamivudine|lamivudine
461162|NCT00043888|zidovudine|zidovudine
461164|NCT00043888|protease inhibitors|protease inhibitors
461165|NCT00043901|PGTC|pgtc
461166|NCT00043901|Lamotrigine|lamotrigine
461167|NCT00043901|epilepsy|epilepsy
461168|NCT00043901|seizures|seizures
461169|NCT00043901|primary generalized tonic-clonic|primary generalized tonic-clonic
461170|NCT00043914|epilepsy|epilepsy
461171|NCT00043914|monotherapy conversion|monotherapy conversion
461172|NCT00043927|Chemotherapy-naive|chemotherapy-naive
461173|NCT00043927|Small Cell Lung Cancer|small cell lung cancer
461174|NCT00043927|SCLC|sclc
461175|NCT00043927|Extensive disease|extensive disease
461176|NCT00043927|ED|ed
461177|NCT00043927|topotecan|topotecan
461178|NCT00043927|Hycamtin|hycamtin
461179|NCT00043927|oral|oral
461180|NCT00043940|thrombosis|thrombosis
461181|NCT00043940|bivalirudin|bivalirudin
461182|NCT00043940|direct thrombin inhibitor|direct thrombin inhibitor
461183|NCT00043940|HIT|hit
461184|NCT00043940|HITTS|hitts
461185|NCT00043940|HIT/HITTS|hit/hitts
461186|NCT00043953|treatment naive|treatment naive
461187|NCT00043966|treatment naive|treatment naive
461188|NCT00043979|Ewing's Sarcoma|ewing's sarcoma
461189|NCT00043979|Rhabdomyosarcoma|rhabdomyosarcoma
461190|NCT00043979|Desmoplastic Small Round Cell Tumor|desmoplastic small round cell tumor
461191|NCT00043979|Sarcoma|sarcoma
461192|NCT00043979|Ewing Sarcoma|ewing sarcoma
461193|NCT00043992|Asthma|asthma
461194|NCT00043992|Allergens|allergens
461195|NCT00044005|Schizophrenia|schizophrenia
461196|NCT00044005|Latuda|latuda
461197|NCT00044005|Lurasidone|lurasidone
461198|NCT00044018|Revimid|revimid
461199|NCT00044018|CC5013|cc5013
461200|NCT00044031|pancreatic cancer|pancreatic cancer
461201|NCT00044031|G17DT|g17dt
461202|NCT00044031|gemcitabine|gemcitabine
461203|NCT00044044|Schizophrenia|schizophrenia
461204|NCT00044044|Latuda|latuda
461205|NCT00044044|Lurasidone|lurasidone
461206|NCT00044057|ARTIST|artist
461207|NCT00044070|ARTIST|artist
461208|NCT00044070|Acute ischemic stroke|acute ischemic stroke
461209|NCT00044083|Catecholamines|catecholamines
461210|NCT00044083|Dopamine|dopamine
461211|NCT00044083|Clinical Trial|clinical trial
461212|NCT00044083|fMRI|fmri
461214|NCT00044083|Vitamin B2|vitamin b2
461215|NCT00044083|Riboflavin|riboflavin
461216|NCT00044083|Tolcapone|tolcapone
461217|NCT00044083|Placebo|placebo
461218|NCT00044083|Normal Volunteers|normal volunteers
461219|NCT00044083|Schizophrenia|schizophrenia
461220|NCT00044083|Healthy Volunteers|healthy volunteers
461221|NCT00044083|HV|hv
461222|NCT00044096|SSRI|ssri
461223|NCT00044096|Anxiety|anxiety
461224|NCT00044096|Stress|stress
461225|NCT00044096|Citalopram|citalopram
461226|NCT00044096|Benadryl|benadryl
461227|NCT00044096|Diphenhydramine|diphenhydramine
461228|NCT00044096|Startle|startle
461229|NCT00044096|Fear-Potentiated Startle|fear-potentiated startle
461230|NCT00044096|Fear|fear
461231|NCT00044096|Normal Volunteers|normal volunteers
461232|NCT00044096|Healthy Volunteers|healthy volunteers
461233|NCT00044096|HV|hv
461234|NCT00044109|Pain|pain
461235|NCT00044109|Low Back|low back
461236|NCT00044109|Radiculopathy|radiculopathy
461237|NCT00044109|Electromagnetic Treatment|electromagnetic treatment
461238|NCT00044109|Back Device|back device
461239|NCT00044109|Sciatica|sciatica
461240|NCT00044109|Low Back Pain|low back pain
461241|NCT00044122|Mastocytosis|mastocytosis
461242|NCT00044122|Urticaria Pigmentosa|urticaria pigmentosa
461243|NCT00044122|Classification|classification
461244|NCT00044122|Tryptase|tryptase
461245|NCT00044122|Mutations|mutations
461246|NCT00044135|clevudine|clevudine
461247|NCT00044135|hepatitis B|hepatitis b
461248|NCT00044148|Persistent Albuminuria|persistent albuminuria
461249|NCT00044174|Depression|depression
461250|NCT00044174|Mother-Infant Interaction|mother-infant interaction
461251|NCT00044174|Still-face|still-face
461252|NCT00044174|Socioemotional Development|socioemotional development
461253|NCT00044174|Cognitive Development|cognitive development
461254|NCT00044174|Healthy|healthy
461255|NCT00044174|Mothers|mothers
461256|NCT00044174|Postpartum|postpartum
461257|NCT00044174|Postpartum Depression|postpartum depression
461258|NCT00044187|schizoaffective disorder|schizoaffective disorder
461259|NCT00044187|schizophreniform disorder|schizophreniform disorder
461260|NCT00044187|bipolar I disorder|bipolar i disorder
461261|NCT00044200|Phospholipase A2|phospholipase a2
461262|NCT00044200|Arachidonic Acid|arachidonic acid
461263|NCT00044200|Blood Flow|blood flow
461264|NCT00044200|Coupling|coupling
461267|NCT00044200|Signal Transduction|signal transduction
461268|NCT00044200|Activation|activation
461269|NCT00044200|Brain|brain
461270|NCT00044200|[15O]H20|[15o]h20
461271|NCT00046254|hip fracture|hip fracture
461272|NCT00046254|recurrent fracture|recurrent fracture
461274|NCT00046254|bone loss|bone loss
461275|NCT00046254|bisphosphonate|bisphosphonate
461276|NCT00046254|bone mineral density|bone mineral density
461277|NCT00046254|osteoporosis|osteoporosis
461278|NCT00046254|zoledronic acid|zoledronic acid
461279|NCT00046254|geriatrics|geriatrics
461280|NCT00046254|rehabilitation|rehabilitation
461281|NCT00046254|elderly|elderly
461282|NCT00046254|nursing home|nursing home
461283|NCT00046254|orthopedic|orthopedic
461284|NCT00046267|Delayed-Action Preparations|delayed-action preparations
461285|NCT00046267|Blood Glucose|blood glucose
461286|NCT00046267|Insulin|insulin
461287|NCT00046267|Alanine Transaminase|alanine transaminase
461288|NCT00046267|Aspartate Aminotransferases|aspartate aminotransferases
461289|NCT00046267|Fructosamine|fructosamine
461290|NCT00046267|Glucose Tolerance Test|glucose tolerance test
461291|NCT00046267|Treatment Experienced|treatment experienced
461292|NCT00046293|Stroke|stroke
461293|NCT00046293|Abciximab|abciximab
461294|NCT00046293|Retavase|retavase
461295|NCT00046293|MRI|mri
461296|NCT00046293|Cerebral Blood Flow|cerebral blood flow
461297|NCT00046306|Oxidative Stress|oxidative stress
461298|NCT00046306|Cardiovascular Disease|cardiovascular disease
461299|NCT00046306|Cancer|cancer
461300|NCT00046319|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
461301|NCT00046319|Primary Pulmonary Hypertension|primary pulmonary hypertension
461302|NCT00046332|Integrase inhibitors|integrase inhibitors
461303|NCT00046332|Monotherapy|monotherapy
461304|NCT00046332|HIV-1 infection|hiv-1 infection
461305|NCT00046345|treatment experienced|treatment experienced
461306|NCT00046358|Cerebrospinal Fluid|cerebrospinal fluid
461307|NCT00046358|Cholesterol|cholesterol
461308|NCT00046358|Statin|statin
461309|NCT00046358|NSAID|nsaid
461310|NCT00046358|Antiinflammatory|antiinflammatory
461311|NCT00046358|Dementia|dementia
461312|NCT00046358|Alzheimer's Disease|alzheimer's disease
461313|NCT00046358|Nonsteroidal Antiinflammatory|nonsteroidal antiinflammatory
461314|NCT00046358|Healthy Volunteer|healthy volunteer
461315|NCT00046371|Cancer Vaccines|cancer vaccines
461316|NCT00046371|Aromatase|aromatase
461317|NCT00046371|Receptors, Estrogen|receptors, estrogen
461318|NCT00046371|Receptors, Progesterone|receptors, progesterone
461319|NCT00046397|Smallpox|smallpox
461324|NCT00046397|Smallpox Vaccine|smallpox vaccine
461325|NCT00046397|Healthy Volunteer|healthy volunteer
461326|NCT00046397|Small Pox|small pox
461327|NCT00046410|MRI|mri
461328|NCT00046410|Diffusion|diffusion
461329|NCT00046410|Cognitive|cognitive
461330|NCT00046410|Stroke|stroke
461331|NCT00046410|Heart|heart
461332|NCT00046410|Coronary Artery Disease|coronary artery disease
461333|NCT00046410|Heart Disease|heart disease
461334|NCT00046423|Cancer|cancer
461335|NCT00046423|solid tumor|solid tumor
460545|NCT00034333|HCC|hcc
461336|NCT00046423|Advanced malignancy|advanced malignancy
461337|NCT00046423|Taxane therapy|taxane therapy
461338|NCT00046423|Biopsy-proven diagnosis of advanced malignancy|biopsy-proven diagnosis of advanced malignancy
461339|NCT00046423|Various solid tumors which are refractory|various solid tumors which are refractory
461340|NCT00046436|AIDS Serodiagnosis|aids serodiagnosis
461341|NCT00046436|Pregnancy Complications, Infectious|pregnancy complications, infectious
461343|NCT00046436|Disease Transmission, Vertical|disease transmission, vertical
461344|NCT00046488|Chronic Lymphoblastic Leukemia|chronic lymphoblastic leukemia
461345|NCT00046488|Leukemia, Lymphoblastic, Chronic|leukemia, lymphoblastic, chronic
461346|NCT00046488|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
461347|NCT00046488|CLL|cll
461348|NCT00046514|Metastatic Breast Cancer|metastatic breast cancer
461349|NCT00046514|Taxol|taxol
461350|NCT00046527|Metastatic breast cancer|metastatic breast cancer
461351|NCT00046527|Taxol|taxol
461352|NCT00046527|Taxane|taxane
461353|NCT00046540|Liposome-Encapsulated SN38|liposome-encapsulated sn38
461354|NCT00046540|Irinotecan|irinotecan
461355|NCT00046540|CPT-11|cpt-11
461356|NCT00046540|Malignant Tumors|malignant tumors
461357|NCT00046553|Cortisol|cortisol
461358|NCT00046553|CRH|crh
461359|NCT00046553|HPA Axis|hpa axis
461360|NCT00046553|Hypothalamus|hypothalamus
461361|NCT00046553|Hippocampus|hippocampus
461362|NCT00046553|Post-Traumatic Stress Disorder|post-traumatic stress disorder
461363|NCT00046553|PTSD|ptsd
461364|NCT00046553|Healthy Volunteer|healthy volunteer
461365|NCT00046631|built environment|built environment
461366|NCT00046631|parks|parks
461367|NCT00046631|retail outlets|retail outlets
461368|NCT00046631|adolescent girls|adolescent girls
461369|NCT00046631|physical activity|physical activity
461370|NCT00046683|Adult acute leukemia|adult acute leukemia
461371|NCT00046683|Adult chronic leukemia|adult chronic leukemia
461372|NCT00046683|Childhood leukemia|childhood leukemia
461373|NCT00046683|Campath|campath
461374|NCT00046683|Alemtuzumab|alemtuzumab
461375|NCT00046696|Cancer|cancer
461213|NCT00044083|PFC|pfc
461376|NCT00046696|Cancer Alternative Therapies|cancer alternative therapies
461377|NCT00046696|Living with Cancer|living with cancer
461378|NCT00046709|Cancer pain|cancer pain
461379|NCT00046709|All types of cancer except lung cancer|all types of cancer except lung cancer
461380|NCT00046722|treatment experienced|treatment experienced
461381|NCT00046722|complementary therapies|complementary therapies
461382|NCT00046722|Neuropathy|neuropathy
461383|NCT00046722|Peripheral Neuropathy|peripheral neuropathy
461384|NCT00046722|HIV-Related Peripheral Neuropathy|hiv-related peripheral neuropathy
461386|NCT00046735|solid tumors|solid tumors
461387|NCT00046735|Revimid|revimid
461388|NCT00046735|CC5013|cc5013
461389|NCT00046735|CC-5013|cc-5013
461390|NCT00046761|Acute Ischemic Stroke|acute ischemic stroke
461391|NCT00046774|Safety|safety
461392|NCT00046774|Nephritis|nephritis
461393|NCT00046774|Biologic Therapy|biologic therapy
461394|NCT00046774|Lymphocytes|lymphocytes
461395|NCT00046774|Response|response
461397|NCT00046774|Systemic Lupus Erythematosus|systemic lupus erythematosus
461398|NCT00046774|SLE|sle
461399|NCT00046787|Small Cell Lung Cancer|small cell lung cancer
461400|NCT00046800|Ovarian Cancer|ovarian cancer
461401|NCT00046826|adenocarcinoma of the prostate|adenocarcinoma of the prostate
461402|NCT00046826|stage IV prostate cancer|stage iv prostate cancer
461403|NCT00046826|recurrent prostate cancer|recurrent prostate cancer
461404|NCT00046839|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
461405|NCT00046839|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
461406|NCT00046839|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
461407|NCT00046852|infection|infection
461408|NCT00046852|refractory multiple myeloma|refractory multiple myeloma
461409|NCT00046852|stage I multiple myeloma|stage i multiple myeloma
461410|NCT00046852|stage II multiple myeloma|stage ii multiple myeloma
461411|NCT00046852|stage III multiple myeloma|stage iii multiple myeloma
461412|NCT00046865|nausea and vomiting|nausea and vomiting
461413|NCT00046865|stage I breast cancer|stage i breast cancer
461414|NCT00046865|stage II breast cancer|stage ii breast cancer
461415|NCT00046865|stage IIIA breast cancer|stage iiia breast cancer
461416|NCT00046865|stage IIIB breast cancer|stage iiib breast cancer
461417|NCT00046865|stage IIIC breast cancer|stage iiic breast cancer
461418|NCT00046865|stage IV breast cancer|stage iv breast cancer
461419|NCT00046878|adult glioblastoma|adult glioblastoma
461420|NCT00046878|adult giant cell glioblastoma|adult giant cell glioblastoma
461421|NCT00046878|adult gliosarcoma|adult gliosarcoma
461422|NCT00046891|neurotoxicity|neurotoxicity
461423|NCT00046891|stage I breast cancer|stage i breast cancer
461424|NCT00046891|stage II breast cancer|stage ii breast cancer
461425|NCT00046891|stage IIIA breast cancer|stage iiia breast cancer
461426|NCT00046891|stage IIIB breast cancer|stage iiib breast cancer
461427|NCT00046891|stage IIIC breast cancer|stage iiic breast cancer
461428|NCT00046904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
461429|NCT00046904|anorexia|anorexia
461430|NCT00046904|cachexia|cachexia
461431|NCT00046930|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
461432|NCT00046930|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
461433|NCT00046930|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
583604|NCT00512369|Atherosclerosis|atherosclerosis
461434|NCT00046930|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
461435|NCT00046930|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
461436|NCT00046930|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
461437|NCT00046930|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
461438|NCT00046930|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
461439|NCT00046930|refractory anemia with excess blasts|refractory anemia with excess blasts
461440|NCT00046930|secondary acute myeloid leukemia|secondary acute myeloid leukemia
461441|NCT00046930|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
461442|NCT00046930|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
461443|NCT00046930|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
461444|NCT00046930|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
461445|NCT00046930|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
461446|NCT00046930|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
461447|NCT00046930|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
461448|NCT00046943|adenocarcinoma of the prostate|adenocarcinoma of the prostate
461449|NCT00046943|recurrent prostate cancer|recurrent prostate cancer
461450|NCT00046943|stage IIB prostate cancer|stage iib prostate cancer
461451|NCT00046943|stage IIA prostate cancer|stage iia prostate cancer
461452|NCT00046943|stage III prostate cancer|stage iii prostate cancer
461453|NCT00046943|stage IV prostate cancer|stage iv prostate cancer
461454|NCT00046969|anemia|anemia
461455|NCT00046969|stage IIB cervical cancer|stage iib cervical cancer
461456|NCT00046969|stage III cervical cancer|stage iii cervical cancer
461457|NCT00046969|stage IVA cervical cancer|stage iva cervical cancer
461458|NCT00046969|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
461459|NCT00046969|cervical squamous cell carcinoma|cervical squamous cell carcinoma
461460|NCT00046969|cervical adenocarcinoma|cervical adenocarcinoma
461461|NCT00046995|adenocarcinoma of the colon|adenocarcinoma of the colon
461462|NCT00046995|stage IIB colon cancer|stage iib colon cancer
461463|NCT00046995|stage IIIA colon cancer|stage iiia colon cancer
461464|NCT00046995|stage IIIB colon cancer|stage iiib colon cancer
461465|NCT00046995|stage IIIC colon cancer|stage iiic colon cancer
461466|NCT00047008|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
461467|NCT00047008|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
461468|NCT00047008|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
461469|NCT00047008|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
461470|NCT00047008|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
461471|NCT00047008|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
461472|NCT00047008|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
461473|NCT00047008|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
461474|NCT00047021|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
461475|NCT00047021|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
461476|NCT00047021|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
461477|NCT00047021|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
461478|NCT00047021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
461479|NCT00047021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
461480|NCT00047021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
461481|NCT00047021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
479837|NCT00106132|Steroid|steroid
461482|NCT00047021|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
461483|NCT00047021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
461484|NCT00047021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
461485|NCT00047021|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
461486|NCT00047021|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
461703|NCT00047580|Spinal Cord Injury|spinal cord injury
461487|NCT00047021|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
461488|NCT00047021|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
461489|NCT00047021|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
461490|NCT00047021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
461491|NCT00047021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
461492|NCT00047021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
461493|NCT00047021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
461494|NCT00047021|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
461495|NCT00047021|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
461496|NCT00047021|secondary acute myeloid leukemia|secondary acute myeloid leukemia
461497|NCT00047021|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
461498|NCT00047021|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
461499|NCT00047021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
461500|NCT00047021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
461501|NCT00047021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
461502|NCT00047021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
461503|NCT00047021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
461504|NCT00047021|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
461505|NCT00047021|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
461506|NCT00047021|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
461507|NCT00047021|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
461508|NCT00047021|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
461509|NCT00047060|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
461510|NCT00047060|Allogeneic PBSCT|allogeneic pbsct
461511|NCT00047060|Low Intensity Regimen|low intensity regimen
461512|NCT00047060|Mycosis Fungoides|mycosis fungoides
461513|NCT00047060|Sezary Syndrome|sezary syndrome
461514|NCT00047060|CTCL|ctcl
461515|NCT00047073|recurrent adult brain tumor|recurrent adult brain tumor
461516|NCT00047073|adult glioblastoma|adult glioblastoma
461517|NCT00047073|adult giant cell glioblastoma|adult giant cell glioblastoma
461518|NCT00047073|adult gliosarcoma|adult gliosarcoma
461519|NCT00047099|stage II breast cancer|stage ii breast cancer
461520|NCT00047099|stage IIIA breast cancer|stage iiia breast cancer
461521|NCT00047099|stage IIIB breast cancer|stage iiib breast cancer
461522|NCT00047112|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
461523|NCT00047112|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
461524|NCT00047112|stage I esophageal cancer|stage i esophageal cancer
461525|NCT00047112|stage II esophageal cancer|stage ii esophageal cancer
461526|NCT00047125|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
461527|NCT00047125|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
461528|NCT00047138|blastema predominant Wilms tumor|blastema predominant wilms tumor
461529|NCT00047138|epithelial predominant Wilms tumor|epithelial predominant wilms tumor
461530|NCT00047138|mixed cell type Wilms tumor|mixed cell type wilms tumor
461531|NCT00047138|stage I Wilms tumor|stage i wilms tumor
461532|NCT00047138|stage II Wilms tumor|stage ii wilms tumor
461533|NCT00047138|stage III Wilms tumor|stage iii wilms tumor
461534|NCT00047138|stage IV Wilms tumor|stage iv wilms tumor
461535|NCT00047138|stage V Wilms tumor|stage v wilms tumor
461536|NCT00047138|stromal predominant Wilms tumor|stromal predominant wilms tumor
461537|NCT00047164|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
461538|NCT00047164|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
461539|NCT00047164|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
461540|NCT00047164|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
461541|NCT00047164|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
461542|NCT00047164|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
461543|NCT00047164|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
461544|NCT00047164|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
461545|NCT00047164|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
461546|NCT00047164|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
461547|NCT00047164|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
461548|NCT00047164|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
461549|NCT00047164|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
461690|NCT00047541|hypertension|hypertension
461550|NCT00047164|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
461551|NCT00047164|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
461552|NCT00047164|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
461553|NCT00047164|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
461702|NCT00047580|spasticity secondary to Multiple Sclerosis|spasticity secondary to multiple sclerosis
461554|NCT00047164|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
461555|NCT00047164|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
461556|NCT00047164|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
461557|NCT00047164|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
460857|NCT00035438|ocd|ocd
461558|NCT00047164|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
461559|NCT00047164|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
461560|NCT00047164|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
461561|NCT00047164|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
461562|NCT00047164|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
461563|NCT00047164|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
461564|NCT00047164|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
461565|NCT00047164|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
461566|NCT00047164|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
461567|NCT00047164|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
461568|NCT00047164|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
461569|NCT00047164|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
461570|NCT00047164|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
461571|NCT00047164|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
461572|NCT00047164|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
461573|NCT00047164|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
461574|NCT00047164|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
461575|NCT00047164|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
461576|NCT00047164|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
461577|NCT00047164|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
461578|NCT00047164|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
461579|NCT00047164|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
461580|NCT00047164|stage I mantle cell lymphoma|stage i mantle cell lymphoma
461581|NCT00047164|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
461582|NCT00047164|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
461583|NCT00047164|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
461584|NCT00047164|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
461585|NCT00047164|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
461586|NCT00047164|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
461587|NCT00047164|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
461588|NCT00047164|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
461589|NCT00047164|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
461590|NCT00047164|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
461591|NCT00047164|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
461592|NCT00047164|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
461593|NCT00047164|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
461594|NCT00047164|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
461595|NCT00047164|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
461596|NCT00047164|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
461597|NCT00047164|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
461598|NCT00047164|splenic marginal zone lymphoma|splenic marginal zone lymphoma
461599|NCT00047164|stage I marginal zone lymphoma|stage i marginal zone lymphoma
461600|NCT00047164|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
461601|NCT00047164|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
461602|NCT00047164|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
461603|NCT00047164|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
461604|NCT00047164|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
461605|NCT00047164|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
461606|NCT00047164|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
461607|NCT00047164|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
461608|NCT00047164|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
461609|NCT00047164|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
461610|NCT00047164|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
461611|NCT00047164|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
461612|NCT00047164|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
461613|NCT00047164|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
461614|NCT00047164|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
461704|NCT00047580|Stroke|stroke
461615|NCT00047164|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
461616|NCT00047164|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
460952|NCT00036257|CLL|cll
461617|NCT00047164|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
461618|NCT00047177|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
461619|NCT00047177|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
461620|NCT00047177|recurrent childhood ependymoma|recurrent childhood ependymoma
461621|NCT00047177|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
461622|NCT00047216|recurrent bladder cancer|recurrent bladder cancer
461623|NCT00047216|stage 0 bladder cancer|stage 0 bladder cancer
461624|NCT00047216|stage I bladder cancer|stage i bladder cancer
461625|NCT00047216|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
461626|NCT00047229|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
461627|NCT00047229|advanced adult primary liver cancer|advanced adult primary liver cancer
461628|NCT00047229|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
461629|NCT00047229|recurrent adult primary liver cancer|recurrent adult primary liver cancer
461630|NCT00047242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
461631|NCT00047255|stage IIIB breast cancer|stage iiib breast cancer
461632|NCT00047255|stage IIIC breast cancer|stage iiic breast cancer
461633|NCT00047255|stage IV breast cancer|stage iv breast cancer
461634|NCT00047255|recurrent breast cancer|recurrent breast cancer
461635|NCT00047268|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
461636|NCT00047268|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
461637|NCT00047268|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
461638|NCT00047268|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
461639|NCT00047268|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
461640|NCT00047281|adult anaplastic astrocytoma|adult anaplastic astrocytoma
461641|NCT00047281|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
461642|NCT00047281|adult glioblastoma|adult glioblastoma
461643|NCT00047281|adult mixed glioma|adult mixed glioma
461644|NCT00047281|recurrent adult brain tumor|recurrent adult brain tumor
461645|NCT00047281|adult giant cell glioblastoma|adult giant cell glioblastoma
461646|NCT00047281|adult gliosarcoma|adult gliosarcoma
461647|NCT00047294|adult mixed glioma|adult mixed glioma
461648|NCT00047294|adult glioblastoma|adult glioblastoma
461649|NCT00047294|adult giant cell glioblastoma|adult giant cell glioblastoma
461650|NCT00047294|adult gliosarcoma|adult gliosarcoma
461651|NCT00047320|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
461652|NCT00047320|childhood teratoma|childhood teratoma
461653|NCT00047320|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
461654|NCT00047320|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
461655|NCT00047320|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
461656|NCT00047320|childhood central nervous system germinoma|childhood central nervous system germinoma
461657|NCT00047320|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
461658|NCT00047320|childhood central nervous system teratoma|childhood central nervous system teratoma
461659|NCT00047320|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
461660|NCT00047320|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
461661|NCT00047385|small cell lung cancer|small cell lung cancer
461662|NCT00047385|non-small cell lung cancer|non-small cell lung cancer
461663|NCT00047411|CPR, AED|cpr, aed
461664|NCT00047450|Psychotic Disorders|psychotic disorders
461665|NCT00047463|epilepsy|epilepsy
461666|NCT00047463|sleep apnea|sleep apnea
461667|NCT00047463|obstructive sleep apnea|obstructive sleep apnea
461668|NCT00047463|continuous positive airway pressure|continuous positive airway pressure
461669|NCT00047463|CPAP|cpap
461670|NCT00047476|neurobehavioral function|neurobehavioral function
461671|NCT00047476|chemobrain|chemobrain
461672|NCT00047476|chemo brain|chemo brain
461673|NCT00047476|fatigue|fatigue
461674|NCT00047476|memory loss|memory loss
461675|NCT00047476|exhausted|exhausted
461676|NCT00047476|trouble concentrating|trouble concentrating
461677|NCT00047515|open-angle|open-angle
461678|NCT00047515|glaucoma|glaucoma
461679|NCT00047515|ocular|ocular
461680|NCT00047515|hypertension|hypertension
461681|NCT00047515|POAG|poag
461682|NCT00047528|open-angle|open-angle
461683|NCT00047528|glaucoma|glaucoma
461684|NCT00047528|ocular|ocular
461685|NCT00047528|hypertension|hypertension
461686|NCT00047528|POAG|poag
461687|NCT00047541|open-angle|open-angle
461688|NCT00047541|glaucoma|glaucoma
461689|NCT00047541|ocular|ocular
461695|NCT00047554|hypertension|hypertension
461696|NCT00047554|primary open-angle glaucoma|primary open-angle glaucoma
461697|NCT00047554|iris|iris
461698|NCT00047554|pigmentation|pigmentation
461699|NCT00047567|ZONISAMIDE|zonisamide
461700|NCT00047567|BIPOLAR|bipolar
461708|NCT00047593|hypertension|hypertension
461709|NCT00047593|POAG|poag
461710|NCT00047593|Iris|iris
461711|NCT00047593|Pigmentation|pigmentation
461712|NCT00047593|Japanese|japanese
461713|NCT00047606|open-angle|open-angle
461714|NCT00047606|glaucoma|glaucoma
461715|NCT00047606|ocular|ocular
461716|NCT00047606|hypertension|hypertension
461717|NCT00047606|POAG|poag
461718|NCT00047606|Iris|iris
461719|NCT00047606|Pigmentation|pigmentation
461720|NCT00047606|Japanese|japanese
461721|NCT00047619|Decubitus Ulcers|decubitus ulcers
461722|NCT00047619|Pulsatile Lavage|pulsatile lavage
461723|NCT00047619|SCI|sci
461724|NCT00047619|Spinal Cord Injury|spinal cord injury
461725|NCT00047619|Wound healing|wound healing
461726|NCT00047619|pressure ulcer|pressure ulcer
461727|NCT00047632|ovarian|ovarian
461728|NCT00047632|carcinoma|carcinoma
461729|NCT00047632|peritoneal|peritoneal
461730|NCT00047632|cancer|cancer
461731|NCT00047632|ovary|ovary
461732|NCT00047632|interferon gamma|interferon gamma
461733|NCT00047645|lung|lung
461734|NCT00047645|IPF|ipf
461735|NCT00047671|Depressive Disorder|depressive disorder
461736|NCT00047684|Child Abuse, Sexual|child abuse, sexual
461737|NCT00047710|pancreatic cancer|pancreatic cancer
461738|NCT00047710|pancreas cancer|pancreas cancer
461739|NCT00047710|pancreas|pancreas
461740|NCT00047723|ALS|als
461741|NCT00047723|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
461742|NCT00047723|minocycline|minocycline
461743|NCT00047736|Non-small cell lung cancer|non-small cell lung cancer
461744|NCT00047749|pain|pain
461745|NCT00047749|ziconotide|ziconotide
461746|NCT00047749|Prialt|prialt
461747|NCT00047749|intrathecal|intrathecal
461748|NCT00047749|Synchromed|synchromed
461749|NCT00047788|Relapsed Multiple Myeloma|relapsed multiple myeloma
461750|NCT00047814|HCV|hcv
461751|NCT00047827|Aspergillus|aspergillus
461752|NCT00047827|Aspergillosis|aspergillosis
461753|NCT00047827|Anti-Fungal|anti-fungal
461754|NCT00047827|AmBisome|ambisome
461755|NCT00047827|Micafungin|micafungin
461756|NCT00047853|Anxiety|anxiety
461757|NCT00047853|Neuroimaging|neuroimaging
461758|NCT00047853|Affective Neuroscience|affective neuroscience
461759|NCT00047853|Healthy Volunteer|healthy volunteer
461760|NCT00047853|HV|hv
461761|NCT00047866|Limbic System|limbic system
461762|NCT00047866|Amphetamine|amphetamine
461763|NCT00047866|Dopamine|dopamine
461764|NCT00047866|Brain Imaging|brain imaging
461765|NCT00047866|Cerebral Blood Flow|cerebral blood flow
461766|NCT00047866|Cerebral Blood Volume|cerebral blood volume
461767|NCT00047866|Alcoholism|alcoholism
461768|NCT00047866|Tyrosine Depletion|tyrosine depletion
461769|NCT00047866|Amino Acids|amino acids
461770|NCT00047866|Affect|affect
461771|NCT00047866|Healthy Volunteer|healthy volunteer
461772|NCT00047866|HV|hv
461773|NCT00047879|Brain Tumors|brain tumors
461774|NCT00047879|Experimental|experimental
461775|NCT00047879|Toxicities|toxicities
461776|NCT00047879|Efficacy|efficacy
461777|NCT00047879|Progression-Free|progression-free
461778|NCT00047879|Brain Tumor|brain tumor
461779|NCT00047879|Glioma|glioma
461780|NCT00047905|Qualitative|qualitative
461781|NCT00047905|Communication Analysis|communication analysis
461782|NCT00047905|RIAS|rias
461783|NCT00047905|Counseling Models|counseling models
461784|NCT00047905|Videotaping|videotaping
461785|NCT00047905|Prenatal Genetic Counselors|prenatal genetic counselors
461786|NCT00047905|Counseling Process|counseling process
461787|NCT00047905|Video Tape Study|video tape study
461788|NCT00047905|Simulated Clients|simulated clients
461789|NCT00047905|Prenatal Genetic Counseling|prenatal genetic counseling
461790|NCT00047918|Mast Cells|mast cells
461791|NCT00047918|Bone Marrow|bone marrow
461792|NCT00047918|Flushing|flushing
461793|NCT00047918|Mutations|mutations
461794|NCT00047918|Mastocytosis|mastocytosis
461795|NCT00047918|Anaphylaxis|anaphylaxis
461796|NCT00047931|Healthy|healthy
461797|NCT00047931|HIV-Negative|hiv-negative
461798|NCT00047931|Placebo-Controlled|placebo-controlled
461799|NCT00047931|Volunteer|volunteer
461800|NCT00047931|Dose-Escalation|dose-escalation
461801|NCT00047931|HIV Seronegativity|hiv seronegativity
461802|NCT00047931|Healthy Volunteer|healthy volunteer
461803|NCT00047931|HV|hv
461804|NCT00047944|Attention|attention
461805|NCT00047944|Emotion|emotion
461806|NCT00047944|Amygdala|amygdala
461807|NCT00047944|Prefrontal Cortex|prefrontal cortex
461808|NCT00047944|Facial Expression|facial expression
461809|NCT00047944|Magnetic Resonance Imaging|magnetic resonance imaging
461810|NCT00047944|fMRI|fmri
461811|NCT00047944|Depression|depression
461812|NCT00047944|Anxiety|anxiety
461813|NCT00047944|Adolescence|adolescence
461814|NCT00047944|Children|children
461815|NCT00047957|Transcranial|transcranial
461816|NCT00047957|Magnetic|magnetic
461817|NCT00047957|Stimulation|stimulation
461818|NCT00047957|Motor|motor
461819|NCT00047957|Cortex|cortex
461820|NCT00047957|Motor Cortex|motor cortex
461821|NCT00047957|Afferent Stimulation|afferent stimulation
461822|NCT00047957|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
461823|NCT00047957|Healthy Volunteer|healthy volunteer
461824|NCT00047957|HV|hv
461825|NCT00047970|Breast Cancer|breast cancer
461826|NCT00047970|Sisters|sisters
461827|NCT00047983|Kidney Transplantation|kidney transplantation
461828|NCT00047983|Fatty Acids, Omega-3|fatty acids, omega-3
461829|NCT00047983|Erythrocyte Membrane|erythrocyte membrane
461830|NCT00047983|Graft Survival|graft survival
461831|NCT00048087|Non-small cell lung cancer|non-small cell lung cancer
461832|NCT00048100|Dendritic cells|dendritic cells
461833|NCT00048100|Lymphocytes|lymphocytes
461834|NCT00048100|AML|aml
461835|NCT00048113|Crohn's|crohn's
461836|NCT00048204|Depression|depression
461837|NCT00048204|Psychiatry|psychiatry
461838|NCT00048204|Major Depressive Disorder|major depressive disorder
461839|NCT00048217|Treatment Experienced|treatment experienced
461840|NCT00048230|Relapsed Multiple Myeloma|relapsed multiple myeloma
461841|NCT00048230|Refractory Multiple Myeloma|refractory multiple myeloma
461842|NCT00048256|Cancer|cancer
461843|NCT00048256|Personality Assessment|personality assessment
461844|NCT00048256|Coping Styles|coping styles
461845|NCT00048256|Psychological Distress|psychological distress
461846|NCT00048256|Bone Marrow Transplants|bone marrow transplants
461847|NCT00048256|Bone Marrow Transplant|bone marrow transplant
461848|NCT00048282|Incidence|incidence
461849|NCT00048282|HIV Seroprevalence|hiv seroprevalence
461850|NCT00048282|Vagina|vagina
461851|NCT00048282|Anti-Infective Agents|anti-infective agents
461852|NCT00048282|Administration, Topical|administration, topical
461853|NCT00048282|Gels|gels
461854|NCT00048282|HIV Seronegativity|hiv seronegativity
461855|NCT00048308|CABG|cabg
461856|NCT00048334|Histone Acetylation|histone acetylation
461857|NCT00048334|Cancer|cancer
461858|NCT00048347|Lymphocyte|lymphocyte
461859|NCT00048347|Monocyte|monocyte
461860|NCT00048347|Inflammation|inflammation
461861|NCT00048347|Th2|th2
461862|NCT00048347|Colonoscopy|colonoscopy
461863|NCT00048347|Ulcerative Colitis|ulcerative colitis
461864|NCT00048360|ADD|add
461865|NCT00048360|ADHD|adhd
461866|NCT00048360|attention deficit|attention deficit
461867|NCT00048360|hyperactivity|hyperactivity
461868|NCT00048373|LANGERHANS|langerhans
461869|NCT00048373|HISTIOCYTOSIS|histiocytosis
461870|NCT00048425|Decompensated chronic heart failure|decompensated chronic heart failure
461871|NCT00048464|Immunotherapy|immunotherapy
461872|NCT00048464|T Cell Therapy|t cell therapy
461873|NCT00048464|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
461874|NCT00048464|Bone marrow transplant|bone marrow transplant
461875|NCT00048464|Adoptive immunotherapy|adoptive immunotherapy
461876|NCT00048464|Xcellerate|xcellerate
461877|NCT00048477|Endothelium|endothelium
461878|NCT00048477|Vasodilation|vasodilation
461879|NCT00048477|Exercise|exercise
461880|NCT00048477|Hemoglobin|hemoglobin
461881|NCT00048477|Blood Flow|blood flow
461882|NCT00048477|Healthy Volunteer|healthy volunteer
461883|NCT00048477|HV|hv
461884|NCT00048490|Seizures|seizures
461885|NCT00048490|Magnetism|magnetism
461886|NCT00048490|Brain|brain
461887|NCT00048490|Stimulation|stimulation
461888|NCT00048490|Therapy|therapy
461889|NCT00048490|Epilepsy|epilepsy
461890|NCT00048503|Zarnestra|zarnestra
461891|NCT00048503|Acute myeloid leukemia|acute myeloid leukemia
461892|NCT00048503|Tipifarnib|tipifarnib
461893|NCT00048529|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
461894|NCT00048542|Polyarticular Juvenile Idiopathic Arthritis|polyarticular juvenile idiopathic arthritis
461895|NCT00048633|Chemotherapy resistance advanced breast cancer|chemotherapy resistance advanced breast cancer
461896|NCT00048646|TBI|tbi
461897|NCT00048646|ProTECT|protect
461898|NCT00048659|Androgen-independent prostate cancer|androgen-independent prostate cancer
461899|NCT00048672|Early Chronic Phase Chronic Myelogenous Leukemia|early chronic phase chronic myelogenous leukemia
461900|NCT00048672|Leukemia|leukemia
461901|NCT00048672|Gleevec|gleevec
461902|NCT00048672|STI571|sti571
461903|NCT00048672|Imatinib mesylate|imatinib mesylate
461904|NCT00048685|Caries|caries
461905|NCT00048685|Bacteria|bacteria
461906|NCT00048685|Saliva|saliva
461907|NCT00048685|Teeth|teeth
461908|NCT00048685|Autoimmune|autoimmune
461909|NCT00048685|Dry Mouth|dry mouth
461910|NCT00048685|Salivary Gland Dysfunction|salivary gland dysfunction
461911|NCT00048685|Sjogren's Syndrome|sjogren's syndrome
461912|NCT00048698|Frontal Lobe|frontal lobe
461913|NCT00048698|Motor Cortex|motor cortex
461914|NCT00048698|Dementia|dementia
461915|NCT00048698|Cognition|cognition
592030|NCT00544128|HIV|hiv
461916|NCT00048698|Healthy Volunteer|healthy volunteer
461917|NCT00048698|HV|hv
461918|NCT00048724|Hepatitis C; Cirrhosis|hepatitis c; cirrhosis
461919|NCT00048737|Leukemia|leukemia
461920|NCT00048737|Lymphoma|lymphoma
461921|NCT00048737|Lymphoid Malignancy|lymphoid malignancy
461922|NCT00048737|Cyclophosphamide|cyclophosphamide
461923|NCT00048737|Cytoxan|cytoxan
461924|NCT00048737|Neosar|neosar
461926|NCT00048737|Fludarabine Phosphate|fludarabine phosphate
461927|NCT00048737|Fludara|fludara
461928|NCT00048737|Rituximab|rituximab
461929|NCT00048737|Rituxan|rituxan
461930|NCT00048737|Zevalin|zevalin
461931|NCT00048737|Indium Zevalin|indium zevalin
461932|NCT00048737|90Y Zevalin|90y zevalin
461933|NCT00048737|CD-20-positive|cd-20-positive
461934|NCT00048737|B-cell Lymphoma|b-cell lymphoma
461935|NCT00048737|CD-20-positive B-cell Lymphoma|cd-20-positive b-cell lymphoma
461936|NCT00048737|NHL|nhl
461937|NCT00048737|CLL|cll
461938|NCT00048737|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
461939|NCT00048737|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
461940|NCT00048737|ASCT|asct
461941|NCT00048750|Anti-Fungal Therapy|anti-fungal therapy
461942|NCT00048750|Preemptive Anti-Fungal Therapy|preemptive anti-fungal therapy
461943|NCT00048750|Invasive Fungal Infection|invasive fungal infection
461944|NCT00048750|Micafungin|micafungin
461945|NCT00048750|ICU|icu
461946|NCT00048763|circulatory|circulatory
461947|NCT00048763|vascular|vascular
461948|NCT00048763|idiopathic|idiopathic
461949|NCT00048776|Secondary Raynaud's|secondary raynaud's
461950|NCT00048776|circulatory|circulatory
461951|NCT00048776|vascular|vascular
461952|NCT00048776|scleroderma|scleroderma
461953|NCT00048776|lupus|lupus
461954|NCT00048776|mixed connective tissue disease|mixed connective tissue disease
461955|NCT00048789|Psoralen|psoralen
461956|NCT00048789|Refractory|refractory
461957|NCT00048789|Transplantation|transplantation
461958|NCT00048789|Stem Cell|stem cell
461959|NCT00048789|UVA|uva
461960|NCT00048789|Graft-versus-host Disease|graft-versus-host disease
461961|NCT00048789|GVHD|gvhd
461962|NCT00048802|Adolescence|adolescence
461963|NCT00048841|Male|male
461964|NCT00048841|Osteoporosis|osteoporosis
461965|NCT00048841|Prostate cancer|prostate cancer
461966|NCT00048841|Hypogonadism|hypogonadism
461967|NCT00048841|Bisphosphonates|bisphosphonates
461968|NCT00048841|Bone mineral density|bone mineral density
461969|NCT00048880|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
461970|NCT00048880|Monoclonal Antibody|monoclonal antibody
461971|NCT00048880|CD30|cd30
461972|NCT00048880|Antibody Saturation|antibody saturation
461973|NCT00048880|Apoptosis|apoptosis
461974|NCT00048880|Flow Cytometry|flow cytometry
461976|NCT00048893|CEA vaccine|cea vaccine
461977|NCT00048893|Metastatic Breast Cancer|metastatic breast cancer
461978|NCT00048893|T- Cell Repertoire|t- cell repertoire
461979|NCT00048893|High-dose Chemotherapy|high-dose chemotherapy
461980|NCT00048893|Breast Cancer|breast cancer
461981|NCT00033917|intraventricular hemorrhage (IVH)|intraventricular hemorrhage (ivh)
461982|NCT00033917|bleeding in the brain|bleeding in the brain
461983|NCT00033917|indomethacin|indomethacin
461984|NCT00033917|prematurity|prematurity
461985|NCT00033917|very low birth weight infants|very low birth weight infants
461986|NCT00033956|Metastatic Melanoma|metastatic melanoma
461987|NCT00033956|Renal Cell Carcinoma|renal cell carcinoma
461988|NCT00033956|IL-2|il-2
461989|NCT00033956|Interleukin-2|interleukin-2
461990|NCT00033956|Hypotension|hypotension
461991|NCT00033969|CRPS|crps
461992|NCT00033969|RSD|rsd
461993|NCT00033969|Causalgia|causalgia
461994|NCT00033969|Chronic Pain|chronic pain
461995|NCT00033969|Neuropathic Pain|neuropathic pain
461996|NCT00033969|Normal Control|normal control
461997|NCT00033969|Complex Regional Pain Syndrome|complex regional pain syndrome
461998|NCT00033969|Healthy Volunteer|healthy volunteer
461999|NCT00033969|HV|hv
462000|NCT00033982|Triazole|triazole
462001|NCT00033982|Refractory|refractory
462002|NCT00033982|Antifungal|antifungal
462003|NCT00033982|Fungal Infection|fungal infection
462004|NCT00033995|Tics|tics
462005|NCT00033995|Basal Ganglia|basal ganglia
462006|NCT00033995|Neuroimaging|neuroimaging
462007|NCT00033995|Sleep|sleep
462008|NCT00033995|Suppression of Tics|suppression of tics
462009|NCT00033995|Tourette Syndrome|tourette syndrome
462010|NCT00033995|Tourette's Syndrome|tourette's syndrome
462011|NCT00033995|Tic Disorder|tic disorder
462012|NCT00033995|Healthy Volunteer|healthy volunteer
462013|NCT00033995|HV|hv
462014|NCT00033995|Normal Control|normal control
462015|NCT00034008|Energy Medicine|energy medicine
462016|NCT00034008|Healing Touch|healing touch
462017|NCT00034008|CAM Research|cam research
462018|NCT00034008|Neonates|neonates
462019|NCT00034008|Stress|stress
462020|NCT00034008|Conditions resulting from stress|conditions resulting from stress
462021|NCT00034008|Neonatal intensive care|neonatal intensive care
461342|NCT00046436|Anti-HIV Agents|anti-hiv agents
462022|NCT00034008|Healing of stress and prevention of negative|healing of stress and prevention of negative
462023|NCT00034008|Developmental outcomes – physical and behavioral|developmental outcomes – physical and behavioral
462024|NCT00034008|Therapeutic Touch|therapeutic touch
462025|NCT00034008|Touch therapies|touch therapies
462026|NCT00034008|Energy therapies|energy therapies
462027|NCT00034008|Infant touch|infant touch
462028|NCT00034008|Infant stimulation|infant stimulation
462029|NCT00034021|Female Sexual Arousal Disorder|female sexual arousal disorder
462030|NCT00034021|Female Orgasmic Disorder|female orgasmic disorder
462031|NCT00034021|ginkgo biloba|ginkgo biloba
462032|NCT00034021|human therapy evaluation|human therapy evaluation
462033|NCT00034021|sex behavior|sex behavior
462034|NCT00034021|antidepressant|antidepressant
462035|NCT00034021|blood flow|blood flow
462036|NCT00034021|clinical trial|clinical trial
462037|NCT00034021|drug adverse effect|drug adverse effect
462038|NCT00034021|mental disorder chemotherapy|mental disorder chemotherapy
462039|NCT00034021|relaxation|relaxation
462040|NCT00034021|smooth muscle|smooth muscle
462041|NCT00034021|alternative medicine|alternative medicine
462042|NCT00034021|blood flow measurement|blood flow measurement
462043|NCT00034021|female|female
462044|NCT00034021|placebo|placebo
462045|NCT00034021|women's health|women's health
462046|NCT00034021|Secondary to either to fluoxetine, sertraline, or paroxetine use.|secondary to either to fluoxetine, sertraline, or paroxetine use.
462047|NCT00039650|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
462048|NCT00039650|T Cells|t cells
462049|NCT00039650|Peripheral Blood Stem Cells|peripheral blood stem cells
462050|NCT00039650|Apheresis|apheresis
462051|NCT00039650|Hematopoietic Progenitor Cell Transplantation|hematopoietic progenitor cell transplantation
462052|NCT00039650|Healthy Volunteer|healthy volunteer
462053|NCT00039650|HV|hv
462054|NCT00039650|Normal Control|normal control
462055|NCT00039663|Hyperlipidemia|hyperlipidemia
462056|NCT00039663|Insulin Resistance|insulin resistance
462057|NCT00039663|Coronary Artery Disease|coronary artery disease
462058|NCT00039663|Lipodystrophy|lipodystrophy
462059|NCT00039663|Antiretroviral Therapy|antiretroviral therapy
462060|NCT00039663|HIV Infection|hiv infection
462061|NCT00039663|Treatment Experienced|treatment experienced
462062|NCT00039676|Genetics|genetics
462063|NCT00039676|Risk Factors|risk factors
462064|NCT00039676|Natural History|natural history
462065|NCT00039676|Lymphoma|lymphoma
462066|NCT00039676|Leukemia|leukemia
462067|NCT00039676|Lymph Node Cancer|lymph node cancer
462068|NCT00039689|Primary HIV Infection|primary hiv infection
462069|NCT00039689|Chronic HIV Infection|chronic hiv infection
462070|NCT00039689|Antiretroviral Therapy|antiretroviral therapy
462071|NCT00039689|Innate Immunity|innate immunity
462072|NCT00039689|B Cell|b cell
462073|NCT00039689|HIV Infection|hiv infection
462074|NCT00039689|Acute Infection|acute infection
462075|NCT00039689|Treatment Naive|treatment naive
462076|NCT00039702|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
462077|NCT00039702|Alzheimer's Disease|alzheimer's disease
462078|NCT00039702|SPECT|spect
462079|NCT00039702|AD|ad
462080|NCT00039702|Healthy Volunteer|healthy volunteer
462081|NCT00039702|HV|hv
462082|NCT00039702|Normal Control|normal control
462083|NCT00039715|Glucocorticoid Receptor|glucocorticoid receptor
462084|NCT00039715|Traumatic Reminders|traumatic reminders
462086|NCT00039715|Hippocampus|hippocampus
462087|NCT00039715|Flashbacks|flashbacks
462088|NCT00039715|PTSD|ptsd
462089|NCT00039715|Type II GR Receptor|type ii gr receptor
462090|NCT00039715|Hydrocortisone|hydrocortisone
462091|NCT00039715|Memory|memory
462092|NCT00039715|Major Depression|major depression
462093|NCT00039715|Post-Traumatic Stress Disorder|post-traumatic stress disorder
462094|NCT00039715|Healthy Volunteer|healthy volunteer
462095|NCT00039715|HV|hv
462096|NCT00039715|Normal Control|normal control
462097|NCT00039741|Drug Therapy, Combination|drug therapy, combination
462098|NCT00039741|HIV Protease Inhibitors|hiv protease inhibitors
462099|NCT00039741|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
462100|NCT00039741|Viral Load|viral load
462101|NCT00039741|Treatment Naive|treatment naive
462102|NCT00039754|Multiple myeloma|multiple myeloma
462103|NCT00039754|Transplant|transplant
462104|NCT00039754|Skeletal Targeted Radiotherapy|skeletal targeted radiotherapy
462105|NCT00039754|Holmium|holmium
462106|NCT00039767|Fibrin Sleeves|fibrin sleeves
462107|NCT00039767|Anticoagulants|anticoagulants
462108|NCT00039767|Catheters|catheters
462109|NCT00039767|Thrombosis|thrombosis
462110|NCT00039767|Hirudin|hirudin
462111|NCT00039767|Lepirudin|lepirudin
462112|NCT00039780|Breast|breast
462113|NCT00039780|Cancer|cancer
462114|NCT00039780|Metastatic|metastatic
462115|NCT00039780|Paclitaxel|paclitaxel
462116|NCT00039780|Peripheral|peripheral
462117|NCT00039780|Taxol|taxol
462118|NCT00039780|Neuropathy|neuropathy
462119|NCT00039780|Neurotoxicity|neurotoxicity
462120|NCT00039780|Paresthesias|paresthesias
462126|NCT00039793|Cancer-related fatigue|cancer-related fatigue
462127|NCT00039793|alternative medicine|alternative medicine
462128|NCT00039793|cancer rehabilitation /care|cancer rehabilitation /care
462129|NCT00039793|fatigue|fatigue
462130|NCT00039793|human therapy evaluation|human therapy evaluation
462131|NCT00039793|physical therapy|physical therapy
462132|NCT00039793|neoplasm /cancer chemotherapy|neoplasm /cancer chemotherapy
462133|NCT00039793|neoplasm /cancer palliative treatment|neoplasm /cancer palliative treatment
462134|NCT00039819|Spinal Cord|spinal cord
462135|NCT00039819|Sensory Stimulation|sensory stimulation
462136|NCT00039819|Locomotion|locomotion
462137|NCT00039819|Magnetic Stimulation|magnetic stimulation
462138|NCT00039819|Reflexes|reflexes
462139|NCT00039819|Healthy Volunteer|healthy volunteer
462141|NCT00039819|Normal Control|normal control
462142|NCT00039832|Stroke|stroke
462143|NCT00039832|Abciximab|abciximab
462144|NCT00039832|Reteplase|reteplase
462145|NCT00039832|MRI|mri
462146|NCT00039832|Cerebral Blood Flow|cerebral blood flow
462147|NCT00039845|Brain|brain
462148|NCT00039845|Imaging|imaging
462149|NCT00039845|Pediatrics|pediatrics
462150|NCT00039845|Mapping|mapping
462151|NCT00039845|Development|development
462152|NCT00039845|fMRI|fmri
462153|NCT00039845|Children|children
462154|NCT00039845|Language|language
462155|NCT00039845|Healthy Volunteer|healthy volunteer
462156|NCT00039845|HV|hv
462157|NCT00039845|Normal Control|normal control
462158|NCT00039858|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
462159|NCT00039858|heparin-induced thrombocytopenia and thrombosis|heparin-induced thrombocytopenia and thrombosis
462160|NCT00039858|HIT|hit
462161|NCT00039858|HITTS|hitts
462162|NCT00039858|anticoagulation|anticoagulation
462163|NCT00039884|Cervical cancer|cervical cancer
462164|NCT00039923|Hemolysis|hemolysis
462165|NCT00039923|CD55|cd55
462166|NCT00039923|CD59|cd59
462167|NCT00039923|Transfusion|transfusion
462168|NCT00039923|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
462169|NCT00039923|PNH|pnh
462170|NCT00039936|Binge Eating|binge eating
462171|NCT00039936|Obesity|obesity
462172|NCT00039936|Cognitive|cognitive
462173|NCT00039936|Behavior|behavior
462174|NCT00039962|hepatitis C|hepatitis c
462175|NCT00039962|hepatitis C, chronic|hepatitis c, chronic
462176|NCT00039962|cirrhosis, liver|cirrhosis, liver
462177|NCT00039975|Drug Interactions|drug interactions
462178|NCT00039975|HIV Protease Inhibitors|hiv protease inhibitors
462179|NCT00039975|Ritonavir|ritonavir
462180|NCT00039975|Indinavir|indinavir
462181|NCT00039975|Calcium Channel Blockers|calcium channel blockers
462182|NCT00039975|Pharmacokinetics|pharmacokinetics
462183|NCT00039975|Diltiazem|diltiazem
462184|NCT00039975|Amlodipine|amlodipine
462185|NCT00039988|Treatment Outcome|treatment outcome
462186|NCT00039988|Multiple Sclerosis|multiple sclerosis
462187|NCT00039988|Albuterol|albuterol
462188|NCT00039988|Copolymer 1|copolymer 1
462189|NCT00040027|hepatitis C|hepatitis c
462190|NCT00040027|hepatitis C, chronic|hepatitis c, chronic
462191|NCT00040053|amphetamine dependence|amphetamine dependence
462192|NCT00040092|Virulizin|virulizin
462193|NCT00040092|Immunotherapy|immunotherapy
462194|NCT00040092|Pancreas|pancreas
462195|NCT00040092|Pancreatic Cancer|pancreatic cancer
462196|NCT00040092|clinical trial|clinical trial
462197|NCT00040105|Chronic Myelogenous Leukemia, Chronic Phase|chronic myelogenous leukemia, chronic phase
462198|NCT00040105|R115777|r115777
462199|NCT00040105|Zarnestra|zarnestra
462200|NCT00040105|Tipifarnib|tipifarnib
462201|NCT00040105|Imatinib Mesylate|imatinib mesylate
462202|NCT00040105|Gleevec|gleevec
462203|NCT00040105|Imatinib|imatinib
462204|NCT00040105|STI571|sti571
462205|NCT00040105|NSC-716051|nsc-716051
462206|NCT00040144|E-Antigen positive,|e-antigen positive,
462207|NCT00040144|Lamivudine-Resistant Chronic Hepatitis B,|lamivudine-resistant chronic hepatitis b,
462208|NCT00040144|Achillion|achillion
462209|NCT00040157|treatment experienced,|treatment experienced,
462210|NCT00040157|Stable triple anti-retroviral combination therapy in HIV-infected,|stable triple anti-retroviral combination therapy in hiv-infected,
462211|NCT00040157|Achillion|achillion
462212|NCT00040170|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
462213|NCT00040183|Tarceva, EGFR, erlotinib, OSI-774|tarceva, egfr, erlotinib, osi-774
462214|NCT00040196|Parkinson's Disease|parkinson's disease
462215|NCT00040196|Levodopa|levodopa
462216|NCT00040196|Perfusion fMRI|perfusion fmri
462217|NCT00040196|Aging|aging
462218|NCT00040196|Motor Control|motor control
462219|NCT00040196|PD|pd
462220|NCT00040196|Healthy Volunteer|healthy volunteer
462221|NCT00040196|HV|hv
462222|NCT00040196|Normal Control|normal control
462223|NCT00040209|JP 1730|jp 1730
462224|NCT00040209|Dyskinesias|dyskinesias
462225|NCT00040209|Levodopa Infusion|levodopa infusion
462226|NCT00040209|Apomorphine Infusion|apomorphine infusion
462227|NCT00040209|Clinical Trial|clinical trial
462228|NCT00040209|Parkinson Disease|parkinson disease
462229|NCT00040209|PD|pd
480459|NCT00100191|menorrhagia|menorrhagia
462230|NCT00040222|Counseling/behavioral/psychosocial|counseling/behavioral/psychosocial
462231|NCT00040222|Gene discovery|gene discovery
462232|NCT00040222|Cancer prevention|cancer prevention
462233|NCT00040222|Risk-reduction|risk-reduction
462234|NCT00040222|Hereditary|hereditary
462235|NCT00040222|Breast Cancer|breast cancer
462236|NCT00040222|Ovarian Cancer|ovarian cancer
462237|NCT00040222|Cowden Syndrome|cowden syndrome
462238|NCT00040222|Peutz-Jegher Syndrome|peutz-jegher syndrome
462239|NCT00040222|Li-Fraumeni Syndrome|li-fraumeni syndrome
462240|NCT00040235|Leukapheresis|leukapheresis
462241|NCT00040235|Hypomagnesemia|hypomagnesemia
462242|NCT00040235|Plateletpheresis|plateletpheresis
462243|NCT00040235|Hypocalcemia|hypocalcemia
462244|NCT00040235|Citrate|citrate
462245|NCT00040235|Healthy Volunteer|healthy volunteer
462246|NCT00040235|HV|hv
462247|NCT00040235|Normal Control|normal control
462248|NCT00040248|Relapse|relapse
462249|NCT00040248|Monoclonal Antibody|monoclonal antibody
462250|NCT00040248|Biologic Agent|biologic agent
462251|NCT00040248|Anti-CD25|anti-cd25
462252|NCT00040248|Activated Lymphocyte|activated lymphocyte
462253|NCT00040248|Wegener Granulomatosis|wegener granulomatosis
462254|NCT00040248|Wegener's Granulomatosis|wegener's granulomatosis
462255|NCT00040248|WG|wg
462256|NCT00040261|Antiglutamatergic|antiglutamatergic
462257|NCT00040261|Neuroprotective|neuroprotective
462258|NCT00040261|Unipolar Depression|unipolar depression
462259|NCT00040261|Treatment|treatment
462260|NCT00040261|Antidepressant|antidepressant
462261|NCT00040261|Depression|depression
462262|NCT00040261|Glutamate|glutamate
462263|NCT00040261|Memantine|memantine
462264|NCT00040261|Pathophysiology|pathophysiology
462265|NCT00040261|Positron Emission Tomography|positron emission tomography
462266|NCT00040261|Major Depression|major depression
462267|NCT00040274|HIV|hiv
462268|NCT00040274|Phase I|phase i
462269|NCT00040287|smoking|smoking
462270|NCT00040287|obesity|obesity
462271|NCT00040287|weight loss|weight loss
462272|NCT00040287|smoking cessation|smoking cessation
462273|NCT00040287|weight control|weight control
462274|NCT00040300|treatment experienced|treatment experienced
462275|NCT00040300|HIV|hiv
462276|NCT00040300|Phase I|phase i
462277|NCT00040300|Combination Therapy|combination therapy
462278|NCT00040326|epilepsy|epilepsy
462279|NCT00040326|mesial temporal lobe epilepsy|mesial temporal lobe epilepsy
462280|NCT00040326|temporal lobe epilepsy|temporal lobe epilepsy
462281|NCT00040326|MTLE|mtle
462282|NCT00040326|seizures|seizures
462283|NCT00040326|anteromesial temporal resection|anteromesial temporal resection
462284|NCT00040326|surgery|surgery
462285|NCT00040326|antiepileptic drugs|antiepileptic drugs
462286|NCT00040326|hippocampal sclerosis|hippocampal sclerosis
462287|NCT00040339|brain injury|brain injury
462288|NCT00040339|hypothermia|hypothermia
462289|NCT00040339|body cooling|body cooling
462290|NCT00040339|body temperature|body temperature
462291|NCT00040352|Genetics|genetics
462292|NCT00040352|Risk Factors|risk factors
462293|NCT00040352|Natural History|natural history
462294|NCT00040352|Melanoma Precursors|melanoma precursors
462295|NCT00040352|Skin Cancer|skin cancer
462296|NCT00040352|Melanoma|melanoma
462297|NCT00040365|Prostate Cancer|prostate cancer
462298|NCT00040365|Radiation Therapy|radiation therapy
462299|NCT00040365|Rectal Toxicity|rectal toxicity
462300|NCT00040365|Amifostine|amifostine
462301|NCT00040365|Radioprotector|radioprotector
462302|NCT00040378|Alzheimer Disease|alzheimer disease
462303|NCT00040378|Vitamin E|vitamin e
462304|NCT00040378|Selenium|selenium
462305|NCT00040391|Pharmacia|pharmacia
462306|NCT00040404|Parkinson's disease|parkinson's disease
462307|NCT00040404|Idiopathic Parkinson's disease|idiopathic parkinson's disease
462308|NCT00040404|Idiopathic Parkinson disease|idiopathic parkinson disease
462309|NCT00040404|Parkinson's disease, idiopathic|parkinson's disease, idiopathic
462310|NCT00040443|Mild Cognitive Impairment|mild cognitive impairment
462311|NCT00040443|Memory Loss|memory loss
462312|NCT00040443|Alzheimer's Disease|alzheimer's disease
462313|NCT00040443|Brain Aging|brain aging
462314|NCT00040443|Ampalex®|ampalex®
462315|NCT00040443|CX516|cx516
462316|NCT00040456|Hemoglobin SC disease|hemoglobin sc disease
462317|NCT00040456|sickle cell-hemoglobin|sickle cell-hemoglobin
462318|NCT00040495|Peptic|peptic
462319|NCT00040495|Ulcer|ulcer
462320|NCT00040495|Hemorrhage|hemorrhage
462321|NCT00040508|Proteinuria|proteinuria
462322|NCT00040508|Renal Failure|renal failure
462323|NCT00040508|Fibrosis|fibrosis
462324|NCT00040508|Rapamycin|rapamycin
462325|NCT00040508|Immunosuppression|immunosuppression
462326|NCT00040508|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
462327|NCT00040508|FSGS|fsgs
462328|NCT00040521|Crohn's Disease|crohn's disease
462329|NCT00040521|Active Crohns Disease|active crohns disease
462330|NCT00040534|Advanced Cancer|advanced cancer
462331|NCT00040547|Cancer-Advanced Solid Tumors|cancer-advanced solid tumors
462332|NCT00040560|Lung Cancer|lung cancer
462333|NCT00040560|Metastatic Brain Cancer|metastatic brain cancer
462334|NCT00040573|Brain neoplasm|brain neoplasm
462335|NCT00040573|Clinical trial, phase I/II|clinical trial, phase i/ii
462336|NCT00040586|hormone-refractory|hormone-refractory
462337|NCT00040599|Colon Cancer|colon cancer
462338|NCT00040599|Rectal Cancer|rectal cancer
462339|NCT00040599|Colorectal Neoplasms|colorectal neoplasms
462340|NCT00040599|Colorectal Carcinoma|colorectal carcinoma
462341|NCT00040599|Colorectal Tumor|colorectal tumor
462342|NCT00040651|Systemic Sclerosis|systemic sclerosis
462343|NCT00040651|Chemotherapy|chemotherapy
462344|NCT00040651|Cyclophosphamide|cyclophosphamide
462345|NCT00040651|Fludarabine|fludarabine
462346|NCT00040651|Leukapheresis|leukapheresis
462350|NCT00040651|Thymoglobulin|thymoglobulin
462351|NCT00040651|Scleroderma|scleroderma
462352|NCT00040664|pediatrics|pediatrics
462353|NCT00040664|HIV|hiv
462354|NCT00040664|protease inhibitors|protease inhibitors
462355|NCT00040664|ritonavir|ritonavir
462356|NCT00040664|fosamprenavir|fosamprenavir
462357|NCT00040664|LEXIVA|lexiva
462358|NCT00040664|AGENERASE|agenerase
462359|NCT00040664|amprenavir|amprenavir
462360|NCT00040677|sickle cell anemia|sickle cell anemia
462361|NCT00040677|sickle cell disease|sickle cell disease
462362|NCT00040677|anemia|anemia
462363|NCT00040677|ICA-17043|ica-17043
462364|NCT00040677|senicapoc|senicapoc
462365|NCT00040690|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
462366|NCT00040690|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
462367|NCT00040690|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
462368|NCT00040690|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
462369|NCT00040690|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
462370|NCT00040690|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
462371|NCT00040690|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
462372|NCT00040729|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
462373|NCT00040742|nausea|nausea
462374|NCT00040742|vomiting|vomiting
462375|NCT00040807|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
462376|NCT00040807|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
462377|NCT00040807|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
462378|NCT00040807|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
462379|NCT00040807|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
462380|NCT00040807|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
13048|NCT03207165|Low cardiac output syndrome|low cardiac output syndrome
462381|NCT00040807|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
462382|NCT00040807|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
462383|NCT00040807|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
462384|NCT00040807|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
462385|NCT00040807|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
462386|NCT00040807|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
462387|NCT00040807|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
462388|NCT00040807|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
462389|NCT00040807|recurrent salivary gland cancer|recurrent salivary gland cancer
462390|NCT00040807|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
462391|NCT00040807|stage IV salivary gland cancer|stage iv salivary gland cancer
462392|NCT00040820|stage III colon cancer|stage iii colon cancer
462393|NCT00040820|stage IV colon cancer|stage iv colon cancer
462394|NCT00040820|stage III rectal cancer|stage iii rectal cancer
462395|NCT00040820|stage IV rectal cancer|stage iv rectal cancer
462396|NCT00040820|recurrent colon cancer|recurrent colon cancer
462397|NCT00040820|recurrent rectal cancer|recurrent rectal cancer
462398|NCT00040820|adenocarcinoma of the colon|adenocarcinoma of the colon
462399|NCT00040820|adenocarcinoma of the rectum|adenocarcinoma of the rectum
462400|NCT00040833|stage III pancreatic cancer|stage iii pancreatic cancer
462401|NCT00040833|recurrent pancreatic cancer|recurrent pancreatic cancer
462403|NCT00040833|stage IV pancreatic cancer|stage iv pancreatic cancer
462404|NCT00040859|stage IV gastric cancer|stage iv gastric cancer
462405|NCT00040859|recurrent gastric cancer|recurrent gastric cancer
462406|NCT00040859|stage III esophageal cancer|stage iii esophageal cancer
462407|NCT00040859|stage IV esophageal cancer|stage iv esophageal cancer
462408|NCT00040859|recurrent esophageal cancer|recurrent esophageal cancer
462409|NCT00040859|adenocarcinoma of the stomach|adenocarcinoma of the stomach
462410|NCT00040859|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
462411|NCT00040872|regional neuroblastoma|regional neuroblastoma
462412|NCT00040872|disseminated neuroblastoma|disseminated neuroblastoma
462413|NCT00040872|recurrent neuroblastoma|recurrent neuroblastoma
462805|NCT00049296|stage IV renal cell cancer|stage iv renal cell cancer
462414|NCT00040872|localized unresectable neuroblastoma|localized unresectable neuroblastoma
462415|NCT00040885|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
462416|NCT00040885|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
462417|NCT00040885|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
462418|NCT00040885|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
462419|NCT00040885|fatigue|fatigue
462420|NCT00040885|anorexia|anorexia
462421|NCT00040885|cachexia|cachexia
462422|NCT00040898|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
462423|NCT00040898|advanced adult primary liver cancer|advanced adult primary liver cancer
462424|NCT00040898|recurrent adult primary liver cancer|recurrent adult primary liver cancer
462425|NCT00040898|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
462426|NCT00040911|nausea and vomiting|nausea and vomiting
462427|NCT00040911|localized osteosarcoma|localized osteosarcoma
462428|NCT00040911|metastatic osteosarcoma|metastatic osteosarcoma
462429|NCT00040911|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
462430|NCT00040911|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
462431|NCT00040911|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
462432|NCT00040911|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
462433|NCT00040911|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
462434|NCT00040911|childhood teratoma|childhood teratoma
462435|NCT00040911|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
462436|NCT00040911|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
462437|NCT00040911|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
462438|NCT00040911|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
462439|NCT00040911|localized resectable neuroblastoma|localized resectable neuroblastoma
462440|NCT00040911|localized unresectable neuroblastoma|localized unresectable neuroblastoma
462441|NCT00040911|disseminated neuroblastoma|disseminated neuroblastoma
462442|NCT00040911|regional neuroblastoma|regional neuroblastoma
462443|NCT00040911|stage 4S neuroblastoma|stage 4s neuroblastoma
462444|NCT00040911|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
462445|NCT00040911|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
462446|NCT00040911|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
462447|NCT00040911|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
462448|NCT00040911|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
462449|NCT00040911|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
462450|NCT00040911|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
462451|NCT00040911|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
462452|NCT00040911|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
462453|NCT00040911|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
462454|NCT00040911|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
462455|NCT00040911|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
462456|NCT00040911|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
462457|NCT00040911|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
462458|NCT00040911|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
462459|NCT00040911|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
462460|NCT00040937|stage I multiple myeloma|stage i multiple myeloma
462461|NCT00040937|stage II multiple myeloma|stage ii multiple myeloma
462462|NCT00040937|stage III multiple myeloma|stage iii multiple myeloma
462463|NCT00040950|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
462464|NCT00040950|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
462465|NCT00040950|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
462466|NCT00040950|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
462467|NCT00040950|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
462468|NCT00040950|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
462469|NCT00040950|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
462470|NCT00040950|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
462471|NCT00040950|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
462472|NCT00040950|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
462473|NCT00040950|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
462474|NCT00040950|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
88634|NCT02733341|Antiplatelet|antiplatelet
462475|NCT00040950|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
462476|NCT00040950|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
462477|NCT00040950|splenic marginal zone lymphoma|splenic marginal zone lymphoma
462478|NCT00041015|extensive stage small cell lung cancer|extensive stage small cell lung cancer
462479|NCT00041015|recurrent small cell lung cancer|recurrent small cell lung cancer
462896|NCT00051285|congestive|congestive
462480|NCT00041028|stage I non-small cell lung cancer|stage i non-small cell lung cancer
462481|NCT00041028|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
462482|NCT00041028|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
462483|NCT00041028|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
462484|NCT00041054|extensive stage small cell lung cancer|extensive stage small cell lung cancer
462485|NCT00041067|stage IV breast cancer|stage iv breast cancer
462486|NCT00041067|recurrent breast cancer|recurrent breast cancer
462487|NCT00041119|stage IB breast cancer|stage ib breast cancer
462488|NCT00041119|stage II breast cancer|stage ii breast cancer
462489|NCT00041132|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
462490|NCT00041132|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
462491|NCT00041132|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
462492|NCT00041132|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
462493|NCT00041171|stage IV breast cancer|stage iv breast cancer
462494|NCT00041171|stage IIIA breast cancer|stage iiia breast cancer
462495|NCT00041171|recurrent breast cancer|recurrent breast cancer
462496|NCT00041171|stage IIIB breast cancer|stage iiib breast cancer
462497|NCT00041171|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
462498|NCT00041171|extensive stage small cell lung cancer|extensive stage small cell lung cancer
462499|NCT00041171|recurrent small cell lung cancer|recurrent small cell lung cancer
462500|NCT00041171|stage III bladder cancer|stage iii bladder cancer
462501|NCT00041171|recurrent bladder cancer|recurrent bladder cancer
462502|NCT00041171|stage IV bladder cancer|stage iv bladder cancer
462503|NCT00041171|stage III prostate cancer|stage iii prostate cancer
462504|NCT00041171|stage IV prostate cancer|stage iv prostate cancer
462505|NCT00041171|recurrent prostate cancer|recurrent prostate cancer
462506|NCT00041171|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
462507|NCT00041171|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
462508|NCT00041171|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
462509|NCT00041171|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
462510|NCT00041171|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
462511|NCT00041171|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
462512|NCT00041171|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
462513|NCT00041171|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
462514|NCT00041171|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
13049|NCT03207139|cancer prostate|cancer prostate
462515|NCT00041171|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
462516|NCT00041171|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
462517|NCT00041171|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
462518|NCT00041171|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
462519|NCT00041171|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
462520|NCT00041171|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
462521|NCT00041171|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
462522|NCT00041171|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
462523|NCT00041171|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
462524|NCT00041171|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
462525|NCT00041171|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
462526|NCT00041171|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
462527|NCT00041171|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
462528|NCT00041171|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
462529|NCT00041171|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
462530|NCT00041171|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
462531|NCT00041171|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
462532|NCT00041171|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
462533|NCT00041171|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
88635|NCT02733341|Myocardial Infarction (MI)|myocardial infarction (mi)
462534|NCT00041171|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
462535|NCT00041171|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
462536|NCT00041171|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
462537|NCT00041171|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
462538|NCT00041171|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
462539|NCT00041171|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
462540|NCT00041171|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
462541|NCT00041171|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
462542|NCT00041171|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
462543|NCT00041171|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
462544|NCT00041171|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
462545|NCT00041171|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
462546|NCT00041171|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
477513|NCT00089414|MRMD|mrmd
462547|NCT00041171|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
462548|NCT00041171|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
462549|NCT00041171|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
462550|NCT00041171|stage III inverting papilloma of the paranasal sinus and nasal cavity|stage iii inverting papilloma of the paranasal sinus and nasal cavity
462551|NCT00041171|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
462552|NCT00041171|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
462553|NCT00041171|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
462554|NCT00041171|stage IV inverting papilloma of the paranasal sinus and nasal cavity|stage iv inverting papilloma of the paranasal sinus and nasal cavity
462555|NCT00041171|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
462556|NCT00041171|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
462557|NCT00041171|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
462558|NCT00041171|recurrent inverting papilloma of the paranasal sinus and nasal cavity|recurrent inverting papilloma of the paranasal sinus and nasal cavity
462559|NCT00041171|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
462560|NCT00041171|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
462561|NCT00041171|recurrent salivary gland cancer|recurrent salivary gland cancer
462562|NCT00041171|stage III salivary gland cancer|stage iii salivary gland cancer
462563|NCT00041171|stage IV salivary gland cancer|stage iv salivary gland cancer
462564|NCT00041210|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
462565|NCT00041210|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
462566|NCT00041210|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
462567|NCT00041210|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
462568|NCT00041210|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
462569|NCT00041210|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
462570|NCT00041210|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
462571|NCT00041210|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
462572|NCT00048906|Pharmacokinetics|pharmacokinetics
462573|NCT00048906|Enzyme|enzyme
462574|NCT00048906|Lysosomal|lysosomal
462575|NCT00048906|Kidney|kidney
462576|NCT00048906|Stroke|stroke
462577|NCT00048906|Fabry Disease|fabry disease
462578|NCT00048906|Fabrys|fabrys
462579|NCT00048906|Fabry's|fabry's
462580|NCT00048971|adenocarcinoma of the colon|adenocarcinoma of the colon
462581|NCT00048971|stage III colon cancer|stage iii colon cancer
462582|NCT00048971|diarrhea|diarrhea
462583|NCT00048971|neutropenia|neutropenia
462584|NCT00048997|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
462585|NCT00048997|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
462586|NCT00049010|stage I melanoma|stage i melanoma
462587|NCT00049010|stage II melanoma|stage ii melanoma
462588|NCT00049023|childhood grade III meningioma|childhood grade iii meningioma
462589|NCT00049023|disseminated neuroblastoma|disseminated neuroblastoma
462590|NCT00049023|localized unresectable neuroblastoma|localized unresectable neuroblastoma
462591|NCT00049023|metastatic pheochromocytoma|metastatic pheochromocytoma
462592|NCT00049023|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
462593|NCT00049023|recurrent childhood brain tumor|recurrent childhood brain tumor
462594|NCT00049023|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
462595|NCT00049023|recurrent neuroblastoma|recurrent neuroblastoma
462596|NCT00049023|recurrent pheochromocytoma|recurrent pheochromocytoma
462597|NCT00049023|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
462598|NCT00049023|regional neuroblastoma|regional neuroblastoma
462599|NCT00049023|regional pheochromocytoma|regional pheochromocytoma
462600|NCT00049023|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
462601|NCT00049023|recurrent childhood ependymoma|recurrent childhood ependymoma
462602|NCT00049023|childhood infratentorial ependymoma|childhood infratentorial ependymoma
462603|NCT00049023|childhood supratentorial ependymoma|childhood supratentorial ependymoma
462604|NCT00049023|recurrent islet cell carcinoma|recurrent islet cell carcinoma
462605|NCT00049023|gastrinoma|gastrinoma
462606|NCT00049023|insulinoma|insulinoma
462607|NCT00049023|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
462608|NCT00049023|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
462609|NCT00049023|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
462610|NCT00049062|recurrent breast cancer|recurrent breast cancer
462611|NCT00049062|stage IIIB breast cancer|stage iiib breast cancer
462612|NCT00049062|stage IIIC breast cancer|stage iiic breast cancer
462613|NCT00049062|stage IV breast cancer|stage iv breast cancer
462744|NCT00049296|recurrent melanoma|recurrent melanoma
462614|NCT00049075|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
462615|NCT00049075|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
462616|NCT00049075|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
462617|NCT00049075|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
462618|NCT00049075|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
462619|NCT00049101|recurrent colon cancer|recurrent colon cancer
462620|NCT00049101|stage IV colon cancer|stage iv colon cancer
462621|NCT00049101|recurrent rectal cancer|recurrent rectal cancer
462622|NCT00049101|stage IV rectal cancer|stage iv rectal cancer
462623|NCT00049140|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
462624|NCT00049140|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
462625|NCT00049140|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
462626|NCT00049140|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
462627|NCT00049140|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
462628|NCT00049140|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
462629|NCT00049140|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
462630|NCT00049140|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
462631|NCT00049140|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
462632|NCT00049140|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
462633|NCT00049140|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
462634|NCT00049140|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
462635|NCT00049140|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
462636|NCT00049140|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
462637|NCT00049140|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
462638|NCT00049140|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
462639|NCT00049140|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
462640|NCT00049140|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
462641|NCT00049140|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
462642|NCT00049140|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
462643|NCT00049140|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
462644|NCT00049140|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
462645|NCT00049140|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
462646|NCT00049140|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
462647|NCT00049140|stage I salivary gland cancer|stage i salivary gland cancer
462648|NCT00049140|stage II salivary gland cancer|stage ii salivary gland cancer
462649|NCT00049140|stage III salivary gland cancer|stage iii salivary gland cancer
462650|NCT00049140|stage IV salivary gland cancer|stage iv salivary gland cancer
462651|NCT00049140|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
462652|NCT00049179|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
462653|NCT00049179|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
462654|NCT00049179|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
462655|NCT00049179|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
462656|NCT00049179|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
462657|NCT00049179|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
462658|NCT00049179|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
462659|NCT00049179|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
462660|NCT00049179|secondary acute myeloid leukemia|secondary acute myeloid leukemia
462661|NCT00049179|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
462662|NCT00049179|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
462663|NCT00049179|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
583606|NCT00512382|GER Gastrointestinal reflux|ger gastrointestinal reflux
462664|NCT00049179|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
462665|NCT00049218|extensive stage small cell lung cancer|extensive stage small cell lung cancer
462667|NCT00049231|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
462668|NCT00049231|cervical squamous cell carcinoma|cervical squamous cell carcinoma
462669|NCT00049231|stage IIB cervical cancer|stage iib cervical cancer
462670|NCT00049231|stage III cervical cancer|stage iii cervical cancer
462671|NCT00049231|stage IVA cervical cancer|stage iva cervical cancer
462672|NCT00049244|recurrent breast cancer|recurrent breast cancer
462673|NCT00049244|stage IV breast cancer|stage iv breast cancer
477514|NCT00089427|brain tumor|brain tumor
462674|NCT00049257|adenocarcinoma of the prostate|adenocarcinoma of the prostate
462675|NCT00049257|recurrent prostate cancer|recurrent prostate cancer
462676|NCT00049257|stage IV prostate cancer|stage iv prostate cancer
462677|NCT00049296|adult anaplastic astrocytoma|adult anaplastic astrocytoma
462678|NCT00049296|male breast cancer|male breast cancer
462679|NCT00049296|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
462680|NCT00049296|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
462681|NCT00049296|adult brain stem glioma|adult brain stem glioma
462682|NCT00049296|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
462683|NCT00049296|adult choroid plexus tumor|adult choroid plexus tumor
462684|NCT00049296|adult craniopharyngioma|adult craniopharyngioma
462685|NCT00049296|adult ependymoblastoma|adult ependymoblastoma
462686|NCT00049296|adult glioblastoma|adult glioblastoma
462687|NCT00049296|adult pilocytic astrocytoma|adult pilocytic astrocytoma
462688|NCT00049296|adult anaplastic ependymoma|adult anaplastic ependymoma
462689|NCT00049296|adult medulloblastoma|adult medulloblastoma
462690|NCT00049296|adult meningioma|adult meningioma
462691|NCT00049296|adult pineoblastoma|adult pineoblastoma
462692|NCT00049296|adult pineocytoma|adult pineocytoma
462693|NCT00049296|adult subependymoma|adult subependymoma
462694|NCT00049296|adult myxopapillary ependymoma|adult myxopapillary ependymoma
462695|NCT00049296|advanced adult primary liver cancer|advanced adult primary liver cancer
462696|NCT00049296|anterior urethral cancer|anterior urethral cancer
462697|NCT00049296|carcinoma of the appendix|carcinoma of the appendix
462698|NCT00049296|chondrosarcoma|chondrosarcoma
462699|NCT00049296|classic Kaposi sarcoma|classic kaposi sarcoma
462700|NCT00049296|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
462701|NCT00049296|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
462702|NCT00049296|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
462703|NCT00049296|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
462704|NCT00049296|disseminated neuroblastoma|disseminated neuroblastoma
462705|NCT00049296|extensive stage small cell lung cancer|extensive stage small cell lung cancer
462706|NCT00049296|gastrointestinal stromal tumor|gastrointestinal stromal tumor
462707|NCT00049296|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
462708|NCT00049296|metastatic osteosarcoma|metastatic osteosarcoma
462709|NCT00049296|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
462710|NCT00049296|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
462711|NCT00049296|adult mixed glioma|adult mixed glioma
462712|NCT00049296|ovarian sarcoma|ovarian sarcoma
462713|NCT00049296|posterior urethral cancer|posterior urethral cancer
462714|NCT00049296|primary central nervous system lymphoma|primary central nervous system lymphoma
462715|NCT00049296|pulmonary carcinoid tumor|pulmonary carcinoid tumor
462716|NCT00049296|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
462717|NCT00049296|recurrent adult brain tumor|recurrent adult brain tumor
462718|NCT00049296|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
462719|NCT00049296|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
462720|NCT00049296|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
462721|NCT00049296|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
462722|NCT00049296|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
462723|NCT00049296|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
462724|NCT00049296|recurrent adult primary liver cancer|recurrent adult primary liver cancer
462725|NCT00049296|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
88636|NCT02733341|Cangrelor|cangrelor
593167|NCT00547898|HIV|hiv
462140|NCT00039819|HV|hv
462726|NCT00049296|recurrent anal cancer|recurrent anal cancer
462727|NCT00049296|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
462728|NCT00049296|recurrent bladder cancer|recurrent bladder cancer
462729|NCT00049296|recurrent breast cancer|recurrent breast cancer
462730|NCT00049296|recurrent colon cancer|recurrent colon cancer
462731|NCT00049296|recurrent esophageal cancer|recurrent esophageal cancer
462732|NCT00049296|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
462733|NCT00049296|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
462734|NCT00049296|recurrent gallbladder cancer|recurrent gallbladder cancer
462735|NCT00049296|recurrent gastric cancer|recurrent gastric cancer
583607|NCT00512382|Aspiration|aspiration
462736|NCT00049296|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
462737|NCT00049296|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
462738|NCT00049296|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
462739|NCT00049296|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
462740|NCT00049296|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
462741|NCT00049296|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
462742|NCT00049296|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
462743|NCT00049296|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
462745|NCT00049296|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
462746|NCT00049296|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
462747|NCT00049296|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
462748|NCT00049296|recurrent neuroblastoma|recurrent neuroblastoma
462749|NCT00049296|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
462750|NCT00049296|recurrent osteosarcoma|recurrent osteosarcoma
462751|NCT00049296|recurrent pancreatic cancer|recurrent pancreatic cancer
462752|NCT00049296|recurrent rectal cancer|recurrent rectal cancer
462753|NCT00049296|recurrent renal cell cancer|recurrent renal cell cancer
462754|NCT00049296|recurrent small cell lung cancer|recurrent small cell lung cancer
462755|NCT00049296|recurrent small intestine cancer|recurrent small intestine cancer
462756|NCT00049296|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
462757|NCT00049296|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
462758|NCT00049296|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
462759|NCT00049296|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
462760|NCT00049296|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
462761|NCT00049296|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
462762|NCT00049296|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
462763|NCT00049296|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
462764|NCT00049296|recurrent urethral cancer|recurrent urethral cancer
462765|NCT00049296|recurrent uterine sarcoma|recurrent uterine sarcoma
462766|NCT00049296|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
462767|NCT00049296|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
462768|NCT00049296|refractory multiple myeloma|refractory multiple myeloma
462769|NCT00049296|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
462770|NCT00049296|small intestine adenocarcinoma|small intestine adenocarcinoma
462771|NCT00049296|small intestine leiomyosarcoma|small intestine leiomyosarcoma
462772|NCT00049296|small intestine lymphoma|small intestine lymphoma
462773|NCT00049296|stage II esophageal cancer|stage ii esophageal cancer
462774|NCT00049296|stage II pancreatic cancer|stage ii pancreatic cancer
462775|NCT00049296|stage III esophageal cancer|stage iii esophageal cancer
462776|NCT00049296|stage III multiple myeloma|stage iii multiple myeloma
462777|NCT00049296|stage III pancreatic cancer|stage iii pancreatic cancer
462778|NCT00049296|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
462779|NCT00049296|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
462780|NCT00049296|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
462781|NCT00049296|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
462782|NCT00049296|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
462783|NCT00049296|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
462784|NCT00049296|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
462785|NCT00049296|stage IV anal cancer|stage iv anal cancer
462786|NCT00049296|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
462787|NCT00049296|stage IV bladder cancer|stage iv bladder cancer
462788|NCT00049296|stage IV breast cancer|stage iv breast cancer
462789|NCT00049296|stage IV colon cancer|stage iv colon cancer
462790|NCT00049296|stage IV esophageal cancer|stage iv esophageal cancer
462791|NCT00049296|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
462792|NCT00049296|stage IV gastric cancer|stage iv gastric cancer
462793|NCT00049296|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
462794|NCT00049296|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
462795|NCT00049296|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
462796|NCT00049296|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
462797|NCT00049296|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
462798|NCT00049296|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
462799|NCT00049296|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
462800|NCT00049296|stage IV melanoma|stage iv melanoma
462801|NCT00049296|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
462802|NCT00049296|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
462803|NCT00049296|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
462804|NCT00049296|stage IV rectal cancer|stage iv rectal cancer
462897|NCT00051285|enoximone|enoximone
462806|NCT00049296|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
462807|NCT00049296|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
462808|NCT00049296|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
462809|NCT00049296|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
462810|NCT00049296|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
462811|NCT00049296|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
462812|NCT00049296|stage IV uterine sarcoma|stage iv uterine sarcoma
462813|NCT00049296|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
462814|NCT00049296|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
462815|NCT00049296|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
462816|NCT00049296|unresectable gallbladder cancer|unresectable gallbladder cancer
462817|NCT00049296|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
462818|NCT00049296|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
462819|NCT00049296|recurrent salivary gland cancer|recurrent salivary gland cancer
462820|NCT00049296|stage IV salivary gland cancer|stage iv salivary gland cancer
462821|NCT00049296|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
462822|NCT00049296|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
462823|NCT00049296|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
462824|NCT00049296|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
462825|NCT00049296|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
462826|NCT00049296|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
462827|NCT00049296|splenic marginal zone lymphoma|splenic marginal zone lymphoma
462828|NCT00049296|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
462829|NCT00049296|adult grade III meningioma|adult grade iii meningioma
462830|NCT00049296|adult oligodendroglioma|adult oligodendroglioma
462831|NCT00049296|adult giant cell glioblastoma|adult giant cell glioblastoma
462832|NCT00049296|adult gliosarcoma|adult gliosarcoma
462833|NCT00049296|stage IV pancreatic cancer|stage iv pancreatic cancer
462834|NCT00051077|HIV Infections|hiv infections
462835|NCT00051077|Hepatitis B|hepatitis b
462837|NCT00051077|Interferon Alfa-2a|interferon alfa-2a
462838|NCT00051077|Adefovir dipivoxil|adefovir dipivoxil
462839|NCT00051077|Ribavirin|ribavirin
462840|NCT00051077|Antiviral Agents|antiviral agents
462841|NCT00051077|Drug Resistance, Viral|drug resistance, viral
462842|NCT00051077|Treatment Experienced|treatment experienced
462843|NCT00051090|Hepatitis B|hepatitis b
462844|NCT00051090|Antiretroviral Therapy, Highly-Active|antiretroviral therapy, highly-active
462845|NCT00051090|HIV Infections|hiv infections
462846|NCT00051090|Lamivudine|lamivudine
462847|NCT00051090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
462848|NCT00051090|Antiviral Agents|antiviral agents
462849|NCT00051090|Drug Therapy, Combination|drug therapy, combination
462850|NCT00051090|Treatment Naive|treatment naive
462851|NCT00051103|Refractory|refractory
462852|NCT00051116|Multiple Myeloma|multiple myeloma
462853|NCT00051116|Revimid|revimid
462854|NCT00051116|CC5013|cc5013
462855|NCT00051116|CC-5013|cc-5013
462857|NCT00051129|anecortave acetate|anecortave acetate
462858|NCT00051129|wet AMD|wet amd
462859|NCT00051129|age-related macular degeneration|age-related macular degeneration
462860|NCT00051129|Macular Degeneration|macular degeneration
462861|NCT00051129|Maculopathy, Age-Related|maculopathy, age-related
462862|NCT00051129|Age-Related Maculopathies|age-related maculopathies
462863|NCT00051129|Age-Related Maculopathy|age-related maculopathy
462864|NCT00051129|Maculopathies, Age-Related|maculopathies, age-related
462865|NCT00051142|Glaucoma|glaucoma
462866|NCT00051142|POAG|poag
462867|NCT00051142|OAG|oag
462868|NCT00051142|OHT|oht
462869|NCT00051155|Glaucoma|glaucoma
462870|NCT00051155|POAG|poag
462871|NCT00051155|OAG|oag
462872|NCT00051155|OHT|oht
462873|NCT00051168|Glaucoma|glaucoma
462874|NCT00051168|POAG|poag
462875|NCT00051168|OAG|oag
462876|NCT00051168|OHT|oht
462877|NCT00051181|Glaucoma|glaucoma
462878|NCT00051181|POAG|poag
462879|NCT00051181|OAG|oag
462880|NCT00051181|OHT|oht
462881|NCT00051194|Glaucoma|glaucoma
462882|NCT00051194|POAG|poag
462883|NCT00051194|OAG|oag
462884|NCT00051194|OHT|oht
462885|NCT00051207|Mood Disorders|mood disorders
462886|NCT00051207|Psychotherapy|psychotherapy
462887|NCT00051207|Comorbidity|comorbidity
462888|NCT00051259|depression|depression
462889|NCT00051259|MDD|mdd
462890|NCT00051259|sexual dysfunction|sexual dysfunction
462891|NCT00051259|orgasm disorder|orgasm disorder
462892|NCT00051272|depression, sexual dysfunction, orgasm disorder, MDD|depression, sexual dysfunction, orgasm disorder, mdd
462893|NCT00051285|CHF|chf
462894|NCT00051285|heart|heart
462895|NCT00051285|failure|failure
462898|NCT00051285|phosphodiesterase|phosphodiesterase
462899|NCT00051285|inhibitor|inhibitor
462900|NCT00051311|Lymphoma|lymphoma
462901|NCT00051311|Leukemia|leukemia
462902|NCT00051311|Hodgkin's Disease|hodgkin's disease
462903|NCT00051311|Multiple Myeloma|multiple myeloma
462904|NCT00051311|Immunotherapy|immunotherapy
462905|NCT00051324|Huntington's disease|huntington's disease
462906|NCT00051324|Huntington disease|huntington disease
462907|NCT00051324|HD|hd
462908|NCT00051337|Kinesiogenic|kinesiogenic
462909|NCT00051337|Psychogenic|psychogenic
462910|NCT00051337|Channelopathy|channelopathy
462911|NCT00051337|Ictal|ictal
462912|NCT00051337|Paroxysmal Dyskinesia|paroxysmal dyskinesia
462913|NCT00051337|Psychogenic Movement Disorders|psychogenic movement disorders
462914|NCT00051337|Single Photon Emission|single photon emission
462915|NCT00051337|Computed Tomography (SPECT)|computed tomography (spect)
462916|NCT00051363|Obstructive Sleep Apnea|obstructive sleep apnea
462917|NCT00051402|Postmenopausal|postmenopausal
462918|NCT00051402|Memory Loss|memory loss
462919|NCT00051402|Cognition|cognition
462920|NCT00051402|Phytoestrogens|phytoestrogens
462921|NCT00051415|Flaxseed|flaxseed
462922|NCT00051415|Cholesterol|cholesterol
462923|NCT00051428|Fibromyalgia, Reiki, Energy Medicine|fibromyalgia, reiki, energy medicine
462924|NCT00051441|stomatitis|stomatitis
462925|NCT00051441|radiation effects|radiation effects
462926|NCT00051454|HIV Seronegativity|hiv seronegativity
462927|NCT00051454|HIV Preventive Vaccine|hiv preventive vaccine
462928|NCT00051493|Non-Small Cell Lung Cancer|non-small cell lung cancer
462929|NCT00051493|Lung Cancer|lung cancer
462930|NCT00051493|NSCLC|nsclc
462931|NCT00051493|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
462932|NCT00051519|HIV|hiv
462933|NCT00051519|AIDS|aids
462934|NCT00051519|Vaccine|vaccine
462935|NCT00051519|HIV-positive|hiv-positive
462936|NCT00051519|Therapy|therapy
462937|NCT00051532|hepatocellular|hepatocellular
462938|NCT00051532|carcinoma|carcinoma
462939|NCT00051532|liver|liver
462940|NCT00051532|cancer|cancer
462941|NCT00051545|liver|liver
462942|NCT00051545|cancer|cancer
462943|NCT00051545|hepatocellular|hepatocellular
462944|NCT00051545|carcinoma|carcinoma
462945|NCT00051571|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
462856|NCT00051129|AMD|amd
462946|NCT00051623|Psoriatic arthritis|psoriatic arthritis
462947|NCT00051623|Infliximab|infliximab
462948|NCT00051623|Remicade|remicade
462949|NCT00051636|Bisphosphonate|bisphosphonate
462950|NCT00051636|SAP|sap
462951|NCT00051636|SAP excess|sap excess
462952|NCT00051636|non-inferiority|non-inferiority
462953|NCT00051636|therapeutic response|therapeutic response
462954|NCT00051636|extended observation period|extended observation period
462955|NCT00051675|adenocarcinoma|adenocarcinoma
462956|NCT00051675|monoclonal antibody|monoclonal antibody
462957|NCT00051701|Non-Hodgkins lymphoma|non-hodgkins lymphoma
462958|NCT00051701|NHL|nhl
462959|NCT00051701|Campath|campath
462960|NCT00051701|alemtuzumab|alemtuzumab
462961|NCT00051714|Social Behavior Disorders|social behavior disorders
462962|NCT00051753|Otitis Media|otitis media
462963|NCT00051753|Acute Otitis Media|acute otitis media
462964|NCT00051753|ear infection|ear infection
462965|NCT00051753|levofloxacin|levofloxacin
462966|NCT00051753|amoxicillin|amoxicillin
462967|NCT00051753|clavulanate|clavulanate
462968|NCT00051766|compliance|compliance
462969|NCT00051766|medication|medication
462970|NCT00051766|antiretroviral|antiretroviral
462971|NCT00051766|adherence|adherence
462972|NCT00051766|intervention|intervention
462973|NCT00051766|treatment experienced|treatment experienced
462974|NCT00051779|CAL|cal
462975|NCT00051779|Parathyroid hormone-related protein (PTHrP)|parathyroid hormone-related protein (pthrp)
462976|NCT00051779|Breast Cancer|breast cancer
462977|NCT00051779|Bone Metastasis|bone metastasis
462978|NCT00051779|Hypercalcemia|hypercalcemia
462979|NCT00051805|Patient Compliance|patient compliance
462980|NCT00051805|Adherence|adherence
462981|NCT00051805|Treatment Experienced|treatment experienced
462982|NCT00051818|chronic HIV infection|chronic hiv infection
462983|NCT00051818|treatment interruption|treatment interruption
462984|NCT00051818|HIV-specific immune response|hiv-specific immune response
462985|NCT00051818|immune response|immune response
462986|NCT00051818|virological response|virological response
462987|NCT00051818|treatment experienced|treatment experienced
462988|NCT00051831|Treatment Naive|treatment naive
462989|NCT00051831|HIV-1|hiv-1
462990|NCT00051831|Virus Replication|virus replication
462991|NCT00051831|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
462992|NCT00051831|Immunologic Memory|immunologic memory
462993|NCT00051831|Pentafuside|pentafuside
462994|NCT00051831|Anti-HIV Agents|anti-hiv agents
462995|NCT00051831|Drug Therapy, Combination|drug therapy, combination
462996|NCT00051831|Saquinavir|saquinavir
462997|NCT00051831|Ritonavir|ritonavir
462998|NCT00051831|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
462999|NCT00051831|RNA, Viral|rna, viral
463000|NCT00051831|Viral Load|viral load
463001|NCT00051831|Fusion Inhibitors|fusion inhibitors
463002|NCT00051831|Entry Inhibitors|entry inhibitors
463003|NCT00051844|HIV|hiv
463004|NCT00051844|NNRTI Failure|nnrti failure
463005|NCT00051844|HIV Infections|hiv infections
463006|NCT00051857|Magnetic Resonance Imaging|magnetic resonance imaging
463007|NCT00051857|Muscle|muscle
463008|NCT00051857|Bone|bone
463009|NCT00051857|Dynamics|dynamics
463010|NCT00051857|Visualization|visualization
463011|NCT00051870|Verbal Memory|verbal memory
463012|NCT00051870|Inhibition|inhibition
463013|NCT00051870|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
463014|NCT00051870|Cortical Excitability|cortical excitability
463015|NCT00051870|Nonverbal Memory|nonverbal memory
463016|NCT00051909|Alzheimer's Disease|alzheimer's disease
463017|NCT00051922|HIV Preventive Vaccine|hiv preventive vaccine
463018|NCT00051922|HIV Seronegativity|hiv seronegativity
463019|NCT00051935|Glycogen Storage Disease Type II|glycogen storage disease type ii
463020|NCT00051935|GSD-II|gsd-ii
463021|NCT00051935|Pompe Disease|pompe disease
463022|NCT00051961|Dopamine|dopamine
463023|NCT00051961|Spinal Physiology|spinal physiology
463024|NCT00051961|Flexor Reflex|flexor reflex
463025|NCT00051961|Ropinirole|ropinirole
463026|NCT00051961|Motor Control|motor control
463027|NCT00051961|Dopaminergic|dopaminergic
463028|NCT00051961|Restless Legs|restless legs
463029|NCT00052013|von Hippel-Lindau disease,|von hippel-lindau disease,
463030|NCT00052013|CNS,|cns,
463031|NCT00052013|hemangioblastoma,|hemangioblastoma,
463032|NCT00052013|retinal|retinal
463033|NCT00052026|Adolescent|adolescent
463034|NCT00052026|Adrenergic alpha-Antagonists/therapeutic use|adrenergic alpha-antagonists/therapeutic use
463035|NCT00052026|Adrenergic alpha-Antagonists/pharmacokinetics|adrenergic alpha-antagonists/pharmacokinetics
463036|NCT00052026|Adrenergic alpha-Antagonists/administration & dosage|adrenergic alpha-antagonists/administration & dosage
463037|NCT00052026|Adrenergic beta-Antagonists/therapeutic use|adrenergic beta-antagonists/therapeutic use
463038|NCT00052026|Adrenergic beta-Antagonists/pharmacokinetics|adrenergic beta-antagonists/pharmacokinetics
463039|NCT00052026|Adrenergic beta-Antagonists/administration & dosage|adrenergic beta-antagonists/administration & dosage
463040|NCT00052026|Age Factors|age factors
463041|NCT00052026|Carbazoles/therapeutic use|carbazoles/therapeutic use
463042|NCT00052026|Carbazoles/administration & dosage|carbazoles/administration & dosage
463043|NCT00052026|Child|child
463044|NCT00052026|Child, Preschool|child, preschool
463045|NCT00052026|Drug Administration Schedule|drug administration schedule
463047|NCT00052026|Heart Failure, Congestive/etiology|heart failure, congestive/etiology
463048|NCT00052026|Heart Failure, Congestive/drug therapy|heart failure, congestive/drug therapy
463049|NCT00052026|Heart Failure, Congestive/blood|heart failure, congestive/blood
463050|NCT00052026|Human|human
463051|NCT00052026|Infant|infant
463052|NCT00052026|Infant, Newborn|infant, newborn
463053|NCT00052026|Male|male
463054|NCT00052026|Natriuretic Peptide, Brain/blood|natriuretic peptide, brain/blood
463055|NCT00052026|Placebos|placebos
463056|NCT00052026|Propanolamines/therapeutic use|propanolamines/therapeutic use
463057|NCT00052026|Propanolamines/administration & dosage|propanolamines/administration & dosage
463058|NCT00052026|Prospective Studies|prospective studies
463059|NCT00052026|Support, Non-U.S. Gov't|support, non-u.s. gov't
463060|NCT00052026|Treatment Outcome|treatment outcome
463061|NCT00052026|Ventricular Dysfunction/drug therapy|ventricular dysfunction/drug therapy
463062|NCT00052026|Ventricular Dysfunction/complications|ventricular dysfunction/complications
463063|NCT00052026|Ventricular Dysfunction/blood|ventricular dysfunction/blood
463064|NCT00052026|Ventricular Function/drug effects|ventricular function/drug effects
463065|NCT00052026|Ventricular Remodeling/drug effects|ventricular remodeling/drug effects
463066|NCT00052039|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
463067|NCT00052052|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
463068|NCT00052052|IPF|ipf
463069|NCT00052078|Phobic Disorders|phobic disorders
463070|NCT00052078|Anxiety, Separation|anxiety, separation
463071|NCT00052091|Geriatrics|geriatrics
463072|NCT00052143|Huntington's disease|huntington's disease
463073|NCT00052143|HD|hd
463074|NCT00052143|Huntington disease|huntington disease
463075|NCT00052169|metastatic breast cancer|metastatic breast cancer
463076|NCT00052169|docetaxel|docetaxel
463077|NCT00052169|Taxotere|taxotere
463078|NCT00052169|ZD 1839|zd 1839
463079|NCT00052169|gefitinib|gefitinib
463080|NCT00052169|NSABP|nsabp
463081|NCT00052169|advanced breast cancer|advanced breast cancer
463082|NCT00052169|AstraZeneca|astrazeneca
463083|NCT00052182|HIV Therapeutic Vaccine|hiv therapeutic vaccine
463084|NCT00052182|CTL Epitope|ctl epitope
463085|NCT00052182|Treatment Experienced|treatment experienced
463086|NCT00052195|Mycobacterium vaccae|mycobacterium vaccae
463088|NCT00052195|Disseminated tuberculosis|disseminated tuberculosis
463089|NCT00052195|SRL-172|srl-172
463090|NCT00052195|DAR-901|dar-901
463091|NCT00052221|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
463092|NCT00052221|fatigue|fatigue
463093|NCT00052273|unspecified adult solid tumor|unspecified adult solid tumor
463094|NCT00052273|protocol specific|protocol specific
463095|NCT00052286|adult brain tumor|adult brain tumor
463096|NCT00052286|fatigue|fatigue
463097|NCT00052286|cognitive/functional effects|cognitive/functional effects
463098|NCT00052299|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
463099|NCT00052299|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
463100|NCT00052299|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
477720|NCT00090077|GW695634X|gw695634x
463101|NCT00052299|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
463102|NCT00052299|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
463103|NCT00052299|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
463104|NCT00052299|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
463105|NCT00052299|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
463106|NCT00052299|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
463107|NCT00052299|secondary acute myeloid leukemia|secondary acute myeloid leukemia
463108|NCT00052299|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
463109|NCT00052299|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
463110|NCT00052299|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
463111|NCT00052299|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
463112|NCT00052312|recurrent endometrial carcinoma|recurrent endometrial carcinoma
463113|NCT00052312|stage III endometrial carcinoma|stage iii endometrial carcinoma
463114|NCT00052312|stage IV endometrial carcinoma|stage iv endometrial carcinoma
463115|NCT00052312|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
463116|NCT00052325|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
463117|NCT00052325|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
463118|NCT00052351|stage II breast cancer|stage ii breast cancer
463119|NCT00052351|stage IIIA breast cancer|stage iiia breast cancer
463120|NCT00052351|stage IIIB breast cancer|stage iiib breast cancer
463121|NCT00052390|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
463122|NCT00052390|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
463123|NCT00052390|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
463124|NCT00052416|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
463125|NCT00052416|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
463126|NCT00052416|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
463127|NCT00052416|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
463128|NCT00052416|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
463129|NCT00052416|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
463130|NCT00052416|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
463131|NCT00052416|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
463132|NCT00052416|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
463133|NCT00052416|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
463134|NCT00052416|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
463135|NCT00052416|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
463136|NCT00052416|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
463137|NCT00052416|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
463138|NCT00052416|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
463139|NCT00052416|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
463140|NCT00052416|Waldenström macroglobulinemia|waldenström macroglobulinemia
463141|NCT00052416|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
463142|NCT00052416|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
463143|NCT00052416|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
463144|NCT00052416|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
463145|NCT00052416|stage I marginal zone lymphoma|stage i marginal zone lymphoma
463146|NCT00052416|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
463147|NCT00052416|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
463148|NCT00052416|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
463149|NCT00052416|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
463150|NCT00052416|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
463151|NCT00052416|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
463152|NCT00052416|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
463153|NCT00052416|splenic marginal zone lymphoma|splenic marginal zone lymphoma
463154|NCT00052429|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
463155|NCT00052429|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
463156|NCT00052429|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
463157|NCT00052429|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
463158|NCT00052429|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
482155|NCT00115414|Neulasta®|neulasta®
463159|NCT00052429|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
463160|NCT00052442|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
463161|NCT00052442|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
463162|NCT00052442|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
463489|NCT00053183|adult glioblastoma|adult glioblastoma
463163|NCT00052442|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
463164|NCT00052442|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
463165|NCT00052442|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
463166|NCT00052442|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
463167|NCT00052442|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
463168|NCT00052455|adult glioblastoma|adult glioblastoma
463169|NCT00052455|adult anaplastic astrocytoma|adult anaplastic astrocytoma
463170|NCT00052455|recurrent adult brain tumor|recurrent adult brain tumor
463171|NCT00052455|adult giant cell glioblastoma|adult giant cell glioblastoma
463172|NCT00052455|adult gliosarcoma|adult gliosarcoma
463173|NCT00052468|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
463174|NCT00052468|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
463175|NCT00052468|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
463176|NCT00052468|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
463177|NCT00052468|fallopian tube cancer|fallopian tube cancer
463178|NCT00052481|stage IIB prostate cancer|stage iib prostate cancer
463179|NCT00052481|stage IIA prostate cancer|stage iia prostate cancer
463180|NCT00052481|adenocarcinoma of the prostate|adenocarcinoma of the prostate
463181|NCT00052494|extensive stage small cell lung cancer|extensive stage small cell lung cancer
463182|NCT00052494|recurrent small cell lung cancer|recurrent small cell lung cancer
463183|NCT00052507|stage IV colon cancer|stage iv colon cancer
463184|NCT00052507|stage IV rectal cancer|stage iv rectal cancer
463185|NCT00052507|adenocarcinoma of the colon|adenocarcinoma of the colon
463186|NCT00052507|adenocarcinoma of the rectum|adenocarcinoma of the rectum
463187|NCT00052507|recurrent colon cancer|recurrent colon cancer
463188|NCT00052507|recurrent rectal cancer|recurrent rectal cancer
463189|NCT00052572|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
463190|NCT00052572|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
13050|NCT03207139|Ga-68 PSMA Ligand|ga-68 psma ligand
463191|NCT00052572|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
463192|NCT00052572|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
463193|NCT00052572|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
463194|NCT00052572|Waldenström macroglobulinemia|waldenström macroglobulinemia
463195|NCT00052572|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
463196|NCT00052572|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
463197|NCT00052572|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
463198|NCT00052572|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
463199|NCT00052572|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
463200|NCT00052572|splenic marginal zone lymphoma|splenic marginal zone lymphoma
463201|NCT00052611|lip and oral cavity cancer|lip and oral cavity cancer
463202|NCT00052611|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
463203|NCT00052611|hypopharyngeal cancer|hypopharyngeal cancer
463204|NCT00052611|laryngeal cancer|laryngeal cancer
463205|NCT00052611|oropharyngeal cancer|oropharyngeal cancer
463206|NCT00052611|nasopharyngeal cancer|nasopharyngeal cancer
463207|NCT00052611|salivary gland cancer|salivary gland cancer
463208|NCT00052624|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
463209|NCT00052637|bladder cancer|bladder cancer
463210|NCT00052637|recurrent bladder cancer|recurrent bladder cancer
463211|NCT00052637|stage 0 bladder cancer|stage 0 bladder cancer
463212|NCT00052676|stage I breast cancer|stage i breast cancer
463213|NCT00052676|stage II breast cancer|stage ii breast cancer
463214|NCT00052715|adult glioblastoma|adult glioblastoma
463215|NCT00052715|adult giant cell glioblastoma|adult giant cell glioblastoma
463216|NCT00052715|adult gliosarcoma|adult gliosarcoma
463217|NCT00052728|stage IV breast cancer|stage iv breast cancer
463218|NCT00052728|recurrent breast cancer|recurrent breast cancer
463219|NCT00052754|adult synovial sarcoma|adult synovial sarcoma
463220|NCT00052754|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
463221|NCT00052754|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
463222|NCT00052754|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
463223|NCT00052832|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
463224|NCT00052832|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
463225|NCT00052832|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
463226|NCT00052832|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
463227|NCT00052832|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
463228|NCT00052832|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
463229|NCT00052845|adenocarcinoma of the prostate|adenocarcinoma of the prostate
463230|NCT00052845|recurrent prostate cancer|recurrent prostate cancer
463231|NCT00052845|stage IV prostate cancer|stage iv prostate cancer
463232|NCT00052884|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
463233|NCT00052884|primary systemic amyloidosis|primary systemic amyloidosis
463234|NCT00052897|anal cancer|anal cancer
463235|NCT00052910|stage I gastric cancer|stage i gastric cancer
463236|NCT00052910|stage II gastric cancer|stage ii gastric cancer
463237|NCT00052910|stage III gastric cancer|stage iii gastric cancer
463238|NCT00052910|adenocarcinoma of the stomach|adenocarcinoma of the stomach
463239|NCT00052910|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
463240|NCT00052910|stage I esophageal cancer|stage i esophageal cancer
463241|NCT00052910|stage II esophageal cancer|stage ii esophageal cancer
463242|NCT00052910|stage III esophageal cancer|stage iii esophageal cancer
463243|NCT00052923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
463244|NCT00052936|anaplastic large cell lymphoma|anaplastic large cell lymphoma
463245|NCT00052936|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
463246|NCT00052936|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
463247|NCT00052936|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
463248|NCT00052936|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
463249|NCT00052936|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
463250|NCT00052936|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
463251|NCT00052936|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
463252|NCT00052936|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
463253|NCT00052936|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
463254|NCT00052936|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
463255|NCT00052936|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
463256|NCT00052936|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
463257|NCT00052936|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
463258|NCT00052936|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
463259|NCT00052936|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
463260|NCT00052936|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
463261|NCT00052936|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
13051|NCT03207139|staging|staging
463262|NCT00052936|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
463263|NCT00052936|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
463264|NCT00052936|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
463265|NCT00052936|stage I mantle cell lymphoma|stage i mantle cell lymphoma
463266|NCT00052936|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
463267|NCT00052936|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
463268|NCT00052936|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
463269|NCT00052936|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
463270|NCT00052936|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
463271|NCT00052936|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
463272|NCT00052936|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
463774|NCT00044356|Experimental Treatment|experimental treatment
463273|NCT00052936|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
463274|NCT00052936|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
463275|NCT00052936|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
463276|NCT00052936|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
463277|NCT00052936|splenic marginal zone lymphoma|splenic marginal zone lymphoma
463278|NCT00052936|stage I marginal zone lymphoma|stage i marginal zone lymphoma
463279|NCT00052936|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
463280|NCT00052936|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
463281|NCT00052962|Appendiceal Cancer|appendiceal cancer
463282|NCT00052962|Regional Therapy|regional therapy
463284|NCT00052962|Hyperthermia|hyperthermia
463285|NCT00053001|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
463286|NCT00053001|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
463287|NCT00053001|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
463288|NCT00053001|anemia|anemia
463289|NCT00053001|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
463290|NCT00053001|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
463291|NCT00053001|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
463292|NCT00053014|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
463293|NCT00053014|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
463294|NCT00053014|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
463295|NCT00053014|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
463296|NCT00053014|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
463297|NCT00053027|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
463298|NCT00053027|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
482353|NCT00116116|HIV/AIDS|hiv/aids
463299|NCT00053027|stage I mantle cell lymphoma|stage i mantle cell lymphoma
463300|NCT00053027|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
463301|NCT00053027|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
463302|NCT00053040|recurrent childhood brain tumor|recurrent childhood brain tumor
463303|NCT00053053|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
463304|NCT00053053|cachexia|cachexia
463305|NCT00053053|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
463306|NCT00053053|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
463307|NCT00053053|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
463308|NCT00053053|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
463309|NCT00053053|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
463310|NCT00053053|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
463311|NCT00053053|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
463312|NCT00053053|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
463313|NCT00053053|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
463314|NCT00053053|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
463315|NCT00053053|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
463316|NCT00053053|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
463317|NCT00053053|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
463318|NCT00053053|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
463319|NCT00053053|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
463320|NCT00053053|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
463321|NCT00053053|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
463322|NCT00053053|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
463323|NCT00053053|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
463324|NCT00053053|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
463325|NCT00053053|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
463326|NCT00053053|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
463327|NCT00053053|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
463328|NCT00053053|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
463329|NCT00053053|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
463330|NCT00053053|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
463331|NCT00053053|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
463332|NCT00053053|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
463333|NCT00053053|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
463334|NCT00053053|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
463335|NCT00053053|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
463336|NCT00053053|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
463337|NCT00053053|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
463338|NCT00053053|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
463339|NCT00053053|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
463340|NCT00053053|intraocular lymphoma|intraocular lymphoma
463341|NCT00053053|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
463342|NCT00053053|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
463343|NCT00053053|anaplastic large cell lymphoma|anaplastic large cell lymphoma
463344|NCT00053053|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
463345|NCT00053053|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
463346|NCT00053053|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
463347|NCT00053053|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
463348|NCT00053053|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
463349|NCT00053053|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
463350|NCT00053053|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
463351|NCT00053053|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
463352|NCT00053053|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
463353|NCT00053053|splenic marginal zone lymphoma|splenic marginal zone lymphoma
463354|NCT00053092|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
463355|NCT00053092|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
463356|NCT00053092|stage I mantle cell lymphoma|stage i mantle cell lymphoma
463357|NCT00053092|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
463358|NCT00053092|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
463359|NCT00053105|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
463360|NCT00053105|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
463361|NCT00053105|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
463362|NCT00053105|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
463363|NCT00053118|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
463364|NCT00053118|childhood choroid plexus tumor|childhood choroid plexus tumor
463365|NCT00053118|childhood craniopharyngioma|childhood craniopharyngioma
463366|NCT00053118|childhood grade I meningioma|childhood grade i meningioma
463367|NCT00053118|childhood grade II meningioma|childhood grade ii meningioma
463368|NCT00053118|childhood grade III meningioma|childhood grade iii meningioma
463369|NCT00053118|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
463370|NCT00053118|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
463371|NCT00053118|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
463372|NCT00053118|recurrent childhood ependymoma|recurrent childhood ependymoma
463373|NCT00053118|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
463374|NCT00053118|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
463375|NCT00053118|recurrent neuroblastoma|recurrent neuroblastoma
463376|NCT00053118|recurrent retinoblastoma|recurrent retinoblastoma
463377|NCT00053118|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
463378|NCT00053118|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
463379|NCT00053118|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
463380|NCT00053131|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
463381|NCT00053131|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
463382|NCT00053131|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
463383|NCT00053131|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
463384|NCT00053144|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
463385|NCT00053144|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
463386|NCT00053144|secondary acute myeloid leukemia|secondary acute myeloid leukemia
463387|NCT00053144|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
463388|NCT00053144|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
463389|NCT00053144|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
463390|NCT00053144|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
463391|NCT00053144|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
463392|NCT00053144|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
463393|NCT00053144|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
463394|NCT00053144|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
463395|NCT00053144|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
463396|NCT00053144|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
463397|NCT00053144|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
463398|NCT00053157|graft versus host disease|graft versus host disease
88637|NCT02733341|Ticagrelor|ticagrelor
463399|NCT00053157|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
463400|NCT00053157|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
463401|NCT00053157|primary myelofibrosis|primary myelofibrosis
463402|NCT00053157|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
463403|NCT00053157|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
463404|NCT00053157|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
463405|NCT00053157|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
463406|NCT00053157|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
583609|NCT00512382|COUGH|cough
463407|NCT00053157|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
463408|NCT00053157|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
463409|NCT00053157|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
463410|NCT00053157|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
463411|NCT00053157|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
463412|NCT00053157|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
463413|NCT00053157|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
463414|NCT00053157|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
463415|NCT00053157|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
463416|NCT00053157|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
463417|NCT00053157|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
463418|NCT00053157|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
463419|NCT00053157|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
463420|NCT00053157|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
463421|NCT00053157|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
463422|NCT00053157|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
463423|NCT00053157|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
463424|NCT00053157|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
463425|NCT00053157|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
463426|NCT00053157|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
463427|NCT00053157|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
463428|NCT00053157|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
463429|NCT00053157|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
463430|NCT00053157|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
463431|NCT00053157|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
463432|NCT00053157|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
463433|NCT00053157|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
463434|NCT00053157|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
463435|NCT00053157|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
463436|NCT00053157|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
463437|NCT00053157|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
463438|NCT00053157|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
463439|NCT00053157|secondary acute myeloid leukemia|secondary acute myeloid leukemia
463440|NCT00053157|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
463441|NCT00053157|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
463442|NCT00053157|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
463443|NCT00053157|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
463444|NCT00053157|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
463445|NCT00053157|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
463446|NCT00053157|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
463447|NCT00053157|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
463448|NCT00053157|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
463449|NCT00053157|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
463450|NCT00053157|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
463451|NCT00053157|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
463452|NCT00053157|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
463453|NCT00053157|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
463454|NCT00053157|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
463455|NCT00053157|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
463456|NCT00053157|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
463457|NCT00053157|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
463458|NCT00053157|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
463459|NCT00053157|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
463460|NCT00053157|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
463461|NCT00053157|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
463462|NCT00053157|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
463463|NCT00053157|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
463464|NCT00053157|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
463465|NCT00053157|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
463466|NCT00053157|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
463467|NCT00053157|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
463468|NCT00053157|chronic eosinophilic leukemia|chronic eosinophilic leukemia
463469|NCT00053157|chronic neutrophilic leukemia|chronic neutrophilic leukemia
463470|NCT00053157|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
463471|NCT00053157|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
463472|NCT00053157|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
463473|NCT00053157|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
463474|NCT00053157|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
463475|NCT00053157|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
463476|NCT00053157|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
463477|NCT00053157|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
463478|NCT00053157|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
463479|NCT00053157|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
463480|NCT00053157|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
463481|NCT00053157|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
463482|NCT00053157|splenic marginal zone lymphoma|splenic marginal zone lymphoma
463483|NCT00053157|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
463484|NCT00053157|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
463485|NCT00053157|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
463486|NCT00053157|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
463487|NCT00053157|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
463488|NCT00053157|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
463490|NCT00053183|adult giant cell glioblastoma|adult giant cell glioblastoma
463491|NCT00053183|adult gliosarcoma|adult gliosarcoma
463492|NCT00053196|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
463493|NCT00053196|prolymphocytic leukemia|prolymphocytic leukemia
463494|NCT00053196|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
463495|NCT00053196|stage I multiple myeloma|stage i multiple myeloma
463496|NCT00053196|stage II multiple myeloma|stage ii multiple myeloma
463497|NCT00053196|stage III multiple myeloma|stage iii multiple myeloma
463498|NCT00053196|refractory multiple myeloma|refractory multiple myeloma
463499|NCT00053196|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
463500|NCT00053196|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
463501|NCT00053196|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
463502|NCT00053196|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
463503|NCT00053196|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
463504|NCT00053196|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
463505|NCT00053196|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
463506|NCT00053196|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
463507|NCT00053196|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
463508|NCT00053196|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
463509|NCT00053196|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
463510|NCT00053196|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
463511|NCT00053196|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
463512|NCT00053196|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
463513|NCT00053196|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
463514|NCT00053196|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
463515|NCT00053196|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
463516|NCT00053196|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
463517|NCT00053196|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
463518|NCT00053196|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
463519|NCT00053196|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
463520|NCT00053196|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
463521|NCT00053196|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
463522|NCT00053196|splenic marginal zone lymphoma|splenic marginal zone lymphoma
463523|NCT00053196|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
463524|NCT00053196|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
463525|NCT00053196|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
463526|NCT00053196|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
463527|NCT00053196|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
463528|NCT00053196|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
463529|NCT00053209|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
463530|NCT00053209|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
463531|NCT00053209|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
463532|NCT00053209|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
463533|NCT00053209|recurrent bladder cancer|recurrent bladder cancer
463534|NCT00053209|stage III bladder cancer|stage iii bladder cancer
463535|NCT00053209|stage IV bladder cancer|stage iv bladder cancer
463536|NCT00053209|anterior urethral cancer|anterior urethral cancer
463537|NCT00053209|posterior urethral cancer|posterior urethral cancer
463538|NCT00053209|recurrent urethral cancer|recurrent urethral cancer
463539|NCT00053209|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
463540|NCT00053222|recurrent pancreatic cancer|recurrent pancreatic cancer
463541|NCT00053222|stage II pancreatic cancer|stage ii pancreatic cancer
463542|NCT00053222|stage III pancreatic cancer|stage iii pancreatic cancer
463543|NCT00053222|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
463544|NCT00053222|stage IV pancreatic cancer|stage iv pancreatic cancer
463545|NCT00053248|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
463546|NCT00053248|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
463547|NCT00053261|sexuality and reproductive issues|sexuality and reproductive issues
463548|NCT00053261|stage IB cervical cancer|stage ib cervical cancer
463549|NCT00053287|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
463550|NCT00053287|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
482355|NCT00116129|Treatment|treatment
463551|NCT00053287|refractory anemia with excess blasts|refractory anemia with excess blasts
463552|NCT00053287|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
463553|NCT00053287|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
463554|NCT00053287|secondary acute myeloid leukemia|secondary acute myeloid leukemia
463555|NCT00053287|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
463556|NCT00053287|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
463557|NCT00053287|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
463558|NCT00053287|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
463559|NCT00053287|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
463560|NCT00053287|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
463561|NCT00053287|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
463562|NCT00053287|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
463563|NCT00053287|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
463564|NCT00053287|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
463565|NCT00053287|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
463566|NCT00053287|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
463567|NCT00053300|extensive stage small cell lung cancer|extensive stage small cell lung cancer
463568|NCT00053378|hypocalcemia, ionized calcium, intensive care|hypocalcemia, ionized calcium, intensive care
463569|NCT00053391|stage III melanoma|stage iii melanoma
463570|NCT00053391|stage IV melanoma|stage iv melanoma
463571|NCT00053391|recurrent melanoma|recurrent melanoma
463572|NCT00053404|Treatment Experienced|treatment experienced
463573|NCT00053404|Drug Resistance|drug resistance
463574|NCT00053417|Walking Ability|walking ability
463575|NCT00053417|Muscle strength|muscle strength
463576|NCT00053417|Spasticity|spasticity
463577|NCT00053430|Immune Modulation|immune modulation
463578|NCT00053430|Thalidomide|thalidomide
463579|NCT00053430|Immune reconstitution|immune reconstitution
463580|NCT00053430|Treatment Experienced|treatment experienced
463582|NCT00053443|Treatment Experienced|treatment experienced
463583|NCT00053456|Endothelium|endothelium
463584|NCT00053456|Nitric Oxide|nitric oxide
463087|NCT00052195|BCG|bcg
463585|NCT00053456|Myocardial Ischemia|myocardial ischemia
463586|NCT00053456|Exercise|exercise
463587|NCT00053456|Endothelial Progenitor Cells|endothelial progenitor cells
463588|NCT00053469|Cognitive Development|cognitive development
463589|NCT00053469|Motor Planning|motor planning
463590|NCT00053469|Categorization|categorization
463591|NCT00053469|Perception|perception
463592|NCT00053469|Adaptation|adaptation
463593|NCT00053482|Smallpox vaccines|smallpox vaccines
463594|NCT00053482|Dryvax®|dryvax®
463595|NCT00053482|Orthopoxvirus|orthopoxvirus
463596|NCT00053482|Vaccinia virus|vaccinia virus
463597|NCT00053482|ACAM2000|acam2000
463598|NCT00053495|Smallpox|smallpox
463599|NCT00053560|lupus|lupus
463600|NCT00053560|systemic lupus erythematosus|systemic lupus erythematosus
463601|NCT00053560|SLE|sle
463602|NCT00053560|bone loss|bone loss
463603|NCT00053560|DHEA|dhea
463604|NCT00053573|Glycogen Storage Disease Type II|glycogen storage disease type ii
463605|NCT00053573|GSD-II|gsd-ii
463606|NCT00053573|Pompe Disease|pompe disease
463607|NCT00053599|Cholesterol-lowering drug|cholesterol-lowering drug
463608|NCT00053599|Mild to Moderate Alzheimer disease|mild to moderate alzheimer disease
463609|NCT00053612|HIV-1|hiv-1
463610|NCT00053612|Women|women
463611|NCT00053612|Vitamin A|vitamin a
463612|NCT00053612|Shedding|shedding
463613|NCT00053625|Parkinson's disease|parkinson's disease
463614|NCT00053625|PD|pd
463615|NCT00053625|deep brain stimulation|deep brain stimulation
463616|NCT00053625|DBS|dbs
463617|NCT00053638|HIV-1 Efavirenz Tenofovir|hiv-1 efavirenz tenofovir
463618|NCT00053677|Impulse Control Disorders|impulse control disorders
463619|NCT00053690|Comorbidity|comorbidity
463620|NCT00053690|Schizophrenia|schizophrenia
463621|NCT00053690|Bipolar Disorder|bipolar disorder
463622|NCT00053690|Depression|depression
463623|NCT00053703|Psychotic Disorders|psychotic disorders
463624|NCT00053703|Schizophreniform Disorder|schizophreniform disorder
463625|NCT00053716|Angioplasty & PGE1 Treatment of Peripheral Vascular Disease|angioplasty & pge1 treatment of peripheral vascular disease
463626|NCT00053742|Smallpox|smallpox
463627|NCT00053742|Vaccine|vaccine
463628|NCT00053742|Vaccination|vaccination
463629|NCT00053742|Variola|variola
463630|NCT00053742|Adults|adults
463631|NCT00053742|Healthy Volunteer|healthy volunteer
463632|NCT00053742|HV|hv
463633|NCT00053742|Smallpox Vaccine|smallpox vaccine
463634|NCT00053768|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
463635|NCT00053768|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
463636|NCT00053768|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
463637|NCT00053768|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
463638|NCT00053768|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
463639|NCT00053768|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
463640|NCT00053768|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
477721|NCT00090077|GW678248X|gw678248x
463641|NCT00053768|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
463642|NCT00053768|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
463643|NCT00053768|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
463644|NCT00053768|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
463645|NCT00053768|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
463646|NCT00053768|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
463647|NCT00053768|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
463648|NCT00053768|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
463649|NCT00053768|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
463650|NCT00053768|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
463651|NCT00053768|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
463652|NCT00053768|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
463653|NCT00053768|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
463654|NCT00053768|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
463655|NCT00053768|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
463656|NCT00053768|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
463657|NCT00053768|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
463658|NCT00053768|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
463659|NCT00053768|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
463660|NCT00053768|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
463661|NCT00053768|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
463662|NCT00053768|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
463663|NCT00053768|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
463664|NCT00053768|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
463665|NCT00053768|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
463666|NCT00053768|stage I mantle cell lymphoma|stage i mantle cell lymphoma
463667|NCT00053768|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
463668|NCT00053768|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
463669|NCT00053781|recurrent melanoma|recurrent melanoma
463670|NCT00053781|stage IV melanoma|stage iv melanoma
463671|NCT00053794|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
463672|NCT00053794|adult angiosarcoma|adult angiosarcoma
463673|NCT00053794|adult fibrosarcoma|adult fibrosarcoma
463674|NCT00053794|adult leiomyosarcoma|adult leiomyosarcoma
463675|NCT00053794|adult liposarcoma|adult liposarcoma
463676|NCT00053794|adult synovial sarcoma|adult synovial sarcoma
463677|NCT00053794|endometrial stromal sarcoma|endometrial stromal sarcoma
463678|NCT00053794|uterine leiomyosarcoma|uterine leiomyosarcoma
463679|NCT00053794|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
463680|NCT00053794|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
463681|NCT00053794|stage III uterine sarcoma|stage iii uterine sarcoma
463682|NCT00053794|stage IV uterine sarcoma|stage iv uterine sarcoma
463683|NCT00053794|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
463684|NCT00053794|recurrent uterine sarcoma|recurrent uterine sarcoma
463685|NCT00053794|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
463686|NCT00053794|adult neurofibrosarcoma|adult neurofibrosarcoma
463687|NCT00053794|adult rhabdomyosarcoma|adult rhabdomyosarcoma
463688|NCT00053794|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
463689|NCT00053807|stage III renal cell cancer|stage iii renal cell cancer
463690|NCT00053807|stage IV renal cell cancer|stage iv renal cell cancer
463691|NCT00053820|stage IV renal cell cancer|stage iv renal cell cancer
463692|NCT00053833|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
463693|NCT00053833|fallopian tube cancer|fallopian tube cancer
463694|NCT00053833|primary peritoneal cavity cancer|primary peritoneal cavity cancer
463695|NCT00053833|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
463696|NCT00053833|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
463697|NCT00053846|dyspnea|dyspnea
463698|NCT00053846|pulmonary complications|pulmonary complications
463699|NCT00053846|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
463700|NCT00053872|untreated childhood medulloblastoma|untreated childhood medulloblastoma
463701|NCT00044226|BPH|bph
463702|NCT00044226|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
463703|NCT00044226|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
463704|NCT00044226|Enlarged Prostate|enlarged prostate
463705|NCT00044239|Tic Disorders|tic disorders
463706|NCT00044239|Neurophyschological|neurophyschological
463707|NCT00044239|Immunology|immunology
463708|NCT00044239|Magnetic Resonance Imaging|magnetic resonance imaging
463709|NCT00044239|Basal Ganglia|basal ganglia
483335|NCT00117039|fatigue|fatigue
463710|NCT00044239|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
463711|NCT00044239|Children|children
463712|NCT00044239|Adolescents|adolescents
463713|NCT00044239|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
463714|NCT00044239|PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated d|pandas (pediatric autoimmune neuropsychiatric disorders associated d
463715|NCT00044239|Obsessive Compulsive Disorder|obsessive compulsive disorder
463717|NCT00044239|Healthy Volunteers|healthy volunteers
463718|NCT00044239|HV|hv
463719|NCT00044252|Neurosteroids|neurosteroids
463720|NCT00044252|Complex Partial Seizure|complex partial seizure
463721|NCT00044252|Menstrual Cycle|menstrual cycle
463722|NCT00044252|Allopregnanolone|allopregnanolone
463723|NCT00044252|Catamenial Epilepsy|catamenial epilepsy
463724|NCT00044252|Seizures|seizures
463725|NCT00044252|Epilepsy|epilepsy
463726|NCT00044252|Healthy Volunteer|healthy volunteer
463727|NCT00044252|HV|hv
463728|NCT00044252|Normal Control|normal control
463729|NCT00044265|ACE inhibitor|ace inhibitor
463730|NCT00044265|high blood pressure|high blood pressure
463731|NCT00044265|pediatric|pediatric
463732|NCT00044278|epilepsy|epilepsy
463733|NCT00044278|pediatric|pediatric
463734|NCT00044278|partial seizures|partial seizures
463735|NCT00044291|Atamestane|atamestane
463736|NCT00044291|Toremifene|toremifene
463737|NCT00044291|Letrozole|letrozole
463738|NCT00044291|Aromatase inhibitor|aromatase inhibitor
463739|NCT00044291|Receptor-positive|receptor-positive
463740|NCT00044291|First line therapy|first line therapy
463741|NCT00044291|Estrogen blocker|estrogen blocker
463742|NCT00044291|Metastatic breast cancer|metastatic breast cancer
463743|NCT00044291|Locally advanced breast cancer|locally advanced breast cancer
463744|NCT00044291|Locally recurrent breast cancer|locally recurrent breast cancer
463745|NCT00044291|stage IV breast cancer|stage iv breast cancer
463746|NCT00044291|ductal breast carcinoma|ductal breast carcinoma
463747|NCT00044291|lobular breast carcinoma|lobular breast carcinoma
463748|NCT00044291|stage IIIA breast cancer|stage iiia breast cancer
463749|NCT00044291|stage IIIB breast cancer|stage iiib breast cancer
463751|NCT00044304|Treatment|treatment
463752|NCT00044304|Eosinophil|eosinophil
463753|NCT00044304|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
463754|NCT00044304|Hypereosinophilia|hypereosinophilia
463755|NCT00044304|Biologicals|biologicals
463756|NCT00044304|Chemotherapy|chemotherapy
463757|NCT00044304|Gleevec|gleevec
463758|NCT00044304|Eosinophils|eosinophils
463759|NCT00044304|Hypereosinophilic Syndrome|hypereosinophilic syndrome
463760|NCT00044304|HES|hes
463761|NCT00044317|FEV|fev
463762|NCT00044317|Smoking|smoking
463763|NCT00044317|antioxidents|antioxidents
463764|NCT00044317|lung growth|lung growth
463765|NCT00044343|colorectal cancer|colorectal cancer
463766|NCT00044343|EGFR inhibitor|egfr inhibitor
463767|NCT00044343|lapatinib|lapatinib
463768|NCT00044343|metastatic|metastatic
463769|NCT00044356|Melanoma|melanoma
463770|NCT00044356|Metastatic Melanoma|metastatic melanoma
463771|NCT00044356|Malignant Melanoma|malignant melanoma
463772|NCT00044356|Skin Cancer|skin cancer
463773|NCT00044356|Tumor|tumor
463775|NCT00044356|Clinical Trial|clinical trial
463776|NCT00044356|Gene Therapy|gene therapy
463777|NCT00044356|Gene Delivery|gene delivery
463778|NCT00044356|Gene Transfer|gene transfer
463779|NCT00044356|Immunotherapy|immunotherapy
463780|NCT00044356|Cancer|cancer
463781|NCT00044356|Neoplasm|neoplasm
463782|NCT00044356|Lesion|lesion
463783|NCT00044356|Metastasis|metastasis
463784|NCT00044356|Cancerous mole|cancerous mole
463785|NCT00044356|Melanoma vaccine|melanoma vaccine
463786|NCT00044356|Cancer research|cancer research
463787|NCT00044356|Cancer cells|cancer cells
463788|NCT00044356|Allovectin-7®|allovectin-7®
463789|NCT00044369|Varicocele|varicocele
463790|NCT00044369|environmental toxins|environmental toxins
463791|NCT00044369|male infertility|male infertility
463792|NCT00044369|cadmium|cadmium
463793|NCT00044382|Revimid|revimid
463794|NCT00044382|CC5013|cc5013
463795|NCT00044382|CC-5013|cc-5013
463796|NCT00044460|Type 2 diabetes drug-naive|type 2 diabetes drug-naive
463797|NCT00044473|Otitis Media|otitis media
463798|NCT00044473|Ear Diaeases|ear diaeases
463799|NCT00044473|Levofloxacin|levofloxacin
463800|NCT00044473|Quinolones|quinolones
463801|NCT00044486|Prophylaxis|prophylaxis
463802|NCT00044486|neutropenia|neutropenia
463803|NCT00044486|AML|aml
463804|NCT00044486|MDS|mds
463805|NCT00044486|fungal infections|fungal infections
463806|NCT00044486|Acute Myelogenous Leukemia|acute myelogenous leukemia
463807|NCT00044486|Anticipated prolonged profound neutropenia|anticipated prolonged profound neutropenia
463808|NCT00044512|Cancer|cancer
463809|NCT00044512|Liver Cancer|liver cancer
463810|NCT00044512|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
463811|NCT00044525|Taxane|taxane
463812|NCT00044525|Breast Cancer|breast cancer
463813|NCT00044525|Metastasis|metastasis
463814|NCT00044538|Taxane|taxane
463815|NCT00044538|Lung cancer, non-small cell|lung cancer, non-small cell
463816|NCT00044538|NSCLC|nsclc
463817|NCT00044551|Taxane|taxane
463818|NCT00044551|Lymphoma|lymphoma
463819|NCT00044551|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
463820|NCT00044564|Taxane|taxane
463821|NCT00044564|Renal Cell Carcinoma|renal cell carcinoma
463822|NCT00044564|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
463823|NCT00044577|HIV-1 Abacavir Lamivudine Tenofovir|hiv-1 abacavir lamivudine tenofovir
463824|NCT00044590|Parkinson's disease|parkinson's disease
463825|NCT00044590|Pesticides|pesticides
463826|NCT00044590|Genetic susceptibility|genetic susceptibility
463827|NCT00044590|Polymorphisms|polymorphisms
463828|NCT00044603|Pregnancy|pregnancy
463829|NCT00044629|Sleep Deprivation|sleep deprivation
463830|NCT00044629|Insomnia|insomnia
463831|NCT00044629|Sleep Disorders|sleep disorders
463832|NCT00044642|Anxiety|anxiety
463833|NCT00044668|exenatide|exenatide
463834|NCT00044668|exendin-4|exendin-4
463835|NCT00044668|diabetes|diabetes
463836|NCT00044668|Amylin|amylin
463837|NCT00044668|Lilly|lilly
463838|NCT00044681|Risperidone|risperidone
463839|NCT00044681|depression|depression
463840|NCT00044681|melancholia|melancholia
463841|NCT00044681|depressive disorder|depressive disorder
463842|NCT00044681|antipsychotic agents|antipsychotic agents
463843|NCT00044694|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
463844|NCT00044707|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
463845|NCT00044720|Kidney Transplant|kidney transplant
463846|NCT00044733|Leukemia|leukemia
463847|NCT00044733|Stem Cell Transplant|stem cell transplant
463848|NCT00044746|Diabetes|diabetes
463849|NCT00044759|Hematologic|hematologic
463850|NCT00044759|Neoplasms|neoplasms
463851|NCT00044772|Panic|panic
463852|NCT00044772|Disorder|disorder
463853|NCT00044785|colorectal cancer|colorectal cancer
463854|NCT00044785|gastric cancer|gastric cancer
463855|NCT00044785|breast cancer|breast cancer
463856|NCT00044798|Aged|aged
463857|NCT00044837|Lopinavir|lopinavir
463858|NCT00044837|HIV-1|hiv-1
463859|NCT00044837|HIV Protease Inhibitors|hiv protease inhibitors
463860|NCT00044837|Ritonavir|ritonavir
463861|NCT00044837|Postmenopause|postmenopause
463862|NCT00044837|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
463863|NCT00044837|Pharmacokinetics|pharmacokinetics
463864|NCT00044837|Area Under Curve|area under curve
463865|NCT00044837|Hormone Replacement Therapy|hormone replacement therapy
463866|NCT00044837|efavirenz|efavirenz
463867|NCT00044837|estradiol|estradiol
463868|NCT00044863|EGFr|egfr
463869|NCT00044863|Metastatic Colorectal Carcinoma|metastatic colorectal carcinoma
463870|NCT00044876|Endometrium|endometrium
463871|NCT00044876|Progesterone|progesterone
463872|NCT00044876|Estrogen|estrogen
463873|NCT00044876|Leiomyoma|leiomyoma
463874|NCT00044876|Uterine Leiomyoma|uterine leiomyoma
463875|NCT00044876|Uterine Fibroids|uterine fibroids
463876|NCT00044876|Fibroids|fibroids
463877|NCT00044889|CLO221|clo221
463878|NCT00044889|clolar|clolar
463879|NCT00044915|Acute Ischemic Stroke Without Hemorrhage|acute ischemic stroke without hemorrhage
463880|NCT00044928|Abdominal Infections|abdominal infections
463881|NCT00044954|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
463882|NCT00044954|stage I multiple myeloma|stage i multiple myeloma
463883|NCT00044954|stage II multiple myeloma|stage ii multiple myeloma
463884|NCT00044954|stage III multiple myeloma|stage iii multiple myeloma
463885|NCT00044954|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
463886|NCT00044954|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
463887|NCT00044954|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
463888|NCT00044954|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
463889|NCT00044954|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
463890|NCT00044954|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
463891|NCT00044954|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
463892|NCT00044954|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
463893|NCT00044954|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
463894|NCT00044954|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
463895|NCT00044954|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
463896|NCT00044954|refractory multiple myeloma|refractory multiple myeloma
463897|NCT00044954|stage I mantle cell lymphoma|stage i mantle cell lymphoma
463898|NCT00044954|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
464083|NCT00045149|recurrent melanoma|recurrent melanoma
463899|NCT00044954|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
463900|NCT00044954|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
463901|NCT00044954|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
463902|NCT00044954|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
463903|NCT00044954|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
463904|NCT00044954|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
463905|NCT00044954|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
463906|NCT00044954|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
463907|NCT00044954|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
463908|NCT00044967|stage I colon cancer|stage i colon cancer
463909|NCT00044967|stage II colon cancer|stage ii colon cancer
463910|NCT00044967|stage III colon cancer|stage iii colon cancer
463911|NCT00044967|stage I rectal cancer|stage i rectal cancer
463912|NCT00044967|stage II rectal cancer|stage ii rectal cancer
463913|NCT00044967|stage III rectal cancer|stage iii rectal cancer
463914|NCT00044967|adenocarcinoma of the colon|adenocarcinoma of the colon
463915|NCT00044967|adenocarcinoma of the rectum|adenocarcinoma of the rectum
463916|NCT00044980|malnutrition|malnutrition
463917|NCT00044980|stage I prostate cancer|stage i prostate cancer
463918|NCT00044980|stage II B prostate cancer|stage ii b prostate cancer
463919|NCT00044980|stage II A prostate cancer|stage ii a prostate cancer
463920|NCT00044993|male breast cancer|male breast cancer
463921|NCT00044993|stage IIIA breast cancer|stage iiia breast cancer
463922|NCT00044993|stage IIIB breast cancer|stage iiib breast cancer
463923|NCT00044993|stage IIIC breast cancer|stage iiic breast cancer
463924|NCT00044993|stage IV breast cancer|stage iv breast cancer
463925|NCT00045006|acute undifferentiated leukemia|acute undifferentiated leukemia
463926|NCT00045006|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
463927|NCT00045006|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
463928|NCT00045006|ovarian sarcoma|ovarian sarcoma
463929|NCT00045006|ovarian stromal cancer|ovarian stromal cancer
463930|NCT00045006|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
463931|NCT00045006|prolymphocytic leukemia|prolymphocytic leukemia
463932|NCT00045006|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
463933|NCT00045006|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
463934|NCT00045006|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
463935|NCT00045006|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
463936|NCT00045006|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
463937|NCT00045006|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
463938|NCT00045006|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
463939|NCT00045006|recurrent bladder cancer|recurrent bladder cancer
463940|NCT00045006|recurrent breast cancer|recurrent breast cancer
463941|NCT00045006|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
463942|NCT00045006|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
463943|NCT00045006|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
463944|NCT00045006|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
463945|NCT00045006|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
463946|NCT00045006|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
463947|NCT00045006|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
463948|NCT00045006|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
463949|NCT00045006|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
463950|NCT00045006|recurrent prostate cancer|recurrent prostate cancer
463951|NCT00045006|recurrent renal cell cancer|recurrent renal cell cancer
463952|NCT00045006|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
463953|NCT00045006|refractory hairy cell leukemia|refractory hairy cell leukemia
463954|NCT00045006|refractory multiple myeloma|refractory multiple myeloma
463955|NCT00045006|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
463956|NCT00045006|secondary acute myeloid leukemia|secondary acute myeloid leukemia
463957|NCT00045006|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
463958|NCT00045006|stage III multiple myeloma|stage iii multiple myeloma
463959|NCT00045006|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
463960|NCT00045006|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
463961|NCT00045006|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
463962|NCT00045006|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
463963|NCT00045006|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
463964|NCT00045006|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
463965|NCT00045006|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
463966|NCT00045006|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
463967|NCT00045006|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
463968|NCT00045006|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
463969|NCT00045006|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
463970|NCT00045006|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
463971|NCT00045006|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
463972|NCT00045006|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
463973|NCT00045006|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
463974|NCT00045006|stage III bladder cancer|stage iii bladder cancer
463975|NCT00045006|stage IV bladder cancer|stage iv bladder cancer
463976|NCT00045006|stage IIIA breast cancer|stage iiia breast cancer
463977|NCT00045006|stage IIIB breast cancer|stage iiib breast cancer
463978|NCT00045006|stage IIIC breast cancer|stage iiic breast cancer
463979|NCT00045006|stage IV breast cancer|stage iv breast cancer
477824|NCT00098046|chickenpox|chickenpox
463980|NCT00045006|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
463981|NCT00045006|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
463982|NCT00045006|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
463983|NCT00045006|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
463984|NCT00045006|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
463985|NCT00045006|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
463986|NCT00045006|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
463987|NCT00045006|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
463988|NCT00045006|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
463989|NCT00045006|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
463990|NCT00045006|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
463991|NCT00045006|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
463992|NCT00045006|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
463993|NCT00045006|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
463994|NCT00045006|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
463995|NCT00045006|stage III prostate cancer|stage iii prostate cancer
463996|NCT00045006|stage IV prostate cancer|stage iv prostate cancer
463997|NCT00045006|stage III renal cell cancer|stage iii renal cell cancer
463998|NCT00045006|stage IV renal cell cancer|stage iv renal cell cancer
595261|NCT00560885|af|af
583610|NCT00512382|WHEEZE|wheeze
463999|NCT00045006|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
464000|NCT00045006|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
464001|NCT00045006|recurrent salivary gland cancer|recurrent salivary gland cancer
464002|NCT00045006|stage IV salivary gland cancer|stage iv salivary gland cancer
464003|NCT00045006|stage III salivary gland cancer|stage iii salivary gland cancer
464004|NCT00045006|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
464005|NCT00045006|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
464006|NCT00045006|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
464007|NCT00045006|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
464008|NCT00045006|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
464009|NCT00045006|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
464010|NCT00045006|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
464011|NCT00045006|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
464012|NCT00045006|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
464013|NCT00045006|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
464014|NCT00045006|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
464015|NCT00045006|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
464016|NCT00045006|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
464017|NCT00045006|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
464018|NCT00045006|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
464019|NCT00045006|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
464020|NCT00045006|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
464021|NCT00045006|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
464022|NCT00045006|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
464023|NCT00045006|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
464024|NCT00045006|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
464025|NCT00045006|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
464026|NCT00045006|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
464027|NCT00045006|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
464028|NCT00045006|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
464029|NCT00045006|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
464030|NCT00045006|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
464031|NCT00045006|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
464032|NCT00045006|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
464033|NCT00045006|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
464034|NCT00045006|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
464035|NCT00045006|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
464099|NCT00045266|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
464036|NCT00045006|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
464037|NCT00045006|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
464038|NCT00045006|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
464039|NCT00045006|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
464040|NCT00045006|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
464041|NCT00045006|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
464042|NCT00045006|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
464043|NCT00045006|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
464044|NCT00045006|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
464045|NCT00045006|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
464046|NCT00045006|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
464047|NCT00045006|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
595367|NCT00561366|ALS|als
464048|NCT00045006|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
464049|NCT00045006|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
464050|NCT00045006|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
464051|NCT00045006|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
464052|NCT00045006|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
464053|NCT00045006|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
464054|NCT00045006|male breast cancer|male breast cancer
464055|NCT00045019|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
464056|NCT00045045|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
464057|NCT00045045|testicular choriocarcinoma|testicular choriocarcinoma
464058|NCT00045045|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
464059|NCT00045045|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
464060|NCT00045045|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
464061|NCT00045045|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
464062|NCT00045045|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
464063|NCT00045045|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
464064|NCT00045045|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
464065|NCT00045045|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
464066|NCT00045045|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
464067|NCT00045045|testicular embryonal carcinoma|testicular embryonal carcinoma
464069|NCT00045045|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
464070|NCT00045045|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
464071|NCT00045045|testicular yolk sac tumor|testicular yolk sac tumor
464072|NCT00045097|male breast cancer|male breast cancer
464073|NCT00045097|recurrent breast cancer|recurrent breast cancer
464074|NCT00045097|stage IIIB breast cancer|stage iiib breast cancer
464075|NCT00045097|stage IIIC breast cancer|stage iiic breast cancer
464076|NCT00045097|stage IV breast cancer|stage iv breast cancer
464077|NCT00045123|adenocarcinoma of the prostate|adenocarcinoma of the prostate
464078|NCT00045123|recurrent prostate cancer|recurrent prostate cancer
464079|NCT00045136|refractory multiple myeloma|refractory multiple myeloma
464080|NCT00045136|stage I multiple myeloma|stage i multiple myeloma
464081|NCT00045136|stage II multiple myeloma|stage ii multiple myeloma
464082|NCT00045136|stage III multiple myeloma|stage iii multiple myeloma
464084|NCT00045149|stage IV melanoma|stage iv melanoma
464085|NCT00045162|extensive stage small cell lung cancer|extensive stage small cell lung cancer
464086|NCT00045175|primary peritoneal cavity cancer|primary peritoneal cavity cancer
464087|NCT00045175|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
464088|NCT00045175|fallopian tube cancer|fallopian tube cancer
464089|NCT00045227|adenocarcinoma of the prostate|adenocarcinoma of the prostate
464090|NCT00045227|recurrent prostate cancer|recurrent prostate cancer
464091|NCT00045227|stage IV prostate cancer|stage iv prostate cancer
464092|NCT00045266|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
464093|NCT00045266|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
464094|NCT00045266|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
464095|NCT00045266|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
464096|NCT00045266|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
464097|NCT00045266|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
483336|NCT00117039|Aranesp®|aranesp®
464098|NCT00045266|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
464372|NCT00045981|cardiovascular|cardiovascular
464100|NCT00045266|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
464101|NCT00045266|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
464102|NCT00045266|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
464103|NCT00045266|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
464104|NCT00045266|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
464105|NCT00045266|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
464106|NCT00045266|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
464107|NCT00045266|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
464108|NCT00045266|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
464109|NCT00045266|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
464110|NCT00045266|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
464111|NCT00045266|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
88638|NCT02733341|Coronary artery bypass graft (CABG)|coronary artery bypass graft (cabg)
464112|NCT00045266|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
464113|NCT00045266|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
464114|NCT00045266|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
464115|NCT00045266|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
464116|NCT00045266|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
464117|NCT00045266|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
464118|NCT00045266|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
464119|NCT00045266|splenic marginal zone lymphoma|splenic marginal zone lymphoma
464120|NCT00045279|stage IV renal cell cancer|stage iv renal cell cancer
464121|NCT00045292|infection|infection
464122|NCT00045292|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
464123|NCT00045292|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
464124|NCT00045292|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
464125|NCT00045292|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
464126|NCT00045292|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
464127|NCT00045292|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
464128|NCT00045292|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
464129|NCT00045292|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
464130|NCT00045292|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
464131|NCT00045292|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
464132|NCT00045292|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
464133|NCT00045292|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
464134|NCT00045292|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
464135|NCT00045292|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
464136|NCT00045292|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
464137|NCT00045292|secondary acute myeloid leukemia|secondary acute myeloid leukemia
464138|NCT00045292|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
464139|NCT00045292|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
464140|NCT00045292|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
464141|NCT00045292|chronic eosinophilic leukemia|chronic eosinophilic leukemia
464142|NCT00045292|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
464143|NCT00045292|chronic neutrophilic leukemia|chronic neutrophilic leukemia
464144|NCT00045292|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
464145|NCT00045292|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
464146|NCT00045292|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
464147|NCT00045292|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
464148|NCT00045292|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
464149|NCT00045292|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
464150|NCT00045292|disseminated neuroblastoma|disseminated neuroblastoma
464151|NCT00045292|recurrent neuroblastoma|recurrent neuroblastoma
464152|NCT00045292|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
464153|NCT00045292|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
464154|NCT00045292|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
464155|NCT00045292|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
464156|NCT00045292|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
464157|NCT00045292|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
464158|NCT00045292|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
464159|NCT00045292|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
464160|NCT00045292|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
464533|NCT00054145|stage IIIB breast cancer|stage iiib breast cancer
464161|NCT00045292|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
464162|NCT00045292|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
464163|NCT00045292|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
464164|NCT00045292|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
464165|NCT00045292|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
464166|NCT00045292|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
464167|NCT00045292|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
464168|NCT00045292|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
464169|NCT00045292|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
464170|NCT00045292|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
464171|NCT00045292|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
464172|NCT00045292|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
464173|NCT00045292|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
464174|NCT00045292|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
464175|NCT00045292|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
464176|NCT00045292|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
464177|NCT00045292|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
464178|NCT00045292|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
464179|NCT00045292|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
464180|NCT00045292|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
13052|NCT03207139|biochemical failure|biochemical failure
464181|NCT00045292|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
464182|NCT00045292|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
464183|NCT00045292|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
464184|NCT00045292|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
464185|NCT00045292|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
464186|NCT00045292|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
464187|NCT00045292|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
464188|NCT00045292|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
464189|NCT00045292|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
464190|NCT00045292|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
464191|NCT00045292|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
464192|NCT00045292|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
464193|NCT00045292|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
464194|NCT00045292|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
464195|NCT00045292|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
464196|NCT00045292|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
464197|NCT00045292|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
464198|NCT00045292|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
464199|NCT00045292|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
464200|NCT00045292|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
464201|NCT00045292|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
464202|NCT00045292|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
464203|NCT00045292|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
464204|NCT00045292|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
464205|NCT00045292|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
464206|NCT00045292|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
464207|NCT00045292|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
464208|NCT00045292|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
464209|NCT00045292|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
464210|NCT00045292|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
464211|NCT00045292|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
464212|NCT00045292|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
464213|NCT00045292|refractory hairy cell leukemia|refractory hairy cell leukemia
464214|NCT00045292|refractory multiple myeloma|refractory multiple myeloma
464215|NCT00045292|stage I multiple myeloma|stage i multiple myeloma
464216|NCT00045292|stage II multiple myeloma|stage ii multiple myeloma
464217|NCT00045292|stage III multiple myeloma|stage iii multiple myeloma
464218|NCT00045292|stage IIIA breast cancer|stage iiia breast cancer
464219|NCT00045292|stage IIIB breast cancer|stage iiib breast cancer
464220|NCT00045292|stage IIIC breast cancer|stage iiic breast cancer
464221|NCT00045292|stage IV breast cancer|stage iv breast cancer
464222|NCT00045292|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
464223|NCT00045292|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
464373|NCT00045981|aged|aged
464224|NCT00045292|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
464225|NCT00045292|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
464226|NCT00045292|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
464227|NCT00045292|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
464228|NCT00045292|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
464229|NCT00045292|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
464230|NCT00045292|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
464231|NCT00045292|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
464232|NCT00045292|splenic marginal zone lymphoma|splenic marginal zone lymphoma
464233|NCT00045292|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
464234|NCT00045305|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
464235|NCT00045305|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
464236|NCT00045305|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
464237|NCT00045305|refractory anemia|refractory anemia
464238|NCT00045305|refractory anemia with excess blasts|refractory anemia with excess blasts
464239|NCT00045305|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
464240|NCT00045305|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
464241|NCT00045305|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
464242|NCT00045305|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
464243|NCT00045318|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
464244|NCT00045331|recurrent prostate cancer|recurrent prostate cancer
464245|NCT00045331|stage I prostate cancer|stage i prostate cancer
464246|NCT00045331|stage IIB prostate cancer|stage iib prostate cancer
13053|NCT03207126|Ultrasound|ultrasound
464247|NCT00045331|stage IIA prostate cancer|stage iia prostate cancer
464248|NCT00045331|stage III prostate cancer|stage iii prostate cancer
464249|NCT00045331|stage IV prostate cancer|stage iv prostate cancer
464250|NCT00045357|recurrent melanoma|recurrent melanoma
464251|NCT00045357|stage IV melanoma|stage iv melanoma
464252|NCT00045370|recurrent renal cell cancer|recurrent renal cell cancer
464253|NCT00045370|stage III renal cell cancer|stage iii renal cell cancer
464254|NCT00045370|stage IV renal cell cancer|stage iv renal cell cancer
464255|NCT00045422|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
464256|NCT00045422|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
464257|NCT00045422|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
464258|NCT00045448|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
464259|NCT00045461|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
464260|NCT00045461|recurrent fallopian tube cancer|recurrent fallopian tube cancer
464261|NCT00045461|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
464262|NCT00045461|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
464263|NCT00045461|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
464264|NCT00045461|stage IV fallopian tube cancer|stage iv fallopian tube cancer
464265|NCT00045461|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
464266|NCT00045461|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
464267|NCT00045461|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
464268|NCT00045461|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
464269|NCT00045461|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
464270|NCT00045461|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
464271|NCT00045461|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
464272|NCT00045461|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
464273|NCT00045461|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
464274|NCT00045474|adult anaplastic astrocytoma|adult anaplastic astrocytoma
464275|NCT00045474|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
464276|NCT00045474|adult glioblastoma|adult glioblastoma
464277|NCT00045474|recurrent adult brain tumor|recurrent adult brain tumor
464278|NCT00045474|adult giant cell glioblastoma|adult giant cell glioblastoma
464279|NCT00045474|adult gliosarcoma|adult gliosarcoma
464280|NCT00045487|recurrent renal cell cancer|recurrent renal cell cancer
464281|NCT00045487|stage III renal cell cancer|stage iii renal cell cancer
464282|NCT00045487|stage IV renal cell cancer|stage iv renal cell cancer
464283|NCT00045500|anaplastic large cell lymphoma|anaplastic large cell lymphoma
464284|NCT00045500|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
464285|NCT00045500|intraocular lymphoma|intraocular lymphoma
464286|NCT00045500|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
464287|NCT00045500|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
464288|NCT00045500|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
464289|NCT00045500|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
464290|NCT00045500|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
464291|NCT00045500|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
465814|NCT00050219|Response|response
464292|NCT00045500|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
464293|NCT00045500|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
464294|NCT00045500|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
464295|NCT00045500|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
464296|NCT00045500|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
464297|NCT00045500|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
464298|NCT00045500|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
464299|NCT00045500|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
464300|NCT00045500|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
464301|NCT00045500|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
464302|NCT00045500|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
464303|NCT00045500|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
464304|NCT00045500|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
464305|NCT00045500|splenic marginal zone lymphoma|splenic marginal zone lymphoma
464306|NCT00045513|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
464307|NCT00045513|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
464308|NCT00045539|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
464309|NCT00045591|recurrent breast cancer|recurrent breast cancer
464310|NCT00045591|stage IV breast cancer|stage iv breast cancer
464311|NCT00045604|extensive stage small cell lung cancer|extensive stage small cell lung cancer
464312|NCT00045617|limited stage small cell lung cancer|limited stage small cell lung cancer
464313|NCT00045630|anterior urethral cancer|anterior urethral cancer
464314|NCT00045630|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
13054|NCT03207126|Biopsy|biopsy
464315|NCT00045630|posterior urethral cancer|posterior urethral cancer
464316|NCT00045630|stage II bladder cancer|stage ii bladder cancer
464317|NCT00045630|stage III bladder cancer|stage iii bladder cancer
464318|NCT00045630|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
464319|NCT00045630|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
464320|NCT00045630|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
464321|NCT00045669|recurrent salivary gland cancer|recurrent salivary gland cancer
464322|NCT00045669|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
464323|NCT00045669|stage III salivary gland cancer|stage iii salivary gland cancer
464324|NCT00045669|stage IV salivary gland cancer|stage iv salivary gland cancer
464325|NCT00045695|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
464326|NCT00045721|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
464327|NCT00045747|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
464328|NCT00045747|recurrent pancreatic cancer|recurrent pancreatic cancer
464329|NCT00045747|stage IV pancreatic cancer|stage iv pancreatic cancer
464330|NCT00045786|myelodysplastic syndrome|myelodysplastic syndrome
464331|NCT00045812|Cholesterol|cholesterol
464332|NCT00045812|Sitosterol|sitosterol
464333|NCT00045812|Atherosclerosis|atherosclerosis
464334|NCT00045812|Intestine|intestine
464335|NCT00045812|Absorption|absorption
464336|NCT00045812|Homozygous Sitosterolemia|homozygous sitosterolemia
464337|NCT00045812|Sterol Metabolism|sterol metabolism
464339|NCT00045838|HIV-Negative|hiv-negative
464340|NCT00045838|Placebo Controlled|placebo controlled
464341|NCT00045838|Volunteer|volunteer
464342|NCT00045838|Dose-Escalation|dose-escalation
464343|NCT00045838|Healthy Volunteers|healthy volunteers
464344|NCT00045838|HV|hv
464345|NCT00045838|HIV Seronegativity|hiv seronegativity
464346|NCT00045838|HIV Preventive Vaccine|hiv preventive vaccine
464347|NCT00045864|Intermediate and High-Grade Non-Hodgkin's Lymphoma|intermediate and high-grade non-hodgkin's lymphoma
464348|NCT00045877|Low-Grade or Follicular Non-Hodgkin's Lymphoma|low-grade or follicular non-hodgkin's lymphoma
464349|NCT00045903|Cognitive Behavioral Therapy|cognitive behavioral therapy
464350|NCT00045916|Electroconvulsive therapy|electroconvulsive therapy
464351|NCT00045916|Antidepressive Agents|antidepressive agents
464352|NCT00045942|AML|aml
464353|NCT00045942|MDS|mds
464354|NCT00045942|high risk myelodysplastic syndrome|high risk myelodysplastic syndrome
464355|NCT00045968|oncology|oncology
464356|NCT00045968|neurology|neurology
464357|NCT00045968|glioma|glioma
464358|NCT00045968|brain tumor|brain tumor
464359|NCT00045968|brain cancer|brain cancer
464360|NCT00045968|glioblastoma multiforme|glioblastoma multiforme
464361|NCT00045968|glioblastoma|glioblastoma
464362|NCT00045968|newly diagnosed glioblastoma|newly diagnosed glioblastoma
464363|NCT00045968|immunotherapy|immunotherapy
464364|NCT00045968|dendritic cells|dendritic cells
464365|NCT00045968|immune therapy|immune therapy
464366|NCT00045968|GBM|gbm
464367|NCT00045968|Brain cancer, primary|brain cancer, primary
464368|NCT00045968|tumor vaccine|tumor vaccine
464369|NCT00045968|grade IV astrocytoma|grade iv astrocytoma
464370|NCT00045968|DCVax|dcvax
464371|NCT00045968|Grade IV brain cancer|grade iv brain cancer
464374|NCT00045981|antihypertensive agents/therapeutic use|antihypertensive agents/therapeutic use
464375|NCT00045981|hypertension/*drug therapy|hypertension/*drug therapy
464376|NCT00045981|blood pressure|blood pressure
464377|NCT00045994|cardiovascular|cardiovascular
464378|NCT00045994|aged|aged
464379|NCT00045994|antihypertensive agents/therapeutic use|antihypertensive agents/therapeutic use
464380|NCT00045994|hypertension/*drug therapy|hypertension/*drug therapy
464381|NCT00045994|blood pressure|blood pressure
464382|NCT00046020|Depression|depression
464383|NCT00046033|Dose-Relationship, Drug|dose-relationship, drug
464384|NCT00046033|HIV Protease Inhibitors|hiv protease inhibitors
464385|NCT00046033|Salvage Therapy|salvage therapy
464386|NCT00046033|Viral Load|viral load
464387|NCT00046033|RNA, Viral|rna, viral
464388|NCT00046033|Drug Therapy, Combination|drug therapy, combination
464389|NCT00046059|Linkage|linkage
464390|NCT00046059|Gene Identification|gene identification
464391|NCT00046059|ADHD|adhd
464392|NCT00046059|Hyperactivity|hyperactivity
464393|NCT00046059|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
464394|NCT00046072|Sepsis|sepsis
464395|NCT00046072|Shock|shock
464396|NCT00046072|Septic|septic
464397|NCT00046072|Sepsis Syndrome|sepsis syndrome
464398|NCT00046072|Septicemia|septicemia
464399|NCT00046072|Endotoxins|endotoxins
464400|NCT00046072|Endotoxemia|endotoxemia
464401|NCT00046072|Infection|infection
464402|NCT00046085|Schizophrenia|schizophrenia
464403|NCT00046085|Family|family
464404|NCT00046085|Psychoeducation|psychoeducation
464405|NCT00046085|Internet|internet
464406|NCT00046111|oral|oral
464407|NCT00046111|Bioequivalence|bioequivalence
464408|NCT00046111|Hycamtin|hycamtin
464409|NCT00046111|Topotecan|topotecan
464410|NCT00046163|Neurology|neurology
464411|NCT00046163|Cardiology|cardiology
464412|NCT00046176|HIV-1 Abacavir Lamivudine Antiretroviral-experienced|hiv-1 abacavir lamivudine antiretroviral-experienced
464413|NCT00046189|Sun Exposure|sun exposure
464414|NCT00046189|Xeroderma Pigmentosum|xeroderma pigmentosum
464415|NCT00046189|Skin Cancer|skin cancer
464416|NCT00046189|Family History|family history
464417|NCT00046189|HETEROZYGOTE|heterozygote
464418|NCT00046189|XP|xp
464419|NCT00046202|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
464420|NCT00046202|Sterol|sterol
464421|NCT00046202|Mutations|mutations
464422|NCT00046202|Dysmorphology|dysmorphology
464423|NCT00046202|Mental Retardation|mental retardation
464424|NCT00046202|Inborn Errors of Cholesterol Synthesis|inborn errors of cholesterol synthesis
464425|NCT00046202|Smith-Lemli-Optiz Syndrome|smith-lemli-optiz syndrome
464426|NCT00046202|Lathosterolosis|lathosterolosis
464427|NCT00046202|Desmosterols|desmosterols
464428|NCT00046202|CHILD Syndrome|child syndrome
464429|NCT00046202|Greenberg Dysplasia|greenberg dysplasia
464430|NCT00046202|X Linked Dominant Chrondrodysplasia|x linked dominant chrondrodysplasia
464431|NCT00046215|Virtual Lesion Study|virtual lesion study
464432|NCT00046215|Motor Imagery|motor imagery
464433|NCT00046215|Primary Motor Cortex|primary motor cortex
464434|NCT00046215|Motor Inhibition|motor inhibition
464435|NCT00046215|Motor Execution|motor execution
464436|NCT00046215|Healthy Volunteer|healthy volunteer
464437|NCT00046228|Myocardial infarction|myocardial infarction
464438|NCT00046228|percutaneous coronary intervention|percutaneous coronary intervention
464439|NCT00046228|abciximab|abciximab
464440|NCT00046228|reteplase|reteplase
464441|NCT00046228|safety and efficacy|safety and efficacy
464442|NCT00046241|seasonal depression winter blues winter depression|seasonal depression winter blues winter depression
464443|NCT00053885|advanced malignant mesothelioma|advanced malignant mesothelioma
464444|NCT00053885|epithelial mesothelioma|epithelial mesothelioma
464445|NCT00053885|recurrent malignant mesothelioma|recurrent malignant mesothelioma
464446|NCT00053885|sarcomatous mesothelioma|sarcomatous mesothelioma
464447|NCT00053898|breast cancer in situ|breast cancer in situ
464448|NCT00053898|ductal breast carcinoma in situ|ductal breast carcinoma in situ
464449|NCT00053911|recurrent breast cancer|recurrent breast cancer
464450|NCT00053911|stage I breast cancer|stage i breast cancer
464451|NCT00053911|stage II breast cancer|stage ii breast cancer
464452|NCT00053911|stage IIIA breast cancer|stage iiia breast cancer
464453|NCT00053924|recurrent pancreatic cancer|recurrent pancreatic cancer
464454|NCT00053924|stage II pancreatic cancer|stage ii pancreatic cancer
464455|NCT00053924|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
464456|NCT00053924|stage III pancreatic cancer|stage iii pancreatic cancer
464457|NCT00053924|stage IV pancreatic cancer|stage iv pancreatic cancer
464458|NCT00053937|plexiform neurofibroma|plexiform neurofibroma
464459|NCT00053937|neurofibromatosis type 1|neurofibromatosis type 1
464460|NCT00053976|graft versus host disease|graft versus host disease
464461|NCT00053989|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
464462|NCT00053989|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
464463|NCT00053989|primary myelofibrosis|primary myelofibrosis
464464|NCT00053989|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
464465|NCT00053989|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
464466|NCT00053989|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
464467|NCT00053989|refractory anemia with excess blasts|refractory anemia with excess blasts
464468|NCT00053989|stage I multiple myeloma|stage i multiple myeloma
464469|NCT00053989|stage II multiple myeloma|stage ii multiple myeloma
464470|NCT00053989|stage III multiple myeloma|stage iii multiple myeloma
464471|NCT00053989|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
464472|NCT00053989|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
464473|NCT00053989|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
464474|NCT00053989|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
464475|NCT00053989|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
464476|NCT00053989|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
464477|NCT00053989|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
464478|NCT00053989|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
464479|NCT00053989|secondary acute myeloid leukemia|secondary acute myeloid leukemia
464480|NCT00053989|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
464481|NCT00053989|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
464482|NCT00053989|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
464483|NCT00053989|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
464484|NCT00053989|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
464485|NCT00053989|refractory multiple myeloma|refractory multiple myeloma
464487|NCT00053989|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
464488|NCT00053989|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
13055|NCT03207126|Endometrial cancer|endometrial cancer
464489|NCT00053989|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
464490|NCT00053989|grade 1 follicular lymphoma|grade 1 follicular lymphoma
464491|NCT00053989|grade 2 follicular lymphoma|grade 2 follicular lymphoma
464492|NCT00053989|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
464493|NCT00053989|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
464494|NCT00053989|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
464495|NCT00053989|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
464496|NCT00053989|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
464497|NCT00053989|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
464498|NCT00053989|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
464499|NCT00053989|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
464500|NCT00053989|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
464501|NCT00053989|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
464502|NCT00053989|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
464503|NCT00053989|splenic marginal zone lymphoma|splenic marginal zone lymphoma
464504|NCT00053989|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
464505|NCT00053989|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
464506|NCT00053989|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
464507|NCT00053989|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
464508|NCT00053989|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
464509|NCT00053989|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
464510|NCT00054002|localized malignant mesothelioma|localized malignant mesothelioma
464511|NCT00054002|recurrent malignant mesothelioma|recurrent malignant mesothelioma
464513|NCT00054002|sarcomatous mesothelioma|sarcomatous mesothelioma
464514|NCT00054015|recurrent prostate cancer|recurrent prostate cancer
464515|NCT00054015|stage IV prostate cancer|stage iv prostate cancer
464516|NCT00054054|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
464517|NCT00054054|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
464518|NCT00054054|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
464519|NCT00054054|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
464520|NCT00054054|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
464521|NCT00054054|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
464522|NCT00054067|cervical adenocarcinoma|cervical adenocarcinoma
464523|NCT00054067|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
464524|NCT00054067|cervical squamous cell carcinoma|cervical squamous cell carcinoma
464525|NCT00054067|stage IB cervical cancer|stage ib cervical cancer
464526|NCT00054106|adenocarcinoma of the prostate|adenocarcinoma of the prostate
464527|NCT00054106|stage III prostate cancer|stage iii prostate cancer
464528|NCT00054106|stage II prostate cancer|stage ii prostate cancer
464529|NCT00054145|male breast cancer|male breast cancer
464530|NCT00054145|recurrent breast cancer|recurrent breast cancer
464531|NCT00054145|stage IV breast cancer|stage iv breast cancer
464532|NCT00054145|stage IIIA breast cancer|stage iiia breast cancer
466322|NCT00060684|antibody|antibody
464534|NCT00054145|stage IIIC breast cancer|stage iiic breast cancer
464535|NCT00054158|stage I multiple myeloma|stage i multiple myeloma
464536|NCT00054158|stage II multiple myeloma|stage ii multiple myeloma
464537|NCT00054158|stage III multiple myeloma|stage iii multiple myeloma
464538|NCT00054171|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
464539|NCT00054171|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
464540|NCT00054171|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
464541|NCT00054171|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
464542|NCT00054171|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
464543|NCT00054184|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
464544|NCT00054184|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
464545|NCT00054184|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
464546|NCT00054197|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
464547|NCT00054197|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
464548|NCT00054197|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
464549|NCT00054210|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
464550|NCT00054210|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
464551|NCT00054210|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
464552|NCT00054223|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
464553|NCT00054223|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
464554|NCT00054236|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
464555|NCT00054236|refractory anemia with excess blasts|refractory anemia with excess blasts
464556|NCT00054236|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
464557|NCT00054236|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
464558|NCT00054236|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
464559|NCT00054236|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
464560|NCT00054236|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
464561|NCT00054236|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
464562|NCT00054236|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
464563|NCT00054236|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
464564|NCT00054236|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
464565|NCT00054236|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
464566|NCT00054236|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
464567|NCT00054236|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
464568|NCT00054236|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
464569|NCT00054236|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
464570|NCT00054236|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
464571|NCT00054236|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
464572|NCT00054236|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
464573|NCT00054236|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
464574|NCT00054236|stage I multiple myeloma|stage i multiple myeloma
464575|NCT00054236|stage II multiple myeloma|stage ii multiple myeloma
464576|NCT00054236|stage III multiple myeloma|stage iii multiple myeloma
464577|NCT00054236|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
464578|NCT00054236|polycythemia vera|polycythemia vera
464579|NCT00054236|primary myelofibrosis|primary myelofibrosis
464580|NCT00054236|essential thrombocythemia|essential thrombocythemia
464581|NCT00054236|refractory multiple myeloma|refractory multiple myeloma
464582|NCT00054236|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
464583|NCT00054236|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
464584|NCT00054236|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
464585|NCT00054236|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
464586|NCT00054236|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
464587|NCT00054236|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
464588|NCT00054236|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
464589|NCT00054236|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
464590|NCT00054236|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
464591|NCT00054236|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
464592|NCT00054236|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
464593|NCT00054236|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
464594|NCT00054236|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
464595|NCT00054236|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
464596|NCT00054236|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
464597|NCT00054236|Burkitt lymphoma|burkitt lymphoma
464598|NCT00054236|anaplastic large cell lymphoma|anaplastic large cell lymphoma
752456|NCT01173068|Clinical outcome|clinical outcome
464068|NCT00045045|testicular teratoma|testicular teratoma
464599|NCT00054236|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
464600|NCT00054236|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
464601|NCT00054236|chronic eosinophilic leukemia|chronic eosinophilic leukemia
464602|NCT00054236|chronic neutrophilic leukemia|chronic neutrophilic leukemia
464603|NCT00054236|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
464604|NCT00054236|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
464605|NCT00054236|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
464606|NCT00054236|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
464607|NCT00054236|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
464608|NCT00054236|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
464609|NCT00054236|splenic marginal zone lymphoma|splenic marginal zone lymphoma
464610|NCT00054236|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
464611|NCT00054236|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
464612|NCT00054236|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
464613|NCT00054236|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
464614|NCT00054236|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
464615|NCT00054236|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
464616|NCT00055926|recurrent breast cancer|recurrent breast cancer
464617|NCT00055926|stage IV breast cancer|stage iv breast cancer
464618|NCT00055926|male breast cancer|male breast cancer
464619|NCT00055939|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
464620|NCT00055939|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
464621|NCT00055952|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
464622|NCT00055952|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
464623|NCT00055952|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
464624|NCT00055952|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
464625|NCT00055952|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
464626|NCT00055952|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
464627|NCT00055952|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
464628|NCT00055965|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
464629|NCT00055965|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
464630|NCT00055965|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
464631|NCT00055978|non-small cell lung cancer|non-small cell lung cancer
464632|NCT00055978|stage I non-small cell lung cancer|stage i non-small cell lung cancer
464634|NCT00056004|non-small cell lung cancer|non-small cell lung cancer
464635|NCT00056004|small cell lung cancer|small cell lung cancer
464636|NCT00056004|stage I non-small cell lung cancer|stage i non-small cell lung cancer
464637|NCT00056004|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
464638|NCT00056004|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
464639|NCT00056004|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
464640|NCT00056004|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
464641|NCT00056004|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
464642|NCT00056004|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
464643|NCT00056004|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
464644|NCT00056004|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
464645|NCT00056004|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
464646|NCT00056004|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
464647|NCT00056030|liver metastases|liver metastases
464648|NCT00056030|stage IV colon cancer|stage iv colon cancer
464649|NCT00056030|stage IV rectal cancer|stage iv rectal cancer
464650|NCT00056030|adenocarcinoma of the colon|adenocarcinoma of the colon
464651|NCT00056030|adenocarcinoma of the rectum|adenocarcinoma of the rectum
464652|NCT00056056|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
464653|NCT00056056|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
464654|NCT00056056|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
464655|NCT00056069|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
464656|NCT00056069|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
464657|NCT00056082|breast cancer|breast cancer
464658|NCT00056095|recurrent renal cell cancer|recurrent renal cell cancer
464659|NCT00056095|stage IV renal cell cancer|stage iv renal cell cancer
464660|NCT00056134|recurrent melanoma|recurrent melanoma
464661|NCT00056134|stage IV melanoma|stage iv melanoma
464662|NCT00056134|stage IIIA melanoma|stage iiia melanoma
464663|NCT00056134|stage IIIB melanoma|stage iiib melanoma
465081|NCT00057616|CC5013|cc5013
464664|NCT00056134|stage IIIC melanoma|stage iiic melanoma
464665|NCT00056147|cystic fibrosis|cystic fibrosis
464666|NCT00056160|Multiple Myeloma|multiple myeloma
464667|NCT00056160|Refractory and Relapsed|refractory and relapsed
464668|NCT00056160|Revlimid|revlimid
464669|NCT00056160|CC5013|cc5013
464670|NCT00056173|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
464671|NCT00056186|Adaptation|adaptation
464672|NCT00056186|Neurodegenerative|neurodegenerative
464673|NCT00056186|Health Care Provider|health care provider
464674|NCT00056186|Psychosocial|psychosocial
464675|NCT00056186|Chronic Illness/Disability|chronic illness/disability
464676|NCT00056186|Friedreich's Ataxia|friedreich's ataxia
464677|NCT00056186|Friedreich Ataxia|friedreich ataxia
464679|NCT00056199|Vision Loss|vision loss
464680|NCT00056199|Optic Nerve Tumors|optic nerve tumors
464681|NCT00056199|Macular Edema|macular edema
464682|NCT00056199|Von Hippel-Lindau Disease|von hippel-lindau disease
464683|NCT00056199|VEGF|vegf
464684|NCT00056199|EYE001|eye001
464685|NCT00056199|VHL|vhl
464686|NCT00056225|homocysteine|homocysteine
464687|NCT00056238|Neurologic Diseases (General)|neurologic diseases (general)
464688|NCT00056238|Hemorrhagic Stroke|hemorrhagic stroke
464689|NCT00056238|Cerebral Amyloid Angiopathy|cerebral amyloid angiopathy
464690|NCT00056238|Cerebrovascular Accident|cerebrovascular accident
464691|NCT00056251|Interstitial Cystitis|interstitial cystitis
464693|NCT00056264|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
464694|NCT00056264|COPD|copd
464695|NCT00056264|Infliximab|infliximab
464696|NCT00056264|Remicade|remicade
464697|NCT00056290|Diabetes Mellitus|diabetes mellitus
464698|NCT00056290|Neuropathy|neuropathy
464699|NCT00056290|Peripheral Artery Disease|peripheral artery disease
464700|NCT00056303|Attachment|attachment
464701|NCT00056303|Intervention|intervention
464702|NCT00056303|Prevention|prevention
464703|NCT00056316|Caregiving|caregiving
464704|NCT00056316|Dementia|dementia
464705|NCT00056316|Alzheimer's|alzheimer's
464706|NCT00056316|Depression|depression
464707|NCT00056316|Technology|technology
464708|NCT00056316|Treatment|treatment
464709|NCT00056329|Aging Persons|aging persons
464710|NCT00056329|Down Syndrome|down syndrome
464711|NCT00056329|Vitamin E|vitamin e
464712|NCT00056329|Alzheimer disease|alzheimer disease
464713|NCT00056355|Pheresis|pheresis
464714|NCT00056355|Cytokine|cytokine
464715|NCT00056355|Lymphocyte|lymphocyte
464716|NCT00056355|Remission|remission
464717|NCT00056355|Ultraviolet A Light|ultraviolet a light
464718|NCT00056355|Crohn's Disease|crohn's disease
464719|NCT00056355|Crohn Disease|crohn disease
464720|NCT00056368|Candida blood stream infections|candida blood stream infections
464721|NCT00056368|Candida infections|candida infections
464722|NCT00056368|Candidemia|candidemia
464723|NCT00056368|Invasive Candidiasis|invasive candidiasis
464724|NCT00056381|neutropenia|neutropenia
464725|NCT00056381|fever|fever
464726|NCT00056381|febrile neutropenia|febrile neutropenia
464727|NCT00056394|Early Rheumatoid Arthritis|early rheumatoid arthritis
464728|NCT00056394|Coping Skills Training|coping skills training
464729|NCT00056394|Pain|pain
464730|NCT00056394|Physical Disability|physical disability
464731|NCT00056394|Psychological Disability|psychological disability
464732|NCT00056394|Daily Diary Measures|daily diary measures
464733|NCT00056407|Prostate cancer prevention|prostate cancer prevention
464734|NCT00056407|prostate|prostate
464735|NCT00056407|BPH|bph
464736|NCT00056407|enlarged prostate|enlarged prostate
464737|NCT00056407|PSA|psa
464738|NCT00056407|prostate cancer|prostate cancer
464739|NCT00056420|Tourette's Syndrome|tourette's syndrome
464740|NCT00056420|Tic Disorder|tic disorder
464741|NCT00056420|(EEG) Electroencephalography|(eeg) electroencephalography
464742|NCT00056420|Event-Related Desynchronization/Synchronization|event-related desynchronization/synchronization
464743|NCT00056420|Coherence|coherence
464744|NCT00056420|Tourette's|tourette's
464745|NCT00056420|Tourette Syndrome|tourette syndrome
464746|NCT00056420|Healthy Volunteer|healthy volunteer
464747|NCT00056420|HV|hv
464748|NCT00056433|Fetal Hemoglobin Induction|fetal hemoglobin induction
464749|NCT00056433|L-Arginine|l-arginine
464750|NCT00056433|Nitric Oxide Therapy|nitric oxide therapy
464751|NCT00056433|Sickle Cell Disease|sickle cell disease
464752|NCT00056433|Sildenafil (Viagra)|sildenafil (viagra)
464753|NCT00056433|Sickle Cell Anemia|sickle cell anemia
464754|NCT00056446|Colorectal Cancer|colorectal cancer
464755|NCT00056446|Oxaliplatin|oxaliplatin
464756|NCT00056446|VEGF inhibitor|vegf inhibitor
464757|NCT00056446|Vatalanib|vatalanib
464758|NCT00056446|PTK787|ptk787
464759|NCT00056446|Colon Cancer|colon cancer
464760|NCT00056446|Colorectal Carcinoma|colorectal carcinoma
464761|NCT00056446|Rectal Cancer|rectal cancer
464762|NCT00056446|Colorectal Tumor|colorectal tumor
464763|NCT00056459|Colorectal Cancer|colorectal cancer
464764|NCT00056459|PTK787|ptk787
464765|NCT00056459|Vatalanib|vatalanib
464766|NCT00056459|VEGF inhibitor|vegf inhibitor
464767|NCT00056459|Oxaliplatin|oxaliplatin
464768|NCT00056459|Angiogenesis|angiogenesis
464769|NCT00056459|Rectal Cancer|rectal cancer
464770|NCT00056459|Colon Cancer|colon cancer
464771|NCT00056459|Colorectal Carcinoma|colorectal carcinoma
464772|NCT00056459|Colorectal Tumor|colorectal tumor
464773|NCT00056472|Major depressive disorder with psychotic features|major depressive disorder with psychotic features
464774|NCT00056472|Delusional Depression|delusional depression
464775|NCT00056472|Randomized Trial|randomized trial
464776|NCT00056472|Combination Treatment|combination treatment
464777|NCT00056472|SSRI|ssri
464778|NCT00056472|Atypical Antipsychotic|atypical antipsychotic
464779|NCT00056485|Nursing homes|nursing homes
464780|NCT00056485|Aging|aging
464781|NCT00056511|Garlic|garlic
464782|NCT00056511|Supplements|supplements
464783|NCT00056511|Adults|adults
464784|NCT00056511|Hypercholesterolemics|hypercholesterolemics
464785|NCT00056511|Randomized Clinical Trial|randomized clinical trial
464786|NCT00056524|ALS|als
464787|NCT00056524|MS|ms
464788|NCT00056524|CNS|cns
464789|NCT00056524|AD|ad
464790|NCT00056524|TBI|tbi
464791|NCT00056524|Dextromethorphan|dextromethorphan
464792|NCT00056524|IEED|ieed
464793|NCT00056524|Emotional|emotional
464794|NCT00056550|Antithrombin Deficiency, Congenital|antithrombin deficiency, congenital
464795|NCT00056550|Antithrombin III Deficiency|antithrombin iii deficiency
464796|NCT00056563|Parkinson's disease|parkinson's disease
464797|NCT00056563|levo-dopa|levo-dopa
464798|NCT00056563|tremor|tremor
464799|NCT00056563|dyskinesia|dyskinesia
464800|NCT00056563|subthalamic nucleus|subthalamic nucleus
464801|NCT00056563|globus pallidus|globus pallidus
464802|NCT00056576|Monotherapy|monotherapy
464803|NCT00056576|Complex Partial Seizures|complex partial seizures
464804|NCT00056576|Epilepsy|epilepsy
464805|NCT00056576|anti-epilepsy drug|anti-epilepsy drug
464807|NCT00056602|Utility|utility
464808|NCT00056602|Health Status|health status
464809|NCT00056602|Preferences|preferences
464810|NCT00056602|Response Criteria|response criteria
464811|NCT00056602|Treatment|treatment
464812|NCT00056602|Rheumatoid Arthritis|rheumatoid arthritis
464813|NCT00056602|RA|ra
464814|NCT00056628|Alzheimer disease|alzheimer disease
464815|NCT00056628|Dementia|dementia
464816|NCT00056628|Ventriculoperitoneal shunt|ventriculoperitoneal shunt
464817|NCT00056628|Tau|tau
464818|NCT00056628|ABeta|abeta
464819|NCT00056654|Leuprolide|leuprolide
464820|NCT00056654|Prostatic Neoplasms|prostatic neoplasms
464821|NCT00056654|Testosterone|testosterone
464822|NCT00056654|Prostate-specific Antigen|prostate-specific antigen
464823|NCT00056654|Pharmacokinetics|pharmacokinetics
464824|NCT00056654|luprolide acetate|luprolide acetate
464825|NCT00056667|Treatment|treatment
464826|NCT00056667|Pain|pain
464827|NCT00056667|Relaxation Response|relaxation response
464828|NCT00056667|Cognitive Behavioral Therapy|cognitive behavioral therapy
464829|NCT00056680|Prematurity|prematurity
464830|NCT00056680|low birthweight|low birthweight
464831|NCT00056680|parenting|parenting
464832|NCT00056680|intervention|intervention
464833|NCT00056693|Neuroendocrine tumor, advanced disease, sunitinib, Phase 2|neuroendocrine tumor, advanced disease, sunitinib, phase 2
464834|NCT00056706|Motor Deficit|motor deficit
464835|NCT00056706|Somatosensory Deficit|somatosensory deficit
464836|NCT00056706|Cortical Reorganization|cortical reorganization
464837|NCT00056706|Disinhibition|disinhibition
464838|NCT00056706|Rehabilitation|rehabilitation
464839|NCT00056706|Plasticity|plasticity
464840|NCT00056706|Stroke|stroke
464841|NCT00056719|Arthritis|arthritis
464842|NCT00056719|Spondylarthropathy|spondylarthropathy
464843|NCT00056719|Spine|spine
464844|NCT00056719|Hereditary|hereditary
464845|NCT00056719|Disability|disability
464846|NCT00056719|Ankylosing Spondylitis|ankylosing spondylitis
464847|NCT00056719|Spondyloarthropathy|spondyloarthropathy
464848|NCT00056719|Spondyloarthritis|spondyloarthritis
464849|NCT00056719|AS|as
464850|NCT00056745|HIV seronegativity|hiv seronegativity
464851|NCT00056745|HIV preventive vaccine|hiv preventive vaccine
464852|NCT00056758|HIV-1|hiv-1
464853|NCT00056758|HAART|haart
464854|NCT00056758|Therapeutic immunization|therapeutic immunization
464855|NCT00056758|HIV Therapeutic Vaccine|hiv therapeutic vaccine
464856|NCT00056758|Treatment Experienced|treatment experienced
464857|NCT00056771|Cataract|cataract
464858|NCT00056771|Congenital Cataracts|congenital cataracts
464859|NCT00056771|Hereditary Cataracts|hereditary cataracts
464860|NCT00056784|TGF-Beta|tgf-beta
464861|NCT00056784|Kidney|kidney
464862|NCT00056784|Transplantation|transplantation
464863|NCT00056784|Rejection|rejection
464864|NCT00056784|Immunosuppression|immunosuppression
464865|NCT00056784|Kidney Transplant|kidney transplant
464866|NCT00056784|Chronic Allograft Nephropathy|chronic allograft nephropathy
464867|NCT00056784|CAN|can
596701|NCT00557648|Anxiety|anxiety
464868|NCT00056797|HIV Therapeutic vaccine|hiv therapeutic vaccine
464869|NCT00056797|IL-2|il-2
464870|NCT00056797|Structured Treatment Interruption|structured treatment interruption
464871|NCT00056797|Treatment Experienced|treatment experienced
464872|NCT00056810|Guillain Barre Syndrome|guillain barre syndrome
464873|NCT00056810|4-aminopyridine|4-aminopyridine
464874|NCT00056823|AMD|amd
464875|NCT00056836|AMD|amd
464876|NCT00056836|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
464877|NCT00056849|Arthritis|arthritis
464878|NCT00056849|Spondyloarthropathy|spondyloarthropathy
464879|NCT00056849|Spine|spine
464880|NCT00056849|Hereditary|hereditary
464881|NCT00056849|Disability|disability
464882|NCT00056849|Ankylosing Spondylitis|ankylosing spondylitis
464883|NCT00056849|AS|as
464884|NCT00056849|Spondyloarthritis|spondyloarthritis
464886|NCT00056862|Antiviral Agents|antiviral agents
464887|NCT00056862|Hemolysis|hemolysis
464888|NCT00056862|Neutropenia|neutropenia
464889|NCT00056862|Cirrhosis|cirrhosis
464890|NCT00056862|Hemolytic Anemia|hemolytic anemia
464891|NCT00056862|Viral Hepatitis|viral hepatitis
464892|NCT00056862|Ribavirin|ribavirin
464893|NCT00056862|Alfa Interferon|alfa interferon
464894|NCT00056862|Pegylated Interferon|pegylated interferon
464895|NCT00056862|Hepatitis C|hepatitis c
464896|NCT00056862|HCV|hcv
464897|NCT00056875|graft versus host disease|graft versus host disease
464898|NCT00056875|bone marrow transplant|bone marrow transplant
464899|NCT00056875|alternative donor|alternative donor
464900|NCT00056888|Electroencephalogram|electroencephalogram
464901|NCT00056888|Functional (BOLD) MRI|functional (bold) mri
464902|NCT00056888|Startle Reflex|startle reflex
464903|NCT00056888|Electromyogram|electromyogram
464904|NCT00056888|Psychogenic|psychogenic
464905|NCT00056888|Paroxysmal|paroxysmal
464906|NCT00056888|Dyskinesia|dyskinesia
464907|NCT00056888|Kinesiogenic|kinesiogenic
464908|NCT00056888|EEG|eeg
464909|NCT00056888|Movement-Related Potential|movement-related potential
464910|NCT00056888|Movement Disorder|movement disorder
464911|NCT00056888|Paroxysmal Hyperkinetic Movement|paroxysmal hyperkinetic movement
464912|NCT00056888|Disorder|disorder
464913|NCT00056888|Paroxysmal Dyskinesia|paroxysmal dyskinesia
464914|NCT00056901|Puerperium|puerperium
464915|NCT00056901|Pregnancy|pregnancy
464916|NCT00056901|Mood Disorders|mood disorders
464917|NCT00056901|Estradiol|estradiol
464918|NCT00056901|Progesterone|progesterone
464919|NCT00056901|Mood|mood
464920|NCT00056901|Behavior|behavior
464921|NCT00056901|Cognition|cognition
464922|NCT00056901|Perimenopause|perimenopause
464923|NCT00056901|Menopause|menopause
464924|NCT00056901|Post Partum Depression|post partum depression
464925|NCT00056901|PPD|ppd
464926|NCT00056901|Healthy Volunteer|healthy volunteer
464927|NCT00056901|HV|hv
464928|NCT00056914|Magnetic Resonance Imaging|magnetic resonance imaging
464929|NCT00056914|Functional Imaging|functional imaging
464930|NCT00056914|Cerebral Blood Flow|cerebral blood flow
464931|NCT00056914|Parallel Imaging|parallel imaging
464932|NCT00056914|BOLD Effect|bold effect
464933|NCT00056914|Spectroscopic Imaging|spectroscopic imaging
464934|NCT00056914|Healthy Volunteer|healthy volunteer
464935|NCT00056914|HV|hv
464936|NCT00056927|Smoking|smoking
464937|NCT00056927|Primary Prevention|primary prevention
464938|NCT00056927|Health Education|health education
464939|NCT00056927|Child|child
464940|NCT00056927|Parents|parents
464941|NCT00056927|Parenting Education|parenting education
464942|NCT00056927|Communication|communication
464943|NCT00056940|Prevention|prevention
464944|NCT00056940|Parenting strategies|parenting strategies
464945|NCT00056940|Media use|media use
464946|NCT00056940|Discipline|discipline
464947|NCT00056940|Firearm storage|firearm storage
464948|NCT00056953|health behavior|health behavior
464949|NCT00056953|adolescent behavior|adolescent behavior
464950|NCT00056953|peer mentoring|peer mentoring
464951|NCT00056966|Acute myeloid leukemia|acute myeloid leukemia
464952|NCT00056966|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
464953|NCT00056966|Chronic myeloid leukemia|chronic myeloid leukemia
464954|NCT00056966|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
464955|NCT00056966|Hodgkin's disease|hodgkin's disease
464956|NCT00056966|Myelodysplastic syndrome|myelodysplastic syndrome
464957|NCT00056966|Myeloproliferative disorders|myeloproliferative disorders
464958|NCT00056966|Multiple myeloma|multiple myeloma
464959|NCT00056966|Severe aplastic anemia|severe aplastic anemia
464960|NCT00056979|Metabolic diseases|metabolic diseases
464961|NCT00057005|LEUKEMIA|leukemia
464962|NCT00057018|stroke|stroke
464963|NCT00057018|cerebrovascular accident|cerebrovascular accident
464964|NCT00057018|upper extremity|upper extremity
464965|NCT00057018|physical therapy|physical therapy
464966|NCT00057018|constraint-induced therapy|constraint-induced therapy
464967|NCT00057031|myelodysplastic syndrome|myelodysplastic syndrome
464968|NCT00057031|MDS|mds
464969|NCT00057083|Telemedicine|telemedicine
464970|NCT00057083|Remote consultation|remote consultation
464971|NCT00057083|Patient Satisfaction|patient satisfaction
464972|NCT00057083|Physician patient relations|physician patient relations
464973|NCT00057083|Provider satisfaction|provider satisfaction
464974|NCT00057083|Doctor-patient relations|doctor-patient relations
464975|NCT00057122|Preventive therapy|preventive therapy
464976|NCT00057135|Schizophrenia|schizophrenia
464977|NCT00057135|Treatment Refusal|treatment refusal
464978|NCT00057135|Drug Packaging|drug packaging
464979|NCT00057135|Reminder Systems|reminder systems
464980|NCT00057135|Antipsychotic Agents|antipsychotic agents
464981|NCT00057148|massage therapy|massage therapy
464982|NCT00057148|pain management|pain management
464983|NCT00057148|post-surgical|post-surgical
464984|NCT00057148|complementary therapy|complementary therapy
464985|NCT00057174|Proton pump inhibitor|proton pump inhibitor
464986|NCT00057200|Home Care|home care
464987|NCT00057213|Major Depressive Disorder (MDD),|major depressive disorder (mdd),
464988|NCT00057213|Flexible|flexible
464989|NCT00057213|GW353162,|gw353162,
464990|NCT00057226|GW353162,|gw353162,
464991|NCT00057226|Major depressive disorder,|major depressive disorder,
464992|NCT00057226|flexible|flexible
464993|NCT00057239|GW353162|gw353162
464994|NCT00057239|Major Depressive Disorder|major depressive disorder
464996|NCT00057252|Diagnostic Radiology|diagnostic radiology
464997|NCT00057252|Imaging|imaging
464998|NCT00057252|Algorithms|algorithms
464999|NCT00057252|Healthy Volunteer|healthy volunteer
465000|NCT00057252|HV|hv
465001|NCT00057278|Gabapentin|gabapentin
465002|NCT00057291|Orphanage|orphanage
465003|NCT00057291|Caregiving|caregiving
465004|NCT00057291|Training|training
465005|NCT00057291|Child development|child development
465006|NCT00057356|Chronic Heart Failure|chronic heart failure
465007|NCT00057356|YM078|ym078
465008|NCT00057382|liver cancer|liver cancer
465009|NCT00057395|Esophageal Neoplasms|esophageal neoplasms
465010|NCT00057395|Esophagus Neoplasm|esophagus neoplasm
465011|NCT00057395|Esophagus Cancer|esophagus cancer
465012|NCT00057395|Esophageal Cancer|esophageal cancer
465013|NCT00057395|Esophageal Tumors|esophageal tumors
465014|NCT00057395|Esophagus Tumors|esophagus tumors
465015|NCT00057395|Neoplasms, Esophageal|neoplasms, esophageal
465016|NCT00057395|Hepatocellular Carcinoma|hepatocellular carcinoma
465017|NCT00057395|Carcinoma, Hepatocellular|carcinoma, hepatocellular
465018|NCT00057395|Hepatoma|hepatoma
465019|NCT00057395|Colorectal Neoplasms|colorectal neoplasms
465020|NCT00057395|Colorectal Cancer|colorectal cancer
465021|NCT00057395|Colorectal Carcinoma|colorectal carcinoma
465022|NCT00057395|Colorectal Tumor|colorectal tumor
465023|NCT00057395|Neoplasms, Colorectal|neoplasms, colorectal
465024|NCT00057395|Ovarian Neoplasms|ovarian neoplasms
465025|NCT00057395|Ovary Neoplasms|ovary neoplasms
465026|NCT00057395|Ovary Cancer|ovary cancer
465027|NCT00057395|Ovary Carcinoma|ovary carcinoma
465028|NCT00057395|Ovarian Cancer|ovarian cancer
465029|NCT00057395|Ovarian Carcinoma|ovarian carcinoma
465030|NCT00057395|Neoplasms, Ovarian|neoplasms, ovarian
465031|NCT00057395|Pancreatic Neoplasms|pancreatic neoplasms
465032|NCT00057395|Pancreatic Cancer|pancreatic cancer
465033|NCT00057395|Pancreas Neoplasms|pancreas neoplasms
465034|NCT00057395|Pancreas Cancer|pancreas cancer
465035|NCT00057395|Neoplasms, Pancreatic|neoplasms, pancreatic
465036|NCT00057395|Neoplasms, Pancreas|neoplasms, pancreas
465037|NCT00057395|and other solid tumors|and other solid tumors
465039|NCT00057408|Pervasive Developmental Disorder|pervasive developmental disorder
465040|NCT00057408|Treatment|treatment
465041|NCT00057408|Olanzapine|olanzapine
465042|NCT00057408|Antipsychotic|antipsychotic
465043|NCT00057421|Tuberculosis|tuberculosis
465044|NCT00057421|HIV infection|hiv infection
465045|NCT00057421|Prednisolone|prednisolone
465046|NCT00057421|Safety|safety
465047|NCT00057421|Immune activation|immune activation
465048|NCT00057434|Vitamin A|vitamin a
465049|NCT00057447|lymphoma|lymphoma
465050|NCT00057460|Antiepileptic Drug|antiepileptic drug
465051|NCT00057460|Neuroprotection|neuroprotection
465052|NCT00057460|Seizure Disorder|seizure disorder
465053|NCT00057460|TMS Stimulation|tms stimulation
465054|NCT00057460|EEG|eeg
465055|NCT00057460|AMPA Antagonist|ampa antagonist
465056|NCT00057460|Dosing|dosing
465057|NCT00057460|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
465058|NCT00057460|Healthy Volunteer|healthy volunteer
465059|NCT00057460|HV|hv
465060|NCT00057473|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
465061|NCT00057486|Chronic Diarrhea|chronic diarrhea
465062|NCT00057486|Interleukin 12|interleukin 12
465063|NCT00057499|Juvenile diabetes|juvenile diabetes
465064|NCT00057499|Diabetes|diabetes
465065|NCT00057499|Insulin|insulin
465066|NCT00057499|Vaccine|vaccine
465067|NCT00057499|Type 1 Diabetes|type 1 diabetes
465068|NCT00057499|Diabetes Mellitus|diabetes mellitus
465069|NCT00057525|Anthrax|anthrax
465070|NCT00057538|HIV|hiv
465071|NCT00057538|Randomized Trial|randomized trial
465072|NCT00057538|Stress|stress
465073|NCT00057538|Spirituality|spirituality
465074|NCT00057538|Quality of Life|quality of life
465075|NCT00057538|Complementary Therapies|complementary therapies
465076|NCT00057564|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
465077|NCT00057564|Multiple Myeloma|multiple myeloma
465078|NCT00057616|Metastatic Melanoma|metastatic melanoma
465079|NCT00057616|Melanoma|melanoma
465080|NCT00057616|Revimid|revimid
465083|NCT00057629|Sex Offenses|sex offenses
465084|NCT00057642|Hispanic Americans|hispanic americans
465085|NCT00057655|Social Welfare|social welfare
465086|NCT00057655|Mentally Ill Persons|mentally ill persons
465087|NCT00057655|Mental Health Services|mental health services
465088|NCT00057681|Mania|mania
465089|NCT00057694|Qualitative|qualitative
465090|NCT00057694|Telephone Interviews|telephone interviews
465091|NCT00057694|Genetic Counseling|genetic counseling
465092|NCT00057694|Family History|family history
465093|NCT00057694|Health Information|health information
465094|NCT00057694|Adult Adoptees|adult adoptees
465095|NCT00057694|Adult Adoptee|adult adoptee
465096|NCT00057694|Interview|interview
465097|NCT00057707|Catecholamines|catecholamines
465098|NCT00057707|Dopamine|dopamine
465099|NCT00057707|fMRI|fmri
465100|NCT00057707|Working Memory|working memory
465101|NCT00057707|Clinical Trial|clinical trial
465102|NCT00057707|Stabilization|stabilization
465103|NCT00057707|Inpatients|inpatients
465104|NCT00057707|Placebo|placebo
465105|NCT00057707|Modafinil|modafinil
465106|NCT00057707|Normal Volunteers|normal volunteers
465107|NCT00057707|Schizophrenia|schizophrenia
465108|NCT00057707|Schizoaffective Disorder|schizoaffective disorder
465109|NCT00057707|Healthy Volunteer|healthy volunteer
465111|NCT00057720|ovary|ovary
465112|NCT00057733|anxiety disorder|anxiety disorder
465113|NCT00057733|depression|depression
465114|NCT00057733|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
465115|NCT00057746|limited stage small cell lung cancer|limited stage small cell lung cancer
465116|NCT00057759|sexual dysfunction|sexual dysfunction
465117|NCT00057759|sexuality and reproductive issues|sexuality and reproductive issues
465118|NCT00057759|radiation toxicity|radiation toxicity
465119|NCT00057759|stage IIB prostate cancer|stage iib prostate cancer
465120|NCT00057759|stage IIA prostate cancer|stage iia prostate cancer
465121|NCT00057759|stage III prostate cancer|stage iii prostate cancer
465122|NCT00057759|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
465123|NCT00057785|oral complications of radiation therapy|oral complications of radiation therapy
465124|NCT00057785|radiation toxicity|radiation toxicity
465125|NCT00057785|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
465126|NCT00057785|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
465127|NCT00057785|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
465128|NCT00057785|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
465129|NCT00057798|stage I non-small cell lung cancer|stage i non-small cell lung cancer
465130|NCT00057798|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
465131|NCT00057798|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
465132|NCT00057798|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
465133|NCT00057837|extensive stage small cell lung cancer|extensive stage small cell lung cancer
465134|NCT00057837|Topotecan|topotecan
465135|NCT00057837|Etoposide|etoposide
465136|NCT00057837|Cisplatin|cisplatin
465137|NCT00057837|Irinotecan|irinotecan
465138|NCT00057850|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
465139|NCT00057850|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
465140|NCT00057850|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
465141|NCT00057850|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
465142|NCT00057850|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
465143|NCT00057850|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
465144|NCT00057850|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
465145|NCT00057850|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
465146|NCT00057850|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
465147|NCT00057850|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
465148|NCT00057850|recurrent salivary gland cancer|recurrent salivary gland cancer
465149|NCT00057850|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
465150|NCT00057850|stage IV salivary gland cancer|stage iv salivary gland cancer
465151|NCT00057876|stage III pancreatic cancer|stage iii pancreatic cancer
464486|NCT00053989|refractory anemia|refractory anemia
465152|NCT00057876|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
465153|NCT00057889|clear cell renal cell carcinoma|clear cell renal cell carcinoma
465154|NCT00057889|stage IV renal cell cancer|stage iv renal cell cancer
465155|NCT00057889|recurrent renal cell cancer|recurrent renal cell cancer
465156|NCT00057915|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
465157|NCT00057928|recurrent cervical cancer|recurrent cervical cancer
465158|NCT00057928|stage IVB cervical cancer|stage ivb cervical cancer
465159|NCT00057954|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
465160|NCT00057954|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
465161|NCT00057954|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
465162|NCT00057954|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
465163|NCT00057954|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
465164|NCT00057954|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
465165|NCT00057954|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
465166|NCT00057954|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
465167|NCT00057954|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
465168|NCT00057954|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
465169|NCT00057954|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
465170|NCT00057954|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
465171|NCT00057954|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
465172|NCT00057954|anaplastic large cell lymphoma|anaplastic large cell lymphoma
465173|NCT00057954|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
465174|NCT00057954|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
465175|NCT00057954|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
465176|NCT00057954|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
465177|NCT00057954|splenic marginal zone lymphoma|splenic marginal zone lymphoma
465178|NCT00057967|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
465179|NCT00057967|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
465180|NCT00057967|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
465181|NCT00057967|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
465182|NCT00057967|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
465183|NCT00057967|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
465184|NCT00057967|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
465185|NCT00057967|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
465186|NCT00057967|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
465187|NCT00057967|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
465188|NCT00057980|advanced adult primary liver cancer|advanced adult primary liver cancer
465189|NCT00057980|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
465190|NCT00057980|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
465191|NCT00057993|stage IV breast cancer|stage iv breast cancer
465192|NCT00057993|stage IIIA breast cancer|stage iiia breast cancer
465193|NCT00057993|stage IIIB breast cancer|stage iiib breast cancer
465194|NCT00057993|stage IIIC breast cancer|stage iiic breast cancer
465195|NCT00058006|stage I non-small cell lung cancer|stage i non-small cell lung cancer
465196|NCT00058006|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
465197|NCT00058006|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
465198|NCT00058006|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
465199|NCT00058006|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
465200|NCT00058006|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
465201|NCT00058006|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
465202|NCT00058006|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
465203|NCT00058006|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
465204|NCT00058006|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
465205|NCT00058006|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
465206|NCT00058006|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
465207|NCT00058006|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
465208|NCT00058006|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
465209|NCT00058006|stage I salivary gland cancer|stage i salivary gland cancer
465210|NCT00058006|stage II salivary gland cancer|stage ii salivary gland cancer
465211|NCT00058032|ovarian epithelial cancer|ovarian epithelial cancer
465212|NCT00058045|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
465213|NCT00058058|ductal breast carcinoma in situ|ductal breast carcinoma in situ
465214|NCT00058058|invasive ductal breast carcinoma|invasive ductal breast carcinoma
465215|NCT00058058|invasive lobular breast carcinoma|invasive lobular breast carcinoma
465216|NCT00058058|breast cancer in situ|breast cancer in situ
465217|NCT00058058|stage I breast cancer|stage i breast cancer
465218|NCT00058058|stage II breast cancer|stage ii breast cancer
465219|NCT00058058|stage IIIA breast cancer|stage iiia breast cancer
465220|NCT00058058|stage IIIB breast cancer|stage iiib breast cancer
465221|NCT00058058|stage IIIC breast cancer|stage iiic breast cancer
465222|NCT00058058|stage IV breast cancer|stage iv breast cancer
465223|NCT00058071|peripheral neuropathy|peripheral neuropathy
465224|NCT00058071|neurotoxicity|neurotoxicity
465225|NCT00058071|hydatidiform mole|hydatidiform mole
465226|NCT00058071|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
465227|NCT00058123|adult anaplastic astrocytoma|adult anaplastic astrocytoma
465228|NCT00058123|adult mixed glioma|adult mixed glioma
465229|NCT00058123|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
465230|NCT00058123|recurrent adult brain tumor|recurrent adult brain tumor
465231|NCT00058123|adult anaplastic ependymoma|adult anaplastic ependymoma
465232|NCT00058149|stage II pancreatic cancer|stage ii pancreatic cancer
465233|NCT00058149|stage III pancreatic cancer|stage iii pancreatic cancer
465234|NCT00058149|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
465235|NCT00058149|stage IV pancreatic cancer|stage iv pancreatic cancer
465236|NCT00058188|osteoporosis|osteoporosis
465237|NCT00058188|stage III prostate cancer|stage iii prostate cancer
465238|NCT00058188|stage IV prostate cancer|stage iv prostate cancer
465239|NCT00058201|acinar cell adenocarcinoma of the pancreas|acinar cell adenocarcinoma of the pancreas
465240|NCT00058201|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
465241|NCT00058201|stage I pancreatic cancer|stage i pancreatic cancer
465242|NCT00058201|stage II pancreatic cancer|stage ii pancreatic cancer
465243|NCT00058201|stage III pancreatic cancer|stage iii pancreatic cancer
465244|NCT00058201|stage IV pancreatic cancer|stage iv pancreatic cancer
465245|NCT00058266|stage I prostate cancer|stage i prostate cancer
465246|NCT00058266|stage II prostate cancer|stage ii prostate cancer
465247|NCT00058279|stage IV melanoma|stage iv melanoma
465248|NCT00058279|extraocular extension melanoma|extraocular extension melanoma
465249|NCT00058279|recurrent melanoma|recurrent melanoma
465251|NCT00058279|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
465252|NCT00058279|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
465253|NCT00058279|recurrent intraocular melanoma|recurrent intraocular melanoma
465254|NCT00058292|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
465255|NCT00058292|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
465256|NCT00058292|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
465257|NCT00058292|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
465258|NCT00058292|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
465259|NCT00058292|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
465260|NCT00058292|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
465261|NCT00058292|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
465262|NCT00058292|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
465263|NCT00058292|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
465264|NCT00058292|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
465265|NCT00058292|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
465266|NCT00058292|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
465267|NCT00058292|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
465268|NCT00058292|splenic marginal zone lymphoma|splenic marginal zone lymphoma
465269|NCT00058318|stage IV renal cell cancer|stage iv renal cell cancer
465270|NCT00058318|stage III renal cell cancer|stage iii renal cell cancer
465271|NCT00058357|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
465273|NCT00058370|adult medulloblastoma|adult medulloblastoma
465274|NCT00058370|untreated childhood medulloblastoma|untreated childhood medulloblastoma
465275|NCT00058396|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
465276|NCT00058396|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
465277|NCT00058396|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
465278|NCT00058396|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
465279|NCT00058396|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
465280|NCT00058396|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
465281|NCT00058396|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
465282|NCT00058396|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
465283|NCT00058396|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
466323|NCT00060684|NHL|nhl
465284|NCT00058396|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
465285|NCT00058396|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
465286|NCT00058422|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
465287|NCT00058422|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
465288|NCT00058422|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
465289|NCT00058435|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
465290|NCT00058435|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
465291|NCT00058435|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
465292|NCT00058435|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
465293|NCT00058435|fallopian tube cancer|fallopian tube cancer
465294|NCT00058435|primary peritoneal cavity cancer|primary peritoneal cavity cancer
465295|NCT00058448|stage II penile cancer|stage ii penile cancer
465296|NCT00058448|stage III penile cancer|stage iii penile cancer
465297|NCT00058448|stage IV penile cancer|stage iv penile cancer
465298|NCT00058474|stage II rectal cancer|stage ii rectal cancer
465299|NCT00058474|stage III rectal cancer|stage iii rectal cancer
465300|NCT00058474|adenocarcinoma of the rectum|adenocarcinoma of the rectum
465301|NCT00058487|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
465302|NCT00058487|advanced adult primary liver cancer|advanced adult primary liver cancer
465303|NCT00058487|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
465304|NCT00058487|recurrent adult primary liver cancer|recurrent adult primary liver cancer
465305|NCT00058526|dHER2-AS15 ASCI|dher2-as15 asci
465306|NCT00058526|Immunotherapeutic|immunotherapeutic
465307|NCT00058526|Dose escalation|dose escalation
465308|NCT00058526|Breast cancer|breast cancer
465309|NCT00058552|Advanced, refractory, or recurrent ovarian cancer|advanced, refractory, or recurrent ovarian cancer
465310|NCT00058617|EBV Positive Hodgkin's Lymphoma|ebv positive hodgkin's lymphoma
465311|NCT00058617|EBV Positive Non-Hodgkin's Lymphoma|ebv positive non-hodgkin's lymphoma
465312|NCT00058617|EBV Specific Cytotoxic T-Lymphocytes|ebv specific cytotoxic t-lymphocytes
465313|NCT00058656|Immunotherapy|immunotherapy
465314|NCT00058656|T Cell Therapy|t cell therapy
465315|NCT00058656|Adoptive immunotherapy|adoptive immunotherapy
465316|NCT00058656|Xcellerate|xcellerate
465317|NCT00058656|Xcellerated|xcellerated
465318|NCT00049309|stage I prostate cancer|stage i prostate cancer
465272|NCT00058357|pain|pain
465319|NCT00049309|stage IIB prostate cancer|stage iib prostate cancer
465320|NCT00049309|stage IIA prostate cancer|stage iia prostate cancer
465321|NCT00049309|stage III prostate cancer|stage iii prostate cancer
465322|NCT00049322|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
465323|NCT00049322|recurrent adult primary liver cancer|recurrent adult primary liver cancer
465324|NCT00049322|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
465325|NCT00049335|recurrent colon cancer|recurrent colon cancer
465326|NCT00049335|stage IV colon cancer|stage iv colon cancer
465327|NCT00049335|recurrent rectal cancer|recurrent rectal cancer
465328|NCT00049335|stage IV rectal cancer|stage iv rectal cancer
465329|NCT00049348|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
465330|NCT00049348|stage II pancreatic cancer|stage ii pancreatic cancer
465331|NCT00049348|stage III pancreatic cancer|stage iii pancreatic cancer
465332|NCT00049361|adult tumors metastatic to brain|adult tumors metastatic to brain
465333|NCT00049361|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
465334|NCT00049374|refractory multiple myeloma|refractory multiple myeloma
465335|NCT00049400|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
465336|NCT00049400|anaplastic large cell lymphoma|anaplastic large cell lymphoma
465337|NCT00049400|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
465338|NCT00049400|intraocular lymphoma|intraocular lymphoma
465339|NCT00049400|primary central nervous system lymphoma|primary central nervous system lymphoma
465340|NCT00049400|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
465341|NCT00049400|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
465342|NCT00049400|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
465343|NCT00049400|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
465344|NCT00049400|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
465345|NCT00049400|recurrent grade 1, 2, or 3 follicular lymphoma|recurrent grade 1, 2, or 3 follicular lymphoma
465346|NCT00049400|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
465347|NCT00049400|small intestine lymphoma|small intestine lymphoma
465348|NCT00049400|stage IV adult diffuse large cell or mixed cell lymphoma|stage iv adult diffuse large cell or mixed cell lymphoma
465349|NCT00049400|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
465350|NCT00049400|stage IV adult Burkitt lymphoma or Hodgkin lymphoma|stage iv adult burkitt lymphoma or hodgkin lymphoma
465351|NCT00049400|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
465352|NCT00049400|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
465353|NCT00049400|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
465354|NCT00049400|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
465355|NCT00049400|stage IV grade 1, 2, or 3 follicular lymphoma|stage iv grade 1, 2, or 3 follicular lymphoma
465356|NCT00049400|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
465357|NCT00049400|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
465358|NCT00049400|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
465359|NCT00049400|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
465360|NCT00049400|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
465361|NCT00049400|extranodal marginal zone B-cell lymphoma of MALT|extranodal marginal zone b-cell lymphoma of malt
465362|NCT00049400|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
465363|NCT00049400|splenic marginal zone lymphoma|splenic marginal zone lymphoma
465364|NCT00049400|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
465365|NCT00049400|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
465366|NCT00049400|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
465707|NCT00049959|Verteporfin PDT|verteporfin pdt
465367|NCT00049400|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
465368|NCT00049413|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
465369|NCT00049413|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
465370|NCT00049413|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
465371|NCT00049413|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
465372|NCT00049413|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
465373|NCT00049413|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
465374|NCT00049413|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
465375|NCT00049413|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
465376|NCT00049413|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
465377|NCT00049413|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
465378|NCT00049413|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
465379|NCT00049413|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
465380|NCT00049439|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
465381|NCT00049439|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
465382|NCT00049439|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
465383|NCT00049439|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
465384|NCT00049439|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
465385|NCT00049439|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
465386|NCT00049452|osteoporosis|osteoporosis
465387|NCT00049452|stage I breast cancer|stage i breast cancer
465388|NCT00049452|stage II breast cancer|stage ii breast cancer
465389|NCT00049465|depression|depression
465391|NCT00049465|menopausal symptoms|menopausal symptoms
465392|NCT00049465|transitional care planning|transitional care planning
465393|NCT00049465|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
465394|NCT00049465|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
465395|NCT00049465|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
465396|NCT00049465|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
465397|NCT00049465|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
465398|NCT00049465|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
465399|NCT00049465|disseminated neuroblastoma|disseminated neuroblastoma
465400|NCT00049465|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
465401|NCT00049465|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
465402|NCT00049465|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
465403|NCT00049465|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
465404|NCT00049465|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
465405|NCT00049465|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
465406|NCT00049465|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
465407|NCT00049465|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
465408|NCT00049465|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
465409|NCT00049465|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
465410|NCT00049465|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
465411|NCT00049465|ovarian choriocarcinoma|ovarian choriocarcinoma
465412|NCT00049465|ovarian embryonal carcinoma|ovarian embryonal carcinoma
465413|NCT00049465|ovarian yolk sac tumor|ovarian yolk sac tumor
465414|NCT00049465|ovarian immature teratoma|ovarian immature teratoma
465415|NCT00049465|ovarian mature teratoma|ovarian mature teratoma
465416|NCT00049465|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
597565|NCT00567099|Memory|memory
465417|NCT00049465|ovarian polyembryoma|ovarian polyembryoma
465418|NCT00049465|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
465419|NCT00049465|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
465420|NCT00049465|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
465421|NCT00049465|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
465422|NCT00049465|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
465423|NCT00049465|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
465424|NCT00049465|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
465425|NCT00049465|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
465426|NCT00049465|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
465427|NCT00049465|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
465428|NCT00049465|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
465429|NCT00049465|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
465430|NCT00049465|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
465431|NCT00049465|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
465432|NCT00049465|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
465433|NCT00049465|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
465434|NCT00049465|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
465435|NCT00049465|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
465436|NCT00049465|recurrent neuroblastoma|recurrent neuroblastoma
465437|NCT00049465|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
465438|NCT00049465|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
465439|NCT00049465|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
465440|NCT00049465|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
465441|NCT00049465|refractory hairy cell leukemia|refractory hairy cell leukemia
465442|NCT00049465|refractory multiple myeloma|refractory multiple myeloma
465443|NCT00049465|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
465444|NCT00049465|secondary acute myeloid leukemia|secondary acute myeloid leukemia
465445|NCT00049465|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
465446|NCT00049465|stage I multiple myeloma|stage i multiple myeloma
465447|NCT00049465|stage II multiple myeloma|stage ii multiple myeloma
465448|NCT00049465|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
465449|NCT00049465|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
465450|NCT00049465|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
465451|NCT00049465|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
465452|NCT00049465|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
465453|NCT00049465|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
465454|NCT00049465|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
465455|NCT00049465|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
465456|NCT00049465|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
465457|NCT00049465|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
465458|NCT00049465|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
465459|NCT00049465|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
465460|NCT00049465|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
465461|NCT00049465|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
465462|NCT00049465|stage IIIA breast cancer|stage iiia breast cancer
465463|NCT00049465|stage IIIB breast cancer|stage iiib breast cancer
465464|NCT00049465|stage IIIC breast cancer|stage iiic breast cancer
465465|NCT00049465|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
465466|NCT00049465|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
465467|NCT00049465|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
465468|NCT00049465|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
465469|NCT00049465|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
465470|NCT00049465|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
465471|NCT00049465|stage IV breast cancer|stage iv breast cancer
465472|NCT00049465|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
465473|NCT00049465|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
465474|NCT00049465|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
465475|NCT00049465|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
465476|NCT00049465|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
465477|NCT00049465|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
465478|NCT00049465|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
465479|NCT00049465|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
464885|NCT00056862|Hepatitis C Virus|hepatitis c virus
465480|NCT00049465|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
465481|NCT00049465|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
465482|NCT00049465|testicular choriocarcinoma|testicular choriocarcinoma
465483|NCT00049465|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
465484|NCT00049465|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
465485|NCT00049465|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
465486|NCT00049465|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
465487|NCT00049465|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
465488|NCT00049465|testicular embryonal carcinoma|testicular embryonal carcinoma
465489|NCT00049465|testicular teratoma|testicular teratoma
583612|NCT00512382|WEEM Wheezy Monitor|weem wheezy monitor
465490|NCT00049465|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
465491|NCT00049465|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
465492|NCT00049465|testicular yolk sac tumor|testicular yolk sac tumor
465493|NCT00049465|stage III multiple myeloma|stage iii multiple myeloma
465494|NCT00049465|chronic eosinophilic leukemia|chronic eosinophilic leukemia
465495|NCT00049465|chronic neutrophilic leukemia|chronic neutrophilic leukemia
465496|NCT00049465|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
465813|NCT00050219|Dopamine|dopamine
465497|NCT00049465|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
465498|NCT00049465|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
465499|NCT00049465|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
465500|NCT00049465|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
465501|NCT00049465|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
465502|NCT00049465|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
465503|NCT00049465|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
465504|NCT00049465|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
465505|NCT00049465|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
465506|NCT00049465|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
465507|NCT00049465|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
465508|NCT00049465|splenic marginal zone lymphoma|splenic marginal zone lymphoma
465509|NCT00049517|acute myeloid leukemia|acute myeloid leukemia
465510|NCT00049517|autologous transplantation|autologous transplantation
465511|NCT00049517|gemtuzumab ozogamicin|gemtuzumab ozogamicin
465512|NCT00049530|recurrent melanoma|recurrent melanoma
465513|NCT00049530|stage IV melanoma|stage iv melanoma
465514|NCT00049556|fallopian tube cancer|fallopian tube cancer
465515|NCT00049556|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
465516|NCT00049556|primary peritoneal cavity cancer|primary peritoneal cavity cancer
465517|NCT00049556|recurrent cervical cancer|recurrent cervical cancer
465518|NCT00049556|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
465519|NCT00049595|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
465520|NCT00049595|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
465521|NCT00049595|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
465522|NCT00049595|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
465523|NCT00049595|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
465524|NCT00049608|male breast cancer|male breast cancer
465525|NCT00049608|recurrent breast cancer|recurrent breast cancer
465526|NCT00049608|recurrent colon cancer|recurrent colon cancer
465527|NCT00049608|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
465528|NCT00049608|recurrent pancreatic cancer|recurrent pancreatic cancer
465529|NCT00049608|recurrent rectal cancer|recurrent rectal cancer
465530|NCT00049608|stage III colon cancer|stage iii colon cancer
465531|NCT00049608|stage III pancreatic cancer|stage iii pancreatic cancer
465532|NCT00049608|stage III rectal cancer|stage iii rectal cancer
465533|NCT00049608|stage IIIA breast cancer|stage iiia breast cancer
465534|NCT00049608|stage IIIB breast cancer|stage iiib breast cancer
465535|NCT00049608|stage IIIC breast cancer|stage iiic breast cancer
465536|NCT00049608|stage IV breast cancer|stage iv breast cancer
465537|NCT00049608|stage IV colon cancer|stage iv colon cancer
465538|NCT00049608|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
465539|NCT00049608|stage IV rectal cancer|stage iv rectal cancer
465540|NCT00049608|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
465541|NCT00049608|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
465542|NCT00049608|stage IV pancreatic cancer|stage iv pancreatic cancer
465543|NCT00049634|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
465544|NCT00049634|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
465545|NCT00049634|essential thrombocythemia|essential thrombocythemia
465546|NCT00049634|polycythemia vera|polycythemia vera
464995|NCT00057239|MDD|mdd
465547|NCT00049634|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
465548|NCT00049634|refractory anemia with excess blasts|refractory anemia with excess blasts
465549|NCT00049634|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
465550|NCT00049634|secondary acute myeloid leukemia|secondary acute myeloid leukemia
465551|NCT00049634|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
465552|NCT00049634|chronic eosinophilic leukemia|chronic eosinophilic leukemia
465553|NCT00049634|chronic neutrophilic leukemia|chronic neutrophilic leukemia
465554|NCT00049634|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
465555|NCT00049634|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
465556|NCT00049660|stage IV breast cancer|stage iv breast cancer
465557|NCT00049673|stage I multiple myeloma|stage i multiple myeloma
465558|NCT00049673|stage II multiple myeloma|stage ii multiple myeloma
465559|NCT00049673|stage III multiple myeloma|stage iii multiple myeloma
465560|NCT00049686|acute undifferentiated leukemia|acute undifferentiated leukemia
465561|NCT00049686|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
465562|NCT00049686|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
465563|NCT00049686|prolymphocytic leukemia|prolymphocytic leukemia
465564|NCT00049686|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
465565|NCT00049686|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
465566|NCT00049686|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
465567|NCT00049686|refractory anemia with excess blasts|refractory anemia with excess blasts
466349|NCT00060749|ELOVL4|elovl4
465568|NCT00049686|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
465569|NCT00049686|refractory hairy cell leukemia|refractory hairy cell leukemia
465570|NCT00049686|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
465571|NCT00049686|secondary acute myeloid leukemia|secondary acute myeloid leukemia
465572|NCT00049686|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
465573|NCT00049686|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
465574|NCT00049686|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
465575|NCT00049699|anaplastic large cell lymphoma|anaplastic large cell lymphoma
465576|NCT00049699|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
465577|NCT00049699|intraocular lymphoma|intraocular lymphoma
465578|NCT00049699|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
465579|NCT00049699|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
465580|NCT00049699|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
465581|NCT00049699|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
465582|NCT00049699|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
465583|NCT00049699|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
465584|NCT00049699|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
465585|NCT00049699|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
465586|NCT00049699|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
465587|NCT00049699|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
465588|NCT00049699|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
465589|NCT00049699|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
465590|NCT00049699|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
465591|NCT00049699|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
465592|NCT00049699|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
465593|NCT00049699|small intestine lymphoma|small intestine lymphoma
465594|NCT00049699|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
465595|NCT00049699|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
465596|NCT00049699|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
465597|NCT00049699|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
465598|NCT00049699|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
465599|NCT00049699|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
465600|NCT00049699|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
465601|NCT00049699|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
465602|NCT00049699|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
465603|NCT00049699|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
465604|NCT00049699|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
465605|NCT00049699|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
465606|NCT00049699|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
465607|NCT00049699|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
465608|NCT00049699|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
465609|NCT00049699|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
465610|NCT00049699|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
465611|NCT00049699|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
465612|NCT00049699|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
465613|NCT00049699|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
465614|NCT00049699|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
465615|NCT00049699|splenic marginal zone lymphoma|splenic marginal zone lymphoma
465616|NCT00049712|anaplastic large cell lymphoma|anaplastic large cell lymphoma
465617|NCT00049712|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
465618|NCT00049712|intraocular lymphoma|intraocular lymphoma
465619|NCT00049712|primary central nervous system lymphoma|primary central nervous system lymphoma
465620|NCT00049712|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
465621|NCT00049712|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
583613|NCT00512395|laparoscopic colorectal surgery|laparoscopic colorectal surgery
465622|NCT00049712|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
465623|NCT00049712|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
465624|NCT00049712|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
465625|NCT00049712|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
465626|NCT00049712|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
465627|NCT00049712|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
465628|NCT00049712|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
465629|NCT00049712|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
465630|NCT00049712|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
466350|NCT00060749|DHA|dha
465631|NCT00049712|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
465632|NCT00049712|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
465633|NCT00049712|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
465634|NCT00049712|small intestine lymphoma|small intestine lymphoma
465635|NCT00049712|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
465636|NCT00049712|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
465637|NCT00049712|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
465638|NCT00049712|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
465639|NCT00049712|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
465640|NCT00049712|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
465641|NCT00049712|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
465642|NCT00049712|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
465643|NCT00049712|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
465644|NCT00049712|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
465645|NCT00049712|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
465646|NCT00049712|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
465647|NCT00049712|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
465648|NCT00049712|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
465649|NCT00049712|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
13056|NCT03207113|prostate-specific antigen|prostate-specific antigen
465650|NCT00049712|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
465651|NCT00049712|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
465652|NCT00049712|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
465653|NCT00049712|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
465654|NCT00049712|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
465655|NCT00049712|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
465656|NCT00049712|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
465657|NCT00049712|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
465658|NCT00049712|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
465659|NCT00049712|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
465660|NCT00049712|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
465661|NCT00049712|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
465662|NCT00049712|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
465663|NCT00049712|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
465664|NCT00049712|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
465665|NCT00049712|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
465666|NCT00049712|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
465667|NCT00049712|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
465668|NCT00049712|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
465669|NCT00049712|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
88711|NCT02733003|Antiretroviral Therapy (ART)|antiretroviral therapy (art)
88712|NCT02732990|Training|training
465670|NCT00049712|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
465671|NCT00049712|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
465672|NCT00049712|splenic marginal zone lymphoma|splenic marginal zone lymphoma
465673|NCT00049725|Autoimmune Disease|autoimmune disease
465674|NCT00049725|Monoclonal Antibody Therapy|monoclonal antibody therapy
465675|NCT00049725|Anti-IL2 Receptor|anti-il2 receptor
465677|NCT00049725|Monoclonal Antibody|monoclonal antibody
465678|NCT00049725|Immune Thrombocytopenia|immune thrombocytopenia
465680|NCT00049738|Psychosis|psychosis
465681|NCT00049738|Childhood Onset Schizophrenia|childhood onset schizophrenia
465682|NCT00049738|Schizophrenia|schizophrenia
465683|NCT00049738|Schizoaffective|schizoaffective
465684|NCT00049738|Psychotic Disorder|psychotic disorder
465685|NCT00049738|Multidimensionally Impaired Syndrome|multidimensionally impaired syndrome
465686|NCT00049790|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
465687|NCT00049803|Narcolepsy|narcolepsy
465688|NCT00049803|Sodium Oxybate|sodium oxybate
465689|NCT00049803|Cataplexy|cataplexy
465690|NCT00049803|Excessive Daytime Sleepiness|excessive daytime sleepiness
465691|NCT00049803|GHB|ghb
465692|NCT00049803|Gamma Hydroxybutyric Acid|gamma hydroxybutyric acid
465693|NCT00049803|Orphan Medical|orphan medical
465694|NCT00049803|Orphan Drug|orphan drug
465695|NCT00049816|knee|knee
465696|NCT00049816|aerobic exercise|aerobic exercise
465697|NCT00049816|walking|walking
465698|NCT00049816|cycling|cycling
465699|NCT00049816|gait|gait
465700|NCT00049816|MRI|mri
465701|NCT00049829|Bisphosphonate,BMD,Height loss, Hip protectors,HRT,|bisphosphonate,bmd,height loss, hip protectors,hrt,
465702|NCT00049829|Osteoporosis|osteoporosis
465703|NCT00049946|Talnetant|talnetant
465704|NCT00049946|schizophrenia|schizophrenia
465705|NCT00049946|NK3 receptor antagonist|nk3 receptor antagonist
465708|NCT00049959|multiple basal cell carcinoma|multiple basal cell carcinoma
465709|NCT00049959|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
465710|NCT00049972|Major Depressive Disorder Open-label discontinued|major depressive disorder open-label discontinued
465711|NCT00049998|Nonsmall Cell Lung cancer|nonsmall cell lung cancer
465712|NCT00049998|advanced|advanced
465713|NCT00049998|Second-line|second-line
465714|NCT00049998|topotecan|topotecan
465715|NCT00049998|Hycamtin|hycamtin
465716|NCT00049998|oral|oral
465717|NCT00049998|docetaxel|docetaxel
465718|NCT00050011|cancer-treatment related bone loss|cancer-treatment related bone loss
465719|NCT00050011|postmenopausal women|postmenopausal women
465720|NCT00050011|breast cancer|breast cancer
465721|NCT00050011|hormone receptor positive breast cancer|hormone receptor positive breast cancer
465722|NCT00050011|adjuvant therapy|adjuvant therapy
465723|NCT00050011|hormonal therapy|hormonal therapy
465724|NCT00050011|bone loss|bone loss
465725|NCT00050011|bisphosphonates|bisphosphonates
465726|NCT00050011|ZFAST|zfast
465727|NCT00050011|Letrozole|letrozole
465728|NCT00050011|Zoledronic Acid|zoledronic acid
465729|NCT00050011|US32|us32
465730|NCT00050024|TMS|tms
465731|NCT00050024|Afferent Stimulation|afferent stimulation
465732|NCT00050024|Motor Cortex|motor cortex
465733|NCT00050024|Writer's Cramp|writer's cramp
465734|NCT00050024|Surround Inhibition|surround inhibition
465735|NCT00050024|Heterotopic Inhibition|heterotopic inhibition
465736|NCT00050024|Focal Dystonia|focal dystonia
465737|NCT00050024|Writer Cramp|writer cramp
465738|NCT00050050|Adult|adult
465739|NCT00050050|ADHD|adhd
465740|NCT00050050|ADD|add
465741|NCT00050063|HIV Therapeutic Vaccine|hiv therapeutic vaccine
465742|NCT00050063|Treatment Experienced|treatment experienced
465743|NCT00050063|AIDS Vaccines|aids vaccines
465744|NCT00050063|Treatment Interruption|treatment interruption
465745|NCT00050063|Viral Load|viral load
465746|NCT00050063|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
465747|NCT00050063|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
465748|NCT00050076|Congestive Heart Failure|congestive heart failure
465749|NCT00050076|Cardiac Failure|cardiac failure
465750|NCT00050076|Heart Decompensation|heart decompensation
465751|NCT00050076|Drug Therapy|drug therapy
465752|NCT00050089|AIDS|aids
465753|NCT00050089|antiretrovirals|antiretrovirals
465754|NCT00050089|ART|art
465755|NCT00050089|drug-free period|drug-free period
465756|NCT00050089|HAART|haart
465757|NCT00050089|HIV|hiv
465758|NCT00050089|human immunodeficiency virus|human immunodeficiency virus
465759|NCT00050089|randomized|randomized
465760|NCT00050089|structured treatment interruptions|structured treatment interruptions
465761|NCT00050115|Bone Marrow Failure|bone marrow failure
465762|NCT00050115|Seronegative Hepatitis|seronegative hepatitis
465763|NCT00050115|Fulminate Hepatitis|fulminate hepatitis
465764|NCT00050115|Hepatitis|hepatitis
465765|NCT00050115|Aplastic Anemia|aplastic anemia
465766|NCT00050115|Hepatitis Associated Aplastic Anemia|hepatitis associated aplastic anemia
465767|NCT00050128|Rehabilitation|rehabilitation
465916|NCT00050427|Cancer|cancer
465768|NCT00050128|Plasticity|plasticity
465769|NCT00050128|Frequency|frequency
465770|NCT00050128|Inhibition|inhibition
465771|NCT00050128|Pinch|pinch
465772|NCT00050128|Stroke|stroke
465773|NCT00050141|Breast cancer|breast cancer
465774|NCT00050141|ZARNESTRA|zarnestra
465775|NCT00050141|tipifarnib|tipifarnib
465776|NCT00050141|R115777|r115777
465777|NCT00050141|Estrogen receptor positive|estrogen receptor positive
465778|NCT00050141|Progesterone receptor positive|progesterone receptor positive
465779|NCT00050141|Anti-estrogen therapy|anti-estrogen therapy
465780|NCT00050154|R115777|r115777
465781|NCT00050154|Myelodysplastic syndromes|myelodysplastic syndromes
465782|NCT00050154|Tipifarnib|tipifarnib
465783|NCT00050154|Zarnestra|zarnestra
465784|NCT00050167|Breast Cancer|breast cancer
465785|NCT00050167|Capecitabine|capecitabine
465786|NCT00050167|Docetaxel|docetaxel
465787|NCT00050167|Paclitaxel|paclitaxel
465788|NCT00050167|Taxotere|taxotere
465789|NCT00050167|Taxol|taxol
465790|NCT00050167|Xeloda|xeloda
465793|NCT00050180|P-Glycoprotein|p-glycoprotein
465794|NCT00050180|Protease Inhibitor|protease inhibitor
465795|NCT00050180|Antiretrovirals|antiretrovirals
465796|NCT00050180|Cytochrome P450|cytochrome p450
465797|NCT00050180|Drug Transporters|drug transporters
465798|NCT00050180|Healthy Volunteer|healthy volunteer
465799|NCT00050180|HV|hv
465800|NCT00050193|Children|children
465801|NCT00050193|Mast Cells|mast cells
465802|NCT00050193|Urticaria Pigmentosa|urticaria pigmentosa
465803|NCT00050193|Bone Marrow|bone marrow
465804|NCT00050193|Severe|severe
465805|NCT00050193|Mastocytosis|mastocytosis
465806|NCT00050193|Pediatric Mastocytosis|pediatric mastocytosis
465807|NCT00050219|Raclopride|raclopride
465808|NCT00050219|D2 Receptors|d2 receptors
465809|NCT00050219|Striatum|striatum
465810|NCT00050219|Low-Response|low-response
465811|NCT00050219|Alcoholism|alcoholism
465812|NCT00050219|Alcohol|alcohol
465815|NCT00050232|Pseudobulbar Affect|pseudobulbar affect
465816|NCT00050232|Uncontrolled|uncontrolled
465817|NCT00050232|Laughing|laughing
465818|NCT00050232|Crying|crying
465819|NCT00050245|Neuropathy|neuropathy
465820|NCT00050245|B Cells|b cells
465821|NCT00050245|Anti-MAG|anti-mag
465822|NCT00050245|Demyelination|demyelination
465823|NCT00050245|MAG|mag
465824|NCT00050245|RITUXAN|rituxan
465825|NCT00050245|Monoclonal Antibodies|monoclonal antibodies
465826|NCT00050245|Retuximab|retuximab
465827|NCT00050245|Demyelinating Neuropathy|demyelinating neuropathy
465828|NCT00050271|Acetylcarnitine|acetylcarnitine
465829|NCT00050271|Dideoxynucleosides|dideoxynucleosides
465830|NCT00050271|Epidermis|epidermis
465831|NCT00050271|Biopsy|biopsy
465832|NCT00050271|Immunohistochemistry|immunohistochemistry
465833|NCT00050271|Nerve Fibers|nerve fibers
465834|NCT00050271|Treatment Experienced|treatment experienced
465835|NCT00050284|Treatment Experienced|treatment experienced
465836|NCT00050284|Disease Progression|disease progression
465837|NCT00050284|Anti-HIV Agents|anti-hiv agents
465838|NCT00050284|Treatment Interruption|treatment interruption
465839|NCT00050310|Confirmed|confirmed
465840|NCT00050310|Suspected|suspected
465841|NCT00050310|Pathogenesis|pathogenesis
465842|NCT00050310|Bronchoscopy|bronchoscopy
465843|NCT00050310|Cultures|cultures
465844|NCT00050310|Anthrax|anthrax
465845|NCT00050310|Natural History|natural history
465846|NCT00050310|Vaccinated Healthy Volunteer|vaccinated healthy volunteer
465847|NCT00050323|Stage IV Renal Cell Carcinoma|stage iv renal cell carcinoma
465848|NCT00050323|Kidney Cancer|kidney cancer
465849|NCT00050323|Cancer (General)|cancer (general)
465850|NCT00050336|Stage 3b or 4 (metastatic) non-small cell lung cancer|stage 3b or 4 (metastatic) non-small cell lung cancer
465851|NCT00050349|cancer|cancer
465852|NCT00050349|tumor|tumor
465853|NCT00050349|tumour|tumour
465854|NCT00050349|neoplasm|neoplasm
465855|NCT00050349|carcinoma|carcinoma
465856|NCT00050349|carcinoid|carcinoid
465857|NCT00050349|neuroendocrine|neuroendocrine
465858|NCT00050349|Islet cell|islet cell
465859|NCT00050349|Gastrinoma|gastrinoma
465860|NCT00050349|VIPoma|vipoma
465861|NCT00050349|metastatic|metastatic
465862|NCT00050349|intravenous|intravenous
465863|NCT00050349|epothilone|epothilone
465864|NCT00050362|Pain|pain
465865|NCT00050362|NSAID|nsaid
465866|NCT00050362|Oral Surgery|oral surgery
465867|NCT00050362|Hyperalgesia|hyperalgesia
465868|NCT00050362|Preemptive Analgesia|preemptive analgesia
465869|NCT00050375|OvaRex|ovarex
465870|NCT00050375|ovarian|ovarian
465871|NCT00050375|CA125|ca125
465872|NCT00050375|murine|murine
465873|NCT00050375|antibody|antibody
465874|NCT00050375|immunotherapy|immunotherapy
465875|NCT00050388|Cancer|cancer
465876|NCT00050388|Carcinoma|carcinoma
465877|NCT00050388|Neoplasm|neoplasm
465878|NCT00050388|Head cancer|head cancer
465879|NCT00050388|Neck cancer|neck cancer
598313|NCT00569322|ICU|icu
465880|NCT00050388|Tongue cancer|tongue cancer
465881|NCT00050388|Lip cancer|lip cancer
465882|NCT00050388|Oral Cavity|oral cavity
465883|NCT00050388|Oropharynx|oropharynx
465884|NCT00050388|Pharynx|pharynx
465885|NCT00050388|Larynx|larynx
465886|NCT00050388|Squamous Cell|squamous cell
465887|NCT00050388|Salivary Glands|salivary glands
465888|NCT00050388|Tumor|tumor
465889|NCT00050388|Lesion|lesion
465890|NCT00050388|Cancer treatment|cancer treatment
465891|NCT00050388|Clinical trial|clinical trial
465892|NCT00050388|Allovectin-7®|allovectin-7®
465893|NCT00050388|Otorhinolaryngologic Neoplasm|otorhinolaryngologic neoplasm
465894|NCT00050388|Otolaryngologic Cancer|otolaryngologic cancer
465895|NCT00050388|Gene therapy|gene therapy
465896|NCT00050388|Immunotherapy|immunotherapy
465897|NCT00050388|Cancer research|cancer research
465898|NCT00050388|Cancer vaccine|cancer vaccine
465899|NCT00050388|Cancer cells|cancer cells
465903|NCT00050414|Ovary|ovary
465904|NCT00050414|Cancer|cancer
465905|NCT00050414|Trabectedin|trabectedin
465906|NCT00050414|Yondelis|yondelis
465907|NCT00050414|ET743|et743
465908|NCT00050414|Ecteinascidin 743|ecteinascidin 743
465909|NCT00050414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
465910|NCT00050414|Alkylating Agents|alkylating agents
465911|NCT00050427|Trabectedin|trabectedin
465912|NCT00050427|Yondelis|yondelis
465913|NCT00050427|ET743|et743
465914|NCT00050427|Advanced breast cancer|advanced breast cancer
465915|NCT00050427|Breast|breast
465917|NCT00050427|Antineoplastic Agents, Alkylating Agents|antineoplastic agents, alkylating agents
465918|NCT00050427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
465919|NCT00050440|Endometrial|endometrial
465920|NCT00050440|Cancer|cancer
465921|NCT00050440|Carcinoma|carcinoma
465922|NCT00050440|Trabectedin|trabectedin
465923|NCT00050440|Ecteinascidin 743|ecteinascidin 743
465924|NCT00050440|ET743|et743
465925|NCT00050440|Antineoplastic Agents|antineoplastic agents
465926|NCT00050440|Alkylating Agents|alkylating agents
465927|NCT00050440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
465928|NCT00050466|Normal Volunteers|normal volunteers
465929|NCT00050466|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
465930|NCT00050466|Corneal Opacities|corneal opacities
465931|NCT00050466|Cornea|cornea
465932|NCT00050466|Transparency|transparency
465933|NCT00050466|Vision|vision
465934|NCT00050479|Types 1 and 2 diabetes|types 1 and 2 diabetes
465935|NCT00050479|Diode Laser Photocoagulation|diode laser photocoagulation
465936|NCT00050479|Elevated Low-Density Lipoprotein (LDL-C) Cholesterol|elevated low-density lipoprotein (ldl-c) cholesterol
465937|NCT00050492|Ocular|ocular
465938|NCT00050492|Cytokine|cytokine
465939|NCT00050492|Chemokine|chemokine
465940|NCT00050492|Viruses|viruses
465941|NCT00050492|Autoantibody|autoantibody
465942|NCT00050492|Retina|retina
465943|NCT00050492|Vasculitis|vasculitis
465944|NCT00050492|Adhesion Molecules|adhesion molecules
465945|NCT00050505|smallpox, Dryvax, vaccine, dilution|smallpox, dryvax, vaccine, dilution
465946|NCT00050518|Smallpox|smallpox
465947|NCT00050518|Aventis Pasteur|aventis pasteur
465948|NCT00050518|Vaccine|vaccine
465949|NCT00050531|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
465950|NCT00050531|CML|cml
465951|NCT00050531|Early Chronic Phase Chronic Myelogenous Leukemia|early chronic phase chronic myelogenous leukemia
465952|NCT00050531|Imatinib Mesylate|imatinib mesylate
465953|NCT00050531|Gleevec|gleevec
465954|NCT00050531|Peg-Alpha Interferon|peg-alpha interferon
465955|NCT00050531|Peg-Intron|peg-intron
465956|NCT00050531|Sargramostim|sargramostim
465957|NCT00050531|GM-CSF|gm-csf
465958|NCT00050635|chemotherapy induced diarrhea|chemotherapy induced diarrhea
465959|NCT00050635|diarrhea|diarrhea
465961|NCT00050635|colorectal cancer|colorectal cancer
465962|NCT00050635|Sandostatin LAR Depot|sandostatin lar depot
465963|NCT00050635|Sandostatin|sandostatin
465964|NCT00050635|adverse events|adverse events
465965|NCT00050635|side effects|side effects
465966|NCT00050648|psoriasis|psoriasis
465967|NCT00050648|Daclizumab|daclizumab
465968|NCT00050648|Cyclosporin|cyclosporin
465969|NCT00050648|anti-TAC|anti-tac
465970|NCT00050648|dermatology|dermatology
465971|NCT00050648|skin|skin
465972|NCT00050661|psoriasis|psoriasis
465973|NCT00050661|Cyclosporine|cyclosporine
465974|NCT00050661|Daclizamub|daclizamub
465975|NCT00050661|anti-TAC|anti-tac
465976|NCT00050661|dermatology|dermatology
465977|NCT00050661|skin|skin
465978|NCT00050661|lesions|lesions
465979|NCT00050674|lung cancer, oncology, neutropenia, chemotherapy, filgrastim|lung cancer, oncology, neutropenia, chemotherapy, filgrastim
465980|NCT00050700|PET|pet
465981|NCT00050700|[18F]FP-TZTP|[18f]fp-tztp
465982|NCT00050700|Bipolar Disorder|bipolar disorder
465983|NCT00050700|Major Depressive Disorder|major depressive disorder
465984|NCT00050700|Muscarinic 2 Receptors|muscarinic 2 receptors
465985|NCT00050713|Kidney Disease|kidney disease
465390|NCT00049465|fatigue|fatigue
465986|NCT00050713|Glomerulonephritis|glomerulonephritis
465987|NCT00050713|Lupus Nephritis|lupus nephritis
465988|NCT00050713|Nephrotic Syndrome|nephrotic syndrome
465989|NCT00050713|Hyperlipidemia|hyperlipidemia
465990|NCT00050726|Interleukin-2|interleukin-2
465991|NCT00050726|Immunotherapy|immunotherapy
465992|NCT00050726|HIV|hiv
465993|NCT00050726|IL-2|il-2
465994|NCT00050752|Renal Cancer|renal cancer
465995|NCT00050752|Hereditary Leiomyomatosis|hereditary leiomyomatosis
465996|NCT00050752|Uterine Fibroid|uterine fibroid
465997|NCT00050752|Cutaneous Leiomyoma|cutaneous leiomyoma
465998|NCT00050765|Myocardial Infarction|myocardial infarction
465999|NCT00050765|Heart disease|heart disease
466000|NCT00050765|Coronary bypass graft (CABG) surgery|coronary bypass graft (cabg) surgery
466001|NCT00050765|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
466003|NCT00050765|ICD|icd
466004|NCT00050765|Heart failure|heart failure
466005|NCT00050778|Multiple Sclerosis|multiple sclerosis
466006|NCT00050778|Active Relapsing-Remitting Multiple Sclerosis|active relapsing-remitting multiple sclerosis
466007|NCT00050791|Obesity|obesity
466008|NCT00050791|Weightloss|weightloss
466009|NCT00050791|Leptin|leptin
466010|NCT00050791|Diet|diet
466011|NCT00050791|Reducing|reducing
466012|NCT00050791|Overweight|overweight
466013|NCT00050791|Fat|fat
466014|NCT00050804|Acute Stress Disorder|acute stress disorder
466015|NCT00050804|PTSD|ptsd
466016|NCT00050804|Treatment|treatment
466017|NCT00050804|SSRI|ssri
466018|NCT00050804|Startle|startle
466019|NCT00050804|Psychophysiology|psychophysiology
466020|NCT00050804|Trauma|trauma
466021|NCT00050804|Anxiety|anxiety
466022|NCT00050804|Emotion|emotion
466023|NCT00050817|Embolism|embolism
466024|NCT00050856|Antiretrovial Therapy|antiretrovial therapy
466025|NCT00050856|Salvage|salvage
466026|NCT00050856|CD4+Lymphocyte Count|cd4+lymphocyte count
466027|NCT00050856|HIV-1 RNA Level|hiv-1 rna level
467087|NCT00062452|Airway|airway
466028|NCT00050856|Subcutaneous Injection|subcutaneous injection
466029|NCT00050869|Mirror Neurons|mirror neurons
466030|NCT00050869|Performance|performance
466031|NCT00050869|Use-Dependent Plasticity|use-dependent plasticity
466032|NCT00050869|Attention|attention
466033|NCT00050869|Premotor Cortex|premotor cortex
466035|NCT00050882|Diabetic gastroparesis|diabetic gastroparesis
466036|NCT00050882|Bloating|bloating
466037|NCT00050882|Delayed gastric emptying|delayed gastric emptying
466038|NCT00050882|Mitemcinal|mitemcinal
466039|NCT00050895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
466040|NCT00050895|HIV Protease Inhibitors|hiv protease inhibitors
466041|NCT00050895|Drug Therapy, Combination|drug therapy, combination
466042|NCT00050895|Delayed Action Preparations|delayed action preparations
466043|NCT00050895|Treatment Naive|treatment naive
466044|NCT00050895|HIV-1|hiv-1
466046|NCT00050908|Endothelium, Vascular|endothelium, vascular
466047|NCT00050908|Vasodilation|vasodilation
466048|NCT00050908|Nitroglycerin|nitroglycerin
466049|NCT00050908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
466050|NCT00050908|HIV Protease Inhibitors|hiv protease inhibitors
466051|NCT00050908|Drug Therapy, Combination|drug therapy, combination
466052|NCT00050908|Ritonavir|ritonavir
466053|NCT00050908|efavirenz|efavirenz
466054|NCT00050908|lopinavir|lopinavir
466055|NCT00050908|stavudine|stavudine
466056|NCT00050908|lamivudine|lamivudine
466057|NCT00050908|zidovudine|zidovudine
466058|NCT00050908|Treatment Naive|treatment naive
466059|NCT00050921|HIV Infections|hiv infections
466060|NCT00050921|CD4 Lymphocyte Count|cd4 lymphocyte count
466061|NCT00050921|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
466062|NCT00050921|Growth Hormone|growth hormone
466064|NCT00050921|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
466065|NCT00050921|Treatment Experienced|treatment experienced
466066|NCT00050934|partial seizures|partial seizures
466067|NCT00050947|partial seizures|partial seizures
466068|NCT00050960|NSCLC|nsclc
466069|NCT00050960|Targretin|targretin
466070|NCT00050960|Retinoid|retinoid
466071|NCT00050960|Bexarotene|bexarotene
466072|NCT00050973|NSCLC|nsclc
466073|NCT00050973|Targretin|targretin
466074|NCT00050973|Retinoid|retinoid
466075|NCT00050973|Bexarotene|bexarotene
466076|NCT00050986|Brain Neoplasms|brain neoplasms
466077|NCT00050986|CNS Diseases|cns diseases
466078|NCT00050986|Glioblastoma Multiforme|glioblastoma multiforme
466079|NCT00050986|Temozolomide|temozolomide
466080|NCT00050986|Temodar|temodar
466081|NCT00050986|R115777|r115777
466082|NCT00050986|Zarnestra|zarnestra
466083|NCT00058682|Fungal Infection|fungal infection
466084|NCT00058682|Mycoses|mycoses
466085|NCT00058682|Candida Species|candida species
466086|NCT00058682|Candidiasis|candidiasis
466087|NCT00058695|Macualar Degeneration|macualar degeneration
466088|NCT00058695|AMD|amd
466089|NCT00058695|Healthy Volunteer|healthy volunteer
466090|NCT00058695|HV|hv
598491|NCT00570154|HV|hv
466091|NCT00058721|Dementia|dementia
466092|NCT00058721|Feasibility|feasibility
466093|NCT00058721|Dopamine|dopamine
466094|NCT00058721|Lewy Body|lewy body
466095|NCT00058721|Parkinson Disease|parkinson disease
466096|NCT00058721|PD|pd
466097|NCT00058721|Healthy Volunteer|healthy volunteer
466098|NCT00058721|HV|hv
466099|NCT00058734|Dendritic Cell|dendritic cell
466100|NCT00058734|Immunotherapy|immunotherapy
466101|NCT00058734|Acute HIV|acute hiv
466102|NCT00058734|Human Immunodeficiency Virus|human immunodeficiency virus
466103|NCT00058734|AIDS|aids
466104|NCT00058734|HIV Therapeutic Vaccine|hiv therapeutic vaccine
466105|NCT00058734|Treatment Experienced|treatment experienced
466106|NCT00058734|Treatment Interruption|treatment interruption
466107|NCT00058747|Granulocytic Leukemia, Chronic|granulocytic leukemia, chronic
466108|NCT00058747|Leukemia, Granulocytic, Chronic|leukemia, granulocytic, chronic
466109|NCT00058747|Leukemia, Myelocytic, Chronic|leukemia, myelocytic, chronic
466110|NCT00058747|Leukemia, Myelogenous, Chronic|leukemia, myelogenous, chronic
466111|NCT00058747|Myelocytic Leukemia, Chronic|myelocytic leukemia, chronic
466112|NCT00058747|Myelogenous Leukemia, Chronic|myelogenous leukemia, chronic
466113|NCT00058747|Myeloid Leukemia, Chronic|myeloid leukemia, chronic
466114|NCT00058760|Prevention of early sexual behavior|prevention of early sexual behavior
466115|NCT00058760|NIA intervention|nia intervention
466116|NCT00058773|Hodgkin disease|hodgkin disease
466117|NCT00058773|non-Hodgkins Lymphoma|non-hodgkins lymphoma
466118|NCT00058773|bone marrow transplant|bone marrow transplant
466119|NCT00058812|Cytotoxic T Lymphocytes|cytotoxic t lymphocytes
466120|NCT00058812|bone marrow transplant|bone marrow transplant
466121|NCT00058812|EBV+ lymphoproliferative disease|ebv+ lymphoproliferative disease
466122|NCT00058825|Campath|campath
466123|NCT00058825|stem cell transplant|stem cell transplant
466124|NCT00058851|Manual lymph drainage|manual lymph drainage
466125|NCT00058851|Combined physiotherapy|combined physiotherapy
466126|NCT00058890|itching|itching
466127|NCT00058890|pruritus|pruritus
466128|NCT00058890|cholestasis|cholestasis
466136|NCT00058903|hepatitis C|hepatitis c
466137|NCT00058942|Drinking Water|drinking water
466138|NCT00058955|ghb|ghb
466139|NCT00058955|Xyrem|xyrem
466140|NCT00058955|triazolam|triazolam
466141|NCT00058955|pentobarbital|pentobarbital
466142|NCT00058955|sedative|sedative
466143|NCT00058955|abuse|abuse
466144|NCT00058968|neuropathy|neuropathy
466145|NCT00058968|pain|pain
466146|NCT00058968|diabetes|diabetes
466147|NCT00058968|chronic pain|chronic pain
466148|NCT00058968|persistent pain|persistent pain
466149|NCT00058968|leg pain|leg pain
466150|NCT00058968|peripheral neuropathy|peripheral neuropathy
466151|NCT00058968|foot pain|foot pain
466152|NCT00058968|painful neuropathy|painful neuropathy
466153|NCT00058968|diabetic neuropathy|diabetic neuropathy
466154|NCT00058981|Diabetes|diabetes
466155|NCT00058981|LADA|lada
466156|NCT00058981|latent autoimmune diabetes in adults|latent autoimmune diabetes in adults
466157|NCT00058994|AMD|amd
466158|NCT00058994|anecortave acetate|anecortave acetate
466159|NCT00058994|wet AMD|wet amd
466160|NCT00058994|age-related macular degeneration|age-related macular degeneration
466161|NCT00058994|Macular Degeneration|macular degeneration
466162|NCT00058994|Maculopathy, Age-Related|maculopathy, age-related
466163|NCT00058994|Age-Related Maculopathies|age-related maculopathies
466164|NCT00058994|Age-Related Maculopathy|age-related maculopathy
466165|NCT00058994|Maculopathies, Age-Related|maculopathies, age-related
466166|NCT00059020|Glioma|glioma
466167|NCT00059020|Brain Tumor|brain tumor
466168|NCT00059020|Epidermal Growth Factor|epidermal growth factor
466169|NCT00059020|Polymorphisms|polymorphisms
466177|NCT00059046|Neuroreceptors|neuroreceptors
466178|NCT00059046|PET Measurements|pet measurements
466185|NCT00060268|stage II esophageal cancer|stage ii esophageal cancer
466186|NCT00060268|stage III esophageal cancer|stage iii esophageal cancer
466187|NCT00060268|stage IV esophageal cancer|stage iv esophageal cancer
466188|NCT00060294|Waldenström macroglobulinemia|waldenström macroglobulinemia
466189|NCT00060320|stage IV breast cancer|stage iv breast cancer
466190|NCT00060320|stage I breast cancer|stage i breast cancer
466191|NCT00060320|stage II breast cancer|stage ii breast cancer
466192|NCT00060320|stage IIIA breast cancer|stage iiia breast cancer
466193|NCT00060320|stage IIIB breast cancer|stage iiib breast cancer
466194|NCT00060320|stage IIIC breast cancer|stage iiic breast cancer
466195|NCT00060320|hot flashes|hot flashes
466196|NCT00060333|recurrent melanoma|recurrent melanoma
466197|NCT00060333|stage I melanoma|stage i melanoma
466198|NCT00060333|stage II melanoma|stage ii melanoma
466199|NCT00060333|stage III melanoma|stage iii melanoma
466200|NCT00060346|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
466201|NCT00060346|Rituximab|rituximab
466202|NCT00060346|CHOP|chop
466203|NCT00060385|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
466204|NCT00060385|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
466205|NCT00060385|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
466206|NCT00060385|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
466207|NCT00060385|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
466208|NCT00060385|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
466209|NCT00060385|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
466210|NCT00060385|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
466211|NCT00060385|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
466212|NCT00060385|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
466213|NCT00060385|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
466214|NCT00060385|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
466215|NCT00060385|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
466216|NCT00060385|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
466217|NCT00060385|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
466218|NCT00060385|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
466219|NCT00060385|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
466220|NCT00060398|recurrent prostate cancer|recurrent prostate cancer
466221|NCT00060398|anemia|anemia
466222|NCT00060398|fatigue|fatigue
466223|NCT00060437|stage IV prostate cancer|stage iv prostate cancer
466224|NCT00060437|recurrent prostate cancer|recurrent prostate cancer
466225|NCT00060437|adenocarcinoma of the prostate|adenocarcinoma of the prostate
466226|NCT00060450|Ischemia-reperfusion lung injury|ischemia-reperfusion lung injury
466227|NCT00060450|IRLI|irli
466228|NCT00060463|Emergency contraceptive pills|emergency contraceptive pills
466229|NCT00060463|Pregnancy|pregnancy
466230|NCT00060463|Sexually transmitted infection|sexually transmitted infection
466231|NCT00060463|Chlamydia|chlamydia
466232|NCT00060463|Gonorrhea|gonorrhea
466233|NCT00060463|Trichomonas|trichomonas
466234|NCT00060463|Contraception|contraception
466235|NCT00060489|Bipolar Depression|bipolar depression
466236|NCT00060502|cachexia|cachexia
466237|NCT00060502|pancreatic cancer|pancreatic cancer
466238|NCT00060502|infliximab|infliximab
466239|NCT00060502|anorexia|anorexia
466240|NCT00060502|anemia|anemia
466241|NCT00060502|Remicade.|remicade.
466242|NCT00060528|Immunotherapy|immunotherapy
466243|NCT00060528|Cytokines|cytokines
466244|NCT00060528|Immune Assays|immune assays
466245|NCT00060528|Prostate Cancer|prostate cancer
466246|NCT00060541|Brain Tumor|brain tumor
466247|NCT00060541|Epilepsy|epilepsy
466248|NCT00060541|Pituitary Adenoma|pituitary adenoma
466249|NCT00060541|Parkinson's Disease|parkinson's disease
466250|NCT00060541|Vascular Malformation|vascular malformation
466251|NCT00060541|Neurosurgery|neurosurgery
466252|NCT00060541|Glioblastoma|glioblastoma
466253|NCT00060541|Astrocytoma|astrocytoma
466254|NCT00060541|Oligodendroglioma|oligodendroglioma
466255|NCT00060541|Spinal Arteriovenous Malformation|spinal arteriovenous malformation
466256|NCT00060541|Oncogenes|oncogenes
466257|NCT00060541|Proteomics|proteomics
466258|NCT00060554|Elective PCI|elective pci
466259|NCT00060554|Heart catherization|heart catherization
466260|NCT00060554|Acute coronary syndromes|acute coronary syndromes
466261|NCT00060567|E7070|e7070
466262|NCT00060567|Irinotecan|irinotecan
466263|NCT00060567|hydrochloride|hydrochloride
466264|NCT00060567|gastrointestinal|gastrointestinal
466265|NCT00060567|cancer|cancer
466266|NCT00060580|Retinal Measurements|retinal measurements
466267|NCT00060580|Lutein in Vivo|lutein in vivo
466268|NCT00060580|Raman Spectroscopy|raman spectroscopy
466269|NCT00060580|Retinal Measurements of Lutein in Vivo in the Human Eye|retinal measurements of lutein in vivo in the human eye
466270|NCT00060580|Healthy Volunteer|healthy volunteer
466271|NCT00060580|HV|hv
466272|NCT00060593|Balance|balance
466273|NCT00060593|Functional Connectivity|functional connectivity
466274|NCT00060593|Healthy Volunteer|healthy volunteer
466275|NCT00060593|HV|hv
466276|NCT00060606|Maternal fetal surgery|maternal fetal surgery
466277|NCT00060606|Fetal diagnosis|fetal diagnosis
466278|NCT00060606|Myelomeningocele|myelomeningocele
466279|NCT00060606|Meningomyelocele|meningomyelocele
466280|NCT00060606|Open neural tube defect|open neural tube defect
466281|NCT00060606|ONTD|ontd
466282|NCT00060606|Spina bifida|spina bifida
466283|NCT00060619|Migraine|migraine
466284|NCT00060619|Functional abdominal pain|functional abdominal pain
466285|NCT00060619|Biofeedback|biofeedback
466286|NCT00060619|Psychological assessment|psychological assessment
466287|NCT00060632|Advanced, refractory or recurrent solid tumors|advanced, refractory or recurrent solid tumors
466288|NCT00060645|Advanced, refractory or recurrent solid tumors|advanced, refractory or recurrent solid tumors
466289|NCT00060658|Prefrontal Cortex|prefrontal cortex
466290|NCT00060658|Calculation|calculation
466291|NCT00060658|Mathematician|mathematician
466292|NCT00060658|Cognition|cognition
466293|NCT00060658|Brain Mapping|brain mapping
466294|NCT00060658|Healthy Volunteer|healthy volunteer
466295|NCT00060658|HV|hv
466296|NCT00060671|Pixantrone|pixantrone
466297|NCT00060671|BBR 2778|bbr 2778
466298|NCT00060671|chemotherapy|chemotherapy
466299|NCT00060671|DNA Intercalator|dna intercalator
466300|NCT00060671|Anthracycline|anthracycline
466301|NCT00060671|Rituximab|rituximab
466302|NCT00060671|Rituxan|rituxan
466303|NCT00060671|Mabthera|mabthera
466304|NCT00060671|monoclonal antibody|monoclonal antibody
466305|NCT00060671|antibody|antibody
466306|NCT00060671|NHL|nhl
466307|NCT00060671|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
466308|NCT00060671|indolent|indolent
466309|NCT00060671|low grade|low grade
466310|NCT00060671|Novuspharma|novuspharma
466311|NCT00060684|Pixantrone|pixantrone
466312|NCT00060684|BBR 2778|bbr 2778
466313|NCT00060684|chemotherapy|chemotherapy
466314|NCT00060684|DNA Intercalator|dna intercalator
466315|NCT00060684|mitoxantrone|mitoxantrone
466316|NCT00060684|fludarabine|fludarabine
466317|NCT00060684|dexamethasone|dexamethasone
466318|NCT00060684|Rituximab|rituximab
466320|NCT00060684|Mabthera|mabthera
466321|NCT00060684|monoclonal antibody|monoclonal antibody
466324|NCT00060684|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
466325|NCT00060684|indolent|indolent
466326|NCT00060684|low grade|low grade
466327|NCT00060684|Novuspharma|novuspharma
466328|NCT00060697|Sexual risk taking|sexual risk taking
466329|NCT00060697|Mother-child communication|mother-child communication
466330|NCT00060697|Problem behaviors|problem behaviors
466331|NCT00060710|melanoma|melanoma
466332|NCT00060723|Polysomnography|polysomnography
466333|NCT00060723|Sleep-disordered breathing|sleep-disordered breathing
466334|NCT00060723|Sleep apnea, obstructive|sleep apnea, obstructive
466335|NCT00060723|Hyperactivity|hyperactivity
466336|NCT00060723|Sleep|sleep
466337|NCT00060723|Child|child
466338|NCT00060736|Hormone Replacement|hormone replacement
466339|NCT00060736|Gonadal Steroids|gonadal steroids
466340|NCT00060736|Estrogen|estrogen
466341|NCT00060736|Major Depression|major depression
466342|NCT00060736|Minor Depression|minor depression
466343|NCT00060736|Perimenopause|perimenopause
466344|NCT00060736|Estradiol|estradiol
466345|NCT00060736|Depression|depression
466346|NCT00060736|Perimenopausal Depression|perimenopausal depression
466347|NCT00060749|Stargardt|stargardt
466348|NCT00060749|Macular Dystrophy|macular dystrophy
466351|NCT00060749|Stargardt's Disease|stargardt's disease
466352|NCT00060749|Autosomal Dominant Macular Dystrophy|autosomal dominant macular dystrophy
466353|NCT00060749|Autosomal Recessive Macular Dystrophy|autosomal recessive macular dystrophy
466354|NCT00060762|Weight Loss|weight loss
466355|NCT00060775|Magnetic Resonance Imaging|magnetic resonance imaging
466356|NCT00060775|fMRI|fmri
466357|NCT00060775|Emotion|emotion
466358|NCT00060775|Children|children
466359|NCT00060775|Adolescence|adolescence
466360|NCT00060775|Affective Neuroscience|affective neuroscience
466361|NCT00060775|Neuroimaging|neuroimaging
466362|NCT00060775|Behavioral Inhibition|behavioral inhibition
466363|NCT00060775|Depression|depression
466364|NCT00060775|Anxiety|anxiety
466365|NCT00060775|Normal Volunteers|normal volunteers
466366|NCT00060775|Healthy Volunteer|healthy volunteer
466367|NCT00060775|HV|hv
466368|NCT00060788|Antisocial behavior|antisocial behavior
466369|NCT00060788|Mauritius Child Health Project|mauritius child health project
466370|NCT00060788|Intergenerational transmission|intergenerational transmission
466371|NCT00060801|Cystic Fibrosis|cystic fibrosis
466372|NCT00060801|BIIL 284|biil 284
466373|NCT00060801|Boehringer Ingelheim|boehringer ingelheim
466374|NCT00060827|Mild traumatic brain injury|mild traumatic brain injury
466375|NCT00060840|Left Ventricular Assist Device Implantation|left ventricular assist device implantation
466376|NCT00060840|Progressive Left Ventricular Failure|progressive left ventricular failure
466377|NCT00060853|Amygdala|amygdala
466378|NCT00060853|Orbitofrontal Cortex|orbitofrontal cortex
466379|NCT00060853|Emotion|emotion
466380|NCT00060853|Cognition|cognition
466381|NCT00060853|Theory of Mind|theory of mind
466382|NCT00060853|Healthy Volunteer|healthy volunteer
466383|NCT00060853|HV|hv
466384|NCT00060866|Beta-Adrenoceptors|beta-adrenoceptors
466385|NCT00060866|Beta-Adrenoceptor Blocker|beta-adrenoceptor blocker
466386|NCT00060866|Neurocardiogenic Syncope|neurocardiogenic syncope
466387|NCT00060866|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
466388|NCT00060866|Neurocardiogenic|neurocardiogenic
466389|NCT00060866|Dysautonomia|dysautonomia
466390|NCT00060866|Autonomic Nervous System|autonomic nervous system
466391|NCT00060866|Nurocardiogenic Syncope|nurocardiogenic syncope
466392|NCT00060866|NCS|ncs
466393|NCT00060866|Sympathoadrenal Imbalance|sympathoadrenal imbalance
466394|NCT00060866|SAI|sai
466395|NCT00060866|Orthostatic Intolerance|orthostatic intolerance
466396|NCT00060892|Critical Limb Ischemia|critical limb ischemia
465676|NCT00049725|Platelets|platelets
466397|NCT00060905|Bipolar Disorder (manic or mixed type)|bipolar disorder (manic or mixed type)
466398|NCT00060918|Type 2 diabetes|type 2 diabetes
466399|NCT00060918|hypertension|hypertension
466400|NCT00060918|beta-blockers|beta-blockers
466401|NCT00060931|hypertension|hypertension
466402|NCT00060931|beta-blockers|beta-blockers
466403|NCT00060931|Type 2 diabetes|type 2 diabetes
466404|NCT00060944|Trabectedin|trabectedin
466405|NCT00060944|Yondelis|yondelis
466406|NCT00060944|ET-743|et-743
466407|NCT00060944|Ecteinascidin|ecteinascidin
466408|NCT00060944|Anthracycline|anthracycline
466409|NCT00060944|Ifosfamide|ifosfamide
466410|NCT00060944|Dexamethasone|dexamethasone
466411|NCT00060944|Intravenous|intravenous
466413|NCT00060944|Malignant|malignant
466414|NCT00060944|Metastatic|metastatic
466415|NCT00060957|Cerebral Palsy|cerebral palsy
466416|NCT00060957|Spasticity|spasticity
466417|NCT00060957|Botulinum toxin|botulinum toxin
466418|NCT00060957|BOTOX|botox
466419|NCT00060970|Disuse atrophy|disuse atrophy
466420|NCT00060970|Ankle fracture|ankle fracture
466421|NCT00060970|Exercise, therapy|exercise, therapy
466422|NCT00060970|Cast immobilization|cast immobilization
466423|NCT00060970|Deconditioning|deconditioning
466424|NCT00060970|Sarcopenia|sarcopenia
466425|NCT00060983|Locomotion|locomotion
466426|NCT00060983|Spinal Cord Injury, ASIA C|spinal cord injury, asia c
466427|NCT00060983|Body weight support (BWS)|body weight support (bws)
466428|NCT00060983|Functional electrical stimulation (FES)|functional electrical stimulation (fes)
466429|NCT00060983|Gait|gait
466430|NCT00060983|Treadmill training|treadmill training
466431|NCT00060983|Physical Therapy|physical therapy
466432|NCT00060996|Critical Limb Ischemia|critical limb ischemia
466433|NCT00060996|Peripheral Vascular Disease|peripheral vascular disease
466434|NCT00060996|UT-15|ut-15
466435|NCT00060996|Remodulin|remodulin
466436|NCT00060996|treprostinil|treprostinil
466437|NCT00061009|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
466438|NCT00061009|Dysautonomia|dysautonomia
466439|NCT00061009|Postural Tachycardia Syndrome|postural tachycardia syndrome
466440|NCT00061009|Neurocardiogenic|neurocardiogenic
466441|NCT00061009|Syncope|syncope
466442|NCT00061009|Neurocardiogenic Syncope|neurocardiogenic syncope
466443|NCT00061009|COI|coi
466444|NCT00061009|POTS|pots
466445|NCT00061009|Neurocardogenic Syncope|neurocardogenic syncope
466446|NCT00061009|NCS|ncs
466447|NCT00061009|Healthy Volunteer|healthy volunteer
466448|NCT00061009|HV|hv
466449|NCT00061022|Stroke|stroke
466450|NCT00061022|cerebral vascular accident|cerebral vascular accident
466451|NCT00061022|CVA|cva
466455|NCT00061022|Transient Ischemic Attack|transient ischemic attack
466456|NCT00061022|Brain Attack|brain attack
466457|NCT00061022|Cataplexy|cataplexy
466458|NCT00061035|Prostate Cancer; Immunotherapy|prostate cancer; immunotherapy
466459|NCT00061048|Monoclonal Antibody|monoclonal antibody
466460|NCT00061048|HTLV-1|htlv-1
466461|NCT00061048|CD52|cd52
466462|NCT00061048|Flow Cytometry|flow cytometry
466463|NCT00061048|Antibody Saturation|antibody saturation
466464|NCT00061048|Adult T-Cell Leukemia (ATL)|adult t-cell leukemia (atl)
466465|NCT00061048|ATL|atl
466466|NCT00061061|Tobacco Cessation|tobacco cessation
466467|NCT00061061|Postmenopausal Women|postmenopausal women
466468|NCT00061074|Smoking|smoking
466469|NCT00061087|ADHD|adhd
466470|NCT00061087|Cocaine|cocaine
466472|NCT00061087|Methadone|methadone
466473|NCT00061100|HIV|hiv
466474|NCT00061100|methadone maintenance|methadone maintenance
466475|NCT00061113|alcohol dependence|alcohol dependence
466476|NCT00061113|marijuana dependence|marijuana dependence
466477|NCT00061126|Prostate Cancer|prostate cancer
466478|NCT00061126|PSA|psa
466479|NCT00061126|Hormone refractory|hormone refractory
466480|NCT00061126|Rising PSA|rising psa
466481|NCT00061139|Cerebral palsy|cerebral palsy
466482|NCT00061139|Hemiparesis|hemiparesis
466483|NCT00061139|Pediatric CI therapy|pediatric ci therapy
466484|NCT00061139|Upper extremity|upper extremity
466485|NCT00061139|Training|training
466486|NCT00061139|Limb restraint|limb restraint
466487|NCT00061152|Pain Measurement|pain measurement
466488|NCT00061152|Diary|diary
466489|NCT00061152|Painful HIV Neuropathy|painful hiv neuropathy
466490|NCT00061152|HIV Neuropathy|hiv neuropathy
466491|NCT00061152|Capsaicin|capsaicin
466492|NCT00061152|Analgesics/*therapeutic use|analgesics/*therapeutic use
466493|NCT00061152|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
466494|NCT00061152|Peripheral Nervous System Diseases/*complications/diagnosis/*therapy|peripheral nervous system diseases/*complications/diagnosis/*therapy
466495|NCT00061152|Peripheral Nervous System Diseases/drug therapy/*etiology/physiopathology|peripheral nervous system diseases/drug therapy/*etiology/physiopathology
466496|NCT00061152|Pain|pain
466497|NCT00061165|obesity|obesity
466498|NCT00061165|overweight|overweight
599009|NCT00573339|MRI|mri
466499|NCT00061165|children|children
466500|NCT00061165|adolescents|adolescents
466501|NCT00061165|African American|african american
466502|NCT00061165|diet|diet
466503|NCT00061165|nutrition|nutrition
466504|NCT00061165|physical activity|physical activity
466505|NCT00061165|Chicago|chicago
466506|NCT00061204|fMRI|fmri
466507|NCT00061204|Susceptibility Artifacts|susceptibility artifacts
466508|NCT00061204|Prefrontal Cortex|prefrontal cortex
466509|NCT00061204|Temporal Lobes|temporal lobes
466510|NCT00061204|Methodology|methodology
466515|NCT00061217|Unrectified sockets|unrectified sockets
466516|NCT00061217|Gait|gait
466517|NCT00061217|Energy expenditure|energy expenditure
466518|NCT00061217|Prosthetic evaluation questionnaire|prosthetic evaluation questionnaire
466519|NCT00061230|Relaxation training|relaxation training
466520|NCT00061243|HIV|hiv
466521|NCT00061243|Vaccine|vaccine
466522|NCT00061243|DNA prime|dna prime
466523|NCT00061243|Protein boost|protein boost
466524|NCT00061243|HIV Seronegativity|hiv seronegativity
466525|NCT00061243|HIV preventive vaccine|hiv preventive vaccine
466526|NCT00061256|Bone Mineral Density|bone mineral density
466527|NCT00061256|Lumbar Vertebrae|lumbar vertebrae
466528|NCT00061256|Treatment Experienced|treatment experienced
466529|NCT00061269|Infected pancreatic necrosis|infected pancreatic necrosis
466530|NCT00061282|Pouchitis|pouchitis
466531|NCT00061282|Colitis|colitis
466532|NCT00061282|Ileitis|ileitis
466533|NCT00061295|Locomotion|locomotion
466534|NCT00061295|Spinal Cord Injury|spinal cord injury
466535|NCT00061295|Body Weight Supported Walking|body weight supported walking
466536|NCT00061308|Ovarian cancer|ovarian cancer
466537|NCT00061308|peritoneal cancer|peritoneal cancer
466538|NCT00061308|cancer|cancer
466539|NCT00061308|Fallopian cancer|fallopian cancer
466540|NCT00061321|Nevirapine|nevirapine
466541|NCT00061321|Pregnancy|pregnancy
466542|NCT00061321|Maternal to Infant transmission|maternal to infant transmission
466543|NCT00061321|Infant|infant
466544|NCT00061321|Breastfeeding|breastfeeding
466545|NCT00061321|HIV Seronegativity|hiv seronegativity
466546|NCT00061334|Attitudes|attitudes
466547|NCT00061334|fMRI|fmri
466548|NCT00061334|Development|development
466549|NCT00061334|Stereotypes|stereotypes
466550|NCT00061334|Memory|memory
466551|NCT00061334|Healthy Volunteer|healthy volunteer
466552|NCT00061334|HV|hv
466553|NCT00061347|Fiducial Marker|fiducial marker
466554|NCT00061347|MRI|mri
466555|NCT00061347|Prostate Cancer|prostate cancer
466556|NCT00061347|Radiation|radiation
466557|NCT00061360|Bone Marrow Failure|bone marrow failure
466558|NCT00061360|Cyclosporine|cyclosporine
466559|NCT00061360|Anti Thymocyte Globulin|anti thymocyte globulin
466560|NCT00061360|Severe Aplastic Anemia|severe aplastic anemia
466561|NCT00061373|Alteplase|alteplase
478876|NCT00094068|Sildenafil|sildenafil
466562|NCT00061373|Recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
466563|NCT00061373|Reperfusion therapy|reperfusion therapy
466564|NCT00061373|Magnetic Resonance Imaging|magnetic resonance imaging
466565|NCT00061373|Clinical Trial|clinical trial
466566|NCT00061373|Tinzaparin|tinzaparin
466567|NCT00061373|Eptifibatide|eptifibatide
466568|NCT00061373|Ischemic Stroke|ischemic stroke
466569|NCT00061386|Postpartum|postpartum
466570|NCT00061386|Low income|low income
466571|NCT00061386|Diet|diet
466572|NCT00061386|Physical activity|physical activity
466573|NCT00061399|TBI|tbi
466574|NCT00061399|Prospective memory|prospective memory
466575|NCT00061412|Low reading and writing achievement|low reading and writing achievement
466576|NCT00061412|At-risk students|at-risk students
466577|NCT00061412|Reading Disability|reading disability
466578|NCT00061412|Writing Disability|writing disability
466579|NCT00061425|NHL|nhl
466580|NCT00061425|recurrent B-cell lymphoma|recurrent b-cell lymphoma
466584|NCT00061490|Osteoarthritis|osteoarthritis
466585|NCT00061490|Arthritis|arthritis
466586|NCT00061490|Weight Loss|weight loss
466587|NCT00061503|Glaucoma|glaucoma
466588|NCT00061503|Ocular Hypertension|ocular hypertension
466589|NCT00061516|Glaucoma|glaucoma
466590|NCT00061516|Ocular Hypertension|ocular hypertension
466591|NCT00061529|Open-Angle Glaucoma|open-angle glaucoma
466592|NCT00061529|Ocular Hypertension|ocular hypertension
466593|NCT00061542|Glaucoma|glaucoma
466594|NCT00061542|Ocular Hypertension|ocular hypertension
466595|NCT00061568|Stem Cell Transplant|stem cell transplant
466596|NCT00061568|Low Dose Radiation|low dose radiation
466597|NCT00061568|Alemtuzumab (Campath)|alemtuzumab (campath)
466598|NCT00061568|Sirolimus (Rapamune)|sirolimus (rapamune)
466599|NCT00061568|Donor Apheresis|donor apheresis
466600|NCT00061568|Graft-Versus-Host Disease|graft-versus-host disease
466601|NCT00061568|Graft-Versus-Marrow|graft-versus-marrow
466602|NCT00061568|Host-Donor Chimerism|host-donor chimerism
466603|NCT00061568|Peripheral Blood Stem Cells|peripheral blood stem cells
466604|NCT00061568|Low Dose Irradiation|low dose irradiation
466605|NCT00061568|Sickle Cell Anemia|sickle cell anemia
466606|NCT00061568|SCA|sca
466607|NCT00061568|Thalassemia|thalassemia
465791|NCT00050167|Taxanes|taxanes
465792|NCT00050167|Operable Breast Cancer|operable breast cancer
466608|NCT00061568|Diamond-Blackfan Anemia|diamond-blackfan anemia
466609|NCT00061568|DBA|dba
466610|NCT00061581|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
583614|NCT00512395|epidural analgesia|epidural analgesia
466611|NCT00061581|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
466612|NCT00061581|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
466613|NCT00061581|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
466614|NCT00061581|Myelodysplastic Syndrome|myelodysplastic syndrome
466615|NCT00061581|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
466616|NCT00061581|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
466617|NCT00061581|Graft-Versus-Host Disease|graft-versus-host disease
466618|NCT00061581|Cyclosporine|cyclosporine
466619|NCT00061581|Fludarabine|fludarabine
466620|NCT00061581|Myelodysplasia Syndrome|myelodysplasia syndrome
466621|NCT00061594|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
466622|NCT00061607|Motor Neuron Disease|motor neuron disease
466623|NCT00061607|Neuromuscular Disease|neuromuscular disease
466624|NCT00061607|Histone Deacytelase Inhibitors|histone deacytelase inhibitors
466625|NCT00061607|Spinal Muscular Atrophy|spinal muscular atrophy
466626|NCT00061607|SMA|sma
466627|NCT00061620|Investigational|investigational
466628|NCT00061620|Chemotherapy|chemotherapy
466629|NCT00061620|Hematologic Malignancies|hematologic malignancies
466630|NCT00061620|Nucleoside analogue|nucleoside analogue
466631|NCT00061646|Stage IIIb with pleural effusion or IV NSCLC|stage iiib with pleural effusion or iv nsclc
466632|NCT00061659|high grade locally advanced/metastatic soft tissue sarcoma|high grade locally advanced/metastatic soft tissue sarcoma
466633|NCT00061672|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
466634|NCT00061672|Hodgkin's Lymphoma (HL)|hodgkin's lymphoma (hl)
466635|NCT00061724|Esophageal|esophageal
466636|NCT00061724|Reflux|reflux
466637|NCT00061737|Pediatric IBD|pediatric ibd
466638|NCT00061737|Inflammatory|inflammatory
466639|NCT00061737|Bowel|bowel
466640|NCT00061750|Thalassemia, iron overload, deferoxamine, hemosiderosis|thalassemia, iron overload, deferoxamine, hemosiderosis
466641|NCT00061763|beta-thalassemia|beta-thalassemia
466642|NCT00061763|iron overload|iron overload
466643|NCT00061763|deferoxamine|deferoxamine
466644|NCT00061763|Myelodysplastic Syndromes|myelodysplastic syndromes
466645|NCT00061763|Fanconi Syndrome|fanconi syndrome
466646|NCT00061763|Anemia, Diamond-Blackfan|anemia, diamond-blackfan
466647|NCT00061763|Anemia, Aplastic|anemia, aplastic
466648|NCT00061776|Dermal assessment|dermal assessment
466649|NCT00061776|Pain measurement|pain measurement
466650|NCT00061776|Diary|diary
466651|NCT00061776|Shingles|shingles
466652|NCT00061776|Neuropathy|neuropathy
466653|NCT00061776|Analgesics/*therapeutic use|analgesics/*therapeutic use
466654|NCT00061776|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
478877|NCT00094068|MS|ms
466655|NCT00061776|Herpes Zoster/*complications/drug therapy|herpes zoster/*complications/drug therapy
466656|NCT00061776|Neuralgia/*drug therapy/etiology|neuralgia/*drug therapy/etiology
466657|NCT00061776|Pain|pain
466658|NCT00061776|Peripheral Nervous System Diseases/*complications|peripheral nervous system diseases/*complications
466659|NCT00061789|Schizophrenia|schizophrenia
466660|NCT00061789|SPECT|spect
466661|NCT00061789|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
466662|NCT00061789|Cigarette Smoking|cigarette smoking
466663|NCT00061789|Cognitive Dysfunction|cognitive dysfunction
466664|NCT00061789|Reproducibility|reproducibility
466665|NCT00061789|Quantification|quantification
466666|NCT00061789|Healthy Volunteer|healthy volunteer
466667|NCT00061789|HV|hv
466668|NCT00061854|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
466669|NCT00061854|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
466670|NCT00061854|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
466671|NCT00061854|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
466672|NCT00061867|adenocarcinoma of the prostate|adenocarcinoma of the prostate
466673|NCT00061867|stage III prostate cancer|stage iii prostate cancer
466674|NCT00061867|stage IV prostate cancer|stage iv prostate cancer
466675|NCT00061880|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
466676|NCT00061880|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
466677|NCT00061880|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
466678|NCT00061880|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
466679|NCT00061880|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
466680|NCT00061880|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
466681|NCT00061880|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
466682|NCT00061880|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
466683|NCT00061880|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
465902|NCT00050414|Ovarian cancer|ovarian cancer
466684|NCT00061880|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
466685|NCT00061893|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
466686|NCT00061906|insular thyroid cancer|insular thyroid cancer
466687|NCT00061906|recurrent thyroid cancer|recurrent thyroid cancer
466688|NCT00061906|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
583615|NCT00512395|pain score|pain score
466689|NCT00061906|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
466690|NCT00061906|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
466691|NCT00061906|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
466692|NCT00061919|extensive stage small cell lung cancer|extensive stage small cell lung cancer
466693|NCT00061919|limited stage small cell lung cancer|limited stage small cell lung cancer
466694|NCT00061984|adult angiosarcoma|adult angiosarcoma
466695|NCT00061984|adult epithelioid sarcoma|adult epithelioid sarcoma
466696|NCT00061984|adult fibrosarcoma|adult fibrosarcoma
466697|NCT00061984|adult leiomyosarcoma|adult leiomyosarcoma
466698|NCT00061984|adult liposarcoma|adult liposarcoma
466699|NCT00061984|adult rhabdomyosarcoma|adult rhabdomyosarcoma
466700|NCT00061984|adult synovial sarcoma|adult synovial sarcoma
466701|NCT00061984|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
466702|NCT00061984|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
466703|NCT00061984|adult neurofibrosarcoma|adult neurofibrosarcoma
466704|NCT00061984|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
466705|NCT00061984|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
466706|NCT00061997|non-small cell lung cancer|non-small cell lung cancer
466707|NCT00061997|small cell lung cancer|small cell lung cancer
466708|NCT00061997|precancerous condition|precancerous condition
466709|NCT00062010|recurrent small cell lung cancer|recurrent small cell lung cancer
466710|NCT00062023|colorectal cancer|colorectal cancer
466711|NCT00062023|stage I colon cancer|stage i colon cancer
466712|NCT00062023|stage II colon cancer|stage ii colon cancer
466713|NCT00062023|stage III colon cancer|stage iii colon cancer
466714|NCT00062023|stage IV colon cancer|stage iv colon cancer
466715|NCT00062036|stage IV melanoma|stage iv melanoma
466716|NCT00062036|recurrent melanoma|recurrent melanoma
466717|NCT00062049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
466718|NCT00062062|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
466719|NCT00062062|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
466720|NCT00062114|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
466721|NCT00062114|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
466722|NCT00062114|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
466723|NCT00062140|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
466724|NCT00062140|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
466725|NCT00062140|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
466726|NCT00062140|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
478881|NCT00094081|oropharynx|oropharynx
466727|NCT00062140|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
466728|NCT00062140|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
466729|NCT00062140|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
466730|NCT00062140|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
466731|NCT00062140|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
466732|NCT00062140|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
466733|NCT00062140|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
466734|NCT00062140|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
466735|NCT00062140|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
466736|NCT00062140|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
466737|NCT00062140|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
466738|NCT00062140|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
466739|NCT00062140|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
466740|NCT00062140|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
466741|NCT00062140|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
466742|NCT00062140|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
466743|NCT00062140|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
466744|NCT00062140|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
466745|NCT00062140|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
466746|NCT00062140|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
466747|NCT00062140|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
466748|NCT00062140|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
466002|NCT00050765|CABG|cabg
466749|NCT00062140|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
466750|NCT00062140|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
466751|NCT00062140|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
466752|NCT00062140|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
466753|NCT00062140|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
466754|NCT00062140|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
583616|NCT00512395|postoperative ileus|postoperative ileus
466755|NCT00062140|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
466756|NCT00062140|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
466757|NCT00062140|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
466758|NCT00062140|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
466759|NCT00062140|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
466760|NCT00062140|secondary acute myeloid leukemia|secondary acute myeloid leukemia
466761|NCT00062140|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
466762|NCT00062140|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
467365|NCT00054704|Glutamate Dysfunction|glutamate dysfunction
466763|NCT00062140|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
466764|NCT00062140|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
466765|NCT00062140|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
466766|NCT00062140|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
466767|NCT00062140|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
466768|NCT00062140|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
466769|NCT00062140|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
466770|NCT00062140|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
466771|NCT00062140|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
466772|NCT00062140|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
466773|NCT00062140|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
466774|NCT00062140|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
466775|NCT00062140|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
466776|NCT00062140|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
466777|NCT00062140|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
466778|NCT00062140|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
466779|NCT00062140|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
466780|NCT00062140|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
466781|NCT00062140|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
466782|NCT00062140|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
466783|NCT00062140|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
466784|NCT00062140|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
466785|NCT00062140|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
478882|NCT00094081|oral cavity|oral cavity
466786|NCT00062140|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
466787|NCT00062140|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
466788|NCT00062140|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
466789|NCT00062140|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
466790|NCT00062140|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
466791|NCT00062140|splenic marginal zone lymphoma|splenic marginal zone lymphoma
466792|NCT00062140|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
466793|NCT00062140|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
466794|NCT00062140|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
466795|NCT00062140|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
466796|NCT00062140|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
466797|NCT00062166|Imaging Studies|imaging studies
466798|NCT00062166|Rate of Tumor Growth|rate of tumor growth
466799|NCT00062166|Familial Cancer Syndrome|familial cancer syndrome
466800|NCT00062166|Surgical Resection|surgical resection
466801|NCT00062179|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
466802|NCT00062205|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
466804|NCT00062231|neutropenia|neutropenia
466805|NCT00062231|fever, sweats, and hot flashes|fever, sweats, and hot flashes
466806|NCT00062231|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
466807|NCT00062231|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
466808|NCT00062231|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
466809|NCT00062231|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
466810|NCT00062231|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
466811|NCT00062231|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
466812|NCT00062231|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
466813|NCT00062231|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
466814|NCT00062231|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
583719|NCT00506467|Vibration Response Imaging|vibration response imaging
466815|NCT00062231|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
466816|NCT00062231|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
466817|NCT00062231|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
466818|NCT00062231|isolated plasmacytoma of bone|isolated plasmacytoma of bone
466819|NCT00062231|extramedullary plasmacytoma|extramedullary plasmacytoma
466820|NCT00062231|refractory multiple myeloma|refractory multiple myeloma
466821|NCT00062231|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
466822|NCT00062231|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
466823|NCT00062231|stage I multiple myeloma|stage i multiple myeloma
466824|NCT00062231|stage II multiple myeloma|stage ii multiple myeloma
466825|NCT00062231|stage III multiple myeloma|stage iii multiple myeloma
466826|NCT00062231|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
466827|NCT00062231|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
466828|NCT00062231|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
466829|NCT00062231|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
466830|NCT00062231|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
466831|NCT00062231|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
466832|NCT00062231|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
466833|NCT00062231|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
466834|NCT00062231|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
467088|NCT00062465|DMARD|dmard
466835|NCT00062231|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
466836|NCT00062231|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
466837|NCT00062231|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
466838|NCT00062231|polycythemia vera|polycythemia vera
466839|NCT00062231|primary myelofibrosis|primary myelofibrosis
466840|NCT00062231|essential thrombocythemia|essential thrombocythemia
466841|NCT00062231|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
466842|NCT00062231|refractory hairy cell leukemia|refractory hairy cell leukemia
466843|NCT00062231|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
466844|NCT00062231|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
466845|NCT00062231|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
466846|NCT00062231|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
466847|NCT00062231|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
466848|NCT00062231|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
466849|NCT00062231|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
466850|NCT00062231|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
478883|NCT00094081|larynx|larynx
466851|NCT00062231|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
466852|NCT00062231|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
466853|NCT00062231|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
466854|NCT00062231|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
466855|NCT00062231|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
466856|NCT00062231|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
466857|NCT00062231|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
466858|NCT00062231|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
466859|NCT00062231|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
466860|NCT00062231|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
466861|NCT00062231|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
466862|NCT00062231|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
466863|NCT00062231|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
466864|NCT00062231|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
466865|NCT00062231|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
466866|NCT00062231|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
466867|NCT00062231|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
466868|NCT00062231|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
466869|NCT00062231|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
466870|NCT00062231|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
466871|NCT00062231|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
466872|NCT00062231|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
466873|NCT00062231|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
466874|NCT00062231|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
583720|NCT00506467|VRI|vri
583721|NCT00506480|Embryo Implantation|embryo implantation
466875|NCT00062231|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
466876|NCT00062231|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
466877|NCT00062231|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
466878|NCT00062231|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
466879|NCT00062231|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
466880|NCT00062231|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
466881|NCT00062231|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
466882|NCT00062231|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
466883|NCT00062231|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
466884|NCT00062231|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
466885|NCT00062231|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
466886|NCT00062231|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
466887|NCT00062231|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
466888|NCT00062231|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
466889|NCT00062231|acute undifferentiated leukemia|acute undifferentiated leukemia
466890|NCT00062231|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
466891|NCT00062231|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
466892|NCT00062231|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
466893|NCT00062231|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
466894|NCT00062231|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
466895|NCT00062231|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
466896|NCT00062231|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
466897|NCT00062231|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
466898|NCT00062231|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
466899|NCT00062231|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
466900|NCT00062231|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
466901|NCT00062231|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
466902|NCT00062231|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
466903|NCT00062231|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
466904|NCT00062231|prolymphocytic leukemia|prolymphocytic leukemia
466905|NCT00062231|primary systemic amyloidosis|primary systemic amyloidosis
466906|NCT00062231|intraocular lymphoma|intraocular lymphoma
466907|NCT00062231|stage I mantle cell lymphoma|stage i mantle cell lymphoma
466908|NCT00062231|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
466909|NCT00062231|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
466910|NCT00062231|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
466911|NCT00062231|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
466912|NCT00062231|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
466913|NCT00062231|anaplastic large cell lymphoma|anaplastic large cell lymphoma
466914|NCT00062231|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
466915|NCT00062231|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
466916|NCT00062231|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
466917|NCT00062231|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
466918|NCT00062231|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
466919|NCT00062231|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
466920|NCT00062231|chronic eosinophilic leukemia|chronic eosinophilic leukemia
466921|NCT00062231|chronic neutrophilic leukemia|chronic neutrophilic leukemia
466922|NCT00062231|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
466923|NCT00062231|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
466924|NCT00062231|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
466925|NCT00062231|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
466926|NCT00062231|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
466927|NCT00062231|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
466928|NCT00062231|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
88713|NCT02732990|One-legged exercise|one-legged exercise
466319|NCT00060684|Rituxan|rituxan
466929|NCT00062231|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
466930|NCT00062231|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
466931|NCT00062231|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
466932|NCT00062231|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
466933|NCT00062231|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
466934|NCT00062231|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
466935|NCT00062231|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
466936|NCT00062231|splenic marginal zone lymphoma|splenic marginal zone lymphoma
466937|NCT00062231|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
466938|NCT00062231|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
466939|NCT00062231|stage I marginal zone lymphoma|stage i marginal zone lymphoma
466940|NCT00062231|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
466941|NCT00062231|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
466942|NCT00062231|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
466943|NCT00062231|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
466944|NCT00062231|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
466945|NCT00062231|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
466946|NCT00062231|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
467366|NCT00054704|Bipolar Mood Disorder|bipolar mood disorder
466947|NCT00062231|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
466948|NCT00062231|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
466949|NCT00062231|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
466950|NCT00062257|recurrent gastric cancer|recurrent gastric cancer
466951|NCT00062257|stage IV gastric cancer|stage iv gastric cancer
466952|NCT00062257|adenocarcinoma of the stomach|adenocarcinoma of the stomach
466953|NCT00062270|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
466954|NCT00062270|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
466955|NCT00062283|advanced malignant mesothelioma|advanced malignant mesothelioma
466956|NCT00062283|recurrent malignant mesothelioma|recurrent malignant mesothelioma
466957|NCT00062283|metastatic osteosarcoma|metastatic osteosarcoma
466958|NCT00062283|recurrent osteosarcoma|recurrent osteosarcoma
466959|NCT00062283|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
466960|NCT00062283|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
466961|NCT00062283|chondrosarcoma|chondrosarcoma
466962|NCT00062283|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
466963|NCT00062283|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
466964|NCT00062283|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
466965|NCT00062283|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
466966|NCT00062283|recurrent pancreatic cancer|recurrent pancreatic cancer
466967|NCT00062283|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
466968|NCT00062283|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
466969|NCT00062283|stage IV pancreatic cancer|stage iv pancreatic cancer
466970|NCT00062296|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
466971|NCT00062296|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
466972|NCT00062296|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
466973|NCT00062296|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
466974|NCT00062296|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
466975|NCT00062296|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
466976|NCT00062296|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
466977|NCT00062296|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
466978|NCT00062296|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
466979|NCT00062296|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
466980|NCT00062296|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
466981|NCT00062296|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
466982|NCT00062296|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
466983|NCT00062296|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
466984|NCT00062296|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
466985|NCT00062296|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
466986|NCT00062296|splenic marginal zone lymphoma|splenic marginal zone lymphoma
466987|NCT00062309|stage II prostate cancer|stage ii prostate cancer
466988|NCT00062309|stage III prostate cancer|stage iii prostate cancer
466989|NCT00062309|adenocarcinoma of the prostate|adenocarcinoma of the prostate
466990|NCT00062322|limited stage small cell lung cancer|limited stage small cell lung cancer
466412|NCT00060944|Cancer|cancer
466991|NCT00062335|stage I non-small cell lung cancer|stage i non-small cell lung cancer
466992|NCT00062335|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
466993|NCT00062335|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
466994|NCT00062348|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
466995|NCT00062348|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
466996|NCT00062348|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
466997|NCT00062348|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
583723|NCT00506480|endometrial implantation|endometrial implantation
466998|NCT00062348|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
466999|NCT00062348|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
467000|NCT00062348|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
467001|NCT00062348|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
467002|NCT00062348|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
467003|NCT00062348|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
467004|NCT00062348|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
467005|NCT00062348|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
467006|NCT00062348|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
467007|NCT00062348|recurrent thyroid cancer|recurrent thyroid cancer
467008|NCT00062348|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
467009|NCT00062348|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
467010|NCT00062348|stage IVA colon cancer|stage iva colon cancer
467011|NCT00062348|stage IVB colon cancer|stage ivb colon cancer
467012|NCT00062348|recurrent colon cancer|recurrent colon cancer
467013|NCT00062348|adenocarcinoma of the colon|adenocarcinoma of the colon
467014|NCT00062348|recurrent rectal cancer|recurrent rectal cancer
467015|NCT00062348|stage IVA rectal cancer|stage iva rectal cancer
467016|NCT00062348|stage IVB rectal cancer|stage ivb rectal cancer
467017|NCT00062348|adenocarcinoma of the rectum|adenocarcinoma of the rectum
467018|NCT00062348|anaplastic thyroid cancer|anaplastic thyroid cancer
467019|NCT00062348|insular thyroid cancer|insular thyroid cancer
467020|NCT00062348|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
467021|NCT00062348|liver metastases|liver metastases
467022|NCT00062348|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
467023|NCT00062348|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
467024|NCT00062348|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
467025|NCT00062348|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
467026|NCT00062348|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
467027|NCT00062348|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
467028|NCT00062348|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
467029|NCT00062348|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
467030|NCT00062348|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
467031|NCT00062348|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
467032|NCT00062348|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
467033|NCT00062348|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
467034|NCT00062348|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
467035|NCT00062348|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
467036|NCT00062348|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
467037|NCT00062348|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
467038|NCT00062348|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
467039|NCT00062348|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
467040|NCT00062348|stage I papillary thyroid cancer|stage i papillary thyroid cancer
467041|NCT00062348|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
467042|NCT00062348|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
467043|NCT00062348|stage I follicular thyroid cancer|stage i follicular thyroid cancer
467044|NCT00062348|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
467045|NCT00062348|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
467046|NCT00062348|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
466511|NCT00061204|Healthy Volunteer|healthy volunteer
466512|NCT00061204|HV|hv
466513|NCT00061217|Transtibial amputees|transtibial amputees
466514|NCT00061217|Rectified sockets|rectified sockets
467047|NCT00062348|recurrent salivary gland cancer|recurrent salivary gland cancer
467048|NCT00062348|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
467049|NCT00062348|stage I salivary gland cancer|stage i salivary gland cancer
467050|NCT00062348|stage II salivary gland cancer|stage ii salivary gland cancer
467051|NCT00062348|stage III salivary gland cancer|stage iii salivary gland cancer
467052|NCT00062348|stage IV salivary gland cancer|stage iv salivary gland cancer
467053|NCT00062348|tongue cancer|tongue cancer
467054|NCT00062387|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
467055|NCT00062387|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
467056|NCT00062387|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
467057|NCT00062387|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
467058|NCT00062387|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
467059|NCT00062387|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
467060|NCT00062387|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
467061|NCT00062387|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
467062|NCT00062387|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
467063|NCT00062387|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
467064|NCT00062387|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
467065|NCT00062387|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
467066|NCT00062387|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
467067|NCT00062387|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
467068|NCT00062387|recurrent salivary gland cancer|recurrent salivary gland cancer
467069|NCT00062387|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
467070|NCT00062387|stage IV salivary gland cancer|stage iv salivary gland cancer
467071|NCT00062400|sexual dysfunction and infertility|sexual dysfunction and infertility
467072|NCT00062400|sexuality and reproductive issues|sexuality and reproductive issues
467073|NCT00062400|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
467074|NCT00062400|stage II breast cancer|stage ii breast cancer
467075|NCT00062400|stage IA breast cancer|stage ia breast cancer
467076|NCT00062400|stage IB breast cancer|stage ib breast cancer
467077|NCT00062426|adenocarcinoma of the colon|adenocarcinoma of the colon
467078|NCT00062426|adenocarcinoma of the rectum|adenocarcinoma of the rectum
467079|NCT00062426|recurrent colon cancer|recurrent colon cancer
467080|NCT00062426|stage IV colon cancer|stage iv colon cancer
467081|NCT00062426|recurrent rectal cancer|recurrent rectal cancer
467082|NCT00062426|stage IV rectal cancer|stage iv rectal cancer
467083|NCT00062439|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
467084|NCT00062439|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
467085|NCT00062439|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
467086|NCT00062452|Esophageal|esophageal
467089|NCT00062465|Clinical Trial|clinical trial
467090|NCT00062465|Thunder God Vine|thunder god vine
467091|NCT00062465|Chinese Herb|chinese herb
467092|NCT00062465|Rheumatoid Arthritis|rheumatoid arthritis
467094|NCT00062517|Amygdala|amygdala
467095|NCT00062517|Generalized Anxiety Disorder|generalized anxiety disorder
467096|NCT00062517|Anxiety Disorder|anxiety disorder
467098|NCT00062517|Social Anxiety Disorder|social anxiety disorder
467099|NCT00062517|SAD|sad
467100|NCT00062530|AIDS|aids
467101|NCT00062530|HIV seronegativity|hiv seronegativity
467102|NCT00062530|HIV preventive vaccine|hiv preventive vaccine
467103|NCT00062543|Severe hepatic dysfunction post stem cell transplantation|severe hepatic dysfunction post stem cell transplantation
467104|NCT00062543|Stem Cell Transplantation|stem cell transplantation
467105|NCT00062543|Hepatic Artery Infusion|hepatic artery infusion
467106|NCT00062543|Liver Diseases|liver diseases
467107|NCT00062543|CD34+ Cells|cd34+ cells
467108|NCT00062543|SCT|sct
467109|NCT00062556|Intermittent Claudication|intermittent claudication
467110|NCT00062556|Peripheral Arterial Disease|peripheral arterial disease
467111|NCT00062556|Atherosclerosis|atherosclerosis
467112|NCT00062556|Niacin|niacin
467113|NCT00062556|Lovastatin|lovastatin
467114|NCT00062556|PAD|pad
467115|NCT00062556|IC|ic
467116|NCT00062569|Alzheimer disease|alzheimer disease
467117|NCT00062569|Resistiveness to baths|resistiveness to baths
467118|NCT00062569|Caregiver stress|caregiver stress
467119|NCT00062569|Bathing support intervention|bathing support intervention
467120|NCT00062569|Reminiscence|reminiscence
467121|NCT00062569|Agitated behavior|agitated behavior
467122|NCT00062569|Resistiveness to care|resistiveness to care
467123|NCT00062582|Roflumilast|roflumilast
467124|NCT00062582|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
467125|NCT00062582|COPD|copd
467126|NCT00062595|Menopause|menopause
467127|NCT00062595|Vitamin K|vitamin k
467129|NCT00062595|Bone Density|bone density
467130|NCT00062608|Abdominal|abdominal
467131|NCT00062621|Immune tolerance|immune tolerance
467132|NCT00062621|Graft vs host disease|graft vs host disease
467133|NCT00062621|Kidney Failure|kidney failure
467134|NCT00062621|Kidney diseases|kidney diseases
467135|NCT00062621|End Stage Renal Disease|end stage renal disease
467136|NCT00062621|Multiple Myeloma|multiple myeloma
467137|NCT00062621|Bone Marrow Transplant|bone marrow transplant
467138|NCT00062621|Kidney Transplant|kidney transplant
467139|NCT00062621|Renal Transplant|renal transplant
467140|NCT00062621|Tolerance|tolerance
467142|NCT00062621|ESRD|esrd
467143|NCT00062634|Female condom use|female condom use
467144|NCT00062634|Male condom use|male condom use
467145|NCT00062634|AIDS education|aids education
467146|NCT00062634|AIDS prevention|aids prevention
467147|NCT00062634|HIV Seronegativity|hiv seronegativity
467148|NCT00062686|Lapatinib|lapatinib
467149|NCT00062686|Metastatic Breast Cancer|metastatic breast cancer
467150|NCT00062686|HERCEPTIN refractory|herceptin refractory
467151|NCT00062712|Immunosuppression|immunosuppression
467152|NCT00062712|Transplant|transplant
467153|NCT00062712|Kidney Transplant|kidney transplant
467154|NCT00062738|Parkinson's disease|parkinson's disease
467155|NCT00062738|Parkinson disease|parkinson disease
467156|NCT00062738|depression|depression
467157|NCT00062738|antidepressants|antidepressants
467158|NCT00062738|nortriptyline|nortriptyline
467159|NCT00062738|paroxetine|paroxetine
467160|NCT00062751|breast|breast
467161|NCT00062751|neoplasms|neoplasms
467162|NCT00062764|Insulin Resistance|insulin resistance
467163|NCT00062764|Obesity|obesity
467164|NCT00062764|Fatty Liver|fatty liver
467165|NCT00062764|Cirrhosis|cirrhosis
467166|NCT00062764|Diabetes|diabetes
467167|NCT00062764|Pioglitazone|pioglitazone
467168|NCT00062764|Thiazolidinediones|thiazolidinediones
467169|NCT00062764|Peroxisome Proliferator-Advanced Receptor Gamma|peroxisome proliferator-advanced receptor gamma
467170|NCT00062764|PPAR Gama|ppar gama
467171|NCT00062764|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
467172|NCT00062764|Hepatitis|hepatitis
467173|NCT00062764|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
467174|NCT00062764|NASH|nash
467175|NCT00062777|Genetics|genetics
467176|NCT00062777|Populations|populations
467177|NCT00062777|CVD Risk|cvd risk
467178|NCT00062777|Gene Mapping|gene mapping
467179|NCT00062777|Epidemiology|epidemiology
467180|NCT00062777|Framingham Study|framingham study
467181|NCT00062777|Vascular Diseases|vascular diseases
467182|NCT00062790|Testosterone|testosterone
467183|NCT00062790|DHT|dht
467184|NCT00062790|TURP|turp
467185|NCT00062816|Hepatitis|hepatitis
467186|NCT00062816|Chronic|chronic
467187|NCT00062829|Teen driving|teen driving
467188|NCT00062829|Adolescent risk behavior|adolescent risk behavior
467189|NCT00062829|Parenting|parenting
467190|NCT00062829|Checkpoints Program|checkpoints program
467191|NCT00062829|Health Education|health education
467205|NCT00062894|Iodine I 131 Tositumomab|iodine i 131 tositumomab
467206|NCT00062894|BEXXAR|bexxar
467207|NCT00062894|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
467208|NCT00054249|recurrent gastric cancer|recurrent gastric cancer
467209|NCT00054262|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
467210|NCT00054262|advanced adult primary liver cancer|advanced adult primary liver cancer
467211|NCT00054262|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
467212|NCT00054275|recurrent breast cancer|recurrent breast cancer
467213|NCT00054275|stage IV breast cancer|stage iv breast cancer
467214|NCT00054275|male breast cancer|male breast cancer
467215|NCT00054288|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
467216|NCT00054301|stage I breast cancer|stage i breast cancer
467217|NCT00054301|stage II breast cancer|stage ii breast cancer
467218|NCT00054301|stage IIIA breast cancer|stage iiia breast cancer
467375|NCT00054743|Population Pharmacokinetics|population pharmacokinetics
467219|NCT00054301|ductal breast carcinoma in situ|ductal breast carcinoma in situ
467220|NCT00054301|breast cancer in situ|breast cancer in situ
467221|NCT00054314|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
467222|NCT00054327|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
467223|NCT00054327|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
467224|NCT00054327|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
467225|NCT00054327|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
467226|NCT00054327|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
467227|NCT00054327|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
467228|NCT00054327|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
467229|NCT00054327|refractory anemia with excess blasts|refractory anemia with excess blasts
467230|NCT00054327|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
467231|NCT00054327|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
467235|NCT00054327|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
467236|NCT00054327|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
467237|NCT00054327|secondary acute myeloid leukemia|secondary acute myeloid leukemia
467238|NCT00054327|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
467239|NCT00054327|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
467240|NCT00054327|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
467241|NCT00054327|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
467242|NCT00054327|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
467243|NCT00054327|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
467244|NCT00054327|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
467245|NCT00054327|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
467247|NCT00054327|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
467248|NCT00054327|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
467249|NCT00054327|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
467250|NCT00054327|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
467251|NCT00054327|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
467252|NCT00054327|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
467253|NCT00054327|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
467254|NCT00054327|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
467255|NCT00054327|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
467256|NCT00054327|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
467257|NCT00054327|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
467258|NCT00054327|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
467259|NCT00054327|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
467260|NCT00054327|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
467261|NCT00054327|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
467262|NCT00054327|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
467263|NCT00054340|graft versus host disease|graft versus host disease
467264|NCT00054340|polycythemia vera|polycythemia vera
467265|NCT00054340|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
467266|NCT00054340|essential thrombocythemia|essential thrombocythemia
467267|NCT00054340|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
467268|NCT00054340|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
467269|NCT00054340|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
467270|NCT00054340|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
467271|NCT00054340|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
467272|NCT00054340|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
467273|NCT00054340|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
467274|NCT00054340|chronic eosinophilic leukemia|chronic eosinophilic leukemia
467275|NCT00054340|chronic neutrophilic leukemia|chronic neutrophilic leukemia
467276|NCT00054340|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
467277|NCT00054340|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
467278|NCT00054340|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
467279|NCT00054340|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
467280|NCT00054340|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
467281|NCT00054340|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
467282|NCT00054340|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
467283|NCT00054392|adenosquamous cell lung cancer|adenosquamous cell lung cancer
467284|NCT00054392|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
467285|NCT00054392|large cell lung cancer|large cell lung cancer
467286|NCT00054392|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
467287|NCT00054392|squamous cell lung cancer|squamous cell lung cancer
467288|NCT00054392|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
467289|NCT00054392|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
467290|NCT00054392|adenocarcinoma of the lung|adenocarcinoma of the lung
467291|NCT00054418|osteoporosis|osteoporosis
467292|NCT00054418|stage I breast cancer|stage i breast cancer
467293|NCT00054418|stage II breast cancer|stage ii breast cancer
467294|NCT00054418|stage IIIA breast cancer|stage iiia breast cancer
467295|NCT00054418|stage IIIB breast cancer|stage iiib breast cancer
467296|NCT00054457|adenocarcinoma of the stomach|adenocarcinoma of the stomach
467297|NCT00054457|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
467298|NCT00054457|stage IV gastric cancer|stage iv gastric cancer
467299|NCT00054457|recurrent gastric cancer|recurrent gastric cancer
467300|NCT00054457|stage IV esophageal cancer|stage iv esophageal cancer
467301|NCT00054457|recurrent esophageal cancer|recurrent esophageal cancer
467302|NCT00054470|stage IV breast cancer|stage iv breast cancer
467303|NCT00054470|recurrent breast cancer|recurrent breast cancer
467305|NCT00054496|adult glioblastoma|adult glioblastoma
467306|NCT00054496|recurrent adult brain tumor|recurrent adult brain tumor
467307|NCT00054496|adult giant cell glioblastoma|adult giant cell glioblastoma
467308|NCT00054496|adult gliosarcoma|adult gliosarcoma
467309|NCT00054522|adenocarcinoma of the prostate|adenocarcinoma of the prostate
467310|NCT00054522|recurrent prostate cancer|recurrent prostate cancer
467311|NCT00054535|stage IV melanoma|stage iv melanoma
467312|NCT00054535|recurrent melanoma|recurrent melanoma
467313|NCT00054561|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
467314|NCT00054561|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
467315|NCT00054561|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
467316|NCT00054561|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
467317|NCT00054561|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
467318|NCT00054561|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
467319|NCT00054561|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
467320|NCT00054561|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
467321|NCT00054574|recurrent prostate cancer|recurrent prostate cancer
467322|NCT00054574|stage I prostate cancer|stage i prostate cancer
467323|NCT00054574|stage II prostate cancer|stage ii prostate cancer
467324|NCT00054574|stage III prostate cancer|stage iii prostate cancer
467325|NCT00054587|stage II breast cancer|stage ii breast cancer
467326|NCT00054587|stage IIIA breast cancer|stage iiia breast cancer
467327|NCT00054600|Extracorporeal Photopheresis|extracorporeal photopheresis
467328|NCT00054600|Graft-versus-Host Disease|graft-versus-host disease
467329|NCT00054613|Graft-versus-Host Disease|graft-versus-host disease
467330|NCT00054613|Extracorporeal Photopheresis|extracorporeal photopheresis
467331|NCT00054626|stage II bladder cancer|stage ii bladder cancer
467332|NCT00054626|stage III bladder cancer|stage iii bladder cancer
467333|NCT00054626|stage IV bladder cancer|stage iv bladder cancer
467437|NCT00054912|Colon Cancer|colon cancer
467334|NCT00054626|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
467335|NCT00054652|Geste Antagoniste|geste antagoniste
467337|NCT00054652|Sensorimotor Integration|sensorimotor integration
467338|NCT00054652|Writer's Cramp|writer's cramp
467339|NCT00054652|Sensory Input|sensory input
467340|NCT00054652|Focal Dystonia|focal dystonia
467341|NCT00054665|BCL-2|bcl-2
467342|NCT00054665|NFK-B|nfk-b
467343|NCT00054665|Drug Resistance|drug resistance
467344|NCT00054665|Translational|translational
467345|NCT00054665|Lymphoma|lymphoma
467346|NCT00054665|Large B-Cell Lymphoma|large b-cell lymphoma
467347|NCT00054678|Myocardial infarction|myocardial infarction
467348|NCT00054678|Heart disease|heart disease
467349|NCT00054678|Endoventricular|endoventricular
467350|NCT00054678|Cardiovascular|cardiovascular
467351|NCT00054678|Interventional|interventional
467352|NCT00054678|ICD|icd
467353|NCT00054678|Heart failure|heart failure
467354|NCT00054678|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
467355|NCT00054691|Skin Cancer|skin cancer
467356|NCT00054691|Squamous Cell Carcinoma of the Skin|squamous cell carcinoma of the skin
467357|NCT00054691|Gefitinib|gefitinib
467358|NCT00054691|ZD1839|zd1839
467359|NCT00054691|Iressa|iressa
467360|NCT00054691|Epidermal Growth Factor Receptor|epidermal growth factor receptor
467361|NCT00054691|EGFR|egfr
467362|NCT00054704|Riluzole|riluzole
467363|NCT00054704|Neuroprotective|neuroprotective
467364|NCT00054704|Open-Label Study|open-label study
467367|NCT00054704|Bipolar Disorder|bipolar disorder
467368|NCT00054704|Mood Disorder|mood disorder
467369|NCT00054730|Fragile X Syndrome|fragile x syndrome
467370|NCT00054730|Autism|autism
467371|NCT00054743|Race|race
467372|NCT00054743|Ethnicity|ethnicity
467373|NCT00054743|Pharmacogenetics|pharmacogenetics
467374|NCT00054743|Cytochrome P450|cytochrome p450
467377|NCT00054756|Hypothalamic Releasing Factor|hypothalamic releasing factor
467378|NCT00054756|Neuropeptide|neuropeptide
467379|NCT00054756|Diagnostic Testing|diagnostic testing
467380|NCT00054756|Pituitary Tumors|pituitary tumors
467381|NCT00054756|Central Hypothyroidism|central hypothyroidism
467382|NCT00054756|Pituitary Disorder|pituitary disorder
467383|NCT00054756|Thyroid Disorder|thyroid disorder
467384|NCT00054756|Healthy Volunteer|healthy volunteer
467386|NCT00054769|Pediatrics|pediatrics
467387|NCT00054769|Polymerase Chain Reaction|polymerase chain reaction
467388|NCT00054795|Brain Neoplasms/radiotherapy|brain neoplasms/radiotherapy
467389|NCT00054795|Neoplasms/complications/prevention & control,|neoplasms/complications/prevention & control,
467390|NCT00054795|Neuropsychological Tests,|neuropsychological tests,
467391|NCT00054795|Metalloporphyrins/therapeutic use,|metalloporphyrins/therapeutic use,
467392|NCT00054795|Combined Modality Therapy,|combined modality therapy,
467393|NCT00054795|Drug therapy,|drug therapy,
467394|NCT00054795|Quality of Life,|quality of life,
467395|NCT00054795|Cranial Irradiation,|cranial irradiation,
467396|NCT00054795|Radiotherapy/Targeted,|radiotherapy/targeted,
467397|NCT00054795|Prospective Studies,|prospective studies,
467398|NCT00054795|Neoplasm Recurrence/Local,|neoplasm recurrence/local,
467399|NCT00054795|Treatment Outcome|treatment outcome
467400|NCT00054795|Brain metastases|brain metastases
467401|NCT00054795|Brain Neoplasms/secondary|brain neoplasms/secondary
467402|NCT00054795|Non-small cell lung cancer|non-small cell lung cancer
467403|NCT00054808|Gallium Nitrate|gallium nitrate
467405|NCT00054808|NHL|nhl
467406|NCT00054808|Relapsed|relapsed
467407|NCT00054821|Osteoarthritis, Ankle|osteoarthritis, ankle
467408|NCT00054821|Ankle Distraction|ankle distraction
467409|NCT00054847|CABG|cabg
467410|NCT00054847|cardiovascular|cardiovascular
467411|NCT00054847|chronic diseases|chronic diseases
467412|NCT00054847|clinical trial|clinical trial
467413|NCT00054847|heart|heart
467414|NCT00054847|multi-site trial|multi-site trial
467415|NCT00054847|prospective|prospective
467416|NCT00054860|HIV Preventive Vaccine|hiv preventive vaccine
467417|NCT00054860|HIV Seronegativity|hiv seronegativity
467418|NCT00054860|HIV-1|hiv-1
467419|NCT00054860|AIDS Vaccines|aids vaccines
467420|NCT00054860|Vaccines, DNA|vaccines, dna
467421|NCT00054860|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
467422|NCT00054860|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
467423|NCT00054860|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
467424|NCT00054860|Epitopes|epitopes
467425|NCT00054873|Adenocarcinoma of the esophagus or stomach|adenocarcinoma of the esophagus or stomach
467426|NCT00054899|vaccine|vaccine
467427|NCT00054899|lung|lung
467428|NCT00054899|cancer|cancer
467429|NCT00054899|Carcinoma, Large Cell|carcinoma, large cell
467430|NCT00054899|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
467431|NCT00054912|vaccine|vaccine
467432|NCT00054912|colon|colon
467433|NCT00054912|cancer|cancer
467434|NCT00054912|colorectal|colorectal
467435|NCT00054912|neoplasm|neoplasm
467436|NCT00054912|Colonic Cancer|colonic cancer
467438|NCT00054912|Cancer of the Colon|cancer of the colon
467439|NCT00054938|SLE|sle
467440|NCT00054938|Accelerated Atherosclerosis|accelerated atherosclerosis
467441|NCT00054938|Cholesterol|cholesterol
467442|NCT00054951|Hepatoma|hepatoma
467443|NCT00054951|Liver Cancer|liver cancer
467444|NCT00054977|cancer|cancer
467445|NCT00054977|tumor|tumor
467446|NCT00054990|Antiepileptic Drugs|antiepileptic drugs
467447|NCT00054990|Cortical Excitability|cortical excitability
467448|NCT00054990|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
467449|NCT00054990|Epilepsy|epilepsy
467450|NCT00054990|TMS|tms
467451|NCT00054990|Healthy Volunteer|healthy volunteer
467452|NCT00054990|HV|hv
467453|NCT00055003|Amygdala|amygdala
467454|NCT00055003|Medial Prefrontal Cortex|medial prefrontal cortex
467455|NCT00055003|Orbitofrontal Cortex|orbitofrontal cortex
467456|NCT00055003|Cortisol|cortisol
467457|NCT00055003|Memory|memory
467458|NCT00055003|Glucocorticoid|glucocorticoid
467459|NCT00055003|Hydrocortisone|hydrocortisone
467460|NCT00055003|Stress|stress
467461|NCT00055003|Perception|perception
467462|NCT00055003|Affect|affect
467463|NCT00055003|Healthy Volunteer|healthy volunteer
467464|NCT00055003|HV|hv
467465|NCT00055016|Lysosomal Disease|lysosomal disease
467466|NCT00055016|Renal Function|renal function
467467|NCT00055016|Stroke|stroke
467468|NCT00055016|Cardiac Disease|cardiac disease
467469|NCT00055016|Natural History|natural history
467470|NCT00055016|Fabry Disease|fabry disease
467471|NCT00055029|Retinoschisis|retinoschisis
467472|NCT00055029|Genomic DNA|genomic dna
467473|NCT00055029|Pedigree Analysis|pedigree analysis
467474|NCT00055029|Genetic Analysis|genetic analysis
467475|NCT00055029|Macular Degeneration|macular degeneration
467476|NCT00055029|Juvenile Retinoschisis|juvenile retinoschisis
467477|NCT00055029|X-Linked Juvenile Retinoschisis|x-linked juvenile retinoschisis
467478|NCT00055029|XLRS|xlrs
467479|NCT00055042|Types 1 and 2 Diabetes|types 1 and 2 diabetes
478884|NCT00094081|hypopharynx|hypopharynx
467480|NCT00055042|Diode Laser Photocoagulation|diode laser photocoagulation
467481|NCT00055042|Vitamin E|vitamin e
467482|NCT00055042|Elevated Low-Density Lipoprotein (LDL-C) Cholesterol|elevated low-density lipoprotein (ldl-c) cholesterol
467483|NCT00055042|Diabetes Type I|diabetes type i
467484|NCT00055042|Diabetes Type II|diabetes type ii
467485|NCT00055042|Diabetic Macular Edema|diabetic macular edema
467486|NCT00055055|Autoimmunity Pathogenesis|autoimmunity pathogenesis
467487|NCT00055055|Microarray Analyses|microarray analyses
467488|NCT00055055|Microchimerism|microchimerism
467489|NCT00055055|Genetic and Environmental Risk Factors|genetic and environmental risk factors
467490|NCT00055055|Adult and Pediatric Disease|adult and pediatric disease
467491|NCT00055055|Rheumatoid Arthritis|rheumatoid arthritis
467492|NCT00055055|Systemic Lupus Erythematosus|systemic lupus erythematosus
467493|NCT00055055|Systemic Sclerosis|systemic sclerosis
467494|NCT00055055|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
467495|NCT00055055|Inflammatory Myopathies|inflammatory myopathies
467496|NCT00055055|Dermatomyositis|dermatomyositis
467497|NCT00055055|Scleroderma|scleroderma
467499|NCT00055055|Lupus|lupus
467500|NCT00055055|Rheumatic Disease|rheumatic disease
467501|NCT00055055|RA|ra
467502|NCT00055055|Healthy Volunteer|healthy volunteer
467503|NCT00055055|HV|hv
467504|NCT00055081|Homeless Persons|homeless persons
467505|NCT00055094|Immune system|immune system
467506|NCT00055094|Helper T-Cells|helper t-cells
467507|NCT00055094|Acute Infection|acute infection
467508|NCT00055094|Treatment naive|treatment naive
467509|NCT00055107|Nitazoxanide|nitazoxanide
467510|NCT00055107|Antiprotozoal Agents|antiprotozoal agents
467511|NCT00055107|Cryptosporidiosis|cryptosporidiosis
467512|NCT00055107|Cryptosporidium parvum|cryptosporidium parvum
467513|NCT00055107|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
467514|NCT00055107|Pharmacokinetics|pharmacokinetics
467515|NCT00055107|Drug Adminstration Schedule|drug adminstration schedule
467516|NCT00055120|Anti-HIV Agents|anti-hiv agents
467517|NCT00055120|Disease Progression|disease progression
467518|NCT00055120|Drug Administration Schedule|drug administration schedule
467519|NCT00055120|Viral Load|viral load
467520|NCT00055120|HIV-1|hiv-1
467521|NCT00055120|Treatment Outcome|treatment outcome
467522|NCT00055120|Survival Analysis|survival analysis
467523|NCT00055120|Treatment Naive|treatment naive
467524|NCT00055133|rheumatoid arthritis|rheumatoid arthritis
467525|NCT00055133|Paxceed|paxceed
467526|NCT00055133|Micellar Paclitaxel|micellar paclitaxel
467527|NCT00055159|RT PA|rt pa
467528|NCT00055159|Blood Clots|blood clots
467529|NCT00055159|Catheter Directed Thrombolytic Therapy|catheter directed thrombolytic therapy
467530|NCT00055159|Alteplase|alteplase
467531|NCT00055159|Deep Vein Thrombosis|deep vein thrombosis
467532|NCT00055159|DVT|dvt
467533|NCT00055172|Cytokines|cytokines
467534|NCT00055172|Mutation|mutation
467535|NCT00055172|DNA|dna
467536|NCT00055172|Phenotype|phenotype
467537|NCT00055172|T Cell|t cell
467538|NCT00055172|Immunodeficiency|immunodeficiency
467539|NCT00055172|Inherited Immunodeficiency|inherited immunodeficiency
468185|NCT00064792|SLOS|slos
467540|NCT00055185|Treatment Experienced|treatment experienced
467541|NCT00055198|Gram positive bacterial infections|gram positive bacterial infections
467542|NCT00055198|expanded access program|expanded access program
467543|NCT00055198|resistant infections|resistant infections
467544|NCT00055198|bacteremia|bacteremia
467545|NCT00055198|Bacterial and fungal infections|bacterial and fungal infections
467546|NCT00055198|bacterial infections|bacterial infections
467547|NCT00055224|Anxiety Disorder|anxiety disorder
467548|NCT00055224|Fear|fear
467549|NCT00055224|Aversive Conditioning|aversive conditioning
467550|NCT00055224|Psychophysiology|psychophysiology
467551|NCT00055224|Predictability|predictability
467552|NCT00055224|Startle|startle
467553|NCT00055224|Context Conditioning|context conditioning
467554|NCT00055224|Fear Conditioning|fear conditioning
467555|NCT00055224|Agoraphobia|agoraphobia
467556|NCT00055224|Panic Disorder|panic disorder
467557|NCT00055224|Generalized Anxiety Disorder|generalized anxiety disorder
467558|NCT00055224|GAD|gad
467559|NCT00055224|Healthy Volunteer|healthy volunteer
467560|NCT00055224|HV|hv
467561|NCT00055237|Angiogenesis|angiogenesis
467562|NCT00055237|Cancer|cancer
467563|NCT00055237|HHV-8|hhv-8
467564|NCT00055237|KSHV|kshv
467565|NCT00055237|Skin|skin
467566|NCT00055237|Kaposi Sarcoma|kaposi sarcoma
467567|NCT00055237|KS|ks
467568|NCT00055263|advanced solid tumor malignancies|advanced solid tumor malignancies
467569|NCT00055289|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
467570|NCT00055289|Counting|counting
467571|NCT00055289|Sensorimotor Integration|sensorimotor integration
467572|NCT00055289|Superior Temporal Cortex|superior temporal cortex
467573|NCT00055289|Dorsal Premotor Cortex|dorsal premotor cortex
467574|NCT00055289|Healthy Volunteer|healthy volunteer
467575|NCT00055289|HV|hv
467576|NCT00055302|vaginal bleeding|vaginal bleeding
467577|NCT00055302|advanced bone age|advanced bone age
467578|NCT00055302|fibrous dysplasia|fibrous dysplasia
467580|NCT00055302|McCune-Albright Syndrome|mccune-albright syndrome
467581|NCT00055354|Acupuncture|acupuncture
467582|NCT00055354|Medicine, Chinese Traditional|medicine, chinese traditional
467583|NCT00055380|Molecular Targets|molecular targets
467584|NCT00055380|Keratinocytes|keratinocytes
467585|NCT00055380|Cell Cycle|cell cycle
467586|NCT00055380|Small Molecule|small molecule
467587|NCT00055380|Gene Expression|gene expression
467588|NCT00055380|Pharmacodynamics|pharmacodynamics
467589|NCT00055380|Surrogate Markers|surrogate markers
467590|NCT00055380|Targeted Therapy|targeted therapy
467591|NCT00055380|Buccal Mucosa|buccal mucosa
467592|NCT00055380|Pharmacogenomics|pharmacogenomics
467593|NCT00055380|Oral Mucosa|oral mucosa
467594|NCT00055419|Stage IV colorectal cancer|stage iv colorectal cancer
467595|NCT00055432|recurrent ovarian cancer|recurrent ovarian cancer
467596|NCT00055432|platinum-resistant|platinum-resistant
467597|NCT00055432|platinum-sensitive|platinum-sensitive
467598|NCT00055432|folate receptor antagonist|folate receptor antagonist
467599|NCT00055445|Complementary Therapies|complementary therapies
467600|NCT00055445|IdB 1016|idb 1016
467602|NCT00055445|Antioxidant|antioxidant
467603|NCT00055445|Hepatitis C Virus|hepatitis c virus
467604|NCT00055445|Phosphatidylcholine|phosphatidylcholine
467605|NCT00055471|prostate cancer|prostate cancer
467606|NCT00055471|Metastatic prostate cancer|metastatic prostate cancer
467607|NCT00055471|bone metastases|bone metastases
467608|NCT00055484|Migraine Headache|migraine headache
467609|NCT00055484|prophylaxis|prophylaxis
467610|NCT00055484|AED|aed
467611|NCT00055484|migraine prophylaxis|migraine prophylaxis
467612|NCT00055510|BO-653|bo-653
467613|NCT00055510|Coronary restenosis|coronary restenosis
467614|NCT00055510|Stent restenosis|stent restenosis
467615|NCT00055510|LDL oxidative inhibitor|ldl oxidative inhibitor
467616|NCT00055510|Antioxidant|antioxidant
467617|NCT00055549|Dextromethorphan|dextromethorphan
467618|NCT00055549|Sensorimotor Modulation|sensorimotor modulation
467619|NCT00055549|Spasmodic Dysphonia|spasmodic dysphonia
467620|NCT00055549|Muscular Tension Dysphonia|muscular tension dysphonia
467621|NCT00055549|Voice Tremor|voice tremor
467622|NCT00055549|Lorazepam|lorazepam
467623|NCT00055549|Dysphonia|dysphonia
467624|NCT00055549|Macular Tension Dysphonia|macular tension dysphonia
467625|NCT00055562|Metastatic Melanoma|metastatic melanoma
467626|NCT00055562|Metastatic Malignant Melanoma|metastatic malignant melanoma
467627|NCT00055562|Revimid|revimid
467628|NCT00055562|CC5013|cc5013
467629|NCT00055575|Scopolamine|scopolamine
467630|NCT00055575|Depression|depression
467631|NCT00055575|fMRI|fmri
467632|NCT00055575|Cognition|cognition
467633|NCT00055575|Emotion|emotion
467634|NCT00055575|Brain|brain
467635|NCT00055575|Bipolar Disorder|bipolar disorder
467636|NCT00055575|Major Depressive Disorder|major depressive disorder
467637|NCT00055575|MDD|mdd
467638|NCT00055575|Healthy Volunteer|healthy volunteer
467639|NCT00055575|HV|hv
467640|NCT00055588|Spinal Reflexes|spinal reflexes
467641|NCT00055588|Motor Practice|motor practice
483513|NCT00118586|HV|hv
467642|NCT00055588|Spinal Cord Injury|spinal cord injury
467643|NCT00055588|Locomotion|locomotion
467644|NCT00055588|Healthy Volunteer|healthy volunteer
467646|NCT00055601|stage II bladder cancer|stage ii bladder cancer
467647|NCT00055601|stage III bladder cancer|stage iii bladder cancer
467648|NCT00055614|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
467649|NCT00055614|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
467650|NCT00055614|fallopian tube cancer|fallopian tube cancer
467651|NCT00055614|primary peritoneal cavity cancer|primary peritoneal cavity cancer
467652|NCT00055640|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
467653|NCT00055640|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
467654|NCT00055640|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
467655|NCT00055640|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
467656|NCT00055640|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
467657|NCT00055653|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
467658|NCT00055653|refractory anemia with excess blasts|refractory anemia with excess blasts
467659|NCT00055653|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
467660|NCT00055653|refractory anemia|refractory anemia
467661|NCT00055653|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
467662|NCT00055653|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
467663|NCT00055653|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
467664|NCT00055653|secondary acute myeloid leukemia|secondary acute myeloid leukemia
467665|NCT00055653|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
467666|NCT00055653|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
467667|NCT00055653|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
467668|NCT00055653|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
467669|NCT00055653|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
467670|NCT00055653|acute undifferentiated leukemia|acute undifferentiated leukemia
467671|NCT00055653|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
467672|NCT00055653|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
467673|NCT00055653|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
467674|NCT00055653|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
467675|NCT00055653|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
583724|NCT00506480|Oocyte Donation|oocyte donation
467676|NCT00055653|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
467677|NCT00055653|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
467678|NCT00055653|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
467679|NCT00055653|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
467680|NCT00055653|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
467681|NCT00055653|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
467682|NCT00055666|graft versus host disease|graft versus host disease
467683|NCT00055679|stage I breast cancer|stage i breast cancer
467684|NCT00055705|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
467685|NCT00055705|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
467686|NCT00055705|fallopian tube cancer|fallopian tube cancer
467687|NCT00055705|primary peritoneal cavity cancer|primary peritoneal cavity cancer
467688|NCT00055705|recurrent colon cancer|recurrent colon cancer
467689|NCT00055705|stage IV colon cancer|stage iv colon cancer
467690|NCT00055705|ovarian sarcoma|ovarian sarcoma
467691|NCT00055705|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
467692|NCT00055705|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
467693|NCT00055705|recurrent endometrial carcinoma|recurrent endometrial carcinoma
467694|NCT00055705|stage IV endometrial carcinoma|stage iv endometrial carcinoma
467695|NCT00055705|recurrent uterine sarcoma|recurrent uterine sarcoma
467696|NCT00055705|stage IV uterine sarcoma|stage iv uterine sarcoma
467697|NCT00055705|ovarian stromal cancer|ovarian stromal cancer
467698|NCT00055705|recurrent rectal cancer|recurrent rectal cancer
467699|NCT00055705|stage IV rectal cancer|stage iv rectal cancer
467700|NCT00055705|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
467701|NCT00055705|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
467702|NCT00055705|gastrointestinal stromal tumor|gastrointestinal stromal tumor
467703|NCT00055705|advanced malignant mesothelioma|advanced malignant mesothelioma
467704|NCT00055705|recurrent malignant mesothelioma|recurrent malignant mesothelioma
467705|NCT00055705|recurrent gastric cancer|recurrent gastric cancer
467706|NCT00055705|stage IV gastric cancer|stage iv gastric cancer
467707|NCT00055705|carcinoma of the appendix|carcinoma of the appendix
467708|NCT00055705|small intestine adenocarcinoma|small intestine adenocarcinoma
467709|NCT00055705|small intestine leiomyosarcoma|small intestine leiomyosarcoma
467710|NCT00055705|small intestine lymphoma|small intestine lymphoma
467711|NCT00055705|recurrent small intestine cancer|recurrent small intestine cancer
467712|NCT00055705|recurrent gallbladder cancer|recurrent gallbladder cancer
467713|NCT00055705|unresectable gallbladder cancer|unresectable gallbladder cancer
467714|NCT00055705|advanced adult primary liver cancer|advanced adult primary liver cancer
467715|NCT00055705|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
467716|NCT00055705|recurrent adult primary liver cancer|recurrent adult primary liver cancer
467717|NCT00055718|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
467718|NCT00055718|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
467719|NCT00055731|stage III prostate cancer|stage iii prostate cancer
467720|NCT00055731|stage IIB prostate cancer|stage iib prostate cancer
467721|NCT00055731|stage IIA prostate cancer|stage iia prostate cancer
467722|NCT00055783|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
467723|NCT00055822|adenocarcinoma of the colon|adenocarcinoma of the colon
467724|NCT00055822|recurrent colon cancer|recurrent colon cancer
467725|NCT00055822|stage III colon cancer|stage iii colon cancer
467726|NCT00055822|stage IV colon cancer|stage iv colon cancer
467727|NCT00055822|adenocarcinoma of the rectum|adenocarcinoma of the rectum
467728|NCT00055822|recurrent rectal cancer|recurrent rectal cancer
467729|NCT00055822|stage III rectal cancer|stage iii rectal cancer
467730|NCT00055822|stage IV rectal cancer|stage iv rectal cancer
467731|NCT00055835|recurrent bladder cancer|recurrent bladder cancer
467732|NCT00055835|stage III bladder cancer|stage iii bladder cancer
467733|NCT00055835|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
467734|NCT00055835|stage II bladder cancer|stage ii bladder cancer
467735|NCT00055835|recurrent urethral cancer|recurrent urethral cancer
467736|NCT00055835|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
467737|NCT00055835|distal urethral cancer|distal urethral cancer
467738|NCT00055835|proximal urethral cancer|proximal urethral cancer
467739|NCT00055835|stage IV bladder cancer|stage iv bladder cancer
467740|NCT00055835|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
467741|NCT00055848|adenocarcinoma of the colon|adenocarcinoma of the colon
467742|NCT00055848|stage I colon cancer|stage i colon cancer
467743|NCT00055848|stage II colon cancer|stage ii colon cancer
467744|NCT00055848|stage III colon cancer|stage iii colon cancer
467745|NCT00055848|stage IV colon cancer|stage iv colon cancer
467746|NCT00055874|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
467747|NCT00055874|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
467748|NCT00055874|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
467749|NCT00055887|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
467750|NCT00055887|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
467751|NCT00055887|adenocarcinoma of the lung|adenocarcinoma of the lung
467752|NCT00055887|squamous cell lung cancer|squamous cell lung cancer
467753|NCT00055887|large cell lung cancer|large cell lung cancer
467754|NCT00062933|Clinical Response|clinical response
467755|NCT00062933|Duration of Response|duration of response
467756|NCT00062933|Quality of Life|quality of life
467757|NCT00062933|Hyperthermia|hyperthermia
467758|NCT00062933|Survival|survival
467759|NCT00062933|Melanoma|melanoma
467760|NCT00062933|Ocular Melanoma|ocular melanoma
467761|NCT00062933|Eye Cancer|eye cancer
467762|NCT00062946|Thalamus|thalamus
467763|NCT00062946|Cerebral Cortices|cerebral cortices
467764|NCT00062946|Quantification|quantification
467765|NCT00062946|Reproducibility|reproducibility
467766|NCT00062946|Dopamine Release|dopamine release
467767|NCT00062946|(18F) Fallypride|(18f) fallypride
467768|NCT00062946|D-Amphetamine|d-amphetamine
467769|NCT00062946|Alpha-Methyl-Para-Tyrosine (AMPT)|alpha-methyl-para-tyrosine (ampt)
467770|NCT00062946|PET|pet
467771|NCT00062946|Dopamine D2 Receptor|dopamine d2 receptor
467772|NCT00062946|Healthy Volunteer|healthy volunteer
467773|NCT00062946|HV|hv
467774|NCT00062959|Adolescence|adolescence
467775|NCT00062959|Parenting|parenting
467776|NCT00062959|School|school
467777|NCT00062959|Primary Prevention|primary prevention
467778|NCT00062959|School-based intervention|school-based intervention
467779|NCT00062972|Multiple Sclerosis|multiple sclerosis
467780|NCT00062972|Cognitive Dysfunction|cognitive dysfunction
467781|NCT00062972|Treatment Interventions|treatment interventions
467782|NCT00062972|Verbal memory deficits|verbal memory deficits
467783|NCT00062985|obesity treatment|obesity treatment
467784|NCT00062985|weight management|weight management
467785|NCT00062985|managed care|managed care
467786|NCT00063011|Weight-bearing exercise|weight-bearing exercise
467787|NCT00063011|Calcium-rich diet|calcium-rich diet
467788|NCT00063011|Adolescents|adolescents
467789|NCT00063011|Females|females
467790|NCT00063011|Bone mass|bone mass
467791|NCT00063011|Osteopenia|osteopenia
467792|NCT00063024|Bone health|bone health
467793|NCT00063024|Weight-bearing physical activity|weight-bearing physical activity
467794|NCT00063024|Calcium|calcium
467795|NCT00063037|Bone mass|bone mass
467796|NCT00063037|Calcium intake|calcium intake
467797|NCT00063037|Prevention of osteoporosis|prevention of osteoporosis
467798|NCT00063037|Optimizing peak bone mass|optimizing peak bone mass
467799|NCT00063037|Bone mineral density|bone mineral density
467800|NCT00063050|Bone density|bone density
467801|NCT00063050|Children|children
467802|NCT00063050|Adolescents|adolescents
467803|NCT00063050|Behavior|behavior
467804|NCT00063050|Health education|health education
467805|NCT00063050|Health promotion|health promotion
467806|NCT00063050|Physical fitness|physical fitness
467807|NCT00063050|Diet|diet
467808|NCT00063050|Parent training|parent training
467809|NCT00063050|Injury control|injury control
467810|NCT00063063|NICHD Neonatal Research Network|nichd neonatal research network
467811|NCT00063063|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
467812|NCT00063063|Prematurity|prematurity
467813|NCT00063076|Alopecia Areata|alopecia areata
467814|NCT00063076|Alopecia Totalis|alopecia totalis
467815|NCT00063076|Alopecia Universalis|alopecia universalis
467816|NCT00063076|Targretin Gel|targretin gel
467817|NCT00063089|Staphylococcal infection|staphylococcal infection
467818|NCT00063089|Gram positive bacteria|gram positive bacteria
467819|NCT00063089|Staphylococcus|staphylococcus
467820|NCT00063089|Staphylococcus aureus|staphylococcus aureus
467821|NCT00063115|Praxis Movements|praxis movements
467822|NCT00063115|Pantomime|pantomime
467823|NCT00063115|Statistical Parametric Mapping|statistical parametric mapping
467824|NCT00063115|Functional Connectivity|functional connectivity
467825|NCT00063115|Path Analysis|path analysis
467826|NCT00063115|Ideomotor Apraxia|ideomotor apraxia
467827|NCT00063115|Healthy Volunteer|healthy volunteer
467828|NCT00063115|HV|hv
467829|NCT00063154|Lung cancer|lung cancer
467830|NCT00063180|Diaschisis|diaschisis
467831|NCT00063180|Glucose|glucose
467832|NCT00063180|GABA|gaba
467833|NCT00063180|N-Acetylaspartate|n-acetylaspartate
467834|NCT00063180|Glutamate|glutamate
467835|NCT00063180|Stroke|stroke
467836|NCT00063180|Healthy Volunteer|healthy volunteer
467837|NCT00063180|HV|hv
601100|NCT00576667|NASH|nash
467141|NCT00062621|Chimerism|chimerism
467838|NCT00063193|Parkinson's disease|parkinson's disease
467839|NCT00063193|minocycline|minocycline
467841|NCT00063193|neuroprotection|neuroprotection
467842|NCT00063206|Depressive Disorder, Major|depressive disorder, major
467843|NCT00063206|Depression, Involutional|depression, involutional
467844|NCT00063219|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
467845|NCT00063219|Lung Cancer|lung cancer
467846|NCT00063219|Cancer of Lung|cancer of lung
467847|NCT00063232|Insulin|insulin
467848|NCT00063232|Obesity|obesity
467849|NCT00063232|Fatty Liver|fatty liver
467850|NCT00063232|Diabetes|diabetes
467851|NCT00063232|Cirrhosis|cirrhosis
467852|NCT00063232|Metformin|metformin
467853|NCT00063232|Insulin Resistance|insulin resistance
467854|NCT00063232|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
467855|NCT00063232|Hepatitis|hepatitis
467856|NCT00063232|NASH|nash
467857|NCT00063245|Motor Cortex|motor cortex
467858|NCT00063245|Mood|mood
467859|NCT00063245|Reward|reward
467860|NCT00063245|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
467861|NCT00063245|Magnetic Coil|magnetic coil
467862|NCT00063245|Healthy Volunteer|healthy volunteer
467864|NCT00063258|Non-Small Cell Lung Cancer|non-small cell lung cancer
467865|NCT00063258|Lung Cancer|lung cancer
467866|NCT00063258|OSI-774|osi-774
467867|NCT00063258|Tarceva|tarceva
467868|NCT00063258|Carboplatin|carboplatin
467869|NCT00063258|Paclitaxel|paclitaxel
467870|NCT00063258|NSCLC|nsclc
467871|NCT00063726|Relapsed Multiple Myeloma|relapsed multiple myeloma
467872|NCT00063726|Refractory Multiple Myeloma|refractory multiple myeloma
467873|NCT00063765|NT-501|nt-501
467874|NCT00063765|CNTF|cntf
467875|NCT00063765|Retinitis Pigmentosa|retinitis pigmentosa
467877|NCT00063778|HIV Seronegativity|hiv seronegativity
467878|NCT00063778|HIV Preventive Vaccine|hiv preventive vaccine
467879|NCT00063778|AIDS Vaccines|aids vaccines
467880|NCT00063778|Gene Products, gag|gene products, gag
467881|NCT00063778|HIV-1|hiv-1
467882|NCT00063778|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
467883|NCT00063778|Injections, Subcutaneous|injections, subcutaneous
467884|NCT00063791|Relapsed or Refractory|relapsed or refractory
467885|NCT00063804|HIV Seronegativity|hiv seronegativity
467886|NCT00063804|CXCR4|cxcr4
467887|NCT00063804|AMD11070|amd11070
467888|NCT00063817|Renal Disease|renal disease
467889|NCT00063817|End-stage renal disease|end-stage renal disease
467890|NCT00063817|Renal Transplant|renal transplant
467891|NCT00063817|Bone Marrow Transplant|bone marrow transplant
467892|NCT00063817|Tolerance, Chimerism|tolerance, chimerism
467893|NCT00063817|Immune Tolerance|immune tolerance
467894|NCT00063817|ESRD|esrd
467895|NCT00063830|Ulcerative Colitis|ulcerative colitis
467896|NCT00063843|Bacillus anthracis (anthrax)|bacillus anthracis (anthrax)
467897|NCT00063856|Smallpox, wetvax|smallpox, wetvax
467898|NCT00063869|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
467899|NCT00063869|Fibrosis, Pulmonary|fibrosis, pulmonary
467900|NCT00063869|Pulmonary Fibroses|pulmonary fibroses
467901|NCT00063869|Fibroses, Pulmonary|fibroses, pulmonary
467902|NCT00063882|stage IIB prostate cancer|stage iib prostate cancer
483514|NCT00118612|Allergy|allergy
467903|NCT00063882|stage IIA prostate cancer|stage iia prostate cancer
467904|NCT00063882|adenocarcinoma of the prostate|adenocarcinoma of the prostate
467905|NCT00063960|stage IV colon cancer|stage iv colon cancer
467906|NCT00063960|adenocarcinoma of the colon|adenocarcinoma of the colon
467907|NCT00063960|adenocarcinoma of the rectum|adenocarcinoma of the rectum
467908|NCT00063960|stage IV rectal cancer|stage iv rectal cancer
467909|NCT00063960|liver metastases|liver metastases
467910|NCT00063986|esophageal cancer|esophageal cancer
467911|NCT00063986|minimally invasive esophagectomy (MIE)|minimally invasive esophagectomy (mie)
467912|NCT00064012|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
467913|NCT00064012|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
467914|NCT00064012|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
467915|NCT00064038|stage I multiple myeloma|stage i multiple myeloma
467916|NCT00064038|stage II multiple myeloma|stage ii multiple myeloma
467917|NCT00064038|stage III multiple myeloma|stage iii multiple myeloma
467918|NCT00064051|stage II pancreatic cancer|stage ii pancreatic cancer
467919|NCT00064051|stage III pancreatic cancer|stage iii pancreatic cancer
467920|NCT00064051|recurrent pancreatic cancer|recurrent pancreatic cancer
467921|NCT00064051|stage IV pancreatic cancer|stage iv pancreatic cancer
467922|NCT00064064|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
467923|NCT00064064|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
467924|NCT00064090|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
467925|NCT00064090|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
467926|NCT00064090|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
467927|NCT00064090|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
467928|NCT00064090|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
467929|NCT00064090|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
467930|NCT00064090|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
467931|NCT00064090|refractory anemia with excess blasts|refractory anemia with excess blasts
467932|NCT00064090|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
467933|NCT00064090|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
467934|NCT00064090|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
467935|NCT00064090|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
467936|NCT00064090|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
467937|NCT00064090|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
467938|NCT00064090|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
467939|NCT00064090|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
467940|NCT00064116|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
467941|NCT00064116|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
467942|NCT00064116|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
467943|NCT00064116|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
467944|NCT00064116|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
467945|NCT00064181|adenocarcinoma of the colon|adenocarcinoma of the colon
467946|NCT00064181|adenocarcinoma of the rectum|adenocarcinoma of the rectum
467948|NCT00064181|stage IV rectal cancer|stage iv rectal cancer
467949|NCT00064194|prostate cancer|prostate cancer
467950|NCT00064194|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
467951|NCT00064207|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
467952|NCT00064207|stage I pancreatic cancer|stage i pancreatic cancer
467953|NCT00064207|stage II pancreatic cancer|stage ii pancreatic cancer
467954|NCT00064207|stage III pancreatic cancer|stage iii pancreatic cancer
467955|NCT00064220|adult leiomyosarcoma|adult leiomyosarcoma
467956|NCT00064220|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
467957|NCT00064220|adult liposarcoma|adult liposarcoma
467958|NCT00064220|adult rhabdomyosarcoma|adult rhabdomyosarcoma
467959|NCT00064220|adult synovial sarcoma|adult synovial sarcoma
467960|NCT00064220|adult fibrosarcoma|adult fibrosarcoma
467961|NCT00064220|adult angiosarcoma|adult angiosarcoma
467962|NCT00064220|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
467963|NCT00064220|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
467964|NCT00064220|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
467965|NCT00064233|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
467966|NCT00064233|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
467967|NCT00064233|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
467968|NCT00064272|nausea and vomiting|nausea and vomiting
467969|NCT00064272|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
467970|NCT00064285|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
467971|NCT00064285|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
483821|NCT00119912|cancer|cancer
467972|NCT00064285|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
467973|NCT00064285|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
467974|NCT00064285|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
467975|NCT00064285|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
467976|NCT00064285|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
467977|NCT00064285|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
467978|NCT00064285|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
467979|NCT00064285|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
467980|NCT00064285|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
467981|NCT00064285|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
467982|NCT00064285|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
467983|NCT00064285|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
467984|NCT00064285|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
467985|NCT00064298|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
467986|NCT00064298|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
467987|NCT00064298|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
467988|NCT00064298|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
88714|NCT02732990|Peripheral blood flow|peripheral blood flow
467989|NCT00064298|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
467990|NCT00064298|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
467991|NCT00064298|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
467992|NCT00064298|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
583725|NCT00506480|in vitro fertilization|in vitro fertilization
468234|NCT00064896|Cardiovascular Disease|cardiovascular disease
467993|NCT00064298|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
467994|NCT00064298|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
467995|NCT00064298|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
467996|NCT00064298|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
467997|NCT00064298|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
467998|NCT00064298|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
467999|NCT00064298|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
468000|NCT00064298|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
468001|NCT00064311|infection|infection
468002|NCT00064311|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
468003|NCT00064311|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
468004|NCT00064311|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
468005|NCT00064311|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
468006|NCT00064311|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
468007|NCT00064311|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
468008|NCT00064311|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
468009|NCT00064311|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
468010|NCT00064311|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
468011|NCT00064311|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
468012|NCT00064311|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
468013|NCT00064311|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
468014|NCT00064311|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
468015|NCT00064311|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
468016|NCT00064311|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
468017|NCT00064311|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
468018|NCT00064311|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
468019|NCT00064311|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
468020|NCT00064311|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
468021|NCT00064311|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
468022|NCT00064311|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
468023|NCT00064311|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
468024|NCT00064311|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
468025|NCT00064311|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
468026|NCT00064311|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
468027|NCT00064311|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
468028|NCT00064311|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
468029|NCT00064311|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
468186|NCT00064792|HMG-COA Reductase Inhibitor|hmg-coa reductase inhibitor
468030|NCT00064311|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
468031|NCT00064311|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
468032|NCT00064311|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
468033|NCT00064311|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
468034|NCT00064311|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
468035|NCT00064311|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
468036|NCT00064311|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
468037|NCT00064311|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
468038|NCT00064311|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
468039|NCT00064311|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
468040|NCT00064311|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
468041|NCT00064311|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
468042|NCT00064311|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
468043|NCT00064311|refractory hairy cell leukemia|refractory hairy cell leukemia
468044|NCT00064311|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
468045|NCT00064311|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
468046|NCT00064311|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
88832|NCT02732236|HBV|hbv
467404|NCT00054808|Ganite|ganite
468047|NCT00064311|stage I multiple myeloma|stage i multiple myeloma
468048|NCT00064311|stage II multiple myeloma|stage ii multiple myeloma
468049|NCT00064311|stage III multiple myeloma|stage iii multiple myeloma
468050|NCT00064311|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
468051|NCT00064311|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
468052|NCT00064311|disseminated neuroblastoma|disseminated neuroblastoma
468054|NCT00064311|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
468055|NCT00064311|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
468056|NCT00064311|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
468057|NCT00064311|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
468058|NCT00064311|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
468059|NCT00064311|stage IIIA breast cancer|stage iiia breast cancer
468060|NCT00064311|stage IIIB breast cancer|stage iiib breast cancer
468061|NCT00064311|stage IV breast cancer|stage iv breast cancer
468062|NCT00064311|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
468063|NCT00064311|primary myelofibrosis|primary myelofibrosis
468064|NCT00064311|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
468065|NCT00064311|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
468066|NCT00064311|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
468067|NCT00064311|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
468068|NCT00064311|secondary acute myeloid leukemia|secondary acute myeloid leukemia
468069|NCT00064311|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
468070|NCT00064311|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
468071|NCT00064311|stage IIIC breast cancer|stage iiic breast cancer
468072|NCT00064311|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
468073|NCT00064311|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
468074|NCT00064311|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
468075|NCT00064311|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
468076|NCT00064311|splenic marginal zone lymphoma|splenic marginal zone lymphoma
468077|NCT00064311|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
468078|NCT00064311|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
468079|NCT00064311|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
468080|NCT00064311|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
468081|NCT00064311|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
468082|NCT00064337|primary systemic amyloidosis|primary systemic amyloidosis
468083|NCT00064337|stage II multiple myeloma|stage ii multiple myeloma
468084|NCT00064337|stage III multiple myeloma|stage iii multiple myeloma
468085|NCT00064350|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
468086|NCT00064350|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
468087|NCT00064350|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
468088|NCT00064350|sorafenib|sorafenib
468089|NCT00064363|recurrent adult brain tumor|recurrent adult brain tumor
468090|NCT00064363|adult anaplastic astrocytoma|adult anaplastic astrocytoma
468091|NCT00064363|adult glioblastoma|adult glioblastoma
468092|NCT00064363|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
468093|NCT00064363|adult mixed glioma|adult mixed glioma
468094|NCT00064363|adult giant cell glioblastoma|adult giant cell glioblastoma
468095|NCT00064363|adult gliosarcoma|adult gliosarcoma
468096|NCT00064363|adult brain stem glioma|adult brain stem glioma
468097|NCT00064376|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
468098|NCT00064376|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
468099|NCT00064376|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
468100|NCT00064376|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
468101|NCT00064376|refractory anemia with excess blasts|refractory anemia with excess blasts
468102|NCT00064376|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
468103|NCT00064376|refractory anemia|refractory anemia
468104|NCT00064376|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
468105|NCT00064428|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
468106|NCT00064428|fondaparinux|fondaparinux
468107|NCT00064428|Acute Myocardial Infarction|acute myocardial infarction
468108|NCT00064428|acute coronary syndrome|acute coronary syndrome
468109|NCT00064441|Ulcerative Colitis|ulcerative colitis
468110|NCT00064454|Ulcerative Colitis|ulcerative colitis
468111|NCT00064467|lethargic|lethargic
468112|NCT00064467|decreased interest|decreased interest
468113|NCT00064467|decreased motivation|decreased motivation
468114|NCT00064467|depression|depression
468115|NCT00064571|unilateral vocal fold paralysis|unilateral vocal fold paralysis
601545|NCT00578344|SCD|scd
468116|NCT00064597|Fetal cells|fetal cells
468117|NCT00064597|Prenatal diagnosis|prenatal diagnosis
468118|NCT00064597|Cytogenetic disorders|cytogenetic disorders
468119|NCT00064597|Chromosomal disorders|chromosomal disorders
468120|NCT00064597|Single gene mutation detection|single gene mutation detection
468121|NCT00064597|Abnormal serum marker profile|abnormal serum marker profile
468122|NCT00064597|Fluorescence activated cell sorting (FACS)|fluorescence activated cell sorting (facs)
468123|NCT00064597|Magnetic activated cell sorting (MACS)|magnetic activated cell sorting (macs)
468124|NCT00064597|Fluorescence in situ hybridization (FISH)|fluorescence in situ hybridization (fish)
468125|NCT00064597|Chromosomal disorders of the fetus|chromosomal disorders of the fetus
468448|NCT00065624|Lipoic acid|lipoic acid
468126|NCT00064597|Single gene defects of the fetus|single gene defects of the fetus
13057|NCT03207113|prostate cancer survivorship|prostate cancer survivorship
468127|NCT00064610|Advanced androgen-independent prostate cancer|advanced androgen-independent prostate cancer
468128|NCT00064623|Dermal assessment|dermal assessment
468129|NCT00064623|Pain measurement|pain measurement
468130|NCT00064623|Diary|diary
468131|NCT00064623|Analgesics/*therapeutic use|analgesics/*therapeutic use
468132|NCT00064623|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
468133|NCT00064623|HIV Infections/*complications/*drug therapy|hiv infections/*complications/*drug therapy
468134|NCT00064623|Peripheral Nervous System Diseases/*complications/diagnosis/*therapy|peripheral nervous system diseases/*complications/diagnosis/*therapy
468135|NCT00064623|Peripheral Nervous System Diseases/drug therapy/*etiology/physiopathology|peripheral nervous system diseases/drug therapy/*etiology/physiopathology
468136|NCT00064649|prostate|prostate
468137|NCT00064649|benign disease|benign disease
468138|NCT00064649|TUNA|tuna
468139|NCT00064649|TUMT|tumt
468140|NCT00064649|medical therapy|medical therapy
468141|NCT00064662|Stress urinary incontinence|stress urinary incontinence
468142|NCT00064662|Surgery|surgery
468143|NCT00064701|De Novo Kidney Transplant|de novo kidney transplant
468144|NCT00064701|cyclosporine|cyclosporine
468145|NCT00064701|Prograf®|prograf®
468146|NCT00064701|mycophenolate mofetil|mycophenolate mofetil
468147|NCT00064701|tacrolimus|tacrolimus
468148|NCT00064714|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
468149|NCT00064714|Beta-Cell|beta-cell
468150|NCT00064714|C-Peptide|c-peptide
468151|NCT00064714|Immunosuppression|immunosuppression
468152|NCT00064714|Insulin|insulin
468153|NCT00064714|Islet|islet
468154|NCT00064714|Function|function
468155|NCT00064714|AC2993 (Synthetic Exendin-4)|ac2993 (synthetic exendin-4)
468156|NCT00064714|Diabetes Mellitus|diabetes mellitus
468157|NCT00064714|Type I Diabetes Mellitus|type i diabetes mellitus
468158|NCT00064714|T1DM|t1dm
468159|NCT00064727|Ventricular Contractile Function|ventricular contractile function
468160|NCT00064727|Diastolic Dysfunction|diastolic dysfunction
468161|NCT00064727|PPAR gamma|ppar gamma
468162|NCT00064727|Gene Expression Patterns|gene expression patterns
468163|NCT00064727|Insulin Sensitization|insulin sensitization
468164|NCT00064727|Glucose Intolerance|glucose intolerance
468165|NCT00064727|Intolerance|intolerance
468166|NCT00064740|Human Immunodeficiency Viruses|human immunodeficiency viruses
468167|NCT00064740|Relaxation|relaxation
468168|NCT00064740|Acupuncture|acupuncture
468169|NCT00064740|Complementary therapies|complementary therapies
468170|NCT00064753|homocysteine|homocysteine
468171|NCT00064753|multi-vitamin|multi-vitamin
468172|NCT00064753|cardiovascular disease|cardiovascular disease
468173|NCT00064753|renal transplant recipients|renal transplant recipients
468174|NCT00064766|Norplant|norplant
468175|NCT00064766|Periodontal disease|periodontal disease
468176|NCT00064766|Endometrial bleeding|endometrial bleeding
468177|NCT00064766|Progestin-induced endometrial bleeding|progestin-induced endometrial bleeding
468178|NCT00064779|CNS neoplasms|cns neoplasms
468179|NCT00064779|Brain neoplasms|brain neoplasms
468180|NCT00064779|neurosurgery|neurosurgery
468181|NCT00064779|intralesional infusion|intralesional infusion
468182|NCT00064779|recombinant proteins|recombinant proteins
468183|NCT00064779|immunotoxins|immunotoxins
468184|NCT00064792|Cholesterol|cholesterol
468192|NCT00064805|Alexia|alexia
468193|NCT00064805|Acquired dyslexia|acquired dyslexia
468194|NCT00064805|Phonological deficits|phonological deficits
468195|NCT00064805|Orthographic deficits|orthographic deficits
468196|NCT00064805|Brain disorders|brain disorders
468197|NCT00064805|Brain injury|brain injury
468198|NCT00064805|Stroke|stroke
468199|NCT00064818|connective tissue|connective tissue
468200|NCT00064818|ultrasound|ultrasound
468201|NCT00064818|acupuncture|acupuncture
468202|NCT00064831|estrogen stimulation|estrogen stimulation
468203|NCT00064831|relief of hot flashes|relief of hot flashes
468204|NCT00064831|nipple aspirate fluid|nipple aspirate fluid
468205|NCT00064831|body fluid levels of black cohosh|body fluid levels of black cohosh
468206|NCT00064844|Smoking|smoking
468207|NCT00064844|Alcoholism|alcoholism
468208|NCT00064857|lymphedema|lymphedema
468209|NCT00064857|breast|breast
468210|NCT00064857|cancer|cancer
468211|NCT00064857|plant preparation|plant preparation
468212|NCT00064857|herbal preparation|herbal preparation
468213|NCT00064857|pine bark extract|pine bark extract
468214|NCT00064870|Alzheimer disease|alzheimer disease
468215|NCT00064870|Late Onset Alzheimer disease risk factor genes|late onset alzheimer disease risk factor genes
468216|NCT00064870|Genetics|genetics
468217|NCT00064870|Initiative|initiative
468218|NCT00064870|Dementia|dementia
468225|NCT00064896|Blood Flow|blood flow
468226|NCT00064896|Revascularization|revascularization
468227|NCT00064896|Image Fusion|image fusion
468228|NCT00064896|Fluoroscopy|fluoroscopy
468230|NCT00064896|Chronic Total Occlusion of Arteries|chronic total occlusion of arteries
468231|NCT00064896|Claudication|claudication
468232|NCT00064896|Safety|safety
468233|NCT00064896|Atherosclerosis|atherosclerosis
468235|NCT00064909|Multiple Sclerosis|multiple sclerosis
468236|NCT00064909|MRI|mri
468243|NCT00064909|Healthy Volunteer|healthy volunteer
468244|NCT00064909|HV|hv
468245|NCT00064922|nicotine dependence|nicotine dependence
468246|NCT00064935|Endometrium|endometrium
468247|NCT00064935|Luteal phase|luteal phase
468248|NCT00064935|Endometrial biopsy|endometrial biopsy
468249|NCT00064961|Smoking Cessation|smoking cessation
468250|NCT00064974|MDS|mds
468251|NCT00064974|CC-5013|cc-5013
468252|NCT00064974|Revlimid|revlimid
468253|NCT00064974|Celgene|celgene
468254|NCT00064987|Male reproduction hormones|male reproduction hormones
468255|NCT00064987|Hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
468256|NCT00064987|FSH|fsh
468257|NCT00064987|LH|lh
468258|NCT00064987|GnRH|gnrh
468259|NCT00065013|obesity|obesity
468260|NCT00065013|gastric bypass|gastric bypass
468261|NCT00065013|obesity surgery|obesity surgery
468262|NCT00065013|bariatric surgery|bariatric surgery
468263|NCT00065013|exercise|exercise
468264|NCT00065052|physical activity|physical activity
468265|NCT00065052|television|television
468266|NCT00065052|child obesity|child obesity
468267|NCT00065052|Reduce TV|reduce tv
468268|NCT00065052|Usual control|usual control
468269|NCT00065065|Rosiglitazone|rosiglitazone
468270|NCT00065065|Ulcerative|ulcerative
468271|NCT00065065|Colitis|colitis
468272|NCT00065078|Home-visits|home-visits
468273|NCT00065078|Community nurse|community nurse
468274|NCT00065078|Unintended pregnancy|unintended pregnancy
468275|NCT00065104|HIV|hiv
468276|NCT00065104|DHEA|dhea
468277|NCT00065104|immune system|immune system
468278|NCT00065104|hormones|hormones
468279|NCT00065104|body composition|body composition
468280|NCT00065104|quality of life|quality of life
468281|NCT00065117|metastatic|metastatic
468282|NCT00065117|colorectal|colorectal
468283|NCT00065117|first-line|first-line
468284|NCT00065117|adjuvant|adjuvant
468285|NCT00065117|cancer|cancer
468286|NCT00065117|Colorectal Cancer|colorectal cancer
468287|NCT00065117|Colorectal Carcinoma|colorectal carcinoma
468288|NCT00065117|Colorectal Tumors|colorectal tumors
468289|NCT00065117|Neoplasms, Colorectal|neoplasms, colorectal
468290|NCT00065143|Newly diagnosed and previously untreated acute myeloid leukemia (AML)|newly diagnosed and previously untreated acute myeloid leukemia (aml)
468291|NCT00065143|High-risk myelodysplastic syndrome (MDS) (>/= 10% bone marrow blasts)|high-risk myelodysplastic syndrome (mds) (>/= 10% bone marrow blasts)
468292|NCT00065143|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
468293|NCT00065143|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
468294|NCT00065156|MDS|mds
468295|NCT00065156|CC-5013|cc-5013
468296|NCT00065156|Revlimid|revlimid
468297|NCT00065156|Celgene|celgene
468298|NCT00065182|Stage IIIB/IV|stage iiib/iv
468299|NCT00065182|topotecan|topotecan
468300|NCT00065182|docetaxel|docetaxel
468301|NCT00065182|TAXOTERE|taxotere
468302|NCT00065182|HYCAMTIN|hycamtin
468303|NCT00065182|non-small cell lung cancer|non-small cell lung cancer
468304|NCT00065182|Advanced|advanced
468305|NCT00065182|NSCLC|nsclc
468306|NCT00065195|Massage|massage
468307|NCT00065195|Palliative Care|palliative care
468308|NCT00065195|Hospices|hospices
468309|NCT00065195|Cancer|cancer
468310|NCT00065208|Prostate cancer|prostate cancer
468311|NCT00065208|Reiki|reiki
468312|NCT00065208|Energy Healing|energy healing
468313|NCT00065221|Ginger|ginger
468314|NCT00065221|Plant preparation|plant preparation
468315|NCT00065221|Herbal medicine|herbal medicine
468316|NCT00065221|Chemotherapy|chemotherapy
468317|NCT00065221|Nausea|nausea
468318|NCT00065234|Colostomy|colostomy
468319|NCT00065234|Ileostomy|ileostomy
468320|NCT00065247|Bone|bone
468321|NCT00065247|Children|children
468322|NCT00065247|After-school program|after-school program
468323|NCT00065247|Osteoporosis|osteoporosis
468324|NCT00065247|Calcium|calcium
468325|NCT00065247|Physical activity|physical activity
468326|NCT00065260|Alemtuzumab (Campath-1H)|alemtuzumab (campath-1h)
468327|NCT00065260|Rabbit ATG|rabbit atg
468328|NCT00065260|Severe Aplastic Anemia|severe aplastic anemia
601824|NCT00587119|PBC|pbc
468329|NCT00065260|Cyclosporine|cyclosporine
468330|NCT00065260|Thrombocytopenia|thrombocytopenia
468331|NCT00065260|Leukopenia|leukopenia
468332|NCT00065260|Neutropenia|neutropenia
468333|NCT00065260|Autoimmunity|autoimmunity
468334|NCT00065260|Relapse|relapse
468335|NCT00065260|Anemia|anemia
468336|NCT00065273|Severe aberrant behavior|severe aberrant behavior
468337|NCT00065273|Risperidone|risperidone
468338|NCT00065273|Clozapine|clozapine
468339|NCT00065273|Haloperidol|haloperidol
468340|NCT00065273|Laboratory operant tasks|laboratory operant tasks
468341|NCT00065273|Simple acquisition procedures|simple acquisition procedures
468342|NCT00065273|Matching to sample task|matching to sample task
468343|NCT00065273|Lag sequential analysis|lag sequential analysis
468344|NCT00065286|Akathisia|akathisia
468345|NCT00065286|Mental retardation|mental retardation
468346|NCT00065286|Schizophrenia|schizophrenia
468555|NCT00065936|Naltrexone|naltrexone
468347|NCT00065286|Neuroleptic medication|neuroleptic medication
468348|NCT00065286|Tardive dyskinesia|tardive dyskinesia
468349|NCT00065286|Brief Psychiatric Rating Scale|brief psychiatric rating scale
468350|NCT00065286|Barnes test|barnes test
468351|NCT00065286|Stereotypy Checklist Test|stereotypy checklist test
468352|NCT00065286|DISCUS Tardive Dyskinesia test|discus tardive dyskinesia test
468353|NCT00065299|Hyperphenylalaninemia|hyperphenylalaninemia
468354|NCT00065299|PKU|pku
468355|NCT00065299|Maternal PKU|maternal pku
468356|NCT00065299|Pregnancy outcome|pregnancy outcome
468357|NCT00065299|Phenylalanine restricted diet|phenylalanine restricted diet
468358|NCT00065299|Tyrosine supplementation|tyrosine supplementation
468359|NCT00065299|Maternal hyperphenylalanemia during pregnancy|maternal hyperphenylalanemia during pregnancy
468360|NCT00065312|Type 2 diabetes|type 2 diabetes
468361|NCT00065325|Locally advanced breast cancer|locally advanced breast cancer
468362|NCT00065325|metastatic breast cancer|metastatic breast cancer
468363|NCT00065325|Breast Cancer|breast cancer
468364|NCT00065325|Cancer of Breast|cancer of breast
468365|NCT00065325|Cancer of the Breast|cancer of the breast
468366|NCT00065338|Physical activity|physical activity
468367|NCT00065351|Multiple Myeloma|multiple myeloma
468368|NCT00065351|CC-5013|cc-5013
468369|NCT00065351|Revlimid|revlimid
468370|NCT00065351|MM|mm
468371|NCT00065351|CC5013|cc5013
468372|NCT00065351|relapsed and refractory multiple myeloma|relapsed and refractory multiple myeloma
468373|NCT00065364|Preterm infant|preterm infant
468374|NCT00065364|Premature infant|premature infant
468375|NCT00065364|Developmental care|developmental care
468376|NCT00065364|MRI|mri
468377|NCT00065364|qEEG|qeeg
468378|NCT00065364|Neurodevelopment|neurodevelopment
468379|NCT00065364|Behavior|behavior
468380|NCT00065364|Infants|infants
468381|NCT00065364|NICU|nicu
468382|NCT00065377|Diabetes|diabetes
468383|NCT00065377|Insulin Resistance|insulin resistance
468384|NCT00065377|Capillary Blood Flow|capillary blood flow
468385|NCT00065377|Osteoarthritis|osteoarthritis
468386|NCT00065377|Endothelial Dysfunction|endothelial dysfunction
468387|NCT00065377|Obesity|obesity
468388|NCT00065377|Healthy Volunteer|healthy volunteer
468389|NCT00065377|HV|hv
468390|NCT00065390|ALPS|alps
468391|NCT00065390|Pyrimethamine|pyrimethamine
468392|NCT00065390|Folinic Acid|folinic acid
468393|NCT00065390|Lymphadenopathy|lymphadenopathy
468394|NCT00065390|Splenomegaly|splenomegaly
468395|NCT00065390|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
468396|NCT00065403|Irritable Bowel Syndrome|irritable bowel syndrome
468397|NCT00065403|Acupuncture|acupuncture
468398|NCT00065416|neck pain|neck pain
468399|NCT00065416|cervicalgia|cervicalgia
468400|NCT00065416|massage|massage
468401|NCT00065442|prostate cancer|prostate cancer
468402|NCT00065442|prostate|prostate
468403|NCT00065442|AIPC|aipc
468404|NCT00065442|androgen-independent|androgen-independent
468405|NCT00065442|androgen independent|androgen independent
468406|NCT00065442|hormone insensitive|hormone insensitive
468407|NCT00065442|hormone-insensitive|hormone-insensitive
468408|NCT00065442|PSA|psa
468409|NCT00065442|prostatic adenocarcinoma|prostatic adenocarcinoma
468410|NCT00065442|hormone-refractory|hormone-refractory
468411|NCT00065442|hormone refractory|hormone refractory
468412|NCT00065442|HRPC|hrpc
468413|NCT00065442|LHRH|lhrh
468414|NCT00065442|immune therapy|immune therapy
468415|NCT00065442|immunotherapy|immunotherapy
468416|NCT00065442|vaccine|vaccine
468417|NCT00065442|dendritic cells|dendritic cells
468418|NCT00065442|antigen-presenting cells|antigen-presenting cells
468419|NCT00065442|antigen presenting cells|antigen presenting cells
468420|NCT00065442|cancer vaccine|cancer vaccine
468421|NCT00065442|therapeutic vaccine|therapeutic vaccine
468422|NCT00065442|therapeutic cancer vaccine|therapeutic cancer vaccine
468423|NCT00065442|recombinant|recombinant
468424|NCT00065442|biological|biological
468425|NCT00065442|biopharmaceutical|biopharmaceutical
468426|NCT00065442|biotechnology|biotechnology
468427|NCT00065442|biotech|biotech
89409|NCT02728687|Diabetes|diabetes
601910|NCT00587561|outcome|outcome
468428|NCT00065455|Retinitis Pigmentosa|retinitis pigmentosa
468429|NCT00065455|Vitamin A|vitamin a
468430|NCT00065455|ERG|erg
468431|NCT00065455|RP|rp
468432|NCT00065468|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
468433|NCT00065468|Kidney Cancer|kidney cancer
468434|NCT00065507|hepatic decompensation|hepatic decompensation
468435|NCT00065572|Kidney Cancer|kidney cancer
468436|NCT00065572|Metastatic|metastatic
468437|NCT00065572|Newly diagnosed renal cell carcinoma|newly diagnosed renal cell carcinoma
468438|NCT00065585|low back pain|low back pain
468439|NCT00065585|acupuncture|acupuncture
468440|NCT00065611|Steroids|steroids
468441|NCT00065611|Osteoporosis|osteoporosis
468442|NCT00065611|Proteinuria|proteinuria
468443|NCT00065611|Minimal Change Disease|minimal change disease
468444|NCT00065611|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
468446|NCT00065611|MCD|mcd
468447|NCT00065611|Kidney Disease|kidney disease
468449|NCT00065624|F2-isoprostanes|f2-isoprostanes
468450|NCT00065624|endothelial dysfunction|endothelial dysfunction
468451|NCT00065624|natural product|natural product
468452|NCT00065650|Diabetes Mellitus Type 2|diabetes mellitus type 2
468453|NCT00065650|Vedic medicine|vedic medicine
468454|NCT00065650|Ayurveda|ayurveda
468455|NCT00065650|Transcendental Meditation|transcendental meditation
468456|NCT00065663|gene transfer|gene transfer
468457|NCT00065663|adenovirus|adenovirus
468458|NCT00065663|platelet-derived growth factor-B|platelet-derived growth factor-b
468459|NCT00065663|collagen|collagen
468460|NCT00065663|diabetic ulcer|diabetic ulcer
468461|NCT00065663|foot|foot
468462|NCT00065663|wounds|wounds
468463|NCT00065663|diabetic|diabetic
468464|NCT00065663|ulcers|ulcers
468465|NCT00065676|Hyperglycemia|hyperglycemia
468466|NCT00065676|Hyperinsulinemia|hyperinsulinemia
468467|NCT00065676|OGTT|ogtt
468468|NCT00065676|GLUT2|glut2
468469|NCT00065676|Post-Prandial|post-prandial
468470|NCT00065676|Type 2 Diabetes|type 2 diabetes
468471|NCT00065676|Obesity|obesity
468472|NCT00065689|Alzheimer's disease|alzheimer's disease
468473|NCT00065689|light therapy|light therapy
468474|NCT00065689|long-term care|long-term care
468475|NCT00065689|depression|depression
468476|NCT00065689|sleep|sleep
468477|NCT00065689|agitation|agitation
468478|NCT00065702|fibromyalgia|fibromyalgia
468479|NCT00065702|homeopathy|homeopathy
468480|NCT00065702|EEG|eeg
468481|NCT00065702|EKG|ekg
468482|NCT00065702|chronic pain|chronic pain
468483|NCT00065715|head cold|head cold
468484|NCT00065715|common cold|common cold
468485|NCT00065715|echinacea|echinacea
468486|NCT00065715|placebo|placebo
468487|NCT00065728|AMD|amd
468488|NCT00065728|age-related macular degeneration|age-related macular degeneration
468489|NCT00065728|Anecortave|anecortave
468490|NCT00065728|Acetate|acetate
468491|NCT00065728|Wet form of age-related macular degeneration|wet form of age-related macular degeneration
468492|NCT00065728|CNV|cnv
468493|NCT00065728|Anecortave Acetate|anecortave acetate
468494|NCT00065741|Milk thistle|milk thistle
468495|NCT00065741|silymarin|silymarin
468496|NCT00065741|piperine|piperine
468497|NCT00065741|glucarate|glucarate
468498|NCT00065741|zidovudine|zidovudine
468499|NCT00065741|abacavir|abacavir
468500|NCT00065741|mycophenolate mofetil|mycophenolate mofetil
468501|NCT00065741|HIV|hiv
468502|NCT00065741|pharmacokinetics|pharmacokinetics
468503|NCT00065741|interaction|interaction
468504|NCT00065741|glucuronidation|glucuronidation
468506|NCT00065741|Complementary Therapies|complementary therapies
468507|NCT00065754|Placebo|placebo
468508|NCT00065754|Analgesia|analgesia
468509|NCT00065754|Pain|pain
468510|NCT00065754|Brain mechanism|brain mechanism
468511|NCT00065754|Expectation|expectation
468512|NCT00065767|Alzheimer disease|alzheimer disease
468513|NCT00065767|Postmenopausal women|postmenopausal women
468514|NCT00065767|Hormone therapy|hormone therapy
468515|NCT00065806|Pediatric lupus|pediatric lupus
468516|NCT00065806|Atherosclerosis|atherosclerosis
468517|NCT00065806|SLE|sle
468518|NCT00065806|HMG CoA reductase inhibitor|hmg coa reductase inhibitor
468519|NCT00065819|HIV|hiv
468520|NCT00065819|African American|african american
468521|NCT00065819|Symptom Management|symptom management
468522|NCT00065832|Reading disabilities|reading disabilities
468523|NCT00065832|Inner-city|inner-city
468524|NCT00065832|Urban|urban
468525|NCT00065845|Urinary incontinence|urinary incontinence
468526|NCT00065845|Pelvic organ prolapse|pelvic organ prolapse
468527|NCT00065845|Stress incontinence|stress incontinence
468528|NCT00065845|Sacrocolpopexy|sacrocolpopexy
468529|NCT00065845|Burch urethropexy|burch urethropexy
468530|NCT00065845|Surgical Trials|surgical trials
468531|NCT00065858|Contraception|contraception
468532|NCT00065858|Nonoxynol 9|nonoxynol 9
468533|NCT00065858|Microbicide|microbicide
468534|NCT00065858|Spermicide|spermicide
89410|NCT02728687|Pain|pain
467876|NCT00063765|RP|rp
468535|NCT00065871|Pharmacist prescribers|pharmacist prescribers
468536|NCT00065871|Increased access|increased access
468537|NCT00065871|Hormonal contraception|hormonal contraception
468538|NCT00065871|Birth control pills|birth control pills
468539|NCT00065871|Birth control patch|birth control patch
468540|NCT00065871|Vaginal contraceptive ring|vaginal contraceptive ring
468541|NCT00065884|Adolescents|adolescents
468542|NCT00065897|Amniocentesis|amniocentesis
468543|NCT00065897|Transabdominal chorionic villus sampling|transabdominal chorionic villus sampling
468544|NCT00065897|Fluorescence in situ hybridization|fluorescence in situ hybridization
468545|NCT00065897|Alpha fetoprotein|alpha fetoprotein
468546|NCT00065897|Acetylcholinesterase|acetylcholinesterase
468547|NCT00065897|Prenatal testing|prenatal testing
468549|NCT00065910|Joint attention|joint attention
468550|NCT00065910|Developmental delay|developmental delay
468551|NCT00065910|Caregiver interaction|caregiver interaction
468552|NCT00065923|Prader-Willi Syndrome|prader-willi syndrome
468553|NCT00065923|Self-Injurious Behavior|self-injurious behavior
468554|NCT00065936|Intractable self-injurious behavior|intractable self-injurious behavior
468556|NCT00065936|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
468557|NCT00065936|Substance P|substance p
468558|NCT00065936|Met-enkephalin|met-enkephalin
468559|NCT00065936|Cortisol|cortisol
468560|NCT00065949|Low birthweight infants|low birthweight infants
468561|NCT00065949|Magnesium supplementation|magnesium supplementation
468562|NCT00065949|Intracranial hemorrhage|intracranial hemorrhage
468563|NCT00065949|Cystic periventricular leukomalacia|cystic periventricular leukomalacia
468564|NCT00065949|Mental retardation|mental retardation
468565|NCT00065962|Pervasive Developmental Disorders|pervasive developmental disorders
468566|NCT00065962|Secretin, synthetic porcine|secretin, synthetic porcine
468567|NCT00065962|Secretin, biological porcine|secretin, biological porcine
468568|NCT00065962|Autism Diagnostic Observation Schedule - Generic (ADOS-G)|autism diagnostic observation schedule - generic (ados-g)
468569|NCT00065962|Rimland Questionnaire|rimland questionnaire
468570|NCT00065962|Expressive Vocabulary Test|expressive vocabulary test
468571|NCT00065962|MacArthur Communication Inventory|macarthur communication inventory
468572|NCT00065962|Aberrant Behavior Checklist|aberrant behavior checklist
468573|NCT00065975|chronic low back pain|chronic low back pain
468574|NCT00065975|acupuncture|acupuncture
468575|NCT00065975|chiropractic|chiropractic
468576|NCT00065975|massage therapy|massage therapy
468577|NCT00065975|CAM therapies|cam therapies
468578|NCT00066014|Dental Implantation-Osseointegrated|dental implantation-osseointegrated
468579|NCT00066014|Dentures|dentures
468580|NCT00066014|Dental Prostheses|dental prostheses
468581|NCT00066014|Denture, Implant-Supported|denture, implant-supported
468582|NCT00066027|periodontitis, metabolic bone diseases, doxycycline|periodontitis, metabolic bone diseases, doxycycline
468583|NCT00066040|mutans streptococci infections|mutans streptococci infections
468584|NCT00066053|Heart attacks|heart attacks
468587|NCT00066079|Sickle Cell Pain|sickle cell pain
468588|NCT00066079|Sickle Cell Disease|sickle cell disease
468589|NCT00066079|Chronic Pain|chronic pain
468590|NCT00066079|Alternative Medicine/Therapy|alternative medicine/therapy
468591|NCT00066079|Complementary Medicine|complementary medicine
468592|NCT00066079|Massage Therapy|massage therapy
468593|NCT00066079|Relaxation Technique|relaxation technique
468594|NCT00066079|Home-based Therapy|home-based therapy
468595|NCT00066092|PBPC transplant|pbpc transplant
468596|NCT00066092|Hodgkin's Disease|hodgkin's disease
468597|NCT00066092|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
468598|NCT00066092|NHL|nhl
468599|NCT00066092|mobilization|mobilization
468600|NCT00066118|neurologic|neurologic
468601|NCT00066118|nerve conduction|nerve conduction
468602|NCT00066118|neurobehavioral|neurobehavioral
468603|NCT00066118|renal disease|renal disease
468604|NCT00066144|menopause|menopause
468605|NCT00066144|hot flashes|hot flashes
468606|NCT00066144|red clover|red clover
468607|NCT00066144|black cohosh|black cohosh
468608|NCT00066144|sexual dysfunction|sexual dysfunction
468609|NCT00066157|Alzheimer disease|alzheimer disease
468610|NCT00066157|Hormone replacement therapy|hormone replacement therapy
468611|NCT00066157|Postmenopausal women|postmenopausal women
468612|NCT00066170|Narcolepsy|narcolepsy
468613|NCT00066170|Daytime Sleepiness|daytime sleepiness
468614|NCT00066170|Daytime sleepiness in narcolepsy|daytime sleepiness in narcolepsy
468615|NCT00066183|Fibroblast Growth Factor 23|fibroblast growth factor 23
468617|NCT00066183|Hypophosphatemia|hypophosphatemia
468618|NCT00066183|Phosphaturia|phosphaturia
468619|NCT00066183|Phosphorus|phosphorus
468620|NCT00066183|Phosphorus Metabolism|phosphorus metabolism
468621|NCT00066209|Inflammation|inflammation
468622|NCT00066209|Coronavirus|coronavirus
468623|NCT00066209|Immunity|immunity
468624|NCT00066209|Interferon|interferon
468625|NCT00066209|Cytokine|cytokine
468626|NCT00066209|Severe Acute Respiratory Syndrome|severe acute respiratory syndrome
468627|NCT00066209|SARS|sars
468628|NCT00066209|Healthy Volunteer|healthy volunteer
468629|NCT00066209|HV|hv
468630|NCT00066222|limited stage small cell lung cancer|limited stage small cell lung cancer
468631|NCT00066248|cachexia|cachexia
468632|NCT00066248|unspecified childhood solid tumor|unspecified childhood solid tumor
468633|NCT00066248|childhood spinal cord neoplasm|childhood spinal cord neoplasm
468634|NCT00066248|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
468635|NCT00066248|untreated childhood medulloblastoma|untreated childhood medulloblastoma
468636|NCT00066248|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
468637|NCT00066248|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
468638|NCT00066248|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
468639|NCT00066248|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
468640|NCT00066248|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
468641|NCT00066248|childhood oligodendroglioma|childhood oligodendroglioma
468642|NCT00066248|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
468643|NCT00066248|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
468644|NCT00066248|hypothalamic glioma|hypothalamic glioma
468645|NCT00066248|untreated childhood brain stem glioma|untreated childhood brain stem glioma
468646|NCT00066248|untreated childhood visual pathway|untreated childhood visual pathway
468647|NCT00066248|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
468648|NCT00066248|childhood craniopharyngioma|childhood craniopharyngioma
468649|NCT00066248|childhood infratentorial ependymoma|childhood infratentorial ependymoma
468650|NCT00066248|childhood supratentorial ependymoma|childhood supratentorial ependymoma
468651|NCT00066248|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
468652|NCT00066248|recurrent childhood ependymoma|recurrent childhood ependymoma
468653|NCT00066248|childhood choroid plexus tumor|childhood choroid plexus tumor
468654|NCT00066248|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
468655|NCT00066248|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
468656|NCT00066248|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
468657|NCT00066248|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
468658|NCT00066248|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
468659|NCT00066248|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
468660|NCT00066248|untreated childhood acute myeloid leukemia|untreated childhood acute myeloid leukemia
468661|NCT00066248|other myeloid malignancies|other myeloid malignancies
468662|NCT00066248|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
468663|NCT00066248|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
468664|NCT00066248|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
468665|NCT00066248|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
468666|NCT00066248|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
468667|NCT00066248|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
468668|NCT00066248|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
468669|NCT00066248|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
468670|NCT00066248|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
468671|NCT00066248|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
468672|NCT00066248|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
468673|NCT00066248|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
468674|NCT00066248|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
468675|NCT00066248|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
468676|NCT00066248|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
468677|NCT00066248|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
468678|NCT00066248|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
468679|NCT00066248|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
468680|NCT00066248|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
468681|NCT00066248|refractory hairy cell leukemia|refractory hairy cell leukemia
468682|NCT00066248|untreated hairy cell leukemia|untreated hairy cell leukemia
468683|NCT00066248|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
468684|NCT00066248|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
468685|NCT00066248|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
468686|NCT00066248|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
468687|NCT00066248|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
468688|NCT00066248|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
468689|NCT00066248|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
468690|NCT00066248|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
468691|NCT00066248|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
468692|NCT00066248|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
468693|NCT00066248|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
468694|NCT00066248|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
468695|NCT00066248|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
468696|NCT00066248|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
468697|NCT00066248|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
468698|NCT00066248|recurrent childhood brain tumor|recurrent childhood brain tumor
468699|NCT00066248|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
468700|NCT00066248|myelodysplastic/myeloproliferative disease|myelodysplastic/myeloproliferative disease
468701|NCT00066248|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
468702|NCT00066248|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
468703|NCT00066248|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
468704|NCT00066248|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
468705|NCT00066248|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
468706|NCT00066274|stage IV colon cancer|stage iv colon cancer
468707|NCT00066274|stage IV rectal cancer|stage iv rectal cancer
468708|NCT00066313|extensive stage small cell lung cancer|extensive stage small cell lung cancer
468709|NCT00066313|limited stage small cell lung cancer|limited stage small cell lung cancer
468710|NCT00066326|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
468908|NCT00059631|Velcade|velcade
468711|NCT00066326|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
468712|NCT00066326|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
468713|NCT00066326|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
468714|NCT00066326|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
468715|NCT00066339|stage IV breast cancer|stage iv breast cancer
468716|NCT00066339|recurrent breast cancer|recurrent breast cancer
468717|NCT00066352|recurrent bladder cancer|recurrent bladder cancer
468718|NCT00066352|stage IV bladder cancer|stage iv bladder cancer
468719|NCT00066352|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
468720|NCT00066352|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
468721|NCT00066352|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
468722|NCT00066352|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
468723|NCT00066365|metastatic osteosarcoma|metastatic osteosarcoma
468724|NCT00066365|recurrent osteosarcoma|recurrent osteosarcoma
468725|NCT00066365|lung metastases|lung metastases
468726|NCT00066378|recurrent breast cancer|recurrent breast cancer
468727|NCT00066378|stage IIIA breast cancer|stage iiia breast cancer
468728|NCT00066378|stage IIIB breast cancer|stage iiib breast cancer
468729|NCT00066378|stage IIIC breast cancer|stage iiic breast cancer
468730|NCT00066378|stage IV breast cancer|stage iv breast cancer
468731|NCT00066391|penile squamous cell carcinoma|penile squamous cell carcinoma
468732|NCT00066391|stage III penile cancer|stage iii penile cancer
468733|NCT00066391|stage IV penile cancer|stage iv penile cancer
468735|NCT00059137|Respiratory Misregistration|respiratory misregistration
468736|NCT00059137|Abdominal Belt|abdominal belt
468737|NCT00059137|Percutaneous|percutaneous
468738|NCT00059137|CT Guided Biopsy|ct guided biopsy
468739|NCT00059137|Respiratory Cycle|respiratory cycle
468740|NCT00059137|Needle Biopsy|needle biopsy
468741|NCT00059189|Occipital Cortex|occipital cortex
468742|NCT00059189|Prefrontal Cortex|prefrontal cortex
468743|NCT00059189|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
468744|NCT00059189|Inhibition|inhibition
468745|NCT00059189|Cortical Excitability|cortical excitability
468746|NCT00059189|Blindness|blindness
468747|NCT00059189|Healthy Volunteer|healthy volunteer
468748|NCT00059189|HV|hv
468749|NCT00059202|Urso|urso
468750|NCT00059202|PSC|psc
468751|NCT00059228|Pregnancy|pregnancy
468752|NCT00059228|Gonadal Steroids|gonadal steroids
468753|NCT00059228|Antidepressants|antidepressants
468754|NCT00059228|Puerperium|puerperium
468755|NCT00059228|Depression|depression
468756|NCT00059228|Postpartum|postpartum
468757|NCT00059228|Estradiol|estradiol
468758|NCT00059228|Estrogen Response Element|estrogen response element
468759|NCT00059228|Postpartum Depression|postpartum depression
468760|NCT00059241|Early sexual initiation|early sexual initiation
468761|NCT00059241|Prevention of early sexual activity|prevention of early sexual activity
468762|NCT00059241|Middle childhood|middle childhood
468763|NCT00059254|fatty acids|fatty acids
468764|NCT00059254|oleic acid|oleic acid
468765|NCT00059254|palmitic acid|palmitic acid
468766|NCT00059254|fat oxidation|fat oxidation
468767|NCT00059254|energy expenditure|energy expenditure
468768|NCT00059254|body composition|body composition
468769|NCT00059254|monounsaturated fat|monounsaturated fat
468770|NCT00059254|human|human
468771|NCT00059280|Pompe disease|pompe disease
468772|NCT00059280|Glycogen storage disease type II|glycogen storage disease type ii
468053|NCT00064311|recurrent neuroblastoma|recurrent neuroblastoma
468773|NCT00059280|GSD-II|gsd-ii
468774|NCT00059280|Acid maltase deficiency disease|acid maltase deficiency disease
468775|NCT00059280|Glycogenosis 2|glycogenosis 2
468776|NCT00059306|stroke|stroke
468777|NCT00059306|hypertension|hypertension
468778|NCT00059306|high blood pressure|high blood pressure
468779|NCT00059306|lacunar stroke|lacunar stroke
468780|NCT00059306|subcortical stroke|subcortical stroke
468782|NCT00059306|clopidogrel|clopidogrel
468783|NCT00059319|coronary artery bypass graft surgery|coronary artery bypass graft surgery
468784|NCT00059319|CABG surgery|cabg surgery
468785|NCT00059319|neurobehavioral impairment|neurobehavioral impairment
468786|NCT00059319|aorta clamping|aorta clamping
468787|NCT00059319|aorta manipulation|aorta manipulation
468788|NCT00059319|microemboli|microemboli
468789|NCT00059332|stroke|stroke
468790|NCT00059332|brain attack|brain attack
468791|NCT00059332|magnesium sulfate|magnesium sulfate
468792|NCT00059332|neuroprotection|neuroprotection
468793|NCT00059332|prehospital care|prehospital care
468794|NCT00059332|emergency medical services|emergency medical services
468795|NCT00059345|Acupuncture|acupuncture
468796|NCT00059345|Arthritis|arthritis
468797|NCT00059358|HIV|hiv
468798|NCT00059358|HCV|hcv
468799|NCT00059358|Ribavirin|ribavirin
468800|NCT00059358|Interferon|interferon
468801|NCT00059358|Co-infection|co-infection
468802|NCT00059358|Treatment experienced|treatment experienced
468803|NCT00059371|Male circumcision|male circumcision
468804|NCT00059371|HIV acquisition|hiv acquisition
468805|NCT00059371|Sexually transmitted infection|sexually transmitted infection
468806|NCT00059371|HIV Seronegativity|hiv seronegativity
468807|NCT00059384|Treatment experienced|treatment experienced
468808|NCT00059384|Therapeutic Drug Monitoring|therapeutic drug monitoring
468809|NCT00059397|Hepatitis C|hepatitis c
468810|NCT00059410|Alzheimer disease|alzheimer disease
468811|NCT00059410|Caregivers|caregivers
468812|NCT00059410|African Americans|african americans
468813|NCT00059410|Perceptions|perceptions
468814|NCT00059410|Cultural Competency|cultural competency
468815|NCT00059423|Leukapheresis|leukapheresis
468816|NCT00059423|G-CSF|g-csf
468817|NCT00059423|Dexamethasone|dexamethasone
468818|NCT00059423|mRNA|mrna
468819|NCT00059423|Benign Ethnic Neutropenia|benign ethnic neutropenia
468820|NCT00059423|BEN|ben
468821|NCT00059423|Healthy Volunteer|healthy volunteer
468822|NCT00059423|HV|hv
468823|NCT00059436|Muscle strengthening|muscle strengthening
468824|NCT00059436|Skeletal muscle Contractions|skeletal muscle contractions
468825|NCT00059436|Rehabilitative exercise|rehabilitative exercise
468826|NCT00059449|Enterocolitis|enterocolitis
468827|NCT00059462|Treatment experienced|treatment experienced
468828|NCT00059475|Adjuvant Therapy|adjuvant therapy
468829|NCT00059475|MART-1 Peptides|mart-1 peptides
468830|NCT00059475|GP100 Peptide|gp100 peptide
468831|NCT00059475|Immunologic Response|immunologic response
468832|NCT00059475|Melanoma|melanoma
468833|NCT00059501|Postural Stability|postural stability
468834|NCT00059501|EEG|eeg
468835|NCT00059501|Aging|aging
468836|NCT00059501|Falls|falls
468837|NCT00059501|Healthy Volunteer|healthy volunteer
468838|NCT00059501|HV|hv
468839|NCT00059514|Youth|youth
468840|NCT00059514|Adolescents|adolescents
468841|NCT00059514|Smoking cessation|smoking cessation
468842|NCT00059514|Smoking prevention|smoking prevention
468843|NCT00059514|Risk factors|risk factors
468844|NCT00059514|Arab Americans|arab americans
468845|NCT00059527|Physical Activity|physical activity
468846|NCT00059527|Nutrition|nutrition
468847|NCT00059527|Self Efficacy|self efficacy
468848|NCT00059527|Middle School|middle school
468849|NCT00059527|Intervention|intervention
468850|NCT00059540|NICHD Neonatal Research Network|nichd neonatal research network
483822|NCT00119912|colon|colon
468851|NCT00059540|Maternal Lifestyle Study|maternal lifestyle study
468852|NCT00059540|Cocaine abuse|cocaine abuse
468853|NCT00059540|Cocaine dependence|cocaine dependence
468854|NCT00059540|Opiate abuse|opiate abuse
468855|NCT00059540|Opiate dependence|opiate dependence
468856|NCT00059540|Follow-up|follow-up
468857|NCT00059540|Neurodevelopmental outcome|neurodevelopmental outcome
468858|NCT00059540|Substance-related disorders|substance-related disorders
468859|NCT00059553|spinal cord injury|spinal cord injury
468860|NCT00059553|walking|walking
468861|NCT00059553|training|training
468862|NCT00059553|treadmill|treadmill
468863|NCT00059553|incomplete spinal cord injury|incomplete spinal cord injury
468864|NCT00059579|Reward|reward
468865|NCT00059579|Cortex|cortex
468866|NCT00059579|Dopamine|dopamine
468867|NCT00059579|Neuroimaging|neuroimaging
468868|NCT00059579|Strirtum|strirtum
468869|NCT00059579|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
468870|NCT00059579|Melancholic Features|melancholic features
468871|NCT00059579|Brain Imaging|brain imaging
468872|NCT00059579|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
468873|NCT00059579|Dopaminergic Mechanisms|dopaminergic mechanisms
468874|NCT00059579|Anhedonia|anhedonia
468875|NCT00059579|Depression|depression
468876|NCT00059579|Major Depressive Disorder|major depressive disorder
468877|NCT00059579|MDD|mdd
468878|NCT00059579|Healthy Volunteer|healthy volunteer
468879|NCT00059579|HV|hv
468880|NCT00059605|Non-Small Cell Lung Cancer|non-small cell lung cancer
468881|NCT00059605|Small Cell Lung Cancer|small cell lung cancer
468882|NCT00059605|Lung Cancer|lung cancer
468883|NCT00059605|NSCLC|nsclc
468884|NCT00059605|SCLC|sclc
468885|NCT00059605|DOTAP:Chol-fus1|dotap:chol-fus1
468886|NCT00059605|gene|gene
468887|NCT00059605|gene transfer|gene transfer
468888|NCT00059618|Platinum Resistant|platinum resistant
468889|NCT00059618|Taxane Resistant|taxane resistant
468890|NCT00059618|Ovarian Cancer|ovarian cancer
468891|NCT00059618|Primary Peritoneal Cancer|primary peritoneal cancer
468892|NCT00059618|Fallopian Tube Cancer|fallopian tube cancer
468893|NCT00059618|Bortezomib|bortezomib
468894|NCT00059618|PS-341|ps-341
468895|NCT00059618|Velcade|velcade
468896|NCT00059618|LDP-341|ldp-341
468898|NCT00059618|Carboplatin|carboplatin
468899|NCT00059618|Paraplatin|paraplatin
468900|NCT00059631|Prostate Cancer|prostate cancer
468901|NCT00059631|Advanced Androgen-Independent Prostate Cancer|advanced androgen-independent prostate cancer
468902|NCT00059631|AI-PCa|ai-pca
468903|NCT00059631|Advanced Prostate Cancer|advanced prostate cancer
468904|NCT00059631|Novantrone|novantrone
468905|NCT00059631|Mitoxantrone|mitoxantrone
468906|NCT00059631|PS-341|ps-341
468907|NCT00059631|Bortezomib|bortezomib
468911|NCT00059631|20S proteasome|20s proteasome
468912|NCT00059644|Ecraprost in lipid emulsion|ecraprost in lipid emulsion
468914|NCT00059644|peripheral|peripheral
468915|NCT00059644|vascular|vascular
468916|NCT00059644|amputation|amputation
468917|NCT00059644|Critical Limb Ischemia due to peripheral arterial disease|critical limb ischemia due to peripheral arterial disease
468918|NCT00059657|Ecraprost in lipid emulsion|ecraprost in lipid emulsion
468919|NCT00059657|CLI|cli
468920|NCT00059657|peripheral, vascular|peripheral, vascular
468921|NCT00059657|amputation|amputation
468922|NCT00059657|Angioplasty|angioplasty
468923|NCT00059657|by-pass|by-pass
468924|NCT00059657|Critical Limb Ischemia due to peripheral arterial disease|critical limb ischemia due to peripheral arterial disease
468925|NCT00059670|UES|ues
468926|NCT00059670|Dysphagia|dysphagia
468927|NCT00059683|Preterm Birth|preterm birth
468928|NCT00059683|Premature Birth|premature birth
468929|NCT00059683|Cervical cerclage|cervical cerclage
468930|NCT00059683|Vaginal ultrasound|vaginal ultrasound
468931|NCT00059683|Cervical length|cervical length
468932|NCT00059696|Constraint-Induced Movement Therapy|constraint-induced movement therapy
468933|NCT00059696|CI therapy|ci therapy
468934|NCT00059696|Rehabilitation|rehabilitation
468935|NCT00059696|Cerebrovascular accident|cerebrovascular accident
468936|NCT00059696|Upper extremity|upper extremity
468937|NCT00059696|Concentrated, extended practice|concentrated, extended practice
468938|NCT00059696|Limb restraint|limb restraint
468939|NCT00059696|Motor Deficits|motor deficits
468940|NCT00059709|Conflict Resolution training|conflict resolution training
468941|NCT00059709|Children|children
468942|NCT00059722|NSCLC|nsclc
468943|NCT00059722|locally advanced or metastatic|locally advanced or metastatic
468944|NCT00059722|second-line|second-line
468945|NCT00059735|kidney cancer|kidney cancer
468946|NCT00059735|kidney neoplasms|kidney neoplasms
468947|NCT00059735|renal cell cancer|renal cell cancer
468948|NCT00059748|Central Nervous System Abnormalities|central nervous system abnormalities
468949|NCT00059748|Arthropathy|arthropathy
468950|NCT00059748|Urticaria|urticaria
468951|NCT00059748|Papilledema|papilledema
468952|NCT00059748|Autoinflammation|autoinflammation
468953|NCT00059748|Neonatal Onset Multisystem Imflammatory|neonatal onset multisystem imflammatory
468954|NCT00059748|Disease|disease
468955|NCT00059748|NOMID|nomid
468956|NCT00059761|limited stage small cell lung cancer|limited stage small cell lung cancer
468957|NCT00059800|recurrent melanoma|recurrent melanoma
468958|NCT00059800|stage 0 melanoma|stage 0 melanoma
468959|NCT00059800|stage I melanoma|stage i melanoma
468960|NCT00059800|stage II melanoma|stage ii melanoma
468961|NCT00059800|stage III melanoma|stage iii melanoma
468962|NCT00059800|stage IV melanoma|stage iv melanoma
468963|NCT00059826|stage I pancreatic cancer|stage i pancreatic cancer
468964|NCT00059826|stage II pancreatic cancer|stage ii pancreatic cancer
468965|NCT00059826|stage III pancreatic cancer|stage iii pancreatic cancer
468966|NCT00059826|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
468967|NCT00059839|anaplastic large cell lymphoma|anaplastic large cell lymphoma
468968|NCT00059852|male breast cancer|male breast cancer
468969|NCT00059852|recurrent breast cancer|recurrent breast cancer
468970|NCT00059852|stage IV breast cancer|stage iv breast cancer
468971|NCT00059865|advanced adult primary liver cancer|advanced adult primary liver cancer
468972|NCT00059865|unresectable gallbladder cancer|unresectable gallbladder cancer
468973|NCT00059865|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
468974|NCT00059865|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
468975|NCT00059878|infection|infection
468976|NCT00059878|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
468977|NCT00059891|perioperative/postoperative complications|perioperative/postoperative complications
468978|NCT00059891|stage II anal cancer|stage ii anal cancer
468979|NCT00059891|stage I anal cancer|stage i anal cancer
468980|NCT00059891|stage III anal cancer|stage iii anal cancer
468981|NCT00059891|stage I rectal cancer|stage i rectal cancer
468982|NCT00059891|stage II rectal cancer|stage ii rectal cancer
468983|NCT00059891|stage III rectal cancer|stage iii rectal cancer
468984|NCT00059904|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
468985|NCT00059904|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
468986|NCT00059904|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
468987|NCT00059917|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
468988|NCT00059930|liver metastases|liver metastases
468989|NCT00059930|stage IV colon cancer|stage iv colon cancer
468990|NCT00059930|stage IV rectal cancer|stage iv rectal cancer
468991|NCT00059930|adenocarcinoma of the colon|adenocarcinoma of the colon
468992|NCT00059930|adenocarcinoma of the rectum|adenocarcinoma of the rectum
468993|NCT00059930|recurrent colon cancer|recurrent colon cancer
468994|NCT00059930|recurrent rectal cancer|recurrent rectal cancer
468995|NCT00059943|stage IV breast cancer|stage iv breast cancer
468996|NCT00059943|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
468997|NCT00059943|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
468998|NCT00059943|recurrent breast cancer|recurrent breast cancer
468999|NCT00059943|stage IV prostate cancer|stage iv prostate cancer
469000|NCT00059943|recurrent prostate cancer|recurrent prostate cancer
469001|NCT00059982|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
469002|NCT00059982|stage II pancreatic cancer|stage ii pancreatic cancer
469003|NCT00059982|stage III pancreatic cancer|stage iii pancreatic cancer
469004|NCT00059982|stage IV pancreatic cancer|stage iv pancreatic cancer
469005|NCT00059995|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
469006|NCT00059995|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
469007|NCT00059995|anaplastic large cell lymphoma|anaplastic large cell lymphoma
469008|NCT00059995|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
469009|NCT00059995|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
469010|NCT00059995|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
469011|NCT00060008|neurofibromatosis type 1|neurofibromatosis type 1
469012|NCT00060008|plexiform neurofibroma|plexiform neurofibroma
469013|NCT00060021|oral complications|oral complications
469014|NCT00060021|pain|pain
469015|NCT00060021|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
469016|NCT00060021|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
469017|NCT00060021|chronic eosinophilic leukemia|chronic eosinophilic leukemia
469018|NCT00060021|primary myelofibrosis|primary myelofibrosis
469019|NCT00060021|chronic neutrophilic leukemia|chronic neutrophilic leukemia
469020|NCT00060021|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
469021|NCT00060021|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
469022|NCT00060021|disseminated neuroblastoma|disseminated neuroblastoma
469023|NCT00060021|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
469024|NCT00060021|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
469025|NCT00060021|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
469026|NCT00060021|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
469027|NCT00060021|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
483823|NCT00119912|rectum|rectum
469028|NCT00060021|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
469029|NCT00060021|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
469030|NCT00060021|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
469031|NCT00060021|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
469032|NCT00060021|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
469033|NCT00060021|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
469034|NCT00060021|ovarian choriocarcinoma|ovarian choriocarcinoma
469035|NCT00060021|ovarian embryonal carcinoma|ovarian embryonal carcinoma
469036|NCT00060021|ovarian yolk sac tumor|ovarian yolk sac tumor
469037|NCT00060021|ovarian immature teratoma|ovarian immature teratoma
469038|NCT00060021|ovarian mature teratoma|ovarian mature teratoma
469039|NCT00060021|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
469040|NCT00060021|ovarian polyembryoma|ovarian polyembryoma
469041|NCT00060021|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
469042|NCT00060021|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
583726|NCT00506480|endometrial sampling|endometrial sampling
469043|NCT00060021|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
469044|NCT00060021|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
469045|NCT00060021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
469046|NCT00060021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
469047|NCT00060021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
469048|NCT00060021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
469049|NCT00060021|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
469050|NCT00060021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
469051|NCT00060021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
469052|NCT00060021|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
469053|NCT00060021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
469054|NCT00060021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
469055|NCT00060021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
469056|NCT00060021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
469057|NCT00060021|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
469058|NCT00060021|recurrent neuroblastoma|recurrent neuroblastoma
469059|NCT00060021|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
469060|NCT00060021|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
469061|NCT00060021|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
469062|NCT00060021|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
469063|NCT00060021|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
478885|NCT00094107|melanoma|melanoma
469064|NCT00060021|refractory hairy cell leukemia|refractory hairy cell leukemia
469065|NCT00060021|refractory multiple myeloma|refractory multiple myeloma
469066|NCT00060021|secondary acute myeloid leukemia|secondary acute myeloid leukemia
469067|NCT00060021|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
469068|NCT00060021|stage I multiple myeloma|stage i multiple myeloma
469069|NCT00060021|stage II multiple myeloma|stage ii multiple myeloma
469070|NCT00060021|stage III multiple myeloma|stage iii multiple myeloma
469071|NCT00060021|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
469072|NCT00060021|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
469073|NCT00060021|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
469074|NCT00060021|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
469075|NCT00060021|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
469076|NCT00060021|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
469077|NCT00060021|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
469078|NCT00060021|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
469079|NCT00060021|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
469080|NCT00060021|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
469081|NCT00060021|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
469082|NCT00060021|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
469083|NCT00060021|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
469084|NCT00060021|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
469085|NCT00060021|stage IIIA breast cancer|stage iiia breast cancer
469086|NCT00060021|stage IIIB breast cancer|stage iiib breast cancer
469087|NCT00060021|stage IIIC breast cancer|stage iiic breast cancer
469088|NCT00060021|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
469089|NCT00060021|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
469090|NCT00060021|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
469091|NCT00060021|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
469092|NCT00060021|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
469093|NCT00060021|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
469094|NCT00060021|stage IV breast cancer|stage iv breast cancer
469095|NCT00060021|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
469096|NCT00060021|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
469097|NCT00060021|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
469098|NCT00060021|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
469099|NCT00060021|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
469100|NCT00060021|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
469101|NCT00060021|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
469102|NCT00060021|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
469103|NCT00060021|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
469104|NCT00060021|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
89411|NCT02728674|COPD|copd
602877|NCT00593541|MRI|mri
468445|NCT00065611|FSGS|fsgs
469105|NCT00060021|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
583827|NCT00512824|Indonesia|indonesia
583828|NCT00512824|Healthy children|healthy children
469106|NCT00060021|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
469107|NCT00060021|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
469108|NCT00060021|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
469109|NCT00060021|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
469110|NCT00060021|testicular embryonal carcinoma|testicular embryonal carcinoma
469111|NCT00060021|testicular teratoma|testicular teratoma
469112|NCT00060021|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
469113|NCT00060021|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
469114|NCT00060021|testicular yolk sac tumor|testicular yolk sac tumor
469115|NCT00060021|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
469116|NCT00060021|testicular choriocarcinoma|testicular choriocarcinoma
469117|NCT00060021|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
469118|NCT00060021|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
13058|NCT03207113|mobile health|mobile health
469119|NCT00060021|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
469120|NCT00060021|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
469121|NCT00060021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
469122|NCT00060021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
469123|NCT00060021|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
469124|NCT00060021|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
469125|NCT00060021|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
469126|NCT00060021|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
469127|NCT00060021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
469128|NCT00060021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
469129|NCT00060021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
469130|NCT00060086|adenocarcinoma of the prostate|adenocarcinoma of the prostate
469131|NCT00060086|recurrent prostate cancer|recurrent prostate cancer
469132|NCT00060099|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
469133|NCT00060099|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
469134|NCT00060099|human papilloma virus infection|human papilloma virus infection
469135|NCT00060138|hypercalcemia of malignancy|hypercalcemia of malignancy
469136|NCT00060138|stage IV breast cancer|stage iv breast cancer
469137|NCT00060138|recurrent breast cancer|recurrent breast cancer
469140|NCT00060151|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
469141|NCT00060203|stage III multiple myeloma|stage iii multiple myeloma
469142|NCT00060203|refractory multiple myeloma|refractory multiple myeloma
469143|NCT00060242|anaplastic thyroid cancer|anaplastic thyroid cancer
469144|NCT00060242|recurrent thyroid cancer|recurrent thyroid cancer
469145|NCT00060255|stage IV breast cancer|stage iv breast cancer
469146|NCT00060255|male breast cancer|male breast cancer
469147|NCT00060255|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
469148|NCT00060255|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
469149|NCT00060255|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
469150|NCT00060255|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
469151|NCT00060255|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
469152|NCT00060255|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
469153|NCT00060255|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
469154|NCT00060255|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
469155|NCT00060255|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
469156|NCT00060255|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
469157|NCT00060255|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
469158|NCT00060255|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
469159|NCT00060255|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
469160|NCT00060255|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
469161|NCT00060255|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
469162|NCT00060255|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
469163|NCT00060255|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
469164|NCT00060255|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
469165|NCT00060255|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
89412|NCT02728674|Breathlessness|breathlessness
602964|NCT00593905|Thelin|thelin
468586|NCT00066053|Angina|angina
469166|NCT00060255|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
469167|NCT00060255|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
469168|NCT00060255|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
469169|NCT00060255|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
469170|NCT00060255|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
469171|NCT00060255|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
469172|NCT00060255|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
469173|NCT00060255|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
469174|NCT00060255|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
469175|NCT00060255|stage IIIA breast cancer|stage iiia breast cancer
469176|NCT00060255|stage IIIB breast cancer|stage iiib breast cancer
469177|NCT00060255|stage IIIC breast cancer|stage iiic breast cancer
469178|NCT00060255|recurrent breast cancer|recurrent breast cancer
469179|NCT00060255|primary systemic amyloidosis|primary systemic amyloidosis
469180|NCT00060255|refractory multiple myeloma|refractory multiple myeloma
469181|NCT00060255|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
469182|NCT00060255|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
469183|NCT00060255|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
469184|NCT00060255|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
469185|NCT00060255|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
469186|NCT00060255|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
469187|NCT00060255|splenic marginal zone lymphoma|splenic marginal zone lymphoma
469188|NCT00060255|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
469189|NCT00060255|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
469190|NCT00060255|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
469191|NCT00060255|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
469192|NCT00060255|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
469193|NCT00066404|advanced malignant mesothelioma|advanced malignant mesothelioma
469194|NCT00066404|male breast cancer|male breast cancer
469195|NCT00066404|localized malignant mesothelioma|localized malignant mesothelioma
469196|NCT00066404|recurrent bladder cancer|recurrent bladder cancer
469197|NCT00066404|recurrent renal cell cancer|recurrent renal cell cancer
469198|NCT00066404|recurrent urethral cancer|recurrent urethral cancer
469199|NCT00066404|recurrent breast cancer|recurrent breast cancer
469200|NCT00066404|recurrent penile cancer|recurrent penile cancer
469201|NCT00066404|recurrent prostate cancer|recurrent prostate cancer
469202|NCT00066404|recurrent anal cancer|recurrent anal cancer
469203|NCT00066404|recurrent colon cancer|recurrent colon cancer
469204|NCT00066404|recurrent esophageal cancer|recurrent esophageal cancer
469205|NCT00066404|recurrent gastric cancer|recurrent gastric cancer
469206|NCT00066404|recurrent pancreatic cancer|recurrent pancreatic cancer
469207|NCT00066404|recurrent rectal cancer|recurrent rectal cancer
469208|NCT00066404|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
469209|NCT00066404|recurrent small intestine cancer|recurrent small intestine cancer
469210|NCT00066404|recurrent gallbladder cancer|recurrent gallbladder cancer
469211|NCT00066404|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
469212|NCT00066404|recurrent adult primary liver cancer|recurrent adult primary liver cancer
469213|NCT00066404|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
469214|NCT00066404|recurrent small cell lung cancer|recurrent small cell lung cancer
469215|NCT00066404|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
469216|NCT00066404|recurrent melanoma|recurrent melanoma
469217|NCT00066404|recurrent malignant mesothelioma|recurrent malignant mesothelioma
469218|NCT00066404|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
469219|NCT00066404|recurrent cervical cancer|recurrent cervical cancer
469220|NCT00066404|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
469221|NCT00066404|fallopian tube cancer|fallopian tube cancer
469222|NCT00066404|recurrent vulvar cancer|recurrent vulvar cancer
469223|NCT00066404|recurrent vaginal cancer|recurrent vaginal cancer
469224|NCT00066404|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
469225|NCT00066404|recurrent endometrial carcinoma|recurrent endometrial carcinoma
469226|NCT00066404|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
469227|NCT00066404|malignant pleural effusion|malignant pleural effusion
469228|NCT00066417|essential thrombocythemia|essential thrombocythemia
469229|NCT00066417|polycythemia vera|polycythemia vera
469230|NCT00066417|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
469231|NCT00066417|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
89413|NCT02728674|Symptom|symptom
469232|NCT00066417|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
469233|NCT00066417|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
469234|NCT00066417|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
469235|NCT00066417|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
469236|NCT00066417|secondary acute myeloid leukemia|secondary acute myeloid leukemia
469237|NCT00066417|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
469238|NCT00066417|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
469239|NCT00066417|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
469240|NCT00066417|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
469241|NCT00066417|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
469242|NCT00066417|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
469243|NCT00066417|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
469244|NCT00066417|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
469245|NCT00066417|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
469246|NCT00066417|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
469247|NCT00066417|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
469248|NCT00066417|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
469249|NCT00066417|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
469250|NCT00066417|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
469251|NCT00066417|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
469252|NCT00066430|anal cancer|anal cancer
469253|NCT00066430|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
469254|NCT00066443|stage IIIA breast cancer|stage iiia breast cancer
469255|NCT00066443|stage IIIB breast cancer|stage iiib breast cancer
469256|NCT00066443|stage IIIC breast cancer|stage iiic breast cancer
469257|NCT00066443|inflammatory breast cancer|inflammatory breast cancer
469258|NCT00066469|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
469259|NCT00066482|childhood teratoma|childhood teratoma
469260|NCT00066482|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
469476|NCT00067613|Chronic Lung Disease (CLD)|chronic lung disease (cld)
469261|NCT00066508|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
469262|NCT00066547|recurrent breast cancer|recurrent breast cancer
469263|NCT00066547|stage IIIA breast cancer|stage iiia breast cancer
469264|NCT00066547|stage IIIB breast cancer|stage iiib breast cancer
469265|NCT00066547|stage IIIC breast cancer|stage iiic breast cancer
469266|NCT00066547|stage IV breast cancer|stage iv breast cancer
469267|NCT00066573|stage IIIA breast cancer|stage iiia breast cancer
469268|NCT00066573|stage I breast cancer|stage i breast cancer
469269|NCT00066573|stage II breast cancer|stage ii breast cancer
469270|NCT00066586|breast cancer|breast cancer
469271|NCT00066599|neutropenia|neutropenia
469272|NCT00066599|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
469273|NCT00066599|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
469274|NCT00066599|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
469275|NCT00066599|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
469276|NCT00066599|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
469277|NCT00066599|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
469278|NCT00066599|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
469279|NCT00066599|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
469280|NCT00066599|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
469281|NCT00066599|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
469282|NCT00066599|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
469283|NCT00066599|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
469284|NCT00066599|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
469285|NCT00066599|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
469286|NCT00066599|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
469287|NCT00066599|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
469288|NCT00066599|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
469289|NCT00066599|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
469290|NCT00066599|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
469291|NCT00066599|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
469292|NCT00066599|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
469293|NCT00066599|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
469294|NCT00066599|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
89414|NCT02728674|Opioids|opioids
468734|NCT00059137|Gating|gating
469295|NCT00066599|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
469430|NCT00067431|Partial Seizures|partial seizures
469296|NCT00066599|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
469297|NCT00066599|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
469298|NCT00066599|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
583829|NCT00512824|acute diarrhea|acute diarrhea
469299|NCT00066599|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
469300|NCT00066599|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
469301|NCT00066599|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
469302|NCT00066599|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
469303|NCT00066599|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
469304|NCT00066599|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
469305|NCT00066599|anaplastic large cell lymphoma|anaplastic large cell lymphoma
469306|NCT00066599|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
469307|NCT00066599|intraocular lymphoma|intraocular lymphoma
469308|NCT00066599|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
469309|NCT00066599|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
469310|NCT00066599|acute undifferentiated leukemia|acute undifferentiated leukemia
469311|NCT00066599|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
469312|NCT00066599|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
469313|NCT00066599|secondary acute myeloid leukemia|secondary acute myeloid leukemia
469314|NCT00066599|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
469315|NCT00066599|disseminated neuroblastoma|disseminated neuroblastoma
469316|NCT00066599|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
469317|NCT00066599|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
469318|NCT00066599|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
469319|NCT00066599|stage I multiple myeloma|stage i multiple myeloma
469320|NCT00066599|stage II multiple myeloma|stage ii multiple myeloma
469321|NCT00066599|stage III multiple myeloma|stage iii multiple myeloma
469322|NCT00066599|refractory multiple myeloma|refractory multiple myeloma
469323|NCT00066599|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
469324|NCT00066599|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
469325|NCT00066599|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
469326|NCT00066599|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
469327|NCT00066599|recurrent neuroblastoma|recurrent neuroblastoma
469328|NCT00066599|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
469329|NCT00066599|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
469330|NCT00066612|recurrent bladder cancer|recurrent bladder cancer
469331|NCT00066612|stage IV bladder cancer|stage iv bladder cancer
469332|NCT00066612|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
469333|NCT00066612|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
469334|NCT00066612|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
469335|NCT00066612|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
469336|NCT00066612|anterior urethral cancer|anterior urethral cancer
469337|NCT00066612|posterior urethral cancer|posterior urethral cancer
469338|NCT00066612|recurrent urethral cancer|recurrent urethral cancer
469339|NCT00066612|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
469340|NCT00066651|ovarian carcinosarcoma|ovarian carcinosarcoma
469341|NCT00066651|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
469342|NCT00066651|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
469343|NCT00066651|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
469344|NCT00066651|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
469345|NCT00066651|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
469346|NCT00066651|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
469347|NCT00066651|Brenner tumor|brenner tumor
469348|NCT00066651|primary peritoneal cavity cancer|primary peritoneal cavity cancer
469349|NCT00066651|fallopian tube cancer|fallopian tube cancer
469350|NCT00066651|epithelial mesothelioma|epithelial mesothelioma
469351|NCT00066651|recurrent malignant mesothelioma|recurrent malignant mesothelioma
469352|NCT00066651|recurrent pancreatic cancer|recurrent pancreatic cancer
469353|NCT00066651|cervical squamous cell carcinoma|cervical squamous cell carcinoma
469354|NCT00066651|recurrent cervical cancer|recurrent cervical cancer
469355|NCT00066651|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
469356|NCT00066651|squamous cell lung cancer|squamous cell lung cancer
603395|NCT00585572|MCI|mci
468781|NCT00059306|aspirin|aspirin
469357|NCT00066651|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
469358|NCT00066651|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
469359|NCT00066651|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
469360|NCT00066651|recurrent salivary gland cancer|recurrent salivary gland cancer
469361|NCT00066651|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
583830|NCT00512837|Telemedicine|telemedicine
469362|NCT00066651|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
469363|NCT00066651|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
469364|NCT00066651|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
469365|NCT00066651|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
469366|NCT00066664|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
469367|NCT00066664|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
469368|NCT00066664|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
469369|NCT00066664|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
469370|NCT00066664|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
469371|NCT00066664|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
469372|NCT00066664|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
469373|NCT00066664|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
469374|NCT00066664|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
469375|NCT00066664|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
469376|NCT00066677|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
469377|NCT00066677|recurrent pancreatic cancer|recurrent pancreatic cancer
469378|NCT00066677|stage IV pancreatic cancer|stage iv pancreatic cancer
469380|NCT00066690|ovarian function suppression + tamoxifen|ovarian function suppression + tamoxifen
469381|NCT00066690|ovarian function suppression + exemestane|ovarian function suppression + exemestane
469382|NCT00066703|stage II breast cancer|stage ii breast cancer
469383|NCT00066703|stage IIIA breast cancer|stage iiia breast cancer
469384|NCT00066703|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
469385|NCT00066703|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
469386|NCT00066703|stage IA breast cancer|stage ia breast cancer
469387|NCT00066703|stage IB breast cancer|stage ib breast cancer
469388|NCT00066716|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
469814|NCT00068848|Initiation|initiation
469389|NCT00066716|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
469390|NCT00066716|stage I esophageal cancer|stage i esophageal cancer
469391|NCT00066716|stage II esophageal cancer|stage ii esophageal cancer
469392|NCT00066716|stage III esophageal cancer|stage iii esophageal cancer
469393|NCT00066716|stage IV esophageal cancer (lymph node metastasis only)|stage iv esophageal cancer (lymph node metastasis only)
469394|NCT00066729|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
469395|NCT00066729|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
469396|NCT00066729|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
469397|NCT00066729|primary peritoneal cavity cancer|primary peritoneal cavity cancer
469398|NCT00066729|fallopian tube cancer|fallopian tube cancer
469399|NCT00066781|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
469400|NCT00066781|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
469401|NCT00066781|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
469402|NCT00066781|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
469403|NCT00066794|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
469404|NCT00066794|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
469405|NCT00066794|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
469406|NCT00066794|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
469407|NCT00066794|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
469408|NCT00066794|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
469409|NCT00066794|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
469410|NCT00066794|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
469411|NCT00066794|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
469412|NCT00066794|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
469413|NCT00066794|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
469414|NCT00066794|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
469415|NCT00066794|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
468913|NCT00059644|CLI|cli
469416|NCT00066794|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
469417|NCT00067392|Partial edentulism|partial edentulism
469418|NCT00067392|Bone atrophy|bone atrophy
469419|NCT00067392|Bone healing|bone healing
469420|NCT00067405|Fibromyalgia|fibromyalgia
469421|NCT00067405|Intravenous micronutrient therapy|intravenous micronutrient therapy
469423|NCT00067405|alternative medicine|alternative medicine
469424|NCT00067405|complementary medicine|complementary medicine
469425|NCT00067405|vitamins|vitamins
469426|NCT00067405|vitamin supplements|vitamin supplements
469427|NCT00067418|Glioma|glioma
469428|NCT00067418|Brain Tumor|brain tumor
469429|NCT00067418|Spectroscopy|spectroscopy
469432|NCT00067444|Major Depressive Disorder|major depressive disorder
469435|NCT00067457|Diarrhea-Predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
469436|NCT00067457|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
469437|NCT00067483|Cataract|cataract
469438|NCT00067483|Pre-Senile|pre-senile
469439|NCT00067483|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
469440|NCT00067483|Light Scattering|light scattering
469441|NCT00067483|Lens|lens
469442|NCT00067483|Cataracts|cataracts
469443|NCT00067496|Pain|pain
469444|NCT00067496|Weakness|weakness
469445|NCT00067496|Depression|depression
469446|NCT00067496|Poliomyelitis|poliomyelitis
469447|NCT00067496|Sleep Apnea|sleep apnea
469448|NCT00067496|Post-Polio Syndrome|post-polio syndrome
469449|NCT00067496|PPS|pps
469450|NCT00067509|Female|female
469451|NCT00067522|Family Planning|family planning
469452|NCT00067522|Sexually Transmitted Diseases|sexually transmitted diseases
469453|NCT00067522|HIV|hiv
469454|NCT00067522|Africa|africa
469455|NCT00067522|Zambia|zambia
469456|NCT00067522|AIDS|aids
469457|NCT00067522|Contraception|contraception
469458|NCT00067522|HIV Prevention|hiv prevention
469459|NCT00067535|cocaine dependence|cocaine dependence
469460|NCT00067548|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
469461|NCT00067561|Dose-ranging|dose-ranging
469462|NCT00067561|Diarrhea-Predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
469463|NCT00067561|d-IBS|d-ibs
469464|NCT00067561|IBS|ibs
469465|NCT00067561|Irritable Bowel Syndrome|irritable bowel syndrome
469466|NCT00067574|Structured treatment interruption|structured treatment interruption
469467|NCT00067574|Treatment experienced|treatment experienced
469468|NCT00067587|Treatment experienced|treatment experienced
469469|NCT00067587|Treatment naive|treatment naive
469470|NCT00067613|NICHD Neonatal Research Network|nichd neonatal research network
469471|NCT00067613|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
469472|NCT00067613|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
469473|NCT00067613|Prematurity|prematurity
469474|NCT00067613|Mechanical ventilation|mechanical ventilation
469475|NCT00067613|Benchmarking|benchmarking
469477|NCT00067626|glucose tolerance test|glucose tolerance test
469478|NCT00067626|minerals|minerals
469479|NCT00067626|chromium|chromium
469480|NCT00067626|complementary and alternative medicine|complementary and alternative medicine
469481|NCT00067639|Multiple Myeloma|multiple myeloma
469482|NCT00067639|PBSC mobilization|pbsc mobilization
469483|NCT00067639|Pegfilgrastim|pegfilgrastim
469484|NCT00067639|Neulasta|neulasta
469485|NCT00067639|PEG-G-CSF|peg-g-csf
469486|NCT00067665|hemodialysis|hemodialysis
469487|NCT00067678|diabetic nephropathy|diabetic nephropathy
469488|NCT00067678|nephropathy|nephropathy
469489|NCT00067678|diabetes|diabetes
469490|NCT00067678|diabetes mellitus|diabetes mellitus
469491|NCT00067678|type I diabetes|type i diabetes
469492|NCT00067678|soy protein|soy protein
469493|NCT00067691|Lung cancer|lung cancer
469494|NCT00067691|Breast cancer|breast cancer
469495|NCT00067691|Shortness of breath|shortness of breath
469496|NCT00067691|Dyspnea|dyspnea
469497|NCT00067691|Metastasis|metastasis
469498|NCT00067691|Breathlessness|breathlessness
469499|NCT00067691|Acupuncture|acupuncture
469500|NCT00067704|Complementary Therapies|complementary therapies
469501|NCT00067717|breast reconstruction surgery|breast reconstruction surgery
469502|NCT00067717|prayer|prayer
469503|NCT00067717|distance healing|distance healing
469504|NCT00067717|wound healing|wound healing
469505|NCT00067743|Pain|pain
469506|NCT00067743|Pain syndrome|pain syndrome
469507|NCT00067743|Reflex sympathetic dystrophy|reflex sympathetic dystrophy
469508|NCT00067743|CC-5013|cc-5013
469509|NCT00067743|CC5013|cc5013
469510|NCT00067743|Revlimid|revlimid
469511|NCT00067743|Celgene|celgene
469512|NCT00067743|CRPS|crps
469513|NCT00067756|Pulmonary Disease|pulmonary disease
469514|NCT00067756|Liver Disease|liver disease
469515|NCT00067769|Encopresis|encopresis
469516|NCT00067769|Internet|internet
469518|NCT00067769|Treatment|treatment
469519|NCT00067769|Intervention|intervention
469520|NCT00067782|HIV|hiv
89415|NCT02728674|Gender bias|gender bias
469521|NCT00067782|Treatment Experienced|treatment experienced
469522|NCT00067795|Treatment Experienced|treatment experienced
469523|NCT00067795|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
469524|NCT00067795|HIV Antigens|hiv antigens
469525|NCT00067795|Cohort Studies|cohort studies
469526|NCT00067795|Immunity, Cellular|immunity, cellular
469527|NCT00067795|T-Lymphocytes|t-lymphocytes
469528|NCT00067808|Myelodysplastic Syndrome|myelodysplastic syndrome
469529|NCT00067808|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
469530|NCT00067808|MDS|mds
469531|NCT00067808|Decitabine|decitabine
469532|NCT00067808|Dacogen|dacogen
469533|NCT00067808|Methylation|methylation
469534|NCT00067821|Brain Tumor|brain tumor
469537|NCT00067821|Spectroscopy|spectroscopy
469538|NCT00067821|PET|pet
469539|NCT00067834|Electromagnetic Fields|electromagnetic fields
469540|NCT00067834|Bone|bone
469541|NCT00067834|Forelimb|forelimb
469542|NCT00067834|Radius|radius
469543|NCT00067847|obesity|obesity
469544|NCT00067847|food policy|food policy
469545|NCT00067847|physical fitness (Respiratory Burst)|physical fitness (respiratory burst)
469546|NCT00067847|academic achievement|academic achievement
469547|NCT00067899|cigarette smoking|cigarette smoking
469548|NCT00067899|tocopherol|tocopherol
469549|NCT00067899|bioavailability|bioavailability
469550|NCT00067899|metabolism|metabolism
469551|NCT00067899|oxidative stress|oxidative stress
469552|NCT00067925|Weight-bearing physical activity|weight-bearing physical activity
469553|NCT00067925|Calcium intake|calcium intake
469554|NCT00067925|School-based health education|school-based health education
469555|NCT00067925|Adolescent girls|adolescent girls
469556|NCT00067925|Child nutrition|child nutrition
469557|NCT00067925|Diet|diet
469558|NCT00067938|bipolar disorder|bipolar disorder
469559|NCT00067938|lamotrigine|lamotrigine
469560|NCT00067951|Hyperglycemia|hyperglycemia
469561|NCT00067951|HbA1c|hba1c
469562|NCT00067951|Hemoglobin A1c|hemoglobin a1c
469563|NCT00067951|Type 2 diabetes mellitus|type 2 diabetes mellitus
469564|NCT00067990|chronic allograft nephropathy|chronic allograft nephropathy
469565|NCT00067990|post transplant proteinuria|post transplant proteinuria
469566|NCT00068003|Adoptive Cell Therapy|adoptive cell therapy
469567|NCT00068003|Screening|screening
469568|NCT00068003|Cell Harvest|cell harvest
469569|NCT00068003|Blood|blood
469570|NCT00068003|Tumor Tissue|tumor tissue
469571|NCT00068055|West Nile Virus, encephalitis, myelitis, immunoglobulin G|west nile virus, encephalitis, myelitis, immunoglobulin g
469572|NCT00068068|Photodynamic therapy|photodynamic therapy
469573|NCT00068068|Liver metastases|liver metastases
469574|NCT00068068|Colorectal cancer|colorectal cancer
469576|NCT00068068|Light Infusion Technology™|light infusion technology™
469577|NCT00068068|Talaporfin sodium|talaporfin sodium
469578|NCT00068068|LS11|ls11
469579|NCT00068068|Liver mets|liver mets
469580|NCT00068068|Metastatic colorectal cancer|metastatic colorectal cancer
469581|NCT00068068|Light emittting diodes (LED)|light emittting diodes (led)
478985|NCT00094575|Abdominal|abdominal
469582|NCT00068068|Tumor ablation|tumor ablation
469583|NCT00068068|Combination therapy|combination therapy
469584|NCT00068081|Dermal assessment|dermal assessment
469585|NCT00068081|Pain measurement|pain measurement
469586|NCT00068081|Diary|diary
469587|NCT00068081|Analgesics/*therapeutic use|analgesics/*therapeutic use
469588|NCT00068081|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
469589|NCT00068081|Herpes zoster/*complication/drug therapy|herpes zoster/*complication/drug therapy
469590|NCT00068081|Neuralgia/*drug therapy/etiology|neuralgia/*drug therapy/etiology
469591|NCT00068081|Pain|pain
469592|NCT00068081|Peripheral nervous system diseases/*complications|peripheral nervous system diseases/*complications
469593|NCT00068094|Probiotics|probiotics
469594|NCT00068094|Bacteria|bacteria
469595|NCT00068107|Lysosomal Storage|lysosomal storage
469596|NCT00068107|Renal Insufficiency|renal insufficiency
469597|NCT00068107|Stroke|stroke
469598|NCT00068107|Hypohidrosis|hypohidrosis
469599|NCT00068107|Peripheral Neuropathy|peripheral neuropathy
469600|NCT00068107|Fabry Disease|fabry disease
469601|NCT00068120|Urinary tract infection|urinary tract infection
469602|NCT00068146|Adenopathy|adenopathy
469603|NCT00068146|Genetic Disorder|genetic disorder
469604|NCT00068146|Apoptosis|apoptosis
469605|NCT00068146|Diagnostic Imaging|diagnostic imaging
469606|NCT00068146|Hodgkins|hodgkins
469607|NCT00068146|Autoimmune Lymphoproliferative|autoimmune lymphoproliferative
469608|NCT00068146|Syndrome|syndrome
469609|NCT00068146|ALPS|alps
469610|NCT00068146|ALPS-Associated Lymphoma|alps-associated lymphoma
469611|NCT00068159|Hereditary Disease|hereditary disease
469612|NCT00068159|Diastolic Dysfunction|diastolic dysfunction
469613|NCT00068159|Exercise Tolerance|exercise tolerance
469614|NCT00068159|Exercise Stress Echocardiography|exercise stress echocardiography
469615|NCT00068159|MRI|mri
469616|NCT00068159|Hereditary Hemochromatosis|hereditary hemochromatosis
469617|NCT00068159|HH|hh
469618|NCT00068159|Iron Overload|iron overload
469619|NCT00068185|Black cohosh|black cohosh
469620|NCT00068185|Pharmacokinetics|pharmacokinetics
469621|NCT00068185|Alternative therapies|alternative therapies
469622|NCT00068185|Natural product|natural product
469623|NCT00068211|Metastatic Melanoma|metastatic melanoma
469624|NCT00068211|Melanoma|melanoma
469625|NCT00068211|Inoperable Locally Advanced Melanoma|inoperable locally advanced melanoma
469626|NCT00068224|Caroli's Syndrome|caroli's syndrome
469627|NCT00068224|Congenital Hepatic Fibrosis|congenital hepatic fibrosis
469628|NCT00068224|Ductal Plate Malformation|ductal plate malformation
469629|NCT00068224|Ciliopathy|ciliopathy
469630|NCT00068224|Polycystic Kidney|polycystic kidney
469631|NCT00068224|Polycystic Liver|polycystic liver
469632|NCT00068224|Nephronophthisis|nephronophthisis
469633|NCT00068224|Molar Tooth Sign|molar tooth sign
469634|NCT00068224|Dandy-Walker Malformation|dandy-walker malformation
469635|NCT00068224|Retinopathy|retinopathy
469636|NCT00068224|Situs Inversus|situs inversus
469637|NCT00068224|Heterotaxia|heterotaxia
469638|NCT00068224|Cerebellar Vermis Hypoplasia|cerebellar vermis hypoplasia
469639|NCT00068224|Autosomal Recessive Polycystic Kidney Disease|autosomal recessive polycystic kidney disease
469640|NCT00068224|ARPKD|arpkd
469641|NCT00068224|Kidney|kidney
469642|NCT00068224|Liver|liver
469643|NCT00068237|xerostomia|xerostomia
469644|NCT00068237|radiation toxicity|radiation toxicity
469645|NCT00068237|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
469646|NCT00068237|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
469647|NCT00068237|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
469648|NCT00068237|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
469649|NCT00068237|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
469650|NCT00068237|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
469651|NCT00068237|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
469652|NCT00068237|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
469653|NCT00068237|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
469654|NCT00068237|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
469655|NCT00068250|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
469656|NCT00068250|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
469657|NCT00068263|stage I breast cancer|stage i breast cancer
469658|NCT00068263|stage II breast cancer|stage ii breast cancer
469659|NCT00068276|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
469660|NCT00068276|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
469661|NCT00068276|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
469662|NCT00068276|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
469663|NCT00068276|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
469664|NCT00068276|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
469665|NCT00068289|extensive stage small cell lung cancer|extensive stage small cell lung cancer
469666|NCT00068289|recurrent small cell lung cancer|recurrent small cell lung cancer
469667|NCT00068302|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
469668|NCT00068302|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
469669|NCT00068302|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
469670|NCT00068302|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
469671|NCT00068302|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
469672|NCT00068328|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
469674|NCT00068328|stage IIIA breast cancer|stage iiia breast cancer
469675|NCT00068328|stage IIIB breast cancer|stage iiib breast cancer
469676|NCT00068328|stage IIIC breast cancer|stage iiic breast cancer
469677|NCT00068328|stage IA breast cancer|stage ia breast cancer
469678|NCT00068328|stage IB breast cancer|stage ib breast cancer
469679|NCT00068328|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
469680|NCT00068328|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
469681|NCT00068341|stage IIIA breast cancer|stage iiia breast cancer
469682|NCT00068341|stage IIIB breast cancer|stage iiib breast cancer
469683|NCT00068341|stage IIIC breast cancer|stage iiic breast cancer
469684|NCT00068341|stage II breast cancer|stage ii breast cancer
469685|NCT00068367|adult neurofibrosarcoma|adult neurofibrosarcoma
469686|NCT00068367|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
469687|NCT00068367|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
469688|NCT00068367|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
469689|NCT00068367|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
469690|NCT00068393|Sarcomatoid|sarcomatoid
469691|NCT00068393|Gemcitabine|gemcitabine
469692|NCT00068393|Doxorubicin|doxorubicin
603864|NCT00597532|Soy|soy
469138|NCT00060138|bone metastases|bone metastases
469693|NCT00068393|Renal cell cancer|renal cell cancer
469694|NCT00068393|Kidney cancer|kidney cancer
469695|NCT00068406|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
469696|NCT00068406|stage III vulvar cancer|stage iii vulvar cancer
469697|NCT00068406|stage IVB vulvar cancer|stage ivb vulvar cancer
469698|NCT00068432|recurrent pancreatic cancer|recurrent pancreatic cancer
469699|NCT00068432|stage IV pancreatic cancer|stage iv pancreatic cancer
469700|NCT00068445|neurotoxicity|neurotoxicity
469701|NCT00068445|pain|pain
469702|NCT00068445|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
469703|NCT00068458|weight changes|weight changes
469704|NCT00068458|depression|depression
469705|NCT00068458|stage I breast cancer|stage i breast cancer
469706|NCT00068458|stage II breast cancer|stage ii breast cancer
469707|NCT00068458|stage IIIA breast cancer|stage iiia breast cancer
469710|NCT00068471|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
469711|NCT00068510|adult glioblastoma|adult glioblastoma
469712|NCT00068510|adult anaplastic astrocytoma|adult anaplastic astrocytoma
469713|NCT00068510|adult brain tumor|adult brain tumor
469714|NCT00068510|adult giant cell glioblastoma|adult giant cell glioblastoma
469715|NCT00068510|adult gliosarcoma|adult gliosarcoma
469716|NCT00068510|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
469717|NCT00068523|refractory multiple myeloma|refractory multiple myeloma
469718|NCT00068523|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
469719|NCT00068523|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
469720|NCT00068523|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
469721|NCT00068523|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
469722|NCT00068523|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
469723|NCT00068523|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
469724|NCT00068523|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
469725|NCT00068523|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
469726|NCT00068523|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
469727|NCT00068523|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
469728|NCT00068523|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
469729|NCT00068523|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
469730|NCT00068523|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
469731|NCT00068523|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
469732|NCT00068523|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
469733|NCT00068523|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
469734|NCT00068523|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
469735|NCT00068523|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
469736|NCT00068523|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
469737|NCT00068523|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
469738|NCT00068523|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
469815|NCT00068848|Continuation|continuation
469739|NCT00068523|refractory anemia with excess blasts|refractory anemia with excess blasts
469740|NCT00068523|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
469741|NCT00068523|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
469742|NCT00068523|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
469743|NCT00068523|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
469744|NCT00068523|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
469745|NCT00068523|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
469746|NCT00068523|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
469747|NCT00068523|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
469748|NCT00068523|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
469749|NCT00068523|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
469750|NCT00068523|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
469751|NCT00068523|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
469752|NCT00068523|secondary acute myeloid leukemia|secondary acute myeloid leukemia
469753|NCT00068523|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
469754|NCT00068523|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
469755|NCT00068523|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
469756|NCT00068523|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
469757|NCT00068523|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
469758|NCT00068523|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
469759|NCT00068523|splenic marginal zone lymphoma|splenic marginal zone lymphoma
469760|NCT00068523|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
469761|NCT00068523|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
469762|NCT00068523|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
469763|NCT00068523|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
469764|NCT00068523|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
469765|NCT00068575|stage I pancreatic cancer|stage i pancreatic cancer
469766|NCT00068575|stage II pancreatic cancer|stage ii pancreatic cancer
469767|NCT00068575|stage III pancreatic cancer|stage iii pancreatic cancer
469768|NCT00068575|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
469769|NCT00068601|infertility|infertility
469770|NCT00068601|menopausal symptoms|menopausal symptoms
469771|NCT00068601|stage II breast cancer|stage ii breast cancer
469772|NCT00068601|stage IIIA breast cancer|stage iiia breast cancer
469773|NCT00068601|stage IA breast cancer|stage ia breast cancer
469774|NCT00068601|stage IB breast cancer|stage ib breast cancer
469775|NCT00068601|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
469776|NCT00068601|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
469777|NCT00068614|stage IV breast cancer|stage iv breast cancer
469778|NCT00068614|stage II breast cancer|stage ii breast cancer
469779|NCT00068614|stage IIIA breast cancer|stage iiia breast cancer
469780|NCT00068614|stage IIIB breast cancer|stage iiib breast cancer
469781|NCT00068614|stage IIIC breast cancer|stage iiic breast cancer
469782|NCT00068653|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
469783|NCT00068666|stage IV melanoma|stage iv melanoma
469784|NCT00068666|recurrent melanoma|recurrent melanoma
469785|NCT00068666|tumors metastatic to brain|tumors metastatic to brain
469786|NCT00068731|stage IV prostate cancer|stage iv prostate cancer
469787|NCT00068731|recurrent prostate cancer|recurrent prostate cancer
469788|NCT00068744|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
469789|NCT00068744|stage II anal cancer|stage ii anal cancer
469790|NCT00068744|stage IIIA anal cancer|stage iiia anal cancer
469791|NCT00068744|stage IIIB anal cancer|stage iiib anal cancer
469792|NCT00068757|recurrent breast cancer|recurrent breast cancer
469793|NCT00068757|stage IIIB breast cancer|stage iiib breast cancer
469794|NCT00068757|stage IIIC breast cancer|stage iiic breast cancer
469795|NCT00068757|stage IV breast cancer|stage iv breast cancer
469796|NCT00068757|male breast cancer|male breast cancer
469797|NCT00068757|HER2-positive breast cancer|her2-positive breast cancer
469798|NCT00068770|adult glioblastoma|adult glioblastoma
469799|NCT00068770|adult giant cell glioblastoma|adult giant cell glioblastoma
469800|NCT00068770|adult gliosarcoma|adult gliosarcoma
469801|NCT00068809|Treatment experienced|treatment experienced
469802|NCT00068809|Treatment interruption|treatment interruption
469803|NCT00068822|Vertebroplasty|vertebroplasty
469804|NCT00068822|Crushed Vertebrae|crushed vertebrae
469805|NCT00068822|Back Pain|back pain
13059|NCT03207113|realist evaluation|realist evaluation
469806|NCT00068822|Structurally Unstable Vertebrae|structurally unstable vertebrae
469807|NCT00068822|polymethylmethacrylate|polymethylmethacrylate
469808|NCT00068822|INVEST|invest
469809|NCT00068822|PMMA|pmma
469810|NCT00068822|RDQ|rdq
469811|NCT00068835|Reading|reading
469812|NCT00068835|Brain imaging|brain imaging
469813|NCT00068848|Oral Contraceptives|oral contraceptives
469816|NCT00068874|African American|african american
469817|NCT00068874|Adolescent|adolescent
469818|NCT00068874|Coping|coping
469819|NCT00068874|Adjustment|adjustment
469820|NCT00068874|Quality of Life|quality of life
469821|NCT00068887|type 2 diabetes|type 2 diabetes
469822|NCT00068887|some studies - family history of type 2 diabetes|some studies - family history of type 2 diabetes
469823|NCT00068913|Lactic Acidosis|lactic acidosis
469824|NCT00068913|Mitochondrial Disorder|mitochondrial disorder
469825|NCT00068913|Stroke|stroke
469826|NCT00068913|Seizure|seizure
469827|NCT00068926|Biodefense|biodefense
469828|NCT00068926|Prevention|prevention
469829|NCT00068926|Emergent|emergent
469830|NCT00068926|Virus|virus
469831|NCT00068926|Immune Response|immune response
469832|NCT00068926|Healthy Volunteer|healthy volunteer
469833|NCT00068926|HV|hv
469834|NCT00068978|HIV Seronegativity|hiv seronegativity
469835|NCT00068978|HIV Preventive Vaccine|hiv preventive vaccine
469836|NCT00068978|HIV Therapeutic Vaccine|hiv therapeutic vaccine
469837|NCT00068991|Behavioral Intervention Study|behavioral intervention study
469838|NCT00068991|Randomized Prevention Trial|randomized prevention trial
469839|NCT00068991|China|china
469840|NCT00068991|Condom Use|condom use
469841|NCT00068991|STDs|stds
469842|NCT00068991|Sexual Partners|sexual partners
469843|NCT00068991|HIV Seronegativity|hiv seronegativity
469844|NCT00069004|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
469845|NCT00069004|HIV Lipodystrophy Syndrome|hiv lipodystrophy syndrome
469846|NCT00069004|Treatment Experienced|treatment experienced
469847|NCT00069004|Lipodystrophy|lipodystrophy
469848|NCT00069004|Dyslipidemia|dyslipidemia
469849|NCT00069004|Osteoporosis|osteoporosis
469850|NCT00069004|Osteopenia|osteopenia
469851|NCT00069030|HIV Seronegativity|hiv seronegativity
469852|NCT00069030|HIV Preventive Vaccine|hiv preventive vaccine
469853|NCT00069030|HIV-1|hiv-1
469854|NCT00069030|AIDS Vaccines|aids vaccines
469855|NCT00069030|Vaccines, DNA|vaccines, dna
469856|NCT00069030|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
469857|NCT00069030|Cytokines|cytokines
469858|NCT00069030|Plasmids|plasmids
469859|NCT00069030|Adjuvants, Immunologic|adjuvants, immunologic
469860|NCT00069030|Drug Administration Schedule|drug administration schedule
469861|NCT00069030|Interleukin|interleukin
469863|NCT00069030|Ig|ig
469864|NCT00069030|IL@/Ig|il@/ig
469865|NCT00069056|Grid Laser|grid laser
469866|NCT00069056|Focal Laser|focal laser
469867|NCT00069056|Glycemic Control|glycemic control
469868|NCT00069056|Diabetes|diabetes
469869|NCT00069056|Diabetic Macular Edema|diabetic macular edema
469870|NCT00069056|Macular Edema|macular edema
469871|NCT00069069|Stroke|stroke
469872|NCT00069069|TIA|tia
469873|NCT00069082|Headache|headache
469874|NCT00069082|Cluster|cluster
469876|NCT00069082|Episodic Cluster|episodic cluster
469877|NCT00069134|glutathione kinetics|glutathione kinetics
469878|NCT00069134|oxidant damage|oxidant damage
469879|NCT00069134|anti-oxidant capacity|anti-oxidant capacity
469880|NCT00069134|oxidative stress|oxidative stress
469881|NCT00069134|cysteine kinetics|cysteine kinetics
469882|NCT00069134|severe childhood malnutrition|severe childhood malnutrition
469883|NCT00069160|Pharmacokinetics|pharmacokinetics
469884|NCT00069160|Pharmacodynamics|pharmacodynamics
469885|NCT00069160|Multidrug Resistance Reversal|multidrug resistance reversal
469886|NCT00069160|Molecular Target|molecular target
469887|NCT00069160|P-Glycoprotein Inhibition|p-glycoprotein inhibition
469888|NCT00069160|Lung Cancer|lung cancer
469889|NCT00069160|Ovarian Cancer|ovarian cancer
469890|NCT00069160|Cervical Cancer|cervical cancer
469891|NCT00069160|Renal Cancer|renal cancer
469892|NCT00069173|Females|females
469893|NCT00069173|Sedentary|sedentary
469894|NCT00069173|School-based|school-based
469895|NCT00069186|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
469896|NCT00069186|ALS|als
469897|NCT00069186|Creatine|creatine
469898|NCT00069186|Creatine Monohydrate|creatine monohydrate
469899|NCT00069186|Muscle Strength|muscle strength
469900|NCT00069199|Reproducibility|reproducibility
469901|NCT00069199|Macular Edema|macular edema
469902|NCT00069199|OCT2|oct2
469903|NCT00069199|OCT3|oct3
469904|NCT00069199|Retina|retina
469905|NCT00069212|Post-Traumatic Stress Disorder|post-traumatic stress disorder
469906|NCT00069212|Neural Circuits|neural circuits
469907|NCT00069212|Fear|fear
469908|NCT00069212|Emotional Regulation|emotional regulation
469909|NCT00069212|Reward|reward
469910|NCT00069212|PTSD|ptsd
469911|NCT00069225|fMRI|fmri
469912|NCT00069225|Prolonged Exposure|prolonged exposure
469913|NCT00069225|Brain Activation|brain activation
469914|NCT00069225|Conditioning|conditioning
469915|NCT00069225|Paroxetine|paroxetine
469916|NCT00069225|PTSD|ptsd
469917|NCT00069225|Differential Fear Conditioning|differential fear conditioning
469918|NCT00069225|Masked Faces|masked faces
469919|NCT00069225|Amygdala|amygdala
469920|NCT00069225|Hippocampus|hippocampus
469921|NCT00069225|Post-Traumatic Stress Disorder|post-traumatic stress disorder
469923|NCT00069238|T-Cell Lymphoma|t-cell lymphoma
469924|NCT00069238|NK -Cell Lymphoma|nk -cell lymphoma
469925|NCT00069251|amphetamine dependence|amphetamine dependence
469926|NCT00069264|Metastatic Tumors|metastatic tumors
469927|NCT00069264|Advanced Solid Tumors|advanced solid tumors
469928|NCT00069264|Stage IV Tumors|stage iv tumors
469929|NCT00069264|Solid Tumors|solid tumors
469930|NCT00069264|Recurrent Solid Tumors|recurrent solid tumors
469931|NCT00069277|Cancer, tumors|cancer, tumors
469932|NCT00069303|West Nile Virus|west nile virus
469933|NCT00069303|Encephalitis|encephalitis
469934|NCT00069303|Virus|virus
469935|NCT00069303|Mosquito|mosquito
469936|NCT00069303|Fever|fever
469937|NCT00069303|WNV|wnv
469938|NCT00069303|Myelitis|myelitis
469939|NCT00069316|West Nile Virus|west nile virus
469940|NCT00069316|Encephalitis|encephalitis
469941|NCT00069316|Virus|virus
469942|NCT00069316|Mosquito|mosquito
469943|NCT00069316|Fever|fever
469944|NCT00069316|WNV|wnv
469945|NCT00069316|Myelitis|myelitis
469946|NCT00069329|Central Nervous System|central nervous system
469947|NCT00069329|Abnormalities|abnormalities
469948|NCT00069329|Arthropathy|arthropathy
469949|NCT00069329|Urticaria|urticaria
469950|NCT00069329|Papilledema|papilledema
469951|NCT00069329|Auto-Inflammation|auto-inflammation
469952|NCT00069329|Inflammatory Disease|inflammatory disease
469953|NCT00069329|Neonatal Onset Multisystem Inflammatory Disease|neonatal onset multisystem inflammatory disease
469954|NCT00069329|NOMID|nomid
469955|NCT00069329|CINCA Syndrome|cinca syndrome
469956|NCT00069342|Chronic Pain|chronic pain
469957|NCT00069342|Pain|pain
469958|NCT00069342|Rheumatoid Arthritis|rheumatoid arthritis
469959|NCT00069342|Depression|depression
469960|NCT00069342|Function|function
469961|NCT00069342|Rheumatic Disease|rheumatic disease
469962|NCT00069355|PTSD|ptsd
469963|NCT00069355|Catecholamines|catecholamines
469964|NCT00069355|Conditioning|conditioning
469965|NCT00069355|Memory|memory
469966|NCT00069355|Psychophysiology|psychophysiology
469967|NCT00069355|Acute Stress Disorder|acute stress disorder
469968|NCT00069355|Post-Traumatic Stress Disorder|post-traumatic stress disorder
469969|NCT00069368|Healthy|healthy
469970|NCT00069407|Bipolar Disorder|bipolar disorder
469971|NCT00069433|Psychotic Disorders|psychotic disorders
469972|NCT00069446|Diabetes|diabetes
469973|NCT00069446|Diabetic|diabetic
469974|NCT00069446|Diabetic Foot Ulcer|diabetic foot ulcer
469975|NCT00069459|Winter depression, winter blues, depression, seasonal depression, seasonal affective disorder|winter depression, winter blues, depression, seasonal depression, seasonal affective disorder
469976|NCT00069472|Genetics|genetics
469977|NCT00069485|HIV Seronegativity|hiv seronegativity
469979|NCT00069498|Inflammation|inflammation
469980|NCT00069498|Tissue Viral Load|tissue viral load
469981|NCT00069498|Anti-inflammatory|anti-inflammatory
469982|NCT00069498|HIV-related diarrhea|hiv-related diarrhea
469983|NCT00069498|Mucosal Inflammation|mucosal inflammation
469984|NCT00069498|Treatment Experienced|treatment experienced
469985|NCT00069511|Hepatitis C|hepatitis c
469986|NCT00069524|Highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
469987|NCT00069524|Ritonavir|ritonavir
469988|NCT00069524|Oyster mushrooms|oyster mushrooms
469989|NCT00069524|Non-HDL cholesterol|non-hdl cholesterol
469990|NCT00069524|Complementary Therapies|complementary therapies
469991|NCT00069524|Treatment Experienced|treatment experienced
469992|NCT00069537|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
469993|NCT00069537|Type 1 Diabetes|type 1 diabetes
469994|NCT00069537|Diabetes in Children|diabetes in children
469995|NCT00069537|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
469996|NCT00069550|Glutamate/NMDA receptors|glutamate/nmda receptors
469997|NCT00069550|Cholinergic upregulation|cholinergic upregulation
469998|NCT00069550|Dextromethorphan|dextromethorphan
469999|NCT00069550|Donepezil hydrochloride|donepezil hydrochloride
470000|NCT00069550|Aricept|aricept
470001|NCT00069563|Internalizing psychopathology|internalizing psychopathology
470002|NCT00069563|Externalizing psychopathology|externalizing psychopathology
470003|NCT00069576|Mild gestational diabetes mellitus|mild gestational diabetes mellitus
470004|NCT00069576|Maternal Fetal Medicine Units Network|maternal fetal medicine units network
470005|NCT00069589|Baldness|baldness
470006|NCT00069589|Autoimmunity|autoimmunity
470007|NCT00069589|Hair|hair
470008|NCT00069589|Alopecia Areata|alopecia areata
470009|NCT00069589|Alopecia Partialis|alopecia partialis
470010|NCT00069589|Alopecia Totalis|alopecia totalis
470011|NCT00069589|Alopecia Universalis|alopecia universalis
470012|NCT00069589|Autoimmune Hair Loss|autoimmune hair loss
470013|NCT00069602|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
470014|NCT00069602|Blood glucose profiles in normal children|blood glucose profiles in normal children
470015|NCT00069602|Blood glucose profiles in non-diabetic children|blood glucose profiles in non-diabetic children
470016|NCT00069615|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
470017|NCT00069615|Type 1 Diabetes|type 1 diabetes
470018|NCT00069615|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
470019|NCT00069615|Electronic Data Collection|electronic data collection
470020|NCT00069628|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
470021|NCT00069628|Type 1 Diabetes|type 1 diabetes
470022|NCT00069628|Diabetes in Children|diabetes in children
470023|NCT00069628|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
470024|NCT00069641|Mucopolysaccharidosis II|mucopolysaccharidosis ii
470025|NCT00069641|MPS II|mps ii
470026|NCT00069641|Hunter Syndrome|hunter syndrome
470027|NCT00069641|iduronate-2-sulfatase|iduronate-2-sulfatase
470028|NCT00069641|I2S|i2s
470029|NCT00069641|Iduronate-2-sulfatase deficiency|iduronate-2-sulfatase deficiency
470030|NCT00069654|Endothelium|endothelium
470031|NCT00069654|Atherosclerosis|atherosclerosis
470032|NCT00069654|Vasodilation|vasodilation
470033|NCT00069654|Ischemia|ischemia
470034|NCT00069654|Exercise|exercise
470035|NCT00069654|Coronary Artery Disease|coronary artery disease
470036|NCT00069654|CAD|cad
470037|NCT00069680|Gene Identification|gene identification
470038|NCT00069680|Linkage Analysis|linkage analysis
470039|NCT00069680|Homozygosity Mapping|homozygosity mapping
470040|NCT00069680|Gray Platelet Syndrome|gray platelet syndrome
470041|NCT00069680|GPS|gps
470042|NCT00069680|Platelet Function Defect|platelet function defect
470043|NCT00069680|Bleeding Disorder|bleeding disorder
470044|NCT00069693|Dysautonomia|dysautonomia
470045|NCT00069693|Sympathetic Nervous System|sympathetic nervous system
470046|NCT00069693|Autonomic Nervous System|autonomic nervous system
470047|NCT00069693|Syncope|syncope
470048|NCT00069693|Post Tachycardia Syndrome|post tachycardia syndrome
470049|NCT00069693|POTS|pots
470050|NCT00069693|Neurocardiogenic Syncope|neurocardiogenic syncope
470051|NCT00069693|Baroreflex|baroreflex
470052|NCT00069693|Norepinephrine|norepinephrine
470053|NCT00069693|Epinephrine|epinephrine
470054|NCT00069693|Neurocardiology|neurocardiology
470055|NCT00069693|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
470056|NCT00069693|COI|coi
470057|NCT00069693|Healthy Volunteer|healthy volunteer
470058|NCT00069693|HV|hv
470059|NCT00069706|open-angle|open-angle
470060|NCT00069706|glaucoma|glaucoma
470061|NCT00069706|ocular|ocular
470062|NCT00069706|hypertension|hypertension
470063|NCT00069706|POAG|poag
470064|NCT00069719|open-angle|open-angle
470065|NCT00069719|glaucoma|glaucoma
470066|NCT00069719|ocular|ocular
470067|NCT00069719|hypertension|hypertension
470068|NCT00069719|POAG|poag
470069|NCT00069732|Overweight|overweight
470070|NCT00069732|Weight loss maintenance|weight loss maintenance
470071|NCT00069732|CAM therapy|cam therapy
470072|NCT00069732|Qigong|qigong
470073|NCT00069732|Acupressure|acupressure
470074|NCT00069732|Traditional Chinese Medicine|traditional chinese medicine
470075|NCT00069745|Prostatic Neoplasms|prostatic neoplasms
470076|NCT00069745|Cancer Treatment Protocols|cancer treatment protocols
470077|NCT00069745|Antineoplastic protocols|antineoplastic protocols
470078|NCT00069745|One Prior Cytotoxic Chemotherapy Regimen|one prior cytotoxic chemotherapy regimen
470079|NCT00069758|NHL, indolent NHL, non-Hodgkin's lymphoma, lymphoma|nhl, indolent nhl, non-hodgkin's lymphoma, lymphoma
470080|NCT00069784|Impaired Fasting Glucose (IFG)|impaired fasting glucose (ifg)
470081|NCT00069784|Impaired Glucose Tolerance (IGT)|impaired glucose tolerance (igt)
470082|NCT00069836|AVANDAMET insulin type 2 diabetes|avandamet insulin type 2 diabetes
470083|NCT00069862|Beta Thalassemia|beta thalassemia
470084|NCT00069901|ovarian cancer|ovarian cancer
470085|NCT00069901|paclitaxel|paclitaxel
470086|NCT00069901|carboplatin|carboplatin
470087|NCT00069914|Immunization|immunization
470088|NCT00069914|Immune Activation|immune activation
470089|NCT00069914|Flu|flu
470090|NCT00069914|Antibodies|antibodies
470091|NCT00069914|Titers|titers
470092|NCT00069914|HIV|hiv
470093|NCT00069914|Healthy Volunteer|healthy volunteer
470094|NCT00069914|HV|hv
470095|NCT00069927|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
470096|NCT00069927|depression|depression
470097|NCT00069927|neurotoxicity|neurotoxicity
470098|NCT00069940|adult glioblastoma|adult glioblastoma
470099|NCT00069940|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
470100|NCT00069940|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
470101|NCT00069940|adult synovial sarcoma|adult synovial sarcoma
470102|NCT00069940|childhood synovial sarcoma|childhood synovial sarcoma
470103|NCT00069940|childhood leiomyosarcoma|childhood leiomyosarcoma
470104|NCT00069940|adult leiomyosarcoma|adult leiomyosarcoma
470105|NCT00069940|adult liposarcoma|adult liposarcoma
470106|NCT00069940|childhood liposarcoma|childhood liposarcoma
470107|NCT00069940|gastrointestinal stromal tumor|gastrointestinal stromal tumor
470108|NCT00069940|recurrent childhood brain tumor|recurrent childhood brain tumor
470109|NCT00069940|recurrent adult brain tumor|recurrent adult brain tumor
470110|NCT00069940|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
470111|NCT00069940|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
470112|NCT00069940|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
470113|NCT00069940|adult giant cell glioblastoma|adult giant cell glioblastoma
470114|NCT00069940|adult gliosarcoma|adult gliosarcoma
470115|NCT00069940|adult anaplastic astrocytoma|adult anaplastic astrocytoma
470116|NCT00069940|adult oligodendroglioma|adult oligodendroglioma
470117|NCT00069940|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
470118|NCT00069940|adult diffuse astrocytoma|adult diffuse astrocytoma
470119|NCT00069940|adult mixed glioma|adult mixed glioma
470120|NCT00069940|adult myxopapillary ependymoma|adult myxopapillary ependymoma
470121|NCT00069940|adult anaplastic ependymoma|adult anaplastic ependymoma
470122|NCT00069940|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
470123|NCT00069940|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
470124|NCT00069940|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
470125|NCT00069940|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
470126|NCT00069940|childhood infratentorial ependymoma|childhood infratentorial ependymoma
470127|NCT00069940|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
470128|NCT00069940|recurrent childhood ependymoma|recurrent childhood ependymoma
470129|NCT00069940|childhood oligodendroglioma|childhood oligodendroglioma
470130|NCT00069953|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
89416|NCT02728648|Pain Management|pain management
469434|NCT00067457|PRN|prn
470131|NCT00069953|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
470132|NCT00069953|stage II esophageal cancer|stage ii esophageal cancer
470133|NCT00069953|stage III esophageal cancer|stage iii esophageal cancer
470134|NCT00069966|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
470135|NCT00069966|anaplastic large cell lymphoma|anaplastic large cell lymphoma
470136|NCT00069966|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
470137|NCT00069966|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
470138|NCT00069966|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
470139|NCT00069966|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
470140|NCT00069992|polycythemia vera|polycythemia vera
470141|NCT00069992|essential thrombocythemia|essential thrombocythemia
470142|NCT00069992|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
470143|NCT00069992|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
470144|NCT00069992|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
470145|NCT00069992|primary myelofibrosis|primary myelofibrosis
470146|NCT00069992|chronic myelogenous leukemia|chronic myelogenous leukemia
470147|NCT00069992|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
470148|NCT00069992|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
470149|NCT00069992|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
470150|NCT00069992|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
470240|NCT00063661|Parkinson Disease|parkinson disease
470241|NCT00063661|PD|pd
470151|NCT00069992|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
470152|NCT00069992|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
470153|NCT00070005|perioperative/postoperative complications|perioperative/postoperative complications
470154|NCT00070005|stage I rectal cancer|stage i rectal cancer
470155|NCT00070005|stage II rectal cancer|stage ii rectal cancer
470156|NCT00070005|stage III rectal cancer|stage iii rectal cancer
470157|NCT00070005|adenocarcinoma of the rectum|adenocarcinoma of the rectum
470158|NCT00070018|stage I mantle cell lymphoma|stage i mantle cell lymphoma
470159|NCT00070018|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
470160|NCT00070018|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
470161|NCT00070018|anaplastic large cell lymphoma|anaplastic large cell lymphoma
470162|NCT00070018|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
470163|NCT00070018|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
470164|NCT00070018|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
470165|NCT00070018|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
470166|NCT00070018|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
470167|NCT00070018|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
470168|NCT00070031|recurrent breast cancer|recurrent breast cancer
470169|NCT00070031|stage IIIA breast cancer|stage iiia breast cancer
470170|NCT00070031|stage IIIB breast cancer|stage iiib breast cancer
470171|NCT00070031|stage IIIC breast cancer|stage iiic breast cancer
470172|NCT00070031|stage IV breast cancer|stage iv breast cancer
470173|NCT00070070|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
470174|NCT00070070|stage I bladder cancer|stage i bladder cancer
13060|NCT03207113|case study|case study
470175|NCT00070083|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
470176|NCT00070083|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
470177|NCT00070083|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
470178|NCT00070083|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
470180|NCT00063284|Human Brain|human brain
470181|NCT00063284|Parkinson Disease|parkinson disease
470183|NCT00063297|schizophrenia with negative symptoms|schizophrenia with negative symptoms
470184|NCT00063310|Alzheimer disease|alzheimer disease
470185|NCT00063310|Aging Women|aging women
470186|NCT00063310|Hormone therapy|hormone therapy
470187|NCT00063323|Maintenance treatment|maintenance treatment
470188|NCT00063323|Smoking relapse|smoking relapse
470189|NCT00063323|Bupropion|bupropion
470190|NCT00063323|Nicotine replacement|nicotine replacement
470191|NCT00063362|Depression|depression
470193|NCT00063388|Small|small
470194|NCT00063388|Cell|cell
470195|NCT00063388|Lung|lung
470196|NCT00063388|Cancer|cancer
470197|NCT00063401|ovarian|ovarian
470198|NCT00063401|primary peritoneal cancer|primary peritoneal cancer
470199|NCT00063401|fallopian tube cancer|fallopian tube cancer
470200|NCT00063427|Colorectal Cancer|colorectal cancer
470201|NCT00063427|Colorectal Carcinoma|colorectal carcinoma
470202|NCT00063427|Colorectal Tumors|colorectal tumors
470203|NCT00063427|Neoplasms, Colorectal|neoplasms, colorectal
470204|NCT00063427|Colorectal Neoplasms|colorectal neoplasms
470205|NCT00063479|Osteogenesis Imperfecta|osteogenesis imperfecta
470206|NCT00063479|OI|oi
470207|NCT00063479|bone markers|bone markers
470208|NCT00063479|fracture|fracture
470209|NCT00063479|bone loss|bone loss
470210|NCT00063479|pediatric|pediatric
470211|NCT00063479|bisphosphonate|bisphosphonate
470212|NCT00063479|brittle bone disease|brittle bone disease
470213|NCT00063479|pamidronate|pamidronate
470214|NCT00063570|Cancer of Breast|cancer of breast
470215|NCT00063570|Cancer of the Breast|cancer of the breast
470216|NCT00063583|Kidney disease|kidney disease
470217|NCT00063596|Vitamin A|vitamin a
470218|NCT00063596|Hepatitis B vaccine|hepatitis b vaccine
470219|NCT00063596|Immune responses|immune responses
470220|NCT00063596|T-cell subsets|t-cell subsets
470221|NCT00063596|Chronic lung disease|chronic lung disease
470222|NCT00063596|Cytokines, intracytoplasmic|cytokines, intracytoplasmic
470223|NCT00063596|Antibodies, hepatitis B and tetanus toxoid|antibodies, hepatitis b and tetanus toxoid
470224|NCT00063609|Prostate Cancer|prostate cancer
470225|NCT00063609|Bone Loss|bone loss
470226|NCT00063609|Osteoporosis|osteoporosis
470227|NCT00063609|Bone Mineral Density|bone mineral density
470228|NCT00063609|Androgen Deprivation Therapy|androgen deprivation therapy
470229|NCT00063622|Non alcoholic steatohepatitis|non alcoholic steatohepatitis
470230|NCT00063622|Steatohepatitis|steatohepatitis
470231|NCT00063635|Non alcoholic fatty liver disease|non alcoholic fatty liver disease
470232|NCT00063648|PTLD|ptld
470233|NCT00063648|CTL Therapy|ctl therapy
470234|NCT00063648|Post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
470235|NCT00063661|fMRI|fmri
470236|NCT00063661|Brain Activity|brain activity
470237|NCT00063661|Overlearned|overlearned
470245|NCT00063674|health education|health education
470246|NCT00063674|obesity prevention|obesity prevention
470247|NCT00063674|diabetes prevention|diabetes prevention
470248|NCT00063674|children|children
470249|NCT00063700|obesity in school aged children|obesity in school aged children
470250|NCT00070096|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
470251|NCT00070096|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
470252|NCT00070096|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
470253|NCT00070096|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
470254|NCT00070096|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
470255|NCT00070096|testicular seminoma|testicular seminoma
470256|NCT00070096|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
470257|NCT00070096|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
470258|NCT00070096|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
470259|NCT00070096|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
470260|NCT00070096|testicular choriocarcinoma|testicular choriocarcinoma
470261|NCT00070096|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
470262|NCT00070096|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
470263|NCT00070096|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
470264|NCT00070096|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
470265|NCT00070096|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
470266|NCT00070096|testicular embryonal carcinoma|testicular embryonal carcinoma
470267|NCT00070096|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
470268|NCT00070096|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
470269|NCT00070096|testicular yolk sac tumor|testicular yolk sac tumor
470270|NCT00070096|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
470271|NCT00070096|recurrent extragonadal seminoma|recurrent extragonadal seminoma
470272|NCT00070096|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
470273|NCT00070096|stage IV extragonadal seminoma|stage iv extragonadal seminoma
479085|NCT00094939|Hippocampus|hippocampus
470274|NCT00070096|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
470275|NCT00070096|testicular immature teratoma|testicular immature teratoma
470276|NCT00070096|testicular mature teratoma|testicular mature teratoma
470277|NCT00070135|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
470278|NCT00070135|secondary acute myeloid leukemia|secondary acute myeloid leukemia
470279|NCT00070135|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
470280|NCT00070135|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
470281|NCT00070135|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
470282|NCT00070135|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
470283|NCT00070135|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
470284|NCT00070135|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
470285|NCT00070135|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
470286|NCT00070135|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
470287|NCT00070135|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
470288|NCT00070135|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
470289|NCT00070135|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
470290|NCT00070135|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
470291|NCT00070148|weight changes|weight changes
470292|NCT00070148|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
470293|NCT00070161|radiation toxicity|radiation toxicity
470294|NCT00070161|adult mixed glioma|adult mixed glioma
470295|NCT00070161|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
470296|NCT00070161|adult brain stem glioma|adult brain stem glioma
470297|NCT00070161|adult craniopharyngioma|adult craniopharyngioma
470298|NCT00070161|adult medulloblastoma|adult medulloblastoma
470299|NCT00070161|adult meningioma|adult meningioma
470300|NCT00070161|adult choroid plexus tumor|adult choroid plexus tumor
470301|NCT00070161|adult tumors metastatic to brain|adult tumors metastatic to brain
470302|NCT00070161|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
470303|NCT00070161|adult anaplastic astrocytoma|adult anaplastic astrocytoma
470304|NCT00070161|adult pilocytic astrocytoma|adult pilocytic astrocytoma
470305|NCT00070161|adult subependymoma|adult subependymoma
470306|NCT00070161|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
470307|NCT00070161|adult ependymoblastoma|adult ependymoblastoma
470308|NCT00070161|adult anaplastic ependymoma|adult anaplastic ependymoma
470309|NCT00070161|adult pineoblastoma|adult pineoblastoma
470310|NCT00070161|adult pineocytoma|adult pineocytoma
470311|NCT00070161|adult myxopapillary ependymoma|adult myxopapillary ependymoma
470312|NCT00070161|adult glioblastoma|adult glioblastoma
470313|NCT00070161|adult grade III meningioma|adult grade iii meningioma
470314|NCT00070161|adult oligodendroglioma|adult oligodendroglioma
470315|NCT00070161|adult giant cell glioblastoma|adult giant cell glioblastoma
470316|NCT00070161|adult gliosarcoma|adult gliosarcoma
470317|NCT00070161|adult ependymoma|adult ependymoma
470318|NCT00070174|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
470319|NCT00070174|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
470320|NCT00070174|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
470321|NCT00070174|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
470322|NCT00070174|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
470323|NCT00070174|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
470324|NCT00070174|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
470325|NCT00070174|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
470326|NCT00070174|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
470327|NCT00070187|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
470328|NCT00070187|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
470329|NCT00070200|recurrent neuroblastoma|recurrent neuroblastoma
470330|NCT00070200|stage 4S neuroblastoma|stage 4s neuroblastoma
470331|NCT00070200|localized unresectable neuroblastoma|localized unresectable neuroblastoma
470332|NCT00070200|localized resectable neuroblastoma|localized resectable neuroblastoma
470333|NCT00070200|regional neuroblastoma|regional neuroblastoma
470334|NCT00070200|disseminated neuroblastoma|disseminated neuroblastoma
470335|NCT00070213|adenocarcinoma of the colon|adenocarcinoma of the colon
470336|NCT00070213|adenocarcinoma of the rectum|adenocarcinoma of the rectum
470337|NCT00070213|stage IV rectal cancer|stage iv rectal cancer
470338|NCT00070213|stage IV colon cancer|stage iv colon cancer
470339|NCT00070213|recurrent rectal cancer|recurrent rectal cancer
470340|NCT00070213|recurrent colon cancer|recurrent colon cancer
470341|NCT00070278|stage II breast cancer|stage ii breast cancer
470342|NCT00070278|stage IIIA breast cancer|stage iiia breast cancer
470343|NCT00070278|stage IIIB breast cancer|stage iiib breast cancer
470344|NCT00070278|stage IIIC breast cancer|stage iiic breast cancer
470345|NCT00070291|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
470346|NCT00070304|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
470347|NCT00070304|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
470348|NCT00070304|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
470349|NCT00070304|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
470350|NCT00070304|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
470351|NCT00070343|stage IV melanoma|stage iv melanoma
470352|NCT00070343|stage III melanoma|stage iii melanoma
470353|NCT00070382|anemia|anemia
470354|NCT00070382|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
470355|NCT00070382|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
470356|NCT00070382|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
470357|NCT00070382|extramedullary plasmacytoma|extramedullary plasmacytoma
470358|NCT00070382|isolated plasmacytoma of bone|isolated plasmacytoma of bone
470359|NCT00070382|refractory multiple myeloma|refractory multiple myeloma
470360|NCT00070382|primary systemic amyloidosis|primary systemic amyloidosis
470361|NCT00070382|stage I multiple myeloma|stage i multiple myeloma
470362|NCT00070382|stage II multiple myeloma|stage ii multiple myeloma
470363|NCT00070382|stage III multiple myeloma|stage iii multiple myeloma
470364|NCT00070382|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
470365|NCT00070382|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
470366|NCT00070382|anaplastic large cell lymphoma|anaplastic large cell lymphoma
470367|NCT00070382|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
583831|NCT00512837|clinical management|clinical management
470368|NCT00070382|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
470369|NCT00070382|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
470370|NCT00070382|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
470371|NCT00070382|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
470372|NCT00070382|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
470373|NCT00070382|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
470374|NCT00070382|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
470375|NCT00070382|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
470376|NCT00070382|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
470377|NCT00070382|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
470378|NCT00070382|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
470379|NCT00070382|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
470380|NCT00070382|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
470381|NCT00070382|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
470382|NCT00070382|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
470383|NCT00070382|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
470384|NCT00070382|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
470385|NCT00070382|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
470386|NCT00070382|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
470387|NCT00070382|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
470388|NCT00070382|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
470389|NCT00070382|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
470390|NCT00070382|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
470391|NCT00070382|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
470392|NCT00070382|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
470393|NCT00070382|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
470394|NCT00070382|prolymphocytic leukemia|prolymphocytic leukemia
470395|NCT00070382|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
470396|NCT00070382|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
470488|NCT00071474|chronic pain|chronic pain
470397|NCT00070382|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
470398|NCT00070382|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
470399|NCT00070382|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
470400|NCT00070382|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
470401|NCT00070382|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
470402|NCT00070382|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
470403|NCT00070382|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
13061|NCT03207074|iKnife|iknife
470404|NCT00070382|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
470405|NCT00070382|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
470406|NCT00070382|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
470407|NCT00070382|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
470408|NCT00070382|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
470571|NCT00071877|Fabry Disease|fabry disease
470409|NCT00070382|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
470410|NCT00070382|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
470411|NCT00070382|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
470412|NCT00070382|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
470413|NCT00070382|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
470414|NCT00070382|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
470415|NCT00070382|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
604978|NCT00601185|06-009|06-009
470416|NCT00070382|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
470417|NCT00070382|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
470418|NCT00070382|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
470419|NCT00070382|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
470420|NCT00070382|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
470421|NCT00070382|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
470422|NCT00070382|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
470423|NCT00070382|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
470424|NCT00070382|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
470425|NCT00070382|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
470426|NCT00070382|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
470427|NCT00070382|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
470428|NCT00070382|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
470429|NCT00070382|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
470430|NCT00070382|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
470431|NCT00070382|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
470432|NCT00070382|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
470433|NCT00070382|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
470434|NCT00070382|stage I mantle cell lymphoma|stage i mantle cell lymphoma
470435|NCT00070382|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
470436|NCT00070382|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
470437|NCT00070382|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
470438|NCT00070382|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
470439|NCT00070382|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
470440|NCT00070382|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
470441|NCT00070382|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
470522|NCT00071682|side effects|side effects
470442|NCT00070382|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
470443|NCT00070421|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
470444|NCT00070421|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
470445|NCT00070421|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
470446|NCT00070421|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
470447|NCT00070421|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
470448|NCT00070421|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
470449|NCT00070421|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
470450|NCT00070421|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
470451|NCT00070421|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
470452|NCT00070421|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
470453|NCT00070421|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
470454|NCT00070421|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
470455|NCT00070421|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
470456|NCT00070421|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
470457|NCT00070421|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
470458|NCT00070421|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
470459|NCT00070421|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
470460|NCT00070421|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
470461|NCT00070421|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
470462|NCT00070421|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
470463|NCT00070421|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
470464|NCT00070421|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
470465|NCT00070421|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
470466|NCT00070421|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
470467|NCT00070421|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
470468|NCT00070421|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
470469|NCT00070434|stage II rectal cancer|stage ii rectal cancer
470470|NCT00070434|stage III rectal cancer|stage iii rectal cancer
470471|NCT00070434|adenocarcinoma of the rectum|adenocarcinoma of the rectum
470472|NCT00070447|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
470473|NCT00070447|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
469862|NCT00069030|IL2|il2
470474|NCT00070447|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
470475|NCT00070447|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
470476|NCT00070473|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
470477|NCT00070486|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
470478|NCT00070486|adenocarcinoma of the lung|adenocarcinoma of the lung
470479|NCT00070486|squamous cell lung cancer|squamous cell lung cancer
470480|NCT00070486|large cell lung cancer|large cell lung cancer
470481|NCT00070486|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
470482|NCT00071461|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
470483|NCT00071461|Interstitial lung disease|interstitial lung disease
470484|NCT00071461|Bosentan|bosentan
470485|NCT00071461|BUILD|build
470486|NCT00071474|temporomandibular disroders|temporomandibular disroders
470487|NCT00071474|shamanism|shamanism
470490|NCT00071500|Compliance|compliance
470491|NCT00071500|Adherence|adherence
470492|NCT00071500|Computerized|computerized
470493|NCT00071500|Electronic Pillbox|electronic pillbox
470494|NCT00071500|Treatment Experienced|treatment experienced
470495|NCT00071513|Adolescent|adolescent
470496|NCT00071513|Substance Abuse|substance abuse
470497|NCT00071513|At-risk|at-risk
470498|NCT00071526|Vitamin C|vitamin c
470499|NCT00071526|Diabetes Mellitus|diabetes mellitus
470500|NCT00071526|Proteinuria|proteinuria
470501|NCT00071526|Renal Threshold|renal threshold
470502|NCT00071526|Healthy Volunteer|healthy volunteer
470503|NCT00071539|gross total resection|gross total resection
470504|NCT00071552|Poorly Controlled Asthma|poorly controlled asthma
470505|NCT00071565|familial intracranial aneurysm|familial intracranial aneurysm
470506|NCT00071565|intracranial aneurysm|intracranial aneurysm
470507|NCT00071565|brain aneurysm|brain aneurysm
470508|NCT00071565|aneurysm|aneurysm
470509|NCT00071565|subarachnoid hemorrhage|subarachnoid hemorrhage
470510|NCT00071565|stroke|stroke
470511|NCT00071578|Psychotherapy|psychotherapy
470512|NCT00071578|Treatment|treatment
470513|NCT00071617|Suicide|suicide
470514|NCT00071617|Adolescence|adolescence
470515|NCT00071630|Adolescent|adolescent
470516|NCT00071643|Stroke|stroke
470517|NCT00071669|Mood Disorder|mood disorder
470518|NCT00071669|Acupuncture|acupuncture
470519|NCT00071682|herbal medicine|herbal medicine
470520|NCT00071682|alternative medicines|alternative medicines
470521|NCT00071682|anticoagulation|anticoagulation
470525|NCT00071721|Alzheimer disease|alzheimer disease
470526|NCT00071721|Agitation|agitation
470527|NCT00071721|Psychosis|psychosis
470528|NCT00071734|fMRI|fmri
470529|NCT00071734|Auditory Feedback|auditory feedback
470530|NCT00071734|Motor Control|motor control
470531|NCT00071734|Adult|adult
470532|NCT00071734|BOLD|bold
470533|NCT00071734|Healthy Volunteer|healthy volunteer
470535|NCT00071747|schizophrenia|schizophrenia
470536|NCT00071747|lamotrigine|lamotrigine
470537|NCT00071760|pediatrics|pediatrics
470538|NCT00071760|ritonavir|ritonavir
470539|NCT00071760|amprenavir|amprenavir
470540|NCT00071760|AGENERASE|agenerase
470541|NCT00071760|HIV|hiv
470542|NCT00071760|Lexiva|lexiva
470543|NCT00071760|protease inhibitors|protease inhibitors
470544|NCT00071760|HIV Infection|hiv infection
470545|NCT00071760|fosamprenavir|fosamprenavir
470546|NCT00071773|diabetic macular edema|diabetic macular edema
470547|NCT00071773|laser photocoagulation|laser photocoagulation
470548|NCT00071773|etdrs|etdrs
470549|NCT00071773|macular grid photocoagulation|macular grid photocoagulation
470550|NCT00071773|DME|dme
470551|NCT00071786|Bipolar Mood Disorder|bipolar mood disorder
470552|NCT00071786|Migraine|migraine
470553|NCT00071786|Behavior Genetics|behavior genetics
470554|NCT00071786|Genetic Epidemiology|genetic epidemiology
470555|NCT00071786|Family Study|family study
470556|NCT00071812|RA|ra
470557|NCT00071838|Neuroimmunology|neuroimmunology
470558|NCT00071838|Therapy|therapy
470559|NCT00071838|Demyelinating Disease|demyelinating disease
470560|NCT00071838|Immunological Mechanism|immunological mechanism
470561|NCT00071838|MRI|mri
470489|NCT00071487|SLE|sle
470562|NCT00071838|Multiple Sclerosis|multiple sclerosis
470563|NCT00071838|MS|ms
470564|NCT00071851|HIV Seronegativity|hiv seronegativity
470565|NCT00071851|HIV Preventive Vaccine|hiv preventive vaccine
470566|NCT00071877|Lysosomal Disease|lysosomal disease
470567|NCT00071877|Hypohidrosis|hypohidrosis
470568|NCT00071877|Pain|pain
470569|NCT00071877|Neuropathy|neuropathy
470570|NCT00071877|X-Linked|x-linked
470573|NCT00071890|Interleukin 2|interleukin 2
470574|NCT00071890|Treatment Interruption|treatment interruption
470575|NCT00071890|HIV|hiv
470576|NCT00071903|Thrombophilia|thrombophilia
470577|NCT00071903|Idiopathic Intracranial Hypertension|idiopathic intracranial hypertension
470578|NCT00071903|Kidney Involvement|kidney involvement
470579|NCT00071903|Lysosomal Storage Disorder|lysosomal storage disorder
470580|NCT00071903|Cystine|cystine
469978|NCT00069498|Mucosa|mucosa
470581|NCT00071903|Pseudotumor Cerebri|pseudotumor cerebri
470582|NCT00071903|Susceptibility to Thrombosis|susceptibility to thrombosis
470583|NCT00071903|Nephropathic Cystinosis|nephropathic cystinosis
470584|NCT00071903|PTC|ptc
470585|NCT00071903|Intracranial Hypertension|intracranial hypertension
470586|NCT00071916|Hepatitis C, African Americans, ribavirin|hepatitis c, african americans, ribavirin
470587|NCT00071929|recurrent endometrial carcinoma|recurrent endometrial carcinoma
470588|NCT00071955|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
470589|NCT00071955|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
470590|NCT00071955|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
470591|NCT00071955|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
470592|NCT00071955|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
470593|NCT00071955|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
470594|NCT00071955|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
583832|NCT00512837|empowerment|empowerment
470595|NCT00071955|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
470596|NCT00071955|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
470597|NCT00071968|adenocarcinoma of the prostate|adenocarcinoma of the prostate
470598|NCT00071968|stage IIB prostate cancer|stage iib prostate cancer
470599|NCT00071968|stage IIA prostate cancer|stage iia prostate cancer
470600|NCT00071968|stage I prostate cancer|stage i prostate cancer
470601|NCT00071981|stage IV melanoma|stage iv melanoma
470602|NCT00071981|recurrent melanoma|recurrent melanoma
470603|NCT00072007|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
470604|NCT00072007|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
470605|NCT00072007|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
470606|NCT00072007|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
470607|NCT00072007|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
470608|NCT00072007|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
470609|NCT00072020|bone metastases|bone metastases
470610|NCT00072020|stage II breast cancer|stage ii breast cancer
470611|NCT00072020|stage IIIA breast cancer|stage iiia breast cancer
470612|NCT00072020|stage IIIB breast cancer|stage iiib breast cancer
470613|NCT00072020|stage IIIC breast cancer|stage iiic breast cancer
470614|NCT00072033|stage II esophageal cancer|stage ii esophageal cancer
470615|NCT00072033|stage III esophageal cancer|stage iii esophageal cancer
470616|NCT00072033|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
470763|NCT00072631|Non-Small Cell Lung Cancer|non-small cell lung cancer
470617|NCT00072033|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
470618|NCT00072046|stage IV renal cell cancer|stage iv renal cell cancer
470619|NCT00072046|clear cell renal cell carcinoma|clear cell renal cell carcinoma
470620|NCT00072046|recurrent renal cell cancer|recurrent renal cell cancer
470621|NCT00072059|anemia|anemia
470622|NCT00072059|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
470623|NCT00072059|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
470624|NCT00072059|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
470625|NCT00072072|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
470626|NCT00072072|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
470627|NCT00072072|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
470628|NCT00072085|stage IV melanoma|stage iv melanoma
470629|NCT00072085|recurrent melanoma|recurrent melanoma
470630|NCT00072098|stage IV colon cancer|stage iv colon cancer
470631|NCT00072098|stage IV rectal cancer|stage iv rectal cancer
470632|NCT00072098|liver metastases|liver metastases
470633|NCT00072098|recurrent rectal cancer|recurrent rectal cancer
470634|NCT00072098|recurrent colon cancer|recurrent colon cancer
470635|NCT00072111|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
470636|NCT00072124|stage IV melanoma|stage iv melanoma
470637|NCT00072124|recurrent melanoma|recurrent melanoma
470638|NCT00072215|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
470639|NCT00072215|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
470640|NCT00072215|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
470641|NCT00072215|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
470642|NCT00072215|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
470643|NCT00072215|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
470644|NCT00072215|testicular choriocarcinoma|testicular choriocarcinoma
470645|NCT00072215|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
470646|NCT00072215|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
470647|NCT00072215|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
470648|NCT00072215|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
89417|NCT02728648|Pharmacokinetics|pharmacokinetics
470649|NCT00072215|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
470650|NCT00072215|testicular embryonal carcinoma|testicular embryonal carcinoma
470651|NCT00072215|testicular seminoma|testicular seminoma
470652|NCT00072215|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
470653|NCT00072215|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
470654|NCT00072215|testicular yolk sac tumor|testicular yolk sac tumor
470655|NCT00072215|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
470656|NCT00072215|recurrent extragonadal seminoma|recurrent extragonadal seminoma
470657|NCT00072215|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
470658|NCT00072215|stage IV extragonadal seminoma|stage iv extragonadal seminoma
470659|NCT00072215|testicular immature teratoma|testicular immature teratoma
470660|NCT00072215|testicular mature teratoma|testicular mature teratoma
470661|NCT00072215|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
470662|NCT00072267|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
470663|NCT00072267|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
470664|NCT00072267|primary peritoneal cavity cancer|primary peritoneal cavity cancer
470665|NCT00072267|fallopian tube cancer|fallopian tube cancer
470666|NCT00072267|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
470667|NCT00072280|childhood fibrosarcoma|childhood fibrosarcoma
470668|NCT00072280|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
470669|NCT00072293|stage IA breast cancer|stage ia breast cancer
470670|NCT00072293|stage IB breast cancer|stage ib breast cancer
470671|NCT00072293|stage II breast cancer|stage ii breast cancer
470672|NCT00072293|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
470673|NCT00072293|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
470674|NCT00072293|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
470675|NCT00072293|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
470676|NCT00072319|stage I breast cancer|stage i breast cancer
470677|NCT00072319|stage II breast cancer|stage ii breast cancer
470678|NCT00072319|stage IIIA breast cancer|stage iiia breast cancer
470679|NCT00072319|stage IIIB breast cancer|stage iiib breast cancer
470680|NCT00072319|stage IIIC breast cancer|stage iiic breast cancer
470681|NCT00072319|inflammatory breast cancer|inflammatory breast cancer
470682|NCT00072332|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
470683|NCT00072332|stage IV esophageal cancer|stage iv esophageal cancer
470684|NCT00072332|stage IV gastric cancer|stage iv gastric cancer
470685|NCT00072345|stage III melanoma|stage iii melanoma
470686|NCT00072345|stage IV melanoma|stage iv melanoma
470687|NCT00072345|recurrent melanoma|recurrent melanoma
470688|NCT00072345|iris melanoma|iris melanoma
470689|NCT00072345|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
470690|NCT00072345|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
470691|NCT00072345|extraocular extension melanoma|extraocular extension melanoma
470692|NCT00072345|recurrent intraocular melanoma|recurrent intraocular melanoma
470693|NCT00072358|disseminated neuroblastoma|disseminated neuroblastoma
470694|NCT00072358|localized unresectable neuroblastoma|localized unresectable neuroblastoma
470695|NCT00072358|recurrent neuroblastoma|recurrent neuroblastoma
470696|NCT00072358|regional neuroblastoma|regional neuroblastoma
470697|NCT00072358|stage 4S neuroblastoma|stage 4s neuroblastoma
470698|NCT00072410|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
470699|NCT00072410|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
470700|NCT00072449|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
470701|NCT00072462|ductal breast carcinoma in situ|ductal breast carcinoma in situ
470702|NCT00072462|breast cancer in situ|breast cancer in situ
470703|NCT00072475|refractory anemia with excess blasts|refractory anemia with excess blasts
470704|NCT00072475|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
470705|NCT00072475|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
470706|NCT00072475|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
470707|NCT00072475|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
470708|NCT00072475|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
470709|NCT00072475|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
470710|NCT00072475|refractory anemia|refractory anemia
470711|NCT00072475|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
470713|NCT00072488|localized resectable neuroblastoma|localized resectable neuroblastoma
470714|NCT00072488|localized unresectable neuroblastoma|localized unresectable neuroblastoma
470715|NCT00072488|regional neuroblastoma|regional neuroblastoma
470716|NCT00072488|stage 4S neuroblastoma|stage 4s neuroblastoma
470717|NCT00072488|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
470718|NCT00072488|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
470719|NCT00072488|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
470720|NCT00072488|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
470721|NCT00072488|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
470722|NCT00072488|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
470723|NCT00072488|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
470724|NCT00072488|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
470725|NCT00072488|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
470726|NCT00072488|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
470727|NCT00072488|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
470728|NCT00072488|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
470729|NCT00072488|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
470730|NCT00072488|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
470731|NCT00072488|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
470732|NCT00072488|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
470733|NCT00072488|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
470734|NCT00072488|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
470735|NCT00072488|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
470736|NCT00072488|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
470737|NCT00072501|breast cancer|breast cancer
470738|NCT00072527|limited stage small cell lung cancer|limited stage small cell lung cancer
470739|NCT00072553|stage IV rectal cancer|stage iv rectal cancer
470740|NCT00072553|stage IV colon cancer|stage iv colon cancer
470741|NCT00072553|adenocarcinoma of the colon|adenocarcinoma of the colon
470742|NCT00072553|adenocarcinoma of the rectum|adenocarcinoma of the rectum
470743|NCT00072553|recurrent rectal cancer|recurrent rectal cancer
470744|NCT00072553|recurrent colon cancer|recurrent colon cancer
470745|NCT00072579|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
470746|NCT00072579|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
470748|NCT00072592|B Lymphocyte|b lymphocyte
470749|NCT00072592|Vasculitis|vasculitis
470750|NCT00072592|Treatment|treatment
470751|NCT00072592|Remission|remission
470752|NCT00072592|Wegener Granulomatosis|wegener granulomatosis
470753|NCT00072592|WG|wg
470754|NCT00072605|Healthy|healthy
470755|NCT00072605|T Cells|t cells
470756|NCT00072605|Immunity|immunity
470757|NCT00072605|Hemorrhagic Fever|hemorrhagic fever
470758|NCT00072605|Healthy Volunteer|healthy volunteer
470759|NCT00072605|HV|hv
470760|NCT00072631|Tarceva|tarceva
470761|NCT00072631|erlotinib|erlotinib
470762|NCT00072631|NSCLC|nsclc
470767|NCT00072644|Osteonecrosis|osteonecrosis
470768|NCT00072644|Drug Interaction|drug interaction
470769|NCT00072644|P-Glycoprotein|p-glycoprotein
470770|NCT00072644|Cytochrome P 450|cytochrome p 450
470771|NCT00072644|Healthy Volunteer|healthy volunteer
470773|NCT00072657|Arthritis|arthritis
470774|NCT00072657|Pain|pain
470775|NCT00072657|Meditation|meditation
470776|NCT00072657|Tai Chi|tai chi
470777|NCT00072657|Chronic Illness|chronic illness
470778|NCT00072657|Depression|depression
470779|NCT00072670|Prostate cancer|prostate cancer
470780|NCT00072670|Advanced prostate cancer|advanced prostate cancer
470781|NCT00072670|Metastatic prostate cancer|metastatic prostate cancer
470782|NCT00072670|Trabectedin|trabectedin
470783|NCT00072670|Yondelis|yondelis
470784|NCT00072670|ET-743|et-743
470785|NCT00072683|Sodium|sodium
470786|NCT00072683|SIADH|siadh
470787|NCT00072683|Vasopressin|vasopressin
470788|NCT00072683|CHF|chf
470789|NCT00072683|Cirrhosis|cirrhosis
470790|NCT00072683|salt|salt
470791|NCT00072683|water|water
470792|NCT00072683|electrolyte|electrolyte
470793|NCT00072709|ALS|als
470794|NCT00072709|Lou Gehrig's disease|lou gehrig's disease
470795|NCT00072722|Prostate Cancer|prostate cancer
470796|NCT00072722|Metastatic Hormone Refractory Prostate Cancer|metastatic hormone refractory prostate cancer
470797|NCT00072722|CC4047|cc4047
470798|NCT00072722|CC-4047|cc-4047
470799|NCT00072722|Prostate Carcinoma|prostate carcinoma
470800|NCT00072722|Celgene|celgene
470801|NCT00072735|Use Dependent Plasticity|use dependent plasticity
470802|NCT00072735|Cortical Reorganization|cortical reorganization
470803|NCT00072735|Rehabilitation|rehabilitation
470804|NCT00072735|Somatosensory Nerve|somatosensory nerve
470805|NCT00072735|Amphetamine|amphetamine
470806|NCT00072735|Stroke|stroke
470807|NCT00072735|Healthy Volunteer|healthy volunteer
470809|NCT00072748|Advanced Colorectal Cancer|advanced colorectal cancer
470810|NCT00072748|Colorectal Carcinoma|colorectal carcinoma
470811|NCT00072748|Colorectal Tumors|colorectal tumors
470812|NCT00072748|Neoplasms, Colorectal|neoplasms, colorectal
470813|NCT00072761|silent cerebral infarct|silent cerebral infarct
470814|NCT00072761|silent stroke|silent stroke
470815|NCT00072761|sickle cell anemia|sickle cell anemia
470816|NCT00072761|stroke|stroke
470817|NCT00072761|transfusion therapy|transfusion therapy
470818|NCT00072774|Depressive Disorder, Major|depressive disorder, major
470819|NCT00072774|Melancholia, Involutional|melancholia, involutional
470820|NCT00072774|Depression, Involutional|depression, involutional
470821|NCT00072787|gastric cancer|gastric cancer
470822|NCT00072787|phase 2 clinical trial|phase 2 clinical trial
470823|NCT00072800|Reliability|reliability
470824|NCT00072800|Muscle Tone Abnormality|muscle tone abnormality
470825|NCT00072800|Spasticity|spasticity
470826|NCT00072800|Dystonia|dystonia
470827|NCT00072800|Rigidity|rigidity
470828|NCT00072800|Cerebral Palsy|cerebral palsy
470829|NCT00072800|CP|cp
470830|NCT00072800|Children|children
470831|NCT00072813|Genetics|genetics
470832|NCT00072813|Seizures|seizures
470833|NCT00072813|Brain Imaging|brain imaging
470834|NCT00072813|Diffusion|diffusion
470835|NCT00072813|Temporal Lobe|temporal lobe
470836|NCT00072826|3-hydroxy-3-methlglutaryl (HMG)|3-hydroxy-3-methlglutaryl (hmg)
470837|NCT00072826|Inhibitors|inhibitors
470838|NCT00072826|Endothelial Function|endothelial function
470839|NCT00072826|Leukocyte Gene Expression|leukocyte gene expression
470840|NCT00072826|Statins|statins
470841|NCT00072826|Atorvastatin|atorvastatin
470842|NCT00072826|Sickle Cell Disease|sickle cell disease
470843|NCT00072891|Diabetes|diabetes
470844|NCT00072904|Cystic Fibrosis Related Diabetes|cystic fibrosis related diabetes
470845|NCT00072904|Diabetes without Fasting Hyperglycemia|diabetes without fasting hyperglycemia
470846|NCT00072917|obesity|obesity
470847|NCT00072917|thinness|thinness
470848|NCT00072917|weight gain|weight gain
470849|NCT00072917|physical activity|physical activity
470850|NCT00072917|diet|diet
470851|NCT00072917|fat oxidation|fat oxidation
470852|NCT00072917|hunger|hunger
470853|NCT00072917|feeding behavior|feeding behavior
470854|NCT00072917|overfeeding|overfeeding
470855|NCT00072943|Crohn's Disease|crohn's disease
470856|NCT00072943|Colitis|colitis
470857|NCT00072943|Monoclonal antibody therapy|monoclonal antibody therapy
470858|NCT00072943|anti-interferon gamma|anti-interferon gamma
470859|NCT00072956|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
470860|NCT00072956|Torticollis|torticollis
470861|NCT00072956|Cervical Dystonia|cervical dystonia
470862|NCT00072956|Surround Inhibition|surround inhibition
470863|NCT00072956|Sensory Tricks|sensory tricks
470864|NCT00072969|Immunosuppression|immunosuppression
470865|NCT00072969|Myelodysplastic Syndrome|myelodysplastic syndrome
470866|NCT00072969|MDS|mds
470867|NCT00072982|Fish oil|fish oil
470868|NCT00072982|Borage oil|borage oil
470869|NCT00073008|EGFR|egfr
470870|NCT00073008|ErbB1|erbb1
470871|NCT00073008|ErbB2|erbb2
470872|NCT00073008|metastatic|metastatic
470875|NCT00073008|protein kinase inhibitor|protein kinase inhibitor
470876|NCT00073008|BAC|bac
470877|NCT00073008|GW572016|gw572016
470878|NCT00073008|Advanced|advanced
470879|NCT00073008|NSCLC|nsclc
470880|NCT00073034|Neuropathic Pain|neuropathic pain
470881|NCT00073034|Diabetic Neuropathy|diabetic neuropathy
470882|NCT00073047|Ulcerative Colitis|ulcerative colitis
470883|NCT00073047|Inflammatory Bowel Disease|inflammatory bowel disease
470884|NCT00073047|Gastrointestinal|gastrointestinal
470885|NCT00073047|Humanized Monoclonal antibody|humanized monoclonal antibody
470886|NCT00073060|Plateletpheresis|plateletpheresis
470887|NCT00073060|Lymphocytapheresis|lymphocytapheresis
470888|NCT00073060|Apheresis|apheresis
470889|NCT00073060|Citrate|citrate
470890|NCT00073060|Bone Density|bone density
470891|NCT00073060|Healthy Volunteer|healthy volunteer
470892|NCT00073060|HV|hv
470893|NCT00073073|Chemoprevention|chemoprevention
470894|NCT00073073|Mammographic Density|mammographic density
470895|NCT00073073|Bone Mineral Density|bone mineral density
470896|NCT00073073|Biomarkers|biomarkers
470897|NCT00073073|Safety|safety
470898|NCT00073073|Breast Cancer|breast cancer
470899|NCT00073073|Postmenopausal|postmenopausal
470900|NCT00073086|Coronavirus|coronavirus
470901|NCT00073086|Pneumonia|pneumonia
470902|NCT00073086|Asia|asia
470903|NCT00073086|China|china
470904|NCT00073086|Severe Acut Respiratory Syndrome|severe acut respiratory syndrome
470905|NCT00073086|SARS|sars
470906|NCT00073086|Suspected SARS|suspected sars
470907|NCT00073099|Dry Eye|dry eye
470908|NCT00073099|Lissamine Green|lissamine green
470772|NCT00072644|HV|hv
470909|NCT00073099|Fluorescein|fluorescein
470910|NCT00073099|Conjunctiva|conjunctiva
470911|NCT00073099|Cornea|cornea
470912|NCT00073099|Digital Photography|digital photography
470913|NCT00073099|Corneal and Conjunctival Staining|corneal and conjunctival staining
470914|NCT00073125|Advanced histologically documented renal cell carcinoma|advanced histologically documented renal cell carcinoma
470915|NCT00073190|Patient Education|patient education
470916|NCT00073190|Physician Education|physician education
470917|NCT00073216|HIV Seronegativity|hiv seronegativity
470918|NCT00073216|HIV Preventive Vaccine|hiv preventive vaccine
470919|NCT00073229|AIDS|aids
470920|NCT00073229|Vertical Transmission|vertical transmission
470921|NCT00073229|Acute Infection|acute infection
470922|NCT00073242|leptin|leptin
470923|NCT00073242|obesity|obesity
470924|NCT00073268|diabetes|diabetes
470925|NCT00073268|adolescent|adolescent
470926|NCT00073281|diabetes|diabetes
470927|NCT00073281|autoimmunity|autoimmunity
470928|NCT00073294|diabetes|diabetes
470929|NCT00073307|Renal Cell Cancer (RCC)|renal cell cancer (rcc)
470930|NCT00073307|Cancer|cancer
470931|NCT00073320|Schizophrenia|schizophrenia
470932|NCT00073320|Paliperidone palmitate|paliperidone palmitate
470933|NCT00073320|R092670|r092670
470934|NCT00073320|antipsychotic|antipsychotic
470935|NCT00073333|Phobic Disorders|phobic disorders
470936|NCT00073346|Compulsive Hoarding|compulsive hoarding
470937|NCT00073359|Adolescent|adolescent
470938|NCT00073372|Acute ischemic stroke|acute ischemic stroke
470939|NCT00073372|abciximab|abciximab
470940|NCT00073372|ReoPro|reopro
470941|NCT00073372|drug safety|drug safety
470942|NCT00073372|drug efficacy|drug efficacy
470943|NCT00073372|intracranial hemorrhage|intracranial hemorrhage
470944|NCT00073372|stroke|stroke
470945|NCT00073385|Lung cancer, Docetaxel, Histone deacetylase inhibitor|lung cancer, docetaxel, histone deacetylase inhibitor
470946|NCT00073398|Anti-tumor Vaccination|anti-tumor vaccination
470947|NCT00073398|Alpha (1,3) Galactosyltransferase|alpha (1,3) galactosyltransferase
470948|NCT00073398|Allogeneic Tumor Cells|allogeneic tumor cells
470949|NCT00073398|Hyperacute Lung|hyperacute lung
470950|NCT00073398|NSCLC|nsclc
470951|NCT00073398|Lung Cancer|lung cancer
470952|NCT00073398|Non-Small Cell Lung Cancer|non-small cell lung cancer
470953|NCT00073424|Treatment Experienced|treatment experienced
470954|NCT00073437|Sarcoidosis|sarcoidosis
470955|NCT00073437|Infliximab|infliximab
470956|NCT00073437|Pulmonary involvement|pulmonary involvement
470957|NCT00073437|Remicade|remicade
470958|NCT00073450|Squamous Cell Carcinoma of the Head & Neck|squamous cell carcinoma of the head & neck
470959|NCT00073463|Gene Transfer|gene transfer
470960|NCT00073463|Pulmonary function|pulmonary function
470961|NCT00073489|chronic leukemia|chronic leukemia
470962|NCT00073489|leukemia|leukemia
470963|NCT00073489|CLL|cll
470964|NCT00073515|central venous access device|central venous access device
470965|NCT00073515|thrombosis|thrombosis
470966|NCT00073515|central venous catheter|central venous catheter
470967|NCT00073515|thrombolysis|thrombolysis
470968|NCT00073515|fibrinolysis|fibrinolysis
470969|NCT00073528|metastatic|metastatic
470970|NCT00073528|advanced breast cancer|advanced breast cancer
470971|NCT00073528|breast cancer|breast cancer
470972|NCT00073541|EGFR; HER-1; monoclonal antibody; targeted therapy|egfr; her-1; monoclonal antibody; targeted therapy
470973|NCT00073580|HIT|hit
470974|NCT00073580|HITTS|hitts
470975|NCT00073580|Heparin-antibodies|heparin-antibodies
470976|NCT00073580|Coronary artery bypass surgery|coronary artery bypass surgery
470978|NCT00073580|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
470979|NCT00073580|Heparin-induced thrombocytopenia and thrombosis syndrome|heparin-induced thrombocytopenia and thrombosis syndrome
470980|NCT00073593|Off-Pump Coronary Artery Bypass Graft Surgery|off-pump coronary artery bypass graft surgery
470981|NCT00073593|CABG|cabg
470982|NCT00073593|OPCAB|opcab
470983|NCT00073593|Heparin|heparin
470984|NCT00073593|Patients requiring off-pump CABG|patients requiring off-pump cabg
470985|NCT00073606|Spinal Reflexes|spinal reflexes
470986|NCT00073606|Locomotion|locomotion
470987|NCT00073606|Motor Practice|motor practice
470988|NCT00073606|Healthy Volunteer|healthy volunteer
470989|NCT00073606|HV|hv
470990|NCT00073619|Violence|violence
470991|NCT00073619|School based|school based
470992|NCT00073619|Urban Youth|urban youth
470993|NCT00073619|Prevention|prevention
470994|NCT00073619|Community|community
470995|NCT00073658|Alzheimer disease|alzheimer disease
470996|NCT00073658|Aggression|aggression
470997|NCT00073658|Delusions|delusions
470998|NCT00073658|Paranoid behavior|paranoid behavior
470999|NCT00073671|Adolescent|adolescent
471000|NCT00073684|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
471001|NCT00073684|Depression|depression
471002|NCT00073684|Anxiety|anxiety
471003|NCT00073697|Psychotherapy|psychotherapy
471004|NCT00073697|Depressive disorder|depressive disorder
471005|NCT00073697|Antidepressive agents|antidepressive agents
471006|NCT00073697|Citalopram|citalopram
471007|NCT00073710|secondary hyperparathyroidism|secondary hyperparathyroidism
471008|NCT00073723|Non-Small Cell Lung Cancer|non-small cell lung cancer
471009|NCT00073723|Taxol|taxol
471010|NCT00073723|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
471011|NCT00073736|Hepatocellular|hepatocellular
471012|NCT00073736|Carcinoma|carcinoma
471013|NCT00073736|Liver|liver
471014|NCT00073736|Cancer|cancer
471015|NCT00073749|B-Cell|b-cell
471016|NCT00073749|Non-Hodgkin's|non-hodgkin's
471017|NCT00073749|Lymphoma|lymphoma
471018|NCT00073801|Neuromusculoskeletal Pain|neuromusculoskeletal pain
471019|NCT00073801|Laparoscopy|laparoscopy
471020|NCT00073801|Cytokines|cytokines
471021|NCT00073801|HPA Axis|hpa axis
471023|NCT00073801|Endometriosis|endometriosis
471024|NCT00073801|Surgical Excision|surgical excision
471025|NCT00073801|Inflammatory Cytokines|inflammatory cytokines
471026|NCT00073814|levalbuterol|levalbuterol
471027|NCT00073814|pediatric|pediatric
471028|NCT00073814|asthma|asthma
471029|NCT00073827|adolescent|adolescent
471030|NCT00073827|adult|adult
471031|NCT00073827|asthma|asthma
471032|NCT00073827|levalbuterol|levalbuterol
471033|NCT00073827|bronchoconstriction|bronchoconstriction
471034|NCT00073840|levalbuterol|levalbuterol
471035|NCT00073840|asthma|asthma
471036|NCT00073840|bronchoconstriction|bronchoconstriction
471037|NCT00073840|adolescent|adolescent
471038|NCT00073840|adult|adult
471039|NCT00073853|paraplegia|paraplegia
471040|NCT00073853|quadraplegia|quadraplegia
471041|NCT00073853|tetraplegia|tetraplegia
471042|NCT00073853|paralysis|paralysis
583833|NCT00512837|engagement|engagement
471043|NCT00073853|nerve regeneration|nerve regeneration
471044|NCT00073853|Acute, Complete SCI|acute, complete sci
471045|NCT00073866|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
471046|NCT00073866|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
471047|NCT00073866|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
471048|NCT00073879|stage IV renal cell cancer|stage iv renal cell cancer
471049|NCT00073879|recurrent renal cell cancer|recurrent renal cell cancer
471050|NCT00073892|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
471051|NCT00073892|stage IV melanoma|stage iv melanoma
471052|NCT00073892|recurrent melanoma|recurrent melanoma
471053|NCT00073905|unresectable gallbladder cancer|unresectable gallbladder cancer
471054|NCT00073905|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
471055|NCT00073905|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
471056|NCT00073905|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
471057|NCT00073905|pain|pain
471058|NCT00073905|recurrent gallbladder cancer|recurrent gallbladder cancer
471059|NCT00073905|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
471060|NCT00073905|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
471061|NCT00073905|advanced adult primary liver cancer|advanced adult primary liver cancer
471062|NCT00073905|recurrent adult primary liver cancer|recurrent adult primary liver cancer
471063|NCT00073931|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
471064|NCT00073931|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
471065|NCT00073931|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
471066|NCT00073931|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
471067|NCT00073931|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
471068|NCT00073931|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
471069|NCT00073931|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
471070|NCT00073931|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
471071|NCT00073931|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
471072|NCT00073931|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
471073|NCT00073944|acute undifferentiated leukemia|acute undifferentiated leukemia
471074|NCT00073944|anaplastic large cell lymphoma|anaplastic large cell lymphoma
471075|NCT00073944|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
471076|NCT00073944|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
471077|NCT00073944|chronic eosinophilic leukemia|chronic eosinophilic leukemia
471078|NCT00073944|primary myelofibrosis|primary myelofibrosis
471079|NCT00073944|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
471080|NCT00073944|chronic neutrophilic leukemia|chronic neutrophilic leukemia
471081|NCT00073944|essential thrombocythemia|essential thrombocythemia
471082|NCT00073944|intraocular lymphoma|intraocular lymphoma
471083|NCT00073944|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
471084|NCT00073944|polycythemia vera|polycythemia vera
471085|NCT00073944|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
471086|NCT00073944|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
471087|NCT00073944|prolymphocytic leukemia|prolymphocytic leukemia
471088|NCT00073944|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
471089|NCT00073944|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
13062|NCT03207074|Mass Spectrometry|mass spectrometry
471090|NCT00073944|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
471091|NCT00073944|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
471092|NCT00073944|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
471093|NCT00073944|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
471094|NCT00073944|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
89710|NCT02726919|clobazam|clobazam
471095|NCT00073944|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
471096|NCT00073944|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
471564|NCT00075166|Metastatic Brain Tumor|metastatic brain tumor
471097|NCT00073944|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
471098|NCT00073944|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
471099|NCT00073944|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
471100|NCT00073944|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
471101|NCT00073944|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
471102|NCT00073944|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
471103|NCT00073944|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
471104|NCT00073944|refractory hairy cell leukemia|refractory hairy cell leukemia
471105|NCT00073944|refractory multiple myeloma|refractory multiple myeloma
471106|NCT00073944|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
471107|NCT00073944|secondary acute myeloid leukemia|secondary acute myeloid leukemia
471108|NCT00073944|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
583834|NCT00512837|education|education
471109|NCT00073944|Waldenström macroglobulinemia|waldenström macroglobulinemia
471110|NCT00073944|adenocarcinoma of the colon|adenocarcinoma of the colon
471111|NCT00073944|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
471112|NCT00073944|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
471113|NCT00073944|adenocarcinoma of the rectum|adenocarcinoma of the rectum
471114|NCT00073944|recurrent adult brain tumor|recurrent adult brain tumor
471115|NCT00073944|recurrent adult primary liver cancer|recurrent adult primary liver cancer
471116|NCT00073944|recurrent colon cancer|recurrent colon cancer
471117|NCT00073944|recurrent esophageal cancer|recurrent esophageal cancer
471118|NCT00073944|recurrent gastric cancer|recurrent gastric cancer
471119|NCT00073944|recurrent melanoma|recurrent melanoma
471120|NCT00073944|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
471121|NCT00073944|recurrent pancreatic cancer|recurrent pancreatic cancer
471122|NCT00073944|recurrent rectal cancer|recurrent rectal cancer
471123|NCT00073944|adenocarcinoma of the stomach|adenocarcinoma of the stomach
471124|NCT00073944|adult anaplastic astrocytoma|adult anaplastic astrocytoma
471125|NCT00073944|adult glioblastoma|adult glioblastoma
471126|NCT00073944|adult pilocytic astrocytoma|adult pilocytic astrocytoma
471127|NCT00073944|adult subependymoma|adult subependymoma
471128|NCT00073944|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
471129|NCT00073944|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
471130|NCT00073944|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
471131|NCT00073944|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
471132|NCT00073944|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
471133|NCT00073944|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
471134|NCT00073944|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
471135|NCT00073944|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
471136|NCT00073944|splenic marginal zone lymphoma|splenic marginal zone lymphoma
471137|NCT00073944|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
471138|NCT00073944|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
483824|NCT00119925|infertility|infertility
471139|NCT00073944|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
471140|NCT00073944|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
471141|NCT00073944|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
471142|NCT00073944|adult diffuse astrocytoma|adult diffuse astrocytoma
471143|NCT00073944|adult giant cell glioblastoma|adult giant cell glioblastoma
471144|NCT00073944|adult gliosarcoma|adult gliosarcoma
471145|NCT00073944|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
471146|NCT00073957|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
471147|NCT00073957|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
471148|NCT00073957|anaplastic large cell lymphoma|anaplastic large cell lymphoma
471149|NCT00073970|recurrent prostate cancer|recurrent prostate cancer
471150|NCT00073970|stage I prostate cancer|stage i prostate cancer
471151|NCT00073970|stage II prostate cancer|stage ii prostate cancer
471152|NCT00073970|adenocarcinoma of the prostate|adenocarcinoma of the prostate
471153|NCT00073983|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
471154|NCT00073983|chondrosarcoma|chondrosarcoma
471155|NCT00073983|recurrent osteosarcoma|recurrent osteosarcoma
471156|NCT00074009|recurrent gastric cancer|recurrent gastric cancer
471157|NCT00074009|stage III gastric cancer|stage iii gastric cancer
471158|NCT00074009|stage IV gastric cancer|stage iv gastric cancer
471159|NCT00074009|adenocarcinoma of the stomach|adenocarcinoma of the stomach
471160|NCT00074048|refractory hairy cell leukemia|refractory hairy cell leukemia
471161|NCT00074074|refractory anemia with excess blasts|refractory anemia with excess blasts
471162|NCT00074074|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
471164|NCT00074074|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
471165|NCT00074074|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
471166|NCT00074074|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
471167|NCT00074087|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
471168|NCT00074087|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
471169|NCT00074087|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
471170|NCT00074087|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
471171|NCT00074087|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
471172|NCT00074087|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
471173|NCT00074100|stage IV breast cancer|stage iv breast cancer
471174|NCT00074100|recurrent breast cancer|recurrent breast cancer
471175|NCT00066807|stage IIIA breast cancer|stage iiia breast cancer
471176|NCT00066807|stage I breast cancer|stage i breast cancer
471177|NCT00066807|stage II breast cancer|stage ii breast cancer
471306|NCT00067197|Healthy Volunteer|healthy volunteer
471178|NCT00066846|adenocarcinoma of the colon|adenocarcinoma of the colon
471179|NCT00066846|adenocarcinoma of the rectum|adenocarcinoma of the rectum
471180|NCT00066846|stage IV rectal cancer|stage iv rectal cancer
471181|NCT00066846|recurrent rectal cancer|recurrent rectal cancer
471182|NCT00066846|stage IV colon cancer|stage iv colon cancer
471183|NCT00066846|recurrent colon cancer|recurrent colon cancer
471184|NCT00066859|depression|depression
471185|NCT00066859|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
471186|NCT00066872|basal cell carcinoma of the skin|basal cell carcinoma of the skin
471187|NCT00066885|DN101|dn101
471188|NCT00066885|Calcitriol|calcitriol
471189|NCT00066885|Lung Cancer|lung cancer
471190|NCT00066885|NSCLC|nsclc
471191|NCT00066885|Taxotere|taxotere
471192|NCT00066898|succinobucol|succinobucol
471193|NCT00066898|AGI-1067|agi-1067
471194|NCT00066898|coronary artery disease|coronary artery disease
471195|NCT00066911|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
471196|NCT00066911|Vocalization|vocalization
471197|NCT00066911|Spasmodic Dysphonia|spasmodic dysphonia
471198|NCT00066911|Muscular Tension Dysphonia|muscular tension dysphonia
471199|NCT00066911|Topical Lidocaine|topical lidocaine
471200|NCT00066911|Voice Disorders|voice disorders
471201|NCT00066911|Vocal Tremor|vocal tremor
471202|NCT00066911|Healthy Volunteer|healthy volunteer
471204|NCT00066924|spirituality|spirituality
471205|NCT00066924|religiosity|religiosity
471206|NCT00066924|immune functioning|immune functioning
471207|NCT00066924|psychoneuroimmunology|psychoneuroimmunology
471208|NCT00066924|cytokines|cytokines
471209|NCT00066924|cancer|cancer
471210|NCT00066924|death|death
471211|NCT00066924|depression|depression
471212|NCT00066950|Early childhood caries|early childhood caries
471213|NCT00066963|Early Childhood Caries|early childhood caries
471214|NCT00066976|Prenatal|prenatal
471215|NCT00066976|Respiration|respiration
471216|NCT00066976|Ultrasound|ultrasound
471217|NCT00066976|Prematurity|prematurity
471218|NCT00066976|Diagnoses|diagnoses
471219|NCT00066976|Fetal Breathing-Movement|fetal breathing-movement
471220|NCT00066976|Doppler Sonography|doppler sonography
471221|NCT00066976|Amniotic Fluid|amniotic fluid
471222|NCT00066976|Oligohydraminos|oligohydraminos
471223|NCT00066976|Polyhydraminos|polyhydraminos
471224|NCT00066976|Pregnancy|pregnancy
471225|NCT00066989|Staphylococcal infection|staphylococcal infection
471226|NCT00066989|Gram positive bacteria|gram positive bacteria
471227|NCT00066989|Staphylococcus|staphylococcus
471228|NCT00066989|Staphylococcus aureus|staphylococcus aureus
471229|NCT00067002|ALL|all
471230|NCT00067002|Leukemia, Lymphocytic, Acute|leukemia, lymphocytic, acute
471231|NCT00067002|AML|aml
471232|NCT00067002|Leukemia, Myelocytic, Acute|leukemia, myelocytic, acute
471233|NCT00067002|CML|cml
471234|NCT00067002|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
471235|NCT00067002|NHL|nhl
471236|NCT00067002|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
471237|NCT00067002|double cord blood transplant|double cord blood transplant
471238|NCT00067002|expanded cord blood transplant|expanded cord blood transplant
471239|NCT00067002|Rituxan|rituxan
471240|NCT00067002|Rituximab|rituximab
471241|NCT00067002|Melphalan|melphalan
471242|NCT00067002|Alkeran|alkeran
471243|NCT00067002|Thiotepa|thiotepa
471244|NCT00067002|Fludarabine|fludarabine
471245|NCT00067002|Fludarabine phosphate|fludarabine phosphate
471246|NCT00067002|Fludara|fludara
471247|NCT00067002|Cyclophosphamide|cyclophosphamide
471248|NCT00067002|Cytoxan|cytoxan
471249|NCT00067002|Neosar|neosar
471250|NCT00067002|Mesna|mesna
471251|NCT00067002|Mesnex|mesnex
471252|NCT00067015|adenocarcinoma of the prostate|adenocarcinoma of the prostate
471253|NCT00067015|stage III prostate cancer|stage iii prostate cancer
471254|NCT00067028|Chronic Myeloid Leukemia|chronic myeloid leukemia
471255|NCT00067028|CML Myeloid Blast Phase|cml myeloid blast phase
471256|NCT00067028|Acute Myeloid Leukemia|acute myeloid leukemia
471257|NCT00067028|Myelodysplastic Syndrome|myelodysplastic syndrome
471258|NCT00067028|Clofarabine|clofarabine
471259|NCT00067028|Clofarex|clofarex
471260|NCT00067028|Clolar|clolar
471261|NCT00067028|Ara-C|ara-c
471262|NCT00067028|Cytarabine|cytarabine
471263|NCT00067028|Cytosar|cytosar
471265|NCT00067028|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
471266|NCT00067028|Idarubicin|idarubicin
471267|NCT00067028|Idamycin|idamycin
471268|NCT00067041|Critical Limb Ischemia|critical limb ischemia
471269|NCT00067041|Autogenous Bypass Graft|autogenous bypass graft
471270|NCT00067041|CLI|cli
471271|NCT00067054|Volunteer|volunteer
471272|NCT00067054|Plasmapheresis|plasmapheresis
471273|NCT00067054|Leukapheresis|leukapheresis
471274|NCT00067054|Immunology|immunology
471275|NCT00067054|Leukocyte|leukocyte
471276|NCT00067054|Healthy Volunteer|healthy volunteer
471277|NCT00067054|HV|hv
471278|NCT00067067|Glioma|glioma
471279|NCT00067067|Brain Tumor|brain tumor
583835|NCT00512850|Folic acid|folic acid
471280|NCT00067067|Endothelial Progenitor Cells|endothelial progenitor cells
471282|NCT00067080|iron overload|iron overload
471283|NCT00067080|deferoxamine|deferoxamine
471284|NCT00067080|hemosiderosis|hemosiderosis
471285|NCT00067106|HIV|hiv
471286|NCT00067106|Women|women
471287|NCT00067106|Genital tract|genital tract
471288|NCT00067106|Treatment experienced|treatment experienced
471289|NCT00067106|Drug resistance|drug resistance
471290|NCT00067119|Graft Failure|graft failure
471291|NCT00067119|Access Blood Flow Monitoring|access blood flow monitoring
471292|NCT00067119|Clinical Trial Vascular Access|clinical trial vascular access
471293|NCT00067119|Fistula Failure|fistula failure
471294|NCT00067119|Hemodialysis|hemodialysis
471295|NCT00067119|Vascular Access|vascular access
471296|NCT00067158|nicotine dependence|nicotine dependence
471297|NCT00067171|behavioral intervention|behavioral intervention
471298|NCT00067184|methadone|methadone
471299|NCT00067184|fetus|fetus
471300|NCT00067197|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
471301|NCT00067197|Cortical Reorganization|cortical reorganization
471302|NCT00067197|Rehabilitation|rehabilitation
471303|NCT00067197|Motor Learning|motor learning
471304|NCT00067197|Activity of Daily Living (ADL)|activity of daily living (adl)
471305|NCT00067197|Stroke|stroke
471307|NCT00067197|HV|hv
471308|NCT00067210|Brain|brain
471309|NCT00067210|Epilepsy|epilepsy
471310|NCT00067210|Core|core
471311|NCT00067210|Temperature|temperature
471312|NCT00067223|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
471313|NCT00067223|Unilateral Finger Movement|unilateral finger movement
471314|NCT00067223|Interhemispheric Inhibition|interhemispheric inhibition
471315|NCT00067223|Motor Training|motor training
471316|NCT00067223|Plasticity|plasticity
471317|NCT00067223|Healthy Volunteer|healthy volunteer
471318|NCT00067223|HV|hv
471319|NCT00067249|Race|race
471320|NCT00067249|Ethnicity|ethnicity
471321|NCT00067249|Complementary and Alternative Medicine|complementary and alternative medicine
471322|NCT00067249|Women's health|women's health
471323|NCT00067249|Social determinants of Health|social determinants of health
471324|NCT00067262|Bipolar Disorder Type 1 (manic or mixed type)|bipolar disorder type 1 (manic or mixed type)
471326|NCT00067275|Motor Training|motor training
471327|NCT00067275|Positron Emission Tomograhy|positron emission tomograhy
471328|NCT00067275|Plasticity|plasticity
471329|NCT00067275|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
471330|NCT00067275|Healthy Volunteer|healthy volunteer
471332|NCT00067288|Stage 3 cancer;|stage 3 cancer;
471333|NCT00067288|Stage 4 cancer;|stage 4 cancer;
471334|NCT00067288|solid tumor cancer;|solid tumor cancer;
471335|NCT00067288|Non-Hodgkin's Lymphoma;|non-hodgkin's lymphoma;
471336|NCT00067288|solid tumors;|solid tumors;
471337|NCT00067288|end-stage cancer;|end-stage cancer;
471338|NCT00067288|group psychotherapy;|group psychotherapy;
471339|NCT00067288|psychotherapy;|psychotherapy;
471340|NCT00067288|emotional support;|emotional support;
471341|NCT00067288|support groups|support groups
471342|NCT00067301|depression|depression
471343|NCT00067301|citalopram|citalopram
471344|NCT00067301|Celexa|celexa
471345|NCT00067301|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
471346|NCT00067301|omega-3|omega-3
471347|NCT00067301|EPA|epa
471348|NCT00067301|antidepressants|antidepressants
471349|NCT00067327|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
471350|NCT00067327|Multiple sclerosis|multiple sclerosis
471351|NCT00067327|Peroxynitrite|peroxynitrite
471352|NCT00067327|Uric acid|uric acid
471353|NCT00067327|Inosine|inosine
471354|NCT00067353|Early Childhood Caries|early childhood caries
471355|NCT00074139|stage IIIA breast cancer|stage iiia breast cancer
471356|NCT00074139|recurrent breast cancer|recurrent breast cancer
471357|NCT00074139|stage IIIB breast cancer|stage iiib breast cancer
606316|NCT00605254|HV|hv
471358|NCT00074139|stage IIIC breast cancer|stage iiic breast cancer
471359|NCT00074139|stage IV breast cancer|stage iv breast cancer
471360|NCT00074152|recurrent breast cancer|recurrent breast cancer
471361|NCT00074152|stage I breast cancer|stage i breast cancer
471362|NCT00074152|stage II breast cancer|stage ii breast cancer
471363|NCT00074152|stage IIIA breast cancer|stage iiia breast cancer
471364|NCT00074152|stage IIIB breast cancer|stage iiib breast cancer
471365|NCT00074152|stage IIIC breast cancer|stage iiic breast cancer
471565|NCT00075166|Surgery|surgery
471366|NCT00074165|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
471367|NCT00074165|thrombocytopenia|thrombocytopenia
471368|NCT00074165|intraocular lymphoma|intraocular lymphoma
471369|NCT00074165|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
471370|NCT00074165|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
471371|NCT00074178|primary central nervous system lymphoma|primary central nervous system lymphoma
471372|NCT00074178|intraocular lymphoma|intraocular lymphoma
471373|NCT00074191|intraocular lymphoma|intraocular lymphoma
471374|NCT00074191|primary central nervous system lymphoma|primary central nervous system lymphoma
471375|NCT00074204|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
471376|NCT00074204|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
471377|NCT00074204|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
471378|NCT00074230|stage IV melanoma|stage iv melanoma
471379|NCT00074230|recurrent melanoma|recurrent melanoma
471380|NCT00074243|adult anaplastic astrocytoma|adult anaplastic astrocytoma
471381|NCT00074243|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
471382|NCT00074243|adult glioblastoma|adult glioblastoma
471383|NCT00074243|adult mixed glioma|adult mixed glioma
471384|NCT00074243|adult brain stem glioma|adult brain stem glioma
471385|NCT00074243|recurrent adult brain tumor|recurrent adult brain tumor
471386|NCT00074243|adult giant cell glioblastoma|adult giant cell glioblastoma
471387|NCT00074243|adult gliosarcoma|adult gliosarcoma
471388|NCT00074269|recurrent breast cancer|recurrent breast cancer
471389|NCT00074269|stage IV breast cancer|stage iv breast cancer
471390|NCT00074282|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
471391|NCT00074282|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
471392|NCT00074295|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
471393|NCT00074295|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
471394|NCT00074295|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
471395|NCT00074295|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
471396|NCT00074334|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
471397|NCT00074334|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
471398|NCT00074334|childhood oligodendroglioma|childhood oligodendroglioma
471399|NCT00074334|childhood supratentorial ependymoma|childhood supratentorial ependymoma
471400|NCT00074334|recurrent childhood ependymoma|recurrent childhood ependymoma
471401|NCT00074334|recurrent childhood brain tumor|recurrent childhood brain tumor
471403|NCT00074360|fMRI|fmri
471404|NCT00074360|Blood Flow|blood flow
471405|NCT00074360|Conditioning|conditioning
471406|NCT00074360|Reinforcement|reinforcement
471407|NCT00074373|Anti-SSA/Ro Antibodies|anti-ssa/ro antibodies
471408|NCT00074373|Anti-SSB/La Antibodies|anti-ssb/la antibodies
471409|NCT00074386|HIV|hiv
471410|NCT00074386|Transplant|transplant
471411|NCT00074386|Liver|liver
471412|NCT00074386|Kidney|kidney
471413|NCT00074386|Organ|organ
471414|NCT00074386|Treatment Experienced|treatment experienced
471415|NCT00074386|Kidney Transplant|kidney transplant
471416|NCT00074386|Liver Transplant|liver transplant
471417|NCT00074399|Maternal/Infant Transmisson|maternal/infant transmisson
471418|NCT00074399|Vertical Transmission|vertical transmission
471419|NCT00074399|Pregnancy|pregnancy
471420|NCT00074399|HIV Seronegativity|hiv seronegativity
471421|NCT00074412|HIV Seronegativity|hiv seronegativity
471422|NCT00074412|Treatment Experienced|treatment experienced
471423|NCT00074412|Treatment Naive|treatment naive
471424|NCT00074425|HIV Seronegativity|hiv seronegativity
471425|NCT00074425|Anti-Infective Agents, Local|anti-infective agents, local
471426|NCT00074425|BufferGel|buffergel
471427|NCT00074425|PRO 2000|pro 2000
471428|NCT00074425|Vagina|vagina
471429|NCT00074425|Risk Factors|risk factors
471430|NCT00074438|Rituxan|rituxan
471431|NCT00074438|RA|ra
471432|NCT00074477|Schizophrenia|schizophrenia
471433|NCT00074477|Paliperidone palmitate|paliperidone palmitate
471434|NCT00074477|R092670|r092670
471435|NCT00074477|antipsychotic|antipsychotic
471436|NCT00074490|Leukemia|leukemia
471437|NCT00074490|Lymphoma|lymphoma
471438|NCT00074490|Multiple Myeloma|multiple myeloma
471439|NCT00074490|Bone Marrow Transplantation|bone marrow transplantation
471440|NCT00074490|Immune Therapy|immune therapy
471441|NCT00074503|Positron Emission Tomography|positron emission tomography
471331|NCT00067275|HV|hv
471442|NCT00074503|Phospholipids|phospholipids
471443|NCT00074503|Alcoholism|alcoholism
606442|NCT00605982|MRI|mri
471444|NCT00074503|[11C]Docosahexaenoate|[11c]docosahexaenoate
471445|NCT00074503|[150]Water|[150]water
471446|NCT00074503|Brain|brain
471447|NCT00074503|Fatty Acids|fatty acids
471448|NCT00074503|Blood Flow|blood flow
471449|NCT00074503|Healthy|healthy
471450|NCT00074763|Leukemia|leukemia
471451|NCT00074763|Lymphoma|lymphoma
471452|NCT00074763|ALL|all
471453|NCT00074763|CLL|cll
471454|NCT00074763|AML|aml
471455|NCT00074763|CML|cml
471456|NCT00074763|MDS|mds
471457|NCT00074763|Remission|remission
471458|NCT00074763|Hematologic Disorder|hematologic disorder
471461|NCT00074763|Autologous Platelet Transfusion|autologous platelet transfusion
471462|NCT00074763|Platelet Transfusion|platelet transfusion
471463|NCT00074763|Single donor platelet apheresis|single donor platelet apheresis
471464|NCT00074763|Cryopreservation|cryopreservation
471465|NCT00074763|Thrombocytopenia|thrombocytopenia
471466|NCT00074776|Bipolar Depression|bipolar depression
471467|NCT00074789|Early Head Start Program|early head start program
471468|NCT00074802|Social Phobia|social phobia
471469|NCT00074815|Child|child
471470|NCT00074815|Adolescent|adolescent
471471|NCT00074828|elective|elective
471472|NCT00074828|primary unilateral|primary unilateral
471473|NCT00074841|MALARIA|malaria
471474|NCT00074841|INDIA|india
471475|NCT00074841|CHLOROQUINE|chloroquine
471476|NCT00074841|PLASMODIUM FALCIPARUM|plasmodium falciparum
471477|NCT00074841|SULFADOXINE-PYRIMETHAMINE|sulfadoxine-pyrimethamine
471478|NCT00074880|Cardiac Hypertrophy|cardiac hypertrophy
471479|NCT00074880|Diastolic Dysfunction|diastolic dysfunction
471480|NCT00074880|Cardiac Glycosides|cardiac glycosides
471481|NCT00074880|Cardiac Fibrosis|cardiac fibrosis
471482|NCT00074880|Atrial Systole|atrial systole
471483|NCT00074893|Repetitive Strain Injuries|repetitive strain injuries
471484|NCT00074893|Vibration Damping|vibration damping
471485|NCT00074893|Protective Brace|protective brace
471486|NCT00074893|Piezoelectric|piezoelectric
471487|NCT00074893|SmartWear|smartwear
471488|NCT00074906|Aspiration of gastric contents|aspiration of gastric contents
471489|NCT00074919|Glycogen Storage Disease Type II|glycogen storage disease type ii
471490|NCT00074919|GSD-II|gsd-ii
471491|NCT00074919|Pompe Disease|pompe disease
471492|NCT00074919|Acid Maltase Deficiency Disease|acid maltase deficiency disease
471493|NCT00074932|Glycogen Storage Disease Type II|glycogen storage disease type ii
471494|NCT00074932|GSD-II|gsd-ii
471495|NCT00074932|Pompe Disease|pompe disease
471496|NCT00074932|Acid Maltase Deficiency Disease|acid maltase deficiency disease
471497|NCT00074945|Obesity|obesity
471498|NCT00074945|Resting Energy Expenditure|resting energy expenditure
471499|NCT00074945|Metabolic Rate|metabolic rate
471500|NCT00074945|Visceral Fat|visceral fat
471501|NCT00074945|Body Fat Distribution|body fat distribution
471502|NCT00074958|a-Galactosidase A|a-galactosidase a
471503|NCT00074958|aGal|agal
471504|NCT00074958|r-haGAL|r-hagal
471505|NCT00074958|Fabry|fabry
471506|NCT00074958|GL-3|gl-3
471507|NCT00074958|Fabrazyme|fabrazyme
471508|NCT00074971|a-Galactosidase A|a-galactosidase a
471509|NCT00074971|aGAL|agal
471510|NCT00074971|r-haGAL|r-hagal
471511|NCT00074971|Fabry|fabry
471512|NCT00074971|GL-3|gl-3
471513|NCT00074971|Fabrazyme|fabrazyme
471514|NCT00074984|a-Galactosidase A|a-galactosidase a
471515|NCT00074984|aGAL|agal
471516|NCT00074984|r-haGAL|r-hagal
471517|NCT00074984|Fabry|fabry
471518|NCT00074984|GL-3|gl-3
471519|NCT00074984|Fabrazyme|fabrazyme
471520|NCT00074997|Gene Therapy|gene therapy
471521|NCT00074997|Anti-HIV-1 Ribozyme|anti-hiv-1 ribozyme
471522|NCT00074997|OZ1|oz1
471523|NCT00074997|HIV-1 Infections|hiv-1 infections
471524|NCT00075010|Relapsed/Refractory Leukemia|relapsed/refractory leukemia
471525|NCT00075010|Myelodysplastic Syndromes|myelodysplastic syndromes
471526|NCT00075023|Stomatitis|stomatitis
471527|NCT00075023|Oropharyngeal pain|oropharyngeal pain
471528|NCT00075023|TNF-alpha|tnf-alpha
471529|NCT00075023|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
471530|NCT00075023|Inflammation|inflammation
471531|NCT00075023|Thalidomide|thalidomide
471532|NCT00075023|Oral chronic graft-versus-host disease|oral chronic graft-versus-host disease
471533|NCT00075036|Health Disparities|health disparities
471534|NCT00075036|Transplantation|transplantation
471535|NCT00075036|Trust|trust
471536|NCT00075036|Interview|interview
471537|NCT00075036|Ethnic Bias|ethnic bias
471538|NCT00075049|malaria|malaria
471539|NCT00075075|Infliximab|infliximab
471540|NCT00075075|Scleritis|scleritis
471541|NCT00075075|Intraocular Inflammatory Disease|intraocular inflammatory disease
471542|NCT00075075|Corticosteroids|corticosteroids
471543|NCT00075075|Immunosuppressives|immunosuppressives
471544|NCT00075088|Telemedicine|telemedicine
471545|NCT00075088|Emergency Care|emergency care
471546|NCT00075088|Cardiac|cardiac
471547|NCT00075101|Drug Adverse Effect|drug adverse effect
471548|NCT00075101|Pediatric Cancer|pediatric cancer
471549|NCT00075114|Self Care|self care
471550|NCT00075114|Behavior Modification|behavior modification
471551|NCT00075140|Patient Care Management|patient care management
471552|NCT00075140|Family|family
471553|NCT00075140|Huntington's Disease|huntington's disease
471554|NCT00075153|ADOLESCENCE|adolescence
471555|NCT00075153|HIV INFECTION|hiv infection
471556|NCT00075153|PEDIATRIC AIDS|pediatric aids
471557|NCT00075153|QUALITY OF LIFE|quality of life
471558|NCT00075153|HIV|hiv
471559|NCT00075166|Stereotactic|stereotactic
471560|NCT00075166|Carcinoma|carcinoma
471561|NCT00075166|Melanoma|melanoma
471562|NCT00075166|Surgical Resection|surgical resection
471563|NCT00075166|Metastases|metastases
472591|NCT00078312|Cataplexy|cataplexy
471566|NCT00075166|Radiosurgery|radiosurgery
471567|NCT00075166|Treatment|treatment
471568|NCT00075179|Pulmonary hypertension|pulmonary hypertension
471569|NCT00075179|cancer|cancer
471570|NCT00075179|lung cancer|lung cancer
471571|NCT00075179|lung disease|lung disease
471572|NCT00075179|cardiothoracic surgery|cardiothoracic surgery
471573|NCT00075179|Nesiritide|nesiritide
471574|NCT00075179|Natrecor|natrecor
471575|NCT00075179|CV Surgery|cv surgery
471576|NCT00075179|Lung Tumor|lung tumor
471577|NCT00075205|Alcohol Consumption|alcohol consumption
471578|NCT00075205|Alcohol Treatment|alcohol treatment
471579|NCT00075205|Medication Trial|medication trial
471580|NCT00075205|Craving|craving
471581|NCT00075205|Cannabinoids|cannabinoids
471582|NCT00075205|CB 1 Receptor Antagonist|cb 1 receptor antagonist
471583|NCT00075205|SR141716|sr141716
471584|NCT00075205|Alcoholism|alcoholism
471585|NCT00075231|Treatment Naive|treatment naive
471586|NCT00075244|Lysosomes|lysosomes
471587|NCT00075244|Storage|storage
471588|NCT00075244|Glycolipid|glycolipid
471589|NCT00075244|Fabry Disease|fabry disease
471590|NCT00075244|Stroke|stroke
471591|NCT00075270|metastatic breast cancer|metastatic breast cancer
471592|NCT00075270|ErbB1|erbb1
471593|NCT00075270|kinase inhibitor|kinase inhibitor
471594|NCT00075270|ErbB2|erbb2
471595|NCT00075270|EGFR|egfr
471596|NCT00075270|lapatinib|lapatinib
471597|NCT00075270|Her2-neu|her2-neu
471598|NCT00075283|Physical Therapy|physical therapy
471599|NCT00075283|Locomotion therapy|locomotion therapy
471600|NCT00075283|Gait training|gait training
471601|NCT00075283|Stroke|stroke
471602|NCT00075283|Robotics|robotics
471603|NCT00075283|Rehabilitation|rehabilitation
471604|NCT00075283|Treadmill|treadmill
471605|NCT00075283|Hemiparetic stroke|hemiparetic stroke
471606|NCT00075283|Unilateral brain lesion|unilateral brain lesion
471607|NCT00075296|Major Depressive Disorder|major depressive disorder
471608|NCT00075296|Bipolar Disorder|bipolar disorder
471609|NCT00075296|Negative Feedback|negative feedback
471610|NCT00075296|Cognitive Performance|cognitive performance
471611|NCT00075296|Negative Affect|negative affect
471612|NCT00075296|Depression|depression
471613|NCT00075296|Major Depression|major depression
471614|NCT00075296|MDD|mdd
471615|NCT00075296|Healthy Volunteer|healthy volunteer
471616|NCT00075296|HV|hv
471617|NCT00075335|Hematopoietic Stem Cells|hematopoietic stem cells
471618|NCT00075335|Mobilization|mobilization
471619|NCT00075335|Alloreactivity|alloreactivity
471620|NCT00075335|T Cell Polarization|t cell polarization
471621|NCT00075335|Dendritic Cells|dendritic cells
471622|NCT00075335|Plerixafor|plerixafor
471623|NCT00075335|Mozobil|mozobil
471624|NCT00075335|Healthy Volunteer|healthy volunteer
471625|NCT00075335|HV|hv
483825|NCT00119925|guideline|guideline
471626|NCT00075348|renal cell carcinoma|renal cell carcinoma
471627|NCT00075348|von Hippel-Lindau syndrome|von hippel-lindau syndrome
471628|NCT00075374|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
471629|NCT00075374|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
471630|NCT00075374|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
471631|NCT00075413|stage IIIB breast cancer|stage iiib breast cancer
471632|NCT00075413|stage IIIC breast cancer|stage iiic breast cancer
471633|NCT00075413|stage IV breast cancer|stage iv breast cancer
471634|NCT00075413|recurrent breast cancer|recurrent breast cancer
471635|NCT00075413|stage IIIA breast cancer|stage iiia breast cancer
471636|NCT00075426|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
471637|NCT00075426|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
471638|NCT00075426|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
471639|NCT00075426|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
471640|NCT00075452|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
471641|NCT00075452|stage II pancreatic cancer|stage ii pancreatic cancer
471642|NCT00075452|stage III pancreatic cancer|stage iii pancreatic cancer
471643|NCT00075452|stage IV pancreatic cancer|stage iv pancreatic cancer
471644|NCT00075465|adenocarcinoma of the stomach|adenocarcinoma of the stomach
471645|NCT00075465|stage III gastric cancer|stage iii gastric cancer
471646|NCT00075465|stage IV gastric cancer|stage iv gastric cancer
471647|NCT00075517|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
471648|NCT00075517|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
471649|NCT00075517|adenocarcinoma of the lung|adenocarcinoma of the lung
471650|NCT00075517|large cell lung cancer|large cell lung cancer
471651|NCT00075517|squamous cell lung cancer|squamous cell lung cancer
471652|NCT00075543|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
471653|NCT00075543|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
471654|NCT00075543|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
471655|NCT00075556|stage III colon cancer|stage iii colon cancer
471656|NCT00075556|stage IV colon cancer|stage iv colon cancer
471657|NCT00075556|stage III rectal cancer|stage iii rectal cancer
471658|NCT00075556|stage IV rectal cancer|stage iv rectal cancer
471659|NCT00075556|adenocarcinoma of the rectum|adenocarcinoma of the rectum
471660|NCT00075556|adenocarcinoma of the colon|adenocarcinoma of the colon
471661|NCT00075569|cervical cancer|cervical cancer
471662|NCT00075569|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
471663|NCT00075595|stage IV colon cancer|stage iv colon cancer
471664|NCT00075595|stage IV rectal cancer|stage iv rectal cancer
471665|NCT00075595|recurrent colon cancer|recurrent colon cancer
471666|NCT00075595|recurrent rectal cancer|recurrent rectal cancer
471667|NCT00075595|adenocarcinoma of the colon|adenocarcinoma of the colon
471668|NCT00075595|adenocarcinoma of the rectum|adenocarcinoma of the rectum
471669|NCT00075608|primary systemic amyloidosis|primary systemic amyloidosis
471670|NCT00075621|primary systemic amyloidosis|primary systemic amyloidosis
471671|NCT00075660|recurrent renal cell cancer|recurrent renal cell cancer
471672|NCT00075660|stage III renal cell cancer|stage iii renal cell cancer
471673|NCT00075660|stage IV renal cell cancer|stage iv renal cell cancer
471674|NCT00075673|recurrent breast cancer|recurrent breast cancer
471675|NCT00075673|stage IV breast cancer|stage iv breast cancer
471676|NCT00075686|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
471677|NCT00075686|stage III pancreatic cancer|stage iii pancreatic cancer
471678|NCT00075686|stage IV pancreatic cancer|stage iv pancreatic cancer
471679|NCT00075699|epithelial mesothelioma|epithelial mesothelioma
471680|NCT00075699|localized malignant mesothelioma|localized malignant mesothelioma
471681|NCT00075699|advanced malignant mesothelioma|advanced malignant mesothelioma
471682|NCT00075712|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
471683|NCT00075712|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
471684|NCT00075712|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
471685|NCT00075712|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
471686|NCT00075712|stage IV fallopian tube cancer|stage iv fallopian tube cancer
471687|NCT00075712|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
471688|NCT00075712|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
471689|NCT00075712|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
471690|NCT00075712|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
471691|NCT00075712|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
471692|NCT00075712|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
471693|NCT00075712|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
471694|NCT00075725|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
471695|NCT00075725|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
471696|NCT00075725|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
471697|NCT00075725|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
471698|NCT00075738|stage IV esophageal cancer|stage iv esophageal cancer
471699|NCT00075738|recurrent esophageal cancer|recurrent esophageal cancer
471700|NCT00075764|stage IV breast cancer|stage iv breast cancer
471701|NCT00075764|recurrent breast cancer|recurrent breast cancer
471702|NCT00075777|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
471703|NCT00075777|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
471704|NCT00075803|Myelodysplastic and Myeloproliferative Diseases|myelodysplastic and myeloproliferative diseases
471705|NCT00075829|Stage II Multiple Myeloma|stage ii multiple myeloma
471706|NCT00075829|Stage III Multiple Myeloma|stage iii multiple myeloma
471707|NCT00075829|Refractory Plasma Cell Neoplasm|refractory plasma cell neoplasm
471709|NCT00075842|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
471711|NCT00075855|sexual dysfunction|sexual dysfunction
471712|NCT00075855|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
471713|NCT00075855|sexuality and reproductive issues|sexuality and reproductive issues
471714|NCT00075855|cancer survivor|cancer survivor
471715|NCT00075868|radiation enteritis|radiation enteritis
471716|NCT00075868|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
471717|NCT00075868|stage I rectal cancer|stage i rectal cancer
471718|NCT00075868|stage II rectal cancer|stage ii rectal cancer
471719|NCT00075868|stage III rectal cancer|stage iii rectal cancer
471720|NCT00075868|stage IIIA anal cancer|stage iiia anal cancer
471721|NCT00075868|stage IIIB anal cancer|stage iiib anal cancer
471722|NCT00075868|recurrent anal cancer|recurrent anal cancer
471723|NCT00075868|stage I anal cancer|stage i anal cancer
471724|NCT00075868|stage II anal cancer|stage ii anal cancer
471725|NCT00075868|recurrent rectal cancer|recurrent rectal cancer
471726|NCT00075894|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
471727|NCT00075894|adult anaplastic astrocytoma|adult anaplastic astrocytoma
471728|NCT00075894|adult glioblastoma|adult glioblastoma
471729|NCT00075894|recurrent adult brain tumor|recurrent adult brain tumor
471730|NCT00075894|adult giant cell glioblastoma|adult giant cell glioblastoma
471731|NCT00075894|adult gliosarcoma|adult gliosarcoma
471732|NCT00075907|Acute Infection|acute infection
471733|NCT00075907|Treatment Experienced|treatment experienced
471734|NCT00075907|Treatment Naive|treatment naive
471735|NCT00075920|Heart|heart
471736|NCT00075920|Function|function
471737|NCT00075920|Ultrasound|ultrasound
471738|NCT00075920|MRI|mri
471739|NCT00075920|Left Ventricle|left ventricle
471740|NCT00075920|Healthy Volunteer|healthy volunteer
471741|NCT00075920|HV|hv
471742|NCT00075920|Heart Disease|heart disease
471743|NCT00075946|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
471744|NCT00075946|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
471745|NCT00075946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
471746|NCT00075946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
471747|NCT00075946|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
471748|NCT00075946|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
471749|NCT00075946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
471750|NCT00075946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
471751|NCT00075946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
471752|NCT00075946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
471753|NCT00075946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
471754|NCT00075959|Stroke|stroke
471755|NCT00075959|cerebral vascular accident|cerebral vascular accident
471756|NCT00075959|CVA|cva
471757|NCT00075959|Hemorrhage|hemorrhage
471758|NCT00075959|Intracerebral Hemorrhage (ICH)|intracerebral hemorrhage (ich)
471759|NCT00075959|Brain Attack|brain attack
471760|NCT00075959|Cataplexy|cataplexy
471761|NCT00075998|Idiopathic|idiopathic
471762|NCT00075998|Pulmonary|pulmonary
471763|NCT00075998|Fibrosis|fibrosis
471764|NCT00075998|IPF|ipf
471765|NCT00075998|Lung|lung
471766|NCT00075998|Interferon|interferon
471767|NCT00075998|Gamma|gamma
471768|NCT00075998|Actimmune|actimmune
471769|NCT00075998|INSPIRE|inspire
471770|NCT00075998|InterMune|intermune
471771|NCT00076024|metastatic breast cancer|metastatic breast cancer
471772|NCT00076037|HIV Preventive Vaccine|hiv preventive vaccine
471773|NCT00076037|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
471774|NCT00076037|AIDS Vaccines|aids vaccines
471775|NCT00076037|HIV-1|hiv-1
471776|NCT00076037|HIV Seronegativity|hiv seronegativity
471777|NCT00076037|Injections, Intramuscular|injections, intramuscular
471778|NCT00076037|RC529|rc529
471779|NCT00076037|Epitopes|epitopes
471780|NCT00076037|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
471781|NCT00076063|HIV Seronegativity|hiv seronegativity
471782|NCT00076063|ALVAC-HIV vCP1452|alvac-hiv vcp1452
471783|NCT00076063|ALVAC Vaccine|alvac vaccine
471784|NCT00076063|HIV-1|hiv-1
471785|NCT00076063|Normal Values|normal values
471786|NCT00076063|HIV Preventive Vaccine|hiv preventive vaccine
471787|NCT00076076|Roflumilast|roflumilast
471788|NCT00076076|Asthma|asthma
471789|NCT00076089|Roflumilast|roflumilast
471790|NCT00076089|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
471791|NCT00076089|COPD|copd
471793|NCT00076102|Oral Administration|oral administration
471794|NCT00076102|Nerve Sheath Tumor|nerve sheath tumor
471795|NCT00076102|Antifibrotic Agent|antifibrotic agent
471796|NCT00076102|Volumetric Tumor Measurement|volumetric tumor measurement
471797|NCT00076102|Plexiform Neurofibroma|plexiform neurofibroma
471798|NCT00076102|Neurofibromatosis Type 1|neurofibromatosis type 1
471799|NCT00076102|Volumetric MRI Analysis|volumetric mri analysis
471800|NCT00076102|Time to Progression|time to progression
471802|NCT00076115|Bipolar|bipolar
471803|NCT00076115|Mania|mania
471804|NCT00076115|Manic|manic
471805|NCT00076115|Depressive|depressive
471806|NCT00076115|Manic Depressive|manic depressive
471807|NCT00076115|Bipolar mania|bipolar mania
471808|NCT00076115|risperidone|risperidone
471809|NCT00076115|adolescents|adolescents
471810|NCT00076115|children|children
471811|NCT00076141|relatively healthy male|relatively healthy male
471812|NCT00076154|ALS|als
471813|NCT00076180|cytotoxic activity against T-LGL cells|cytotoxic activity against t-lgl cells
471814|NCT00076180|chronic lymphoproliferative disorder|chronic lymphoproliferative disorder
471815|NCT00076180|T-LGL Leukemia|t-lgl leukemia
471816|NCT00076180|Natural Killer Cells|natural killer cells
471817|NCT00076180|Leukemia|leukemia
471818|NCT00076180|Lymphocytic Leukemia|lymphocytic leukemia
471819|NCT00076180|T-LGL|t-lgl
471820|NCT00076219|Acute Renal Failure|acute renal failure
471821|NCT00076219|Renal Replacement Therapy|renal replacement therapy
471822|NCT00076219|multi-site randomization trial|multi-site randomization trial
471824|NCT00076219|Hemofiltration|hemofiltration
471825|NCT00076219|Critical Illness|critical illness
471826|NCT00076219|Hemodiafiltration|hemodiafiltration
471827|NCT00076232|HIV Seronegativity|hiv seronegativity
471828|NCT00076245|Phototherapy|phototherapy
471829|NCT00076258|Exercise therapy|exercise therapy
471830|NCT00076258|Complementary Therapies|complementary therapies
471831|NCT00076271|Strabismus|strabismus
471832|NCT00076271|Cataract, Pediatric|cataract, pediatric
471833|NCT00076271|Optic Nerve Anomaly|optic nerve anomaly
471834|NCT00076271|Coloboma|coloboma
471835|NCT00076271|Evaluation and Treatment|evaluation and treatment
471836|NCT00076271|Pediatric Ophthalmology|pediatric ophthalmology
471837|NCT00076271|Genetic Eye Disease|genetic eye disease
471838|NCT00076271|Nystagmus|nystagmus
471839|NCT00076271|Pediatric Eye Disease|pediatric eye disease
471840|NCT00076271|Developmental Eye Condition|developmental eye condition
471841|NCT00076271|Cataract|cataract
471842|NCT00076271|Juvenile Glaucoma|juvenile glaucoma
471843|NCT00076271|Eye Movement Disorder|eye movement disorder
471844|NCT00076284|CCR5 Antagonist|ccr5 antagonist
471845|NCT00076284|Coreceptor Inhibitor|coreceptor inhibitor
471846|NCT00076284|Fusion Inhibitor|fusion inhibitor
471847|NCT00076284|Entry Inhibitor|entry inhibitor
471848|NCT00076284|Antiretroviral|antiretroviral
471849|NCT00076284|HIV|hiv
471850|NCT00076310|Head and Neck Cancer|head and neck cancer
471851|NCT00076310|Squamous Cell Cancer|squamous cell cancer
471852|NCT00076310|OSI-774|osi-774
471853|NCT00076310|Cisplatin|cisplatin
471854|NCT00076310|Platinol®-AQ|platinol®-aq
471855|NCT00076310|Platinol®|platinol®
471856|NCT00076310|CDDP|cddp
471857|NCT00076310|Docetaxel|docetaxel
471858|NCT00076310|Taxotere|taxotere
471859|NCT00076310|Tarceva|tarceva
471860|NCT00076310|HNSCC|hnscc
471861|NCT00076310|Erlotinib Hydrochloride|erlotinib hydrochloride
471862|NCT00076323|G6PD|g6pd
471863|NCT00076323|Favism|favism
471864|NCT00076323|G6PD Deficiency|g6pd deficiency
471865|NCT00076323|hemolysis|hemolysis
471866|NCT00076323|drug reaction|drug reaction
471867|NCT00076323|drug-induced hemolysis|drug-induced hemolysis
471868|NCT00076349|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
471869|NCT00076349|NHL|nhl
471870|NCT00076349|Rituxan|rituxan
471871|NCT00076349|Mantle Cell|mantle cell
471872|NCT00076349|mabs|mabs
471873|NCT00076375|Atopic Dermatitis|atopic dermatitis
471874|NCT00076375|Eczema|eczema
471875|NCT00076388|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
471876|NCT00076401|CLL|cll
471877|NCT00076401|chronic lymphocytic leukemia|chronic lymphocytic leukemia
471878|NCT00076401|relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
471879|NCT00076401|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
471880|NCT00076401|Leukemia|leukemia
471881|NCT00076401|Motexafin gadolinium|motexafin gadolinium
471882|NCT00076401|Chronic leukemia|chronic leukemia
471883|NCT00076401|Lymphocytic leukemia, chronic|lymphocytic leukemia, chronic
471884|NCT00076414|Endothelial Function|endothelial function
471885|NCT00076414|Lopinavir/Ritonavir|lopinavir/ritonavir
471886|NCT00076414|HIV|hiv
471887|NCT00076414|Blood Flow Studies|blood flow studies
471888|NCT00076414|Flow-Mediated Vasodilatation|flow-mediated vasodilatation
471889|NCT00076414|Healthy Volunteer|healthy volunteer
471890|NCT00076414|HV|hv
471891|NCT00076427|Immunity|immunity
471892|NCT00076427|Liver|liver
471893|NCT00076427|Apheresis|apheresis
471894|NCT00076427|Cytokine|cytokine
471898|NCT00076427|Hepatitis C co-infection|hepatitis c co-infection
471899|NCT00076440|Alzheimer disease|alzheimer disease
471900|NCT00076453|Knee Pain|knee pain
471901|NCT00076453|Degenerative Arthritis|degenerative arthritis
471902|NCT00076453|Cartilage Disease|cartilage disease
471903|NCT00076453|Non-drug Therapy|non-drug therapy
471904|NCT00076466|Brain Excitability|brain excitability
471905|NCT00076466|Reaction Time|reaction time
471906|NCT00076466|Plasticity|plasticity
471907|NCT00076466|Motor Evoked Potential|motor evoked potential
471908|NCT00076466|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
471909|NCT00076466|Healthy Volunteer|healthy volunteer
471911|NCT00076479|Aphasia|aphasia
471912|NCT00076479|Rehabilitation|rehabilitation
471913|NCT00076479|Neuroplasticity|neuroplasticity
471914|NCT00076479|Picture Naming|picture naming
471915|NCT00076479|Transcranial Magnetic|transcranial magnetic
471916|NCT00076479|Stroke|stroke
471917|NCT00076479|Healthy Volunteer|healthy volunteer
471918|NCT00076479|HV|hv
471919|NCT00076492|Parkinson's disease|parkinson's disease
471920|NCT00076492|Parkinson disease|parkinson disease
471921|NCT00076492|CoQ10|coq10
471922|NCT00076492|GPI 1485|gpi 1485
471923|NCT00076505|Mitochondria|mitochondria
471924|NCT00076505|Proteasome|proteasome
471925|NCT00076505|Lipid|lipid
471926|NCT00076505|Polymorphism|polymorphism
471927|NCT00076505|Genetic|genetic
471928|NCT00076505|Parkinson's Disease|parkinson's disease
471930|NCT00076505|PD|pd
471931|NCT00076505|Heredity|heredity
471932|NCT00076505|Parkinson Disease At Risk|parkinson disease at risk
471933|NCT00076505|Healthy Volunteer|healthy volunteer
471934|NCT00076505|HV|hv
471935|NCT00076518|Treatment Experienced|treatment experienced
471936|NCT00076531|Prostate|prostate
471937|NCT00076531|Cancer|cancer
471938|NCT00076531|PSA|psa
471939|NCT00076531|Leuprolide|leuprolide
471940|NCT00076544|Intrathecal|intrathecal
471941|NCT00076557|Hemophilia B|hemophilia b
471942|NCT00076557|Factor IX|factor ix
471943|NCT00076557|Gene Transfer|gene transfer
471944|NCT00076557|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
471945|NCT00076570|Tolerance|tolerance
471946|NCT00076570|Kidney|kidney
471947|NCT00076570|Transplant|transplant
471948|NCT00076570|Polyclonal|polyclonal
471949|NCT00076570|Antibody|antibody
471950|NCT00076570|Kidney Transplant|kidney transplant
471951|NCT00076583|Motor Learning|motor learning
471952|NCT00076583|Co-contraction|co-contraction
471953|NCT00076583|Reciprocal Inhibition|reciprocal inhibition
471954|NCT00076583|Spinal Plasticity|spinal plasticity
471955|NCT00076583|Rhythmic Movement|rhythmic movement
471956|NCT00076583|Healthy Volunteer|healthy volunteer
471957|NCT00076583|HV|hv
471958|NCT00076596|Corticospinal Tracts|corticospinal tracts
471959|NCT00076596|Spastic Hemiplegia|spastic hemiplegia
471960|NCT00076596|Spastic Diplegia|spastic diplegia
471961|NCT00076596|Cortical Re-Organization|cortical re-organization
471962|NCT00076596|Functional Outcome|functional outcome
471963|NCT00076596|Cerebral Palsy|cerebral palsy
471964|NCT00076609|hepatocellular carcinoma|hepatocellular carcinoma
471965|NCT00076609|advanced|advanced
471966|NCT00076609|unresectable|unresectable
471967|NCT00076609|liver cancer|liver cancer
471968|NCT00076609|systemic chemotherapy|systemic chemotherapy
471969|NCT00076609|botanical|botanical
471970|NCT00076609|herbal|herbal
471971|NCT00076609|alternative and complementary medicine|alternative and complementary medicine
471972|NCT00076609|capecitabine|capecitabine
471973|NCT00076609|PHY906|phy906
471974|NCT00076609|oral|oral
471975|NCT00076609|HCC|hcc
471976|NCT00076609|traditional chinese medicine|traditional chinese medicine
471977|NCT00076609|tcm|tcm
471978|NCT00076609|QOL|qol
471979|NCT00076609|quality of life|quality of life
471980|NCT00076622|Antidepressant drugs|antidepressant drugs
471981|NCT00076622|Nursing Homes|nursing homes
471982|NCT00076635|Idiopathic|idiopathic
471983|NCT00076635|Pulmonary|pulmonary
471984|NCT00076635|Fibrosis|fibrosis
471985|NCT00076635|IPF|ipf
471986|NCT00076635|Lung|lung
471987|NCT00076635|Actimmune|actimmune
471988|NCT00076635|Interferon|interferon
471989|NCT00076635|Gamma|gamma
471990|NCT00076635|InterMune|intermune
471991|NCT00076674|Parkinson's Disease|parkinson's disease
471992|NCT00076674|Keppra|keppra
471993|NCT00076674|Motor Fluctuations|motor fluctuations
471994|NCT00076674|Intravenous Levodopa|intravenous levodopa
471995|NCT00076674|Antiparkinsonian Response|antiparkinsonian response
471996|NCT00076674|Parkinson Disease|parkinson disease
471997|NCT00076674|PD|pd
471998|NCT00076700|Cross-Modal Plasticity|cross-modal plasticity
471999|NCT00076700|Functional MRI|functional mri
472000|NCT00076700|Behavior|behavior
472001|NCT00076700|Memory|memory
472002|NCT00076700|Blind|blind
472003|NCT00076700|Blindness|blindness
472004|NCT00076700|Healthy Volunteer|healthy volunteer
472005|NCT00076700|HV|hv
472006|NCT00076713|Antiphospholipid|antiphospholipid
472007|NCT00076726|Giant Cell Arteritis|giant cell arteritis
472008|NCT00076726|infliximab|infliximab
472009|NCT00076739|Prefrontal Cortex|prefrontal cortex
472010|NCT00076739|Semantic Memory|semantic memory
472011|NCT00076739|Semantic Relations|semantic relations
472012|NCT00076739|Priming Paradigm|priming paradigm
472013|NCT00076739|fMRI|fmri
472014|NCT00076739|Healthy Volunteer|healthy volunteer
472015|NCT00076739|HV|hv
472016|NCT00076752|Refractory SLE|refractory sle
472017|NCT00076752|Immunoablation|immunoablation
472018|NCT00076752|Immunological Recovery|immunological recovery
472019|NCT00076752|Efficacy|efficacy
472020|NCT00076752|Mechanism of Disease|mechanism of disease
472021|NCT00076752|Lupus|lupus
472022|NCT00076752|Systemic Lupus Erythematosus|systemic lupus erythematosus
472023|NCT00076752|SLE|sle
472024|NCT00076791|HIV Seronegativity|hiv seronegativity
472025|NCT00076804|Directly Observed Therapy|directly observed therapy
472026|NCT00076804|DOT|dot
472027|NCT00076817|HIV Preventive Vaccine|hiv preventive vaccine
472028|NCT00076817|ALVAC Vaccine|alvac vaccine
472029|NCT00076817|Immunization Site|immunization site
472030|NCT00076817|Deltoid|deltoid
472031|NCT00076817|Groin|groin
472032|NCT00076817|Targeted Inguinal Lymph Node|targeted inguinal lymph node
471281|NCT00067080|Sickle cell disease|sickle cell disease
472033|NCT00076817|TILN|tiln
472034|NCT00076830|Errors of Bone Matrix and Metabolism|errors of bone matrix and metabolism
471910|NCT00076466|HV|hv
472035|NCT00076830|Connective Tissue Disorders|connective tissue disorders
472036|NCT00076843|Interleukin-15|interleukin-15
472037|NCT00076843|CD8+ T-cells|cd8+ t-cells
472039|NCT00076843|HTLV-1|htlv-1
472040|NCT00076843|HTLV-1 Associated Myelopathy|htlv-1 associated myelopathy
472041|NCT00076843|Tropical Spastic Paraparesis|tropical spastic paraparesis
472042|NCT00076869|Definite or probable Invasive Aspergillosis either refractory or intolerant to prior antifungal treatment.|definite or probable invasive aspergillosis either refractory or intolerant to prior antifungal treatment.
472043|NCT00076934|Ataxia|ataxia
472044|NCT00076934|MRI|mri
472045|NCT00076934|MS|ms
472046|NCT00076934|CTLA4-IgG4m|ctla4-igg4m
472047|NCT00076934|Costimulatory Signals|costimulatory signals
472048|NCT00076934|Autoimmune Disorders|autoimmune disorders
472049|NCT00076947|HIV Preventive Vaccine|hiv preventive vaccine
472050|NCT00076947|HIV Seronegativity|hiv seronegativity
472051|NCT00076947|Protein|protein
472052|NCT00076960|hyperbilirubinemia|hyperbilirubinemia
472053|NCT00076960|jaundice|jaundice
472054|NCT00076960|tin-mesoporphyrin|tin-mesoporphyrin
472055|NCT00076960|stannsoporfin|stannsoporfin
472056|NCT00076960|exchange transfusion|exchange transfusion
472057|NCT00076960|neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
472058|NCT00076973|RSV Bronchiolitis|rsv bronchiolitis
472059|NCT00076986|brain tumor|brain tumor
472060|NCT00076986|recurrent malignant glioma|recurrent malignant glioma
472061|NCT00076986|brain neoplasm|brain neoplasm
472062|NCT00076986|central nervous system|central nervous system
472063|NCT00076986|surgery|surgery
472064|NCT00076986|resection|resection
472065|NCT00076986|GLIADEL|gliadel
472066|NCT00076986|infusion|infusion
472067|NCT00076986|glioblastoma multiforme|glioblastoma multiforme
472068|NCT00076986|convection-enhanced delivery|convection-enhanced delivery
472069|NCT00076986|first recurrence|first recurrence
472070|NCT00076986|recurrent GBM|recurrent gbm
472071|NCT00076986|GBM|gbm
472072|NCT00076986|supratentorial GBM|supratentorial gbm
472073|NCT00077012|BPH|bph
472074|NCT00077025|metastatic breast cancer|metastatic breast cancer
472075|NCT00077038|Visual Feedback|visual feedback
472076|NCT00077038|Cortical Connectivity|cortical connectivity
472077|NCT00077038|Magnetoencephalography|magnetoencephalography
472078|NCT00077038|Eye Tracking|eye tracking
472079|NCT00077038|Healthy Volunteer|healthy volunteer
472080|NCT00077038|HV|hv
472081|NCT00077051|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
472082|NCT00077051|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
472083|NCT00077051|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
472084|NCT00077051|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
472085|NCT00077064|radiation fibrosis|radiation fibrosis
472086|NCT00077064|pulmonary complications|pulmonary complications
472087|NCT00077064|limited stage small cell lung cancer|limited stage small cell lung cancer
472088|NCT00077064|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
472089|NCT00077064|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
472090|NCT00077064|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
472091|NCT00077064|stage I non-small cell lung cancer|stage i non-small cell lung cancer
472092|NCT00077077|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
472093|NCT00077090|lymphedema|lymphedema
472094|NCT00077090|radiation fibrosis|radiation fibrosis
472095|NCT00077090|perioperative/postoperative complications|perioperative/postoperative complications
472096|NCT00077090|stage I breast cancer|stage i breast cancer
472097|NCT00077090|stage II breast cancer|stage ii breast cancer
472098|NCT00077090|stage IIIA breast cancer|stage iiia breast cancer
472099|NCT00077103|anaplastic thyroid cancer|anaplastic thyroid cancer
472100|NCT00077116|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
472101|NCT00077116|refractory anemia with excess blasts|refractory anemia with excess blasts
472102|NCT00077116|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
472103|NCT00077116|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
472104|NCT00077116|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
472105|NCT00077116|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
472106|NCT00077116|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
472107|NCT00077116|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
472108|NCT00077116|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
472109|NCT00077116|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
472110|NCT00077116|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
472111|NCT00077116|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
472112|NCT00077129|stage III renal cell cancer|stage iii renal cell cancer
472113|NCT00077129|stage IV renal cell cancer|stage iv renal cell cancer
472114|NCT00077129|recurrent renal cell cancer|recurrent renal cell cancer
472115|NCT00077142|advanced adult primary liver cancer|advanced adult primary liver cancer
472116|NCT00077142|recurrent adult primary liver cancer|recurrent adult primary liver cancer
472117|NCT00077142|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
472118|NCT00077142|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
472119|NCT00077142|Oral TAC-101|oral tac-101
472120|NCT00077168|ductal breast carcinoma in situ|ductal breast carcinoma in situ
472121|NCT00077168|breast cancer in situ|breast cancer in situ
472122|NCT00077194|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
472123|NCT00077194|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
472124|NCT00077194|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
472125|NCT00077207|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
472126|NCT00077207|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
472127|NCT00077207|childhood spinal cord neoplasm|childhood spinal cord neoplasm
472128|NCT00077207|childhood oligodendroglioma|childhood oligodendroglioma
472129|NCT00077207|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
472130|NCT00077220|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
472131|NCT00077220|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
472132|NCT00077220|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
472133|NCT00077233|adenocarcinoma of the colon|adenocarcinoma of the colon
472134|NCT00077233|adenocarcinoma of the rectum|adenocarcinoma of the rectum
472135|NCT00077233|recurrent colon cancer|recurrent colon cancer
472136|NCT00077233|recurrent rectal cancer|recurrent rectal cancer
472137|NCT00077233|stage IV colon cancer|stage iv colon cancer
472138|NCT00077233|stage IV rectal cancer|stage iv rectal cancer
472139|NCT00077246|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
472140|NCT00077246|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
472141|NCT00077259|recurrent colon cancer|recurrent colon cancer
472142|NCT00077259|recurrent rectal cancer|recurrent rectal cancer
472143|NCT00077259|stage III colon cancer|stage iii colon cancer
472144|NCT00077259|stage III rectal cancer|stage iii rectal cancer
472145|NCT00077259|stage IV colon cancer|stage iv colon cancer
472146|NCT00077259|stage IV rectal cancer|stage iv rectal cancer
472147|NCT00077259|adenocarcinoma of the colon|adenocarcinoma of the colon
472148|NCT00077259|adenocarcinoma of the rectum|adenocarcinoma of the rectum
472149|NCT00077285|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
472150|NCT00077285|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
472151|NCT00077285|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
472152|NCT00077285|adult rhabdomyosarcoma|adult rhabdomyosarcoma
472153|NCT00077285|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
472154|NCT00077285|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
472155|NCT00077285|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
472156|NCT00077285|childhood malignant mesenchymoma|childhood malignant mesenchymoma
472157|NCT00077285|adult malignant mesenchymoma|adult malignant mesenchymoma
472158|NCT00077285|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
472159|NCT00077285|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
472160|NCT00077285|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
472161|NCT00077311|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
472162|NCT00077311|anemia|anemia
472163|NCT00077311|neutropenia|neutropenia
472164|NCT00077311|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
472165|NCT00077311|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
472166|NCT00077311|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
472167|NCT00077311|squamous cell lung cancer|squamous cell lung cancer
472168|NCT00077311|large cell lung cancer|large cell lung cancer
472169|NCT00077311|adenocarcinoma of the lung|adenocarcinoma of the lung
472170|NCT00077311|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
472171|NCT00077311|adenosquamous cell lung cancer|adenosquamous cell lung cancer
472172|NCT00077324|stage I non-small cell lung cancer|stage i non-small cell lung cancer
472173|NCT00077337|recurrent colon cancer|recurrent colon cancer
472174|NCT00077337|stage III colon cancer|stage iii colon cancer
472175|NCT00077337|stage IV colon cancer|stage iv colon cancer
472176|NCT00077337|recurrent rectal cancer|recurrent rectal cancer
472177|NCT00077337|stage III rectal cancer|stage iii rectal cancer
472178|NCT00077337|stage IV rectal cancer|stage iv rectal cancer
472179|NCT00077389|childhood hepatoblastoma|childhood hepatoblastoma
472180|NCT00077389|stage IV childhood liver cancer|stage iv childhood liver cancer
472181|NCT00077402|recurrent prostate cancer|recurrent prostate cancer
472182|NCT00077402|stage III prostate cancer|stage iii prostate cancer
472183|NCT00077402|stage IV prostate cancer|stage iv prostate cancer
472184|NCT00077402|adenocarcinoma of the prostate|adenocarcinoma of the prostate
89711|NCT02726906|Alzheimer's disease|alzheimer's disease
472185|NCT00077415|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
472186|NCT00077415|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
472187|NCT00077415|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
472188|NCT00077415|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
472189|NCT00077415|adenocarcinoma of the lung|adenocarcinoma of the lung
472190|NCT00077415|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
472191|NCT00077415|large cell lung cancer|large cell lung cancer
472192|NCT00077415|squamous cell lung cancer|squamous cell lung cancer
472193|NCT00070538|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
472194|NCT00070538|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
472195|NCT00070538|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
472196|NCT00070538|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
472197|NCT00070538|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
472198|NCT00070538|refractory anemia with excess blasts|refractory anemia with excess blasts
472199|NCT00070538|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
583836|NCT00512850|Adenoma of Large Intestine|adenoma of large intestine
472200|NCT00070538|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
472201|NCT00070538|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
472202|NCT00070538|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
472203|NCT00070538|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
472204|NCT00070538|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
472205|NCT00070538|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
472206|NCT00070538|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
472207|NCT00070538|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
472208|NCT00070538|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
472209|NCT00070538|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
472210|NCT00070564|stage II breast cancer|stage ii breast cancer
472211|NCT00070564|stage IA breast cancer|stage ia breast cancer
472212|NCT00070564|stage IB breast cancer|stage ib breast cancer
472213|NCT00070564|stage IIIC breast cancer|stage iiic breast cancer
472214|NCT00070564|male breast cancer|male breast cancer
472215|NCT00070564|HER2-positive breast cancer|her2-positive breast cancer
472216|NCT00070564|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
472217|NCT00070564|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
472218|NCT00070564|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
472219|NCT00070564|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
472220|NCT00070577|Alcohol Clamp|alcohol clamp
472221|NCT00070577|Pharmacokinetics|pharmacokinetics
472222|NCT00070577|Pharmacodynamics|pharmacodynamics
472224|NCT00070577|Metabolism|metabolism
472225|NCT00070577|Response|response
472226|NCT00070577|Age|age
472227|NCT00070577|Sex|sex
472228|NCT00070577|Healthy Volunteer|healthy volunteer
472229|NCT00070577|HV|hv
472230|NCT00070590|Scleroderma|scleroderma
472231|NCT00070590|Fibrosing alveolitis|fibrosing alveolitis
472232|NCT00070590|Build|build
472233|NCT00070590|bosentan|bosentan
472234|NCT00070616|mucositis|mucositis
472235|NCT00070616|chemotherapy|chemotherapy
472236|NCT00070616|radiation therapy|radiation therapy
472237|NCT00070629|Immunotherapy|immunotherapy
472238|NCT00070629|lung cancer|lung cancer
472239|NCT00070642|Immunotherapy, skin cancer|immunotherapy, skin cancer
472240|NCT00070694|Affective Disorders|affective disorders
472241|NCT00070694|Refractory|refractory
472242|NCT00070694|Augmentation|augmentation
472243|NCT00070694|Polysomogram|polysomogram
472244|NCT00070694|Combination Therapy|combination therapy
472245|NCT00070694|Affective Disorder|affective disorder
472246|NCT00070694|Depression|depression
472247|NCT00070694|Major Depression|major depression
472248|NCT00070707|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
472249|NCT00070707|Concomitant Asthma|concomitant asthma
472250|NCT00070720|Behavior change|behavior change
472251|NCT00070720|Change in practitioner behavior|change in practitioner behavior
472252|NCT00070720|Episiotomy|episiotomy
472253|NCT00070720|Active management of third stage of labor|active management of third stage of labor
472254|NCT00070720|Global Network|global network
472255|NCT00070720|Latin America|latin america
472256|NCT00070720|Uruguay|uruguay
472257|NCT00070720|Argentina|argentina
472258|NCT00070720|Maternal and child health|maternal and child health
472259|NCT00070720|International|international
472260|NCT00070720|Women's health|women's health
472261|NCT00070733|Testosterone|testosterone
472262|NCT00070733|5-alpha Reductase|5-alpha reductase
472263|NCT00070733|Muscle Strength|muscle strength
472264|NCT00070733|Libido|libido
472265|NCT00070733|Sexual Function|sexual function
472266|NCT00070733|Muscle Mass|muscle mass
472267|NCT00070733|Testosterone 5-alpha-Reductase|testosterone 5-alpha-reductase
472268|NCT00070746|Perinatal mortality [PNM]|perinatal mortality [pnm]
472269|NCT00070746|Neonatal mortality|neonatal mortality
472270|NCT00070746|Low birth weight [LBW]|low birth weight [lbw]
472271|NCT00070746|Spontaneous preterm delivery [SPTD]|spontaneous preterm delivery [sptd]
472272|NCT00070746|Premature rupture of membranes [PROM]|premature rupture of membranes [prom]
472273|NCT00070746|Histological chorioamnionitis|histological chorioamnionitis
472274|NCT00070746|Global Network|global network
472275|NCT00070746|Pakistan|pakistan
472276|NCT00070746|Maternal and child health|maternal and child health
472277|NCT00070746|International|international
472278|NCT00070746|Women's health|women's health
472279|NCT00070759|Daclizumab|daclizumab
472280|NCT00070759|Uveitis|uveitis
472281|NCT00070759|Active|active
472282|NCT00070759|Acute|acute
472283|NCT00070785|Nasopharyngeal Cancer|nasopharyngeal cancer
472284|NCT00070785|EBV Virus|ebv virus
472285|NCT00070785|Epitope Mapping|epitope mapping
472286|NCT00070785|Epstein-Barr Virus|epstein-barr virus
472287|NCT00070785|Latent Protein-2|latent protein-2
583837|NCT00512889|CTL|ctl
472288|NCT00070785|Healthy Volunteer|healthy volunteer
472289|NCT00070785|HV|hv
472290|NCT00070811|Facial form|facial form
472291|NCT00070811|Facial animation|facial animation
472292|NCT00070811|Lip muscle reconstruction|lip muscle reconstruction
472293|NCT00070811|Lip form|lip form
472294|NCT00070811|Lip function|lip function
472295|NCT00070824|Acupuncture|acupuncture
472296|NCT00070824|SPECT|spect
472297|NCT00070824|f-MRI|f-mri
472692|NCT00078572|Metastatic|metastatic
472298|NCT00070824|Functional brain imaging|functional brain imaging
472299|NCT00070824|RCT|rct
472300|NCT00070850|Screening|screening
472301|NCT00070850|Prenatal|prenatal
472302|NCT00070850|Amniocentesis|amniocentesis
472303|NCT00070876|Child|child
472304|NCT00070876|Adolescent|adolescent
472305|NCT00070889|Complementary Therapies|complementary therapies
472306|NCT00070902|Spinal Manipulation|spinal manipulation
472307|NCT00070902|Chiropractic|chiropractic
472308|NCT00070902|Zygapophysial Joints|zygapophysial joints
472309|NCT00070928|Sleep|sleep
472310|NCT00070941|Parkinsons Disease|parkinsons disease
472311|NCT00070941|Depression|depression
472312|NCT00070941|SAM-e|sam-e
472313|NCT00070954|ECT|ect
472314|NCT00070954|Memory|memory
472315|NCT00070954|Ginkgo biloba|ginkgo biloba
472316|NCT00070967|Acupuncture|acupuncture
472317|NCT00070967|Quality of Life|quality of life
472318|NCT00070967|Complementary Therapies|complementary therapies
472319|NCT00070967|TCM|tcm
472320|NCT00070967|Traditional Chinese Medicine|traditional chinese medicine
472321|NCT00070980|Complementary Therapies|complementary therapies
472322|NCT00070993|ALS|als
472323|NCT00070993|Creatine|creatine
472324|NCT00071032|Blood Disease|blood disease
472325|NCT00071032|blood transfusion|blood transfusion
472326|NCT00071045|Tissue Procurement|tissue procurement
472327|NCT00071045|Sample Collection|sample collection
472328|NCT00071045|Laboratory Research|laboratory research
472329|NCT00071045|Tissue Sample|tissue sample
472330|NCT00071045|Solid Tumor|solid tumor
472331|NCT00071045|Blood Disorder|blood disorder
472332|NCT00071045|HLA Donor|hla donor
472333|NCT00071058|P-glycoprotein Inhibition|p-glycoprotein inhibition
472334|NCT00071058|Drug Resistance Reversal|drug resistance reversal
472335|NCT00071058|Pharmacodynamics|pharmacodynamics
472336|NCT00071058|Molecular Target|molecular target
472337|NCT00071058|Endocrine Cancer|endocrine cancer
472338|NCT00071058|Adrenocortical Cancer|adrenocortical cancer
472339|NCT00071058|ACC|acc
472340|NCT00071058|Adrenocortical Tumor|adrenocortical tumor
472341|NCT00071071|Skin cancer|skin cancer
472342|NCT00071071|Lymphoma|lymphoma
472343|NCT00071071|Mycosis fungoides|mycosis fungoides
472344|NCT00071071|Sezary syndrome|sezary syndrome
472345|NCT00071084|Skin cancer|skin cancer
472346|NCT00071084|Lymphoma|lymphoma
472347|NCT00071084|Mycosis fungoides|mycosis fungoides
472348|NCT00071084|Sezary syndrome|sezary syndrome
472349|NCT00071097|HIV|hiv
472350|NCT00071097|TMC114|tmc114
472351|NCT00071097|Ritonavir|ritonavir
472352|NCT00071097|Tolerability|tolerability
472353|NCT00071097|Safety and efficacy|safety and efficacy
472354|NCT00071097|TMC114-C211|tmc114-c211
472355|NCT00071110|Acupuncture|acupuncture
472356|NCT00071110|Electroacupuncture|electroacupuncture
472357|NCT00071110|Alternative therapy|alternative therapy
472358|NCT00071123|fMRI|fmri
472359|NCT00071123|Habituation|habituation
472360|NCT00071123|Extinction|extinction
472361|NCT00071123|Amygdala|amygdala
472362|NCT00071123|Emotion|emotion
472363|NCT00071123|Major Depressive Disorder|major depressive disorder
472364|NCT00071123|Medial Prefrontal Cortex|medial prefrontal cortex
472365|NCT00071123|Backward Masking|backward masking
472366|NCT00071123|Depression|depression
472367|NCT00071123|MDD|mdd
472368|NCT00071123|Healthy Volunteer|healthy volunteer
472369|NCT00071123|HV|hv
472370|NCT00071149|Rheumatoid Arthritis|rheumatoid arthritis
472371|NCT00071149|TCM|tcm
472372|NCT00071149|Diagnosis|diagnosis
471708|NCT00075842|sleep disorders|sleep disorders
472373|NCT00071149|Traditional Chinese Medicine|traditional chinese medicine
472374|NCT00071149|Complementary Therapies|complementary therapies
472375|NCT00071162|Pain|pain
472376|NCT00071162|Fatigue|fatigue
472377|NCT00071162|Sleep|sleep
472378|NCT00071162|Depression|depression
472379|NCT00071162|Irritable Bowel Syndrome|irritable bowel syndrome
472380|NCT00071162|Chronic Fatigue Syndrome|chronic fatigue syndrome
472381|NCT00071175|Lupus|lupus
472382|NCT00071175|Genetics|genetics
472383|NCT00071188|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
472384|NCT00071214|Staphylococcal infection|staphylococcal infection
472385|NCT00071214|Gram positive bacteria|gram positive bacteria
472387|NCT00071214|Staphylococcus aureus|staphylococcus aureus
472388|NCT00071214|Staphylococcus aureus infection|staphylococcus aureus infection
472389|NCT00071227|Age Related Macular Degeneration|age related macular degeneration
472390|NCT00071227|Macular Edema|macular edema
472391|NCT00071227|Inflammation|inflammation
472392|NCT00071227|Choroidal Neovascularization|choroidal neovascularization
472393|NCT00071227|CRVO|crvo
472394|NCT00071227|Diabetic Retinopathy|diabetic retinopathy
472395|NCT00071227|Age Related Macular Edema|age related macular edema
472397|NCT00071240|Growth Hormone|growth hormone
472398|NCT00071240|HIV|hiv
472399|NCT00071240|AIDS|aids
472400|NCT00071240|Thymus|thymus
472401|NCT00071240|CD4 Cell|cd4 cell
472402|NCT00071240|Immune System|immune system
472403|NCT00071240|Treatment Experienced|treatment experienced
472404|NCT00071253|Bipolar Disorder - Mania|bipolar disorder - mania
472405|NCT00071266|Intermittent Claudication|intermittent claudication
472406|NCT00071266|Peripheral Arterial Disease|peripheral arterial disease
472407|NCT00071266|Atherosclerosis|atherosclerosis
472408|NCT00071266|Niacin|niacin
472409|NCT00071266|Lovastatin|lovastatin
472410|NCT00071266|PAD|pad
472411|NCT00071266|IC|ic
472412|NCT00071292|rheumatoid arthritis|rheumatoid arthritis
472413|NCT00071292|stress reduction|stress reduction
472414|NCT00071292|meditation|meditation
472415|NCT00071292|mindfulness|mindfulness
472416|NCT00071292|MBSR|mbsr
472417|NCT00071292|mindfulness-based stress reduction|mindfulness-based stress reduction
472418|NCT00071292|mind-body skills|mind-body skills
472419|NCT00071305|Magnetoencephalography|magnetoencephalography
472420|NCT00071305|Electroencephalography|electroencephalography
472421|NCT00071305|Epilepsy|epilepsy
472422|NCT00071305|Dipole Modeling|dipole modeling
472423|NCT00071305|Surgery|surgery
472424|NCT00071331|chronic heart failure|chronic heart failure
472425|NCT00071331|heart failure|heart failure
472426|NCT00071344|Microarray|microarray
472427|NCT00071344|Genomics|genomics
472428|NCT00071344|Trastuzumab|trastuzumab
472429|NCT00071344|Carcinoma|carcinoma
472430|NCT00071344|Non-Small Cell Lung Cancer|non-small cell lung cancer
472431|NCT00071344|Metastatic Brain Tumor|metastatic brain tumor
472432|NCT00071344|Brain|brain
472433|NCT00071344|Microarrays|microarrays
472434|NCT00071344|Microdissection|microdissection
472435|NCT00071344|Lung Cancer|lung cancer
472436|NCT00071344|NSCLC|nsclc
472437|NCT00071357|Microarray|microarray
472438|NCT00071357|Herceptin|herceptin
472439|NCT00071357|Trastuzumab|trastuzumab
472440|NCT00071357|Carcinoma|carcinoma
472441|NCT00071357|Proteomics|proteomics
472442|NCT00071357|Breast Cancer|breast cancer
472443|NCT00071357|Metastatic Breast Cancer|metastatic breast cancer
472444|NCT00071357|Metastatic Breast Tumor|metastatic breast tumor
472445|NCT00071370|Magnetoencephalography|magnetoencephalography
472446|NCT00071370|Electroencephalogram (EEG)|electroencephalogram (eeg)
472447|NCT00071370|Interictal Epileptiform Discharges|interictal epileptiform discharges
472448|NCT00071370|Epilepsy|epilepsy
472449|NCT00071370|Sleep Deprivation|sleep deprivation
472450|NCT00071370|Seizure|seizure
472451|NCT00071383|Herceptin|herceptin
472452|NCT00071383|Trastuzumab|trastuzumab
472453|NCT00071383|Microdissection|microdissection
472454|NCT00071383|Proteomics|proteomics
472455|NCT00071383|Microarrays|microarrays
472456|NCT00071383|Metastatic Brain Tumor|metastatic brain tumor
472457|NCT00071383|Breast Cancer|breast cancer
472458|NCT00071383|Brain|brain
472459|NCT00071383|Carcinoma|carcinoma
472460|NCT00071383|Genomics|genomics
484355|NCT00113347|Radiation|radiation
472461|NCT00071383|Metastatic Breast Cancer|metastatic breast cancer
472462|NCT00071383|Metastatic Breast Tumor|metastatic breast tumor
472463|NCT00071396|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
472464|NCT00071396|CD-52 and CD-20 Positive|cd-52 and cd-20 positive
472465|NCT00071396|Refractory|refractory
472466|NCT00071396|Relapsed|relapsed
472467|NCT00071409|Type 1 diabetes|type 1 diabetes
472468|NCT00071422|Type 2 diabetes|type 2 diabetes
472469|NCT00071435|EEG|eeg
472470|NCT00071435|Voluntary Movement|voluntary movement
472471|NCT00071435|Motor Cortex|motor cortex
472472|NCT00071435|Reaction Time|reaction time
472473|NCT00071435|Corticospinal|corticospinal
472474|NCT00071435|Primary Lateral Sclerosis|primary lateral sclerosis
472475|NCT00071435|PLS|pls
472476|NCT00071435|Healthy Volunteer|healthy volunteer
472477|NCT00071435|HV|hv
472478|NCT00077493|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
472479|NCT00077493|Burkitt lymphoma|burkitt lymphoma
472480|NCT00077493|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
472481|NCT00077493|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
472482|NCT00077493|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
472483|NCT00077519|stage II pancreatic cancer|stage ii pancreatic cancer
472484|NCT00077519|stage III pancreatic cancer|stage iii pancreatic cancer
472485|NCT00077519|recurrent pancreatic cancer|recurrent pancreatic cancer
472486|NCT00077532|stage IV melanoma|stage iv melanoma
472487|NCT00077532|recurrent melanoma|recurrent melanoma
472488|NCT00077558|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
472489|NCT00077558|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
472490|NCT00077558|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
472491|NCT00077558|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
472492|NCT00077558|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
472493|NCT00077558|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
472494|NCT00077558|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
472495|NCT00077558|prolymphocytic leukemia|prolymphocytic leukemia
472496|NCT00077558|refractory anemia with excess blasts|refractory anemia with excess blasts
472497|NCT00077558|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
472498|NCT00077558|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
472499|NCT00077558|secondary acute myeloid leukemia|secondary acute myeloid leukemia
472500|NCT00077558|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
472501|NCT00077558|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
472502|NCT00077558|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
472503|NCT00077558|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
472504|NCT00077558|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
472505|NCT00077558|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
472506|NCT00077558|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
472507|NCT00077558|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
472508|NCT00077558|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
472509|NCT00077558|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
472510|NCT00077558|adult acute basophilic leukemia|adult acute basophilic leukemia
472511|NCT00077558|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
472512|NCT00077558|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
472513|NCT00077558|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
472514|NCT00077558|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
472515|NCT00077558|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
472516|NCT00077558|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
472517|NCT00077558|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
472518|NCT00077584|Scleroderma|scleroderma
472519|NCT00077584|Finger Ulcers|finger ulcers
472520|NCT00077584|Digital Ulcers|digital ulcers
472521|NCT00077584|Systemic Sclerosis|systemic sclerosis
472522|NCT00077662|Pompe Disease|pompe disease
472523|NCT00077662|Glycogen Storage Disease Type II|glycogen storage disease type ii
472524|NCT00077662|GSD-II|gsd-ii
472525|NCT00077662|Acid Maltase Deficiency Disease|acid maltase deficiency disease
472526|NCT00077662|Glycogenosis 2|glycogenosis 2
472527|NCT00077675|Abscess|abscess
472528|NCT00077675|Burns|burns
472529|NCT00077675|Cellulitis|cellulitis
472530|NCT00077675|Ulcer|ulcer
472531|NCT00077675|Wound infections|wound infections
472532|NCT00077714|Schizophrenia|schizophrenia
472533|NCT00077714|Paliperidone|paliperidone
472534|NCT00077727|Schizophrenia|schizophrenia
472535|NCT00077727|cognitive impairment|cognitive impairment
472536|NCT00077727|galantamine|galantamine
472537|NCT00077727|acetylcholinesterase inhibitors|acetylcholinesterase inhibitors
472538|NCT00077727|antipsychotic drugs|antipsychotic drugs
472539|NCT00077727|BACS|bacs
484448|NCT00113633|Asthma|asthma
472540|NCT00077792|Receiving fibrinolytic therapy|receiving fibrinolytic therapy
472541|NCT00078182|HIV Prevention|hiv prevention
472543|NCT00078195|Immunotherapy|immunotherapy
472544|NCT00078195|Rush Immunotherapy|rush immunotherapy
472545|NCT00078195|RIT|rit
472546|NCT00078195|Hayfever|hayfever
472547|NCT00078195|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
472548|NCT00078208|Pediatric|pediatric
472549|NCT00078208|Non-Invasive|non-invasive
472550|NCT00078208|Anti-Inflammatory|anti-inflammatory
472551|NCT00078208|pH|ph
607881|NCT00616590|fatigue|fatigue
472552|NCT00078208|Mediators|mediators
472553|NCT00078208|Asthma|asthma
472554|NCT00078208|Childhood Asthma|childhood asthma
472555|NCT00078208|Healthy Volunteer|healthy volunteer
472556|NCT00078208|HV|hv
472557|NCT00078221|Dry AMD|dry amd
472558|NCT00078221|Age-related Macular Degeneration|age-related macular degeneration
472559|NCT00078221|Rheopheresis|rheopheresis
472560|NCT00078234|CLL|cll
472561|NCT00078234|Leukemia|leukemia
472562|NCT00078234|Chronic|chronic
472563|NCT00078234|Cancer|cancer
472564|NCT00078234|Adult|adult
472565|NCT00078234|Lymphocytic|lymphocytic
472566|NCT00078234|Genasense|genasense
472567|NCT00078234|G3139|g3139
472569|NCT00078234|Bcl-2|bcl-2
472570|NCT00078234|Antisense|antisense
472571|NCT00078234|Oligonucleotide|oligonucleotide
472572|NCT00078234|oblimersen|oblimersen
472573|NCT00078247|Antiretroviral Therapy|antiretroviral therapy
472574|NCT00078247|Africa|africa
472575|NCT00078273|Gambling|gambling
472576|NCT00078273|Pathological Gambling|pathological gambling
472577|NCT00078273|Problem Gambling|problem gambling
472578|NCT00078273|College Students|college students
472579|NCT00078273|Prevention|prevention
472580|NCT00078286|Antidepressive Agents|antidepressive agents
472581|NCT00078299|Cortical|cortical
472582|NCT00078299|Nuclear Sclerosis|nuclear sclerosis
472583|NCT00078299|Posterior Subcapsular|posterior subcapsular
472584|NCT00078299|Photographic Methods|photographic methods
472585|NCT00078299|Reproducibility (intra and interobserver)|reproducibility (intra and interobserver)
472586|NCT00078299|Cataract|cataract
472587|NCT00078299|Agreement|agreement
472588|NCT00078299|Grading System|grading system
472589|NCT00078312|Excessive Sleepiness|excessive sleepiness
472590|NCT00078312|Narcolepsy|narcolepsy
472592|NCT00078312|Sleep Attacks|sleep attacks
472593|NCT00078312|Obstructive Sleep Apnea|obstructive sleep apnea
472594|NCT00078312|Obstructive Sleep Hypopnea|obstructive sleep hypopnea
472595|NCT00078312|nCPAP|ncpap
472596|NCT00078312|Chronic Shift Work Sleep Disorder|chronic shift work sleep disorder
472597|NCT00078312|Chronic SWSD|chronic swsd
472598|NCT00078312|Circadian Rhythm Disorder|circadian rhythm disorder
472599|NCT00078312|Shift Worker|shift worker
472600|NCT00078312|Cepahlon|cepahlon
472601|NCT00078312|Cephalon, Inc|cephalon, inc
472602|NCT00078312|Nuvigil|nuvigil
472603|NCT00078325|Excessive Sleepiness|excessive sleepiness
472604|NCT00078325|Obstructive Sleep Apnea|obstructive sleep apnea
472605|NCT00078325|Obstructive Sleep Hypopnea|obstructive sleep hypopnea
472606|NCT00078325|nCPAP|ncpap
472607|NCT00078325|Cephalon|cephalon
472608|NCT00078325|Cephalon, Inc|cephalon, inc
472609|NCT00078325|NUVIGIL|nuvigil
472610|NCT00078351|Chronic Pain|chronic pain
472611|NCT00078351|Synvisc|synvisc
472612|NCT00078351|Temporomandibular Joint|temporomandibular joint
472613|NCT00078351|Osteoarthritis|osteoarthritis
472614|NCT00078351|TMD|tmd
472615|NCT00078351|Temporomandibular Joint Osteoarthritis|temporomandibular joint osteoarthritis
472616|NCT00078351|TMJ OA|tmj oa
472617|NCT00078351|Temporomandibular Joint Disease|temporomandibular joint disease
472618|NCT00078351|TMJ|tmj
472619|NCT00078364|MRI|mri
472620|NCT00078364|NSAID Analgesia|nsaid analgesia
472621|NCT00078364|Pain Mechanisms|pain mechanisms
472622|NCT00078364|SNP's|snp's
472623|NCT00078364|Acute Pain|acute pain
472624|NCT00078364|Wisdom Teeth|wisdom teeth
472625|NCT00078364|Third Molar Extraction|third molar extraction
472626|NCT00078364|Third Molar Impaction|third molar impaction
472627|NCT00078377|Narcolepsy|narcolepsy
472628|NCT00078377|Excessive Sleepiness|excessive sleepiness
472629|NCT00078377|Cataplexy|cataplexy
472630|NCT00078377|Sleep Attacks|sleep attacks
472631|NCT00078377|Excessive Sleepiness associated with Narcolepsy|excessive sleepiness associated with narcolepsy
472632|NCT00078377|Cephalon|cephalon
472633|NCT00078377|Cephalon, Inc|cephalon, inc
472634|NCT00078377|Nuvigil|nuvigil
472635|NCT00078390|Lung cancer|lung cancer
472636|NCT00078390|Lung carcinoma|lung carcinoma
472637|NCT00078390|Non small cell lung cancer|non small cell lung cancer
472638|NCT00078390|Stage IIIA non small cell lung cancer|stage iiia non small cell lung cancer
472639|NCT00078390|Stage IIIB non small cell lung cancer|stage iiib non small cell lung cancer
472640|NCT00078390|NSCLC|nsclc
472641|NCT00078390|Stage III|stage iii
472642|NCT00078390|chemotherapy|chemotherapy
472643|NCT00078390|radiation|radiation
472644|NCT00078390|chemoradiation|chemoradiation
472645|NCT00078390|matrix metalloproteinases|matrix metalloproteinases
472646|NCT00078390|neovascularization|neovascularization
472647|NCT00078390|antiangiogenesis|antiangiogenesis
472648|NCT00078390|type IV collagenases|type iv collagenases
472649|NCT00078390|Unresectable locally advanced non-small cell lung cancer|unresectable locally advanced non-small cell lung cancer
472650|NCT00078403|Treatment Experienced|treatment experienced
472651|NCT00078442|Treatment Experienced|treatment experienced
472652|NCT00078442|Treatment Interruption|treatment interruption
472653|NCT00078442|Treatment Naive|treatment naive
472654|NCT00078455|NSCLC|nsclc
472655|NCT00078455|Non-small Cell Lung Cancer|non-small cell lung cancer
472656|NCT00078455|Non-small Cell Lung Carcinoma|non-small cell lung carcinoma
472657|NCT00078455|Locally Advanced NSCLC|locally advanced nsclc
472658|NCT00078455|Metastatic NSCLC|metastatic nsclc
472659|NCT00078481|Neurodegeneration|neurodegeneration
472660|NCT00078481|Anti-Oxidant|anti-oxidant
472661|NCT00078481|Neuropathy|neuropathy
472662|NCT00078481|Hereditary|hereditary
472663|NCT00078481|Spinocerebellar|spinocerebellar
472664|NCT00078481|Friedreich Ataxia|friedreich ataxia
472665|NCT00078481|FRDA|frda
472666|NCT00078494|Immunization|immunization
472667|NCT00078494|Vaccine|vaccine
472668|NCT00078494|Nasopharyngeal Cancer|nasopharyngeal cancer
472669|NCT00078494|Immunotherapy|immunotherapy
472670|NCT00078494|Cancer|cancer
472671|NCT00078494|NPC|npc
472672|NCT00078507|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
472673|NCT00078507|Behavior Control|behavior control
472674|NCT00078507|Sensation|sensation
472675|NCT00078507|Randomized Controlled Trials|randomized controlled trials
472676|NCT00078507|Adolescent|adolescent
472677|NCT00078507|Adult|adult
472678|NCT00078520|Leukemia|leukemia
472679|NCT00078533|Allogeneic|allogeneic
472680|NCT00078533|Transplant|transplant
472681|NCT00078533|CMV|cmv
472682|NCT00078533|Stem Cell|stem cell
472683|NCT00078533|Donor|donor
472684|NCT00078533|Allogeneic stem cell recipients at risk for CMV reactivation|allogeneic stem cell recipients at risk for cmv reactivation
472685|NCT00078546|EBV|ebv
472686|NCT00078546|NASOPHARYNGEAL|nasopharyngeal
472687|NCT00078546|CARCINOMA|carcinoma
472688|NCT00078546|EBV POSITIVE NASOPHARYNGEAL CARCINOMA|ebv positive nasopharyngeal carcinoma
472689|NCT00078559|Immunosuppression|immunosuppression
472690|NCT00078559|Renal Failure|renal failure
472691|NCT00078572|XELODA|xeloda
472693|NCT00078572|Breast Cancer|breast cancer
472694|NCT00078572|Advanced|advanced
472695|NCT00078572|HERCEPTIN|herceptin
472696|NCT00078598|Relapsed|relapsed
472697|NCT00078598|Follicular|follicular
472698|NCT00078611|Crohn's disease|crohn's disease
472699|NCT00078611|Inflammatory Bowel Disease|inflammatory bowel disease
472700|NCT00078611|IBD|ibd
472701|NCT00078611|Gastroenterology|gastroenterology
472702|NCT00078611|Regional Enteritis|regional enteritis
472703|NCT00078611|Colitis|colitis
472704|NCT00078624|Osteoarthritis|osteoarthritis
472705|NCT00078624|Knee Joint|knee joint
472706|NCT00078624|Joint Stability|joint stability
472707|NCT00078624|Motor Control|motor control
472708|NCT00078624|Exercise Therapy|exercise therapy
472709|NCT00078663|Oral Care|oral care
472710|NCT00078663|ICU|icu
472711|NCT00078663|Pneumonia|pneumonia
472712|NCT00078663|Pathogens|pathogens
472713|NCT00078663|Intubation|intubation
472714|NCT00078663|Intubated|intubated
472715|NCT00078663|Oral Hygiene|oral hygiene
472716|NCT00078663|Intensive Care|intensive care
472717|NCT00078689|Sirolimus|sirolimus
472718|NCT00078689|Daclizumab|daclizumab
472719|NCT00078689|Inflammation|inflammation
472720|NCT00078689|Induce Tolerance|induce tolerance
472721|NCT00078689|Uveitis|uveitis
472722|NCT00078689|Immune Tolerance|immune tolerance
472723|NCT00078689|T Cell|t cell
472724|NCT00078715|Yohimbine|yohimbine
472725|NCT00078715|Sleep Deprivation|sleep deprivation
472726|NCT00078715|Depression|depression
472727|NCT00078715|Mood Disorder|mood disorder
472728|NCT00078715|Fast|fast
472729|NCT00078715|Affective Disorder|affective disorder
472730|NCT00078715|Rapid Onset|rapid onset
472731|NCT00078715|Major Depression|major depression
472732|NCT00078715|MDD|mdd
472733|NCT00078728|Anxiety|anxiety
472734|NCT00078741|Psychotic Disorders|psychotic disorders
472735|NCT00078767|PTSD|ptsd
472736|NCT00078767|Depression|depression
472737|NCT00078767|Anxiety|anxiety
472738|NCT00078793|JRA|jra
472739|NCT00078793|Registry|registry
472740|NCT00078806|Systemic Onset Juvenile Rheumatoid Arthiritis|systemic onset juvenile rheumatoid arthiritis
472741|NCT00078806|SOJRA|sojra
472742|NCT00078806|Fever|fever
472743|NCT00078806|Rash|rash
472744|NCT00078806|Joint Pain|joint pain
472745|NCT00078819|Pediatric Psoriasis|pediatric psoriasis
472746|NCT00078832|breast cancer, chemoprevention|breast cancer, chemoprevention
472747|NCT00078845|neurotoxicity|neurotoxicity
472748|NCT00078845|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
484449|NCT00113633|Emergency|emergency
472749|NCT00078845|recurrent prostate cancer|recurrent prostate cancer
472750|NCT00078845|stage I prostate cancer|stage i prostate cancer
472751|NCT00078845|stage IIB prostate cancer|stage iib prostate cancer
472752|NCT00078845|stage IIA prostate cancer|stage iia prostate cancer
472753|NCT00078845|stage III prostate cancer|stage iii prostate cancer
472754|NCT00078845|stage IV prostate cancer|stage iv prostate cancer
472755|NCT00078845|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
472756|NCT00078845|stage I non-small cell lung cancer|stage i non-small cell lung cancer
472757|NCT00078845|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
472758|NCT00078845|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
472759|NCT00078845|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
472760|NCT00078845|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
472761|NCT00078845|limited stage small cell lung cancer|limited stage small cell lung cancer
472762|NCT00078845|extensive stage small cell lung cancer|extensive stage small cell lung cancer
472763|NCT00078845|recurrent small cell lung cancer|recurrent small cell lung cancer
472764|NCT00078845|recurrent breast cancer|recurrent breast cancer
472765|NCT00078845|stage I breast cancer|stage i breast cancer
472766|NCT00078845|stage II breast cancer|stage ii breast cancer
472767|NCT00078845|stage IIIA breast cancer|stage iiia breast cancer
472768|NCT00078845|stage IIIB breast cancer|stage iiib breast cancer
472769|NCT00078845|stage IIIC breast cancer|stage iiic breast cancer
472771|NCT00078845|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
583838|NCT00512889|MART-1|mart-1
472772|NCT00078845|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
472773|NCT00078845|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
472774|NCT00078845|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
472775|NCT00078845|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
472776|NCT00078897|colon cancer|colon cancer
472777|NCT00078897|rectal cancer|rectal cancer
472778|NCT00078897|colorectal cancer|colorectal cancer
472779|NCT00078897|adenomatous polyp|adenomatous polyp
472780|NCT00078910|adenocarcinoma of the prostate|adenocarcinoma of the prostate
472781|NCT00078910|stage IIB prostate cancer|stage iib prostate cancer
472782|NCT00078910|stage IIA prostate cancer|stage iia prostate cancer
472783|NCT00078910|stage III prostate cancer|stage iii prostate cancer
472784|NCT00078923|stage I prostate cancer|stage i prostate cancer
472785|NCT00078923|stage II prostate cancer|stage ii prostate cancer
472786|NCT00078923|adenocarcinoma of the prostate|adenocarcinoma of the prostate
472787|NCT00078949|anaplastic large cell lymphoma|anaplastic large cell lymphoma
472788|NCT00078949|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
472789|NCT00078949|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
472790|NCT00078949|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
472791|NCT00078975|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
472792|NCT00078975|recurrent pancreatic cancer|recurrent pancreatic cancer
472793|NCT00078975|stage II pancreatic cancer|stage ii pancreatic cancer
472794|NCT00078975|stage III pancreatic cancer|stage iii pancreatic cancer
472795|NCT00078975|stage IV pancreatic cancer|stage iv pancreatic cancer
472796|NCT00078988|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
472797|NCT00078988|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
472798|NCT00078988|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
472799|NCT00079001|adenocarcinoma of the prostate|adenocarcinoma of the prostate
472800|NCT00079001|recurrent prostate cancer|recurrent prostate cancer
472801|NCT00079001|stage IV prostate cancer|stage iv prostate cancer
472802|NCT00079001|bone metastases|bone metastases
472803|NCT00079027|advanced adult primary liver cancer|advanced adult primary liver cancer
472804|NCT00079027|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
472805|NCT00079053|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
472806|NCT00079053|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
472807|NCT00079053|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
472808|NCT00079053|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
472809|NCT00079053|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
472810|NCT00079053|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
472811|NCT00079053|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
472812|NCT00079053|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
472813|NCT00079053|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
472814|NCT00079053|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
472815|NCT00079053|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
472816|NCT00079053|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
472817|NCT00079053|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
472818|NCT00079053|stage III salivary gland cancer|stage iii salivary gland cancer
484550|NCT00113997|Antidote|antidote
472819|NCT00079053|stage IV salivary gland cancer|stage iv salivary gland cancer
472820|NCT00079066|quality of life|quality of life
472821|NCT00079066|stage IV colon cancer|stage iv colon cancer
472822|NCT00079066|recurrent colon cancer|recurrent colon cancer
472823|NCT00079066|recurrent rectal cancer|recurrent rectal cancer
472824|NCT00079066|stage IV rectal cancer|stage iv rectal cancer
89712|NCT02726906|Mild Cognitive Impairment|mild cognitive impairment
472825|NCT00079079|stage II salivary gland cancer|stage ii salivary gland cancer
472826|NCT00079079|stage III salivary gland cancer|stage iii salivary gland cancer
472827|NCT00079079|stage IV salivary gland cancer|stage iv salivary gland cancer
472828|NCT00079079|recurrent salivary gland cancer|recurrent salivary gland cancer
472829|NCT00079079|salivary gland acinic cell tumor|salivary gland acinic cell tumor
472830|NCT00079079|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
472831|NCT00079079|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
472832|NCT00079079|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
472833|NCT00079079|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
472834|NCT00079079|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
472835|NCT00079079|salivary gland adenocarcinoma|salivary gland adenocarcinoma
472836|NCT00079079|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
472837|NCT00079079|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
583839|NCT00512889|Melan-A|melan-a
472838|NCT00079092|recurrent adult brain tumor|recurrent adult brain tumor
472839|NCT00079092|adult anaplastic astrocytoma|adult anaplastic astrocytoma
472840|NCT00079092|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
472842|NCT00079092|adult mixed glioma|adult mixed glioma
472843|NCT00079092|adult giant cell glioblastoma|adult giant cell glioblastoma
472844|NCT00079092|adult gliosarcoma|adult gliosarcoma
472845|NCT00079105|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
472846|NCT00079105|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
472847|NCT00079105|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
472848|NCT00079105|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
472849|NCT00079118|stage IV breast cancer|stage iv breast cancer
472850|NCT00079118|recurrent breast cancer|recurrent breast cancer
472851|NCT00079118|male breast cancer|male breast cancer
472852|NCT00079144|recurrent melanoma|recurrent melanoma
472853|NCT00079144|stage IV melanoma|stage iv melanoma
472854|NCT00079157|recurrent breast cancer|recurrent breast cancer
479173|NCT00103428|metastatic|metastatic
472855|NCT00079157|stage IV breast cancer|stage iv breast cancer
472856|NCT00079170|male breast cancer|male breast cancer
472857|NCT00079170|recurrent breast cancer|recurrent breast cancer
472858|NCT00079170|stage IIIA breast cancer|stage iiia breast cancer
472859|NCT00079170|stage IIIB breast cancer|stage iiib breast cancer
472860|NCT00079170|stage IIIC breast cancer|stage iiic breast cancer
472861|NCT00079170|stage IV breast cancer|stage iv breast cancer
472862|NCT00079222|infection|infection
472863|NCT00079222|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
472864|NCT00079222|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
472865|NCT00079222|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
472866|NCT00079222|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
472867|NCT00079222|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
472868|NCT00079222|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
472869|NCT00079222|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
472870|NCT00079222|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
472871|NCT00079222|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
472872|NCT00079222|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
472873|NCT00079222|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
472874|NCT00079222|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
472875|NCT00079222|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
472876|NCT00079222|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
472877|NCT00079222|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
472878|NCT00079222|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
472879|NCT00079222|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
472880|NCT00079222|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
472881|NCT00079222|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
472882|NCT00079222|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
472883|NCT00079222|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
472884|NCT00079222|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
472885|NCT00079222|secondary acute myeloid leukemia|secondary acute myeloid leukemia
472886|NCT00079222|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
472887|NCT00079222|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
472888|NCT00079222|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
472889|NCT00079222|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
472890|NCT00079222|chronic eosinophilic leukemia|chronic eosinophilic leukemia
472891|NCT00079222|primary myelofibrosis|primary myelofibrosis
472892|NCT00079222|chronic neutrophilic leukemia|chronic neutrophilic leukemia
472893|NCT00079222|stage I multiple myeloma|stage i multiple myeloma
608323|NCT00618020|CTO|cto
472894|NCT00079222|stage II multiple myeloma|stage ii multiple myeloma
472895|NCT00079222|stage III multiple myeloma|stage iii multiple myeloma
472896|NCT00079222|refractory hairy cell leukemia|refractory hairy cell leukemia
472897|NCT00079222|refractory multiple myeloma|refractory multiple myeloma
472898|NCT00079222|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
472899|NCT00079222|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
472900|NCT00079222|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
472901|NCT00079222|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
472902|NCT00079222|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
472903|NCT00079222|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
472904|NCT00079222|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
13250|NCT03205813|Intrathecal morphine|intrathecal morphine
472905|NCT00079222|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
472906|NCT00079222|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
472907|NCT00079222|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
472908|NCT00079222|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
472909|NCT00079222|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
472910|NCT00079222|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
472911|NCT00079222|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
472912|NCT00079222|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
472913|NCT00079222|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
472914|NCT00079222|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
472915|NCT00079222|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
472916|NCT00079222|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
472917|NCT00079222|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
472981|NCT00079248|stage I breast cancer|stage i breast cancer
472918|NCT00079222|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
472919|NCT00079222|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
472920|NCT00079222|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
472921|NCT00079222|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
472922|NCT00079222|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
472923|NCT00079222|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
472924|NCT00079222|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
472925|NCT00079222|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
472926|NCT00079222|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
472927|NCT00079222|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
472928|NCT00079222|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
472929|NCT00079222|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
472930|NCT00079222|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
472931|NCT00079222|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
472932|NCT00079222|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
472933|NCT00079222|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
472934|NCT00079222|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
472935|NCT00079222|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
472936|NCT00079222|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
472937|NCT00079222|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
472938|NCT00079222|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
472939|NCT00079222|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
472940|NCT00079222|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
472941|NCT00079222|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
472942|NCT00079222|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
472943|NCT00079222|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
472944|NCT00079222|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
472945|NCT00079222|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
472946|NCT00079222|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
472947|NCT00079222|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
472948|NCT00079222|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
472949|NCT00079222|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
472950|NCT00079222|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
472951|NCT00079222|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
472952|NCT00079222|disseminated neuroblastoma|disseminated neuroblastoma
472953|NCT00079222|recurrent neuroblastoma|recurrent neuroblastoma
472954|NCT00079222|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
472955|NCT00079222|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
472956|NCT00079222|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
472957|NCT00079222|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
472958|NCT00079222|stage IIIA breast cancer|stage iiia breast cancer
472959|NCT00079222|stage IIIB breast cancer|stage iiib breast cancer
472960|NCT00079222|stage IIIC breast cancer|stage iiic breast cancer
472961|NCT00079222|stage IV breast cancer|stage iv breast cancer
472962|NCT00079222|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
472963|NCT00079222|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
472964|NCT00079222|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
472965|NCT00079222|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
583840|NCT00512889|artificial APC|artificial apc
472966|NCT00079222|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
472967|NCT00079222|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
472968|NCT00079222|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
472969|NCT00079222|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
472970|NCT00079222|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
472971|NCT00079222|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
472972|NCT00079222|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
472973|NCT00079222|splenic marginal zone lymphoma|splenic marginal zone lymphoma
472974|NCT00079222|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
472975|NCT00079222|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
472976|NCT00079222|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
472977|NCT00079222|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
472978|NCT00079222|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
472979|NCT00079222|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
472980|NCT00079248|osteoporosis|osteoporosis
472982|NCT00079248|stage II breast cancer|stage ii breast cancer
472983|NCT00079248|menopausal symptoms|menopausal symptoms
472984|NCT00079248|hot flashes|hot flashes
472985|NCT00079261|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
472986|NCT00079261|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
472987|NCT00079261|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
472988|NCT00079261|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
472989|NCT00079261|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
472990|NCT00079261|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
472991|NCT00079261|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
472992|NCT00079261|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
472993|NCT00079261|anaplastic large cell lymphoma|anaplastic large cell lymphoma
472994|NCT00079261|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
472995|NCT00079261|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
472996|NCT00079261|small intestine lymphoma|small intestine lymphoma
472997|NCT00079287|adenocarcinoma of the lung|adenocarcinoma of the lung
472998|NCT00079287|large cell lung cancer|large cell lung cancer
472999|NCT00079287|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
473000|NCT00079287|squamous cell lung cancer|squamous cell lung cancer
473001|NCT00079287|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
473002|NCT00079287|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
473003|NCT00079300|basal cell carcinoma of the skin|basal cell carcinoma of the skin
473004|NCT00079313|CMML|cmml
473005|NCT00079313|CML|cml
473006|NCT00079313|Gleevec|gleevec
473007|NCT00079313|Glivec|glivec
473008|NCT00079313|STI-571|sti-571
473009|NCT00079313|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
473010|NCT00079313|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
473011|NCT00079313|Atypical Chronic Myelogenous Leukemia|atypical chronic myelogenous leukemia
473012|NCT00079313|Chronic Myelomoncytic Leukemia|chronic myelomoncytic leukemia
473013|NCT00079313|Leukemia|leukemia
473014|NCT00079365|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
473015|NCT00079365|stage II pancreatic cancer|stage ii pancreatic cancer
473016|NCT00079365|stage III pancreatic cancer|stage iii pancreatic cancer
473017|NCT00079365|stage IV pancreatic cancer|stage iv pancreatic cancer
473018|NCT00079391|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
473019|NCT00079391|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
473020|NCT00079391|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
473021|NCT00079391|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
608631|NCT00607633|ARB|arb
473022|NCT00079391|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
473023|NCT00079391|Peripheral Blood Stem Cells|peripheral blood stem cells
473126|NCT00079755|Monoclonal Antibody|monoclonal antibody
473024|NCT00079391|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
473025|NCT00079391|Graft-Versus-Host Disease (GVHD)|graft-versus-host disease (gvhd)
473026|NCT00079391|Cyclosporine|cyclosporine
473027|NCT00079391|Fludarabine|fludarabine
473028|NCT00079391|Leukemia|leukemia
473029|NCT00079391|Myelodysplastic Syndrome|myelodysplastic syndrome
473030|NCT00079391|Myeloproliferative Syndrome|myeloproliferative syndrome
473031|NCT00079391|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
473032|NCT00079469|cancer survivor|cancer survivor
473033|NCT00079469|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
473034|NCT00079482|AML|aml
473035|NCT00079495|MS|ms
473036|NCT00079495|Autoimmune disease|autoimmune disease
473037|NCT00079495|relapsing|relapsing
473038|NCT00079495|progressive|progressive
473039|NCT00079495|Myelin|myelin
473040|NCT00079495|Myelin Basic Protein|myelin basic protein
473041|NCT00079495|MBP|mbp
473042|NCT00079495|acute fulminating|acute fulminating
473043|NCT00079495|chronic progressive|chronic progressive
473044|NCT00079495|Altered Peptide Ligand|altered peptide ligand
473045|NCT00079495|APL|apl
473046|NCT00079495|Neurocrine|neurocrine
473047|NCT00079495|NBI-5788|nbi-5788
473048|NCT00079495|Relapse|relapse
473049|NCT00079508|Heparin-induced Thrombocytopenia|heparin-induced thrombocytopenia
473050|NCT00079508|Heparin-induced Thrombocytopenia/Thrombosis Syndrome|heparin-induced thrombocytopenia/thrombosis syndrome
473051|NCT00079508|HIT/HITTS|hit/hitts
473052|NCT00079508|Heparin anti-body positive|heparin anti-body positive
473053|NCT00079521|Bone Metabolism|bone metabolism
473054|NCT00079521|Therapeutic Touch|therapeutic touch
473055|NCT00079534|AIDS|aids
473056|NCT00079534|HIV|hiv
473057|NCT00079534|Prayer|prayer
473058|NCT00079534|Healing|healing
473059|NCT00079534|Complementary Therapies|complementary therapies
473060|NCT00079547|Weight Loss|weight loss
473061|NCT00079560|HIV|hiv
473062|NCT00079560|Marijuana|marijuana
473063|NCT00079560|Marinol|marinol
473064|NCT00079560|Oral THC|oral thc
473065|NCT00079560|Appetite|appetite
473066|NCT00079560|Complementary Therapies|complementary therapies
473067|NCT00079573|Weight Loss|weight loss
473068|NCT00079573|Obesity|obesity
473070|NCT00079573|Premenopausal women|premenopausal women
473071|NCT00079573|Diet|diet
473072|NCT00079599|Carnitine Deficiency|carnitine deficiency
473073|NCT00079599|Fatigue|fatigue
473074|NCT00079599|Complementary Therapies|complementary therapies
473075|NCT00079612|Renal Cell Cancer|renal cell cancer
473077|NCT00079612|Cancer|cancer
473078|NCT00079625|Engraftment|engraftment
473079|NCT00079625|Graft-Versus-Host Disease|graft-versus-host disease
473080|NCT00079625|Metastatic Breast Cancer|metastatic breast cancer
473081|NCT00079625|MBC|mbc
473082|NCT00079638|Niaspan|niaspan
473083|NCT00079638|Niacin|niacin
473084|NCT00079638|Statin|statin
473085|NCT00079638|Cholesterol|cholesterol
473086|NCT00079638|Triglycerides|triglycerides
473087|NCT00079638|Lipid-Modifying Therapies|lipid-modifying therapies
473088|NCT00079638|Dyslipidemia|dyslipidemia
473089|NCT00079638|Coronary Heart Disease|coronary heart disease
473090|NCT00079638|Atherosclerosis|atherosclerosis
473091|NCT00079638|Stroke|stroke
473092|NCT00079638|VA-HIT|va-hit
473093|NCT00079638|Niacin Statin Combination Threrapy|niacin statin combination threrapy
473094|NCT00079638|High Density Lipoprotein|high density lipoprotein
473095|NCT00079638|Low Density Lipoprotein|low density lipoprotein
473096|NCT00079638|Hypertension|hypertension
473097|NCT00079638|Diabetes|diabetes
473098|NCT00079638|Adult Treatment Panel III|adult treatment panel iii
473099|NCT00079651|Aged|aged
473100|NCT00079651|Nursing Homes|nursing homes
473101|NCT00079651|Assisted Living Facilities|assisted living facilities
473102|NCT00079664|Tai Ji|tai ji
473103|NCT00079677|Excessive Sleepiness|excessive sleepiness
473104|NCT00079677|Obstructive Sleep Apnea|obstructive sleep apnea
473105|NCT00079677|Obstructive Sleep Hypopnea|obstructive sleep hypopnea
473106|NCT00079677|nCPAP|ncpap
473107|NCT00079677|Cephalon|cephalon
473108|NCT00079677|Cephalon, Inc|cephalon, inc
473109|NCT00079677|Nuvigil|nuvigil
473110|NCT00079716|Antigens, CD40|antigens, cd40
473111|NCT00079716|Antibody, Monoclonal|antibody, monoclonal
473112|NCT00079716|Blood Coagulation Disorders|blood coagulation disorders
473113|NCT00079716|Hematologic Diseases|hematologic diseases
473114|NCT00079716|Hemorrhagic Disorders|hemorrhagic disorders
473115|NCT00079716|Hemostatic Disorders|hemostatic disorders
473116|NCT00079716|Immunoproliferative Disorders|immunoproliferative disorders
473117|NCT00079716|Lymphoproliferative Disorders|lymphoproliferative disorders
473118|NCT00079716|Paraproteinemias|paraproteinemias
473119|NCT00079716|Vascular Diseases|vascular diseases
89713|NCT02726906|Brain Imaging|brain imaging
473120|NCT00079716|Antibody-Dependent Cell Cytotoxicity|antibody-dependent cell cytotoxicity
473121|NCT00079729|Treatment Experienced|treatment experienced
473122|NCT00079742|Growth restriction in children with cystic fibrosis|growth restriction in children with cystic fibrosis
473123|NCT00079755|Anaplastic Large-Cell Lymphoma|anaplastic large-cell lymphoma
473124|NCT00079755|Lymphoma|lymphoma
473125|NCT00079755|antigens, CD30|antigens, cd30
473127|NCT00079768|Inflammation|inflammation
473128|NCT00079768|Myositis|myositis
473129|NCT00079768|Humanized Monoclonal Antibody|humanized monoclonal antibody
473130|NCT00079768|Cytotoxic T Cells|cytotoxic t cells
473131|NCT00079768|Endomysial T Cells|endomysial t cells
473132|NCT00079768|Alemtuzumab|alemtuzumab
473133|NCT00079768|Monoclonal Antibodies|monoclonal antibodies
473135|NCT00079768|Anti-CD 52|anti-cd 52
473136|NCT00079768|Inclusion Body Myositis|inclusion body myositis
473137|NCT00079781|Responsive Stimulation|responsive stimulation
473138|NCT00079781|Brain Stimulator|brain stimulator
473139|NCT00079781|Epilepsy|epilepsy
473140|NCT00079781|Seizures|seizures
473141|NCT00079794|lung cancer|lung cancer
473142|NCT00079794|herbal medicine|herbal medicine
473143|NCT00079794|non-small cell cancer|non-small cell cancer
473144|NCT00079794|Iscar|iscar
473145|NCT00079794|mistletoe|mistletoe
473146|NCT00079807|HIV|hiv
473147|NCT00079807|Peripheral neuropathy|peripheral neuropathy
473148|NCT00079807|Alpha-Lipoic Acid|alpha-lipoic acid
473150|NCT00079807|Complementary Therapies|complementary therapies
473151|NCT00079820|Smallpox|smallpox
473152|NCT00079820|Smallpox Vaccine|smallpox vaccine
473153|NCT00079820|Variola virus|variola virus
473154|NCT00079820|Smallpox Virus|smallpox virus
473155|NCT00079820|MODIFIED VACCINIA ANKARA|modified vaccinia ankara
473156|NCT00079820|MVA|mva
473157|NCT00079820|Dryvax|dryvax
473158|NCT00079820|Dryvax vaccine|dryvax vaccine
473159|NCT00079820|Protection against smallpox|protection against smallpox
473160|NCT00079833|gastric acid hypersecretory conditions|gastric acid hypersecretory conditions
473161|NCT00079833|Idiopathic Hypersecretion|idiopathic hypersecretion
473162|NCT00079833|Excessive Gastric Acid secretion|excessive gastric acid secretion
473163|NCT00079846|Homozygous Familial Hypercholesterolemia (HoFH)|homozygous familial hypercholesterolemia (hofh)
473164|NCT00079859|Heterozygous Familial Hypercholesterolemia (HeFH)|heterozygous familial hypercholesterolemia (hefh)
473165|NCT00079885|Bacterial Pneumonia|bacterial pneumonia
473166|NCT00079911|Herpes|herpes
473167|NCT00079911|Genital Herpes|genital herpes
473168|NCT00079911|HIV|hiv
473169|NCT00079911|HSV|hsv
473170|NCT00079937|allergic|allergic
473171|NCT00079937|asthma|asthma
473174|NCT00079937|immunoglobulin E|immunoglobulin e
473175|NCT00079937|IgE|ige
473176|NCT00079937|anti-IgE|anti-ige
473177|NCT00079950|soft|soft
473178|NCT00079950|sarcoma|sarcoma
473179|NCT00079950|metastatic|metastatic
473180|NCT00079976|Staphylococcus aureus|staphylococcus aureus
473181|NCT00079976|Bacterial Infections|bacterial infections
473182|NCT00079989|Bacterial Infections|bacterial infections
473183|NCT00080002|cancer|cancer
473184|NCT00080002|gastric|gastric
473185|NCT00080002|gastroesophageal junction|gastroesophageal junction
473186|NCT00080002|neoplasms|neoplasms
473187|NCT00080002|gastric cancer|gastric cancer
473188|NCT00080002|gastric neoplasms|gastric neoplasms
473189|NCT00080028|Head and Neck Cancer|head and neck cancer
473190|NCT00080028|SCCHN|scchn
473191|NCT00080028|Oropharynx Cancer|oropharynx cancer
473192|NCT00080028|Hypopharynx Cancer|hypopharynx cancer
473193|NCT00080028|Larynx Cancer|larynx cancer
473194|NCT00080028|Soft palate Cancer|soft palate cancer
473195|NCT00080028|Tonsil Cancer|tonsil cancer
473196|NCT00080028|Base of tongue Cancer|base of tongue cancer
473197|NCT00080028|Supraglottic Cancer|supraglottic cancer
473198|NCT00080028|Glottic Cancer|glottic cancer
473199|NCT00080028|Pyriform Sinus Cancer|pyriform sinus cancer
473200|NCT00080028|Pharyngeal wall Cancer|pharyngeal wall cancer
473201|NCT00080028|Throat cancer|throat cancer
473202|NCT00080041|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
473203|NCT00080054|Malignant Glioma|malignant glioma
473204|NCT00080054|Glioblastoma multiforme|glioblastoma multiforme
473205|NCT00080054|GBM|gbm
473206|NCT00080054|Anaplastic astrocytoma|anaplastic astrocytoma
473207|NCT00080054|AA|aa
473208|NCT00080054|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
473209|NCT00080054|Anaplastic mixed glioma|anaplastic mixed glioma
473210|NCT00080054|Brain tumor|brain tumor
473211|NCT00080054|Brain neoplasm|brain neoplasm
473212|NCT00080054|Glioma|glioma
473213|NCT00080067|Movement|movement
473214|NCT00080067|Anticipation|anticipation
473215|NCT00080067|Stimulation|stimulation
473216|NCT00080067|Timing|timing
473217|NCT00080067|Execution|execution
473218|NCT00080067|Perception|perception
473219|NCT00080067|Rhythm|rhythm
473220|NCT00080067|Healthy Volunteer|healthy volunteer
473221|NCT00080067|HV|hv
473222|NCT00080093|Condom|condom
89864|NCT02725970|DGA|dga
473223|NCT00080093|HIV Seronegativity|hiv seronegativity
473224|NCT00080093|HIV Prevention|hiv prevention
473225|NCT00080093|Behavioral Intervention|behavioral intervention
473226|NCT00080106|HIV Therapeutic Vaccine|hiv therapeutic vaccine
473227|NCT00080106|Treatment Experienced|treatment experienced
473228|NCT00080106|Treatment Interruption|treatment interruption
473229|NCT00080106|Adenovirus Vector|adenovirus vector
473230|NCT00080119|Treatment Naive|treatment naive
473231|NCT00080119|INH Prophylaxis|inh prophylaxis
473232|NCT00080119|HIV Seronegativity|hiv seronegativity
473233|NCT00080132|HTG|htg
473234|NCT00080132|Hypertriglyceridemia, Fredrickson Type I|hypertriglyceridemia, fredrickson type i
473235|NCT00080132|Hypertriglyceridemia, Fredrickson Type V|hypertriglyceridemia, fredrickson type v
473236|NCT00080145|Autistic Disorder|autistic disorder
473237|NCT00080145|Asperger Syndrome|asperger syndrome
473238|NCT00080158|Dysthymic Disorder|dysthymic disorder
473239|NCT00080158|Adolescent|adolescent
473240|NCT00080171|Osteoarthritis|osteoarthritis
473241|NCT00080171|Knee Pain|knee pain
473242|NCT00080171|Knee Health|knee health
473243|NCT00080184|Fibromyalgia|fibromyalgia
473244|NCT00080184|Electroencephalograph (EEG) biofeedback|electroencephalograph (eeg) biofeedback
473245|NCT00080184|Electromagnetic stimulation|electromagnetic stimulation
473246|NCT00080184|Neurofeedback|neurofeedback
473247|NCT00080184|Neurotherapy|neurotherapy
473248|NCT00080184|Complementary and Alternative Medicine|complementary and alternative medicine
473249|NCT00080197|Breast Cancer|breast cancer
473250|NCT00080197|Cancer of the Breast|cancer of the breast
473251|NCT00080210|elevated uric acid|elevated uric acid
473252|NCT00080210|Elevated serum uric acid level|elevated serum uric acid level
473253|NCT00080210|Symptomatic gout|symptomatic gout
473254|NCT00080223|pulmonary fibrosis|pulmonary fibrosis
473255|NCT00080223|respiratory diseases|respiratory diseases
473256|NCT00080236|Liver Transplantation|liver transplantation
473257|NCT00080262|Metastatic Breast Cancer|metastatic breast cancer
473260|NCT00080275|Zocor|zocor
473261|NCT00080275|Simvastatin|simvastatin
473262|NCT00080275|Coronary Heart Disease|coronary heart disease
473263|NCT00080275|Dyslipidemia|dyslipidemia
473264|NCT00080275|Atherosclerosis|atherosclerosis
473265|NCT00080275|Hypercholesterolemia|hypercholesterolemia
473266|NCT00080275|Stroke|stroke
473267|NCT00080275|High-Density Lipoprotein Cholesterol|high-density lipoprotein cholesterol
473268|NCT00080275|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
473269|NCT00080275|Lipoprotein|lipoprotein
473270|NCT00080275|Lipid|lipid
473271|NCT00080275|Niacin ER/simvastatin|niacin er/simvastatin
473272|NCT00080275|Total Cholesterol|total cholesterol
473273|NCT00080275|Triglycerides|triglycerides
473274|NCT00080288|Excessive Sleepiness|excessive sleepiness
473275|NCT00080288|Chronic Shift Work Sleep Disorder|chronic shift work sleep disorder
473276|NCT00080288|Chronic SWSD|chronic swsd
473277|NCT00080288|Circadian Rhythm Disorder|circadian rhythm disorder
473278|NCT00080288|Shift Worker|shift worker
473279|NCT00080288|Cephalon|cephalon
473280|NCT00080288|Cephalon, Inc|cephalon, inc
473281|NCT00080288|Nuvigil|nuvigil
473282|NCT00080301|Metastatic Breast Cancer|metastatic breast cancer
473283|NCT00080314|Bipolar 1 Disorder, depressed|bipolar 1 disorder, depressed
473284|NCT00080353|Complete Tumor Regression|complete tumor regression
473285|NCT00080353|Cell Survival|cell survival
473286|NCT00080353|Chemotherapy Preparative Regimen|chemotherapy preparative regimen
473287|NCT00080353|IL-2|il-2
473288|NCT00080353|Toxicity|toxicity
473289|NCT00080353|Metastatic Melanoma|metastatic melanoma
473290|NCT00080366|Essential Tremor|essential tremor
473291|NCT00080366|Cross over Design|cross over design
473292|NCT00080366|Accelerometry|accelerometry
473293|NCT00080366|Placebo|placebo
473294|NCT00080366|Alcohol Responsive|alcohol responsive
473295|NCT00080366|Double Blind|double blind
473296|NCT00080366|1-Octanol|1-octanol
473297|NCT00080392|Gene Transfer|gene transfer
473298|NCT00080392|Therapeutic Angiogenesis|therapeutic angiogenesis
473299|NCT00080392|Peripheral Arterial Disease|peripheral arterial disease
473300|NCT00080392|Perfusion|perfusion
473301|NCT00080392|Magnetic Resonance Imaging|magnetic resonance imaging
473302|NCT00080392|Peripheral Vascular Disease|peripheral vascular disease
473303|NCT00080392|Claudication|claudication
473304|NCT00080392|PAD|pad
473305|NCT00080392|Leg Claudication|leg claudication
473306|NCT00080392|Intermittent Claudication|intermittent claudication
473307|NCT00080405|Relapsed|relapsed
473308|NCT00080405|Multiple Myeloma|multiple myeloma
473309|NCT00080405|Pharmacokinetic|pharmacokinetic
473310|NCT00080405|Pharmacodynamic|pharmacodynamic
473311|NCT00080418|neoplasm|neoplasm
473312|NCT00080418|cancer|cancer
473313|NCT00080418|NeoPharm|neopharm
473314|NCT00080418|liposomes|liposomes
473315|NCT00080418|Taxol|taxol
473316|NCT00080418|paclitaxel|paclitaxel
473317|NCT00080418|anti-cancer|anti-cancer
473318|NCT00080418|advanced neoplasm|advanced neoplasm
473319|NCT00080418|advanced cancer|advanced cancer
473320|NCT00080418|chemotherapy|chemotherapy
473321|NCT00080418|refractory cancer|refractory cancer
473322|NCT00080418|metastatic cancer|metastatic cancer
473323|NCT00080431|Reservoir|reservoir
473324|NCT00080431|Viral Load|viral load
473325|NCT00080431|Immunosuppression|immunosuppression
473326|NCT00080431|Activation|activation
473327|NCT00080431|Latency|latency
473328|NCT00080431|HIV|hiv
473329|NCT00080431|HAART|haart
473330|NCT00080431|Immunosuppressive Drug|immunosuppressive drug
473331|NCT00080431|Viral Reservoirs|viral reservoirs
473332|NCT00080457|Primary or secondary pulmonary arterial hypertension|primary or secondary pulmonary arterial hypertension
473333|NCT00080457|Scleroderma|scleroderma
473334|NCT00080457|Connective tissue disease|connective tissue disease
473335|NCT00080457|Congenital heart defects|congenital heart defects
473336|NCT00080457|Lupus|lupus
473337|NCT00080457|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
473338|NCT00080470|Incontinence|incontinence
473339|NCT00080470|Refractory|refractory
473340|NCT00080470|Urinary|urinary
473341|NCT00080470|Urge|urge
473342|NCT00080470|Stimulation|stimulation
473343|NCT00080470|Nerve|nerve
473344|NCT00080470|Microstimulator|microstimulator
473345|NCT00080470|Neuromodulation|neuromodulation
473346|NCT00080496|Pneumonia|pneumonia
473347|NCT00080522|Treatment Naive|treatment naive
473348|NCT00080522|Resource Poor Setting|resource poor setting
473349|NCT00080522|Drug Delivery|drug delivery
473350|NCT00080522|Household|household
473351|NCT00080522|South Africa|south africa
473353|NCT00080535|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
473354|NCT00080535|CTCL|ctcl
473355|NCT00080535|Immunotoxin|immunotoxin
473356|NCT00080535|Oncology|oncology
473357|NCT00080548|Bereitschafts Potential|bereitschafts potential
473358|NCT00080548|Timing of Volition|timing of volition
473359|NCT00080548|Somatic Passivity Phenomenon|somatic passivity phenomenon
473360|NCT00080548|Conscious Will|conscious will
473361|NCT00080548|Libet's Clock|libet's clock
473362|NCT00080548|Schizophrenia|schizophrenia
473363|NCT00080548|Healthy Volunteer|healthy volunteer
473364|NCT00080548|HV|hv
473365|NCT00080574|Pharmacokinetics|pharmacokinetics
473366|NCT00080574|Drug Metabolism|drug metabolism
473367|NCT00080574|Levothyroxine|levothyroxine
473368|NCT00080574|Hypothyroidism|hypothyroidism
473369|NCT00080574|Hyperthyroidism|hyperthyroidism
473370|NCT00080574|Drug Interactions|drug interactions
473371|NCT00080574|Cytochrome P450|cytochrome p450
473372|NCT00080574|P-Glycoprotein|p-glycoprotein
473373|NCT00080574|Drug Transport Proteins|drug transport proteins
473374|NCT00080574|Thyroid Hormone|thyroid hormone
473375|NCT00080574|Thyroid Cancer|thyroid cancer
473376|NCT00080587|Intravascular Ultrasound|intravascular ultrasound
473377|NCT00080587|Magnetic Resonance Imaging|magnetic resonance imaging
473378|NCT00080587|Hyperlipidemia|hyperlipidemia
473380|NCT00080587|Coronary Artery Disease|coronary artery disease
473381|NCT00080600|Post Polio Syndrome|post polio syndrome
473382|NCT00080600|Magnetic Stimulation|magnetic stimulation
473383|NCT00080600|Fatigue|fatigue
473384|NCT00080600|Exercise|exercise
473385|NCT00080600|Weakness|weakness
473386|NCT00080600|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
473387|NCT00080600|Post-Exercise Fatigue|post-exercise fatigue
473388|NCT00080600|Motor Neuron Disease|motor neuron disease
473389|NCT00080600|Cortical Reorganization|cortical reorganization
473390|NCT00080600|Intracortical Facilitation|intracortical facilitation
473391|NCT00080600|Polio|polio
473392|NCT00080600|Healthy Volunteer|healthy volunteer
473393|NCT00080600|HV|hv
473394|NCT00080626|stage I breast cancer|stage i breast cancer
473395|NCT00080626|stage II breast cancer|stage ii breast cancer
473396|NCT00080626|stage IIIA breast cancer|stage iiia breast cancer
473397|NCT00080626|stage IIIB breast cancer|stage iiib breast cancer
473398|NCT00080626|stage IIIC breast cancer|stage iiic breast cancer
473399|NCT00080626|stage IV breast cancer|stage iv breast cancer
473400|NCT00080639|ovarian epithelial cancer|ovarian epithelial cancer
473401|NCT00080665|male breast cancer|male breast cancer
473402|NCT00080665|stage IIIB breast cancer|stage iiib breast cancer
473403|NCT00080665|stage IIIC breast cancer|stage iiic breast cancer
473404|NCT00080665|stage IV breast cancer|stage iv breast cancer
473405|NCT00080665|recurrent breast cancer|recurrent breast cancer
473406|NCT00080678|adenocarcinoma of the prostate|adenocarcinoma of the prostate
473407|NCT00080678|recurrent prostate cancer|recurrent prostate cancer
473408|NCT00080678|stage IV prostate cancer|stage iv prostate cancer
473409|NCT00080678|bone metastases|bone metastases
473410|NCT00080743|recurrent breast cancer|recurrent breast cancer
473411|NCT00080743|stage IV breast cancer|stage iv breast cancer
473412|NCT00080756|breast cancer|breast cancer
473413|NCT00080756|BRCA1 mutation carrier|brca1 mutation carrier
473414|NCT00080756|BRCA2 mutation carrier|brca2 mutation carrier
473415|NCT00080782|recurrent prostate cancer|recurrent prostate cancer
473416|NCT00080782|stage IV prostate cancer|stage iv prostate cancer
473417|NCT00080782|bone metastases|bone metastases
90052|NCT02724943|BMI|bmi
473418|NCT00080782|Progressive Androgen-Independent Prostate Cancer|progressive androgen-independent prostate cancer
473419|NCT00080782|Metastron|metastron
473420|NCT00080782|Sr-89|sr-89
473421|NCT00080782|Strontium-89|strontium-89
473422|NCT00080782|strontium chloride Sr 89|strontium chloride sr 89
473423|NCT00080782|Celecoxib|celecoxib
473424|NCT00080782|Celebrex|celebrex
473425|NCT00080782|Doxorubicin|doxorubicin
473426|NCT00080782|Rubex|rubex
473427|NCT00080782|Adriamycin|adriamycin
473428|NCT00080795|stage III bladder cancer|stage iii bladder cancer
473429|NCT00080795|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
473430|NCT00080795|anterior urethral cancer|anterior urethral cancer
473431|NCT00080795|posterior urethral cancer|posterior urethral cancer
473432|NCT00080795|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
473433|NCT00080808|perioperative/postoperative complications|perioperative/postoperative complications
473434|NCT00080808|sexual dysfunction and infertility|sexual dysfunction and infertility
473435|NCT00080808|sexuality and reproductive issues|sexuality and reproductive issues
473436|NCT00080808|adenocarcinoma of the prostate|adenocarcinoma of the prostate
473437|NCT00080808|stage I prostate cancer|stage i prostate cancer
473438|NCT00080808|stage II prostate cancer|stage ii prostate cancer
473439|NCT00080808|prostaglandin E1|prostaglandin e1
473440|NCT00080808|papaverine|papaverine
473441|NCT00080808|phentolamine|phentolamine
473442|NCT00080808|Nerve-sparing radical prostatectomy|nerve-sparing radical prostatectomy
473443|NCT00080808|nerve grafting|nerve grafting
473444|NCT00080834|adenocarcinoma of the colon|adenocarcinoma of the colon
473445|NCT00080834|adenocarcinoma of the rectum|adenocarcinoma of the rectum
473446|NCT00080834|recurrent colon cancer|recurrent colon cancer
473447|NCT00080834|recurrent rectal cancer|recurrent rectal cancer
473448|NCT00080834|stage III colon cancer|stage iii colon cancer
473449|NCT00080834|stage IV colon cancer|stage iv colon cancer
473450|NCT00080834|stage III rectal cancer|stage iii rectal cancer
473451|NCT00080834|stage IV rectal cancer|stage iv rectal cancer
473452|NCT00080860|stage II breast cancer|stage ii breast cancer
473453|NCT00080860|stage IIIA breast cancer|stage iiia breast cancer
473454|NCT00080860|stage IIIB breast cancer|stage iiib breast cancer
473455|NCT00080860|stage IIIC breast cancer|stage iiic breast cancer
473456|NCT00080860|stage IV breast cancer|stage iv breast cancer
473457|NCT00080873|oral complications|oral complications
473458|NCT00080873|disseminated neuroblastoma|disseminated neuroblastoma
473459|NCT00080873|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
473460|NCT00080873|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
473461|NCT00080873|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
473462|NCT00080873|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
473463|NCT00080873|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
479611|NCT00105170|hCBE-11|hcbe-11
473464|NCT00080873|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
473465|NCT00080873|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
473466|NCT00080873|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
473467|NCT00080873|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
473468|NCT00080873|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
473469|NCT00080873|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
473470|NCT00080873|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
473471|NCT00080873|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
473472|NCT00080873|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
473473|NCT00080873|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
473474|NCT00080873|recurrent neuroblastoma|recurrent neuroblastoma
473475|NCT00080886|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
473476|NCT00080886|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
473477|NCT00080886|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
473478|NCT00080886|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
473479|NCT00080886|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
473480|NCT00080886|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
473481|NCT00080886|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
473482|NCT00080886|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
473483|NCT00080886|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
473484|NCT00080886|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
473485|NCT00080886|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
473486|NCT00080886|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
473487|NCT00080886|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
472841|NCT00079092|adult glioblastoma|adult glioblastoma
473488|NCT00080886|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
473489|NCT00080886|splenic marginal zone lymphoma|splenic marginal zone lymphoma
473490|NCT00074516|Immunosuppression|immunosuppression
473492|NCT00074516|Cysteamine|cysteamine
473493|NCT00074516|Steroid-Free|steroid-free
473494|NCT00074516|Outcomes|outcomes
473495|NCT00074542|Crohn's|crohn's
473496|NCT00074542|colon|colon
473497|NCT00074542|small bowel|small bowel
473498|NCT00074542|inflammation|inflammation
473499|NCT00074542|steroid therapy|steroid therapy
473500|NCT00074542|free fatty acids|free fatty acids
473736|NCT00081861|Rituxan|rituxan
473501|NCT00074555|African American, Rheumatoid Arthritis|african american, rheumatoid arthritis
473502|NCT00074568|Genetic Study|genetic study
473503|NCT00074568|Transmission Dysequilibrium Testing|transmission dysequilibrium testing
473504|NCT00074568|Genome Wide Scan|genome wide scan
473505|NCT00074568|Family Study|family study
473506|NCT00074581|HIV Infections|hiv infections
473507|NCT00074581|HIV Seronegativity|hiv seronegativity
473508|NCT00074607|Neoplastic meningitis|neoplastic meningitis
473509|NCT00074620|Haemodialysis|haemodialysis
473510|NCT00074620|PEG-Hirudin|peg-hirudin
473511|NCT00074620|Vascular graft occlusion|vascular graft occlusion
473512|NCT00074620|Renal replacement therapy|renal replacement therapy
473513|NCT00074620|Hemodialysis|hemodialysis
473514|NCT00074633|Type 2 Diabetes|type 2 diabetes
473515|NCT00074633|Self-Esteem|self-esteem
473516|NCT00074646|CC-8490|cc-8490
473517|NCT00074646|CC8490|cc8490
473518|NCT00074646|Glio|glio
473519|NCT00074646|Glioblastoma|glioblastoma
473520|NCT00074646|Malignant Gliomas|malignant gliomas
473521|NCT00074672|Prepulse Inhibition|prepulse inhibition
473522|NCT00074672|PPI|ppi
473524|NCT00074672|Sensorimotor Integration|sensorimotor integration
473525|NCT00074672|Dopaminergic|dopaminergic
473526|NCT00074685|Congenital|congenital
473527|NCT00074685|Epidermal nevus|epidermal nevus
473528|NCT00074685|Erythroderma|erythroderma
473529|NCT00074685|Darier|darier
473530|NCT00074685|Hailey-Hailey|hailey-hailey
473531|NCT00074685|Harlequin|harlequin
473532|NCT00074685|Ichthyosiform|ichthyosiform
473533|NCT00074685|Ichthyosiform erythroderma|ichthyosiform erythroderma
473534|NCT00074685|Keratoderma|keratoderma
473535|NCT00074685|Keratosis|keratosis
473536|NCT00074685|Pachyonychia|pachyonychia
473537|NCT00074685|Sjogren-Larsson|sjogren-larsson
473538|NCT00074698|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
473539|NCT00074698|IPF|ipf
473540|NCT00074698|Pulmonary fibrosis|pulmonary fibrosis
473541|NCT00074698|Respiratory disease|respiratory disease
473542|NCT00074711|Bone Mineral Density|bone mineral density
473543|NCT00074711|Calcium|calcium
473544|NCT00074737|Refractory or Relapsed Acute Myelogenous Leukemia (AML)|refractory or relapsed acute myelogenous leukemia (aml)
473545|NCT00074737|Antisense|antisense
473546|NCT00074750|AML|aml
473547|NCT00074750|CMML|cmml
473548|NCT00080912|bone metastases|bone metastases
473549|NCT00080912|pain|pain
480224|NCT00099333|Amylin|amylin
473550|NCT00080925|prolymphocytic leukemia|prolymphocytic leukemia
473551|NCT00080925|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
473552|NCT00080925|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
473553|NCT00080925|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
473554|NCT00080925|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
473555|NCT00080925|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
473556|NCT00080925|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
473557|NCT00080925|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
473558|NCT00080925|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
473559|NCT00080925|secondary acute myeloid leukemia|secondary acute myeloid leukemia
473560|NCT00080925|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
473561|NCT00080925|refractory anemia with excess blasts|refractory anemia with excess blasts
473562|NCT00080925|refractory multiple myeloma|refractory multiple myeloma
473563|NCT00080925|primary myelofibrosis|primary myelofibrosis
473564|NCT00080925|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
473565|NCT00080925|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
473566|NCT00080925|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
473567|NCT00080925|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
473568|NCT00080925|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
473569|NCT00080925|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
473570|NCT00080925|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
473571|NCT00080925|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
473572|NCT00080925|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
473573|NCT00080925|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
473574|NCT00080925|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
473575|NCT00080925|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
473576|NCT00080925|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
473577|NCT00080925|polycythemia vera|polycythemia vera
473578|NCT00080925|essential thrombocythemia|essential thrombocythemia
473579|NCT00080925|stage II multiple myeloma|stage ii multiple myeloma
473580|NCT00080925|stage III multiple myeloma|stage iii multiple myeloma
473581|NCT00080925|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
473582|NCT00080925|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
473583|NCT00080925|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
473584|NCT00080925|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
473585|NCT00080925|splenic marginal zone lymphoma|splenic marginal zone lymphoma
473586|NCT00080925|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
473587|NCT00080925|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
473588|NCT00080925|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
583841|NCT00512889|melanoma|melanoma
583842|NCT00512889|metastatic melanoma|metastatic melanoma
473589|NCT00080925|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
473590|NCT00080925|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
473591|NCT00080938|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
473592|NCT00080938|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
473593|NCT00080938|squamous cell lung cancer|squamous cell lung cancer
473594|NCT00080938|adenocarcinoma of the lung|adenocarcinoma of the lung
473595|NCT00080938|large cell lung cancer|large cell lung cancer
473596|NCT00080938|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
473598|NCT00080938|tumors metastatic to brain|tumors metastatic to brain
473599|NCT00080951|stage IV colon cancer|stage iv colon cancer
473600|NCT00080951|stage IV rectal cancer|stage iv rectal cancer
473601|NCT00080951|adenocarcinoma of the colon|adenocarcinoma of the colon
473602|NCT00080951|adenocarcinoma of the rectum|adenocarcinoma of the rectum
473603|NCT00080977|recurrent renal cell cancer|recurrent renal cell cancer
473604|NCT00080977|stage IV renal cell cancer|stage iv renal cell cancer
473605|NCT00081003|breast cancer|breast cancer
473606|NCT00081029|xerostomia|xerostomia
473607|NCT00081029|radiation toxicity|radiation toxicity
473608|NCT00081029|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
473609|NCT00081029|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
473610|NCT00081029|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
473611|NCT00081029|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
473612|NCT00081029|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
473613|NCT00081029|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
473614|NCT00081029|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
473615|NCT00081029|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
473616|NCT00081042|recurrent melanoma|recurrent melanoma
473617|NCT00081042|stage III melanoma|stage iii melanoma
473618|NCT00081042|stage IV melanoma|stage iv melanoma
473619|NCT00081055|graft versus host disease|graft versus host disease
473620|NCT00081055|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
473621|NCT00081055|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
473622|NCT00081055|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
473623|NCT00081055|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
473624|NCT00081055|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
473625|NCT00081055|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
473626|NCT00081055|refractory anemia|refractory anemia
473627|NCT00081055|refractory anemia with excess blasts|refractory anemia with excess blasts
473628|NCT00081055|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
473629|NCT00081055|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
473630|NCT00081055|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
473631|NCT00081055|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
473632|NCT00081055|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
473633|NCT00081055|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
473634|NCT00081055|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
473635|NCT00081055|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
473636|NCT00081055|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
473637|NCT00081068|Waldenström macroglobulinemia|waldenström macroglobulinemia
91210|NCT02717988|rheumatoid arthritis|rheumatoid arthritis
473638|NCT00081094|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
473639|NCT00081094|recurrent adult primary liver cancer|recurrent adult primary liver cancer
473640|NCT00081094|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
473641|NCT00081107|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
473642|NCT00081107|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
473643|NCT00081107|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
473644|NCT00081133|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
473645|NCT00081133|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
473646|NCT00081133|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
473647|NCT00081133|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
473648|NCT00081159|recurrent prostate cancer|recurrent prostate cancer
473649|NCT00081159|stage IV prostate cancer|stage iv prostate cancer
473650|NCT00081159|bone metastases|bone metastases
473651|NCT00081172|adenocarcinoma of the prostate|adenocarcinoma of the prostate
473652|NCT00081172|recurrent prostate cancer|recurrent prostate cancer
473653|NCT00081172|stage IV prostate cancer|stage iv prostate cancer
473654|NCT00081224|adenocarcinoma of the rectum|adenocarcinoma of the rectum
473655|NCT00081224|stage II rectal cancer|stage ii rectal cancer
473656|NCT00081224|stage III rectal cancer|stage iii rectal cancer
473657|NCT00081237|recurrent colon cancer|recurrent colon cancer
473658|NCT00081237|stage III colon cancer|stage iii colon cancer
473659|NCT00081237|stage IV colon cancer|stage iv colon cancer
473660|NCT00081237|recurrent rectal cancer|recurrent rectal cancer
473661|NCT00081237|stage III rectal cancer|stage iii rectal cancer
473662|NCT00081237|stage IV rectal cancer|stage iv rectal cancer
473663|NCT00081250|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
473664|NCT00081250|cachexia|cachexia
473665|NCT00081250|anorexia|anorexia
473666|NCT00081250|weight changes|weight changes
473667|NCT00081289|stage III rectal cancer|stage iii rectal cancer
473668|NCT00081289|adenocarcinoma of the rectum|adenocarcinoma of the rectum
473669|NCT00081289|stage II rectal cancer|stage ii rectal cancer
473670|NCT00081302|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
473671|NCT00081302|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
473672|NCT00081302|squamous cell lung cancer|squamous cell lung cancer
473673|NCT00081302|large cell lung cancer|large cell lung cancer
473674|NCT00081302|adenocarcinoma of the lung|adenocarcinoma of the lung
473675|NCT00081302|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
473676|NCT00081315|- Non-Small cell lung cancer|- non-small cell lung cancer
473678|NCT00081783|Immunotherapy|immunotherapy
473679|NCT00081783|NHL|nhl
473680|NCT00081783|Xcellerated T Cells|xcellerated t cells
473681|NCT00081796|Metastatic Breast Cancer|metastatic breast cancer
473682|NCT00081809|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
473683|NCT00081809|Brill-Symmers Disease|brill-symmers disease
473684|NCT00081809|Follicular Lymphoma|follicular lymphoma
473685|NCT00081809|Lymphoma, Giant Follicular|lymphoma, giant follicular
473686|NCT00081809|Lymphoma, Nodular|lymphoma, nodular
473687|NCT00081809|Follicular Lymphoma, Giant|follicular lymphoma, giant
473688|NCT00081809|Giant Follicular Lymphoma|giant follicular lymphoma
473689|NCT00081809|Lymphocytic Lymphoma, Diffuse, Well-Differentiated|lymphocytic lymphoma, diffuse, well-differentiated
473690|NCT00081809|Lymphocytic Lymphoma, Well-Differentiated|lymphocytic lymphoma, well-differentiated
473691|NCT00081809|Lymphoma, Lymphocytic, Diffuse, Well-Differentiated|lymphoma, lymphocytic, diffuse, well-differentiated
473692|NCT00081809|Lymphoma, Lymphocytic, Well-Differentiated|lymphoma, lymphocytic, well-differentiated
473693|NCT00081809|Lymphoma, Lymphoplasmacytoid, CLL|lymphoma, lymphoplasmacytoid, cll
473694|NCT00081809|Lymphoma, Small Lymphocytic, Plasmacytoid|lymphoma, small lymphocytic, plasmacytoid
473695|NCT00081809|Lymphoplasmacytoid Lymphoma, CLL|lymphoplasmacytoid lymphoma, cll
473696|NCT00081809|Diffuse Well-Differentiated Lymphocytic Lymphoma|diffuse well-differentiated lymphocytic lymphoma
473697|NCT00081809|Lymphocytic Lymphoma, Diffuse, Well Differentiated|lymphocytic lymphoma, diffuse, well differentiated
473698|NCT00081809|Lymphocytic Lymphoma, Well Differentiated|lymphocytic lymphoma, well differentiated
473699|NCT00081809|Lymphoma, Lymphocytic, Diffuse, Well Differentiated|lymphoma, lymphocytic, diffuse, well differentiated
473700|NCT00081809|Lymphoma, Lymphocytic, Well Differentiated|lymphoma, lymphocytic, well differentiated
473701|NCT00081809|Lymphoma, Mucosa-Associated Lymphoid Tissue|lymphoma, mucosa-associated lymphoid tissue
473702|NCT00081809|MALT Lymphoma|malt lymphoma
473703|NCT00081809|Lymphoma of Mucosa-Associated Lymphoid Tissue|lymphoma of mucosa-associated lymphoid tissue
473704|NCT00081809|Mucosa-Associated Lymphoid Tissue Lymphoma|mucosa-associated lymphoid tissue lymphoma
473705|NCT00081809|Monocytoid B-cell lymphoma|monocytoid b-cell lymphoma
473706|NCT00081809|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
473707|NCT00081809|Marginal zone lymphoma|marginal zone lymphoma
473708|NCT00081822|Foran|foran
473709|NCT00081822|clofarabine|clofarabine
473710|NCT00081822|cytosine arabinoside|cytosine arabinoside
473711|NCT00081822|acute myeloid leukemia|acute myeloid leukemia
473712|NCT00081835|Smallpox|smallpox
473713|NCT00081835|Cowpox|cowpox
473714|NCT00081835|Corneal Ulcer|corneal ulcer
473715|NCT00081835|Keratitis|keratitis
473716|NCT00081835|Immune Response, Vaccine|immune response, vaccine
473717|NCT00081835|Cornea|cornea
473718|NCT00081835|Vaccinia|vaccinia
473719|NCT00081835|Vaccinia Immune Globulin (VIG)|vaccinia immune globulin (vig)
473720|NCT00081835|Conjunctivitis|conjunctivitis
473721|NCT00081835|Vaccinia Vaccination|vaccinia vaccination
473722|NCT00081835|Smallpox Vaccination|smallpox vaccination
473723|NCT00081848|Colon Cancer|colon cancer
473724|NCT00081848|Gastrointestinal Cancer|gastrointestinal cancer
473725|NCT00081848|Cytokines|cytokines
473726|NCT00081848|Immunotherapy|immunotherapy
473727|NCT00081848|Cancer|cancer
473728|NCT00081848|Solid Tumor|solid tumor
473729|NCT00081848|Liver Metastasis|liver metastasis
473730|NCT00081861|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
473731|NCT00081861|B-Cell Lymphoma|b-cell lymphoma
473732|NCT00081861|Lymphoma|lymphoma
473733|NCT00081861|Avastin|avastin
473734|NCT00081861|Bevacizumab|bevacizumab
473735|NCT00081861|Rituximab|rituximab
473738|NCT00081874|Mantle cell lymphoma|mantle cell lymphoma
473739|NCT00081874|Myelofibrosis|myelofibrosis
583843|NCT00512889|adoptive immunotherapy|adoptive immunotherapy
473740|NCT00081874|Relapsed or Refractory Acute Myeloid Leukemia|relapsed or refractory acute myeloid leukemia
473741|NCT00081874|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
473742|NCT00081874|Chronic Myeloid Leukemia in Blastic-Phase|chronic myeloid leukemia in blastic-phase
473743|NCT00081874|Agnogenic Myeloid Metaplasia|agnogenic myeloid metaplasia
473744|NCT00081874|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
473746|NCT00081874|RAD001|rad001
473747|NCT00081874|Everolimus|everolimus
473748|NCT00081874|Afinitor|afinitor
473749|NCT00081887|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
473750|NCT00081887|CLL|cll
473751|NCT00081887|Leukemia|leukemia
473752|NCT00081887|Clofarabine|clofarabine
473753|NCT00081887|Clofarex|clofarex
473754|NCT00081887|Clolar|clolar
473755|NCT00081900|Carcinoma, Hepatocellular|carcinoma, hepatocellular
473756|NCT00081913|Apheresis|apheresis
473757|NCT00081913|Cell Transfer|cell transfer
473758|NCT00081913|Chest Pain|chest pain
473759|NCT00081913|Adult Stem Cell Therapy|adult stem cell therapy
473761|NCT00081926|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
473762|NCT00081926|RIGHT Trial|right trial
473765|NCT00081952|Postmenopause|postmenopause
473766|NCT00081965|breast cancer in situ|breast cancer in situ
473767|NCT00081965|stage I breast cancer|stage i breast cancer
473768|NCT00081965|stage II breast cancer|stage ii breast cancer
473769|NCT00081965|stage IIIA breast cancer|stage iiia breast cancer
473770|NCT00081965|stage IIIB breast cancer|stage iiib breast cancer
473771|NCT00081965|stage IV breast cancer|stage iv breast cancer
473772|NCT00081965|recurrent breast cancer|recurrent breast cancer
473773|NCT00081965|stage IIIC breast cancer|stage iiic breast cancer
473774|NCT00081965|hot flashes|hot flashes
473775|NCT00081978|HIV infection|hiv infection
473776|NCT00081978|TMC125|tmc125
473777|NCT00081978|Non-nucleoside reverse transcriptase inhibitor, TMC125-C223|non-nucleoside reverse transcriptase inhibitor, tmc125-c223
473778|NCT00081991|Cataract|cataract
473779|NCT00081991|Blindness|blindness
473780|NCT00081991|Clinical|clinical
473781|NCT00081991|Human Aging|human aging
473782|NCT00081991|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
473783|NCT00081991|Aging-Related Lens Changes|aging-related lens changes
473784|NCT00081991|Early Cataract|early cataract
473785|NCT00081991|Lens|lens
473786|NCT00081991|AREDS Grading|areds grading
473787|NCT00081991|In Vivo|in vivo
473788|NCT00081991|Healthy Volunteer|healthy volunteer
473789|NCT00082017|Protein Kinase Inhibition|protein kinase inhibition
473790|NCT00082017|Soluble Tac|soluble tac
473791|NCT00082017|Gene Expression Profiling|gene expression profiling
473792|NCT00082017|ALK Expression|alk expression
473793|NCT00082017|Apoptosis|apoptosis
473794|NCT00082017|Lymphoma|lymphoma
473795|NCT00082017|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
473796|NCT00082017|ALCL|alcl
473797|NCT00082017|T-Cell Lymphoma|t-cell lymphoma
473798|NCT00082030|Depression|depression
473799|NCT00082030|PET|pet
473800|NCT00082030|fMRI|fmri
473801|NCT00082030|Dopamine|dopamine
473802|NCT00082030|Norepinephrine Depletion|norepinephrine depletion
473803|NCT00082030|Emotional Stimuli|emotional stimuli
473804|NCT00082030|Anhedonia|anhedonia
473805|NCT00082030|Norepinephrine|norepinephrine
473806|NCT00082030|Dopamine Depletion|dopamine depletion
473807|NCT00082030|Major Depressive Disorder|major depressive disorder
473808|NCT00082030|MDD|mdd
473809|NCT00082030|Healthy Volunteer|healthy volunteer
473810|NCT00082030|HV|hv
473811|NCT00082043|Neurosteroids|neurosteroids
473812|NCT00082043|5 Alpha-Reductase Inhibitor|5 alpha-reductase inhibitor
473813|NCT00082043|Depression|depression
473814|NCT00082043|Menstrual Cycle|menstrual cycle
473815|NCT00082043|Gonadal Steroids|gonadal steroids
473816|NCT00082043|Menstrual Cycle Related Mood Disorder|menstrual cycle related mood disorder
473817|NCT00082043|MRMD|mrmd
473818|NCT00082043|Healthy Volunteer|healthy volunteer
473819|NCT00082069|Shigella|shigella
473820|NCT00082069|diarrhea|diarrhea
473821|NCT00082095|Metastatic breast cancer|metastatic breast cancer
473822|NCT00082095|Breast Cancer|breast cancer
473823|NCT00082095|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
473824|NCT00082095|Capecitabine|capecitabine
473825|NCT00082095|DOXIL|doxil
473826|NCT00082095|Xeloda|xeloda
473827|NCT00082108|Registry|registry
473828|NCT00082108|FSHD|fshd
473829|NCT00082108|DM|dm
473830|NCT00082108|Muscular Dystrophy|muscular dystrophy
473831|NCT00082108|Facioscapulohumeral Myotonic Dystrophy|facioscapulohumeral myotonic dystrophy
473832|NCT00082108|Myotonic Dystrophy|myotonic dystrophy
473833|NCT00082108|DM1|dm1
473834|NCT00082108|DM2|dm2
473835|NCT00082108|FSH|fsh
473836|NCT00082108|MMD|mmd
473837|NCT00082121|cardiac bypass|cardiac bypass
473838|NCT00082121|CABG|cabg
473839|NCT00082121|complement activation|complement activation
473840|NCT00082134|Prostate cancer|prostate cancer
473945|NCT00082420|low vitamin A status|low vitamin a status
473841|NCT00082134|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
473843|NCT00082134|Prostate|prostate
473844|NCT00082134|Docetaxel|docetaxel
473845|NCT00082134|PSA progression|psa progression
473846|NCT00082134|PSA progressed|psa progressed
473847|NCT00082147|MRI|mri
473848|NCT00082147|Biopsy|biopsy
473849|NCT00082147|Fiducial Marker|fiducial marker
473850|NCT00082147|Prostate Cancer|prostate cancer
473851|NCT00082160|Meditation|meditation
473852|NCT00082160|Relaxation|relaxation
473853|NCT00082212|ovarian|ovarian
473854|NCT00082212|primary peritoneal cancer|primary peritoneal cancer
473855|NCT00082212|Persistent or Recurrent Ovarian Cancer|persistent or recurrent ovarian cancer
473856|NCT00082212|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
473857|NCT00082225|Hodgkins|hodgkins
473858|NCT00082225|Non-Hodgkins|non-hodgkins
473859|NCT00082225|Lymphoma|lymphoma
473860|NCT00082251|Dyslipidemia|dyslipidemia
473861|NCT00082251|High Blood Cholesterol|high blood cholesterol
473862|NCT00082251|Coronary Heart Disease|coronary heart disease
473863|NCT00082251|Hypertension|hypertension
473864|NCT00082251|National Cholesterol Education Program|national cholesterol education program
473865|NCT00082251|Adult Treatment Panel III|adult treatment panel iii
473866|NCT00082251|Niacin|niacin
473867|NCT00082251|Simvastatin|simvastatin
473868|NCT00082251|Diabetes|diabetes
473869|NCT00082251|Peripheral Vascular Disease|peripheral vascular disease
473870|NCT00082251|Cerebrovascular disease|cerebrovascular disease
473871|NCT00082251|Stroke|stroke
473872|NCT00082251|High-Density Lipoprotein Cholesterol|high-density lipoprotein cholesterol
473873|NCT00082251|Hydroxymethyl Glutaryl Coenzyme A|hydroxymethyl glutaryl coenzyme a
473874|NCT00082251|High-Sensitivity C-Reactive Protein|high-sensitivity c-reactive protein
473875|NCT00082251|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
473876|NCT00082251|Lipoprotein (a)|lipoprotein (a)
473877|NCT00082251|Lipoprotein A-I|lipoprotein a-i
473878|NCT00082251|Total Cholesterol|total cholesterol
473879|NCT00082251|Triglycerides|triglycerides
473880|NCT00082277|hormone-receptor positive, breast cancer|hormone-receptor positive, breast cancer
473881|NCT00082277|Osteopenia|osteopenia
473882|NCT00082277|Osteoporosis|osteoporosis
473883|NCT00082277|risk of fracture|risk of fracture
473884|NCT00082277|bone loss|bone loss
473885|NCT00082290|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
473886|NCT00082290|pain|pain
473887|NCT00082303|Music Therapy|music therapy
473890|NCT00082316|Dermal assessment|dermal assessment
473891|NCT00082316|Pain assessment|pain assessment
473892|NCT00082316|Diary|diary
473893|NCT00082316|Analgesics|analgesics
473894|NCT00082316|Capsaicin|capsaicin
473895|NCT00082316|Herpes zoster|herpes zoster
473896|NCT00082316|Neuralgia|neuralgia
473897|NCT00082316|HIV Infections|hiv infections
473898|NCT00082316|Peripheral Nervous System Diseases|peripheral nervous system diseases
473899|NCT00082316|Diabetic Neuropathies|diabetic neuropathies
473900|NCT00082316|Diabetes Mellitus|diabetes mellitus
473901|NCT00082316|Polyneuropathies|polyneuropathies
473902|NCT00082316|Complementary Therapies|complementary therapies
473903|NCT00082329|Hematopoietic Stem Cells|hematopoietic stem cells
473904|NCT00082329|PBSC's|pbsc's
473905|NCT00082329|Mobilization|mobilization
473906|NCT00082329|Alloreactivity|alloreactivity
473907|NCT00082329|T Cell Polarization|t cell polarization
473908|NCT00082329|Dendritic Cells|dendritic cells
473909|NCT00082329|CXCR4|cxcr4
473910|NCT00082329|Plerixafor|plerixafor
473911|NCT00082329|Healthy Volunteer (HV)|healthy volunteer (hv)
473912|NCT00082342|Human Brain|human brain
473913|NCT00082342|Electrical Stimulation|electrical stimulation
473914|NCT00082342|Parkinson Disease|parkinson disease
473915|NCT00082342|PD|pd
473916|NCT00082355|r-tPA|r-tpa
473917|NCT00082355|Thrombolysis|thrombolysis
473918|NCT00082355|Clot|clot
473258|NCT00080275|Niacin|niacin
473919|NCT00082355|Anticoagulation|anticoagulation
473920|NCT00082355|Fibrinolysis|fibrinolysis
473921|NCT00082355|Deep Vein Thrombosis|deep vein thrombosis
473922|NCT00082355|DVT|dvt
473923|NCT00082368|Tariquidar|tariquidar
473924|NCT00082368|PET|pet
473925|NCT00082368|Sestamibi|sestamibi
473926|NCT00082368|Cancer|cancer
473927|NCT00082381|Diabetes|diabetes
473928|NCT00082381|Insulin glargine|insulin glargine
473929|NCT00082381|comparator|comparator
473930|NCT00082381|Amylin|amylin
473931|NCT00082381|Lilly|lilly
473932|NCT00082394|safety|safety
473933|NCT00082394|drug efficacy|drug efficacy
473934|NCT00082394|TRIZIVIR|trizivir
473935|NCT00082394|tolerability|tolerability
473936|NCT00082394|COMBIVIR|combivir
473937|NCT00082394|HIV|hiv
473938|NCT00082394|atazanavir|atazanavir
473939|NCT00082407|diabetes|diabetes
473940|NCT00082407|exendin|exendin
473941|NCT00082407|Amylin|amylin
473942|NCT00082407|Lilly|lilly
473943|NCT00082407|insulin aspart|insulin aspart
473944|NCT00082420|Vitamin A malnutrition|vitamin a malnutrition
474389|NCT00083382|Myeloma|myeloma
473946|NCT00082446|Smallpox, vaccine|smallpox, vaccine
473947|NCT00082459|Kidney Cancer|kidney cancer
473949|NCT00082459|Tumor|tumor
473950|NCT00082459|Immunotherapy|immunotherapy
473951|NCT00082472|NSCLC|nsclc
473952|NCT00082472|Metastatic|metastatic
473953|NCT00082472|Unresectable|unresectable
473954|NCT00082472|No Prior Chemotherapy|no prior chemotherapy
473955|NCT00082485|Cocaine Dependence|cocaine dependence
473956|NCT00082498|SCH-D|sch-d
473957|NCT00082498|Schering D|schering d
473958|NCT00082498|Treatment Experienced|treatment experienced
473959|NCT00082498|Entry Inhibitors|entry inhibitors
473960|NCT00082498|Fusion Inhibitors|fusion inhibitors
473961|NCT00082498|Vicriviroc|vicriviroc
473962|NCT00082511|Lupus|lupus
473963|NCT00082511|Systemic Lupus Erythematosus|systemic lupus erythematosus
473964|NCT00082511|SLE|sle
473965|NCT00082511|Bone Loss|bone loss
473966|NCT00082511|DHEA|dhea
473968|NCT00082550|Serotonin Transporter|serotonin transporter
473969|NCT00082550|Brain Imaging|brain imaging
473970|NCT00082550|Neurotransmitter|neurotransmitter
473971|NCT00082550|OCD|ocd
473972|NCT00082550|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
473973|NCT00082550|PET|pet
473974|NCT00082550|Obsessive Compulsive Disorder|obsessive compulsive disorder
473975|NCT00082550|Healthy Volunteer|healthy volunteer
473976|NCT00082550|HV|hv
473977|NCT00082602|galantamine|galantamine
473978|NCT00082602|Alzheimer's disease|alzheimer's disease
473979|NCT00082615|Movement Disorders|movement disorders
473980|NCT00082615|Recovery Cycle|recovery cycle
473981|NCT00082615|Blink Reflex|blink reflex
473982|NCT00082615|Cervical Dystonia|cervical dystonia
473983|NCT00082615|Blepharospasm|blepharospasm
473984|NCT00082615|Dystonia|dystonia
473985|NCT00082615|Craniofacial Dystonia|craniofacial dystonia
473986|NCT00082615|Healthy Volunteer|healthy volunteer
473987|NCT00082615|HV|hv
473988|NCT00082628|growth hormone|growth hormone
473989|NCT00082628|Serostim®|serostim®
473990|NCT00082628|Human Adipose Redistribution Syndrome|human adipose redistribution syndrome
473991|NCT00082628|Human Immunodeficiency Virus lipodystrophy|human immunodeficiency virus lipodystrophy
473992|NCT00082628|Treatment Experienced|treatment experienced
473993|NCT00082641|stage IIIA breast cancer|stage iiia breast cancer
473994|NCT00082641|stage IIIB breast cancer|stage iiib breast cancer
473995|NCT00082654|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
473996|NCT00082654|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
473997|NCT00082654|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
473998|NCT00082654|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
473999|NCT00082654|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
474000|NCT00082654|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
474001|NCT00082654|chronic eosinophilic leukemia|chronic eosinophilic leukemia
474002|NCT00082654|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
474003|NCT00082654|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
474004|NCT00082654|chronic neutrophilic leukemia|chronic neutrophilic leukemia
474005|NCT00082654|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
474006|NCT00082654|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
474007|NCT00082654|disseminated neuroblastoma|disseminated neuroblastoma
474008|NCT00082654|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
474009|NCT00082654|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
474010|NCT00082654|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
474011|NCT00082654|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
91211|NCT02717988|healthy volunteers|healthy volunteers
91540|NCT02715986|ECT|ect
473352|NCT00080535|LMB-2|lmb-2
474012|NCT00082654|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
474013|NCT00082654|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
474014|NCT00082654|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
474015|NCT00082654|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
474016|NCT00082654|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
474017|NCT00082654|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
474018|NCT00082654|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
474019|NCT00082654|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
474020|NCT00082654|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
474021|NCT00082654|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
474022|NCT00082654|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
474023|NCT00082654|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
474024|NCT00082654|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
474025|NCT00082654|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
474026|NCT00082654|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
474027|NCT00082654|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
474028|NCT00082654|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
474029|NCT00082654|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
474030|NCT00082654|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
474031|NCT00082654|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
474032|NCT00082654|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
474033|NCT00082654|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
474034|NCT00082654|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
474035|NCT00082654|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
474037|NCT00082654|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
13251|NCT03205761|Advanced Breast Cancer|advanced breast cancer
474038|NCT00082654|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
474039|NCT00082654|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
474040|NCT00082654|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
474041|NCT00082654|refractory hairy cell leukemia|refractory hairy cell leukemia
474042|NCT00082654|refractory multiple myeloma|refractory multiple myeloma
474043|NCT00082654|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
474044|NCT00082654|secondary acute myeloid leukemia|secondary acute myeloid leukemia
474045|NCT00082654|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
474046|NCT00082654|stage I multiple myeloma|stage i multiple myeloma
474047|NCT00082654|stage II multiple myeloma|stage ii multiple myeloma
474048|NCT00082654|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
474049|NCT00082654|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
474050|NCT00082654|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
474051|NCT00082654|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
474052|NCT00082654|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
474053|NCT00082654|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
474054|NCT00082654|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
474055|NCT00082654|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
474056|NCT00082654|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
474057|NCT00082654|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
480225|NCT00099333|Eli Lilly|eli lilly
474058|NCT00082654|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
474059|NCT00082654|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
474060|NCT00082654|stage III multiple myeloma|stage iii multiple myeloma
474061|NCT00082654|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
474062|NCT00082654|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
474063|NCT00082654|stage IIIA breast cancer|stage iiia breast cancer
474064|NCT00082654|stage IIIB breast cancer|stage iiib breast cancer
474065|NCT00082654|stage IIIC breast cancer|stage iiic breast cancer
474066|NCT00082654|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
474067|NCT00082654|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
474068|NCT00082654|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
474069|NCT00082654|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
474070|NCT00082654|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
474071|NCT00082654|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
474072|NCT00082654|stage IV breast cancer|stage iv breast cancer
91916|NCT02713945|Ras|ras
92518|NCT02710422|RARP|rarp
473491|NCT00074516|Kidney|kidney
474073|NCT00082654|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
474074|NCT00082654|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
474075|NCT00082654|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
474076|NCT00082654|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
474077|NCT00082654|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
474078|NCT00082654|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
474079|NCT00082654|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
474080|NCT00082654|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
474081|NCT00082654|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
474082|NCT00082654|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
474083|NCT00082654|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
474084|NCT00082654|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
474085|NCT00082654|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
474086|NCT00082654|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
474087|NCT00082654|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
474088|NCT00082654|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
474089|NCT00082654|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
474090|NCT00082654|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
474091|NCT00082654|splenic marginal zone lymphoma|splenic marginal zone lymphoma
474092|NCT00082654|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
474093|NCT00082654|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
474094|NCT00082654|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
474095|NCT00082654|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
474096|NCT00082654|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
474097|NCT00082667|breast cancer in situ|breast cancer in situ
474098|NCT00082667|ductal breast carcinoma in situ|ductal breast carcinoma in situ
474099|NCT00082706|adenocarcinoma of the bladder|adenocarcinoma of the bladder
474100|NCT00082706|recurrent bladder cancer|recurrent bladder cancer
474101|NCT00082706|stage IV bladder cancer|stage iv bladder cancer
474102|NCT00082706|recurrent urethral cancer|recurrent urethral cancer
474103|NCT00082706|anterior urethral cancer|anterior urethral cancer
474104|NCT00082706|posterior urethral cancer|posterior urethral cancer
474105|NCT00082706|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
474106|NCT00082706|stage III bladder cancer|stage iii bladder cancer
474107|NCT00082719|stage II bladder cancer|stage ii bladder cancer
474108|NCT00082719|stage III bladder cancer|stage iii bladder cancer
474109|NCT00082719|stage IV bladder cancer|stage iv bladder cancer
474110|NCT00082719|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
474111|NCT00082719|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
474112|NCT00082719|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
474113|NCT00082719|anterior urethral cancer|anterior urethral cancer
474114|NCT00082719|posterior urethral cancer|posterior urethral cancer
474115|NCT00082719|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
474116|NCT00082732|stage I prostate cancer|stage i prostate cancer
474117|NCT00082732|stage II prostate cancer|stage ii prostate cancer
474118|NCT00082732|adenocarcinoma of the prostate|adenocarcinoma of the prostate
474119|NCT00082758|recurrent neuroblastoma|recurrent neuroblastoma
474120|NCT00082797|adult glioblastoma|adult glioblastoma
474121|NCT00082797|adult giant cell glioblastoma|adult giant cell glioblastoma
474122|NCT00082797|adult gliosarcoma|adult gliosarcoma
474123|NCT00082823|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
474124|NCT00082823|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
474125|NCT00082823|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
474126|NCT00082823|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
474127|NCT00082823|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
474128|NCT00082823|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
474129|NCT00082823|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
474130|NCT00082823|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
474131|NCT00082823|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
474132|NCT00082823|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
474133|NCT00082823|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
474134|NCT00082823|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
474135|NCT00082823|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
92796|NCT02708420|Hemodynamic response|hemodynamic response
474136|NCT00082823|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
474137|NCT00082823|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
474138|NCT00082823|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
474139|NCT00082823|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
474140|NCT00082823|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
474141|NCT00082823|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
474142|NCT00082823|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
474143|NCT00082823|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
474144|NCT00082823|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
474145|NCT00082823|advanced adult primary liver cancer|advanced adult primary liver cancer
474146|NCT00082823|recurrent adult primary liver cancer|recurrent adult primary liver cancer
474147|NCT00082823|recurrent cervical cancer|recurrent cervical cancer
474148|NCT00082823|stage IVA cervical cancer|stage iva cervical cancer
474149|NCT00082823|stage IVB cervical cancer|stage ivb cervical cancer
474150|NCT00082823|fallopian tube cancer|fallopian tube cancer
474151|NCT00082823|ovarian sarcoma|ovarian sarcoma
474152|NCT00082823|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
474153|NCT00082823|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
474154|NCT00082823|recurrent endometrial carcinoma|recurrent endometrial carcinoma
474155|NCT00082823|stage IV endometrial carcinoma|stage iv endometrial carcinoma
474156|NCT00082823|recurrent uterine sarcoma|recurrent uterine sarcoma
474157|NCT00082823|stage IV uterine sarcoma|stage iv uterine sarcoma
474158|NCT00082823|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
474159|NCT00082823|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
474160|NCT00082823|ovarian stromal cancer|ovarian stromal cancer
474161|NCT00082823|recurrent vaginal cancer|recurrent vaginal cancer
474162|NCT00082823|stage IVA vaginal cancer|stage iva vaginal cancer
474163|NCT00082823|stage IVB vaginal cancer|stage ivb vaginal cancer
474164|NCT00082823|recurrent prostate cancer|recurrent prostate cancer
474165|NCT00082823|stage IV prostate cancer|stage iv prostate cancer
474166|NCT00082823|recurrent penile cancer|recurrent penile cancer
474167|NCT00082823|stage IV penile cancer|stage iv penile cancer
474168|NCT00082823|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
474169|NCT00082823|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
474170|NCT00082823|recurrent bladder cancer|recurrent bladder cancer
474171|NCT00082823|stage IV bladder cancer|stage iv bladder cancer
474172|NCT00082823|recurrent vulvar cancer|recurrent vulvar cancer
474173|NCT00082823|stage IVB vulvar cancer|stage ivb vulvar cancer
474174|NCT00082823|distal urethral cancer|distal urethral cancer
474175|NCT00082823|proximal urethral cancer|proximal urethral cancer
474176|NCT00082823|recurrent urethral cancer|recurrent urethral cancer
474177|NCT00082823|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
474178|NCT00082823|primary peritoneal cavity cancer|primary peritoneal cavity cancer
474179|NCT00082823|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
474180|NCT00082823|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
474181|NCT00082823|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
474182|NCT00082823|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
474183|NCT00082823|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
474184|NCT00082823|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
474185|NCT00082823|splenic marginal zone lymphoma|splenic marginal zone lymphoma
474186|NCT00082823|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
474187|NCT00082836|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
474188|NCT00082862|stage II pancreatic cancer|stage ii pancreatic cancer
474189|NCT00082862|stage III pancreatic cancer|stage iii pancreatic cancer
474190|NCT00082862|recurrent pancreatic cancer|recurrent pancreatic cancer
474191|NCT00082862|stage IV pancreatic cancer|stage iv pancreatic cancer
474192|NCT00082914|recurrent renal cell cancer|recurrent renal cell cancer
474193|NCT00082914|stage IV renal cell cancer|stage iv renal cell cancer
474194|NCT00082914|recurrent melanoma|recurrent melanoma
474195|NCT00082914|stage IV melanoma|stage iv melanoma
474196|NCT00082927|stage IV prostate cancer|stage iv prostate cancer
474197|NCT00082927|bone metastases|bone metastases
474199|NCT00082927|recurrent prostate cancer|recurrent prostate cancer
474200|NCT00082940|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
474201|NCT00082940|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
474202|NCT00082979|breast cancer|breast cancer
474203|NCT00083005|adenocarcinoma of the prostate|adenocarcinoma of the prostate
474204|NCT00083005|recurrent prostate cancer|recurrent prostate cancer
474205|NCT00083005|stage IV prostate cancer|stage iv prostate cancer
474206|NCT00083018|stage II breast cancer|stage ii breast cancer
474207|NCT00083018|stage IIIA breast cancer|stage iiia breast cancer
474208|NCT00083018|stage IIIB breast cancer|stage iiib breast cancer
474209|NCT00083018|stage IIIC breast cancer|stage iiic breast cancer
474210|NCT00083018|stage IA breast cancer|stage ia breast cancer
474211|NCT00083018|stage IB breast cancer|stage ib breast cancer
474212|NCT00083031|recurrent breast cancer|recurrent breast cancer
474213|NCT00083031|stage IV breast cancer|stage iv breast cancer
474214|NCT00083044|breast cancer|breast cancer
474215|NCT00083044|breast cancer in situ|breast cancer in situ
474216|NCT00083044|stage I breast cancer|stage i breast cancer
474217|NCT00083044|lobular breast carcinoma in situ|lobular breast carcinoma in situ
474218|NCT00083044|ductal breast carcinoma in situ|ductal breast carcinoma in situ
474219|NCT00083057|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
474220|NCT00083057|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
474221|NCT00083057|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
474222|NCT00083057|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
474223|NCT00083057|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
474224|NCT00083057|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
474225|NCT00083057|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
474226|NCT00083057|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
474227|NCT00083057|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
474228|NCT00083057|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
474229|NCT00083057|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
474230|NCT00083057|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
474231|NCT00083057|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
474390|NCT00083382|Thalidomide|thalidomide
474232|NCT00083057|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
474233|NCT00083057|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
474234|NCT00083057|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
474235|NCT00083070|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
474236|NCT00083070|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
474237|NCT00083070|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
474238|NCT00083070|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
474239|NCT00083070|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
474240|NCT00083083|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
474241|NCT00083083|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
474242|NCT00083083|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
474243|NCT00083096|recurrent adult brain tumor|recurrent adult brain tumor
474244|NCT00083096|adult mixed glioma|adult mixed glioma
474245|NCT00083096|adult anaplastic astrocytoma|adult anaplastic astrocytoma
474246|NCT00083096|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
474247|NCT00083096|adult glioblastoma|adult glioblastoma
474248|NCT00083096|adult pilocytic astrocytoma|adult pilocytic astrocytoma
474249|NCT00083096|adult anaplastic ependymoma|adult anaplastic ependymoma
474250|NCT00083096|adult subependymoma|adult subependymoma
474251|NCT00083096|adult myxopapillary ependymoma|adult myxopapillary ependymoma
474252|NCT00083096|adult oligodendroglioma|adult oligodendroglioma
474253|NCT00083096|adult giant cell glioblastoma|adult giant cell glioblastoma
474254|NCT00083096|adult gliosarcoma|adult gliosarcoma
474255|NCT00083096|adult diffuse astrocytoma|adult diffuse astrocytoma
474256|NCT00083096|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
474257|NCT00083096|adult pineal gland astrocytoma|adult pineal gland astrocytoma
474258|NCT00083135|recurrent neuroblastoma|recurrent neuroblastoma
474259|NCT00083148|recurrent breast cancer|recurrent breast cancer
474260|NCT00083148|stage IV breast cancer|stage iv breast cancer
474261|NCT00083161|extensive stage small cell lung cancer|extensive stage small cell lung cancer
474262|NCT00083161|recurrent small cell lung cancer|recurrent small cell lung cancer
474263|NCT00083174|breast cancer|breast cancer
474264|NCT00083187|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
474265|NCT00083187|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
474266|NCT00083187|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
474267|NCT00083187|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
474268|NCT00083187|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
474269|NCT00083187|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
474270|NCT00083187|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
474271|NCT00083187|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
474272|NCT00083187|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
474273|NCT00083187|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
474274|NCT00083187|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
474275|NCT00083187|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
474276|NCT00083213|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
474277|NCT00083213|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
474278|NCT00083213|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
474279|NCT00083213|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
474280|NCT00083213|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
474281|NCT00083213|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
474282|NCT00083213|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
474283|NCT00083213|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
474284|NCT00083213|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
474285|NCT00083213|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
474286|NCT00083213|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
474287|NCT00083213|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
583844|NCT00512889|adoptive cell transfer|adoptive cell transfer
474288|NCT00083213|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
474289|NCT00083213|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
474290|NCT00083213|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
474291|NCT00083213|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
474292|NCT00083213|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
474293|NCT00083213|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
474294|NCT00083213|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
474295|NCT00083213|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
474296|NCT00083213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
474297|NCT00083213|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
474298|NCT00083213|recurrent adult primary liver cancer|recurrent adult primary liver cancer
474299|NCT00083213|advanced adult primary liver cancer|advanced adult primary liver cancer
474300|NCT00083213|recurrent cervical cancer|recurrent cervical cancer
474301|NCT00083213|stage IVA cervical cancer|stage iva cervical cancer
474302|NCT00083213|stage IVB cervical cancer|stage ivb cervical cancer
474303|NCT00083213|fallopian tube cancer|fallopian tube cancer
474304|NCT00083213|ovarian sarcoma|ovarian sarcoma
474305|NCT00083213|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
474306|NCT00083213|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
474307|NCT00083213|recurrent endometrial carcinoma|recurrent endometrial carcinoma
474308|NCT00083213|stage IV endometrial carcinoma|stage iv endometrial carcinoma
474309|NCT00083213|recurrent uterine sarcoma|recurrent uterine sarcoma
474310|NCT00083213|stage IV uterine sarcoma|stage iv uterine sarcoma
474311|NCT00083213|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
474312|NCT00083213|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
474313|NCT00083213|ovarian stromal cancer|ovarian stromal cancer
474314|NCT00083213|recurrent vaginal cancer|recurrent vaginal cancer
474315|NCT00083213|stage IVA vaginal cancer|stage iva vaginal cancer
474316|NCT00083213|stage IVB vaginal cancer|stage ivb vaginal cancer
474317|NCT00083213|recurrent prostate cancer|recurrent prostate cancer
474318|NCT00083213|stage IV prostate cancer|stage iv prostate cancer
474319|NCT00083213|recurrent penile cancer|recurrent penile cancer
474320|NCT00083213|stage IV penile cancer|stage iv penile cancer
474321|NCT00083213|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
474322|NCT00083213|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
474323|NCT00083213|recurrent bladder cancer|recurrent bladder cancer
474324|NCT00083213|stage IV bladder cancer|stage iv bladder cancer
474325|NCT00083213|recurrent vulvar cancer|recurrent vulvar cancer
474326|NCT00083213|stage IVB vulvar cancer|stage ivb vulvar cancer
474327|NCT00083213|distal urethral cancer|distal urethral cancer
474328|NCT00083213|proximal urethral cancer|proximal urethral cancer
474329|NCT00083213|recurrent urethral cancer|recurrent urethral cancer
474330|NCT00083213|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
474331|NCT00083213|primary peritoneal cavity cancer|primary peritoneal cavity cancer
474332|NCT00083213|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
474333|NCT00083213|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
474334|NCT00083213|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
474335|NCT00083213|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
474336|NCT00083213|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
474337|NCT00083213|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
474338|NCT00083213|splenic marginal zone lymphoma|splenic marginal zone lymphoma
474339|NCT00083213|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
474340|NCT00083226|doxorubicin|doxorubicin
92797|NCT02708420|Anesthesia|anesthesia
473745|NCT00081874|T-Cell Leukemia|t-cell leukemia
474341|NCT00083226|doxorubicin hydrochloride|doxorubicin hydrochloride
474342|NCT00083226|bortezomib|bortezomib
474343|NCT00083226|hepatocellular carcinoma|hepatocellular carcinoma
474344|NCT00083265|Adenosine Receptor|adenosine receptor
474345|NCT00083265|Panic Disorder|panic disorder
474346|NCT00083265|Polymorphism|polymorphism
474347|NCT00083265|Challenge Study|challenge study
474348|NCT00083265|Caffeine|caffeine
474349|NCT00083265|Healthy Volunteer|healthy volunteer
474351|NCT00083278|Breast Cancer|breast cancer
474352|NCT00083278|Stage IV adenocarcinoma of the breast|stage iv adenocarcinoma of the breast
474353|NCT00083291|Dry Eyes|dry eyes
474354|NCT00083291|Conjunctiva|conjunctiva
474355|NCT00083291|Infection|infection
474356|NCT00083291|Antibodies|antibodies
474357|NCT00083291|Inflammation|inflammation
474358|NCT00083291|Ocular Surface Disease|ocular surface disease
474359|NCT00083291|Helicobacter Pylori|helicobacter pylori
474360|NCT00083304|Breast|breast
474361|NCT00083304|Brain|brain
474362|NCT00083304|RSR13|rsr13
474363|NCT00083304|efaproxiral|efaproxiral
474364|NCT00083304|Whole Brain Radiation Therapy|whole brain radiation therapy
474365|NCT00083304|Brain metastases|brain metastases
474366|NCT00083304|Metastatic breast cancer|metastatic breast cancer
474367|NCT00083317|PFC|pfc
474369|NCT00083317|Bargaining Games|bargaining games
474370|NCT00083317|Hyper-Brain Scanning|hyper-brain scanning
474371|NCT00083317|fMRI|fmri
474372|NCT00083317|Healthy Volunteer|healthy volunteer
474373|NCT00083317|HV|hv
474374|NCT00083330|Healthy|healthy
474375|NCT00083330|T Cells|t cells
474376|NCT00083330|Immunity|immunity
474377|NCT00083330|Healthy Volunteer|healthy volunteer
474378|NCT00083330|HV|hv
474379|NCT00083356|Pain|pain
474380|NCT00083356|Kinins|kinins
474381|NCT00083356|Inflammation|inflammation
474382|NCT00083356|Gene Expression|gene expression
474383|NCT00083356|Oral Surgey|oral surgey
474384|NCT00083356|Bradykinin B1 Receptors|bradykinin b1 receptors
474385|NCT00083356|Acute Peripheral Inflammation|acute peripheral inflammation
474386|NCT00083356|Inflammatory Gene Expression|inflammatory gene expression
474387|NCT00083356|Wisdom Teeth|wisdom teeth
474388|NCT00083356|Third Molar Extraction|third molar extraction
474393|NCT00083382|Bisphosphonate|bisphosphonate
474394|NCT00083382|Anti-Angiogenesis|anti-angiogenesis
474395|NCT00083382|Smoldering/Indolent Myeloma|smoldering/indolent myeloma
474396|NCT00083382|Zometa|zometa
474397|NCT00083395|ARVC/ARVD|arvc/arvd
474398|NCT00083395|Genetics|genetics
474399|NCT00083395|Sudden Death|sudden death
474400|NCT00083395|Heart|heart
474401|NCT00083395|MRI|mri
474402|NCT00083395|Cardiomyopathy|cardiomyopathy
474403|NCT00083395|Arrhythmogenic Right Ventricular|arrhythmogenic right ventricular
474404|NCT00083395|ARVC|arvc
474405|NCT00083395|Healthy Volunteer|healthy volunteer
474406|NCT00083395|HV|hv
474407|NCT00083408|Multiple Myeloma|multiple myeloma
474408|NCT00083408|Pamidronate|pamidronate
474409|NCT00083408|Thalidomide|thalidomide
474410|NCT00083408|refractory myeloma|refractory myeloma
474411|NCT00083408|bisphosphonates|bisphosphonates
474412|NCT00083408|Aredia|aredia
474413|NCT00083434|Anemia|anemia
474414|NCT00083434|Cancer|cancer
474415|NCT00083447|brain tumor|brain tumor
474416|NCT00083447|GBM|gbm
474417|NCT00083447|glioblastoma|glioblastoma
474418|NCT00083447|glioblastoma multiforme|glioblastoma multiforme
474419|NCT00083447|brain cancer|brain cancer
474420|NCT00083447|treatment|treatment
474421|NCT00083460|Multiple Myeloma|multiple myeloma
474422|NCT00083460|Thalidomide|thalidomide
474423|NCT00083460|Velcade|velcade
474424|NCT00083460|PS-341|ps-341
474425|NCT00083460|Refractory|refractory
474426|NCT00083460|Bortezomid|bortezomid
474427|NCT00083473|Leukemia Lymphocytic Chronic,|leukemia lymphocytic chronic,
474428|NCT00083473|Pivanex,|pivanex,
474429|NCT00083473|Histone deacetylase inhibitor|histone deacetylase inhibitor
474430|NCT00083499|Pental of Cantrell|pental of cantrell
474431|NCT00083499|TAS Syndrome|tas syndrome
474432|NCT00083499|Midline Defects|midline defects
474433|NCT00083499|Contractile Proteins|contractile proteins
474434|NCT00083499|Herniation|herniation
474435|NCT00083499|Nonmuscle Myosin IIC|nonmuscle myosin iic
474436|NCT00083499|Pentalogy of Cantrell|pentalogy of cantrell
474437|NCT00083499|Non-muscle Myosin Heavy Chain Genes|non-muscle myosin heavy chain genes
474438|NCT00083512|Blood|blood
474442|NCT00083512|Glioblastoma Multiforme|glioblastoma multiforme
474443|NCT00083538|Multiple Myeloma|multiple myeloma
474444|NCT00083538|DTPACE|dtpace
474445|NCT00083538|Dexamethasone|dexamethasone
474446|NCT00083538|Thalidomide|thalidomide
474447|NCT00083538|Cisplatin|cisplatin
474448|NCT00083538|Cytoxan|cytoxan
474449|NCT00083538|Doxorubicin|doxorubicin
474450|NCT00083538|Etoposide|etoposide
473842|NCT00082134|HRPC|hrpc
474451|NCT00083538|Dendritic Cell Vaccination|dendritic cell vaccination
474452|NCT00083538|Leukapheresis|leukapheresis
474453|NCT00083551|Multiple Myeloma|multiple myeloma
474454|NCT00083551|Cancer|cancer
474455|NCT00083551|Therapy|therapy
474456|NCT00083551|Thalidomide|thalidomide
474457|NCT00083551|DTPACE|dtpace
474458|NCT00083551|Transplant|transplant
474459|NCT00083551|VAD|vad
474460|NCT00083551|DCEP|dcep
474461|NCT00083551|CAD|cad
474462|NCT00083551|Consolidation|consolidation
474463|NCT00083551|Melphalan|melphalan
474464|NCT00083564|Multiple myeloma|multiple myeloma
474465|NCT00083564|Primary refractory multiple myeloma|primary refractory multiple myeloma
474466|NCT00083564|STR|str
474467|NCT00083564|Skeletal Targeted Radiotherapy|skeletal targeted radiotherapy
474468|NCT00083564|Holmium-166|holmium-166
474469|NCT00083564|166-Ho-DOTMP|166-ho-dotmp
474470|NCT00083577|Multiple Myeloma|multiple myeloma
474471|NCT00083577|Thalidomide|thalidomide
474472|NCT00083577|Anti-Angiogenesis|anti-angiogenesis
474473|NCT00083590|Alzheimer disease|alzheimer disease
474474|NCT00083590|Cholinesterase inhibitor|cholinesterase inhibitor
474475|NCT00083603|HIV Seronegativity|hiv seronegativity
474476|NCT00083603|HIV Preventive Vaccine|hiv preventive vaccine
474477|NCT00083603|Vaccinia vector|vaccinia vector
474478|NCT00083603|Pox vector|pox vector
474479|NCT00083616|EGFr|egfr
474480|NCT00083616|Clinical Trial|clinical trial
474481|NCT00083616|Panitumumab|panitumumab
474482|NCT00083616|ABX-EGF|abx-egf
474483|NCT00083616|Immunex|immunex
474484|NCT00083616|Metastatic Cancer|metastatic cancer
474485|NCT00083616|Vectibix|vectibix
474486|NCT00083616|Abgenix|abgenix
474487|NCT00083616|Amgen|amgen
474488|NCT00083629|[18F]FECNT|[18f]fecnt
474489|NCT00083629|Biodistribution|biodistribution
474490|NCT00083629|Dosimetry|dosimetry
474491|NCT00083629|Dopamine Transporter|dopamine transporter
474492|NCT00083629|MIRD|mird
474493|NCT00083629|Kinetic Analysis|kinetic analysis
474494|NCT00083629|Compartment Analysis|compartment analysis
474495|NCT00083629|Healthy Volunteer|healthy volunteer
474497|NCT00083642|Brain Plasticity|brain plasticity
474498|NCT00083642|Functional MRI|functional mri
474499|NCT00083642|Finger Movement|finger movement
474500|NCT00083642|Rehabilitation|rehabilitation
474501|NCT00083642|Improvement|improvement
474502|NCT00083642|Stroke|stroke
474503|NCT00083642|Motor Recovery|motor recovery
474504|NCT00083642|Observation|observation
474505|NCT00083642|fMRI|fmri
474506|NCT00083642|Healthy Volunteer|healthy volunteer
474507|NCT00083642|HV|hv
474508|NCT00083668|Schizophrenia|schizophrenia
474509|NCT00083668|Paliperidone|paliperidone
474510|NCT00083668|Olanzapine|olanzapine
474511|NCT00083668|PANSS|panss
474512|NCT00083668|Extended release|extended release
474513|NCT00083668|Atypical neuroleptic|atypical neuroleptic
474514|NCT00083681|Multiple Myeloma|multiple myeloma
474515|NCT00083681|Thalidomide|thalidomide
474516|NCT00083681|G-CSF|g-csf
474517|NCT00083681|Cisplatin|cisplatin
474518|NCT00083681|Etoposide|etoposide
474519|NCT00083681|Dexamethasone|dexamethasone
474520|NCT00083681|Cytoxan|cytoxan
474521|NCT00083681|DCEP|dcep
474522|NCT00083681|Relapse|relapse
474523|NCT00083694|Leukemia|leukemia
474524|NCT00083694|Thalidomide|thalidomide
474525|NCT00083694|relapsed|relapsed
474526|NCT00083707|Macroglobulinemia|macroglobulinemia
474528|NCT00083707|Thalidomide|thalidomide
474529|NCT00083720|EGFR-undetectable|egfr-undetectable
474530|NCT00083720|Metastatic Colorectal Cancer|metastatic colorectal cancer
474531|NCT00083733|Gene Expression|gene expression
474532|NCT00083733|Microarray|microarray
474533|NCT00083733|Stem Cell|stem cell
474534|NCT00083733|Proteomics|proteomics
474535|NCT00083733|Metastases|metastases
474536|NCT00083733|Breast Tissue|breast tissue
474537|NCT00083733|Normal Breast Tissue|normal breast tissue
474538|NCT00083733|Breast Cancer|breast cancer
474539|NCT00083772|Heart failure|heart failure
474540|NCT00083772|Diastolic heart failure|diastolic heart failure
474541|NCT00083772|Congestive heart failure|congestive heart failure
474542|NCT00083772|Nesiritide|nesiritide
474543|NCT00083772|Natrecor|natrecor
474544|NCT00083772|Left ventricular (LV) diastolic function|left ventricular (lv) diastolic function
474545|NCT00083772|Fatigue|fatigue
474546|NCT00083772|Shortness of breath|shortness of breath
474547|NCT00083772|Edema|edema
474548|NCT00083772|Heart disease|heart disease
474549|NCT00083876|Multiple Myeloma|multiple myeloma
474550|NCT00083876|D.T. PACE|d.t. pace
474551|NCT00083876|Melphalan|melphalan
474552|NCT00083876|Transplant|transplant
474554|NCT00083876|Dexamethasone|dexamethasone
474555|NCT00083876|Cisplatin|cisplatin
474556|NCT00083876|Cyclophosphamide|cyclophosphamide
474557|NCT00083876|Doxorubicin|doxorubicin
474558|NCT00083876|Etoposide|etoposide
474559|NCT00083876|Filgrastim|filgrastim
474560|NCT00083876|Interferon-alpha 2b|interferon-alpha 2b
474561|NCT00083876|Sargramostim|sargramostim
474562|NCT00083902|Myeloma|myeloma
474563|NCT00083902|Thalidomide|thalidomide
474564|NCT00083902|Dexamethasone|dexamethasone
474565|NCT00083915|Multiple Myeloma|multiple myeloma
474566|NCT00083915|DTPACE|dtpace
474567|NCT00083915|Tandem Transplant|tandem transplant
474568|NCT00083915|Cisplatin|cisplatin
474569|NCT00083915|Cyclophosphamide|cyclophosphamide
474570|NCT00083915|Dexamethasone|dexamethasone
474571|NCT00083915|Doxorubicin|doxorubicin
474572|NCT00083915|Etoposide|etoposide
474573|NCT00083915|Sargramostim|sargramostim
474574|NCT00083915|Thalidomide|thalidomide
474575|NCT00083915|Melphalan|melphalan
474576|NCT00083928|Asymptomatic|asymptomatic
474577|NCT00083928|subcutaneous|subcutaneous
474578|NCT00083928|CA125 Progression|ca125 progression
474579|NCT00083928|Angstrom|angstrom
474580|NCT00083928|Ångstrom|ångstrom
474581|NCT00083928|ovarian cancer|ovarian cancer
474582|NCT00083941|Renal Cell Cancer|renal cell cancer
474583|NCT00083941|Requiring IL-2 treatment|requiring il-2 treatment
474584|NCT00083941|Stage IV Renal Cell Cancer|stage iv renal cell cancer
474585|NCT00083954|Bipolar I Disorder|bipolar i disorder
474586|NCT00083967|rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
474587|NCT00083967|detached retina|detached retina
474588|NCT00083967|retinal tear|retinal tear
474589|NCT00083967|retinal break|retinal break
474590|NCT00083980|Kava|kava
474591|NCT00083980|Complementary Therapies|complementary therapies
474592|NCT00083980|Medicine, Herbal|medicine, herbal
474593|NCT00083993|Breast Cancer|breast cancer
474594|NCT00084019|Treatment Experienced|treatment experienced
474595|NCT00084032|Acute Infection|acute infection
474596|NCT00084032|Treatment Interruption|treatment interruption
474597|NCT00084032|Treatment Naive|treatment naive
474598|NCT00084032|Primary HIV Infection|primary hiv infection
474600|NCT00084045|HIV Seronegativity|hiv seronegativity
474601|NCT00084045|Treatment Naive|treatment naive
474602|NCT00084045|Pediatric HIV|pediatric hiv
474603|NCT00084045|Perinatal Transmission|perinatal transmission
474604|NCT00084058|Dose Intensification|dose intensification
474605|NCT00084058|Pharmacokinetic Sampling|pharmacokinetic sampling
474606|NCT00084058|Treatment Experienced|treatment experienced
474607|NCT00084058|Child|child
474608|NCT00084084|Lysosomes|lysosomes
474609|NCT00084084|Storage|storage
474610|NCT00084084|Glycolipid|glycolipid
474611|NCT00084084|Fabry disease|fabry disease
474612|NCT00084084|Stroke|stroke
474613|NCT00084084|Children|children
474614|NCT00084084|Pediatrics|pediatrics
474615|NCT00084097|Allergy|allergy
474616|NCT00084097|IgE|ige
474617|NCT00084097|Eosinophil|eosinophil
474618|NCT00084097|Monoclonal Antibody|monoclonal antibody
474619|NCT00084097|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
474620|NCT00084097|EG|eg
474621|NCT00084110|Aged|aged
474622|NCT00084110|Mexican Americans|mexican americans
474623|NCT00084110|Complementary Therapies|complementary therapies
474624|NCT00084123|Relaxation Techniques|relaxation techniques
474625|NCT00084123|Radiation|radiation
474626|NCT00084123|Drug Therapy|drug therapy
474627|NCT00084123|Healing Touch|healing touch
474628|NCT00084136|Treatment Naive|treatment naive
474629|NCT00084136|Adherence|adherence
474630|NCT00084136|Drug Resistance|drug resistance
474631|NCT00084136|Treatment Failure|treatment failure
474632|NCT00084149|Acute Infection|acute infection
474633|NCT00084149|Treatment Naive|treatment naive
474634|NCT00084162|PET|pet
474635|NCT00084162|Heart Rate Variability|heart rate variability
474636|NCT00084162|N-Back Task|n-back task
474637|NCT00084162|Isometric Handgrip|isometric handgrip
474638|NCT00084162|MRI|mri
474639|NCT00084162|Depression|depression
474640|NCT00084162|MDD|mdd
474641|NCT00084162|Heart|heart
474642|NCT00084175|behavioral intervention|behavioral intervention
474643|NCT00084188|behavioral intervention|behavioral intervention
474644|NCT00084201|Vaccinium macrocarpon|vaccinium macrocarpon
474645|NCT00084214|metastatic|metastatic
474646|NCT00084214|increased antitumor effect|increased antitumor effect
474647|NCT00084253|HIV|hiv
474648|NCT00084253|Treatment Naive|treatment naive
474649|NCT00084266|Staphylococcal pneumonia|staphylococcal pneumonia
474650|NCT00084266|Methicillin-resistant staphylococcal pneumonia|methicillin-resistant staphylococcal pneumonia
474651|NCT00084266|healthcare-associated pneumonia|healthcare-associated pneumonia
474652|NCT00084279|Chronic Hepatitis C|chronic hepatitis c
474653|NCT00084279|Liver|liver
474654|NCT00084279|Pegylated|pegylated
474655|NCT00084279|Interferon|interferon
474656|NCT00084279|Alpha|alpha
474657|NCT00084279|Gamma|gamma
474658|NCT00084279|Ribavirin|ribavirin
474659|NCT00084279|Combination|combination
474660|NCT00084279|Nonresponder|nonresponder
474036|NCT00082654|recurrent neuroblastoma|recurrent neuroblastoma
474666|NCT00084292|Treatment|treatment
474667|NCT00084292|Outcome|outcome
474668|NCT00084292|Childhood Stroke|childhood stroke
474669|NCT00084292|Pediatric Stroke|pediatric stroke
474670|NCT00084292|Ischemic Stroke|ischemic stroke
474671|NCT00084292|Spastic Hemiplegia|spastic hemiplegia
474672|NCT00084292|Hemiplegic cerebral palsy|hemiplegic cerebral palsy
474673|NCT00084305|Bronchoscopy|bronchoscopy
474674|NCT00084305|Pulmonary Fibrosis|pulmonary fibrosis
474675|NCT00084305|Lung Biopsy (Clinically-Indicated)|lung biopsy (clinically-indicated)
474676|NCT00084305|Hereditary Pulmonary Fibrosis|hereditary pulmonary fibrosis
474677|NCT00084305|Healthy Volunteer|healthy volunteer
474678|NCT00084305|HV|hv
474679|NCT00084318|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
474680|NCT00084318|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
474681|NCT00084318|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
474682|NCT00084318|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
474683|NCT00084318|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
474684|NCT00084318|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
474685|NCT00084318|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
474686|NCT00084318|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
474687|NCT00084344|breast cancer|breast cancer
474688|NCT00084370|ovarian epithelial cancer|ovarian epithelial cancer
474689|NCT00084370|BRCA1 mutation carrier|brca1 mutation carrier
474690|NCT00084370|BRCA2 mutation carrier|brca2 mutation carrier
474691|NCT00084383|stage I pancreatic cancer|stage i pancreatic cancer
474692|NCT00084383|stage II pancreatic cancer|stage ii pancreatic cancer
474693|NCT00084383|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
474694|NCT00084396|stage II breast cancer|stage ii breast cancer
474695|NCT00084396|stage IIIA breast cancer|stage iiia breast cancer
474696|NCT00084396|stage IIIB breast cancer|stage iiib breast cancer
474697|NCT00084409|non-small cell lung cancer|non-small cell lung cancer
474698|NCT00084409|squamous lung dysplasia|squamous lung dysplasia
474699|NCT00084422|recurrent neuroblastoma|recurrent neuroblastoma
474700|NCT00084435|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
474701|NCT00084435|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
474702|NCT00084435|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
474703|NCT00084435|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
474704|NCT00084435|stage III salivary gland cancer|stage iii salivary gland cancer
474705|NCT00084435|stage IV salivary gland cancer|stage iv salivary gland cancer
474706|NCT00084435|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
474707|NCT00084435|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
474708|NCT00084435|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
474709|NCT00084435|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
474710|NCT00084435|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
474711|NCT00084435|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
474712|NCT00084435|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
474713|NCT00084448|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
474714|NCT00084448|primary peritoneal cavity cancer|primary peritoneal cavity cancer
474715|NCT00077870|Moderate to severe rheumatoid arthritis|moderate to severe rheumatoid arthritis
474717|NCT00077896|Transcranial Stimulation|transcranial stimulation
474718|NCT00077896|Frontal Lobe|frontal lobe
474719|NCT00077896|Pick's Disease|pick's disease
474720|NCT00077896|Cognitive Impairment|cognitive impairment
474721|NCT00077896|Dementia|dementia
474722|NCT00077896|Frontotemporal Dementia|frontotemporal dementia
474723|NCT00077896|FTD|ftd
474724|NCT00077909|Proteomics|proteomics
474725|NCT00077909|Infection|infection
474726|NCT00077909|Pneumonia|pneumonia
474727|NCT00077909|Mass Spectrometry|mass spectrometry
474728|NCT00077909|BAL|bal
474729|NCT00077909|Lung|lung
474730|NCT00077909|Pulmonary Disease|pulmonary disease
474731|NCT00077909|Lung Infiltrates|lung infiltrates
474732|NCT00077922|LMB-2|lmb-2
474733|NCT00077922|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
474734|NCT00077922|CLL|cll
474735|NCT00077922|Immunotoxin|immunotoxin
474736|NCT00077922|Oncology|oncology
474737|NCT00077922|Lymphocytes|lymphocytes
474738|NCT00077922|Hematological Disease|hematological disease
474739|NCT00077922|Monoclonal Antibody|monoclonal antibody
474740|NCT00077922|Neutralizing Antibodies|neutralizing antibodies
474741|NCT00077948|positive inotrope|positive inotrope
474742|NCT00077948|enoximone|enoximone
474743|NCT00077948|beta-blocker|beta-blocker
474744|NCT00077948|intolerant|intolerant
474745|NCT00077961|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
474746|NCT00077961|NHL|nhl
474752|NCT00078013|acute myocardial infarction with ST segment elevation|acute myocardial infarction with st segment elevation
474753|NCT00078026|Apomine|apomine
474754|NCT00078026|Osteoporosis|osteoporosis
474755|NCT00078026|Bone Mass|bone mass
474756|NCT00078026|Postmenopausal|postmenopausal
474757|NCT00078039|Schizophrenia, paliperidone|schizophrenia, paliperidone
474758|NCT00078065|multiple myeloma|multiple myeloma
474759|NCT00078065|fludarabine|fludarabine
474760|NCT00078065|Xcellerated T Cells|xcellerated t cells
474761|NCT00078078|Vitamin B12|vitamin b12
474762|NCT00078078|Methylmalonic Acidemia|methylmalonic acidemia
474763|NCT00078078|Hyperhomocysteinemia|hyperhomocysteinemia
474764|NCT00078078|MMA|mma
474765|NCT00078078|Metabolic Disease|metabolic disease
474766|NCT00078091|Obesity|obesity
474767|NCT00078091|Retinopathy|retinopathy
474768|NCT00078091|Dyslipidemia|dyslipidemia
474769|NCT00078091|Insulin Resistance|insulin resistance
474770|NCT00078091|Hypogonadism|hypogonadism
474771|NCT00078091|Polydactyly|polydactyly
474772|NCT00078091|Bardet-Biedl Syndrome|bardet-biedl syndrome
474773|NCT00078091|BBS|bbs
474774|NCT00078104|Prostanoid|prostanoid
474775|NCT00078104|Cyclooxygenase (COX)|cyclooxygenase (cox)
474776|NCT00078104|Selective Cox Inhibitor|selective cox inhibitor
474777|NCT00078104|Acute Peripheral Inflammation|acute peripheral inflammation
474778|NCT00078104|Neuronal Expression of COX|neuronal expression of cox
474779|NCT00078104|Pain|pain
474780|NCT00078104|Coxibs|coxibs
474781|NCT00078104|Wisdom Teeth|wisdom teeth
474782|NCT00078104|Third Molar Extraction|third molar extraction
474783|NCT00078104|Third Molar Impaction|third molar impaction
474784|NCT00078117|opiate dependence|opiate dependence
474785|NCT00078130|opioid dependence|opioid dependence
474786|NCT00078130|behavioral intervention|behavioral intervention
474787|NCT00078143|behavioral intervention|behavioral intervention
474788|NCT00078156|behavioral intervention|behavioral intervention
474789|NCT00078169|behavioral intervention|behavioral intervention
474790|NCT00084513|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
474791|NCT00084526|recurrent prostate cancer|recurrent prostate cancer
474792|NCT00084526|stage I prostate cancer|stage i prostate cancer
474793|NCT00084526|stage II prostate cancer|stage ii prostate cancer
474794|NCT00084526|stage III prostate cancer|stage iii prostate cancer
474795|NCT00084526|stage IV prostate cancer|stage iv prostate cancer
474796|NCT00084539|stage I breast cancer|stage i breast cancer
474797|NCT00084539|stage II breast cancer|stage ii breast cancer
474798|NCT00084539|breast cancer in situ|breast cancer in situ
474799|NCT00084552|sexual dysfunction|sexual dysfunction
474800|NCT00084552|sexuality and reproductive issues|sexuality and reproductive issues
474801|NCT00084552|adenocarcinoma of the prostate|adenocarcinoma of the prostate
474802|NCT00084552|stage IIB prostate cancer|stage iib prostate cancer
474803|NCT00084552|stage IIA prostate cancer|stage iia prostate cancer
474804|NCT00084565|stage IV prostate cancer|stage iv prostate cancer
474805|NCT00084565|adenocarcinoma of the prostate|adenocarcinoma of the prostate
474806|NCT00084578|stage 0 bladder cancer|stage 0 bladder cancer
474807|NCT00084578|stage I bladder cancer|stage i bladder cancer
474808|NCT00084578|stage II bladder cancer|stage ii bladder cancer
474809|NCT00084578|stage III bladder cancer|stage iii bladder cancer
474810|NCT00084578|stage IV bladder cancer|stage iv bladder cancer
474811|NCT00084578|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
474812|NCT00084591|stage II rectal cancer|stage ii rectal cancer
474813|NCT00084591|stage III rectal cancer|stage iii rectal cancer
474814|NCT00084591|adenocarcinoma of the rectum|adenocarcinoma of the rectum
474815|NCT00084656|stage III melanoma|stage iii melanoma
474816|NCT00084656|stage IV melanoma|stage iv melanoma
474817|NCT00084656|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
474818|NCT00084656|extraocular extension melanoma|extraocular extension melanoma
474820|NCT00084656|recurrent melanoma|recurrent melanoma
474821|NCT00084656|recurrent intraocular melanoma|recurrent intraocular melanoma
474822|NCT00084656|metastatic intraocular melanoma|metastatic intraocular melanoma
474823|NCT00084669|hot flashes|hot flashes
474824|NCT00084669|sleep disorders|sleep disorders
474825|NCT00084669|ductal breast carcinoma in situ|ductal breast carcinoma in situ
474826|NCT00084669|breast cancer in situ|breast cancer in situ
474827|NCT00084669|lobular breast carcinoma in situ|lobular breast carcinoma in situ
474828|NCT00084669|lobular breast carcinoma|lobular breast carcinoma
474829|NCT00084669|recurrent breast cancer|recurrent breast cancer
474830|NCT00084669|stage I breast cancer|stage i breast cancer
474831|NCT00084669|stage II breast cancer|stage ii breast cancer
474832|NCT00084669|stage IIIA breast cancer|stage iiia breast cancer
474833|NCT00084669|stage IIIB breast cancer|stage iiib breast cancer
474198|NCT00082927|pain|pain
474834|NCT00084669|stage IIIC breast cancer|stage iiic breast cancer
474835|NCT00084669|stage IV breast cancer|stage iv breast cancer
474836|NCT00084695|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
474837|NCT00084695|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
474838|NCT00084695|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
474977|NCT00085579|stage III melanoma|stage iii melanoma
474839|NCT00084695|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
474840|NCT00084695|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
474841|NCT00084695|disseminated neuroblastoma|disseminated neuroblastoma
474842|NCT00084695|regional neuroblastoma|regional neuroblastoma
474843|NCT00084695|recurrent neuroblastoma|recurrent neuroblastoma
474844|NCT00084695|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
474845|NCT00084695|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
474846|NCT00084695|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
474847|NCT00084695|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
474848|NCT00084695|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
474849|NCT00084695|childhood Burkitt lymphoma|childhood burkitt lymphoma
474850|NCT00084695|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
474851|NCT00084695|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
474852|NCT00084695|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
474853|NCT00084695|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
474854|NCT00084695|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
474855|NCT00084695|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
474856|NCT00084695|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
474857|NCT00084695|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
474858|NCT00084695|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
474859|NCT00084695|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
474860|NCT00084695|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
474861|NCT00084695|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
474862|NCT00084695|Fanconi anemia|fanconi anemia
474863|NCT00084695|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
474864|NCT00084695|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
474865|NCT00084695|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
474866|NCT00084695|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
474867|NCT00084695|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
474868|NCT00084695|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
474869|NCT00084695|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
474870|NCT00084695|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
474871|NCT00084708|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
474872|NCT00084721|diarrhea|diarrhea
474873|NCT00084721|recurrent colon cancer|recurrent colon cancer
474874|NCT00084721|stage IV colon cancer|stage iv colon cancer
474875|NCT00084721|recurrent rectal cancer|recurrent rectal cancer
474876|NCT00084721|stage IV rectal cancer|stage iv rectal cancer
474877|NCT00084721|stage III colon cancer|stage iii colon cancer
474878|NCT00084721|stage III rectal cancer|stage iii rectal cancer
474879|NCT00084734|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
474880|NCT00084747|stage II multiple myeloma|stage ii multiple myeloma
474881|NCT00084747|stage III multiple myeloma|stage iii multiple myeloma
474882|NCT00084773|recurrent rectal cancer|recurrent rectal cancer
474883|NCT00084773|stage II rectal cancer|stage ii rectal cancer
474884|NCT00084773|stage III rectal cancer|stage iii rectal cancer
474885|NCT00084773|adenocarcinoma of the rectum|adenocarcinoma of the rectum
474886|NCT00084786|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
474887|NCT00084799|recurrent small cell lung cancer|recurrent small cell lung cancer
474888|NCT00084812|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
474889|NCT00084825|adenocarcinoma of the prostate|adenocarcinoma of the prostate
474890|NCT00084825|recurrent prostate cancer|recurrent prostate cancer
474891|NCT00084825|stage IV prostate cancer|stage iv prostate cancer
474892|NCT00084825|bone metastases|bone metastases
474893|NCT00085202|untreated childhood medulloblastoma|untreated childhood medulloblastoma
474894|NCT00085202|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
474895|NCT00085202|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
474896|NCT00085202|untreated childhood pineoblastoma|untreated childhood pineoblastoma
474897|NCT00085228|adenocarcinoma of the prostate|adenocarcinoma of the prostate
474898|NCT00085228|recurrent prostate cancer|recurrent prostate cancer
474899|NCT00085228|stage IV prostate cancer|stage iv prostate cancer
474900|NCT00085306|recurrent melanoma|recurrent melanoma
474901|NCT00085306|stage IV melanoma|stage iv melanoma
474902|NCT00085306|iris melanoma|iris melanoma
474903|NCT00085306|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
474904|NCT00085306|extraocular extension melanoma|extraocular extension melanoma
474905|NCT00085306|recurrent intraocular melanoma|recurrent intraocular melanoma
474906|NCT00085332|recurrent endometrial carcinoma|recurrent endometrial carcinoma
474907|NCT00085332|stage III endometrial carcinoma|stage iii endometrial carcinoma
475065|NCT00085839|OSI-774|osi-774
474908|NCT00085332|stage IV endometrial carcinoma|stage iv endometrial carcinoma
474909|NCT00085384|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
474910|NCT00085384|peritoneal cavity cancer|peritoneal cavity cancer
474911|NCT00085384|fallopian tube cancer|fallopian tube cancer
474912|NCT00085397|recurrent melanoma|recurrent melanoma
474913|NCT00085397|stage III melanoma|stage iii melanoma
474914|NCT00085397|stage IV melanoma|stage iv melanoma
474915|NCT00085423|recurrent melanoma|recurrent melanoma
474916|NCT00085423|stage IV melanoma|stage iv melanoma
474917|NCT00085436|recurrent renal cell cancer|recurrent renal cell cancer
474918|NCT00085436|stage IV renal cell cancer|stage iv renal cell cancer
474919|NCT00085449|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
474920|NCT00085449|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
474921|NCT00085449|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
583845|NCT00512889|immunotherapy|immunotherapy
474922|NCT00085449|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
474923|NCT00085449|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
474924|NCT00085449|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
474925|NCT00085449|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
474926|NCT00085449|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
474927|NCT00085449|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
474928|NCT00085449|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
474929|NCT00085449|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
474930|NCT00085449|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
474931|NCT00085449|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
474932|NCT00085449|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
474933|NCT00085449|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
474934|NCT00085449|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
474935|NCT00085449|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
474936|NCT00085449|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
474937|NCT00085449|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
474938|NCT00085449|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
474939|NCT00085449|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
475117|NCT00085995|Spondyloarthropathy|spondyloarthropathy
474940|NCT00085449|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
474941|NCT00085449|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
474942|NCT00085449|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
474943|NCT00085449|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
474944|NCT00085449|refractory multiple myeloma|refractory multiple myeloma
474945|NCT00085449|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
474946|NCT00085449|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
474947|NCT00085449|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
474948|NCT00085449|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
474949|NCT00085449|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
474950|NCT00085449|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
474951|NCT00085449|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
474952|NCT00085462|recurrent melanoma|recurrent melanoma
474953|NCT00085462|stage IV melanoma|stage iv melanoma
474954|NCT00085475|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
474955|NCT00085475|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
474956|NCT00085475|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
474957|NCT00085475|adult fibrosarcoma|adult fibrosarcoma
474958|NCT00085475|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
474959|NCT00085488|recurrent melanoma|recurrent melanoma
474960|NCT00085488|stage III melanoma|stage iii melanoma
474961|NCT00085488|stage IV melanoma|stage iv melanoma
474962|NCT00085501|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
474963|NCT00085501|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
474964|NCT00085501|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
474965|NCT00085501|adenocarcinoma of the lung|adenocarcinoma of the lung
474966|NCT00085501|squamous cell lung cancer|squamous cell lung cancer
474967|NCT00085501|large cell lung cancer|large cell lung cancer
474968|NCT00085527|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
474969|NCT00085527|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
474970|NCT00085527|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
474971|NCT00085566|adult glioblastoma|adult glioblastoma
474972|NCT00085566|recurrent prostate cancer|recurrent prostate cancer
474973|NCT00085566|recurrent adult brain tumor|recurrent adult brain tumor
474974|NCT00085566|stage IV prostate cancer|stage iv prostate cancer
474975|NCT00085566|adult giant cell glioblastoma|adult giant cell glioblastoma
474976|NCT00085566|adult gliosarcoma|adult gliosarcoma
474978|NCT00085579|stage IV melanoma|stage iv melanoma
474979|NCT00085631|stage IA cervical cancer|stage ia cervical cancer
474980|NCT00085631|stage IB cervical cancer|stage ib cervical cancer
474981|NCT00085631|stage IIA cervical cancer|stage iia cervical cancer
474982|NCT00085631|stage IIB cervical cancer|stage iib cervical cancer
474983|NCT00085631|stage III cervical cancer|stage iii cervical cancer
474984|NCT00085631|stage IVA cervical cancer|stage iva cervical cancer
474985|NCT00085631|cervical adenocarcinoma|cervical adenocarcinoma
474986|NCT00085631|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
474987|NCT00085631|cervical squamous cell carcinoma|cervical squamous cell carcinoma
474988|NCT00085657|Direct Current Stimulation|direct current stimulation
474989|NCT00085657|Cortical Reorganization|cortical reorganization
474990|NCT00085657|Rehabilitation|rehabilitation
474991|NCT00085657|Acute Stroke|acute stroke
474993|NCT00085670|Tumor Necrosis Factor Alpha (TNF-Alpha)|tumor necrosis factor alpha (tnf-alpha)
474994|NCT00085670|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
474995|NCT00085670|Transforming Growth Factor Beta 1 (TGF-B1)|transforming growth factor beta 1 (tgf-b1)
474996|NCT00085670|Interleukin-10 (IL-10)|interleukin-10 (il-10)
474997|NCT00085670|Interleukin-1 Receptor Antagonist (IL-1 Ra)|interleukin-1 receptor antagonist (il-1 ra)
474998|NCT00085670|Vitamin D Receptor (VitD R)|vitamin d receptor (vitd r)
474999|NCT00085670|Interleukin-6 (IL-6)|interleukin-6 (il-6)
475000|NCT00085670|Bone Marrow Failure|bone marrow failure
475001|NCT00085670|Aplastic Anemia|aplastic anemia
475002|NCT00085670|Myelodysplastic Syndrome|myelodysplastic syndrome
475003|NCT00085670|MDS|mds
475004|NCT00085670|Pure Red Cell Aplasia|pure red cell aplasia
475005|NCT00085670|PRCA|prca
475006|NCT00085683|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
475007|NCT00085683|Lumbar Puncture|lumbar puncture
475008|NCT00085683|Healthy Control Subjects|healthy control subjects
475009|NCT00085683|Mesial Temporal Sclerosis|mesial temporal sclerosis
475010|NCT00085683|Neuroexcitotoxicity|neuroexcitotoxicity
475011|NCT00085683|Seizure Disorder|seizure disorder
475012|NCT00085683|Epilepsy|epilepsy
475013|NCT00085683|Healthy Volunteer|healthy volunteer
475015|NCT00085696|Lymphoma|lymphoma
475016|NCT00085696|Non-Hodgkin's|non-hodgkin's
475017|NCT00085696|NHL|nhl
475018|NCT00085696|B-Cell|b-cell
475019|NCT00085696|Indolent|indolent
475020|NCT00085709|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
475021|NCT00085709|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
475022|NCT00085709|adult acute basophilic leukemia|adult acute basophilic leukemia
475023|NCT00085709|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
475024|NCT00085709|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
475025|NCT00085709|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
475026|NCT00085709|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
475027|NCT00085709|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
475028|NCT00085709|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
475029|NCT00085709|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
475030|NCT00085709|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
475031|NCT00085709|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
475032|NCT00085709|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
475033|NCT00085709|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
475034|NCT00085709|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
475035|NCT00085722|Injection Therapy|injection therapy
475036|NCT00085748|schizophrenia|schizophrenia
475039|NCT00085761|Dermal assessment|dermal assessment
475040|NCT00085761|Pain measurement|pain measurement
475041|NCT00085761|Diary|diary
475042|NCT00085761|Neuropathy|neuropathy
475043|NCT00085761|Analgesics/*therapeutic use|analgesics/*therapeutic use
475044|NCT00085761|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
475045|NCT00085761|HIV Infections/*complications/*drug therapy|hiv infections/*complications/*drug therapy
475046|NCT00085761|Pain|pain
475047|NCT00085761|Complementary Therapies|complementary therapies
475048|NCT00085774|albuterol|albuterol
474368|NCT00083317|Competition|competition
475049|NCT00085774|aerosol inhaler|aerosol inhaler
475050|NCT00085774|metered-dose inhaler|metered-dose inhaler
475051|NCT00085774|breath-actuated inhaler|breath-actuated inhaler
475052|NCT00085774|exercise-induced bronchospasm|exercise-induced bronchospasm
475053|NCT00085813|Platinum-Refractory|platinum-refractory
475054|NCT00085813|Platinum-Relapsed|platinum-relapsed
475055|NCT00085813|Non-Small Cell Lung Cancer|non-small cell lung cancer
475056|NCT00085826|Lung Cancer|lung cancer
475057|NCT00085826|NSCLC|nsclc
475058|NCT00085826|Non-small Cell Lung Cancer|non-small cell lung cancer
475059|NCT00085839|Tarceva|tarceva
475060|NCT00085839|NSCLC|nsclc
475061|NCT00085839|EGFR|egfr
475062|NCT00085839|ECOG Performance Status 2|ecog performance status 2
475063|NCT00085839|erlotinib|erlotinib
475064|NCT00085839|Non-Small Cell Lung Cancer|non-small cell lung cancer
475067|NCT00085852|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
475068|NCT00085852|lung volume reduction|lung volume reduction
475069|NCT00085852|bronchoscopic|bronchoscopic
475070|NCT00085852|bronchoscopy|bronchoscopy
475071|NCT00085852|bronchoscope|bronchoscope
475072|NCT00085865|5 HT|5 ht
475073|NCT00085865|Neuroreceptors|neuroreceptors
475074|NCT00085865|Radiotracer|radiotracer
475075|NCT00085865|Neuroimaging|neuroimaging
475076|NCT00085865|Serotonin Transporter|serotonin transporter
475077|NCT00085865|Alcoholism|alcoholism
475079|NCT00085865|Healthy Volunteer|healthy volunteer
475080|NCT00085865|HV|hv
475081|NCT00085878|IL-18|il-18
475082|NCT00085878|subcutaneous|subcutaneous
475083|NCT00085878|pharmacokinetics|pharmacokinetics
475084|NCT00085878|Phase 1|phase 1
475085|NCT00085891|Schizophrenia|schizophrenia
475086|NCT00085891|Schizophrenic disorder|schizophrenic disorder
475087|NCT00085904|Advanced cancer|advanced cancer
475088|NCT00085904|IL-18|il-18
475089|NCT00085904|repeat dosing|repeat dosing
475090|NCT00085904|Phase 1|phase 1
475091|NCT00085904|pharmacokinetics|pharmacokinetics
475092|NCT00085904|oncology|oncology
475093|NCT00085917|Pegasys|pegasys
475094|NCT00085917|Ribavirin|ribavirin
475095|NCT00085917|Early Virological Response|early virological response
475096|NCT00085917|Hepatitis C|hepatitis c
475097|NCT00085917|HIV|hiv
475098|NCT00085930|Neuroblastoma|neuroblastoma
475099|NCT00085943|ritonavir|ritonavir
475100|NCT00085943|abacavir|abacavir
475101|NCT00085943|HIV|hiv
475102|NCT00085943|lopinavir|lopinavir
475103|NCT00085943|lamivudine|lamivudine
475104|NCT00085943|fosamprenavir|fosamprenavir
475105|NCT00085943|Epzicom|epzicom
475106|NCT00085969|diabetes|diabetes
475107|NCT00085969|exenatide|exenatide
475108|NCT00085969|Amylin|amylin
475109|NCT00085969|Lilly|lilly
475110|NCT00085982|Rabson Mendenhall|rabson mendenhall
475111|NCT00085982|Type B Insulin Resistance|type b insulin resistance
475112|NCT00085982|Type A Insulin Resistance|type a insulin resistance
475113|NCT00085982|Diabetes|diabetes
475114|NCT00085995|Syndesmophyte|syndesmophyte
475115|NCT00085995|Ankylosing Spondylitis|ankylosing spondylitis
475116|NCT00085995|AS|as
475118|NCT00085995|Spondyloarthritis|spondyloarthritis
475119|NCT00086021|Headache|headache
475120|NCT00086021|Acupuncture|acupuncture
475121|NCT00086034|Lymphoma|lymphoma
475122|NCT00086034|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
475123|NCT00086034|Indolent lymphoma|indolent lymphoma
475124|NCT00086034|Relapsed lymphoma|relapsed lymphoma
475125|NCT00086034|Refractory lymphoma|refractory lymphoma
475126|NCT00086034|Motexafin gadolinium|motexafin gadolinium
475127|NCT00086047|Juvenile Fibromyalgia Syndrome|juvenile fibromyalgia syndrome
475128|NCT00086047|JPFS|jpfs
475129|NCT00086047|Fibromyalgia|fibromyalgia
475130|NCT00086047|Chronic Pain|chronic pain
475131|NCT00086047|Pediatric Pain|pediatric pain
475132|NCT00086047|Juvenile Fibromyalgia|juvenile fibromyalgia
475133|NCT00086060|Internal-External Control|internal-external control
475134|NCT00086060|Magnetic Resonance Imaging|magnetic resonance imaging
475136|NCT00086060|Exercise|exercise
475137|NCT00086060|Relaxation|relaxation
475138|NCT00086073|Parkinson disease|parkinson disease
475139|NCT00086073|Parkinson's disease|parkinson's disease
475140|NCT00086073|PD|pd
475141|NCT00086073|genetics|genetics
475142|NCT00086073|genes|genes
475143|NCT00086073|siblings|siblings
475144|NCT00086073|family|family
475145|NCT00086086|Symptomatic Congestive Heart Failure|symptomatic congestive heart failure
475146|NCT00086086|CHF|chf
475147|NCT00086086|Anaemia|anaemia
475148|NCT00086086|Anemia|anemia
475149|NCT00086112|Anxiety|anxiety
475150|NCT00086112|antipsychotic|antipsychotic
475151|NCT00086125|Relapsed or refractory hematologic malignancies|relapsed or refractory hematologic malignancies
475152|NCT00086138|Alzheimer's disease|alzheimer's disease
475153|NCT00086138|Depression|depression
475154|NCT00086164|edifoligide|edifoligide
475155|NCT00086164|E2F Decoy|e2f decoy
474496|NCT00083629|HV|hv
475156|NCT00086164|Chronic Renal failure|chronic renal failure
475157|NCT00086164|hemodialysis|hemodialysis
475158|NCT00086164|AV Graft|av graft
475159|NCT00086164|neointimal hyperplasia|neointimal hyperplasia
475160|NCT00086177|Pregnancy,|pregnancy,
475161|NCT00086177|prevention of preterm birth,|prevention of preterm birth,
475162|NCT00086177|prevention of preterm labor,|prevention of preterm labor,
475163|NCT00086190|Parkinson disease|parkinson disease
475164|NCT00086190|depression|depression
475165|NCT00086190|Parkinson's disease|parkinson's disease
475166|NCT00086190|paroxetine|paroxetine
475167|NCT00086190|venlafaxine|venlafaxine
475168|NCT00086190|antidepressant|antidepressant
475169|NCT00086216|Multiple myeloma|multiple myeloma
475170|NCT00086229|Complementary Therapies|complementary therapies
475171|NCT00086242|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
475172|NCT00086242|stage IA cervical cancer|stage ia cervical cancer
475173|NCT00086242|stage IB cervical cancer|stage ib cervical cancer
475174|NCT00086242|stage IIA cervical cancer|stage iia cervical cancer
475175|NCT00086242|stage IIB cervical cancer|stage iib cervical cancer
475176|NCT00086242|stage III cervical cancer|stage iii cervical cancer
475177|NCT00086255|cocaine dependence|cocaine dependence
475178|NCT00086268|lung cancer|lung cancer
475179|NCT00086268|ZPACT|zpact
475180|NCT00086268|US75|us75
475181|NCT00086268|Bone Metastases|bone metastases
475182|NCT00086281|Sleep-disordered breathing|sleep-disordered breathing
475183|NCT00086281|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
475184|NCT00086294|Non-Dopaminergic|non-dopaminergic
475185|NCT00086294|Dyskinesias|dyskinesias
475186|NCT00086294|Fluctuations|fluctuations
475187|NCT00086294|Inverse Agonist|inverse agonist
475188|NCT00086294|ACP-103|acp-103
475189|NCT00086294|Parkinson Disease|parkinson disease
475190|NCT00086294|PD|pd
475191|NCT00086307|Pramipexole|pramipexole
475192|NCT00086307|Escitalopran|escitalopran
475193|NCT00086307|Antidepressant|antidepressant
475194|NCT00086307|Dopaminergic Receptor Agonist|dopaminergic receptor agonist
475195|NCT00086307|Depression|depression
475196|NCT00086307|Major Depression|major depression
475197|NCT00086320|Schizophrenia|schizophrenia
475198|NCT00086320|paliperidone|paliperidone
475199|NCT00086320|Risperidone|risperidone
475200|NCT00086333|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
475201|NCT00086333|Taxotere|taxotere
475202|NCT00086333|docetaxel|docetaxel
475203|NCT00086333|taxanes|taxanes
475204|NCT00086346|Liver|liver
475205|NCT00086346|Transplant|transplant
475206|NCT00086359|Treatment Naive|treatment naive
475207|NCT00086359|Perinatal Transmission|perinatal transmission
475208|NCT00086359|Mother-to-Child Transmission|mother-to-child transmission
475209|NCT00086359|MTCT|mtct
475210|NCT00086359|Treatment Experienced|treatment experienced
475211|NCT00086372|Acute Infection|acute infection
475212|NCT00086372|Treatment Experienced|treatment experienced
475213|NCT00086372|Treatment Naive|treatment naive
475214|NCT00086385|Smoking cessation|smoking cessation
475215|NCT00086385|Tobacco|tobacco
475216|NCT00086411|light smokers, smoking cessation treatment programs|light smokers, smoking cessation treatment programs
475217|NCT00086463|STEP|step
475218|NCT00086463|PAH|pah
475219|NCT00086463|iloprost|iloprost
475221|NCT00086463|prostacyclin|prostacyclin
475222|NCT00086476|Gray Platelet Syndrome|gray platelet syndrome
475223|NCT00086476|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
475224|NCT00086476|Storage Pool Deficiency|storage pool deficiency
475225|NCT00086476|Organelle Formation|organelle formation
475226|NCT00086476|Megakaryocyte Development|megakaryocyte development
475227|NCT00086476|Megakaryocytes|megakaryocytes
475228|NCT00086476|Platelets|platelets
475229|NCT00086476|Dense Granules|dense granules
475230|NCT00086476|Alpha Granules|alpha granules
475231|NCT00086476|Lysosome-related Organelles|lysosome-related organelles
475232|NCT00086476|GPS|gps
475233|NCT00086476|HPS|hps
475234|NCT00086476|Griscelli Disease|griscelli disease
475235|NCT00086476|Chediak Higashi Syndrome|chediak higashi syndrome
475236|NCT00086476|Wiskott Aldrich Syndrome|wiskott aldrich syndrome
475237|NCT00086476|Platelet|platelet
475238|NCT00086476|Congenital Bleeding Disorders|congenital bleeding disorders
475240|NCT00086476|Vesicle|vesicle
475241|NCT00086489|metastatic melanoma|metastatic melanoma
475242|NCT00086489|multiple dose|multiple dose
475243|NCT00086515|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
475244|NCT00086528|Solid Tumors|solid tumors
475245|NCT00086541|Chronic Hepatitis C|chronic hepatitis c
475246|NCT00086541|Liver|liver
475247|NCT00086541|Pegylated|pegylated
475248|NCT00086541|Interferon|interferon
475249|NCT00086541|Alpha|alpha
475250|NCT00086541|Ribavirin|ribavirin
475251|NCT00086541|Combination|combination
475252|NCT00086541|Nonresponder|nonresponder
475253|NCT00086541|HCV|hcv
475254|NCT00086541|Infergen|infergen
475255|NCT00086541|SVR|svr
475256|NCT00086554|Surgery|surgery
475257|NCT00086554|Intestinal Resection|intestinal resection
475258|NCT00086554|Blood Sample|blood sample
475259|NCT00086567|Blood|blood
475260|NCT00086567|Testing|testing
475261|NCT00086567|Gynecologic|gynecologic
475262|NCT00086567|Urine|urine
475263|NCT00086567|CA125|ca125
475264|NCT00086567|Epithelial Ovarian Cancer|epithelial ovarian cancer
475265|NCT00086567|Peritoneal Cancer|peritoneal cancer
475266|NCT00086567|Fallopian Tube Cancer|fallopian tube cancer
475267|NCT00086593|adjunctive|adjunctive
475268|NCT00086593|atypical antipsychotics|atypical antipsychotics
475269|NCT00086593|add-on|add-on
475270|NCT00086593|Schizophrenia|schizophrenia
475271|NCT00086593|psychosis|psychosis
475272|NCT00086606|Peanut|peanut
475273|NCT00086619|Osteoporosis|osteoporosis
475274|NCT00086619|Parathyroid hormone|parathyroid hormone
475275|NCT00086619|Teriparatide|teriparatide
475276|NCT00086619|Bone formation|bone formation
475277|NCT00086619|Bone resorption|bone resorption
475278|NCT00086632|oregovomab|oregovomab
475279|NCT00086632|ovarex|ovarex
475280|NCT00086632|ovarian cancer|ovarian cancer
475281|NCT00086632|ovary|ovary
475282|NCT00086632|ovarian carcinoma|ovarian carcinoma
475283|NCT00086632|front-line|front-line
475284|NCT00086645|Autism|autism
475285|NCT00086645|Asperger Syndrome|asperger syndrome
475286|NCT00086645|Pervasive Developmental Disorder|pervasive developmental disorder
475287|NCT00086645|PDD|pdd
475288|NCT00086645|Rituals|rituals
475289|NCT00086645|Compulsions|compulsions
475290|NCT00086645|Stereotypy|stereotypy
475291|NCT00086645|Routines|routines
475292|NCT00086645|Repetitive behavior|repetitive behavior
475293|NCT00086645|SSRI|ssri
475294|NCT00086645|Serotonin|serotonin
475295|NCT00086658|Hypereosinophilic Syndrome Hypereosinophilia|hypereosinophilic syndrome hypereosinophilia
475296|NCT00086658|mepolizumab|mepolizumab
475297|NCT00086658|anti IL-5|anti il-5
475298|NCT00086684|Interstitial Cystitis|interstitial cystitis
475299|NCT00086684|Urinary Bladder Pain|urinary bladder pain
475300|NCT00086723|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
475301|NCT00086736|stage I prostate cancer|stage i prostate cancer
475302|NCT00086736|stage IIB prostate cancer|stage iib prostate cancer
475303|NCT00086736|stage IIA prostate cancer|stage iia prostate cancer
475304|NCT00086736|stage III prostate cancer|stage iii prostate cancer
475305|NCT00086749|breast cancer|breast cancer
475306|NCT00086749|stage I breast cancer|stage i breast cancer
475307|NCT00086749|stage II breast cancer|stage ii breast cancer
475308|NCT00086749|stage IIIA breast cancer|stage iiia breast cancer
475309|NCT00086749|stage IIIB breast cancer|stage iiib breast cancer
475310|NCT00086749|stage IIIC breast cancer|stage iiic breast cancer
475311|NCT00086762|nausea and vomiting|nausea and vomiting
475312|NCT00086762|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
475313|NCT00086762|mindfulness relaxation|mindfulness relaxation
475314|NCT00086775|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
475315|NCT00086775|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
475316|NCT00086801|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
475317|NCT00086801|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
475318|NCT00086866|stage III melanoma|stage iii melanoma
475319|NCT00086866|stage IV melanoma|stage iv melanoma
475320|NCT00086866|recurrent melanoma|recurrent melanoma
484816|NCT00121602|Nephrology|nephrology
475321|NCT00086879|adult glioblastoma|adult glioblastoma
475322|NCT00086879|recurrent adult brain tumor|recurrent adult brain tumor
475323|NCT00086879|adult giant cell glioblastoma|adult giant cell glioblastoma
475324|NCT00086879|adult gliosarcoma|adult gliosarcoma
475325|NCT00086892|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
475326|NCT00086892|primary peritoneal cavity cancer|primary peritoneal cavity cancer
475327|NCT00086931|adenocarcinoma of the rectum|adenocarcinoma of the rectum
475328|NCT00086931|stage III rectal cancer|stage iii rectal cancer
475329|NCT00086931|stage II rectal cancer|stage ii rectal cancer
475330|NCT00086957|stage IV breast cancer|stage iv breast cancer
475331|NCT00086957|male breast cancer|male breast cancer
475332|NCT00086957|recurrent breast cancer|recurrent breast cancer
475333|NCT00086996|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
475334|NCT00086996|stage II esophageal cancer|stage ii esophageal cancer
475335|NCT00086996|stage III esophageal cancer|stage iii esophageal cancer
475336|NCT00087009|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
475337|NCT00087009|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
475338|NCT00087009|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
475339|NCT00087009|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
475340|NCT00087009|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
475341|NCT00087009|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
475342|NCT00087009|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
475343|NCT00087009|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
475344|NCT00087022|clear cell renal cell carcinoma|clear cell renal cell carcinoma
475345|NCT00087022|stage I renal cell cancer|stage i renal cell cancer
475346|NCT00087022|stage II renal cell cancer|stage ii renal cell cancer
475347|NCT00087022|stage III renal cell cancer|stage iii renal cell cancer
475348|NCT00087022|stage IV renal cell cancer|stage iv renal cell cancer
475349|NCT00087035|adenocarcinoma of the prostate|adenocarcinoma of the prostate
475350|NCT00087035|recurrent prostate cancer|recurrent prostate cancer
475351|NCT00087048|extensive stage small cell lung cancer|extensive stage small cell lung cancer
475352|NCT00087048|recurrent small cell lung cancer|recurrent small cell lung cancer
475353|NCT00087061|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
475354|NCT00087061|recurrent adult brain tumor|recurrent adult brain tumor
475355|NCT00087061|adult glioblastoma|adult glioblastoma
475356|NCT00087061|adult anaplastic astrocytoma|adult anaplastic astrocytoma
475357|NCT00087061|adult giant cell glioblastoma|adult giant cell glioblastoma
475358|NCT00087061|adult gliosarcoma|adult gliosarcoma
475359|NCT00087087|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
475360|NCT00087087|primary peritoneal cavity cancer|primary peritoneal cavity cancer
475361|NCT00087100|recurrent endometrial carcinoma|recurrent endometrial carcinoma
475362|NCT00087100|endometrial adenocarcinoma|endometrial adenocarcinoma
475363|NCT00087100|stage III endometrial carcinoma|stage iii endometrial carcinoma
475364|NCT00087100|stage IV endometrial carcinoma|stage iv endometrial carcinoma
475365|NCT00087113|cervical squamous cell carcinoma|cervical squamous cell carcinoma
475366|NCT00087113|recurrent cervical cancer|recurrent cervical cancer
475367|NCT00087113|stage III cervical cancer|stage iii cervical cancer
475368|NCT00087113|stage IVA cervical cancer|stage iva cervical cancer
475369|NCT00087113|stage IVB cervical cancer|stage ivb cervical cancer
475370|NCT00087126|recurrent cervical cancer|recurrent cervical cancer
475371|NCT00087126|cervical squamous cell carcinoma|cervical squamous cell carcinoma
475372|NCT00087152|stage IV breast cancer|stage iv breast cancer
475373|NCT00087152|recurrent breast cancer|recurrent breast cancer
475374|NCT00087165|adenocarcinoma of the prostate|adenocarcinoma of the prostate
475375|NCT00087165|recurrent prostate cancer|recurrent prostate cancer
475376|NCT00087178|stage I breast cancer|stage i breast cancer
475377|NCT00087178|stage II breast cancer|stage ii breast cancer
475378|NCT00087256|stage I colon cancer|stage i colon cancer
475379|NCT00087256|adenocarcinoma of the colon|adenocarcinoma of the colon
475380|NCT00087282|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
475381|NCT00087282|advanced adult primary liver cancer|advanced adult primary liver cancer
475382|NCT00087282|recurrent adult primary liver cancer|recurrent adult primary liver cancer
475383|NCT00087295|recurrent bladder cancer|recurrent bladder cancer
475384|NCT00087295|stage IV bladder cancer|stage iv bladder cancer
475385|NCT00087295|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
475386|NCT00087295|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
475387|NCT00087295|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
475388|NCT00087295|anterior urethral cancer|anterior urethral cancer
475389|NCT00087295|posterior urethral cancer|posterior urethral cancer
475390|NCT00087295|recurrent urethral cancer|recurrent urethral cancer
475391|NCT00087295|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
475392|NCT00087334|recurrent colon cancer|recurrent colon cancer
475393|NCT00087334|stage IV colon cancer|stage iv colon cancer
475394|NCT00087334|recurrent rectal cancer|recurrent rectal cancer
475395|NCT00087334|stage IV rectal cancer|stage iv rectal cancer
475396|NCT00087347|recurrent prostate cancer|recurrent prostate cancer
475397|NCT00087347|stage I prostate cancer|stage i prostate cancer
475398|NCT00087347|stage IIB prostate cancer|stage iib prostate cancer
475399|NCT00087347|stage IIA prostate cancer|stage iia prostate cancer
475400|NCT00087347|stage III prostate cancer|stage iii prostate cancer
475401|NCT00087347|stage IV prostate cancer|stage iv prostate cancer
475402|NCT00087347|stage I breast cancer|stage i breast cancer
475403|NCT00087347|stage II breast cancer|stage ii breast cancer
475404|NCT00087347|stage IIIA breast cancer|stage iiia breast cancer
475405|NCT00087347|stage IIIB breast cancer|stage iiib breast cancer
475406|NCT00087347|stage IIIC breast cancer|stage iiic breast cancer
475407|NCT00087347|stage IV breast cancer|stage iv breast cancer
475408|NCT00087347|recurrent breast cancer|recurrent breast cancer
475409|NCT00087360|colon cancer|colon cancer
475410|NCT00087360|rectal cancer|rectal cancer
475411|NCT00087399|breast cancer|breast cancer
475412|NCT00087399|hot flashes|hot flashes
475413|NCT00087425|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
475414|NCT00087425|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
475415|NCT00087425|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
475416|NCT00087425|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
475417|NCT00087425|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
475418|NCT00087425|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
475419|NCT00087425|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
475420|NCT00087425|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
475421|NCT00087425|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
475422|NCT00087425|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
475423|NCT00087425|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
475424|NCT00087425|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
475425|NCT00087425|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
475426|NCT00087425|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
475427|NCT00087425|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
475428|NCT00087425|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
475429|NCT00087425|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
475430|NCT00087425|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
475431|NCT00087425|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
475432|NCT00087425|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
475433|NCT00087425|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
475434|NCT00087425|Waldenström macroglobulinemia|waldenström macroglobulinemia
475435|NCT00087425|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
475436|NCT00087425|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
475437|NCT00087425|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
475438|NCT00087425|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
475439|NCT00087425|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
475440|NCT00087438|stage I non-small cell lung cancer|stage i non-small cell lung cancer
475441|NCT00087438|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
475442|NCT00087438|squamous cell lung cancer|squamous cell lung cancer
475443|NCT00087438|large cell lung cancer|large cell lung cancer
475444|NCT00087438|adenocarcinoma of the lung|adenocarcinoma of the lung
475445|NCT00087438|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
475446|NCT00087451|Progressive or recurrent malignant glioma|progressive or recurrent malignant glioma
475447|NCT00087464|Acute Infection|acute infection
475448|NCT00087464|Treatment Naive|treatment naive
475449|NCT00087464|Treatment Interruption|treatment interruption
475450|NCT00087477|Malignant Melanoma, Pivanex, Histone deacetylases inhibitor|malignant melanoma, pivanex, histone deacetylases inhibitor
475452|NCT00087529|Primary progressive MS|primary progressive ms
475453|NCT00087529|Primary progressive multiple sclerosis|primary progressive multiple sclerosis
475455|NCT00087529|MS|ms
475456|NCT00087542|Hallucinosis/Psychosis|hallucinosis/psychosis
475457|NCT00087555|Fibromyalgia|fibromyalgia
475458|NCT00087555|Pain|pain
475459|NCT00087659|ADT, BMD, US63, H014|adt, bmd, us63, h014
475460|NCT00087672|Myelofibrosis|myelofibrosis
475461|NCT00087672|Philadelphia negative myeloproliferative disorder|philadelphia negative myeloproliferative disorder
475462|NCT00087672|CC-5013|cc-5013
475463|NCT00087672|Lenalidomide|lenalidomide
475464|NCT00087672|Revlimid|revlimid
475465|NCT00087672|Antiangiogenesis|antiangiogenesis
475466|NCT00087685|Recurrent Endometrial Cancer|recurrent endometrial cancer
475467|NCT00087685|Endometrial|endometrial
475468|NCT00087685|Endometrioid|endometrioid
475469|NCT00087685|RAD001|rad001
475470|NCT00087685|Uterine Cancer|uterine cancer
475471|NCT00087763|AMD|amd
475472|NCT00087763|Age Related Macular Degeneration|age related macular degeneration
475473|NCT00087763|Exudative Subfoveal Age Related Macular Degeneration with Subfoveal Choroidal Neovascularization|exudative subfoveal age related macular degeneration with subfoveal choroidal neovascularization
475474|NCT00087789|Alzheimer's Disease|alzheimer's disease
475475|NCT00087789|Gene Transfer|gene transfer
475476|NCT00087815|cognitive/functional effects|cognitive/functional effects
475477|NCT00087815|radiation toxicity|radiation toxicity
475478|NCT00087815|adult brain tumor|adult brain tumor
475479|NCT00087815|childhood brain tumor|childhood brain tumor
475480|NCT00087828|Vaccinium macrocarpon|vaccinium macrocarpon
475481|NCT00087841|Hypnosis|hypnosis
475482|NCT00087841|Analgesia|analgesia
475483|NCT00087841|Embolization, Therapeutic|embolization, therapeutic
475484|NCT00087841|Chemoembolization, Therapeutic|chemoembolization, therapeutic
475485|NCT00087867|Multiple Myeloma|multiple myeloma
475486|NCT00087867|SCIO-469|scio-469
475487|NCT00087867|p38 MAP kinase|p38 map kinase
475489|NCT00087867|bone marrow|bone marrow
475490|NCT00087880|smoking cessation|smoking cessation
475491|NCT00081354|Esophageal Adenocarcinoma|esophageal adenocarcinoma
475492|NCT00081354|Dysplasia|dysplasia
475493|NCT00081354|Surveillance|surveillance
475494|NCT00081354|Proteomics|proteomics
475496|NCT00081354|Barrett Esophagus|barrett esophagus
475497|NCT00081354|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
475498|NCT00081354|GERD|gerd
475499|NCT00081354|Dysphagia|dysphagia
475500|NCT00081354|Swallowing Difficulty|swallowing difficulty
475501|NCT00081367|Minority Groups|minority groups
475502|NCT00081380|Bipolar I Disorder|bipolar i disorder
475503|NCT00081380|Manic Depressive Disorder|manic depressive disorder
475504|NCT00081380|Manic Depression, Mixed|manic depression, mixed
475505|NCT00081419|Bereitschaftspotential|bereitschaftspotential
475506|NCT00081419|Timing of Volition|timing of volition
475507|NCT00081419|Urge|urge
475508|NCT00081419|Conscious Will|conscious will
475509|NCT00081419|Libet's Clock|libet's clock
475510|NCT00081419|Tourette Syndrome|tourette syndrome
475511|NCT00081419|Tic Disorder|tic disorder
475512|NCT00081419|Healthy Volunteer|healthy volunteer
475513|NCT00081419|HV|hv
475514|NCT00081432|Seizures|seizures
475515|NCT00081432|Language|language
475516|NCT00081432|Memory|memory
475517|NCT00081432|Brain|brain
475518|NCT00081432|Imaging|imaging
475519|NCT00081432|Epilepsy|epilepsy
475520|NCT00081432|Temporal Lobe Epilepsy|temporal lobe epilepsy
475521|NCT00081458|Short Bowel Syndrome|short bowel syndrome
475522|NCT00081458|Parenteral Nutrition|parenteral nutrition
475523|NCT00081458|SBS|sbs
475524|NCT00081497|alpha-galactosidase A|alpha-galactosidase a
475525|NCT00081497|a-GAL|a-gal
475526|NCT00081497|r-haGAL|r-hagal
475527|NCT00081497|Fabry|fabry
475528|NCT00081497|GL-3|gl-3
475529|NCT00081497|Fabrazyme|fabrazyme
475530|NCT00081523|Hemoglobin|hemoglobin
475531|NCT00081523|Pain Crisis|pain crisis
475532|NCT00081523|Treatment Options|treatment options
475533|NCT00081523|Sickle Cell Disease|sickle cell disease
475534|NCT00081523|Sickle Cell Trait|sickle cell trait
475535|NCT00081523|Red Blood Cell Disorder|red blood cell disorder
475536|NCT00081523|Thalassemia|thalassemia
475537|NCT00081523|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
475538|NCT00081523|Hemolytic Disorders|hemolytic disorders
475539|NCT00081536|Colorectal Neoplasms|colorectal neoplasms
475540|NCT00081536|Colorectal Cancer|colorectal cancer
475541|NCT00081536|Colorectal Carcinoma|colorectal carcinoma
475542|NCT00081536|Colorectal Tumor|colorectal tumor
475543|NCT00081536|Neoplasms, Colorectal|neoplasms, colorectal
475544|NCT00081536|Unresectable|unresectable
475545|NCT00081536|Metastatic|metastatic
475546|NCT00081536|Refractory|refractory
475547|NCT00081549|Pancreatic Cancer|pancreatic cancer
475548|NCT00081549|Neoplasms Pancreatic|neoplasms pancreatic
475549|NCT00081549|Pancreas Cancer|pancreas cancer
475550|NCT00081549|Pancreas Neoplasms|pancreas neoplasms
475551|NCT00081549|Pancreatic Tumor|pancreatic tumor
475552|NCT00081549|Pancreas Tumor|pancreas tumor
475553|NCT00081549|Unresectable|unresectable
475554|NCT00081549|Metastatic|metastatic
475555|NCT00081549|Refractory|refractory
475556|NCT00081575|Bacterial Pneumonia|bacterial pneumonia
475557|NCT00081588|TMC114-C215|tmc114-c215
475558|NCT00081588|Ritonavir|ritonavir
475559|NCT00081588|HIV infections|hiv infections
475560|NCT00081588|TMC114-C202|tmc114-c202
475561|NCT00081588|TMC114-C213|tmc114-c213
475562|NCT00081601|prostate cancer|prostate cancer
475563|NCT00081601|prostate specific antigen|prostate specific antigen
475564|NCT00081601|PSA|psa
475565|NCT00081614|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
475566|NCT00081640|HIV Seronegativity|hiv seronegativity
475567|NCT00081640|Vaginal Microbicide|vaginal microbicide
475568|NCT00081744|Bacterial Infections|bacterial infections
475569|NCT00081757|Advanced|advanced
475570|NCT00081757|Refractory|refractory
475571|NCT00081757|Plasmacytoma|plasmacytoma
475572|NCT00081757|Myeloma Proteins|myeloma proteins
475573|NCT00087932|Complementary Therapies|complementary therapies
475574|NCT00087945|Treatment Experienced|treatment experienced
475575|NCT00087958|Metastatic breast cancer|metastatic breast cancer
475576|NCT00087984|Kidney cancer|kidney cancer
475577|NCT00087984|Renal cancer|renal cancer
475578|NCT00087997|sarcoma|sarcoma
475579|NCT00088023|Solid tumors|solid tumors
475580|NCT00088062|Crohn's Disease|crohn's disease
475581|NCT00088075|Schizophrenia|schizophrenia
475582|NCT00088075|Risperidone|risperidone
475583|NCT00088075|Adolescents|adolescents
475584|NCT00088101|Hematological Malignancies|hematological malignancies
475585|NCT00088101|Leukemia|leukemia
475586|NCT00088101|Lymphoma|lymphoma
475587|NCT00088101|Metastatic|metastatic
475588|NCT00088101|Unresectable solid tumors|unresectable solid tumors
475589|NCT00088153|Anorexia Nervosa|anorexia nervosa
475590|NCT00088153|Amenorrhea|amenorrhea
475591|NCT00088153|Bone Mass|bone mass
475592|NCT00088153|Growth hormone|growth hormone
475593|NCT00088166|peritumoral brain edema|peritumoral brain edema
475594|NCT00088166|edema|edema
475595|NCT00088166|malignant brain tumor|malignant brain tumor
475596|NCT00088166|astrocytoma|astrocytoma
475597|NCT00088166|brain tumor|brain tumor
475598|NCT00088166|dexamethasone|dexamethasone
475599|NCT00088166|Decadron|decadron
475600|NCT00088179|CABG|cabg
475601|NCT00088179|CPB|cpb
475602|NCT00088192|AMD|amd
475603|NCT00088192|Age-Related Macular Degeneration|age-related macular degeneration
475604|NCT00088192|Exudative Subfoveal Age Related Macular Degeneration with Subfoveal Choroidal Neovascularization|exudative subfoveal age related macular degeneration with subfoveal choroidal neovascularization
475605|NCT00088218|Acute Myeloid Leukemia|acute myeloid leukemia
475606|NCT00088218|AML|aml
475607|NCT00088218|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
475608|NCT00088218|MDS|mds
475609|NCT00088218|Clofarabine|clofarabine
475610|NCT00088218|Cytarabine|cytarabine
475611|NCT00088218|ara-C|ara-c
475612|NCT00088231|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
475613|NCT00088231|Agnogenic Myeloid Metaplasia (AMM)|agnogenic myeloid metaplasia (amm)
475614|NCT00088231|Chronic Myelogenous Leukemia-Blastic Phase (CML-BP)|chronic myelogenous leukemia-blastic phase (cml-bp)
475615|NCT00088283|CRVO|crvo
475616|NCT00088283|Central Retinal Vein Occlusion|central retinal vein occlusion
475617|NCT00088283|RVO|rvo
475618|NCT00088283|Retinal Vein Occlusion|retinal vein occlusion
475619|NCT00090181|Arcoxia|arcoxia
475620|NCT00090194|Kidney Transplantation|kidney transplantation
475621|NCT00090194|Transplantation, Homologous|transplantation, homologous
475622|NCT00090194|HLA Antigens|hla antigens
475623|NCT00090194|Autoantibodies|autoantibodies
475624|NCT00090194|Immunoglobulins, Intravenous|immunoglobulins, intravenous
475625|NCT00090194|Living Donors|living donors
475626|NCT00090194|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
475627|NCT00090285|anogenital warts|anogenital warts
475628|NCT00090311|Bipolar I Mania|bipolar i mania
475629|NCT00090324|Schizophrenia|schizophrenia
475631|NCT00090337|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
475632|NCT00090337|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
475633|NCT00090337|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
475634|NCT00090337|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
475635|NCT00090337|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
475636|NCT00090337|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
475637|NCT00090337|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
475638|NCT00090337|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
475639|NCT00090337|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
475640|NCT00090337|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
475641|NCT00090337|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
475642|NCT00090337|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
475643|NCT00090337|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
475644|NCT00090337|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
475645|NCT00090337|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
475646|NCT00090337|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
475647|NCT00090337|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
475648|NCT00090337|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
475649|NCT00090337|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
475650|NCT00090337|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
475651|NCT00090337|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
475652|NCT00090337|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
475653|NCT00090337|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
475798|NCT00090818|Genetic Disease|genetic disease
475654|NCT00090337|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
475655|NCT00090337|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
475656|NCT00090337|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
475657|NCT00090337|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
475658|NCT00090337|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
475659|NCT00090337|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
475660|NCT00090337|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
475661|NCT00090337|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
13252|NCT03205761|Triple Negative|triple negative
13255|NCT03205761|BRCA|brca
475662|NCT00090337|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
475663|NCT00090337|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
475664|NCT00090337|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
475665|NCT00090337|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
475666|NCT00090337|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
475667|NCT00090337|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
92798|NCT02708381|Population 70 years and older|population 70 years and older
475668|NCT00090337|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
475669|NCT00090337|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
475670|NCT00090337|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
475671|NCT00090337|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
475672|NCT00090337|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
475673|NCT00090337|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
475674|NCT00090337|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
475675|NCT00090337|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
475676|NCT00090337|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
475677|NCT00090337|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
475678|NCT00090337|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
475679|NCT00090337|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
475680|NCT00090337|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
475681|NCT00090337|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
475682|NCT00090337|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
475683|NCT00090337|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
475684|NCT00090337|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
475685|NCT00090337|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
475686|NCT00090337|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
475687|NCT00090337|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
475688|NCT00090337|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
475689|NCT00090337|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
475690|NCT00090337|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
475691|NCT00090337|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
475692|NCT00090337|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
475693|NCT00090337|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
475694|NCT00090337|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
475695|NCT00090337|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
475696|NCT00090337|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
475697|NCT00090337|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
475698|NCT00090337|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
475699|NCT00090337|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
475700|NCT00090337|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
475701|NCT00090337|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
475702|NCT00090337|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
475703|NCT00090337|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
475704|NCT00090337|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
475799|NCT00090818|Amelogensis Imperfecta|amelogensis imperfecta
475705|NCT00090337|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
475706|NCT00090337|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
475707|NCT00090337|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
475708|NCT00090337|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
475709|NCT00090337|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
475710|NCT00090337|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
475711|NCT00090337|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
475712|NCT00090337|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
475713|NCT00090337|recurrent salivary gland cancer|recurrent salivary gland cancer
475714|NCT00090337|stage I salivary gland cancer|stage i salivary gland cancer
475078|NCT00085865|PET|pet
475715|NCT00090337|stage II salivary gland cancer|stage ii salivary gland cancer
475716|NCT00090337|stage III salivary gland cancer|stage iii salivary gland cancer
475717|NCT00090337|stage IV salivary gland cancer|stage iv salivary gland cancer
475718|NCT00090363|rising PSA|rising psa
475719|NCT00090363|bone metastases|bone metastases
475720|NCT00090363|Clinical study|clinical study
475721|NCT00090363|pain-free or mildly symptomatic|pain-free or mildly symptomatic
475722|NCT00090376|Erectile Dysfunction|erectile dysfunction
475723|NCT00090376|Impotence|impotence
475724|NCT00090376|Prostate Cancer|prostate cancer
475725|NCT00090376|Prostatectomy|prostatectomy
475726|NCT00090389|Acupuncture|acupuncture
475727|NCT00090389|Medicine, Chinese Traditional|medicine, chinese traditional
475728|NCT00090402|Fish Oils|fish oils
475729|NCT00090402|Thioctic Acid|thioctic acid
475730|NCT00090402|Antioxidants|antioxidants
475731|NCT00090402|Dietary Supplements|dietary supplements
475732|NCT00090415|Autism|autism
475733|NCT00090415|Developmental Delay Disorders|developmental delay disorders
475734|NCT00090428|Autism|autism
475735|NCT00090428|Applied Behavioral Analysis|applied behavioral analysis
475736|NCT00090428|Gluten|gluten
475737|NCT00090428|Casein|casein
475738|NCT00090480|Cancer|cancer
475739|NCT00090493|Myeloma|myeloma
475740|NCT00090493|Mage-A3|mage-a3
475741|NCT00090493|Transplant|transplant
475742|NCT00090493|Peptide|peptide
475743|NCT00090493|DTPACE|dtpace
475744|NCT00090493|vaccines|vaccines
475745|NCT00090493|Immunotherapy|immunotherapy
475746|NCT00090493|NY-ESO-1|ny-eso-1
475747|NCT00090506|Yoga|yoga
475748|NCT00090506|Meditation|meditation
475749|NCT00090545|Hormone-Refractory|hormone-refractory
475750|NCT00090545|Proteomics|proteomics
475751|NCT00090545|Angiogenesis|angiogenesis
475753|NCT00090545|Prostate Cancer|prostate cancer
475754|NCT00090545|Metastatic Prostate Cancer|metastatic prostate cancer
475755|NCT00090558|Atherosclerosis|atherosclerosis
475756|NCT00090558|Bone Marrow|bone marrow
475757|NCT00090558|Exercise|exercise
475758|NCT00090558|Endothelium|endothelium
475759|NCT00090558|Nitroglycerin|nitroglycerin
475760|NCT00090558|Coronary Artery Disease|coronary artery disease
475761|NCT00090558|CAD|cad
475762|NCT00090571|JRA ASPs|jra asps
475763|NCT00090571|Genomics|genomics
475764|NCT00090584|Urge urinary incontinence (UUI)|urge urinary incontinence (uui)
475765|NCT00090584|Drug/Behavior treatment|drug/behavior treatment
475766|NCT00090610|Relapsed ovarian cancer|relapsed ovarian cancer
475767|NCT00090623|Subfoveal neovascular|subfoveal neovascular
475768|NCT00090623|Age-related macular degeneration|age-related macular degeneration
475769|NCT00090623|AMD|amd
475770|NCT00090623|Wet AMD|wet amd
475771|NCT00090662|Normal Volunteer|normal volunteer
475772|NCT00090662|Eosinophilopoiesis|eosinophilopoiesis
475773|NCT00090662|Healthy Volunteer|healthy volunteer
475774|NCT00090662|HV|hv
475775|NCT00090688|diarrhea|diarrhea
475776|NCT00090714|DNA|dna
475777|NCT00090714|Circular|circular
475778|NCT00090714|Gene Therapy|gene therapy
475779|NCT00090727|diffuse|diffuse
475780|NCT00090727|follicular|follicular
475781|NCT00090727|chronic lymphocytic leukemia|chronic lymphocytic leukemia
475782|NCT00090727|colorectal cancer|colorectal cancer
475783|NCT00090727|pancreatic cancer|pancreatic cancer
475784|NCT00090727|acute myelogenous leukemia|acute myelogenous leukemia
475785|NCT00090727|head and neck cancer|head and neck cancer
475786|NCT00090727|breast cancer|breast cancer
475787|NCT00090727|prostate cancer|prostate cancer
475788|NCT00090727|ovarian cancer|ovarian cancer
475789|NCT00090727|bladder cancer|bladder cancer
475790|NCT00090727|hypoxia|hypoxia
475791|NCT00090727|refractory|refractory
475792|NCT00090727|metastatic|metastatic
475793|NCT00090779|Acute Infection|acute infection
475794|NCT00090779|Treatment Naive|treatment naive
475795|NCT00090818|Dental Abnormalities|dental abnormalities
475796|NCT00090818|Lichen Planus|lichen planus
475797|NCT00090818|Oral Mucosal Disease|oral mucosal disease
475800|NCT00090818|Maxillofacial Abnormalities|maxillofacial abnormalities
475801|NCT00090818|Craniofacial Abnormalities|craniofacial abnormalities
475802|NCT00090818|Craniofacial Genetic Abnormalities|craniofacial genetic abnormalities
475803|NCT00090831|Emotional Learning|emotional learning
475804|NCT00090831|Neurotransmitter|neurotransmitter
475805|NCT00090831|Neural Systems|neural systems
475806|NCT00090831|Response Control|response control
475807|NCT00090831|Orbitofrontal Cortex|orbitofrontal cortex
475808|NCT00090831|Amygdala|amygdala
475809|NCT00090831|Serotonin|serotonin
475810|NCT00090831|Healthy Volunteer|healthy volunteer
475811|NCT00090831|HV|hv
475812|NCT00090844|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
475813|NCT00090844|hormone changes|hormone changes
475814|NCT00090844|stage I breast cancer|stage i breast cancer
475815|NCT00090844|stage II breast cancer|stage ii breast cancer
475816|NCT00090857|breast cancer|breast cancer
475817|NCT00090857|stage I breast cancer|stage i breast cancer
475818|NCT00090857|stage II breast cancer|stage ii breast cancer
475819|NCT00090857|stage IIIA breast cancer|stage iiia breast cancer
475820|NCT00090857|stage IIIB breast cancer|stage iiib breast cancer
475821|NCT00090857|stage IIIC breast cancer|stage iiic breast cancer
475822|NCT00090857|stage IV breast cancer|stage iv breast cancer
475823|NCT00090857|breast cancer in situ|breast cancer in situ
475824|NCT00090857|ductal breast carcinoma in situ|ductal breast carcinoma in situ
475825|NCT00090870|stage IV renal cell cancer|stage iv renal cell cancer
475826|NCT00090896|recurrent melanoma|recurrent melanoma
475827|NCT00090896|stage III melanoma|stage iii melanoma
475828|NCT00090896|stage IV melanoma|stage iv melanoma
475829|NCT00090909|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
475830|NCT00090961|pulmonary complications|pulmonary complications
475831|NCT00090961|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
475832|NCT00090961|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
475833|NCT00090961|squamous cell lung cancer|squamous cell lung cancer
475834|NCT00090961|large cell lung cancer|large cell lung cancer
475835|NCT00090961|adenocarcinoma of the lung|adenocarcinoma of the lung
475836|NCT00090961|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
475837|NCT00090961|limited stage small cell lung cancer|limited stage small cell lung cancer
475838|NCT00090974|stage I breast cancer|stage i breast cancer
475839|NCT00090974|stage II breast cancer|stage ii breast cancer
475840|NCT00090974|stage IIIA breast cancer|stage iiia breast cancer
475841|NCT00090987|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
475842|NCT00090987|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
475843|NCT00091039|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
475844|NCT00091039|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
475845|NCT00091052|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
475846|NCT00091091|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
475847|NCT00091091|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
475848|NCT00091091|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
475849|NCT00091091|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
475850|NCT00091091|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
475851|NCT00091104|stage IV melanoma|stage iv melanoma
475852|NCT00091104|recurrent melanoma|recurrent melanoma
475853|NCT00091143|recurrent melanoma|recurrent melanoma
475854|NCT00091143|stage III melanoma|stage iii melanoma
475855|NCT00091143|stage IV melanoma|stage iv melanoma
475856|NCT00091156|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
475857|NCT00091156|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
475859|NCT00091169|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
475860|NCT00091169|levocarnitine|levocarnitine
475861|NCT00091169|depression|depression
475862|NCT00091169|pain|pain
475863|NCT00091169|carnitine deficiency|carnitine deficiency
475864|NCT00091234|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
475865|NCT00091234|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
475866|NCT00091234|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
475867|NCT00091234|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
475868|NCT00091234|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
475869|NCT00091234|secondary acute myeloid leukemia|secondary acute myeloid leukemia
475870|NCT00091234|adult acute basophilic leukemia|adult acute basophilic leukemia
475871|NCT00091234|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
475872|NCT00091234|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
475873|NCT00091234|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
475874|NCT00091234|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
475875|NCT00091234|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
475876|NCT00091234|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
475877|NCT00091234|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
476066|NCT00092222|Malignancy|malignancy
475878|NCT00091234|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
475879|NCT00091234|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
475880|NCT00091234|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
475881|NCT00091247|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
475882|NCT00091260|primary systemic amyloidosis|primary systemic amyloidosis
475883|NCT00091273|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
475884|NCT00091273|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
475885|NCT00091273|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
475886|NCT00091273|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
475887|NCT00091273|primary peritoneal cavity cancer|primary peritoneal cavity cancer
475888|NCT00091286|recurrent colon cancer|recurrent colon cancer
92799|NCT02708381|Geriatric|geriatric
475889|NCT00091286|stage IIB colon cancer|stage iib colon cancer
475890|NCT00091286|stage IIIA colon cancer|stage iiia colon cancer
475891|NCT00091286|stage IIIB colon cancer|stage iiib colon cancer
475892|NCT00091286|stage IIIC colon cancer|stage iiic colon cancer
475893|NCT00091286|stage IVA colon cancer|stage iva colon cancer
475894|NCT00091286|stage IVB colon cancer|stage ivb colon cancer
475895|NCT00091286|recurrent rectal cancer|recurrent rectal cancer
475896|NCT00091286|stage IIB rectal cancer|stage iib rectal cancer
475897|NCT00091286|stage IIIA rectal cancer|stage iiia rectal cancer
475898|NCT00091286|stage IIIB rectal cancer|stage iiib rectal cancer
475899|NCT00091286|stage IIIC rectal cancer|stage iiic rectal cancer
475900|NCT00091286|stage IVA rectal cancer|stage iva rectal cancer
475901|NCT00091286|stage IVB rectal cancer|stage ivb rectal cancer
475902|NCT00091299|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
475903|NCT00091312|stage II colon cancer|stage ii colon cancer
475904|NCT00091312|adenocarcinoma of the colon|adenocarcinoma of the colon
475905|NCT00091325|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
475906|NCT00091338|recurrent melanoma|recurrent melanoma
475907|NCT00091338|stage IV melanoma|stage iv melanoma
475908|NCT00091351|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
475909|NCT00091351|adult angiosarcoma|adult angiosarcoma
475910|NCT00091351|adult epithelioid sarcoma|adult epithelioid sarcoma
475911|NCT00091351|adult fibrosarcoma|adult fibrosarcoma
475912|NCT00091351|adult leiomyosarcoma|adult leiomyosarcoma
475913|NCT00091351|adult liposarcoma|adult liposarcoma
475914|NCT00091351|adult neurofibrosarcoma|adult neurofibrosarcoma
475915|NCT00091351|adult synovial sarcoma|adult synovial sarcoma
475916|NCT00091351|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
475917|NCT00091351|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
475918|NCT00091351|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
475919|NCT00091351|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
475920|NCT00091377|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
475921|NCT00091377|fallopian tube cancer|fallopian tube cancer
475922|NCT00091377|primary peritoneal cavity cancer|primary peritoneal cavity cancer
475923|NCT00091390|adenocarcinoma of the prostate|adenocarcinoma of the prostate
475924|NCT00091390|stage IIB prostate cancer|stage iib prostate cancer
475925|NCT00091390|stage IIA prostate cancer|stage iia prostate cancer
475926|NCT00091390|stage III prostate cancer|stage iii prostate cancer
475927|NCT00091416|HIV Seronegativity|hiv seronegativity
475928|NCT00091416|HIV Preventive Vaccine|hiv preventive vaccine
475930|NCT00091429|Chest Pain|chest pain
475931|NCT00091429|Coronary Artery Disease|coronary artery disease
475932|NCT00091429|Heart Disease|heart disease
475933|NCT00091442|Breast Cancer|breast cancer
475934|NCT00091442|Advanced breast cancer|advanced breast cancer
475935|NCT00091442|Breast Tumors|breast tumors
475936|NCT00091442|Cancer of Breast|cancer of breast
475937|NCT00091442|Human Mammary Carcinoma|human mammary carcinoma
475938|NCT00091442|Mammary Neoplasms, Human|mammary neoplasms, human
475939|NCT00091442|DOXIL|doxil
475940|NCT00091442|Docetaxel|docetaxel
475941|NCT00091468|Age-Related Memory Loss|age-related memory loss
475942|NCT00091468|Nicotine|nicotine
475943|NCT00091468|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
475944|NCT00091481|Stage V Chronic Kidney Disease|stage v chronic kidney disease
475945|NCT00091507|Acute Coronary Syndrome|acute coronary syndrome
475946|NCT00091520|Congestive heart failure|congestive heart failure
475947|NCT00091520|Nesiritide|nesiritide
475948|NCT00091533|fMRI|fmri
475949|NCT00091533|Mirror Neuron System|mirror neuron system
475950|NCT00091533|Bimodal Neurons|bimodal neurons
475951|NCT00091533|Somatosensory Cortex|somatosensory cortex
475952|NCT00091533|Rehabilitation|rehabilitation
475953|NCT00091533|Healthy Volunteer|healthy volunteer
475955|NCT00091559|CTCL|ctcl
475956|NCT00091572|Metastatic Melanoma|metastatic melanoma
475957|NCT00091598|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
475958|NCT00091611|Clinical Response|clinical response
475959|NCT00091611|Intravenous|intravenous
475960|NCT00091611|Intra-Arterial|intra-arterial
475961|NCT00091611|Lymphodepletion|lymphodepletion
475962|NCT00091611|Traffic of Cells|traffic of cells
475963|NCT00091611|T-Cell Transfer|t-cell transfer
475964|NCT00091611|Renal Cell Carcinoma|renal cell carcinoma
475965|NCT00091611|Metastatic Renal Cell Cancer|metastatic renal cell cancer
475966|NCT00091624|CC-5013|cc-5013
475967|NCT00091624|CC5013|cc5013
475968|NCT00091624|Revlimid|revlimid
475969|NCT00091624|Lenalidomide|lenalidomide
475970|NCT00091624|Multiple myeloma|multiple myeloma
475971|NCT00091663|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
475972|NCT00091676|follicular|follicular
475973|NCT00091676|lymphoma|lymphoma
475974|NCT00091676|Non-Hodgkins|non-hodgkins
475975|NCT00091676|idiotype|idiotype
475976|NCT00091676|vaccine|vaccine
475977|NCT00091676|indolent follicular Non-Hodgkins Lymphoma|indolent follicular non-hodgkins lymphoma
475979|NCT00091676|B-cell|b-cell
475980|NCT00091676|cancer|cancer
475981|NCT00091689|Advanced Metastatic Melanoma|advanced metastatic melanoma
475982|NCT00091702|FluMist|flumist
475983|NCT00091702|Influenza Vaccine|influenza vaccine
475984|NCT00091702|Adolescent|adolescent
475985|NCT00091702|Treatment Experienced|treatment experienced
475986|NCT00091715|Pulmonary arterial hypertension|pulmonary arterial hypertension
475988|NCT00091715|PPH|pph
475989|NCT00091715|bosentan|bosentan
475990|NCT00091715|early|early
475991|NCT00091728|epidemiology|epidemiology
475992|NCT00091728|relative risk|relative risk
475993|NCT00091728|cervical ectopy|cervical ectopy
475994|NCT00091728|hormonal contraceptives|hormonal contraceptives
475995|NCT00091728|sexually transmitted infections|sexually transmitted infections
475996|NCT00091741|HIV|hiv
475997|NCT00091741|Treatment Experienced|treatment experienced
475998|NCT00091741|Complementary Therapies|complementary therapies
475999|NCT00091793|Osteoporosis|osteoporosis
476000|NCT00091793|Postmenopausal|postmenopausal
476001|NCT00091806|Targeted Therapy|targeted therapy
476002|NCT00091806|Solid tumors|solid tumors
476003|NCT00091806|ABX-EGF, panitumumab|abx-egf, panitumumab
476004|NCT00091806|EGFr|egfr
476005|NCT00091806|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
476006|NCT00091806|Monoclonal Antibody|monoclonal antibody
476007|NCT00091819|staph|staph
476008|NCT00091819|MRSA|mrsa
476009|NCT00091819|cSSSI|csssi
476010|NCT00091832|Breast Cancer|breast cancer
476011|NCT00091832|Cancer|cancer
476012|NCT00091845|West Nile Fever Myelitis|west nile fever myelitis
476013|NCT00091845|West Nile Fever Encephalitis|west nile fever encephalitis
476014|NCT00091845|West Nile Fever Meningitis|west nile fever meningitis
476015|NCT00091845|West Nile Fever Meningoencephalitis|west nile fever meningoencephalitis
476016|NCT00091858|Cancer-related anemia|cancer-related anemia
476017|NCT00091871|Genetic|genetic
476018|NCT00091871|Eosinophils|eosinophils
476019|NCT00091871|Familial Hypereosinophilia|familial hypereosinophilia
476020|NCT00091871|Hypereosinophilia|hypereosinophilia
476021|NCT00091871|FE|fe
476022|NCT00091884|HIV|hiv
476023|NCT00091884|Immune Recovery|immune recovery
476024|NCT00091884|Reactivation|reactivation
476025|NCT00091884|Anti-Viral Medication|anti-viral medication
476026|NCT00091884|HAART|haart
476027|NCT00091884|CMV Retinitis|cmv retinitis
476028|NCT00091884|Retinal Disease|retinal disease
476029|NCT00091897|RITUXAN|rituxan
476030|NCT00091897|GABA|gaba
476031|NCT00091897|B Cells|b cells
476032|NCT00091897|Humanized Monoclonal Antibodies|humanized monoclonal antibodies
476033|NCT00091897|GAD|gad
476034|NCT00091897|Stiff Person Syndrome|stiff person syndrome
476035|NCT00091897|SPS|sps
476036|NCT00091910|Anemia|anemia
476037|NCT00091910|Epoetin alfa|epoetin alfa
476038|NCT00091910|Erythropoietin|erythropoietin
476039|NCT00091910|Blood transfusion|blood transfusion
476040|NCT00091910|Intensive care units|intensive care units
476041|NCT00091936|Treatment Naive|treatment naive
476042|NCT00091936|Directly Observed Therapy|directly observed therapy
476043|NCT00091936|DOT|dot
476044|NCT00091936|TB|tb
476045|NCT00091949|stroke|stroke
476046|NCT00091949|heart attack|heart attack
476047|NCT00091949|diabetes|diabetes
476048|NCT00091949|pioglitazone|pioglitazone
476049|NCT00091949|insulin resistance|insulin resistance
476050|NCT00091975|Chronic Kidney Disease|chronic kidney disease
476051|NCT00091988|Urinary Incontinence|urinary incontinence
476052|NCT00091988|Weight Loss|weight loss
476053|NCT00091988|Obesity|obesity
476054|NCT00091988|Motivation|motivation
476055|NCT00092001|Non-small cell lung cancer, carcinoma, sunitinib, Phase 2|non-small cell lung cancer, carcinoma, sunitinib, phase 2
476056|NCT00092053|Postmenopausal|postmenopausal
476057|NCT00092053|Osteoporosis|osteoporosis
476058|NCT00092105|Rhinitis, Allergic|rhinitis, allergic
476059|NCT00092157|High cholesterol|high cholesterol
476060|NCT00092170|Intra-abdominal infections|intra-abdominal infections
476061|NCT00092170|Acute pelvic infections|acute pelvic infections
476062|NCT00092183|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
476063|NCT00092196|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
476064|NCT00092222|HHV-8|hhv-8
476065|NCT00092222|HIV|hiv
476067|NCT00092222|Lymphoproliferation|lymphoproliferation
476068|NCT00092222|Lymph Node Hyperplasia|lymph node hyperplasia
476069|NCT00092222|Multicentric Castleman DIsease|multicentric castleman disease
476070|NCT00092222|MCD|mcd
476071|NCT00092222|KSHV-MCD|kshv-mcd
476072|NCT00092222|KSHV Associated MCD|kshv associated mcd
476073|NCT00092222|HIV Infections|hiv infections
476074|NCT00092222|Herpes Viruses|herpes viruses
476075|NCT00092235|cGVHD-associated graft-versus-tumor effects (GVT)|cgvhd-associated graft-versus-tumor effects (gvt)
476076|NCT00092235|Allo-HSCT controls|allo-hsct controls
476077|NCT00092235|Leukapheresis|leukapheresis
476078|NCT00092235|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
476079|NCT00092235|cGVHD|cgvhd
476080|NCT00092274|Follicular Lymphoma|follicular lymphoma
476081|NCT00092274|Non Hodgkin´s Lymphoma|non hodgkin´s lymphoma
476082|NCT00092287|Carcinoid Syndrome|carcinoid syndrome
475451|NCT00087529|PPMS|ppms
476083|NCT00092287|Neuroendocrine Tumuors|neuroendocrine tumuors
476084|NCT00092300|dental surgery|dental surgery
476085|NCT00092300|molar removal|molar removal
476086|NCT00092313|dental surgery|dental surgery
476087|NCT00092313|molar removal|molar removal
476088|NCT00092326|dental surgery|dental surgery
476089|NCT00092326|molar removal|molar removal
476090|NCT00092339|dental surgery|dental surgery
476091|NCT00092339|molar removal|molar removal
476092|NCT00092378|Bunionectomy|bunionectomy
476093|NCT00092508|Ulcerative Colitis Remission|ulcerative colitis remission
476094|NCT00092508|ulcerative|ulcerative
476095|NCT00092508|colitis|colitis
476096|NCT00092508|remission|remission
476097|NCT00092508|relapse|relapse
476098|NCT00092508|Asacol®|asacol®
476099|NCT00092508|maintain|maintain
476100|NCT00092508|maintenance|maintenance
476101|NCT00092508|flare|flare
476102|NCT00092508|rectal|rectal
476103|NCT00092508|bleeding|bleeding
476104|NCT00092508|bowel|bowel
476105|NCT00092560|mixed hyperlipidemia|mixed hyperlipidemia
476106|NCT00092560|high cholesterol|high cholesterol
476107|NCT00092560|high triglycerides|high triglycerides
585109|NCT00518531|satisfaction|satisfaction
476108|NCT00092573|Mixed hyperlipidemia (high cholesterol and high triglycerides)|mixed hyperlipidemia (high cholesterol and high triglycerides)
476109|NCT00092599|Elevated Cholesterol|elevated cholesterol
476110|NCT00092612|Elevated Cholesterol|elevated cholesterol
476111|NCT00092625|Elevated Cholesterol|elevated cholesterol
476112|NCT00092638|Elevated Cholesterol|elevated cholesterol
476113|NCT00092651|Primary hypercholesterolemia|primary hypercholesterolemia
476114|NCT00092664|Primary hypercholesterolemia|primary hypercholesterolemia
476116|NCT00092742|Arcoxia|arcoxia
476117|NCT00092755|Arcoxia|arcoxia
476118|NCT00092768|Arcoxia|arcoxia
476119|NCT00092781|Arcoxia|arcoxia
476120|NCT00092807|Homozygous Sitosterolemia|homozygous sitosterolemia
476121|NCT00092820|Homozygous Sitosterolemia|homozygous sitosterolemia
476122|NCT00092846|High Blood Cholesterol Levels|high blood cholesterol levels
476123|NCT00084838|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
476124|NCT00084864|adenocarcinoma of the prostate|adenocarcinoma of the prostate
476125|NCT00084864|stage II prostate cancer|stage ii prostate cancer
476126|NCT00084864|stage III prostate cancer|stage iii prostate cancer
476127|NCT00084890|stage IVB cervical cancer|stage ivb cervical cancer
476128|NCT00084890|recurrent cervical cancer|recurrent cervical cancer
476129|NCT00084890|cervical squamous cell carcinoma|cervical squamous cell carcinoma
476130|NCT00084903|cervical cancer|cervical cancer
476131|NCT00084903|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
476132|NCT00084929|colon cancer|colon cancer
476133|NCT00084929|rectal cancer|rectal cancer
476134|NCT00084942|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
476135|NCT00084942|recurrent gallbladder cancer|recurrent gallbladder cancer
476136|NCT00084942|unresectable gallbladder cancer|unresectable gallbladder cancer
476137|NCT00084942|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
476138|NCT00084942|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
476139|NCT00084942|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
476140|NCT00085020|stage IV breast cancer|stage iv breast cancer
476141|NCT00085020|male breast cancer|male breast cancer
476142|NCT00085020|recurrent breast cancer|recurrent breast cancer
476143|NCT00085059|stage IV melanoma|stage iv melanoma
476144|NCT00085059|recurrent melanoma|recurrent melanoma
476145|NCT00085098|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
476146|NCT00085150|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
476147|NCT00085150|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
476148|NCT00085150|childhood Burkitt lymphoma|childhood burkitt lymphoma
476149|NCT00085150|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
476150|NCT00085150|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
476151|NCT00085150|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
476152|NCT00085150|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
476153|NCT00085150|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
476245|NCT00095264|Myelodysplastic Syndrome|myelodysplastic syndrome
476154|NCT00085150|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
476155|NCT00085150|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
476156|NCT00085150|acute undifferentiated leukemia|acute undifferentiated leukemia
476157|NCT00085163|adenocarcinoma of the colon|adenocarcinoma of the colon
476158|NCT00085163|stage III colon cancer|stage iii colon cancer
476159|NCT00085176|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
476160|NCT00085176|neurotoxicity|neurotoxicity
476161|NCT00085176|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
94189|NCT02699476|TBI|tbi
613052|NCT00633776|CT|ct
476162|NCT00085176|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
13349|NCT03205176|BRD4|brd4
476163|NCT00092898|Sitosterolemia|sitosterolemia
476164|NCT00092937|Chronic Granulomatous Disease|chronic granulomatous disease
476165|NCT00092937|Nonmyeloablative|nonmyeloablative
476166|NCT00092937|CD34 Positive Cells|cd34 positive cells
476167|NCT00092937|Donor Engraftment|donor engraftment
476168|NCT00092937|Myeloid Chimerism|myeloid chimerism
476169|NCT00092950|Exercise|exercise
476170|NCT00092950|Pedometer|pedometer
476171|NCT00092950|Physician Prescription|physician prescription
476172|NCT00092950|Biomarkers|biomarkers
476173|NCT00092950|Compliance|compliance
476174|NCT00092950|Breast Cancer Survivor|breast cancer survivor
476175|NCT00092950|Breast Cancer Risk|breast cancer risk
476176|NCT00092976|Hemophilia A|hemophilia a
476177|NCT00093002|Early Breast Cancer|early breast cancer
476178|NCT00093002|neoadjuvant therapy|neoadjuvant therapy
476179|NCT00093002|hormonal treatment|hormonal treatment
476180|NCT00093002|newly diagnosed breast cancer|newly diagnosed breast cancer
476181|NCT00093002|Estrogen Receptor Positive Breast Cancer|estrogen receptor positive breast cancer
476182|NCT00093002|treatment naïve|treatment naïve
476183|NCT00093002|neoadjuvant treatment|neoadjuvant treatment
476184|NCT00093002|neoadjuvant setting|neoadjuvant setting
476185|NCT00093002|invasive breast cancer|invasive breast cancer
476186|NCT00093028|Myeloma|myeloma
476187|NCT00093028|Revlimid|revlimid
476188|NCT00093028|bortezomib|bortezomib
476189|NCT00093028|CC-5013|cc-5013
476190|NCT00093028|Dexamethasone|dexamethasone
476191|NCT00093041|Head and neck cancer|head and neck cancer
476192|NCT00093041|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
476193|NCT00093054|Vaccinium macrocarpon|vaccinium macrocarpon
476194|NCT00093067|Gram-positive bacterial infections|gram-positive bacterial infections
476195|NCT00093067|Staph Aureus|staph aureus
476196|NCT00093067|endocarditis|endocarditis
476197|NCT00093067|bacteremia|bacteremia
476198|NCT00093067|Cubist|cubist
476199|NCT00093080|Metastatic and/or unresectable soft tissue or|metastatic and/or unresectable soft tissue or
476200|NCT00093093|Viramidine|viramidine
476201|NCT00093093|Ribavirin|ribavirin
476202|NCT00093093|Valeant|valeant
476203|NCT00093093|Hepatitis C|hepatitis c
476204|NCT00093093|Pegylated interferon alfa-2a|pegylated interferon alfa-2a
476205|NCT00093119|Metastatic Melanoma|metastatic melanoma
476206|NCT00093132|Non-Small Cell Lung Cancer (stage II or III)|non-small cell lung cancer (stage ii or iii)
476207|NCT00093132|NSCLC|nsclc
476208|NCT00093132|Squamous Cell Lung Cancer|squamous cell lung cancer
476209|NCT00093132|adenocarcinoma of the lung|adenocarcinoma of the lung
476210|NCT00093132|adenosquamous cell lung cancer|adenosquamous cell lung cancer
476211|NCT00093132|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
476212|NCT00093132|carcinoma, non-small cell lung|carcinoma, non-small cell lung
476213|NCT00093145|Advanced Breast Cancer|advanced breast cancer
476214|NCT00093158|Acute Coronary Syndromes|acute coronary syndromes
476215|NCT00093184|ST-Segment Elevation|st-segment elevation
476216|NCT00093184|Acute Myocardial Infarction|acute myocardial infarction
476217|NCT00093184|PCI|pci
476218|NCT00093184|Percutaneous Coronary Intervention|percutaneous coronary intervention
476219|NCT00093223|In-Stent Restenosis|in-stent restenosis
476220|NCT00095160|Solid Organ Tumors|solid organ tumors
476221|NCT00095173|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
476222|NCT00095186|Cancer|cancer
476223|NCT00095186|Metastatic|metastatic
476224|NCT00095186|Kidney|kidney
476225|NCT00095186|Refractive|refractive
476226|NCT00095186|Lactoferrin|lactoferrin
476227|NCT00095186|Oral|oral
476228|NCT00095199|Recurrent or Progressive Non-Small Cell Lung Cancer|recurrent or progressive non-small cell lung cancer
476229|NCT00095199|Second-line therapy|second-line therapy
476230|NCT00095199|Docetaxel|docetaxel
476231|NCT00095199|Pemetrexed|pemetrexed
476232|NCT00095199|Cetuximab|cetuximab
476233|NCT00095199|Failed platinum-based therapy|failed platinum-based therapy
476234|NCT00095199|NSCLC|nsclc
476235|NCT00095212|HIV|hiv
476236|NCT00095212|women|women
476237|NCT00095212|androgen|androgen
476238|NCT00095212|Treatment Experienced|treatment experienced
476239|NCT00095225|Recurrent or refractory non-small cell lung cancer|recurrent or refractory non-small cell lung cancer
476240|NCT00095251|Delirium|delirium
476241|NCT00095251|Hypnotics and Sedatives|hypnotics and sedatives
476242|NCT00095251|Adrenergic alpha-Agonists|adrenergic alpha-agonists
476243|NCT00095251|efficacy of sedation|efficacy of sedation
476244|NCT00095251|cognitive impairment|cognitive impairment
476246|NCT00095277|non-myeloid malignancies|non-myeloid malignancies
476247|NCT00095277|myeloma|myeloma
476248|NCT00095277|Anemia of Cancer|anemia of cancer
476249|NCT00095290|Albuminuria|albuminuria
476250|NCT00095290|Hypertension|hypertension
476251|NCT00095290|Elevated Cardiovascular Risk|elevated cardiovascular risk
95171|NCT02693873|Disease Management|disease management
475630|NCT00090337|pain|pain
476252|NCT00095290|Albuminuria in Hypertensive Subjects at Elevated Cardiovascular Risk|albuminuria in hypertensive subjects at elevated cardiovascular risk
476253|NCT00095303|BSFT|bsft
476254|NCT00095303|Family Therapy|family therapy
476255|NCT00095303|Adolescents|adolescents
476256|NCT00095303|Substance Abuse|substance abuse
476257|NCT00095316|candidiasis, caspofungin, fungal infection, prophylaxis|candidiasis, caspofungin, fungal infection, prophylaxis
476258|NCT00095329|relapsing-remitting MS|relapsing-remitting ms
476259|NCT00095329|nonresponsive to standard of care MS|nonresponsive to standard of care ms
476260|NCT00095329|sirolimus|sirolimus
476261|NCT00095355|BDNF|bdnf
476262|NCT00095355|Lithium|lithium
476263|NCT00095355|Divalproex|divalproex
476264|NCT00095355|Huntington Disease|huntington disease
476265|NCT00095355|HD|hd
476266|NCT00095368|Pharyngitis|pharyngitis
476267|NCT00095368|Tonsillitis|tonsillitis
476268|NCT00095381|Leukemia, Lymphocytic, T-Cell|leukemia, lymphocytic, t-cell
476269|NCT00095381|Entry Term Lymphocytic Leukemia, T-Cell|entry term lymphocytic leukemia, t-cell
476270|NCT00095381|T-Cell Leukemia|t-cell leukemia
476271|NCT00095381|T-Lymphocytic Leukemia|t-lymphocytic leukemia
476272|NCT00095381|Leukemia, Lymphocytic, T Cell|leukemia, lymphocytic, t cell
476273|NCT00095381|T Lymphocytic Leukemia|t lymphocytic leukemia
476274|NCT00095381|BCX-1777|bcx-1777
476275|NCT00095381|forodesine hydrochloride|forodesine hydrochloride
476276|NCT00095381|BioCryst|biocryst
476277|NCT00095394|Severe Hypertension|severe hypertension
476278|NCT00095407|Social Cognition|social cognition
476279|NCT00095407|Semantic Memory|semantic memory
476280|NCT00095407|Prefrontal Cortex|prefrontal cortex
476281|NCT00095407|Temporal Cortex|temporal cortex
476282|NCT00095407|Conceptual Self|conceptual self
476283|NCT00095420|Interpersonal Relationships|interpersonal relationships
476284|NCT00095420|Child|child
476286|NCT00095433|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
476287|NCT00095446|Diabetes Mellitus|diabetes mellitus
476288|NCT00095446|Diabetes|diabetes
476289|NCT00095459|Raf-Kinase Inhibitor|raf-kinase inhibitor
476290|NCT00095459|Combinatorial Therapy|combinatorial therapy
476291|NCT00095459|Pathway Profiling|pathway profiling
476292|NCT00095459|VEGFR|vegfr
476293|NCT00095459|Bevacizumab|bevacizumab
476294|NCT00095459|Sorafenib|sorafenib
476295|NCT00095459|Advanced Solid Tumors|advanced solid tumors
476296|NCT00095459|Angiogenesis|angiogenesis
476297|NCT00095459|Targeted Therapy|targeted therapy
476298|NCT00095459|VEGF|vegf
476299|NCT00095459|Cancer|cancer
476301|NCT00095459|Metastatic Uresectable Solid Tumors|metastatic uresectable solid tumors
476302|NCT00095472|Blood Flow|blood flow
476303|NCT00095472|Nitric Oxide|nitric oxide
476304|NCT00095472|Vascular Function|vascular function
476305|NCT00095472|Vasodilation|vasodilation
476306|NCT00095472|Vaso-Occlusive Pain Crisis|vaso-occlusive pain crisis
476307|NCT00095472|Sickle Cell Disease|sickle cell disease
476308|NCT00095485|Activity Level|activity level
476309|NCT00095485|Musculoskeletal|musculoskeletal
476310|NCT00095485|Healthy Volunteer|healthy volunteer
476311|NCT00095485|Physical Activity|physical activity
476312|NCT00095498|arthritis|arthritis
476313|NCT00095498|joint pain|joint pain
476314|NCT00095498|Methotrexate|methotrexate
476315|NCT00095511|Bipolar Mania|bipolar mania
476316|NCT00095524|Patient weight change|patient weight change
476317|NCT00095524|changes in metabolic status|changes in metabolic status
476318|NCT00095537|Solid tumors|solid tumors
476319|NCT00095537|cancer|cancer
476320|NCT00095537|HER-2-expressing tumors|her-2-expressing tumors
476321|NCT00095550|Moderate Hypertension|moderate hypertension
476322|NCT00095589|bladder cancer|bladder cancer
476323|NCT00095589|stage 0 bladder cancer|stage 0 bladder cancer
476324|NCT00095589|stage I bladder cancer|stage i bladder cancer
476325|NCT00095589|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
476326|NCT00095654|diabetes prevention|diabetes prevention
476327|NCT00095654|ramipril|ramipril
476328|NCT00095654|rosiglitazone|rosiglitazone
476329|NCT00095654|impaired glucose tolerance|impaired glucose tolerance
476330|NCT00095654|isolated impaired fasting glucose|isolated impaired fasting glucose
476331|NCT00095654|Isolated Impaired Glucose Tolerance|isolated impaired glucose tolerance
476332|NCT00095680|Multiple Myeloma|multiple myeloma
476333|NCT00095680|SCIO-469|scio-469
476334|NCT00095680|Bortezomib|bortezomib
476335|NCT00095680|p38 MAP kinase|p38 map kinase
476336|NCT00095706|Metastatic breast cancer|metastatic breast cancer
476337|NCT00095706|HER2|her2
476338|NCT00095706|Trastuzumab|trastuzumab
476339|NCT00095706|Herceptin|herceptin
476340|NCT00095706|VEGF|vegf
476341|NCT00095706|Bevacizumab|bevacizumab
476342|NCT00095706|Avastin|avastin
476618|NCT00096421|Intensive Care Units|intensive care units
476343|NCT00095719|Acute agitation in patients diagnosed with Dementia|acute agitation in patients diagnosed with dementia
476344|NCT00095732|Pancreatic Insufficiency|pancreatic insufficiency
476345|NCT00095732|Cystic Fibrosis|cystic fibrosis
476346|NCT00095732|Enzymes|enzymes
476347|NCT00095771|untreated childhood brain stem glioma|untreated childhood brain stem glioma
476348|NCT00095771|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
476349|NCT00095810|Psychosis, Parkinson's Disease|psychosis, parkinson's disease
476350|NCT00095836|recurrent thyroid cancer|recurrent thyroid cancer
476351|NCT00095836|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
476352|NCT00095836|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
13444|NCT03204500|Dual therapy|dual therapy
476353|NCT00095836|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
476354|NCT00095836|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
476355|NCT00095836|anaplastic thyroid cancer|anaplastic thyroid cancer
476356|NCT00095836|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
476357|NCT00095862|recurrent breast cancer|recurrent breast cancer
476358|NCT00095862|stage IV breast cancer|stage iv breast cancer
476359|NCT00095862|male breast cancer|male breast cancer
476360|NCT00095862|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
476361|NCT00095875|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
476362|NCT00095875|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
476363|NCT00095875|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
476364|NCT00095875|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
476365|NCT00095875|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
476366|NCT00095875|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
476367|NCT00095875|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
476368|NCT00095875|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
476369|NCT00095901|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
476370|NCT00095901|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
476371|NCT00095901|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
476372|NCT00095901|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
476373|NCT00095914|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
476374|NCT00095927|radiation toxicity|radiation toxicity
476375|NCT00095927|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
476376|NCT00095927|mucositis|mucositis
476377|NCT00095927|xerostomia|xerostomia
476378|NCT00095927|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
476445|NCT00096083|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
476379|NCT00095927|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
476380|NCT00095927|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
476381|NCT00095927|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
476382|NCT00095927|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
476383|NCT00095927|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
476384|NCT00095927|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
476385|NCT00095927|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
476386|NCT00095927|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
476701|NCT00096824|Treatment Naive|treatment naive
476387|NCT00095927|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
476388|NCT00095927|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
476389|NCT00095927|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
476390|NCT00095927|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
476391|NCT00095927|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
476392|NCT00095927|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
476393|NCT00095927|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
476394|NCT00095927|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
476395|NCT00095953|recurrent melanoma|recurrent melanoma
476396|NCT00095953|stage IV melanoma|stage iv melanoma
476397|NCT00095992|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
476398|NCT00095992|advanced adult primary liver cancer|advanced adult primary liver cancer
476399|NCT00095992|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
476400|NCT00095992|recurrent adult primary liver cancer|recurrent adult primary liver cancer
476401|NCT00096018|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
476402|NCT00096018|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
476403|NCT00096018|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
476404|NCT00096018|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
476405|NCT00096018|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
476406|NCT00096031|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
476407|NCT00096031|recurrent esophageal cancer|recurrent esophageal cancer
476408|NCT00096031|stage IV esophageal cancer|stage iv esophageal cancer
476409|NCT00096044|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
476410|NCT00096057|recurrent breast cancer|recurrent breast cancer
476411|NCT00096057|stage IIIA breast cancer|stage iiia breast cancer
476412|NCT00096057|stage IIIB breast cancer|stage iiib breast cancer
476413|NCT00096057|stage IIIC breast cancer|stage iiic breast cancer
476414|NCT00096057|stage IV breast cancer|stage iv breast cancer
476415|NCT00096083|advanced adult primary liver cancer|advanced adult primary liver cancer
476416|NCT00096083|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
476417|NCT00096083|recurrent adult primary liver cancer|recurrent adult primary liver cancer
476418|NCT00096083|liver metastases|liver metastases
476419|NCT00096083|adenocarcinoma of the colon|adenocarcinoma of the colon
476420|NCT00096083|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
476421|NCT00096083|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
476422|NCT00096083|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
476423|NCT00096083|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
476424|NCT00096083|adenocarcinoma of the rectum|adenocarcinoma of the rectum
476425|NCT00096083|adenocarcinoma of the stomach|adenocarcinoma of the stomach
476426|NCT00096083|carcinoma of the appendix|carcinoma of the appendix
476427|NCT00096083|recurrent gallbladder cancer|recurrent gallbladder cancer
476428|NCT00096083|unresectable gallbladder cancer|unresectable gallbladder cancer
476429|NCT00096083|recurrent colon cancer|recurrent colon cancer
476430|NCT00096083|stage IV colon cancer|stage iv colon cancer
476431|NCT00096083|recurrent esophageal cancer|recurrent esophageal cancer
476432|NCT00096083|stage IV esophageal cancer|stage iv esophageal cancer
476433|NCT00096083|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
476434|NCT00096083|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
476435|NCT00096083|recurrent gastric cancer|recurrent gastric cancer
476436|NCT00096083|stage IV gastric cancer|stage iv gastric cancer
476437|NCT00096083|recurrent rectal cancer|recurrent rectal cancer
476438|NCT00096083|stage IV rectal cancer|stage iv rectal cancer
476439|NCT00096083|small intestine adenocarcinoma|small intestine adenocarcinoma
476440|NCT00096083|recurrent small intestine cancer|recurrent small intestine cancer
476441|NCT00096083|recurrent islet cell carcinoma|recurrent islet cell carcinoma
476442|NCT00096083|recurrent pheochromocytoma|recurrent pheochromocytoma
476443|NCT00096083|metastatic pheochromocytoma|metastatic pheochromocytoma
476444|NCT00096083|pulmonary carcinoid tumor|pulmonary carcinoid tumor
476446|NCT00096083|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
476447|NCT00096083|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
476448|NCT00096083|recurrent pancreatic cancer|recurrent pancreatic cancer
476449|NCT00096083|insulinoma|insulinoma
476450|NCT00096083|WDHA syndrome|wdha syndrome
476451|NCT00096083|glucagonoma|glucagonoma
476452|NCT00096083|pancreatic polypeptide tumor|pancreatic polypeptide tumor
476453|NCT00096083|somatostatinoma|somatostatinoma
476454|NCT00096083|stage IV pancreatic cancer|stage iv pancreatic cancer
476455|NCT00096083|intraocular melanoma|intraocular melanoma
476456|NCT00096083|conjunctival melanoma|conjunctival melanoma
476457|NCT00096083|iris melanoma|iris melanoma
476458|NCT00096083|recurrent melanoma|recurrent melanoma
476459|NCT00096083|stage IV melanoma|stage iv melanoma
476460|NCT00096096|graft versus host disease|graft versus host disease
476461|NCT00096096|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
476462|NCT00096096|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
476463|NCT00096096|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
476464|NCT00096096|refractory multiple myeloma|refractory multiple myeloma
476465|NCT00096096|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
476466|NCT00096096|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
476467|NCT00096096|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
476468|NCT00096096|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
476469|NCT00096096|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
476470|NCT00096096|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
476471|NCT00096096|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
476472|NCT00096096|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
476473|NCT00096096|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
476474|NCT00096096|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
476475|NCT00096096|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
476476|NCT00096096|secondary acute myeloid leukemia|secondary acute myeloid leukemia
613571|NCT00627380|HIV|hiv
475858|NCT00091169|fatigue|fatigue
476477|NCT00096096|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
476478|NCT00096096|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
476479|NCT00096096|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
476480|NCT00096096|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
476481|NCT00096096|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
476482|NCT00096096|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
476483|NCT00096096|refractory anemia with excess blasts|refractory anemia with excess blasts
476484|NCT00096096|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
476485|NCT00096096|refractory hairy cell leukemia|refractory hairy cell leukemia
476702|NCT00096837|Myeloma|myeloma
476486|NCT00096096|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
476487|NCT00096096|chronic eosinophilic leukemia|chronic eosinophilic leukemia
476488|NCT00096096|chronic neutrophilic leukemia|chronic neutrophilic leukemia
476489|NCT00096096|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
476490|NCT00096096|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
476491|NCT00096096|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
476492|NCT00096096|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
476493|NCT00096096|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
476494|NCT00096096|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
476495|NCT00096096|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
476496|NCT00096096|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
476497|NCT00096096|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
476498|NCT00096096|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
476499|NCT00096096|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
476500|NCT00096096|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
476501|NCT00096096|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
476502|NCT00096096|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
476503|NCT00096096|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
476504|NCT00096096|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
476505|NCT00096096|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
476506|NCT00096096|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
476507|NCT00096096|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
476508|NCT00096096|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
476509|NCT00096096|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
476510|NCT00096096|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
476511|NCT00096096|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
476512|NCT00096096|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
476513|NCT00096096|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
476514|NCT00096096|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
476515|NCT00096096|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
476516|NCT00096096|stage I multiple myeloma|stage i multiple myeloma
476517|NCT00096096|stage II multiple myeloma|stage ii multiple myeloma
476518|NCT00096096|stage III multiple myeloma|stage iii multiple myeloma
476519|NCT00096096|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
476520|NCT00096096|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
476521|NCT00096096|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
476522|NCT00096096|splenic marginal zone lymphoma|splenic marginal zone lymphoma
476523|NCT00096096|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
476524|NCT00096096|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
476525|NCT00096096|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
476526|NCT00096096|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
476527|NCT00096096|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
476528|NCT00096096|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
476529|NCT00096096|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
476530|NCT00096096|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
476531|NCT00096096|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
476532|NCT00096096|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
476533|NCT00096096|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
476534|NCT00096096|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
95172|NCT02693873|Evidence-Based Health Care|evidence-based health care
613663|NCT00627718|HRT|hrt
475929|NCT00091429|Angina|angina
476535|NCT00096096|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
476536|NCT00096096|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
476537|NCT00096096|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
476538|NCT00096096|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
476539|NCT00096096|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
476619|NCT00096421|Insulin resistance|insulin resistance
476540|NCT00096096|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
476541|NCT00096096|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
476542|NCT00096096|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
476543|NCT00096096|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
476544|NCT00096096|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
476545|NCT00096096|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
476546|NCT00096096|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
476547|NCT00096096|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
476548|NCT00096096|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
476549|NCT00096096|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
476550|NCT00096096|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
476551|NCT00096096|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
476552|NCT00096096|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
476553|NCT00096096|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
476554|NCT00096096|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
585110|NCT00518531|postmenopausal|postmenopausal
476555|NCT00096135|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
476556|NCT00096135|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
476557|NCT00096135|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
476558|NCT00096135|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
476559|NCT00096174|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
476560|NCT00096174|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
476561|NCT00096174|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
476562|NCT00096174|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
476563|NCT00096187|low risk metastatic gestational trophoblastic tumor|low risk metastatic gestational trophoblastic tumor
476564|NCT00096187|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
476565|NCT00096187|nonmetastatic gestational trophoblastic tumor|nonmetastatic gestational trophoblastic tumor
476566|NCT00096213|chondrosarcoma|chondrosarcoma
476567|NCT00096226|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
476568|NCT00096226|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
476569|NCT00096239|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
476570|NCT00096239|primary peritoneal cavity cancer|primary peritoneal cavity cancer
476571|NCT00096239|fallopian tube cancer|fallopian tube cancer
476572|NCT00096291|stage II breast cancer|stage ii breast cancer
476573|NCT00096291|stage IIIA breast cancer|stage iiia breast cancer
476574|NCT00096291|stage IIIB breast cancer|stage iiib breast cancer
476575|NCT00096291|stage IIIC breast cancer|stage iiic breast cancer
476576|NCT00096304|adenocarcinoma of the prostate|adenocarcinoma of the prostate
476577|NCT00096304|recurrent prostate cancer|recurrent prostate cancer
476578|NCT00096304|stage IV prostate cancer|stage iv prostate cancer
476579|NCT00096317|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
476580|NCT00096330|colon cancer|colon cancer
476581|NCT00096330|rectal cancer|rectal cancer
476582|NCT00096343|invasive ductal breast carcinoma|invasive ductal breast carcinoma
476583|NCT00096343|invasive lobular breast carcinoma|invasive lobular breast carcinoma
476584|NCT00096343|stage II breast cancer|stage ii breast cancer
476585|NCT00096343|stage IIIA breast cancer|stage iiia breast cancer
476586|NCT00096343|stage IIIB breast cancer|stage iiib breast cancer
476587|NCT00096343|inflammatory breast cancer|inflammatory breast cancer
476588|NCT00096356|fatigue|fatigue
476589|NCT00096356|stage I breast cancer|stage i breast cancer
476590|NCT00096356|stage II breast cancer|stage ii breast cancer
476591|NCT00096356|stage IIIA breast cancer|stage iiia breast cancer
476592|NCT00096356|stage IIIB breast cancer|stage iiib breast cancer
476593|NCT00096356|stage IIIC breast cancer|stage iiic breast cancer
476594|NCT00096356|stage IV breast cancer|stage iv breast cancer
476595|NCT00096369|breast cancer|breast cancer
476596|NCT00096369|lobular breast carcinoma in situ|lobular breast carcinoma in situ
476597|NCT00096369|breast cancer in situ|breast cancer in situ
476598|NCT00096382|stage IV melanoma|stage iv melanoma
476599|NCT00096382|recurrent melanoma|recurrent melanoma
476600|NCT00096408|Endometrial|endometrial
476601|NCT00096408|Endometrium|endometrium
476602|NCT00096408|Uterus|uterus
476603|NCT00096408|Cancer|cancer
476604|NCT00096408|Carcinoma|carcinoma
476605|NCT00096408|Adenocarcinoma|adenocarcinoma
476606|NCT00096408|Stage 1|stage 1
476607|NCT00096408|Hysterectomy|hysterectomy
476608|NCT00096408|Laparoscopy|laparoscopy
476609|NCT00096408|Abdominal|abdominal
476610|NCT00096408|Total|total
476611|NCT00096408|Surgery|surgery
476612|NCT00096408|Quality of Life|quality of life
476613|NCT00096408|Disease-free survival|disease-free survival
476614|NCT00096421|Critical illness|critical illness
476615|NCT00096421|Critical care|critical care
476616|NCT00096421|Hyperglycemia|hyperglycemia
476617|NCT00096421|Intensive care|intensive care
476718|NCT00096902|Behavior|behavior
476620|NCT00096421|Intensive insulin therapy|intensive insulin therapy
476621|NCT00096421|Conventional insulin therapy|conventional insulin therapy
476622|NCT00096473|Alzheimer's Disease|alzheimer's disease
476623|NCT00096473|dementia|dementia
476624|NCT00096473|acetylcholinesterase|acetylcholinesterase
476625|NCT00096473|donepezil|donepezil
476627|NCT00096473|memory loss|memory loss
476628|NCT00096473|Severe dementia of the Alzheimer's type|severe dementia of the alzheimer's type
476629|NCT00096486|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
476630|NCT00096486|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
476631|NCT00096486|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
476633|NCT00096525|stage III renal cell cancer|stage iii renal cell cancer
476634|NCT00096525|stage IV renal cell cancer|stage iv renal cell cancer
476635|NCT00096538|classic Kaposi sarcoma|classic kaposi sarcoma
476636|NCT00096538|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
476637|NCT00096551|Biochemical Failure|biochemical failure
476638|NCT00096551|Immunotherapy|immunotherapy
476639|NCT00096551|TRICOM|tricom
476640|NCT00096551|Pox-virus|pox-virus
476641|NCT00096551|Fowlpox|fowlpox
476642|NCT00096551|Prostate Cancer|prostate cancer
476643|NCT00096564|Mirror Neuron|mirror neuron
476644|NCT00096564|Urge|urge
476645|NCT00096564|Statistical Parametric Mapping|statistical parametric mapping
476646|NCT00096564|Healthy Volunteer|healthy volunteer
476648|NCT00096590|thromboembolism|thromboembolism
476649|NCT00096590|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
476650|NCT00096603|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
476651|NCT00096629|recurrent renal cell cancer|recurrent renal cell cancer
476652|NCT00096629|stage I renal cell cancer|stage i renal cell cancer
476653|NCT00096629|stage II renal cell cancer|stage ii renal cell cancer
476654|NCT00096629|stage III renal cell cancer|stage iii renal cell cancer
476655|NCT00096629|stage IV renal cell cancer|stage iv renal cell cancer
476656|NCT00096642|cognitive behavioral therapy|cognitive behavioral therapy
476657|NCT00096642|depression|depression
476658|NCT00096642|group therapy|group therapy
476659|NCT00096642|parenting|parenting
476660|NCT00096642|children and adolescents|children and adolescents
476661|NCT00096655|Ulcerative colitis|ulcerative colitis
476662|NCT00096655|Infliximab|infliximab
476663|NCT00096655|Remicade|remicade
476664|NCT00096668|Breast cancer|breast cancer
476665|NCT00096668|TOCOSOL Paclitaxel|tocosol paclitaxel
476666|NCT00096694|Intrauterine Device|intrauterine device
476667|NCT00096694|IUD|iud
476668|NCT00096694|Contraceptive|contraceptive
476669|NCT00096694|Levonorgestrel|levonorgestrel
476670|NCT00096707|advanced solid tumors|advanced solid tumors
476671|NCT00096707|cancer|cancer
476672|NCT00096707|docetaxel|docetaxel
476673|NCT00096707|2-deoxy-D-glucose (2DG)|2-deoxy-d-glucose (2dg)
476674|NCT00096707|phase 1|phase 1
476675|NCT00096720|parkinson|parkinson
476676|NCT00096720|brain imaging|brain imaging
476677|NCT00096720|diagnosis|diagnosis
476678|NCT00096733|Living donors|living donors
476679|NCT00096733|Organ procurement|organ procurement
476680|NCT00096733|Liver transplantation|liver transplantation
476681|NCT00096733|Hepatitis C|hepatitis c
476682|NCT00096733|Hepatocellular carcinoma|hepatocellular carcinoma
476683|NCT00096733|Hepatectomy|hepatectomy
476684|NCT00096733|Liver regeneration|liver regeneration
476685|NCT00096733|Graft rejection|graft rejection
476686|NCT00096733|Quality of life|quality of life
476687|NCT00096733|Informed consent|informed consent
476688|NCT00096746|Treatment Experienced|treatment experienced
476689|NCT00096759|Arthritis|arthritis
476690|NCT00096759|Tai Chi|tai chi
476691|NCT00096759|Meditation|meditation
476692|NCT00096759|Relaxation Techniques|relaxation techniques
476693|NCT00096772|Genetic Testing|genetic testing
476694|NCT00096772|Genomics|genomics
476695|NCT00096772|Human Genetic Factors|human genetic factors
476696|NCT00096785|chronic hepatitis B infection|chronic hepatitis b infection
476697|NCT00096798|Fatty Acids, Omega-3|fatty acids, omega-3
476698|NCT00096798|Antidepressive Agents|antidepressive agents
476699|NCT00096798|Eicosapentanoic Acid|eicosapentanoic acid
476700|NCT00096824|Acute Infection|acute infection
476703|NCT00096837|Multiple Myeloma|multiple myeloma
95174|NCT02693847|HCV|hcv
476115|NCT00092703|Arcoxia|arcoxia
476704|NCT00096837|Relapsed Multiple Myeloma|relapsed multiple myeloma
476705|NCT00096837|Refractory Multiple Myeloma|refractory multiple myeloma
476706|NCT00096850|HIV Seronegativity|hiv seronegativity
476707|NCT00096850|Antitubercular agents|antitubercular agents
476708|NCT00096863|Delirium|delirium
476709|NCT00096863|Cognition Disorders|cognition disorders
476710|NCT00096863|Antipsychotics|antipsychotics
476711|NCT00096863|Mechanical Ventilation|mechanical ventilation
476712|NCT00096863|Critical Illness|critical illness
476713|NCT00096876|Parkinsonian syndrome|parkinsonian syndrome
476714|NCT00096902|Orthostatic Intolerance|orthostatic intolerance
476715|NCT00096902|Hypnosis|hypnosis
476716|NCT00096902|Cold Pressor|cold pressor
476717|NCT00096902|Isometric Exercise|isometric exercise
476719|NCT00096902|Neurocardiogenic Syncope|neurocardiogenic syncope
476720|NCT00096915|chronic kidney disease, CKD|chronic kidney disease, ckd
476721|NCT00096915|renal failure|renal failure
476722|NCT00096915|anemia|anemia
476723|NCT00096915|hemodialysis|hemodialysis
476724|NCT00096915|peritoneal dialysis|peritoneal dialysis
476725|NCT00096915|Aranesp®, Darbepoetin Alfa|aranesp®, darbepoetin alfa
476726|NCT00096928|Plaque Psoriasis|plaque psoriasis
476727|NCT00096928|RESPONSE|response
476728|NCT00096928|Raptiva|raptiva
476729|NCT00096928|efalizumab|efalizumab
476730|NCT00096941|Advanced solid cancers|advanced solid cancers
476731|NCT00096941|HER2|her2
476732|NCT00096941|EGFR|egfr
476733|NCT00096954|Omalizumab (Xolair)|omalizumab (xolair)
476734|NCT00096954|Atopic Asthma|atopic asthma
476735|NCT00096967|Metastatic breast cancer|metastatic breast cancer
476736|NCT00096967|Metastatic colorectal cancer|metastatic colorectal cancer
476737|NCT00096993|Omnitarg|omnitarg
476738|NCT00096993|Cancer|cancer
476739|NCT00096993|Platinum-Resistant|platinum-resistant
476740|NCT00097019|Recurrent ovarian cancer|recurrent ovarian cancer
476741|NCT00097019|Refractory ovarian cancer|refractory ovarian cancer
476742|NCT00097032|Bipolar I Disorder|bipolar i disorder
476743|NCT00097032|risperidone|risperidone
476744|NCT00097032|quetiapine|quetiapine
476745|NCT00097032|sedation|sedation
476746|NCT00097032|cognition|cognition
476747|NCT00097045|Hepatitis C|hepatitis c
476749|NCT00097045|Omega Interferon|omega interferon
476750|NCT00097045|Interferon|interferon
476751|NCT00097045|HCV genotype 1|hcv genotype 1
476752|NCT00097058|Aging|aging
476753|NCT00097058|Menopause|menopause
476754|NCT00097058|Estrogen Replacement Therapy|estrogen replacement therapy
476755|NCT00097058|Cognitive Decline|cognitive decline
476756|NCT00097071|Diabetes, Type 1|diabetes, type 1
476757|NCT00097097|Asphyxia|asphyxia
476758|NCT00097097|Neonatal mortality|neonatal mortality
476759|NCT00097097|Neonatal morbidity|neonatal morbidity
476760|NCT00097097|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
476761|NCT00097097|Neurodevelopmental impairment|neurodevelopmental impairment
476762|NCT00097097|Neonatal resuscitation|neonatal resuscitation
476763|NCT00097097|Global Network|global network
476764|NCT00097097|Zambia|zambia
476765|NCT00097097|Africa|africa
476766|NCT00097097|Cerebral palsy|cerebral palsy
476767|NCT00097097|Child health|child health
476768|NCT00097097|International|international
476769|NCT00097110|Vitamin C|vitamin c
476770|NCT00097110|Vitamin E|vitamin e
476771|NCT00097110|Preeclampsia|preeclampsia
476772|NCT00097110|Antioxidants|antioxidants
476773|NCT00097110|Global Network|global network
476774|NCT00097110|Preterm birth|preterm birth
476775|NCT00097110|Low birth weight infants|low birth weight infants
476776|NCT00097110|Brazil|brazil
476777|NCT00097110|Brasil|brasil
476778|NCT00097110|Maternal and child health|maternal and child health
476779|NCT00097110|International|international
476780|NCT00097110|Women's health|women's health
476781|NCT00097123|Acute postpartum hemorrhage|acute postpartum hemorrhage
476782|NCT00097123|PPH|pph
476783|NCT00097123|Misoprostol|misoprostol
476784|NCT00097123|Global Network|global network
476785|NCT00097123|Uterotonics|uterotonics
476786|NCT00097123|India|india
476787|NCT00097123|Maternal and child health|maternal and child health
476788|NCT00097123|International|international
476789|NCT00097123|Women's health|women's health
476790|NCT00097149|Congenital birth defects|congenital birth defects
476791|NCT00097149|Cleft lip|cleft lip
476792|NCT00097149|Cleft palate|cleft palate
476793|NCT00097149|Global Network|global network
476794|NCT00097149|Neurodevelopmental outcome|neurodevelopmental outcome
476795|NCT00097149|Maternal and child health|maternal and child health
476796|NCT00097149|International|international
476797|NCT00097149|Women's health|women's health
476798|NCT00097149|Brazil|brazil
476799|NCT00097149|Brasil|brasil
476800|NCT00097149|Latin America|latin america
476801|NCT00097149|ECLAMC|eclamc
476802|NCT00097149|Argentina|argentina
476803|NCT00097149|Bolivia|bolivia
476804|NCT00097149|Chile|chile
476805|NCT00097149|Colombia|colombia
476806|NCT00097149|Ecuador|ecuador
476807|NCT00097149|Venezuela|venezuela
476808|NCT00097162|Anisometropia|anisometropia
476809|NCT00097162|Strabismus|strabismus
476810|NCT00097162|Cortical Suppression|cortical suppression
476811|NCT00097162|Impaired Vision|impaired vision
476812|NCT00097162|Cortical Plasticity|cortical plasticity
476813|NCT00097162|Amblyopia|amblyopia
476814|NCT00097162|Adult Amblyopia|adult amblyopia
476815|NCT00097175|Major Depressive Disorder|major depressive disorder
476816|NCT00097175|Serotonin|serotonin
476817|NCT00097175|Functional MRI|functional mri
476818|NCT00097175|Genotype|genotype
476819|NCT00097175|Negative Affect|negative affect
476820|NCT00097175|MDD|mdd
476821|NCT00097175|Healthy Volunteer|healthy volunteer
476822|NCT00097175|HV|hv
476823|NCT00097188|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
476824|NCT00097214|NSCLC|nsclc
476831|NCT00097214|Stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
476957|NCT00097682|Cancer|cancer
476832|NCT00097214|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
476833|NCT00097227|NSCLC|nsclc
476834|NCT00097227|non-small|non-small
476835|NCT00097227|lung|lung
476836|NCT00097227|IIIb|iiib
476838|NCT00097227|Carboplatin|carboplatin
476839|NCT00097227|Paclitaxel|paclitaxel
476840|NCT00097227|Cetuximab|cetuximab
476841|NCT00097227|Stage IIIB Non-Small Cell Lung Cancer|stage iiib non-small cell lung cancer
476842|NCT00097227|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
476843|NCT00097240|FOLLOW|follow
476844|NCT00097240|Psoriasis|psoriasis
476845|NCT00097240|Pregnancy|pregnancy
476846|NCT00097253|Aromatherapy|aromatherapy
476847|NCT00097253|Smell|smell
476848|NCT00097266|Bipolar Mania|bipolar mania
476849|NCT00097292|"at risk for developing type 1 diabetes"|"at risk for developing type 1 diabetes"
476850|NCT00097292|T1DM|t1dm
476852|NCT00097292|juvenile diabetes|juvenile diabetes
476853|NCT00097292|Type 1 Diabetes TrialNet|type 1 diabetes trialnet
476854|NCT00097292|TrialNet|trialnet
476855|NCT00097305|Mental Health|mental health
476856|NCT00097305|Psychotherapy|psychotherapy
476857|NCT00097318|Ischemic|ischemic
476859|NCT00097318|Inflammation|inflammation
476860|NCT00097318|Clinical Trial|clinical trial
476861|NCT00097318|Stroke|stroke
476862|NCT00097331|multiple sclerosis|multiple sclerosis
476863|NCT00097331|relapsing|relapsing
476864|NCT00097331|remitting|remitting
476865|NCT00097331|Relapsing-Remitting MS (RRMS)|relapsing-remitting ms (rrms)
476866|NCT00097344|Aromatase inhibitor|aromatase inhibitor
476867|NCT00097344|Atamestane|atamestane
476868|NCT00097344|Breast neoplasms|breast neoplasms
476869|NCT00097344|Combined hormonal therapy|combined hormonal therapy
476870|NCT00097344|Complete estrogen blockade|complete estrogen blockade
476871|NCT00097344|Ductal breast carcinoma|ductal breast carcinoma
476872|NCT00097344|Estrogen blocker|estrogen blocker
476873|NCT00097344|Fareston®|fareston®
476874|NCT00097344|Femara®|femara®
476875|NCT00097344|First line therapy|first line therapy
476876|NCT00097344|Letrozole|letrozole
476877|NCT00097344|Lobular breast carcinoma|lobular breast carcinoma
476878|NCT00097344|Locally advanced breast cancer|locally advanced breast cancer
476879|NCT00097344|Locally recurrent breast cancer|locally recurrent breast cancer
476880|NCT00097344|Maximal estrogen inhibition|maximal estrogen inhibition
476881|NCT00097344|Metastatic breast cancer|metastatic breast cancer
476882|NCT00097344|Neoplasms, Hormone-dependent|neoplasms, hormone-dependent
476883|NCT00097344|Receptor-positive|receptor-positive
476884|NCT00097344|Stage IIIA breast cancer|stage iiia breast cancer
476885|NCT00097344|Stage IIIB breast cancer|stage iiib breast cancer
476886|NCT00097344|Stage IV breast cancer|stage iv breast cancer
476887|NCT00097344|Toremifene|toremifene
476888|NCT00097357|Prevention of deep vein thrombosis and pulmonary embolism|prevention of deep vein thrombosis and pulmonary embolism
476889|NCT00097357|Preventive therapy|preventive therapy
476890|NCT00097370|Mepolizumab|mepolizumab
476891|NCT00097370|Open-label|open-label
476892|NCT00097370|Anti-IL-5|anti-il-5
476893|NCT00097370|Hypereosinophilic Syndrome|hypereosinophilic syndrome
476894|NCT00097370|Hypereosinophilia|hypereosinophilia
476895|NCT00097396|plague|plague
476896|NCT00097396|recombinant plague vaccine|recombinant plague vaccine
476897|NCT00097396|vaccine|vaccine
476898|NCT00097396|plague vaccine|plague vaccine
476899|NCT00097396|Protection against pneumonic plague|protection against pneumonic plague
476900|NCT00097409|ovarian cancer|ovarian cancer
476901|NCT00097409|platinum/taxane-refractory chemotherapy|platinum/taxane-refractory chemotherapy
476902|NCT00097409|Persistent|persistent
476903|NCT00097409|Recurrent|recurrent
476904|NCT00097422|CDAD, diarrhea|cdad, diarrhea
476905|NCT00097422|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
476906|NCT00097448|sudden hearing loss|sudden hearing loss
476907|NCT00097448|unilateral sudden sensorineural hearing loss|unilateral sudden sensorineural hearing loss
476908|NCT00097448|sudden sensorineural hearing loss|sudden sensorineural hearing loss
476909|NCT00097448|sudden unilateral hearing loss|sudden unilateral hearing loss
476910|NCT00097461|Employee Health|employee health
476285|NCT00095433|AMD|amd
476911|NCT00097461|Insurance Benefit|insurance benefit
476912|NCT00097461|Fringe Benefit|fringe benefit
476913|NCT00097461|Health Status|health status
476914|NCT00097461|Socioeconomic Factors|socioeconomic factors
476915|NCT00097474|Cortisol|cortisol
476916|NCT00097474|Travel|travel
476917|NCT00097474|Saliva|saliva
476918|NCT00097474|Body Clock|body clock
476919|NCT00097474|Sleep|sleep
476920|NCT00097474|Healthy Volunteer|healthy volunteer
476921|NCT00097474|HV|hv
476922|NCT00097474|Jet Lag|jet lag
476923|NCT00097487|Metastatic Breast Cancer|metastatic breast cancer
476924|NCT00097500|diabetes|diabetes
476925|NCT00097500|exenatide|exenatide
476926|NCT00097500|exendin-4|exendin-4
476927|NCT00097500|Amylin|amylin
476928|NCT00097500|Lilly|lilly
476929|NCT00097513|Pubertal Growth Hormone Deficiency|pubertal growth hormone deficiency
476930|NCT00097526|Growth Hormone Deficiency|growth hormone deficiency
476931|NCT00097539|Pediatric growth disorders|pediatric growth disorders
476932|NCT00097565|Follicular Non-Hodgkin's Lymphoma|follicular non-hodgkin's lymphoma
476933|NCT00097604|Sleep|sleep
476934|NCT00097604|Aged|aged
476935|NCT00097604|Valerian|valerian
476936|NCT00097604|Complementary Therapies|complementary therapies
476937|NCT00097604|Medicine, Herbal|medicine, herbal
476938|NCT00097630|mechanical ventilation|mechanical ventilation
476939|NCT00097630|delirium|delirium
476940|NCT00097630|sedation scoring|sedation scoring
476837|NCT00097227|IV|iv
476941|NCT00097630|cognitive impairment|cognitive impairment
476942|NCT00097630|ventilation weaning|ventilation weaning
476943|NCT00097643|exercise|exercise
476944|NCT00097643|health promotion|health promotion
476945|NCT00097643|independent living|independent living
476946|NCT00097643|affective aspects|affective aspects
476947|NCT00097669|VITATOPS|vitatops
476948|NCT00097669|stroke|stroke
476949|NCT00097669|prevention|prevention
476950|NCT00097669|multivitamins|multivitamins
476951|NCT00097669|homocysteine|homocysteine
476952|NCT00097682|Financial Ties|financial ties
476953|NCT00097682|Institution|institution
476954|NCT00097682|Research Doctor|research doctor
476955|NCT00097682|Oncology|oncology
476956|NCT00097682|Attitudes|attitudes
476958|NCT00097682|Survey|survey
476959|NCT00097695|Hereditary Angioedema|hereditary angioedema
476960|NCT00097695|C1 inhibitor deficiency|c1 inhibitor deficiency
476962|NCT00097695|Icatibant|icatibant
476963|NCT00097695|Bradykinin antagonist|bradykinin antagonist
476964|NCT00097695|acute attack|acute attack
476965|NCT00097695|subcutaneous|subcutaneous
476966|NCT00097708|Double Blind, Placebo controlled, Safety and Efficacy|double blind, placebo controlled, safety and efficacy
476967|NCT00097708|Generalized Anxiety Disorder|generalized anxiety disorder
476968|NCT00097721|breast neoplasm|breast neoplasm
476969|NCT00097721|breast cancer|breast cancer
476970|NCT00097721|breast tumor|breast tumor
476971|NCT00088296|Osteoarthritis|osteoarthritis
476972|NCT00088296|MS Contin|ms contin
476973|NCT00088296|Placebo|placebo
476974|NCT00088296|Cortisol|cortisol
476975|NCT00088296|Testosterone|testosterone
476976|NCT00088296|Degenerative Joint Disease|degenerative joint disease
476977|NCT00088296|OA|oa
476978|NCT00088296|Arthritis|arthritis
476979|NCT00088296|Joint Pain|joint pain
476980|NCT00088296|Arthritic Pain|arthritic pain
476981|NCT00088296|Opioid|opioid
476982|NCT00088309|Drug Resistance|drug resistance
476983|NCT00088309|HAART|haart
476984|NCT00088309|Pamidronate|pamidronate
476989|NCT00088309|Treatment Experienced|treatment experienced
476990|NCT00088335|Parkinsonism|parkinsonism
476991|NCT00088335|Biomarker|biomarker
476992|NCT00088335|Proteomics|proteomics
476993|NCT00088335|Parkinson's Disease|parkinson's disease
476994|NCT00088335|Neurodegenerative Disorders|neurodegenerative disorders
476995|NCT00088335|Parkinson Disease|parkinson disease
476996|NCT00088335|PD|pd
476997|NCT00088348|Cornea|cornea
476998|NCT00088348|Conjunctiva|conjunctiva
476999|NCT00088348|Keratitis|keratitis
477000|NCT00088348|Ocular Surface|ocular surface
477001|NCT00088348|Inflammation|inflammation
477002|NCT00088348|Evaluation|evaluation
477003|NCT00088348|Screening|screening
477004|NCT00088348|Ocular Surface Disease|ocular surface disease
477005|NCT00088348|Eye|eye
477006|NCT00088348|Ocular Disease|ocular disease
477007|NCT00088348|Anterior Segment Disease|anterior segment disease
477008|NCT00088361|Reconstruction|reconstruction
477009|NCT00088361|PET Artifacts|pet artifacts
477010|NCT00088361|PET/CT Motion Artifacts|pet/ct motion artifacts
477011|NCT00088361|Liver|liver
477012|NCT00088361|Heart|heart
477013|NCT00088361|Respiratory Motion|respiratory motion
477014|NCT00088374|Kidney Cancer|kidney cancer
477015|NCT00088374|VHL|vhl
477016|NCT00088374|17 AAG|17 aag
477017|NCT00088374|Chemotherapy|chemotherapy
477018|NCT00088374|Von Hippel Lindau Disease|von hippel lindau disease
477019|NCT00088374|Renal Tumor|renal tumor
477020|NCT00088387|Tau|tau
477021|NCT00088387|T181|t181
477022|NCT00088387|T231|t231
477023|NCT00088387|Amyloid Beta|amyloid beta
477024|NCT00088387|Beta-Catenin|beta-catenin
477025|NCT00088387|Alzheimer Disease|alzheimer disease
477026|NCT00088387|AD|ad
477027|NCT00088400|Transferrin|transferrin
477028|NCT00088400|Brain Tumor|brain tumor
477029|NCT00088400|Convection|convection
477030|NCT00088400|Immunotherapy|immunotherapy
477031|NCT00088400|Targeted Protein Toxin|targeted protein toxin
477032|NCT00088400|Glioblastoma Multiforme|glioblastoma multiforme
477033|NCT00088400|GBM|gbm
477034|NCT00088413|CEA|cea
477035|NCT00088413|Vaccine|vaccine
477036|NCT00088413|Immunotherapy|immunotherapy
477037|NCT00088413|MUC-1|muc-1
477038|NCT00088413|Cancer|cancer
477039|NCT00088413|Adenocarcinoma|adenocarcinoma
477040|NCT00088413|Metastatic Adenocarcinoma|metastatic adenocarcinoma
477041|NCT00088426|Holoprosencephaly|holoprosencephaly
477042|NCT00088426|HPE|hpe
477043|NCT00088452|childhood absence epilepsy|childhood absence epilepsy
477044|NCT00088452|CAE|cae
477045|NCT00088452|petit mal epilepsy|petit mal epilepsy
477046|NCT00088452|epilepsy|epilepsy
477047|NCT00088452|seizures|seizures
477048|NCT00088452|ethosuximide|ethosuximide
477049|NCT00088452|lamotrigine|lamotrigine
477050|NCT00088452|valproic acid|valproic acid
477051|NCT00088504|Hepatitis|hepatitis
477052|NCT00088517|Biodistribution|biodistribution
477053|NCT00088517|MIRD|mird
477054|NCT00088517|Radiation Absorbed Dose|radiation absorbed dose
477055|NCT00088517|Healthy|healthy
477056|NCT00088517|Prefrontal Cortex|prefrontal cortex
477057|NCT00088517|Radiation Exposure|radiation exposure
477058|NCT00088517|PET|pet
477059|NCT00088517|Dopamine D1 Receptor|dopamine d1 receptor
477060|NCT00088517|(11C)NNC-112|(11c)nnc-112
477061|NCT00088517|Healthy Volunteer|healthy volunteer
477062|NCT00088517|HV|hv
477063|NCT00088530|Pixantrone|pixantrone
477064|NCT00088530|Non-Hodgkins lymphoma|non-hodgkins lymphoma
477065|NCT00088543|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
477066|NCT00088543|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
477067|NCT00088543|Anti-T cell antibodies|anti-t cell antibodies
477068|NCT00088543|Allogenic stem cell transplant|allogenic stem cell transplant
477069|NCT00088543|Graft vs. Host Disease (GvHD)|graft vs. host disease (gvhd)
477070|NCT00088556|Non-small cell lung cancer|non-small cell lung cancer
477071|NCT00088569|Frontal Lobe|frontal lobe
477072|NCT00088569|Working Memory|working memory
477073|NCT00088569|Treatment|treatment
477074|NCT00088569|Transcranial|transcranial
477075|NCT00088569|Electrical|electrical
477076|NCT00088569|Healthy Volunteer|healthy volunteer
477077|NCT00088569|HV|hv
477078|NCT00088582|Acromegaly|acromegaly
477079|NCT00088582|SOM230|som230
477080|NCT00088582|Sandostatin|sandostatin
477081|NCT00088595|SOM230|som230
477082|NCT00088595|Sandostatin|sandostatin
477083|NCT00088595|Carcinoid syndrome|carcinoid syndrome
477084|NCT00088621|Schizophrenia|schizophrenia
477085|NCT00088621|Latuda|latuda
477086|NCT00088621|Lurasidone|lurasidone
477087|NCT00088634|Schizophrenia|schizophrenia
477088|NCT00088634|Latuda|latuda
477089|NCT00088634|Lurasidone|lurasidone
477090|NCT00088647|advanced malignant solid tumors|advanced malignant solid tumors
477091|NCT00088647|breast cancer|breast cancer
477092|NCT00088660|Metastatic|metastatic
477093|NCT00088673|Alzheimer Disease|alzheimer disease
477094|NCT00088686|Preemptive Analgesia|preemptive analgesia
477095|NCT00088686|Vanilloid|vanilloid
477096|NCT00088686|Capsaicin|capsaicin
477097|NCT00088686|Acute Pain|acute pain
477099|NCT00088686|Vanilloid Receptor (VR)|vanilloid receptor (vr)
477100|NCT00088686|Visual Analog Scale (VAS)|visual analog scale (vas)
477101|NCT00088686|Wisdom Teeth|wisdom teeth
477102|NCT00088686|Third Molar Extraction|third molar extraction
477103|NCT00088699|Depression|depression
477104|NCT00088699|NMDA Antagonist|nmda antagonist
477105|NCT00088699|Treatment Resistant|treatment resistant
477106|NCT00088699|Glutamatergic System|glutamatergic system
477107|NCT00088699|Bipolar Disorder|bipolar disorder
477108|NCT00088699|Major Depression|major depression
477109|NCT00088712|Behavior and Neurocognition|behavior and neurocognition
477110|NCT00088712|Functional Brian Activity|functional brian activity
477111|NCT00088712|Visual Perception|visual perception
477112|NCT00088712|Selective Attention|selective attention
477113|NCT00088712|Information Processing|information processing
477114|NCT00088712|Age Differences|age differences
477115|NCT00088712|Childhood Growth and Development|childhood growth and development
477116|NCT00088712|Cognitive Development|cognitive development
477117|NCT00088712|Brain Connectivity|brain connectivity
477118|NCT00088712|Healthy Volunteer|healthy volunteer
477119|NCT00088712|HV|hv
477120|NCT00088738|Tachykinin|tachykinin
477121|NCT00088738|Anxiety|anxiety
477122|NCT00088738|Neuroreceptor|neuroreceptor
477123|NCT00088738|Internalization|internalization
477124|NCT00088738|Carbon Dioxide|carbon dioxide
477125|NCT00088738|Healthy Volunteer|healthy volunteer
477126|NCT00088738|HV|hv
477127|NCT00088738|Panic Disorder|panic disorder
477128|NCT00088751|Frontotemporal Dementia|frontotemporal dementia
477129|NCT00088751|Alzheimer's Disease|alzheimer's disease
477130|NCT00088751|Atypical Antipsychotic|atypical antipsychotic
477131|NCT00088751|Stimulant|stimulant
477132|NCT00088751|Apathy|apathy
477133|NCT00088751|Disinhibition|disinhibition
477134|NCT00088751|Antipsychotic|antipsychotic
477135|NCT00088751|Biomarkers|biomarkers
477136|NCT00088751|Dementia|dementia
477137|NCT00088751|FTD|ftd
477138|NCT00088764|Stress|stress
477139|NCT00088764|Coping|coping
477140|NCT00088764|Expressive Writing|expressive writing
477141|NCT00088764|Self-Efficacy|self-efficacy
477142|NCT00088764|Disclosure|disclosure
477474|NCT00089245|recurrent osteosarcoma|recurrent osteosarcoma
477143|NCT00088790|advanced, solid, malignancies|advanced, solid, malignancies
477144|NCT00088803|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
477145|NCT00088803|stage I Wilms tumor|stage i wilms tumor
477146|NCT00088803|stage II Wilms tumor|stage ii wilms tumor
477147|NCT00088803|stage III Wilms tumor|stage iii wilms tumor
477148|NCT00088803|stage IV Wilms tumor|stage iv wilms tumor
477149|NCT00088803|stage V Wilms tumor|stage v wilms tumor
477150|NCT00088816|stage IV gastric cancer|stage iv gastric cancer
477151|NCT00088816|adenocarcinoma of the stomach|adenocarcinoma of the stomach
477152|NCT00088829|stage II breast cancer|stage ii breast cancer
477153|NCT00088829|stage IIIA breast cancer|stage iiia breast cancer
477154|NCT00088829|stage IIIB breast cancer|stage iiib breast cancer
477155|NCT00088829|stage IIIC breast cancer|stage iiic breast cancer
477156|NCT00088829|stage IV breast cancer|stage iv breast cancer
477157|NCT00088829|stage IA breast cancer|stage ia breast cancer
477158|NCT00088829|stage IB breast cancer|stage ib breast cancer
477159|NCT00088829|HER2-negative breast cancer|her2-negative breast cancer
477160|NCT00088829|HER2-positive breast cancer|her2-positive breast cancer
477161|NCT00088868|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
477162|NCT00088868|anaplastic large cell lymphoma|anaplastic large cell lymphoma
477163|NCT00088868|intraocular lymphoma|intraocular lymphoma
477164|NCT00088868|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
477165|NCT00088868|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
477166|NCT00088868|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
477167|NCT00088868|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
477168|NCT00088868|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
477169|NCT00088868|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
477170|NCT00088868|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
477171|NCT00088868|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
477172|NCT00088868|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
477173|NCT00088868|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
477174|NCT00088868|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
477175|NCT00088868|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
477176|NCT00088868|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
477177|NCT00088868|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
477178|NCT00088868|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
477179|NCT00088868|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
477180|NCT00088868|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
477181|NCT00088868|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
477182|NCT00088868|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
477183|NCT00088868|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
477184|NCT00088868|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
477185|NCT00088868|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
477186|NCT00088868|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
477187|NCT00088868|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
477188|NCT00088868|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
477189|NCT00088868|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
477190|NCT00088868|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
477191|NCT00088868|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
477192|NCT00088868|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
477193|NCT00088868|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
477194|NCT00088868|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
477195|NCT00088868|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
477196|NCT00088868|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
477197|NCT00088868|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
95175|NCT02693847|HIV|hiv
477198|NCT00088868|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
477199|NCT00088868|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
477200|NCT00088868|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
477201|NCT00088868|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
477202|NCT00088868|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
477203|NCT00088868|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
477204|NCT00088868|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
477205|NCT00088868|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
477206|NCT00088868|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
477207|NCT00088868|small intestine lymphoma|small intestine lymphoma
477208|NCT00088868|Waldenström macroglobulinemia|waldenström macroglobulinemia
477209|NCT00088868|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
477210|NCT00088868|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
477211|NCT00088868|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
477212|NCT00088868|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
477213|NCT00088868|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
477214|NCT00088868|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
477215|NCT00088868|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
477216|NCT00088868|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
477217|NCT00088868|splenic marginal zone lymphoma|splenic marginal zone lymphoma
477218|NCT00088907|docetaxel|docetaxel
477219|NCT00088907|gefitinib|gefitinib
13446|NCT03204500|ALSFRS-R|alsfrs-r
477220|NCT00088907|head and neck cancer|head and neck cancer
585111|NCT00518531|women|women
477221|NCT00088946|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
477222|NCT00088946|stage 0 bladder cancer|stage 0 bladder cancer
477223|NCT00088946|stage I bladder cancer|stage i bladder cancer
477224|NCT00088972|breast cancer|breast cancer
477225|NCT00088972|breast cancer in situ|breast cancer in situ
477226|NCT00088972|lobular breast carcinoma in situ|lobular breast carcinoma in situ
477227|NCT00088972|ductal breast carcinoma|ductal breast carcinoma
477228|NCT00088985|recurrent breast cancer|recurrent breast cancer
477229|NCT00088985|stage IIIB breast cancer|stage iiib breast cancer
477230|NCT00088985|stage IIIC breast cancer|stage iiic breast cancer
477231|NCT00088985|stage IV breast cancer|stage iv breast cancer
477232|NCT00088998|male breast cancer|male breast cancer
477233|NCT00088998|recurrent breast cancer|recurrent breast cancer
477234|NCT00088998|stage IV breast cancer|stage iv breast cancer
477235|NCT00089024|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
477236|NCT00089024|stage II pancreatic cancer|stage ii pancreatic cancer
477237|NCT00089024|stage III pancreatic cancer|stage iii pancreatic cancer
477238|NCT00089037|graft versus host disease|graft versus host disease
477239|NCT00089037|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
477240|NCT00089037|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
477241|NCT00089037|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
477242|NCT00089037|chronic eosinophilic leukemia|chronic eosinophilic leukemia
477243|NCT00089037|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
477244|NCT00089037|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
477245|NCT00089037|chronic neutrophilic leukemia|chronic neutrophilic leukemia
477246|NCT00089037|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
477247|NCT00089037|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
477248|NCT00089037|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
477249|NCT00089037|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
477250|NCT00089037|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
477251|NCT00089037|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
477252|NCT00089037|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
477253|NCT00089037|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
477254|NCT00089037|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
477255|NCT00089037|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
477256|NCT00089037|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
477257|NCT00089037|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
477258|NCT00089037|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
477259|NCT00089037|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
477260|NCT00089037|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
477261|NCT00089037|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
477262|NCT00089037|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
477263|NCT00089037|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
477264|NCT00089037|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
477265|NCT00089037|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
477266|NCT00089037|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
477267|NCT00089037|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
477268|NCT00089037|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
477269|NCT00089037|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
477270|NCT00089037|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
477271|NCT00089037|refractory hairy cell leukemia|refractory hairy cell leukemia
477272|NCT00089037|refractory multiple myeloma|refractory multiple myeloma
477273|NCT00089037|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
477274|NCT00089037|secondary acute myeloid leukemia|secondary acute myeloid leukemia
477275|NCT00089037|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
477276|NCT00089037|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
477277|NCT00089037|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
477278|NCT00089037|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
477279|NCT00089037|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
477570|NCT00089557|Diabetes Mellitus|diabetes mellitus
477280|NCT00089037|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
477281|NCT00089037|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
477282|NCT00089037|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
477283|NCT00089037|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
477284|NCT00089037|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
13745|NCT03202849|vitamin d|vitamin d
477285|NCT00089037|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
477286|NCT00089037|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
477287|NCT00089037|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
477288|NCT00089037|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
477289|NCT00089037|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
477290|NCT00089037|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
477291|NCT00089037|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
477292|NCT00089037|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
477293|NCT00089037|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
477294|NCT00089037|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
477295|NCT00089037|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
477296|NCT00089037|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
477297|NCT00089037|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
477298|NCT00089037|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
477299|NCT00089037|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
477300|NCT00089037|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
477301|NCT00089037|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
477302|NCT00089037|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
477303|NCT00089037|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
477304|NCT00089037|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
477305|NCT00089037|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
477306|NCT00089037|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
477307|NCT00089037|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
477308|NCT00089037|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
477309|NCT00089037|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
477310|NCT00089037|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
477311|NCT00089037|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
477312|NCT00089037|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
477313|NCT00089037|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
477314|NCT00089037|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
477315|NCT00089037|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
477316|NCT00089037|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
477317|NCT00089037|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
477318|NCT00089037|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
477319|NCT00089037|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
477320|NCT00089037|splenic marginal zone lymphoma|splenic marginal zone lymphoma
477321|NCT00089037|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
476647|NCT00096564|HV|hv
477322|NCT00089037|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
477323|NCT00089037|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
477324|NCT00089037|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
477325|NCT00089037|stage I multiple myeloma|stage i multiple myeloma
477326|NCT00089037|stage II multiple myeloma|stage ii multiple myeloma
477327|NCT00089037|stage III multiple myeloma|stage iii multiple myeloma
477328|NCT00089037|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
477329|NCT00089037|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
477330|NCT00089037|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
477331|NCT00089050|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
477332|NCT00089050|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
477333|NCT00089050|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
477334|NCT00089050|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
477335|NCT00089050|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
477336|NCT00089050|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
477337|NCT00089050|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
477338|NCT00089050|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
477339|NCT00089050|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
477340|NCT00089050|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
477341|NCT00089050|adult acute basophilic leukemia|adult acute basophilic leukemia
477342|NCT00089050|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
477343|NCT00089050|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
477344|NCT00089050|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
477345|NCT00089050|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
477346|NCT00089050|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
477347|NCT00089102|recurrent renal cell cancer|recurrent renal cell cancer
477348|NCT00089102|stage III renal cell cancer|stage iii renal cell cancer
477349|NCT00089102|stage IV renal cell cancer|stage iv renal cell cancer
477350|NCT00089115|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
477351|NCT00089115|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
477352|NCT00089115|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
477353|NCT00089115|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
477354|NCT00089115|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
477355|NCT00089115|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
477356|NCT00089115|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
477357|NCT00089115|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
477358|NCT00089115|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
477359|NCT00089115|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
477360|NCT00089115|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
477361|NCT00089115|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
477362|NCT00089115|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
477363|NCT00089115|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
477364|NCT00089115|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
477365|NCT00089115|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
477366|NCT00089115|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
477367|NCT00089115|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
477368|NCT00089128|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
477369|NCT00089128|recurrent bladder cancer|recurrent bladder cancer
477370|NCT00089128|stage III bladder cancer|stage iii bladder cancer
477371|NCT00089128|stage IV bladder cancer|stage iv bladder cancer
477372|NCT00089141|graft versus host disease|graft versus host disease
477373|NCT00089141|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
477374|NCT00089141|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
477375|NCT00089141|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
477376|NCT00089141|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
477377|NCT00089141|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
477378|NCT00089141|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
477379|NCT00089141|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
477380|NCT00089141|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
477381|NCT00089141|chronic eosinophilic leukemia|chronic eosinophilic leukemia
477382|NCT00089141|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
477383|NCT00089141|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
477384|NCT00089141|chronic neutrophilic leukemia|chronic neutrophilic leukemia
477385|NCT00089141|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
477386|NCT00089141|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
477387|NCT00089141|disseminated neuroblastoma|disseminated neuroblastoma
477388|NCT00089141|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
477389|NCT00089141|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
477390|NCT00089141|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
477391|NCT00089141|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
477392|NCT00089141|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
477393|NCT00089141|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
477394|NCT00089141|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
477395|NCT00089141|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
477396|NCT00089141|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
477397|NCT00089141|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
477398|NCT00089141|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
477399|NCT00089141|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
477400|NCT00089141|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
477401|NCT00089141|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
477402|NCT00089141|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
477403|NCT00089141|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
583846|NCT00512902|active alveolitis in systemic sclerosis|active alveolitis in systemic sclerosis
477404|NCT00089141|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
477405|NCT00089141|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
477406|NCT00089141|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
477407|NCT00089141|secondary acute myeloid leukemia|secondary acute myeloid leukemia
477408|NCT00089141|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
477409|NCT00089141|splenic marginal zone lymphoma|splenic marginal zone lymphoma
477410|NCT00089141|stage I multiple myeloma|stage i multiple myeloma
477411|NCT00089141|stage II multiple myeloma|stage ii multiple myeloma
477412|NCT00089141|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
477413|NCT00089141|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
477414|NCT00089141|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
477415|NCT00089141|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
477416|NCT00089141|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
477417|NCT00089141|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
477418|NCT00089141|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
477419|NCT00089141|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
477420|NCT00089141|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
477421|NCT00089141|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
477422|NCT00089141|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
477423|NCT00089141|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
477424|NCT00089141|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
477425|NCT00089141|stage III multiple myeloma|stage iii multiple myeloma
477426|NCT00089141|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
477427|NCT00089141|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
477428|NCT00089141|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
477429|NCT00089141|stage IIIA breast cancer|stage iiia breast cancer
477430|NCT00089141|stage IIIB breast cancer|stage iiib breast cancer
477431|NCT00089141|stage IIIC breast cancer|stage iiic breast cancer
477432|NCT00089141|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
477433|NCT00089141|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
477434|NCT00089141|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
477435|NCT00089141|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
477515|NCT00089427|malignant glioma|malignant glioma
477436|NCT00089141|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
477437|NCT00089141|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
477438|NCT00089141|stage IV breast cancer|stage iv breast cancer
477439|NCT00089141|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
477440|NCT00089141|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
477441|NCT00089141|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
477442|NCT00089141|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
477443|NCT00089141|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
476858|NCT00097318|Brain|brain
477444|NCT00089141|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
477445|NCT00089141|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
477446|NCT00089141|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
477447|NCT00089141|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
477448|NCT00089167|primary systemic amyloidosis|primary systemic amyloidosis
477449|NCT00089193|stage II melanoma|stage ii melanoma
477450|NCT00089193|stage III melanoma|stage iii melanoma
477451|NCT00089193|stage IV melanoma|stage iv melanoma
477452|NCT00089193|recurrent melanoma|recurrent melanoma
477453|NCT00089206|stage III melanoma|stage iii melanoma
477454|NCT00089206|stage IV melanoma|stage iv melanoma
477455|NCT00089206|recurrent melanoma|recurrent melanoma
477456|NCT00089206|recurrent intraocular melanoma|recurrent intraocular melanoma
477457|NCT00089206|iris melanoma|iris melanoma
477458|NCT00089206|extraocular extension melanoma|extraocular extension melanoma
477459|NCT00089206|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
477460|NCT00089219|stage III melanoma|stage iii melanoma
477461|NCT00089219|stage IV melanoma|stage iv melanoma
477462|NCT00089219|recurrent melanoma|recurrent melanoma
477463|NCT00089219|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
477464|NCT00089219|extraocular extension melanoma|extraocular extension melanoma
477465|NCT00089219|iris melanoma|iris melanoma
477466|NCT00089219|recurrent intraocular melanoma|recurrent intraocular melanoma
477467|NCT00089245|leptomeningeal metastases|leptomeningeal metastases
477468|NCT00089245|recurrent neuroblastoma|recurrent neuroblastoma
477469|NCT00089245|disseminated neuroblastoma|disseminated neuroblastoma
477470|NCT00089245|recurrent adult brain tumor|recurrent adult brain tumor
477471|NCT00089245|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
477472|NCT00089245|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
477473|NCT00089245|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
477773|NCT00097851|combination|combination
477475|NCT00089245|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
477476|NCT00089245|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
477477|NCT00089245|adult medulloblastoma|adult medulloblastoma
477478|NCT00089245|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
13747|NCT03202758|Durvalumab|durvalumab
13945|NCT03201393|Radiculopathy|radiculopathy
477479|NCT00089245|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
477480|NCT00089245|metastatic osteosarcoma|metastatic osteosarcoma
477481|NCT00089245|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
477482|NCT00089245|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
477483|NCT00089245|adult rhabdomyosarcoma|adult rhabdomyosarcoma
477484|NCT00089245|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
477485|NCT00089245|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
477486|NCT00089258|localized unresectable neuroblastoma|localized unresectable neuroblastoma
477487|NCT00089258|disseminated neuroblastoma|disseminated neuroblastoma
477488|NCT00089258|regional neuroblastoma|regional neuroblastoma
477489|NCT00089258|stage 4S neuroblastoma|stage 4s neuroblastoma
477490|NCT00089258|recurrent neuroblastoma|recurrent neuroblastoma
477491|NCT00089297|Stage III head and neck cancer|stage iii head and neck cancer
477492|NCT00089297|Stage IV head and neck cancer|stage iv head and neck cancer
477493|NCT00089297|Cetuximab|cetuximab
477494|NCT00089297|Paclitaxel|paclitaxel
477495|NCT00089297|Carboplatin|carboplatin
477496|NCT00089310|stage I non-small cell lung cancer|stage i non-small cell lung cancer
477497|NCT00089323|stage IA breast cancer|stage ia breast cancer
477498|NCT00089323|stage II breast cancer|stage ii breast cancer
477499|NCT00089323|stage IIIA breast cancer|stage iiia breast cancer
477500|NCT00089323|male breast cancer|male breast cancer
477501|NCT00089323|stage IB breast cancer|stage ib breast cancer
477502|NCT00089401|recurrent colon cancer|recurrent colon cancer
477503|NCT00089401|stage IV colon cancer|stage iv colon cancer
477504|NCT00089401|recurrent rectal cancer|recurrent rectal cancer
477505|NCT00089401|stage IV rectal cancer|stage iv rectal cancer
477506|NCT00089401|liver metastases|liver metastases
477507|NCT00089414|Depression|depression
477508|NCT00089414|Menstrual Cycle|menstrual cycle
477509|NCT00089414|Gonadal Steroids|gonadal steroids
477510|NCT00089414|Ethinyl Estradiol|ethinyl estradiol
477511|NCT00089414|Drospirenone|drospirenone
477512|NCT00089414|Menstrually Related Mood Disorder|menstrually related mood disorder
477516|NCT00089427|brain neoplasm|brain neoplasm
477517|NCT00089427|central nervous system|central nervous system
477518|NCT00089427|surgery|surgery
477519|NCT00089427|resection|resection
477520|NCT00089427|temozolomide|temozolomide
477521|NCT00089427|infusion|infusion
477522|NCT00089427|glioblastoma multiforme|glioblastoma multiforme
615119|NCT00640887|HIV|hiv
476961|NCT00097695|HAE|hae
477523|NCT00089427|anaplastic astrocytoma|anaplastic astrocytoma
477524|NCT00089427|oligoastrocytoma|oligoastrocytoma
477525|NCT00089427|Temodar|temodar
477526|NCT00089427|radiation|radiation
477527|NCT00089427|convection-enhanced delivery|convection-enhanced delivery
477528|NCT00089427|GBM|gbm
477529|NCT00089453|Myeloma|myeloma
477530|NCT00089453|Transplant|transplant
477531|NCT00089453|Relapsed|relapsed
477532|NCT00089453|Donor|donor
477533|NCT00089453|Stem Cell|stem cell
477534|NCT00089453|Thalidomide|thalidomide
477535|NCT00089453|Dexamethasone|dexamethasone
477536|NCT00089453|Cisplatin|cisplatin
477537|NCT00089453|Adriamycin|adriamycin
477538|NCT00089453|Cyclophosphamide|cyclophosphamide
477539|NCT00089453|Etoposide|etoposide
477540|NCT00089453|Melphalan|melphalan
477541|NCT00089466|Entry Inhibitors|entry inhibitors
477542|NCT00089466|CXCR4 Entry Inhibitors|cxcr4 entry inhibitors
477543|NCT00089466|Treatment Experienced|treatment experienced
477544|NCT00089466|Treatment Naive|treatment naive
477545|NCT00089505|Treatment Experienced|treatment experienced
477546|NCT00089505|Treatment Naive|treatment naive
477547|NCT00089505|MTCT|mtct
477548|NCT00089505|HIV Seronegativity|hiv seronegativity
477549|NCT00089518|Treatment Experienced|treatment experienced
477550|NCT00089531|Healthy|healthy
477551|NCT00089531|Virus|virus
477552|NCT00089531|T-Cells|t-cells
477553|NCT00089531|HIV-Negative|hiv-negative
477554|NCT00089531|Immunity|immunity
477555|NCT00089531|Healthy Volunteer|healthy volunteer
477556|NCT00089531|HV|hv
477557|NCT00089531|HIV Preventive Vaccine|hiv preventive vaccine
477558|NCT00089531|HIV Seronegativity|hiv seronegativity
477559|NCT00089557|Dermal assessment|dermal assessment
477560|NCT00089557|Pain assessment|pain assessment
477561|NCT00089557|Diary|diary
477562|NCT00089557|Analgesics|analgesics
477563|NCT00089557|Capsaicin|capsaicin
477564|NCT00089557|Herpes zoster|herpes zoster
477565|NCT00089557|Neuralgia|neuralgia
477566|NCT00089557|Pain|pain
477567|NCT00089557|HIV Infections|hiv infections
477568|NCT00089557|Peripheral Nervous System Diseases|peripheral nervous system diseases
477569|NCT00089557|Diabetic Neuropathies|diabetic neuropathies
477571|NCT00089557|Polyneuropathies|polyneuropathies
477572|NCT00089557|Complementary Therapies|complementary therapies
477573|NCT00089570|hepatorenal syndrome|hepatorenal syndrome
477574|NCT00089570|terlipressin|terlipressin
477575|NCT00089583|antiretroviral therapy|antiretroviral therapy
477576|NCT00089583|pediatrics|pediatrics
477577|NCT00089583|AGENERASE|agenerase
477578|NCT00089583|amprenavir|amprenavir
477579|NCT00089583|fosamprenavir|fosamprenavir
477580|NCT00089583|HIV Infection|hiv infection
477581|NCT00089583|ritonavir|ritonavir
477582|NCT00089583|protease inhibitor|protease inhibitor
477583|NCT00089583|LEXIVA|lexiva
477584|NCT00089596|umbilical cord blood|umbilical cord blood
477585|NCT00089596|transplant|transplant
477588|NCT00089596|MDS|mds
477589|NCT00089596|NHL|nhl
477590|NCT00089596|CML|cml
477591|NCT00089609|Hormones|hormones
477592|NCT00089609|Angiogenesis|angiogenesis
477593|NCT00089609|Markers|markers
477594|NCT00089609|Tumor|tumor
477595|NCT00089609|Prostate Cancer|prostate cancer
477596|NCT00089622|Parkinson's Disease|parkinson's disease
477597|NCT00089622|Motor Fluctuations|motor fluctuations
477598|NCT00089622|Intravenous Levodopa|intravenous levodopa
477599|NCT00089622|Antiparkinsonian Response|antiparkinsonian response
477600|NCT00089622|Lisuride Patch|lisuride patch
477601|NCT00089622|Parkinson Disease|parkinson disease
477602|NCT00089622|PD|pd
477603|NCT00089635|Colon, Rectal Cancer|colon, rectal cancer
477604|NCT00089635|ABX-EGF, Panitumumab, EGFr|abx-egf, panitumumab, egfr
477605|NCT00089635|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
477606|NCT00089635|Metastatic Colorectal Cancer|metastatic colorectal cancer
477607|NCT00089635|Vectibix|vectibix
477608|NCT00089661|Breast Cancer|breast cancer
477609|NCT00089661|Bone loss associated with Aromatase Inhibitor therapy (AIT) for non-metastatic BC|bone loss associated with aromatase inhibitor therapy (ait) for non-metastatic bc
477610|NCT00089661|osteopenia|osteopenia
477611|NCT00089661|Low bone density|low bone density
477612|NCT00089674|Prostate Cancer|prostate cancer
477613|NCT00089674|Bone Loss with Prostate Cancer|bone loss with prostate cancer
477614|NCT00089674|Treatment of bone loss in patients undergoing androgen deprivation therapy (ADT) for non-metastatic prostate cancer (PC).|treatment of bone loss in patients undergoing androgen deprivation therapy (adt) for non-metastatic prostate cancer (pc).
477615|NCT00089700|HIV|hiv
477616|NCT00089700|AIDS|aids
477617|NCT00089700|Treatment Experienced|treatment experienced
477618|NCT00089700|Optimized Background Therapy|optimized background therapy
477619|NCT00089700|HIV-1|hiv-1
477620|NCT00089713|antihypertensive agents/therapeutic use|antihypertensive agents/therapeutic use
477621|NCT00089713|hypertension/drug therapy|hypertension/drug therapy
477622|NCT00089713|blood pressure|blood pressure
477623|NCT00089726|cancer vaccine|cancer vaccine
477624|NCT00089726|NSCLC|nsclc
477625|NCT00089726|immunotherapy|immunotherapy
477626|NCT00089739|Uveitis|uveitis
477627|NCT00089739|Suppressor of Cytokine Secretion|suppressor of cytokine secretion
477628|NCT00089739|GITR|gitr
477629|NCT00089739|Immunosuppression|immunosuppression
477630|NCT00089739|GITR Ligand|gitr ligand
477631|NCT00089739|Intraocular Inflammation|intraocular inflammation
477632|NCT00089765|Retinal Angioma|retinal angioma
477633|NCT00089765|Tumor|tumor
477634|NCT00089765|Anti-VEGF|anti-vegf
477635|NCT00089765|Monoclonal Antibody|monoclonal antibody
477636|NCT00089765|Macular Edema|macular edema
477637|NCT00089765|Von Hippel-Lindau Disease|von hippel-lindau disease
477638|NCT00089765|VEGF|vegf
477639|NCT00089765|Ranibizumab|ranibizumab
477640|NCT00089765|VHL|vhl
477641|NCT00089778|Clinical Response|clinical response
477642|NCT00089778|Toxicity|toxicity
477643|NCT00089778|Immunologic Response|immunologic response
477644|NCT00089778|Adjuvant|adjuvant
477645|NCT00089778|IL-2|il-2
477646|NCT00089778|Renal Cancer|renal cancer
477647|NCT00089791|Postmenopausal Osteoporosis|postmenopausal osteoporosis
477648|NCT00089804|Lupus|lupus
477649|NCT00089804|Nephritis|nephritis
477650|NCT00089804|Kidney|kidney
477651|NCT00089804|SLE|sle
477652|NCT00089804|Systemic Lupus Erythematosus|systemic lupus erythematosus
477653|NCT00089804|Nephritis, Lupus|nephritis, lupus
477654|NCT00089830|Subfoveal Choroidal Neovascularization|subfoveal choroidal neovascularization
477655|NCT00089830|Squalamine Lactate|squalamine lactate
477656|NCT00089843|Eating Disorders|eating disorders
477657|NCT00089843|Osteopenia|osteopenia
477658|NCT00089856|Prostate|prostate
477659|NCT00089856|Cancer|cancer
477660|NCT00089856|Metastatic|metastatic
477661|NCT00089856|Hormone-refractory|hormone-refractory
477662|NCT00089856|GVAX|gvax
477663|NCT00089856|Chemotherapy|chemotherapy
477664|NCT00089856|Taxotere|taxotere
477665|NCT00089856|Docetaxel|docetaxel
477666|NCT00089856|Prednisone|prednisone
477667|NCT00089856|Vaccine|vaccine
477668|NCT00089856|Allogeneic cells|allogeneic cells
477669|NCT00089856|Advanced Prostate Cancer|advanced prostate cancer
477670|NCT00089882|Alzheimer disease|alzheimer disease
477671|NCT00089882|Apolipoproteins E (APOE)|apolipoproteins e (apoe)
477672|NCT00089882|Genetic susceptibility testing|genetic susceptibility testing
477673|NCT00089895|myocardial infarction|myocardial infarction
477674|NCT00089895|acute coronary syndrome|acute coronary syndrome
477675|NCT00089895|non-ST-segment elevation|non-st-segment elevation
477676|NCT00089895|eptifibatide|eptifibatide
477678|NCT00089895|glycoprotein IIb/IIIa inhibitor (GP IIb/IIIa)|glycoprotein iib/iiia inhibitor (gp iib/iiia)
477679|NCT00089895|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
477680|NCT00089895|coronary artery bypass graph surgery (CABG)|coronary artery bypass graph surgery (cabg)
477681|NCT00089895|catheterization|catheterization
477682|NCT00089895|angina|angina
477683|NCT00089895|ischemia|ischemia
477684|NCT00089895|cardiac ischemia|cardiac ischemia
477685|NCT00089895|cardiovascular disease|cardiovascular disease
477686|NCT00089908|Dengue Vaccine|dengue vaccine
477687|NCT00089908|Dengue Virus|dengue virus
477688|NCT00089908|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
477689|NCT00089908|Dengue Shock Syndrome|dengue shock syndrome
477690|NCT00089921|Rheumatoid Arthritis|rheumatoid arthritis
477691|NCT00089921|DMARDs|dmards
477692|NCT00089921|Methotrexate|methotrexate
477693|NCT00089921|p38 kinase|p38 kinase
477694|NCT00089947|Anti-T cell antibodies|anti-t cell antibodies
477695|NCT00089947|Living Donor Renal Transplantation|living donor renal transplantation
477696|NCT00089947|Acute Renal Allograft Rejection|acute renal allograft rejection
477697|NCT00089947|Induction Therapy with Reduction of Calcineurin inhibitors|induction therapy with reduction of calcineurin inhibitors
477698|NCT00089960|GIST|gist
477699|NCT00089973|breast cancer|breast cancer
477700|NCT00089986|severe sepsis|severe sepsis
477701|NCT00089986|septic shock|septic shock
477702|NCT00089986|Gram-negative infection|gram-negative infection
477703|NCT00089986|phospholipid emulsion|phospholipid emulsion
477704|NCT00089999|lapatinib|lapatinib
477705|NCT00089999|advanced|advanced
477706|NCT00089999|metastatic breast cancer|metastatic breast cancer
477707|NCT00089999|GW572016|gw572016
477708|NCT00089999|ErbB2|erbb2
477709|NCT00090025|Advanced Biliary Cancer|advanced biliary cancer
477710|NCT00090025|Cholangiocarcinoma|cholangiocarcinoma
477711|NCT00090025|Gall bladder tumor|gall bladder tumor
477712|NCT00090025|Gall bladder cancer|gall bladder cancer
477713|NCT00090025|Bile duct tumor|bile duct tumor
477714|NCT00090025|Tumor of biliary tree|tumor of biliary tree
477715|NCT00090064|MDMA|mdma
477716|NCT00090064|Methylenedioxymethamphetamine|methylenedioxymethamphetamine
477717|NCT00090064|PTSD|ptsd
477718|NCT00090064|psychotherapy|psychotherapy
477719|NCT00090077|GW695634G|gw695634g
477722|NCT00090077|pharmacokinetics|pharmacokinetics
477723|NCT00090077|NNRTI|nnrti
477724|NCT00090077|HIV|hiv
477725|NCT00090103|Combination Therapy|combination therapy
477726|NCT00090103|dutasteride|dutasteride
477727|NCT00090103|BPH|bph
477728|NCT00090116|Neramexane|neramexane
477729|NCT00090116|NMDA receptor antagonist|nmda receptor antagonist
477730|NCT00090116|Memory Loss|memory loss
477731|NCT00090116|Alzheimer Disease|alzheimer disease
477732|NCT00090129|Psoriatic Arthritis|psoriatic arthritis
477733|NCT00090129|Moderate plaque psoriasis|moderate plaque psoriasis
477734|NCT00090129|severe plaque psoriasis|severe plaque psoriasis
477735|NCT00090129|Onercept|onercept
477736|NCT00090129|Placebo|placebo
477737|NCT00097734|diverticulitis|diverticulitis
477738|NCT00097734|Invanz|invanz
477739|NCT00097734|Ertapenem|ertapenem
477740|NCT00097734|acute attacks|acute attacks
477741|NCT00097734|sigmoid diverticulitis|sigmoid diverticulitis
477742|NCT00097734|Acute attacks of sigmoid diverticulitis|acute attacks of sigmoid diverticulitis
477743|NCT00097747|anemia|anemia
477744|NCT00097747|chronic kidney disease|chronic kidney disease
477746|NCT00097747|chronic renal failure|chronic renal failure
477747|NCT00097747|CRF|crf
477748|NCT00097747|erythropoietin|erythropoietin
477749|NCT00097747|EPO|epo
477750|NCT00097747|erythropoiesis stimulating agent|erythropoiesis stimulating agent
477751|NCT00097747|ESA|esa
477752|NCT00097747|Hematide™|hematide™
477753|NCT00097747|hemoglobin|hemoglobin
477754|NCT00097747|Hb|hb
477755|NCT00097747|Hgb|hgb
477756|NCT00097747|Omontys|omontys
477757|NCT00097747|peginesatide|peginesatide
477758|NCT00097747|red blood cell|red blood cell
477759|NCT00097747|red blood cell production|red blood cell production
477760|NCT00097760|Multiple Sclerosis|multiple sclerosis
477761|NCT00097760|MS|ms
477762|NCT00097773|Lung Diseases|lung diseases
477763|NCT00097773|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
477764|NCT00097786|Prevention|prevention
477765|NCT00097786|Diabetes type 2|diabetes type 2
477766|NCT00097786|valsartan|valsartan
477767|NCT00097786|nateglinide|nateglinide
477768|NCT00097812|osteoporosis, osteopenia, post-menopausal, zoledronic acid|osteoporosis, osteopenia, post-menopausal, zoledronic acid
477769|NCT00097825|Male Osteoporosis|male osteoporosis
477770|NCT00097838|HIV Seronegativity|hiv seronegativity
477771|NCT00097838|HIV Preventive Vaccine|hiv preventive vaccine
477772|NCT00097851|second-line|second-line
477774|NCT00097851|chemotherapy|chemotherapy
477775|NCT00097851|anti-angiogenic|anti-angiogenic
477776|NCT00097877|Type 2 Diabetes|type 2 diabetes
477777|NCT00097890|Lysosomes|lysosomes
477778|NCT00097890|Storage|storage
477779|NCT00097890|Glycolipid|glycolipid
477780|NCT00097890|Fabry Disease|fabry disease
477781|NCT00097890|Stroke|stroke
477782|NCT00097903|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
477783|NCT00097903|Solid Tumors|solid tumors
477784|NCT00097903|Oral|oral
477785|NCT00097916|memantine HCl|memantine hcl
477786|NCT00097916|Dementia|dementia
477787|NCT00097916|Agitation|agitation
477788|NCT00097916|Alzheimer Disease|alzheimer disease
477789|NCT00097929|Relapsed Diffuse Large B-cell Lymphoma|relapsed diffuse large b-cell lymphoma
477790|NCT00097942|memantine|memantine
477791|NCT00097942|adjunctive therapy|adjunctive therapy
477792|NCT00097942|schizophrenia|schizophrenia
477793|NCT00097955|diabetes|diabetes
477794|NCT00097955|nephropathy|nephropathy
477795|NCT00097955|hypertension|hypertension
477796|NCT00097955|aliskiren|aliskiren
477797|NCT00097955|losartan|losartan
477798|NCT00097968|transplant, heart, adult, everolimus|transplant, heart, adult, everolimus
477799|NCT00097968|allograft rejection|allograft rejection
477800|NCT00097981|Multiple myeloma|multiple myeloma
477801|NCT00097981|Newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
477802|NCT00097981|Thalidomide|thalidomide
477803|NCT00097981|Dexamethasone|dexamethasone
477804|NCT00097981|DOXIL|doxil
477805|NCT00097981|Pegylated liposomal hydrochloride doxorubicin injection|pegylated liposomal hydrochloride doxorubicin injection
477806|NCT00097994|Menopause|menopause
477807|NCT00097994|Quality of Life|quality of life
477808|NCT00097994|Health Services|health services
477809|NCT00097994|Complementary Therapies|complementary therapies
477810|NCT00098007|Heart transplantation|heart transplantation
477811|NCT00098007|Everolimus|everolimus
477812|NCT00098007|De novo heart transplant patients|de novo heart transplant patients
477813|NCT00098020|Glomerulosclerosis|glomerulosclerosis
477814|NCT00098020|Proteinuria|proteinuria
477815|NCT00098020|Fibrosis|fibrosis
477816|NCT00098020|Chronic Kidney Disease|chronic kidney disease
477817|NCT00098020|Nephrotic Syndrome|nephrotic syndrome
477818|NCT00098033|clinical|clinical
477819|NCT00098033|pharmacodynamics|pharmacodynamics
477820|NCT00098033|investigational drug clofarabine|investigational drug clofarabine
477821|NCT00098033|AML, ALL, CML-accelerated phase, CML-blastic phase|aml, all, cml-accelerated phase, cml-blastic phase
477822|NCT00098033|Chronic Myelogenous Leukemia - accelerated phase|chronic myelogenous leukemia - accelerated phase
477823|NCT00098033|Chronic Myelogenous Leukemia - blastic phase|chronic myelogenous leukemia - blastic phase
477825|NCT00098046|herpes zoster|herpes zoster
477826|NCT00098046|children|children
477827|NCT00098046|Famvir|famvir
477828|NCT00098046|varicella zoster virus|varicella zoster virus
477829|NCT00098059|herpes simplex|herpes simplex
477830|NCT00098059|cold sores|cold sores
477831|NCT00098059|fever blisters|fever blisters
477832|NCT00098059|children|children
477833|NCT00098059|Famvir|famvir
477834|NCT00098059|famciclovir|famciclovir
477835|NCT00098072|Cytometry|cytometry
477836|NCT00098072|Genes|genes
477837|NCT00098072|Hypertension|hypertension
477838|NCT00098072|Lung|lung
477839|NCT00098072|Proteomics|proteomics
477840|NCT00098072|Primary Pulmonary Hypertenion|primary pulmonary hypertenion
477842|NCT00098072|Healthy Volunteers|healthy volunteers
477844|NCT00100594|Treatment Naive|treatment naive
477845|NCT00100607|osteoporosis/osteopenia, BMD, postmenopausal|osteoporosis/osteopenia, bmd, postmenopausal
477846|NCT00100620|Corticosteroid induced osteoporosis|corticosteroid induced osteoporosis
477847|NCT00100620|prevention|prevention
477848|NCT00100620|treatment|treatment
477849|NCT00100620|zoledronic acid|zoledronic acid
477850|NCT00100633|Hepatitis B Vaccine|hepatitis b vaccine
477851|NCT00100633|Treatment Experienced|treatment experienced
477852|NCT00100633|Treatment Naive|treatment naive
477853|NCT00100646|Treatment Interruption|treatment interruption
477854|NCT00100646|Treatment Naive|treatment naive
477855|NCT00100659|pediatric|pediatric
477856|NCT00100659|hepatitis|hepatitis
477857|NCT00100659|children|children
477858|NCT00100659|HCV|hcv
477859|NCT00100659|PEG|peg
477860|NCT00100659|PEG-2a|peg-2a
477861|NCT00100659|peginterferon alfa-2a|peginterferon alfa-2a
477862|NCT00100659|Pegylated Interferon|pegylated interferon
477863|NCT00100659|RV|rv
477864|NCT00100659|ribavirin|ribavirin
477865|NCT00100659|Pegasys|pegasys
477866|NCT00100659|CHC|chc
477867|NCT00100659|chronic hepatitis C|chronic hepatitis c
477868|NCT00100659|chronic hepatitis C virus|chronic hepatitis c virus
477869|NCT00100659|hepatitis c|hepatitis c
477870|NCT00100659|pediatric hepatitis|pediatric hepatitis
477871|NCT00100659|pediatric HCV|pediatric hcv
477872|NCT00100672|LErafAON-ETU|lerafaon-etu
477873|NCT00100672|Signal transduction|signal transduction
477874|NCT00100672|Neoplasm|neoplasm
477875|NCT00100672|Cancer|cancer
477880|NCT00100672|Advanced neoplasm|advanced neoplasm
477881|NCT00100672|Advanced cancer|advanced cancer
477882|NCT00100672|Chemotherapy|chemotherapy
477883|NCT00100672|Refractory cancer|refractory cancer
477884|NCT00100672|Metastatic cancer|metastatic cancer
477885|NCT00100685|Kidney|kidney
477886|NCT00100685|renal|renal
477887|NCT00100685|cancer|cancer
477888|NCT00100685|carcinoma|carcinoma
477889|NCT00100685|cell|cell
477890|NCT00100685|metastatic|metastatic
477891|NCT00100685|metastatic renal cell carcinoma|metastatic renal cell carcinoma
477894|NCT00100698|lipodystrophy|lipodystrophy
477895|NCT00100698|growth hormone|growth hormone
477896|NCT00100698|visceral fat|visceral fat
477897|NCT00100698|IGF-I|igf-i
477898|NCT00100698|Treatment Experienced|treatment experienced
477899|NCT00100711|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
477900|NCT00100711|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
477901|NCT00100711|Leukemia|leukemia
477902|NCT00100711|Lymphoma|lymphoma
477903|NCT00100711|Motexafin Gadolinium|motexafin gadolinium
477904|NCT00100711|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
477905|NCT00100711|Relapsed Chronic Lymphocycic Lymphoma|relapsed chronic lymphocycic lymphoma
477906|NCT00100711|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
477907|NCT00100711|Refractory Small Lymphocytic Lymphoma|refractory small lymphocytic lymphoma
477908|NCT00100724|Anthrax|anthrax
477909|NCT00100724|rPA102|rpa102
477910|NCT00100724|vaccine|vaccine
477911|NCT00100737|non-hodgkins lymphoma|non-hodgkins lymphoma
477912|NCT00100737|interleukin-2|interleukin-2
477913|NCT00100737|rituximab|rituximab
477914|NCT00100737|CD20+ follicular B-cell non-hodgkins lymphoma (grade I, II,III)|cd20+ follicular b-cell non-hodgkins lymphoma (grade i, ii,iii)
477915|NCT00100789|Recurrent|recurrent
477916|NCT00100789|stage IV|stage iv
477917|NCT00100789|squamous cell carcinoma|squamous cell carcinoma
477918|NCT00100789|hypopharynx|hypopharynx
477919|NCT00100789|larynx|larynx
477920|NCT00100789|lip|lip
477921|NCT00100789|oral cavity|oral cavity
477922|NCT00100789|nasopharynx|nasopharynx
477923|NCT00100789|oropharynx|oropharynx
477924|NCT00100789|paranasal|paranasal
477925|NCT00100789|nasal cavity|nasal cavity
477926|NCT00100789|metastatic|metastatic
477927|NCT00100789|neck cancer|neck cancer
477928|NCT00100802|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
477929|NCT00100802|childhood spinal cord neoplasm|childhood spinal cord neoplasm
477930|NCT00100815|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
477931|NCT00100815|recurrent pancreatic cancer|recurrent pancreatic cancer
477932|NCT00100815|stage IV pancreatic cancer|stage iv pancreatic cancer
477933|NCT00100828|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
477934|NCT00100828|recurrent thyroid cancer|recurrent thyroid cancer
477935|NCT00100854|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
477936|NCT00100854|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
477937|NCT00100854|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
477938|NCT00100867|Perinatal Transmission|perinatal transmission
477939|NCT00100867|Mother-to-Child Transmission|mother-to-child transmission
477940|NCT00100893|breast cancer|breast cancer
477941|NCT00100906|stage IV renal cell cancer|stage iv renal cell cancer
477942|NCT00100906|recurrent renal cell cancer|recurrent renal cell cancer
477943|NCT00100906|clear cell renal cell carcinoma|clear cell renal cell carcinoma
477944|NCT00100919|Kinesithesia|kinesithesia
477945|NCT00100919|Sensorimotor Function|sensorimotor function
477946|NCT00100919|Somatosensory|somatosensory
477947|NCT00100919|Muscle Spindles|muscle spindles
477948|NCT00100919|Sensory Feedback|sensory feedback
477949|NCT00100919|Healthy Volunteer|healthy volunteer
477950|NCT00100919|HV|hv
477951|NCT00100945|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
477952|NCT00100945|stage II esophageal cancer|stage ii esophageal cancer
477953|NCT00100958|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
477954|NCT00100971|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
477955|NCT00100971|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
477956|NCT00100971|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
477957|NCT00100971|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
477958|NCT00100971|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
477959|NCT00100971|secondary acute myeloid leukemia|secondary acute myeloid leukemia
477960|NCT00100997|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
477961|NCT00100997|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
477962|NCT00100997|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
477963|NCT00101010|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
477964|NCT00101010|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
477965|NCT00101010|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
477966|NCT00101010|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
477967|NCT00101062|stage IIIA breast cancer|stage iiia breast cancer
477968|NCT00101062|stage IIIB breast cancer|stage iiib breast cancer
477969|NCT00101062|stage IIIC breast cancer|stage iiic breast cancer
477970|NCT00101062|stage IV breast cancer|stage iv breast cancer
477971|NCT00101062|recurrent breast cancer|recurrent breast cancer
13946|NCT03201393|Allodynia|allodynia
13947|NCT03201367|Portal vein|portal vein
477972|NCT00101075|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
477973|NCT00101075|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
477974|NCT00101075|salivary gland acinic cell tumor|salivary gland acinic cell tumor
477975|NCT00101075|salivary gland adenocarcinoma|salivary gland adenocarcinoma
477976|NCT00101075|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
477977|NCT00101075|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
478085|NCT00101582|Radiochemotherapy|radiochemotherapy
477978|NCT00101075|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
477979|NCT00101075|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
477980|NCT00101075|recurrent salivary gland cancer|recurrent salivary gland cancer
477981|NCT00101075|stage III salivary gland cancer|stage iii salivary gland cancer
477982|NCT00101075|stage IV salivary gland cancer|stage iv salivary gland cancer
477983|NCT00101101|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
477984|NCT00101101|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
477985|NCT00101101|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
477986|NCT00101101|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
477987|NCT00101101|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
477988|NCT00101127|recurrent uterine sarcoma|recurrent uterine sarcoma
477989|NCT00101127|stage III uterine sarcoma|stage iii uterine sarcoma
477990|NCT00101127|stage IV uterine sarcoma|stage iv uterine sarcoma
477991|NCT00101127|uterine leiomyosarcoma|uterine leiomyosarcoma
477992|NCT00101140|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
477993|NCT00101140|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
477994|NCT00101140|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
477995|NCT00101140|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
477996|NCT00101140|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
477997|NCT00101140|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
477998|NCT00101140|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
95176|NCT02693847|Liver cirrhosis|liver cirrhosis
477999|NCT00101140|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
478000|NCT00101140|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
478001|NCT00101140|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
478002|NCT00101140|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
478003|NCT00101140|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
478004|NCT00101153|adult acute basophilic leukemia|adult acute basophilic leukemia
478005|NCT00101153|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
478006|NCT00101153|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
478007|NCT00101153|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
478008|NCT00101153|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
478009|NCT00101153|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
478010|NCT00101153|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
478011|NCT00101153|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
478012|NCT00101153|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
478013|NCT00101153|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
478014|NCT00101153|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
478015|NCT00101153|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
478016|NCT00101153|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
478017|NCT00101153|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
478018|NCT00101153|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
478019|NCT00101153|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
478020|NCT00101166|recurrent melanoma|recurrent melanoma
478021|NCT00101166|stage III melanoma|stage iii melanoma
478022|NCT00101166|stage IV melanoma|stage iv melanoma
478023|NCT00101192|recurrent cervical cancer|recurrent cervical cancer
478024|NCT00101192|cervical adenocarcinoma|cervical adenocarcinoma
583847|NCT00512915|Farfield Sensing|farfield sensing
478025|NCT00101192|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
478026|NCT00101192|cervical small cell carcinoma|cervical small cell carcinoma
478027|NCT00101192|cervical squamous cell carcinoma|cervical squamous cell carcinoma
478028|NCT00101192|stage III cervical cancer|stage iii cervical cancer
478029|NCT00101192|stage IVA cervical cancer|stage iva cervical cancer
478030|NCT00101192|stage IVB cervical cancer|stage ivb cervical cancer
478031|NCT00101257|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
478032|NCT00101257|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
478033|NCT00101257|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
478034|NCT00101257|peritoneal cavity cancer|peritoneal cavity cancer
478035|NCT00101283|advanced malignant mesothelioma|advanced malignant mesothelioma
478036|NCT00101283|recurrent malignant mesothelioma|recurrent malignant mesothelioma
478037|NCT00101309|recurrent neuroblastoma|recurrent neuroblastoma
478038|NCT00101309|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
478039|NCT00101335|hypopharyngeal cancer|hypopharyngeal cancer
478040|NCT00101335|lip and oral cavity cancer|lip and oral cavity cancer
478041|NCT00101335|nasopharyngeal cancer|nasopharyngeal cancer
478042|NCT00101335|oropharyngeal cancer|oropharyngeal cancer
478043|NCT00101335|tongue cancer|tongue cancer
478044|NCT00101335|oral leukoplakia|oral leukoplakia
478045|NCT00101361|dermatologic|dermatologic
478047|NCT00101361|clinical trial|clinical trial
478048|NCT00101361|androgen/anabolic|androgen/anabolic
478049|NCT00101374|Immunomodulatory Drug|immunomodulatory drug
478050|NCT00101374|Antiviral|antiviral
478051|NCT00101374|Ki67+|ki67+
478052|NCT00101374|Immune Activation|immune activation
478053|NCT00101374|T Cell Proliferation|t cell proliferation
478054|NCT00101374|HIV|hiv
478055|NCT00101374|Activated CD4+T-cell|activated cd4+t-cell
478056|NCT00101374|Proliferation|proliferation
478057|NCT00101387|Aged|aged
478058|NCT00101387|Acupuncture|acupuncture
478059|NCT00101400|Cancer|cancer
478060|NCT00101413|NSCLC|nsclc
478061|NCT00101426|Diabetic sensorimotor polyneuropathy|diabetic sensorimotor polyneuropathy
478062|NCT00101426|Diabetic Neuropathy|diabetic neuropathy
478063|NCT00101439|Primary Hypercholesterolemia|primary hypercholesterolemia
478064|NCT00101452|Depression|depression
478065|NCT00101452|Antidepressive Agents|antidepressive agents
478066|NCT00101452|Complementary Therapies|complementary therapies
478067|NCT00101465|Heart Failure|heart failure
478068|NCT00101543|Gait Training|gait training
478069|NCT00101543|Motor learning|motor learning
478070|NCT00101543|Electrical stimulation|electrical stimulation
478071|NCT00101543|Body Weight supported Treadmill Training|body weight supported treadmill training
478072|NCT00101543|Cerebrovascular Accident|cerebrovascular accident
478073|NCT00101582|SCCHN|scchn
478074|NCT00101582|Palifermin|palifermin
478075|NCT00101582|Mucositis|mucositis
478076|NCT00101582|Oral Cavity|oral cavity
478077|NCT00101582|Oropharynx|oropharynx
478078|NCT00101582|Nasopharynx|nasopharynx
478079|NCT00101582|Hypopharynx|hypopharynx
478080|NCT00101582|Larynx|larynx
478081|NCT00101582|Mouth Pain|mouth pain
478082|NCT00101582|Mouth Sores|mouth sores
478083|NCT00101582|Radiation Therapy|radiation therapy
478084|NCT00101582|Radiotherapy|radiotherapy
478086|NCT00101582|Concurrent Chemotherapy|concurrent chemotherapy
478087|NCT00101582|Xerostomia|xerostomia
478088|NCT00101582|Stomatitis|stomatitis
478089|NCT00101582|Mucosa|mucosa
478090|NCT00101582|KGF|kgf
478091|NCT00101582|rHuKGF|rhukgf
478092|NCT00101582|Keratinocyte Growth Factor|keratinocyte growth factor
478093|NCT00101582|HNC|hnc
478094|NCT00101582|Head and Neck Cancer|head and neck cancer
478095|NCT00101582|Oral Mucositis|oral mucositis
478096|NCT00101595|Lymphoid blast phase chronic myeloid leukemia|lymphoid blast phase chronic myeloid leukemia
478097|NCT00101595|Philadelphia chromosome positive acute lymphoblastic leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
478098|NCT00101608|urothelium|urothelium
478099|NCT00101621|cancer|cancer
478100|NCT00101621|pain|pain
478101|NCT00101621|Cancers, Pain|cancers, pain
478102|NCT00101634|Schizophrenia|schizophrenia
478103|NCT00101634|Paliperidone palmitate|paliperidone palmitate
478104|NCT00101634|R092670|r092670
478105|NCT00101634|antipsychotic|antipsychotic
478106|NCT00101647|Chronic myelogenous leukemia (CML): Accelerated phase|chronic myelogenous leukemia (cml): accelerated phase
478107|NCT00101660|Chronic phase Philadelphia chromosome chronic myeloid leukemia (Ph+CML)|chronic phase philadelphia chromosome chronic myeloid leukemia (ph+cml)
478108|NCT00101673|type 2 diabetes|type 2 diabetes
478109|NCT00101673|vildagliptin|vildagliptin
478110|NCT00101699|Women|women
478111|NCT00101699|Soy Foods|soy foods
478112|NCT00101699|Middle Aged|middle aged
478113|NCT00101712|type 2 diabetes|type 2 diabetes
478114|NCT00101712|vildagliptin|vildagliptin
478115|NCT00101725|Diarrhea|diarrhea
478116|NCT00101725|IBS|ibs
478117|NCT00101725|Irritable Bowel Syndrome|irritable bowel syndrome
478118|NCT00101725|Abdominal pain|abdominal pain
478119|NCT00101738|MPA|mpa
478120|NCT00101738|Kidney Transplantation|kidney transplantation
478121|NCT00101738|Acute rejection|acute rejection
478122|NCT00101738|Kidney function|kidney function
478123|NCT00101764|AMD|amd
478124|NCT00101764|CRVO|crvo
478125|NCT00101764|BRVO|brvo
478126|NCT00101764|Uveitis|uveitis
478127|NCT00101764|Choroidal Neovascularization|choroidal neovascularization
478128|NCT00101764|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
478129|NCT00101764|Macular Edema|macular edema
478130|NCT00101764|Central Retinal Vein Occlusion|central retinal vein occlusion
478131|NCT00101764|Branch Retinal Vein Occlusion|branch retinal vein occlusion
478132|NCT00101764|Inflammation|inflammation
478133|NCT00101764|Age Related Macular Degeneration|age related macular degeneration
478134|NCT00101764|Retinal Disorder|retinal disorder
478135|NCT00101777|Anxiety|anxiety
478136|NCT00101777|Ventilation|ventilation
478137|NCT00101777|Panic Disorder|panic disorder
478139|NCT00101777|Healthy Volunteer|healthy volunteer
478140|NCT00101777|HV|hv
478141|NCT00101777|Normal Control|normal control
478142|NCT00101790|low back pain|low back pain
478143|NCT00101790|pamidronate|pamidronate
478144|NCT00101803|type 2 diabetes|type 2 diabetes
478145|NCT00101803|vildagliptin|vildagliptin
478146|NCT00101816|Myeloid blast phase Chronic Myeloid Leukemia (CML)|myeloid blast phase chronic myeloid leukemia (cml)
478147|NCT00101829|Autoimmune Diseases|autoimmune diseases
478148|NCT00101855|prevention|prevention
478149|NCT00101855|internet|internet
478150|NCT00101855|quality of care|quality of care
478151|NCT00101868|Aged|aged
478152|NCT00101868|Hospitalists|hospitalists
478153|NCT00101868|Outcome and process assessment (health care)|outcome and process assessment (health care)
478154|NCT00101868|Human|human
478155|NCT00101868|Hospitals, teaching|hospitals, teaching
478156|NCT00101868|Physicians, family|physicians, family
478157|NCT00101868|Medical records|medical records
478158|NCT00101868|Quality assurance, health care|quality assurance, health care
478159|NCT00101868|Medical errors|medical errors
478160|NCT00101881|Cardiac arrest|cardiac arrest
478161|NCT00101881|Defibrillation|defibrillation
478162|NCT00101881|Biphasic defibrillation|biphasic defibrillation
478163|NCT00101881|Monophasic defibrillation|monophasic defibrillation
478164|NCT00101881|Ventricular fibrillation|ventricular fibrillation
478165|NCT00101894|AMG 706|amg 706
478166|NCT00101894|Panitumumab|panitumumab
478167|NCT00101907|Advanced Cancer|advanced cancer
478168|NCT00101907|AMG 706|amg 706
478169|NCT00101907|Panitumumab|panitumumab
478170|NCT00101907|Gemcitabine-Cisplatin|gemcitabine-cisplatin
478171|NCT00101933|Direct brain stimulation, SANTE|direct brain stimulation, sante
478172|NCT00101946|CD|cd
478173|NCT00101946|Crohn's Disease|crohn's disease
478174|NCT00101972|adenocarcinoma of the bladder|adenocarcinoma of the bladder
478175|NCT00101972|adenocarcinoma of the colon|adenocarcinoma of the colon
478176|NCT00101972|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
478177|NCT00101972|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
478178|NCT00101972|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
478179|NCT00101972|adenocarcinoma of the lung|adenocarcinoma of the lung
478180|NCT00101972|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
478181|NCT00101972|adenocarcinoma of the prostate|adenocarcinoma of the prostate
478182|NCT00101972|adenocarcinoma of the rectum|adenocarcinoma of the rectum
478183|NCT00101972|adenocarcinoma of the stomach|adenocarcinoma of the stomach
478184|NCT00101972|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
478185|NCT00101972|cervical adenocarcinoma|cervical adenocarcinoma
478186|NCT00101972|endometrial adenocarcinoma|endometrial adenocarcinoma
478187|NCT00101972|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
478188|NCT00101972|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
478189|NCT00101972|salivary gland adenocarcinoma|salivary gland adenocarcinoma
478190|NCT00101972|small intestine adenocarcinoma|small intestine adenocarcinoma
478191|NCT00101972|vaginal adenocarcinoma|vaginal adenocarcinoma
478192|NCT00101972|vaginal clear cell adenocarcinoma|vaginal clear cell adenocarcinoma
478193|NCT00101972|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
478194|NCT00101972|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
478195|NCT00101972|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
478196|NCT00101972|stage IV bladder cancer|stage iv bladder cancer
478197|NCT00101972|stage IV breast cancer|stage iv breast cancer
478198|NCT00101972|stage IV colon cancer|stage iv colon cancer
478199|NCT00101972|stage IV endometrial carcinoma|stage iv endometrial carcinoma
478200|NCT00101972|stage IV esophageal cancer|stage iv esophageal cancer
478201|NCT00101972|stage IV gastric cancer|stage iv gastric cancer
478202|NCT00101972|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
478203|NCT00101972|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
478204|NCT00101972|stage IV prostate cancer|stage iv prostate cancer
478205|NCT00101972|stage IV rectal cancer|stage iv rectal cancer
478206|NCT00101972|stage IV renal cell cancer|stage iv renal cell cancer
478207|NCT00101972|stage IV salivary gland cancer|stage iv salivary gland cancer
478208|NCT00101972|stage IVA cervical cancer|stage iva cervical cancer
478209|NCT00101972|stage IVA vaginal cancer|stage iva vaginal cancer
478210|NCT00101972|stage IVB cervical cancer|stage ivb cervical cancer
478211|NCT00101972|stage IVB vaginal cancer|stage ivb vaginal cancer
478212|NCT00101972|recurrent bladder cancer|recurrent bladder cancer
478213|NCT00101972|recurrent breast cancer|recurrent breast cancer
478214|NCT00101972|recurrent cervical cancer|recurrent cervical cancer
478215|NCT00101972|recurrent colon cancer|recurrent colon cancer
478216|NCT00101972|recurrent endometrial carcinoma|recurrent endometrial carcinoma
478217|NCT00101972|recurrent esophageal cancer|recurrent esophageal cancer
478222|NCT00101972|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
478223|NCT00101972|recurrent pancreatic cancer|recurrent pancreatic cancer
478224|NCT00101972|recurrent prostate cancer|recurrent prostate cancer
478225|NCT00101972|recurrent rectal cancer|recurrent rectal cancer
478226|NCT00101972|recurrent renal cell cancer|recurrent renal cell cancer
478231|NCT00101972|unresectable gallbladder cancer|unresectable gallbladder cancer
478232|NCT00101972|stage IV pancreatic cancer|stage iv pancreatic cancer
478233|NCT00101985|Quality of Life|quality of life
478234|NCT00101985|Irritable bowel syndrome|irritable bowel syndrome
478235|NCT00101985|IBS|ibs
478236|NCT00101985|SB223412|sb223412
478237|NCT00101985|Qol|qol
478244|NCT00102011|colon cancer|colon cancer
478245|NCT00102011|rectal cancer|rectal cancer
478246|NCT00102024|Metastatic Colorectal Adenocarcinoma|metastatic colorectal adenocarcinoma
478247|NCT00102024|Anti TAG-72|anti tag-72
478248|NCT00102024|Monoclonal Antibody|monoclonal antibody
478249|NCT00102050|NM-702 tablets|nm-702 tablets
478250|NCT00102050|intermittent claudication|intermittent claudication
478251|NCT00102050|peripheral|peripheral
478252|NCT00102050|arterial|arterial
478253|NCT00102050|vascular|vascular
478254|NCT00102050|peripheral arterial disease|peripheral arterial disease
478255|NCT00102063|Schizophrenia|schizophrenia
478256|NCT00102063|Aripiprazole|aripiprazole
478257|NCT00102076|Minimal|minimal
478258|NCT00102076|Risk|risk
478259|NCT00102076|Regulations|regulations
478260|NCT00102076|Parents|parents
478261|NCT00102076|IRB|irb
478262|NCT00102076|Surgery|surgery
478263|NCT00102076|Assent Requirement|assent requirement
478264|NCT00102089|HIV-Negative|hiv-negative
478265|NCT00102089|Healthy|healthy
478266|NCT00102089|Immunity|immunity
478267|NCT00102089|Preventive|preventive
478268|NCT00102089|Virus|virus
478269|NCT00102089|Healthy Volunteer|healthy volunteer
478270|NCT00102089|HV|hv
478271|NCT00102102|Substance P|substance p
478272|NCT00102102|Neurokinin|neurokinin
478273|NCT00102102|Tachykinin|tachykinin
478274|NCT00102102|Anxiety|anxiety
478275|NCT00102102|Neuroreceptor Imaging|neuroreceptor imaging
478276|NCT00102102|Post-Traumatic Stress Disorder|post-traumatic stress disorder
478277|NCT00102102|PTSD|ptsd
478278|NCT00102102|Healthy Volunteer|healthy volunteer
616087|NCT00646464|CPT|cpt
478279|NCT00102102|HV|hv
478280|NCT00102115|Macular disease|macular disease
478281|NCT00102115|Wet AMD|wet amd
478282|NCT00102115|AMD|amd
478283|NCT00102115|Age-Related Macular Disease|age-related macular disease
478284|NCT00102115|PDT|pdt
478285|NCT00102115|Photodynamic Therapy|photodynamic therapy
478286|NCT00102141|Postmenopausal|postmenopausal
478287|NCT00102141|vasomotor symptoms|vasomotor symptoms
478288|NCT00102141|essential hypertension|essential hypertension
478289|NCT00102193|Ulcerative Colitis, Apheresis|ulcerative colitis, apheresis
478290|NCT00102206|Treatment Experienced|treatment experienced
478291|NCT00102206|Child|child
478292|NCT00102232|phosphatidylcholine|phosphatidylcholine
478293|NCT00102232|choline|choline
478294|NCT00102232|homocysteine|homocysteine
478295|NCT00102232|cardiovascular disease prevention|cardiovascular disease prevention
478296|NCT00102232|human|human
478297|NCT00102232|cardiovascular health|cardiovascular health
478298|NCT00102245|Hemoglobin|hemoglobin
478299|NCT00102245|Hemoglobinapathies|hemoglobinapathies
478300|NCT00102245|Human Genome|human genome
478301|NCT00102245|Recombinant DNA Technology|recombinant dna technology
478302|NCT00102245|Sequencing|sequencing
478303|NCT00102245|Erythrocyte|erythrocyte
478304|NCT00102258|Short Stature|short stature
478305|NCT00102258|Constitutional Delay of Growth and Development|constitutional delay of growth and development
478306|NCT00102258|Body Composition|body composition
478307|NCT00102258|Energy Expenditure|energy expenditure
478308|NCT00102258|Dietary Supplements|dietary supplements
478309|NCT00102258|Constitutional Delay of Growth|constitutional delay of growth
478310|NCT00102258|CDGM|cdgm
478311|NCT00102271|Sodium Nitrite|sodium nitrite
478312|NCT00102271|Oxypurinol|oxypurinol
478313|NCT00102271|Ascorbic Acid|ascorbic acid
478314|NCT00102271|Hypoxic Gas|hypoxic gas
478315|NCT00102271|Forearm Blood Flow|forearm blood flow
478316|NCT00102271|Healthy Volunteer|healthy volunteer
478317|NCT00102271|HV|hv
478318|NCT00102284|language acquisition|language acquisition
478319|NCT00102284|plasticity|plasticity
478320|NCT00102284|stroke recovery|stroke recovery
478321|NCT00102284|associative learning|associative learning
478322|NCT00102297|Incipient Nephropathy|incipient nephropathy
478323|NCT00102297|Type 1 or Type 2 Diabetes|type 1 or type 2 diabetes
478324|NCT00102310|Nausea|nausea
478325|NCT00102310|Indigestion|indigestion
478326|NCT00102310|Bloating|bloating
478327|NCT00102310|Functional Dyspepsia|functional dyspepsia
478328|NCT00102310|Fullness after Meals|fullness after meals
14353|NCT03198897|arcus senilis corneae|arcus senilis corneae
478329|NCT00102323|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
478330|NCT00102323|post-splenectomy|post-splenectomy
478331|NCT00102323|ITP|itp
478332|NCT00102323|Thrombopenia|thrombopenia
478333|NCT00102336|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
478334|NCT00102336|pre-splenectomy|pre-splenectomy
478335|NCT00102336|ITP|itp
478336|NCT00102336|Thrombopenia|thrombopenia
478337|NCT00102349|behavioral intervention|behavioral intervention
478338|NCT00102362|behavioral intervention|behavioral intervention
478339|NCT00102375|Ovarian Cancer|ovarian cancer
478340|NCT00102375|first-line|first-line
478341|NCT00102375|Topotecan|topotecan
478342|NCT00102388|type 2 diabetes|type 2 diabetes
478343|NCT00102388|vildagliptin|vildagliptin
478344|NCT00102401|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
478345|NCT00102401|Pulmonary Disease, chronic obstructive|pulmonary disease, chronic obstructive
478346|NCT00102401|Lung disease, obstructive|lung disease, obstructive
478347|NCT00102401|Self-care|self-care
478348|NCT00102401|Self-management|self-management
478349|NCT00102401|Patient education|patient education
478350|NCT00102414|Ovarian cancer|ovarian cancer
478351|NCT00102414|Recurrence or progression|recurrence or progression
478352|NCT00102414|Gemcitabine plus Carboplatin vs Carboplatin|gemcitabine plus carboplatin vs carboplatin
478353|NCT00102427|Anxiety|anxiety
478354|NCT00102427|Panic|panic
478355|NCT00102427|Generalized Anxiety Disorder|generalized anxiety disorder
478356|NCT00102440|uric Acid|uric acid
478357|NCT00102440|xanthine oxidase|xanthine oxidase
478358|NCT00102440|tophi|tophi
478359|NCT00102440|Drug Therapy|drug therapy
478360|NCT00102453|Duchenne|duchenne
478361|NCT00102453|Genetics|genetics
478362|NCT00102466|type 2 diabetes|type 2 diabetes
478363|NCT00102466|vildagliptin|vildagliptin
478364|NCT00102479|Pharmacokinetics,|pharmacokinetics,
478365|NCT00102479|Aripiprazole|aripiprazole
478366|NCT00102479|acute mania in pediatric populations|acute mania in pediatric populations
478367|NCT00102492|Major Depressive Disorder|major depressive disorder
478368|NCT00102492|Major Depression|major depression
478369|NCT00102492|Mood Disorders|mood disorders
478370|NCT00102492|Major Depressive Episode|major depressive episode
478371|NCT00102505|Non-Small Cell Lung Cancer|non-small cell lung cancer
478372|NCT00102505|Lung Cancer|lung cancer
478373|NCT00102505|Metastatic lung cancer|metastatic lung cancer
477677|NCT00089895|Integrilin|integrilin
478374|NCT00102505|Inoperable lung cancer|inoperable lung cancer
478375|NCT00102505|Advanced lung cancer|advanced lung cancer
478376|NCT00102505|Large-cell lung cancer|large-cell lung cancer
478377|NCT00102505|Adenocarcinoma, lung|adenocarcinoma, lung
478378|NCT00102505|Squamous cell carcinoma, lung|squamous cell carcinoma, lung
478379|NCT00102505|Squamous cell lung cancer|squamous cell lung cancer
478380|NCT00102505|Large cell carcinoma, lung|large cell carcinoma, lung
478381|NCT00102505|Bronchogenic|bronchogenic
478382|NCT00102518|Open Label|open label
478383|NCT00102518|Aripiprazole|aripiprazole
478384|NCT00102518|Bipolar I Disorder, Manic or Mixed Episode|bipolar i disorder, manic or mixed episode
478385|NCT00102531|Osteosarcoma|osteosarcoma
478386|NCT00102531|relapsed|relapsed
478387|NCT00102531|progressive|progressive
478388|NCT00102531|metastatic|metastatic
478389|NCT00102531|lung|lung
478390|NCT00102544|CT-Guided|ct-guided
478391|NCT00102544|Electromagnetic Tracking|electromagnetic tracking
478392|NCT00102544|Ultrasound-Guided Biopsy|ultrasound-guided biopsy
478393|NCT00102544|Ablation|ablation
478394|NCT00102544|Surgical Navigation|surgical navigation
478395|NCT00102557|Vesiculobullous|vesiculobullous
478396|NCT00102557|Mucosal Lesions|mucosal lesions
478397|NCT00102557|Oral Health|oral health
478398|NCT00102557|Dermatology|dermatology
478399|NCT00102557|Plaquenil|plaquenil
478400|NCT00102557|Oral Lichen Planus|oral lichen planus
478401|NCT00102557|Mouth Lesions|mouth lesions
478402|NCT00102557|Oral Lesions|oral lesions
478403|NCT00102570|Pediatric|pediatric
478404|NCT00102570|Atopic|atopic
478405|NCT00102570|Asthma|asthma
478406|NCT00102570|Rhinitis|rhinitis
478407|NCT00102570|Outpatient|outpatient
478408|NCT00102570|Allergy|allergy
478409|NCT00102570|Pediatric Allergy|pediatric allergy
478410|NCT00102570|Food Allergy|food allergy
478411|NCT00102570|Stinging Insect Allergy|stinging insect allergy
478412|NCT00102570|Atopic Dermatitis|atopic dermatitis
478413|NCT00102570|Insect Sting|insect sting
478414|NCT00102583|Dry Eye|dry eye
478415|NCT00102583|Lacrimal Gland|lacrimal gland
478416|NCT00102583|Tear Deficiency|tear deficiency
478417|NCT00102583|Keratitis Sicca|keratitis sicca
478418|NCT00102583|GVHD|gvhd
478419|NCT00102583|Ocular GVHD|ocular gvhd
478420|NCT00102583|Ocular Graft Vs Host Disease|ocular graft vs host disease
478421|NCT00102596|Ethanol|ethanol
478422|NCT00102596|Alcohol Responsive|alcohol responsive
478423|NCT00102596|Movement Disorder|movement disorder
478424|NCT00102596|Gas Chromatography|gas chromatography
478425|NCT00102596|Bioavailability|bioavailability
478426|NCT00102596|Pharmacokinetics|pharmacokinetics
478427|NCT00102596|Essential Tremor|essential tremor
478428|NCT00102609|Doxorubicin|doxorubicin
478429|NCT00102609|Adriamycin|adriamycin
478430|NCT00102609|Trabectedin|trabectedin
478431|NCT00102609|Yondelis|yondelis
478432|NCT00102609|Ecteinascidin 743|ecteinascidin 743
478433|NCT00102609|Filgrastim, Antineoplastic|filgrastim, antineoplastic
478434|NCT00102609|Antineoplastic Agents|antineoplastic agents
478435|NCT00102609|Pharmacologic Actions|pharmacologic actions
478436|NCT00102609|Alkylating Agents|alkylating agents
478437|NCT00102622|Ovary|ovary
478438|NCT00102622|ovarian cancer|ovarian cancer
478439|NCT00102622|biologic therapy|biologic therapy
478440|NCT00102622|platinum-resistant|platinum-resistant
478441|NCT00102622|platinum-refractory ovarian cancer|platinum-refractory ovarian cancer
478442|NCT00102622|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
478443|NCT00102622|paclitaxel|paclitaxel
478444|NCT00102622|tgDCC-E1A|tgdcc-e1a
478445|NCT00102622|E1A|e1a
478446|NCT00102622|Taxol|taxol
478447|NCT00102635|apoptotic activity|apoptotic activity
478448|NCT00102635|4-HPR|4-hpr
478449|NCT00102635|FTI|fti
478450|NCT00102635|Fenretinide|fenretinide
478451|NCT00102635|SCH66336|sch66336
478452|NCT00102635|Farnesyl Transferase Inhibitor|farnesyl transferase inhibitor
478453|NCT00102635|HNC|hnc
478454|NCT00102648|Glioblastoma Multiforme|glioblastoma multiforme
478455|NCT00102648|Gliosarcoma|gliosarcoma
478456|NCT00102648|Brain Tumors|brain tumors
478457|NCT00102648|Sarasar|sarasar
478458|NCT00102648|Temodar|temodar
478459|NCT00102648|Temozolomide|temozolomide
478460|NCT00102648|Lonafarnib|lonafarnib
478461|NCT00102648|SCH 66336|sch 66336
478462|NCT00102674|cangrelor|cangrelor
478463|NCT00102674|clopidogrel|clopidogrel
478464|NCT00102700|cancer|cancer
478465|NCT00102700|solid tumor|solid tumor
478466|NCT00102700|advanced solid tumor|advanced solid tumor
478467|NCT00102700|pancreas|pancreas
478468|NCT00102700|pancreatic cancer|pancreatic cancer
478469|NCT00102700|cancer of the pancreas|cancer of the pancreas
478470|NCT00102713|Partial Seizures|partial seizures
478471|NCT00102726|chemotherapy|chemotherapy
478472|NCT00102726|thrombopoietin|thrombopoietin
478473|NCT00102726|platelets|platelets
478474|NCT00102726|chemotherapy induced|chemotherapy induced
478475|NCT00102739|thrombopoietin|thrombopoietin
478476|NCT00102739|immune thrombocytopenic purpura|immune thrombocytopenic purpura
478477|NCT00102739|platelets|platelets
478478|NCT00102739|chronic thrombocytopenia|chronic thrombocytopenia
478479|NCT00102752|Pancreas|pancreas
478480|NCT00102752|Cancer|cancer
478481|NCT00102752|Metastatic|metastatic
478482|NCT00102752|Glufosfamide|glufosfamide
478483|NCT00102752|Advanced|advanced
478484|NCT00102752|Solid|solid
478485|NCT00102752|Tumor|tumor
478486|NCT00102752|Advanced Solid Tumors|advanced solid tumors
478487|NCT00102752|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
478488|NCT00102765|asthma exacerbation|asthma exacerbation
478489|NCT00102765|asthma|asthma
478490|NCT00102778|HIV infected|hiv infected
478491|NCT00102778|therapy-naive subjects|therapy-naive subjects
478492|NCT00102791|Sickle Cell Anemia|sickle cell anemia
478493|NCT00102817|Growth Hormone Disorder|growth hormone disorder
478494|NCT00102830|Solid Tumor|solid tumor
478495|NCT00102830|Metastatic Cancer|metastatic cancer
478496|NCT00102830|Advanced Solid Tumors|advanced solid tumors
478497|NCT00102843|folic acid|folic acid
478498|NCT00102843|betaine|betaine
478499|NCT00102843|homocysteine|homocysteine
478500|NCT00102843|cardiovascular disease prevention|cardiovascular disease prevention
478501|NCT00102843|human|human
478502|NCT00102843|Cardiovascular health|cardiovascular health
478503|NCT00102856|language acquisition|language acquisition
478504|NCT00102856|plasticity|plasticity
478505|NCT00102856|stroke recovery|stroke recovery
478506|NCT00102856|associative learning|associative learning
478507|NCT00102869|language acquisition|language acquisition
478508|NCT00102869|plasticity|plasticity
478509|NCT00102869|stroke recovery|stroke recovery
478510|NCT00102869|aphasia treatment|aphasia treatment
478511|NCT00102869|naming|naming
478512|NCT00102869|levodopa|levodopa
478513|NCT00102869|stroke|stroke
478514|NCT00102882|genotype|genotype
478515|NCT00102882|Salmeterol|salmeterol
478516|NCT00102882|ADVAIR|advair
478517|NCT00102908|Bone Metabolism|bone metabolism
478518|NCT00102908|Osteopenia|osteopenia
478519|NCT00102908|Osteoporosis|osteoporosis
478520|NCT00102908|Treatment Experienced|treatment experienced
478521|NCT00102921|Crohn Disease|crohn disease
478522|NCT00102921|oral medication|oral medication
478524|NCT00102934|Drug Resistance|drug resistance
478525|NCT00102934|Viral Fitness|viral fitness
478526|NCT00102934|HIV Specific Immunity|hiv specific immunity
478527|NCT00102934|T Cell Activation|t cell activation
478528|NCT00102934|Drug Resistant Viremia|drug resistant viremia
478529|NCT00102934|Treatment Experienced|treatment experienced
478530|NCT00102947|renal impairment|renal impairment
478531|NCT00102947|daptomycin|daptomycin
478532|NCT00102947|Cubist|cubist
478533|NCT00102947|complicated skin and skin structure infections|complicated skin and skin structure infections
478534|NCT00102960|Infant|infant
478536|NCT00102960|HIV|hiv
478537|NCT00102960|Disease Transmission, Vertical|disease transmission, vertical
478538|NCT00102960|Anti-Retroviral Agents|anti-retroviral agents
478539|NCT00102960|Treatment Interruption|treatment interruption
478540|NCT00102960|Treatment Naive|treatment naive
478541|NCT00102960|Acute Infection|acute infection
478542|NCT00102960|Mother-to-Child Transmission|mother-to-child transmission
478543|NCT00102973|Ovary|ovary
478544|NCT00102986|Kaletra|kaletra
478545|NCT00102986|Treatment Experienced|treatment experienced
478546|NCT00102999|Learning|learning
478547|NCT00102999|PAS|pas
478548|NCT00102999|Upper Limb|upper limb
478549|NCT00102999|TMS|tms
478550|NCT00102999|Somatosensory|somatosensory
478551|NCT00102999|Dystonia|dystonia
478552|NCT00102999|Upper Limb Dystonia|upper limb dystonia
478553|NCT00102999|Healthy Volunteer|healthy volunteer
478554|NCT00102999|HV|hv
478555|NCT00103012|Antiretrovirals|antiretrovirals
478556|NCT00103012|Protease Inhibitors|protease inhibitors
478557|NCT00103012|Herbal Supplements|herbal supplements
478558|NCT00103012|Drug Interactions|drug interactions
478559|NCT00103012|Metabolism|metabolism
478560|NCT00103012|Healthy Volunteer|healthy volunteer
478561|NCT00103012|HV|hv
478562|NCT00103025|Vasodilation|vasodilation
478563|NCT00103025|Hypotension|hypotension
478564|NCT00103025|Hypertension|hypertension
478565|NCT00103025|EDRF|edrf
478566|NCT00103025|Methemoglobinemia|methemoglobinemia
478567|NCT00103025|Healthy Volunteer|healthy volunteer
478568|NCT00103025|HV|hv
478569|NCT00103051|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
478570|NCT00103090|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
478571|NCT00103090|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
478572|NCT00103090|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
478573|NCT00103090|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
478574|NCT00103090|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
478575|NCT00103090|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
478576|NCT00103090|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
478577|NCT00103090|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
478578|NCT00103090|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
478579|NCT00103090|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
478580|NCT00103090|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
478581|NCT00103090|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
478582|NCT00103090|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
478878|NCT00094068|Healthy Volunteer|healthy volunteer
478583|NCT00103090|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
478584|NCT00103090|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
478585|NCT00103090|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
478586|NCT00103090|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
478587|NCT00103090|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
478588|NCT00103090|recurrent salivary gland cancer|recurrent salivary gland cancer
478589|NCT00103090|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
478590|NCT00103090|stage III salivary gland cancer|stage iii salivary gland cancer
478591|NCT00103090|stage IV salivary gland cancer|stage iv salivary gland cancer
478592|NCT00103090|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
478593|NCT00103090|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
478594|NCT00103103|recurrent gastric cancer|recurrent gastric cancer
478595|NCT00103103|stage IV gastric cancer|stage iv gastric cancer
478596|NCT00103103|adenocarcinoma of the stomach|adenocarcinoma of the stomach
478597|NCT00103116|stage I non-small cell lung cancer|stage i non-small cell lung cancer
478598|NCT00103116|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
478599|NCT00103116|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
478600|NCT00103116|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
478601|NCT00103116|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
478602|NCT00103142|liver metastases|liver metastases
478603|NCT00103142|adenocarcinoma of the colon|adenocarcinoma of the colon
478604|NCT00103142|recurrent colon cancer|recurrent colon cancer
478605|NCT00103142|stage IV colon cancer|stage iv colon cancer
478606|NCT00103142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
478607|NCT00103142|recurrent rectal cancer|recurrent rectal cancer
478608|NCT00103142|stage IV rectal cancer|stage iv rectal cancer
478609|NCT00103142|lung metastases|lung metastases
478610|NCT00103155|stage I papillary thyroid cancer|stage i papillary thyroid cancer
478611|NCT00103168|gastrointestinal stromal tumor|gastrointestinal stromal tumor
478612|NCT00093249|Pre-operative hypertension|pre-operative hypertension
478613|NCT00093262|Postoperative Hypertension|postoperative hypertension
478615|NCT00093288|bupropion|bupropion
478616|NCT00093288|Depression|depression
478617|NCT00093301|Shock|shock
478618|NCT00093301|Levosimendan|levosimendan
478619|NCT00093301|Inotropes|inotropes
478620|NCT00093301|Dobutamine|dobutamine
478621|NCT00093301|Heart failure|heart failure
478622|NCT00093301|Sepsis|sepsis
478623|NCT00093314|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
478624|NCT00093314|B-cell Lymphoma|b-cell lymphoma
478625|NCT00093353|diarrhea|diarrhea
478626|NCT00093353|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
478627|NCT00093353|disseminated neuroblastoma|disseminated neuroblastoma
478628|NCT00093353|recurrent neuroblastoma|recurrent neuroblastoma
478629|NCT00093366|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
478630|NCT00093366|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
478631|NCT00093366|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
478632|NCT00093366|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
478633|NCT00093366|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
478634|NCT00093366|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
478635|NCT00093379|stage II anal cancer|stage ii anal cancer
478636|NCT00093379|stage IIIA anal cancer|stage iiia anal cancer
478637|NCT00093379|stage IIIB anal cancer|stage iiib anal cancer
478638|NCT00093379|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
478639|NCT00093379|Capecitabine|capecitabine
478640|NCT00093379|Xeloda|xeloda
478641|NCT00093379|Oxaliplatin|oxaliplatin
478642|NCT00093379|Eloxatin|eloxatin
478643|NCT00093379|Radiotherapy|radiotherapy
478644|NCT00093379|XRT|xrt
478645|NCT00093405|recurrent renal cell cancer|recurrent renal cell cancer
478646|NCT00093405|stage IV renal cell cancer|stage iv renal cell cancer
478647|NCT00093405|clear cell renal cell carcinoma|clear cell renal cell carcinoma
95177|NCT02693847|Hepatocellular carcinoma|hepatocellular carcinoma
478648|NCT00093444|advanced adult primary liver cancer|advanced adult primary liver cancer
478649|NCT00093444|liver metastases|liver metastases
478650|NCT00093444|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
478651|NCT00093444|recurrent adult primary liver cancer|recurrent adult primary liver cancer
478652|NCT00093457|recurrent prostate cancer|recurrent prostate cancer
478653|NCT00093457|stage IV prostate cancer|stage iv prostate cancer
478654|NCT00093457|adenocarcinoma of the prostate|adenocarcinoma of the prostate
478655|NCT00093470|Leukemia|leukemia
478656|NCT00093470|Acute Myeloid Leukemia|acute myeloid leukemia
478657|NCT00093470|AML|aml
478658|NCT00093470|Farnesyl Transferase Inhibitor|farnesyl transferase inhibitor
478659|NCT00093470|R115777|r115777
478660|NCT00093483|adult acute basophilic leukemia|adult acute basophilic leukemia
478879|NCT00094068|HV|hv
478661|NCT00093483|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
478662|NCT00093483|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
478663|NCT00093483|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
478664|NCT00093483|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
478665|NCT00093483|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
478666|NCT00093483|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
478667|NCT00093483|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
478668|NCT00093483|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
478669|NCT00093483|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
478670|NCT00093483|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
478671|NCT00093483|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
478672|NCT00093483|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
478673|NCT00093483|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
583848|NCT00512915|Pacing lead|pacing lead
478674|NCT00093483|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
478675|NCT00093483|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
478676|NCT00093483|secondary acute myeloid leukemia|secondary acute myeloid leukemia
478677|NCT00093509|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
478678|NCT00093509|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
478679|NCT00093509|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
478680|NCT00093509|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
484817|NCT00121602|Amgen|amgen
478681|NCT00093522|recurrent renal cell cancer|recurrent renal cell cancer
478682|NCT00093522|stage IV renal cell cancer|stage iv renal cell cancer
478683|NCT00093548|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
478684|NCT00093548|advanced adult primary liver cancer|advanced adult primary liver cancer
478685|NCT00093548|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
478686|NCT00093548|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
478688|NCT00093587|graft versus host disease|graft versus host disease
478689|NCT00093587|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
478690|NCT00093587|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
478691|NCT00093587|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
478692|NCT00093587|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
478693|NCT00093587|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
478694|NCT00093587|secondary acute myeloid leukemia|secondary acute myeloid leukemia
478695|NCT00093587|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
478696|NCT00093587|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
478697|NCT00093600|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
478698|NCT00093600|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
478699|NCT00093600|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
478700|NCT00093600|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
478701|NCT00093600|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
478702|NCT00093600|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
478703|NCT00093639|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
478704|NCT00093639|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
478705|NCT00093652|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
478706|NCT00093652|recurrent esophageal cancer|recurrent esophageal cancer
478707|NCT00093652|stage II esophageal cancer|stage ii esophageal cancer
478708|NCT00093652|stage III esophageal cancer|stage iii esophageal cancer
478709|NCT00093652|stage IV esophageal cancer|stage iv esophageal cancer
478710|NCT00093652|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
478711|NCT00093665|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
616700|NCT00639834|RA|ra
478046|NCT00101361|skin|skin
478712|NCT00093665|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
478713|NCT00093665|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
478714|NCT00093665|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
478715|NCT00093665|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
478716|NCT00093665|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
478717|NCT00093678|pain|pain
478718|NCT00093678|cachexia|cachexia
478719|NCT00093678|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
478720|NCT00093678|recurrent uterine sarcoma|recurrent uterine sarcoma
478721|NCT00093678|stage III uterine sarcoma|stage iii uterine sarcoma
478722|NCT00093678|stage IV uterine sarcoma|stage iv uterine sarcoma
478723|NCT00093678|ovarian sarcoma|ovarian sarcoma
478724|NCT00093678|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
478725|NCT00093678|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
478726|NCT00093678|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
478727|NCT00093678|recurrent melanoma|recurrent melanoma
478728|NCT00093678|stage III melanoma|stage iii melanoma
478729|NCT00093678|stage IV melanoma|stage iv melanoma
478730|NCT00093678|chondrosarcoma|chondrosarcoma
478731|NCT00093678|metastatic osteosarcoma|metastatic osteosarcoma
478732|NCT00093678|recurrent osteosarcoma|recurrent osteosarcoma
478733|NCT00093678|classic Kaposi sarcoma|classic kaposi sarcoma
478734|NCT00093678|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
478735|NCT00093678|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
478736|NCT00093678|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
478737|NCT00093678|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
478738|NCT00093678|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
585312|NCT00519363|age eighteen to sixty|age eighteen to sixty
478739|NCT00093678|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
478740|NCT00093678|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
478741|NCT00093678|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
478742|NCT00093678|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
478743|NCT00093678|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
478744|NCT00093678|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
478745|NCT00093678|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
478746|NCT00093678|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
478747|NCT00093678|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
478748|NCT00093678|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
478749|NCT00093678|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
478750|NCT00093678|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
478751|NCT00093678|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
478752|NCT00093678|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
478753|NCT00093678|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
478754|NCT00093678|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
478755|NCT00093678|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
478756|NCT00093678|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
478757|NCT00093678|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
478758|NCT00093678|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
478759|NCT00093678|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
478760|NCT00093678|intraocular lymphoma|intraocular lymphoma
478761|NCT00093678|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
478762|NCT00093678|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
478763|NCT00093678|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
478764|NCT00093678|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
478765|NCT00093678|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
478766|NCT00093678|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
478767|NCT00093678|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
478768|NCT00093678|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
478769|NCT00093678|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
478770|NCT00093678|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
478771|NCT00093678|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
478772|NCT00093678|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
478773|NCT00093678|primary central nervous system lymphoma|primary central nervous system lymphoma
478774|NCT00093678|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
478775|NCT00093678|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
478776|NCT00093678|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
478777|NCT00093678|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
478778|NCT00093678|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
478779|NCT00093678|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
478780|NCT00093678|anaplastic large cell lymphoma|anaplastic large cell lymphoma
478781|NCT00093678|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
478782|NCT00093678|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
478783|NCT00093678|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
478784|NCT00093678|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
478785|NCT00093678|splenic marginal zone lymphoma|splenic marginal zone lymphoma
478786|NCT00093678|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
478787|NCT00093678|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
478788|NCT00093678|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
478789|NCT00093678|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
478880|NCT00094081|squamous cell carcinoma|squamous cell carcinoma
478790|NCT00093678|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
478791|NCT00093678|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
478792|NCT00093678|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
478793|NCT00093678|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
478794|NCT00093678|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
478795|NCT00093678|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
478796|NCT00093678|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
478797|NCT00093704|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
478798|NCT00093704|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
478799|NCT00093704|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
478800|NCT00093704|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
478801|NCT00093704|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
478802|NCT00093704|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
478803|NCT00093730|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
478804|NCT00093769|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
478805|NCT00093769|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
478806|NCT00093769|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
478807|NCT00093769|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
478808|NCT00093769|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
478809|NCT00093769|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
478810|NCT00093769|splenic marginal zone lymphoma|splenic marginal zone lymphoma
478811|NCT00093795|stage II breast cancer|stage ii breast cancer
478812|NCT00093795|stage IIIA breast cancer|stage iiia breast cancer
478813|NCT00093795|stage IIIC breast cancer|stage iiic breast cancer
478814|NCT00093808|recurrent breast cancer|recurrent breast cancer
478815|NCT00093808|stage IV breast cancer|stage iv breast cancer
478816|NCT00093808|male breast cancer|male breast cancer
478817|NCT00093834|stage IV breast cancer|stage iv breast cancer
479018|NCT00094731|Aging|aging
478818|NCT00093834|recurrent breast cancer|recurrent breast cancer
478819|NCT00093847|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
478820|NCT00093847|S-adenosyl Methionine|s-adenosyl methionine
478821|NCT00093847|SSRI|ssri
478822|NCT00093847|SAMe|same
478823|NCT00093860|Adrenaline|adrenaline
478824|NCT00093860|Norepinephrine|norepinephrine
478825|NCT00093860|Sympathetic Nervous System|sympathetic nervous system
478826|NCT00093860|Fainting|fainting
478827|NCT00093860|Hypotension|hypotension
478828|NCT00093860|Beta-Adrenoceptors|beta-adrenoceptors
478829|NCT00093860|Neurocardiogenic Syncope|neurocardiogenic syncope
478830|NCT00093860|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
478831|NCT00093860|Sympathoadrenal Imbalance|sympathoadrenal imbalance
478832|NCT00093860|SAI|sai
478833|NCT00093860|Children|children
478834|NCT00093873|Cancer|cancer
478835|NCT00093873|antiangiogenesis|antiangiogenesis
478836|NCT00093873|Solid Tumors|solid tumors
478837|NCT00093886|Preoperative hypertension|preoperative hypertension
478838|NCT00093899|Mixed Hyperlipidemia|mixed hyperlipidemia
478839|NCT00093912|Perioperative Hypertension|perioperative hypertension
478840|NCT00093925|Postoperative hypertension|postoperative hypertension
478841|NCT00093938|Vaccinium macrocarpon|vaccinium macrocarpon
478842|NCT00093938|Asymptomatic Bacteriuria|asymptomatic bacteriuria
478843|NCT00093951|Alzheimer disease|alzheimer disease
478844|NCT00093951|memory|memory
478845|NCT00093951|cognition|cognition
478846|NCT00093951|GABA(B)receptor antagonist|gaba(b)receptor antagonist
478847|NCT00093964|brain cancer|brain cancer
478848|NCT00093964|brain tumor|brain tumor
478849|NCT00093977|Chronic Kidney Disease|chronic kidney disease
478850|NCT00093977|Dialysis|dialysis
478851|NCT00093977|Anemia|anemia
478852|NCT00093977|Nephrology|nephrology
478853|NCT00093990|Myeloid leukemia acute disease|myeloid leukemia acute disease
478854|NCT00093990|Tipifarnib|tipifarnib
478855|NCT00093990|Bone marrow aspirate|bone marrow aspirate
478856|NCT00094003|Liver metastases|liver metastases
478857|NCT00094003|Colorectal cancer|colorectal cancer
478858|NCT00094003|Gastric cancer|gastric cancer
478859|NCT00094003|Esophagus cancer|esophagus cancer
478860|NCT00094003|Breast cancer|breast cancer
478861|NCT00094003|Lung cancer|lung cancer
478862|NCT00094003|Skin cancer|skin cancer
478863|NCT00094003|Renal Cancer|renal cancer
478864|NCT00094003|Liver metastasis|liver metastasis
478865|NCT00094042|Socioeconomic Factors|socioeconomic factors
478866|NCT00094042|Dietary Supplementation|dietary supplementation
478867|NCT00094068|Gray Matter|gray matter
478868|NCT00094068|White Matter|white matter
478869|NCT00094068|Cerebral Blood Flow|cerebral blood flow
478870|NCT00094068|Cerebral Blood Volume|cerebral blood volume
478871|NCT00094068|Lesion|lesion
478872|NCT00094068|MRI|mri
478873|NCT00094068|Multiple Sclerosis|multiple sclerosis
478874|NCT00094068|Perfusion|perfusion
478875|NCT00094068|Imaging|imaging
478886|NCT00094107|antiangiogenesis|antiangiogenesis
478887|NCT00094120|Age-Related Macular Degeneration - Wet Type|age-related macular degeneration - wet type
478888|NCT00094133|cancer survivor|cancer survivor
478889|NCT00094133|stage IA breast cancer|stage ia breast cancer
478890|NCT00094133|stage IB breast cancer|stage ib breast cancer
478891|NCT00094133|stage II breast cancer|stage ii breast cancer
478892|NCT00094133|stage IIIA breast cancer|stage iiia breast cancer
478893|NCT00094133|stage IIIB breast cancer|stage iiib breast cancer
478894|NCT00094133|stage IIIC breast cancer|stage iiic breast cancer
478895|NCT00094133|stage IV breast cancer|stage iv breast cancer
478896|NCT00094133|breast cancer in situ|breast cancer in situ
478897|NCT00094133|inflammatory breast cancer|inflammatory breast cancer
478898|NCT00094133|hot flashes|hot flashes
478899|NCT00094146|Primary Insulin Hypersecretion|primary insulin hypersecretion
478901|NCT00094146|Obesity|obesity
478902|NCT00094172|Early Multiple Sclerosis|early multiple sclerosis
478903|NCT00094172|MS|ms
478904|NCT00094172|Clinically Isolated Syndrome|clinically isolated syndrome
478905|NCT00094302|Heart Failure|heart failure
478906|NCT00094302|Diastolic Heart Failure|diastolic heart failure
478907|NCT00094302|Preserved Ejection Fraction|preserved ejection fraction
478908|NCT00094328|Testotoxicosis|testotoxicosis
478909|NCT00094328|Familial Male-limited Precocious Puberty (FMPP)|familial male-limited precocious puberty (fmpp)
478910|NCT00094341|Arthritis|arthritis
478911|NCT00094341|Rheumatology|rheumatology
478912|NCT00094354|HIV infected former Plasma Donors|hiv infected former plasma donors
478913|NCT00094354|Needs assessment|needs assessment
478914|NCT00094354|HIV-related stigma and discrimination|hiv-related stigma and discrimination
478915|NCT00094354|In-depth interview|in-depth interview
478916|NCT00094354|Focus Groups|focus groups
478917|NCT00094367|1592U89|1592u89
478918|NCT00094367|GR109714|gr109714
478919|NCT00094367|abacavir|abacavir
478920|NCT00094367|lamivudine|lamivudine
478921|NCT00094367|fixed-dose combination|fixed-dose combination
478922|NCT00094367|once-daily|once-daily
478923|NCT00094367|twice-daily|twice-daily
478924|NCT00094367|HIV infection|hiv infection
478925|NCT00094367|naive|naive
478926|NCT00094380|SLE|sle
478927|NCT00094380|Lupus|lupus
478928|NCT00094380|Systemic Lupus Erythematosus|systemic lupus erythematosus
478929|NCT00094380|Lupus Nephritis|lupus nephritis
478930|NCT00094393|Ageing|ageing
478931|NCT00094393|Atherosclerosis|atherosclerosis
478932|NCT00094393|Lamin A|lamin a
478933|NCT00094393|Lipodystrophy|lipodystrophy
478934|NCT00094393|Growth Impairment|growth impairment
478935|NCT00094393|Premature Aging|premature aging
478936|NCT00094393|Hutchinson-Gilford Progeria Syndrome|hutchinson-gilford progeria syndrome
478937|NCT00094393|HGPS|hgps
478938|NCT00094406|Lung Permeability|lung permeability
478939|NCT00094406|Endotoxin Tolerance|endotoxin tolerance
478940|NCT00094406|Bronchoscopy|bronchoscopy
478941|NCT00094406|Carbon Monoxide Inhalation|carbon monoxide inhalation
478942|NCT00094419|Complementary Therapies|complementary therapies
478943|NCT00094432|depressed|depressed
478944|NCT00094445|Pancreatic Cancer|pancreatic cancer
478945|NCT00094445|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
478946|NCT00094445|Alternative therapy|alternative therapy
478947|NCT00094445|Pancreas|pancreas
478948|NCT00094445|Pancreatic Neoplasm|pancreatic neoplasm
478949|NCT00094445|Cancer of the pancreas|cancer of the pancreas
478950|NCT00094458|Crohn's Disease|crohn's disease
478951|NCT00094458|infliximab|infliximab
478952|NCT00094458|azathioprine|azathioprine
478953|NCT00094458|Remicade|remicade
478954|NCT00094458|SONIC|sonic
478955|NCT00094484|Sensipar®|sensipar®
478956|NCT00094484|Mimpara®|mimpara®
478957|NCT00094484|Cinacalcet|cinacalcet
478958|NCT00094484|Calcimimetic|calcimimetic
478959|NCT00094484|Chronic Kidney Disease|chronic kidney disease
478960|NCT00094510|Prefrontal GABA|prefrontal gaba
478961|NCT00094510|Stress|stress
478962|NCT00094510|Emotion Recognition|emotion recognition
478963|NCT00094510|Differential Reward|differential reward
478964|NCT00094510|Gabapentin|gabapentin
478965|NCT00094510|GABA|gaba
478966|NCT00094510|Prefrontal Cortex|prefrontal cortex
478967|NCT00094510|Emotional Processing|emotional processing
478968|NCT00094510|Healthy Humans|healthy humans
478969|NCT00094510|Healthy Volunteer|healthy volunteer
478970|NCT00094510|HV|hv
478971|NCT00094523|fosamprenavir LEXIVA non-inferiority safety tolerability|fosamprenavir lexiva non-inferiority safety tolerability
478972|NCT00094536|Menorrhagia|menorrhagia
478973|NCT00094536|Excessive Uterine Bleeding|excessive uterine bleeding
478974|NCT00094536|Cryoablation|cryoablation
478975|NCT00094536|Menstrual disorder|menstrual disorder
478976|NCT00094536|Endometrial ablation|endometrial ablation
478977|NCT00094536|Abnormal uterine bleeding|abnormal uterine bleeding
478978|NCT00094536|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
478979|NCT00094562|Cancer|cancer
478980|NCT00094562|Cancer Cachexia|cancer cachexia
478981|NCT00094562|Weight Loss|weight loss
478982|NCT00094562|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
478983|NCT00094562|Chronic Heart Failure|chronic heart failure
478984|NCT00094562|Rheumatoid Arthritis|rheumatoid arthritis
478986|NCT00094575|Aortic Aneurysm|aortic aneurysm
478987|NCT00094575|cost of AAA repair|cost of aaa repair
478988|NCT00094575|Endovascular Repair|endovascular repair
478989|NCT00094575|Grafts|grafts
478990|NCT00094575|Long-term survival|long-term survival
478991|NCT00094575|secondary outcomes|secondary outcomes
478992|NCT00094601|Positron Emission Tomograhy|positron emission tomograhy
478993|NCT00094601|[18F] FDOPA|[18f] fdopa
478994|NCT00094601|[11C] NNC-112|[11c] nnc-112
478995|NCT00094601|Dopamine|dopamine
478996|NCT00094601|Molecular Imaging|molecular imaging
478997|NCT00094601|Dopamine D1 Receptor|dopamine d1 receptor
478999|NCT00094601|Parkinson's Disease|parkinson's disease
479000|NCT00094601|Cognition|cognition
479001|NCT00094601|Parkinson Disease|parkinson disease
479002|NCT00094601|PD|pd
479003|NCT00094601|Healthy Volunteer|healthy volunteer
479004|NCT00094601|HV|hv
479005|NCT00094653|melanoma|melanoma
479006|NCT00094653|metastatic melanoma|metastatic melanoma
479007|NCT00094653|skin cancer|skin cancer
479008|NCT00094692|Amblyopia|amblyopia
479009|NCT00094692|Patching|patching
479010|NCT00094692|Spectacles|spectacles
479011|NCT00094705|Dengue Vaccine|dengue vaccine
479012|NCT00094705|Dengue Virus|dengue virus
479013|NCT00094705|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
479014|NCT00094705|Dengue Shock Syndrome|dengue shock syndrome
479015|NCT00094718|Chimeric Virus Vaccine|chimeric virus vaccine
479016|NCT00094718|West Nile Virus|west nile virus
479017|NCT00094718|Dengue Virus|dengue virus
479019|NCT00094731|Memory|memory
479020|NCT00094731|Mental Recall|mental recall
479021|NCT00094731|Mental Processes|mental processes
479022|NCT00094783|Magnetic Resonance Imaging|magnetic resonance imaging
479023|NCT00094783|Interventional MRI|interventional mri
479024|NCT00094783|Arterial Stenosis|arterial stenosis
479025|NCT00094783|Revascularization|revascularization
479026|NCT00094783|Lllac Artery Stenosis|lllac artery stenosis
479027|NCT00094783|Peripheral Arterial Disease|peripheral arterial disease
479028|NCT00094783|Cardiovascular Disease|cardiovascular disease
479029|NCT00094796|Insulin Resistance|insulin resistance
479030|NCT00094796|Brachial Artery Reactivity|brachial artery reactivity
479031|NCT00094796|Endothelial Progenitor Cells|endothelial progenitor cells
479032|NCT00094796|Metabolic Stress Test|metabolic stress test
479033|NCT00094796|Mitochondrial Function|mitochondrial function
479034|NCT00094796|Type 2 Diabetes|type 2 diabetes
479035|NCT00094796|T2DM|t2dm
479036|NCT00094796|Pre-Diabetes|pre-diabetes
479037|NCT00094809|Neulasta®|neulasta®
479038|NCT00094809|pegfilgrastim|pegfilgrastim
479039|NCT00094809|Advanced|advanced
479040|NCT00094809|Chemotherapy|chemotherapy
479041|NCT00094822|Metastatic Cancer|metastatic cancer
479042|NCT00094822|Neulasta®|neulasta®
479043|NCT00094822|pegfilgrastim|pegfilgrastim
479044|NCT00094835|Lung cancer, Non-small cell lung cancer, NSCLC|lung cancer, non-small cell lung cancer, nsclc
479045|NCT00094835|Clinical Trial, Panitumumab, AMG 706|clinical trial, panitumumab, amg 706
479046|NCT00094835|Anti-angiogenesis|anti-angiogenesis
479047|NCT00094835|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
479048|NCT00094835|Stage IIIB, Stage IV, Unresectable|stage iiib, stage iv, unresectable
479049|NCT00094861|dysphagia|dysphagia
479050|NCT00094861|palifermin, KGF|palifermin, kgf
479051|NCT00094861|chemoradiotherapy|chemoradiotherapy
479052|NCT00094861|NSCLC, non-small cell lung cancer|nsclc, non-small cell lung cancer
479053|NCT00094861|lung cancer|lung cancer
479054|NCT00094861|supportive care|supportive care
479055|NCT00094861|clinical trial|clinical trial
479056|NCT00094861|consolidation chemotherapy|consolidation chemotherapy
479057|NCT00094861|radiotherapy|radiotherapy
479058|NCT00094874|pelvic pain, bladder pain, urgency, frequency, nocturia|pelvic pain, bladder pain, urgency, frequency, nocturia
479059|NCT00094887|Blood Flow|blood flow
479060|NCT00094887|Nitric Oxide|nitric oxide
479061|NCT00094887|Pain Crisis|pain crisis
479062|NCT00094887|Sickle Cell Anemia|sickle cell anemia
479063|NCT00094887|Vaso-Occlusive Crisis|vaso-occlusive crisis
479064|NCT00094887|Sickle Cell Disease|sickle cell disease
479065|NCT00094887|SCD|scd
479066|NCT00094900|Muckle Wells Syndrome|muckle wells syndrome
479067|NCT00094900|NOMID|nomid
479068|NCT00094900|Adult Stills Disease|adult stills disease
479069|NCT00094900|Familial Mediterranean|familial mediterranean
479070|NCT00094900|Treatment Trial/Fever|treatment trial/fever
479071|NCT00094900|Autoinflammatory Disease|autoinflammatory disease
479072|NCT00094913|Aging|aging
479073|NCT00094913|Mild Cognitive Impairment|mild cognitive impairment
479074|NCT00094913|Alzheimer disease, preclinical|alzheimer disease, preclinical
479075|NCT00094913|Hippocampal formation|hippocampal formation
479076|NCT00094913|Glucose metabolism|glucose metabolism
479077|NCT00094926|Risperidal CONSTA|risperidal consta
479078|NCT00094926|Bipolar disorder|bipolar disorder
479079|NCT00094926|mood episodes|mood episodes
479080|NCT00094926|Safety and efficacy, adjuvant therapy|safety and efficacy, adjuvant therapy
479081|NCT00094939|mild cognitive impairment|mild cognitive impairment
479082|NCT00094939|Alzheimer disease|alzheimer disease
479083|NCT00094939|magnetic resonance imaging|magnetic resonance imaging
479084|NCT00094939|CSF tau protein|csf tau protein
479086|NCT00094952|Mild Cognitive Impairment|mild cognitive impairment
479087|NCT00094952|Alzheimer's disease|alzheimer's disease
479088|NCT00094952|magnetic resonance imaging|magnetic resonance imaging
479089|NCT00094952|cerebrospinal fluid (CSF) biomarkers|cerebrospinal fluid (csf) biomarkers
479090|NCT00094965|Advanced Gastrointestinal tumors and normal to severely abnormal renal function|advanced gastrointestinal tumors and normal to severely abnormal renal function
479091|NCT00094978|Apoptosis|apoptosis
479092|NCT00094978|Toxicity|toxicity
479093|NCT00094978|Pharmacokinetic|pharmacokinetic
479094|NCT00094978|Gene Induction|gene induction
479095|NCT00094978|Maximally Tolerated Dose|maximally tolerated dose
479096|NCT00094978|Small Cell Lung Cancer|small cell lung cancer
479097|NCT00094978|SCLC|sclc
479098|NCT00094978|Non-Small Cell Lung Cancer|non-small cell lung cancer
479099|NCT00094978|NSCLC|nsclc
479100|NCT00094978|Esophageal Cancer|esophageal cancer
479101|NCT00094978|Pleural Mesothelioma|pleural mesothelioma
479102|NCT00094991|Type 2 diabetes|type 2 diabetes
479103|NCT00095017|Arcoxia|arcoxia
479104|NCT00095030|Diabetes|diabetes
479105|NCT00095056|Type 2 Diabetes Mellitus and Chronic Renal Insufficiency|type 2 diabetes mellitus and chronic renal insufficiency
479106|NCT00095082|Diabetes Mellitus, Type I|diabetes mellitus, type i
479107|NCT00095095|Spine|spine
479108|NCT00095095|Lumbar spine|lumbar spine
479109|NCT00095095|Spinal fusion|spinal fusion
479110|NCT00095095|Low back pain|low back pain
479111|NCT00095095|Fusion cage|fusion cage
479112|NCT00095095|Posterior lumbar interbody fusion|posterior lumbar interbody fusion
479113|NCT00095095|Bioresorbable|bioresorbable
479114|NCT00095095|Peek|peek
479115|NCT00095108|Metastatic Melanoma|metastatic melanoma
479116|NCT00095108|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
479117|NCT00095121|Hepatitis B|hepatitis b
479118|NCT00095121|Children|children
479119|NCT00095121|Pediatric|pediatric
479120|NCT00095121|Adefovir Dipivoxil|adefovir dipivoxil
479121|NCT00103181|stage II breast cancer|stage ii breast cancer
479122|NCT00103181|ductal breast carcinoma in situ|ductal breast carcinoma in situ
479123|NCT00103181|breast cancer in situ|breast cancer in situ
479124|NCT00103181|stage IA breast cancer|stage ia breast cancer
479125|NCT00103181|stage IB breast cancer|stage ib breast cancer
479126|NCT00103207|bronchioalveolar carcinoma (BAC)|bronchioalveolar carcinoma (bac)
479127|NCT00103207|adenocarcinoma with BAC features|adenocarcinoma with bac features
479128|NCT00103207|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
479129|NCT00103207|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
479130|NCT00103207|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
479131|NCT00103207|cetuximab|cetuximab
479132|NCT00103233|stage IV breast cancer|stage iv breast cancer
479133|NCT00103233|recurrent breast cancer|recurrent breast cancer
479134|NCT00103246|skin cancer|skin cancer
479135|NCT00103246|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
479136|NCT00103246|basal cell carcinoma of the skin|basal cell carcinoma of the skin
479137|NCT00103246|recurrent skin cancer|recurrent skin cancer
479138|NCT00103246|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
479139|NCT00103246|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
479140|NCT00103246|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
479141|NCT00103246|actinic keratosis|actinic keratosis
479142|NCT00103246|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
479143|NCT00103246|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
479144|NCT00103246|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
479145|NCT00103298|recurrent colon cancer|recurrent colon cancer
479146|NCT00103298|stage IV colon cancer|stage iv colon cancer
479147|NCT00103298|recurrent rectal cancer|recurrent rectal cancer
479148|NCT00103298|stage IV rectal cancer|stage iv rectal cancer
479149|NCT00103298|liver metastases|liver metastases
479150|NCT00103350|myocardial infarction|myocardial infarction
479151|NCT00103350|infarct size|infarct size
479152|NCT00103350|angioplasty|angioplasty
479153|NCT00103350|percutaneous coronary intervention|percutaneous coronary intervention
479154|NCT00103350|Acute Myocardial Infarction|acute myocardial infarction
479155|NCT00103363|non-small cell lung cancer|non-small cell lung cancer
479156|NCT00103363|small cell lung cancer|small cell lung cancer
479157|NCT00103376|adenocarcinoma of the prostate|adenocarcinoma of the prostate
479158|NCT00103376|recurrent prostate cancer|recurrent prostate cancer
479159|NCT00103389|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
479160|NCT00103389|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
479161|NCT00103389|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
479162|NCT00103402|Prostatitis|prostatitis
479163|NCT00103402|Non-bacterial Prostatitis|non-bacterial prostatitis
479164|NCT00103402|Prostatodynia|prostatodynia
479165|NCT00103402|Alfuzosin|alfuzosin
479166|NCT00103402|Alpha-adrenergic blocker|alpha-adrenergic blocker
479167|NCT00103415|Depression|depression
479168|NCT00103415|Exercise|exercise
479169|NCT00103415|Job|job
479170|NCT00103428|chemotherapy|chemotherapy
479171|NCT00103428|prostate cancer|prostate cancer
479172|NCT00103428|cancer|cancer
479174|NCT00103428|hormone refractory|hormone refractory
479175|NCT00103428|chemotherapy naive|chemotherapy naive
479176|NCT00103428|dose escalation|dose escalation
479177|NCT00103454|allergic rhinitis|allergic rhinitis
479178|NCT00103454|GW685698X|gw685698x
479179|NCT00103454|Perennial Allergic Rhinitis|perennial allergic rhinitis
479180|NCT00103506|Multiple Myeloma|multiple myeloma
479181|NCT00103506|Doxil|doxil
479182|NCT00103506|Caelyx|caelyx
479183|NCT00103506|Doxorubicin|doxorubicin
479184|NCT00103506|Velcade|velcade
479185|NCT00103506|Bortezomib|bortezomib
479186|NCT00103519|Heart Failure, DITPA|heart failure, ditpa
479187|NCT00103532|motivational enhancement|motivational enhancement
479188|NCT00103532|health behaviors|health behaviors
479189|NCT00103532|risk behaviors|risk behaviors
479190|NCT00103844|Chronic Phase Philadelphia chromosome Positive (Ph+) chronic myeloid leukemia|chronic phase philadelphia chromosome positive (ph+) chronic myeloid leukemia
479191|NCT00103870|Music Therapy|music therapy
479192|NCT00103870|Electric Stimulation|electric stimulation
479193|NCT00103870|Electric Shock|electric shock
479194|NCT00103870|Analgesics|analgesics
479195|NCT00103870|Distraction|distraction
479196|NCT00103883|HIV|hiv
479197|NCT00103883|Detuned Assay|detuned assay
479198|NCT00103883|Enzyme Immunoassay (EIA)|enzyme immunoassay (eia)
479199|NCT00103883|HIV Incidence|hiv incidence
479200|NCT00103883|Laboratory assay|laboratory assay
479201|NCT00103883|Sensitive/Less sensitive Assay|sensitive/less sensitive assay
479202|NCT00103883|Acute Infection|acute infection
479203|NCT00103896|High-risk youth|high-risk youth
479204|NCT00103896|HIV infected youth|hiv infected youth
479205|NCT00103896|Community mobilization|community mobilization
479206|NCT00103896|HIV serosurveys|hiv serosurveys
479207|NCT00103922|smokers cough|smokers cough
479208|NCT00103935|diabetes|diabetes
479209|NCT00103935|exenatide|exenatide
479210|NCT00103935|long acting release|long acting release
479211|NCT00103935|Amylin|amylin
479212|NCT00103935|Lilly|lilly
479213|NCT00103961|Acute Infection|acute infection
479214|NCT00103961|HIV|hiv
479215|NCT00103961|AIDS|aids
479216|NCT00103961|Acute HIV|acute hiv
479217|NCT00103961|Early HIV|early hiv
479218|NCT00103974|multiple sclerosis|multiple sclerosis
479219|NCT00103974|relapsing-remitting|relapsing-remitting
479220|NCT00103974|secondary progressive|secondary progressive
479221|NCT00103987|Panic Disorder|panic disorder
479222|NCT00103987|Norepinephrine|norepinephrine
479223|NCT00103987|Yohimbine|yohimbine
479224|NCT00103987|Genes|genes
479225|NCT00103987|Pathophysiology|pathophysiology
479226|NCT00103987|Noradrenergic Mechanisms|noradrenergic mechanisms
479227|NCT00103987|PET Imaging|pet imaging
479228|NCT00103987|PD|pd
479229|NCT00103987|Healthy Volunteer|healthy volunteer
479230|NCT00103987|HV|hv
479231|NCT00104000|Neuromuscular|neuromuscular
479232|NCT00104000|Elevation|elevation
479233|NCT00104000|Current|current
479234|NCT00104000|Videofluoroscopy|videofluoroscopy
479235|NCT00104000|Nasoendoscopy|nasoendoscopy
479236|NCT00104000|Healthy Volunteer|healthy volunteer
479237|NCT00104000|HV|hv
617388|NCT00652574|MPM|mpm
479238|NCT00104026|Periodontal Disease|periodontal disease
479239|NCT00104026|Dilantin|dilantin
479240|NCT00104026|Cyclosporin|cyclosporin
479241|NCT00104026|Calcium-Channel Blockers|calcium-channel blockers
479242|NCT00104026|Genetics|genetics
479243|NCT00104026|Hereditary Gingival Fibromatosis|hereditary gingival fibromatosis
479244|NCT00104026|HGF|hgf
479245|NCT00104026|Gingival Overgrowth|gingival overgrowth
479246|NCT00104026|Gum Overgrowth|gum overgrowth
479247|NCT00104039|Amygdala|amygdala
479248|NCT00104039|Orbital Frontal Cortex|orbital frontal cortex
479249|NCT00104039|Serotonin|serotonin
479250|NCT00104039|Orbitofrontal Cortex|orbitofrontal cortex
479251|NCT00104039|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
479252|NCT00104039|ADHD|adhd
479253|NCT00104039|Anti-Social Behavior|anti-social behavior
479254|NCT00104039|Healthy Volunteer|healthy volunteer
479255|NCT00104039|HV|hv
479256|NCT00104065|oral mucositis|oral mucositis
479257|NCT00104065|oncology - supportive care|oncology - supportive care
479258|NCT00104065|mouth diseases|mouth diseases
479259|NCT00104091|Gross Total Resection|gross total resection
479260|NCT00104091|Convection Enhanced Delivery|convection enhanced delivery
479261|NCT00104091|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
479262|NCT00104104|Z-MAX, multiple myeloma, zoledronic acid, bone metastases|z-max, multiple myeloma, zoledronic acid, bone metastases
479263|NCT00104130|prostate|prostate
479264|NCT00104156|Knee pain|knee pain
479265|NCT00104156|Arthritis|arthritis
479266|NCT00104156|Qigong|qigong
479268|NCT00104156|Meditation|meditation
479269|NCT00104156|Breathing Exercises|breathing exercises
479270|NCT00104169|Anemia|anemia
479271|NCT00104169|Frailty|frailty
479272|NCT00104169|Epoetin|epoetin
479273|NCT00104169|Erythropoietin|erythropoietin
479274|NCT00104169|EPO|epo
479275|NCT00104195|Anxiety|anxiety
479276|NCT00104195|Adolescence|adolescence
479277|NCT00104195|Generalized Anxiety Disorder|generalized anxiety disorder
479278|NCT00104247|Phenylalanine Hydroxylase|phenylalanine hydroxylase
479279|NCT00104273|Dementia, Alzheimer's Disease|dementia, alzheimer's disease
479280|NCT00104299|ANCA|anca
479281|NCT00104299|Vasculitis|vasculitis
479282|NCT00104299|Wegener's Granulomatosis|wegener's granulomatosis
479283|NCT00104299|microscopic polyangiitis|microscopic polyangiitis
479284|NCT00104299|ANCA-positive|anca-positive
479285|NCT00104299|ANCA-associated|anca-associated
479286|NCT00104299|ANCA-associated vasculitis|anca-associated vasculitis
479287|NCT00104299|MPA|mpa
479288|NCT00104312|Knee Osteoarthritis|knee osteoarthritis
479289|NCT00104312|Muscle|muscle
479290|NCT00104312|Cytokine|cytokine
479291|NCT00104312|Mobility|mobility
479292|NCT00104312|Function|function
479293|NCT00104325|Cytapheresis|cytapheresis
479294|NCT00104325|Blood Collection|blood collection
479295|NCT00104325|Volunteer Donor|volunteer donor
479296|NCT00104325|White Blood Cells|white blood cells
479297|NCT00104338|Investigational Therapies|investigational therapies
479298|NCT00104338|Treatment Effectiveness|treatment effectiveness
479299|NCT00104338|Treatment Efficacy|treatment efficacy
479300|NCT00104338|Immunosuppressant|immunosuppressant
479301|NCT00104338|BK Nephropathy|bk nephropathy
479302|NCT00104338|Polyomavirus, BK|polyomavirus, bk
479303|NCT00104338|Human Polyomavirus BK|human polyomavirus bk
479304|NCT00104338|Polyomavirus hominis 1|polyomavirus hominis 1
479305|NCT00104377|Allergy|allergy
479306|NCT00104377|Allergoid|allergoid
479307|NCT00104377|Specific Immunotherapy|specific immunotherapy
479308|NCT00104390|allergy|allergy
479309|NCT00104390|skin prick test|skin prick test
479310|NCT00104390|allergoid|allergoid
479311|NCT00104390|allergenicity|allergenicity
479312|NCT00104390|specific immunotherapy|specific immunotherapy
479314|NCT00104403|CINV|cinv
479315|NCT00104403|Emesis|emesis
479316|NCT00104403|Nausea|nausea
479317|NCT00104403|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
479318|NCT00104416|antiepileptic drugs|antiepileptic drugs
479319|NCT00104416|seizures|seizures
479320|NCT00104416|primary generalized tonic-clonic seizures|primary generalized tonic-clonic seizures
479321|NCT00104416|Epilepsy|epilepsy
479322|NCT00104416|lamotrigine|lamotrigine
479323|NCT00104416|anticonvulsants|anticonvulsants
479324|NCT00104416|LAMICTAL|lamictal
479325|NCT00104429|HIV infections|hiv infections
479326|NCT00104429|therapy naive|therapy naive
479327|NCT00104442|Alzheimer's disease|alzheimer's disease
479328|NCT00104442|memory loss|memory loss
479329|NCT00104442|dementia|dementia
479330|NCT00104442|senility|senility
479331|NCT00104442|forgetful|forgetful
479332|NCT00104442|geriatric|geriatric
479333|NCT00104442|behavior|behavior
479334|NCT00104442|mood swings|mood swings
479335|NCT00104455|rFVIIa|rfviia
479336|NCT00104455|Punch Biopsy|punch biopsy
479337|NCT00104455|Dose Response|dose response
479338|NCT00104455|Healthy People Programs|healthy people programs
95178|NCT02693847|Liver transplant|liver transplant
479339|NCT00104468|Single-arm, open-label, multi-center, dose escalation, continuous infusion, multi-dose, acute myeloid leukemia|single-arm, open-label, multi-center, dose escalation, continuous infusion, multi-dose, acute myeloid leukemia
479340|NCT00104468|Acute myelogenous leukemia (AML) that has been refractory to prior therapy and/or is unlikely to benefit from known therapies|acute myelogenous leukemia (aml) that has been refractory to prior therapy and/or is unlikely to benefit from known therapies
479341|NCT00104481|cognitive behavior therapy|cognitive behavior therapy
479342|NCT00104481|coping|coping
479343|NCT00104481|smoking cessation|smoking cessation
479344|NCT00104481|acceptance|acceptance
479345|NCT00104481|expectancies|expectancies
479346|NCT00104481|quit smoking|quit smoking
479347|NCT00104481|quitting smoking|quitting smoking
479348|NCT00104494|Cystic Fibrosis|cystic fibrosis
479349|NCT00104494|Zinc supplementation|zinc supplementation
479350|NCT00104494|Nutrition|nutrition
479351|NCT00104494|Zinc absorption|zinc absorption
479352|NCT00104494|Zinc excretion|zinc excretion
479353|NCT00104494|Zinc status|zinc status
479354|NCT00104507|Serotonin|serotonin
479355|NCT00104507|5-HT2c|5-ht2c
479356|NCT00104507|Satiety|satiety
479357|NCT00104507|Obesity|obesity
479358|NCT00104507|Appetite suppressant|appetite suppressant
479359|NCT00104507|Weight Loss|weight loss
479360|NCT00104507|Overweight|overweight
479361|NCT00104520|Cystic Fibrosis|cystic fibrosis
479362|NCT00104520|Pseudomonas aeruginosa|pseudomonas aeruginosa
479363|NCT00104520|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
479364|NCT00104533|Static magnetic therapy|static magnetic therapy
479365|NCT00104533|Pain|pain
479366|NCT00104533|Analgesia|analgesia
479367|NCT00104533|Opioids|opioids
479368|NCT00104546|Dysmenorrhea|dysmenorrhea
479369|NCT00104546|Acupuncture|acupuncture
479370|NCT00104546|Vitamin K|vitamin k
479371|NCT00104546|Medicine, Chinese Traditional|medicine, chinese traditional
479372|NCT00104546|Women|women
479373|NCT00104546|Menstruation|menstruation
479374|NCT00104546|Pain, Menstrual|pain, menstrual
479375|NCT00104546|China|china
479377|NCT00104559|Informed Consent|informed consent
479378|NCT00104572|Estrogen|estrogen
479379|NCT00104572|Glucose Tolerance|glucose tolerance
479380|NCT00104572|Bone Density|bone density
479381|NCT00104572|Quality-of-Life|quality-of-life
479382|NCT00104572|Sarcopenia|sarcopenia
479383|NCT00104585|Parkinson's disease|parkinson's disease
479384|NCT00104585|PD|pd
479385|NCT00104585|gene|gene
479386|NCT00104585|environment|environment
479387|NCT00104585|early-onset Parkinson's disease|early-onset parkinson's disease
479388|NCT00104611|Major Depressive Disorder|major depressive disorder
479389|NCT00104611|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
479390|NCT00104611|rTMS|rtms
479391|NCT00104611|Non-invasive Neuromodulation|non-invasive neuromodulation
479392|NCT00104611|Antidepressant|antidepressant
479393|NCT00104624|stage IV breast cancer|stage iv breast cancer
479394|NCT00104624|recurrent breast cancer|recurrent breast cancer
479395|NCT00104637|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
479396|NCT00104637|Emphysema|emphysema
479397|NCT00104637|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
479398|NCT00104637|Sildenafil|sildenafil
479399|NCT00104637|Exercise testing|exercise testing
479400|NCT00104637|Quality of life|quality of life
479401|NCT00104650|Bone Metastases|bone metastases
479402|NCT00104650|AMG 162|amg 162
479403|NCT00104650|Bisphosphonates|bisphosphonates
479404|NCT00104650|Solid Tumor Carcinomas|solid tumor carcinomas
479405|NCT00104650|Advanced|advanced
479406|NCT00104663|Creutzfeldt-Jakob disease|creutzfeldt-jakob disease
479407|NCT00104663|inherited|inherited
479408|NCT00104663|sporadic|sporadic
479409|NCT00104663|acquired|acquired
479410|NCT00104663|new variant CJD|new variant cjd
479411|NCT00104676|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
479412|NCT00104676|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
479413|NCT00104676|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
479414|NCT00104676|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
479415|NCT00104676|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
479416|NCT00104676|testicular choriocarcinoma|testicular choriocarcinoma
479417|NCT00104676|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
479418|NCT00104676|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
479419|NCT00104676|testicular embryonal carcinoma|testicular embryonal carcinoma
479420|NCT00104676|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
479421|NCT00104676|testicular yolk sac tumor|testicular yolk sac tumor
479422|NCT00104676|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
479423|NCT00104676|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
479424|NCT00104676|testicular immature teratoma|testicular immature teratoma
479425|NCT00104676|testicular mature teratoma|testicular mature teratoma
479426|NCT00104676|adult teratoma|adult teratoma
479427|NCT00104689|stage IV colon cancer|stage iv colon cancer
479428|NCT00104689|stage IV rectal cancer|stage iv rectal cancer
479429|NCT00104689|adenocarcinoma of the colon|adenocarcinoma of the colon
479430|NCT00104689|adenocarcinoma of the rectum|adenocarcinoma of the rectum
479431|NCT00104702|stage I breast cancer|stage i breast cancer
479432|NCT00104702|stage II breast cancer|stage ii breast cancer
479433|NCT00104715|adenocarcinoma of the prostate|adenocarcinoma of the prostate
479434|NCT00104715|recurrent prostate cancer|recurrent prostate cancer
479435|NCT00104715|stage IV prostate cancer|stage iv prostate cancer
479436|NCT00104728|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
479437|NCT00104728|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
479438|NCT00104728|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
479439|NCT00104728|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
479440|NCT00104741|stage IIB prostate cancer|stage iib prostate cancer
479441|NCT00104741|stage IIA prostate cancer|stage iia prostate cancer
479442|NCT00104741|stage III prostate cancer|stage iii prostate cancer
479443|NCT00104754|extensive stage small cell lung cancer|extensive stage small cell lung cancer
479444|NCT00104754|limited stage small cell lung cancer|limited stage small cell lung cancer
479445|NCT00104754|recurrent small cell lung cancer|recurrent small cell lung cancer
479446|NCT00104767|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
479447|NCT00104767|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
479448|NCT00104767|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
479449|NCT00104780|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
479450|NCT00104780|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
479451|NCT00104780|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
479452|NCT00104793|extensive stage small cell lung cancer|extensive stage small cell lung cancer
479453|NCT00104806|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
479454|NCT00104806|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
479455|NCT00104806|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
479456|NCT00104806|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
479528|NCT00104949|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
479457|NCT00104806|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
479458|NCT00104806|refractory anemia with excess blasts|refractory anemia with excess blasts
479459|NCT00104806|refractory anemia|refractory anemia
479460|NCT00104806|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
479461|NCT00104806|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
479462|NCT00104806|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
479463|NCT00104806|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
479464|NCT00104819|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
479465|NCT00104819|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
479466|NCT00104819|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
479467|NCT00104845|stage II melanoma|stage ii melanoma
479468|NCT00104845|stage III melanoma|stage iii melanoma
479469|NCT00104845|stage IV melanoma|stage iv melanoma
479470|NCT00104845|recurrent melanoma|recurrent melanoma
479471|NCT00104871|National Thyroid Cancer Treatment Cooperative Study Group|national thyroid cancer treatment cooperative study group
479473|NCT00104871|bortezomib|bortezomib
479474|NCT00104871|velcade|velcade
479475|NCT00104871|metastatic differentiated thyroid carcinoma|metastatic differentiated thyroid carcinoma
485014|NCT00122369|Relaxation|relaxation
479476|NCT00104871|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
479477|NCT00104871|follicular epithelial thyroid cells|follicular epithelial thyroid cells
479478|NCT00104871|papillary|papillary
479479|NCT00104871|oxyphilic cell|oxyphilic cell
479480|NCT00104871|Hurthle cell|hurthle cell
479481|NCT00104871|insular cell|insular cell
479482|NCT00104871|columnar cell|columnar cell
479483|NCT00104871|tall cell|tall cell
479484|NCT00104884|stage III melanoma|stage iii melanoma
479485|NCT00104884|stage IV melanoma|stage iv melanoma
479486|NCT00104884|Depsipeptide|depsipeptide
479487|NCT00104897|recurrent melanoma|recurrent melanoma
479488|NCT00104897|stage IV melanoma|stage iv melanoma
479489|NCT00104923|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
479490|NCT00104923|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
479491|NCT00104923|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
479492|NCT00104923|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
479595|NCT00105131|Alpha-Synuclein|alpha-synuclein
479493|NCT00104923|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
479494|NCT00104923|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
479495|NCT00104923|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
479496|NCT00104923|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
479497|NCT00104923|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
479498|NCT00104923|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
479499|NCT00104923|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
479500|NCT00104923|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
479501|NCT00104923|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
479502|NCT00104923|secondary acute myeloid leukemia|secondary acute myeloid leukemia
479503|NCT00104923|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
479504|NCT00104923|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
479505|NCT00104923|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
479506|NCT00104923|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
479507|NCT00104923|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
479508|NCT00104923|refractory multiple myeloma|refractory multiple myeloma
479509|NCT00104923|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
479510|NCT00104923|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
479511|NCT00104923|chronic eosinophilic leukemia|chronic eosinophilic leukemia
479512|NCT00104923|primary myelofibrosis|primary myelofibrosis
479513|NCT00104923|chronic neutrophilic leukemia|chronic neutrophilic leukemia
479514|NCT00104923|essential thrombocythemia|essential thrombocythemia
479515|NCT00104923|polycythemia vera|polycythemia vera
479516|NCT00104923|stage II multiple myeloma|stage ii multiple myeloma
479517|NCT00104923|stage III multiple myeloma|stage iii multiple myeloma
479518|NCT00104923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
479519|NCT00104923|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
479520|NCT00104923|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
479521|NCT00104923|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
479522|NCT00104923|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
479523|NCT00104923|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
479524|NCT00104923|splenic marginal zone lymphoma|splenic marginal zone lymphoma
479525|NCT00104923|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
479526|NCT00104936|adult grade I meningioma|adult grade i meningioma
479527|NCT00104949|adult synovial sarcoma|adult synovial sarcoma
479610|NCT00105170|Tumors|tumors
479529|NCT00104949|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
479530|NCT00104949|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
479531|NCT00104975|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
479532|NCT00104975|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
479533|NCT00104975|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
479534|NCT00104975|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
479535|NCT00104975|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
479536|NCT00104975|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
479537|NCT00104975|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
479538|NCT00104975|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
479539|NCT00104975|refractory anemia with excess blasts|refractory anemia with excess blasts
479540|NCT00104975|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
479541|NCT00104975|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
479542|NCT00104975|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
479543|NCT00104975|chronic eosinophilic leukemia|chronic eosinophilic leukemia
479544|NCT00104975|primary myelofibrosis|primary myelofibrosis
479545|NCT00104975|chronic neutrophilic leukemia|chronic neutrophilic leukemia
479546|NCT00104975|essential thrombocythemia|essential thrombocythemia
479547|NCT00104975|polycythemia vera|polycythemia vera
479548|NCT00104975|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
479549|NCT00104975|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
479550|NCT00104975|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
479551|NCT00104975|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
479552|NCT00104975|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
479553|NCT00104975|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
479554|NCT00104975|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
479555|NCT00104975|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
479556|NCT00104975|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
479557|NCT00104975|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
479558|NCT00104975|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
479559|NCT00104975|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
479560|NCT00104975|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
479561|NCT00104975|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
478900|NCT00094146|PIH|pih
479562|NCT00104975|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
479563|NCT00104975|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
479564|NCT00104975|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
479565|NCT00104988|stage IV melanoma|stage iv melanoma
479566|NCT00105027|macular edema|macular edema
479567|NCT00105027|central retinal vein occlusion (CRVO)|central retinal vein occlusion (crvo)
479568|NCT00105027|branch retinal vein occlusion (BRVO)|branch retinal vein occlusion (brvo)
479569|NCT00105040|Partial onset seizures|partial onset seizures
479570|NCT00105040|epilepsy|epilepsy
479571|NCT00105040|levetiracetam|levetiracetam
479572|NCT00105040|Keppra|keppra
479573|NCT00105040|cognition|cognition
479574|NCT00105040|behavior|behavior
479575|NCT00105040|pediatry|pediatry
479576|NCT00105066|Metabolic Syndrome|metabolic syndrome
479577|NCT00105066|triglycerides|triglycerides
479579|NCT00105066|LDL|ldl
479580|NCT00105066|High Blood Pressure|high blood pressure
479581|NCT00105066|High Cholesterol|high cholesterol
479582|NCT00105066|High Blood Sugar|high blood sugar
479583|NCT00105105|Alzheimers|alzheimers
479584|NCT00105105|cognition|cognition
479585|NCT00105105|acetyl cholinesterase inhibitor|acetyl cholinesterase inhibitor
479586|NCT00105105|GR-II antagonist|gr-ii antagonist
479587|NCT00105118|Cognition|cognition
479588|NCT00105118|Alpha|alpha
479589|NCT00105118|Schizophrenia|schizophrenia
479590|NCT00105118|Functional Connectivity|functional connectivity
479591|NCT00105118|Oscillatory Potential|oscillatory potential
479592|NCT00105131|Parkinson's Disease|parkinson's disease
479593|NCT00105131|Movement Disorders|movement disorders
479594|NCT00105131|Tremor|tremor
479596|NCT00105131|Lewy Bodies|lewy bodies
479597|NCT00105131|Parkinson Disease|parkinson disease
479598|NCT00105131|PD|pd
479599|NCT00105131|Movement Disorder|movement disorder
479600|NCT00105131|Healthy Volunteer|healthy volunteer
479601|NCT00105131|HV|hv
479602|NCT00105144|Treatment Effectiveness|treatment effectiveness
479603|NCT00105144|Treatment Efficacy|treatment efficacy
479604|NCT00105144|Investigational, Therapies|investigational, therapies
479605|NCT00105144|Antifungal, Systemic|antifungal, systemic
479606|NCT00105144|Antibiotics, Antifungal|antibiotics, antifungal
479607|NCT00105144|Micafungin|micafungin
479608|NCT00105170|Monoclonal antibody|monoclonal antibody
479609|NCT00105170|Advanced solid tumors|advanced solid tumors
479612|NCT00105183|pulmonary transplantation|pulmonary transplantation
479613|NCT00105183|Pulmonary Allograft Rejection|pulmonary allograft rejection
479614|NCT00105196|Single or recurrent|single or recurrent
479615|NCT00105196|non-psychotic episode of Major Depressive Disorder|non-psychotic episode of major depressive disorder
479616|NCT00105209|Platelets|platelets
479617|NCT00105222|Cycle Ergometer|cycle ergometer
479618|NCT00105222|Exercise Physiology|exercise physiology
479619|NCT00105222|Nitric Oxide|nitric oxide
479620|NCT00105222|Sodium Nitrite|sodium nitrite
479621|NCT00105222|Healthy Volunteers|healthy volunteers
479622|NCT00105222|Normal Volunteer|normal volunteer
479623|NCT00105222|Healthy Volunteer|healthy volunteer
479624|NCT00105222|HV|hv
479625|NCT00105235|transplantation|transplantation
479626|NCT00105235|liver transplant|liver transplant
479627|NCT00105235|rejection|rejection
479628|NCT00105235|tolerance|tolerance
479629|NCT00105235|antibody induction|antibody induction
479630|NCT00105248|acute repiratory infections|acute repiratory infections
479631|NCT00105248|antibiotic therapy|antibiotic therapy
479632|NCT00105248|patient-centred communication|patient-centred communication
479633|NCT00105248|randomized controlled trial|randomized controlled trial
479634|NCT00105274|Velocardiofacial Syndrome|velocardiofacial syndrome
479635|NCT00105274|Susceptibility Genes|susceptibility genes
479636|NCT00105274|Neuroimaging|neuroimaging
479637|NCT00105274|22q11.2|22q11.2
479638|NCT00105274|Psychosis|psychosis
479639|NCT00105274|Mircodeletion|mircodeletion
479640|NCT00105274|DiGeorge Syndrome|digeorge syndrome
479641|NCT00105274|22q11.2 Syndrome|22q11.2 syndrome
479642|NCT00105287|cancer|cancer
479643|NCT00105287|pain|pain
479644|NCT00105287|Breakthrough Pain in cancer patients|breakthrough pain in cancer patients
479645|NCT00105326|Schizophrenia|schizophrenia
479646|NCT00105326|Schizophrenia-related insomnia|schizophrenia-related insomnia
479647|NCT00105326|insomnia|insomnia
479648|NCT00105326|paliperidone|paliperidone
479649|NCT00105326|placebo|placebo
479650|NCT00105326|polysomnography|polysomnography
479651|NCT00105339|consent form, vaccine trial|consent form, vaccine trial
479652|NCT00105339|Simplified consent form|simplified consent form
479653|NCT00105352|Type 1 Diabetes Study Group|type 1 diabetes study group
479654|NCT00105352|TrialNet|trialnet
479655|NCT00105352|type 1 diabetes|type 1 diabetes
479656|NCT00105352|juvenile onset diabetes|juvenile onset diabetes
479657|NCT00105365|lateral wedge inserts|lateral wedge inserts
479658|NCT00105365|shoe inserts|shoe inserts
618013|NCT00654446|Crestor|crestor
478998|NCT00094601|PET|pet
479659|NCT00105378|health care services research|health care services research
479660|NCT00105378|frail elderly|frail elderly
479661|NCT00105378|intermediate care|intermediate care
479662|NCT00105378|patient centered care|patient centered care
479663|NCT00105378|comprehensive health care|comprehensive health care
479664|NCT00105378|geriatric nursing|geriatric nursing
479665|NCT00105378|Behavioral symptoms|behavioral symptoms
479666|NCT00105404|Steroid|steroid
479667|NCT00105404|Diabetic Macular Edema|diabetic macular edema
479668|NCT00105404|DME|dme
479669|NCT00105417|Immune Reconstitution|immune reconstitution
479670|NCT00105417|Thymus|thymus
479671|NCT00105417|Cytokines|cytokines
479672|NCT00105417|HIV|hiv
479673|NCT00105430|Surgery|surgery
479674|NCT00105430|Treatment|treatment
479675|NCT00105430|Physiology|physiology
479676|NCT00105430|Pediatric|pediatric
479677|NCT00105430|Neurosurgery|neurosurgery
479678|NCT00105430|Generalized Primary Dystonia|generalized primary dystonia
479679|NCT00105443|Liver Cancer|liver cancer
479680|NCT00105443|Cancer|cancer
479681|NCT00105456|HER2-Positive Metastatic Breast Cancer|her2-positive metastatic breast cancer
479682|NCT00105456|HER2|her2
479683|NCT00105469|Bacterial Conjunctivitis|bacterial conjunctivitis
479684|NCT00105469|Pink Eye|pink eye
479685|NCT00105469|Conjunctivitis|conjunctivitis
479686|NCT00105469|Eye Infection|eye infection
479687|NCT00105482|Tobacco|tobacco
479688|NCT00105482|Smoking|smoking
479689|NCT00105482|Weight|weight
479690|NCT00105482|Weight perception|weight perception
479691|NCT00105482|Naltrexone|naltrexone
479692|NCT00105495|Iron Overload|iron overload
479693|NCT00105495|Thalassemia|thalassemia
479694|NCT00105495|Haemosiderosis|haemosiderosis
479695|NCT00105495|Cardiac|cardiac
479696|NCT00105495|Deferiprone|deferiprone
479697|NCT00105495|Chelation|chelation
479698|NCT00105508|Parkinson's Disease|parkinson's disease
479699|NCT00105508|Dyskinesia|dyskinesia
479700|NCT00105508|Dyskinesia associated with dopaminergic treatment|dyskinesia associated with dopaminergic treatment
479701|NCT00105521|Parkinson's Disease|parkinson's disease
479702|NCT00105521|Dyskinesia|dyskinesia
479703|NCT00105521|Dyskinesia associated with dopaminergic treatment|dyskinesia associated with dopaminergic treatment
479704|NCT00105534|Bacterial Conjunctivitis|bacterial conjunctivitis
479705|NCT00105534|Pink Eye|pink eye
479706|NCT00105534|Conjunctivitis|conjunctivitis
479707|NCT00105534|Eye Infection|eye infection
479708|NCT00105534|Eye Discharge|eye discharge
479709|NCT00105547|Alzheimer's|alzheimer's
479710|NCT00105547|Dementia|dementia
479711|NCT00105547|Dementia of Alzheimer Type|dementia of alzheimer type
479712|NCT00105560|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
479713|NCT00105560|untreated childhood medulloblastoma|untreated childhood medulloblastoma
479714|NCT00105560|untreated childhood pineoblastoma|untreated childhood pineoblastoma
479715|NCT00105573|Mother-Child Relations|mother-child relations
479716|NCT00105573|Infant|infant
479717|NCT00105573|Child Development|child development
479718|NCT00105573|Poverty|poverty
479719|NCT00105586|Anxiety|anxiety
479720|NCT00105586|Elderly|elderly
479721|NCT00105586|Aged|aged
479722|NCT00105586|Serotonin Reuptake Inhibitors|serotonin reuptake inhibitors
479723|NCT00105586|SSRI|ssri
479724|NCT00105586|SERT|sert
479725|NCT00105612|Informed Consent|informed consent
479726|NCT00105612|Memory Aid|memory aid
479727|NCT00105625|Geriatrics|geriatrics
479728|NCT00105625|Nutrition|nutrition
479729|NCT00105625|Immune function|immune function
479730|NCT00105625|Infection|infection
479731|NCT00105625|Rehabilitation|rehabilitation
479732|NCT00105625|Inpatient|inpatient
479733|NCT00105638|Intervention studies|intervention studies
479734|NCT00105638|Health Care Costs|health care costs
479735|NCT00105638|Telephone|telephone
479737|NCT00105664|Outcomes Assessment|outcomes assessment
479738|NCT00105664|Primary Health Care|primary health care
479739|NCT00105664|Group Process|group process
479740|NCT00105677|Racial/ethnic health disparities|racial/ethnic health disparities
479741|NCT00105677|Attitudes|attitudes
479742|NCT00105677|Osteoarthritis Management|osteoarthritis management
479743|NCT00105677|Patient Perceptions|patient perceptions
479744|NCT00105703|Nurse practitioners|nurse practitioners
479745|NCT00105703|Case management|case management
479746|NCT00105716|hypertension|hypertension
479747|NCT00105716|adherence|adherence
479748|NCT00105716|cardiovascular diseases|cardiovascular diseases
479749|NCT00105729|Self-help groups|self-help groups
479750|NCT00105729|Referral and consultation|referral and consultation
479751|NCT00105755|Activity Cycles|activity cycles
479752|NCT00105755|Amputation|amputation
479753|NCT00105755|Prevention|prevention
479754|NCT00105755|Temperature|temperature
479755|NCT00105781|Nurses|nurses
479756|NCT00105781|Telephone|telephone
479757|NCT00105781|Counseling|counseling
479758|NCT00105781|Exercise|exercise
479759|NCT00105794|advance directives|advance directives
479760|NCT00105794|advance directive adherence|advance directive adherence
479761|NCT00105794|patient-centered care|patient-centered care
479762|NCT00105794|patient satisfaction|patient satisfaction
479763|NCT00105794|coercion|coercion
479764|NCT00105794|informed consent|informed consent
479765|NCT00105794|commitment of mentally ill|commitment of mentally ill
479766|NCT00105794|physician-patient relations|physician-patient relations
479767|NCT00105820|Evaluation|evaluation
479768|NCT00105820|Quality improvement|quality improvement
479769|NCT00105820|Cluster randomized trial|cluster randomized trial
479770|NCT00105820|Care model|care model
479771|NCT00105820|Collaborative care|collaborative care
479772|NCT00105820|Informatics|informatics
479773|NCT00105872|insomnia|insomnia
479774|NCT00105872|cognitive behavior therapy|cognitive behavior therapy
479775|NCT00105885|Telephone|telephone
479776|NCT00105885|Telemedicine|telemedicine
479777|NCT00105885|Psychopharmacology|psychopharmacology
479778|NCT00105898|Diabetes mellitus|diabetes mellitus
479779|NCT00105898|Hypertension|hypertension
479780|NCT00105898|Telemedicine|telemedicine
479781|NCT00105898|Case management|case management
479782|NCT00105911|Cognitive Behavioral Therapy|cognitive behavioral therapy
479783|NCT00105937|Cancer|cancer
479784|NCT00105937|Pain|pain
479785|NCT00105950|ErbB2 overexpressing|erbb2 overexpressing
479786|NCT00105950|ErbB1 expressing|erbb1 expressing
479787|NCT00105950|relapsed breast cancer|relapsed breast cancer
479788|NCT00105950|refractory inflammatory breast cancer|refractory inflammatory breast cancer
479789|NCT00105963|abuse|abuse
479790|NCT00106015|inherited pure red cell aplasia|inherited pure red cell aplasia
479791|NCT00106028|Primary disease: Osteogenesis Imperfecta|primary disease: osteogenesis imperfecta
479792|NCT00106041|end of life care|end of life care
479793|NCT00106041|evaluation studies|evaluation studies
479794|NCT00106041|quality of death and dying|quality of death and dying
479795|NCT00106041|palliative care|palliative care
479796|NCT00106041|coordination of care|coordination of care
479797|NCT00106041|satisfaction with care|satisfaction with care
479798|NCT00106041|healthcare cost|healthcare cost
479799|NCT00106041|utilization of healthcare resources|utilization of healthcare resources
479800|NCT00106041|caregivers|caregivers
479801|NCT00106041|veterans|veterans
479802|NCT00106067|aging|aging
479803|NCT00106067|behavioral research|behavioral research
479804|NCT00106067|quality of life|quality of life
479805|NCT00106067|end of life|end of life
479806|NCT00106067|family relations|family relations
479807|NCT00106067|supportive care|supportive care
479808|NCT00106067|advanced care|advanced care
479809|NCT00106067|bereavement|bereavement
479810|NCT00106080|Communication|communication
480226|NCT00099333|diabetes|diabetes
479811|NCT00106080|Palliative Care|palliative care
479812|NCT00106093|Alcohol|alcohol
479813|NCT00106093|Alcohol Treatment|alcohol treatment
479814|NCT00106093|DNA|dna
479815|NCT00106093|Treatment|treatment
479816|NCT00106093|Alcohol Dependence|alcohol dependence
479817|NCT00106093|Alcoholism|alcoholism
479818|NCT00106093|Alcohol Drinking Related Problems|alcohol drinking related problems
479819|NCT00106106|Alcoholism|alcoholism
479820|NCT00106106|Acamprosate|acamprosate
479821|NCT00106106|Withdrawal|withdrawal
479822|NCT00106106|Glutamate|glutamate
479823|NCT00106106|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
479824|NCT00106106|Alcohol Dependence|alcohol dependence
479825|NCT00106106|Healthy Volunteer|healthy volunteer
479826|NCT00106106|HV|hv
479827|NCT00106119|Levothyroxine|levothyroxine
479828|NCT00106119|Liothyronine|liothyronine
479829|NCT00106119|Lipid Metabolism|lipid metabolism
479830|NCT00106119|Gluconeogensis|gluconeogensis
479831|NCT00106119|Thyrotropin Releasing Hormone|thyrotropin releasing hormone
479832|NCT00106119|Deiodinase|deiodinase
479833|NCT00106119|Replacement Thyroid Hormone Therapy|replacement thyroid hormone therapy
479834|NCT00106119|Thyroidectomy|thyroidectomy
479835|NCT00106119|Near Total Thyroidectomy|near total thyroidectomy
479836|NCT00106132|Macular Edema|macular edema
479838|NCT00106132|Fluorescein Angiogram|fluorescein angiogram
479839|NCT00106132|Ocular Coherence Tomography|ocular coherence tomography
479840|NCT00106132|Laser|laser
479841|NCT00106132|Retinal Vein Occlusion|retinal vein occlusion
479842|NCT00106145|Advanced Breast Cancer|advanced breast cancer
479843|NCT00106145|Solid Tumors|solid tumors
479844|NCT00106145|Advanced Solid Tumors|advanced solid tumors
479845|NCT00106158|cancer/testis antigen|cancer/testis antigen
479846|NCT00106158|cancer vaccine|cancer vaccine
479847|NCT00106158|recombinant protein|recombinant protein
479848|NCT00106171|HIV|hiv
479849|NCT00106171|Acute/Early Seroconverters|acute/early seroconverters
479850|NCT00106171|Acute Infection|acute infection
479851|NCT00106171|Treatment Naive|treatment naive
479852|NCT00106171|Primary HIV Infection|primary hiv infection
479853|NCT00106184|rituximab|rituximab
479854|NCT00106184|myositis|myositis
479855|NCT00106184|dermatomyositis|dermatomyositis
479856|NCT00106184|polymyositis|polymyositis
479857|NCT00106184|refractory|refractory
479858|NCT00106184|Juvenile Dermatomyositis|juvenile dermatomyositis
479859|NCT00106197|Sleep, REM|sleep, rem
479860|NCT00106197|Antidepressant|antidepressant
479861|NCT00106197|Adolescent|adolescent
479862|NCT00106197|Cortisol|cortisol
479863|NCT00106210|Child|child
479864|NCT00106223|Cognitive Behavioral Therapy|cognitive behavioral therapy
479865|NCT00106223|CBT|cbt
479866|NCT00106223|BDD|bdd
479867|NCT00106223|Body dysmorphic disorder|body dysmorphic disorder
479868|NCT00106236|Exercise|exercise
479869|NCT00106236|Fitness Club|fitness club
479870|NCT00106236|Randomized Controlled Trial|randomized controlled trial
479871|NCT00106236|Cardiovascular Risk Factor|cardiovascular risk factor
479872|NCT00106236|Overweight|overweight
479873|NCT00106236|Inactivity|inactivity
479874|NCT00106249|TMS, Supplementary Motor Area, Obsessive-Compulsive Disorder|tms, supplementary motor area, obsessive-compulsive disorder
479875|NCT00106262|advanced cervical cancer|advanced cervical cancer
479876|NCT00106262|metastatic cervical cancer|metastatic cervical cancer
479877|NCT00106275|Fibromyalgia|fibromyalgia
479878|NCT00106275|Meditation|meditation
479879|NCT00106275|Stress, Psychological|stress, psychological
479880|NCT00106275|Monitoring, Ambulatory|monitoring, ambulatory
479881|NCT00106275|Electrocardiographie, Ambulatory|electrocardiographie, ambulatory
479882|NCT00106275|Psychophysiology|psychophysiology
479883|NCT00106288|Candidaemia|candidaemia
479884|NCT00106288|Micafungin|micafungin
479885|NCT00106301|FK228|fk228
479886|NCT00106301|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
479887|NCT00106314|Dehydroepiandrosterone|dehydroepiandrosterone
479888|NCT00106314|DHEA|dhea
479889|NCT00106314|Crohn's disease|crohn's disease
479890|NCT00106314|C-reactive protein|c-reactive protein
479891|NCT00106314|CRP|crp
479892|NCT00106314|Crohn's Disease Activity Index|crohn's disease activity index
479893|NCT00106314|CDAI|cdai
585313|NCT00519363|female with SLE|female with sle
479894|NCT00106314|Inflammatory Bowel Disease Questionnaire|inflammatory bowel disease questionnaire
479896|NCT00106340|type 2 diabetes|type 2 diabetes
479897|NCT00106340|vildagliptin|vildagliptin
479898|NCT00106353|Pediatric Tumors|pediatric tumors
479899|NCT00106366|Diabetes, Type 2|diabetes, type 2
479900|NCT00106379|HIV-1|hiv-1
479901|NCT00106379|Treatment Naive|treatment naive
479902|NCT00106379|Treatment Experienced|treatment experienced
479903|NCT00106392|Treatment effectiveness|treatment effectiveness
479904|NCT00106392|Treatment efficacy|treatment efficacy
479905|NCT00106392|Investigational, Therapies|investigational, therapies
479906|NCT00106392|Immunosuppressant|immunosuppressant
479907|NCT00106392|Erectile dysfunction|erectile dysfunction
479908|NCT00106392|Prostatectomy|prostatectomy
479909|NCT00106405|Bipolar I Disorder|bipolar i disorder
479910|NCT00106405|Mania|mania
479911|NCT00106405|Memantine HCl|memantine hcl
479912|NCT00106418|Prostate Cancer|prostate cancer
479913|NCT00106418|Androgen independent metastatic prostate cancer patients with rising PSA|androgen independent metastatic prostate cancer patients with rising psa
479914|NCT00106418|romidepsin|romidepsin
479915|NCT00098085|Lung cancer|lung cancer
479916|NCT00098085|Non-small cell lung cancer|non-small cell lung cancer
479917|NCT00098085|Pulmonary|pulmonary
479918|NCT00098085|Immunotherapy|immunotherapy
479919|NCT00098085|Vaccine|vaccine
479920|NCT00098098|Botulinum|botulinum
479921|NCT00098098|Recombinant Botulinum Vaccine|recombinant botulinum vaccine
479922|NCT00098098|botulinum neurotoxins|botulinum neurotoxins
479923|NCT00098111|Crohn's disease|crohn's disease
479924|NCT00098111|inflammatory bowel disease|inflammatory bowel disease
479925|NCT00098111|IMURAN|imuran
479926|NCT00098111|azathioprine|azathioprine
479927|NCT00098124|NSRI|nsri
479928|NCT00098124|milnacipran|milnacipran
479929|NCT00098124|fibromyalgia|fibromyalgia
479930|NCT00098137|atrial fibrillation|atrial fibrillation
479931|NCT00098137|angiotensin II|angiotensin ii
479932|NCT00098137|angiotensin receptor antagonist|angiotensin receptor antagonist
479933|NCT00098137|drug|drug
479934|NCT00098137|controlled clinical trial|controlled clinical trial
479935|NCT00098150|Safety, atopic dermatitis, adverse event, SAE, extension|safety, atopic dermatitis, adverse event, sae, extension
479936|NCT00098163|HIV Seronegativity|hiv seronegativity
479937|NCT00098163|HIV Preventive Vaccine|hiv preventive vaccine
479938|NCT00098189|Safety, psoriasis, adverse event, SAE, extension|safety, psoriasis, adverse event, sae, extension
479939|NCT00098202|Global Network|global network
479940|NCT00098202|Micronutrients|micronutrients
479941|NCT00098202|Zinc|zinc
479942|NCT00098202|Maternal and child health|maternal and child health
479943|NCT00098202|Women's health|women's health
479944|NCT00098202|International|international
479945|NCT00098202|Guatemala|guatemala
479946|NCT00098202|Nutrition|nutrition
479947|NCT00098202|Corn|corn
479948|NCT00098202|Maize|maize
479949|NCT00098215|Residency training|residency training
479950|NCT00098228|COPD, adults, QAB149|copd, adults, qab149
479951|NCT00098241|pediatric|pediatric
479952|NCT00098241|renal|renal
479953|NCT00098241|transplant recipients|transplant recipients
479954|NCT00098241|de novo|de novo
479955|NCT00098241|De novo renal pediatric transplant|de novo renal pediatric transplant
479956|NCT00098254|Non-Small Cell|non-small cell
479957|NCT00098254|Molecular|molecular
479958|NCT00098254|Targeted|targeted
479959|NCT00098254|Therapies|therapies
479960|NCT00098254|Cancer|cancer
479961|NCT00098254|Non-Small Cell Lung Cancer|non-small cell lung cancer
479962|NCT00098254|NSCLC|nsclc
479963|NCT00098267|Bacteria|bacteria
479964|NCT00098267|Biofilm Formation|biofilm formation
479965|NCT00098267|Secretory Antibodies|secretory antibodies
479966|NCT00098267|Teeth|teeth
479967|NCT00098267|Health and Disease|health and disease
479968|NCT00098280|H5g1|h5g1
479969|NCT00098280|PNH|pnh
479970|NCT00098280|TRIUMPH|triumph
479971|NCT00098280|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
479972|NCT00098293|Aids|aids
479973|NCT00098293|HIV|hiv
479974|NCT00098319|Cleft palate|cleft palate
479975|NCT00098319|Cleft lip|cleft lip
479976|NCT00098319|Folic acid|folic acid
479977|NCT00098319|Global Network|global network
479978|NCT00098319|Maternal and child health|maternal and child health
479979|NCT00098319|International|international
479980|NCT00098319|Women's health|women's health
479982|NCT00098319|Brasil|brasil
479983|NCT00098319|Latin America|latin america
479984|NCT00098319|ECLAMC|eclamc
479985|NCT00098319|Congenital defects|congenital defects
479986|NCT00098319|Pregnancy|pregnancy
479987|NCT00098332|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
479988|NCT00098332|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
479989|NCT00098332|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
479990|NCT00098332|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
479991|NCT00098332|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
479992|NCT00098332|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
479993|NCT00098332|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
479994|NCT00098332|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
479995|NCT00098345|Caprelsa (vandetanib)|caprelsa (vandetanib)
479996|NCT00098345|ZD6474|zd6474
479997|NCT00098358|Leukotrienes|leukotrienes
479998|NCT00098358|inflammation|inflammation
479999|NCT00098384|Travelers’ diarrhea|travelers’ diarrhea
480000|NCT00098384|rifaximin|rifaximin
480001|NCT00098384|prophylaxis|prophylaxis
480002|NCT00098384|enterotoxigenic E. coli|enterotoxigenic e. coli
480003|NCT00098436|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
480004|NCT00098436|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
480005|NCT00098436|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
480006|NCT00098436|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
480007|NCT00098436|secondary acute myeloid leukemia|secondary acute myeloid leukemia
480008|NCT00098436|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
480009|NCT00098436|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
480010|NCT00098436|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
480011|NCT00098436|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
480012|NCT00098436|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
480013|NCT00098462|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
480014|NCT00098462|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
480015|NCT00098462|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
480016|NCT00098514|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
480017|NCT00098553|stage IV melanoma|stage iv melanoma
480018|NCT00098553|recurrent melanoma|recurrent melanoma
480019|NCT00098566|quality of life|quality of life
480020|NCT00098566|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
480021|NCT00098566|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
480022|NCT00098566|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
480092|NCT00098943|recurrent renal cell cancer|recurrent renal cell cancer
480023|NCT00098566|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
480024|NCT00098566|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
480025|NCT00098566|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
480026|NCT00098566|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
751943|NCT01171300|staged T3-4 N0 and T1-4N1-2|staged t3-4 n0 and t1-4n1-2
480027|NCT00098566|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
480028|NCT00098566|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
480029|NCT00098566|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
480030|NCT00098566|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
480031|NCT00098566|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
479376|NCT00104559|HIV|hiv
480032|NCT00098566|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
480033|NCT00098566|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
480034|NCT00098566|splenic marginal zone lymphoma|splenic marginal zone lymphoma
480035|NCT00098566|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
480036|NCT00098566|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
480037|NCT00098683|refractory anemia with excess blasts|refractory anemia with excess blasts
480039|NCT00098683|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
480040|NCT00098683|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
480041|NCT00098683|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
480042|NCT00098683|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
480043|NCT00098709|pregnancy|pregnancy
480044|NCT00098709|labor, obstetric|labor, obstetric
480045|NCT00098709|fetal monitoring|fetal monitoring
480046|NCT00098709|oximetry|oximetry
480047|NCT00098709|fetal heart rate|fetal heart rate
480048|NCT00098709|cardiotocography|cardiotocography
480049|NCT00098735|Kidney,Transplantation, rejection, immunosuppression|kidney,transplantation, rejection, immunosuppression
480050|NCT00098761|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
480051|NCT00098761|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
480052|NCT00098761|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
480053|NCT00098761|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
480054|NCT00098761|recurrent childhood ependymoma|recurrent childhood ependymoma
480055|NCT00098761|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
480056|NCT00098761|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
585314|NCT00519363|SLEDAI, greater than four|sledai, greater than four
480057|NCT00098761|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
480058|NCT00098761|childhood choroid plexus tumor|childhood choroid plexus tumor
480059|NCT00098761|childhood craniopharyngioma|childhood craniopharyngioma
480060|NCT00098761|childhood infratentorial ependymoma|childhood infratentorial ependymoma
480061|NCT00098761|childhood grade I meningioma|childhood grade i meningioma
480062|NCT00098761|childhood grade II meningioma|childhood grade ii meningioma
480063|NCT00098761|childhood grade III meningioma|childhood grade iii meningioma
480064|NCT00098761|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
480065|NCT00098761|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
480066|NCT00098774|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
480067|NCT00098787|recurrent colon cancer|recurrent colon cancer
480068|NCT00098787|stage IV colon cancer|stage iv colon cancer
480069|NCT00098787|recurrent rectal cancer|recurrent rectal cancer
480070|NCT00098787|stage IV rectal cancer|stage iv rectal cancer
480071|NCT00098787|adenocarcinoma of the colon|adenocarcinoma of the colon
480072|NCT00098787|adenocarcinoma of the rectum|adenocarcinoma of the rectum
480073|NCT00098800|ovarian epithelial cancer|ovarian epithelial cancer
480074|NCT00098800|BRCA1 mutation carrier|brca1 mutation carrier
480075|NCT00098800|BRCA2 mutation carrier|brca2 mutation carrier
480076|NCT00098852|recurrent thyroid cancer|recurrent thyroid cancer
480077|NCT00098852|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
480078|NCT00098852|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
480079|NCT00098852|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
480080|NCT00098852|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
480081|NCT00098878|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
480082|NCT00098878|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
480083|NCT00098878|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
480084|NCT00098878|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
480085|NCT00098878|fallopian tube cancer|fallopian tube cancer
480086|NCT00098878|primary peritoneal cavity cancer|primary peritoneal cavity cancer
480087|NCT00098917|stage I non-small cell lung cancer|stage i non-small cell lung cancer
480088|NCT00098917|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
480089|NCT00098917|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
480090|NCT00098943|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
480091|NCT00098943|stage IV renal cell cancer|stage iv renal cell cancer
480458|NCT00100191|uterus|uterus
480093|NCT00098943|stage IV colon cancer|stage iv colon cancer
480094|NCT00098943|recurrent colon cancer|recurrent colon cancer
480095|NCT00098943|anaplastic thyroid cancer|anaplastic thyroid cancer
480096|NCT00098943|insular thyroid cancer|insular thyroid cancer
480097|NCT00098943|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
480098|NCT00098943|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
480099|NCT00098943|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
480100|NCT00098943|recurrent thyroid cancer|recurrent thyroid cancer
479472|NCT00104871|NTCTCSG|ntctcsg
480101|NCT00098943|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
480102|NCT00098943|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
480103|NCT00098943|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
480104|NCT00098943|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
480105|NCT00098943|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
480106|NCT00098943|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
480107|NCT00098943|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
480108|NCT00098943|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
480109|NCT00098943|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
480110|NCT00098943|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
480111|NCT00098943|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
480112|NCT00098943|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
480113|NCT00098943|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
480114|NCT00098943|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
480115|NCT00098943|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
480116|NCT00098943|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
480117|NCT00098943|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
480118|NCT00098943|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
480119|NCT00098943|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
480120|NCT00098943|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
585315|NCT00519363|LDL cholesterol elevated|ldl cholesterol elevated
480121|NCT00098943|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
480122|NCT00098943|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
480123|NCT00098943|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
480124|NCT00098943|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
480125|NCT00098943|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
480126|NCT00098943|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
480127|NCT00098943|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
480128|NCT00098943|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
480129|NCT00098943|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
480130|NCT00098943|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
480131|NCT00098943|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
480132|NCT00098943|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
480133|NCT00098943|metastatic parathyroid cancer|metastatic parathyroid cancer
480134|NCT00098943|recurrent parathyroid cancer|recurrent parathyroid cancer
480135|NCT00098943|recurrent salivary gland cancer|recurrent salivary gland cancer
480136|NCT00098943|stage IV salivary gland cancer|stage iv salivary gland cancer
480137|NCT00098969|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
480138|NCT00098982|stage III colon cancer|stage iii colon cancer
480139|NCT00098982|stage IV colon cancer|stage iv colon cancer
480140|NCT00098982|stage III rectal cancer|stage iii rectal cancer
480141|NCT00098982|stage IV rectal cancer|stage iv rectal cancer
480142|NCT00098982|recurrent colon cancer|recurrent colon cancer
480143|NCT00098982|recurrent rectal cancer|recurrent rectal cancer
480144|NCT00098995|stage IB cervical cancer|stage ib cervical cancer
480145|NCT00098995|stage IIA cervical cancer|stage iia cervical cancer
480146|NCT00098995|stage IIB cervical cancer|stage iib cervical cancer
480147|NCT00098995|stage III cervical cancer|stage iii cervical cancer
480148|NCT00098995|stage IVA cervical cancer|stage iva cervical cancer
480149|NCT00098995|cervical adenocarcinoma|cervical adenocarcinoma
480150|NCT00098995|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
480151|NCT00098995|cervical squamous cell carcinoma|cervical squamous cell carcinoma
480152|NCT00099008|breast cancer|breast cancer
480153|NCT00099008|endometrial cancer|endometrial cancer
480154|NCT00099060|adult giant cell glioblastoma|adult giant cell glioblastoma
480155|NCT00099060|adult gliosarcoma|adult gliosarcoma
480156|NCT00099060|recurrent adult brain tumor|recurrent adult brain tumor
480157|NCT00099086|adenocarcinoma of the prostate|adenocarcinoma of the prostate
480158|NCT00099086|stage IIB prostate cancer|stage iib prostate cancer
485015|NCT00122369|Anxiety|anxiety
480159|NCT00099086|stage IIA prostate cancer|stage iia prostate cancer
480160|NCT00099086|stage III prostate cancer|stage iii prostate cancer
480161|NCT00099086|stage IV prostate cancer|stage iv prostate cancer
480162|NCT00099099|Longevity|longevity
480163|NCT00099099|Calorie restriction|calorie restriction
480164|NCT00099099|Physical activity|physical activity
480165|NCT00099099|Weight loss|weight loss
480166|NCT00099112|basal cell carcinoma of the skin|basal cell carcinoma of the skin
480167|NCT00099112|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
480168|NCT00099112|actinic keratosis|actinic keratosis
480169|NCT00099125|adult giant cell glioblastoma|adult giant cell glioblastoma
480170|NCT00099125|adult gliosarcoma|adult gliosarcoma
480171|NCT00099125|adult glioblastoma|adult glioblastoma
480172|NCT00099138|Diet|diet
480173|NCT00099138|Caloric Restriction|caloric restriction
480174|NCT00099138|Exercise|exercise
480175|NCT00099138|Energy Metabolism|energy metabolism
480176|NCT00099138|Primary Aging|primary aging
480177|NCT00099138|Secondary Aging|secondary aging
480178|NCT00099151|Longevity|longevity
480179|NCT00099151|Dietary restriction|dietary restriction
480180|NCT00099151|Physical activity|physical activity
480181|NCT00099151|Weight Loss|weight loss
480182|NCT00099151|Diabetes|diabetes
480183|NCT00099164|preterm birth|preterm birth
480184|NCT00099164|pregnancy|pregnancy
480185|NCT00099164|multifetal|multifetal
480186|NCT00099164|Progesterone|progesterone
480187|NCT00099190|cancer|cancer
480188|NCT00099190|solid tumor|solid tumor
480189|NCT00099190|advanced solid tumor|advanced solid tumor
480190|NCT00099216|Dementia,vascular,rivastigmine,stroke,memory loss|dementia,vascular,rivastigmine,stroke,memory loss
480191|NCT00099229|bipolar disorder|bipolar disorder
480192|NCT00099229|manic episode|manic episode
480193|NCT00099229|treatment|treatment
480194|NCT00099229|licarbazepine|licarbazepine
480195|NCT00099242|Alzheimer's Disease|alzheimer's disease
480196|NCT00099242|Dementia|dementia
480197|NCT00099255|Keyword?|keyword?
480198|NCT00099255|Primary Cutaneous Anaplastic Large Cell Lymphoma|primary cutaneous anaplastic large cell lymphoma
480199|NCT00099255|Large Cell Transformation of Mycosis Fungoides|large cell transformation of mycosis fungoides
480200|NCT00099255|Lymphomatoid Papulosis|lymphomatoid papulosis
480201|NCT00099268|Parkinson's disease, levodopa therapy, dyskinesia|parkinson's disease, levodopa therapy, dyskinesia
480202|NCT00099281|Metastatic breast cancer|metastatic breast cancer
480203|NCT00099294|Pancreas|pancreas
480204|NCT00099294|Cancer|cancer
480205|NCT00099294|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
480206|NCT00099294|Metastatic|metastatic
480207|NCT00099294|Glufosfamide|glufosfamide
480208|NCT00099307|White Matter|white matter
480209|NCT00099307|Grey Matter|grey matter
480210|NCT00099307|Brain|brain
480211|NCT00099307|Disability|disability
480212|NCT00099307|Lesions|lesions
480213|NCT00099307|Multiple Sclerosis|multiple sclerosis
480214|NCT00099307|MS|ms
480215|NCT00099307|Healthy Volunteer|healthy volunteer
480216|NCT00099307|HV|hv
480217|NCT00099320|exenatide|exenatide
480218|NCT00099320|exendin-4|exendin-4
480219|NCT00099320|diabetes|diabetes
480220|NCT00099320|Amylin|amylin
480221|NCT00099320|Lilly|lilly
480222|NCT00099333|exenatide|exenatide
480223|NCT00099333|exendin-4|exendin-4
480227|NCT00099359|HIV|hiv
480228|NCT00099359|Perinatal|perinatal
480229|NCT00099359|Prevention|prevention
480230|NCT00099359|Transmission|transmission
480231|NCT00099359|Nevirapine|nevirapine
480232|NCT00099359|Epivir|epivir
480233|NCT00099359|Zidovudine|zidovudine
480234|NCT00099359|Nelfinavir|nelfinavir
480235|NCT00099359|ZDV|zdv
480236|NCT00099359|NVP|nvp
480237|NCT00099359|3TC|3tc
480238|NCT00099359|NFV|nfv
480239|NCT00099359|Viracept|viracept
480240|NCT00099359|Viramune|viramune
480241|NCT00099359|HIV Seronegativity|hiv seronegativity
480242|NCT00099359|Treatment Naive|treatment naive
480243|NCT00099372|sacrocolpopexy|sacrocolpopexy
480244|NCT00099372|abdominal sacrocolpopexy|abdominal sacrocolpopexy
480245|NCT00099372|surgical procedure, prolapse|surgical procedure, prolapse
480246|NCT00099372|pelvic organ prolapse|pelvic organ prolapse
480247|NCT00099372|urinary incontinence|urinary incontinence
480248|NCT00099372|stress urinary incontinence|stress urinary incontinence
480249|NCT00099385|social development|social development
480250|NCT00099385|risk behaviors|risk behaviors
480251|NCT00099385|social emotional education|social emotional education
480252|NCT00099385|classroom instruction|classroom instruction
480253|NCT00099424|exercise training|exercise training
480254|NCT00099424|resistance training|resistance training
480255|NCT00099424|endurance training|endurance training
480256|NCT00099424|Boeck's Sarcoid|boeck's sarcoid
480257|NCT00099424|Besnier-Boeck Disease|besnier-boeck disease
480258|NCT00099437|Advanced Breast Cancer|advanced breast cancer
480259|NCT00099437|Metastatic Breast Cancer|metastatic breast cancer
480260|NCT00099450|bleeding|bleeding
480261|NCT00099450|blood transfusion|blood transfusion
480262|NCT00099450|surgeries|surgeries
480263|NCT00099463|Coronavirus|coronavirus
480264|NCT00099463|Healthy|healthy
480265|NCT00099463|Immunity|immunity
480266|NCT00099463|Preventive|preventive
480267|NCT00099463|Virus|virus
480268|NCT00099463|Healthy Volunteer|healthy volunteer
480269|NCT00099463|HV|hv
480270|NCT00099476|Epicatechin|epicatechin
480271|NCT00099476|Polyphenols|polyphenols
480272|NCT00099476|Chocolate|chocolate
480273|NCT00099476|Insulin Resistance|insulin resistance
480274|NCT00099476|Endothelial Dysfunction|endothelial dysfunction
480275|NCT00099476|Hypertension|hypertension
480276|NCT00099489|Chronic Inflammatory Demyelinating Polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
480277|NCT00099489|CIDP|cidp
480278|NCT00099489|IVIg|ivig
480279|NCT00099489|AVONEX|avonex
480280|NCT00099502|Relapsing multiple sclerosis|relapsing multiple sclerosis
480281|NCT00099502|interferon beta 1b|interferon beta 1b
480282|NCT00099502|Betaferon|betaferon
480283|NCT00099502|Betaseron|betaseron
480284|NCT00099528|Post-herpetic neuralgia|post-herpetic neuralgia
480285|NCT00099528|Shingles|shingles
480286|NCT00099528|Herpes Zoster|herpes zoster
480287|NCT00099528|Neuropathic pain|neuropathic pain
480288|NCT00099528|Neuralgia|neuralgia
480289|NCT00099528|Anti-TNF agents|anti-tnf agents
480290|NCT00099528|Inflammatory cytokines|inflammatory cytokines
480291|NCT00099528|Hyperalgesia|hyperalgesia
480292|NCT00099528|Allodynia|allodynia
480293|NCT00099528|Irritable nociceptor|irritable nociceptor
480294|NCT00099541|Lung Cancer|lung cancer
480295|NCT00099541|Bone Metastases|bone metastases
480296|NCT00099541|Bone Markers|bone markers
480297|NCT00099541|NTX|ntx
480298|NCT00099541|zoledronic acid|zoledronic acid
480299|NCT00099541|Registry|registry
480300|NCT00099541|Unresectable Stage IV Non Small-cell Lung Cancer (NSCLC)|unresectable stage iv non small-cell lung cancer (nsclc)
480301|NCT00099541|Unresectable Stage IIIB NSCLC with Pleural Effusion|unresectable stage iiib nsclc with pleural effusion
480302|NCT00099567|Metabolic Syndrome|metabolic syndrome
480303|NCT00099567|Alzheimer's Disease|alzheimer's disease
480304|NCT00099567|Cognitive Impairment|cognitive impairment
480305|NCT00099567|Inflammation|inflammation
480306|NCT00099580|Congestive Heart Failure|congestive heart failure
480307|NCT00099580|AC2592|ac2592
480308|NCT00099580|GLP-1|glp-1
480309|NCT00099580|Amylin|amylin
480310|NCT00099580|metabolic abnormality|metabolic abnormality
480311|NCT00099593|Cutaneous T-cell lymphoma (CTCL)|cutaneous t-cell lymphoma (ctcl)
480312|NCT00099593|Sezary Syndrome|sezary syndrome
480313|NCT00099593|Mycosis Fungoides|mycosis fungoides
480314|NCT00099593|Vaccine|vaccine
480315|NCT00099619|exenatide|exenatide
480316|NCT00099619|exendin-4|exendin-4
480317|NCT00099619|diabetes|diabetes
480318|NCT00099619|Amylin|amylin
480319|NCT00099619|Lilly|lilly
480320|NCT00099632|Treatment Naive|treatment naive
480321|NCT00099645|Mifepristone|mifepristone
480322|NCT00099645|Mifeprex|mifeprex
480323|NCT00099645|RU486|ru486
480324|NCT00099645|VGX-410|vgx-410
480325|NCT00099645|Abortion Pill|abortion pill
480326|NCT00099645|Investigational Drug|investigational drug
480327|NCT00099658|MTCT|mtct
480328|NCT00099671|Treatment Experienced|treatment experienced
480329|NCT00099684|Treatment Experienced|treatment experienced
480330|NCT00099697|abdominal fat|abdominal fat
480430|NCT00100126|Pharyngitis|pharyngitis
480331|NCT00099697|dehydroepiandrosterone|dehydroepiandrosterone
480332|NCT00099697|Insulin sensitivity|insulin sensitivity
480333|NCT00099710|Curcumin|curcumin
480334|NCT00099710|Turmeric|turmeric
480335|NCT00099710|Curry|curry
480336|NCT00099710|NSAID|nsaid
480337|NCT00099710|anti-inflammatory|anti-inflammatory
480338|NCT00099710|Cholesterol|cholesterol
480339|NCT00099710|anti-oxidant|anti-oxidant
480340|NCT00099723|Hepatic steatosis|hepatic steatosis
480341|NCT00099723|adult-onset diabetes|adult-onset diabetes
480342|NCT00099723|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
480343|NCT00099736|Kidney, transplantation, rejection, immunosuppression|kidney, transplantation, rejection, immunosuppression
480344|NCT00099749|Kidney, immunosuppression, transplant, rejection|kidney, immunosuppression, transplant, rejection
480345|NCT00099762|Tumor Induced Osteomalacia|tumor induced osteomalacia
480346|NCT00099762|FGF-23|fgf-23
480347|NCT00099762|Phosphatonin|phosphatonin
480348|NCT00099762|Hypophosphatemia|hypophosphatemia
480349|NCT00099762|Oncogenic Osteomalacia|oncogenic osteomalacia
480350|NCT00099762|Phosphaturic Mesenchymal Tumor|phosphaturic mesenchymal tumor
480351|NCT00099762|TIO|tio
480352|NCT00099762|Osteogenic Osteomalacia|osteogenic osteomalacia
480353|NCT00099762|OOM|oom
480354|NCT00099775|Mycoses|mycoses
480355|NCT00099775|Candida|candida
480356|NCT00099775|Echinocandin|echinocandin
480357|NCT00099775|Immunocompromised Host|immunocompromised host
480358|NCT00099775|Invasive Fungal Infection|invasive fungal infection
480359|NCT00099775|Fungal Infection|fungal infection
480360|NCT00099788|Acute Coronary Syndrome|acute coronary syndrome
480361|NCT00099788|Myocardial Infarction|myocardial infarction
480362|NCT00099788|Heart Attack|heart attack
480363|NCT00099788|Angina|angina
480364|NCT00099788|Chest pain|chest pain
480365|NCT00099788|Ischemia|ischemia
480366|NCT00099788|Non-ST Elevation Acute Coronary Syndrome|non-st elevation acute coronary syndrome
480367|NCT00099801|Kidney, Transplantation, Rejection, Immunosuppression|kidney, transplantation, rejection, immunosuppression
480368|NCT00099814|tooth movement|tooth movement
480369|NCT00099814|orthodontics|orthodontics
480370|NCT00099814|force|force
480371|NCT00099814|humans|humans
480372|NCT00099814|clinical trial|clinical trial
480373|NCT00099827|Depression|depression
480374|NCT00099840|common cold|common cold
480375|NCT00099840|pharyngitis|pharyngitis
480376|NCT00099840|tonsillitis|tonsillitis
480377|NCT00099840|rhinosinusitis|rhinosinusitis
480378|NCT00099840|tracheo-bronchitis|tracheo-bronchitis
480379|NCT00099840|otitis media|otitis media
480380|NCT00099840|acute exacerbations of asthma|acute exacerbations of asthma
480381|NCT00099840|acute exacerbations of chronic pulmonary disease|acute exacerbations of chronic pulmonary disease
480382|NCT00099840|community acquired pneumonia|community acquired pneumonia
480383|NCT00099853|type 2 diabetes|type 2 diabetes
480384|NCT00099853|vildagliptin|vildagliptin
480385|NCT00099866|type 2 diabetes|type 2 diabetes
480386|NCT00099866|vildagliptin|vildagliptin
480387|NCT00099892|type 2 diabetes|type 2 diabetes
480388|NCT00099892|vildagliptin|vildagliptin
480389|NCT00099905|type 2 diabetes|type 2 diabetes
480390|NCT00099905|vildagliptin|vildagliptin
480391|NCT00099918|type 2 diabetes|type 2 diabetes
480392|NCT00099918|vildagliptin|vildagliptin
480393|NCT00099931|type 2 diabetes|type 2 diabetes
480394|NCT00099931|vildagliptin|vildagliptin
480395|NCT00099944|type 2 diabetes|type 2 diabetes
480396|NCT00099944|vildagliptin|vildagliptin
480397|NCT00099957|type 2 diabetes|type 2 diabetes
480398|NCT00099957|vildagliptin|vildagliptin
480399|NCT00099970|Solid tumors|solid tumors
480400|NCT00099970|Metastatic melanoma|metastatic melanoma
480401|NCT00099983|PTSD|ptsd
480402|NCT00099996|Sitosterolemia|sitosterolemia
480403|NCT00099996|Sitosterol|sitosterol
480404|NCT00099996|Ezetimibe|ezetimibe
480405|NCT00099996|Absorption|absorption
480406|NCT00099996|Intestine|intestine
480407|NCT00099996|Cholesterol|cholesterol
480408|NCT00099996|Atherosclerosis|atherosclerosis
480409|NCT00099996|Homozygous Sitosterolemia|homozygous sitosterolemia
480410|NCT00100009|Steroid|steroid
480411|NCT00100009|Inflammation|inflammation
480412|NCT00100009|Choroidal Neovascularization|choroidal neovascularization
480413|NCT00100009|Intravitreal Injection|intravitreal injection
480414|NCT00100009|Verteporfin|verteporfin
480415|NCT00100009|Age-Related Macular Degeneration|age-related macular degeneration
480416|NCT00100009|Photodynamic Therapy|photodynamic therapy
480417|NCT00100009|Age Related Macular Degeneration|age related macular degeneration
480418|NCT00100009|AMD|amd
480419|NCT00100035|Caregivers|caregivers
480420|NCT00100035|Complementary Therapies|complementary therapies
480421|NCT00100061|Cranberry|cranberry
480422|NCT00100061|Vaccinium macrocarpon|vaccinium macrocarpon
480423|NCT00100087|macular degeneration|macular degeneration
480424|NCT00100087|brachytherapy|brachytherapy
480425|NCT00100087|choroidal neovascularization|choroidal neovascularization
480426|NCT00100087|retinal degeneration|retinal degeneration
480427|NCT00100087|retinal diseases|retinal diseases
480428|NCT00100100|cocaine dependence|cocaine dependence
480429|NCT00100113|cocaine dependence|cocaine dependence
480431|NCT00100126|Strep throat|strep throat
480432|NCT00100139|Neoplasm|neoplasm
480433|NCT00100139|Cancer|cancer
480434|NCT00100139|NeoPharm|neopharm
480435|NCT00100139|Liposomes|liposomes
480436|NCT00100139|Taxol|taxol
480437|NCT00100139|Paclitaxel|paclitaxel
480438|NCT00100139|Anti-cancer|anti-cancer
480439|NCT00100139|Advanced neoplasm|advanced neoplasm
480440|NCT00100139|Advanced cancer|advanced cancer
480441|NCT00100139|Chemotherapy|chemotherapy
480442|NCT00100139|Refractory cancer|refractory cancer
480443|NCT00100139|Metastatic cancer|metastatic cancer
480444|NCT00100152|Relapsed or refractory T-cell ALL acute lymphoblastic/leukemia|relapsed or refractory t-cell all acute lymphoblastic/leukemia
480445|NCT00100152|Relapsed/refractory T-cell acute Lymphoblastic/leukemia|relapsed/refractory t-cell acute lymphoblastic/leukemia
480446|NCT00100152|Acute/chronic myelogenous leukemia|acute/chronic myelogenous leukemia
480447|NCT00100152|Poor-risk myelodysplasia|poor-risk myelodysplasia
480448|NCT00100165|Schizophrenia|schizophrenia
480449|NCT00100178|immunosuppressive therapy|immunosuppressive therapy
480450|NCT00100178|Type 1 Diabetes TrialNet|type 1 diabetes trialnet
480451|NCT00100178|TrialNet|trialnet
480452|NCT00100178|POPPII|poppii
480453|NCT00100178|POPPII-1|poppii-1
480454|NCT00100191|hysterectomy|hysterectomy
480455|NCT00100191|fibroids|fibroids
480456|NCT00100191|uterine artery embolization|uterine artery embolization
619164|NCT00658918|PAR|par
480457|NCT00100191|therapeutic embolization|therapeutic embolization
480460|NCT00100204|Head and Neck Radiation|head and neck radiation
480461|NCT00100204|Diabetes|diabetes
480462|NCT00100204|Sarcoidosis|sarcoidosis
480463|NCT00100204|Sjogren's Syndrome|sjogren's syndrome
480464|NCT00100204|Caries|caries
480465|NCT00100204|Healthy Volunteer|healthy volunteer
480467|NCT00100204|Saliva Sample|saliva sample
480468|NCT00100217|Training|training
480469|NCT00100217|Critical Care|critical care
480470|NCT00100217|Heart Failure|heart failure
480471|NCT00100217|Pulmonary Hypertension|pulmonary hypertension
480472|NCT00100217|Infectious Diseases|infectious diseases
480473|NCT00100230|retina|retina
480474|NCT00100230|electroretinography|electroretinography
480475|NCT00100230|clinical trial|clinical trial
480476|NCT00100230|docosahexaenoic acid|docosahexaenoic acid
480477|NCT00100230|omega-3 fatty acid|omega-3 fatty acid
480478|NCT00100230|x-linked inheritance|x-linked inheritance
480479|NCT00100243|androgen-independent|androgen-independent
480480|NCT00100243|prostate cancer|prostate cancer
480481|NCT00100256|Advanced or recurrent stage IIIb or IV non small cell lung cancer|advanced or recurrent stage iiib or iv non small cell lung cancer
480482|NCT00100256|Disseminated or recurrent small cell lung cancer|disseminated or recurrent small cell lung cancer
480483|NCT00100269|Male infertility|male infertility
480484|NCT00100269|sperm|sperm
480485|NCT00100269|pregnancy|pregnancy
480486|NCT00100269|IVF (in vitro fertilisation)|ivf (in vitro fertilisation)
480487|NCT00100269|oxidative stress|oxidative stress
480488|NCT00100269|free radicals|free radicals
480489|NCT00100269|DNA damage|dna damage
480490|NCT00100282|Mild-moderate Alzheimer's disease|mild-moderate alzheimer's disease
480491|NCT00100295|Adolescent|adolescent
480492|NCT00100295|Child|child
480493|NCT00100295|Phytotherapy|phytotherapy
480494|NCT00100308|sepsis|sepsis
480495|NCT00100308|Randomized clinical trial|randomized clinical trial
480496|NCT00100308|Heparin|heparin
480497|NCT00100308|Therapy|therapy
480498|NCT00100321|Tumor Antigen Identification|tumor antigen identification
480499|NCT00100321|Standard Treatment|standard treatment
480500|NCT00100321|Tissue Acquisition|tissue acquisition
480501|NCT00100321|Surgery|surgery
480502|NCT00100321|Adjuvant Chemotherapy|adjuvant chemotherapy
480503|NCT00100321|Pancreatic Cancer|pancreatic cancer
480504|NCT00100321|Pancreatic Tumor|pancreatic tumor
480505|NCT00100334|Alzheimer's Disease|alzheimer's disease
480506|NCT00100347|non-Hodgkin lymphoma|non-hodgkin lymphoma
480507|NCT00100347|non-Hodgkin’s lymphoma|non-hodgkin’s lymphoma
480509|NCT00100347|MetAP2|metap2
480510|NCT00100347|Solid Tumors|solid tumors
480511|NCT00100360|Gonadal Steroids|gonadal steroids
480512|NCT00100360|GnRH Agonist|gnrh agonist
480513|NCT00100360|Depression|depression
480514|NCT00100360|Menstrual Cycle|menstrual cycle
480515|NCT00100360|Menstrually Related Mood Disorder|menstrually related mood disorder
480516|NCT00100360|MRMD|mrmd
480517|NCT00100360|Healthy Volunteer|healthy volunteer
480518|NCT00100360|HV|hv
480519|NCT00100373|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
480520|NCT00100386|Hand hygiene, antibiotic resistance, contact precautions|hand hygiene, antibiotic resistance, contact precautions
480521|NCT00100399|influenza, flu, Fluarix, vaccine, GSK, immunogenicity|influenza, flu, fluarix, vaccine, gsk, immunogenicity
480522|NCT00100425|Irritable Bowel Syndrome|irritable bowel syndrome
480523|NCT00100425|Visceral Hypersensitivity|visceral hypersensitivity
480524|NCT00100425|Visceral Pain|visceral pain
480525|NCT00100451|Adipose tissue|adipose tissue
480526|NCT00100451|Aging|aging
480527|NCT00100451|Exercise|exercise
480528|NCT00100451|Lipolysis|lipolysis
480529|NCT00100451|Estrogens|estrogens
480530|NCT00100464|Serotonin|serotonin
480531|NCT00100464|Sleep Apnea Syndrome|sleep apnea syndrome
480532|NCT00100464|Pharyngeal Muscles|pharyngeal muscles
480533|NCT00100477|Multiple Myeloma|multiple myeloma
480534|NCT00100477|Lymphoma|lymphoma
480535|NCT00100477|Leukemia|leukemia
480536|NCT00100477|Etoposide|etoposide
480537|NCT00100477|Drug Therapy|drug therapy
480538|NCT00100477|Clinical Trials|clinical trials
480539|NCT00100503|Rehabilitation|rehabilitation
480540|NCT00100503|Forced Use|forced use
480541|NCT00100503|Hemiplegia|hemiplegia
480542|NCT00100503|Magnetic Resonance Imaging|magnetic resonance imaging
480543|NCT00100503|TMS|tms
480544|NCT00100503|Cerebral Palsy|cerebral palsy
480545|NCT00100503|Spastic Hemiplegia|spastic hemiplegia
480546|NCT00100503|Healthy Volunteer|healthy volunteer
480547|NCT00100503|HV|hv
480548|NCT00100516|Renal|renal
480549|NCT00100516|Allografts|allografts
480550|NCT00100516|Nephrectomy|nephrectomy
480551|NCT00100516|Pneumoperitoneum|pneumoperitoneum
480552|NCT00100516|LaparoscopIC|laparoscopic
480553|NCT00100516|Kidney Donation|kidney donation
480554|NCT00100529|Facial Imaging|facial imaging
480555|NCT00100529|Genetics|genetics
480556|NCT00100529|Growth|growth
480557|NCT00100529|Development|development
479895|NCT00106314|IBDQ|ibdq
480558|NCT00100529|Diagnostics|diagnostics
480559|NCT00100529|Craniofacial Dysmorphologies|craniofacial dysmorphologies
480560|NCT00100529|Facial Features|facial features
480561|NCT00100542|Treatment Experienced|treatment experienced
480562|NCT00100542|Treatment Naive|treatment naive
480563|NCT00100542|Psychopathology|psychopathology
480564|NCT00100542|Anti-Retroviral Agents|anti-retroviral agents
480566|NCT00100542|Adolescent|adolescent
480567|NCT00100555|Osteoporosis, osteopenia, post-menopausal, zoledronic acid|osteoporosis, osteopenia, post-menopausal, zoledronic acid
480568|NCT00100568|Treatment Naive|treatment naive
480569|NCT00100581|Treatment Naive|treatment naive
480570|NCT00106431|romidepsin|romidepsin
480571|NCT00106470|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
480572|NCT00106483|Cardiovascular Diseases|cardiovascular diseases
480573|NCT00106483|Coronary Disease|coronary disease
480574|NCT00106483|Heart Diseases|heart diseases
480575|NCT00106496|Treatment Effectiveness|treatment effectiveness
480576|NCT00106496|Treatment Efficacy|treatment efficacy
480577|NCT00106496|Immunomodulator, Topical|immunomodulator, topical
480578|NCT00106496|Tacrolimus, Topical|tacrolimus, topical
480579|NCT00106496|Dermatitis, Atopic|dermatitis, atopic
480580|NCT00106496|Eczema, Atopic|eczema, atopic
480581|NCT00106496|Atopic Dermatitis|atopic dermatitis
480582|NCT00106509|Clostridium Enterocolitis|clostridium enterocolitis
480583|NCT00106509|Pseudomembranous Colitis|pseudomembranous colitis
480584|NCT00106509|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
480585|NCT00106509|C. difficile|c. difficile
480586|NCT00106509|CDAD|cdad
480587|NCT00106561|spironolactone|spironolactone
480588|NCT00106561|proteinuria|proteinuria
480589|NCT00106561|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
480590|NCT00106561|angiotensin receptor blocker|angiotensin receptor blocker
480591|NCT00106561|renin angiotensin aldosterone system|renin angiotensin aldosterone system
480592|NCT00106561|aldosterone|aldosterone
480593|NCT00106587|in stent restenosis|in stent restenosis
480594|NCT00106587|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
480595|NCT00106587|paccocath|paccocath
480596|NCT00106587|drug eluting balloon|drug eluting balloon
480597|NCT00106600|Relapsed|relapsed
480599|NCT00106613|Renal Cell Carcinoma|renal cell carcinoma
480600|NCT00106613|Metastatic Cancer|metastatic cancer
480601|NCT00106613|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
480602|NCT00106626|Advanced solid tumors including MPM and NSCLC|advanced solid tumors including mpm and nsclc
480603|NCT00106639|tofacitinib|tofacitinib
480604|NCT00106639|CP-690550|cp-690550
480605|NCT00106639|kidney transplant|kidney transplant
480606|NCT00106652|autism|autism
480607|NCT00106652|neurodevelopment|neurodevelopment
480608|NCT00106652|neurotoxicology|neurotoxicology
480609|NCT00106652|perinatology|perinatology
480610|NCT00106652|teratology|teratology
480611|NCT00106665|ICU acquired weakness|icu acquired weakness
480612|NCT00106665|Critical care polyneuropathy|critical care polyneuropathy
480613|NCT00106665|Critical care myopathy|critical care myopathy
480614|NCT00106678|HIV|hiv
480615|NCT00106678|Antiretroviral therapy (ART)|antiretroviral therapy (art)
480616|NCT00106678|HAART|haart
480617|NCT00106678|Adherence|adherence
480618|NCT00106678|Barriers|barriers
480619|NCT00106691|neoplasia|neoplasia
480620|NCT00106691|chemoprevention|chemoprevention
480621|NCT00106691|cancer|cancer
480622|NCT00106691|premalignant|premalignant
480623|NCT00106691|precancerous|precancerous
480624|NCT00106691|Chemoprophylaxis|chemoprophylaxis
480625|NCT00106691|Intraepithelial Prostatic Neoplasia|intraepithelial prostatic neoplasia
480626|NCT00106691|Neoplasia, Prostatic Intraepithelial|neoplasia, prostatic intraepithelial
480627|NCT00106717|Cancer pain|cancer pain
480628|NCT00106717|Quality of life|quality of life
480629|NCT00106717|Narrative medicine|narrative medicine
480630|NCT00106717|Pain relief|pain relief
480631|NCT00106743|Usher Syndrome|usher syndrome
480632|NCT00106743|Retinitis Pigmentosa|retinitis pigmentosa
480633|NCT00106743|Congenital Deafness|congenital deafness
480634|NCT00106756|Exudation|exudation
480635|NCT00106756|Avascular Retina|avascular retina
480636|NCT00106756|Retina Fold|retina fold
480637|NCT00106769|Flavivirus|flavivirus
480638|NCT00106769|Mosquito|mosquito
480639|NCT00106769|Immunity|immunity
480640|NCT00106769|Preventive|preventive
480641|NCT00106769|Virus|virus
480642|NCT00106769|West Nile Fever|west nile fever
480643|NCT00106769|Healthy Volunteer|healthy volunteer
480644|NCT00106769|HV|hv
480645|NCT00106782|Electrical|electrical
480646|NCT00106782|Stimulation|stimulation
480647|NCT00106782|Dystonia|dystonia
480648|NCT00106782|Brain|brain
480649|NCT00106782|Focal Hand Dystonia|focal hand dystonia
480650|NCT00106782|FHD|fhd
480651|NCT00109330|Prevention of Diphtheria, Tetanus, Pertussis|prevention of diphtheria, tetanus, pertussis
480652|NCT00109356|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
480653|NCT00109356|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
480654|NCT00109356|Small Lymphocytic Leukemia|small lymphocytic leukemia
480655|NCT00109369|Chronic Disease|chronic disease
480656|NCT00109369|Multi-Hospital Information Systems|multi-hospital information systems
480657|NCT00109369|Clinical Decision Support Systems|clinical decision support systems
480658|NCT00109369|Reminder Systems|reminder systems
480659|NCT00109369|Registries|registries
480660|NCT00109369|Quality of Healthcare|quality of healthcare
480662|NCT00109369|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
480663|NCT00109369|Technology Assessment, Biomedical|technology assessment, biomedical
480664|NCT00109369|Primary Health Care|primary health care
480665|NCT00109369|Hypercholesterolemia|hypercholesterolemia
480666|NCT00109369|Hypertension|hypertension
480667|NCT00109369|Hyperglycemia|hyperglycemia
480668|NCT00109382|Transient Ischemic Attack|transient ischemic attack
480669|NCT00109382|Stroke|stroke
480670|NCT00109382|Stroke Prevention|stroke prevention
480671|NCT00109382|Recurrence|recurrence
480672|NCT00109382|Neuroprotection|neuroprotection
480673|NCT00109382|Antiplatelet Therapy|antiplatelet therapy
480674|NCT00109382|Statins|statins
480675|NCT00109395|Lorazepam|lorazepam
480676|NCT00109395|Midazolam|midazolam
480677|NCT00109395|Best Pharmaceuticals for Children Act|best pharmaceuticals for children act
480678|NCT00109395|Critically ill|critically ill
480679|NCT00109395|pediatrics|pediatrics
480680|NCT00109395|mechanical ventilation|mechanical ventilation
480681|NCT00109395|sedation|sedation
480682|NCT00109421|adolescent|adolescent
480683|NCT00109421|female|female
480684|NCT00109421|community-based|community-based
480685|NCT00109421|social network|social network
480686|NCT00109421|HIV/STI intervention|hiv/sti intervention
480687|NCT00109421|High HIV-risk African American adolescent females|high hiv-risk african american adolescent females
480688|NCT00109434|exercise|exercise
480689|NCT00109434|hypoglycemia|hypoglycemia
480690|NCT00109434|Diabetes Mellitus, Type I|diabetes mellitus, type i
480691|NCT00109434|glucose monitoring|glucose monitoring
480692|NCT00109460|Tobacco|tobacco
480693|NCT00109473|Pediatric Crohn's disease|pediatric crohn's disease
480694|NCT00109473|Pediatric|pediatric
480695|NCT00109473|Crohn's Disease|crohn's disease
480696|NCT00109486|GW685698X|gw685698x
480697|NCT00109486|seasonal allergic rhinitis|seasonal allergic rhinitis
480698|NCT00109486|perennial allergic rhinitis|perennial allergic rhinitis
480699|NCT00109486|knemometry|knemometry
480700|NCT00109486|children|children
480701|NCT00109499|Wet Age-Related Macular Degeneration|wet age-related macular degeneration
480702|NCT00109499|Age-Related Maculopathies|age-related maculopathies
480703|NCT00109512|endometriosis|endometriosis
480704|NCT00109512|pelvic pain|pelvic pain
480705|NCT00109512|painful periods|painful periods
480706|NCT00109512|dysmenorrhea|dysmenorrhea
480707|NCT00109512|painful menstruation|painful menstruation
480708|NCT00109512|GnRH|gnrh
480709|NCT00109512|agonist|agonist
480710|NCT00109512|antagonist|antagonist
480711|NCT00109512|menstrual pain|menstrual pain
480712|NCT00109525|NICHD Neonatal Research Network|nichd neonatal research network
480713|NCT00109525|Fungal Infection|fungal infection
480714|NCT00109525|Mycosis|mycosis
480715|NCT00109525|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
480716|NCT00109525|Prematurity|prematurity
480717|NCT00109525|Clinical Judgement|clinical judgement
480718|NCT00109525|Polymerase chain reaction (PCR) testing|polymerase chain reaction (pcr) testing
480719|NCT00109525|Beta-glucan assay|beta-glucan assay
480720|NCT00109525|Mass Spectrometry|mass spectrometry
480721|NCT00109525|Lumbar puncture|lumbar puncture
480722|NCT00109538|Lonafarnib|lonafarnib
480723|NCT00109551|zinc|zinc
480724|NCT00109551|child mortality|child mortality
480725|NCT00109551|child morbidity|child morbidity
480726|NCT00109551|community trial|community trial
480727|NCT00109551|prevention trial|prevention trial
480728|NCT00109551|dietary supplement|dietary supplement
480729|NCT00109564|AAMI|aami
480730|NCT00109564|Memory Impairment|memory impairment
481722|NCT00112021|pramlintide|pramlintide
480731|NCT00109564|Decline in Cognitive Function|decline in cognitive function
480732|NCT00109564|Age Associated Memory Impairment|age associated memory impairment
480733|NCT00109577|bipolar disorder|bipolar disorder
480734|NCT00109577|mood disorders|mood disorders
480735|NCT00109577|manic depression|manic depression
480736|NCT00109577|nutrition|nutrition
480737|NCT00109590|HIV Seronegativity|hiv seronegativity
480738|NCT00109590|Treatment Naive|treatment naive
480739|NCT00109590|Pregnancy|pregnancy
480740|NCT00109590|Perinatal Transmission|perinatal transmission
480741|NCT00109590|Vertical Transmission|vertical transmission
480742|NCT00109590|Mother-To-Child Transmission|mother-to-child transmission
480743|NCT00109590|MTCT|mtct
480744|NCT00109603|Treatment Experienced|treatment experienced
480745|NCT00109603|TDF|tdf
480746|NCT00109616|neonatal mortality|neonatal mortality
480747|NCT00109616|chlorhexidine|chlorhexidine
480748|NCT00109616|newborn cleansing|newborn cleansing
480749|NCT00109616|umbilical cord care|umbilical cord care
480750|NCT00109616|community-based trial|community-based trial
480751|NCT00109616|prevention trial|prevention trial
480752|NCT00109616|omphalitis|omphalitis
480753|NCT00109629|HIV-Negative|hiv-negative
480754|NCT00109629|Healthy|healthy
480755|NCT00109629|Immunity|immunity
480756|NCT00109629|Preventive|preventive
480757|NCT00109629|Virus|virus
480758|NCT00109629|Healthy Volunteer|healthy volunteer
480759|NCT00109642|Amygdala|amygdala
480760|NCT00109642|Orbitofrontal Cortex|orbitofrontal cortex
480761|NCT00109642|Yohimbine|yohimbine
480762|NCT00109642|Emotion|emotion
480763|NCT00109642|Guanfacine|guanfacine
480764|NCT00109642|Norepinephrine|norepinephrine
480765|NCT00109642|Healthy Volunteer|healthy volunteer
480766|NCT00109655|Superficial Transitional Cell Carcinoma|superficial transitional cell carcinoma
480767|NCT00109655|Bacillus Calmette-Guerin (BCG)|bacillus calmette-guerin (bcg)
480768|NCT00109655|Superficial Bladder Cancer|superficial bladder cancer
480769|NCT00109655|Gene Therapy|gene therapy
480770|NCT00109655|Vaccine|vaccine
480771|NCT00109655|Adenovirus|adenovirus
480772|NCT00109655|Carcinoma in situ|carcinoma in situ
480773|NCT00109681|ACTIVE|active
480774|NCT00109681|iloprost|iloprost
480775|NCT00109681|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
480776|NCT00109681|pulmonary arterial hypertension|pulmonary arterial hypertension
480777|NCT00109707|CML in blast crisis|cml in blast crisis
480778|NCT00109707|CML in chronic phase|cml in chronic phase
480779|NCT00109707|CML in accelerated phase|cml in accelerated phase
480780|NCT00109707|Gleevec resistance|gleevec resistance
480781|NCT00109707|Gleevec intolerant|gleevec intolerant
480782|NCT00109707|Gleevec and CML|gleevec and cml
480783|NCT00109707|imatinib resistance|imatinib resistance
480784|NCT00109707|imatinib intolerant|imatinib intolerant
480785|NCT00109707|Hypereosinophilic Syndrome|hypereosinophilic syndrome
480786|NCT00109707|Systemic Mastocytosis|systemic mastocytosis
480787|NCT00109707|Chronic eosinophilic syndrome|chronic eosinophilic syndrome
480788|NCT00109707|Philadelphia chromosome positive acute lymphoblastic leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
480789|NCT00109707|HES|hes
480790|NCT00109707|CEL|cel
480791|NCT00109707|CML|cml
480792|NCT00109707|SM|sm
480793|NCT00109707|Ph+ ALL refractory to standard therapy|ph+ all refractory to standard therapy
480794|NCT00109707|Ph+ALL relapsed|ph+all relapsed
480795|NCT00109707|AMN107A|amn107a
480796|NCT00109720|Diabetes|diabetes
480797|NCT00109720|Self Management|self management
480798|NCT00109720|Type 2 diabetes|type 2 diabetes
480799|NCT00109733|Childhood-onset growth hormone deficiency (COGHD)|childhood-onset growth hormone deficiency (coghd)
480800|NCT00109733|Saizen®|saizen®
480801|NCT00109746|HIV|hiv
480802|NCT00109746|Treatment Experienced|treatment experienced
480803|NCT00109746|Anti-Retroviral Agents|anti-retroviral agents
480804|NCT00109746|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
480805|NCT00109746|Picolinic acid|picolinic acid
480806|NCT00109746|Dietary Supplements|dietary supplements
480807|NCT00109759|allergy|allergy
480808|NCT00109759|allergoid|allergoid
480809|NCT00109759|specific immunotherapy|specific immunotherapy
480810|NCT00109759|ragweed|ragweed
480811|NCT00109772|CRPS|crps
480812|NCT00109772|RSDS|rsds
480813|NCT00109772|Pain|pain
480814|NCT00109772|CC-5013|cc-5013
480815|NCT00109772|Revlimid|revlimid
480816|NCT00109772|Complex Regional Pain Syndrome|complex regional pain syndrome
480817|NCT00109772|Reflex Sympathy Dystrophy Syndrome|reflex sympathy dystrophy syndrome
480818|NCT00109772|Lenalidomide|lenalidomide
480819|NCT00109772|CRPS Type I|crps type i
480820|NCT00109772|Celgene|celgene
480821|NCT00109785|stage IIIA breast cancer|stage iiia breast cancer
480822|NCT00109785|stage IIIB breast cancer|stage iiib breast cancer
480823|NCT00109785|stage IIIC breast cancer|stage iiic breast cancer
480824|NCT00109785|male breast cancer|male breast cancer
480825|NCT00109798|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
480826|NCT00109798|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
480827|NCT00109837|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
480828|NCT00109837|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
480829|NCT00109837|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
480830|NCT00109850|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
480831|NCT00109850|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
480832|NCT00109850|stage III esophageal cancer|stage iii esophageal cancer
480833|NCT00109863|recurrent melanoma|recurrent melanoma
480834|NCT00109863|stage IV melanoma|stage iv melanoma
480835|NCT00109876|stage I non-small cell lung cancer|stage i non-small cell lung cancer
480836|NCT00109889|extramedullary plasmacytoma|extramedullary plasmacytoma
480837|NCT00109889|isolated plasmacytoma of bone|isolated plasmacytoma of bone
480838|NCT00109928|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
480839|NCT00109928|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
480840|NCT00109928|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
480841|NCT00109928|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
480842|NCT00109928|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
480843|NCT00109928|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
480844|NCT00109928|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
485016|NCT00122369|Pain|pain
480845|NCT00109928|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
480846|NCT00109928|anaplastic large cell lymphoma|anaplastic large cell lymphoma
480847|NCT00109941|recurrent pancreatic cancer|recurrent pancreatic cancer
480848|NCT00109941|stage III pancreatic cancer|stage iii pancreatic cancer
480849|NCT00109941|stage IV pancreatic cancer|stage iv pancreatic cancer
480850|NCT00109954|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
480851|NCT00109954|advanced adult primary liver cancer|advanced adult primary liver cancer
480852|NCT00109954|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
480853|NCT00109954|recurrent adult primary liver cancer|recurrent adult primary liver cancer
480854|NCT00109980|Complementary Therapies|complementary therapies
480855|NCT00109980|Plants, Medicinal|plants, medicinal
480856|NCT00109980|Dominican Republic|dominican republic
480857|NCT00109980|Hispanic Americans|hispanic americans
480858|NCT00109993|graft versus host disease|graft versus host disease
480859|NCT00109993|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
480860|NCT00109993|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
480861|NCT00109993|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
480862|NCT00109993|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
480863|NCT00109993|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
480864|NCT00109993|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
480865|NCT00109993|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
480866|NCT00109993|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
480867|NCT00109993|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
480868|NCT00109993|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
480869|NCT00109993|chronic eosinophilic leukemia|chronic eosinophilic leukemia
480870|NCT00109993|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
480871|NCT00109993|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
480872|NCT00109993|chronic neutrophilic leukemia|chronic neutrophilic leukemia
480873|NCT00109993|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
480874|NCT00109993|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
480875|NCT00109993|disseminated neuroblastoma|disseminated neuroblastoma
480876|NCT00109993|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
480877|NCT00109993|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
480878|NCT00109993|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
480879|NCT00109993|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
480880|NCT00109993|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
480881|NCT00109993|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
480882|NCT00109993|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
480883|NCT00109993|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
480884|NCT00109993|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
480885|NCT00109993|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
480886|NCT00109993|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
480887|NCT00109993|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
480888|NCT00109993|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
480889|NCT00109993|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
481417|NCT00111085|endothelin A receptor|endothelin a receptor
480890|NCT00109993|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
480891|NCT00109993|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
480892|NCT00109993|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
480893|NCT00109993|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
480894|NCT00109993|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
480895|NCT00109993|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
480896|NCT00109993|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
480897|NCT00109993|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
480898|NCT00109993|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
480899|NCT00109993|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
480900|NCT00109993|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
480901|NCT00109993|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
480902|NCT00109993|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
480903|NCT00109993|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
480904|NCT00109993|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
480905|NCT00109993|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
480906|NCT00109993|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
480907|NCT00109993|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
480908|NCT00109993|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
480909|NCT00109993|recurrent neuroblastoma|recurrent neuroblastoma
480910|NCT00109993|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
480911|NCT00109993|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
480912|NCT00109993|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
480913|NCT00109993|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
480914|NCT00109993|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
480915|NCT00109993|refractory multiple myeloma|refractory multiple myeloma
480916|NCT00109993|refractory hairy cell leukemia|refractory hairy cell leukemia
480917|NCT00109993|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
480918|NCT00109993|secondary acute myeloid leukemia|secondary acute myeloid leukemia
480919|NCT00109993|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
480920|NCT00109993|splenic marginal zone lymphoma|splenic marginal zone lymphoma
480921|NCT00109993|stage I multiple myeloma|stage i multiple myeloma
480922|NCT00109993|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
480923|NCT00109993|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
480924|NCT00109993|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
480925|NCT00109993|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
480926|NCT00109993|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
480927|NCT00109993|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
480928|NCT00109993|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
480929|NCT00109993|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
480930|NCT00109993|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
480931|NCT00109993|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
480932|NCT00109993|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
480933|NCT00109993|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
480934|NCT00109993|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
480935|NCT00109993|stage III multiple myeloma|stage iii multiple myeloma
480936|NCT00109993|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
480937|NCT00109993|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
480938|NCT00109993|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
480939|NCT00109993|stage IIIA breast cancer|stage iiia breast cancer
480940|NCT00109993|stage IIIB breast cancer|stage iiib breast cancer
480941|NCT00109993|stage IIIC breast cancer|stage iiic breast cancer
480942|NCT00109993|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
480943|NCT00109993|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
480944|NCT00109993|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
480945|NCT00109993|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
480946|NCT00109993|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
480947|NCT00109993|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
480948|NCT00109993|stage IV breast cancer|stage iv breast cancer
480949|NCT00109993|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
480950|NCT00109993|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
480951|NCT00109993|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
480952|NCT00109993|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
480953|NCT00109993|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
480954|NCT00109993|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
480955|NCT00109993|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
480956|NCT00109993|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
480957|NCT00110006|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
480958|NCT00110006|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
480959|NCT00110006|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
480960|NCT00110006|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
480961|NCT00110006|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
480962|NCT00110006|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
480963|NCT00110006|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
480964|NCT00110006|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
95179|NCT02693847|Liver stiffness|liver stiffness
619876|NCT00660361|HIV|hiv
480965|NCT00110006|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
480966|NCT00110006|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
480967|NCT00110006|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
480968|NCT00110006|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
480969|NCT00110006|stage I mantle cell lymphoma|stage i mantle cell lymphoma
480970|NCT00110006|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
480971|NCT00110006|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
480972|NCT00110006|anaplastic large cell lymphoma|anaplastic large cell lymphoma
480973|NCT00110045|infection|infection
480974|NCT00110045|ataxia-telangiectasia|ataxia-telangiectasia
753934|NCT01178320|Atherosclerotic Plaque|atherosclerotic plaque
480975|NCT00110045|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
480976|NCT00110045|acute undifferentiated leukemia|acute undifferentiated leukemia
480977|NCT00110045|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
480978|NCT00110045|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
480979|NCT00110045|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
480980|NCT00110045|chronic eosinophilic leukemia|chronic eosinophilic leukemia
480981|NCT00110045|primary myelofibrosis|primary myelofibrosis
480982|NCT00110045|chronic neutrophilic leukemia|chronic neutrophilic leukemia
480983|NCT00110045|essential thrombocythemia|essential thrombocythemia
480984|NCT00110045|polycythemia vera|polycythemia vera
480985|NCT00110045|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
480986|NCT00110045|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
480987|NCT00110045|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
480988|NCT00110045|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
480989|NCT00110045|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
480990|NCT00110045|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
480991|NCT00110045|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
480992|NCT00110045|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
481429|NCT00111137|Chemotherapy|chemotherapy
480993|NCT00110045|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
480994|NCT00110045|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
480995|NCT00110045|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
480996|NCT00110045|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
480997|NCT00110045|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
480998|NCT00110045|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
480999|NCT00110045|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
481000|NCT00110045|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
481001|NCT00110045|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
481002|NCT00110045|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
481003|NCT00110045|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
481004|NCT00110045|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
481005|NCT00110045|refractory hairy cell leukemia|refractory hairy cell leukemia
481006|NCT00110045|prolymphocytic leukemia|prolymphocytic leukemia
481007|NCT00110045|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
481008|NCT00110045|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
481009|NCT00110045|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
481010|NCT00110045|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
481011|NCT00110045|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
481012|NCT00110045|anaplastic large cell lymphoma|anaplastic large cell lymphoma
481013|NCT00110045|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
481014|NCT00110045|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
481015|NCT00110045|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
481016|NCT00110045|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
481017|NCT00110045|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
481018|NCT00110045|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
481418|NCT00111085|clazosentan|clazosentan
481019|NCT00110045|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
481020|NCT00110045|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
481021|NCT00110045|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
481022|NCT00110045|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
481023|NCT00110045|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
481024|NCT00110045|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
481025|NCT00110045|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
481026|NCT00110045|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
481027|NCT00110045|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
481028|NCT00110045|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
481029|NCT00110045|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
481030|NCT00110045|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
481031|NCT00110045|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
481032|NCT00110045|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
481033|NCT00110045|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
481034|NCT00110045|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
481035|NCT00110045|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
481036|NCT00110045|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
485395|NCT00123877|Metastasis|metastasis
753935|NCT01178320|Lipid Lowering Therapy|lipid lowering therapy
481037|NCT00110045|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
481038|NCT00110045|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
481039|NCT00110045|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
481040|NCT00110045|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
481041|NCT00110045|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
481042|NCT00110045|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
481043|NCT00110045|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
481044|NCT00110045|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
481045|NCT00110045|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
481046|NCT00110045|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
481047|NCT00110045|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
481048|NCT00110045|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
481049|NCT00110045|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
481050|NCT00110045|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
481051|NCT00110045|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
481052|NCT00110045|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
585316|NCT00519376|pharmacodynamics,|pharmacodynamics,
481053|NCT00110045|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
481054|NCT00110045|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
481055|NCT00110045|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
481056|NCT00110045|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
481057|NCT00110045|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
481058|NCT00110045|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
481059|NCT00110045|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
481060|NCT00110045|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
481061|NCT00110045|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
481062|NCT00110045|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
481063|NCT00110045|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
481064|NCT00110045|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
481065|NCT00110045|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
481066|NCT00110045|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
481067|NCT00110045|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
481068|NCT00110045|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
481069|NCT00110045|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
481070|NCT00110045|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
481071|NCT00110045|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
481072|NCT00110045|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
481073|NCT00110045|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
481074|NCT00110045|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
481075|NCT00110045|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
481076|NCT00110045|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
481419|NCT00111098|Anemia|anemia
481077|NCT00110045|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
481078|NCT00110045|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
481079|NCT00110045|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
481080|NCT00110045|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
481081|NCT00110045|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
481082|NCT00110045|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
480508|NCT00100347|NHL|nhl
481083|NCT00110045|stage I mantle cell lymphoma|stage i mantle cell lymphoma
481084|NCT00110045|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
481085|NCT00110045|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
481086|NCT00110045|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
481087|NCT00110045|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
481088|NCT00110045|stage I marginal zone lymphoma|stage i marginal zone lymphoma
481089|NCT00110045|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
481090|NCT00110045|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
481091|NCT00110045|splenic marginal zone lymphoma|splenic marginal zone lymphoma
481092|NCT00110045|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
481093|NCT00110045|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
481094|NCT00110045|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
481095|NCT00110045|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
481096|NCT00110045|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
481097|NCT00110045|intraocular lymphoma|intraocular lymphoma
753936|NCT01178333|Thrombocytopenia|thrombocytopenia
481098|NCT00110045|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
481099|NCT00110045|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
481100|NCT00110045|extramedullary plasmacytoma|extramedullary plasmacytoma
481101|NCT00110045|isolated plasmacytoma of bone|isolated plasmacytoma of bone
481102|NCT00110045|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
481103|NCT00110045|stage I multiple myeloma|stage i multiple myeloma
481104|NCT00110045|stage II multiple myeloma|stage ii multiple myeloma
481105|NCT00110045|stage III multiple myeloma|stage iii multiple myeloma
481106|NCT00110045|primary systemic amyloidosis|primary systemic amyloidosis
481107|NCT00110045|refractory multiple myeloma|refractory multiple myeloma
481108|NCT00110045|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
481109|NCT00110045|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
481110|NCT00110045|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
481111|NCT00110045|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
481112|NCT00110045|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
481113|NCT00110045|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
481114|NCT00110045|disseminated neuroblastoma|disseminated neuroblastoma
481115|NCT00110045|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
481116|NCT00110045|recurrent neuroblastoma|recurrent neuroblastoma
481117|NCT00110045|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
481118|NCT00110045|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
481119|NCT00110045|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
481120|NCT00110045|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
481121|NCT00110045|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
481122|NCT00110045|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
481123|NCT00110045|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
481124|NCT00110045|secondary acute myeloid leukemia|secondary acute myeloid leukemia
481125|NCT00110045|stage IIIA breast cancer|stage iiia breast cancer
481126|NCT00110045|stage IIIB breast cancer|stage iiib breast cancer
481127|NCT00110045|stage IIIC breast cancer|stage iiic breast cancer
481128|NCT00110045|stage IV breast cancer|stage iv breast cancer
481129|NCT00110045|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
481130|NCT00110045|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
481131|NCT00110045|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
481132|NCT00110045|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
481133|NCT00110045|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
481134|NCT00110045|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
481135|NCT00110045|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
481136|NCT00110045|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
481137|NCT00110058|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
481138|NCT00110058|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
481139|NCT00110058|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
481140|NCT00110058|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
481141|NCT00110058|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
481142|NCT00110084|recurrent breast cancer|recurrent breast cancer
481143|NCT00110084|stage IV breast cancer|stage iv breast cancer
481144|NCT00110110|intraocular retinoblastoma|intraocular retinoblastoma
481145|NCT00110123|liver metastases|liver metastases
95180|NCT02693847|Transient elastography|transient elastography
480598|NCT00106600|Refractory|refractory
481146|NCT00110123|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
481147|NCT00110123|iris melanoma|iris melanoma
481148|NCT00110123|extraocular extension melanoma|extraocular extension melanoma
481149|NCT00110123|recurrent intraocular melanoma|recurrent intraocular melanoma
481150|NCT00110123|metastatic intraocular melanoma|metastatic intraocular melanoma
481151|NCT00110136|recurrent breast cancer|recurrent breast cancer
481152|NCT00110136|stage I breast cancer|stage i breast cancer
481153|NCT00110136|stage II breast cancer|stage ii breast cancer
481154|NCT00110136|stage IIIA breast cancer|stage iiia breast cancer
481155|NCT00110136|stage IIIB breast cancer|stage iiib breast cancer
481156|NCT00110136|breast cancer in situ|breast cancer in situ
481157|NCT00110136|ductal breast carcinoma in situ|ductal breast carcinoma in situ
481158|NCT00110136|hot flashes|hot flashes
481159|NCT00110149|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
481160|NCT00110149|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
481161|NCT00110149|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
481162|NCT00110149|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
481163|NCT00110149|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
481164|NCT00110149|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
481165|NCT00110149|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
481166|NCT00110149|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
481167|NCT00110149|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
481168|NCT00110149|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
481169|NCT00110149|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
481170|NCT00110149|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
481171|NCT00110149|splenic marginal zone lymphoma|splenic marginal zone lymphoma
481172|NCT00110149|stage I marginal zone lymphoma|stage i marginal zone lymphoma
481173|NCT00110149|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
481174|NCT00110149|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
481175|NCT00110149|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
481176|NCT00110149|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
481177|NCT00110149|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
481178|NCT00110149|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
481179|NCT00110149|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
481180|NCT00110149|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
481181|NCT00110149|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
481182|NCT00110162|adenocarcinoma of the prostate|adenocarcinoma of the prostate
481183|NCT00110162|stage I prostate cancer|stage i prostate cancer
481184|NCT00110162|stage IIB prostate cancer|stage iib prostate cancer
481185|NCT00110162|stage IIA prostate cancer|stage iia prostate cancer
481186|NCT00110162|stage III prostate cancer|stage iii prostate cancer
481187|NCT00110162|stage IV prostate cancer|stage iv prostate cancer
481188|NCT00110162|recurrent prostate cancer|recurrent prostate cancer
481189|NCT00110175|Cortical Reorganization|cortical reorganization
481190|NCT00110175|Motor Function|motor function
481191|NCT00110175|Somatosensory Stimulation|somatosensory stimulation
481192|NCT00110175|Rehabilitation|rehabilitation
481193|NCT00110175|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
481194|NCT00110175|Direct Current Stimulation|direct current stimulation
481195|NCT00110175|Stroke|stroke
481196|NCT00110175|Healthy Volunteer|healthy volunteer
481197|NCT00110188|prostate|prostate
481198|NCT00110188|cancer|cancer
481199|NCT00110201|Acute renal failure|acute renal failure
481200|NCT00110201|Nesiritide|nesiritide
481201|NCT00110201|Cardiovascular surgery|cardiovascular surgery
481202|NCT00110227|Complementary Therapies|complementary therapies
481203|NCT00110227|Tai Chi|tai chi
481204|NCT00110240|Type 2 diabetes|type 2 diabetes
481205|NCT00110240|vildagliptin|vildagliptin
481206|NCT00110266|ICL670|icl670
481207|NCT00110266|Deferasirox|deferasirox
481208|NCT00110266|Iron chelation|iron chelation
481209|NCT00110266|Chelator|chelator
481210|NCT00110266|Desferal|desferal
481211|NCT00110279|Bird Flu|bird flu
481212|NCT00110292|Public health|public health
481213|NCT00110292|Primary care|primary care
481214|NCT00110292|Parenting education|parenting education
481215|NCT00110292|Child rearing|child rearing
481216|NCT00110292|Parenting newsletters|parenting newsletters
481217|NCT00110292|Child development|child development
481218|NCT00110292|Language delay|language delay
481219|NCT00110305|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
481220|NCT00110305|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
481221|NCT00110305|Antiretroviral|antiretroviral
481222|NCT00110305|Antiviral|antiviral
481223|NCT00110305|ARV|arv
481224|NCT00110305|TMC278|tmc278
481225|NCT00110305|Efavirenz|efavirenz
481226|NCT00110305|Combivir|combivir
481227|NCT00110305|Truvada|truvada
481228|NCT00110305|Zidovudine|zidovudine
481229|NCT00110305|Lamivudine|lamivudine
481230|NCT00110305|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
481231|NCT00110305|Emtricitabine|emtricitabine
481232|NCT00110318|Tennis Elbow|tennis elbow
481233|NCT00110318|Physical Therapy Techniques|physical therapy techniques
481234|NCT00110318|Evidence-Based Medicine|evidence-based medicine
481235|NCT00110318|Primary Health Care|primary health care
481236|NCT00110331|Encephalopathy|encephalopathy
481237|NCT00110331|Neuroimaging|neuroimaging
481238|NCT00110331|Cognition|cognition
481239|NCT00110331|Neuroinflammation|neuroinflammation
481240|NCT00110331|Opportunistic Infections|opportunistic infections
481241|NCT00110331|HIV|hiv
481242|NCT00110331|Central Nervous System Disease|central nervous system disease
481243|NCT00110331|Bipolar Disorder|bipolar disorder
481244|NCT00110331|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
481245|NCT00110331|ADHD|adhd
481246|NCT00110331|Major Depression|major depression
481247|NCT00110331|Psychosis|psychosis
481248|NCT00110344|Cancer|cancer
481249|NCT00110396|Multiple Sclerosis|multiple sclerosis
481250|NCT00110396|Relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
481251|NCT00110422|Metabolic Syndrome|metabolic syndrome
481252|NCT00110448|type 2 diabetes|type 2 diabetes
481253|NCT00110448|coronary heart diseases|coronary heart diseases
481254|NCT00110448|primary prevention|primary prevention
481255|NCT00110448|atherosclerosis|atherosclerosis
481257|NCT00110461|Aripiprazole|aripiprazole
481258|NCT00110461|Bipolar I Disorder, Manic or Mixed Episode with or without Psychotic Features|bipolar i disorder, manic or mixed episode with or without psychotic features
481259|NCT00110474|Glucosamine sulfate|glucosamine sulfate
481260|NCT00110474|Osteoarthritis|osteoarthritis
481261|NCT00110474|Acetaminophen|acetaminophen
481262|NCT00110474|Paracetamol|paracetamol
481263|NCT00110474|Clinical trial|clinical trial
481264|NCT00110487|Endometriosis|endometriosis
481265|NCT00110500|Diabetes|diabetes
481266|NCT00110500|Neuropathy|neuropathy
481267|NCT00110513|Antithrombin Deficiency, Congenital or Hereditary|antithrombin deficiency, congenital or hereditary
481268|NCT00110513|Antithrombin III Deficiency|antithrombin iii deficiency
481270|NCT00110513|Hereditary Antithrombin Deficiency (HD)|hereditary antithrombin deficiency (hd)
481271|NCT00110526|Prostate Cancer|prostate cancer
481272|NCT00110526|Radiation Therapy|radiation therapy
481273|NCT00110526|Local recurrence|local recurrence
481274|NCT00110526|Gene Therapy|gene therapy
481275|NCT00110539|Medicine, Herbal|medicine, herbal
481276|NCT00110539|Dietary Supplements|dietary supplements
481277|NCT00110539|Complementary and Alternative Medicine|complementary and alternative medicine
481278|NCT00110539|Physicians|physicians
481279|NCT00110565|Magnetics|magnetics
481280|NCT00110565|Pulsed Magnetic Pad|pulsed magnetic pad
481281|NCT00110565|Magnetic Field|magnetic field
481282|NCT00110565|Electromagnetic Field|electromagnetic field
481283|NCT00110565|Women|women
481284|NCT00110565|Pulsed Magnetic Field|pulsed magnetic field
481285|NCT00110578|Treatment Naive|treatment naive
481286|NCT00110578|Treatment Experienced|treatment experienced
481287|NCT00110604|Folic acid|folic acid
481288|NCT00110604|Atherosclerosis|atherosclerosis
481289|NCT00110604|Cognitive function|cognitive function
481290|NCT00110604|Hearing|hearing
481291|NCT00110604|Inflammation|inflammation
481292|NCT00110604|Hemostasis|hemostasis
481293|NCT00110604|Arterial stiffness|arterial stiffness
481294|NCT00110617|Sickle Cell Disease|sickle cell disease
481295|NCT00110617|Iron Overload from Repeated Blood Transfusions|iron overload from repeated blood transfusions
481296|NCT00110617|Iron Overload|iron overload
481297|NCT00110617|Blood Transfusions|blood transfusions
481298|NCT00110630|nicotine dependence|nicotine dependence
481299|NCT00110643|Acne|acne
481300|NCT00110643|laser|laser
481301|NCT00110656|Kidney transplant|kidney transplant
481302|NCT00110669|Muscular dystrophy, Duchenne and Beckers|muscular dystrophy, duchenne and beckers
481303|NCT00110669|Beckers Muscular dystrophy|beckers muscular dystrophy
481304|NCT00110682|Actinic Keratosis|actinic keratosis
481305|NCT00110682|Cryotherapy|cryotherapy
481306|NCT00110682|Imiquimod|imiquimod
481307|NCT00110695|NSABP|nsabp
481308|NCT00110695|Abraxis|abraxis
481309|NCT00110695|Abraxane|abraxane
481310|NCT00110695|Locally advanced breast cancer|locally advanced breast cancer
481311|NCT00110695|Fluorouracil|fluorouracil
481312|NCT00110695|Epirubicin|epirubicin
481313|NCT00110695|Cyclophosphamide|cyclophosphamide
481314|NCT00110695|FEC|fec
481315|NCT00110708|autism|autism
481316|NCT00110708|gastrointestinal dysfunction|gastrointestinal dysfunction
481317|NCT00110708|autistic disorder|autistic disorder
481318|NCT00110708|diarrhea|diarrhea
481319|NCT00110708|constipation|constipation
481320|NCT00110708|abdominal pain|abdominal pain
481321|NCT00110708|gastrointestinal problems associated with autism|gastrointestinal problems associated with autism
481322|NCT00110708|immune globulin|immune globulin
481323|NCT00110708|immunoglobulin|immunoglobulin
481324|NCT00110708|Immunoglobulins, Intravenous|immunoglobulins, intravenous
481325|NCT00110708|Intestinal Mucosa/immunology/pathology|intestinal mucosa/immunology/pathology
481326|NCT00110708|Administration, Oral|administration, oral
481327|NCT00110708|Autistic Disorder/*drug therapy|autistic disorder/*drug therapy
481328|NCT00110708|Child Behavior/*drug effects|child behavior/*drug effects
481329|NCT00110708|Constipation/drug therapy|constipation/drug therapy
481330|NCT00110708|Diarrhea/drug therapy|diarrhea/drug therapy
481331|NCT00110708|Gastrointestinal Agents/*therapeutic use|gastrointestinal agents/*therapeutic use
481332|NCT00110721|colorectal cancer|colorectal cancer
481333|NCT00110721|DAVANAT|davanat
481334|NCT00110721|5-fluorouracil|5-fluorouracil
481335|NCT00110786|Allergy|allergy
481336|NCT00110786|Specific Immunotherapy|specific immunotherapy
481337|NCT00110786|Ragweed|ragweed
481338|NCT00110786|Environmental Exposure Chamber|environmental exposure chamber
481339|NCT00110799|thrombopoietin|thrombopoietin
481340|NCT00110799|platelets|platelets
481341|NCT00110799|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
481342|NCT00110799|Hepatitis C|hepatitis c
481343|NCT00110812|Treatment Naive|treatment naive
481344|NCT00110812|IL-2|il-2
481345|NCT00110812|rIL-2|ril-2
481346|NCT00110838|fish oil|fish oil
481347|NCT00110838|n-3 fatty acids|n-3 fatty acids
481348|NCT00110838|n-3 PUFA|n-3 pufa
481349|NCT00110838|omega-3 fatty acids|omega-3 fatty acids
481350|NCT00110838|arrhythmia|arrhythmia
481351|NCT00110838|ICD|icd
481352|NCT00110838|human|human
481269|NCT00110513|ATIII|atiii
481353|NCT00110838|Patients with an implantable cardioverter defibrillator|patients with an implantable cardioverter defibrillator
481354|NCT00110851|diabetes, type 2|diabetes, type 2
481355|NCT00110864|diabetes, type 2|diabetes, type 2
481356|NCT00110877|Human Immunodeficiency Virus|human immunodeficiency virus
481357|NCT00110877|Treatment Experienced|treatment experienced
481358|NCT00110877|TMC114-C214|tmc114-c214
481359|NCT00110890|Secondary HyperParaThyroidism (SHPT)|secondary hyperparathyroidism (shpt)
481360|NCT00110890|Dialysis, End Stage Renal Disease (ESRD)|dialysis, end stage renal disease (esrd)
481361|NCT00110890|KDOQI, Cinacalcet|kdoqi, cinacalcet
481362|NCT00110890|Clinical Trial, Amgen|clinical trial, amgen
481363|NCT00110903|Rheumatoid arthritis|rheumatoid arthritis
481364|NCT00110903|RA|ra
481365|NCT00110903|etanercept|etanercept
481366|NCT00110903|Immunex|immunex
481367|NCT00110903|Amgen|amgen
481368|NCT00110916|Intra-articular|intra-articular
481369|NCT00110916|Osteoarthritis|osteoarthritis
481370|NCT00110916|OA|oa
481371|NCT00110916|anakinra|anakinra
481372|NCT00110916|Amgen|amgen
481373|NCT00110929|Sensipar®|sensipar®
481374|NCT00110929|Secondary HPT|secondary hpt
481375|NCT00110929|Mimpara®|mimpara®
481376|NCT00110929|Cinacalcet|cinacalcet
481377|NCT00110929|calcimimetic|calcimimetic
481378|NCT00110929|End-Stage Renal Disease (ESRD)|end-stage renal disease (esrd)
481379|NCT00110942|Intra-articular|intra-articular
481380|NCT00110942|Osteoarthritis|osteoarthritis
481381|NCT00110942|OA|oa
481382|NCT00110942|anakinra|anakinra
481383|NCT00110942|Amgen|amgen
481384|NCT00110955|Non-myeloid malignancy|non-myeloid malignancy
481385|NCT00110955|Chemotherapy-induced anemia|chemotherapy-induced anemia
481386|NCT00110968|Abdominal Symptom relief|abdominal symptom relief
481387|NCT00110968|Fullness|fullness
481388|NCT00110968|Bloating|bloating
481389|NCT00110968|Indigestion|indigestion
481390|NCT00110968|Functional dyspepsia|functional dyspepsia
481391|NCT00110981|psoriasis|psoriasis
481392|NCT00110981|dermatology|dermatology
481393|NCT00110981|plaque psoriasis|plaque psoriasis
481394|NCT00110981|skin|skin
481395|NCT00110981|etanercept|etanercept
481396|NCT00110981|ENBREL|enbrel
481397|NCT00110981|NB-UVB, narrow-band UVB, phototherapy|nb-uvb, narrow-band uvb, phototherapy
481398|NCT00110981|combination therapy, 50 mg prefilled syringes|combination therapy, 50 mg prefilled syringes
481399|NCT00111046|Pain Relief|pain relief
481400|NCT00111046|Choroidal melanoma|choroidal melanoma
481401|NCT00111046|plaque radiotherapy|plaque radiotherapy
481402|NCT00111059|obesity|obesity
481403|NCT00111059|cardiovascular disease|cardiovascular disease
481404|NCT00111059|depression|depression
481405|NCT00111059|stress|stress
481406|NCT00111072|Mucosal Disease|mucosal disease
481407|NCT00111072|Topical Steroids|topical steroids
481408|NCT00111072|Salivary Diagnostics|salivary diagnostics
481409|NCT00111072|Oral Pain|oral pain
481410|NCT00111072|Quality of Life Indicators|quality of life indicators
481411|NCT00111072|Oral Lichen Planus|oral lichen planus
481412|NCT00111085|aneurysmal subarachnoid hemorrhage (aSAH)|aneurysmal subarachnoid hemorrhage (asah)
481413|NCT00111085|vasospasm|vasospasm
481414|NCT00111085|delayed ischemic neurological deficits (DIND)|delayed ischemic neurological deficits (dind)
481415|NCT00111085|computer tomography scan (CT scan)|computer tomography scan (ct scan)
481416|NCT00111085|digital subtraction angiography (DSA)|digital subtraction angiography (dsa)
481420|NCT00111098|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
481421|NCT00111111|Psoriasis|psoriasis
481422|NCT00111124|psoriasis|psoriasis
481423|NCT00111124|arthritis|arthritis
481424|NCT00111124|Enbrel®|enbrel®
481425|NCT00111124|etanercept|etanercept
481426|NCT00111137|darbepoetin alfa|darbepoetin alfa
481427|NCT00111137|anemia|anemia
481428|NCT00111137|Amgen|amgen
481430|NCT00111150|HIV incidence|hiv incidence
481431|NCT00111150|HIV prevention|hiv prevention
481432|NCT00111163|malaria|malaria
481433|NCT00111163|anemia|anemia
481434|NCT00111163|Plasmodium falciparum|plasmodium falciparum
481435|NCT00111163|infants|infants
481436|NCT00111163|prevention|prevention
481437|NCT00111163|safety|safety
481438|NCT00111163|efficacy|efficacy
481439|NCT00111163|antimalarials|antimalarials
481440|NCT00111176|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
481441|NCT00111176|Descending|descending
481442|NCT00111176|minimally invasive|minimally invasive
481443|NCT00111176|endovascular|endovascular
481444|NCT00111176|rupture|rupture
481445|NCT00111176|back pain|back pain
481446|NCT00111176|stent graft|stent graft
481447|NCT00111176|endovascular aneurysm repair|endovascular aneurysm repair
481448|NCT00111176|aortic aneurysm|aortic aneurysm
481449|NCT00111176|thoracic|thoracic
481450|NCT00111189|Schizophrenia|schizophrenia
481451|NCT00111189|Paliperidone palmitate|paliperidone palmitate
481452|NCT00111189|R092670|r092670
481453|NCT00111189|antipsychotic|antipsychotic
481454|NCT00111189|recurrence prevention|recurrence prevention
753937|NCT01178333|Heparin|heparin
481455|NCT00111202|Genetic counseling|genetic counseling
481456|NCT00111202|Genetic counselling|genetic counselling
481457|NCT00111202|Genetics|genetics
481458|NCT00111202|Schizophrenia|schizophrenia
481459|NCT00111215|Menorrhagia|menorrhagia
481460|NCT00111215|Von Willebrand's Disease|von willebrand's disease
481461|NCT00111215|Platelet Disorder|platelet disorder
481462|NCT00111228|Diabetes|diabetes
481463|NCT00111241|bone fracture|bone fracture
481464|NCT00111241|cartilage|cartilage
481465|NCT00111241|osteoporosis|osteoporosis
481466|NCT00111241|breast cancer|breast cancer
481467|NCT00111241|aromatase inhibitors|aromatase inhibitors
481468|NCT00111241|knee articular cartilage volume|knee articular cartilage volume
481469|NCT00111254|microdermabrasion|microdermabrasion
481470|NCT00111254|skin|skin
481471|NCT00111254|wrinkles|wrinkles
481472|NCT00111254|collagen|collagen
481473|NCT00111254|photoaging|photoaging
481474|NCT00111254|wrinkled skin|wrinkled skin
481475|NCT00111267|vitamin B12|vitamin b12
481476|NCT00111267|cognitive function|cognitive function
481477|NCT00111267|oral supplementation|oral supplementation
481478|NCT00111267|elderly|elderly
481479|NCT00111280|HIV infection|hiv infection
481480|NCT00111280|TMC125|tmc125
481481|NCT00111280|Nucleoside reverse transcriptase inhibitors (NRTIs)|nucleoside reverse transcriptase inhibitors (nrtis)
481482|NCT00111280|roll-over trial|roll-over trial
481483|NCT00111280|antiretrovirals (ARVs)|antiretrovirals (arvs)
481484|NCT00111293|Attention|attention
481485|NCT00111293|Executive Function|executive function
481486|NCT00111293|Vision|vision
481487|NCT00111293|fMRI|fmri
481488|NCT00111293|Top-Down|top-down
481489|NCT00111293|Visual Processing|visual processing
481490|NCT00111293|Lesion|lesion
481491|NCT00111293|Prefrontal|prefrontal
481492|NCT00111293|Parietal|parietal
481493|NCT00111293|Focal Brain Lesion|focal brain lesion
481494|NCT00111293|Healthy Volunteer|healthy volunteer
481495|NCT00111306|Lupus|lupus
481496|NCT00111306|Antibody|antibody
481497|NCT00111306|B-cell immunotherapy|b-cell immunotherapy
481498|NCT00111319|Front Line|front line
481499|NCT00111319|Multiple Myeloma|multiple myeloma
481500|NCT00111319|Untreated|untreated
481501|NCT00111345|Acute|acute
481502|NCT00111345|myeloid|myeloid
481503|NCT00111345|leukemia|leukemia
481504|NCT00111345|Acute myeloid leukemia|acute myeloid leukemia
481505|NCT00111358|HIV, AIDS, metabolic syndrome|hiv, aids, metabolic syndrome
481506|NCT00111371|artificial grammar learning|artificial grammar learning
481507|NCT00111371|dyslexia|dyslexia
481508|NCT00111371|healthy subjects|healthy subjects
481509|NCT00111371|levodopa|levodopa
481510|NCT00111371|drug|drug
481511|NCT00111371|treatment|treatment
481512|NCT00111371|intervention|intervention
481513|NCT00111384|Phenotype|phenotype
481514|NCT00111384|NF1-associated tumors|nf1-associated tumors
481515|NCT00111384|NF1|nf1
481516|NCT00111384|EQTL|eqtl
481517|NCT00111384|Modifier Genes|modifier genes
481518|NCT00111384|Neurofibroma|neurofibroma
481519|NCT00111384|Neurofibromatosis Type 1|neurofibromatosis type 1
481520|NCT00111397|Mycobacterial|mycobacterial
481521|NCT00111397|Interferon|interferon
481522|NCT00111397|GM-CSF|gm-csf
481523|NCT00111397|Microarray|microarray
481524|NCT00111397|Proteomics|proteomics
481525|NCT00111397|Mycobacterium Avium Complex Infection|mycobacterium avium complex infection
481526|NCT00111397|MAC|mac
481626|NCT00103545|immune response|immune response
481527|NCT00111410|Rheumatoid Arthritis, Inflammation|rheumatoid arthritis, inflammation
481528|NCT00111410|Interleukin-1 (IL-1), r-metHuIL-1ra|interleukin-1 (il-1), r-methuil-1ra
481529|NCT00111410|Autoimmune, Kineret®|autoimmune, kineret®
481530|NCT00111410|Anakinra, Immunex|anakinra, immunex
481531|NCT00111410|Amgen, Clinical Trials|amgen, clinical trials
481532|NCT00111423|Rheumatoid Arthritis, Inflammation|rheumatoid arthritis, inflammation
481533|NCT00111423|Pegsunercept, PEG sTNF-RI|pegsunercept, peg stnf-ri
481534|NCT00111423|Autoimmune, Amgen|autoimmune, amgen
481535|NCT00111423|Clinical Trials|clinical trials
481536|NCT00111436|Psoriasis, adults, skin|psoriasis, adults, skin
481537|NCT00111436|Phase 3, clinical trial|phase 3, clinical trial
481538|NCT00111436|Amgen, etanercept|amgen, etanercept
481539|NCT00111436|Enbrel®, moderate|enbrel®, moderate
481540|NCT00111436|severe, extension|severe, extension
481541|NCT00111449|Psoriasis, adults|psoriasis, adults
481542|NCT00111449|skin, Phase 3|skin, phase 3
481543|NCT00111449|clinical trial, Amgen|clinical trial, amgen
481544|NCT00111449|etanercept, Enbrel®|etanercept, enbrel®
481545|NCT00111449|moderate, severe|moderate, severe
481546|NCT00111462|non-myeloid malignancy|non-myeloid malignancy
481547|NCT00111462|chemotherapy-induced anemia|chemotherapy-induced anemia
481548|NCT00111475|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
481549|NCT00111475|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
481550|NCT00111475|Thrombocytopenic|thrombocytopenic
481551|NCT00111475|Thrombocytopenia|thrombocytopenia
481552|NCT00111475|ITP|itp
481553|NCT00111488|atrial fibrillation|atrial fibrillation
481554|NCT00111501|smoking|smoking
481555|NCT00111501|tobacco|tobacco
481556|NCT00111514|Leishmaniasis|leishmaniasis
481558|NCT00111514|therapeutic|therapeutic
481560|NCT00111514|pentavalent antimony|pentavalent antimony
481561|NCT00111527|Heart failure|heart failure
481562|NCT00111527|Atrial fibrillation|atrial fibrillation
481563|NCT00111527|Cardiac resynchronization|cardiac resynchronization
481564|NCT00111527|Cardiac pacing|cardiac pacing
481565|NCT00111527|Catheter ablation|catheter ablation
481566|NCT00111527|Quality of life|quality of life
481567|NCT00111527|Echocardiography|echocardiography
481568|NCT00111540|exenatide|exenatide
481569|NCT00111540|diabetes|diabetes
481571|NCT00111540|exendin-4|exendin-4
481572|NCT00111553|Leishmaniasis|leishmaniasis
481573|NCT00111553|Subunit vaccine|subunit vaccine
481574|NCT00111553|Therapeutic|therapeutic
481575|NCT00111553|T cell|t cell
481576|NCT00111553|Antimony|antimony
481577|NCT00111566|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
481578|NCT00111566|Glycoprotein IIb/IIIa blockade|glycoprotein iib/iiia blockade
481579|NCT00111566|Ischemic complications following PCI|ischemic complications following pci
481580|NCT00111592|BPH|bph
481581|NCT00111592|benign prostatic hyperplasia|benign prostatic hyperplasia
481582|NCT00111605|AIDS Vaccines|aids vaccines
481583|NCT00111605|HIV Vaccines|hiv vaccines
481584|NCT00111605|HIV Preventive Vaccine|hiv preventive vaccine
481585|NCT00111605|HIV Seronegativity|hiv seronegativity
481586|NCT00111618|vascular disrupting agent|vascular disrupting agent
481588|NCT00111618|tolerability|tolerability
481589|NCT00111618|efficacy|efficacy
481590|NCT00111618|hormone refractory prostate cancer|hormone refractory prostate cancer
481591|NCT00111657|Gout|gout
481592|NCT00111657|Tophi|tophi
481593|NCT00111657|Tophaceous gout|tophaceous gout
481594|NCT00111657|Allergy to allopurinol|allergy to allopurinol
481595|NCT00111657|Post-transplant gout|post-transplant gout
481596|NCT00111683|Myelodysplastic Syndrome[Refractory Anemia with|myelodysplastic syndrome[refractory anemia with
481597|NCT00111683|Excess Blasts-1 or 2 (WHO Classification)]|excess blasts-1 or 2 (who classification)]
481598|NCT00111683|Chronic Myelogenous Leukemia in blast crisis|chronic myelogenous leukemia in blast crisis
481599|NCT00111748|Myeloma|myeloma
481600|NCT00111761|Immunex|immunex
481601|NCT00111761|Panitumumab|panitumumab
481602|NCT00111761|ABX-EGF|abx-egf
481603|NCT00111761|Abgenix|abgenix
481604|NCT00111774|Colon Cancer, Rectal Cancer|colon cancer, rectal cancer
481605|NCT00111774|Colorectal Carcinoma, EGFr|colorectal carcinoma, egfr
481606|NCT00111774|Metastatic Cancer, ABX-EGF|metastatic cancer, abx-egf
481607|NCT00111774|Panitumumab, Abgenix|panitumumab, abgenix
481608|NCT00111774|Clinical Trial, Immunex, Amgen|clinical trial, immunex, amgen
481609|NCT00111774|Metastatic Colorectal|metastatic colorectal
481610|NCT00111787|breast cancer|breast cancer
481611|NCT00111800|NIDDM|niddm
481612|NCT00111826|Intermittent Claudication|intermittent claudication
481613|NCT00111826|Peripheral Arterial Disease|peripheral arterial disease
481614|NCT00111826|Immune modulation therapy|immune modulation therapy
481615|NCT00111826|Inflammation|inflammation
481616|NCT00111839|Lung cancer|lung cancer
481617|NCT00111852|Desmoteplase|desmoteplase
481618|NCT00111852|Acute Ischemic Stroke|acute ischemic stroke
481619|NCT00111852|Stroke, Acute|stroke, acute
481620|NCT00111865|physical exercise|physical exercise
481621|NCT00111865|quality of life|quality of life
481622|NCT00111865|lymphoma|lymphoma
481623|NCT00103545|Ovarian Cancer|ovarian cancer
481624|NCT00103545|ACA 125|aca 125
481625|NCT00103545|6 or 9 vaccinations|6 or 9 vaccinations
481627|NCT00103545|Fallopian tube cancer|fallopian tube cancer
481628|NCT00103545|Peritoneal cancer|peritoneal cancer
481629|NCT00103597|Orthostatic hypotension|orthostatic hypotension
481630|NCT00103597|Parkinson's Disease|parkinson's disease
481631|NCT00103610|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
481632|NCT00103610|Stem cell mobilization|stem cell mobilization
481633|NCT00103623|Advanced|advanced
481634|NCT00103623|Symptomatic|symptomatic
481635|NCT00103623|Prostate|prostate
481636|NCT00103623|Cancer|cancer
481637|NCT00103623|Advanced Symptomatic Prostate Cancer|advanced symptomatic prostate cancer
481638|NCT00103636|Phlebitis/etiology|phlebitis/etiology
481639|NCT00103636|Infusions|infusions
481640|NCT00103636|Intravenous/adverse effects|intravenous/adverse effects
481641|NCT00103636|Randomised controlled trial|randomised controlled trial
481642|NCT00103636|Phlebitis/prevention|phlebitis/prevention
481643|NCT00103636|Adult|adult
481644|NCT00103636|Time factors|time factors
481645|NCT00103675|Acupuncture|acupuncture
481646|NCT00103701|Chronic myelogenous leukemia (CML) chronic, accelerated, blast phase|chronic myelogenous leukemia (cml) chronic, accelerated, blast phase
481647|NCT00103701|Philadelphia chromosome positive acute (Ph+ALL)|philadelphia chromosome positive acute (ph+all)
481648|NCT00103714|lung disease|lung disease
481649|NCT00103727|paranoid|paranoid
481650|NCT00103727|catatonic|catatonic
481651|NCT00103727|undifferentiated types|undifferentiated types
481652|NCT00103727|disorganized|disorganized
481653|NCT00103740|Zoledronic acid, risedronate, Paget's disease of bone|zoledronic acid, risedronate, paget's disease of bone
481654|NCT00103753|Randomized Controlled Trial|randomized controlled trial
481655|NCT00103753|Deferiprone|deferiprone
481656|NCT00103753|Deferoxamine|deferoxamine
481657|NCT00103753|Iron chelation|iron chelation
481658|NCT00103753|Beta Thalassemia Major|beta thalassemia major
481659|NCT00103766|Alteplase|alteplase
481660|NCT00103766|Empyema|empyema
481661|NCT00103766|Complicated Parapneumonic Effusion|complicated parapneumonic effusion
481662|NCT00103779|Antigens, CD40|antigens, cd40
481663|NCT00103779|Antibody, Monoclonal|antibody, monoclonal
481664|NCT00103779|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
481665|NCT00103779|Lymphoma, B-Cell|lymphoma, b-cell
481666|NCT00103779|Hematologic Diseases|hematologic diseases
481667|NCT00103779|Immunoproliferative Disorders|immunoproliferative disorders
481668|NCT00103779|Lymphatic Diseases|lymphatic diseases
481669|NCT00103779|Lymphoproliferative Disorders|lymphoproliferative disorders
481670|NCT00103779|Lymphoma|lymphoma
481671|NCT00103792|Induction therapy|induction therapy
481672|NCT00103792|ANCA-associated vasculitis|anca-associated vasculitis
481673|NCT00103792|Wegener's granulomatosis|wegener's granulomatosis
481674|NCT00103792|microscopic polyangiitis|microscopic polyangiitis
481675|NCT00103792|mycophenolate mofetil|mycophenolate mofetil
481676|NCT00103792|cyclophosphamide|cyclophosphamide
481677|NCT00103805|language acquisition|language acquisition
481678|NCT00103805|plasticity|plasticity
481679|NCT00103805|stroke recovery|stroke recovery
481680|NCT00103805|associative learning|associative learning
481681|NCT00103831|NSCLC - non-small cell lung cancer|nsclc - non-small cell lung cancer
481682|NCT00111878|Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3)|respiratory syncytial virus (rsv) and parainfluenza virus type 3 (piv3)
481683|NCT00111904|stage III pancreatic cancer|stage iii pancreatic cancer
481684|NCT00111904|recurrent pancreatic cancer|recurrent pancreatic cancer
481685|NCT00111904|stage IV pancreatic cancer|stage iv pancreatic cancer
481686|NCT00111917|Chronic Beryllium Disease|chronic beryllium disease
481687|NCT00111917|Berylliosis|berylliosis
481688|NCT00111917|Beryllium Disease|beryllium disease
481690|NCT00111917|Infliximab|infliximab
481691|NCT00111930|dehydroepiandrosterone|dehydroepiandrosterone
481692|NCT00111930|DHEAS|dheas
481693|NCT00111930|bone mineral density|bone mineral density
481694|NCT00111930|body composition|body composition
481695|NCT00111930|lean mass|lean mass
481696|NCT00111930|fat mass|fat mass
481697|NCT00111930|bone mass|bone mass
481698|NCT00111930|decreased DHEAS levels|decreased dheas levels
481699|NCT00111943|Anti-Infective Agents, Local|anti-infective agents, local
481700|NCT00111943|HIV Seronegativity|hiv seronegativity
481701|NCT00111943|Tenofovir|tenofovir
481702|NCT00111943|Vaginal gel|vaginal gel
481703|NCT00111943|Microbicide|microbicide
481704|NCT00111943|Vaginal Microbicide|vaginal microbicide
481705|NCT00111943|PMPA|pmpa
481706|NCT00111956|TNF|tnf
481707|NCT00111956|metabolic syndrome|metabolic syndrome
481708|NCT00111956|inflammation|inflammation
481709|NCT00111956|CRP|crp
481710|NCT00111956|adiponectin|adiponectin
481711|NCT00111969|Heart failure|heart failure
481712|NCT00111969|Immune modulation therapy|immune modulation therapy
481713|NCT00111969|Inflammation|inflammation
481714|NCT00111969|Chronic systolic heart failure|chronic systolic heart failure
481715|NCT00111982|bilateral, idiopathic Parkinson's Disease|bilateral, idiopathic parkinson's disease
481716|NCT00111995|Chronic Renal Failure (CRF)|chronic renal failure (crf)
481717|NCT00111995|Anemia|anemia
481718|NCT00112008|Anemia|anemia
481719|NCT00112021|obesity|obesity
481720|NCT00112021|weight loss|weight loss
481721|NCT00112021|Amylin|amylin
481723|NCT00112021|Symlin|symlin
481724|NCT00112034|Multiple Sclerosis|multiple sclerosis
481725|NCT00112034|Relapsing-Remitting|relapsing-remitting
481726|NCT00112034|AVONEX|avonex
481727|NCT00112034|Combination|combination
481728|NCT00112034|Methotrexate|methotrexate
481729|NCT00112034|IV Methylprednisolone|iv methylprednisolone
481730|NCT00112034|IVMP|ivmp
481731|NCT00112034|ACT|act
481732|NCT00112034|MTX|mtx
481733|NCT00112047|Human Immunodeficiency Virus|human immunodeficiency virus
481734|NCT00112060|Talotrexin|talotrexin
481735|NCT00112060|PT-523|pt-523
481736|NCT00112060|Non-Small Cell Lung Carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
481737|NCT00112073|Alzheimer's disease|alzheimer's disease
481738|NCT00112073|immunotherapy|immunotherapy
481739|NCT00112073|beta amyloid|beta amyloid
481740|NCT00112086|ovarian neoplasms|ovarian neoplasms
481741|NCT00112086|laparoscopy|laparoscopy
481742|NCT00112086|neoadjuvant therapy|neoadjuvant therapy
481743|NCT00112086|interval cytoreductive surgery|interval cytoreductive surgery
481744|NCT00112099|gastric neoplasm|gastric neoplasm
481745|NCT00112099|gastrectomy|gastrectomy
481746|NCT00112099|splenectomy|splenectomy
481747|NCT00112099|randomized trial|randomized trial
481748|NCT00112099|T2, T3 and T4 carcinoma in the proximal third of the stomach|t2, t3 and t4 carcinoma in the proximal third of the stomach
481749|NCT00112112|cancer, pediatric, influenza, vaccine|cancer, pediatric, influenza, vaccine
481750|NCT00112125|cardiac contractility modulation|cardiac contractility modulation
481751|NCT00112125|heart failure|heart failure
481752|NCT00112125|cardiopulmonary exercise test|cardiopulmonary exercise test
481753|NCT00112125|chronic heart disease|chronic heart disease
481754|NCT00112138|gabapentin|gabapentin
481755|NCT00112138|hot flashes or flushes|hot flashes or flushes
481756|NCT00112138|menopause|menopause
481757|NCT00112151|andropause|andropause
481758|NCT00112151|hypogonadism|hypogonadism
481759|NCT00112151|AndroGel|androgel
481760|NCT00112151|exercise|exercise
481761|NCT00112151|PRT|prt
481762|NCT00112151|Testosterone|testosterone
481763|NCT00112151|T supplementation|t supplementation
481764|NCT00112164|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
481765|NCT00112177|Functional dyspepsia|functional dyspepsia
481766|NCT00112177|Abdominal Symptom relief|abdominal symptom relief
481767|NCT00112177|Fullness|fullness
481768|NCT00112177|Bloating|bloating
481769|NCT00112177|Indigestion|indigestion
481770|NCT00112190|Functional dyspepsia|functional dyspepsia
481771|NCT00112190|Abdominal Symptom relief|abdominal symptom relief
481772|NCT00112190|Fullness|fullness
481773|NCT00112190|Bloating|bloating
481774|NCT00112190|Indigestion|indigestion
481775|NCT00112203|Abdominal Symptom Relief|abdominal symptom relief
481776|NCT00112203|Fullness|fullness
481777|NCT00112203|Bloating|bloating
481778|NCT00112203|Indigestion|indigestion
481779|NCT00112203|Functional dyspepsia|functional dyspepsia
481780|NCT00114296|breast cancer|breast cancer
481781|NCT00114309|High grade recurrent glioma|high grade recurrent glioma
481782|NCT00114309|Phase II|phase ii
481783|NCT00114309|Multi-Center|multi-center
481784|NCT00114309|Open label|open label
481785|NCT00114309|Multiple dose|multiple dose
481786|NCT00114309|Brain Cancer|brain cancer
481787|NCT00114309|Brain Tumor|brain tumor
481789|NCT00114309|glioma|glioma
481790|NCT00114335|low molecular weight heparin|low molecular weight heparin
481791|NCT00114335|unfractionated heparin|unfractionated heparin
481792|NCT00114348|non-B ALL|non-b all
481793|NCT00114348|relapse|relapse
481794|NCT00114348|treatment|treatment
481795|NCT00114348|Relapsed non-B ALL or non-B non-Hodgkin lymphoma|relapsed non-b all or non-b non-hodgkin lymphoma
481796|NCT00114361|HBeAg-negative|hbeag-negative
481797|NCT00114361|chronic|chronic
481798|NCT00114361|hepatitis B|hepatitis b
481799|NCT00114361|viral|viral
481800|NCT00114374|Acute Stress Disorder|acute stress disorder
481801|NCT00114374|Posttraumatic Stress Disorder|posttraumatic stress disorder
481802|NCT00114374|Escitalopram|escitalopram
481803|NCT00114374|Double-Blind|double-blind
481804|NCT00114387|vitamin E|vitamin e
481805|NCT00114400|cardiovascular disease|cardiovascular disease
481806|NCT00114400|CVD|cvd
481807|NCT00114413|Exhaled Nitric Oxide|exhaled nitric oxide
481808|NCT00114413|Lung|lung
481809|NCT00114413|Urban Health|urban health
481810|NCT00114413|Child|child
481811|NCT00114413|Adolescent|adolescent
481812|NCT00114426|randomized controlled trial; COPD|randomized controlled trial; copd
481813|NCT00114439|cannabis withdrawal|cannabis withdrawal
481814|NCT00114439|lithium|lithium
481815|NCT00114439|Cannabis withdrawal syndrome|cannabis withdrawal syndrome
481816|NCT00114452|Acute Myocardial Infarction|acute myocardial infarction
481817|NCT00114452|Heart Attack|heart attack
481818|NCT00114452|Cardiovascular Disease|cardiovascular disease
481819|NCT00114452|Stem cells|stem cells
481820|NCT00114452|Congestive Heart Failure|congestive heart failure
481821|NCT00114452|Heart Attack Repair|heart attack repair
481822|NCT00114465|Randomized|randomized
481823|NCT00114465|Double-Blind|double-blind
481824|NCT00114465|Probiotic|probiotic
481825|NCT00114465|Remission|remission
481826|NCT00114465|Crohn's Disease|crohn's disease
481827|NCT00114478|Bronchiolitis|bronchiolitis
481828|NCT00114478|disposition|disposition
481829|NCT00114478|pediatric|pediatric
481830|NCT00114478|epinephrine|epinephrine
481831|NCT00114478|albuterol|albuterol
481832|NCT00114491|Aortic Stenosis|aortic stenosis
481833|NCT00114491|Statins|statins
481834|NCT00114491|Hypercholesterolemia|hypercholesterolemia
481835|NCT00114504|atherosclerosis|atherosclerosis
481836|NCT00114504|inflammation|inflammation
481837|NCT00114504|statins|statins
481838|NCT00114504|PET|pet
481839|NCT00114504|carotid ultrasonography|carotid ultrasonography
481840|NCT00114517|atherosclerosis|atherosclerosis
481841|NCT00114517|CAD|cad
481842|NCT00114517|cardiac computed tomography|cardiac computed tomography
481843|NCT00114517|cardiovascular disease|cardiovascular disease
481844|NCT00114517|carotid artery intima-media thickness|carotid artery intima-media thickness
481845|NCT00114517|cognitive function|cognitive function
481846|NCT00114517|computed tomography|computed tomography
481847|NCT00114517|coronary artery calcium|coronary artery calcium
481848|NCT00114517|coronary artery disease|coronary artery disease
481849|NCT00114517|coronary artery lesions|coronary artery lesions
481850|NCT00114517|CVD|cvd
481851|NCT00114517|estrogen|estrogen
481852|NCT00114517|estrogen therapy|estrogen therapy
481853|NCT00114517|hormone therapy|hormone therapy
481854|NCT00114517|postmenopausal|postmenopausal
481855|NCT00114517|subclinical vascular disease|subclinical vascular disease
485583|NCT00117702|Tacrolimus|tacrolimus
481856|NCT00114517|timing hypothesis|timing hypothesis
481857|NCT00114517|ultrasonography|ultrasonography
481858|NCT00114530|systemic sclerosis|systemic sclerosis
481859|NCT00114530|hematopoietic stem cell transplant|hematopoietic stem cell transplant
481860|NCT00114530|clinical trial|clinical trial
481861|NCT00114530|global rank composite score|global rank composite score
481862|NCT00114543|NICHD Neonatal Research Network|nichd neonatal research network
481863|NCT00114543|Bilirubin|bilirubin
481864|NCT00114543|Phototherapy|phototherapy
481865|NCT00114543|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
481866|NCT00114543|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
481867|NCT00114543|Prematurity|prematurity
481868|NCT00114543|Neurodevelopmental outcome|neurodevelopmental outcome
481869|NCT00114556|osteoporosis|osteoporosis
481870|NCT00114556|liver transplantation|liver transplantation
481871|NCT00114569|children|children
481872|NCT00114569|status epilepticus|status epilepticus
481873|NCT00114569|lorazepam|lorazepam
481874|NCT00114569|safety|safety
481875|NCT00114569|pharmacokinetics|pharmacokinetics
481876|NCT00114569|status epilepticus in children|status epilepticus in children
481877|NCT00114582|family style dinner|family style dinner
481878|NCT00114582|quality of life|quality of life
481879|NCT00114582|nutritional status|nutritional status
481880|NCT00114582|nursing home residents|nursing home residents
481881|NCT00114595|eicosapentaenoic acid|eicosapentaenoic acid
481882|NCT00114595|tardive dyskinesia|tardive dyskinesia
481883|NCT00114595|omega-3|omega-3
481884|NCT00114595|schizophrenia|schizophrenia
481885|NCT00114608|Electrical foot stimulation|electrical foot stimulation
481886|NCT00114608|Intermittent pneumatic compression|intermittent pneumatic compression
481887|NCT00114608|Venous thromboembolism|venous thromboembolism
481888|NCT00114608|Immobilization|immobilization
481889|NCT00114608|Total hip replacement|total hip replacement
481890|NCT00114608|Prolonged travel|prolonged travel
481891|NCT00114608|Venous thromboembolic disease (VTE)|venous thromboembolic disease (vte)
481892|NCT00114608|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
481893|NCT00114608|Pulmonary embolism (PE)|pulmonary embolism (pe)
481894|NCT00114621|PA|pa
481895|NCT00114621|Phase I|phase i
481896|NCT00114621|Phase 2|phase 2
481897|NCT00114621|Safety|safety
481898|NCT00114621|Immunogenicity|immunogenicity
481899|NCT00114634|SLOS|slos
481900|NCT00114634|RSH syndrome|rsh syndrome
481901|NCT00114634|ABC Checklist|abc checklist
481902|NCT00114634|Cholesterol supplementation|cholesterol supplementation
481903|NCT00114634|Egg yolk|egg yolk
481904|NCT00114634|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
481905|NCT00114647|Plasmapheresis|plasmapheresis
481906|NCT00114647|Leukapheresis|leukapheresis
481907|NCT00114647|Lymphocytes|lymphocytes
481908|NCT00114647|Apheresis|apheresis
481909|NCT00114660|striae gravidarum|striae gravidarum
481910|NCT00114660|stretch marks|stretch marks
481911|NCT00114660|cocoa butter|cocoa butter
481912|NCT00114660|prevention|prevention
481913|NCT00114673|Uneven skin color|uneven skin color
481914|NCT00114673|Wrinkles|wrinkles
481915|NCT00114673|Wrinkles and uneven skin color in the area around the eyes|wrinkles and uneven skin color in the area around the eyes
481916|NCT00114686|Bipolar I Disorder|bipolar i disorder
481917|NCT00114686|Alcohol Dependency|alcohol dependency
481918|NCT00114699|HIV|hiv
481919|NCT00114699|Treatment Naive|treatment naive
481920|NCT00114712|Birth Defects|birth defects
481921|NCT00114712|Pregnancy|pregnancy
481922|NCT00114712|Ribavirin|ribavirin
481923|NCT00114712|Hepatitis C|hepatitis c
481924|NCT00114725|In Vitro Fertilization|in vitro fertilization
481925|NCT00114725|Intracytoplasmic Sperm Injection|intracytoplasmic sperm injection
481926|NCT00114725|Oocytes|oocytes
481927|NCT00114725|Zona Pellucida|zona pellucida
481928|NCT00114725|Oolemma|oolemma
481929|NCT00114725|Fertilization|fertilization
481930|NCT00114725|Preimplantation Embryo Development|preimplantation embryo development
481931|NCT00114738|Proteasome Inhibition|proteasome inhibition
481932|NCT00114738|NF-Kappa-B|nf-kappa-b
481933|NCT00114738|Gene Expression Signature|gene expression signature
481934|NCT00114738|Cyclin D1|cyclin d1
481935|NCT00114738|Translational Studies|translational studies
481936|NCT00114738|Lymphoma|lymphoma
481937|NCT00114738|Mantle Cell Lymphoma|mantle cell lymphoma
481938|NCT00114738|MCL|mcl
481939|NCT00114764|Acute myeloid leukaemia|acute myeloid leukaemia
481940|NCT00114764|Pegfilgrastim|pegfilgrastim
481941|NCT00114764|Neulasta®|neulasta®
481942|NCT00114764|Neutropenia|neutropenia
481943|NCT00114764|Induction chemotherapy|induction chemotherapy
481944|NCT00114764|Consolidation|consolidation
481945|NCT00114790|head and neck cancer|head and neck cancer
481946|NCT00114790|boron neutron capture therapy|boron neutron capture therapy
481947|NCT00114790|radiation therapy|radiation therapy
481948|NCT00114790|boronophenylalanine|boronophenylalanine
481949|NCT00114803|bone mineral density|bone mineral density
481950|NCT00114803|osteoporosis|osteoporosis
481951|NCT00114803|osteopenia|osteopenia
481952|NCT00114803|children|children
481953|NCT00114803|adolescents|adolescents
481954|NCT00114803|DXA|dxa
485584|NCT00117702|Everolimus|everolimus
481955|NCT00114816|breast cancer|breast cancer
481956|NCT00114816|chemotherapy|chemotherapy
481957|NCT00114816|adjuvant|adjuvant
481958|NCT00114816|capecitabine|capecitabine
481959|NCT00114816|docetaxel|docetaxel
481960|NCT00114829|Colorectal cancer|colorectal cancer
481961|NCT00114829|Colorectal tumor|colorectal tumor
481962|NCT00114829|Dynamic contrast uptake|dynamic contrast uptake
481963|NCT00114829|MR colonography|mr colonography
481964|NCT00114842|colorectal polyps|colorectal polyps
481965|NCT00114842|colorectal cancer|colorectal cancer
481966|NCT00114842|Virtual colonoscopy|virtual colonoscopy
481967|NCT00114842|Fecal tagging|fecal tagging
585507|NCT00513084|Mediators,|mediators,
481968|NCT00114842|MR colonography|mr colonography
481969|NCT00114855|Hypocol|hypocol
481970|NCT00114855|Red yeast rice|red yeast rice
481971|NCT00114855|Patients with mild Type IIa, Type IIb or IV hyperlipidaemia (LDL-cholesterol >3.0 mmol/L< 6.0 mmol/L.|patients with mild type iia, type iib or iv hyperlipidaemia (ldl-cholesterol >3.0 mmol/l< 6.0 mmol/l.
481972|NCT00114855|Mildly elevated blood glucose|mildly elevated blood glucose
481973|NCT00114868|vitamin A|vitamin a
481974|NCT00114868|mortality|mortality
481975|NCT00114868|newborn|newborn
481976|NCT00114868|liveborn infants|liveborn infants
481977|NCT00114881|Children|children
481978|NCT00114881|Urban Health|urban health
481979|NCT00114881|Pregnancy|pregnancy
481980|NCT00114881|Asthma|asthma
481981|NCT00114894|Jellyfish|jellyfish
481982|NCT00114894|Stings|stings
481983|NCT00114894|Marine|marine
481984|NCT00114894|Envenomation|envenomation
481985|NCT00114894|Jellyfish stings|jellyfish stings
481987|NCT00114907|Oxidative stress markers|oxidative stress markers
481988|NCT00114907|cardiovascular disease|cardiovascular disease
481989|NCT00114907|polyphenolics|polyphenolics
481990|NCT00114907|double blind|double blind
481991|NCT00114907|Ischaemic cardiac disease|ischaemic cardiac disease
481992|NCT00114920|Wart(s)|wart(s)
481993|NCT00114920|Adults|adults
481994|NCT00114920|Common Wart(s)|common wart(s)
481995|NCT00114933|HIV|hiv
481996|NCT00114933|AIDS|aids
481997|NCT00114933|Treatment Experienced|treatment experienced
481998|NCT00114946|Metastatic Colorectal Cancer OASIS|metastatic colorectal cancer oasis
481999|NCT00114959|ChemGenex Pharmaceuticals, Ltd|chemgenex pharmaceuticals, ltd
482000|NCT00114959|ChemGenex Pharmaceuticals|chemgenex pharmaceuticals
482001|NCT00114959|ChemGenex|chemgenex
482002|NCT00114959|Chronic Myeloid Leukemia|chronic myeloid leukemia
482003|NCT00114959|Myeloid Leukemia, Chronic|myeloid leukemia, chronic
482004|NCT00114959|Leukemia|leukemia
482005|NCT00114959|Myeloid Leukemia|myeloid leukemia
482006|NCT00114959|Chronic Phase|chronic phase
482007|NCT00114959|Accelerated Phase|accelerated phase
482008|NCT00114959|Blast Phase|blast phase
482009|NCT00114959|Myeloid, Leukemia, Chronic, Accelerated Phase|myeloid, leukemia, chronic, accelerated phase
482010|NCT00114959|Myeloid, Leukemia, Chronic|myeloid, leukemia, chronic
482011|NCT00114959|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
482012|NCT00114959|Leukemia, Myeloid, Chronic-Phase|leukemia, myeloid, chronic-phase
482013|NCT00114959|Leukemia, Myeloid, Chronic Phase|leukemia, myeloid, chronic phase
482014|NCT00114959|Leukemia, Myeloid, Accelerated-Phase|leukemia, myeloid, accelerated-phase
482015|NCT00114959|Myeloid, Leukemia, Chronic, Chronic Phase|myeloid, leukemia, chronic, chronic phase
482016|NCT00114959|Leukemia, Myeloid, Accelerated Phase|leukemia, myeloid, accelerated phase
482017|NCT00114959|Homoharringtonine|homoharringtonine
482018|NCT00114959|Omacetaxine|omacetaxine
482221|NCT00115687|nicotine addiction|nicotine addiction
482019|NCT00114972|Three-vessel coronary artery disease|three-vessel coronary artery disease
482020|NCT00114972|Left main coronary artery disease|left main coronary artery disease
482021|NCT00114985|Total Androgen Suppression|total androgen suppression
482022|NCT00114985|Simulation|simulation
482023|NCT00114985|3-D Conformal External Beam Radiation Therapy|3-d conformal external beam radiation therapy
482024|NCT00114985|Intra-rectal immobilization device|intra-rectal immobilization device
482025|NCT00114985|Quality of Life Assessment Questionnaire|quality of life assessment questionnaire
482026|NCT00114985|Rectal Bleeding|rectal bleeding
482027|NCT00114985|Late effects|late effects
482028|NCT00115011|Skin Picking|skin picking
482029|NCT00115011|Escitalopram|escitalopram
482030|NCT00115011|Lexapro|lexapro
482031|NCT00115011|Body Focused Repetitive Behaviors|body focused repetitive behaviors
482032|NCT00115011|Obsessive Compulsive Spectrum Disorders|obsessive compulsive spectrum disorders
482033|NCT00115024|cardiovascular disease|cardiovascular disease
482034|NCT00115024|CVD|cvd
482035|NCT00115024|estrogen|estrogen
482036|NCT00115024|cholesterol|cholesterol
482037|NCT00115024|LDL|ldl
482038|NCT00115024|lipids|lipids
482039|NCT00115024|postmenopausal|postmenopausal
482040|NCT00115037|Alcoholism|alcoholism
482041|NCT00115037|alcohol abuse|alcohol abuse
482042|NCT00115037|therapy|therapy
482043|NCT00115037|drug resistance|drug resistance
482044|NCT00115037|naltrexone|naltrexone
482045|NCT00115037|patient care management|patient care management
482046|NCT00115037|human subject|human subject
482047|NCT00115050|HIV infections|hiv infections
482048|NCT00115050|Antiretroviral|antiretroviral
482049|NCT00115050|TMC114|tmc114
482050|NCT00115050|Ritonavir|ritonavir
482051|NCT00115050|Safety, TMC114-C209|safety, tmc114-c209
482052|NCT00115063|obesity|obesity
482053|NCT00115063|Low Calorie Diet|low calorie diet
482054|NCT00115063|Obesity Pharmacotherapy|obesity pharmacotherapy
482055|NCT00115063|Pragmatic Clinical Trial|pragmatic clinical trial
482056|NCT00115076|skin|skin
482057|NCT00115076|psoriasis|psoriasis
482058|NCT00115089|Allergic Rhinitis|allergic rhinitis
482059|NCT00115089|Nasal Spray|nasal spray
482060|NCT00115089|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
482061|NCT00115102|Atypical odontalgia|atypical odontalgia
482062|NCT00115102|capsaicin|capsaicin
482063|NCT00115102|pain|pain
482064|NCT00115102|neuropathic pain|neuropathic pain
482065|NCT00115115|Donor dopamine|donor dopamine
482066|NCT00115115|Immediate graft function|immediate graft function
482067|NCT00115115|Kidney transplantation|kidney transplantation
482068|NCT00115128|normal PBPC donors|normal pbpc donors
482069|NCT00115141|Wart(s)|wart(s)
482070|NCT00115141|Adults|adults
482071|NCT00115141|Common Wart(s)|common wart(s)
482072|NCT00115154|Actinic Keratosis|actinic keratosis
482074|NCT00115154|3M Pharmaceuticals|3m pharmaceuticals
482075|NCT00115154|Aldara|aldara
482076|NCT00115154|Imiquimod|imiquimod
482077|NCT00115154|Actinic Keratosis (AK)|actinic keratosis (ak)
482078|NCT00115167|Oncology|oncology
482079|NCT00115167|Cancer-related anemia|cancer-related anemia
482080|NCT00115180|analgesia|analgesia
482081|NCT00115180|adult|adult
482082|NCT00115180|opioid|opioid
482083|NCT00115180|Long Bone Fractures|long bone fractures
482084|NCT00115193|Oncology|oncology
482086|NCT00115193|Mantle cell|mantle cell
482087|NCT00115193|Diffuse large B-cell|diffuse large b-cell
482088|NCT00115193|Chemotherapy|chemotherapy
482089|NCT00115193|RCHOP|rchop
482090|NCT00115193|Neulasta®|neulasta®
482091|NCT00115193|Neutropenia|neutropenia
482092|NCT00115193|Pegfilgrastim|pegfilgrastim
482093|NCT00115193|Amgen|amgen
482094|NCT00115206|Non Small Cell Lung Cancer|non small cell lung cancer
482095|NCT00115206|NSCLC|nsclc
482096|NCT00115206|Fever|fever
482097|NCT00115206|Neutropenia|neutropenia
482098|NCT00115206|Neulasta®|neulasta®
482099|NCT00115206|Quality of Life|quality of life
482100|NCT00115206|Chemotherapy|chemotherapy
482101|NCT00115206|Amgen|amgen
482102|NCT00115219|Rheumatoid Arthritis, RA|rheumatoid arthritis, ra
482103|NCT00115219|Enbrel® (etanercept)|enbrel® (etanercept)
482104|NCT00115219|Clinical Trials, Amgen|clinical trials, amgen
482105|NCT00115219|Immunex, Methotrexate (MTX)|immunex, methotrexate (mtx)
482106|NCT00115219|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
482107|NCT00115232|cardiovascular disease|cardiovascular disease
482108|NCT00115232|metabolic syndrome|metabolic syndrome
482109|NCT00115232|hypercholesterolemia|hypercholesterolemia
482110|NCT00115232|child|child
482111|NCT00115232|family history|family history
482112|NCT00115232|inflammation|inflammation
482113|NCT00115258|Nutrition, Parenteral|nutrition, parenteral
482114|NCT00115258|Body Composition|body composition
482115|NCT00115258|Energy Expenditure|energy expenditure
482116|NCT00115271|Micronutrients|micronutrients
482117|NCT00115271|Supplementation|supplementation
482118|NCT00115271|Pregnancy|pregnancy
482119|NCT00115271|Birth weight|birth weight
482120|NCT00115271|Infant mortality|infant mortality
482121|NCT00115284|Asthma|asthma
482122|NCT00115284|Education, Medical, Continuing|education, medical, continuing
482123|NCT00115284|American Board of Internal Medicine|american board of internal medicine
482124|NCT00115284|Recertification|recertification
482125|NCT00115284|Continuous Professional Development|continuous professional development
482126|NCT00115284|Practice improvement|practice improvement
482127|NCT00115310|dermal assessment|dermal assessment
482128|NCT00115310|pain measurement|pain measurement
482129|NCT00115310|diary|diary
482130|NCT00115310|PHN|phn
482131|NCT00115310|shingles|shingles
482132|NCT00115310|neuropathy|neuropathy
482133|NCT00115310|analgesics|analgesics
482134|NCT00115310|capsaicin|capsaicin
482135|NCT00115310|postherpetic neuralgia|postherpetic neuralgia
482136|NCT00115336|Blood Diseases|blood diseases
482137|NCT00115336|Sickle Cell Anemia|sickle cell anemia
482138|NCT00115362|functional dyspepsia;|functional dyspepsia;
482139|NCT00115362|Serotonin Uptake Inhibitors;|serotonin uptake inhibitors;
482140|NCT00115362|Antidepressive Agents.|antidepressive agents.
482141|NCT00115375|THROMBOSIS|thrombosis
482142|NCT00115375|PLATELET AGGREGATION|platelet aggregation
482143|NCT00115375|Pediatrics|pediatrics
482144|NCT00115388|Pelvic inflammatory disease|pelvic inflammatory disease
482145|NCT00115388|Chlamydia trachomatis|chlamydia trachomatis
482146|NCT00115388|Screening|screening
482147|NCT00115401|Walking|walking
482148|NCT00115401|Compensation|compensation
482149|NCT00115401|Leg Weakness|leg weakness
482150|NCT00115401|Orthotics|orthotics
482151|NCT00115401|Joint Impairment|joint impairment
482152|NCT00115401|Healthy Volunteer|healthy volunteer
482153|NCT00115401|HV|hv
482156|NCT00115414|Chemotherapy|chemotherapy
482158|NCT00115414|Amgen|amgen
482159|NCT00115427|Bilateral, Idiopathic Parkinson's Disease|bilateral, idiopathic parkinson's disease
482160|NCT00115440|glioblastoma|glioblastoma
482161|NCT00115440|anaplastic astrocytoma|anaplastic astrocytoma
482162|NCT00115440|boron neutron capture therapy|boron neutron capture therapy
482163|NCT00115440|radiation therapy|radiation therapy
482164|NCT00115440|boronophenylalanine|boronophenylalanine
482165|NCT00115453|glioblastoma|glioblastoma
482166|NCT00115453|boron neutron capture therapy|boron neutron capture therapy
482167|NCT00115453|boronophenylalanine|boronophenylalanine
482168|NCT00115453|brain tumor|brain tumor
482169|NCT00115466|ASCs (adult stem cells derived from adipose tissue)|ascs (adult stem cells derived from adipose tissue)
482170|NCT00115466|Fistula|fistula
482171|NCT00115466|Cell Therapy|cell therapy
482172|NCT00115466|Complex perianal fistula|complex perianal fistula
482173|NCT00115479|critical illness|critical illness
482174|NCT00115479|intensive care|intensive care
482175|NCT00115479|outcome|outcome
482176|NCT00115479|insulin|insulin
482177|NCT00115479|blood glucose|blood glucose
482178|NCT00115492|Breathing|breathing
482179|NCT00115492|Exacerbation|exacerbation
482180|NCT00115492|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
482181|NCT00115505|stage IA breast cancer|stage ia breast cancer
482182|NCT00115505|stage II breast cancer|stage ii breast cancer
482183|NCT00115505|stage IB breast cancer|stage ib breast cancer
482184|NCT00115505|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
482185|NCT00115505|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
482186|NCT00115505|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
482187|NCT00115505|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
482188|NCT00115531|Elderly, influenza, vaccine, parent protocol|elderly, influenza, vaccine, parent protocol
482189|NCT00115544|neonatal|neonatal
482190|NCT00115544|jaundice|jaundice
482191|NCT00115544|hyperbilirubinemia|hyperbilirubinemia
482192|NCT00115557|translational research|translational research
482193|NCT00115557|prevention|prevention
482194|NCT00115557|primary care|primary care
482195|NCT00115557|practice-based research network|practice-based research network
482196|NCT00115570|Diabetes,Insulin-Dependent, pediatric,rapid acting injection|diabetes,insulin-dependent, pediatric,rapid acting injection
482197|NCT00115596|Procedure|procedure
482198|NCT00115596|Training|training
482199|NCT00115596|Simulation|simulation
482200|NCT00115596|Pediatrics|pediatrics
482201|NCT00115596|Curriculum|curriculum
482202|NCT00115596|Evaluation|evaluation
482203|NCT00115609|HIV infections|hiv infections
482204|NCT00115609|tuberculosis|tuberculosis
482205|NCT00115609|tuberculosis agents|tuberculosis agents
482206|NCT00115609|Anti HIV agents|anti hiv agents
482207|NCT00115609|Treatment Naive|treatment naive
482208|NCT00115622|GW685698X|gw685698x
482209|NCT00115622|once daily|once daily
482210|NCT00115622|mountain cedar|mountain cedar
482211|NCT00115622|allergic rhinitis|allergic rhinitis
482212|NCT00115622|fluticasone furoate|fluticasone furoate
482213|NCT00115635|Hormonal refractory, chemotherapy, docetaxel, gemcitabine|hormonal refractory, chemotherapy, docetaxel, gemcitabine
482214|NCT00115648|HIV|hiv
482215|NCT00115648|MTCT|mtct
482216|NCT00115648|Infants|infants
482217|NCT00115648|africa|africa
482218|NCT00115648|HIV Seronegativity|hiv seronegativity
482219|NCT00115661|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
482220|NCT00115661|treatment of endometriosis|treatment of endometriosis
482222|NCT00115700|Radiotherapy|radiotherapy
482223|NCT00115700|Chemotherapy|chemotherapy
482224|NCT00115700|Rituximab|rituximab
482225|NCT00115700|Randomised Trial|randomised trial
482226|NCT00115700|Stage I-II low grade follicular lymphoma|stage i-ii low grade follicular lymphoma
482227|NCT00115713|Aerobic Exercise|aerobic exercise
482228|NCT00115713|Weight Lifting|weight lifting
482229|NCT00115713|Breast Cancer|breast cancer
482230|NCT00115713|Quality of Life|quality of life
482231|NCT00115726|anesthesia|anesthesia
482232|NCT00115726|hypotension|hypotension
482233|NCT00115726|furosemide|furosemide
482234|NCT00115726|blood pressure|blood pressure
482235|NCT00115726|peripheral edema|peripheral edema
482236|NCT00115726|diuretic|diuretic
482237|NCT00115726|surgery|surgery
482238|NCT00115726|congestive heart failure|congestive heart failure
482239|NCT00115739|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
482240|NCT00115752|Single Nucleotide Polymorphism|single nucleotide polymorphism
482241|NCT00115752|Analgesic Efficacy|analgesic efficacy
482242|NCT00115752|Oral Surgery Model|oral surgery model
482243|NCT00115752|Cyclooxygenase Inhibitor|cyclooxygenase inhibitor
482244|NCT00115752|Gene Expression Profile|gene expression profile
482245|NCT00115752|Wisdom Teeth|wisdom teeth
482246|NCT00115752|Third Molar Extraction|third molar extraction
482247|NCT00115765|Panitumumab Advanced Colorectal Cancer Evaluation Study (PACCE Study)|panitumumab advanced colorectal cancer evaluation study (pacce study)
482354|NCT00116129|Fibromyalgia|fibromyalgia
482248|NCT00115765|Colorectal, Colon, Rectal Cancer, Metastatic Colorectal|colorectal, colon, rectal cancer, metastatic colorectal
482249|NCT00115765|Cancer|cancer
482250|NCT00115765|EGFr, Clinical Trial|egfr, clinical trial
482251|NCT00115765|Panitumumab, ABX-EGF|panitumumab, abx-egf
482252|NCT00115765|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
482253|NCT00115765|Metastatic Colorectal Cancer|metastatic colorectal cancer
482254|NCT00115765|Oncology|oncology
482255|NCT00115778|Hypogammaglobulinemia|hypogammaglobulinemia
482256|NCT00115778|Lung Transplantation|lung transplantation
482257|NCT00115791|Atrial Flutters|atrial flutters
482258|NCT00115791|Atrial Fibrillations|atrial fibrillations
482259|NCT00115791|RSD1235|rsd1235
482260|NCT00115804|Fibromyalgia|fibromyalgia
482261|NCT00115804|Juvenile|juvenile
482262|NCT00115843|Atrial fibrillation|atrial fibrillation
482263|NCT00115843|Arrhythmia|arrhythmia
482264|NCT00115843|Tachycardia|tachycardia
482265|NCT00115856|Arterial Disease|arterial disease
482266|NCT00115869|smoking prevention|smoking prevention
482267|NCT00115869|tobacco use prevention|tobacco use prevention
482268|NCT00115869|adolescent tobacco use|adolescent tobacco use
482269|NCT00115869|prevention intervention|prevention intervention
482270|NCT00115882|Adolescent|adolescent
482271|NCT00115882|smoking|smoking
482272|NCT00115882|smoking cessation|smoking cessation
482273|NCT00115882|counseling|counseling
482274|NCT00115895|radioiodine|radioiodine
482275|NCT00115895|serum thyroglobulin|serum thyroglobulin
482276|NCT00115895|whole body radioiodine scanning|whole body radioiodine scanning
482277|NCT00115908|Hepatitis C|hepatitis c
482278|NCT00115921|Home-based care|home-based care
482279|NCT00115921|Malaria|malaria
482280|NCT00115921|Africa|africa
482281|NCT00115960|IL-12|il-12
482282|NCT00115960|IL-15|il-15
482283|NCT00115960|HIV Seronegativity|hiv seronegativity
482284|NCT00115960|HIV Preventive Vaccine|hiv preventive vaccine
482285|NCT00115973|Pump|pump
482286|NCT00115973|Diabetes|diabetes
482287|NCT00115986|A/H5N1, Influenza, Vaccine, parent protocol|a/h5n1, influenza, vaccine, parent protocol
482288|NCT00115999|PAO|pao
482289|NCT00115999|acute peripheral arterial occlusion|acute peripheral arterial occlusion
482290|NCT00115999|thrombolysis|thrombolysis
482291|NCT00115999|blood clot|blood clot
482292|NCT00115999|leg attack|leg attack
482293|NCT00115999|alfimeprase|alfimeprase
482294|NCT00115999|thrombus|thrombus
482295|NCT00115999|embolism|embolism
482296|NCT00115999|thromboembolism|thromboembolism
482297|NCT00115999|claudication|claudication
482298|NCT00115999|thrombolytic|thrombolytic
482299|NCT00115999|thrombosis|thrombosis
482300|NCT00115999|plasminogen activator|plasminogen activator
482301|NCT00115999|arterial flow|arterial flow
482302|NCT00116012|acute coronary syndrome|acute coronary syndrome
482303|NCT00116012|rNAPc2|rnapc2
482304|NCT00116012|unstable angina|unstable angina
482305|NCT00116012|Non-STE myocardial infarction|non-ste myocardial infarction
482306|NCT00116012|ST elevation|st elevation
482307|NCT00116012|cardiac enzymes|cardiac enzymes
482308|NCT00116012|acute coronary syndromes|acute coronary syndromes
482309|NCT00116012|factor VIIa|factor viia
482310|NCT00116012|tissue factor|tissue factor
482311|NCT00116012|nematode anticoagulant protein c2|nematode anticoagulant protein c2
481587|NCT00111618|safety|safety
482312|NCT00116012|anticoagulants|anticoagulants
482313|NCT00116012|thrombin inhibitors|thrombin inhibitors
482314|NCT00116012|thrombosis|thrombosis
482316|NCT00116038|Osteoarthritis|osteoarthritis
482317|NCT00116038|Hip arthroplasty|hip arthroplasty
482318|NCT00116038|DEXA|dexa
482319|NCT00116051|RSA|rsa
482320|NCT00116051|DEXA|dexa
482321|NCT00116051|Osteoarthritis|osteoarthritis
482322|NCT00116051|Hip arthroplasty|hip arthroplasty
482323|NCT00116064|intranasal|intranasal
482324|NCT00116064|lorazepam|lorazepam
482325|NCT00116064|paediatric|paediatric
482326|NCT00116064|convulsions|convulsions
482327|NCT00116077|PET|pet
482328|NCT00116077|[C-11] NNC-112|[c-11] nnc-112
482329|NCT00116077|[F-18] Fallypride|[f-18] fallypride
482330|NCT00116077|Dopamine Receptors|dopamine receptors
482331|NCT00116077|Mood Disorders|mood disorders
482332|NCT00116077|DA Receptors|da receptors
482333|NCT00116077|Major Depressive Disorder|major depressive disorder
482334|NCT00116077|Bipolar Disorder|bipolar disorder
482335|NCT00116077|MDD|mdd
482336|NCT00116077|Bipolar Depression|bipolar depression
482337|NCT00116077|Healthy Volunteer|healthy volunteer
482338|NCT00116077|HV|hv
482339|NCT00116090|Uveitis|uveitis
482340|NCT00116090|Immunosuppression|immunosuppression
482341|NCT00116090|Cancer|cancer
482342|NCT00116090|Infections|infections
482343|NCT00116090|Mortality|mortality
482344|NCT00116090|Ocular Inflammatory Disease|ocular inflammatory disease
482345|NCT00116090|Scleritis|scleritis
482346|NCT00116090|Mucous Membranes Pemphigoid|mucous membranes pemphigoid
482347|NCT00116103|Treatment Effectiveness|treatment effectiveness
482348|NCT00116103|Treatment Efficacy|treatment efficacy
482349|NCT00116103|Investigational, Therapies|investigational, therapies
482350|NCT00116103|Asthma|asthma
482351|NCT00116103|Antiasthmatics|antiasthmatics
482356|NCT00116129|Growth hormone|growth hormone
482357|NCT00116129|IGF-1|igf-1
482358|NCT00116129|MK-0677|mk-0677
482359|NCT00116129|Oral growth hormone secretagogue|oral growth hormone secretagogue
482360|NCT00116142|Prostate Cancer|prostate cancer
482361|NCT00116142|Hormone Refractory|hormone refractory
482362|NCT00116142|Metastatic|metastatic
482363|NCT00116142|Localized|localized
482364|NCT00116142|Locally Advanced|locally advanced
482365|NCT00116142|Prostate Cancer - High Risk Localized or Locally Advanced|prostate cancer - high risk localized or locally advanced
482366|NCT00116155|Hormone Refractory Metastatic Prostate Cancer|hormone refractory metastatic prostate cancer
482367|NCT00116194|exercise|exercise
482368|NCT00116194|activities of daily living|activities of daily living
482369|NCT00116194|ADL|adl
482370|NCT00116194|loss of mobility|loss of mobility
482371|NCT00116194|risk of disability|risk of disability
482372|NCT00116194|physical activity|physical activity
482373|NCT00116194|mobility disability|mobility disability
482374|NCT00116207|Type 1 Diabetes|type 1 diabetes
482375|NCT00116207|Oxidative Stress|oxidative stress
482376|NCT00116207|Diabetic Complications|diabetic complications
482377|NCT00116207|Neuropathy|neuropathy
482378|NCT00116220|Prostate Cancer|prostate cancer
482379|NCT00116220|Total Androgen Suppression|total androgen suppression
482380|NCT00116220|endorectal coil MRI|endorectal coil mri
482381|NCT00116220|External Beam Radiation Therapy|external beam radiation therapy
482382|NCT00116220|Prostate Cancer- High Risk, clinically Organ-Confined|prostate cancer- high risk, clinically organ-confined
482383|NCT00116233|post operative adhesions|post operative adhesions
482384|NCT00116246|Labour|labour
482385|NCT00116246|vaginal delivery|vaginal delivery
482386|NCT00116246|primigravida|primigravida
482387|NCT00116246|McRobert's Manoeuvre|mcrobert's manoeuvre
482388|NCT00116246|operative delivery|operative delivery
482389|NCT00116259|clinical trial|clinical trial
482390|NCT00116259|aripiprazole|aripiprazole
482391|NCT00116259|Bipolar Disorder|bipolar disorder
482392|NCT00116259|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
482393|NCT00116259|ADHD|adhd
482394|NCT00116272|pregnancy|pregnancy
482395|NCT00116272|Autoimmune Disease|autoimmune disease
482396|NCT00116285|allergy|allergy
482397|NCT00116285|skin prick test|skin prick test
482398|NCT00116285|allergoid|allergoid
482399|NCT00116285|allergenicity|allergenicity
482400|NCT00116285|specific immunotherapy|specific immunotherapy
482401|NCT00116298|Antivirals|antivirals
482402|NCT00116298|HIV|hiv
482403|NCT00116311|Adenosine receptors|adenosine receptors
482404|NCT00116311|asthma|asthma
482405|NCT00116311|sputum|sputum
482406|NCT00116311|peripheral blood|peripheral blood
482407|NCT00116311|healthy|healthy
482408|NCT00116324|Asthma|asthma
482409|NCT00116324|Leukotriene receptor antagonist|leukotriene receptor antagonist
482410|NCT00116324|Hypertonic saline challenge|hypertonic saline challenge
482411|NCT00116337|spinal cord injury|spinal cord injury
482412|NCT00116337|paralysis|paralysis
482413|NCT00116337|cough|cough
482414|NCT00116337|cervical spinal cord injury|cervical spinal cord injury
482415|NCT00116337|thoracic spinal cord injury|thoracic spinal cord injury
481689|NCT00111917|CBD|cbd
482416|NCT00116350|Postpartum hemorrhage|postpartum hemorrhage
482417|NCT00116350|Misoprostol|misoprostol
482418|NCT00116350|Developing countries|developing countries
482419|NCT00116350|Maternal morbidity|maternal morbidity
482420|NCT00116350|Randomized controlled trial|randomized controlled trial
482421|NCT00116363|gene therapy|gene therapy
482422|NCT00116363|melanoma|melanoma
482423|NCT00116363|adenovirus|adenovirus
482424|NCT00116363|in-transit melanoma|in-transit melanoma
482425|NCT00116363|metastatic melanoma|metastatic melanoma
482426|NCT00116376|GBM|gbm
482427|NCT00116376|recurrent/relapse|recurrent/relapse
482428|NCT00116376|EGFR|egfr
482429|NCT00116376|VEGFR|vegfr
482430|NCT00116389|pancreatic cancer|pancreatic cancer
482431|NCT00116389|cancer of the pancreas|cancer of the pancreas
482432|NCT00116389|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
482433|NCT00116389|pancreatic neoplasms|pancreatic neoplasms
482434|NCT00116389|Metastatic pancreatic cancer (Stage IV)|metastatic pancreatic cancer (stage iv)
482435|NCT00116389|Stage IV Adenocarcinoma of the Pancreas|stage iv adenocarcinoma of the pancreas
482436|NCT00116402|COPD|copd
482437|NCT00116402|Chronic Obstructive|chronic obstructive
482438|NCT00116402|Pulmonary Disease|pulmonary disease
482439|NCT00116402|Inhaled Corticosteroids|inhaled corticosteroids
482440|NCT00116402|Airway Inflammation|airway inflammation
482441|NCT00116402|Bronchoscopy|bronchoscopy
482442|NCT00116415|HIV/AIDS|hiv/aids
482443|NCT00116428|Atrial Fibrillation|atrial fibrillation
482444|NCT00116428|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
482445|NCT00116441|Multiple Myeloma|multiple myeloma
482446|NCT00116441|Cancer|cancer
482447|NCT00116441|PSCT|psct
482448|NCT00116441|Peripheral Stem Cell Transplant|peripheral stem cell transplant
482449|NCT00116441|Chemotherapy|chemotherapy
482450|NCT00116441|GVAX|gvax
482451|NCT00116454|Carcinoma, Hepatocellular|carcinoma, hepatocellular
482452|NCT00116454|Viral Hepatitis, Alcoholic Hepatitis|viral hepatitis, alcoholic hepatitis
482454|NCT00116467|Acute Myelogenous Leukemia|acute myelogenous leukemia
482455|NCT00116467|GVAX|gvax
482456|NCT00116467|Vaccine|vaccine
482457|NCT00116467|Stem Cell Transplant|stem cell transplant
482458|NCT00116467|Autologous|autologous
482459|NCT00116480|Postpartum Haemorrhage|postpartum haemorrhage
482460|NCT00116480|Misoprostol|misoprostol
482461|NCT00116493|severe anemia|severe anemia
482462|NCT00116493|anthelminthic|anthelminthic
482463|NCT00116493|multivitamins|multivitamins
482464|NCT00116493|pregnancy|pregnancy
482465|NCT00116493|children|children
482466|NCT00116493|Pakistan|pakistan
482467|NCT00116506|Metastatic Colorectal Cancer|metastatic colorectal cancer
482468|NCT00116506|Bevacizumab|bevacizumab
482469|NCT00116506|Erlotinib|erlotinib
482470|NCT00116506|FOLFOX|folfox
482471|NCT00116532|Obsessive Compulsive Disorder|obsessive compulsive disorder
482472|NCT00116532|Escitalopram|escitalopram
482473|NCT00116532|SSRI|ssri
482474|NCT00116532|Open Label|open label
482475|NCT00116545|IDDM|iddm
482476|NCT00116545|Insulin|insulin
482477|NCT00116545|cardiovascular disease|cardiovascular disease
482478|NCT00116558|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
482479|NCT00116558|ALS|als
482480|NCT00116558|Lou Gehrig's disease|lou gehrig's disease
482481|NCT00116558|nutrition|nutrition
482482|NCT00116558|NIPPV|nippv
482483|NCT00116558|non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
482484|NCT00116558|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
482485|NCT00116558|PEG|peg
482486|NCT00116571|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
482487|NCT00116571|Photodynamic Therapy (PDT)|photodynamic therapy (pdt)
482488|NCT00116571|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
482489|NCT00116584|heliox|heliox
482490|NCT00116584|bronchiolitis|bronchiolitis
482491|NCT00116584|racemic epinephrine|racemic epinephrine
482492|NCT00116597|Active Specific Immunotherapy|active specific immunotherapy
482493|NCT00116597|Intranodal|intranodal
482494|NCT00116597|Cancer|cancer
482495|NCT00116597|Melanoma stages IIb to IV|melanoma stages iib to iv
482496|NCT00116597|Gene Therapy|gene therapy
482497|NCT00116597|Recombinant Vaccinia virus|recombinant vaccinia virus
482498|NCT00116597|HLA-A2|hla-a2
482499|NCT00116597|Mart-1/Melan-A, Gp-100, tyrosinase|mart-1/melan-a, gp-100, tyrosinase
482500|NCT00116597|Clinical Trial|clinical trial
482501|NCT00116597|Phase I/II|phase i/ii
482502|NCT00116610|small cell lung cancer|small cell lung cancer
482503|NCT00116610|resistant|resistant
482504|NCT00116610|refractory|refractory
482505|NCT00116610|platinum|platinum
482506|NCT00116610|chemotherapy|chemotherapy
482507|NCT00116610|second-line|second-line
482508|NCT00116610|relapse|relapse
482509|NCT00116610|sensitive|sensitive
482510|NCT00116636|HIV|hiv
482511|NCT00116636|Treatment Naive|treatment naive
482512|NCT00116649|actinic keratosis lesions large head torso extremities|actinic keratosis lesions large head torso extremities
482513|NCT00116649|actinic keratosis|actinic keratosis
481788|NCT00114309|GBM|gbm
482514|NCT00116662|Wart(s)|wart(s)
482515|NCT00116662|Common Wart(s)|common wart(s)
482516|NCT00116662|Children|children
482517|NCT00116662|Pediatric|pediatric
482518|NCT00116662|3M Pharmaceuticals|3m pharmaceuticals
482519|NCT00116662|Resiquimod|resiquimod
482520|NCT00116675|Common Wart(s)|common wart(s)
482521|NCT00116675|Pediatric|pediatric
482522|NCT00116675|Wart(s)|wart(s)
482523|NCT00116675|Children|children
482524|NCT00116675|3M Pharmaceuticals|3m pharmaceuticals
482525|NCT00116675|Resiquimod|resiquimod
483093|NCT00108654|Virus|virus
482526|NCT00116688|Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|immune (idiopathic) thrombocytopenic purpura (itp)
482527|NCT00116688|Thrombocytopenic|thrombocytopenic
482528|NCT00116701|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
482529|NCT00116701|Haemoglobin (Hb)|haemoglobin (hb)
482530|NCT00116701|Erthropoetin (EPO)|erthropoetin (epo)
482531|NCT00116701|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
482532|NCT00116701|Recombinant Human Erthropoetic (rHuEPO)|recombinant human erthropoetic (rhuepo)
482533|NCT00116701|Anaemia|anaemia
482534|NCT00116701|Darbepoetin Alfa, Aranesp®|darbepoetin alfa, aranesp®
482535|NCT00116701|Haemodialysis|haemodialysis
482536|NCT00116701|Clinical Trial|clinical trial
482537|NCT00116714|rheumatoid arthritis|rheumatoid arthritis
482538|NCT00116714|RA|ra
482539|NCT00116714|DMARD|dmard
482540|NCT00116727|Rheumatoid Arthritis|rheumatoid arthritis
482541|NCT00116727|DMARD|dmard
482542|NCT00116740|Serotonin|serotonin
482543|NCT00116740|5-HT2c|5-ht2c
482544|NCT00116740|Satiety|satiety
482545|NCT00116740|Obesity|obesity
482546|NCT00116740|Appetite suppressant|appetite suppressant
482547|NCT00116740|Weight Loss|weight loss
482548|NCT00116740|Overweight|overweight
482549|NCT00116753|Prostate Cancer|prostate cancer
482550|NCT00116753|Androgen ablation therapy|androgen ablation therapy
482551|NCT00106795|Antiretrovirals|antiretrovirals
482552|NCT00106795|Adipocytes|adipocytes
482553|NCT00106795|Skeletal Muscle|skeletal muscle
482555|NCT00106795|HIV|hiv
482556|NCT00106795|AIDS|aids
482557|NCT00106795|Lymphocytes|lymphocytes
482558|NCT00106795|Lipodystrophy|lipodystrophy
482559|NCT00106795|HIV Positive|hiv positive
482560|NCT00106795|Healthy Volunteer|healthy volunteer
482561|NCT00106795|HV|hv
482562|NCT00106808|Type 2 Diabetes|type 2 diabetes
482563|NCT00106834|Psoriasis|psoriasis
482564|NCT00106834|Infliximab|infliximab
482565|NCT00106834|Remicade|remicade
482566|NCT00106847|plaque-type psoriasis|plaque-type psoriasis
482567|NCT00106847|psoriasis|psoriasis
482568|NCT00106847|drug safety|drug safety
482569|NCT00106847|drug efficacy|drug efficacy
482570|NCT00106847|maintenance therapy|maintenance therapy
482571|NCT00106847|induction therapy|induction therapy
482572|NCT00106847|remicade|remicade
482573|NCT00106860|Anxiety|anxiety
482574|NCT00106860|Generalized Anxiety Disorder|generalized anxiety disorder
482575|NCT00106886|homocysteine|homocysteine
482576|NCT00106886|folic acid|folic acid
482577|NCT00106886|micronutrients|micronutrients
482578|NCT00106886|multivitamins|multivitamins
482579|NCT00106886|vitamin supplements|vitamin supplements
482580|NCT00106899|neuroimaging|neuroimaging
482581|NCT00106899|brain metabolism|brain metabolism
482582|NCT00106899|biomarkers|biomarkers
482583|NCT00106899|cognition disorder|cognition disorder
482584|NCT00106899|Mild Cognitive Impairment|mild cognitive impairment
482585|NCT00106912|Genetic|genetic
482586|NCT00106912|Stroke|stroke
482587|NCT00106912|Heart|heart
482588|NCT00106912|Lysosomal|lysosomal
482589|NCT00106912|Glycolipid|glycolipid
482590|NCT00106912|Fabry Disease|fabry disease
482591|NCT00106925|Peripheral Blood Stem Cells|peripheral blood stem cells
482592|NCT00106925|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
482593|NCT00106925|Graft-Versus-Host Disease|graft-versus-host disease
482594|NCT00106925|Whole Body Irradiation|whole body irradiation
482595|NCT00106925|Leukemic Relapse|leukemic relapse
482596|NCT00106925|Allogeneic Stem Cell Transplantation Recipient|allogeneic stem cell transplantation recipient
482597|NCT00106938|Carotid stenting|carotid stenting
482598|NCT00106938|Carotid endarterectomy|carotid endarterectomy
482599|NCT00106938|Carotid artery disease with severe narrowing of the artery|carotid artery disease with severe narrowing of the artery
482600|NCT00106938|Stroke prevention|stroke prevention
482601|NCT00106951|Surveillance|surveillance
482602|NCT00106951|coronary heart disease|coronary heart disease
482603|NCT00106951|neighborhood SES|neighborhood ses
482604|NCT00106964|Hepatitis B vaccines|hepatitis b vaccines
482605|NCT00106964|HIV-infected adolescents|hiv-infected adolescents
482606|NCT00106964|Hepatitis B infection (negative)|hepatitis b infection (negative)
482607|NCT00106977|Craniosynostosis|craniosynostosis
482608|NCT00106977|Hearing Loss|hearing loss
482609|NCT00106977|Genectic Disorders|genectic disorders
482610|NCT00106977|Muenke Syndrome|muenke syndrome
482611|NCT00107003|Brain|brain
482612|NCT00107003|Tumor|tumor
482613|NCT00107003|Surgery|surgery
482614|NCT00107003|Therapy|therapy
482615|NCT00107003|Trial|trial
482616|NCT00107003|Brain Tumor|brain tumor
482617|NCT00107003|Glioblastoma Multiforme|glioblastoma multiforme
482618|NCT00107003|GBM|gbm
482619|NCT00107003|Gliosarcoma|gliosarcoma
482620|NCT00107003|GS|gs
482621|NCT00107016|Breast Cancer|breast cancer
482622|NCT00107016|Cancer of the Breast|cancer of the breast
482623|NCT00107016|Neo-adjuvant|neo-adjuvant
482624|NCT00107016|Primary breast cancer|primary breast cancer
482625|NCT00107016|postmenopausal|postmenopausal
482626|NCT00107016|pre-operative|pre-operative
482627|NCT00107029|HIV infection|hiv infection
482628|NCT00107029|CD8+ T-cells|cd8+ t-cells
482629|NCT00107029|HIV-1 genotype|hiv-1 genotype
482630|NCT00107042|Hepatitis B|hepatitis b
482631|NCT00107042|HIV vaccine trial|hiv vaccine trial
482632|NCT00107055|Herniated nucleus pulposus|herniated nucleus pulposus
482633|NCT00107055|Lumbosacral radiculopathy|lumbosacral radiculopathy
482634|NCT00107055|Anti-TNF alpha|anti-tnf alpha
482635|NCT00107055|Tumor necrosis factor alpha|tumor necrosis factor alpha
482636|NCT00107068|Stroke|stroke
482637|NCT00107068|Exercise|exercise
482638|NCT00107068|Aerobic|aerobic
482639|NCT00107068|PRT|prt
482640|NCT00107068|Walking ability|walking ability
482641|NCT00107081|children|children
482642|NCT00107081|oral antibiotics|oral antibiotics
482643|NCT00107081|outpatient treatment|outpatient treatment
482644|NCT00107081|fever and neutropenia|fever and neutropenia
482645|NCT00107094|Breast Cancer|breast cancer
482646|NCT00107094|Adriamycin|adriamycin
482647|NCT00107094|Cyclophosphamide|cyclophosphamide
482648|NCT00107094|Abraxane|abraxane
482649|NCT00107107|Diabetes|diabetes
482650|NCT00107107|Amylin|amylin
482651|NCT00107107|pramlintide|pramlintide
482652|NCT00107107|Symlin|symlin
482653|NCT00107120|Major Depressive Disorder|major depressive disorder
482654|NCT00107120|Depression|depression
482655|NCT00107120|Adolescents|adolescents
482656|NCT00107120|Escitalopram|escitalopram
482657|NCT00107120|Pediatrics|pediatrics
482659|NCT00107159|stage III melanoma|stage iii melanoma
482660|NCT00107159|stage IV melanoma|stage iv melanoma
486156|NCT00125996|ANAEMIA|anaemia
482661|NCT00107172|stage I non-small cell lung cancer|stage i non-small cell lung cancer
482662|NCT00107185|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
482663|NCT00107185|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
482664|NCT00107185|childhood oligodendroglioma|childhood oligodendroglioma
585508|NCT00513084|Predictors,|predictors,
482665|NCT00107211|ductal breast carcinoma in situ|ductal breast carcinoma in situ
482666|NCT00107211|breast cancer in situ|breast cancer in situ
482667|NCT00107237|adult glioblastoma|adult glioblastoma
482668|NCT00107237|recurrent adult brain tumor|recurrent adult brain tumor
482669|NCT00107237|adult giant cell glioblastoma|adult giant cell glioblastoma
482670|NCT00107237|adult gliosarcoma|adult gliosarcoma
482671|NCT00107250|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
482672|NCT00107250|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
482673|NCT00107250|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
482674|NCT00107250|stage IV colon cancer|stage iv colon cancer
482675|NCT00107250|stage IV rectal cancer|stage iv rectal cancer
482676|NCT00107250|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
482677|NCT00107263|osteoporosis|osteoporosis
482678|NCT00107263|stage I breast cancer|stage i breast cancer
482679|NCT00107263|stage II breast cancer|stage ii breast cancer
482680|NCT00107263|stage IIIA breast cancer|stage iiia breast cancer
482681|NCT00107276|stage IV breast cancer|stage iv breast cancer
482682|NCT00107276|recurrent breast cancer|recurrent breast cancer
482683|NCT00107289|metastatic pheochromocytoma|metastatic pheochromocytoma
482684|NCT00107289|recurrent pheochromocytoma|recurrent pheochromocytoma
482685|NCT00107289|regional pheochromocytoma|regional pheochromocytoma
482686|NCT00107289|recurrent neuroblastoma|recurrent neuroblastoma
482687|NCT00107289|04-148|04-148
482688|NCT00107315|recurrent colon cancer|recurrent colon cancer
482689|NCT00107315|stage IV colon cancer|stage iv colon cancer
482690|NCT00107315|recurrent rectal cancer|recurrent rectal cancer
482691|NCT00107315|stage IV rectal cancer|stage iv rectal cancer
482692|NCT00107341|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
482693|NCT00107341|stage IV esophageal cancer|stage iv esophageal cancer
482694|NCT00107341|recurrent esophageal cancer|recurrent esophageal cancer
482695|NCT00107354|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
482696|NCT00107354|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
482697|NCT00107354|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
482698|NCT00107354|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
482699|NCT00107354|secondary acute myeloid leukemia|secondary acute myeloid leukemia
482700|NCT00107354|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
482701|NCT00107354|refractory anemia with excess blasts|refractory anemia with excess blasts
95181|NCT02693834|foot drop|foot drop
95182|NCT02693834|Subacute stroke|subacute stroke
481986|NCT00114907|Tea|tea
482702|NCT00107354|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
482703|NCT00107354|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
482704|NCT00107354|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
482705|NCT00107354|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
482706|NCT00107354|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
482707|NCT00107354|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
482708|NCT00107354|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
482783|NCT00107627|Gynaecological Cancer|gynaecological cancer
482709|NCT00107354|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
482710|NCT00107354|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
482711|NCT00107354|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
482712|NCT00107354|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
482713|NCT00107354|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
482714|NCT00107354|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
482715|NCT00107367|tumors metastatic to brain|tumors metastatic to brain
482716|NCT00107380|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
482717|NCT00107380|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
482718|NCT00107380|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
482719|NCT00107380|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
482720|NCT00107393|recurrent breast cancer|recurrent breast cancer
482721|NCT00107393|stage IV breast cancer|stage iv breast cancer
482722|NCT00107419|chondrosarcoma|chondrosarcoma
482723|NCT00107458|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
482724|NCT00107458|recurrent childhood brain tumor|recurrent childhood brain tumor
482725|NCT00107458|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
482726|NCT00107458|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
482727|NCT00107458|recurrent childhood ependymoma|recurrent childhood ependymoma
482728|NCT00107458|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
482729|NCT00107458|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
482730|NCT00107458|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
482731|NCT00107458|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
585509|NCT00513084|Weight|weight
482732|NCT00107458|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
482733|NCT00107458|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
482734|NCT00107458|childhood infratentorial ependymoma|childhood infratentorial ependymoma
482735|NCT00107458|childhood supratentorial ependymoma|childhood supratentorial ependymoma
482736|NCT00107458|childhood spinal cord neoplasm|childhood spinal cord neoplasm
482737|NCT00107458|childhood grade I meningioma|childhood grade i meningioma
482738|NCT00107458|childhood grade II meningioma|childhood grade ii meningioma
482739|NCT00107458|childhood grade III meningioma|childhood grade iii meningioma
482740|NCT00107458|childhood craniopharyngioma|childhood craniopharyngioma
482741|NCT00107458|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
482742|NCT00107471|untreated childhood brain stem glioma|untreated childhood brain stem glioma
482743|NCT00107484|stage IV breast cancer|stage iv breast cancer
482744|NCT00107484|stage I breast cancer|stage i breast cancer
482745|NCT00107484|stage II breast cancer|stage ii breast cancer
482746|NCT00107484|stage IIIA breast cancer|stage iiia breast cancer
482747|NCT00107484|stage IIIB breast cancer|stage iiib breast cancer
482748|NCT00107484|stage IIIC breast cancer|stage iiic breast cancer
482749|NCT00107484|male breast cancer|male breast cancer
482750|NCT00107497|stage I breast cancer|stage i breast cancer
482751|NCT00107497|stage II breast cancer|stage ii breast cancer
482752|NCT00107510|stage II breast cancer|stage ii breast cancer
482753|NCT00107510|stage IIIA breast cancer|stage iiia breast cancer
482754|NCT00107510|stage IIIB breast cancer|stage iiib breast cancer
482755|NCT00107510|stage IIIC breast cancer|stage iiic breast cancer
482756|NCT00107510|male breast cancer|male breast cancer
482757|NCT00107523|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
482758|NCT00107523|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
482759|NCT00107523|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
482760|NCT00107523|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
482761|NCT00107523|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
482762|NCT00107523|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
482763|NCT00107523|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
482764|NCT00107549|Treatment Experienced|treatment experienced
482765|NCT00107549|HIV Therapeutic Vaccine|hiv therapeutic vaccine
622286|NCT00669890|AML|aml
482766|NCT00107562|risk behavior|risk behavior
482767|NCT00107562|social networks|social networks
482768|NCT00107562|behavior|behavior
482769|NCT00107575|tobacco|tobacco
482770|NCT00107575|alcohol|alcohol
482771|NCT00107588|marijuana dependence|marijuana dependence
482772|NCT00107588|self-efficacy|self-efficacy
482773|NCT00107588|coping skills|coping skills
482774|NCT00107588|attendance|attendance
482775|NCT00107588|marijuana abstinence|marijuana abstinence
482776|NCT00107601|Glucose|glucose
482777|NCT00107601|Glucose Control|glucose control
482778|NCT00107601|Insulin|insulin
482779|NCT00107601|Insulin therapy|insulin therapy
482780|NCT00107601|Critically ill|critically ill
482781|NCT00107601|Intensive Care|intensive care
482782|NCT00107614|Waldenstrom|waldenstrom
483091|NCT00108654|Immunity|immunity
482784|NCT00107627|Surgical Staples|surgical staples
482785|NCT00107627|Subcuticular Sutures|subcuticular sutures
482786|NCT00107640|At-risk drinking|at-risk drinking
482787|NCT00107640|Alcohol education|alcohol education
482788|NCT00107640|Effectiveness|effectiveness
482789|NCT00107640|Cost-effectiveness|cost-effectiveness
482790|NCT00107666|Coronary artery bypass grafting|coronary artery bypass grafting
482791|NCT00107666|Heart valve prosthesis implantation|heart valve prosthesis implantation
482792|NCT00107666|Cardiopulmonary bypass|cardiopulmonary bypass
482793|NCT00107666|Oxidative stress|oxidative stress
482794|NCT00107666|Inflammation|inflammation
482795|NCT00107666|Endotoxemia|endotoxemia
482796|NCT00107679|Treatment Experienced|treatment experienced
482797|NCT00107679|HIV|hiv
482798|NCT00107679|HPV|hpv
482799|NCT00107679|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
482800|NCT00107679|Papillomavirus, Human|papillomavirus, human
482801|NCT00107692|Child Obesity|child obesity
482802|NCT00107692|Physical activity|physical activity
482803|NCT00107692|community intervention study|community intervention study
482804|NCT00107692|competence|competence
482805|NCT00107692|diet and nutrition|diet and nutrition
482806|NCT00107692|Nutrition|nutrition
482807|NCT00107705|allergy|allergy
482808|NCT00107705|skin prick test|skin prick test
482809|NCT00107705|allergoid|allergoid
482810|NCT00107705|allergenicity|allergenicity
482811|NCT00107705|specific immunotherapy|specific immunotherapy
482813|NCT00107718|treatment naive|treatment naive
482814|NCT00107718|Phase 2|phase 2
482815|NCT00107718|melanoma|melanoma
482816|NCT00107731|Bipolar I Disorder|bipolar i disorder
482817|NCT00107731|Manic Depressive Disorder|manic depressive disorder
482818|NCT00107731|Manic Depression|manic depression
482819|NCT00107744|Blood Pressure; Lipids; Dietary Protein|blood pressure; lipids; dietary protein
482821|NCT00107757|Seasonal allergic rhinitis|seasonal allergic rhinitis
482822|NCT00107770|ALS|als
482823|NCT00107770|histone deacetylase inhibition|histone deacetylase inhibition
482824|NCT00107770|open label|open label
482825|NCT00107770|safety study|safety study
482826|NCT00107770|sodium phenylbutyrate|sodium phenylbutyrate
482827|NCT00107783|Arthritis|arthritis
482828|NCT00107783|Homogentisic Acid|homogentisic acid
482829|NCT00107783|Corneal Damage|corneal damage
482830|NCT00107783|Tyrosine|tyrosine
482831|NCT00107783|Alkaptonuria|alkaptonuria
482832|NCT00107783|Photophobia|photophobia
482833|NCT00107783|Nitisinone|nitisinone
482834|NCT00107796|Pediatric Narcolepsy|pediatric narcolepsy
482835|NCT00107796|Excessive sleepiness|excessive sleepiness
482836|NCT00107809|Pediatric Obstructive sleep Apnea|pediatric obstructive sleep apnea
482837|NCT00107809|Excessive sleepiness|excessive sleepiness
482838|NCT00107809|CPAP|cpap
482839|NCT00107809|Pediatric OSAHS|pediatric osahs
482840|NCT00107822|Pain|pain
482841|NCT00107835|Pain|pain
482842|NCT00107848|Pediatric Narcolepsy|pediatric narcolepsy
482843|NCT00107848|Pediatric OSA|pediatric osa
482844|NCT00107848|CPAP|cpap
482845|NCT00107848|Pediatric Narcolepsy or OSAHS|pediatric narcolepsy or osahs
482846|NCT00107874|Maternal|maternal
482847|NCT00107874|morbidity|morbidity
482848|NCT00107874|mortality|mortality
482849|NCT00107874|pregnancy|pregnancy
482850|NCT00107874|postpartum hemorrhage|postpartum hemorrhage
482851|NCT00107874|Cesarean Section|cesarean section
482852|NCT00107887|TST|tst
482853|NCT00107887|isoniazid|isoniazid
482854|NCT00107887|HAART|haart
482855|NCT00107887|Brazil|brazil
482856|NCT00107887|HIV|hiv
482857|NCT00107900|Deep Vein Thrombosis,|deep vein thrombosis,
482858|NCT00107900|Anticoagulant,|anticoagulant,
482859|NCT00107900|Venous thromboembolic|venous thromboembolic
482860|NCT00107913|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
482861|NCT00107926|bipolar disorder|bipolar disorder
482862|NCT00107926|manic episode|manic episode
482863|NCT00107926|treatment|treatment
482864|NCT00107926|licarbazepine|licarbazepine
482865|NCT00107939|bipolar disorder|bipolar disorder
482866|NCT00107939|manic episode|manic episode
482867|NCT00107939|treatment|treatment
482868|NCT00107939|licarbazepine|licarbazepine
482869|NCT00107952|Nosocomial pneumonia|nosocomial pneumonia
482870|NCT00107952|MRSA|mrsa
482871|NCT00107965|Actinic Keratosis|actinic keratosis
482872|NCT00107965|Solar Keratosis|solar keratosis
482873|NCT00107965|AK|ak
482874|NCT00107965|Sun spots|sun spots
482875|NCT00107965|PEP005|pep005
482876|NCT00107965|Topical|topical
482877|NCT00107965|Dermatology|dermatology
482878|NCT00107978|cSSSI (complicated Skin and Skin Structure Infections)|csssi (complicated skin and skin structure infections)
482879|NCT00107978|Staph (Staphylococcus)|staph (staphylococcus)
482880|NCT00107978|MRSA (Methicillin-resistant Staphylococcus Aureus)|mrsa (methicillin-resistant staphylococcus aureus)
482881|NCT00107991|clinical trial; efficacy; etanercept; hidradenitis suppurativa; quality of life; safety; tnf|clinical trial; efficacy; etanercept; hidradenitis suppurativa; quality of life; safety; tnf
482882|NCT00108004|Diabetes|diabetes
482883|NCT00108004|Amylin|amylin
482884|NCT00108004|Symlin|symlin
482885|NCT00108004|pramlintide acetate|pramlintide acetate
482886|NCT00108017|Ocular hypertension (excessive pressure in the eye)|ocular hypertension (excessive pressure in the eye)
482887|NCT00108030|PBWST training|pbwst training
482888|NCT00108030|Strength training|strength training
482889|NCT00108030|6-min walking endurance|6-min walking endurance
482890|NCT00108030|Cardiovascular fitness|cardiovascular fitness
482891|NCT00108030|Psychosocial attributes|psychosocial attributes
482892|NCT00108043|Functional Electrical Stimulation|functional electrical stimulation
482893|NCT00108043|Gait|gait
482894|NCT00108043|Blood pressure|blood pressure
482895|NCT00108043|Orthostatic Hypotension|orthostatic hypotension
482896|NCT00108043|Cardiovascular responses|cardiovascular responses
482897|NCT00108043|Near-infra red spectroscopy|near-infra red spectroscopy
482898|NCT00108056|Brain|brain
482899|NCT00108056|Tumor|tumor
482900|NCT00108056|Malignant|malignant
482901|NCT00108056|Therapy|therapy
482902|NCT00108056|Progression|progression
482903|NCT00108056|Malignant Brain Tumor|malignant brain tumor
482904|NCT00108056|Malignant Glioma|malignant glioma
482905|NCT00108056|Glioma|glioma
482906|NCT00108069|Brain|brain
482907|NCT00108069|Tumor|tumor
482908|NCT00108069|Malignant|malignant
482909|NCT00108069|Therapy|therapy
482910|NCT00108069|Progression|progression
482911|NCT00108069|Chemotherapy|chemotherapy
482912|NCT00108069|Antiangiogenesis|antiangiogenesis
482913|NCT00108069|Radiation|radiation
482914|NCT00108069|Malignant Brain Tumor|malignant brain tumor
482916|NCT00108069|Glioma|glioma
482917|NCT00108082|left ventricular hypertrophy (LVH)|left ventricular hypertrophy (lvh)
482918|NCT00108082|echocardiogram|echocardiogram
486254|NCT00126321|cladribine|cladribine
482919|NCT00108082|left ventricular mass regression|left ventricular mass regression
482920|NCT00108082|cardiac MRI|cardiac mri
482921|NCT00108082|left ventricular mass index (LVMI)hypertension|left ventricular mass index (lvmi)hypertension
482922|NCT00108095|emesis|emesis
482923|NCT00108095|nausea|nausea
482924|NCT00108095|post operative nausea and vomiting|post operative nausea and vomiting
482925|NCT00108095|vomiting|vomiting
482926|NCT00108095|PONV|ponv
482927|NCT00108108|Lymphocytic Leukemia|lymphocytic leukemia
482928|NCT00108121|Nodular basal cell carcinoma|nodular basal cell carcinoma
482929|NCT00108121|basal cell carcinoma|basal cell carcinoma
482930|NCT00108121|nBCC|nbcc
482932|NCT00108121|PEP005|pep005
482933|NCT00108121|Topical|topical
482934|NCT00108121|Dermatology|dermatology
482935|NCT00108134|Superficial basal cell carcinoma|superficial basal cell carcinoma
482936|NCT00108134|basal cell carcinoma|basal cell carcinoma
482937|NCT00108134|sBCC|sbcc
482938|NCT00108134|BCC|bcc
482939|NCT00108134|PEP005|pep005
482940|NCT00108134|Topical|topical
482941|NCT00108134|Dermatology|dermatology
482942|NCT00108147|Aged|aged
482943|NCT00108147|Congestive Heart Failure|congestive heart failure
482944|NCT00108147|Exercise|exercise
482945|NCT00108160|mupirocin|mupirocin
482946|NCT00108160|prevention and control|prevention and control
482947|NCT00108160|s. aureus|s. aureus
482948|NCT00108173|Position Emission Tomography (PET)|position emission tomography (pet)
482949|NCT00108173|Nicotine dependence|nicotine dependence
482950|NCT00108173|functional magnetic resonance imaging|functional magnetic resonance imaging
482951|NCT00108173|cigarette cues|cigarette cues
482952|NCT00108186|cyclooxygenase 2|cyclooxygenase 2
482953|NCT00108186|lung cancer|lung cancer
482954|NCT00108186|lymphocytes|lymphocytes
482955|NCT00108186|non small cell|non small cell
482956|NCT00108186|therapeutics|therapeutics
482957|NCT00108199|Schizophrenia|schizophrenia
482958|NCT00108199|vocational rehabilitation|vocational rehabilitation
482959|NCT00108199|neuropsychology|neuropsychology
482960|NCT00108212|Diet|diet
482961|NCT00108212|triglyceride|triglyceride
482962|NCT00108212|inflammation|inflammation
482963|NCT00108212|Genetic polymorphism|genetic polymorphism
482964|NCT00108225|Cholesterol|cholesterol
482965|NCT00108225|Creatinine Clearance|creatinine clearance
482966|NCT00108225|Diabetes|diabetes
482967|NCT00108225|Glycohemoglobin|glycohemoglobin
482968|NCT00108225|High Protein Diet|high protein diet
482969|NCT00108238|endothelial function|endothelial function
482970|NCT00108238|hormone replacement therapy|hormone replacement therapy
482971|NCT00108238|coronary flow reserve|coronary flow reserve
482972|NCT00108238|posmenopausal women|posmenopausal women
482973|NCT00108238|women's cardiovascular heatlh|women's cardiovascular heatlh
482974|NCT00108251|controlled clinical trial|controlled clinical trial
482975|NCT00108251|Diastole|diastole
482976|NCT00108251|Echocardiography|echocardiography
482977|NCT00108251|exercise tolerance|exercise tolerance
482978|NCT00108251|Heart Failure, Congestive|heart failure, congestive
482979|NCT00108251|Receptors, Aldosterone|receptors, aldosterone
482980|NCT00108264|Prostatic Neoplasms|prostatic neoplasms
482981|NCT00108264|Neoplasm Metastasis|neoplasm metastasis
482982|NCT00108264|Immunotherapy|immunotherapy
482983|NCT00108264|Active|active
482984|NCT00108264|Dendritic Cells|dendritic cells
482985|NCT00108277|Anxiety|anxiety
482986|NCT00108277|Breathing Training|breathing training
483092|NCT00108654|Preventive|preventive
482987|NCT00108277|Respiratory Dysregulation|respiratory dysregulation
482988|NCT00108290|Prostate cancer|prostate cancer
482989|NCT00108290|chemotherapy|chemotherapy
482990|NCT00108290|hormone therapy|hormone therapy
482991|NCT00108290|surgery|surgery
482992|NCT00108290|PSA|psa
482993|NCT00108290|Gleason score|gleason score
482994|NCT00108303|schizophrenia|schizophrenia
482995|NCT00108316|Depressive Disorder|depressive disorder
482996|NCT00108316|DNA|dna
482997|NCT00108316|Serotonin|serotonin
482998|NCT00108329|aging|aging
482999|NCT00108329|exercise|exercise
483000|NCT00108329|metabolic syndrome|metabolic syndrome
483001|NCT00108329|insulin resistance|insulin resistance
483002|NCT00108342|nicotine|nicotine
483003|NCT00108342|drug therapy|drug therapy
483004|NCT00108342|Smoking Cessation|smoking cessation
483005|NCT00108355|albumin|albumin
483006|NCT00108355|ascites|ascites
483007|NCT00108355|paracentesis|paracentesis
483008|NCT00108368|schizophrenia|schizophrenia
483009|NCT00108368|cognition|cognition
483010|NCT00108368|antipsychotic medication|antipsychotic medication
483011|NCT00108368|information processing|information processing
483012|NCT00108368|social cognition|social cognition
483013|NCT00108368|Psychotic|psychotic
483014|NCT00108381|chronic back pain|chronic back pain
482931|NCT00108121|BCC|bcc
483015|NCT00108381|cognitive-behavioral|cognitive-behavioral
483016|NCT00108381|pain|pain
483017|NCT00108381|stages of change|stages of change
483018|NCT00108394|Uremia|uremia
483020|NCT00108394|Clinical Trials|clinical trials
483021|NCT00108394|Bone Diseases, Metabolic|bone diseases, metabolic
483022|NCT00108394|adynamic bone disease|adynamic bone disease
483023|NCT00108394|low bone turnover|low bone turnover
483024|NCT00108407|Alcohol Abuse/Dependence|alcohol abuse/dependence
483025|NCT00108407|Alcohol Use Disorders|alcohol use disorders
483026|NCT00108407|Cannabis Abuse/Dependence|cannabis abuse/dependence
483027|NCT00108407|Depression|depression
483028|NCT00108407|Dual diagnosis|dual diagnosis
483029|NCT00108407|Dysthymia|dysthymia
483030|NCT00108407|Stimulant Abuse/Dependence|stimulant abuse/dependence
483031|NCT00108407|Substance Use Disorders|substance use disorders
483032|NCT00108420|Prazosin|prazosin
483033|NCT00108420|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
483034|NCT00108446|Irritable Bowel Syndrome|irritable bowel syndrome
483035|NCT00108446|visceral hypersensitivity|visceral hypersensitivity
483036|NCT00108446|cutaneous hypersensitivity|cutaneous hypersensitivity
483037|NCT00108446|lidocaine|lidocaine
483038|NCT00108459|Obesity|obesity
483039|NCT00108459|Type 2 Diabetes|type 2 diabetes
483040|NCT00108459|Hyperlipidemia|hyperlipidemia
483041|NCT00108459|Insulin resistance|insulin resistance
483042|NCT00108485|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
483043|NCT00108485|Kidney Failure, Chronic|kidney failure, chronic
483044|NCT00108485|Hyperlipidemia|hyperlipidemia
483045|NCT00108485|Randomized Controlled Trials|randomized controlled trials
483046|NCT00108498|sleep apnea|sleep apnea
483047|NCT00108498|mirtazapine|mirtazapine
483048|NCT00108498|sleep|sleep
483049|NCT00108511|hypertriglyceridemia|hypertriglyceridemia
483050|NCT00108511|lipoproteins|lipoproteins
483051|NCT00108511|triglycerides|triglycerides
483052|NCT00108511|serum GPI-PLD (glycosylphosphatidylinositol-specific phospholipase D)|serum gpi-pld (glycosylphosphatidylinositol-specific phospholipase d)
483053|NCT00108524|anti-obesity agents|anti-obesity agents
483054|NCT00108524|diet therapy|diet therapy
483055|NCT00108524|diet, reducing|diet, reducing
483056|NCT00108524|obesity|obesity
483057|NCT00108524|overweight|overweight
483058|NCT00108524|risk factors|risk factors
483059|NCT00108524|weight loss|weight loss
483060|NCT00108537|smoking|smoking
483061|NCT00108537|nicotine|nicotine
483062|NCT00108537|drug therapy|drug therapy
483063|NCT00108537|smoking cessation|smoking cessation
483064|NCT00108550|analgesia|analgesia
483065|NCT00108550|antidepressant agents|antidepressant agents
483066|NCT00108550|back pain|back pain
483067|NCT00108550|pain|pain
483068|NCT00108563|Hepatitis C|hepatitis c
483069|NCT00108563|Depression|depression
483070|NCT00108563|Interferon-alpha|interferon-alpha
483071|NCT00108563|Citalopram|citalopram
483072|NCT00108563|ribavirin|ribavirin
483073|NCT00108563|antidepressive agents|antidepressive agents
483074|NCT00108576|anticonvulsant|anticonvulsant
483075|NCT00108576|anxiety|anxiety
483076|NCT00108576|divalproex|divalproex
483077|NCT00108576|PTSD|ptsd
483078|NCT00108589|s-adenosylmethionine|s-adenosylmethionine
483079|NCT00108589|fatty liver|fatty liver
483080|NCT00108589|obesity|obesity
483081|NCT00108589|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
483082|NCT00108602|sleep apnea|sleep apnea
483083|NCT00108602|stroke|stroke
483084|NCT00108602|ventilatory control|ventilatory control
483085|NCT00108628|Imagery|imagery
483086|NCT00108628|Nightmares|nightmares
483087|NCT00108628|Post-Traumatic Stress Disorder|post-traumatic stress disorder
483088|NCT00108628|Psychotherapy|psychotherapy
483089|NCT00108654|HIV-Negative|hiv-negative
483090|NCT00108654|Healthy|healthy
483094|NCT00108654|Healthy Volunteer|healthy volunteer
483095|NCT00108667|Parkinson's Disease|parkinson's disease
483096|NCT00108667|AMPA Antagonist|ampa antagonist
483097|NCT00108667|Dyskinesias|dyskinesias
483098|NCT00108667|Glutamate Antagonist|glutamate antagonist
483099|NCT00108667|Parkinson Disease|parkinson disease
483100|NCT00108667|PD|pd
483101|NCT00108680|Hemiparesis|hemiparesis
483102|NCT00108680|Rehabilitation|rehabilitation
483103|NCT00108680|Reaching|reaching
483104|NCT00108680|Interlimb Coupling|interlimb coupling
483105|NCT00108680|Cortical Excitability|cortical excitability
483106|NCT00108680|Stroke|stroke
483107|NCT00108706|Acute Stroke|acute stroke
483108|NCT00108706|Cerebrovascular Accident|cerebrovascular accident
483109|NCT00108706|Ischaemic Stroke|ischaemic stroke
483110|NCT00108706|Candesartan|candesartan
483111|NCT00108706|Angiotensin Receptor Blocker|angiotensin receptor blocker
483112|NCT00108771|Pain|pain
483113|NCT00108771|Chronic Pain|chronic pain
483114|NCT00108771|Osteoarthritis Pain|osteoarthritis pain
483115|NCT00108771|Osteoarthritis|osteoarthritis
483116|NCT00108784|reduced-energy-density diet|reduced-energy-density diet
483117|NCT00108784|fat-restricted diet|fat-restricted diet
483118|NCT00108784|fruit|fruit
483119|NCT00108784|vegetables|vegetables
483120|NCT00108784|ad libitum intake|ad libitum intake
483121|NCT00108784|weight loss|weight loss
483122|NCT00108784|obesity|obesity
483123|NCT00108810|Pain|pain
483124|NCT00108810|Osteoarthritis|osteoarthritis
483125|NCT00108810|OA|oa
483126|NCT00108810|Mild to Moderate Osteoarthritis (OA) Pain of the Knee|mild to moderate osteoarthritis (oa) pain of the knee
483127|NCT00108836|GAD|gad
483128|NCT00108836|Anxiety|anxiety
483129|NCT00108836|XBD173|xbd173
483130|NCT00108836|Generalized Anxiety Disorder|generalized anxiety disorder
483131|NCT00108862|Treatment Naive|treatment naive
483132|NCT00108862|TB|tb
483133|NCT00108862|HIV|hiv
483134|NCT00108862|Antiretroviral Agents|antiretroviral agents
483135|NCT00108862|Strategy Study|strategy study
483136|NCT00108875|Peptide vaccine therapy|peptide vaccine therapy
483137|NCT00108875|Survivin|survivin
483138|NCT00108901|prevention|prevention
483139|NCT00108901|children|children
483140|NCT00108901|diabetes|diabetes
483141|NCT00108901|overweight|overweight
483142|NCT00108901|obesity|obesity
483143|NCT00108901|metabolic syndrome|metabolic syndrome
483144|NCT00108901|exercise|exercise
483145|NCT00108901|insulin resistance|insulin resistance
483146|NCT00108901|female|female
483147|NCT00108901|male|male
483148|NCT00108901|black, African-American|black, african-american
483149|NCT00108901|white, Caucasian|white, caucasian
483150|NCT00108901|cognition|cognition
483151|NCT00108901|executive function|executive function
483152|NCT00108914|Perennial allergic rhinitis|perennial allergic rhinitis
483153|NCT00108914|pediatric|pediatric
483154|NCT00108927|Clinical trial|clinical trial
483155|NCT00108927|Diabetes|diabetes
483156|NCT00108927|Quality Improvement|quality improvement
483157|NCT00108940|stroke|stroke
483158|NCT00108940|ischemic stroke|ischemic stroke
483159|NCT00108940|siblings|siblings
483160|NCT00108953|Cancer|cancer
483161|NCT00108953|Liver Cancer|liver cancer
483162|NCT00108953|Hepatocellular carcinoma|hepatocellular carcinoma
483163|NCT00108953|HCC|hcc
483164|NCT00108979|Depression|depression
483165|NCT00108979|Major Depressive Disorder|major depressive disorder
483166|NCT00108979|Escitalopram|escitalopram
483167|NCT00108992|topical NSAID|topical nsaid
483168|NCT00108992|topical diclofenac|topical diclofenac
483169|NCT00109005|Response Rate|response rate
483170|NCT00109005|Toxicity|toxicity
483171|NCT00109005|Progression-Free Survival|progression-free survival
483172|NCT00109005|Overall Survival|overall survival
483173|NCT00109005|Pharmacokinetic|pharmacokinetic
483174|NCT00109005|Ocular Melanoma|ocular melanoma
483175|NCT00109018|Risk Assessment|risk assessment
483176|NCT00109018|Coronary Heart Disease|coronary heart disease
95183|NCT02693834|AFO|afo
483177|NCT00109018|Vascular Function|vascular function
483178|NCT00109018|Nitric Oxide Metabolites|nitric oxide metabolites
483179|NCT00109018|Blood Tests|blood tests
483181|NCT00109018|Flow-Mediated Dilation|flow-mediated dilation
483182|NCT00109018|Biomarker|biomarker
483183|NCT00109018|Endothelial Dysfunction|endothelial dysfunction
483184|NCT00109018|Coronary Artery Disease|coronary artery disease
483185|NCT00109018|CAD|cad
483186|NCT00109018|Coronary Artery Disease At Risk|coronary artery disease at risk
483187|NCT00109018|Healthy Volunteer|healthy volunteer
483188|NCT00109031|Cancer|cancer
483189|NCT00109031|Oncology|oncology
483190|NCT00109044|Depression|depression
483191|NCT00109044|Major Depressive Disorder|major depressive disorder
483192|NCT00109044|Escitalopram|escitalopram
483193|NCT00109057|Cancer|cancer
483194|NCT00109057|Advanced malignancies|advanced malignancies
483195|NCT00109070|Metastatic|metastatic
483196|NCT00109083|Migraine|migraine
483197|NCT00109083|Headaches|headaches
483198|NCT00109083|Migraine headaches|migraine headaches
483199|NCT00109083|Head pain|head pain
483200|NCT00109148|Obesity and obesity-related medical conditions|obesity and obesity-related medical conditions
483201|NCT00109161|Multiple Sclerosis, MS, CNS, Daclizumab|multiple sclerosis, ms, cns, daclizumab
483202|NCT00109174|Glutamate|glutamate
483203|NCT00109174|Excitatory Amino Acid|excitatory amino acid
483204|NCT00109174|Neurochemistry|neurochemistry
483205|NCT00109174|GABA|gaba
483206|NCT00109174|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
483207|NCT00109187|Moderate Persistent Asthma|moderate persistent asthma
483208|NCT00109187|Severe Persistent Asthma|severe persistent asthma
483209|NCT00109200|Allergic Asthma|allergic asthma
483210|NCT00109200|Severe Allergic Asthma|severe allergic asthma
483211|NCT00109213|Spinal Stenosis|spinal stenosis
483212|NCT00109213|Lumbar Spine|lumbar spine
483213|NCT00109213|Decompression|decompression
483214|NCT00109213|Fusion|fusion
483215|NCT00109213|Spondylolisthesis|spondylolisthesis
483216|NCT00109213|Prospective, randomized clinical trial|prospective, randomized clinical trial
483217|NCT00109226|Metastatic Colorectal Cancer|metastatic colorectal cancer
483218|NCT00109226|Cancer|cancer
483219|NCT00109239|Metastatic Breast Cancer|metastatic breast cancer
483220|NCT00109239|Metastatic|metastatic
483221|NCT00109239|Cancer|cancer
483222|NCT00109252|Plaque Psoriasis|plaque psoriasis
483223|NCT00109252|Topical|topical
483224|NCT00109265|Advanced Breast Cancer|advanced breast cancer
483225|NCT00109265|Metastatic Breast Cancer|metastatic breast cancer
483227|NCT00109278|Prevention of Measles|prevention of measles
486436|NCT00126984|Safety|safety
483229|NCT00109291|chronic kidney disease|chronic kidney disease
483231|NCT00109291|chronic renal failure|chronic renal failure
483232|NCT00109291|CRF|crf
483233|NCT00109291|dialysis|dialysis
483234|NCT00109291|erythropoietin|erythropoietin
483235|NCT00109291|EPO|epo
483236|NCT00109291|erythropoiesis stimulating agent|erythropoiesis stimulating agent
483237|NCT00109291|ESA|esa
483238|NCT00109291|Hematide™|hematide™
483239|NCT00109291|hemoglobin|hemoglobin
483240|NCT00109291|Hb|hb
483241|NCT00109291|Hgb|hgb
483242|NCT00109291|Omontys|omontys
483243|NCT00109291|peginesatide|peginesatide
483244|NCT00109291|red blood cell|red blood cell
483245|NCT00109291|red blood cell production|red blood cell production
483246|NCT00109304|Venezuelan Equine Encephalitis|venezuelan equine encephalitis
483247|NCT00109304|VEE|vee
483248|NCT00109304|Vaccine|vaccine
483249|NCT00109304|Provide protective immunity against VEE subtypes IA/B|provide protective immunity against vee subtypes ia/b
483250|NCT00109317|Moderate Plaque Psoriasis|moderate plaque psoriasis
483251|NCT00109317|Severe Plaque Psoriasis|severe plaque psoriasis
483252|NCT00109317|Topical|topical
483253|NCT00116766|mosquitoes|mosquitoes
483254|NCT00116766|malaria|malaria
483255|NCT00116766|vector control|vector control
483256|NCT00116766|plant-based|plant-based
483257|NCT00116779|Prostate Cancer|prostate cancer
483258|NCT00116779|Androgen ablation therapy|androgen ablation therapy
483259|NCT00116792|CAD|cad
483260|NCT00116792|Diabetes Mellitus|diabetes mellitus
483261|NCT00116792|Restenosis|restenosis
483262|NCT00116792|ppar gamma|ppar gamma
483263|NCT00116792|glitazone|glitazone
483264|NCT00116805|tenofovir|tenofovir
483265|NCT00116805|adefovir|adefovir
483266|NCT00116805|hepatitis B|hepatitis b
483267|NCT00116805|HBeAg Positive|hbeag positive
483268|NCT00116818|perennial allergic rhinitis|perennial allergic rhinitis
483269|NCT00116818|intranasal corticosteroid|intranasal corticosteroid
483270|NCT00116818|HPA axis function|hpa axis function
483271|NCT00116818|GW685698X|gw685698x
483272|NCT00116831|atheroma|atheroma
483273|NCT00116831|IVUS|ivus
483274|NCT00116831|Intravascular ultrasound|intravascular ultrasound
483275|NCT00116831|atherosclerosis|atherosclerosis
483276|NCT00116844|viral shedding|viral shedding
483277|NCT00116844|Recurrent|recurrent
483278|NCT00116844|herpes|herpes
483279|NCT00116844|genital herpes|genital herpes
483280|NCT00116870|CAD|cad
483281|NCT00116870|familial hypercholesterolemia|familial hypercholesterolemia
483282|NCT00116883|GW685698X|gw685698x
483283|NCT00116883|perennial allergic rhinitis|perennial allergic rhinitis
483284|NCT00116883|pediatric|pediatric
483285|NCT00116883|intranasal corticosteroid|intranasal corticosteroid
483286|NCT00116883|HPA axis function|hpa axis function
483287|NCT00116922|Diabetes|diabetes
483288|NCT00116922|Prevention.|prevention.
483289|NCT00116922|Rosiglitazone|rosiglitazone
483290|NCT00116922|Metformin|metformin
483291|NCT00116922|Lifestyle|lifestyle
483292|NCT00116922|Impaired glucose Tolerance|impaired glucose tolerance
483293|NCT00116935|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
483294|NCT00116935|GIST|gist
483295|NCT00116935|Sarcoma|sarcoma
483296|NCT00116935|Imatinib|imatinib
483297|NCT00116935|Adjuvant therapy|adjuvant therapy
483298|NCT00116935|KIT|kit
483299|NCT00116935|PDGFRA|pdgfra
483300|NCT00116935|Receptor tyrosine kinase|receptor tyrosine kinase
483301|NCT00116935|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
483302|NCT00116948|Osteoarthrosis|osteoarthrosis
483303|NCT00116948|RSA|rsa
483304|NCT00116948|DEXA|dexa
483305|NCT00116948|Hip arthroplasty|hip arthroplasty
483306|NCT00116948|Metal ion|metal ion
483307|NCT00116948|Inflammatory response|inflammatory response
483308|NCT00116948|Gait analysis|gait analysis
483309|NCT00116974|Dental scaling|dental scaling
483310|NCT00116987|physiologic pacing|physiologic pacing
483311|NCT00116987|ventricular pacing|ventricular pacing
483312|NCT00116987|hospitalizations|hospitalizations
483313|NCT00117000|testosterone|testosterone
483314|NCT00117000|food, formulated|food, formulated
483315|NCT00117000|malnutrition|malnutrition
483316|NCT00117000|undernutrition|undernutrition
483317|NCT00117000|aging|aging
483318|NCT00117000|aged|aged
483319|NCT00117000|aged, 80 and over|aged, 80 and over
483320|NCT00117000|frail elderly|frail elderly
483321|NCT00117013|Phase I|phase i
483322|NCT00117013|Antiangiogenesis|antiangiogenesis
483323|NCT00117013|Targeted Therapy|targeted therapy
483324|NCT00117013|Chronic Schedule|chronic schedule
483325|NCT00117013|VEGF|vegf
483326|NCT00117013|Cancer|cancer
483327|NCT00117013|Metastatic Solid Tumor|metastatic solid tumor
483328|NCT00117026|Diabetes Complications|diabetes complications
483332|NCT00117026|nerve function|nerve function
483230|NCT00109291|CKD|ckd
483333|NCT00117026|advanced glycation end products|advanced glycation end products
483338|NCT00117052|Clinical trial|clinical trial
483339|NCT00117052|Amgen|amgen
483340|NCT00117052|Secondary HyperParaThyroidism (SHPT)|secondary hyperparathyroidism (shpt)
483341|NCT00117052|Dialysis|dialysis
483342|NCT00117052|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
483343|NCT00117052|KDOQI|kdoqi
483344|NCT00117052|Cinacalcet|cinacalcet
483345|NCT00117065|Kidney transplant, Renal transplant|kidney transplant, renal transplant
483346|NCT00117065|Aranesp®, Darbepoetin alfa|aranesp®, darbepoetin alfa
483347|NCT00117065|Amgen, Q2W dosing, Q4W dosing|amgen, q2w dosing, q4w dosing
483348|NCT00117078|Kidney disease, Renal, CKD (Chronic Kidney Disease)|kidney disease, renal, ckd (chronic kidney disease)
483349|NCT00117078|CRI (Chronic Renal Insufficiency), Pre-dialysis, Amgen|cri (chronic renal insufficiency), pre-dialysis, amgen
483350|NCT00117078|Aranesp®, Darbepoetin alfa, QW dosing|aranesp®, darbepoetin alfa, qw dosing
483351|NCT00117078|Q2W dosing, Q4W dosing|q2w dosing, q4w dosing
483352|NCT00117078|Patient preference, Subject preference|patient preference, subject preference
483353|NCT00117091|Rheumatoid Arthritis|rheumatoid arthritis
483354|NCT00117091|RA|ra
483355|NCT00117091|Anakinra (Kineret®)|anakinra (kineret®)
483356|NCT00118105|recurrent colon cancer|recurrent colon cancer
483357|NCT00118105|stage IV colon cancer|stage iv colon cancer
483358|NCT00118105|recurrent rectal cancer|recurrent rectal cancer
483359|NCT00118105|stage IV rectal cancer|stage iv rectal cancer
483360|NCT00118105|liver metastases|liver metastases
483361|NCT00118131|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
483362|NCT00118131|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
483363|NCT00118131|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
483364|NCT00118196|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
483365|NCT00118196|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
483366|NCT00118196|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
483367|NCT00118196|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
483368|NCT00118222|adult mixed glioma|adult mixed glioma
483369|NCT00118222|adult anaplastic astrocytoma|adult anaplastic astrocytoma
483370|NCT00118222|recurrent adult brain tumor|recurrent adult brain tumor
483371|NCT00118222|adult giant cell glioblastoma|adult giant cell glioblastoma
483372|NCT00118222|adult gliosarcoma|adult gliosarcoma
483373|NCT00118261|stage IV rectal cancer|stage iv rectal cancer
483374|NCT00118261|stage IV colon cancer|stage iv colon cancer
483375|NCT00118261|recurrent rectal cancer|recurrent rectal cancer
483376|NCT00118261|recurrent colon cancer|recurrent colon cancer
483380|NCT00118300|stage III cervical cancer|stage iii cervical cancer
483381|NCT00118300|stage IVA cervical cancer|stage iva cervical cancer
483382|NCT00118300|recurrent cervical cancer|recurrent cervical cancer
483383|NCT00118300|stage III endometrial carcinoma|stage iii endometrial carcinoma
483384|NCT00118300|recurrent endometrial carcinoma|recurrent endometrial carcinoma
483385|NCT00118300|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
483386|NCT00118300|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
483387|NCT00118300|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
483388|NCT00118300|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
483389|NCT00118300|stage III vaginal cancer|stage iii vaginal cancer
483390|NCT00118300|stage IVA vaginal cancer|stage iva vaginal cancer
483391|NCT00118300|recurrent vaginal cancer|recurrent vaginal cancer
483392|NCT00118300|ovarian sarcoma|ovarian sarcoma
483393|NCT00118300|ovarian stromal cancer|ovarian stromal cancer
483394|NCT00118300|stage IV endometrial carcinoma|stage iv endometrial carcinoma
483395|NCT00118300|stage IB cervical cancer|stage ib cervical cancer
483396|NCT00118300|stage IIA cervical cancer|stage iia cervical cancer
483397|NCT00118300|stage IIB cervical cancer|stage iib cervical cancer
483398|NCT00118300|stage II vaginal cancer|stage ii vaginal cancer
483399|NCT00118300|stage I vaginal cancer|stage i vaginal cancer
483400|NCT00118313|stage II melanoma|stage ii melanoma
483401|NCT00118313|stage III melanoma|stage iii melanoma
483402|NCT00118313|stage IV melanoma|stage iv melanoma
483403|NCT00118326|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
483404|NCT00118326|disseminated neuroblastoma|disseminated neuroblastoma
483405|NCT00118326|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
483406|NCT00118326|recurrent neuroblastoma|recurrent neuroblastoma
483407|NCT00118326|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
483408|NCT00118326|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
483409|NCT00118326|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
483410|NCT00118326|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
483411|NCT00118326|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
483412|NCT00118326|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
483413|NCT00118326|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
483414|NCT00118326|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
483415|NCT00118326|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
483416|NCT00118326|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
483417|NCT00118326|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
483418|NCT00118326|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
483419|NCT00118326|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
483420|NCT00118326|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
483421|NCT00118326|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
483422|NCT00118326|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
483423|NCT00118339|oral complications|oral complications
483424|NCT00118339|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
483425|NCT00118339|stage I multiple myeloma|stage i multiple myeloma
483426|NCT00118339|stage II multiple myeloma|stage ii multiple myeloma
483427|NCT00118339|stage III multiple myeloma|stage iii multiple myeloma
483430|NCT00118378|Modafinil|modafinil
483431|NCT00118378|Depression|depression
483432|NCT00118391|Pathological Gambling|pathological gambling
483433|NCT00118391|CBT|cbt
483434|NCT00118391|CM|cm
483435|NCT00118404|Cognitive therapy|cognitive therapy
483436|NCT00118404|Antidepressants|antidepressants
483437|NCT00118404|Psychotherapy|psychotherapy
483438|NCT00118417|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
483439|NCT00118417|Anxiety|anxiety
483440|NCT00118417|Pharmacotherapy|pharmacotherapy
483441|NCT00118417|Cognitive behavioral therapy|cognitive behavioral therapy
483442|NCT00118417|CBT|cbt
483443|NCT00118430|Back Pain|back pain
483444|NCT00118430|Knee Pain|knee pain
483445|NCT00118430|Hip Pain|hip pain
483446|NCT00118430|Stepped Care|stepped care
483447|NCT00118430|Antidepressant|antidepressant
483448|NCT00118430|Relaxation Techniques|relaxation techniques
483449|NCT00118430|Exercise|exercise
483450|NCT00118443|Suicide Prevention|suicide prevention
483451|NCT00118443|Depression|depression
483452|NCT00118443|Adolescent|adolescent
483453|NCT00118443|Students|students
483454|NCT00118443|School Teachers|school teachers
483455|NCT00118456|Advanced cancers|advanced cancers
483456|NCT00118456|EGFR|egfr
483457|NCT00118456|Her2|her2
483458|NCT00118456|VEGFR|vegfr
483459|NCT00118469|Adolescent|adolescent
483460|NCT00118469|CBT|cbt
483461|NCT00118469|Parents|parents
483462|NCT00118482|vasovagal syncope|vasovagal syncope
483463|NCT00118482|randomized clinical trial|randomized clinical trial
483464|NCT00118482|quality of life|quality of life
483465|NCT00118495|female sexual dysfunction|female sexual dysfunction
483466|NCT00118495|FSD|fsd
483467|NCT00118495|arousal|arousal
483468|NCT00118495|orgasm|orgasm
483469|NCT00118495|desire|desire
483470|NCT00118495|Zestra|zestra
483471|NCT00118495|Mixed FSD|mixed fsd
483472|NCT00118495|Hypoactive sexual desire disorder|hypoactive sexual desire disorder
483473|NCT00118495|Sexual arousal disorder|sexual arousal disorder
483474|NCT00118495|Orgasmic disorder|orgasmic disorder
483475|NCT00118521|Anterior Knee Pain|anterior knee pain
483476|NCT00118534|addictive disorders|addictive disorders
483477|NCT00118534|clinical trial|clinical trial
483478|NCT00118534|cost effectiveness|cost effectiveness
483479|NCT00118534|mental health|mental health
483480|NCT00118534|military or environmental exposure|military or environmental exposure
483481|NCT00118534|multi-site trial|multi-site trial
483482|NCT00118534|nicotine|nicotine
483483|NCT00118534|nicotine replacement|nicotine replacement
483484|NCT00118534|post traumatic stress|post traumatic stress
483485|NCT00118534|post traumatic stress disorder|post traumatic stress disorder
483486|NCT00118534|psychiatric|psychiatric
483487|NCT00118534|psychological|psychological
483488|NCT00118534|PTSD|ptsd
483489|NCT00118534|smoking cessation|smoking cessation
483490|NCT00118534|smoking cessation medications|smoking cessation medications
483491|NCT00118534|substance abuse|substance abuse
483492|NCT00118547|Adherence|adherence
483493|NCT00118547|Medication|medication
483494|NCT00118547|Multiple Sclerosis|multiple sclerosis
483495|NCT00118560|Collateral Circulation|collateral circulation
483496|NCT00118560|Exercise Therapy|exercise therapy
483497|NCT00118560|Microcirculation|microcirculation
483498|NCT00118560|Oxygen|oxygen
483499|NCT00118560|Positron-emission tomography|positron-emission tomography
483500|NCT00118560|Walking|walking
483501|NCT00118573|abdominal aortic aneurysm|abdominal aortic aneurysm
483502|NCT00118573|randomized controlled trial|randomized controlled trial
483503|NCT00118573|endovascular aneurysm repair|endovascular aneurysm repair
483504|NCT00118586|Neuroanatomy|neuroanatomy
483505|NCT00118586|Brain Damage|brain damage
483506|NCT00118586|Dystonia|dystonia
483507|NCT00118586|Pathology|pathology
483508|NCT00118586|Brain Imaging|brain imaging
483509|NCT00118586|Spasmodic Dysphonia|spasmodic dysphonia
483510|NCT00118586|SD|sd
483511|NCT00118586|Focal Dystonia|focal dystonia
483515|NCT00118612|Specific Immunotherapy|specific immunotherapy
483516|NCT00118612|Allergy Vaccination|allergy vaccination
483517|NCT00118612|Allergenicity|allergenicity
483518|NCT00118625|Allergy|allergy
483519|NCT00118625|Specific Immunotherapy|specific immunotherapy
483520|NCT00118625|Adjuvant|adjuvant
483521|NCT00118625|Allergy Vaccination|allergy vaccination
483522|NCT00118625|Allergenicity|allergenicity
483523|NCT00118638|Non-myeloid malignancy|non-myeloid malignancy
483524|NCT00118638|Darbepoetin alfa|darbepoetin alfa
483525|NCT00118638|Clinical Trial|clinical trial
483526|NCT00118651|pneumonia|pneumonia
483527|NCT00118651|chest x-ray|chest x-ray
483528|NCT00118651|diagnosis|diagnosis
483529|NCT00118664|Septic Shock|septic shock
483530|NCT00118664|Thrombocytopenia|thrombocytopenia
483531|NCT00118664|Multiple Organ Failure|multiple organ failure
483532|NCT00118664|Pediatric|pediatric
483533|NCT00118677|HIV Infections|hiv infections
483534|NCT00118690|bronchospasm|bronchospasm
483535|NCT00118690|asthma|asthma
483536|NCT00118703|nonallergic rhinitis|nonallergic rhinitis
483537|NCT00118703|GW685698X|gw685698x
483538|NCT00118703|VMR|vmr
483539|NCT00118703|vasomotor rhinitis|vasomotor rhinitis
483540|NCT00118716|asthma|asthma
483541|NCT00118716|bronchospasm|bronchospasm
483542|NCT00118729|Ragweed|ragweed
483543|NCT00118729|GW685698X|gw685698x
483544|NCT00118729|seasonal allergic rhinitis|seasonal allergic rhinitis
483545|NCT00118729|onset|onset
483546|NCT00118768|Genotype-1, Chronic Hepatitis C|genotype-1, chronic hepatitis c
483547|NCT00118781|ventilator-associated pneumonia|ventilator-associated pneumonia
483548|NCT00118781|VAP|vap
483549|NCT00118781|pneumonia|pneumonia
483550|NCT00118781|ICU infection|icu infection
483551|NCT00118794|uncomplicated malaria|uncomplicated malaria
483552|NCT00118794|G6PD deficiency|g6pd deficiency
483553|NCT00118794|haemolytic anaemia|haemolytic anaemia
483554|NCT00118794|Lapdap|lapdap
483555|NCT00118794|Artemsinin based combination treatment|artemsinin based combination treatment
483556|NCT00118794|compliance|compliance
483557|NCT00118794|pragmatic trials|pragmatic trials
483558|NCT00118807|malaria treatment|malaria treatment
483559|NCT00118807|artemisinin based combination therapy|artemisinin based combination therapy
483560|NCT00118807|Plasmodium falciparum|plasmodium falciparum
483561|NCT00118807|pragmatic trial|pragmatic trial
483562|NCT00118807|effectiveness|effectiveness
483563|NCT00118820|Dry socket|dry socket
483564|NCT00118820|Third molar|third molar
483565|NCT00118820|Infection|infection
483566|NCT00118820|postop-infection|postop-infection
483567|NCT00118820|Antibiotic efficacy|antibiotic efficacy
483568|NCT00118820|Infection characterized by pus,erythema,edema and pain|infection characterized by pus,erythema,edema and pain
483569|NCT00118833|Social Anxiety Disorder|social anxiety disorder
483570|NCT00118833|Social Phobia|social phobia
482820|NCT00107757|pediatric|pediatric
483571|NCT00118833|Generalized Anxiety Disorder|generalized anxiety disorder
483572|NCT00118833|Hypericum|hypericum
483573|NCT00118833|St. John's wort|st. john's wort
483574|NCT00118833|Medicine, Herbal|medicine, herbal
483575|NCT00118833|Complementary Therapies|complementary therapies
483576|NCT00118846|Women|women
483577|NCT00118846|Complementary and Alternative Medicine|complementary and alternative medicine
483578|NCT00118846|CAM|cam
483579|NCT00118859|Back Pain|back pain
483580|NCT00118859|Integrative Care|integrative care
483581|NCT00118859|Acupuncture|acupuncture
483582|NCT00118859|Chiropractic|chiropractic
483583|NCT00118859|Exercise|exercise
483584|NCT00118859|Massage Therapy|massage therapy
483585|NCT00118859|Mind-Body Therapy|mind-body therapy
483586|NCT00118859|Nutritional Counseling|nutritional counseling
483587|NCT00118859|Complementary Therapies|complementary therapies
483588|NCT00118859|Complementary and Alternative Medicine|complementary and alternative medicine
483589|NCT00118872|Growth and Development|growth and development
483590|NCT00118872|Pakistan|pakistan
483591|NCT00118872|Weaning|weaning
483592|NCT00118872|Probiotics|probiotics
483593|NCT00118872|Infant|infant
483594|NCT00118872|Lactobacillus GG|lactobacillus gg
483595|NCT00118885|Shingles|shingles
483596|NCT00118885|depression|depression
483597|NCT00118885|varicella zoster virus|varicella zoster virus
483598|NCT00118885|alternative medicine|alternative medicine
483599|NCT00118885|psychoneuroimmunology|psychoneuroimmunology
483600|NCT00118898|Treatment Naive|treatment naive
483601|NCT00118911|Adult|adult
483602|NCT00118911|ADHD|adhd
483603|NCT00118911|ADD|add
483604|NCT00118911|CBT|cbt
483605|NCT00118911|Relaxation Techniques|relaxation techniques
483606|NCT00118911|Education|education
483607|NCT00118924|Dengue Vaccine|dengue vaccine
483608|NCT00118924|Tick-Borne Illnesses|tick-borne illnesses
483609|NCT00118924|Flavivirus|flavivirus
483610|NCT00118976|diabetic nephropathy|diabetic nephropathy
483611|NCT00118976|type 1 diabetes|type 1 diabetes
483612|NCT00118976|albuminuria|albuminuria
483613|NCT00118976|hypertension|hypertension
483614|NCT00118989|Curcumin|curcumin
483615|NCT00118989|chemoprevention|chemoprevention
483616|NCT00118989|adenomatous polyps|adenomatous polyps
483617|NCT00118989|colorectal cancer|colorectal cancer
483618|NCT00119002|randomized clinical trial|randomized clinical trial
483619|NCT00119002|placebo-controlled|placebo-controlled
483620|NCT00119002|double-blind|double-blind
483621|NCT00119002|double-masked|double-masked
483622|NCT00119002|infant|infant
483623|NCT00119002|dexamethasone|dexamethasone
483624|NCT00119002|wheezing|wheezing
483625|NCT00119015|perennial allergic rhinitis|perennial allergic rhinitis
483626|NCT00119028|Quality Improvement|quality improvement
483627|NCT00119028|Cluster Randomized Trial|cluster randomized trial
483628|NCT00119028|Care Model|care model
483629|NCT00119041|Diabetes Mellitus|diabetes mellitus
483630|NCT00119041|Telemedicine|telemedicine
483631|NCT00119041|Referral|referral
483632|NCT00119041|Consultation|consultation
483633|NCT00119054|Hypertension|hypertension
483634|NCT00119054|Diabetes Mellitus|diabetes mellitus
483635|NCT00119054|Telemedicine|telemedicine
483636|NCT00119054|Nursing Care|nursing care
483637|NCT00119067|Anthrax|anthrax
483638|NCT00119067|Vaccine|vaccine
483639|NCT00119067|Immunogenicity|immunogenicity
483640|NCT00119067|Reactogenicity|reactogenicity
483641|NCT00119080|Meningococcal carriage|meningococcal carriage
483642|NCT00119080|Conjugate vaccine|conjugate vaccine
483643|NCT00119093|Antiretroviral therapy|antiretroviral therapy
483645|NCT00119093|Adherence|adherence
483646|NCT00119093|Viral Load|viral load
483647|NCT00119093|Opportunistic illness|opportunistic illness
483648|NCT00119106|HIV|hiv
483649|NCT00119106|Prevention|prevention
483650|NCT00119106|Tenofovir|tenofovir
483651|NCT00119106|HIV Seronegativity|hiv seronegativity
483652|NCT00119119|Hepatitis C|hepatitis c
483653|NCT00119119|Liver Cirrhosis|liver cirrhosis
483654|NCT00119119|Tocopherols|tocopherols
483655|NCT00119132|intermittent preventive treatment|intermittent preventive treatment
483656|NCT00119132|effectiveness|effectiveness
483657|NCT00119132|malaria|malaria
483658|NCT00119145|antimalarial drugs|antimalarial drugs
483659|NCT00119145|efficacy|efficacy
483660|NCT00119145|safety|safety
483661|NCT00119145|trial|trial
483662|NCT00119158|THerapy for acute moderate to severe flares|therapy for acute moderate to severe flares
483663|NCT00119171|Safety|safety
483664|NCT00119171|tolerability|tolerability
483665|NCT00119171|dose limiting toxicity|dose limiting toxicity
483666|NCT00119171|solid tumors|solid tumors
483667|NCT00119171|capecitabine|capecitabine
483668|NCT00119184|anesthesia|anesthesia
483669|NCT00119184|breech|breech
483670|NCT00119184|external cephalic version|external cephalic version
483671|NCT00119184|spinal|spinal
483672|NCT00119184|success|success
483673|NCT00119184|anesthesia,spinal|anesthesia,spinal
623342|NCT00673049|871|871
483674|NCT00119197|watery diarrhea|watery diarrhea
483675|NCT00119197|cholera vaccine|cholera vaccine
483676|NCT00119210|Tobacco use cessation|tobacco use cessation
483677|NCT00119210|Bupropion|bupropion
483678|NCT00119210|Zyban|zyban
483679|NCT00119210|Puerperium|puerperium
483680|NCT00119301|recurrent osteosarcoma|recurrent osteosarcoma
483681|NCT00119314|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
483682|NCT00119314|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
483683|NCT00119340|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
483684|NCT00119340|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
483685|NCT00119340|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
483686|NCT00119340|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
483687|NCT00119379|lipoatrophy|lipoatrophy
483688|NCT00119379|mitochondria|mitochondria
483689|NCT00119379|HIV|hiv
483690|NCT00119379|treatment experienced|treatment experienced
483691|NCT00119405|Lipoatrophy|lipoatrophy
483692|NCT00119405|Mitochondria|mitochondria
483693|NCT00119405|Treatment Naive|treatment naive
483694|NCT00119418|hot flash|hot flash
483695|NCT00119418|menopause|menopause
483696|NCT00119418|herbal medicine|herbal medicine
483697|NCT00119418|kampo|kampo
484103|NCT00112515|depression|depression
483698|NCT00119418|alternative medicine|alternative medicine
483699|NCT00119431|Hereditary angioedema type I (MeSH: angioneurotic edema, complement 1 inactivators)|hereditary angioedema type i (mesh: angioneurotic edema, complement 1 inactivators)
483700|NCT00119444|PET|pet
483701|NCT00119444|Periacetabular osteotomy|periacetabular osteotomy
483702|NCT00119457|antithrombotic agents|antithrombotic agents
483703|NCT00119457|anticoagulants|anticoagulants
483704|NCT00119457|prophylaxis|prophylaxis
483705|NCT00119457|embolism|embolism
483706|NCT00119457|deep vein thrombosis|deep vein thrombosis
483707|NCT00119457|hip fracture|hip fracture
483709|NCT00119483|testosterone|testosterone
483710|NCT00119483|hypogonadal|hypogonadal
483711|NCT00119483|aging|aging
483712|NCT00119483|body composition|body composition
483713|NCT00119483|quality og life|quality og life
483714|NCT00119483|Muscle strength|muscle strength
483715|NCT00119483|Aging male|aging male
483716|NCT00119496|Corticosteroid|corticosteroid
483717|NCT00119496|Rosiglitazone|rosiglitazone
483718|NCT00119496|Theophylline|theophylline
483719|NCT00119496|Beclomethasone|beclomethasone
483720|NCT00119496|Inflammation|inflammation
483721|NCT00119496|Asthma|asthma
483722|NCT00119496|Smoking|smoking
483723|NCT00119496|Pulmonary|pulmonary
483724|NCT00119509|Cervix Neoplasms|cervix neoplasms
483725|NCT00119509|Vaginal smears|vaginal smears
483726|NCT00119509|Papillomavirus - Human|papillomavirus - human
483727|NCT00119522|wheelchairs|wheelchairs
483728|NCT00119522|falls|falls
483729|NCT00119522|spinal cord injury|spinal cord injury
483730|NCT00119522|accidental falls|accidental falls
483731|NCT00119522|safety|safety
483732|NCT00119535|Diabetes mellitus|diabetes mellitus
483733|NCT00119535|Diabetic retinopathy|diabetic retinopathy
483734|NCT00119535|Organizational change|organizational change
483735|NCT00119535|Quality improvement|quality improvement
483736|NCT00119535|Quasi-experimental|quasi-experimental
483737|NCT00119548|HIV Rapid Testing|hiv rapid testing
483738|NCT00119548|Cost-effectiveness|cost-effectiveness
483739|NCT00119548|HIV Seronegativity|hiv seronegativity
483740|NCT00119561|Caregiver|caregiver
483741|NCT00119561|Dementia|dementia
483742|NCT00119561|Alzheimer Disease|alzheimer disease
483743|NCT00119561|Telephone|telephone
483744|NCT00119561|Randomized Controlled Trials|randomized controlled trials
483745|NCT00119574|Randomized Controlled Trial|randomized controlled trial
483746|NCT00119574|Quality of Health Care|quality of health care
483747|NCT00119574|Health Services Research|health services research
483748|NCT00119574|Guidelines|guidelines
483749|NCT00119574|Medical Informatics Computing|medical informatics computing
483750|NCT00119574|Services, Mental Health|services, mental health
483751|NCT00119574|Medicine, Evidence-Based|medicine, evidence-based
483752|NCT00119574|Quality Assurance, Healthcare|quality assurance, healthcare
483753|NCT00119574|Quality Indicators, Health Care|quality indicators, health care
483754|NCT00119574|Veterans|veterans
483755|NCT00119587|Hemodialysis|hemodialysis
483756|NCT00119587|darbepoetin alfa|darbepoetin alfa
483757|NCT00119587|Clinical Trial|clinical trial
483758|NCT00119587|Amgen|amgen
483759|NCT00119600|Non-myeloid malignancy|non-myeloid malignancy
483760|NCT00119600|Clinical Trial|clinical trial
483761|NCT00119613|Oncology|oncology
483762|NCT00119613|Clinical Trial|clinical trial
483763|NCT00119613|Hemoglobin|hemoglobin
483764|NCT00119613|Darbepoetin alfa|darbepoetin alfa
483765|NCT00119613|Survival|survival
483766|NCT00119613|Carboplatin|carboplatin
483767|NCT00119613|Cisplatin|cisplatin
483768|NCT00119613|Etoposide|etoposide
483769|NCT00119613|Extensive Stage Small Cell Lung Cancer|extensive stage small cell lung cancer
483019|NCT00108394|Dialysis|dialysis
483770|NCT00119626|Stroke, Acute|stroke, acute
483771|NCT00119626|Cerebrovascular Stroke|cerebrovascular stroke
483772|NCT00119652|Bipolar disorder|bipolar disorder
483773|NCT00119652|bipolar depression|bipolar depression
483774|NCT00119652|depression|depression
483775|NCT00119665|Postmenopausal symptoms|postmenopausal symptoms
483776|NCT00119665|Hot Flashes|hot flashes
483777|NCT00119665|Postmenopausal Hot Flashes|postmenopausal hot flashes
483779|NCT00119717|acute|acute
483780|NCT00119717|ischemic|ischemic
483781|NCT00119717|stroke|stroke
483782|NCT00119717|randomized|randomized
483783|NCT00119717|device|device
483784|NCT00119717|treatment|treatment
483785|NCT00119730|Fludarabine|fludarabine
483786|NCT00119730|Mitoxantrone|mitoxantrone
483787|NCT00119730|Rituximab|rituximab
483788|NCT00119730|Zevalin|zevalin
483789|NCT00119730|Mantle Cell Lymphoma|mantle cell lymphoma
483790|NCT00119730|Relapsed Mantle Cell Lymphoma|relapsed mantle cell lymphoma
483791|NCT00119743|Prophylaxis pneumococcal vaccine|prophylaxis pneumococcal vaccine
483792|NCT00119756|Schizophrenia|schizophrenia
483793|NCT00119756|Intramuscular injection|intramuscular injection
483794|NCT00119756|Deltoid muscle|deltoid muscle
483795|NCT00119756|Gluteus muscle|gluteus muscle
483796|NCT00119756|Paliperidone palmitate|paliperidone palmitate
483797|NCT00119769|HIV|hiv
483798|NCT00119769|immune stimulation|immune stimulation
483799|NCT00119769|lipodystrophy|lipodystrophy
483800|NCT00119769|growth hormone|growth hormone
483801|NCT00119769|recombinant growth hormone|recombinant growth hormone
483802|NCT00119769|Treatment Experienced|treatment experienced
483803|NCT00119834|Heart Failure|heart failure
483804|NCT00119834|Intermacs|intermacs
483805|NCT00119834|Pedimacs|pedimacs
483806|NCT00119834|Mechanical Circulatory Support|mechanical circulatory support
483807|NCT00119834|Ventricular Assist Device|ventricular assist device
483808|NCT00119873|HIV Preventive Vaccine|hiv preventive vaccine
483809|NCT00119873|AIDS Vaccines|aids vaccines
483810|NCT00119873|Adenoviridae|adenoviridae
483811|NCT00119899|Colorectal Cancer;|colorectal cancer;
483813|NCT00119899|Metastases;|metastases;
483814|NCT00119899|Resection;|resection;
483815|NCT00119899|Fluorodeoxyglucose;|fluorodeoxyglucose;
483816|NCT00119899|Tomography;|tomography;
483817|NCT00119899|Positron-Emission|positron-emission
483818|NCT00119912|screening|screening
483819|NCT00119912|flexible sigmoidoscopy|flexible sigmoidoscopy
483820|NCT00119912|fecal occult blood|fecal occult blood
483826|NCT00119925|health care implementation|health care implementation
483827|NCT00119925|intervention|intervention
483828|NCT00119925|gynecology|gynecology
483829|NCT00119938|Disease management|disease management
483830|NCT00119938|Patient access to records|patient access to records
483831|NCT00119938|Medical records systems, computerized|medical records systems, computerized
483832|NCT00119938|Questionnaires|questionnaires
483833|NCT00119938|Physician-patient relations|physician-patient relations
483834|NCT00119938|Medical records|medical records
483835|NCT00119951|Behavioral|behavioral
483836|NCT00119977|cartilage thickness|cartilage thickness
483837|NCT00119977|RSA|rsa
483838|NCT00119977|DEXA|dexa
483839|NCT00119977|ultra sound|ultra sound
483840|NCT00119977|MRI|mri
483841|NCT00119977|osteoarthritis|osteoarthritis
483842|NCT00119977|periacetabular osteotomy|periacetabular osteotomy
483843|NCT00119990|vasopressin|vasopressin
483844|NCT00119990|icodextrin|icodextrin
483845|NCT00119990|cardiac output|cardiac output
483846|NCT00120003|Acute stroke|acute stroke
483847|NCT00120003|Elevated blood pressure|elevated blood pressure
483848|NCT00120003|Blood pressure lowering treatment|blood pressure lowering treatment
483849|NCT00120016|cancer prevention|cancer prevention
483850|NCT00120016|diet|diet
483851|NCT00120016|nutrition|nutrition
483852|NCT00120016|polyunsaturated fat|polyunsaturated fat
483853|NCT00120016|olive oil|olive oil
483854|NCT00120029|weight loss|weight loss
483855|NCT00120029|survivorship|survivorship
483856|NCT00120029|breast ductal lavage|breast ductal lavage
483857|NCT00120029|exercise|exercise
483858|NCT00120029|diet|diet
483859|NCT00120042|Abortion|abortion
483860|NCT00120042|Retained placenta|retained placenta
483861|NCT00120042|Hemorrhage|hemorrhage
483862|NCT00120042|Postpartum ultrasound|postpartum ultrasound
483863|NCT00120081|Vaccine|vaccine
483864|NCT00120081|Hookworm|hookworm
483865|NCT00120081|Phase 1|phase 1
483866|NCT00120081|Human Hookworm Infection|human hookworm infection
483867|NCT00120081|Na-ASP-2|na-asp-2
483868|NCT00120094|Syncope|syncope
483869|NCT00120094|Electrocardiographic monitoring|electrocardiographic monitoring
483870|NCT00120120|Radiculopathy|radiculopathy
483871|NCT00120120|Back Pain|back pain
483872|NCT00120120|Lumbar Pain|lumbar pain
483873|NCT00120120|CC-5013|cc-5013
483874|NCT00120120|Revlimid|revlimid
483875|NCT00120120|Lenalidomide|lenalidomide
483876|NCT00120133|Osteoporosis|osteoporosis
483877|NCT00120133|Bisphosphonates|bisphosphonates
483878|NCT00120133|Atorvastatin|atorvastatin
483879|NCT00120159|Necrotizing Enterocolitis|necrotizing enterocolitis
483880|NCT00120172|colorectal|colorectal
483881|NCT00120172|metastatic|metastatic
483882|NCT00120172|elderly|elderly
483883|NCT00120172|metastatic colorectal cancer|metastatic colorectal cancer
483884|NCT00120185|HIV Infections|hiv infections
483885|NCT00120185|Interleukin-2|interleukin-2
483886|NCT00120198|NHL|nhl
483887|NCT00120198|elderly|elderly
483888|NCT00120224|Mifepristone|mifepristone
483889|NCT00120224|Medical abortion|medical abortion
483890|NCT00120224|Ultrasound|ultrasound
483891|NCT00120237|Postpartum hemorrhage|postpartum hemorrhage
483892|NCT00120237|Misoprostol|misoprostol
483893|NCT00120237|Maternal morbidity|maternal morbidity
483894|NCT00120237|Developing countries|developing countries
483895|NCT00120237|Traditional birth attendants|traditional birth attendants
483896|NCT00120250|PTSD|ptsd
483897|NCT00120250|Sleep disturbance|sleep disturbance
483898|NCT00120250|Eszopiclone|eszopiclone
483899|NCT00120250|Double-blind|double-blind
483900|NCT00120250|Crossover|crossover
483901|NCT00120263|Plasma Exchange|plasma exchange
483902|NCT00120263|Myeloma|myeloma
483903|NCT00120263|Acute renal failure|acute renal failure
483904|NCT00120263|Light Chains|light chains
483905|NCT00120263|Bence Jones Proteins|bence jones proteins
483906|NCT00120263|Kidney Function|kidney function
483907|NCT00120276|Functional Mitral Regurgitation (FMR)|functional mitral regurgitation (fmr)
483908|NCT00120276|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
484788|NCT00121524|epinephrine|epinephrine
483909|NCT00120276|Less invasive repair|less invasive repair
483910|NCT00120276|Surgical MV repair|surgical mv repair
483911|NCT00120276|Mitral Valve Repair|mitral valve repair
483912|NCT00120276|Heart Failure|heart failure
483913|NCT00120276|Left Ventricular Dysfunction|left ventricular dysfunction
483914|NCT00120302|Randomised|randomised
483915|NCT00120302|Placebo-controlled|placebo-controlled
483916|NCT00120302|Elidel|elidel
483917|NCT00120302|Quality of Life|quality of life
483918|NCT00120302|Atopic Eczema|atopic eczema
483919|NCT00120315|dyspepsia|dyspepsia
483920|NCT00120315|discontinuation|discontinuation
483921|NCT00120315|Primary health care|primary health care
483922|NCT00120315|Helicobacter pylori|helicobacter pylori
483923|NCT00120315|Proton Pump Inhibitor|proton pump inhibitor
483924|NCT00120315|Histamine-2-receptor-antagonist|histamine-2-receptor-antagonist
483925|NCT00120328|serum creatinine|serum creatinine
483926|NCT00120328|end stage renal disease|end stage renal disease
483927|NCT00120328|cardiovascular mortality|cardiovascular mortality
483928|NCT00120328|cardiovascular morbidity|cardiovascular morbidity
483929|NCT00120328|non-cardiovascular mortality|non-cardiovascular mortality
483930|NCT00120328|non-cardiovascular morbidity|non-cardiovascular morbidity
483932|NCT00120354|Antiviral Resistance|antiviral resistance
483933|NCT00120354|Drug Withdrawal|drug withdrawal
483934|NCT00120354|Immune Response|immune response
483935|NCT00120354|Hepatitis B Surface Antigen|hepatitis b surface antigen
483936|NCT00120354|Liver Biopsy|liver biopsy
483937|NCT00120354|Hepatitis B|hepatitis b
483938|NCT00120367|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
483939|NCT00120367|HIV infections|hiv infections
483940|NCT00120367|HIV Fusion Inhibitors|hiv fusion inhibitors
483941|NCT00120380|Idiopathic pulmonary arterial hypertension|idiopathic pulmonary arterial hypertension
483942|NCT00120393|Treatment Experienced|treatment experienced
483943|NCT00120406|Peripheral Arterial Disease (PAD)|peripheral arterial disease (pad)
483944|NCT00120406|Peripheral Vascular Disease|peripheral vascular disease
483945|NCT00120406|Drug-Eluting Stent|drug-eluting stent
483946|NCT00120406|Drug-Coated Stent|drug-coated stent
483947|NCT00120419|HIV-1 infection|hiv-1 infection
483948|NCT00120419|immunomodulatory therapy|immunomodulatory therapy
483949|NCT00120419|Treatment Naive|treatment naive
483950|NCT00120432|single dose|single dose
483951|NCT00120432|mydriatic drug|mydriatic drug
483952|NCT00120432|pupillary dilation|pupillary dilation
483953|NCT00120445|retinal detachment|retinal detachment
483954|NCT00120445|pneumatic retinopexy|pneumatic retinopexy
483955|NCT00120458|Black Cohosh|black cohosh
483956|NCT00120458|Cimicifuga|cimicifuga
483958|NCT00120458|Women|women
483959|NCT00120458|Complementary and Alternative Medicine|complementary and alternative medicine
483960|NCT00120471|Perinatal Transmission|perinatal transmission
483961|NCT00120471|MTCT|mtct
483962|NCT00120471|HIV Seronegativity|hiv seronegativity
483963|NCT00120484|Circadian Rhythm|circadian rhythm
483964|NCT00120484|Biological Clock|biological clock
483965|NCT00120484|Complementary and Alternative Medicine|complementary and alternative medicine
483966|NCT00120497|short stature|short stature
483967|NCT00120497|intrauterine growth restriction|intrauterine growth restriction
483968|NCT00120497|insulin resistance|insulin resistance
483969|NCT00120497|intramyocellular lipid|intramyocellular lipid
483970|NCT00120497|small for gestational age|small for gestational age
483971|NCT00120497|glucose tolerance|glucose tolerance
483972|NCT00120510|Treatment Naive|treatment naive
483973|NCT00120510|TB|tb
95184|NCT02693834|gait symmetry|gait symmetry
483226|NCT00109265|Cancer|cancer
483974|NCT00120523|Atopic dermatitis, children, infants, pimecrolimus|atopic dermatitis, children, infants, pimecrolimus
483975|NCT00120536|Type 2 diabetes|type 2 diabetes
483976|NCT00120536|vildagliptin|vildagliptin
483977|NCT00120549|Assisted Hatching|assisted hatching
483978|NCT00120549|Cleavage Stage, Ovum|cleavage stage, ovum
483979|NCT00120549|Embryo Transfer|embryo transfer
483980|NCT00120549|Pregnancy|pregnancy
483981|NCT00120549|Embryo Implantation|embryo implantation
483982|NCT00120562|weight loss surgery|weight loss surgery
483983|NCT00120562|gastric bypass surgery|gastric bypass surgery
483984|NCT00120575|Hemofiltration|hemofiltration
483985|NCT00120575|Pediatrics|pediatrics
483986|NCT00120588|brain protection|brain protection
483987|NCT00120588|white matter injury|white matter injury
483988|NCT00120588|neurodevelopmental sequelae|neurodevelopmental sequelae
483989|NCT00120588|magnesium sulfate|magnesium sulfate
483990|NCT00120588|intraventricular hemorrhage|intraventricular hemorrhage
483991|NCT00120601|treatment|treatment
483992|NCT00120601|alcohol|alcohol
483993|NCT00120601|dependence|dependence
483994|NCT00120601|medication|medication
483995|NCT00120614|Premature Infant|premature infant
483996|NCT00120614|Premature Birth|premature birth
483997|NCT00120614|Parenting Interventions|parenting interventions
483998|NCT00120614|NICU Interventional studies|nicu interventional studies
483999|NCT00120614|Parental coping|parental coping
484000|NCT00120614|Low birthweight infant|low birthweight infant
484001|NCT00120614|Coping Behavior|coping behavior
484002|NCT00120614|Infant, Premature|infant, premature
484003|NCT00120627|Randomized Controlled Trial|randomized controlled trial
484004|NCT00120627|Intervention Study|intervention study
484005|NCT00120627|Mindfulness|mindfulness
484006|NCT00120627|Complementary Therapy|complementary therapy
484007|NCT00120627|Mind-Body Relations (Metaphysics)|mind-body relations (metaphysics)
484009|NCT00120627|Meditation|meditation
484010|NCT00120627|Qualitative Analysis|qualitative analysis
484011|NCT00120640|Premature birth|premature birth
484012|NCT00120640|Premature labor|premature labor
484013|NCT00120640|Progesterone|progesterone
484014|NCT00120653|Reglan|reglan
484015|NCT00120653|Prolactin|prolactin
484016|NCT00120653|MDS|mds
484017|NCT00120653|Metoclopramide|metoclopramide
484018|NCT00120653|Myelodysplastic Syndrome|myelodysplastic syndrome
484019|NCT00120666|Exercise|exercise
484020|NCT00120666|Stimulation|stimulation
484021|NCT00120666|Nerve|nerve
484022|NCT00120666|Electrical|electrical
484023|NCT00120666|Muscle|muscle
484024|NCT00120666|Healthy Volunteer|healthy volunteer
484025|NCT00120666|HV|hv
484026|NCT00120679|non-small cell lung cancer|non-small cell lung cancer
484027|NCT00120679|darbepoetin alfa|darbepoetin alfa
484028|NCT00120679|Amgen|amgen
484029|NCT00112216|Immunotherapy|immunotherapy
484031|NCT00112216|Melanoma|melanoma
484032|NCT00112216|Melan-A/Mart-1 peptide|melan-a/mart-1 peptide
484033|NCT00112216|Flu peptide|flu peptide
484034|NCT00112216|Mage-A10 peptide|mage-a10 peptide
484035|NCT00112216|SB AS-2 adjuvant|sb as-2 adjuvant
484036|NCT00112216|Montanide adjuvant|montanide adjuvant
484037|NCT00112229|Immunotherapy|immunotherapy
484038|NCT00112229|Vaccination|vaccination
484039|NCT00112229|Melanoma|melanoma
484040|NCT00112229|Melan-A/Mart-1 peptide|melan-a/mart-1 peptide
484041|NCT00112229|Tyrosinase peptide|tyrosinase peptide
484042|NCT00112229|CpG|cpg
484043|NCT00112229|Montanide|montanide
484044|NCT00112242|Immunotherapy|immunotherapy
484045|NCT00112242|Vaccination|vaccination
484046|NCT00112242|Melanoma|melanoma
484047|NCT00112242|Melan-A/Mart-1 peptide|melan-a/mart-1 peptide
484048|NCT00112242|MAGE-A10 peptide|mage-a10 peptide
484049|NCT00112242|NY-ESO-1 peptide|ny-eso-1 peptide
484050|NCT00112242|Montanide|montanide
484051|NCT00112255|Chlamydia trachomatis|chlamydia trachomatis
484052|NCT00112255|Chlamydia infections|chlamydia infections
484053|NCT00112255|Randomized controlled trials|randomized controlled trials
484054|NCT00112255|Contact tracing|contact tracing
484055|NCT00112255|Family practice|family practice
484056|NCT00112268|randomized controlled trial|randomized controlled trial
484057|NCT00112268|primary health care|primary health care
484058|NCT00112268|smoking cessation|smoking cessation
484059|NCT00112281|"shock, cardiogenic, myocardial infarction"|"shock, cardiogenic, myocardial infarction"
484060|NCT00112294|Non-Small Cell Lung Cancer|non-small cell lung cancer
484062|NCT00112307|Brachytherapy|brachytherapy
484063|NCT00112307|Carcinoma|carcinoma
484064|NCT00112307|Cervix|cervix
484065|NCT00112307|Uterus|uterus
484066|NCT00112307|Vagina|vagina
484067|NCT00112307|Vulva|vulva
484068|NCT00112307|Carcinoma of the cervix|carcinoma of the cervix
484069|NCT00112307|Carcinoma of the uterus|carcinoma of the uterus
484070|NCT00112307|Carcinoma of the vagina|carcinoma of the vagina
484071|NCT00112307|Carcinoma of the vulva|carcinoma of the vulva
484072|NCT00112320|Pulmonary Valve Regurgitation|pulmonary valve regurgitation
484073|NCT00112320|Right Ventricular Dysfunction|right ventricular dysfunction
484074|NCT00112320|Heart Diseases|heart diseases
483329|NCT00117026|benfotiamine|benfotiamine
483330|NCT00117026|type 1 diabetes|type 1 diabetes
483331|NCT00117026|elevated urinary albumin excretion|elevated urinary albumin excretion
483334|NCT00117039|anemia|anemia
484075|NCT00112333|Dyspepsia, fMRI|dyspepsia, fmri
484076|NCT00112346|Non-Small Lung Cancer|non-small lung cancer
484077|NCT00112359|Cystic Fibrosis|cystic fibrosis
484078|NCT00112359|Pseudomonas aeruginosa|pseudomonas aeruginosa
484079|NCT00112359|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
484080|NCT00112372|unresectable|unresectable
484081|NCT00112372|metastatic|metastatic
484082|NCT00112372|cancer|cancer
484083|NCT00112372|recurrent|recurrent
484084|NCT00112372|malignancies|malignancies
484085|NCT00112372|progressive|progressive
484086|NCT00112385|dermatomyositis|dermatomyositis
484087|NCT00112385|etanercept|etanercept
484088|NCT00112385|tumor necrosis factor alpha|tumor necrosis factor alpha
484089|NCT00112398|Head injuries|head injuries
484090|NCT00112398|Prehospital|prehospital
484091|NCT00112398|Advanced Interventions|advanced interventions
484092|NCT00112424|Superior cavo-pulmonary anastomosis|superior cavo-pulmonary anastomosis
484093|NCT00112424|Glenn operation|glenn operation
484094|NCT00112424|Congenital heart defects|congenital heart defects
484095|NCT00112424|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
484096|NCT00112489|recurrent uterine sarcoma|recurrent uterine sarcoma
484097|NCT00112489|stage III uterine sarcoma|stage iii uterine sarcoma
484098|NCT00112489|stage IV uterine sarcoma|stage iv uterine sarcoma
484099|NCT00112489|uterine carcinosarcoma|uterine carcinosarcoma
484100|NCT00112502|adult giant cell glioblastoma|adult giant cell glioblastoma
484101|NCT00112502|adult gliosarcoma|adult gliosarcoma
484102|NCT00112502|adult glioblastoma|adult glioblastoma
484104|NCT00112515|cognitive/functional effects|cognitive/functional effects
484105|NCT00112515|fatigue|fatigue
484106|NCT00112515|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
484107|NCT00112528|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
484108|NCT00112528|recurrent pancreatic cancer|recurrent pancreatic cancer
484109|NCT00112528|stage IV pancreatic cancer|stage iv pancreatic cancer
484110|NCT00112554|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
484111|NCT00112554|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
484112|NCT00112554|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
484113|NCT00112554|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
484114|NCT00112554|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
484115|NCT00112554|adult acute basophilic leukemia|adult acute basophilic leukemia
484116|NCT00112554|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
484117|NCT00112554|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
486704|NCT00129259|T1D|t1d
484118|NCT00112554|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
484119|NCT00112554|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
484120|NCT00112554|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
484121|NCT00112554|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
484122|NCT00112554|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
484123|NCT00112554|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
484124|NCT00112554|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
484125|NCT00112554|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
484126|NCT00112567|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
484127|NCT00112567|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
484128|NCT00112567|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
484129|NCT00112567|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
484130|NCT00112567|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
484131|NCT00112567|secondary acute myeloid leukemia|secondary acute myeloid leukemia
484132|NCT00112567|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
484133|NCT00112567|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
484134|NCT00112567|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
484135|NCT00112567|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
484136|NCT00112567|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
484137|NCT00112567|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
484138|NCT00112567|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
484139|NCT00112580|recurrent pancreatic cancer|recurrent pancreatic cancer
484140|NCT00112580|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
483512|NCT00118586|Healthy Volunteer|healthy volunteer
484141|NCT00112580|stage IV pancreatic cancer|stage iv pancreatic cancer
484144|NCT00112593|Leukemia|leukemia
484145|NCT00112619|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
484146|NCT00112619|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
484147|NCT00112619|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
484148|NCT00112619|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
484149|NCT00112619|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
484150|NCT00112619|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
484151|NCT00112619|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
484152|NCT00112619|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
484153|NCT00112619|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
484154|NCT00112619|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
484155|NCT00112619|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
484156|NCT00112619|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
484157|NCT00112619|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
484158|NCT00112619|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
484159|NCT00112619|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
484160|NCT00112619|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
484161|NCT00112619|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
484162|NCT00112619|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
484163|NCT00112619|childhood grade I meningioma|childhood grade i meningioma
484164|NCT00112619|childhood grade II meningioma|childhood grade ii meningioma
484165|NCT00112619|childhood grade III meningioma|childhood grade iii meningioma
484166|NCT00112619|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
585510|NCT00513097|Epidemiology|epidemiology
484167|NCT00112619|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
484789|NCT00121524|intravenous|intravenous
484168|NCT00112619|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
484169|NCT00112619|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
484170|NCT00112619|childhood choroid plexus tumor|childhood choroid plexus tumor
484171|NCT00112619|childhood craniopharyngioma|childhood craniopharyngioma
484172|NCT00112619|childhood infratentorial ependymoma|childhood infratentorial ependymoma
484173|NCT00112619|childhood supratentorial ependymoma|childhood supratentorial ependymoma
484174|NCT00112619|recurrent childhood ependymoma|recurrent childhood ependymoma
484175|NCT00112619|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
484176|NCT00112619|childhood oligodendroglioma|childhood oligodendroglioma
484177|NCT00112619|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
484178|NCT00112619|leptomeningeal metastases|leptomeningeal metastases
484179|NCT00112619|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
484180|NCT00112619|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
484181|NCT00112619|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
484182|NCT00112619|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
484183|NCT00112619|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
484142|NCT00112593|HIV|hiv
484184|NCT00112619|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
484185|NCT00112619|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
484186|NCT00112619|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
484187|NCT00112619|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
484188|NCT00112619|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
484189|NCT00112619|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
484190|NCT00112619|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
484191|NCT00112619|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
484192|NCT00112619|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
484193|NCT00112619|meningeal leukemia|meningeal leukemia
484194|NCT00112619|secondary central nervous system Hodgkin lymphoma|secondary central nervous system hodgkin lymphoma
484195|NCT00112619|secondary central nervous system non-Hodgkin lymphoma|secondary central nervous system non-hodgkin lymphoma
484196|NCT00112632|gastrointestinal stromal tumor|gastrointestinal stromal tumor
484197|NCT00112645|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
484198|NCT00112645|recurrent neuroblastoma|recurrent neuroblastoma
484199|NCT00112645|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
484200|NCT00112645|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
484201|NCT00112658|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
484202|NCT00112658|stage IV pancreatic cancer|stage iv pancreatic cancer
484203|NCT00112697|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
484204|NCT00112697|stage IV pancreatic cancer|stage iv pancreatic cancer
484205|NCT00112710|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
484206|NCT00112710|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
484207|NCT00112749|stage I breast cancer|stage i breast cancer
484208|NCT00112749|stage II breast cancer|stage ii breast cancer
484209|NCT00112749|breast cancer in situ|breast cancer in situ
484211|NCT00112775|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
484212|NCT00112775|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
484213|NCT00112775|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
484214|NCT00112892|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
484215|NCT00112918|stage II colon cancer|stage ii colon cancer
484216|NCT00112918|stage III colon cancer|stage iii colon cancer
484217|NCT00112931|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
484218|NCT00112931|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
484219|NCT00112931|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
484220|NCT00112931|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
484221|NCT00112931|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
484222|NCT00112931|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
484223|NCT00112931|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
484224|NCT00112931|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
484225|NCT00112931|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
484226|NCT00112931|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
484227|NCT00112931|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
484228|NCT00112931|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
484229|NCT00112957|fallopian tube cancer|fallopian tube cancer
484230|NCT00112957|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
484231|NCT00112957|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
484232|NCT00112957|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
484233|NCT00112957|peritoneal cavity cancer|peritoneal cavity cancer
484234|NCT00112983|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
484235|NCT00112983|adult acute myeloid leukemia|adult acute myeloid leukemia
484237|NCT00112996|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
484238|NCT00112996|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
484239|NCT00113009|Peripheral arterial disease|peripheral arterial disease
484240|NCT00113022|Depression|depression
484241|NCT00113022|Glutamate|glutamate
484242|NCT00113022|Ampakine|ampakine
484243|NCT00113022|Treatment|treatment
484244|NCT00113022|Memory|memory
484245|NCT00113022|Major Depressive Disorder|major depressive disorder
484246|NCT00113022|AMPA Receptor Activation|ampa receptor activation
484247|NCT00113022|BDNF|bdnf
484248|NCT00113035|Glycogen Storage Disease Type II|glycogen storage disease type ii
484249|NCT00113035|GSD-II|gsd-ii
484250|NCT00113035|Pompe Disease|pompe disease
484251|NCT00113035|Pompe Disease (Late-Onset)|pompe disease (late-onset)
484497|NCT00113828|HLA-Matched|hla-matched
484252|NCT00113035|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
484253|NCT00113035|Acid Maltase Deficiency|acid maltase deficiency
484254|NCT00113035|Glycogenosis 2|glycogenosis 2
753938|NCT01178346|Pharmacoeconomic|pharmacoeconomic
484255|NCT00113048|CD52 Expressing Hematologic Malignancies|cd52 expressing hematologic malignancies
484256|NCT00113061|Coronary Heart Disease Risk Reduction|coronary heart disease risk reduction
484257|NCT00113100|skin|skin
484258|NCT00113100|estrogen|estrogen
484259|NCT00113100|sun damage|sun damage
484260|NCT00113100|Photodamaged Skin|photodamaged skin
484261|NCT00113113|rubitecan|rubitecan
484262|NCT00113113|Orathecin|orathecin
484263|NCT00113113|9-nitrocamptothecin|9-nitrocamptothecin
484264|NCT00113113|solid tumors|solid tumors
484265|NCT00113113|organ dysfunction|organ dysfunction
484266|NCT00113113|renal dysfunction|renal dysfunction
484267|NCT00113113|hepatic dysfunction|hepatic dysfunction
484268|NCT00113113|RFS 2000|rfs 2000
484269|NCT00113126|Scheduled treatment interruptions|scheduled treatment interruptions
484270|NCT00113126|STI|sti
484271|NCT00113152|Cardiac Arrhythmias|cardiac arrhythmias
484272|NCT00113152|Diastolic Dysfunction|diastolic dysfunction
484273|NCT00113152|Pulmonary Hypertension|pulmonary hypertension
484274|NCT00113152|Sickle Cell Anemia|sickle cell anemia
484275|NCT00113152|Sudden Death|sudden death
484276|NCT00113152|Thalassemia|thalassemia
484277|NCT00113165|partial seizures|partial seizures
484278|NCT00113165|Epilepsy|epilepsy
484279|NCT00113165|antiepileptic drugs|antiepileptic drugs
484280|NCT00113165|anticonvulsants|anticonvulsants
484281|NCT00113165|LAMICTAL|lamictal
484282|NCT00113165|seizures|seizures
484283|NCT00113165|lamotrigine|lamotrigine
484284|NCT00113178|atrial flutter|atrial flutter
484285|NCT00113178|cryoablation|cryoablation
484286|NCT00113191|late onset sepsis|late onset sepsis
484287|NCT00113191|premature infants|premature infants
484288|NCT00113191|staphylococcus|staphylococcus
484289|NCT00113191|candida|candida
484290|NCT00113191|prevention|prevention
484291|NCT00113204|Multiple myeloma|multiple myeloma
484292|NCT00113204|Relapsed|relapsed
484293|NCT00113204|Relapsed refractory|relapsed refractory
484294|NCT00113204|Hematologic cancer|hematologic cancer
484295|NCT00113204|hematologic disease|hematologic disease
484296|NCT00113204|plasma cells|plasma cells
484297|NCT00113217|Renal Cell Carcinoma|renal cell carcinoma
484298|NCT00113217|Kidney Cancer|kidney cancer
484299|NCT00113217|Bevacizumab|bevacizumab
484300|NCT00113217|Avastin|avastin
484301|NCT00113217|RCC|rcc
484302|NCT00113230|Rectal Cancer|rectal cancer
484303|NCT00113230|Bevacizumab|bevacizumab
484304|NCT00113230|RHUMAB VEGF|rhumab vegf
484305|NCT00113230|Avastin|avastin
484306|NCT00113230|Capecitabine|capecitabine
484307|NCT00113230|Neoadjuvant Concurrent Capecitabine|neoadjuvant concurrent capecitabine
484308|NCT00113230|Xeloda|xeloda
484309|NCT00113230|Radiation|radiation
484310|NCT00113230|Radiotherapy|radiotherapy
484311|NCT00113230|Radiation Therapy|radiation therapy
484312|NCT00113230|XRT|xrt
484313|NCT00113256|rubitecan|rubitecan
484314|NCT00113256|Orathecin|orathecin
484315|NCT00113256|9-nitrocamptothecin|9-nitrocamptothecin
484316|NCT00113256|gemcitabine|gemcitabine
484317|NCT00113256|Gemzar|gemzar
484318|NCT00113256|pancreatic cancer|pancreatic cancer
484319|NCT00113256|adenocarcinoma|adenocarcinoma
484320|NCT00113256|RFS 2000|rfs 2000
484321|NCT00113269|Treatment Effectiveness|treatment effectiveness
484322|NCT00113269|Treatment Efficacy|treatment efficacy
484323|NCT00113269|Anti-rejection therapy|anti-rejection therapy
484324|NCT00113269|Immunosuppression|immunosuppression
484325|NCT00113269|Therapy, antirejection|therapy, antirejection
484326|NCT00113269|Renal Transplantation|renal transplantation
484327|NCT00113269|Transplantation, Kidney|transplantation, kidney
484328|NCT00113269|Transplantation, Renal|transplantation, renal
484329|NCT00113269|Grafting, Kidney|grafting, kidney
484330|NCT00113282|Treatment failure|treatment failure
484331|NCT00113282|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
484332|NCT00113282|Interleukin-2|interleukin-2
484333|NCT00113282|Treatment Experienced|treatment experienced
484334|NCT00113295|generalized anxiety disorder|generalized anxiety disorder
484335|NCT00113295|pharmacotherapy|pharmacotherapy
484336|NCT00113295|treatment refractory|treatment refractory
484337|NCT00113295|double-blind|double-blind
484338|NCT00113308|Rheumatoid Arthritis|rheumatoid arthritis
484339|NCT00113308|COX-2 Inhibitor|cox-2 inhibitor
484340|NCT00113321|Myelodysplastic Syndrome|myelodysplastic syndrome
484341|NCT00113321|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
484342|NCT00113321|Azacytidine Failure|azacytidine failure
484343|NCT00113321|Decitabine|decitabine
484344|NCT00113334|Head and Neck Cancer|head and neck cancer
484345|NCT00113334|Thrombospondin Analogue|thrombospondin analogue
484346|NCT00113334|ABT-510|abt-510
484347|NCT00113334|Antiangiogenic agent|antiangiogenic agent
484348|NCT00113334|Lung|lung
484349|NCT00113334|Skin|skin
484350|NCT00113334|Thyroid|thyroid
484351|NCT00113347|Head and Neck Cancer|head and neck cancer
484352|NCT00113347|Squamous Cell Carcinoma|squamous cell carcinoma
484353|NCT00113347|Erlotinib|erlotinib
484354|NCT00113347|Docetaxel|docetaxel
484356|NCT00113347|Radiotherapy|radiotherapy
484357|NCT00113347|Concomitant Boost Radiation|concomitant boost radiation
484358|NCT00113360|Neuroendocrine Carcinoma|neuroendocrine carcinoma
484359|NCT00113360|Low Grade Neuroendocrine Carcinoma|low grade neuroendocrine carcinoma
484360|NCT00113360|Neuroendocrine Carcinoid|neuroendocrine carcinoid
484361|NCT00113360|Islet Cell Carcinoma|islet cell carcinoma
484362|NCT00113360|RAD001|rad001
484363|NCT00113360|Everolimus|everolimus
484364|NCT00113360|Octreotide Depot|octreotide depot
484365|NCT00113360|Sandostatin LAR|sandostatin lar
484366|NCT00113360|Octreotide long-acting release (LAR)|octreotide long-acting release (lar)
484367|NCT00113360|Octreotide LAR|octreotide lar
484368|NCT00113386|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
484369|NCT00113386|adenocarcinoma of the lung|adenocarcinoma of the lung
484370|NCT00113386|large cell lung cancer|large cell lung cancer
484371|NCT00113386|squamous cell lung cancer|squamous cell lung cancer
484372|NCT00113386|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
484373|NCT00113399|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
484374|NCT00113399|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
484498|NCT00113841|Multiple Myeloma|multiple myeloma
484375|NCT00113399|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
95185|NCT02693834|Gait endurance|gait endurance
95186|NCT02693821|Gabapentin|gabapentin
483708|NCT00119483|Men|men
484376|NCT00113399|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
484377|NCT00113399|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
484378|NCT00113399|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
484379|NCT00113412|HIV|hiv
484380|NCT00113412|Treatment Experienced|treatment experienced
484381|NCT00113425|non-ablative laser|non-ablative laser
484382|NCT00113425|acne|acne
484383|NCT00113425|photosensitizer|photosensitizer
484384|NCT00113425|photodynamic therapy|photodynamic therapy
484385|NCT00113438|cancer|cancer
484386|NCT00113438|tumor|tumor
484387|NCT00113438|imageable|imageable
484388|NCT00113438|CA4P|ca4p
484389|NCT00113438|Combretastatin|combretastatin
484390|NCT00113438|Combretastatin A4 Phosphate|combretastatin a4 phosphate
484391|NCT00113438|Combretastatin A-4 Phosphate|combretastatin a-4 phosphate
484392|NCT00113438|Carboplatin|carboplatin
484393|NCT00113438|Paclitaxel|paclitaxel
484394|NCT00113438|carbo|carbo
484395|NCT00113438|taxol|taxol
484396|NCT00113451|radial artery|radial artery
484397|NCT00113451|angina pectoris|angina pectoris
484398|NCT00113451|infarction|infarction
484399|NCT00113451|bypass|bypass
484400|NCT00113451|angiography|angiography
484401|NCT00113464|SCID (Severe Combined Immunodeficiency)|scid (severe combined immunodeficiency)
484402|NCT00113464|TREC (T cell Receptor Excision Circle)|trec (t cell receptor excision circle)
484403|NCT00113464|Bone Marrow Transplant|bone marrow transplant
484404|NCT00113464|Dried Blood Spots|dried blood spots
484405|NCT00113464|Early Detection|early detection
484406|NCT00113464|T Cell Immunodeficiency Diseases|t cell immunodeficiency diseases
484407|NCT00113464|Immunodeficiency Diseases|immunodeficiency diseases
484408|NCT00113464|Primary Immunodeficiency|primary immunodeficiency
484409|NCT00113464|T Cell Immunodeficiency Disease|t cell immunodeficiency disease
484410|NCT00113464|Severe Combined Immunodeficiency|severe combined immunodeficiency
484411|NCT00113464|SCID|scid
484412|NCT00113477|Q10|q10
484413|NCT00113477|CoQ10|coq10
484414|NCT00113477|Coenzyme Q10|coenzyme q10
484415|NCT00113477|selen|selen
484416|NCT00113477|selenoprotein|selenoprotein
484417|NCT00113477|selenoproteins|selenoproteins
484418|NCT00113477|adverse events|adverse events
484419|NCT00113477|adverse effects|adverse effects
484420|NCT00113477|AE|ae
484421|NCT00113477|myalgia|myalgia
484422|NCT00113477|muscle|muscle
484423|NCT00113477|statin therapy|statin therapy
484424|NCT00113477|Indication for statin therapy|indication for statin therapy
484425|NCT00113490|motavizumab, palivizumab, synagis|motavizumab, palivizumab, synagis
484426|NCT00113490|Rezield, MEDI-524|rezield, medi-524
484427|NCT00113503|Inflammatory Bowel Disease, Crohn's disease, Crohn's Colitis|inflammatory bowel disease, crohn's disease, crohn's colitis
484428|NCT00113516|Lung Neoplasms|lung neoplasms
484429|NCT00113542|Psoriasis|psoriasis
484430|NCT00113542|Tetrathiomolybdate|tetrathiomolybdate
484431|NCT00113555|urinary incontinence|urinary incontinence
484432|NCT00113568|Menorrhagia|menorrhagia
484433|NCT00113568|Heavy Menstrual Bleeding|heavy menstrual bleeding
484434|NCT00113581|EMD 72000|emd 72000
484435|NCT00113581|matuzumab|matuzumab
484436|NCT00113581|Esophageal adenocarcinoma|esophageal adenocarcinoma
484437|NCT00113581|Gastric adenocarcinoma|gastric adenocarcinoma
484438|NCT00113607|Ovarian cancer|ovarian cancer
484439|NCT00113607|Trabectedin|trabectedin
484440|NCT00113607|Yondelis|yondelis
484441|NCT00113607|Advanced Relapsed Ovarian Cancer|advanced relapsed ovarian cancer
484442|NCT00113607|DOXIL|doxil
484443|NCT00113607|CAELYX|caelyx
484444|NCT00113620|distal symmetrical|distal symmetrical
484445|NCT00113620|pain|pain
484446|NCT00113620|lower extremities|lower extremities
484447|NCT00113620|dextromethorphan|dextromethorphan
484450|NCT00113633|Primary Care|primary care
484451|NCT00113633|Children|children
484452|NCT00113646|Non-Myeloablative|non-myeloablative
484453|NCT00113646|T-cell Depleted|t-cell depleted
484454|NCT00113646|Mismatched|mismatched
484455|NCT00113646|Stem Cell Transplantation|stem cell transplantation
484457|NCT00113659|Probiotics|probiotics
484458|NCT00113659|Prevention|prevention
484459|NCT00113659|Eczema|eczema
484460|NCT00113724|taxane|taxane
484461|NCT00113724|multi-drug resistance|multi-drug resistance
484462|NCT00113724|mutant tubulin binding|mutant tubulin binding
484463|NCT00113724|Advanced malignancies|advanced malignancies
484464|NCT00113724|Hodgkin's or Non-Hodgkin's Lymphoma|hodgkin's or non-hodgkin's lymphoma
484465|NCT00113750|Allergy|allergy
484466|NCT00113750|Allergoid|allergoid
484467|NCT00113750|Specific Immunotherapy|specific immunotherapy
484468|NCT00113763|Metastatic Colorectal Cancer, Colon|metastatic colorectal cancer, colon
484469|NCT00113763|Colorectal, Rectal Cancer, Cancer|colorectal, rectal cancer, cancer
484470|NCT00113763|Metastatic, EGFr, Clinical Trial|metastatic, egfr, clinical trial
484471|NCT00113763|Panitumumab, ABX-EGF|panitumumab, abx-egf
484472|NCT00113763|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
483812|NCT00119899|Liver;|liver;
484473|NCT00113776|Metastatic Colorectal Cancer, Colon|metastatic colorectal cancer, colon
484474|NCT00113776|Colorectal, Rectal Cancer, EGFr|colorectal, rectal cancer, egfr
484475|NCT00113776|Metastatic, Cancer, ABX-EGF|metastatic, cancer, abx-egf
484476|NCT00113776|Panitumumab, Clinical Trial|panitumumab, clinical trial
484477|NCT00113776|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
484478|NCT00113789|ovarian cancer|ovarian cancer
484479|NCT00113789|topotecan|topotecan
484480|NCT00113789|neutropenia|neutropenia
484481|NCT00113789|Neulasta®|neulasta®
484482|NCT00113802|Epratuzumab (hLL2- anti-CD22 humanized antibody)|epratuzumab (hll2- anti-cd22 humanized antibody)
484483|NCT00113802|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
484484|NCT00113802|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
484485|NCT00113802|Hematologic Disease|hematologic disease
484486|NCT00113802|Hematologic Diseases|hematologic diseases
484487|NCT00113802|Paraproteinemias|paraproteinemias
484488|NCT00113802|Vascular Hemostatic Disorders|vascular hemostatic disorders
484489|NCT00113802|Lymphoproliferative Disorders|lymphoproliferative disorders
484490|NCT00113815|Partial seizure disorder|partial seizure disorder
484491|NCT00113815|Topiramate|topiramate
484492|NCT00113815|Epilepsy|epilepsy
484493|NCT00113815|Infants|infants
484494|NCT00113828|Non-Myeloablative|non-myeloablative
484495|NCT00113828|Stem Cell Transplantation|stem cell transplantation
484496|NCT00113828|T-cell Depletion|t-cell depletion
484499|NCT00113841|Diferuloylmethane Derivative|diferuloylmethane derivative
484500|NCT00113841|Curcumin|curcumin
484501|NCT00113841|Bioperine|bioperine
484502|NCT00113854|cerebral|cerebral
484503|NCT00113854|malaria|malaria
484504|NCT00113854|children|children
484505|NCT00113854|mannitol|mannitol
484506|NCT00113854|adjunct|adjunct
484507|NCT00113854|therapy|therapy
484508|NCT00113854|Uganda|uganda
484509|NCT00113867|IVF|ivf
484510|NCT00113867|in vitro fertilization|in vitro fertilization
484511|NCT00113867|hormones|hormones
484512|NCT00113867|stress|stress
484513|NCT00113867|memory|memory
484514|NCT00113867|Cognitive Function|cognitive function
484515|NCT00113867|adoption|adoption
484516|NCT00113893|Myelodysplastic syndromes|myelodysplastic syndromes
484517|NCT00113893|p38 MAP kinase|p38 map kinase
484518|NCT00113893|Bone marrow diseases|bone marrow diseases
484519|NCT00113893|SCIO-469|scio-469
484520|NCT00113906|melatonin,|melatonin,
484521|NCT00113906|fatigue,|fatigue,
484522|NCT00113906|sleep quality,|sleep quality,
484523|NCT00113906|circadian,|circadian,
484524|NCT00113906|postoperative|postoperative
484525|NCT00113906|Postoperative fatigue|postoperative fatigue
484526|NCT00113906|postoperative sleep disturbance|postoperative sleep disturbance
484527|NCT00113906|general wellbeing|general wellbeing
484528|NCT00113919|Myeloma, MM|myeloma, mm
484529|NCT00113932|Myeloma|myeloma
484530|NCT00113945|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
484531|NCT00113945|secondary hyperparathyroidism|secondary hyperparathyroidism
484532|NCT00113945|hemodialysis, biPTH|hemodialysis, bipth
484533|NCT00113945|AMG 073, Amgen|amg 073, amgen
484534|NCT00113958|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
484535|NCT00113958|secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
484536|NCT00113958|hemodialysis|hemodialysis
484537|NCT00113958|biPTH|bipth
484538|NCT00113958|AMG 073, Amgen|amg 073, amgen
484539|NCT00113971|study of epratuzumab in systemic lupus erythematosus|study of epratuzumab in systemic lupus erythematosus
484540|NCT00113971|systemic lupus erythematosus|systemic lupus erythematosus
484541|NCT00113971|SLE|sle
484542|NCT00113984|Monoclonal Antibody|monoclonal antibody
484543|NCT00113984|Vaccine|vaccine
484544|NCT00113984|Cytokines|cytokines
484545|NCT00113984|Immunotherapy|immunotherapy
484546|NCT00113984|Elispot Assay|elispot assay
484547|NCT00113984|Prostate Cancer|prostate cancer
484548|NCT00113984|Metastatic Prostate Cancer|metastatic prostate cancer
484549|NCT00113997|Anticoagulant|anticoagulant
484551|NCT00113997|Pharmacokinetics|pharmacokinetics
484553|NCT00113997|Healthy Volunteer|healthy volunteer
484554|NCT00113997|HV|hv
484555|NCT00114010|B Cells|b cells
484556|NCT00114010|T Cells|t cells
484557|NCT00114010|Erythrocyte Stage|erythrocyte stage
484558|NCT00114010|Antibody|antibody
484559|NCT00114010|Immunogenicity|immunogenicity
484560|NCT00114010|Healthy Volunteer|healthy volunteer
484561|NCT00114023|AK|ak
484562|NCT00114023|Imiquimod 5% cream|imiquimod 5% cream
484563|NCT00114023|3M Pharmaceuticals|3m pharmaceuticals
484564|NCT00114023|Aldara|aldara
484565|NCT00114023|Actinic Keratosis|actinic keratosis
484566|NCT00114036|Antibiotic prophylaxis|antibiotic prophylaxis
484567|NCT00114036|Surgical wound infections|surgical wound infections
484568|NCT00114049|Dental Pain|dental pain
484569|NCT00114049|Dental Surgery|dental surgery
484570|NCT00114049|Cox-2 inhibitor|cox-2 inhibitor
484571|NCT00114062|uveitis|uveitis
484572|NCT00114062|macular edema|macular edema
484573|NCT00114062|uveitis associated macular edema|uveitis associated macular edema
484574|NCT00114075|gait|gait
484575|NCT00114075|walking|walking
484576|NCT00114075|orthopedic surgery|orthopedic surgery
484577|NCT00114075|orthopaedic surgery|orthopaedic surgery
484578|NCT00114088|Hysterectomy,|hysterectomy,
484579|NCT00114088|Endometrial ablation,|endometrial ablation,
484580|NCT00114088|Ovulatory dysfunctional uterine bleeding,|ovulatory dysfunctional uterine bleeding,
484581|NCT00114088|Anovulatory dysfucntional uterine bleeding,|anovulatory dysfucntional uterine bleeding,
484582|NCT00114088|DUB|dub
484583|NCT00114088|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
484584|NCT00114114|Testosterone|testosterone
484585|NCT00114114|Bone turnover|bone turnover
484586|NCT00114114|Aging|aging
484587|NCT00114114|Body composition|body composition
484588|NCT00114114|Hypogonadism|hypogonadism
484589|NCT00114114|Sexual function|sexual function
484590|NCT00114127|social anxiety disorder|social anxiety disorder
484591|NCT00114127|social phobia|social phobia
484592|NCT00114127|duloxetine|duloxetine
484593|NCT00114127|serotonin norepinephrine reuptake inhibitor|serotonin norepinephrine reuptake inhibitor
484594|NCT00114127|SNRI|snri
484595|NCT00114127|double blind|double blind
484596|NCT00114140|adult diffuse astrocytoma|adult diffuse astrocytoma
484597|NCT00114140|adult oligodendroglioma|adult oligodendroglioma
484598|NCT00114140|adult mixed glioma|adult mixed glioma
484599|NCT00114153|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
484600|NCT00114153|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
484601|NCT00114153|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
484602|NCT00114153|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
484603|NCT00114153|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
484604|NCT00114153|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
484605|NCT00114166|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
484606|NCT00114166|fallopian tube cancer|fallopian tube cancer
484607|NCT00114166|primary peritoneal cavity cancer|primary peritoneal cavity cancer
484608|NCT00114192|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
484609|NCT00114192|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
484610|NCT00114192|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
484611|NCT00114192|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
484612|NCT00114205|malignant pleural effusion|malignant pleural effusion
484613|NCT00114231|adenocarcinoma of the rectum|adenocarcinoma of the rectum
484614|NCT00114231|stage I rectal cancer|stage i rectal cancer
484615|NCT00114257|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
484686|NCT00120770|WB Western Blot|wb western blot
484616|NCT00114257|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
484617|NCT00114257|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
484727|NCT00120939|Breast Cancer|breast cancer
484618|NCT00114257|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
484619|NCT00114257|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
484620|NCT00114257|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
484621|NCT00114257|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
484622|NCT00114257|secondary acute myeloid leukemia|secondary acute myeloid leukemia
484623|NCT00114257|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
484624|NCT00114257|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
484625|NCT00114257|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
484626|NCT00114257|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
484627|NCT00114257|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
484628|NCT00114257|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
484629|NCT00114257|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
484630|NCT00114257|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
484631|NCT00114257|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
484632|NCT00114257|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
484633|NCT00114257|chronic eosinophilic leukemia|chronic eosinophilic leukemia
484634|NCT00114257|primary myelofibrosis|primary myelofibrosis
484635|NCT00114257|chronic neutrophilic leukemia|chronic neutrophilic leukemia
484636|NCT00114257|essential thrombocythemia|essential thrombocythemia
484637|NCT00114257|polycythemia vera|polycythemia vera
484638|NCT00114257|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
484639|NCT00114257|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
484640|NCT00114257|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
484641|NCT00114257|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
95187|NCT02693821|prevention|prevention
95188|NCT02693821|incidence|incidence
484008|NCT00120627|Spiritual Therapy|spiritual therapy
484642|NCT00114257|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
484643|NCT00114257|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
484644|NCT00114257|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
484645|NCT00114257|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
484646|NCT00114257|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
484647|NCT00114257|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
484648|NCT00114257|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
484649|NCT00114257|adult acute basophilic leukemia|adult acute basophilic leukemia
484650|NCT00114257|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
484651|NCT00114270|breast cancer|breast cancer
484652|NCT00114270|osteoporosis|osteoporosis
484653|NCT00120692|breast cancer|breast cancer
484654|NCT00120692|darbepoetin alfa|darbepoetin alfa
484656|NCT00120705|anemia|anemia
484657|NCT00120705|darbepoetin alfa|darbepoetin alfa
484658|NCT00120705|Amgen|amgen
484659|NCT00120705|Non-myeloid Malignancies|non-myeloid malignancies
484660|NCT00120731|Recurrent nephrolithiasis|recurrent nephrolithiasis
484661|NCT00120731|Potassium Citrate|potassium citrate
484662|NCT00120731|Hypercalciuria|hypercalciuria
484663|NCT00120731|Distal Renal Tubular Acidosis|distal renal tubular acidosis
484664|NCT00120731|Nephrolithiasis in children|nephrolithiasis in children
484665|NCT00120757|Osteoporosis|osteoporosis
484666|NCT00120770|AE adverse event|ae adverse event
484667|NCT00120770|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
484668|NCT00120770|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
484669|NCT00120770|ART antiretroviral therapy|art antiretroviral therapy
484670|NCT00120770|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
484671|NCT00120770|DCF data collection forms|dcf data collection forms
484672|NCT00120770|DMC Data Monitoring Committee|dmc data monitoring committee
484673|NCT00120770|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
484674|NCT00120770|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
484675|NCT00120770|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
484676|NCT00120770|ICH International Conference of Harmonisation|ich international conference of harmonisation
484677|NCT00120770|IND Investigational New Drug Application|ind investigational new drug application
484678|NCT00120770|IRB Institutional Review Board|irb institutional review board
484679|NCT00120770|IU international units|iu international units
484680|NCT00120770|mg milligram(s)|mg milligram(s)
484681|NCT00120770|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
484682|NCT00120770|PCR polymerase chain reaction|pcr polymerase chain reaction
484683|NCT00120770|SAE serious adverse event|sae serious adverse event
484684|NCT00120770|µg microgram|µg microgram
484685|NCT00120770|ULN upper limit of the normal range|uln upper limit of the normal range
484687|NCT00120770|Human Immunodeficiency Virus|human immunodeficiency virus
484688|NCT00120770|Neisseria gonorrhoeae|neisseria gonorrhoeae
484689|NCT00120770|Chlamydia trachomatis|chlamydia trachomatis
484690|NCT00120770|HIV Seronegativity|hiv seronegativity
484691|NCT00120783|Treatment Failure|treatment failure
484692|NCT00120783|HIV infections|hiv infections
484693|NCT00120796|Hepatitis B|hepatitis b
484694|NCT00120796|Hepatitis B Vaccines|hepatitis b vaccines
484695|NCT00120796|Lamivudine|lamivudine
484696|NCT00120809|Malaria|malaria
484697|NCT00120809|Pregnancy|pregnancy
484698|NCT00120809|Multigravidae|multigravidae
484699|NCT00120809|Intermittent preventative treatment|intermittent preventative treatment
484700|NCT00120809|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
484701|NCT00120822|Malaria|malaria
484702|NCT00120822|Pregnancy|pregnancy
484703|NCT00120822|Folic acid|folic acid
484704|NCT00120822|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
484705|NCT00120835|Genotype-1|genotype-1
484706|NCT00120835|Treatment-Naive|treatment-naive
484707|NCT00120848|HPV vaccine efficacy|hpv vaccine efficacy
484708|NCT00120848|Prophylaxis HPV 16/18 infections|prophylaxis hpv 16/18 infections
484709|NCT00120861|Genotype-1|genotype-1
484710|NCT00120861|Previously failed treatment|previously failed treatment
484711|NCT00120874|Alzheimer's disease|alzheimer's disease
484712|NCT00120874|caregiver training|caregiver training
484713|NCT00120874|caregiver counseling|caregiver counseling
484714|NCT00120874|individualized management|individualized management
484716|NCT00120874|dementia|dementia
484717|NCT00120887|Atherosclerosis, SLE, statins|atherosclerosis, sle, statins
484718|NCT00120900|COX-2 inhibitor|cox-2 inhibitor
484719|NCT00120900|Knee osteoarthritis|knee osteoarthritis
484720|NCT00120913|Breakthrough bleeding while taking continuously dosed oral contraceptives|breakthrough bleeding while taking continuously dosed oral contraceptives
484721|NCT00120926|Premature neonate|premature neonate
484722|NCT00120926|Parenteral nutrition|parenteral nutrition
484723|NCT00120926|Growth|growth
484724|NCT00120926|Amino Acids|amino acids
484725|NCT00120926|Nutrition|nutrition
624882|NCT00680862|HIV|hiv
484726|NCT00120939|Lung Cancer|lung cancer
484728|NCT00120939|Prostate Cancer|prostate cancer
484729|NCT00120939|Ovarian Cancer|ovarian cancer
484730|NCT00120939|Head and Neck Cancer|head and neck cancer
484731|NCT00120939|Gastrointestinal Cancer|gastrointestinal cancer
484732|NCT00120939|Metastatic Cancer|metastatic cancer
484733|NCT00120939|Advanced Cancer|advanced cancer
484734|NCT00120939|Genitourinary Cancer|genitourinary cancer
484735|NCT00120939|Glioblastoma Multiforme|glioblastoma multiforme
484736|NCT00120939|Recurrent Cancer|recurrent cancer
484737|NCT00120939|Colon Cancer|colon cancer
484738|NCT00120939|Gastric Cancer|gastric cancer
484739|NCT00120939|Stomach Cancer|stomach cancer
484740|NCT00120939|Pancreatic Cancer|pancreatic cancer
484741|NCT00120939|Esophageal Cancer|esophageal cancer
484742|NCT00120939|Throat Cancer|throat cancer
484743|NCT00120939|Bladder Cancer|bladder cancer
484744|NCT00120939|Kidney Cancer|kidney cancer
484745|NCT00120939|Renal Cancer|renal cancer
484746|NCT00120939|Cervical Cancer|cervical cancer
484747|NCT00120939|Endometrial Cancer|endometrial cancer
484748|NCT00120939|Colorectal Cancer|colorectal cancer
484750|NCT00120952|Osteoarthritis|osteoarthritis
484751|NCT00120952|Hip arthroplasty|hip arthroplasty
484752|NCT00120952|DEXA|dexa
484753|NCT00120952|Titanium|titanium
484754|NCT00120952|Cobalt chromium|cobalt chromium
484755|NCT00120952|Bone cement|bone cement
484756|NCT00120965|Cardiac arrest|cardiac arrest
484757|NCT00120965|OOH-cardiac arrest|ooh-cardiac arrest
484758|NCT00120965|CPR|cpr
484759|NCT00120965|Chest compressions|chest compressions
484760|NCT00120965|Chest compression device|chest compression device
484761|NCT00120978|Clinical Trial; C-reactive protein; fluticasone; salmeterol|clinical trial; c-reactive protein; fluticasone; salmeterol
484762|NCT00120991|Coronary artery bypass grafting|coronary artery bypass grafting
484763|NCT00120991|OPCAB|opcab
484764|NCT00121004|Advance Directive|advance directive
484765|NCT00121004|Living Will|living will
484766|NCT00121004|Terminal Illness|terminal illness
484767|NCT00121017|HCV Infection|hcv infection
484768|NCT00121017|Treatment Naive|treatment naive
484769|NCT00121459|Diaphragm|diaphragm
484770|NCT00121459|HIV prevention|hiv prevention
484771|NCT00121459|Southern/South Africa, Zimbabwe|southern/south africa, zimbabwe
484772|NCT00121459|female-controlled methods|female-controlled methods
484773|NCT00121459|Replens|replens
484774|NCT00121459|STI prevention|sti prevention
484775|NCT00121459|HIV Seronegativity|hiv seronegativity
484776|NCT00121472|Heart-assist devices|heart-assist devices
484777|NCT00121485|Heart-assist devices|heart-assist devices
484778|NCT00121498|Pain|pain
484779|NCT00121498|Hysterectomy|hysterectomy
484780|NCT00121498|Preemptive|preemptive
484781|NCT00121498|Lidocaine|lidocaine
484782|NCT00121511|photoaging|photoaging
484783|NCT00121511|Actinic Keratoses|actinic keratoses
484784|NCT00121511|Efudex|efudex
484785|NCT00121511|5 fluorouracil|5 fluorouracil
484786|NCT00121524|cardiac arrest|cardiac arrest
484787|NCT00121524|resuscitation|resuscitation
484790|NCT00121524|survival|survival
484791|NCT00121537|wounds-open|wounds-open
484792|NCT00121550|Coronary heart disease|coronary heart disease
484793|NCT00121550|Clarithromycin|clarithromycin
484794|NCT00121550|Macrolides|macrolides
484795|NCT00121550|Cardiovascular mortality|cardiovascular mortality
484796|NCT00121550|Chlamydia pneumoniae|chlamydia pneumoniae
484797|NCT00121563|Cytokines|cytokines
484798|NCT00121563|Inflammation|inflammation
484799|NCT00121563|Pain|pain
484800|NCT00121563|Injury|injury
484801|NCT00121563|Peripheral|peripheral
484802|NCT00121563|Wisdom Teeth|wisdom teeth
484803|NCT00121563|Third Molar Extraction|third molar extraction
484804|NCT00121589|AMD|amd
484805|NCT00121589|Macular Pigment|macular pigment
484806|NCT00121589|Serum Lutein Levels|serum lutein levels
484807|NCT00121589|Vitamin Supplementation|vitamin supplementation
484808|NCT00121589|Carotenoids|carotenoids
484809|NCT00121589|Lutein|lutein
484810|NCT00121589|Zeaxanthin|zeaxanthin
484811|NCT00121589|DHA|dha
484812|NCT00121589|Age Related Macular Degeneration|age related macular degeneration
484813|NCT00121602|Hemodialysis|hemodialysis
484814|NCT00121602|Darbepoetin Alfa|darbepoetin alfa
484815|NCT00121602|Clinical Trials|clinical trials
484818|NCT00121602|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
484819|NCT00121615|Clinical Trials|clinical trials
484820|NCT00121628|Thyroid cancer|thyroid cancer
484821|NCT00121628|Advanced thyroid cancer|advanced thyroid cancer
484822|NCT00121628|Metastatic thyroid cancer|metastatic thyroid cancer
484823|NCT00121628|Medullary thyroid cancer|medullary thyroid cancer
484824|NCT00121628|Follicular thyroid cancer|follicular thyroid cancer
484825|NCT00121628|Papillary thyroid cancer|papillary thyroid cancer
484826|NCT00121628|Hurthle cell thyroid cancer|hurthle cell thyroid cancer
484827|NCT00121628|Thyroid cancer treatments|thyroid cancer treatments
95189|NCT02693808|Temporal hollowing|temporal hollowing
624950|NCT00681161|OSA|osa
484210|NCT00112749|fatigue|fatigue
484828|NCT00121628|Differentiated thyroid cancer and medullary thyroid cancer|differentiated thyroid cancer and medullary thyroid cancer
484829|NCT00121654|Angina pectoris|angina pectoris
484830|NCT00121654|Spinal cord stimulation|spinal cord stimulation
484831|NCT00121654|Refractory angina pectoris|refractory angina pectoris
484832|NCT00121680|cancer|cancer
484833|NCT00121693|Fall prevention|fall prevention
484834|NCT00121693|posturography|posturography
484835|NCT00121693|music therapy|music therapy
484836|NCT00121719|Resistant and refractory solid tumors|resistant and refractory solid tumors
484837|NCT00121719|lymphomas|lymphomas
484838|NCT00121719|hodgkins disease|hodgkins disease
484839|NCT00121719|non-hodgkins lymphoma|non-hodgkins lymphoma
484840|NCT00121719|neoplasms|neoplasms
484841|NCT00121745|gene transfer|gene transfer
484842|NCT00121745|cell cycle control|cell cycle control
484843|NCT00121745|cancer gene therapy|cancer gene therapy
484844|NCT00121745|pathotropic targeting|pathotropic targeting
484845|NCT00121745|tumor targeted retroviral vector|tumor targeted retroviral vector
484846|NCT00121758|HIV Vaccines|hiv vaccines
484847|NCT00121758|HIV Seronegativity|hiv seronegativity
484848|NCT00121771|Malaria|malaria
484849|NCT00121771|Vaccines|vaccines
484850|NCT00121771|Safety|safety
484851|NCT00121771|Immunogenicity|immunogenicity
484852|NCT00121797|Postpartum Period|postpartum period
484853|NCT00121823|Malaria|malaria
484854|NCT00121823|PCR|pcr
484855|NCT00121823|Vaccines|vaccines
484856|NCT00121823|Acceptability|acceptability
484857|NCT00121849|Leishmaniasis,|leishmaniasis,
484858|NCT00121849|Subunit Vaccine,|subunit vaccine,
484859|NCT00121849|Prevention,|prevention,
484860|NCT00121849|T cell|t cell
484861|NCT00121862|Leishmaniasis|leishmaniasis
484862|NCT00121862|Subunit Vaccine|subunit vaccine
484863|NCT00121862|Prevention|prevention
484864|NCT00121862|T cell|t cell
484865|NCT00121875|short stature|short stature
484866|NCT00121875|insulin resistance|insulin resistance
484867|NCT00121875|body composition|body composition
484868|NCT00121875|Turner syndrome|turner syndrome
484869|NCT00121875|intramyocellular lipid|intramyocellular lipid
484870|NCT00121875|glucose tolerance|glucose tolerance
484871|NCT00121888|post traumatic stress disorder|post traumatic stress disorder
484872|NCT00121888|Prolonged Exposure Therapy|prolonged exposure therapy
484873|NCT00121888|pharmacotherapy|pharmacotherapy
484874|NCT00121888|double-blind|double-blind
484875|NCT00121888|Anxiety Disorder|anxiety disorder
484876|NCT00121901|Pancreatitis|pancreatitis
484877|NCT00121901|Cholangiopancreatograpy, Endoscopic Retrograde/adverse|cholangiopancreatograpy, endoscopic retrograde/adverse
484878|NCT00121901|Nitroglycerin|nitroglycerin
484879|NCT00121901|Randomized Controlled Trial,|randomized controlled trial,
484880|NCT00121914|Carcinoma, Hepatocellular,|carcinoma, hepatocellular,
484881|NCT00121914|percutaneous ethanol instillation|percutaneous ethanol instillation
484882|NCT00121914|long-acting somatostatin|long-acting somatostatin
484883|NCT00121927|intractable|intractable
484884|NCT00121927|ketogenic|ketogenic
484885|NCT00121927|ketosis|ketosis
484886|NCT00121927|Atkins|atkins
484887|NCT00121940|Chronic Disease|chronic disease
484888|NCT00121940|Nurses|nurses
484889|NCT00121940|Caregivers|caregivers
484890|NCT00121940|Support Groups|support groups
484891|NCT00121953|Endometriosis|endometriosis
484892|NCT00121953|Peritoneal fluid|peritoneal fluid
484893|NCT00121953|Cytokines|cytokines
484894|NCT00121953|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
484895|NCT00121966|Type 2 diabetes|type 2 diabetes
484896|NCT00121966|Insulin Aspart|insulin aspart
484897|NCT00121966|Insulin NPH|insulin nph
484898|NCT00121966|Metformin|metformin
484899|NCT00121966|Rosiglitazone|rosiglitazone
484900|NCT00121979|HIV|hiv
484901|NCT00121979|treatment-experienced|treatment-experienced
484902|NCT00121979|lamivudine|lamivudine
484903|NCT00121979|3TC|3tc
484904|NCT00121992|High risk node negative breast cancer|high risk node negative breast cancer
484905|NCT00121992|Disease-Free survival|disease-free survival
484906|NCT00121992|Quality of life|quality of life
484907|NCT00122005|Metastatic|metastatic
484908|NCT00122005|Prostate|prostate
484909|NCT00122005|Advanced|advanced
484910|NCT00122005|Cancer|cancer
484911|NCT00122005|GVAX|gvax
484912|NCT00122005|Vaccine|vaccine
484913|NCT00122018|Kidney failure|kidney failure
484914|NCT00122018|Cardiac Surgery|cardiac surgery
484915|NCT00122018|Fenoldopam|fenoldopam
484916|NCT00122018|N-acetylcysteine|n-acetylcysteine
484917|NCT00122031|Major Depression|major depression
753939|NCT01178346|Quality of Life|quality of life
484918|NCT00122031|Treatment Refractory Major Depression|treatment refractory major depression
484919|NCT00122044|childhood|childhood
484920|NCT00122044|cerebral palsy|cerebral palsy
484921|NCT00122044|dystonia|dystonia
484922|NCT00122044|secondary|secondary
484923|NCT00122044|trihexyphenidyl|trihexyphenidyl
95517|NCT02692183|ET|et
484236|NCT00112996|neurotoxicity|neurotoxicity
484924|NCT00122044|pediatric dystonia|pediatric dystonia
484925|NCT00122057|ventilator-associated tracheobronchitis|ventilator-associated tracheobronchitis
484926|NCT00122057|nosocomial tracheobronchitis|nosocomial tracheobronchitis
484927|NCT00122070|Borderline Personality Disorder|borderline personality disorder
484928|NCT00122070|Personality Disorder|personality disorder
484929|NCT00122070|Quetiapine|quetiapine
484930|NCT00122070|Atypical Antipsychotics|atypical antipsychotics
484931|NCT00122070|Seroquel|seroquel
484932|NCT00122070|Antipsychotics|antipsychotics
484933|NCT00122083|Depression|depression
484934|NCT00122083|Students|students
484935|NCT00122083|Health education|health education
484936|NCT00122096|neurosurgery|neurosurgery
484938|NCT00122096|inflammation|inflammation
484939|NCT00122096|pain|pain
484940|NCT00122109|Posttraumatic Stress Disorder|posttraumatic stress disorder
484941|NCT00122109|Anger Management|anger management
484942|NCT00122109|Telemedicine modality|telemedicine modality
484943|NCT00122135|end-of-life care|end-of-life care
484944|NCT00122135|clinical decision-making|clinical decision-making
484945|NCT00122135|values inventory|values inventory
484946|NCT00122135|racial disparities|racial disparities
484947|NCT00122148|Quality of health care|quality of health care
484948|NCT00122148|Feedback|feedback
484949|NCT00122161|Drug therapy|drug therapy
484950|NCT00122161|Practice guidelines|practice guidelines
484951|NCT00122161|Reminder systems|reminder systems
484952|NCT00122161|Ambulatory care|ambulatory care
484953|NCT00122161|Hypertension|hypertension
484954|NCT00122161|Clinical protocols|clinical protocols
484955|NCT00122161|Quality Assurance, Health Care|quality assurance, health care
484956|NCT00122174|Caregivers|caregivers
484957|NCT00122174|Stress|stress
484958|NCT00122174|Coping|coping
484959|NCT00122174|Immune|immune
484960|NCT00122174|Relaxation|relaxation
484961|NCT00122174|Biofeedback|biofeedback
484962|NCT00122174|Bioinstrumentation|bioinstrumentation
484963|NCT00122174|Homecare|homecare
484964|NCT00122187|cancer|cancer
484965|NCT00122187|colonoscopy|colonoscopy
484966|NCT00122187|mass screening|mass screening
484967|NCT00122187|colorectal cancer|colorectal cancer
484968|NCT00122187|colorectal carcinoma|colorectal carcinoma
484969|NCT00122187|reminder systems|reminder systems
484970|NCT00122187|rectal cancers|rectal cancers
484971|NCT00122187|colorectal tumor|colorectal tumor
484972|NCT00122187|guidelines|guidelines
484973|NCT00122187|CRC secondary prevention|crc secondary prevention
484974|NCT00122187|colorectal neoplasms|colorectal neoplasms
484975|NCT00122187|colonic neoplasms|colonic neoplasms
484976|NCT00122187|colonic diseases|colonic diseases
484977|NCT00122187|hemoccult testing|hemoccult testing
484978|NCT00122213|Prevention|prevention
484979|NCT00122213|Retirement|retirement
484980|NCT00122213|Physical activity|physical activity
484981|NCT00122213|Diet|diet
484982|NCT00122213|Weight gain|weight gain
484983|NCT00122213|Body composition|body composition
484985|NCT00122226|HIV-associated lipodystrophy syndrome|hiv-associated lipodystrophy syndrome
484986|NCT00122239|radiotherapy|radiotherapy
484987|NCT00122239|radiation toxicity|radiation toxicity
484988|NCT00122239|single nucleotide polymorphism|single nucleotide polymorphism
484989|NCT00122239|breast carcinoma|breast carcinoma
485173|NCT00122889|Garlic|garlic
484990|NCT00122239|prostate carcinoma|prostate carcinoma
484991|NCT00122239|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
484992|NCT00122239|lung carcinoma (non-small cell)|lung carcinoma (non-small cell)
484993|NCT00122252|prostate cancer|prostate cancer
484994|NCT00122252|radiotherapy|radiotherapy
484995|NCT00122252|biological imaging|biological imaging
484996|NCT00122265|prostate cancer|prostate cancer
484997|NCT00122265|radiotherapy|radiotherapy
484998|NCT00122265|radiation toxicity|radiation toxicity
484999|NCT00122265|single nucleotide polymorphism|single nucleotide polymorphism
485000|NCT00122278|migraine, emergency department, dexamethasone|migraine, emergency department, dexamethasone
485001|NCT00122278|Migraine with or without aura or probable migraine without aura as defined by ICHD, 2nd edition|migraine with or without aura or probable migraine without aura as defined by ichd, 2nd edition
485002|NCT00122291|preoperative|preoperative
485003|NCT00122291|chemotherapy|chemotherapy
485004|NCT00122291|radiation therapy|radiation therapy
485005|NCT00122291|rectal cancer|rectal cancer
485006|NCT00122291|transmural rectal wall invasion|transmural rectal wall invasion
485007|NCT00122291|nodal metastasis|nodal metastasis
485008|NCT00122317|Transfusion dependent, hemolytic paroxysmal nocturnal hemoglobinuria|transfusion dependent, hemolytic paroxysmal nocturnal hemoglobinuria
485009|NCT00122343|Endometrial|endometrial
485010|NCT00122343|Cancer|cancer
485011|NCT00122369|Breast|breast
485012|NCT00122369|Biopsy|biopsy
485013|NCT00122369|Hypnosis|hypnosis
484937|NCT00122096|COX-2|cox-2
485017|NCT00122369|Medical and Surgical Procedures|medical and surgical procedures
485018|NCT00122382|abatacept, methotrexate, erosive RA|abatacept, methotrexate, erosive ra
485019|NCT00122395|Domestic violence|domestic violence
485020|NCT00122395|Screening|screening
485021|NCT00122395|Emergency department|emergency department
485022|NCT00122408|ventilator-associated pneumonia|ventilator-associated pneumonia
485023|NCT00122408|probiotic|probiotic
485024|NCT00122408|mechanical ventilation|mechanical ventilation
485025|NCT00122408|intensive care|intensive care
485026|NCT00122421|diabetes|diabetes
485027|NCT00122421|quality of care|quality of care
485028|NCT00122421|pharmacist recommendations|pharmacist recommendations
485029|NCT00122447|Prediabetic state|prediabetic state
485030|NCT00122447|Cardiovascular disease|cardiovascular disease
485031|NCT00122447|Diabetes|diabetes
485032|NCT00122447|Glucose intolerance|glucose intolerance
485033|NCT00122460|Head and Neck Cancer|head and neck cancer
485034|NCT00122473|Dermatofibrosarcoma|dermatofibrosarcoma
485035|NCT00122473|Imatinib|imatinib
485036|NCT00122473|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
485037|NCT00122486|AE adverse event|ae adverse event
485038|NCT00122486|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
485039|NCT00122486|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
485040|NCT00122486|ART antiretroviral therapy|art antiretroviral therapy
485041|NCT00122486|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
485042|NCT00122486|DCF data collection forms|dcf data collection forms
485043|NCT00122486|DMC Data Monitoring Committee|dmc data monitoring committee
485044|NCT00122486|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
485045|NCT00122486|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
485046|NCT00122486|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
485047|NCT00122486|ICH International Conference of Harmonisation|ich international conference of harmonisation
485048|NCT00122486|IND Investigational New Drug Application|ind investigational new drug application
485049|NCT00122486|IRB Institutional Review Board|irb institutional review board
485050|NCT00122486|IU international units|iu international units
485051|NCT00122486|mg milligram(s)|mg milligram(s)
485052|NCT00122486|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
485053|NCT00122486|PCR polymerase chain reaction|pcr polymerase chain reaction
485054|NCT00122486|SAE serious adverse event|sae serious adverse event
485055|NCT00122486|µg microgram|µg microgram
485056|NCT00122486|ULN upper limit of the normal range|uln upper limit of the normal range
485057|NCT00122486|WB Western Blot|wb western blot
485058|NCT00122486|Human Immunodeficiency Virus|human immunodeficiency virus
485059|NCT00122499|Prostate cancer|prostate cancer
485060|NCT00122499|Radiotherapy|radiotherapy
485061|NCT00122499|Erectile dysfunction|erectile dysfunction
485062|NCT00122499|Tadalafil|tadalafil
485063|NCT00122512|AE adverse event|ae adverse event
485064|NCT00122512|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
485065|NCT00122512|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
485066|NCT00122512|ART antiretroviral therapy|art antiretroviral therapy
485067|NCT00122512|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
485068|NCT00122512|DCF data collection forms|dcf data collection forms
485069|NCT00122512|DMC Data Monitoring Committee|dmc data monitoring committee
485070|NCT00122512|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
485071|NCT00122512|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
485072|NCT00122512|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
485073|NCT00122512|ICH International Conference of Harmonisation|ich international conference of harmonisation
485074|NCT00122512|IND Investigational New Drug Application|ind investigational new drug application
485075|NCT00122512|IRB Institutional Review Board|irb institutional review board
485076|NCT00122512|IU international units|iu international units
485077|NCT00122512|mg milligram(s)|mg milligram(s)
485078|NCT00122512|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
485079|NCT00122512|PCR polymerase chain reaction|pcr polymerase chain reaction
485080|NCT00122512|SAE serious adverse event|sae serious adverse event
485081|NCT00122512|TDF tenofovir disoproxil fumarate, GS-4331-05, PMPA prodrug|tdf tenofovir disoproxil fumarate, gs-4331-05, pmpa prodrug
485082|NCT00122512|µg microgram|µg microgram
485083|NCT00122512|ULN upper limit of the normal range|uln upper limit of the normal range
485084|NCT00122512|WB Western Blot|wb western blot
485085|NCT00122512|Human Immunodeficiency Virus|human immunodeficiency virus
485086|NCT00122512|HIV Seronegativity|hiv seronegativity
485087|NCT00122525|HIV|hiv
485088|NCT00122525|Male circumcision|male circumcision
485089|NCT00122525|Prevention|prevention
485090|NCT00122525|HSV-2|hsv-2
485091|NCT00122525|Africa|africa
485092|NCT00122525|Sexual behavior|sexual behavior
485093|NCT00122538|HAART|haart
485094|NCT00122538|once-daily|once-daily
485095|NCT00122538|child|child
485096|NCT00122538|africa|africa
485097|NCT00122538|HIV|hiv
485098|NCT00122538|AIDS|aids
485099|NCT00122538|Treatment Naive|treatment naive
485100|NCT00122551|HIV infections|hiv infections
485101|NCT00122564|HIV Vaccines|hiv vaccines
485102|NCT00122564|HIV Seronegativity|hiv seronegativity
485103|NCT00122577|HIV infections|hiv infections
485104|NCT00122577|Treatment Failure|treatment failure
485105|NCT00122577|tenofovir|tenofovir
485106|NCT00122577|atazanavir|atazanavir
485107|NCT00122590|protease inhibitors|protease inhibitors
485108|NCT00122590|nelfinavir|nelfinavir
485109|NCT00122590|lopinavir|lopinavir
485110|NCT00122590|indinavir|indinavir
485111|NCT00122590|Pharmacokinetics|pharmacokinetics
485112|NCT00122603|HIV Protease Inhibitors|hiv protease inhibitors
485113|NCT00122603|HIV infections|hiv infections
485114|NCT00122603|Atazanavir|atazanavir
485115|NCT00122603|Saquinavir|saquinavir
485116|NCT00122603|Fosamprenavir|fosamprenavir
485117|NCT00122603|ritonavir|ritonavir
485118|NCT00122603|Treatment Naive|treatment naive
485119|NCT00122616|HIV infections|hiv infections
485120|NCT00122616|peginterferon alfa-2a|peginterferon alfa-2a
485121|NCT00122616|Treatment Failure|treatment failure
485122|NCT00122616|Hepatitis C, Chronic|hepatitis c, chronic
485123|NCT00122616|Treatment Experienced|treatment experienced
485124|NCT00122629|Hepatitis C, Chronic|hepatitis c, chronic
485125|NCT00122629|peginterferon alfa-2b|peginterferon alfa-2b
485126|NCT00122629|ribavirin|ribavirin
485127|NCT00122629|Amantadine|amantadine
485128|NCT00122642|catheterization|catheterization
485129|NCT00122642|Catheters, Indwelling|catheters, indwelling
485130|NCT00122655|HIV infections|hiv infections
485131|NCT00122655|HIV Lipodystrophy Syndrome|hiv lipodystrophy syndrome
485132|NCT00122668|HIV Protease Inhibitors|hiv protease inhibitors
485133|NCT00122668|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
485134|NCT00122668|HIV infections|hiv infections
485135|NCT00122694|carbon monoxide|carbon monoxide
485136|NCT00122694|COPD|copd
485137|NCT00122694|inflammation|inflammation
485138|NCT00122694|sputum induction|sputum induction
485139|NCT00122694|stable COPD|stable copd
485140|NCT00122707|catheter-related infection|catheter-related infection
485141|NCT00122707|mechanical complications of catheters|mechanical complications of catheters
485142|NCT00122720|colorectal cancer|colorectal cancer
485143|NCT00122720|erythropoietin|erythropoietin
485144|NCT00122720|rehabilitation|rehabilitation
485145|NCT00122720|physical capacity|physical capacity
485146|NCT00122733|Mechanical ventilation|mechanical ventilation
485147|NCT00122733|Agitation|agitation
485148|NCT00122733|Difficult weaning|difficult weaning
485149|NCT00122746|Cervical Cancer|cervical cancer
485150|NCT00122746|AIDS|aids
485151|NCT00122746|External Beam Radiotherapy|external beam radiotherapy
485152|NCT00122746|Brachytherapy|brachytherapy
485153|NCT00122746|Cisplatin|cisplatin
485154|NCT00122759|Mechanical ventilation|mechanical ventilation
485155|NCT00122759|Agitation|agitation
485156|NCT00122785|bronchiolitis|bronchiolitis
485157|NCT00122785|wheezing|wheezing
485158|NCT00122785|dexamethasone|dexamethasone
485159|NCT00122785|young children|young children
583849|NCT00512915|Postventricular atrial blanking|postventricular atrial blanking
485160|NCT00122798|Stroke, stroke treatment, atrial fibrillation, medication, rehabilitation|stroke, stroke treatment, atrial fibrillation, medication, rehabilitation
485161|NCT00122811|Aged|aged
485162|NCT00122811|Hypertension|hypertension
485163|NCT00122811|Stroke|stroke
485164|NCT00122876|Hepatocellular Carcinoma|hepatocellular carcinoma
485165|NCT00122876|HCC|hcc
485166|NCT00122876|Photodynamic therapy|photodynamic therapy
485167|NCT00122876|Talaporfin Sodium (LS11)|talaporfin sodium (ls11)
485168|NCT00122876|Light emitting diodes (LEDs)|light emitting diodes (leds)
485169|NCT00122876|Litx|litx
485170|NCT00122876|Light Infusion Technology|light infusion technology
485171|NCT00122889|Drug Interactions|drug interactions
485172|NCT00122889|Pharmacokinetics|pharmacokinetics
485174|NCT00122889|Complementary Therapies|complementary therapies
485175|NCT00122889|Complementary and Alternative Medicine|complementary and alternative medicine
485176|NCT00122902|HIV|hiv
485177|NCT00122902|AIDS|aids
485178|NCT00122902|Spirituality|spirituality
485179|NCT00122915|Motor Cortex Stimulation|motor cortex stimulation
485180|NCT00122915|Pain treatment|pain treatment
485181|NCT00122915|Central post-stroke pain (CPSP)|central post-stroke pain (cpsp)
485182|NCT00122915|Trigeminal neuropathic pain (TGN)|trigeminal neuropathic pain (tgn)
485183|NCT00122915|Facial pain|facial pain
485184|NCT00122915|Neurostimuation|neurostimuation
485185|NCT00122915|Cortical lead|cortical lead
485186|NCT00122915|Neuropathic pain|neuropathic pain
485187|NCT00122928|Worksite|worksite
485188|NCT00122928|Workplace|workplace
485189|NCT00122928|Return on Investment|return on investment
485190|NCT00122928|Financial Impact|financial impact
485191|NCT00122941|multiple|multiple
485192|NCT00122941|micronutrients|micronutrients
485193|NCT00122941|supplementation|supplementation
485194|NCT00122941|HIV|hiv
485195|NCT00122941|children|children
485196|NCT00122941|randomised|randomised
485197|NCT00122941|trial|trial
485198|NCT00122941|mortality|mortality
485199|NCT00122941|morbidity|morbidity
485200|NCT00122941|growth|growth
485201|NCT00122941|Uganda|uganda
485202|NCT00122954|Fatty Acids, Omega-3|fatty acids, omega-3
485203|NCT00122954|Fish Oils|fish oils
485204|NCT00122954|Complementary Therapies|complementary therapies
485205|NCT00122980|Blood Diseases|blood diseases
485206|NCT00123058|Hypertension|hypertension
485207|NCT00123058|Cariovascular Diseases|cariovascular diseases
485208|NCT00123058|Health Illiteracy|health illiteracy
485209|NCT00123084|Parkinson's disease|parkinson's disease
485210|NCT00123084|Swallowing difficulties|swallowing difficulties
485211|NCT00123084|speech|speech
485212|NCT00123084|voice|voice
485213|NCT00123097|Facial Neoplasms|facial neoplasms
485214|NCT00123097|Head and Neck Neoplasms|head and neck neoplasms
485215|NCT00123097|Head Injuries, Penetrating|head injuries, penetrating
485216|NCT00123097|Birth Injuries|birth injuries
485217|NCT00123123|Ventilator-associated pneumonia|ventilator-associated pneumonia
485218|NCT00123136|pulsed magnetic field therapy|pulsed magnetic field therapy
485219|NCT00123136|diabetic peripheral neuropathy|diabetic peripheral neuropathy
485220|NCT00123136|neuromodulation|neuromodulation
485221|NCT00123136|diabetic peripheral neuropathic pain|diabetic peripheral neuropathic pain
485222|NCT00123136|sleep benefit|sleep benefit
485223|NCT00123136|diabetic peripheral neuropathic functioning|diabetic peripheral neuropathic functioning
485224|NCT00123149|Anemia|anemia
485225|NCT00123149|Rheumatoid arthritis|rheumatoid arthritis
485226|NCT00123149|Hemoglobin level|hemoglobin level
485227|NCT00123162|Sildenafil|sildenafil
485228|NCT00123175|Endometrial Hyperplasia without atypia|endometrial hyperplasia without atypia
485229|NCT00123201|efficacy & safety, migraine headache, placebo-controlled|efficacy & safety, migraine headache, placebo-controlled
485230|NCT00123201|migraine headache with or without aura|migraine headache with or without aura
485231|NCT00123214|Diet|diet
485232|NCT00123214|Chronic sleep deprivation|chronic sleep deprivation
485233|NCT00123214|Weight|weight
485234|NCT00123214|Cognitive impairment|cognitive impairment
485235|NCT00123214|Lipids|lipids
485236|NCT00123214|Inflammation|inflammation
485237|NCT00123214|Resting metabolic rate|resting metabolic rate
485238|NCT00123214|Weight Gain|weight gain
485239|NCT00123214|Percent Body Fat|percent body fat
485240|NCT00123214|Hyperlipidemia|hyperlipidemia
485241|NCT00123227|Randomised controlled trial|randomised controlled trial
485242|NCT00123227|Rosiglitazone|rosiglitazone
485243|NCT00123227|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
485244|NCT00123227|Diabetes Mellitus|diabetes mellitus
485245|NCT00123227|Vascular Diseases|vascular diseases
485246|NCT00123227|Hypertension|hypertension
485247|NCT00123240|overweight|overweight
485248|NCT00123240|obese|obese
485249|NCT00123240|diet|diet
485250|NCT00123253|HIV|hiv
485251|NCT00123253|Lipodystrophy|lipodystrophy
485252|NCT00123253|Abdominal fat accumulation|abdominal fat accumulation
485253|NCT00123253|Growth hormone releasing factor/Growth hormone releasing hormone|growth hormone releasing factor/growth hormone releasing hormone
485254|NCT00123253|Treatment Experienced|treatment experienced
485255|NCT00123266|stroke|stroke
485256|NCT00123266|vertebrobasilar|vertebrobasilar
485257|NCT00123266|basilar|basilar
485258|NCT00123266|Acute vertebrobasilar artery occlusion|acute vertebrobasilar artery occlusion
485259|NCT00123279|diabetic macular edema|diabetic macular edema
485260|NCT00123279|macular hole|macular hole
485261|NCT00123279|vitreomacular traction syndrome|vitreomacular traction syndrome
485262|NCT00123292|arterial occlusion|arterial occlusion
485263|NCT00123292|thromboembolism|thromboembolism
485264|NCT00123292|Acute Peripheral Arterial Occlusion|acute peripheral arterial occlusion
485265|NCT00123305|Stroke|stroke
485266|NCT00123305|Acute Ischemic Stroke|acute ischemic stroke
485267|NCT00123318|Gastric cancer|gastric cancer
485268|NCT00123318|Radiotherapy|radiotherapy
485269|NCT00123318|Chemotherapy|chemotherapy
485270|NCT00123318|Chemoradiation|chemoradiation
485271|NCT00123331|Heart transplantation|heart transplantation
485272|NCT00123331|Renal failure|renal failure
485273|NCT00123331|Cyclosporine|cyclosporine
485274|NCT00123331|Rapamycin|rapamycin
485275|NCT00123344|symptomatic bradycardia|symptomatic bradycardia
485276|NCT00123344|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
485277|NCT00123344|antitachycardia pacing therapies|antitachycardia pacing therapies
485278|NCT00123344|prevention algorithms|prevention algorithms
485279|NCT00123370|Modafinil|modafinil
485280|NCT00123370|Amphetamine Dependence|amphetamine dependence
485281|NCT00123370|Randomised placebo-controlled trial|randomised placebo-controlled trial
485282|NCT00123383|Modafinil|modafinil
485283|NCT00123383|Cocaine Dependence|cocaine dependence
485284|NCT00123383|Randomised placebo-controlled trial|randomised placebo-controlled trial
485285|NCT00123396|Bioterrorism|bioterrorism
485286|NCT00123396|Education, Medical, Continuing|education, medical, continuing
485287|NCT00123396|Internet|internet
485288|NCT00123409|Primary Care|primary care
485289|NCT00123409|Telephone|telephone
485290|NCT00123409|Quality of Life|quality of life
485291|NCT00123422|Breathing exercise|breathing exercise
485292|NCT00123422|Exercise Therapy|exercise therapy
485293|NCT00123422|Helium|helium
485294|NCT00123422|Oxygen inhalation therapy|oxygen inhalation therapy
485295|NCT00123422|Pulmonary emphysema|pulmonary emphysema
485296|NCT00123422|Pulmonary ventilation|pulmonary ventilation
484655|NCT00120692|Amgen|amgen
485297|NCT00123422|Rehabilitation|rehabilitation
485298|NCT00123435|Behavioral Research|behavioral research
485299|NCT00123435|Nutritional management|nutritional management
485300|NCT00123435|Physical activity|physical activity
485301|NCT00123435|Prevention|prevention
485302|NCT00123435|Randomized control trial|randomized control trial
485303|NCT00123435|walking program|walking program
485304|NCT00123435|Weight loss|weight loss
485305|NCT00123435|World wide web|world wide web
485306|NCT00123448|Mirror Neurons|mirror neurons
485307|NCT00123448|fMRI|fmri
485308|NCT00123448|Premotor Cortex|premotor cortex
485309|NCT00123448|gesture|gesture
485310|NCT00123448|Healthy Volunteer|healthy volunteer
485311|NCT00123448|HV|hv
485312|NCT00123474|Chronic Phase Chronic Myelogenous Leukemia|chronic phase chronic myelogenous leukemia
485313|NCT00123487|Accelerated Phase Chronic Myeloid Leukemia|accelerated phase chronic myeloid leukemia
485314|NCT00123487|Lymphoid Blast Phase Chronic Myeloid Leukemia|lymphoid blast phase chronic myeloid leukemia
485315|NCT00123487|Myeloid Blast Phase Chronic Myeloid Leukemia|myeloid blast phase chronic myeloid leukemia
485316|NCT00123487|Philadelphia Positive Acute Lymphoblastic Leukemia|philadelphia positive acute lymphoblastic leukemia
485317|NCT00123552|Uganda, malaria, combination antimalarial therapy|uganda, malaria, combination antimalarial therapy
485318|NCT00123565|Coronary Disease|coronary disease
485319|NCT00123604|beta-blockers|beta-blockers
485320|NCT00123604|endothelial function|endothelial function
485321|NCT00123617|Chest pain|chest pain
485322|NCT00123617|Women|women
485323|NCT00123617|Syndrome X|syndrome x
485324|NCT00123617|Cardiac rehabilitation|cardiac rehabilitation
485325|NCT00123617|Psychological morbidity|psychological morbidity
485326|NCT00123617|Cardiovascular risk factors|cardiovascular risk factors
485327|NCT00123630|eosinophilic esophagitis|eosinophilic esophagitis
485328|NCT00123630|omalizumab|omalizumab
485329|NCT00123643|thiazolidinedione|thiazolidinedione
485330|NCT00123643|sulfonylurea|sulfonylurea
485331|NCT00123643|endothelial function|endothelial function
485332|NCT00123656|Eosinophilic esophagitis|eosinophilic esophagitis
485333|NCT00123656|esomeprazole|esomeprazole
485334|NCT00123656|fluticasone|fluticasone
485335|NCT00123669|Cancer of the Breast|cancer of the breast
485336|NCT00123669|Neoplasm|neoplasm
485337|NCT00123682|Smoking Cessation|smoking cessation
485338|NCT00123682|Care Management|care management
485339|NCT00123682|Substance Use Disorder QUERI|substance use disorder queri
485340|NCT00123682|Primary Care|primary care
485341|NCT00123682|Regional Expansion|regional expansion
485342|NCT00123682|Telephone|telephone
485343|NCT00123695|Subarachnoid hemorrhage|subarachnoid hemorrhage
485344|NCT00123695|Takotsubo cardiomyopathy|takotsubo cardiomyopathy
485345|NCT00123695|Cardiac abnormalities|cardiac abnormalities
485347|NCT00123708|Spasticity|spasticity
485348|NCT00123708|Dystonia|dystonia
485349|NCT00123708|Movement Disorders|movement disorders
485350|NCT00123708|Walking|walking
485351|NCT00123708|Muscle Weakness|muscle weakness
485352|NCT00123708|Resistance|resistance
485353|NCT00123708|Gait|gait
485354|NCT00123708|Cerebral Palsy|cerebral palsy
485355|NCT00123708|CP|cp
485356|NCT00123747|Positron Emission Tomography|positron emission tomography
485357|NCT00123747|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
485358|NCT00123747|Tomography scanners, X-Ray Computed|tomography scanners, x-ray computed
485359|NCT00123760|Positron-Emission Tomography|positron-emission tomography
485360|NCT00123760|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
485361|NCT00123760|Tomography scanners, X-Ray computed|tomography scanners, x-ray computed
485362|NCT00123773|positron emission tomography|positron emission tomography
485363|NCT00123773|fluorodeoxyglucose F18|fluorodeoxyglucose f18
485364|NCT00123773|Tomography scanners, x-ray computed|tomography scanners, x-ray computed
485365|NCT00123786|positron emission tomography|positron emission tomography
485366|NCT00123786|fluorodeoxyglucose F18|fluorodeoxyglucose f18
485367|NCT00123786|tomography scanners, x-ray computed|tomography scanners, x-ray computed
485368|NCT00123799|positron emission tomography|positron emission tomography
485369|NCT00123799|fluorodeoxyglucose F18|fluorodeoxyglucose f18
485370|NCT00123799|sentinel lymph node biopsy|sentinel lymph node biopsy
485371|NCT00123812|quality assurance|quality assurance
485372|NCT00123812|frequency of port films|frequency of port films
485373|NCT00123825|Gallbladder|gallbladder
485374|NCT00123825|Biliary Tract|biliary tract
485375|NCT00123825|Cholangiocarcinoma|cholangiocarcinoma
485376|NCT00123838|Prostate|prostate
485377|NCT00123838|Cancer|cancer
485378|NCT00123838|Radiotherapy|radiotherapy
485379|NCT00123838|Neoplasm|neoplasm
485380|NCT00123838|Localization|localization
485381|NCT00123838|Tracking|tracking
485382|NCT00123838|Cancer of Prostate|cancer of prostate
485383|NCT00123838|Neoplasms, Prostate|neoplasms, prostate
485384|NCT00123851|Colorectal|colorectal
485385|NCT00123851|Metastatic Colorectal Cancer|metastatic colorectal cancer
485386|NCT00123851|Oxaliplatin|oxaliplatin
485387|NCT00123851|Tarceva|tarceva
485388|NCT00123851|Capecitabine|capecitabine
485389|NCT00123851|Xeloda|xeloda
485390|NCT00123864|intensity modulated radiation therapy|intensity modulated radiation therapy
485391|NCT00123864|parotid|parotid
485392|NCT00123864|nasopharyngeal carcinoma|nasopharyngeal carcinoma
485394|NCT00123877|Cancer|cancer
485396|NCT00123890|HIV-1 GW873140 CCR5 antagonist experienced|hiv-1 gw873140 ccr5 antagonist experienced
485397|NCT00123903|hypertension|hypertension
485398|NCT00123903|urine albumin:creatinine ratio|urine albumin:creatinine ratio
485399|NCT00123903|microalbuminuria|microalbuminuria
485400|NCT00123916|Chagas Disease|chagas disease
485401|NCT00123916|Trypanosomiasis|trypanosomiasis
485402|NCT00123916|Benznidazole|benznidazole
485403|NCT00123916|Chronic Heart disease|chronic heart disease
485404|NCT00123916|Trypanosoma Cruzi|trypanosoma cruzi
485405|NCT00123929|breast cancer|breast cancer
485406|NCT00123929|neoadjuvant chemotherapy|neoadjuvant chemotherapy
485407|NCT00123929|genetic signature|genetic signature
485408|NCT00123929|doxorubicin|doxorubicin
485409|NCT00123929|docetaxel|docetaxel
485410|NCT00123942|CD2+ Lymphoproliferative disorder|cd2+ lymphoproliferative disorder
485411|NCT00123968|HIV Seronegativity|hiv seronegativity
485412|NCT00123968|HIV Preventive Vaccine|hiv preventive vaccine
485413|NCT00117104|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
485414|NCT00117104|Kidney Disease, Dialysis|kidney disease, dialysis
485415|NCT00117104|Aranesp®, rHuEPO|aranesp®, rhuepo
485416|NCT00117104|Anemia, Hemoglobin|anemia, hemoglobin
485417|NCT00117104|Dosing, Amgen|dosing, amgen
485418|NCT00117117|Chemotherapy induced anemia|chemotherapy induced anemia
485419|NCT00117117|Amgen|amgen
485420|NCT00117117|Aranesp®|aranesp®
485421|NCT00117117|darbepoetin alfa|darbepoetin alfa
485422|NCT00117130|Kidney disease, Renal, CKD (Chronic Kidney Disease)|kidney disease, renal, ckd (chronic kidney disease)
485423|NCT00117130|CRI (Chronic Renal Insufficiency), Pre-dialysis, Amgen|cri (chronic renal insufficiency), pre-dialysis, amgen
485424|NCT00117130|Aranesp®, Darbepoetin alfa, QW dosing|aranesp®, darbepoetin alfa, qw dosing
485425|NCT00117130|Q2W dosing, Q4W dosing|q2w dosing, q4w dosing
485426|NCT00117130|Patient preference, Subject preference|patient preference, subject preference
485427|NCT00117143|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
485428|NCT00117143|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
485429|NCT00117143|ITP|itp
485430|NCT00117143|Thrombocytopenia|thrombocytopenia
485431|NCT00117156|Fludarabine|fludarabine
485432|NCT00117156|Rituximab|rituximab
485433|NCT00117156|Marginal Zone Lymphoma|marginal zone lymphoma
485434|NCT00117156|MALT lymphoma|malt lymphoma
485435|NCT00117169|Pulmonary embolism|pulmonary embolism
485436|NCT00117169|multi-detector helical computed tomography clinical probability|multi-detector helical computed tomography clinical probability
485437|NCT00117169|clinical score|clinical score
485438|NCT00117195|parkinson|parkinson
485439|NCT00117195|diagnosis|diagnosis
485440|NCT00117195|screening|screening
485441|NCT00117208|cystic fibrosis|cystic fibrosis
485442|NCT00117221|Magnetic Resonance Imaging|magnetic resonance imaging
485443|NCT00117221|Functional Imaging|functional imaging
485444|NCT00117221|Cerebral Blood Flow|cerebral blood flow
485445|NCT00117221|BOLD Effect|bold effect
485446|NCT00117221|Sleep|sleep
485447|NCT00117234|chronic heart failure|chronic heart failure
485448|NCT00117234|congestive heart failure|congestive heart failure
485449|NCT00117234|low hemoglobin|low hemoglobin
485450|NCT00117234|anemia|anemia
485451|NCT00117234|CHF|chf
485452|NCT00117234|Symptomatic Congestive Heart Failure (CHF)|symptomatic congestive heart failure (chf)
485453|NCT00117247|Heart Failure|heart failure
485454|NCT00117260|osteopenia|osteopenia
485455|NCT00117260|bone mineral density|bone mineral density
485456|NCT00117260|amenorrhea|amenorrhea
485457|NCT00117260|adolescents|adolescents
485458|NCT00117286|Prostate Cancer|prostate cancer
485459|NCT00117286|Androgen ablation therapy|androgen ablation therapy
485460|NCT00117299|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
485461|NCT00117299|GIST|gist
485462|NCT00117299|Sarcoma|sarcoma
485463|NCT00117299|PTK787|ptk787
485464|NCT00117299|ZK 222584|zk 222584
485465|NCT00117299|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
485466|NCT00117299|Tyrosine kinase|tyrosine kinase
485467|NCT00117299|VEGF|vegf
485468|NCT00117299|Vascular endothelial growth factor|vascular endothelial growth factor
485469|NCT00117299|VEGFR|vegfr
485470|NCT00117299|Vascular endothelial growth factor receptor|vascular endothelial growth factor receptor
485471|NCT00117299|KDR|kdr
485472|NCT00117299|KIT|kit
485473|NCT00117299|c-KIT|c-kit
485474|NCT00117299|Platelet derived growth factor receptor|platelet derived growth factor receptor
485475|NCT00117299|PDGFR|pdgfr
485476|NCT00117312|Prostate Cancer|prostate cancer
485477|NCT00117312|Androgen ablation therapy|androgen ablation therapy
485478|NCT00117325|Vasomotor Rhinitis|vasomotor rhinitis
485479|NCT00117325|VMR|vmr
485480|NCT00117325|nonallergic rhinitis|nonallergic rhinitis
485481|NCT00117325|GW685698X|gw685698x
485482|NCT00117351|Adenocarcinoma|adenocarcinoma
485483|NCT00117351|Bronchiolo-Alveolar|bronchiolo-alveolar
485484|NCT00117351|Carcinoma, Bronchioloalveolar|carcinoma, bronchioloalveolar
485485|NCT00117351|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
485486|NCT00117351|Carcinoma, Bronchiolo-Alveolar|carcinoma, bronchiolo-alveolar
485487|NCT00117364|chronic ulcer|chronic ulcer
485488|NCT00117364|poor healing|poor healing
485585|NCT00117702|Stem cell transplantation|stem cell transplantation
485489|NCT00117364|The patients with a poorly healed wound, in which skin graft is clinically indicated, are included in this study|the patients with a poorly healed wound, in which skin graft is clinically indicated, are included in this study
485490|NCT00117377|Atopic dermatitis, pimecrolimus, cellular, molecular|atopic dermatitis, pimecrolimus, cellular, molecular
485491|NCT00117403|dementia|dementia
485492|NCT00117403|anti-oxidant|anti-oxidant
485493|NCT00117403|biomarkers|biomarkers
485494|NCT00117403|alpha-tocopherol|alpha-tocopherol
485496|NCT00117429|HIV-1|hiv-1
485497|NCT00117429|therapeutic vaccination|therapeutic vaccination
485498|NCT00117429|cellular immunity|cellular immunity
485499|NCT00117429|humoral immunity|humoral immunity
485500|NCT00117429|HAART|haart
485501|NCT00117429|chronic HIV-1 infection|chronic hiv-1 infection
485502|NCT00117429|Treatment Experienced|treatment experienced
485503|NCT00117429|HIV Therapeutic Vaccine|hiv therapeutic vaccine
485504|NCT00117442|solid tumour|solid tumour
485505|NCT00117442|unknown primary tumour|unknown primary tumour
485506|NCT00117442|carboplatin|carboplatin
485507|NCT00117442|paclitaxel|paclitaxel
485508|NCT00117455|ICE|ice
485509|NCT00117455|BEAM|beam
485510|NCT00117455|PBPC transplant|pbpc transplant
485511|NCT00117468|luteal phase replacement|luteal phase replacement
485512|NCT00117468|oocyte donation|oocyte donation
485513|NCT00117468|infertility|infertility
485514|NCT00117468|progesterone|progesterone
485515|NCT00117481|endometriosis|endometriosis
485516|NCT00117481|pelvic pain|pelvic pain
485517|NCT00117481|hormonal treatment|hormonal treatment
485518|NCT00117494|Hyperlipidemia|hyperlipidemia
485519|NCT00117494|HIV infections|hiv infections
485520|NCT00117494|STATINS, HMG-COA|statins, hmg-coa
485521|NCT00117494|Protease Inhibitor|protease inhibitor
485522|NCT00117494|Treatment Experienced|treatment experienced
485523|NCT00117507|MDS|mds
485524|NCT00117507|Myelodysplastic Syndrome|myelodysplastic syndrome
485525|NCT00117507|ICL-670|icl-670
485526|NCT00117507|ICL-670 and Myelodysplastic Syndrome|icl-670 and myelodysplastic syndrome
485527|NCT00117520|caffeine, endurance, postural stability, elderly|caffeine, endurance, postural stability, elderly
485528|NCT00117533|chronic hepatitis B;|chronic hepatitis b;
485529|NCT00117533|chronic hepatitis delta;|chronic hepatitis delta;
485530|NCT00117533|treatment;|treatment;
485531|NCT00117533|pegylated interferon alfa-2b;|pegylated interferon alfa-2b;
485532|NCT00117533|ribavirin|ribavirin
485533|NCT00117546|CAPACITY trial|capacity trial
485534|NCT00117546|preeclampsia|preeclampsia
485535|NCT00117546|plasma volume|plasma volume
485536|NCT00117546|sympathetic activity|sympathetic activity
485537|NCT00117546|hypertension|hypertension
485538|NCT00117546|cardiovascular system|cardiovascular system
485539|NCT00117559|Psychotherapy,group|psychotherapy,group
485540|NCT00117559|Rehabilitation|rehabilitation
485541|NCT00117559|Telecommunications|telecommunications
485542|NCT00117572|Cancer of the Pharynx (Nasopharynx, Oropharynx, Hypopharynx)|cancer of the pharynx (nasopharynx, oropharynx, hypopharynx)
485543|NCT00117572|Cancer of the Nasal Cavity and Paranasal Sinuses|cancer of the nasal cavity and paranasal sinuses
485544|NCT00117585|Aging|aging
485545|NCT00117585|Blood pressure|blood pressure
485546|NCT00117585|Hypotension|hypotension
485547|NCT00117585|Orthostatic|orthostatic
485548|NCT00117585|Rehabilitation|rehabilitation
485549|NCT00117598|Lymphoma|lymphoma
485550|NCT00117611|chronic sinusitis|chronic sinusitis
485551|NCT00117624|Non-myeloid malignancy|non-myeloid malignancy
485552|NCT00117624|Darbepoetin alfa|darbepoetin alfa
485553|NCT00117624|Clinical Trial|clinical trial
485554|NCT00117637|Renal Cell Cancer|renal cell cancer
485555|NCT00117637|RCC|rcc
485556|NCT00117637|Cancer|cancer
485557|NCT00117650|leg pain|leg pain
485558|NCT00117650|gene transfer|gene transfer
485559|NCT00117650|angiogenesis|angiogenesis
485560|NCT00117650|Phase 2|phase 2
485561|NCT00117650|Genzyme|genzyme
485562|NCT00117650|peripheral arterial disease|peripheral arterial disease
485563|NCT00117663|Randomized controlled trial|randomized controlled trial
485564|NCT00117663|Mammography|mammography
485565|NCT00117663|health care setting|health care setting
485566|NCT00117663|hormone replacement therapy|hormone replacement therapy
485567|NCT00117663|breast density|breast density
485568|NCT00117663|mammography performance|mammography performance
485569|NCT00117663|Breast Carcinoma|breast carcinoma
485570|NCT00117676|tenofovir|tenofovir
485571|NCT00117676|adefovir|adefovir
485572|NCT00117676|hepatitis B virus|hepatitis b virus
485573|NCT00117676|HBeAg Negative|hbeag negative
485574|NCT00117689|Anti-T cell antibodies|anti-t cell antibodies
485575|NCT00117689|Primary Liver Transplantation and Renal Dysfunction|primary liver transplantation and renal dysfunction
485576|NCT00117689|Liver Transplant Rejection|liver transplant rejection
96196|NCT02688153|Aortic Valve Replacement|aortic valve replacement
485577|NCT00117689|Induction Therapy with reduction of Calcineurin inhibitors|induction therapy with reduction of calcineurin inhibitors
485578|NCT00117689|Primary Liver Transplantation|primary liver transplantation
485579|NCT00117689|Primary Transplant Rejection|primary transplant rejection
485580|NCT00117689|Transplantation, Liver|transplantation, liver
485581|NCT00117689|Rejection, Transplant|rejection, transplant
485586|NCT00117715|Developmental regulation of CYPs 1A2, 2D6, 3A4|developmental regulation of cyps 1a2, 2d6, 3a4
485587|NCT00117715|Ontogeny|ontogeny
485588|NCT00117715|pharmacokinetics|pharmacokinetics
485589|NCT00117715|drug biotransformation|drug biotransformation
485590|NCT00117715|enzymatic biotransformation of drugs|enzymatic biotransformation of drugs
485591|NCT00117728|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
485592|NCT00117728|Drug Resistance|drug resistance
485593|NCT00117728|HIV Seronegativity|hiv seronegativity
485594|NCT00117728|Treatment Naive|treatment naive
485595|NCT00117741|Opiate Dependence|opiate dependence
485597|NCT00117741|Dialectical Behavior Therapy|dialectical behavior therapy
485598|NCT00117741|Drug Counseling|drug counseling
485599|NCT00117741|Therapy, Cognitive Behavior|therapy, cognitive behavior
485600|NCT00117754|Terbinafine, Tinea capitis, pediatric, antifungal|terbinafine, tinea capitis, pediatric, antifungal
485601|NCT00117767|Terbinafine, Tinea capitis, pediatric, antifungal|terbinafine, tinea capitis, pediatric, antifungal
485602|NCT00117793|Amputee|amputee
485603|NCT00117793|Artificial limbs|artificial limbs
485604|NCT00117793|Gait|gait
485605|NCT00117793|Walking|walking
485606|NCT00117806|Adult|adult
485607|NCT00117806|Depression|depression
485608|NCT00117806|Employment, supported|employment, supported
485609|NCT00117806|Health Service/ut|health service/ut
485610|NCT00117806|Humans|humans
485611|NCT00117806|Outcomes|outcomes
485612|NCT00117806|Quality of life|quality of life
485613|NCT00117806|Veterans/rh (rehabilitation)|veterans/rh (rehabilitation)
485614|NCT00117806|Workplace|workplace
485615|NCT00117806|Spinal Cord Injuries|spinal cord injuries
485616|NCT00117819|parkinson|parkinson
485617|NCT00117819|family history|family history
485618|NCT00117819|diagnosis|diagnosis
485619|NCT00117832|allergic rhinitis|allergic rhinitis
485620|NCT00117845|Denileukin Diftitox (Ontak)|denileukin diftitox (ontak)
485621|NCT00117845|Recombinant Immunotoxin|recombinant immunotoxin
485622|NCT00117845|Human T-Cell Lymphotropic Virus (HTLV1)|human t-cell lymphotropic virus (htlv1)
485623|NCT00117845|CD25 Positive|cd25 positive
485624|NCT00117845|IL-2R|il-2r
485625|NCT00117845|ATL|atl
485626|NCT00117845|Ontak|ontak
485627|NCT00117845|Adult T-Cell Leukemia|adult t-cell leukemia
485628|NCT00117845|Lymphoproliferative Disorders|lymphoproliferative disorders
485629|NCT00117858|Frontal Lobe|frontal lobe
485630|NCT00117858|Language|language
485631|NCT00117858|Behavior|behavior
485632|NCT00117858|Degenerative Diseases|degenerative diseases
485633|NCT00117858|Pick's Disease|pick's disease
485634|NCT00117858|Frontotemporal Dementia|frontotemporal dementia
485635|NCT00117858|FTP|ftp
485636|NCT00117871|Warts|warts
485637|NCT00117871|Adults|adults
485638|NCT00117871|Common Warts|common warts
485639|NCT00117871|Resiquimod|resiquimod
485640|NCT00117884|Papillomavirus infections;|papillomavirus infections;
485641|NCT00117884|Cervix Dysplasia|cervix dysplasia
485642|NCT00117897|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
485643|NCT00117897|R-CHOP-14|r-chop-14
485644|NCT00117897|pegfilgrastim|pegfilgrastim
485645|NCT00117897|neutropenia, clinical trial|neutropenia, clinical trial
485646|NCT00117897|haematopoietic growth factor|haematopoietic growth factor
485647|NCT00117910|Aged, Granulocyte Colony-Stimulating Factor|aged, granulocyte colony-stimulating factor
485648|NCT00117910|Combined Modality Therapy, Neutropenia|combined modality therapy, neutropenia
485649|NCT00117910|pegfilgrastim, Neulasta®|pegfilgrastim, neulasta®
485650|NCT00117910|FEC-100, Antineoplastic Agents|fec-100, antineoplastic agents
485651|NCT00117910|Breast Cancer, Female|breast cancer, female
485652|NCT00117923|Warts|warts
485653|NCT00117923|Adults|adults
485654|NCT00117923|Common Warts|common warts
485655|NCT00117923|Resiquimod|resiquimod
485656|NCT00117936|Angiogenesis|angiogenesis
485657|NCT00117936|No-option heart patients|no-option heart patients
485658|NCT00117936|Blocked coronary artery|blocked coronary artery
485659|NCT00117936|Revascularization|revascularization
485660|NCT00117936|FGF-1|fgf-1
485661|NCT00117936|growth factor|growth factor
485662|NCT00117949|Prostate Cancer|prostate cancer
485663|NCT00117949|Androgen ablation therapy|androgen ablation therapy
485664|NCT00117962|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
485665|NCT00117962|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
485666|NCT00117962|squamous cell lung cancer|squamous cell lung cancer
485667|NCT00117962|large cell lung cancer|large cell lung cancer
485668|NCT00117962|adenocarcinoma of the lung|adenocarcinoma of the lung
485669|NCT00117962|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
485670|NCT00117975|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
96197|NCT02688153|Aortic Stenosis|aortic stenosis
485671|NCT00117975|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
485672|NCT00117975|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
485673|NCT00117975|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
485674|NCT00117975|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
485675|NCT00117975|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
485676|NCT00117975|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
485677|NCT00117975|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
485678|NCT00117975|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
485679|NCT00117975|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
485680|NCT00117975|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
485681|NCT00117975|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
485682|NCT00118001|Psychotherapy|psychotherapy
485683|NCT00118001|Generalized Anxiety Disorder|generalized anxiety disorder
485684|NCT00118001|randomized-controlled trial|randomized-controlled trial
485685|NCT00118001|worry exposure|worry exposure
485686|NCT00118001|applied relaxation|applied relaxation
485687|NCT00118014|Trichotillomania|trichotillomania
485688|NCT00118014|Habit Reversal Training|habit reversal training
485689|NCT00118014|Sertraline|sertraline
485690|NCT00118014|Zoloft|zoloft
485691|NCT00118027|Malaria in pregnancy|malaria in pregnancy
485692|NCT00118027|Anaemia|anaemia
485693|NCT00118027|Low birth weight|low birth weight
485694|NCT00118053|inflammatory breast cancer|inflammatory breast cancer
485695|NCT00118053|stage II breast cancer|stage ii breast cancer
485696|NCT00118053|stage IIIA breast cancer|stage iiia breast cancer
485697|NCT00118053|stage IIIB breast cancer|stage iiib breast cancer
485698|NCT00118053|stage IIIC breast cancer|stage iiic breast cancer
485699|NCT00118066|prostate cancer|prostate cancer
485700|NCT00118066|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
485701|NCT00123981|Off-pump Coronary Artery By-pass Grafting|off-pump coronary artery by-pass grafting
485702|NCT00123981|Randomization|randomization
485703|NCT00123981|stroke|stroke
485704|NCT00123981|myocardial infarction|myocardial infarction
485705|NCT00123981|mortality|mortality
485706|NCT00123981|graft patency|graft patency
485707|NCT00123981|quality of life|quality of life
485708|NCT00123994|TaiChi|taichi
485709|NCT00123994|Hydrotherapy|hydrotherapy
485710|NCT00123994|Exercise|exercise
485711|NCT00123994|Joint pain|joint pain
485712|NCT00123994|Disability|disability
485713|NCT00124007|HIV Seronegativity|hiv seronegativity
485714|NCT00124007|HIV Preventive Vaccine|hiv preventive vaccine
485715|NCT00124033|Cholecystectomy|cholecystectomy
485716|NCT00124033|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
485717|NCT00124046|Urinary Incontinence in Children|urinary incontinence in children
485718|NCT00124046|Surgical Section of the Filum Terminale|surgical section of the filum terminale
485719|NCT00124046|Occult Tethered Cord Syndrome|occult tethered cord syndrome
485720|NCT00124046|Urodynamic Scale|urodynamic scale
485721|NCT00124046|Enuresis-Specific Quality of Life Scale|enuresis-specific quality of life scale
485722|NCT00124059|alcohol dependence|alcohol dependence
485723|NCT00124072|Myocardial infarction|myocardial infarction
485724|NCT00124072|Coronary heart disease|coronary heart disease
485725|NCT00124072|Cholesterol|cholesterol
485726|NCT00124072|Stroke|stroke
485727|NCT00124098|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
485728|NCT00124098|anemia, clinical trial|anemia, clinical trial
485729|NCT00124098|darbepoetin alfa|darbepoetin alfa
485730|NCT00124098|Aranesp®|aranesp®
485731|NCT00124098|Amgen|amgen
485732|NCT00124111|clinical trial|clinical trial
485733|NCT00124111|pegfilgrastim|pegfilgrastim
485734|NCT00124111|haematopoietic growth factor|haematopoietic growth factor
485735|NCT00124111|neutropenia|neutropenia
485736|NCT00124111|CMF|cmf
485737|NCT00124111|Cancer|cancer
485738|NCT00124137|Ultrafiltration|ultrafiltration
485739|NCT00124137|acute decompensated heart failure|acute decompensated heart failure
485740|NCT00124137|fluid overload|fluid overload
485741|NCT00124137|pulmonary congestion|pulmonary congestion
485742|NCT00124150|subarachnoid hemorrhage|subarachnoid hemorrhage
485743|NCT00124150|magnesium sulfate|magnesium sulfate
485744|NCT00124163|CT Virtual Colonoscopy|ct virtual colonoscopy
485745|NCT00124163|Optical Colonoscopy|optical colonoscopy
485746|NCT00124163|Stool Tagging|stool tagging
485747|NCT00124163|Patient Preparation|patient preparation
485748|NCT00124176|Asthma|asthma
485749|NCT00124176|Levalbuterol|levalbuterol
485750|NCT00124176|Albuterol|albuterol
485751|NCT00124176|Children|children
485752|NCT00124189|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
485753|NCT00124189|T-cell prolymphocytic leukemia|t-cell prolymphocytic leukemia
485754|NCT00124189|Chronic lymphoproliferative diseases|chronic lymphoproliferative diseases
485755|NCT00124189|Telomerase|telomerase
485756|NCT00124189|Telomerase Inhibition|telomerase inhibition
485757|NCT00124202|a fatty meal|a fatty meal
485758|NCT00124202|ERCP|ercp
485759|NCT00124215|Hepatitis|hepatitis
485760|NCT00124215|HCV|hcv
485761|NCT00124215|vaccine|vaccine
485762|NCT00124215|Hepatitis C Infection|hepatitis c infection
485763|NCT00124228|Cirrhosis|cirrhosis
485764|NCT00124228|Infection|infection
485765|NCT00124228|Sepsis|sepsis
485766|NCT00124228|Renal failure|renal failure
485767|NCT00124254|Metacarpophalangeal Joint|metacarpophalangeal joint
485768|NCT00124254|Arthroplasty|arthroplasty
485769|NCT00124254|Outcomes|outcomes
485770|NCT00124254|Michigan Hand Outcomes Questionnaire|michigan hand outcomes questionnaire
485771|NCT00124254|Joint Replacement|joint replacement
485772|NCT00124267|Cerebral|cerebral
485774|NCT00124267|intra-rectal|intra-rectal
485775|NCT00124267|quinine|quinine
485776|NCT00124267|children|children
485777|NCT00124267|Uganda|uganda
485778|NCT00124267|efficacy|efficacy
485779|NCT00124267|safety|safety
485780|NCT00124280|Lung cancer|lung cancer
485781|NCT00124280|non-small cell|non-small cell
485782|NCT00124280|everolimus|everolimus
485783|NCT00124280|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
485784|NCT00124306|painful bladder syndrome|painful bladder syndrome
485785|NCT00124306|interstitial cystitis|interstitial cystitis
485786|NCT00124306|newly diagnosed|newly diagnosed
485787|NCT00124579|stage I multiple myeloma|stage i multiple myeloma
485788|NCT00124579|stage II multiple myeloma|stage ii multiple myeloma
485789|NCT00124579|stage III multiple myeloma|stage iii multiple myeloma
485790|NCT00124579|refractory multiple myeloma|refractory multiple myeloma
485791|NCT00124618|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
485792|NCT00124618|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
485793|NCT00124644|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
485794|NCT00124644|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
485795|NCT00124644|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
485796|NCT00124644|secondary acute myeloid leukemia|secondary acute myeloid leukemia
485797|NCT00124657|adult anaplastic astrocytoma|adult anaplastic astrocytoma
485798|NCT00124657|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
485799|NCT00124657|adult glioblastoma|adult glioblastoma
485800|NCT00124657|adult giant cell glioblastoma|adult giant cell glioblastoma
485801|NCT00124657|adult gliosarcoma|adult gliosarcoma
485802|NCT00124657|adult mixed glioma|adult mixed glioma
485803|NCT00124657|childhood mixed glioma|childhood mixed glioma
485804|NCT00124657|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
485805|NCT00124657|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
485806|NCT00124657|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
485807|NCT00124657|childhood oligodendroglioma|childhood oligodendroglioma
583850|NCT00512915|Bradycardia|bradycardia
485808|NCT00124657|childhood spinal cord neoplasm|childhood spinal cord neoplasm
485809|NCT00124683|nicotine dependence|nicotine dependence
485810|NCT00124696|cocaine dependence|cocaine dependence
485811|NCT00124709|Atopic, dermatitis, asthma, children, modification|atopic, dermatitis, asthma, children, modification
485812|NCT00124709|Atopic dermatitis/atopy|atopic dermatitis/atopy
485814|NCT00124748|Philadelphia positive|philadelphia positive
485815|NCT00124748|Bcr-abl|bcr-abl
485816|NCT00124748|imatinib mesylate|imatinib mesylate
485817|NCT00124748|Chronic myeloid leukemia (CML) in chronic phase|chronic myeloid leukemia (cml) in chronic phase
485818|NCT00124761|Radiosurgery|radiosurgery
485819|NCT00124761|Brain metastases|brain metastases
485820|NCT00124761|Whole Brain Radiotherapy|whole brain radiotherapy
485821|NCT00124761|Neurosurgery|neurosurgery
485822|NCT00124761|Solitary Brain Metastases|solitary brain metastases
485823|NCT00124761|Adult Tumours Metastatic to Brain|adult tumours metastatic to brain
485824|NCT00124774|hernia|hernia
485825|NCT00124774|nucleoplasty|nucleoplasty
485826|NCT00124774|radicular pain|radicular pain
485954|NCT00125281|Liver Disease|liver disease
485827|NCT00124774|Contained lumbar herniated disc|contained lumbar herniated disc
485828|NCT00124800|tinnitus|tinnitus
485829|NCT00124826|stroke|stroke
485830|NCT00124826|cerebrovascular disease|cerebrovascular disease
485831|NCT00124826|hyperglycemia|hyperglycemia
485832|NCT00124826|magnetic resonance imaging|magnetic resonance imaging
485833|NCT00124826|acute ischemic stroke|acute ischemic stroke
485834|NCT00124839|Dissociation|dissociation
485835|NCT00124839|Flashbacks|flashbacks
485836|NCT00124839|Self-injurious behavior|self-injurious behavior
485837|NCT00124852|cognition|cognition
485838|NCT00124852|depression|depression
485839|NCT00124852|elderly|elderly
485840|NCT00124865|Campylobacter|campylobacter
485841|NCT00124865|Bacterial enteritis|bacterial enteritis
485843|NCT00124878|STDs|stds
485844|NCT00124878|Male circumcision|male circumcision
485845|NCT00124878|HIV+ males|hiv+ males
485846|NCT00124878|HIV-negative males|hiv-negative males
485847|NCT00124878|Female partners|female partners
485848|NCT00124878|STDs such as the following:|stds such as the following:
485849|NCT00124878|HPV|hpv
626310|NCT00678639|ACS|acs
485850|NCT00124878|HSV-2|hsv-2
485851|NCT00124878|HIV Seronegativity|hiv seronegativity
485852|NCT00124891|Arrhythmias|arrhythmias
485853|NCT00124904|Biofeedback|biofeedback
485854|NCT00124904|Incontinence|incontinence
485855|NCT00124917|Prostate Cancer|prostate cancer
485856|NCT00124917|MRI|mri
485857|NCT00124917|Fiducial Marker|fiducial marker
485858|NCT00124917|IMRT|imrt
485859|NCT00124930|olanzapine|olanzapine
485860|NCT00124930|haldol|haldol
485861|NCT00124930|cancer|cancer
485862|NCT00124930|nausea|nausea
485863|NCT00124930|second line treatment|second line treatment
485864|NCT00124930|refractory nausea|refractory nausea
485865|NCT00124943|Prevention of Instent Restenosis|prevention of instent restenosis
485866|NCT00124969|End-stage renal disease, hemodialysis|end-stage renal disease, hemodialysis
485867|NCT00125008|Salmonella|salmonella
485868|NCT00125008|Typhoid vaccine|typhoid vaccine
485869|NCT00125008|enteric fever|enteric fever
485870|NCT00125021|Second Line Therapy|second line therapy
485871|NCT00125021|Gemcitabine Refractory|gemcitabine refractory
485872|NCT00125021|Pancreatic Cancer|pancreatic cancer
485873|NCT00125021|Capecitabine|capecitabine
485874|NCT00125021|Tarceva|tarceva
485875|NCT00125021|OSI-774|osi-774
485876|NCT00125021|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
485877|NCT00125034|FOLFOX-4|folfox-4
485878|NCT00125034|Cetuximab|cetuximab
485879|NCT00125034|First-line mCRC|first-line mcrc
485880|NCT00125034|EGFR positive|egfr positive
485881|NCT00125034|metastatic CRC|metastatic crc
485882|NCT00125047|Salmonellosis|salmonellosis
485883|NCT00125047|typhoid vaccine|typhoid vaccine
485884|NCT00125047|enteric fever|enteric fever
485885|NCT00125060|Aorta|aorta
485886|NCT00125060|Atherosclerosis|atherosclerosis
485888|NCT00125060|statin|statin
485889|NCT00125060|inflammatory markers|inflammatory markers
485890|NCT00125073|Standard Care|standard care
485891|NCT00125073|Nutritional Counseling|nutritional counseling
485892|NCT00125086|wounds|wounds
485893|NCT00125086|healing|healing
485894|NCT00125086|Acute wounds healing by secondary intention|acute wounds healing by secondary intention
485895|NCT00125099|Acute Infection|acute infection
485896|NCT00125099|Treatment Experienced|treatment experienced
485897|NCT00125099|Treatment Interruption|treatment interruption
485898|NCT00125099|HIV Therapeutic Vaccine|hiv therapeutic vaccine
485899|NCT00125112|binge eating|binge eating
485900|NCT00125112|weight loss|weight loss
485901|NCT00125112|obesity|obesity
485902|NCT00125125|Dyslipidemia, adults, fluvastatin|dyslipidemia, adults, fluvastatin
485903|NCT00125151|MeSH: angioneurotic edema, complement 1 inactivators|mesh: angioneurotic edema, complement 1 inactivators
485904|NCT00125151|Hereditary angioedema type I or II, Acquired angioedema|hereditary angioedema type i or ii, acquired angioedema
485905|NCT00125164|Primary IGF-1 Deficiency|primary igf-1 deficiency
485906|NCT00125177|pelvic muscle therapy|pelvic muscle therapy
485907|NCT00125177|urinary incontinence therapy|urinary incontinence therapy
485908|NCT00125177|stress incontinence intervention|stress incontinence intervention
485909|NCT00125177|incontinence intervention|incontinence intervention
485910|NCT00125177|Incontinence|incontinence
485912|NCT00125177|Stress Incontinence|stress incontinence
485913|NCT00125190|Primary IGF-1 Deficiency|primary igf-1 deficiency
485914|NCT00125190|IGF-1|igf-1
485915|NCT00125203|ALS|als
485916|NCT00125203|Lou Gehrig's Disease|lou gehrig's disease
485917|NCT00125203|Motor Neuron Disease|motor neuron disease
485918|NCT00125203|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
485919|NCT00125203|Sialorrhea|sialorrhea
485920|NCT00125203|Hypersalivation|hypersalivation
485921|NCT00125203|Excessive Drooling|excessive drooling
485922|NCT00125203|Myobloc|myobloc
485923|NCT00125203|botulinum toxin type B|botulinum toxin type b
485924|NCT00125203|Clostridium botulinum B toxin|clostridium botulinum b toxin
485925|NCT00125203|botulinum B toxin|botulinum b toxin
485926|NCT00125203|botulinum neurotoxin B|botulinum neurotoxin b
485927|NCT00125203|NeuroBloc|neurobloc
485928|NCT00125216|Aphasia|aphasia
485929|NCT00125216|Language Therapy|language therapy
485930|NCT00125216|Rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
485931|NCT00125216|Speech-language pathology|speech-language pathology
485932|NCT00125229|Hypertonic Saline|hypertonic saline
485933|NCT00125229|Mannitol|mannitol
485934|NCT00125229|Intracranial hypertension|intracranial hypertension
485935|NCT00125229|Cerebral blood flow|cerebral blood flow
485936|NCT00125229|Traumatic brain injury|traumatic brain injury
485937|NCT00125242|Aphasia|aphasia
485938|NCT00125242|Language therapy|language therapy
485939|NCT00125242|Rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
485940|NCT00125242|Speech-language pathology|speech-language pathology
485941|NCT00125268|painful|painful
485942|NCT00125268|peripheral|peripheral
485943|NCT00125268|neuropathy|neuropathy
485944|NCT00125268|light|light
485945|NCT00125268|therapy|therapy
485946|NCT00125281|Fatigue|fatigue
485947|NCT00125281|Cirrhosis|cirrhosis
485948|NCT00125281|S-Adenosyl Methionine|s-adenosyl methionine
485949|NCT00125281|Primary Biliary Cirrhosis|primary biliary cirrhosis
485950|NCT00125281|Pruritus|pruritus
485951|NCT00125281|Symptomatic Releif|symptomatic releif
485952|NCT00125281|Serum Liver-Related Enzymes|serum liver-related enzymes
485953|NCT00125281|PBC|pbc
485955|NCT00125294|cancer pain|cancer pain
485956|NCT00125294|breakthrough pain|breakthrough pain
485957|NCT00125294|methadone|methadone
485958|NCT00125294|dose titration|dose titration
485959|NCT00125294|sublingual route of administration|sublingual route of administration
485960|NCT00125294|Cancer related pain|cancer related pain
485961|NCT00125294|currently taking narcotics|currently taking narcotics
485963|NCT00125307|glomerulonephritis|glomerulonephritis
485964|NCT00125307|immunosuppressive therapy|immunosuppressive therapy
485965|NCT00125307|type V (membranous) lupus nephritis|type v (membranous) lupus nephritis
485966|NCT00125320|Treatment|treatment
485967|NCT00125333|atopic dermatitis, eczema|atopic dermatitis, eczema
485968|NCT00125346|Tobramycin Inhalation Powder|tobramycin inhalation powder
485970|NCT00125359|targretin|targretin
485971|NCT00125359|non-small cell lung cancer|non-small cell lung cancer
485972|NCT00125359|Carcinoma, non-small cell lung cancer|carcinoma, non-small cell lung cancer
485973|NCT00125359|NSCLC|nsclc
485974|NCT00125372|tarceva|tarceva
485975|NCT00125372|targretin|targretin
485976|NCT00125372|non-small cell lung cancer|non-small cell lung cancer
485977|NCT00125372|carcinoma, non-small cell lung cancer|carcinoma, non-small cell lung cancer
485978|NCT00125372|nsclc|nsclc
485979|NCT00125385|IPF|ipf
485980|NCT00125385|Idiopathic|idiopathic
485981|NCT00125385|Pulmonary|pulmonary
485982|NCT00125385|Fibrosis|fibrosis
485983|NCT00125398|AQUAVAN|aquavan
485984|NCT00125398|GPI 15715|gpi 15715
485985|NCT00125398|ICU|icu
485986|NCT00125398|Sedation|sedation
485987|NCT00125411|satraplatin|satraplatin
485988|NCT00125411|docetaxel|docetaxel
485989|NCT00125411|cancer|cancer
485990|NCT00125411|Phase I|phase i
485991|NCT00125411|advanced solid tumors|advanced solid tumors
485992|NCT00125424|Colonoscopy|colonoscopy
485993|NCT00125424|Sedation|sedation
485994|NCT00125424|AQUAVAN|aquavan
485995|NCT00125424|(fospropofol disodium)|(fospropofol disodium)
485996|NCT00125424|Endoscopic sedation|endoscopic sedation
485997|NCT00125424|Endoscopic outcomes|endoscopic outcomes
485998|NCT00125424|Endoscopy|endoscopy
485999|NCT00125437|aldosterone antagonists|aldosterone antagonists
486000|NCT00125437|spironolactone|spironolactone
486001|NCT00125437|left ventricular remodeling|left ventricular remodeling
486002|NCT00125450|Acute Bronchiolitis|acute bronchiolitis
486003|NCT00125450|Chest Physiotherapy|chest physiotherapy
486004|NCT00125450|Forced Expiratory Techniques|forced expiratory techniques
486005|NCT00125450|Double Blind Trial|double blind trial
486006|NCT00125450|Children|children
486007|NCT00125450|Pediatric|pediatric
486008|NCT00125450|RESPIRATORY SYNCYTIAL VIRUS|respiratory syncytial virus
486009|NCT00125463|Hypertension|hypertension
486010|NCT00125463|clinical trial|clinical trial
486011|NCT00125463|Candesartan Antihypertensive Survival Evaluation in Japan trial|candesartan antihypertensive survival evaluation in japan trial
486012|NCT00125463|candesartan cilexetil|candesartan cilexetil
486013|NCT00125463|amlodipine besilate|amlodipine besilate
486014|NCT00125476|Postmenopause|postmenopause
486015|NCT00125489|chloroquine, malaria, sulfadoxine/pyrimethamine, Malawi|chloroquine, malaria, sulfadoxine/pyrimethamine, malawi
486016|NCT00125502|CMV, Cytomegalovirus, vaccine, women, postpartum|cmv, cytomegalovirus, vaccine, women, postpartum
486017|NCT00125515|Heroin|heroin
486018|NCT00125515|Opiates|opiates
486019|NCT00125515|naltrexone|naltrexone
486020|NCT00125515|memantine|memantine
486021|NCT00125528|chronic pain|chronic pain
486022|NCT00125528|low back pain|low back pain
486023|NCT00125528|D-cycloserine|d-cycloserine
486024|NCT00125541|MeSH: angioneurotic edema, complement 1 inactivators|mesh: angioneurotic edema, complement 1 inactivators
486025|NCT00125541|Hereditary Angioedema Type I or II, Acquired Angioedema|hereditary angioedema type i or ii, acquired angioedema
486026|NCT00125554|Clinical trial|clinical trial
486027|NCT00125554|double-blind|double-blind
486028|NCT00125554|randomized placebo-controlled trial|randomized placebo-controlled trial
486029|NCT00125554|metyrapone|metyrapone
486030|NCT00125554|Major Depression|major depression
486031|NCT00125580|Obesity|obesity
486032|NCT00125580|Childhood Obesity|childhood obesity
486033|NCT00125580|Infant Sleep|infant sleep
486034|NCT00125580|Infant growth|infant growth
486035|NCT00125580|Infant feeding|infant feeding
486036|NCT00125593|Kidney Disease, Chronic|kidney disease, chronic
486037|NCT00125593|LDL cholesterol|ldl cholesterol
486038|NCT00125593|simvastatin|simvastatin
486039|NCT00125593|ezetimibe|ezetimibe
486040|NCT00125593|cardiovascular disease|cardiovascular disease
486041|NCT00125593|atherosclerosis|atherosclerosis
486042|NCT00125606|AML|aml
486043|NCT00125606|allogeneic HSCT|allogeneic hsct
486044|NCT00125606|reduced intensity conditioning|reduced intensity conditioning
486045|NCT00125606|randomized trail|randomized trail
486046|NCT00125619|biomechanics|biomechanics
486047|NCT00125619|stroke|stroke
486048|NCT00125619|electromyography|electromyography
486049|NCT00125619|Gait disability stroke|gait disability stroke
486050|NCT00125619|locomotor therapy|locomotor therapy
486051|NCT00125619|muscular weakness|muscular weakness
486052|NCT00125619|reflex variability stroke|reflex variability stroke
486053|NCT00125632|Reading|reading
486054|NCT00125632|Rehabilitation|rehabilitation
486055|NCT00125632|Treatment Outcomes|treatment outcomes
486056|NCT00125632|Low vision|low vision
486057|NCT00125645|AMI|ami
486058|NCT00125645|Left ventricular function|left ventricular function
486059|NCT00125645|Myocardial performance index|myocardial performance index
486060|NCT00125645|Acute myocardial infarction (AMI)|acute myocardial infarction (ami)
486061|NCT00125658|biomechanics|biomechanics
486062|NCT00125658|Cerebrovascular Accident|cerebrovascular accident
486063|NCT00125658|electromyography|electromyography
486064|NCT00125658|muscular weakness|muscular weakness
486065|NCT00125658|recovery of function|recovery of function
486066|NCT00125658|reflex variability stroke|reflex variability stroke
486067|NCT00125658|upper-extremity kinematics|upper-extremity kinematics
486068|NCT00125671|Warfarin and Antiplatelet Vascular Evaluation|warfarin and antiplatelet vascular evaluation
486069|NCT00125671|Peripheral vascular disease|peripheral vascular disease
486070|NCT00125671|Atherosclerosis|atherosclerosis
486071|NCT00125671|cardiovascular events|cardiovascular events
486072|NCT00125671|Ischemia|ischemia
486073|NCT00125671|oral anticoagulants|oral anticoagulants
486074|NCT00125671|low ankle-brachial index|low ankle-brachial index
486075|NCT00125671|moderate intensity warfarin|moderate intensity warfarin
486076|NCT00125671|International normalized ratio [INR]|international normalized ratio [inr]
486077|NCT00125684|transdermal morphine|transdermal morphine
486078|NCT00125684|cancer|cancer
486079|NCT00125684|pain|pain
486080|NCT00125684|bioavailability|bioavailability
486081|NCT00125684|pharmacokinetics|pharmacokinetics
486082|NCT00125684|cancer related pain|cancer related pain
486083|NCT00125684|stable baseline pain|stable baseline pain
486084|NCT00125684|currently taking opioids|currently taking opioids
486085|NCT00125697|malignant glioma|malignant glioma
486086|NCT00125697|spectroscopy|spectroscopy
486087|NCT00125697|magnetic resonance|magnetic resonance
486088|NCT00125710|cryogenic analysis|cryogenic analysis
486089|NCT00125710|oncogenes|oncogenes
486090|NCT00125723|Phase 4 Clinical Trial|phase 4 clinical trial
486091|NCT00125723|Chemotherapy|chemotherapy
486092|NCT00125723|Neulasta®|neulasta®
486093|NCT00125723|Oncology|oncology
486094|NCT00125723|Malignancy|malignancy
486095|NCT00125749|Dendritic|dendritic
486096|NCT00125749|Vaccine|vaccine
486097|NCT00125749|Melanoma|melanoma
583851|NCT00512928|vitamin K2|vitamin k2
486098|NCT00125749|Stage IV metastatic melanoma|stage iv metastatic melanoma
486099|NCT00125788|sickle cell disease|sickle cell disease
486100|NCT00125788|sickle cell anemia|sickle cell anemia
486101|NCT00125788|L-glutamine|l-glutamine
486102|NCT00125788|Sickle Cell Anemia (homozygous)|sickle cell anemia (homozygous)
486103|NCT00125788|Sickle ß0-Thalassemia|sickle ß0-thalassemia
486104|NCT00125814|Interferon Alfa-2b|interferon alfa-2b
486105|NCT00125814|HIV infections|hiv infections
486106|NCT00125827|CLO152|clo152
486107|NCT00125827|Clolar|clolar
486108|NCT00125840|CLO151|clo151
486109|NCT00125840|Clolar|clolar
486110|NCT00125840|Pediatric ALL and AML|pediatric all and aml
486111|NCT00125840|Adult ALL and AML and MDS|adult all and aml and mds
486112|NCT00125853|blood pressure|blood pressure
486113|NCT00125853|insulin sensitivity|insulin sensitivity
486114|NCT00125853|beta blockers|beta blockers
486115|NCT00125853|randomised double blind crossover trial|randomised double blind crossover trial
486116|NCT00125866|randomised double blind trial|randomised double blind trial
486117|NCT00125866|blood pressure|blood pressure
486118|NCT00125866|cocoa flavonoids|cocoa flavonoids
486119|NCT00125879|Glycogen Storage Disease Type II|glycogen storage disease type ii
486120|NCT00125879|GSD-II|gsd-ii
486121|NCT00125879|Pompe Disease|pompe disease
486122|NCT00125879|Pompe Disease (Late-onset)|pompe disease (late-onset)
486123|NCT00125879|Acid Maltase Deficiency Disease|acid maltase deficiency disease
486124|NCT00125879|Glycogenosis 2|glycogenosis 2
486125|NCT00125879|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
486126|NCT00125905|Primary Care|primary care
486127|NCT00125905|Smoking Cessation|smoking cessation
486128|NCT00125905|Stages of Change Model|stages of change model
486129|NCT00125905|Health Education|health education
486869|NCT00129688|children|children
486130|NCT00125905|Clinical Practice guideline|clinical practice guideline
486131|NCT00125918|Hypertension, Pulmonary; Pulmonary Heart Disease|hypertension, pulmonary; pulmonary heart disease
486132|NCT00125931|bipolar disorder|bipolar disorder
486133|NCT00125931|mania|mania
486134|NCT00125931|manic state|manic state
486135|NCT00125931|opiate|opiate
486136|NCT00125931|kappa|kappa
486137|NCT00125957|depression|depression
486138|NCT00125957|serotonin|serotonin
486139|NCT00125957|norepinephrine|norepinephrine
486140|NCT00125957|SSRI|ssri
486141|NCT00125957|Wellbutrin|wellbutrin
486142|NCT00125957|bupropion|bupropion
486143|NCT00125957|executive function|executive function
486144|NCT00125957|residual symptoms|residual symptoms
486145|NCT00125970|HIV Seronegativity|hiv seronegativity
486146|NCT00125970|HIV Preventive Vaccine|hiv preventive vaccine
486147|NCT00125983|Birth Control Pills|birth control pills
486148|NCT00125983|Oral Contraceptives|oral contraceptives
486149|NCT00125983|Contraceptive Patch|contraceptive patch
486150|NCT00125983|Pharmacokinetics|pharmacokinetics
486151|NCT00125983|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
486152|NCT00125983|Protease Inhibitor|protease inhibitor
486153|NCT00125983|Treatment Experienced|treatment experienced
486154|NCT00125983|Treatment Naive|treatment naive
486155|NCT00125983|Contraception|contraception
486157|NCT00125996|Iron Deficiency|iron deficiency
486158|NCT00126022|Atrial fibrillation|atrial fibrillation
486159|NCT00126022|atrial flutter|atrial flutter
486160|NCT00126022|anti-arrhythmic agents|anti-arrhythmic agents
486161|NCT00126022|conversion to normal sinus rhythm|conversion to normal sinus rhythm
486162|NCT00126035|Acute Migraine|acute migraine
486164|NCT00126035|Migraid|migraid
486165|NCT00126035|Treatment|treatment
486166|NCT00126035|Aura|aura
486167|NCT00126048|Atopy|atopy
486168|NCT00126048|Statin|statin
486169|NCT00126048|Asthma|asthma
486170|NCT00126048|methacholine|methacholine
486171|NCT00126048|FEV1|fev1
486172|NCT00126061|Atrial fibrillation|atrial fibrillation
486173|NCT00126061|atrial flutter|atrial flutter
486174|NCT00126061|anti-arrhythmic agents|anti-arrhythmic agents
486175|NCT00126061|conversion to normal sinus rhythm|conversion to normal sinus rhythm
486176|NCT00126074|Atrial fibrillation, atrial flutter, anti-arrhythmic agents, conversion to normal sinus rhythm|atrial fibrillation, atrial flutter, anti-arrhythmic agents, conversion to normal sinus rhythm
486177|NCT00126087|dopamine|dopamine
486178|NCT00126087|NMDA receptor|nmda receptor
486179|NCT00126087|brain imaging|brain imaging
486180|NCT00126087|neuroplasticity|neuroplasticity
486181|NCT00126087|learning|learning
486182|NCT00126087|transcranial direct current stimulation|transcranial direct current stimulation
486183|NCT00126087|rehabilitation|rehabilitation
486184|NCT00126087|aging|aging
486185|NCT00126100|Stem Cells|stem cells
486186|NCT00126113|Audiologic rehabilitation|audiologic rehabilitation
486187|NCT00126113|Counseling|counseling
486188|NCT00126126|Artificial Limbs|artificial limbs
486189|NCT00126126|Evidence based medicine|evidence based medicine
486190|NCT00126126|Exercise|exercise
486191|NCT00126126|Outcomes research|outcomes research
486192|NCT00126126|Physical therapy|physical therapy
486193|NCT00126139|stroke, ischemic|stroke, ischemic
486194|NCT00126139|stenosis, internal carotid artery|stenosis, internal carotid artery
486195|NCT00126139|Acute ischemic stroke|acute ischemic stroke
486196|NCT00126139|Stenosis of extracranial internal carotid artery|stenosis of extracranial internal carotid artery
486197|NCT00126152|Falls|falls
486198|NCT00126152|Exercise|exercise
486199|NCT00126152|Fall Risk Factors|fall risk factors
486200|NCT00126152|Older Adults|older adults
486201|NCT00126165|prostate cancer|prostate cancer
486202|NCT00126165|radiotherapy|radiotherapy
486203|NCT00126165|hypofraction|hypofraction
486204|NCT00126165|radiosensitivity|radiosensitivity
486205|NCT00126165|image-guidance|image-guidance
486206|NCT00126178|Kidney Cancer|kidney cancer
486207|NCT00126178|Renal|renal
486208|NCT00126178|Immunotherapy|immunotherapy
486209|NCT00126178|Vaccine|vaccine
486210|NCT00126191|Burkitt Lymphoma|burkitt lymphoma
486211|NCT00126191|atypical Burkitt lymphoma|atypical burkitt lymphoma
486212|NCT00126191|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
486213|NCT00126191|rituximab|rituximab
486214|NCT00126204|endoleak|endoleak
486215|NCT00126204|doxycycline|doxycycline
486216|NCT00126204|matrix metalloproteinase|matrix metalloproteinase
486217|NCT00126204|inflammation|inflammation
486218|NCT00126204|endograft|endograft
486219|NCT00126204|circulating markers|circulating markers
486220|NCT00126217|Non-specific effects of vaccines|non-specific effects of vaccines
486221|NCT00126217|Infant mortality|infant mortality
486222|NCT00126217|Morbidity|morbidity
486223|NCT00126217|Low income country|low income country
486224|NCT00126217|Malaria|malaria
486225|NCT00126217|BCG|bcg
486226|NCT00126217|immunisation|immunisation
486227|NCT00126217|BCG revaccination|bcg revaccination
486228|NCT00126217|Tuberculin|tuberculin
486229|NCT00126217|Mortality|mortality
486321|NCT00126620|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
486230|NCT00126230|hormone-refractory advanced prostate cancer who achieve a response or a stabilization to docetaxel-estramustine|hormone-refractory advanced prostate cancer who achieve a response or a stabilization to docetaxel-estramustine
486231|NCT00126243|AIDS related Lymphoma|aids related lymphoma
486232|NCT00126243|chemotherapy|chemotherapy
486233|NCT00126243|rituximab|rituximab
486234|NCT00126256|Colorectal cancer|colorectal cancer
486235|NCT00126256|metastatic|metastatic
486236|NCT00126256|chemotherapy|chemotherapy
486237|NCT00126256|randomized trial|randomized trial
96493|NCT02686073|BMI|bmi
96990|NCT02682979|therapeutic limitation code|therapeutic limitation code
486238|NCT00126269|Patients with Carcinoma of Unknown Primary and a Predicted Favorable Prognosis|patients with carcinoma of unknown primary and a predicted favorable prognosis
486239|NCT00126282|obsessive-compulsive disorder|obsessive-compulsive disorder
486240|NCT00126282|behavior therapy|behavior therapy
486241|NCT00126282|D-Cycloserine|d-cycloserine
486242|NCT00126282|medication|medication
486243|NCT00126282|treatment trial|treatment trial
486244|NCT00126282|placebo-controlled|placebo-controlled
486245|NCT00126282|double-blind|double-blind
486246|NCT00126282|randomized|randomized
486247|NCT00126308|HIV|hiv
486248|NCT00126308|Lipodystrophy|lipodystrophy
486249|NCT00126308|Intervention|intervention
486250|NCT00126308|Poly-L-lactic acid|poly-l-lactic acid
486251|NCT00126308|HIV facial lipoatrophy|hiv facial lipoatrophy
486252|NCT00126308|Treatment Experienced|treatment experienced
486255|NCT00126321|chemotherapy|chemotherapy
486256|NCT00126334|Myocardial Infarction|myocardial infarction
486257|NCT00126334|Anemia|anemia
486258|NCT00126334|Erythrocyte Transfusion|erythrocyte transfusion
486259|NCT00126347|betaine|betaine
486260|NCT00126347|serine|serine
486261|NCT00126347|folic acid|folic acid
486262|NCT00126347|methionine load|methionine load
486263|NCT00126347|homocysteine|homocysteine
486264|NCT00126347|cardiovascular health|cardiovascular health
486265|NCT00126347|vascular function|vascular function
486266|NCT00126347|human|human
486267|NCT00126360|Breast Cancer|breast cancer
486268|NCT00126360|Timing of Radiotherapy|timing of radiotherapy
486269|NCT00126360|Local Control|local control
486270|NCT00126373|Crohn disease|crohn disease
486271|NCT00126373|TNF-alpha|tnf-alpha
486272|NCT00126386|tumor induced hypercalcemia|tumor induced hypercalcemia
486273|NCT00126386|malignant bone pain|malignant bone pain
486274|NCT00126386|bisphosphonates|bisphosphonates
486275|NCT00126386|cancer|cancer
486276|NCT00126386|palliative|palliative
486277|NCT00126386|Zometa|zometa
486278|NCT00126386|palliative patient|palliative patient
486279|NCT00126386|treatment in community|treatment in community
486280|NCT00126399|rosacea|rosacea
486281|NCT00126399|acne rosacea|acne rosacea
486282|NCT00126412|Phaeochromocytoma|phaeochromocytoma
486283|NCT00126412|Neuroblastoma|neuroblastoma
486284|NCT00126412|diagnosis|diagnosis
486285|NCT00126412|123I-mIBG|123i-mibg
486286|NCT00126425|Heart Failure|heart failure
486287|NCT00126425|nuclear cardiology|nuclear cardiology
486288|NCT00126425|sympathetic innervation|sympathetic innervation
486289|NCT00126425|123I-mIBG|123i-mibg
486290|NCT00126438|Heart Failure|heart failure
486291|NCT00126438|nuclear cardiology|nuclear cardiology
486292|NCT00126438|sympathetic innervation|sympathetic innervation
486293|NCT00126438|123I-mIBG|123i-mibg
486294|NCT00126464|ductal breast carcinoma in situ|ductal breast carcinoma in situ
486295|NCT00126464|breast cancer in situ|breast cancer in situ
486296|NCT00126477|quality of life|quality of life
486297|NCT00126477|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
486298|NCT00126477|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
486299|NCT00126477|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
486300|NCT00126477|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
486301|NCT00126477|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
486302|NCT00126477|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
486303|NCT00126477|childhood large cell lymphoma|childhood large cell lymphoma
486304|NCT00126477|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
486305|NCT00126477|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
486306|NCT00126477|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
486307|NCT00126477|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
486308|NCT00126516|silent brain infarction|silent brain infarction
486309|NCT00126516|cognitive decline|cognitive decline
486310|NCT00126516|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
486311|NCT00126516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
486312|NCT00126516|hypertension|hypertension
486313|NCT00126555|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
486314|NCT00126555|recurrent skin cancer|recurrent skin cancer
486315|NCT00126555|non-melanomatous skin cancer|non-melanomatous skin cancer
486316|NCT00126555|Radiation|radiation
486317|NCT00126555|ZD1839|zd1839
486318|NCT00126555|Iressa|iressa
486319|NCT00126555|Gefitinib|gefitinib
486320|NCT00126581|A Phase II Randomized Study of OSI-774|a phase ii randomized study of osi-774
486867|NCT00129688|amikacin|amikacin
486322|NCT00126633|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
486323|NCT00126633|stage IV pancreatic cancer|stage iv pancreatic cancer
486324|NCT00126646|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
486325|NCT00126646|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
486326|NCT00126646|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
486327|NCT00126646|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
486328|NCT00126646|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
486329|NCT00126646|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
486330|NCT00126646|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
486331|NCT00126646|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
486332|NCT00126646|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
486333|NCT00126646|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
486334|NCT00126646|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
486335|NCT00126646|splenic marginal zone lymphoma|splenic marginal zone lymphoma
486336|NCT00126646|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
486337|NCT00126646|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
486338|NCT00126646|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
486339|NCT00126646|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
486340|NCT00126646|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
486341|NCT00126646|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
486342|NCT00126646|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
486343|NCT00126646|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
486344|NCT00126646|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
486345|NCT00126646|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
486346|NCT00126646|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
486347|NCT00126646|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
486348|NCT00126646|prolymphocytic leukemia|prolymphocytic leukemia
486349|NCT00126672|angiomyolipoma|angiomyolipoma
486350|NCT00126685|stage IV melanoma|stage iv melanoma
486351|NCT00126685|recurrent melanoma|recurrent melanoma
486352|NCT00126698|Bacteriuria|bacteriuria
486353|NCT00126698|Urinary Catheter|urinary catheter
486354|NCT00126698|Urinary tract infection|urinary tract infection
486355|NCT00126698|Prophylaxis|prophylaxis
486356|NCT00126698|Urinary catheter removal|urinary catheter removal
486357|NCT00126724|tgAAC94|tgaac94
486358|NCT00126724|Rheumatoid arthritis|rheumatoid arthritis
486359|NCT00126724|Inflammatory arthritis|inflammatory arthritis
486360|NCT00126724|Arthritis|arthritis
486361|NCT00126724|Gene therapy|gene therapy
486362|NCT00126724|AAV|aav
486363|NCT00126737|Elderly|elderly
486364|NCT00126737|Exercise|exercise
486365|NCT00126737|lean body mass|lean body mass
486366|NCT00126737|muscle strength|muscle strength
486367|NCT00126737|Nutrition program|nutrition program
486368|NCT00126737|Pain control|pain control
486369|NCT00126737|stair climb|stair climb
486370|NCT00126737|walking distance|walking distance
486371|NCT00126737|weight loss|weight loss
486372|NCT00126750|Myocardial Infarction|myocardial infarction
486373|NCT00126750|Comorbidities|comorbidities
486375|NCT00126750|Computer Assisted Instruction|computer assisted instruction
486376|NCT00126750|Physician Practice Instruction|physician practice instruction
486377|NCT00126750|Online Systems|online systems
486378|NCT00126763|Chronic Pain|chronic pain
486379|NCT00126763|Pain|pain
486380|NCT00126776|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
486381|NCT00126776|case management|case management
486382|NCT00126776|self management|self management
486383|NCT00126789|Pain Cancer|pain cancer
486384|NCT00126789|Chronic Pain|chronic pain
486385|NCT00126802|tomotherapy|tomotherapy
486386|NCT00126802|MRSZ|mrsz
486387|NCT00126802|high risk prostate cancer|high risk prostate cancer
486388|NCT00126815|prostate cancer|prostate cancer
486389|NCT00126815|prostate specific antigen|prostate specific antigen
486390|NCT00126815|radiotherapy|radiotherapy
486391|NCT00126815|mathematical modeling|mathematical modeling
486392|NCT00126828|radiotherapy, conformal|radiotherapy, conformal
486393|NCT00126828|lung neoplasm|lung neoplasm
486394|NCT00126828|radiotherapy dosage|radiotherapy dosage
486395|NCT00126841|radiotherapy planning CT/MR fusion|radiotherapy planning ct/mr fusion
486396|NCT00126854|brachytherapy|brachytherapy
486397|NCT00126854|magnetic resonance spectroscopy|magnetic resonance spectroscopy
486398|NCT00126867|thymidylate synthase polymers|thymidylate synthase polymers
486399|NCT00126867|rapecitabine|rapecitabine
486400|NCT00126867|adjuvant|adjuvant
486401|NCT00126867|colon cancer|colon cancer
486402|NCT00126867|toxicity|toxicity
486403|NCT00126867|Stage II colon cancer|stage ii colon cancer
486404|NCT00126867|Stage III colon cancer|stage iii colon cancer
486405|NCT00126867|adenocarcinoma of the colon|adenocarcinoma of the colon
486406|NCT00126880|Human Immunodeficiency Virus|human immunodeficiency virus
486407|NCT00126880|anti-retroviral therapy|anti-retroviral therapy
486408|NCT00126880|nucleoside analogue|nucleoside analogue
486409|NCT00126880|reverse transcriptase|reverse transcriptase
486410|NCT00126880|lamivudine|lamivudine
486411|NCT00126880|resistance mutation|resistance mutation
486412|NCT00126880|Treatment Experienced|treatment experienced
486413|NCT00126893|Leukemia|leukemia
486414|NCT00126893|AML|aml
486415|NCT00126893|CC401|cc401
486416|NCT00126893|CC-401|cc-401
486417|NCT00126893|Celgene|celgene
486418|NCT00126893|High Risk Myeloid Leukemia|high risk myeloid leukemia
486419|NCT00126893|Myeloid Leukemia|myeloid leukemia
486420|NCT00126906|Malaria|malaria
486421|NCT00126906|Pregnancy|pregnancy
486422|NCT00126906|HIV|hiv
486423|NCT00126945|Meningococcal serogroups A, C, W-135, Y disease|meningococcal serogroups a, c, w-135, y disease
486424|NCT00126958|superficial urothelial cell carcinoma|superficial urothelial cell carcinoma
486425|NCT00126958|urinary analysis|urinary analysis
486426|NCT00126958|Loss of heterozygosity|loss of heterozygosity
486427|NCT00126958|FGFR3 mutation|fgfr3 mutation
486428|NCT00126958|follow-up|follow-up
486429|NCT00126971|malaria|malaria
486430|NCT00126971|pregnancy|pregnancy
486431|NCT00126971|Plasmodium falciparum|plasmodium falciparum
486432|NCT00126971|antimalarials|antimalarials
486433|NCT00126971|pharmacokinetics|pharmacokinetics
486434|NCT00126971|treatment outcome|treatment outcome
486435|NCT00126971|safety|safety
486437|NCT00126984|Reactogenicity|reactogenicity
486438|NCT00126984|Immunogenicity|immunogenicity
486439|NCT00126984|Meningococcal vaccine|meningococcal vaccine
486440|NCT00126984|Dose selection|dose selection
486441|NCT00126984|Conjugate vaccine|conjugate vaccine
486442|NCT00126997|Prophylaxis measles, mumps, rubella and chickenpox|prophylaxis measles, mumps, rubella and chickenpox
486443|NCT00127010|Prophylaxis measles, mumps, rubella and chickenpox|prophylaxis measles, mumps, rubella and chickenpox
486444|NCT00127023|Prophylaxis measles, mumps, rubella and chickenpox|prophylaxis measles, mumps, rubella and chickenpox
486445|NCT00127036|colon|colon
486446|NCT00127036|adenocarcinoma|adenocarcinoma
486447|NCT00127036|adenocarcinoma-colon|adenocarcinoma-colon
486448|NCT00127036|adenocarcinoma-rectum|adenocarcinoma-rectum
486449|NCT00127049|Patients with relapsed non-seminomatous germ-cell tumors (NSGCT)|patients with relapsed non-seminomatous germ-cell tumors (nsgct)
486450|NCT00127062|Exposure to Oxford Street|exposure to oxford street
486451|NCT00127062|Exposure to Hyde Park|exposure to hyde park
486452|NCT00127075|Multiple sclerosis. Relapses. Post partum. Pregnancy. Delivery. Hormones. Progesterone. Estradiol. Clinical trial. Prevention.|multiple sclerosis. relapses. post partum. pregnancy. delivery. hormones. progesterone. estradiol. clinical trial. prevention.
486453|NCT00127088|Patients with localized Gleason 7 pT2a-pT2b adenocarcinoma of the prostate|patients with localized gleason 7 pt2a-pt2b adenocarcinoma of the prostate
486454|NCT00121030|uterine cancer|uterine cancer
486455|NCT00121030|ovarian cancer|ovarian cancer
486456|NCT00121030|darbepoetin alfa|darbepoetin alfa
486457|NCT00121030|Amgen|amgen
486458|NCT00121030|Gynecological Malignancies|gynecological malignancies
486459|NCT00121043|Rheumatoid Arthritis, Inflammation|rheumatoid arthritis, inflammation
486460|NCT00121043|Interleukin-1 (IL-1), r-metHuIL-1ra|interleukin-1 (il-1), r-methuil-1ra
486461|NCT00121043|Autoimmune, Kineret®|autoimmune, kineret®
486462|NCT00121043|Anakinra, Immunex|anakinra, immunex
486463|NCT00121043|Amgen, Clinical Trials|amgen, clinical trials
486464|NCT00121069|specific phobia|specific phobia
486465|NCT00121069|anxiety|anxiety
486466|NCT00121069|SSRI|ssri
486467|NCT00121069|clinical trial|clinical trial
486468|NCT00121069|escitalopram|escitalopram
486469|NCT00121095|prostate cancer|prostate cancer
486470|NCT00121121|HIV Vaccines|hiv vaccines
486471|NCT00121121|HIV Seronegativity|hiv seronegativity
486472|NCT00121134|Bevacizumab|bevacizumab
486473|NCT00121134|Metronomic Chemotherapy|metronomic chemotherapy
486474|NCT00121134|Breast Cancer Stages II-III|breast cancer stages ii-iii
486475|NCT00121134|Invasive breast cancer stages II-III|invasive breast cancer stages ii-iii
486476|NCT00121147|glaucoma|glaucoma
486477|NCT00121147|pseudoexfoliation|pseudoexfoliation
486478|NCT00121160|immune response to vaccines|immune response to vaccines
486479|NCT00121160|stress management|stress management
486480|NCT00121160|breast cancer|breast cancer
486481|NCT00121173|cervical cancer|cervical cancer
486482|NCT00121173|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
486483|NCT00121173|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
486484|NCT00121186|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
486485|NCT00121186|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
486486|NCT00121186|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
486487|NCT00121186|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
486488|NCT00121186|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
486489|NCT00121186|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
486490|NCT00121186|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
486491|NCT00121212|stage I prostate cancer|stage i prostate cancer
486492|NCT00121212|stage IIB prostate cancer|stage iib prostate cancer
486493|NCT00121212|stage IIA prostate cancer|stage iia prostate cancer
486494|NCT00121212|stage III prostate cancer|stage iii prostate cancer
486495|NCT00121277|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
486496|NCT00121303|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
486497|NCT00121303|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
486498|NCT00121303|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
485842|NCT00124878|HIV|hiv
486499|NCT00121303|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
486500|NCT00121303|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
486501|NCT00121303|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
486502|NCT00121303|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
486503|NCT00121303|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
486504|NCT00121303|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
486505|NCT00121303|refractory anemia with excess blasts|refractory anemia with excess blasts
486506|NCT00121303|secondary acute myeloid leukemia|secondary acute myeloid leukemia
486507|NCT00121303|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
486508|NCT00121303|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
486509|NCT00121303|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
14354|NCT03198897|Primary hyperlipoproteinemia|primary hyperlipoproteinemia
486510|NCT00121303|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
486705|NCT00129259|type 1 diabetes|type 1 diabetes
486511|NCT00121303|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
486512|NCT00121303|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
486513|NCT00121303|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
486514|NCT00121303|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
486515|NCT00121316|Atopic dermatitis|atopic dermatitis
486516|NCT00121316|pimecrolimus|pimecrolimus
486517|NCT00121329|Pain with procedures|pain with procedures
486518|NCT00121368|Global Network|global network
486519|NCT00121368|Maternal and child health|maternal and child health
486520|NCT00121368|International|international
486521|NCT00121368|Women's health|women's health
486522|NCT00121368|Tobacco|tobacco
486523|NCT00121368|Smoking|smoking
486524|NCT00121368|Africa|africa
486525|NCT00121368|Latin America|latin america
486526|NCT00121368|South America|south america
486527|NCT00121368|Guatemala|guatemala
486528|NCT00121368|Zambia|zambia
486529|NCT00121368|India|india
486530|NCT00121368|Argentina|argentina
486531|NCT00121368|Democratic Republic of the Congo|democratic republic of the congo
486532|NCT00121381|Atopic dermatitis|atopic dermatitis
486533|NCT00121381|T-cell|t-cell
486534|NCT00121381|pimecrolimus|pimecrolimus
486535|NCT00121381|children|children
486536|NCT00121381|topical corticosteroids|topical corticosteroids
486537|NCT00121394|Chlorhexidine|chlorhexidine
486538|NCT00121394|Vaginal wash|vaginal wash
486539|NCT00121394|Neonatal mortality|neonatal mortality
486540|NCT00121394|Sepsis|sepsis
486541|NCT00121394|Global Network|global network
486542|NCT00121394|Maternal and child health|maternal and child health
486543|NCT00121394|Women's Health|women's health
486544|NCT00121394|International|international
486545|NCT00121394|Pakistan|pakistan
486546|NCT00121407|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
486547|NCT00121407|Photodynamic Therapy (PDT)|photodynamic therapy (pdt)
486548|NCT00121407|Visudyne|visudyne
486549|NCT00121420|Brain Neoplasms/secondary|brain neoplasms/secondary
486550|NCT00121420|Brain neoplasms/radiotherapy|brain neoplasms/radiotherapy
486551|NCT00121420|Brain metastasis|brain metastasis
486552|NCT00121420|Neoplasm metastasis|neoplasm metastasis
486553|NCT00121420|Cranial irradiation|cranial irradiation
486554|NCT00121420|Radiosurgery|radiosurgery
486555|NCT00121420|Lung Neoplasms|lung neoplasms
486556|NCT00121420|Breast Neoplasms|breast neoplasms
486557|NCT00121420|Kidney Neoplasms|kidney neoplasms
486558|NCT00121420|Melanoma|melanoma
486559|NCT00121420|Radiotherapy|radiotherapy
486560|NCT00121420|Carcinoma, non-small cell lung|carcinoma, non-small cell lung
486561|NCT00121446|Heart Attack|heart attack
486562|NCT00121446|ST Elevation Myocardial Infarction|st elevation myocardial infarction
486563|NCT00121446|fibrinolytic therapy|fibrinolytic therapy
486564|NCT00121446|percutaneous coronary intervention|percutaneous coronary intervention
486565|NCT00121446|Acute Myocardial Infarction|acute myocardial infarction
486566|NCT00127114|Behavioral disturbance|behavioral disturbance
486567|NCT00127114|Frontotemporal dementia|frontotemporal dementia
486568|NCT00127114|Dementia|dementia
486569|NCT00127114|Amantadine|amantadine
486570|NCT00127114|Behavioral disturbance due to frontotemporal dementia|behavioral disturbance due to frontotemporal dementia
486571|NCT00127127|Solid tumors|solid tumors
486572|NCT00127205|stage I breast cancer|stage i breast cancer
486573|NCT00127205|stage II breast cancer|stage ii breast cancer
486574|NCT00127205|stage IIIA breast cancer|stage iiia breast cancer
486575|NCT00127205|stage IIIB breast cancer|stage iiib breast cancer
486576|NCT00127205|stage IIIC breast cancer|stage iiic breast cancer
486577|NCT00127218|atherosclerotic plaque|atherosclerotic plaque
486578|NCT00127218|MRI|mri
486579|NCT00127218|inflammatory markers|inflammatory markers
485911|NCT00125177|SUI|sui
486580|NCT00127218|statins|statins
486581|NCT00127231|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
486582|NCT00127231|Alcohol Consumption|alcohol consumption
486583|NCT00127231|Behavioral Research|behavioral research
486584|NCT00127231|HIV|hiv
486585|NCT00127231|Alcohol Abuse|alcohol abuse
486586|NCT00127257|Constipation|constipation
486587|NCT00127257|Biofeedback|biofeedback
486588|NCT00127257|Dyssynergia|dyssynergia
486589|NCT00127257|Pelvic floor dyssynergia|pelvic floor dyssynergia
486590|NCT00127257|Outlet dysfunction|outlet dysfunction
486591|NCT00127270|OAB|oab
486592|NCT00127270|Overactive Bladder|overactive bladder
486593|NCT00127270|Bladder hyperactivity|bladder hyperactivity
486594|NCT00127270|Urge Incontinence|urge incontinence
486595|NCT00127270|Incontinence|incontinence
486596|NCT00127270|Bladder|bladder
486597|NCT00127309|hangover|hangover
486598|NCT00127309|hangover symptoms|hangover symptoms
486599|NCT00127322|Heart Failure, Congestive|heart failure, congestive
486600|NCT00127322|survival|survival
486601|NCT00127322|patient admission|patient admission
486602|NCT00127335|rhabdomyolysis,|rhabdomyolysis,
486603|NCT00127335|myositis,|myositis,
486604|NCT00127335|myopathy,|myopathy,
486605|NCT00127335|statin side effects,|statin side effects,
486606|NCT00127335|fatty acid oxidation|fatty acid oxidation
486607|NCT00127335|Statin induced Muscle toxicity|statin induced muscle toxicity
486608|NCT00127361|doula|doula
486609|NCT00127361|caregivers|caregivers
486610|NCT00127361|labor support|labor support
486611|NCT00127361|being with woman|being with woman
486612|NCT00127361|continuous labor support|continuous labor support
486613|NCT00127361|maternal outcomes|maternal outcomes
486614|NCT00127361|Parturition|parturition
486615|NCT00127374|Overweight; self-esteem; depression|overweight; self-esteem; depression
486616|NCT00127387|Bone metastasis|bone metastasis
486617|NCT00127387|Radiation therapy|radiation therapy
486618|NCT00127387|Lung cancer|lung cancer
486619|NCT00127387|Prostate cancer|prostate cancer
486620|NCT00127387|Advanced lung cancer receiving radiation therapy|advanced lung cancer receiving radiation therapy
486621|NCT00127387|Advanced prostate cancer receiving radiation therapy|advanced prostate cancer receiving radiation therapy
486622|NCT00127387|Any cancer with bone mets receiving radiation therapy|any cancer with bone mets receiving radiation therapy
486623|NCT00127400|anger|anger
486624|NCT00127400|intermittent|intermittent
486625|NCT00127400|explosive|explosive
486626|NCT00127413|Chronic pain|chronic pain
486627|NCT00127413|Co-morbid|co-morbid
486628|NCT00127413|Intervention|intervention
486629|NCT00127413|Posttraumatic Stress Disorder|posttraumatic stress disorder
486630|NCT00127413|Treatment|treatment
486631|NCT00127439|Ambulatory Disability|ambulatory disability
486632|NCT00127439|Disability Ambulation|disability ambulation
486633|NCT00127439|Locomotion Disorders|locomotion disorders
486634|NCT00127439|Motor Activity|motor activity
486635|NCT00127439|Rehabilitation|rehabilitation
486636|NCT00127439|Spinal Cord Injury|spinal cord injury
486637|NCT00127452|alpha-linolenic acid|alpha-linolenic acid
486638|NCT00127452|cardiovascular diseases|cardiovascular diseases
486639|NCT00127452|coronary heart disease|coronary heart disease
486640|NCT00127452|coronary patients|coronary patients
486642|NCT00127452|dietary intervention|dietary intervention
486643|NCT00127452|dietary supplementation|dietary supplementation
486644|NCT00127452|docosahexaenoic acid|docosahexaenoic acid
486645|NCT00127452|eicosapentaenoic acid|eicosapentaenoic acid
486646|NCT00127452|EPA|epa
486647|NCT00127452|fish oil|fish oil
486648|NCT00127452|fish fatty acids|fish fatty acids
486649|NCT00127452|human subjects|human subjects
486650|NCT00127452|ischaemic heart disease|ischaemic heart disease
486651|NCT00127452|margarine|margarine
486652|NCT00127452|marine fatty acids|marine fatty acids
486653|NCT00127452|mortality|mortality
486654|NCT00127452|myocardial infarction|myocardial infarction
486655|NCT00127452|n-3 fatty acids|n-3 fatty acids
486656|NCT00127452|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
486657|NCT00127452|n-3 PUFA|n-3 pufa
486658|NCT00127452|omega-3 fatty acids|omega-3 fatty acids
486659|NCT00127452|omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
486660|NCT00127452|prevention|prevention
486661|NCT00127452|randomized controlled trial|randomized controlled trial
486662|NCT00127452|secondary prevention|secondary prevention
486663|NCT00129142|Prostate cancer|prostate cancer
486664|NCT00129142|Bone Loss|bone loss
486665|NCT00129142|Osteoporosis|osteoporosis
486666|NCT00129142|Fractures|fractures
486667|NCT00129142|Androgen Deprivation Therapy|androgen deprivation therapy
486668|NCT00129155|Allogenic stem cell transplantation|allogenic stem cell transplantation
486669|NCT00129155|Treosulfan|treosulfan
486670|NCT00129155|Haematological malignancies|haematological malignancies
486671|NCT00129155|allogeneic stem cell transplantation in patients with hematological malignancies|allogeneic stem cell transplantation in patients with hematological malignancies
486672|NCT00129168|Leukemia, Myeloid|leukemia, myeloid
486673|NCT00129168|Relapse|relapse
627425|NCT00690079|MAD|mad
486674|NCT00129168|Chemotherapy|chemotherapy
486675|NCT00129168|Zosuquidar|zosuquidar
486676|NCT00129168|Daunorubicin|daunorubicin
486677|NCT00129168|Cytarabine|cytarabine
486678|NCT00129168|Acute|acute
486679|NCT00129168|AML|aml
486680|NCT00129168|Adult AML|adult aml
486681|NCT00129181|parkinson|parkinson
486682|NCT00129181|brain imaging|brain imaging
486683|NCT00129181|diagnosis|diagnosis
486684|NCT00129194|HIV|hiv
486685|NCT00129194|Treatment Experienced|treatment experienced
486686|NCT00129207|pharmacokinetic|pharmacokinetic
486687|NCT00129207|pharmacodynamics|pharmacodynamics
486688|NCT00129207|VELCADE|velcade
486689|NCT00129207|Ketoconazole|ketoconazole
486690|NCT00129207|CYP 3A4|cyp 3a4
486691|NCT00129207|Solid Tumor|solid tumor
486692|NCT00129207|Advanced Solid Tumors|advanced solid tumors
486693|NCT00129220|Manic or mixed episode associated with bipolar I disorder|manic or mixed episode associated with bipolar i disorder
486694|NCT00129233|cardiovascular disease|cardiovascular disease
486695|NCT00129233|rennin-angiotensin system|rennin-angiotensin system
486696|NCT00129233|calcium channel blocker|calcium channel blocker
486697|NCT00129233|impaired glucose tolerance|impaired glucose tolerance
486698|NCT00129246|Tobacco|tobacco
486699|NCT00129246|Smoking|smoking
486700|NCT00129246|Weight|weight
486701|NCT00129246|Weight perception|weight perception
486702|NCT00129246|Naltrexone|naltrexone
486703|NCT00129246|Bupropion|bupropion
486706|NCT00129259|type 1 diabetes mellitus|type 1 diabetes mellitus
486707|NCT00129259|juvenile diabetes|juvenile diabetes
486708|NCT00129259|autoimmune diabetes|autoimmune diabetes
486709|NCT00129259|autoimmune|autoimmune
486710|NCT00129259|anti-CD3 mAb|anti-cd3 mab
486711|NCT00129259|mAb hOKT3g1(Ala-Ala)|mab hokt3g1(ala-ala)
486712|NCT00129259|teplizumab|teplizumab
486713|NCT00129272|adolescents, cigarettes, smoking, tobacco|adolescents, cigarettes, smoking, tobacco
486714|NCT00129285|cocaine|cocaine
486715|NCT00129298|cocaine abuse|cocaine abuse
486716|NCT00129298|opiate dependent|opiate dependent
486717|NCT00129298|tiagabine|tiagabine
486718|NCT00129298|methadone|methadone
486719|NCT00129311|Tobacco|tobacco
486720|NCT00129324|HOME|home
486721|NCT00129324|Environmental Exposure|environmental exposure
486722|NCT00129324|Neurobehavior|neurobehavior
486723|NCT00129324|Child Development|child development
486724|NCT00129324|Lead Exposure|lead exposure
486725|NCT00129324|Child Injury|child injury
486726|NCT00129324|Adolescence|adolescence
486727|NCT00129324|Adiposity|adiposity
486728|NCT00129324|Neuroimaging|neuroimaging
486729|NCT00129337|monoclonal antibody|monoclonal antibody
486730|NCT00129337|phase 1|phase 1
486731|NCT00129337|solid tumor|solid tumor
486732|NCT00129337|anti-angiogenesis|anti-angiogenesis
583852|NCT00512928|oral anticoagulation|oral anticoagulation
486733|NCT00129337|refractory advanced solid tumor malignancy|refractory advanced solid tumor malignancy
486734|NCT00129350|End Stage Fibrotic Lung Disease|end stage fibrotic lung disease
486735|NCT00129363|Adolescent|adolescent
486736|NCT00129363|Adrenergic alpha-Antagonists/therapeutic use|adrenergic alpha-antagonists/therapeutic use
486737|NCT00129363|Adrenergic alpha-Antagonists/pharmacokinetics|adrenergic alpha-antagonists/pharmacokinetics
486738|NCT00129363|Adrenergic alpha-Antagonists/administration & dosage|adrenergic alpha-antagonists/administration & dosage
486739|NCT00129363|Adrenergic beta-Antagonists/therapeutic use|adrenergic beta-antagonists/therapeutic use
486740|NCT00129363|Adrenergic beta-Antagonists/pharmacokinetics|adrenergic beta-antagonists/pharmacokinetics
486741|NCT00129363|Adrenergic beta-Antagonists/administration & dosage|adrenergic beta-antagonists/administration & dosage
486742|NCT00129363|Age Factors|age factors
486743|NCT00129363|Carbazoles/therapeutic use|carbazoles/therapeutic use
486744|NCT00129363|Carbazoles/administration & dosage|carbazoles/administration & dosage
486745|NCT00129363|Child|child
486746|NCT00129363|Child, Preschool|child, preschool
486747|NCT00129363|Drug Administration Schedule|drug administration schedule
486748|NCT00129363|Female|female
486749|NCT00129363|Heart Failure, Congestive/etiology|heart failure, congestive/etiology
486750|NCT00129363|Heart Failure, Congestive/drug therapy|heart failure, congestive/drug therapy
486751|NCT00129363|Heart Failure, Congestive/blood|heart failure, congestive/blood
486752|NCT00129363|Human|human
486753|NCT00129363|Infant|infant
486754|NCT00129363|Infant, Newborn|infant, newborn
486755|NCT00129363|Male|male
486756|NCT00129363|Natriuretic Peptide, Brain/blood|natriuretic peptide, brain/blood
486757|NCT00129363|Placebos|placebos
486758|NCT00129363|Propanolamines/therapeutic use|propanolamines/therapeutic use
486759|NCT00129363|Propanolamines/administration & dosage|propanolamines/administration & dosage
486760|NCT00129363|Prospective Studies|prospective studies
486761|NCT00129363|Support, Non-U.S. Gov't|support, non-u.s. gov't
486762|NCT00129363|Treatment Outcome|treatment outcome
486763|NCT00129363|Ventricular Dysfunction/drug therapy|ventricular dysfunction/drug therapy
486764|NCT00129363|Ventricular Dysfunction/complications|ventricular dysfunction/complications
486765|NCT00129363|Ventricular Dysfunction/blood|ventricular dysfunction/blood
486766|NCT00129363|Ventricular Function/drug effects|ventricular function/drug effects
486767|NCT00129363|Ventricular Remodeling/drug effects|ventricular remodeling/drug effects
486868|NCT00129688|cloxacillin|cloxacillin
486768|NCT00129376|Stage II and IIIA breast Cancer.|stage ii and iiia breast cancer.
486769|NCT00129376|Neoadjuvant chemotherapy.|neoadjuvant chemotherapy.
486770|NCT00129376|Weekly docetaxel.|weekly docetaxel.
486771|NCT00129389|Node negative, high risk breast cancer.|node negative, high risk breast cancer.
486772|NCT00129389|Prognostic gene profile.|prognostic gene profile.
486773|NCT00129389|Saint Gallen high risk criteria.|saint gallen high risk criteria.
486774|NCT00129389|Weekly paclitaxel.|weekly paclitaxel.
486775|NCT00129402|cholesterol|cholesterol
486776|NCT00129402|drugs|drugs
486777|NCT00129402|hypercholesterolemia|hypercholesterolemia
486778|NCT00129402|adolescent|adolescent
486779|NCT00129402|randomized controlled trials|randomized controlled trials
486780|NCT00129415|UVA1|uva1
486782|NCT00129415|atopic dermatitis|atopic dermatitis
486783|NCT00129415|psoriasis|psoriasis
486784|NCT00129415|alopecia|alopecia
486785|NCT00129415|mycosis fungoides (CTCL)|mycosis fungoides (ctcl)
486786|NCT00129415|urticaria|urticaria
486787|NCT00129415|inflammatory dermatoses|inflammatory dermatoses
486788|NCT00129415|stretch marks|stretch marks
486789|NCT00129428|UVB|uvb
486790|NCT00129428|keloid|keloid
486791|NCT00129428|scleroderma|scleroderma
486792|NCT00129428|acne keloidalis nuchae|acne keloidalis nuchae
486793|NCT00129428|scars|scars
486794|NCT00129428|granuloma annulare|granuloma annulare
486795|NCT00129441|schizophrenia|schizophrenia
486796|NCT00129454|Telemedicine|telemedicine
486998|NCT00130234|urticaria|urticaria
486797|NCT00129454|Cognitive Behavior Therapy|cognitive behavior therapy
486798|NCT00129454|Utilization|utilization
486799|NCT00129454|Randomized Control Trial|randomized control trial
486800|NCT00129454|Gulf War Illness|gulf war illness
486801|NCT00129454|Symptom-Based Illness|symptom-based illness
486802|NCT00129454|Multisymptom Illness|multisymptom illness
486803|NCT00129454|High utilization|high utilization
486804|NCT00129467|Depression|depression
486805|NCT00129467|Hospice Care|hospice care
486806|NCT00129467|Antidepressive Agents|antidepressive agents
486807|NCT00129467|Methylphenidate|methylphenidate
486808|NCT00129467|Central Nervous System Stimulant|central nervous system stimulant
486809|NCT00129467|Pain|pain
486810|NCT00129467|Caregiver Burden|caregiver burden
486811|NCT00129467|Cancer|cancer
486812|NCT00129480|veterans|veterans
486813|NCT00129480|pain and chronic disease|pain and chronic disease
486814|NCT00129480|disease management|disease management
486815|NCT00129480|depression|depression
486816|NCT00129480|primary health care|primary health care
486817|NCT00129480|practice guidelines|practice guidelines
486818|NCT00129480|guideline adherence|guideline adherence
486819|NCT00129480|narcotics|narcotics
486820|NCT00129480|patient compliance|patient compliance
486821|NCT00129480|randomized controlled trial|randomized controlled trial
486822|NCT00129493|Practice guidelines|practice guidelines
486823|NCT00129493|Hypertension|hypertension
486824|NCT00129493|Primary health care|primary health care
486825|NCT00129493|Patient-centered care|patient-centered care
486826|NCT00129493|Healthcare quality|healthcare quality
486827|NCT00129493|Office visits|office visits
486828|NCT00129493|Self-efficacy|self-efficacy
486829|NCT00129493|Self care|self care
486830|NCT00129493|Guideline adherence|guideline adherence
486831|NCT00129493|Patient noncompliance|patient noncompliance
486832|NCT00129506|medical abortion|medical abortion
486833|NCT00129506|methotrexate|methotrexate
486834|NCT00129506|misoprostol|misoprostol
486835|NCT00129519|BCC curettage|bcc curettage
486836|NCT00129532|HIV transmission|hiv transmission
486837|NCT00129545|Atrial Fibrillation|atrial fibrillation
486838|NCT00129545|AF|af
486839|NCT00129545|A Fib|a fib
486840|NCT00129545|Stroke|stroke
486841|NCT00129545|Coumadin|coumadin
486842|NCT00129545|Warfarin|warfarin
486843|NCT00129545|Blood thinning medication|blood thinning medication
486844|NCT00129545|transient ischemic attack (TIA)|transient ischemic attack (tia)
486845|NCT00129545|WATCHMAN|watchman
486846|NCT00129545|Left atrial appendage|left atrial appendage
486847|NCT00129545|LAA isolation|laa isolation
486848|NCT00129545|LAA occlusion|laa occlusion
486849|NCT00129584|Endobronchial Valve (EBV) Procedure|endobronchial valve (ebv) procedure
486850|NCT00129584|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
486851|NCT00129597|Ketalar|ketalar
486852|NCT00129597|NMDA|nmda
486853|NCT00129597|mastectomy|mastectomy
486854|NCT00129597|postoperative chronic pain|postoperative chronic pain
486855|NCT00129597|Chronic pain after mastectomy for breast cancer|chronic pain after mastectomy for breast cancer
486856|NCT00129610|Agoraphobia|agoraphobia
486857|NCT00129610|panic disorder|panic disorder
486858|NCT00129610|Virtual Reality Therapy|virtual reality therapy
486859|NCT00129610|Cognitive Behavior Therapy|cognitive behavior therapy
486860|NCT00129610|cognition|cognition
486861|NCT00129610|spatial cognition|spatial cognition
486862|NCT00129610|PANIC DISORDER WITH AGORAPHOBIA|panic disorder with agoraphobia
486863|NCT00129675|parkinson|parkinson
486864|NCT00129675|diagnosis|diagnosis
486865|NCT00129688|febrile neutropenia|febrile neutropenia
486866|NCT00129688|once-daily|once-daily
486870|NCT00129714|cervical radiculopathy conservative treatment|cervical radiculopathy conservative treatment
486871|NCT00129727|Carboplatin|carboplatin
486872|NCT00129727|Paclitaxel|paclitaxel
486873|NCT00129727|Bevacizumab|bevacizumab
486874|NCT00129727|Ovarian|ovarian
486875|NCT00129727|Cancer|cancer
486876|NCT00129740|Chronic phase CML|chronic phase cml
486877|NCT00129740|Newly diagnosed chronic phase CML|newly diagnosed chronic phase cml
486878|NCT00129740|AMN107|amn107
486879|NCT00129753|Campath-1H Monoclonal Antibody|campath-1h monoclonal antibody
486880|NCT00129753|Alemtuzumab|alemtuzumab
486881|NCT00129753|Campath|campath
486882|NCT00129753|Campath-1H|campath-1h
486883|NCT00129753|Relapsed and Resistant Classical Hodgkin's Disease|relapsed and resistant classical hodgkin's disease
486884|NCT00129753|Lymphoma|lymphoma
486885|NCT00129766|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
486886|NCT00129766|motavizumab|motavizumab
486887|NCT00129766|palivizumab|palivizumab
486888|NCT00129766|Synagis|synagis
486889|NCT00129779|COPD|copd
486890|NCT00129792|Blood Glucose|blood glucose
486891|NCT00129792|Cholesterol|cholesterol
486892|NCT00129792|Weight Loss|weight loss
486893|NCT00129792|Insulin|insulin
486894|NCT00129792|Complementary Therapies|complementary therapies
486895|NCT00129818|Genital herpes|genital herpes
486896|NCT00129818|viral shedding|viral shedding
486897|NCT00129818|famciclovir|famciclovir
486898|NCT00129818|Symptomatic genital herpes|symptomatic genital herpes
486899|NCT00129818|Asymptomatic genital herpes|asymptomatic genital herpes
486900|NCT00129831|COPD, indacaterol, PK|copd, indacaterol, pk
486901|NCT00129844|Motexafin Gadolinium|motexafin gadolinium
486902|NCT00129844|non-small cell, lung cancer|non-small cell, lung cancer
486903|NCT00129844|Lung cancer|lung cancer
486904|NCT00129844|cancer of the lung|cancer of the lung
486905|NCT00129844|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
486906|NCT00129883|quality of care|quality of care
486907|NCT00129883|antibiotic use|antibiotic use
486908|NCT00129883|intervention|intervention
486909|NCT00129883|lower respiratory tract infections|lower respiratory tract infections
486910|NCT00129883|Community acquired Pneumonia|community acquired pneumonia
486911|NCT00129883|Acute Exacerbation of Chronic Bronchitis or COPD|acute exacerbation of chronic bronchitis or copd
486912|NCT00129896|Her2neu positive breast cancer.|her2neu positive breast cancer.
486913|NCT00129896|Neoadjuvant treatment.|neoadjuvant treatment.
486914|NCT00129909|hypertension|hypertension
486915|NCT00129909|family physicians|family physicians
486916|NCT00129909|fixed dose combination therapy|fixed dose combination therapy
486917|NCT00129909|cluster randomized controlled trial|cluster randomized controlled trial
486918|NCT00129922|Axillary node positive breast cancer.|axillary node positive breast cancer.
486919|NCT00129922|Sequential drug administration.|sequential drug administration.
486920|NCT00129922|Weekly paclitaxel.|weekly paclitaxel.
486921|NCT00129935|HER2 negative breast cancer|her2 negative breast cancer
486922|NCT00129935|Node positive breast cancer|node positive breast cancer
486923|NCT00129935|Adjuvant treatment|adjuvant treatment
486924|NCT00129935|Oral chemotherapy|oral chemotherapy
486925|NCT00129948|Acute myeloid leukemia|acute myeloid leukemia
486926|NCT00129948|AML|aml
486927|NCT00129948|refractory|refractory
486928|NCT00129948|relapsed|relapsed
486929|NCT00129961|Kidney|kidney
486930|NCT00129961|Transplant|transplant
486931|NCT00129961|Skin Cancer|skin cancer
486932|NCT00129974|Lung cancer|lung cancer
486933|NCT00129974|Phase II|phase ii
486934|NCT00129974|Drug Therapy|drug therapy
486935|NCT00129987|Asthma|asthma
486936|NCT00130000|h5g.1|h5g.1
486937|NCT00130000|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
486938|NCT00130000|SHEPHERD|shepherd
486939|NCT00130000|PNH|pnh
486940|NCT00130013|Children|children
486941|NCT00130013|Non-severe pneumonia|non-severe pneumonia
486942|NCT00130013|Oral amoxicillin|oral amoxicillin
486943|NCT00130039|Infarction, Cerebral|infarction, cerebral
486944|NCT00130039|cilostazol|cilostazol
486945|NCT00130039|stenosis|stenosis
486946|NCT00130039|atherosclerosis|atherosclerosis
486947|NCT00130039|clopidogrel|clopidogrel
486948|NCT00130065|Malaria|malaria
486949|NCT00130065|Pregnancy|pregnancy
486950|NCT00130065|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
486951|NCT00130065|Folic acid|folic acid
486952|NCT00130065|Folate|folate
486953|NCT00130078|HIV Seronegativity|hiv seronegativity
486954|NCT00130078|HIV transmission|hiv transmission
486955|NCT00130091|unilateral|unilateral
486956|NCT00130091|hernia|hernia
486957|NCT00130091|hydrocele|hydrocele
486958|NCT00130091|pediatric|pediatric
486959|NCT00130091|clonidine|clonidine
486960|NCT00130091|nerve block|nerve block
486961|NCT00130104|digital block|digital block
486962|NCT00130104|regional anesthesia|regional anesthesia
486963|NCT00130104|finger repair|finger repair
486964|NCT00130104|Fingers|fingers
486965|NCT00130104|Anesthesia, Conduction|anesthesia, conduction
486966|NCT00130117|leptin|leptin
486967|NCT00130117|hypothalamic amenorrhea|hypothalamic amenorrhea
486968|NCT00130117|exercise-induced amenorrhea|exercise-induced amenorrhea
486969|NCT00130117|neuroendocrine function|neuroendocrine function
486970|NCT00130117|bone metabolism|bone metabolism
486971|NCT00130156|Blood pressure|blood pressure
486972|NCT00130156|SBP|sbp
486973|NCT00130156|DBP|dbp
486974|NCT00130169|Cancer|cancer
486975|NCT00130169|malignant tumors|malignant tumors
486976|NCT00130182|lung disease|lung disease
486977|NCT00130195|acute lymphoblastic leukemia|acute lymphoblastic leukemia
486978|NCT00130195|BCR-ABL|bcr-abl
486979|NCT00130195|Philadelphia-chromosome|philadelphia-chromosome
486980|NCT00130195|newly diagnosed|newly diagnosed
486981|NCT00130208|Diabetes|diabetes
486982|NCT00130208|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
486983|NCT00130208|Albuminuria|albuminuria
486984|NCT00130208|Diabetic Nephropathy|diabetic nephropathy
486985|NCT00130221|Chlorhexidine|chlorhexidine
486986|NCT00130221|Blood stream infections|blood stream infections
486987|NCT00130221|central venous catheter associated|central venous catheter associated
486988|NCT00130221|Nosocomial infection|nosocomial infection
486989|NCT00130221|Bacteremia|bacteremia
486990|NCT00130221|sepsis|sepsis
486991|NCT00130221|Pneumonia|pneumonia
486992|NCT00130221|Urinary tract infection|urinary tract infection
486993|NCT00130221|Clostridium Difficile|clostridium difficile
486994|NCT00130221|intensive care unit|intensive care unit
486995|NCT00130221|catheter|catheter
486996|NCT00130221|nosocomial pneumonia|nosocomial pneumonia
486997|NCT00130221|Infection control|infection control
487000|NCT00130234|Xolair|xolair
487001|NCT00130247|Tuberculosis, Uganda, Brazil, Philippines|tuberculosis, uganda, brazil, philippines
487002|NCT00130260|Staphylococcus aureus|staphylococcus aureus
487003|NCT00130260|Vaccine|vaccine
487004|NCT00130260|Randomized Controlled Trial|randomized controlled trial
487005|NCT00130273|HIV|hiv
487006|NCT00130273|AIDS|aids
487007|NCT00130273|Problem Solving|problem solving
487008|NCT00130273|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
487009|NCT00130273|Patient Compliance|patient compliance
487010|NCT00130286|Lipodystrophy|lipodystrophy
487011|NCT00130286|HIV|hiv
487012|NCT00130286|Growth hormone|growth hormone
487013|NCT00130286|Rosiglitazone|rosiglitazone
487014|NCT00130286|Visceral fat|visceral fat
487015|NCT00130286|Metabolic syndrome|metabolic syndrome
487016|NCT00130286|Treatment Experienced|treatment experienced
487017|NCT00130286|Visceral fat accumulation|visceral fat accumulation
487018|NCT00130286|fat accumulation|fat accumulation
487019|NCT00130286|HIV-Associated Metabolic Syndrome|hiv-associated metabolic syndrome
487020|NCT00130312|Diabetes|diabetes
487021|NCT00130312|Diabetic Nephropathy|diabetic nephropathy
487022|NCT00130312|Proteinuria|proteinuria
487023|NCT00130325|ELISPOT,|elispot,
487024|NCT00130325|tuberculosis,|tuberculosis,
487025|NCT00130325|Mycobacterium tuberculosis|mycobacterium tuberculosis
487026|NCT00130325|Isoniazid|isoniazid
487027|NCT00130325|Clinical trial|clinical trial
487028|NCT00130338|Dementia|dementia
487029|NCT00130338|Vascular|vascular
487030|NCT00130338|Rivastigmine|rivastigmine
487031|NCT00130338|Stroke|stroke
487032|NCT00130338|Memory loss|memory loss
487033|NCT00130351|asthma, formoterol multi-dose dry powder inhaler (MDDPI)|asthma, formoterol multi-dose dry powder inhaler (mddpi)
487034|NCT00130364|Atopic dermatitis|atopic dermatitis
487035|NCT00130364|T-cell|t-cell
487036|NCT00130364|pimecrolimus|pimecrolimus
487037|NCT00130364|children|children
487038|NCT00130364|facial|facial
487039|NCT00130364|Facial atopic dermatitis|facial atopic dermatitis
487040|NCT00130377|Stem Cell|stem cell
487041|NCT00130377|Heart|heart
487042|NCT00130377|Lung|lung
487043|NCT00130377|Vascular|vascular
487044|NCT00130377|cell therapy registry|cell therapy registry
487045|NCT00130390|Crohn's Disease|crohn's disease
487046|NCT00130416|behavior|behavior
487047|NCT00130416|randomized trial|randomized trial
487048|NCT00130416|communication|communication
487049|NCT00130416|patient|patient
487050|NCT00130416|internet|internet
487051|NCT00130416|coaching|coaching
487052|NCT00130416|self-efficacy|self-efficacy
487053|NCT00130416|nurse|nurse
487054|NCT00130416|primary care|primary care
487055|NCT00130416|physician|physician
487056|NCT00130416|screening|screening
487057|NCT00130416|survey|survey
487058|NCT00130416|pain|pain
487059|NCT00130416|mobility|mobility
487060|NCT00130416|disability|disability
487061|NCT00130416|depression|depression
487062|NCT00130429|dementia|dementia
487063|NCT00130429|memory|memory
487064|NCT00130429|Hopkins verbal learning test|hopkins verbal learning test
487065|NCT00130429|paired associated learning|paired associated learning
487066|NCT00130442|phase II|phase ii
487067|NCT00130442|metastatic melanoma|metastatic melanoma
487068|NCT00130442|dacarbazine|dacarbazine
487069|NCT00130442|combination|combination
627887|NCT00691496|gay|gay
486374|NCT00126750|Guidelines|guidelines
487070|NCT00130442|PI-88|pi-88
487071|NCT00130481|Diabetes|diabetes
487072|NCT00130481|Children|children
487073|NCT00130481|Adolescents|adolescents
487074|NCT00130481|Arterial Compliance|arterial compliance
487171|NCT00130936|epirubicin|epirubicin
487075|NCT00130481|Physiology Cardiovascular Endothelium|physiology cardiovascular endothelium
487076|NCT00130494|Non-symptomatic bone metastases.|non-symptomatic bone metastases.
487077|NCT00130507|HER2 positive breast cancer.|her2 positive breast cancer.
487078|NCT00130507|Progression to trastuzumab and taxanes.|progression to trastuzumab and taxanes.
487079|NCT00130520|advanced ovarian cancer|advanced ovarian cancer
487080|NCT00130520|refractory ovarian cancer|refractory ovarian cancer
487081|NCT00130520|primary peritoneal cancer|primary peritoneal cancer
487082|NCT00130533|TNBC Triple-Negative Early Breast Cancer|tnbc triple-negative early breast cancer
487083|NCT00130533|Maintenance Adjuvant Chemotherapy|maintenance adjuvant chemotherapy
487084|NCT00130533|Capecitabine|capecitabine
487085|NCT00130533|Basal-like genotype|basal-like genotype
487086|NCT00130546|coronary artery disease|coronary artery disease
487087|NCT00130546|coronary intervention|coronary intervention
487088|NCT00130546|drug eluting stent implantation|drug eluting stent implantation
487089|NCT00130546|Cypher - Stent|cypher - stent
487090|NCT00130546|Sirolimus|sirolimus
487091|NCT00130546|Taxus - Stent|taxus - stent
487092|NCT00130546|Paclitaxel|paclitaxel
487093|NCT00130559|Respiratory failure|respiratory failure
487094|NCT00130559|BNP|bnp
487095|NCT00130585|Folate|folate
487096|NCT00130585|Bioavailability|bioavailability
487097|NCT00130585|Stable isotopes|stable isotopes
487098|NCT00130598|contrast nephropathy|contrast nephropathy
487099|NCT00130598|contrast media|contrast media
487100|NCT00130598|renal dysfunction|renal dysfunction
487101|NCT00130611|heart failure|heart failure
487102|NCT00130611|cost effectiveness|cost effectiveness
487103|NCT00130611|BNP|bnp
487104|NCT00130611|private practice|private practice
487105|NCT00130611|Acute dyspnoea|acute dyspnoea
487106|NCT00130624|Falls|falls
487107|NCT00130624|Elderly|elderly
487108|NCT00130624|multidisciplinary assessment|multidisciplinary assessment
487109|NCT00130637|Anterior Uveitis|anterior uveitis
487110|NCT00130637|Arthritis, Juvenile Idiopathic|arthritis, juvenile idiopathic
487111|NCT00130637|Daclizumab|daclizumab
487112|NCT00130637|Iritis|iritis
487113|NCT00130637|Immunosuppression|immunosuppression
487114|NCT00130637|Chronic Inflammatory Eye-Disease|chronic inflammatory eye-disease
487115|NCT00130637|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
487116|NCT00130650|IV|iv
487117|NCT00130650|cannulation|cannulation
487118|NCT00130650|Injections, Intravenous|injections, intravenous
487120|NCT00130676|Psychotic Major Depression|psychotic major depression
487121|NCT00130676|Depression|depression
487122|NCT00130676|Major Depression|major depression
487123|NCT00130676|Psychosis|psychosis
487124|NCT00130689|Esophageal Cancer|esophageal cancer
487125|NCT00130689|Gastric Cancer|gastric cancer
487126|NCT00130689|Metastatic Esophageal Cancer|metastatic esophageal cancer
487127|NCT00130689|Metastatic Gastric Cancer|metastatic gastric cancer
487128|NCT00130689|Cetuximab|cetuximab
487129|NCT00130689|Metastatic Esophageal and Gastric Cancer|metastatic esophageal and gastric cancer
487130|NCT00130702|AML|aml
487131|NCT00130702|acute myelogenous leukemia|acute myelogenous leukemia
487132|NCT00130702|gefitinib|gefitinib
487133|NCT00130702|Iressa|iressa
487134|NCT00130715|Patients undergoing a variety of abdominal surgical procedures|patients undergoing a variety of abdominal surgical procedures
487135|NCT00130728|NSCLC|nsclc
487136|NCT00130728|Avastin|avastin
487137|NCT00130728|Tarceva|tarceva
487138|NCT00130728|Lung Cancer|lung cancer
487139|NCT00130767|Prostate|prostate
487140|NCT00130767|apoptosis|apoptosis
487141|NCT00130767|finasteride kinetics|finasteride kinetics
487142|NCT00130780|Multi-modality treatment for lung cancer|multi-modality treatment for lung cancer
487143|NCT00130780|Carcinoma, Squamous Cell|carcinoma, squamous cell
487144|NCT00130780|Bevacizumab|bevacizumab
487145|NCT00130780|BEACON|beacon
487146|NCT00130780|05-052|05-052
487147|NCT00130819|Drug Dependence|drug dependence
487148|NCT00130819|Opiate Dependence|opiate dependence
487149|NCT00130819|Human Immunodeficiency Viruses|human immunodeficiency viruses
487150|NCT00130819|Buprenorphine|buprenorphine
487151|NCT00130845|Diabetic retinopathy, Octreotide Acetate in Microspheres|diabetic retinopathy, octreotide acetate in microspheres
487152|NCT00130858|Sarcoma, Soft Tissue|sarcoma, soft tissue
487153|NCT00130871|levosimendan|levosimendan
487154|NCT00130871|weaning|weaning
487155|NCT00130871|cardio-pulmonary bypass|cardio-pulmonary bypass
487156|NCT00130884|levosimendan|levosimendan
487157|NCT00130884|chronic heart failure|chronic heart failure
487158|NCT00130884|oral administration|oral administration
487159|NCT00130910|HIV|hiv
487160|NCT00130910|Helminthiasis|helminthiasis
487161|NCT00130910|Co-infection|co-infection
487162|NCT00130910|Intestinal immune activation|intestinal immune activation
628029|NCT00685126|RAD|rad
487163|NCT00130910|Treatment Naive|treatment naive
487164|NCT00130923|Risperidone|risperidone
487165|NCT00130923|Schizophrenia|schizophrenia
487166|NCT00130923|Substance Use Disorder|substance use disorder
487167|NCT00130923|Alcohol Use Disorder|alcohol use disorder
487168|NCT00130923|Treatment|treatment
487169|NCT00130923|Schizoaffective Disorder|schizoaffective disorder
487170|NCT00130936|phase I|phase i
487172|NCT00130936|solid tumors|solid tumors
487173|NCT00130949|Acute lateral epicondylitis|acute lateral epicondylitis
487174|NCT00130949|Tennis elbow|tennis elbow
487175|NCT00130949|Capsaicin|capsaicin
487176|NCT00130962|Intermetatarsal neuroma|intermetatarsal neuroma
487177|NCT00130962|Morton's neuroma|morton's neuroma
487178|NCT00130962|ALGRX 4975|algrx 4975
487179|NCT00130962|capsaicin|capsaicin
487180|NCT00130975|Atrial fibrillation.|atrial fibrillation.
487181|NCT00130975|Cardioversion.|cardioversion.
487182|NCT00130975|Recurrence.|recurrence.
487183|NCT00130975|Candesartan.|candesartan.
487184|NCT00130988|Somatoform Disorders|somatoform disorders
487185|NCT00130988|Medically unexplained symptoms|medically unexplained symptoms
487186|NCT00130988|Physician-Patient Relations|physician-patient relations
487187|NCT00130988|Primary Health Care|primary health care
487188|NCT00130988|Family Physician|family physician
487189|NCT00130988|psychosocial therapy|psychosocial therapy
487190|NCT00130988|re-attribution of symptoms|re-attribution of symptoms
487191|NCT00130988|cluster randomised controlled trial|cluster randomised controlled trial
487192|NCT00131001|Carotid artery stenosis|carotid artery stenosis
487193|NCT00131001|cost effectiveness|cost effectiveness
487194|NCT00131001|magnetic resonance angiography|magnetic resonance angiography
487195|NCT00131001|computed tomography angiography|computed tomography angiography
487196|NCT00131001|digital subtraction angiography|digital subtraction angiography
487197|NCT00131014|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
487198|NCT00131014|Hodgkin's disease|hodgkin's disease
487199|NCT00131014|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
487200|NCT00131014|Lymphoproliferative disorder|lymphoproliferative disorder
487202|NCT00131027|acute lymphoblastic leukemia|acute lymphoblastic leukemia
487203|NCT00131027|newly diagnosed|newly diagnosed
487204|NCT00131027|BCR-ABL-negative|bcr-abl-negative
487205|NCT00131040|Cardiopulmonary|cardiopulmonary
487206|NCT00131040|Surgery|surgery
487207|NCT00131040|leukocyte|leukocyte
487208|NCT00131040|inflammation|inflammation
487209|NCT00131040|Coronary Artery Bypass Grafting|coronary artery bypass grafting
487210|NCT00131053|acute lymphoblastic leukemia|acute lymphoblastic leukemia
487211|NCT00131053|newly diagnosed|newly diagnosed
487212|NCT00131053|BCR-ABL-negative|bcr-abl-negative
487213|NCT00131066|Previously enrolled on a MEDI-507 for psoriasis|previously enrolled on a medi-507 for psoriasis
487214|NCT00131079|Primary Health Care|primary health care
487215|NCT00131079|Physicians, Family|physicians, family
487216|NCT00131079|Family Practice|family practice
487217|NCT00131079|Health Promotion|health promotion
487218|NCT00131079|Randomized Controlled Trials|randomized controlled trials
487219|NCT00131079|Multicenter Studies|multicenter studies
487220|NCT00131079|Physical Fitness|physical fitness
487221|NCT00131079|Quality of Life|quality of life
487222|NCT00131092|exercise|exercise
487223|NCT00131092|aging|aging
487224|NCT00131092|physical activity|physical activity
487225|NCT00131105|Healthy|healthy
487226|NCT00131105|Caregivers|caregivers
487227|NCT00131105|Aging|aging
487228|NCT00131118|Osteogenesis Imperfecta, Brittle bone disease, bisphosphonate, children|osteogenesis imperfecta, brittle bone disease, bisphosphonate, children
487229|NCT00131131|physical activity|physical activity
487230|NCT00131131|cholelithiasis|cholelithiasis
487231|NCT00131131|pregnancy complication|pregnancy complication
487232|NCT00131144|Diabetic retinopathy,Octreotide Acetate in Microspheres|diabetic retinopathy,octreotide acetate in microspheres
487233|NCT00131157|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
487234|NCT00131157|Family Practice|family practice
487235|NCT00131157|Spirometry|spirometry
487236|NCT00131157|Decision Support Systems|decision support systems
487237|NCT00131157|Feedback|feedback
487238|NCT00131183|Angina Pectoris|angina pectoris
487239|NCT00131183|Arteriosclerosis|arteriosclerosis
487240|NCT00131183|Testosterone|testosterone
487241|NCT00131196|pneumonia|pneumonia
487242|NCT00131196|peritonitis|peritonitis
487243|NCT00131196|sepsis|sepsis
487244|NCT00131196|outcome|outcome
487245|NCT00131196|genomics|genomics
487246|NCT00131209|Infant|infant
487247|NCT00131209|Sub-Saharan Africa|sub-saharan africa
487248|NCT00131209|Complementary feeding|complementary feeding
487249|NCT00131209|Malnutrition|malnutrition
487250|NCT00131209|Growth|growth
487251|NCT00131209|Fortified spread|fortified spread
487252|NCT00131209|Haemoglobin|haemoglobin
487253|NCT00131222|Infant|infant
487254|NCT00131222|Malnutrition|malnutrition
487255|NCT00131222|Sub-Saharan Africa|sub-saharan africa
487256|NCT00131222|Treatment|treatment
487257|NCT00131222|Growth|growth
628124|NCT00685464|PCI|pci
487258|NCT00131222|Haemoglobin|haemoglobin
487259|NCT00131222|Fortified spread|fortified spread
487260|NCT00131222|Food supplement|food supplement
487261|NCT00131235|Malaria|malaria
487262|NCT00131235|STI|sti
487263|NCT00131235|Pregnancy|pregnancy
487264|NCT00131235|Prevention|prevention
487265|NCT00131235|Preterm birth|preterm birth
487266|NCT00131235|Low birth weight|low birth weight
487267|NCT00131235|Sub-Saharan Africa|sub-saharan africa
487268|NCT00131261|Multiple Myeloma|multiple myeloma
487269|NCT00131261|Neoplasms|neoplasms
487270|NCT00131274|Pulmonary Fibrosis|pulmonary fibrosis
487271|NCT00131274|Respiratory Diseases|respiratory diseases
487272|NCT00131274|Interstitial Lung Disease|interstitial lung disease
487273|NCT00131274|Usual Interstitial Pneumonia|usual interstitial pneumonia
487274|NCT00131287|Agaricus Blazei Murill|agaricus blazei murill
487275|NCT00131287|type II DM|type ii dm
487276|NCT00131287|insulin index|insulin index
487277|NCT00131300|Osteoarthritis of the shoulder|osteoarthritis of the shoulder
487278|NCT00131300|Musculoskeletal|musculoskeletal
487279|NCT00131313|Leukemia|leukemia
487280|NCT00131313|Cancer|cancer
487281|NCT00131313|Nipent|nipent
487282|NCT00131313|Rituxan|rituxan
487283|NCT00131313|Cytoxan|cytoxan
487284|NCT00131326|osteoarthritis of the hip|osteoarthritis of the hip
487285|NCT00131326|Musculoskeletal Diseases|musculoskeletal diseases
487286|NCT00131339|panic disorder|panic disorder
487287|NCT00131339|cognitive behavioral therapy|cognitive behavioral therapy
487288|NCT00131339|D-cycloserine|d-cycloserine
487289|NCT00131339|medication|medication
487290|NCT00131339|treatment trial|treatment trial
487291|NCT00131339|placebo-controlled|placebo-controlled
487292|NCT00131339|double-blind|double-blind
487293|NCT00131339|randomized|randomized
487294|NCT00131352|Osteoarthritis of the knee|osteoarthritis of the knee
487295|NCT00131352|Musculoskeletal|musculoskeletal
487296|NCT00131365|fibroids|fibroids
487297|NCT00131365|Uterine Fibroids|uterine fibroids
487298|NCT00131365|ExAblate|exablate
487299|NCT00131365|MrgFUS|mrgfus
487300|NCT00131378|Visceral obesity|visceral obesity
487301|NCT00131378|Growth hormone|growth hormone
487302|NCT00131378|Cardiovascular risk|cardiovascular risk
487303|NCT00131378|Insulin resistance|insulin resistance
487304|NCT00131417|severe|severe
487305|NCT00131417|malnutrition|malnutrition
487306|NCT00131417|ready-to-use-therapeutic-food|ready-to-use-therapeutic-food
487307|NCT00131417|children|children
487308|NCT00131417|Uganda|uganda
487309|NCT00131443|Basilar/Hemiplegic Migraine|basilar/hemiplegic migraine
487310|NCT00131443|Prophylaxis|prophylaxis
487311|NCT00131456|cannabis dependence|cannabis dependence
487312|NCT00131456|depression|depression
487313|NCT00131456|treatment|treatment
487314|NCT00131456|venlafaxine|venlafaxine
487315|NCT00131469|Osteogenesis Imperfecta|osteogenesis imperfecta
487316|NCT00131469|Brittle Bone Disease|brittle bone disease
487317|NCT00131469|Fragility Fractures|fragility fractures
487318|NCT00131482|Chrysalin|chrysalin
487319|NCT00131482|TP508|tp508
487320|NCT00131482|Fracture|fracture
487321|NCT00131482|Wrist|wrist
487322|NCT00131482|Healing|healing
487323|NCT00131495|Low Libido|low libido
487324|NCT00131495|Low Desire|low desire
487325|NCT00131495|Distress|distress
487326|NCT00131508|Hemoglobin S Disease|hemoglobin s disease
487327|NCT00131508|Sickle Cell Anemia|sickle cell anemia
487328|NCT00131521|mucus obstruction, ventilator management|mucus obstruction, ventilator management
487329|NCT00131534|Complex trauma|complex trauma
487330|NCT00131534|Trauma recovery|trauma recovery
487331|NCT00131534|Resiliency|resiliency
487332|NCT00131534|Posttraumatic stress|posttraumatic stress
487333|NCT00131534|Individual psychotherapy|individual psychotherapy
487334|NCT00131534|Group psychotherapy|group psychotherapy
487335|NCT00131547|Obesity|obesity
487336|NCT00131547|Obstructive Sleep Apnea|obstructive sleep apnea
487337|NCT00131560|HIV, gene therapy, leukapheresis, autologous CD4 T cell, lentivector|hiv, gene therapy, leukapheresis, autologous cd4 t cell, lentivector
487338|NCT00131573|Urgency-Frequency|urgency-frequency
487339|NCT00131573|Syndrome|syndrome
487340|NCT00131573|Urinary|urinary
487341|NCT00131573|Refractory|refractory
487342|NCT00131573|Stimulation|stimulation
487343|NCT00131573|Nerve|nerve
487344|NCT00131573|Neuromodulation|neuromodulation
487345|NCT00131573|Microstimulator|microstimulator
487346|NCT00131573|bion|bion
487347|NCT00131573|Pudendal|pudendal
487348|NCT00131573|Overactive bladder|overactive bladder
487349|NCT00131586|platinum analogues|platinum analogues
487350|NCT00131586|cisplatin, carboplatin, oxaliplatin|cisplatin, carboplatin, oxaliplatin
487351|NCT00131586|proteomics|proteomics
487352|NCT00131586|hemoglobin|hemoglobin
487353|NCT00131599|5-fluorouracil|5-fluorouracil
487354|NCT00131599|thymidylate synthase|thymidylate synthase
487355|NCT00131599|pharmacogenetics|pharmacogenetics
487356|NCT00131612|adjuvant therapy|adjuvant therapy
487357|NCT00131612|epirubicin|epirubicin
96991|NCT02682979|emergency unit admittance|emergency unit admittance
487358|NCT00131612|uridine glucuronosyl/transferase 2B7|uridine glucuronosyl/transferase 2b7
487359|NCT00131612|pharmacogenetics|pharmacogenetics
487360|NCT00124319|Biomechanics|biomechanics
487361|NCT00124319|Neuromuscular|neuromuscular
487362|NCT00124319|Lower limb|lower limb
487363|NCT00124319|Injury|injury
487364|NCT00124319|ACL|acl
487365|NCT00124319|Anterior Cruciate Ligament injury|anterior cruciate ligament injury
487366|NCT00124345|temperature|temperature
487367|NCT00124345|humidity|humidity
487368|NCT00124345|non invasive mechanical ventilation|non invasive mechanical ventilation
487369|NCT00124358|Drug Abuse|drug abuse
487370|NCT00124358|Drug Addiction|drug addiction
487371|NCT00124358|Drug Dependence|drug dependence
487372|NCT00124358|Drug Use Disorders|drug use disorders
487373|NCT00124358|Drug Use Disorder|drug use disorder
487374|NCT00124358|Substance Abuse|substance abuse
487375|NCT00124358|Substance Use Disorder|substance use disorder
487376|NCT00124358|Buprenorphine|buprenorphine
487377|NCT00124358|Opiate Addiction|opiate addiction
487378|NCT00124358|Substance-related disorders|substance-related disorders
487379|NCT00124358|HIV|hiv
487380|NCT00124371|coronary artery bypass surgery|coronary artery bypass surgery
487381|NCT00124371|risk factors|risk factors
487382|NCT00124371|nurse-led secondary prevention|nurse-led secondary prevention
487383|NCT00124371|prehabilitation|prehabilitation
487384|NCT00124371|waiting period|waiting period
487385|NCT00124384|primary insomnia, stimulants, cognitive behavioral therapy|primary insomnia, stimulants, cognitive behavioral therapy
487386|NCT00124410|prostate cancer|prostate cancer
487387|NCT00124410|androgen suppression therapy (hormone therapy)|androgen suppression therapy (hormone therapy)
487388|NCT00124410|osteoporosis|osteoporosis
487389|NCT00124423|brachytherapy megavoltage CT imaging|brachytherapy megavoltage ct imaging
487390|NCT00124436|Patients who have been enrolled in study protocol BAP089, and whose severe chronic hand dermatitis responded with mild or moderate disease, or who relapsed|patients who have been enrolled in study protocol bap089, and whose severe chronic hand dermatitis responded with mild or moderate disease, or who relapsed
487391|NCT00124475|Chronic Hand Dermatitis|chronic hand dermatitis
487392|NCT00124488|radiotherapy planning|radiotherapy planning
487393|NCT00124488|computer assisted radiotherapy|computer assisted radiotherapy
487395|NCT00124501|Biofeedback|biofeedback
487396|NCT00124514|SLE|sle
487397|NCT00124514|Lupus|lupus
487398|NCT00124514|Ovarian damage|ovarian damage
487399|NCT00124514|Menopause|menopause
487400|NCT00124527|Irofulven, Thyroid Cancer|irofulven, thyroid cancer
487401|NCT00124540|Misoprostol|misoprostol
487402|NCT00124540|Active management|active management
487403|NCT00124540|Postpartum hemorrhage|postpartum hemorrhage
487404|NCT00124540|Maternal morbidity|maternal morbidity
487405|NCT00124540|Anemia|anemia
487406|NCT00124540|Developing countries|developing countries
487407|NCT00124553|Type 2 diabetes|type 2 diabetes
487408|NCT00124553|cardiovascular risk|cardiovascular risk
487409|NCT00124553|glycaemic control|glycaemic control
487410|NCT00124553|dietary modification|dietary modification
487412|NCT00124566|Docetaxel|docetaxel
487413|NCT00124566|Taxotere|taxotere
487414|NCT00131625|Exclusive breast-feeding|exclusive breast-feeding
487415|NCT00131625|Mortality|mortality
487416|NCT00131625|Morbidity|morbidity
487417|NCT00131625|Nutrition|nutrition
487418|NCT00131625|Low income country|low income country
487419|NCT00131638|Oncology|oncology
487420|NCT00131638|KGF|kgf
487421|NCT00131638|Palifermin|palifermin
487422|NCT00131638|Oral mucositis|oral mucositis
487423|NCT00131638|Clinical Trial|clinical trial
487424|NCT00131638|Amgen|amgen
487425|NCT00131638|head and neck|head and neck
487426|NCT00131651|renal|renal
487427|NCT00131651|cancer|cancer
487428|NCT00131651|advanced|advanced
487429|NCT00131651|unresectable|unresectable
487430|NCT00131651|metastatic|metastatic
487431|NCT00131651|recurrent|recurrent
487432|NCT00131651|anti-angiogenic|anti-angiogenic
487433|NCT00131651|targeted|targeted
487434|NCT00131651|ATN-161|atn-161
487435|NCT00131651|Recurrent renal cell cancer|recurrent renal cell cancer
487436|NCT00131651|Renal clear cell carcinoma|renal clear cell carcinoma
487437|NCT00131651|Advanced Renal Cell Cancer|advanced renal cell cancer
487438|NCT00131690|Caffeine|caffeine
487439|NCT00131690|Coffee|coffee
487440|NCT00131690|Randomized|randomized
487441|NCT00131690|Birth weight|birth weight
487442|NCT00131703|Screening|screening
487443|NCT00131703|Treatment|treatment
487444|NCT00131703|Amodiaquine|amodiaquine
487445|NCT00131703|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
487446|NCT00131703|Malaria in pregnancy|malaria in pregnancy
487447|NCT00131716|prevention|prevention
487448|NCT00131716|recurrence|recurrence
487449|NCT00131716|severe|severe
487450|NCT00131716|anaemia|anaemia
487451|NCT00131729|Amblyopia|amblyopia
487452|NCT00131729|Occlusion therapy|occlusion therapy
487453|NCT00131729|Compliance|compliance
487454|NCT00131729|Risk factors|risk factors
487455|NCT00131755|type 1 diabetes|type 1 diabetes
487456|NCT00131755|beta cell rest|beta cell rest
487457|NCT00131755|diazoxide|diazoxide
628377|NCT00696761|BPH|bph
486781|NCT00129415|UVB|uvb
487458|NCT00131755|insulin secretion|insulin secretion
487459|NCT00131768|osteoarthritis of the ankle|osteoarthritis of the ankle
487460|NCT00131768|musculoskeletal|musculoskeletal
487461|NCT00131781|Borderline personality disorder|borderline personality disorder
487462|NCT00131781|Controlled trials|controlled trials
487463|NCT00131781|Cognitive Therapy|cognitive therapy
487464|NCT00131781|Supportive Therapy|supportive therapy
487465|NCT00131781|suicide|suicide
487466|NCT00131781|impulsivity|impulsivity
487467|NCT00131794|Malaria|malaria
487468|NCT00131794|BCG vaccine|bcg vaccine
487469|NCT00131794|Guinea Bissau|guinea bissau
487470|NCT00131807|Blood Pressure|blood pressure
487472|NCT00131807|Antiretroviral therapy|antiretroviral therapy
487473|NCT00131820|Salmonella|salmonella
487474|NCT00131820|typhoid vaccine|typhoid vaccine
487475|NCT00131820|enteric fever|enteric fever
487476|NCT00131820|socioeconomic costs|socioeconomic costs
487477|NCT00131833|salmonella|salmonella
487478|NCT00131833|typhoid vaccine|typhoid vaccine
487479|NCT00131833|enteric fever|enteric fever
487480|NCT00131846|Thiazide diuretics|thiazide diuretics
487481|NCT00131846|Essential hypertension|essential hypertension
487482|NCT00131846|Type 2 diabetes|type 2 diabetes
487483|NCT00131846|Randomized clinical trial|randomized clinical trial
487484|NCT00131846|Cost-effectiveness|cost-effectiveness
487485|NCT00131859|Perinatal brain injury|perinatal brain injury
487486|NCT00131859|Diffusion-tensor imaging|diffusion-tensor imaging
487487|NCT00131872|vascular access graft|vascular access graft
487488|NCT00131872|hemodialysis|hemodialysis
487489|NCT00131872|dialysis|dialysis
487490|NCT00131872|end stage renal disease|end stage renal disease
487491|NCT00131885|Menstruation|menstruation
487492|NCT00131885|Complementary Therapies|complementary therapies
487493|NCT00131885|Pharmacokinetics|pharmacokinetics
487494|NCT00131885|Hypericum|hypericum
487495|NCT00131885|St. John's wort|st. john's wort
487496|NCT00131885|Levonorgestrel|levonorgestrel
487497|NCT00131885|Women|women
487498|NCT00131898|IMRT+Surgery versus Surgery For Sarcoma|imrt+surgery versus surgery for sarcoma
487499|NCT00131924|recurrent breast cancer|recurrent breast cancer
487500|NCT00131924|stage IV breast cancer|stage iv breast cancer
487502|NCT00132327|Lyme Disease|lyme disease
487503|NCT00132327|Borrelia Burgdorferi|borrelia burgdorferi
487504|NCT00132327|Inflammation|inflammation
487506|NCT00132327|Host Response|host response
487507|NCT00132327|Erythema Migrans Rash|erythema migrans rash
487508|NCT00132327|Healthy Volunteer|healthy volunteer
487509|NCT00132327|HV|hv
487510|NCT00132340|Spasmodic Torticollis|spasmodic torticollis
487511|NCT00132340|Treatment|treatment
487512|NCT00132340|Physiology|physiology
487513|NCT00132340|Surgery|surgery
487514|NCT00132340|Cervical Dystonia|cervical dystonia
487515|NCT00132353|Magnetic Stimulation|magnetic stimulation
487516|NCT00132353|Single Fiber EMG|single fiber emg
487517|NCT00132353|Ultrasonography|ultrasonography
487518|NCT00132353|Quantitative Sensory Testing|quantitative sensory testing
487519|NCT00132353|Near-nerve recording|near-nerve recording
487520|NCT00132353|Neurological Disorders|neurological disorders
487521|NCT00132353|Neuromuscular Transmission Disorders|neuromuscular transmission disorders
487522|NCT00132353|Central Demyelinating Disorders|central demyelinating disorders
487523|NCT00132353|Myelopathy|myelopathy
487524|NCT00132353|Motor Neuron Disease|motor neuron disease
487525|NCT00132353|Movement Disorders|movement disorders
487526|NCT00132353|Healthy Volunteer|healthy volunteer
487527|NCT00132366|Neurotransmission|neurotransmission
487528|NCT00132366|Cortical Excitability|cortical excitability
487529|NCT00132366|GABA|gaba
487530|NCT00132366|Seizures|seizures
487531|NCT00132366|Succinic Semialdehyde Dehydrogenase Deficiency|succinic semialdehyde dehydrogenase deficiency
487532|NCT00132366|SSADH|ssadh
487533|NCT00132366|Healthy Volunteer|healthy volunteer
487534|NCT00132366|HV|hv
487535|NCT00132392|Arthroplasty|arthroplasty
487536|NCT00132392|Total knee arthroplasty|total knee arthroplasty
487537|NCT00132392|Capsaicin|capsaicin
487538|NCT00132392|Pain|pain
487539|NCT00132392|Analgesia|analgesia
487540|NCT00132405|Needlestick pain|needlestick pain
487541|NCT00132405|Venipuncture pain|venipuncture pain
487542|NCT00132405|Procedural pain|procedural pain
487543|NCT00132418|rheumatoid arthritis and at least 1 qualifying comorbid condition (diabetes, chronic pulmonary disease, recent infection)|rheumatoid arthritis and at least 1 qualifying comorbid condition (diabetes, chronic pulmonary disease, recent infection)
487544|NCT00132418|RA|ra
487545|NCT00132418|rheumatoid arthritis|rheumatoid arthritis
487546|NCT00132431|calcimimetic|calcimimetic
487547|NCT00132431|cinacalcet|cinacalcet
487548|NCT00132431|hemodialysis|hemodialysis
487549|NCT00132431|secondary hyperparathyroidism|secondary hyperparathyroidism
487550|NCT00132431|chronic kidney disease|chronic kidney disease
487551|NCT00132444|HIV|hiv
487552|NCT00132444|topical microbicides|topical microbicides
487553|NCT00132457|Chlamydia|chlamydia
487554|NCT00132457|screening|screening
487555|NCT00132457|Sexually transmitted disease|sexually transmitted disease
487556|NCT00132483|Physical activity|physical activity
487557|NCT00132483|cerebral infarct|cerebral infarct
487558|NCT00132496|GERD|gerd
487559|NCT00132509|rt-PA|rt-pa
487560|NCT00132509|thrombolysis|thrombolysis
487561|NCT00132509|Acute ischemic stroke|acute ischemic stroke
487562|NCT00132522|EpCAM|epcam
487563|NCT00132522|monoclonal-antibody|monoclonal-antibody
487564|NCT00132522|targeted therapy|targeted therapy
487565|NCT00132522|colorectal|colorectal
487566|NCT00132522|prostate|prostate
487567|NCT00132522|non-small cell lung cancer|non-small cell lung cancer
487568|NCT00132522|ovarian|ovarian
487569|NCT00132522|solid tumor|solid tumor
487570|NCT00132535|Malaria in pregnancy|malaria in pregnancy
487571|NCT00132535|IPT|ipt
487572|NCT00132535|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
487573|NCT00132535|Chloroquine|chloroquine
487574|NCT00132535|HIV|hiv
487575|NCT00132535|Viral load|viral load
487576|NCT00132535|birth weight|birth weight
487577|NCT00132535|anaemia|anaemia
487578|NCT00132548|Malaria|malaria
487579|NCT00132548|Children|children
487580|NCT00132548|Intermittent preventive treatment|intermittent preventive treatment
487581|NCT00132548|Senegal|senegal
487582|NCT00132574|acne, dairy|acne, dairy
487583|NCT00132587|Knee arthroplasty|knee arthroplasty
487584|NCT00132587|Femoral loosening|femoral loosening
487585|NCT00132587|Total Knee Arthroplasty|total knee arthroplasty
487586|NCT00132600|Allergic contact dermatitis|allergic contact dermatitis
487587|NCT00132600|Patch testing|patch testing
487588|NCT00132600|bacitracin|bacitracin
487589|NCT00132613|pulmonary neoplasm|pulmonary neoplasm
487590|NCT00132613|malignant pericardial effusion|malignant pericardial effusion
487591|NCT00132613|pericardial drainage|pericardial drainage
487592|NCT00132613|randomized trial|randomized trial
487593|NCT00132613|bleomycin|bleomycin
487594|NCT00132613|intrapericardial instillation|intrapericardial instillation
487595|NCT00132626|parkinson|parkinson
487596|NCT00132626|diagnosis|diagnosis
487597|NCT00132639|pulmonary neoplasm|pulmonary neoplasm
487598|NCT00132639|preoperative chemotherapy|preoperative chemotherapy
487599|NCT00132639|cisplatin, docetaxel|cisplatin, docetaxel
487600|NCT00132639|randomized trial|randomized trial
487601|NCT00132639|clinical stage IB or II nonsmall cell lung cancer|clinical stage ib or ii nonsmall cell lung cancer
487602|NCT00132665|non-small cell lung cancer|non-small cell lung cancer
487603|NCT00132665|elderly patients|elderly patients
487604|NCT00132665|carboplatin|carboplatin
487605|NCT00132665|chemoradiotherapy|chemoradiotherapy
487606|NCT00132678|Mood episodes|mood episodes
487607|NCT00132678|Bipolar 1 disorder|bipolar 1 disorder
487608|NCT00132678|Intramuscular Injectable|intramuscular injectable
487609|NCT00132678|risperidone|risperidone
487610|NCT00132678|safety and efficacy|safety and efficacy
487611|NCT00132691|uveitis|uveitis
487612|NCT00132691|non-infectious intermediate uveitis|non-infectious intermediate uveitis
487613|NCT00132691|non-infectious posterior uveitis|non-infectious posterior uveitis
487614|NCT00132691|non-infectious panuveitis|non-infectious panuveitis
487615|NCT00132704|Lung cancer metastases to the CNS (adenocarcinomas)|lung cancer metastases to the cns (adenocarcinomas)
487616|NCT00132704|Melanoma metastases to the CNS|melanoma metastases to the cns
487617|NCT00132704|Breast cancer metastases to the CNS (ductal carcinomas)|breast cancer metastases to the cns (ductal carcinomas)
487618|NCT00132704|Central nervous system gliomas|central nervous system gliomas
487619|NCT00132704|Colorectal cancers (adenocarcinomas)|colorectal cancers (adenocarcinomas)
487620|NCT00132704|Ovarian cancers (papillary serous carcinomas)|ovarian cancers (papillary serous carcinomas)
487621|NCT00132704|Endometrial cancers (endometrioid carcinomas)|endometrial cancers (endometrioid carcinomas)
487622|NCT00132704|Cervical cancers (squamous cell carcinomas)|cervical cancers (squamous cell carcinomas)
487623|NCT00132704|Sarcomas (liposarcomas and leiomyosarcomas)|sarcomas (liposarcomas and leiomyosarcomas)
487624|NCT00132704|Thoracic mesotheliomas|thoracic mesotheliomas
487625|NCT00132704|Colorectal cancers metastatic to the liver|colorectal cancers metastatic to the liver
487626|NCT00132704|Primary adenocarcinomas of the lung|primary adenocarcinomas of the lung
487627|NCT00132704|Primary squamous cell carcinomas of the lung|primary squamous cell carcinomas of the lung
487628|NCT00132704|Pancreatic Cancers-adenocarcinoma|pancreatic cancers-adenocarcinoma
487629|NCT00132756|Hormone Refractory|hormone refractory
487630|NCT00132756|Taxane Refractory|taxane refractory
487631|NCT00132795|Cognitive Therapy|cognitive therapy
487632|NCT00132795|Recurrence|recurrence
487633|NCT00132795|Prevention|prevention
487634|NCT00132795|Educational Technology|educational technology
487635|NCT00132808|Postmenopausal osteoporosis|postmenopausal osteoporosis
487636|NCT00132808|osteopenia|osteopenia
487637|NCT00132808|zoledronic acid|zoledronic acid
487638|NCT00132808|Osteopenia (osteoporosis prevention)|osteopenia (osteoporosis prevention)
487639|NCT00132821|Nicotine dependence|nicotine dependence
487640|NCT00132821|Sleep disorders|sleep disorders
487641|NCT00132821|smoking cessation|smoking cessation
487642|NCT00132821|Relapse|relapse
487643|NCT00132847|Child|child
487644|NCT00132847|Adolescent|adolescent
628626|NCT00697788|burn|burn
487645|NCT00132847|Urban Health|urban health
487646|NCT00132873|Narcolepsy|narcolepsy
487647|NCT00132873|Cataplexy|cataplexy
487648|NCT00132899|Crohn's Disease|crohn's disease
487649|NCT00132899|multi-centre randomized placebo-controlled|multi-centre randomized placebo-controlled
487650|NCT00132899|infliximab|infliximab
487651|NCT00132899|methotrexate|methotrexate
487652|NCT00132899|inflammatory bowel disease|inflammatory bowel disease
487653|NCT00132912|Platelets|platelets
487654|NCT00132912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
487655|NCT00132912|Protease-Activated Receptor 1|protease-activated receptor 1
487656|NCT00132912|Hemorrhage|hemorrhage
487657|NCT00132925|allergic rhinitis|allergic rhinitis
487658|NCT00132964|pediatric|pediatric
487659|NCT00132964|ankle fractures|ankle fractures
487660|NCT00132964|randomized controlled trial|randomized controlled trial
487661|NCT00132964|management|management
487662|NCT00132977|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
487663|NCT00132977|Heart Failure|heart failure
487664|NCT00132977|Mechanical Dyssynchrony|mechanical dyssynchrony
487665|NCT00132990|Cervical dystonia|cervical dystonia
487666|NCT00132990|Deep brain stimulation|deep brain stimulation
487667|NCT00133016|Induction of labor|induction of labor
487668|NCT00133042|anti-IgE, omalizumab|anti-ige, omalizumab
487669|NCT00133055|parenting|parenting
487670|NCT00133055|sleep problems|sleep problems
487671|NCT00133055|behavior problems|behavior problems
487672|NCT00133055|brief intervention|brief intervention
487673|NCT00133055|self-help|self-help
487674|NCT00133055|preschool-age children|preschool-age children
487675|NCT00133055|psychosocial|psychosocial
487676|NCT00133068|High Blood Pressure|high blood pressure
487677|NCT00133068|Health Behaviors|health behaviors
487678|NCT00133068|Patient Compliance|patient compliance
487679|NCT00133081|epilepsy|epilepsy
487680|NCT00133081|antiepileptic drugs|antiepileptic drugs
487681|NCT00133081|side effects|side effects
487682|NCT00133081|quality of life|quality of life
487683|NCT00133094|Hypercholesterolemia|hypercholesterolemia
487684|NCT00133094|Decision Support Systems, Clinical|decision support systems, clinical
487685|NCT00133133|Postoperative pain|postoperative pain
487686|NCT00133133|Open cholecystectomy|open cholecystectomy
487687|NCT00133133|Capsaicin|capsaicin
487688|NCT00133146|Allergy|allergy
487689|NCT00133146|Specific Immunotherapy|specific immunotherapy
487690|NCT00133159|Allergy|allergy
487691|NCT00133159|Specific Immunotherapy|specific immunotherapy
487692|NCT00133172|Treatment Efficacy|treatment efficacy
487693|NCT00133172|Treatment Effectiveness|treatment effectiveness
487694|NCT00133172|Anti-rejection therapy|anti-rejection therapy
487695|NCT00133172|Immunosuppression|immunosuppression
487696|NCT00133172|Antirejection|antirejection
487697|NCT00133172|Renal Transplantation|renal transplantation
487698|NCT00133172|Transplantation, Renal|transplantation, renal
487699|NCT00133172|Transplantation, Kidney|transplantation, kidney
487700|NCT00133172|Grafting, Kidney|grafting, kidney
487701|NCT00133211|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
487702|NCT00133211|Heart arrhythmia|heart arrhythmia
487703|NCT00133211|Ablation|ablation
487704|NCT00133211|Drug treatment|drug treatment
487705|NCT00133224|Advanced Prostate Cancer|advanced prostate cancer
487706|NCT00133224|HRPC|hrpc
487707|NCT00133224|Prostate|prostate
487708|NCT00133224|Cancer|cancer
487709|NCT00133224|Metastatic|metastatic
487710|NCT00133224|Hormone-refractory|hormone-refractory
487711|NCT00133224|GVAX|gvax
487712|NCT00133224|Chemotherapy|chemotherapy
487713|NCT00133224|Taxotere|taxotere
487714|NCT00133224|Docetaxel|docetaxel
487715|NCT00133224|Prednisone|prednisone
487716|NCT00133224|Vaccine|vaccine
487717|NCT00133224|Allogeneic cells|allogeneic cells
487718|NCT00133263|Randomized controlled trial|randomized controlled trial
487719|NCT00133263|Primary Care|primary care
487720|NCT00133276|Hepatitis C|hepatitis c
487721|NCT00133276|Peg-interferon|peg-interferon
487722|NCT00133276|Psychiatric side-effects|psychiatric side-effects
487723|NCT00133302|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
487724|NCT00133302|intermediate-grade lymphoma|intermediate-grade lymphoma
487725|NCT00133302|high-grade lymphoma|high-grade lymphoma
487726|NCT00133302|CHOP protocol|chop protocol
487727|NCT00133302|granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
487728|NCT00133328|stroke|stroke
487729|NCT00133328|myocardial infarction|myocardial infarction
487730|NCT00133328|angina|angina
487731|NCT00133328|renal damage|renal damage
487732|NCT00133341|Allergic contact dermatitis,patch testing, dilution series|allergic contact dermatitis,patch testing, dilution series
487733|NCT00133354|Puberty|puberty
487734|NCT00133354|Growth hormone deficiency|growth hormone deficiency
487735|NCT00133354|aromatase inhibitors|aromatase inhibitors
487736|NCT00133354|estrogen|estrogen
487737|NCT00133354|bone mineral density|bone mineral density
487738|NCT00133354|short stature|short stature
487739|NCT00133367|Hematologic malignancy|hematologic malignancy
487740|NCT00133367|Cord blood transfusion|cord blood transfusion
487741|NCT00133367|Graft versus host disease|graft versus host disease
487742|NCT00133367|tacrolimus|tacrolimus
487743|NCT00133367|sirolimus|sirolimus
487744|NCT00133406|Brazil, Child Nutrition Disorders, Deficiency Diseases|brazil, child nutrition disorders, deficiency diseases
487745|NCT00133419|micronutrient, supplementation, Africa, children, HIV|micronutrient, supplementation, africa, children, hiv
487746|NCT00133432|Pneumonia, acute respiratory infections, zinc, Tanzania, children, infants, hospitalization|pneumonia, acute respiratory infections, zinc, tanzania, children, infants, hospitalization
487747|NCT00133445|Pentavalent vaccine, Pediarix, DTaP-Hep B-IPV vaccine|pentavalent vaccine, pediarix, dtap-hep b-ipv vaccine
487748|NCT00133458|Albenza, Subarachnoid cysticercosis|albenza, subarachnoid cysticercosis
487749|NCT00133471|Influenza, vaccine, A/H9N2, MF59, adjuvant|influenza, vaccine, a/h9n2, mf59, adjuvant
487750|NCT00133484|Anthrax, rPA|anthrax, rpa
487751|NCT00133497|cytomegalovirus, vaccine, women, children, parent protocol|cytomegalovirus, vaccine, women, children, parent protocol
487752|NCT00133510|children, immunocompromised, influenza, liver transplant|children, immunocompromised, influenza, liver transplant
487753|NCT00133523|FLU-VACS, influenza, vaccine|flu-vacs, influenza, vaccine
487754|NCT00133536|H5N1, Influenza, children|h5n1, influenza, children
487755|NCT00133549|pneumococcal vaccine, 23-valent polysaccharide vaccine, elderly|pneumococcal vaccine, 23-valent polysaccharide vaccine, elderly
487756|NCT00133562|Malnutrition, pediatric, Brazil, alanyl-glutamine|malnutrition, pediatric, brazil, alanyl-glutamine
487757|NCT00133575|MVA, smallpox, Acambis|mva, smallpox, acambis
487758|NCT00133588|influenza, vaccine, proteomic profiling, elderly|influenza, vaccine, proteomic profiling, elderly
487759|NCT00133627|Allergic|allergic
487760|NCT00133627|Conjunctivitis|conjunctivitis
487761|NCT00133627|Ketotifen|ketotifen
487762|NCT00133627|Histamine|histamine
487763|NCT00133640|Vitamin D|vitamin d
487764|NCT00133640|Elderly|elderly
487765|NCT00133640|Hip fracture|hip fracture
487766|NCT00133640|Falls|falls
487767|NCT00133640|Physical Therapy|physical therapy
487768|NCT00133640|Disability|disability
487769|NCT00133653|Hypertension; Job Strain; Marital Strain; Blood Pressure|hypertension; job strain; marital strain; blood pressure
487770|NCT00133679|Chronic lung disease|chronic lung disease
487771|NCT00133679|Nitric oxide|nitric oxide
487772|NCT00133679|cyclic guanosine monophosphate|cyclic guanosine monophosphate
487773|NCT00133679|phosphodiesterase inhibitor|phosphodiesterase inhibitor
487774|NCT00133692|Hypertension|hypertension
487775|NCT00133692|Coronary Artery Disease|coronary artery disease
487776|NCT00133692|INVEST|invest
487777|NCT00133692|Diabetes|diabetes
487778|NCT00133692|Verapamil SR|verapamil sr
487779|NCT00133692|Trandolapril|trandolapril
487780|NCT00133692|Atenolol|atenolol
487781|NCT00133692|HCTZ|hctz
487782|NCT00133705|A benign tumor derived from smooth uterine muscle tissue.|a benign tumor derived from smooth uterine muscle tissue.
487783|NCT00133718|Type 2 diabetes mellitus|type 2 diabetes mellitus
487784|NCT00133718|Cardiovascular|cardiovascular
487785|NCT00133718|Coronary artery disease|coronary artery disease
487786|NCT00133718|Glycemic control|glycemic control
487787|NCT00133718|Treatment|treatment
487788|NCT00133718|Diabetes Mellitus|diabetes mellitus
487789|NCT00133744|pregnancy|pregnancy
487790|NCT00133744|vitamins|vitamins
487791|NCT00133744|minerals|minerals
487792|NCT00133744|supplements|supplements
487793|NCT00133744|mortality|mortality
487794|NCT00133744|prenatal|prenatal
487795|NCT00133744|perinatal|perinatal
487796|NCT00133744|anemia|anemia
487797|NCT00133744|birthweight|birthweight
487798|NCT00133744|preterm|preterm
487799|NCT00133744|iron|iron
487800|NCT00133744|micronutrients|micronutrients
487801|NCT00133744|Stillbirths|stillbirths
487802|NCT00133744|Early neonatal deaths|early neonatal deaths
487803|NCT00133757|Tobacco|tobacco
487804|NCT00133757|Nicotine|nicotine
487805|NCT00133757|Bupropion|bupropion
487806|NCT00133757|Cue-reactivity|cue-reactivity
487807|NCT00133757|Craving|craving
487808|NCT00133770|IV pantoprazole|iv pantoprazole
487809|NCT00133770|Esophagitis|esophagitis
487810|NCT00133783|Intermedin|intermedin
487811|NCT00133783|estradiol|estradiol
487812|NCT00133783|female hypertension|female hypertension
487813|NCT00133783|Premenopausal and postmenopausal women|premenopausal and postmenopausal women
487814|NCT00133783|Surgically-induced menopause women|surgically-induced menopause women
487815|NCT00133783|IVF treatment patients|ivf treatment patients
487816|NCT00133796|Breast Cancer|breast cancer
487817|NCT00133796|Advanced Breast Cancer|advanced breast cancer
487818|NCT00133809|Type 1 Diabetes|type 1 diabetes
487819|NCT00133809|Islet Transplantation|islet transplantation
487820|NCT00133809|Immunology|immunology
487821|NCT00133822|Post-Traumatic Stress Disorder|post-traumatic stress disorder
487822|NCT00133822|Sertraline|sertraline
487823|NCT00133822|Risperidone|risperidone
487824|NCT00133835|Randomized controlled trial|randomized controlled trial
487825|NCT00133835|Lithotripsy|lithotripsy
487826|NCT00133835|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
487827|NCT00133835|Abdominal pain|abdominal pain
487828|NCT00133848|impetigo|impetigo
487119|NCT00130676|PMD|pmd
487829|NCT00133848|topical antibacterial|topical antibacterial
487830|NCT00133848|topical antibiotic|topical antibiotic
487831|NCT00133861|cerebral palsy children|cerebral palsy children
487832|NCT00133861|Botulinum toxin|botulinum toxin
487833|NCT00133874|topical antibacterial|topical antibacterial
487834|NCT00133874|topical antibiotic|topical antibiotic
487835|NCT00133874|impetigo|impetigo
487836|NCT00133887|Squamous cell carcinoma|squamous cell carcinoma
487837|NCT00133887|kidney transplant recipients|kidney transplant recipients
487838|NCT00133887|rapamycin|rapamycin
487839|NCT00133887|Skin cancers in kidney transplant recipients|skin cancers in kidney transplant recipients
487840|NCT00133900|hormone refractory prostate cancer|hormone refractory prostate cancer
487841|NCT00133913|metastatic colorectal cancer|metastatic colorectal cancer
487842|NCT00133926|Periodontal disease|periodontal disease
487843|NCT00133926|Pregnancy|pregnancy
487844|NCT00133926|Pre-term birth|pre-term birth
487845|NCT00133926|Fetal growth|fetal growth
487846|NCT00133926|Pre-eclampsia|pre-eclampsia
487847|NCT00133926|Infant, Low Birth Weight|infant, low birth weight
488425|NCT00128414|Prevention|prevention
487848|NCT00133939|Proportional assisted ventilation|proportional assisted ventilation
487849|NCT00133939|Pressure support ventilation|pressure support ventilation
487850|NCT00133939|Synchronism during mechanical ventilation|synchronism during mechanical ventilation
487851|NCT00133939|Patients undergoing partial mechanical ventilation|patients undergoing partial mechanical ventilation
487852|NCT00133965|Advanced Cancer|advanced cancer
487853|NCT00133965|Dignity Care|dignity care
487854|NCT00133965|Supportive Care|supportive care
487855|NCT00133965|Quality of Life|quality of life
487856|NCT00133965|Psychotherapy|psychotherapy
487857|NCT00133965|Palliative Care|palliative care
487858|NCT00133978|randomized trial|randomized trial
487859|NCT00133978|antioxidants|antioxidants
487860|NCT00133978|glutamine|glutamine
487861|NCT00133978|organ failure|organ failure
487862|NCT00133991|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
487863|NCT00133991|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
487864|NCT00133991|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
487865|NCT00133991|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
487866|NCT00133991|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
487867|NCT00133991|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
487868|NCT00133991|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
487869|NCT00134004|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
487870|NCT00134004|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
488062|NCT00134160|Combination Drug Therapy|combination drug therapy
487871|NCT00134004|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
487872|NCT00134004|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
487873|NCT00134004|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
487874|NCT00134004|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
487875|NCT00134004|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
487876|NCT00134004|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
487877|NCT00134004|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
487878|NCT00134004|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
487879|NCT00134004|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
487880|NCT00134004|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
487881|NCT00134004|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
487882|NCT00134004|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
487883|NCT00134004|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
487884|NCT00134004|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
487885|NCT00134004|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
487886|NCT00134004|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
487887|NCT00134004|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
487888|NCT00134004|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
487889|NCT00134004|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
487890|NCT00134004|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
487891|NCT00134004|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
487892|NCT00134004|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
487893|NCT00134004|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
487894|NCT00134004|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
96993|NCT02682966|coronary artery disease|coronary artery disease
487895|NCT00134004|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
487896|NCT00134004|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
487897|NCT00134004|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
487898|NCT00134004|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
487899|NCT00134004|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
487900|NCT00134004|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
487901|NCT00134004|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
487902|NCT00134004|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
487903|NCT00134004|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
487904|NCT00134004|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
487905|NCT00134004|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
487906|NCT00134004|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
487907|NCT00134004|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
487908|NCT00134004|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
487909|NCT00134004|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
487910|NCT00134004|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
487911|NCT00134004|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
487912|NCT00134004|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
487913|NCT00134004|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
487914|NCT00134004|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
487915|NCT00134004|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
487916|NCT00134004|refractory multiple myeloma|refractory multiple myeloma
487917|NCT00134004|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
487918|NCT00134004|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
487919|NCT00134004|splenic marginal zone lymphoma|splenic marginal zone lymphoma
487920|NCT00134004|stage I multiple myeloma|stage i multiple myeloma
487921|NCT00134004|stage II multiple myeloma|stage ii multiple myeloma
487922|NCT00134004|stage III multiple myeloma|stage iii multiple myeloma
487923|NCT00134004|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
487924|NCT00134004|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
487925|NCT00134004|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
487926|NCT00134004|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
487927|NCT00134004|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
487928|NCT00134004|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
487929|NCT00134004|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
487930|NCT00134004|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
487931|NCT00134004|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
487932|NCT00134004|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
487933|NCT00134004|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
487934|NCT00134004|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
487935|NCT00134004|polycythemia vera|polycythemia vera
487936|NCT00134004|essential thrombocythemia|essential thrombocythemia
487937|NCT00134004|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
487938|NCT00134004|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
487939|NCT00134004|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
487940|NCT00134004|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
487941|NCT00134004|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
487942|NCT00134004|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
487943|NCT00134004|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
487944|NCT00134004|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
487945|NCT00134004|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
487946|NCT00134004|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
487947|NCT00134004|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
487948|NCT00134004|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
487949|NCT00134004|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
487950|NCT00134004|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
487951|NCT00134004|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
487952|NCT00134017|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
487953|NCT00134017|refractory anemia with excess blasts|refractory anemia with excess blasts
487954|NCT00134017|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
487955|NCT00134017|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
487956|NCT00134017|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
487957|NCT00134017|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
487958|NCT00134017|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
487959|NCT00134017|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
487960|NCT00134017|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
487961|NCT00134017|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
487962|NCT00134017|secondary acute myeloid leukemia|secondary acute myeloid leukemia
487963|NCT00134017|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
487964|NCT00134017|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
487965|NCT00134017|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
487966|NCT00134017|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
487967|NCT00134017|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
487968|NCT00134017|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
487969|NCT00134017|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
487970|NCT00134017|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
487971|NCT00134017|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
487972|NCT00134017|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
487973|NCT00134017|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
487974|NCT00134017|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
487975|NCT00134017|chronic eosinophilic leukemia|chronic eosinophilic leukemia
487976|NCT00134017|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
487977|NCT00134017|chronic neutrophilic leukemia|chronic neutrophilic leukemia
487978|NCT00134017|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
487979|NCT00134017|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
487980|NCT00134017|stage II multiple myeloma|stage ii multiple myeloma
487981|NCT00134017|stage III multiple myeloma|stage iii multiple myeloma
487982|NCT00134017|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
487983|NCT00134017|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
487984|NCT00134017|splenic marginal zone lymphoma|splenic marginal zone lymphoma
487985|NCT00134017|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
487986|NCT00134017|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
487987|NCT00134017|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
487988|NCT00134017|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
487989|NCT00134017|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
487990|NCT00134017|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
487991|NCT00134017|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
487992|NCT00134017|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
488063|NCT00134160|Diabetes Mellitus Type 2|diabetes mellitus type 2
487993|NCT00134017|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
487994|NCT00134017|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
487995|NCT00134017|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
487996|NCT00134017|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
487997|NCT00134017|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
487998|NCT00134017|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
487999|NCT00134017|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
488000|NCT00134017|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
488001|NCT00134017|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
488002|NCT00134017|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
488003|NCT00134017|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
488004|NCT00134017|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
488005|NCT00134017|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
488006|NCT00134017|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
488007|NCT00134017|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
488008|NCT00134017|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
488009|NCT00134017|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
488010|NCT00134017|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
488011|NCT00134017|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
488012|NCT00134017|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
488013|NCT00134017|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
488014|NCT00134017|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
488015|NCT00134017|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
487411|NCT00124566|Irofulven|irofulven
488016|NCT00134017|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
488017|NCT00134017|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
488018|NCT00134017|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
488019|NCT00134017|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
488020|NCT00134017|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
488021|NCT00134017|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
488022|NCT00134017|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
488023|NCT00134017|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
488024|NCT00134017|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
488025|NCT00134017|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
488026|NCT00134017|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
488027|NCT00134017|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
488028|NCT00134017|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
488029|NCT00134017|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
488030|NCT00134017|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
488031|NCT00134017|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
488032|NCT00134017|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
488033|NCT00134017|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
488034|NCT00134017|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
488035|NCT00134017|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
488036|NCT00134017|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
488037|NCT00134017|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
488038|NCT00134017|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
488039|NCT00134017|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
488040|NCT00134017|refractory multiple myeloma|refractory multiple myeloma
488041|NCT00134017|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
488042|NCT00134017|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
488043|NCT00134017|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
488044|NCT00134056|adenocarcinoma of the prostate|adenocarcinoma of the prostate
488045|NCT00134056|stage IV prostate cancer|stage iv prostate cancer
488046|NCT00134056|recurrent prostate cancer|recurrent prostate cancer
488048|NCT00134082|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
488049|NCT00134095|adenocarcinoma of the stomach|adenocarcinoma of the stomach
488050|NCT00134095|stage II gastric cancer|stage ii gastric cancer
488051|NCT00134095|stage III gastric cancer|stage iii gastric cancer
488052|NCT00134095|stage IV gastric cancer|stage iv gastric cancer
488053|NCT00134134|hidradenitis suppurativa|hidradenitis suppurativa
488055|NCT00134134|biologic|biologic
488057|NCT00134160|Aged|aged
488058|NCT00134160|Hypertension|hypertension
488059|NCT00134160|Cardiovascular Diseases|cardiovascular diseases
488060|NCT00134160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
488061|NCT00134160|Calcium Channel Blockers|calcium channel blockers
488064|NCT00134186|Kidney cancer|kidney cancer
488065|NCT00134186|Renal cell carcinoma|renal cell carcinoma
488066|NCT00134186|Motexafin gadolinium|motexafin gadolinium
488067|NCT00134212|Splanchnic perfusion, hepatic damage, oxidative stress.|splanchnic perfusion, hepatic damage, oxidative stress.
488068|NCT00134225|Musculoskeletal abnormality|musculoskeletal abnormality
488069|NCT00134225|Musculoskeletal physiology|musculoskeletal physiology
488070|NCT00134225|Musculoskeletal disease|musculoskeletal disease
488071|NCT00134225|Musculoskeletal dysfunction|musculoskeletal dysfunction
488072|NCT00134251|Parkinson's disease|parkinson's disease
488073|NCT00134251|adjunctive to L-dopa therapy|adjunctive to l-dopa therapy
488074|NCT00134251|Advanced stage Parkinson's disease|advanced stage parkinson's disease
488075|NCT00134316|sexual dysfunction|sexual dysfunction
488076|NCT00134342|tuberculosis|tuberculosis
488077|NCT00134342|tuberculin test|tuberculin test
488078|NCT00134342|immunologic tests|immunologic tests
488079|NCT00134342|Latent tuberculosis|latent tuberculosis
488080|NCT00134342|end stage renal disease|end stage renal disease
488081|NCT00134342|solid organ transplantation|solid organ transplantation
488082|NCT00134342|bone marrow transplantation|bone marrow transplantation
488083|NCT00134342|rheumatologic disease|rheumatologic disease
488084|NCT00134355|antiangiogenesis therapy|antiangiogenesis therapy
488085|NCT00134355|vatalanib|vatalanib
488086|NCT00134368|vitiligo|vitiligo
488087|NCT00134368|etanercept|etanercept
488088|NCT00134381|Normal volunteer study|normal volunteer study
488090|NCT00134394|tacrolimus|tacrolimus
488091|NCT00134394|etanercept|etanercept
488092|NCT00134407|Nutrition|nutrition
488093|NCT00134407|Postoperative|postoperative
488094|NCT00134407|oral|oral
488095|NCT00134407|jejunal|jejunal
488096|NCT00134407|feeding|feeding
488097|NCT00134407|Surgery|surgery
488098|NCT00134407|major|major
488099|NCT00134407|abdominal|abdominal
488100|NCT00134407|adult|adult
488101|NCT00134420|Growth Hormone|growth hormone
488102|NCT00134420|Chromosomes, Human, Pair 18|chromosomes, human, pair 18
488103|NCT00134420|Child|child
488104|NCT00134433|Coronary Artery Disease, Diffuse|coronary artery disease, diffuse
488105|NCT00134433|Coronary Artery Disease, Deemed Inoperable|coronary artery disease, deemed inoperable
488106|NCT00134446|post traumatic stress disorder|post traumatic stress disorder
488107|NCT00134446|PTSD|ptsd
488108|NCT00134446|trauma|trauma
488109|NCT00134446|transcranial magnetic stimulation|transcranial magnetic stimulation
488110|NCT00134446|randomized clinical trial|randomized clinical trial
488111|NCT00134459|Depression|depression
488112|NCT00134459|Bipolar Disorder|bipolar disorder
488113|NCT00134472|Hypothermia, induced|hypothermia, induced
488114|NCT00134472|Traumatic Brain injuries|traumatic brain injuries
488115|NCT00134472|Anesthesia|anesthesia
488116|NCT00134472|Neuro-intensive care|neuro-intensive care
488117|NCT00134472|neurochemistry|neurochemistry
488118|NCT00134524|Magnetics|magnetics
488119|NCT00134524|Electromagnetics|electromagnetics
488120|NCT00134524|Diabetic neuropathy|diabetic neuropathy
488121|NCT00134524|Pain|pain
488122|NCT00134537|Degenerative Disc Disease of the lumbar spine|degenerative disc disease of the lumbar spine
488123|NCT00134550|Diabetes Mellitus|diabetes mellitus
488124|NCT00134550|Foot ulcers|foot ulcers
488125|NCT00134550|Complication|complication
488126|NCT00134550|Foot Ulcer, Diabetic|foot ulcer, diabetic
488127|NCT00134563|Multiple Sclerosis|multiple sclerosis
488128|NCT00134563|Relapsing Remitting|relapsing remitting
488129|NCT00134563|Secondary Progressive|secondary progressive
488130|NCT00134563|Progressive Relapsing|progressive relapsing
488131|NCT00134589|Academic Detailing|academic detailing
488132|NCT00134589|Decision Aid|decision aid
488133|NCT00134589|Colorectal Cancer Screening|colorectal cancer screening
488134|NCT00134589|RECTAL NEOPLASMS|rectal neoplasms
488135|NCT00134589|COLONIC POLYPS|colonic polyps
488136|NCT00134602|HIV infection, antiretroviral therapy, adherence, pediatric|hiv infection, antiretroviral therapy, adherence, pediatric
488137|NCT00134615|decision-making|decision-making
488138|NCT00134615|patient activation|patient activation
488139|NCT00134615|empowerment|empowerment
488140|NCT00134615|mental health|mental health
488141|NCT00134615|Depression|depression
488142|NCT00134615|Anxiety|anxiety
488143|NCT00134615|Other Psychiatric Disorder|other psychiatric disorder
488144|NCT00134628|Hyperbaric Oxygenation|hyperbaric oxygenation
488145|NCT00134628|Radiation injuries|radiation injuries
488146|NCT00134628|Prophylaxis|prophylaxis
488147|NCT00134628|Proctitis|proctitis
488148|NCT00134628|Cystitis|cystitis
488149|NCT00134628|Enteritis|enteritis
488150|NCT00134628|Osteoradionecrosis|osteoradionecrosis
488151|NCT00134641|soft tissue sarcoma|soft tissue sarcoma
488152|NCT00134641|metastatic soft tissue sarcoma|metastatic soft tissue sarcoma
488153|NCT00134641|gemcitabine|gemcitabine
488154|NCT00134641|vinorelbine|vinorelbine
14355|NCT03198871|Post-operative pain|post-operative pain
488155|NCT00134654|Androgen-independent prostate cancer|androgen-independent prostate cancer
488157|NCT00134654|conjugated estrogen|conjugated estrogen
488158|NCT00134667|AMD|amd
488159|NCT00134667|Age-Related Macular Degeneration|age-related macular degeneration
488160|NCT00134667|Macular Degeneration|macular degeneration
488162|NCT00134667|Photodynamic Therapy|photodynamic therapy
488163|NCT00134667|PDT|pdt
488164|NCT00134667|Visudyne|visudyne
488165|NCT00134667|pegaptanib sodium|pegaptanib sodium
488166|NCT00134667|verteporfin|verteporfin
488167|NCT00134667|Predominantly Classic|predominantly classic
488168|NCT00134667|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
488169|NCT00134680|estrogen receptor positive|estrogen receptor positive
488170|NCT00134680|progesterone receptor positive|progesterone receptor positive
488171|NCT00134680|ErbB2 positive|erbb2 positive
488172|NCT00134680|metastatic breast cancer|metastatic breast cancer
488173|NCT00134693|SB-681323 rheumatoid arthritis CRP biomarkers|sb-681323 rheumatoid arthritis crp biomarkers
488174|NCT00134706|Prostate Cancer|prostate cancer
488175|NCT00134706|Cancer of the prostate|cancer of the prostate
488176|NCT00134706|Cancer of prostate|cancer of prostate
488177|NCT00134706|Docetaxel|docetaxel
488178|NCT00134706|Carboplatin|carboplatin
488179|NCT00134719|Invasive Hib & N. meningitidis diseases|invasive hib & n. meningitidis diseases
488180|NCT00134732|Prophylaxis of Rotavirus Gastroenteritis|prophylaxis of rotavirus gastroenteritis
488181|NCT00134745|Turner Syndrome|turner syndrome
488182|NCT00134745|Hormonal replacement therapy|hormonal replacement therapy
488183|NCT00134745|Bone mineralization|bone mineralization
488184|NCT00134745|Uterine size|uterine size
488185|NCT00134745|aortic root dilatation|aortic root dilatation
488186|NCT00134758|Treatment of adenomas of the duodenum in FAP patients.|treatment of adenomas of the duodenum in fap patients.
488187|NCT00134758|Adenoma|adenoma
488188|NCT00134771|Infants whose birthweight is less than the 20th centile for gestational age (UK standards)|infants whose birthweight is less than the 20th centile for gestational age (uk standards)
488189|NCT00134771|Infants who are formula fed from birth|infants who are formula fed from birth
488190|NCT00134771|Singletons|singletons
488191|NCT00134771|Infants free from major congenital disease|infants free from major congenital disease
488192|NCT00134784|parkinson|parkinson
488193|NCT00134784|brain imaging|brain imaging
488194|NCT00134797|GFR|gfr
488195|NCT00134797|serum creatinine|serum creatinine
488196|NCT00127465|Medical Informatics|medical informatics
488197|NCT00127465|Patient education|patient education
488198|NCT00127465|Social support|social support
488199|NCT00127465|Cancer|cancer
488200|NCT00127465|Anxiety|anxiety
488201|NCT00127478|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
488202|NCT00127478|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
488203|NCT00127491|Acute Lung Injury|acute lung injury
488204|NCT00127491|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
488205|NCT00127491|Mechanical Ventilation|mechanical ventilation
488206|NCT00127491|Esophageal Pressures|esophageal pressures
488207|NCT00127491|Randomized Controlled Trial|randomized controlled trial
488208|NCT00127504|Onchocerciasis|onchocerciasis
488209|NCT00127504|Wolbachia|wolbachia
488210|NCT00127504|Therapy|therapy
488211|NCT00127517|Oncology|oncology
488212|NCT00127517|Palliative Care|palliative care
488213|NCT00127517|Advanced Cancer|advanced cancer
488214|NCT00127517|Palliative Cancer Care|palliative cancer care
488215|NCT00127530|Walking Ability|walking ability
488216|NCT00127543|Medication Education|medication education
488217|NCT00127543|Pediatric|pediatric
488218|NCT00127556|Transfusion|transfusion
488219|NCT00127556|Safety|safety
488220|NCT00127569|HIV infections|hiv infections
488221|NCT00127569|Giant Lymph Node Hyperplasia|giant lymph node hyperplasia
488222|NCT00127569|Herpesvirus 8, Human|herpesvirus 8, human
488223|NCT00127569|Rituximab (Mabthera)|rituximab (mabthera)
488224|NCT00127569|Antibodies, Monoclonal|antibodies, monoclonal
488225|NCT00127582|Myotonic dystrophy type 1|myotonic dystrophy type 1
488226|NCT00127582|Sudden cardiac death|sudden cardiac death
488227|NCT00127582|Ventricular tachyarrhythmias|ventricular tachyarrhythmias
488228|NCT00127582|Bradyarrhythmias|bradyarrhythmias
488229|NCT00127595|carcinoma of the urothelial tract|carcinoma of the urothelial tract
488230|NCT00127621|ICU patients needing prolonged ventilatory support|icu patients needing prolonged ventilatory support
488232|NCT00127673|Antidepressants|antidepressants
488233|NCT00127673|Cognitive behavior therapy|cognitive behavior therapy
488234|NCT00127686|cough|cough
488235|NCT00127686|nocturnal cough|nocturnal cough
488236|NCT00127686|upper respiratory tract infection|upper respiratory tract infection
488237|NCT00127686|sleep quality|sleep quality
488238|NCT00127686|childhood cough|childhood cough
488239|NCT00127686|Dextromethorphan|dextromethorphan
488240|NCT00127686|Honey|honey
488241|NCT00127699|Umbilical cord|umbilical cord
488242|NCT00127699|Triple dye|triple dye
488243|NCT00127699|Infant care|infant care
488244|NCT00127712|amiodarone|amiodarone
488245|NCT00127712|atrial fibrillation|atrial fibrillation
488246|NCT00127712|surgical procedures, thoracic|surgical procedures, thoracic
488248|NCT00127725|fracture|fracture
488249|NCT00127725|PEMF|pemf
488250|NCT00127725|electromagnetic|electromagnetic
488252|NCT00127725|revision|revision
488253|NCT00127725|Diaphyseal fractures of the tibia|diaphyseal fractures of the tibia
488254|NCT00127738|Hypertension|hypertension
488255|NCT00127738|Renal artery stenosis|renal artery stenosis
488256|NCT00127738|Kidney disease|kidney disease
488257|NCT00127738|Renal vascular disease|renal vascular disease
488258|NCT00127738|Atherosclerosis|atherosclerosis
488259|NCT00127751|Risk factor reduction|risk factor reduction
488260|NCT00127751|cardiovascular disease prevention|cardiovascular disease prevention
488261|NCT00127764|pemphigus|pemphigus
488262|NCT00127764|dexamethasone|dexamethasone
488263|NCT00127764|glucocorticoids|glucocorticoids
488265|NCT00127764|therapy|therapy
488266|NCT00127764|randomised|randomised
488267|NCT00127764|placebo-controlled|placebo-controlled
488268|NCT00127777|HCV genotype 1|hcv genotype 1
488269|NCT00127777|peginterferon alfa-2a|peginterferon alfa-2a
488270|NCT00127777|ribavirin|ribavirin
488271|NCT00127777|amantadine|amantadine
488272|NCT00127777|treatment-naive|treatment-naive
488273|NCT00127790|Insomnia|insomnia
488274|NCT00127790|Sleep|sleep
488275|NCT00127790|Pain|pain
488276|NCT00127790|Pain, Chronic|pain, chronic
488277|NCT00127790|Behavior Therapy|behavior therapy
488278|NCT00127790|CBT|cbt
488279|NCT00127790|CBT-I|cbt-i
488280|NCT00127790|cognitive-behavioral|cognitive-behavioral
488281|NCT00127803|Clostridium difficile|clostridium difficile
488282|NCT00127816|brachytherapy|brachytherapy
488283|NCT00127816|implant radiotherapy|implant radiotherapy
488284|NCT00127829|Solid Tumors|solid tumors
488285|NCT00127842|Psoriatic Arthritis|psoriatic arthritis
488286|NCT00127842|PsA|psa
488287|NCT00127842|Commercial product|commercial product
488288|NCT00127842|American College of Rheumatology|american college of rheumatology
488289|NCT00127842|ACR/PASI|acr/pasi
488290|NCT00127855|Invasive bacterial disease caused by Hib|invasive bacterial disease caused by hib
488291|NCT00127855|Neisseria meningitidis serogroups C & Y|neisseria meningitidis serogroups c & y
488292|NCT00127868|Tinea Capitis|tinea capitis
488293|NCT00127868|Children|children
488294|NCT00127868|Pediatric|pediatric
488295|NCT00127868|Treatment|treatment
488296|NCT00127868|Therapy|therapy
488297|NCT00127868|Adjunctive|adjunctive
488298|NCT00127868|Selenium Sulfide|selenium sulfide
488299|NCT00127868|Ciclopirox|ciclopirox
488300|NCT00127868|Shampoo|shampoo
488301|NCT00127881|Refractory or intolerant to Mycosis Fungoides and sezary syndrome|refractory or intolerant to mycosis fungoides and sezary syndrome
488302|NCT00127881|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
488303|NCT00127881|To evaluate the efficacy and safety of zanolimumab in Mycosis Fungoides and sezary syndrome|to evaluate the efficacy and safety of zanolimumab in mycosis fungoides and sezary syndrome
488304|NCT00127907|Out-of-hospital cardiac arrest - Vasopressin - Epinephrine|out-of-hospital cardiac arrest - vasopressin - epinephrine
488305|NCT00127959|HIV-1|hiv-1
488306|NCT00127959|HBV|hbv
488307|NCT00127959|treatment|treatment
488308|NCT00127959|tenofovir|tenofovir
488309|NCT00127959|emtricitabine|emtricitabine
488310|NCT00127959|Treatment Naive|treatment naive
488311|NCT00127959|HIV-1 infection|hiv-1 infection
488312|NCT00127959|Hepatitis B virus infection|hepatitis b virus infection
488313|NCT00127972|nevirapine|nevirapine
488314|NCT00127972|efavirenz|efavirenz
488315|NCT00127972|hiv-1|hiv-1
488316|NCT00127972|Treatment Experienced|treatment experienced
488317|NCT00127985|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
488318|NCT00127985|corticosteroids|corticosteroids
488319|NCT00127985|mortality|mortality
488320|NCT00127998|malaria|malaria
488321|NCT00127998|Plasmodium falciparum|plasmodium falciparum
488322|NCT00127998|drug resistance|drug resistance
488323|NCT00127998|antimalarials|antimalarials
488324|NCT00127998|genotype|genotype
488325|NCT00127998|treatment outcome|treatment outcome
488326|NCT00128011|watery diarrhea|watery diarrhea
488327|NCT00128011|cholera vaccine|cholera vaccine
488328|NCT00128024|randomized prospective study|randomized prospective study
488329|NCT00128024|lipid-lowering therapy with any available statins|lipid-lowering therapy with any available statins
488330|NCT00128024|multicenter study|multicenter study
488331|NCT00128024|Japanese|japanese
488332|NCT00128024|acute myocardial infarction|acute myocardial infarction
488333|NCT00128024|primary percutaneous coronary intervention|primary percutaneous coronary intervention
488334|NCT00128037|pulmonary neoplasm|pulmonary neoplasm
488335|NCT00128037|preoperative chemoradiotherapy|preoperative chemoradiotherapy
488336|NCT00128037|surgical resection|surgical resection
488337|NCT00128037|superior sulcus tumor|superior sulcus tumor
488338|NCT00128037|chest wall invasion|chest wall invasion
488339|NCT00128037|mytomicin C|mytomicin c
488341|NCT00128037|cisplatin|cisplatin
488342|NCT00128050|Spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
488343|NCT00128050|ICH|ich
488344|NCT00128050|intracerebral rebleeding|intracerebral rebleeding
488345|NCT00128050|cerebral hematoma evacuation|cerebral hematoma evacuation
488346|NCT00128050|cerebral hematoma volume|cerebral hematoma volume
488347|NCT00128063|HIV-1|hiv-1
488264|NCT00127764|pulse|pulse
488348|NCT00128063|succinylated human serum albumin|succinylated human serum albumin
488349|NCT00128063|Treatment Naive|treatment naive
488350|NCT00128076|shoulder surgery|shoulder surgery
488351|NCT00128076|rotator cuff|rotator cuff
488352|NCT00128076|arthroscopic repair|arthroscopic repair
488353|NCT00128076|mini-open repair|mini-open repair
488354|NCT00128089|Obesity|obesity
488355|NCT00128089|Dietary treatment|dietary treatment
488356|NCT00128089|Fasting as medical therapy|fasting as medical therapy
488357|NCT00128102|Advanced malignant pleural mesothelioma|advanced malignant pleural mesothelioma
488358|NCT00128128|Vaccinium macrocarpon|vaccinium macrocarpon
488359|NCT00128128|Cranberry|cranberry
488360|NCT00128128|Complementary Therapies|complementary therapies
488361|NCT00128154|Chromium|chromium
488362|NCT00128154|Chromium picolinate|chromium picolinate
488363|NCT00128154|Blood Glucose|blood glucose
488364|NCT00128154|Cholesterol|cholesterol
488365|NCT00128154|Complementary Therapies|complementary therapies
488366|NCT00128180|hantaviruses, methylprednisolone, cardiopulmonary syndrome|hantaviruses, methylprednisolone, cardiopulmonary syndrome
488367|NCT00128193|leprosy, Mycobacterium leprae, Hansen's Disease, skin test, Nepal|leprosy, mycobacterium leprae, hansen's disease, skin test, nepal
488368|NCT00128206|LTBI, tuberculosis, rifampin, isoniazid, prisoners|ltbi, tuberculosis, rifampin, isoniazid, prisoners
488369|NCT00128219|Group B Streptococcus, women, vaccine|group b streptococcus, women, vaccine
488370|NCT00128232|Acromegaly|acromegaly
488371|NCT00128232|untreated|untreated
488372|NCT00128232|newly diagnosed|newly diagnosed
488373|NCT00128232|octreotide LAR|octreotide lar
488374|NCT00128245|KCS|kcs
488375|NCT00128245|dry eye|dry eye
488376|NCT00128245|pimecrolimus|pimecrolimus
488377|NCT00128245|Keratoconjunctivitis sicca (dry eye syndrome)|keratoconjunctivitis sicca (dry eye syndrome)
488378|NCT00128258|Stem Cell|stem cell
488379|NCT00128258|Heart Failure|heart failure
488380|NCT00128258|Bone Marrow|bone marrow
488381|NCT00128271|HCV|hcv
488382|NCT00128271|monoclonal antibody|monoclonal antibody
488383|NCT00128271|phase 1|phase 1
488384|NCT00128284|gastroparesis|gastroparesis
488385|NCT00128284|Digestive|digestive
488386|NCT00128284|Gastrointestinal|gastrointestinal
488387|NCT00128284|Stomach|stomach
488388|NCT00128284|Motility|motility
488389|NCT00128284|Non-Invasive|non-invasive
488390|NCT00128284|Capsule|capsule
488391|NCT00128284|GI|gi
488392|NCT00128284|Device|device
488393|NCT00128284|Digestive System Diseases|digestive system diseases
488394|NCT00128297|Breast cancer patients with symptomatic bone metastases|breast cancer patients with symptomatic bone metastases
488395|NCT00128310|Drug-resistant metastatic breast cancer|drug-resistant metastatic breast cancer
488396|NCT00128323|Children|children
488397|NCT00128323|oropharyngeal candidiasis|oropharyngeal candidiasis
488398|NCT00128323|GV solution|gv solution
488399|NCT00128323|nystatin drops|nystatin drops
488400|NCT00128336|Weight|weight
488401|NCT00128336|Diet|diet
488402|NCT00128336|exercise|exercise
488403|NCT00128336|maintenance|maintenance
488404|NCT00128362|Sentinel node|sentinel node
488405|NCT00128362|Axillary sampling|axillary sampling
488406|NCT00128362|Operable breast cancer|operable breast cancer
488407|NCT00128375|Smoking Cessation|smoking cessation
488408|NCT00128375|Work-site|work-site
488409|NCT00128375|Incentives|incentives
488410|NCT00128375|Cost Effectiveness|cost effectiveness
488411|NCT00128375|Health Behavior|health behavior
488412|NCT00128375|Smoking|smoking
488413|NCT00128388|panic disorder,|panic disorder,
488414|NCT00128388|psychodynamic psychotherapy,|psychodynamic psychotherapy,
488415|NCT00128388|efficacy trial|efficacy trial
488416|NCT00128401|Cognitive|cognitive
488417|NCT00128401|Behavioral|behavioral
488418|NCT00128401|Adolescent|adolescent
488419|NCT00128401|Therapy|therapy
488420|NCT00128401|Extinction|extinction
488421|NCT00128401|Social Phobia|social phobia
488422|NCT00128414|Pericarditis|pericarditis
488423|NCT00128414|Recurrence|recurrence
488424|NCT00128414|Therapeutics|therapeutics
488426|NCT00128414|Colchicine|colchicine
488427|NCT00128427|Postpericardiotomy Syndrome|postpericardiotomy syndrome
488428|NCT00128427|Pericarditis|pericarditis
488429|NCT00128427|Prevention|prevention
488430|NCT00128427|Colchicine|colchicine
488431|NCT00128427|Recurrence|recurrence
488432|NCT00128453|Pericarditis|pericarditis
488433|NCT00128453|Recurrence|recurrence
488434|NCT00128453|Therapeutics|therapeutics
488435|NCT00128453|Prevention|prevention
488436|NCT00128453|Colchicine|colchicine
488437|NCT00128466|bubonic plague|bubonic plague
488438|NCT00128466|pneumonic plague|pneumonic plague
488439|NCT00128466|septicemic plague|septicemic plague
488440|NCT00128466|Yersinia pestis|yersinia pestis
488441|NCT00128466|Pasteurella pestis|pasteurella pestis
488442|NCT00128479|PMD|pmd
488443|NCT00128479|Psychotic Depression|psychotic depression
488444|NCT00128479|Psychosis|psychosis
488445|NCT00128479|Major Depression|major depression
488446|NCT00128479|Depression|depression
488447|NCT00128479|Psychotic Major Depression|psychotic major depression
488448|NCT00128492|cystic fibrosis|cystic fibrosis
488449|NCT00128492|Pseudomonas aeruginosa|pseudomonas aeruginosa
488450|NCT00128505|PMD|pmd
488451|NCT00128505|Depression|depression
488452|NCT00128505|Psychosis|psychosis
488453|NCT00128505|Psychotic Major Depression|psychotic major depression
488454|NCT00128505|Major Depression|major depression
488455|NCT00128518|Hypertension - Drugs - Blood pressure response - Responders - pharmacogenetics|hypertension - drugs - blood pressure response - responders - pharmacogenetics
488456|NCT00128531|Phase III|phase iii
488457|NCT00128531|open label|open label
488458|NCT00128531|multiple dose|multiple dose
488459|NCT00128531|safety study|safety study
488460|NCT00128531|pharmacokinetic study|pharmacokinetic study
488461|NCT00128531|efficacy study|efficacy study
488462|NCT00128557|Vitamin A|vitamin a
488463|NCT00128557|Newborn health|newborn health
488464|NCT00128557|Infant Mortality|infant mortality
488465|NCT00128557|Supplementation|supplementation
488466|NCT00128557|Micronutrients|micronutrients
488467|NCT00128557|Bangladesh|bangladesh
488468|NCT00128570|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
488469|NCT00128583|stage III melanoma|stage iii melanoma
488470|NCT00128596|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
488471|NCT00128596|advanced adult primary liver cancer|advanced adult primary liver cancer
488472|NCT00128596|recurrent adult primary liver cancer|recurrent adult primary liver cancer
488473|NCT00128622|male breast cancer|male breast cancer
488474|NCT00128622|recurrent breast cancer|recurrent breast cancer
488475|NCT00128622|stage IV breast cancer|stage iv breast cancer
488476|NCT00128622|recurrent colon cancer|recurrent colon cancer
488477|NCT00128622|stage IV colon cancer|stage iv colon cancer
488478|NCT00128622|recurrent rectal cancer|recurrent rectal cancer
488479|NCT00128622|stage IV rectal cancer|stage iv rectal cancer
488480|NCT00128622|recurrent pancreatic cancer|recurrent pancreatic cancer
488481|NCT00128622|extensive stage small cell lung cancer|extensive stage small cell lung cancer
488482|NCT00128622|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
488483|NCT00128622|recurrent small cell lung cancer|recurrent small cell lung cancer
488484|NCT00128622|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
488485|NCT00128622|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
488486|NCT00128622|stage IV pancreatic cancer|stage iv pancreatic cancer
488487|NCT00128635|adult glioblastoma|adult glioblastoma
488488|NCT00128635|adult gliosarcoma|adult gliosarcoma
488489|NCT00128635|adult giant cell glioblastoma|adult giant cell glioblastoma
488490|NCT00128635|recurrent adult brain tumor|recurrent adult brain tumor
488491|NCT00128661|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
488492|NCT00128661|cervical cancer|cervical cancer
488493|NCT00128661|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
488494|NCT00128700|adult glioblastoma|adult glioblastoma
488495|NCT00128700|adult giant cell glioblastoma|adult giant cell glioblastoma
488496|NCT00128700|adult gliosarcoma|adult gliosarcoma
488497|NCT00128713|Blood Transfusion|blood transfusion
488498|NCT00128713|Blood Platelets|blood platelets
488499|NCT00128726|continuous combined oral contraceptive|continuous combined oral contraceptive
488500|NCT00128726|endometrial and ovarian suppression|endometrial and ovarian suppression
488501|NCT00128752|vitamin A|vitamin a
488502|NCT00128752|beta Carotene|beta carotene
488503|NCT00128752|diet|diet
488504|NCT00128752|nutrition|nutrition
488505|NCT00128752|nutritional requirements|nutritional requirements
488506|NCT00128765|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
488507|NCT00128765|self-management|self-management
488508|NCT00128765|practice nurse|practice nurse
488509|NCT00128765|cost-effectiveness|cost-effectiveness
488510|NCT00128765|randomized controlled trial|randomized controlled trial
488511|NCT00128778|Breast cancer|breast cancer
488512|NCT00128778|Metastases|metastases
488513|NCT00128778|Maintenance treatment|maintenance treatment
488514|NCT00128791|myocardial infarction|myocardial infarction
488515|NCT00128791|angioplasty|angioplasty
488516|NCT00128791|nitric oxide|nitric oxide
488517|NCT00128791|prevention|prevention
488518|NCT00128791|acute myocardial infarction|acute myocardial infarction
488519|NCT00128804|vitamin A|vitamin a
488520|NCT00128804|beta Carotene|beta carotene
488521|NCT00128804|diet|diet
488522|NCT00128804|nutrition|nutrition
488523|NCT00128804|nutritional requirements|nutritional requirements
488524|NCT00128817|neoplasm|neoplasm
488525|NCT00128817|larynx|larynx
488526|NCT00128817|surgery|surgery
488527|NCT00128817|radiotherapy|radiotherapy
488528|NCT00128817|chemotherapy|chemotherapy
488529|NCT00128830|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
488530|NCT00128830|HIV-1 infection|hiv-1 infection
488531|NCT00128830|TMC125|tmc125
488532|NCT00128830|Etravirine|etravirine
488533|NCT00128830|Enfuvirtide|enfuvirtide
488534|NCT00128830|Antiretroviral therapy|antiretroviral therapy
488535|NCT00128843|Metastatic breast cancer|metastatic breast cancer
488536|NCT00128843|First line of hormone treatment|first line of hormone treatment
488537|NCT00128843|Postmenopausal women|postmenopausal women
488538|NCT00128843|Positive hormone receptor tumours|positive hormone receptor tumours
488539|NCT00128856|Neoadjuvant chemotherapy.|neoadjuvant chemotherapy.
488540|NCT00128856|Stage III disease.|stage iii disease.
488541|NCT00128869|Manipulation|manipulation
488638|NCT00134992|eye drops|eye drops
488542|NCT00128869|Mobilization|mobilization
488543|NCT00128869|Neck Pain|neck pain
488544|NCT00128869|Physical Therapy|physical therapy
488545|NCT00128882|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
488546|NCT00128882|Treatment|treatment
488547|NCT00128882|Anti-D|anti-d
488548|NCT00128882|Subcutaneous|subcutaneous
488549|NCT00128882|Clinical evaluation|clinical evaluation
488550|NCT00128882|Platelet count|platelet count
488551|NCT00128882|IVIG|ivig
488552|NCT00128895|Wegener's granulomatosis, ANCA, vasculitis, proteinase 3|wegener's granulomatosis, anca, vasculitis, proteinase 3
488553|NCT00128895|ANCA-associated vasculitis|anca-associated vasculitis
488554|NCT00128895|ANCA|anca
488555|NCT00128908|HIV-1|hiv-1
488556|NCT00128908|HAART|haart
488557|NCT00128908|sequential HAART|sequential haart
488558|NCT00128908|resistance|resistance
488559|NCT00128908|salvage therapy|salvage therapy
488560|NCT00128908|Treatment Experienced|treatment experienced
488561|NCT00128921|Multiple Myeloma|multiple myeloma
488562|NCT00128934|Premenstrual Syndrome (PMS)|premenstrual syndrome (pms)
488563|NCT00128934|Hormone Therapy|hormone therapy
488564|NCT00128947|Immunosuppresant|immunosuppresant
488565|NCT00128947|Pharmacogenetics|pharmacogenetics
488566|NCT00128947|Glucuronidation|glucuronidation
488567|NCT00128947|Metabolism|metabolism
488568|NCT00128947|UGT|ugt
488569|NCT00128960|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
488570|NCT00128960|Health Related Quality of Life|health related quality of life
488571|NCT00128960|Symptom Experience|symptom experience
488572|NCT00128960|Fatigue|fatigue
488573|NCT00128960|Functional Status|functional status
488574|NCT00128960|Survey|survey
488575|NCT00128960|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
488576|NCT00128973|CGD|cgd
488577|NCT00128973|LAD|lad
488578|NCT00128973|XSCID|xscid
488579|NCT00128973|cGVHD|cgvhd
488580|NCT00128973|Infection|infection
488581|NCT00128973|Abnormal Immune Function|abnormal immune function
488582|NCT00128973|Recurrent Infection|recurrent infection
488583|NCT00128973|Chronic Granulomatous Disease|chronic granulomatous disease
488584|NCT00128973|X-Linked Severe Combined Immune Deficiency (XSCID)|x-linked severe combined immune deficiency (xscid)
488585|NCT00128973|Leukocyte Adhesion Deficiency 1|leukocyte adhesion deficiency 1
488586|NCT00128973|Healthy Volunteer|healthy volunteer
488587|NCT00128973|HV|hv
488588|NCT00128986|radiotherapy|radiotherapy
488589|NCT00128986|brain|brain
488590|NCT00128999|radiation therapy|radiation therapy
488591|NCT00129012|radiation therapy|radiation therapy
488592|NCT00129012|carcinoma|carcinoma
488593|NCT00129012|non-small cell lung|non-small cell lung
488594|NCT00129025|conformal hypofractionated radiotherapy|conformal hypofractionated radiotherapy
488595|NCT00129025|localized prostate cancer|localized prostate cancer
488596|NCT00129051|tomotherapy|tomotherapy
488597|NCT00129051|metastatic carcinoma|metastatic carcinoma
488598|NCT00129064|Referrals|referrals
488599|NCT00129064|Quality of care|quality of care
488600|NCT00129064|Ambulatory care|ambulatory care
488601|NCT00129064|Electronic medical record|electronic medical record
488602|NCT00129064|Referral communication|referral communication
488603|NCT00129077|Pediatric critical care|pediatric critical care
488604|NCT00129077|neuromuscular blocking agents|neuromuscular blocking agents
488605|NCT00129077|corneal abrasions|corneal abrasions
488606|NCT00129116|Invasive bacterial disease caused by Hib|invasive bacterial disease caused by hib
488607|NCT00129116|Neisseria meningitidis serogroups C & Y|neisseria meningitidis serogroups c & y
488608|NCT00129129|Immunogenicity|immunogenicity
488609|NCT00129129|Primary & booster vaccination|primary & booster vaccination
488610|NCT00129129|Infants|infants
488611|NCT00129129|Meningococcal vaccine|meningococcal vaccine
488612|NCT00129129|Safety|safety
488613|NCT00129129|Children|children
488614|NCT00129129|Hib disease|hib disease
488615|NCT00129129|Meningococcal disease|meningococcal disease
488616|NCT00134810|Myofascial pain syndrome|myofascial pain syndrome
488617|NCT00134823|Parent Experience of Care|parent experience of care
488618|NCT00134823|Quality Improvement|quality improvement
488619|NCT00134823|Medication Errors|medication errors
488620|NCT00134823|Abnormal Lab Values|abnormal lab values
488621|NCT00134823|Guideline Adherence|guideline adherence
488622|NCT00134849|hypertension|hypertension
488623|NCT00134875|opioid dependence|opioid dependence
488624|NCT00134888|Opioid Dependence|opioid dependence
488625|NCT00134901|Cocaine dependence|cocaine dependence
488626|NCT00134901|treatment|treatment
488627|NCT00134901|memantine|memantine
488628|NCT00134914|opiate dependence|opiate dependence
488629|NCT00134940|Transplantation, heart|transplantation, heart
488630|NCT00134940|Organ transplant|organ transplant
488631|NCT00134953|Mild cognitive impairment|mild cognitive impairment
488632|NCT00134953|Alzheimer's disease|alzheimer's disease
488633|NCT00134953|Dementia|dementia
488634|NCT00134953|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
488635|NCT00134966|Parkinson's disease, levodopa, dyskinesia|parkinson's disease, levodopa, dyskinesia
488636|NCT00134979|COPD, formoterol,|copd, formoterol,
488637|NCT00134992|Prednisolone acetate|prednisolone acetate
488639|NCT00134992|tolerability|tolerability
488640|NCT00134992|Healthy volunteers|healthy volunteers
488641|NCT00135005|GIST|gist
488642|NCT00135005|AMN107|amn107
488643|NCT00135005|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
488644|NCT00135044|taurine|taurine
488645|NCT00135044|intestinal failure|intestinal failure
488647|NCT00135044|hepatobiliary complications|hepatobiliary complications
488648|NCT00135044|chronic intestinal failure (CIF)|chronic intestinal failure (cif)
488649|NCT00135070|Diabetes Mellitus|diabetes mellitus
488650|NCT00135122|migraine|migraine
488651|NCT00135122|analgesics|analgesics
488652|NCT00135122|tension type headache|tension type headache
488653|NCT00135135|Cancer|cancer
488654|NCT00135135|Childhood Tumor|childhood tumor
488655|NCT00135135|Neoplasms|neoplasms
488656|NCT00137215|burns|burns
488657|NCT00137215|donor site care|donor site care
488658|NCT00137215|Silverlon dressing|silverlon dressing
488659|NCT00137228|Hand Edema|hand edema
488660|NCT00137228|Figure of eight method|figure of eight method
488661|NCT00137228|Measuring edema in burn patients|measuring edema in burn patients
488662|NCT00137241|health literacy|health literacy
488663|NCT00137241|screening|screening
488664|NCT00137241|cancer|cancer
488665|NCT00137241|health disparities|health disparities
488666|NCT00137254|Severe burns|severe burns
488667|NCT00137254|Hyperinsulinemia|hyperinsulinemia
488668|NCT00137254|Insulin|insulin
488054|NCT00134134|efalizumab|efalizumab
488669|NCT00137254|Muscle protein kinetics|muscle protein kinetics
488670|NCT00137254|Immune function|immune function
488671|NCT00137254|Exercise|exercise
488672|NCT00137267|Schizophrenia / disorders w psychotic features|schizophrenia / disorders w psychotic features
488673|NCT00137267|Substance-related disorders|substance-related disorders
488674|NCT00137267|Community Mental Health Services|community mental health services
488675|NCT00137267|Case Management|case management
488676|NCT00137267|Health Education|health education
488677|NCT00137280|Randomized Controlled Trial|randomized controlled trial
488678|NCT00137280|Quality of Health Care|quality of health care
488679|NCT00137280|Health Services Research|health services research
488680|NCT00137280|Guidelines|guidelines
488681|NCT00137280|Medical Informatics Computing|medical informatics computing
488682|NCT00137280|Services, Mental Health|services, mental health
488683|NCT00137280|Medicine, Evidenced-Based|medicine, evidenced-based
488684|NCT00137280|Quality Assurance, Healthcare|quality assurance, healthcare
488685|NCT00137280|Quality Indicators, Health Care|quality indicators, health care
488686|NCT00137280|Veterans|veterans
488687|NCT00137280|Unemployment|unemployment
488688|NCT00137280|Obesity|obesity
488689|NCT00137280|Quality Improvement|quality improvement
488690|NCT00137293|Arrhythmia, syncope, antiarrhythmic|arrhythmia, syncope, antiarrhythmic
488691|NCT00137306|Guideline Adherence|guideline adherence
488692|NCT00137306|Quality Assurance, Health Care|quality assurance, health care
488693|NCT00137319|inspiratory impedance threshold device|inspiratory impedance threshold device
488694|NCT00137319|blood pressure regulation|blood pressure regulation
488695|NCT00137319|head-up tilt test|head-up tilt test
488696|NCT00137319|tilt table testing|tilt table testing
488697|NCT00137319|burn injury|burn injury
488698|NCT00137319|Burns|burns
488699|NCT00137332|Arrhythmia|arrhythmia
488700|NCT00137332|antiarrhythmic|antiarrhythmic
488701|NCT00137332|programmed electrical stimulation|programmed electrical stimulation
488702|NCT00137345|Randomized controlled trial|randomized controlled trial
488703|NCT00137345|Clinical Trial Phase III|clinical trial phase iii
488704|NCT00137345|Drug therapy|drug therapy
488705|NCT00137345|Immunosuppression|immunosuppression
488706|NCT00137345|Treatment outcome|treatment outcome
488707|NCT00137345|Kidney transplantation|kidney transplantation
488708|NCT00137345|Kidney function tests|kidney function tests
488709|NCT00137358|Cervical|cervical
488710|NCT00137358|Uterine|uterine
488711|NCT00137358|Para-aortic|para-aortic
488712|NCT00137358|Nodes|nodes
488713|NCT00137358|IMRT|imrt
488714|NCT00137358|Cancer|cancer
488715|NCT00137371|Postmenopause|postmenopause
488716|NCT00137371|Vaginitis|vaginitis
488717|NCT00137384|Magnetoencephalogram|magnetoencephalogram
488718|NCT00137384|Functional Connectivity|functional connectivity
488719|NCT00137384|Electroencephalogram (EEG)|electroencephalogram (eeg)
488720|NCT00137384|Focal Hand Dystonia|focal hand dystonia
488721|NCT00137384|Spectral Analysis|spectral analysis
488722|NCT00137384|Healthy Volunteer|healthy volunteer
488723|NCT00137384|HV|hv
488724|NCT00137436|First-line treatment of metastatic hormone-refractory prostate cancer SUTENT in combination with docetaxel and prednisone|first-line treatment of metastatic hormone-refractory prostate cancer sutent in combination with docetaxel and prednisone
488725|NCT00137475|IMRT|imrt
488726|NCT00137475|head and neck cancer|head and neck cancer
488727|NCT00137475|parotid sparing|parotid sparing
488728|NCT00137488|non-enhancing lesion|non-enhancing lesion
488729|NCT00137488|low grade glioma|low grade glioma
488730|NCT00137488|high risk group selection|high risk group selection
488731|NCT00137514|malaria|malaria
488732|NCT00137514|Plasmodium falciparum|plasmodium falciparum
488733|NCT00137514|chloroquine|chloroquine
488734|NCT00137514|amodiaquine|amodiaquine
488735|NCT00137514|treatment|treatment
488736|NCT00137514|Guinea-Bissau|guinea-bissau
488737|NCT00137514|children|children
488738|NCT00137527|Cardiac Surgery|cardiac surgery
488739|NCT00137527|Cardiopulmonary Bypass|cardiopulmonary bypass
488740|NCT00137527|Cerebral Oxygenation|cerebral oxygenation
488741|NCT00137527|Neurologic Dysfunction|neurologic dysfunction
488742|NCT00137527|Neurocognitive Dysfunction|neurocognitive dysfunction
488743|NCT00137527|Neurological manifestations|neurological manifestations
488744|NCT00137527|Memory loss|memory loss
488745|NCT00137527|Delirium|delirium
488746|NCT00137527|Coronary Artery Bypass|coronary artery bypass
488747|NCT00137540|First line ablation therapy|first line ablation therapy
488748|NCT00137553|Children|children
488749|NCT00137553|malaria|malaria
488750|NCT00137553|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
488751|NCT00137553|Guinea-Bissau|guinea-bissau
488752|NCT00137553|treatment|treatment
488753|NCT00137566|malaria|malaria
488754|NCT00137566|treatment|treatment
488755|NCT00137566|paracetamol|paracetamol
488756|NCT00137566|chloroquine|chloroquine
488757|NCT00137566|Guinea-Bissau|guinea-bissau
488758|NCT00137566|children|children
488759|NCT00137566|P.falciparum|p.falciparum
488760|NCT00137579|Influenza Vaccines|influenza vaccines
488761|NCT00137579|Acenocoumarol|acenocoumarol
488762|NCT00137579|Drug Administration Routes|drug administration routes
488763|NCT00137579|Anticoagulants|anticoagulants
488764|NCT00137592|screening|screening
488765|NCT00137592|community health education|community health education
488766|NCT00137605|HIV|hiv
488767|NCT00137605|HIV Infections|hiv infections
488768|NCT00137618|Prostatic neoplasm|prostatic neoplasm
488769|NCT00137618|Prostate cancer|prostate cancer
488770|NCT00137618|Informed decision making|informed decision making
488771|NCT00137618|Prostate cancer screening|prostate cancer screening
488772|NCT00137618|Prostate specific antigen|prostate specific antigen
488773|NCT00137631|Adult|adult
488774|NCT00137631|HIV Infections / pc [Prevention & Control]|hiv infections / pc [prevention & control]
488775|NCT00137631|Homosexuality, Male|homosexuality, male
488776|NCT00137631|Humans|humans
488777|NCT00137631|Male|male
488778|NCT00137631|Risk-Taking|risk-taking
488779|NCT00137631|Safe Sex|safe sex
488780|NCT00137631|Sexual Behavior|sexual behavior
488781|NCT00137631|HIV|hiv
488782|NCT00137644|Adolescent|adolescent
488783|NCT00137644|*HIV Infections/ pc [Prevention & Control]|*hiv infections/ pc [prevention & control]
488784|NCT00137644|Male|male
488785|NCT00137644|Humans|humans
488786|NCT00137644|Risk-Taking|risk-taking
488787|NCT00137644|Safe Sex|safe sex
488788|NCT00137644|Sexual Behavior|sexual behavior
488789|NCT00137644|HIV|hiv
488790|NCT00137644|HIV Seronegativity|hiv seronegativity
488791|NCT00137657|HIV|hiv
488792|NCT00137657|malaria|malaria
488793|NCT00137657|E. Coli|e. coli
488794|NCT00137657|S. pneumoniae|s. pneumoniae
488795|NCT00137657|drug resistance|drug resistance
488796|NCT00137657|antifolate|antifolate
488797|NCT00137657|opportunistic infections|opportunistic infections
488798|NCT00137657|Africa|africa
488799|NCT00137657|Kenya|kenya
488800|NCT00137657|East Africa|east africa
488801|NCT00137670|Intervention studies|intervention studies
488802|NCT00137670|HIV|hiv
488803|NCT00137683|screening|screening
488804|NCT00137683|prevention|prevention
488805|NCT00137683|community health education|community health education
488806|NCT00137696|polio|polio
488807|NCT00137696|vaccine|vaccine
488808|NCT00137696|immunogenicity|immunogenicity
488809|NCT00137709|epilepsy|epilepsy
488810|NCT00137709|hormone|hormone
488811|NCT00137722|Asthma|asthma
488812|NCT00137722|Disease Management|disease management
488813|NCT00137722|Outcomes|outcomes
488814|NCT00137722|Utilization|utilization
490141|NCT00136474|Amifostine|amifostine
488815|NCT00137735|carpal tunnel syndrome|carpal tunnel syndrome
488816|NCT00137735|gabapentin|gabapentin
488817|NCT00137748|Lung transplantation|lung transplantation
488818|NCT00137761|Pancreatic Carcinoma|pancreatic carcinoma
488820|NCT00137761|Docetaxel|docetaxel
488821|NCT00137774|Metastatic Neuroendocrine Tumor|metastatic neuroendocrine tumor
488822|NCT00137774|Advanced Neuroendocrine tumor|advanced neuroendocrine tumor
488823|NCT00137774|Bevacizumab|bevacizumab
488824|NCT00137774|Temozolomide|temozolomide
488825|NCT00137787|febrile neutropenia|febrile neutropenia
488826|NCT00137787|hematologic disease|hematologic disease
488827|NCT00137800|Non-Small Cell Lung Cancer|non-small cell lung cancer
488828|NCT00137800|Elderly Cancer Patients|elderly cancer patients
488829|NCT00137800|Tarceva|tarceva
488830|NCT00137800|Erlotinib|erlotinib
488831|NCT00137800|OSI-774|osi-774
488832|NCT00137800|Stage IIIB or IV Non-Small Cell Lung Cancer|stage iiib or iv non-small cell lung cancer
488833|NCT00137813|Bevacizumab|bevacizumab
488834|NCT00137813|Docetaxel|docetaxel
488835|NCT00137813|AvaTax|avatax
488836|NCT00137813|Metastatic Esophagogastric Cancer|metastatic esophagogastric cancer
488837|NCT00137826|Mesothelioma|mesothelioma
488838|NCT00137826|Avastin|avastin
488839|NCT00137826|Bevacizumab|bevacizumab
488840|NCT00137826|Tarceva|tarceva
488841|NCT00137826|OSI-774|osi-774
488842|NCT00137826|Erlotinib|erlotinib
488843|NCT00137839|Tarceva|tarceva
488844|NCT00137839|Erlotinib|erlotinib
488845|NCT00137839|OSI-774|osi-774
488846|NCT00137839|Adenocarcinoma|adenocarcinoma
488847|NCT00137839|Advanced Lung Cancer|advanced lung cancer
488848|NCT00137852|Esophageal Cancer|esophageal cancer
488849|NCT00137852|Resectable Esophageal Cancer|resectable esophageal cancer
488850|NCT00137852|Radiation Therapy|radiation therapy
488851|NCT00137852|Celecoxib|celecoxib
488852|NCT00137852|Irinotecan|irinotecan
488853|NCT00137852|Cisplatin|cisplatin
488854|NCT00137891|Multinodular goiter|multinodular goiter
488855|NCT00137904|multiple sclerosis|multiple sclerosis
488856|NCT00137904|fatigue|fatigue
488857|NCT00137904|sleep disorders|sleep disorders
488858|NCT00137917|Prophylaxis meningococcal serogroup B disease|prophylaxis meningococcal serogroup b disease
488859|NCT00137930|Prophylaxis of rotavirus gastroenteritis|prophylaxis of rotavirus gastroenteritis
488860|NCT00137943|Parent-child communication|parent-child communication
488861|NCT00137943|Primary prevention|primary prevention
488862|NCT00137943|sexual risk prevention|sexual risk prevention
488863|NCT00137943|HIV|hiv
488864|NCT00137956|Endobronchial Valve|endobronchial valve
488865|NCT00137956|Endobronchial Valve ProcedureEBV|endobronchial valve procedureebv
630372|NCT00696306|MRI|mri
488156|NCT00134654|Premarin|premarin
488866|NCT00137956|EBV Procedure|ebv procedure
488867|NCT00137956|Endobronchial Lung Volume Reduction|endobronchial lung volume reduction
488868|NCT00137956|Lung Volume Reduction|lung volume reduction
488869|NCT00137969|Rituxan|rituxan
488870|NCT00137969|SLE|sle
488871|NCT00137969|Lupus|lupus
488872|NCT00137982|Ectopic pregnancy|ectopic pregnancy
488873|NCT00137982|Surgical treatment|surgical treatment
488874|NCT00137982|Medical treatment|medical treatment
488875|NCT00137982|Fertility|fertility
488876|NCT00137995|Lymphoma|lymphoma
488877|NCT00137995|Chemotherapy|chemotherapy
488878|NCT00137995|rituximab|rituximab
488879|NCT00138008|prostate cancer|prostate cancer
488880|NCT00138008|radical prostatectomy|radical prostatectomy
488881|NCT00138008|PSA failure|psa failure
488882|NCT00138008|RCT|rct
488883|NCT00138008|radiation|radiation
488884|NCT00138008|endocrinotherapy|endocrinotherapy
488885|NCT00138021|Serious mental illness|serious mental illness
488886|NCT00138021|Supported Employment|supported employment
488887|NCT00138021|Cognitive remediation|cognitive remediation
488888|NCT00138021|Cognitive impairments|cognitive impairments
488889|NCT00138034|Open infarct-related artery within 72 hours of thrombolysis|open infarct-related artery within 72 hours of thrombolysis
488890|NCT00138047|zinc|zinc
488891|NCT00138047|HIV|hiv
488892|NCT00138047|children|children
488893|NCT00138060|genotypic profile|genotypic profile
488894|NCT00138060|metastatic colorectal cancer|metastatic colorectal cancer
488895|NCT00138073|pulmonary artery catheter|pulmonary artery catheter
488896|NCT00138073|waveform interpretation|waveform interpretation
488897|NCT00138073|computer-based learning|computer-based learning
488898|NCT00138073|medical education|medical education
488899|NCT00138086|lymphoma|lymphoma
488900|NCT00138086|chemotherapy|chemotherapy
488901|NCT00138086|Zevalin ( Yttrium-90 Ibritumomab Tiuxetan)|zevalin ( yttrium-90 ibritumomab tiuxetan)
488902|NCT00138099|Critically ill patients (ICU)|critically ill patients (icu)
488903|NCT00138099|Deep Venous Thromboembolism prevention|deep venous thromboembolism prevention
488904|NCT00138099|Renal Failure|renal failure
488905|NCT00138099|Critically ill|critically ill
488906|NCT00138112|Streptococcal Sepsis|streptococcal sepsis
488907|NCT00138112|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
488908|NCT00138112|Hematologic Malignancies|hematologic malignancies
488909|NCT00138112|Streptococci|streptococci
488910|NCT00138112|Transplant|transplant
488911|NCT00138125|stage IV breast cancer|stage iv breast cancer
488912|NCT00138125|recurrent breast cancer|recurrent breast cancer
488913|NCT00138151|recurrent cervical cancer|recurrent cervical cancer
488914|NCT00138151|stage IVB cervical cancer|stage ivb cervical cancer
488915|NCT00138164|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
488916|NCT00138164|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
488917|NCT00138164|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
488918|NCT00138164|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
488919|NCT00138164|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
488920|NCT00138216|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
488921|NCT00138216|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
488922|NCT00138216|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
488923|NCT00138216|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
488924|NCT00138216|recurrent childhood brain tumor|recurrent childhood brain tumor
488925|NCT00138216|recurrent childhood ependymoma|recurrent childhood ependymoma
488926|NCT00138216|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
488927|NCT00138216|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
488928|NCT00138216|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
488929|NCT00138216|childhood oligodendroglioma|childhood oligodendroglioma
488930|NCT00138216|childhood craniopharyngioma|childhood craniopharyngioma
488931|NCT00138216|childhood choroid plexus tumor|childhood choroid plexus tumor
488932|NCT00138216|childhood infratentorial ependymoma|childhood infratentorial ependymoma
488933|NCT00138216|childhood supratentorial ependymoma|childhood supratentorial ependymoma
488934|NCT00138216|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
488935|NCT00138216|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
488936|NCT00138216|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
488937|NCT00138216|childhood grade I meningioma|childhood grade i meningioma
488938|NCT00138216|childhood grade II meningioma|childhood grade ii meningioma
488939|NCT00138216|childhood grade III meningioma|childhood grade iii meningioma
488940|NCT00138216|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
488941|NCT00138216|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
488942|NCT00138229|recurrent melanoma|recurrent melanoma
630483|NCT00702325|Asthma|asthma
488247|NCT00127725|tibia|tibia
488943|NCT00138229|stage IV melanoma|stage iv melanoma
489059|NCT00138957|Quality of life|quality of life
488944|NCT00138242|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
488945|NCT00138242|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
488946|NCT00138242|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
488947|NCT00138242|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
488948|NCT00138242|fallopian tube cancer|fallopian tube cancer
488949|NCT00138242|primary peritoneal cavity cancer|primary peritoneal cavity cancer
488950|NCT00138268|umbilical cord blood, vaccine, pregnant women|umbilical cord blood, vaccine, pregnant women
488951|NCT00138281|influenza, vaccine, respiratory virus, Fluzone, FluMist|influenza, vaccine, respiratory virus, fluzone, flumist
488952|NCT00138294|influenza vaccine|influenza vaccine
488953|NCT00138294|live attenuated influenza vaccine (LAIV or FluMist)|live attenuated influenza vaccine (laiv or flumist)
488954|NCT00138294|inactivated influenza vaccine (IIV)|inactivated influenza vaccine (iiv)
488955|NCT00138294|School-based influenza vaccination program|school-based influenza vaccination program
488956|NCT00138294|children|children
488957|NCT00138294|herd protection|herd protection
488958|NCT00138307|malaria, children, naturally acquired immunity, Ghana|malaria, children, naturally acquired immunity, ghana
488959|NCT00138320|Herpes Simplex, vaccine, antibodies, mother|herpes simplex, vaccine, antibodies, mother
488960|NCT00138333|Thimerosal, mercury levels, low birth weight, Argentina|thimerosal, mercury levels, low birth weight, argentina
488961|NCT00138346|hydatid disease, Echinococcus granulosus, tapeworm|hydatid disease, echinococcus granulosus, tapeworm
488962|NCT00138359|T solium, cysticercus, pig triquina, solitaria, intestinal parasites, Niclosamide, tapeworms, Taeniasis|t solium, cysticercus, pig triquina, solitaria, intestinal parasites, niclosamide, tapeworms, taeniasis
488963|NCT00138372|malaria|malaria
488964|NCT00138372|immunity|immunity
488965|NCT00138372|MSP-1|msp-1
488966|NCT00138372|Kenya|kenya
488967|NCT00138372|infants|infants
488968|NCT00138385|inactivated, attenuated, influenza vaccine, FluMist, Fluzone|inactivated, attenuated, influenza vaccine, flumist, fluzone
488969|NCT00138398|Influenza, T cell, vaccine, Congestive heart failure|influenza, t cell, vaccine, congestive heart failure
488970|NCT00138411|anthrax, Bacillus anthracis, monoclonal antibody, ETI-204|anthrax, bacillus anthracis, monoclonal antibody, eti-204
488971|NCT00138424|Vistide®, Cidofovir, renal transplant, BK Virus Nephropathy|vistide®, cidofovir, renal transplant, bk virus nephropathy
488972|NCT00138437|leprosy|leprosy
488973|NCT00138437|Colombia|colombia
488974|NCT00138450|Schistosomiasis, S. haematobium, morbidity, Kenya|schistosomiasis, s. haematobium, morbidity, kenya
488975|NCT00138463|West Nile Virus, Neuroinvasive Disease|west nile virus, neuroinvasive disease
488976|NCT00138476|Norovirus, calicivirus, gastroenteritis, Norwalk virus, challenge|norovirus, calicivirus, gastroenteritis, norwalk virus, challenge
489074|NCT00139009|intracellular concentration|intracellular concentration
488977|NCT00138489|Malaria, Papua New Guinea, infants, children|malaria, papua new guinea, infants, children
488978|NCT00138502|Candidiasis, Funguria|candidiasis, funguria
488979|NCT00138515|Type 2 diabetes|type 2 diabetes
488980|NCT00138515|vildagliptin|vildagliptin
488981|NCT00138528|Metabolic Syndrome, fluvastatin|metabolic syndrome, fluvastatin
488982|NCT00138541|type 2 diabetes|type 2 diabetes
488983|NCT00138541|vildagliptin|vildagliptin
488984|NCT00138554|Type 2 diabetes|type 2 diabetes
488985|NCT00138554|vildagliptin|vildagliptin
488986|NCT00138567|Type 2 diabetes|type 2 diabetes
488987|NCT00138567|vildagliptin|vildagliptin
488988|NCT00138580|Type 2 diabetes|type 2 diabetes
488989|NCT00138580|vildagliptin|vildagliptin
488990|NCT00138593|Type 2 diabetes|type 2 diabetes
488991|NCT00138593|vildagliptin|vildagliptin
488992|NCT00138606|Type 2 diabetes|type 2 diabetes
488993|NCT00138606|vildagliptin|vildagliptin
488994|NCT00138619|Type 2 diabetes|type 2 diabetes
488995|NCT00138619|vildagliptin|vildagliptin
488996|NCT00138632|Wet Age-related macular degeneration|wet age-related macular degeneration
488997|NCT00138632|PTK787|ptk787
488998|NCT00138658|NSCLC|nsclc
488999|NCT00138658|custirsen sodium|custirsen sodium
489000|NCT00138658|OGX-011|ogx-011
489001|NCT00138658|Stage IIIB or IV advanced non-small cell lung cancer|stage iiib or iv advanced non-small cell lung cancer
489002|NCT00138684|insulin resistance|insulin resistance
489003|NCT00138684|iron overload|iron overload
489004|NCT00138684|phlebotomy|phlebotomy
489005|NCT00138684|hepatic iron overload|hepatic iron overload
489006|NCT00138697|Agammaglobulinemia|agammaglobulinemia
489007|NCT00138697|Hypogammaglobulinemia|hypogammaglobulinemia
489008|NCT00138697|Immunoglobulins, Intravenous|immunoglobulins, intravenous
489009|NCT00138710|obesity|obesity
489010|NCT00138710|Hypogonadotrophic hypogonadism|hypogonadotrophic hypogonadism
489011|NCT00138710|aromatase inhibition|aromatase inhibition
489012|NCT00138736|MBL-deficient|mbl-deficient
489013|NCT00138736|chemotherapy|chemotherapy
489014|NCT00138736|neutropenia|neutropenia
489015|NCT00138736|chemotherapy-induced neutropenia|chemotherapy-induced neutropenia
489016|NCT00138775|D-serine|d-serine
489017|NCT00138775|Negative symptoms|negative symptoms
489018|NCT00138775|Cognition|cognition
489019|NCT00138775|Schizophrenia|schizophrenia
488340|NCT00128037|vindesine|vindesine
489020|NCT00138775|Amino acid|amino acid
489021|NCT00138788|Radiotherapy|radiotherapy
489022|NCT00138788|Qualify of life|qualify of life
489023|NCT00138788|Neoplasm metastasis of the brain|neoplasm metastasis of the brain
489024|NCT00138801|Neuroborreliosis|neuroborreliosis
489025|NCT00138814|Neoplasm recurrence, local|neoplasm recurrence, local
489026|NCT00138814|Radiotherapy dosage|radiotherapy dosage
489027|NCT00138814|Cosmesis|cosmesis
489028|NCT00138814|Mastectomy, segmental|mastectomy, segmental
489029|NCT00138827|Radiotherapy|radiotherapy
489030|NCT00138827|Mucositis|mucositis
489031|NCT00138827|Xerostomia|xerostomia
489032|NCT00138840|Crohn's disease|crohn's disease
489033|NCT00138840|Gastroenterology|gastroenterology
489035|NCT00138853|Genoarthrosis|genoarthrosis
489036|NCT00138853|Knee arthroplasty|knee arthroplasty
489037|NCT00138853|Micromotion of polyethylene liner|micromotion of polyethylene liner
489038|NCT00138866|Spinal cord injury|spinal cord injury
489039|NCT00138879|Citrulline|citrulline
489040|NCT00138879|Parenteral Nutrition|parenteral nutrition
489041|NCT00138879|functioning intestinal mass|functioning intestinal mass
489042|NCT00138879|small bowel permeability and absorption|small bowel permeability and absorption
489043|NCT00138879|Granulomatous Enteritis|granulomatous enteritis
489044|NCT00138892|Quality of life|quality of life
489045|NCT00138892|waiting time|waiting time
489046|NCT00138892|total joint replacement|total joint replacement
489047|NCT00138905|Base station, EMF, human exposure study,Well-being,cognitive|base station, emf, human exposure study,well-being,cognitive
489048|NCT00138918|Prostate Cancer|prostate cancer
489049|NCT00138918|Clusterin|clusterin
489050|NCT00138918|Neoadjuvant|neoadjuvant
489051|NCT00138918|Phase II|phase ii
489052|NCT00138931|Cardiomyopathy|cardiomyopathy
489053|NCT00138931|Arrhythmia|arrhythmia
489054|NCT00138931|Muscular Dystrophy|muscular dystrophy
489055|NCT00138944|Essential hypertension|essential hypertension
489056|NCT00138957|Laparoscopic parastomal hernia repair|laparoscopic parastomal hernia repair
489057|NCT00138957|Intraperitoneally|intraperitoneally
489058|NCT00138957|Mesh|mesh
489060|NCT00138957|Postoperative pain|postoperative pain
489061|NCT00138957|Recurrence|recurrence
489062|NCT00138970|Cadaveric donor|cadaveric donor
489063|NCT00138970|Calcineurine free|calcineurine free
489064|NCT00138983|glucocorticoid-induced osteoporosis|glucocorticoid-induced osteoporosis
489065|NCT00138983|rheumatic diseases|rheumatic diseases
489066|NCT00138983|prevention|prevention
489067|NCT00138983|randomized double-blind, double placebo controlled trial|randomized double-blind, double placebo controlled trial
489068|NCT00138983|alendronate versus alfacalcidol|alendronate versus alfacalcidol
489069|NCT00138996|cardiac arrest|cardiac arrest
489070|NCT00138996|resuscitation|resuscitation
489071|NCT00138996|quality|quality
489072|NCT00138996|feedback|feedback
489073|NCT00138996|training|training
489075|NCT00139009|cyclosporine A|cyclosporine a
489076|NCT00139009|renal biopsies|renal biopsies
489077|NCT00139009|heart biopsies|heart biopsies
489078|NCT00139009|Renal transplant recipients|renal transplant recipients
489079|NCT00139022|sleep apnea, home monitoring, CPAP|sleep apnea, home monitoring, cpap
489080|NCT00139035|glucose intolerance|glucose intolerance
489081|NCT00139035|insulin|insulin
489082|NCT00139035|microvascular function|microvascular function
489083|NCT00139035|genotyping|genotyping
489084|NCT00139035|CYP3A5|cyp3a5
489085|NCT00139035|pharmacokinetics|pharmacokinetics
489086|NCT00139035|renal transplantation|renal transplantation
489087|NCT00139048|informed choice|informed choice
489088|NCT00139048|shared decision making|shared decision making
489089|NCT00139048|decision aid|decision aid
489090|NCT00139048|mammography screening|mammography screening
489091|NCT00139048|decision support|decision support
489092|NCT00139074|Bipolar I Disorder (DSM-IV 296.01, DSM-IV 296.4, DSM-IV 296.61)|bipolar i disorder (dsm-iv 296.01, dsm-iv 296.4, dsm-iv 296.61)
489093|NCT00139113|hepatitis A|hepatitis a
489094|NCT00139113|hepatitis A vaccine|hepatitis a vaccine
489095|NCT00139139|hepatitis A|hepatitis a
489096|NCT00139139|hepatitis A vaccine|hepatitis a vaccine
489097|NCT00139139|immune globulin|immune globulin
489098|NCT00139152|moderate to severe allergic asthma|moderate to severe allergic asthma
489099|NCT00139165|Collagenous colitis|collagenous colitis
489100|NCT00139165|Budesonide treatment|budesonide treatment
489101|NCT00139165|Diarrhea|diarrhea
489102|NCT00139191|Prostate Cancer|prostate cancer
489103|NCT00139191|positron emission tomography|positron emission tomography
489104|NCT00139191|carbon 11 acetate|carbon 11 acetate
489105|NCT00139191|PET|pet
489106|NCT00139191|fatty acid synthase|fatty acid synthase
489107|NCT00139191|FAS|fas
489108|NCT00139204|Prostate cancer|prostate cancer
489109|NCT00139204|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
489110|NCT00139204|PET scan|pet scan
489111|NCT00139204|C11-methionine|c11-methionine
489112|NCT00139204|positron emission tomography|positron emission tomography
489113|NCT00139217|Persistent pulmonary hypertension|persistent pulmonary hypertension
489114|NCT00139217|Non-invasive inhaled nitric oxide|non-invasive inhaled nitric oxide
489115|NCT00139217|iNO|ino
489116|NCT00139230|Squamous Cell Carcinoma of Head and Neck|squamous cell carcinoma of head and neck
489117|NCT00139230|Compressed TPFL|compressed tpfl
489118|NCT00139230|Taxotere|taxotere
489119|NCT00139230|Growth Factor Support|growth factor support
489120|NCT00139243|squamous cell carcinoma|squamous cell carcinoma
489121|NCT00139243|Taxotere|taxotere
489122|NCT00139243|carcinoma of head/neck|carcinoma of head/neck
489123|NCT00139243|Cisplatin|cisplatin
489124|NCT00139243|5-Fluorouracil|5-fluorouracil
489125|NCT00139243|Leucovorin|leucovorin
489126|NCT00139256|Glucocorticoid|glucocorticoid
489127|NCT00139256|Antepartum Betamethasone Treatment|antepartum betamethasone treatment
489128|NCT00139256|Elective Cesarean Section|elective cesarean section
489129|NCT00139256|Respiratory Distress in Infants|respiratory distress in infants
489130|NCT00139269|Advanced Squamous Cell Carcinoma|advanced squamous cell carcinoma
489131|NCT00139269|Squamous cell Carcinoma of Head and Neck|squamous cell carcinoma of head and neck
489132|NCT00139269|SSCHN|sschn
489133|NCT00139269|Docetaxel|docetaxel
489134|NCT00139282|wet AMD|wet amd
489135|NCT00139282|macular degeneration|macular degeneration
489136|NCT00139295|musculoskeletal|musculoskeletal
489137|NCT00139295|osteoarthritis of the knee|osteoarthritis of the knee
489138|NCT00139308|Tourette's syndrome|tourette's syndrome
489139|NCT00139308|High frequency stimulation|high frequency stimulation
489140|NCT00139308|Globus pallidus|globus pallidus
489141|NCT00139308|Thalamus|thalamus
489142|NCT00139321|Gait disorders|gait disorders
489143|NCT00139321|Postural instability|postural instability
489144|NCT00139321|parkinsonian syndrome|parkinsonian syndrome
489145|NCT00139321|Gait initiation|gait initiation
489146|NCT00139321|Parkinson's disease|parkinson's disease
489147|NCT00139321|Adults|adults
489148|NCT00139373|Progressive supranuclear palsy|progressive supranuclear palsy
489149|NCT00139373|Frontal lobe|frontal lobe
489150|NCT00139373|Oculomotor testing|oculomotor testing
489151|NCT00139373|Neuropsychological scores|neuropsychological scores
489152|NCT00139373|Motor disability (UPDRS)|motor disability (updrs)
489153|NCT00139373|Distractibility|distractibility
489154|NCT00139386|Drug-eluting stent|drug-eluting stent
489155|NCT00139386|Candesartan|candesartan
489156|NCT00139386|Randomized control study|randomized control study
489157|NCT00139386|Coronary Angioplasty|coronary angioplasty
489158|NCT00139399|Coronary artery bypass|coronary artery bypass
489159|NCT00139399|Coronary arteries|coronary arteries
489160|NCT00139399|Atherosclerosis|atherosclerosis
489161|NCT00139399|Angiography|angiography
489162|NCT00139399|Blood flow|blood flow
489163|NCT00139451|GH|gh
489164|NCT00139451|Delayed Growth|delayed growth
489165|NCT00139451|Energy Expenditure|energy expenditure
489166|NCT00139451|Puberty|puberty
489167|NCT00139451|Nutrition|nutrition
489168|NCT00139451|Short Stature|short stature
489169|NCT00139490|Blood Pressure, High|blood pressure, high
489170|NCT00139542|human|human
489740|NCT00142571|Gemcitabine|gemcitabine
489171|NCT00139542|ventricular fibrillation|ventricular fibrillation
489172|NCT00139542|out-of-hospital|out-of-hospital
489173|NCT00139542|cardiac arrest|cardiac arrest
489174|NCT00139542|automated external defibrillators (AED)|automated external defibrillators (aed)
489175|NCT00139542|defibrillators|defibrillators
489176|NCT00139542|electrick countershock|electrick countershock
489177|NCT00139542|cardiopulmonary resuscitation|cardiopulmonary resuscitation
489178|NCT00139555|Hypertension|hypertension
489179|NCT00139555|Left ventricular hypertrophy|left ventricular hypertrophy
489180|NCT00139568|Chronic constipation|chronic constipation
489181|NCT00139568|5-HT,5-HT4,|5-ht,5-ht4,
489182|NCT00139568|functional GI|functional gi
489183|NCT00139568|China|china
489184|NCT00139568|tegaserod|tegaserod
489185|NCT00139581|Atopic dermatitis, children, infants, pimecrolimus, bid, od|atopic dermatitis, children, infants, pimecrolimus, bid, od
489186|NCT00139594|Bipolar disorder, manic episode/treatment/licarbazepine|bipolar disorder, manic episode/treatment/licarbazepine
489187|NCT00139620|advanced cancer, solid tumor|advanced cancer, solid tumor
489188|NCT00139633|esophageal cancer, chemotherapy, radiation|esophageal cancer, chemotherapy, radiation
489189|NCT00131963|stage One A (IA) breast cancer|stage one a (ia) breast cancer
489190|NCT00131963|stage Two (II) breast cancer|stage two (ii) breast cancer
489191|NCT00131963|stage Three A (IIIA) breast cancer|stage three a (iiia) breast cancer
489192|NCT00131963|stage Three B(IIIB) breast cancer|stage three b(iiib) breast cancer
489193|NCT00131963|stage Three C(IIIC) breast cancer|stage three c(iiic) breast cancer
489194|NCT00131963|stage One B (IB) breast cancer|stage one b (ib) breast cancer
489195|NCT00132015|Waldenström macroglobulinemia|waldenström macroglobulinemia
489196|NCT00132015|multicentric Castleman disease|multicentric castleman disease
489197|NCT00132015|unicentric Castleman disease|unicentric castleman disease
489198|NCT00132015|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
489199|NCT00132015|polycythemia vera|polycythemia vera
489200|NCT00132015|essential thrombocythemia|essential thrombocythemia
489201|NCT00132015|hairy cell leukemia|hairy cell leukemia
97004|NCT02682914|Stroke etiology|stroke etiology
489202|NCT00132015|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
489203|NCT00132015|adult Burkitt lymphoma|adult burkitt lymphoma
489204|NCT00132015|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
489205|NCT00132015|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
489206|NCT00132015|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
489207|NCT00132015|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
489208|NCT00132015|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
489209|NCT00132015|grade 1 follicular lymphoma|grade 1 follicular lymphoma
489210|NCT00132015|grade 2 follicular lymphoma|grade 2 follicular lymphoma
489211|NCT00132015|grade 3 follicular lymphoma|grade 3 follicular lymphoma
489212|NCT00132015|mantle cell lymphoma|mantle cell lymphoma
489213|NCT00132015|marginal zone lymphoma|marginal zone lymphoma
489214|NCT00132015|small lymphocytic lymphoma|small lymphocytic lymphoma
489215|NCT00132015|precancerous condition|precancerous condition
489216|NCT00132041|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
489217|NCT00132041|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
489218|NCT00132054|extensive stage small cell lung cancer|extensive stage small cell lung cancer
489219|NCT00132054|recurrent small cell lung cancer|recurrent small cell lung cancer
489220|NCT00132093|Left ventricular remodelling|left ventricular remodelling
489221|NCT00132093|Acute myocardial infarction|acute myocardial infarction
489222|NCT00132093|Left ventricular dysfunction|left ventricular dysfunction
489224|NCT00132093|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
489225|NCT00132132|BMI|bmi
489226|NCT00132132|obesity|obesity
489227|NCT00132132|behavioral intervention|behavioral intervention
489228|NCT00132132|longterm randomized controlled trial|longterm randomized controlled trial
489229|NCT00132132|exercise|exercise
489230|NCT00132132|empowerment|empowerment
489231|NCT00132132|nutrition|nutrition
489232|NCT00132145|Vascular diseases|vascular diseases
489233|NCT00132145|Computerized decision support systems|computerized decision support systems
489234|NCT00132145|Shared care|shared care
489235|NCT00132145|Patient motivation|patient motivation
489236|NCT00132145|Quality of care|quality of care
489237|NCT00132171|Helicobacter pylori|helicobacter pylori
489238|NCT00132171|Eradication|eradication
489239|NCT00132171|Sequential therapy|sequential therapy
489240|NCT00132171|Standard therapy|standard therapy
489241|NCT00132184|Vitamin D|vitamin d
489242|NCT00132184|Crohns Disease|crohns disease
489243|NCT00132197|Functional somatic symptoms|functional somatic symptoms
489244|NCT00132197|Cognitive behavioral therapy|cognitive behavioral therapy
489245|NCT00132197|somatization disorder|somatization disorder
489246|NCT00132197|SF-36|sf-36
489247|NCT00132197|cost-effectiveness|cost-effectiveness
489248|NCT00132197|Medically unexplained symptoms|medically unexplained symptoms
489249|NCT00132210|acute hepatitis C|acute hepatitis c
489250|NCT00132210|HIV|hiv
489251|NCT00132210|pegylated interferon|pegylated interferon
489252|NCT00132223|magnetic imaging|magnetic imaging
489253|NCT00132223|angiography|angiography
489254|NCT00132223|contrast agent|contrast agent
489255|NCT00132223|signal/noise ratio|signal/noise ratio
489256|NCT00132223|contrast/noise ratio|contrast/noise ratio
489257|NCT00132223|vessel|vessel
489258|NCT00132236|smoking cessation|smoking cessation
489259|NCT00132236|nicotine sublingual tablets|nicotine sublingual tablets
489260|NCT00132236|behaviour support|behaviour support
489261|NCT00132236|smoking reduction|smoking reduction
489262|NCT00132236|quality of life|quality of life
489263|NCT00132236|COPD|copd
489264|NCT00132236|weight|weight
489265|NCT00132249|Traumatic Brain Injury|traumatic brain injury
489266|NCT00132249|Penetrating head wound|penetrating head wound
489267|NCT00132249|Closed head trauma|closed head trauma
489268|NCT00132249|Vietnam Veteran|vietnam veteran
489269|NCT00132262|Screening and Brief Intervention|screening and brief intervention
489270|NCT00132262|Ethnic Differences|ethnic differences
489271|NCT00132262|Trauma Center|trauma center
489272|NCT00132275|bacterial|bacterial
489273|NCT00132275|sinusitis|sinusitis
489274|NCT00132275|treatment|treatment
489275|NCT00132275|diagnosis|diagnosis
489276|NCT00132275|guideline|guideline
489277|NCT00132275|acute bacterial sinusitis|acute bacterial sinusitis
489278|NCT00132288|Aging|aging
489279|NCT00132288|Frailty|frailty
489280|NCT00132288|Sedentary|sedentary
489281|NCT00132288|Falls|falls
489282|NCT00132288|Physical Activity|physical activity
489283|NCT00132301|multi-site clinical trial|multi-site clinical trial
489284|NCT00132301|prostate|prostate
489285|NCT00132301|radical prostatectomy|radical prostatectomy
489286|NCT00132301|randomized|randomized
489287|NCT00139737|Open-label extension Ziprasidone study in Schizophrenia|open-label extension ziprasidone study in schizophrenia
489288|NCT00139776|Chronic treatment osteoarthritis, Celecoxib, Continuous Use, Intermittent Use|chronic treatment osteoarthritis, celecoxib, continuous use, intermittent use
489289|NCT00139815|unstable angina|unstable angina
489290|NCT00139815|acute coronary syndrome|acute coronary syndrome
489291|NCT00139815|fondaparinux sodium|fondaparinux sodium
630969|NCT00704925|3,4 DAP|3,4 dap
488646|NCT00135044|HPN|hpn
489292|NCT00139815|non ST segment elevation myocardial infarction|non st segment elevation myocardial infarction
489293|NCT00139815|myocardial infarction|myocardial infarction
489294|NCT00139828|haemophilia B|haemophilia b
489295|NCT00139828|factor IX|factor ix
489296|NCT00139828|Product Surveillance, Postmarketing|product surveillance, postmarketing
489297|NCT00139828|plasma products|plasma products
489298|NCT00139841|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
489299|NCT00139841|Rituximab Refractory|rituximab refractory
489300|NCT00139841|Rituximab Failure|rituximab failure
489301|NCT00139841|Indolent Non-Hodgkins Lymphoma|indolent non-hodgkins lymphoma
489302|NCT00139906|Titration Study|titration study
489303|NCT00139906|Schizophrenia|schizophrenia
489304|NCT00139906|BID dosing|bid dosing
489305|NCT00139906|Pharmacokinetic|pharmacokinetic
489306|NCT00139919|Decreasing Titration Study|decreasing titration study
489307|NCT00139919|Schizophrenia|schizophrenia
489308|NCT00139919|Bipolar|bipolar
489309|NCT00139919|Pharmacokinetic|pharmacokinetic
489310|NCT00139958|Acute coronary syndrome|acute coronary syndrome
489311|NCT00139958|HIV infection|hiv infection
489312|NCT00139958|Prognosis|prognosis
489313|NCT00139958|Coronary heart disease|coronary heart disease
489314|NCT00139958|Revascularization|revascularization
489315|NCT00139984|Hypertension|hypertension
489316|NCT00139984|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
489317|NCT00139984|Blood pressure|blood pressure
489318|NCT00139984|Risk assessment|risk assessment
489319|NCT00139997|Major Depression|major depression
489320|NCT00139997|Seasonal Affective Disorder (SAD)|seasonal affective disorder (sad)
489321|NCT00140010|aneurysm|aneurysm
489322|NCT00140010|autoregulation|autoregulation
489323|NCT00140010|erythropoietion|erythropoietion
489324|NCT00140010|stroke|stroke
489325|NCT00140010|subarachnoid hemorrhage|subarachnoid hemorrhage
489326|NCT00140010|vasospasm|vasospasm
489327|NCT00140543|simultaneous pancreas/kidney transplantation|simultaneous pancreas/kidney transplantation
489328|NCT00140543|Immunosuppression|immunosuppression
489329|NCT00140556|head and neck cancer|head and neck cancer
489330|NCT00140556|targeted therapy|targeted therapy
489331|NCT00140556|bevacizumab|bevacizumab
489332|NCT00140556|erlotinib|erlotinib
489333|NCT00140556|Tarceva|tarceva
489334|NCT00140556|radiotherapy|radiotherapy
489335|NCT00140556|concurrent chemotherapy|concurrent chemotherapy
489336|NCT00140556|pharynx cancer|pharynx cancer
489337|NCT00140556|tonsil cancer|tonsil cancer
489338|NCT00140556|hyperfractionation|hyperfractionation
489339|NCT00140556|angiogenesis|angiogenesis
489340|NCT00140556|epidermal growth factor|epidermal growth factor
489341|NCT00140556|vascular endothelial growth factor|vascular endothelial growth factor
489342|NCT00140556|magnetic resonance spectroscopy|magnetic resonance spectroscopy
489343|NCT00140556|cancer of the head and neck|cancer of the head and neck
489344|NCT00140556|upper aerodigestive tract neoplasms|upper aerodigestive tract neoplasms
489345|NCT00140556|pharynx neoplasms|pharynx neoplasms
489346|NCT00140569|follicular lymphoma|follicular lymphoma
489347|NCT00140569|CHVP + interferon|chvp + interferon
489348|NCT00140569|fludarabine|fludarabine
489349|NCT00140569|autotransplant|autotransplant
489350|NCT00140582|lymphoma|lymphoma
489351|NCT00140582|follicular|follicular
489352|NCT00140582|maintenance|maintenance
489353|NCT00140595|Lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
489354|NCT00140595|rituximab|rituximab
489355|NCT00140595|chemotherapy|chemotherapy
489357|NCT00140621|cardiac fabry disease|cardiac fabry disease
489358|NCT00140647|atherosclerosis|atherosclerosis
489359|NCT00140647|carotid artery|carotid artery
489360|NCT00140647|ramipril|ramipril
489361|NCT00140647|rosiglitazone|rosiglitazone
489362|NCT00140647|impaired glucose tolerance|impaired glucose tolerance
489363|NCT00140647|impaired fasting glucose|impaired fasting glucose
489364|NCT00140647|diabetes prevention|diabetes prevention
489365|NCT00140660|lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
489366|NCT00140660|rituximab|rituximab
489367|NCT00140660|chemotherapy|chemotherapy
489368|NCT00140699|Children, Hearing loss, Balance control, Sensory inputs|children, hearing loss, balance control, sensory inputs
489369|NCT00140712|Adolescent|adolescent
489370|NCT00140712|RLS|rls
489371|NCT00140712|Periodic Limb Movements of Sleep|periodic limb movements of sleep
489372|NCT00140712|PLMS|plms
489373|NCT00140712|Ropinirole|ropinirole
489374|NCT00140725|HBeAg-positive|hbeag-positive
489375|NCT00140725|chronic|chronic
489376|NCT00140725|Hepatitis B|hepatitis b
489377|NCT00140725|lamivudine|lamivudine
489378|NCT00140725|seroconversion|seroconversion
489379|NCT00140725|Chronic Hepatitis B|chronic hepatitis b
489380|NCT00140751|HIV-1|hiv-1
489381|NCT00140751|Treatment simplification|treatment simplification
489382|NCT00140751|Lopinavir/ritonavir|lopinavir/ritonavir
489383|NCT00140751|Treatment Experienced|treatment experienced
489384|NCT00140751|HIV Seropositivity|hiv seropositivity
489385|NCT00140764|Genitourinary symptoms|genitourinary symptoms
631115|NCT00692770|HCC|hcc
489386|NCT00140790|Cardiorenal syndrome|cardiorenal syndrome
489387|NCT00140790|Renal dysfunction|renal dysfunction
489388|NCT00140790|Cardiovascular events|cardiovascular events
489389|NCT00140790|Valsartan|valsartan
489390|NCT00140829|Cerebellar ataxias|cerebellar ataxias
489391|NCT00140829|Spastic paraplegias|spastic paraplegias
489392|NCT00140829|Mutations spectrum|mutations spectrum
489393|NCT00140829|Linkage studies|linkage studies
489394|NCT00140829|Genetic counselling|genetic counselling
489395|NCT00140842|Obesity, adolescent, ghrelin, growth hormone, cortisol|obesity, adolescent, ghrelin, growth hormone, cortisol
489396|NCT00140855|synovial sarcoma|synovial sarcoma
489397|NCT00140855|immunotherapy|immunotherapy
489398|NCT00140855|cancer-testis antigen|cancer-testis antigen
489399|NCT00140855|cancer-germ cell antigen|cancer-germ cell antigen
489400|NCT00140855|soft tissue sarcoma|soft tissue sarcoma
489401|NCT00140855|SYT-SSX chromosomal translocation|syt-ssx chromosomal translocation
489402|NCT00140868|Colonic Pseudo-Obstruction|colonic pseudo-obstruction
489403|NCT00140868|Large bowel obstruction|large bowel obstruction
489404|NCT00140868|Stents|stents
489405|NCT00140868|Laparotomy|laparotomy
489406|NCT00140868|Palliative Surgery|palliative surgery
489407|NCT00140868|Surgery, Palliative|surgery, palliative
489408|NCT00140868|Palliative Therapy|palliative therapy
489409|NCT00140894|Osteoarthritis|osteoarthritis
489410|NCT00140894|Cancer Pain|cancer pain
489411|NCT00140972|Arcoxia|arcoxia
489412|NCT00140998|Turner syndrome|turner syndrome
489413|NCT00140998|Hypogonadism|hypogonadism
489414|NCT00140998|GH|gh
489415|NCT00140998|Estrogen|estrogen
489416|NCT00140998|Estrogen Patches|estrogen patches
489417|NCT00140998|IGF-I|igf-i
489418|NCT00140998|Body Composition|body composition
489419|NCT00140998|Protein Metabolism|protein metabolism
489420|NCT00140998|Lipolysis|lipolysis
489421|NCT00141011|Stroke|stroke
489422|NCT00141011|Fibrinogen|fibrinogen
489423|NCT00141011|Reperfusion|reperfusion
489424|NCT00141011|Thrombolysis|thrombolysis
489425|NCT00141024|HIV Seronegativity|hiv seronegativity
489426|NCT00141024|HIV Preventive Vaccine|hiv preventive vaccine
489427|NCT00141037|Organ Rejection|organ rejection
489428|NCT00141037|Corticosteroids|corticosteroids
489429|NCT00141037|Child|child
489430|NCT00141037|Adolescent|adolescent
489431|NCT00141037|Immunosuppression|immunosuppression
489432|NCT00141037|Steroids|steroids
489433|NCT00141050|ADHD, children|adhd, children
489434|NCT00141063|ADHD, children|adhd, children
489435|NCT00141076|obesity|obesity
489436|NCT00141076|glycemic index|glycemic index
489437|NCT00141076|insulin resistance|insulin resistance
489438|NCT00141076|cardiovascular disease|cardiovascular disease
489439|NCT00141076|diabetes|diabetes
489440|NCT00141089|Male patients, chronic constipation, tegaserod|male patients, chronic constipation, tegaserod
489441|NCT00141102|GI events in high risk GI arthritis patients|gi events in high risk gi arthritis patients
489442|NCT00141115|Substance-induced anxiety disorder|substance-induced anxiety disorder
489443|NCT00141271|Bipolar I Disorder|bipolar i disorder
489444|NCT00141297|Advanced cancer|advanced cancer
489445|NCT00141440|gas exchange|gas exchange
489446|NCT00141440|pressure support ventilation|pressure support ventilation
489447|NCT00141440|respiratory mechanics|respiratory mechanics
489741|NCT00142571|Docetaxel|docetaxel
489448|NCT00141440|COPD patients|copd patients
489449|NCT00141453|angiotensin II type I receptor blockers|angiotensin ii type i receptor blockers
489450|NCT00141453|diabetic nephropathy|diabetic nephropathy
489451|NCT00141453|end-stage renal disease|end-stage renal disease
489452|NCT00141453|renal failure|renal failure
489453|NCT00141453|type 2 diabetes|type 2 diabetes
489454|NCT00141453|olmesartan medoxomil|olmesartan medoxomil
489455|NCT00141466|Hereditary colorectal cancer|hereditary colorectal cancer
489456|NCT00141466|Microsatellite instability|microsatellite instability
489457|NCT00141466|Physician roles|physician roles
489458|NCT00141466|Health care implementation|health care implementation
489459|NCT00141466|Intervention|intervention
489460|NCT00141479|Treatment interruption on reinitiation|treatment interruption on reinitiation
489461|NCT00141479|Schizophrenia|schizophrenia
489462|NCT00141479|Schizoaffective disorder|schizoaffective disorder
489463|NCT00141492|Type 2 diabetes|type 2 diabetes
489464|NCT00141492|hypogonadism|hypogonadism
489465|NCT00141492|testosterone|testosterone
489466|NCT00141492|glycosylated hemoglobin A1C|glycosylated hemoglobin a1c
489467|NCT00141505|drug interaction|drug interaction
489468|NCT00141505|pharmacokinetics|pharmacokinetics
489469|NCT00141505|valproate|valproate
489471|NCT00141518|Health economics,Quality of life|health economics,quality of life
489472|NCT00141531|Bladder cancer|bladder cancer
489473|NCT00141531|Superficial|superficial
489474|NCT00141531|Carcinoma in situ|carcinoma in situ
489475|NCT00141531|Intravesical instillation|intravesical instillation
489773|NCT00142766|Analgesic|analgesic
489476|NCT00141531|Chemotherapy|chemotherapy
489477|NCT00141531|Adjuvant|adjuvant
489478|NCT00141544|Menopause; Postmenopause; Estrogen; Hormone Therapy|menopause; postmenopause; estrogen; hormone therapy
488819|NCT00137761|Iressa|iressa
489479|NCT00141557|Menopause; Postmenopause; Estrogen; Hormone Therapy|menopause; postmenopause; estrogen; hormone therapy
489480|NCT00141570|Menopause; Postmenopause; Estrogen; Hormone Therapy|menopause; postmenopause; estrogen; hormone therapy
489481|NCT00141583|Renin-angiotensin system|renin-angiotensin system
489482|NCT00141583|ACE Inhibitor|ace inhibitor
489483|NCT00141583|Angiotensin Receptor Blocker|angiotensin receptor blocker
489484|NCT00141596|Resistant Hypertension|resistant hypertension
489485|NCT00141596|Extracellular Fluid Volume|extracellular fluid volume
489486|NCT00141609|End-stage renal failure|end-stage renal failure
489487|NCT00141609|Haemodialysis|haemodialysis
489488|NCT00141609|Sodium|sodium
489489|NCT00141609|Blood Pressure|blood pressure
489490|NCT00141622|Endothelial dysfunction|endothelial dysfunction
489491|NCT00141622|ADMA|adma
489492|NCT00141622|DDAH|ddah
489493|NCT00141622|Sodium|sodium
489494|NCT00141635|Quality of Life|quality of life
489495|NCT00141635|Breast Cancer|breast cancer
489496|NCT00141635|Referee's Report|referee's report
489497|NCT00141635|Diagnostics|diagnostics
489498|NCT00141635|Therapy|therapy
489499|NCT00141648|Osteolymphoma|osteolymphoma
489500|NCT00141648|Chemotherapy|chemotherapy
489501|NCT00141648|Radiotherapy|radiotherapy
489502|NCT00141648|Lymphoma|lymphoma
489503|NCT00141661|Interventional, Alzheimer, Safety and Tolerability|interventional, alzheimer, safety and tolerability
489504|NCT00141674|Blood transfusion|blood transfusion
489505|NCT00141674|Age of blood|age of blood
489506|NCT00141674|Traumatic Brain Injury|traumatic brain injury
489507|NCT00141674|Cerebral Oxygen Extraction Ratio|cerebral oxygen extraction ratio
489508|NCT00141674|Age of transfused blood in traumatic brain injury|age of transfused blood in traumatic brain injury
489509|NCT00141687|External cephalic version|external cephalic version
489510|NCT00141687|Cesarean section|cesarean section
489511|NCT00141687|pregnancy|pregnancy
489512|NCT00141687|labour|labour
489513|NCT00141687|Breech pregnancy|breech pregnancy
489514|NCT00141726|Enbrel|enbrel
489515|NCT00141726|Stem Cell Transplantation|stem cell transplantation
489516|NCT00141726|Lung Injury|lung injury
489517|NCT00141739|Stem Cell Transplantation|stem cell transplantation
489518|NCT00141739|Graft-Versus-Host Disease|graft-versus-host disease
489519|NCT00141739|prophylaxis|prophylaxis
489520|NCT00141752|Cerebrovascular Accident|cerebrovascular accident
489521|NCT00141752|Deglutition Disorders|deglutition disorders
489522|NCT00141752|stroke|stroke
489523|NCT00141752|dysphagia|dysphagia
489524|NCT00141752|screening|screening
489525|NCT00141778|atrial fibrillation|atrial fibrillation
489526|NCT00141778|cardiac surgery|cardiac surgery
489527|NCT00141791|Asthma|asthma
489528|NCT00141791|Anti-Asthmatic Agents|anti-asthmatic agents
489529|NCT00141791|Receptors|receptors
489530|NCT00141791|Tumor Necrosis Factor|tumor necrosis factor
489531|NCT00141804|renal transplantation|renal transplantation
489532|NCT00141804|immunosuppression|immunosuppression
489533|NCT00141804|prevention of acute rejection|prevention of acute rejection
489534|NCT00141817|Gastrointestinal Reflux Disease|gastrointestinal reflux disease
489535|NCT00141830|Rheumatoid Arthritis|rheumatoid arthritis
489536|NCT00141843|Hemophilia A|hemophilia a
489537|NCT00141856|Dis Management|dis management
489538|NCT00141856|Heart Decompensation|heart decompensation
489539|NCT00141856|Hearts|hearts
489540|NCT00141856|Veteran (M01.930)|veteran (m01.930)
489541|NCT00141869|Sensory Processing|sensory processing
489542|NCT00141869|Magnetoencephalogram|magnetoencephalogram
489543|NCT00141869|Tourete Syndrome|tourete syndrome
489544|NCT00141869|Trigeminal Nerve|trigeminal nerve
489545|NCT00141869|Tics|tics
489546|NCT00141869|TS|ts
489547|NCT00141869|Healthy Volunteer|healthy volunteer
489548|NCT00141869|HV|hv
489549|NCT00141895|Intrauterine fetal death, 2nd trimester, induction|intrauterine fetal death, 2nd trimester, induction
489550|NCT00141908|Hydroxyprogesterone Caproate, twins, preterm delivery|hydroxyprogesterone caproate, twins, preterm delivery
489551|NCT00141921|Immunex|immunex
489552|NCT00141921|Amgen|amgen
489553|NCT00141921|Pediatric,|pediatric,
489554|NCT00141921|plaque psoriasis|plaque psoriasis
489555|NCT00141921|clinical trial|clinical trial
489556|NCT00141934|Rheumatoid Arthritis|rheumatoid arthritis
489557|NCT00141934|RA|ra
489558|NCT00141934|ACR20 endpoint|acr20 endpoint
489559|NCT00141934|Tender/swollen joints|tender/swollen joints
489560|NCT00141934|Improvement in pain|improvement in pain
489561|NCT00141934|Health assessment questionnaire|health assessment questionnaire
489562|NCT00141934|Profile of mood states|profile of mood states
489563|NCT00141947|bexarotene|bexarotene
489564|NCT00141947|schizophrenia|schizophrenia
489565|NCT00141947|psychopathology|psychopathology
489566|NCT00141947|cognitive impairment|cognitive impairment
489567|NCT00141947|quality of life|quality of life
489568|NCT00141947|open lable trial|open lable trial
489569|NCT00141960|Treatment efficacy|treatment efficacy
489570|NCT00141960|Treatment effectiveness|treatment effectiveness
489875|NCT00135395|HIV/AIDS|hiv/aids
489571|NCT00141960|Gastrointestinal Diseases|gastrointestinal diseases
489572|NCT00141960|Reflux, Gastroesophageal|reflux, gastroesophageal
489573|NCT00141960|GERD|gerd
489574|NCT00141973|Procalcitonin|procalcitonin
489575|NCT00141973|Sepsis|sepsis
489576|NCT00141973|Corticosteroids|corticosteroids
489577|NCT00141986|vitamin D|vitamin d
489578|NCT00141986|type 1 diabetes|type 1 diabetes
489579|NCT00141986|prevention trial|prevention trial
489580|NCT00141999|vaccine|vaccine
489581|NCT00141999|hepatitis|hepatitis
489582|NCT00142012|School-based|school-based
489583|NCT00142012|Obesity|obesity
489584|NCT00142012|Prevention|prevention
489585|NCT00142025|Bronchial asthma|bronchial asthma
489586|NCT00142025|Oxcarbazepine|oxcarbazepine
489587|NCT00142025|Antiepileptic drug|antiepileptic drug
489588|NCT00142025|Efficacy|efficacy
489589|NCT00142038|gastric cancer|gastric cancer
489590|NCT00142038|metastatic|metastatic
489591|NCT00142038|locally advanced|locally advanced
489592|NCT00142038|docetaxel|docetaxel
489593|NCT00142038|capecitabine|capecitabine
489594|NCT00142051|sickle cell disease|sickle cell disease
489595|NCT00142051|pain crisis|pain crisis
489596|NCT00142051|vaso-occlusive crisis|vaso-occlusive crisis
489597|NCT00142051|nitric oxide|nitric oxide
489598|NCT00142064|Topical analgesia|topical analgesia
489599|NCT00142064|Urinary catheterization|urinary catheterization
489600|NCT00142064|FlACC Pain Scale|flacc pain scale
489601|NCT00142064|Lidocaine jelly|lidocaine jelly
489602|NCT00142077|Influenza|influenza
489603|NCT00142077|Electronic health record|electronic health record
489604|NCT00142077|Behavior modification|behavior modification
489605|NCT00142090|Brain Concussion|brain concussion
489606|NCT00142090|Post-Concussion Syndrome|post-concussion syndrome
489607|NCT00142090|Closed Head Injury|closed head injury
489608|NCT00142090|Traumatic Brain Injury|traumatic brain injury
489609|NCT00142090|Hypertonic Saline Solution|hypertonic saline solution
489610|NCT00142103|Hepatitis c virus|hepatitis c virus
489611|NCT00142103|HCV|hcv
489612|NCT00142103|Liver|liver
489613|NCT00142116|thalidomide|thalidomide
489614|NCT00142116|rituximab|rituximab
489615|NCT00142116|Waldenstrom's|waldenstrom's
489616|NCT00142129|bortezomib|bortezomib
489617|NCT00142129|Velcade|velcade
489618|NCT00142129|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
489619|NCT00142155|monoclonal antibody|monoclonal antibody
489620|NCT00142155|Fc gamma RIII receptor expression|fc gamma riii receptor expression
489621|NCT00142155|rituximab|rituximab
489622|NCT00142168|CC-5103 (lenalidomide)|cc-5103 (lenalidomide)
489623|NCT00142168|rituximab|rituximab
489624|NCT00142168|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
489625|NCT00142181|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
489626|NCT00142181|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
489627|NCT00142181|Antibody|antibody
489628|NCT00142181|Campath-1H|campath-1h
489629|NCT00142194|Atrial Fibrillation|atrial fibrillation
489630|NCT00142194|Oxidative stress|oxidative stress
489631|NCT00142194|Cardiology|cardiology
489632|NCT00142207|malaria|malaria
489633|NCT00142207|pregnancy|pregnancy
489634|NCT00142207|intermittent preventive treatment|intermittent preventive treatment
489635|NCT00142207|insecticide-treated nets|insecticide-treated nets
489636|NCT00142233|EUROPAC 2, ANTOX (vers)1.2, MGCT (Magnesiocard) Hereditary Pancreatitis, Idiopathic chronic pancreatitis.|europac 2, antox (vers)1.2, mgct (magnesiocard) hereditary pancreatitis, idiopathic chronic pancreatitis.
489637|NCT00142233|Hereditary Pancreatitis|hereditary pancreatitis
489638|NCT00142233|idiopathic chronic pancreatitis|idiopathic chronic pancreatitis
489639|NCT00142246|malaria|malaria
489640|NCT00142246|anaemia|anaemia
489641|NCT00142246|school performance|school performance
489642|NCT00142246|education|education
489643|NCT00142246|intermittent preventive treatment|intermittent preventive treatment
489644|NCT00142246|schools|schools
489645|NCT00142259|deep brain stimulation|deep brain stimulation
489646|NCT00142259|internal globus pallidus|internal globus pallidus
489647|NCT00142259|dystonia|dystonia
489648|NCT00142272|Ciprofloxacin|ciprofloxacin
489649|NCT00142272|children|children
489650|NCT00142272|V.cholerae O1 and O139|v.cholerae o1 and o139
489651|NCT00142272|drug resistance|drug resistance
489652|NCT00142272|Bangladesh|bangladesh
489653|NCT00142285|pneumonia|pneumonia
489654|NCT00142285|zinc|zinc
489655|NCT00142285|treatment|treatment
489656|NCT00142285|efficacy|efficacy
489657|NCT00142285|children|children
489658|NCT00142311|Parkinson's disease|parkinson's disease
489659|NCT00142311|Parkin mutations|parkin mutations
489660|NCT00142311|Metabolic explorations|metabolic explorations
489661|NCT00142311|Clinics|clinics
489662|NCT00142311|Genetics|genetics
489663|NCT00142324|Dementia|dementia
489664|NCT00142337|zidovudine|zidovudine
489665|NCT00142337|didanosine|didanosine
489666|NCT00142337|Prevention of mother to child transmission of HIV|prevention of mother to child transmission of hiv
489667|NCT00142337|nevirapine|nevirapine
489668|NCT00142337|Thailand|thailand
489669|NCT00142337|Resistance|resistance
489670|NCT00142337|HIV|hiv
489671|NCT00142337|Postpartum period|postpartum period
631461|NCT00699556|alcohol|alcohol
489034|NCT00138853|RSA|rsa
489672|NCT00142350|gastric cancer|gastric cancer
489673|NCT00142350|5-fluorouracil|5-fluorouracil
489674|NCT00142350|irinotecan|irinotecan
489675|NCT00142350|cisplatin|cisplatin
489677|NCT00142350|advanced or recurrent gastric cancer|advanced or recurrent gastric cancer
489678|NCT00142363|Parkinson's disease|parkinson's disease
489679|NCT00142363|Parkin|parkin
489680|NCT00142363|Epilepsy|epilepsy
489681|NCT00142363|Phenotype-genotype correlations|phenotype-genotype correlations
489682|NCT00142363|Ionic channels|ionic channels
489683|NCT00142389|gestational immunization,|gestational immunization,
489684|NCT00142389|infant antibody,|infant antibody,
489685|NCT00142389|cord antibody|cord antibody
489686|NCT00142402|Multiple Sclerosis|multiple sclerosis
489687|NCT00142402|Memory|memory
489688|NCT00142402|New Learning|new learning
489689|NCT00142402|Fatigue|fatigue
489690|NCT00142415|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
489691|NCT00142415|Clear Cell Renal Cell Carcinoma (CCRCC)|clear cell renal cell carcinoma (ccrcc)
489692|NCT00142415|Lutetium-177|lutetium-177
489693|NCT00142415|177-Lu|177-lu
489694|NCT00142415|cG250|cg250
489695|NCT00142415|DOTA-cG250|dota-cg250
489696|NCT00142415|Monoclonal Antibody|monoclonal antibody
489697|NCT00142428|Hepatocellular carcinoma|hepatocellular carcinoma
489698|NCT00142428|cetuximab|cetuximab
489699|NCT00142428|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
489700|NCT00142428|Metastatic hepatocellular carcinoma|metastatic hepatocellular carcinoma
489701|NCT00142441|Pulsed dye laser|pulsed dye laser
489702|NCT00142441|Keloids|keloids
489703|NCT00142441|Hypertrophic scars|hypertrophic scars
489704|NCT00142441|Pulse width|pulse width
489705|NCT00142441|Pulse duration|pulse duration
489706|NCT00142454|Malignant melanoma|malignant melanoma
489707|NCT00142454|Stages IIB-III|stages iib-iii
489708|NCT00142467|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
489709|NCT00142467|Metastatic hepatocellular carcinoma|metastatic hepatocellular carcinoma
489710|NCT00142467|gemcitabine|gemcitabine
489711|NCT00142467|oxaliplatin|oxaliplatin
489712|NCT00142467|bevacizumab|bevacizumab
489713|NCT00142467|Avastin|avastin
489714|NCT00142480|locally advanced biliary adenocarcinoma|locally advanced biliary adenocarcinoma
489715|NCT00142480|unresectable biliary adenocarcinoma|unresectable biliary adenocarcinoma
489716|NCT00142480|gallbladder adenocarcinoma|gallbladder adenocarcinoma
489717|NCT00142480|capecitabine|capecitabine
489718|NCT00142480|oxaliplatin|oxaliplatin
489719|NCT00142480|bevacizumab|bevacizumab
489720|NCT00142480|Biliary tract adenocarcinoma|biliary tract adenocarcinoma
489721|NCT00142493|Episodic Memory|episodic memory
489722|NCT00142493|Amnesia|amnesia
489723|NCT00142493|Amnesia, Temporary|amnesia, temporary
489724|NCT00142506|Prostate Cancer|prostate cancer
489725|NCT00142506|Cancer of the Prostate|cancer of the prostate
489726|NCT00142506|Prostate Neoplasms|prostate neoplasms
489727|NCT00142506|Prostatic Cancer|prostatic cancer
489728|NCT00142506|Viagra|viagra
489729|NCT00142506|05-007|05-007
489730|NCT00142519|Pain|pain
489731|NCT00142519|Analgesics|analgesics
489732|NCT00142519|Retroperitoneal lymph node dissection|retroperitoneal lymph node dissection
489733|NCT00142532|Acupuncture|acupuncture
489734|NCT00142532|Pain|pain
489735|NCT00142532|Lung Cancer|lung cancer
489736|NCT00142532|Thoracotomy|thoracotomy
489737|NCT00142532|Surgery|surgery
489738|NCT00142558|Arcoxia|arcoxia
489739|NCT00142571|Sarcoma, Soft Tissue|sarcoma, soft tissue
489742|NCT00142584|safety and tolerability study|safety and tolerability study
489743|NCT00142584|hypertension|hypertension
489744|NCT00142584|beta-blockers|beta-blockers
489745|NCT00142597|acupuncture|acupuncture
489746|NCT00142597|analgesia|analgesia
489747|NCT00142597|pain|pain
489748|NCT00142597|fibromyalgia|fibromyalgia
489749|NCT00142597|fMRI|fmri
489751|NCT00142610|alpha tocopherol|alpha tocopherol
489752|NCT00142610|vitamin E|vitamin e
489753|NCT00142610|ascorbate|ascorbate
489754|NCT00142610|vitamin C|vitamin c
489755|NCT00142610|antioxidant|antioxidant
489756|NCT00142610|allergic|allergic
489757|NCT00142610|asthma|asthma
489758|NCT00142636|Chronic Kideny Disease|chronic kideny disease
489759|NCT00142636|Hypertension|hypertension
489760|NCT00142714|sexual response|sexual response
489761|NCT00142714|sexual dysfunction in females|sexual dysfunction in females
489762|NCT00142714|spinal cord injury|spinal cord injury
489763|NCT00142740|Hepatitis B vaccines|hepatitis b vaccines
489764|NCT00142740|HIV-infected adolescents|hiv-infected adolescents
489765|NCT00142740|Hepatitis B infection (negative)|hepatitis b infection (negative)
489766|NCT00142740|HIV vaccine trial|hiv vaccine trial
489767|NCT00142753|Hepatitis B vaccines|hepatitis b vaccines
489768|NCT00142753|HIV-infected adolescents|hiv-infected adolescents
489769|NCT00142753|Hepatitis B infection|hepatitis b infection
489770|NCT00142766|Sedation|sedation
489771|NCT00142766|Mechanical ventilation|mechanical ventilation
489676|NCT00142350|S-1|s-1
489772|NCT00142766|Critical illness|critical illness
489774|NCT00142766|Opioid Withdrawal|opioid withdrawal
489775|NCT00142766|Benzodiazepine Withdrawal|benzodiazepine withdrawal
489776|NCT00142766|Nurse|nurse
489777|NCT00142779|Cocaine Addiction|cocaine addiction
489778|NCT00142779|Cocaine Dependence|cocaine dependence
489779|NCT00142779|Opiate Addiction|opiate addiction
489780|NCT00142779|Opiate Dependence|opiate dependence
489781|NCT00142792|stroke|stroke
489782|NCT00142792|recovery of function|recovery of function
489783|NCT00142792|functional electrical stimulation (FES)|functional electrical stimulation (fes)
489784|NCT00142805|ketones|ketones
489785|NCT00142805|Apolipoprotein E|apolipoprotein e
489786|NCT00142805|ApoE genotype|apoe genotype
489787|NCT00142805|cognitive function|cognitive function
489788|NCT00142805|glucose metabolism|glucose metabolism
489789|NCT00142818|Alcohol Abuse|alcohol abuse
489790|NCT00142818|Cocaine Abuse|cocaine abuse
489791|NCT00142831|nicotine dependence|nicotine dependence
489792|NCT00142844|cocaine|cocaine
489793|NCT00142870|marijuana|marijuana
489794|NCT00142870|treatment|treatment
489795|NCT00142883|addiction, crack, cocaine|addiction, crack, cocaine
489796|NCT00142896|Opiate Addiction|opiate addiction
489797|NCT00142896|Opiate Dependence|opiate dependence
489798|NCT00142909|Opioid dependence|opioid dependence
489799|NCT00142922|Adherence|adherence
489800|NCT00142922|self-care|self-care
489801|NCT00142922|Behavioral intervention|behavioral intervention
489802|NCT00142922|Diabetes|diabetes
489803|NCT00142935|HIV Prevention|hiv prevention
489804|NCT00142935|Opioid-Related Disorders|opioid-related disorders
489805|NCT00142935|Medication Assisted Treatment|medication assisted treatment
489806|NCT00142935|Methadone|methadone
489807|NCT00142948|Heroin Abuse|heroin abuse
489808|NCT00142948|Heroin Addiction|heroin addiction
489809|NCT00142961|cannabis abuse|cannabis abuse
489810|NCT00142961|atomoxetine|atomoxetine
489811|NCT00142961|ADHD|adhd
489812|NCT00142974|Diabetes, tegaserod, gastropathy|diabetes, tegaserod, gastropathy
489813|NCT00142987|Tegaserod, IBS-C, women, mixed bowel habit|tegaserod, ibs-c, women, mixed bowel habit
489814|NCT00143000|Hepatitis C Virus|hepatitis c virus
489815|NCT00143000|Genotype 2|genotype 2
489816|NCT00143000|Genotype 3|genotype 3
489817|NCT00143013|type 2 diabetes|type 2 diabetes
489818|NCT00143013|microarray|microarray
489819|NCT00143013|skeletal muscle|skeletal muscle
489820|NCT00143013|bioinformatics|bioinformatics
489821|NCT00143026|Parkinson's disease, levodopa, motor fluctuations|parkinson's disease, levodopa, motor fluctuations
489822|NCT00135161|neoplasms (squamous cell carcinoma of the head and neck region)|neoplasms (squamous cell carcinoma of the head and neck region)
489823|NCT00135174|Pacemaker|pacemaker
489824|NCT00135174|routine|routine
489825|NCT00135174|follow-up|follow-up
489826|NCT00135174|complications|complications
489827|NCT00135174|Quality of Life|quality of life
489828|NCT00135213|passive smoking|passive smoking
489829|NCT00135213|pediatric practice|pediatric practice
489830|NCT00135213|smoking cessation|smoking cessation
489831|NCT00135226|Diabetes Mellitus|diabetes mellitus
489832|NCT00135226|Cardiovascular Disease|cardiovascular disease
489833|NCT00135226|Aspirin|aspirin
489834|NCT00135226|Omega-3 fatty acids|omega-3 fatty acids
489835|NCT00135226|Primary prevention|primary prevention
489836|NCT00135226|Randomized Controlled Trial|randomized controlled trial
489837|NCT00135226|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
489838|NCT00135226|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
489839|NCT00135239|back|back
489840|NCT00135239|Lower Mechanical Back Pain|lower mechanical back pain
489841|NCT00135239|Rehabilitation|rehabilitation
489842|NCT00135252|developing chronic lung disease|developing chronic lung disease
489843|NCT00135265|smoking cessation|smoking cessation
489844|NCT00135265|adolescents|adolescents
489845|NCT00135278|Neuroprotection|neuroprotection
489846|NCT00135278|inflammation|inflammation
489847|NCT00135278|cytokines|cytokines
489848|NCT00135278|CSF|csf
489849|NCT00135291|transfusion-induced immunomodulation|transfusion-induced immunomodulation
489850|NCT00135291|leukoreduction|leukoreduction
489851|NCT00135291|surgical site infections|surgical site infections
489852|NCT00135291|nosocomial infections|nosocomial infections
489853|NCT00135291|transfusion|transfusion
489854|NCT00135291|Infection|infection
489855|NCT00135291|Sepsis|sepsis
489856|NCT00135291|Hemorrhage|hemorrhage
489857|NCT00135304|Vitamin D|vitamin d
489858|NCT00135304|Sensipar®|sensipar®
489859|NCT00135304|Cinacalcet HCl|cinacalcet hcl
489860|NCT00135304|Chronic Kidney Disease|chronic kidney disease
489861|NCT00135317|oncology|oncology
489862|NCT00135317|darbepoetin alfa|darbepoetin alfa
489863|NCT00135317|Aranesp®|aranesp®
489864|NCT00135317|Amgen|amgen
489865|NCT00135317|Non-myeloid malignancy|non-myeloid malignancy
489866|NCT00135330|diabetes|diabetes
489867|NCT00135330|exenatide|exenatide
489868|NCT00135330|rosiglitazone|rosiglitazone
489869|NCT00135330|Amylin|amylin
489870|NCT00135330|Lilly|lilly
489871|NCT00135343|HIV/AIDS|hiv/aids
489872|NCT00135356|HIV infections|hiv infections
489873|NCT00135369|HIV-AIDS|hiv-aids
489874|NCT00135382|HIV/AIDS|hiv/aids
489876|NCT00135395|Treatment Experienced|treatment experienced
489877|NCT00135408|Unresectable Stage III or IV Malignant Melanoma|unresectable stage iii or iv malignant melanoma
489878|NCT00135447|HIV/AIDS|hiv/aids
489879|NCT00135447|Treatment Experienced|treatment experienced
489880|NCT00135460|HIV|hiv
489881|NCT00135460|Lipoatrophy|lipoatrophy
489882|NCT00135460|Lipodystrophy|lipodystrophy
489883|NCT00135460|Treatment Naive|treatment naive
489884|NCT00135460|HIV Infections|hiv infections
489885|NCT00135460|Hypercholesterolemia|hypercholesterolemia
489886|NCT00135473|Severe sepsis|severe sepsis
489887|NCT00135473|septic shock|septic shock
489888|NCT00135473|volume substitution|volume substitution
489889|NCT00135473|intensive insulin therapy|intensive insulin therapy
489890|NCT00135473|colloids|colloids
489891|NCT00135473|crystalloids|crystalloids
489892|NCT00135473|outcome|outcome
489893|NCT00135473|safety|safety
489894|NCT00135486|Haemophilus Influenzae type b/Meningococcal vaccine|haemophilus influenzae type b/meningococcal vaccine
489895|NCT00135486|Prophylaxis meningococcal serogroup C disease, Hib diseases|prophylaxis meningococcal serogroup c disease, hib diseases
489896|NCT00135499|Lymphoma|lymphoma
489897|NCT00135499|chemotherapy|chemotherapy
489898|NCT00135499|rituximab|rituximab
489899|NCT00135512|MDD|mdd
489900|NCT00135525|Generalized Anxiety Disorder|generalized anxiety disorder
489901|NCT00135538|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
489902|NCT00135538|Intermittent Positive-Pressure Ventilation|intermittent positive-pressure ventilation
489903|NCT00135538|Rehabilitation|rehabilitation
489904|NCT00135551|Hypertension|hypertension
489905|NCT00135551|Multicenter clinical trial|multicenter clinical trial
489906|NCT00135551|PROBE|probe
489907|NCT00135551|Combination therapy|combination therapy
489908|NCT00135551|Benidipine|benidipine
489909|NCT00135551|Essential Hypertension|essential hypertension
489910|NCT00135564|Haemophilus Influenzae type b/Meningococcal (vaccine)|haemophilus influenzae type b/meningococcal (vaccine)
489911|NCT00135564|Prophylaxis meningococcal serogroup C disease, Hib diseases|prophylaxis meningococcal serogroup c disease, hib diseases
489912|NCT00135577|opioids|opioids
489913|NCT00135577|constipation|constipation
489914|NCT00135577|opioid-induced bowel dysfunction|opioid-induced bowel dysfunction
489915|NCT00135590|Protein pulse-feeding|protein pulse-feeding
489916|NCT00135590|Nutritional supplementation|nutritional supplementation
489917|NCT00135590|Protein-energy malnutrition|protein-energy malnutrition
489918|NCT00135590|Elderly subjects|elderly subjects
489919|NCT00135590|Body composition|body composition
489920|NCT00135603|appendicitis.|appendicitis.
489922|NCT00135603|treatment.|treatment.
489923|NCT00135603|antibiotic therapy.|antibiotic therapy.
489924|NCT00135603|CT scanning.|ct scanning.
489925|NCT00135603|randomized trial|randomized trial
489926|NCT00135603|safety|safety
489927|NCT00135616|urinary incontinence|urinary incontinence
489928|NCT00135616|stress incontinence|stress incontinence
489929|NCT00135616|urethra|urethra
489930|NCT00135616|gynaecologic surgical procedures|gynaecologic surgical procedures
489931|NCT00135616|suburethral sling|suburethral sling
489932|NCT00135629|Hayfever|hayfever
489933|NCT00135629|Sublingual Immunotherapy|sublingual immunotherapy
489934|NCT00135629|Grass pollen immunotherapy|grass pollen immunotherapy
489935|NCT00135629|Late cutaneous response|late cutaneous response
489936|NCT00135629|Intradermal allergen challenge|intradermal allergen challenge
489937|NCT00135629|Seasonal Allergic Rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
489938|NCT00135642|Hayfever|hayfever
489939|NCT00135642|Subcutaneous Immunotherapy|subcutaneous immunotherapy
490039|NCT00136032|Pituitary|pituitary
489940|NCT00135642|Grass pollen immunotherapy|grass pollen immunotherapy
489941|NCT00135642|Seasonal Allergic Rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
489942|NCT00135655|macular edema|macular edema
489943|NCT00135655|post cataract extraction|post cataract extraction
489944|NCT00135655|cystoid macular edema|cystoid macular edema
489945|NCT00135655|post cataract extraction macular edema|post cataract extraction macular edema
489946|NCT00135668|children|children
489947|NCT00135668|sodium nitroprusside|sodium nitroprusside
489948|NCT00135668|controlled hypotension|controlled hypotension
489949|NCT00135668|dose-response|dose-response
489950|NCT00135668|pharmacokinetics|pharmacokinetics
489951|NCT00135668|pharmacodynamics|pharmacodynamics
489952|NCT00135668|safety|safety
489953|NCT00135668|efficacy|efficacy
489954|NCT00135694|hepatitis|hepatitis
489955|NCT00135694|hepatitis C|hepatitis c
489956|NCT00135694|HCV|hcv
489957|NCT00135694|liver|liver
489958|NCT00135694|liver disease|liver disease
489959|NCT00135694|liver transplant|liver transplant
489960|NCT00135694|liver transplantation|liver transplantation
489961|NCT00135694|transplant|transplant
489962|NCT00135694|hepatic|hepatic
489963|NCT00135694|hepatic transplantation|hepatic transplantation
489964|NCT00135694|immunosuppression|immunosuppression
489965|NCT00135694|rejection|rejection
489966|NCT00135707|Antioxidants|antioxidants
489967|NCT00135707|Preeclampsia|preeclampsia
489968|NCT00135707|Pregnancy|pregnancy
489969|NCT00135707|Hypertension|hypertension
489970|NCT00135720|Pemphigus Vulgaris|pemphigus vulgaris
489971|NCT00135720|Chronic Pemphigus|chronic pemphigus
489972|NCT00135720|Etanercept|etanercept
489973|NCT00135720|Enbrel|enbrel
489974|NCT00135720|anti-TNF-alpha|anti-tnf-alpha
489975|NCT00135720|TNF-alpha antagonist|tnf-alpha antagonist
489976|NCT00135720|biologic|biologic
489977|NCT00135720|immunomodulator|immunomodulator
489978|NCT00135720|subcutaneous medication|subcutaneous medication
489979|NCT00135733|Lichen Planus|lichen planus
489980|NCT00135733|Mucosal lichen planus|mucosal lichen planus
489981|NCT00135733|Alefacept|alefacept
489982|NCT00135733|T-cell mediated|t-cell mediated
489983|NCT00135733|subcutaneous medication|subcutaneous medication
489984|NCT00135733|Autoimmune disease|autoimmune disease
489985|NCT00135746|tobacco|tobacco
489986|NCT00135759|opiate dependence|opiate dependence
489987|NCT00135772|nicotine dependence|nicotine dependence
489988|NCT00135798|Hepatitis C|hepatitis c
489989|NCT00135798|Ribavirin|ribavirin
489990|NCT00135798|PegInterferon alfa2b|peginterferon alfa2b
489991|NCT00135811|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
489992|NCT00135824|Artificial eye drops|artificial eye drops
489993|NCT00135824|tolerability|tolerability
489994|NCT00135824|healthy volunteers|healthy volunteers
489995|NCT00135824|povidone|povidone
489996|NCT00135824|healthy subjects|healthy subjects
489997|NCT00135837|Age related Macula Degeneration,|age related macula degeneration,
489998|NCT00135837|AMD,|amd,
489999|NCT00135837|choroidal neovascularisation (CNV),|choroidal neovascularisation (cnv),
490000|NCT00135837|occult CNV lesion,|occult cnv lesion,
490001|NCT00135837|verteporfin for injection,|verteporfin for injection,
490002|NCT00135837|photodynamic therapy (PDT)|photodynamic therapy (pdt)
490003|NCT00135850|Gene therapy|gene therapy
490004|NCT00135850|VEGF|vegf
490005|NCT00135850|Stem cells|stem cells
490006|NCT00135850|myocardial ischemia|myocardial ischemia
490007|NCT00135850|angiogenesis|angiogenesis
490008|NCT00135876|deep vein thrombosis|deep vein thrombosis
490009|NCT00135876|pulmonary embolism|pulmonary embolism
490010|NCT00135876|glioma|glioma
490011|NCT00135876|fragmin|fragmin
490012|NCT00135876|anticoagulant|anticoagulant
490013|NCT00135876|prophylaxis|prophylaxis
490014|NCT00135876|dalteparin|dalteparin
490015|NCT00135889|Total Knee Arthroplasty secondary to osteoarthritis|total knee arthroplasty secondary to osteoarthritis
490016|NCT00135902|Preterm birth|preterm birth
490017|NCT00135902|Progesterone|progesterone
490018|NCT00135902|Omega-3 fatty acid|omega-3 fatty acid
490019|NCT00135902|Pregnancy|pregnancy
490020|NCT00135928|ST-elevation myocardial infarction|st-elevation myocardial infarction
490021|NCT00135928|granulocyte-colony stimulating factor angiogenesis|granulocyte-colony stimulating factor angiogenesis
490022|NCT00135928|stem cells|stem cells
490023|NCT00135941|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
490024|NCT00135954|membranous nephropathy|membranous nephropathy
490025|NCT00135954|cyclophosphamide|cyclophosphamide
490026|NCT00135954|prednisone|prednisone
490027|NCT00135967|membranous nephropathy|membranous nephropathy
490028|NCT00135967|mycophenolate mofetil|mycophenolate mofetil
490029|NCT00135967|cyclophosphamide|cyclophosphamide
490030|NCT00135967|prednisone|prednisone
490031|NCT00135993|Idiopathic Restless Leg syndrome|idiopathic restless leg syndrome
490032|NCT00136006|Epidemiology|epidemiology
490033|NCT00136006|Lung health|lung health
490034|NCT00136006|lung function|lung function
490035|NCT00136006|COPD|copd
490036|NCT00136019|Epilepsy with partial seizures|epilepsy with partial seizures
490037|NCT00136032|Growth Hormone|growth hormone
490038|NCT00136032|Cardiovascular risk|cardiovascular risk
490040|NCT00136032|Hypothalamic|hypothalamic
490041|NCT00136032|GH Deficiency|gh deficiency
490042|NCT00136032|Pituitary Tumor|pituitary tumor
490043|NCT00136032|Pituitary Disease|pituitary disease
490044|NCT00136045|Idiopathic RLS|idiopathic rls
490045|NCT00136058|osteoporosis|osteoporosis
490046|NCT00136058|hip fracture|hip fracture
490047|NCT00136071|Stress Urinary Incontinence,|stress urinary incontinence,
490048|NCT00136071|TOT,|tot,
490049|NCT00136071|TVT-O|tvt-o
490050|NCT00136084|Leukemia,Erythroblastic, Acute|leukemia,erythroblastic, acute
490051|NCT00136084|Erythroblastic Leukemia, Acute|erythroblastic leukemia, acute
490052|NCT00136084|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
490053|NCT00136084|Myeloid Leukemia, Acute|myeloid leukemia, acute
490054|NCT00136097|colonisation of the catheter|colonisation of the catheter
490056|NCT00136110|Sodium Valproate|sodium valproate
490057|NCT00136110|randomised trial|randomised trial
490058|NCT00136110|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
490059|NCT00136175|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
490060|NCT00136188|Prediabetes|prediabetes
490061|NCT00136188|Metabolic Syndrome|metabolic syndrome
489356|NCT00140608|sinus|sinus
490062|NCT00136188|Healthy Controls|healthy controls
490063|NCT00136188|Endothelial function|endothelial function
490064|NCT00136201|Peritonitis|peritonitis
490065|NCT00136201|Community-Acquired Infections|community-acquired infections
490066|NCT00136201|Cross Infection|cross infection
490067|NCT00136227|screening,|screening,
490068|NCT00136227|community health education,|community health education,
490069|NCT00136227|decision making,|decision making,
490070|NCT00136227|computer-assisted decision making|computer-assisted decision making
490071|NCT00136266|Adherence|adherence
490072|NCT00136266|Supplements|supplements
490073|NCT00136266|Iron|iron
490074|NCT00136266|Iron deficiency|iron deficiency
490075|NCT00136266|Anemia|anemia
490076|NCT00136266|Vitamins|vitamins
490077|NCT00136266|Minerals|minerals
490078|NCT00136279|adolescent behavior|adolescent behavior
490079|NCT00136279|sexual behavior|sexual behavior
490080|NCT00136279|smoking|smoking
490081|NCT00136279|parents|parents
490082|NCT00136279|communication|communication
490083|NCT00136279|health education|health education
490084|NCT00136279|schools|schools
490085|NCT00136279|Sexual initiation|sexual initiation
490086|NCT00136292|Gram-Positive Infection|gram-positive infection
490087|NCT00136305|pediatric asthma|pediatric asthma
490088|NCT00136305|asthma action plans|asthma action plans
490089|NCT00136305|patient education|patient education
490090|NCT00136305|medication adherence|medication adherence
490091|NCT00136318|Pegasys-Induced depression|pegasys-induced depression
490092|NCT00136331|Pandemic|pandemic
490093|NCT00136331|Influenza|influenza
490094|NCT00136331|Prevention|prevention
490095|NCT00136331|Vaccine|vaccine
490096|NCT00136331|Prevention of Pandemic Influenza|prevention of pandemic influenza
490097|NCT00136344|cataract surgery|cataract surgery
490098|NCT00136344|phacoemulsification|phacoemulsification
490099|NCT00136344|post-operative endophthalmitis|post-operative endophthalmitis
490100|NCT00136357|posttraumatic stress|posttraumatic stress
490101|NCT00136357|mind-body techniques|mind-body techniques
490102|NCT00136357|war|war
490103|NCT00136357|adolescents|adolescents
490104|NCT00136370|Chlorhexidine|chlorhexidine
490105|NCT00136370|Prevention|prevention
490106|NCT00136370|Neonatal sepsis|neonatal sepsis
490107|NCT00136370|Peripartum infections|peripartum infections
490108|NCT00136396|Steroid-refractory Chronic Graft vs. Host Disease|steroid-refractory chronic graft vs. host disease
490109|NCT00136396|Chronic Graft vs. Host Disease|chronic graft vs. host disease
490110|NCT00136396|GVHD|gvhd
490111|NCT00136396|steroid-refractory|steroid-refractory
490112|NCT00136396|rituximab|rituximab
490113|NCT00136409|myelofibrosis|myelofibrosis
490114|NCT00136409|agnogenic myeloid metaplasia with myelofibrosis|agnogenic myeloid metaplasia with myelofibrosis
490115|NCT00136409|CMML|cmml
490116|NCT00136409|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
490117|NCT00136409|imatinib mesylate|imatinib mesylate
490118|NCT00136409|Gleevec|gleevec
490119|NCT00136422|AML|aml
490120|NCT00136422|acute myelogenous leukemia|acute myelogenous leukemia
490121|NCT00136422|MDS|mds
490122|NCT00136422|myelodysplasia|myelodysplasia
490123|NCT00136422|vaccine|vaccine
490125|NCT00136435|acute lymphoblastic leukemia|acute lymphoblastic leukemia
490126|NCT00136435|chemotherapy|chemotherapy
490127|NCT00136435|asparaginase|asparaginase
490128|NCT00136448|AML|aml
490129|NCT00136448|acute myelogenous leukemia|acute myelogenous leukemia
490130|NCT00136448|cytarabine|cytarabine
490131|NCT00136448|interleukin-2|interleukin-2
490132|NCT00136461|AML|aml
490133|NCT00136461|acute myelogenous leukemia|acute myelogenous leukemia
490134|NCT00136461|MDS|mds
490135|NCT00136461|myelodysplastic syndrome|myelodysplastic syndrome
490136|NCT00136461|bryostatin 1|bryostatin 1
490137|NCT00136461|all-trans retinoic acid|all-trans retinoic acid
490138|NCT00136461|ATRA|atra
490139|NCT00136474|Lymphoma|lymphoma
490140|NCT00136474|Radiation therapy|radiation therapy
490142|NCT00136487|Prostate Cancer|prostate cancer
490143|NCT00136487|Cancer of Prostate|cancer of prostate
490144|NCT00136487|Cancer of the Prostate|cancer of the prostate
490145|NCT00136487|Prostate-Specific Antigen|prostate-specific antigen
490146|NCT00136500|genetics|genetics
490147|NCT00136500|biomarkers|biomarkers
490148|NCT00136500|pre-symptomatic|pre-symptomatic
490149|NCT00136500|natural history|natural history
490150|NCT00136513|Safety|safety
490151|NCT00136513|tolerability|tolerability
490152|NCT00136513|dose limiting toxicity|dose limiting toxicity
490153|NCT00136513|solid tumors|solid tumors
490154|NCT00136526|Prostate Cancer|prostate cancer
490155|NCT00136526|Hormone refractory prostate cancer|hormone refractory prostate cancer
490156|NCT00136526|Metastatic prostate cancer|metastatic prostate cancer
490157|NCT00136539|Breast Cancer|breast cancer
490158|NCT00136539|Early Stage Breast Cancer|early stage breast cancer
490159|NCT00136539|HER2-positive|her2-positive
490160|NCT00136539|HER2-positive breast cancer|her2-positive breast cancer
489470|NCT00141505|bipolar|bipolar
490161|NCT00136539|Herceptin|herceptin
490162|NCT00136539|Taxol|taxol
490163|NCT00136539|Stage II Breast Cancer|stage ii breast cancer
490164|NCT00136539|Stage III Breast Cancer|stage iii breast cancer
490165|NCT00136552|lymphoma|lymphoma
490166|NCT00136552|follicular|follicular
490167|NCT00136552|B-cell|b-cell
490168|NCT00136552|rituximab|rituximab
490169|NCT00136552|interferon|interferon
490170|NCT00136565|peripheral T-cell lymphomas|peripheral t-cell lymphomas
490171|NCT00136565|bortezomib|bortezomib
490172|NCT00136565|ACVBP regimen|acvbp regimen
490173|NCT00136578|Safety|safety
490174|NCT00136578|tolerability|tolerability
490175|NCT00136578|dose limiting toxicity|dose limiting toxicity
490176|NCT00136578|solid tumors|solid tumors
490177|NCT00136578|carboplatin|carboplatin
490178|NCT00136591|follicular lymphoma|follicular lymphoma
490179|NCT00136591|bortezomib|bortezomib
490180|NCT00136591|relapse|relapse
490181|NCT00136604|Prophylaxis diphtheria|prophylaxis diphtheria
490182|NCT00136604|Hib & meningococcal serogroup A & C disease|hib & meningococcal serogroup a & c disease
490183|NCT00136617|Short Alcohol Withdrawal Scale|short alcohol withdrawal scale
490184|NCT00136617|Documentation|documentation
490185|NCT00136630|dominant spinocerebellar degenerations|dominant spinocerebellar degenerations
490186|NCT00136630|new rate scales|new rate scales
490187|NCT00136630|natural history|natural history
490188|NCT00136630|molecular biology|molecular biology
490189|NCT00136630|candidate genes|candidate genes
490190|NCT00136643|microbicide|microbicide
490191|NCT00136643|Women|women
490192|NCT00136643|Prevention|prevention
490193|NCT00136643|HIV|hiv
490194|NCT00136643|STIs|stis
490195|NCT00136643|HIV Seronegativity|hiv seronegativity
490196|NCT00136643|prevention of sexually transmitted infections including HIV.|prevention of sexually transmitted infections including hiv.
490197|NCT00136656|infant|infant
490198|NCT00136656|children|children
490199|NCT00136656|pyelonephritis|pyelonephritis
490200|NCT00136656|Renal scars|renal scars
490201|NCT00136656|DMSA scan|dmsa scan
490202|NCT00136669|Acupuncture|acupuncture
490203|NCT00136669|Pain|pain
490204|NCT00136669|Pancreatic Neoplasms|pancreatic neoplasms
490205|NCT00136682|Major abdominal or pelvic surgery|major abdominal or pelvic surgery
490206|NCT00136682|Patient-Controlled Epidural Analgesia (PCEA)|patient-controlled epidural analgesia (pcea)
490207|NCT00136682|Length of hospital stay after surgery|length of hospital stay after surgery
490208|NCT00136695|Aging|aging
490209|NCT00136708|Global Network|global network
490210|NCT00136708|Neonatal mortality|neonatal mortality
490211|NCT00136708|Asphyxia|asphyxia
490212|NCT00136708|Maternal and child health|maternal and child health
490213|NCT00136708|International|international
490214|NCT00136708|Zambia|zambia
490215|NCT00136708|Pakistan|pakistan
490216|NCT00136708|India|india
490217|NCT00136708|Democratic Republic of Congo|democratic republic of congo
490218|NCT00136708|Uruguay|uruguay
490219|NCT00136708|Guatemala|guatemala
490220|NCT00136708|Argentina|argentina
490221|NCT00136708|Neonatal resuscitation|neonatal resuscitation
490222|NCT00136721|Parkinson's disease|parkinson's disease
490223|NCT00136721|phenotype-genotype correlations|phenotype-genotype correlations
490224|NCT00136721|mutations spectrum|mutations spectrum
490225|NCT00136721|candidate genes|candidate genes
490226|NCT00136734|ADHD|adhd
490227|NCT00136734|Cocaine dependence|cocaine dependence
490228|NCT00136734|treatment|treatment
490229|NCT00136734|methylphenidate|methylphenidate
490230|NCT00136747|tobacco use|tobacco use
490231|NCT00136760|tobacco|tobacco
490232|NCT00136773|Albuminuria|albuminuria
490233|NCT00136773|Type 2 diabetes mellitus|type 2 diabetes mellitus
490234|NCT00136773|Hypertension|hypertension
490235|NCT00136786|tobacco use|tobacco use
490236|NCT00136799|Mixed Dyslipidemia|mixed dyslipidemia
490237|NCT00136799|high cholesterol|high cholesterol
490238|NCT00136799|adults|adults
490239|NCT00136799|fluvastatin|fluvastatin
490240|NCT00136812|tobacco|tobacco
490241|NCT00136825|cocaine|cocaine
490242|NCT00136825|treatment|treatment
490243|NCT00136838|tobacco use|tobacco use
490244|NCT00136851|Hypertension|hypertension
490245|NCT00136864|Positron-Emission Tomography|positron-emission tomography
490246|NCT00136864|PET Scan|pet scan
490247|NCT00136864|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
490248|NCT00136864|Diagnosis|diagnosis
490249|NCT00136864|Radiation Oncology|radiation oncology
490250|NCT00136864|Lung Cancer|lung cancer
490251|NCT00136864|Randomized Controlled Trial|randomized controlled trial
490252|NCT00136864|Oncology|oncology
490253|NCT00136864|Radiation Planning|radiation planning
490254|NCT00136877|recurrent tonsillitis|recurrent tonsillitis
490255|NCT00136877|streptococcus|streptococcus
490256|NCT00136877|tonsillectomy|tonsillectomy
490257|NCT00136877|prevention|prevention
490258|NCT00136890|Positron-Emission Tomography|positron-emission tomography
490259|NCT00136890|PET Scan|pet scan
490260|NCT00136890|Lung Cancer|lung cancer
490261|NCT00136890|Thoracic Surgery|thoracic surgery
490262|NCT00136890|Diagnostic|diagnostic
490263|NCT00136890|Randomized Controlled Trial|randomized controlled trial
490264|NCT00136890|Oncology|oncology
490265|NCT00136903|Graft vs Host Disease|graft vs host disease
490266|NCT00136903|GVHD|gvhd
490267|NCT00136903|Graft Versus Host Disease|graft versus host disease
490268|NCT00136903|Bone marrow transplant|bone marrow transplant
490269|NCT00136903|Stem cells|stem cells
490270|NCT00136903|Mesenchymal stem cells|mesenchymal stem cells
490271|NCT00136903|Adult stem cells|adult stem cells
490272|NCT00136903|Leukemia|leukemia
490273|NCT00136903|Lymphoma|lymphoma
490275|NCT00136929|MI|mi
490276|NCT00136929|Acute myocardial infarction (AMI), (MI)|acute myocardial infarction (ami), (mi)
490277|NCT00136955|Weekly Irinotecan(60mg/sqm, D1, 8, 15) in combination with Cisplatin (60mg/sqm, D1), Squamous Cell Carcinoma Of The Uterine Cervix|weekly irinotecan(60mg/sqm, d1, 8, 15) in combination with cisplatin (60mg/sqm, d1), squamous cell carcinoma of the uterine cervix
490278|NCT00137085|procedural sedation|procedural sedation
490279|NCT00137111|Leukemia|leukemia
490280|NCT00137124|Essential hypertension|essential hypertension
490281|NCT00137163|burns|burns
490282|NCT00137163|donor site care|donor site care
490283|NCT00137163|Dermafill dressing|dermafill dressing
490284|NCT00137176|Clinically Isolated Syndrome|clinically isolated syndrome
490285|NCT00137189|Motivation|motivation
490286|NCT00137189|Music Therapy|music therapy
490287|NCT00137189|Psychotherapy|psychotherapy
490288|NCT00137202|pruritus|pruritus
490289|NCT00137202|burn wound|burn wound
490290|NCT00143039|NIH|nih
490291|NCT00143039|Severe Symmetrical IUGR|severe symmetrical iugr
490292|NCT00143039|Tandem Mass Spectrometry|tandem mass spectrometry
490293|NCT00143039|Nonimmune Hydrops|nonimmune hydrops
490410|NCT00143975|refractory disease|refractory disease
490294|NCT00143039|Severe Symmetrical Intrauterine Growth Restriction|severe symmetrical intrauterine growth restriction
490295|NCT00143052|Hirsutism|hirsutism
490296|NCT00143052|Bone status|bone status
490297|NCT00143052|Androgens|androgens
490299|NCT00143065|Antigens, CD5|antigens, cd5
490300|NCT00143065|Antigens, CD19|antigens, cd19
490301|NCT00143065|Antigens, CD20|antigens, cd20
490302|NCT00143078|Obesity|obesity
490303|NCT00143078|Reproduction|reproduction
490304|NCT00143078|Weight Loss|weight loss
490305|NCT00143078|Reproductive System|reproductive system
490306|NCT00143091|Major Depressive Disorder, Recurrent|major depressive disorder, recurrent
490307|NCT00143130|phase 4, open label, seizures, epilepsy, add-on therapy, pregabalin, lyrica|phase 4, open label, seizures, epilepsy, add-on therapy, pregabalin, lyrica
490308|NCT00143312|Invasive Fungal Infection, Allogenic Stem Cell Transplant, prophylaxis, leukemia, voriconazole|invasive fungal infection, allogenic stem cell transplant, prophylaxis, leukemia, voriconazole
490309|NCT00143429|Primary Open Angle Glaucoma|primary open angle glaucoma
490310|NCT00143468|gas exchange|gas exchange
490311|NCT00143468|respiratory mechanics|respiratory mechanics
490312|NCT00143520|Placebo and active control dose response study of rivoglitazone in type 2 diabetics|placebo and active control dose response study of rivoglitazone in type 2 diabetics
490313|NCT00143533|Solid Tumors|solid tumors
490314|NCT00143546|Hepatic Veno-occlusive Disease|hepatic veno-occlusive disease
490315|NCT00143559|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
583853|NCT00512928|interference|interference
490316|NCT00143559|Haploidentical stem cell transplant|haploidentical stem cell transplant
490317|NCT00143559|Mismatched family member stem cell donor transplant|mismatched family member stem cell donor transplant
490318|NCT00143559|Bone marrow transplant|bone marrow transplant
490319|NCT00143559|High risk hematological malignancies|high risk hematological malignancies
490320|NCT00143559|T-cell depletion methodology|t-cell depletion methodology
490321|NCT00143559|Miltenyi Biotec CliniMACS stem cell selection device|miltenyi biotec clinimacs stem cell selection device
490322|NCT00143572|Hematologic Diseases|hematologic diseases
490323|NCT00143572|Anemia, Sickle Cell|anemia, sickle cell
490324|NCT00143585|angiogenesis|angiogenesis
490325|NCT00143585|VEGF|vegf
490326|NCT00143598|Postphlebitic Syndrome|postphlebitic syndrome
490327|NCT00143598|Post-Thrombotic Syndrome|post-thrombotic syndrome
490328|NCT00143598|Elastic Stockings|elastic stockings
490329|NCT00143598|Stockings, Compression|stockings, compression
490330|NCT00143598|Randomized Controlled Trials|randomized controlled trials
490331|NCT00143598|Quality of Life|quality of life
490332|NCT00143611|Shock, Septic|shock, septic
490333|NCT00143611|Sepsis Syndrome|sepsis syndrome
490334|NCT00143611|Respiratory Insufficiency|respiratory insufficiency
490335|NCT00143611|SIRS (Systemic Inflammatory Response Syndrome)|sirs (systemic inflammatory response syndrome)
490336|NCT00143611|Respiratory Failure|respiratory failure
490337|NCT00143611|Drug Therapy|drug therapy
490338|NCT00143624|Treatment Experienced|treatment experienced
490339|NCT00143624|HIV Metabolic Syndrome|hiv metabolic syndrome
490340|NCT00143624|Atherosclerosis in HIV|atherosclerosis in hiv
490341|NCT00143637|Office dust|office dust
490342|NCT00143637|Glucan|glucan
490343|NCT00143637|dose-response|dose-response
490344|NCT00143637|lung function|lung function
490345|NCT00143637|peak expiratory flow|peak expiratory flow
490346|NCT00143637|inflammation|inflammation
490347|NCT00143637|perception|perception
490348|NCT00143650|Upper airway, irritation inflammation, discomfort, house dust, damp buildings, climate chamber, humans|upper airway, irritation inflammation, discomfort, house dust, damp buildings, climate chamber, humans
490349|NCT00143663|Hypercholesterolemia|hypercholesterolemia
490350|NCT00143663|Hyperlipidemia|hyperlipidemia
490351|NCT00143663|Drug Therapy|drug therapy
490352|NCT00143676|Hyperlipidemia|hyperlipidemia
490353|NCT00143676|Dyslipidemia|dyslipidemia
490354|NCT00143676|Drug Therapy|drug therapy
490355|NCT00143702|Elevated Lactic Acid|elevated lactic acid
490356|NCT00143715|Vitamin K1 (phytonadione)|vitamin k1 (phytonadione)
490357|NCT00143715|Randomized controlled trial|randomized controlled trial
490358|NCT00143715|Warfarin|warfarin
490359|NCT00143715|Coagulopathy|coagulopathy
490360|NCT00143715|Bleeding|bleeding
490361|NCT00143715|Thrombosis|thrombosis
490362|NCT00143715|Warfarin associated coagulopathy defined as an INR of 4.5 and 10.0 (for entry into randomized tria) or greater than 10.0 (for entry into parallel cohort study|warfarin associated coagulopathy defined as an inr of 4.5 and 10.0 (for entry into randomized tria) or greater than 10.0 (for entry into parallel cohort study
490363|NCT00143715|Warfarin associated coagulopathy|warfarin associated coagulopathy
490365|NCT00143728|Treatment Experienced|treatment experienced
490366|NCT00143741|Kidney Disease, Lipitor, Atorvastatin, Allosensitization|kidney disease, lipitor, atorvastatin, allosensitization
490367|NCT00143767|Magnetic Resonance Imaging|magnetic resonance imaging
490368|NCT00143780|Bone Marrow Transplant|bone marrow transplant
490369|NCT00143780|Pneumonia|pneumonia
490370|NCT00143780|Vaccine|vaccine
490371|NCT00143780|Conjugate Vaccine|conjugate vaccine
490372|NCT00143780|Polysaccharide Vaccine|polysaccharide vaccine
490373|NCT00143793|natruretic peptides|natruretic peptides
490374|NCT00143793|NT-proBNP|nt-probnp
490375|NCT00143793|new biomarkers|new biomarkers
490376|NCT00143793|congestive heart failure|congestive heart failure
490377|NCT00143793|atrial fibrillation|atrial fibrillation
490378|NCT00143793|acute myocardial infarction|acute myocardial infarction
490379|NCT00143793|lung embolism|lung embolism
490380|NCT00143806|psoriasis|psoriasis
490381|NCT00143806|cyclosporine|cyclosporine
490382|NCT00143806|transition|transition
490383|NCT00143806|alefacept|alefacept
490384|NCT00143819|psoriasis|psoriasis
490385|NCT00143819|dry skin|dry skin
490386|NCT00143819|eczema|eczema
490387|NCT00143819|atopic dermatitis|atopic dermatitis
490388|NCT00143832|fMRI|fmri
490389|NCT00143858|Peripheral Pulse Volume|peripheral pulse volume
490390|NCT00143910|Medication adherence|medication adherence
490391|NCT00143910|Patient compliance|patient compliance
490392|NCT00143910|Kidney transplant|kidney transplant
490393|NCT00143910|Organ rejection|organ rejection
490394|NCT00143910|Allograft loss|allograft loss
490395|NCT00143910|Drug monitoring|drug monitoring
490396|NCT00143923|Cardiovascular Diseases|cardiovascular diseases
490397|NCT00143923|Ethnic Groups|ethnic groups
490398|NCT00143923|Risk Factors|risk factors
490399|NCT00143923|Sleep disordered breathing|sleep disordered breathing
490400|NCT00143923|Environmental exposures|environmental exposures
490401|NCT00143923|Cognitive Function|cognitive function
490402|NCT00143936|Weight Loss|weight loss
490403|NCT00143949|diabetes|diabetes
490404|NCT00143949|nephropathy|nephropathy
490405|NCT00143949|kidney|kidney
490406|NCT00143949|retinopathy|retinopathy
490407|NCT00143962|Weight Loss|weight loss
490408|NCT00143975|Acute myeloid leukemia|acute myeloid leukemia
490409|NCT00143975|gemtuzumab ozogamicin|gemtuzumab ozogamicin
490411|NCT00143988|Blood Pressure|blood pressure
490412|NCT00143988|Heart Rate|heart rate
490413|NCT00143988|Sexual Activity|sexual activity
490414|NCT00144001|Epilepsy|epilepsy
490415|NCT00144001|Pharmacoepidemiology|pharmacoepidemiology
490416|NCT00144001|Quality of Care|quality of care
490417|NCT00144001|Outcomes|outcomes
490418|NCT00144014|Acute|acute
490419|NCT00144014|Ischaemic|ischaemic
490420|NCT00144014|Stroke|stroke
490421|NCT00144027|patient non-adherence|patient non-adherence
490422|NCT00144027|intervention studies|intervention studies
490423|NCT00144040|Antibiotics|antibiotics
490424|NCT00144040|Respiratory Infections|respiratory infections
490425|NCT00144040|Quality Assurance, Healthcare|quality assurance, healthcare
490426|NCT00144040|Professional Education|professional education
490427|NCT00144040|Emergency Services, Medical|emergency services, medical
490428|NCT00144040|Education, Patient|education, patient
490429|NCT00144079|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
490430|NCT00144079|radiotherapy|radiotherapy
490431|NCT00144079|radioiodine therapy|radioiodine therapy
490432|NCT00144079|thyroidectomy|thyroidectomy
490433|NCT00144092|autologous and allogeneic stem cell transplantation|autologous and allogeneic stem cell transplantation
490434|NCT00144092|low grade lymphoma|low grade lymphoma
490435|NCT00144092|mantle cell|mantle cell
490436|NCT00144131|Chemotherapy, Anemia|chemotherapy, anemia
490437|NCT00144131|Aranesp®, rHuEPO|aranesp®, rhuepo
490438|NCT00144131|Chemotherapy Induced Anemia|chemotherapy induced anemia
490439|NCT00144131|non-myeloid malignancy|non-myeloid malignancy
490440|NCT00144131|Non-Myeloid Malignancies|non-myeloid malignancies
490441|NCT00144131|Chemotherapy|chemotherapy
490442|NCT00144144|Hypertension|hypertension
490443|NCT00144144|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
490444|NCT00144144|Calcium Channel Blocker|calcium channel blocker
490445|NCT00144144|Angiotensin II type 1 Receptor Blocker|angiotensin ii type 1 receptor blocker
490446|NCT00144313|vaccine|vaccine
490447|NCT00144313|hepatitis B|hepatitis b
490448|NCT00144313|immune memory|immune memory
490449|NCT00144352|Malaria|malaria
490451|NCT00144352|AIDS|aids
490452|NCT00144352|drug efficacy|drug efficacy
490453|NCT00144352|Kenya|kenya
490454|NCT00144352|Africa|africa
490455|NCT00144352|Sulfadoxine pyirmethamine|sulfadoxine pyirmethamine
490456|NCT00144352|fansidar|fansidar
490457|NCT00144365|HIV|hiv
490458|NCT00144365|Africa|africa
490459|NCT00144365|Adherence|adherence
490460|NCT00144365|HIV viral load|hiv viral load
490461|NCT00144365|Sexual behavior|sexual behavior
490462|NCT00144365|Voluntary counseling and testing|voluntary counseling and testing
490463|NCT00144378|gastric cancer|gastric cancer
490464|NCT00144378|metastatic|metastatic
490465|NCT00144378|irinotecan|irinotecan
490466|NCT00144417|tuberculosis|tuberculosis
490467|NCT00144417|TB|tb
490468|NCT00144417|treatment|treatment
490469|NCT00144417|efficacy|efficacy
490470|NCT00144417|safety|safety
490471|NCT00144430|chronic graft versus host disease|chronic graft versus host disease
490472|NCT00144430|graft|graft
490473|NCT00144430|host|host
490474|NCT00144430|transplant|transplant
490475|NCT00144430|stem cell|stem cell
490476|NCT00144430|pediatric|pediatric
490477|NCT00144430|GVH0313|gvh0313
490478|NCT00144430|leukemia|leukemia
490479|NCT00144443|Aerobiology|aerobiology
490480|NCT00144443|Asthma|asthma
490481|NCT00144443|Indoor Fungi|indoor fungi
490482|NCT00144443|Allergen|allergen
490483|NCT00144443|Home Remediation|home remediation
490484|NCT00144677|Graft versus Host Disease|graft versus host disease
490485|NCT00144677|GVHD|gvhd
490486|NCT00144677|sirolimus|sirolimus
490487|NCT00144677|tacrolimus|tacrolimus
490488|NCT00144677|Stem cell transplant|stem cell transplant
490489|NCT00144690|Epilepsy refractory partial seizures|epilepsy refractory partial seizures
490490|NCT00144703|Graft versus host disease|graft versus host disease
490491|NCT00144703|GVHD|gvhd
490492|NCT00144703|Stem cell transplantation|stem cell transplantation
490493|NCT00144703|sirolimus|sirolimus
490494|NCT00144703|tacrolimus|tacrolimus
490495|NCT00144716|Vector Control|vector control
490496|NCT00144716|repellent|repellent
490497|NCT00144716|ITN's|itn's
490498|NCT00144716|malaria|malaria
490499|NCT00144716|Amazon|amazon
490500|NCT00144755|lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
490501|NCT00144755|rituximab|rituximab
490502|NCT00144755|chemotherapy|chemotherapy
490503|NCT00144755|erythropoetin|erythropoetin
490504|NCT00144755|darbepoetin alfa|darbepoetin alfa
490505|NCT00144794|Hurler's Syndrome|hurler's syndrome
490506|NCT00144794|Hurler-Scheie Syndrome|hurler-scheie syndrome
490507|NCT00144794|Scheie Syndrome|scheie syndrome
490508|NCT00144807|lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
490509|NCT00144807|rituximab|rituximab
490510|NCT00144807|chemotherapy|chemotherapy
490511|NCT00144807|autologous stem cell transplant|autologous stem cell transplant
490512|NCT00144820|Hyaluronan|hyaluronan
490513|NCT00144820|Gonarthrosis|gonarthrosis
490514|NCT00144820|Osteoarthritis,knee|osteoarthritis,knee
490515|NCT00144820|Double-blinded|double-blinded
490516|NCT00144820|Placebo controlled|placebo controlled
490517|NCT00144820|Randomised|randomised
490518|NCT00144833|Protease inhibitors-experienced HIV-1 infected patients|protease inhibitors-experienced hiv-1 infected patients
490519|NCT00144833|Highly-resistant HIV-1|highly-resistant hiv-1
490520|NCT00144833|Dual boosted Pis|dual boosted pis
490521|NCT00144833|fosamprenavir|fosamprenavir
490522|NCT00144833|lopinavir|lopinavir
490523|NCT00144846|wheezing|wheezing
490524|NCT00144846|bronchospasm|bronchospasm
490525|NCT00144846|albuterol sulfate HFA|albuterol sulfate hfa
490526|NCT00144859|P38 map kinase|p38 map kinase
490528|NCT00144859|COPD|copd
490529|NCT00144859|safety|safety
490530|NCT00144872|Absence Seizures|absence seizures
490531|NCT00144872|EEG|eeg
490532|NCT00144872|LTG|ltg
490729|NCT00145743|Therapy|therapy
490533|NCT00144872|Typical Absence Epilepsy|typical absence epilepsy
490534|NCT00144872|Epilepsy|epilepsy
490535|NCT00144872|LAMICTAL|lamictal
490536|NCT00144885|Endocarditis|endocarditis
490537|NCT00144885|RMI|rmi
490538|NCT00144885|Impact measure|impact measure
490539|NCT00144898|Breast cancer|breast cancer
490540|NCT00144898|sentinel node resection|sentinel node resection
490541|NCT00144898|survival|survival
490542|NCT00144898|Breast cancer unifocal N0|breast cancer unifocal n0
490543|NCT00144911|exacerbations|exacerbations
490544|NCT00144911|breathing|breathing
490545|NCT00144911|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
632681|NCT00712933|SLE|sle
490546|NCT00144976|Head and Neck Neoplasms|head and neck neoplasms
490547|NCT00144976|Tarceva|tarceva
490548|NCT00144976|ENT|ent
490549|NCT00144989|Small-cell lung cancer|small-cell lung cancer
490550|NCT00144989|Limited-Stage Small-Cell Lung Cancer|limited-stage small-cell lung cancer
490551|NCT00144989|Combined modality therapy|combined modality therapy
490552|NCT00144989|chemotherapy|chemotherapy
490553|NCT00144989|radiotherapy|radiotherapy
490554|NCT00144989|Irinotecan|irinotecan
490555|NCT00144989|Cisplatin|cisplatin
490556|NCT00145002|ATLL|atll
490557|NCT00145002|chemotherapy|chemotherapy
490558|NCT00145002|phase III study|phase iii study
490559|NCT00145002|VCAP-AMP-VECP|vcap-amp-vecp
490560|NCT00145002|biweekly-CHOP|biweekly-chop
490561|NCT00145015|Intervention|intervention
490562|NCT00145015|Adults|adults
490563|NCT00145015|Colorectal cancer|colorectal cancer
490564|NCT00145015|Nutrition|nutrition
490566|NCT00145015|n-3 fatty acids|n-3 fatty acids
490567|NCT00145015|Apoptosis|apoptosis
490568|NCT00145015|Ulcerative colitis|ulcerative colitis
490569|NCT00145015|Polyps|polyps
490570|NCT00145015|Gastro-intestinal tract|gastro-intestinal tract
490571|NCT00145028|Neoplasms|neoplasms
490572|NCT00145028|Carboplatin|carboplatin
490573|NCT00145028|optimal exposure|optimal exposure
490574|NCT00145028|AUC|auc
490575|NCT00145093|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
490576|NCT00145093|Chromium|chromium
490577|NCT00145093|Saccharomyces cerevisiae|saccharomyces cerevisiae
490578|NCT00145106|acne, tazarotene, minocycline, maintenance, retinoid, efficacy, combination|acne, tazarotene, minocycline, maintenance, retinoid, efficacy, combination
490579|NCT00145119|Acute myocardial infarction|acute myocardial infarction
490580|NCT00145119|Cardiac arrhythmias|cardiac arrhythmias
490581|NCT00145119|Left ventricular dysfunction|left ventricular dysfunction
490582|NCT00145119|Implantable loop recorder|implantable loop recorder
490583|NCT00145119|Risk stratifiers|risk stratifiers
490584|NCT00145132|depression|depression
490585|NCT00145132|β-CIT-SPECT|β-cit-spect
490586|NCT00145132|SERT|sert
490587|NCT00145132|DAT|dat
490588|NCT00145132|neurophysiology|neurophysiology
490589|NCT00145132|LDAEP|ldaep
490590|NCT00145132|escitalopram|escitalopram
490591|NCT00145132|SSRI|ssri
490592|NCT00145145|Melanoma|melanoma
490593|NCT00145145|Vaccine|vaccine
490594|NCT00145145|Peptide|peptide
490595|NCT00145145|MAGE|mage
490596|NCT00145145|CpG|cpg
490597|NCT00145158|Melanoma|melanoma
490598|NCT00145158|Vaccine|vaccine
490599|NCT00145158|Peptide|peptide
490600|NCT00145158|Montanide|montanide
490601|NCT00145184|multivitamin, supplements, tuberculosis, Tanzania|multivitamin, supplements, tuberculosis, tanzania
490602|NCT00145197|breast cancer|breast cancer
490603|NCT00145197|adjuvant treatment|adjuvant treatment
490604|NCT00145197|racial disparities|racial disparities
490605|NCT00145197|Early-Stage Breast Cancer|early-stage breast cancer
490606|NCT00145210|Nebivolol|nebivolol
490607|NCT00145223|Wuchereria bancrofti, filariasis, Egypt|wuchereria bancrofti, filariasis, egypt
490608|NCT00145236|Nebivolol|nebivolol
490609|NCT00145236|Beta-Blocker|beta-blocker
583854|NCT00512928|level of anticoagulation|level of anticoagulation
490610|NCT00145249|Bacterial infections, HIV infection, cryptococcal meningitis|bacterial infections, hiv infection, cryptococcal meningitis
490611|NCT00145262|critical limb ischemia|critical limb ischemia
490612|NCT00145262|bone marrow mononuclear cells|bone marrow mononuclear cells
490613|NCT00145262|angiogenesis|angiogenesis
490614|NCT00145262|vasculogenesis|vasculogenesis
490615|NCT00145262|Arteriosclerosis Obliterans (ASO)|arteriosclerosis obliterans (aso)
490616|NCT00145262|Ischemic ulcers|ischemic ulcers
490617|NCT00145275|zoledronic acid|zoledronic acid
490618|NCT00145275|bisphosphonate|bisphosphonate
490619|NCT00145275|Low bone mass|low bone mass
490620|NCT00145288|hirsutism|hirsutism
490621|NCT00145288|type 2 diabetes|type 2 diabetes
490622|NCT00145288|polycystic ovary syndrome|polycystic ovary syndrome
490623|NCT00145288|metabolism|metabolism
490624|NCT00145301|Osteoarthritis, lumiracoxib, retention on treatment, efficacy, safety|osteoarthritis, lumiracoxib, retention on treatment, efficacy, safety
490625|NCT00145314|Metastatic colorectal cancer|metastatic colorectal cancer
490626|NCT00145314|FLOX|flox
490627|NCT00145314|Cetuximab|cetuximab
490628|NCT00145327|Osteoporosis, Zoledronic Acid|osteoporosis, zoledronic acid
490629|NCT00145340|polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
490630|NCT00145340|PPARgamma|ppargamma
490631|NCT00145340|growth hormone|growth hormone
490632|NCT00145340|insulin resistance|insulin resistance
490633|NCT00145340|pioglitazone|pioglitazone
490634|NCT00145340|glucose metabolism|glucose metabolism
490635|NCT00145340|microarray|microarray
490636|NCT00145353|type 1 diabetes mellitus|type 1 diabetes mellitus
490637|NCT00145353|hypoglycaemia|hypoglycaemia
490638|NCT00145353|insulin profiles|insulin profiles
490639|NCT00145353|growth hormone|growth hormone
490640|NCT00145353|cortisol|cortisol
490641|NCT00145353|glucagon|glucagon
490642|NCT00145366|Benign nontoxic and toxic goiter|benign nontoxic and toxic goiter
490643|NCT00145366|rhTSH|rhtsh
490644|NCT00145366|131I|131i
490645|NCT00145366|goiter reduction|goiter reduction
490646|NCT00145366|131I kinetic|131i kinetic
490647|NCT00145366|thyroid size|thyroid size
490648|NCT00145366|patient satisfaction|patient satisfaction
490649|NCT00145366|adverse effects|adverse effects
490650|NCT00145366|BRT|brt
490651|NCT00145366|Graves' disease|graves' disease
490652|NCT00145379|type 1 diabetes mellitus|type 1 diabetes mellitus
490653|NCT00145379|insulin resistance|insulin resistance
490654|NCT00145379|metformin|metformin
490655|NCT00145379|randomized, controlled study|randomized, controlled study
490656|NCT00145392|Polycystic ovary syndrome|polycystic ovary syndrome
490657|NCT00145392|growth hormone|growth hormone
490658|NCT00145392|insulin resistance|insulin resistance
490659|NCT00145392|overweight|overweight
490660|NCT00145392|glucose metabolism|glucose metabolism
490661|NCT00145405|Acromegaly|acromegaly
490662|NCT00145405|somatostatin analogues|somatostatin analogues
490663|NCT00145405|lanreotide|lanreotide
490664|NCT00145405|octreotide|octreotide
490665|NCT00145405|GH|gh
490666|NCT00145405|IGF-I|igf-i
490667|NCT00145405|injection site|injection site
490668|NCT00145418|Non small Cell Lung Cancer Stage IIIb and IV|non small cell lung cancer stage iiib and iv
490669|NCT00145522|Menopause, IGF-1, HRT|menopause, igf-1, hrt
490670|NCT00145535|Glaucoma|glaucoma
490671|NCT00145535|Glaucoma, open angle|glaucoma, open angle
490672|NCT00145535|Intraocular Pressure|intraocular pressure
490673|NCT00145535|Trabeculoplasty|trabeculoplasty
490674|NCT00145535|laser|laser
490675|NCT00145535|laser, surgery|laser, surgery
490676|NCT00145548|COPD|copd
490677|NCT00145561|HIV|hiv
490678|NCT00145574|Pediatric|pediatric
490679|NCT00145574|hypercholesterolemia|hypercholesterolemia
490680|NCT00145574|colesevelam|colesevelam
490681|NCT00145587|Osteopetrosis|osteopetrosis
490682|NCT00145587|Autosomal recessive bone disease|autosomal recessive bone disease
490683|NCT00145587|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
490684|NCT00145587|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
490685|NCT00145587|T-cell depletion methodology|t-cell depletion methodology
490686|NCT00145587|Miltenyi Biotec CliniMACS stem cell selection device|miltenyi biotec clinimacs stem cell selection device
490687|NCT00145600|Lymphoma|lymphoma
490688|NCT00145600|Hodgkin Disease|hodgkin disease
490689|NCT00145613|Haploidentical stem cell transplant|haploidentical stem cell transplant
490690|NCT00145613|High risk hematologic malignancies|high risk hematologic malignancies
490691|NCT00145613|Allogeneic stem cell transplant|allogeneic stem cell transplant
490692|NCT00145613|Mismatched family member stem cell donor|mismatched family member stem cell donor
490693|NCT00145626|Stem cell transplantation|stem cell transplantation
490694|NCT00145626|Stem cell transplant|stem cell transplant
490695|NCT00145626|Haploidentical transplant|haploidentical transplant
490696|NCT00145639|Osteosarcoma|osteosarcoma
490697|NCT00145639|Treatment, Carboplatin|treatment, carboplatin
490698|NCT00145652|erythropoetin|erythropoetin
490699|NCT00145652|adjuvant iron therapy|adjuvant iron therapy
490700|NCT00145652|anemia|anemia
490701|NCT00145652|cancer|cancer
490702|NCT00145665|FLT-PET|flt-pet
490703|NCT00145665|colorectal liver metastases|colorectal liver metastases
490704|NCT00145665|proliferation|proliferation
490705|NCT00145665|proliferation markers|proliferation markers
490706|NCT00145665|recurrence|recurrence
490707|NCT00145678|borderline|borderline
490708|NCT00145678|alcohol|alcohol
490709|NCT00145678|substance|substance
490710|NCT00145678|psychodynamic|psychodynamic
490711|NCT00145678|psychotherapy|psychotherapy
490712|NCT00145678|psychoanalytic|psychoanalytic
490713|NCT00145704|osteopenia|osteopenia
490714|NCT00145704|growth hormone deficiency|growth hormone deficiency
490715|NCT00145704|pediatric malignancy|pediatric malignancy
490716|NCT00145717|Phytosterols|phytosterols
490717|NCT00145717|Cholesterol|cholesterol
490718|NCT00145717|China|china
490719|NCT00145717|Randomized controlled trial|randomized controlled trial
490720|NCT00145730|osteoarthritis hip|osteoarthritis hip
490721|NCT00145730|arthroplasty|arthroplasty
490722|NCT00145730|ectopic bone formation|ectopic bone formation
490723|NCT00145730|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
490724|NCT00145730|disability|disability
490725|NCT00145743|Quality of Life|quality of life
490726|NCT00145743|Breast Cancer|breast cancer
490727|NCT00145743|Referee's Report|referee's report
490728|NCT00145743|Diagnostics|diagnostics
490730|NCT00145756|Sodium Chloride|sodium chloride
490731|NCT00145756|Blood Pressure|blood pressure
490732|NCT00145756|Cardiovascular Diseases|cardiovascular diseases
490733|NCT00145756|Clinical Trial|clinical trial
490734|NCT00145769|rectal cancer|rectal cancer
490735|NCT00145769|radiotherapy|radiotherapy
490736|NCT00145769|chemotherapy|chemotherapy
490737|NCT00145769|chemoradiation|chemoradiation
490738|NCT00145769|adjuvant therapy|adjuvant therapy
490739|NCT00145782|multiphasic screening|multiphasic screening
490740|NCT00145782|primary health care|primary health care
490741|NCT00145782|randomized controlled trial|randomized controlled trial
490742|NCT00145782|Risk factors|risk factors
490744|NCT00145795|HAART (Highly Active Anti-Retroviral Therapy) partial immune response|haart (highly active anti-retroviral therapy) partial immune response
490745|NCT00145795|no immune response|no immune response
490746|NCT00145795|Treatment Experienced|treatment experienced
490747|NCT00145808|Ulcerative colitis|ulcerative colitis
490748|NCT00145834|psychosocial factors|psychosocial factors
490749|NCT00145834|breastfeeding|breastfeeding
490750|NCT00145834|postnatal intervention|postnatal intervention
490751|NCT00145834|health visitor|health visitor
490752|NCT00145847|alcohol|alcohol
490753|NCT00145847|schizophrenia|schizophrenia
490754|NCT00145847|naltrexone|naltrexone
490755|NCT00145860|Colorectal Cancer|colorectal cancer
490756|NCT00145873|heart failure|heart failure
490757|NCT00145873|nesiritide|nesiritide
490758|NCT00145873|heart disease|heart disease
490759|NCT00145873|cardiovascular disease|cardiovascular disease
490861|NCT00140400|Allogeneic cells|allogeneic cells
490760|NCT00145886|low bone turnover; sclerosing bone disorders,|low bone turnover; sclerosing bone disorders,
490761|NCT00145886|osteopetrosis|osteopetrosis
490762|NCT00145912|Depression in adolescents and young adults, depression web-base activity|depression in adolescents and young adults, depression web-base activity
490763|NCT00145925|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
490764|NCT00145925|Blood Pressure|blood pressure
490765|NCT00145925|Stroke|stroke
490766|NCT00145925|MI|mi
490767|NCT00145938|Portopulmonary hypertension|portopulmonary hypertension
490768|NCT00145938|PTPH|ptph
490769|NCT00145938|pulmonary hypertension|pulmonary hypertension
490770|NCT00145938|high blood pressure in the pulmonary arteries|high blood pressure in the pulmonary arteries
490771|NCT00140088|Needlestick pain|needlestick pain
490772|NCT00140088|Venipuncture pain|venipuncture pain
490773|NCT00140101|drug eluting stents|drug eluting stents
490774|NCT00140101|stents|stents
490775|NCT00140101|angioplasty|angioplasty
490776|NCT00140101|coronary artery disease|coronary artery disease
490777|NCT00140101|total coronary occlusion|total coronary occlusion
490778|NCT00140101|coronary artery restenosis|coronary artery restenosis
490779|NCT00140101|stent thrombosis|stent thrombosis
490780|NCT00140101|vascular disease|vascular disease
490781|NCT00140101|myocardial ischemia|myocardial ischemia
490782|NCT00140101|coronary artery stenosis|coronary artery stenosis
490783|NCT00140114|Vaginal, sublingual, misoprostol, cervical ripening|vaginal, sublingual, misoprostol, cervical ripening
490784|NCT00140140|Breast cancer|breast cancer
490785|NCT00140153|androgel|androgel
490786|NCT00140153|female sexuale dysfunction|female sexuale dysfunction
490787|NCT00140153|controlled double-blind|controlled double-blind
490788|NCT00140153|testosterone|testosterone
490789|NCT00140166|schizophrenia|schizophrenia
490790|NCT00140166|niacinamide|niacinamide
490791|NCT00140179|valnoctamide|valnoctamide
490792|NCT00140179|teratogenicity|teratogenicity
490793|NCT00140179|double-blind|double-blind
490794|NCT00140179|mania|mania
490795|NCT00140192|creatine metabolism|creatine metabolism
490796|NCT00140192|schizophrenia|schizophrenia
490797|NCT00140192|energy metabolism|energy metabolism
490798|NCT00140205|leptin|leptin
490799|NCT00140205|fasting|fasting
490800|NCT00140205|pharmacokinetics|pharmacokinetics
490801|NCT00140218|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
490802|NCT00140218|pramipexole|pramipexole
490803|NCT00140218|oxidative stress|oxidative stress
490804|NCT00140218|neuroprotection|neuroprotection
490805|NCT00140231|leptin|leptin
490806|NCT00140231|fasting|fasting
490807|NCT00140231|reproductive|reproductive
490808|NCT00140231|neuroendocrine|neuroendocrine
490809|NCT00140231|immune function|immune function
490810|NCT00140231|energy deficiency associated with short-term fasting|energy deficiency associated with short-term fasting
490811|NCT00140244|leptin|leptin
490812|NCT00140244|lipodystrophy|lipodystrophy
490813|NCT00140244|insulin resistance|insulin resistance
490814|NCT00140244|hyperlipidemia|hyperlipidemia
490815|NCT00140244|metabolic syndrome|metabolic syndrome
490816|NCT00140257|Myocardial Infarction|myocardial infarction
490817|NCT00140283|Effectiveness|effectiveness
490818|NCT00140283|Educational intervention|educational intervention
490819|NCT00140283|Primary health care|primary health care
490821|NCT00140309|Pulmonary Tuberculosis|pulmonary tuberculosis
490822|NCT00140309|Tuberculosis|tuberculosis
490823|NCT00140309|Pulmonary TB|pulmonary tb
490824|NCT00140322|falls|falls
490825|NCT00140322|injury|injury
490826|NCT00140322|elderly|elderly
490827|NCT00140335|handwashing|handwashing
490828|NCT00140335|communicable diseases|communicable diseases
490829|NCT00140335|health education|health education
490830|NCT00140348|Prostate|prostate
490831|NCT00140348|Cancer|cancer
490832|NCT00140348|Advanced Prostate Cancer|advanced prostate cancer
490833|NCT00140348|Metastatic|metastatic
490834|NCT00140348|Hormone-refractory|hormone-refractory
490835|NCT00140348|GVAX|gvax
490124|NCT00136435|ALL|all
490836|NCT00140348|Vaccine|vaccine
490837|NCT00140348|Allogeneic cells|allogeneic cells
490838|NCT00140361|malaria|malaria
490839|NCT00140361|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
490840|NCT00140361|sulfadoxine-pyrimethamine plus artsunate|sulfadoxine-pyrimethamine plus artsunate
490841|NCT00140361|lumefantrine plus artemether|lumefantrine plus artemether
490842|NCT00140361|combination therapy|combination therapy
490843|NCT00140374|Prostate|prostate
490844|NCT00140374|Cancer|cancer
490845|NCT00140374|Vaccine|vaccine
490846|NCT00140374|GVAX|gvax
490847|NCT00140374|Allogeneic cells|allogeneic cells
490848|NCT00140387|Prostate|prostate
490849|NCT00140387|Cancer|cancer
490850|NCT00140387|GVAX|gvax
490851|NCT00140387|Metastatic|metastatic
490852|NCT00140387|Vaccine|vaccine
490853|NCT00140387|Allogeneic cells|allogeneic cells
490854|NCT00140400|Prostate|prostate
490855|NCT00140400|Cancer|cancer
490856|NCT00140400|Advanced prostate cancer|advanced prostate cancer
490857|NCT00140400|Metastatic|metastatic
490858|NCT00140400|Hormone-refractory|hormone-refractory
490860|NCT00140400|Vaccine|vaccine
491356|NCT00151268|LINCL|lincl
490862|NCT00140413|Optic Nerve Hypoplasia|optic nerve hypoplasia
490863|NCT00140426|Anorexia Nervosa|anorexia nervosa
490864|NCT00140426|Risperidone|risperidone
490865|NCT00140426|Atypical Neuroleptics|atypical neuroleptics
490866|NCT00140426|Dopamine|dopamine
490868|NCT00140426|Body Image|body image
490869|NCT00140426|Adolescents|adolescents
490870|NCT00140439|asthma|asthma
490871|NCT00140439|emergency department|emergency department
490872|NCT00140439|compliance|compliance
490873|NCT00140439|randomized clinical trial|randomized clinical trial
490875|NCT00140478|Androgen Independent Prostate Cancer|androgen independent prostate cancer
490876|NCT00140478|Prostate Cancer|prostate cancer
490877|NCT00140478|Mifepristone|mifepristone
490878|NCT00140478|RU-486|ru-486
490879|NCT00140491|Non-Arteritic Anterior Ischemic Optic Neuropathy|non-arteritic anterior ischemic optic neuropathy
490880|NCT00140491|Visual Field Defect|visual field defect
490881|NCT00140491|Neuroplasticity|neuroplasticity
490882|NCT00140491|Rehabilitation|rehabilitation
490883|NCT00140504|Adverse drug event|adverse drug event
490884|NCT00140504|Patient safety|patient safety
490885|NCT00140504|Internet portal|internet portal
490886|NCT00140504|PatientSite|patientsite
490887|NCT00140504|Preventive health|preventive health
490888|NCT00140504|Primary care|primary care
490889|NCT00140517|Plasmodium falciparum|plasmodium falciparum
490890|NCT00140517|malaria|malaria
490891|NCT00140517|pregnancy|pregnancy
490892|NCT00140517|resistance|resistance
490893|NCT00145964|Biliary Cirrhosis, Primary|biliary cirrhosis, primary
490894|NCT00145964|genes|genes
490895|NCT00145964|autoimmune disease|autoimmune disease
490896|NCT00145977|osteoporosis|osteoporosis
490897|NCT00145977|bone density|bone density
490898|NCT00145977|women|women
490899|NCT00145977|endocrine|endocrine
490900|NCT00145977|musculoskeletal|musculoskeletal
490901|NCT00145977|metabolic|metabolic
490902|NCT00145990|methacholine PC20|methacholine pc20
490903|NCT00145990|dosimeter|dosimeter
490904|NCT00145990|asthma|asthma
490905|NCT00146003|eczema|eczema
490906|NCT00146003|atopic dermatitis|atopic dermatitis
490907|NCT00146003|efalizumab|efalizumab
490908|NCT00146016|Chronic Hepatitis C|chronic hepatitis c
490909|NCT00146016|Amantadine|amantadine
490910|NCT00146016|Triple therapy|triple therapy
490911|NCT00146029|Patients who participated in UMCC 9900/9901 (Phase II Studies of Tailored-Dose Docetaxel in Metastatic Breast Cancer)|patients who participated in umcc 9900/9901 (phase ii studies of tailored-dose docetaxel in metastatic breast cancer)
490912|NCT00146068|Clinically Isolated Syndrome|clinically isolated syndrome
490913|NCT00146081|African Americans|african americans
490914|NCT00146081|weight control|weight control
490915|NCT00146081|social support|social support
490916|NCT00146094|Osteopenia|osteopenia
490917|NCT00146094|osteoporosis|osteoporosis
490918|NCT00146094|bone mineral density|bone mineral density
490919|NCT00146094|HIV infection|hiv infection
490920|NCT00146094|bone metabolism|bone metabolism
490921|NCT00146094|Treatment Naive|treatment naive
490922|NCT00146107|obesity|obesity
490923|NCT00146107|aging|aging
490924|NCT00146107|exercise|exercise
490925|NCT00146107|diet|diet
490926|NCT00146107|weight loss|weight loss
490927|NCT00146107|physical function|physical function
490928|NCT00146107|Obesity in the Elderly|obesity in the elderly
490929|NCT00146133|Obesity, Aging, Frailty, exercise, weight loss|obesity, aging, frailty, exercise, weight loss
490930|NCT00146146|transsexualism|transsexualism
490931|NCT00146146|testosterone|testosterone
490932|NCT00146146|dihydrotestosterone|dihydrotestosterone
490933|NCT00146146|estradiol|estradiol
490934|NCT00146159|Multiple Sclerosis|multiple sclerosis
490935|NCT00146172|Tumors|tumors
490936|NCT00146185|Needlestick pain|needlestick pain
490937|NCT00146185|Venipuncture pain|venipuncture pain
490938|NCT00146185|Procedural pain|procedural pain
490939|NCT00146198|Postoperative pain|postoperative pain
490940|NCT00146198|Inguinal Hernia Repair|inguinal hernia repair
490941|NCT00146198|Capsaicin|capsaicin
490942|NCT00146211|Trial|trial
490943|NCT00146211|ethyl-EPA|ethyl-epa
490944|NCT00146211|Miraxion™|miraxion™
490945|NCT00146211|treating|treating
490946|NCT00146211|mild|mild
490947|NCT00146211|moderate|moderate
490948|NCT00146211|Huntington's|huntington's
490949|NCT00146224|anemia|anemia
490950|NCT00146224|chronic kidney disease, CKD|chronic kidney disease, ckd
490951|NCT00146224|hemodialysis|hemodialysis
490952|NCT00146224|epoetin|epoetin
490953|NCT00146224|Epogen®|epogen®
490954|NCT00146237|phenytoin|phenytoin
490955|NCT00146237|SSRI failure|ssri failure
490956|NCT00146237|depression|depression
490957|NCT00146263|mild cognitive impairment|mild cognitive impairment
490958|NCT00146263|dementia|dementia
490959|NCT00146263|Alzheimer's Disease|alzheimer's disease
490960|NCT00146263|cognitive training|cognitive training
490961|NCT00146276|bladder cancer|bladder cancer
490962|NCT00146276|cystectomy|cystectomy
490963|NCT00146276|gemcitabine|gemcitabine
490964|NCT00146276|adjuvant chemotherapy|adjuvant chemotherapy
490965|NCT00146276|locally advanced bladder cancer|locally advanced bladder cancer
490966|NCT00149279|stomach neoplasms|stomach neoplasms
490967|NCT00149279|lymph node excision|lymph node excision
490968|NCT00149279|abdominal aorta|abdominal aorta
490969|NCT00149305|Gouty diathesis|gouty diathesis
490970|NCT00149305|Acid uric nephrolithiasis|acid uric nephrolithiasis
490971|NCT00149331|Diabetes, Insulin, Education|diabetes, insulin, education
490972|NCT00149344|cost-utility analysis;|cost-utility analysis;
490973|NCT00149344|breast reduction;|breast reduction;
490974|NCT00149344|vertical scar mammoplasty;|vertical scar mammoplasty;
490975|NCT00149344|pedicle reduction mammoplasty|pedicle reduction mammoplasty
490976|NCT00149357|venous thromboembolism|venous thromboembolism
490978|NCT00149357|thrombophilia|thrombophilia
490979|NCT00149357|fetal loss|fetal loss
490980|NCT00149370|breast hypertrophy|breast hypertrophy
490981|NCT00149370|breast reduction surgery|breast reduction surgery
490982|NCT00149370|health-related quality of life|health-related quality of life
490983|NCT00149370|Health Utilities Index|health utilities index
490984|NCT00149370|HUI|hui
490985|NCT00149370|prospective|prospective
490986|NCT00149370|SF-36|sf-36
490987|NCT00149370|quality-adjusted life years|quality-adjusted life years
490988|NCT00149370|QALY|qaly
490989|NCT00149383|randomized controlled trial|randomized controlled trial
490990|NCT00149383|malaria|malaria
490991|NCT00149383|Plasmodium falciparum|plasmodium falciparum
490992|NCT00149383|thiazolidinediones|thiazolidinediones
490993|NCT00149383|rosiglitazone|rosiglitazone
490994|NCT00149383|atovaquone-proguanil|atovaquone-proguanil
490995|NCT00149396|Colorectal cancer metastases to liver|colorectal cancer metastases to liver
490996|NCT00149396|Colorectal Cancer|colorectal cancer
490997|NCT00149396|Colorectal Carcinoma|colorectal carcinoma
490998|NCT00149396|Colorectal Tumors|colorectal tumors
490999|NCT00149396|Colorectal Neoplasms|colorectal neoplasms
491000|NCT00149396|Rectum Cancer|rectum cancer
491001|NCT00149396|Rectum tumors|rectum tumors
491002|NCT00149396|Rectum carcinoma|rectum carcinoma
491003|NCT00149396|Colon cancer|colon cancer
491004|NCT00149396|Colon tumors|colon tumors
491005|NCT00149396|Colon carcinoma|colon carcinoma
491006|NCT00149396|Rectum Neoplasms|rectum neoplasms
491007|NCT00149396|Colon Neoplasms|colon neoplasms
491008|NCT00149396|Liver Neoplasms|liver neoplasms
491009|NCT00149396|Hepatic Neoplasms|hepatic neoplasms
491010|NCT00149396|Liver Tumors|liver tumors
491011|NCT00149396|Liver cancer|liver cancer
491012|NCT00149396|Hepatic Cancer|hepatic cancer
491013|NCT00149396|Hepatic tumors|hepatic tumors
491014|NCT00149396|metastatic to the liver|metastatic to the liver
491016|NCT00149461|Asthma Action Plans|asthma action plans
491017|NCT00149461|African Americans|african americans
491018|NCT00149461|Latinos|latinos
491019|NCT00149461|Health Literacy|health literacy
491020|NCT00149461|Asthma Education|asthma education
491021|NCT00149552|Treatment Naive|treatment naive
491022|NCT00149552|Treatment Experienced|treatment experienced
491023|NCT00149578|pancreatic cancer|pancreatic cancer
491024|NCT00149578|gemcitabine|gemcitabine
491025|NCT00149578|oxaliplatin|oxaliplatin
491026|NCT00149578|5-Fluorouracil|5-fluorouracil
491027|NCT00149578|radiation|radiation
491028|NCT00149591|Myocardial infarction|myocardial infarction
491029|NCT00149591|Viability|viability
491030|NCT00149591|Coronary angioplasty|coronary angioplasty
491031|NCT00149591|Prevention|prevention
491032|NCT00149591|Prognosis|prognosis
491033|NCT00149604|metabolic syndrome|metabolic syndrome
491034|NCT00149604|hormone therapy|hormone therapy
491035|NCT00149604|abdominal adiposity|abdominal adiposity
491036|NCT00149604|lipolysis|lipolysis
491037|NCT00149617|Marijuana|marijuana
491038|NCT00149617|Mood Disorder|mood disorder
491039|NCT00149630|Opioid Dependence|opioid dependence
491040|NCT00149630|Substance Related Disorders|substance related disorders
491041|NCT00149643|Cannabis|cannabis
491042|NCT00149643|MDD|mdd
491043|NCT00149656|Treatment Naive|treatment naive
491044|NCT00149656|Multivitamins|multivitamins
491045|NCT00149656|Selenium|selenium
491046|NCT00149656|Supplementation|supplementation
491047|NCT00149656|HIV Disease Progression|hiv disease progression
491048|NCT00149669|Behavior Therapy|behavior therapy
491050|NCT00149669|Cocaine (IV)|cocaine (iv)
491051|NCT00149669|Cocaine Abuse|cocaine abuse
491052|NCT00149669|Cocaine Dependence|cocaine dependence
491053|NCT00149669|Contingency management|contingency management
491054|NCT00149669|HIV risk behaviors|hiv risk behaviors
491055|NCT00149669|Heroin|heroin
491056|NCT00149669|Naltrexone|naltrexone
491057|NCT00149669|Opioid Dependence|opioid dependence
491058|NCT00149669|sexual risk behaviors|sexual risk behaviors
491059|NCT00149682|Obesity|obesity
491060|NCT00149695|Obesity, beverages, weight loss, body mass index, diet|obesity, beverages, weight loss, body mass index, diet
491061|NCT00149708|Growth hormone|growth hormone
491062|NCT00149708|Deficiency|deficiency
491063|NCT00149708|Cardiovascular risk|cardiovascular risk
491064|NCT00149708|Body composition|body composition
491065|NCT00149721|hydrocephalus|hydrocephalus
491066|NCT00149721|pituitary function|pituitary function
491067|NCT00149721|shunting|shunting
491068|NCT00149734|Schizophrenia|schizophrenia
491069|NCT00149734|Ondansetron|ondansetron
491070|NCT00149734|P50 sensory gating|p50 sensory gating
491071|NCT00149734|Evoked potentials|evoked potentials
491072|NCT00149734|5-HT3 receptors|5-ht3 receptors
491073|NCT00149734|Atypical antipsychotics|atypical antipsychotics
491074|NCT00149747|Sleep|sleep
491075|NCT00149747|Exercise|exercise
491076|NCT00149747|Older Adults|older adults
491077|NCT00149760|Cognitive Behavior Therapy|cognitive behavior therapy
491078|NCT00149760|Treatment Outcome|treatment outcome
491079|NCT00149760|Health Care Utilization|health care utilization
491080|NCT00149760|Somatization Disorder|somatization disorder
491081|NCT00149760|Somatoform Disorder|somatoform disorder
491082|NCT00149773|Cognitive therapy|cognitive therapy
491083|NCT00149773|Suicide|suicide
491084|NCT00149773|Older men|older men
491085|NCT00149773|Death ideation|death ideation
491086|NCT00149773|Primary care|primary care
491087|NCT00149786|Anorexia Nervosa|anorexia nervosa
491088|NCT00149786|Adolescents|adolescents
491089|NCT00149786|Family therapy|family therapy
491090|NCT00149786|Individual therapy|individual therapy
491091|NCT00149799|Body Dysmorphic Disorder|body dysmorphic disorder
491092|NCT00149799|Escitalopram|escitalopram
491093|NCT00149799|Lexapro|lexapro
491094|NCT00149799|BDD|bdd
491095|NCT00149799|Body Image|body image
491096|NCT00149812|Depression|depression
491097|NCT00149812|Child disruptive behavior|child disruptive behavior
491098|NCT00149812|Family functioning|family functioning
491099|NCT00149825|Major Depressive Disorder|major depressive disorder
491100|NCT00149825|Insomnia|insomnia
491101|NCT00149825|Sleep|sleep
491102|NCT00149825|Mental Health|mental health
491103|NCT00149838|Electric Stimulation|electric stimulation
491104|NCT00149838|Magnetic Stimulation|magnetic stimulation
491105|NCT00149838|Prefrontal Cortex|prefrontal cortex
491106|NCT00149838|Brain|brain
491107|NCT00149851|GERD, heartburn, regurgitation, reflux disease|gerd, heartburn, regurgitation, reflux disease
491108|NCT00149864|Renal Transplant, adults, immunosuppressant|renal transplant, adults, immunosuppressant
491109|NCT00149877|Chronic constipation, tegaserod|chronic constipation, tegaserod
491110|NCT00149890|pediatric|pediatric
491111|NCT00149890|liver transplantation|liver transplantation
491112|NCT00149890|Simulect|simulect
491113|NCT00149890|Basiliximab|basiliximab
491114|NCT00149890|ciclosporin microemulsion|ciclosporin microemulsion
491115|NCT00149890|steroid reduction|steroid reduction
491116|NCT00149890|pediatric liver transplantation|pediatric liver transplantation
491117|NCT00149916|Renal Transplant, adults, immunosuppressants|renal transplant, adults, immunosuppressants
491118|NCT00149929|Renal Transplant, adults, immunosuppressant|renal transplant, adults, immunosuppressant
491119|NCT00149942|Enteric coated mycophenolate sodium|enteric coated mycophenolate sodium
491120|NCT00149942|transplantation|transplantation
491121|NCT00149942|gastrointestinal adverse events|gastrointestinal adverse events
491122|NCT00149942|Kidney and liver transplantation patients experiencing GI AEs with current MMF treatment|kidney and liver transplantation patients experiencing gi aes with current mmf treatment
491123|NCT00149968|Renal transplantation|renal transplantation
491124|NCT00149968|MMF|mmf
491125|NCT00149968|EC-MPS|ec-mps
491126|NCT00149968|GI problems|gi problems
491127|NCT00149981|Kidney, heart, lung, liver, pancreas|kidney, heart, lung, liver, pancreas
491128|NCT00149994|Liver transplant, adults, C2 monitoring|liver transplant, adults, c2 monitoring
491129|NCT00150007|Kidney, maintenance transplant, GI complaints, patient reported outcome|kidney, maintenance transplant, gi complaints, patient reported outcome
491130|NCT00150020|Renal/Kidney|renal/kidney
491131|NCT00150020|Transplantation|transplantation
491132|NCT00150020|MPA|mpa
491133|NCT00150020|EC-MPS|ec-mps
491134|NCT00150020|Renal Transplantation Patients with GI Intolerance with MMF|renal transplantation patients with gi intolerance with mmf
491135|NCT00150033|thyroid disease|thyroid disease
491136|NCT00150033|Quality of Life|quality of life
491137|NCT00150033|Patient reported outcome|patient reported outcome
491138|NCT00150033|questionnaire|questionnaire
491139|NCT00150033|Quality of Life measurement|quality of life measurement
491140|NCT00150046|Heart transplantation|heart transplantation
491141|NCT00150046|Everolimus|everolimus
491142|NCT00150046|Heart transplant recipient|heart transplant recipient
491143|NCT00150059|atopic dermatitis, eczema, mild to moderate, children, IGA|atopic dermatitis, eczema, mild to moderate, children, iga
491144|NCT00150072|chordoma|chordoma
491145|NCT00150072|imatinib|imatinib
491146|NCT00150072|PDGFR|pdgfr
491147|NCT00150085|diabetes, glucose, tacrolimus, cyclosporine micro-emulsion, liver, kidney, renal|diabetes, glucose, tacrolimus, cyclosporine micro-emulsion, liver, kidney, renal
491148|NCT00150098|HIV|hiv
491149|NCT00150098|vaccines|vaccines
491150|NCT00150098|women|women
491151|NCT00150098|substance use|substance use
491152|NCT00150111|Graves disease|graves disease
491153|NCT00150111|thyroid|thyroid
491154|NCT00150111|ophthalmopathy|ophthalmopathy
491155|NCT00150111|autoimmunity|autoimmunity
491156|NCT00150111|B lymphocyte depletion|b lymphocyte depletion
491157|NCT00150111|rituximab|rituximab
491158|NCT00150111|immunization|immunization
491159|NCT00150124|Radioiodine therapy|radioiodine therapy
491160|NCT00150124|Graves' disease|graves' disease
491161|NCT00150124|toxic nodular goiter|toxic nodular goiter
491162|NCT00150124|antithyroid drugs|antithyroid drugs
491163|NCT00150124|levothyroxine|levothyroxine
491164|NCT00150124|radioprotection|radioprotection
491165|NCT00150137|Radioiodine therapy|radioiodine therapy
491166|NCT00150137|Graves’ disease|graves’ disease
491167|NCT00150137|toxic nodular goiter|toxic nodular goiter
491168|NCT00150137|antithyroid drugs|antithyroid drugs
491169|NCT00150137|radioprotection|radioprotection
491170|NCT00150150|Interventional ultrasound|interventional ultrasound
491171|NCT00150150|interstitial laser theraphy|interstitial laser theraphy
491172|NCT00150150|tumor ablation|tumor ablation
491173|NCT00150150|nodule reduction|nodule reduction
491174|NCT00150150|adverse effects|adverse effects
491175|NCT00150150|patient satesfaction|patient satesfaction
491176|NCT00150163|Androgens|androgens
491177|NCT00150163|Bone|bone
491178|NCT00150163|Muscle|muscle
491179|NCT00150163|Estrogens|estrogens
491180|NCT00150163|Fat|fat
491181|NCT00150163|Lipid and glucose metabolism|lipid and glucose metabolism
491182|NCT00150189|Pain|pain
491183|NCT00150189|Procedural Pain|procedural pain
491184|NCT00150189|Sucrose|sucrose
491185|NCT00150189|Infant|infant
491186|NCT00150189|Newborn|newborn
491187|NCT00150345|Neutropenia|neutropenia
491188|NCT00150345|Fever of unknown origin|fever of unknown origin
491189|NCT00150345|Empirical treatment|empirical treatment
491190|NCT00150345|Voriconazole|voriconazole
491191|NCT00150371|(D006937)|(d006937)
491192|NCT00150462|Hematological|hematological
491193|NCT00150462|Proteasome|proteasome
491194|NCT00150462|Myeloma|myeloma
491195|NCT00150462|Lymphoma|lymphoma
583944|NCT00514007|Metastatic cancer|metastatic cancer
491196|NCT00150475|Severe Acute Respiratory Syndrome|severe acute respiratory syndrome
491197|NCT00150488|PBS|pbs
491198|NCT00150488|Painful Bladder Syndrome|painful bladder syndrome
491199|NCT00150488|Interstitial Cystitis|interstitial cystitis
491200|NCT00150488|chrondroitin sulfate|chrondroitin sulfate
491201|NCT00150514|nasal biopsy grasspollen sublingual immunotherapy|nasal biopsy grasspollen sublingual immunotherapy
491202|NCT00150527|antidepressive agents|antidepressive agents
491203|NCT00150631|Hypertension|hypertension
491204|NCT00150631|Prevention|prevention
491205|NCT00150631|Offspring|offspring
491206|NCT00150631|Prevent or delay development of hypertension|prevent or delay development of hypertension
491207|NCT00150644|Fibroid Uterus|fibroid uterus
491208|NCT00150644|Leiomyoma|leiomyoma
491209|NCT00150644|Uterine Fibroids|uterine fibroids
491210|NCT00150644|Hysterectomy|hysterectomy
491211|NCT00150644|Asoprisnil|asoprisnil
491212|NCT00150670|Stomach cancer|stomach cancer
491213|NCT00150683|Spinal Cord Injury.|spinal cord injury.
491214|NCT00150683|Osteoporosis.|osteoporosis.
491215|NCT00150683|Standing.|standing.
491216|NCT00150683|Vibration.|vibration.
491217|NCT00150696|Osteoporosis|osteoporosis
491218|NCT00150696|Spinal Cord Injury|spinal cord injury
491219|NCT00150709|Epilepsy, Pediatric , partial onset epilepsy,|epilepsy, pediatric , partial onset epilepsy,
491220|NCT00150709|Levetiracetam (Keppra®)|levetiracetam (keppra®)
491221|NCT00150722|atherosclerosis|atherosclerosis
491222|NCT00150722|endothelial function|endothelial function
491223|NCT00150722|HDL|hdl
491224|NCT00150722|Niacin|niacin
491225|NCT00150722|statins|statins
491226|NCT00150722|Stable Atherosclerotic Vascular Disease|stable atherosclerotic vascular disease
491227|NCT00150735|Monotherapy, epilepsy, Levetiracetam, Keppra.|monotherapy, epilepsy, levetiracetam, keppra.
491228|NCT00150748|Generalized Epilepsy, Primary Generalized Seizures|generalized epilepsy, primary generalized seizures
491229|NCT00150748|Keppra, Levetiracetam|keppra, levetiracetam
490527|NCT00144859|CRP|crp
491230|NCT00150761|Nasal histamine provocation, facial thermography, levocetirizine, cetirizine,|nasal histamine provocation, facial thermography, levocetirizine, cetirizine,
491231|NCT00150761|Xyzal, Zyrtec|xyzal, zyrtec
491232|NCT00150774|Idiopathic Generalized Epilepsy, Myoclonic seizures|idiopathic generalized epilepsy, myoclonic seizures
491233|NCT00150774|Keppra - Levetiracetam|keppra - levetiracetam
491234|NCT00150787|Monotherapy, epilepsy|monotherapy, epilepsy
491235|NCT00150787|Levetiracetam|levetiracetam
491236|NCT00150787|Keppra|keppra
491237|NCT00150800|Brivaracetam|brivaracetam
491238|NCT00150800|Epilepsy|epilepsy
491239|NCT00150800|Partial Onset Seizures|partial onset seizures
491240|NCT00150800|open label|open label
491241|NCT00150813|Monotherapy, epilepsy|monotherapy, epilepsy
491242|NCT00150813|Keppra, levetiracetam|keppra, levetiracetam
491243|NCT00150826|microvascular disease|microvascular disease
491244|NCT00150826|women|women
491245|NCT00150826|renin angiotensin system|renin angiotensin system
491246|NCT00150826|WISE|wise
491247|NCT00150826|ischemic heart disease|ischemic heart disease
491248|NCT00150839|Depressive Disorder, Major|depressive disorder, major
491249|NCT00150839|Venlafaxine|venlafaxine
491250|NCT00150839|Mirtazapine|mirtazapine
491251|NCT00150839|Double-blind RCT|double-blind rct
491252|NCT00150839|Magnetic resonance imaging|magnetic resonance imaging
491253|NCT00150839|Hippocampal volume|hippocampal volume
491254|NCT00150852|Gastrostomy|gastrostomy
491255|NCT00150852|Wound infection|wound infection
491256|NCT00150852|Antibiotic prophylaxis|antibiotic prophylaxis
491257|NCT00150865|ropivacaine|ropivacaine
491258|NCT00150865|posterior lumbar plexus block|posterior lumbar plexus block
491259|NCT00150865|hip arthroplasy|hip arthroplasy
491260|NCT00150865|analgesia|analgesia
491261|NCT00150865|postoperative|postoperative
491262|NCT00150878|Reduced-intensity conditioning|reduced-intensity conditioning
491263|NCT00150878|Fludarabine|fludarabine
491264|NCT00150878|Acute myeloid Leukemia|acute myeloid leukemia
491265|NCT00150878|Treatment-related mortality|treatment-related mortality
491266|NCT00150891|Th1|th1
491267|NCT00150891|Th2|th2
491268|NCT00150891|B cell|b cell
491269|NCT00150891|monokines|monokines
491270|NCT00150891|kidney transplantation|kidney transplantation
491271|NCT00150891|acute rejection|acute rejection
491272|NCT00150891|chronic rejection|chronic rejection
491273|NCT00150904|HIV|hiv
491274|NCT00150904|hepatitis C|hepatitis c
491275|NCT00150904|virologic|virologic
491276|NCT00150904|immunologic|immunologic
491277|NCT00150904|HIV / Hepatitis C coinfection|hiv / hepatitis c coinfection
491278|NCT00150917|Breast cancer|breast cancer
491279|NCT00150917|Genetics|genetics
491280|NCT00150917|Psychotherapy|psychotherapy
491281|NCT00150917|Group counselling|group counselling
491282|NCT00150917|Randomized control trial|randomized control trial
491283|NCT00150917|Risk counselling|risk counselling
491284|NCT00150917|Women's mental health|women's mental health
491285|NCT00150917|Familial breast cancer|familial breast cancer
491286|NCT00150930|psoriasis|psoriasis
491287|NCT00150930|ultraviolet|ultraviolet
491288|NCT00150930|UVB|uvb
491289|NCT00150930|phototherapy|phototherapy
491290|NCT00150930|home care|home care
491291|NCT00150930|narrowband|narrowband
491292|NCT00150943|Renal artery stenosis|renal artery stenosis
491294|NCT00150943|Renal failure|renal failure
491295|NCT00150943|Atorvastatin|atorvastatin
491296|NCT00150943|Hypertension|hypertension
491297|NCT00150943|Atherosclerosis|atherosclerosis
491298|NCT00150969|vitamin K|vitamin k
491299|NCT00150969|bone mineral density|bone mineral density
491300|NCT00150969|post-menopausal women|post-menopausal women
491301|NCT00150969|randomized double blind placebo controlled trial|randomized double blind placebo controlled trial
491302|NCT00150969|osteoporosis|osteoporosis
491303|NCT00150969|women's health|women's health
491304|NCT00150982|psoriasis|psoriasis
491305|NCT00150982|alefacept|alefacept
491306|NCT00151008|psoriasis|psoriasis
491307|NCT00151008|bexarotene|bexarotene
491308|NCT00151008|narrow band|narrow band
491309|NCT00151008|UVB|uvb
491310|NCT00151021|Diabetes|diabetes
491311|NCT00151021|Pedometer|pedometer
491312|NCT00151021|Behavioral|behavioral
491313|NCT00151034|Urothelial Cancer|urothelial cancer
491314|NCT00151034|Herceptin|herceptin
491315|NCT00151034|Advanced Urothelial Cancer|advanced urothelial cancer
491316|NCT00151073|Zometa|zometa
491317|NCT00151073|Prostate Cancer|prostate cancer
491318|NCT00151073|Metastatic Prostate Cancer|metastatic prostate cancer
491319|NCT00151099|preoperative nutrition|preoperative nutrition
491320|NCT00151099|postoperative nausea and vomiting|postoperative nausea and vomiting
491321|NCT00151099|Dysgnathia|dysgnathia
491322|NCT00151099|anesthesia|anesthesia
491323|NCT00151112|nerve block|nerve block
491324|NCT00151112|regional anesthesia|regional anesthesia
491325|NCT00151112|injuries|injuries
491326|NCT00151112|diverse malformations|diverse malformations
491327|NCT00151125|Von Willebrand Disease|von willebrand disease
491328|NCT00151125|Bleeding|bleeding
491329|NCT00151125|Coagulation|coagulation
491330|NCT00151125|Hemostatic agent|hemostatic agent
491331|NCT00151138|cerebral blood flow, positron emission tomography, magnetic resonance imaging, neuropsychology|cerebral blood flow, positron emission tomography, magnetic resonance imaging, neuropsychology
491332|NCT00151151|pregnancy prevention|pregnancy prevention
491333|NCT00151151|STD prevention|std prevention
491334|NCT00151151|adolescents|adolescents
491335|NCT00151151|motivational interviewing|motivational interviewing
491336|NCT00151151|abstinence|abstinence
491337|NCT00151151|contraception|contraception
491338|NCT00151151|transtheoretical model|transtheoretical model
491339|NCT00151151|sexual behavior|sexual behavior
491340|NCT00151164|transplantation tolerance|transplantation tolerance
491341|NCT00151164|thymus|thymus
491342|NCT00151164|bone marrow|bone marrow
491343|NCT00151164|pediatric heart transplantation|pediatric heart transplantation
491344|NCT00151177|ischemic stroke|ischemic stroke
491345|NCT00151177|CPAP ventilation|cpap ventilation
491346|NCT00151203|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
491347|NCT00151216|Batten Disease|batten disease
491348|NCT00151216|Late Infantile Neuronal Ceroid Lipofuscinosis|late infantile neuronal ceroid lipofuscinosis
491349|NCT00151216|LINCL|lincl
491350|NCT00151229|isolated systolic hypertension|isolated systolic hypertension
491351|NCT00151229|valsartan|valsartan
491352|NCT00151229|target blood pressure|target blood pressure
491353|NCT00151255|age > 60 years|age > 60 years
491354|NCT00151268|Batten Disease|batten disease
14356|NCT03198871|Abdominal surgery|abdominal surgery
491355|NCT00151268|Late Infantile Neuronal Lipofuscinosis|late infantile neuronal lipofuscinosis
491357|NCT00151281|relapsed mantle cell lymphoma|relapsed mantle cell lymphoma
491358|NCT00151294|Depression (mild to moderate)|depression (mild to moderate)
491359|NCT00151294|Affective symptoms|affective symptoms
491360|NCT00151294|Emotional lability|emotional lability
491361|NCT00151294|Multiple Sclerosis|multiple sclerosis
491362|NCT00151307|Heart surgery|heart surgery
491363|NCT00151307|Cerebral oxygen saturation|cerebral oxygen saturation
491364|NCT00151307|Neuropsychological function|neuropsychological function
491365|NCT00151320|diffuse large B cell|diffuse large b cell
491366|NCT00151320|mantle cell lymphoma|mantle cell lymphoma
491367|NCT00151346|Epidural|epidural
491368|NCT00151346|Labour pain|labour pain
491369|NCT00151346|Pregnant women|pregnant women
491370|NCT00151346|Epidural anesthesia|epidural anesthesia
491371|NCT00151346|Labour, Obstetric|labour, obstetric
491372|NCT00151346|labor pain|labor pain
491373|NCT00151346|labor, obstetric|labor, obstetric
491374|NCT00151346|labor analgesia|labor analgesia
491375|NCT00151411|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
491376|NCT00151411|Anovulation|anovulation
491377|NCT00151411|Elevated Testosterone|elevated testosterone
491378|NCT00151476|Familial adenomatous polyposis|familial adenomatous polyposis
491379|NCT00151476|celecoxib|celecoxib
491380|NCT00151476|IRA|ira
491381|NCT00151476|IPAA|ipaa
491382|NCT00151515|Alopecia, Balding|alopecia, balding
491383|NCT00151541|Acne Vulgaris|acne vulgaris
491384|NCT00151541|Acne|acne
491385|NCT00151541|Dermatology|dermatology
491386|NCT00151541|Dapsone|dapsone
491388|NCT00151554|Anxiety|anxiety
491389|NCT00151554|Intensive Care Unit (ICU)|intensive care unit (icu)
491390|NCT00151554|Preoperative Information|preoperative information
491391|NCT00151554|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
491392|NCT00151554|Chronic heart disease|chronic heart disease
491393|NCT00151567|Ureterolithiasis|ureterolithiasis
491394|NCT00151567|Alpha1-blocker|alpha1-blocker
491395|NCT00151567|Lower ureteral stone|lower ureteral stone
491396|NCT00151580|Hepatitis C|hepatitis c
491397|NCT00151580|Viral recurrence|viral recurrence
491398|NCT00151580|Ribavirin / Interferon|ribavirin / interferon
491399|NCT00151593|Cold storage|cold storage
491400|NCT00151593|Liver transplantation|liver transplantation
491401|NCT00151593|Preservation solution|preservation solution
491402|NCT00151606|Infection prevention|infection prevention
491403|NCT00151606|Isolation|isolation
491404|NCT00151606|Resistant bacteria|resistant bacteria
491405|NCT00151606|MRSA colonization|mrsa colonization
491406|NCT00151619|Calcium channel blockers|calcium channel blockers
491407|NCT00151619|Heart failure|heart failure
491408|NCT00151619|Hemodynamics|hemodynamics
491409|NCT00151632|Immunosuppression|immunosuppression
491410|NCT00151632|Liver transplantation|liver transplantation
491411|NCT00151632|Acute graft rejection|acute graft rejection
491412|NCT00151632|Treatment combination|treatment combination
491413|NCT00151645|Immunotherapy|immunotherapy
491414|NCT00151645|Renal cell carcinoma|renal cell carcinoma
491415|NCT00151645|Metastasis|metastasis
491416|NCT00151645|Lymphokine activated killers|lymphokine activated killers
491417|NCT00151645|Cell therapy|cell therapy
491418|NCT00151658|Coronary complex lesions|coronary complex lesions
491419|NCT00151658|Restenosis|restenosis
491420|NCT00151658|Drug eluting stents|drug eluting stents
491422|NCT00151671|Liver Cancer|liver cancer
491423|NCT00151671|Cirrhosis|cirrhosis
490743|NCT00145795|HIV|hiv
491424|NCT00151671|Nutrition|nutrition
491425|NCT00151684|Obesity|obesity
491426|NCT00151684|Hyperinsulinism|hyperinsulinism
491427|NCT00151684|Diazoxide|diazoxide
491428|NCT00151697|diabetes|diabetes
491429|NCT00151697|failing oral treatment|failing oral treatment
491430|NCT00151697|weight gain|weight gain
491431|NCT00151723|endogenous subclinical hyperthyroidism|endogenous subclinical hyperthyroidism
491432|NCT00151736|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
491433|NCT00151736|CLL|cll
491434|NCT00151736|Leukemia|leukemia
491435|NCT00151749|Diabetes mellitus|diabetes mellitus
491436|NCT00151762|Open label, Diabetes Mellitus|open label, diabetes mellitus
491437|NCT00151762|Long term safety study, extension study|long term safety study, extension study
491438|NCT00151775|Treatment of hypertension or high blood pressure in children ages 1-16 years.|treatment of hypertension or high blood pressure in children ages 1-16 years.
491439|NCT00151801|multiple sclerosis|multiple sclerosis
491440|NCT00151801|estroprogestins|estroprogestins
491441|NCT00151801|interferon-beta|interferon-beta
491442|NCT00151801|sex hormones|sex hormones
491443|NCT00151801|MRI|mri
491444|NCT00151814|Olmesartan PK in children|olmesartan pk in children
491445|NCT00151840|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
491446|NCT00151840|ITP|itp
491447|NCT00151840|Immunoglobulin, Intravenous|immunoglobulin, intravenous
491448|NCT00151853|CPB|cpb
491449|NCT00151853|oral anticoagulant therapy|oral anticoagulant therapy
491450|NCT00151853|plasma|plasma
491451|NCT00151853|PCC|pcc
491452|NCT00151866|Thrombopenia|thrombopenia
491453|NCT00151866|Platelet transfusion|platelet transfusion
491454|NCT00151866|Increment|increment
491455|NCT00151866|Transfusion reactions|transfusion reactions
491456|NCT00151866|Bleeding complication|bleeding complication
491457|NCT00151879|partial seizures with or without secondary generalization|partial seizures with or without secondary generalization
491458|NCT00151905|bronchiolitis|bronchiolitis
491459|NCT00151905|hypertonic saline|hypertonic saline
491460|NCT00152061|HIV|hiv
491461|NCT00152061|Antiretroviral Drug Resistance|antiretroviral drug resistance
491462|NCT00152061|Treatment Experienced|treatment experienced
491463|NCT00152074|Blood pressure|blood pressure
491464|NCT00152074|Sodium|sodium
491465|NCT00152074|Dietary|dietary
491466|NCT00152074|Hypertension or prehypertension|hypertension or prehypertension
491467|NCT00152087|Liver cancer|liver cancer
491468|NCT00152087|Brachytherapy|brachytherapy
491469|NCT00152100|Severe combined immunodeficiency|severe combined immunodeficiency
491470|NCT00152100|Transplantation|transplantation
491471|NCT00152100|Haploidentical|haploidentical
491472|NCT00153673|celecoxib|celecoxib
491473|NCT00153673|arthritis|arthritis
491474|NCT00153673|ulcer healing|ulcer healing
491475|NCT00153686|Capsule Endoscopy|capsule endoscopy
491476|NCT00153686|Mesenteric angiogram|mesenteric angiogram
491477|NCT00153699|Side effects|side effects
491478|NCT00153699|Topiramate|topiramate
491479|NCT00153712|Non-NSAID|non-nsaid
491480|NCT00153712|Non-Hp Bleeding Peptic Ulcer|non-hp bleeding peptic ulcer
491481|NCT00153738|LDL-C, phytosterol|ldl-c, phytosterol
491482|NCT00153751|Traditional Chinese Medicine|traditional chinese medicine
491483|NCT00153764|supplement|supplement
491484|NCT00153764|omega-3 fatty acid|omega-3 fatty acid
491485|NCT00153764|Homocysteine|homocysteine
491486|NCT00153764|LDL cholesterol|ldl cholesterol
491487|NCT00153777|HIV prevention|hiv prevention
491488|NCT00153777|Randomized controlled trial|randomized controlled trial
491489|NCT00153777|Women|women
491490|NCT00153777|Sexually transmitted infections|sexually transmitted infections
491491|NCT00153777|HIV Seronegativity|hiv seronegativity
491492|NCT00153790|green tea|green tea
491493|NCT00153790|weight|weight
491494|NCT00153790|women|women
491495|NCT00153803|Erlotinib|erlotinib
491496|NCT00153803|Tarceva|tarceva
491497|NCT00153803|Web based|web based
491498|NCT00153803|Stage III NSCLC|stage iii nsclc
491499|NCT00153816|Colorectal neoplasms|colorectal neoplasms
491500|NCT00153816|Adenomatous polyps|adenomatous polyps
491501|NCT00153829|Chronic Disease|chronic disease
491502|NCT00153829|Quality of Life|quality of life
491503|NCT00153842|NSCLC|nsclc
491504|NCT00153842|Bexarotene|bexarotene
491505|NCT00153842|Targretin|targretin
491506|NCT00153855|etiology|etiology
491507|NCT00153855|pathology|pathology
491508|NCT00153868|Anemia|anemia
491509|NCT00153868|Cancer|cancer
491510|NCT00153868|Quality of life|quality of life
491511|NCT00153868|Web-based|web-based
491512|NCT00153868|Aranesp|aranesp
491513|NCT00153868|Darbepoetin alfa|darbepoetin alfa
491514|NCT00153881|Esophageal Cancer|esophageal cancer
491515|NCT00153881|Trimodality|trimodality
491516|NCT00153881|Capecitabine|capecitabine
491517|NCT00153881|Xeloda|xeloda
491518|NCT00153881|Gastro-esophageal Neoplasm|gastro-esophageal neoplasm
491519|NCT00153881|Carcinoma of the Esophagus|carcinoma of the esophagus
491520|NCT00153894|Breast cancer survivor|breast cancer survivor
491521|NCT00153894|Insulin levels|insulin levels
490874|NCT00140452|ALS|als
491522|NCT00153894|exercise regimen|exercise regimen
491523|NCT00153894|endurance training|endurance training
491524|NCT00153894|strength training|strength training
491525|NCT00153907|Xeloda|xeloda
491526|NCT00153907|Navelbine|navelbine
491527|NCT00153907|capecitabine|capecitabine
491528|NCT00153907|metastatic breast cancer|metastatic breast cancer
491529|NCT00153920|multiple myeloma|multiple myeloma
491530|NCT00153920|Velcade|velcade
491531|NCT00153920|bortezomib|bortezomib
491532|NCT00153933|Multiple Myeloma|multiple myeloma
491533|NCT00153933|bortezomib|bortezomib
491534|NCT00153933|Revlimid|revlimid
491535|NCT00153933|CC-5013|cc-5013
491536|NCT00153946|Free Radical Scavenger|free radical scavenger
491537|NCT00153946|Selective Thrombin Inhibitor|selective thrombin inhibitor
491538|NCT00153946|Acute ischemic stroke (nonlacunar and noncardioembolic)|acute ischemic stroke (nonlacunar and noncardioembolic)
491539|NCT00153972|Parkinson's disease|parkinson's disease
491540|NCT00153972|Fluoro-Dopa-PET|fluoro-dopa-pet
491541|NCT00153972|Dopamine agonists|dopamine agonists
491542|NCT00153972|Cabergoline|cabergoline
491543|NCT00153972|Surrogate marker|surrogate marker
491544|NCT00153972|Dopamine turnover|dopamine turnover
491545|NCT00153985|Hemoglobinopathies|hemoglobinopathies
491546|NCT00153985|Sickle cell anemia|sickle cell anemia
491547|NCT00153985|sickle cell-hemoglobin C disease|sickle cell-hemoglobin c disease
491548|NCT00153985|sickle cell-B-thalassemia|sickle cell-b-thalassemia
491549|NCT00153985|transfusion-dependant thalassemia|transfusion-dependant thalassemia
491550|NCT00153985|allogeneic transplant|allogeneic transplant
491551|NCT00153985|nonmyeloablative transplant|nonmyeloablative transplant
491552|NCT00153985|Stem cell transfusion|stem cell transfusion
491553|NCT00153985|graft vs. host disease|graft vs. host disease
491554|NCT00153998|Cetuximab|cetuximab
491555|NCT00153998|Oxaliplatin|oxaliplatin
491556|NCT00153998|Irinotecan|irinotecan
491557|NCT00153998|5-FU|5-fu
491558|NCT00153998|Chemotherapy|chemotherapy
491559|NCT00153998|Resection|resection
491560|NCT00153998|Liver resection|liver resection
491561|NCT00153998|Neoadjuvant|neoadjuvant
491562|NCT00154011|vascular reactivity, venodilation|vascular reactivity, venodilation
491563|NCT00154024|venoconstriction|venoconstriction
491564|NCT00154024|venodilation|venodilation
491565|NCT00154024|pleiotropic effects|pleiotropic effects
491566|NCT00154037|vascular reactivity|vascular reactivity
491567|NCT00154037|venodilation|venodilation
491568|NCT00154037|pulse wave velocity|pulse wave velocity
491569|NCT00154050|restenosis|restenosis
491570|NCT00154050|intima hyperproliferation|intima hyperproliferation
491571|NCT00154050|stent angioplasty|stent angioplasty
491572|NCT00154050|pain-free walking distance|pain-free walking distance
491573|NCT00154089|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
491574|NCT00154089|CIN|cin
491575|NCT00154089|HPV|hpv
491576|NCT00154102|Metastatic colorectal cancer|metastatic colorectal cancer
491577|NCT00154102|EGFR|egfr
491578|NCT00154102|Irinotecan|irinotecan
491579|NCT00154102|cetuximab|cetuximab
491580|NCT00154102|first-line treatment|first-line treatment
491581|NCT00154115|heart failure|heart failure
491582|NCT00154115|levosimendan|levosimendan
491583|NCT00154115|cardiac surgery|cardiac surgery
491584|NCT00154128|temporomandibular disorder|temporomandibular disorder
491585|NCT00154128|craniomandibular disorder|craniomandibular disorder
491586|NCT00154128|occlusal appliance|occlusal appliance
491587|NCT00154128|clinical trial|clinical trial
491588|NCT00154154|borderline personality disorder|borderline personality disorder
491589|NCT00154154|BPD|bpd
491590|NCT00154154|treatment|treatment
491591|NCT00154154|dialectical behavior therapy|dialectical behavior therapy
491592|NCT00154154|DBT|dbt
491593|NCT00154154|general Psychiatric management|general psychiatric management
491594|NCT00154154|GPM|gpm
491595|NCT00154154|suicide|suicide
491596|NCT00154154|parasuicide|parasuicide
491597|NCT00154154|randomized control trials|randomized control trials
491598|NCT00154180|Perimenopause|perimenopause
491599|NCT00154180|Coronary Disease|coronary disease
491600|NCT00154180|Estrogen Replacement Therapy|estrogen replacement therapy
491601|NCT00154180|Hormone Replacement Therapy|hormone replacement therapy
491602|NCT00154193|Heart transplant, lung transplant, renal function, cyclosporine C2 Levels|heart transplant, lung transplant, renal function, cyclosporine c2 levels
491603|NCT00154206|Enteric-coated mycophenolate sodium,|enteric-coated mycophenolate sodium,
491604|NCT00154206|de novo,|de novo,
491605|NCT00154206|renal transplantation,|renal transplantation,
491606|NCT00154206|pediatric|pediatric
491607|NCT00154206|De novo pediatric renal transplantation|de novo pediatric renal transplantation
491608|NCT00154219|Osteoarthritis, Hip, Lumiracoxib, Efficacy, Safety|osteoarthritis, hip, lumiracoxib, efficacy, safety
491609|NCT00154232|Renal transplantation, DGF, basiliximab, EC-MPS, cyclosporine|renal transplantation, dgf, basiliximab, ec-mps, cyclosporine
491610|NCT00154245|Enteric-coated mycophenolate sodium, transplantation, de novo, cyclosporine|enteric-coated mycophenolate sodium, transplantation, de novo, cyclosporine
753031|NCT01175161|Immediate postpartum IUD|immediate postpartum iud
490977|NCT00149357|VTE|vte
491611|NCT00154258|Schizophrenia, treatment-resistant, clozapine|schizophrenia, treatment-resistant, clozapine
491612|NCT00154271|Hypertension (HTN)|hypertension (htn)
491613|NCT00154271|High Sensitivity C-Reactive Protein|high sensitivity c-reactive protein
491614|NCT00154284|Renal transplantation,|renal transplantation,
491615|NCT00154284|everolimus,|everolimus,
491616|NCT00154284|immunosuppressants,|immunosuppressants,
491617|NCT00154284|basiliximab,|basiliximab,
491618|NCT00154284|cyclosporine microemulsion discontinuation, cyclosporine microemulsion minimization|cyclosporine microemulsion discontinuation, cyclosporine microemulsion minimization
491619|NCT00154297|Renal transplantation|renal transplantation
491620|NCT00154297|everolimus|everolimus
491621|NCT00154297|immunosuppressants|immunosuppressants
491622|NCT00154297|wound-healing|wound-healing
491623|NCT00154310|Renal transplantation, everolimus, immunosuppressants, CNI-free|renal transplantation, everolimus, immunosuppressants, cni-free
491624|NCT00154323|Oxcarbazepine, bipolar disorder|oxcarbazepine, bipolar disorder
491625|NCT00154336|Rheumatoid arthritis, imatinib, methotrexate|rheumatoid arthritis, imatinib, methotrexate
491626|NCT00154349|Ph+ALL|ph+all
491627|NCT00154349|imatinib mesylate|imatinib mesylate
491628|NCT00154362|Oxcarbazepine, conduct disorder, adolescents|oxcarbazepine, conduct disorder, adolescents
491629|NCT00154375|Open label|open label
491630|NCT00154375|Imatinib mesylate|imatinib mesylate
491631|NCT00154375|hydroxyurea|hydroxyurea
491632|NCT00154375|temozolomide|temozolomide
491633|NCT00154375|resistant|resistant
491634|NCT00154375|protein tyrosine kinases|protein tyrosine kinases
491635|NCT00154375|adenocarcinoma|adenocarcinoma
491636|NCT00154375|glioblastoma multiforme|glioblastoma multiforme
491637|NCT00154375|astrocytoma|astrocytoma
491638|NCT00154375|brain tumor|brain tumor
491639|NCT00154375|brain cancer|brain cancer
491640|NCT00154388|adenocarcinoma|adenocarcinoma
491641|NCT00154388|leiomyosarcoma|leiomyosarcoma
491642|NCT00154388|angiosarcoma|angiosarcoma
491643|NCT00154388|synovial sarcoma|synovial sarcoma
491644|NCT00154388|myelodysplastic syndrome/HES|myelodysplastic syndrome/hes
491645|NCT00154388|CMML|cmml
491646|NCT00154388|multiple myeloma|multiple myeloma
491647|NCT00154388|embryonal rhabdomyosarcoma|embryonal rhabdomyosarcoma
491648|NCT00154388|endometrial sarcoma|endometrial sarcoma
491649|NCT00154388|adenoid cystic carcinoma|adenoid cystic carcinoma
491650|NCT00154388|fibromatosis|fibromatosis
491651|NCT00154388|ductal invasive breast carcinoma|ductal invasive breast carcinoma
491652|NCT00154388|chondrosarcoma|chondrosarcoma
491653|NCT00154388|pleural tumor|pleural tumor
491654|NCT00154388|brenner tumor|brenner tumor
491655|NCT00154388|ewing sarcoma|ewing sarcoma
491656|NCT00154388|round cell tumor|round cell tumor
491657|NCT00154388|seminoma|seminoma
491658|NCT00154388|thymic carcinoma|thymic carcinoma
491659|NCT00154388|malignant melanoma|malignant melanoma
491660|NCT00154388|fibrosarcoma breast|fibrosarcoma breast
491661|NCT00154388|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
491662|NCT00154388|DFSP|dfsp
491663|NCT00154388|ovarian stromal tumor|ovarian stromal tumor
491664|NCT00154388|osteosarcoma|osteosarcoma
491665|NCT00154388|chorioideal melanoma|chorioideal melanoma
491666|NCT00154388|hemangiopericytoma|hemangiopericytoma
491667|NCT00154388|myelofibrosis|myelofibrosis
491668|NCT00154388|liposarcoma|liposarcoma
491669|NCT00154388|SCLC|sclc
491670|NCT00154388|small cell lung carcinoma|small cell lung carcinoma
491671|NCT00154388|hypereosinophilic syndrome|hypereosinophilic syndrome
491672|NCT00154388|chronic myelo-monocytic leukemia|chronic myelo-monocytic leukemia
491673|NCT00154388|neurofibrosarcoma|neurofibrosarcoma
491674|NCT00154388|mesothelioma|mesothelioma
491675|NCT00154388|malignant mesenchymoma|malignant mesenchymoma
491676|NCT00154388|malignant schwannoma|malignant schwannoma
491677|NCT00154388|mast cell leukemia / mastocytosis|mast cell leukemia / mastocytosis
491678|NCT00154388|renal cell carcinoma|renal cell carcinoma
491679|NCT00154388|malignant histocytoma|malignant histocytoma
491680|NCT00154388|chordoma|chordoma
491681|NCT00154440|primary gastric MALT lymphoma|primary gastric malt lymphoma
491682|NCT00154440|Helicobacter pylori|helicobacter pylori
491683|NCT00154440|eradication therapy|eradication therapy
491684|NCT00154440|radiation|radiation
491685|NCT00154440|marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
491686|NCT00154440|Mucosa-associated Lymphoid Tissue|mucosa-associated lymphoid tissue
491687|NCT00154440|B-cell Non-Hodgkin's Lymphoma of the stomach|b-cell non-hodgkin's lymphoma of the stomach
491688|NCT00154440|primary gastric lymphoma|primary gastric lymphoma
491689|NCT00154453|Aging|aging
491690|NCT00154453|Orbicularis oculi|orbicularis oculi
491691|NCT00154453|Blepharoplasty|blepharoplasty
491692|NCT00154453|Myosin heavy chain (MHC)|myosin heavy chain (mhc)
491693|NCT00154466|Myocardial infarction, stem cell, cardiac rehabilitation|myocardial infarction, stem cell, cardiac rehabilitation
491694|NCT00154479|Cervical cancer|cervical cancer
491695|NCT00154479|Human papillomavirus|human papillomavirus
491696|NCT00154479|Human leukocyte antigen|human leukocyte antigen
491697|NCT00154479|immunologic response|immunologic response
491015|NCT00149422|NT-proBNP|nt-probnp
491698|NCT00154479|healthy volunteers|healthy volunteers
491699|NCT00154492|Active variceal bleeding in patients with advanced cirrhosis|active variceal bleeding in patients with advanced cirrhosis
491700|NCT00154505|Scoliosis|scoliosis
491701|NCT00154505|Spinal Cord Injury|spinal cord injury
491702|NCT00154505|Lateral Trunk Support|lateral trunk support
491703|NCT00154505|Radiography|radiography
491704|NCT00154518|orthodontic tooth movement|orthodontic tooth movement
491705|NCT00154518|matrix metalloproteinase|matrix metalloproteinase
491706|NCT00154518|Orthodontics|orthodontics
491707|NCT00154557|Judo, Performance, Injury|judo, performance, injury
491708|NCT00154570|reflux esophagitis|reflux esophagitis
491709|NCT00154570|24 hour esophageal pH|24 hour esophageal ph
491710|NCT00154570|electrogastrography (EGG)|electrogastrography (egg)
491711|NCT00154570|Running Spectral Analysis (RSA)|running spectral analysis (rsa)
491712|NCT00154583|cervical cancer|cervical cancer
491713|NCT00154583|human papillomavirus|human papillomavirus
491714|NCT00154583|cancer vaccine|cancer vaccine
491715|NCT00154583|normal volunteer|normal volunteer
491716|NCT00154596|etiology|etiology
491717|NCT00154596|transmission|transmission
491718|NCT00154596|vasculitis|vasculitis
491719|NCT00154596|household|household
491720|NCT00154596|etiology of disease|etiology of disease
491721|NCT00154622|musculoskeletal disorder, work hardening, return to work|musculoskeletal disorder, work hardening, return to work
491722|NCT00154635|Alzheimer's disease|alzheimer's disease
491723|NCT00154635|Fo-ti|fo-ti
491724|NCT00154635|Chinese herbs|chinese herbs
491726|NCT00154648|DSA|dsa
491727|NCT00154648|gadovist|gadovist
491728|NCT00154648|angiography|angiography
491729|NCT00154661|glomerulonephritis|glomerulonephritis
491730|NCT00154687|Combination, Chemotherapy,transitional cell carcinoma|combination, chemotherapy,transitional cell carcinoma
491731|NCT00154700|Combination,Chemotherapy,Esophageal Cancer|combination,chemotherapy,esophageal cancer
491732|NCT00154713|colorectal cancer|colorectal cancer
491733|NCT00154713|dendritic cell|dendritic cell
491734|NCT00154713|CEA|cea
491735|NCT00154713|IL-2|il-2
491831|NCT00155272|Dynamic contrast enhanced MRI|dynamic contrast enhanced mri
491725|NCT00154648|MRA|mra
491736|NCT00154726|Paclitaxel-HDFL,Locally Advanced and Recurrent/Metastatic Gastric Cancer|paclitaxel-hdfl,locally advanced and recurrent/metastatic gastric cancer
491737|NCT00154739|Combination, Chemotherapy,non-small cell lung cancer|combination, chemotherapy,non-small cell lung cancer
491738|NCT00154752|Rectal cancer, CCRT, Pelvic lymphadenoectomy.|rectal cancer, ccrt, pelvic lymphadenoectomy.
491739|NCT00154778|Combination,Chemotherapy,Advanced Gastric Cancer|combination,chemotherapy,advanced gastric cancer
491740|NCT00154791|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
491741|NCT00154791|Oxaliplatin|oxaliplatin
491742|NCT00154791|Gemcitabine|gemcitabine
491743|NCT00154791|5-FU|5-fu
491744|NCT00154804|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
491745|NCT00154804|Esophageal Cancer|esophageal cancer
491746|NCT00154817|radiotherapy|radiotherapy
491747|NCT00154817|dynamic contrast enhanced MRI|dynamic contrast enhanced mri
491748|NCT00154817|hepatocellular carcinoma|hepatocellular carcinoma
491749|NCT00154843|Lycopene|lycopene
491750|NCT00154843|BPH|bph
491751|NCT00154843|PSA|psa
491752|NCT00154843|IPSS|ipss
491753|NCT00154856|osteogenesis|osteogenesis
491754|NCT00154856|Ilizarov fixator|ilizarov fixator
491755|NCT00154856|motion analysis|motion analysis
491756|NCT00154856|FEM|fem
491757|NCT00154856|bone stress|bone stress
491758|NCT00154869|Patients with dual chronic hepatitis B and C|patients with dual chronic hepatitis b and c
491759|NCT00154882|Breast Cancer|breast cancer
491760|NCT00154882|First-line|first-line
491761|NCT00154895|minocycline|minocycline
491762|NCT00154895|pleurodesis|pleurodesis
491763|NCT00154895|thoracoscopy|thoracoscopy
491764|NCT00154895|primary spontaneous pneumothorax|primary spontaneous pneumothorax
491765|NCT00154895|clinical trial|clinical trial
491766|NCT00154960|Spinal muscular atrophy (SMA)|spinal muscular atrophy (sma)
491767|NCT00154960|SMN1/SMN2 gene|smn1/smn2 gene
491768|NCT00154960|denaturing high-performance liquid chromatography (DHPLC)|denaturing high-performance liquid chromatography (dhplc)
491769|NCT00154960|multiplex PCR|multiplex pcr
491770|NCT00154960|gene dose|gene dose
491771|NCT00154960|carrier test|carrier test
491772|NCT00154960|screen|screen
491773|NCT00154960|stool|stool
491774|NCT00154960|microsatellite|microsatellite
491775|NCT00154973|oral precancers|oral precancers
491776|NCT00154973|oral cancer|oral cancer
491777|NCT00154973|hypoxia-inducible factor|hypoxia-inducible factor
491778|NCT00154986|invasion|invasion
491779|NCT00154986|migration|migration
491780|NCT00154986|metastasis|metastasis
491781|NCT00154986|IGFBP-3|igfbp-3
491782|NCT00154986|transfection|transfection
491783|NCT00154986|signal transduction.|signal transduction.
491784|NCT00154999|hyperbilirubinemia|hyperbilirubinemia
491785|NCT00154999|free radicals|free radicals
491786|NCT00154999|Health neonate|health neonate
491787|NCT00155025|Prostatic neoplasms|prostatic neoplasms
491788|NCT00155025|Family history|family history
753032|NCT01175174|asthma|asthma
491789|NCT00155038|Breast neoplasms|breast neoplasms
491790|NCT00155038|breast radiography|breast radiography
491791|NCT00155038|young women.|young women.
491792|NCT00155064|Primary aldosteronism|primary aldosteronism
491793|NCT00155064|kallikrein|kallikrein
491794|NCT00155064|aldosterone|aldosterone
491795|NCT00155064|captopril|captopril
491796|NCT00155077|cervical cancer, chemoradiotherapy, angiogenesis|cervical cancer, chemoradiotherapy, angiogenesis
491797|NCT00155090|Magnetic resonance imaging,|magnetic resonance imaging,
491798|NCT00155090|breast disease|breast disease
491799|NCT00155103|Hepatitis B|hepatitis b
491800|NCT00155103|Carcinoma, Hepatocellular|carcinoma, hepatocellular
491801|NCT00155103|Polymorphism, Genetic|polymorphism, genetic
491802|NCT00155129|migraine|migraine
491803|NCT00155129|CGRP|cgrp
491804|NCT00155129|nociceptin|nociceptin
491805|NCT00155168|Spinal muscular atrophy (SMA)|spinal muscular atrophy (sma)
491806|NCT00155168|SMN1/SMN2 gene|smn1/smn2 gene
491807|NCT00155168|denaturing high-performance liquid chromatography (DHPLC)|denaturing high-performance liquid chromatography (dhplc)
491808|NCT00155168|multiplex PCR|multiplex pcr
491809|NCT00155168|gene dose|gene dose
491810|NCT00155168|carrier test|carrier test
491811|NCT00155181|Epstein-Barr virus|epstein-barr virus
491812|NCT00155181|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
491813|NCT00155181|Carcinogenesis|carcinogenesis
491814|NCT00155207|Schizophrenia|schizophrenia
491815|NCT00155207|endophenotype|endophenotype
491816|NCT00155207|risk genetic mutation|risk genetic mutation
491817|NCT00155207|vulnerability genes|vulnerability genes
491818|NCT00155207|affected sib-pairs|affected sib-pairs
491819|NCT00155207|case-control design|case-control design
491820|NCT00155207|animal model|animal model
491821|NCT00155207|functional validity|functional validity
491822|NCT00155207|genetic epidemiological analysis|genetic epidemiological analysis
491823|NCT00155233|analgeisa|analgeisa
491824|NCT00155233|postoperatve|postoperatve
491825|NCT00155233|side effects|side effects
491826|NCT00155246|CKD, pentoxifylline|ckd, pentoxifylline
491827|NCT00155259|Breast Cancer , Neoadjuvant Chemotherapy|breast cancer , neoadjuvant chemotherapy
491828|NCT00155272|Hepatocellular Carcinoma|hepatocellular carcinoma
491829|NCT00155272|Radiotherapy|radiotherapy
491830|NCT00155272|Thalidomide|thalidomide
491832|NCT00155285|heart diseases|heart diseases
491833|NCT00155285|congenital|congenital
491834|NCT00155311|orthodontic tooth movement|orthodontic tooth movement
491835|NCT00155311|OPG|opg
491836|NCT00155311|RANKL|rankl
491837|NCT00155324|plantar fasciitis|plantar fasciitis
491838|NCT00155324|ultrasonographic examination|ultrasonographic examination
491839|NCT00155337|leukoplakia|leukoplakia
491840|NCT00155337|erythroleukoplakia|erythroleukoplakia
491841|NCT00155337|photodynamic therapy|photodynamic therapy
491842|NCT00155350|atherosclerosis|atherosclerosis
491843|NCT00155350|calcification|calcification
491844|NCT00155350|coronary|coronary
491845|NCT00155350|inflammation|inflammation
491846|NCT00155350|insulin|insulin
491847|NCT00155350|plaque|plaque
491848|NCT00155350|Coronary calcification|coronary calcification
491849|NCT00155350|Plaque vulnerability|plaque vulnerability
491850|NCT00155389|Helicobacter pylori|helicobacter pylori
491851|NCT00155389|Gastric cancer|gastric cancer
491852|NCT00155389|single nucleotide polymorphism|single nucleotide polymorphism
491853|NCT00155402|fibrin glue|fibrin glue
491854|NCT00155402|corneal perforation|corneal perforation
491855|NCT00155402|pterygium|pterygium
491856|NCT00155402|conjunctiva|conjunctiva
491857|NCT00155402|corneal ulcer|corneal ulcer
491858|NCT00155415|Colonoscopy|colonoscopy
491859|NCT00155415|Polyethylene glycol(PEG)|polyethylene glycol(peg)
491860|NCT00155415|Colon neoplasm|colon neoplasm
491861|NCT00155415|Colon cleansing|colon cleansing
491862|NCT00155415|Timing|timing
491863|NCT00155428|biomodel|biomodel
491864|NCT00155428|rapid prototyping|rapid prototyping
491865|NCT00155428|computed tomograpgy|computed tomograpgy
491866|NCT00155441|sleep disorder|sleep disorder
491867|NCT00155441|peritoneal dialysis|peritoneal dialysis
491868|NCT00155441|cognitive-behavioral therapy|cognitive-behavioral therapy
491869|NCT00155441|sleep disorder:C23.888.592.796|sleep disorder:c23.888.592.796
491870|NCT00155441|peritoneal dialysis: F03.870.664|peritoneal dialysis: f03.870.664
491871|NCT00155454|Diabetic retinopathy|diabetic retinopathy
491872|NCT00155454|Vitrectomy|vitrectomy
491873|NCT00155454|Postoperative vitreous hemorrahge|postoperative vitreous hemorrahge
491874|NCT00155454|Intravitreal gas injection|intravitreal gas injection
491875|NCT00155467|CT|ct
491876|NCT00155467|children|children
491877|NCT00155467|congenital|congenital
491878|NCT00155480|thoracic aorta|thoracic aorta
491879|NCT00155480|finite element mesh|finite element mesh
491880|NCT00155506|Schizophrenia|schizophrenia
491881|NCT00155506|Niacin|niacin
491882|NCT00155506|Genotyping|genotyping
491883|NCT00155506|candidate gene|candidate gene
491884|NCT00155506|one proband, normal parents and one normal sibling|one proband, normal parents and one normal sibling
491885|NCT00155519|Schizophrenia|schizophrenia
491886|NCT00155519|Latent Schizophrenia|latent schizophrenia
491887|NCT00155519|Schizotypal Disorder|schizotypal disorder
491888|NCT00155519|Psychopathology|psychopathology
491889|NCT00155519|Neuropsychological Function|neuropsychological function
491890|NCT00155519|Family History|family history
491891|NCT00155519|Nosology|nosology
491892|NCT00155519|basic symptoms|basic symptoms
491893|NCT00155532|Peripheral neuropathy;systemic lupus erythematosus|peripheral neuropathy;systemic lupus erythematosus
491894|NCT00155545|functional scoliosis|functional scoliosis
491895|NCT00155545|idiopathic scoliosis|idiopathic scoliosis
491896|NCT00155545|leg length discrepancy|leg length discrepancy
491897|NCT00155545|motion analysis|motion analysis
491898|NCT00155545|biomechanics|biomechanics
491899|NCT00155558|Colorectal Cancer, Maximum tolerated dose|colorectal cancer, maximum tolerated dose
491900|NCT00155571|betel nut|betel nut
491901|NCT00155571|periodontitis|periodontitis
491902|NCT00155571|periodontal microbiology|periodontal microbiology
491903|NCT00155584|warts|warts
491904|NCT00155584|photodynamic therapy|photodynamic therapy
491905|NCT00155584|5-ALA|5-ala
491906|NCT00155597|physical therapy|physical therapy
491907|NCT00155597|post surgery|post surgery
491908|NCT00155610|diabetic cystopathy|diabetic cystopathy
491909|NCT00155610|bladder|bladder
491910|NCT00155610|voiding dysfunction|voiding dysfunction
491911|NCT00155610|current perception test|current perception test
491912|NCT00155623|H. pylori, 13C-urea breath test, serology, epidemiology|h. pylori, 13c-urea breath test, serology, epidemiology
491913|NCT00155636|Schizophrenia|schizophrenia
491914|NCT00155649|schizophrenia|schizophrenia
491915|NCT00155649|vulnerability gene|vulnerability gene
491916|NCT00155649|positional cloning|positional cloning
491917|NCT00155649|subtype definition|subtype definition
491918|NCT00155649|endophenotype|endophenotype
491919|NCT00155649|genetic marker|genetic marker
491920|NCT00155649|genetic linkage|genetic linkage
491921|NCT00155649|candidate genes|candidate genes
491922|NCT00155662|work hardening|work hardening
491923|NCT00155662|chronic low back pain over 3 months|chronic low back pain over 3 months
491924|NCT00155688|Schizophrenia|schizophrenia
491925|NCT00155688|linkage|linkage
491926|NCT00155688|Taiwan|taiwan
491927|NCT00155688|Han Chinese population|han chinese population
491928|NCT00155701|DISC1|disc1
491929|NCT00155701|Schizophrenia|schizophrenia
491930|NCT00155701|Chromosome 1q|chromosome 1q
491931|NCT00155701|Polymorphism detection|polymorphism detection
491932|NCT00155701|Association study|association study
491933|NCT00155701|Balanced translocation|balanced translocation
491934|NCT00155701|DHPLC|dhplc
491935|NCT00155714|pulmonary arterial hypertension|pulmonary arterial hypertension
491936|NCT00155714|type-5 phosphodiesterase Inhibitors|type-5 phosphodiesterase inhibitors
491937|NCT00155714|Sildenafil|sildenafil
491938|NCT00155727|colorectal cancer, laparoscopic colectomy|colorectal cancer, laparoscopic colectomy
491939|NCT00155740|ovarian cancer|ovarian cancer
491940|NCT00155740|tumor marker|tumor marker
491941|NCT00155740|mesothelin|mesothelin
491942|NCT00155753|pathological myopia, genomic|pathological myopia, genomic
491943|NCT00155766|cervical cancer, immunotherapy, DC|cervical cancer, immunotherapy, dc
491944|NCT00155779|adult respiratory distress syndrome|adult respiratory distress syndrome
491945|NCT00155779|angiotensin-converting enzyme|angiotensin-converting enzyme
491946|NCT00155779|polymorphism|polymorphism
491947|NCT00155792|ervical cancer, human papillomavirus, immunotherapy|ervical cancer, human papillomavirus, immunotherapy
491948|NCT00155805|Gastroesophageal reflux disease|gastroesophageal reflux disease
491949|NCT00155805|reflux esophagitis|reflux esophagitis
491950|NCT00155805|nonerosive reflux disease|nonerosive reflux disease
491951|NCT00155805|Barrett’s esophagus|barrett’s esophagus
491952|NCT00155805|hiatus hernia|hiatus hernia
491953|NCT00155805|lower esophageal sphincter pressure|lower esophageal sphincter pressure
491954|NCT00155805|24 hours esophageal pH monitor|24 hours esophageal ph monitor
491955|NCT00155805|Helicobacter pylori|helicobacter pylori
491956|NCT00155818|DISC1|disc1
491957|NCT00155818|Schizophrenia|schizophrenia
491958|NCT00155818|Chromosome 1q|chromosome 1q
491959|NCT00155818|Polymorphism detection|polymorphism detection
491960|NCT00155818|Association study|association study
491961|NCT00155818|Balanced translocation|balanced translocation
491962|NCT00155818|DHPLC|dhplc
491963|NCT00155831|Premature infants|premature infants
491964|NCT00155831|Kicking|kicking
491965|NCT00155831|Stepping|stepping
491966|NCT00155831|Walking|walking
491967|NCT00155831|Motor development|motor development
491968|NCT00155831|Kinematics|kinematics
491969|NCT00155857|glaucoma, genetic|glaucoma, genetic
491970|NCT00155870|laparoscopic assisted vaginal hysterectomy leiomyoma|laparoscopic assisted vaginal hysterectomy leiomyoma
491971|NCT00155870|adenomyosis|adenomyosis
491972|NCT00155870|quality of life|quality of life
491973|NCT00155896|BRCA1 gene, BRCA2 gene, DHPLC, genetic diagnosis|brca1 gene, brca2 gene, dhplc, genetic diagnosis
491974|NCT00155909|Radiation Pneumonitis|radiation pneumonitis
491975|NCT00155909|Radiotherapy Planning, Computer-Assisted|radiotherapy planning, computer-assisted
491976|NCT00155922|Diabetes mellitus|diabetes mellitus
634432|NCT00711230|HIV|hiv
491293|NCT00150943|Stent|stent
491977|NCT00155922|Monocyte|monocyte
491978|NCT00155922|Gene expression|gene expression
491979|NCT00155922|Monocyte gene expression|monocyte gene expression
491980|NCT00155935|ovarian cancer|ovarian cancer
491981|NCT00155935|immunotherapy|immunotherapy
491982|NCT00155935|folate receptor|folate receptor
491983|NCT00155935|Chemotherapy|chemotherapy
491984|NCT00155948|Ultrasonography|ultrasonography
491985|NCT00155948|Cervical Multifidus|cervical multifidus
491986|NCT00155961|Androgens|androgens
491987|NCT00155961|Metabolic syndrome|metabolic syndrome
491988|NCT00155961|Bone mineral density|bone mineral density
491989|NCT00155961|Body composition|body composition
491990|NCT00155961|Questionnaire|questionnaire
491991|NCT00155974|Influenza|influenza
491992|NCT00155974|Vaccination|vaccination
491993|NCT00155974|Hard-to-Reach Populations|hard-to-reach populations
491994|NCT00155974|Urban|urban
491995|NCT00155974|Disadvantaged|disadvantaged
491996|NCT00155987|Severe diffuse TBI refractory intracranial hypertension.|severe diffuse tbi refractory intracranial hypertension.
491997|NCT00156000|Preterm Delivery|preterm delivery
491998|NCT00156000|Multifetal pregnancy|multifetal pregnancy
491999|NCT00156000|Preterm Birth|preterm birth
492000|NCT00156000|17-alpha Hydroxyprogesterone Caproate|17-alpha hydroxyprogesterone caproate
492001|NCT00156000|Markers of Preterm Birth|markers of preterm birth
492002|NCT00156013|B-Cell NHL|b-cell nhl
492003|NCT00156026|CIN 1|cin 1
492004|NCT00156026|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
492005|NCT00156026|cervix|cervix
492006|NCT00156026|cancer|cancer
492007|NCT00156026|loop electrosurgical excision procedure|loop electrosurgical excision procedure
492008|NCT00156026|LEEP|leep
492009|NCT00156026|expectant management|expectant management
492010|NCT00156026|human papilloma virus|human papilloma virus
492011|NCT00156026|HPV|hpv
492012|NCT00156026|colposcopy|colposcopy
492013|NCT00156039|Breast Cancer|breast cancer
492014|NCT00156039|Follow-up Strategy|follow-up strategy
492015|NCT00156039|Follow-up Care|follow-up care
492016|NCT00156039|Family Physician|family physician
492017|NCT00156039|Oncologist|oncologist
492018|NCT00156052|Breast Cancer|breast cancer
492019|NCT00156052|Hypofractionated Radiotherapy|hypofractionated radiotherapy
492020|NCT00156052|Lumpectomy|lumpectomy
492021|NCT00156130|Breast Cancer|breast cancer
492022|NCT00156130|Lumpectomy|lumpectomy
492023|NCT00156130|Radiotherapy|radiotherapy
492024|NCT00156130|Hypofractionated Radiotherapy|hypofractionated radiotherapy
492025|NCT00156130|Long Term Outcomes|long term outcomes
492026|NCT00146302|Non-specific effects of vaccines|non-specific effects of vaccines
492027|NCT00146302|Infant mortality|infant mortality
492028|NCT00146302|Morbidity|morbidity
492029|NCT00146302|Low income country|low income country
492030|NCT00146302|BCG|bcg
492031|NCT00146302|Vaccine policy|vaccine policy
492032|NCT00146302|immunisation|immunisation
492033|NCT00146302|Low birth weight|low birth weight
492034|NCT00146302|Tuberculin|tuberculin
492035|NCT00146302|Mortality|mortality
492036|NCT00146315|Primary Health Care|primary health care
492037|NCT00146315|Family Practice|family practice
492038|NCT00146315|Family Physician|family physician
492039|NCT00146315|Exercise|exercise
492040|NCT00146315|Coronary Heart Disease|coronary heart disease
492041|NCT00146315|Randomized Controlled Trials|randomized controlled trials
492042|NCT00146315|Multicenter Studies|multicenter studies
492043|NCT00146354|Electronic Medical Record|electronic medical record
492044|NCT00146354|Electronic Results Tracking|electronic results tracking
492045|NCT00146354|Patient Safety|patient safety
492046|NCT00146354|Post-Discharge Test Results|post-discharge test results
492047|NCT00146367|arthritis|arthritis
492048|NCT00146367|osteoarthritis|osteoarthritis
492049|NCT00146367|rheumatoid arthritis|rheumatoid arthritis
492050|NCT00146367|rheumatic disease|rheumatic disease
492051|NCT00146367|exercise|exercise
492052|NCT00146367|physical activity|physical activity
492053|NCT00146367|physical function|physical function
492054|NCT00146367|disability|disability
492055|NCT00146380|Prevention Mother-to-Child HIV transmission|prevention mother-to-child hiv transmission
492056|NCT00146380|HIV Seronegativity|hiv seronegativity
492057|NCT00146393|exercise|exercise
492058|NCT00146393|physical activity|physical activity
492059|NCT00146393|physical conditioning|physical conditioning
492060|NCT00146393|pain|pain
492061|NCT00146393|physical function|physical function
492062|NCT00146406|Adolescent Health|adolescent health
492063|NCT00146406|Sexually Transmitted Disease|sexually transmitted disease
492064|NCT00146406|Sexual Behavior|sexual behavior
492065|NCT00146718|malaria|malaria
492066|NCT00146718|drug resistance|drug resistance
492067|NCT00146718|antimalarials|antimalarials
492068|NCT00146731|malaria|malaria
492069|NCT00146731|pregnancy|pregnancy
492070|NCT00146731|treatment|treatment
492071|NCT00146731|Africa|africa
492072|NCT00146731|Tanzania|tanzania
491387|NCT00151541|Dapsone Topical Gel|dapsone topical gel
492073|NCT00146783|intermittent preventive treatment|intermittent preventive treatment
492074|NCT00146783|malaria|malaria
492075|NCT00146783|pregnancy|pregnancy
492076|NCT00146783|efficacy|efficacy
492077|NCT00146783|safety|safety
492078|NCT00146796|Malaria|malaria
492079|NCT00146796|Diagnosis|diagnosis
492080|NCT00146796|RDT|rdt
492081|NCT00146796|Africa|africa
492082|NCT00146796|Tanzania|tanzania
492083|NCT00146809|Multi-System-Atrophy|multi-system-atrophy
492084|NCT00146809|Minocycline|minocycline
492085|NCT00146887|Coronary CT|coronary ct
492086|NCT00146887|sensitivity|sensitivity
492087|NCT00146887|specificity|specificity
492088|NCT00146900|Traumatic Events|traumatic events
492089|NCT00146900|Post-traumatic Stress Disorder|post-traumatic stress disorder
492090|NCT00146900|Treatment (psychological)|treatment (psychological)
492091|NCT00146900|Treatment (pharmacological)|treatment (pharmacological)
492092|NCT00146900|Prevention|prevention
492093|NCT00146900|SSRIs|ssris
492094|NCT00146913|Chronic myeloid leukaemia|chronic myeloid leukaemia
492095|NCT00146913|resistant|resistant
492096|NCT00146913|refractory|refractory
492097|NCT00146913|Imatinib mesylate|imatinib mesylate
492098|NCT00146926|Propofol|propofol
492099|NCT00146926|pain|pain
492100|NCT00146926|general anesthesia|general anesthesia
492101|NCT00146926|prevention|prevention
492102|NCT00146952|Hemineglects|hemineglects
492103|NCT00147004|Septic shock|septic shock
492104|NCT00147004|Steroids|steroids
492105|NCT00147004|Hydrocortisone|hydrocortisone
492106|NCT00147004|Mortality|mortality
492107|NCT00147004|Reversal of shock|reversal of shock
492108|NCT00147004|Adrenal insufficiency|adrenal insufficiency
492109|NCT00147017|macrophage|macrophage
492110|NCT00147017|inflammation|inflammation
492111|NCT00147017|COPD|copd
492112|NCT00147030|Hypoxia|hypoxia
492113|NCT00147030|Ischaemia|ischaemia
492114|NCT00147030|Encephalopathy|encephalopathy
492115|NCT00147030|Neonatal|neonatal
492116|NCT00147030|Hypothermia|hypothermia
492117|NCT00147030|Perinatal|perinatal
492118|NCT00147030|Cooling|cooling
492119|NCT00147030|Whole/Total Body|whole/total body
492120|NCT00147043|Adult stem cells|adult stem cells
492121|NCT00147043|Liver disease|liver disease
492122|NCT00147043|CD34 positive cells|cd34 positive cells
492123|NCT00147056|Brain tumor|brain tumor
492124|NCT00147056|Brain Lesions|brain lesions
492125|NCT00147056|Brain Cancer|brain cancer
492126|NCT00147056|ExAblate|exablate
492127|NCT00147069|sputum|sputum
492128|NCT00147069|macrophage|macrophage
492129|NCT00147069|neutrophil|neutrophil
492130|NCT00147082|chemokine|chemokine
492131|NCT00147082|chemokine receptor|chemokine receptor
492133|NCT00147082|lymphocyte|lymphocyte
492134|NCT00147082|monocyte|monocyte
492135|NCT00147095|macrophages|macrophages
492136|NCT00147095|neutrophils|neutrophils
492137|NCT00147095|lymphocytes|lymphocytes
492138|NCT00147108|Breast Cancer|breast cancer
492139|NCT00147121|Rituximab|rituximab
492140|NCT00147121|CHOP|chop
492141|NCT00147121|Bi-weekly|bi-weekly
492142|NCT00147121|low-grade B-cell lymphoma|low-grade b-cell lymphoma
492143|NCT00147121|advanced stage|advanced stage
492144|NCT00147121|follicular lymphoma|follicular lymphoma
492145|NCT00147121|G-CSF|g-csf
492146|NCT00147121|Untreated stage III/IV low-grade B-cell lymphoma|untreated stage iii/iv low-grade b-cell lymphoma
492147|NCT00147134|colorectal cancer|colorectal cancer
492148|NCT00147134|laparoscopic surgery|laparoscopic surgery
492149|NCT00147134|randomized controlled trial|randomized controlled trial
492150|NCT00147134|oncological outcome|oncological outcome
492151|NCT00147147|gastric neoplasm|gastric neoplasm
492152|NCT00147147|gastrectomy|gastrectomy
492153|NCT00147147|adjuvant chemotherapy|adjuvant chemotherapy
492154|NCT00147147|randomized trial|randomized trial
492155|NCT00147147|T3 and T4 carcinoma of the stomach/Gastric Neoplasm|t3 and t4 carcinoma of the stomach/gastric neoplasm
492156|NCT00147199|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
492157|NCT00147212|Advanced Prostate Cancer|advanced prostate cancer
492158|NCT00147212|Prostate Cancer|prostate cancer
492159|NCT00147212|Trabectedin|trabectedin
492160|NCT00147212|ET 743|et 743
492161|NCT00147212|Yondelis|yondelis
492162|NCT00147225|Advanced Cancer|advanced cancer
492163|NCT00147225|Advanced Malignancy|advanced malignancy
492164|NCT00147225|Solid Tumors|solid tumors
492165|NCT00147225|Thrombocytopenia|thrombocytopenia
492166|NCT00147225|AMG 531|amg 531
492167|NCT00147225|Romiplostim|romiplostim
492168|NCT00147225|Carboplatin|carboplatin
492169|NCT00147225|Paraplatin|paraplatin
492170|NCT00147225|Platelets|platelets
492171|NCT00147225|Adriamycin|adriamycin
492172|NCT00147225|Doxorubicin|doxorubicin
492173|NCT00147225|Rubex|rubex
492174|NCT00147225|Ifosfamide|ifosfamide
492175|NCT00147225|Ifex|ifex
492176|NCT00147238|Bladder Cancer|bladder cancer
492177|NCT00147238|Genitourinary Cancer|genitourinary cancer
492178|NCT00147238|Prostate Cancer|prostate cancer
492179|NCT00147238|MR Lymphangiography|mr lymphangiography
492180|NCT00147238|Ferumoxtran-10|ferumoxtran-10
492181|NCT00147238|SPIO|spio
492182|NCT00147238|Ultra-small superparamagnetic agent iron oxide|ultra-small superparamagnetic agent iron oxide
492183|NCT00147251|lowering LDL and BP below current targets|lowering ldl and bp below current targets
492184|NCT00147251|LDL cholesterol treatment|ldl cholesterol treatment
492185|NCT00147251|blood pressure treatment|blood pressure treatment
492186|NCT00147251|carotid intimal medial thickness|carotid intimal medial thickness
492187|NCT00147251|prevent progression of CVD|prevent progression of cvd
492188|NCT00147264|insulin resistance, myocellular lipids, adipose tissue|insulin resistance, myocellular lipids, adipose tissue
492190|NCT00147277|Thachy|thachy
492191|NCT00147277|FVT|fvt
492192|NCT00147290|ATP|atp
492193|NCT00147290|Tachycardia|tachycardia
492194|NCT00147290|CRT-D|crt-d
492195|NCT00147316|acute stroke|acute stroke
492196|NCT00147316|thrombolytic therapy|thrombolytic therapy
492197|NCT00147316|tissue plasminogen activator|tissue plasminogen activator
492198|NCT00147342|exercise|exercise
492199|NCT00147342|hypoglycemia|hypoglycemia
492200|NCT00147342|Diabetes Mellitus, Type I|diabetes mellitus, type i
492201|NCT00147342|glucose monitoring|glucose monitoring
492202|NCT00147355|rIL-2-toxicity|ril-2-toxicity
492203|NCT00147355|interleukin-2 therapy|interleukin-2 therapy
492204|NCT00147355|HIV|hiv
492205|NCT00147355|Toxicity substudy of ESPRIT|toxicity substudy of esprit
492206|NCT00147368|falciparum|falciparum
492207|NCT00147368|malaria|malaria
492208|NCT00147368|arginine|arginine
492209|NCT00147381|Campath-1H|campath-1h
492210|NCT00147381|Alemtuzumab|alemtuzumab
492211|NCT00147381|Tacrolimus|tacrolimus
492212|NCT00147381|renal transplantation|renal transplantation
492213|NCT00147381|immunosuppression|immunosuppression
492214|NCT00147381|prevention of acute rejection|prevention of acute rejection
492215|NCT00147394|Risperidone|risperidone
492216|NCT00147394|Autism|autism
492217|NCT00147394|PDD|pdd
492218|NCT00147394|Pervasive Developmental Disorder|pervasive developmental disorder
492219|NCT00147420|Tibet|tibet
492220|NCT00147420|Third Stage Labor|third stage labor
492221|NCT00147420|Post Partum Hemorrhage|post partum hemorrhage
492222|NCT00147420|Misoprostol|misoprostol
492223|NCT00147420|Zhi Byed 11|zhi byed 11
492224|NCT00147420|Global Network|global network
492225|NCT00147433|free thyroxine|free thyroxine
492226|NCT00147433|pregnancy|pregnancy
492227|NCT00147433|fetal brain development|fetal brain development
492228|NCT00147433|thyroid stimulating hormone|thyroid stimulating hormone
492229|NCT00147433|IQ|iq
492230|NCT00147446|Stress|stress
492231|NCT00147446|Stress Management|stress management
492232|NCT00147446|Behavioral Medicine|behavioral medicine
492233|NCT00147446|Multiple Sclerosis|multiple sclerosis
492234|NCT00147446|Psychoneuroimmunology|psychoneuroimmunology
492235|NCT00147459|hepatitis B virus|hepatitis b virus
492236|NCT00147459|vaccine|vaccine
492237|NCT00147459|booster|booster
492238|NCT00147459|liver transplantation|liver transplantation
492239|NCT00147472|Head and neck|head and neck
492240|NCT00147472|Cancer|cancer
492241|NCT00147472|Diagnosis|diagnosis
492242|NCT00147472|Fluorodeoxyglucose|fluorodeoxyglucose
492243|NCT00147472|Positron-Emission Tomography|positron-emission tomography
492244|NCT00147472|PET|pet
492245|NCT00147472|Oncology|oncology
492246|NCT00147498|oral JAK inhibitor|oral jak inhibitor
492247|NCT00147498|clinical trial|clinical trial
492248|NCT00147498|joint diseases|joint diseases
492249|NCT00147498|anti-Inflammatory agents|anti-inflammatory agents
492250|NCT00147498|rheumatic diseases|rheumatic diseases
492251|NCT00147498|DMARD|dmard
492252|NCT00147498|Antirheumatic Agents|antirheumatic agents
492253|NCT00147498|Autoimmune Diseases|autoimmune diseases
492254|NCT00147498|Immune System Diseases|immune system diseases
492255|NCT00147537|non-small cell lung cancer|non-small cell lung cancer
492256|NCT00147537|chemotherapy|chemotherapy
492257|NCT00147537|figitumumab|figitumumab
492258|NCT00147537|insulin-like growth 1 factor receptor|insulin-like growth 1 factor receptor
492259|NCT00147537|IGF-IR|igf-ir
492260|NCT00147537|monoclonal antibody|monoclonal antibody
492261|NCT00147667|COPD|copd
492262|NCT00147667|EXACERBATIONS|exacerbations
492263|NCT00147667|AIRWAY INFLAMMATION|airway inflammation
492264|NCT00147680|Uterine Papillary Serous Carcinoma (UPSC)|uterine papillary serous carcinoma (upsc)
492265|NCT00147693|Dementia|dementia
492266|NCT00147693|Alzheimer Disease|alzheimer disease
492267|NCT00147693|Lewy-Body|lewy-body
492268|NCT00147693|Cost*|cost*
492269|NCT00147693|Community (dwelling)|community (dwelling)
492270|NCT00147693|Caregiver(s)|caregiver(s)
492271|NCT00147693|Institutionalization|institutionalization
492272|NCT00147693|Quality of life|quality of life
492273|NCT00147693|Randomized Control Trail|randomized control trail
492274|NCT00147693|Vascular dementia|vascular dementia
492275|NCT00147706|Electronic Health Record|electronic health record
492276|NCT00147706|Patient Portal|patient portal
492277|NCT00147706|Chronic Diseases|chronic diseases
634849|NCT00718978|ski|ski
492278|NCT00147719|Diabetes Mellitus|diabetes mellitus
492279|NCT00147732|larynx carcinoma|larynx carcinoma
492280|NCT00147732|radiotherapy|radiotherapy
492281|NCT00147732|carbogen|carbogen
492282|NCT00147732|nicotinamide|nicotinamide
492283|NCT00147745|Mechanism of action insulin sensitivity|mechanism of action insulin sensitivity
492284|NCT00147758|Diabetes Mellitus|diabetes mellitus
492285|NCT00147771|localized scleroderma|localized scleroderma
492286|NCT00147771|morphea|morphea
492287|NCT00147771|imiquimod|imiquimod
492288|NCT00147771|pediatrics|pediatrics
492289|NCT00147784|Chronical Hepatitis C treatment|chronical hepatitis c treatment
492290|NCT00147784|Methadone Maintenance Treatment|methadone maintenance treatment
492291|NCT00147784|Pegylated Interferon and Ribavirin|pegylated interferon and ribavirin
492292|NCT00147784|14 weeks treatment|14 weeks treatment
492293|NCT00147784|Genotype 2 and 3|genotype 2 and 3
492294|NCT00147797|Atherosclerosis|atherosclerosis
492295|NCT00147797|intima media thickness|intima media thickness
492296|NCT00147797|aortic stiffness|aortic stiffness
492297|NCT00147797|HIV infection|hiv infection
492298|NCT00147797|Dyslipidemia|dyslipidemia
492299|NCT00147797|Treatment Experienced|treatment experienced
492300|NCT00147810|telephone outreach|telephone outreach
492301|NCT00147810|asthma care|asthma care
492302|NCT00147823|Bone formation|bone formation
492303|NCT00147823|Bone lesions|bone lesions
492304|NCT00147823|Benign bone lesion|benign bone lesion
492305|NCT00147836|type 2 diabetes mellitus|type 2 diabetes mellitus
492306|NCT00147836|therapy|therapy
492307|NCT00147836|sulfonylureas|sulfonylureas
492308|NCT00147836|metformin|metformin
492309|NCT00147836|insulin|insulin
492310|NCT00147849|knowledge translation|knowledge translation
492311|NCT00147849|health care utilization|health care utilization
492312|NCT00147849|economic analysis|economic analysis
492313|NCT00147862|Tranexamic Acid|tranexamic acid
492314|NCT00147862|Antifibrinolytic Agents|antifibrinolytic agents
492315|NCT00147862|Head and Neck Neoplasms|head and neck neoplasms
492316|NCT00147862|Thromboelastography|thromboelastography
492317|NCT00147875|Lymphoma|lymphoma
492318|NCT00147875|Gemcitabine|gemcitabine
492319|NCT00147875|Advanced stages Hodgkin's lymphoma|advanced stages hodgkin's lymphoma
492320|NCT00147875|Elderly|elderly
492321|NCT00147888|Mucosal congestion|mucosal congestion
492322|NCT00147888|Acoustic rhinometry|acoustic rhinometry
492323|NCT00147888|Physiology|physiology
492324|NCT00147901|CLL|cll
492325|NCT00147901|Immunochemotherapy|immunochemotherapy
492326|NCT00147914|Acute bacterial sinusitis|acute bacterial sinusitis
492327|NCT00147927|email|email
492328|NCT00147927|internet|internet
492329|NCT00147927|health promotion|health promotion
492330|NCT00147927|behavior change|behavior change
492331|NCT00147927|health status|health status
492332|NCT00147927|work productivity|work productivity
492333|NCT00147927|healthcare cost|healthcare cost
492334|NCT00147927|employee|employee
492335|NCT00147940|Allergy|allergy
492336|NCT00147953|NHL|nhl
492337|NCT00147953|Lymphoma|lymphoma
492338|NCT00147953|Radiotherapy|radiotherapy
492339|NCT00147953|Rituximab|rituximab
492340|NCT00147953|Palliative treatment|palliative treatment
492341|NCT00147966|active disease despite concomitant methotrexate|active disease despite concomitant methotrexate
492342|NCT00148018|Hodgkin disease|hodgkin disease
492343|NCT00148018|Bortezomib|bortezomib
492344|NCT00148018|Relapse|relapse
492345|NCT00148018|Lymphoma|lymphoma
492346|NCT00148031|behavior modification|behavior modification
492347|NCT00148031|health care service utilization|health care service utilization
492348|NCT00148031|hepatitis C,|hepatitis c,
492349|NCT00148031|injection drug use|injection drug use
492350|NCT00148031|therapy compliance|therapy compliance
492351|NCT00148031|alcoholism|alcoholism
492352|NCT00148031|alcohol abuse|alcohol abuse
492354|NCT00148031|drug abuse|drug abuse
492355|NCT00148031|liver disorder|liver disorder
492356|NCT00148031|HCV|hcv
492357|NCT00148031|methadone|methadone
492358|NCT00148057|Diet|diet
492359|NCT00148057|Dietary fat|dietary fat
492360|NCT00148057|Breast cancer|breast cancer
492361|NCT00148057|Prevention|prevention
492362|NCT00148083|Schizophrenia|schizophrenia
492363|NCT00148083|Cognition|cognition
492364|NCT00148083|Clinical Trial|clinical trial
492365|NCT00148096|asthma|asthma
492366|NCT00148096|house dust mite|house dust mite
492367|NCT00148096|allergy|allergy
492368|NCT00148096|housing|housing
492369|NCT00148096|avoidance|avoidance
492370|NCT00148096|humidity|humidity
492371|NCT00148109|Unresectable/metastatic high grade soft tissue bony sarcoma|unresectable/metastatic high grade soft tissue bony sarcoma
492372|NCT00148122|Squamous cell cancer of the oral cavity and pharynx|squamous cell cancer of the oral cavity and pharynx
492373|NCT00148135|Carcinoma of Unknown Primary Site (CUP)|carcinoma of unknown primary site (cup)
492374|NCT00148148|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
492375|NCT00148148|Caspofungin|caspofungin
492376|NCT00148148|Liposomal Amphotericin B|liposomal amphotericin b
492377|NCT00148161|Magnetoencephalography|magnetoencephalography
492378|NCT00148161|Auditory cortex|auditory cortex
492379|NCT00148161|Stuttering|stuttering
492380|NCT00148161|Non stuttering|non stuttering
492381|NCT00148174|Medication adherence|medication adherence
492382|NCT00148174|Patient compliance|patient compliance
492383|NCT00148174|Kidney transplant|kidney transplant
492384|NCT00148174|Organ rejection|organ rejection
492385|NCT00148174|Allograft loss|allograft loss
492386|NCT00148174|Drug monitoring|drug monitoring
492387|NCT00148187|Medication adherence|medication adherence
492388|NCT00148187|Patient compliance|patient compliance
492389|NCT00148187|Kidney transplant|kidney transplant
492390|NCT00148187|Organ rejection|organ rejection
492391|NCT00148187|Allograft loss|allograft loss
492392|NCT00148187|Drug monitoring|drug monitoring
492393|NCT00148200|female sexual dysfunction|female sexual dysfunction
492394|NCT00148200|desire|desire
492395|NCT00148200|arousal|arousal
492396|NCT00148200|lubrification|lubrification
492397|NCT00148200|orgasm|orgasm
492398|NCT00148200|satisfaction|satisfaction
492399|NCT00148200|pain|pain
492599|NCT00149032|Metastatic solid tumor|metastatic solid tumor
492400|NCT00148213|differentiated thyroid carcinoma|differentiated thyroid carcinoma
492401|NCT00148213|thyroglobulin|thyroglobulin
492402|NCT00148213|immunoassay|immunoassay
492403|NCT00148213|thyroidectomy|thyroidectomy
492404|NCT00148213|radioiodine therapy|radioiodine therapy
492405|NCT00148226|Decision Aid|decision aid
492406|NCT00148226|Faecal Occult Blood Test|faecal occult blood test
492407|NCT00148226|Colorectal Cancer Screening|colorectal cancer screening
492408|NCT00148226|Informed Decision-making|informed decision-making
492409|NCT00148239|SCI|sci
492410|NCT00148239|Caregiving|caregiving
492411|NCT00148239|Aging|aging
492412|NCT00148239|Disability|disability
492413|NCT00148239|Paralysis|paralysis
492414|NCT00148252|Calcineurin|calcineurin
492415|NCT00148252|reduction|reduction
492416|NCT00148252|immunosuppression|immunosuppression
492417|NCT00148252|cyclosporine A|cyclosporine a
492418|NCT00148252|mycophenolate mofetil|mycophenolate mofetil
492419|NCT00148265|Diabetic macular oedema|diabetic macular oedema
492420|NCT00148265|Triamcinolone acetate|triamcinolone acetate
492421|NCT00148265|Intravitreal injection|intravitreal injection
492422|NCT00148265|Clinical trial|clinical trial
492423|NCT00148265|Laser treatment|laser treatment
492424|NCT00148278|Catecholamines|catecholamines
492425|NCT00148278|Septic shock|septic shock
492426|NCT00148304|Decision-making|decision-making
492427|NCT00148304|Insulin|insulin
492428|NCT00148304|Preference|preference
492429|NCT00148304|Treatment Variation|treatment variation
492430|NCT00148304|Provider|provider
492431|NCT00148304|Patient|patient
492432|NCT00148330|Diabetic macular oedema|diabetic macular oedema
492433|NCT00148330|Triamcinolone acetate|triamcinolone acetate
492434|NCT00148330|Intravitreal injection|intravitreal injection
492435|NCT00148330|Clinical trial|clinical trial
492436|NCT00148330|Laser treatment|laser treatment
492437|NCT00148343|hemiplegia|hemiplegia
492438|NCT00148343|hemiparesis|hemiparesis
492439|NCT00148343|stroke|stroke
492440|NCT00148343|foot-drop|foot-drop
492441|NCT00148343|electrical stimulation|electrical stimulation
492442|NCT00148343|ankle-foot-orthosis|ankle-foot-orthosis
492443|NCT00148356|drug eluting stents|drug eluting stents
492444|NCT00148356|stents|stents
492445|NCT00148356|angioplasty|angioplasty
492446|NCT00148356|coronary artery disease|coronary artery disease
492447|NCT00148356|total coronary occlusion|total coronary occlusion
492448|NCT00148356|coronary artery restenosis|coronary artery restenosis
492449|NCT00148356|stent thrombosis|stent thrombosis
492450|NCT00148356|vascular disease|vascular disease
492451|NCT00148356|myocardial ischemia|myocardial ischemia
492452|NCT00148356|coronary artery stenosis|coronary artery stenosis
492453|NCT00148382|Obesity|obesity
492454|NCT00148382|Pharmacokinetics|pharmacokinetics
492455|NCT00148382|Pharmacodynamics|pharmacodynamics
492456|NCT00148408|Asthma|asthma
492457|NCT00148408|Placebo|placebo
492458|NCT00148408|Education|education
492459|NCT00148421|Non-myeloid malignancy|non-myeloid malignancy
492460|NCT00148421|Chemotherapy-induced anemia|chemotherapy-induced anemia
492461|NCT00148434|hypertension|hypertension
492462|NCT00148434|guidelines|guidelines
492463|NCT00148434|patient empowerment|patient empowerment
492464|NCT00148434|anxiety|anxiety
492465|NCT00148447|negative symptoms|negative symptoms
492466|NCT00148447|depression|depression
492467|NCT00148447|ssri|ssri
492468|NCT00148447|schizophrenia|schizophrenia
492469|NCT00148473|Cervical ripening.|cervical ripening.
492470|NCT00148473|Induction of labor.|induction of labor.
492471|NCT00148473|Misoprostol.|misoprostol.
492472|NCT00148525|automated telephony, cancer prevention, healthy diet|automated telephony, cancer prevention, healthy diet
492473|NCT00148538|Type 1 Diabetes|type 1 diabetes
492474|NCT00148538|Resistance Exercise|resistance exercise
492475|NCT00148538|Aerobic Exercise|aerobic exercise
492476|NCT00148538|Exercise & Disease|exercise & disease
492477|NCT00148538|Exercise|exercise
492478|NCT00148538|Diabetes|diabetes
492479|NCT00148551|AMD|amd
492480|NCT00148551|Triamcinolone|triamcinolone
492481|NCT00148551|Macular Degeneration|macular degeneration
492482|NCT00148564|weight gain|weight gain
492483|NCT00148564|schizophrenia|schizophrenia
492484|NCT00148564|atypical antipsychotics|atypical antipsychotics
492485|NCT00148577|Pain Relief, TENS, Acupuncture Points|pain relief, tens, acupuncture points
492486|NCT00148590|Memantine|memantine
492487|NCT00148590|Negative syndrome|negative syndrome
492488|NCT00148590|Schizophrenia|schizophrenia
492489|NCT00148590|Cognitive impairment|cognitive impairment
492490|NCT00148590|Glutamate|glutamate
492491|NCT00148603|dyspepsia|dyspepsia
492492|NCT00148603|eosinophilic gastroenteritis|eosinophilic gastroenteritis
492493|NCT00148603|montelukast|montelukast
492494|NCT00148616|Memantine|memantine
492495|NCT00148616|Negative Syndrome|negative syndrome
492496|NCT00148616|Schizophrenia|schizophrenia
492497|NCT00148616|Cognitive impairment|cognitive impairment
492498|NCT00148629|Anemia|anemia
492499|NCT00148629|Birth weight|birth weight
492500|NCT00148629|Neonatal Mortality|neonatal mortality
492501|NCT00148629|Tanzania|tanzania
492502|NCT00148629|Pregnancy|pregnancy
492503|NCT00148642|ventilator-associated pneumonia|ventilator-associated pneumonia
492504|NCT00148642|nosocomial pneumonia|nosocomial pneumonia
492505|NCT00148655|educational intervention|educational intervention
492506|NCT00148655|decision board|decision board
492507|NCT00148655|DCIS|dcis
492508|NCT00148668|HER-2 Positive Breast Cancer|her-2 positive breast cancer
492509|NCT00148668|herceptin|herceptin
492510|NCT00148668|navelbine|navelbine
492511|NCT00148668|taxotere|taxotere
492512|NCT00148668|carboplatin|carboplatin
492513|NCT00148668|Early stage Breast Cancer|early stage breast cancer
492514|NCT00148681|HER-2 Positive breast cancer|her-2 positive breast cancer
492515|NCT00148681|herceptin|herceptin
492516|NCT00148681|navelbine|navelbine
492517|NCT00148694|Cisplatin|cisplatin
492518|NCT00148694|Early Stage Breast Cancer|early stage breast cancer
492519|NCT00148694|ER Negative Breast Cancer|er negative breast cancer
492520|NCT00148694|PR Negative Breast Cancer|pr negative breast cancer
492521|NCT00148694|HER-2 Negative Breast Cancer|her-2 negative breast cancer
492522|NCT00148707|Metastatic Breast Cancer|metastatic breast cancer
492523|NCT00148707|HER2-negative Breast Cancer|her2-negative breast cancer
492524|NCT00148707|CT-2103|ct-2103
492525|NCT00148707|Xyotax|xyotax
492526|NCT00148720|Invasive Breast Cancer|invasive breast cancer
492527|NCT00148720|Operable Breast Cancer|operable breast cancer
492528|NCT00148720|Capecitabine|capecitabine
492529|NCT00148733|Child|child
492530|NCT00148733|pneumonia|pneumonia
492531|NCT00148733|Zinc|zinc
492532|NCT00148733|clinical trial|clinical trial
492533|NCT00148733|Nepal|nepal
492534|NCT00148733|nutrition|nutrition
492535|NCT00148733|therapeutic|therapeutic
492536|NCT00148746|atopic dermatitis, atopy|atopic dermatitis, atopy
492537|NCT00148759|Sex differences|sex differences
492538|NCT00148759|Pharmacokinetic|pharmacokinetic
492540|NCT00148759|Treatment Experienced|treatment experienced
492541|NCT00148759|HIV-infection|hiv-infection
492542|NCT00148772|Prostate Cancer|prostate cancer
492543|NCT00148772|Rising PSA|rising psa
492544|NCT00148772|Erlotinib|erlotinib
492546|NCT00148772|Androgen Deprivation Therapy|androgen deprivation therapy
492547|NCT00148772|Hormone Therapy|hormone therapy
492548|NCT00148772|Rising Prostate Specific Antigen (PSA)|rising prostate specific antigen (psa)
492549|NCT00148772|Non-Metastatic Prostate Cancer|non-metastatic prostate cancer
492550|NCT00148785|Antiretroviral drugs|antiretroviral drugs
492551|NCT00148785|Pharmacokinetic|pharmacokinetic
492552|NCT00148785|Indinavir|indinavir
492553|NCT00148785|Ritonavir|ritonavir
492554|NCT00148785|Fosamprenavir|fosamprenavir
492555|NCT00148798|Cetuximab|cetuximab
492556|NCT00148798|Non small cell lung cancer|non small cell lung cancer
492557|NCT00148798|Lung cancer|lung cancer
492558|NCT00148798|Cisplatin/vinorelbine|cisplatin/vinorelbine
492559|NCT00148798|Monoclonal antibody|monoclonal antibody
492560|NCT00148798|Erbitux|erbitux
492561|NCT00148824|HIV infections|hiv infections
492562|NCT00148824|Pneumococcal vaccines|pneumococcal vaccines
492563|NCT00148824|Treatment Experienced|treatment experienced
492564|NCT00148824|Treatment Naive|treatment naive
492565|NCT00148837|Hepatitis C, Chronic|hepatitis c, chronic
492566|NCT00148837|Fibrosis|fibrosis
492567|NCT00148837|Interferon Alfa-2b|interferon alfa-2b
492568|NCT00148837|Ribavirin|ribavirin
492569|NCT00148837|Prazosin|prazosin
492570|NCT00148850|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
492571|NCT00148850|pioglitazone|pioglitazone
492572|NCT00148850|HIV infections|hiv infections
492573|NCT00148850|Treatment Experienced|treatment experienced
492574|NCT00148863|Hepatitis C, Chronic|hepatitis c, chronic
492575|NCT00148863|Interferon Alfa-2a|interferon alfa-2a
492576|NCT00148863|Ribavirin|ribavirin
492577|NCT00148863|Interferon-gamma, Recombinant|interferon-gamma, recombinant
492578|NCT00148876|Progression after treatment with Trastuzumab|progression after treatment with trastuzumab
492579|NCT00148876|Metastatic Breast Cancer|metastatic breast cancer
635147|NCT00719576|MACI,|maci,
492580|NCT00148876|Palliative Study|palliative study
492581|NCT00148889|cervical dystonia|cervical dystonia
492582|NCT00148889|torticollis|torticollis
492583|NCT00148889|deep brain stimulation|deep brain stimulation
492584|NCT00148889|pallidal stimulation|pallidal stimulation
492585|NCT00148889|globus pallidus internus|globus pallidus internus
492586|NCT00148902|tumor|tumor
492587|NCT00148915|Osteoporosis|osteoporosis
492588|NCT00148915|bisphosphonates|bisphosphonates
492589|NCT00148915|bone|bone
492590|NCT00148967|right ventricular pacing|right ventricular pacing
492591|NCT00148967|implantable cardioverter defibrillator|implantable cardioverter defibrillator
492592|NCT00148980|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
492593|NCT00148980|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
492594|NCT00148980|Demineralized bone matrix (DBM)|demineralized bone matrix (dbm)
492595|NCT00148980|Bone marrow microenvironment|bone marrow microenvironment
492596|NCT00148993|Tumor cell vaccine|tumor cell vaccine
492597|NCT00149006|Metastatic solid tumor|metastatic solid tumor
492598|NCT00149006|Mismatch allogeneic cell mediated immunotherapy|mismatch allogeneic cell mediated immunotherapy
493094|NCT00158548|Asia|asia
492600|NCT00149045|familial peripheral Neuropathy Anticipation|familial peripheral neuropathy anticipation
492601|NCT00149058|acute myocardial infarction|acute myocardial infarction
492602|NCT00149058|primary angioplasty|primary angioplasty
492603|NCT00149071|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
492604|NCT00149071|Major depression|major depression
492605|NCT00149071|treatment resistant major depression|treatment resistant major depression
492606|NCT00149084|The tailored H. pylori eradication therapy|the tailored h. pylori eradication therapy
492607|NCT00149084|CYP2C19 genotype|cyp2c19 genotype
492608|NCT00149084|23S rRNA|23s rrna
492609|NCT00149084|clarithromycin|clarithromycin
492610|NCT00149084|Lansoprazole|lansoprazole
492611|NCT00149084|Amoxicillin|amoxicillin
492612|NCT00149084|H. pylori infection|h. pylori infection
492613|NCT00149110|Sleep deprivation|sleep deprivation
492614|NCT00149110|Exercise|exercise
492615|NCT00149110|Light therapy|light therapy
492616|NCT00149110|Major depression|major depression
492617|NCT00149110|Bipolar depression|bipolar depression
492618|NCT00149110|Sleep-wake cycle|sleep-wake cycle
492619|NCT00149123|Burn|burn
492620|NCT00149123|adrenal insufficiency|adrenal insufficiency
492621|NCT00149123|hydrocortisone|hydrocortisone
492622|NCT00149123|short corticotropin test|short corticotropin test
492623|NCT00149136|Acute Lymphocytic Leukemia,|acute lymphocytic leukemia,
492624|NCT00149136|Ph+,|ph+,
492625|NCT00149136|elderly patients,|elderly patients,
492626|NCT00149136|Imatinib|imatinib
492627|NCT00149149|Reduction in NSAID related gut damage|reduction in nsaid related gut damage
492628|NCT00149162|Controlled|controlled
492629|NCT00149162|Multicenter|multicenter
492630|NCT00149162|International|international
492631|NCT00149162|Randomized study|randomized study
492632|NCT00149162|Direct individual benefit|direct individual benefit
492633|NCT00149162|complete remission after chemotherapy|complete remission after chemotherapy
492634|NCT00149162|non allogeneic transplanted|non allogeneic transplanted
492635|NCT00149175|Alzheimer's disease|alzheimer's disease
492636|NCT00149175|Dementia|dementia
492637|NCT00149175|Phenotype-genotype correlations|phenotype-genotype correlations
492638|NCT00149175|Candidate genes|candidate genes
492639|NCT00149175|Related disorders|related disorders
492640|NCT00149188|Growth Hormone|growth hormone
492641|NCT00149201|gastric cancer|gastric cancer
492642|NCT00149201|peritoneal metastasis|peritoneal metastasis
492643|NCT00149201|randomized trial|randomized trial
492645|NCT00149201|MTX|mtx
492646|NCT00149227|High risk hypertension|high risk hypertension
492647|NCT00149227|Ischemic heart disease|ischemic heart disease
492648|NCT00149227|Angiotensin receptor blockers|angiotensin receptor blockers
492649|NCT00149227|Cardiovascular mortality- morbidity|cardiovascular mortality- morbidity
492650|NCT00149227|KYOTO HEART Study|kyoto heart study
492651|NCT00149240|DYSPORT|dysport
492652|NCT00149240|botulinum toxin A|botulinum toxin a
492653|NCT00149240|myofascial pain syndrome|myofascial pain syndrome
492654|NCT00149253|Abdominal hysterectomy,|abdominal hysterectomy,
492655|NCT00149253|Etoricoxib,|etoricoxib,
492656|NCT00149253|morphine consumption,|morphine consumption,
492657|NCT00149253|pre-emptive analgesia|pre-emptive analgesia
492658|NCT00149266|stomach neoplasms|stomach neoplasms
492659|NCT00149266|lymph node resection|lymph node resection
492660|NCT00149266|cardia|cardia
492661|NCT00149266|thoracotomy|thoracotomy
492662|NCT00156156|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
492663|NCT00156156|Excessive Uterine Bleeding|excessive uterine bleeding
492664|NCT00156156|Uterine Hemorrhage|uterine hemorrhage
492665|NCT00156182|Fibroid Uterus|fibroid uterus
492666|NCT00156182|Leiomyoma|leiomyoma
492667|NCT00156182|Uterine Fibroids|uterine fibroids
492668|NCT00156182|asoprisnil|asoprisnil
492669|NCT00156195|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
492670|NCT00156195|Excessive Uterine Bleeding|excessive uterine bleeding
492671|NCT00156195|Uterine Hemorrhage|uterine hemorrhage
492672|NCT00156195|asoprisnil|asoprisnil
492673|NCT00156208|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
492674|NCT00156208|Excessive Uterine Bleeding|excessive uterine bleeding
492675|NCT00156208|Uterine Hemorrhage|uterine hemorrhage
492676|NCT00156208|asoprisnil|asoprisnil
492677|NCT00156221|Autism|autism
492678|NCT00156221|MRI|mri
492679|NCT00156221|Developmental Disorders|developmental disorders
492680|NCT00156247|psoriasis|psoriasis
492681|NCT00156247|etanercept|etanercept
492682|NCT00156247|acitretin|acitretin
492683|NCT00156299|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
492684|NCT00156299|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
492685|NCT00156299|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
492686|NCT00156299|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
492687|NCT00156299|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
492688|NCT00156299|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
492689|NCT00156299|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
492789|NCT00156988|partial thickness|partial thickness
492690|NCT00156299|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
492691|NCT00156299|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
492692|NCT00156299|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
492693|NCT00156299|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
492694|NCT00156299|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
492695|NCT00156299|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
492696|NCT00156299|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
492697|NCT00156325|Bipolar Disorder|bipolar disorder
492698|NCT00156325|Depression|depression
492699|NCT00156325|Hypomania|hypomania
492700|NCT00156325|Mood Stabilizer|mood stabilizer
492701|NCT00156338|Fluid therapy|fluid therapy
492702|NCT00156351|African Americans|african americans
492703|NCT00156351|Women|women
492704|NCT00156351|Internet|internet
492705|NCT00156351|Telephone Counseling|telephone counseling
492706|NCT00156364|Diabetic Nephropathy|diabetic nephropathy
492707|NCT00156364|Kidney Transplant|kidney transplant
492708|NCT00156364|Pancreas Transplant|pancreas transplant
492709|NCT00156364|Renal Interstitium|renal interstitium
492710|NCT00156364|Diabetes Mellitus|diabetes mellitus
492711|NCT00156364|Cyclosporine|cyclosporine
492712|NCT00156364|Tacrolimus|tacrolimus
492713|NCT00156377|Mupirocin|mupirocin
492714|NCT00156377|Staphylococcus aureus|staphylococcus aureus
492715|NCT00156377|Nasal Cavity|nasal cavity
492716|NCT00156377|Preventive measures|preventive measures
492717|NCT00156403|pancreatitis, hereditary|pancreatitis, hereditary
492718|NCT00156403|trypsinogen, cationic|trypsinogen, cationic
492719|NCT00156403|pilot study|pilot study
492720|NCT00156416|menopause|menopause
492721|NCT00156416|hot flash|hot flash
492722|NCT00156416|night sweat|night sweat
492723|NCT00156416|meditation|meditation
492724|NCT00156416|breast cancer|breast cancer
492725|NCT00156429|genetic testing|genetic testing
492726|NCT00156442|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
492727|NCT00156442|Cleft lip/palate|cleft lip/palate
492728|NCT00156442|Children|children
492729|NCT00156455|Children|children
492730|NCT00156455|Hypoplastic left heart syndrome|hypoplastic left heart syndrome
492731|NCT00156455|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
492732|NCT00156455|Single Ventricle Physiology|single ventricle physiology
492733|NCT00156793|coronary artery disease|coronary artery disease
492734|NCT00156793|ischemia|ischemia
492735|NCT00156793|echocardiography|echocardiography
492736|NCT00156793|cardiac imaging|cardiac imaging
492737|NCT00156793|heart disease|heart disease
492738|NCT00156793|myocardial contrast enhancement|myocardial contrast enhancement
492739|NCT00156793|myocardial perfusion|myocardial perfusion
492740|NCT00156793|wall motion|wall motion
492741|NCT00156793|ultrasound contrast agent|ultrasound contrast agent
492743|NCT00156806|radiation dermatitis|radiation dermatitis
492744|NCT00156806|radiation therapy|radiation therapy
492745|NCT00156819|Asthma|asthma
492746|NCT00156819|Asthma Control|asthma control
492747|NCT00156845|coronary artery disease|coronary artery disease
492748|NCT00156845|ischemia|ischemia
492749|NCT00156845|echocardiography|echocardiography
492750|NCT00156845|cardiac imaging|cardiac imaging
492751|NCT00156845|heart disease|heart disease
492752|NCT00156845|myocardial contrast enhancement|myocardial contrast enhancement
492753|NCT00156845|myocardial perfusion|myocardial perfusion
492754|NCT00156845|wall motion|wall motion
492755|NCT00156845|ultrasound contrast agent|ultrasound contrast agent
492756|NCT00156858|pharmacokinetics|pharmacokinetics
492757|NCT00156858|transplantation|transplantation
492758|NCT00156858|busulfan|busulfan
492759|NCT00156871|transplant|transplant
492760|NCT00156871|fatigue|fatigue
492761|NCT00156871|exercise|exercise
492762|NCT00156871|Malignant disease|malignant disease
492763|NCT00156884|prostate cancer|prostate cancer
492764|NCT00156884|cisplatin|cisplatin
492765|NCT00156884|strontium-89|strontium-89
492766|NCT00156884|phase II|phase ii
492767|NCT00156897|Non-insulin-dependent diabetes mellitus|non-insulin-dependent diabetes mellitus
492768|NCT00156897|NIDDM|niddm
492769|NCT00156897|Type II diabetes|type ii diabetes
492770|NCT00156897|Obesity|obesity
492771|NCT00156897|Lipase inhibitor|lipase inhibitor
492772|NCT00156923|Alcohol dependence|alcohol dependence
492773|NCT00156949|Epogen|epogen
492774|NCT00156949|Procrit|procrit
492775|NCT00156949|Chronic Kidney Disease|chronic kidney disease
492776|NCT00156949|Anemia Treatment for Dialysis Patients|anemia treatment for dialysis patients
492777|NCT00156962|Epogen|epogen
492778|NCT00156962|Procrit|procrit
492779|NCT00156962|Chronic Kidney Disease|chronic kidney disease
492780|NCT00156962|Anemia Treatment|anemia treatment
492781|NCT00156975|Oxaliplatin|oxaliplatin
492782|NCT00156975|Capecitabine|capecitabine
492783|NCT00156975|Chemotherapy|chemotherapy
492784|NCT00156975|Resection|resection
492785|NCT00156975|Liver metastases|liver metastases
492786|NCT00156975|Liver resection|liver resection
492787|NCT00156975|Adjuvant|adjuvant
492788|NCT00156988|burns|burns
492790|NCT00156988|cerium flamazine|cerium flamazine
492791|NCT00156988|randomised clinical trial|randomised clinical trial
492792|NCT00157014|Antirejection|antirejection
492793|NCT00157014|Treatment Outcome|treatment outcome
492794|NCT00157014|Immunosuppression|immunosuppression
492795|NCT00157014|Treatment Effectiveness|treatment effectiveness
492796|NCT00157014|Anti-rejection therapy|anti-rejection therapy
492797|NCT00157027|Treatment Experienced|treatment experienced
492798|NCT00157027|HIV-1 Positive by ELISA Assay|hiv-1 positive by elisa assay
492799|NCT00157027|Confirmed by Western Blot|confirmed by western blot
492800|NCT00157027|Refractory or intolerant to HAART|refractory or intolerant to haart
492801|NCT00157040|Factor VIII Deficiency|factor viii deficiency
492802|NCT00157053|Factor VIII Deficiency|factor viii deficiency
492803|NCT00157066|Latent tuberculosis infection|latent tuberculosis infection
492804|NCT00157066|Active tuberculosis infection|active tuberculosis infection
492805|NCT00157079|PID|pid
492806|NCT00157079|Immune Thrombocytopenic Purpura (ITP)|immune thrombocytopenic purpura (itp)
492807|NCT00157079|Kawasaki syndrome|kawasaki syndrome
492808|NCT00157079|Immunodeficiency|immunodeficiency
492809|NCT00157118|Severe congenital protein C deficiency|severe congenital protein c deficiency
492810|NCT00157131|autologous sheet skin grafts|autologous sheet skin grafts
492811|NCT00157131|FS 4IU VH S/D|fs 4iu vh s/d
492812|NCT00157131|skin grafts|skin grafts
492813|NCT00157131|burn|burn
492814|NCT00157144|Lung Transplantation|lung transplantation
492815|NCT00157144|Heart Transplantation|heart transplantation
492816|NCT00157157|Factor VIII Deficiency|factor viii deficiency
492817|NCT00157170|exercise|exercise
492818|NCT00157170|self efficacy|self efficacy
492819|NCT00157170|quality of life|quality of life
492820|NCT00157170|HIV|hiv
492821|NCT00157183|cystic fibrosis|cystic fibrosis
492822|NCT00157183|hypoxia|hypoxia
492823|NCT00157183|oxygen|oxygen
492824|NCT00157183|noninvasive ventilation|noninvasive ventilation
492825|NCT00157183|quality of life|quality of life
492826|NCT00157196|Carcinoma, Non-Small-Cell Lung, L-BLP25, Tecemotide|carcinoma, non-small-cell lung, l-blp25, tecemotide
492827|NCT00157222|Charcot|charcot
492828|NCT00157222|Diabetic|diabetic
492829|NCT00157222|osteoporosis|osteoporosis
492830|NCT00157274|Alemtuzumab|alemtuzumab
492831|NCT00157274|Mycosis fungoides|mycosis fungoides
492832|NCT00157274|Sezary|sezary
492833|NCT00157300|erythropoietin|erythropoietin
492834|NCT00157300|kidney transplantation|kidney transplantation
492835|NCT00157300|delayed graft function|delayed graft function
492836|NCT00157313|Schizophrenia|schizophrenia
492837|NCT00157313|First episode psychosis|first episode psychosis
492838|NCT00157313|Psychosocial intervention|psychosocial intervention
492839|NCT00157326|High Blood Pressure|high blood pressure
492840|NCT00157378|first episode,|first episode,
492841|NCT00157378|schizophrenia,|schizophrenia,
492842|NCT00157378|atypical neuroleptics,|atypical neuroleptics,
492843|NCT00157378|negative symptoms|negative symptoms
492844|NCT00157534|Hepatitis C|hepatitis c
492845|NCT00157534|Celgosivir|celgosivir
492846|NCT00157534|HCV|hcv
492847|NCT00157534|Genotype 1|genotype 1
492848|NCT00157547|Depression|depression
492849|NCT00157547|Quantitative EEG (QEEG)|quantitative eeg (qeeg)
492850|NCT00157547|Antidepressants|antidepressants
492851|NCT00157573|Asymptomatic|asymptomatic
492852|NCT00157573|Clinical trial|clinical trial
492853|NCT00157573|Phase II|phase ii
492854|NCT00157573|GM-CSF|gm-csf
492855|NCT00157573|Immunotherapy|immunotherapy
492856|NCT00157599|deep vein thrombosis|deep vein thrombosis
492857|NCT00157599|DVT|dvt
492858|NCT00157612|pneumonia|pneumonia
492859|NCT00157612|lower respiratory tract infection|lower respiratory tract infection
492860|NCT00157612|clinical pathway|clinical pathway
492189|NCT00147277|ATP|atp
492861|NCT00157612|nursing home|nursing home
492862|NCT00157612|long-term care|long-term care
492863|NCT00157612|randomized control trial|randomized control trial
492864|NCT00157625|urinary infections, catheters, bacteriuria, trial|urinary infections, catheters, bacteriuria, trial
492865|NCT00157638|pharmacist|pharmacist
492866|NCT00157638|physician|physician
492867|NCT00157638|primary care|primary care
492868|NCT00157638|collaboration|collaboration
492869|NCT00157638|therapeutics|therapeutics
492870|NCT00157651|end stage renal disease|end stage renal disease
492871|NCT00157651|thrombosis|thrombosis
492872|NCT00157651|bleeding|bleeding
492873|NCT00157677|deep vein thrombosis|deep vein thrombosis
492874|NCT00157677|pulmonary embolism|pulmonary embolism
492875|NCT00157677|D-dimer testing|d-dimer testing
492876|NCT00157690|Alendronate|alendronate
492877|NCT00157690|Bisphosphonates|bisphosphonates
492878|NCT00157690|Cystic Fibrosis|cystic fibrosis
492879|NCT00157690|Osteoporosis|osteoporosis
492880|NCT00157703|Malignant glioma|malignant glioma
492881|NCT00157703|Glioblastoma multiforme|glioblastoma multiforme
492882|NCT00157703|GBM|gbm
492883|NCT00157703|Gliosarcoma|gliosarcoma
492884|NCT00157703|Anaplastic astrocytoma|anaplastic astrocytoma
492885|NCT00157703|Brain cancer|brain cancer
492886|NCT00157703|Brain tumor|brain tumor
492887|NCT00157703|Glioma|glioma
492987|NCT00158184|Abuse Liability|abuse liability
492888|NCT00157703|recurrent/progressive malignant glioma|recurrent/progressive malignant glioma
492889|NCT00157716|Coronary|coronary
492890|NCT00157716|surgery|surgery
492891|NCT00157716|ischemia|ischemia
492892|NCT00157716|reperfusion injury|reperfusion injury
492893|NCT00157716|cardiac|cardiac
492894|NCT00157716|heart|heart
492895|NCT00157716|neurological|neurological
492896|NCT00157716|cardiopulmonary bypass|cardiopulmonary bypass
492897|NCT00157716|cardioprotection|cardioprotection
492898|NCT00157729|Hypertension|hypertension
492899|NCT00157729|antihypertensive agents|antihypertensive agents
492900|NCT00157729|diabetes mellitus type 2|diabetes mellitus type 2
492901|NCT00157729|metabolic syndrome|metabolic syndrome
492902|NCT00157742|Angina Pectoris|angina pectoris
492903|NCT00157742|Spinal Cord Stimulation (SCS)|spinal cord stimulation (scs)
492904|NCT00157742|Percutaneous Myocardial Revascularisation (PMR)|percutaneous myocardial revascularisation (pmr)
492905|NCT00157742|Refractory Angina Pectoris|refractory angina pectoris
492906|NCT00157755|Nausea and Vomiting|nausea and vomiting
492907|NCT00157768|Acute myocardial infarction|acute myocardial infarction
492908|NCT00157768|Non-sustained ventricular tachycardia|non-sustained ventricular tachycardia
492909|NCT00157768|Left ventricular dysfunction|left ventricular dysfunction
492910|NCT00157768|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
492911|NCT00157768|ICD|icd
492912|NCT00157768|Risk-stratification|risk-stratification
492913|NCT00157781|Atrial Fibrillation|atrial fibrillation
492914|NCT00157781|Atrial Tachyarrhythmia|atrial tachyarrhythmia
492915|NCT00157781|Pacing|pacing
492916|NCT00157781|Electrophysiology|electrophysiology
492917|NCT00157794|Sinus Node Disease|sinus node disease
492918|NCT00157794|Pacemaker|pacemaker
492919|NCT00157794|Dual Chamber Pacemaker|dual chamber pacemaker
492920|NCT00157807|Persistent Atrial Fibrillation|persistent atrial fibrillation
492921|NCT00157807|Permanent Atrial Fibrillation|permanent atrial fibrillation
492922|NCT00157807|Mitral Valve Defect|mitral valve defect
492923|NCT00157807|Tricuspid Valve Defect|tricuspid valve defect
492924|NCT00157807|Aortic Valve Defect|aortic valve defect
492925|NCT00157820|Defibrillators, Implantable|defibrillators, implantable
492926|NCT00157820|Atrial Fibrillation|atrial fibrillation
492927|NCT00157820|Ventricular Tachyarrhythmias|ventricular tachyarrhythmias
492928|NCT00157820|Clinical Trial|clinical trial
492929|NCT00157833|Coartemether|coartemether
492930|NCT00157833|Artekin|artekin
492931|NCT00157833|Papua|papua
492932|NCT00157833|Uncomplicated malaria|uncomplicated malaria
492933|NCT00157846|Heart Failure|heart failure
492934|NCT00157846|LVEF < 35%|lvef < 35%
492935|NCT00157846|Bradycardia|bradycardia
492936|NCT00157859|Falciparum|falciparum
492937|NCT00157859|Vivax|vivax
492938|NCT00157859|Papua|papua
492939|NCT00157859|Chloroquine|chloroquine
492940|NCT00157859|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
492941|NCT00157885|Falciparum|falciparum
492942|NCT00157885|Vivax|vivax
492943|NCT00157885|Papua|papua
492944|NCT00157885|Amodiaquine|amodiaquine
492945|NCT00157885|Artekin|artekin
492946|NCT00157885|Artemisinin Combination Therapy|artemisinin combination therapy
492947|NCT00157885|Dihydroartemisinin|dihydroartemisinin
492948|NCT00157885|Piperaquine|piperaquine
492949|NCT00157885|Lumefantrine|lumefantrine
492950|NCT00157885|Artemether|artemether
492951|NCT00157950|Human Papilloma Virus|human papilloma virus
492952|NCT00157976|Macular Degeneration|macular degeneration
492953|NCT00157976|AMD|amd
492954|NCT00157976|Visual Acuity|visual acuity
492955|NCT00157989|Infant, Premature|infant, premature
492956|NCT00158002|Basilar/Hemiplegic Migraine|basilar/hemiplegic migraine
492957|NCT00158002|Prophylaxis|prophylaxis
492958|NCT00158015|Echocardiography|echocardiography
492959|NCT00158015|tissue Doppler Imaging|tissue doppler imaging
492960|NCT00158015|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
492961|NCT00158028|Schizotypal Personality Disorder|schizotypal personality disorder
492962|NCT00158028|Risperidone|risperidone
492963|NCT00158028|Treatment|treatment
492964|NCT00158028|Cognitive|cognitive
492965|NCT00158041|Amifostine|amifostine
492966|NCT00158041|Mucositis|mucositis
492967|NCT00158041|Nausea|nausea
492968|NCT00158041|Hypotension|hypotension
492969|NCT00158041|Rash|rash
492970|NCT00158054|depression|depression
492971|NCT00158054|acute coronary syndrome|acute coronary syndrome
492972|NCT00158054|clinical trials|clinical trials
492973|NCT00158067|Epilepsy|epilepsy
492974|NCT00158067|Neurostimulation|neurostimulation
492975|NCT00158106|functional communicative ability|functional communicative ability
492976|NCT00158106|cost effectiveness|cost effectiveness
492977|NCT00158106|service user preferences|service user preferences
492978|NCT00158119|strength training|strength training
492979|NCT00158119|power training|power training
492980|NCT00158119|exercise training|exercise training
492981|NCT00158119|functional performance tasks|functional performance tasks
492982|NCT00158132|cocaine|cocaine
492983|NCT00158158|smoking addiction|smoking addiction
492984|NCT00158171|smoking addiction|smoking addiction
492985|NCT00158184|Opiate|opiate
492986|NCT00158184|Opioid|opioid
493093|NCT00158548|Treatment|treatment
492988|NCT00158184|Abuse Potential|abuse potential
492989|NCT00158197|Adherence|adherence
492990|NCT00158197|Amphetamine-Related Disorders|amphetamine-related disorders
492991|NCT00158197|Behavior Therapy|behavior therapy
492992|NCT00158197|Contingency management|contingency management
492993|NCT00158197|Drug Counseling|drug counseling
492994|NCT00158197|health behaviors|health behaviors
492995|NCT00158197|methamphetamine|methamphetamine
492996|NCT00158197|sexual risk behaviors|sexual risk behaviors
492997|NCT00158197|substance dependence|substance dependence
492998|NCT00158223|Schizophrenia|schizophrenia
492999|NCT00158223|Clozapine|clozapine
493000|NCT00158223|Treatment|treatment
493001|NCT00158223|Combination|combination
493002|NCT00158223|Unresponsive|unresponsive
493003|NCT00158223|Schizoaffective Disorders|schizoaffective disorders
493004|NCT00158236|Opiate Addiction|opiate addiction
493005|NCT00158236|Opiate Dependence|opiate dependence
493006|NCT00158249|citicoline, drug abuse, marijuana|citicoline, drug abuse, marijuana
493007|NCT00158262|Post-Traumatic Stress Disorder|post-traumatic stress disorder
493008|NCT00158262|Prevention|prevention
493009|NCT00158262|Propranolol|propranolol
493010|NCT00158262|Psychophysiology|psychophysiology
493011|NCT00158275|Cognitive behavioral therapy|cognitive behavioral therapy
493012|NCT00158275|Problem solving therapy|problem solving therapy
493013|NCT00158275|CBT|cbt
493014|NCT00158288|Substance Use Disorders|substance use disorders
493015|NCT00158301|Child|child
493016|NCT00158301|Adolescent|adolescent
493017|NCT00158301|CBT|cbt
493018|NCT00158301|Drug Therapy|drug therapy
493019|NCT00158314|Pathological gambling|pathological gambling
493020|NCT00158314|Gambler's anonymous|gambler's anonymous
493021|NCT00158314|Cognitive behavioral therapy|cognitive behavioral therapy
493022|NCT00158314|CBT|cbt
493023|NCT00158327|Primary Health Care|primary health care
493024|NCT00158340|Binge Eating|binge eating
493025|NCT00158340|Overeating|overeating
493026|NCT00158340|Compulsive Eating|compulsive eating
493027|NCT00158340|Hyperphagia|hyperphagia
493028|NCT00158353|Mentors|mentors
493029|NCT00158353|Self-esteem|self-esteem
493030|NCT00158353|Adolescent|adolescent
493031|NCT00158353|Mental health|mental health
493032|NCT00158353|Social support|social support
493033|NCT00158353|Substance use|substance use
493034|NCT00158353|Violence|violence
493035|NCT00158353|Exercise|exercise
493036|NCT00158353|Nutrition|nutrition
493037|NCT00158353|Sexual behavior|sexual behavior
493038|NCT00158353|Female|female
493039|NCT00158366|Weight Loss|weight loss
493041|NCT00158405|Structured treatment interruption|structured treatment interruption
493042|NCT00158405|HAART|haart
493043|NCT00158405|Sub-saharian africa|sub-saharian africa
493044|NCT00158405|Treatment Interruption|treatment interruption
493045|NCT00158405|Treatment Naive|treatment naive
493046|NCT00158418|osteoarthritis|osteoarthritis
493047|NCT00158418|shoulder|shoulder
493048|NCT00158418|randomized trial|randomized trial
493049|NCT00158418|cement|cement
493050|NCT00158431|osteoarthritis|osteoarthritis
493051|NCT00158431|randomized trial|randomized trial
493052|NCT00158431|knee|knee
493053|NCT00158431|quality of life|quality of life
493054|NCT00158444|arthroplasty|arthroplasty
493055|NCT00158444|Resurfacing|resurfacing
493056|NCT00158444|implant|implant
493057|NCT00158457|Simplification regimen|simplification regimen
493058|NCT00158457|HIV infection|hiv infection
493059|NCT00158457|Once a day|once a day
493060|NCT00158457|Naive patients|naive patients
493061|NCT00158457|Sub-saharian Africa|sub-saharian africa
492353|NCT00148031|prevention|prevention
493062|NCT00158457|Treatment Naive|treatment naive
493063|NCT00158470|HIV infection|hiv infection
493064|NCT00158470|injecting drug users|injecting drug users
493065|NCT00158470|HAART|haart
493066|NCT00158470|once daily regimen|once daily regimen
493067|NCT00158470|Treatment Naive|treatment naive
493068|NCT00158483|Genital herpes|genital herpes
493069|NCT00158483|Cofactors of sexual transmission|cofactors of sexual transmission
493070|NCT00158483|Syndromic treatment|syndromic treatment
493071|NCT00158483|Genital viral load|genital viral load
493072|NCT00158483|Ulcer|ulcer
493073|NCT00158496|Chronic Hepatitis C|chronic hepatitis c
493074|NCT00158496|Genotype 4|genotype 4
493075|NCT00158496|Pegylated Interferon|pegylated interferon
493076|NCT00158496|Ribavirin|ribavirin
493077|NCT00158496|Egypt|egypt
493078|NCT00158509|Valacyclovir|valacyclovir
493079|NCT00158509|HIV-1|hiv-1
493080|NCT00158509|HSV-2|hsv-2
493081|NCT00158509|genital shedding|genital shedding
493082|NCT00158509|herpes genitalis|herpes genitalis
493083|NCT00158509|HIV infection|hiv infection
493084|NCT00158522|Acute hepatitis C|acute hepatitis c
493085|NCT00158522|Genotype 4|genotype 4
493086|NCT00158522|Pegylated Interferon|pegylated interferon
493087|NCT00158522|Egypt|egypt
493088|NCT00158535|Liver Transplantation|liver transplantation
493089|NCT00158535|Hepatitis C|hepatitis c
493090|NCT00158535|HIV Infections|hiv infections
493091|NCT00158548|Falciparum|falciparum
493092|NCT00158548|Vivax|vivax
493095|NCT00158561|vivax|vivax
493096|NCT00158561|treatment|treatment
493097|NCT00158561|Asia|asia
493098|NCT00158574|intermittent preventive treatment|intermittent preventive treatment
493099|NCT00158574|malaria|malaria
493100|NCT00158574|efficacy|efficacy
493101|NCT00158574|safety|safety
493102|NCT00158574|drug options|drug options
493103|NCT00158587|Vivax|vivax
493104|NCT00158587|Treatment|treatment
493105|NCT00158587|Primaquine|primaquine
493106|NCT00158587|Asia|asia
493107|NCT00158600|Glycogen Storage Disease Type II|glycogen storage disease type ii
493108|NCT00158600|GSD-II|gsd-ii
493109|NCT00158600|Pompe Disease|pompe disease
493110|NCT00158626|physical therapy|physical therapy
493111|NCT00158626|physiotherapy|physiotherapy
493112|NCT00158626|pelvic organ prolapse|pelvic organ prolapse
493113|NCT00158639|Blood Pressure Monitoring, home|blood pressure monitoring, home
493114|NCT00158639|Pharmaceutical services|pharmaceutical services
493115|NCT00158639|Self care|self care
493116|NCT00158652|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
493117|NCT00158652|Radiotherapy|radiotherapy
493118|NCT00158652|Chemotherapy|chemotherapy
493119|NCT00158665|Influenza|influenza
493120|NCT00158665|Vaccination|vaccination
493121|NCT00158665|Immunization|immunization
493122|NCT00158665|Flu|flu
493123|NCT00158665|Immunogenicity|immunogenicity
493124|NCT00158678|oral cancer|oral cancer
493125|NCT00158678|oropharynx cancer|oropharynx cancer
493126|NCT00158678|hypopharynx cancer|hypopharynx cancer
493127|NCT00158678|IMRT|imrt
493128|NCT00158691|Head and Neck cancer|head and neck cancer
493129|NCT00158691|Radiotherapy|radiotherapy
493130|NCT00158691|Xerostomia|xerostomia
493131|NCT00158691|Randomized trial|randomized trial
493132|NCT00158704|Chronic Hepatitis B|chronic hepatitis b
493133|NCT00158717|Chronic Hepatitis B|chronic hepatitis b
493134|NCT00158743|Pre-eclampsia|pre-eclampsia
493136|NCT00158743|Endogenous digitalis-like factor|endogenous digitalis-like factor
493137|NCT00158743|Anti-digoxin antibody|anti-digoxin antibody
493138|NCT00158743|Digibind|digibind
493139|NCT00158756|Diphtheria|diphtheria
493140|NCT00158756|Pertussis|pertussis
493141|NCT00158756|Prophylaxis|prophylaxis
493142|NCT00158756|Hepatitis B diseases|hepatitis b diseases
493143|NCT00158756|Tetanus|tetanus
493144|NCT00158769|Hepatic Impairment|hepatic impairment
493145|NCT00158769|Emulsion|emulsion
493146|NCT00158769|GR270773|gr270773
493147|NCT00158782|Cancer GW786034 Lapatinib Pazopanib|cancer gw786034 lapatinib pazopanib
493148|NCT00158821|HIV|hiv
493149|NCT00158821|Antiretroviral|antiretroviral
493150|NCT00158821|Treatment Experienced|treatment experienced
493151|NCT00158821|HIV-1|hiv-1
493152|NCT00158834|Children|children
493153|NCT00158834|Asthma|asthma
493154|NCT00158834|bronchial hyperresponsiveness|bronchial hyperresponsiveness
493155|NCT00158834|symptoms|symptoms
493156|NCT00158847|COPD inflammation sputum lung function biopsy|copd inflammation sputum lung function biopsy
493157|NCT00158860|VALTREX®|valtrex®
493158|NCT00158860|valaciclovir|valaciclovir
493159|NCT00158860|genital herpes|genital herpes
493160|NCT00158860|HSV-2|hsv-2
493161|NCT00158860|suppression|suppression
493162|NCT00158873|ICU mechanical ventilation analgesia sedation|icu mechanical ventilation analgesia sedation
493163|NCT00158886|oral topotecan rectal cancer pelvic radiation|oral topotecan rectal cancer pelvic radiation
493164|NCT00158899|HDLc|hdlc
493165|NCT00158899|high-density lipoprotein|high-density lipoprotein
493166|NCT00158899|Dyslipidemia|dyslipidemia
493167|NCT00158925|Artificial Cardiac Pacing|artificial cardiac pacing
493168|NCT00158925|Implanted Electrodes|implanted electrodes
493169|NCT00158938|Artificial Cardiac Pacemaker|artificial cardiac pacemaker
493170|NCT00158938|Implanted Electrodes|implanted electrodes
493171|NCT00158951|Left Ventricular Lead|left ventricular lead
493172|NCT00158951|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
493173|NCT00158951|Congestive Heart Failure|congestive heart failure
493174|NCT00158964|left ventricular lead|left ventricular lead
493175|NCT00158964|pacing|pacing
493176|NCT00158964|heart failure|heart failure
493177|NCT00158977|heart failure|heart failure
493178|NCT00158977|atrial fibrillation|atrial fibrillation
493179|NCT00158977|cardiac resynchronization therapy defibrillator|cardiac resynchronization therapy defibrillator
493180|NCT00158990|major depression|major depression
493181|NCT00158990|bipolar disorder|bipolar disorder
493182|NCT00158990|unipolar depression|unipolar depression
493183|NCT00158990|sertraline|sertraline
493184|NCT00158990|triiodothyronine|triiodothyronine
493185|NCT00159003|drug metabolism and disposition enzymes|drug metabolism and disposition enzymes
493186|NCT00159081|Schizophrenia|schizophrenia
493187|NCT00159081|first episode|first episode
493188|NCT00159081|long-term treatment|long-term treatment
493189|NCT00159081|typical vs. atypical neuroleptics|typical vs. atypical neuroleptics
493190|NCT00159107|alcoholism|alcoholism
493191|NCT00159107|abstinence enhancement|abstinence enhancement
493192|NCT00159107|psychotherapy|psychotherapy
493193|NCT00159107|cognitive behavior therapy vs. supportive counseling|cognitive behavior therapy vs. supportive counseling
493194|NCT00159107|Acamprosate vs. Placebo|acamprosate vs. placebo
493195|NCT00159107|multi-center study|multi-center study
493196|NCT00159120|Schizophrenia|schizophrenia
493197|NCT00159120|first episode|first episode
493198|NCT00159120|neuroleptic maintenance treatment|neuroleptic maintenance treatment
493199|NCT00159120|drug discontinuation|drug discontinuation
493200|NCT00159120|prodrome based early intervention|prodrome based early intervention
493201|NCT00159133|Schizophrenia|schizophrenia
493202|NCT00159133|first episode|first episode
493203|NCT00159133|prodrome based early intervention|prodrome based early intervention
493204|NCT00159133|antipsychotics - benzodiazepine|antipsychotics - benzodiazepine
493205|NCT00159133|maintenance treatment|maintenance treatment
493206|NCT00159133|drug discontinuation|drug discontinuation
493207|NCT00159146|Major Depression|major depression
493208|NCT00159146|Pindolol|pindolol
493209|NCT00159146|Venlafaxine|venlafaxine
493210|NCT00159146|Augmentation|augmentation
493211|NCT00159146|Major depression (DSM-IVR)|major depression (dsm-ivr)
493212|NCT00159159|Cardiac Transplant|cardiac transplant
493213|NCT00159159|ciclosporine|ciclosporine
493214|NCT00159159|immunosuppressive|immunosuppressive
493215|NCT00159172|Advanced parkinson disease|advanced parkinson disease
493216|NCT00159172|Stimulation|stimulation
493217|NCT00159172|Motor Cortex|motor cortex
493218|NCT00159172|Parkinson disease C10.574.812|parkinson disease c10.574.812
493219|NCT00159172|Electric Stimulation Therapy E02.831.580.438|electric stimulation therapy e02.831.580.438
493220|NCT00159172|Neuronavigation E05.873.249|neuronavigation e05.873.249
493221|NCT00159185|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
493222|NCT00159185|Epidemiology|epidemiology
493223|NCT00159198|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
493224|NCT00159198|Frontotemporal dementia|frontotemporal dementia
493225|NCT00159198|Mutations spectrum|mutations spectrum
493226|NCT00159198|Linkage studies|linkage studies
493227|NCT00159198|Genetic epidemiology|genetic epidemiology
493228|NCT00159211|type 2 diabetes|type 2 diabetes
493229|NCT00159224|HIV|hiv
493230|NCT00159224|Simplification|simplification
493231|NCT00159224|Monotherapy|monotherapy
493232|NCT00159224|Treatment Naive|treatment naive
493233|NCT00159224|HIV-1 infection|hiv-1 infection
493234|NCT00159250|Duchenne muscular dystrophy;|duchenne muscular dystrophy;
493235|NCT00159250|antisense oligonucleotides;|antisense oligonucleotides;
493236|NCT00159250|gene restoration;|gene restoration;
493237|NCT00159250|deletion|deletion
493238|NCT00159289|Mild to moderate Chronic Obstructive Pulmonary Disease (COPD)|mild to moderate chronic obstructive pulmonary disease (copd)
493239|NCT00159289|Volunteers (healthy non-smokers)|volunteers (healthy non-smokers)
493240|NCT00159289|Volunteers (current or ex-smokers)|volunteers (current or ex-smokers)
493241|NCT00159315|Healthy Volunteers (smokers)|healthy volunteers (smokers)
493242|NCT00159315|Healthy Volunteers (Non-smokers)|healthy volunteers (non-smokers)
493243|NCT00159315|Asthma Patients|asthma patients
493244|NCT00159315|COPD Patients|copd patients
493245|NCT00159328|Magnetic Resonance Guided Focused Ultrasound|magnetic resonance guided focused ultrasound
493246|NCT00159328|Gonadotrophin Releasing Hormone Agonist|gonadotrophin releasing hormone agonist
493247|NCT00159328|Uterine Fibroids|uterine fibroids
493248|NCT00159341|cigarette smoke|cigarette smoke
493249|NCT00159341|nasal|nasal
493250|NCT00159341|whole blood|whole blood
493251|NCT00159341|cytokines|cytokines
493252|NCT00159341|chemokines|chemokines
635945|NCT00722943|infant|infant
493253|NCT00159341|nasal fluid|nasal fluid
493254|NCT00159341|filter paper|filter paper
493255|NCT00159354|FDG−PET|fdg−pet
493256|NCT00159354|pulmonary inflammation,|pulmonary inflammation,
493257|NCT00159354|smoking,|smoking,
493258|NCT00159354|COPD|copd
493259|NCT00159354|steroid intervention|steroid intervention
493260|NCT00159367|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
493261|NCT00159380|Healthy Volunteers|healthy volunteers
493262|NCT00159393|Kidney stones|kidney stones
493263|NCT00159393|nephrolithotripsy percutaneous|nephrolithotripsy percutaneous
493264|NCT00159406|BPH treatment|bph treatment
493265|NCT00159406|Laser Prostatectomy|laser prostatectomy
493266|NCT00159406|Treatment of enlarged Prostates|treatment of enlarged prostates
493267|NCT00159406|BPH|bph
493268|NCT00146419|Treatment Experienced|treatment experienced
493269|NCT00146419|Treatment Naive|treatment naive
493270|NCT00146445|IV drug users|iv drug users
493271|NCT00146458|Cervical cancer|cervical cancer
493272|NCT00146458|FDG-PET|fdg-pet
493273|NCT00146458|Lymph node metastasis|lymph node metastasis
493274|NCT00146458|Radiotherapy|radiotherapy
493275|NCT00146458|Chemotherapy|chemotherapy
493276|NCT00146471|alcohol withdrawal|alcohol withdrawal
493277|NCT00146471|detoxification|detoxification
493278|NCT00146471|Inpatients|inpatients
493400|NCT00152256|Uterine Hemorrhage|uterine hemorrhage
493279|NCT00146471|alcohol dependence according to DSM-IV/ICD-10|alcohol dependence according to dsm-iv/icd-10
493280|NCT00146471|withdrawal symptoms|withdrawal symptoms
493281|NCT00146484|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
493282|NCT00146484|Child|child
493283|NCT00146484|Adolescent|adolescent
493284|NCT00146484|Disease Management|disease management
493565|NCT00153361|HIV|hiv
493285|NCT00146484|Newly Diagnosed|newly diagnosed
493286|NCT00146484|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
493287|NCT00146497|Respiratory distress syndrome (RDS)|respiratory distress syndrome (rds)
493288|NCT00146497|Premature infants|premature infants
493289|NCT00146497|Chronic lung disease (CLD)|chronic lung disease (cld)
493290|NCT00146497|Bronchoalveolar lavage fluid (BALF)|bronchoalveolar lavage fluid (balf)
493291|NCT00146497|Cytokines|cytokines
493292|NCT00146510|weight control|weight control
493293|NCT00146510|compliance|compliance
493294|NCT00146510|physical activity|physical activity
493295|NCT00146510|nutrition|nutrition
493296|NCT00146510|Health Behavior|health behavior
493297|NCT00146510|Patient Compliance|patient compliance
493298|NCT00146523|Psychotic Major Depression|psychotic major depression
493299|NCT00146523|PMD|pmd
493300|NCT00146523|Depression|depression
493301|NCT00146523|Major Depression|major depression
493302|NCT00146523|Psychosis|psychosis
493303|NCT00146536|ALH|alh
493304|NCT00146536|LCIS|lcis
493305|NCT00146536|DCIS|dcis
493306|NCT00146536|adjacent ipsilateral infiltrating carcinoma|adjacent ipsilateral infiltrating carcinoma
493307|NCT00146536|core needle biopsy|core needle biopsy
493308|NCT00146536|Lobular neoplasia of the breast|lobular neoplasia of the breast
493309|NCT00146549|HER2-positive Breast cancer|her2-positive breast cancer
493310|NCT00146549|HER2 overexpressing|her2 overexpressing
493311|NCT00146549|trastuzumab|trastuzumab
493312|NCT00146549|Herceptin|herceptin
493313|NCT00146549|vinorelbine|vinorelbine
493314|NCT00146549|Navelbine|navelbine
493315|NCT00146549|Taxotere|taxotere
493316|NCT00146549|taxol|taxol
493317|NCT00146562|adjuvant chemotherapy|adjuvant chemotherapy
493319|NCT00146562|pegfilgrastim|pegfilgrastim
493320|NCT00146562|darbepoetin alfa|darbepoetin alfa
493321|NCT00146588|Breast cancer|breast cancer
493322|NCT00146588|cytoxan|cytoxan
493323|NCT00146588|epirubicin|epirubicin
493324|NCT00146588|capecitabine|capecitabine
493325|NCT00146601|Fulvestrant|fulvestrant
493326|NCT00146601|Advanced breast cancer|advanced breast cancer
493327|NCT00146601|Invasive breast cancer|invasive breast cancer
493328|NCT00146601|Stage IV Breast Cancer|stage iv breast cancer
493329|NCT00146601|Hormone Receptor-Positive Breast Cancer|hormone receptor-positive breast cancer
493330|NCT00146614|Graft versus Host Disease|graft versus host disease
493331|NCT00146614|GVHD|gvhd
493332|NCT00146614|Stem Cell Transplantation|stem cell transplantation
493333|NCT00146614|Tacrolimus|tacrolimus
493334|NCT00146614|Sirolimus|sirolimus
493335|NCT00146614|Methotrexate|methotrexate
493336|NCT00146614|allogeneic stem cell transplantation|allogeneic stem cell transplantation
493337|NCT00146627|Human African Trypanosomiasis|human african trypanosomiasis
493338|NCT00146627|Combination|combination
493339|NCT00146627|Trypanosoma brucei gambiense Human African Trypanosomiasis|trypanosoma brucei gambiense human african trypanosomiasis
493340|NCT00146640|active disease|active disease
493341|NCT00146640|morning stiffness of joints|morning stiffness of joints
493342|NCT00146640|nighttime application of prednisone|nighttime application of prednisone
493343|NCT00146640|modified releae prednisone|modified releae prednisone
493344|NCT00146653|pediatrics|pediatrics
493345|NCT00146653|cardiopulmonary bypass|cardiopulmonary bypass
493346|NCT00146653|surgery|surgery
493347|NCT00146666|Peak walking time|peak walking time
492644|NCT00149201|5-FU|5-fu
493348|NCT00146666|Absolute claudication distance|absolute claudication distance
493349|NCT00146666|Claudication onset time|claudication onset time
493350|NCT00146666|Initial claudication distance|initial claudication distance
493351|NCT00146666|Intermittent compression|intermittent compression
493352|NCT00146679|Heart failure|heart failure
493353|NCT00146679|Ventricular arrhythmias|ventricular arrhythmias
493355|NCT00146679|Psychoeducational intervention|psychoeducational intervention
493356|NCT00146692|Malaria|malaria
493357|NCT00146692|Cost|cost
493358|NCT00146692|Treatment|treatment
493359|NCT00146692|Diagnosis|diagnosis
493360|NCT00146692|Africa|africa
493361|NCT00146692|Ghana|ghana
493362|NCT00146705|chronic HBV|chronic hbv
493363|NCT00146705|Peginterferon|peginterferon
493364|NCT00146705|long term follow-up|long term follow-up
493365|NCT00152113|Sickle Cell Anemia|sickle cell anemia
493366|NCT00152113|Stem Cell Transplantation|stem cell transplantation
493367|NCT00152113|Haploidentical stem cell transplant|haploidentical stem cell transplant
493368|NCT00152113|T cell depletion|t cell depletion
493369|NCT00152113|CliniMACS device|clinimacs device
493370|NCT00152126|Autologous stem cell transplantation|autologous stem cell transplantation
493371|NCT00152126|CD133 cell selection|cd133 cell selection
493372|NCT00152126|CliniMACS device|clinimacs device
493373|NCT00152126|Tumor marker|tumor marker
493374|NCT00152126|Tumor purging|tumor purging
493375|NCT00152139|High risk hematologic malignancies|high risk hematologic malignancies
493376|NCT00152139|Allogeneic stem cell transplant|allogeneic stem cell transplant
493377|NCT00152139|Matched unrelated donor transplantation|matched unrelated donor transplantation
493378|NCT00152139|Unmanipulated stem cell graft|unmanipulated stem cell graft
493379|NCT00152139|Bone marrow transplantation|bone marrow transplantation
493380|NCT00152152|spinal motion|spinal motion
493566|NCT00153400|CVD risk|cvd risk
493381|NCT00152152|tantalum beads|tantalum beads
493382|NCT00152165|spinal motion|spinal motion
493383|NCT00152165|tantalum beads|tantalum beads
493384|NCT00152165|DYNESYS Stabilization system|dynesys stabilization system
493385|NCT00152165|spinal fusion|spinal fusion
493386|NCT00152165|Radiostereometric Analysis following spinal fusion|radiostereometric analysis following spinal fusion
493387|NCT00152165|Radiostereometric Analysis following surgery with DYNESYS Stabilization System|radiostereometric analysis following surgery with dynesys stabilization system
493388|NCT00152178|Breast Cancer|breast cancer
493389|NCT00152191|Breast Cancer|breast cancer
493390|NCT00152204|Use-Effectiveness|use-effectiveness
493391|NCT00152204|Cost Effectiveness|cost effectiveness
493392|NCT00152204|Patient Acceptance of Health Care|patient acceptance of health care
493393|NCT00152204|Drug Resistance|drug resistance
493394|NCT00152204|Delivery of Health Care|delivery of health care
493395|NCT00152217|Stomach cancer|stomach cancer
493396|NCT00152230|Colorectal Cancer|colorectal cancer
493397|NCT00152243|Stomach Cancer|stomach cancer
493398|NCT00152256|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
493399|NCT00152256|Excessive Uterine Bleeding|excessive uterine bleeding
493401|NCT00152269|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
493402|NCT00152269|Excessive Uterine Bleeding|excessive uterine bleeding
493403|NCT00152269|Uterine Hemorrhage|uterine hemorrhage
493404|NCT00152269|asoprisnil|asoprisnil
493405|NCT00152282|Postmenopausal|postmenopausal
493406|NCT00152282|Amenorrhea|amenorrhea
493407|NCT00152282|Hormone replacement therapy|hormone replacement therapy
493408|NCT00152282|HRT|hrt
493409|NCT00152282|asoprisnil|asoprisnil
493410|NCT00152295|Postmenopausal|postmenopausal
493411|NCT00152295|Amenorrhea|amenorrhea
493412|NCT00152295|Hormone replacement therapy|hormone replacement therapy
493413|NCT00152295|HRT|hrt
493415|NCT00152295|Estrogen Replacement Therapy, postmenopause|estrogen replacement therapy, postmenopause
493416|NCT00152321|osteoporosis|osteoporosis
493417|NCT00152321|wrist fractures|wrist fractures
493418|NCT00152321|quality improvement|quality improvement
493419|NCT00152321|knowledge translation|knowledge translation
493420|NCT00152334|Efficacy study|efficacy study
493421|NCT00152334|assessment of patient outcomes following treatment|assessment of patient outcomes following treatment
493422|NCT00152360|Obesity|obesity
493423|NCT00152360|weight loss|weight loss
493424|NCT00152360|cardiovascular risk factors|cardiovascular risk factors
493425|NCT00152360|Obesity and obesity related pathology|obesity and obesity related pathology
493426|NCT00152373|Epilepsy, Partial Onset Seizures; Keppra; Levetiracetam|epilepsy, partial onset seizures; keppra; levetiracetam
493427|NCT00152386|Rheumatoid Arthritis, CDP870|rheumatoid arthritis, cdp870
493428|NCT00152386|Certolizumab pegol, Cimzia|certolizumab pegol, cimzia
493429|NCT00152399|Peptic ulcer bleeding, upper intestinal bleeding, endoscopy, somatostatin|peptic ulcer bleeding, upper intestinal bleeding, endoscopy, somatostatin
493430|NCT00152412|Allergic Rhinitis, safety, levocetirizine, children|allergic rhinitis, safety, levocetirizine, children
493431|NCT00152412|Xyzal|xyzal
493432|NCT00152425|Crohn's disease, CDP870, CDAI, clinical response, remission, Certolizumab Pegol, Cimzia|crohn's disease, cdp870, cdai, clinical response, remission, certolizumab pegol, cimzia
493433|NCT00152438|Vasomotor symptoms|vasomotor symptoms
493434|NCT00152438|Menopause|menopause
492742|NCT00156806|aloe|aloe
493435|NCT00152451|Epilepsy: partial onset seizures, seletracetam|epilepsy: partial onset seizures, seletracetam
493436|NCT00152464|EPAAC , atopic Children, asthma, XYZAL, levocetirizine|epaac , atopic children, asthma, xyzal, levocetirizine
493437|NCT00152477|Non-small-cell-lung cancer|non-small-cell-lung cancer
493438|NCT00152477|carboplatin|carboplatin
493439|NCT00152477|paclitaxel|paclitaxel
493440|NCT00152477|VEGF|vegf
493441|NCT00152477|monoclonal antibody|monoclonal antibody
493442|NCT00152490|Crohn's disease, CDP870, CDAI, clinical response, remission,|crohn's disease, cdp870, cdai, clinical response, remission,
493443|NCT00152490|Certolizumab Pegol, Cimzia|certolizumab pegol, cimzia
493444|NCT00152503|Epilepsy, Partial Onset Seizures, Seletracetam|epilepsy, partial onset seizures, seletracetam
493445|NCT00152516|Partial Onset Seizures|partial onset seizures
493446|NCT00152516|levetiracetam|levetiracetam
493447|NCT00152516|Epilepsy|epilepsy
493448|NCT00152516|Keppra|keppra
493449|NCT00152529|Depression, educational site for depression|depression, educational site for depression
493450|NCT00152542|Inhaled nitric oxide,|inhaled nitric oxide,
493451|NCT00152542|Lung recruitment,|lung recruitment,
493452|NCT00152542|Ventilatory approach,|ventilatory approach,
493453|NCT00152542|Neurodevelopmental outcomes,|neurodevelopmental outcomes,
493454|NCT00152542|School age children|school age children
493455|NCT00152555|SLE,|sle,
493456|NCT00152555|exercize,|exercize,
493457|NCT00152555|physical therapy,|physical therapy,
493458|NCT00152555|Systemic lupus erythematosus|systemic lupus erythematosus
493459|NCT00152555|relaxation therapy|relaxation therapy
493460|NCT00152568|Car Seat Check|car seat check
493461|NCT00152581|HCV, genotype 1, treatment, HCV kinetics, T-cells|hcv, genotype 1, treatment, hcv kinetics, t-cells
493462|NCT00152607|Liver Transplantation|liver transplantation
493463|NCT00152607|Living Donors|living donors
493464|NCT00152607|End Stage Liver Disease|end stage liver disease
493465|NCT00152620|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
493564|NCT00153361|HIV Seronegativity|hiv seronegativity
493466|NCT00152633|endothelium, hypertension, retina, AT1|endothelium, hypertension, retina, at1
493467|NCT00152659|Epilepsy|epilepsy
493468|NCT00152659|Tumor|tumor
493469|NCT00152659|Surgery|surgery
493470|NCT00152659|Brain|brain
493471|NCT00152724|Physiology|physiology
493472|NCT00152724|Microcirculation|microcirculation
493473|NCT00152724|Laser-Doppler Flowmetry|laser-doppler flowmetry
493474|NCT00152737|Intermittent Claudication|intermittent claudication
493475|NCT00152737|Peripheral Vascular Diseases|peripheral vascular diseases
493476|NCT00152737|Blood Gas Monitoring, Transcutaneous|blood gas monitoring, transcutaneous
493477|NCT00152737|Surgery|surgery
493478|NCT00152750|Tourette's Syndrome|tourette's syndrome
493479|NCT00152750|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
493480|NCT00152750|Children|children
493481|NCT00152750|Sleep disorders|sleep disorders
493482|NCT00152750|Aggression|aggression
493483|NCT00152763|health anxiety|health anxiety
493484|NCT00152776|menopausal symptoms|menopausal symptoms
493485|NCT00152776|complementary medicine|complementary medicine
493486|NCT00152802|liver transplant|liver transplant
493487|NCT00152802|antibody response|antibody response
493488|NCT00152802|opsonophagocytic assay|opsonophagocytic assay
493489|NCT00152802|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
493490|NCT00152802|pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
493491|NCT00152815|HIV|hiv
493492|NCT00152815|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
493493|NCT00152854|cancer pain|cancer pain
493494|NCT00152854|acetaminophen|acetaminophen
493495|NCT00152854|opioids|opioids
493496|NCT00152867|quality of life|quality of life
493497|NCT00152867|dexamethasone|dexamethasone
493498|NCT00152867|emesis|emesis
493499|NCT00152880|Hepatitis B, apoptosis|hepatitis b, apoptosis
493501|NCT00152893|blood sugar > 6.1 mmol/l|blood sugar > 6.1 mmol/l
493502|NCT00152893|triglycerides > 2 mmol/l|triglycerides > 2 mmol/l
493503|NCT00152893|total cholesterol > 5.5 mmol/l or HDL < 0.9 mmol/l|total cholesterol > 5.5 mmol/l or hdl < 0.9 mmol/l
493504|NCT00152932|Glaucoma|glaucoma
493505|NCT00152932|Intraocular pressure|intraocular pressure
493506|NCT00152932|Ocular blood flow|ocular blood flow
493507|NCT00152932|Laser-Doppler Flowmetry|laser-doppler flowmetry
493508|NCT00152945|intestinal lipoprotein|intestinal lipoprotein
493509|NCT00152945|very low density lipoprotein|very low density lipoprotein
493510|NCT00152945|free fatty acids|free fatty acids
493511|NCT00152945|Apo B48 and Apo B100|apo b48 and apo b100
493512|NCT00152945|triglycerides|triglycerides
493513|NCT00152945|Intestinal lipoprotein production|intestinal lipoprotein production
493514|NCT00153166|peripheral arterial disease|peripheral arterial disease
493515|NCT00153166|intermittent claudication|intermittent claudication
493516|NCT00153179|insulin resistance|insulin resistance
493517|NCT00153179|insulin signaling|insulin signaling
493518|NCT00153179|endothelium-dependent vasodilation|endothelium-dependent vasodilation
493519|NCT00153192|Marinol|marinol
493520|NCT00153192|Dronabinol|dronabinol
493521|NCT00153192|Cannabinoid|cannabinoid
493522|NCT00153192|Chronic Pain|chronic pain
493523|NCT00153205|medication errors|medication errors
493524|NCT00153205|medical records systems, computerized|medical records systems, computerized
493525|NCT00153205|patient safety|patient safety
493526|NCT00153218|Metastatic Breast Cancer|metastatic breast cancer
493527|NCT00153218|Her2neu|her2neu
493528|NCT00153218|trastuzumab|trastuzumab
493529|NCT00153244|Bronchial asthma|bronchial asthma
493530|NCT00153244|Lamotrigine|lamotrigine
493531|NCT00153244|Antiepileptic drug|antiepileptic drug
493532|NCT00153244|Efficacy|efficacy
493533|NCT00153270|Bronchial asthma|bronchial asthma
493534|NCT00153270|Sodium valproate|sodium valproate
493535|NCT00153270|Antiepileptic drug|antiepileptic drug
493536|NCT00153270|Efficacy|efficacy
493537|NCT00153283|Bronchial asthma|bronchial asthma
493538|NCT00153283|Gabapentin|gabapentin
493539|NCT00153283|Antiepileptic drug|antiepileptic drug
493540|NCT00153283|Efficacy|efficacy
493541|NCT00153296|Bronchial asthma|bronchial asthma
493542|NCT00153296|Carbamazepine|carbamazepine
493543|NCT00153296|Antiepileptic drugs|antiepileptic drugs
493544|NCT00153296|Efficacy|efficacy
493545|NCT00153309|arthritis|arthritis
493546|NCT00153309|exercise|exercise
493547|NCT00153309|physical activity|physical activity
493548|NCT00153309|physical function|physical function
493549|NCT00153309|pain|pain
493550|NCT00153322|Childhood Obesity|childhood obesity
493551|NCT00153322|Community-based Participatory Research|community-based participatory research
493552|NCT00153322|School intervention|school intervention
493553|NCT00153322|Parental Involvement|parental involvement
493554|NCT00153335|Health Risk Assessment|health risk assessment
493555|NCT00153335|Behavior Change|behavior change
493556|NCT00153335|Patient-Provider Interaction|patient-provider interaction
493557|NCT00153335|Employee Health|employee health
493558|NCT00153335|Absenteeism|absenteeism
493559|NCT00153335|Tobacco Use|tobacco use
493560|NCT00153335|Substance Use|substance use
493561|NCT00153335|Diet|diet
493562|NCT00153335|Exercise|exercise
493563|NCT00153335|Medication Adherence|medication adherence
493567|NCT00153439|parenting|parenting
493568|NCT00153439|motivation|motivation
493569|NCT00153439|child maltreatment|child maltreatment
493570|NCT00153439|program attrition|program attrition
493571|NCT00153465|Parent training|parent training
493572|NCT00153465|Child maltreatment|child maltreatment
493573|NCT00153465|Motivation|motivation
493574|NCT00153465|Program attrition|program attrition
493575|NCT00153478|Alcohol-Exposed Pregnancy|alcohol-exposed pregnancy
493576|NCT00153478|Binge drinking|binge drinking
493577|NCT00153478|Frequent drinking|frequent drinking
493578|NCT00153478|Unintended pregnancy|unintended pregnancy
493579|NCT00153478|Fetal Alcohol Syndrome|fetal alcohol syndrome
493580|NCT00153491|malaria|malaria
493581|NCT00153491|artemether-lumefantrine|artemether-lumefantrine
493582|NCT00153491|co-artem|co-artem
493583|NCT00153491|Tanzania|tanzania
493584|NCT00153491|adherence|adherence
493585|NCT00153504|HIV|hiv
493586|NCT00153504|AIDS|aids
493587|NCT00153504|Homeless|homeless
493588|NCT00153504|Homelessness|homelessness
493589|NCT00153504|Housing|housing
493590|NCT00153504|HIV seropositive|hiv seropositive
493591|NCT00153504|HIV risk behavior|hiv risk behavior
493592|NCT00153517|Bacterial Vaginosis|bacterial vaginosis
493593|NCT00153517|Metronidazole|metronidazole
493594|NCT00153530|primary central nervous system lymphoma|primary central nervous system lymphoma
493595|NCT00153556|Haemophilus influenza type B|haemophilus influenza type b
493596|NCT00153556|Carrier state|carrier state
493597|NCT00153556|Bacterial Vaccines|bacterial vaccines
493598|NCT00153556|Anti-PRP antibody|anti-prp antibody
493599|NCT00153556|Antibody avidity|antibody avidity
493600|NCT00153556|Serum bacteriocidal antibody|serum bacteriocidal antibody
493601|NCT00153556|American Indians/Alaska Natives|american indians/alaska natives
493602|NCT00153556|Case control study|case control study
493603|NCT00153556|Adult vaccines|adult vaccines
493604|NCT00153595|Allergic rhinitis|allergic rhinitis
493605|NCT00153595|EWO1|ewo1
493606|NCT00153621|Pediatrics|pediatrics
493607|NCT00153621|Chronic Kidney Failure|chronic kidney failure
493609|NCT00153621|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
493610|NCT00153621|AIDS-Associated Nephropathy|aids-associated nephropathy
493611|NCT00153634|Cystic fibrosis|cystic fibrosis
493612|NCT00153634|Antibiotic susceptibility testing|antibiotic susceptibility testing
493613|NCT00153634|Pseudomonas aeruginosa|pseudomonas aeruginosa
493614|NCT00153634|Chronic bronchitis|chronic bronchitis
493615|NCT00153634|Biofilms|biofilms
493616|NCT00159419|Osteogenesis Imperfecta|osteogenesis imperfecta
493617|NCT00159419|Fractures|fractures
493618|NCT00159419|Pediatric|pediatric
493619|NCT00159419|Osteoporosis|osteoporosis
493620|NCT00159419|Juvenile Pagets|juvenile pagets
493621|NCT00159432|colorectal|colorectal
493622|NCT00159432|cancer|cancer
493623|NCT00159484|phase 1|phase 1
493624|NCT00159484|phase one|phase one
493625|NCT00159484|phase I|phase i
493626|NCT00159497|THA|tha
493627|NCT00159510|sepsis, methylene blue, nitric oxide, acute lung injury|sepsis, methylene blue, nitric oxide, acute lung injury
493628|NCT00159523|Prevention|prevention
493629|NCT00159523|Probiotics|probiotics
493630|NCT00159523|Allergy|allergy
493631|NCT00159523|Hypersensitivity|hypersensitivity
493632|NCT00159536|PCOS|pcos
493633|NCT00159536|metformin|metformin
493634|NCT00159536|pregnancy|pregnancy
493635|NCT00159536|preeclampsia|preeclampsia
493636|NCT00159536|diabetes|diabetes
493637|NCT00159536|preterm delivery|preterm delivery
493638|NCT00159549|Patient education|patient education
493639|NCT00159562|Bipolar Disorder|bipolar disorder
493640|NCT00159562|Psycho-education|psycho-education
493641|NCT00159575|Polycystic ovarian syndrome|polycystic ovarian syndrome
493642|NCT00159575|Clinical pregnancy rate|clinical pregnancy rate
493643|NCT00159575|Oligo- or anovulation|oligo- or anovulation
493644|NCT00159588|Medication-overuse headache|medication-overuse headache
493645|NCT00159588|preventative medication|preventative medication
493646|NCT00159588|controls|controls
493647|NCT00159588|follow-up|follow-up
493648|NCT00159588|randomized|randomized
493649|NCT00159588|abrupt withdrawal|abrupt withdrawal
493650|NCT00159601|Quality of Life|quality of life
493651|NCT00159601|Mental health|mental health
493652|NCT00159601|Children|children
493653|NCT00159601|Adolescents|adolescents
493654|NCT00159601|Normal population|normal population
493655|NCT00159614|renal insufficiency|renal insufficiency
493656|NCT00159614|diuretic|diuretic
493657|NCT00159614|heart failure, congestive|heart failure, congestive
493658|NCT00159627|heart failure, congestive|heart failure, congestive
493659|NCT00159627|diuretic|diuretic
493660|NCT00159874|children|children
493661|NCT00159900|Impotence|impotence
493662|NCT00159926|systemic inflammatory response syndrome|systemic inflammatory response syndrome
493663|NCT00159926|coronary artery bypass grafting|coronary artery bypass grafting
493664|NCT00159926|cell saver|cell saver
493665|NCT00159926|interleukins|interleukins
493666|NCT00159926|tumor necrosis factor alfa|tumor necrosis factor alfa
493667|NCT00159939|ARDS|ards
493668|NCT00159939|prone position|prone position
493669|NCT00159952|Sepsis|sepsis
493670|NCT00159952|Septic shock|septic shock
493671|NCT00159952|Hyperglycemia|hyperglycemia
493672|NCT00159952|Fibrinolysis|fibrinolysis
493673|NCT00159952|PAI 1|pai 1
493674|NCT00159965|nonepileptic seizure|nonepileptic seizure
493675|NCT00159965|pseudoseizure|pseudoseizure
493676|NCT00159965|conversion disorder|conversion disorder
493677|NCT00159965|psychogenic|psychogenic
493678|NCT00159965|Depression|depression
493679|NCT00159965|Anxiety|anxiety
493680|NCT00159965|Abuse|abuse
493681|NCT00159965|post-traumatic stress disorder|post-traumatic stress disorder
493682|NCT00159965|sertraline|sertraline
493683|NCT00159965|serotonin|serotonin
493684|NCT00159965|randomized controlled trial|randomized controlled trial
493685|NCT00159978|head and neck cancer|head and neck cancer
493686|NCT00159978|hypoxia|hypoxia
493687|NCT00159978|tumor cell proliferation|tumor cell proliferation
493688|NCT00159978|PET|pet
493689|NCT00159991|Coronary artery bypass grafting|coronary artery bypass grafting
493690|NCT00159991|Total arterial revascularization|total arterial revascularization
493691|NCT00159991|Internal mammary artery grafting|internal mammary artery grafting
493692|NCT00159991|Radial artery grafting|radial artery grafting
493693|NCT00160004|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
493695|NCT00160004|Fatigue|fatigue
493696|NCT00160004|Quality-of-life|quality-of-life
493697|NCT00160017|Quality assurance health care|quality assurance health care
493698|NCT00160017|Diabetes|diabetes
493699|NCT00160017|Breakthrough collaborative (IHI)|breakthrough collaborative (ihi)
493700|NCT00160017|Evaluation|evaluation
493701|NCT00160056|Hypoglycemia unawareness|hypoglycemia unawareness
493702|NCT00160056|Diabetes|diabetes
493703|NCT00160056|adrenal receptor|adrenal receptor
493704|NCT00160056|adrenerg respons|adrenerg respons
493705|NCT00160056|adrenergic beta-agonists|adrenergic beta-agonists
493706|NCT00160056|salbutamol|salbutamol
493707|NCT00160069|Stage IIIB or stage IV non-small-cell lung cancer.|stage iiib or stage iv non-small-cell lung cancer.
493708|NCT00160082|Post Polio Syndrome|post polio syndrome
493710|NCT00160082|Poliomyelitis|poliomyelitis
493711|NCT00160082|Paralylic Polio|paralylic polio
493712|NCT00160082|Late effects of polio|late effects of polio
493713|NCT00160082|Late onset polio sequele|late onset polio sequele
493714|NCT00160082|Xepol|xepol
493715|NCT00160082|IvIg|ivig
493716|NCT00160082|Intravenous Immunoglobuline|intravenous immunoglobuline
493717|NCT00160095|larynx carcinoma|larynx carcinoma
493718|NCT00160095|Tumor hypoxia|tumor hypoxia
493719|NCT00160095|microregional imaging|microregional imaging
493720|NCT00160095|hypoxia modifying treatment|hypoxia modifying treatment
493721|NCT00160134|congestive heart failure, adenosine receptor blocker, cardiac hemodynamic|congestive heart failure, adenosine receptor blocker, cardiac hemodynamic
493722|NCT00160160|comparator trial|comparator trial
493723|NCT00160160|hypertension|hypertension
636560|NCT00725218|NSAIDs|nsaids
493724|NCT00160160|diabetes|diabetes
493725|NCT00160160|blood pressure|blood pressure
493726|NCT00160173|Post menopausal vasomotor symptoms|post menopausal vasomotor symptoms
493727|NCT00160199|To collect additional data on 300 and 400 mg doses of PROMETRIUM in women with secondary amenorrhea|to collect additional data on 300 and 400 mg doses of prometrium in women with secondary amenorrhea
493728|NCT00160212|blood pressure|blood pressure
493729|NCT00160225|blood pressure, diabetic nephropathy, proteinuria|blood pressure, diabetic nephropathy, proteinuria
493730|NCT00160238|Meniere's disease|meniere's disease
493731|NCT00160238|Vestibular neurotomy|vestibular neurotomy
493732|NCT00160251|PEG-Intron|peg-intron
493733|NCT00160251|Ribavirin|ribavirin
493734|NCT00160251|Protease Inhibitor|protease inhibitor
493735|NCT00160264|lactulose; randomised clinical trial; osteopenia; postmenopause|lactulose; randomised clinical trial; osteopenia; postmenopause
493736|NCT00160277|Efficacy and safety of moxonidine in Indian hypertensives|efficacy and safety of moxonidine in indian hypertensives
493737|NCT00160290|lactulose|lactulose
493738|NCT00160290|randomised clinical trial|randomised clinical trial
493739|NCT00160290|hemorrhoids|hemorrhoids
493740|NCT00160290|anal fissures|anal fissures
493741|NCT00160303|Prolotherapy|prolotherapy
493742|NCT00160303|Lateral Epicondylitis|lateral epicondylitis
493743|NCT00160303|Tennis Elbow|tennis elbow
493744|NCT00160303|Corticosteroid Therapy|corticosteroid therapy
493745|NCT00160342|Hormone replacement therapy, hot flushes, postmenopause|hormone replacement therapy, hot flushes, postmenopause
493746|NCT00160355|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
493747|NCT00160355|Immunodeficiency|immunodeficiency
493748|NCT00160355|Haploidentical transplantation|haploidentical transplantation
493749|NCT00160368|Hypertension, potassium salts|hypertension, potassium salts
493750|NCT00160381|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
493751|NCT00160381|Excessive Uterine Bleeding|excessive uterine bleeding
493752|NCT00160381|Uterine Hemorrhage|uterine hemorrhage
493753|NCT00160381|asoprisnil|asoprisnil
493754|NCT00160394|Mild to Moderate|mild to moderate
493755|NCT00160407|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
493756|NCT00160407|enzyme inhibitors|enzyme inhibitors
493757|NCT00160407|lipase|lipase
493758|NCT00160407|obesity|obesity
493759|NCT00160407|insulin resistance|insulin resistance
493760|NCT00160420|Pelvic pain|pelvic pain
493761|NCT00160420|Dysmenorrhea|dysmenorrhea
493762|NCT00160420|Dyspareunia|dyspareunia
493763|NCT00160420|Infertility|infertility
493764|NCT00160420|asoprisnil|asoprisnil
493765|NCT00160433|Pelvic pain|pelvic pain
493766|NCT00160433|Dysmenorrhea|dysmenorrhea
493767|NCT00160433|Dyspareunia|dyspareunia
493768|NCT00160433|Infertility|infertility
493769|NCT00160433|asoprisnil|asoprisnil
493770|NCT00160446|Pelvic pain|pelvic pain
493771|NCT00160446|Dysmenorrhea|dysmenorrhea
493772|NCT00160446|Dyspareunia|dyspareunia
493773|NCT00160446|Infertility|infertility
493774|NCT00160446|Asoprisnil|asoprisnil
493775|NCT00160459|Fibroid Uterus|fibroid uterus
493776|NCT00160459|Leiomyoma|leiomyoma
493777|NCT00160459|Uterine Fibroids|uterine fibroids
493778|NCT00160459|asoprisnil|asoprisnil
493779|NCT00160472|vasopressin|vasopressin
493780|NCT00160472|ovarian|ovarian
493781|NCT00160472|neoplasm|neoplasm
493782|NCT00160485|Gestational Diabetes|gestational diabetes
493783|NCT00160485|Pregnancy|pregnancy
493784|NCT00160485|Glyburide|glyburide
493785|NCT00160485|Insulin|insulin
493786|NCT00160498|Lercanidipine, calcium antagonist, hypertension, obesity|lercanidipine, calcium antagonist, hypertension, obesity
493787|NCT00160511|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
493788|NCT00160511|Levetiracetam|levetiracetam
493789|NCT00160511|Keppra|keppra
493790|NCT00160511|Nerve Pain|nerve pain
493791|NCT00160524|Certolizumab Pegol|certolizumab pegol
493792|NCT00160524|Cimzia|cimzia
493793|NCT00160524|CDP870|cdp870
493794|NCT00160524|CZP|czp
14357|NCT03198871|Colorectal surgery|colorectal surgery
493795|NCT00160537|Seasonal Allergic Rhinitis (SAR), Grass pollen, SAR Symptoms (sneezing, rhinorrhea, nasal / ocular pruritus, nasal congestion)|seasonal allergic rhinitis (sar), grass pollen, sar symptoms (sneezing, rhinorrhea, nasal / ocular pruritus, nasal congestion)
493796|NCT00160537|POPULAR, Xyzal, Levocetirizine|popular, xyzal, levocetirizine
493797|NCT00160550|Idiopathic Generalized Epilepsy, tonic-clonic seizures|idiopathic generalized epilepsy, tonic-clonic seizures
493798|NCT00160550|Levetiracetam, Keppra|levetiracetam, keppra
493800|NCT00160563|EPAAC|epaac
493801|NCT00160563|atopic Children|atopic children
493802|NCT00160563|prevention of asthma|prevention of asthma
493803|NCT00160563|Levocetirizine|levocetirizine
493804|NCT00160563|Xyzal|xyzal
493805|NCT00160576|Idiopathic Parkinson's Disease, levodopa induced dyskinesia,|idiopathic parkinson's disease, levodopa induced dyskinesia,
493806|NCT00160576|Levetiracetam, Keppra|levetiracetam, keppra
493807|NCT00160589|Allergic Rhinits, Symptoms (sneezing, rhinorrhea, nasal/ocular pruritus, nasal congestion), LEADER, Xyzal, Levocetirizine|allergic rhinits, symptoms (sneezing, rhinorrhea, nasal/ocular pruritus, nasal congestion), leader, xyzal, levocetirizine
493808|NCT00160602|Rheumatoid Arthritis|rheumatoid arthritis
493135|NCT00158743|Hypertension|hypertension
493809|NCT00160602|Certolizumab Pegol, Cimzia|certolizumab pegol, cimzia
493810|NCT00160615|Epilepsy, Partial,|epilepsy, partial,
493811|NCT00160615|Keppra, levetiracetam|keppra, levetiracetam
493812|NCT00160628|Epilepsy|epilepsy
493813|NCT00160628|Partial Onset Seizures|partial onset seizures
493814|NCT00160628|Keppra|keppra
493815|NCT00160628|Levetiracetam|levetiracetam
493816|NCT00160641|Rheumatoid Arthritis|rheumatoid arthritis
493817|NCT00160641|CDP870|cdp870
493818|NCT00160641|Certolizumab Pegol|certolizumab pegol
493819|NCT00160641|Cimzia|cimzia
493820|NCT00160654|Epilepsy|epilepsy
493821|NCT00160654|Partial Onset Seizures|partial onset seizures
493822|NCT00160654|Keppra|keppra
493823|NCT00160654|Levetiracetam|levetiracetam
493824|NCT00160667|Post-herpetic Neuralgia (PHN)|post-herpetic neuralgia (phn)
493825|NCT00160667|Brivaracetam|brivaracetam
493826|NCT00160680|Persistent Allergic Rhinitis, HDM, Parietaria, sneezing, rhinorrhea, ocular pruritus, Rhinasthma, inflammatory cells, ICAM-1, ATAREAL, Xyzal, Levocetirizine|persistent allergic rhinitis, hdm, parietaria, sneezing, rhinorrhea, ocular pruritus, rhinasthma, inflammatory cells, icam-1, atareal, xyzal, levocetirizine
493827|NCT00160693|Rheumatoid Arthritis|rheumatoid arthritis
493828|NCT00160693|America College of Rheumatology|america college of rheumatology
493829|NCT00160693|Disease modifying anti-rheumatic drug|disease modifying anti-rheumatic drug
493830|NCT00160693|Certolizumab Pegol (CDP870)|certolizumab pegol (cdp870)
493831|NCT00160732|Islet Cell Transplant|islet cell transplant
493832|NCT00160732|Human islet cell infusion|human islet cell infusion
493833|NCT00160732|Juvenile-onset diabetes|juvenile-onset diabetes
493834|NCT00160745|endothelium, NO, renal, statins|endothelium, no, renal, statins
493835|NCT00160810|distal|distal
493836|NCT00160810|radius|radius
493837|NCT00160810|fractures|fractures
493838|NCT00160823|Colon cleansing|colon cleansing
493839|NCT00160823|Quality|quality
493840|NCT00160823|Cost-effectiveness|cost-effectiveness
493841|NCT00160836|Tissue diagnosis|tissue diagnosis
493842|NCT00160849|Treatment Experienced|treatment experienced
493843|NCT00160875|esophageal|esophageal
493844|NCT00160875|esophagus|esophagus
493845|NCT00160875|irinotecan|irinotecan
493846|NCT00160875|CPT11|cpt11
493847|NCT00160875|cisplatin|cisplatin
493848|NCT00160901|Breast cancer|breast cancer
493849|NCT00160901|Chemotherapy|chemotherapy
493850|NCT00160901|Phytotherapy|phytotherapy
493851|NCT00160901|Nutritional counseling|nutritional counseling
493852|NCT00160914|Childhood obesity|childhood obesity
493853|NCT00160927|microcirculation|microcirculation
493854|NCT00160927|Laser doppler flowmetry|laser doppler flowmetry
493855|NCT00160927|neuropathy|neuropathy
493856|NCT00160927|endothelial function|endothelial function
493857|NCT00160940|gene expression|gene expression
493858|NCT00160940|viral hepatitis|viral hepatitis
493859|NCT00160940|autoimmune disease|autoimmune disease
493860|NCT00160966|kidney transplantation|kidney transplantation
493861|NCT00160966|polyoma virus associated transplant nephropathy|polyoma virus associated transplant nephropathy
493862|NCT00160966|tacrolimus|tacrolimus
493863|NCT00160966|mycophenolate mofetil|mycophenolate mofetil
493864|NCT00160966|everolimus|everolimus
493865|NCT00160966|cyclosporin A|cyclosporin a
493866|NCT00160966|BK virus PCR|bk virus pcr
493867|NCT00160966|viruria screening|viruria screening
493868|NCT00160966|BK polyomavirus|bk polyomavirus
493869|NCT00160966|immunosuppression|immunosuppression
493870|NCT00160992|Adoptive cell transfer|adoptive cell transfer
493871|NCT00160992|peptide vaccination|peptide vaccination
493872|NCT00160992|melanoma|melanoma
493873|NCT00160992|immunosuppression and homeostatic proliferation|immunosuppression and homeostatic proliferation
493874|NCT00161005|Acute myocardial infarction|acute myocardial infarction
493875|NCT00161005|Fibrinolysis|fibrinolysis
493876|NCT00161005|Health effects /Quality of life|health effects /quality of life
493877|NCT00161057|Schizophrenia|schizophrenia
493878|NCT00161057|Medication-naive|medication-naive
493879|NCT00161057|Functional MRI|functional mri
493880|NCT00161057|Working memory|working memory
493881|NCT00161057|Language lateralization|language lateralization
493882|NCT00161057|schizoaffective disorder|schizoaffective disorder
493883|NCT00161057|psychotic disorder Not Otherwise Specified|psychotic disorder not otherwise specified
493884|NCT00161070|secondary prevention|secondary prevention
493885|NCT00161070|TIA / minor stroke|tia / minor stroke
493886|NCT00161070|atherosclerotic origin|atherosclerotic origin
493887|NCT00161070|TIA (Transient Ischemic Attack)|tia (transient ischemic attack)
493888|NCT00161070|prevention & control|prevention & control
493889|NCT00161083|ursodeoxycholic acid|ursodeoxycholic acid
493891|NCT00161083|complications|complications
493892|NCT00161083|pancreatitis|pancreatitis
493893|NCT00161083|gallbladder motility|gallbladder motility
493894|NCT00161083|colic|colic
493895|NCT00161096|on-demand therapy|on-demand therapy
493896|NCT00161096|pantoprazole|pantoprazole
493897|NCT00161096|gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
493898|NCT00161096|proton pump inhibitor|proton pump inhibitor
493899|NCT00161096|acid suppression|acid suppression
493900|NCT00161096|intermittent|intermittent
493901|NCT00161109|22q11.2 deletion syndrome|22q11.2 deletion syndrome
493902|NCT00161109|Psychopathology|psychopathology
493903|NCT00161109|Psychiatry|psychiatry
493904|NCT00161109|Neuropsychology|neuropsychology
493905|NCT00161109|Psychiophysiology|psychiophysiology
493906|NCT00161109|Autism|autism
493907|NCT00161109|Psychosis|psychosis
493908|NCT00161109|Deletion size|deletion size
493909|NCT00161109|Candidate genes|candidate genes
493910|NCT00161109|Psychiatric symptoms|psychiatric symptoms
493911|NCT00161109|Neuropsychological impairments|neuropsychological impairments
493912|NCT00161109|Psychophysiological performance|psychophysiological performance
493914|NCT00161135|PDD-NOS, MCDD|pdd-nos, mcdd
493915|NCT00161148|PSC|psc
493916|NCT00161148|Liver biochemistry|liver biochemistry
493917|NCT00161148|Probiotics|probiotics
493918|NCT00161148|Pruritus|pruritus
493919|NCT00161161|ADHD; MRI; genetics|adhd; mri; genetics
493920|NCT00161174|testicular cancer|testicular cancer
493921|NCT00161174|cardiovascular morbidity|cardiovascular morbidity
493922|NCT00161174|cardiovascular risk factors|cardiovascular risk factors
493923|NCT00161174|pharmacogenomic determinants|pharmacogenomic determinants
493924|NCT00161187|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
493925|NCT00161187|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
493926|NCT00161187|prolymphocytic leukemia|prolymphocytic leukemia
493927|NCT00161187|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
493928|NCT00161187|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
493929|NCT00161187|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
493930|NCT00161187|splenic marginal zone lymphoma|splenic marginal zone lymphoma
493931|NCT00161187|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
493932|NCT00161187|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
493933|NCT00161187|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
493934|NCT00161187|stage I multiple myeloma|stage i multiple myeloma
493935|NCT00161187|stage II multiple myeloma|stage ii multiple myeloma
493936|NCT00161187|stage III multiple myeloma|stage iii multiple myeloma
493937|NCT00161187|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
493938|NCT00161187|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
493939|NCT00161187|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
493940|NCT00161187|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
494011|NCT00161187|stage III cervical cancer|stage iii cervical cancer
493941|NCT00161187|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
493942|NCT00161187|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
493943|NCT00161187|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
493944|NCT00161187|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
493945|NCT00161187|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
493946|NCT00161187|anaplastic large cell lymphoma|anaplastic large cell lymphoma
493947|NCT00161187|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
493948|NCT00161187|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
493949|NCT00161187|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
493950|NCT00161187|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
493951|NCT00161187|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
493952|NCT00161187|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
493953|NCT00161187|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
493954|NCT00161187|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
493955|NCT00161187|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
493956|NCT00161187|recurrent renal cell cancer|recurrent renal cell cancer
493957|NCT00161187|stage IV renal cell cancer|stage iv renal cell cancer
493958|NCT00161187|recurrent bladder cancer|recurrent bladder cancer
493959|NCT00161187|stage IV bladder cancer|stage iv bladder cancer
493960|NCT00161187|recurrent prostate cancer|recurrent prostate cancer
493961|NCT00161187|stage IV prostate cancer|stage iv prostate cancer
493962|NCT00161187|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
493963|NCT00161187|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
493964|NCT00161187|recurrent gastric cancer|recurrent gastric cancer
493965|NCT00161187|stage IV gastric cancer|stage iv gastric cancer
493966|NCT00161187|recurrent pancreatic cancer|recurrent pancreatic cancer
493967|NCT00161187|stage IV pancreatic cancer|stage iv pancreatic cancer
493968|NCT00161187|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
493969|NCT00161187|recurrent adult primary liver cancer|recurrent adult primary liver cancer
493970|NCT00161187|recurrent childhood liver cancer|recurrent childhood liver cancer
493971|NCT00161187|recurrent colon cancer|recurrent colon cancer
493972|NCT00161187|stage IV colon cancer|stage iv colon cancer
493973|NCT00161187|recurrent rectal cancer|recurrent rectal cancer
493974|NCT00161187|stage IV rectal cancer|stage iv rectal cancer
493975|NCT00161187|recurrent breast cancer|recurrent breast cancer
493976|NCT00161187|stage IV breast cancer|stage iv breast cancer
493977|NCT00161187|extensive stage small cell lung cancer|extensive stage small cell lung cancer
493978|NCT00161187|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
493979|NCT00161187|recurrent small cell lung cancer|recurrent small cell lung cancer
493980|NCT00161187|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
493981|NCT00161187|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
493982|NCT00161187|recurrent cervical cancer|recurrent cervical cancer
493983|NCT00161187|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
493984|NCT00161187|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
493985|NCT00161187|chondrosarcoma|chondrosarcoma
493986|NCT00161187|recurrent osteosarcoma|recurrent osteosarcoma
493987|NCT00161187|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
493988|NCT00161187|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
493989|NCT00161187|ovarian sarcoma|ovarian sarcoma
493990|NCT00161187|recurrent uterine sarcoma|recurrent uterine sarcoma
494191|NCT00161343|STD|std
493991|NCT00161187|stage IV uterine sarcoma|stage iv uterine sarcoma
493992|NCT00161187|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
493993|NCT00161187|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
493994|NCT00161187|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
493995|NCT00161187|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
493996|NCT00161187|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
493997|NCT00161187|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
493998|NCT00161187|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
493999|NCT00161187|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
494000|NCT00161187|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
494001|NCT00161187|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
494002|NCT00161187|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
494003|NCT00161187|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
494004|NCT00161187|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
494005|NCT00161187|advanced adult primary liver cancer|advanced adult primary liver cancer
494006|NCT00161187|ovarian stromal cancer|ovarian stromal cancer
494007|NCT00161187|stage IA cervical cancer|stage ia cervical cancer
494008|NCT00161187|stage IB cervical cancer|stage ib cervical cancer
494009|NCT00161187|stage IIA cervical cancer|stage iia cervical cancer
494010|NCT00161187|stage IIB cervical cancer|stage iib cervical cancer
494012|NCT00161187|stage IVA cervical cancer|stage iva cervical cancer
494013|NCT00161187|stage IVB cervical cancer|stage ivb cervical cancer
494014|NCT00161187|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
494015|NCT00161187|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
494016|NCT00161187|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
494017|NCT00161187|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
494018|NCT00161187|recurrent endometrial carcinoma|recurrent endometrial carcinoma
494019|NCT00161187|stage I endometrial carcinoma|stage i endometrial carcinoma
494020|NCT00161187|stage II endometrial carcinoma|stage ii endometrial carcinoma
494021|NCT00161187|stage III endometrial carcinoma|stage iii endometrial carcinoma
494022|NCT00161187|stage IV endometrial carcinoma|stage iv endometrial carcinoma
494023|NCT00161187|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
494024|NCT00161187|stage III childhood liver cancer|stage iii childhood liver cancer
494025|NCT00161187|stage IV childhood liver cancer|stage iv childhood liver cancer
494026|NCT00161187|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
494027|NCT00161187|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
494028|NCT00161187|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
494029|NCT00161187|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
494170|NCT00161213|recurrent pancreatic cancer|recurrent pancreatic cancer
753940|NCT01178346|Health Outcomes|health outcomes
494030|NCT00161187|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
494031|NCT00161187|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
494032|NCT00161187|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
494033|NCT00161187|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
494034|NCT00161187|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
494035|NCT00161187|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
494036|NCT00161187|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
494037|NCT00161187|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
494038|NCT00161187|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
494039|NCT00161187|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
494040|NCT00161187|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
494041|NCT00161187|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
494042|NCT00161187|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
494043|NCT00161187|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
494044|NCT00161187|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
494045|NCT00161187|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
494046|NCT00161187|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
494047|NCT00161187|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
494048|NCT00161187|stage I marginal zone lymphoma|stage i marginal zone lymphoma
494049|NCT00161187|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
494050|NCT00161187|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
494051|NCT00161187|localized osteosarcoma|localized osteosarcoma
494052|NCT00161187|metastatic osteosarcoma|metastatic osteosarcoma
494053|NCT00161187|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
494054|NCT00161187|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
494055|NCT00161187|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
494056|NCT00161187|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
494057|NCT00161187|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
494058|NCT00161187|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
494059|NCT00161187|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
494060|NCT00161187|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
494061|NCT00161187|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
494062|NCT00161187|limited stage small cell lung cancer|limited stage small cell lung cancer
494063|NCT00161187|refractory multiple myeloma|refractory multiple myeloma
494064|NCT00161187|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
494065|NCT00161187|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
494066|NCT00161187|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
494067|NCT00161187|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
494068|NCT00161187|stage I bladder cancer|stage i bladder cancer
494069|NCT00161187|stage II bladder cancer|stage ii bladder cancer
494070|NCT00161187|stage III bladder cancer|stage iii bladder cancer
494072|NCT00161187|stage I breast cancer|stage i breast cancer
494073|NCT00161187|stage II breast cancer|stage ii breast cancer
494074|NCT00161187|stage IIIA breast cancer|stage iiia breast cancer
494075|NCT00161187|stage IIIB breast cancer|stage iiib breast cancer
494076|NCT00161187|stage IIIC breast cancer|stage iiic breast cancer
494077|NCT00161187|stage I colon cancer|stage i colon cancer
494078|NCT00161187|stage II colon cancer|stage ii colon cancer
494438|NCT00163423|Asthma|asthma
494079|NCT00161187|stage III colon cancer|stage iii colon cancer
494080|NCT00161187|stage I gastric cancer|stage i gastric cancer
494081|NCT00161187|stage II gastric cancer|stage ii gastric cancer
494082|NCT00161187|stage III gastric cancer|stage iii gastric cancer
494083|NCT00161187|stage I non-small cell lung cancer|stage i non-small cell lung cancer
494084|NCT00161187|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
494085|NCT00161187|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
494086|NCT00161187|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
494087|NCT00161187|stage I pancreatic cancer|stage i pancreatic cancer
494088|NCT00161187|stage II pancreatic cancer|stage ii pancreatic cancer
494089|NCT00161187|stage III pancreatic cancer|stage iii pancreatic cancer
494090|NCT00161187|stage I prostate cancer|stage i prostate cancer
494091|NCT00161187|stage II prostate cancer|stage ii prostate cancer
494092|NCT00161187|stage III prostate cancer|stage iii prostate cancer
494093|NCT00161187|stage I rectal cancer|stage i rectal cancer
494094|NCT00161187|stage II rectal cancer|stage ii rectal cancer
494095|NCT00161187|stage III rectal cancer|stage iii rectal cancer
494096|NCT00161187|stage I renal cell cancer|stage i renal cell cancer
494097|NCT00161187|stage II renal cell cancer|stage ii renal cell cancer
494098|NCT00161187|stage III renal cell cancer|stage iii renal cell cancer
494099|NCT00161187|stage I uterine sarcoma|stage i uterine sarcoma
494100|NCT00161187|stage II uterine sarcoma|stage ii uterine sarcoma
494101|NCT00161187|stage III uterine sarcoma|stage iii uterine sarcoma
494102|NCT00161187|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
753941|NCT01178346|Smoking|smoking
494103|NCT00161187|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
494104|NCT00161187|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
494105|NCT00161187|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
494106|NCT00161187|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
494107|NCT00161187|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
494108|NCT00161187|stage I mantle cell lymphoma|stage i mantle cell lymphoma
494109|NCT00161187|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
494110|NCT00161187|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
637169|NCT00729235|during|during
493500|NCT00152893|HIV|hiv
494111|NCT00161187|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
494112|NCT00161187|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
494113|NCT00161187|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
494114|NCT00161187|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
494115|NCT00161187|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
494116|NCT00161187|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
494117|NCT00161187|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
494118|NCT00161187|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
494119|NCT00161187|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
494120|NCT00161187|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
494121|NCT00161187|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
494122|NCT00161187|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
494123|NCT00161187|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
494124|NCT00161187|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
494125|NCT00161187|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
494126|NCT00161187|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
494127|NCT00161187|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
494128|NCT00161187|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
494129|NCT00161187|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
494130|NCT00161187|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
494131|NCT00161187|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
494132|NCT00161187|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
494133|NCT00161187|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
494134|NCT00161187|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
494135|NCT00161187|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
494136|NCT00161187|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
494137|NCT00161187|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
494138|NCT00161187|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
494139|NCT00161187|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
494140|NCT00161187|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
494141|NCT00161187|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
494142|NCT00161187|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
494143|NCT00161187|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
494144|NCT00161187|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
494145|NCT00161187|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
494146|NCT00161187|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
494147|NCT00161187|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
494148|NCT00161187|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
494149|NCT00161187|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
494150|NCT00161187|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
494151|NCT00161187|Burkitt lymphoma|burkitt lymphoma
494152|NCT00161187|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
494153|NCT00161187|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
494154|NCT00161187|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
494155|NCT00161187|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
494156|NCT00161187|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
494157|NCT00161187|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
494158|NCT00161187|childhood renal cell carcinoma|childhood renal cell carcinoma
494159|NCT00161187|stage IA melanoma|stage ia melanoma
494160|NCT00161187|stage IB melanoma|stage ib melanoma
494161|NCT00161187|stage IIA melanoma|stage iia melanoma
494162|NCT00161187|stage IIB melanoma|stage iib melanoma
494163|NCT00161187|stage IIC melanoma|stage iic melanoma
494164|NCT00161187|stage IIIA melanoma|stage iiia melanoma
494165|NCT00161187|stage IIIB melanoma|stage iiib melanoma
494166|NCT00161187|stage IIIC melanoma|stage iiic melanoma
494167|NCT00161187|stage IV melanoma|stage iv melanoma
494168|NCT00161187|recurrent melanoma|recurrent melanoma
494169|NCT00161200|Esophageal Metaplasia|esophageal metaplasia
494171|NCT00161213|stage IV pancreatic cancer|stage iv pancreatic cancer
494172|NCT00161213|stage III pancreatic cancer|stage iii pancreatic cancer
494173|NCT00161213|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
494174|NCT00161213|stage II pancreatic cancer|stage ii pancreatic cancer
494176|NCT00161239|T-Cell Lymphomas|t-cell lymphomas
493608|NCT00153621|HIV|hiv
494178|NCT00161291|Carcinoma of the breast|carcinoma of the breast
494179|NCT00161291|Breast cancer|breast cancer
494180|NCT00161330|urinary tract infection,|urinary tract infection,
494181|NCT00161330|antibiotic treatment|antibiotic treatment
494182|NCT00161330|childhood|childhood
494183|NCT00161330|amoxicilline/clavulanic acid|amoxicilline/clavulanic acid
494184|NCT00161330|ceftriaxone|ceftriaxone
494185|NCT00161330|renal ultrasonography|renal ultrasonography
494186|NCT00161330|renal scintigraphy|renal scintigraphy
494188|NCT00161343|Prevention Intervention|prevention intervention
494189|NCT00161343|Female|female
494190|NCT00161343|Adolescents|adolescents
494192|NCT00161343|HIV Seronegativity|hiv seronegativity
494193|NCT00161369|homocysteine|homocysteine
494194|NCT00161369|asymmetric dimethylarginine|asymmetric dimethylarginine
494195|NCT00161369|atherosclerosis|atherosclerosis
494196|NCT00161369|cardiovascular event|cardiovascular event
494197|NCT00161369|hemodialysis|hemodialysis
494198|NCT00161382|HIV Seronegativity|hiv seronegativity
494199|NCT00161382|HIV|hiv
494200|NCT00161395|fertility|fertility
494201|NCT00161395|pregnancy|pregnancy
494202|NCT00161408|schizophrenia, first episode, cognitive behavioural therapy, psychoeducation|schizophrenia, first episode, cognitive behavioural therapy, psychoeducation
494203|NCT00161421|Male Contraception|male contraception
494204|NCT00161421|Testosterone|testosterone
494205|NCT00161421|Hypogonadism|hypogonadism
494206|NCT00161434|HIV-1|hiv-1
494207|NCT00161447|Male contraception|male contraception
494208|NCT00161447|testosterone|testosterone
494209|NCT00161447|acyline|acyline
494210|NCT00161460|Colorectal cancer|colorectal cancer
494211|NCT00161460|Mass screening|mass screening
494212|NCT00161473|double-blind|double-blind
494213|NCT00161473|treatment|treatment
494214|NCT00161473|prazosin|prazosin
494215|NCT00161486|Male contraception|male contraception
494216|NCT00161486|Prostate|prostate
494217|NCT00161486|Acyline|acyline
494218|NCT00161486|Androgen replacement|androgen replacement
494219|NCT00161525|Subretinal Hemorrhage, Perfluorocarbon gas|subretinal hemorrhage, perfluorocarbon gas
494220|NCT00161538|Cardiac Pacing, artificial|cardiac pacing, artificial
494221|NCT00161538|Atrial fibrillation|atrial fibrillation
494222|NCT00161538|Pacemaker leads|pacemaker leads
494223|NCT00161538|Lead positions|lead positions
494224|NCT00161551|Cardiac Pacing, artificial|cardiac pacing, artificial
494225|NCT00161551|Atrial Fibrillation|atrial fibrillation
494226|NCT00161551|Heart Failure|heart failure
494227|NCT00161551|Pacemaker leads|pacemaker leads
494228|NCT00161551|Pacing Mode|pacing mode
494229|NCT00161564|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
494230|NCT00161564|ITP|itp
494231|NCT00161564|Non-Malignant Hematology|non-malignant hematology
494232|NCT00161577|Ketorolac|ketorolac
494233|NCT00161590|NK cell lymphoma|nk cell lymphoma
494234|NCT00161590|Null cell lymphoma|null cell lymphoma
494235|NCT00161603|Angioplasty|angioplasty
494236|NCT00161603|Behavior change|behavior change
494237|NCT00161603|Physical activity|physical activity
494238|NCT00161603|Risk reduction|risk reduction
494239|NCT00161616|Open Diaphyseal Tibia Fractures|open diaphyseal tibia fractures
494240|NCT00161629|Distal Radius Fractures|distal radius fractures
494241|NCT00161642|Malignant Tumors|malignant tumors
494242|NCT00161655|Psoriasis|psoriasis
494243|NCT00161655|Arthritis|arthritis
494244|NCT00161668|Leukemia|leukemia
494245|NCT00161681|Levonorgestrel|levonorgestrel
494246|NCT00161681|ethinyl estradiol|ethinyl estradiol
494247|NCT00161681|premenstrual syndrome|premenstrual syndrome
494248|NCT00161681|menstrual cycle related symptoms|menstrual cycle related symptoms
494249|NCT00161694|pain control|pain control
494250|NCT00161720|Severe Congenital Protein C Deficiency|severe congenital protein c deficiency
494251|NCT00161733|Cardiopulmonary bypass|cardiopulmonary bypass
494252|NCT00161733|Median sternotomy|median sternotomy
494253|NCT00161733|Fibrin sealant|fibrin sealant
494255|NCT00161733|Cardiac surgery|cardiac surgery
494256|NCT00161746|Tick-Borne Encephalitis|tick-borne encephalitis
494257|NCT00161837|Influenza|influenza
494258|NCT00161837|Vaccine|vaccine
494259|NCT00161876|tick-borne encephalitis|tick-borne encephalitis
494260|NCT00161902|Arthroplasty|arthroplasty
494261|NCT00161902|Hip Prosthesis|hip prosthesis
494262|NCT00161902|Cement Free Hip Prosthesis|cement free hip prosthesis
494263|NCT00161902|Femur Head Necrosis|femur head necrosis
494264|NCT00161902|Coxarthrosis|coxarthrosis
494265|NCT00161915|Liver cirrhosis|liver cirrhosis
494266|NCT00161928|Meningococcal Vaccine|meningococcal vaccine
494267|NCT00161928|Meningococcal Meningitis, Serogroup C|meningococcal meningitis, serogroup c
494268|NCT00161928|Neisseria Meningitidis|neisseria meningitidis
494269|NCT00161941|Meningococcal Vaccine|meningococcal vaccine
494187|NCT00161343|HIV|hiv
494270|NCT00161941|Meningococcal Meningitis, Serogroup C|meningococcal meningitis, serogroup c
494271|NCT00161941|Neisseria Meningitidis|neisseria meningitidis
494272|NCT00161954|Tick-Borne Encephalitis|tick-borne encephalitis
494273|NCT00161967|tick-borne encephalitis|tick-borne encephalitis
494274|NCT00161980|Axillary wound|axillary wound
493694|NCT00160004|Exercise|exercise
494276|NCT00161980|Fistulae|fistulae
494277|NCT00161993|Gammaglobulin|gammaglobulin
494278|NCT00162006|Chronic idiopathic thrombocytopenic purpura|chronic idiopathic thrombocytopenic purpura
494279|NCT00162019|Factor VIII Deficiency|factor viii deficiency
494280|NCT00162123|ipilimumab|ipilimumab
494281|NCT00162123|previously treated|previously treated
494282|NCT00162214|Advanced Solid Tumors|advanced solid tumors
494283|NCT00162240|Metabolics Diabetes New Onset|metabolics diabetes new onset
494284|NCT00156533|Insomnia|insomnia
494285|NCT00156533|Sleep|sleep
494286|NCT00156533|zolpidem|zolpidem
494287|NCT00156533|Ambien|ambien
494288|NCT00156533|Hypnotics|hypnotics
494289|NCT00156546|Urinary tract infections|urinary tract infections
494290|NCT00156546|Children|children
494291|NCT00156546|Antibiotic prophylaxis|antibiotic prophylaxis
494292|NCT00156546|Renal scintigraphy|renal scintigraphy
494293|NCT00156546|Vesico ureteral reflux|vesico ureteral reflux
494294|NCT00156559|immunization|immunization
494295|NCT00156559|vaccine|vaccine
494296|NCT00156559|low birth weight infant|low birth weight infant
494297|NCT00156559|premature infant|premature infant
494298|NCT00156585|cerebral metastases|cerebral metastases
494299|NCT00156585|dynamic contrast enhanced magnetic resonance imaging|dynamic contrast enhanced magnetic resonance imaging
494300|NCT00156585|DCE-MRI|dce-mri
494301|NCT00156585|gamma knife|gamma knife
494302|NCT00156598|metal ion concentration|metal ion concentration
494303|NCT00156611|peripheral vascular disease|peripheral vascular disease
494304|NCT00156611|intervention|intervention
494305|NCT00156611|restenosis|restenosis
494306|NCT00156611|Age above 18 years|age above 18 years
494307|NCT00156624|Intervention|intervention
494308|NCT00156624|Peripheral Vascular Disease|peripheral vascular disease
494309|NCT00156624|Drug|drug
494310|NCT00156624|Restenosis|restenosis
494311|NCT00156624|18 years and above|18 years and above
494312|NCT00156637|schizophrenia|schizophrenia
494313|NCT00156637|quality of health care|quality of health care
494314|NCT00156637|quality indicators|quality indicators
494315|NCT00156637|intervention studies|intervention studies
494316|NCT00156650|Male contraception|male contraception
494317|NCT00156650|Testosterone|testosterone
494318|NCT00156663|Women|women
494319|NCT00156663|Veterans|veterans
494320|NCT00156663|Delivery of Healthcare|delivery of healthcare
494321|NCT00156663|Intervention Studies|intervention studies
494322|NCT00156663|United States Department of Veterans Affairs|united states department of veterans affairs
494323|NCT00156663|Women's Health|women's health
494324|NCT00156676|Disability|disability
494325|NCT00156676|Gait|gait
494326|NCT00156676|Multiple Sclerosis|multiple sclerosis
494327|NCT00156676|Rehabilitation|rehabilitation
494328|NCT00156676|Robot|robot
494329|NCT00156689|polyneuropathy|polyneuropathy
494330|NCT00156702|Smoking|smoking
494331|NCT00156702|Adolescents|adolescents
494332|NCT00156702|Motivational Interviewing|motivational interviewing
494333|NCT00156715|Quetiapine|quetiapine
494334|NCT00156715|Seroquel|seroquel
494335|NCT00156715|Schizophrenia|schizophrenia
494336|NCT00156715|Dual Diagnosis|dual diagnosis
494337|NCT00156715|Substance Abuse|substance abuse
494338|NCT00156715|Alcohol Abuse|alcohol abuse
494339|NCT00156728|Pacemaker artificial, congestive heart failure and atrial fibrillation|pacemaker artificial, congestive heart failure and atrial fibrillation
494340|NCT00156741|Refined ventricular pacing|refined ventricular pacing
494341|NCT00156767|Critical Care|critical care
494342|NCT00156767|Adrenal Insufficiency|adrenal insufficiency
494343|NCT00156767|Septic Shock|septic shock
494344|NCT00156767|Cortrosyn|cortrosyn
494345|NCT00156767|Steroids|steroids
494346|NCT00156767|Cortisol|cortisol
494347|NCT00156767|Critical Care Unit|critical care unit
494348|NCT00156767|Adrenal Gland Function|adrenal gland function
494349|NCT00156780|ultrasound contrast agent|ultrasound contrast agent
494350|NCT00156780|pharmacokinetics|pharmacokinetics
494351|NCT00156780|congestive heart failure|congestive heart failure
494352|NCT00156780|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
494354|NCT00162396|Albuterol|albuterol
494355|NCT00162396|β2 Adrenergic receptor|β2 adrenergic receptor
494356|NCT00162396|Polymorphism|polymorphism
494357|NCT00162448|Patients requiring dual-chamber pacemakers or defibrillators|patients requiring dual-chamber pacemakers or defibrillators
494358|NCT00162461|Healthy Volunteers|healthy volunteers
494359|NCT00162474|Healthy Volunteers|healthy volunteers
494360|NCT00162500|Metastatic solid tumors|metastatic solid tumors
494361|NCT00162539|foetal thyroid mensuration|foetal thyroid mensuration
494362|NCT00162552|multicenter-randomized-trial|multicenter-randomized-trial
494363|NCT00162552|pentoxifyllinE|pentoxifylline
494364|NCT00162552|placebo|placebo
494365|NCT00162552|cirrhosis|cirrhosis
494366|NCT00162552|liver failure|liver failure
494367|NCT00162552|cytokine|cytokine
494368|NCT00162565|Heart Failure, Congestive|heart failure, congestive
494369|NCT00162565|beta-Adrenergic Blockers|beta-adrenergic blockers
494370|NCT00162578|pneumococcal meningitis|pneumococcal meningitis
494371|NCT00162578|intensive care unit|intensive care unit
494372|NCT00162578|vancomycin|vancomycin
494373|NCT00162578|dexamethasone|dexamethasone
494374|NCT00162578|drug diffusion in cerebrospinal fluid|drug diffusion in cerebrospinal fluid
494375|NCT00162591|Bispectral index|bispectral index
494376|NCT00162591|sedation|sedation
494377|NCT00162591|remifentanyl|remifentanyl
494378|NCT00162591|Bronchoalveolar lavage|bronchoalveolar lavage
494379|NCT00162591|Intensive care|intensive care
494380|NCT00162591|Nociceptive stimuli|nociceptive stimuli
494381|NCT00162591|Sedated patient|sedated patient
494382|NCT00162591|BIS variation|bis variation
494383|NCT00162604|Prophylactic antibiotic|prophylactic antibiotic
494384|NCT00162604|Postoperative infections|postoperative infections
494385|NCT00162604|Uterine prolapse grade I - II|uterine prolapse grade i - ii
494386|NCT00162604|cystocele|cystocele
494387|NCT00162604|rectocele|rectocele
494388|NCT00162604|enterocele|enterocele
494389|NCT00162604|defects of the perineal body|defects of the perineal body
494390|NCT00162617|Hip fracture|hip fracture
494391|NCT00162617|Rehabilitation|rehabilitation
494392|NCT00162617|Transfusion|transfusion
494393|NCT00162617|Outcome|outcome
494394|NCT00162630|Hip fracture, pain, regional anaesthesia, analgesia|hip fracture, pain, regional anaesthesia, analgesia
494395|NCT00162643|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
494396|NCT00162643|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
494397|NCT00162643|Protease Inhibitors|protease inhibitors
494398|NCT00162643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
494399|NCT00163280|Mucositis|mucositis
494400|NCT00163280|Peripheral blood stem cell transplant|peripheral blood stem cell transplant
494401|NCT00163293|Asthma|asthma
494402|NCT00163293|Ciclesonide|ciclesonide
494403|NCT00163293|Exacerbation|exacerbation
494404|NCT00163306|Gastroesophageal Reflux|gastroesophageal reflux
494405|NCT00163306|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
494406|NCT00163306|Pantoprazole|pantoprazole
494407|NCT00163319|Asthma|asthma
494408|NCT00163319|Ciclesonide|ciclesonide
494409|NCT00163319|Fluticasone propionate|fluticasone propionate
494410|NCT00163332|Asthma|asthma
494411|NCT00163332|Ciclesonide|ciclesonide
494412|NCT00163332|Fluticasone propionate|fluticasone propionate
494413|NCT00163345|Asthma|asthma
494414|NCT00163345|Ciclesonide|ciclesonide
494415|NCT00163345|Small Airways|small airways
494416|NCT00163358|Asthma|asthma
494417|NCT00163358|Ciclesonide|ciclesonide
494418|NCT00163358|Fluticasone propionate|fluticasone propionate
494419|NCT00163358|Salmeterol|salmeterol
494420|NCT00163371|Asthma|asthma
494421|NCT00163371|Ciclesonide|ciclesonide
494422|NCT00163371|Child|child
494423|NCT00163371|Fluticasone propionate|fluticasone propionate
494424|NCT00163371|HPA-axis|hpa-axis
494425|NCT00163371|Pediatric|pediatric
494426|NCT00163371|Linear growth rate|linear growth rate
494427|NCT00163384|Asthma|asthma
494428|NCT00163384|Ciclesonide|ciclesonide
494429|NCT00163384|Budesonide|budesonide
494430|NCT00163397|Asthma|asthma
494431|NCT00163397|Ciclesonide|ciclesonide
494432|NCT00163397|Budesonide|budesonide
494433|NCT00163410|Asthma|asthma
494434|NCT00163410|Ciclesonide|ciclesonide
494435|NCT00163410|Child|child
494436|NCT00163410|Fluticasone propionate|fluticasone propionate
494437|NCT00163410|Pediatric|pediatric
494439|NCT00163423|Ciclesonide|ciclesonide
494440|NCT00163423|Fluticasone propionate|fluticasone propionate
494442|NCT00163436|Ciclesonide|ciclesonide
494443|NCT00163449|Asthma|asthma
494444|NCT00163449|Ciclesonide|ciclesonide
494445|NCT00163449|Child|child
494446|NCT00163449|Pediatric|pediatric
494447|NCT00163462|Asthma|asthma
494448|NCT00163462|Ciclesonide|ciclesonide
494449|NCT00163462|Child|child
494450|NCT00163462|Fluticasone propionate|fluticasone propionate
494451|NCT00163462|Pediatric|pediatric
494452|NCT00163475|Asthma|asthma
494453|NCT00163475|Roflumilast|roflumilast
494454|NCT00163488|Allergy|allergy
494455|NCT00163488|Perennial Allergic Rhinitis|perennial allergic rhinitis
494456|NCT00163488|Allergic Rhinitis|allergic rhinitis
494457|NCT00163488|Hay Fever|hay fever
494458|NCT00163501|Allergy|allergy
494459|NCT00163501|Perennial Allergic Rhinitis|perennial allergic rhinitis
494460|NCT00163501|Allergic Rhinitis|allergic rhinitis
494461|NCT00163501|Hay Fever|hay fever
494462|NCT00163514|Allergy|allergy
494463|NCT00163514|Perennial Allergic Rhinitis|perennial allergic rhinitis
494464|NCT00163514|Allergic Rhinitis|allergic rhinitis
494465|NCT00163514|Hay Fever|hay fever
494466|NCT00163527|Asthma|asthma
494467|NCT00163527|Roflumilast|roflumilast
494468|NCT00163527|Corticosteroids|corticosteroids
494469|NCT00163540|tick-borne encephalitis|tick-borne encephalitis
494470|NCT00163553|spinal surgery|spinal surgery
494471|NCT00163553|pethidine|pethidine
494472|NCT00163553|analgesia|analgesia
494473|NCT00163566|libido|libido
494474|NCT00163566|depression strength|depression strength
494475|NCT00163566|testosterone|testosterone
493890|NCT00161083|gallstone|gallstone
494476|NCT00163566|dihydrotestosterone|dihydrotestosterone
494477|NCT00163579|premature birth|premature birth
494478|NCT00163579|cerclage|cerclage
494479|NCT00163579|tocolysis|tocolysis
494480|NCT00163579|drug therapy|drug therapy
494481|NCT00163592|Vascular reconstruction|vascular reconstruction
494482|NCT00163592|Polytetraflouroethylene (PTFE) prosthesis|polytetraflouroethylene (ptfe) prosthesis
494483|NCT00163605|Sinus augmentation|sinus augmentation
494484|NCT00163605|Alloplastic bone substitute|alloplastic bone substitute
494485|NCT00163605|Hydroxyl apatite|hydroxyl apatite
494486|NCT00163618|tick-borne encephalitis|tick-borne encephalitis
494487|NCT00163644|Hematological malignancies.|hematological malignancies.
494488|NCT00163644|Bone- marrow/ haemopoetic transplant|bone- marrow/ haemopoetic transplant
494489|NCT00163644|Exercise|exercise
494490|NCT00163657|Hepatitis C Virus|hepatitis c virus
494491|NCT00163657|Immunosuppressive Agents|immunosuppressive agents
494492|NCT00163683|Dietary Intervention|dietary intervention
494493|NCT00163696|MBNW|mbnw
494494|NCT00163696|Ventilation|ventilation
494495|NCT00163696|small airways|small airways
494496|NCT00163696|Lung Transplant recipients (Bronchiolitis Obliterans syndrome)|lung transplant recipients (bronchiolitis obliterans syndrome)
494497|NCT00163709|Atrial natriuretic factor.|atrial natriuretic factor.
494498|NCT00163709|Biochemistry.|biochemistry.
494499|NCT00163709|Cardiac failure.|cardiac failure.
494500|NCT00163709|Randomised trials.|randomised trials.
494501|NCT00163709|Hormones.|hormones.
494502|NCT00163709|Systolic heart failure.|systolic heart failure.
494503|NCT00163709|Diastolic heart failure.|diastolic heart failure.
494504|NCT00163709|Ischaemic cardiomyopathy.|ischaemic cardiomyopathy.
494505|NCT00163709|Ventricular hypertrophy.|ventricular hypertrophy.
494506|NCT00163709|AMI|ami
494507|NCT00163735|Food allergy|food allergy
494508|NCT00163735|wine|wine
494509|NCT00163735|milk allergy|milk allergy
494510|NCT00163735|egg allergy|egg allergy
494511|NCT00163735|nut allergy|nut allergy
494512|NCT00163735|fish allergy|fish allergy
494513|NCT00163748|Lymphoma|lymphoma
494514|NCT00163761|Lymphoma|lymphoma
494515|NCT00163787|mobility|mobility
494516|NCT00163787|falls|falls
494517|NCT00163787|activity level|activity level
494518|NCT00163800|Outcome predictors|outcome predictors
494519|NCT00163800|Acute brain injury|acute brain injury
494520|NCT00163813|Mechanically-ventilated|mechanically-ventilated
494521|NCT00163813|medical-surgical critically ill patients|medical-surgical critically ill patients
494522|NCT00163813|reduced gastric motility|reduced gastric motility
494523|NCT00163826|cervical spine injury|cervical spine injury
494524|NCT00163826|multiple trauma|multiple trauma
494525|NCT00163839|Dietary Intervention|dietary intervention
494526|NCT00163839|Pseudoallergen free diet|pseudoallergen free diet
494527|NCT00163852|Cystic fibrosis|cystic fibrosis
494528|NCT00163852|Metabolic alkalosis|metabolic alkalosis
494529|NCT00163852|Hypercapnia|hypercapnia
494530|NCT00163852|Salt replacement|salt replacement
494531|NCT00163865|Boredom|boredom
494532|NCT00163865|Adolescent|adolescent
494533|NCT00163865|Mental illness|mental illness
494534|NCT00163865|Depression|depression
494535|NCT00163865|Anxiety|anxiety
494536|NCT00163878|Sensory Stimulation Programs|sensory stimulation programs
494537|NCT00163891|Respiratory Therapy|respiratory therapy
494538|NCT00163891|Postoperative Care|postoperative care
494539|NCT00163891|Treatment Outcome|treatment outcome
494540|NCT00163904|Heart Failure|heart failure
494541|NCT00163904|Inflammatory mediators|inflammatory mediators
494542|NCT00163904|insulin sensitivity|insulin sensitivity
494543|NCT00163904|overweight|overweight
494544|NCT00163904|high monounsaturated diet|high monounsaturated diet
494545|NCT00163917|Hypnosis|hypnosis
494546|NCT00163917|Analgesia|analgesia
494547|NCT00163930|Uterine Fibroids|uterine fibroids
494548|NCT00163930|embolisation|embolisation
494549|NCT00163930|pain management|pain management
494550|NCT00163943|Metabolic syndrome|metabolic syndrome
494551|NCT00163943|Sympathetic nervous system activity|sympathetic nervous system activity
494552|NCT00163943|Insulin sensitivity|insulin sensitivity
494553|NCT00163943|weight loss|weight loss
494554|NCT00163943|aerobic exercise|aerobic exercise
494555|NCT00163956|IVC filters|ivc filters
494556|NCT00163956|failed retrieval|failed retrieval
494557|NCT00163969|Pain|pain
494558|NCT00163969|Wind-up|wind-up
494559|NCT00163969|opioid|opioid
494560|NCT00163969|ketamine|ketamine
494561|NCT00163969|pre-emptive|pre-emptive
494562|NCT00163982|HVPG > 12 mmHg|hvpg > 12 mmhg
494563|NCT00163995|Chronic Liver Disease|chronic liver disease
494564|NCT00164021|gastroesophageal reflux, gastric reflux, acid reflux, lung transplantation, physiotherapy, anti-reflux medication|gastroesophageal reflux, gastric reflux, acid reflux, lung transplantation, physiotherapy, anti-reflux medication
494565|NCT00164034|Trauma|trauma
494566|NCT00164034|Wounds|wounds
494567|NCT00164034|Injuries|injuries
494568|NCT00164047|Nitrous Oxide|nitrous oxide
494569|NCT00164047|Anaesthesia|anaesthesia
494570|NCT00164047|Anesthesia|anesthesia
494571|NCT00164047|Recovery|recovery
494572|NCT00164047|Quality|quality
494573|NCT00164060|HCV|hcv
494574|NCT00164060|HIV co-infection|hiv co-infection
494575|NCT00164073|HCV and microarray|hcv and microarray
494576|NCT00164073|HCV|hcv
494577|NCT00164099|Coronary Artery Bypass|coronary artery bypass
494578|NCT00164099|Postoperative Complications|postoperative complications
494579|NCT00164099|Probiotics|probiotics
494580|NCT00164099|Surgical Wound infection|surgical wound infection
494581|NCT00164099|cystitis|cystitis
494582|NCT00164099|bacteremia|bacteremia
494583|NCT00164099|pneumonia|pneumonia
494584|NCT00164099|Enterocolitis, Pseudomembranous|enterocolitis, pseudomembranous
494585|NCT00164112|Cooperstown Cocktail|cooperstown cocktail
494586|NCT00164112|Drug Metabolizing Enzymes|drug metabolizing enzymes
494587|NCT00164112|Drug Interactions|drug interactions
494588|NCT00164112|Phenotyping|phenotyping
494589|NCT00164138|Incontinence|incontinence
494590|NCT00164138|physiotherapy|physiotherapy
494591|NCT00164138|treatment|treatment
494592|NCT00164138|pelvic floor muscle function|pelvic floor muscle function
494593|NCT00164138|coughing|coughing
494594|NCT00164138|forced expirations|forced expirations
494595|NCT00164138|lung disease|lung disease
494596|NCT00164151|colonoscopy preparation|colonoscopy preparation
494597|NCT00164151|prep|prep
494598|NCT00164164|colonoscopy preparation|colonoscopy preparation
494599|NCT00164164|prep|prep
494600|NCT00164177|virtual colonoscopy|virtual colonoscopy
494601|NCT00164177|colonoscopy preparation|colonoscopy preparation
494602|NCT00164177|bowel prep|bowel prep
494603|NCT00164190|Myocardial Infarction|myocardial infarction
494604|NCT00164190|Thrombolysis|thrombolysis
494605|NCT00164190|Angioplasty|angioplasty
494606|NCT00164190|ST Elevation Myocardial Infarction|st elevation myocardial infarction
494607|NCT00164216|malaria|malaria
494608|NCT00164216|combination therapy|combination therapy
494609|NCT00164216|mefloquine|mefloquine
494610|NCT00164216|artesunate|artesunate
494611|NCT00164216|Peru|peru
494612|NCT00164216|malaria, uncomplicated|malaria, uncomplicated
494613|NCT00164229|treatment|treatment
494614|NCT00164229|control|control
494615|NCT00164242|Tardive dyskinesia|tardive dyskinesia
494616|NCT00164242|Galantamine|galantamine
494617|NCT00164242|Cholinesterase inhibitors|cholinesterase inhibitors
494618|NCT00164255|malaria|malaria
494619|NCT00164255|birthweight|birthweight
494620|NCT00164255|placental malaria|placental malaria
494621|NCT00164255|intermittent protective treatment|intermittent protective treatment
494622|NCT00164255|sulfadoxine/ pyrimethamine|sulfadoxine/ pyrimethamine
494623|NCT00164255|artesuate|artesuate
494624|NCT00164255|combination therapy|combination therapy
494625|NCT00164255|Pregnancy|pregnancy
494626|NCT00164268|Intimate partner violence|intimate partner violence
494627|NCT00164268|Sexual violence|sexual violence
494628|NCT00164268|Cultural intervention|cultural intervention
494629|NCT00164268|Native Hawaiian|native hawaiian
494630|NCT00164281|TB|tb
494631|NCT00164281|Tuberculosis|tuberculosis
494632|NCT00164281|INH|inh
494633|NCT00164281|Isoniazid|isoniazid
494634|NCT00164281|Preventive therapy|preventive therapy
494635|NCT00164281|HIV|hiv
494636|NCT00164281|AIDS|aids
494637|NCT00164281|Botswana|botswana
494638|NCT00164281|LTBI|ltbi
494639|NCT00164281|Latent TB Infection|latent tb infection
494640|NCT00164346|fetal alcohol syndrome (FAS)|fetal alcohol syndrome (fas)
494641|NCT00164346|alcohol-related neurodevelopmental disorder (ARND)|alcohol-related neurodevelopmental disorder (arnd)
494642|NCT00164359|malaria, falciparum|malaria, falciparum
494643|NCT00164359|antimalarials|antimalarials
494644|NCT00164372|IV Drug users|iv drug users
494645|NCT00164372|HIV|hiv
494646|NCT00164372|hepatitis C virus|hepatitis c virus
494647|NCT00164372|HIV Seronegativity|hiv seronegativity
494648|NCT00164385|HIV/AIDS|hiv/aids
494649|NCT00164398|HIV|hiv
494650|NCT00164411|Diptheria-Tetanus vaccine|diptheria-tetanus vaccine
494651|NCT00164411|Pneumococcal vaccine|pneumococcal vaccine
494652|NCT00164411|Adverse events following vaccination|adverse events following vaccination
494653|NCT00164411|Immunization|immunization
494654|NCT00164411|Immunogenicity|immunogenicity
494655|NCT00164424|HSV2|hsv2
494656|NCT00164424|genital ulcer|genital ulcer
494657|NCT00164424|HIV|hiv
494658|NCT00164424|South Africa|south africa
494659|NCT00164424|Treatment|treatment
494660|NCT00164424|Acyclovir|acyclovir
494661|NCT00164424|Prevention|prevention
494662|NCT00164437|screening|screening
494663|NCT00164437|community healt education|community healt education
494664|NCT00164437|decision making|decision making
494665|NCT00164437|computer-assisted decision making|computer-assisted decision making
494666|NCT00164450|tuberculosis|tuberculosis
494667|NCT00164450|TB|tb
494668|NCT00164450|pharmacokinetics|pharmacokinetics
494669|NCT00164450|children|children
494670|NCT00164463|tuberculosis|tuberculosis
494671|NCT00164463|TB|tb
494772|NCT00165152|BRCA2 gene|brca2 gene
753033|NCT01175174|preschool children|preschool children
494071|NCT00161187|male breast cancer|male breast cancer
494672|NCT00164515|obesity, mobility limitations, women, physical activity|obesity, mobility limitations, women, physical activity
753942|NCT01178346|NicVAX|nicvax
494674|NCT00164541|violence against women|violence against women
494675|NCT00164554|treatment|treatment
494676|NCT00164554|control|control
494677|NCT00164567|partner abuse|partner abuse
494678|NCT00164567|screening|screening
494679|NCT00164567|intimate partner violence|intimate partner violence
494680|NCT00164580|Homosexuality, Male|homosexuality, male
494681|NCT00164580|Adolescents|adolescents
494682|NCT00164580|Minority Groups|minority groups
494683|NCT00164580|Community Participation|community participation
494684|NCT00164580|Community Surveys|community surveys
494685|NCT00164580|HIV Seronegativity|hiv seronegativity
494686|NCT00164580|HIV|hiv
494687|NCT00164593|Youth Violence|youth violence
494688|NCT00164593|Prevention|prevention
494689|NCT00164606|child maltreatment|child maltreatment
494690|NCT00164606|child abuse|child abuse
494691|NCT00164606|prevention|prevention
494692|NCT00164619|controlled clinical trial|controlled clinical trial
494693|NCT00164619|behavioral intervention|behavioral intervention
494694|NCT00164619|prevention intervention|prevention intervention
494695|NCT00164645|Emotional outcomes|emotional outcomes
494696|NCT00164645|health outcomes|health outcomes
494697|NCT00164645|traumatic brain injury|traumatic brain injury
494698|NCT00164645|caregiving|caregiving
494699|NCT00164658|family history|family history
494700|NCT00164658|familial risk|familial risk
494701|NCT00164658|behavior change|behavior change
494702|NCT00164671|Male condoms|male condoms
494703|NCT00164671|Female condoms|female condoms
494704|NCT00164671|Self-efficacy|self-efficacy
494705|NCT00164684|batterers|batterers
494706|NCT00164684|prevention|prevention
494707|NCT00164684|African American|african american
494708|NCT00164684|Latino|latino
494709|NCT00164697|Child Development|child development
494710|NCT00164697|Parenting|parenting
494711|NCT00164697|Child Rearing|child rearing
494712|NCT00164697|Parent-Child Relations|parent-child relations
494713|NCT00164710|antimalarials|antimalarials
494714|NCT00164723|Capsule Endoscopy|capsule endoscopy
494715|NCT00164736|HIV|hiv
494716|NCT00164736|Clinical trial|clinical trial
494717|NCT00164736|breastfeeding|breastfeeding
494718|NCT00164736|mother-to-child-transmission|mother-to-child-transmission
494719|NCT00164736|nutrition|nutrition
494720|NCT00164736|HIV Seronegativity|hiv seronegativity
494721|NCT00164749|dementia|dementia
494722|NCT00164749|cognition|cognition
494723|NCT00164749|memory|memory
494724|NCT00164749|neurodegenerative disease|neurodegenerative disease
494725|NCT00164749|brain|brain
494726|NCT00164762|HIV|hiv
494727|NCT00164762|drug resistance|drug resistance
494728|NCT00164762|nevirapine|nevirapine
494729|NCT00164762|anti-retroviral drugs|anti-retroviral drugs
494730|NCT00164762|mother-to-child transmission|mother-to-child transmission
494731|NCT00164762|Treatment Naive|treatment naive
494732|NCT00164762|pregnancy|pregnancy
494733|NCT00164775|Functional dyspepsia, refractory, antidepressant|functional dyspepsia, refractory, antidepressant
494734|NCT00164788|24 hours pH monitoring|24 hours ph monitoring
494735|NCT00164840|GERD|gerd
494736|NCT00164866|Peptic ulcer|peptic ulcer
494737|NCT00164866|IVPPI prior endoscopy|ivppi prior endoscopy
494738|NCT00164879|Obstructing|obstructing
494739|NCT00164879|Left-sided|left-sided
494740|NCT00164879|Colorectal neoplasms|colorectal neoplasms
494741|NCT00164879|Obstructing left-sided colorectal cancers|obstructing left-sided colorectal cancers
494742|NCT00164905|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
494743|NCT00164905|Doppler ultrasound|doppler ultrasound
494744|NCT00164931|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
494745|NCT00164931|Omeprazole|omeprazole
494746|NCT00164931|Scheduled second endoscopy|scheduled second endoscopy
494747|NCT00164944|Colonoscopy|colonoscopy
494748|NCT00164944|First degree relatives|first degree relatives
494749|NCT00164996|upper endoscopy|upper endoscopy
494750|NCT00164996|local pharyngeal anaesthesia|local pharyngeal anaesthesia
494751|NCT00164996|ultrathin endoscope|ultrathin endoscope
494752|NCT00165009|Bleeding Peptic Ulcer|bleeding peptic ulcer
494753|NCT00165009|Endoscopic treatment|endoscopic treatment
494754|NCT00165035|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
494755|NCT00165035|Drug eluting stent (DES)|drug eluting stent (des)
494756|NCT00165074|Prematurity|prematurity
494757|NCT00165074|Lung Disease|lung disease
494758|NCT00165074|Hyaline Membrane|hyaline membrane
494759|NCT00165074|Surfactant|surfactant
494760|NCT00165087|childhood ALL|childhood all
494761|NCT00165087|standard risk|standard risk
494762|NCT00165087|high risk|high risk
494763|NCT00165087|infant/high risk|infant/high risk
494764|NCT00165100|DAT|dat
494765|NCT00165100|imaging modality|imaging modality
494766|NCT00165126|dosimetric analysis|dosimetric analysis
494767|NCT00165126|vaginal cuff brachytherapy|vaginal cuff brachytherapy
494768|NCT00165139|Stem cell transplant|stem cell transplant
494769|NCT00165139|High-risk pediatric tumors|high-risk pediatric tumors
494770|NCT00165152|Genetic testing|genetic testing
494771|NCT00165152|BRCA1 gene|brca1 gene
494773|NCT00165152|Counseling interventions|counseling interventions
494774|NCT00165152|Genetic counseling|genetic counseling
494775|NCT00165178|Acute lymphoblastic leukemia in children|acute lymphoblastic leukemia in children
494776|NCT00165178|High Risk ALL|high risk all
494777|NCT00165178|Standard Risk ALL|standard risk all
494778|NCT00165178|E. coli asparaginase|e. coli asparaginase
494779|NCT00165191|doxorubicin|doxorubicin
494780|NCT00165191|cisplatin|cisplatin
494781|NCT00165191|5-fluorouracil|5-fluorouracil
494782|NCT00165191|stomach cancer|stomach cancer
494783|NCT00165191|esophagus cancer|esophagus cancer
494784|NCT00165204|Tibolone|tibolone
494785|NCT00165204|High risk women|high risk women
494786|NCT00165204|Oophorectomy|oophorectomy
494787|NCT00165204|Breast Density|breast density
494788|NCT00165204|Bone Density|bone density
494789|NCT00165217|capecitabine|capecitabine
494790|NCT00165217|thalidomide|thalidomide
494791|NCT00165217|colorectal cancer|colorectal cancer
494792|NCT00165230|thalidomide|thalidomide
494793|NCT00165230|temodar|temodar
494794|NCT00165230|metastatic neuroendocrine tumor|metastatic neuroendocrine tumor
494795|NCT00165230|unresectable neuroendocrine tumor|unresectable neuroendocrine tumor
494796|NCT00165243|Axillary Dissection|axillary dissection
494797|NCT00165243|Tangential Radiation|tangential radiation
494798|NCT00165243|Breast Cancer|breast cancer
494799|NCT00165256|Ductal carcinoma in situ|ductal carcinoma in situ
494800|NCT00165256|DCIS|dcis
494801|NCT00165256|wide excision|wide excision
494802|NCT00165269|Hodgkin's Disease Stage IA-IIA|hodgkin's disease stage ia-iia
494803|NCT00165269|mantle irradiation|mantle irradiation
494804|NCT00165282|Meditation|meditation
494805|NCT00165282|Mindfulness meditation|mindfulness meditation
494806|NCT00165282|Bone Marrow Transplant|bone marrow transplant
494807|NCT00165282|Stem Cell Transplant|stem cell transplant
494808|NCT00165295|sildenafil citrate|sildenafil citrate
494809|NCT00165295|Viagra|viagra
494810|NCT00165295|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
494811|NCT00165308|Hodgkin's disease|hodgkin's disease
494812|NCT00165308|breast cancer prevention|breast cancer prevention
494813|NCT00165308|tamoxifen|tamoxifen
494814|NCT00165334|Non-small cell lung cancer|non-small cell lung cancer
494815|NCT00165334|Cetuximab|cetuximab
494816|NCT00165334|Vinorelbine|vinorelbine
494817|NCT00165334|Navelbine|navelbine
494818|NCT00165334|Previously untreated lung cancer|previously untreated lung cancer
494819|NCT00165347|Multiple myeloma|multiple myeloma
494820|NCT00165347|PTK|ptk
494821|NCT00165347|Relapsed multiple myeloma|relapsed multiple myeloma
494822|NCT00165347|Refractory Multiple myeloma|refractory multiple myeloma
494823|NCT00165347|Myeloma|myeloma
494824|NCT00165360|low-grade glioma|low-grade glioma
494825|NCT00165360|astrocytoma|astrocytoma
494826|NCT00165360|oligodendroglioma|oligodendroglioma
494827|NCT00165360|oligoastrocytoma|oligoastrocytoma
494828|NCT00165360|temozolomide|temozolomide
494829|NCT00165360|mixed oligoastrocytoma|mixed oligoastrocytoma
494830|NCT00165373|pediatric solid tumors|pediatric solid tumors
494831|NCT00165373|rhEndostatin|rhendostatin
494832|NCT00165386|MRI-guided bone marrow biopsy|mri-guided bone marrow biopsy
494833|NCT00165399|Prostate cancer|prostate cancer
494834|NCT00165399|PSA level|psa level
494835|NCT00165399|docetaxel|docetaxel
494836|NCT00165399|estramustine|estramustine
494837|NCT00165399|hormone therapy|hormone therapy
494838|NCT00165399|androgen withdrawal|androgen withdrawal
494839|NCT00165412|Breast screening|breast screening
494840|NCT00165412|Breast MRI|breast mri
494841|NCT00165412|Mammogram|mammogram
494842|NCT00165412|Mammography|mammography
494843|NCT00165425|Cardiac screening|cardiac screening
494844|NCT00165425|Cardiac stress test|cardiac stress test
494845|NCT00165425|Echocardiogram|echocardiogram
494846|NCT00165438|Pulmonary function|pulmonary function
494847|NCT00165438|Bleomycin-based chemotherapy|bleomycin-based chemotherapy
494848|NCT00165438|mediastinal irradiation|mediastinal irradiation
494849|NCT00165451|Relapsed tumors|relapsed tumors
494850|NCT00165451|Progressive Poor Prognosis Tumors|progressive poor prognosis tumors
494851|NCT00165451|Thalidomide|thalidomide
494852|NCT00165451|Celecoxib|celecoxib
494853|NCT00165451|Etoposide|etoposide
494854|NCT00165451|Cyclophosphamide|cyclophosphamide
494855|NCT00165464|Esophageal Cancer|esophageal cancer
494856|NCT00165464|Gastric Cancer|gastric cancer
494857|NCT00165464|GE Junction|ge junction
494858|NCT00165464|Cisplatin|cisplatin
494859|NCT00165464|Taxotere|taxotere
494860|NCT00165464|CPT-11|cpt-11
494861|NCT00165464|Irinotecan|irinotecan
494862|NCT00165477|Glioblastoma|glioblastoma
494863|NCT00165477|Gliosarcoma|gliosarcoma
494864|NCT00165477|Malignant Gliomas|malignant gliomas
494865|NCT00165477|Radiation Therapy|radiation therapy
494866|NCT00165477|IMiD|imid
494867|NCT00165477|Lenalidomide|lenalidomide
494868|NCT00165490|adenocarcinoma of esophagus|adenocarcinoma of esophagus
494177|NCT00161252|Prostate Cancer|prostate cancer
494869|NCT00165490|squamous cell carcinoma of esophagus|squamous cell carcinoma of esophagus
494870|NCT00165490|combination chemotherapy|combination chemotherapy
494871|NCT00165490|cisplatin|cisplatin
494872|NCT00165490|irinotecan|irinotecan
494873|NCT00165490|radiation therapy|radiation therapy
494874|NCT00165490|resectable esophageal cancer|resectable esophageal cancer
494875|NCT00165503|pleurectomy|pleurectomy
494876|NCT00165503|decortication|decortication
494877|NCT00165503|cisplatin|cisplatin
494878|NCT00165503|ALIMTA|alimta
494879|NCT00165516|Extrapleural pneumonectomy|extrapleural pneumonectomy
494880|NCT00165516|cisplatin|cisplatin
494881|NCT00165516|heated cisplatin|heated cisplatin
494882|NCT00165542|A-protein level|a-protein level
494883|NCT00165542|brain tumor|brain tumor
494884|NCT00165555|cisplatin|cisplatin
494885|NCT00165555|pleurectomy|pleurectomy
494886|NCT00165555|decortication|decortication
494887|NCT00165555|heated cisplatin|heated cisplatin
494888|NCT00165568|Positron emission tomography|positron emission tomography
494889|NCT00165568|PET|pet
494890|NCT00165568|bevacizumab|bevacizumab
494891|NCT00165568|5fluorouracil|5fluorouracil
494892|NCT00165568|Metastatic colorectal cancer|metastatic colorectal cancer
494893|NCT00165581|Intracavitary brachytherapy|intracavitary brachytherapy
494894|NCT00165581|radiation therapy|radiation therapy
494895|NCT00165581|Stage I breast cancer|stage i breast cancer
494896|NCT00165581|Stage II breast cancer|stage ii breast cancer
494897|NCT00165594|gastric cancer|gastric cancer
494898|NCT00165594|Phase I|phase i
494899|NCT00165594|Phase IIa|phase iia
494900|NCT00165594|E7070|e7070
494901|NCT00165594|Indisulam|indisulam
494902|NCT00165594|Pharmacogenomic|pharmacogenomic
494903|NCT00165594|2C19|2c19
494904|NCT00165633|Hepatocellular|hepatocellular
494905|NCT00165633|Carcinoma|carcinoma
494906|NCT00165633|Hepatitis C Virus|hepatitis c virus
494907|NCT00165633|Hepatitis B Virus|hepatitis b virus
494908|NCT00165633|recurrence|recurrence
494909|NCT00165633|Vitamin K2|vitamin k2
494910|NCT00165633|E0167|e0167
494911|NCT00165646|non-erosive gastroesophageal reflux disease|non-erosive gastroesophageal reflux disease
494912|NCT00165646|NERD|nerd
494913|NCT00165646|proton pump inhibitor|proton pump inhibitor
494914|NCT00165646|rabeprazole|rabeprazole
494915|NCT00165672|24-hour esophageal pH monitoring|24-hour esophageal ph monitoring
494916|NCT00165672|non-erosive gastroesophageal reflux disease|non-erosive gastroesophageal reflux disease
494917|NCT00165672|NERD|nerd
494918|NCT00165672|proton pump inhibitor|proton pump inhibitor
494919|NCT00165672|rabeprazole|rabeprazole
494920|NCT00165698|Postmenopausal|postmenopausal
494921|NCT00165698|osteoporosis|osteoporosis
494922|NCT00165737|Dementia cerebrovascular disease|dementia cerebrovascular disease
494923|NCT00165763|Vascular Dementia|vascular dementia
494924|NCT00165802|Cancer|cancer
494925|NCT00165802|malignant tumors|malignant tumors
494926|NCT00165828|Epilepsy|epilepsy
494927|NCT00165841|non-erosive symptomatic GERD|non-erosive symptomatic gerd
494928|NCT00165841|GERD|gerd
494929|NCT00165893|low back pain|low back pain
494930|NCT00165893|DDD|ddd
494931|NCT00165906|neonates|neonates
494932|NCT00165906|cardiac|cardiac
494933|NCT00165906|non-cardiac|non-cardiac
494934|NCT00165906|surgery|surgery
494935|NCT00165906|anticoagulation|anticoagulation
494936|NCT00165919|Hepatitis C|hepatitis c
494937|NCT00165919|HIV|hiv
494938|NCT00165919|Immunopathogenesis|immunopathogenesis
494939|NCT00165919|HIV-1|hiv-1
494940|NCT00165932|tachycardia|tachycardia
494941|NCT00165932|pediatrics|pediatrics
494942|NCT00165945|pediatric, cardiology, diagnostic imaging using MRI|pediatric, cardiology, diagnostic imaging using mri
494944|NCT00165958|Epidermoid cyst|epidermoid cyst
495043|NCT00168155|survival|survival
494945|NCT00165958|Sebaceous cyst|sebaceous cyst
494946|NCT00165958|Pilar cyst|pilar cyst
494947|NCT00165971|Cognitive decline|cognitive decline
494948|NCT00165971|Inflammation|inflammation
494949|NCT00165971|Monitoring|monitoring
494950|NCT00165971|Recovery|recovery
494951|NCT00165971|Bispectral index|bispectral index
494952|NCT00165984|cardiac|cardiac
494953|NCT00165984|hypoplastic|hypoplastic
494954|NCT00165984|pediatric|pediatric
494955|NCT00165984|hypoplastic heart ventricle|hypoplastic heart ventricle
494956|NCT00165997|pediatrics|pediatrics
494957|NCT00165997|cardiology|cardiology
494958|NCT00165997|Radiofrequency ablation|radiofrequency ablation
494959|NCT00165997|structurally normal heart|structurally normal heart
494960|NCT00166010|drug|drug
494961|NCT00166010|pediatrics|pediatrics
494962|NCT00166010|cardiac|cardiac
494963|NCT00166010|Children with Cardiac Ventricular Failure|children with cardiac ventricular failure
494964|NCT00166023|pediatric|pediatric
494965|NCT00166023|cardiology|cardiology
494966|NCT00166049|Heart failure|heart failure
494967|NCT00166049|Family partnership|family partnership
494968|NCT00166049|Patient family education|patient family education
494969|NCT00166062|intimate partner violence|intimate partner violence
494254|NCT00161733|Clot|clot
494970|NCT00166062|perpetration|perpetration
494971|NCT00166075|Suicidality|suicidality
494972|NCT00166075|PTSD|ptsd
494973|NCT00166075|depression|depression
494974|NCT00166088|Oxidative Stress|oxidative stress
494975|NCT00166088|Diet, Mediterranean|diet, mediterranean
494976|NCT00166101|pediatric|pediatric
495182|NCT00168740|follicular|follicular
494977|NCT00166101|cardiac surgery|cardiac surgery
494978|NCT00166114|platelet function|platelet function
494979|NCT00166114|childhood abuse|childhood abuse
494980|NCT00166114|depression|depression
494981|NCT00166114|antidepressants|antidepressants
494982|NCT00166114|immune function|immune function
494983|NCT00166114|stress response|stress response
494984|NCT00166127|heart failure|heart failure
494985|NCT00166127|cardiac surgery|cardiac surgery
494986|NCT00166127|pharmacokinetics|pharmacokinetics
494987|NCT00166127|pharmacodynamics|pharmacodynamics
494988|NCT00166140|pediatrics|pediatrics
494989|NCT00166140|cardiac|cardiac
494990|NCT00166140|surgery|surgery
494991|NCT00167934|Diabetes|diabetes
494992|NCT00167934|Metabolic|metabolic
494993|NCT00167947|Kidney|kidney
494994|NCT00167947|Transplant|transplant
494995|NCT00167960|Bacterial Infections|bacterial infections
494996|NCT00167973|Hemophilia B|hemophilia b
494997|NCT00167986|Bacterial Infections|bacterial infections
494998|NCT00167999|Bacterial Infections|bacterial infections
494999|NCT00168012|Immunoglobulin intravenous|immunoglobulin intravenous
495000|NCT00168012|Agammaglobulinemia|agammaglobulinemia
495001|NCT00168012|Hypogammaglobulinemia|hypogammaglobulinemia
495002|NCT00168012|Common variable immunodeficiency|common variable immunodeficiency
495003|NCT00168012|Immunoglobulin G|immunoglobulin g
495004|NCT00168012|Children|children
495005|NCT00168025|Immunoglobulin Intravenous|immunoglobulin intravenous
495006|NCT00168025|Agammaglobulinemia|agammaglobulinemia
495007|NCT00168025|Hypogammaglobulinemia|hypogammaglobulinemia
495008|NCT00168025|Common variable immunodeficiency|common variable immunodeficiency
495009|NCT00168025|Immunoglobulin G|immunoglobulin g
495010|NCT00168025|Children|children
495011|NCT00168038|Chronic Immune Thrombocytopenic Purpura|chronic immune thrombocytopenic purpura
495012|NCT00168038|Chronic Idiopathic Thrombocytopenic Purpura|chronic idiopathic thrombocytopenic purpura
495013|NCT00168038|Werlhofs Disease|werlhofs disease
495014|NCT00168038|Autoimmune Thrombocytopenia|autoimmune thrombocytopenia
495015|NCT00168038|Immunglobulin Intravenous|immunglobulin intravenous
495016|NCT00168038|Chronic ITP|chronic itp
495017|NCT00168038|Platelet count|platelet count
495018|NCT00168038|Thrombocytopenia|thrombocytopenia
495019|NCT00168051|Hemophilia A|hemophilia a
495020|NCT00168064|Mycosis Fungoides|mycosis fungoides
495021|NCT00168064|Nitrogen Mustard|nitrogen mustard
495022|NCT00168064|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
495023|NCT00168064|CTCL - Mycosis Fungoides|ctcl - mycosis fungoides
495024|NCT00168077|Prothrombin Complex Concentrate|prothrombin complex concentrate
495025|NCT00168077|Anticoagulant reversal|anticoagulant reversal
495026|NCT00168090|von Willebrand Factor|von willebrand factor
495027|NCT00168090|Blood Coagulation Disorders|blood coagulation disorders
495028|NCT00168090|Factor VIII|factor viii
495029|NCT00168103|C1 Inhibitor|c1 inhibitor
495030|NCT00168103|Hereditary angioedema|hereditary angioedema
495031|NCT00168103|Acute HAE attack|acute hae attack
495032|NCT00168116|nasopharynx|nasopharynx
495033|NCT00168116|xerostomia|xerostomia
495034|NCT00168116|prevention|prevention
495035|NCT00168129|tomotherapy|tomotherapy
495036|NCT00168129|bone metastases|bone metastases
495037|NCT00168129|radiotherapy|radiotherapy
495038|NCT00168129|intensity modulated|intensity modulated
495039|NCT00168142|Helical tomotherapy|helical tomotherapy
495040|NCT00168142|Megavoltage imaging|megavoltage imaging
495041|NCT00168155|resectable liver metastases|resectable liver metastases
495042|NCT00168155|colorectal adenocarcinoma|colorectal adenocarcinoma
495044|NCT00168155|neoadjuvant chemotherapy|neoadjuvant chemotherapy
495045|NCT00168168|G-CSF|g-csf
495046|NCT00168168|Filgrastim|filgrastim
495047|NCT00168168|Engraftment time|engraftment time
495048|NCT00168168|Autologus transplant|autologus transplant
495049|NCT00168181|salagen|salagen
495050|NCT00168181|gland transfer|gland transfer
495051|NCT00168181|randomized|randomized
495052|NCT00168181|xerostomia|xerostomia
495054|NCT00168207|Treatment Experienced|treatment experienced
495055|NCT00168207|HIV|hiv
495056|NCT00168220|Treatment Experienced|treatment experienced
495057|NCT00168220|HIV|hiv
495058|NCT00168233|Treatment Naive|treatment naive
495059|NCT00168233|HIV|hiv
495060|NCT00168246|HIV|hiv
495061|NCT00168259|Treatment Naive|treatment naive
495062|NCT00168259|HIV|hiv
495063|NCT00168272|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
495064|NCT00168272|Depression|depression
495065|NCT00168285|Exercise|exercise
495066|NCT00168285|Pulmonary rehabilitation|pulmonary rehabilitation
495067|NCT00168285|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
494353|NCT00156780|safety|safety
495068|NCT00168285|Connective tissue disorders|connective tissue disorders
495069|NCT00168311|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
495070|NCT00168311|Schizophrenia|schizophrenia
495071|NCT00168311|Negative Symptoms|negative symptoms
495072|NCT00168376|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
495073|NCT00168376|Depression|depression
495074|NCT00168402|Axillary Hyperhidrosis|axillary hyperhidrosis
495075|NCT00168493|Major Depression|major depression
495076|NCT00168493|Cardiac disease|cardiac disease
495077|NCT00168506|panic disorder|panic disorder
495078|NCT00168506|cardiac risk|cardiac risk
495079|NCT00168519|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
495081|NCT00168519|Exercise|exercise
495082|NCT00168519|Muscle Contraction|muscle contraction
495083|NCT00168519|Nitric Oxide|nitric oxide
495084|NCT00168519|Nitrates|nitrates
495085|NCT00168532|Prophylactic antibiotics|prophylactic antibiotics
495087|NCT00168532|Pneumonia|pneumonia
495088|NCT00168532|Post-measles pneumonia|post-measles pneumonia
495089|NCT00168532|Low income country|low income country
495090|NCT00168532|Guinea-Bissau|guinea-bissau
495091|NCT00168532|Bandim Health Project|bandim health project
495092|NCT00168545|Non-specific effects of vaccines|non-specific effects of vaccines
495093|NCT00168545|Immunology|immunology
495094|NCT00168545|Cytokines|cytokines
495095|NCT00168545|Infant mortality|infant mortality
495096|NCT00168545|Child mortality|child mortality
495097|NCT00168545|Mortality|mortality
495098|NCT00168545|Morbidity|morbidity
495099|NCT00168545|Diphtheria-tetanus-pertussis vaccine|diphtheria-tetanus-pertussis vaccine
495100|NCT00168545|Measles vaccine|measles vaccine
495101|NCT00168545|Measles|measles
495102|NCT00168545|Immunisation|immunisation
495103|NCT00168545|Low income country|low income country
495104|NCT00168545|Guinea-Bissau|guinea-bissau
495105|NCT00168545|Bandim Health Project|bandim health project
495106|NCT00168545|Immunology of measles and DTP vaccination|immunology of measles and dtp vaccination
495107|NCT00168558|Non-specific effects of vaccines|non-specific effects of vaccines
495108|NCT00168558|Infant mortality|infant mortality
495109|NCT00168558|Child mortality|child mortality
495110|NCT00168558|Mortality|mortality
495111|NCT00168558|Morbidity|morbidity
495112|NCT00168558|Diphtheria-tetanus-pertussis vaccine|diphtheria-tetanus-pertussis vaccine
495113|NCT00168558|Measles vaccine|measles vaccine
495114|NCT00168558|Measles|measles
495115|NCT00168558|Immunisation|immunisation
495116|NCT00168558|Low income country|low income country
495117|NCT00168558|Guinea-Bissau|guinea-bissau
495118|NCT00168558|Bandim Health Project|bandim health project
495119|NCT00168558|Immunology|immunology
495120|NCT00168571|Measles vaccine|measles vaccine
495121|NCT00168571|Measles|measles
495122|NCT00168571|Measles antibodies|measles antibodies
495123|NCT00168571|Immunisation|immunisation
495124|NCT00168571|Low income country|low income country
495125|NCT00168571|Guinea-Bissau|guinea-bissau
495126|NCT00168571|Bandim Health Project|bandim health project
495127|NCT00168571|Measles antibody level|measles antibody level
495128|NCT00168584|Vitamin A|vitamin a
495129|NCT00168584|Mortality|mortality
495130|NCT00168584|Morbidity|morbidity
495131|NCT00168584|Doses|doses
495132|NCT00168584|OPV|opv
495133|NCT00168597|Vitamin A|vitamin a
495134|NCT00168597|BCG|bcg
495135|NCT00168597|Infant mortality|infant mortality
495136|NCT00168597|Morbidity|morbidity
495137|NCT00168597|Low-income country|low-income country
495138|NCT00168610|Vitamin A|vitamin a
495139|NCT00168610|BCG|bcg
495140|NCT00168610|Infant mortality|infant mortality
495141|NCT00168610|Morbidity|morbidity
495142|NCT00168610|Low-income country|low-income country
495143|NCT00168610|Mortality|mortality
495144|NCT00168623|Vitamin A|vitamin a
495145|NCT00168623|Vaccines|vaccines
495146|NCT00168623|Mortality|mortality
495147|NCT00168623|Morbidity|morbidity
495148|NCT00168636|Vitamin A|vitamin a
495149|NCT00168636|Mortality|mortality
495150|NCT00168636|Morbidity|morbidity
495152|NCT00168636|Sex|sex
495153|NCT00168649|Vitamin A|vitamin a
495154|NCT00168649|Endotoxin|endotoxin
495155|NCT00168649|TNF-alfa|tnf-alfa
495156|NCT00168662|Non-specific effects of vaccines|non-specific effects of vaccines
495157|NCT00168662|Infant mortality|infant mortality
495158|NCT00168662|Child mortality|child mortality
495159|NCT00168662|Mortality|mortality
495160|NCT00168662|Morbidity|morbidity
495161|NCT00168662|Measles vaccine|measles vaccine
495162|NCT00168662|Measles|measles
495163|NCT00168662|Immunisation|immunisation
495164|NCT00168662|Low income country|low income country
495165|NCT00168662|Guinea-Bissau|guinea-bissau
495166|NCT00168662|Bandim Health Project|bandim health project
495167|NCT00168662|Immunology|immunology
495168|NCT00168688|micronutrient supplementation|micronutrient supplementation
495169|NCT00168688|pregnancy|pregnancy
495170|NCT00168688|birth weight|birth weight
494441|NCT00163436|Asthma|asthma
495171|NCT00168688|perinatal mortality|perinatal mortality
495172|NCT00168701|Multiple Sclerosis|multiple sclerosis
495173|NCT00168701|MRI|mri
495174|NCT00168714|AVONEX|avonex
495175|NCT00168714|Pregnancy|pregnancy
495176|NCT00168727|Radioimmunotherapy|radioimmunotherapy
495177|NCT00168727|Antigens, CD20|antigens, cd20
495178|NCT00168740|rituximab|rituximab
495179|NCT00168740|Rituxan|rituxan
495180|NCT00168740|B-cell lymphoma|b-cell lymphoma
495181|NCT00168740|low-grade|low-grade
495183|NCT00168740|anti-CD20 monoclonal antibody|anti-cd20 monoclonal antibody
495184|NCT00168753|Extended dosing|extended dosing
495185|NCT00168753|alefacept|alefacept
495086|NCT00168532|Measles|measles
495186|NCT00168766|Combination therapy for multiple sclerosis|combination therapy for multiple sclerosis
495187|NCT00168870|metastatic ocular melanoma|metastatic ocular melanoma
495188|NCT00168883|NSCLC|nsclc
495189|NCT00168883|curative non-treatable NSCLC UICC stage IIIB and IV|curative non-treatable nsclc uicc stage iiib and iv
495190|NCT00168896|SCLC|sclc
495191|NCT00168909|osteoporosis|osteoporosis
495192|NCT00168909|frailty|frailty
495193|NCT00168909|falls|falls
495194|NCT00168922|recurrent SCLC|recurrent sclc
495195|NCT00168948|Intermittent preventive treatment|intermittent preventive treatment
495196|NCT00168948|IPTi|ipti
495197|NCT00168948|Malaria control|malaria control
495198|NCT00168948|Ghana|ghana
495199|NCT00168961|liver cirrhosis Child B or C|liver cirrhosis child b or c
495200|NCT00168987|oral nutritional supplement|oral nutritional supplement
495201|NCT00168987|eicosapentanoic acid|eicosapentanoic acid
495331|NCT00169520|tolerability|tolerability
495202|NCT00168987|gastroenterological tumors|gastroenterological tumors
495203|NCT00168987|muscle function|muscle function
495204|NCT00168987|quality of life|quality of life
495205|NCT00168987|body composition|body composition
495206|NCT00169000|breast cancer|breast cancer
495207|NCT00169000|capecitabine|capecitabine
495208|NCT00169000|docetaxel|docetaxel
495209|NCT00169000|pharmacokinetic/pharmacodynamic|pharmacokinetic/pharmacodynamic
495210|NCT00169000|bcl-2|bcl-2
495212|NCT00169026|Clozapine|clozapine
495213|NCT00169026|Atypical Antipsychotic|atypical antipsychotic
495214|NCT00169026|Conventional antipsychotic|conventional antipsychotic
495215|NCT00169026|Schizophrenia|schizophrenia
495216|NCT00169026|Dual Diagnosis|dual diagnosis
495217|NCT00169026|Substance Abuse|substance abuse
495218|NCT00169026|Alcohol Abuse|alcohol abuse
495219|NCT00169039|Clozapine|clozapine
495220|NCT00169039|Chlorpromazine|chlorpromazine
495221|NCT00169039|Schizophrenia|schizophrenia
495222|NCT00169039|Biochemistry|biochemistry
495223|NCT00169052|geriatric,|geriatric,
495224|NCT00169052|older|older
495225|NCT00169052|serious mental illness|serious mental illness
495226|NCT00169052|SMI|smi
495227|NCT00169065|Clozapine|clozapine
495228|NCT00169065|olanzapine|olanzapine
495229|NCT00169078|Transmission intensity|transmission intensity
495230|NCT00169078|Insecticide-treated materials|insecticide-treated materials
495231|NCT00169078|antimalarial drug resistance|antimalarial drug resistance
495232|NCT00169091|Clozapine|clozapine
495233|NCT00169091|Haloperidol|haloperidol
495234|NCT00169091|Schizophrenia|schizophrenia
495235|NCT00169104|Breast cancer|breast cancer
495236|NCT00169104|Her-2/neu|her-2/neu
495237|NCT00169104|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
495238|NCT00169104|Trastuzumab|trastuzumab
495239|NCT00169104|Vinorelbine|vinorelbine
495240|NCT00169104|Antibody-dependent cellular cytotoxicity|antibody-dependent cellular cytotoxicity
495241|NCT00169104|Effector cells|effector cells
495242|NCT00169117|Mosquito nets|mosquito nets
495243|NCT00169117|Malaria prevention|malaria prevention
495244|NCT00169117|Songs|songs
495245|NCT00169117|Posters|posters
495246|NCT00169117|Net repair|net repair
495247|NCT00169117|Bednets|bednets
495248|NCT00169130|lymphoma|lymphoma
495249|NCT00169130|autologous stem cell transplant|autologous stem cell transplant
495250|NCT00169130|chemotherapy|chemotherapy
495251|NCT00169130|BCL2|bcl2
495252|NCT00169143|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
495253|NCT00169143|Pegfilgrastim|pegfilgrastim
495254|NCT00169143|Autotransplant|autotransplant
495255|NCT00169156|T-cell angioimmunoblastic lymphoma|t-cell angioimmunoblastic lymphoma
495256|NCT00169156|Rituximab|rituximab
495257|NCT00169169|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
495258|NCT00169169|Rituximab|rituximab
495259|NCT00169169|Autotransplant|autotransplant
495260|NCT00169182|Larynx cancer|larynx cancer
495261|NCT00169182|Hypopharynx cancer|hypopharynx cancer
495262|NCT00169182|Chemotherapy|chemotherapy
495263|NCT00169182|Randomized trial|randomized trial
495264|NCT00169182|Larynx preservation|larynx preservation
495265|NCT00169195|B-cell lymphoma|b-cell lymphoma
495266|NCT00169195|Salvage Therapy|salvage therapy
495267|NCT00169195|rituximab|rituximab
495268|NCT00169195|oxaliplatine|oxaliplatine
495269|NCT00169195|gemcitabine|gemcitabine
495270|NCT00169208|relapsed/refractory.|relapsed/refractory.
495271|NCT00169208|lymphoma, follicular|lymphoma, follicular
495272|NCT00169208|rituximab|rituximab
495273|NCT00169208|chemotherapy|chemotherapy
495274|NCT00169234|Pneumococcal disease|pneumococcal disease
495275|NCT00169234|Vaccination|vaccination
495276|NCT00169234|Immunization|immunization
495277|NCT00169234|PPV23|ppv23
495278|NCT00169234|PCV7|pcv7
495279|NCT00169247|larynx cancer|larynx cancer
495280|NCT00169247|hypopharynx cancer|hypopharynx cancer
495281|NCT00169247|larynx preservation|larynx preservation
495282|NCT00169247|concomitant radiochemotherapy|concomitant radiochemotherapy
495283|NCT00169247|cisplatin|cisplatin
495284|NCT00169247|cetuximab|cetuximab
495285|NCT00169247|randomized trial|randomized trial
495286|NCT00169260|smoking|smoking
495287|NCT00169260|tobacco|tobacco
495288|NCT00169260|behavior therapy|behavior therapy
495290|NCT00169273|Depression|depression
495291|NCT00169273|Behavioral|behavioral
495292|NCT00169273|Cognitive|cognitive
495293|NCT00169273|Treatment|treatment
495294|NCT00169299|Menopause|menopause
495295|NCT00169299|Vasomotor|vasomotor
495296|NCT00169299|Black cohosh|black cohosh
495297|NCT00169299|Herbs|herbs
495298|NCT00169299|Hot flashes|hot flashes
495299|NCT00169299|HT|ht
495300|NCT00169299|CAM|cam
495301|NCT00169312|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
495302|NCT00169325|basal ganglia|basal ganglia
495303|NCT00169325|loss of psychic self-activation|loss of psychic self-activation
495304|NCT00169338|Dystonia|dystonia
495305|NCT00169338|deep brain stimulation|deep brain stimulation
495306|NCT00169338|globus pallidus|globus pallidus
495307|NCT00169338|Post-anoxic dystonia|post-anoxic dystonia
495308|NCT00169364|Parkinson's disease|parkinson's disease
495309|NCT00169364|parkin mutation|parkin mutation
495310|NCT00169364|Juvenile parkinson's disease|juvenile parkinson's disease
495311|NCT00169364|positron emission tomography|positron emission tomography
495312|NCT00169377|Obsessive compulsive disorder|obsessive compulsive disorder
495313|NCT00169377|deep brain stimulation|deep brain stimulation
495314|NCT00169377|subthalamic nucleus|subthalamic nucleus
495315|NCT00169390|smoking|smoking
495316|NCT00169390|pregnancy|pregnancy
495317|NCT00169390|newborns|newborns
495318|NCT00169390|monoamine oxidases|monoamine oxidases
495319|NCT00169403|Idiopathic dystonia|idiopathic dystonia
495320|NCT00169403|deep brain stimulation|deep brain stimulation
495321|NCT00169403|globus pallidus|globus pallidus
495322|NCT00169403|generalised Idiopathic dystonia|generalised idiopathic dystonia
495323|NCT00169416|chicken pox|chicken pox
495324|NCT00169416|varicella|varicella
495325|NCT00169416|VZV|vzv
495326|NCT00169416|pharmacokinetics|pharmacokinetics
495327|NCT00169468|B Lymphoma|b lymphoma
495328|NCT00169468|Velcade|velcade
495329|NCT00169468|Chemotherapy|chemotherapy
495330|NCT00169520|Safety|safety
495332|NCT00169520|dose limiting toxicity|dose limiting toxicity
495333|NCT00169520|solid tumors|solid tumors
495334|NCT00169520|docetaxel|docetaxel
495335|NCT00169533|safety|safety
495336|NCT00169533|tolerating lapatinib|tolerating lapatinib
495337|NCT00169533|Lapatinib|lapatinib
495338|NCT00169546|Asthma|asthma
495339|NCT00169546|inhaled corticosteroids|inhaled corticosteroids
495340|NCT00169559|triglycerides|triglycerides
495341|NCT00169559|Hypertriglyceridemia|hypertriglyceridemia
495342|NCT00169559|cholesterol|cholesterol
495343|NCT00169559|LDL|ldl
495344|NCT00169559|HDL|hdl
495345|NCT00169572|Nausea|nausea
495346|NCT00169572|Vomiting|vomiting
495347|NCT00169572|Emesis|emesis
495348|NCT00169572|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
495349|NCT00169572|CINV|cinv
495350|NCT00169585|diagnostic-therapeutic pathway|diagnostic-therapeutic pathway
495352|NCT00169585|DRE|dre
495353|NCT00169585|Levofloxacin|levofloxacin
495354|NCT00169598|Lymphoma|lymphoma
495355|NCT00169598|positron emission tomography|positron emission tomography
495356|NCT00169598|stem cell transplantation|stem cell transplantation
495357|NCT00169598|therapeutic impact|therapeutic impact
495358|NCT00169611|Neurofibromatosis type 1|neurofibromatosis type 1
495359|NCT00169611|Attention deficit with hyperactivity disorder school difficulties|attention deficit with hyperactivity disorder school difficulties
495360|NCT00169611|methylphenidate|methylphenidate
495361|NCT00169624|Diabetes,|diabetes,
495362|NCT00169624|coronary endothelial dysfunction,|coronary endothelial dysfunction,
495363|NCT00169624|metformin,|metformin,
495364|NCT00169624|glyclazide,|glyclazide,
495365|NCT00169624|MRI.|mri.
495366|NCT00169637|Short bowel syndrome|short bowel syndrome
495367|NCT00169637|Growth hormone|growth hormone
495368|NCT00169637|Children|children
495369|NCT00169650|UPJ Obstruction|upj obstruction
495370|NCT00169650|Renal Obstruction|renal obstruction
495371|NCT00169650|Delayed Renal Flow|delayed renal flow
495372|NCT00169663|Brushite Kidney Stones|brushite kidney stones
495373|NCT00169663|Nephrolithiasis|nephrolithiasis
495374|NCT00169676|Prostate Cancer|prostate cancer
495375|NCT00169689|schizophrenia, rTMS|schizophrenia, rtms
753034|NCT01175174|adenosine provocation test|adenosine provocation test
638760|NCT00726843|Yoga|yoga
495376|NCT00169702|Schizophrenia, weight management programme|schizophrenia, weight management programme
495377|NCT00169715|Kidney stones|kidney stones
495378|NCT00169715|renal Calculi|renal calculi
495379|NCT00169715|Tic|tic
495380|NCT00169715|Caliceal Diverticula|caliceal diverticula
495381|NCT00169728|allogeneic haematopoietic stem cell transplantation|allogeneic haematopoietic stem cell transplantation
495382|NCT00169728|bone marrow transplantation|bone marrow transplantation
495383|NCT00169728|children|children
495384|NCT00169728|vaccination|vaccination
495385|NCT00169728|invasive pneumococcal disease|invasive pneumococcal disease
495386|NCT00169728|tetanus|tetanus
495387|NCT00169728|diphtheria|diphtheria
495388|NCT00169728|poliomyelitis|poliomyelitis
495389|NCT00169728|pertussis|pertussis
495390|NCT00169728|Hepatitis B|hepatitis b
495391|NCT00169728|Haemophilus influenzae type B infection|haemophilus influenzae type b infection
495393|NCT00169741|Renal Calculi|renal calculi
495394|NCT00169754|Nephrolithiasis|nephrolithiasis
495395|NCT00169754|Renal Calculi|renal calculi
495396|NCT00169754|Perc|perc
495397|NCT00169754|Attached Stones|attached stones
495398|NCT00169767|Enlarged Prostate|enlarged prostate
495399|NCT00169767|BPH|bph
495400|NCT00169780|Renal Calculi|renal calculi
495401|NCT00169780|Radiology|radiology
495402|NCT00169780|High Reslolution CT|high reslolution ct
495403|NCT00169793|Obesity|obesity
495404|NCT00169793|Nephrolithiasis|nephrolithiasis
495405|NCT00169806|Randall's Plaque|randall's plaque
495406|NCT00169806|Kidney stones|kidney stones
495407|NCT00169819|Same day discharge|same day discharge
495408|NCT00169819|Trans-radial|trans-radial
495409|NCT00169819|Coronary artery stenting|coronary artery stenting
495410|NCT00169819|Abciximab bolus|abciximab bolus
495411|NCT00169832|Atherosclerosis progression|atherosclerosis progression
495412|NCT00169832|Ischemic heart disease|ischemic heart disease
495413|NCT00169832|Saphenous vein graft|saphenous vein graft
495414|NCT00169832|Metabolic risk factors|metabolic risk factors
495415|NCT00169832|Rosiglitazone|rosiglitazone
495416|NCT00169845|chemoprevention trial|chemoprevention trial
495417|NCT00169845|antioxidant|antioxidant
495418|NCT00169845|alpha-tocopherol|alpha-tocopherol
495419|NCT00169845|beta-carotene|beta-carotene
495420|NCT00169845|second primary cancer|second primary cancer
495421|NCT00169845|head and neck cancer|head and neck cancer
495422|NCT00169845|adverse effect of radiation therapy|adverse effect of radiation therapy
495423|NCT00169845|quality of life|quality of life
495424|NCT00169845|mortality|mortality
495425|NCT00169845|cancer free survival|cancer free survival
495426|NCT00169845|cancer recurrence|cancer recurrence
495427|NCT00169858|Hepatitis B|hepatitis b
495428|NCT00169858|Vaccination|vaccination
495429|NCT00169858|Engerix-B|engerix-b
495430|NCT00169858|Immunogenicity|immunogenicity
495431|NCT00169858|Long-term immunity|long-term immunity
495432|NCT00169858|Booster dose|booster dose
495433|NCT00169858|Safety|safety
495434|NCT00169884|Deliberate Self-Harm,|deliberate self-harm,
495435|NCT00169884|cognitive-behavioural therapy,|cognitive-behavioural therapy,
495436|NCT00169884|integrative approach|integrative approach
495437|NCT00169897|COPD|copd
495438|NCT00169897|Exercise|exercise
495439|NCT00169897|Self-management|self-management
495440|NCT00169897|Rehabilitation|rehabilitation
495441|NCT00169897|Quality of life|quality of life
495442|NCT00169897|Health economy|health economy
495443|NCT00169897|Cost effectiveness|cost effectiveness
495444|NCT00169897|Health care utilization|health care utilization
495445|NCT00169910|Renal Transplantation|renal transplantation
495446|NCT00169910|Calcineurin Inhibitor|calcineurin inhibitor
495447|NCT00169910|Mycophenolate Mofetil|mycophenolate mofetil
495448|NCT00169910|Cardiovascular Disease|cardiovascular disease
495449|NCT00169949|early intervention|early intervention
495450|NCT00169949|social functioning|social functioning
495451|NCT00169949|role functioning|role functioning
495452|NCT00169949|cognition|cognition
495453|NCT00169962|acute disease|acute disease
495454|NCT00169988|clinical high risk|clinical high risk
495455|NCT00169988|attenuated positive symptoms|attenuated positive symptoms
495456|NCT00169988|attenuated negative symptoms|attenuated negative symptoms
495457|NCT00169988|cognition|cognition
495547|NCT00162734|Combination|combination
495458|NCT00169988|functional status|functional status
495459|NCT00169988|prodromal psychosis|prodromal psychosis
495460|NCT00170001|supraesophageal reflux|supraesophageal reflux
495461|NCT00170001|laryngopharyngeal symptoms|laryngopharyngeal symptoms
495462|NCT00170001|pharynx|pharynx
495463|NCT00170001|esophagus|esophagus
495464|NCT00170053|Kidney Transplantation|kidney transplantation
495465|NCT00170105|Age 18 years or older|age 18 years or older
495466|NCT00170105|No cognitive impairment or altered mental status|no cognitive impairment or altered mental status
495467|NCT00170105|Stable|stable
495468|NCT00170105|No aphasia|no aphasia
495469|NCT00170105|English-speaking|english-speaking
495470|NCT00170170|cytomegalovirus|cytomegalovirus
495471|NCT00170183|Heart failure|heart failure
495472|NCT00170183|Renal dysfunction|renal dysfunction
638876|NCT00734136|Ascites|ascites
495473|NCT00170196|pneumonia|pneumonia
495474|NCT00170196|corticosteroids|corticosteroids
495475|NCT00170209|Tuberculosis|tuberculosis
495476|NCT00170209|Children|children
495477|NCT00170222|Acute bronchitis|acute bronchitis
495478|NCT00170222|antibiotics|antibiotics
495479|NCT00170235|Breast cancer|breast cancer
495480|NCT00170235|Prehabilitation|prehabilitation
495481|NCT00170235|Rehabilitation|rehabilitation
495482|NCT00170235|Exercise|exercise
495483|NCT00170248|Asthma|asthma
495484|NCT00170248|Primary Care|primary care
495485|NCT00170248|Computer-Based Decision Support|computer-based decision support
495486|NCT00170248|Outcome Evaluation|outcome evaluation
495856|NCT00175162|Cement|cement
495487|NCT00170261|Syncope of uncertain etiology|syncope of uncertain etiology
495488|NCT00170261|Repeated presyncopes|repeated presyncopes
495489|NCT00170274|Indication for cardiac pacing|indication for cardiac pacing
495490|NCT00170274|Atrial Arrhythmia|atrial arrhythmia
495491|NCT00170274|Indication for the implantation of a pacemaker according to the German guidelines|indication for the implantation of a pacemaker according to the german guidelines
495492|NCT00170274|Documented (ECG) atrial tachyarrhythmia within the last three months before enrollment|documented (ecg) atrial tachyarrhythmia within the last three months before enrollment
495493|NCT00170287|Unstable Ventricular Tachycardia|unstable ventricular tachycardia
495494|NCT00170300|Cardiac resynchronisation therapy (CRT therapy),|cardiac resynchronisation therapy (crt therapy),
495495|NCT00170300|all-cause mortality,|all-cause mortality,
495496|NCT00170300|quality of life assesment,|quality of life assesment,
495497|NCT00170300|echocardiographic left ventricular function,|echocardiographic left ventricular function,
495498|NCT00170300|CRT and neurohormonal activation,|crt and neurohormonal activation,
495499|NCT00170300|CRT and health economics|crt and health economics
495500|NCT00170313|Heart Failure|heart failure
495501|NCT00170313|Primary Prevention of Sudden Cardiac Death|primary prevention of sudden cardiac death
495502|NCT00170313|Secondary Prevention of Sudden Cardiac Death|secondary prevention of sudden cardiac death
495503|NCT00170313|Cardiac Desynchronization|cardiac desynchronization
495504|NCT00170313|CRT-D|crt-d
495505|NCT00170313|Cardiac Dyssynchrony|cardiac dyssynchrony
495506|NCT00170326|Permanent Pacing artificial internal|permanent pacing artificial internal
495507|NCT00170339|Opiate Dependence|opiate dependence
495508|NCT00170339|Methadone Maintenance|methadone maintenance
495509|NCT00170339|Osteoporosis|osteoporosis
495510|NCT00170339|Hypogonadism|hypogonadism
495511|NCT00170352|hyperbaric oxygen|hyperbaric oxygen
495512|NCT00170352|cerebral metabolism|cerebral metabolism
495513|NCT00170352|hyperoxia|hyperoxia
495514|NCT00170352|traumatic brain injury|traumatic brain injury
495515|NCT00170365|Stress|stress
495516|NCT00170365|Yoga|yoga
495517|NCT00170378|Enoxaparin|enoxaparin
495518|NCT00170378|Safety|safety
495519|NCT00170391|Insomnia|insomnia
495520|NCT00170391|Sleep|sleep
495521|NCT00170391|PSG|psg
495522|NCT00170391|Behavioural treatment|behavioural treatment
495523|NCT00170404|HIV Infections, Tuberculosis, Malnutrition, Tanzania|hiv infections, tuberculosis, malnutrition, tanzania
495524|NCT00170430|HIV-1, sexually transmitted diseases, females, Kenya|hiv-1, sexually transmitted diseases, females, kenya
495525|NCT00162656|B-Cell Lymphoma|b-cell lymphoma
495526|NCT00162669|Hepatocellular carcinoma, advanced, bevacizumab, phase II, VGEF, neovascularization|hepatocellular carcinoma, advanced, bevacizumab, phase ii, vgef, neovascularization
495527|NCT00162682|HIV|hiv
495528|NCT00162682|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
495529|NCT00162682|Monitoring|monitoring
495530|NCT00162682|Viral load|viral load
495531|NCT00162682|CD4|cd4
495532|NCT00162682|Thailand|thailand
495533|NCT00162682|Future Drug Options|future drug options
495534|NCT00162682|Resistance|resistance
495535|NCT00162682|Developing Country|developing country
495536|NCT00162682|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
495537|NCT00162708|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
495538|NCT00162708|Radiotherapy|radiotherapy
495539|NCT00162708|Chemotherapy|chemotherapy
495540|NCT00162721|Uterine sarcoma non metastatic|uterine sarcoma non metastatic
495541|NCT00162734|Chronic Hepatitis C|chronic hepatitis c
495542|NCT00162734|Liver|liver
495543|NCT00162734|Pegylated|pegylated
495544|NCT00162734|Interferon|interferon
495545|NCT00162734|Alpha|alpha
495546|NCT00162734|Ribavirin|ribavirin
495548|NCT00162734|Nonresponder|nonresponder
495549|NCT00162734|HCV|hcv
495550|NCT00162734|Infergen|infergen
495551|NCT00162734|SVR|svr
495552|NCT00162747|Pre-term infants|pre-term infants
495553|NCT00162747|skin infections|skin infections
495554|NCT00162747|infant skin|infant skin
495555|NCT00162747|Aquaphor|aquaphor
495556|NCT00162747|sunflower seed oil|sunflower seed oil
495557|NCT00162747|nutrition|nutrition
495558|NCT00162747|skin care|skin care
495559|NCT00162773|asthma|asthma
495560|NCT00162786|Driving performance|driving performance
495561|NCT00162786|Antihistamine|antihistamine
495562|NCT00162799|insulin resistance and inflamation|insulin resistance and inflamation
495563|NCT00162799|insulin sensitibity|insulin sensitibity
495564|NCT00162799|obesity-induced insuline resistence|obesity-induced insuline resistence
495565|NCT00162799|obesity-diabetes link|obesity-diabetes link
495566|NCT00162799|salicylate|salicylate
495567|NCT00162799|insulin resistance in obesity health adults|insulin resistance in obesity health adults
495568|NCT00162812|neoadjuvant chemotherapy|neoadjuvant chemotherapy
495569|NCT00162812|early breast cancer|early breast cancer
495570|NCT00162812|inflammatory breast cancer|inflammatory breast cancer
495571|NCT00162825|Psoriasis, T cell, inflammation, CD7, cytokine|psoriasis, t cell, inflammation, cd7, cytokine
495572|NCT00162864|asthma|asthma
495573|NCT00162864|COPD|copd
495574|NCT00162864|montelukast sodium|montelukast sodium
495575|NCT00162864|leukotriene modifier|leukotriene modifier
495576|NCT00162864|older adults|older adults
495577|NCT00162877|rabeprazole, omeprazole, CYP2C19, H. pylori, PK/PD|rabeprazole, omeprazole, cyp2c19, h. pylori, pk/pd
495578|NCT00162890|degenerated cervical spine|degenerated cervical spine
495579|NCT00162890|assessment|assessment
495580|NCT00162890|physical therapy|physical therapy
495581|NCT00162903|Preterm infant, Patent ductus arteriosus, Nitric oxide,Endothelin-1|preterm infant, patent ductus arteriosus, nitric oxide,endothelin-1
495582|NCT00162916|Traumatic Brain Injury|traumatic brain injury
495583|NCT00162916|Depression|depression
495584|NCT00162916|Antidepressant medication|antidepressant medication
495585|NCT00162916|Double-Blind Study|double-blind study
495586|NCT00162916|Brain Injuries|brain injuries
495587|NCT00162916|Antidepressive Agents|antidepressive agents
495588|NCT00162916|Citalopram|citalopram
495589|NCT00162916|Double-Blind Method|double-blind method
495590|NCT00162929|metastatic breast cancer|metastatic breast cancer
495591|NCT00162929|locally recurrent breast cancer|locally recurrent breast cancer
495592|NCT00162942|Crohn's Disease|crohn's disease
495593|NCT00162955|untreated adult Non-Hodgkin's Lymphoma|untreated adult non-hodgkin's lymphoma
495594|NCT00162955|CHOP protocol|chop protocol
495595|NCT00162955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
495596|NCT00162955|Cardiomyopathy|cardiomyopathy
495597|NCT00162968|polyneuropathies|polyneuropathies
495599|NCT00162968|drug effects|drug effects
495600|NCT00162968|escitalopram|escitalopram
495601|NCT00162968|serotonin uptake inhibitors|serotonin uptake inhibitors
495602|NCT00162994|recurrent otitis media|recurrent otitis media
495603|NCT00162994|adenoidectomy|adenoidectomy
495604|NCT00162994|tympanostomy|tympanostomy
495605|NCT00162994|young children|young children
495606|NCT00162994|prevention|prevention
495607|NCT00162994|quality of life|quality of life
495608|NCT00163020|Preterm Birth|preterm birth
495609|NCT00163020|Preterm Delivery|preterm delivery
495610|NCT00163020|Multiple gestation|multiple gestation
495611|NCT00163020|17-alpha-hydroxyprogesterone caproate|17-alpha-hydroxyprogesterone caproate
495612|NCT00163020|Progesterone|progesterone
495613|NCT00163033|phase I study|phase i study
495614|NCT00163072|transdermal|transdermal
495615|NCT00163072|Megace|megace
495616|NCT00163072|pharmacokinetics|pharmacokinetics
495617|NCT00163124|chiropractic|chiropractic
495618|NCT00163124|spinal manipulation|spinal manipulation
495619|NCT00163124|low back pain|low back pain
495620|NCT00163176|cell proliferation|cell proliferation
495622|NCT00163176|radiotherapy|radiotherapy
495623|NCT00163228|C05.550.114.606.500|c05.550.114.606.500
495624|NCT00163228|C05.550.114.606.508|c05.550.114.606.508
495625|NCT00163254|Chronic limb ischemia|chronic limb ischemia
495626|NCT00163254|Intervention|intervention
495627|NCT00163254|Restenosis|restenosis
495628|NCT00163254|Patients above 18 years|patients above 18 years
495629|NCT00163267|peripheral arterial intervention|peripheral arterial intervention
495630|NCT00163267|atherosclerosis|atherosclerosis
495631|NCT00163267|platelets|platelets
495632|NCT00163267|Age above 18|age above 18
495633|NCT00170443|Influenza, Baculovirus, Immunogenicity, Geriatrics|influenza, baculovirus, immunogenicity, geriatrics
495634|NCT00170456|Anthrax vaccine|anthrax vaccine
495635|NCT00170469|Anthrax|anthrax
495636|NCT00170482|influenza vaccine, Fluzone, inactivated, trivalent|influenza vaccine, fluzone, inactivated, trivalent
495637|NCT00170495|respiratory illness, influenza, bronchitis, pneumonia, cold|respiratory illness, influenza, bronchitis, pneumonia, cold
495638|NCT00170508|Influenza, sub-study|influenza, sub-study
495639|NCT00170521|group A streptococci, pharyngitis, epidemiology, Streptococcus pyogenes, children, Nicaragua|group a streptococci, pharyngitis, epidemiology, streptococcus pyogenes, children, nicaragua
495640|NCT00170534|India, male, sexually transmitted infection, STI, STD|india, male, sexually transmitted infection, sti, std
495641|NCT00170547|inactivated, trivalent, influenza, vaccine, Fluzone|inactivated, trivalent, influenza, vaccine, fluzone
495642|NCT00170560|hospital, acquired, infections, mortality|hospital, acquired, infections, mortality
495643|NCT00170573|biweekly schedule of PLD - Ovarian cancer - pegylated liposomal doxorubicin -quality of life - Toxic skin reactions|biweekly schedule of pld - ovarian cancer - pegylated liposomal doxorubicin -quality of life - toxic skin reactions
495644|NCT00170586|Underglove, polyvinylidene fluoride, acrylic polymer|underglove, polyvinylidene fluoride, acrylic polymer
495645|NCT00170612|Pneumococcal infections|pneumococcal infections
495646|NCT00170612|Fiji|fiji
639114|NCT00735111|QOL|qol
494943|NCT00165958|Epidermal cyst|epidermal cyst
495647|NCT00170612|infants|infants
495648|NCT00170612|vaccine|vaccine
495649|NCT00170625|platin-resistant|platin-resistant
495650|NCT00170638|Tuberculosis, children, infants|tuberculosis, children, infants
495651|NCT00170664|Ovarian neoplasms|ovarian neoplasms
495652|NCT00170664|paclitaxel, carboplatin|paclitaxel, carboplatin
495653|NCT00170664|clinical trials, phase II|clinical trials, phase ii
495654|NCT00170664|first-line chemotherapy|first-line chemotherapy
495655|NCT00170664|weekly therapy schedule|weekly therapy schedule
495656|NCT00170703|Cortical Electrical Stimulation|cortical electrical stimulation
495657|NCT00170703|Ischemic Stroke|ischemic stroke
495658|NCT00170703|Broca's Aphasia|broca's aphasia
495659|NCT00170703|Speech Rehabilitation|speech rehabilitation
495660|NCT00170703|Functional MRI|functional mri
495661|NCT00170716|Motor Cortex Electrical Stimulation|motor cortex electrical stimulation
495662|NCT00170716|Ischemic Stroke|ischemic stroke
495953|NCT00175604|torticollis|torticollis
495663|NCT00170716|Upper Extremity Hemiparesis|upper extremity hemiparesis
495665|NCT00170716|Motor Recovery|motor recovery
495666|NCT00170716|Functional MRI|functional mri
495667|NCT00170729|Prednisolone acetate,|prednisolone acetate,
495668|NCT00170729|efficacy,|efficacy,
495669|NCT00170729|cataract,|cataract,
495670|NCT00170729|eye drops,|eye drops,
495671|NCT00170729|tolerability,|tolerability,
495672|NCT00170729|inflammation|inflammation
495673|NCT00170742|Open label,|open label,
495674|NCT00170742|phase III,|phase iii,
495675|NCT00170742|disease,|disease,
495676|NCT00170742|clinical trial,|clinical trial,
495677|NCT00170742|octreotide,|octreotide,
495678|NCT00170742|proliferative diabetic retinopathy, lasercoagulation|proliferative diabetic retinopathy, lasercoagulation
495679|NCT00170755|Overactive Bladder, incontinence, antimuscarinic, darifenacin, long-term treatment|overactive bladder, incontinence, antimuscarinic, darifenacin, long-term treatment
495680|NCT00170768|Darifenacin, oxybutynin, cognition, memory|darifenacin, oxybutynin, cognition, memory
495681|NCT00170781|Pain, acute gout, arthritis, cyclooxygenase-2 inhibitors, lumiracoxib, indomethacin|pain, acute gout, arthritis, cyclooxygenase-2 inhibitors, lumiracoxib, indomethacin
495682|NCT00170794|cardiac transplantation, everolimus, cyclosporine microemulsion, GFR|cardiac transplantation, everolimus, cyclosporine microemulsion, gfr
495683|NCT00173836|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
495684|NCT00173836|Saliva|saliva
495685|NCT00173836|Swallowing|swallowing
495686|NCT00173836|Videofluoroscopy|videofluoroscopy
495687|NCT00173836|Radiation|radiation
495688|NCT00173849|oral cancer|oral cancer
495689|NCT00173849|CXCR4|cxcr4
495690|NCT00173849|stromal-cell-derived factor-1(SDF-1)|stromal-cell-derived factor-1(sdf-1)
495691|NCT00173849|metastasis|metastasis
495692|NCT00173862|Combination, Chemotherapy,transitional cell carcinoma|combination, chemotherapy,transitional cell carcinoma
495693|NCT00173875|EGFR Non-small cell lung cancer|egfr non-small cell lung cancer
495694|NCT00173888|Combination, Chemotherapy,non-small cell lung cancer|combination, chemotherapy,non-small cell lung cancer
495695|NCT00173901|ceftazidime|ceftazidime
495696|NCT00173901|safety|safety
495697|NCT00173901|infection|infection
495698|NCT00173914|1. Transplant vasculopathy|1. transplant vasculopathy
495699|NCT00173914|2. Endothelial dysfunction|2. endothelial dysfunction
495700|NCT00173914|3. Myocardial perfusion imaging|3. myocardial perfusion imaging
495701|NCT00173914|4. Intravascular vascular ultrasound|4. intravascular vascular ultrasound
495702|NCT00173927|extracranial atherosclerosis|extracranial atherosclerosis
495703|NCT00173927|imaging|imaging
495704|NCT00173927|biomarkers|biomarkers
495705|NCT00173940|chronic diseases, such as hypertension, diabetes, obesity, chronic renal failure, and so on|chronic diseases, such as hypertension, diabetes, obesity, chronic renal failure, and so on
583945|NCT00514007|Breast cancer|breast cancer
495706|NCT00173953|H. pylori、immune response、lymphocytic subsets、cytokine|h. pylori、immune response、lymphocytic subsets、cytokine
495707|NCT00173979|muscle|muscle
495708|NCT00173979|tendon|tendon
495709|NCT00173992|Stroke|stroke
495710|NCT00173992|Balance|balance
495711|NCT00173992|Proactive control|proactive control
495712|NCT00173992|Reactive control|reactive control
495713|NCT00173992|Recovery|recovery
495714|NCT00173992|Training|training
495715|NCT00173992|Fall|fall
495716|NCT00174005|muscle|muscle
495717|NCT00174005|tendon|tendon
495718|NCT00174018|subacrominal space|subacrominal space
495719|NCT00174031|baseball|baseball
495720|NCT00174031|injury|injury
495721|NCT00174057|Graves' ophthalmopathy|graves' ophthalmopathy
495722|NCT00174057|real time PCR|real time pcr
495723|NCT00174057|cytokines|cytokines
495724|NCT00174057|Tsh receptor|tsh receptor
495725|NCT00174070|Respiratory failure|respiratory failure
495726|NCT00174070|Community|community
495727|NCT00174083|Tuberculosis, TB-ELISPOT, active tuberculosis latent infection interferon|tuberculosis, tb-elispot, active tuberculosis latent infection interferon
495728|NCT00174096|laryngeal cancer|laryngeal cancer
495729|NCT00174096|hypopharyngeal cancer|hypopharyngeal cancer
495730|NCT00174096|CXCR4|cxcr4
495053|NCT00168194|HIV|hiv
495731|NCT00174096|stromal-cell-derived factor-1(SDF-1)|stromal-cell-derived factor-1(sdf-1)
495732|NCT00174096|metastasis|metastasis
495733|NCT00174109|arecoline, oral cancer, MAP2, cell migration|arecoline, oral cancer, map2, cell migration
495734|NCT00174122|Emergency department|emergency department
495735|NCT00174122|Blood culture|blood culture
495736|NCT00174122|Antimicrobial therapy|antimicrobial therapy
495737|NCT00174135|Sarcopenia|sarcopenia
495738|NCT00174135|exercise|exercise
495739|NCT00174161|Premenstrual Syndrome,Health Related Quality of Life|premenstrual syndrome,health related quality of life
495740|NCT00174213|iliotibial tract|iliotibial tract
495741|NCT00174499|Tooth stain|tooth stain
495742|NCT00174525|Alzheimer's Caregivers|alzheimer's caregivers
495743|NCT00174525|Alzheimer disease|alzheimer disease
495744|NCT00174538|codeine|codeine
495745|NCT00174538|pain|pain
495746|NCT00174538|CYP2D6|cyp2d6
495747|NCT00174538|genotype|genotype
495748|NCT00174538|morphine|morphine
495749|NCT00174538|sickle cell|sickle cell
495750|NCT00174538|pharmacokinetic|pharmacokinetic
495751|NCT00174590|depression|depression
495752|NCT00174603|depression|depression
495753|NCT00174603|psychosis|psychosis
495754|NCT00174720|Glucocorticosteroid. Bronchospasm|glucocorticosteroid. bronchospasm
495755|NCT00174733|Glucocorticosteroid. Bronchospasm|glucocorticosteroid. bronchospasm
495756|NCT00174746|Glucocorticosteroid; Dose response; Bronchospasm|glucocorticosteroid; dose response; bronchospasm
495757|NCT00174785|Mortality, Hospitalization|mortality, hospitalization
495758|NCT00174798|Cystometry NK1 Antagonist SSR240600C|cystometry nk1 antagonist ssr240600c
495759|NCT00174811|acute otitis media|acute otitis media
495760|NCT00174811|controlled clinical trial|controlled clinical trial
495761|NCT00174811|telithromycin|telithromycin
495762|NCT00174811|cefuroxime axetil|cefuroxime axetil
495763|NCT00174811|middle ear infections|middle ear infections
495764|NCT00174811|tympanocentecis|tympanocentecis
495765|NCT00174824|Diabetes|diabetes
495766|NCT00174824|Diabetic Retinopathy|diabetic retinopathy
495767|NCT00174837|Tirapazamine|tirapazamine
495768|NCT00174837|Head and Neck Cancer|head and neck cancer
495769|NCT00174837|Cisplatin|cisplatin
495770|NCT00174837|Radiation|radiation
495771|NCT00174850|anxiety|anxiety
495772|NCT00174850|sexual dysfunction|sexual dysfunction
495773|NCT00174850|ssri|ssri
495774|NCT00174876|depression|depression
495775|NCT00174889|Schizophrenia|schizophrenia
495776|NCT00174889|Pregnenolone|pregnenolone
495777|NCT00174889|Neurosteroids|neurosteroids
495778|NCT00174902|Randomized controlled trial|randomized controlled trial
495779|NCT00174902|Blood platelets|blood platelets
495780|NCT00174902|Hemostasis|hemostasis
495781|NCT00174902|Stress, psychological|stress, psychological
495782|NCT00174902|Adrenergic beta-antagonists|adrenergic beta-antagonists
495783|NCT00174902|Aspirin|aspirin
495784|NCT00174902|Endothelium|endothelium
495785|NCT00174902|Arteriosclerosis|arteriosclerosis
495786|NCT00174915|Uric Acid, gout, xanthine oxidase, febuxostat, tophi|uric acid, gout, xanthine oxidase, febuxostat, tophi
495787|NCT00174928|Pediatric GERD|pediatric gerd
495788|NCT00174928|Pediatric Gastroesophageal Reflux Disease|pediatric gastroesophageal reflux disease
495789|NCT00174928|Neonates|neonates
495790|NCT00174928|lansoprazole|lansoprazole
495791|NCT00174941|Uric acid|uric acid
495792|NCT00174941|xanthine oxidase|xanthine oxidase
495793|NCT00174941|tophi|tophi
495794|NCT00174941|Drug Therapy|drug therapy
495795|NCT00174954|Gout|gout
495796|NCT00174954|Tophus|tophus
495798|NCT00174967|Uric Acid|uric acid
495799|NCT00174967|xanthine oxidase|xanthine oxidase
495800|NCT00174967|tophi|tophi
495801|NCT00174967|Drug Therapy|drug therapy
495802|NCT00174980|Oxycyte|oxycyte
495803|NCT00174980|perfluorocarbon oxygen carrier|perfluorocarbon oxygen carrier
495804|NCT00174980|brain oxygen tension|brain oxygen tension
495805|NCT00174993|Glucose Metabolism Disorder|glucose metabolism disorder
495806|NCT00174993|Dysmetabolic Syndrome|dysmetabolic syndrome
495807|NCT00174993|Type II Diabetes; Diabetes Mellitus|type ii diabetes; diabetes mellitus
495808|NCT00174993|Lipoatrophic|lipoatrophic
495809|NCT00174993|Dyslipidemia|dyslipidemia
495810|NCT00174993|Drug Therapy|drug therapy
495811|NCT00175006|Hyperuricemia|hyperuricemia
495813|NCT00175006|Tophus|tophus
495814|NCT00175006|Drug Therapy|drug therapy
495815|NCT00175019|uric acid|uric acid
495816|NCT00175019|xanthine oxidase|xanthine oxidase
495817|NCT00175019|hyperuricemia|hyperuricemia
495818|NCT00175019|tophi|tophi
495819|NCT00175019|Drug Therapy|drug therapy
495820|NCT00175032|Low dose aspirin|low dose aspirin
495821|NCT00175032|Peptic Ulcer|peptic ulcer
495822|NCT00175032|gastric ulcer|gastric ulcer
495823|NCT00175032|duodenal ulcer|duodenal ulcer
495824|NCT00175032|NSAIDs|nsaids
495825|NCT00175045|Intravenous|intravenous
495826|NCT00175045|gastric acid secretion|gastric acid secretion
495827|NCT00175045|Lansoprazole|lansoprazole
495828|NCT00175045|Esophagitis|esophagitis
495829|NCT00175045|reflux|reflux
495151|NCT00168636|OPV|opv
495830|NCT00175058|Heart Attack|heart attack
495831|NCT00175097|soy protein|soy protein
495832|NCT00175097|lipids|lipids
495833|NCT00175097|lipoproteins|lipoproteins
495834|NCT00175097|apolipoproteins|apolipoproteins
495835|NCT00175097|cholesterol|cholesterol
495836|NCT00175097|endothelial function|endothelial function
495837|NCT00175110|pre-hypertension|pre-hypertension
495838|NCT00175110|mild hypertension|mild hypertension
495839|NCT00175123|Myelomeningocele|myelomeningocele
495840|NCT00175123|Neurogenic Bladder|neurogenic bladder
495841|NCT00175123|Intervention|intervention
495842|NCT00175123|Botulinum A toxin|botulinum a toxin
495843|NCT00175123|Oxybutynin|oxybutynin
495844|NCT00175136|RSA|rsa
495845|NCT00175136|DEXA|dexa
495846|NCT00175136|Gonarthrosis|gonarthrosis
495847|NCT00175136|Knee Arthroplasty|knee arthroplasty
495848|NCT00175136|Micromotion of polyethylen liner|micromotion of polyethylen liner
495849|NCT00175136|Stem arthroplasty design|stem arthroplasty design
495850|NCT00175149|CKD 3-4|ckd 3-4
495851|NCT00175162|RSA|rsa
495852|NCT00175162|DEXA|dexa
495853|NCT00175162|Genoarthrosis|genoarthrosis
495854|NCT00175162|Knee Arthroplasty|knee arthroplasty
495855|NCT00175162|Micromotion of polyethylene liner|micromotion of polyethylene liner
495857|NCT00175175|osteoporosis treatment|osteoporosis treatment
495858|NCT00175175|osteoporosis testing|osteoporosis testing
495859|NCT00175175|hip fracture|hip fracture
495860|NCT00175175|quality improvement|quality improvement
495862|NCT00175188|DEXA|dexa
495863|NCT00175188|Osteoarthritis|osteoarthritis
495864|NCT00175188|Finger implant|finger implant
495865|NCT00175188|Micromotion|micromotion
495866|NCT00175188|Bone density|bone density
495867|NCT00175188|Cement|cement
495868|NCT00175214|osteoporosis|osteoporosis
495869|NCT00175214|wrist fractures|wrist fractures
495870|NCT00175214|quality improvement|quality improvement
495871|NCT00175214|knowledge translation|knowledge translation
495872|NCT00175227|contrast-induced nephropathy|contrast-induced nephropathy
495873|NCT00175227|prevention|prevention
495874|NCT00175227|renal failure|renal failure
495875|NCT00175227|cardiac angiogram|cardiac angiogram
495876|NCT00175240|Coronary disease|coronary disease
495877|NCT00175240|quality improvement|quality improvement
495878|NCT00175240|knowledge translation|knowledge translation
495879|NCT00175253|islet|islet
495880|NCT00175253|transplantation|transplantation
495881|NCT00175266|islet|islet
495882|NCT00175266|transplantation|transplantation
495883|NCT00175279|coronary disease|coronary disease
495884|NCT00175279|heart failure|heart failure
495885|NCT00175279|quality improvement|quality improvement
495886|NCT00175279|knowledge translation|knowledge translation
495887|NCT00175279|opinion leaders|opinion leaders
495888|NCT00175305|Prader-Willi Syndrome|prader-willi syndrome
495889|NCT00175305|Somatostatin|somatostatin
495890|NCT00175305|Ghrelin|ghrelin
495891|NCT00175305|Obesity|obesity
495892|NCT00175305|Hyperphagia|hyperphagia
495893|NCT00175305|Hyperphagia in Prader-Willi syndrome|hyperphagia in prader-willi syndrome
495894|NCT00175318|Motivational interviewing|motivational interviewing
495895|NCT00175318|behavioural modification|behavioural modification
495896|NCT00175318|maternal counseling|maternal counseling
495897|NCT00175344|Breast cancer|breast cancer
495898|NCT00175344|scar massage|scar massage
495899|NCT00175344|breast conserving surgery|breast conserving surgery
495900|NCT00175344|scar pain|scar pain
495901|NCT00175344|quality of life|quality of life
495902|NCT00175344|Breast cancer treated with breast conserving surgery with or without axillary dissection or sentinel node sampling.|breast cancer treated with breast conserving surgery with or without axillary dissection or sentinel node sampling.
495903|NCT00175357|Opiate addiction|opiate addiction
495904|NCT00175357|medical heroin|medical heroin
495905|NCT00175357|methadoneRCT|methadonerct
495906|NCT00175370|Vancomycin|vancomycin
495907|NCT00175370|Coagulase Negative Staphylococcus|coagulase negative staphylococcus
495908|NCT00175370|Central Venous Catheter|central venous catheter
495909|NCT00175370|Bloodstream infection|bloodstream infection
495910|NCT00175370|CNS bloodstream infection|cns bloodstream infection
495911|NCT00175383|Prostate cancer, LHRH, hormone therapy, testosterone level|prostate cancer, lhrh, hormone therapy, testosterone level
495912|NCT00175396|ASCENDE-RT|ascende-rt
495913|NCT00175409|Pain Response|pain response
495914|NCT00175422|Prevention|prevention
495915|NCT00175422|Randomized controlled trial|randomized controlled trial
495916|NCT00175422|Community education|community education
495917|NCT00175422|Shaken Baby Syndrome|shaken baby syndrome
495918|NCT00175422|Crying|crying
495919|NCT00175422|Colic|colic
495920|NCT00175435|Topical Immune Modulator|topical immune modulator
495921|NCT00175435|resiquimod gel|resiquimod gel
495922|NCT00175435|Hepatitis B booster response|hepatitis b booster response
495923|NCT00175435|Vaccine Evaluation|vaccine evaluation
495924|NCT00175435|Prevention of Hepatitis B disease|prevention of hepatitis b disease
495925|NCT00175487|Osteoarthritis/Avascular Necrosis|osteoarthritis/avascular necrosis
495926|NCT00175487|Hip|hip
495927|NCT00175500|Post-Arthroplasty Hip Dislocation|post-arthroplasty hip dislocation
495928|NCT00175513|Psychosis|psychosis
495929|NCT00175513|early psychosis|early psychosis
495930|NCT00175513|first episode psychosis|first episode psychosis
495931|NCT00175513|schizophrenia|schizophrenia
495932|NCT00175513|schizoaffective|schizoaffective
495933|NCT00175513|schizophreniform|schizophreniform
495934|NCT00175513|bipolar disorder|bipolar disorder
495935|NCT00175513|valtrex|valtrex
495936|NCT00175513|valacyclovir.|valacyclovir.
495937|NCT00175539|sexual dysfunction|sexual dysfunction
495938|NCT00175539|group treatment|group treatment
495939|NCT00175552|Depression|depression
495940|NCT00175552|Adolescents|adolescents
495941|NCT00175552|IPT|ipt
495942|NCT00175552|Knowledge translation|knowledge translation
495943|NCT00175552|Psychotherapy|psychotherapy
495944|NCT00175565|inflammation|inflammation
495945|NCT00175565|trial|trial
495946|NCT00175565|fluticasone|fluticasone
495947|NCT00175578|Early stage (0/I) non-small cell lung cancer|early stage (0/i) non-small cell lung cancer
495948|NCT00175591|Femur fracture|femur fracture
495949|NCT00175591|morphine sparing|morphine sparing
495950|NCT00175591|preemptive analgesia|preemptive analgesia
495951|NCT00175591|Post-operative pain and post- operative opioid use|post-operative pain and post- operative opioid use
495952|NCT00175604|Botox|botox
495861|NCT00175188|RSA|rsa
495954|NCT00175604|Congenital Muscular Torticollis (CMT)|congenital muscular torticollis (cmt)
495955|NCT00175630|ACL reconstruction|acl reconstruction
495956|NCT00175630|morphine sparing|morphine sparing
495957|NCT00175630|preemptive analgesia|preemptive analgesia
495958|NCT00175630|Post-operative pain and post- operative opioid use|post-operative pain and post- operative opioid use
495959|NCT00175643|actinic keratoses|actinic keratoses
495960|NCT00175643|imiquimod|imiquimod
495961|NCT00175643|pre-malignant|pre-malignant
495962|NCT00175643|squamous cell carcinoma|squamous cell carcinoma
495963|NCT00175643|immunosuppression|immunosuppression
495964|NCT00175656|Femur fracture|femur fracture
495965|NCT00175656|titanium elastic nails|titanium elastic nails
495966|NCT00175669|Randomized control trial; placebo-control study|randomized control trial; placebo-control study
495967|NCT00175682|Autonomic Dysreflexia|autonomic dysreflexia
495969|NCT00175682|Vibrostimulation|vibrostimulation
495970|NCT00175682|Ejaculation|ejaculation
495971|NCT00175708|Evaluation of an outcome tool|evaluation of an outcome tool
495972|NCT00175708|clubfoot|clubfoot
495973|NCT00175708|foot pressure profiles|foot pressure profiles
495974|NCT00175708|pedobarographs|pedobarographs
495975|NCT00175721|Combined Clinic|combined clinic
495976|NCT00175721|Chronic Kidney Disease|chronic kidney disease
495977|NCT00175721|Diabetes|diabetes
495978|NCT00175734|Vascular Reactivity|vascular reactivity
495979|NCT00175734|Anemia Correction Therapy|anemia correction therapy
495980|NCT00175734|Hemodialysis patients|hemodialysis patients
495981|NCT00175734|Diabetic and non-diabetic patients|diabetic and non-diabetic patients
495982|NCT00175734|Diabetes in Hemodialysis patients|diabetes in hemodialysis patients
495983|NCT00175747|dysplasia|dysplasia
495984|NCT00175747|lung cancer|lung cancer
495985|NCT00175747|chemoprevention|chemoprevention
495987|NCT00175760|pediatric|pediatric
495988|NCT00175760|comparison study|comparison study
495989|NCT00175773|Orthostatic stress|orthostatic stress
495990|NCT00175786|Glaucoma|glaucoma
495991|NCT00175786|Normal Tensions Glaucoma|normal tensions glaucoma
495992|NCT00175786|Neuroradiology|neuroradiology
495993|NCT00175786|Tumor|tumor
495994|NCT00175786|MRI|mri
495995|NCT00175786|Magnetic Resonance Imaging|magnetic resonance imaging
495996|NCT00175786|Compressive Lesion|compressive lesion
583301|NCT00511212|Severe peritonitis after lower digestive tract surgery|severe peritonitis after lower digestive tract surgery
583302|NCT00511225|dialysis|dialysis
583303|NCT00511225|Vitamin D|vitamin d
495997|NCT00175799|Observational study of physiological status at entry into PICU as a predictor of outcome, comparison of two commonly used scores (PRISM and PIM)|observational study of physiological status at entry into picu as a predictor of outcome, comparison of two commonly used scores (prism and pim)
495999|NCT00175812|Acute myelogenous leukemia|acute myelogenous leukemia
496001|NCT00175812|All trans retinoic acid|all trans retinoic acid
496002|NCT00175812|Valproic acid|valproic acid
496003|NCT00175812|Theophyllamin|theophyllamin
496004|NCT00175825|Epilepsy: partial onset seizures|epilepsy: partial onset seizures
496005|NCT00175825|brivaracetam|brivaracetam
496006|NCT00175838|Primary Thrombocythmeia|primary thrombocythmeia
496007|NCT00175838|Hydroxyurea|hydroxyurea
496008|NCT00175838|Randomised|randomised
496009|NCT00175838|Thrombosis|thrombosis
496010|NCT00175838|Haemorrhage|haemorrhage
496011|NCT00175851|Partial onset, primary generalized seizures, seletracetam|partial onset, primary generalized seizures, seletracetam
496012|NCT00175864|Partial Onset, Primary Generalized Seizures, Seletracetam|partial onset, primary generalized seizures, seletracetam
496013|NCT00175877|Rheumatoid Arthritis|rheumatoid arthritis
496014|NCT00175877|CDP870|cdp870
496015|NCT00175877|Certolizumab Pegol|certolizumab pegol
496016|NCT00175877|Cimzia|cimzia
496017|NCT00175890|Partial Onset Seizure|partial onset seizure
495351|NCT00169585|PSA|psa
496018|NCT00175890|levetiracetam|levetiracetam
496019|NCT00175890|Video Electroencephalogram|video electroencephalogram
496020|NCT00175890|Keppra|keppra
496021|NCT00175903|Newly Diagnosed Epilepsy|newly diagnosed epilepsy
496022|NCT00175903|Levetiracetam|levetiracetam
496023|NCT00175903|Keppra|keppra
496024|NCT00175903|Carbamazepine|carbamazepine
496025|NCT00175903|Valproate|valproate
496029|NCT00175929|Epilepsy|epilepsy
496030|NCT00175929|Focal Epilepsy|focal epilepsy
496031|NCT00175929|Partial Onset Seizures|partial onset seizures
496032|NCT00175929|Brivaracetam|brivaracetam
496033|NCT00175942|acute myocardial infarction|acute myocardial infarction
496034|NCT00175942|ventricular fibrillation|ventricular fibrillation
496035|NCT00175942|coagulation|coagulation
496036|NCT00175942|inflammation|inflammation
496037|NCT00175955|Neuroleptic-induced tardive dyskinesia|neuroleptic-induced tardive dyskinesia
496038|NCT00175955|Keppra, Levetiracetam|keppra, levetiracetam
496039|NCT00175994|voriconazole|voriconazole
496040|NCT00175994|genotype|genotype
496041|NCT00175994|bioavailability|bioavailability
496042|NCT00175994|metabolic clearance|metabolic clearance
496043|NCT00176020|nicotinic acid|nicotinic acid
496044|NCT00176020|flush symptom|flush symptom
496045|NCT00176020|pharmacodynamic|pharmacodynamic
496046|NCT00176020|pharmacokinetic|pharmacokinetic
496047|NCT00176033|ritonavir|ritonavir
496048|NCT00176033|lopinavir|lopinavir
496049|NCT00176033|HIV Infections|hiv infections
496050|NCT00176046|breast cancer|breast cancer
496052|NCT00176046|complementary therapy|complementary therapy
496053|NCT00176046|quality of life|quality of life
496054|NCT00176046|immune function|immune function
496055|NCT00176046|breast cancer (UICC stage I/II)|breast cancer (uicc stage i/ii)
496056|NCT00176059|immunoglobulins, intravenous|immunoglobulins, intravenous
496057|NCT00176059|kidney transplantation|kidney transplantation
496058|NCT00176059|acute rejection|acute rejection
496059|NCT00176059|chronic rejection|chronic rejection
496060|NCT00176059|regulatory autoantibodies|regulatory autoantibodies
496061|NCT00176059|Th1|th1
496062|NCT00176059|Th2|th2
496063|NCT00176059|B Cell|b cell
496064|NCT00176059|Monokines|monokines
496065|NCT00176059|Cytokine promoter gene polymorphisms|cytokine promoter gene polymorphisms
496066|NCT00176098|Cataract surgery|cataract surgery
496067|NCT00176098|Hypnosis|hypnosis
496068|NCT00176098|C11.510.245|c11.510.245
496069|NCT00176098|F04.754.424.771|f04.754.424.771
496070|NCT00176098|Suggestion|suggestion
496071|NCT00176111|peripheral nerve stimulation|peripheral nerve stimulation
496072|NCT00176111|saline|saline
496073|NCT00176111|local anesthestics|local anesthestics
496074|NCT00176111|regional anesthestia|regional anesthestia
496075|NCT00176111|nerve damage|nerve damage
496076|NCT00176124|leukocyte depletion, autologous transfusion,|leukocyte depletion, autologous transfusion,
496077|NCT00176124|infection|infection
496078|NCT00176124|bacterial infection|bacterial infection
496079|NCT00176124|sepsis, antibiotics|sepsis, antibiotics
496080|NCT00176137|multimodality treatment|multimodality treatment
496081|NCT00176150|anorexia nervosa|anorexia nervosa
496082|NCT00176150|multidrug resistance|multidrug resistance
496083|NCT00176150|cholesterol metabolism|cholesterol metabolism
496084|NCT00176163|Fibromyalgia|fibromyalgia
496085|NCT00176163|Back pain|back pain
496086|NCT00176163|Behavior Therapy|behavior therapy
496087|NCT00176163|Operant learning|operant learning
496088|NCT00176163|Tetrahydrocannabinol|tetrahydrocannabinol
496089|NCT00176176|cerebral circulation|cerebral circulation
496090|NCT00176189|FPD, all-ceramic|fpd, all-ceramic
496091|NCT00176241|head and neck|head and neck
496092|NCT00176241|Gemcitabine|gemcitabine
496093|NCT00176241|Paclitaxel|paclitaxel
496094|NCT00176241|radiation|radiation
496095|NCT00176241|low-dose radiation|low-dose radiation
496096|NCT00176241|recurrent|recurrent
496097|NCT00176241|metastatic|metastatic
496098|NCT00176254|head and neck|head and neck
496099|NCT00176254|squamous cell carcinoma|squamous cell carcinoma
496100|NCT00176254|squamous cell|squamous cell
496101|NCT00176254|carcinoma|carcinoma
496102|NCT00176254|paclitaxel|paclitaxel
496103|NCT00176254|carboplatin|carboplatin
496104|NCT00176254|radiotherapy|radiotherapy
496105|NCT00176254|induction therapy|induction therapy
496106|NCT00176267|head and neck|head and neck
496107|NCT00176267|squamous cell carcinoma|squamous cell carcinoma
496108|NCT00176267|squamous cell|squamous cell
496109|NCT00176267|carcinoma|carcinoma
496110|NCT00176267|paclitaxel|paclitaxel
496111|NCT00176267|carboplatin|carboplatin
496112|NCT00176267|radiotherapy|radiotherapy
496113|NCT00176267|induction therapy|induction therapy
496115|NCT00176280|Carcinoma|carcinoma
496116|NCT00176280|Renal Cell Carcinoma|renal cell carcinoma
496117|NCT00176280|RCC|rcc
496118|NCT00176280|Leukine|leukine
496119|NCT00176280|Dexamethasone|dexamethasone
496120|NCT00176280|Gemcitabine|gemcitabine
496121|NCT00176280|5 Fluorouracil|5 fluorouracil
496122|NCT00176280|5 FU|5 fu
496123|NCT00176280|Metastatic|metastatic
496124|NCT00176293|prostate|prostate
496125|NCT00176293|prostate cancer|prostate cancer
496126|NCT00176293|doxil|doxil
496127|NCT00176293|dexamethasone|dexamethasone
496128|NCT00176293|metastatic|metastatic
496129|NCT00176293|hormone refractory|hormone refractory
496130|NCT00166153|cardiac transplantation|cardiac transplantation
496131|NCT00166153|pediatrics|pediatrics
496132|NCT00166153|cardiology|cardiology
496133|NCT00166153|drug metabolism|drug metabolism
496134|NCT00166166|hyperlipidaemia|hyperlipidaemia
496135|NCT00166166|EDHF|edhf
496136|NCT00166166|FMD|fmd
496137|NCT00166179|CAD|cad
496138|NCT00166192|Melasma|melasma
496139|NCT00166192|Jessner's solution|jessner's solution
496140|NCT00166192|Trichloroacetic acid (TCA)|trichloroacetic acid (tca)
496141|NCT00166205|Obesity, Morbid|obesity, morbid
496142|NCT00166205|Obesity|obesity
496143|NCT00166205|Body Weight|body weight
496144|NCT00166218|pediatrics|pediatrics
496145|NCT00166218|cardiac defects|cardiac defects
496146|NCT00166231|Innocent heart murmurs|innocent heart murmurs
496147|NCT00166231|Chest pain|chest pain
496148|NCT00166231|pediatric Cardiology|pediatric cardiology
496149|NCT00166231|Somatization|somatization
496150|NCT00166231|life stress|life stress
496151|NCT00166244|Mycophenolate mofetil|mycophenolate mofetil
496152|NCT00166244|Therapeutic Drug Monitoring|therapeutic drug monitoring
496153|NCT00166244|Adult kidney transplantation|adult kidney transplantation
496154|NCT00166244|Paediatric kidney transplantation|paediatric kidney transplantation
496155|NCT00166257|Paradoxical embolism, Patent foramen ovale,|paradoxical embolism, patent foramen ovale,
496156|NCT00166270|Fibroids|fibroids
496157|NCT00166270|ExAblate|exablate
496158|NCT00166270|MrgFus|mrgfus
496159|NCT00166270|Uterine Fibroids|uterine fibroids
496160|NCT00166283|memory|memory
496161|NCT00166283|learning|learning
496162|NCT00166283|Multiple Sclerosis|multiple sclerosis
496163|NCT00166283|Cognition|cognition
496164|NCT00166283|treatment|treatment
496165|NCT00166283|therapy|therapy
496166|NCT00166296|Major depressive disorder, chemically induced.|major depressive disorder, chemically induced.
496167|NCT00166296|Peginterferon alfa-2a.|peginterferon alfa-2a.
496168|NCT00166296|Escitalopram.|escitalopram.
496169|NCT00166296|Chronic hepatitis C, psychology.|chronic hepatitis c, psychology.
496170|NCT00166296|Prophylactic treatment.|prophylactic treatment.
496171|NCT00166309|Hemophilia A|hemophilia a
496172|NCT00166309|Inhibitors|inhibitors
496173|NCT00166322|IBZM-SPECT|ibzm-spect
496174|NCT00166322|Amphetamine Challenge|amphetamine challenge
496175|NCT00166322|Schizophrenia|schizophrenia
496176|NCT00166322|dopaminergic neurotransmission|dopaminergic neurotransmission
496177|NCT00166322|Persons at risk for the development of schizophrenia|persons at risk for the development of schizophrenia
496178|NCT00166322|healthy subjects|healthy subjects
496179|NCT00166348|Cognitive Rehabilitation|cognitive rehabilitation
496180|NCT00166361|Extrinsic ureteral obstruction|extrinsic ureteral obstruction
496181|NCT00166361|Memokath 051 Ureteral Stent|memokath 051 ureteral stent
496182|NCT00166361|JJ Stent|jj stent
496183|NCT00166361|Stent|stent
496184|NCT00166387|Hemophilia|hemophilia
496185|NCT00166387|Inhibitors|inhibitors
496186|NCT00166439|C04.557.386|c04.557.386
496187|NCT00166517|Gastrointestinal Rotavirus|gastrointestinal rotavirus
496188|NCT00166543|locally advanced breast carcinoma|locally advanced breast carcinoma
496189|NCT00166543|locally recurrent inoperable breast carcinoma|locally recurrent inoperable breast carcinoma
496190|NCT00166543|progressive metastatic breast carcinoma|progressive metastatic breast carcinoma
496191|NCT00166569|Polycystic Ovary Syndrome|polycystic ovary syndrome
496192|NCT00166582|pediatric asthma, medication adherence, adolescents|pediatric asthma, medication adherence, adolescents
496193|NCT00166595|Risperidone|risperidone
496194|NCT00166595|Autism|autism
496195|NCT00166595|Pervasive Developmental Disorder (PDD)|pervasive developmental disorder (pdd)
496196|NCT00166608|acetaminophen toxicity|acetaminophen toxicity
496197|NCT00166608|liver damage|liver damage
496198|NCT00166608|tylenol overdose|tylenol overdose
496199|NCT00166621|Autism|autism
496200|NCT00166621|Neuroplasticity|neuroplasticity
496201|NCT00166634|Hypertension|hypertension
496202|NCT00166634|ABPM|abpm
496203|NCT00166634|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
496204|NCT00166647|Cancer|cancer
496205|NCT00166647|Chemotherapy|chemotherapy
496206|NCT00166647|Hematological disorder|hematological disorder
496207|NCT00166660|Preterm infants|preterm infants
496208|NCT00166660|Developmental Care|developmental care
496209|NCT00166660|NIDCAP|nidcap
496210|NCT00166660|Fetal Growth Restriction|fetal growth restriction
496211|NCT00166660|Neurobehavior|neurobehavior
496212|NCT00166660|APIB|apib
496214|NCT00166660|EEG|eeg
496215|NCT00166660|Parent Stress|parent stress
496216|NCT00166673|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
496217|NCT00166673|Type 1 Diabetes|type 1 diabetes
496218|NCT00166673|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
496219|NCT00166673|Electronic Data Collection|electronic data collection
496220|NCT00166686|Cancer|cancer
496221|NCT00166686|Clonidine|clonidine
496222|NCT00166686|Neurocognitive sequelae|neurocognitive sequelae
496223|NCT00166699|ultrasonography|ultrasonography
496224|NCT00166699|obesity|obesity
496225|NCT00166699|Cesarean Section|cesarean section
496226|NCT00166699|Anesthesia|anesthesia
496227|NCT00166699|Epidural|epidural
496228|NCT00166712|Kidney Transplant|kidney transplant
496229|NCT00166712|Living Donor Kidney Transplant Recipients|living donor kidney transplant recipients
496230|NCT00166725|HRPC|hrpc
496231|NCT00166725|octreotide LAR|octreotide lar
496232|NCT00166725|CgA|cga
496233|NCT00166738|Schizophrenia|schizophrenia
496234|NCT00166738|multiple genes|multiple genes
496235|NCT00166738|array-comparative genomic hybridization (CGH)|array-comparative genomic hybridization (cgh)
496236|NCT00166738|genomic DNA|genomic dna
496237|NCT00166738|Chinese Han People|chinese han people
496238|NCT00166751|Videofluoroscopic examination,|videofluoroscopic examination,
496239|NCT00166751|ultrasound|ultrasound
496240|NCT00166751|laryngeal elevation|laryngeal elevation
496241|NCT00166751|dysphagia|dysphagia
496242|NCT00166764|Psychiatric Disorders|psychiatric disorders
496243|NCT00166764|Evaluation of Mental Health Index|evaluation of mental health index
496244|NCT00166790|Human Chorionic Gonadotropin|human chorionic gonadotropin
496245|NCT00166790|Dual Polarization Interferometry,|dual polarization interferometry,
496246|NCT00166790|Gestational Trophoblastic Neoplasms|gestational trophoblastic neoplasms
753943|NCT01178346|Smoking vaccine|smoking vaccine
496247|NCT00166803|Diabetes Mellitus, PPARγ agonist, FDG PET|diabetes mellitus, pparγ agonist, fdg pet
496248|NCT00166816|Sirolimus|sirolimus
496249|NCT00166816|Tacrolimus|tacrolimus
496250|NCT00166816|Cyclosporine|cyclosporine
496251|NCT00166816|Pharmacokinetics|pharmacokinetics
496252|NCT00166816|Immunosuppressive Agents|immunosuppressive agents
496253|NCT00166816|Immunosuppression|immunosuppression
496254|NCT00166816|Kidney Transplantation|kidney transplantation
496255|NCT00166816|Transplantation|transplantation
496256|NCT00166829|Tacrolimus|tacrolimus
496257|NCT00166829|Sirolimus|sirolimus
496258|NCT00166829|Mycophenolic acid|mycophenolic acid
496259|NCT00166829|Immunosuppressive Agents|immunosuppressive agents
496260|NCT00166829|Immunosuppression|immunosuppression
496261|NCT00166829|Kidney Transplantation|kidney transplantation
496262|NCT00166829|Transplantation|transplantation
496263|NCT00166842|Pharmacokinetics|pharmacokinetics
496264|NCT00166842|Sirolimus|sirolimus
496265|NCT00166842|Cyclosporine|cyclosporine
496266|NCT00166842|Tacrolimus|tacrolimus
496267|NCT00166842|Immunosuppressive Agents|immunosuppressive agents
496268|NCT00166842|Immunosuppression|immunosuppression
496269|NCT00166842|Transplantation|transplantation
496270|NCT00166842|Kidney Transplantation|kidney transplantation
496271|NCT00166855|angiogenesis|angiogenesis
496272|NCT00166855|bone marrow perfusion|bone marrow perfusion
496273|NCT00166855|dynamic MRI|dynamic mri
496274|NCT00166855|multiple myeloma|multiple myeloma
496275|NCT00166855|prognosis|prognosis
496276|NCT00166868|Biliary atresia, cholangitis, probiotics, prophylaxis|biliary atresia, cholangitis, probiotics, prophylaxis
496277|NCT00166881|Combination, Chemotherapy, Inoperable Gastric Cancer|combination, chemotherapy, inoperable gastric cancer
496278|NCT00166894|pleural effusion|pleural effusion
496279|NCT00166894|TREM-1|trem-1
496280|NCT00166907|Stroke|stroke
496281|NCT00166907|Balance|balance
496282|NCT00166907|Proactive control|proactive control
496283|NCT00166907|Reactive control|reactive control
496284|NCT00166907|Recovery|recovery
496285|NCT00166907|Training|training
496286|NCT00166907|Fall|fall
496287|NCT00166933|minimal erythema dose|minimal erythema dose
496288|NCT00166933|UVB|uvb
496289|NCT00166933|normal|normal
496290|NCT00166959|Stroke patients|stroke patients
496291|NCT00166959|Falls|falls
496292|NCT00166959|Reliability|reliability
496293|NCT00166959|Validity|validity
496294|NCT00166972|metastasis, survival, malignancy, female, trophinin|metastasis, survival, malignancy, female, trophinin
496295|NCT00166985|endometrial cancer, MRI, Doppler sonography, angiogenesis|endometrial cancer, mri, doppler sonography, angiogenesis
496296|NCT00166998|Breast neoplasms|breast neoplasms
496297|NCT00166998|diagnosis|diagnosis
496298|NCT00167011|coronary artery|coronary artery
496299|NCT00167024|prostate cancer, DNA repair gene, genetic polymorphism|prostate cancer, dna repair gene, genetic polymorphism
496300|NCT00167037|Hemiplegia|hemiplegia
496301|NCT00167037|Waist pulling perturbation|waist pulling perturbation
496302|NCT00167037|Reactive balance strategy|reactive balance strategy
496303|NCT00167037|Trajectory of center of pressure|trajectory of center of pressure
496304|NCT00167037|Parameters of center of pressure|parameters of center of pressure
496305|NCT00167063|Stroke|stroke
496306|NCT00167063|Fall|fall
496307|NCT00167063|Fall prediction|fall prediction
496308|NCT00167063|Clinical manifestations|clinical manifestations
496309|NCT00167063|Frequent faller|frequent faller
496310|NCT00167076|Stroke|stroke
496311|NCT00167076|Foot pressure|foot pressure
496312|NCT00167076|Walking speed|walking speed
496313|NCT00167076|Gait|gait
496314|NCT00167089|Stroke|stroke
496315|NCT00167089|Hemiplegia|hemiplegia
496316|NCT00167089|Gait|gait
496317|NCT00167089|Ambulation training|ambulation training
496318|NCT00167089|Neurologic physical therapy|neurologic physical therapy
496319|NCT00167102|Alopecia Areata|alopecia areata
496320|NCT00167115|Alcohol|alcohol
496321|NCT00167115|Type 2 diabetes mellitus|type 2 diabetes mellitus
496322|NCT00167115|Plama glucose|plama glucose
496323|NCT00167115|HDL cholesterol|hdl cholesterol
496324|NCT00167128|Auditory Processing Disorder|auditory processing disorder
496325|NCT00167128|speech-in-noise intelligibility|speech-in-noise intelligibility
496326|NCT00167141|male fertility|male fertility
496327|NCT00167141|semen parameters|semen parameters
496328|NCT00167154|suicidality|suicidality
496329|NCT00167154|antipsychotic|antipsychotic
496330|NCT00167154|antidepressant|antidepressant
496331|NCT00167154|treatment|treatment
496332|NCT00167167|Donor Lymphocyte Infusion|donor lymphocyte infusion
496333|NCT00167167|relapse|relapse
496334|NCT00167167|post-transplant|post-transplant
496335|NCT00167180|donor lymphocyte infusions|donor lymphocyte infusions
496336|NCT00167180|BMT|bmt
496337|NCT00167180|bone marrow transplant|bone marrow transplant
496338|NCT00167206|Stem Cell Transplant|stem cell transplant
496339|NCT00167206|Thymic Shielding|thymic shielding
496340|NCT00167206|Total Body Irradiation|total body irradiation
496341|NCT00167206|Chemotherapy|chemotherapy
496342|NCT00167219|Stem cell transplant|stem cell transplant
497026|NCT00178880|imaging|imaging
496343|NCT00167219|long term survival|long term survival
496344|NCT00167219|retinoic acid|retinoic acid
496346|NCT00167232|cocaine dependence|cocaine dependence
496347|NCT00167232|alcohol dependence|alcohol dependence
496348|NCT00167232|psychosocial treatment|psychosocial treatment
496349|NCT00167245|Topiramate|topiramate
496350|NCT00167245|alcoholism|alcoholism
496351|NCT00167245|cocaine dependence|cocaine dependence
496352|NCT00167271|Cognitive therapy|cognitive therapy
496353|NCT00167284|chronic care model, diabetes, community, diabetes education|chronic care model, diabetes, community, diabetes education
496354|NCT00167297|atomoxetine|atomoxetine
496355|NCT00167297|cannabis dependence|cannabis dependence
496356|NCT00167297|treatment|treatment
496357|NCT00167310|Omega-3 fatty acids|omega-3 fatty acids
496358|NCT00167310|Statins|statins
496359|NCT00167310|Antipsychotic drug|antipsychotic drug
496360|NCT00167310|Antidepressant drug|antidepressant drug
496361|NCT00167310|Antimanic drug|antimanic drug
496362|NCT00167310|Placebos|placebos
496363|NCT00167310|Double-blind method|double-blind method
496364|NCT00167310|Bipolar (depressed phase)|bipolar (depressed phase)
496365|NCT00167323|Bipolar|bipolar
496366|NCT00167323|Alcoholism|alcoholism
496367|NCT00167336|Computer|computer
496368|NCT00167336|Kinematics|kinematics
496369|NCT00167336|Instrument development|instrument development
496370|NCT00167336|Reliability|reliability
496371|NCT00167336|Cumulative Trauma Disorder|cumulative trauma disorder
496372|NCT00167349|cardiac surgery|cardiac surgery
496373|NCT00167349|cardiopulmonary bypass|cardiopulmonary bypass
496374|NCT00167349|cytokines|cytokines
496375|NCT00167362|Schizophrenia|schizophrenia
496376|NCT00167362|Cognition|cognition
496377|NCT00167362|Enhancement|enhancement
496378|NCT00167362|Randomized|randomized
496379|NCT00167375|Insomnia|insomnia
496380|NCT00167375|polysomnography|polysomnography
496381|NCT00167375|sleep onset|sleep onset
583304|NCT00511238|Onyx|onyx
496382|NCT00167375|time series analysis|time series analysis
496383|NCT00167388|anemia|anemia
496384|NCT00167388|prematurity|prematurity
496385|NCT00167388|blood flow velocity|blood flow velocity
496386|NCT00167388|superior mesenteric artery|superior mesenteric artery
496387|NCT00167388|intestinal blood flow in premature infants|intestinal blood flow in premature infants
496388|NCT00167414|conformal radiotherapy|conformal radiotherapy
496389|NCT00167440|cardiac index|cardiac index
496390|NCT00167440|cardiac output|cardiac output
496391|NCT00167440|indwelling central venous catheter|indwelling central venous catheter
496392|NCT00167440|indwelling arterial catheter|indwelling arterial catheter
496393|NCT00167453|Nervous system disease|nervous system disease
496394|NCT00167453|movement disorder|movement disorder
496395|NCT00167453|exercise|exercise
496396|NCT00167453|balance|balance
496397|NCT00167453|education|education
496398|NCT00167466|periodontal disease|periodontal disease
496399|NCT00167466|toothbrush|toothbrush
496400|NCT00167466|titanium dioxide semiconductor|titanium dioxide semiconductor
496401|NCT00167466|mild-to-moderate periodontal disease|mild-to-moderate periodontal disease
496402|NCT00167466|adult patients 18 to 70 years of age|adult patients 18 to 70 years of age
496403|NCT00167479|Bipolar Anxiety|bipolar anxiety
496404|NCT00167479|Bipolar Disorder|bipolar disorder
496405|NCT00167479|Anxiety|anxiety
496406|NCT00167479|Panic Disorder|panic disorder
496407|NCT00167479|Generalized Anxiety Disorder|generalized anxiety disorder
496408|NCT00167479|GAD|gad
496409|NCT00167479|Risperidone|risperidone
496410|NCT00167479|Double-Blind|double-blind
496411|NCT00167479|Placebo Controlled|placebo controlled
496412|NCT00167505|adolescents|adolescents
496413|NCT00167505|sexual health|sexual health
496414|NCT00167505|HIV|hiv
496415|NCT00167505|STD|std
496416|NCT00167505|pregnancy prevention|pregnancy prevention
496517|NCT00167830|Self-esteem|self-esteem
496417|NCT00167505|abstinence education|abstinence education
496418|NCT00167505|HIV Seronegativity|hiv seronegativity
496419|NCT00167505|human immunodeficiency virus|human immunodeficiency virus
496420|NCT00167518|Diabetic macular oedema|diabetic macular oedema
496421|NCT00167518|Triamcinolone acetate|triamcinolone acetate
496422|NCT00167518|Intravitreal injection|intravitreal injection
496423|NCT00167518|Clinical trial|clinical trial
496424|NCT00167518|Laser treatment|laser treatment
496425|NCT00167531|Stroke|stroke
496426|NCT00167531|health outcomes|health outcomes
496427|NCT00167531|physiotherapy|physiotherapy
496428|NCT00167531|rehabilitation|rehabilitation
496429|NCT00167531|treadmill|treadmill
496430|NCT00167544|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
496431|NCT00167544|Encephalomalacia|encephalomalacia
496432|NCT00167544|Brain injury|brain injury
496433|NCT00167544|Neurosensory impairment|neurosensory impairment
496434|NCT00167544|Corticosteroids|corticosteroids
496435|NCT00167544|Anti-Inflammatory Agents|anti-inflammatory agents
496436|NCT00167544|Extremely Low Birth Weight (ELBW) infants|extremely low birth weight (elbw) infants
496437|NCT00167544|Premature Birth|premature birth
496438|NCT00167544|Magnetic Resonance Imaging|magnetic resonance imaging
496439|NCT00167557|Liver Transplantation|liver transplantation
496440|NCT00167570|Artificial Limbs|artificial limbs
496441|NCT00167570|Amputees|amputees
496442|NCT00167570|Computer-Aided Design|computer-aided design
496443|NCT00167583|Ocular Behcet`s disease|ocular behcet`s disease
496444|NCT00167583|Panuveitis|panuveitis
496445|NCT00167583|Posterior Uveitis|posterior uveitis
496446|NCT00167583|Retinal vasculitis|retinal vasculitis
496447|NCT00167583|Treatment|treatment
496448|NCT00167583|Interferon-alpha|interferon-alpha
496449|NCT00167583|Cyclosporin A|cyclosporin a
496450|NCT00167596|near infrared spectroscopy|near infrared spectroscopy
496451|NCT00167596|tissue oxygenation|tissue oxygenation
496452|NCT00167596|organ dysfunction|organ dysfunction
496453|NCT00167596|mortality|mortality
496454|NCT00167609|myotonic dystrophy|myotonic dystrophy
496455|NCT00167609|hypersomnia|hypersomnia
496456|NCT00167609|dehydroepiandrosterone|dehydroepiandrosterone
496457|NCT00167622|Guillain Barré|guillain barré
496458|NCT00167622|Mechanical ventilation, invasive|mechanical ventilation, invasive
496459|NCT00167622|Mechanical ventilation, non invasive|mechanical ventilation, non invasive
496460|NCT00167622|Pneumonia|pneumonia
496461|NCT00167635|Irritable Bowel Syndrome|irritable bowel syndrome
496462|NCT00167635|Cognitive-behavioral intervention|cognitive-behavioral intervention
496463|NCT00167635|Psychological distress|psychological distress
496464|NCT00167635|Quality of life|quality of life
496465|NCT00167661|living or deceased donor renal transplant recipient|living or deceased donor renal transplant recipient
496466|NCT00167674|breastmilk|breastmilk
496467|NCT00167674|HIV-1|hiv-1
496468|NCT00167674|antiretroviral|antiretroviral
496469|NCT00167674|mother-to-child|mother-to-child
496470|NCT00167674|transmission|transmission
496471|NCT00167687|Alcoholism|alcoholism
496472|NCT00167687|Randomized Controlled Trial|randomized controlled trial
496473|NCT00167700|atopic disease|atopic disease
496474|NCT00167700|probiotics|probiotics
496475|NCT00167700|gut microbiota|gut microbiota
496476|NCT00167700|allergy|allergy
496477|NCT00167700|nutrition|nutrition
496478|NCT00167700|growth|growth
496479|NCT00167700|allergic rhinitis|allergic rhinitis
496480|NCT00167700|atopic sensitization|atopic sensitization
496481|NCT00167700|risk-markers of life-style related diseases|risk-markers of life-style related diseases
496482|NCT00167713|Malaria|malaria
496483|NCT00167713|Fever|fever
496484|NCT00167713|Ibuprofen|ibuprofen
496485|NCT00167713|Gabon|gabon
496486|NCT00167739|Malaria|malaria
496487|NCT00167739|Quinine|quinine
496488|NCT00167739|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
496489|NCT00167739|Gabon|gabon
496490|NCT00167765|stroke, ischemic|stroke, ischemic
496491|NCT00167765|acute ischemic stroke|acute ischemic stroke
496492|NCT00167778|Amputation|amputation
496493|NCT00167778|Amputee|amputee
496494|NCT00167778|Artificial limbs|artificial limbs
496495|NCT00167778|Gait|gait
496496|NCT00167778|Locomotion|locomotion
496497|NCT00167778|Walking|walking
496498|NCT00167791|transplant|transplant
496499|NCT00167791|desensitization|desensitization
496500|NCT00167791|kidney transplant|kidney transplant
496501|NCT00167804|Exposure Therapy|exposure therapy
496502|NCT00167804|Post Traumatic Stress Disorder|post traumatic stress disorder
496503|NCT00167804|Treatment Outcome|treatment outcome
496504|NCT00167804|Veterans|veterans
496505|NCT00167804|Virtual Reality|virtual reality
496506|NCT00167817|Schizophrenia|schizophrenia
496507|NCT00167817|Smoking|smoking
496508|NCT00167817|Metabolic|metabolic
496509|NCT00167817|Health|health
496510|NCT00167817|Glucose|glucose
496511|NCT00167817|Lipids|lipids
495812|NCT00175006|Tophi|tophi
496512|NCT00167830|Pediatric Overweight,|pediatric overweight,
496513|NCT00167830|African American;|african american;
496514|NCT00167830|Adolescent;|adolescent;
496515|NCT00167830|Intervention,|intervention,
496516|NCT00167830|Teasing;|teasing;
496518|NCT00167830|Quality of Life|quality of life
496519|NCT00167830|Metabolic syndrome|metabolic syndrome
496520|NCT00167830|Insulin resistance|insulin resistance
496521|NCT00167830|Diabetes|diabetes
496522|NCT00167830|Nutrition|nutrition
496523|NCT00167830|Motivation|motivation
496524|NCT00167830|Culture|culture
496525|NCT00167830|BMI|bmi
496526|NCT00167830|Cardiorespiratory fitness|cardiorespiratory fitness
496527|NCT00167830|Resistance Training|resistance training
496528|NCT00167830|Compliance|compliance
496529|NCT00167843|Malaria|malaria
496530|NCT00167843|Anemia|anemia
496531|NCT00167843|Children|children
496532|NCT00167843|Gabon|gabon
496533|NCT00167843|Intermittent preventive treatment|intermittent preventive treatment
496534|NCT00167856|Burning pain|burning pain
496535|NCT00167856|Clinical trial|clinical trial
496536|NCT00167856|Effexor|effexor
496537|NCT00167856|Pain|pain
496538|NCT00167856|Spinal cord injury|spinal cord injury
496539|NCT00167856|Venalafaxine|venalafaxine
496540|NCT00167856|Neuropathic Pain|neuropathic pain
496541|NCT00167869|hypertension|hypertension
496542|NCT00167869|blood pressure|blood pressure
496543|NCT00167869|dairy peptides|dairy peptides
496544|NCT00167869|bioactive peptides|bioactive peptides
496545|NCT00167869|randomized controlled trial|randomized controlled trial
496546|NCT00167882|Crohn's disease|crohn's disease
496547|NCT00167882|Ulcerative colitis|ulcerative colitis
496548|NCT00167882|Inflammatory bowel disease|inflammatory bowel disease
496549|NCT00167882|azathioprine|azathioprine
496550|NCT00167882|6-mercaptopurine|6-mercaptopurine
496551|NCT00167882|5-aminosalicylate|5-aminosalicylate
496552|NCT00167882|metabolism|metabolism
496553|NCT00167895|osteoarthritis|osteoarthritis
496554|NCT00167895|knee|knee
496555|NCT00167895|platelet concentrate|platelet concentrate
496556|NCT00176319|heart failure|heart failure
496557|NCT00176319|ageing|ageing
496558|NCT00176332|chronic heart failure|chronic heart failure
496559|NCT00176332|rosuvastatin|rosuvastatin
496560|NCT00176332|endothelial function|endothelial function
496561|NCT00176332|skeletal muscle|skeletal muscle
496562|NCT00176345|exercise training|exercise training
496563|NCT00176345|endothelial function|endothelial function
496564|NCT00176371|Physical fitness|physical fitness
496565|NCT00176384|chronic heart failure|chronic heart failure
496566|NCT00176384|exercise training|exercise training
496567|NCT00176397|left main coronary artery|left main coronary artery
496568|NCT00176397|coronary artery disease|coronary artery disease
496569|NCT00176410|aortic valve stenosis|aortic valve stenosis
496570|NCT00176410|statin therapy|statin therapy
496571|NCT00176423|schizophrenia|schizophrenia
496572|NCT00176423|acetylcholine|acetylcholine
496573|NCT00176423|cognitive impairments|cognitive impairments
496574|NCT00176423|attention|attention
496575|NCT00176423|processing speed|processing speed
496576|NCT00176423|sensory gating|sensory gating
496577|NCT00176423|eye-tracking|eye-tracking
496578|NCT00176436|Weight loss|weight loss
496579|NCT00176436|Support group|support group
496580|NCT00176436|Exercise|exercise
496581|NCT00176436|Atomoxetine|atomoxetine
583305|NCT00511238|PR171|pr171
496582|NCT00176449|Nicotine Dependence|nicotine dependence
496583|NCT00176449|Nicotine Use Disorder|nicotine use disorder
496584|NCT00176449|Tobacco Dependence|tobacco dependence
496585|NCT00176449|Tobacco-Use Disorder|tobacco-use disorder
496586|NCT00176449|Smoking Cessation|smoking cessation
496587|NCT00176462|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
496588|NCT00176462|Leukemia|leukemia
496589|NCT00176475|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
496590|NCT00176475|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
496591|NCT00176475|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
496592|NCT00176475|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
496593|NCT00176475|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
496594|NCT00176475|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
496595|NCT00176475|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
496596|NCT00176475|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
496597|NCT00176475|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
496598|NCT00176475|refractory hairy cell leukemia|refractory hairy cell leukemia
496599|NCT00176475|prolymphocytic leukemia|prolymphocytic leukemia
496600|NCT00176475|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
496601|NCT00176475|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
496602|NCT00176475|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
496603|NCT00176475|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
496604|NCT00176475|refractory multiple myeloma|refractory multiple myeloma
496605|NCT00176475|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
496606|NCT00176475|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
496607|NCT00176475|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
496608|NCT00176475|splenic marginal zone lymphoma|splenic marginal zone lymphoma
496609|NCT00176475|stage II multiple myeloma|stage ii multiple myeloma
496610|NCT00176475|stage III multiple myeloma|stage iii multiple myeloma
496611|NCT00176475|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
496612|NCT00176475|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
496613|NCT00176475|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
496614|NCT00176475|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
496615|NCT00176475|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
496616|NCT00176475|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
496617|NCT00176475|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
496618|NCT00176475|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
496619|NCT00176475|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
496620|NCT00176475|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
496621|NCT00176475|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
496622|NCT00176475|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
496623|NCT00176475|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
496624|NCT00176475|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
496625|NCT00176475|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
496626|NCT00176475|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
753944|NCT01178346|Smoking cessation|smoking cessation
496627|NCT00176475|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
496628|NCT00176475|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
496629|NCT00176475|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
496630|NCT00176475|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
496631|NCT00176475|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
496632|NCT00176475|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
496633|NCT00176475|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
496634|NCT00176488|recurrent breast cancer|recurrent breast cancer
496635|NCT00176488|stage II breast cancer|stage ii breast cancer
496636|NCT00176488|stage IIIA breast cancer|stage iiia breast cancer
496637|NCT00176488|stage IIIB breast cancer|stage iiib breast cancer
496638|NCT00176488|stage IV breast cancer|stage iv breast cancer
496639|NCT00176488|male breast cancer|male breast cancer
496640|NCT00176501|recurrent renal cell cancer|recurrent renal cell cancer
496641|NCT00176501|clear cell renal cell carcinoma|clear cell renal cell carcinoma
496642|NCT00176501|stage IV renal cell cancer|stage iv renal cell cancer
496644|NCT00176527|recurrent prostate cancer|recurrent prostate cancer
496645|NCT00176527|stage IV prostate cancer|stage iv prostate cancer
496646|NCT00176540|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
496647|NCT00176540|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
496648|NCT00176540|fatigue|fatigue
496649|NCT00176553|methotrexate neurotoxicity|methotrexate neurotoxicity
496650|NCT00176566|oral leukoplakia|oral leukoplakia
496651|NCT00176579|osteoporosis|osteoporosis
496652|NCT00176579|stage I prostate cancer|stage i prostate cancer
496653|NCT00176592|Multiple Sclerosis|multiple sclerosis
496655|NCT00176592|Betaseron|betaseron
496656|NCT00176592|Copaxone|copaxone
496658|NCT00176605|prostate cancer|prostate cancer
496659|NCT00176605|recurrent prostate cancer|recurrent prostate cancer
496660|NCT00176605|stage IV prostate cancer|stage iv prostate cancer
496661|NCT00176618|Aberrant Crypt Foci|aberrant crypt foci
496662|NCT00176631|adenocarcinoma of the prostate|adenocarcinoma of the prostate
496663|NCT00176631|recurrent prostate cancer|recurrent prostate cancer
496664|NCT00176631|stage IV prostate cancer|stage iv prostate cancer
496665|NCT00176644|prostate cancer|prostate cancer
496666|NCT00176930|stem cell transplant|stem cell transplant
496667|NCT00176930|chronic leukemia|chronic leukemia
496668|NCT00176930|acute leukemia|acute leukemia
496669|NCT00176930|irradiation|irradiation
496670|NCT00176930|chemotherapy|chemotherapy
496671|NCT00176956|Post Pediatric Heart Transplant|post pediatric heart transplant
496672|NCT00176982|treatment of alopecia areata|treatment of alopecia areata
496673|NCT00177008|Schizophrenia|schizophrenia
496674|NCT00177008|Schizoaffective Disorder|schizoaffective disorder
496675|NCT00177008|Social Anxiety Disorder|social anxiety disorder
496676|NCT00177034|Keratinocyte|keratinocyte
496677|NCT00177047|stem cell transplantation|stem cell transplantation
496678|NCT00177047|chemotherapy|chemotherapy
496679|NCT00177047|multiple myeloma|multiple myeloma
496680|NCT00177047|autologous|autologous
496681|NCT00177112|Cystoscopy|cystoscopy
496682|NCT00177138|Campath Study|campath study
495998|NCT00175799|Data from children admitted to a Paediatric Intensive Care unit|data from children admitted to a paediatric intensive care unit
496000|NCT00175812|Differentiation|differentiation
496683|NCT00177138|Pancreas After Kidney Transplantation|pancreas after kidney transplantation
496684|NCT00177138|Alemtuzumab|alemtuzumab
496685|NCT00177164|Bipolar I Disorder|bipolar i disorder
496686|NCT00177164|Risperidone Consta - Long Acting Injection|risperidone consta - long acting injection
496687|NCT00177164|Oral second generation antipsychotic agents|oral second generation antipsychotic agents
496688|NCT00177177|L-carnosine|l-carnosine
496792|NCT00177671|Depression|depression
496689|NCT00177177|Schizophrenia|schizophrenia
496690|NCT00177177|Schizoaffective disorder|schizoaffective disorder
496691|NCT00177177|Cognitive enhancement|cognitive enhancement
496692|NCT00177190|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
496693|NCT00177190|Sezary Syndrome|sezary syndrome
496694|NCT00177190|Mycosis Fungoides|mycosis fungoides
496695|NCT00177190|Immune Responses|immune responses
496696|NCT00177203|Insomnia|insomnia
496697|NCT00177203|Sleep Disorders|sleep disorders
496698|NCT00177203|Sleeplessness|sleeplessness
496699|NCT00177203|Chronic Insomnia|chronic insomnia
496700|NCT00177203|Sleep Studies|sleep studies
496701|NCT00177203|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
496702|NCT00177203|Primary Care|primary care
496703|NCT00177216|Primary Insomnia|primary insomnia
496704|NCT00177216|Insomnia|insomnia
496705|NCT00177216|Placebo-Controlled|placebo-controlled
496706|NCT00177216|Double-Blind|double-blind
496707|NCT00177216|Polysomnography|polysomnography
496708|NCT00177216|PET Studies|pet studies
496709|NCT00177216|Escitalopram|escitalopram
496710|NCT00177216|Zolpidem|zolpidem
496711|NCT00177242|pancreas|pancreas
496712|NCT00177242|pancreatic|pancreatic
496713|NCT00177255|gastric|gastric
496714|NCT00177255|stomach|stomach
496715|NCT00177255|esophagus|esophagus
496716|NCT00177255|esophageal|esophageal
496717|NCT00177268|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
496718|NCT00177268|Sezary Syndrome|sezary syndrome
496720|NCT00177268|Blood/tissue banking|blood/tissue banking
496721|NCT00177268|eczema|eczema
496722|NCT00177268|atopic dermatitis|atopic dermatitis
496723|NCT00177294|Elderly|elderly
496724|NCT00177294|Remission|remission
496725|NCT00177294|Escitalopram|escitalopram
496726|NCT00177294|Interpersonal Psychotherapy|interpersonal psychotherapy
496727|NCT00177294|Psychotherapy|psychotherapy
496728|NCT00177294|Caregiving|caregiving
496729|NCT00177294|Late-Life|late-life
496730|NCT00177307|colon|colon
496731|NCT00177307|rectum|rectum
496732|NCT00177320|Rheumatic Disorders|rheumatic disorders
496733|NCT00177320|Computer Use|computer use
496734|NCT00177333|Abortion, Induced|abortion, induced
496735|NCT00177333|Doxycycline|doxycycline
496736|NCT00177333|Antibiotic Prophylaxis|antibiotic prophylaxis
496737|NCT00177333|Vomiting|vomiting
496738|NCT00177333|Abortion, Therapeutic|abortion, therapeutic
496739|NCT00177359|gait impairment|gait impairment
496740|NCT00177385|Sleep|sleep
496741|NCT00177385|Sleep Hygiene|sleep hygiene
496742|NCT00177385|Modest sleep deprivation|modest sleep deprivation
496743|NCT00177385|Healthy Aging and sleep|healthy aging and sleep
496744|NCT00177385|Health Promotion|health promotion
496745|NCT00177398|Type 2 diabetes|type 2 diabetes
496746|NCT00177398|Hyperglycemia|hyperglycemia
496747|NCT00177398|Enteral nutrition|enteral nutrition
496748|NCT00177411|Endocrine System Diseases|endocrine system diseases
496749|NCT00177411|MusculoSkeletal System Diseases|musculoskeletal system diseases
496750|NCT00177411|Hormone|hormone
496751|NCT00177411|Postmenopausal Women|postmenopausal women
496752|NCT00177424|Rehabilitation|rehabilitation
496753|NCT00177463|L-carnosine|l-carnosine
496754|NCT00177463|Bipolar I disorder|bipolar i disorder
496755|NCT00177463|Cognitive enhancement|cognitive enhancement
496756|NCT00177489|Family Caregivers|family caregivers
496757|NCT00177489|Dementia|dementia
496758|NCT00177489|Alzheimer Disease|alzheimer disease
496759|NCT00177489|Randomized Controlled Trial|randomized controlled trial
496760|NCT00177489|Intervention Studies|intervention studies
496761|NCT00177515|emergency contraception|emergency contraception
496762|NCT00177515|folic acid|folic acid
496763|NCT00177515|education|education
496764|NCT00177515|preventive health|preventive health
496765|NCT00177528|Elderly|elderly
496766|NCT00177541|urge incontinence|urge incontinence
496767|NCT00177541|biofeedback|biofeedback
496768|NCT00177541|pelvic floor muscle training|pelvic floor muscle training
496769|NCT00177541|behavior modification|behavior modification
496770|NCT00177554|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
496771|NCT00177567|Bipolar Disorder|bipolar disorder
496772|NCT00177567|Manic Depression|manic depression
496773|NCT00177567|Elderly|elderly
496774|NCT00177567|Late-Life|late-life
496775|NCT00177580|schizophrenia|schizophrenia
496776|NCT00177580|schizoaffective disorder|schizoaffective disorder
496114|NCT00176280|Renal|renal
496777|NCT00177580|positive symptoms|positive symptoms
496778|NCT00177580|negative symptoms|negative symptoms
496779|NCT00177580|cognitive functioning|cognitive functioning
496780|NCT00177580|pravastatin|pravastatin
496781|NCT00177606|withdrawal|withdrawal
496782|NCT00177606|life-sustaining|life-sustaining
496783|NCT00177606|treatments|treatments
496784|NCT00177606|UNOS|unos
496785|NCT00177606|organ donation|organ donation
496786|NCT00177619|Prostatic neoplasms|prostatic neoplasms
496787|NCT00177619|Bisphosphonates|bisphosphonates
496788|NCT00177619|Hypogonadism|hypogonadism
496789|NCT00177645|cystic fibrosis|cystic fibrosis
496790|NCT00177645|mucus clearance|mucus clearance
496791|NCT00177658|Salmonella|salmonella
496793|NCT00177671|Dementia|dementia
496794|NCT00177671|Alzheimer's Disease|alzheimer's disease
496795|NCT00177671|Cognitive|cognitive
496796|NCT00177671|Donepezil|donepezil
496797|NCT00177671|Memory|memory
496798|NCT00177671|Function|function
496799|NCT00177671|Elderly|elderly
496800|NCT00177671|Late-Life|late-life
496801|NCT00177723|receiving antibiotic Linezolid clinically|receiving antibiotic linezolid clinically
496802|NCT00177736|ventilator associated pneumonia|ventilator associated pneumonia
496803|NCT00177749|invasive fungal infections|invasive fungal infections
496804|NCT00177788|liver transplant|liver transplant
496805|NCT00177788|voriconazole prophylaxis|voriconazole prophylaxis
496806|NCT00177788|liver transplantation|liver transplantation
496807|NCT00177788|voriconazole|voriconazole
496808|NCT00177814|pipercillin|pipercillin
496809|NCT00177814|gram negative bacteria infections|gram negative bacteria infections
496810|NCT00177840|cancer-related fatigue|cancer-related fatigue
496811|NCT00177840|acupuncture|acupuncture
496812|NCT00177840|breast cancer|breast cancer
496813|NCT00177853|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
496814|NCT00177853|invasion of major arteries and veins around pancreas|invasion of major arteries and veins around pancreas
496815|NCT00177853|No prior radiation or chemo|no prior radiation or chemo
496816|NCT00177879|website|website
496817|NCT00177879|comparison|comparison
496818|NCT00177892|Sleep fragmentation|sleep fragmentation
496819|NCT00177892|Intermittent hypoxia|intermittent hypoxia
497027|NCT00178906|depression|depression
496820|NCT00177892|Obstructive Sleep Apnea|obstructive sleep apnea
496821|NCT00177892|Metabolic Syndrome|metabolic syndrome
496822|NCT00177892|Insulin resistance|insulin resistance
496823|NCT00177918|Lung Transplant|lung transplant
496824|NCT00177931|Liver transplant|liver transplant
496825|NCT00177931|cefepime|cefepime
496826|NCT00177931|antibiotics|antibiotics
496827|NCT00177944|invasive fungal infection|invasive fungal infection
496828|NCT00177957|Gram negative bacteremia|gram negative bacteremia
496829|NCT00177983|Schizophrenia|schizophrenia
496830|NCT00177983|Relapse|relapse
496831|NCT00177983|Psychological distress|psychological distress
496832|NCT00177996|depression|depression
496833|NCT00177996|anxiety|anxiety
496834|NCT00178009|computer-assisted instruction|computer-assisted instruction
496835|NCT00178009|instruction (video)|instruction (video)
496837|NCT00178022|intervention|intervention
496838|NCT00178022|depression|depression
496839|NCT00178022|anxiety|anxiety
496840|NCT00178035|Depression|depression
496841|NCT00178035|Unipolar Depression|unipolar depression
496842|NCT00178035|Elderly depression|elderly depression
496843|NCT00178035|Late-Life|late-life
496844|NCT00178048|primary insomnia|primary insomnia
496845|NCT00178048|insomnia|insomnia
496846|NCT00178048|depression|depression
496847|NCT00178048|late life|late life
496848|NCT00178048|elderly|elderly
496849|NCT00178048|sleep disorders|sleep disorders
496850|NCT00178074|depression|depression
496851|NCT00178074|imaging|imaging
496853|NCT00178074|elderly|elderly
496854|NCT00178074|late life|late life
496855|NCT00178074|sleep deprivation|sleep deprivation
496856|NCT00178087|late-life depression|late-life depression
496857|NCT00178087|mild cognitive impairment|mild cognitive impairment
496858|NCT00178087|dementia|dementia
496859|NCT00178100|Depression|depression
496860|NCT00178100|Elderly|elderly
496861|NCT00178100|Late Life|late life
496862|NCT00178113|Prostatic Intraepithelial Neoplasia|prostatic intraepithelial neoplasia
496863|NCT00178113|Prostate-Specific Antigen|prostate-specific antigen
496864|NCT00178113|lycopene|lycopene
496865|NCT00178126|pressure ulcer|pressure ulcer
496866|NCT00178139|Music Therapy|music therapy
496867|NCT00178139|Mechanical ventilation|mechanical ventilation
496868|NCT00178139|Weaning from mechanical ventilation|weaning from mechanical ventilation
496869|NCT00178139|complementary and alternative therapy|complementary and alternative therapy
496870|NCT00178165|Family Caregivers|family caregivers
496871|NCT00178165|Dementia|dementia
496872|NCT00178165|Alzheimer Disease|alzheimer disease
496873|NCT00178165|Randomized Controlled Trial|randomized controlled trial
496874|NCT00178165|Intervention Studies|intervention studies
753921|NCT01178294|hemorrhagic disorders|hemorrhagic disorders
496875|NCT00178178|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
496876|NCT00178178|Pain Care 3000|pain care 3000
496877|NCT00178178|Catheter Placement|catheter placement
496878|NCT00178178|Pain|pain
496879|NCT00178178|Breg, Inc|breg, inc
496880|NCT00178204|delta sleep|delta sleep
496881|NCT00178204|Cancer-related fatigue|cancer-related fatigue
496882|NCT00178204|Sleep Disturbance|sleep disturbance
496883|NCT00178204|chemotherapy|chemotherapy
496884|NCT00178217|Botulinum Toxin|botulinum toxin
496885|NCT00178217|Music Therapy|music therapy
496886|NCT00178217|Cerebral Palsy|cerebral palsy
496887|NCT00178217|Procedural Support|procedural support
496888|NCT00178321|Sleep|sleep
496889|NCT00178321|Criticall Ill|criticall ill
496890|NCT00178321|Children|children
496891|NCT00178321|Earplugs|earplugs
496990|NCT00178763|Pancreatic Cancer|pancreatic cancer
496892|NCT00178360|Huntington's Disease, Music Therapy, quality of life|huntington's disease, music therapy, quality of life
496893|NCT00178373|cancer-related fatigue|cancer-related fatigue
496894|NCT00178373|chemotherapy|chemotherapy
496895|NCT00178373|modafinil|modafinil
496896|NCT00178386|cancer|cancer
496897|NCT00178386|education|education
496898|NCT00178386|learning|learning
496899|NCT00178386|brain tumor|brain tumor
496900|NCT00178386|school|school
496901|NCT00178412|Hospitalized elders|hospitalized elders
496902|NCT00178412|Family caregivers|family caregivers
496903|NCT00178412|Acute care|acute care
496904|NCT00178425|mycophenolate mofetil hydrochloride|mycophenolate mofetil hydrochloride
496905|NCT00178425|pharmacokinetics|pharmacokinetics
496906|NCT00178425|tacrolimus|tacrolimus
496907|NCT00178438|capsule endoscopy in small bowel|capsule endoscopy in small bowel
496908|NCT00178464|sickle cell disease|sickle cell disease
496909|NCT00178464|hemoglobin SS disease|hemoglobin ss disease
496910|NCT00178464|hemoglobin S Beta-0 Thalassemia|hemoglobin s beta-0 thalassemia
496911|NCT00178464|silent infarction in sickle cell disease|silent infarction in sickle cell disease
496912|NCT00178464|overt stroke in sickle cell disease|overt stroke in sickle cell disease
496913|NCT00178464|aspirin|aspirin
496914|NCT00178464|transcranial Doppler ultrasound|transcranial doppler ultrasound
496915|NCT00178464|neurocognitive testing|neurocognitive testing
496916|NCT00178490|Neurocognitive Function|neurocognitive function
496917|NCT00178516|male|male
496918|NCT00178516|infertility|infertility
496919|NCT00178529|Stroke|stroke
496920|NCT00178529|Caregivers|caregivers
496921|NCT00178542|von Willebrand Disease|von willebrand disease
496922|NCT00178542|Healthy Women and Women with von Willebrand Disease|healthy women and women with von willebrand disease
496923|NCT00178555|Endotracheal Intubation, Video Laryngoscopy|endotracheal intubation, video laryngoscopy
496924|NCT00178568|Caregiving|caregiving
496925|NCT00178568|Spousal|spousal
496926|NCT00178568|Sleep disturbances|sleep disturbances
496927|NCT00178568|Progressive dementia|progressive dementia
496928|NCT00178568|Stress|stress
496929|NCT00178568|Health outcomes|health outcomes
496930|NCT00178568|Intervention|intervention
496931|NCT00178568|Affective self-management|affective self-management
496932|NCT00178568|Caregivers M01.526.485.200|caregivers m01.526.485.200
496933|NCT00178568|Spouses F01.829.263.500.660|spouses f01.829.263.500.660
496934|NCT00178568|Alzheimer's disease C10.574.945.249|alzheimer's disease c10.574.945.249
496935|NCT00178568|Parkinson's disease C10.574.812|parkinson's disease c10.574.812
496936|NCT00178568|Sleep disorder C10.886.425.800.800|sleep disorder c10.886.425.800.800
496937|NCT00178581|Trauma|trauma
496938|NCT00178581|Critical Illness|critical illness
496939|NCT00178581|Shock|shock
496940|NCT00178581|Enteral Nutrition|enteral nutrition
496941|NCT00178581|Glutamine|glutamine
496942|NCT00178594|Hereditary Bleeding disorder|hereditary bleeding disorder
496943|NCT00178594|Thrombotic Disorder|thrombotic disorder
496944|NCT00178607|Inhibitors|inhibitors
496945|NCT00178620|Heart Disease|heart disease
496946|NCT00178620|Heart Attack|heart attack
496947|NCT00178620|Myocardial Infarction|myocardial infarction
496948|NCT00178620|Thrombolytic Therapy|thrombolytic therapy
496949|NCT00178620|Emergency Medicine|emergency medicine
496950|NCT00178633|Obesity|obesity
496951|NCT00178633|Insulin Resistance|insulin resistance
496952|NCT00178633|Free Fatty Acids|free fatty acids
496953|NCT00178633|Heart Failure|heart failure
496954|NCT00178646|Stroke|stroke
496955|NCT00178646|Brain Injuries|brain injuries
496956|NCT00178646|Spasticity|spasticity
496957|NCT00178646|Botulinum Toxins|botulinum toxins
496958|NCT00178659|Traumatic Brain Injury|traumatic brain injury
496959|NCT00178659|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
496960|NCT00178659|Proteomics|proteomics
496961|NCT00178672|CVA|cva
496962|NCT00178672|TIA|tia
496963|NCT00178672|Carotid disease|carotid disease
496964|NCT00178672|Stroke|stroke
496965|NCT00178672|Neurology|neurology
496966|NCT00178672|Carotid Stenting|carotid stenting
496967|NCT00178685|Self-determination|self-determination
496968|NCT00178685|motivation|motivation
496969|NCT00178685|adherence|adherence
496970|NCT00178685|competence|competence
496971|NCT00178685|autonomy|autonomy
496972|NCT00178685|tobacco dependence|tobacco dependence
496973|NCT00178685|Tobacco use and dependence|tobacco use and dependence
496974|NCT00178685|Behavior change|behavior change
496975|NCT00178698|thermochemotherapy|thermochemotherapy
496976|NCT00178698|fever range whole body|fever range whole body
496977|NCT00178698|cisplatin|cisplatin
496978|NCT00178698|gemcitabine|gemcitabine
496979|NCT00178698|daily low dose interferon alpha|daily low dose interferon alpha
496980|NCT00178711|Traumatic Brain Injury|traumatic brain injury
496981|NCT00178711|Hypothermia|hypothermia
496982|NCT00178724|spinal cord injury|spinal cord injury
496983|NCT00178724|SCI|sci
496984|NCT00178724|traumatic spinal cord injury|traumatic spinal cord injury
496985|NCT00178724|acute spinal cord injury|acute spinal cord injury
496986|NCT00178724|paralysis|paralysis
496987|NCT00178750|Epidural placement|epidural placement
496988|NCT00178750|CompuFlo®|compuflo®
496989|NCT00178763|Cancer|cancer
496991|NCT00178763|Pancreas|pancreas
496992|NCT00178763|Neoplasms|neoplasms
496993|NCT00178776|Group|group
496994|NCT00178776|Therapy|therapy
496995|NCT00178776|Cocaine|cocaine
496996|NCT00178776|Drugs|drugs
496997|NCT00178776|Trial|trial
496998|NCT00178776|Outcome|outcome
496999|NCT00178776|Study|study
497000|NCT00178776|Feasibility|feasibility
497001|NCT00178776|Transtheoretical|transtheoretical
497002|NCT00178776|Stages|stages
497003|NCT00178776|Motivation|motivation
497004|NCT00178776|Change|change
497005|NCT00178789|Deep Venous Thrombosis|deep venous thrombosis
497006|NCT00178789|Blood Clot|blood clot
497007|NCT00178789|Lower Extremity|lower extremity
497008|NCT00178789|Sonography|sonography
497009|NCT00178802|breast cancer|breast cancer
497010|NCT00178802|endometrial cancer|endometrial cancer
497011|NCT00178802|cervical cancer|cervical cancer
497012|NCT00178802|ovarian cancer|ovarian cancer
497013|NCT00178828|Depression|depression
497014|NCT00178828|antidepressant|antidepressant
497015|NCT00178828|SSRI|ssri
497016|NCT00178841|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
497017|NCT00178841|CTCL|ctcl
497018|NCT00178841|Mycosis Fungoides|mycosis fungoides
497019|NCT00178841|Sezary Syndrome|sezary syndrome
497020|NCT00178841|Bexarotene|bexarotene
497021|NCT00178841|Targretin|targretin
497022|NCT00178841|Rosiglitazone|rosiglitazone
497023|NCT00178841|Avandia|avandia
497024|NCT00178880|depression|depression
497028|NCT00178906|suicide|suicide
497029|NCT00178906|voice|voice
497030|NCT00178919|Endothelial Nitric Oxide|endothelial nitric oxide
497031|NCT00178919|L-NMMA|l-nmma
497032|NCT00178919|Trimethaphan|trimethaphan
497033|NCT00178919|Autonomic Nervous System|autonomic nervous system
497034|NCT00178919|Nitric Oxide Inhibition|nitric oxide inhibition
497035|NCT00178984|Blood supply|blood supply
497036|NCT00178984|Mesentery|mesentery
497037|NCT00178997|Blood supply|blood supply
497038|NCT00178997|Mesentery|mesentery
497039|NCT00179010|Adenosine|adenosine
497040|NCT00179010|AMP|amp
497041|NCT00179010|Microdialysis|microdialysis
497042|NCT00179010|Blood Flow|blood flow
497043|NCT00179023|OBESITY|obesity
497044|NCT00179023|RESTING ENERGY EXPENDITURE|resting energy expenditure
497045|NCT00179023|SYMPATHETIC NERVOUS SYSTEM|sympathetic nervous system
497046|NCT00179023|HYPERTENSION|hypertension
497047|NCT00179023|AUTONOMIC FAILURE|autonomic failure
497048|NCT00179036|Blood supply|blood supply
497049|NCT00179036|Mesentery|mesentery
497050|NCT00179049|T-Lymphocyte Subsets|t-lymphocyte subsets
583306|NCT00511238|carfilzomib|carfilzomib
497051|NCT00179062|major depression with psychotic features|major depression with psychotic features
497052|NCT00179062|bipolar disorder with psychotic features|bipolar disorder with psychotic features
497054|NCT00179088|Weight-Bearing|weight-bearing
497055|NCT00179088|Total Hip Replacement|total hip replacement
497056|NCT00179088|Non-cemented|non-cemented
497057|NCT00179088|Randomized|randomized
497058|NCT00179088|Fiber-Metal-Taper-Stem|fiber-metal-taper-stem
497059|NCT00179088|Hip|hip
497060|NCT00179088|Osteoarthritis|osteoarthritis
497061|NCT00179101|Parkinson's Disease|parkinson's disease
497062|NCT00179101|Depression|depression
497063|NCT00179101|Quality of Life|quality of life
497064|NCT00179101|Deep Brain Stimulation|deep brain stimulation
497065|NCT00179114|Spasticity|spasticity
497066|NCT00179114|Developmental Disabilities|developmental disabilities
497067|NCT00179114|Intrathecal baclofen (ITB)|intrathecal baclofen (itb)
497068|NCT00179114|Botulinum Toxin Type A (Botox)|botulinum toxin type a (botox)
497069|NCT00179127|Pediatrics|pediatrics
497070|NCT00179127|Diabetes|diabetes
497071|NCT00179127|Emergency Care|emergency care
497072|NCT00179127|Endocrinology|endocrinology
497073|NCT00179127|Critical Care|critical care
497074|NCT00179192|End Stage Renal Disease|end stage renal disease
497075|NCT00179192|ESRD|esrd
497076|NCT00179192|Chronic Maintenance Hemodialysis|chronic maintenance hemodialysis
497077|NCT00179244|Treatment Resistant Depression|treatment resistant depression
497078|NCT00179257|Failure to Escitalopram|failure to escitalopram
497079|NCT00179309|CEA|cea
497080|NCT00179309|MUC-1|muc-1
497081|NCT00179309|Immunotherapy|immunotherapy
497082|NCT00179309|GM-CSF|gm-csf
497083|NCT00179309|Vaccine|vaccine
497084|NCT00179309|Breast Cancer|breast cancer
497085|NCT00179309|Metastatic Breast Cancer|metastatic breast cancer
497086|NCT00179322|Sleep Architecture|sleep architecture
497087|NCT00179322|Sleep Measures|sleep measures
497088|NCT00179322|Speech Articulation|speech articulation
497089|NCT00179322|Cerebral Perfusion|cerebral perfusion
497090|NCT00179322|Neuroimaging|neuroimaging
497091|NCT00179322|Healthy Volunteer|healthy volunteer
497092|NCT00179322|HV|hv
497093|NCT00179335|Regular lopinavir/ritonavir or Efavirenz use|regular lopinavir/ritonavir or efavirenz use
497094|NCT00179335|Age >/= 55 y or </= 35 y|age >/= 55 y or </= 35 y
497095|NCT00179335|HIV+|hiv+
497096|NCT00179374|Medication adherence|medication adherence
497097|NCT00179374|Self-care behaviors|self-care behaviors
497098|NCT00179374|Telephonic intervention|telephonic intervention
497099|NCT00179374|Diabetes|diabetes
497100|NCT00179374|Nutrition|nutrition
497101|NCT00179374|Exercise|exercise
497102|NCT00179387|Neoplasms|neoplasms
497103|NCT00179387|Needs Assessment|needs assessment
497104|NCT00179387|Adaptation Psychological|adaptation psychological
497105|NCT00179387|Minority Groups|minority groups
497106|NCT00179387|Psychotherapy, Group|psychotherapy, group
497107|NCT00179387|Program Evaluation|program evaluation
497108|NCT00179387|Spirituality|spirituality
497109|NCT00179387|Spiritual Therapies|spiritual therapies
497110|NCT00179413|hepatitis C|hepatitis c
497111|NCT00179413|cirrhosis|cirrhosis
497112|NCT00179413|interferon|interferon
497113|NCT00179413|colchicine|colchicine
497114|NCT00179426|Seizure Disorder|seizure disorder
497115|NCT00179426|Hypogonadism|hypogonadism
497116|NCT00179426|Sexual Function|sexual function
497117|NCT00179426|Epilepsy|epilepsy
497118|NCT00179439|PSC|psc
497119|NCT00179439|IBD|ibd
497120|NCT00179439|CFTR|cftr
497121|NCT00179452|epilepsy, yoga|epilepsy, yoga
497122|NCT00179465|Treatment|treatment
497123|NCT00179465|fMRI|fmri
497124|NCT00179465|Cognition|cognition
497125|NCT00179465|Brain development|brain development
497126|NCT00179478|Multiple sclerosis|multiple sclerosis
497127|NCT00179478|Interferon Beta|interferon beta
497128|NCT00179478|MRI|mri
497129|NCT00179478|Optic neuritis|optic neuritis
497130|NCT00179478|Transverse Myelitis|transverse myelitis
497731|NCT00179803|CNS tumor|cns tumor
497131|NCT00170820|Renal transplantation, maintenance, switch, everolimus, CNI-free|renal transplantation, maintenance, switch, everolimus, cni-free
497132|NCT00171366|amlodipine|amlodipine
497133|NCT00171366|benazepril|benazepril
497134|NCT00171366|hypertension|hypertension
497135|NCT00171366|diastolic|diastolic
497136|NCT00171379|Kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium.|kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium.
497137|NCT00171392|Kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium, tacrolimus.|kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium, tacrolimus.
497138|NCT00171405|hypertension|hypertension
497139|NCT00171405|aliskiren|aliskiren
497140|NCT00171405|hydrochlorothiazide|hydrochlorothiazide
497141|NCT00171418|GERD|gerd
497142|NCT00171418|PPI|ppi
497143|NCT00171431|IBS-C|ibs-c
497144|NCT00171431|female|female
497145|NCT00171444|hypertension,|hypertension,
497146|NCT00171444|valsartan+hydrochlorothiazide|valsartan+hydrochlorothiazide
497147|NCT00171457|functional heartburn|functional heartburn
497148|NCT00171457|dyspepsia|dyspepsia
497150|NCT00171457|female|female
497151|NCT00171457|visceral sensitivity|visceral sensitivity
497152|NCT00171470|dyspepsia|dyspepsia
497153|NCT00171470|hearburn|hearburn
497154|NCT00171470|female|female
497155|NCT00171470|PPI|ppi
497156|NCT00171483|GERD|gerd
497157|NCT00171483|PPI|ppi
497158|NCT00171483|heartburn|heartburn
497159|NCT00171483|regurgitation|regurgitation
497160|NCT00171496|Kidney transplant, adults, NODM, immunosuppressants|kidney transplant, adults, nodm, immunosuppressants
497161|NCT00171509|Liver transplant, adults, once a day administration, Immunosuppressants|liver transplant, adults, once a day administration, immunosuppressants
497162|NCT00171522|Constipation|constipation
497163|NCT00171522|Tegaserod|tegaserod
497164|NCT00171522|Polyethylene Glycol 3350|polyethylene glycol 3350
497165|NCT00171522|PEG|peg
497166|NCT00171535|hypertension|hypertension
497167|NCT00171535|high blood pressure|high blood pressure
497168|NCT00171535|valsartan|valsartan
497169|NCT00171535|amlodipine|amlodipine
497170|NCT00171548|Metabolic syndrome, cardiovascular risk reduction|metabolic syndrome, cardiovascular risk reduction
497171|NCT00171561|hypertension|hypertension
497172|NCT00171561|diabetes|diabetes
497173|NCT00171561|albuminuria|albuminuria
497174|NCT00171561|valsartan|valsartan
497175|NCT00171561|hydrochlorothiazide|hydrochlorothiazide
497176|NCT00171561|amlodipine|amlodipine
497177|NCT00171574|valsartan|valsartan
497178|NCT00171574|lisinopril|lisinopril
497179|NCT00171574|antiproteinuric|antiproteinuric
497180|NCT00171574|diabetic nephropathy|diabetic nephropathy
497181|NCT00171587|Metastatic solid tumors|metastatic solid tumors
497182|NCT00171587|PTK787/ZK 222584|ptk787/zk 222584
497183|NCT00171587|Vatalanib|vatalanib
497184|NCT00171587|Capecitabine|capecitabine
497185|NCT00171587|VEGF (vascular endothelial growth factor)|vegf (vascular endothelial growth factor)
497186|NCT00171587|Histologically confirmed metastatic solid tumors|histologically confirmed metastatic solid tumors
497187|NCT00171600|valsartan|valsartan
497188|NCT00171600|lisinopril|lisinopril
497189|NCT00171600|albuminuria|albuminuria
497190|NCT00171600|diabetic nephropathy|diabetic nephropathy
497191|NCT00171613|Obesity|obesity
497192|NCT00171626|Knee osteoarthritis, Topical NSAID, Diclofenac sodium|knee osteoarthritis, topical nsaid, diclofenac sodium
497193|NCT00171652|Hand osteoarthritis, Topical NSAID, Diclofenac sodium|hand osteoarthritis, topical nsaid, diclofenac sodium
497194|NCT00171665|Hand osteoarthritis, Topical NSAID, Diclofenac sodium|hand osteoarthritis, topical nsaid, diclofenac sodium
497195|NCT00171678|Knee osteoarthritis, Topical NSAID, Diclofenac sodium|knee osteoarthritis, topical nsaid, diclofenac sodium
497196|NCT00171691|Knee osteoarthritis, Topical NSAID, Diclofenac sodium|knee osteoarthritis, topical nsaid, diclofenac sodium
497197|NCT00171704|Breast Cancer|breast cancer
497198|NCT00171704|Letrozole|letrozole
497199|NCT00171704|Bone Mineral Density|bone mineral density
497200|NCT00171704|Bone Markers|bone markers
497201|NCT00171704|Serum lipid|serum lipid
497202|NCT00171704|Postmenopausal|postmenopausal
497203|NCT00171717|Cyclosporine, liver transplantation, maintenance, diabetes|cyclosporine, liver transplantation, maintenance, diabetes
497204|NCT00171730|Acromegaly|acromegaly
497205|NCT00171730|Pasireotide|pasireotide
497206|NCT00171730|GH|gh
497207|NCT00171730|IGF-1|igf-1
497208|NCT00171743|Adults|adults
497209|NCT00171743|Post transplant diabetes|post transplant diabetes
497210|NCT00171756|hypertension|hypertension
497211|NCT00171756|valsartan|valsartan
497212|NCT00171782|HYPERTENSION|hypertension
497213|NCT00171782|VALSARTAN|valsartan
497214|NCT00171782|VALSARTAN AND HYDROCHLOROTHIAZIDE|valsartan and hydrochlorothiazide
497215|NCT00171782|RISK FACTORS|risk factors
497216|NCT00171795|Traumatic brain injury,|traumatic brain injury,
497217|NCT00171795|cognitive impairment,|cognitive impairment,
497218|NCT00171795|rivastigmine|rivastigmine
497219|NCT00171808|Endometrial Cancer|endometrial cancer
497220|NCT00171808|Aromatase inhibitor|aromatase inhibitor
497221|NCT00171808|Advanced or recurrent|advanced or recurrent
497222|NCT00171808|hormone receptor positive|hormone receptor positive
497224|NCT00171821|Myelodysplastic Syndrome|myelodysplastic syndrome
497226|NCT00171821|Sickle cell|sickle cell
497227|NCT00171821|Diamond-Blackfan anemia|diamond-blackfan anemia
497228|NCT00171821|Transfusion|transfusion
497229|NCT00171821|Anemia|anemia
497230|NCT00171821|Fanconi|fanconi
497231|NCT00171821|Chelation|chelation
497232|NCT00171821|Deferasirox|deferasirox
497233|NCT00171834|EPO|epo
497234|NCT00171834|EPO906|epo906
497235|NCT00171834|Brain metastasis|brain metastasis
497236|NCT00171834|Lung cancer|lung cancer
497237|NCT00171834|Lung metastasis|lung metastasis
497238|NCT00171834|NSCLC|nsclc
497239|NCT00171847|Breast cancer|breast cancer
497240|NCT00171847|Metastatic|metastatic
497241|NCT00171847|Trastuzumab|trastuzumab
497242|NCT00171847|Letrozole|letrozole
497243|NCT00171860|Hypereosinophilic syndrome|hypereosinophilic syndrome
497244|NCT00171860|Imatinib|imatinib
497245|NCT00171873|Double blind|double blind
497246|NCT00171873|Phase III|phase iii
497247|NCT00171873|Disease|disease
497248|NCT00171873|Clinical trial|clinical trial
497249|NCT00171873|Octreotide|octreotide
497250|NCT00171873|Neuroendocrine tumor|neuroendocrine tumor
497251|NCT00171873|Cancer|cancer
497252|NCT00171873|Tumor|tumor
497253|NCT00171873|Midgut|midgut
497254|NCT00171886|Acromegaly|acromegaly
497255|NCT00171886|Otreotide|otreotide
497256|NCT00171886|Tumor reduction|tumor reduction
497257|NCT00171899|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
497258|NCT00171899|Complete cytogenetic response|complete cytogenetic response
497259|NCT00171899|Imatinib mesylate|imatinib mesylate
497260|NCT00171899|Major molecular response|major molecular response
497261|NCT00171899|Chronic phase Ph+ Chronic Myelogenous Leukemia|chronic phase ph+ chronic myelogenous leukemia
497262|NCT00171912|Imatinib mesylate|imatinib mesylate
497263|NCT00171912|tyrosine kinases|tyrosine kinases
497264|NCT00171912|imatinib sensitivity|imatinib sensitivity
497265|NCT00171912|Diverse malignancies either associated with|diverse malignancies either associated with
497266|NCT00171912|or thought to be associated with|or thought to be associated with
497267|NCT00171912|activated tyrosine kinase enzymes|activated tyrosine kinase enzymes
497268|NCT00171912|including hypereosinophilic syndrome|including hypereosinophilic syndrome
497269|NCT00171912|systemic mastocytosis|systemic mastocytosis
497270|NCT00171912|chronic myelomonocytic leukaemia,|chronic myelomonocytic leukaemia,
754051|NCT01178723|pro-inflammatory cytokines|pro-inflammatory cytokines
641231|NCT00746018|cervix|cervix
497271|NCT00171912|dermatofibrosarcoma protuberans and other diseases.|dermatofibrosarcoma protuberans and other diseases.
497272|NCT00171912|Not included:|not included:
497273|NCT00171912|patients with chronic myeloid leukemia,|patients with chronic myeloid leukemia,
497274|NCT00171912|some other types of leukemias (abl-mutated)|some other types of leukemias (abl-mutated)
497275|NCT00171912|some types of gastrointestinal stromal tumours (c-KIT-positive),|some types of gastrointestinal stromal tumours (c-kit-positive),
497276|NCT00171912|some systemic mastocytosis (if c-KIT D816V mutation),|some systemic mastocytosis (if c-kit d816v mutation),
497277|NCT00171912|brain,|brain,
497278|NCT00171912|prostate,|prostate,
497279|NCT00171912|breast or lung cancers.|breast or lung cancers.
497280|NCT00171925|Multiple Myeloma|multiple myeloma
497281|NCT00171925|Stage I|stage i
497282|NCT00171925|Zoledronic acid|zoledronic acid
497283|NCT00171925|Progression|progression
497284|NCT00171938|Glioblastoma|glioblastoma
497285|NCT00171938|Brain tumors|brain tumors
497286|NCT00171938|Imatinib|imatinib
497287|NCT00171938|PDGFR|pdgfr
497288|NCT00171951|Cushing's disease|cushing's disease
497289|NCT00171951|ACTH|acth
497290|NCT00171951|Cortisol|cortisol
497291|NCT00171951|ACTH dependent Cushing's disease|acth dependent cushing's disease
497292|NCT00171964|Pain|pain
497293|NCT00171964|Bone metastasis|bone metastasis
497294|NCT00171964|Analgesic consumption|analgesic consumption
497295|NCT00171964|Cancer patients|cancer patients
497296|NCT00171964|Cancer patients with painful bone metastasis|cancer patients with painful bone metastasis
497297|NCT00171977|GIST|gist
497298|NCT00171977|Imatinib|imatinib
497299|NCT00171977|Postoperative Adjuvant|postoperative adjuvant
497300|NCT00171990|genital herpes|genital herpes
497301|NCT00171990|herpes|herpes
497302|NCT00171990|famciclovir|famciclovir
497303|NCT00172003|Renal Cell Cancer|renal cell cancer
497304|NCT00172003|Bone metastasis|bone metastasis
497305|NCT00172003|Skeletal related event|skeletal related event
497306|NCT00172003|Renal Cell Cancer patients with bone metastasis|renal cell cancer patients with bone metastasis
497307|NCT00172016|Zoledronic acid|zoledronic acid
497308|NCT00172016|SRE|sre
497309|NCT00172016|Prostate cancer|prostate cancer
497310|NCT00172029|Zoledronic acid|zoledronic acid
497311|NCT00172029|Radiotherapy|radiotherapy
497312|NCT00172029|Bone pain|bone pain
497313|NCT00172029|Breast cancer|breast cancer
497314|NCT00172042|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
497315|NCT00172042|Bisphosphonates|bisphosphonates
497316|NCT00172042|Zoledronic acid|zoledronic acid
497317|NCT00172042|Bone metastases|bone metastases
497225|NCT00171821|MDS|mds
497318|NCT00172042|Prevention of bone metastases|prevention of bone metastases
497319|NCT00172055|Zoledronic acid|zoledronic acid
497320|NCT00172055|Zometa|zometa
497321|NCT00172055|prostate cancer|prostate cancer
497322|NCT00172055|osteoporosis|osteoporosis
497323|NCT00172068|Primary breast cancer|primary breast cancer
497324|NCT00172068|Bone metastases|bone metastases
497325|NCT00172068|Minimal residual disease|minimal residual disease
497326|NCT00172068|Bisphosphonates|bisphosphonates
497327|NCT00172081|Post-menopausal|post-menopausal
497328|NCT00172081|Osteoporosis|osteoporosis
497329|NCT00172081|Parathyroid Hormone|parathyroid hormone
497330|NCT00172081|PTH|pth
497331|NCT00172081|ALX1-11|alx1-11
497332|NCT00172094|Migraine|migraine
497333|NCT00172107|Post-menopausal|post-menopausal
497334|NCT00172107|Osteoporosis|osteoporosis
497335|NCT00172107|Parathyroid Hormone|parathyroid hormone
497336|NCT00172107|PTH|pth
497337|NCT00172107|ALX1-11|alx1-11
497338|NCT00172120|Post-menopausal|post-menopausal
497339|NCT00172120|Osteoporosis|osteoporosis
497340|NCT00172120|Parathyroid Hormone|parathyroid hormone
497342|NCT00172120|ALX1-11|alx1-11
497343|NCT00172133|Post-menopausal|post-menopausal
497344|NCT00172133|Osteoporosis|osteoporosis
497345|NCT00172133|Parathyroid Hormone|parathyroid hormone
497346|NCT00172133|PTH|pth
497347|NCT00172133|ALX1-11|alx1-11
497348|NCT00172146|Hemiplegia|hemiplegia
497349|NCT00172146|Regular cane|regular cane
497350|NCT00172146|Volitional stepping|volitional stepping
497351|NCT00172146|Dynamic equilibrium|dynamic equilibrium
497352|NCT00172146|Attention|attention
497353|NCT00172146|Dual task|dual task
497354|NCT00172159|Colorectal cancer|colorectal cancer
497355|NCT00172159|Chemotherapy|chemotherapy
497356|NCT00172159|Surgery|surgery
497357|NCT00172159|Liver metastasis|liver metastasis
497358|NCT00172172|Post-menopausal|post-menopausal
497359|NCT00172172|Osteoporosis|osteoporosis
497360|NCT00172172|Parathyroid Hormone|parathyroid hormone
497361|NCT00172172|PTH|pth
497362|NCT00172172|ALX1-11|alx1-11
497363|NCT00172185|Short Bowel Syndrome|short bowel syndrome
497364|NCT00172185|Parenteral Nutrition|parenteral nutrition
497365|NCT00172185|SBS|sbs
497366|NCT00172185|Teduglutide|teduglutide
497367|NCT00172198|w-3 fish oil|w-3 fish oil
497368|NCT00172198|Nutrition|nutrition
497369|NCT00172198|immune|immune
497370|NCT00172198|intensive care|intensive care
641359|NCT00746525|BCI|bci
496654|NCT00176592|Brain|brain
497371|NCT00172198|patients|patients
497372|NCT00172211|Physioneal|physioneal
497373|NCT00172211|Peritoneal dialysis|peritoneal dialysis
497374|NCT00172211|Oxidative stress|oxidative stress
497375|NCT00172211|insulin resistance|insulin resistance
497376|NCT00172224|osteoporosis|osteoporosis
497377|NCT00172224|compression fracture|compression fracture
497378|NCT00172224|bone marrow perfusion|bone marrow perfusion
497379|NCT00172224|MR spectroscopy|mr spectroscopy
497380|NCT00172224|hormone therapy|hormone therapy
497381|NCT00172237|eye-head coordination|eye-head coordination
497382|NCT00172237|proprioception|proprioception
497383|NCT00172237|cervical spine with degenerative disease|cervical spine with degenerative disease
497384|NCT00172237|degenerated cervical spine|degenerated cervical spine
497385|NCT00172263|Immunology|immunology
497386|NCT00172289|pulse wave velocity|pulse wave velocity
497387|NCT00172289|sympathetic nerve activity|sympathetic nerve activity
497388|NCT00172289|spinal cord injury|spinal cord injury
497389|NCT00172289|cerebrovascular accident|cerebrovascular accident
497390|NCT00172315|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
497391|NCT00172315|lipodystrophy|lipodystrophy
497590|NCT00173550|Attitude|attitude
497392|NCT00172315|MR spectroscopy|mr spectroscopy
497393|NCT00172328|Hepatitis B|hepatitis b
497394|NCT00172328|vaccine|vaccine
497395|NCT00172367|Urothelial carcinoma|urothelial carcinoma
497396|NCT00172367|Lycopene|lycopene
497397|NCT00172367|uremia|uremia
497398|NCT00172367|prevention|prevention
497399|NCT00172367|biomarker|biomarker
497400|NCT00172367|progression|progression
497401|NCT00172367|anti-oxidant|anti-oxidant
497402|NCT00172393|EV71,|ev71,
497403|NCT00172393|CNS,|cns,
497404|NCT00172393|Outcome,|outcome,
497405|NCT00172393|Neurological,|neurological,
497406|NCT00172393|Psychiatric|psychiatric
497407|NCT00172419|statin, inflammation, FDG, positron emission tomography|statin, inflammation, fdg, positron emission tomography
497408|NCT00172484|cerebrovascular accident|cerebrovascular accident
497409|NCT00172484|stroke center|stroke center
497410|NCT00172484|stroke team|stroke team
497411|NCT00172484|intensive care of stroke|intensive care of stroke
497412|NCT00172484|rehabilitation of stroke|rehabilitation of stroke
497413|NCT00172497|aggressive acts|aggressive acts
497414|NCT00172562|acute myeloid leukemia|acute myeloid leukemia
497415|NCT00172562|age and sex matched normal subjects|age and sex matched normal subjects
497416|NCT00172562|dynamic MRI|dynamic mri
497417|NCT00172562|bone marrow perfusion|bone marrow perfusion
497418|NCT00172562|tumor angiogenesis|tumor angiogenesis
497419|NCT00172575|Lung neoplasms|lung neoplasms
497420|NCT00172575|Magnetic resonance imaging|magnetic resonance imaging
497421|NCT00172588|adenomyosis|adenomyosis
497422|NCT00172588|apoptosis|apoptosis
497423|NCT00172588|flowcytometry|flowcytometry
497424|NCT00172614|metabolic syndrome|metabolic syndrome
497425|NCT00172653|shoulder, reliability, validity|shoulder, reliability, validity
497426|NCT00172666|SLE|sle
497427|NCT00172666|healthy subjects|healthy subjects
497428|NCT00172679|Tai Chi|tai chi
497429|NCT00172679|NK Cells|nk cells
497430|NCT00172679|T lymphocytes|t lymphocytes
497431|NCT00172679|Exercise|exercise
497432|NCT00172692|Chewing efficiency,|chewing efficiency,
497433|NCT00172692|Gum chewing|gum chewing
497434|NCT00172692|Chewing velocity|chewing velocity
497435|NCT00172692|Occlusal surface area|occlusal surface area
497436|NCT00172692|EMG|emg
497437|NCT00172692|Jaw movement|jaw movement
497438|NCT00172744|stem cells|stem cells
497439|NCT00172744|periodontal cells|periodontal cells
497440|NCT00172744|mechanical stress|mechanical stress
497441|NCT00172744|differentiation|differentiation
497442|NCT00172744|periodontal ligament|periodontal ligament
497443|NCT00172757|MSI, TS, Colorectal Cancer, DM.|msi, ts, colorectal cancer, dm.
497444|NCT00172783|TB|tb
497445|NCT00172783|PPD|ppd
497446|NCT00172783|ELISPOT|elispot
497447|NCT00172783|BCG|bcg
497448|NCT00172796|Metabolic syndrome|metabolic syndrome
497449|NCT00172809|Chronic Hepatitis C|chronic hepatitis c
497450|NCT00172809|End stage renal disease|end stage renal disease
497451|NCT00172809|Hemodialysis|hemodialysis
497452|NCT00172809|Interferon|interferon
497453|NCT00172809|Pegylated interferon|pegylated interferon
497454|NCT00172822|appendicitis|appendicitis
497455|NCT00172835|pleural effusion|pleural effusion
497456|NCT00172835|procalcitonin|procalcitonin
497457|NCT00172861|gastric cancer, cyclooxygenase-2, microarray|gastric cancer, cyclooxygenase-2, microarray
497458|NCT00172874|cross-cultural,|cross-cultural,
497459|NCT00172874|eating disorders,|eating disorders,
497460|NCT00172874|EDI,|edi,
497461|NCT00172874|psychometrics|psychometrics
497462|NCT00172887|Psychiatrists|psychiatrists
497463|NCT00172900|Diffusion tensor imaging|diffusion tensor imaging
497464|NCT00172900|MR spectroscopy|mr spectroscopy
497465|NCT00172900|dementia|dementia
497466|NCT00172900|white matter|white matter
497467|NCT00172913|Wavefront Aberration|wavefront aberration
641517|NCT00747214|RA|ra
497468|NCT00172913|LASIK|lasik
497469|NCT00172913|Contrast Sensitivity|contrast sensitivity
497470|NCT00172913|Visual Performance|visual performance
497471|NCT00172913|Ablation Profile|ablation profile
497472|NCT00172926|Physical Constitution|physical constitution
497473|NCT00172926|Disease Pattern|disease pattern
497474|NCT00172926|Laboratory Data|laboratory data
497475|NCT00172926|Integrative Chinese Medicine and Western Medicine|integrative chinese medicine and western medicine
497476|NCT00172952|high myopia, genomic|high myopia, genomic
497477|NCT00172965|Optic coherence tomography|optic coherence tomography
497478|NCT00172965|oral cancer|oral cancer
497479|NCT00172965|oral precancers|oral precancers
497480|NCT00173017|N95 mask|n95 mask
497481|NCT00173017|medical staff|medical staff
497482|NCT00173017|hypoxemia|hypoxemia
497483|NCT00173017|hypercapnia|hypercapnia
497484|NCT00173017|neurological study|neurological study
497485|NCT00173056|Peritoneal dialysis|peritoneal dialysis
497486|NCT00173069|Schizophrenia|schizophrenia
497487|NCT00173069|PPI|ppi
497488|NCT00173069|P50I|p50i
497489|NCT00173069|MRS|mrs
497490|NCT00173069|Niacin|niacin
497491|NCT00173069|Candidate Genes|candidate genes
497492|NCT00173082|primary aldosteronism|primary aldosteronism
497493|NCT00173082|Insulin resistance|insulin resistance
497591|NCT00173563|Immunology|immunology
497494|NCT00173082|Metabolic syndrome|metabolic syndrome
497495|NCT00173082|OGTT|ogtt
497496|NCT00173108|Prematurity|prematurity
497497|NCT00173108|Early intervention|early intervention
497498|NCT00173108|Neurodevelopment|neurodevelopment
497499|NCT00173108|Cost-effectiveness|cost-effectiveness
497500|NCT00173121|enterovirus, environment, aerosol, air|enterovirus, environment, aerosol, air
497501|NCT00173134|diabetes|diabetes
497502|NCT00173134|erectile dysfunction|erectile dysfunction
497503|NCT00173134|erectile dysfunction related quality of life|erectile dysfunction related quality of life
497504|NCT00173160|Eating disorders|eating disorders
497505|NCT00173160|risk factors|risk factors
497506|NCT00173160|prospective study|prospective study
497507|NCT00173160|case-controled study|case-controled study
497508|NCT00173160|outcome|outcome
497509|NCT00173160|gifted dance students|gifted dance students
497510|NCT00173173|Gifted dance students|gifted dance students
497511|NCT00173173|eating disorders|eating disorders
497512|NCT00173173|prevalence|prevalence
497513|NCT00173173|risk factors|risk factors
497514|NCT00173173|BITE|bite
497515|NCT00173186|ventricular septal defect|ventricular septal defect
497516|NCT00173186|aortic regurgitation|aortic regurgitation
497517|NCT00173212|adenomyosis|adenomyosis
497518|NCT00173212|cell proliferation|cell proliferation
497519|NCT00173212|Immunocytochemistry|immunocytochemistry
497520|NCT00173225|nociceptin|nociceptin
497521|NCT00173225|sunstance P|sunstance p
497522|NCT00173225|asthma|asthma
497523|NCT00173225|COPD|copd
497524|NCT00173225|cough|cough
497525|NCT00173238|atherosclerosis|atherosclerosis
497621|NCT00173771|activities of daily living|activities of daily living
497526|NCT00173238|optical coherence tomography|optical coherence tomography
497527|NCT00173238|polarization|polarization
497528|NCT00173238|phase retardation|phase retardation
497529|NCT00173238|birefringence|birefringence
497530|NCT00173277|colorectal cancer screening|colorectal cancer screening
497532|NCT00173290|Cervical cancer|cervical cancer
497533|NCT00173290|Breast cancer|breast cancer
497534|NCT00173290|T lymphocyte|t lymphocyte
497535|NCT00173290|NK receptor|nk receptor
497536|NCT00173303|Breast neoplasms|breast neoplasms
497537|NCT00173303|Breast radiography|breast radiography
497538|NCT00173303|Cancer screening|cancer screening
497539|NCT00173316|vascular endothelial growth factor-C|vascular endothelial growth factor-c
497541|NCT00173316|lymphangiogenesis|lymphangiogenesis
497542|NCT00173316|host inflammatory responses|host inflammatory responses
497543|NCT00173316|oral carcinogenesis|oral carcinogenesis
497544|NCT00173316|oral cancers|oral cancers
497545|NCT00173316|oral premalignant lesions|oral premalignant lesions
497546|NCT00173329|HIV|hiv
497547|NCT00173342|Right bundle branch block|right bundle branch block
497548|NCT00173342|Electrocardiography|electrocardiography
497549|NCT00173342|Ion channel|ion channel
497550|NCT00173355|pediatric Dermatofibrosarcoma Protuberans|pediatric dermatofibrosarcoma protuberans
497551|NCT00173368|Sphincterotomy|sphincterotomy
497552|NCT00173368|needle knife|needle knife
497553|NCT00173368|hemorrhage|hemorrhage
497554|NCT00173368|complication|complication
497555|NCT00173381|lymphangiogenesis|lymphangiogenesis
497556|NCT00173381|head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
497557|NCT00173381|vascular endothelial growth factor-C (VEGF-C)|vascular endothelial growth factor-c (vegf-c)
497558|NCT00173381|cyclooxygenase-2 (COX-2)|cyclooxygenase-2 (cox-2)
497559|NCT00173381|interleukin-6 (IL-6)|interleukin-6 (il-6)
497560|NCT00173394|ovarian cancer|ovarian cancer
497561|NCT00173394|immunotherapy|immunotherapy
497562|NCT00173394|mesothelin|mesothelin
497563|NCT00173394|normal volunteer|normal volunteer
496852|NCT00178074|PET|pet
497564|NCT00173407|Ovarian endometrioid carcinoma|ovarian endometrioid carcinoma
497565|NCT00173407|invasion|invasion
497566|NCT00173407|IGFBP-3|igfbp-3
497567|NCT00173407|transfection|transfection
497568|NCT00173407|signal transduction|signal transduction
497569|NCT00173407|PTEN|pten
497570|NCT00173407|methylation|methylation
497571|NCT00173420|Normal Controls|normal controls
497572|NCT00173433|tuberculosis|tuberculosis
497573|NCT00173433|relapse|relapse
497574|NCT00173433|reinfection|reinfection
497575|NCT00173433|reactivation|reactivation
497576|NCT00173433|dormancy|dormancy
497577|NCT00173433|tuberculin skin test|tuberculin skin test
497578|NCT00173446|Normal part of the adrenal gland|normal part of the adrenal gland
497579|NCT00173472|colorectal cancer, MSI, TS, DPD, EGFR, chemotherapy.|colorectal cancer, msi, ts, dpd, egfr, chemotherapy.
497580|NCT00173485|peritonitis, peritoneal dialysis, dialysate|peritonitis, peritoneal dialysis, dialysate
497581|NCT00173498|atopic dermatitis, skin test|atopic dermatitis, skin test
497582|NCT00173524|EGFR Non-small cell lung cancer|egfr non-small cell lung cancer
497583|NCT00173537|idiopathic pulmonary artery hypertension|idiopathic pulmonary artery hypertension
497584|NCT00173550|Menopause, premature|menopause, premature
497585|NCT00173550|Hysterectomy|hysterectomy
497586|NCT00173550|Ovariectomy|ovariectomy
497587|NCT00173550|Estrogen Replacement Therapy|estrogen replacement therapy
497588|NCT00173550|Knowledge|knowledge
497589|NCT00173550|Perception|perception
497592|NCT00173602|Peritoneal Dialysis|peritoneal dialysis
497593|NCT00173615|ECMO|ecmo
497594|NCT00173615|CPR|cpr
497595|NCT00173693|CEA, Osteoporosis, Fracture, Prevention, Exercise|cea, osteoporosis, fracture, prevention, exercise
497596|NCT00173706|L-Carnitine|l-carnitine
497597|NCT00173706|hemodialysis|hemodialysis
497598|NCT00173706|cardiac complications|cardiac complications
497599|NCT00173706|impaired exercise and functional capacities|impaired exercise and functional capacities
497600|NCT00173706|muscle symptoms|muscle symptoms
497601|NCT00173706|intradialytic hypotension|intradialytic hypotension
497602|NCT00173706|erythropoietin-resistant anemia|erythropoietin-resistant anemia
497603|NCT00173719|Hemiplegia|hemiplegia
497604|NCT00173719|Assisstive device|assisstive device
497605|NCT00173719|Walking|walking
497606|NCT00173719|Dynamic equilibrium|dynamic equilibrium
497607|NCT00173719|Reaction time|reaction time
497608|NCT00173719|Attention|attention
497609|NCT00173719|Dual task|dual task
497610|NCT00173732|Preimplantation genetic diagnosis (PGD)|preimplantation genetic diagnosis (pgd)
497611|NCT00173732|single cell|single cell
497612|NCT00173732|Multiple displacement amplification (MDA)|multiple displacement amplification (mda)
497613|NCT00173745|cerebral palsy|cerebral palsy
497614|NCT00173745|drooling|drooling
497615|NCT00173745|botulinum toxin|botulinum toxin
497616|NCT00173758|IL-15|il-15
497617|NCT00173758|IL-15 receptor|il-15 receptor
497618|NCT00173758|decidual natural killer cells|decidual natural killer cells
497619|NCT00173758|endometrium|endometrium
497620|NCT00173771|stroke|stroke
497622|NCT00173771|psychometrics|psychometrics
497623|NCT00173784|psychometrics|psychometrics
497624|NCT00173784|activities of daily living|activities of daily living
497625|NCT00173797|depression|depression
497626|NCT00173797|psychometrics|psychometrics
497627|NCT00173810|stroke|stroke
497628|NCT00173810|movement|movement
497629|NCT00173810|psychomterics|psychomterics
497630|NCT00179491|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
497631|NCT00179517|Seizure|seizure
497632|NCT00179517|Epilepsy|epilepsy
497633|NCT00179517|Testosterone|testosterone
497634|NCT00179517|Hormone|hormone
497635|NCT00179517|Sexual Dysfunction|sexual dysfunction
497636|NCT00179517|Hypogonadism|hypogonadism
497637|NCT00179517|Men|men
497638|NCT00179556|Hot flashes|hot flashes
497639|NCT00179556|Menopausal symptoms|menopausal symptoms
497640|NCT00179556|Soybean germ|soybean germ
497641|NCT00179556|Aglycones|aglycones
497642|NCT00179556|Menopause|menopause
497643|NCT00179582|IBS|ibs
497644|NCT00179582|Functional bowel disorder|functional bowel disorder
497645|NCT00179582|Diarrhea|diarrhea
497646|NCT00179582|probiotic|probiotic
497647|NCT00179595|nitric oxide, volumetric oxygen consumption|nitric oxide, volumetric oxygen consumption
497648|NCT00179608|CC-5013|cc-5013
497649|NCT00179608|CC5013|cc5013
497650|NCT00179608|celgene|celgene
497651|NCT00179608|Melanoma|melanoma
497652|NCT00179608|Revlimid|revlimid
497653|NCT00179608|Metastatic Malignant Melanoma|metastatic malignant melanoma
497654|NCT00179608|Lenalidomide|lenalidomide
497655|NCT00179621|MDS|mds
497656|NCT00179621|transfusion dependent|transfusion dependent
497657|NCT00179621|anaemia|anaemia
497658|NCT00179621|cytogenetic abnormality 5q-|cytogenetic abnormality 5q-
497659|NCT00179621|erythroid response|erythroid response
497660|NCT00179621|leukaemia|leukaemia
497661|NCT00179621|CC-5013|cc-5013
497662|NCT00179621|Celgene|celgene
497663|NCT00179621|revlimid|revlimid
497664|NCT00179621|lenalidomide|lenalidomide
497665|NCT00179634|Mastectomy|mastectomy
497666|NCT00179634|Randomized Controlled Trial|randomized controlled trial
497667|NCT00179634|Imagery|imagery
497668|NCT00179647|Multiple Myeloma|multiple myeloma
497669|NCT00179647|MM|mm
497670|NCT00179647|Revlimid|revlimid
497671|NCT00179647|CC5013|cc5013
497672|NCT00179647|celgene|celgene
497673|NCT00179647|cc-5013|cc-5013
497674|NCT00179647|relapsed/refractory|relapsed/refractory
497675|NCT00179647|lenalidomide|lenalidomide
497676|NCT00179647|dexamethasone|dexamethasone
497677|NCT00179647|Decadron|decadron
497678|NCT00179660|celgene|celgene
497679|NCT00179660|cc-5013|cc-5013
497680|NCT00179660|CC5013|cc5013
497681|NCT00179660|NHL|nhl
497682|NCT00179660|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
497683|NCT00179660|Revlimid|revlimid
497684|NCT00179673|NHL|nhl
497685|NCT00179673|CC5013|cc5013
497686|NCT00179673|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
497687|NCT00179673|revlimid|revlimid
497688|NCT00179673|cc-5013|cc-5013
497689|NCT00179673|celgene|celgene
497690|NCT00179686|celgene|celgene
497691|NCT00179686|cc-5013|cc-5013
497692|NCT00179686|NSCLC|nsclc
497693|NCT00179686|CC5013|cc5013
497694|NCT00179686|Revlimid|revlimid
497695|NCT00179686|Non-Small Cell Lung Cancer|non-small cell lung cancer
497696|NCT00179699|cc-5013|cc-5013
497697|NCT00179699|Non Small Cell Lung Cancer|non small cell lung cancer
497698|NCT00179699|revlimid|revlimid
497699|NCT00179699|celgene|celgene
497700|NCT00179699|cc5013|cc5013
497701|NCT00179712|cc-5013|cc-5013
497702|NCT00179712|revlimid|revlimid
497703|NCT00179712|ovarian cancer|ovarian cancer
497704|NCT00179712|celgene|celgene
497705|NCT00179725|cc-5013|cc-5013
497706|NCT00179725|revlimid|revlimid
497707|NCT00179725|ovarian cancer|ovarian cancer
497708|NCT00179725|celgene|celgene
497709|NCT00179738|Androgen Independent Prostate Cancer|androgen independent prostate cancer
497710|NCT00179751|cc-5013|cc-5013
497711|NCT00179751|revlimid|revlimid
497712|NCT00179751|pancreatic cancer|pancreatic cancer
497713|NCT00179764|Patients with recurrent solid tumors|patients with recurrent solid tumors
497714|NCT00179764|Patients with malignant melanoma|patients with malignant melanoma
497715|NCT00179764|Patients with hematological malignancies|patients with hematological malignancies
497716|NCT00179764|Acute lymphoblastic leukemia (ALL)|acute lymphoblastic leukemia (all)
497717|NCT00179764|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
497718|NCT00179777|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
497719|NCT00179777|Genetic Predisposition to Disease|genetic predisposition to disease
497720|NCT00179777|Infant Nutrition|infant nutrition
497721|NCT00179777|Primary Prevention|primary prevention
497722|NCT00179790|cancer|cancer
497723|NCT00179790|hemoglobinopathy|hemoglobinopathy
497724|NCT00179790|immune deficiency|immune deficiency
497725|NCT00179790|photopheresis|photopheresis
497727|NCT00179790|extracorporeal photopheresis|extracorporeal photopheresis
497728|NCT00179803|brain tumor|brain tumor
497729|NCT00179803|medulloblastoma|medulloblastoma
497730|NCT00179803|germ cell tumor|germ cell tumor
497732|NCT00179803|glioblastoma|glioblastoma
497733|NCT00179803|astrocytoma|astrocytoma
497734|NCT00179803|pineoblastoma|pineoblastoma
497735|NCT00179803|rhabdoid tumor|rhabdoid tumor
497736|NCT00179803|supratentorial PNET|supratentorial pnet
497737|NCT00179803|high grade astrocytoma|high grade astrocytoma
497738|NCT00179816|wilm's tumor|wilm's tumor
497739|NCT00179816|stem cell transplantation|stem cell transplantation
497740|NCT00179816|solid tumor|solid tumor
497741|NCT00180661|Severe asthma|severe asthma
497742|NCT00180661|corticosteroid responsiveness|corticosteroid responsiveness
497743|NCT00180674|Hepatic fibrosis|hepatic fibrosis
497744|NCT00180674|anticoagulation|anticoagulation
497746|NCT00180674|Warfarin|warfarin
497747|NCT00180674|Chronic hepatitis C virus infection|chronic hepatitis c virus infection
497748|NCT00180687|Pain|pain
497749|NCT00180687|Nebulisation|nebulisation
497750|NCT00180687|Cholecystectomy|cholecystectomy
497751|NCT00180687|Laparoscopic|laparoscopic
497752|NCT00180687|Bupivacaine|bupivacaine
497753|NCT00180687|Local Anaesthetic|local anaesthetic
497754|NCT00180700|HIV|hiv
497755|NCT00180700|Stress|stress
497756|NCT00180700|Psychoneuroimmunology|psychoneuroimmunology
497757|NCT00180700|stress management|stress management
497758|NCT00180700|hypnosis|hypnosis
497759|NCT00180700|Johrei|johrei
497760|NCT00180700|psychological intervention|psychological intervention
497761|NCT00180713|Pulmonary hypertension|pulmonary hypertension
497762|NCT00180713|Simvastatin|simvastatin
497763|NCT00180713|Statins|statins
497764|NCT00180726|asthma, inflammatory, corticosteroid|asthma, inflammatory, corticosteroid
497765|NCT00180739|MR guided FUS|mr guided fus
497766|NCT00180739|Uterine Fibroids|uterine fibroids
497767|NCT00180739|Fertility|fertility
497768|NCT00180739|Pregnancy|pregnancy
497769|NCT00180765|Leukocytes|leukocytes
497770|NCT00180765|Eosinophils|eosinophils
497771|NCT00180765|Neutrophils|neutrophils
497053|NCT00179075|T-Lymphocyte Subsets|t-lymphocyte subsets
497772|NCT00180765|Chronic Obstructive Airway Disease|chronic obstructive airway disease
497773|NCT00180765|Apoptosis|apoptosis
497774|NCT00180765|Signal Transduction|signal transduction
497775|NCT00180791|Brain PNET|brain pnet
497776|NCT00180856|Lung metastasis|lung metastasis
497777|NCT00180856|Lung cancer|lung cancer
497778|NCT00180856|Radiofrequency ablation|radiofrequency ablation
497779|NCT00180869|cancer|cancer
497780|NCT00180869|peroperative transfusion|peroperative transfusion
497781|NCT00180869|allogeneic red blood cell concentrate|allogeneic red blood cell concentrate
497782|NCT00180869|leuko-reduced red blood cell concentrate|leuko-reduced red blood cell concentrate
497783|NCT00180895|Burkitt lymphoma|burkitt lymphoma
497784|NCT00180895|B-cell non Hodgkin lymphoma|b-cell non hodgkin lymphoma
497785|NCT00180895|B-cell ALL|b-cell all
497786|NCT00180895|Refractory|refractory
497787|NCT00180895|Relapse|relapse
497788|NCT00180895|Rituximab|rituximab
497789|NCT00180895|Children|children
497790|NCT00180908|Osteosarcoma|osteosarcoma
497791|NCT00180921|Adenoid cystic carcinoma of the head and neck|adenoid cystic carcinoma of the head and neck
497792|NCT00180947|Soft parts tissue|soft parts tissue
497793|NCT00181012|Cancer Related Visceral Pain Resistant to Morphinics|cancer related visceral pain resistant to morphinics
497794|NCT00181025|Limbs’ girdle|limbs’ girdle
497795|NCT00181038|Oro-Pharyngeal Carcinoma Surgery|oro-pharyngeal carcinoma surgery
497796|NCT00181064|headache|headache
497797|NCT00181064|Atkins|atkins
497798|NCT00181064|ketosis|ketosis
497799|NCT00181064|intractable|intractable
497800|NCT00181077|preeclampsia, hypertonic saline, diuresis|preeclampsia, hypertonic saline, diuresis
497801|NCT00181090|Epilepsy|epilepsy
497802|NCT00181090|Ketosis|ketosis
497803|NCT00181090|Atkins|atkins
497804|NCT00181090|seizures|seizures
497805|NCT00181116|Epilepsy|epilepsy
497806|NCT00181116|Benign rolandic|benign rolandic
497807|NCT00181116|Levetiracetam|levetiracetam
497808|NCT00181129|Fatigue|fatigue
497809|NCT00181129|Cancer treatment|cancer treatment
497810|NCT00181142|Induciton therapy, Daclizumab, Thymoglobulin, lung transplantation|induciton therapy, daclizumab, thymoglobulin, lung transplantation
497811|NCT00181155|metabolism|metabolism
497812|NCT00181155|congestive heart failure|congestive heart failure
497813|NCT00181155|allopurinol|allopurinol
497814|NCT00181155|Adenosine triphosphate (ATP)|adenosine triphosphate (atp)
497815|NCT00181168|thyroid cancer|thyroid cancer
497816|NCT00181168|PET scan|pet scan
497817|NCT00181168|recombinant thyrotropin|recombinant thyrotropin
497818|NCT00181168|thyroglobulin|thyroglobulin
497819|NCT00181168|Thyroid cancer, differentiated epithelial|thyroid cancer, differentiated epithelial
497820|NCT00181181|Hypertension|hypertension
497821|NCT00181194|Asthma|asthma
497822|NCT00181207|COPD|copd
497823|NCT00181246|Neuropathic pain|neuropathic pain
497824|NCT00181246|Efficacy|efficacy
497825|NCT00181272|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
497826|NCT00181272|undifferentiated asthma/COPD|undifferentiated asthma/copd
497827|NCT00181298|Memantine|memantine
497828|NCT00181298|SLE|sle
497829|NCT00181298|Anti NR2|anti nr2
497830|NCT00181298|ANAM|anam
498602|NCT00183404|Olanzapine|olanzapine
497831|NCT00181298|Cognitive functioning|cognitive functioning
497832|NCT00181311|vaginal hysterectomy|vaginal hysterectomy
497833|NCT00181311|abdominal hysterectomy|abdominal hysterectomy
497834|NCT00181311|complications|complications
497835|NCT00181311|physical well being|physical well being
497836|NCT00181311|mental well being|mental well being
497837|NCT00181350|brain tumor|brain tumor
497838|NCT00181350|fractionated stereotactic radiotherapy|fractionated stereotactic radiotherapy
497839|NCT00181350|fixationsystems|fixationsystems
497840|NCT00181350|repositioning|repositioning
497841|NCT00181363|Breast cancer|breast cancer
497842|NCT00181363|Breast conserving surgery|breast conserving surgery
497843|NCT00181363|Radiotherapy|radiotherapy
497844|NCT00181363|Pendulous breasts|pendulous breasts
497845|NCT00181506|radiotherapy|radiotherapy
497846|NCT00181506|radiation dose|radiation dose
497847|NCT00181506|lung cancer|lung cancer
497848|NCT00181532|NSCLC|nsclc
497849|NCT00181532|cox-2-inhibitor|cox-2-inhibitor
497850|NCT00181532|radiosensitizer|radiosensitizer
497851|NCT00181532|radiotherapy|radiotherapy
497852|NCT00181545|Non-small cell lung carcinoma|non-small cell lung carcinoma
497853|NCT00181545|radiotherapy|radiotherapy
497854|NCT00181545|mean lung dose|mean lung dose
497855|NCT00181558|Prostate Cancer|prostate cancer
497856|NCT00181558|bone metastases|bone metastases
497857|NCT00181558|Atrasentan|atrasentan
497858|NCT00181558|Zometa|zometa
497859|NCT00181558|Androgen Independent Prostate Cancer|androgen independent prostate cancer
497860|NCT00181571|ADHD|adhd
497861|NCT00181571|Adults|adults
497862|NCT00181571|Concerta|concerta
497863|NCT00181571|Double-Blind|double-blind
497864|NCT00181584|Androgen deprivation therapy|androgen deprivation therapy
497865|NCT00181584|bone loss|bone loss
497149|NCT00171457|male|male
497866|NCT00181584|prostate cancer|prostate cancer
497867|NCT00181584|Zoledronic Acid|zoledronic acid
497868|NCT00181584|Zometa|zometa
497869|NCT00181597|Trilostane|trilostane
497870|NCT00181597|Androgen-independent prostate cancer|androgen-independent prostate cancer
497871|NCT00181610|Lactation|lactation
497872|NCT00181610|Breastfeeding|breastfeeding
497873|NCT00181610|Premature infants|premature infants
497874|NCT00181610|Prolactin|prolactin
497875|NCT00181610|Primary lactation insufficiency|primary lactation insufficiency
497876|NCT00181623|Lactation|lactation
497877|NCT00181623|Breastfeeding|breastfeeding
497878|NCT00181623|Prolactin|prolactin
497879|NCT00181623|Primary lactation insufficiency|primary lactation insufficiency
497880|NCT00181649|Lactation|lactation
497881|NCT00181649|Breastfeeding|breastfeeding
497882|NCT00181649|Adoptive mothers|adoptive mothers
497883|NCT00181649|Prolactin|prolactin
497884|NCT00181649|Relative lactation insufficiency|relative lactation insufficiency
497885|NCT00181662|Curcumin|curcumin
497886|NCT00181662|Piperine|piperine
497887|NCT00181662|Silybin|silybin
497888|NCT00181662|Healthy volunteer|healthy volunteer
497889|NCT00181662|Female|female
497890|NCT00181675|Adult|adult
497891|NCT00181675|ADHD|adhd
497892|NCT00181675|galantamine|galantamine
497893|NCT00181675|double-blind|double-blind
497894|NCT00181688|Iressa|iressa
497895|NCT00181688|ZD1839|zd1839
497896|NCT00181688|Anastrozole|anastrozole
497897|NCT00181688|Arimidex|arimidex
497898|NCT00181701|Ovarian cancer|ovarian cancer
497899|NCT00181701|Epithelial carcinoma of mullerian origin|epithelial carcinoma of mullerian origin
497900|NCT00181701|Intraperitoneal paclitaxel|intraperitoneal paclitaxel
497901|NCT00181701|Intraperitoneal carboplatin|intraperitoneal carboplatin
497902|NCT00181701|Primary peritoneal carcinoma|primary peritoneal carcinoma
497903|NCT00181701|Tubal carcinoma|tubal carcinoma
497904|NCT00181714|cigarette smoking|cigarette smoking
497905|NCT00181714|ADHD|adhd
497906|NCT00181714|adolescents|adolescents
497907|NCT00181714|Concerta|concerta
497908|NCT00181727|bipolar disorder|bipolar disorder
497909|NCT00181727|mania|mania
497910|NCT00181727|depakote ER|depakote er
497911|NCT00181727|children|children
497912|NCT00181740|ADHD NOS|adhd nos
497913|NCT00181740|Adults|adults
497914|NCT00181740|Concerta|concerta
497915|NCT00181740|Open-Label|open-label
497916|NCT00181753|glutamine metabolic kinetics|glutamine metabolic kinetics
497917|NCT00181753|glutamate metabolic kinetics|glutamate metabolic kinetics
497918|NCT00181753|enteral nutrition|enteral nutrition
497919|NCT00181753|parenteral nutrition|parenteral nutrition
497920|NCT00181753|burn injury|burn injury
497921|NCT00181753|stable isotopes|stable isotopes
497922|NCT00181766|ADHD NOS|adhd nos
497923|NCT00181766|Adults|adults
497924|NCT00181766|Strattera (atomoxetine)|strattera (atomoxetine)
497925|NCT00181766|Open-Label|open-label
497926|NCT00181779|mania|mania
497927|NCT00181779|Abilify|abilify
497928|NCT00181779|children|children
497929|NCT00181779|bipolar disorder|bipolar disorder
497930|NCT00181792|ADHD|adhd
497931|NCT00181792|smoking|smoking
497932|NCT00181792|familial risk|familial risk
497933|NCT00181805|GER|ger
497934|NCT00181818|Smoking cessation|smoking cessation
497935|NCT00181818|Bupropion SR|bupropion sr
497936|NCT00181818|Hospital intervention|hospital intervention
497937|NCT00181818|Myocardial infarction|myocardial infarction
497938|NCT00181818|Unstable angina|unstable angina
497939|NCT00181831|SPECT|spect
497940|NCT00181831|bipolar disorder|bipolar disorder
497941|NCT00181831|ADHD|adhd
497942|NCT00181831|children|children
497943|NCT00181844|bipolar disorder|bipolar disorder
497944|NCT00181844|lamotrigine|lamotrigine
497945|NCT00181844|children|children
497946|NCT00181844|mania|mania
497947|NCT00181857|ADHD NOS|adhd nos
497948|NCT00181857|familial risk|familial risk
497950|NCT00181870|bipolar disorder|bipolar disorder
497951|NCT00181870|children|children
497952|NCT00181870|mania|mania
497953|NCT00181870|Equetro|equetro
497954|NCT00181883|children|children
497955|NCT00181883|bipolar disorder|bipolar disorder
497956|NCT00181883|quetiapine|quetiapine
497957|NCT00181883|preschoolers|preschoolers
497958|NCT00181896|depression|depression
497959|NCT00181896|bipolar disorder|bipolar disorder
497960|NCT00181896|children|children
497961|NCT00181896|bupropion SR|bupropion sr
497962|NCT00181909|Pregnancy|pregnancy
497963|NCT00181909|Smoking cessation|smoking cessation
497964|NCT00181922|bipolar disorder|bipolar disorder
497965|NCT00181922|children|children
497966|NCT00181922|ziprasidone|ziprasidone
497967|NCT00181922|mania|mania
497968|NCT00181935|bipolar disorder|bipolar disorder
497969|NCT00181935|preschoolers|preschoolers
497970|NCT00181935|risperdal|risperdal
497971|NCT00181935|zyprexa|zyprexa
497972|NCT00181948|ADHD|adhd
497973|NCT00181948|children|children
497974|NCT00181948|stimulant non-responders|stimulant non-responders
497975|NCT00181948|Strattera|strattera
497976|NCT00181961|antidepressant-induced sexual dysfunction|antidepressant-induced sexual dysfunction
497977|NCT00181974|burns|burns
497978|NCT00181974|hemostasis|hemostasis
497979|NCT00181974|skin graft|skin graft
497980|NCT00181974|Surgical Hemostasis|surgical hemostasis
497981|NCT00181974|Grafting, Skin|grafting, skin
497982|NCT00181987|ADHD|adhd
497983|NCT00181987|bipolar disorder|bipolar disorder
497984|NCT00181987|children|children
497985|NCT00181987|Concerta|concerta
497986|NCT00182000|OCD|ocd
497987|NCT00182026|diabetes|diabetes
497988|NCT00182026|community intervention|community intervention
497989|NCT00182026|self-management|self-management
497990|NCT00182026|prevention|prevention
497991|NCT00182039|randomized controlled trial|randomized controlled trial
497992|NCT00182039|blinded|blinded
497993|NCT00182039|noncardiac surgery|noncardiac surgery
497994|NCT00182039|cardiovascular events|cardiovascular events
497995|NCT00182052|rosiglitazone|rosiglitazone
497996|NCT00182052|Avandia|avandia
497997|NCT00182052|androgen dependant prostate cancer|androgen dependant prostate cancer
497998|NCT00182065|Heart failure|heart failure
497999|NCT00182065|Functional decline|functional decline
498000|NCT00182065|Cognitive impairment|cognitive impairment
498001|NCT00182065|Neuropsychiatric health|neuropsychiatric health
498002|NCT00182065|Longitudinal|longitudinal
498003|NCT00182065|Long-term care|long-term care
498004|NCT00182065|Elderly|elderly
498005|NCT00182078|sertraline|sertraline
498006|NCT00182078|children|children
498007|NCT00182078|adolescents|adolescents
498008|NCT00182078|posttraumatic stress disorder|posttraumatic stress disorder
498009|NCT00182078|depression|depression
498010|NCT00182078|prevention|prevention
498011|NCT00182078|burns|burns
498012|NCT00182078|injuries|injuries
498013|NCT00182091|Acromegaly|acromegaly
498014|NCT00182091|Growth Hormone Deficiency|growth hormone deficiency
498015|NCT00182091|Cardiovascular Risk|cardiovascular risk
498016|NCT00182091|Pituitary|pituitary
498017|NCT00182091|Hypothalamic|hypothalamic
498018|NCT00182104|Fontan procedure|fontan procedure
498019|NCT00182104|Anticoagulation|anticoagulation
498020|NCT00182104|Thrombosis|thrombosis
498021|NCT00182104|Thromboembolism|thromboembolism
498022|NCT00182104|Prevention|prevention
498023|NCT00182117|bleeding|bleeding
498024|NCT00182117|end stage renal disease|end stage renal disease
498025|NCT00182117|antiplatelet therapy|antiplatelet therapy
498026|NCT00182117|anticoagulant therapy|anticoagulant therapy
498027|NCT00182117|hemodialysis|hemodialysis
498028|NCT00182130|rectal cancer|rectal cancer
498029|NCT00182130|surgery|surgery
498030|NCT00182130|physician behaviour|physician behaviour
498031|NCT00182130|knowledge translation|knowledge translation
498032|NCT00182143|Critically Ill|critically ill
498033|NCT00182143|Deep Venous ThromboEmbolism|deep venous thromboembolism
498034|NCT00182143|Randomized Controlled Trial|randomized controlled trial
498035|NCT00182156|hemodialysis|hemodialysis
498036|NCT00182156|platelet function analyzer|platelet function analyzer
498037|NCT00182156|bioimpedance|bioimpedance
498038|NCT00182156|pulse wave velocity|pulse wave velocity
498039|NCT00182156|end stage renal disease|end stage renal disease
498040|NCT00182169|Severe heart failure|severe heart failure
498041|NCT00182169|Growth hormone|growth hormone
498042|NCT00182169|exercise capacity|exercise capacity
498043|NCT00182169|quality of life|quality of life
498044|NCT00182169|cardiac function|cardiac function
498045|NCT00182182|Heart Failure|heart failure
498046|NCT00182182|Family physicians|family physicians
498047|NCT00182182|academic detailing|academic detailing
498048|NCT00182182|process of care|process of care
498050|NCT00182208|Post phlebitic Syndrome|post phlebitic syndrome
498051|NCT00182208|Activities of Daily Living|activities of daily living
498052|NCT00182208|Quality of Life|quality of life
498053|NCT00182221|Pulmonary Embolism|pulmonary embolism
498054|NCT00182221|Deep Vein Thrombosis|deep vein thrombosis
498055|NCT00182221|MDA D-Dimer Testing|mda d-dimer testing
498056|NCT00182221|Diagnostic Algorithm|diagnostic algorithm
498057|NCT00182234|unmet supportive care needs|unmet supportive care needs
498058|NCT00182247|deep vein thrombosis|deep vein thrombosis
498060|NCT00182247|pulmonary embolism|pulmonary embolism
498061|NCT00182247|PE|pe
498062|NCT00182247|venous thromboembolism|venous thromboembolism
498063|NCT00182247|VTE|vte
498064|NCT00182247|d-dimer|d-dimer
498065|NCT00182247|IPG|ipg
498066|NCT00182273|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
498067|NCT00182273|Canalith repositioning maneuver|canalith repositioning maneuver
498068|NCT00182273|Dizziness|dizziness
498069|NCT00182273|Primary Care|primary care
498070|NCT00182286|Diabetes|diabetes
498071|NCT00182286|Continuity of Care|continuity of care
498072|NCT00182286|Patient Perspective|patient perspective
498073|NCT00182286|Health Service Organization|health service organization
498074|NCT00182312|preterm infants|preterm infants
497341|NCT00172120|PTH|pth
498075|NCT00182312|very low birthweight|very low birthweight
498076|NCT00182312|apnea of prematurity|apnea of prematurity
498077|NCT00182312|methylxanthines|methylxanthines
498078|NCT00182312|developmental disabilities|developmental disabilities
498079|NCT00182325|medical record|medical record
498080|NCT00182325|pregnancy|pregnancy
498081|NCT00182325|Internet|internet
498082|NCT00182338|cardiovascular outcomes|cardiovascular outcomes
498083|NCT00182338|congestive heart failure|congestive heart failure
498084|NCT00182338|Peritoneal Membrane transport properties|peritoneal membrane transport properties
498085|NCT00182338|Arterial stiffening|arterial stiffening
498086|NCT00182338|Inflammatory markers|inflammatory markers
498087|NCT00182351|deep vein thrombosis|deep vein thrombosis
498088|NCT00182351|d-dimer|d-dimer
498089|NCT00182351|serial compression ultrasound|serial compression ultrasound
498090|NCT00182364|Critically Ill|critically ill
498091|NCT00182364|Deep Venous Thrombosis|deep venous thrombosis
498092|NCT00182364|Randomized Control Trial|randomized control trial
498093|NCT00182364|Pilot Study|pilot study
498094|NCT00182377|patients undergoing cardiac surgery requiring cardiopulmonary bypass|patients undergoing cardiac surgery requiring cardiopulmonary bypass
498095|NCT00182390|ELBW premature infants|elbw premature infants
498096|NCT00182390|neonatal transfusion|neonatal transfusion
498097|NCT00182390|bronchopulmonary dysplasia|bronchopulmonary dysplasia
498098|NCT00182390|periventricular leukomalacia|periventricular leukomalacia
498099|NCT00182390|ventriculomegaly|ventriculomegaly
498100|NCT00182390|retinopathy of prematurity|retinopathy of prematurity
498101|NCT00182403|Unfractionated Heparin|unfractionated heparin
498102|NCT00182403|Low Molecular Weight Heparin|low molecular weight heparin
498103|NCT00182403|Venous Thromboembolism|venous thromboembolism
498104|NCT00182403|APTT|aptt
498105|NCT00182403|Treatment|treatment
498106|NCT00182416|pacemakers|pacemakers
498107|NCT00182416|atrial fibrillation|atrial fibrillation
498108|NCT00182416|stroke|stroke
498109|NCT00182416|cardiovascular death|cardiovascular death
498110|NCT00182429|Antibiotic associated diarrhea|antibiotic associated diarrhea
498111|NCT00182429|C. difficile|c. difficile
498112|NCT00182429|Metronidazole|metronidazole
498113|NCT00182429|Rifampin|rifampin
498114|NCT00182442|Cognitive deficits|cognitive deficits
498115|NCT00182442|Psychosocial functioning|psychosocial functioning
498116|NCT00182442|Quality of Life|quality of life
498117|NCT00182455|Treatment Refractory Generalized Social Phobia|treatment refractory generalized social phobia
498118|NCT00182468|Domestic violence|domestic violence
498119|NCT00182468|Spouse Abuse|spouse abuse
498120|NCT00182481|asthma treatment|asthma treatment
498121|NCT00182481|induced sputum cell counts|induced sputum cell counts
498122|NCT00182481|asthma exacerbations|asthma exacerbations
498123|NCT00182481|eosinophilic bronchitis|eosinophilic bronchitis
498124|NCT00182481|non-eosinophilic bronchitis|non-eosinophilic bronchitis
498125|NCT00182494|Schizophrenia, Diabetes, Weight gain, Antipsychotic drugs|schizophrenia, diabetes, weight gain, antipsychotic drugs
498126|NCT00182520|Treatment Refractory Obsessive Compulsive Disorder|treatment refractory obsessive compulsive disorder
498127|NCT00182533|Generalized social phobia|generalized social phobia
498128|NCT00182533|Comorbid panic disorder with agoraphobia|comorbid panic disorder with agoraphobia
498129|NCT00182533|Comorbid obsessive compulsive disorder|comorbid obsessive compulsive disorder
498130|NCT00182533|Comorbid generalized anxiety disorder|comorbid generalized anxiety disorder
498131|NCT00182533|Comorbid major depressive disorder/Dysthymia|comorbid major depressive disorder/dysthymia
498132|NCT00182546|Pulmonary Embolism|pulmonary embolism
498133|NCT00182546|DVT|dvt
498134|NCT00182546|Venous Thrombosis|venous thrombosis
498135|NCT00182546|D dimer|d dimer
498136|NCT00182546|DD|dd
498137|NCT00182546|Thrombosis|thrombosis
498138|NCT00182546|Diagnosis|diagnosis
498139|NCT00182559|kidney|kidney
498140|NCT00182559|transplantation|transplantation
498141|NCT00182559|tacrolimus|tacrolimus
498142|NCT00182559|cyclosporine|cyclosporine
498143|NCT00182559|conversion|conversion
498144|NCT00182572|heroin|heroin
498145|NCT00182572|opiate|opiate
498146|NCT00182572|addiction|addiction
498147|NCT00182572|adolescent|adolescent
498148|NCT00182572|treatment|treatment
498149|NCT00182585|HIV|hiv
498150|NCT00182585|hepatitis|hepatitis
498151|NCT00182585|STDs|stds
498152|NCT00182585|adolescents|adolescents
498153|NCT00182585|addiction|addiction
498154|NCT00182585|treatment|treatment
498155|NCT00182585|prevention|prevention
498156|NCT00182585|HIV and related risk behavior among youth in drug treatment|hiv and related risk behavior among youth in drug treatment
498157|NCT00182598|buprenorphine|buprenorphine
498158|NCT00182598|computer|computer
498159|NCT00182598|treatment|treatment
498160|NCT00182598|opioid|opioid
498161|NCT00182598|heroin|heroin
498162|NCT00182611|stage III gastric cancer|stage iii gastric cancer
498163|NCT00182611|adenocarcinoma of the stomach|adenocarcinoma of the stomach
498164|NCT00182624|Prostate Cancer|prostate cancer
498165|NCT00182624|Magnetic Resonance Imaging|magnetic resonance imaging
498166|NCT00182624|Spectroscopy|spectroscopy
498167|NCT00182637|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
498168|NCT00182637|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
498169|NCT00182637|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
498170|NCT00182637|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
498171|NCT00182637|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
498172|NCT00182637|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
498173|NCT00182637|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
498174|NCT00182637|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
498175|NCT00182637|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
498176|NCT00182637|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
498177|NCT00182650|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
498178|NCT00182650|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
498179|NCT00182650|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
498180|NCT00182715|adenocarcinoma of the colon|adenocarcinoma of the colon
498181|NCT00182715|stage IV colon cancer|stage iv colon cancer
498182|NCT00182715|adenocarcinoma of the rectum|adenocarcinoma of the rectum
498183|NCT00182715|stage IV rectal cancer|stage iv rectal cancer
498184|NCT00182728|invasive ductal breast carcinoma|invasive ductal breast carcinoma
498185|NCT00182728|stage I breast cancer|stage i breast cancer
498186|NCT00182728|stage II breast cancer|stage ii breast cancer
498187|NCT00182741|recurrent prostate cancer|recurrent prostate cancer
498188|NCT00182741|stage IV prostate cancer|stage iv prostate cancer
498189|NCT00182754|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
498190|NCT00182754|malignant ascites|malignant ascites
498191|NCT00182780|fatigue|fatigue
498192|NCT00182780|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
498193|NCT00182793|stage IIIB breast cancer|stage iiib breast cancer
498477|NCT00171171|Deferasirox|deferasirox
498194|NCT00182793|stage IIIC breast cancer|stage iiic breast cancer
498195|NCT00182793|stage IV breast cancer|stage iv breast cancer
498196|NCT00182793|inflammatory breast cancer|inflammatory breast cancer
498197|NCT00182793|male breast cancer|male breast cancer
498198|NCT00182793|recurrent breast cancer|recurrent breast cancer
498199|NCT00182793|invasive ductal breast carcinoma with predominant intraductal component|invasive ductal breast carcinoma with predominant intraductal component
498200|NCT00182793|invasive ductal breast carcinoma|invasive ductal breast carcinoma
498201|NCT00182793|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
498202|NCT00182793|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
498203|NCT00182793|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
498204|NCT00182793|papillary ductal breast carcinoma|papillary ductal breast carcinoma
498205|NCT00182793|tubular ductal breast carcinoma|tubular ductal breast carcinoma
498206|NCT00182793|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
498207|NCT00182793|invasive lobular breast carcinoma|invasive lobular breast carcinoma
498208|NCT00182793|comedo ductal breast carcinoma|comedo ductal breast carcinoma
498209|NCT00182806|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
498210|NCT00182806|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
498211|NCT00182806|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
498212|NCT00182806|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
498213|NCT00182819|adult oligodendroglioma|adult oligodendroglioma
498214|NCT00182819|adult diffuse astrocytoma|adult diffuse astrocytoma
498215|NCT00182819|adult mixed glioma|adult mixed glioma
498216|NCT00182832|Physician Behavior|physician behavior
498217|NCT00182832|Hospital Acquired Complications|hospital acquired complications
498219|NCT00182832|Mild Cognitive Impairment|mild cognitive impairment
498221|NCT00182845|MCI|mci
498222|NCT00182845|Aricept|aricept
498223|NCT00182845|Adverse Effects|adverse effects
498224|NCT00182845|Hospital Acquired Complications|hospital acquired complications
498225|NCT00182845|Cognitive Impairment|cognitive impairment
498226|NCT00182845|Aging|aging
498227|NCT00182858|Tissue|tissue
498228|NCT00182858|Procurement|procurement
498229|NCT00182858|Exploratory Methods|exploratory methods
498230|NCT00182858|Disease Correlation|disease correlation
498231|NCT00182858|Sampling|sampling
498232|NCT00182871|geriatric medicine|geriatric medicine
498233|NCT00182871|hormone therapy|hormone therapy
498234|NCT00182871|HT|ht
498235|NCT00182871|andropause|andropause
498236|NCT00182884|Hospital acquired complications|hospital acquired complications
498237|NCT00182884|adverse effects|adverse effects
498238|NCT00182884|Cognitive Impairment|cognitive impairment
498239|NCT00182884|Aging|aging
498240|NCT00182897|caregiver|caregiver
498241|NCT00182897|home health care|home health care
498242|NCT00182897|coping|coping
498243|NCT00182923|Blood pressure|blood pressure
498244|NCT00182923|genetics|genetics
498245|NCT00182936|Cognition disorder|cognition disorder
498246|NCT00182936|organic brain syndrome|organic brain syndrome
498247|NCT00182936|patient care management|patient care management
498248|NCT00182936|long term care|long term care
498249|NCT00182936|extended care facility|extended care facility
498250|NCT00182949|Epidemiology|epidemiology
498251|NCT00182949|Genetics|genetics
498252|NCT00182949|Aging|aging
498253|NCT00182949|Sardinian Population|sardinian population
498254|NCT00182949|Cardiovascular Diseases|cardiovascular diseases
498255|NCT00182949|Personality Traits|personality traits
498256|NCT00182949|Frailty|frailty
498257|NCT00182962|Activities of Daily Living|activities of daily living
498258|NCT00182962|Low-income|low-income
498259|NCT00182962|geriatric medicine|geriatric medicine
498260|NCT00182962|computer assisted patient care|computer assisted patient care
498261|NCT00182975|Metabolic syndrome|metabolic syndrome
498262|NCT00182988|communication behavior|communication behavior
498263|NCT00182988|coping|coping
498264|NCT00182988|functional ability|functional ability
498265|NCT00182988|quality of life|quality of life
498266|NCT00182988|caregiving|caregiving
498267|NCT00183001|nutritional supplement|nutritional supplement
498268|NCT00183001|dietary supplement|dietary supplement
498269|NCT00183001|vitamin therapy|vitamin therapy
498270|NCT00183001|Vitamin K deficiency|vitamin k deficiency
498271|NCT00183001|bone density|bone density
498272|NCT00183014|behavior therapy|behavior therapy
498273|NCT00183014|exercise|exercise
498274|NCT00183014|gait|gait
498275|NCT00183014|physical activity|physical activity
498276|NCT00183027|Dietary restriction|dietary restriction
498277|NCT00183027|Caloric restriction|caloric restriction
498278|NCT00183040|andropause|andropause
498279|NCT00183040|hormone therapy|hormone therapy
498280|NCT00183040|HRT|hrt
498281|NCT00183053|Hospitalization|hospitalization
498282|NCT00183053|Fall Risk|fall risk
498283|NCT00183053|Frailty|frailty
498284|NCT00183079|Depression|depression
498285|NCT00183079|Alcohol Use|alcohol use
498286|NCT00183079|Motivational Interviewing|motivational interviewing
498287|NCT00183092|dementia|dementia
498679|NCT00183690|Adolescents|adolescents
498288|NCT00183092|spongiform encephalopathy|spongiform encephalopathy
498289|NCT00183092|nervous system disorder|nervous system disorder
498290|NCT00183092|acridine|acridine
498291|NCT00183092|prion|prion
498292|NCT00183092|neuropharmacologic agent|neuropharmacologic agent
498293|NCT00183105|Alcohol|alcohol
498294|NCT00183105|Alcohol abuse|alcohol abuse
498295|NCT00183105|Alcohol dependence|alcohol dependence
498296|NCT00183105|Utilization|utilization
498297|NCT00183105|Alcohol consumption|alcohol consumption
498298|NCT00183105|Unhealthy alcohol use|unhealthy alcohol use
498299|NCT00183105|Hospitalization|hospitalization
498300|NCT00183105|Screening|screening
498301|NCT00183105|Brief Intervention|brief intervention
498302|NCT00183105|Motivational Interviewing|motivational interviewing
498303|NCT00183105|Randomized trial|randomized trial
498304|NCT00183105|Effectiveness|effectiveness
498425|NCT00171015|VALSARTAN|valsartan
498426|NCT00171015|HYDROCHLOROTHIAZIDE|hydrochlorothiazide
498305|NCT00183105|Unhealthy alcohol use (Risky alcohol consumption amounts, problem alcohol use, hazardous alcohol use, alcohol abuse and alcohol dependence)|unhealthy alcohol use (risky alcohol consumption amounts, problem alcohol use, hazardous alcohol use, alcohol abuse and alcohol dependence)
498306|NCT00183118|HIV|hiv
498307|NCT00183118|Russia|russia
498308|NCT00183118|Prevention|prevention
498309|NCT00183118|Behavioral intervention|behavioral intervention
498310|NCT00183118|Alcohol dependence|alcohol dependence
498311|NCT00183131|Alcohol|alcohol
498312|NCT00183131|Alcohol abuse|alcohol abuse
498313|NCT00183131|Alcohol dependence|alcohol dependence
498218|NCT00182832|MCI|mci
498315|NCT00183131|Unhealthy alcohol use|unhealthy alcohol use
498316|NCT00183131|Screening|screening
498317|NCT00183131|Brief Intervention|brief intervention
498318|NCT00183131|Effectiveness|effectiveness
498319|NCT00183131|Electronic intervention|electronic intervention
498320|NCT00183131|Web-based intervention|web-based intervention
498321|NCT00183131|College students|college students
498322|NCT00183144|contingency management|contingency management
498323|NCT00183144|reinforcement|reinforcement
498324|NCT00183144|employment|employment
498325|NCT00183144|Therapeutic Workplace|therapeutic workplace
498326|NCT00183157|High risk drinking|high risk drinking
498327|NCT00183157|Alcohol dependence|alcohol dependence
498328|NCT00183157|Alcohol related injury|alcohol related injury
498329|NCT00183170|Alcohol abuse|alcohol abuse
498330|NCT00183170|Alcoholic beverages (beer)|alcoholic beverages (beer)
498331|NCT00183170|Residual effects|residual effects
498332|NCT00183170|Psychomotor performance|psychomotor performance
498333|NCT00183170|Psychomotor vigilance test|psychomotor vigilance test
498334|NCT00183170|Neurobehavioral Evaluation System|neurobehavioral evaluation system
498335|NCT00183170|Family history of alcohol use|family history of alcohol use
498336|NCT00183170|Alcoholic Consumption|alcoholic consumption
498337|NCT00183170|Unhealthy alcohol use|unhealthy alcohol use
498338|NCT00183170|Alcohol|alcohol
498339|NCT00183183|Alcohol Abuse|alcohol abuse
498340|NCT00183183|Harm Reduction|harm reduction
498341|NCT00183183|Motivational Interviewing|motivational interviewing
498342|NCT00183183|Emergency Department|emergency department
498343|NCT00183183|Risky Drinking|risky drinking
498344|NCT00183183|Prevention|prevention
498345|NCT00183196|Alcohol dependence|alcohol dependence
498346|NCT00183196|Alcoholism|alcoholism
498347|NCT00183196|Heavy drinking|heavy drinking
498348|NCT00183209|Substance use disorders|substance use disorders
498349|NCT00183209|Parent child relationship|parent child relationship
498350|NCT00183222|Alcohol dependence|alcohol dependence
498351|NCT00183222|Alcoholism|alcoholism
498352|NCT00183222|Craving|craving
498353|NCT00183235|Alcohol dependence|alcohol dependence
498354|NCT00183235|Alcoholism|alcoholism
498355|NCT00183235|Craving|craving
498356|NCT00183248|kidney|kidney
498357|NCT00183248|kidney transplant|kidney transplant
498358|NCT00183248|kidney transplantation|kidney transplantation
498359|NCT00183248|transplant|transplant
498360|NCT00183248|transplantation|transplantation
498361|NCT00183248|renal|renal
498362|NCT00183248|renal transplant|renal transplant
498363|NCT00183248|renal transplantation|renal transplantation
498364|NCT00183248|kidney disease|kidney disease
498365|NCT00183248|chronic|chronic
498366|NCT00183248|renal failure|renal failure
498367|NCT00183248|kidney failure|kidney failure
498368|NCT00183261|Treatment Interruption|treatment interruption
498369|NCT00183261|HIV Therapeutic Vaccine|hiv therapeutic vaccine
498370|NCT00183261|Acute Infection|acute infection
498371|NCT00183261|Acute Retroviral Syndrome|acute retroviral syndrome
498372|NCT00183274|Generalized Anxiety Disorder|generalized anxiety disorder
498373|NCT00183274|Chronic Mediation Treatment|chronic mediation treatment
498374|NCT00183274|Double-Blind|double-blind
498375|NCT00183274|Placebo Controlled|placebo controlled
498376|NCT00183274|Venlafaxine XR|venlafaxine xr
498377|NCT00183274|Relapse|relapse
498378|NCT00183300|Post-traumatic stress disorder|post-traumatic stress disorder
498379|NCT00183300|PTSD|ptsd
498380|NCT00183300|Prolonged Exposure|prolonged exposure
498381|NCT00183300|Cognitive-Behavior Therapy|cognitive-behavior therapy
498382|NCT00183313|Mental Health|mental health
498383|NCT00183313|Primary health care|primary health care
498384|NCT00183313|Case management|case management
498385|NCT00183326|Posttraumatic Stress Disorder|posttraumatic stress disorder
498386|NCT00183326|Domestic Violence|domestic violence
498387|NCT00183326|Children|children
498388|NCT00183326|Cognitive Behavioral Therapy|cognitive behavioral therapy
498389|NCT00183326|CBT|cbt
498390|NCT00170833|Renal/Kidney, transplantation, everolimus, calcineurin sparing|renal/kidney, transplantation, everolimus, calcineurin sparing
498391|NCT00170846|Renal transplantation, everolimus, calcineurin inhibitors, GFR|renal transplantation, everolimus, calcineurin inhibitors, gfr
498392|NCT00170859|everolimus|everolimus
498393|NCT00170859|cyclosporine microemulsion|cyclosporine microemulsion
498394|NCT00170859|renal function|renal function
498395|NCT00170872|Osteoarthritis|osteoarthritis
498396|NCT00170872|Rheumatoid Arthritis|rheumatoid arthritis
498397|NCT00170872|Cox-2|cox-2
498398|NCT00170872|lumiracoxib|lumiracoxib
498399|NCT00170885|acute rejection|acute rejection
498400|NCT00170885|renal function|renal function
498401|NCT00170885|everolimus|everolimus
498402|NCT00170885|cyclosporine microemulsion|cyclosporine microemulsion
498403|NCT00170898|Musculoskeletal pain|musculoskeletal pain
498404|NCT00170898|cyclooxygenase-2 inhibitors|cyclooxygenase-2 inhibitors
498405|NCT00170898|lumiracoxib|lumiracoxib
498406|NCT00170898|naproxen|naproxen
498407|NCT00170911|Osteoporosis|osteoporosis
498408|NCT00170911|Postmenopausal women|postmenopausal women
498409|NCT00170911|Cathepsin K inhibitor|cathepsin k inhibitor
498410|NCT00170924|Hypertension, High Blood Pressure, Diastolic Dysfunction,|hypertension, high blood pressure, diastolic dysfunction,
498411|NCT00170924|Heart Disease|heart disease
498412|NCT00170937|METABOLIC SYNDROME, VALSARTAN, HYDROCHLOROTHIAZIDE, HYPERTENSION,|metabolic syndrome, valsartan, hydrochlorothiazide, hypertension,
498413|NCT00170950|cardiovascular morbidity|cardiovascular morbidity
498414|NCT00170950|cardiovascular mortality|cardiovascular mortality
498415|NCT00170950|benazepril|benazepril
498416|NCT00170950|amlodipine|amlodipine
498417|NCT00170950|high risk population|high risk population
498418|NCT00170963|Hypertension, high blood pressure, valsartan, amlodipine|hypertension, high blood pressure, valsartan, amlodipine
498419|NCT00170976|HYPERTENSION, VALSARTAN, AMLODIPINE< SAFETY|hypertension, valsartan, amlodipine< safety
498420|NCT00170989|hypertension|hypertension
498421|NCT00170989|high blood pressure|high blood pressure
498422|NCT00170989|valsartan|valsartan
498423|NCT00170989|hydrochlorothiazide|hydrochlorothiazide
498424|NCT00171002|Hypertension, high blood pressure, valsartan, amlodipine|hypertension, high blood pressure, valsartan, amlodipine
498427|NCT00171015|OLMESARTAN|olmesartan
498428|NCT00171015|HYPERTENSION|hypertension
498429|NCT00171028|PEDIATRIC HYPERTENSION|pediatric hypertension
498430|NCT00171028|PEDIATRIC|pediatric
498431|NCT00171028|VALSARTAN|valsartan
498432|NCT00171041|PEDIATRIC HYPERTENSION|pediatric hypertension
498433|NCT00171041|PEDIATRIC|pediatric
498434|NCT00171041|VALSARTAN|valsartan
497745|NCT00180674|Coumarin|coumarin
498435|NCT00171054|hypertension|hypertension
498436|NCT00171054|postmenopausal|postmenopausal
498437|NCT00171054|valsartan|valsartan
498438|NCT00171054|amlodipine|amlodipine
498439|NCT00171054|hydrochlorothiazide|hydrochlorothiazide
498440|NCT00171067|Microalbuminuria, urinary albumin excretion, urinary albumin creatinine ratio, hypertension, valsartan, lisinopril, combination|microalbuminuria, urinary albumin excretion, urinary albumin creatinine ratio, hypertension, valsartan, lisinopril, combination
498441|NCT00171080|Hypertension|hypertension
498442|NCT00171080|Valsartan|valsartan
498443|NCT00171080|Dialysis|dialysis
498444|NCT00171080|Renal Disease|renal disease
498445|NCT00171093|HYPERTENSION|hypertension
498446|NCT00171093|HYPERCHOLESTEROLEMIA|hypercholesterolemia
498447|NCT00171093|BLOOD PRESSURE|blood pressure
498448|NCT00171093|CHOLESTEROL|cholesterol
498449|NCT00171093|VALSARTAN|valsartan
498450|NCT00171093|SIMVASTATIN|simvastatin
498451|NCT00171106|diastolic dysfunction|diastolic dysfunction
498452|NCT00171106|heart failure|heart failure
498453|NCT00171106|exercise tolerance|exercise tolerance
498454|NCT00171106|valsartan|valsartan
498455|NCT00171119|HYPERTENSION|hypertension
498456|NCT00171119|DIABETES MELLITUS TYPE II|diabetes mellitus type ii
498457|NCT00171119|VALSARTAN|valsartan
498458|NCT00171119|BENAZAPRIL|benazapril
498459|NCT00171132|Postmenopausal|postmenopausal
498461|NCT00171132|overweight|overweight
498462|NCT00171132|hypertension|hypertension
498463|NCT00171132|impaired|impaired
498464|NCT00171132|exercise|exercise
498465|NCT00171132|capacity|capacity
498466|NCT00171132|valsartan|valsartan
498467|NCT00171132|atenolol|atenolol
498468|NCT00171132|hydrochlorothiazide|hydrochlorothiazide
498469|NCT00171145|Overactive Bladder, incontinence, antimuscarinic, warning time, darifenacin|overactive bladder, incontinence, antimuscarinic, warning time, darifenacin
498470|NCT00171158|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
498472|NCT00171158|Philadelphia Chromosome|philadelphia chromosome
498473|NCT00171158|Blast crisis|blast crisis
498474|NCT00171158|Imatinib mesylate|imatinib mesylate
498475|NCT00171171|Thalassemia (beta-thal. major)|thalassemia (beta-thal. major)
498476|NCT00171171|Transfusional hemosiderosis|transfusional hemosiderosis
498478|NCT00171171|Beta-thalassemia major patients|beta-thalassemia major patients
498479|NCT00171171|Unable to be chelated with deferoxamine or deferiprone|unable to be chelated with deferoxamine or deferiprone
498480|NCT00171184|Overactive bladder, Darifenacin, M3 muscarinic receptor antagonist, elderly population|overactive bladder, darifenacin, m3 muscarinic receptor antagonist, elderly population
498481|NCT00171210|β-thalassemia|β-thalassemia
498482|NCT00171210|iron overload|iron overload
498483|NCT00171210|deferasirox|deferasirox
498484|NCT00171223|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
498486|NCT00171223|Philadelphia Chromosome|philadelphia chromosome
498487|NCT00171223|Accelerated phase|accelerated phase
498488|NCT00171223|Acute Myelogenous Leukemia|acute myelogenous leukemia
498489|NCT00171223|AML|aml
498490|NCT00171223|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
498491|NCT00171223|ALL|all
498492|NCT00171223|Imatinib mesylate|imatinib mesylate
498493|NCT00171236|Heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
498494|NCT00171236|mixed dyslipidemia|mixed dyslipidemia
498495|NCT00171249|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
498496|NCT00171249|CML|cml
498497|NCT00171249|Philadelphia Chromosome|philadelphia chromosome
498498|NCT00171249|Accelerated phase|accelerated phase
498499|NCT00171249|Acute Myelogenous Leukemia|acute myelogenous leukemia
498500|NCT00171249|AML|aml
498501|NCT00171249|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
498502|NCT00171249|ALL|all
498603|NCT00183417|Adolescent|adolescent
498503|NCT00171249|Imatinib mesylate|imatinib mesylate
498504|NCT00171262|Dyslipidemia, chronic renal disease, fluvastatin|dyslipidemia, chronic renal disease, fluvastatin
498505|NCT00171275|Coronary disease|coronary disease
498506|NCT00171275|Myocardial infarction|myocardial infarction
498507|NCT00171275|Statins|statins
498508|NCT00171288|Dyslipidemia, ezetimibe, inflammatory markers, fluvastatin|dyslipidemia, ezetimibe, inflammatory markers, fluvastatin
498509|NCT00171301|Transfusional hemosiderosis|transfusional hemosiderosis
498510|NCT00171301|Beta-thalassemia major|beta-thalassemia major
498511|NCT00171301|Deferasirox|deferasirox
498512|NCT00171301|iron overload|iron overload
498513|NCT00171301|rare anemia|rare anemia
498514|NCT00171301|iron overload due to transfusion|iron overload due to transfusion
498515|NCT00171314|breast cancer|breast cancer
498516|NCT00171314|letrozole|letrozole
498517|NCT00171314|zoledronic acid|zoledronic acid
498518|NCT00171314|adjuvant|adjuvant
498519|NCT00171314|postmenopausal|postmenopausal
498520|NCT00171327|arterial hypertension|arterial hypertension
498521|NCT00171327|dyslipidemia|dyslipidemia
498522|NCT00171327|valsartan|valsartan
498523|NCT00171327|fluvastatin|fluvastatin
498524|NCT00171340|Bone Loss|bone loss
498525|NCT00171340|Osteopenia|osteopenia
498526|NCT00171340|Breast cancer|breast cancer
498527|NCT00171340|letrozole|letrozole
498528|NCT00171340|zoledronic acid|zoledronic acid
498529|NCT00171340|postmenopausal|postmenopausal
498530|NCT00171353|arterial hypertension|arterial hypertension
498531|NCT00171353|albuminuria|albuminuria
498532|NCT00171353|valsartan|valsartan
498533|NCT00176657|cardiac surgery|cardiac surgery
498534|NCT00176657|transfusion|transfusion
498535|NCT00176670|presurgical anxiety, children,|presurgical anxiety, children,
498536|NCT00176683|intubation|intubation
498537|NCT00176683|capnography|capnography
498538|NCT00176696|general anesthesia|general anesthesia
498539|NCT00176696|pain|pain
498540|NCT00176696|depth of anesthesia|depth of anesthesia
498541|NCT00176722|Spine Surgery|spine surgery
498542|NCT00176722|Intraocular Pressure|intraocular pressure
498543|NCT00176722|lumbar or thoracic Spine Surgery in the prone position|lumbar or thoracic spine surgery in the prone position
498544|NCT00176722|and its association with visual change|and its association with visual change
498545|NCT00176826|Stem Cell Transplant|stem cell transplant
498546|NCT00176826|T-cell depletion|t-cell depletion
498547|NCT00176826|immune deficiencies|immune deficiencies
498548|NCT00176826|Busulfan pharmacokinetics|busulfan pharmacokinetics
498549|NCT00176826|Non-Malignant Hematological Disorders|non-malignant hematological disorders
498550|NCT00176839|Stem Cell transplant|stem cell transplant
498551|NCT00176839|retransplant|retransplant
498552|NCT00176839|hematological malignancies|hematological malignancies
498553|NCT00176852|high risk hemoglobinopathy|high risk hemoglobinopathy
498554|NCT00176852|stem cell transplant|stem cell transplant
498555|NCT00176852|donor lymphocyte infusion|donor lymphocyte infusion
498556|NCT00176852|transfusion dependent|transfusion dependent
498557|NCT00176852|stem cell donor|stem cell donor
498558|NCT00176852|cord blood|cord blood
498560|NCT00176852|transfusion dependent non-malignant hematologic disorders|transfusion dependent non-malignant hematologic disorders
498561|NCT00176865|Stem cell transplant|stem cell transplant
498562|NCT00176865|immunodeficiency|immunodeficiency
498563|NCT00176865|donor lymphocyte infusion|donor lymphocyte infusion
498564|NCT00176878|Stem cell transplant|stem cell transplant
498565|NCT00176878|T-cell depletion|t-cell depletion
498566|NCT00176878|TLI|tli
498567|NCT00176878|bone marrow failure disorders|bone marrow failure disorders
498568|NCT00176891|Laronidase ERT|laronidase ert
498569|NCT00176891|Stem cell transplant|stem cell transplant
498570|NCT00176891|storage disease|storage disease
498571|NCT00176891|inborn errors of metabolism|inborn errors of metabolism
498572|NCT00176891|hurler syndrome|hurler syndrome
498573|NCT00176891|glycosaminoglycans|glycosaminoglycans
498574|NCT00176891|enzyme replacement|enzyme replacement
498575|NCT00176904|Inborn errors|inborn errors
498576|NCT00176904|Storage disease|storage disease
498577|NCT00176904|errors of metabolism|errors of metabolism
498578|NCT00176904|stem cell transplant|stem cell transplant
498579|NCT00176917|stem cell transplant|stem cell transplant
498580|NCT00176917|storage disease|storage disease
498581|NCT00176917|errors of metabolism|errors of metabolism
498582|NCT00183339|Autism|autism
498583|NCT00183352|Women|women
498584|NCT00183352|Mood|mood
498585|NCT00183352|Menarche|menarche
498586|NCT00183352|Menstruation|menstruation
498587|NCT00183365|Family|family
498588|NCT00183365|Parenting|parenting
498589|NCT00183365|Depression|depression
498590|NCT00183365|Group Intervention|group intervention
498591|NCT00183378|Alzheimer's Disease|alzheimer's disease
498592|NCT00183378|Insomnia|insomnia
498593|NCT00183378|Sleep Problems|sleep problems
498594|NCT00183378|Elderly|elderly
498595|NCT00183378|Caregivers|caregivers
498596|NCT00183391|ADHD|adhd
498597|NCT00183391|Child|child
498598|NCT00183391|Adolescent|adolescent
498599|NCT00183391|School|school
498600|NCT00183404|Drug Treatment|drug treatment
498601|NCT00183404|Child|child
498604|NCT00183417|CBT|cbt
498605|NCT00183430|Prazosin|prazosin
498606|NCT00183430|Sleep Disorders|sleep disorders
498607|NCT00183443|Mania|mania
498608|NCT00183443|Manic-depressive|manic-depressive
498609|NCT00183443|Psychotic disorder|psychotic disorder
498610|NCT00183456|Sex Education|sex education
498611|NCT00183456|Peer Group|peer group
498612|NCT00183456|Social Identity Theory|social identity theory
498613|NCT00183456|HIV Seronegativity|hiv seronegativity
498614|NCT00183456|Intervention|intervention
498615|NCT00183456|women|women
498616|NCT00183456|Social Networks|social networks
498617|NCT00183456|Peer Education|peer education
498618|NCT00183469|Lamotrigine|lamotrigine
498619|NCT00183469|Divalproex|divalproex
498620|NCT00183469|Antidepressant|antidepressant
498621|NCT00183482|Parents|parents
498622|NCT00183482|Child|child
498623|NCT00183482|Stress|stress
498624|NCT00183482|CBT|cbt
498625|NCT00183495|Depression, Bipolar|depression, bipolar
498626|NCT00183495|Manic-Depressive Psychosis|manic-depressive psychosis
498627|NCT00183508|PTSD|ptsd
498628|NCT00183508|Occupational Health|occupational health
498629|NCT00183508|Trauma|trauma
498630|NCT00183508|Job|job
498631|NCT00183508|CBT|cbt
498632|NCT00183521|Hyperventilation|hyperventilation
754052|NCT01178736|neoplasms|neoplasms
497949|NCT00181857|children|children
498633|NCT00183521|Breathing Exercises|breathing exercises
498634|NCT00183521|Carbon Dioxide|carbon dioxide
498635|NCT00183521|Panic Attack|panic attack
498636|NCT00183547|Postpartum Depression|postpartum depression
498637|NCT00183547|Postpartum Period|postpartum period
498638|NCT00183547|Indians, North American|indians, north american
498639|NCT00183547|Adolescent|adolescent
498640|NCT00183547|Female|female
498641|NCT00183547|CBT|cbt
498642|NCT00183560|Depression Recurrence|depression recurrence
498643|NCT00183560|Drug Therapy|drug therapy
498644|NCT00183560|Cognitive Therapy|cognitive therapy
498645|NCT00183560|Relapse|relapse
498646|NCT00183560|Antidepressants|antidepressants
498647|NCT00183573|STDs|stds
498648|NCT00183573|Sexual Behavior|sexual behavior
498649|NCT00183573|Health Behavior|health behavior
498650|NCT00183573|HIV Seronegativity|hiv seronegativity
498651|NCT00183586|Treatment outcomes study|treatment outcomes study
498652|NCT00183586|Anorexia|anorexia
498653|NCT00183586|Anorexia nervosa|anorexia nervosa
498654|NCT00183599|Brief interventions|brief interventions
498655|NCT00183599|Motivational Enhancement Therapy|motivational enhancement therapy
498656|NCT00183599|Cognitive Behavioral Therapy|cognitive behavioral therapy
498657|NCT00183612|Child|child
498658|NCT00183612|Adolescent|adolescent
498659|NCT00183612|Mental Health|mental health
498660|NCT00183612|Olanzapine|olanzapine
498661|NCT00183612|Pharmacokinetics|pharmacokinetics
498662|NCT00183612|Pharmacology|pharmacology
498663|NCT00183625|Antipsychotic Agents|antipsychotic agents
498664|NCT00183625|Employment|employment
498665|NCT00183638|Internet|internet
498666|NCT00183638|Interactive Computer Program|interactive computer program
498667|NCT00183638|HIV Prevention|hiv prevention
498668|NCT00183651|Suicide|suicide
498669|NCT00183651|Women|women
498670|NCT00183651|Emotions|emotions
498671|NCT00183651|Psychotherapy, Group|psychotherapy, group
498672|NCT00183677|Brain Bioenergetic Metabolism|brain bioenergetic metabolism
498673|NCT00183677|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
498674|NCT00183677|Major Depressive Disorder|major depressive disorder
498675|NCT00183677|Treatment Response|treatment response
498676|NCT00183690|PTSD|ptsd
498677|NCT00183690|Anxiety Disorder|anxiety disorder
498678|NCT00183690|Trauma|trauma
498680|NCT00183690|Cognitive Behavioral Therapy|cognitive behavioral therapy
498681|NCT00188812|dementia|dementia
498682|NCT00188812|stroke|stroke
498683|NCT00188825|Lung|lung
498684|NCT00188825|Transplant|transplant
498685|NCT00188825|Rejection|rejection
498686|NCT00188825|BOS|bos
498687|NCT00188838|Bipolar Disorder|bipolar disorder
498688|NCT00188838|Psychosocial Factors|psychosocial factors
498689|NCT00188838|Mania|mania
498690|NCT00188838|Depression|depression
498691|NCT00188838|Social Adjustment|social adjustment
498692|NCT00188838|Coping Skills|coping skills
498693|NCT00188851|HIV|hiv
498694|NCT00188851|salvage regimen|salvage regimen
498695|NCT00188851|virologic failure|virologic failure
498696|NCT00188851|treatment interruption|treatment interruption
498697|NCT00188851|ARV experienced|arv experienced
498698|NCT00188890|Lung Cancer|lung cancer
498699|NCT00188890|Mesothelioma|mesothelioma
498700|NCT00188890|Asbestos|asbestos
498701|NCT00188890|Screening|screening
498702|NCT00188890|Early Diagnosis|early diagnosis
498703|NCT00188903|Cardiac Surgery|cardiac surgery
498704|NCT00188903|Diastolic Dysfunction|diastolic dysfunction
498705|NCT00188903|Atrial Fibrillation|atrial fibrillation
498706|NCT00188916|Bronchial blockers|bronchial blockers
498707|NCT00188916|Lung isolation|lung isolation
498708|NCT00188916|Thoracic Anesthesia|thoracic anesthesia
498709|NCT00188942|Magnetic Resonance Imaging|magnetic resonance imaging
498710|NCT00188942|Diagnostic Imaging|diagnostic imaging
498712|NCT00188942|Major Depressive Disorder|major depressive disorder
498713|NCT00188942|Antipsychotic|antipsychotic
498714|NCT00188942|Olanzapine|olanzapine
498715|NCT00188942|Fluoxetine|fluoxetine
498716|NCT00188955|pediatric|pediatric
498717|NCT00188955|chronic allograft nephropathy|chronic allograft nephropathy
498718|NCT00188955|chronic rejection|chronic rejection
498719|NCT00188955|interstitial fibrosis|interstitial fibrosis
498720|NCT00188968|Xanthines|xanthines
498721|NCT00188968|Reintubation|reintubation
498722|NCT00188968|Nasal Intermittent Ventilation|nasal intermittent ventilation
498723|NCT00188968|Nasal continous positive airway pressure|nasal continous positive airway pressure
498724|NCT00188981|psychosis|psychosis
498725|NCT00188981|high risk|high risk
498726|NCT00188981|prodrome|prodrome
498727|NCT00188981|Multiple Complex Developmental Disorder|multiple complex developmental disorder
498728|NCT00188994|Myocardial Protection|myocardial protection
498729|NCT00188994|Myocardial Metabolism|myocardial metabolism
498730|NCT00188994|Ventricular Function|ventricular function
498731|NCT00188994|Cardiovascular Disease|cardiovascular disease
498732|NCT00188994|Cardioplegic Additives|cardioplegic additives
498733|NCT00189007|allopurinol|allopurinol
498734|NCT00189007|neuroprotection|neuroprotection
498735|NCT00189007|reperfusion injury|reperfusion injury
498736|NCT00189007|fetal hypoxia|fetal hypoxia
498737|NCT00189007|post hypoxic-ischemic reperfusion damage|post hypoxic-ischemic reperfusion damage
498738|NCT00189020|pneumococcal conjugate vaccination|pneumococcal conjugate vaccination
498739|NCT00189020|nasopharyngeal carriage|nasopharyngeal carriage
498740|NCT00189020|herd immunity|herd immunity
498741|NCT00189020|antipneumococcal antibodies|antipneumococcal antibodies
498742|NCT00189020|respiratory tract infections|respiratory tract infections
498743|NCT00189020|National infant vaccination program|national infant vaccination program
498744|NCT00189033|Irritable Bowel Syndrome|irritable bowel syndrome
498745|NCT00189033|Diet Therapy|diet therapy
498746|NCT00189033|Dietary Fiber|dietary fiber
498747|NCT00189033|Randomized Controlled Trial|randomized controlled trial
498748|NCT00189033|Family Practice|family practice
498749|NCT00189046|driving, chronic pain, attention|driving, chronic pain, attention
498750|NCT00189059|neuropathic pain|neuropathic pain
498752|NCT00189059|driving|driving
498753|NCT00189059|attention|attention
498754|NCT00189059|amitriptyline|amitriptyline
498755|NCT00189072|gabapentin|gabapentin
498756|NCT00189072|neuropathic pain|neuropathic pain
498757|NCT00189072|driving|driving
498758|NCT00189072|attention|attention
498759|NCT00189085|Metabolic syndrome|metabolic syndrome
498760|NCT00189111|peripheral arterial disease|peripheral arterial disease
498761|NCT00189111|computed tomography|computed tomography
498762|NCT00189111|cardiac asymptomatic|cardiac asymptomatic
498763|NCT00189111|dobutamine magnetic resonance imaging|dobutamine magnetic resonance imaging
498764|NCT00189124|Systemic Lupus Erythematosus|systemic lupus erythematosus
498765|NCT00189124|Dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
498766|NCT00189124|DHEA|dhea
498767|NCT00189124|SLE|sle
498768|NCT00189124|Lupus|lupus
498769|NCT00189150|Valganciclovir|valganciclovir
498770|NCT00189150|Mycophenolate Mofetil|mycophenolate mofetil
498771|NCT00189150|Pharmacokinetic|pharmacokinetic
498772|NCT00189150|Interaction|interaction
498773|NCT00189150|MPA|mpa
498774|NCT00189163|Hepatitis C|hepatitis c
498775|NCT00189163|Genotype 1|genotype 1
498776|NCT00189163|Insulin Resistance|insulin resistance
498777|NCT00189163|Pioglitazone|pioglitazone
498778|NCT00189189|prevention|prevention
498779|NCT00189189|oppositional defiant disorder|oppositional defiant disorder
498780|NCT00189189|conduct disorder|conduct disorder
498781|NCT00189215|coronary artery disease|coronary artery disease
498782|NCT00189215|cardiopulmonary bypass|cardiopulmonary bypass
498783|NCT00189215|cognition disorders|cognition disorders
498784|NCT00189241|Aldara|aldara
498785|NCT00189241|Superficial Basal Cell Carcinoma|superficial basal cell carcinoma
498786|NCT00189241|Long-Term Study|long-term study
498787|NCT00189254|1 year follow up|1 year follow up
498788|NCT00189267|Aldara|aldara
498789|NCT00189267|Actinic Keratosis|actinic keratosis
498790|NCT00189267|Graft Recipients|graft recipients
498791|NCT00189280|Aldara, sBCC|aldara, sbcc
498792|NCT00189293|External Ano-Genital Warts|external ano-genital warts
498793|NCT00189293|Ablative Therapy|ablative therapy
498794|NCT00189293|Aldara|aldara
498795|NCT00189306|Superficial Basal Cell Carcinoma|superficial basal cell carcinoma
498796|NCT00189306|Aldara|aldara
498797|NCT00189319|Tambocor|tambocor
498798|NCT00189319|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
498799|NCT00189319|Quality of Life|quality of life
498800|NCT00189332|Oncology|oncology
498801|NCT00189332|Melanoma|melanoma
498802|NCT00189345|Cancer|cancer
498803|NCT00189345|Cancer alternative therapies|cancer alternative therapies
498804|NCT00189345|ovarian cancer|ovarian cancer
498805|NCT00189358|cancer|cancer
498806|NCT00189358|cancer alternative therapies|cancer alternative therapies
498807|NCT00189358|ovarian cancer|ovarian cancer
498808|NCT00189358|tyrosine kinase inhibitor|tyrosine kinase inhibitor
498809|NCT00189384|Neonatal sepsis|neonatal sepsis
498810|NCT00189384|Neonatal pneumonia|neonatal pneumonia
498811|NCT00189384|Bacterial infections|bacterial infections
498812|NCT00189384|Young infants|young infants
498814|NCT00189384|Community|community
498815|NCT00189384|Developing country|developing country
498816|NCT00189397|Parthenium dermatitis|parthenium dermatitis
498817|NCT00189423|Heart Arrest|heart arrest
498818|NCT00189423|Cardiac Arrest|cardiac arrest
498819|NCT00189423|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
498820|NCT00189423|Impedance Threshold Device|impedance threshold device
498821|NCT00189423|Active Compression Decompression|active compression decompression
498822|NCT00189423|ResQPOD|resqpod
498823|NCT00189423|ResQPump|resqpump
498824|NCT00189423|Survival|survival
498825|NCT00189423|Out-of-hospital|out-of-hospital
498826|NCT00189423|Prehospital|prehospital
498827|NCT00189423|ResQCPR System|resqcpr system
498828|NCT00189436|Asthma|asthma
498829|NCT00189449|Allergic Rhinitis|allergic rhinitis
498830|NCT00189449|Allergy|allergy
498831|NCT00189449|Growth|growth
498832|NCT00189462|Ear Infections|ear infections
498833|NCT00189462|Otitis Media|otitis media
498834|NCT00189475|Cold|cold
498835|NCT00189475|Upper Respiratory Infection|upper respiratory infection
498836|NCT00189488|Hematological Malignancies|hematological malignancies
498837|NCT00189488|Graft-versus-host-disease|graft-versus-host-disease
498838|NCT00189488|Oral Mucositis|oral mucositis
498839|NCT00189488|Allogeneic Transplantation|allogeneic transplantation
498840|NCT00189501|Chronic Kidney Disease, CKD,|chronic kidney disease, ckd,
498841|NCT00189501|Secondary Hyperparathyroidism, HPT|secondary hyperparathyroidism, hpt
498842|NCT00189514|obesity|obesity
498843|NCT00189514|weight loss|weight loss
498844|NCT00189514|Amylin|amylin
498845|NCT00189514|pramlintide|pramlintide
498846|NCT00189540|Ischemic ulcers|ischemic ulcers
498847|NCT00189540|Critical Limb Ischemia|critical limb ischemia
498848|NCT00189553|Extra-ovarian papillary serous tumors|extra-ovarian papillary serous tumors
498849|NCT00189553|Relapse over 6 months|relapse over 6 months
498850|NCT00189553|Previously received taxane derivative|previously received taxane derivative
498851|NCT00189566|Relapse within 6 months|relapse within 6 months
498852|NCT00189566|Previously received taxane derivative|previously received taxane derivative
498853|NCT00189579|HERCEPTIN|herceptin
498854|NCT00189579|Carboplatin|carboplatin
498855|NCT00189579|Paclitaxel|paclitaxel
498856|NCT00189579|Relapse|relapse
498857|NCT00189592|plantar fascia|plantar fascia
498858|NCT00189592|plantar fasciitis|plantar fasciitis
498859|NCT00189592|Coblation|coblation
498860|NCT00189592|fasciotomy|fasciotomy
498861|NCT00189592|conventional surgical fasciotomy|conventional surgical fasciotomy
498862|NCT00189592|heel spur|heel spur
498863|NCT00189592|heel pain|heel pain
498864|NCT00189592|aponeurosis|aponeurosis
498865|NCT00189592|plasma based radiofrequency|plasma based radiofrequency
498866|NCT00189592|angiogenesis|angiogenesis
498867|NCT00189605|Plasma disc decompression|plasma disc decompression
498868|NCT00189605|Intradiscal Pressure|intradiscal pressure
498869|NCT00189605|Steroid Injection|steroid injection
498870|NCT00189605|Epidural Steroid Injection|epidural steroid injection
498871|NCT00189605|Selective Nerve Root Injection|selective nerve root injection
498872|NCT00189605|Leg Pain|leg pain
498873|NCT00189605|Radicular Pain|radicular pain
498874|NCT00189605|Coblation|coblation
498875|NCT00189605|SNRI|snri
498876|NCT00189618|Peripheral vascular disease|peripheral vascular disease
498877|NCT00189618|Peripheral arterial disease|peripheral arterial disease
498878|NCT00189618|Walking Capacity|walking capacity
498879|NCT00189618|Aspirin|aspirin
498880|NCT00189618|Clopidogrel|clopidogrel
498881|NCT00189696|Irritable Bowel Syndrome, Diarrhea|irritable bowel syndrome, diarrhea
498882|NCT00189709|micafungin|micafungin
498883|NCT00189709|fluconazole|fluconazole
498884|NCT00189709|invasive candidiasis|invasive candidiasis
498885|NCT00189709|candidemia|candidemia
498886|NCT00189722|Tacrolimus|tacrolimus
498887|NCT00189722|Immunosuppressant|immunosuppressant
498888|NCT00189722|Anti-asthmatic drug|anti-asthmatic drug
498889|NCT00189722|Administration, inhalation|administration, inhalation
498890|NCT00189735|Treatment Efficacy|treatment efficacy
498891|NCT00189735|Treatment Effectiveness|treatment effectiveness
498892|NCT00189735|Anti-rejection therapy|anti-rejection therapy
498893|NCT00189735|Immunosuppression|immunosuppression
498894|NCT00189735|Antirejection|antirejection
498895|NCT00189735|Malononitrilamide|malononitrilamide
498896|NCT00189748|Tacrolimus|tacrolimus
498897|NCT00189748|Immunosuppression|immunosuppression
498898|NCT00189748|Bone Marrow Transplantation|bone marrow transplantation
498899|NCT00189748|Graft versus Host Disease|graft versus host disease
498900|NCT00189761|Tacrolimus|tacrolimus
498901|NCT00189761|Immunosuppression|immunosuppression
498902|NCT00189761|Bone Marrow Transplantation|bone marrow transplantation
498903|NCT00189761|Graft versus Host Disease|graft versus host disease
498904|NCT00189774|nateglinide|nateglinide
498905|NCT00189774|pioglitazone|pioglitazone
498906|NCT00189774|combination drug therapy|combination drug therapy
498907|NCT00189774|treatment|treatment
498909|NCT00189787|Immunosuppressant|immunosuppressant
498910|NCT00189787|Anti-asthmatic drug|anti-asthmatic drug
498911|NCT00189787|Administration, inhalation|administration, inhalation
498912|NCT00189800|Solifenacin|solifenacin
498913|NCT00189800|tolterodine|tolterodine
498914|NCT00189800|randomized controlled trial|randomized controlled trial
498915|NCT00189800|double-blind method|double-blind method
498916|NCT00189813|Irritable Bowel Syndrome|irritable bowel syndrome
498917|NCT00189813|Diarrhea|diarrhea
498918|NCT00189813|Nasea®|nasea®
498919|NCT00189813|Irribow®|irribow®
498920|NCT00189813|ramosetron|ramosetron
498921|NCT00189826|Tacrolimus|tacrolimus
498922|NCT00189826|Liver transplantation|liver transplantation
498923|NCT00189839|Tacrolimus|tacrolimus
498924|NCT00189839|Kidney transplantation|kidney transplantation
498925|NCT00189839|Transplantation, kidney|transplantation, kidney
498926|NCT00189839|Renal Transplantation|renal transplantation
498927|NCT00189839|Transplantation, renal|transplantation, renal
498928|NCT00189852|Telecare|telecare
498929|NCT00189852|chronic|chronic
498930|NCT00189852|older people|older people
498931|NCT00189852|heart failure|heart failure
498932|NCT00189878|chronic idiopathic urticaria|chronic idiopathic urticaria
498933|NCT00189878|methotrexate|methotrexate
498935|NCT00189930|Treatment Experienced|treatment experienced
498936|NCT00189982|Factor VIII Deficiency|factor viii deficiency
498937|NCT00189995|schizophrenia|schizophrenia
498938|NCT00189995|aggression|aggression
498939|NCT00189995|clozapine|clozapine
498940|NCT00189995|efficacy|efficacy
498941|NCT00189995|double-blind|double-blind
498942|NCT00190008|tardive dyskinesia|tardive dyskinesia
498943|NCT00190008|piracetam|piracetam
498944|NCT00190021|Alzheimer's type dementia|alzheimer's type dementia
498945|NCT00190021|donepezil|donepezil
498946|NCT00190021|double-blind|double-blind
498947|NCT00190034|Acetylcysteine|acetylcysteine
498948|NCT00190034|cardiac surgery|cardiac surgery
498949|NCT00190034|cardiopulmonary bypass|cardiopulmonary bypass
498950|NCT00190034|acute renal insufficiency|acute renal insufficiency
498951|NCT00190047|Cerebral Ischemia|cerebral ischemia
498952|NCT00190047|Ischemic Brain Injury|ischemic brain injury
498953|NCT00190047|Brain Infarction|brain infarction
498954|NCT00190047|Brain Ischemia|brain ischemia
498955|NCT00190060|Frailty|frailty
498956|NCT00190060|Muscle strength|muscle strength
498957|NCT00190060|Physical performance|physical performance
498958|NCT00190060|Bone mineral density|bone mineral density
498959|NCT00190060|Quality of life|quality of life
498960|NCT00190073|Epidermal nerves;protein gene product 9.5; ethanol|epidermal nerves;protein gene product 9.5; ethanol
498961|NCT00190099|In-stent restenosis,|in-stent restenosis,
498962|NCT00190099|Drug eluting stent,|drug eluting stent,
498963|NCT00190099|dexamethasone,|dexamethasone,
498964|NCT00190099|Acute coronary syndrome|acute coronary syndrome
498965|NCT00190125|Hemodialysis|hemodialysis
498966|NCT00190125|Malnutrition|malnutrition
498967|NCT00190125|Inflammation|inflammation
498968|NCT00190138|Bi-ventricular pacing|bi-ventricular pacing
498969|NCT00190138|ventricular resynchronization|ventricular resynchronization
498970|NCT00190138|baroreflex sensitivity|baroreflex sensitivity
498971|NCT00190138|heart rate variability|heart rate variability
498972|NCT00190151|ciprofloxacin|ciprofloxacin
498973|NCT00190151|commensal flora|commensal flora
498974|NCT00190151|resistance|resistance
498975|NCT00190151|Pharmacokinetic|pharmacokinetic
498976|NCT00190164|Macular hole|macular hole
498977|NCT00190164|Vitrectomy|vitrectomy
498978|NCT00190164|positioning|positioning
498979|NCT00190164|retina|retina
498980|NCT00190164|surgery|surgery
498981|NCT00190190|Macular hole|macular hole
498982|NCT00190190|internal limiting membrane|internal limiting membrane
498983|NCT00190190|retina|retina
498984|NCT00190190|surgery|surgery
498985|NCT00190203|Malignant middle cerebral artery infarction|malignant middle cerebral artery infarction
498986|NCT00190203|Decompressive surgery|decompressive surgery
498987|NCT00190203|Hemicraniectomy|hemicraniectomy
498988|NCT00190203|Brain edema|brain edema
498989|NCT00190216|Resistant depression|resistant depression
498990|NCT00190216|Transcranial Magnetic Stimulation,|transcranial magnetic stimulation,
498991|NCT00190216|Neuroimaging|neuroimaging
498992|NCT00190229|Vasculitis|vasculitis
498993|NCT00190229|Cyclophosphamide|cyclophosphamide
498994|NCT00190229|Renal failure|renal failure
498995|NCT00190242|HIV|hiv
498996|NCT00190242|hepatitis A|hepatitis a
498997|NCT00190242|vaccine|vaccine
498998|NCT00190242|HBV and/or HCV co-infection|hbv and/or hcv co-infection
498999|NCT00190255|gastrointestinal haemorrhage|gastrointestinal haemorrhage
499000|NCT00190255|stomach ulcer|stomach ulcer
499001|NCT00190255|anti-inflammatory agents, non-steroidal|anti-inflammatory agents, non-steroidal
499002|NCT00190255|CYP2C9 protein, human|cyp2c9 protein, human
499003|NCT00190255|genotype|genotype
499004|NCT00190255|pharmacogenetics|pharmacogenetics
499005|NCT00190268|multiple sclerosis|multiple sclerosis
499006|NCT00190268|fatigue|fatigue
499007|NCT00190268|3,4-diaminopyridine|3,4-diaminopyridine
499008|NCT00190281|FUNCTIONAL STUDY|functional study
499009|NCT00190281|CONTRAST-ENHANCED US|contrast-enhanced us
499010|NCT00190281|PERFUSION|perfusion
499011|NCT00190294|Pregnancy Complications|pregnancy complications
499012|NCT00190307|Long term antiplatelet therapy|long term antiplatelet therapy
499013|NCT00190307|Scheduled surgery|scheduled surgery
499014|NCT00190320|Fetal macrosomia|fetal macrosomia
499015|NCT00190320|Neonatal traumatism|neonatal traumatism
499016|NCT00190320|Maternal morbidity|maternal morbidity
499017|NCT00190333|pulmonary hypertension|pulmonary hypertension
499018|NCT00190333|6 minutes walking test|6 minutes walking test
499019|NCT00190333|serotonin|serotonin
499020|NCT00190333|primary or associated pulmonary hypertension|primary or associated pulmonary hypertension
499021|NCT00190346|Acute respiratory distress|acute respiratory distress
499022|NCT00190346|with hypercapnia|with hypercapnia
499023|NCT00190346|with hypoxemia|with hypoxemia
499024|NCT00190346|requiring NIV|requiring niv
499025|NCT00190359|heart failure|heart failure
499026|NCT00190359|hormones|hormones
499027|NCT00190359|growth substances|growth substances
499028|NCT00190372|Alzheimer's disease training programme|alzheimer's disease training programme
499029|NCT00190372|educational programme caregivers carers dementia treatment|educational programme caregivers carers dementia treatment
499030|NCT00190372|Dementia Cognitive disorder|dementia cognitive disorder
499031|NCT00190385|Cirrhosis|cirrhosis
499032|NCT00190385|Hepatocellular carcinoma|hepatocellular carcinoma
499033|NCT00190385|Screening|screening
499034|NCT00190385|Randomized|randomized
499035|NCT00190385|HBV|hbv
499036|NCT00190385|HCV|hcv
499037|NCT00190385|alcohol|alcohol
499038|NCT00190385|hemochromatosis|hemochromatosis
499039|NCT00190398|Prospective|prospective
499040|NCT00190398|Randomised|randomised
499041|NCT00190398|Open|open
499042|NCT00190398|Blinded End-point|blinded end-point
499043|NCT00190398|PROBE Study|probe study
499044|NCT00190398|Ischemic stroke|ischemic stroke
499045|NCT00190411|Arteries|arteries
499046|NCT00190411|ultrasonography|ultrasonography
499047|NCT00190411|Ehlers Danlos syndrome|ehlers danlos syndrome
499048|NCT00190411|Cardiovascular disease|cardiovascular disease
499049|NCT00190411|beta adrenergic antagonists|beta adrenergic antagonists
499050|NCT00190424|Glioblastoma|glioblastoma
499051|NCT00190424|Immunotherapy|immunotherapy
499178|NCT00180050|lymphocytic colitis|lymphocytic colitis
499052|NCT00190437|Chronic Obstructive Lung Disease (COLD)|chronic obstructive lung disease (cold)
499053|NCT00190437|Randomized Clinical Trial|randomized clinical trial
499054|NCT00190437|Antibiotics|antibiotics
499055|NCT00190437|Acute Exacerbation|acute exacerbation
499056|NCT00190437|Mechanical|mechanical
499057|NCT00190437|Ventilation|ventilation
499058|NCT00190437|Intensive Care|intensive care
499059|NCT00190437|Length of Stay|length of stay
499060|NCT00190437|Mortality|mortality
499061|NCT00190450|Huntington|huntington
499063|NCT00190450|cellular therapy|cellular therapy
499064|NCT00190450|striatum|striatum
499065|NCT00190463|aspergillosis|aspergillosis
499066|NCT00190463|antifungal therapy|antifungal therapy
499067|NCT00190463|empirical antifungal treatment|empirical antifungal treatment
499068|NCT00190476|Elderly|elderly
499069|NCT00190476|advanced|advanced
499070|NCT00190476|non-small-cell lung cancer|non-small-cell lung cancer
499071|NCT00190476|cisplatin|cisplatin
499072|NCT00190476|docetaxel|docetaxel
499073|NCT00190476|weekly|weekly
499074|NCT00190476|combination|combination
499075|NCT00190476|chemotherapy|chemotherapy
499076|NCT00190476|randomized trial|randomized trial
499077|NCT00190489|metastatic breast cancer|metastatic breast cancer
499078|NCT00190489|drug therapy|drug therapy
499079|NCT00190489|doxorubicin|doxorubicin
499080|NCT00190489|docetaxel|docetaxel
499980|NCT00185055|valsartan|valsartan
499081|NCT00190502|Type 1 diabetes mellitus|type 1 diabetes mellitus
499082|NCT00190502|Immune intervention|immune intervention
499083|NCT00190502|Polyclonal antibodies|polyclonal antibodies
499084|NCT00190502|Type 1 diabetes of recent onset|type 1 diabetes of recent onset
499085|NCT00190502|C-peptide level 0.3 pmol/l or higher|c-peptide level 0.3 pmol/l or higher
499086|NCT00190502|Positivity of at least one marker of autoimmunity (diabetes)|positivity of at least one marker of autoimmunity (diabetes)
499087|NCT00190515|adjuvant chemotherapy|adjuvant chemotherapy
499088|NCT00190515|Stage III colorectal cancer|stage iii colorectal cancer
499089|NCT00190515|5-FU+l-LV|5-fu+l-lv
499090|NCT00190515|UFT+LV|uft+lv
499091|NCT00190515|randomized controlled trial|randomized controlled trial
499092|NCT00190528|cervical cancer|cervical cancer
499093|NCT00190528|drug therapy|drug therapy
499094|NCT00190528|cisplatin|cisplatin
499095|NCT00190528|bleomycin|bleomycin
499096|NCT00190528|mitomycin|mitomycin
499097|NCT00190528|vincristine|vincristine
499098|NCT00190541|Rectal Cancer|rectal cancer
499099|NCT00190541|Lymph Node Dissection|lymph node dissection
499100|NCT00190541|Rectal Surgery|rectal surgery
499101|NCT00190541|Autonomic Nerves|autonomic nerves
499102|NCT00190541|Stage II, III lower rectal cancer|stage ii, iii lower rectal cancer
499103|NCT00190554|esophageal cancer|esophageal cancer
499104|NCT00190554|squamous cell carcinoma|squamous cell carcinoma
499105|NCT00190554|esophagectomy|esophagectomy
499106|NCT00190554|neoadjuvant chemotherapy|neoadjuvant chemotherapy
499107|NCT00190554|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
499109|NCT00190580|chronic kidney disease|chronic kidney disease
499110|NCT00190580|hypertension|hypertension
499111|NCT00190580|angiotensin II receptor blocker|angiotensin ii receptor blocker
499112|NCT00190580|cardiovascular disease|cardiovascular disease
499113|NCT00190580|valsartan|valsartan
499114|NCT00190580|KVT|kvt
499115|NCT00190671|Advanced Breast Cancer|advanced breast cancer
499116|NCT00191113|syndrome|syndrome
499117|NCT00191113|Turner|turner
499118|NCT00191113|Turner's|turner's
499119|NCT00191113|height|height
499120|NCT00191113|growth|growth
499121|NCT00191113|growth hormone|growth hormone
499122|NCT00191113|somatropin|somatropin
499123|NCT00191113|short stature|short stature
499124|NCT00191113|short|short
499125|NCT00191113|hearing|hearing
499126|NCT00191113|glucose metabolism|glucose metabolism
499127|NCT00191243|breast cancer|breast cancer
498471|NCT00171158|CML|cml
499128|NCT00191269|after|after
499129|NCT00191269|anthracycline|anthracycline
499130|NCT00191269|taxane|taxane
499131|NCT00191269|regimen|regimen
499132|NCT00191282|diabetes|diabetes
499133|NCT00191282|MI|mi
499134|NCT00191282|heart attack|heart attack
499135|NCT00179829|leukemia|leukemia
499136|NCT00179829|acute lymphocytic leukemia|acute lymphocytic leukemia
499137|NCT00179829|chronic myelogenous leukemia|chronic myelogenous leukemia
499138|NCT00179829|acute myelogenous leukemia|acute myelogenous leukemia
499139|NCT00179855|graft versus host disease|graft versus host disease
499140|NCT00179855|ECP|ecp
499141|NCT00179855|extracorporeal photopheresis|extracorporeal photopheresis
499142|NCT00179855|allogeneic transplantation|allogeneic transplantation
499143|NCT00179868|cancer|cancer
499144|NCT00179868|leukemia|leukemia
499145|NCT00179868|stem cell transplant|stem cell transplant
499146|NCT00179868|complications|complications
499147|NCT00179881|Brain stem glioma|brain stem glioma
499148|NCT00179894|ADHD|adhd
499149|NCT00179894|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
499150|NCT00179933|developmental care|developmental care
499151|NCT00179933|Neonatal Intensive Care Unit|neonatal intensive care unit
499152|NCT00179972|Pulse oximetry|pulse oximetry
499153|NCT00179972|Pulse oximetry sensors|pulse oximetry sensors
499154|NCT00179972|Skin Integrity|skin integrity
499155|NCT00179972|Prematurity|prematurity
499156|NCT00179972|Neonatal Intensive Care Unit|neonatal intensive care unit
499157|NCT00179972|Infant, premature|infant, premature
499158|NCT00179985|Developmental Care|developmental care
499159|NCT00179985|Neonatal Intensive Care Unit (NICU)|neonatal intensive care unit (nicu)
499160|NCT00179998|Cystic fibrosis|cystic fibrosis
499161|NCT00179998|Infants|infants
499162|NCT00179998|Children|children
499163|NCT00179998|Pulmozyme|pulmozyme
499164|NCT00179998|Pulmonary function|pulmonary function
499165|NCT00179998|Computed tomography|computed tomography
499166|NCT00180011|omalizumab|omalizumab
499167|NCT00180011|severe asthma|severe asthma
499168|NCT00180011|moderate asthma|moderate asthma
499169|NCT00180011|injectable asthma medication|injectable asthma medication
499170|NCT00180011|Xolair|xolair
499171|NCT00180024|AT1-receptor|at1-receptor
499172|NCT00180024|AT2-receptor|at2-receptor
499173|NCT00180024|human pharmacology|human pharmacology
499174|NCT00180037|Parkinson's disease|parkinson's disease
499175|NCT00180037|Coenzyme Q10|coenzyme q10
499176|NCT00180037|Treatment|treatment
499177|NCT00180037|Neuroprotection|neuroprotection
499179|NCT00180050|microscopic colitis|microscopic colitis
499180|NCT00180050|budesonide|budesonide
499181|NCT00180076|collagenous colitis|collagenous colitis
499182|NCT00180076|microscopic colitis|microscopic colitis
499183|NCT00180076|budesonide|budesonide
499184|NCT00180089|graft-versus-host disease|graft-versus-host disease
499185|NCT00180089|budesonide|budesonide
499186|NCT00180089|stem cell transplantation|stem cell transplantation
499187|NCT00180102|acute myeloid leukemia|acute myeloid leukemia
499188|NCT00180102|risk adapted treatment|risk adapted treatment
499189|NCT00180102|early allogeneic stem cell transplantation|early allogeneic stem cell transplantation
499190|NCT00180102|autologous stem cell transplantation|autologous stem cell transplantation
499191|NCT00180115|acute myeloid leukemia|acute myeloid leukemia
499192|NCT00180115|cytarabine postremission dosage|cytarabine postremission dosage
499193|NCT00180115|risk adapted treatment strategy|risk adapted treatment strategy
499194|NCT00180115|allogeneic stem cell transplantation|allogeneic stem cell transplantation
499195|NCT00180115|autologous stem cell transplantation|autologous stem cell transplantation
499196|NCT00180128|acute promyelocytic leukemia|acute promyelocytic leukemia
499197|NCT00180128|risk adapted therapy|risk adapted therapy
499198|NCT00180141|Atopic dermatitis on both lower arm.|atopic dermatitis on both lower arm.
499199|NCT00180154|radiation therapy|radiation therapy
499200|NCT00180154|F-18-FDG|f-18-fdg
499201|NCT00180154|NSCLC|nsclc
499202|NCT00180167|Chemotherapy|chemotherapy
499204|NCT00180180|head-and-neck cancer|head-and-neck cancer
499205|NCT00180180|radiation therapy|radiation therapy
499206|NCT00180180|F-18-FMISO|f-18-fmiso
499207|NCT00180193|Radiotherapy|radiotherapy
499208|NCT00180193|F-18-OMFD|f-18-omfd
499209|NCT00180206|Arthritis|arthritis
499211|NCT00180206|Hip arthroplasty|hip arthroplasty
499212|NCT00180206|Hip resurfacing arthroplasty|hip resurfacing arthroplasty
499213|NCT00180219|G08.520.769.550.408|g08.520.769.550.408
499214|NCT00180219|G08.520.769.550.490|g08.520.769.550.490
499215|NCT00180219|G08.520.769.550.520|g08.520.769.550.520
499216|NCT00180245|Radiation therapy|radiation therapy
499217|NCT00180245|F-18-FDG|f-18-fdg
499218|NCT00180258|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
499219|NCT00180258|Heart Failure|heart failure
499220|NCT00180258|Defibrillator|defibrillator
499221|NCT00180258|Pacemaker|pacemaker
499222|NCT00180271|Defibrillator|defibrillator
499223|NCT00180271|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
499224|NCT00180271|MADIT|madit
499225|NCT00180284|Pacemaker leads|pacemaker leads
499226|NCT00180284|Electrodes, implantable|electrodes, implantable
499227|NCT00180284|Cardiac pacing, aritificial|cardiac pacing, aritificial
499228|NCT00180310|drug eluting stents|drug eluting stents
499229|NCT00180310|stents|stents
499230|NCT00180310|angioplasty|angioplasty
499231|NCT00180310|coronary artery disease|coronary artery disease
499232|NCT00180310|total coronary occlusion|total coronary occlusion
499233|NCT00180310|coronary artery restenosis|coronary artery restenosis
499234|NCT00180310|stent thrombosis|stent thrombosis
499235|NCT00180310|vascular disease|vascular disease
499236|NCT00180310|myocardial ischemia|myocardial ischemia
499237|NCT00180310|coronary artery stenosis|coronary artery stenosis
499238|NCT00180336|Heart Failure|heart failure
499239|NCT00180336|Tachycardia|tachycardia
499240|NCT00180336|Atrial Fibrillation|atrial fibrillation
499241|NCT00180336|Atrial Flutter|atrial flutter
499242|NCT00180336|Ventricular Fibrillation|ventricular fibrillation
499243|NCT00180388|cardiovascular system|cardiovascular system
499244|NCT00180388|veins|veins
499245|NCT00180388|saphenous vein|saphenous vein
499246|NCT00180414|heart failure|heart failure
499247|NCT00180453|Cardiovascular disease|cardiovascular disease
499248|NCT00180453|Ischemia|ischemia
499249|NCT00180466|drug eluting stents|drug eluting stents
499250|NCT00180466|stents|stents
499251|NCT00180466|angioplasty|angioplasty
499252|NCT00180466|coronary artery disease|coronary artery disease
499253|NCT00180466|total coronary occlusion|total coronary occlusion
499254|NCT00180466|coronary artery restenosis|coronary artery restenosis
499255|NCT00180466|stent thrombosis|stent thrombosis
499256|NCT00180466|vascular disease|vascular disease
499257|NCT00180466|myocardial ischemia|myocardial ischemia
499258|NCT00180466|coronary artery stenosis|coronary artery stenosis
499259|NCT00180479|Everolimus|everolimus
499260|NCT00180492|Atherosclerotic disease|atherosclerotic disease
499261|NCT00180505|Peripheral Artery Disease|peripheral artery disease
499262|NCT00180505|Restenosis Rate|restenosis rate
499263|NCT00180505|Patency Rates|patency rates
499264|NCT00180505|Self-Expandable Nitinol Stents|self-expandable nitinol stents
499265|NCT00180505|Stent Fractures|stent fractures
499266|NCT00180518|Carotid artery disease|carotid artery disease
499267|NCT00180518|High risk|high risk
499268|NCT00180518|High surgical risk|high surgical risk
499269|NCT00180648|Short Bowel Syndrome|short bowel syndrome
499270|NCT00180648|Intestinal Failure|intestinal failure
499271|NCT00180648|Glucagon Like Peptide 2|glucagon like peptide 2
499272|NCT00180648|Parenteral Nutrition|parenteral nutrition
499273|NCT00194194|BMI|bmi
499274|NCT00194194|RMR|rmr
499275|NCT00194194|Personal Computer|personal computer
499276|NCT00194207|Ectopic pregnancy|ectopic pregnancy
499277|NCT00194220|Infertility|infertility
499278|NCT00194220|Oxidative stress|oxidative stress
499279|NCT00194233|Endometriosis|endometriosis
499280|NCT00194272|Ectopic pregnancy|ectopic pregnancy
499281|NCT00194272|Methotrexate|methotrexate
499282|NCT00194285|Prosthesis|prosthesis
499283|NCT00194285|[18 F] Fluorodeoxyglucose|[18 f] fluorodeoxyglucose
499284|NCT00194285|Positron Emission Tomography Imaging|positron emission tomography imaging
499285|NCT00194298|diabetic foot disease|diabetic foot disease
499286|NCT00194298|osteomyelitis|osteomyelitis
499287|NCT00194298|charcot|charcot
499288|NCT00194298|neuropathy|neuropathy
499289|NCT00194298|hypoxia|hypoxia
499290|NCT00194298|[18 F] Fluorodeoxyglucose|[18 f] fluorodeoxyglucose
499291|NCT00194298|Positron Emission Tomography Imaging|positron emission tomography imaging
499292|NCT00194311|HPV|hpv
499293|NCT00194311|Pregnancy|pregnancy
499294|NCT00194337|stage I breast cancer|stage i breast cancer
499295|NCT00194337|stage II breast cancer|stage ii breast cancer
499296|NCT00194337|stage IIIA breast cancer|stage iiia breast cancer
499297|NCT00194337|stage IIIB breast cancer|stage iiib breast cancer
499298|NCT00194337|stage IIIC breast cancer|stage iiic breast cancer
499299|NCT00194337|stage IV breast cancer|stage iv breast cancer
499300|NCT00194350|Infertility|infertility
499301|NCT00194350|Factor V Leiden|factor v leiden
499302|NCT00194363|breast cancer|breast cancer
499303|NCT00194363|breast cancer survivors|breast cancer survivors
499203|NCT00180167|elderly|elderly
499304|NCT00194363|lymphedema|lymphedema
499305|NCT00194363|strength training|strength training
499306|NCT00194363|breast cancer survivorship|breast cancer survivorship
499307|NCT00194402|cholesterol|cholesterol
499308|NCT00194402|dyslipidemia|dyslipidemia
499309|NCT00194402|hypercholesterolemia|hypercholesterolemia
499310|NCT00194402|C-reactive protein|c-reactive protein
499311|NCT00194428|Obesity,|obesity,
499312|NCT00194428|Metabolic Syndrome,|metabolic syndrome,
499314|NCT00194441|cerebral circulation|cerebral circulation
499315|NCT00194441|monitoring, physiologic|monitoring, physiologic
499316|NCT00194441|informatics|informatics
499317|NCT00194441|nursing care|nursing care
499318|NCT00194441|physiologic variability|physiologic variability
499319|NCT00194441|outcome|outcome
499320|NCT00194441|quality adjusted life years|quality adjusted life years
499321|NCT00194454|Depressive symptoms|depressive symptoms
499322|NCT00194454|Behavior and behavior mechanisms|behavior and behavior mechanisms
499323|NCT00194454|Recovery|recovery
499324|NCT00194480|Hepatitis C, peg-Interferon, drug abuse|hepatitis c, peg-interferon, drug abuse
499325|NCT00194493|Cancer|cancer
499326|NCT00194493|Quality of Life|quality of life
499327|NCT00194493|Signs and Symptoms|signs and symptoms
499328|NCT00194493|Computers|computers
499329|NCT00194493|Patient-Reported Outcomes|patient-reported outcomes
499330|NCT00194506|Diabetes|diabetes
499331|NCT00194506|Health Education|health education
499332|NCT00194506|Information Technology|information technology
499333|NCT00194506|Disease Management|disease management
499334|NCT00194506|Internet|internet
499335|NCT00194506|Patient Education|patient education
499336|NCT00194519|HIV infection|hiv infection
499337|NCT00194519|HIV transmission|hiv transmission
499338|NCT00194519|genital herpes|genital herpes
499339|NCT00194519|sexual intercourse|sexual intercourse
499340|NCT00194519|sexual transmitted infection|sexual transmitted infection
499341|NCT00194519|acyclovir|acyclovir
499342|NCT00194519|HIV Seronegativity|hiv seronegativity
499343|NCT00194519|Treatment Naive|treatment naive
499344|NCT00194519|HIV-discordant couples|hiv-discordant couples
499345|NCT00194519|HIV serodiagnosis|hiv serodiagnosis
499347|NCT00194545|HIV-1|hiv-1
499348|NCT00194545|pediatric adherence|pediatric adherence
499349|NCT00194545|medication diaries|medication diaries
499350|NCT00194545|HAART|haart
499351|NCT00194545|Treatment Naive|treatment naive
499352|NCT00194558|Diabetes|diabetes
499353|NCT00194558|Health Education|health education
499354|NCT00194558|Information Technology|information technology
499355|NCT00194558|Disease Management|disease management
499356|NCT00194558|Internet|internet
499357|NCT00194558|Patient Education|patient education
499358|NCT00194571|breast cancer,|breast cancer,
499359|NCT00194571|child functioning,|child functioning,
499360|NCT00194571|parenting,|parenting,
499361|NCT00194571|self-efficacy,|self-efficacy,
499362|NCT00194571|psychoeducational intervention|psychoeducational intervention
499363|NCT00194571|counseling|counseling
499364|NCT00194584|children|children
499365|NCT00194584|chronic illness|chronic illness
499366|NCT00194584|parent education|parent education
499367|NCT00194584|parent support|parent support
499368|NCT00194597|Prostatitis|prostatitis
499369|NCT00194623|prostatitis|prostatitis
499370|NCT00194636|Prostatitis|prostatitis
499371|NCT00194636|Chronic Male Pelvic Pain Syndrome|chronic male pelvic pain syndrome
499372|NCT00194649|Glycosphingolipids (GSL)|glycosphingolipids (gsl)
499373|NCT00194675|androgen deficiency|androgen deficiency
499374|NCT00194675|testosterone|testosterone
499375|NCT00194675|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
499376|NCT00194675|hypogonadism|hypogonadism
499377|NCT00194675|prostate|prostate
499378|NCT00194675|BPH|bph
499379|NCT00194688|ammonia|ammonia
499380|NCT00194701|heart failure|heart failure
499381|NCT00194701|sleep|sleep
499382|NCT00194701|exercise|exercise
499383|NCT00194701|heart rate variability|heart rate variability
499384|NCT00194727|Breast cancer|breast cancer
499385|NCT00194740|Breast cancer|breast cancer
499386|NCT00194753|Breast cancer|breast cancer
499387|NCT00194766|Breast cancer|breast cancer
499388|NCT00194766|Soft tissue sarcoma|soft tissue sarcoma
499389|NCT00194805|Internet|internet
499390|NCT00194805|Diabetes|diabetes
499391|NCT00194805|Education|education
499392|NCT00194805|Social Support|social support
499393|NCT00194844|caring|caring
499394|NCT00194844|miscarriage|miscarriage
499395|NCT00194844|grief|grief
499396|NCT00194844|couples|couples
499397|NCT00194844|counseling|counseling
499398|NCT00194857|anemia|anemia
499399|NCT00194857|dose reduction|dose reduction
499400|NCT00194857|neutropenia|neutropenia
499401|NCT00194857|hepatitis C virus|hepatitis c virus
499402|NCT00194857|human immunodeficiency virus|human immunodeficiency virus
499403|NCT00194870|EEG|eeg
499404|NCT00194870|DBS|dbs
499405|NCT00194883|Recombinant Human Growth Hormone|recombinant human growth hormone
499406|NCT00194883|Leptin|leptin
499407|NCT00194883|Cytokines|cytokines
499408|NCT00194883|Chronic Renal Insufficiency|chronic renal insufficiency
499409|NCT00194883|Children|children
499410|NCT00194896|type 2 diabetes mellitus|type 2 diabetes mellitus
499411|NCT00194896|autoantibodies|autoantibodies
499412|NCT00194896|islet proteins|islet proteins
499413|NCT00194896|rosiglitazone|rosiglitazone
499414|NCT00194896|glyburide|glyburide
499415|NCT00194896|c-peptide|c-peptide
499416|NCT00194935|Ovarian Cancer|ovarian cancer
499417|NCT00194935|Cancer of the Ovary|cancer of the ovary
499418|NCT00194961|Chronic Kidney Disease|chronic kidney disease
499419|NCT00194961|Growth Failure|growth failure
499420|NCT00194961|Cytokines|cytokines
499422|NCT00194974|pregnancy|pregnancy
499423|NCT00194974|chronic hypertension|chronic hypertension
499424|NCT00194974|Toxemia|toxemia
499425|NCT00194974|Blood Pressure|blood pressure
499426|NCT00194987|Alloimmune thrombocytopenia|alloimmune thrombocytopenia
499427|NCT00194987|Fetal alloimmune thrombocytopenia|fetal alloimmune thrombocytopenia
499428|NCT00195000|Acute Myeloid Leukemia|acute myeloid leukemia
499429|NCT00195000|Myelodysplastic Syndrome|myelodysplastic syndrome
499430|NCT00195039|Prostate Cancer|prostate cancer
499431|NCT00195052|epilepsy|epilepsy
499432|NCT00195052|optical imaging|optical imaging
499433|NCT00195052|optical mapping|optical mapping
499434|NCT00195065|Asthma|asthma
499435|NCT00195065|Behavior change|behavior change
499436|NCT00195065|Physical activity|physical activity
499437|NCT00195065|Risk reduction|risk reduction
499438|NCT00195078|head and neck cancer|head and neck cancer
499439|NCT00195078|squamous cell carcinoma of the oral cavity|squamous cell carcinoma of the oral cavity
499440|NCT00195078|squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
499441|NCT00195078|squamous cell carcinoma of the larynx|squamous cell carcinoma of the larynx
499442|NCT00195078|squamous cell carcinoma of the hypopharynx|squamous cell carcinoma of the hypopharynx
499443|NCT00195104|Myelodysplastic Syndrome|myelodysplastic syndrome
499444|NCT00195117|Asthma|asthma
499445|NCT00195117|Behavior change|behavior change
499446|NCT00195117|Physical activity|physical activity
499447|NCT00195117|Risk reduction|risk reduction
499448|NCT00195130|prognosis|prognosis
499449|NCT00195130|risk of death|risk of death
499450|NCT00195130|morbidity|morbidity
499451|NCT00195130|mortality|mortality
499452|NCT00195130|quality of life|quality of life
499453|NCT00195143|Parkinson's disease|parkinson's disease
499454|NCT00195143|GABA|gaba
499455|NCT00195143|Subthalamic nucleus|subthalamic nucleus
499456|NCT00195143|Adeno-associated virus|adeno-associated virus
499458|NCT00195143|Gene therapy|gene therapy
499459|NCT00195156|Solid Tumor Malignancies|solid tumor malignancies
499460|NCT00195169|Myocardial Infarction|myocardial infarction
499461|NCT00195169|Social support|social support
499462|NCT00195182|Hypertension|hypertension
499463|NCT00195182|African-American|african-american
499464|NCT00195182|Perceived Racism|perceived racism
499465|NCT00195182|Psychological Stress|psychological stress
499466|NCT00195182|Medication Adherence|medication adherence
499467|NCT00195195|Transplantation|transplantation
499468|NCT00195208|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
499469|NCT00195221|Hemophilia B|hemophilia b
499470|NCT00195234|HIV|hiv
499471|NCT00195234|Treatment Experienced|treatment experienced
499472|NCT00195247|Tumors|tumors
499473|NCT00195247|Advanced malignant solid tumors|advanced malignant solid tumors
499474|NCT00195260|Solid tumors|solid tumors
499475|NCT00195273|Kidney|kidney
499476|NCT00195273|Transplant|transplant
499477|NCT00195286|Urinary Infections|urinary infections
499478|NCT00195299|Carcinoma|carcinoma
499479|NCT00195299|Head|head
499480|NCT00195299|Neck|neck
499481|NCT00195312|HIV|hiv
499482|NCT00195312|Vaccine|vaccine
499483|NCT00195312|Treatment Experienced|treatment experienced
499981|NCT00185055|irbesartan|irbesartan
499484|NCT00195325|Advanced Malignant Solid Tumors|advanced malignant solid tumors
499485|NCT00195338|Rheumatoid Arthritis|rheumatoid arthritis
499486|NCT00195351|Complicated intra-abdominal infection|complicated intra-abdominal infection
499487|NCT00195351|Appendicitis with abscess|appendicitis with abscess
499488|NCT00195351|Perforated diverticulitis|perforated diverticulitis
499489|NCT00195351|Purulent peritonitis|purulent peritonitis
499490|NCT00195351|Complicated cholecystitis|complicated cholecystitis
499491|NCT00195364|Rheumatoid Arthritis|rheumatoid arthritis
499492|NCT00195390|Vaccine|vaccine
499493|NCT00195390|heptavalent pneumococcal conjugate vaccine|heptavalent pneumococcal conjugate vaccine
499494|NCT00195403|Rheumatoid Arthritis|rheumatoid arthritis
499495|NCT00195416|Ankylosing Spondylitis|ankylosing spondylitis
499496|NCT00195429|Kidney|kidney
499497|NCT00195429|Transplant|transplant
499498|NCT00195442|Hemophilia A|hemophilia a
499499|NCT00195455|Postmenopause|postmenopause
499500|NCT00195468|Kidney Failure|kidney failure
499501|NCT00195468|Transplant|transplant
499502|NCT00195481|Kidney|kidney
499503|NCT00195481|Transplant|transplant
499504|NCT00195494|Rheumatoid Arthritis|rheumatoid arthritis
499505|NCT00195507|Psoriasis|psoriasis
499506|NCT00195520|Menopause|menopause
499507|NCT00195520|Sleep Disorder|sleep disorder
499508|NCT00195520|Hot Flashes|hot flashes
499457|NCT00195143|AAV|aav
499509|NCT00195533|Leukemia|leukemia
499510|NCT00195533|Lymphoma|lymphoma
499511|NCT00195533|Myeloma|myeloma
499512|NCT00195546|Menopause|menopause
499513|NCT00195559|Premenstrual Syndrome (PMS)|premenstrual syndrome (pms)
499514|NCT00195559|Hormone Therapy|hormone therapy
499515|NCT00195572|Gastric Cancer|gastric cancer
499516|NCT00195572|Advanced/Recurrent Gastric Cancer|advanced/recurrent gastric cancer
499517|NCT00195585|Colon Cancer|colon cancer
499518|NCT00195598|Panic Disorders|panic disorders
499519|NCT00195611|Middle Ear Infection|middle ear infection
499520|NCT00195624|Immunosuppression|immunosuppression
499521|NCT00195624|Alemtuzumab/Campath|alemtuzumab/campath
499522|NCT00195624|Severe Aplastic Anemia|severe aplastic anemia
499523|NCT00195624|T-cells|t-cells
499524|NCT00195624|Hematopoiesis|hematopoiesis
498813|NCT00189384|Neonate|neonate
499525|NCT00195624|Autoimmunity|autoimmunity
499526|NCT00195624|Thrombocytopenia|thrombocytopenia
499527|NCT00195624|Neutropenia|neutropenia
499529|NCT00195637|GNE Gene|gne gene
499530|NCT00195637|Alpha-Dystroglycan|alpha-dystroglycan
499531|NCT00195637|Sialic Acid|sialic acid
499532|NCT00195637|Glycosylation|glycosylation
499533|NCT00195637|Dystroglycanopathy|dystroglycanopathy
499534|NCT00195637|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
499535|NCT00195637|Immune Globulin|immune globulin
499536|NCT00195637|HIBM|hibm
499537|NCT00195650|Rheumatoid Arthritis|rheumatoid arthritis
499538|NCT00195663|Early Rheumatoid Arthritis|early rheumatoid arthritis
499539|NCT00195702|Rheumatoid Arthritis|rheumatoid arthritis
499540|NCT00195728|Hydrocodone/Acetaminophen|hydrocodone/acetaminophen
499541|NCT00195728|Vicodin CR|vicodin cr
499542|NCT00195741|Migraine|migraine
499543|NCT00195741|Depakote ER|depakote er
499544|NCT00195754|Migraines|migraines
499545|NCT00195754|Depakote ER|depakote er
499546|NCT00195754|divalproex sodium|divalproex sodium
499547|NCT00195767|Bipolar I Disorder|bipolar i disorder
499548|NCT00195767|Depakote ER|depakote er
499549|NCT00195767|divalproex sodium|divalproex sodium
499550|NCT00195780|Bipolar I Disorder|bipolar i disorder
499551|NCT00195780|Depakote|depakote
499552|NCT00195793|Hyperlipidemia|hyperlipidemia
499553|NCT00195793|fenofibrate|fenofibrate
499554|NCT00195793|ezetimibe|ezetimibe
499555|NCT00195793|atorvastatin|atorvastatin
499556|NCT00195806|Migraine|migraine
499557|NCT00195806|Depakote ER|depakote er
499558|NCT00195806|Divalproex sodium|divalproex sodium
499559|NCT00195819|ankylosing spondylitis|ankylosing spondylitis
499560|NCT00195819|adalimumab|adalimumab
499561|NCT00195858|Youth|youth
499562|NCT00195858|Exercise|exercise
499563|NCT00195858|Physical Activity|physical activity
499564|NCT00195858|Aerobic|aerobic
499565|NCT00195858|Resistance|resistance
499566|NCT00195858|Overweight|overweight
499567|NCT00195858|obese|obese
499568|NCT00195858|Canada|canada
499569|NCT00195858|Sigal|sigal
499570|NCT00195871|Non-Hodgkin|non-hodgkin
499571|NCT00195871|Lymphoma|lymphoma
499572|NCT00195871|Lymphoblastic|lymphoblastic
499573|NCT00195884|Diabetes Mellitus|diabetes mellitus
499574|NCT00195884|Type 2 Diabetes|type 2 diabetes
499575|NCT00195884|Aerobic|aerobic
499576|NCT00195884|Resistance|resistance
499577|NCT00195884|weight training|weight training
499578|NCT00195884|Exercise|exercise
499579|NCT00195897|Lymphoma|lymphoma
499580|NCT00195897|Anthracyclines|anthracyclines
499581|NCT00195897|Heart Failure|heart failure
499582|NCT00195897|Radionuclide|radionuclide
499583|NCT00195897|Magnetic Resonance Imaging|magnetic resonance imaging
499584|NCT00195897|Troponin|troponin
499585|NCT00195897|Natriuretic Peptide, Brain|natriuretic peptide, brain
499586|NCT00195910|Acute|acute
499587|NCT00195910|Pain|pain
499588|NCT00195910|Emergency Department|emergency department
499589|NCT00195910|Morphine|morphine
499590|NCT00195910|Hydromorphone|hydromorphone
499591|NCT00195910|Dilaudid|dilaudid
499592|NCT00195923|appendicitis|appendicitis
499593|NCT00195923|perforation|perforation
499594|NCT00195936|Cinacalcet|cinacalcet
499595|NCT00195936|PTH|pth
499596|NCT00195936|XLH|xlh
499597|NCT00195936|children and adolescents with hypophosphatemic rickets (XLH)|children and adolescents with hypophosphatemic rickets (xlh)
499598|NCT00195949|Pyloric Stenosis|pyloric stenosis
499599|NCT00195949|Laparoscopy|laparoscopy
499600|NCT00195949|Idiopathic Hypertrophic Pyloric Stenosis|idiopathic hypertrophic pyloric stenosis
499601|NCT00195962|Breastfeeding|breastfeeding
499602|NCT00195962|Post-partum mothers of healthy breast-fed newborns|post-partum mothers of healthy breast-fed newborns
499603|NCT00195975|Abdominal Pain|abdominal pain
499604|NCT00195975|Functional Gastrointestinal Disorders|functional gastrointestinal disorders
499605|NCT00195975|Stress|stress
499606|NCT00195975|Anxiety|anxiety
499607|NCT00195975|Autonomic Nervous System|autonomic nervous system
499608|NCT00195988|immunosuppression,|immunosuppression,
499609|NCT00195988|steroid avoidance,|steroid avoidance,
499610|NCT00195988|liver transplantation,|liver transplantation,
499611|NCT00195988|children|children
499612|NCT00196001|Adrenal sufficiency|adrenal sufficiency
499613|NCT00196001|Low-dose ACTH stimulation|low-dose acth stimulation
499614|NCT00196001|G proteins|g proteins
499615|NCT00196014|Registered Nurses|registered nurses
499616|NCT00196014|Workload|workload
499617|NCT00196014|Clinical staff nurses that are currently working|clinical staff nurses that are currently working
499618|NCT00196053|Intrathecal pain management|intrathecal pain management
499619|NCT00196053|constant flow pump|constant flow pump
499620|NCT00196079|coronary artery|coronary artery
499621|NCT00196079|stenosis|stenosis
499622|NCT00196079|drug eluting stent|drug eluting stent
499623|NCT00196079|stent|stent
499624|NCT00196105|Stents|stents
499625|NCT00196105|Stent-graft|stent-graft
499626|NCT00196105|Minimally invasive|minimally invasive
499627|NCT00196105|Biliary Tract Cancer|biliary tract cancer
644118|NCT00751842|GAD|gad
498908|NCT00189787|Tacrolimus|tacrolimus
499628|NCT00196105|Pancreatic Cancer|pancreatic cancer
499629|NCT00196105|Jaundice|jaundice
499630|NCT00196105|Biliary Tract Neoplasms|biliary tract neoplasms
499631|NCT00196105|Pancreatic Neoplasms|pancreatic neoplasms
499632|NCT00196105|Jaundice, Obstructive|jaundice, obstructive
499633|NCT00196105|Zilver|zilver
499634|NCT00196118|Pulmonary Embolism|pulmonary embolism
499635|NCT00196118|Venous Thromboembolism|venous thromboembolism
499636|NCT00196118|Inferior Vena Cava Filter|inferior vena cava filter
499637|NCT00196118|IVC|ivc
499638|NCT00196118|PE|pe
499639|NCT00196131|morphine|morphine
499640|NCT00196131|head injury|head injury
499641|NCT00196131|SAH|sah
499642|NCT00196196|Hydrocephalus|hydrocephalus
499643|NCT00196196|Codman Hakim Programmable Valve|codman hakim programmable valve
499644|NCT00196196|Programmable Valve|programmable valve
499645|NCT00196196|Shunt System|shunt system
499646|NCT00196209|atrial fibrillation|atrial fibrillation
499647|NCT00196209|catheter ablation|catheter ablation
499648|NCT00196235|Assessment, Risk|assessment, risk
499649|NCT00196235|Diabetes mellitus|diabetes mellitus
499650|NCT00196235|Autonomic nervous system|autonomic nervous system
499651|NCT00196261|Assessment, Risk|assessment, risk
499652|NCT00196261|Autonomic nervous system|autonomic nervous system
499653|NCT00196274|AUTONOMIC NERVOUS SYSTEM|autonomic nervous system
499654|NCT00196274|Assessment, Risk|assessment, risk
499655|NCT00196287|Assessment, risk|assessment, risk
499656|NCT00196287|autonomic nervous system|autonomic nervous system
499657|NCT00196287|Gender|gender
499658|NCT00196300|Assessment, Risk|assessment, risk
499659|NCT00196300|Autonomic nervous system|autonomic nervous system
499660|NCT00196300|Aged|aged
499661|NCT00196313|cyclic pelvic pain|cyclic pelvic pain
499662|NCT00196313|dysmenorrhea|dysmenorrhea
499663|NCT00196313|oral contraceptives|oral contraceptives
499664|NCT00196326|pregnancy prevention|pregnancy prevention
499665|NCT00196326|oral contraceptives|oral contraceptives
499666|NCT00196339|prostate cancer|prostate cancer
499667|NCT00196339|hot flashes|hot flashes
499668|NCT00196339|hot flushes|hot flushes
499669|NCT00196339|vasomotor symptoms|vasomotor symptoms
499670|NCT00196352|oral contraceptives|oral contraceptives
499671|NCT00196352|birth control|birth control
499672|NCT00196352|ethinyl estradiol|ethinyl estradiol
499673|NCT00196352|pregnancy prevention|pregnancy prevention
499674|NCT00196365|cyclic pelvic pain|cyclic pelvic pain
499675|NCT00196365|dysmenorrhea|dysmenorrhea
499676|NCT00196378|vaginal atrophy|vaginal atrophy
499677|NCT00196378|vaginal dryness|vaginal dryness
499678|NCT00196378|vaginal itching|vaginal itching
499679|NCT00196378|vaginal pain|vaginal pain
499680|NCT00196378|dyspareunia|dyspareunia
499681|NCT00196391|secondary amenorrhea|secondary amenorrhea
499682|NCT00196391|progesterone|progesterone
499683|NCT00196404|overactive bladder|overactive bladder
499684|NCT00196404|urge incontinence|urge incontinence
499685|NCT00196404|urinary incontinence|urinary incontinence
499686|NCT00196417|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
499688|NCT00196417|unfractionated heparin|unfractionated heparin
499689|NCT00196417|UFH|ufh
499690|NCT00196417|low-molecular-weight heparin|low-molecular-weight heparin
499691|NCT00196417|LMWH|lmwh
499692|NCT00196417|thrombosis prophylaxis|thrombosis prophylaxis
499693|NCT00196417|HIT-antibody|hit-antibody
499694|NCT00196456|Photodynamic lasertherapy|photodynamic lasertherapy
499695|NCT00196456|Periodontol disease|periodontol disease
499696|NCT00196482|growth|growth
499697|NCT00196482|oral feeding|oral feeding
499698|NCT00196482|nutrition|nutrition
499699|NCT00196508|Childbirth|childbirth
499701|NCT00196547|Respiratory viral infections|respiratory viral infections
499702|NCT00196547|Exacerbations|exacerbations
499703|NCT00196547|Pediatric|pediatric
499704|NCT00196547|Leukotriene receptor antagonists|leukotriene receptor antagonists
499705|NCT00196547|School|school
499706|NCT00196560|Immobilization in External Rotation|immobilization in external rotation
499707|NCT00196560|Acute primary anterior shoulder dislocation|acute primary anterior shoulder dislocation
499708|NCT00196573|Rotator Cuff|rotator cuff
499709|NCT00196573|Tendinosis|tendinosis
499710|NCT00196573|Impingement Syndrome|impingement syndrome
499711|NCT00196573|Partial Thickness Tears|partial thickness tears
499712|NCT00196573|Rotator Cuff Tendinosis|rotator cuff tendinosis
499713|NCT00196573|Partial Thickness Rotator Cuff Tears|partial thickness rotator cuff tears
499714|NCT00196586|Chronic Hepatitis C|chronic hepatitis c
499715|NCT00196586|HIV infection|hiv infection
499716|NCT00196586|Interleukin-2|interleukin-2
499717|NCT00196586|Pegylated interferon alpha 2 a|pegylated interferon alpha 2 a
499718|NCT00196586|ribavirin|ribavirin
499719|NCT00196599|HIV infections|hiv infections
499720|NCT00196599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
499721|NCT00196612|HIV Infections|hiv infections
499722|NCT00196612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
644308|NCT00752453|ICU|icu
499723|NCT00196612|Treatment simplification|treatment simplification
499724|NCT00196625|HIV infections|hiv infections
499725|NCT00196625|Salvage therapy|salvage therapy
499726|NCT00196625|Amprenavir|amprenavir
499727|NCT00196625|Lopinavir|lopinavir
499728|NCT00196625|Ritonavir|ritonavir
499729|NCT00196638|HIV infections|hiv infections
499730|NCT00196638|Primary acute infection|primary acute infection
499731|NCT00196638|Interferon-alpha|interferon-alpha
499732|NCT00196651|HIV infection|hiv infection
499733|NCT00196651|AIDS Vaccines|aids vaccines
499734|NCT00196651|ALVAC vaccine|alvac vaccine
499735|NCT00196651|Interleukin-2|interleukin-2
499736|NCT00196651|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
499737|NCT00196664|Chronic Hepatitis C|chronic hepatitis c
499738|NCT00196664|Paroxetine|paroxetine
499739|NCT00196664|Depression|depression
499740|NCT00196690|Aphasia|aphasia
499741|NCT00196690|Donepezil|donepezil
499742|NCT00183703|Depression, Bipolar|depression, bipolar
499743|NCT00183703|Manic-Depressive Psychosis|manic-depressive psychosis
499744|NCT00183716|PTSD|ptsd
499745|NCT00183716|Physical Abuse|physical abuse
499746|NCT00183716|Sexual Abuse|sexual abuse
499747|NCT00183716|Women|women
499748|NCT00183716|Trauma|trauma
499749|NCT00183716|Group Therapy|group therapy
499750|NCT00183716|Substance Abuse|substance abuse
499751|NCT00183729|Major depressive disorder|major depressive disorder
499752|NCT00183729|Rehabilitating|rehabilitating
499753|NCT00183729|Elderly|elderly
499754|NCT00183729|Apathy|apathy
499755|NCT00183742|Phase 1|phase 1
499756|NCT00183742|Phase I|phase i
499757|NCT00183742|Phase one|phase one
499758|NCT00183742|Solid tumor|solid tumor
499759|NCT00183755|Reward Processing|reward processing
499760|NCT00183755|Anhedonia|anhedonia
499761|NCT00183755|Major Depressive Disorder|major depressive disorder
499762|NCT00183755|Depression|depression
499763|NCT00183768|Cognitive Behavioral Treatment For Depression|cognitive behavioral treatment for depression
499764|NCT00183768|Antidepressant Psychopharmacology|antidepressant psychopharmacology
499765|NCT00183768|HIV Risk Behavior|hiv risk behavior
499766|NCT00183768|Injection Drug Use|injection drug use
499768|NCT00183781|Telephone intervention|telephone intervention
499769|NCT00183794|Primary Peritoneal|primary peritoneal
499770|NCT00183820|Testicular|testicular
499771|NCT00183820|Extra gonadal germ cell neoplasm|extra gonadal germ cell neoplasm
499772|NCT00183833|phase 1|phase 1
499773|NCT00183833|phase I|phase i
499774|NCT00183833|phase one|phase one
499775|NCT00183833|colon cancer|colon cancer
499776|NCT00183833|colorectal cancer|colorectal cancer
499777|NCT00183846|pancreas|pancreas
499778|NCT00183846|stomach|stomach
499779|NCT00183846|common bile duct cancer|common bile duct cancer
499780|NCT00183846|ampulla of Vater cancer|ampulla of vater cancer
499781|NCT00183859|solid tumor|solid tumor
499782|NCT00183859|phase I|phase i
499783|NCT00183859|phase one|phase one
499784|NCT00183872|Gastroesophageal cancer|gastroesophageal cancer
499785|NCT00183872|Gastric Adenocarcinoma|gastric adenocarcinoma
499879|NCT00184431|Musculoskeletal Equilibrium|musculoskeletal equilibrium
499786|NCT00183872|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
499787|NCT00183898|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
499788|NCT00183976|Diffuse mixed NHL|diffuse mixed nhl
499789|NCT00183976|Diffuse or follicular large B-cell NHL|diffuse or follicular large b-cell nhl
499790|NCT00183976|Immunoblastic NHL|immunoblastic nhl
499791|NCT00183976|Burkitt or Burkitt-like lymphomas|burkitt or burkitt-like lymphomas
499792|NCT00184093|Cervical Carcinoma|cervical carcinoma
499793|NCT00184106|Phobic disorders|phobic disorders
499794|NCT00184106|Therapy, cognitive|therapy, cognitive
499795|NCT00184106|Paroxetine|paroxetine
499796|NCT00184119|Emergency services, psychiatric|emergency services, psychiatric
499797|NCT00184119|Intensive care units|intensive care units
499798|NCT00184119|Hospitals, psychiatric|hospitals, psychiatric
499800|NCT00184119|Violence|violence
499801|NCT00184132|Intensive care units|intensive care units
499802|NCT00184132|Emergency services, psychiatric|emergency services, psychiatric
499803|NCT00184132|Interior Design and Furnishings|interior design and furnishings
499804|NCT00184132|Intensive Care|intensive care
499805|NCT00184145|Specific (Animal) Phobia|specific (animal) phobia
499806|NCT00184145|EMDR|emdr
499807|NCT00184145|Exposure therapy|exposure therapy
499808|NCT00184158|Cubital tunnel|cubital tunnel
499809|NCT00184158|treatment|treatment
499810|NCT00184158|nerve compression|nerve compression
499811|NCT00184171|Microscopic colitis|microscopic colitis
499812|NCT00184171|Drug treatment|drug treatment
499813|NCT00184171|Diarrhoea|diarrhoea
499814|NCT00184184|Emergency Services, Psychiatric|emergency services, psychiatric
499815|NCT00184184|Tobacco use cessation|tobacco use cessation
499816|NCT00184184|Coffee use cessation|coffee use cessation
499817|NCT00184184|substance use detection|substance use detection
499818|NCT00184184|Substance Abuse Detection|substance abuse detection
499819|NCT00184197|Injection|injection
499820|NCT00184197|Headache|headache
499108|NCT00190580|CKD|ckd
499821|NCT00184197|Cervical muscles|cervical muscles
499822|NCT00184210|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
499823|NCT00184223|Motivational Interviewing|motivational interviewing
499824|NCT00184223|Substance abuse|substance abuse
499825|NCT00184223|Acuteley admitted psychiatric patients|acuteley admitted psychiatric patients
499826|NCT00184223|Emergency Services, Psychiatric|emergency services, psychiatric
499827|NCT00184236|Exercise Training|exercise training
499828|NCT00184236|Cardiovascular diseases|cardiovascular diseases
499829|NCT00184236|Risk factors|risk factors
499830|NCT00184249|Catheter ablation|catheter ablation
499831|NCT00184249|Heart/surgery|heart/surgery
499832|NCT00184249|Cardial surgical procedures|cardial surgical procedures
499833|NCT00184275|Brain metastasis|brain metastasis
499834|NCT00184275|HR MAS spectroscopy|hr mas spectroscopy
499835|NCT00184275|Tissue micro array|tissue micro array
499836|NCT00184275|DNA micro array|dna micro array
499838|NCT00184288|choline|choline
499839|NCT00184288|metastasis|metastasis
499840|NCT00184288|magnetic resonance spectroscopy|magnetic resonance spectroscopy
499841|NCT00184288|treatment response|treatment response
499842|NCT00184301|Eating disorders|eating disorders
499843|NCT00184301|Anorexia nervosa|anorexia nervosa
499844|NCT00184301|Bulimia nervosa|bulimia nervosa
499845|NCT00184301|Personality disorders|personality disorders
499846|NCT00184301|In-patient treatment|in-patient treatment
499847|NCT00184301|out-patient treatment|out-patient treatment
499848|NCT00184301|group therapy|group therapy
499849|NCT00184327|Severe and longstanding psychiatric symptoms in children|severe and longstanding psychiatric symptoms in children
499850|NCT00184340|eTherapy supplementary|etherapy supplementary
499851|NCT00184353|brain metastasis|brain metastasis
499852|NCT00184353|signal to noise ratio|signal to noise ratio
499853|NCT00184353|spectral resolution|spectral resolution
499854|NCT00184366|drug therapy|drug therapy
499855|NCT00184366|efalizumab|efalizumab
499856|NCT00184379|Family|family
499857|NCT00184379|Coping Skills|coping skills
499858|NCT00184379|Psychoeducation|psychoeducation
499859|NCT00184379|Stress, Psychological|stress, psychological
499860|NCT00184379|Health Education|health education
499861|NCT00184392|Sinus surgery|sinus surgery
499862|NCT00184392|endoscopic|endoscopic
499863|NCT00184392|postoperative care|postoperative care
499864|NCT00184392|debridement|debridement
499865|NCT00184392|randomized|randomized
499866|NCT00184392|acute recurrent rhinosinusitis|acute recurrent rhinosinusitis
499867|NCT00184392|chronic rhinosinusitis|chronic rhinosinusitis
499868|NCT00184392|nasal polyps|nasal polyps
499869|NCT00184392|Chronic rhinosinusitis with nasal polyps|chronic rhinosinusitis with nasal polyps
499870|NCT00184392|Chronic rhinosinusitis without nasal polyps|chronic rhinosinusitis without nasal polyps
499871|NCT00184405|Parents with psychiatric or addictive problems|parents with psychiatric or addictive problems
499872|NCT00184418|Immunity|immunity
499873|NCT00184418|Immune System|immune system
499874|NCT00184418|Cytokines|cytokines
499875|NCT00184418|Psychophysiology|psychophysiology
499876|NCT00184418|Psychoneuroimmunology|psychoneuroimmunology
499877|NCT00184431|Cerebrovascular Accident|cerebrovascular accident
499878|NCT00184431|Physical Therapy Techniques|physical therapy techniques
499880|NCT00184431|Rehabilitation|rehabilitation
499881|NCT00184444|angina pectoris|angina pectoris
499882|NCT00184444|hyperoxia|hyperoxia
499883|NCT00184444|endurance training|endurance training
499884|NCT00184444|stroke volume|stroke volume
499885|NCT00184444|cardiac perfusion|cardiac perfusion
499886|NCT00184457|Cardiac heart failure|cardiac heart failure
499887|NCT00184457|Leg press|leg press
499888|NCT00184457|Maximal strength training|maximal strength training
499889|NCT00184457|Serum testosterone|serum testosterone
499890|NCT00184457|Work economy|work economy
499891|NCT00184470|Adult|adult
499892|NCT00184470|Child|child
499893|NCT00184470|Hospitalization/statistics & numerical data|hospitalization/statistics & numerical data
499894|NCT00184470|Retrospective studies|retrospective studies
499895|NCT00184483|Surgery|surgery
499896|NCT00184483|Lichtenstein|lichtenstein
499897|NCT00184483|Prolene Hernia System|prolene hernia system
499898|NCT00184483|Postoperative pain|postoperative pain
499899|NCT00184483|Recurrence|recurrence
499900|NCT00184496|Analgesics, Opioid/pharmacokinetics|analgesics, opioid/pharmacokinetics
499901|NCT00184496|Humans|humans
499902|NCT00184496|Methadone/therapeutic use|methadone/therapeutic use
499903|NCT00184496|Neoplasms/complications|neoplasms/complications
499904|NCT00184496|pain/drug therapy|pain/drug therapy
499905|NCT00184509|schizophrenia|schizophrenia
499906|NCT00184509|psychosocial treatment|psychosocial treatment
499907|NCT00184509|outcome|outcome
499908|NCT00184522|Gastroesophageal Reflux|gastroesophageal reflux
499909|NCT00184522|Esomeprazole|esomeprazole
499910|NCT00184522|Drug treatment|drug treatment
499911|NCT00184535|Low back pain|low back pain
499912|NCT00184535|Neuromuscular control|neuromuscular control
499913|NCT00184535|Anticipatory motor control|anticipatory motor control
499914|NCT00184535|Musculoskeletal Physiologic Processes|musculoskeletal physiologic processes
499915|NCT00184535|Muscle, Skeletal|muscle, skeletal
499916|NCT00184535|Ultrasonography|ultrasonography
499917|NCT00184535|Electromyography|electromyography
499918|NCT00184587|prophylactic|prophylactic
499919|NCT00184587|episodic|episodic
499920|NCT00184587|cluster|cluster
499921|NCT00184587|candesartan|candesartan
499922|NCT00184587|angiotensin II receptor blocker|angiotensin ii receptor blocker
499923|NCT00184587|randomized placebo controlled parallel study|randomized placebo controlled parallel study
499924|NCT00184587|headache diary|headache diary
499925|NCT00184782|colorectal cancer|colorectal cancer
499926|NCT00184782|liver metastases|liver metastases
499927|NCT00184782|metabolic activity|metabolic activity
499928|NCT00184795|Hot flashes|hot flashes
499929|NCT00184821|Diabetes|diabetes
499930|NCT00184821|Ischemia|ischemia
499931|NCT00184821|Annexin A5 scintigraphy|annexin a5 scintigraphy
499932|NCT00184834|colorectal|colorectal
499933|NCT00184834|liver|liver
499934|NCT00184834|metastases|metastases
499935|NCT00184834|health-related quality of life|health-related quality of life
499936|NCT00184834|surgery|surgery
499937|NCT00184847|acetylcholine|acetylcholine
499938|NCT00184847|adenosine|adenosine
499939|NCT00184847|caffeine|caffeine
499940|NCT00184847|ischemic preconditioning|ischemic preconditioning
499941|NCT00184873|randomized controlled trial|randomized controlled trial
499942|NCT00184873|health-counseling|health-counseling
499943|NCT00184873|multi-center study|multi-center study
499944|NCT00184899|free fatty acids|free fatty acids
499945|NCT00184899|vasodilation|vasodilation
499946|NCT00184899|sympathetic activity|sympathetic activity
499947|NCT00184938|opioids|opioids
499948|NCT00184938|ischemic preconditioning|ischemic preconditioning
499949|NCT00184938|morphine|morphine
499950|NCT00184951|HIV|hiv
499951|NCT00184977|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
499952|NCT00184977|Randomized Controlled Trial|randomized controlled trial
499953|NCT00184977|Family Practice|family practice
499954|NCT00184977|Respiratory Function Tests|respiratory function tests
499955|NCT00184977|Health Status|health status
499956|NCT00184990|Endotoxemia|endotoxemia
499957|NCT00184990|Aminoguanidine|aminoguanidine
499958|NCT00185003|Endotoxemia|endotoxemia
499959|NCT00185003|vascular potassium channels|vascular potassium channels
499960|NCT00185003|cytokine|cytokine
499961|NCT00185003|norepinephrine|norepinephrine
499962|NCT00185003|regional blood flow,|regional blood flow,
499963|NCT00185003|inflammation,|inflammation,
499964|NCT00185003|ion channels,|ion channels,
499965|NCT00185003|nitric oxide synthase,|nitric oxide synthase,
499966|NCT00185003|pharmacology.|pharmacology.
499967|NCT00185016|intimate partner abuse|intimate partner abuse
499968|NCT00185016|gender|gender
499969|NCT00185016|education|education
499970|NCT00185016|attitude|attitude
499971|NCT00185016|family doctor|family doctor
499972|NCT00185016|health care utilisation|health care utilisation
499973|NCT00185016|abused women|abused women
499974|NCT00185029|prostate|prostate
499975|NCT00185029|ferumoxtran-10|ferumoxtran-10
499976|NCT00185029|lymph nodes|lymph nodes
499977|NCT00185029|USPIO|uspio
499978|NCT00185042|Atherosclerosis, intravascular ultrasound|atherosclerosis, intravascular ultrasound
499979|NCT00185055|olmesartan|olmesartan
499982|NCT00185055|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
499983|NCT00185068|Systolic hypertension, Angiotensin receptor blocker|systolic hypertension, angiotensin receptor blocker
499984|NCT00185081|colon cancer|colon cancer
499985|NCT00185081|radioimmunoscintigraphy|radioimmunoscintigraphy
499986|NCT00185081|colon-specific antigen,|colon-specific antigen,
499987|NCT00185081|radioimmunotherapy,|radioimmunotherapy,
499988|NCT00185081|radioimmunodetection|radioimmunodetection
499989|NCT00185107|Safety|safety
499990|NCT00185107|Efficacy|efficacy
499991|NCT00185107|WelChol®|welchol®
499992|NCT00185107|Zocor®|zocor®
499993|NCT00185107|Zetia®|zetia®
499994|NCT00186329|Vasodilation|vasodilation
499995|NCT00186329|Congestive heart failure|congestive heart failure
499996|NCT00186329|Renal insufficiency|renal insufficiency
499997|NCT00186329|Diuresis|diuresis
499998|NCT00186329|Serum creatinine|serum creatinine
499999|NCT00186368|Prostate cancer|prostate cancer
500000|NCT00186368|Gene expression|gene expression
500001|NCT00186368|tumor markers|tumor markers
500002|NCT00186368|microarray analysis|microarray analysis
500003|NCT00186420|Prostate Cancer|prostate cancer
500004|NCT00186420|Taxotere|taxotere
500005|NCT00186537|Insulin resistance|insulin resistance
500006|NCT00186537|Insulin resistance syndrome|insulin resistance syndrome
500007|NCT00186537|dyslipidemia|dyslipidemia
500008|NCT00186537|atherogenic dyslipidemia|atherogenic dyslipidemia
500009|NCT00186537|triglyceride/HDL-C ratio|triglyceride/hdl-c ratio
500010|NCT00186641|chronic Graft vs Host Disease|chronic graft vs host disease
500011|NCT00186693|Airway remodeling|airway remodeling
499346|NCT00194532|UTI|uti
500012|NCT00186693|Asthma|asthma
500013|NCT00186693|Hyper-responsiveness|hyper-responsiveness
500014|NCT00186706|Selenium|selenium
500015|NCT00186706|Chronic Obstructive Pulmonaary Disease|chronic obstructive pulmonaary disease
500016|NCT00186706|Cardiovascular Disease|cardiovascular disease
500017|NCT00186706|Anti-oxidant|anti-oxidant
500018|NCT00186706|Pulmonary|pulmonary
500019|NCT00186719|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
500020|NCT00186719|Smoking Related Disease|smoking related disease
500021|NCT00186719|Immune System Changes|immune system changes
500022|NCT00186732|wound closure|wound closure
500023|NCT00186732|Pfannenstiel incision|pfannenstiel incision
500024|NCT00186732|surgical staples|surgical staples
500025|NCT00186732|subcuticular suture|subcuticular suture
500026|NCT00186745|Venous thrombosis|venous thrombosis
500027|NCT00186745|Pulmonary embolism|pulmonary embolism
500028|NCT00186745|Kidney failure|kidney failure
500029|NCT00186745|Anticoagulants|anticoagulants
500030|NCT00186745|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
500031|NCT00186758|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
500032|NCT00186758|TMS|tms
500033|NCT00186771|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
500034|NCT00186771|Paired Pulse|paired pulse
500035|NCT00186784|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
500036|NCT00186784|TMS|tms
500037|NCT00186797|Aplastic Anemia|aplastic anemia
500038|NCT00186810|Anemia|anemia
500039|NCT00186810|Sickle Cell|sickle cell
500040|NCT00186823|Haploidentical stem cell transplant|haploidentical stem cell transplant
500041|NCT00186823|Allogeneic stem cell transplant|allogeneic stem cell transplant
500042|NCT00186823|Mismatched family member stem cell donor transplant|mismatched family member stem cell donor transplant
500043|NCT00186823|Bone marrow transplantHigh risk hematologic malignancies|bone marrow transplanthigh risk hematologic malignancies
500044|NCT00186836|Hepatitis A|hepatitis a
500045|NCT00186836|Hepatitis B|hepatitis b
500046|NCT00186836|Hemodialysis|hemodialysis
500047|NCT00186836|Vaccine|vaccine
500048|NCT00186849|Neuroblastoma|neuroblastoma
500049|NCT00186862|Neuroblastoma|neuroblastoma
500050|NCT00186862|Immunotherapy|immunotherapy
500051|NCT00186862|Gene therapy|gene therapy
500052|NCT00186875|Leukemia|leukemia
500053|NCT00186875|Lymphoblastic|lymphoblastic
500054|NCT00186875|Acute|acute
500055|NCT00186875|Lymphoma|lymphoma
500056|NCT00186875|Non-Hodgkin's|non-hodgkin's
500057|NCT00186888|Cancer of the Eye|cancer of the eye
500058|NCT00186888|Eye Enucleation|eye enucleation
500059|NCT00186901|Bone Density|bone density
500060|NCT00186914|Bone marrow transplant|bone marrow transplant
500061|NCT00186914|bone marrow stromal cells|bone marrow stromal cells
500062|NCT00186914|allogeneic transplant|allogeneic transplant
500063|NCT00186914|Osteodysplasia|osteodysplasia
500064|NCT00186914|Osteogenesis imperfecta|osteogenesis imperfecta
500065|NCT00186914|Gene marking|gene marking
500066|NCT00186914|Stromal cell|stromal cell
500067|NCT00186927|Vaccine|vaccine
500068|NCT00186927|Sendai virus vaccine|sendai virus vaccine
500069|NCT00186940|leukemia|leukemia
500070|NCT00186953|Ultrasound|ultrasound
500071|NCT00186953|Abdominal tumors|abdominal tumors
500072|NCT00186953|Pelvic tumors|pelvic tumors
500073|NCT00186979|Refractory Childhood Solid Tumors|refractory childhood solid tumors
500074|NCT00186992|Sarcoma|sarcoma
500075|NCT00186992|radiation therapy|radiation therapy
500076|NCT00186992|Other musculoskeletal tumors|other musculoskeletal tumors
500077|NCT00187005|Leukemia|leukemia
500078|NCT00187018|Collagen Disease|collagen disease
500079|NCT00187031|Wilms Tumor|wilms tumor
500080|NCT00187044|Vaccine|vaccine
500081|NCT00187044|Prevention|prevention
500082|NCT00187044|HIV|hiv
500083|NCT00187044|AIDS|aids
500084|NCT00187057|Ataxia|ataxia
500085|NCT00187057|alphafetoprotein|alphafetoprotein
500086|NCT00187083|Leukemia|leukemia
500087|NCT00187083|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
500088|NCT00187083|Refractory Acute Lymphoblastic Leukemia|refractory acute lymphoblastic leukemia
500089|NCT00187083|Relapsed Acute Lymphoblastic Leukemia|relapsed acute lymphoblastic leukemia
500090|NCT00187096|Leukemia|leukemia
500091|NCT00187096|Myeloid|myeloid
500092|NCT00187096|Acute|acute
500093|NCT00187109|Thrombocytopenia|thrombocytopenia
500094|NCT00187109|Platelets|platelets
500095|NCT00187109|Thrombopoietin|thrombopoietin
500096|NCT00187122|Non-Hodgkin|non-hodgkin
500097|NCT00187122|Lymphoma|lymphoma
500098|NCT00187135|Pain Management|pain management
500099|NCT00187135|Bone Marrow Aspiration|bone marrow aspiration
500100|NCT00187148|Vaccine|vaccine
500101|NCT00187148|Prevention|prevention
500103|NCT00187148|AIDS|aids
500104|NCT00187161|Mature B-Cell Leukemia|mature b-cell leukemia
500105|NCT00187161|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
500106|NCT00187161|Burkitt's lymphoma|burkitt's lymphoma
500107|NCT00187161|Small noncleaved cell non Hodgkin lymphoma|small noncleaved cell non hodgkin lymphoma
754053|NCT01178749|Hepatitis C|hepatitis c
500108|NCT00187161|Large cell lymphoma|large cell lymphoma
500109|NCT00187174|Brain tumors|brain tumors
500110|NCT00187174|Soft Tissue Sarcomas|soft tissue sarcomas
500111|NCT00187174|Refractory solid tumors|refractory solid tumors
500112|NCT00187174|Recurrent or Refractory Rhabdomyosarcomatous Soft Tissue and Non-Rhabdomyosarcoma Soft Tissue Sarcomas|recurrent or refractory rhabdomyosarcomatous soft tissue and non-rhabdomyosarcoma soft tissue sarcomas
500113|NCT00187213|Ventricular Dyssynchrony|ventricular dyssynchrony
500114|NCT00187226|Brain neoplasm|brain neoplasm
500115|NCT00187226|Brain cancer|brain cancer
500116|NCT00187226|Neoplasm intracranial|neoplasm intracranial
500117|NCT00187239|ICDs|icds
500118|NCT00187239|Ventricular pacing|ventricular pacing
500119|NCT00187239|Patient has been implanted with a dual chamber SJM ICD with AICS for 1 month (± 2 weeks).|patient has been implanted with a dual chamber sjm icd with aics for 1 month (± 2 weeks).
500120|NCT00187239|At the time of enrollment, patient is paced in the RV ≤25% of the time as determined by the device diagnostics.|at the time of enrollment, patient is paced in the rv ≤25% of the time as determined by the device diagnostics.
500121|NCT00187239|Patient is medically stable.|patient is medically stable.
500122|NCT00187252|Ventricular Dyssynchrony|ventricular dyssynchrony
500123|NCT00187278|Standard pacing indication|standard pacing indication
500124|NCT00187291|T-Wave Alternans|t-wave alternans
500125|NCT00187291|ICD|icd
500126|NCT00187291|Primary Prevention|primary prevention
500127|NCT00187317|Exercise|exercise
500128|NCT00187317|Rehabilitation|rehabilitation
500129|NCT00187317|Postural Balance|postural balance
500130|NCT00187317|Accidental Falls|accidental falls
500131|NCT00187317|Geriatrics|geriatrics
500132|NCT00187330|cardiopulmonary bypass|cardiopulmonary bypass
500133|NCT00187330|renal insufficiency|renal insufficiency
500134|NCT00187330|cardiac surgery|cardiac surgery
500135|NCT00187330|n-acetylcysteine|n-acetylcysteine
500136|NCT00187343|Radiotherapy|radiotherapy
500137|NCT00187343|IMRT|imrt
500138|NCT00187356|Coronary Bypass Surgery|coronary bypass surgery
500139|NCT00187356|Coronary Artery Disease|coronary artery disease
500140|NCT00187356|Angiography|angiography
500141|NCT00187356|Arterial Grafts|arterial grafts
500142|NCT00187356|Radial Artery|radial artery
500143|NCT00187356|Saphenous Vein|saphenous vein
500144|NCT00187369|twins|twins
500145|NCT00187369|twin births|twin births
500146|NCT00187369|multiples|multiples
500147|NCT00187382|antenatal corticosteroids|antenatal corticosteroids
500148|NCT00187382|preterm birth|preterm birth
500149|NCT00187382|multiple versus single doses|multiple versus single doses
500150|NCT00187382|follow-up|follow-up
500151|NCT00187395|hypertension|hypertension
500152|NCT00187395|blood pressure|blood pressure
500153|NCT00187395|pregnancy|pregnancy
500154|NCT00187408|Thrombosis|thrombosis
500155|NCT00187408|Pulmonary Embolism|pulmonary embolism
500156|NCT00187408|Low Molecular Weight Heparin|low molecular weight heparin
500157|NCT00187408|Tibial Fractures|tibial fractures
500158|NCT00187421|coronary disease|coronary disease
500159|NCT00187421|angiography|angiography
500160|NCT00187421|intraoperative care|intraoperative care
500161|NCT00187421|vascular patency|vascular patency
500162|NCT00187434|premature infant|premature infant
500163|NCT00187434|supporting extubation|supporting extubation
500164|NCT00187447|prematurity|prematurity
500165|NCT00187447|chronic lung disease|chronic lung disease
500166|NCT00187447|necrotizing enterocolitis|necrotizing enterocolitis
500167|NCT00187447|indomethacin|indomethacin
500168|NCT00187447|ductus arteriosus|ductus arteriosus
500169|NCT00187460|Acute myocardial infarction|acute myocardial infarction
500170|NCT00187460|Congestive heart failure|congestive heart failure
500171|NCT00187460|Quality of care|quality of care
500172|NCT00187460|Reperfusion|reperfusion
500173|NCT00187460|Report cards|report cards
500174|NCT00187460|Quality indicators|quality indicators
500175|NCT00187473|hepatitis C|hepatitis c
500176|NCT00187473|HCV|hcv
500177|NCT00187473|natural history|natural history
500178|NCT00187486|Glioblastoma Multiforme|glioblastoma multiforme
500179|NCT00187486|Gliosarcoma|gliosarcoma
500180|NCT00187486|GBM|gbm
500181|NCT00187486|GS|gs
500182|NCT00187486|Tarceva|tarceva
500183|NCT00187486|Temodar|temodar
500184|NCT00187486|Radiation|radiation
500185|NCT00187486|Newly Diagnosed|newly diagnosed
500186|NCT00187499|Asthma|asthma
500187|NCT00187499|Corticosteroid|corticosteroid
500188|NCT00187499|Gene expression|gene expression
500189|NCT00187512|HIV|hiv
500190|NCT00187512|Antiretroviral Agents|antiretroviral agents
500191|NCT00187512|Drug Resistance, Multiple|drug resistance, multiple
500192|NCT00187512|Long Term Non Progression|long term non progression
500193|NCT00187512|Long Term Non Progressor|long term non progressor
500194|NCT00187512|Elite Suppression|elite suppression
500195|NCT00187512|Elite Suppressor|elite suppressor
500196|NCT00187512|Natural History|natural history
500197|NCT00187512|Observational|observational
500198|NCT00187551|enfuvirtide|enfuvirtide
500199|NCT00187551|T20|t20
500200|NCT00187551|Fuzeon|fuzeon
500201|NCT00187551|Treatment|treatment
500102|NCT00187148|HIV|hiv
644930|NCT00748761|OCD|ocd
499528|NCT00195624|SAA|saa
500202|NCT00187551|Interruption|interruption
500203|NCT00187551|Resistance|resistance
500204|NCT00187551|HIV Drug Resistance|hiv drug resistance
500205|NCT00187551|Antiretroviral Agents|antiretroviral agents
500206|NCT00187551|Salvage Therapy|salvage therapy
500207|NCT00187551|Drug Resistance, Multiple|drug resistance, multiple
500208|NCT00187551|Human Immunodeficiency virus|human immunodeficiency virus
500209|NCT00187564|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
500210|NCT00187564|lipoic acid|lipoic acid
500211|NCT00187564|oxidative stress|oxidative stress
500212|NCT00187577|Alopecia areata|alopecia areata
500213|NCT00187577|Eyelash growth|eyelash growth
500214|NCT00187577|Latanoprost|latanoprost
500215|NCT00187577|Bimatoprost|bimatoprost
500216|NCT00187590|HIV|hiv
500217|NCT00187590|case management|case management
500218|NCT00187603|tobacco|tobacco
500219|NCT00187603|cessation|cessation
500220|NCT00187603|smoking|smoking
500221|NCT00187603|smoking cessation|smoking cessation
500222|NCT00187616|adverse events|adverse events
500223|NCT00187616|clinical trial methodology|clinical trial methodology
500224|NCT00187655|Healthy volunteers willing to be dosed with cefotaxime|healthy volunteers willing to be dosed with cefotaxime
500225|NCT00187668|Healthy Cohort|healthy cohort
500226|NCT00187681|Healthy controls|healthy controls
500227|NCT00187720|Healthy Control|healthy control
500228|NCT00187733|L-carnitine|l-carnitine
500229|NCT00187746|Healthy Control|healthy control
500230|NCT00187759|Abscess|abscess
500231|NCT00187759|Antibitoics|antibitoics
500232|NCT00187759|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
500233|NCT00187772|domestic violence|domestic violence
500234|NCT00187772|preschoolers|preschoolers
500235|NCT00187772|trauma|trauma
500236|NCT00187772|intervention|intervention
500237|NCT00187785|Hispanic|hispanic
500238|NCT00187785|communication|communication
500239|NCT00187798|Healthy Control Twins|healthy control twins
500240|NCT00187811|Angioplasty,|angioplasty,
500241|NCT00187811|Restenosis,|restenosis,
500242|NCT00187811|Photodynamic therapy|photodynamic therapy
500243|NCT00187824|prospective|prospective
500244|NCT00187824|observational|observational
500245|NCT00187824|hormonal|hormonal
500246|NCT00187824|inflammatory|inflammatory
500247|NCT00187824|vioenergetic|vioenergetic
500248|NCT00187824|immune|immune
500249|NCT00187824|sepsis|sepsis
500250|NCT00187837|Stepwise excavation|stepwise excavation
500251|NCT00187850|Pulp capping|pulp capping
500252|NCT00187850|partial pulpotomy|partial pulpotomy
500253|NCT00187850|Exposure of the pulp|exposure of the pulp
500254|NCT00187889|Microvascular Disease|microvascular disease
500255|NCT00187889|Women|women
500256|NCT00187889|Ischemic Heart Disease|ischemic heart disease
500257|NCT00187889|WISE|wise
500258|NCT00187902|Sexually Transmitted Diseases|sexually transmitted diseases
500259|NCT00187902|Chlamydia trachomatis|chlamydia trachomatis
500260|NCT00187902|Neisseria gonorrhoeae|neisseria gonorrhoeae
500261|NCT00187915|Renal transplant|renal transplant
500262|NCT00187915|Cellcept|cellcept
500263|NCT00187915|Therapeutic drug level|therapeutic drug level
500264|NCT00187915|Mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
500265|NCT00187915|Mycophenolate Acid (MPA)|mycophenolate acid (mpa)
500266|NCT00187915|Oral Bioavailability|oral bioavailability
500267|NCT00187915|Immunosuppression|immunosuppression
500268|NCT00187928|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
500269|NCT00187928|Obsessions|obsessions
500270|NCT00187928|Compulsions|compulsions
500271|NCT00187928|Adjunctive treatment|adjunctive treatment
500272|NCT00187941|transplant|transplant
500273|NCT00187941|renal|renal
500274|NCT00187941|Cellcept|cellcept
500275|NCT00187941|therapeutic drug level|therapeutic drug level
500276|NCT00187941|MMF|mmf
500277|NCT00187941|MPA|mpa
500278|NCT00187941|immunosuppression|immunosuppression
500279|NCT00187954|women|women
500280|NCT00187954|chest pain|chest pain
500281|NCT00187954|microvascular dysfunction|microvascular dysfunction
500282|NCT00187954|retinal photography|retinal photography
500283|NCT00187954|Retinal vascular function|retinal vascular function
500284|NCT00187993|growth hormone deficiency|growth hormone deficiency
500285|NCT00187993|growth hormone|growth hormone
500286|NCT00187993|energy expenditure|energy expenditure
500287|NCT00187993|body composition|body composition
500288|NCT00188006|cardiopulmonary bypass, inflammatory response|cardiopulmonary bypass, inflammatory response
500289|NCT00188006|neurologic injury|neurologic injury
500290|NCT00188006|neurocognitive deficit|neurocognitive deficit
500291|NCT00188006|biomaterials|biomaterials
500292|NCT00188006|coronary artery bypass surgery|coronary artery bypass surgery
500293|NCT00188032|pulmonary embolism|pulmonary embolism
500294|NCT00188032|clinical practice|clinical practice
500295|NCT00188032|quality of health care|quality of health care
500296|NCT00188032|diagnostic criteria|diagnostic criteria
500297|NCT00188032|Computer-Assisted Decision Support|computer-assisted decision support
500298|NCT00188032|reminders|reminders
14450|NCT03198156|Transcranial Direct Current Stimulation|transcranial direct current stimulation
14451|NCT03198156|Without Cataplexy|without cataplexy
500299|NCT00188045|Portal hypertension, alcoholic cirrhosis, Hepatic venous pressure gradient, hemodynamic, spironolactone, propranolol|portal hypertension, alcoholic cirrhosis, hepatic venous pressure gradient, hemodynamic, spironolactone, propranolol
500300|NCT00188058|Acute respiratory distress syndrome|acute respiratory distress syndrome
500426|NCT00196742|alpha Galactosidase A|alpha galactosidase a
500301|NCT00188058|Positive end-expiratory pressure|positive end-expiratory pressure
500302|NCT00188058|Acute lung injury|acute lung injury
500303|NCT00188058|Mechanical ventilation|mechanical ventilation
500304|NCT00188058|Randomized controlled trial|randomized controlled trial
500305|NCT00188071|medical abortion|medical abortion
500306|NCT00188071|analgesia|analgesia
500307|NCT00188110|Water-Enema Computed Tomography|water-enema computed tomography
500308|NCT00188110|colon tumor|colon tumor
500309|NCT00188110|coloscopy|coloscopy
500310|NCT00188110|suspicion of colon tumor|suspicion of colon tumor
500311|NCT00188110|coloscopy or surgery|coloscopy or surgery
500312|NCT00188123|Myocardial infarction|myocardial infarction
500313|NCT00188123|MRI late enhancement|mri late enhancement
500314|NCT00188123|Atrial fibrillation|atrial fibrillation
500315|NCT00188136|AML, allogeneic transplantation, high-risk, karyotype|aml, allogeneic transplantation, high-risk, karyotype
500316|NCT00188149|Hodgkin's Lymphoma|hodgkin's lymphoma
500317|NCT00188149|Chemotherapy|chemotherapy
500318|NCT00188149|Radiation therapy|radiation therapy
500319|NCT00188149|PET|pet
500320|NCT00188188|Endothelial|endothelial
500321|NCT00188188|Dysfunction|dysfunction
500322|NCT00188188|Systemic|systemic
500323|NCT00188188|Lupus|lupus
500324|NCT00188201|Hepatitis C|hepatitis c
500325|NCT00188201|neucognitive functions|neucognitive functions
500326|NCT00188201|neuropsychological testing|neuropsychological testing
500327|NCT00188201|antiviral treatment|antiviral treatment
500328|NCT00188214|perfusion|perfusion
500329|NCT00188214|CT|ct
500330|NCT00188214|CAT|cat
500331|NCT00188214|non-small|non-small
500332|NCT00188214|lung|lung
500333|NCT00188227|Bone marrow puncture|bone marrow puncture
500334|NCT00188227|Pain|pain
500335|NCT00188240|hepatitis C|hepatitis c
500336|NCT00188240|insulin resistance|insulin resistance
500337|NCT00188240|antiviral therapy|antiviral therapy
500338|NCT00188253|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
500339|NCT00188253|PET scan|pet scan
500340|NCT00188253|MRI|mri
500341|NCT00188253|EBV virus|ebv virus
500342|NCT00188279|ct|ct
500343|NCT00188279|scan|scan
500344|NCT00188279|lung|lung
500345|NCT00188279|follow-up|follow-up
500346|NCT00188292|Human Papillomavirus|human papillomavirus
500347|NCT00188292|Anal|anal
500348|NCT00188292|Cancer screening|cancer screening
500349|NCT00188292|Immunodeficiency|immunodeficiency
500350|NCT00188292|HIV|hiv
500351|NCT00188305|Risk counselling|risk counselling
500352|NCT00188305|Health education|health education
500353|NCT00188305|Prevention|prevention
500354|NCT00188305|Behavioral|behavioral
500355|NCT00188305|Screening|screening
500356|NCT00188305|Intervention|intervention
500357|NCT00188305|Telephone vs in person|telephone vs in person
500358|NCT00188331|cognitive function|cognitive function
500359|NCT00188331|fatigue|fatigue
500360|NCT00188331|colorectal cancer|colorectal cancer
500361|NCT00188331|chemotherapy|chemotherapy
500362|NCT00188331|cognitive impairment|cognitive impairment
500363|NCT00188344|laparoscopic myotomy|laparoscopic myotomy
500364|NCT00188344|pneumatic dilatation|pneumatic dilatation
500365|NCT00188344|motility disorder|motility disorder
500366|NCT00188344|dysphasia|dysphasia
500367|NCT00188344|health-related quality of life|health-related quality of life
500368|NCT00188383|Hyperalgesia|hyperalgesia
500369|NCT00188383|Quantitative Sensory Testing|quantitative sensory testing
500370|NCT00188383|Pain|pain
500371|NCT00188383|Opioid use|opioid use
500373|NCT00188396|Major Depressive Disorder|major depressive disorder
500374|NCT00188396|Women's Mental Health|women's mental health
500375|NCT00188396|Hormones|hormones
500376|NCT00188396|Citalopram|citalopram
500377|NCT00188396|Antidepressive agents|antidepressive agents
500378|NCT00188396|Mental Health|mental health
500379|NCT00188500|epilepsy|epilepsy
500380|NCT00188500|atkins diet|atkins diet
500381|NCT00188591|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
500382|NCT00188591|Breast Cancer Risk|breast cancer risk
500383|NCT00188617|LUNG CANCER|lung cancer
500384|NCT00188617|IRESSA|iressa
500385|NCT00188617|GEFITINIB|gefitinib
500386|NCT00188617|STAGE 1A & 1B|stage 1a & 1b
500387|NCT00188617|NEOADJUVANT|neoadjuvant
500388|NCT00188617|PHASE 2|phase 2
500389|NCT00188630|Cardiac Surgery|cardiac surgery
500390|NCT00188630|Acute Renal Failure|acute renal failure
500391|NCT00188630|N-acetylcysteine|n-acetylcysteine
500392|NCT00188630|Cardiopulmonary bypass|cardiopulmonary bypass
97089|NCT02682459|Extracapillary glomerulonephritis|extracapillary glomerulonephritis
499700|NCT00196547|Asthma|asthma
500393|NCT00188643|Bipolar Disorder, Depression, Anticonvulsants, Antidepressants|bipolar disorder, depression, anticonvulsants, antidepressants
500486|NCT00196989|Phase IIb|phase iib
500394|NCT00188682|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
500395|NCT00188682|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
500396|NCT00188682|Breast Cancer Risk|breast cancer risk
500397|NCT00188721|Breast Cancer Risk|breast cancer risk
500398|NCT00188721|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
500399|NCT00188721|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
500401|NCT00188734|Eary Diagnosis|eary diagnosis
500402|NCT00188734|Screening|screening
500403|NCT00188747|Coagulopathy|coagulopathy
500404|NCT00188747|Cardiac Surgery|cardiac surgery
500405|NCT00188747|Point of Care|point of care
500406|NCT00188747|Monitoring|monitoring
500407|NCT00188760|Breast Transillumination Spectroscopy|breast transillumination spectroscopy
500408|NCT00188760|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
500409|NCT00188760|Breast Cancer Risk|breast cancer risk
500410|NCT00188773|n-acetylcysteine,|n-acetylcysteine,
500411|NCT00188773|free fatty acid,|free fatty acid,
500412|NCT00188773|glucose stimulated insulin secretion,|glucose stimulated insulin secretion,
500413|NCT00188773|insulin resistance syndrome|insulin resistance syndrome
500414|NCT00188773|antioxidant therapy|antioxidant therapy
500415|NCT00188773|Insulin Resistance|insulin resistance
500416|NCT00196703|Aphasia|aphasia
500417|NCT00196703|Memantine|memantine
500418|NCT00196703|Constraint-induced language therapy|constraint-induced language therapy
500419|NCT00196703|Event-related potentials|event-related potentials
500420|NCT00196716|alpha Galactosidase A|alpha galactosidase a
500421|NCT00196716|aGAL|agal
500422|NCT00196716|rh aGAL|rh agal
500423|NCT00196716|Fabry|fabry
500424|NCT00196716|GL3|gl3
500425|NCT00196716|Fabrazyme|fabrazyme
500427|NCT00196742|aGAL (alpha-galactosidase)|agal (alpha-galactosidase)
500428|NCT00196742|Fabry|fabry
500429|NCT00196742|GL3 (globotriaosylceramide)|gl3 (globotriaosylceramide)
500430|NCT00196742|Anderson-Fabry Disease|anderson-fabry disease
500431|NCT00196742|angiokeratomas|angiokeratomas
500432|NCT00196742|GLA deficiency (gene deficiency)|gla deficiency (gene deficiency)
500433|NCT00196742|errors in metabolism|errors in metabolism
500434|NCT00196768|relapsed|relapsed
500435|NCT00196768|acute promyelocytic leukemia|acute promyelocytic leukemia
500436|NCT00196768|arsenic|arsenic
500437|NCT00196781|prostate cancer treatment|prostate cancer treatment
500438|NCT00196781|medical decision making|medical decision making
500439|NCT00196781|informed decision making|informed decision making
500440|NCT00196781|shared decision making|shared decision making
500441|NCT00196781|decision aid|decision aid
500442|NCT00196781|patient education|patient education
500443|NCT00196794|Pseudomembranous Colitis|pseudomembranous colitis
500444|NCT00196794|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
500445|NCT00196794|C. difficile|c. difficile
500446|NCT00196794|CDAD|cdad
500447|NCT00196807|prostate cancer screening|prostate cancer screening
500448|NCT00196807|medical decision making|medical decision making
500449|NCT00196807|informed decision making|informed decision making
500450|NCT00196807|patient education|patient education
500451|NCT00196807|male|male
500452|NCT00196820|Metastatic breast cancer|metastatic breast cancer
500453|NCT00196820|HER2 negative, medium-risk, metastatic breast cancer|her2 negative, medium-risk, metastatic breast cancer
500454|NCT00196833|Breast Cancer in Pregnancy|breast cancer in pregnancy
500455|NCT00196833|Prospective and Retrospective Register|prospective and retrospective register
500456|NCT00196833|Study|study
500457|NCT00196846|hormone insensitive breast cancer|hormone insensitive breast cancer
500458|NCT00196846|Prevention of Chemotherapy induced ovarian failure|prevention of chemotherapy induced ovarian failure
500459|NCT00196846|P.O.F.|p.o.f.
500460|NCT00196846|GnRH-Agonist Goserelin|gnrh-agonist goserelin
500461|NCT00196859|Early Breast Cancer in elderly Patients|early breast cancer in elderly patients
500462|NCT00196859|Ibandronate plus/minus Capecitabine in elderly patients|ibandronate plus/minus capecitabine in elderly patients
500463|NCT00196872|dose dense sequence|dose dense sequence
500464|NCT00196872|dose dense combination|dose dense combination
500465|NCT00196872|node positive disease|node positive disease
500466|NCT00196885|cancer cachexia|cancer cachexia
500467|NCT00196885|muscle wasting|muscle wasting
500468|NCT00196885|weight loss|weight loss
500469|NCT00196885|proteolysis|proteolysis
500470|NCT00196898|Parkinson´s disease|parkinson´s disease
500471|NCT00196898|fibrotic valvular heart fibrosis|fibrotic valvular heart fibrosis
500472|NCT00196898|ergot dopamine agonists|ergot dopamine agonists
500473|NCT00196898|non-ergot dopamine agonists|non-ergot dopamine agonists
500474|NCT00196937|HPV Vaccine Safety|hpv vaccine safety
500475|NCT00196976|Safety|safety
500476|NCT00196976|Meningococcal vaccine|meningococcal vaccine
500477|NCT00196976|Dose selection|dose selection
500478|NCT00196976|Toddlers|toddlers
500479|NCT00196976|Immunogenicity|immunogenicity
499799|NCT00184119|Aggression|aggression
500480|NCT00196976|Conjugate vaccine|conjugate vaccine
500481|NCT00196976|Reactogenicity|reactogenicity
500482|NCT00196976|Children|children
500483|NCT00196989|Efficacy|efficacy
500484|NCT00196989|PPARpan|pparpan
500485|NCT00196989|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
500487|NCT00196989|Safety|safety
500488|NCT00196989|Pharmacokinetics|pharmacokinetics
500489|NCT00196989|GW677954|gw677954
500490|NCT00196989|Pharmacodynamics|pharmacodynamics
500491|NCT00196989|Tolerability|tolerability
500492|NCT00196989|Dose-Ranging|dose-ranging
500493|NCT00198874|drug abuse|drug abuse
500494|NCT00198874|drug dependence|drug dependence
500495|NCT00198874|treatment|treatment
500496|NCT00198874|randomized trial|randomized trial
500497|NCT00198874|stage II study|stage ii study
500498|NCT00198874|adolescents|adolescents
500499|NCT00198874|young adults|young adults
500500|NCT00198874|efficacy study|efficacy study
500501|NCT00198887|newborn|newborn
500502|NCT00198887|operations research|operations research
500503|NCT00198887|newborn survival|newborn survival
500504|NCT00198887|Neonatal illness/mortality|neonatal illness/mortality
500505|NCT00198887|Delivery complications|delivery complications
500506|NCT00198939|drug prevention|drug prevention
500507|NCT00198939|adolescence|adolescence
500508|NCT00198939|middle school|middle school
500509|NCT00198939|randomized trial|randomized trial
500510|NCT00198939|family therapy|family therapy
500511|NCT00198939|cognitive-behavioral|cognitive-behavioral
500512|NCT00198939|efficacy|efficacy
500513|NCT00198939|selected youth|selected youth
500514|NCT00198939|indicated youth|indicated youth
500516|NCT00198978|Treatment|treatment
500517|NCT00198978|Elderly|elderly
500518|NCT00198978|De novo|de novo
500519|NCT00198991|ALL|all
500520|NCT00198991|Treatment|treatment
500521|NCT00198991|de novo|de novo
500522|NCT00198991|Minimal residual disease|minimal residual disease
500523|NCT00198991|Adult|adult
500524|NCT00199004|ALL|all
500525|NCT00199004|Treatment|treatment
500526|NCT00199004|De novo|de novo
500527|NCT00199004|Minimal residual disease|minimal residual disease
500528|NCT00199004|Rituximab|rituximab
500529|NCT00199004|Adult|adult
500530|NCT00199017|T-LBL|t-lbl
500531|NCT00199017|Treatment|treatment
500532|NCT00199017|De novo|de novo
500533|NCT00199017|Chemotherapy|chemotherapy
500534|NCT00199017|Adult|adult
500535|NCT00199017|Lymphoma, lymphoblastic, T-cell|lymphoma, lymphoblastic, t-cell
500536|NCT00199030|Relapse|relapse
500537|NCT00199030|T-ALL|t-all
500538|NCT00199030|T-LBL|t-lbl
500539|NCT00199030|MabCampath|mabcampath
500540|NCT00199030|Minimal residual disease|minimal residual disease
500541|NCT00199030|Lymphoma, lymphoblastic, T-cell|lymphoma, lymphoblastic, t-cell
500542|NCT00199056|ALL|all
500543|NCT00199056|Treatment|treatment
500544|NCT00199056|De Novo|de novo
500545|NCT00199056|Adult|adult
500546|NCT00199069|ALL|all
500547|NCT00199069|Treatment|treatment
500548|NCT00199069|De Novo|de novo
500549|NCT00199069|Adult|adult
500550|NCT00199082|High-grade NHL|high-grade nhl
500551|NCT00199082|De novo|de novo
500552|NCT00199082|Mature B-ALL|mature b-all
500553|NCT00199082|Burkitt'S NHL|burkitt's nhl
500554|NCT00199082|Chemotherapy|chemotherapy
500555|NCT00199082|Rituximab|rituximab
500556|NCT00199082|Primary mediastinal diffuse large cell lymphoma|primary mediastinal diffuse large cell lymphoma
500557|NCT00199082|B-precursor lymphoblastic lymphoma|b-precursor lymphoblastic lymphoma
500559|NCT00199095|Elderly|elderly
500560|NCT00199095|Chemotherapy|chemotherapy
500561|NCT00199108|CNS relapse|cns relapse
500562|NCT00199108|ALL|all
500563|NCT00199108|Treatment|treatment
500564|NCT00199134|neoadjuvant treatment|neoadjuvant treatment
500565|NCT00199160|local recurrence and or metastatic disease|local recurrence and or metastatic disease
500566|NCT00199160|Previously treated with platinum|previously treated with platinum
500567|NCT00199160|carcinoma of the head and neck|carcinoma of the head and neck
500568|NCT00199173|colorectal cancer|colorectal cancer
500569|NCT00199173|liver metastasis|liver metastasis
500570|NCT00199173|intraarterial hepatic injection|intraarterial hepatic injection
500571|NCT00199173|yttrium loaded microspheres|yttrium loaded microspheres
500572|NCT00199173|colorectal neoplasm metastatic to the liver|colorectal neoplasm metastatic to the liver
500573|NCT00199212|HER-2 positive|her-2 positive
500574|NCT00199212|metastatic breast cancer patients|metastatic breast cancer patients
500575|NCT00199225|Thorough study QT/QTc|thorough study qt/qtc
500576|NCT00199225|Cardiac repolarization|cardiac repolarization
500577|NCT00199225|QT prolongation|qt prolongation
500578|NCT00199238|ANTIHISTAMINE|antihistamine
500579|NCT00199238|RUPATADINE|rupatadine
500580|NCT00199238|WHEAL|wheal
500581|NCT00199238|FLARE|flare
500582|NCT00199238|DERMATOLOGY|dermatology
500583|NCT00199251|URTICARIA, WHEALS, FLARE, ANTIHISTAMINE, ANTIHISTAMINE|urticaria, wheals, flare, antihistamine, antihistamine
500584|NCT00199264|antifungal oral therapy|antifungal oral therapy
645396|NCT00759603|CLL|cll
500585|NCT00199264|efficacy acute candidiasis vulvaginitis|efficacy acute candidiasis vulvaginitis
500586|NCT00199290|Trafermin|trafermin
500587|NCT00199290|Periodontitis|periodontitis
500588|NCT00199303|NMDAreceptor antagonist, dextromethorphan|nmdareceptor antagonist, dextromethorphan
500589|NCT00199303|pain, post-operative|pain, post-operative
500590|NCT00199303|opioid consumption, morphine|opioid consumption, morphine
500684|NCT00199745|atorvastatin|atorvastatin
14452|NCT03198143|Decision-making|decision-making
14647|NCT03197038|Cognitive function|cognitive function
14648|NCT03197038|Kidney Disease|kidney disease
500591|NCT00199316|patient who recieve kidney surgery and Patient controlled anesthesia with spinal morphine, intrathecal|patient who recieve kidney surgery and patient controlled anesthesia with spinal morphine, intrathecal
500594|NCT00199342|Melanoma|melanoma
500595|NCT00199342|Monoclonal Antibody|monoclonal antibody
500596|NCT00199342|Anti-GD-3|anti-gd-3
500597|NCT00199355|Parkinson's Disease|parkinson's disease
500598|NCT00199355|levodopa|levodopa
500599|NCT00199355|end of dose wearing off|end of dose wearing off
500600|NCT00199355|OFF time|off time
500601|NCT00199368|Parkinson's disease|parkinson's disease
500602|NCT00199368|levodopa|levodopa
500603|NCT00199368|end of dose wearing off|end of dose wearing off
500604|NCT00199368|OFF time|off time
500605|NCT00199381|Parkinson's Disease|parkinson's disease
500606|NCT00199381|levodopa|levodopa
500607|NCT00199381|end of dose wearing off|end of dose wearing off
500608|NCT00199381|OFF time|off time
500609|NCT00199394|KW-6002 (istradefylline)|kw-6002 (istradefylline)
500610|NCT00199394|Entacapone|entacapone
500611|NCT00199394|Placebo|placebo
500612|NCT00199394|Parkinson's Disease|parkinson's disease
500613|NCT00199394|Motor Response Complications|motor response complications
500614|NCT00199394|Levodopa Therapy|levodopa therapy
500615|NCT00199407|Parkinson's disease|parkinson's disease
500616|NCT00199407|levodopa|levodopa
500617|NCT00199407|end of dose wearing off|end of dose wearing off
500618|NCT00199407|OFF time|off time
500619|NCT00199420|levodopa|levodopa
500620|NCT00199420|end of dose wearing off|end of dose wearing off
500621|NCT00199420|OFF time|off time
500622|NCT00199433|Parkinson's Disease|parkinson's disease
500623|NCT00199433|Movement Disorder|movement disorder
500624|NCT00199433|Neurology,|neurology,
500625|NCT00199433|Clinical Trial|clinical trial
500626|NCT00199446|Sleep -Sleep Disorder|sleep -sleep disorder
500627|NCT00199446|Sleep- Restless Legs Syndrome|sleep- restless legs syndrome
500628|NCT00199446|Clinical Trial|clinical trial
500629|NCT00199459|calculi|calculi
500630|NCT00199459|proteomics|proteomics
500631|NCT00199485|prostate cancer|prostate cancer
500632|NCT00199485|Luteinizing Hormone Releasing Hormone|luteinizing hormone releasing hormone
500633|NCT00199485|LHRH|lhrh
500634|NCT00199498|Permanent Pacemaker Implantation- Lead Position|permanent pacemaker implantation- lead position
500635|NCT00199511|Brain Tumor|brain tumor
500636|NCT00199511|Intracranial Pressure|intracranial pressure
500637|NCT00199511|Osmolarity|osmolarity
500638|NCT00199511|Seric|seric
500639|NCT00199511|Hypertonic Solution|hypertonic solution
500640|NCT00199524|ureteroscopy|ureteroscopy
500641|NCT00199524|stone free|stone free
500642|NCT00199550|Transurethral Resection of Prostate|transurethral resection of prostate
500643|NCT00199550|TURP|turp
500644|NCT00199563|Viagra|viagra
500645|NCT00199563|sildenafil|sildenafil
500646|NCT00199576|Corticosteroids|corticosteroids
500647|NCT00199576|Laryngotracheal injury|laryngotracheal injury
500648|NCT00199576|Intubation-extubation|intubation-extubation
500649|NCT00199589|Spastic equinovarus|spastic equinovarus
500650|NCT00199589|Botox|botox
500651|NCT00199589|Ankle foot orthosis|ankle foot orthosis
500652|NCT00199615|lung cancer, 18 FDG, PET|lung cancer, 18 fdg, pet
500653|NCT00199628|fetomaternal tissular alloimmunization|fetomaternal tissular alloimmunization
500654|NCT00199628|Mothers having a child suffering from:|mothers having a child suffering from:
500655|NCT00199628|neonatal membranous glomerulonephritis|neonatal membranous glomerulonephritis
500656|NCT00199628|unexplained neonatal tubular defect|unexplained neonatal tubular defect
500863|NCT00200538|Mémantine|mémantine
500657|NCT00199628|unexplained thrombotic microangiopathy|unexplained thrombotic microangiopathy
500658|NCT00199628|neonatal hemochromatosis|neonatal hemochromatosis
500659|NCT00199654|colorectal cancer stage II and III|colorectal cancer stage ii and iii
500660|NCT00199667|MMF, Monitoring, area under curve (AUC), kidney transplantation|mmf, monitoring, area under curve (auc), kidney transplantation
500661|NCT00199680|PETscan, cervical cancer|petscan, cervical cancer
500662|NCT00199693|Hemodynamic and respiratory changes and pregnancy|hemodynamic and respiratory changes and pregnancy
500663|NCT00199693|Healthy pregnant women|healthy pregnant women
500664|NCT00199706|Intracranial Pressure|intracranial pressure
500665|NCT00199706|Intracranial Hypertension|intracranial hypertension
500666|NCT00199706|Hypertonic Solutions|hypertonic solutions
500667|NCT00199706|Saline Solutions, Hypertonic|saline solutions, hypertonic
500668|NCT00199719|drug monitoring|drug monitoring
500669|NCT00199719|ribavirin-pharmacokinetic|ribavirin-pharmacokinetic
500670|NCT00199719|pharmacodynamics|pharmacodynamics
500671|NCT00199719|chronic hepatitis C|chronic hepatitis c
500672|NCT00199719|non 2 non 3 genotype|non 2 non 3 genotype
500673|NCT00199732|Chronic hepatitis B|chronic hepatitis b
500674|NCT00199732|CCC DNA kinetics|ccc dna kinetics
500675|NCT00199732|Total HBV DNA kinetics|total hbv dna kinetics
500676|NCT00199732|Adefovir-Dipovixil|adefovir-dipovixil
500677|NCT00199732|Peg interferon alpha 2a|peg interferon alpha 2a
500679|NCT00199745|statins|statins
500680|NCT00199745|statin therapy|statin therapy
500681|NCT00199745|adverse events|adverse events
500682|NCT00199745|side effect|side effect
500683|NCT00199745|Myotoxicity|myotoxicity
500685|NCT00199745|Atorvastatin Therapy|atorvastatin therapy
500686|NCT00199758|Non small cell lung carcinoma|non small cell lung carcinoma
500687|NCT00199758|Cisplatin|cisplatin
500688|NCT00199758|Gemcitabine|gemcitabine
500689|NCT00199758|Paclitaxel|paclitaxel
500690|NCT00199771|Cardiac Surgery|cardiac surgery
500691|NCT00199771|Infant|infant
500692|NCT00199771|Infant, Newborn|infant, newborn
500693|NCT00199771|Hypertonic Solutions|hypertonic solutions
500694|NCT00199771|Saline Solution, Hypertonic|saline solution, hypertonic
500695|NCT00199771|Capillary leak|capillary leak
500696|NCT00199771|Inflammation Mediators|inflammation mediators
500697|NCT00199784|Hemodynamic|hemodynamic
500698|NCT00199784|Hypotension|hypotension
500699|NCT00199784|Spinal|spinal
500700|NCT00199784|Anesthesia|anesthesia
500701|NCT00199784|Healthy pregnant women for elective cesarean section|healthy pregnant women for elective cesarean section
500702|NCT00199797|Colorectal Cancer|colorectal cancer
500703|NCT00199797|huA33|hua33
500704|NCT00199797|antibody|antibody
500705|NCT00199797|chemotherapy|chemotherapy
500706|NCT00199810|Cardiac output|cardiac output
500707|NCT00199810|Preeclamptic women|preeclamptic women
500708|NCT00199810|systemic vascular resistance|systemic vascular resistance
500709|NCT00199810|blood pressure|blood pressure
500710|NCT00199823|Myocardial infarction|myocardial infarction
500711|NCT00199823|bone marrow cells|bone marrow cells
500712|NCT00199823|cell transplantation|cell transplantation
500713|NCT00199836|cancer vaccine|cancer vaccine
500714|NCT00199836|NY-ESO-1b peptide|ny-eso-1b peptide
500715|NCT00199836|CpG 7909|cpg 7909
500716|NCT00199836|Montanide ISA-51|montanide isa-51
500717|NCT00199836|LAGE-1|lage-1
500718|NCT00199836|immune response|immune response
500719|NCT00199836|safety|safety
500720|NCT00199849|NY-ESO-1|ny-eso-1
500721|NCT00199849|DNA|dna
500722|NCT00199862|huA33|hua33
500723|NCT00199862|antibody|antibody
500724|NCT00199862|colorectal cancer|colorectal cancer
500725|NCT00199862|Iodine 124|iodine 124
500726|NCT00199862|124I|124i
500727|NCT00199862|03-124|03-124
500728|NCT00199875|antibody|antibody
500729|NCT00199875|renal cell carcinoma|renal cell carcinoma
500730|NCT00199875|advanced renal cancer|advanced renal cancer
500731|NCT00199875|cG250|cg250
500732|NCT00199875|90Y|90y
500733|NCT00199888|Kidney Cancer|kidney cancer
500734|NCT00199888|Renal Cancer|renal cancer
500735|NCT00199888|Neoplasms, Kidney|neoplasms, kidney
500736|NCT00199888|cG250|cg250
500737|NCT00199888|antibody|antibody
500738|NCT00199888|Iodine 124|iodine 124
500739|NCT00199901|Phase II|phase ii
500740|NCT00199901|Randomized Controlled Trial|randomized controlled trial
500741|NCT00199901|Double-Blind|double-blind
500742|NCT00199901|Cancer Vaccine|cancer vaccine
500743|NCT00199901|NY-ESO-1 protein, human|ny-eso-1 protein, human
500744|NCT00199901|ISCOMATRIX, immunological adjuvant|iscomatrix, immunological adjuvant
500745|NCT00199914|Diathermy|diathermy
500746|NCT00199914|Short-wave therapy|short-wave therapy
500747|NCT00199914|Osteoarthritis|osteoarthritis
500748|NCT00199914|Knee|knee
500749|NCT00199940|Schizophrenia|schizophrenia
500750|NCT00199940|Pediatric psychotic disorders|pediatric psychotic disorders
500751|NCT00199940|Ziprasidone|ziprasidone
500752|NCT00199953|Postnasal drainage|postnasal drainage
500753|NCT00199953|Extraesophageal reflux|extraesophageal reflux
500754|NCT00199966|Bipolar Disorder; Pediatric Bipolar Disorder; Depakote ER|bipolar disorder; pediatric bipolar disorder; depakote er
500755|NCT00199979|Antiretroviral Therapy|antiretroviral therapy
500756|NCT00199979|Nevirapine|nevirapine
500757|NCT00199979|HIV Viral Load|hiv viral load
500758|NCT00199979|Adherence|adherence
500759|NCT00199979|Quality of Life|quality of life
500760|NCT00199979|Resistance Mutations|resistance mutations
500761|NCT00199992|acute wounds|acute wounds
500762|NCT00199992|wounds|wounds
500763|NCT00199992|platelets|platelets
500764|NCT00199992|platelet gel|platelet gel
500765|NCT00200005|Slow transit constipation|slow transit constipation
500766|NCT00200005|Fecal incontinence|fecal incontinence
500767|NCT00200005|Constipation|constipation
500768|NCT00200005|Idiopathic slow transit constipation|idiopathic slow transit constipation
500769|NCT00200005|Chronic constipation|chronic constipation
500770|NCT00200018|Obesity|obesity
500771|NCT00200018|Morbid obesity|morbid obesity
500772|NCT00200018|Diabetes|diabetes
500773|NCT00200044|GERD|gerd
500774|NCT00200057|Fecal Incontinence|fecal incontinence
645672|NCT00762125|FMS|fms
500775|NCT00200057|InterStim|interstim
500776|NCT00200070|Angina Pectoris Pain|angina pectoris pain
500777|NCT00200083|Obesity|obesity
500778|NCT00200083|Morbid Obesity|morbid obesity
500779|NCT00200083|SHAPE|shape
500780|NCT00200083|IGS|igs
500781|NCT00200083|Implantable Gastric Stimulator|implantable gastric stimulator
500782|NCT00200096|Cancer|cancer
500783|NCT00200096|Fatigue|fatigue
500784|NCT00200135|motorcycle accident|motorcycle accident
500785|NCT00200135|helmet|helmet
500786|NCT00200135|traumatic brain injury|traumatic brain injury
500787|NCT00200135|financial burden|financial burden
500788|NCT00200148|Pancreaticoduodenectomy|pancreaticoduodenectomy
500789|NCT00200148|Hepatectomy|hepatectomy
500790|NCT00200148|Major Hepatic resection|major hepatic resection
500791|NCT00200148|Acute Normovolemic Hemodilution|acute normovolemic hemodilution
500792|NCT00200174|Breast cancer|breast cancer
500793|NCT00200174|estrogen|estrogen
500794|NCT00200174|postmenopausal|postmenopausal
500795|NCT00200187|Prostatectomy|prostatectomy
500796|NCT00200187|Anesthesia|anesthesia
500797|NCT00200187|Blood Loss|blood loss
500798|NCT00200200|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
500799|NCT00200200|DEXAMETHASONE|dexamethasone
500800|NCT00200200|FLOXURIDINE|floxuridine
500801|NCT00200200|FLUOROURACIL|fluorouracil
500802|NCT00200200|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
500803|NCT00200200|LEUCOVORIN|leucovorin
500804|NCT00200200|OXALIPLATIN|oxaliplatin
500805|NCT00200200|Colon|colon
500806|NCT00200200|Rectal|rectal
500807|NCT00200200|04-086|04-086
500808|NCT00200200|Adjuvant postoperative chemo for CLM|adjuvant postoperative chemo for clm
500809|NCT00200226|pain/discomfort|pain/discomfort
500810|NCT00200226|cervical dilatation|cervical dilatation
500811|NCT00200226|side effects|side effects
500812|NCT00200252|oxytocin|oxytocin
500813|NCT00200252|third stage|third stage
500814|NCT00200252|dose|dose
500815|NCT00200252|route|route
500816|NCT00200252|blood loss|blood loss
500817|NCT00200278|Exercise|exercise
500818|NCT00200278|Intervention studies|intervention studies
500819|NCT00200278|Decision-making|decision-making
500820|NCT00200278|computer assisted Expert systems|computer assisted expert systems
500821|NCT00200278|telephone|telephone
500822|NCT00200304|Obesity|obesity
500823|NCT00200304|Weight loss|weight loss
500824|NCT00200304|Internet|internet
500825|NCT00200317|Exercise|exercise
500826|NCT00200317|Internet|internet
500827|NCT00200317|Print|print
500828|NCT00200317|Randomized Controlled Trial|randomized controlled trial
500829|NCT00200317|Exercise Intervention|exercise intervention
500830|NCT00200330|weight loss|weight loss
500831|NCT00200330|physical activity|physical activity
500832|NCT00200330|diet|diet
500833|NCT00200330|home environment|home environment
500834|NCT00200343|Chronic hepatitis C, Ursodeoxycholic acid|chronic hepatitis c, ursodeoxycholic acid
500835|NCT00200369|HIV|hiv
500836|NCT00200369|Adherence|adherence
500837|NCT00200369|Antiretroviral therapy|antiretroviral therapy
500838|NCT00200369|Protease inhibitor|protease inhibitor
500839|NCT00200369|Lopinavir|lopinavir
500840|NCT00200408|cancer of head and neck|cancer of head and neck
500841|NCT00200408|smoking|smoking
500842|NCT00200421|Nebivolol|nebivolol
500843|NCT00200421|Atenolol|atenolol
500844|NCT00200421|Exercise|exercise
500845|NCT00200421|Hypertension|hypertension
500846|NCT00200434|Nebivolol|nebivolol
500847|NCT00200434|Beta-Blocker|beta-blocker
500848|NCT00200434|Hypertension|hypertension
500849|NCT00200447|Parkinson|parkinson
500850|NCT00200447|brain imaging|brain imaging
500851|NCT00200460|Nebivolol|nebivolol
500852|NCT00200460|Hypertension|hypertension
500853|NCT00200460|Beta-Blocker|beta-blocker
500854|NCT00200473|Nebivolol|nebivolol
500855|NCT00200473|Hypertension|hypertension
500856|NCT00200473|Beta-Blockers|beta-blockers
500857|NCT00200486|genetic microarray|genetic microarray
500858|NCT00200486|head and neck cancer|head and neck cancer
500859|NCT00200499|Nebivolol|nebivolol
500860|NCT00200499|Hypertension|hypertension
500861|NCT00200499|Beta-Blocker|beta-blocker
500862|NCT00200538|frontotemporal dementia|frontotemporal dementia
500864|NCT00200538|Patients with frontotemporal dementia|patients with frontotemporal dementia
500865|NCT00200564|Pediatrics|pediatrics
500866|NCT00200564|ketamine|ketamine
500867|NCT00200564|postoperative analgesia|postoperative analgesia
500868|NCT00200564|nalbuphine|nalbuphine
500869|NCT00200564|Postoperative analgesia in children|postoperative analgesia in children
500870|NCT00200577|Adjuvant therapy|adjuvant therapy
500871|NCT00200577|immunotherapy|immunotherapy
500872|NCT00200577|TIL|til
500873|NCT00200577|melanoma|melanoma
500874|NCT00200590|prostaglandin|prostaglandin
500875|NCT00200590|analgesia|analgesia
500876|NCT00200590|congenital|congenital
500877|NCT00200590|heart|heart
500878|NCT00200590|defect|defect
500879|NCT00200590|induced|induced
500880|NCT00200603|Calcium phosphate ceramic|calcium phosphate ceramic
500881|NCT00200603|tibial osteotomy|tibial osteotomy
500882|NCT00200603|osteoarthritis|osteoarthritis
500883|NCT00200616|Urinary tract infection|urinary tract infection
500884|NCT00200616|Vesico-renal reflux|vesico-renal reflux
500885|NCT00200616|Child|child
500886|NCT00200616|Antimicrobial prophylaxis|antimicrobial prophylaxis
500887|NCT00200616|Recurrence of urinary tract infection|recurrence of urinary tract infection
500888|NCT00200629|Women|women
500889|NCT00200629|Diagnostic Testing|diagnostic testing
500890|NCT00200629|Radionuclide Imaging|radionuclide imaging
500891|NCT00200629|Stress Testing|stress testing
500892|NCT00200629|Adenosine|adenosine
500893|NCT00200642|Gastroesophageal reflux. PPI. Radiofrequency|gastroesophageal reflux. ppi. radiofrequency
14649|NCT03197038|Exercise|exercise
500894|NCT00200681|Secretory Multiple Myeloma|secretory multiple myeloma
500895|NCT00200681|First line treatment|first line treatment
500896|NCT00200681|Velcade®|velcade®
500897|NCT00200681|autograft|autograft
500898|NCT00200681|Newly diagnosed secretory Multiple Myeloma (MM)|newly diagnosed secretory multiple myeloma (mm)
500899|NCT00200694|Proteinuria|proteinuria
500900|NCT00200694|ACEI|acei
500901|NCT00200694|ARB|arb
500902|NCT00200694|diuretics|diuretics
500903|NCT00200694|blood pressure|blood pressure
500904|NCT00200694|renal failure|renal failure
500905|NCT00200707|Cell therapy|cell therapy
500906|NCT00200707|bone marrow mononuclear cells|bone marrow mononuclear cells
500907|NCT00200707|myocardial infarction|myocardial infarction
500908|NCT00200720|Diet|diet
500909|NCT00200720|Carbohydrates|carbohydrates
500910|NCT00200720|Weight Loss|weight loss
500911|NCT00200733|acupuncture|acupuncture
500912|NCT00200733|patient narratives|patient narratives
500913|NCT00200733|qualitative methods|qualitative methods
500914|NCT00200746|Hepatitis|hepatitis
500915|NCT00200746|Liver Diseases|liver diseases
500916|NCT00200746|Alcoholism|alcoholism
500917|NCT00200746|Arginine|arginine
500918|NCT00200759|Vaccinium macrocarpon|vaccinium macrocarpon
500919|NCT00200759|Antioxidants|antioxidants
500920|NCT00200759|Drug Interactions|drug interactions
500921|NCT00200785|garlic|garlic
500922|NCT00200798|Milk Thistle|milk thistle
500923|NCT00200798|Silymarin|silymarin
500924|NCT00200798|pharmacokinetics|pharmacokinetics
500925|NCT00200798|drug interactions|drug interactions
500926|NCT00200798|Normal volunteers|normal volunteers
500927|NCT00200824|isoflavones|isoflavones
500928|NCT00200824|soy|soy
500929|NCT00200824|postmenopausal|postmenopausal
500930|NCT00200824|men|men
500931|NCT00200824|prostate|prostate
500932|NCT00200824|breast|breast
500933|NCT00200824|bone|bone
500934|NCT00200837|oral mucosal pain|oral mucosal pain
500935|NCT00200837|oral inflammations|oral inflammations
500936|NCT00200837|anisillo|anisillo
500937|NCT00200837|cordonsillo|cordonsillo
500938|NCT00200837|Piperaceae|piperaceae
500939|NCT00200837|oral ulcers|oral ulcers
500940|NCT00200837|oral tumors|oral tumors
500941|NCT00200837|mucosal pain|mucosal pain
500942|NCT00200837|mucosal inflammations|mucosal inflammations
500943|NCT00200837|cordoncillo|cordoncillo
500944|NCT00200850|Breathing|breathing
500945|NCT00200850|Allergy|allergy
500946|NCT00200850|Mites, House Dust|mites, house dust
500947|NCT00200863|light|light
500948|NCT00200863|wavelength|wavelength
500949|NCT00200863|action spectrum|action spectrum
500950|NCT00200863|circadian|circadian
500951|NCT00200863|melatonin|melatonin
500952|NCT00200863|alertness|alertness
500953|NCT00200863|performance|performance
500954|NCT00200863|arousal|arousal
500955|NCT00200876|Positron-Emission Tomography|positron-emission tomography
500956|NCT00200876|Endorphins|endorphins
500957|NCT00200876|Pain Relief|pain relief
500958|NCT00200876|Opioid Receptors|opioid receptors
500959|NCT00200876|Stress|stress
500960|NCT00200876|Analgesia|analgesia
500961|NCT00200889|Acupuncture|acupuncture
500962|NCT00200889|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
500963|NCT00200889|Brain Mapping|brain mapping
500964|NCT00200889|normal volunteers|normal volunteers
500965|NCT00200902|Major depressive disorder|major depressive disorder
500966|NCT00200902|MDD|mdd
500967|NCT00200902|Antidepressant|antidepressant
500968|NCT00200928|prospective|prospective
500969|NCT00200928|randomised|randomised
500970|NCT00200928|intervention|intervention
500971|NCT00200928|BCG|bcg
500972|NCT00200928|atopy|atopy
500973|NCT00200941|Restless Legs Syndrome|restless legs syndrome
500974|NCT00200941|Topiramate|topiramate
500975|NCT00200941|Actigraphy|actigraphy
500976|NCT00200941|Polysomnography|polysomnography
500977|NCT00200954|prospective|prospective
500978|NCT00200954|intervention|intervention
500979|NCT00200954|randomised|randomised
500980|NCT00200954|probiotics|probiotics
500981|NCT00200954|atopy|atopy
500982|NCT00201045|Hypertension management|hypertension management
500983|NCT00201045|Pharmacist management|pharmacist management
97094|NCT02682459|fibrosis|fibrosis
500984|NCT00201045|Physician pharmacist collaboration|physician pharmacist collaboration
500985|NCT00201045|Blood pressure control|blood pressure control
500986|NCT00201058|urban|urban
500987|NCT00201058|adolescents|adolescents
500988|NCT00201058|African American|african american
500989|NCT00201058|web-based|web-based
500990|NCT00201058|computer tailoring|computer tailoring
500991|NCT00201058|school based|school based
500992|NCT00201110|African Americans|african americans
500993|NCT00201136|Behavioral intervention|behavioral intervention
500994|NCT00201136|Lifestyle modification|lifestyle modification
500995|NCT00201136|Guidelines|guidelines
500996|NCT00201201|Older Adults|older adults
500997|NCT00201201|Primary Care|primary care
500998|NCT00201201|Hypertension|hypertension
500999|NCT00201201|Adherence|adherence
501000|NCT00201292|Metabolic syndrome|metabolic syndrome
501001|NCT00201292|Diabetes|diabetes
501002|NCT00201292|Insulin resistance|insulin resistance
501003|NCT00201292|pharmacogenetics|pharmacogenetics
501004|NCT00201344|Radiotherapy|radiotherapy
501005|NCT00201344|Adjuvant chemotherapy|adjuvant chemotherapy
501006|NCT00201344|Chemtherapy|chemtherapy
501007|NCT00201344|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
501008|NCT00201357|hormone-refractory prostate cancer|hormone-refractory prostate cancer
501009|NCT00201357|thalidomide|thalidomide
501010|NCT00201357|quality of life|quality of life
501011|NCT00201370|cervical neoplasia;|cervical neoplasia;
501012|NCT00201370|human papillomavirus,|human papillomavirus,
501013|NCT00201370|PCR,|pcr,
501014|NCT00201370|risk factors,|risk factors,
501015|NCT00201370|Taiwan|taiwan
501016|NCT00201396|A Multicenter Phase III Trial|a multicenter phase iii trial
501017|NCT00201396|Induction Chemotherapy|induction chemotherapy
501018|NCT00201396|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
501019|NCT00201396|Stage IV Nasopharyngeal Carcinoma (NPC)|stage iv nasopharyngeal carcinoma (npc)
501020|NCT00201396|randomization|randomization
501021|NCT00201396|disease-free survival|disease-free survival
501022|NCT00201422|MALT lymphoma|malt lymphoma
501023|NCT00201422|diffuse large B-cell lymphoma,|diffuse large b-cell lymphoma,
501024|NCT00201422|stomach|stomach
501025|NCT00201422|Helicobacter pylori|helicobacter pylori
501026|NCT00201422|antibiotic therapy|antibiotic therapy
501027|NCT00185120|Hypertension|hypertension
501028|NCT00185120|angiotensin receptor blocker|angiotensin receptor blocker
501029|NCT00185120|calcium channel blocker|calcium channel blocker
501030|NCT00185120|angiotensin converting enzyme inhibitor hydroclorothiazide|angiotensin converting enzyme inhibitor hydroclorothiazide
501031|NCT00185133|Treatment of high blood pressure in mild to severe hypertensive patients|treatment of high blood pressure in mild to severe hypertensive patients
501032|NCT00185159|Microalbuminuria|microalbuminuria
501033|NCT00185198|Partial androgen deficiency of aging males (PADAM)|partial androgen deficiency of aging males (padam)
501034|NCT00185237|Menopause|menopause
501035|NCT00191971|Transitional cell carcinoma of urothelium|transitional cell carcinoma of urothelium
501036|NCT00192543|dialysis|dialysis
501037|NCT00192543|omega-3 fatty acids|omega-3 fatty acids
501038|NCT00192543|antioxidants|antioxidants
501039|NCT00192543|cardiovascular markers|cardiovascular markers
501040|NCT00192543|Mortality|mortality
501041|NCT00192543|End-stage renal disease|end-stage renal disease
501042|NCT00192556|tuberculosis|tuberculosis
501043|NCT00192556|nutrition|nutrition
501044|NCT00192556|directly observed therapy|directly observed therapy
501045|NCT00192556|Timor Leste|timor leste
501046|NCT00192556|cost-effectiveness|cost-effectiveness
501047|NCT00192569|Acute Hepatitis C|acute hepatitis c
501048|NCT00192582|Motivational interview|motivational interview
501049|NCT00192582|Care plan|care plan
501050|NCT00192582|Relapse prevention|relapse prevention
501051|NCT00192582|Psychoeducation|psychoeducation
501052|NCT00192582|Indigenous mental health|indigenous mental health
501053|NCT00192595|Hepatitis B|hepatitis b
501054|NCT00192595|HIV|hiv
501055|NCT00192595|Treatment Naive|treatment naive
501056|NCT00192608|Pharmacokinetics, atazanavir, saquinavir, ritonavir, HIV|pharmacokinetics, atazanavir, saquinavir, ritonavir, hiv
501057|NCT00192621|HIV negative healthy subjects|hiv negative healthy subjects
501058|NCT00192621|Lipid metabolism|lipid metabolism
501059|NCT00192621|Glucose metabolism|glucose metabolism
501060|NCT00192621|Metabolic abnormality|metabolic abnormality
501061|NCT00192621|Lipodystrophy|lipodystrophy
501062|NCT00192621|Cardiovascular disease|cardiovascular disease
501063|NCT00192621|Treatment Naive|treatment naive
501064|NCT00192621|HIV|hiv
501066|NCT00192634|Antiretroviral therapy|antiretroviral therapy
501067|NCT00192634|nucleoside analogue reverse transcriptase|nucleoside analogue reverse transcriptase
501068|NCT00192634|fixed dose combination|fixed dose combination
501069|NCT00192634|Treatment Experienced|treatment experienced
501070|NCT00192660|HIV|hiv
501071|NCT00192660|Metabolic abnormality|metabolic abnormality
501072|NCT00192660|Lipodystrophy|lipodystrophy
501073|NCT00192660|Cardiovascular disease|cardiovascular disease
501074|NCT00192660|Treatment Naive|treatment naive
501075|NCT00192660|Treatment Experienced|treatment experienced
501076|NCT00192660|HIV Infections|hiv infections
500372|NCT00188383|Elderly|elderly
501077|NCT00192673|Asparaginase|asparaginase
501078|NCT00192673|intramuscular administration|intramuscular administration
501079|NCT00192673|Silent antibodies|silent antibodies
501080|NCT00192673|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
501081|NCT00192673|Side effects|side effects
501082|NCT00192673|5-year EFS|5-year efs
501083|NCT00192699|Osteoarthritis|osteoarthritis
501084|NCT00192712|carcinoma|carcinoma
501085|NCT00192712|pancreas|pancreas
501086|NCT00192712|chemotherapy|chemotherapy
501087|NCT00192712|radiotherapy|radiotherapy
501088|NCT00192725|bipolar disorder|bipolar disorder
501089|NCT00192725|acute mania|acute mania
501090|NCT00192725|tryptophan depletion|tryptophan depletion
501091|NCT00192725|placebo controlled add-on|placebo controlled add-on
501092|NCT00192725|Bipolar disorder- manic type|bipolar disorder- manic type
501093|NCT00192738|telephone,|telephone,
501094|NCT00192738|internal medicine,|internal medicine,
501095|NCT00192738|readmission,|readmission,
501097|NCT00192751|Schizophrenia|schizophrenia
501098|NCT00192751|Major depression|major depression
501099|NCT00192751|Bipolar disorder|bipolar disorder
501100|NCT00192751|Compliance|compliance
501101|NCT00192751|Relapse prevention|relapse prevention
501102|NCT00192764|large cell lymphoma|large cell lymphoma
501103|NCT00192764|CHOP|chop
501104|NCT00192764|cyclophosphamide|cyclophosphamide
501105|NCT00192764|high-dose|high-dose
501106|NCT00192777|Solid Tumors|solid tumors
501107|NCT00192777|Bone Metastases|bone metastases
501108|NCT00192777|Radiotherapy|radiotherapy
501109|NCT00192777|Xeloda|xeloda
501110|NCT00192777|Concurrent|concurrent
501111|NCT00192777|Radiosensitization|radiosensitization
501112|NCT00192790|Therma,pain, Silent myocardial ischemia, catastrophizing|therma,pain, silent myocardial ischemia, catastrophizing
501113|NCT00192803|niddm|niddm
501114|NCT00192803|ace2|ace2
501115|NCT00192803|NIDDM patients|niddm patients
501116|NCT00192829|Lung cancer|lung cancer
501117|NCT00192829|Thrombosis|thrombosis
501118|NCT00192829|Hypercoagulable|hypercoagulable
501119|NCT00192842|carcinoma|carcinoma
501120|NCT00192842|pancreas|pancreas
501121|NCT00192842|gemcitabine|gemcitabine
501122|NCT00192842|curcumin|curcumin
501123|NCT00192855|schizophrenia|schizophrenia
501124|NCT00192855|negative symptoms|negative symptoms
501125|NCT00192855|entacapone|entacapone
501126|NCT00192868|primary PCI|primary pci
501127|NCT00192868|distal protection|distal protection
501128|NCT00192868|drug eluting stent|drug eluting stent
501129|NCT00192868|restenosis|restenosis
501130|NCT00192881|Percutaneous coronary intervention|percutaneous coronary intervention
501131|NCT00192881|Balloon angioplasty|balloon angioplasty
501132|NCT00192881|Restenosis|restenosis
501133|NCT00192881|Stents|stents
501134|NCT00192946|Cardiac resynchronization|cardiac resynchronization
501135|NCT00192946|Heart failure|heart failure
501136|NCT00192946|open heart surgery|open heart surgery
501137|NCT00192946|surgery|surgery
501138|NCT00192959|Anaesthesia|anaesthesia
501139|NCT00192959|Surgery|surgery
501140|NCT00192959|Postoperative|postoperative
501141|NCT00192959|Neuropsychological test|neuropsychological test
501142|NCT00192972|Catheter ablation|catheter ablation
501143|NCT00192972|Atrial fibrillation|atrial fibrillation
501144|NCT00192998|Affective disorder|affective disorder
501145|NCT00192998|Alzheimer dementia|alzheimer dementia
501146|NCT00192998|healthy controls|healthy controls
501147|NCT00193037|Breast Cancer|breast cancer
501148|NCT00193128|Esophagus Cancer|esophagus cancer
501149|NCT00193154|Kidney Cancer|kidney cancer
501150|NCT00193180|Breast Cancer|breast cancer
501151|NCT00193206|Locally Advanced Breast Cancer|locally advanced breast cancer
501152|NCT00193206|Inflammatory Breast Cancer|inflammatory breast cancer
501153|NCT00193206|Breast Cancer|breast cancer
501154|NCT00193206|Abraxane|abraxane
501155|NCT00193206|nab Paclitaxel|nab paclitaxel
501156|NCT00193206|Epirubicin|epirubicin
501157|NCT00193206|Gemcitabine|gemcitabine
501158|NCT00193206|Gemzar|gemzar
501159|NCT00193219|Colon Cancer|colon cancer
501160|NCT00193258|Recurrent clear cell renal cell carcinoma|recurrent clear cell renal cell carcinoma
501161|NCT00193258|Bevacizumab|bevacizumab
501162|NCT00193258|Erlotinib|erlotinib
501163|NCT00193258|Imatinib|imatinib
501164|NCT00193297|Ovary Cancer|ovary cancer
501165|NCT00193336|NSCLC Lung Cancer|nsclc lung cancer
501166|NCT00193336|Non Small Cell Lung Cancer|non small cell lung cancer
501167|NCT00193453|Lung Cancer|lung cancer
501168|NCT00193492|Lymphoma|lymphoma
501169|NCT00193492|Bevacizumab|bevacizumab
501170|NCT00193492|Rituximab|rituximab
501171|NCT00193596|Neoplasms, Unknown Primary|neoplasms, unknown primary
501172|NCT00193609|Neoplasms, Unknown Primary|neoplasms, unknown primary
501173|NCT00193635|Congenital uropathies|congenital uropathies
501174|NCT00193635|Mycophenolate mofetil|mycophenolate mofetil
501175|NCT00193635|GFR|gfr
501176|NCT00193635|Iothalamate clearance|iothalamate clearance
501177|NCT00193635|Urine cytometry|urine cytometry
501178|NCT00193635|Children|children
501179|NCT00193635|Congenital urological abnormalities which represent stuctural defects in the genitourinary system|congenital urological abnormalities which represent stuctural defects in the genitourinary system
501180|NCT00193648|FSGS|fsgs
501181|NCT00193648|Pharmacokinetics|pharmacokinetics
501182|NCT00193648|Rosiglitazone|rosiglitazone
501183|NCT00193648|PPAR-gamma agonist|ppar-gamma agonist
501184|NCT00193648|Adalimumab|adalimumab
501185|NCT00193648|TNF-alpha antagonist|tnf-alpha antagonist
501186|NCT00193648|Steroid and immunosuppressive drug resistance|steroid and immunosuppressive drug resistance
501187|NCT00193648|Resistant primary FSGS|resistant primary fsgs
501188|NCT00193661|Hypogonadism|hypogonadism
501189|NCT00193674|Pregnancy|pregnancy
501190|NCT00193674|Immunology|immunology
501191|NCT00193674|Unexplained recurrent miscarriage|unexplained recurrent miscarriage
501192|NCT00193687|open-label study in the treatment of schizophrenia|open-label study in the treatment of schizophrenia
501193|NCT00193700|Hypogonadism|hypogonadism
501590|NCT00203528|bipolar|bipolar
501194|NCT00193713|double-blind study in the treatment of schizophrenia|double-blind study in the treatment of schizophrenia
501195|NCT00193726|Estrogen|estrogen
501196|NCT00193726|Priming|priming
501197|NCT00193726|Adjuvant chemotherapy|adjuvant chemotherapy
501198|NCT00193726|Breast cancer|breast cancer
501199|NCT00193739|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
501200|NCT00193739|Surgery|surgery
501201|NCT00193739|Cervix cancer|cervix cancer
501202|NCT00193739|Concurrent chemoradiation|concurrent chemoradiation
501203|NCT00193752|FDG-PET Imaging|fdg-pet imaging
501204|NCT00193752|Cervical Cancer|cervical cancer
501205|NCT00193752|Post-treatment evaluation|post-treatment evaluation
501206|NCT00193752|Para-aortic Nodal Staging|para-aortic nodal staging
501207|NCT00193752|Extended field Radiation|extended field radiation
501208|NCT00193752|Extended field IMRT|extended field imrt
501209|NCT00193752|Cancer of the Cervix|cancer of the cervix
501210|NCT00193765|neck dissection|neck dissection
501211|NCT00193765|survival|survival
501212|NCT00193765|early oral cancer|early oral cancer
501213|NCT00193765|Early oral cavity squamous cancer with node negative neck|early oral cavity squamous cancer with node negative neck
501214|NCT00193778|Metastatic breast cancer|metastatic breast cancer
501215|NCT00193778|Locoregional treatment|locoregional treatment
501216|NCT00193778|Survival|survival
501217|NCT00193791|Carcinoma Cervix|carcinoma cervix
501218|NCT00193791|FIGO Stage IIIB|figo stage iiib
501219|NCT00193791|Radiation therapy|radiation therapy
501220|NCT00193791|Chemoradiation|chemoradiation
501221|NCT00193791|Treatment related toxicities|treatment related toxicities
501222|NCT00193791|Cervical Cancer|cervical cancer
501223|NCT00193791|Cervix Cancer|cervix cancer
501224|NCT00193804|Cervical Cancer|cervical cancer
501225|NCT00193804|FIGO STAGE IIB|figo stage iib
501226|NCT00193804|CHEMORADIATION|chemoradiation
501227|NCT00193804|Intensity Modulated Radiation Therapy(IMRT)|intensity modulated radiation therapy(imrt)
501228|NCT00193804|Conventional Radiation Therapy|conventional radiation therapy
501229|NCT00193804|Cancer of the Cervix|cancer of the cervix
501230|NCT00193804|Cervix Cancer|cervix cancer
501231|NCT00193817|Cancer|cancer
501232|NCT00193817|Esophagus|esophagus
501233|NCT00193817|Lymphadenectomy|lymphadenectomy
501234|NCT00193830|Cervical Cancer|cervical cancer
501235|NCT00193830|High Dose Rate (HDR) Brachytherapy|high dose rate (hdr) brachytherapy
501236|NCT00193830|Low Dose Rate (LDR) Brachytherapy|low dose rate (ldr) brachytherapy
501237|NCT00193830|Acute Toxicities|acute toxicities
501238|NCT00193830|Late Radiation Sequelae|late radiation sequelae
501239|NCT00193843|Oral cancer|oral cancer
501240|NCT00193843|Head and neck surgery|head and neck surgery
501241|NCT00193843|Accelerated radiotherapy|accelerated radiotherapy
501242|NCT00193843|Chemo-radiotherapy|chemo-radiotherapy
501243|NCT00193856|Prostate Cancer|prostate cancer
501244|NCT00193856|Androgen Deprivation|androgen deprivation
501245|NCT00193856|Hormone Therapy|hormone therapy
501246|NCT00193856|RadiotherapyBisphosphonate|radiotherapybisphosphonate
501247|NCT00193856|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
501248|NCT00193869|Radiotherapy|radiotherapy
501249|NCT00193869|Dose fractionation|dose fractionation
501250|NCT00193882|Oesophageal|oesophageal
501251|NCT00193882|Dysphagia|dysphagia
501252|NCT00193882|Palliation|palliation
501253|NCT00193882|Quality of Life|quality of life
501254|NCT00193882|Radiotherapy|radiotherapy
501255|NCT00193882|Chemotherapy|chemotherapy
501256|NCT00193895|Skin cancer|skin cancer
501257|NCT00193895|radiotherapy|radiotherapy
501258|NCT00193895|chemotherapy|chemotherapy
501260|NCT00193908|Skin care|skin care
501261|NCT00193908|Radiotherapy|radiotherapy
501262|NCT00193921|Chemoradiotherapy|chemoradiotherapy
501263|NCT00193921|High dose|high dose
501264|NCT00193921|palliative radiotherapy|palliative radiotherapy
501265|NCT00193921|Quality of life|quality of life
501266|NCT00193934|Women's Health|women's health
501267|NCT00193934|Multidisciplinary, multicentre prospective study|multidisciplinary, multicentre prospective study
501268|NCT00193934|Cancer:mechanisms of growth, invasion, metastases|cancer:mechanisms of growth, invasion, metastases
501269|NCT00193934|Figo Stages cervical cancer|figo stages cervical cancer
501270|NCT00193934|Advances in diagnosis using radiological methods|advances in diagnosis using radiological methods
501271|NCT00193934|Quantitative Magnetic Resonance Imaging|quantitative magnetic resonance imaging
501272|NCT00193934|Patient Management Strategies|patient management strategies
501273|NCT00193934|Selecting patients for therapy|selecting patients for therapy
501274|NCT00193960|Seton surgery, glaucoma, Ahmed valve, intraocular pressure|seton surgery, glaucoma, ahmed valve, intraocular pressure
501275|NCT00193973|Lymphoma|lymphoma
501276|NCT00193973|PCNSL|pcnsl
501277|NCT00193973|Primary CNS lymphoma|primary cns lymphoma
501278|NCT00193986|Prepulse|prepulse
501279|NCT00193986|Defibrillator|defibrillator
501280|NCT00193999|Nasogastric Tubes|nasogastric tubes
501281|NCT00193999|Nausea|nausea
501282|NCT00193999|Vomiting|vomiting
501283|NCT00193999|Cardiac surgery|cardiac surgery
501284|NCT00194012|bipolar disorder|bipolar disorder
501285|NCT00194025|Schizophrenia|schizophrenia
501286|NCT00194025|Anticonvulsants|anticonvulsants
501287|NCT00194025|Valproic Acid|valproic acid
501289|NCT00194038|Bipolar Disorder|bipolar disorder
501290|NCT00194038|Geriatric Psychiatry|geriatric psychiatry
501291|NCT00194038|Aripiprazole|aripiprazole
501292|NCT00194051|obesity|obesity
501293|NCT00194051|gait biomechanics|gait biomechanics
501294|NCT00194051|knee osteoarthritis|knee osteoarthritis
501295|NCT00194090|pain|pain
501296|NCT00194090|osteoarthritis|osteoarthritis
501297|NCT00194142|Pregnancy|pregnancy
501298|NCT00194142|Cytomegalovirus|cytomegalovirus
501299|NCT00194155|cytomegalovirus|cytomegalovirus
501300|NCT00194155|pregnancy|pregnancy
501301|NCT00194155|placenta|placenta
501302|NCT00194168|ectopic pregnancy|ectopic pregnancy
501303|NCT00194181|dialysis|dialysis
501304|NCT00194181|fibrin|fibrin
501305|NCT00194181|sheath|sheath
501306|NCT00194181|clot|clot
501307|NCT00194181|tpa|tpa
501308|NCT00201435|Breast|breast
501309|NCT00201435|Cancer|cancer
501310|NCT00201435|Paclitaxel|paclitaxel
501311|NCT00201435|Docetaxel|docetaxel
501312|NCT00201435|Qulaity of life|qulaity of life
501313|NCT00201448|CMV, cytomegalovirus, vaccine, Towne strain|cmv, cytomegalovirus, vaccine, towne strain
501314|NCT00201461|Patent Foramen Ovale|patent foramen ovale
501315|NCT00201461|STARFlex|starflex
501316|NCT00201461|CLOSURE I|closure i
501317|NCT00201461|Septal Closure System|septal closure system
501318|NCT00201461|Stroke|stroke
501319|NCT00201461|Cerebrovascular Accident|cerebrovascular accident
501320|NCT00201461|Transient Ischemic Attack|transient ischemic attack
501321|NCT00201461|Heart Septal Defects, Atrial|heart septal defects, atrial
501322|NCT00201474|brief depressive episodes|brief depressive episodes
501323|NCT00201474|affective disorders|affective disorders
501324|NCT00201474|EEG and QEEG|eeg and qeeg
501325|NCT00201474|epilepsy|epilepsy
501326|NCT00201474|organic brain disorders|organic brain disorders
501327|NCT00201474|acute psychiatry|acute psychiatry
501328|NCT00201513|Muscle, Skeletal|muscle, skeletal
501329|NCT00201513|Neuromuscular control|neuromuscular control
501330|NCT00201513|Stability|stability
501331|NCT00201513|Exercise|exercise
501332|NCT00201513|Anticipatory muscle control|anticipatory muscle control
501333|NCT00201526|Bipolar Disorder|bipolar disorder
501334|NCT00201539|analgesics, opioid/pharmacokinetics|analgesics, opioid/pharmacokinetics
501335|NCT00201539|humans|humans
501336|NCT00201539|morphine/therapeutic use*|morphine/therapeutic use*
501337|NCT00201539|neoplasms|neoplasms
501338|NCT00201539|pain/drugtherapy|pain/drugtherapy
501339|NCT00201565|pulse wave velocity|pulse wave velocity
501340|NCT00201565|cardiovascular disease|cardiovascular disease
501341|NCT00201578|Herbal Drugs|herbal drugs
501342|NCT00201578|Alternative medicine|alternative medicine
501343|NCT00201591|Coronary artery disease|coronary artery disease
501344|NCT00201591|Exercise training|exercise training
501345|NCT00201591|Intensity|intensity
501346|NCT00201591|Randomized|randomized
501347|NCT00201591|echocardiography|echocardiography
501348|NCT00201591|Aerobic Exercise|aerobic exercise
501349|NCT00201617|Unilateral hearing loss|unilateral hearing loss
501350|NCT00201617|Unilateral deafness|unilateral deafness
501351|NCT00201617|Bone anchored hearing aid|bone anchored hearing aid
501352|NCT00201630|Prostate|prostate
501353|NCT00201630|cancer|cancer
501354|NCT00201630|Brachytherapy|brachytherapy
501355|NCT00201630|Alpha Blocker|alpha blocker
501356|NCT00201643|Preterm Labor|preterm labor
501357|NCT00201643|Preterm delivery|preterm delivery
501358|NCT00201656|PPROM|pprom
501359|NCT00201656|Cerclage|cerclage
501559|NCT00203203|Stem Cell|stem cell
501360|NCT00201656|Preterm Premature Rupture of the Membranes with Cerclage|preterm premature rupture of the membranes with cerclage
501361|NCT00201669|Aggressive|aggressive
501362|NCT00201669|Clofarabine|clofarabine
501363|NCT00201682|Leukemia|leukemia
501364|NCT00201682|Lymphoma|lymphoma
501365|NCT00201695|Untreated Patients|untreated patients
501366|NCT00201695|Symptomatic|symptomatic
501367|NCT00201708|Adjuvant Trial|adjuvant trial
501368|NCT00201708|Dose-Dense|dose-dense
501369|NCT00201708|Axillary Node-Positive|axillary node-positive
646305|NCT00755209|Adults|adults
500678|NCT00199745|statin|statin
501370|NCT00201721|Previously Untreated|previously untreated
501371|NCT00201734|Adenocarcinoma|adenocarcinoma
501372|NCT00201747|Advanced|advanced
501373|NCT00201760|metastatic|metastatic
501374|NCT00201773|Post-Menopause|post-menopause
501375|NCT00201773|Neoadjuvant Therapy|neoadjuvant therapy
501376|NCT00202202|personality disorder|personality disorder
501377|NCT00202202|user satisfaction|user satisfaction
501378|NCT00202215|Day hospital treatment|day hospital treatment
501379|NCT00202228|HIV|hiv
501380|NCT00202228|HIV/AIDS|hiv/aids
501381|NCT00202228|Lactic Acidosis|lactic acidosis
501382|NCT00202228|Supplementation|supplementation
501383|NCT00202228|Lactate Clearance|lactate clearance
501384|NCT00202228|Mitochondrial Toxicity|mitochondrial toxicity
501385|NCT00202228|HAART|haart
501386|NCT00202241|HIV|hiv
501387|NCT00202241|AIDS|aids
501388|NCT00202241|testosterone|testosterone
501389|NCT00202241|anabolic steroid|anabolic steroid
501390|NCT00202241|body composition|body composition
501391|NCT00202241|lipodystrophy|lipodystrophy
501392|NCT00202241|MRI|mri
501393|NCT00202241|BIA|bia
501394|NCT00202241|skinfold measurements|skinfold measurements
501395|NCT00202241|protease inhibitors|protease inhibitors
501396|NCT00202254|Mulitple Sclerosis|mulitple sclerosis
501397|NCT00202254|MS|ms
501398|NCT00202267|leg ulcer, compression, bandage, APBI, venous insufficiency|leg ulcer, compression, bandage, apbi, venous insufficiency
501399|NCT00202293|Bipolar|bipolar
501400|NCT00202293|Mania|mania
501401|NCT00202293|Drug treatment|drug treatment
501402|NCT00202293|First episode|first episode
501403|NCT00202293|Psychosis|psychosis
501404|NCT00202293|Therapy|therapy
501405|NCT00202293|Antipsychotic|antipsychotic
501406|NCT00202306|at risk mental state|at risk mental state
501407|NCT00202306|prodrome|prodrome
501408|NCT00202306|ultra high risk|ultra high risk
501409|NCT00202306|first episode psychosis|first episode psychosis
501410|NCT00202306|schizophrenia|schizophrenia
501411|NCT00202306|bipolar disorder|bipolar disorder
501412|NCT00202319|sedation|sedation
501413|NCT00202319|mechanical ventilation|mechanical ventilation
501414|NCT00202319|sedation protocols|sedation protocols
501415|NCT00202319|critical care|critical care
501416|NCT00202319|intensive care outcomes|intensive care outcomes
501417|NCT00202319|staffing|staffing
501418|NCT00202345|Creatinine Clearance|creatinine clearance
501419|NCT00202345|Hemoglobin|hemoglobin
501420|NCT00202345|Iron sucrose|iron sucrose
501421|NCT00202345|Oral iron therapy|oral iron therapy
501422|NCT00202345|Ferritin|ferritin
501423|NCT00202345|Transferrin saturation|transferrin saturation
501424|NCT00202345|Iron|iron
501425|NCT00202358|perioperative|perioperative
501426|NCT00202358|beta-blockers|beta-blockers
501427|NCT00202358|inflammation|inflammation
501428|NCT00202358|outcomes|outcomes
501429|NCT00202371|MDS, Fatigue, RBC transfusion|mds, fatigue, rbc transfusion
501430|NCT00202384|Multiple Sclerosis|multiple sclerosis
501431|NCT00202384|microarrays|microarrays
501432|NCT00202397|cerebellar ataxia|cerebellar ataxia
501433|NCT00202397|deep cerebellar nuclei (DCN)|deep cerebellar nuclei (dcn)
501434|NCT00202397|small-conductance calcium-activated potassium(SK)channels|small-conductance calcium-activated potassium(sk)channels
501435|NCT00202397|riluzole|riluzole
501436|NCT00202397|Sporadic ataxia|sporadic ataxia
501437|NCT00202397|Multiple system atrophy type C|multiple system atrophy type c
501438|NCT00202410|Multiple Sclerosis|multiple sclerosis
501439|NCT00202410|Tuberculosis vaccine|tuberculosis vaccine
501440|NCT00202410|Therapy|therapy
501441|NCT00202423|Multiple sclerosis|multiple sclerosis
501442|NCT00202423|Cannabinoids|cannabinoids
501443|NCT00202423|Spasticity|spasticity
501444|NCT00202423|fMRI|fmri
501445|NCT00202423|TMS|tms
501446|NCT00202449|Prazosin|prazosin
501447|NCT00202449|Paroxetine|paroxetine
501448|NCT00202449|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
501449|NCT00202449|Sleep Disorders|sleep disorders
501450|NCT00202462|testosterone|testosterone
501451|NCT00202462|depression|depression
501452|NCT00202462|subsyndromal depression|subsyndromal depression
501453|NCT00202462|quality of life|quality of life
501454|NCT00202475|Dubble eerythrocytapheresis|dubble eerythrocytapheresis
501455|NCT00202488|anemia, iron-deficiency|anemia, iron-deficiency
501456|NCT00202488|Helicobacter pylori|helicobacter pylori
501457|NCT00202514|alcoholism|alcoholism
501458|NCT00202514|alcohol related disorders|alcohol related disorders
501459|NCT00202514|mood disorders|mood disorders
501460|NCT00202514|anticonvulsants|anticonvulsants
501461|NCT00202514|divalproex sodium|divalproex sodium
501462|NCT00202527|Sleep apnea|sleep apnea
501463|NCT00202527|Hypertension|hypertension
501464|NCT00202527|CPAP|cpap
501465|NCT00202618|Hypertension|hypertension
501466|NCT00202618|Type 2 diabetes mellitus|type 2 diabetes mellitus
501467|NCT00202618|Microalbuminuria|microalbuminuria
501468|NCT00202618|Amlodipine|amlodipine
501469|NCT00202618|Calcium channel blocker|calcium channel blocker
501470|NCT00202618|Valsartan|valsartan
501471|NCT00202618|Angiotensin type 2 receptor blocker|angiotensin type 2 receptor blocker
501472|NCT00202631|tetraplegia|tetraplegia
501473|NCT00202631|quadriplegia|quadriplegia
501474|NCT00202631|spinal cord injury|spinal cord injury
501475|NCT00202631|functional electrical stimulation|functional electrical stimulation
501476|NCT00202631|abdominal stimulation|abdominal stimulation
501477|NCT00202657|parkinson's disease|parkinson's disease
501478|NCT00202657|pergolide|pergolide
501479|NCT00202657|heart valve disease|heart valve disease
501480|NCT00202670|coronary artery disease|coronary artery disease
501481|NCT00202670|stress myocardial scintigraphy|stress myocardial scintigraphy
501482|NCT00202670|stress echocardiography|stress echocardiography
501483|NCT00202683|Altitude|altitude
501484|NCT00202683|Anoxemia|anoxemia
501485|NCT00202683|Mitochondria|mitochondria
501486|NCT00202683|Reflex|reflex
501487|NCT00202683|Genetic research|genetic research
501488|NCT00202709|Anxiety disorder|anxiety disorder
501489|NCT00202709|Thought Field Therapy|thought field therapy
501490|NCT00202709|Psychotherapy|psychotherapy
501491|NCT00202709|Agoraphobia|agoraphobia
501492|NCT00202709|Social Phobia|social phobia
501493|NCT00202709|Post Traumatic Stress Disorder|post traumatic stress disorder
501494|NCT00202722|Remifentanil, parenteral opioids, obstetric analgesia, IVPCA|remifentanil, parenteral opioids, obstetric analgesia, ivpca
501495|NCT00202735|shoulder dislocation|shoulder dislocation
501497|NCT00202735|traumatic|traumatic
501498|NCT00202735|primary|primary
501499|NCT00202735|first time|first time
501500|NCT00202735|initial|initial
501501|NCT00202735|immobilization|immobilization
501502|NCT00202735|external|external
501503|NCT00202735|rotation|rotation
501504|NCT00202748|metabolic syndrome|metabolic syndrome
501505|NCT00202748|lifestyle|lifestyle
501506|NCT00202748|obesity|obesity
501507|NCT00202761|Cerebral palsy|cerebral palsy
501508|NCT00202761|Functional training|functional training
501509|NCT00202761|preschool children|preschool children
501510|NCT00202761|Gross Motor Functional Classification Level|gross motor functional classification level
501511|NCT00202761|Gross motor functional Measure test|gross motor functional measure test
501512|NCT00202761|Pediatric Evaluation of Disability Inventory|pediatric evaluation of disability inventory
501513|NCT00202761|Parental Stress Index|parental stress index
501514|NCT00202774|colorectal cancer, capecitabine, oxaliplatin, 5-fluorouracil|colorectal cancer, capecitabine, oxaliplatin, 5-fluorouracil
501515|NCT00202787|colorectal cancer|colorectal cancer
501516|NCT00202787|cetuximab|cetuximab
501517|NCT00202787|FOLFOX4|folfox4
501518|NCT00202800|Pancreatic Cancer|pancreatic cancer
501519|NCT00202800|Gemcitabine/Etoposide|gemcitabine/etoposide
501520|NCT00202800|Ras-mutation|ras-mutation
501521|NCT00202813|CVC|cvc
501522|NCT00202813|central venous catheter|central venous catheter
501523|NCT00202813|infection|infection
501524|NCT00202813|bloodstream infection|bloodstream infection
501525|NCT00202813|catheter infection|catheter infection
501526|NCT00202813|pediatric|pediatric
501527|NCT00202813|children|children
501528|NCT00202813|antibiotic impregnated catheters|antibiotic impregnated catheters
501529|NCT00202878|hypercholesterolemia|hypercholesterolemia
501530|NCT00202878|myocardial infarction|myocardial infarction
501531|NCT00202878|cholesterol|cholesterol
501532|NCT00202878|randomized controlled trials|randomized controlled trials
501533|NCT00202878|acute coronary syndrome|acute coronary syndrome
501534|NCT00202878|angina|angina
501535|NCT00202891|pyoderma|pyoderma
501536|NCT00202891|sisomicin|sisomicin
501537|NCT00202891|nadifloxacin|nadifloxacin
501538|NCT00202904|ezetimibe|ezetimibe
501539|NCT00202904|atorvastatin|atorvastatin
501540|NCT00202904|hypercholesterolemia|hypercholesterolemia
501541|NCT00202904|coronary heart disease|coronary heart disease
501542|NCT00202917|haploidentical transplantation|haploidentical transplantation
501543|NCT00202917|immunomagnetic cell sorting|immunomagnetic cell sorting
501544|NCT00202917|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
501545|NCT00202917|dose reduced conditioning|dose reduced conditioning
501546|NCT00202930|neuroblastoma|neuroblastoma
501547|NCT00202930|Opsoclonus-myoclonus|opsoclonus-myoclonus
501548|NCT00202930|rituximab|rituximab
501549|NCT00202943|TCRFVR, LAUP, Snorer|tcrfvr, laup, snorer
501550|NCT00202969|Stomach cancer|stomach cancer
501551|NCT00203047|Multiple Sclerosis|multiple sclerosis
501552|NCT00203047|brain atrophy|brain atrophy
501553|NCT00203047|Glatiramer Acetate|glatiramer acetate
501554|NCT00203047|Copaxone|copaxone
501555|NCT00203047|Steroids|steroids
501556|NCT00203047|Prednisone|prednisone
501557|NCT00203203|Autologous|autologous
501558|NCT00203203|Cardiac|cardiac
501560|NCT00203203|Transplant|transplant
501561|NCT00203229|Double-Blind|double-blind
501562|NCT00203229|Placebo-Controlled|placebo-controlled
501563|NCT00203255|Menstrually-Associated Migraine|menstrually-associated migraine
501564|NCT00203268|migraine|migraine
501565|NCT00203268|cutaneous allodynia|cutaneous allodynia
501566|NCT00203281|renal transplantation|renal transplantation
501567|NCT00203333|Epilepsy|epilepsy
501568|NCT00203385|divalproex sodium, depakote, ptsd, long-term ptsd treatments|divalproex sodium, depakote, ptsd, long-term ptsd treatments
501569|NCT00203450|obesity|obesity
501570|NCT00203450|zonisamide|zonisamide
501571|NCT00203450|zonegran|zonegran
501572|NCT00203450|psychotropic weight gain|psychotropic weight gain
501573|NCT00203450|psychotropic|psychotropic
501574|NCT00203463|topiramate|topiramate
501575|NCT00203463|PTSD|ptsd
501576|NCT00203463|posttraumatic stress disorder|posttraumatic stress disorder
501577|NCT00203463|topamax|topamax
501578|NCT00203476|ezetimibe|ezetimibe
501579|NCT00203476|niacin|niacin
501580|NCT00203476|colestipol|colestipol
501581|NCT00203476|hyperlipidemia|hyperlipidemia
501582|NCT00203476|adjunct therapy|adjunct therapy
501583|NCT00203476|zetia|zetia
501584|NCT00203502|Operable and Locally advanced Breast Cancer|operable and locally advanced breast cancer
501585|NCT00203515|Urinary Catheterization|urinary catheterization
501586|NCT00203528|divalproex sodium|divalproex sodium
501587|NCT00203528|risperidone|risperidone
501588|NCT00203528|dual diagnosis|dual diagnosis
501589|NCT00203528|substance use|substance use
501591|NCT00203554|osteoporosis|osteoporosis
501592|NCT00203554|vertebra|vertebra
501593|NCT00203554|fracture|fracture
501594|NCT00203554|pain|pain
501595|NCT00203554|percutaneous|percutaneous
501596|NCT00203554|vertebroplasty|vertebroplasty
501597|NCT00203554|polymethylmetacrylate|polymethylmetacrylate
501598|NCT00203567|bipolar depression|bipolar depression
501599|NCT00203567|carbamazepine ER|carbamazepine er
501600|NCT00203567|Equetro|equetro
501601|NCT00203580|venous thromboembolism|venous thromboembolism
501602|NCT00203580|low-molecular-weight heparin|low-molecular-weight heparin
501603|NCT00203593|exercise|exercise
501604|NCT00203593|total peripheral resistance|total peripheral resistance
501605|NCT00203593|venoconstriction|venoconstriction
501606|NCT00203593|blood volume expansion|blood volume expansion
501607|NCT00203593|orthostatic tolerance|orthostatic tolerance
501608|NCT00203632|diabetes mellitus|diabetes mellitus
501609|NCT00203632|endothelium|endothelium
501610|NCT00203632|thiazolidinediones|thiazolidinediones
501611|NCT00203632|atherosclerosis|atherosclerosis
501612|NCT00203645|Problem gambling|problem gambling
501613|NCT00203645|Self-help manual|self-help manual
501614|NCT00203645|Motivation enhancement|motivation enhancement
501615|NCT00203645|Telephone support|telephone support
501616|NCT00203645|Treatment|treatment
501617|NCT00203645|Pathological gambling|pathological gambling
501618|NCT00203671|renal|renal
501619|NCT00203671|transplant|transplant
501620|NCT00203671|kidney|kidney
501621|NCT00203671|rejection|rejection
501622|NCT00203671|MMF|mmf
501623|NCT00203671|Mycophenolate Mofetil|mycophenolate mofetil
501624|NCT00203671|outcomes|outcomes
501625|NCT00203671|Kidney Transplantation|kidney transplantation
501626|NCT00203697|Eric Kleerup|eric kleerup
501627|NCT00203697|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
501628|NCT00203710|Concentric Retriever Device|concentric retriever device
501629|NCT00203710|embolectomy|embolectomy
501630|NCT00203710|acute ischemic stroke|acute ischemic stroke
501631|NCT00203710|treatment|treatment
501632|NCT00203723|mood disorder|mood disorder
501633|NCT00203723|affective disorder|affective disorder
501634|NCT00203723|depression|depression
501635|NCT00203723|treatment-resistant|treatment-resistant
501636|NCT00203736|Malaria|malaria
501637|NCT00203736|Efficacy|efficacy
501638|NCT00203736|Pharmacokinetic|pharmacokinetic
501639|NCT00203736|Gametocyte|gametocyte
501640|NCT00203736|Molecular Markers|molecular markers
501641|NCT00203736|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
501642|NCT00203736|Artesunate|artesunate
501643|NCT00203736|Artemisinin|artemisinin
501644|NCT00203749|HIV|hiv
501645|NCT00203749|Testing|testing
501646|NCT00203749|Counseling|counseling
501647|NCT00203762|Pragmatic cluster non-randomized controlled trial|pragmatic cluster non-randomized controlled trial
501648|NCT00203762|antiretroviral treatment|antiretroviral treatment
501649|NCT00203762|tuberculosis|tuberculosis
501650|NCT00203762|childhood immunization|childhood immunization
501651|NCT00203762|primary care|primary care
501652|NCT00203762|resource-restricted settings|resource-restricted settings
501653|NCT00203788|work outcome|work outcome
501654|NCT00203788|supported employment|supported employment
501655|NCT00203788|social skills training|social skills training
501656|NCT00203788|risperidone|risperidone
501657|NCT00203788|cognition|cognition
501658|NCT00203788|first-episode schizophrenia|first-episode schizophrenia
501659|NCT00203801|Malaria|malaria
501660|NCT00203801|Efficacy|efficacy
501661|NCT00203801|Pharmacokinetic|pharmacokinetic
501662|NCT00203801|Gametocyte|gametocyte
501663|NCT00203801|Molecular markers|molecular markers
501664|NCT00203801|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
501665|NCT00203801|Artesunate|artesunate
501666|NCT00203801|Artemisinin|artemisinin
501667|NCT00203814|Malaria|malaria
501668|NCT00203814|Efficacy|efficacy
501669|NCT00203814|Pharmacokinetic|pharmacokinetic
501670|NCT00203814|Gametocyte|gametocyte
501671|NCT00203814|Molecular markers|molecular markers
501672|NCT00203814|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
501673|NCT00203814|Artesunate|artesunate
501674|NCT00203814|Artemisinin|artemisinin
501675|NCT00203827|Sleep Disorders|sleep disorders
501676|NCT00203840|Sleep Disorders|sleep disorders
501678|NCT00203853|HAART|haart
501679|NCT00203853|medication adherance|medication adherance
501680|NCT00203853|pillbox|pillbox
501681|NCT00203853|wristwatch|wristwatch
501682|NCT00203866|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
501683|NCT00203879|metastatic melanoma|metastatic melanoma
501684|NCT00203892|Adenocarcinoma|adenocarcinoma
501685|NCT00203892|Pancreas|pancreas
501686|NCT00203905|Head and Neck Cancer|head and neck cancer
501687|NCT00203918|Prostate Cancer|prostate cancer
501688|NCT00203918|Cost-Effectiveness Analysis|cost-effectiveness analysis
501689|NCT00203918|Utility Assessment|utility assessment
501690|NCT00203931|Non-small cell lung cancer|non-small cell lung cancer
501691|NCT00203944|Adoption|adoption
501692|NCT00203944|Stress Response|stress response
501693|NCT00203944|Child Development|child development
501694|NCT00203957|Parkinson's Disease|parkinson's disease
501695|NCT00203970|Thrombosis|thrombosis
501696|NCT00203970|Low Molecular Weight Heparin|low molecular weight heparin
501697|NCT00203996|polycystic ovary syndrome|polycystic ovary syndrome
501698|NCT00203996|metabolic syndrome|metabolic syndrome
501699|NCT00203996|obstructive sleep apnea|obstructive sleep apnea
501700|NCT00203996|impaired glucose tolerance|impaired glucose tolerance
501701|NCT00203996|insulin resistance|insulin resistance
501702|NCT00204009|children and adolescents|children and adolescents
501703|NCT00204009|epidemiology|epidemiology
501704|NCT00204022|Lupus nephritis|lupus nephritis
501705|NCT00204022|Treatment|treatment
501706|NCT00204022|Maintenance therapy|maintenance therapy
501707|NCT00204022|Mycophenolate mofetil|mycophenolate mofetil
501708|NCT00204022|Azathioprine|azathioprine
501709|NCT00204035|Training early achievers for careers in health|training early achievers for careers in health
501710|NCT00204048|Hospitalists|hospitalists
501711|NCT00204061|schizophrenia|schizophrenia
501712|NCT00204061|psychosis|psychosis
501713|NCT00204061|ultra high risk|ultra high risk
501714|NCT00204061|prodromal state|prodromal state
501715|NCT00204061|early intervention|early intervention
501716|NCT00204061|amisulpride|amisulpride
501717|NCT00204074|Migraine|migraine
501718|NCT00204074|Menstrual cycle|menstrual cycle
501719|NCT00204074|17 beta-estradiol|17 beta-estradiol
501720|NCT00204074|Transdermal administration|transdermal administration
501721|NCT00204087|Schizophrenia|schizophrenia
501722|NCT00204087|Psychosis|psychosis
501723|NCT00204087|Prodrome|prodrome
501724|NCT00204087|Early Initial Prodromal State|early initial prodromal state
501725|NCT00204087|Early Intervention|early intervention
501726|NCT00204087|Cognitive Behavioral Therapy|cognitive behavioral therapy
501727|NCT00204100|paraplegia|paraplegia
501728|NCT00204100|spinal cord injury|spinal cord injury
501729|NCT00204100|functional electrical stimulation|functional electrical stimulation
501730|NCT00204100|cycling|cycling
501731|NCT00204100|exercise|exercise
501732|NCT00204100|cardiopulmonary fitness|cardiopulmonary fitness
501733|NCT00204113|spinal cord injury|spinal cord injury
501734|NCT00204113|standing|standing
501735|NCT00204113|balance|balance
501736|NCT00204113|functional electrical stimulation|functional electrical stimulation
501737|NCT00204126|exercise testing|exercise testing
501738|NCT00204126|treadmill|treadmill
501739|NCT00204126|incomplete spinal cord injury|incomplete spinal cord injury
501740|NCT00204126|novel methods|novel methods
501741|NCT00204152|Early onset depression|early onset depression
501742|NCT00204152|early adversity|early adversity
501743|NCT00204178|Kidney transplantation|kidney transplantation
501744|NCT00204178|Reperfusion injury|reperfusion injury
501745|NCT00204191|kidney transplantation|kidney transplantation
501746|NCT00204191|Immunosuppression|immunosuppression
501747|NCT00204191|Cyclosporine|cyclosporine
501748|NCT00204191|Tacrolimus|tacrolimus
501749|NCT00204204|multiple trauma|multiple trauma
501750|NCT00204204|traffic accident|traffic accident
501751|NCT00204204|outcome|outcome
501752|NCT00204204|safety|safety
501753|NCT00204204|injury severity|injury severity
501754|NCT00204217|cardiac arrest|cardiac arrest
501755|NCT00204217|resuscitation|resuscitation
501756|NCT00204217|ventilation|ventilation
501757|NCT00204217|impedance|impedance
501758|NCT00204230|Kidney Failure, Chronic|kidney failure, chronic
501759|NCT00204230|Kidney Transplantation|kidney transplantation
501760|NCT00204243|naltrexone implant|naltrexone implant
501761|NCT00204243|methadone|methadone
501762|NCT00204243|inmates|inmates
501763|NCT00204243|randomized controlled trial|randomized controlled trial
501764|NCT00204256|chronic kidney disease|chronic kidney disease
501765|NCT00204256|anemia|anemia
501766|NCT00204256|intravenous iron|intravenous iron
646803|NCT00757159|Human|human
501065|NCT00192634|HIV|hiv
501767|NCT00204256|recombinant human erythropoetin|recombinant human erythropoetin
501768|NCT00204269|Hypogonadism|hypogonadism
501769|NCT00204269|Testosterone|testosterone
501770|NCT00204269|Substitution|substitution
501771|NCT00204282|Diabetes prevention|diabetes prevention
501772|NCT00204295|Brain neoplasms|brain neoplasms
501773|NCT00204295|Positron-Emission Tomography|positron-emission tomography
501774|NCT00204295|Amino Acids|amino acids
501775|NCT00204295|Magnetic Resonance Imaging|magnetic resonance imaging
501776|NCT00204308|HIV|hiv
501777|NCT00204308|Pregnancy|pregnancy
501778|NCT00204308|Mother-to-child transmission of HIV|mother-to-child transmission of hiv
501779|NCT00204308|Drug resistance|drug resistance
501780|NCT00204308|Nevirapine resistance|nevirapine resistance
501781|NCT00204308|NNRTI resistance|nnrti resistance
501782|NCT00204321|rejection|rejection
501783|NCT00204321|vesselwall function|vesselwall function
501784|NCT00204321|endothelial cell function|endothelial cell function
501785|NCT00204321|monocytes|monocytes
501786|NCT00204334|Kidney transplantation|kidney transplantation
501787|NCT00204334|anemia|anemia
501788|NCT00204334|vascular endothelium|vascular endothelium
501789|NCT00204334|monocytes|monocytes
501790|NCT00204334|apoptosis|apoptosis
501791|NCT00204347|risperidone|risperidone
501792|NCT00204360|epilepsy|epilepsy
501902|NCT00186030|HIV|hiv
501793|NCT00204386|Posttraumatic Stress Disorder|posttraumatic stress disorder
501794|NCT00204412|Cholesterol|cholesterol
501795|NCT00204412|High density lipoprotein|high density lipoprotein
501796|NCT00204412|Low density lipoprotein|low density lipoprotein
501797|NCT00204412|Triglyceride|triglyceride
501798|NCT00204412|Glucose|glucose
501799|NCT00204412|Exercise|exercise
501800|NCT00204412|Fitness|fitness
501801|NCT00204412|Flax|flax
501802|NCT00204412|Lignan|lignan
501803|NCT00204412|Phytoestrogen|phytoestrogen
501804|NCT00204412|bone|bone
501805|NCT00204425|Osteoporosis|osteoporosis
501806|NCT00204425|Bone|bone
501807|NCT00204425|Exercise|exercise
501808|NCT00204425|Soy|soy
501809|NCT00204425|Isoflavone|isoflavone
501810|NCT00204425|Phytoestrogen|phytoestrogen
501811|NCT00204425|Menopause|menopause
501812|NCT00204425|Lipids|lipids
501813|NCT00204438|female contraception|female contraception
501814|NCT00204438|oral contraceptive|oral contraceptive
501815|NCT00204438|emergency contraceptive|emergency contraceptive
501816|NCT00204438|ovary|ovary
501817|NCT00204438|follicle|follicle
501818|NCT00204438|ovulation|ovulation
501819|NCT00204451|emergency contraception|emergency contraception
501820|NCT00204451|follicle|follicle
501821|NCT00204451|ovulation|ovulation
501822|NCT00204451|blood pressure|blood pressure
501823|NCT00204451|Fertility Control|fertility control
501824|NCT00204451|Inhibition of fertilization|inhibition of fertilization
501825|NCT00204464|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
501826|NCT00204464|Exercise|exercise
501827|NCT00204477|soy diet|soy diet
501828|NCT00204477|breast cancer|breast cancer
501829|NCT00204477|ovarian hormones|ovarian hormones
501830|NCT00204477|breast density|breast density
501831|NCT00204477|prevention|prevention
501832|NCT00204490|soy|soy
501833|NCT00204490|isoflavones|isoflavones
501834|NCT00204490|phytoestrogens|phytoestrogens
501835|NCT00204490|prevention|prevention
501836|NCT00204490|mammographic density|mammographic density
501837|NCT00204490|bone density|bone density
501838|NCT00204503|Bipolar I or II|bipolar i or ii
501839|NCT00204503|Depression|depression
501840|NCT00204503|Alcohol Abuse or Dependence|alcohol abuse or dependence
501841|NCT00204503|Mental Health Issues|mental health issues
501842|NCT00204516|vaccination|vaccination
501843|NCT00204516|mRNA|mrna
501844|NCT00204529|malignant melanoma|malignant melanoma
501845|NCT00204529|adjuvant therapy|adjuvant therapy
501846|NCT00204529|Adjuvants, Immunologic|adjuvants, immunologic
501847|NCT00204542|actinic keratosis|actinic keratosis
501848|NCT00204542|diclofenac sodium|diclofenac sodium
501849|NCT00204555|nodular basal cell carcinoma|nodular basal cell carcinoma
501851|NCT00204555|topical treatment|topical treatment
501852|NCT00204555|Adjuvants, Immunologic|adjuvants, immunologic
501853|NCT00204555|Antineoplastic Agents|antineoplastic agents
501854|NCT00204555|Interferon Inducers|interferon inducers
501855|NCT00204581|Melanoma|melanoma
501856|NCT00204581|Soft tissue metastases|soft tissue metastases
501857|NCT00204581|Interleukin-2|interleukin-2
501858|NCT00204594|mRNA|mrna
501859|NCT00204594|vaccination|vaccination
501860|NCT00204594|melanoma|melanoma
501861|NCT00204659|Rituximab|rituximab
501862|NCT00204659|CHOP|chop
501863|NCT00204659|DLBCL|dlbcl
501864|NCT00204659|gastric lymphoma|gastric lymphoma
501865|NCT00204672|Asthma|asthma
501866|NCT00185536|Taste|taste
501867|NCT00185536|preschool children|preschool children
501868|NCT00185536|fast food|fast food
501869|NCT00185549|Cystic Fibrosis;|cystic fibrosis;
501870|NCT00185549|patient education,|patient education,
501871|NCT00185549|Internet|internet
501872|NCT00185562|Osteoarthritis|osteoarthritis
501873|NCT00185705|Insulin resistance|insulin resistance
501874|NCT00185705|obesity|obesity
501875|NCT00185705|hypertension|hypertension
501876|NCT00185705|adolescents|adolescents
501877|NCT00185705|telmisartan|telmisartan
501878|NCT00185705|lifestyle intervention|lifestyle intervention
501879|NCT00185770|Obesity prevention|obesity prevention
501880|NCT00185770|Television|television
501881|NCT00185770|Screen time|screen time
501882|NCT00185770|Schools|schools
501883|NCT00185770|Preadolescents|preadolescents
501884|NCT00185783|Sepsis|sepsis
501885|NCT00185783|Adrenal Insufficiency|adrenal insufficiency
501886|NCT00185783|Hydrocortisone|hydrocortisone
501887|NCT00185783|Gene Expression|gene expression
501888|NCT00185783|Microarray|microarray
501889|NCT00185783|RNA|rna
501890|NCT00185783|Critically Ill|critically ill
501891|NCT00185939|dog bites|dog bites
501892|NCT00185939|infection|infection
501893|NCT00185939|prophylactic antibiotics|prophylactic antibiotics
501894|NCT00185939|cost effectiveness|cost effectiveness
501895|NCT00185965|non-Hodgkin|non-hodgkin
501896|NCT00185965|lymphoma|lymphoma
501897|NCT00185965|mycosis|mycosis
501898|NCT00185965|fungoides|fungoides
501899|NCT00185978|obesity prevention|obesity prevention
501900|NCT00185978|preadolescents|preadolescents
501901|NCT00185978|schools|schools
501903|NCT00186030|AIDS|aids
501905|NCT00186030|Prevention|prevention
501906|NCT00186095|Amyloidosis|amyloidosis
501907|NCT00186095|nonmyeloablative|nonmyeloablative
501908|NCT00186095|hematopoietic|hematopoietic
501909|NCT00186095|cell transplantation|cell transplantation
501910|NCT00186108|Oral Triamcinalone|oral triamcinalone
501911|NCT00186108|Prostate Cancer|prostate cancer
501912|NCT00186134|Physical Activity|physical activity
501913|NCT00186134|Walking|walking
501914|NCT00186134|Primary Schools|primary schools
501915|NCT00186134|Transportation|transportation
501916|NCT00186173|Obesity|obesity
501917|NCT00186173|Physical activity|physical activity
501918|NCT00186199|voiding patterns|voiding patterns
501919|NCT00186199|flow rate|flow rate
501920|NCT00186199|ultrasound|ultrasound
501921|NCT00197080|Restless Legs Syndrome|restless legs syndrome
501922|NCT00197080|RLS|rls
501923|NCT00197093|Schizophrenia|schizophrenia
501924|NCT00197093|safety|safety
501925|NCT00197093|tolerability|tolerability
501926|NCT00197093|pharmacokinetics|pharmacokinetics
501927|NCT00197106|salmeterol/fluticasone combination|salmeterol/fluticasone combination
501928|NCT00197106|Asthma|asthma
501929|NCT00197106|bronchial hyperresponsiveness|bronchial hyperresponsiveness
501930|NCT00197106|Children|children
501931|NCT00197106|symptom control|symptom control
501932|NCT00197119|Hepatitis B|hepatitis b
501933|NCT00197119|TWINRIX™ Adult|twinrix™ adult
501934|NCT00197119|Hepatitis A|hepatitis a
501935|NCT00197119|TWINRIX™ Junior|twinrix™ junior
501936|NCT00197132|Insulin resistance vasodilatory response|insulin resistance vasodilatory response
501937|NCT00197145|HIV-1 GW873140 CCR5 antagonist experienced|hiv-1 gw873140 ccr5 antagonist experienced
501938|NCT00197184|Combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
501939|NCT00197184|Twinrix™|twinrix™
501940|NCT00197197|HIV-1 GW873140 CCR5 antagonist treatment experienced|hiv-1 gw873140 ccr5 antagonist treatment experienced
501941|NCT00197236|Hepatitis A|hepatitis a
501942|NCT00197249|Hepatitis A & B|hepatitis a & b
501943|NCT00197249|Typhoid|typhoid
501944|NCT00197262|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
501945|NCT00197262|GW685698X|gw685698x
501946|NCT00197262|allergic rhinitis|allergic rhinitis
501947|NCT00197262|Hayfever|hayfever
501948|NCT00197275|Haemophilus influenzae type b|haemophilus influenzae type b
501949|NCT00197275|diphtheria|diphtheria
501950|NCT00197275|tetanus|tetanus
501951|NCT00197275|Prophylaxis diphtheria|prophylaxis diphtheria
501952|NCT00197275|pertussis|pertussis
501953|NCT00197275|hepatitis B|hepatitis b
501954|NCT00197275|meningococcal serogroups A & C diseases|meningococcal serogroups a & c diseases
501955|NCT00197288|Prophylaxis: Influenza virus infection|prophylaxis: influenza virus infection
501956|NCT00197301|Intranasal vaccination, Influenza|intranasal vaccination, influenza
501957|NCT00197314|Urinary stress incontinence|urinary stress incontinence
501958|NCT00197314|Randomized trial|randomized trial
501959|NCT00197314|circular muscle training|circular muscle training
501960|NCT00197314|pelvic floor training|pelvic floor training
501961|NCT00197314|bioequivalence|bioequivalence
501962|NCT00197327|Labor Pain|labor pain
501963|NCT00197327|Analgesia, Obstetrical|analgesia, obstetrical
501964|NCT00197327|Pharmacology|pharmacology
501965|NCT00197327|Treatment Outcome|treatment outcome
501966|NCT00197340|Pre-Eclampsia|pre-eclampsia
501967|NCT00197340|Fetal Growth Retardation|fetal growth retardation
501968|NCT00197340|Anesthesia, Epidural|anesthesia, epidural
501969|NCT00197340|Placental Circulation|placental circulation
501970|NCT00197340|Dose-Response Relationship, Drug|dose-response relationship, drug
501259|NCT00193895|surgery|surgery
501971|NCT00197353|Anesthesia, Epidural|anesthesia, epidural
501972|NCT00197353|Pharmacology|pharmacology
501973|NCT00197353|Dose-Response Relationship, Drug|dose-response relationship, drug
501974|NCT00197353|Sympathectomy|sympathectomy
501975|NCT00197353|Photoplethysmography|photoplethysmography
501976|NCT00197366|pregnancy|pregnancy
501977|NCT00197366|HIV-positive|hiv-positive
501978|NCT00197366|HIV resistance|hiv resistance
501979|NCT00197366|HIV|hiv
501980|NCT00197379|androgenetic alopecia|androgenetic alopecia
501981|NCT00197379|roxitromycin|roxitromycin
501982|NCT00197379|apoptosis|apoptosis
501983|NCT00197392|Ventriculostomy|ventriculostomy
501984|NCT00197392|EVD|evd
501985|NCT00197418|H. pylori infection|h. pylori infection
501986|NCT00197444|esophageal cancer|esophageal cancer
501987|NCT00197444|Nedaplatin|nedaplatin
501988|NCT00197444|5-FU|5-fu
501989|NCT00197444|chemotherapy|chemotherapy
501990|NCT00197444|radiation|radiation
501991|NCT00197444|chemoradiotherapy|chemoradiotherapy
501992|NCT00197483|Pergolide|pergolide
501993|NCT00197483|Dopamine D1|dopamine d1
501994|NCT00197483|Schizophrenia|schizophrenia
501995|NCT00197483|Cognitive disturbance|cognitive disturbance
501996|NCT00197483|Negative symptoms|negative symptoms
501997|NCT00197509|Long-Term Care|long-term care
501998|NCT00197509|Clinical Protocols|clinical protocols
501999|NCT00197509|Sit-To-Stand|sit-to-stand
502000|NCT00197522|breast cancer|breast cancer
502001|NCT00197522|vaccination|vaccination
502002|NCT00197522|dendritic cells|dendritic cells
502004|NCT00197522|CD34+ stem cells|cd34+ stem cells
502005|NCT00197548|Women|women
502006|NCT00197548|Pregnancy Outcomes|pregnancy outcomes
502007|NCT00197548|Nutrition|nutrition
502008|NCT00197548|Vitamins|vitamins
502009|NCT00197548|Tanzania|tanzania
502010|NCT00197548|Maternal and Child Health Outcomes|maternal and child health outcomes
502012|NCT00197561|Selenium|selenium
502013|NCT00197561|Nutrition|nutrition
502014|NCT00197561|Women|women
502015|NCT00197561|Pregnancy|pregnancy
502016|NCT00197561|Tanzania|tanzania
502017|NCT00197561|Maternal and child health outcomes|maternal and child health outcomes
502018|NCT00197561|HIV/AIDS|hiv/aids
502019|NCT00197561|Pregnancy Outcome|pregnancy outcome
502020|NCT00197639|indinavir, HIV, ritonavir, pharmacokinetics, Thailand|indinavir, hiv, ritonavir, pharmacokinetics, thailand
502021|NCT00197652|Prevention of Mother-Infant HIV Transmission|prevention of mother-infant hiv transmission
502022|NCT00197678|HIV|hiv
502023|NCT00197678|AIDS|aids
502024|NCT00197678|Multivitamins|multivitamins
502025|NCT00197678|Pregnancy Outcomes|pregnancy outcomes
502026|NCT00197678|Women|women
502027|NCT00197678|Tanzania|tanzania
502028|NCT00197678|Africa|africa
502029|NCT00197691|HIV infected mothers|hiv infected mothers
502030|NCT00197691|Infants at risk of HIV-infection|infants at risk of hiv-infection
502031|NCT00197691|Infant lower respiratory tract disease|infant lower respiratory tract disease
502032|NCT00197691|Infant bloodstream infection|infant bloodstream infection
502033|NCT00197704|Tuberculosis|tuberculosis
502034|NCT00197704|HIV|hiv
502035|NCT00197704|Tanzania|tanzania
502036|NCT00197704|multivitamins|multivitamins
502037|NCT00197730|Birth Outcomes|birth outcomes
502038|NCT00197730|Nutrition|nutrition
502039|NCT00197730|HIV|hiv
502040|NCT00197730|AIDS|aids
502041|NCT00197730|Vitamins|vitamins
502042|NCT00197730|Multivitamins|multivitamins
502043|NCT00197730|Maternal and child health outcomes|maternal and child health outcomes
502044|NCT00197730|Tanzania|tanzania
502045|NCT00197730|Africa|africa
502046|NCT00197743|HIV|hiv
502047|NCT00197743|Multivitamins|multivitamins
502048|NCT00197743|Pregnancy outcomes|pregnancy outcomes
502049|NCT00197743|Tanzania|tanzania
502050|NCT00197743|Women|women
502051|NCT00197756|HIV|hiv
502052|NCT00197756|Breastfeeding|breastfeeding
502053|NCT00197756|Vitamins|vitamins
502054|NCT00197756|Tanzania|tanzania
502055|NCT00197756|Children|children
502056|NCT00197808|Streptococcus pneumoniae|streptococcus pneumoniae
502057|NCT00197808|Neisseria meningitidis|neisseria meningitidis
502058|NCT00197834|Depakote|depakote
502059|NCT00197834|Agitation|agitation
502060|NCT00197834|Dementia|dementia
502061|NCT00197834|Atypical antipsychotic|atypical antipsychotic
502062|NCT00197834|Behavioral Symptoms|behavioral symptoms
502063|NCT00197834|Psychiatric Symptoms|psychiatric symptoms
502064|NCT00197834|Psychological Symptoms|psychological symptoms
502065|NCT00197834|Geriatric|geriatric
502066|NCT00197834|Behavioral and Psychological Symptoms|behavioral and psychological symptoms
502067|NCT00197860|dendritic cell|dendritic cell
502068|NCT00197860|vaccine|vaccine
502069|NCT00197860|renal cell carcinoma|renal cell carcinoma
502070|NCT00197873|colorectal cancer|colorectal cancer
502071|NCT00197873|probiotics|probiotics
502072|NCT00197873|chemotherapy|chemotherapy
502073|NCT00197873|prevention|prevention
502074|NCT00197873|adverse effects|adverse effects
647173|NCT00768183|fed|fed
502075|NCT00197873|diarrhoea|diarrhoea
502076|NCT00197912|dendritic cell|dendritic cell
502077|NCT00197912|cancer vaccine|cancer vaccine
502078|NCT00197912|cyclophosphamide|cyclophosphamide
502079|NCT00197912|melanoma|melanoma
502080|NCT00197925|breast cancer|breast cancer
502081|NCT00197925|dendritic cells|dendritic cells
502082|NCT00197925|vaccine|vaccine
502083|NCT00197951|Psychiatric symptoms associated to alcoholism recovery|psychiatric symptoms associated to alcoholism recovery
502084|NCT00197951|Alcoholism treatment|alcoholism treatment
502085|NCT00197951|Alcohol craving|alcohol craving
502086|NCT00197951|Relapse to heavy drinking|relapse to heavy drinking
502087|NCT00197951|Abuse of other substances during alcoholism recovery|abuse of other substances during alcoholism recovery
502088|NCT00197964|Self-management|self-management
502089|NCT00197964|Self-efficacy|self-efficacy
502090|NCT00197964|Quality of life|quality of life
502091|NCT00197964|Resource utilization|resource utilization
502092|NCT00197977|knee arthritis|knee arthritis
502093|NCT00197977|total knee arthroplasty|total knee arthroplasty
502094|NCT00197977|expectations|expectations
502095|NCT00197977|education|education
502096|NCT00197990|total hip arthroplasty|total hip arthroplasty
502097|NCT00197990|expectations|expectations
502098|NCT00197990|satisfaction|satisfaction
502099|NCT00197990|quality of life|quality of life
502100|NCT00198003|hip arthritis|hip arthritis
502101|NCT00198003|total hip arthroplasty|total hip arthroplasty
502102|NCT00198003|expectations|expectations
502103|NCT00198003|education|education
502104|NCT00198016|coronary fistulas.|coronary fistulas.
502003|NCT00197522|HER-2|her-2
502105|NCT00198016|coils embolization.|coils embolization.
502106|NCT00198029|Osteoarthritis|osteoarthritis
502107|NCT00198029|Hyaluronan|hyaluronan
502108|NCT00198029|Carpometacarpal|carpometacarpal
502109|NCT00198029|Outcomes|outcomes
502111|NCT00198042|Tunnel|tunnel
502112|NCT00198042|Widening|widening
502113|NCT00198055|Aggression|aggression
502114|NCT00198055|Behavioral symptoms|behavioral symptoms
502115|NCT00198068|Pregnancy outcomes|pregnancy outcomes
502116|NCT00198068|Systemic lupus erythematosus|systemic lupus erythematosus
502117|NCT00198068|Antiphospholipid syndrome|antiphospholipid syndrome
502118|NCT00198081|celecoxib for pancreas lesions|celecoxib for pancreas lesions
502119|NCT00198107|Children|children
502120|NCT00198107|Adolescents|adolescents
502121|NCT00198107|Aripiprazole|aripiprazole
502122|NCT00198107|Cycloserine|cycloserine
502123|NCT00198107|Aggression|aggression
502124|NCT00198107|Irritability|irritability
502125|NCT00198107|Self-Injurious Behavior|self-injurious behavior
502126|NCT00198107|Social Interaction|social interaction
502127|NCT00198107|Antipsychotics|antipsychotics
502128|NCT00198107|Pharmacology|pharmacology
502129|NCT00198107|Glutamatergic Agents|glutamatergic agents
502130|NCT00198120|Autistic Disorder|autistic disorder
502131|NCT00198120|cycloserine|cycloserine
502132|NCT00198120|pharmacology|pharmacology
502133|NCT00198120|glutamatergic agents|glutamatergic agents
502134|NCT00198120|communication|communication
502135|NCT00198120|social interaction|social interaction
502136|NCT00198120|Double-Blind Method|double-blind method
502137|NCT00198133|Thymoma|thymoma
502138|NCT00198133|Thymic Carcinoma|thymic carcinoma
502139|NCT00198159|Refractory Germ Cell Tumors|refractory germ cell tumors
502140|NCT00198159|Germ Cell Tumors|germ cell tumors
502141|NCT00198172|Germ Cell Tumor|germ cell tumor
502142|NCT00198172|Refractory Germ Cell Tumors|refractory germ cell tumors
502143|NCT00198172|Cisplatin plus Epirubicin Salvage Chemotherapy|cisplatin plus epirubicin salvage chemotherapy
502144|NCT00198185|Full Thickness Tendon Defect of Rotator Cuff|full thickness tendon defect of rotator cuff
502145|NCT00198224|immunosuppression|immunosuppression
502146|NCT00198237|Breast Cancer|breast cancer
502147|NCT00198237|Stage II Breast Cancer|stage ii breast cancer
502148|NCT00198237|Stage III Breast Cancer|stage iii breast cancer
502149|NCT00198250|Breast cancer survivorship|breast cancer survivorship
502150|NCT00198250|hot flashes|hot flashes
502151|NCT00198250|treatment|treatment
502152|NCT00198263|head and neck cancer|head and neck cancer
502153|NCT00198263|cancer|cancer
502154|NCT00198263|bleomycin|bleomycin
502155|NCT00198263|medpulser|medpulser
502156|NCT00198263|electroporation|electroporation
502157|NCT00198263|primary oral cavity, primary pharyngeal, primary laryngeal, salivary gland, limited recurrent and second primary tumors|primary oral cavity, primary pharyngeal, primary laryngeal, salivary gland, limited recurrent and second primary tumors
502158|NCT00198276|cancer|cancer
502159|NCT00198276|cutaneous|cutaneous
502160|NCT00198276|subcutaneous|subcutaneous
502161|NCT00198276|MedPulser|medpulser
502162|NCT00198276|bleomycin|bleomycin
502163|NCT00198276|electroporation|electroporation
502164|NCT00198276|Cutaneous or subcutaneous cancer|cutaneous or subcutaneous cancer
502165|NCT00198289|Cystic Fibrosis|cystic fibrosis
502166|NCT00198289|Staphylococcus aureus|staphylococcus aureus
502167|NCT00198289|lungs|lungs
502168|NCT00198302|staphylococcus aureus|staphylococcus aureus
502169|NCT00198302|bacteremia|bacteremia
502170|NCT00198302|sepsis|sepsis
502171|NCT00198315|Squamous Cell Carcinoma|squamous cell carcinoma
502172|NCT00198315|Carcinoma|carcinoma
502173|NCT00198315|Head and Neck Cancer|head and neck cancer
502174|NCT00198315|Oral|oral
502175|NCT00198315|Soft Palate|soft palate
502176|NCT00198315|Cancer|cancer
502177|NCT00198315|Medpulser|medpulser
502178|NCT00198315|Electroporation|electroporation
502179|NCT00198315|Local recurrent or second primary squamous cell carcinoma of anterior oral cavity, soft palate, or tonsil|local recurrent or second primary squamous cell carcinoma of anterior oral cavity, soft palate, or tonsil
502180|NCT00198328|Squamous Cell Carcinoma|squamous cell carcinoma
502181|NCT00198328|carcinoma|carcinoma
502182|NCT00198328|head and neck cancer|head and neck cancer
502183|NCT00198328|larynx|larynx
502184|NCT00198328|electroporation|electroporation
502185|NCT00198328|medpulser|medpulser
502186|NCT00198328|bleomycin|bleomycin
502187|NCT00198328|cancer|cancer
502188|NCT00198328|Locally recurrent or second primary squamous cell carcinoma of the base of the tongue, posterior lateral pharyngeal wall, hypopharynx, or larynx|locally recurrent or second primary squamous cell carcinoma of the base of the tongue, posterior lateral pharyngeal wall, hypopharynx, or larynx
502189|NCT00198341|Post-surgical Non-small cell lung cancer|post-surgical non-small cell lung cancer
502190|NCT00198367|operable and resectable stage IIIA (T1-3, N2) NSCLC|operable and resectable stage iiia (t1-3, n2) nsclc
502191|NCT00198380|Adenocarcinoma, Bronchiolo-Alveolar|adenocarcinoma, bronchiolo-alveolar
502192|NCT00198393|stage IIIB/IV NSCLC|stage iiib/iv nsclc
502193|NCT00198393|patients with performance status 2 or 3.|patients with performance status 2 or 3.
502194|NCT00198445|Cataract Extraction|cataract extraction
502195|NCT00198445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
502196|NCT00198484|Adjuvants, Anesthesia|adjuvants, anesthesia
502197|NCT00198484|Spreading Factor|spreading factor
502198|NCT00198523|Cataract Extraction|cataract extraction
502199|NCT00198523|Anti-Bacterial Agents|anti-bacterial agents
502200|NCT00198523|Steroids|steroids
502201|NCT00198549|Adjuvants, Anesthesia|adjuvants, anesthesia
502202|NCT00198549|hyaluronate lyase|hyaluronate lyase
502203|NCT00198562|Antihypertensive therapy|antihypertensive therapy
502204|NCT00198562|Home blood pressure|home blood pressure
502205|NCT00198562|Systolic blood pressure|systolic blood pressure
502206|NCT00198562|Morning blood pressure|morning blood pressure
502207|NCT00198562|Calcium antagonist|calcium antagonist
502208|NCT00198562|Angiotensin receptor antagonist|angiotensin receptor antagonist
502209|NCT00198575|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
502210|NCT00198575|cardiovascular surgery|cardiovascular surgery
502211|NCT00198575|percutaneous coronary intervention|percutaneous coronary intervention
502212|NCT00198588|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
502213|NCT00198588|argatroban|argatroban
502214|NCT00198588|cardiac surgery|cardiac surgery
502215|NCT00198588|acute coronary syndrome|acute coronary syndrome
502216|NCT00198588|thrombosis|thrombosis
502217|NCT00198588|amputation|amputation
502218|NCT00198588|anticoagulation|anticoagulation
502219|NCT00198601|meningitis|meningitis
502220|NCT00198601|neonatal deaths|neonatal deaths
502221|NCT00198601|gentamicin|gentamicin
502222|NCT00198601|Uniject|uniject
502223|NCT00198601|aminoglycoside|aminoglycoside
502224|NCT00198614|Adrenergic beta-Antagonists|adrenergic beta-antagonists
502225|NCT00198614|Carvedilol|carvedilol
502226|NCT00198614|Metoprolol|metoprolol
502227|NCT00198614|Coronary Artery Bypass|coronary artery bypass
502228|NCT00198614|Atrial Fibrillation|atrial fibrillation
502229|NCT00198627|Neonatal bacterial infection|neonatal bacterial infection
502230|NCT00198640|animal antibiotics|animal antibiotics
502231|NCT00198640|human antibiotics|human antibiotics
502232|NCT00198653|Hypothermia|hypothermia
502233|NCT00198653|Newborn|newborn
502234|NCT00198653|India|india
502235|NCT00198653|Maternal/Child Health|maternal/child health
502236|NCT00198653|Infant|infant
502237|NCT00198653|Kangaroo Mother Care|kangaroo mother care
502238|NCT00198666|Pneumonia|pneumonia
502239|NCT00198666|zinc|zinc
502240|NCT00198679|skin cleansing|skin cleansing
502241|NCT00198679|Bangladesh|bangladesh
502242|NCT00198679|Skin Flora|skin flora
502243|NCT00198679|Newborn|newborn
502244|NCT00198679|infectious disease|infectious disease
502245|NCT00198679|chlorhexidine|chlorhexidine
502246|NCT00198692|amputation|amputation
502247|NCT00198692|depression|depression
502248|NCT00198692|pain|pain
502249|NCT00198692|anxiety|anxiety
502250|NCT00198692|self-management|self-management
502251|NCT00198692|secondary conditions|secondary conditions
502252|NCT00198718|Vitamin A supplementation|vitamin a supplementation
502254|NCT00198718|Mother to child transmission of HIV|mother to child transmission of hiv
502255|NCT00198718|Breastfeeding|breastfeeding
502256|NCT00198731|maternal health|maternal health
502257|NCT00198731|Bangladesh|bangladesh
502258|NCT00198731|care seeking|care seeking
502259|NCT00198822|Maternal mortality|maternal mortality
502260|NCT00198822|Infant mortality|infant mortality
502261|NCT00198822|Vitamin A|vitamin a
502262|NCT00198822|Beta-carotene|beta-carotene
502263|NCT00198822|Micronutrients|micronutrients
502264|NCT00198822|Bangladesh|bangladesh
502265|NCT00198822|Neonatal mortality|neonatal mortality
502266|NCT00198835|malnutrition|malnutrition
502267|NCT00198835|anemia|anemia
502268|NCT00198835|infants|infants
502269|NCT00198835|children|children
502270|NCT00198835|India|india
502271|NCT00198848|Iron deficiency anemia|iron deficiency anemia
502272|NCT00198848|Adolescent girls|adolescent girls
502273|NCT00198848|India|india
502274|NCT00198861|HIV Epidemiology|hiv epidemiology
502275|NCT00198861|Neurology|neurology
502276|NCT00198861|Neuropsychological|neuropsychological
502277|NCT00198861|HIV Risk Factors|hiv risk factors
502278|NCT00198861|Cognitive Risk Factors|cognitive risk factors
502279|NCT00198861|HIV|hiv
502280|NCT00204711|patients having outpatient surgery with sedation|patients having outpatient surgery with sedation
502281|NCT00204711|patients having procedures with sedation|patients having procedures with sedation
502282|NCT00204750|lower esophageal ring|lower esophageal ring
502283|NCT00204750|dysphagia|dysphagia
502284|NCT00204750|electrosurgical incision|electrosurgical incision
502285|NCT00204750|bougie dilation|bougie dilation
502286|NCT00204750|GERD|gerd
502287|NCT00204763|manometry catheters|manometry catheters
502288|NCT00204763|diffuse esophageal spasm or hypertensive LES|diffuse esophageal spasm or hypertensive les
502289|NCT00204763|incontinence|incontinence
502290|NCT00204867|colorectal|colorectal
502291|NCT00204867|polyps|polyps
502292|NCT00204919|osteoporosis|osteoporosis
502293|NCT00204919|vitamin D deficiency|vitamin d deficiency
502294|NCT00204945|arterial stiffness|arterial stiffness
502295|NCT00204945|echocardiography|echocardiography
502296|NCT00204945|nesiritide|nesiritide
502297|NCT00204945|high heart pressures|high heart pressures
502392|NCT00209586|Sedation|sedation
502298|NCT00204945|cardiac catheterization|cardiac catheterization
502299|NCT00204958|bone marrow transplant (BMT)|bone marrow transplant (bmt)
502300|NCT00204958|hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
502301|NCT00204984|arterial stiffness|arterial stiffness
502302|NCT00204984|echocardiography|echocardiography
502303|NCT00204984|nesiritide|nesiritide
502304|NCT00204997|Cervical Cancer|cervical cancer
502305|NCT00204997|Squamous Cell|squamous cell
502306|NCT00204997|Laparoscopy|laparoscopy
502307|NCT00204997|Ovarian Function|ovarian function
502308|NCT00205049|acute alcoholic hepatitis|acute alcoholic hepatitis
502309|NCT00209339|Mitral Valve Insufficiency|mitral valve insufficiency
502310|NCT00209339|Mitral Valve Regurgitation|mitral valve regurgitation
502311|NCT00209339|Mitral Valve Incompetence|mitral valve incompetence
502312|NCT00209339|Mitral Regurgitation|mitral regurgitation
502313|NCT00209339|Mitral Insufficiency|mitral insufficiency
502314|NCT00209339|Mitral Valve|mitral valve
502315|NCT00209339|MR|mr
502316|NCT00209339|Mitral Valve Prolapse|mitral valve prolapse
502317|NCT00209339|E2E - Edge to Edge|e2e - edge to edge
502318|NCT00209339|Alfieri Technique|alfieri technique
502319|NCT00209339|MitraClip|mitraclip
502320|NCT00209339|Functional MR|functional mr
502321|NCT00209339|Degenerative MR|degenerative mr
502322|NCT00209339|Echocardiogram|echocardiogram
502323|NCT00209339|CAD - Coronary Artery Disease|cad - coronary artery disease
502324|NCT00209339|Heart Failure|heart failure
502325|NCT00209339|Heart Attack|heart attack
502326|NCT00209339|EVEREST|everest
502327|NCT00209339|EVEREST I|everest i
502328|NCT00209339|EVEREST II|everest ii
502329|NCT00209352|Varicella Zoster Virus Infection|varicella zoster virus infection
502330|NCT00209352|VZV infection|vzv infection
502331|NCT00209352|Oral Acyclovir|oral acyclovir
502332|NCT00209352|Allogeneic Bone Marrow Transplantation|allogeneic bone marrow transplantation
502333|NCT00209352|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
502334|NCT00209378|Continuous venovenous hemofiltration (CVVH)|continuous venovenous hemofiltration (cvvh)
502335|NCT00209378|Continuous renal replacement therapy (CRRT)|continuous renal replacement therapy (crrt)
502336|NCT00209378|Acute Kidney Injury|acute kidney injury
502337|NCT00209378|Regional citrate anticoagulation|regional citrate anticoagulation
502338|NCT00209378|filter survival|filter survival
502339|NCT00209378|trisodium citrate|trisodium citrate
502340|NCT00209378|bleeding complication|bleeding complication
502341|NCT00209378|Hemofiltration|hemofiltration
502342|NCT00209391|Renal Artery Stenosis|renal artery stenosis
502343|NCT00209391|Occlusion|occlusion
502344|NCT00209391|Diagnostic Imaging|diagnostic imaging
502345|NCT00209391|Omniscan|omniscan
502346|NCT00209391|Magnetic Resonance Angiography|magnetic resonance angiography
502347|NCT00209391|Contrast Media|contrast media
502348|NCT00209404|MDCT|mdct
502349|NCT00209404|Coronary Artery|coronary artery
502350|NCT00209404|Heart Rate|heart rate
502351|NCT00209404|Image Quality|image quality
502352|NCT00209404|Diagnostic Quality|diagnostic quality
502353|NCT00209417|Iodixanol|iodixanol
502354|NCT00209417|Iopamidol|iopamidol
502355|NCT00209417|computed tomography|computed tomography
752457|NCT01173068|Complicated Urinary Tract Infections|complicated urinary tract infections
647536|NCT00760513|RCT|rct
501677|NCT00203853|HIV|hiv
502356|NCT00209417|Patients with pre-existing renal impairment and diabetes|patients with pre-existing renal impairment and diabetes
502357|NCT00209430|Iodixanol|iodixanol
502358|NCT00209430|Iopamidol|iopamidol
502860|NCT00211523|acne|acne
502359|NCT00209430|coronary angiography|coronary angiography
502360|NCT00209430|Contrast media-induced nephropathy|contrast media-induced nephropathy
502361|NCT00209443|Aorto-iliac Stenosis|aorto-iliac stenosis
502362|NCT00209443|Occlusion|occlusion
502363|NCT00209443|Diagnostic Imaging|diagnostic imaging
502364|NCT00209443|Omniscan|omniscan
502365|NCT00209443|Magnetic Resonance Angiography|magnetic resonance angiography
502366|NCT00209443|Contrast Media|contrast media
502367|NCT00209456|Lewy Body Dementia|lewy body dementia
502368|NCT00209456|non-DLB dementia|non-dlb dementia
502369|NCT00209456|Dopamine Transporter|dopamine transporter
502370|NCT00209456|Striatal Uptake|striatal uptake
502371|NCT00209495|Abdominal hysterectomy|abdominal hysterectomy
502372|NCT00209495|Pregabalin|pregabalin
502373|NCT00209495|Dexamethasone|dexamethasone
502374|NCT00209495|Multimodal postoperative analgesia|multimodal postoperative analgesia
502375|NCT00209508|Parkinson's Disease|parkinson's disease
502376|NCT00209508|SPECT Scanning|spect scanning
502377|NCT00209521|Coronary Artery Bypass Surgery|coronary artery bypass surgery
502378|NCT00209521|AQUAVAN® Injection|aquavan® injection
502379|NCT00209521|DISOPRIVAN® Injectable Emulsion.|disoprivan® injectable emulsion.
502380|NCT00209521|ischemic coronary artery disease|ischemic coronary artery disease
502381|NCT00209547|AQUAVAN® Injection|aquavan® injection
502382|NCT00209547|Midazolam|midazolam
502383|NCT00209547|Angioplasty|angioplasty
502384|NCT00209547|Coronary catheterization|coronary catheterization
502385|NCT00209560|AQUAVAN® Injection|aquavan® injection
502386|NCT00209560|Midazolam|midazolam
502387|NCT00209560|Minor surgical procedures|minor surgical procedures
502388|NCT00209560|Sedation|sedation
502389|NCT00209573|Colonoscopy|colonoscopy
502390|NCT00209573|Sedation|sedation
502391|NCT00209586|Bronchoscopy|bronchoscopy
502394|NCT00209599|Seadation|seadation
502395|NCT00209625|Irinotecan, leucovorin, fluorouracil, PhaseI/II, colorectal cancer,|irinotecan, leucovorin, fluorouracil, phasei/ii, colorectal cancer,
502396|NCT00209638|Irinotecan,|irinotecan,
502397|NCT00209638|S-1,|s-1,
502398|NCT00209638|Phase I/II,|phase i/ii,
502399|NCT00209638|gastric cancer|gastric cancer
502400|NCT00209651|Irinotecan, S-1, Phase II, colorectal cancer,|irinotecan, s-1, phase ii, colorectal cancer,
502401|NCT00209664|Irinotecan, S-1, Phase II, gastric cancer|irinotecan, s-1, phase ii, gastric cancer
502402|NCT00209729|Docetaxel|docetaxel
502403|NCT00209729|S-1|s-1
502404|NCT00209729|Elderly Patients|elderly patients
502405|NCT00209729|Gastric cancer|gastric cancer
502406|NCT00209742|Colorectal Cancer,UFT,LV,Krestin,adjuvant therapy,phase III|colorectal cancer,uft,lv,krestin,adjuvant therapy,phase iii
502407|NCT00209755|chronic hepatitis C|chronic hepatitis c
502408|NCT00209768|pediatric intensive care|pediatric intensive care
502409|NCT00209768|critically ill children|critically ill children
502410|NCT00209768|in-line filtration|in-line filtration
502411|NCT00209768|prospective randomized study|prospective randomized study
502412|NCT00209768|complications|complications
502413|NCT00209768|sepsis|sepsis
502414|NCT00209768|SIRS|sirs
502415|NCT00209768|thrombosis|thrombosis
502416|NCT00209768|organ failure|organ failure
502417|NCT00209807|major depression|major depression
502418|NCT00209807|pain|pain
502419|NCT00209807|escitalopram|escitalopram
502420|NCT00209807|reboxetine|reboxetine
502421|NCT00209807|visceral sensitivity|visceral sensitivity
502422|NCT00209807|somatic sensitivity|somatic sensitivity
502423|NCT00209820|low back pain|low back pain
502424|NCT00209820|randomized clinical trial|randomized clinical trial
502425|NCT00209820|Nordic walking|nordic walking
502426|NCT00209820|supervision|supervision
502427|NCT00209820|Advice to stay active|advice to stay active
502428|NCT00209846|Primary insomnia|primary insomnia
502429|NCT00209898|Chronic hepatits C|chronic hepatits c
502430|NCT00209898|peginterferon|peginterferon
502431|NCT00209898|ribavirin|ribavirin
502432|NCT00209898|inmate|inmate
502433|NCT00209898|fast initiation procedure|fast initiation procedure
502434|NCT00209911|atrial volume|atrial volume
502435|NCT00209911|ventricular volume|ventricular volume
502436|NCT00209911|atrial function|atrial function
502437|NCT00209911|ventricular function|ventricular function
502438|NCT00209911|magnetic resonance imaging|magnetic resonance imaging
502440|NCT00209911|natriuretic peptides|natriuretic peptides
502441|NCT00209924|Primary insomnia|primary insomnia
502442|NCT00209937|Primary insomnia|primary insomnia
502443|NCT00209950|Primary insomnia|primary insomnia
502444|NCT00209963|Primary insomnia|primary insomnia
502445|NCT00209989|Glioblastoma Multiforme|glioblastoma multiforme
502446|NCT00209989|Zarnestra|zarnestra
502447|NCT00209989|Radiation therapy|radiation therapy
502448|NCT00210002|Neoplasms|neoplasms
502449|NCT00210002|Solid|solid
502450|NCT00210002|Anemia|anemia
647666|NCT00761098|SBP|sbp
502451|NCT00210002|darbepoetin alfa|darbepoetin alfa
502452|NCT00210002|ferric saccharose|ferric saccharose
502453|NCT00210002|Venofer®|venofer®
502454|NCT00210002|Aranesp®|aranesp®
502455|NCT00210028|Breast Neoplasms|breast neoplasms
502456|NCT00210028|Zarnestra|zarnestra
502457|NCT00210028|Tamoxifen|tamoxifen
502458|NCT00210028|estrogen receptor|estrogen receptor
502459|NCT00210028|progesterone receptor|progesterone receptor
502460|NCT00210041|Genital Neoplasms, Male|genital neoplasms, male
502461|NCT00210106|Radiofrequency ablation|radiofrequency ablation
502462|NCT00210106|Colorectal cancer|colorectal cancer
502463|NCT00210106|Liver metastases|liver metastases
502464|NCT00210119|Chronic myeloid leukemia|chronic myeloid leukemia
502465|NCT00210119|imatinib mesylate|imatinib mesylate
502466|NCT00210119|zoledronate|zoledronate
502467|NCT00210119|molecular response|molecular response
502468|NCT00210132|Thoracic surgery|thoracic surgery
502469|NCT00210132|postoperative pain|postoperative pain
502470|NCT00210132|ropivacaine|ropivacaine
502471|NCT00210132|inter pleural analgesia|inter pleural analgesia
502472|NCT00210145|Aesthetic care,|aesthetic care,
502473|NCT00210145|Mastectomy,|mastectomy,
502474|NCT00210145|Breast cancer,|breast cancer,
502475|NCT00210145|Quality of life,|quality of life,
502476|NCT00210145|Body image,|body image,
502477|NCT00210145|Psychological adjustment|psychological adjustment
502478|NCT00210158|Current opioid treatment|current opioid treatment
502479|NCT00210158|Nitrous oxide|nitrous oxide
502480|NCT00210158|Chronic pain|chronic pain
502481|NCT00210158|Opioid therapy|opioid therapy
502482|NCT00210158|Postoperative hyperalgesia|postoperative hyperalgesia
502483|NCT00210158|Acute opioid tolerance|acute opioid tolerance
502484|NCT00210171|Carcinoma|carcinoma
502485|NCT00210171|Stage IIIA Non Small Cell Lung|stage iiia non small cell lung
502486|NCT00210171|Stage IIIB Non-Small-Cell Lung|stage iiib non-small-cell lung
502487|NCT00210171|Concomitant chemo-radiotherapy|concomitant chemo-radiotherapy
502488|NCT00210171|Consolidation chemotherapy|consolidation chemotherapy
502489|NCT00210184|Chemotherapy|chemotherapy
502793|NCT00211133|Hemoglobin|hemoglobin
502490|NCT00210184|gastric cancer|gastric cancer
502491|NCT00210184|geriatric evaluation|geriatric evaluation
502492|NCT00210184|efficacy|efficacy
502493|NCT00210184|safety|safety
502494|NCT00210197|Hypercoagulability|hypercoagulability
502495|NCT00210197|Plasma coagulation parameters|plasma coagulation parameters
502496|NCT00210197|Breast cancer|breast cancer
502497|NCT00210210|Post-operative-pain|post-operative-pain
502498|NCT00210210|Breast cancer|breast cancer
502499|NCT00210210|Morphine|morphine
502500|NCT00210210|Analgesia|analgesia
502501|NCT00210223|Radiofrequency|radiofrequency
502502|NCT00210223|Percutaneous technique|percutaneous technique
502503|NCT00210223|breast cancer|breast cancer
502504|NCT00210223|tolerance|tolerance
502505|NCT00210236|Breast neoplasms|breast neoplasms
502506|NCT00210236|Local recurrence|local recurrence
502507|NCT00210236|Survival|survival
502508|NCT00210236|Surgery|surgery
502509|NCT00210249|Cancer|cancer
502510|NCT00210249|elderly|elderly
502511|NCT00210249|geriatric evaluation|geriatric evaluation
502512|NCT00210249|safety|safety
502513|NCT00210249|chemotherapy|chemotherapy
502514|NCT00210288|Healthy Volunteer|healthy volunteer
502515|NCT00210288|Shigella|shigella
502516|NCT00210288|Oral Vaccine|oral vaccine
502517|NCT00210288|Double Blind|double blind
502518|NCT00210288|Placebo|placebo
502519|NCT00210288|Immunogenicity|immunogenicity
502520|NCT00210288|Safety|safety
502521|NCT00210301|MS|ms
502522|NCT00210301|cognition|cognition
502523|NCT00210301|attention|attention
502524|NCT00210301|fatigue|fatigue
502525|NCT00210405|Anemia|anemia
502526|NCT00210405|Infant nutrition|infant nutrition
502527|NCT00210405|Dietary supplements|dietary supplements
502528|NCT00210405|Randomized controlled trials|randomized controlled trials
502529|NCT00210405|Evaluation studies|evaluation studies
502530|NCT00210405|Haiti|haiti
502531|NCT00210418|Malnutrition|malnutrition
502532|NCT00210418|Infant nutrition|infant nutrition
502533|NCT00210418|Food, fortified|food, fortified
502534|NCT00210418|Growth|growth
502535|NCT00210418|Randomized controlled trials|randomized controlled trials
502536|NCT00210418|Evaluation studies|evaluation studies
502537|NCT00210418|Haiti|haiti
502538|NCT00210470|Head and Neck Cancer|head and neck cancer
502539|NCT00210470|Immunotherapy|immunotherapy
502540|NCT00210470|IRX-2|irx-2
502541|NCT00210470|Mouth Cancer|mouth cancer
502542|NCT00210470|Throat Cancer|throat cancer
502543|NCT00210483|pain|pain
502544|NCT00210483|Migraine|migraine
502545|NCT00210483|aura|aura
502546|NCT00210483|headache|headache
502547|NCT00210496|Migraine headache|migraine headache
502548|NCT00210496|Topiramate, Almotriptan malate|topiramate, almotriptan malate
502549|NCT00210509|aura|aura
502550|NCT00210509|Migraine|migraine
502551|NCT00210509|pain|pain
501850|NCT00204555|Imiquimod|imiquimod
502552|NCT00210509|headache|headache
502553|NCT00210522|RWJ-333369|rwj-333369
502554|NCT00210522|Anticonvulsants|anticonvulsants
502555|NCT00210522|Epilepsy|epilepsy
502556|NCT00210522|Refractory partial epilepsy|refractory partial epilepsy
502557|NCT00210522|Seizure disorder|seizure disorder
502558|NCT00210522|Antiepileptic drugs|antiepileptic drugs
502559|NCT00210535|Topiramate|topiramate
502560|NCT00210535|Migraine|migraine
502862|NCT00211523|MBI 226|mbi 226
502561|NCT00210535|Migraine headache|migraine headache
502562|NCT00210535|Migraine prevention|migraine prevention
502563|NCT00210535|Pediatric|pediatric
502564|NCT00210548|schizophrenia|schizophrenia
502565|NCT00210548|intramuscular injection|intramuscular injection
502566|NCT00210548|antipsychotic agents|antipsychotic agents
502567|NCT00210548|dementia praecox|dementia praecox
502568|NCT00210548|paliperidone palmitate|paliperidone palmitate
502569|NCT00210548|mental disorders|mental disorders
502570|NCT00210548|PANSS.|panss.
502571|NCT00210561|Pain|pain
502572|NCT00210561|Acute Low Back Pain|acute low back pain
502573|NCT00210561|Back|back
502574|NCT00210561|Lower back|lower back
502575|NCT00210574|childhood absence epilepsy|childhood absence epilepsy
502576|NCT00210574|epilepsy|epilepsy
502577|NCT00210574|seizures|seizures
502578|NCT00210574|absence seizures|absence seizures
502579|NCT00210587|Anemia|anemia
502580|NCT00210587|Neoplasms|neoplasms
502581|NCT00210587|hemoglobin level|hemoglobin level
502582|NCT00210600|Anemia|anemia
502583|NCT00210600|Hemoglobin level|hemoglobin level
502584|NCT00210613|dapoxetine|dapoxetine
502585|NCT00210613|premature ejaculation|premature ejaculation
502586|NCT00210613|sexual dysfunction|sexual dysfunction
502587|NCT00210613|orgasmic disorder|orgasmic disorder
502588|NCT00210613|sexual intercourse|sexual intercourse
502589|NCT00210613|ejaculation|ejaculation
502590|NCT00210626|Anemia, erythropoetin, Epoetin alfa, erythropoetin recombinant, Critical care, critical illness, intensive care|anemia, erythropoetin, epoetin alfa, erythropoetin recombinant, critical care, critical illness, intensive care
502591|NCT00210639|Musculoskeletal Diseases|musculoskeletal diseases
502592|NCT00210639|Musculoskeletal Disorders|musculoskeletal disorders
502593|NCT00210639|Childhood Disease|childhood disease
502594|NCT00210639|Bone Diseases|bone diseases
502595|NCT00210639|Joint Diseases|joint diseases
502596|NCT00210639|Levofloxacin|levofloxacin
502597|NCT00210639|Quinolones|quinolones
502598|NCT00210639|Bacterial infections|bacterial infections
502599|NCT00210652|Epilepsy|epilepsy
502600|NCT00210652|Refractory partial epilepsy|refractory partial epilepsy
502601|NCT00210652|seizure disorder|seizure disorder
502602|NCT00210652|antiepileptic drugs|antiepileptic drugs
502603|NCT00210665|Sarcoma|sarcoma
502604|NCT00210665|Soft tissue sarcoma|soft tissue sarcoma
502605|NCT00210665|Standard care|standard care
502606|NCT00210665|Trabectedin|trabectedin
502607|NCT00210665|Antitumor agent|antitumor agent
502608|NCT00210665|Safety|safety
502609|NCT00210678|Erectile Dysfunction|erectile dysfunction
502610|NCT00210678|Dapoxetine|dapoxetine
502611|NCT00210678|Premature ejaculation|premature ejaculation
502612|NCT00210678|Ejaculation|ejaculation
502613|NCT00210678|Sexual dysfunction|sexual dysfunction
502614|NCT00210678|Orgasmic disorder|orgasmic disorder
502615|NCT00210691|Schizophrenia|schizophrenia
502616|NCT00210691|intramuscular injection|intramuscular injection
502617|NCT00210691|psychotropic agents|psychotropic agents
502618|NCT00210691|long-acting risperidone|long-acting risperidone
502619|NCT00210704|dapoxetine|dapoxetine
502620|NCT00210704|premature ejaculation|premature ejaculation
502621|NCT00210704|ejaculation|ejaculation
502622|NCT00210704|sexual dysfunction|sexual dysfunction
502623|NCT00210704|orgasmic disorder|orgasmic disorder
502624|NCT00210704|sexual intercourse|sexual intercourse
502625|NCT00210717|schizophrenia|schizophrenia
502626|NCT00210717|intramuscular injection|intramuscular injection
502627|NCT00210717|antipsychotic agents|antipsychotic agents
502628|NCT00210717|risperidone|risperidone
502629|NCT00210717|paliperidone palmitate|paliperidone palmitate
502630|NCT00210717|dementia praecox|dementia praecox
502631|NCT00210717|mental disorders|mental disorders
502632|NCT00210717|PANSS|panss
502633|NCT00210730|Anemia|anemia
502634|NCT00210730|Neoplasm|neoplasm
502635|NCT00210730|Hemoglobin Level|hemoglobin level
502636|NCT00210743|Anemia|anemia
502637|NCT00210743|chronic kidney disease|chronic kidney disease
502638|NCT00210743|erythropoetin, Epoetin alfa|erythropoetin, epoetin alfa
502639|NCT00210743|erythropoetin recombinant|erythropoetin recombinant
502640|NCT00210743|pre-dialysis|pre-dialysis
502641|NCT00210756|Anemia|anemia
502642|NCT00210756|pharmacokinetics|pharmacokinetics
502643|NCT00210756|erythropoetin|erythropoetin
502644|NCT00210756|Epoetin alfa|epoetin alfa
502645|NCT00210756|erythropoetin recombinant|erythropoetin recombinant
502646|NCT00210756|Critical care|critical care
502647|NCT00210756|critical illness, intensive care,|critical illness, intensive care,
502648|NCT00210769|schizophrenia|schizophrenia
754054|NCT01178749|Interferon|interferon
502649|NCT00210769|extended release|extended release
502650|NCT00210769|oral administration|oral administration
502651|NCT00210769|antipsychotic agents|antipsychotic agents
502652|NCT00210769|dementia praecox|dementia praecox
502653|NCT00210769|mental disorders|mental disorders
502654|NCT00210769|paliperidone|paliperidone
502655|NCT00210769|PANSS|panss
502656|NCT00210782|epilepsy|epilepsy
502657|NCT00210782|seizures|seizures
502658|NCT00210782|epileptic seizures|epileptic seizures
502659|NCT00210782|complex partial seizures|complex partial seizures
502660|NCT00210782|generalized tonic-clonic seizures|generalized tonic-clonic seizures
502661|NCT00210795|Anemia|anemia
502662|NCT00210795|Subcutaneous injection|subcutaneous injection
502663|NCT00210795|PROCRIT|procrit
502664|NCT00210795|Erythropoietin|erythropoietin
502665|NCT00210795|Epoetin Alfa|epoetin alfa
502666|NCT00210795|Hemoglobin Level|hemoglobin level
502667|NCT00210795|Elderly|elderly
502668|NCT00210808|Binge-Eating Disorder|binge-eating disorder
502669|NCT00210808|medication treatment|medication treatment
502670|NCT00210808|obesity|obesity
502671|NCT00210808|bingeing|bingeing
502672|NCT00210821|migraine|migraine
502673|NCT00210821|headache|headache
502674|NCT00210821|analgesics|analgesics
502675|NCT00210821|prophylaxis|prophylaxis
502676|NCT00210821|prevention|prevention
502677|NCT00210834|PROCRIT, Erythropoietin, Epoetin alfa, Hemoglobin level|procrit, erythropoietin, epoetin alfa, hemoglobin level
502678|NCT00210847|peripheral neuropathy|peripheral neuropathy
502679|NCT00210847|Diabetic neuropathy|diabetic neuropathy
502680|NCT00210847|pain|pain
502681|NCT00210847|diabetes|diabetes
502682|NCT00210847|extremities|extremities
502683|NCT00210847|neuropathy|neuropathy
502684|NCT00210847|diabetic|diabetic
502685|NCT00210860|chronic|chronic
502686|NCT00210860|headache|headache
502687|NCT00210860|prevention|prevention
502688|NCT00210860|Migraine|migraine
502689|NCT00210873|Migraine|migraine
502690|NCT00210873|headache|headache
502691|NCT00210873|chronic|chronic
502692|NCT00210873|prevention|prevention
502693|NCT00210886|complicated urinary tract infection|complicated urinary tract infection
502694|NCT00210886|urinary tract infection|urinary tract infection
502695|NCT00210886|acute pyelonephritis|acute pyelonephritis
502696|NCT00210886|pyelonephritis|pyelonephritis
502697|NCT00210886|kidney infection|kidney infection
502698|NCT00210886|bladder infection|bladder infection
502699|NCT00210899|Complicated Skin Infections|complicated skin infections
502700|NCT00210899|Infectious Skin Diseases|infectious skin diseases
502701|NCT00210899|Bacterial Skin Diseases|bacterial skin diseases
502702|NCT00210899|Staphylococcal Skin Infections|staphylococcal skin infections
502703|NCT00210899|Cephalosporin|cephalosporin
502704|NCT00210912|prevention|prevention
502705|NCT00210912|Migraine|migraine
502706|NCT00210912|chronic|chronic
502707|NCT00210912|headache|headache
502708|NCT00210925|alcoholism|alcoholism
502709|NCT00210925|alcohol dependence|alcohol dependence
502710|NCT00210925|medication treatment.|medication treatment.
502711|NCT00210938|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
502712|NCT00210938|Appendicitis|appendicitis
502713|NCT00210938|Cholecystitis|cholecystitis
502714|NCT00210938|Peritonitis|peritonitis
502715|NCT00210951|Epoetin alfa|epoetin alfa
502716|NCT00210951|Erythropoietin|erythropoietin
502717|NCT00210951|Red Cell Aplasia, Pure|red cell aplasia, pure
502718|NCT00210951|Chronic Renal Failure|chronic renal failure
502719|NCT00210964|Ceftobiprole medocaril|ceftobiprole medocaril
502720|NCT00210964|Nosocominal Pneumonia|nosocominal pneumonia
502721|NCT00210964|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
502722|NCT00210964|Cephalosporins|cephalosporins
502723|NCT00210964|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
502724|NCT00210977|Anemia|anemia
502725|NCT00210977|Erythropoietin|erythropoietin
502726|NCT00210977|Epoetin alfa|epoetin alfa
502727|NCT00210977|Erythropoietin receptor agonist (ERA) therapy|erythropoietin receptor agonist (era) therapy
502728|NCT00210977|Anti-erythropoietin antibodies (anti-EPO Ab)|anti-erythropoietin antibodies (anti-epo ab)
502729|NCT00210977|Recombinant human erythropoietin|recombinant human erythropoietin
502730|NCT00210977|Pure red cell aplasia|pure red cell aplasia
502731|NCT00210977|Darbepoetin|darbepoetin
502732|NCT00210990|Complicated Urinary Tract Infections|complicated urinary tract infections
502733|NCT00210990|Pyelonephritis|pyelonephritis
502734|NCT00211003|Hospital-Acquired Pneumonia|hospital-acquired pneumonia
502735|NCT00211003|Mechanical Ventilation|mechanical ventilation
502736|NCT00211016|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
502737|NCT00211029|Anemia, Hemoglobin, Red Blood Cells, Epoetin alfa|anemia, hemoglobin, red blood cells, epoetin alfa
502738|NCT00211029|Epoetin|epoetin
502739|NCT00211029|erythropoietin|erythropoietin
502740|NCT00211029|Red Cell Aplasia, Pure Red Cell Aplasia|red cell aplasia, pure red cell aplasia
502741|NCT00211029|Chronic Renal Failure|chronic renal failure
502742|NCT00211029|Kidney Failure|kidney failure
502743|NCT00211042|Pure red-cell aplasia|pure red-cell aplasia
502744|NCT00211042|Anemia|anemia
502745|NCT00211042|Red blood cells|red blood cells
648071|NCT00770198|HCV|hcv
502746|NCT00211042|Epoetin alfa (Eprex)|epoetin alfa (eprex)
502747|NCT00211042|Anti-erythropoietin antibodies|anti-erythropoietin antibodies
502748|NCT00211042|Recombinant human erythropoietin|recombinant human erythropoietin
502749|NCT00211055|Critically Ill|critically ill
502750|NCT00211055|Intensive Care Unit|intensive care unit
502751|NCT00211055|Blood transfusion|blood transfusion
502752|NCT00211055|Blood loss|blood loss
502753|NCT00211055|Pediatric|pediatric
502754|NCT00211055|Children|children
502861|NCT00211523|acne vulgaris|acne vulgaris
502755|NCT00211055|Anemia, Pediatric Intensive Care Unit|anemia, pediatric intensive care unit
502756|NCT00211055|Hemoglobin|hemoglobin
502757|NCT00211055|Transfusion|transfusion
502758|NCT00211068|Pure red-cell aplasia|pure red-cell aplasia
502759|NCT00211068|Chronic kidney failure|chronic kidney failure
502760|NCT00211068|Epoetin alfa (Eprex)|epoetin alfa (eprex)
502761|NCT00211068|Erythropoietin|erythropoietin
502762|NCT00211068|Kidney disease|kidney disease
502763|NCT00211068|Anemia|anemia
502764|NCT00211081|Congenital Heart Disease|congenital heart disease
502765|NCT00211081|Spironolactone|spironolactone
502766|NCT00211081|>17 years old|>17 years old
502767|NCT00211081|undergone Fontan procedure|undergone fontan procedure
502768|NCT00211081|endothelial function|endothelial function
502769|NCT00211094|dapoxetine|dapoxetine
502770|NCT00211094|premature ejaculation|premature ejaculation
502771|NCT00211094|ejaculation|ejaculation
502772|NCT00211094|sexual dysfunction|sexual dysfunction
502773|NCT00211094|orgasmic disorder|orgasmic disorder
502774|NCT00211094|sexual intercourse|sexual intercourse
502775|NCT00211107|dapoxetine|dapoxetine
502776|NCT00211107|rapid ejaculation|rapid ejaculation
502777|NCT00211107|premature ejaculation|premature ejaculation
502778|NCT00211107|ejaculation|ejaculation
502779|NCT00211107|sexual dysfunction|sexual dysfunction
502780|NCT00211107|orgasmic disorder|orgasmic disorder
502781|NCT00211107|sexual intercourse|sexual intercourse
502782|NCT00211120|Anemia|anemia
502783|NCT00211120|Low Blood Count|low blood count
502784|NCT00211120|Chronic Kidney Failure|chronic kidney failure
502785|NCT00211120|Chronic Kidney Disease|chronic kidney disease
502786|NCT00211133|Anemia|anemia
502787|NCT00211133|Breast Cancer|breast cancer
502788|NCT00211133|Breast Tumor|breast tumor
502789|NCT00211133|Quality of Life|quality of life
502790|NCT00211133|Women|women
502791|NCT00211133|Female|female
502792|NCT00211133|Chemotherapy|chemotherapy
502795|NCT00211133|Epoetin|epoetin
502796|NCT00211133|Epoetin alfa|epoetin alfa
502797|NCT00211133|erythropoietin|erythropoietin
502798|NCT00211146|Anemia, erythropoetin, PROCRIT, deep vein thrombosis, thrombovascular event|anemia, erythropoetin, procrit, deep vein thrombosis, thrombovascular event
502799|NCT00211159|Alzheimer's disease|alzheimer's disease
502800|NCT00211159|Omega-3 fatty acid|omega-3 fatty acid
502801|NCT00211159|Dietary supplementation|dietary supplementation
502802|NCT00211159|Cognition|cognition
502803|NCT00211159|Safety|safety
502804|NCT00211172|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
502805|NCT00211172|Heart Attack|heart attack
502806|NCT00211172|Adherence|adherence
502807|NCT00211172|Beta-blocker|beta-blocker
502808|NCT00211172|Behavior change|behavior change
502809|NCT00211198|Cutaneous|cutaneous
502810|NCT00211198|T-cell lymphoma|t-cell lymphoma
502811|NCT00211198|ONTAK|ontak
502812|NCT00211198|CD25|cd25
502813|NCT00211211|Osteopenia|osteopenia
502814|NCT00211211|Osteoporosis|osteoporosis
502815|NCT00211211|Multiple Myeloma|multiple myeloma
502816|NCT00211211|Osteolytic Metastatic Tumors|osteolytic metastatic tumors
502817|NCT00211211|Vertebral Compression Fracture|vertebral compression fracture
502818|NCT00211211|Back Pain|back pain
502820|NCT00211224|multiple system atrophy|multiple system atrophy
502821|NCT00211224|progressive supranuclear palsy|progressive supranuclear palsy
502822|NCT00211224|riluzole|riluzole
502824|NCT00211224|PSP|psp
502825|NCT00211237|Balloon Kyphoplasty|balloon kyphoplasty
502826|NCT00211237|Cancer|cancer
502827|NCT00211237|Vertebral Compression Fracture|vertebral compression fracture
502828|NCT00211237|Back Pain|back pain
502829|NCT00211237|Spine|spine
502830|NCT00211250|Depakote Er and Valproic Acid|depakote er and valproic acid
502831|NCT00211263|Bipolar Disorder|bipolar disorder
502832|NCT00211289|Educational Interventions|educational interventions
502833|NCT00211289|Heart Failure|heart failure
502834|NCT00211289|Compliance|compliance
502835|NCT00211302|Cognition|cognition
502836|NCT00211302|Schizophrenia|schizophrenia
502837|NCT00211302|Schizoaffective disorder|schizoaffective disorder
502838|NCT00211341|Pregnancy|pregnancy
502839|NCT00211341|Mortality|mortality
502840|NCT00211341|Maternal|maternal
502841|NCT00211341|Vitamin A|vitamin a
502842|NCT00211367|Radiation Retinopathy|radiation retinopathy
502843|NCT00211380|cognition|cognition
502844|NCT00211380|schizophrenia|schizophrenia
502845|NCT00211380|schizoaffective disorder|schizoaffective disorder
502846|NCT00211419|Exudative Age-Related Macular Degeneration|exudative age-related macular degeneration
502847|NCT00211419|AMD|amd
502848|NCT00211458|Age-Related Macular Degeneration|age-related macular degeneration
502849|NCT00211497|acne vulgaris|acne vulgaris
502850|NCT00211497|acne|acne
502851|NCT00211497|Propionibacterium acnes|propionibacterium acnes
502852|NCT00211497|topical|topical
502853|NCT00211497|inflammatory|inflammatory
502854|NCT00211497|non-inflammatory|non-inflammatory
502855|NCT00211497|lesion counts|lesion counts
502856|NCT00211497|lesions|lesions
502857|NCT00211510|Diabetes|diabetes
502858|NCT00211510|Continuous Glucose Monitoring|continuous glucose monitoring
502859|NCT00211510|Glycemic Control|glycemic control
502863|NCT00211523|Propionibacterium acnes|propionibacterium acnes
502864|NCT00211523|lesion counts|lesion counts
502865|NCT00211523|lesions|lesions
502866|NCT00211523|inflammatory|inflammatory
502867|NCT00211523|non-inflammatory|non-inflammatory
502868|NCT00211523|topical|topical
502869|NCT00211536|Diabetes|diabetes
502870|NCT00211536|Implantable Insulin Pump|implantable insulin pump
502871|NCT00211536|Intraperitoneal Insulin Delivery|intraperitoneal insulin delivery
502872|NCT00211549|Osteoarthritis|osteoarthritis
502873|NCT00211562|weight gain|weight gain
502874|NCT00211562|weight gain supplementation|weight gain supplementation
502875|NCT00211562|antioxidants|antioxidants
502876|NCT00211562|olanzapine|olanzapine
502877|NCT00211588|cognition|cognition
502878|NCT00211614|Obstructive Sleep Apnea|obstructive sleep apnea
502879|NCT00211614|Gastroesophageal Reflux|gastroesophageal reflux
502880|NCT00211614|Proton Pump Inhibitor|proton pump inhibitor
502881|NCT00211614|Lansoprazole (Prevacid)|lansoprazole (prevacid)
502882|NCT00211614|Quality of Life|quality of life
502883|NCT00211653|Kidney failure|kidney failure
502884|NCT00211653|Thoracic surgery|thoracic surgery
502885|NCT00211653|Acetylcysteine|acetylcysteine
502886|NCT00211666|Hypertension|hypertension
502887|NCT00211666|blood pressure|blood pressure
502888|NCT00211666|self management|self management
502889|NCT00211666|nurse management|nurse management
502890|NCT00211666|racial disparities|racial disparities
502891|NCT00211666|cardiovascular disease|cardiovascular disease
502892|NCT00211679|Joint pain|joint pain
502893|NCT00211679|Knee Pain|knee pain
502894|NCT00211679|Arthritis|arthritis
502895|NCT00211679|Intra-articular Botulinum Toxin Type A|intra-articular botulinum toxin type a
502896|NCT00211692|Hepatitis C|hepatitis c
502897|NCT00211692|interferon alfa|interferon alfa
502898|NCT00211692|ribavirin|ribavirin
502899|NCT00211692|interferon alfacon-1|interferon alfacon-1
502900|NCT00211692|antiviral therapy|antiviral therapy
502901|NCT00211705|Hyperlipidemia|hyperlipidemia
502902|NCT00211705|coronary heart disease|coronary heart disease
502903|NCT00211705|prevention|prevention
502904|NCT00211705|stroke|stroke
502905|NCT00211705|pravastatin|pravastatin
502906|NCT00211718|shoulder pain|shoulder pain
502907|NCT00211718|arthritis|arthritis
502908|NCT00211718|intra-articular botulinum toxin a|intra-articular botulinum toxin a
502909|NCT00211718|joint pain|joint pain
502910|NCT00211731|Acute stroke|acute stroke
502911|NCT00211731|recurrent stroke preventive measures|recurrent stroke preventive measures
502912|NCT00211731|racial disparities|racial disparities
502913|NCT00211744|OCD|ocd
502914|NCT00211744|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
502915|NCT00211744|OCD treatment|ocd treatment
502916|NCT00211757|autism|autism
502917|NCT00211757|aggression|aggression
502918|NCT00211757|irritability|irritability
502919|NCT00211757|divalproex sodium|divalproex sodium
502920|NCT00211770|Autism|autism
502921|NCT00211770|Functional Behavioral Assessment|functional behavioral assessment
502922|NCT00211770|Citalopram|citalopram
502923|NCT00211783|autism|autism
502924|NCT00211783|fMRI|fmri
502925|NCT00211783|response inhibition|response inhibition
502926|NCT00211783|face processing|face processing
502927|NCT00211783|linguistic processing|linguistic processing
502928|NCT00211796|autism|autism
502929|NCT00211796|divalproex sodium ER|divalproex sodium er
502930|NCT00211796|aggression|aggression
502931|NCT00211796|irritability|irritability
502932|NCT00185250|Cardiomyopathy|cardiomyopathy
502933|NCT00185250|idiopathic chronic heart failure|idiopathic chronic heart failure
502934|NCT00185250|Adenovirus|adenovirus
502935|NCT00185250|Enterovirus|enterovirus
502936|NCT00185250|Parvovirus|parvovirus
502937|NCT00185263|angina|angina
502938|NCT00185263|FGF-4|fgf-4
502939|NCT00185263|angiogenesis|angiogenesis
502940|NCT00185263|adenovector|adenovector
502941|NCT00185263|growth factor|growth factor
502942|NCT00185263|myocardial ischemia|myocardial ischemia
502943|NCT00185263|revascularization|revascularization
502944|NCT00185276|Structural abnormalities of the infrarenal aorta and peripheral arteries|structural abnormalities of the infrarenal aorta and peripheral arteries
502945|NCT00185302|Non-resectable metastatic melanoma|non-resectable metastatic melanoma
502946|NCT00185328|Postmenopause|postmenopause
502947|NCT00185341|Endometriosis associated pelvic pain|endometriosis associated pelvic pain
502948|NCT00185354|FC patch|fc patch
502949|NCT00185354|comparator study|comparator study
502950|NCT00185393|Follicular Non Hodgkin lymphoma|follicular non hodgkin lymphoma
502951|NCT00185445|Non Hodgkin Lymphoma|non hodgkin lymphoma
502952|NCT00185484|Oral contraception|oral contraception
502953|NCT00201786|Corticosteroids|corticosteroids
502954|NCT00201799|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
502955|NCT00201812|Advanced Solid Tumors|advanced solid tumors
502956|NCT00201825|Previously Untreated|previously untreated
502957|NCT00201825|Advanced|advanced
502958|NCT00201838|Advanced Stage|advanced stage
502959|NCT00201838|Chemotherapy Naive|chemotherapy naive
502960|NCT00201851|Asian|asian
502961|NCT00201851|Premenopausal|premenopausal
502962|NCT00201851|Women|women
502963|NCT00201851|Oophorectomy|oophorectomy
502964|NCT00201864|Postmenopausal|postmenopausal
502965|NCT00201864|Women|women
502966|NCT00201877|Relapsed/Refractory|relapsed/refractory
502967|NCT00201877|NHL|nhl
502968|NCT00201877|Follicular|follicular
502969|NCT00201877|Mantle Cell|mantle cell
502970|NCT00201877|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
502971|NCT00201890|Breast Cancer|breast cancer
502972|NCT00201890|Lymphedema|lymphedema
502973|NCT00201890|Treatment|treatment
502974|NCT00201890|Massage|massage
502975|NCT00201890|Randomized|randomized
502976|NCT00201890|DLT therapy|dlt therapy
502977|NCT00201890|Quality of Life|quality of life
502978|NCT00201890|Decongestive Therapy|decongestive therapy
502979|NCT00201890|Breast Cancer related Lymphedema|breast cancer related lymphedema
502980|NCT00201903|venous thromboembolism|venous thromboembolism
502981|NCT00201903|brain tumours|brain tumours
502982|NCT00201903|glioma|glioma
502983|NCT00201903|tissue factor|tissue factor
502984|NCT00201903|blood coagulation|blood coagulation
502985|NCT00201903|tumour progression|tumour progression
502986|NCT00201903|low molecular weight heparin|low molecular weight heparin
502987|NCT00201916|prostate cancer|prostate cancer
502988|NCT00201916|prostate specific antigen|prostate specific antigen
502989|NCT00201916|PSA|psa
502990|NCT00201916|radiation fractionation|radiation fractionation
502991|NCT00201929|breast cancer|breast cancer
502992|NCT00201929|decision aid|decision aid
502993|NCT00201929|Decision Board|decision board
502994|NCT00201929|information transfer|information transfer
502995|NCT00201942|Breast Cancer|breast cancer
502996|NCT00201942|Diagnosis|diagnosis
502997|NCT00201942|PET|pet
502998|NCT00201942|Positronic Emission Tomography|positronic emission tomography
502999|NCT00201942|fluorodeoxyglucose|fluorodeoxyglucose
503001|NCT00201955|keratoconjunctivitis sicca|keratoconjunctivitis sicca
503002|NCT00201981|dry eye|dry eye
503003|NCT00201981|keratoconjunctivitis sicca|keratoconjunctivitis sicca
503004|NCT00201994|Sodium|sodium
503005|NCT00201994|SIADH|siadh
503006|NCT00201994|Vasopressin|vasopressin
503007|NCT00201994|CHF|chf
503008|NCT00201994|Cirrhosis|cirrhosis
503009|NCT00201994|salt|salt
503010|NCT00201994|water|water
503011|NCT00201994|electrolyte|electrolyte
503012|NCT00202007|Aripiprazole|aripiprazole
503013|NCT00202007|Schizophrenia|schizophrenia
503014|NCT00202007|Clinical trial|clinical trial
503015|NCT00202007|Risperidone|risperidone
503016|NCT00202020|Cerebral infarction|cerebral infarction
503017|NCT00202020|Prevention|prevention
503018|NCT00202020|Cilostazol|cilostazol
503019|NCT00202020|Aspirin|aspirin
503020|NCT00202020|Stroke|stroke
503021|NCT00202020|Clinical trial|clinical trial
503022|NCT00202033|referred to|referred to
503023|NCT00202033|comprehensive|comprehensive
503024|NCT00202033|diabetes|diabetes
503025|NCT00202033|education|education
503026|NCT00202033|program|program
503027|NCT00202046|Breast cancer|breast cancer
503028|NCT00202046|Lymphedema|lymphedema
503029|NCT00202046|Quality of life|quality of life
503030|NCT00202059|Breast cancer|breast cancer
503031|NCT00202059|Bone mineral density|bone mineral density
503032|NCT00202059|Chemotherapy|chemotherapy
503033|NCT00202072|lung|lung
503034|NCT00202072|airway|airway
503035|NCT00202072|pulmonary exacerbation|pulmonary exacerbation
503036|NCT00202072|mucus|mucus
503037|NCT00202098|ARDS|ards
503038|NCT00202098|mechanical ventilation|mechanical ventilation
503039|NCT00202098|variable ventilation|variable ventilation
503040|NCT00202098|chaotic ventilation|chaotic ventilation
503041|NCT00202111|Clinical Trial|clinical trial
503042|NCT00202111|Colonic Neoplasms|colonic neoplasms
503043|NCT00202111|Laparoscopic Surgery|laparoscopic surgery
503044|NCT00202111|Morbidity|morbidity
503045|NCT00202111|Port Site Metastasis|port site metastasis
503046|NCT00202111|Disease-Free Survival|disease-free survival
503047|NCT00202137|Home Blood Pressure, Hypertension, Blood Pressure Control|home blood pressure, hypertension, blood pressure control
503048|NCT00202150|Advanced chronic diseases|advanced chronic diseases
503049|NCT00202150|Heart failure|heart failure
503050|NCT00202150|Chronic obstructive lung disease|chronic obstructive lung disease
503051|NCT00202150|primary care|primary care
503052|NCT00202150|Chronic Care|chronic care
503054|NCT00202163|DHEA|dhea
503055|NCT00202163|testosterone|testosterone
503056|NCT00202176|Chronic|chronic
503057|NCT00202176|Obstructive|obstructive
503058|NCT00202176|Pulmonary|pulmonary
503059|NCT00202176|Disease|disease
503060|NCT00202176|COPD|copd
503061|NCT00202176|Atrovent|atrovent
503062|NCT00202176|Ipratropium|ipratropium
503063|NCT00202176|Bromide|bromide
503064|NCT00202176|Exercise|exercise
503065|NCT00202176|Dyspnea|dyspnea
503066|NCT00202189|COPD|copd
503067|NCT00202189|Pulmicort|pulmicort
503068|NCT00202189|Budesonide|budesonide
503069|NCT00202189|Chronic|chronic
503070|NCT00202189|Obstructive|obstructive
503071|NCT00202189|Pulmonary|pulmonary
503072|NCT00202189|Disease|disease
503073|NCT00202189|Exercise|exercise
503074|NCT00202189|Emphysema|emphysema
503075|NCT00211809|Body Dysmorphic Disorder|body dysmorphic disorder
503076|NCT00211809|SRIs|sris
503077|NCT00211809|Cognitive Behavioral Therapy|cognitive behavioral therapy
503078|NCT00211822|Pathological Gambling|pathological gambling
503079|NCT00211822|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
503080|NCT00211822|Go No-go|go no-go
503081|NCT00211822|Monetary incentives delay|monetary incentives delay
503082|NCT00211822|fMRI|fmri
503083|NCT00211835|TBI|tbi
503084|NCT00211835|traumatic brain injury|traumatic brain injury
503085|NCT00211835|depression|depression
503086|NCT00211835|cognitive behavioral therapy|cognitive behavioral therapy
503087|NCT00211835|supportive psychotherapy|supportive psychotherapy
503088|NCT00211835|psychotherapy|psychotherapy
503089|NCT00211848|Chemical Compounds-drugs|chemical compounds-drugs
503090|NCT00211848|Human Subjects- adults|human subjects- adults
503091|NCT00211848|Gastrointestinal System-liver|gastrointestinal system-liver
503092|NCT00211848|Pathology|pathology
503093|NCT00211874|Congestive heart failure|congestive heart failure
503094|NCT00211874|nurse management|nurse management
503095|NCT00211874|effectiveness trial|effectiveness trial
503096|NCT00211874|quality improvement|quality improvement
503097|NCT00211874|minority communities|minority communities
503098|NCT00211874|disease management|disease management
503099|NCT00211887|Multiple Sclerosis|multiple sclerosis
503100|NCT00211887|Clinical trial|clinical trial
503101|NCT00211887|treatment trial|treatment trial
503102|NCT00211887|autoimmune disease|autoimmune disease
503103|NCT00211887|Relapsing Remitting|relapsing remitting
503104|NCT00211887|MS Treatment|ms treatment
503105|NCT00211887|interferon beta-1a|interferon beta-1a
503106|NCT00211887|glatiramer acetate|glatiramer acetate
503107|NCT00211926|vaccine|vaccine
503108|NCT00211926|Staphylococcus aureus vaccine|staphylococcus aureus vaccine
503109|NCT00211939|PhosLo (Calcium acetate)|phoslo (calcium acetate)
503110|NCT00211939|Renagel (sevelamer, polyallylamine HCL)|renagel (sevelamer, polyallylamine hcl)
503111|NCT00211939|kidney dialysis|kidney dialysis
503112|NCT00211939|hyperphosphatemia|hyperphosphatemia
503113|NCT00211939|Kidney failure|kidney failure
503114|NCT00211965|Knee replacement surgery|knee replacement surgery
503115|NCT00211965|hip replacement surgery|hip replacement surgery
503116|NCT00211965|nosocomial infections|nosocomial infections
503117|NCT00211965|Arthroplasty|arthroplasty
503118|NCT00211978|PhosLo (Calcium acetate)|phoslo (calcium acetate)
503119|NCT00212004|diabetes mellitus|diabetes mellitus
503120|NCT00212004|myocardial infarction|myocardial infarction
503121|NCT00212004|pioglitazone|pioglitazone
503122|NCT00212017|IGT|igt
503123|NCT00212017|Myocardial Infarction|myocardial infarction
503124|NCT00212017|alpha-glucosidase inhibitor|alpha-glucosidase inhibitor
503125|NCT00212017|re-infarction prevention|re-infarction prevention
503126|NCT00212030|Acute myocardial infarction|acute myocardial infarction
503127|NCT00212030|Data mining|data mining
503128|NCT00212030|Nicorandil|nicorandil
503129|NCT00212030|Randomized clinical trial|randomized clinical trial
503130|NCT00212030|SNPs|snps
503131|NCT00212043|randomised phase II trial gemcitabine and carboplatin|randomised phase ii trial gemcitabine and carboplatin
503132|NCT00212056|Acute myocardial infarction|acute myocardial infarction
503133|NCT00212056|Atrial natriuretic peptide|atrial natriuretic peptide
503134|NCT00212056|Data mining|data mining
503135|NCT00212056|Randomized clinical trial|randomized clinical trial
503136|NCT00212056|SNPs|snps
503137|NCT00212069|breast cancer|breast cancer
503138|NCT00212069|serum proteomics|serum proteomics
503140|NCT00212069|carboplatin|carboplatin
503141|NCT00212069|chemotherapy sensitivity|chemotherapy sensitivity
503142|NCT00212082|breast cancer|breast cancer
503143|NCT00212082|chemotherapy response|chemotherapy response
503144|NCT00212082|gene expression profiles|gene expression profiles
503145|NCT00212082|proteomics|proteomics
503146|NCT00212095|breast cancer|breast cancer
503147|NCT00212095|docetaxel|docetaxel
503148|NCT00212095|gene expression|gene expression
503149|NCT00212095|proteomics|proteomics
503150|NCT00212108|celecoxib, NPC, gefitinib|celecoxib, npc, gefitinib
503151|NCT00212121|breast cancer|breast cancer
503152|NCT00212121|radiotherapy|radiotherapy
503153|NCT00212121|microarrays|microarrays
648456|NCT00771693|NIDDM|niddm
502439|NCT00209911|cardioversion|cardioversion
503154|NCT00212134|cataract surgery|cataract surgery
503155|NCT00212134|intraocular lens|intraocular lens
503156|NCT00212134|contact lens|contact lens
503157|NCT00212134|infants|infants
503158|NCT00212134|aphakia|aphakia
503159|NCT00212147|cobalamin|cobalamin
503160|NCT00212147|anesthesia|anesthesia
503161|NCT00212147|cognition|cognition
503162|NCT00212381|cervical dysplasia, diindolylmethane, pap smear|cervical dysplasia, diindolylmethane, pap smear
503163|NCT00212394|Tourniquet|tourniquet
503164|NCT00212394|paresis|paresis
503165|NCT00212407|Cord blood transplantation|cord blood transplantation
503166|NCT00212407|bone marrow transplantation|bone marrow transplantation
503167|NCT00212420|fistula; enterocutaneous; nutrition;enteral; parenteral; TPN|fistula; enterocutaneous; nutrition;enteral; parenteral; tpn
503751|NCT00205946|Bupropion|bupropion
503168|NCT00212433|colorectal neoplasia|colorectal neoplasia
503169|NCT00212433|CT colonography|ct colonography
503170|NCT00212433|faecal tagging|faecal tagging
503171|NCT00212446|Tocolysis|tocolysis
503172|NCT00212446|Electrical Pacemaker|electrical pacemaker
503173|NCT00212459|Bleeding logs|bleeding logs
503174|NCT00212459|Factor Infusions|factor infusions
503175|NCT00212485|Hemophilia|hemophilia
503176|NCT00212485|Factor Deficiency|factor deficiency
503177|NCT00212485|synovitis|synovitis
503178|NCT00212485|sonogram|sonogram
503179|NCT00212537|Asthma and normal|asthma and normal
503180|NCT00212576|Child development|child development
503181|NCT00212576|Language Development|language development
503182|NCT00212576|Parenting|parenting
503183|NCT00212589|Patients preference|patients preference
503184|NCT00212589|Colorectal cancer|colorectal cancer
503185|NCT00212589|Capecitabine|capecitabine
503186|NCT00212589|Fluorouracil + folinic acid|fluorouracil + folinic acid
503187|NCT00212589|Cross-over study|cross-over study
503188|NCT00212602|ONO-7436, Aprepitant, Vomiting, Nausea|ono-7436, aprepitant, vomiting, nausea
503189|NCT00212615|Colorectal neoplasm|colorectal neoplasm
503190|NCT00212615|Capecitabine (Xeloda)|capecitabine (xeloda)
503191|NCT00212615|Oxaliplatin (Eloxatin)|oxaliplatin (eloxatin)
503192|NCT00212615|Advanced disease|advanced disease
503193|NCT00212615|Metastatic disease|metastatic disease
503194|NCT00212615|First-line treatment|first-line treatment
503195|NCT00212615|Phase II study|phase ii study
503196|NCT00212628|ONO-5920|ono-5920
503197|NCT00212628|osteoporosis|osteoporosis
503198|NCT00212628|bisphosphonate|bisphosphonate
503199|NCT00212654|ONO-1101|ono-1101
503684|NCT00205660|Obesity|obesity
503200|NCT00212654|Landiolol Hydrochloride|landiolol hydrochloride
503201|NCT00212654|Postoperative|postoperative
503202|NCT00212654|supraventricular tachyarrhythmia|supraventricular tachyarrhythmia
503203|NCT00212667|ONO-5920, osteoporosis, bisphosphonate|ono-5920, osteoporosis, bisphosphonate
503204|NCT00212680|ONO-1101,Landiolol Hydrochloride, Postoperative, Supraventricular Tachyarrhythmia|ono-1101,landiolol hydrochloride, postoperative, supraventricular tachyarrhythmia
503205|NCT00212693|ONO-2506PO, Parkinson's disease|ono-2506po, parkinson's disease
503206|NCT00212706|ONO-8025, KRP-197, overactive bladder, antimuscarinic|ono-8025, krp-197, overactive bladder, antimuscarinic
503207|NCT00212719|ONO-5920, osteoporosis, bisphosphonate|ono-5920, osteoporosis, bisphosphonate
503208|NCT00212732|ONO-8025, KRP-197, overactive bladder, antimuscarinic|ono-8025, krp-197, overactive bladder, antimuscarinic
503209|NCT00212745|Behavior Therapy|behavior therapy
503210|NCT00212745|Relaxation Techniques|relaxation techniques
503211|NCT00212758|Short stature|short stature
503212|NCT00212758|children|children
503213|NCT00212758|kidney failure, chronic|kidney failure, chronic
503214|NCT00212758|Growth|growth
503215|NCT00212810|Migraine|migraine
503216|NCT00212810|Headache|headache
503217|NCT00212810|Migraine Headache|migraine headache
503218|NCT00212823|Migraine|migraine
503219|NCT00212849|Articular Cartilage Lesions|articular cartilage lesions
503220|NCT00212849|Patellar lesions|patellar lesions
503221|NCT00212849|Trochlear lesions|trochlear lesions
503222|NCT00212849|Patellofemoral joint|patellofemoral joint
503223|NCT00212849|Carticel|carticel
503224|NCT00212849|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
503225|NCT00212862|Anemia|anemia
503226|NCT00212862|Cancer|cancer
503227|NCT00212862|Epoetin alfa|epoetin alfa
503228|NCT00212862|Darbepoetin alfa|darbepoetin alfa
503229|NCT00212862|Registry|registry
503230|NCT00212875|Chronic Kidney disease|chronic kidney disease
503231|NCT00212875|anemia|anemia
503233|NCT00212888|Vaccination|vaccination
503234|NCT00212901|Diabetes|diabetes
503235|NCT00212901|Proteinuria|proteinuria
503236|NCT00212901|Angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
503237|NCT00212901|Angiotensin receptor antagonists|angiotensin receptor antagonists
503238|NCT00212940|Treatment Naive|treatment naive
503239|NCT00212940|HIV|hiv
503240|NCT00212953|Chest Pain,|chest pain,
503241|NCT00212953|Shortness of breath,|shortness of breath,
503242|NCT00212953|Injury,|injury,
503243|NCT00212953|Trauma|trauma
503244|NCT00212966|psychosocial|psychosocial
503245|NCT00212979|glomerular filtration rate|glomerular filtration rate
503246|NCT00212979|cystatin C|cystatin c
503247|NCT00212979|creatinine|creatinine
503248|NCT00212992|defibrillation|defibrillation
503249|NCT00212992|ventricular fibrillation|ventricular fibrillation
503250|NCT00212992|heart arrest|heart arrest
503251|NCT00213005|Microbicides|microbicides
503252|NCT00213005|HIV prevention|hiv prevention
503253|NCT00213005|HIV positive|hiv positive
503254|NCT00213005|carrageenan|carrageenan
503255|NCT00213005|safety trial|safety trial
503256|NCT00213005|Treatment Experienced|treatment experienced
503257|NCT00213005|HIV|hiv
503258|NCT00213018|microbicides|microbicides
503259|NCT00213018|HIV prevention|hiv prevention
503260|NCT00213018|sexually transmitted infections|sexually transmitted infections
503261|NCT00213018|female-initiated protection|female-initiated protection
503262|NCT00213018|carrageenan|carrageenan
503263|NCT00213018|expanded safety trial|expanded safety trial
503264|NCT00213018|HIV Seronegativity|hiv seronegativity
503265|NCT00213018|HIV|hiv
503266|NCT00213031|microbicides|microbicides
503267|NCT00213031|HIV prevention|hiv prevention
503268|NCT00213031|sexually transmitted infections|sexually transmitted infections
503269|NCT00213031|female-initiated protection|female-initiated protection
503270|NCT00213031|carrageenan|carrageenan
503271|NCT00213031|expanded safety trial|expanded safety trial
503272|NCT00213031|HIV Seronegativity|hiv seronegativity
503273|NCT00213031|HIV|hiv
503274|NCT00213044|Microbicides|microbicides
503275|NCT00213044|HIV prevention|hiv prevention
503276|NCT00213044|HIV-positive women|hiv-positive women
503277|NCT00213044|safety|safety
503278|NCT00213044|carrageenan|carrageenan
503279|NCT00213044|HIV|hiv
503280|NCT00213057|Microbicides|microbicides
503281|NCT00213057|HIV prevention|hiv prevention
503282|NCT00213057|sexually transmitted infections|sexually transmitted infections
503283|NCT00213057|carrageenan|carrageenan
503284|NCT00213057|sero-concordant couples|sero-concordant couples
503285|NCT00213057|HIV Seronegativity|hiv seronegativity
503286|NCT00213057|HIV|hiv
503287|NCT00213070|alpha-glucosidase inhibitor,Insulin|alpha-glucosidase inhibitor,insulin
503288|NCT00213083|Microbicide|microbicide
503289|NCT00213083|HIV|hiv
503290|NCT00213083|AIDS|aids
503291|NCT00213083|STIs|stis
503292|NCT00213083|STDs|stds
503293|NCT00213083|Efficacy|efficacy
503294|NCT00213083|HSV|hsv
503295|NCT00213083|Women|women
503296|NCT00213083|South Africa|south africa
503297|NCT00213083|seroconversion|seroconversion
503298|NCT00213083|condom|condom
503299|NCT00213083|safe-sex|safe-sex
503300|NCT00213083|vaginal intercourse|vaginal intercourse
503302|NCT00213083|HIV Seronegativity|hiv seronegativity
503303|NCT00213096|Contraceptive agents|contraceptive agents
503304|NCT00213096|female|female
503305|NCT00213109|alpha-glucosidase inhibitor,Insulin|alpha-glucosidase inhibitor,insulin
503306|NCT00213122|alpha-glucosidase inhibitor,Insulin|alpha-glucosidase inhibitor,insulin
503307|NCT00213161|anemia|anemia
503308|NCT00213161|iron deficiency|iron deficiency
503309|NCT00213161|iron drops|iron drops
503310|NCT00213161|iron supplement|iron supplement
503311|NCT00213161|malnutrition|malnutrition
503312|NCT00213161|pediatrics|pediatrics
503313|NCT00213174|pediatrics|pediatrics
503314|NCT00213174|injury|injury
503315|NCT00213174|arm fractures|arm fractures
503316|NCT00213174|trauma|trauma
503317|NCT00213174|playground surfaces|playground surfaces
503318|NCT00213174|fractures|fractures
503319|NCT00213187|Juvenile Rheumatoid Arthritis,|juvenile rheumatoid arthritis,
503320|NCT00213187|Randomized Control Trial,|randomized control trial,
503321|NCT00213187|attention placebo,|attention placebo,
503322|NCT00213187|exercise testing,|exercise testing,
503323|NCT00213187|aerobics,|aerobics,
503324|NCT00213187|Qi Gong,|qi gong,
503325|NCT00213187|exercise video,|exercise video,
503326|NCT00213187|activities of daily living,|activities of daily living,
503327|NCT00213187|quality of life,|quality of life,
503328|NCT00213187|economy of walking,|economy of walking,
503329|NCT00213187|fitness|fitness
503330|NCT00213187|pediatrics|pediatrics
503331|NCT00213200|pain|pain
503332|NCT00213200|analgesia|analgesia
503333|NCT00213200|morphine|morphine
503334|NCT00213200|amethocaine|amethocaine
503335|NCT00213200|neonate|neonate
503336|NCT00213213|sucrose|sucrose
503337|NCT00213213|analgesia|analgesia
503338|NCT00213213|pain|pain
503339|NCT00213213|neonates|neonates
503340|NCT00213213|diabetes|diabetes
503341|NCT00213226|bronchiolitis|bronchiolitis
503342|NCT00213226|pediatrics|pediatrics
503343|NCT00213226|corticosteroids|corticosteroids
503344|NCT00213239|spinal puncture|spinal puncture
503345|NCT00213239|remifentanil|remifentanil
503346|NCT00213239|propofol|propofol
503347|NCT00213239|anesthesia|anesthesia
503348|NCT00213239|dose finding|dose finding
503349|NCT00213239|pediatrics|pediatrics
503350|NCT00213252|asthma, randomized trial, pediatrics|asthma, randomized trial, pediatrics
503351|NCT00213265|organ transplantation|organ transplantation
503352|NCT00213265|immunosuppression|immunosuppression
503353|NCT00213265|vaccine|vaccine
503354|NCT00213265|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
503355|NCT00213265|pediatrics|pediatrics
503356|NCT00213278|glioma|glioma
503357|NCT00213278|brain tumour|brain tumour
503358|NCT00213278|cancer|cancer
503359|NCT00213278|pediatrics|pediatrics
503360|NCT00213278|vinblastine sulfate|vinblastine sulfate
503361|NCT00213291|chronic kidney failure|chronic kidney failure
503362|NCT00213291|darbepoetin|darbepoetin
503363|NCT00213291|pediatrics|pediatrics
503364|NCT00213291|anemia|anemia
503365|NCT00213304|organ transplantation|organ transplantation
503366|NCT00213304|immunosuppression|immunosuppression
503367|NCT00213304|vaccine|vaccine
503368|NCT00213304|varicella|varicella
503369|NCT00213304|pediatrics|pediatrics
503370|NCT00213317|sacral magnetic stimulation|sacral magnetic stimulation
503371|NCT00213317|fecal incontinence|fecal incontinence
503372|NCT00213317|constipation|constipation
503373|NCT00213330|cerebral activity|cerebral activity
503374|NCT00213330|rectal distension|rectal distension
503375|NCT00213330|colitis ulcerative|colitis ulcerative
503376|NCT00213330|irritable bowel syndrome|irritable bowel syndrome
503377|NCT00213330|magnetic resonance imaging|magnetic resonance imaging
503378|NCT00213343|aspiration|aspiration
503379|NCT00213343|phrenic nerve|phrenic nerve
503380|NCT00213343|magnetic stimulation|magnetic stimulation
503381|NCT00213356|spinal cord injuries - anal sphincter - evoked potentials|spinal cord injuries - anal sphincter - evoked potentials
503382|NCT00213369|aspiration|aspiration
503383|NCT00213369|stroke|stroke
503384|NCT00213369|motor evoked potential|motor evoked potential
503385|NCT00213369|cortical evoked potential|cortical evoked potential
503386|NCT00213369|neuromodulation|neuromodulation
503387|NCT00213382|swallowing|swallowing
503388|NCT00213382|ventilation|ventilation
503389|NCT00213382|pressure|pressure
503391|NCT00213382|cortical magnetic stimulation|cortical magnetic stimulation
503392|NCT00213382|Brain Mapping|brain mapping
503393|NCT00213395|Noninvasive ventilation|noninvasive ventilation
503394|NCT00213395|Acute hypercapnic respiratory failure|acute hypercapnic respiratory failure
503395|NCT00213395|Cephalic mask|cephalic mask
503396|NCT00213395|Facial Mask|facial mask
503397|NCT00213408|Arrhythmia|arrhythmia
503398|NCT00213408|atrial flutter|atrial flutter
503399|NCT00213408|catheter ablation|catheter ablation
503400|NCT00213434|prospective|prospective
503401|NCT00213434|randomized|randomized
503402|NCT00213434|polysomnography|polysomnography
503403|NCT00213434|orthodontic appliance, removable|orthodontic appliance, removable
503884|NCT00207233|Weight loss|weight loss
503404|NCT00213473|acquired haemophilia|acquired haemophilia
503405|NCT00213499|Mechanical ventilation|mechanical ventilation
503406|NCT00213499|Weaning|weaning
503407|NCT00213499|Noninvasive ventilation|noninvasive ventilation
503408|NCT00213499|Acute on chronic respiratory failure|acute on chronic respiratory failure
503409|NCT00213577|overactive neurogenic bladder|overactive neurogenic bladder
503410|NCT00213603|precancerous lesions|precancerous lesions
503411|NCT00213603|Lung cancer|lung cancer
503412|NCT00213603|Follow-up|follow-up
503413|NCT00213603|Randomized study|randomized study
503414|NCT00213603|Autofluorescence endoscopy|autofluorescence endoscopy
503415|NCT00213603|precancerous conditions|precancerous conditions
503416|NCT00213616|bilateral vocal cord paralysis|bilateral vocal cord paralysis
503417|NCT00213616|reinnervation|reinnervation
503418|NCT00213616|phrenic nerve|phrenic nerve
503419|NCT00213629|myositis|myositis
503420|NCT00213629|cDNA arrays|cdna arrays
503421|NCT00213629|Genes, T-Cell Receptor beta|genes, t-cell receptor beta
503422|NCT00213642|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide
503423|NCT00213642|Radionuclide Imaging|radionuclide imaging
503424|NCT00213642|Cisplatin|cisplatin
503425|NCT00213642|Kidney failure|kidney failure
503426|NCT00213642|Drug Toxicity|drug toxicity
503427|NCT00213642|Cancer|cancer
503428|NCT00213668|glutamine|glutamine
503429|NCT00213668|premature neonate|premature neonate
503430|NCT00213668|gastric emptying|gastric emptying
503431|NCT00213681|Pulmonary edema, respiratory failure, pressure support ventilation, continuous positive pressure|pulmonary edema, respiratory failure, pressure support ventilation, continuous positive pressure
503432|NCT00213707|Dendritic cells|dendritic cells
503433|NCT00213707|liver transplantation|liver transplantation
503434|NCT00213707|hepatitis C virus|hepatitis c virus
503435|NCT00213707|quasispecies|quasispecies
503436|NCT00213707|virological markers|virological markers
503437|NCT00213707|biochemical markers|biochemical markers
503438|NCT00213707|immunological markers|immunological markers
503439|NCT00213707|clinical markers|clinical markers
503440|NCT00213720|Hyperthyroidism|hyperthyroidism
503441|NCT00213720|atrial fibrillation|atrial fibrillation
503442|NCT00213720|quality of life|quality of life
503443|NCT00213720|radioiodine treatment|radioiodine treatment
503444|NCT00213733|Lung cancer patients|lung cancer patients
503445|NCT00213733|non-small cell lung cancer|non-small cell lung cancer
648869|NCT00765544|MS|ms
503446|NCT00213733|molecular marker|molecular marker
503447|NCT00213733|lymph node completed resected|lymph node completed resected
503448|NCT00213733|Lung cancer samples and paired lymph node resected|lung cancer samples and paired lymph node resected
503449|NCT00213746|Coronary Arteriosclerosis|coronary arteriosclerosis
503450|NCT00213746|Heart Failure, Congestive|heart failure, congestive
503451|NCT00213746|Myocardial Infarction|myocardial infarction
503452|NCT00213746|Myocardial Revascularization|myocardial revascularization
503453|NCT00213746|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
503454|NCT00213746|Dobutamine|dobutamine
503455|NCT00213746|Myocardial Stunning|myocardial stunning
503456|NCT00213746|Myocardial Hibernation|myocardial hibernation
503457|NCT00213759|neutropenia|neutropenia
503458|NCT00213759|prematurity|prematurity
503459|NCT00213759|nosocomial infection|nosocomial infection
503460|NCT00213759|G-CSF|g-csf
503461|NCT00213772|Porphyria cutanea tarda|porphyria cutanea tarda
503462|NCT00213772|hepatitis C|hepatitis c
503463|NCT00213772|hemochromatosis|hemochromatosis
503464|NCT00213785|AreET1|areet1
503465|NCT00213785|ANP|anp
503466|NCT00213785|BNP pronostic markers of stroke|bnp pronostic markers of stroke
503467|NCT00213798|Lung cancer|lung cancer
503468|NCT00213798|plasma DNA|plasma dna
503469|NCT00213798|allelotyping|allelotyping
503470|NCT00213798|follow-up|follow-up
503471|NCT00213798|Prospective Study|prospective study
503472|NCT00213798|Non-Small Cell Lung Cancer|non-small cell lung cancer
503473|NCT00213798|Small Cell Lung Cancer|small cell lung cancer
503474|NCT00213811|Bardet-Biedl syndrome, retinitis pigmentosa, obesity, genes|bardet-biedl syndrome, retinitis pigmentosa, obesity, genes
503475|NCT00213824|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
503476|NCT00213824|Nogo gene|nogo gene
503477|NCT00213824|reticulon genes|reticulon genes
503478|NCT00213837|porous titanium implants|porous titanium implants
503479|NCT00213837|thyroplasty|thyroplasty
503480|NCT00213837|vocal cord paralysis|vocal cord paralysis
503481|NCT00213837|male or female more than 18 years old|male or female more than 18 years old
503482|NCT00213850|Interrupter technique|interrupter technique
503483|NCT00213850|Respiratory resistance|respiratory resistance
503484|NCT00213850|Normal adults|normal adults
503485|NCT00213863|porous titanium implants|porous titanium implants
503486|NCT00213863|thyroplasty|thyroplasty
503487|NCT00213863|vocal cord paralysis|vocal cord paralysis
503488|NCT00213863|male or female more than 18 years old|male or female more than 18 years old
503489|NCT00213876|Brain tumours|brain tumours
503490|NCT00213876|oligodendrogliomas|oligodendrogliomas
503491|NCT00213876|allelotyping|allelotyping
503492|NCT00213876|SAGE|sage
503493|NCT00213876|Presence of molecular abnormalities statistically linked to survival or response to chemotherapy|presence of molecular abnormalities statistically linked to survival or response to chemotherapy
503494|NCT00213889|Facial clefting|facial clefting
503496|NCT00213889|craniofacial development genes|craniofacial development genes
503497|NCT00213889|Human cleft lip and palate|human cleft lip and palate
503498|NCT00213889|cleft lip and palate|cleft lip and palate
503499|NCT00213902|Heart failure|heart failure
503500|NCT00213902|Diastolic|diastolic
503501|NCT00213902|functionClonidine|functionclonidine
503502|NCT00213902|Left ventricular diastolic dysfunction with preserved ejection fraction|left ventricular diastolic dysfunction with preserved ejection fraction
503503|NCT00213915|L-arginine|l-arginine
503504|NCT00213915|exercise capacity|exercise capacity
503505|NCT00213915|renal function|renal function
503506|NCT00213915|nitric oxide|nitric oxide
503507|NCT00213915|exercise capacity using a maximal exercise test|exercise capacity using a maximal exercise test
503508|NCT00213915|urinary elimination of a saline load using blood and urinary samples|urinary elimination of a saline load using blood and urinary samples
503509|NCT00213941|transient tachypnoea of the newborn|transient tachypnoea of the newborn
503510|NCT00213941|surfactant deficiency|surfactant deficiency
503511|NCT00213941|persistant pulmonary hypertension of the neonate|persistant pulmonary hypertension of the neonate
503512|NCT00213941|lung maturity tests|lung maturity tests
503513|NCT00213954|Nerve block anaesthesia|nerve block anaesthesia
503514|NCT00213954|ultrasound-guidance|ultrasound-guidance
503515|NCT00213967|Influenza vaccine|influenza vaccine
503516|NCT00213980|bone mineral density|bone mineral density
503517|NCT00213980|postmenopausal women|postmenopausal women
583307|NCT00511238|multiple myeloma|multiple myeloma
503518|NCT00214032|lymphedema of the arm in breast cancer survivors|lymphedema of the arm in breast cancer survivors
503519|NCT00214045|Bladder cancer surveillance|bladder cancer surveillance
503520|NCT00214045|Voiding dysfunction|voiding dysfunction
503521|NCT00214045|Cystoscopy|cystoscopy
503522|NCT00214175|low grade gliomas and benign CNS lesions|low grade gliomas and benign cns lesions
503523|NCT00214227|patient who will undergo definitive radiotherapy|patient who will undergo definitive radiotherapy
503524|NCT00214344|dying|dying
503525|NCT00214370|pediatric|pediatric
503526|NCT00214370|acute leukemia/lymphoma|acute leukemia/lymphoma
503527|NCT00214383|pediatric asthma|pediatric asthma
503528|NCT00214422|Prostate|prostate
503529|NCT00214422|Radiation|radiation
503530|NCT00214422|Cancer|cancer
503531|NCT00214422|Prostate Cancer|prostate cancer
503532|NCT00214435|HIV infection|hiv infection
503533|NCT00214435|AIDS|aids
503534|NCT00214435|Adherence|adherence
503535|NCT00214435|MEMS caps|mems caps
503536|NCT00214435|Treatment Experienced|treatment experienced
503537|NCT00214448|Multiple genetic conditions will be studied|multiple genetic conditions will be studied
503538|NCT00214461|Clostridium difficile|clostridium difficile
503539|NCT00214474|Disease Management|disease management
503540|NCT00214474|Health Literacy|health literacy
503541|NCT00214474|Telephone Care|telephone care
503542|NCT00214474|Group Medical Visits|group medical visits
503543|NCT00214474|Type 2 Diabetes|type 2 diabetes
503544|NCT00214474|Access to Care|access to care
503545|NCT00214474|Technology|technology
503546|NCT00214474|Language Barriers|language barriers
503547|NCT00214487|Myopia Progression|myopia progression
503548|NCT00214487|Myopia Control|myopia control
503549|NCT00214487|Bifocal Contact Lenses|bifocal contact lenses
503550|NCT00214487|Esophoria|esophoria
503551|NCT00214487|Fixation Disparity|fixation disparity
503552|NCT00214526|Asthma|asthma
503553|NCT00214526|Bronchial Thermoplasty|bronchial thermoplasty
503752|NCT00205959|Humerus|humerus
503554|NCT00214526|Airway Hyperresponsiveness|airway hyperresponsiveness
503555|NCT00214539|Asthma|asthma
503556|NCT00214539|Bronchial Thermoplasty|bronchial thermoplasty
503557|NCT00214552|GERD|gerd
503558|NCT00214552|Gastroesophageal reflux disease|gastroesophageal reflux disease
503559|NCT00214552|Asthma symptoms|asthma symptoms
503560|NCT00214565|Type 2 diabetes|type 2 diabetes
503561|NCT00214578|Schizophrenia|schizophrenia
503562|NCT00214591|Type 2 diabetes|type 2 diabetes
503563|NCT00214617|hypercholesterolemia|hypercholesterolemia
503564|NCT00214617|HMG CoA Reductase Inhibtors|hmg coa reductase inhibtors
503565|NCT00214617|tracer kinetics|tracer kinetics
503566|NCT00214617|Apolipoproteins|apolipoproteins
503568|NCT00214643|Fosmidomycin|fosmidomycin
503569|NCT00214643|Clindamycin|clindamycin
503570|NCT00214643|Chemotherapy|chemotherapy
503571|NCT00214643|Gabon|gabon
503572|NCT00214656|Cardiac surgical procedures|cardiac surgical procedures
503573|NCT00214656|Surgical blood loss|surgical blood loss
503574|NCT00214656|Surgical haemostasis|surgical haemostasis
503575|NCT00214656|Factor VIIa|factor viia
503576|NCT00214656|Anaesthesia|anaesthesia
503577|NCT00214669|ethnicity|ethnicity
503578|NCT00214669|primary care|primary care
503579|NCT00214669|education|education
503580|NCT00214682|Depression|depression
503581|NCT00214682|Cognition|cognition
503582|NCT00214682|Depressive disorder|depressive disorder
503583|NCT00214682|Mental health literacy|mental health literacy
503584|NCT00214682|Older adults|older adults
503585|NCT00214682|Randomzed controlled trial|randomzed controlled trial
503586|NCT00214708|Tuberculosis|tuberculosis
503587|NCT00214708|Screening|screening
503588|NCT00214708|Heaf|heaf
503590|NCT00214747|HIV Seronegativity|hiv seronegativity
503592|NCT00214760|Hip prosthesis|hip prosthesis
503593|NCT00214760|Centralizer|centralizer
503594|NCT00214760|Uncemented|uncemented
503595|NCT00214786|Diabetes Mellitus|diabetes mellitus
503596|NCT00214786|Hypoglycemia|hypoglycemia
503597|NCT00214786|Hyperglycemia|hyperglycemia
503598|NCT00214812|HIV Seronegativity|hiv seronegativity
503599|NCT00214812|HIV|hiv
503600|NCT00214838|cancer, atiprimod|cancer, atiprimod
503601|NCT00214851|Familial Cold Urticaria|familial cold urticaria
503602|NCT00214851|Kineret (anakinra)|kineret (anakinra)
503603|NCT00214851|Interleukin 1 beta|interleukin 1 beta
503604|NCT00214851|C-Reactive Protein|c-reactive protein
503605|NCT00214851|Serum Amyloid A protein|serum amyloid a protein
503606|NCT00214864|Metastatic Breast Cancer|metastatic breast cancer
503607|NCT00214864|Taxotere (docetaxel)|taxotere (docetaxel)
503608|NCT00214864|Xeloda (capecitabine)|xeloda (capecitabine)
503609|NCT00214877|methylene blue for cognitive dysfunction in bipolar disorder|methylene blue for cognitive dysfunction in bipolar disorder
503610|NCT00214890|HIV|hiv
503611|NCT00214890|nucleoside pharmacology|nucleoside pharmacology
503612|NCT00214890|drug-drug interaction|drug-drug interaction
503613|NCT00214890|Treatment Naive|treatment naive
503614|NCT00214890|Drug resistance|drug resistance
503615|NCT00214890|Drug pharmacokinetics|drug pharmacokinetics
503616|NCT00214903|Postmenopause|postmenopause
503617|NCT00214903|HRT|hrt
503618|NCT00214916|Tight glycemic control with|tight glycemic control with
503619|NCT00214916|intensive insulin treatment|intensive insulin treatment
503620|NCT00214916|versus conventional glycemic control|versus conventional glycemic control
503621|NCT00214916|in infant or child in ICU|in infant or child in icu
503622|NCT00205101|Transforaminal lumbar interbody fusion|transforaminal lumbar interbody fusion
503623|NCT00205101|Posterior lumbar interbody fusion|posterior lumbar interbody fusion
503624|NCT00205101|Isthmic spondylolisthesis, degenerative spondylolisthesis|isthmic spondylolisthesis, degenerative spondylolisthesis
503625|NCT00205101|Pseudoarthritis|pseudoarthritis
503626|NCT00205101|Severe Foraminal Stenosis|severe foraminal stenosis
503627|NCT00205127|Cardiac PET imaging|cardiac pet imaging
503628|NCT00205127|Radiopharmaceutical tracers|radiopharmaceutical tracers
649060|NCT00766272|MS|ms
503629|NCT00205153|hypertension in African Americans|hypertension in african americans
503630|NCT00205166|adenosine tracer scans|adenosine tracer scans
503631|NCT00205166|coronary artery disease|coronary artery disease
503632|NCT00205166|caffeine|caffeine
503633|NCT00205192|Heart Failure|heart failure
503634|NCT00205192|Cardiac resynchronization|cardiac resynchronization
503635|NCT00205192|echocardiography|echocardiography
503636|NCT00205231|HIV|hiv
503637|NCT00205270|Pre or post-lung transplant|pre or post-lung transplant
503638|NCT00205270|Healthy|healthy
503639|NCT00205283|HIV|hiv
503640|NCT00205309|intubated patients|intubated patients
503641|NCT00205387|echocardiography|echocardiography
503642|NCT00205387|cardiac elastography|cardiac elastography
503643|NCT00205387|Normal volunteers|normal volunteers
503644|NCT00205413|surveillance for lung cancer|surveillance for lung cancer
503645|NCT00205426|Pulmonary hypertension in lung transplant recipients|pulmonary hypertension in lung transplant recipients
503646|NCT00205491|depression after brain injury|depression after brain injury
503647|NCT00205491|traumatic brain injury|traumatic brain injury
503648|NCT00205491|Venlafaxine|venlafaxine
503649|NCT00205504|Inflammatory markers, oral contraceptions, obesity, metabolic syndrome X|inflammatory markers, oral contraceptions, obesity, metabolic syndrome x
503650|NCT00205530|brain injury, family treatment|brain injury, family treatment
503651|NCT00205543|obstructive sleep apnea|obstructive sleep apnea
503652|NCT00205543|airway obstruction|airway obstruction
503653|NCT00205543|sleep-disordered breathing|sleep-disordered breathing
503654|NCT00205556|online hemodiafiltration|online hemodiafiltration
503655|NCT00205556|low flux hemodialysis|low flux hemodialysis
503656|NCT00205556|cardiovascular disease|cardiovascular disease
503657|NCT00205556|endothelial dysfunction|endothelial dysfunction
503658|NCT00205556|uremic toxicity|uremic toxicity
503659|NCT00205556|quality of life|quality of life
503660|NCT00205556|nutritional status|nutritional status
503661|NCT00205569|brain injury, acute rehabilitation|brain injury, acute rehabilitation
503662|NCT00205582|Traumatic Brain Injury|traumatic brain injury
503663|NCT00205582|PET|pet
503664|NCT00205582|microglia|microglia
503665|NCT00205595|microglia|microglia
503666|NCT00205595|PET|pet
503667|NCT00205595|PK11195|pk11195
503668|NCT00205608|schizophrenia|schizophrenia
503669|NCT00205608|microglia|microglia
503670|NCT00205608|PET|pet
503671|NCT00205621|Alzheimer's disease|alzheimer's disease
503672|NCT00205621|amyloid|amyloid
503673|NCT00205621|PET|pet
503674|NCT00205621|PIB|pib
503675|NCT00205621|FDDNP|fddnp
503676|NCT00205634|Cystic Fibrosis (CF)|cystic fibrosis (cf)
503677|NCT00205634|Macrolide antiobiotics|macrolide antiobiotics
503678|NCT00205634|airway inflammation|airway inflammation
503679|NCT00205647|Chronic Bronchitis|chronic bronchitis
503680|NCT00205647|N-acetylcysteine (NAC)|n-acetylcysteine (nac)
503681|NCT00205647|Quality of Life|quality of life
503682|NCT00205647|Mucus|mucus
503683|NCT00205660|Schizophrenia|schizophrenia
503685|NCT00205660|Hyperglycemia|hyperglycemia
503686|NCT00205660|Dyslipidemia|dyslipidemia
503687|NCT00205660|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
503688|NCT00205686|Aging, dhea, bone density, muscle mass, insulin action|aging, dhea, bone density, muscle mass, insulin action
503689|NCT00205699|Antipsychotic treatment|antipsychotic treatment
503690|NCT00205699|Insulin action/secretion|insulin action/secretion
503691|NCT00205699|Abdominal fat mass, total body fat|abdominal fat mass, total body fat
503692|NCT00205699|Aggression|aggression
503693|NCT00205699|Resting metabolic rates|resting metabolic rates
503694|NCT00205712|NMDA antagonist-induced psychosis|nmda antagonist-induced psychosis
503695|NCT00205712|Children|children
503696|NCT00205712|Memory Impairment|memory impairment
503697|NCT00205712|Decreased cognitive function|decreased cognitive function
503698|NCT00205712|Increased memory impairment|increased memory impairment
503699|NCT00205725|Schizophrenia|schizophrenia
503701|NCT00205725|T2DM|t2dm
503702|NCT00205738|Schizophrenia|schizophrenia
503703|NCT00205738|BMI|bmi
503704|NCT00205738|T2DM|t2dm
503705|NCT00205751|Multiple Myeloma|multiple myeloma
503706|NCT00205751|first line treatment|first line treatment
503707|NCT00205751|thalidomide|thalidomide
503708|NCT00205751|melphalan|melphalan
503709|NCT00205764|Multiple Myeloma|multiple myeloma
503710|NCT00205764|first line tretment|first line tretment
583308|NCT00511238|relapsed|relapsed
503711|NCT00205764|high dose chemotherapy|high dose chemotherapy
503712|NCT00205764|stem cell transplantation|stem cell transplantation
503713|NCT00205764|maintenance therapy|maintenance therapy
503714|NCT00205777|Osteoporosis|osteoporosis
503715|NCT00205777|Postmenopause|postmenopause
503716|NCT00205803|Infant Vaccine|infant vaccine
503717|NCT00205816|Bacterial Infections|bacterial infections
503718|NCT00205829|Chronic headaches|chronic headaches
503719|NCT00205829|greater occipital nerve stimulation|greater occipital nerve stimulation
503720|NCT00205855|Pain|pain
503721|NCT00205855|Chronic Pain|chronic pain
503722|NCT00205855|Neurostimulation|neurostimulation
503723|NCT00205868|Back Pain|back pain
503053|NCT00202163|ED|ed
503724|NCT00205868|Low Back Pain|low back pain
503725|NCT00205868|Chronic Pain|chronic pain
503726|NCT00205868|Spinal Cord Stimulation|spinal cord stimulation
503727|NCT00205881|HiResolution Bionic Ear|hiresolution bionic ear
503728|NCT00205881|severe to profound hearing loss|severe to profound hearing loss
503729|NCT00205881|bilateral implantation|bilateral implantation
503730|NCT00205894|Headache|headache
503731|NCT00205894|Chronic headache|chronic headache
503732|NCT00205894|Migraine|migraine
503733|NCT00205894|Pain|pain
503734|NCT00205894|Cluster headache|cluster headache
503735|NCT00205907|BLVR|blvr
503736|NCT00205907|emphysema|emphysema
503737|NCT00205907|COPD|copd
503738|NCT00205907|COLD|cold
503739|NCT00205907|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
503740|NCT00205907|pulmonary emphysema|pulmonary emphysema
503741|NCT00205920|emphysema|emphysema
503742|NCT00205920|pulmonary emphysema|pulmonary emphysema
503743|NCT00205920|COPD|copd
503744|NCT00205920|COLD|cold
503745|NCT00205920|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
503746|NCT00205933|Depression|depression
503747|NCT00205933|Bipolar Disorder|bipolar disorder
503748|NCT00205933|Reward Processing|reward processing
503749|NCT00205946|Reward Processing|reward processing
503750|NCT00205946|Wellbutrin|wellbutrin
503753|NCT00205959|Fractures|fractures
503754|NCT00205959|Locking Plates|locking plates
503755|NCT00205959|Nail System|nail system
503756|NCT00205972|Fractures|fractures
503757|NCT00205972|Humerus|humerus
503758|NCT00205972|Conservative treatment|conservative treatment
503759|NCT00205972|Operative treatment|operative treatment
503760|NCT00205985|Return to work|return to work
503761|NCT00205985|Scaphoid fracture|scaphoid fracture
503762|NCT00205985|Operative treatment|operative treatment
503763|NCT00205985|Activity level|activity level
503764|NCT00205998|Locking Compression Plate|locking compression plate
503765|NCT00205998|Conservative treatment|conservative treatment
503766|NCT00205998|Surgical treatment|surgical treatment
503767|NCT00205998|Radius fractures|radius fractures
503768|NCT00205998|AO 23|ao 23
503769|NCT00206011|Condylar neck|condylar neck
503770|NCT00206011|fractures|fractures
503771|NCT00206011|endoscopic|endoscopic
503772|NCT00206011|Helkimo Dysfunction index|helkimo dysfunction index
503773|NCT00206037|Tibia osteotomy|tibia osteotomy
503774|NCT00206037|Bone healing|bone healing
503775|NCT00206037|Bone filler|bone filler
503776|NCT00206037|Equine Protein|equine protein
503777|NCT00206037|COLLOSS E|colloss e
503778|NCT00206037|TomoFix|tomofix
503779|NCT00206076|Liver transplantation|liver transplantation
503780|NCT00206076|Calcineurin inhibitor withdraw|calcineurin inhibitor withdraw
503781|NCT00206076|mycophenolate mofetil|mycophenolate mofetil
503782|NCT00206076|Immunosuppression side effects|immunosuppression side effects
503783|NCT00206076|Graft rejection|graft rejection
503885|NCT00207233|MCT oil hypocaloric liquid diet|mct oil hypocaloric liquid diet
504191|NCT00208689|pediatric|pediatric
503784|NCT00206089|Prevention of venous thromboembolic events in patients undergoing elective hip replacement or hip fracture surgery|prevention of venous thromboembolic events in patients undergoing elective hip replacement or hip fracture surgery
503785|NCT00206102|Schizophrenia|schizophrenia
503786|NCT00206102|Schizoaffective Disorder|schizoaffective disorder
503787|NCT00206115|Schizophrenic disorder|schizophrenic disorder
503788|NCT00206128|Schizophrenia|schizophrenia
503789|NCT00206141|Bipolar disorder|bipolar disorder
503790|NCT00206141|bipolar depression|bipolar depression
503791|NCT00206141|depression|depression
503792|NCT00206193|termination of pregnancy|termination of pregnancy
503793|NCT00206219|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
503794|NCT00206232|Diastolic Heart Failure|diastolic heart failure
503795|NCT00206245|GERD with erosive esophagitis|gerd with erosive esophagitis
503796|NCT00206258|type 1 diabetes|type 1 diabetes
503797|NCT00206258|hypoglycemia|hypoglycemia
503798|NCT00206258|hyperglycemia|hyperglycemia
503799|NCT00206271|whiplash injuries|whiplash injuries
503800|NCT00206271|neck pain|neck pain
503801|NCT00206271|exercise movement techniques|exercise movement techniques
503802|NCT00206271|immobilisation|immobilisation
503803|NCT00206284|GERD without erosive esophagitis|gerd without erosive esophagitis
503804|NCT00206297|Type 1 diabetes|type 1 diabetes
503805|NCT00206297|hypoglycemia|hypoglycemia
503806|NCT00206297|hyperglycemia|hyperglycemia
503807|NCT00206778|Mixed mania|mixed mania
503808|NCT00206778|Bipolar Disorder|bipolar disorder
503809|NCT00206791|bone substitutes|bone substitutes
503810|NCT00206791|Bone Replacement Materials|bone replacement materials
503811|NCT00206791|bone void filler|bone void filler
503812|NCT00206791|Grafting, Bone|grafting, bone
503813|NCT00206791|Bone Cysts|bone cysts
503814|NCT00206882|sunburn|sunburn
503815|NCT00206882|corticosteroids|corticosteroids
503816|NCT00206921|Telangiectasia|telangiectasia
503139|NCT00212069|gemcitabine|gemcitabine
503817|NCT00206921|Skin redness|skin redness
503818|NCT00206934|PPI|ppi
503819|NCT00206934|P50 suppression|p50 suppression
503820|NCT00206934|P300|p300
503821|NCT00206934|mismatch negativity|mismatch negativity
503822|NCT00206934|escitalopram|escitalopram
503823|NCT00206947|Cognitive deficits|cognitive deficits
503824|NCT00206947|Cholinergic Augmentation|cholinergic augmentation
503825|NCT00206947|Schizophrenia|schizophrenia
503826|NCT00206960|drug-naive|drug-naive
503827|NCT00206960|epidepride|epidepride
503828|NCT00206960|single tomography|single tomography
503829|NCT00206960|D2 receptor|d2 receptor
503830|NCT00206960|information processing|information processing
503831|NCT00206960|PPI|ppi
503832|NCT00206960|antipsychotic treatment|antipsychotic treatment
503833|NCT00206960|MRI|mri
503834|NCT00206960|fMRI|fmri
503835|NCT00206960|cognitive disturbances|cognitive disturbances
503836|NCT00206986|Schizophrenia|schizophrenia
503837|NCT00206986|Information processing|information processing
503838|NCT00206986|PPI|ppi
503839|NCT00206986|P50 gating|p50 gating
503840|NCT00206986|P300|p300
503841|NCT00206986|mismatch negativity|mismatch negativity
503842|NCT00206986|clonidine|clonidine
503843|NCT00206999|Psychophysiology|psychophysiology
503844|NCT00206999|PPI|ppi
503845|NCT00206999|P50 suppression|p50 suppression
503846|NCT00206999|Imipramine|imipramine
503847|NCT00207025|Patients with advanced solid tumors|patients with advanced solid tumors
503848|NCT00207038|Asthma|asthma
503849|NCT00207038|Airway inflammation|airway inflammation
503850|NCT00207038|Sport|sport
503851|NCT00207051|Advanced Gastrointestinal Malignancies|advanced gastrointestinal malignancies
503852|NCT00207064|first-episode|first-episode
503853|NCT00207064|altanserin|altanserin
503854|NCT00207064|5-HT2A receptors|5-ht2a receptors
503855|NCT00207064|MRI|mri
503856|NCT00207064|fMRI|fmri
503857|NCT00207064|PPI|ppi
503858|NCT00207064|P300|p300
503859|NCT00207064|P50 gating|p50 gating
503860|NCT00207064|endophenotypes|endophenotypes
503861|NCT00207064|vulnerability indicators|vulnerability indicators
503862|NCT00207064|quetiapine|quetiapine
503863|NCT00207077|Advanced Solid Tumors|advanced solid tumors
503864|NCT00207103|Advanced metastatic or solid tumors|advanced metastatic or solid tumors
503865|NCT00207116|Metastatic Non Small Cell Lung Cancer|metastatic non small cell lung cancer
503866|NCT00207142|Treatment Naive|treatment naive
503867|NCT00207142|HIV-1 infected treatment naive patients|hiv-1 infected treatment naive patients
503868|NCT00207181|Cancer prevention|cancer prevention
503869|NCT00207181|Physical activity|physical activity
503870|NCT00207181|Self-report|self-report
503871|NCT00207181|Paper diary|paper diary
503872|NCT00207181|Electronic|electronic
503873|NCT00207181|Computerized|computerized
503874|NCT00207181|Measurement|measurement
503875|NCT00207181|PDA|pda
503876|NCT00207181|Accelerometer|accelerometer
503877|NCT00207207|Alternate Site|alternate site
503878|NCT00207207|Blood Glucose Testing|blood glucose testing
503879|NCT00207207|Blood Sugar Testing|blood sugar testing
503880|NCT00207207|Hemoglobin A1C|hemoglobin a1c
503881|NCT00207220|heart failure|heart failure
503882|NCT00207220|preserved ejection fraction|preserved ejection fraction
503883|NCT00207220|vascular stiffness|vascular stiffness
503886|NCT00207233|LCT oil hypocaloric liquid diet|lct oil hypocaloric liquid diet
503887|NCT00207233|Gastric Bypass|gastric bypass
503888|NCT00207259|Prostate Cancer|prostate cancer
503889|NCT00207259|Reiki|reiki
503890|NCT00207259|Relaxation Response|relaxation response
503891|NCT00207259|Cognitive Restructuring|cognitive restructuring
503892|NCT00207259|Feasibility|feasibility
503893|NCT00207272|Hypocaloric MCT oil liquid diet|hypocaloric mct oil liquid diet
503894|NCT00207272|Hypocaloric LCT oil liquid diet|hypocaloric lct oil liquid diet
503895|NCT00207272|Visceral and omental adipose tissue|visceral and omental adipose tissue
503896|NCT00207272|Subcutaneous abdominal adipose tissue|subcutaneous abdominal adipose tissue
503897|NCT00207272|Gastric bypass surgery|gastric bypass surgery
503898|NCT00207285|Police|police
503899|NCT00207285|Sleep|sleep
503900|NCT00207285|Fatigue|fatigue
503901|NCT00207285|Work Hours|work hours
503902|NCT00207285|Sleep disorder|sleep disorder
503903|NCT00207285|Performance|performance
503904|NCT00207311|Hepatitis C|hepatitis c
503905|NCT00207311|Fatty Liver|fatty liver
503906|NCT00207311|NASH|nash
503907|NCT00207311|Steatohepatitis|steatohepatitis
503908|NCT00207337|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
503909|NCT00207337|Emphysema|emphysema
503910|NCT00207337|Minimally invasive|minimally invasive
503911|NCT00207350|Brain Tumor|brain tumor
503912|NCT00207363|Hepatitis C|hepatitis c
503913|NCT00207389|Incretins:GIP , GLP-1|incretins:gip , glp-1
503914|NCT00207389|Gastric bypass surgery|gastric bypass surgery
503915|NCT00207389|Laparoscopic gastric bypass surgery|laparoscopic gastric bypass surgery
503916|NCT00207389|Postprandial expression of GIP|postprandial expression of gip
503917|NCT00207402|Hepatitis C|hepatitis c
503918|NCT00207402|Insulin resistance|insulin resistance
649409|NCT00773552|OAB|oab
503919|NCT00207415|arthritis|arthritis
503920|NCT00207415|self management|self management
503921|NCT00207428|Bronchial asthma|bronchial asthma
503922|NCT00207428|Carbamazepine|carbamazepine
503923|NCT00207428|Efficacy|efficacy
503924|NCT00207441|arthritis|arthritis
503925|NCT00207441|chronic disease|chronic disease
503926|NCT00207441|self management|self management
503927|NCT00207441|self efficacy|self efficacy
503928|NCT00207454|Partner Referral|partner referral
503929|NCT00207454|Social Cognitive Intervention|social cognitive intervention
503930|NCT00207454|Partner Delivered Medication|partner delivered medication
503931|NCT00207467|patient-delivered partner treatment|patient-delivered partner treatment
503932|NCT00207467|partner referral|partner referral
503933|NCT00207467|sexually transmitted diseases|sexually transmitted diseases
503934|NCT00207493|sexually transmitted disease|sexually transmitted disease
503935|NCT00207493|structural intervention|structural intervention
503936|NCT00207493|behavioral intervention|behavioral intervention
503938|NCT00207506|Lay Health|lay health
503939|NCT00207506|Access|access
503940|NCT00207506|Prevention|prevention
503941|NCT00207506|HIV Seronegativity|hiv seronegativity
503942|NCT00207506|HIV|hiv
503943|NCT00207519|overweight|overweight
503944|NCT00207519|obesity|obesity
503945|NCT00207519|adolescent|adolescent
503946|NCT00207571|computer|computer
503947|NCT00207571|video|video
503948|NCT00207571|partner notification|partner notification
503949|NCT00207610|Anemia|anemia
503950|NCT00207610|Postpartum|postpartum
503951|NCT00207610|iron|iron
503952|NCT00207610|supplements|supplements
503953|NCT00207623|arthritis|arthritis
503954|NCT00207623|self management|self management
503955|NCT00207623|patient education|patient education
503956|NCT00207636|Computer-Assisted Decision Making|computer-assisted decision making
503957|NCT00207636|Workplace|workplace
503958|NCT00207636|Screening|screening
503959|NCT00207649|shared decision-making|shared decision-making
503960|NCT00207649|prostate cancer screening|prostate cancer screening
503961|NCT00207649|evidence-based medicine|evidence-based medicine
503962|NCT00207649|computer-assisted learning tools|computer-assisted learning tools
503963|NCT00207649|standardized patients|standardized patients
503964|NCT00207649|randomized controlled trial|randomized controlled trial
503965|NCT00207649|educational intervention|educational intervention
503966|NCT00207649|patient education|patient education
503967|NCT00207649|physician education|physician education
503968|NCT00207662|Crohn's Disease|crohn's disease
503969|NCT00207675|Crohn's Disease|crohn's disease
503970|NCT00207675|pediatric Crohn's Disease|pediatric crohn's disease
503971|NCT00207688|Ulcerative Colitis|ulcerative colitis
503972|NCT00207688|Infliximab|infliximab
503973|NCT00207688|Remicade|remicade
503974|NCT00207688|Safety|safety
503975|NCT00207701|Ankylosing Spondylitis|ankylosing spondylitis
503976|NCT00207701|infusion|infusion
503977|NCT00207714|Rheumatoid Arthritis|rheumatoid arthritis
503978|NCT00207714|CNTO 148|cnto 148
503979|NCT00207714|Methotrexate|methotrexate
503980|NCT00207714|Joint pain|joint pain
503981|NCT00207714|Arthritis|arthritis
503982|NCT00207727|Multiple Sclerosis|multiple sclerosis
503983|NCT00207740|Asthma|asthma
503984|NCT00207740|Severe Persistent Asthma|severe persistent asthma
503985|NCT00207740|Subcutaneous injections|subcutaneous injections
503986|NCT00207740|Immunology disorder|immunology disorder
503987|NCT00207740|Breathlesness|breathlesness
503990|NCT00207753|strongyloides|strongyloides
503991|NCT00207753|hookworm|hookworm
503992|NCT00207753|head lice|head lice
503993|NCT00207766|Crohn's Disease|crohn's disease
503994|NCT00207766|infusions|infusions
503995|NCT00207779|central venous catheter|central venous catheter
503996|NCT00207779|catheter related bloodstream infection|catheter related bloodstream infection
503997|NCT00207779|heparin|heparin
503998|NCT00207792|Granulocyte colony stimulating factor|granulocyte colony stimulating factor
503999|NCT00207818|tissue engineered wound dressing; autologous skin substitute; biological dressing; wound care|tissue engineered wound dressing; autologous skin substitute; biological dressing; wound care
504000|NCT00207831|rectal cancer|rectal cancer
504001|NCT00207831|neoadjuvant therapy|neoadjuvant therapy
504002|NCT00207831|UFT|uft
504003|NCT00207831|radiochemotherapy|radiochemotherapy
504004|NCT00207844|Selenium|selenium
504005|NCT00207844|Oxidative stress|oxidative stress
504006|NCT00207844|Septic shock|septic shock
504007|NCT00207844|Sodium selenite|sodium selenite
504008|NCT00207857|Duchenne's Muscular Dystrophy|duchenne's muscular dystrophy
504009|NCT00207857|Scoliosis|scoliosis
504010|NCT00207870|Type II Supracondylar Fracture|type ii supracondylar fracture
504011|NCT00207870|Orthopaedics|orthopaedics
504012|NCT00207883|Vascular Access|vascular access
504013|NCT00207883|Ultrasound|ultrasound
504014|NCT00207883|Pediatric|pediatric
504015|NCT00207883|Pediatric intensive care patient|pediatric intensive care patient
504016|NCT00207896|Pediatric Intensive Care|pediatric intensive care
504017|NCT00207896|Neuroendocrine Dysfunction|neuroendocrine dysfunction
504018|NCT00207909|Acute Renal Failure|acute renal failure
504019|NCT00207909|Contiuous Veno Venous Hemofiltration|contiuous veno venous hemofiltration
504020|NCT00207922|cytokine|cytokine
504022|NCT00207922|chemokine|chemokine
504023|NCT00207922|graft-versus-host disease|graft-versus-host disease
504024|NCT00207935|Seizures|seizures
504025|NCT00207935|Depakote|depakote
504026|NCT00207935|Developmental Delay|developmental delay
504027|NCT00207935|Mental Retardation|mental retardation
504028|NCT00207935|Swallow|swallow
504029|NCT00207948|Human Immunodeficiency Virus|human immunodeficiency virus
504030|NCT00207948|Protease Inhibitors|protease inhibitors
504031|NCT00207948|Pharmacogenetics|pharmacogenetics
504032|NCT00207948|Genes, MDR1, Cytochrome P-450 enzymes|genes, mdr1, cytochrome p-450 enzymes
504033|NCT00207948|Pharmacokinetics|pharmacokinetics
504034|NCT00207948|Pediatrics|pediatrics
504035|NCT00207948|Treatment Experienced|treatment experienced
504036|NCT00207974|Hyperuricemia, Anserine, Pharmacokinetic|hyperuricemia, anserine, pharmacokinetic
504037|NCT00207987|controlled hypotension|controlled hypotension
504038|NCT00208013|resting energy expenditure|resting energy expenditure
504039|NCT00208013|cachexia|cachexia
504040|NCT00208013|advanced cancer|advanced cancer
504041|NCT00208013|advanced cancer patients|advanced cancer patients
504042|NCT00208039|Prematurity|prematurity
504043|NCT00208039|Lung Disease|lung disease
504044|NCT00208039|Hyaline Membrane|hyaline membrane
504045|NCT00208039|Surfactant|surfactant
504046|NCT00208065|migraine|migraine
504047|NCT00208065|biological markers|biological markers
504048|NCT00208065|rhinosinusitis|rhinosinusitis
504049|NCT00208065|CGRP|cgrp
504050|NCT00208065|histamine|histamine
504051|NCT00208065|VIP|vip
504052|NCT00208078|Hypercapnia|hypercapnia
504053|NCT00208078|Non-Invasive Ventilation|non-invasive ventilation
504054|NCT00208091|Myloboc|myloboc
504055|NCT00208091|Botulinum Toxin Type B|botulinum toxin type b
504056|NCT00208091|Focal Dystonia|focal dystonia
504057|NCT00208091|Musicians|musicians
504058|NCT00208091|Muscle Relaxants|muscle relaxants
504059|NCT00208091|Motor Impairments|motor impairments
504060|NCT00208091|Motor Performance|motor performance
504061|NCT00208091|Tremor|tremor
504062|NCT00208091|Abnormal Postures|abnormal postures
504063|NCT00208104|Hypertension|hypertension
504064|NCT00208104|African Americans|african americans
504065|NCT00208104|Adherence|adherence
504066|NCT00208104|Motivational Interviewing|motivational interviewing
504067|NCT00208117|depression|depression
504068|NCT00208117|inflammation|inflammation
504069|NCT00208117|heart disease|heart disease
504070|NCT00208117|randomized clinical trial|randomized clinical trial
504071|NCT00208117|sertraline|sertraline
504072|NCT00208117|simvastatin|simvastatin
504073|NCT00208117|placebo|placebo
504074|NCT00208130|PTSD|ptsd
504075|NCT00208130|trauma|trauma
504076|NCT00208143|Cocaine Abuse|cocaine abuse
504077|NCT00208143|Cocaine Dependence|cocaine dependence
504078|NCT00208143|Amphetamine Abuse|amphetamine abuse
504079|NCT00208143|Amphetamine Dependence|amphetamine dependence
504080|NCT00208143|Schizophrenia|schizophrenia
504081|NCT00208143|Comorbid|comorbid
504082|NCT00208143|Schizoaffective Disorder|schizoaffective disorder
504083|NCT00208156|Depression|depression
504084|NCT00208156|Major Depression|major depression
504085|NCT00208156|Psychotic Major Depression|psychotic major depression
504087|NCT00208156|Psychosis|psychosis
504088|NCT00208169|Comorbid substance abuse/dependence|comorbid substance abuse/dependence
504089|NCT00208169|Comorbid diagnoses|comorbid diagnoses
504090|NCT00208169|Substance abuse and/or dependence|substance abuse and/or dependence
504091|NCT00208195|Bipolar Disorder|bipolar disorder
504092|NCT00208195|Mania|mania
504093|NCT00208195|Substance Abuse|substance abuse
504094|NCT00208195|Substance Dependence|substance dependence
504095|NCT00208195|Comorbid|comorbid
504096|NCT00208208|Posttraumatic Stress Disorder|posttraumatic stress disorder
504097|NCT00208208|Post-traumatic Stress Disorder|post-traumatic stress disorder
504098|NCT00208208|PTSD|ptsd
504099|NCT00208208|Geodon|geodon
504100|NCT00208208|Ziprasidone|ziprasidone
504101|NCT00208221|Hypertension|hypertension
504102|NCT00208221|Diabetes|diabetes
504103|NCT00208221|Microalbuminuria|microalbuminuria
504104|NCT00208221|Blood pressure|blood pressure
504105|NCT00208234|asthma|asthma
504106|NCT00208273|Postmenopausal breast cancer, radiohormonotherapy sequences|postmenopausal breast cancer, radiohormonotherapy sequences
504107|NCT00208273|ER+ and/or PgR+,|er+ and/or pgr+,
504108|NCT00208273|Postmenopausal Breast cancer,|postmenopausal breast cancer,
504109|NCT00208273|Adjuvant setting|adjuvant setting
504110|NCT00208299|Lexiscan|lexiscan
504111|NCT00208299|Regadenoson|regadenoson
504112|NCT00208299|Adenoscan®|adenoscan®
504113|NCT00208299|Adenosine|adenosine
504114|NCT00208299|SPECT Myocardial Perfusion Imaging|spect myocardial perfusion imaging
504115|NCT00208299|Reversible Perfusion Defect|reversible perfusion defect
504116|NCT00208312|Lexiscan|lexiscan
504117|NCT00208312|Regadenoson|regadenoson
504118|NCT00208312|Adenoscan®|adenoscan®
504119|NCT00208312|Adenosine|adenosine
504120|NCT00208312|SPECT Myocardial Perfusion Imaging|spect myocardial perfusion imaging
504121|NCT00208312|Reversible Perfusion Defect|reversible perfusion defect
504122|NCT00208338|Rotator cuff tear repair|rotator cuff tear repair
504123|NCT00208351|Hip|hip
504124|NCT00208351|Cemented|cemented
504125|NCT00208364|Hip|hip
504126|NCT00208364|Cementless|cementless
504127|NCT00208364|Metal-on-Metal|metal-on-metal
504128|NCT00208377|Hip|hip
504129|NCT00208377|Conservative|conservative
504130|NCT00208377|Metal-on-Metal|metal-on-metal
504131|NCT00208377|Resurfacing|resurfacing
504132|NCT00208390|Hip|hip
504133|NCT00208390|Cementless|cementless
504134|NCT00208403|Hip|hip
504135|NCT00208403|Cement|cement
504136|NCT00208416|Hip|hip
504137|NCT00208416|Surgical Technique|surgical technique
504138|NCT00208429|Hip|hip
504139|NCT00208429|Cementless|cementless
504140|NCT00208442|Hip|hip
504141|NCT00208442|Cemented|cemented
504142|NCT00208455|Arthroplasty|arthroplasty
504143|NCT00208455|Replacement|replacement
504144|NCT00208455|Hip|hip
504145|NCT00208455|Conservative|conservative
504146|NCT00208455|Anatomic|anatomic
504147|NCT00208455|Cementless|cementless
504148|NCT00208468|Hip|hip
504149|NCT00208468|Cementless|cementless
504150|NCT00208494|Non-Inflammatory Degenerative Joint Disease|non-inflammatory degenerative joint disease
504151|NCT00208507|Joint Diseases|joint diseases
504152|NCT00208507|Non-Inflammatory Degenerative Joint Disease|non-inflammatory degenerative joint disease
504153|NCT00208520|Epilepsy|epilepsy
504154|NCT00208520|Valproate|valproate
504155|NCT00208520|Levetiracetam|levetiracetam
504156|NCT00208520|Lamotrigine|lamotrigine
504157|NCT00208520|Carbamazepine|carbamazepine
504158|NCT00208533|Autism|autism
504159|NCT00208533|Pervasive developmental disorder|pervasive developmental disorder
504160|NCT00208533|Aripiprazole|aripiprazole
504161|NCT00208533|Antipsychotic medication|antipsychotic medication
504162|NCT00208533|Adolescents|adolescents
504163|NCT00208546|capecitabine|capecitabine
504164|NCT00208546|oxaliplatin|oxaliplatin
504165|NCT00208546|bevacizumab|bevacizumab
504166|NCT00208546|cetuximab|cetuximab
504167|NCT00208546|advanced colorectal cancer|advanced colorectal cancer
504168|NCT00208559|Autism|autism
504169|NCT00208559|Pervasive Developmental Disorder|pervasive developmental disorder
504170|NCT00208559|Ziprasidone|ziprasidone
504171|NCT00208559|Adolescents|adolescents
504172|NCT00208572|Traumatic Brain Injury; Anxiety Disorders; SRI Treatment|traumatic brain injury; anxiety disorders; sri treatment
504173|NCT00208598|Maori|maori
504174|NCT00208598|Body Composition|body composition
504175|NCT00208598|DEXA|dexa
504176|NCT00208598|Cardiovascular disease|cardiovascular disease
504177|NCT00208598|Diabetes|diabetes
504178|NCT00208624|arrhythmia|arrhythmia
504179|NCT00208624|pediatrics|pediatrics
504180|NCT00208624|cardiac|cardiac
504181|NCT00208637|Maori|maori
504182|NCT00208637|insulin sensitivity|insulin sensitivity
504183|NCT00208637|cardiovascular risk|cardiovascular risk
504184|NCT00208637|diabetes prevention|diabetes prevention
504185|NCT00208637|diet modification|diet modification
504186|NCT00208650|pediatrics|pediatrics
504187|NCT00208650|transplant|transplant
504188|NCT00208650|cardiac|cardiac
504189|NCT00208676|heart defects|heart defects
504190|NCT00208676|pediatrics|pediatrics
504192|NCT00208689|congenital heart disease|congenital heart disease
504193|NCT00208702|Major Depressive Disorder|major depressive disorder
504195|NCT00208702|Depression|depression
504196|NCT00208715|Depression|depression
504197|NCT00208728|pediatric|pediatric
504198|NCT00208728|congenital heart disease|congenital heart disease
504199|NCT00208728|cardiac surgery|cardiac surgery
504200|NCT00208741|Social Anxiety Disorder|social anxiety disorder
504201|NCT00208741|Mental Health|mental health
504202|NCT00208754|heart defects|heart defects
504203|NCT00208754|cardiology|cardiology
504204|NCT00208754|adults who have congenital heart defects|adults who have congenital heart defects
504205|NCT00208767|Angiotensin receptor blockade|angiotensin receptor blockade
504206|NCT00208767|Oxidative stress|oxidative stress
504207|NCT00208767|Endothelial dysfunction|endothelial dysfunction
504208|NCT00208780|Oxidative Stress|oxidative stress
504209|NCT00208780|Endothelium|endothelium
504210|NCT00208793|colonic polyps|colonic polyps
504211|NCT00208793|adenomatous polyps|adenomatous polyps
504212|NCT00208793|colon cancer prevention|colon cancer prevention
504213|NCT00208793|dietary supplements|dietary supplements
504214|NCT00208806|Dilated Cardiomyopathy|dilated cardiomyopathy
504215|NCT00208806|Pediatric|pediatric
504216|NCT00208806|Bi-ventricular Pacemaker|bi-ventricular pacemaker
504217|NCT00208819|Alzheimer's Disease|alzheimer's disease
504218|NCT00208819|Geriatric|geriatric
504219|NCT00208819|Dementia|dementia
504220|NCT00208819|Agitation|agitation
504221|NCT00208819|Behavioral Disturbances|behavioral disturbances
504222|NCT00208819|Psychosis|psychosis
504223|NCT00208832|Medication Compliance|medication compliance
504224|NCT00208832|Health Literacy|health literacy
503591|NCT00214747|HIV|hiv
504225|NCT00208871|Stereoscopic digital mammography|stereoscopic digital mammography
504226|NCT00208871|Breast cancer detection|breast cancer detection
504227|NCT00208871|Reduced rate of recall|reduced rate of recall
504228|NCT00208871|Focal abnormalities detection|focal abnormalities detection
504229|NCT00208884|pediatric|pediatric
504230|NCT00208884|orthotopic heart transplantation|orthotopic heart transplantation
504231|NCT00208884|graft failure|graft failure
504232|NCT00208897|Early Life Stress|early life stress
504233|NCT00208897|HPA-axis|hpa-axis
504235|NCT00208910|Anxiety|anxiety
504236|NCT00208910|Mental Health|mental health
504237|NCT00208923|Hematologic Malignancies|hematologic malignancies
504238|NCT00208936|Esophageal Diseases|esophageal diseases
504239|NCT00208949|Hematologic Diseases|hematologic diseases
504240|NCT00208962|Hematologic Diseases|hematologic diseases
504241|NCT00208975|Lymphoma|lymphoma
504242|NCT00208988|Health literacy|health literacy
504243|NCT00208988|Physician-Patient Relationship|physician-patient relationship
504244|NCT00208988|Prostate Cancer|prostate cancer
504245|NCT00209001|Breast Cancer|breast cancer
504246|NCT00209014|B-Cell Lymphoma|b-cell lymphoma
504247|NCT00209014|Hodgkin's Disease|hodgkin's disease
504248|NCT00209027|schizophrenia|schizophrenia
504249|NCT00209027|reward|reward
504250|NCT00209027|fMRI|fmri
504251|NCT00209040|PTSD|ptsd
504252|NCT00209040|Acoustic startle|acoustic startle
504253|NCT00209066|Major Depressive Disorder|major depressive disorder
504254|NCT00209066|Electroconvulsive Therapy|electroconvulsive therapy
504255|NCT00209066|Platelet Activation|platelet activation
504256|NCT00209079|Gastric Adenocarcinoma|gastric adenocarcinoma
504257|NCT00209092|Breast Cancer|breast cancer
504258|NCT00209105|Child Abuse|child abuse
504259|NCT00209105|Hypothalamic-Pituitary-Adrenal Axis|hypothalamic-pituitary-adrenal axis
504572|NCT00216762|Hives|hives
504260|NCT00209105|Brain Imaging|brain imaging
504261|NCT00209105|Depression|depression
504262|NCT00209118|Hepatitis C|hepatitis c
504263|NCT00209118|Interferon-alpha associated side effects|interferon-alpha associated side effects
504264|NCT00209118|Antidepressants|antidepressants
504265|NCT00209118|Prevention|prevention
504266|NCT00209131|urolithiasis|urolithiasis
504267|NCT00209144|Inflammation|inflammation
504268|NCT00209144|Thrombosis|thrombosis
504269|NCT00209144|Hyperglycemia|hyperglycemia
504270|NCT00209144|Myocardial Infarction|myocardial infarction
504271|NCT00209144|Angioplasty|angioplasty
504272|NCT00209196|pediatric|pediatric
504273|NCT00209196|transplantation|transplantation
504274|NCT00209196|psychosocial|psychosocial
504275|NCT00209196|kidney transplant recipient|kidney transplant recipient
504276|NCT00209196|liver transplant recipient|liver transplant recipient
504277|NCT00209196|heart transplant recipient|heart transplant recipient
504278|NCT00209196|lung transplant recipient|lung transplant recipient
504279|NCT00209196|heart-lung transplant recipient|heart-lung transplant recipient
504280|NCT00209209|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
504281|NCT00209209|Elderly patients|elderly patients
504282|NCT00209209|Chemotherapy|chemotherapy
504283|NCT00209209|Maintenance therapy|maintenance therapy
504284|NCT00209209|C04.557.386.480.300.725.500|c04.557.386.480.300.725.500
504285|NCT00209209|C15.604.515.569.480.300.725.500|c15.604.515.569.480.300.725.500
504286|NCT00209209|C20.683.515.761.480.300.725.500|c20.683.515.761.480.300.725.500
504287|NCT00209222|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
504288|NCT00209222|younger patients|younger patients
504289|NCT00209222|chemotherapy|chemotherapy
504290|NCT00209222|high dose therapy|high dose therapy
504291|NCT00209222|C04.557.386.480.300.725.500|c04.557.386.480.300.725.500
504292|NCT00209222|C15.604.515.569.480.300.725.500|c15.604.515.569.480.300.725.500
504293|NCT00209222|C20.683.515.761.480.300.725.500|c20.683.515.761.480.300.725.500
504294|NCT00209235|Pseudohypoparathyroidism Type 1A (PHP 1A)|pseudohypoparathyroidism type 1a (php 1a)
504295|NCT00209235|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
504296|NCT00209235|Growth Hormone Deficiency|growth hormone deficiency
504297|NCT00209274|Mitral Valve Insufficiency|mitral valve insufficiency
504298|NCT00209274|Mitral Valve Regurgitation|mitral valve regurgitation
504299|NCT00209274|Mitral Valve Incompetence|mitral valve incompetence
504300|NCT00209274|Mitral Regurgitation|mitral regurgitation
504301|NCT00209274|Mitral Insufficiency|mitral insufficiency
504302|NCT00209274|Mitral Valve|mitral valve
504304|NCT00209274|Mitral Valve Prolapse|mitral valve prolapse
504305|NCT00209274|Edge to Edge (E2E)|edge to edge (e2e)
504306|NCT00209274|Alfieri Technique|alfieri technique
504307|NCT00209274|MitraClip|mitraclip
504308|NCT00209274|Functional MR|functional mr
504309|NCT00209274|Degenerative MR|degenerative mr
504310|NCT00209274|Echocardiogram|echocardiogram
504311|NCT00209274|CAD - Coronary Artery Disease|cad - coronary artery disease
504312|NCT00209274|Heart Failure|heart failure
504313|NCT00209274|Heart Attack|heart attack
504314|NCT00209274|EVEREST|everest
504315|NCT00209274|EVEREST I|everest i
504316|NCT00209274|EVEREST II|everest ii
504317|NCT00209274|REALISM|realism
752458|NCT01173081|Jones fracture|jones fracture
504318|NCT00209287|Ulcerative Colitis for Maintenance of Remission|ulcerative colitis for maintenance of remission
504319|NCT00209300|Ulcerative Colitis for Maintenance of Remission|ulcerative colitis for maintenance of remission
504320|NCT00209313|HIV-1|hiv-1
504321|NCT00209313|HSV-2|hsv-2
504322|NCT00209313|Coinfection|coinfection
504323|NCT00209313|Africa|africa
504324|NCT00209313|Cameroon|cameroon
504325|NCT00214929|Pulmonary Embolism|pulmonary embolism
504326|NCT00214929|Therapy|therapy
504327|NCT00214929|Home Nursing|home nursing
504328|NCT00214929|Economics|economics
504329|NCT00214981|ADHD|adhd
504330|NCT00214981|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
504331|NCT00215020|Isoprostanes|isoprostanes
504332|NCT00215033|Epstein-Barr virus|epstein-barr virus
504333|NCT00215033|pediatric health|pediatric health
504334|NCT00215033|cardiac|cardiac
504335|NCT00215033|heart transplant|heart transplant
504336|NCT00215033|lymphoproliferative disease|lymphoproliferative disease
504337|NCT00215033|post-transplant|post-transplant
504338|NCT00215033|pediatric transplant|pediatric transplant
504339|NCT00215046|vinblastine|vinblastine
504340|NCT00215046|methotrexate|methotrexate
504341|NCT00215059|angiogenic related growth factor|angiogenic related growth factor
504342|NCT00215072|Death after heart surgery|death after heart surgery
504343|NCT00215072|surgical mortality|surgical mortality
504344|NCT00215072|post-operative mortality|post-operative mortality
504345|NCT00215072|pediatric health|pediatric health
504346|NCT00215072|cardiac|cardiac
504347|NCT00215085|pediatric health|pediatric health
504348|NCT00215085|cardiac|cardiac
504349|NCT00215085|cardiac tumor|cardiac tumor
504350|NCT00215085|children|children
504351|NCT00215098|pediatric health|pediatric health
504352|NCT00215098|cardiac|cardiac
504353|NCT00215098|congenital heart surgery|congenital heart surgery
504354|NCT00215098|post-operative chylous effusions|post-operative chylous effusions
504573|NCT00216788|Sucrose|sucrose
504355|NCT00215098|heart defects|heart defects
504356|NCT00215098|children|children
504357|NCT00215111|childhood obesity|childhood obesity
504358|NCT00215111|weight management|weight management
504359|NCT00215111|dietary interventions|dietary interventions
504360|NCT00215111|cardiovascular disease risk factors|cardiovascular disease risk factors
504361|NCT00215137|OCD|ocd
504362|NCT00215137|SSRI|ssri
504363|NCT00215137|escitalopram|escitalopram
504364|NCT00215137|relapse|relapse
504365|NCT00215150|anxiety disorder|anxiety disorder
504366|NCT00215150|SAD|sad
504367|NCT00215150|ziprasidone|ziprasidone
504368|NCT00215150|sertraline|sertraline
504369|NCT00215150|antidepressant|antidepressant
504370|NCT00215150|antipsychotic|antipsychotic
504371|NCT00215163|PTSD|ptsd
504372|NCT00215163|Anxiety|anxiety
504373|NCT00215163|CBT|cbt
504374|NCT00215163|Exposure|exposure
504375|NCT00215163|Paroxetine|paroxetine
504376|NCT00215163|Paroxetine-CR|paroxetine-cr
504377|NCT00215176|atypical depression|atypical depression
504378|NCT00215176|psychostimulants|psychostimulants
504379|NCT00215176|modafinil|modafinil
504380|NCT00215189|health|health
504381|NCT00215189|mental illness|mental illness
504382|NCT00215189|fitness|fitness
504383|NCT00215202|Adrenocortical Cancer|adrenocortical cancer
504384|NCT00215202|Iressa|iressa
504385|NCT00215202|Adrenal Cancer|adrenal cancer
504386|NCT00215215|Vagus Nerve Stimulation Therapy|vagus nerve stimulation therapy
504387|NCT00215215|Epilepsies, Partial|epilepsies, partial
504388|NCT00215215|Seizures|seizures
504389|NCT00215215|Antiepileptic Drugs|antiepileptic drugs
504390|NCT00215215|Refractory Partial Seizures|refractory partial seizures
504391|NCT00215241|PTSD|ptsd
504392|NCT00215241|sertraline|sertraline
504393|NCT00215241|risperidone|risperidone
504394|NCT00215241|antidepressant|antidepressant
504395|NCT00215241|antipsychotic|antipsychotic
504396|NCT00215241|anxiety|anxiety
504397|NCT00215241|trauma|trauma
504398|NCT00215254|quetiapine|quetiapine
504399|NCT00215254|social anxiety disorder|social anxiety disorder
504400|NCT00215254|antipsychotic|antipsychotic
504401|NCT00215254|pilot study|pilot study
504402|NCT00215891|Treatment Experienced|treatment experienced
504403|NCT00215917|Schizophrenia|schizophrenia
504404|NCT00215917|NMDA|nmda
504405|NCT00215917|D-serine|d-serine
504406|NCT00215930|malignant pleural effusion|malignant pleural effusion
504407|NCT00215943|hematologic malignancy|hematologic malignancy
504408|NCT00215956|Topotecan|topotecan
504409|NCT00215956|Rectal Neoplasms|rectal neoplasms
504410|NCT00215956|Radiosensitizing|radiosensitizing
504411|NCT00215969|Pre-eclampsia|pre-eclampsia
504412|NCT00215969|Pregnancy|pregnancy
504413|NCT00215969|Hypercoagulation|hypercoagulation
504414|NCT00215969|Screening|screening
504415|NCT00215969|Cardiovascular complications|cardiovascular complications
504416|NCT00215982|advanced|advanced
504417|NCT00215982|colon|colon
504418|NCT00215982|rectal|rectal
504419|NCT00215995|esophageal cancer|esophageal cancer
504420|NCT00215995|esophagogastric cancer|esophagogastric cancer
504421|NCT00215995|gastric cancer|gastric cancer
650096|NCT00776243|GIP|gip
504422|NCT00216021|Breast Cancer|breast cancer
504423|NCT00216034|Gastric Cancer|gastric cancer
504424|NCT00216034|TS-1|ts-1
504426|NCT00216034|Disease-free survival|disease-free survival
504427|NCT00216034|Overall survival|overall survival
504428|NCT00216047|Breast Cancer|breast cancer
504429|NCT00216073|Breast Cancer|breast cancer
504430|NCT00216086|Rectal Cancer|rectal cancer
504431|NCT00216099|Prostate Cancer|prostate cancer
504432|NCT00216112|Ovarian Cancer|ovarian cancer
504433|NCT00216125|Non-Small Cell Lung Cancer|non-small cell lung cancer
504434|NCT00216138|Head and Neck Cancer|head and neck cancer
504435|NCT00216151|Multiple Myeloma|multiple myeloma
504436|NCT00216151|Bisphosphonates|bisphosphonates
504437|NCT00216164|Lymphoma|lymphoma
504438|NCT00216190|Sedation, ICU, Anesthesia, Dexmedetomidine, Midazolam|sedation, icu, anesthesia, dexmedetomidine, midazolam
504439|NCT00216203|Non-Small Cell Lung Cancer|non-small cell lung cancer
504440|NCT00216229|combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
504441|NCT00216229|hepatitis B virus|hepatitis b virus
504442|NCT00216229|immunity|immunity
504443|NCT00216242|influenza|influenza
504444|NCT00216242|vaccine|vaccine
504445|NCT00216242|efficacy|efficacy
504446|NCT00216242|safety|safety
504447|NCT00216242|immunogenicity|immunogenicity
504448|NCT00216255|Persistent Developmental Stuttering|persistent developmental stuttering
504449|NCT00216281|Schizophrenia|schizophrenia
504450|NCT00216281|Clozapine|clozapine
504451|NCT00216281|Atomoxetine|atomoxetine
504452|NCT00216294|Obsessive Compulsive Disorder|obsessive compulsive disorder
504453|NCT00216294|RG 1068 (Synthetic Human Secretin)|rg 1068 (synthetic human secretin)
504454|NCT00216320|electrical stimulation|electrical stimulation
504455|NCT00216333|tuberculosis|tuberculosis
504456|NCT00216333|fixed dose combination|fixed dose combination
504457|NCT00216333|DOT|dot
504458|NCT00216333|shot-course chemotherapy|shot-course chemotherapy
504840|NCT00206401|Adolescents|adolescents
504459|NCT00216359|Treatment Experienced|treatment experienced
504460|NCT00216372|carcinomatosis|carcinomatosis
504461|NCT00216385|Tuberculosis|tuberculosis
504462|NCT00216385|Treatment|treatment
504463|NCT00216385|Quinolone|quinolone
504464|NCT00216385|Short course chemotherapy|short course chemotherapy
504465|NCT00216398|acromegaly|acromegaly
504466|NCT00216398|growth hormone|growth hormone
504467|NCT00216424|Colon cancer|colon cancer
504468|NCT00216424|Rectal cancer|rectal cancer
504469|NCT00216437|Liver cancer|liver cancer
504470|NCT00216450|rabeprazole|rabeprazole
504471|NCT00216450|proton pump inhibitor|proton pump inhibitor
504472|NCT00216450|Helicobacter infections|helicobacter infections
504473|NCT00216450|Helicobacter pylori|helicobacter pylori
504474|NCT00216450|H pylori|h pylori
504475|NCT00216450|bacterial infections|bacterial infections
504476|NCT00216463|LDL-cholesterol|ldl-cholesterol
504477|NCT00216463|apoB-100|apob-100
504478|NCT00216463|apoB-48|apob-48
504479|NCT00216476|Schizophrenia, relapse prevention|schizophrenia, relapse prevention
504480|NCT00216476|Antipsychotic agents|antipsychotic agents
504481|NCT00216476|Long-acting risperidone|long-acting risperidone
504482|NCT00216476|Quetiapine|quetiapine
504483|NCT00216476|Aripiprazole|aripiprazole
504484|NCT00216489|gastroesophageal reflux|gastroesophageal reflux
504485|NCT00216489|heartburn|heartburn
504486|NCT00216489|rabeprazole|rabeprazole
504487|NCT00216489|GERD|gerd
504488|NCT00216489|anti-ulcer agents|anti-ulcer agents
504489|NCT00216489|proton pump inhibitor|proton pump inhibitor
504490|NCT00216502|Alzheimer's disease|alzheimer's disease
504491|NCT00216502|Dementia|dementia
504496|NCT00216502|Memory loss|memory loss
504497|NCT00216515|Alzheimer's disease|alzheimer's disease
504502|NCT00216528|risperidone|risperidone
504503|NCT00216528|Intramuscular injection, long-acting risperidone|intramuscular injection, long-acting risperidone
504504|NCT00216541|Anemia|anemia
504505|NCT00216541|cancer|cancer
504506|NCT00216541|transfusion|transfusion
504507|NCT00216541|chemotherapy|chemotherapy
504508|NCT00216541|hemoglobin|hemoglobin
504509|NCT00216541|standard care|standard care
504510|NCT00216541|epoetin alfa|epoetin alfa
504511|NCT00216541|epoetin|epoetin
504512|NCT00216541|erythropoietin|erythropoietin
504513|NCT00216554|Bipolar|bipolar
504514|NCT00216554|risperidone|risperidone
504515|NCT00216554|Adjunctive therapy|adjunctive therapy
504516|NCT00216567|Benign rolandic epilepsy|benign rolandic epilepsy
504517|NCT00216567|Topiramate|topiramate
504518|NCT00216580|Schizophrenia|schizophrenia
504519|NCT00216580|Intramuscular injection|intramuscular injection
504520|NCT00216580|Antipsychotic agents|antipsychotic agents
504521|NCT00216580|Long-acting risperidone|long-acting risperidone
504522|NCT00216580|Schizophreniform disorders|schizophreniform disorders
504523|NCT00216580|Schizoaffective disorder|schizoaffective disorder
504524|NCT00216593|dementia|dementia
504525|NCT00216593|cognition function|cognition function
504526|NCT00216593|Alzheimer disease|alzheimer disease
504527|NCT00216593|behavioral symptoms|behavioral symptoms
504528|NCT00216593|galantamine hydrobromide|galantamine hydrobromide
504529|NCT00216606|Chronic migraine|chronic migraine
504530|NCT00216606|Migraine|migraine
504531|NCT00216606|Headache|headache
504532|NCT00216606|Migraine headache|migraine headache
504533|NCT00216606|Topiramate|topiramate
504534|NCT00216619|chronic migraine|chronic migraine
504535|NCT00216619|Topiramate|topiramate
504536|NCT00216619|migraine|migraine
504537|NCT00216619|headache|headache
504538|NCT00216619|chronic headache|chronic headache
504539|NCT00216632|Schizophrenia, Schizoaffective disorder|schizophrenia, schizoaffective disorder
504540|NCT00216632|antipsychotic agents|antipsychotic agents
504541|NCT00216632|long-acting risperidone|long-acting risperidone
504542|NCT00216632|intramuscular injection|intramuscular injection
504543|NCT00216645|Müllerian Carcinoma|müllerian carcinoma
504544|NCT00216645|Doxil|doxil
504545|NCT00216645|Japanese Patients|japanese patients
504546|NCT00216658|Fentanyl|fentanyl
504547|NCT00216658|Cancer pain|cancer pain
504548|NCT00216658|Japanese patients|japanese patients
504549|NCT00216671|Schizophrenia|schizophrenia
504550|NCT00216671|intramuscular injection|intramuscular injection
504551|NCT00216671|antipsychotic agents|antipsychotic agents
504552|NCT00216671|long-acting risperidone|long-acting risperidone
504553|NCT00216684|Fentanyl, Chronic intractable pain, Japanese patients|fentanyl, chronic intractable pain, japanese patients
504554|NCT00216697|Multiple myeloma|multiple myeloma
504555|NCT00216697|Proteasome inhibitor|proteasome inhibitor
504556|NCT00216697|Ubiquitin|ubiquitin
504557|NCT00216697|Boronic acids|boronic acids
504558|NCT00216697|Bortezomib|bortezomib
504563|NCT00216723|Aripiprazole|aripiprazole
504564|NCT00216723|Schizophrenia|schizophrenia
504565|NCT00216723|Bipolar Disorder|bipolar disorder
504566|NCT00216736|Migraine|migraine
504567|NCT00216736|Headache|headache
504568|NCT00216736|Rebound headache|rebound headache
504569|NCT00216749|Cerebral Infarction Prevention|cerebral infarction prevention
504570|NCT00216749|Cilostazol|cilostazol
504571|NCT00216762|Urticaria|urticaria
504574|NCT00216788|Barrett's esophagus|barrett's esophagus
504575|NCT00216788|Esophagitis|esophagitis
504576|NCT00216788|GERD|gerd
504577|NCT00216788|Reflux|reflux
504578|NCT00216788|Esophagus|esophagus
504579|NCT00216788|Esomeprazole|esomeprazole
504580|NCT00216801|Upper Tract Transitional Cell (TCC)|upper tract transitional cell (tcc)
504581|NCT00216814|antiangiogenic effects of bcg treatment and prognosis|antiangiogenic effects of bcg treatment and prognosis
504582|NCT00216866|Embolism|embolism
504583|NCT00216866|Thrombosis|thrombosis
504584|NCT00216905|Patients with alcoholism according to ICD-10 after detoxification|patients with alcoholism according to icd-10 after detoxification
504585|NCT00216944|Intubation|intubation
504586|NCT00216944|premedication|premedication
504587|NCT00216970|parenteral nutrition|parenteral nutrition
504588|NCT00216970|burn injury|burn injury
504589|NCT00216970|stable isotopes|stable isotopes
504590|NCT00216970|Arginine Metabolic Kinetics|arginine metabolic kinetics
504591|NCT00216970|Nitric Oxide Formation|nitric oxide formation
504873|NCT00206518|Breast|breast
504592|NCT00216970|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
504593|NCT00216983|parenteral nutrition|parenteral nutrition
504594|NCT00216983|burn injury|burn injury
504595|NCT00216983|stable isotopes|stable isotopes
504492|NCT00216502|galantamine|galantamine
504596|NCT00216983|Proline Metabolic Kinetics|proline metabolic kinetics
504597|NCT00216983|Ornithine Metabolic Kinetics|ornithine metabolic kinetics
504598|NCT00216983|Glutamate Metabolic Kinetics|glutamate metabolic kinetics
504599|NCT00216983|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
504600|NCT00216996|parenteral nutrition|parenteral nutrition
504601|NCT00216996|burn injury|burn injury
504602|NCT00216996|stable isotopes|stable isotopes
504603|NCT00216996|Glutamate Metabolic Kinetics|glutamate metabolic kinetics
504604|NCT00216996|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
504605|NCT00217022|Lymphocytic Colitis|lymphocytic colitis
504606|NCT00217022|diarrhea|diarrhea
504607|NCT00217022|budesonide|budesonide
583309|NCT00511238|refractory|refractory
504608|NCT00217035|parenteral nutrition|parenteral nutrition
504609|NCT00217035|burn injury|burn injury
504610|NCT00217035|stable isotopes|stable isotopes
504611|NCT00217035|Proline Metabolic Kinetics|proline metabolic kinetics
504612|NCT00217035|Ornithine Metabolic Kinetics|ornithine metabolic kinetics
504613|NCT00217035|Glutamate Metabolic Kinetics|glutamate metabolic kinetics
504614|NCT00217035|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
504615|NCT00217139|Hepatitis C|hepatitis c
504616|NCT00217139|Celgosivir|celgosivir
504617|NCT00217139|HCV|hcv
504618|NCT00217139|Genotype 1|genotype 1
504619|NCT00217139|Non-responders|non-responders
504620|NCT00217139|Early Viral Response|early viral response
504621|NCT00217139|EVR|evr
504622|NCT00217152|Kidney Transplant|kidney transplant
504623|NCT00217165|bipolar|bipolar
504624|NCT00217165|mania|mania
504625|NCT00217165|depression|depression
504626|NCT00217165|taurine|taurine
504627|NCT00217165|alternative|alternative
650262|NCT00777075|NOS|nos
503937|NCT00207506|Latino|latino
504628|NCT00217178|Atherosclerosis|atherosclerosis
504629|NCT00217178|CV Risk Factors|cv risk factors
504630|NCT00217178|Homocysteine|homocysteine
504631|NCT00217178|CV disease|cv disease
504632|NCT00217178|Cardiovascular disease|cardiovascular disease
504633|NCT00217191|Premature Infants|premature infants
504634|NCT00217191|Patent ductus arteriosus|patent ductus arteriosus
504635|NCT00217191|Renal function|renal function
504636|NCT00217191|Ibuprofen|ibuprofen
504637|NCT00217204|Cystic fibrosis|cystic fibrosis
504638|NCT00217204|Pancreatic insufficiency|pancreatic insufficiency
504639|NCT00217204|Steatorrhea|steatorrhea
504640|NCT00217204|Fat malabsorption|fat malabsorption
504641|NCT00217204|Pancrelipase|pancrelipase
504642|NCT00217217|non-pharmaceutical|non-pharmaceutical
504643|NCT00217217|alternative|alternative
504644|NCT00217217|imaging|imaging
504645|NCT00217217|magnetic resonance imaging|magnetic resonance imaging
504646|NCT00217217|low field magnetic stimulation|low field magnetic stimulation
504647|NCT00217217|bipolar disorder|bipolar disorder
504648|NCT00217217|depression|depression
504649|NCT00217217|bipolar depression|bipolar depression
504650|NCT00217243|Pain|pain
504651|NCT00217243|Magnetoencephalography|magnetoencephalography
504652|NCT00217243|Median|median
504653|NCT00217243|Ulnar|ulnar
504654|NCT00217243|Causalgia|causalgia
504655|NCT00217243|Complex regional pain syndrome|complex regional pain syndrome
504656|NCT00217243|Evoked fields|evoked fields
504657|NCT00217243|Nerve injury|nerve injury
504658|NCT00217243|Neuropathic pain|neuropathic pain
504659|NCT00217256|Restenosis|restenosis
504660|NCT00217269|Restenosis|restenosis
504661|NCT00217295|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
504662|NCT00217295|Brain atrophy|brain atrophy
504663|NCT00217295|Disease progression|disease progression
504664|NCT00217321|Parkinson's disease|parkinson's disease
504665|NCT00217321|Parkinson disease|parkinson disease
504666|NCT00217321|Registry|registry
504667|NCT00217321|quality of life|quality of life
504668|NCT00217321|database|database
504669|NCT00217334|Hypertension|hypertension
504670|NCT00217334|Cardiovascular diseases|cardiovascular diseases
504671|NCT00217334|Randomized controlled trial|randomized controlled trial
504672|NCT00217334|Cluster randomization|cluster randomization
504673|NCT00217334|Primary care|primary care
504674|NCT00217347|Gastroesophageal reflux|gastroesophageal reflux
504675|NCT00217347|Dyspepsia|dyspepsia
504676|NCT00217347|Esophageal Capsule Endoscopy|esophageal capsule endoscopy
504677|NCT00217386|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
504678|NCT00217386|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
504679|NCT00217386|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
504680|NCT00217386|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
504681|NCT00217386|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
504682|NCT00217425|anaplastic large cell lymphoma|anaplastic large cell lymphoma
504683|NCT00217425|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
504684|NCT00217425|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
504685|NCT00217425|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
504874|NCT00206518|Cancer|cancer
504686|NCT00217425|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
504687|NCT00217425|peripheral T-cell lymphoma|peripheral t-cell lymphoma
504688|NCT00217451|Malaria|malaria
504689|NCT00217451|Fosmidomycin|fosmidomycin
504690|NCT00217451|Clindamycin|clindamycin
504691|NCT00217451|Gabon|gabon
504692|NCT00217464|adenocarcinoma of the prostate|adenocarcinoma of the prostate
504693|NCT00217464|recurrent prostate cancer|recurrent prostate cancer
504694|NCT00217477|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
504695|NCT00217490|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
504696|NCT00217503|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
504697|NCT00217516|adenocarcinoma of the prostate|adenocarcinoma of the prostate
504698|NCT00217516|stage I prostate cancer|stage i prostate cancer
583310|NCT00511251|IS-SEM|is-sem
504699|NCT00217516|stage II prostate cancer|stage ii prostate cancer
504700|NCT00217529|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
504701|NCT00217529|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
504702|NCT00217529|peritoneal cavity cancer|peritoneal cavity cancer
504703|NCT00217529|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
504704|NCT00217529|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
504705|NCT00217529|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
504706|NCT00217529|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
504707|NCT00217529|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
504708|NCT00217529|Brenner tumor|brenner tumor
504709|NCT00217529|fallopian tube cancer|fallopian tube cancer
650371|NCT00777452|FACT-P|fact-p
504021|NCT00207922|T-cell|t-cell
504710|NCT00217529|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
504711|NCT00217555|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
504712|NCT00217555|fallopian tube cancer|fallopian tube cancer
504713|NCT00217555|peritoneal cavity cancer|peritoneal cavity cancer
504714|NCT00217568|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
504715|NCT00217568|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
504716|NCT00217568|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
504717|NCT00217568|peritoneal cavity cancer|peritoneal cavity cancer
504718|NCT00217581|recurrent gastric cancer|recurrent gastric cancer
504719|NCT00217581|stage III gastric cancer|stage iii gastric cancer
504720|NCT00217581|stage IV gastric cancer|stage iv gastric cancer
504721|NCT00217581|recurrent esophageal cancer|recurrent esophageal cancer
504722|NCT00217581|stage III esophageal cancer|stage iii esophageal cancer
504723|NCT00217581|stage IV esophageal cancer|stage iv esophageal cancer
504724|NCT00217581|adenocarcinoma of the stomach|adenocarcinoma of the stomach
504725|NCT00217594|Immunosuppression|immunosuppression
504726|NCT00217594|T Cells|t cells
504727|NCT00217594|Hematopoiesis|hematopoiesis
504728|NCT00217594|Anti-CD52|anti-cd52
504729|NCT00217594|Monoclonal Antibody Therapy|monoclonal antibody therapy
504730|NCT00217607|adult angiosarcoma|adult angiosarcoma
504731|NCT00217607|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
504732|NCT00217607|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
504733|NCT00217607|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
504734|NCT00217620|adult angiosarcoma|adult angiosarcoma
504735|NCT00217620|adult leiomyosarcoma|adult leiomyosarcoma
504736|NCT00217620|adult liposarcoma|adult liposarcoma
504737|NCT00217620|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
504738|NCT00217620|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
504739|NCT00217620|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
504740|NCT00217620|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
504741|NCT00217659|male breast cancer|male breast cancer
504742|NCT00217659|recurrent breast cancer|recurrent breast cancer
504743|NCT00217659|stage IV breast cancer|stage iv breast cancer
504744|NCT00217672|stage IV breast cancer|stage iv breast cancer
504841|NCT00206401|Lantus|lantus
504745|NCT00217672|recurrent breast cancer|recurrent breast cancer
504746|NCT00217698|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
504747|NCT00217698|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
504748|NCT00217698|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
504749|NCT00217698|adenocarcinoma of the lung|adenocarcinoma of the lung
504750|NCT00217698|large cell lung cancer|large cell lung cancer
504751|NCT00217698|squamous cell lung cancer|squamous cell lung cancer
504752|NCT00217711|stage III colon cancer|stage iii colon cancer
504753|NCT00217711|stage IV colon cancer|stage iv colon cancer
504754|NCT00217711|stage III rectal cancer|stage iii rectal cancer
504755|NCT00217711|stage IV rectal cancer|stage iv rectal cancer
504756|NCT00217724|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
504757|NCT00217724|pain|pain
504758|NCT00217763|Dementia|dementia
504759|NCT00217763|Alzheimer's disease|alzheimer's disease
504760|NCT00217841|MRSA|mrsa
504761|NCT00217854|asthma, corticosteroids|asthma, corticosteroids
504762|NCT00217932|Behavioral Disorders|behavioral disorders
504763|NCT00217971|cannabis dependence|cannabis dependence
504764|NCT00217971|dronabinol|dronabinol
504765|NCT00217971|treatment|treatment
504766|NCT00217984|Tobacco use disorder|tobacco use disorder
504767|NCT00217984|Alcohol dependence|alcohol dependence
504768|NCT00217997|cocaine abuse|cocaine abuse
504769|NCT00217997|Cocaine-Related Disorders|cocaine-related disorders
504770|NCT00218010|methadone|methadone
504771|NCT00218010|lactation|lactation
504772|NCT00218010|breastfeeding|breastfeeding
504773|NCT00218010|maternal opioid dependency|maternal opioid dependency
504774|NCT00218023|cocaine|cocaine
504775|NCT00218023|cocaine addiction|cocaine addiction
504776|NCT00218023|cocaine abuse|cocaine abuse
504777|NCT00218023|relapse prevention|relapse prevention
504778|NCT00218036|Cocaine Abuse|cocaine abuse
504779|NCT00218036|Opiate Abuse|opiate abuse
504780|NCT00218075|Cocaine addiction|cocaine addiction
504781|NCT00218075|cocaine treatment|cocaine treatment
504782|NCT00218101|opioid dependence|opioid dependence
583311|NCT00511264|Laparoscopy|laparoscopy
504783|NCT00218114|ADHD, disruptive behavior disorder, marijuana abuse|adhd, disruptive behavior disorder, marijuana abuse
504784|NCT00218127|Heroin dependence|heroin dependence
504785|NCT00218140|tobacco|tobacco
504786|NCT00218153|nicotine dependence|nicotine dependence
504787|NCT00218166|cocaine|cocaine
504788|NCT00218166|tiagabine|tiagabine
504789|NCT00218166|baclofen|baclofen
504790|NCT00218179|Lung Cancer|lung cancer
504791|NCT00218179|Cotinine|cotinine
504792|NCT00218179|NNAL|nnal
504793|NCT00218179|Carcinogens|carcinogens
504794|NCT00218179|Case-control|case-control
504795|NCT00218179|SNPs|snps
504796|NCT00218192|hepatitis c|hepatitis c
504797|NCT00218192|injection drug use|injection drug use
504798|NCT00218205|Epirubicin|epirubicin
504799|NCT00218205|Estramustine Phosphate|estramustine phosphate
504800|NCT00218205|Celecoxib|celecoxib
504801|NCT00218205|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
504802|NCT00218218|Nicotine Dependence|nicotine dependence
504803|NCT00218218|Tobacco Dependence|tobacco dependence
504804|NCT00218231|schizophrenia|schizophrenia
504805|NCT00218231|tobacco dependence|tobacco dependence
504806|NCT00218231|nicotine|nicotine
504807|NCT00218244|Brand Switching, smokeless tobacco use|brand switching, smokeless tobacco use
504808|NCT00218257|Cocaine|cocaine
504809|NCT00218270|Smokeless tobacco, harm reduction|smokeless tobacco, harm reduction
504810|NCT00218283|Nicotine Dependence|nicotine dependence
504811|NCT00218283|Tobacco Dependence|tobacco dependence
504812|NCT00218296|Nicotine Dependence|nicotine dependence
504813|NCT00218296|Tobacco Dependence|tobacco dependence
504814|NCT00218309|opiate dependence|opiate dependence
504815|NCT00218335|HIV prevention Intervention, injection drug user,peer-oriented, randomized controlled trial, social network|hiv prevention intervention, injection drug user,peer-oriented, randomized controlled trial, social network
504816|NCT00218348|Cocaine Abuse|cocaine abuse
504817|NCT00218348|Dextro-Amphetamine Sulfate|dextro-amphetamine sulfate
504818|NCT00218361|Behavioral economics|behavioral economics
504819|NCT00218361|Drug self administration|drug self administration
504820|NCT00218361|Opioid|opioid
504821|NCT00218374|Opiate Addiction|opiate addiction
504822|NCT00218374|Opiate Dependence|opiate dependence
504823|NCT00206349|Depression|depression
504824|NCT00206349|Socioeconomic status|socioeconomic status
504825|NCT00206349|Type 1 diabetes mellitus|type 1 diabetes mellitus
504826|NCT00206349|Children|children
504827|NCT00206349|Adolescents|adolescents
504828|NCT00206362|Depression|depression
504829|NCT00206362|Socioeconomic status|socioeconomic status
504830|NCT00206362|Type 1 diabetes mellitus|type 1 diabetes mellitus
504831|NCT00206362|Children|children
504832|NCT00206362|Adolescents|adolescents
504833|NCT00206375|Hypothyroidism|hypothyroidism
504834|NCT00206375|Growth hormone|growth hormone
504835|NCT00206388|NEUROBLASTOMA|neuroblastoma
504836|NCT00206388|RECURRENT|recurrent
504837|NCT00206388|REFRACTORY|refractory
504838|NCT00206388|CORTICAL|cortical
504839|NCT00206388|BONE|bone
504842|NCT00206414|HORMONE RECEPTOR POSITIVE BREAST CANCER|hormone receptor positive breast cancer
504843|NCT00206427|Advanced|advanced
504844|NCT00206427|Breast|breast
504845|NCT00206427|Cancer|cancer
504846|NCT00206427|Neoadjuvant|neoadjuvant
504847|NCT00206427|HER2|her2
504848|NCT00206440|chemotherapy|chemotherapy
504849|NCT00206440|nausea|nausea
504850|NCT00206440|vomiting|vomiting
504851|NCT00206440|breast cancer|breast cancer
504852|NCT00206453|Breast|breast
504853|NCT00206453|Cancer|cancer
504854|NCT00206453|Gene|gene
504855|NCT00206453|Expression|expression
504856|NCT00206453|Taxotere|taxotere
504857|NCT00206466|neoadjuvant|neoadjuvant
504858|NCT00206466|chemosensitivity|chemosensitivity
504859|NCT00206466|chemotherapy|chemotherapy
504860|NCT00206466|breast cancer|breast cancer
504861|NCT00206466|tumor|tumor
504862|NCT00206466|taxotere|taxotere
504863|NCT00206466|AC|ac
504864|NCT00206492|Breast|breast
504865|NCT00206492|Cancer|cancer
504866|NCT00206492|Neoadjuvant|neoadjuvant
504867|NCT00206492|HER2|her2
504868|NCT00206492|Overexpressing|overexpressing
504869|NCT00206505|Breast|breast
504870|NCT00206505|Cancer|cancer
504871|NCT00206505|Neoadjuvant|neoadjuvant
504872|NCT00206505|Taxotere|taxotere
504875|NCT00206518|Taxotere|taxotere
504876|NCT00206518|AC|ac
504877|NCT00206518|Validation|validation
504878|NCT00206518|Neoadjuvant|neoadjuvant
504879|NCT00206531|HIV-1|hiv-1
504880|NCT00206531|Naive T-cells|naive t-cells
504881|NCT00206531|CD31|cd31
504882|NCT00206531|Treatment Naive|treatment naive
504883|NCT00206544|Bipolar Affective Disorder|bipolar affective disorder
504884|NCT00206544|Mania|mania
504885|NCT00206544|Anti-Estrogen|anti-estrogen
504886|NCT00206544|Schizoaffective Disorder|schizoaffective disorder
504887|NCT00206544|Mood|mood
504888|NCT00206557|Schizophrenia|schizophrenia
504889|NCT00206557|Mental Illness|mental illness
504890|NCT00206557|Hormone Therapy|hormone therapy
504891|NCT00206557|Post-menopausal|post-menopausal
504892|NCT00206557|SERM|serm
504893|NCT00206557|Raloxifene|raloxifene
504894|NCT00206570|Schizophrenia|schizophrenia
504895|NCT00206570|Gender differences|gender differences
504896|NCT00206570|Hormones|hormones
504897|NCT00206570|Estradiol|estradiol
504898|NCT00206570|PANSS|panss
504899|NCT00206609|Cancer|cancer
504900|NCT00206609|palliative care|palliative care
504901|NCT00206609|dyspnoea|dyspnoea
504902|NCT00206609|oxygen|oxygen
504903|NCT00206661|Crohn Disease|crohn disease
504234|NCT00208897|CRF|crf
504904|NCT00206674|Morbus Crohn|morbus crohn
504905|NCT00206674|Sargramostim|sargramostim
504906|NCT00206674|Phase III|phase iii
504907|NCT00206674|Placebo Controlled|placebo controlled
504908|NCT00206713|Crohn Disease|crohn disease
504909|NCT00206739|Malaria|malaria
504910|NCT00206739|Anemia|anemia
504911|NCT00206739|IPTi|ipti
504912|NCT00206739|Intermittent Preventive Treatment in Infants|intermittent preventive treatment in infants
504913|NCT00206739|Sulfadoxine-Pyrimethamine|sulfadoxine-pyrimethamine
504914|NCT00206739|Chemoprophylaxis|chemoprophylaxis
504915|NCT00206739|Ghana|ghana
504916|NCT00206765|panic|panic
504917|NCT00212173|Adolescent|adolescent
504918|NCT00212173|Weight Management|weight management
504919|NCT00212173|Obesity Treatment|obesity treatment
504920|NCT00212173|Behavioral Treatment|behavioral treatment
504921|NCT00212199|Obesity Treatment|obesity treatment
504922|NCT00212199|Effectiveness of weight management treatment|effectiveness of weight management treatment
504923|NCT00212199|Counseling for weight management|counseling for weight management
504924|NCT00212212|selenium supplements|selenium supplements
504925|NCT00212212|selenate|selenate
504926|NCT00212212|selenomethionine|selenomethionine
504927|NCT00212212|biomarkers|biomarkers
504928|NCT00212212|plasma selenium concentration|plasma selenium concentration
504929|NCT00212212|plasma glutathione peroxidase|plasma glutathione peroxidase
504930|NCT00212212|selenoprotein P|selenoprotein p
504931|NCT00212225|gastric disease|gastric disease
504932|NCT00212225|H. pylori|h. pylori
504933|NCT00212225|children|children
504934|NCT00212225|Helicobacter pylori|helicobacter pylori
504935|NCT00212225|child|child
504936|NCT00212225|epidemiology|epidemiology
504937|NCT00212238|obesity|obesity
504938|NCT00212238|weight loss|weight loss
504939|NCT00212238|Internet|internet
504940|NCT00212238|cognitive behavior therapy|cognitive behavior therapy
504941|NCT00212238|computer assisted patient care|computer assisted patient care
504942|NCT00212238|human therapy evaluation|human therapy evaluation
504943|NCT00212238|physical activity|physical activity
504944|NCT00212238|clinical trial|clinical trial
504945|NCT00212238|nutrient intake activity|nutrient intake activity
504946|NCT00212238|outcomes research|outcomes research
504947|NCT00212238|personal log /diary|personal log /diary
504948|NCT00212238|reinforcer|reinforcer
504949|NCT00212238|self care|self care
504950|NCT00212238|social support network|social support network
504951|NCT00212238|weight control|weight control
504952|NCT00212238|behavioral /social science research tag|behavioral /social science research tag
504953|NCT00212238|clinical research|clinical research
504954|NCT00212238|human subject|human subject
504955|NCT00212238|questionnaire|questionnaire
504956|NCT00212251|obesity|obesity
504957|NCT00212251|postpartum period|postpartum period
504958|NCT00212251|exercise|exercise
504959|NCT00212251|diet|diet
504960|NCT00212251|motivation|motivation
504961|NCT00212264|urinary incontinence|urinary incontinence
504962|NCT00212264|therapy|therapy
504963|NCT00212264|prostatectomy|prostatectomy
504964|NCT00212264|prostate cancer|prostate cancer
504965|NCT00212290|impaired glucose tolerance|impaired glucose tolerance
504966|NCT00212303|type 2 diabetes|type 2 diabetes
504967|NCT00212303|hypertension|hypertension
504968|NCT00212303|exercise training|exercise training
504969|NCT00212303|cardiac, peripheral|cardiac, peripheral
504970|NCT00212303|body composition|body composition
504971|NCT00212303|physical fitness|physical fitness
504972|NCT00212303|inflammation|inflammation
504973|NCT00212316|Huntington's Disease|huntington's disease
504974|NCT00212316|phenylbutyrate|phenylbutyrate
504975|NCT00212316|HDAC inhibitors|hdac inhibitors
504976|NCT00212316|transcription|transcription
504977|NCT00212329|Type 1 Diabetes|type 1 diabetes
504978|NCT00212329|Juvenile Onset Diabetes|juvenile onset diabetes
504979|NCT00212329|Insulin Dependent Diabetes|insulin dependent diabetes
504981|NCT00218413|Vaccine|vaccine
504982|NCT00218413|Immunogenicity|immunogenicity
504983|NCT00218413|Randomized Controlled Trial|randomized controlled trial
504984|NCT00218413|Addiction|addiction
504985|NCT00218439|Smoking|smoking
504986|NCT00218452|Tobacco use cessation|tobacco use cessation
504987|NCT00218465|Drugs, Investigational|drugs, investigational
504988|NCT00218465|Therapies for Relapse to Nicotine|therapies for relapse to nicotine
504989|NCT00218465|Relapse Prevention|relapse prevention
504990|NCT00218465|Nicotine Cessation Therapies|nicotine cessation therapies
504991|NCT00218465|Smoking Cessation|smoking cessation
504992|NCT00218465|Nicotine Dependence|nicotine dependence
504993|NCT00218517|cannabis use disorder|cannabis use disorder
504994|NCT00218543|ADHD|adhd
504995|NCT00218543|Cocaine Abuse|cocaine abuse
504996|NCT00218556|Hepatitis C, Depressive Symptoms|hepatitis c, depressive symptoms
504997|NCT00218569|Alcohol Dependence|alcohol dependence
504998|NCT00218569|Cocaine Dependence|cocaine dependence
504999|NCT00218582|12 step groups|12 step groups
505000|NCT00218582|self help|self help
504303|NCT00209274|MR|mr
505001|NCT00218582|psychiatric day treatment|psychiatric day treatment
505002|NCT00218582|co-occurring disorders|co-occurring disorders
505003|NCT00218582|dual diagnosis|dual diagnosis
505004|NCT00218608|Cocaine Abuse|cocaine abuse
505005|NCT00218621|Buprenorphine|buprenorphine
505006|NCT00218621|Methadone|methadone
505007|NCT00218673|HIV|hiv
505008|NCT00218673|injection drug use|injection drug use
505009|NCT00218673|social networks|social networks
505010|NCT00218686|HIV|hiv
505011|NCT00218686|injection drug use|injection drug use
505012|NCT00218686|social networks|social networks
505013|NCT00218699|HIV|hiv
505014|NCT00218699|MSM Men Who Have Sex with Men|msm men who have sex with men
505015|NCT00218699|Men Who Have Sex With Men|men who have sex with men
505016|NCT00218699|Cognitive-Behavioral|cognitive-behavioral
505017|NCT00218699|HIV Counseling and Testing|hiv counseling and testing
505018|NCT00218699|HIV Seronegativity|hiv seronegativity
505019|NCT00218712|HIV|hiv
505020|NCT00218712|AIDS|aids
505021|NCT00218712|MSM|msm
505022|NCT00218712|Cognitive-Behavioral|cognitive-behavioral
505023|NCT00218712|HIV Seronegativity|hiv seronegativity
505024|NCT00218725|Cognitive Therapy|cognitive therapy
505025|NCT00218725|Suicide|suicide
505026|NCT00218725|Addictions|addictions
505027|NCT00218725|Substance Abuse|substance abuse
505028|NCT00218751|Child abuse|child abuse
505029|NCT00218751|Neglect|neglect
505030|NCT00218751|Home Visitation|home visitation
505031|NCT00218751|Program Evaluation|program evaluation
505032|NCT00218777|Chronic tic disorder|chronic tic disorder
505033|NCT00218777|Motor tics|motor tics
505034|NCT00218777|Vocal tics|vocal tics
505035|NCT00221624|Hepatitis C, chronic|hepatitis c, chronic
505036|NCT00221624|HCV infection|hcv infection
505037|NCT00221624|Treatment failure|treatment failure
505038|NCT00221624|PEG Interferon|peg interferon
505039|NCT00221624|(Interferons/therapeutic use|(interferons/therapeutic use
505040|NCT00221624|Interferon Alfa-2a/adverse effects)|interferon alfa-2a/adverse effects)
505041|NCT00221624|ribavirin|ribavirin
505042|NCT00221624|(Ribavirin/therapeutic use|(ribavirin/therapeutic use
505043|NCT00221624|Ribavirin/adverse effects)|ribavirin/adverse effects)
505044|NCT00221624|Amantadine|amantadine
505045|NCT00221624|Drug Therapy, Combination|drug therapy, combination
505046|NCT00221637|Neuralgia|neuralgia
505047|NCT00221637|Valproate|valproate
505048|NCT00221637|Anticonvulsant Drugs|anticonvulsant drugs
505049|NCT00221637|Pain Measurement|pain measurement
505050|NCT00221637|Randomized Controlled Trials|randomized controlled trials
505051|NCT00221650|Hepatitis C, Chronic|hepatitis c, chronic
505052|NCT00221650|HCV infection|hcv infection
505053|NCT00221650|HIV infection|hiv infection
505054|NCT00221650|Treatment Failure|treatment failure
505055|NCT00221650|PEG interferon|peg interferon
505056|NCT00221650|Interferons/therapeutic use|interferons/therapeutic use
505057|NCT00221650|Interferon Alfa-2a/adverse effects|interferon alfa-2a/adverse effects
505058|NCT00221650|Ribavirin/therapeutic use|ribavirin/therapeutic use
505059|NCT00221650|Ribavirin/adverse effects|ribavirin/adverse effects
505060|NCT00221650|Drug Therapy, Combination|drug therapy, combination
505061|NCT00221650|Treatment Experienced|treatment experienced
505062|NCT00221650|Treatment Naive|treatment naive
505063|NCT00221663|Cardiac surgery|cardiac surgery
505064|NCT00221663|Aortic valve replacement|aortic valve replacement
505065|NCT00221663|Minimally invasive surgery|minimally invasive surgery
505066|NCT00221663|Perioperative course|perioperative course
505067|NCT00221676|influenza vaccine|influenza vaccine
505068|NCT00221676|general practitioner|general practitioner
505069|NCT00221689|Severe brain injury|severe brain injury
505070|NCT00221689|Coma|coma
505071|NCT00221689|Hypertonia|hypertonia
505072|NCT00221689|Dysautonomia|dysautonomia
505073|NCT00221689|Baclofen|baclofen
505074|NCT00221689|Randomized Controlled Trials|randomized controlled trials
505075|NCT00221702|Melanoma|melanoma
505076|NCT00221702|Neoplasm metastasis|neoplasm metastasis
505077|NCT00221702|Interferon alfa-2b|interferon alfa-2b
505078|NCT00221702|Adjuvants|adjuvants
505079|NCT00221702|Randomized clinical trial|randomized clinical trial
505080|NCT00221702|Disease-free survival time|disease-free survival time
505082|NCT00221702|Drug toxicity|drug toxicity
505083|NCT00221702|Quality of life|quality of life
505084|NCT00221715|arteritis|arteritis
505085|NCT00221715|lower limb ischemia|lower limb ischemia
505086|NCT00221715|femoropopliteal artery bypass|femoropopliteal artery bypass
505087|NCT00221715|blood vessel prothesis implantation|blood vessel prothesis implantation
505088|NCT00221715|saphenous vein|saphenous vein
505089|NCT00221715|vascular permeability|vascular permeability
505090|NCT00221715|doppler ultrasonography|doppler ultrasonography
505091|NCT00221715|randomized clinical trials|randomized clinical trials
505092|NCT00221715|efficacy study|efficacy study
505093|NCT00221728|Kidney Neoplasms|kidney neoplasms
505094|NCT00221728|Surgery|surgery
505095|NCT00221728|Catheter Ablation|catheter ablation
505096|NCT00221728|Randomized controlled trials|randomized controlled trials
505097|NCT00221728|Kidney Failure, Chronic|kidney failure, chronic
505098|NCT00221741|Heart surgery|heart surgery
505099|NCT00221741|Blood Loss, Surgical|blood loss, surgical
505100|NCT00221741|Mortality|mortality
505101|NCT00221741|Blood Transfusion|blood transfusion
505102|NCT00221741|Cohort Studies|cohort studies
505103|NCT00221754|HIV,|hiv,
505104|NCT00221754|protease inhibitors|protease inhibitors
505105|NCT00221754|pravastatin|pravastatin
505106|NCT00221754|Treatment Experienced|treatment experienced
505107|NCT00221767|Neurogenic bladder|neurogenic bladder
505108|NCT00221767|electric stimulation therapy|electric stimulation therapy
505109|NCT00221767|urinary tract infection|urinary tract infection
505110|NCT00221767|urinary incontinence|urinary incontinence
505111|NCT00221767|spinal cord injuries|spinal cord injuries
505112|NCT00221767|spinal nerve roots|spinal nerve roots
505113|NCT00221767|nonRandomized Controlled Trials|nonrandomized controlled trials
505114|NCT00221767|open Study|open study
505115|NCT00221780|Heart failure|heart failure
505116|NCT00221780|Cardiomyopathy, dilated|cardiomyopathy, dilated
505117|NCT00221780|Coronary disease|coronary disease
505118|NCT00221780|Cardiac Pacing, Artificial|cardiac pacing, artificial
505119|NCT00221780|Hemodynamics|hemodynamics
505120|NCT00221780|Randomized Controlled Trials|randomized controlled trials
505121|NCT00221780|Single-Blind Study|single-blind study
505122|NCT00221793|Parkinson|parkinson
505123|NCT00221793|deep subthalamic stimulation|deep subthalamic stimulation
505124|NCT00221793|pharmacological treatment|pharmacological treatment
505125|NCT00221806|Arteritis, femoro popliteal bypass, endothelialised prosthesis, saphenous vein graft, permeability, Doppler echography|arteritis, femoro popliteal bypass, endothelialised prosthesis, saphenous vein graft, permeability, doppler echography
505126|NCT00221819|Humidification|humidification
505127|NCT00221819|Heat and moisture exchanger|heat and moisture exchanger
505128|NCT00221819|Heated humidifier, non invasive ventilation|heated humidifier, non invasive ventilation
505129|NCT00221832|Long QT Syndrome|long qt syndrome
505130|NCT00221832|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
505131|NCT00221832|arrhythmogenic right ventricular dysplasia|arrhythmogenic right ventricular dysplasia
505132|NCT00221832|Short QT Syndrome|short qt syndrome
505133|NCT00221832|Brugada Syndrome|brugada syndrome
505134|NCT00221845|Ramipril|ramipril
505135|NCT00221845|Hypertension|hypertension
505136|NCT00221845|Chronic renal failure|chronic renal failure
505137|NCT00221845|Disease progression|disease progression
505138|NCT00221845|Left ventricular hypertrophy|left ventricular hypertrophy
505139|NCT00221845|Intima media thickness|intima media thickness
505140|NCT00221845|Cardiovascular disease|cardiovascular disease
505141|NCT00221845|Biomarkers|biomarkers
505142|NCT00221845|Gene polymorphisms|gene polymorphisms
505143|NCT00221897|Primary open angle glaucoma|primary open angle glaucoma
505737|NCT00215527|intrathecal|intrathecal
505144|NCT00221897|Glaucoma/pathology|glaucoma/pathology
505145|NCT00221897|Glaucoma/physiopathology|glaucoma/physiopathology
505146|NCT00221897|Nerve Fibers/pathology|nerve fibers/pathology
505147|NCT00221897|Risk factors glaucoma|risk factors glaucoma
505148|NCT00221923|Primary open angle glaucoma|primary open angle glaucoma
505149|NCT00221923|African American|african american
505150|NCT00221923|Glaucoma/pathology|glaucoma/pathology
505151|NCT00221923|Glaucoma/ physiopathology|glaucoma/ physiopathology
505152|NCT00221923|Nerve Fibers/pathology|nerve fibers/pathology
505153|NCT00221923|Risk factor glaucoma|risk factor glaucoma
505154|NCT00221962|ADHD|adhd
505155|NCT00221988|Elderly|elderly
505156|NCT00221988|Epilepsy|epilepsy
505157|NCT00221988|Cognition|cognition
505158|NCT00221988|Health Outcome|health outcome
505159|NCT00222014|Refractory ascites|refractory ascites
505160|NCT00222014|Cirrhosis|cirrhosis
505161|NCT00222014|Paracentesesis|paracentesesis
505162|NCT00222027|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
505163|NCT00222027|adult patient|adult patient
505164|NCT00222027|chemotherapy|chemotherapy
505165|NCT00222027|stem cell transplantation|stem cell transplantation
505166|NCT00222027|Young adult patients|young adult patients
505167|NCT00222040|Stroke|stroke
505168|NCT00222040|thrombolysis|thrombolysis
505169|NCT00222040|ultrasound|ultrasound
505170|NCT00222040|microbubbles|microbubbles
505171|NCT00222040|alteplase|alteplase
505173|NCT00222053|Autologous transplantation|autologous transplantation
505175|NCT00222053|Thalidomide|thalidomide
505176|NCT00222066|Aspiration|aspiration
505177|NCT00222066|Fetal ovarian cyst|fetal ovarian cyst
505178|NCT00222066|Ovarian torsion|ovarian torsion
505179|NCT00222092|post-ERCP pancreatitis|post-ercp pancreatitis
505180|NCT00222092|prophylaxis|prophylaxis
505181|NCT00222092|prognosis|prognosis
505182|NCT00222092|natural course|natural course
505183|NCT00222092|molecular markers|molecular markers
505184|NCT00222131|Epigastric Pain|epigastric pain
505185|NCT00222131|Non-Ulcer Dyspepsia (NUD)|non-ulcer dyspepsia (nud)
505186|NCT00222183|Lupus erythematodes|lupus erythematodes
505187|NCT00222183|Elidel|elidel
505188|NCT00222183|Pimecrolimus|pimecrolimus
505189|NCT00222183|Chronic discoid lupus erythematosus (dLE)|chronic discoid lupus erythematosus (dle)
650972|NCT00781625|QoL|qol
505190|NCT00222183|subacute cutaneous lupus erythematosus (scLE)|subacute cutaneous lupus erythematosus (scle)
505191|NCT00222196|atherosclerosis|atherosclerosis
505192|NCT00222196|quality of life|quality of life
505193|NCT00222196|pain-score|pain-score
505194|NCT00222196|biomarkers|biomarkers
505195|NCT00222209|Experimental study|experimental study
505196|NCT00222209|chronic pain|chronic pain
505197|NCT00222209|operant learning|operant learning
505198|NCT00222209|comorbidity|comorbidity
505199|NCT00222209|stress|stress
505200|NCT00222209|Fibromyalgia w visceral hypersensitivity|fibromyalgia w visceral hypersensitivity
505201|NCT00222209|Fibromyalgia w/o visceral hypersensitivity|fibromyalgia w/o visceral hypersensitivity
505202|NCT00222222|severe sepsis|severe sepsis
505203|NCT00222222|prognostic markers|prognostic markers
505204|NCT00222222|polymorphisms|polymorphisms
505205|NCT00222222|SIRS|sirs
505206|NCT00222235|schizophrenia|schizophrenia
505207|NCT00222235|schizoaffective disorder|schizoaffective disorder
505208|NCT00222235|negative symptoms|negative symptoms
505209|NCT00222235|cognitive impairments|cognitive impairments
505210|NCT00222248|Stress urinary incontinence|stress urinary incontinence
505211|NCT00222248|Pelvic floor muscle training|pelvic floor muscle training
505212|NCT00222248|Bladder training|bladder training
505213|NCT00222248|Older women|older women
505214|NCT00222261|antiplatelet therapy|antiplatelet therapy
505215|NCT00222261|aspirin non-responders|aspirin non-responders
505216|NCT00222261|aspirin resistance|aspirin resistance
505217|NCT00222261|clopidogrel|clopidogrel
505218|NCT00222261|coronary heart disease|coronary heart disease
505219|NCT00222261|stable angina pectoris|stable angina pectoris
505220|NCT00222274|fibromyalgia|fibromyalgia
505221|NCT00222274|pain|pain
505222|NCT00222274|biofeedback|biofeedback
505223|NCT00222274|heart rate variability|heart rate variability
505224|NCT00222287|Feldenkrais Method|feldenkrais method
505225|NCT00222287|movement class|movement class
505226|NCT00222287|balance|balance
505227|NCT00222287|Four square step test|four square step test
505228|NCT00222287|Activities Specific Balance Confidence Scale|activities specific balance confidence scale
505229|NCT00222287|systems theory|systems theory
505230|NCT00222300|Total hip replacement|total hip replacement
505231|NCT00222300|Strength training|strength training
505232|NCT00222300|Gait analysis|gait analysis
505233|NCT00222326|Hysterectomy,|hysterectomy,
505234|NCT00222326|Prolapse,|prolapse,
505235|NCT00222326|Pelvic floor muscles,|pelvic floor muscles,
505236|NCT00222326|Bladder,|bladder,
505237|NCT00222326|Bowel.|bowel.
505238|NCT00222339|Stroke|stroke
505239|NCT00222339|Hand function|hand function
505240|NCT00222339|Task-specific training|task-specific training
505241|NCT00222352|Unstable Angina|unstable angina
505242|NCT00222352|Non-ST-segment Myocardial Infarction|non-st-segment myocardial infarction
505243|NCT00222352|Myocardial Necrosis|myocardial necrosis
505244|NCT00222352|Troponin I|troponin i
505245|NCT00222365|homeopathy|homeopathy
505246|NCT00222365|assessment|assessment
505247|NCT00222365|pain|pain
505248|NCT00222365|ligamentoplasty|ligamentoplasty
505249|NCT00222378|Crohn's disease|crohn's disease
505250|NCT00222378|ulcerative colitis|ulcerative colitis
505251|NCT00222378|cytomegalovirus|cytomegalovirus
505252|NCT00222378|Epstein Bar Virus|epstein bar virus
505253|NCT00222378|Human Herpes virus 6|human herpes virus 6
505254|NCT00222404|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
505255|NCT00222404|Pharmacogenomic|pharmacogenomic
505256|NCT00222430|Fluoroscopy|fluoroscopy
505257|NCT00222430|Femoral Artery|femoral artery
505258|NCT00222430|Arterial Vascular Access|arterial vascular access
505259|NCT00222443|Recurrent solid tumors|recurrent solid tumors
505260|NCT00222443|recurrent lymphomas|recurrent lymphomas
505261|NCT00222443|Pediatrics|pediatrics
505262|NCT00222443|Adolescents|adolescents
505263|NCT00222456|preterm infants|preterm infants
505264|NCT00222456|early intervention|early intervention
505265|NCT00222456|outcome|outcome
505266|NCT00222456|behavioral problems|behavioral problems
505267|NCT00222456|parenting stress|parenting stress
505268|NCT00222469|pancreatic cancer|pancreatic cancer
505269|NCT00222469|unresectable pancreatic cancer|unresectable pancreatic cancer
505172|NCT00222053|Myeloma|myeloma
505270|NCT00222469|metastatic pancreatic cancer|metastatic pancreatic cancer
505272|NCT00222469|oxaliplatin|oxaliplatin
505273|NCT00222469|gemcitabine|gemcitabine
505274|NCT00222469|1st line treatment|1st line treatment
505275|NCT00222469|first line treatment|first line treatment
505276|NCT00222469|locally advanced (unresectable) pancreatic cancer|locally advanced (unresectable) pancreatic cancer
505277|NCT00222482|Borderline Personality Disorder|borderline personality disorder
505278|NCT00222495|Psychotic Disorders in adolescents|psychotic disorders in adolescents
505279|NCT00222495|Schizophrenia in adolescents|schizophrenia in adolescents
505280|NCT00222495|Schizophreniform Disorders in adolescents|schizophreniform disorders in adolescents
505281|NCT00222495|Schizoaffective Disorders in adolescents|schizoaffective disorders in adolescents
505282|NCT00222508|Cystic Fibrosis|cystic fibrosis
505283|NCT00222508|Diabetes|diabetes
505284|NCT00222508|Complications|complications
505285|NCT00222521|Cystic Fibrosis|cystic fibrosis
505286|NCT00222521|Diabetes|diabetes
505287|NCT00222534|Respiratory Insufficiency|respiratory insufficiency
505288|NCT00222534|Alkalosis|alkalosis
505289|NCT00222560|physical activity counselling|physical activity counselling
505290|NCT00222560|physical activity behavior change intervention|physical activity behavior change intervention
505291|NCT00222560|prevention|prevention
505292|NCT00222560|collaborative health care|collaborative health care
505293|NCT00222560|physical inactivity|physical inactivity
505294|NCT00222560|motivation|motivation
505295|NCT00222560|fitness|fitness
505296|NCT00222560|randomized controlled trial|randomized controlled trial
505297|NCT00222573|clopidogrel|clopidogrel
505298|NCT00222573|metoprolol|metoprolol
505299|NCT00222573|myocardial infarction|myocardial infarction
505300|NCT00222573|randomised trial|randomised trial
505301|NCT00222625|Intracerebral Hemorrhage|intracerebral hemorrhage
505302|NCT00222625|Oral Anticoagulants|oral anticoagulants
505303|NCT00222625|Antiplatelet Agents|antiplatelet agents
505304|NCT00222625|Recombinant Activated Factor VII|recombinant activated factor vii
505305|NCT00222638|Oral anticoagulants|oral anticoagulants
505306|NCT00222638|Influenza virus|influenza virus
505307|NCT00222638|Influenza vaccine|influenza vaccine
505308|NCT00222638|Pharmacological interference|pharmacological interference
505309|NCT00222651|pulmonary embolism|pulmonary embolism
505310|NCT00222651|right ventricular dysfunction|right ventricular dysfunction
505311|NCT00222651|thrombolysis|thrombolysis
505312|NCT00222651|echocardiography|echocardiography
505313|NCT00222664|hepatitis B|hepatitis b
505314|NCT00222664|hepatocellular carcinoma|hepatocellular carcinoma
505315|NCT00222664|prevention|prevention
505316|NCT00222664|vaccination|vaccination
505317|NCT00222677|venous thromboembolism|venous thromboembolism
505318|NCT00222677|deep vein thrombosis|deep vein thrombosis
505319|NCT00222677|pulmonary embolism|pulmonary embolism
505320|NCT00222677|antithrombotic agents|antithrombotic agents
505321|NCT00222690|qualitative interview|qualitative interview
505322|NCT00222690|symptom triggers|symptom triggers
505323|NCT00222690|activity and participation|activity and participation
505324|NCT00222703|nicotine addiction|nicotine addiction
505325|NCT00222703|relapse|relapse
505326|NCT00222703|smoking|smoking
505327|NCT00222703|chronic disorders|chronic disorders
505328|NCT00222703|randomized controlled trial|randomized controlled trial
505329|NCT00222703|intervention|intervention
505330|NCT00222716|Treatment adherence|treatment adherence
505332|NCT00222716|Self-efficacy|self-efficacy
505333|NCT00222716|Treatment Experienced|treatment experienced
505334|NCT00222729|head|head
505335|NCT00222729|neck|neck
505336|NCT00222742|hypothermia|hypothermia
505337|NCT00222742|pediatric TBI|pediatric tbi
505338|NCT00222755|Mood disorders-bipolar|mood disorders-bipolar
505339|NCT00222755|Disease management|disease management
505340|NCT00222755|Quality of care|quality of care
505341|NCT00222768|Adipose tissue|adipose tissue
505342|NCT00222768|PET imaging|pet imaging
505343|NCT00222781|Skeletal muscle|skeletal muscle
505344|NCT00222781|Triple-tracer PET imaging|triple-tracer pet imaging
505345|NCT00222794|Schizophrenia|schizophrenia
505346|NCT00222794|Schizo-Affective Disorder|schizo-affective disorder
505347|NCT00222794|Negative Symptoms|negative symptoms
505348|NCT00222794|Atomoxetine|atomoxetine
505349|NCT00222794|Strattera|strattera
505350|NCT00222807|schizophrenia, psychosis, type 2 diabetes mellitus|schizophrenia, psychosis, type 2 diabetes mellitus
505351|NCT00222833|Schizophrenia|schizophrenia
505352|NCT00222833|Schizoaffective disorder|schizoaffective disorder
505353|NCT00222833|Aripiprazole|aripiprazole
505354|NCT00222833|Obese|obese
505355|NCT00222833|Overweight|overweight
505356|NCT00222833|Heart Health|heart health
505357|NCT00222833|Antipsychotic|antipsychotic
505358|NCT00222833|Heart Health Factors|heart health factors
505359|NCT00222833|Cardiovascular Health Indices|cardiovascular health indices
505360|NCT00222833|Cardiovascular health|cardiovascular health
505361|NCT00222846|Clinical trial|clinical trial
505362|NCT00222846|Behavioral research|behavioral research
505363|NCT00222846|Patient compliance|patient compliance
505364|NCT00222859|HIV|hiv
505365|NCT00222859|HCV|hcv
505366|NCT00222872|Endocrine System Diseases|endocrine system diseases
505367|NCT00222872|MusculoSkeletal System Diseases|musculoskeletal system diseases
505369|NCT00222872|Postmenopausal Women|postmenopausal women
505370|NCT00222885|PET imaging|pet imaging
505371|NCT00222885|Skeletal muscle|skeletal muscle
505372|NCT00222885|In vivo insulin-stimulated tissue perfusion|in vivo insulin-stimulated tissue perfusion
505373|NCT00222885|Glucose transport|glucose transport
505374|NCT00222885|Glucose phosphorylation|glucose phosphorylation
505375|NCT00222898|Pancreatic Cyst|pancreatic cyst
505376|NCT00222898|PANDA Study|panda study
505377|NCT00222911|plantar fasciitis|plantar fasciitis
505378|NCT00222911|heel pain|heel pain
505379|NCT00222911|heel spur|heel spur
505380|NCT00222911|night splint|night splint
505381|NCT00222911|arch support|arch support
505382|NCT00222911|foot orthosis|foot orthosis
505383|NCT00222911|physical therapy|physical therapy
505384|NCT00222924|Mitochondria|mitochondria
505385|NCT00222937|Voice Problems|voice problems
505386|NCT00222937|Voice Disorders|voice disorders
505387|NCT00222950|plant sterols, serum, aortic valve cusps|plant sterols, serum, aortic valve cusps
505388|NCT00222963|Obesity|obesity
505389|NCT00222963|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
505390|NCT00222963|Children|children
505391|NCT00222963|Adolescents|adolescents
505392|NCT00222963|Adenotonsillectomy|adenotonsillectomy
505393|NCT00222989|GERD|gerd
505395|NCT00222989|Functional heartburn|functional heartburn
505396|NCT00223015|renal transplantation|renal transplantation
505397|NCT00223015|pharmacokinetics|pharmacokinetics
505398|NCT00223015|Fluvastatin|fluvastatin
505399|NCT00223015|Mycophenolat mofetil|mycophenolat mofetil
505400|NCT00223015|tacrolimus|tacrolimus
505401|NCT00223028|fluvastain|fluvastain
505402|NCT00223028|sirolimus|sirolimus
505403|NCT00223028|mycophenolat mofetil|mycophenolat mofetil
505404|NCT00223028|renal transplantation|renal transplantation
505405|NCT00223041|renal transplantation|renal transplantation
505406|NCT00223041|cardiovasculary disease|cardiovasculary disease
505407|NCT00223041|statin|statin
505408|NCT00223054|cyclosporin A|cyclosporin a
505409|NCT00223054|Tacrolimus|tacrolimus
505410|NCT00223054|Everolimus|everolimus
505411|NCT00223054|Sirolimus|sirolimus
505412|NCT00223054|Fluvastatin|fluvastatin
505413|NCT00223067|renal transplantation|renal transplantation
505414|NCT00223067|TAIZ|taiz
505415|NCT00223080|HIV Seronegativity|hiv seronegativity
505416|NCT00223093|renal transplantation, TAIZ-moncytes|renal transplantation, taiz-moncytes
505417|NCT00223106|urge incontinence|urge incontinence
505418|NCT00223106|urinary incontinence|urinary incontinence
505419|NCT00223106|vault prolapse|vault prolapse
505420|NCT00223106|stess incontinence|stess incontinence
505421|NCT00223106|mixed incontinence|mixed incontinence
505422|NCT00223106|urine leakage|urine leakage
505423|NCT00223106|enterocele|enterocele
505424|NCT00223106|rectocele|rectocele
505425|NCT00223106|cystocele|cystocele
505426|NCT00223119|perineal trauma|perineal trauma
505427|NCT00223119|perineal laceration|perineal laceration
505428|NCT00223119|persistent perineal pain|persistent perineal pain
505429|NCT00223132|bariatric surgery|bariatric surgery
505430|NCT00223132|body contouring|body contouring
505431|NCT00223132|skin laxity|skin laxity
505432|NCT00223132|plastic surgery|plastic surgery
505433|NCT00223132|suture granuloma|suture granuloma
505434|NCT00223132|absorbable sutures|absorbable sutures
505435|NCT00223145|Prostate adenocarcinoma|prostate adenocarcinoma
505436|NCT00223145|Gleason score <= 6 and PSA 10-20|gleason score <= 6 and psa 10-20
505437|NCT00223145|Gleason score = 7 and PSA <=20|gleason score = 7 and psa <=20
505438|NCT00223158|Thyroid cancer|thyroid cancer
505439|NCT00223158|Hypothyroidism|hypothyroidism
505440|NCT00223158|Whole Body Scintigraphy|whole body scintigraphy
505441|NCT00223158|Liothyronine|liothyronine
505442|NCT00223158|TSH elevation|tsh elevation
505443|NCT00223171|Stage T3 T4|stage t3 t4
505444|NCT00223171|PSA > 20|psa > 20
505445|NCT00223171|Gleason Score > 7|gleason score > 7
505446|NCT00223197|Bipolar with depression|bipolar with depression
505447|NCT00223197|Recurrent major depressive disorder|recurrent major depressive disorder
505448|NCT00223197|substance abuse dependence|substance abuse dependence
505449|NCT00223210|bipolar disorder|bipolar disorder
505450|NCT00223210|cocaine dependence|cocaine dependence
505451|NCT00223210|quetiapine|quetiapine
505452|NCT00223275|Bipolar Disorder|bipolar disorder
505453|NCT00223275|Alcohol Dependence|alcohol dependence
505454|NCT00223275|Dual Diagnosis|dual diagnosis
505455|NCT00223275|Naltrexone|naltrexone
505456|NCT00223314|HIV|hiv
505457|NCT00223314|Sexually Transmitted Diseases|sexually transmitted diseases
505458|NCT00223314|Pregnancy|pregnancy
505459|NCT00223314|HIV Seronegativity|hiv seronegativity
505460|NCT00223327|pain|pain
505461|NCT00223327|Normal pulp and normal periodontal status|normal pulp and normal periodontal status
505462|NCT00223327|Chronic apical periodontitis of pulpal origin|chronic apical periodontitis of pulpal origin
505564|NCT00223743|zonisamide|zonisamide
505463|NCT00223340|patient activation|patient activation
505464|NCT00223340|primary care|primary care
505465|NCT00223340|diabetes|diabetes
505466|NCT00223340|cardiovascular risk|cardiovascular risk
505467|NCT00223353|Biomechanics|biomechanics
505468|NCT00223353|Gait|gait
505469|NCT00223353|Balance|balance
505470|NCT00223366|Pain in teeth|pain in teeth
505471|NCT00223379|Apical Periodontitis, Root Canal Therapy, Apical Preparation|apical periodontitis, root canal therapy, apical preparation
505472|NCT00223405|enamel wear against ceramic crowns|enamel wear against ceramic crowns
505473|NCT00223418|aripiprazole|aripiprazole
505474|NCT00223418|olanzapine|olanzapine
505475|NCT00223418|vocational|vocational
505476|NCT00223418|learning|learning
505477|NCT00223418|cognition|cognition
505478|NCT00223418|cognitive|cognitive
505479|NCT00223444|alcohol|alcohol
505480|NCT00223444|GABA|gaba
505481|NCT00223444|genetic variation|genetic variation
505482|NCT00223457|multiple sclerosis|multiple sclerosis
505483|NCT00223457|compliance|compliance
505484|NCT00223457|adherence|adherence
505485|NCT00223457|disease modifying therapy|disease modifying therapy
505486|NCT00223457|depression|depression
505487|NCT00223457|hope|hope
505488|NCT00223457|quality of life|quality of life
505489|NCT00223470|pain|pain
505490|NCT00223483|Hematologic Diseases|hematologic diseases
505491|NCT00223483|Genomics|genomics
505492|NCT00223483|Cytokines|cytokines
505493|NCT00223483|Chemokines|chemokines
505494|NCT00223483|Receptors|receptors
505495|NCT00223496|Bipolar Depression|bipolar depression
505496|NCT00223496|Refractory|refractory
505497|NCT00223509|mixed mania|mixed mania
505498|NCT00223509|lamotrigine|lamotrigine
505499|NCT00223522|Schizophrenia|schizophrenia
505500|NCT00223522|Schizoaffective|schizoaffective
505501|NCT00223522|MEMS|mems
505502|NCT00223522|adherence to antipsychotic medication|adherence to antipsychotic medication
505503|NCT00223535|Schizophrenia|schizophrenia
505504|NCT00223535|Cognitive Remediation|cognitive remediation
505505|NCT00223535|Social Skills Training|social skills training
505506|NCT00223535|Psychosocial|psychosocial
505507|NCT00223548|prophylaxis|prophylaxis
505508|NCT00223548|contrast-induced nephropathy|contrast-induced nephropathy
505509|NCT00223548|mesna|mesna
505510|NCT00223548|acute renal failure|acute renal failure
505511|NCT00223561|adult|adult
505512|NCT00223587|driving|driving
505513|NCT00223587|memory|memory
505514|NCT00223600|lipids|lipids
505515|NCT00223600|lipoproproteins|lipoproproteins
505516|NCT00223600|growth|growth
505517|NCT00223600|neurological development|neurological development
505518|NCT00223600|vascular wall|vascular wall
505519|NCT00223600|blood pressure|blood pressure
505520|NCT00223600|nutrient intake|nutrient intake
505521|NCT00223613|diabetes|diabetes
505522|NCT00223613|juvenile diabetes|juvenile diabetes
505523|NCT00223613|insulin deficiency|insulin deficiency
505524|NCT00223626|Cocaine Addiction|cocaine addiction
505525|NCT00223626|Cocaine Dependence|cocaine dependence
505526|NCT00223639|alcoholism /alcohol abuse|alcoholism /alcohol abuse
505527|NCT00223639|alcoholism antagonist|alcoholism antagonist
505528|NCT00223639|anticonvulsant|anticonvulsant
505529|NCT00223639|cognition|cognition
505530|NCT00223639|neuropharmacology|neuropharmacology
505531|NCT00223639|substance abuse related behavior|substance abuse related behavior
505532|NCT00223639|craving|craving
505533|NCT00223639|euphoria|euphoria
505534|NCT00223639|relapse /recurrence|relapse /recurrence
505535|NCT00223639|patient oriented research|patient oriented research
505536|NCT00223652|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
505537|NCT00223652|Telephone psychotherapy|telephone psychotherapy
505538|NCT00223652|Clinical Trial|clinical trial
505539|NCT00223652|Primary Care Clinic|primary care clinic
505540|NCT00223652|Treatment for Depression|treatment for depression
505738|NCT00215527|LA Biomed|la biomed
505541|NCT00223665|Intermittent Hormone Therapy|intermittent hormone therapy
505542|NCT00223691|orthostatic hypotension|orthostatic hypotension
505543|NCT00223691|autonomic failure|autonomic failure
505544|NCT00223704|Coronary Artery Bypass|coronary artery bypass
505545|NCT00223704|Blood Transfusion|blood transfusion
505546|NCT00223704|Bradykinin Receptor Antagonism|bradykinin receptor antagonism
505547|NCT00223704|Anti-Inflammatory Agents|anti-inflammatory agents
505548|NCT00223704|Antifibrinolytic Agents|antifibrinolytic agents
505549|NCT00223717|Supine Hypertension|supine hypertension
505550|NCT00223717|Hypertension|hypertension
505551|NCT00223717|Treatment|treatment
505552|NCT00223717|Autonomic failure|autonomic failure
505553|NCT00223717|Pure autonomic failure|pure autonomic failure
505554|NCT00223717|Multiple System Atrophy|multiple system atrophy
505555|NCT00223717|Shy-Drager Syndrome|shy-drager syndrome
505556|NCT00223730|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
505557|NCT00223730|Bone Marrow Transplant|bone marrow transplant
505558|NCT00223730|Citrulline|citrulline
505559|NCT00223730|Urea Cycle|urea cycle
505560|NCT00223730|Hepatic Injury|hepatic injury
505561|NCT00223730|Allogeneic PBSCT|allogeneic pbsct
505562|NCT00223730|Matched-Unrelated PBSCT|matched-unrelated pbsct
505563|NCT00223743|essential tremor|essential tremor
583312|NCT00511264|Ultrasound|ultrasound
505565|NCT00223743|clinical trial|clinical trial
505566|NCT00223756|Vision, Low|vision, low
505567|NCT00223769|oxandrolone|oxandrolone
505568|NCT00223769|oxandrin|oxandrin
505569|NCT00223769|lean body mass|lean body mass
505570|NCT00223769|functional recovery|functional recovery
505571|NCT00223769|resistance training|resistance training
505572|NCT00223782|Diabetes|diabetes
505573|NCT00223782|Peripheral Neuropathy|peripheral neuropathy
505574|NCT00223782|Walking|walking
505575|NCT00223795|Cane|cane
505576|NCT00223795|Gait|gait
505577|NCT00223795|Obesity|obesity
505578|NCT00223795|Osteoarthritis|osteoarthritis
505579|NCT00223795|Walking Aids|walking aids
505580|NCT00223808|Rehabilitation|rehabilitation
505581|NCT00223808|Robotics|robotics
505582|NCT00223821|Behavior Therapy|behavior therapy
504980|NCT00212329|T1D|t1d
505583|NCT00223821|Behavioral Medicine|behavioral medicine
505584|NCT00223821|Behavioral Research|behavioral research
505585|NCT00223821|Behavioral Sciences|behavioral sciences
505586|NCT00223821|Combined Modality Therapy|combined modality therapy
505587|NCT00223821|Drug Therapy|drug therapy
505588|NCT00223821|Overactive bladder|overactive bladder
505589|NCT00223821|Treatment Outcome|treatment outcome
505590|NCT00223821|Urge incontinence|urge incontinence
505591|NCT00223821|Urinary incontinence|urinary incontinence
505592|NCT00223834|Counseling|counseling
505593|NCT00223834|Motivation|motivation
505594|NCT00223834|Psychotherapy, brief|psychotherapy, brief
505595|NCT00223847|Aphasia rehabilitation|aphasia rehabilitation
505596|NCT00223847|Aphasia therapy|aphasia therapy
505597|NCT00223847|Constraint therapy|constraint therapy
505598|NCT00223847|Language therapy|language therapy
505599|NCT00223860|Hypogonadal|hypogonadal
505600|NCT00223860|Hypothalamus|hypothalamus
505601|NCT00223860|Pituitary|pituitary
505602|NCT00223860|Spinal Cord Injury|spinal cord injury
505603|NCT00223860|Testes|testes
505604|NCT00223860|Testosterone|testosterone
505605|NCT00223873|Penile Vibratory Stimulation|penile vibratory stimulation
505606|NCT00223873|Muscles Spasticity|muscles spasticity
505607|NCT00223873|Spasms|spasms
505608|NCT00223873|Ferti Care Vibrator|ferti care vibrator
505609|NCT00223873|Antispasmotic treatment|antispasmotic treatment
505610|NCT00223899|Melanoma|melanoma
505611|NCT00223899|Electroporation|electroporation
505612|NCT00223899|IL-2|il-2
505613|NCT00223912|Cardiovascular Disease|cardiovascular disease
505614|NCT00223912|Exercise|exercise
505615|NCT00223912|Functional electrical stimulation|functional electrical stimulation
505616|NCT00223912|hemostasis|hemostasis
505617|NCT00223912|Spinal cord injury|spinal cord injury
505618|NCT00223925|Stem cell transplantation|stem cell transplantation
505619|NCT00223925|Allogeneic transplantation|allogeneic transplantation
505620|NCT00223951|Healthy volunteers, safety, ocular, allergic conjunctivitis, ophthalmic|healthy volunteers, safety, ocular, allergic conjunctivitis, ophthalmic
505621|NCT00223964|Iron Deficiency|iron deficiency
505622|NCT00223964|Anemia in Pediatric Hemodialysis|anemia in pediatric hemodialysis
505623|NCT00223977|Anemia.|anemia.
505624|NCT00223990|Plasmodium|plasmodium
505625|NCT00223990|falciparum|falciparum
505626|NCT00223990|malaria|malaria
505627|NCT00223990|vaccine|vaccine
505628|NCT00223990|AS02A adjuvant|as02a adjuvant
505629|NCT00223990|FMP1|fmp1
505630|NCT00223990|Merozoite surface protein-1|merozoite surface protein-1
505631|NCT00224003|Anemia|anemia
505632|NCT00224042|Iron deficiency|iron deficiency
505633|NCT00224042|Anemia|anemia
505634|NCT00224042|Chronic kidney disease|chronic kidney disease
505635|NCT00224042|Erythropoietic agents|erythropoietic agents
505636|NCT00224042|Sodium Ferric Gluconate|sodium ferric gluconate
505637|NCT00224042|Anemia, Iron-Deficiency/drug therapy/etiology|anemia, iron-deficiency/drug therapy/etiology
505736|NCT00215527|enzyme replacement therapy|enzyme replacement therapy
505638|NCT00224042|Kidney Failure, Chronic/blood/complications/therapy|kidney failure, chronic/blood/complications/therapy
505639|NCT00224042|Erythropoietin, Recombinant/adverse effects/therapeutic use|erythropoietin, recombinant/adverse effects/therapeutic use
505640|NCT00224055|Iron deficiency|iron deficiency
505641|NCT00224055|Anemia|anemia
505642|NCT00224055|Chronic kidney disease|chronic kidney disease
505643|NCT00224055|Sodium Ferric Gluconate|sodium ferric gluconate
505644|NCT00224055|Anemia, Iron-Deficiency/drug therapy/etiology|anemia, iron-deficiency/drug therapy/etiology
505645|NCT00224055|Kidney Failure, Chronic/blood/complications/therapy|kidney failure, chronic/blood/complications/therapy
505646|NCT00224068|Iron deficiency|iron deficiency
505647|NCT00224068|Sodium ferric gluconate|sodium ferric gluconate
505648|NCT00224068|anemia|anemia
505649|NCT00224068|cancer chemotherapy|cancer chemotherapy
505650|NCT00224068|epoetin alfa|epoetin alfa
505651|NCT00224068|Anemia/drug therapy|anemia/drug therapy
505652|NCT00224068|Anemia, Iron-Deficiency/drug therapy/etiology|anemia, iron-deficiency/drug therapy/etiology
505653|NCT00224068|Hematinics/administration & dosage/pharmacology|hematinics/administration & dosage/pharmacology
505654|NCT00224068|Antineoplastic Agents/adverse effects|antineoplastic agents/adverse effects
505655|NCT00224068|Erythropoietin, Recombinant/therapeutic use/adverse effects|erythropoietin, recombinant/therapeutic use/adverse effects
505656|NCT00224081|iron deficiency anemia|iron deficiency anemia
505657|NCT00224081|ferritin|ferritin
505658|NCT00224081|hemodialysis|hemodialysis
505659|NCT00224081|sodium ferric gluconate|sodium ferric gluconate
505660|NCT00224081|epoetin alfa|epoetin alfa
505661|NCT00224094|Menopause|menopause
505662|NCT00224094|Testosterone|testosterone
505663|NCT00224094|Androgens|androgens
505664|NCT00224094|Sex Hormone Binding Globulin|sex hormone binding globulin
505665|NCT00224094|Thyroid function|thyroid function
505666|NCT00224094|Cortisol|cortisol
505667|NCT00224107|Benign prostatic hyperplasia, BPH, alpha blocker|benign prostatic hyperplasia, bph, alpha blocker
505668|NCT00215267|Schistosoma mansoni|schistosoma mansoni
505669|NCT00215267|hepatosplenomegaly|hepatosplenomegaly
505670|NCT00215267|malaria|malaria
505671|NCT00215267|Uganda|uganda
651551|NCT00783991|PC|pc
505672|NCT00215280|Mansonella perstans|mansonella perstans
505673|NCT00215280|microfilaraemia|microfilaraemia
505674|NCT00215280|ivermectin|ivermectin
505675|NCT00215280|albendazole|albendazole
505676|NCT00215280|Uganda|uganda
505677|NCT00215293|fusion|fusion
505678|NCT00215293|cervical|cervical
505679|NCT00215293|spine|spine
505680|NCT00215306|arthroplasty|arthroplasty
505681|NCT00215306|lumbar|lumbar
505682|NCT00215306|spine|spine
505683|NCT00215319|Degenerative disc disease at up to 2 levels (L2-S1)|degenerative disc disease at up to 2 levels (l2-s1)
505684|NCT00215332|arthroplasty|arthroplasty
505685|NCT00215332|lumbar|lumbar
505686|NCT00215332|disc|disc
505687|NCT00215345|Celecoxib|celecoxib
505688|NCT00215345|Taxotere|taxotere
505689|NCT00215345|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
505690|NCT00215358|Asthma|asthma
505691|NCT00215358|Formoterol|formoterol
505692|NCT00215358|Fumarate|fumarate
505693|NCT00215358|Foradil|foradil
505694|NCT00215371|Asthma|asthma
505695|NCT00215371|Pediatric|pediatric
505696|NCT00215371|Formoterol Fumarate|formoterol fumarate
505697|NCT00215371|Foradil|foradil
505698|NCT00215384|COPD|copd
505699|NCT00215384|formoterol|formoterol
505700|NCT00215397|Asthma|asthma
505701|NCT00215397|Formoterol|formoterol
505702|NCT00215397|Fumarate|fumarate
505703|NCT00215410|Asthma|asthma
505704|NCT00215410|Formoterol|formoterol
505705|NCT00215410|Fumarate|fumarate
505706|NCT00215423|COPD|copd
505707|NCT00215423|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
505708|NCT00215423|Formoterol Fumarate|formoterol fumarate
505709|NCT00215423|Formoterol|formoterol
505710|NCT00215436|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
505711|NCT00215436|COPD|copd
505712|NCT00215436|formoterol|formoterol
505713|NCT00215449|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
505714|NCT00215449|COPD|copd
505715|NCT00215449|formoterol|formoterol
505716|NCT00215449|formoterol fumarate|formoterol fumarate
505717|NCT00215462|gastric adenocarcinoma|gastric adenocarcinoma
505718|NCT00215462|esophageal adenocarcinoma|esophageal adenocarcinoma
505719|NCT00215462|vinorelbine|vinorelbine
505720|NCT00215501|advanced solid tumor malignancy|advanced solid tumor malignancy
505721|NCT00215501|capecitabine|capecitabine
505722|NCT00215501|continuous infusion|continuous infusion
505723|NCT00215501|5-FU|5-fu
505724|NCT00215501|irinotecan|irinotecan
505725|NCT00215501|5-fluorouracil|5-fluorouracil
505726|NCT00215501|cisplatin|cisplatin
505727|NCT00215514|adjuvant chemoradiation|adjuvant chemoradiation
505728|NCT00215514|GE junction|ge junction
505729|NCT00215514|epirubicin|epirubicin
505730|NCT00215527|mucopolysaccharidosis|mucopolysaccharidosis
505731|NCT00215527|Hurler-Scheie|hurler-scheie
505732|NCT00215527|Scheie|scheie
505733|NCT00215527|laronidase|laronidase
505734|NCT00215527|spinal cord compression|spinal cord compression
505735|NCT00215527|central nervous system|central nervous system
505739|NCT00215540|Double-blind|double-blind
505740|NCT00215540|Low Birth Weight|low birth weight
505741|NCT00215540|Surfactant|surfactant
505742|NCT00215540|Placebo-Controlled|placebo-controlled
505743|NCT00215540|Premature Birth|premature birth
505745|NCT00215566|IBS-c|ibs-c
505746|NCT00215605|Advanced Malignancies|advanced malignancies
505747|NCT00215605|Solid Tumor|solid tumor
505748|NCT00215605|Medullary Thyroid Cancer|medullary thyroid cancer
505749|NCT00215631|prostate cancer|prostate cancer
505750|NCT00215631|radiotherapy|radiotherapy
505751|NCT00215631|erectile dysfunction|erectile dysfunction
505752|NCT00215631|tadalafil|tadalafil
505753|NCT00215644|Esophagus|esophagus
505754|NCT00215644|Gastric|gastric
505755|NCT00215644|Adenocarcinoma|adenocarcinoma
505756|NCT00215644|EGFR|egfr
505757|NCT00215644|matuzumab|matuzumab
505758|NCT00215644|EMD 72000|emd 72000
505759|NCT00215644|randomized|randomized
505760|NCT00215644|Epirubicin|epirubicin
505761|NCT00215644|cisplatin|cisplatin
505762|NCT00215644|capecitabine|capecitabine
505763|NCT00215644|Metastatic Esophago-Gastric cancer|metastatic esophago-gastric cancer
505764|NCT00215670|AMD|amd
505765|NCT00215670|Macugen|macugen
505766|NCT00215670|Pharmacokinetics|pharmacokinetics
505767|NCT00215670|Age-Related Macular Degeneration|age-related macular degeneration
505768|NCT00215670|PK|pk
505769|NCT00215683|Prostate Cancer|prostate cancer
505770|NCT00215683|Androgen ablation therapy|androgen ablation therapy
505771|NCT00215709|elderly|elderly
505772|NCT00215735|diabetes|diabetes
505773|NCT00215735|Ulcer|ulcer
505774|NCT00215735|APC|apc
505775|NCT00215748|Elderly|elderly
505776|NCT00215748|Weekly|weekly
505777|NCT00215761|Atrial fibrillation|atrial fibrillation
505778|NCT00215761|Preventive stimulation|preventive stimulation
651680|NCT00784537|ABVD|abvd
505779|NCT00215761|Pacemaker|pacemaker
505780|NCT00215774|Atrial fibrillation|atrial fibrillation
505781|NCT00215787|Nasal polyps|nasal polyps
505782|NCT00215787|Gastroesophageal Reflux|gastroesophageal reflux
505783|NCT00215800|Chronic Fatigue Syndrome|chronic fatigue syndrome
505784|NCT00215800|Myalgic Encephalomyelitis|myalgic encephalomyelitis
505785|NCT00215800|CFS|cfs
505786|NCT00215800|Ampligen|ampligen
505787|NCT00215800|Poly I:ploy C12U|poly i:ploy c12u
505788|NCT00215813|Chronic Fatigue Syndrome|chronic fatigue syndrome
505789|NCT00215813|CFS|cfs
505790|NCT00215813|ME|me
505791|NCT00215813|Ampligen|ampligen
505792|NCT00215813|poly I:poly C12U|poly i:poly c12u
505793|NCT00215813|Rintatolimod|rintatolimod
505794|NCT00215826|SARS|sars
505795|NCT00215826|Alferon LDO|alferon ldo
505796|NCT00215826|Low Dose Oral Interferon ALFA-n3|low dose oral interferon alfa-n3
505797|NCT00215826|Human Leukocyte Derived|human leukocyte derived
505798|NCT00215826|Exposure to SARS|exposure to sars
505799|NCT00215826|Possible SARS|possible sars
505800|NCT00215839|Treatment Experienced|treatment experienced
505801|NCT00215852|Alferon LDO|alferon ldo
505802|NCT00215852|Low Dose Oral Interferon|low dose oral interferon
505803|NCT00215852|Alfa-n3|alfa-n3
505804|NCT00215852|Human Leukocyte Derived|human leukocyte derived
505805|NCT00215852|HIV|hiv
505806|NCT00215852|Asymptomatic HIV|asymptomatic hiv
505807|NCT00215852|Treatment Experienced|treatment experienced
505808|NCT00224120|Benign prostatic hyperplasia, alpha blocker|benign prostatic hyperplasia, alpha blocker
505809|NCT00224133|benign prostatic hyperplasia, alpha blocker|benign prostatic hyperplasia, alpha blocker
505810|NCT00224146|Oxytrol(r)|oxytrol(r)
505811|NCT00224146|transdermal oxybutynin|transdermal oxybutynin
505812|NCT00224146|overactive bladder|overactive bladder
505813|NCT00224159|Statin therapy|statin therapy
505814|NCT00224159|Dietary behavior|dietary behavior
505815|NCT00224159|Attitudes and beliefs|attitudes and beliefs
505816|NCT00224159|Self efficacy|self efficacy
505817|NCT00224172|Pre-hospitalization characteristics|pre-hospitalization characteristics
505818|NCT00224172|Post-hospitalization characteristics|post-hospitalization characteristics
505819|NCT00224172|Psychosocial measures|psychosocial measures
505820|NCT00224172|Predict re-hospitalization|predict re-hospitalization
505821|NCT00224185|Healthy individuals|healthy individuals
505822|NCT00224185|smokers|smokers
505823|NCT00224185|ex-smokers|ex-smokers
505824|NCT00224185|non-smokers|non-smokers
505825|NCT00224224|Clinical performance|clinical performance
505826|NCT00224224|Continuity of care|continuity of care
505827|NCT00224224|Utilization of resources|utilization of resources
505828|NCT00224237|Latino patients|latino patients
505829|NCT00224237|Health practices|health practices
505830|NCT00224237|Culture influences|culture influences
505831|NCT00224263|Traditional Chinese Medicine|traditional chinese medicine
505832|NCT00224263|Lingzhi|lingzhi
505833|NCT00224289|Latanoprost|latanoprost
505834|NCT00224289|Glaucoma|glaucoma
505835|NCT00224289|Intraocular pressure|intraocular pressure
505836|NCT00224302|Schizophrenia,|schizophrenia,
505837|NCT00224302|schizoaffective disorder,|schizoaffective disorder,
505838|NCT00224302|major depressive episode,|major depressive episode,
505839|NCT00224302|combination,|combination,
505840|NCT00224302|duloxetine|duloxetine
505841|NCT00224315|Schizophrenia,|schizophrenia,
505842|NCT00224315|schizoaffective disorder,|schizoaffective disorder,
505843|NCT00224315|treatment resistancy|treatment resistancy
505844|NCT00224315|clozapine,|clozapine,
505845|NCT00224315|ziprasidone|ziprasidone
505846|NCT00224315|risperidone|risperidone
505847|NCT00224315|combination|combination
505848|NCT00224328|Tissue Oxygen Saturation|tissue oxygen saturation
505849|NCT00224328|Peripheral Arterial Disease|peripheral arterial disease
505850|NCT00224328|Critical Limb Ischemia|critical limb ischemia
505851|NCT00224328|Near-infrared Spectroscopy|near-infrared spectroscopy
505852|NCT00224341|Pacemaker|pacemaker
505853|NCT00224341|Atrial Fibrillation|atrial fibrillation
505854|NCT00224341|Prevention pacing|prevention pacing
505855|NCT00224341|Algorithms|algorithms
505856|NCT00224341|Sick sinus syndrome + Atrial Fibrillation|sick sinus syndrome + atrial fibrillation
505857|NCT00224354|LYMPHOCYTIC|lymphocytic
505858|NCT00224354|B-LEUKEMIA|b-leukemia
505859|NCT00224354|B-CLL|b-cll
505860|NCT00224367|fracture|fracture
505861|NCT00224367|hip|hip
505862|NCT00224367|ambulation|ambulation
505863|NCT00224380|Serious mental illness|serious mental illness
505864|NCT00224380|medication adherence|medication adherence
505865|NCT00224393|Amyloidosis|amyloidosis
505866|NCT00224393|Enbrel|enbrel
505867|NCT00224406|Lung transplantation|lung transplantation
506246|NCT00227864|sexual risk|sexual risk
505868|NCT00224406|Reperfusion Injury|reperfusion injury
505869|NCT00224406|Survival|survival
505870|NCT00224419|Smoking cessation|smoking cessation
505871|NCT00224419|Pregnancy|pregnancy
505872|NCT00224419|Nicotine replacement therapy|nicotine replacement therapy
505873|NCT00224419|Motivational interviewing|motivational interviewing
505874|NCT00224432|Atopic Dermatitis|atopic dermatitis
505875|NCT00224432|SCORAD|scorad
505876|NCT00224432|probiotics|probiotics
505877|NCT00224432|cytokines|cytokines
505878|NCT00224432|Infant|infant
505879|NCT00224445|Treatment Naive|treatment naive
505880|NCT00224445|HIV-1|hiv-1
505881|NCT00226005|pancreas|pancreas
505882|NCT00226005|adenocarcinoma|adenocarcinoma
505883|NCT00226005|cancer|cancer
505884|NCT00226005|metastatic|metastatic
505885|NCT00226005|advanced cancer|advanced cancer
505886|NCT00226005|Phase II|phase ii
505887|NCT00226005|growth factor|growth factor
505888|NCT00226005|VEGF|vegf
505889|NCT00226005|angiogenesis|angiogenesis
505890|NCT00226031|Osteoporosis|osteoporosis
505891|NCT00226031|Wrist fractures|wrist fractures
505892|NCT00226031|Knowledge translation|knowledge translation
505893|NCT00226031|Implementation|implementation
505894|NCT00226031|Educational reminder|educational reminder
505895|NCT00226044|Omeprazole, suppository, infants|omeprazole, suppository, infants
505896|NCT00226057|Atopic dermatitis|atopic dermatitis
505897|NCT00226057|Raptiva|raptiva
505898|NCT00226070|selfrated health,|selfrated health,
505899|NCT00226070|SF-36,|sf-36,
505900|NCT00226070|rehabilitation,|rehabilitation,
505901|NCT00226070|total hip replacement,|total hip replacement,
505902|NCT00226070|patients above 65|patients above 65
505903|NCT00226096|Clinical Trial|clinical trial
505904|NCT00226096|Blood Pressure|blood pressure
505905|NCT00226096|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
505906|NCT00226109|Alcoholism|alcoholism
505907|NCT00226109|cardiomyopathy|cardiomyopathy
505908|NCT00226109|skeletal muscle|skeletal muscle
505909|NCT00226109|spironolactone|spironolactone
505910|NCT00226109|Na,K-pumps|na,k-pumps
505911|NCT00226109|Magnesium|magnesium
505912|NCT00226122|Enuresis|enuresis
505913|NCT00226122|Nocturnal|nocturnal
505914|NCT00226122|Monosymptomatic|monosymptomatic
505915|NCT00226122|DDAVP|ddavp
505916|NCT00226122|Indomethacin|indomethacin
505917|NCT00226122|Randomized|randomized
505918|NCT00226135|Bipolar disorder|bipolar disorder
505919|NCT00226135|Treatment|treatment
505920|NCT00226135|Long-term|long-term
505921|NCT00226135|Lithium|lithium
505922|NCT00226135|Lamotrigine|lamotrigine
505923|NCT00226135|Randomised Clinical Trial|randomised clinical trial
505924|NCT00226148|Implant|implant
505925|NCT00226148|Immediate placement|immediate placement
505926|NCT00226148|Molar tooth|molar tooth
505927|NCT00226174|Curcuminoids|curcuminoids
505928|NCT00226174|Oral Lichen Planus|oral lichen planus
505929|NCT00226187|Fatty acids|fatty acids
505930|NCT00226187|Human milk|human milk
505931|NCT00226187|Infant development|infant development
505932|NCT00226187|Very low birthweight infants|very low birthweight infants
505933|NCT00226200|Allergic|allergic
505934|NCT00226200|Non allergic|non allergic
505935|NCT00226239|head|head
505936|NCT00226239|neck|neck
505937|NCT00226252|Wheelchair|wheelchair
505938|NCT00226252|Propulsion|propulsion
505939|NCT00226252|Biomechanics|biomechanics
505940|NCT00226265|Cardiac surgery patients|cardiac surgery patients
505941|NCT00226265|Quality of Life|quality of life
505942|NCT00226265|Recall bias|recall bias
505943|NCT00226265|Aortic valve replacement|aortic valve replacement
505944|NCT00226265|Mitral valve replacement|mitral valve replacement
506319|NCT00228202|PCR|pcr
505945|NCT00226265|Tricuspid valve replacement|tricuspid valve replacement
505946|NCT00226265|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
505947|NCT00226291|EBM|ebm
505948|NCT00226291|evidence based medicine|evidence based medicine
505949|NCT00226291|informationist|informationist
505950|NCT00226291|clinical medical librarian|clinical medical librarian
505951|NCT00226304|Focal Brain Lesions|focal brain lesions
505952|NCT00226304|AIDS|aids
505953|NCT00226304|Lymphoma|lymphoma
505954|NCT00226304|EBV|ebv
505955|NCT00226304|FDG-PET|fdg-pet
505956|NCT00226304|HIV Infection|hiv infection
505957|NCT00226304|Brain Lesion|brain lesion
505958|NCT00226330|Patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study GALLANT 6.|patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study gallant 6.
505959|NCT00226369|Pediatric|pediatric
505960|NCT00226369|Cardiopulmonary bypass|cardiopulmonary bypass
505961|NCT00226369|Congenital heart disease|congenital heart disease
505962|NCT00226369|Reperfusion injury|reperfusion injury
505963|NCT00226382|Chronic Hepatitis B|chronic hepatitis b
505964|NCT00226382|Pegylated Interferon-alfa-2a|pegylated interferon-alfa-2a
505965|NCT00226382|Pegasys|pegasys
505966|NCT00226395|oxymorphone|oxymorphone
505967|NCT00226395|acute pain|acute pain
505968|NCT00226395|abdominal surgery|abdominal surgery
505969|NCT00226395|opioids|opioids
505970|NCT00226408|melanoma,adjuvant therapy,stageIII Interferon|melanoma,adjuvant therapy,stageiii interferon
505971|NCT00226408|high dose|high dose
505972|NCT00226421|opioid|opioid
505973|NCT00226421|oxymorphone|oxymorphone
505974|NCT00226421|chronic pain|chronic pain
505331|NCT00222716|HIV|hiv
505975|NCT00226421|randomized, double-blind trial|randomized, double-blind trial
505976|NCT00226421|low back pain|low back pain
505977|NCT00226434|HIV infection|hiv infection
505978|NCT00226434|Tuberculosis|tuberculosis
505979|NCT00226434|Paradoxical reaction|paradoxical reaction
505980|NCT00226434|Treatment Naive|treatment naive
505981|NCT00226447|Chronic Hepatitis B|chronic hepatitis b
505982|NCT00226447|Pegylated Interferon|pegylated interferon
505983|NCT00226447|Lamivudine|lamivudine
505984|NCT00226473|malignant Melanoma|malignant melanoma
505985|NCT00226473|Chemotherapy|chemotherapy
505986|NCT00226473|Metastasis|metastasis
505987|NCT00226473|standard palliative care|standard palliative care
505988|NCT00226473|best supportive care|best supportive care
505989|NCT00226525|Restenosis, skin metal allergy|restenosis, skin metal allergy
505990|NCT00226577|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
505991|NCT00226577|resectable|resectable
505992|NCT00226577|NSCLC|nsclc
505993|NCT00226590|non-small cell lung cancer|non-small cell lung cancer
505994|NCT00226590|carcinoma|carcinoma
505995|NCT00226590|unresectable|unresectable
505996|NCT00226590|Stage IIIA|stage iiia
505997|NCT00226590|Stage IIIB|stage iiib
505998|NCT00226590|thoracic radiation|thoracic radiation
505999|NCT00226603|groin injury|groin injury
506000|NCT00226603|football|football
506001|NCT00226603|prevention|prevention
506002|NCT00226603|traing programme|traing programme
506003|NCT00226603|cluster randomized study|cluster randomized study
506004|NCT00226616|Zinc|zinc
506005|NCT00226616|cholera|cholera
506006|NCT00226616|children|children
506007|NCT00226616|Bangladesh|bangladesh
506008|NCT00226642|depression|depression
506009|NCT00226642|primary care|primary care
506010|NCT00226655|peritumoral brain edema|peritumoral brain edema
506011|NCT00226655|edema|edema
506012|NCT00226655|malignant brain tumor|malignant brain tumor
506013|NCT00226655|astrocytoma|astrocytoma
506014|NCT00226655|brain tumor|brain tumor
506015|NCT00226655|dexamethasone|dexamethasone
506016|NCT00226655|Decadron|decadron
506017|NCT00226668|peritumoral brain edema|peritumoral brain edema
506018|NCT00226668|edema|edema
506019|NCT00226668|malignant brain tumor|malignant brain tumor
506020|NCT00226668|astrocytoma|astrocytoma
506021|NCT00226668|brain tumor|brain tumor
506022|NCT00226668|dexamethasone|dexamethasone
506023|NCT00226668|Decadron|decadron
506024|NCT00226694|Alcoholism|alcoholism
506025|NCT00226694|Stress|stress
506026|NCT00226694|Gender Differences|gender differences
506027|NCT00226694|Addiction|addiction
506028|NCT00226694|Alcohol Dependence|alcohol dependence
506029|NCT00226707|Chronic hand dermatitis, pimecrolimus, dermatitis|chronic hand dermatitis, pimecrolimus, dermatitis
506030|NCT00226720|alcoholism|alcoholism
506031|NCT00226720|Alcohol dependence|alcohol dependence
506032|NCT00226720|Detoxification|detoxification
506033|NCT00226720|Abstinence maintain|abstinence maintain
506034|NCT00226720|Efficacy|efficacy
506035|NCT00226720|Ambulatory detoxification|ambulatory detoxification
506036|NCT00226733|Coronary Artery Bypass (E04.928.220.520.220)|coronary artery bypass (e04.928.220.520.220)
506037|NCT00226733|Exercise Test [E01.370.370.380.250]|exercise test [e01.370.370.380.250]
506038|NCT00226733|Echocardiography [E01.370.370.380.220]|echocardiography [e01.370.370.380.220]
506039|NCT00226733|Quality of Life [K01.752.400.750]|quality of life [k01.752.400.750]
506040|NCT00226746|Pancreatic Cancer|pancreatic cancer
506041|NCT00226746|Hyperfractionated Radiation Therapy|hyperfractionated radiation therapy
506042|NCT00226746|Gemcitabine|gemcitabine
506043|NCT00226746|Paclitaxel|paclitaxel
506044|NCT00226746|Carcinoma, Pancreatic Ductal|carcinoma, pancreatic ductal
506045|NCT00226759|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
506046|NCT00226759|ACL reconstruction|acl reconstruction
506047|NCT00226772|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
506048|NCT00226772|ACL reconstruction|acl reconstruction
506049|NCT00226824|Tourette's disorder|tourette's disorder
506050|NCT00226824|tic|tic
506051|NCT00226876|dreaming|dreaming
506052|NCT00226876|anaesthesia|anaesthesia
506053|NCT00226876|electroencephalography|electroencephalography
506054|NCT00226876|bispectral index|bispectral index
506055|NCT00226876|awareness|awareness
506056|NCT00226889|Scleroderma|scleroderma
506057|NCT00226889|Fibrosis|fibrosis
506058|NCT00226889|Therapy|therapy
506059|NCT00226889|Bosentan|bosentan
506060|NCT00226889|Endothelin-1|endothelin-1
506061|NCT00226902|Diabetes|diabetes
506062|NCT00226902|Hemoglobin|hemoglobin
506063|NCT00226902|Dialysis|dialysis
506064|NCT00226902|Vascular reactivity|vascular reactivity
506065|NCT00226915|ovarian neoplasms|ovarian neoplasms
506066|NCT00226915|randomized controlled trial|randomized controlled trial
506067|NCT00226915|paclitaxel|paclitaxel
506068|NCT00226915|carboplatin|carboplatin
506069|NCT00227032|adult giant cell glioblastoma|adult giant cell glioblastoma
506071|NCT00227032|adult glioblastoma|adult glioblastoma
506072|NCT00227032|recurrent adult brain tumor|recurrent adult brain tumor
505394|NCT00222989|PPI|ppi
506073|NCT00227045|Kidney Transplantation|kidney transplantation
506074|NCT00227058|allergic rhinitis|allergic rhinitis
506075|NCT00227071|accidental falls|accidental falls
506076|NCT00227071|osteoporosis|osteoporosis
506077|NCT00227071|risk factors|risk factors
506078|NCT00227084|Mammary glands|mammary glands
506079|NCT00227084|hemostasis|hemostasis
506080|NCT00227084|Mammaplasty|mammaplasty
506081|NCT00227097|therapeutic education|therapeutic education
506082|NCT00227097|thrombi embolic disease|thrombi embolic disease
506083|NCT00227110|NASH, IGT, T2DM|nash, igt, t2dm
506084|NCT00227123|Bipolar, cocaine, methamphetamine,quetiapine,risperidone|bipolar, cocaine, methamphetamine,quetiapine,risperidone
506085|NCT00227136|5Hydroxytryptamine|5hydroxytryptamine
506086|NCT00227136|Chromogranin A|chromogranin a
506088|NCT00227136|carcinoid|carcinoid
506089|NCT00227149|C06.552.380.705.440|c06.552.380.705.440
506090|NCT00227162|Asthma|asthma
506091|NCT00227162|Behavior change|behavior change
506092|NCT00227162|Physical activity|physical activity
506093|NCT00227162|Risk reduction|risk reduction
506094|NCT00227175|African American|african american
506095|NCT00227175|Hypertension|hypertension
506096|NCT00227175|Medication adherence|medication adherence
506097|NCT00227175|Risk reduction|risk reduction
506098|NCT00227201|African-American|african-american
506099|NCT00227201|Hypertension|hypertension
506100|NCT00227201|Complementary medicine|complementary medicine
506101|NCT00227201|Medication adherence|medication adherence
506102|NCT00227253|Phenotype|phenotype
506103|NCT00227253|Growth|growth
506104|NCT00227253|Genotype|genotype
506105|NCT00227253|Chromosome 18|chromosome 18
506106|NCT00227266|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
506107|NCT00227266|SMA Type 2|sma type 2
506108|NCT00227266|SMA Type 3|sma type 3
506109|NCT00227279|Grass pollen allergy|grass pollen allergy
506110|NCT00227279|Hayfever|hayfever
506111|NCT00227279|Allergen immunotherapy|allergen immunotherapy
506112|NCT00227279|Specific immunotherapy|specific immunotherapy
506113|NCT00227292|Low back pain|low back pain
506114|NCT00227292|Depression|depression
506115|NCT00227305|Schizophrenia|schizophrenia
506116|NCT00227305|Bipolar I Disorder|bipolar i disorder
506117|NCT00227331|Pneumonia|pneumonia
506118|NCT00227357|HIV|hiv
506119|NCT00227357|AIDS|aids
506120|NCT00227357|Buprenorphine|buprenorphine
506121|NCT00227357|Methadone|methadone
506122|NCT00227357|Primary care|primary care
506123|NCT00227357|dual diagnosis|dual diagnosis
506124|NCT00227357|ptsd|ptsd
506125|NCT00227370|Acute rejection|acute rejection
506126|NCT00227370|Non-CMV infections|non-cmv infections
506127|NCT00227370|Resistance|resistance
506128|NCT00227383|Diabetes|diabetes
506129|NCT00227383|gastroparesis|gastroparesis
506130|NCT00227383|electroacupuncture|electroacupuncture
506131|NCT00227409|Repeated chelation therapy|repeated chelation therapy
506132|NCT00227409|Progressive renal insufficiency|progressive renal insufficiency
506133|NCT00227409|Body lead burden|body lead burden
506134|NCT00227409|Long-term outcome|long-term outcome
506135|NCT00227409|Glomerular filtration rate|glomerular filtration rate
506136|NCT00227422|Neisseria meningitidis serogroups A & C diseases|neisseria meningitidis serogroups a & c diseases
506137|NCT00227422|Hib diseases|hib diseases
506138|NCT00227448|Ischemic|ischemic
506139|NCT00227448|Stroke|stroke
506140|NCT00227461|Aphasia|aphasia
506141|NCT00227461|Stroke|stroke
506142|NCT00227474|stage IIIB breast cancer|stage iiib breast cancer
506143|NCT00227474|stage IIIC breast cancer|stage iiic breast cancer
506144|NCT00227474|stage IV breast cancer|stage iv breast cancer
506145|NCT00227487|autism|autism
506146|NCT00227487|intestine|intestine
506147|NCT00227487|disaccharidases|disaccharidases
506148|NCT00227487|inflammation|inflammation
506149|NCT00227487|permeability|permeability
506150|NCT00227500|Hyperlipidaemia|hyperlipidaemia
506151|NCT00227500|Lipid metabolism|lipid metabolism
506152|NCT00227500|Glucose metabolism|glucose metabolism
506153|NCT00227500|HMG CoA reductase inhibitors|hmg coa reductase inhibitors
506154|NCT00227500|Lipodystrophy|lipodystrophy
506155|NCT00227500|Cardiovascular disease|cardiovascular disease
506156|NCT00227500|Treatment Experienced|treatment experienced
506157|NCT00227500|HIV|hiv
506158|NCT00227526|Colon|colon
506159|NCT00227526|Surgery|surgery
506160|NCT00227526|Prehabilitation|prehabilitation
506161|NCT00227526|Exercise|exercise
583313|NCT00511264|Cancer|cancer
506162|NCT00227539|stage I non-small cell lung cancer|stage i non-small cell lung cancer
506163|NCT00227539|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
506164|NCT00227539|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
506165|NCT00227539|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
506166|NCT00227565|extensive stage small cell lung cancer|extensive stage small cell lung cancer
506167|NCT00227617|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
506168|NCT00227617|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
506169|NCT00227617|pulmonary carcinoid tumor|pulmonary carcinoid tumor
506170|NCT00227617|gastrinoma|gastrinoma
506171|NCT00227617|insulinoma|insulinoma
506172|NCT00227617|WDHA syndrome|wdha syndrome
506173|NCT00227617|glucagonoma|glucagonoma
506174|NCT00227617|pancreatic polypeptide tumor|pancreatic polypeptide tumor
506175|NCT00227617|somatostatinoma|somatostatinoma
506176|NCT00227617|recurrent islet cell carcinoma|recurrent islet cell carcinoma
506177|NCT00227617|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
506178|NCT00227630|epithelial mesothelioma|epithelial mesothelioma
506179|NCT00227630|sarcomatous mesothelioma|sarcomatous mesothelioma
506180|NCT00227630|localized malignant mesothelioma|localized malignant mesothelioma
506181|NCT00227630|recurrent malignant mesothelioma|recurrent malignant mesothelioma
506182|NCT00227656|stage IV breast cancer|stage iv breast cancer
506183|NCT00227656|recurrent breast cancer|recurrent breast cancer
506184|NCT00227656|male breast cancer|male breast cancer
506185|NCT00227656|tumors metastatic to brain|tumors metastatic to brain
506186|NCT00227669|uterine leiomyosarcoma|uterine leiomyosarcoma
506187|NCT00227669|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
506188|NCT00227669|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
506189|NCT00227669|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
506190|NCT00227669|stage III uterine sarcoma|stage iii uterine sarcoma
506191|NCT00227669|stage IV uterine sarcoma|stage iv uterine sarcoma
506192|NCT00227669|recurrent uterine sarcoma|recurrent uterine sarcoma
506193|NCT00227669|adult leiomyosarcoma|adult leiomyosarcoma
506194|NCT00227682|refractory multiple myeloma|refractory multiple myeloma
506195|NCT00227695|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
506196|NCT00227695|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
506197|NCT00227695|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
506198|NCT00227695|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
506199|NCT00227695|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
506200|NCT00227695|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
506201|NCT00227695|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
506202|NCT00227695|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
506203|NCT00227695|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
506204|NCT00227695|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
506205|NCT00227695|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
506206|NCT00227695|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
506207|NCT00227695|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
506208|NCT00227695|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
506209|NCT00227695|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
506210|NCT00227695|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
506211|NCT00227695|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
506212|NCT00227695|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
506213|NCT00227708|adenocarcinoma of the lung|adenocarcinoma of the lung
506214|NCT00227708|adenosquamous cell lung cancer|adenosquamous cell lung cancer
506215|NCT00227708|large cell lung cancer|large cell lung cancer
506216|NCT00227708|squamous cell lung cancer|squamous cell lung cancer
506217|NCT00227708|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
506218|NCT00227708|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
506219|NCT00227708|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
506220|NCT00227721|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
506221|NCT00227721|peritoneal cavity cancer|peritoneal cavity cancer
506222|NCT00227734|stage IV colon cancer|stage iv colon cancer
506223|NCT00227734|stage IV rectal cancer|stage iv rectal cancer
506224|NCT00227734|recurrent colon cancer|recurrent colon cancer
506225|NCT00227734|recurrent rectal cancer|recurrent rectal cancer
506226|NCT00227747|adenocarcinoma of the rectum|adenocarcinoma of the rectum
506227|NCT00227747|stage II rectal cancer|stage ii rectal cancer
506228|NCT00227747|stage III rectal cancer|stage iii rectal cancer
506229|NCT00227773|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
506230|NCT00227773|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
506231|NCT00227773|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
506232|NCT00227773|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
506233|NCT00227773|recurrent islet cell carcinoma|recurrent islet cell carcinoma
506234|NCT00227773|gastrinoma|gastrinoma
506235|NCT00227773|insulinoma|insulinoma
506236|NCT00227773|WDHA syndrome|wdha syndrome
506237|NCT00227773|glucagonoma|glucagonoma
506238|NCT00227773|pancreatic polypeptide tumor|pancreatic polypeptide tumor
506239|NCT00227773|somatostatinoma|somatostatinoma
506240|NCT00227786|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
506241|NCT00227786|tobacco use disorder|tobacco use disorder
506242|NCT00227812|cocaine dependence|cocaine dependence
506243|NCT00227825|Behavioral Intervention|behavioral intervention
506244|NCT00227838|substance abuse|substance abuse
506245|NCT00227864|marijuana|marijuana
506247|NCT00227877|alcohol abuse|alcohol abuse
506248|NCT00227877|substance abuse|substance abuse
506249|NCT00227877|substance related disorders|substance related disorders
506250|NCT00227890|substance abuse|substance abuse
506251|NCT00227916|alcohol, marijuana|alcohol, marijuana
506252|NCT00227929|Major Depressive Disorder|major depressive disorder
506254|NCT00227942|Women|women
506255|NCT00227942|Menopause|menopause
506256|NCT00227942|Depression|depression
506257|NCT00227942|Hot flash|hot flash
506258|NCT00227942|Insomnia|insomnia
506259|NCT00227942|Sleep Disruption|sleep disruption
506260|NCT00227942|Estrogen Replacement Therapy|estrogen replacement therapy
506261|NCT00227955|Major depression|major depression
506262|NCT00227968|Manic-depressive psychosis|manic-depressive psychosis
506263|NCT00227968|Depression, bipolar|depression, bipolar
506264|NCT00227981|Depression Relapse|depression relapse
506265|NCT00227981|Maintenance Therapy|maintenance therapy
506266|NCT00227994|Cholinesterase Inhibitors|cholinesterase inhibitors
506267|NCT00227994|Elderly|elderly
506268|NCT00227994|Stroke|stroke
506269|NCT00227994|Cognition|cognition
506270|NCT00228007|Injection Drug Use|injection drug use
506271|NCT00228007|HIV Risk Behavior|hiv risk behavior
506272|NCT00228007|HIV Seronegativity|hiv seronegativity
506273|NCT00228020|pediatric, kidney transplantation, basiliximab|pediatric, kidney transplantation, basiliximab
506274|NCT00228033|Calcium|calcium
506275|NCT00228033|Pregnancy|pregnancy
506276|NCT00228033|Postpartum Depression|postpartum depression
506277|NCT00228033|Depression|depression
506278|NCT00228046|ADHD|adhd
506279|NCT00228046|ODD|odd
506280|NCT00228046|Conduct Disorder|conduct disorder
506281|NCT00228046|CD|cd
506282|NCT00228059|Bipolar disorder, manic episode/treatment/licarbazepine|bipolar disorder, manic episode/treatment/licarbazepine
506283|NCT00228072|Hyperhidrosis|hyperhidrosis
506284|NCT00228072|Axillary|axillary
506285|NCT00228072|Excision|excision
506286|NCT00228072|Suction-curettage|suction-curettage
506287|NCT00228072|Outcome|outcome
506288|NCT00228111|Computed tomography|computed tomography
506289|NCT00228111|wounds and injuries,non penetrating|wounds and injuries,non penetrating
506290|NCT00228111|algorithms|algorithms
506291|NCT00228111|Blunt trauma of the thorax and abdomen|blunt trauma of the thorax and abdomen
506292|NCT00228124|Prostate cancer|prostate cancer
506293|NCT00228124|Continuous androgen suppression|continuous androgen suppression
506294|NCT00228124|Intermittent androgen suppression|intermittent androgen suppression
506295|NCT00228124|Bone loss|bone loss
506296|NCT00228124|Osteoporosis|osteoporosis
506297|NCT00228150|Parkinson Disease|parkinson disease
506298|NCT00228150|levodopa|levodopa
506299|NCT00228150|dopamine agonists|dopamine agonists
506300|NCT00228163|Multiple Sclerosis Relapsing Remitting|multiple sclerosis relapsing remitting
506301|NCT00228163|Secondary Progressive|secondary progressive
506302|NCT00228163|Progressive Relapsing|progressive relapsing
506303|NCT00228176|Metabolic syndrome|metabolic syndrome
506304|NCT00228176|Carotid Atherosclerosis|carotid atherosclerosis
506305|NCT00228189|Dendritic cells|dendritic cells
506306|NCT00228189|Colorectal cancer|colorectal cancer
506307|NCT00228189|Carcinoembryonic antigen|carcinoembryonic antigen
506308|NCT00228189|Vaccine|vaccine
506309|NCT00228189|Immunotherapy|immunotherapy
506310|NCT00228202|cytomegalovirus|cytomegalovirus
506312|NCT00228202|pregnancy|pregnancy
506313|NCT00228202|amniotic fluid|amniotic fluid
506314|NCT00228202|bone marrow|bone marrow
506315|NCT00228202|transplantation|transplantation
506316|NCT00228202|viral load|viral load
506317|NCT00228202|glycoprotein B|glycoprotein b
506318|NCT00228202|genotyping|genotyping
506320|NCT00228202|real-time PCR|real-time pcr
506321|NCT00228202|CMV disease|cmv disease
506322|NCT00228202|Congenital CMV infection|congenital cmv infection
506323|NCT00228215|sleep|sleep
506324|NCT00228215|neonates|neonates
506325|NCT00228215|mothers|mothers
506326|NCT00228215|behavioural intervention|behavioural intervention
506327|NCT00228228|Multiple Sclerosis|multiple sclerosis
506328|NCT00228228|T-cell vaccination|t-cell vaccination
506329|NCT00228228|Autoreactive T cells|autoreactive t cells
506330|NCT00228241|Sick sinus syndrome|sick sinus syndrome
506331|NCT00228241|AV-block|av-block
506332|NCT00228254|acute respiratory infection|acute respiratory infection
583314|NCT00511264|Biopsy|biopsy
506333|NCT00228254|acute lower respiratory infection|acute lower respiratory infection
506335|NCT00228267|Chronic Headache|chronic headache
506336|NCT00228267|Analgesic Rebound Headache|analgesic rebound headache
506337|NCT00228267|Chronic Daily Headache|chronic daily headache
506338|NCT00228267|Headache, Intractable|headache, intractable
506339|NCT00228267|Randomised controlled trial|randomised controlled trial
506340|NCT00228267|Propofol|propofol
506341|NCT00228280|Apicoectomy|apicoectomy
506342|NCT00228280|Retrograde|retrograde
506343|NCT00228280|MTA|mta
506344|NCT00228293|cardiac arrest|cardiac arrest
506345|NCT00228293|CPR|cpr
506346|NCT00228345|Idiopathic Axonal Polyneuropathy|idiopathic axonal polyneuropathy
506347|NCT00228345|abnormal OGTT|abnormal ogtt
506348|NCT00228371|Epilepsy|epilepsy
506349|NCT00228371|deep brain stimulation|deep brain stimulation
506350|NCT00228371|Subthalamic nucleus|subthalamic nucleus
506351|NCT00228371|Drug resistant epilepsy|drug resistant epilepsy
506352|NCT00228397|Multiple Sclerosis|multiple sclerosis
506353|NCT00228410|Skin Infections|skin infections
506354|NCT00228410|Skin Disease|skin disease
506355|NCT00228423|Saphenous vein|saphenous vein
506356|NCT00228423|Intimal hyperplasia|intimal hyperplasia
506357|NCT00228423|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
506358|NCT00228423|Antiplatelet therapy|antiplatelet therapy
506359|NCT00228423|Clopidogrel|clopidogrel
506360|NCT00228423|Saphenous vein graft disease|saphenous vein graft disease
506361|NCT00228436|anemia|anemia
506362|NCT00228436|chronic kidney disease|chronic kidney disease
506363|NCT00228436|CKD|ckd
506364|NCT00228436|chronic renal failure|chronic renal failure
506365|NCT00228436|CRF|crf
506366|NCT00228436|dialysis|dialysis
506367|NCT00228436|erythropoietin|erythropoietin
506368|NCT00228436|EPO|epo
506369|NCT00228436|erythropoiesis stimulating agent|erythropoiesis stimulating agent
506370|NCT00228436|ESA|esa
506371|NCT00228436|Hematide™|hematide™
506372|NCT00228436|hemoglobin|hemoglobin
506373|NCT00228436|Hb|hb
506374|NCT00228436|Hgb|hgb
506375|NCT00228436|Omontys|omontys
506376|NCT00228436|peginesatide|peginesatide
506377|NCT00228436|red blood cell|red blood cell
506378|NCT00228436|red blood cell production|red blood cell production
506379|NCT00228449|anemia|anemia
506380|NCT00228449|chronic kidney disease|chronic kidney disease
506381|NCT00228449|CKD|ckd
506382|NCT00228449|chronic renal failure|chronic renal failure
506383|NCT00228449|CRF|crf
506384|NCT00228449|dialysis|dialysis
506385|NCT00228449|erythropoietin|erythropoietin
506386|NCT00228449|EPO|epo
506387|NCT00228449|erythropoiesis stimulating agent|erythropoiesis stimulating agent
506388|NCT00228449|ESA|esa
506389|NCT00228449|Hematide™|hematide™
506390|NCT00228449|hemodialysis|hemodialysis
506391|NCT00228449|hemoglobin|hemoglobin
506392|NCT00228449|Hb|hb
506393|NCT00228449|Hgb|hgb
506394|NCT00228449|Omontys|omontys
506395|NCT00228449|peginesatide|peginesatide
506396|NCT00228449|red blood cell|red blood cell
506397|NCT00228449|red blood cell production|red blood cell production
506398|NCT00228462|Schizophrenia|schizophrenia
506399|NCT00228488|advanced non-nasopharyngeal head and neck carcinoma|advanced non-nasopharyngeal head and neck carcinoma
506400|NCT00219089|Hypertension, aliskiren, blood pressure, diabetes mellitus, ramipril|hypertension, aliskiren, blood pressure, diabetes mellitus, ramipril
506401|NCT00219102|Hypertension,|hypertension,
506402|NCT00219102|diabetes,|diabetes,
506403|NCT00219102|aliskiren,|aliskiren,
506404|NCT00219102|blood pressure,|blood pressure,
506405|NCT00219102|valsartan,|valsartan,
506406|NCT00219102|hydrochlorothiazide|hydrochlorothiazide
506407|NCT00219115|Hypertension, aliskiren, blood pressure, irbesartan, amlodipine, hydrochlorothiazide|hypertension, aliskiren, blood pressure, irbesartan, amlodipine, hydrochlorothiazide
506408|NCT00219128|Hypertension, aliskiren, blood pressure, placebo|hypertension, aliskiren, blood pressure, placebo
506409|NCT00219167|hypertension|hypertension
506410|NCT00219167|aliskiren|aliskiren
506411|NCT00219167|age|age
506412|NCT00219180|Hypertension, Aliskiren|hypertension, aliskiren
506413|NCT00219193|Hypertension, aliskiren, blood pressure, valsartan, HCTZ|hypertension, aliskiren, blood pressure, valsartan, hctz
506414|NCT00219219|zoledronic acid|zoledronic acid
506415|NCT00219219|prostate cancer|prostate cancer
506416|NCT00219219|SRE|sre
506417|NCT00219232|Alzheimer's disease|alzheimer's disease
506418|NCT00219232|Dementia|dementia
506507|NCT00219726|Imatinib mesylate|imatinib mesylate
506419|NCT00219245|Traumatic brain injury, head trauma, rivastigmine, cognitive deficits|traumatic brain injury, head trauma, rivastigmine, cognitive deficits
506420|NCT00219271|Prostate cancer|prostate cancer
506421|NCT00219271|molecular staging|molecular staging
506422|NCT00219271|antitumor potential|antitumor potential
506423|NCT00219284|Parkinson's disease, tremor|parkinson's disease, tremor
506424|NCT00219297|EPO|epo
506425|NCT00219297|EPO906|epo906
506426|NCT00219297|Brain cancer|brain cancer
506427|NCT00219297|Brain metastasis|brain metastasis
506428|NCT00219297|Lung cancer|lung cancer
506429|NCT00219297|Lung metastasis|lung metastasis
583315|NCT00511277|quetiapine|quetiapine
506430|NCT00219297|Brain metastasis from non-small cell lung cancer|brain metastasis from non-small cell lung cancer
506431|NCT00219310|Recurrent Genital Herpes (RGH), famciclovir, episodic treatment, suppressive treatment, Polymerase Chain Reaction (PCR).|recurrent genital herpes (rgh), famciclovir, episodic treatment, suppressive treatment, polymerase chain reaction (pcr).
506432|NCT00219323|Asthma, IgE, Omalizumab|asthma, ige, omalizumab
506433|NCT00219336|Prevent Alcohol Exposed Pregnancies|prevent alcohol exposed pregnancies
506434|NCT00219336|Reduced Alcohol Used|reduced alcohol used
506435|NCT00219336|Self-Guided Motivational Intervention|self-guided motivational intervention
506436|NCT00219336|Effective Contraception|effective contraception
652590|NCT00794352|HV|hv
506438|NCT00219336|College Students|college students
506439|NCT00219349|Anxiety Disorders|anxiety disorders
506440|NCT00219349|Anxiety Neuroses|anxiety neuroses
506441|NCT00219349|Behavior Therapy, Cognitive|behavior therapy, cognitive
506443|NCT00219362|HIV-1 infection|hiv-1 infection
506444|NCT00219362|therapeutic vaccine|therapeutic vaccine
506445|NCT00219362|Treatment Experienced|treatment experienced
506446|NCT00219375|sivelestat sodium hydrate|sivelestat sodium hydrate
506447|NCT00219375|acute lung injury|acute lung injury
506448|NCT00219375|systemic inflammatory response syndrome|systemic inflammatory response syndrome
506449|NCT00219375|Elaspol|elaspol
506450|NCT00219375|Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS)|acute lung injury (ali) associated with systemic inflammatory response syndrome (sirs)
506451|NCT00219388|Safety|safety
506452|NCT00219388|Efficacy|efficacy
506453|NCT00219388|Levosimendan|levosimendan
506454|NCT00219388|Dobutamine|dobutamine
506455|NCT00219388|Intravenous|intravenous
506456|NCT00219388|Invasive hemodynamics|invasive hemodynamics
506457|NCT00219388|Decompensated Heart Failure|decompensated heart failure
506458|NCT00219401|Pneumococcal vaccine|pneumococcal vaccine
506459|NCT00219401|Antibody responses|antibody responses
506460|NCT00219401|Cellular immunology|cellular immunology
506461|NCT00219401|Th1/Th2 immune responses|th1/th2 immune responses
506462|NCT00219401|Paediatric|paediatric
506463|NCT00219401|Neonatal|neonatal
506464|NCT00219401|Infectious diseases|infectious diseases
506465|NCT00219401|Papua New Guinea|papua new guinea
506466|NCT00219427|Low vision|low vision
506467|NCT00219453|Pilot Projects|pilot projects
506468|NCT00219453|Injections, Jet|injections, jet
506469|NCT00219453|Injections, Jet/instrumentation|injections, jet/instrumentation
506470|NCT00219453|Equipment Contamination/prevention and control|equipment contamination/prevention and control
506471|NCT00219453|Blood-Borne Pathogens|blood-borne pathogens
506472|NCT00219453|Disease Transmission, Horizontal|disease transmission, horizontal
506473|NCT00219479|seizure prophylaxis|seizure prophylaxis
506474|NCT00219479|enteral nutrition|enteral nutrition
506475|NCT00219492|NCCP, mast cell, esophagus|nccp, mast cell, esophagus
506476|NCT00219505|Diarrhea-predominant irritable bowel syndrome|diarrhea-predominant irritable bowel syndrome
506477|NCT00219505|Acupuncture|acupuncture
506478|NCT00219505|abdominal pain|abdominal pain
506479|NCT00219518|Defecography|defecography
506480|NCT00219518|Pelvic floor dyssynergia|pelvic floor dyssynergia
506481|NCT00219518|Anismus|anismus
506482|NCT00219531|functional MRI|functional mri
506483|NCT00219531|pain perception|pain perception
506484|NCT00219531|anxiety|anxiety
506485|NCT00219531|brain-gut axis|brain-gut axis
506486|NCT00219557|Randomized Phase 2 Study of AG-013736 in Combination with Gemcitabine versus Gemcitabine Alone in Advanced Pancreatic Cancer|randomized phase 2 study of ag-013736 in combination with gemcitabine versus gemcitabine alone in advanced pancreatic cancer
506487|NCT00219661|randomised control trial|randomised control trial
506488|NCT00219661|intensive care unit|intensive care unit
506489|NCT00219661|mechanical ventilation|mechanical ventilation
506490|NCT00219661|ventilator-associated pneumonia|ventilator-associated pneumonia
506491|NCT00219661|drainage of subglottic secretions|drainage of subglottic secretions
506492|NCT00219674|education|education
506493|NCT00219674|training, defibrillators|training, defibrillators
506494|NCT00219674|home defibrillators|home defibrillators
506495|NCT00219674|automated external defibrillators|automated external defibrillators
506496|NCT00219674|psychological adjustment|psychological adjustment
506497|NCT00219687|Heart arrest|heart arrest
506498|NCT00219687|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
506499|NCT00219687|Dispatcher|dispatcher
506500|NCT00219700|NSAID-PC|nsaid-pc
506501|NCT00219700|IBU-PC|ibu-pc
506502|NCT00219713|Nitrous oxide and oxygen|nitrous oxide and oxygen
506503|NCT00219713|Pain|pain
506504|NCT00219713|Bone marrow biopsy|bone marrow biopsy
506505|NCT00219713|Bone marrow aspiration|bone marrow aspiration
506508|NCT00219726|Stem cell transplantation|stem cell transplantation
506509|NCT00219739|CML|cml
506510|NCT00219739|Imatinib|imatinib
506511|NCT00219739|Interferon|interferon
506512|NCT00219739|Cytarabine|cytarabine
506513|NCT00219752|CML - ederly patients - Imatinib mesylate|cml - ederly patients - imatinib mesylate
506514|NCT00219765|CML|cml
506515|NCT00219765|Acute Phase|acute phase
506516|NCT00219765|Imatinib mesylate|imatinib mesylate
506517|NCT00219765|Cytarabine|cytarabine
506518|NCT00219765|Daunorubicine|daunorubicine
506519|NCT00219791|methotrexate|methotrexate
506520|NCT00219791|delayed elimination|delayed elimination
506521|NCT00219791|renal insufficiency|renal insufficiency
506522|NCT00219791|CPG2|cpg2
506523|NCT00219791|Voraxaze|voraxaze
506524|NCT00219817|Anorexia|anorexia
506525|NCT00219817|Cachexia|cachexia
506526|NCT00219830|Cardiac Rehabilitation|cardiac rehabilitation
506527|NCT00219830|Walking|walking
506528|NCT00219830|Acute Myocardial Infarction|acute myocardial infarction
506529|NCT00219830|Secondary Prevention|secondary prevention
506530|NCT00219843|Stage III and IV melanoma|stage iii and iv melanoma
506531|NCT00219856|Propofol|propofol
506532|NCT00219856|Hepatectomy|hepatectomy
506533|NCT00219856|Oxidative stress|oxidative stress
506534|NCT00219869|Post|post
506535|NCT00219869|Traumatic|traumatic
506537|NCT00219869|Cognitive|cognitive
506538|NCT00219882|Cystic Fibrosis|cystic fibrosis
506539|NCT00219882|curcuminoids|curcuminoids
506540|NCT00219882|turmeric root extract|turmeric root extract
506541|NCT00219882|nasal potential difference (NPD)|nasal potential difference (npd)
506542|NCT00219882|sweat chloride|sweat chloride
506543|NCT00219895|Cystic Fibrosis|cystic fibrosis
506544|NCT00219895|Anti-inflammatory Agents|anti-inflammatory agents
506545|NCT00219895|Ibuprofen|ibuprofen
506546|NCT00219908|Multiple sclerosis|multiple sclerosis
506547|NCT00219908|Mitoxantrone|mitoxantrone
506548|NCT00219908|Methylprednisolone|methylprednisolone
506549|NCT00219908|Interferon beta1b|interferon beta1b
506550|NCT00219908|Relapse|relapse
506551|NCT00219908|MRI|mri
506552|NCT00219908|EDSS|edss
506553|NCT00219921|total hip replacement|total hip replacement
506554|NCT00219921|pain treatment|pain treatment
506555|NCT00219934|New HIV Infection|new hiv infection
506556|NCT00219934|Acute HIV Infection|acute hiv infection
506557|NCT00219934|Primary HIV Infection|primary hiv infection
506558|NCT00219934|Acute Seroconversion Syndrome|acute seroconversion syndrome
506559|NCT00219947|HIV Infection|hiv infection
506560|NCT00219947|Acute HIV Infection|acute hiv infection
506561|NCT00219947|Primary HIV Infection|primary hiv infection
506562|NCT00219947|Acute Seroconversion Syndrome|acute seroconversion syndrome
506563|NCT00219960|Hypertension|hypertension
506564|NCT00219960|Blood Pressure|blood pressure
506565|NCT00219960|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
506566|NCT00219960|Complementary and Alternative Medicine|complementary and alternative medicine
506567|NCT00219960|Herbal|herbal
506568|NCT00219960|North American Ginseng|north american ginseng
506569|NCT00219960|Panax Quinquefolius|panax quinquefolius
506570|NCT00219973|venous thromboembolism|venous thromboembolism
506571|NCT00219973|deep vein thrombosis|deep vein thrombosis
506572|NCT00219973|pulmonary embolism|pulmonary embolism
506573|NCT00219973|bleeding|bleeding
506574|NCT00219973|low-molecular-weight heparin|low-molecular-weight heparin
506575|NCT00219973|cancer|cancer
506576|NCT00219973|surgery|surgery
506577|NCT00219986|Treatment Experienced|treatment experienced
506578|NCT00219986|HIV|hiv
506579|NCT00219999|Hepatitis|hepatitis
506580|NCT00219999|Hepacivirus|hepacivirus
506581|NCT00219999|B Lymphocytes|b lymphocytes
506582|NCT00219999|Chemokines|chemokines
506583|NCT00219999|Antibodies|antibodies
506584|NCT00220090|Irritable Bowel Syndrome|irritable bowel syndrome
506585|NCT00220090|Cholecystokinin|cholecystokinin
506586|NCT00220090|Dexloxiglumide|dexloxiglumide
506587|NCT00220090|Randomized/withdrawal|randomized/withdrawal
506588|NCT00220181|Nutritional status|nutritional status
506589|NCT00220181|Bowel symptoms|bowel symptoms
506590|NCT00220181|Radical radiotherapy to pelvis|radical radiotherapy to pelvis
506591|NCT00220181|Gynaecological, urological or rectal cancer|gynaecological, urological or rectal cancer
506592|NCT00220207|Diabetes|diabetes
506593|NCT00220207|Health Education|health education
506594|NCT00220207|Information Technology|information technology
506595|NCT00220207|African Americans|african americans
506596|NCT00220207|Disease Management|disease management
506597|NCT00220207|Internet|internet
506598|NCT00220207|Patient Education|patient education
506599|NCT00220246|Hereditary colorectal cancer|hereditary colorectal cancer
506600|NCT00220246|Microsatellite instability|microsatellite instability
506601|NCT00220246|Chromosomal instability|chromosomal instability
506602|NCT00220259|Cystic Fibrosis, inhaled corticosteroids|cystic fibrosis, inhaled corticosteroids
506603|NCT00220272|Parkinson Disease|parkinson disease
506604|NCT00220272|5-fluorodopa|5-fluorodopa
506605|NCT00220285|Antigen|antigen
506606|NCT00220285|CD20|cd20
506607|NCT00220324|Contraception|contraception
506608|NCT00220350|arousal|arousal
506609|NCT00220350|sex offender|sex offender
506610|NCT00220350|suppression of arousal|suppression of arousal
506611|NCT00220350|pedohilia|pedohilia
506612|NCT00220350|leuprolide acetate|leuprolide acetate
506613|NCT00220428|T cell|t cell
506614|NCT00220441|IGT|igt
506616|NCT00220441|cognition|cognition
506617|NCT00220441|insulin|insulin
506618|NCT00220441|aging|aging
506619|NCT00220441|aerobic|aerobic
506620|NCT00220454|cognition|cognition
506621|NCT00220454|estradiol|estradiol
506622|NCT00220454|cortisol|cortisol
506623|NCT00220454|postmenopause|postmenopause
506624|NCT00220467|MCI|mci
506625|NCT00220467|aging|aging
506626|NCT00220467|cognition|cognition
506627|NCT00220467|exercise|exercise
506628|NCT00220467|aerobic|aerobic
506629|NCT00220467|insulin|insulin
506630|NCT00220493|MS|ms
506631|NCT00220493|RITALIN|ritalin
506632|NCT00220493|PASAT|pasat
506633|NCT00220493|COGNITION|cognition
506634|NCT00220493|ATTENTION|attention
652822|NCT00795470|ICU|icu
506635|NCT00220493|Relapsing remitting|relapsing remitting
506636|NCT00220493|Secondary progressive|secondary progressive
506637|NCT00220493|Primary progressive|primary progressive
506638|NCT00220506|provigil|provigil
506639|NCT00220506|fatigue|fatigue
506640|NCT00220506|Multiple Sclerosis|multiple sclerosis
506641|NCT00220506|cognition|cognition
506642|NCT00220532|Randomised placebo controlled intervention trial|randomised placebo controlled intervention trial
506643|NCT00220532|Folic acid|folic acid
506644|NCT00220532|Riboflavin|riboflavin
506645|NCT00220532|cervical cancer|cervical cancer
506646|NCT00220545|Polycystic ovarY|polycystic ovary
506647|NCT00220545|Laparoscopic ovarian diathermy|laparoscopic ovarian diathermy
506648|NCT00220545|Induction of ovulation|induction of ovulation
506649|NCT00220545|Clomiphene citrate|clomiphene citrate
506650|NCT00220558|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
506651|NCT00220558|Bare metal stents|bare metal stents
506652|NCT00220558|drug eluting stents|drug eluting stents
506653|NCT00220571|AMI|ami
506654|NCT00220571|stent|stent
506655|NCT00220571|PTCA|ptca
506656|NCT00220571|abciximab|abciximab
506657|NCT00220571|reteplase|reteplase
506658|NCT00220571|combo therapy|combo therapy
506659|NCT00220597|group therapy|group therapy
506660|NCT00220597|sexual revictimization|sexual revictimization
506661|NCT00220597|risky sex|risky sex
506662|NCT00220597|addiction|addiction
506663|NCT00220623|major depression|major depression
506664|NCT00220623|psychotherapy|psychotherapy
506665|NCT00220623|antidepressant medications|antidepressant medications
506666|NCT00220623|clincial trial|clincial trial
506667|NCT00220636|Major Depression|major depression
506668|NCT00220636|Depression|depression
506669|NCT00220636|Unipolar Depression|unipolar depression
506670|NCT00220636|Treatment Resistant Depression|treatment resistant depression
506671|NCT00220636|Adjunctive treatment|adjunctive treatment
506672|NCT00220649|solid tumors or adenocarcinoma of the exocrine pancreas|solid tumors or adenocarcinoma of the exocrine pancreas
506673|NCT00220662|anorexia nervosa|anorexia nervosa
506674|NCT00220662|bulimia nervosa|bulimia nervosa
506675|NCT00220662|readiness and motivation|readiness and motivation
506676|NCT00220675|Malignant extradural spinal cord compression|malignant extradural spinal cord compression
506677|NCT00220675|Erythropoietin|erythropoietin
506678|NCT00220675|Neuroprotectant|neuroprotectant
506679|NCT00220675|Radiotherapy|radiotherapy
506680|NCT00220675|Palliation|palliation
506681|NCT00220688|nausea|nausea
506682|NCT00220688|vomiting|vomiting
506683|NCT00220688|palliative|palliative
506684|NCT00220688|acupressure|acupressure
506685|NCT00220701|Dysthymic Disorder|dysthymic disorder
506686|NCT00220701|Depression|depression
506687|NCT00220701|Chronic Depression|chronic depression
506688|NCT00220701|Escitalopram|escitalopram
506689|NCT00220714|schizophrenia|schizophrenia
506690|NCT00220714|first-episode|first-episode
506691|NCT00220714|patient compliance|patient compliance
506692|NCT00220714|long-acting risperidone|long-acting risperidone
506693|NCT00220714|relapse|relapse
506694|NCT00220727|Idiopathic (Immune) Thrombocytopenic Purpura|idiopathic (immune) thrombocytopenic purpura
506695|NCT00220727|Immunoglobulin G|immunoglobulin g
506696|NCT00220740|Immunoglobulin G|immunoglobulin g
506697|NCT00220753|Dog allergy|dog allergy
506698|NCT00220753|Pet allergy|pet allergy
506699|NCT00220753|Air cleaners|air cleaners
506700|NCT00220753|HEPA filters|hepa filters
506701|NCT00220753|Air filtration|air filtration
506702|NCT00220753|Can f1|can f1
506703|NCT00220753|Asthma|asthma
506704|NCT00220753|Children|children
506705|NCT00220753|Adolescents|adolescents
506706|NCT00220753|Indoor environment|indoor environment
506707|NCT00220753|Indoor allergy|indoor allergy
506708|NCT00220753|Perennial allergy|perennial allergy
506709|NCT00220766|Primary Immune Deficiency|primary immune deficiency
506710|NCT00220766|IGIV|igiv
506711|NCT00220766|Immunoglobulin G|immunoglobulin g
506712|NCT00220792|Primary breast cancer|primary breast cancer
506713|NCT00220792|support groups|support groups
506714|NCT00220792|mood disturbance|mood disturbance
506715|NCT00220818|Pediatric GERD|pediatric gerd
506716|NCT00220818|Pediatric Gastroesophageal Reflux Disease|pediatric gastroesophageal reflux disease
506718|NCT00220831|Diabetes|diabetes
506719|NCT00220831|MI|mi
506720|NCT00220831|CVD disease|cvd disease
506721|NCT00220857|Rabeprazole|rabeprazole
506722|NCT00220857|Nonsteroidal Antiinflammatory Drugs|nonsteroidal antiinflammatory drugs
506723|NCT00220857|Gastric erosions|gastric erosions
506724|NCT00220870|schizophrenia|schizophrenia
506725|NCT00220870|shared decision making|shared decision making
506726|NCT00220870|compliance|compliance
506727|NCT00220870|maintenance therapy|maintenance therapy
506728|NCT00220883|Functional Dyspepsia|functional dyspepsia
506729|NCT00220883|Electrogastrography|electrogastrography
506730|NCT00220896|Delirium|delirium
506731|NCT00220896|Prevention|prevention
506732|NCT00220896|Donepezil|donepezil
506733|NCT00220909|Gastric erosions|gastric erosions
506734|NCT00220909|Proton pump inhibitors|proton pump inhibitors
506735|NCT00220922|Copaxone|copaxone
506736|NCT00220935|Randomized controlled clinical trial|randomized controlled clinical trial
506737|NCT00220948|discogenic pain|discogenic pain
506738|NCT00220948|myoelectric activity|myoelectric activity
506739|NCT00220961|Impaired Glucose Tolerance|impaired glucose tolerance
506740|NCT00220961|Type 2 Diabetes|type 2 diabetes
506741|NCT00220961|Prevention|prevention
506742|NCT00220961|Pioglitazone|pioglitazone
506743|NCT00220987|Hyperglycemia in the critically ill patient|hyperglycemia in the critically ill patient
506744|NCT00220987|Intensive Insulin Therapy|intensive insulin therapy
506745|NCT00220987|Conventional insulin therapy|conventional insulin therapy
506746|NCT00220987|Hypoglycaemia|hypoglycaemia
506747|NCT00221000|Rheumatoid Arthritis|rheumatoid arthritis
506748|NCT00221013|Acute Renal Failure|acute renal failure
506749|NCT00221013|Continuous Renal Replacement Therapy|continuous renal replacement therapy
506750|NCT00221013|Continuous Veno-Venous Haemofiltration|continuous veno-venous haemofiltration
506751|NCT00221013|Continuous Veno-Venous Haemodiafiltration|continuous veno-venous haemodiafiltration
506752|NCT00221013|Renal Replacement Therapy|renal replacement therapy
506753|NCT00221039|ECP|ecp
506754|NCT00221039|Photopheresis|photopheresis
506755|NCT00221039|CTCL|ctcl
506756|NCT00221039|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
506757|NCT00221039|Mycosis Fungoides|mycosis fungoides
506758|NCT00221065|Sleep Apnea Syndromes|sleep apnea syndromes
506759|NCT00221065|Cerebrovascular Accident|cerebrovascular accident
506760|NCT00221078|Cerebrovascular Accident|cerebrovascular accident
506761|NCT00221078|Stroke|stroke
506762|NCT00221091|idiopathic normal pressure hydrocephalus|idiopathic normal pressure hydrocephalus
506763|NCT00221091|shunt|shunt
506764|NCT00221104|stroke|stroke
506765|NCT00221104|brain ischemia|brain ischemia
506766|NCT00221104|cerebrovascular accident|cerebrovascular accident
506767|NCT00221104|statin|statin
506768|NCT00221104|hydroxymethylglutaryl-CoA reductase inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
506769|NCT00221104|cholesterol|cholesterol
506770|NCT00221104|hypercholesterolemia|hypercholesterolemia
506771|NCT00221104|hyperlipidemia|hyperlipidemia
506772|NCT00221104|multicenter studies|multicenter studies
506773|NCT00221104|prospective studies|prospective studies
506774|NCT00221104|endpoint determination|endpoint determination
506775|NCT00221104|randomized controlled trials|randomized controlled trials
506776|NCT00221104|recurrence|recurrence
506777|NCT00221104|pravastatin|pravastatin
506778|NCT00221117|Spinal Cord Injuries|spinal cord injuries
506779|NCT00221130|Regenerative medicine|regenerative medicine
506780|NCT00221130|Periodontal tissue|periodontal tissue
506781|NCT00221143|Ulcer/ gangrene|ulcer/ gangrene
506782|NCT00221143|Leg diseases|leg diseases
506783|NCT00221143|Pain|pain
506784|NCT00221143|Vascular diseases|vascular diseases
506785|NCT00221143|Chronic limb ischemia|chronic limb ischemia
506786|NCT00221143|Peripheral artery disease|peripheral artery disease
506787|NCT00221156|Abnormal Glucose Tolerance|abnormal glucose tolerance
506788|NCT00221156|coronary artery disease|coronary artery disease
506789|NCT00221156|diabetes mellitus|diabetes mellitus
506790|NCT00221156|clinical outcome|clinical outcome
506791|NCT00221169|Non-small cell lung cancer|non-small cell lung cancer
506792|NCT00221169|Positron emission tomography|positron emission tomography
506793|NCT00221169|Gross tumor volume|gross tumor volume
506794|NCT00221169|Radiation therapy|radiation therapy
506796|NCT00221182|Heart diseases|heart diseases
506797|NCT00221182|Pain|pain
506798|NCT00221182|Vascular diseases|vascular diseases
506799|NCT00221208|Diabetes|diabetes
506800|NCT00221208|Resistance Training|resistance training
506801|NCT00221221|breast cancer survivors|breast cancer survivors
506802|NCT00221221|physical activity|physical activity
506803|NCT00221221|health promotion|health promotion
506804|NCT00221234|Diabetes|diabetes
506805|NCT00221234|Physical Activity|physical activity
506806|NCT00221247|cerebral palsy; acupuncture|cerebral palsy; acupuncture
506807|NCT00221260|Analgesia|analgesia
506808|NCT00221260|anesthesia|anesthesia
506809|NCT00221286|chronic hepatitis B|chronic hepatitis b
506909|NCT00228878|Diabetes|diabetes
506810|NCT00221286|human immunodeficiency virus|human immunodeficiency virus
506811|NCT00221286|pegylated interferon|pegylated interferon
506812|NCT00221286|tenofovir DF|tenofovir df
506813|NCT00221286|emtricitabine|emtricitabine
506814|NCT00221299|Osteoporosis|osteoporosis
506815|NCT00221299|Steroids|steroids
506816|NCT00221299|Prednisone|prednisone
506817|NCT00221312|Perimenopausal bone loss|perimenopausal bone loss
506818|NCT00221325|Phase I Clinical Trial|phase i clinical trial
506819|NCT00221325|Pharmacokinetics|pharmacokinetics
506820|NCT00221325|Pharmacodynamics|pharmacodynamics
506821|NCT00221325|CNS Lymphoma|cns lymphoma
506822|NCT00221325|Ocular Lymphoma|ocular lymphoma
506823|NCT00221338|gabapentin|gabapentin
506824|NCT00221338|pain|pain
506825|NCT00221338|surgery|surgery
506826|NCT00221338|delirium|delirium
506827|NCT00221338|cognitive decline|cognitive decline
506828|NCT00221351|cough|cough
506829|NCT00221351|acute bronchitis|acute bronchitis
506830|NCT00221351|upper respiratory tract infection|upper respiratory tract infection
506831|NCT00221351|pneumonia|pneumonia
506832|NCT00221351|lower respiratory tract infection|lower respiratory tract infection
506833|NCT00221364|Trachoma|trachoma
506834|NCT00221364|Chlamydia|chlamydia
506835|NCT00221364|Azithromycin|azithromycin
506836|NCT00221377|intubation|intubation
506837|NCT00221377|trachea|trachea
506838|NCT00221377|tube|tube
506839|NCT00221377|cuff|cuff
506840|NCT00221377|children|children
506841|NCT00221390|stroke|stroke
506842|NCT00221390|Chronic stroke with hemiparesis|chronic stroke with hemiparesis
506843|NCT00221403|child|child
506844|NCT00221403|adolescent|adolescent
506845|NCT00221403|bipolar disorder|bipolar disorder
506846|NCT00221416|child|child
506847|NCT00221416|adolescent|adolescent
506848|NCT00221429|child|child
506849|NCT00221429|adolescent|adolescent
506850|NCT00221442|Adults|adults
506851|NCT00221442|Binge eating disorder|binge eating disorder
506852|NCT00221442|Blood draw|blood draw
506853|NCT00221442|E.Coli enterprotoxin|e.coli enterprotoxin
506854|NCT00221442|Eating disorders|eating disorders
506855|NCT00221442|Electrocardiogram|electrocardiogram
506856|NCT00221442|Females|females
506857|NCT00221442|Males|males
506858|NCT00221442|Physical exam|physical exam
506859|NCT00221442|Psychiatric evaluation|psychiatric evaluation
506860|NCT00221442|Questionnaire|questionnaire
506861|NCT00221455|Diabetes Mellitus|diabetes mellitus
506862|NCT00221455|Chronic disease management|chronic disease management
506863|NCT00221455|Patient portal|patient portal
506864|NCT00221455|Patient empowerment|patient empowerment
506865|NCT00221468|Adolescents|adolescents
506866|NCT00221481|Bipolar|bipolar
506867|NCT00221481|Alcohol|alcohol
506868|NCT00221494|depression|depression
506869|NCT00221507|Vaccination|vaccination
506870|NCT00221507|Prevention & Control|prevention & control
506871|NCT00221520|Sedation, mechanical ventilation|sedation, mechanical ventilation
506872|NCT00228579|diabetes|diabetes
506873|NCT00228579|insulin resistance|insulin resistance
506874|NCT00228605|Pain|pain
506875|NCT00228605|Sudden Pain|sudden pain
506876|NCT00228605|Flares|flares
506877|NCT00228605|noncancer|noncancer
506878|NCT00228605|low back pain|low back pain
506879|NCT00228605|neuropathic pain|neuropathic pain
506880|NCT00228605|osteoarthritis pain|osteoarthritis pain
506881|NCT00228605|migraine|migraine
506882|NCT00228605|chronic headache|chronic headache
506883|NCT00228605|diabetic peripheral neuropathy|diabetic peripheral neuropathy
506884|NCT00228618|oxidative stress|oxidative stress
506885|NCT00228618|amino acids|amino acids
506886|NCT00228618|dietary requirements|dietary requirements
506887|NCT00228631|sickle|sickle
506888|NCT00228631|cell|cell
506889|NCT00228644|oxidative stress|oxidative stress
506890|NCT00228644|amino acids|amino acids
506891|NCT00228644|acetaminophen|acetaminophen
506892|NCT00228644|dietary requirements|dietary requirements
506893|NCT00228670|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
506894|NCT00228670|herpesvirus|herpesvirus
506895|NCT00228670|lung biopsy|lung biopsy
506896|NCT00228670|Having diagnosed lung disease|having diagnosed lung disease
506897|NCT00228670|Scheduled to have a lung biopsy as part of the evaluation for your lung disease|scheduled to have a lung biopsy as part of the evaluation for your lung disease
506898|NCT00228696|late effects|late effects
506899|NCT00228839|Recipients of an allogeneic hematopoietic stem cell transplant who have acute GVHD|recipients of an allogeneic hematopoietic stem cell transplant who have acute gvhd
506900|NCT00228852|Patients with severe T-cell immune deficiency diseases|patients with severe t-cell immune deficiency diseases
506901|NCT00228865|Pulsatile intravenous insulin|pulsatile intravenous insulin
506902|NCT00228865|Oral carbohydrate loading|oral carbohydrate loading
506903|NCT00228865|Mindstream testing|mindstream testing
506904|NCT00228865|Wechsler Memory Scale II|wechsler memory scale ii
506905|NCT00228865|Respiratory Quotients|respiratory quotients
506906|NCT00228865|Hypoglycemia|hypoglycemia
506907|NCT00228865|Diabetes Mellitus with cognitive impairment|diabetes mellitus with cognitive impairment
506908|NCT00228865|Diabetes Mellitus with complications|diabetes mellitus with complications
506910|NCT00228878|Pulsatile intravenous insulin|pulsatile intravenous insulin
506911|NCT00228878|Oral carbohydrate loading|oral carbohydrate loading
506912|NCT00228878|Respiratory Quotients|respiratory quotients
506913|NCT00228878|Hypoglycemia|hypoglycemia
506914|NCT00228878|Diabetes Mellitus, with complications|diabetes mellitus, with complications
506915|NCT00228891|Pulsatile intravenous insulin|pulsatile intravenous insulin
506916|NCT00228891|Oral carbohydrate loading|oral carbohydrate loading
506917|NCT00228891|Respiratory Quotients|respiratory quotients
506918|NCT00228891|Hypoglycemia|hypoglycemia
506919|NCT00228891|Diabetic Neuropathy|diabetic neuropathy
506920|NCT00228904|Pulsatile intravenous insulin|pulsatile intravenous insulin
506921|NCT00228904|Oral carbohydrate loading|oral carbohydrate loading
506922|NCT00228904|Respiratory Quotients|respiratory quotients
506923|NCT00228904|Hypoglycemia|hypoglycemia
506924|NCT00228904|Diabetic Neuropathy|diabetic neuropathy
506925|NCT00228904|Diabetes Mellitus, with complications|diabetes mellitus, with complications
506926|NCT00228917|Hib & Neisseria meningitidis serogroups A & C diseases|hib & neisseria meningitidis serogroups a & c diseases
506927|NCT00228930|Breast Cancer|breast cancer
506928|NCT00228930|Tamoxifen|tamoxifen
506929|NCT00228930|Prevention|prevention
506930|NCT00228943|Breast cancer survivorship|breast cancer survivorship
506931|NCT00228943|Hot Flashes|hot flashes
506932|NCT00228943|Serotonin|serotonin
506933|NCT00228956|Breast Cancer|breast cancer
506934|NCT00228956|Aromatase Inhibitor|aromatase inhibitor
506935|NCT00228956|Letrozole|letrozole
506936|NCT00228956|Exemestane|exemestane
506937|NCT00228982|Complicated Skin Infections|complicated skin infections
506938|NCT00228982|Infectious Skin Diseases|infectious skin diseases
506939|NCT00228982|Bacterial Skin Diseases|bacterial skin diseases
506940|NCT00228982|Staphylococcal Skin Infections|staphylococcal skin infections
506941|NCT00228982|Cephalosporin|cephalosporin
506943|NCT00228995|Subcutaneous injection|subcutaneous injection
506944|NCT00228995|PROCRIT|procrit
506945|NCT00228995|Erythropoietin|erythropoietin
506946|NCT00228995|Epoetin Alfa|epoetin alfa
506947|NCT00228995|Hemoglobin Level|hemoglobin level
506948|NCT00228995|Elderly|elderly
506949|NCT00229008|Ceftobiprole medocaril|ceftobiprole medocaril
506950|NCT00229008|Nosocomial Pneumonia|nosocomial pneumonia
506951|NCT00229008|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
506952|NCT00229008|Cephalosporins|cephalosporins
506953|NCT00229008|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
506954|NCT00229021|Complicated Urinary Tract Infection|complicated urinary tract infection
506955|NCT00229021|Pyelonephritis|pyelonephritis
506956|NCT00229268|Healthy Volunteers|healthy volunteers
506957|NCT00229307|Post traumatic stress disorder|post traumatic stress disorder
506958|NCT00229333|Escitalopram|escitalopram
506959|NCT00229333|Depression|depression
506960|NCT00229333|Dementia|dementia
506961|NCT00229333|Treatment|treatment
506962|NCT00229333|Depressive Syndrome in Alzheimer’s Disease|depressive syndrome in alzheimer’s disease
506963|NCT00229333|Depressive Syndrome in Vascular Dementia|depressive syndrome in vascular dementia
506964|NCT00229333|Depressive Syndrome in Mixed Vascular and Alzheimer’s Dementia|depressive syndrome in mixed vascular and alzheimer’s dementia
506965|NCT00229411|intensive care|intensive care
506966|NCT00229411|teamwork|teamwork
506967|NCT00229411|medical errors|medical errors
506968|NCT00229411|education|education
506969|NCT00229411|simulation|simulation
506970|NCT00229424|lafutidine|lafutidine
506971|NCT00229424|reflux oesophagitis|reflux oesophagitis
506972|NCT00229424|Gastroesophageal Reflux|gastroesophageal reflux
506973|NCT00229424|famotidine|famotidine
506974|NCT00229424|Double Blind|double blind
506975|NCT00229424|Controlled Study|controlled study
506976|NCT00229424|H2 receptor antagonist|h2 receptor antagonist
506977|NCT00229424|H2-blocker|h2-blocker
506978|NCT00229437|Diabetic Mononeuropathy|diabetic mononeuropathy
506979|NCT00229437|Diabetic Neuralgia|diabetic neuralgia
506980|NCT00229437|Mononeuropathy, Diabetic|mononeuropathy, diabetic
506981|NCT00229437|Neuralgia, Diabetic|neuralgia, diabetic
506982|NCT00229437|Diabetic Polyneuropathy|diabetic polyneuropathy
506983|NCT00229437|Drug Therapy|drug therapy
506984|NCT00229450|depression|depression
506985|NCT00229450|menopause|menopause
506986|NCT00229450|perimenopause|perimenopause
506987|NCT00229450|mood|mood
506988|NCT00229450|memory|memory
506989|NCT00229450|perimenopausal|perimenopausal
506990|NCT00229450|antidepressant|antidepressant
506991|NCT00229450|estrogen|estrogen
506992|NCT00229463|Depression|depression
506993|NCT00229463|genetic|genetic
506994|NCT00229463|gene|gene
506995|NCT00229463|antidepressant|antidepressant
506996|NCT00229463|research|research
506997|NCT00229476|Depression|depression
506999|NCT00229476|QEEG|qeeg
507000|NCT00229476|cordance|cordance
507001|NCT00229476|Zoloft|zoloft
507002|NCT00229476|sertraline|sertraline
507003|NCT00229476|placebo|placebo
507004|NCT00229476|electroencephalogram|electroencephalogram
507005|NCT00229476|brain|brain
507006|NCT00229476|antidepressants|antidepressants
507007|NCT00229515|Myocardial infarction|myocardial infarction
507107|NCT00229879|cardiac|cardiac
507008|NCT00229515|Revascularization|revascularization
507009|NCT00229515|Stent|stent
507010|NCT00229515|ST segment elevation|st segment elevation
507011|NCT00229541|Medical in-patient rehabilitation|medical in-patient rehabilitation
507012|NCT00229541|Gainfully employed|gainfully employed
507013|NCT00229541|Work incapacity|work incapacity
507014|NCT00229554|health surveys|health surveys
507015|NCT00229554|questionnaires|questionnaires
507016|NCT00229567|ketamine|ketamine
507017|NCT00229567|lidocaine|lidocaine
507018|NCT00229567|postoperative ileus|postoperative ileus
507019|NCT00229567|randomized controlled trial|randomized controlled trial
507020|NCT00229567|acute postoperative pain|acute postoperative pain
507021|NCT00229580|Brief Intervention|brief intervention
506334|NCT00228254|diarrhea|diarrhea
507022|NCT00229580|Motivational Interviewing|motivational interviewing
507023|NCT00229580|Health Psychology|health psychology
507024|NCT00229580|Alcohol|alcohol
507025|NCT00229580|Hepatitis C|hepatitis c
507026|NCT00229580|Patient Education|patient education
507027|NCT00229593|Male contraception|male contraception
507028|NCT00229593|Androgen|androgen
507029|NCT00229593|Progestin|progestin
507030|NCT00229593|Spermatogenesis|spermatogenesis
507031|NCT00229593|Gonadotropin suppression|gonadotropin suppression
507032|NCT00229593|Testosterone|testosterone
506942|NCT00228995|Anemia|anemia
507035|NCT00229619|Immunosuppression|immunosuppression
507036|NCT00229619|Bone Marrow Failure|bone marrow failure
507037|NCT00229619|Monoclonal Antibody Therapy|monoclonal antibody therapy
507038|NCT00229619|Diamond Blackfan Anemia (DBA)|diamond blackfan anemia (dba)
507039|NCT00229619|T -Cells|t -cells
507040|NCT00229619|B-Cells|b-cells
507041|NCT00229619|Hematopoiesis|hematopoiesis
507042|NCT00229619|Moderate Aplastic Anemia (MAA)|moderate aplastic anemia (maa)
507043|NCT00229619|Diamond-Blackfan Anemia|diamond-blackfan anemia
507044|NCT00229619|DBA|dba
507045|NCT00229619|Pure Red Cell Aplasia|pure red cell aplasia
507046|NCT00229619|PRCA|prca
507047|NCT00229632|Friedreich's Ataxia|friedreich's ataxia
507048|NCT00229632|Idebenone|idebenone
507049|NCT00229632|Ataxia|ataxia
507050|NCT00229632|Drug Trial|drug trial
507051|NCT00229632|Randomized Trial|randomized trial
507052|NCT00229632|Friedreich Ataxia|friedreich ataxia
507053|NCT00229632|FA|fa
507054|NCT00229645|Major Depression|major depression
507055|NCT00229645|Anxiety|anxiety
507056|NCT00229658|diabetes|diabetes
507057|NCT00229658|pramlintide|pramlintide
507058|NCT00229658|Symlin|symlin
507059|NCT00229658|Amylin|amylin
507060|NCT00229658|phase 4|phase 4
507061|NCT00229684|Type 2 Diabetes|type 2 diabetes
507062|NCT00229697|Breast cancer|breast cancer
507063|NCT00229697|metastatic breast cancer|metastatic breast cancer
507064|NCT00229710|Diabetes Mellitus, Type II|diabetes mellitus, type ii
507065|NCT00229710|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
507066|NCT00229723|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
507067|NCT00229723|Head and Neck Squamous Cell Cancer|head and neck squamous cell cancer
507068|NCT00229723|Squamous Cell Carcinoma|squamous cell carcinoma
507069|NCT00229723|Squamous Cell Cancer|squamous cell cancer
507070|NCT00229749|HCV|hcv
507071|NCT00229762|pneumococcal vaccination coverage with no disease or efficacy outcomes recorded|pneumococcal vaccination coverage with no disease or efficacy outcomes recorded
507072|NCT00229775|Plasmodium falciparum malaria|plasmodium falciparum malaria
507073|NCT00229775|malaria|malaria
507074|NCT00229775|artemether lumafantrine|artemether lumafantrine
507075|NCT00229775|chloroquine|chloroquine
507076|NCT00229775|sulfadoxine pyrimethamine|sulfadoxine pyrimethamine
507077|NCT00229775|Coartem|coartem
507078|NCT00229788|orthotopic heart transplantation|orthotopic heart transplantation
507079|NCT00229801|Renal Function, MRI|renal function, mri
507080|NCT00229814|Tectal Plate Glioma|tectal plate glioma
507081|NCT00229814|Tumor|tumor
507082|NCT00229814|Brain|brain
507083|NCT00229814|MRI|mri
507084|NCT00229814|Spectroscopy|spectroscopy
507085|NCT00229827|pediatric health|pediatric health
507086|NCT00229827|cardiac|cardiac
507087|NCT00229827|pediatric population|pediatric population
507088|NCT00229827|congenital heart surgery|congenital heart surgery
507089|NCT00229827|left to right shunt lesions|left to right shunt lesions
507090|NCT00229827|heart surgery|heart surgery
507091|NCT00229827|Atrioventricular canal defects|atrioventricular canal defects
507092|NCT00229840|MRI, fMRI, Epilepsy, Pediatric|mri, fmri, epilepsy, pediatric
507093|NCT00229853|Children's Healthcare of Atlanta|children's healthcare of atlanta
507094|NCT00229853|pediatric|pediatric
507095|NCT00229853|Thoracoscopic Vascular ring|thoracoscopic vascular ring
507096|NCT00229853|diverticulopexy|diverticulopexy
507097|NCT00229853|Vascular Ring Division|vascular ring division
507098|NCT00229866|newborn|newborn
507099|NCT00229866|pediatric health|pediatric health
507100|NCT00229866|Feeding difficulty|feeding difficulty
507101|NCT00229866|discharge with a NG tube|discharge with a ng tube
507102|NCT00229866|G-tube placement|g-tube placement
507103|NCT00229866|Nissen fundoplication|nissen fundoplication
507104|NCT00229879|pediatric health|pediatric health
507105|NCT00229879|rare tumor|rare tumor
507106|NCT00229879|children|children
507108|NCT00229892|pediatric health|pediatric health
507109|NCT00229892|cardiac|cardiac
507110|NCT00229892|small incisions|small incisions
507111|NCT00229892|operations|operations
507112|NCT00229892|minimally invasive|minimally invasive
507113|NCT00229905|pediatric health|pediatric health
507114|NCT00229905|children|children
507115|NCT00229905|single case study|single case study
507116|NCT00229918|Diabetic macular edema|diabetic macular edema
507117|NCT00229918|Clinically significant macular edema|clinically significant macular edema
507118|NCT00229931|CATARACT EXTRACTION|cataract extraction
506437|NCT00219336|Contraception|contraception
507119|NCT00229931|MACULAR EDEMA|macular edema
507120|NCT00229931|DIABETES|diabetes
507121|NCT00229931|FOCAL LASER|focal laser
507122|NCT00229931|TRIAMCINOLONE|triamcinolone
507123|NCT00229944|Azithromycin|azithromycin
507124|NCT00229944|V. cholerae O1 / O139|v. cholerae o1 / o139
507125|NCT00229944|adults|adults
507126|NCT00229944|Bangladesh|bangladesh
507127|NCT00229944|Clinical trial|clinical trial
507128|NCT00229957|Occupational therapy|occupational therapy
507129|NCT00229957|Physical therapy techniques|physical therapy techniques
507130|NCT00229957|Primary health care|primary health care
507131|NCT00229957|Chronic disease|chronic disease
507132|NCT00229957|Rehabilitation|rehabilitation
507133|NCT00229957|Disease management|disease management
507134|NCT00229957|Self care|self care
507135|NCT00229983|Substance use disorders|substance use disorders
507136|NCT00229983|Substance abuse|substance abuse
507137|NCT00229983|Alcohol abuse|alcohol abuse
507138|NCT00229983|Drug abuse|drug abuse
507139|NCT00229996|endometriosis|endometriosis
507140|NCT00229996|pelvic pain|pelvic pain
507141|NCT00229996|treatment|treatment
507142|NCT00230009|child abuse, child neglect, substance use, violence exposure, brief intervention|child abuse, child neglect, substance use, violence exposure, brief intervention
507143|NCT00230061|HIV|hiv
507144|NCT00230074|Amyotrophic Lateral Sclerosis; ALS|amyotrophic lateral sclerosis; als
507145|NCT00230087|diabetes|diabetes
507146|NCT00230087|nafld|nafld
507147|NCT00230087|nash|nash
507148|NCT00230087|phlebotomy|phlebotomy
507149|NCT00230100|Gender differences|gender differences
507150|NCT00230100|Women|women
507151|NCT00230100|Substance use disorders|substance use disorders
507152|NCT00230100|Alcohol use disorders|alcohol use disorders
507153|NCT00230100|Treatment outcomes|treatment outcomes
507154|NCT00230100|Group therapy|group therapy
507155|NCT00230113|NAFLD|nafld
507156|NCT00230113|NASH|nash
507157|NCT00230113|Fatty Liver Disease|fatty liver disease
507158|NCT00230113|Omega-3 Fatty Acid|omega-3 fatty acid
507159|NCT00230113|Fish oil|fish oil
507160|NCT00230126|African Americans|african americans
507161|NCT00230165|Platelets|platelets
507162|NCT00230165|Erythrocytes|erythrocytes
507163|NCT00230165|Leukocytes|leukocytes
507164|NCT00230165|Coagulation|coagulation
507165|NCT00230165|Thrombosis|thrombosis
507166|NCT00230178|Hyperuricemia|hyperuricemia
507167|NCT00230178|Tumor lysis syndrome|tumor lysis syndrome
507168|NCT00230178|Leukemia|leukemia
507169|NCT00230178|Lymphoma|lymphoma
507170|NCT00230178|Myelodysplastic Syndromes|myelodysplastic syndromes
507171|NCT00230178|Solid tumor cancers|solid tumor cancers
507172|NCT00230178|Solid Tumor cancers with hyperuricemia Hyperuricemia (cancer patients only)|solid tumor cancers with hyperuricemia hyperuricemia (cancer patients only)
507173|NCT00230178|Tumor lysis syndrome (cancer patients only)|tumor lysis syndrome (cancer patients only)
507174|NCT00230191|Oral|oral
507175|NCT00230191|Mucositis|mucositis
507176|NCT00230191|Stomatitis|stomatitis
507177|NCT00230191|Head and Neck Cancer|head and neck cancer
507178|NCT00230204|Multiple sclerosis|multiple sclerosis
507179|NCT00230204|Antibodies|antibodies
507180|NCT00230204|Serum|serum
507181|NCT00230204|Infectious agents|infectious agents
507182|NCT00230204|Immunoglobulin G|immunoglobulin g
507183|NCT00230204|Immunoglobulin M|immunoglobulin m
507184|NCT00230217|Relapse|relapse
507185|NCT00230217|Refracturing|refracturing
507186|NCT00230217|Leukemia|leukemia
507187|NCT00230217|Lymphoma|lymphoma
507188|NCT00230217|Solid Tumor|solid tumor
507189|NCT00230243|Aspergillosis|aspergillosis
507190|NCT00230243|CandidiasisMucormycosis|candidiasismucormycosis
507191|NCT00230243|FusariosisCryptococcosis|fusariosiscryptococcosis
507192|NCT00230243|Endemic Fungal infections|endemic fungal infections
507193|NCT00230243|Phaeohyphomycosis|phaeohyphomycosis
507194|NCT00230308|Head and Neck Cancer|head and neck cancer
507195|NCT00230360|constipation|constipation
507196|NCT00230360|fecal incontinence|fecal incontinence
507197|NCT00230360|diagnosis|diagnosis
507198|NCT00230360|children|children
507199|NCT00230373|Localized scleroderma|localized scleroderma
507200|NCT00230412|Kidney Failure, Acute|kidney failure, acute
507201|NCT00230412|Acute Renal Failure|acute renal failure
507202|NCT00230412|Kidney Failure|kidney failure
507203|NCT00230412|Heat-Shock Proteins|heat-shock proteins
507204|NCT00230412|Children|children
507205|NCT00230425|Alcohol Abuse|alcohol abuse
507206|NCT00230425|Anxiety Disorders|anxiety disorders
507207|NCT00230425|Mood Disorders|mood disorders
507208|NCT00230464|diabetes|diabetes
507209|NCT00230464|rate of appearance of glucose|rate of appearance of glucose
507210|NCT00230464|insulin secretion|insulin secretion
507211|NCT00230464|glucagon|glucagon
507212|NCT00230477|Hepatitis B|hepatitis b
507213|NCT00230490|Hepatitis B, Chronic|hepatitis b, chronic
507214|NCT00230490|Hepatitis B Virus|hepatitis b virus
507215|NCT00230490|Pradefovir Mesylate|pradefovir mesylate
507216|NCT00230490|Adefovir Dipivoxyl|adefovir dipivoxyl
507217|NCT00230503|Hepatitis B, Chronic|hepatitis b, chronic
507218|NCT00230503|Hepatitis B Virus|hepatitis b virus
507219|NCT00230503|Pradefovir Mesylate|pradefovir mesylate
507220|NCT00230503|Adefovir Dipivoxyl|adefovir dipivoxyl
507221|NCT00230516|N/A this study is being conducted with healthy volunteers|n/a this study is being conducted with healthy volunteers
507222|NCT00230529|Plaque-type Psoriasis|plaque-type psoriasis
507223|NCT00230529|infliximab|infliximab
507224|NCT00230529|Remicade|remicade
507225|NCT00230529|biologics|biologics
507226|NCT00230542|platinum-sensitive recurrence|platinum-sensitive recurrence
507227|NCT00230542|carboplatin|carboplatin
507228|NCT00230542|pemetrexed|pemetrexed
507229|NCT00230555|child, preschool|child, preschool
507230|NCT00230555|environment|environment
507231|NCT00230555|intelligence|intelligence
507232|NCT00230568|Mild to Moderate Alzheimer's Disease|mild to moderate alzheimer's disease
507235|NCT00230568|Spanish-speaking|spanish-speaking
507236|NCT00230581|IBS-d, IBS|ibs-d, ibs
507237|NCT00230607|alpha Galactosidase A|alpha galactosidase a
507238|NCT00230607|aGAL|agal
507239|NCT00230607|rh aGAL|rh agal
507240|NCT00230607|Fabry|fabry
507241|NCT00230607|GL3|gl3
507242|NCT00230607|Fabrazyme|fabrazyme
507243|NCT00230607|Lysosomal Storage Disorder|lysosomal storage disorder
507244|NCT00230607|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
507245|NCT00230646|cancer recovery|cancer recovery
507246|NCT00230646|physical activity|physical activity
507247|NCT00230685|Pulmonary arteriovenous malformations|pulmonary arteriovenous malformations
507248|NCT00230698|Epilepsy|epilepsy
507249|NCT00230698|Partial Epilepsies|partial epilepsies
507250|NCT00230698|Seizures|seizures
507251|NCT00230698|Topiramate|topiramate
507252|NCT00230711|Physical activity|physical activity
507253|NCT00230711|Cancer follow-up care|cancer follow-up care
507254|NCT00230724|Exercise maintenance|exercise maintenance
507255|NCT00230737|Aged|aged
507256|NCT00230737|Sleep|sleep
507257|NCT00230737|Insomnia|insomnia
507258|NCT00230737|Melatonin|melatonin
507259|NCT00230737|Neurobehavioral Manifestations|neurobehavioral manifestations
507260|NCT00230737|Circadian Rhythms|circadian rhythms
507261|NCT00230737|Human|human
507262|NCT00230737|Polysomnography|polysomnography
507263|NCT00230737|Elderly|elderly
507264|NCT00230750|influenza, elderly, vaccine, H5N1, parent protocol|influenza, elderly, vaccine, h5n1, parent protocol
507265|NCT00230802|pregnancy|pregnancy
507266|NCT00230802|hypothyroidism|hypothyroidism
507267|NCT00230802|levothyroxine|levothyroxine
507268|NCT00230815|Oligoanovulatory infertility|oligoanovulatory infertility
507269|NCT00230815|Follitropin alfa|follitropin alfa
507270|NCT00230815|Pen device|pen device
507271|NCT00230815|Gonal-f®|gonal-f®
507272|NCT00230815|Recombinant Human Choriogonadotropin (r-hCG)|recombinant human choriogonadotropin (r-hcg)
507273|NCT00230815|Ovidrel®|ovidrel®
507274|NCT00230841|croup|croup
507275|NCT00230841|humidity therapy|humidity therapy
507276|NCT00230841|pediatrics|pediatrics
507277|NCT00230854|hepatitis C|hepatitis c
507278|NCT00230854|genotype 1|genotype 1
507279|NCT00230854|non-responders|non-responders
507280|NCT00230854|viral hepatitis|viral hepatitis
507281|NCT00230867|herpes labialis|herpes labialis
507282|NCT00230867|cold sore|cold sore
507283|NCT00230867|acyclovir|acyclovir
507284|NCT00230867|iontophoresis|iontophoresis
507285|NCT00230867|topical|topical
507286|NCT00230880|Contraception behavior|contraception behavior
507287|NCT00230880|Condoms|condoms
507288|NCT00230880|Unsafe sex|unsafe sex
507289|NCT00230880|Pregnancy unwanted|pregnancy unwanted
507290|NCT00230880|Adolescent pregnancy|adolescent pregnancy
507291|NCT00230880|Condom use|condom use
507292|NCT00230880|Unprotected sex|unprotected sex
507293|NCT00230880|Unintended pregnancy|unintended pregnancy
507294|NCT00230893|Antipsychotics|antipsychotics
507295|NCT00230893|PTSD|ptsd
507296|NCT00230893|Post Traumatic Stress Disorder|post traumatic stress disorder
507297|NCT00230893|monotherapy|monotherapy
507298|NCT00230893|adjunct therapy|adjunct therapy
507299|NCT00230919|Obesity,|obesity,
507300|NCT00230919|weight loss,|weight loss,
507301|NCT00230919|diet counseling|diet counseling
507302|NCT00230919|low-glycemic load|low-glycemic load
507303|NCT00230932|Veterans|veterans
507304|NCT00230932|Pain|pain
507305|NCT00230932|Palliative Care|palliative care
507306|NCT00230932|Cardiology|cardiology
507307|NCT00230932|Reproducibility of Results|reproducibility of results
507308|NCT00230932|Health Personnel|health personnel
507309|NCT00230932|Heart Failure, Congestive|heart failure, congestive
507310|NCT00230958|Viramidine|viramidine
507311|NCT00230958|Ribavirin|ribavirin
507312|NCT00230958|Valeant|valeant
507313|NCT00230958|Hepatitis C|hepatitis c
507314|NCT00230958|Pegylated interferon alfa-2b|pegylated interferon alfa-2b
507315|NCT00230971|Intra-Abdominal Infections|intra-abdominal infections
507316|NCT00230971|Abscess|abscess
507317|NCT00230984|Chronic Respiratory Failure|chronic respiratory failure
507318|NCT00230984|Pulmonary Rehabilitation|pulmonary rehabilitation
506615|NCT00220441|exercise|exercise
507319|NCT00230984|Nutritional Depletion|nutritional depletion
507320|NCT00230984|Home|home
507321|NCT00230984|COPD|copd
507322|NCT00230984|Oral Dietary Supplements|oral dietary supplements
507323|NCT00230984|Therapeutic Education|therapeutic education
507324|NCT00230984|Androgens|androgens
507325|NCT00230984|Exacerbation|exacerbation
507326|NCT00230984|Survival|survival
507327|NCT00230997|Galantamine|galantamine
507328|NCT00230997|Dementia with Lewy Bodies|dementia with lewy bodies
507329|NCT00230997|Treatment|treatment
507330|NCT00231010|Retnitis Pigmentosa|retnitis pigmentosa
507331|NCT00231010|Retinal Degeneration|retinal degeneration
507332|NCT00231010|Retinitis Pigmentosa|retinitis pigmentosa
507334|NCT00231010|Usher Syndrome|usher syndrome
14650|NCT03197038|Older adults|older adults
507336|NCT00231010|Bietti Crystalline Dystrophy|bietti crystalline dystrophy
507337|NCT00231010|BCD|bcd
507338|NCT00231023|Anterior Subtenon|anterior subtenon
507339|NCT00231023|Posterior Peribulbar|posterior peribulbar
507340|NCT00231023|Laser Photocoagulation|laser photocoagulation
507341|NCT00231023|Diabetes|diabetes
507342|NCT00231023|Diabetic Retinopathy|diabetic retinopathy
507343|NCT00231023|Diabetic Macular Edema|diabetic macular edema
507344|NCT00231023|DME|dme
507345|NCT00231049|Genital Herpes|genital herpes
507346|NCT00231049|HSV-2 Seropositive|hsv-2 seropositive
507347|NCT00231049|Vaccine|vaccine
507348|NCT00231062|sinusitis|sinusitis
507349|NCT00231062|rhinitis|rhinitis
507350|NCT00231062|sinus surgery|sinus surgery
507351|NCT00231062|maxillary|maxillary
507352|NCT00231062|ethmoid|ethmoid
507353|NCT00231062|sphenoid|sphenoid
507354|NCT00231062|frontal|frontal
507355|NCT00231062|FESS|fess
507356|NCT00231062|sinuplasty|sinuplasty
507357|NCT00231075|Epithelial ovary cancer F.I.G.O. stages III or IV|epithelial ovary cancer f.i.g.o. stages iii or iv
507358|NCT00231075|70 years or older|70 years or older
507359|NCT00231101|Smoking|smoking
507360|NCT00231101|Schizophrenia|schizophrenia
507361|NCT00231114|Asthma|asthma
507362|NCT00231127|COPD|copd
507363|NCT00231127|Osteoporosis|osteoporosis
507364|NCT00231127|Osteopenia|osteopenia
507365|NCT00231127|Glucocorticoids|glucocorticoids
507366|NCT00231127|GOLD|gold
507367|NCT00231127|BODE|bode
507368|NCT00231140|ALS, motor neuron disease|als, motor neuron disease
507369|NCT00231153|catheter site infection|catheter site infection
507370|NCT00231153|catheter colonization|catheter colonization
507371|NCT00231153|catheter related blood stream infection|catheter related blood stream infection
507372|NCT00231153|patients with central venous catheters|patients with central venous catheters
507373|NCT00231166|dose-finding|dose-finding
507374|NCT00231166|monoclonal antibody|monoclonal antibody
507375|NCT00231166|Multiple Myeloma|multiple myeloma
507376|NCT00231179|child, preschool|child, preschool
507377|NCT00231179|intelligence|intelligence
507378|NCT00231179|environment|environment
507379|NCT00231179|home visiting|home visiting
507380|NCT00231192|Diabetes|diabetes
507381|NCT00231192|Adolescents|adolescents
507382|NCT00231192|Cystic Fibrosis|cystic fibrosis
507383|NCT00231192|Insulin|insulin
507384|NCT00231192|Repaglinide|repaglinide
507385|NCT00231205|viability|viability
507386|NCT00231205|myocardium|myocardium
507387|NCT00231205|preejection velocity|preejection velocity
507388|NCT00231205|CAD|cad
507389|NCT00231205|echocardiography|echocardiography
507390|NCT00231205|tissue Doppler|tissue doppler
507391|NCT00231218|vitamin c|vitamin c
507392|NCT00231218|echinacea|echinacea
507393|NCT00231218|propolis|propolis
507394|NCT00231218|upper respiratory tract infection|upper respiratory tract infection
507395|NCT00231218|common cold|common cold
507396|NCT00231218|gastroenteritis|gastroenteritis
507397|NCT00231218|dietary supplement|dietary supplement
507398|NCT00231218|herbal remedy|herbal remedy
507399|NCT00231296|cryoablation|cryoablation
507400|NCT00231296|atrial fibrillation|atrial fibrillation
507401|NCT00231309|G-CSF|g-csf
507402|NCT00231309|Bone Marrow|bone marrow
507403|NCT00231309|Hematologic malignancies|hematologic malignancies
507404|NCT00231309|Non-malignancies|non-malignancies
507405|NCT00231309|Matched sibling donor|matched sibling donor
507406|NCT00231309|Allogeneic BMT|allogeneic bmt
507407|NCT00231322|Schistosoma haematobium|schistosoma haematobium
507408|NCT00231322|haematuria|haematuria
507409|NCT00231322|ultrasonography|ultrasonography
507410|NCT00231322|Uganda|uganda
507411|NCT00231322|Vesical polyps|vesical polyps
507412|NCT00231335|schizophrenia|schizophrenia
507413|NCT00231335|depression|depression
507414|NCT00231335|anxiety|anxiety
507415|NCT00231335|negative symptoms|negative symptoms
508011|NCT00233090|Fatigue|fatigue
507416|NCT00231348|Social anxiety disorder|social anxiety disorder
507417|NCT00231348|social phobia|social phobia
507418|NCT00231348|positron emission tomography (PET|positron emission tomography (pet
507419|NCT00231348|regional cerebral blood flow (rCBF)|regional cerebral blood flow (rcbf)
507420|NCT00231348|nefazodone|nefazodone
506717|NCT00220818|lansoprazole|lansoprazole
507421|NCT00231348|amygdala|amygdala
507422|NCT00231374|cerebrospinal fluid|cerebrospinal fluid
507423|NCT00231374|pain in cervical spine|pain in cervical spine
507424|NCT00231374|pain in lumbar spine|pain in lumbar spine
507425|NCT00231374|myelogram|myelogram
507426|NCT00231387|diabetes rosiglitazone plaque|diabetes rosiglitazone plaque
507427|NCT00231400|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
507428|NCT00231400|GSD-II|gsd-ii
507429|NCT00231400|Pompe Disease|pompe disease
507430|NCT00231400|Pompe Disease (late-onset)|pompe disease (late-onset)
507431|NCT00231400|Acid Maltase Deficiency Disease|acid maltase deficiency disease
507432|NCT00231400|Glycogenosis II|glycogenosis ii
507433|NCT00231439|Post-polio syndrome|post-polio syndrome
507434|NCT00231439|IvIg|ivig
507435|NCT00231452|natural acquired immunity,|natural acquired immunity,
507436|NCT00231452|clinical malaria,|clinical malaria,
507437|NCT00231452|P. falciparum,|p. falciparum,
507438|NCT00231452|age,|age,
507439|NCT00231452|exposure,|exposure,
507440|NCT00231452|neonatal immunology,|neonatal immunology,
507441|NCT00231452|infants|infants
507442|NCT00231465|elderly|elderly
507443|NCT00231465|malignant pleural effusion|malignant pleural effusion
507444|NCT00231491|Overactive bladder|overactive bladder
507445|NCT00231491|Urgency|urgency
507446|NCT00231491|Urge incontinence|urge incontinence
507447|NCT00231491|Botulinum toxin A|botulinum toxin a
507448|NCT00231491|Quality of life|quality of life
507449|NCT00231504|Polymorphism P1|polymorphism p1
507450|NCT00231504|Polymorphism P2|polymorphism p2
507451|NCT00231504|FSH Receptor|fsh receptor
507452|NCT00231504|Antral follicle count|antral follicle count
507453|NCT00231504|FSH receptor polymorphism|fsh receptor polymorphism
507454|NCT00231530|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
507455|NCT00231530|Obesity|obesity
507456|NCT00231530|Diabetic Diet|diabetic diet
507457|NCT00231530|Hypertension|hypertension
507458|NCT00231530|Hyperlipidemia|hyperlipidemia
507459|NCT00231530|Adult-Onset Diabetes Mellitus(AODM)|adult-onset diabetes mellitus(aodm)
507460|NCT00231556|Epilepsy|epilepsy
507461|NCT00231556|Seizures|seizures
507462|NCT00231556|Parital Epilepsies|parital epilepsies
507463|NCT00231556|Generalized Epilepsy|generalized epilepsy
507464|NCT00231556|Tonic-Clonic Epilepsy|tonic-clonic epilepsy
507465|NCT00231556|Topiramate|topiramate
507466|NCT00231569|LDL-cholesterol|ldl-cholesterol
507467|NCT00231569|apoB-100|apob-100
507468|NCT00231569|apoB-48|apob-48
507469|NCT00231582|High-dose with autologous germ-cell tumors|high-dose with autologous germ-cell tumors
507470|NCT00231595|Migraine|migraine
507471|NCT00231595|Common Migraine|common migraine
507472|NCT00231595|Classic Migraine|classic migraine
507473|NCT00231595|Headache|headache
507474|NCT00231595|Topiramate|topiramate
507475|NCT00231595|Prophylaxis|prophylaxis
507476|NCT00231595|Prevention|prevention
507477|NCT00231608|Obesity|obesity
507478|NCT00231608|Abdominal Obesity|abdominal obesity
507479|NCT00231608|Visceral Fat|visceral fat
507480|NCT00231608|Subcutaneous Fat|subcutaneous fat
507481|NCT00231608|Dislipidemia|dislipidemia
507482|NCT00231608|Hypertension|hypertension
507483|NCT00231608|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
507484|NCT00231621|Obesity|obesity
507485|NCT00231621|Dyslipidemia|dyslipidemia
507486|NCT00231621|Hyperlipidemia|hyperlipidemia
507487|NCT00231621|Triglyceride|triglyceride
507489|NCT00231621|LDL|ldl
507490|NCT00231621|Diabetes|diabetes
507491|NCT00231634|Obesity|obesity
507492|NCT00231634|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
507493|NCT00231634|HbA1c|hba1c
507494|NCT00231634|Sulfonylurea|sulfonylurea
507495|NCT00231634|Topiramate|topiramate
507496|NCT00231634|Adult-Onset Diabetes Mellitus (AODM)|adult-onset diabetes mellitus (aodm)
507497|NCT00231647|Obesity|obesity
507498|NCT00231647|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
507499|NCT00231647|Metformin|metformin
507500|NCT00231647|Diabetic Diet|diabetic diet
507501|NCT00231647|Topiramate|topiramate
507502|NCT00231647|Adult-Onset Diabetes Mellitus (AODM)|adult-onset diabetes mellitus (aodm)
507503|NCT00231660|Type 2 Diabetes|type 2 diabetes
507504|NCT00231660|Obesity|obesity
507505|NCT00231660|Metformin|metformin
507506|NCT00231660|Hemoglobin A1c|hemoglobin a1c
507507|NCT00231660|Adult-Onset Diabetes Mellitus (AODM)|adult-onset diabetes mellitus (aodm)
507508|NCT00231673|Diabetic peripheral polyneuropathy|diabetic peripheral polyneuropathy
507509|NCT00231673|Electrophysiology|electrophysiology
507510|NCT00231673|Nerve Conduction Study|nerve conduction study
507511|NCT00231673|Neurological Examination|neurological examination
507512|NCT00231673|Quantitative Sensory Testing|quantitative sensory testing
507513|NCT00231673|Topiramate|topiramate
507514|NCT00231686|Lung function test|lung function test
508210|NCT00234104|Tolvaptan|tolvaptan
507515|NCT00231686|Physical conditioning, human|physical conditioning, human
507516|NCT00231686|Physical fitness|physical fitness
507517|NCT00231686|Quality of life|quality of life
507518|NCT00231699|Prevention of Hypothermia|prevention of hypothermia
507519|NCT00231699|Pediatric Patient|pediatric patient
507520|NCT00231699|Cotton|cotton
507521|NCT00231699|Plastic wrap|plastic wrap
507522|NCT00231712|prospective analysis of immune function,|prospective analysis of immune function,
507523|NCT00231712|spectratype|spectratype
507524|NCT00231712|immunoscope|immunoscope
507525|NCT00231712|TREC analysis|trec analysis
507526|NCT00231712|solid tumor|solid tumor
507527|NCT00231738|Eicosapentaenoic acid|eicosapentaenoic acid
507528|NCT00231738|Coronary artery disease|coronary artery disease
507529|NCT00231751|Hemophilia A|hemophilia a
507530|NCT00231751|Inhibitors|inhibitors
507531|NCT00231764|Renal transplantation|renal transplantation
507532|NCT00231764|Immunosuppression|immunosuppression
507533|NCT00231764|Daclizumab|daclizumab
507534|NCT00231764|GFR|gfr
507535|NCT00218790|Sleep|sleep
507536|NCT00218790|Renal failure|renal failure
507537|NCT00218790|Dialysis|dialysis
507538|NCT00218829|Photodynamic treatment|photodynamic treatment
507539|NCT00218829|Basal cell carcinoma|basal cell carcinoma
507540|NCT00218829|DMSO|dmso
507541|NCT00218842|exercise|exercise
507542|NCT00218842|functioning|functioning
507543|NCT00218842|frail elderly|frail elderly
507544|NCT00218855|Multiple Myeloma|multiple myeloma
507793|NCT00225368|All-cause mortality|all-cause mortality
507545|NCT00218855|Phase 3, randomised, double blind study|phase 3, randomised, double blind study
507546|NCT00218855|thalidomide|thalidomide
507547|NCT00218868|Cytodiagnosis|cytodiagnosis
507548|NCT00218868|Skin Scrape|skin scrape
507549|NCT00218868|Touch Imprint|touch imprint
507550|NCT00218868|Papanicolaou|papanicolaou
507551|NCT00218868|May-Grunvald-Giemsa|may-grunvald-giemsa
507552|NCT00218881|HIV prevention|hiv prevention
507553|NCT00218881|HIV screening|hiv screening
507554|NCT00218881|Emergency Medicine|emergency medicine
507555|NCT00218881|HIV counseling and Testing|hiv counseling and testing
507556|NCT00218881|HIV Seronegativity|hiv seronegativity
507558|NCT00218894|Balance|balance
507559|NCT00218894|Gait|gait
507560|NCT00218894|Falls|falls
507561|NCT00218907|HIV prevention|hiv prevention
507562|NCT00218907|HIV counseling|hiv counseling
507563|NCT00218907|HIV testing|hiv testing
507564|NCT00218907|Emergency Medicine|emergency medicine
507565|NCT00218907|HIV Seronegativity|hiv seronegativity
507566|NCT00218920|aerobic capacity|aerobic capacity
507567|NCT00218920|endothelial function|endothelial function
507568|NCT00218920|exercise|exercise
507569|NCT00218933|Interval training|interval training
507570|NCT00218933|Endothelial dysfunction|endothelial dysfunction
507571|NCT00218933|Aerobic capacity|aerobic capacity
507572|NCT00218933|Exercise|exercise
507573|NCT00218946|pain|pain
507574|NCT00218946|infant, premature|infant, premature
507575|NCT00218946|intubation, gastrointestinal|intubation, gastrointestinal
507576|NCT00218946|Neonatal nursing|neonatal nursing
507577|NCT00218959|PTSD|ptsd
507578|NCT00218959|trauma treatment|trauma treatment
507579|NCT00218959|refugees|refugees
507580|NCT00218959|randomized controlled|randomized controlled
507581|NCT00218972|Hypertension|hypertension
507582|NCT00218972|endurance training|endurance training
507583|NCT00218972|endothelial function|endothelial function
507584|NCT00218972|left ventricular function|left ventricular function
507585|NCT00218972|Echocardiography|echocardiography
507586|NCT00218972|Quality of life|quality of life
507587|NCT00218972|Essential hypertension grade 1 - 2|essential hypertension grade 1 - 2
507588|NCT00218985|Aerobic capacity|aerobic capacity
507589|NCT00218985|Exercise training|exercise training
507590|NCT00218985|CABG|cabg
507591|NCT00218985|Endothelial function|endothelial function
507592|NCT00218998|Exercise|exercise
507593|NCT00218998|Exercise therapy|exercise therapy
507594|NCT00219011|Aliskiren, heart failure,hypertension|aliskiren, heart failure,hypertension
507595|NCT00219024|Hypertension, aliskiren, blood pressure, hydrochlorothiazide (HCTZ).|hypertension, aliskiren, blood pressure, hydrochlorothiazide (hctz).
507596|NCT00219037|Hypertension, blood pressure, aliskiren|hypertension, blood pressure, aliskiren
507597|NCT00219063|Hypertension, aliskiren, blood pressure, Ramipril, hydrochlorothiazide|hypertension, aliskiren, blood pressure, ramipril, hydrochlorothiazide
507598|NCT00219076|Hypertension, aliskiren, blood pressure, amlodipine|hypertension, aliskiren, blood pressure, amlodipine
507599|NCT00224458|Treatment Experienced|treatment experienced
507600|NCT00224458|HIV-1|hiv-1
507601|NCT00224471|Adolescents|adolescents
507602|NCT00224471|Immunogenicity|immunogenicity
507603|NCT00224471|Safety|safety
507604|NCT00224471|Herpes Simplex vaccine|herpes simplex vaccine
507605|NCT00224484|Herpes Simplex vaccine|herpes simplex vaccine
507606|NCT00224484|Safety|safety
507607|NCT00224484|Adolescents|adolescents
507608|NCT00224484|Immunogenicity|immunogenicity
507609|NCT00224497|Alzheimer's disease|alzheimer's disease
507610|NCT00224497|cognition global functioning|cognition global functioning
507611|NCT00224497|symptomatic|symptomatic
507612|NCT00224497|B-742457|b-742457
507613|NCT00224510|bipolar disorder bipolar depression lamotrigine|bipolar disorder bipolar depression lamotrigine
507614|NCT00224523|perennial allergic rhinitis|perennial allergic rhinitis
507615|NCT00224523|nasal biopsy|nasal biopsy
507616|NCT00224523|GW685698X|gw685698x
507617|NCT00224536|Myocardial infarction|myocardial infarction
507618|NCT00224536|Bone marrow cells|bone marrow cells
507619|NCT00224536|Intracoronary|intracoronary
507620|NCT00224549|Resistant hypertension|resistant hypertension
507621|NCT00224549|Combined diuretic therapy|combined diuretic therapy
507622|NCT00224549|Combined RAS blockers|combined ras blockers
507623|NCT00224562|TNF alpha antagonists|tnf alpha antagonists
507624|NCT00224562|infections|infections
507625|NCT00224562|lymphoma|lymphoma
507626|NCT00224562|safety|safety
507627|NCT00224575|Veterans|veterans
507628|NCT00224588|Ketamine|ketamine
507629|NCT00224588|Chronic post thoracotomy pain|chronic post thoracotomy pain
507630|NCT00224588|NMDA|nmda
507631|NCT00224588|Post operative|post operative
507632|NCT00224601|Colorectal cancer|colorectal cancer
507633|NCT00224601|HNPCC|hnpcc
507634|NCT00224601|Diagnosis|diagnosis
507635|NCT00224601|Coloscopy|coloscopy
507636|NCT00224601|Chromoscopy|chromoscopy
507637|NCT00224601|Indigo carmine|indigo carmine
507638|NCT00224601|Colorectal Neoplasms|colorectal neoplasms
507639|NCT00224601|Hereditary Nonpolyposis|hereditary nonpolyposis
507640|NCT00224614|stem cell transplantation|stem cell transplantation
507641|NCT00224614|reduced-intensity conditioning regimen|reduced-intensity conditioning regimen
507642|NCT00224614|acute myeloid leukemia|acute myeloid leukemia
507643|NCT00224627|Randomized study|randomized study
507644|NCT00224627|Capsule endoscopy|capsule endoscopy
507645|NCT00224627|Push enteroscopy|push enteroscopy
507646|NCT00224627|Occult gastrointestinal bleeding|occult gastrointestinal bleeding
507647|NCT00224627|Endoscopy|endoscopy
507648|NCT00224640|Iron-chelating treatment|iron-chelating treatment
507649|NCT00224653|Obesity.|obesity.
507650|NCT00224653|Respiration. Respiration, artificial.|respiration. respiration, artificial.
507651|NCT00224653|Ventilation. Pressure controlled. Volume controlled.|ventilation. pressure controlled. volume controlled.
507652|NCT00224666|Cortex stimulation ,Rebel neuropathic pains|cortex stimulation ,rebel neuropathic pains
507653|NCT00224679|Colon cancer|colon cancer
507654|NCT00224679|Aspirin|aspirin
507655|NCT00224679|Adenomas|adenomas
507656|NCT00224679|Prevention|prevention
507657|NCT00224692|Mucositis|mucositis
507658|NCT00224692|Pain|pain
507659|NCT00224692|Morphine|morphine
507660|NCT00224692|Ketamine|ketamine
507661|NCT00224705|Albumin dialysis|albumin dialysis
507662|NCT00224705|MARS system|mars system
507663|NCT00224705|Extracorporeal artificial liver support|extracorporeal artificial liver support
507664|NCT00224705|Fulminant hepatitis|fulminant hepatitis
507665|NCT00224705|Subfulminant hepatitis|subfulminant hepatitis
507666|NCT00224705|Acute liver failure|acute liver failure
507667|NCT00224718|Abdominal aortic aneurysm|abdominal aortic aneurysm
507668|NCT00224718|Endograft|endograft
507669|NCT00224718|Open repair|open repair
507670|NCT00224718|Endovascular repair|endovascular repair
507672|NCT00224731|Attention disorder with hyperactivity|attention disorder with hyperactivity
507673|NCT00224731|sleep|sleep
507674|NCT00224731|stimulants|stimulants
507675|NCT00224731|actigraphy|actigraphy
507676|NCT00224744|Vulvar Neoplasms|vulvar neoplasms
507677|NCT00224744|Skin Neoplasms|skin neoplasms
507678|NCT00224744|Ultracision|ultracision
507679|NCT00224744|Lymphadenectomy|lymphadenectomy
507680|NCT00224757|Echocardiography|echocardiography
507681|NCT00224796|Wound closure|wound closure
507682|NCT00224796|Foot salvage|foot salvage
507683|NCT00224796|Accelerated healing|accelerated healing
507684|NCT00224796|Amputation Wounds of the Diabetic Foot|amputation wounds of the diabetic foot
507685|NCT00224822|Psychiatry|psychiatry
507686|NCT00224822|Antipsychotic|antipsychotic
507687|NCT00224822|Psychopharmacology|psychopharmacology
507688|NCT00224822|Clinical Trial|clinical trial
507689|NCT00224822|Open Label|open label
507690|NCT00224822|Schizophrenia|schizophrenia
507691|NCT00224822|Schizoaffective Disorder|schizoaffective disorder
507692|NCT00224822|Bipolar Disorder|bipolar disorder
507693|NCT00224822|Metabolic Syndrome|metabolic syndrome
507694|NCT00224874|Acute Graft vs Host Disease|acute graft vs host disease
507695|NCT00224874|GVHD|gvhd
507696|NCT00224900|Perinatally-acquired HIV infection|perinatally-acquired hiv infection
507697|NCT00224900|Life Skills|life skills
507698|NCT00224900|Focus Group|focus group
507699|NCT00224900|Young adolescents|young adolescents
507700|NCT00224900|Caregivers|caregivers
507701|NCT00224913|osteoarthritis|osteoarthritis
507702|NCT00224913|quadriceps|quadriceps
507703|NCT00224913|inhibition|inhibition
507704|NCT00224913|functional outcome|functional outcome
507705|NCT00224913|electrical stimulation|electrical stimulation
507706|NCT00224926|Tinea Capitis|tinea capitis
507707|NCT00224952|seizures|seizures
507708|NCT00224952|Epilepsy|epilepsy
507709|NCT00224965|nicotine dependence|nicotine dependence
507710|NCT00224991|osteoporosis|osteoporosis
507711|NCT00224991|fall frequency|fall frequency
507712|NCT00224991|medical treatment|medical treatment
507713|NCT00224991|compliance|compliance
507714|NCT00224991|quality of life|quality of life
507715|NCT00224991|systematic education|systematic education
507716|NCT00225004|Colles Fracture|colles fracture
507717|NCT00225004|Osteoporosis|osteoporosis
507719|NCT00225004|Quality assurance|quality assurance
507720|NCT00225017|Atazanavir|atazanavir
507721|NCT00225017|Endothelial function|endothelial function
507722|NCT00225017|Treatment Experienced|treatment experienced
507723|NCT00225069|Facial blushing|facial blushing
507724|NCT00225069|Sympathectomy|sympathectomy
507725|NCT00225082|Lipoatrophy|lipoatrophy
507726|NCT00225082|Mitochondrial function|mitochondrial function
507727|NCT00225082|Nucleoside analogue switch|nucleoside analogue switch
507728|NCT00225082|Treatment Experienced|treatment experienced
507729|NCT00225095|meniscectomy|meniscectomy
507730|NCT00225095|Chondrogen|chondrogen
507731|NCT00225095|Mesenchymal Stem Cells|mesenchymal stem cells
507732|NCT00225095|Osiris|osiris
507733|NCT00225108|Deep vein thrombosis|deep vein thrombosis
507734|NCT00225108|bleeding|bleeding
507735|NCT00225160|HIV|hiv
507736|NCT00225160|poly neuropathy|poly neuropathy
507837|NCT00225537|heparvit|heparvit
507737|NCT00225160|acetyl L-carnitine|acetyl l-carnitine
507738|NCT00225160|treatment naïve|treatment naïve
507739|NCT00225160|combination antiretroviral therapy|combination antiretroviral therapy
507740|NCT00225160|Lipid abnormalities|lipid abnormalities
507741|NCT00225173|nodular sclerosis|nodular sclerosis
507742|NCT00225173|lymphocyte rich|lymphocyte rich
507743|NCT00225173|lymphocyte depleted|lymphocyte depleted
507744|NCT00225173|mixed cellularity|mixed cellularity
507745|NCT00225212|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
507746|NCT00225212|diffuse large cell lymphoma|diffuse large cell lymphoma
507747|NCT00225212|mantle cell lymphoma|mantle cell lymphoma
507748|NCT00225212|transformed lymphoma|transformed lymphoma
507749|NCT00225212|other subtypes of B cell lymphoma|other subtypes of b cell lymphoma
507750|NCT00225212|recurrent lymphoma|recurrent lymphoma
507751|NCT00225238|colonoscopy prep|colonoscopy prep
507752|NCT00225251|Dysthymic Disorder|dysthymic disorder
507753|NCT00225251|Dysthymia|dysthymia
507754|NCT00225251|Depression|depression
507755|NCT00225251|Chronic Depression|chronic depression
507756|NCT00225251|Wellbutrin XL|wellbutrin xl
507757|NCT00225264|Glucose Metabolism Disorder|glucose metabolism disorder
507758|NCT00225264|Dysmetabolic Syndrome|dysmetabolic syndrome
507759|NCT00225264|Type II Diabetes|type ii diabetes
507760|NCT00225264|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
507761|NCT00225264|Dyslipidemia|dyslipidemia
507762|NCT00225264|Drug Therapy|drug therapy
507763|NCT00225277|Glucose Metabolism Disorder|glucose metabolism disorder
507764|NCT00225277|Dysmetabolic Syndrome|dysmetabolic syndrome
507765|NCT00225277|Type II Diabetes|type ii diabetes
507766|NCT00225277|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
507767|NCT00225277|Dyslipidemia|dyslipidemia
507768|NCT00225277|Drug Therapy|drug therapy
507769|NCT00225277|Atherosclerosis|atherosclerosis
507770|NCT00225290|Phase III|phase iii
507771|NCT00225290|Hepatocellular Carcinoma|hepatocellular carcinoma
507772|NCT00225303|HIV infection|hiv infection
507773|NCT00225303|TMC125|tmc125
507774|NCT00225303|Non-Nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
507775|NCT00225303|Protease inhibitor|protease inhibitor
507776|NCT00225303|TMC125-C227|tmc125-c227
507777|NCT00225316|RCT|rct
507778|NCT00225316|intervention study|intervention study
507779|NCT00225316|addiction|addiction
507780|NCT00225316|substance use|substance use
507781|NCT00225316|pregnancy|pregnancy
507782|NCT00225329|RCT|rct
507783|NCT00225329|intervention study|intervention study
507784|NCT00225329|labour management|labour management
507785|NCT00225329|assessment|assessment
507786|NCT00225342|Angina|angina
507787|NCT00225342|Ischaemic heart disease|ischaemic heart disease
507788|NCT00225342|Diabetes|diabetes
507789|NCT00225355|Angina pectoris|angina pectoris
507790|NCT00225355|Metabolic syndrome|metabolic syndrome
507791|NCT00225355|Ischaemic heart disease|ischaemic heart disease
507792|NCT00225368|Malaria|malaria
507794|NCT00225368|Africa|africa
507795|NCT00225368|Burkina Faso|burkina faso
507796|NCT00225381|Oxygen consumption|oxygen consumption
507797|NCT00225381|CO2 production|co2 production
507798|NCT00225381|Indirect calorimetry|indirect calorimetry
507799|NCT00225381|Non steady state|non steady state
507800|NCT00225381|Anesthesia monitoring|anesthesia monitoring
507801|NCT00225381|Critical events during anesthesia|critical events during anesthesia
507802|NCT00225381|Acid base balance|acid base balance
507803|NCT00225381|Metabolism during anesthesia|metabolism during anesthesia
507805|NCT00225394|Kidney Transplant|kidney transplant
507806|NCT00225394|Pancreas Transplant|pancreas transplant
507807|NCT00225394|Ganciclovir-resistance|ganciclovir-resistance
507808|NCT00225394|Valganciclovir|valganciclovir
507809|NCT00225394|CMV Disease|cmv disease
507810|NCT00225407|Cannabis|cannabis
507811|NCT00225407|Tetrahydrocannabinol|tetrahydrocannabinol
507812|NCT00225407|Pharmacokinetics|pharmacokinetics
507813|NCT00225407|Psychomotor tests|psychomotor tests
507814|NCT00225407|Event related potentials|event related potentials
507815|NCT00225420|adenocarcinoma of the prostate|adenocarcinoma of the prostate
507816|NCT00225420|stage I prostate cancer|stage i prostate cancer
507817|NCT00225420|stage II prostate cancer|stage ii prostate cancer
507818|NCT00225420|stage III prostate cancer|stage iii prostate cancer
507819|NCT00225420|stage IV prostate cancer|stage iv prostate cancer
507820|NCT00225433|infertility|infertility
507821|NCT00225433|in vitro fertilization|in vitro fertilization
507822|NCT00225446|Orthognathic surgery.|orthognathic surgery.
507823|NCT00225446|optic repositioning system.|optic repositioning system.
507824|NCT00225459|Religious psychology|religious psychology
507825|NCT00225459|Anxiety disorder|anxiety disorder
507826|NCT00225459|Mood disorder|mood disorder
507827|NCT00225459|Suicide|suicide
507828|NCT00225485|Depression|depression
507829|NCT00225511|Depression|depression
507830|NCT00225524|Depression|depression
507831|NCT00225537|hcv|hcv
507832|NCT00225537|hbv|hbv
507833|NCT00225537|methylumbelliferone|methylumbelliferone
507834|NCT00225537|liver|liver
507835|NCT00225537|hepatitis|hepatitis
507836|NCT00225537|viral|viral
507838|NCT00225537|hiv|hiv
507839|NCT00225537|aids|aids
507840|NCT00225550|Cancer;|cancer;
507841|NCT00225550|Tumors;|tumors;
507842|NCT00225550|Neoplasms;|neoplasms;
507843|NCT00225550|Anticarcinogenic Agents;|anticarcinogenic agents;
507844|NCT00225550|Antineoplastic Agents;|antineoplastic agents;
507845|NCT00225550|Cadherins|cadherins
507846|NCT00225563|Electronic medical records|electronic medical records
507847|NCT00225563|Electronic prescribing|electronic prescribing
507848|NCT00225563|Quality measures|quality measures
507849|NCT00225576|medication errors|medication errors
507850|NCT00225576|adverse drug events|adverse drug events
507851|NCT00225576|electronic health records|electronic health records
507852|NCT00225589|Hypercholesteremia|hypercholesteremia
507853|NCT00225602|Schizophrenia|schizophrenia
507854|NCT00225602|Assertive community treatment|assertive community treatment
507855|NCT00225615|Phenylalanine Hydroxylase|phenylalanine hydroxylase
507856|NCT00225628|Computerized clinical decision support|computerized clinical decision support
507857|NCT00225628|Patient Safety|patient safety
507858|NCT00225628|Quality of Care|quality of care
507859|NCT00225628|Electronic Medical Records|electronic medical records
507860|NCT00225628|Chronic Disease Management|chronic disease management
507861|NCT00225628|Drug Monitoring|drug monitoring
507862|NCT00225628|Guideline Adherence|guideline adherence
507863|NCT00225628|Reminder Systems|reminder systems
507864|NCT00225641|Follow-up|follow-up
507865|NCT00225654|coronary artery|coronary artery
507866|NCT00225654|stent|stent
507867|NCT00225654|drug eluting|drug eluting
507868|NCT00225654|patency|patency
507869|NCT00225654|restenosis|restenosis
507870|NCT00225667|Atrial Fibrillation|atrial fibrillation
507871|NCT00225667|Arrhythmia|arrhythmia
507872|NCT00225667|Pacemaker, Artificial|pacemaker, artificial
507873|NCT00225667|Atrial High Rate Episodes|atrial high rate episodes
507874|NCT00225667|Electrophysiology|electrophysiology
507875|NCT00225667|Renin-Angiotensin System|renin-angiotensin system
507876|NCT00225667|Hypertension|hypertension
507877|NCT00225667|Cardiac Remodeling|cardiac remodeling
507878|NCT00225680|coronary artery|coronary artery
507879|NCT00225680|stent|stent
507880|NCT00225680|drug eluting|drug eluting
507881|NCT00225680|patency|patency
507882|NCT00225680|restenosis|restenosis
507883|NCT00225693|coronary artery|coronary artery
507884|NCT00225693|restenosis|restenosis
507885|NCT00225693|patency|patency
507886|NCT00225693|drug eluting|drug eluting
507887|NCT00225693|stent|stent
507888|NCT00225745|Ghrelin|ghrelin
507889|NCT00225758|breast cancer|breast cancer
507890|NCT00225758|endocrine therapy|endocrine therapy
507891|NCT00225758|drug resistance|drug resistance
507892|NCT00225758|lapatinib|lapatinib
507893|NCT00225758|epidermal growth factor receptor|epidermal growth factor receptor
507894|NCT00225784|Stage I, II, III pancreatic adenocarcinoma|stage i, ii, iii pancreatic adenocarcinoma
507895|NCT00225784|Radiographically measurable disease|radiographically measurable disease
507896|NCT00225797|chronic pain|chronic pain
507897|NCT00225797|lower back|lower back
507898|NCT00225797|opioid|opioid
507899|NCT00225797|efficacy|efficacy
507900|NCT00225797|safety|safety
507901|NCT00225823|Seasonal Allergic Rhinitis Intranasal Corticosteroid|seasonal allergic rhinitis intranasal corticosteroid
507902|NCT00225836|Dysmenorrhoea|dysmenorrhoea
507904|NCT00225836|Pain|pain
507905|NCT00225836|TENS|tens
507906|NCT00225849|Aspirin|aspirin
507907|NCT00225849|Primary prevention|primary prevention
507908|NCT00225862|RLS|rls
507909|NCT00225862|Restless Legs Syndrome|restless legs syndrome
507910|NCT00225875|Autoimmune thrombocytopenic purpura|autoimmune thrombocytopenic purpura
507911|NCT00225875|Rituximab|rituximab
507912|NCT00225888|Diabetes|diabetes
507913|NCT00225888|Nutrition|nutrition
507914|NCT00225888|Digital photography|digital photography
507915|NCT00225888|Self-management|self-management
507916|NCT00225914|Menopause|menopause
507917|NCT00225914|Hormone Therapy|hormone therapy
507918|NCT00225914|Paxil|paxil
507919|NCT00225914|Hot Flash|hot flash
507920|NCT00225914|Sleep Disturbance|sleep disturbance
507921|NCT00225914|Night Sweats|night sweats
507922|NCT00225914|Antidepressants|antidepressants
507923|NCT00225927|invasive breast cancer|invasive breast cancer
507924|NCT00225927|in situ breast cancer|in situ breast cancer
507925|NCT00225927|radioguided seed localization|radioguided seed localization
507926|NCT00225927|nonpalpable tumour|nonpalpable tumour
507927|NCT00225927|needle localization|needle localization
507928|NCT00225927|margin status|margin status
507929|NCT00225966|Urinary urgency-frequency|urinary urgency-frequency
507930|NCT00225979|Acromegaly|acromegaly
507931|NCT00225979|Untreated|untreated
507932|NCT00225979|Newly diagnosed|newly diagnosed
507933|NCT00225979|Octreotide LAR|octreotide lar
507934|NCT00225979|Pituitary surgery|pituitary surgery
507935|NCT00231816|Prevention of Herpes Zoster|prevention of herpes zoster
507936|NCT00231829|Treatment|treatment
507937|NCT00231829|Uterine Papillary Serous Carcinoma|uterine papillary serous carcinoma
507938|NCT00231829|Clear Cell Carcinoma|clear cell carcinoma
508036|NCT00233155|Neuropathy|neuropathy
507939|NCT00231829|COX-2 Inhibitors|cox-2 inhibitors
507940|NCT00231842|Mixed Mesodermal Tumor|mixed mesodermal tumor
507942|NCT00231842|Uterine Cancer|uterine cancer
507943|NCT00231842|Radiation Therapy|radiation therapy
507944|NCT00231842|Chemotherapy|chemotherapy
507945|NCT00231855|Epithelial Ovarian Cancer|epithelial ovarian cancer
507946|NCT00231855|Uterine Cancer|uterine cancer
507947|NCT00231855|Prior Therapy|prior therapy
507948|NCT00231855|Chemotherapy|chemotherapy
507949|NCT00231855|Recurrence|recurrence
507950|NCT00231868|Uterine Papillary Serous Carcinoma|uterine papillary serous carcinoma
507952|NCT00231868|Radiation Therapy|radiation therapy
507953|NCT00231868|Chemotherapy|chemotherapy
507954|NCT00231881|GORD – Oesophageal sensitivity- Oesophageal permeability|gord – oesophageal sensitivity- oesophageal permeability
507955|NCT00231894|atypical antipsychotics|atypical antipsychotics
507956|NCT00231894|hyperglycemia|hyperglycemia
507957|NCT00231894|triglycerides|triglycerides
507958|NCT00231894|HDL|hdl
507959|NCT00231894|cholesterol|cholesterol
507960|NCT00231894|insulin resistance|insulin resistance
507961|NCT00231894|schizophrenia|schizophrenia
507962|NCT00231894|verbal memory|verbal memory
507963|NCT00231907|influenza, vaccine, TIV, LAIV, booster, children|influenza, vaccine, tiv, laiv, booster, children
507964|NCT00231920|Influenza, Vaccine, Infants|influenza, vaccine, infants
507965|NCT00231933|Person-centered Care|person-centered care
507966|NCT00231933|Recovery|recovery
507967|NCT00231933|Disparities|disparities
507968|NCT00231933|Culturally Responsive Care|culturally responsive care
507969|NCT00231933|Psychosis|psychosis
507970|NCT00231946|gonadotropins|gonadotropins
507971|NCT00231946|hormone therapy|hormone therapy
507972|NCT00231946|HRT|hrt
507973|NCT00231946|Antigonadotropin|antigonadotropin
507974|NCT00231946|Leuprolide|leuprolide
507975|NCT00231959|Depression, Treatment-Resistant|depression, treatment-resistant
507976|NCT00231972|HIV|hiv
507977|NCT00231972|MSM|msm
507978|NCT00231985|Habit-reversal Therapy|habit-reversal therapy
507979|NCT00231985|Behavior Therapy|behavior therapy
507980|NCT00231985|Supportive Therapy|supportive therapy
507981|NCT00231998|Atopic dermatitis, ASM981, pimecrolimus|atopic dermatitis, asm981, pimecrolimus
507982|NCT00232011|Atopic dermatitis, ASM981, pimecrolimus|atopic dermatitis, asm981, pimecrolimus
507983|NCT00232024|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
507984|NCT00232037|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
507985|NCT00232050|Asthma, IgE, Omalizumab|asthma, ige, omalizumab
507986|NCT00232063|Atopic Dermatitis, Ciclosporin,|atopic dermatitis, ciclosporin,
507987|NCT00232076|Atopic Dermatitis, Ciclosporin,|atopic dermatitis, ciclosporin,
507988|NCT00232089|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
507989|NCT00232102|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
507990|NCT00232115|Perioral Dermatitis, pimecrolimus cream|perioral dermatitis, pimecrolimus cream
507991|NCT00232999|Allergic asthma|allergic asthma
507992|NCT00232999|Allergen challenge|allergen challenge
507993|NCT00232999|Bronchial hyperresponsiveness|bronchial hyperresponsiveness
507994|NCT00233012|Refractory partial-onset seizures|refractory partial-onset seizures
507995|NCT00233012|Infants aged 1-24 months|infants aged 1-24 months
507996|NCT00233012|Pharmacokinetics|pharmacokinetics
507997|NCT00233012|Topiramate|topiramate
507998|NCT00233038|Pancreatic cancer|pancreatic cancer
507999|NCT00233038|Pancreatic adenoma|pancreatic adenoma
508000|NCT00233038|Ethanol|ethanol
508001|NCT00233038|Endoscopic ultrasound|endoscopic ultrasound
508002|NCT00233038|Cyst ablation|cyst ablation
508003|NCT00233051|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
508004|NCT00233051|Emphysema|emphysema
508005|NCT00233051|Chronic Bronchitis|chronic bronchitis
508006|NCT00233051|Inhaled Steroid|inhaled steroid
508007|NCT00233051|Salmeterol|salmeterol
508008|NCT00233077|breast cancer|breast cancer
508009|NCT00233077|adjuvant treatment|adjuvant treatment
508010|NCT00233077|racial disparities|racial disparities
507335|NCT00231010|USH|ush
508013|NCT00233090|brain injury|brain injury
508014|NCT00233090|Modafinil|modafinil
508015|NCT00233090|traumatic brain injury|traumatic brain injury
508016|NCT00233103|Sertraline|sertraline
508017|NCT00233103|TBI|tbi
508018|NCT00233103|depression|depression
508019|NCT00233103|SSRI|ssri
508020|NCT00233103|brain injury|brain injury
508021|NCT00233129|Day treatment|day treatment
508022|NCT00233129|executive function|executive function
508023|NCT00233129|problem solving|problem solving
508024|NCT00233129|attention|attention
508025|NCT00233129|participation|participation
508026|NCT00233129|TBI|tbi
508027|NCT00233129|brain injury|brain injury
508028|NCT00233129|traumatic brain injury|traumatic brain injury
508029|NCT00233142|Diabetes|diabetes
508030|NCT00233142|Emotions|emotions
508031|NCT00233142|Blood glucose|blood glucose
508032|NCT00233142|Expressive Writing|expressive writing
508033|NCT00233155|Analgesics|analgesics
508034|NCT00233155|Capsaicin|capsaicin
508035|NCT00233155|Neuropathic pain|neuropathic pain
508037|NCT00233155|PHN|phn
508038|NCT00233155|Shingles|shingles
508039|NCT00233272|Frailty|frailty
508040|NCT00233272|Disease Processes|disease processes
508041|NCT00233298|Hypoglycemia|hypoglycemia
508042|NCT00233298|Blood Sugar|blood sugar
508043|NCT00233298|Blood Glucose Level|blood glucose level
508044|NCT00233298|Insulin Sensitivity|insulin sensitivity
508045|NCT00233298|Metabolism|metabolism
508046|NCT00233298|Type 2 Diabetes|type 2 diabetes
508047|NCT00233298|Healthy|healthy
508048|NCT00233311|high fat diet|high fat diet
508049|NCT00233311|inflammation|inflammation
508050|NCT00233311|inflammatory markers|inflammatory markers
508051|NCT00233311|C-reactive protein|c-reactive protein
508052|NCT00233311|Aging|aging
508053|NCT00233324|NICHD Neonatal Research Network|nichd neonatal research network
508054|NCT00233324|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
508055|NCT00233324|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
508056|NCT00233324|Prematurity|prematurity
508057|NCT00233324|Mechanical ventilation|mechanical ventilation
508058|NCT00233324|Surfactant|surfactant
508059|NCT00233324|Intubation|intubation
508060|NCT00233324|Neurodevelopmental impairment|neurodevelopmental impairment
508061|NCT00233324|Pulse oximetry|pulse oximetry
508062|NCT00233324|Oxygen saturation|oxygen saturation
508063|NCT00233324|Positive-Pressure Respiration|positive-pressure respiration
508064|NCT00233337|Malaria, non-immune travelers|malaria, non-immune travelers
508065|NCT00233350|Neuronavigation|neuronavigation
508066|NCT00233350|Ultrasound|ultrasound
508067|NCT00233350|Brain tumour surgery|brain tumour surgery
508068|NCT00233350|Biopsy|biopsy
508069|NCT00233350|Histopathology|histopathology
508070|NCT00233350|Intraoperative imaging|intraoperative imaging
508071|NCT00233350|3D ultrasound imaging|3d ultrasound imaging
508072|NCT00233376|Decision support system|decision support system
508073|NCT00233376|Causal probabilistic network|causal probabilistic network
508074|NCT00233376|Antibiotics|antibiotics
508075|NCT00233376|Antibiotic resistance|antibiotic resistance
508076|NCT00233376|Community-acquired infections|community-acquired infections
508077|NCT00233376|Cross-infections|cross-infections
508078|NCT00233402|Bladder Cancer|bladder cancer
508079|NCT00233402|Hexvix|hexvix
508080|NCT00233402|Fluorescence|fluorescence
508081|NCT00233402|Cystoscopy|cystoscopy
508082|NCT00233428|Healthy volunteers|healthy volunteers
508083|NCT00233441|Atrial Fibrillation|atrial fibrillation
508084|NCT00233441|Atrial Flutter|atrial flutter
508085|NCT00233441|Arrhythmia|arrhythmia
508086|NCT00233441|Anti-Arrhythmia Agents|anti-arrhythmia agents
508087|NCT00233467|antipsychotics|antipsychotics
508088|NCT00233467|PTSD|ptsd
508089|NCT00233467|posttraumatic stress disorder|posttraumatic stress disorder
508090|NCT00233480|Randomized Controlled Trial|randomized controlled trial
508091|NCT00233480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
508092|NCT00233480|Sympathetic Nervous System|sympathetic nervous system
508093|NCT00233480|Ventricular Remodeling|ventricular remodeling
508094|NCT00233480|Chemokines|chemokines
508095|NCT00233493|dermatophytes|dermatophytes
508096|NCT00233506|CpG 7909|cpg 7909
508097|NCT00233506|CLL|cll
508098|NCT00233532|Hypertension|hypertension
508099|NCT00233532|Trandolapril|trandolapril
508100|NCT00233545|cutaneous|cutaneous
508101|NCT00233545|leishmaniasis|leishmaniasis
508102|NCT00233545|drug|drug
508103|NCT00233545|miltefosine|miltefosine
508104|NCT00233584|Children of asthmatic mothers|children of asthmatic mothers
508105|NCT00233597|anemia|anemia
508106|NCT00233597|iron|iron
508107|NCT00233610|Casodex monotherapy|casodex monotherapy
508108|NCT00233623|Metastatic Colorectal Cancer|metastatic colorectal cancer
508109|NCT00233636|Squamous Cell Carcinoma of Head and Neck|squamous cell carcinoma of head and neck
508110|NCT00233636|Inoperable locally advanced Squamous Cell Carcinoma of Head and Neck|inoperable locally advanced squamous cell carcinoma of head and neck
508111|NCT00233701|NPH|nph
507488|NCT00231621|HDL|hdl
508112|NCT00233701|Hydrocephalus|hydrocephalus
508113|NCT00233727|cervical cancer|cervical cancer
508114|NCT00233727|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
508115|NCT00233727|prevention|prevention
508116|NCT00233727|cryotherapy|cryotherapy
508117|NCT00233727|HPV testing|hpv testing
508118|NCT00233727|cytology|cytology
508119|NCT00233753|Intracranial|intracranial
508120|NCT00233753|Wide-neck|wide-neck
508121|NCT00233753|Saccular|saccular
508122|NCT00233753|Aneurysms|aneurysms
508123|NCT00233831|Postoperative pain|postoperative pain
508124|NCT00233831|analgesia|analgesia
508125|NCT00233831|total knee arthroplasty|total knee arthroplasty
508126|NCT00233844|Acute pain|acute pain
508127|NCT00233844|pain on venipuncture|pain on venipuncture
508128|NCT00233844|"cough-trick"|"cough-trick"
508129|NCT00233844|distraction|distraction
508130|NCT00233857|Acute pain|acute pain
508131|NCT00233857|postoperative pain|postoperative pain
508132|NCT00233857|auricular acupuncture|auricular acupuncture
508133|NCT00233896|Hematopoietic cell transplant|hematopoietic cell transplant
508134|NCT00233896|Acute graft-vs.-host disease|acute graft-vs.-host disease
508135|NCT00233896|Gastrointestinal tract|gastrointestinal tract
508136|NCT00233896|Randomized trial|randomized trial
508137|NCT00233896|Topical corticosteroid|topical corticosteroid
508138|NCT00233896|Beclomethasone dipropionate|beclomethasone dipropionate
508139|NCT00233896|Prednisone|prednisone
508140|NCT00233896|Survival|survival
508141|NCT00233909|Leukemia, Myeloid|leukemia, myeloid
508142|NCT00233909|Relapse|relapse
508143|NCT00233909|Chemotherapy|chemotherapy
508144|NCT00233909|Zosuquidar|zosuquidar
508145|NCT00233909|gemtuzumab ozogamicin (GO)|gemtuzumab ozogamicin (go)
508146|NCT00233922|orbit|orbit
508147|NCT00233922|orbital|orbital
508148|NCT00233922|trauma|trauma
508149|NCT00233922|fractures|fractures
508150|NCT00233922|facial|facial
508151|NCT00233961|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
508152|NCT00233974|stage IIIA breast cancer|stage iiia breast cancer
508153|NCT00233974|stage IIIB breast cancer|stage iiib breast cancer
508154|NCT00233974|stage IIIC breast cancer|stage iiic breast cancer
508155|NCT00233974|stage IV breast cancer|stage iv breast cancer
508156|NCT00233987|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
508157|NCT00234000|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
508158|NCT00234000|refractory anemia with excess blasts|refractory anemia with excess blasts
508159|NCT00234000|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
508160|NCT00234000|refractory anemia|refractory anemia
508161|NCT00234000|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
508162|NCT00234000|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
508163|NCT00234000|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
508164|NCT00234000|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
508165|NCT00234026|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
508166|NCT00234026|stage I mantle cell lymphoma|stage i mantle cell lymphoma
508167|NCT00234026|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
508168|NCT00234026|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
508169|NCT00234026|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
508170|NCT00234026|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
508171|NCT00234039|recurrent bladder cancer|recurrent bladder cancer
508172|NCT00234039|stage 0 bladder cancer|stage 0 bladder cancer
508173|NCT00234039|stage I bladder cancer|stage i bladder cancer
508174|NCT00234039|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
508175|NCT00234052|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
508176|NCT00234052|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
508177|NCT00234052|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
508178|NCT00234052|adenocarcinoma of the lung|adenocarcinoma of the lung
508179|NCT00234052|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
508180|NCT00234052|large cell lung cancer|large cell lung cancer
508181|NCT00234078|OPC-12759|opc-12759
508182|NCT00234078|Dry eye syndromes|dry eye syndromes
508183|NCT00234091|Treatment Naive|treatment naive
508184|NCT00234091|Treatment Initiation|treatment initiation
508185|NCT00234091|Infant|infant
508186|NCT00234091|Preschool Child|preschool child
508187|NCT00234091|Child|child
508188|NCT00234091|Zidovudine|zidovudine
508190|NCT00234091|Retrovir|retrovir
508191|NCT00234091|3TC|3tc
508192|NCT00234091|Lamivudine|lamivudine
508193|NCT00234091|Epivir|epivir
508194|NCT00234091|Nevirapine|nevirapine
508195|NCT00234091|NVP|nvp
508196|NCT00234091|Viramune|viramune
508197|NCT00234091|Efavirenz|efavirenz
508198|NCT00234091|EFV|efv
508199|NCT00234091|Sustiva|sustiva
508200|NCT00234091|Lopinavir/Ritonavir|lopinavir/ritonavir
508201|NCT00234091|LPV/r|lpv/r
508202|NCT00234091|Kaletra|kaletra
508203|NCT00234091|Nelfinavir|nelfinavir
654743|NCT00789607|MRI|mri
508204|NCT00234091|NFV|nfv
508205|NCT00234091|Viracept|viracept
508206|NCT00234091|ABC|abc
508207|NCT00234091|Abacavir|abacavir
508208|NCT00234091|Ziagen|ziagen
508209|NCT00234104|OPC-41061|opc-41061
508211|NCT00234104|Heart Failure|heart failure
508212|NCT00234104|Edema|edema
508213|NCT00234104|Extracellular volume expansion|extracellular volume expansion
508214|NCT00234130|Dialysis|dialysis
508215|NCT00234130|Cytokines|cytokines
508216|NCT00234130|Triglycerides|triglycerides
508217|NCT00234130|Insulin|insulin
508218|NCT00234143|MDS|mds
508219|NCT00234143|EPO|epo
508220|NCT00234143|G-CSF|g-csf
508221|NCT00234143|REGiM|regim
508222|NCT00234156|Fructose|fructose
508223|NCT00234156|Lipogenesis|lipogenesis
508224|NCT00234156|Triglycerides|triglycerides
508225|NCT00234156|Dialysis|dialysis
508226|NCT00234169|Multiple Myeloma|multiple myeloma
508227|NCT00234169|Lymphoma|lymphoma
508228|NCT00234182|liver cancer|liver cancer
508229|NCT00234182|hepatectomy|hepatectomy
508230|NCT00234182|survival|survival
508231|NCT00234182|recurrence|recurrence
508232|NCT00234195|Breast Cancer|breast cancer
508233|NCT00234195|Major Depressive Disorder|major depressive disorder
508736|NCT00236483|dental|dental
508234|NCT00234208|Complicated parapneumonic effusion|complicated parapneumonic effusion
508235|NCT00234208|Pleural empyema|pleural empyema
508236|NCT00234208|Intervention|intervention
508237|NCT00234208|Medical thoracoscopy|medical thoracoscopy
508238|NCT00234208|Chest tube drainage|chest tube drainage
508239|NCT00234234|Biologics|biologics
508240|NCT00234260|Genetics|genetics
508241|NCT00234273|Adapted Physical Activity|adapted physical activity
508242|NCT00234273|Quality of life|quality of life
508243|NCT00234273|cardiovascular risk|cardiovascular risk
508244|NCT00234273|teaching|teaching
508245|NCT00234273|Directly Observed Therapy|directly observed therapy
508246|NCT00234273|Physical activity|physical activity
508247|NCT00234286|Palliative Care|palliative care
508248|NCT00234286|Terminal Care|terminal care
508249|NCT00234286|Hospice Care|hospice care
508250|NCT00234286|Patient Care Planning|patient care planning
508251|NCT00234286|Nursing Care Plans|nursing care plans
508252|NCT00234286|Quality of Health Care|quality of health care
508253|NCT00234286|Inpatients|inpatients
508254|NCT00234286|Professional education|professional education
508255|NCT00234286|Resuscitation orders|resuscitation orders
508256|NCT00234286|Pastoral Care|pastoral care
508257|NCT00234299|Cancer|cancer
508258|NCT00234299|Prostate|prostate
508259|NCT00234299|Preventive Therapy|preventive therapy
508260|NCT00234312|Depressive Disorders|depressive disorders
508261|NCT00234338|Children|children
508262|NCT00234338|Vaccine|vaccine
508263|NCT00234338|Prevenar|prevenar
508264|NCT00234364|Pergolide|pergolide
508265|NCT00234364|Ergotamine derivates|ergotamine derivates
508266|NCT00234364|Valvular heart disease|valvular heart disease
508267|NCT00234377|Schizophrenia|schizophrenia
508268|NCT00234403|Advanced breast cancer|advanced breast cancer
508269|NCT00234403|Metastatic breast cancer|metastatic breast cancer
508270|NCT00234403|ER positive breast cancer|er positive breast cancer
508271|NCT00234403|PR positive breast cancer|pr positive breast cancer
508272|NCT00234416|Pancreatic Cancer|pancreatic cancer
508273|NCT00234416|EGF-R|egf-r
508274|NCT00234429|Colorectal carcinoma advanced disease|colorectal carcinoma advanced disease
508275|NCT00234442|Non symptomatic brain metastases|non symptomatic brain metastases
508276|NCT00234442|Iressa|iressa
508277|NCT00234468|Locally Advanced Non Small Cell Lung Cancer (Stage IIIA and IIIB)|locally advanced non small cell lung cancer (stage iiia and iiib)
508278|NCT00234533|growth|growth
508279|NCT00234533|child development|child development
508280|NCT00234533|growth hormone|growth hormone
508281|NCT00234533|inadequate growth hormone secretion|inadequate growth hormone secretion
508282|NCT00234533|growth failure|growth failure
508283|NCT00234559|Angiogenesis|angiogenesis
508284|NCT00234559|Post surgical dehisced wounds of the lower extremity|post surgical dehisced wounds of the lower extremity
508285|NCT00234598|Pneumonia|pneumonia
508286|NCT00234598|Dental Health|dental health
508287|NCT00234598|Critical Care|critical care
508288|NCT00234637|Alzheimer's disease,|alzheimer's disease,
508289|NCT00234637|switch,|switch,
508290|NCT00234637|rivastigmine,|rivastigmine,
508291|NCT00234637|memantine|memantine
508292|NCT00234650|position change|position change
508293|NCT00234650|adenoma|adenoma
508294|NCT00234650|colonoscopy|colonoscopy
508295|NCT00234663|Cystic fibrosis|cystic fibrosis
508296|NCT00234663|Nonsense mutation|nonsense mutation
508297|NCT00234663|Premature stop codon|premature stop codon
508298|NCT00234676|Parkinson disease|parkinson disease
508299|NCT00234676|women|women
508300|NCT00234676|postmenopause|postmenopause
508301|NCT00234676|estrogen replacement therapy|estrogen replacement therapy
508302|NCT00234676|clinical trials|clinical trials
508303|NCT00234715|Breast Cancer|breast cancer
507671|NCT00224718|AAA|aaa
508304|NCT00234715|Breast Cancer Risk|breast cancer risk
508305|NCT00234715|Breast Cancer Risk Assessment|breast cancer risk assessment
508306|NCT00234715|Psychosocial|psychosocial
508307|NCT00234715|Acceptance|acceptance
508308|NCT00234728|psoriasis|psoriasis
508309|NCT00234728|hydrogel|hydrogel
508310|NCT00234728|occlusive dressing|occlusive dressing
508311|NCT00234728|occlusion|occlusion
508312|NCT00234728|hydrocortisone|hydrocortisone
508313|NCT00234728|tacrolimus|tacrolimus
508314|NCT00234728|Protopic|protopic
508315|NCT00234728|triamcinolone|triamcinolone
508316|NCT00234728|calcipotriene|calcipotriene
508317|NCT00234728|Dovonex|dovonex
508318|NCT00234728|halobetasol|halobetasol
508319|NCT00234728|Ultravate|ultravate
508320|NCT00234754|Incontinence|incontinence
508321|NCT00234754|Surgery|surgery
508322|NCT00234754|Trans-vaginal tape|trans-vaginal tape
508323|NCT00234754|Trans-obturator tape|trans-obturator tape
508324|NCT00234767|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
508325|NCT00234767|ARDS|ards
508326|NCT00234767|Acute Lung Injury|acute lung injury
508327|NCT00234767|ALI|ali
508328|NCT00234767|Cost-effectiveness|cost-effectiveness
508329|NCT00234767|Pharmacoeconomics|pharmacoeconomics
508330|NCT00234767|Long-term follow-up|long-term follow-up
508331|NCT00234780|acute home care|acute home care
508332|NCT00234793|childhood cancer|childhood cancer
508333|NCT00234793|intervention|intervention
508334|NCT00234793|maternal coping|maternal coping
508335|NCT00234793|problem solving skills|problem solving skills
508338|NCT00234793|problem solving|problem solving
508339|NCT00234806|telehealth|telehealth
508340|NCT00234806|telemedicine|telemedicine
508341|NCT00234819|Menopause|menopause
508342|NCT00234832|Obesity|obesity
508343|NCT00234832|Sibutramine|sibutramine
508344|NCT00234858|Hypertension|hypertension
508345|NCT00234858|Metabolic Syndrome|metabolic syndrome
508346|NCT00234858|Tarka|tarka
508347|NCT00234858|Hyzaar|hyzaar
508348|NCT00234871|Hypertension|hypertension
508349|NCT00234871|Diabetes|diabetes
508350|NCT00234871|Proteinuria|proteinuria
508351|NCT00234871|Tarka|tarka
508352|NCT00234871|Lotrel|lotrel
508353|NCT00234884|rheumatoid arthritis|rheumatoid arthritis
508354|NCT00234884|adalimumab|adalimumab
508355|NCT00234897|adalimumab|adalimumab
508356|NCT00234897|rheumatoid arthritis|rheumatoid arthritis
508357|NCT00234910|Lopinavir|lopinavir
508358|NCT00234910|Ritonavir|ritonavir
508359|NCT00234910|Kaletra|kaletra
508360|NCT00234910|Tenofovir|tenofovir
508361|NCT00234910|HIV infection|hiv infection
508362|NCT00234910|Treatment Naive|treatment naive
508363|NCT00234923|HIV Infection|hiv infection
508364|NCT00234923|Kaletra|kaletra
508365|NCT00234923|Lopinavir|lopinavir
508366|NCT00234923|Ritonavir|ritonavir
508367|NCT00234923|Treatment Naive|treatment naive
508368|NCT00234936|rheumatoid arthritis|rheumatoid arthritis
508369|NCT00234936|adalimumab|adalimumab
508370|NCT00234936|quality of life|quality of life
508371|NCT00234949|Cefdinir|cefdinir
508372|NCT00234949|Cephalexin|cephalexin
508373|NCT00234949|Skin Infection|skin infection
508374|NCT00234962|HIV Infection|hiv infection
508375|NCT00234962|HAART|haart
508376|NCT00234962|Lopinavir|lopinavir
508377|NCT00234962|Ritonavir|ritonavir
508378|NCT00234962|Treatment Experienced|treatment experienced
508379|NCT00234962|Treatment Naive|treatment naive
508380|NCT00234975|Lopinavir|lopinavir
508381|NCT00234975|Ritonavir|ritonavir
508382|NCT00234975|Phase 4|phase 4
508384|NCT00234988|Sibutramine|sibutramine
508385|NCT00234988|Obesity|obesity
508386|NCT00235001|Hypertension|hypertension
508387|NCT00235001|Tarka|tarka
508388|NCT00235014|hypertension|hypertension
508389|NCT00235014|diabetes|diabetes
508390|NCT00235014|trandolapril|trandolapril
508391|NCT00235014|verapamil|verapamil
508392|NCT00235014|albuminuria|albuminuria
508393|NCT00235040|Upper Respiratory Infections|upper respiratory infections
508394|NCT00235040|Respiratory Tract Infections|respiratory tract infections
508395|NCT00235040|Tree Number C01.539.739|tree number c01.539.739
508396|NCT00235040|Tree Number C08.730|tree number c08.730
508397|NCT00235040|Unique ID D012141|unique id d012141
508398|NCT00235053|asthma|asthma
508399|NCT00235053|candidiasis, oral|candidiasis, oral
508400|NCT00235053|voice disorders|voice disorders
508401|NCT00235079|Pericarditis|pericarditis
508402|NCT00235079|Recurrence|recurrence
508403|NCT00235079|Therapeutics|therapeutics
508404|NCT00235079|Prevention|prevention
508405|NCT00235079|Colchicine|colchicine
508406|NCT00235105|early ankylosing spondylitis|early ankylosing spondylitis
508407|NCT00235105|spondyloarthritis|spondyloarthritis
508408|NCT00235105|trial|trial
508409|NCT00235105|adalimumab|adalimumab
508410|NCT00235131|Peripheral Artery Occlusive Disease|peripheral artery occlusive disease
508411|NCT00235183|plasma|plasma
508412|NCT00235183|bleeding|bleeding
508413|NCT00235183|liver transplantation|liver transplantation
508414|NCT00235222|Stavudine|stavudine
508415|NCT00235222|Reduced dose of stavudine|reduced dose of stavudine
508416|NCT00235222|Viral load|viral load
508417|NCT00235222|Peripheral neuropathy|peripheral neuropathy
508418|NCT00235222|Treatment Experienced|treatment experienced
508419|NCT00235248|TIA/Brain infarct|tia/brain infarct
508420|NCT00235248|and plaque>4mm in the aortic arch|and plaque>4mm in the aortic arch
508421|NCT00235248|Or peripheral embolism|or peripheral embolism
508422|NCT00235248|and plaque>4 mm in the thoracic aorta|and plaque>4 mm in the thoracic aorta
508423|NCT00235261|Total hip replacement|total hip replacement
508424|NCT00235261|Pregablin|pregablin
508425|NCT00235261|Dexamethasone|dexamethasone
508426|NCT00235261|Multimodal postoperative analgesia.|multimodal postoperative analgesia.
508427|NCT00235274|Schizophrenia|schizophrenia
508428|NCT00235274|Secretin|secretin
508429|NCT00235287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
508430|NCT00235287|type 1 angiotensin receptor antagonists|type 1 angiotensin receptor antagonists
508431|NCT00235287|blood pressure|blood pressure
508432|NCT00235300|Anti-T cells antibodies|anti-t cells antibodies
508433|NCT00235300|Cadaveric Donor Renal Transplantation|cadaveric donor renal transplantation
508434|NCT00235300|Acute Renal Allograft Rejection|acute renal allograft rejection
508435|NCT00235300|Induction Therapy|induction therapy
508436|NCT00235313|Nicotine replacement therapies|nicotine replacement therapies
508437|NCT00235313|Smoking|smoking
508438|NCT00235313|Smoking related diseases|smoking related diseases
508439|NCT00235313|Saliva cotinine|saliva cotinine
508440|NCT00235313|Dose adjustment|dose adjustment
508441|NCT00235313|Smoker; patients with smoking related disease conditions|smoker; patients with smoking related disease conditions
508442|NCT00235326|residents of Walkerton ontario at outbreak|residents of walkerton ontario at outbreak
508443|NCT00235339|Oxygen Consumption|oxygen consumption
508444|NCT00235339|Exercise|exercise
508445|NCT00235339|Rehabilitation|rehabilitation
508446|NCT00235352|Schizphrenia|schizphrenia
508447|NCT00235352|Cognition|cognition
508448|NCT00235352|Negative Symptoms|negative symptoms
508449|NCT00235378|Lupus|lupus
508450|NCT00235378|SLE|sle
508451|NCT00235391|Deferasirox|deferasirox
508452|NCT00235391|Congenital Anemias|congenital anemias
508453|NCT00235391|Anemias|anemias
508454|NCT00235391|Red Blood Cell Disorders|red blood cell disorders
508455|NCT00235391|Chronic Iron Overload|chronic iron overload
508456|NCT00235391|Transfusional Iron Overload|transfusional iron overload
508457|NCT00235391|Iron Chelators|iron chelators
508458|NCT00235391|Oral Iron Chelators|oral iron chelators
508459|NCT00235391|Thalassemia|thalassemia
508460|NCT00235391|Sickle Cell Disease|sickle cell disease
508461|NCT00235391|Diamond Blackfan Anemia|diamond blackfan anemia
508462|NCT00235391|Myelofibrosis|myelofibrosis
508463|NCT00235391|ICL670A|icl670a
508464|NCT00235404|Treatment of elderly.|treatment of elderly.
508465|NCT00235404|Nursing home.|nursing home.
508466|NCT00235404|Rehabilitation.|rehabilitation.
508467|NCT00235404|Readmissions.|readmissions.
508468|NCT00235417|Bone Marrow Transplantation|bone marrow transplantation
508469|NCT00235443|Painful Distal Diabetic Neuropathy|painful distal diabetic neuropathy
508470|NCT00235456|oxygen|oxygen
508471|NCT00235456|surgical complications|surgical complications
508472|NCT00235456|colo-rectal resections|colo-rectal resections
508473|NCT00235469|PAINFUL DISTAL DIABETIC NEUROPATHY|painful distal diabetic neuropathy
508474|NCT00235495|stroke|stroke
508475|NCT00235508|Insomnia|insomnia
508476|NCT00235508|Anxiety|anxiety
508477|NCT00235508|Generalized Anxiety Disorder|generalized anxiety disorder
508478|NCT00235521|Pulmonary hypertension|pulmonary hypertension
508479|NCT00235521|Cardiac Surgery|cardiac surgery
508480|NCT00235521|Children|children
508481|NCT00235521|Pediatric Patients|pediatric patients
508482|NCT00235521|Iloprost|iloprost
508483|NCT00235521|NO|no
508484|NCT00235521|nitric oxide|nitric oxide
508485|NCT00235521|Pulmonary hypertension after cardiac surgery in pediatric patients, 0 - 2 years old|pulmonary hypertension after cardiac surgery in pediatric patients, 0 - 2 years old
508486|NCT00229034|Systemic Inflammation|systemic inflammation
508487|NCT00229034|Microvascular Perfusion|microvascular perfusion
508488|NCT00229034|Septic Shock|septic shock
508489|NCT00229047|Ischemic Preconditioning|ischemic preconditioning
508490|NCT00229047|Microvascular Perfusion|microvascular perfusion
508491|NCT00229047|Inflammation|inflammation
508492|NCT00229047|Ischemia and Reperfusion|ischemia and reperfusion
508493|NCT00229047|Chronic Limb Ischemia|chronic limb ischemia
508494|NCT00229060|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
508495|NCT00229060|Appendicitis|appendicitis
508496|NCT00229060|Cholecystitis|cholecystitis
508497|NCT00229060|Peritonitis|peritonitis
508498|NCT00229073|dapoxetine|dapoxetine
508499|NCT00229073|premature ejaculation|premature ejaculation
508500|NCT00229073|ejaculation|ejaculation
508501|NCT00229073|sexual dysfunction|sexual dysfunction
508502|NCT00229073|orgasmic disorder|orgasmic disorder
508503|NCT00229073|sexual intercourse|sexual intercourse
508504|NCT00229125|Alcohol Withdrawal Syndrome|alcohol withdrawal syndrome
508505|NCT00229125|CIWA-Ar|ciwa-ar
507804|NCT00225394|CMV|cmv
508506|NCT00229125|Acoustic Startle Procedure|acoustic startle procedure
508507|NCT00229125|Rebound Effect|rebound effect
508508|NCT00229138|De novo kidney recipients,|de novo kidney recipients,
508509|NCT00229138|EC-MPS,|ec-mps,
508510|NCT00229138|tacrolimus,|tacrolimus,
508511|NCT00229138|efficacy,|efficacy,
508512|NCT00229138|safety,|safety,
508513|NCT00229138|glomerular filtration rate|glomerular filtration rate
508514|NCT00229138|Treatment in de novo kidney recipients|treatment in de novo kidney recipients
508515|NCT00229164|Primary Dysmenorrhea,|primary dysmenorrhea,
508516|NCT00229164|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
508517|NCT00229177|ONO-2506|ono-2506
508518|NCT00229177|stroke|stroke
508519|NCT00229177|Acute ischemic stroke|acute ischemic stroke
508520|NCT00229190|Nasal lavage fluid|nasal lavage fluid
508521|NCT00229190|Eosinophils|eosinophils
508522|NCT00229190|Reproducibility of results|reproducibility of results
508523|NCT00229203|Myeloma|myeloma
508524|NCT00229203|Aplidin|aplidin
508525|NCT00229203|Plitidepsin|plitidepsin
508526|NCT00229203|PharmaMar|pharmamar
508527|NCT00229229|Obesity|obesity
508528|NCT00229229|Cardiovascular Disease|cardiovascular disease
508529|NCT00229229|Metabolic Syndrome|metabolic syndrome
508530|NCT00229229|Canada Food Guide|canada food guide
508531|NCT00229229|Glycemic Index|glycemic index
508532|NCT00229229|Glycemic Load|glycemic load
508533|NCT00229242|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
508737|NCT00236496|tremor|tremor
508534|NCT00229242|Echocardiography|echocardiography
508535|NCT00229242|Diastolic function|diastolic function
508536|NCT00229242|Left ventricular mass regression|left ventricular mass regression
508537|NCT00229255|Non-Alcoholic hepatic steatosis|non-alcoholic hepatic steatosis
508538|NCT00235534|abortion|abortion
508539|NCT00235534|randomized|randomized
508540|NCT00235534|contraception|contraception
508541|NCT00235534|pregnancy|pregnancy
508542|NCT00235534|compliance|compliance
508543|NCT00235534|continuation|continuation
508544|NCT00235534|oral contraceptive pills|oral contraceptive pills
508545|NCT00235547|abortion|abortion
508546|NCT00235547|randomized|randomized
508547|NCT00235547|contraception|contraception
508548|NCT00235547|pregnancy|pregnancy
508549|NCT00235547|compliance|compliance
508550|NCT00235547|continuation|continuation
508551|NCT00235547|contraceptive patch|contraceptive patch
508552|NCT00235547|transdermal hormonal contraception|transdermal hormonal contraception
508553|NCT00235560|AML|aml
508554|NCT00235560|Rapamycin|rapamycin
508555|NCT00235560|Elderly|elderly
508556|NCT00235560|Elderly patients not eligible for intensive chemotherapy|elderly patients not eligible for intensive chemotherapy
508557|NCT00235573|Vitamin B12 absorption|vitamin b12 absorption
508558|NCT00235573|Holo-transcobalamin|holo-transcobalamin
508559|NCT00235586|vitamin D deficiency postmenopausal women|vitamin d deficiency postmenopausal women
508560|NCT00235599|Growth|growth
508561|NCT00235599|Hormone|hormone
508562|NCT00235599|Deficiency|deficiency
508563|NCT00235625|Alternative Medicine|alternative medicine
508564|NCT00235625|Psoriasis|psoriasis
508565|NCT00235625|Turmeric|turmeric
508566|NCT00235625|Curcumin|curcumin
508567|NCT00235625|Dermatology|dermatology
508568|NCT00235651|Lung transplant recipient|lung transplant recipient
508569|NCT00235664|liver transplant recipients|liver transplant recipients
508570|NCT00235664|intestinal transplant recipients|intestinal transplant recipients
508571|NCT00235664|multivisceral transplant recipients|multivisceral transplant recipients
508572|NCT00235677|Endoscopic antireflux treatment|endoscopic antireflux treatment
508573|NCT00235677|GERD|gerd
508574|NCT00235677|Sham-controlled|sham-controlled
508575|NCT00235677|Endocinch|endocinch
508576|NCT00235716|Alzheimer's Disease|alzheimer's disease
508577|NCT00235716|clinical trial|clinical trial
508578|NCT00235716|randomized controlled trial|randomized controlled trial
508579|NCT00235716|alpha-tocopherol|alpha-tocopherol
508580|NCT00235716|vitamin E|vitamin e
508581|NCT00235716|Namenda|namenda
508582|NCT00235716|memantine|memantine
508583|NCT00235729|Opiate addiction|opiate addiction
508584|NCT00235729|Opiate dependence|opiate dependence
508585|NCT00235729|Withdrawal symptoms|withdrawal symptoms
508586|NCT00235755|Partial Seizures|partial seizures
508587|NCT00235755|Complex Partial Seizures|complex partial seizures
508588|NCT00235755|Epilepsy|epilepsy
508589|NCT00235755|Potassium Channels|potassium channels
508590|NCT00235755|Anticonvulsant|anticonvulsant
508591|NCT00235768|Ecstasy|ecstasy
508592|NCT00235768|MDMA|mdma
508593|NCT00235768|Cognition|cognition
508594|NCT00235768|Brain function|brain function
508595|NCT00235768|Neuroimaging|neuroimaging
508596|NCT00235781|Kidney Transplantation|kidney transplantation
508597|NCT00235781|Antilymphocyte Serum|antilymphocyte serum
508598|NCT00235781|Induction|induction
508599|NCT00235781|Graft Rejection|graft rejection
508600|NCT00235807|Audiology|audiology
508601|NCT00235807|Rehabilitation|rehabilitation
508602|NCT00235807|Tinnitus|tinnitus
655257|NCT00791843|CHF|chf
507903|NCT00225836|Women|women
508603|NCT00235820|Psoriasis|psoriasis
508604|NCT00235820|adalimumab|adalimumab
508605|NCT00235833|Rheumatoid Arthritis|rheumatoid arthritis
508606|NCT00235846|Endoscopic vein harvesting|endoscopic vein harvesting
508607|NCT00235846|Saphenous vein|saphenous vein
508608|NCT00235859|Rheumatoid Arthritis|rheumatoid arthritis
508609|NCT00235859|adalimumab|adalimumab
508610|NCT00235872|Rheumatoid arthritis|rheumatoid arthritis
508611|NCT00235885|Psoriatic Arthritis|psoriatic arthritis
508612|NCT00235885|adalimumab|adalimumab
509888|NCT00241423|Amylin|amylin
508613|NCT00236028|Early Rheumatoid Arthritis|early rheumatoid arthritis
508614|NCT00236041|Breakthrough Pain|breakthrough pain
508615|NCT00236041|Cancer|cancer
508616|NCT00236041|Sickle Cell|sickle cell
508617|NCT00236041|Severe Burns|severe burns
508618|NCT00236041|Children|children
508619|NCT00236041|Adolescents|adolescents
508620|NCT00236041|Analgesia|analgesia
508621|NCT00236041|Sickle Cell Disease|sickle cell disease
508622|NCT00236041|Non-Cancer|non-cancer
508623|NCT00236093|Sickle Cell|sickle cell
508624|NCT00236145|BTP|btp
508625|NCT00236145|Break through pain|break through pain
508626|NCT00236145|breakthrough pain|breakthrough pain
508627|NCT00236171|topical therapy|topical therapy
508628|NCT00236171|Psoriasis Plaque Test|psoriasis plaque test
508629|NCT00236197|Heartburn|heartburn
508630|NCT00236197|Rabeprazole|rabeprazole
508631|NCT00236210|Vascular Intervention Program|vascular intervention program
508632|NCT00236210|Vascular Disease|vascular disease
508633|NCT00236210|Coronary Artery Disease|coronary artery disease
508634|NCT00236210|Diabetes|diabetes
508635|NCT00236210|Lifestyle Modification|lifestyle modification
508636|NCT00236210|Modifiable Risk Factors|modifiable risk factors
14657|NCT03196999|PTSD|ptsd
508637|NCT00236223|Primary hip replacement|primary hip replacement
508638|NCT00236223|Gabapentin|gabapentin
508639|NCT00236223|Dexamethasone|dexamethasone
508640|NCT00236223|Ketamine|ketamine
508641|NCT00236223|Multimodal postoperative analgesia.|multimodal postoperative analgesia.
508642|NCT00236249|Double blind method|double blind method
508643|NCT00236249|Prospective study|prospective study
508644|NCT00236249|Lidocaine/administration and dosage/therapeutic use|lidocaine/administration and dosage/therapeutic use
508645|NCT00236249|Anaesthetics local/administration and dosage|anaesthetics local/administration and dosage
508646|NCT00236249|Opioids/administration and dosage|opioids/administration and dosage
508647|NCT00236249|Pain, postoperative|pain, postoperative
508648|NCT00236249|Perioperative care|perioperative care
508649|NCT00236249|Postoperative care|postoperative care
508650|NCT00236249|Analgesia, Patient-controlled|analgesia, patient-controlled
508651|NCT00236249|Length of stay|length of stay
508652|NCT00236249|Survival analysis|survival analysis
508653|NCT00236249|Patient satisfaction|patient satisfaction
508654|NCT00236249|Surgery|surgery
508655|NCT00236249|Middle age|middle age
508656|NCT00236249|Adult|adult
508657|NCT00236249|Aged|aged
508658|NCT00236262|SDRA|sdra
508659|NCT00236262|Distress|distress
508660|NCT00236262|Expiratory|expiratory
508661|NCT00236262|Pressure|pressure
508662|NCT00236262|Ventilatory|ventilatory
508663|NCT00236275|Comparison of imaging modalities|comparison of imaging modalities
508664|NCT00236275|predict the effectiveness of neoadjuvant chemotherapy|predict the effectiveness of neoadjuvant chemotherapy
508665|NCT00236288|Cancer treatment and tobacco abuse|cancer treatment and tobacco abuse
508666|NCT00236301|Hormone|hormone
508667|NCT00236301|Menopause|menopause
508668|NCT00236301|Inflammation|inflammation
508669|NCT00236301|Dose effects|dose effects
508670|NCT00236301|Apoptosis|apoptosis
508671|NCT00236327|Fentanyl|fentanyl
508672|NCT00236327|Analgesia|analgesia
508673|NCT00236327|Pain|pain
508674|NCT00236327|Cancer pain|cancer pain
508675|NCT00236327|Opioid analgesia|opioid analgesia
508676|NCT00236327|Transdermal fentanyl|transdermal fentanyl
508677|NCT00236327|Patient-controlled analgesia|patient-controlled analgesia
508678|NCT00236340|Amniodrainage|amniodrainage
508679|NCT00236340|Pregnancy|pregnancy
508680|NCT00236340|Amniocentesis|amniocentesis
508681|NCT00236353|schizophrenia|schizophrenia
508682|NCT00236353|schizoaffective disorder|schizoaffective disorder
508683|NCT00236353|long-acting risperidone|long-acting risperidone
508684|NCT00236353|intramuscular injection|intramuscular injection
508685|NCT00236366|Fentanyl|fentanyl
508686|NCT00236366|opioid analgesics|opioid analgesics
508687|NCT00236366|osteoarthritis|osteoarthritis
508688|NCT00236366|arthritis|arthritis
508689|NCT00236366|transdermal administration|transdermal administration
508690|NCT00236379|schizophrenia|schizophrenia
508691|NCT00236379|blood glucose|blood glucose
508692|NCT00236379|glucose metabolism|glucose metabolism
508693|NCT00236379|diabetes mellitus|diabetes mellitus
508694|NCT00236379|risperidone|risperidone
508695|NCT00236379|olanzapine|olanzapine
508696|NCT00236392|Gastroesophageal reflux|gastroesophageal reflux
508697|NCT00236392|Heartburn|heartburn
508698|NCT00236392|Rabeprazole|rabeprazole
508012|NCT00233090|TBI|tbi
508699|NCT00236392|Anti-ulcer agents|anti-ulcer agents
508700|NCT00236392|GERD|gerd
508701|NCT00236392|Proton pump inhibitor|proton pump inhibitor
508702|NCT00236392|GORD|gord
508703|NCT00236392|Non-Erosive Reflux Disease|non-erosive reflux disease
508704|NCT00236392|NERD|nerd
508705|NCT00236405|Anemia|anemia
508706|NCT00236405|erythropoetin|erythropoetin
508707|NCT00236405|quality-of-life outcomes|quality-of-life outcomes
508708|NCT00236418|Epilepsy|epilepsy
508709|NCT00236418|Seizures|seizures
508710|NCT00236418|Topiramate|topiramate
508711|NCT00236418|Prophylaxis|prophylaxis
508712|NCT00236418|Antiepileptic|antiepileptic
508713|NCT00236418|Tonic-clonic seizures|tonic-clonic seizures
508714|NCT00236418|Grand mal seizures|grand mal seizures
508715|NCT00236431|Mild cognitive impairment|mild cognitive impairment
508716|NCT00236431|Galantamine hydrobromide|galantamine hydrobromide
508717|NCT00236431|Memory disorders|memory disorders
508718|NCT00236444|Child|child
508719|NCT00236444|adolescent|adolescent
508720|NCT00236444|disruptive behavior disorders|disruptive behavior disorders
508721|NCT00236444|risperidone|risperidone
508722|NCT00236444|antipsychotropic agents|antipsychotropic agents
508723|NCT00236457|Schizophrenia|schizophrenia
508724|NCT00236457|Intramuscular injection|intramuscular injection
508725|NCT00236457|Antipsychotic agents|antipsychotic agents
508726|NCT00236457|Long-acting risperidone|long-acting risperidone
508727|NCT00236457|Olanzapine|olanzapine
508728|NCT00236470|Disruptive behavior disorder|disruptive behavior disorder
508729|NCT00236470|risperidone|risperidone
508730|NCT00236470|antipsychotropic agents|antipsychotropic agents
508731|NCT00236470|child|child
508732|NCT00236470|adolescent|adolescent
508733|NCT00236483|Oral Surgery|oral surgery
508734|NCT00236483|Analgesics|analgesics
508735|NCT00236483|Postoperative Pain|postoperative pain
508738|NCT00236496|essential tremor|essential tremor
508739|NCT00236509|Migraine|migraine
508740|NCT00236509|Common Migraine|common migraine
508741|NCT00236509|Classic Migraine|classic migraine
508742|NCT00236509|Headache|headache
508743|NCT00236509|Topiramate|topiramate
508744|NCT00236509|Prophylaxis|prophylaxis
508745|NCT00236522|sinus infection|sinus infection
508746|NCT00236522|acute bacterial sinusitis|acute bacterial sinusitis
508747|NCT00236522|sinusitis|sinusitis
508748|NCT00236522|bacterial sinus infection|bacterial sinus infection
508749|NCT00236535|musculoskeletal|musculoskeletal
508750|NCT00236535|Pain|pain
508751|NCT00236535|sprained ankle|sprained ankle
508752|NCT00236535|ligament|ligament
508753|NCT00236535|sprain|sprain
508754|NCT00236535|ankle|ankle
508755|NCT00236548|Schizophrenia|schizophrenia
508756|NCT00236548|schizoaffective disorder|schizoaffective disorder
508757|NCT00236548|patient compliance|patient compliance
508758|NCT00236548|long-acting risperidone|long-acting risperidone
508759|NCT00236548|intramuscular injection|intramuscular injection
508760|NCT00236548|Treatment Guidebook|treatment guidebook
508761|NCT00236561|Migraine|migraine
508762|NCT00236561|Common Migraine|common migraine
508763|NCT00236561|Classic Migraine|classic migraine
508764|NCT00236561|Headache|headache
508765|NCT00236561|Topiramate|topiramate
508766|NCT00236561|Propranolol|propranolol
508767|NCT00236561|Prophylaxis|prophylaxis
508768|NCT00236561|Prevention|prevention
508769|NCT00236574|Dementia|dementia
508770|NCT00236574|Alzheimer disease|alzheimer disease
508771|NCT00236574|Mild cognitive impairment|mild cognitive impairment
508772|NCT00236574|Galantamine hydrobromide|galantamine hydrobromide
508773|NCT00236574|Memory disorder|memory disorder
508774|NCT00236587|Schizophrenia|schizophrenia
508775|NCT00236587|Intramuscular injection|intramuscular injection
508776|NCT00236587|Antipsychotic agents|antipsychotic agents
508777|NCT00236587|Long-acting risperidone|long-acting risperidone
508778|NCT00236600|Obesity|obesity
508779|NCT00236600|Hypertension|hypertension
508780|NCT00236600|Hyperlipidemia|hyperlipidemia
508781|NCT00236600|Type 2 Diabetes|type 2 diabetes
508782|NCT00236600|Life style modification|life style modification
508783|NCT00236613|Obesity|obesity
508784|NCT00236613|Hypertension|hypertension
508785|NCT00236613|Hyperlipidemia|hyperlipidemia
508786|NCT00236613|Body Mass Index|body mass index
508787|NCT00236626|Type 2 Diabetes|type 2 diabetes
508788|NCT00236626|Obesity|obesity
508789|NCT00236626|Insulin Resistance|insulin resistance
508790|NCT00236626|Body Mass Index|body mass index
508791|NCT00236626|Hypertension|hypertension
508792|NCT00236626|Hyperlipidemia|hyperlipidemia
508793|NCT00236626|Sulfonylurea|sulfonylurea
508794|NCT00236626|Topiramate|topiramate
508795|NCT00236626|Adult-Onset Diabetes Mellitus|adult-onset diabetes mellitus
508796|NCT00236626|Metabolic Syndrome|metabolic syndrome
508797|NCT00236639|Obesity|obesity
508798|NCT00236639|Hypertension|hypertension
508799|NCT00236639|Hyperlipidemia|hyperlipidemia
508800|NCT00236639|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
508801|NCT00236639|Body Mass Index|body mass index
508802|NCT00236652|Maxillary Sinusitis|maxillary sinusitis
508803|NCT00236652|Infection|infection
508804|NCT00236665|Obesity|obesity
508805|NCT00236665|Essential Hypertension|essential hypertension
508806|NCT00236665|Mild Hypertension|mild hypertension
508807|NCT00236665|Moderate Hypertension|moderate hypertension
508808|NCT00236665|High Blood Pressure|high blood pressure
508809|NCT00236678|Anemia|anemia
508810|NCT00236678|Rheumatoid arthritis|rheumatoid arthritis
508811|NCT00236678|Hemoglobin level|hemoglobin level
508812|NCT00236691|topiramate|topiramate
508813|NCT00236691|epilepsy|epilepsy
508814|NCT00236691|partial epilepsies|partial epilepsies
508815|NCT00236691|partial epilepsy|partial epilepsy
508816|NCT00236691|seizures|seizures
508817|NCT00236691|epileptic seizures|epileptic seizures
508818|NCT00236691|partial seizure disorder|partial seizure disorder
508819|NCT00236691|brain diseases|brain diseases
508820|NCT00236704|Epilepsy|epilepsy
508821|NCT00236704|Seizures|seizures
508822|NCT00236704|Topiramate|topiramate
508823|NCT00236704|Prophylaxis|prophylaxis
508824|NCT00236704|Antiepileptic|antiepileptic
508825|NCT00236704|Tonic-clonic seizures|tonic-clonic seizures
508826|NCT00236704|Grand mal seizures|grand mal seizures
508827|NCT00236717|Epilepsy|epilepsy
508828|NCT00236717|Seizures|seizures
508829|NCT00236717|Topiramate|topiramate
508830|NCT00236717|Prophylaxis|prophylaxis
508831|NCT00236717|Antiepileptic|antiepileptic
508832|NCT00236730|topiramate|topiramate
508833|NCT00236730|epilepsy|epilepsy
508834|NCT00236730|partial epilepsies|partial epilepsies
508835|NCT00236730|partial epilepsy|partial epilepsy
508836|NCT00236730|seizures|seizures
508837|NCT00236730|epileptic seizures|epileptic seizures
508838|NCT00236730|partial seizure disorder|partial seizure disorder
508839|NCT00236730|brain diseases|brain diseases
508840|NCT00236743|topiramate|topiramate
508841|NCT00236743|epilepsy|epilepsy
508842|NCT00236743|partial epilepsies|partial epilepsies
508843|NCT00236743|partial epilepsy|partial epilepsy
508844|NCT00236743|seizures|seizures
508845|NCT00236743|epileptic seizures|epileptic seizures
508846|NCT00236743|partial seizure disorder|partial seizure disorder
508847|NCT00236743|children|children
508848|NCT00236743|pediatric|pediatric
508849|NCT00236756|Epilepsy|epilepsy
508850|NCT00236756|Seizures|seizures
508851|NCT00236756|Topiramate|topiramate
508852|NCT00236756|Prophylaxis|prophylaxis
508853|NCT00236756|Antiepileptic|antiepileptic
508854|NCT00236756|Lennox-Gastaut syndrome|lennox-gastaut syndrome
508855|NCT00236756|Seizures, tonic|seizures, tonic
508856|NCT00236769|contraception|contraception
508857|NCT00236769|transdermal contraception|transdermal contraception
508858|NCT00236769|hormonal, steroidal contraception|hormonal, steroidal contraception
508859|NCT00236769|ethinyl estradiol|ethinyl estradiol
508860|NCT00236769|progesterone|progesterone
508861|NCT00236782|contraception|contraception
508862|NCT00236782|hormonal contraception|hormonal contraception
508863|NCT00236782|oral contraception|oral contraception
508864|NCT00236782|steroid, ethinyl estradiol, progestin contraception|steroid, ethinyl estradiol, progestin contraception
508865|NCT00236782|transdermal.|transdermal.
508866|NCT00236795|contraception|contraception
508867|NCT00236795|hormonal contraception|hormonal contraception
508868|NCT00236795|oral contraception|oral contraception
508869|NCT00236795|steroid, ethinyl estradiol, horgestimate, levonorgestrel contraception|steroid, ethinyl estradiol, horgestimate, levonorgestrel contraception
508870|NCT00236795|transdermal.|transdermal.
508871|NCT00236808|quinolones, ciprofloxacin|quinolones, ciprofloxacin
508872|NCT00236808|levofloxacin|levofloxacin
508873|NCT00236808|chronic bacterial prostatitis|chronic bacterial prostatitis
508874|NCT00236808|inflammation|inflammation
508875|NCT00236808|chronic prostatitis|chronic prostatitis
508876|NCT00236808|prostatitis|prostatitis
508877|NCT00236808|prostate|prostate
508878|NCT00236808|antibiotic|antibiotic
508879|NCT00236821|respiratory tract diseases|respiratory tract diseases
508880|NCT00236821|pneumonia|pneumonia
508881|NCT00236821|levofloxacin|levofloxacin
508882|NCT00236821|community-acquired pneumonia|community-acquired pneumonia
508883|NCT00236821|lung diseases|lung diseases
508884|NCT00236821|quinolones|quinolones
508885|NCT00236834|respiratory tract diseases|respiratory tract diseases
508886|NCT00236834|levofloxacin|levofloxacin
508887|NCT00236834|pneumonia|pneumonia
508888|NCT00236834|quinolones, hospital-acquired pneumonia|quinolones, hospital-acquired pneumonia
508889|NCT00236834|lung diseases|lung diseases
508890|NCT00236847|topiramate|topiramate
508891|NCT00236847|epilepsy|epilepsy
508892|NCT00236847|partial epilepsy|partial epilepsy
508893|NCT00236847|seizures|seizures
508894|NCT00236847|epileptic seizures|epileptic seizures
508895|NCT00236847|partial seizure disorder|partial seizure disorder
508896|NCT00236847|brain diseases|brain diseases
508897|NCT00236860|partial seizure disorder|partial seizure disorder
508898|NCT00236860|brain diseases|brain diseases
508899|NCT00236860|topiramate|topiramate
508900|NCT00236860|epilepsy|epilepsy
508189|NCT00234091|AZT|azt
508901|NCT00236860|partial epilepsies|partial epilepsies
508902|NCT00236860|partial epilepsy|partial epilepsy
508903|NCT00236860|seizures|seizures
508904|NCT00236860|epileptic seizures|epileptic seizures
508905|NCT00236873|topiramate|topiramate
508906|NCT00236873|epilepsy|epilepsy
508907|NCT00236873|partial epilepsies|partial epilepsies
508908|NCT00236873|partial epilepsy|partial epilepsy
508909|NCT00236873|seizures|seizures
508910|NCT00236873|epileptic seizures|epileptic seizures
508911|NCT00236873|partial seizure disorder|partial seizure disorder
508912|NCT00236873|brain diseases|brain diseases
508913|NCT00236886|Epilepsy|epilepsy
508914|NCT00236886|Partial Epilepsy|partial epilepsy
508915|NCT00236886|Secondary Generalized Epilepsy|secondary generalized epilepsy
508916|NCT00236886|Primary Generalized Epilepsy|primary generalized epilepsy
508917|NCT00236886|Tonic-Clonic Seizures|tonic-clonic seizures
508918|NCT00236886|Topiramate|topiramate
508919|NCT00236886|Weight Loss|weight loss
508920|NCT00236912|complicated appendicitis|complicated appendicitis
508921|NCT00236912|antibiotics|antibiotics
508922|NCT00236912|appendicitis|appendicitis
508923|NCT00236912|infection|infection
508924|NCT00236925|Fibromyalgia|fibromyalgia
508925|NCT00236925|Cortisol|cortisol
508926|NCT00236925|Hydrocortisone|hydrocortisone
508927|NCT00236925|Stress|stress
508928|NCT00236938|iron|iron
508929|NCT00236938|peritoneal dialysis|peritoneal dialysis
508930|NCT00236938|anemia|anemia
508931|NCT00236951|Anemia|anemia
508932|NCT00236951|Cancer|cancer
508933|NCT00236951|Chemotherapy|chemotherapy
508934|NCT00236964|Anemia|anemia
508935|NCT00236964|Chronic Kidney Disease|chronic kidney disease
508937|NCT00236977|iron|iron
508938|NCT00236977|anemia|anemia
508939|NCT00236990|prostatitis|prostatitis
508940|NCT00236990|Elmiron|elmiron
508941|NCT00236990|pentosan polysulfate sodium|pentosan polysulfate sodium
508942|NCT00237003|women|women
508943|NCT00237003|incarceration|incarceration
508944|NCT00237003|alcohol use|alcohol use
508945|NCT00237003|motivational interviewing|motivational interviewing
508946|NCT00237042|Temporomandibular Disorders|temporomandibular disorders
508947|NCT00237042|TMJ Disorders|tmj disorders
508948|NCT00237055|Children|children
508949|NCT00237055|Crohn's disease|crohn's disease
508950|NCT00237055|Inflammatory bowel disease|inflammatory bowel disease
508951|NCT00237055|Infectious agents|infectious agents
508952|NCT00237055|Colonoscopy|colonoscopy
508953|NCT00237068|Gastroesophageal Reflux|gastroesophageal reflux
508954|NCT00237081|Interstitial Cystitis|interstitial cystitis
508955|NCT00237081|Painful Bladder Syndrome|painful bladder syndrome
508956|NCT00237081|Genetics|genetics
508957|NCT00237081|Risk factors|risk factors
508958|NCT00237081|Family history|family history
508959|NCT00237094|Diabetes|diabetes
508960|NCT00237094|Self Management|self management
508961|NCT00237094|Interdisciplinary team|interdisciplinary team
508962|NCT00237107|Cytoreduction Surgical Procedures|cytoreduction surgical procedures
508963|NCT00237107|Curretage|curretage
508964|NCT00237107|Photochemotherapy|photochemotherapy
508965|NCT00237120|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
508966|NCT00237120|Imatinib|imatinib
508967|NCT00237120|CML|cml
508968|NCT00237133|Breast cancer,|breast cancer,
508969|NCT00237133|Letrozole,|letrozole,
508970|NCT00237133|Hormonal receptors|hormonal receptors
508971|NCT00237146|Prostate cancer|prostate cancer
508972|NCT00237146|Zoledronic acid|zoledronic acid
508973|NCT00237146|Bone metastasis|bone metastasis
508974|NCT00237159|Prostate cancer|prostate cancer
508975|NCT00237159|Bone metastasis|bone metastasis
508976|NCT00237159|Skeletal related event|skeletal related event
508977|NCT00237172|GIST|gist
508978|NCT00237172|Imatinib|imatinib
508979|NCT00237172|STI571|sti571
508980|NCT00237172|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
508981|NCT00237185|GIST|gist
508982|NCT00237185|c-kit|c-kit
508983|NCT00237185|imatinib mesylate|imatinib mesylate
508984|NCT00237198|Aromatase inhibitor|aromatase inhibitor
508985|NCT00237198|letrozole|letrozole
508986|NCT00237198|breast cancer|breast cancer
508987|NCT00237211|Aromatase inhibitor|aromatase inhibitor
508988|NCT00237211|letrozole|letrozole
508989|NCT00237211|breast cancer|breast cancer
508990|NCT00237224|Breast Cancer, ER and/or PgR positive, Letrozole|breast cancer, er and/or pgr positive, letrozole
508991|NCT00237237|Type 2 diabetes|type 2 diabetes
508992|NCT00237237|vildagliptin|vildagliptin
508993|NCT00237250|Pre-diabetes|pre-diabetes
508994|NCT00237250|vildagliptin|vildagliptin
508995|NCT00237250|IGT|igt
583316|NCT00511277|schizophrenia|schizophrenia
508996|NCT00237263|Parkinson's disease, end-of -dose wearing-off, entacapone|parkinson's disease, end-of -dose wearing-off, entacapone
508997|NCT00237276|colonoscopy, chromoendoscopy, autoflurescence, narrow band imaging, high definition endoscopy, colorectal cancer, colitis, polyp, DALM, adenoma, video|colonoscopy, chromoendoscopy, autoflurescence, narrow band imaging, high definition endoscopy, colorectal cancer, colitis, polyp, dalm, adenoma, video
508998|NCT00237289|Manic depression|manic depression
508999|NCT00237289|Mania|mania
509000|NCT00237289|Depression|depression
509001|NCT00237289|Bipolar disorder|bipolar disorder
509002|NCT00237289|Psychosis|psychosis
509003|NCT00237302|pediatric migraine|pediatric migraine
509004|NCT00237302|migraine headache|migraine headache
509005|NCT00237302|migraine prophylaxis|migraine prophylaxis
509006|NCT00237302|migraine prevention|migraine prevention
509007|NCT00237302|migraine|migraine
509008|NCT00237315|Urea|urea
509009|NCT00237315|Inherited metabolic disorders|inherited metabolic disorders
509010|NCT00237328|Heparin resistance|heparin resistance
509011|NCT00237328|Blood clotting|blood clotting
509012|NCT00237328|Heart surgery|heart surgery
509013|NCT00237328|Cardiopulmonary bypass|cardiopulmonary bypass
509014|NCT00237341|chronic low back pain|chronic low back pain
509015|NCT00237341|opioid|opioid
509016|NCT00237341|fentanyl|fentanyl
509889|NCT00241423|Lilly|lilly
509017|NCT00237354|Recurrent soft tissue breast carcinoma|recurrent soft tissue breast carcinoma
509018|NCT00237367|Gastroesophageal Reflux|gastroesophageal reflux
509019|NCT00237367|GERD|gerd
509020|NCT00237367|Nighttime heartburn|nighttime heartburn
509021|NCT00237367|heartburn|heartburn
509022|NCT00237367|esophagus|esophagus
509023|NCT00237367|esophageal acid exposure|esophageal acid exposure
509024|NCT00237367|EAE|eae
509025|NCT00237367|Aciphex|aciphex
509026|NCT00237367|Pariet|pariet
509027|NCT00237367|rabeprazole|rabeprazole
509028|NCT00237367|Protonix|protonix
509029|NCT00237367|pantoprazole|pantoprazole
509030|NCT00237380|Cystic fibrosis|cystic fibrosis
509031|NCT00237380|Nonsense mutation|nonsense mutation
509032|NCT00237380|Premature stop codon|premature stop codon
509033|NCT00237393|PTSD|ptsd
509034|NCT00237393|Posttraumatic stress disorder|posttraumatic stress disorder
509035|NCT00237393|Treatment|treatment
509036|NCT00237393|Quetiapine|quetiapine
509037|NCT00237406|IVR, methadone|ivr, methadone
509038|NCT00237406|methadone maintenance|methadone maintenance
509039|NCT00237419|Ankylosing spondylitis|ankylosing spondylitis
509040|NCT00237419|Long-term therapy with infliximab|long-term therapy with infliximab
509041|NCT00237419|Radiographic progression|radiographic progression
509511|NCT00232349|cognition|cognition
509042|NCT00237471|Acute Myocardial Infarction|acute myocardial infarction
509044|NCT00237471|Insulin Infusion|insulin infusion
509045|NCT00237484|pegylated interferon alfa-2b|pegylated interferon alfa-2b
509046|NCT00237484|ribavirin|ribavirin
509047|NCT00237484|infliximab|infliximab
509048|NCT00237484|chronic hepatitis C|chronic hepatitis c
509049|NCT00237497|Insomnia|insomnia
509050|NCT00237497|Center of Pressure|center of pressure
509051|NCT00237497|Postural Sway|postural sway
509052|NCT00237497|Drug Therapy|drug therapy
509053|NCT00237497|Balance and Stability|balance and stability
509054|NCT00237510|Antidepressant induced excessive sweating|antidepressant induced excessive sweating
509055|NCT00237523|Breast pain|breast pain
509056|NCT00237523|Mastalgia|mastalgia
509057|NCT00237523|Cyclic mastalgia|cyclic mastalgia
509058|NCT00237523|Periodic mastalgia|periodic mastalgia
509059|NCT00237523|Non-cyclic mastalgia|non-cyclic mastalgia
509060|NCT00237523|Fibrosis|fibrosis
509061|NCT00237523|Nodularity|nodularity
509063|NCT00237523|Fibrocystic breast disease|fibrocystic breast disease
509064|NCT00237523|Fibrocystic breast condition|fibrocystic breast condition
509065|NCT00237523|Fibocystic breast syndrome|fibocystic breast syndrome
509066|NCT00237536|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
509067|NCT00237536|BPH|bph
509068|NCT00237536|Enlarged Prostate|enlarged prostate
509069|NCT00237549|Type 2 diabetes|type 2 diabetes
509070|NCT00237549|Screening|screening
509071|NCT00237549|Intensive treatment|intensive treatment
509072|NCT00237549|Polypharmacy|polypharmacy
509073|NCT00237549|Primary care|primary care
509074|NCT00237575|urothelial|urothelial
509075|NCT00237575|bladder|bladder
509076|NCT00237575|gemcitabine|gemcitabine
509077|NCT00237575|cisplatin|cisplatin
509078|NCT00237575|leukine|leukine
509079|NCT00237575|neupogen|neupogen
509080|NCT00237575|filgrastim|filgrastim
509081|NCT00237575|sargramostim|sargramostim
509082|NCT00237575|metastatic|metastatic
509083|NCT00237575|Regionally Advanced|regionally advanced
509084|NCT00237575|Advanced|advanced
509085|NCT00237588|Angiotensin II Type I Receptor Blockers|angiotensin ii type i receptor blockers
509086|NCT00237588|Amlodipine|amlodipine
509087|NCT00237588|Calcium Channel Blockers|calcium channel blockers
509088|NCT00237588|Diabetes Mellitus|diabetes mellitus
509089|NCT00237588|Hypertension|hypertension
509090|NCT00237588|Insulin Resistance|insulin resistance
509091|NCT00237588|Losartan|losartan
509093|NCT00237601|Hospital birth|hospital birth
509094|NCT00237601|Midwifery|midwifery
509095|NCT00237601|Effectivity|effectivity
509096|NCT00237601|Efficiency|efficiency
509097|NCT00237614|Contrast-induced nephropathy|contrast-induced nephropathy
509098|NCT00237614|Acute myocardial infarction|acute myocardial infarction
509099|NCT00237614|Primary coronary angioplasty|primary coronary angioplasty
509100|NCT00237627|stage IIIA breast cancer|stage iiia breast cancer
509101|NCT00237627|stage IIIB breast cancer|stage iiib breast cancer
509102|NCT00237627|stage IIIC breast cancer|stage iiic breast cancer
509103|NCT00237627|stage IV breast cancer|stage iv breast cancer
509104|NCT00237627|male breast cancer|male breast cancer
509105|NCT00237627|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
509106|NCT00237627|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
509107|NCT00237627|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
509108|NCT00237627|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
509109|NCT00237627|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
509110|NCT00237627|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
509111|NCT00237627|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
509112|NCT00237627|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
510111|NCT00242840|GW433908|gw433908
509113|NCT00237627|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
509114|NCT00237627|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
509115|NCT00237627|secondary acute myeloid leukemia|secondary acute myeloid leukemia
509116|NCT00237627|mast cell leukemia|mast cell leukemia
509117|NCT00237627|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
509118|NCT00237627|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
509119|NCT00237627|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
509120|NCT00237627|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
509121|NCT00237627|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
509122|NCT00237627|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
509123|NCT00237627|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
509124|NCT00237627|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
509125|NCT00237627|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
509126|NCT00237627|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
509127|NCT00237627|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
509128|NCT00237627|refractory hairy cell leukemia|refractory hairy cell leukemia
509129|NCT00237627|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
509130|NCT00237627|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
509131|NCT00237627|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
509132|NCT00237627|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
509133|NCT00237627|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
509134|NCT00237627|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
509135|NCT00237627|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
509136|NCT00237627|anaplastic large cell lymphoma|anaplastic large cell lymphoma
509137|NCT00237627|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
509138|NCT00237627|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
509139|NCT00237627|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
509140|NCT00237627|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
509141|NCT00237627|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
509142|NCT00237627|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
509143|NCT00237627|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
509144|NCT00237627|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
509145|NCT00237627|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
509146|NCT00237627|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
509147|NCT00237627|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
509148|NCT00237627|splenic marginal zone lymphoma|splenic marginal zone lymphoma
509149|NCT00237627|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
509150|NCT00237627|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
509151|NCT00237627|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
509152|NCT00237627|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
509153|NCT00237627|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
509154|NCT00237627|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
509155|NCT00237627|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
509156|NCT00237627|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
509157|NCT00237627|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
509158|NCT00237627|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
509159|NCT00237627|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
509160|NCT00237627|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
509161|NCT00237627|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
509162|NCT00237627|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
509163|NCT00237627|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
509164|NCT00237627|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
509165|NCT00237627|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
509166|NCT00237627|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
509167|NCT00237627|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
509168|NCT00237627|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
509169|NCT00237627|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
509170|NCT00237627|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
509171|NCT00237627|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
509172|NCT00237627|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
509173|NCT00237627|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
509174|NCT00237627|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
509175|NCT00237627|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
509176|NCT00237627|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
509177|NCT00237627|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
509178|NCT00237627|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
509179|NCT00237627|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
509180|NCT00237627|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
509181|NCT00237627|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
509182|NCT00237627|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
509183|NCT00237627|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
509184|NCT00237627|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
509185|NCT00237627|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
509186|NCT00237627|intraocular lymphoma|intraocular lymphoma
509187|NCT00237627|primary central nervous system lymphoma|primary central nervous system lymphoma
509188|NCT00237627|stage III multiple myeloma|stage iii multiple myeloma
509189|NCT00237627|stage II multiple myeloma|stage ii multiple myeloma
509190|NCT00237627|refractory multiple myeloma|refractory multiple myeloma
509191|NCT00237627|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
509192|NCT00237627|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
14937|NCT03195101|orbital tumors|orbital tumors
509193|NCT00237627|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
509194|NCT00237627|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
509195|NCT00237627|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
509196|NCT00237627|recurrent breast cancer|recurrent breast cancer
509197|NCT00237627|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
509198|NCT00237640|Cinnamon|cinnamon
509199|NCT00237640|Diabetes mellitus|diabetes mellitus
509200|NCT00237640|Hyperlipidemia|hyperlipidemia
509201|NCT00237640|Insulin Resistance|insulin resistance
509202|NCT00237653|Valganciclovir|valganciclovir
509203|NCT00237653|Cytomegalovirus|cytomegalovirus
509204|NCT00237653|Cryptogenic inflammatory bowel diseases|cryptogenic inflammatory bowel diseases
509205|NCT00237653|Crohn Disease|crohn disease
509206|NCT00237653|colitis, ulcerative|colitis, ulcerative
509207|NCT00237666|Bipolar II Disorder|bipolar ii disorder
509208|NCT00237666|Major Depressive Episode|major depressive episode
509209|NCT00237679|behavior therapy|behavior therapy
509210|NCT00237679|combination therapy|combination therapy
509211|NCT00237679|gastrointestinal disorder chemotherapy|gastrointestinal disorder chemotherapy
509212|NCT00237679|human therapy evaluation|human therapy evaluation
509213|NCT00237679|larynx disorder|larynx disorder
509214|NCT00237679|middle childhood (6-11)|middle childhood (6-11)
509215|NCT00237679|lansoprazole|lansoprazole
509216|NCT00237679|reflux esophagitis|reflux esophagitis
509217|NCT00237679|quality of life|quality of life
509218|NCT00237679|clinical research|clinical research
509219|NCT00237679|human subject|human subject
509220|NCT00237679|laryngoscopy|laryngoscopy
509221|NCT00237679|patient oriented research|patient oriented research
509222|NCT00237679|questionnaire|questionnaire
509223|NCT00237692|Telemedicine|telemedicine
509224|NCT00237692|Adherence|adherence
509225|NCT00237692|Tailored Nurse Intervention|tailored nurse intervention
509226|NCT00237692|Home Blood Pressure Monitoring|home blood pressure monitoring
509227|NCT00237692|cardiovascular disease|cardiovascular disease
509228|NCT00237705|Headache|headache
509229|NCT00237705|Concussion|concussion
509230|NCT00237705|Post concussive syndrome|post concussive syndrome
509231|NCT00237705|Head trauma|head trauma
509232|NCT00237731|Acute pain|acute pain
509233|NCT00237731|Morphine titration|morphine titration
509234|NCT00237731|Analgesia|analgesia
509235|NCT00237731|Pre-hospital care|pre-hospital care
509236|NCT00237744|Motor Learning|motor learning
509237|NCT00237744|Rehabilitation|rehabilitation
509238|NCT00237744|Robotics|robotics
509239|NCT00237744|Therapeutic Electric Stimulation|therapeutic electric stimulation
509240|NCT00237757|Patient Care Team|patient care team
509241|NCT00237757|Rehabilitation outcomes|rehabilitation outcomes
509242|NCT00237757|Treatment outcomes|treatment outcomes
509243|NCT00237770|Blood Pressure|blood pressure
509244|NCT00237770|Cardiovascular Autonomic Control|cardiovascular autonomic control
509245|NCT00237770|Nitric Oxide|nitric oxide
509246|NCT00237770|NOS Inhibitor|nos inhibitor
509247|NCT00237770|Orthostatic Hypotension|orthostatic hypotension
509248|NCT00237770|Spinal Cord Injury|spinal cord injury
509249|NCT00237770|Tetraplegia|tetraplegia
509250|NCT00237783|Renal dialysis|renal dialysis
509251|NCT00237783|Hypotension|hypotension
509252|NCT00237783|Dialysis solutions|dialysis solutions
509253|NCT00237796|Behavioral|behavioral
509254|NCT00237796|Cognitive|cognitive
509255|NCT00237796|Functioning|functioning
509256|NCT00237796|Older|older
509257|NCT00237796|CBT|cbt
509258|NCT00237796|Rehabilitation|rehabilitation
509259|NCT00237796|Schizophrenia|schizophrenia
509260|NCT00237796|Skills|skills
509261|NCT00237796|Social|social
509262|NCT00237796|Training|training
509263|NCT00237822|Treatment Adherence|treatment adherence
509264|NCT00237822|Co-Occurring Disorders|co-occurring disorders
509265|NCT00237822|Motivational Enhancement Therapy|motivational enhancement therapy
509266|NCT00237822|Contingency Management|contingency management
509267|NCT00237822|MEMS Caps|mems caps
509268|NCT00237874|prodrome|prodrome
509269|NCT00237874|ultra high risk|ultra high risk
509270|NCT00237874|aripiprazole|aripiprazole
509271|NCT00237887|Psoriasis|psoriasis
509272|NCT00237887|adalimumab|adalimumab
509273|NCT00237926|Sleep|sleep
509274|NCT00237926|Fatigue|fatigue
509275|NCT00237926|Exercise tolerance|exercise tolerance
509276|NCT00237926|Quality of life|quality of life
509277|NCT00237926|Health status|health status
509278|NCT00237965|Skin Self Examination|skin self examination
509279|NCT00237965|Mole Mapping Diagram|mole mapping diagram
509280|NCT00237965|Melanoma|melanoma
509281|NCT00238004|Niacin|niacin
509282|NCT00238017|malaria, amodiaquine, artesunate, safety, efficacy|malaria, amodiaquine, artesunate, safety, efficacy
509283|NCT00238030|organ donation|organ donation
509284|NCT00238030|thyroid replacement|thyroid replacement
509285|NCT00238043|Biogeneric Epoetin treatment|biogeneric epoetin treatment
509286|NCT00238043|Renal anaemia|renal anaemia
509287|NCT00238043|Chronic Kidney Disease|chronic kidney disease
509288|NCT00238043|Pure Red Blood Cell Aplasia|pure red blood cell aplasia
509289|NCT00238043|Hemodialysis|hemodialysis
509513|NCT00232375|LADA|lada
509290|NCT00238056|Domperidone, QT, prematurity|domperidone, qt, prematurity
509291|NCT00238069|Asthma|asthma
509292|NCT00238069|Sleep Apnea|sleep apnea
509293|NCT00238069|Obesity|obesity
509294|NCT00238069|CPAP|cpap
509295|NCT00238082|COPD|copd
509296|NCT00238082|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
509297|NCT00238082|Emphysema|emphysema
509298|NCT00238082|Chronic Bronchitis|chronic bronchitis
509299|NCT00238108|Sleep disorders|sleep disorders
509300|NCT00238108|High blood pressure|high blood pressure
509301|NCT00238147|stage II esophageal cancer|stage ii esophageal cancer
509302|NCT00238147|stage III esophageal cancer|stage iii esophageal cancer
509303|NCT00238173|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
509304|NCT00238173|bone marrow suppression|bone marrow suppression
509305|NCT00238173|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
509306|NCT00238173|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
509307|NCT00238173|untreated childhood brain stem glioma|untreated childhood brain stem glioma
509308|NCT00238173|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
509309|NCT00238173|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
509310|NCT00238173|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
509311|NCT00238173|recurrent childhood brain tumor|recurrent childhood brain tumor
509312|NCT00238173|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
509313|NCT00238173|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
509314|NCT00238173|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
509315|NCT00238173|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
509316|NCT00238173|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
509317|NCT00238173|childhood oligodendroglioma|childhood oligodendroglioma
509318|NCT00238173|childhood infratentorial ependymoma|childhood infratentorial ependymoma
509319|NCT00238173|childhood supratentorial ependymoma|childhood supratentorial ependymoma
509320|NCT00238173|recurrent childhood ependymoma|recurrent childhood ependymoma
509321|NCT00238173|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
509322|NCT00238173|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
509323|NCT00238173|childhood central nervous system germinoma|childhood central nervous system germinoma
509324|NCT00238173|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
752459|NCT01173081|fifth metatarsal fracture|fifth metatarsal fracture
509325|NCT00238173|childhood central nervous system teratoma|childhood central nervous system teratoma
509326|NCT00238173|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
509327|NCT00238173|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
509328|NCT00238199|stage III pancreatic cancer|stage iii pancreatic cancer
509329|NCT00238199|stage IV pancreatic cancer|stage iv pancreatic cancer
509330|NCT00238225|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
509331|NCT00238238|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
509332|NCT00238238|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
509333|NCT00238238|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
509334|NCT00238251|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
509335|NCT00238251|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
509336|NCT00238251|tumors metastatic to brain|tumors metastatic to brain
509337|NCT00238264|childhood oligodendroglioma|childhood oligodendroglioma
509338|NCT00238264|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
509339|NCT00238264|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
509340|NCT00238264|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
509483|NCT00232258|NK1 Antagonist|nk1 antagonist
509341|NCT00238264|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
509342|NCT00238264|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
509343|NCT00238264|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
509344|NCT00238277|adult glioblastoma|adult glioblastoma
509345|NCT00238277|adult giant cell glioblastoma|adult giant cell glioblastoma
509346|NCT00238277|adult gliosarcoma|adult gliosarcoma
509347|NCT00238290|recurrent breast cancer|recurrent breast cancer
509348|NCT00238290|stage IIIA breast cancer|stage iiia breast cancer
509349|NCT00238290|stage IIIB breast cancer|stage iiib breast cancer
509350|NCT00238290|stage IIIC breast cancer|stage iiic breast cancer
509351|NCT00238290|stage IV breast cancer|stage iv breast cancer
509352|NCT00238316|breast cancer|breast cancer
509353|NCT00238329|recurrent melanoma|recurrent melanoma
509354|NCT00238329|stage IV melanoma|stage iv melanoma
509355|NCT00238329|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
509356|NCT00238329|extraocular extension melanoma|extraocular extension melanoma
509357|NCT00238329|iris melanoma|iris melanoma
509358|NCT00238329|recurrent intraocular melanoma|recurrent intraocular melanoma
509359|NCT00238342|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
509360|NCT00238342|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
509713|NCT00240695|galantamine|galantamine
509361|NCT00238342|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
509362|NCT00238342|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
509363|NCT00238342|fallopian tube cancer|fallopian tube cancer
509364|NCT00238342|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
509365|NCT00238342|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
509366|NCT00238342|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
509367|NCT00238342|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
509368|NCT00238342|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
509370|NCT00238355|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
509371|NCT00238368|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
509372|NCT00238368|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
509373|NCT00238368|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
509374|NCT00238368|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
509375|NCT00238368|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
509376|NCT00238368|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
509377|NCT00238368|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
509378|NCT00238368|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
509379|NCT00238368|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
509380|NCT00238368|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
509381|NCT00238368|anaplastic large cell lymphoma|anaplastic large cell lymphoma
509382|NCT00238368|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
509383|NCT00238368|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
509384|NCT00238368|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
509385|NCT00238368|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
509386|NCT00238381|adenocarcinoma of the rectum|adenocarcinoma of the rectum
509387|NCT00238381|stage 0 rectal cancer|stage 0 rectal cancer
509388|NCT00238381|stage I rectal cancer|stage i rectal cancer
509389|NCT00238381|stage II rectal cancer|stage ii rectal cancer
509390|NCT00238381|stage III rectal cancer|stage iii rectal cancer
509391|NCT00238381|stage IV rectal cancer|stage iv rectal cancer
509392|NCT00238381|recurrent rectal cancer|recurrent rectal cancer
509393|NCT00238407|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
509394|NCT00238407|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
509395|NCT00238407|stage III esophageal cancer|stage iii esophageal cancer
509396|NCT00238407|stage IV esophageal cancer|stage iv esophageal cancer
509397|NCT00238433|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
509398|NCT00238433|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
509399|NCT00238433|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
509400|NCT00238433|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
509401|NCT00238433|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
509402|NCT00238433|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
509403|NCT00238433|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
509404|NCT00238433|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
509405|NCT00238433|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
509406|NCT00238433|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
509407|NCT00238433|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
509408|NCT00238433|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
509409|NCT00238433|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
509886|NCT00241423|exenatide|exenatide
509410|NCT00238433|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
509411|NCT00238433|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
509412|NCT00238433|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
509413|NCT00238433|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
509414|NCT00238433|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
509415|NCT00238433|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
509416|NCT00238433|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
509417|NCT00238433|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
509418|NCT00238433|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
509419|NCT00238433|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
509420|NCT00238433|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
509421|NCT00238433|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
509422|NCT00238433|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
509423|NCT00238433|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
509424|NCT00238433|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
509425|NCT00238433|splenic marginal zone lymphoma|splenic marginal zone lymphoma
509426|NCT00238433|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
509427|NCT00238433|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
509428|NCT00238433|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
509429|NCT00238433|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
509430|NCT00238433|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
509431|NCT00238433|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
509432|NCT00238433|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
509433|NCT00238433|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
509434|NCT00238433|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
509435|NCT00238433|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
509436|NCT00238433|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
509437|NCT00238433|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
509438|NCT00238433|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
509439|NCT00238433|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
509440|NCT00238433|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
509441|NCT00238433|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
509442|NCT00238433|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
509443|NCT00238433|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
509444|NCT00238433|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
509445|NCT00238433|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
509446|NCT00238433|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
509447|NCT00238433|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
509448|NCT00238446|Enteric-coated mycophenolate sodium, heart transplant recipients, long term safety|enteric-coated mycophenolate sodium, heart transplant recipients, long term safety
509449|NCT00238459|Immunity to HIV|immunity to hiv
509450|NCT00238459|Acute Infection|acute infection
509451|NCT00238459|Treatment Naive|treatment naive
509452|NCT00238459|Treatment Interruption|treatment interruption
509453|NCT00238459|Structured Treatment Interruption|structured treatment interruption
509454|NCT00238459|STI|sti
509455|NCT00238472|Type 2 diabetes|type 2 diabetes
509456|NCT00238472|nateglinide|nateglinide
509457|NCT00238485|Bipolar I Disorder|bipolar i disorder
509458|NCT00238498|Type 2 diabetes|type 2 diabetes
509459|NCT00238498|vildagliptin|vildagliptin
509460|NCT00238498|HbA1c|hba1c
509461|NCT00238524|painful distal diabetic neuropathy|painful distal diabetic neuropathy
509462|NCT00238537|Stroke|stroke
509463|NCT00238537|Thrombolysis|thrombolysis
509464|NCT00238537|MRI|mri
509465|NCT00238537|Echoplanar|echoplanar
509466|NCT00238537|Penumbra|penumbra
509467|NCT00232180|Open-label|open-label
509468|NCT00232180|single arm mortality/morbidity trial eplerenone chronic systolic heart failure|single arm mortality/morbidity trial eplerenone chronic systolic heart failure
509469|NCT00232193|Multiple Sclerosis|multiple sclerosis
509470|NCT00232193|Interferon Beta 1-a|interferon beta 1-a
509471|NCT00232193|Pulsed steroids|pulsed steroids
509472|NCT00232206|NSCLC|nsclc
509473|NCT00232206|Lung|lung
509474|NCT00232206|Cancer|cancer
509475|NCT00232206|Metastatic|metastatic
509476|NCT00232206|Neoadjuvant|neoadjuvant
509477|NCT00232206|Stage IB Non-Small Cell Lung Cancer (NSCLC)|stage ib non-small cell lung cancer (nsclc)
509478|NCT00232206|IIA Non-Small Cell Lung Cancer (NSCLC)|iia non-small cell lung cancer (nsclc)
509479|NCT00232206|IIB Non-Small Cell Lung Cancer (NSCLC)|iib non-small cell lung cancer (nsclc)
509480|NCT00232206|Some IIIA Non-Small Cell Lung Cancer (NSCLC)|some iiia non-small cell lung cancer (nsclc)
509481|NCT00232232|Atrial mechanical stunning and|atrial mechanical stunning and
509482|NCT00232232|atrial electrical remodeling|atrial electrical remodeling
509484|NCT00232258|Inflammatory Bowel Disease|inflammatory bowel disease
509485|NCT00232258|Mesalamine|mesalamine
509486|NCT00232297|Tachycardia, Ventricular|tachycardia, ventricular
509487|NCT00232297|Ventricular Fibrillation|ventricular fibrillation
509488|NCT00232297|Defibrillators Implantable|defibrillators implantable
509489|NCT00232297|Arrhythmia|arrhythmia
509490|NCT00232297|Anti-arrhythmia agents|anti-arrhythmia agents
509491|NCT00232310|Atrial Fibrillation|atrial fibrillation
509492|NCT00232310|Atrial Flutter|atrial flutter
509493|NCT00232310|Electric Countershock|electric countershock
509494|NCT00232323|intensive care|intensive care
509495|NCT00232323|stress|stress
509496|NCT00232323|education|education
509497|NCT00232323|simulation|simulation
509498|NCT00232336|cocaine|cocaine
509499|NCT00232336|drug|drug
509500|NCT00232336|substance|substance
509501|NCT00232336|abuse|abuse
509502|NCT00232336|addiction|addiction
509503|NCT00232336|dependence|dependence
509504|NCT00232336|quetiapine|quetiapine
509505|NCT00232336|antipsychotic|antipsychotic
509506|NCT00232336|treatment|treatment
509507|NCT00232349|schizophrenia|schizophrenia
509508|NCT00232349|galantamine|galantamine
509509|NCT00232349|cholinesterase inhibitors|cholinesterase inhibitors
509510|NCT00232349|quality of life|quality of life
509514|NCT00232375|GAD antibody|gad antibody
509515|NCT00232375|Beta cell function|beta cell function
509516|NCT00232375|Insulin|insulin
509517|NCT00232388|Ejection Fraction <35%|ejection fraction <35%
509518|NCT00232401|urine|urine
509519|NCT00232401|circadian rhythm|circadian rhythm
509520|NCT00232414|bipolar|bipolar
509521|NCT00232414|with acute depressive episode|with acute depressive episode
509522|NCT00232427|Liver cirrhosis|liver cirrhosis
509523|NCT00232427|Hemodynamics|hemodynamics
509524|NCT00232427|Fluid balance|fluid balance
509525|NCT00232466|Vertebroplasty|vertebroplasty
509526|NCT00232466|Vertebral fracture|vertebral fracture
509527|NCT00232466|Actonel|actonel
509528|NCT00232466|Osteoporotic|osteoporotic
509529|NCT00232466|vertebral|vertebral
509530|NCT00232466|fractures|fractures
509531|NCT00232492|Wisdom|wisdom
509532|NCT00232492|Tooth|tooth
509533|NCT00232492|Teeth|teeth
509534|NCT00232492|Third|third
509535|NCT00232492|Molar|molar
509536|NCT00232505|recurrent breast cancer|recurrent breast cancer
509537|NCT00232505|stage IV breast cancer|stage iv breast cancer
509538|NCT00232518|immune system|immune system
509539|NCT00232518|infection|infection
509540|NCT00232518|allergic rhinitis|allergic rhinitis
509541|NCT00232544|sleep apnea, obstructive|sleep apnea, obstructive
509542|NCT00232544|Quality of Life|quality of life
509543|NCT00232544|Depression|depression
509544|NCT00232544|Patient Compliance|patient compliance
509545|NCT00232557|Asthma|asthma
509546|NCT00232557|Disease Management|disease management
509547|NCT00232557|Telecommunications|telecommunications
509548|NCT00232557|Health Services|health services
509549|NCT00232557|Quality of Life|quality of life
509550|NCT00232557|Patient Compliance|patient compliance
509551|NCT00232570|sleep disturbance|sleep disturbance
509552|NCT00232570|dementia|dementia
509553|NCT00232583|TYpe 2 diabetes mellitus|type 2 diabetes mellitus
509554|NCT00232583|Newly diagnosed|newly diagnosed
509555|NCT00232583|Beta-cell function|beta-cell function
509556|NCT00232596|Partial Seizures|partial seizures
509557|NCT00232596|Anticonvulsant|anticonvulsant
509558|NCT00232596|Complex Partial Seizures|complex partial seizures
509559|NCT00232596|Potassium Channels|potassium channels
509560|NCT00232596|Epilepsy|epilepsy
509561|NCT00232609|Wheelchair|wheelchair
509562|NCT00232609|Exercise|exercise
509563|NCT00232609|Cardiovascular Disease|cardiovascular disease
509564|NCT00232622|Prosthetic valve thrombosis|prosthetic valve thrombosis
509565|NCT00232622|Fibrinolysis|fibrinolysis
509566|NCT00232622|Streptokinase|streptokinase
509567|NCT00232635|RSV|rsv
509568|NCT00232635|HSCT|hsct
509569|NCT00232635|HEMATOPOIETIC STEM CELL TRANSPL|hematopoietic stem cell transpl
509570|NCT00232674|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
509571|NCT00232700|Major depressive disorder|major depressive disorder
509572|NCT00232700|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
509573|NCT00232713|Birth Defects|birth defects
509574|NCT00232713|Pregnancy|pregnancy
509575|NCT00232713|Uterine Fibroids|uterine fibroids
509576|NCT00232713|Fibroids|fibroids
509577|NCT00232726|Malignant melanoma|malignant melanoma
509578|NCT00232726|CP-4055|cp-4055
509579|NCT00232726|Chemotherapy-naïve patients|chemotherapy-naïve patients
509580|NCT00232726|Phase II|phase ii
509581|NCT00232726|Chemotherapy-naive patients|chemotherapy-naive patients
509582|NCT00232726|Metastatic malignant melanoma|metastatic malignant melanoma
509583|NCT00232817|Postoperative pain|postoperative pain
509584|NCT00232843|Peripheral Artery Occlusive Disease|peripheral artery occlusive disease
509585|NCT00232882|Hypertension|hypertension
509586|NCT00232882|Blood pressure|blood pressure
509587|NCT00232882|Antihypertensive drugs|antihypertensive drugs
509588|NCT00232882|Clinical Pharmacology|clinical pharmacology
509589|NCT00232882|Autonomic nervous system|autonomic nervous system
509590|NCT00232882|Renin angiotensin system|renin angiotensin system
509591|NCT00232882|Oxidative stress|oxidative stress
509592|NCT00232882|Inflammatory markers|inflammatory markers
509593|NCT00232934|Myeloma|myeloma
509594|NCT00232934|Thalidomide|thalidomide
509595|NCT00232934|Diagnosis|diagnosis
509596|NCT00232934|Elderly patients|elderly patients
509597|NCT00232947|vaccine|vaccine
509598|NCT00232947|elderly|elderly
509599|NCT00232947|immunogenicity|immunogenicity
509600|NCT00232947|safety|safety
509601|NCT00232960|oral and oropharynx carcinoma|oral and oropharynx carcinoma
509602|NCT00232960|surgery|surgery
509603|NCT00232960|postoperative radiotherapy|postoperative radiotherapy
509604|NCT00232960|molecular analysis|molecular analysis
509605|NCT00232960|microsatellite instability|microsatellite instability
509606|NCT00238550|Diabetes|diabetes
509607|NCT00238550|Pain|pain
509608|NCT00238550|Peripheral neuropathy|peripheral neuropathy
509609|NCT00238667|Extracranial carotid artery dissection|extracranial carotid artery dissection
509610|NCT00238667|Dissection and stroke|dissection and stroke
509611|NCT00238680|Overactive bladder|overactive bladder
509612|NCT00238680|Children|children
509613|NCT00238680|Bladder rehabilitation|bladder rehabilitation
509614|NCT00238693|transplant|transplant
509615|NCT00238693|transplantation of liver, kidney, pancreas|transplantation of liver, kidney, pancreas
509616|NCT00238706|Radiofrequency catheter ablation|radiofrequency catheter ablation
509617|NCT00238706|Atrial fibrillation|atrial fibrillation
509618|NCT00238706|Randomized trial|randomized trial
509619|NCT00238719|Social Anxiety|social anxiety
509620|NCT00238719|Children Disorders|children disorders
509621|NCT00238732|Vaginal Atrophy|vaginal atrophy
509622|NCT00238732|Postmenopause|postmenopause
509623|NCT00238745|Postmenopausal Osteoporosis|postmenopausal osteoporosis
509624|NCT00238758|Mood Disorder|mood disorder
509625|NCT00238797|Glioblastoma multiforme|glioblastoma multiforme
509626|NCT00238797|Brain tumour|brain tumour
509628|NCT00238810|Pediatrics|pediatrics
509629|NCT00238810|Congenital heart disease|congenital heart disease
509630|NCT00238810|b-type natriuretic peptide|b-type natriuretic peptide
509631|NCT00238823|cryoablation|cryoablation
509632|NCT00238823|radiofrequency ablation|radiofrequency ablation
509633|NCT00238823|pediatrics|pediatrics
509634|NCT00238823|cardiology|cardiology
509635|NCT00238849|Non-small cell lung cancer|non-small cell lung cancer
509636|NCT00238862|Diabetes|diabetes
509637|NCT00238862|Corneal transplant|corneal transplant
509638|NCT00238862|Neurotrophic keratitis|neurotrophic keratitis
509639|NCT00238862|Post-bacterial keratitis|post-bacterial keratitis
509640|NCT00238862|Metaherpetic keratitis|metaherpetic keratitis
509641|NCT00238875|stereotactic body radiation therapy|stereotactic body radiation therapy
509642|NCT00238875|T1N0M0 non-small cell lung cancer|t1n0m0 non-small cell lung cancer
509643|NCT00238875|radiotherapy|radiotherapy
509644|NCT00238888|asthma|asthma
509645|NCT00238888|children|children
509646|NCT00238888|adolescent|adolescent
509647|NCT00238888|education|education
509648|NCT00238888|medical review|medical review
509649|NCT00238888|asthma control|asthma control
509650|NCT00238888|questionnaire|questionnaire
509651|NCT00238888|quality of life|quality of life
509652|NCT00238888|emergency department visit|emergency department visit
509653|NCT00238888|use of medication|use of medication
509654|NCT00238888|adherence to treatment|adherence to treatment
509092|NCT00237601|Home birth|home birth
509655|NCT00238901|Liver transplant, HCV+, steroid free|liver transplant, hcv+, steroid free
509656|NCT00240461|respiratory|respiratory
509657|NCT00240461|infection|infection
509658|NCT00240461|influenza|influenza
509659|NCT00240487|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
509660|NCT00240487|ARDS|ards
509661|NCT00240487|Nitric Oxide|nitric oxide
509662|NCT00240500|Long-term follow-up|long-term follow-up
509663|NCT00240500|Hepatitis B antibody persistence|hepatitis b antibody persistence
509664|NCT00240513|Acne|acne
509665|NCT00240526|Hepatitis B immunoglobulin|hepatitis b immunoglobulin
509666|NCT00240526|Hepatitis B antibody persistence|hepatitis b antibody persistence
509667|NCT00240539|Hepatitis B|hepatitis b
509668|NCT00240552|protease inhibitor|protease inhibitor
509669|NCT00240552|Treatment Experienced|treatment experienced
509670|NCT00240552|amprenavir|amprenavir
509671|NCT00240552|fosamprenavir|fosamprenavir
509672|NCT00240552|GW433908|gw433908
509673|NCT00240552|HIV|hiv
509674|NCT00240552|pro drug|pro drug
509675|NCT00240565|BEXXAR|bexxar
509676|NCT00240565|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
509677|NCT00240565|tositumomab|tositumomab
509678|NCT00240565|I-131|i-131
509679|NCT00240578|Long-Term Follow-up|long-term follow-up
509680|NCT00240578|BEXXAR|bexxar
509681|NCT00240578|Iodine I 131 Tositumomab|iodine i 131 tositumomab
509682|NCT00240578|Low-grade lymphoma|low-grade lymphoma
509683|NCT00240591|BEXXAR|bexxar
509684|NCT00240591|Tositumomab|tositumomab
509685|NCT00240591|Iodine I 131 Tositumomab|iodine i 131 tositumomab
509686|NCT00240591|low-grade follicular lymphomas|low-grade follicular lymphomas
509887|NCT00241423|diabetes|diabetes
509687|NCT00240604|corticosteroid treatment|corticosteroid treatment
509688|NCT00240604|inflammatory diseases|inflammatory diseases
509689|NCT00240617|consistency of response|consistency of response
509690|NCT00240617|migraine|migraine
509691|NCT00240617|satisfaction|satisfaction
509692|NCT00240617|early intervention|early intervention
509693|NCT00240630|acute migraine|acute migraine
509694|NCT00240630|consistency of response|consistency of response
509695|NCT00240630|satisfaction|satisfaction
509696|NCT00240630|migraine|migraine
509697|NCT00240630|early intervention|early intervention
509698|NCT00240643|non valvular atrial fibrillation|non valvular atrial fibrillation
509699|NCT00240643|stroke|stroke
509700|NCT00240643|aspirin|aspirin
509701|NCT00240656|aldosterone antagonists, spironolactone, captopril carvedilol|aldosterone antagonists, spironolactone, captopril carvedilol
509702|NCT00240669|Maxillo facial surgery,|maxillo facial surgery,
509703|NCT00240669|osteosynthesis,|osteosynthesis,
509704|NCT00240669|resorbable device|resorbable device
509705|NCT00240682|Carcinoma, Squamous Cell|carcinoma, squamous cell
509706|NCT00240682|Skin|skin
509707|NCT00240682|cetuximab|cetuximab
509708|NCT00240682|epidermal growth factor receptor|epidermal growth factor receptor
509709|NCT00240695|Alzheimer's disease|alzheimer's disease
509710|NCT00240695|Dementia|dementia
509711|NCT00240695|Brain Disease|brain disease
509712|NCT00240695|Memory Loss|memory loss
509714|NCT00240695|Nervous System Diseases|nervous system diseases
509715|NCT00240695|open-label|open-label
509716|NCT00240695|elderly|elderly
509717|NCT00240708|Schizophrenia|schizophrenia
509718|NCT00240708|intramuscular injection|intramuscular injection
509719|NCT00240708|antipsychotic agents|antipsychotic agents
509720|NCT00240708|risperidone|risperidone
509721|NCT00240708|long-acting injectable|long-acting injectable
509722|NCT00240721|topiramate|topiramate
509723|NCT00240721|bipolar disorders|bipolar disorders
509724|NCT00240721|mood disorders|mood disorders
509725|NCT00240721|manic state|manic state
509726|NCT00240721|depression|depression
509727|NCT00240721|manic-depressive psychoses|manic-depressive psychoses
509728|NCT00240734|Anemia|anemia
509729|NCT00240734|Chronic renal failure|chronic renal failure
509730|NCT00240734|pre-dialysis|pre-dialysis
509731|NCT00240734|diabetic|diabetic
509732|NCT00240760|Memantine|memantine
509733|NCT00240760|Down syndrome|down syndrome
509734|NCT00240760|Dementia|dementia
509735|NCT00240760|learning Disability|learning disability
509736|NCT00240760|Treatment of Dementia|treatment of dementia
509737|NCT00240773|osteoarthritis hip|osteoarthritis hip
509738|NCT00240773|osteoarthritis knee|osteoarthritis knee
509739|NCT00240773|acetaminophen, naproxen|acetaminophen, naproxen
509740|NCT00240786|osteoarthritis hip|osteoarthritis hip
509741|NCT00240786|osteoarthritis knee|osteoarthritis knee
509742|NCT00240786|acetaminophen|acetaminophen
509743|NCT00240799|osteoarthritis hip|osteoarthritis hip
509744|NCT00240799|osteoarthritis knee|osteoarthritis knee
509745|NCT00240799|acetaminophen|acetaminophen
509746|NCT00240812|nocturnal enuresis|nocturnal enuresis
509747|NCT00240812|bedwetting|bedwetting
509748|NCT00240812|ibuprofen|ibuprofen
509749|NCT00240825|postoperative dental pain|postoperative dental pain
509750|NCT00240825|acetaminophen|acetaminophen
509751|NCT00240825|ibuprofen|ibuprofen
509752|NCT00240838|muscle soreness|muscle soreness
509512|NCT00232375|SPIDDM|spiddm
509753|NCT00240838|pain, acetaminophen|pain, acetaminophen
509754|NCT00240838|ibuprofen|ibuprofen
509755|NCT00240851|muscle ache|muscle ache
509756|NCT00240851|pain|pain
509757|NCT00240851|soreness|soreness
509758|NCT00240851|acetaminophen|acetaminophen
509759|NCT00240864|postoperative dental pain|postoperative dental pain
509760|NCT00240864|acetaminophen|acetaminophen
509761|NCT00240864|ibuprofen|ibuprofen
509762|NCT00240903|revaccination, vaccination, influenza, H5N1 vaccine|revaccination, vaccination, influenza, h5n1 vaccine
509763|NCT00240942|Endometriosis|endometriosis
509764|NCT00240942|GnRH analog|gnrh analog
509765|NCT00240942|Aromataseinhibitor|aromataseinhibitor
509766|NCT00240942|Letrozole|letrozole
509767|NCT00240955|Renal/Kidney, Transplantation, steroids, EC-MPS|renal/kidney, transplantation, steroids, ec-mps
509768|NCT00240968|Avian influenza, vaccine, A/H5N1, sub-study|avian influenza, vaccine, a/h5n1, sub-study
509769|NCT00240981|Andropause|andropause
509770|NCT00240981|frailty|frailty
509771|NCT00240981|hormone replacement therapy|hormone replacement therapy
509772|NCT00240981|Aging|aging
509773|NCT00240994|End stage renal disease|end stage renal disease
509774|NCT00240994|Kidney transplantation|kidney transplantation
509775|NCT00240994|Renal transplantation|renal transplantation
509776|NCT00240994|Kidney failure|kidney failure
509777|NCT00240994|Pediatric renal transplant recipients|pediatric renal transplant recipients
509778|NCT00240994|Alemtuzumab|alemtuzumab
509779|NCT00240994|Campath|campath
509780|NCT00240994|Mycophenolate mofetil|mycophenolate mofetil
509782|NCT00240994|CellCept|cellcept
509783|NCT00240994|Tacrolimus|tacrolimus
509784|NCT00240994|Prograf|prograf
509785|NCT00240994|Sirolimus|sirolimus
509786|NCT00240994|Rapamycin|rapamycin
509787|NCT00241007|HYPERTENSION, VALSARTAN|hypertension, valsartan
509788|NCT00241020|hepatocellular carcinoma|hepatocellular carcinoma
509789|NCT00241020|Octreotide|octreotide
509790|NCT00241046|Breast cancer|breast cancer
509791|NCT00241046|Machine learning techniques|machine learning techniques
509792|NCT00241046|Aromatase inhibitors|aromatase inhibitors
509793|NCT00241046|1st line treatment|1st line treatment
509794|NCT00241046|2nd line treatment|2nd line treatment
509795|NCT00241059|Renal transplantation, maintenance patients, tolerability, EC-MPS|renal transplantation, maintenance patients, tolerability, ec-mps
509796|NCT00241085|proteinuria|proteinuria
509797|NCT00241085|hypertension|hypertension
509798|NCT00241085|valsartan|valsartan
509799|NCT00241085|type 2 diabetes|type 2 diabetes
509800|NCT00241098|HYPERTENSION|hypertension
509801|NCT00241098|HEART FAILURE|heart failure
509802|NCT00241098|PEPTIDE|peptide
509803|NCT00241098|valsartan|valsartan
509804|NCT00241111|Prostate|prostate
509805|NCT00241111|cancer|cancer
509806|NCT00241111|bone metastasis|bone metastasis
509807|NCT00241111|zoledronic acid|zoledronic acid
509808|NCT00241124|hypertension|hypertension
509809|NCT00241124|valsartan|valsartan
509810|NCT00241124|morning/evening dosing|morning/evening dosing
509811|NCT00241124|lisinopril|lisinopril
509812|NCT00241137|hypertension|hypertension
509813|NCT00241137|valsartan|valsartan
509814|NCT00241150|valsartan|valsartan
509815|NCT00241150|hypertension|hypertension
510772|NCT00245427|antibiotics|antibiotics
509816|NCT00241150|metabolic syndrome|metabolic syndrome
509817|NCT00241150|endothelial function|endothelial function
509818|NCT00241176|Psychiatric|psychiatric
509819|NCT00241176|Clinical Trial|clinical trial
509820|NCT00241176|Pediatrics|pediatrics
509821|NCT00241176|Tourette's Disorder|tourette's disorder
509822|NCT00241176|Tic Disorder|tic disorder
509823|NCT00241189|Systemic sclerosis|systemic sclerosis
509824|NCT00241189|Scleroderma|scleroderma
509825|NCT00241189|Rapamycin|rapamycin
509826|NCT00241189|Methotrexate|methotrexate
509827|NCT00241202|signs and symptoms|signs and symptoms
509828|NCT00241202|self care|self care
509829|NCT00241202|patient compliance|patient compliance
509830|NCT00241202|quality of life|quality of life
509831|NCT00241215|Botulinum toxin serotype A|botulinum toxin serotype a
509832|NCT00241215|Cervicobrachial syndrome|cervicobrachial syndrome
509833|NCT00241215|Myofascial pain|myofascial pain
509834|NCT00241215|Cervicothoracic myofascial pain|cervicothoracic myofascial pain
509835|NCT00241215|Propulsion|propulsion
509836|NCT00241215|Postural abnormality|postural abnormality
509837|NCT00241228|Shock, Septic|shock, septic
509838|NCT00241228|Renal Failure, Acute|renal failure, acute
509839|NCT00241228|Venovenous Hemofiltration|venovenous hemofiltration
509840|NCT00241228|Randomized Controlled Trial|randomized controlled trial
509841|NCT00241228|Multicenter Study|multicenter study
509842|NCT00241228|Mortality|mortality
509843|NCT00241241|myeloproliferative disorder|myeloproliferative disorder
509844|NCT00241241|polycythemia vera|polycythemia vera
509845|NCT00241241|interferon|interferon
509846|NCT00241254|Multiple Sclerosis, Chronic Progressive|multiple sclerosis, chronic progressive
509847|NCT00241254|Cyclophosphamide|cyclophosphamide
509848|NCT00241254|Methylprednisolone|methylprednisolone
509849|NCT00241254|Randomized Controlled Trials|randomized controlled trials
656947|NCT00804388|Hip|hip
509850|NCT00241254|Double-Blind Study|double-blind study
509851|NCT00241267|Pulmonary|pulmonary
509852|NCT00241267|Neoplasms|neoplasms
509853|NCT00241267|Endobronchial|endobronchial
509854|NCT00241267|Ultrasonography|ultrasonography
509856|NCT00241293|language|language
509858|NCT00241306|language|language
509859|NCT00241306|gender|gender
509860|NCT00241319|ocular, allergic conjunctivitis, ophthalmic|ocular, allergic conjunctivitis, ophthalmic
509861|NCT00241332|pain|pain
509862|NCT00241332|hyperalgesia|hyperalgesia
509863|NCT00241332|drug tolerance|drug tolerance
509864|NCT00241332|remifentanil|remifentanil
509865|NCT00241332|fentanyl|fentanyl
509866|NCT00241332|Anterior Cruciate Ligament|anterior cruciate ligament
509867|NCT00241332|Posterior Cruciate Ligament|posterior cruciate ligament
509868|NCT00241332|Medial Collateral Ligament, Knee|medial collateral ligament, knee
509869|NCT00241345|post transplant|post transplant
509870|NCT00241345|Any patient receiving an allogeneic bone marrow or peripheral blood stem cell transplant at Washington University Medical Center|any patient receiving an allogeneic bone marrow or peripheral blood stem cell transplant at washington university medical center
509871|NCT00241358|Plerixafor|plerixafor
509872|NCT00241358|Stem cell transplantation|stem cell transplantation
509873|NCT00241358|Stem cells|stem cells
509874|NCT00241358|Mobilization|mobilization
509875|NCT00241371|Multiple Myeloma|multiple myeloma
509876|NCT00241384|Prostatic Cancer|prostatic cancer
509877|NCT00241384|Brachytherapy|brachytherapy
509878|NCT00241384|Prostatic neoplasm|prostatic neoplasm
509879|NCT00241384|Radiation therapy|radiation therapy
509880|NCT00241397|pain|pain
509881|NCT00241397|depression|depression
509882|NCT00241397|anxiety disorder|anxiety disorder
509883|NCT00241410|Allergy|allergy
509884|NCT00241410|Specific Immunotherapy|specific immunotherapy
509885|NCT00241410|Sublingual Immunotherapy|sublingual immunotherapy
509890|NCT00241449|Locally advanced breast cancer or metastatic breast cancer|locally advanced breast cancer or metastatic breast cancer
509891|NCT00241462|Advanced Breast Cancer|advanced breast cancer
509892|NCT00241475|Cancer of the Prostate|cancer of the prostate
509893|NCT00241514|NSAIDs|nsaids
509894|NCT00241514|Upper GI symptoms|upper gi symptoms
509895|NCT00241540|NSAIDs|nsaids
509896|NCT00241540|Upper GI symptoms|upper gi symptoms
509897|NCT00241566|Neuropathic pain|neuropathic pain
509898|NCT00241566|Electric cortical stimulation|electric cortical stimulation
509899|NCT00241566|Economic Medical evaluation|economic medical evaluation
509900|NCT00241579|Pain|pain
509901|NCT00241579|Cannabis|cannabis
509902|NCT00241579|Analgesic|analgesic
509903|NCT00241592|Cannabis|cannabis
509904|NCT00241592|Marijuana|marijuana
509905|NCT00241592|Vaporization|vaporization
509906|NCT00241592|Volcano|volcano
509907|NCT00241592|THC|thc
509908|NCT00241605|Metformin|metformin
509909|NCT00241605|AVANDAMET|avandamet
509910|NCT00241605|Type 2 diabetes|type 2 diabetes
509911|NCT00241618|Clinical trial|clinical trial
509912|NCT00241618|Randomized|randomized
509913|NCT00241618|Treatment|treatment
509914|NCT00241618|Prospective|prospective
509915|NCT00241618|Parallel Assignment|parallel assignment
509936|NCT00241943|Hepatitis C|hepatitis c
509937|NCT00241943|Heroin|heroin
509938|NCT00241943|Populations at risk|populations at risk
509939|NCT00241943|testing|testing
509940|NCT00241943|vaccination|vaccination
509941|NCT00241969|nutrition therapy|nutrition therapy
509942|NCT00241969|preschool children|preschool children
509943|NCT00241969|cystic fibrosis|cystic fibrosis
509944|NCT00241982|rheumatoid arthritis|rheumatoid arthritis
509945|NCT00241982|long circulating liposomes|long circulating liposomes
509946|NCT00242008|IDIOPATHIC PARKINSON'S DISEASE|idiopathic parkinson's disease
509947|NCT00242021|Satiety, ad libitum food intake, fatty acids, hormones|satiety, ad libitum food intake, fatty acids, hormones
509948|NCT00242047|Tuberculosis.|tuberculosis.
509949|NCT00242047|Children.|children.
509950|NCT00242047|Vaccine.|vaccine.
509951|NCT00242047|BCG.|bcg.
509952|NCT00242099|liver transplant|liver transplant
509953|NCT00242099|HHV-6|hhv-6
509954|NCT00242099|HHV-7|hhv-7
509955|NCT00242099|Human Herpesvirus-6|human herpesvirus-6
509956|NCT00242099|Human Herpesvirus-7|human herpesvirus-7
509957|NCT00242125|Primary biliary Cirrhosis|primary biliary cirrhosis
509959|NCT00242125|DNA|dna
509960|NCT00242151|Delirium, Confusion, Cardiac Surgery, Organic Brain Injury, Diffusion Weighted Magnetic Resonance Imaging (DW-MRI)|delirium, confusion, cardiac surgery, organic brain injury, diffusion weighted magnetic resonance imaging (dw-mri)
509961|NCT00242164|Hemodialysis|hemodialysis
509962|NCT00242164|Magnesium|magnesium
509963|NCT00242164|Arrhythmia|arrhythmia
509964|NCT00242164|QTc interval|qtc interval
509965|NCT00242164|QT dispersion|qt dispersion
509966|NCT00242177|Multiple Sclerosis|multiple sclerosis
509967|NCT00242177|Relapsing, Remitting|relapsing, remitting
509968|NCT00242177|Autoimmune disease|autoimmune disease
509969|NCT00242190|drug therapy|drug therapy
509970|NCT00242190|radiotherapy|radiotherapy
509971|NCT00242190|clinical trial|clinical trial
509972|NCT00242203|Breast Cancer|breast cancer
509973|NCT00242203|Neoadjuvant|neoadjuvant
509974|NCT00242203|Micrometastasis|micrometastasis
509975|NCT00242216|HIV-1 infected people|hiv-1 infected people
509976|NCT00242216|Antiretroviral treatment-naïve|antiretroviral treatment-naïve
509977|NCT00242216|Atazanavir|atazanavir
509978|NCT00242216|Fosamprenavir|fosamprenavir
509979|NCT00242216|ARV Treatment Naive|arv treatment naive
509980|NCT00242229|Depression|depression
509981|NCT00242242|Stroke|stroke
509982|NCT00242242|BCI|bci
509983|NCT00242242|Healthy Volunteer|healthy volunteer
509984|NCT00242242|HV|hv
509985|NCT00242255|Histone|histone
509986|NCT00242255|Chromatin|chromatin
509987|NCT00242255|Epigenome|epigenome
509988|NCT00242255|Senescence|senescence
509989|NCT00242255|Acetylation|acetylation
509990|NCT00242255|Aging|aging
509991|NCT00242255|Tissue Sample|tissue sample
509992|NCT00242281|Sore Throat|sore throat
509993|NCT00242281|Pharyngitis|pharyngitis
509994|NCT00242281|Tonsillitis|tonsillitis
509995|NCT00242294|COPD|copd
509996|NCT00242294|Phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
509997|NCT00242294|Roflumilast|roflumilast
509998|NCT00242307|Asthma|asthma
509999|NCT00242307|Roflumilast|roflumilast
510000|NCT00242307|phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
510001|NCT00242320|COPD|copd
510002|NCT00242320|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
510003|NCT00242320|Roflumilast|roflumilast
510004|NCT00242333|COPD|copd
510005|NCT00242333|COAD|coad
510006|NCT00242333|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
510007|NCT00242333|emphysema|emphysema
510008|NCT00242333|chronic bronchitis|chronic bronchitis
510009|NCT00242346|Hypertension|hypertension
510010|NCT00242372|Insulin dependent Type 2 diabetes|insulin dependent type 2 diabetes
510011|NCT00242385|Severe congenital Alpha1-Proteinase Inhibitor (Alpha1-PI) deficiency|severe congenital alpha1-proteinase inhibitor (alpha1-pi) deficiency
510012|NCT00242398|Intensive care unit|intensive care unit
510013|NCT00242398|Patients with bleeding high risk|patients with bleeding high risk
510014|NCT00242398|Intermittent hemodialysis without anticoagulation|intermittent hemodialysis without anticoagulation
510015|NCT00242398|Blood lost|blood lost
510016|NCT00242424|influenza vaccine|influenza vaccine
510017|NCT00242424|infants|infants
510019|NCT00242424|immunogenicity|immunogenicity
510020|NCT00242450|metoclopramide|metoclopramide
510021|NCT00242450|feeding|feeding
510022|NCT00242450|very low birthweightnewborn|very low birthweightnewborn
510023|NCT00242463|malnutrition|malnutrition
510024|NCT00242463|anabolic steroids|anabolic steroids
509918|NCT00241644|HRV vaccine|hrv vaccine
510025|NCT00242463|intensive care unit|intensive care unit
510027|NCT00242489|Arcoxia|arcoxia
510028|NCT00242502|Hepatocellular Carcinoma|hepatocellular carcinoma
510029|NCT00242502|Liver Cancer|liver cancer
510030|NCT00242502|Bevacizumab|bevacizumab
510031|NCT00242502|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
510032|NCT00242502|rhuMAb-VEGF|rhumab-vegf
510033|NCT00242502|Erlotinib Hydrochloride|erlotinib hydrochloride
510034|NCT00242502|OSI-774|osi-774
510035|NCT00242502|Tarceva|tarceva
510036|NCT00242502|Erlotinib|erlotinib
510037|NCT00242502|Avastin|avastin
510038|NCT00242515|High risk Myelodysplastic Syndrome (MDS)|high risk myelodysplastic syndrome (mds)
510039|NCT00242528|Bone Lesions|bone lesions
510040|NCT00242528|Multiple Myeloma|multiple myeloma
510041|NCT00242528|zoledronic acid|zoledronic acid
510042|NCT00242541|microadenoma|microadenoma
510043|NCT00242541|macroadenoma|macroadenoma
510044|NCT00242554|Prostate Cancer|prostate cancer
510045|NCT00242554|Bone Metastases|bone metastases
510046|NCT00242554|Zoledronic acid|zoledronic acid
510047|NCT00242567|zoledronic acid|zoledronic acid
510048|NCT00242567|bone metastases|bone metastases
510049|NCT00242567|prostate cancer|prostate cancer
510050|NCT00242567|hormone-sensitive|hormone-sensitive
510052|NCT00242580|age-related macular degeneration|age-related macular degeneration
510053|NCT00242580|choroidal neovascularization|choroidal neovascularization
510054|NCT00242593|cognition disorders|cognition disorders
510055|NCT00242593|Alzheimer's disease|alzheimer's disease
510056|NCT00242593|memory|memory
510057|NCT00242606|Newly diagnosed epilepsy|newly diagnosed epilepsy
510058|NCT00242606|Initial monotherapy|initial monotherapy
510059|NCT00242606|Levetiracetam|levetiracetam
510060|NCT00242606|Lamotrigine|lamotrigine
510061|NCT00242645|Doctor-Patient relation|doctor-patient relation
510062|NCT00242645|Physician-Patient relation|physician-patient relation
510063|NCT00242645|Diabetes|diabetes
510064|NCT00242645|Office visits|office visits
510065|NCT00242645|Comparative Study|comparative study
510066|NCT00242645|Health behavior|health behavior
510067|NCT00242645|Randomized controlled trials|randomized controlled trials
510068|NCT00242645|Health Promotion|health promotion
510069|NCT00242645|Health Education|health education
510018|NCT00242424|safety|safety
510070|NCT00242645|Computer-tailor information|computer-tailor information
510071|NCT00242658|Physical Activity|physical activity
510072|NCT00242658|Wellness Programs|wellness programs
510073|NCT00242658|Health Promotion|health promotion
510074|NCT00242658|Blood Pressure, High|blood pressure, high
510075|NCT00242671|general anesthesia, hyperventilation, carbon dioxide, isocapnic hyperponea|general anesthesia, hyperventilation, carbon dioxide, isocapnic hyperponea
510076|NCT00242684|Aging|aging
510077|NCT00242684|Undernutrition|undernutrition
510078|NCT00242684|Inflammation|inflammation
510079|NCT00242684|Frail Elderly|frail elderly
510080|NCT00242697|coronary artery bypass surgery|coronary artery bypass surgery
510081|NCT00242697|anesthesia, general|anesthesia, general
510082|NCT00242697|anesthesia, spinal|anesthesia, spinal
510083|NCT00242697|heart-lung machine|heart-lung machine
510084|NCT00242710|Endometrium|endometrium
510085|NCT00242710|Uterus|uterus
510086|NCT00242710|Menopause|menopause
510087|NCT00242723|Lung Cancers|lung cancers
510088|NCT00242723|Esophageal Cancer|esophageal cancer
510089|NCT00242723|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
510090|NCT00242723|Biopsy|biopsy
510091|NCT00242723|Staging Studies|staging studies
510092|NCT00242723|Lung Cancer|lung cancer
510093|NCT00242749|Head and Neck Cancer Disease|head and neck cancer disease
510094|NCT00242749|Head Cancer|head cancer
510095|NCT00242749|Neck Cancer|neck cancer
510096|NCT00242749|Cancer of Head|cancer of head
510097|NCT00242749|Cancer of Neck|cancer of neck
510098|NCT00242749|Cancer of the Head|cancer of the head
510099|NCT00242749|Cancer of the Head and Neck|cancer of the head and neck
510100|NCT00242749|Cancer of the Neck|cancer of the neck
510101|NCT00242749|Neoplasms, Head and Neck|neoplasms, head and neck
510102|NCT00242762|Head and Neck Neoplasms|head and neck neoplasms
510103|NCT00242762|Cancer of Head and Neck|cancer of head and neck
510104|NCT00242762|Head and Neck Cancer|head and neck cancer
510105|NCT00242762|Head Cancer|head cancer
510106|NCT00242762|Neck Cancer|neck cancer
510107|NCT00242775|Asthma|asthma
510108|NCT00242788|Colorectal Cancer|colorectal cancer
510109|NCT00242840|protease inhibitor|protease inhibitor
510110|NCT00242840|ritonavir|ritonavir
510112|NCT00242840|HIV-1|hiv-1
510113|NCT00242840|fosamprenavir|fosamprenavir
510114|NCT00242853|iNOS|inos
510115|NCT00242853|Rheumatoid arthritis|rheumatoid arthritis
510116|NCT00242853|Exhaled NO|exhaled no
510117|NCT00242866|Productivity|productivity
510118|NCT00242866|Efficacy|efficacy
510119|NCT00242866|without aura|without aura
510120|NCT00242866|iNOS|inos
510121|NCT00242866|Safety|safety
510122|NCT00242866|Nitric Oxide|nitric oxide
510123|NCT00242866|Pharmacokinetics|pharmacokinetics
510124|NCT00242866|GW274150|gw274150
510125|NCT00242866|with aura|with aura
510126|NCT00242866|Migraine|migraine
510127|NCT00242866|Prophylaxis|prophylaxis
510128|NCT00242866|Quality of Life|quality of life
510129|NCT00242879|treatment-experienced|treatment-experienced
510130|NCT00242879|RTV|rtv
510131|NCT00242879|protease inhibitor|protease inhibitor
510132|NCT00242879|ritonavir|ritonavir
510133|NCT00242879|GW640385|gw640385
510134|NCT00242879|HIV-1|hiv-1
510135|NCT00242892|Deployment stent optimisation|deployment stent optimisation
510136|NCT00242892|Fractional Flow Reserve|fractional flow reserve
510137|NCT00242892|Stent|stent
510138|NCT00242892|Restenosis|restenosis
510139|NCT00242892|Coronary|coronary
510140|NCT00242905|Memory|memory
510141|NCT00242905|Epilepsy|epilepsy
510142|NCT00242905|Children|children
510143|NCT00242905|Magnetic resonance imaging|magnetic resonance imaging
510144|NCT00242905|Functional magnetic resonance imaging|functional magnetic resonance imaging
510145|NCT00242918|High risk|high risk
510146|NCT00242918|adenocarcinoma|adenocarcinoma
510147|NCT00242918|prostate cancer|prostate cancer
510148|NCT00242918|neoadjuvant|neoadjuvant
510149|NCT00242931|adenocarcinoma of the prostate|adenocarcinoma of the prostate
510150|NCT00242931|recurrent prostate cancer|recurrent prostate cancer
510151|NCT00242931|stage IV prostate cancer|stage iv prostate cancer
510152|NCT00242944|Acute coronary syndrome|acute coronary syndrome
510153|NCT00242944|Hypercholesterolemia|hypercholesterolemia
510154|NCT00242944|Primary coronary intervention|primary coronary intervention
583317|NCT00511277|first-episode psychosis|first-episode psychosis
510155|NCT00242944|Hydroxymethylglutaryl-CoA reductase inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
510156|NCT00242944|coronary plaque|coronary plaque
510157|NCT00242944|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
510158|NCT00242944|Ultrasonography, Interventional|ultrasonography, interventional
510159|NCT00242957|HIV/AIDS|hiv/aids
510160|NCT00242957|Gender Based Violence|gender based violence
510161|NCT00242957|Structural Interventions|structural interventions
510162|NCT00242957|South Africa|south africa
510163|NCT00242957|HIV Seronegativity|hiv seronegativity
510164|NCT00235924|menopause|menopause
510165|NCT00235924|isoflavone|isoflavone
510166|NCT00235924|endometrial safety|endometrial safety
510167|NCT00235924|breast innocuity assessment|breast innocuity assessment
510168|NCT00235924|hot flushes|hot flushes
510169|NCT00235937|Premenopausal|premenopausal
510170|NCT00235937|Advanced Breast Cancer|advanced breast cancer
510171|NCT00235937|Metastatic Breast Cancer|metastatic breast cancer
510172|NCT00235950|Coronary Heart Disease|coronary heart disease
510173|NCT00235950|Percutaeous Coronary Intervention (PCI)|percutaeous coronary intervention (pci)
510174|NCT00235976|Neuromuscular Blocking Agent|neuromuscular blocking agent
510175|NCT00235976|Anesthesia|anesthesia
510176|NCT00235976|Succinylcholine|succinylcholine
510177|NCT00235976|Tracheal Intubation|tracheal intubation
510178|NCT00235976|Adjunct for tracheal intubation|adjunct for tracheal intubation
510179|NCT00235989|Relapsing multiple sclerosis|relapsing multiple sclerosis
510180|NCT00235989|interferon beta 1b|interferon beta 1b
510181|NCT00235989|Betaferon|betaferon
510182|NCT00235989|Betaseron|betaseron
510183|NCT00242983|adenocarcinoma of the lung|adenocarcinoma of the lung
510184|NCT00242983|large cell lung cancer|large cell lung cancer
510185|NCT00242983|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
510186|NCT00242983|squamous cell lung cancer|squamous cell lung cancer
510187|NCT00242983|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
510188|NCT00242983|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
510189|NCT00242996|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
510190|NCT00243009|recurrent renal cell cancer|recurrent renal cell cancer
510191|NCT00243009|stage IV renal cell cancer|stage iv renal cell cancer
510192|NCT00243009|clear cell renal cell carcinoma|clear cell renal cell carcinoma
510193|NCT00243022|cerebral edema|cerebral edema
510194|NCT00243022|adult glioblastoma|adult glioblastoma
510195|NCT00243022|adult giant cell glioblastoma|adult giant cell glioblastoma
510196|NCT00243022|adult gliosarcoma|adult gliosarcoma
510197|NCT00243022|adult anaplastic astrocytoma|adult anaplastic astrocytoma
510198|NCT00243022|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
510199|NCT00243048|stage I prostate cancer|stage i prostate cancer
510200|NCT00243048|stage II prostate cancer|stage ii prostate cancer
510201|NCT00243087|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
510202|NCT00243087|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
510389|NCT00244491|geriatric|geriatric
510203|NCT00243087|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
510204|NCT00243087|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
510205|NCT00243087|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
510206|NCT00243087|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
510207|NCT00243087|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
510773|NCT00245440|S.pneumonia|s.pneumonia
510208|NCT00243087|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
510209|NCT00243087|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
510210|NCT00243087|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
510211|NCT00243087|anaplastic large cell lymphoma|anaplastic large cell lymphoma
510212|NCT00243087|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
510213|NCT00243087|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
510214|NCT00243087|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
510215|NCT00243087|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
510216|NCT00243087|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
510217|NCT00243087|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
510218|NCT00243087|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
510219|NCT00243087|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
510220|NCT00243113|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
510221|NCT00243113|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
510222|NCT00243113|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
510223|NCT00243113|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
510224|NCT00243126|HIV prevention|hiv prevention
510225|NCT00243126|HIV Seronegativity|hiv seronegativity
510226|NCT00243126|HIV negative|hiv negative
510227|NCT00243139|Oral appliances|oral appliances
510228|NCT00243139|Obstructive sleep apnea|obstructive sleep apnea
510229|NCT00243139|Epworth Sleepiness Scale|epworth sleepiness scale
510230|NCT00243139|SF-36|sf-36
510231|NCT00243152|pain|pain
510232|NCT00243152|neuropathic|neuropathic
510233|NCT00243152|face|face
510234|NCT00243152|trigeminal|trigeminal
510235|NCT00243165|breast cancer|breast cancer
510236|NCT00243165|honey|honey
510237|NCT00243165|myelosuppression|myelosuppression
510238|NCT00243165|chemotherapy|chemotherapy
510239|NCT00243178|Atrial fibrillation|atrial fibrillation
510240|NCT00243178|Anticoagulant therapy|anticoagulant therapy
510241|NCT00243178|Thromboembolic prevention|thromboembolic prevention
510242|NCT00243191|newly diagnosed or recurrent|newly diagnosed or recurrent
752460|NCT01173081|teriparatide|teriparatide
510243|NCT00243204|Stage IIIb/IV non-small cell lung cancer|stage iiib/iv non-small cell lung cancer
510244|NCT00243204|NSCLC|nsclc
510245|NCT00243204|Lung Cancer|lung cancer
510246|NCT00243243|Burns|burns
510247|NCT00243269|nausea, acupressure bands, relaxation|nausea, acupressure bands, relaxation
510248|NCT00243282|Complementary Therapies|complementary therapies
510249|NCT00243282|Dyspnea|dyspnea
510250|NCT00243282|Palliative Care|palliative care
510251|NCT00243282|Meditation|meditation
510252|NCT00243282|Quality of Life|quality of life
510253|NCT00243295|osteoarthritis|osteoarthritis
510254|NCT00243295|deformity of knee|deformity of knee
510255|NCT00243854|Pancreatic Cancer|pancreatic cancer
510256|NCT00243854|Resectable Pancreatic Cancer|resectable pancreatic cancer
510257|NCT00243854|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
510258|NCT00243867|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
510259|NCT00243880|acute ischemic stroke|acute ischemic stroke
510260|NCT00243880|lovastatin|lovastatin
510261|NCT00243880|statin|statin
510262|NCT00243880|neuroprotection|neuroprotection
510263|NCT00243880|SPOTRIAS|spotrias
510264|NCT00243893|giant aneurysms|giant aneurysms
510265|NCT00243893|arteriovenous malformations|arteriovenous malformations
510266|NCT00243893|minocycline|minocycline
510267|NCT00243893|doxycycline|doxycycline
510268|NCT00243893|BAVM|bavm
510269|NCT00243906|acute ischemic stroke|acute ischemic stroke
510270|NCT00243906|stroke|stroke
510271|NCT00243906|rt-PA|rt-pa
510272|NCT00243906|thrombolytic|thrombolytic
510273|NCT00243906|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
510274|NCT00243919|stroke|stroke
510275|NCT00243919|locomotor|locomotor
510276|NCT00243919|exercise|exercise
510277|NCT00243919|walking|walking
510278|NCT00243919|training program|training program
510279|NCT00243919|body weight support training|body weight support training
510280|NCT00243919|physical therapy|physical therapy
510281|NCT00243932|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
510283|NCT00243932|Lou Gehrig's disease|lou gehrig's disease
510284|NCT00243932|CoQ10|coq10
510285|NCT00243932|coenzyme Q10|coenzyme q10
510286|NCT00243932|antioxidants|antioxidants
510287|NCT00243932|free radicals|free radicals
510288|NCT00243932|mitochondrial dysfunction|mitochondrial dysfunction
510289|NCT00243971|EARLY-STAGE, IDIOPATHIC PARKINSON'S DISEASE|early-stage, idiopathic parkinson's disease
510290|NCT00243984|metabolic syndrome|metabolic syndrome
510291|NCT00243984|type 2 diabetes|type 2 diabetes
510292|NCT00243984|topiramate|topiramate
510293|NCT00243984|weight loss|weight loss
510294|NCT00243997|parents|parents
510295|NCT00243997|fathers|fathers
510296|NCT00243997|mothers|mothers
510297|NCT00244010|Aplastic anemia|aplastic anemia
510298|NCT00244010|Amegakaryocytic thrombocytopenia|amegakaryocytic thrombocytopenia
510774|NCT00245440|sinusitis|sinusitis
510299|NCT00244010|Diamond-Blackfan Anemia|diamond-blackfan anemia
510300|NCT00244010|Kostmann syndrome|kostmann syndrome
510301|NCT00244010|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
510302|NCT00244010|Haploidentical stem cell transplant|haploidentical stem cell transplant
510303|NCT00244010|T-cell depletion|t-cell depletion
510304|NCT00244010|Partially matched family member donor transplant|partially matched family member donor transplant
510305|NCT00244010|Refractory cytopenia|refractory cytopenia
510306|NCT00244023|Erectile Dysfunction|erectile dysfunction
510307|NCT00244023|Testosterone|testosterone
510308|NCT00244023|Testosterone Therapy|testosterone therapy
510309|NCT00244023|PDE V Inhibitor|pde v inhibitor
510310|NCT00244023|Tadalafil|tadalafil
510311|NCT00244088|Abdominal infection|abdominal infection
510312|NCT00244101|Prematurity|prematurity
510313|NCT00244101|respiratory distress syndrome|respiratory distress syndrome
510314|NCT00244101|surfactant|surfactant
510315|NCT00244101|nasal continuous positive airway pressure|nasal continuous positive airway pressure
510316|NCT00244114|Hemophilia B|hemophilia b
510317|NCT00244114|Allergic Reaction|allergic reaction
510318|NCT00244140|Ultravist 370|ultravist 370
510319|NCT00244140|CECT|cect
510320|NCT00244140|CT Scan|ct scan
510321|NCT00244153|intraarticular morphine, steroids, arthroscopy|intraarticular morphine, steroids, arthroscopy
510322|NCT00244166|treatment|treatment
510323|NCT00244166|ankylosing spondylitis|ankylosing spondylitis
510324|NCT00244166|prednisolone|prednisolone
510325|NCT00244166|trial|trial
510326|NCT00244166|steroid|steroid
510327|NCT00244179|reactive arthritis|reactive arthritis
510328|NCT00244179|trial|trial
510329|NCT00244179|interferon-gamma|interferon-gamma
510330|NCT00244179|infliximab|infliximab
510331|NCT00244179|chronic|chronic
510332|NCT00244179|tnf-blocker|tnf-blocker
510333|NCT00244192|COPD|copd
510334|NCT00244192|infliximab|infliximab
510335|NCT00244192|Remicade|remicade
510336|NCT00244192|inflammation|inflammation
510337|NCT00244192|cachexia|cachexia
510338|NCT00244192|fat-free mass|fat-free mass
510339|NCT00244192|health status|health status
510340|NCT00244192|exercise capacity|exercise capacity
510341|NCT00244218|phenylketonuria|phenylketonuria
510342|NCT00244218|hyperphenylalaninemia|hyperphenylalaninemia
510343|NCT00244231|Niacin|niacin
510344|NCT00244231|Hyperlipidemia|hyperlipidemia
510345|NCT00244257|idiopathic thrombocytopenia purpura|idiopathic thrombocytopenia purpura
510346|NCT00244270|totally implantable vascular access devices|totally implantable vascular access devices
510347|NCT00244270|thromboembolism|thromboembolism
510348|NCT00244270|genetic susceptibility to venous thrombosis.|genetic susceptibility to venous thrombosis.
510349|NCT00244283|Myocardial preconditioning|myocardial preconditioning
510350|NCT00244283|anesthetics|anesthetics
510351|NCT00244283|epidural anesthesia|epidural anesthesia
510352|NCT00244283|sevoflurane|sevoflurane
510353|NCT00244283|NT proBNP|nt probnp
510354|NCT00244309|brachytherapy|brachytherapy
510355|NCT00244309|urinary symptoms|urinary symptoms
510356|NCT00244335|Post-Traumatic Stress Disorders|post-traumatic stress disorders
510357|NCT00244335|PTSD|ptsd
510358|NCT00244348|hepatic artery infusion|hepatic artery infusion
510359|NCT00244348|colorectal cancer|colorectal cancer
510360|NCT00244348|liver metastasis|liver metastasis
510361|NCT00244348|oxaliplatin|oxaliplatin
510362|NCT00244348|5 fluorouracil|5 fluorouracil
510363|NCT00244361|opsoclonus|opsoclonus
510364|NCT00244361|myoclonus|myoclonus
510365|NCT00244387|advanced stage idiopathic Parkinson's disease|advanced stage idiopathic parkinson's disease
510366|NCT00244400|Femur Head Necrosis|femur head necrosis
510367|NCT00244400|CYP3A|cyp3a
510368|NCT00244413|Myotonia|myotonia
510369|NCT00244413|Paramyotonia Congenita|paramyotonia congenita
510370|NCT00244413|Thomsen's Disease|thomsen's disease
510371|NCT00244426|Prevention of thromboembolic events in patients with non valvular atrial fibrillation|prevention of thromboembolic events in patients with non valvular atrial fibrillation
510372|NCT00244439|Head Lice|head lice
510373|NCT00244439|Pediculosis capitis|pediculosis capitis
510374|NCT00244452|Endometriosis|endometriosis
510375|NCT00244452|Cetrorelix|cetrorelix
510376|NCT00244452|Hormone|hormone
510377|NCT00244452|Symptoms relief|symptoms relief
510378|NCT00244452|Safety|safety
510379|NCT00244452|Tolerability|tolerability
510380|NCT00244452|Pharmacodynamic|pharmacodynamic
510381|NCT00244452|Pharmacokinetic|pharmacokinetic
510382|NCT00244465|Narcolepsy|narcolepsy
510383|NCT00244465|Cataplexy|cataplexy
510384|NCT00244465|Oxybate|oxybate
510385|NCT00244465|Xyrem|xyrem
510386|NCT00244465|Misuse|misuse
510387|NCT00244465|Safety|safety
510388|NCT00244491|care transitions|care transitions
510390|NCT00244491|care coordination|care coordination
510391|NCT00244491|self-management|self-management
510392|NCT00244491|chronic illness|chronic illness
510393|NCT00244491|patient-centered care|patient-centered care
510394|NCT00244517|ventricular function|ventricular function
510395|NCT00244517|diastolic function|diastolic function
510396|NCT00244517|inhalative anaesthetics|inhalative anaesthetics
510397|NCT00244530|Preventive Therapy|preventive therapy
510398|NCT00244530|Calcium Channel Blockers|calcium channel blockers
510399|NCT00244530|Kidney Failure, Chronic|kidney failure, chronic
510400|NCT00244530|Coronary Artery Bypass|coronary artery bypass
510401|NCT00244530|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
510402|NCT00244543|ocular, allergic conjunctivitis, ophthalmic|ocular, allergic conjunctivitis, ophthalmic
510403|NCT00244556|Rheumatoid Arthritis|rheumatoid arthritis
510404|NCT00244569|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
510405|NCT00244569|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
510407|NCT00244569|Metabolism|metabolism
510408|NCT00244569|Cirrhosis|cirrhosis
510409|NCT00244569|Fibrosis|fibrosis
510410|NCT00244569|Liver|liver
510411|NCT00244582|Central Nervous System|central nervous system
510412|NCT00244582|Enzyme Replacement Therapy|enzyme replacement therapy
510413|NCT00244582|Convection|convection
510414|NCT00244582|Gaucher Disease|gaucher disease
510415|NCT00244582|Neuronopathic Gaucher Disease|neuronopathic gaucher disease
510416|NCT00244582|Type 2 Gaucher Disease|type 2 gaucher disease
510417|NCT00244595|Pediatric hypertension|pediatric hypertension
510418|NCT00244595|Hypertension in children|hypertension in children
510419|NCT00244621|Pediatric hypertension|pediatric hypertension
510420|NCT00244647|restenosis|restenosis
510421|NCT00244647|in-stent restenosis|in-stent restenosis
510422|NCT00244673|Vaccination|vaccination
510423|NCT00244673|DTP|dtp
510424|NCT00244673|Child mortality|child mortality
510425|NCT00244673|Sex|sex
510426|NCT00244673|Non-specific effects|non-specific effects
510427|NCT00244686|Hypereosinophilic Syndrome|hypereosinophilic syndrome
510428|NCT00244686|Mepo|mepo
510429|NCT00244686|HES|hes
510430|NCT00244686|Compassionate Use|compassionate use
510431|NCT00244686|Mepolizumab|mepolizumab
510432|NCT00244699|youth|youth
510433|NCT00244699|drug addiction|drug addiction
510434|NCT00244699|substance abuse|substance abuse
510435|NCT00244699|mindfulness|mindfulness
510436|NCT00244699|motivational interviewing|motivational interviewing
510437|NCT00244699|brief treatment|brief treatment
510438|NCT00244699|skills training|skills training
510439|NCT00244699|group therapy|group therapy
657654|NCT00808249|GAD|gad
510440|NCT00244699|emotion regulation|emotion regulation
510441|NCT00244712|HEAT|heat
510442|NCT00244712|Antiretroviral-naive|antiretroviral-naive
510443|NCT00244712|HIV|hiv
510444|NCT00244712|EPZICOM|epzicom
510445|NCT00244712|TRUVADA|truvada
510446|NCT00244712|KALETRA|kaletra
510447|NCT00244712|once-daily|once-daily
510448|NCT00244725|deep vein thrombosis|deep vein thrombosis
510449|NCT00244725|total knee replacement|total knee replacement
510450|NCT00244725|PE|pe
510451|NCT00244725|Venous thromboembolism|venous thromboembolism
510452|NCT00244725|DVT|dvt
510453|NCT00244725|pulmonary embolism|pulmonary embolism
510454|NCT00244725|VTE|vte
510455|NCT00244738|pregnancy|pregnancy
510456|NCT00244738|post-date|post-date
510457|NCT00244738|induction of labor|induction of labor
510458|NCT00244738|castor oil|castor oil
510459|NCT00244751|Hepatitis C liver fibrosis|hepatitis c liver fibrosis
510460|NCT00244764|Angiogenesis|angiogenesis
510461|NCT00244764|Renal Cell Carcinoma|renal cell carcinoma
510462|NCT00244764|Solid tumors|solid tumors
510463|NCT00244764|Pazopanib(GW786034)|pazopanib(gw786034)
510464|NCT00244777|Seizure|seizure
510465|NCT00244777|Altered consciousness|altered consciousness
510466|NCT00244777|Hyponatraemia|hyponatraemia
510467|NCT00244777|Diarrhoea|diarrhoea
510468|NCT00244777|Hypo osmolar ORS|hypo osmolar ors
510469|NCT00244790|glomerular hyperfiltration|glomerular hyperfiltration
510470|NCT00244790|proteinuria|proteinuria
510471|NCT00244803|Human Immunodeficiency Virus|human immunodeficiency virus
510472|NCT00244803|FRAM 1|fram 1
510473|NCT00244829|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
510474|NCT00244829|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
510475|NCT00244829|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
510476|NCT00244829|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
510477|NCT00244829|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
510478|NCT00244829|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
510479|NCT00244829|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
510480|NCT00244842|Randomized Controlled Trials|randomized controlled trials
510481|NCT00244842|Immunosuppression|immunosuppression
510482|NCT00244842|Adult|adult
510483|NCT00244842|Chronic Disease|chronic disease
510484|NCT00244842|Dermatologic Agents|dermatologic agents
510485|NCT00244842|Female|female
510486|NCT00244842|Humans|humans
510487|NCT00244842|Male|male
510488|NCT00244842|Middle Aged|middle aged
510489|NCT00244842|Severity of Illness Index|severity of illness index
510490|NCT00244842|Treatment Outcome|treatment outcome
510491|NCT00244842|Quality of Life|quality of life
510492|NCT00244842|Double-Blind Method|double-blind method
510493|NCT00244868|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
510775|NCT00245440|ams|ams
510494|NCT00244868|metastatic cancer|metastatic cancer
510495|NCT00244894|fatigue|fatigue
510496|NCT00244894|recurrent prostate cancer|recurrent prostate cancer
510497|NCT00244894|stage II prostate cancer|stage ii prostate cancer
510498|NCT00244894|stage III prostate cancer|stage iii prostate cancer
510499|NCT00244894|stage IV prostate cancer|stage iv prostate cancer
510501|NCT00244907|Bone Resorption|bone resorption
510502|NCT00244907|Phytoestrogens|phytoestrogens
510503|NCT00244907|Calcium|calcium
510504|NCT00244907|Genistein|genistein
510505|NCT00244907|Equol|equol
510506|NCT00244920|adenocarcinoma of the prostate|adenocarcinoma of the prostate
510507|NCT00244920|stage III prostate cancer|stage iii prostate cancer
510508|NCT00244933|stage IV breast cancer|stage iv breast cancer
510509|NCT00244933|recurrent breast cancer|recurrent breast cancer
510510|NCT00244946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
510511|NCT00244946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
510512|NCT00244946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
510513|NCT00244946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
510514|NCT00244946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
510515|NCT00244946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
510516|NCT00244946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
510517|NCT00244946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
510518|NCT00244946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
510519|NCT00244946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
510520|NCT00244946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
510521|NCT00244946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
510522|NCT00244946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
510523|NCT00244946|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
510524|NCT00244946|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
509857|NCT00241306|aging|aging
510525|NCT00244946|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
510526|NCT00244946|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
510527|NCT00244946|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
510528|NCT00244946|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
510529|NCT00244946|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
510530|NCT00244946|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
510531|NCT00244946|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
510532|NCT00244946|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
510533|NCT00244946|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
510534|NCT00244946|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
510535|NCT00244946|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
510536|NCT00244946|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
510537|NCT00244946|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
510538|NCT00244946|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
510539|NCT00244946|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
510540|NCT00244946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
510541|NCT00244946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
510542|NCT00244946|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
510543|NCT00244946|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
510544|NCT00244946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
510545|NCT00244946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
510546|NCT00244946|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
510547|NCT00244946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
510548|NCT00244946|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
510549|NCT00244946|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
510550|NCT00244946|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
510551|NCT00244946|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
510552|NCT00244946|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
510553|NCT00244946|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
510554|NCT00244946|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
510555|NCT00244946|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
510623|NCT00245037|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
510556|NCT00244946|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
510557|NCT00244946|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
510558|NCT00244946|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
510559|NCT00244946|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
510560|NCT00244959|stage I breast cancer|stage i breast cancer
510561|NCT00244959|stage II breast cancer|stage ii breast cancer
510562|NCT00244959|stage IIIA breast cancer|stage iiia breast cancer
510563|NCT00244959|stage IIIB breast cancer|stage iiib breast cancer
510564|NCT00244959|stage IIIC breast cancer|stage iiic breast cancer
510565|NCT00244959|ductal breast carcinoma in situ|ductal breast carcinoma in situ
510566|NCT00244959|breast cancer in situ|breast cancer in situ
510567|NCT00244985|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
510568|NCT00244985|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
510569|NCT00244985|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
510570|NCT00244985|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
510571|NCT00244985|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
510572|NCT00244985|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
510573|NCT00244985|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
510574|NCT00244985|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
510575|NCT00244985|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
510576|NCT00244985|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
510577|NCT00244985|splenic marginal zone lymphoma|splenic marginal zone lymphoma
510578|NCT00244998|adenocarcinoma of the prostate|adenocarcinoma of the prostate
510579|NCT00244998|stage III prostate cancer|stage iii prostate cancer
510580|NCT00244998|stage IV prostate cancer|stage iv prostate cancer
510581|NCT00245011|recurrent osteosarcoma|recurrent osteosarcoma
510582|NCT00245011|metastatic osteosarcoma|metastatic osteosarcoma
510583|NCT00245011|localized osteosarcoma|localized osteosarcoma
510584|NCT00245024|breast cancer|breast cancer
510585|NCT00245024|ductal breast carcinoma in situ|ductal breast carcinoma in situ
510586|NCT00245024|lobular breast carcinoma in situ|lobular breast carcinoma in situ
510587|NCT00245024|breast cancer in situ|breast cancer in situ
509958|NCT00242125|genes|genes
510588|NCT00245037|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
510589|NCT00245037|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
510590|NCT00245037|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
510591|NCT00245037|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
510592|NCT00245037|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
510593|NCT00245037|atypical chronic myeloid leukemia, breakpoint cluster region-Abelson (BCR-ABL) negative|atypical chronic myeloid leukemia, breakpoint cluster region-abelson (bcr-abl) negative
510594|NCT00245037|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
510595|NCT00245037|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
510596|NCT00245037|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
510597|NCT00245037|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
510598|NCT00245037|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
510599|NCT00245037|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
510600|NCT00245037|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
510601|NCT00245037|stage II multiple myeloma|stage ii multiple myeloma
510602|NCT00245037|stage III multiple myeloma|stage iii multiple myeloma
510603|NCT00245037|primary systemic amyloidosis|primary systemic amyloidosis
510604|NCT00245037|refractory multiple myeloma|refractory multiple myeloma
510605|NCT00245037|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
510606|NCT00245037|chronic eosinophilic leukemia|chronic eosinophilic leukemia
510607|NCT00245037|primary myelofibrosis|primary myelofibrosis
510608|NCT00245037|chronic neutrophilic leukemia|chronic neutrophilic leukemia
510609|NCT00245037|essential thrombocythemia|essential thrombocythemia
510610|NCT00245037|polycythemia vera|polycythemia vera
510611|NCT00245037|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
510612|NCT00245037|acute undifferentiated leukemia|acute undifferentiated leukemia
510613|NCT00245037|extramedullary plasmacytoma|extramedullary plasmacytoma
510614|NCT00245037|isolated plasmacytoma of bone|isolated plasmacytoma of bone
510615|NCT00245037|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
510616|NCT00245037|stage I multiple myeloma|stage i multiple myeloma
510617|NCT00245037|secondary acute myeloid leukemia|secondary acute myeloid leukemia
510618|NCT00245037|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
510619|NCT00245037|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
510620|NCT00245037|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
510621|NCT00245037|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
510622|NCT00245037|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
510759|NCT00245349|F-18|f-18
510624|NCT00245037|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
510625|NCT00245037|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
510626|NCT00245037|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
510627|NCT00245037|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
510776|NCT00245440|azithromycin|azithromycin
510777|NCT00245453|pneumonia|pneumonia
510628|NCT00245037|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
14938|NCT03195101|transconjunctival approach|transconjunctival approach
510629|NCT00245037|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
510630|NCT00245037|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
510631|NCT00245037|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
510632|NCT00245037|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
510633|NCT00245037|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
510634|NCT00245037|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
510635|NCT00245037|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
510636|NCT00245037|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
510637|NCT00245037|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
510638|NCT00245037|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
510639|NCT00245037|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
583318|NCT00511277|depression|depression
510640|NCT00245037|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
510641|NCT00245037|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
510642|NCT00245037|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
510643|NCT00245037|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
510644|NCT00245037|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
510645|NCT00245037|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
510646|NCT00245037|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
510647|NCT00245037|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
510648|NCT00245037|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
510649|NCT00245037|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
510650|NCT00245037|splenic marginal zone lymphoma|splenic marginal zone lymphoma
510651|NCT00245037|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
510652|NCT00245037|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
510653|NCT00245037|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
510654|NCT00245037|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
510655|NCT00245037|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
510656|NCT00245037|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
510657|NCT00245037|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
510658|NCT00245037|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
510659|NCT00245037|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
510660|NCT00245037|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
510661|NCT00245037|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
510662|NCT00245037|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
510663|NCT00245037|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
510664|NCT00245037|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
510665|NCT00245037|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
510666|NCT00245037|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
510667|NCT00245037|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
510668|NCT00245037|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
510669|NCT00245037|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
510670|NCT00245037|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
510671|NCT00245037|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
510672|NCT00245037|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
510673|NCT00245037|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
510674|NCT00245037|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
510675|NCT00245037|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
510676|NCT00245037|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
510677|NCT00245037|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
510678|NCT00245050|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
510679|NCT00245050|fallopian tube cancer|fallopian tube cancer
510680|NCT00245050|peritoneal cavity cancer|peritoneal cavity cancer
510681|NCT00245050|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
510682|NCT00245050|recurrent endometrial carcinoma|recurrent endometrial carcinoma
510683|NCT00245050|stage III endometrial carcinoma|stage iii endometrial carcinoma
510684|NCT00245050|stage IV endometrial carcinoma|stage iv endometrial carcinoma
510685|NCT00245050|stage IV breast cancer|stage iv breast cancer
510686|NCT00245050|male breast cancer|male breast cancer
510687|NCT00245050|recurrent breast cancer|recurrent breast cancer
510688|NCT00245076|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
510689|NCT00245089|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
510690|NCT00245089|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
510691|NCT00245089|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
510778|NCT00245453|Spneumoniae|spneumoniae
15240|NCT03193333|primary open-angle glaucoma|primary open-angle glaucoma
510692|NCT00245115|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
510693|NCT00245115|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
510694|NCT00245115|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
510695|NCT00245115|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
510696|NCT00245115|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
510697|NCT00245115|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
510698|NCT00245115|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
510699|NCT00245115|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
510700|NCT00245115|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
510701|NCT00245115|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
510702|NCT00245115|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
510703|NCT00245115|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
510704|NCT00245115|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
510705|NCT00245115|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
510706|NCT00245115|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
510707|NCT00245115|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
510708|NCT00245115|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
510709|NCT00245115|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
510710|NCT00245115|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
510711|NCT00245115|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
510712|NCT00245115|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
510713|NCT00245115|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
510714|NCT00245115|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
510715|NCT00245115|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
510716|NCT00245115|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
510717|NCT00245115|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
510718|NCT00245115|secondary acute myeloid leukemia|secondary acute myeloid leukemia
510719|NCT00245128|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
510720|NCT00245128|polycythemia vera|polycythemia vera
510721|NCT00245128|essential thrombocythemia|essential thrombocythemia
510722|NCT00245141|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
510723|NCT00245141|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
510724|NCT00245141|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
510725|NCT00245154|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
510726|NCT00245154|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
510727|NCT00245193|Major Depression|major depression
510728|NCT00245206|Antipsychotic|antipsychotic
510729|NCT00245206|Diabetes|diabetes
510730|NCT00245206|Hyperlipidemia|hyperlipidemia
510731|NCT00245206|Stroke|stroke
510732|NCT00245232|PTSD|ptsd
510733|NCT00245232|Cognitive therapy|cognitive therapy
510734|NCT00245232|Rape|rape
510735|NCT00245245|hemophilia A|hemophilia a
510736|NCT00245245|inhibitor|inhibitor
510737|NCT00245245|treatment|treatment
510738|NCT00245271|Knee|knee
510739|NCT00245271|Musculoskeletal System|musculoskeletal system
510740|NCT00245271|Ligament|ligament
510741|NCT00245271|ACL reconstruction|acl reconstruction
510742|NCT00245297|Bleeding disorder|bleeding disorder
510743|NCT00245297|severe Haemophilia A|severe haemophilia a
510744|NCT00245297|Prophylaxis|prophylaxis
510745|NCT00245310|ICG clearance|icg clearance
510746|NCT00245310|liver cirrhosis|liver cirrhosis
510747|NCT00245310|acute liver failure|acute liver failure
510748|NCT00245310|prognosis|prognosis
510749|NCT00245323|smoking|smoking
510750|NCT00245336|hemostasis|hemostasis
510751|NCT00245336|surgery|surgery
510752|NCT00245336|hemostatics|hemostatics
510753|NCT00245336|randomized controlled trial|randomized controlled trial
510754|NCT00245336|phase 3|phase 3
510755|NCT00245349|Head and Neck cancer|head and neck cancer
510756|NCT00245349|Squamous cell carcinoma|squamous cell carcinoma
510757|NCT00245349|FLT|flt
510758|NCT00245349|Fluorothymidine|fluorothymidine
510760|NCT00245362|cancer vaccine|cancer vaccine
510761|NCT00245362|pancreatic cancer|pancreatic cancer
510762|NCT00245362|metastatic pancreatic cancer|metastatic pancreatic cancer
510763|NCT00245362|unresectable pancreatic cancer|unresectable pancreatic cancer
510764|NCT00245362|immunotherapy|immunotherapy
510765|NCT00245375|Outpatient Surgery for:|outpatient surgery for:
510766|NCT00245375|inguinal hernia repair|inguinal hernia repair
510767|NCT00245375|abdominal hernia repair|abdominal hernia repair
510768|NCT00245375|umbilical hernia repair|umbilical hernia repair
510769|NCT00245388|Mixed Dyslipidemia|mixed dyslipidemia
510770|NCT00245427|beta-lactam|beta-lactam
510771|NCT00245427|macrolide|macrolide
510780|NCT00245453|telithromycin|telithromycin
510781|NCT00245453|azithromycin|azithromycin
510782|NCT00245466|Prostate Cancer|prostate cancer
510783|NCT00245466|Androgen ablation therapy|androgen ablation therapy
510784|NCT00245479|Primary nocturnal enuresis|primary nocturnal enuresis
510785|NCT00245492|Colonoscopy|colonoscopy
510786|NCT00245492|Chromoscopy|chromoscopy
510787|NCT00245492|Prevention|prevention
510788|NCT00245518|prostate cancer|prostate cancer
510789|NCT00245518|soy|soy
510790|NCT00245518|androgen deprivation|androgen deprivation
510791|NCT00245518|quality of life|quality of life
510792|NCT00245518|isoflavones|isoflavones
510793|NCT00245531|endocrine abnormalities|endocrine abnormalities
510794|NCT00245531|cognitive performance|cognitive performance
510795|NCT00245557|Depression|depression
510796|NCT00245557|Geriatric|geriatric
510797|NCT00245557|MRI|mri
510798|NCT00245557|Sertraline|sertraline
510799|NCT00245583|Pathological Gambling|pathological gambling
510800|NCT00245583|Compulsive Gambling|compulsive gambling
510801|NCT00245583|Gambling|gambling
510802|NCT00245583|topiramate|topiramate
510803|NCT00245622|Phase 2b Tovaxin|phase 2b tovaxin
658356|NCT00812175|HCC|hcc
510804|NCT00245622|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
510805|NCT00245622|Relapse-Remitting Multiple Sclerosis (RR-MS)|relapse-remitting multiple sclerosis (rr-ms)
510806|NCT00245635|Body Dysmorphic Disorder|body dysmorphic disorder
510807|NCT00245635|BDD|bdd
510808|NCT00245635|BDD treatment|bdd treatment
510809|NCT00245635|delusionality variant|delusionality variant
510810|NCT00245635|OCD|ocd
510811|NCT00245661|COPD|copd
510812|NCT00245661|respiratory|respiratory
510813|NCT00245661|sleep quality|sleep quality
510814|NCT00245661|temazepam|temazepam
510815|NCT00245661|dyspnea|dyspnea
510816|NCT00245687|feeding tube, nutrition, gastric, jejunal|feeding tube, nutrition, gastric, jejunal
510817|NCT00245713|Levetiracetam, adult, partial-onset epilepsy, antiepileptic|levetiracetam, adult, partial-onset epilepsy, antiepileptic
510818|NCT00245739|HIV infections|hiv infections
510819|NCT00245739|HIV-1|hiv-1
510820|NCT00245739|TMC114|tmc114
510821|NCT00245739|Early access|early access
510822|NCT00245739|Highly antiretroviral treatment experienced patients|highly antiretroviral treatment experienced patients
510823|NCT00245739|Anti-retroviral agents|anti-retroviral agents
510824|NCT00245752|post term pregnancy|post term pregnancy
510825|NCT00245752|acupuncture|acupuncture
510826|NCT00245752|induction|induction
510827|NCT00245765|chronic plaque psoriasis, anti TNFα|chronic plaque psoriasis, anti tnfα
510828|NCT00245765|CDP870, Cimzia|cdp870, cimzia
510829|NCT00245791|Complicated Urinary Infection|complicated urinary infection
510830|NCT00245817|Anxiety. Depression. HRQOL. Psycho-educative intervention|anxiety. depression. hrqol. psycho-educative intervention
510831|NCT00245830|Ischemia/reperfusion of the liver|ischemia/reperfusion of the liver
510832|NCT00245830|Ischemic Preconditioning|ischemic preconditioning
510833|NCT00245830|Cadaver organ donor|cadaver organ donor
510834|NCT00245843|Premature birth|premature birth
510835|NCT00245843|moderate preterm|moderate preterm
510836|NCT00245843|late preterm|late preterm
510837|NCT00245843|Joint attention|joint attention
510838|NCT00245843|Social interaction|social interaction
510839|NCT00245843|Child development|child development
510840|NCT00245843|Parent|parent
510841|NCT00245843|infant|infant
510842|NCT00245856|Upper Extremity Deep-Vein Thrombosis|upper extremity deep-vein thrombosis
510843|NCT00245856|DVT|dvt
510844|NCT00245856|Fragmin|fragmin
510845|NCT00245856|Deep-Vein Thrombosis|deep-vein thrombosis
510846|NCT00245856|Thrombosis|thrombosis
510847|NCT00245869|Contrast-enhanced Ultrasound|contrast-enhanced ultrasound
510848|NCT00245869|Ultrasound Contrast agents, microbubbles|ultrasound contrast agents, microbubbles
510849|NCT00245869|breast cancer|breast cancer
510850|NCT00245869|chemotherapy|chemotherapy
510851|NCT00245869|vascularization|vascularization
510852|NCT00245882|Telehealth|telehealth
510853|NCT00245882|Veterans|veterans
510854|NCT00245882|Glycemic control|glycemic control
510855|NCT00245882|Active care management|active care management
510856|NCT00245882|Care coordination|care coordination
510857|NCT00245895|Anemia,|anemia,
510858|NCT00245895|Prostate Cancer|prostate cancer
510859|NCT00245908|Asthma|asthma
510860|NCT00245908|Chlamydia pneumoniae|chlamydia pneumoniae
510861|NCT00245908|Chlamydophila pneumoniae|chlamydophila pneumoniae
510862|NCT00245908|Azithromycin|azithromycin
510863|NCT00245921|contraception|contraception
511055|NCT00239603|anovulation|anovulation
510864|NCT00245934|Rheumatoid Arthritis|rheumatoid arthritis
510865|NCT00245947|Crohn's Disease|crohn's disease
510866|NCT00245947|Inflammation|inflammation
510867|NCT00245960|Psoriatic Arthritis|psoriatic arthritis
510868|NCT00245960|Skin Disease|skin disease
510869|NCT00245960|Joint Disease|joint disease
510870|NCT00245986|Pharmacokinetics|pharmacokinetics
510871|NCT00245986|Cytochrome P450|cytochrome p450
510872|NCT00245986|HIV Resistance|hiv resistance
510873|NCT00245986|Drug Interaction|drug interaction
510874|NCT00245986|Non-Nucleoside Reverse Transcriptase Inhibitors|non-nucleoside reverse transcriptase inhibitors
510875|NCT00245986|HIV Positive|hiv positive
510876|NCT00245986|Healthy Volunteer|healthy volunteer
510878|NCT00246012|Melanoma|melanoma
510879|NCT00246012|Neoplasm|neoplasm
510880|NCT00246012|CNTO 95|cnto 95
510881|NCT00246012|Dacarbazine|dacarbazine
510882|NCT00246012|Intetumumab|intetumumab
510883|NCT00246038|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
510884|NCT00246038|Aortic Aneurysm|aortic aneurysm
510885|NCT00246038|AAA|aaa
510886|NCT00246038|Endovascular|endovascular
510887|NCT00246038|Stent Graft|stent graft
510888|NCT00246038|Endograft|endograft
510889|NCT00246038|Vascular Prostheses|vascular prostheses
510890|NCT00246051|Police|police
510891|NCT00246051|Sleep|sleep
510892|NCT00246051|Fatigue|fatigue
510893|NCT00246051|Work Hours|work hours
510894|NCT00246051|Sleep disorder|sleep disorder
510895|NCT00246051|Performance|performance
510896|NCT00246064|Rheumatoid Arthritis|rheumatoid arthritis
510897|NCT00246064|Infliximab infusions|infliximab infusions
510898|NCT00246064|Methotrexate|methotrexate
510899|NCT00246064|Remicade|remicade
510900|NCT00246077|chronic transfusion therapy|chronic transfusion therapy
510901|NCT00246077|quality of life|quality of life
510902|NCT00246103|Valproic Acid|valproic acid
510903|NCT00246103|Epirubicin|epirubicin
510904|NCT00246103|Solid Tumor|solid tumor
510905|NCT00246103|Malignancies|malignancies
510906|NCT00246116|Lung Cancer|lung cancer
510907|NCT00246116|Radiation Oncology|radiation oncology
510908|NCT00246116|Treated with Stereostatic Body Radiation|treated with stereostatic body radiation
510909|NCT00246129|Kidney Transplantation|kidney transplantation
510910|NCT00246129|Kidney Disease|kidney disease
510911|NCT00246129|Kidney Failure|kidney failure
510912|NCT00246129|Graft Rejection|graft rejection
510913|NCT00246155|chronic|chronic
510914|NCT00246155|muscular|muscular
510915|NCT00246168|Rheumatoid arthritis|rheumatoid arthritis
510916|NCT00246168|NSAID add-on therapy|nsaid add-on therapy
510917|NCT00246168|tramadol|tramadol
510918|NCT00246168|acetaminophen|acetaminophen
510919|NCT00246181|Lung cancer|lung cancer
510920|NCT00246181|stereotactic body radiotherapy|stereotactic body radiotherapy
510921|NCT00246194|Schizophrenia|schizophrenia
510922|NCT00246194|Mental disorder|mental disorder
510923|NCT00246194|DSM-IV|dsm-iv
510924|NCT00246194|RISPERDAL CONSTA|risperdal consta
510925|NCT00246194|Risperidone|risperidone
510926|NCT00246194|Long-acting risperidone|long-acting risperidone
510927|NCT00246194|Disorganized|disorganized
510928|NCT00246194|Catatonic|catatonic
510929|NCT00246194|Paranoid|paranoid
510930|NCT00246207|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
510931|NCT00246207|once-day oral tablets|once-day oral tablets
510932|NCT00246220|Attention deficit/hyperactivity disorder|attention deficit/hyperactivity disorder
510933|NCT00246220|methylphenidate|methylphenidate
510934|NCT00246220|central nervous system stimulants|central nervous system stimulants
510935|NCT00246233|methylphenidate hydrochloride|methylphenidate hydrochloride
510936|NCT00246233|oral tablets|oral tablets
510937|NCT00246233|Major Depressive Disorder|major depressive disorder
510938|NCT00246246|risperidone|risperidone
510939|NCT00246246|long-acting injectable|long-acting injectable
510940|NCT00246246|bipolar disorder|bipolar disorder
510941|NCT00246246|intramuscular injection|intramuscular injection
510942|NCT00246259|Schizophrenia|schizophrenia
510943|NCT00246259|Schizoaffective disorder|schizoaffective disorder
510944|NCT00246259|Schizophreniform disorder|schizophreniform disorder
510945|NCT00246259|Risperidone|risperidone
510946|NCT00246259|Risperdal Consta|risperdal consta
510947|NCT00246272|risperidone|risperidone
510948|NCT00246272|schizophrenia|schizophrenia
510949|NCT00246272|rapidly-dissolving|rapidly-dissolving
510950|NCT00246285|schizophrenia|schizophrenia
510951|NCT00246285|antipsychotic agents|antipsychotic agents
510952|NCT00246285|risperidone|risperidone
510953|NCT00246285|adolescents|adolescents
510954|NCT00246298|Anemia|anemia
510955|NCT00246298|erythropoetin|erythropoetin
510956|NCT00246298|Epoetin alfa|epoetin alfa
510957|NCT00246298|erythropoietin recombinant|erythropoietin recombinant
510958|NCT00246298|HIV infection|hiv infection
510960|NCT00246298|AIDS|aids
510961|NCT00246350|Headaches|headaches
510962|NCT00246350|Spinal manipulation|spinal manipulation
510963|NCT00246350|Massage|massage
510964|NCT00246350|chiropractic|chiropractic
510965|NCT00238927|asthma|asthma
510966|NCT00238927|preschool|preschool
510967|NCT00238927|viral|viral
511056|NCT00239603|infertility|infertility
510968|NCT00238927|upper respiratory track infection|upper respiratory track infection
510969|NCT00238927|fluticasone|fluticasone
510970|NCT00238927|inhaled corticosteroids|inhaled corticosteroids
510971|NCT00238927|placebo|placebo
510972|NCT00238927|exacerbations|exacerbations
510973|NCT00238927|severity|severity
510974|NCT00238927|safety|safety
510975|NCT00238927|growth|growth
510976|NCT00238927|bone mineral density|bone mineral density
510977|NCT00238927|adrenal function|adrenal function
510978|NCT00238927|rescue beta2-agonists|rescue beta2-agonists
15241|NCT03193333|Ophthalmic antihypertensives|ophthalmic antihypertensives
510979|NCT00238940|Renal transplantation, Enteric-Coated Mycophenolate Sodium (EC-MPS)|renal transplantation, enteric-coated mycophenolate sodium (ec-mps)
510980|NCT00238953|Kidney transplantation|kidney transplantation
510981|NCT00238953|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
510982|NCT00238966|Renal transplantation, Enteric-Coated Mycophenolate Sodium (EC-MPS)|renal transplantation, enteric-coated mycophenolate sodium (ec-mps)
510983|NCT00238979|Renal transplantation, Enteric-coated mycophenolate sodium|renal transplantation, enteric-coated mycophenolate sodium
510984|NCT00238992|Kidney, de novo transplant, steroid withdrawal, adults, EC-MPS and cyclosporine|kidney, de novo transplant, steroid withdrawal, adults, ec-mps and cyclosporine
510985|NCT00239005|QoL|qol
510986|NCT00239005|GI Side Effects|gi side effects
510987|NCT00239005|MPA|mpa
583319|NCT00511277|psychopathology|psychopathology
510988|NCT00239018|Enteric-Coated Mycophenolate Sodium (EC-MPS), de novo, kidney transplantation, long-term safety.|enteric-coated mycophenolate sodium (ec-mps), de novo, kidney transplantation, long-term safety.
510989|NCT00239031|Renal transplantation, EC-MPS|renal transplantation, ec-mps
510990|NCT00239044|Kidney transplant recipients; Enteric-coated Mycophenolate sodium (EC-MPS)|kidney transplant recipients; enteric-coated mycophenolate sodium (ec-mps)
510991|NCT00239057|Renal transplantation, EC-MPS|renal transplantation, ec-mps
510992|NCT00239070|EC-MPS, renal transplantation, de novo patients|ec-mps, renal transplantation, de novo patients
510993|NCT00239083|MYFORMS, Kidney Transplantation, Enteric-Coated Mycophenolate Sodium (EC-MPS), Cyclosporine microemulsion (CsA-ME)|myforms, kidney transplantation, enteric-coated mycophenolate sodium (ec-mps), cyclosporine microemulsion (csa-me)
510994|NCT00239096|alcoholic liver cirrhosis|alcoholic liver cirrhosis
510995|NCT00239096|ascites|ascites
510996|NCT00239096|sodium retention|sodium retention
510997|NCT00239122|Cognitive Therapy|cognitive therapy
510998|NCT00239122|Psychotic Disorders|psychotic disorders
510999|NCT00239122|Treatment Outcome|treatment outcome
511000|NCT00239135|Actinic Keratosis|actinic keratosis
511001|NCT00239135|Topical|topical
511002|NCT00239135|Maximum Tolerated Dose|maximum tolerated dose
511003|NCT00239135|Solar Keratosis|solar keratosis
511004|NCT00239135|Sun Spots|sun spots
511005|NCT00239135|Dermatology|dermatology
511006|NCT00239148|Type 1 diabetes|type 1 diabetes
511007|NCT00239161|Pyelonephritis|pyelonephritis
511008|NCT00239174|obesity|obesity
511009|NCT00239187|Type 2 diabetes|type 2 diabetes
511010|NCT00239213|catechins|catechins
511011|NCT00239213|gargling|gargling
511012|NCT00239213|healthy volunteers|healthy volunteers
511013|NCT00239226|atrial fibrillation|atrial fibrillation
511014|NCT00239226|interatrial septum|interatrial septum
511015|NCT00239226|atrial pacing|atrial pacing
511016|NCT00239226|symptomatic sinus node dysfunction,|symptomatic sinus node dysfunction,
511017|NCT00239226|pacemaker indication class I|pacemaker indication class i
511018|NCT00239239|Non-myeloid malignancy|non-myeloid malignancy
511019|NCT00239239|Chemotherapy-induced anemia|chemotherapy-induced anemia
511020|NCT00239239|Oncology|oncology
511021|NCT00239239|Clinical Trials|clinical trials
511022|NCT00239239|Pharmacokinetics|pharmacokinetics
511023|NCT00239239|Darbepoetin alfa|darbepoetin alfa
511024|NCT00239239|Aranesp|aranesp
511025|NCT00239239|Amgen|amgen
511026|NCT00239252|Interferon alfacon-1|interferon alfacon-1
511027|NCT00239252|Virus disease|virus disease
511028|NCT00239252|Hepatitis C|hepatitis c
511029|NCT00239265|tamsulosin|tamsulosin
511030|NCT00239265|urinary tract diseases|urinary tract diseases
511031|NCT00239265|female|female
511032|NCT00239304|Stage III Head and Neck Cancer|stage iii head and neck cancer
511033|NCT00239304|Stage IV Head and Neck Cancer|stage iv head and neck cancer
511034|NCT00239317|tamsulosin|tamsulosin
511035|NCT00239317|urinary tract diseases|urinary tract diseases
511036|NCT00239317|male|male
511037|NCT00239330|high blood cholesterol levels|high blood cholesterol levels
511038|NCT00239512|PDA|pda
511039|NCT00239512|VLBW infants|vlbw infants
511040|NCT00239512|Indomethacin|indomethacin
511041|NCT00239512|Ibuprofen|ibuprofen
511042|NCT00239525|Cerebrovascular Accident|cerebrovascular accident
511043|NCT00239525|Intracranial Hypertension|intracranial hypertension
511044|NCT00239551|gastric stress ulcer|gastric stress ulcer
511045|NCT00239551|Prevacid|prevacid
511046|NCT00239551|Prostaglandin|prostaglandin
511047|NCT00239564|IPX054|ipx054
511048|NCT00239564|Parkinson disease|parkinson disease
511049|NCT00239564|Levodopa|levodopa
511050|NCT00239577|Dengue infection|dengue infection
511051|NCT00239603|OV-Watch|ov-watch
511052|NCT00239603|fertility monitor|fertility monitor
511053|NCT00239603|ovulation induction|ovulation induction
511054|NCT00239603|clomiphene citrate|clomiphene citrate
511057|NCT00239616|Anemia|anemia
511058|NCT00239616|Pharmacokinetics|pharmacokinetics
511059|NCT00239642|Iron|iron
511060|NCT00239642|Anemia|anemia
511061|NCT00239642|CKD|ckd
511062|NCT00239668|Burns|burns
511063|NCT00239668|Functional|functional
511064|NCT00239668|Psychosocial|psychosocial
511065|NCT00239668|Recovery|recovery
511066|NCT00239668|Long-term|long-term
511067|NCT00239668|Pediatric|pediatric
511068|NCT00239668|Surgical|surgical
511069|NCT00239668|Outcomes|outcomes
511070|NCT00239668|Benchmarking|benchmarking
511071|NCT00239681|Primary prevention|primary prevention
511072|NCT00239681|Cardiovascular disease|cardiovascular disease
511073|NCT00239681|Statin therapy|statin therapy
511074|NCT00239681|C-reactive protein|c-reactive protein
511075|NCT00239694|Immune response|immune response
511076|NCT00239694|Antibody response|antibody response
511077|NCT00239707|insulin sensitivity|insulin sensitivity
511078|NCT00239707|blood sugar|blood sugar
511079|NCT00239720|Psoriatic Arthritis|psoriatic arthritis
511080|NCT00239720|Arthritis|arthritis
511081|NCT00239720|Psoriasis|psoriasis
511082|NCT00239720|Psoriatic|psoriatic
511084|NCT00239733|HIV|hiv
511085|NCT00239733|HCV|hcv
511086|NCT00239733|Hepatitis C|hepatitis c
511087|NCT00239733|Thrombocytopenia|thrombocytopenia
511088|NCT00239746|Nonsteroidal Anti-inflammatories|nonsteroidal anti-inflammatories
511090|NCT00239759|Epidemiological study|epidemiological study
511091|NCT00239772|Cognitive Therapy|cognitive therapy
511092|NCT00239772|PTSD|ptsd
511093|NCT00239772|Females|females
511094|NCT00239772|Rape|rape
511095|NCT00239772|Trauma|trauma
511096|NCT00239785|Transplantation, kidney, and organ transplant.|transplantation, kidney, and organ transplant.
511097|NCT00239798|Transplantation, kidney, organ transplant|transplantation, kidney, organ transplant
511098|NCT00239811|Transplantation, kidney, and organ transplant.|transplantation, kidney, and organ transplant.
511099|NCT00239824|urinary incontinence|urinary incontinence
511100|NCT00239824|pelvic floor muscle training|pelvic floor muscle training
511101|NCT00239824|radical prostatectomy|radical prostatectomy
511102|NCT00239824|physiotherapy|physiotherapy
511103|NCT00239837|Adolescent|adolescent
511104|NCT00239837|Foster Care|foster care
511105|NCT00239837|Female|female
511106|NCT00239850|obesity|obesity
511107|NCT00239850|lifestyle|lifestyle
511108|NCT00239850|treatment|treatment
511109|NCT00239850|Complications|complications
511110|NCT00239850|endocrine changes|endocrine changes
511111|NCT00239850|Lipids|lipids
511112|NCT00239850|C18.654.726.500.495|c18.654.726.500.495
511113|NCT00239863|Transplantation, kidney,organ transplant|transplantation, kidney,organ transplant
511114|NCT00239876|Transplantation, kidney, and organ transplant|transplantation, kidney, and organ transplant
511115|NCT00239889|Forearm fracture|forearm fracture
511116|NCT00239889|Postmenopausal women|postmenopausal women
511117|NCT00239889|Pain|pain
511118|NCT00239889|Grip strength|grip strength
511119|NCT00239889|Salmon calcitonin|salmon calcitonin
511120|NCT00239902|Transplantation, kidney, and organ transplantation|transplantation, kidney, and organ transplantation
511121|NCT00239928|Long-Term Study For Pegaptanib Sodium In Patients With Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration|long-term study for pegaptanib sodium in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration
511122|NCT00239967|dyslipidemia|dyslipidemia
511123|NCT00239967|obesity|obesity
511124|NCT00239980|antineoplastic agent|antineoplastic agent
511125|NCT00239980|ovarian cancer|ovarian cancer
511126|NCT00239980|fragmin|fragmin
511127|NCT00239980|dalteparin|dalteparin
511128|NCT00240006|Multiple Sclerosis|multiple sclerosis
511129|NCT00240006|Copaxone®|copaxone®
511130|NCT00240006|Shared Solutions®|shared solutions®
511131|NCT00240045|Hepatorenal syndrome|hepatorenal syndrome
511132|NCT00240045|Refractory ascites|refractory ascites
511133|NCT00240045|Midodrine|midodrine
511134|NCT00240045|Octreotide|octreotide
511135|NCT00240045|Albumin|albumin
511136|NCT00240045|Cirrhosis|cirrhosis
511137|NCT00240058|Blood Pressure|blood pressure
511138|NCT00240058|Nitric Oxide|nitric oxide
511139|NCT00240058|L-NMMA|l-nmma
511140|NCT00240058|Phenylephrine|phenylephrine
511141|NCT00240058|Nitroprusside|nitroprusside
511142|NCT00240058|Vasoreactivity|vasoreactivity
511143|NCT00240071|Breast cancer|breast cancer
511144|NCT00240071|Metastatic breast cancer|metastatic breast cancer
511145|NCT00240071|Hormonal therapy|hormonal therapy
511146|NCT00240071|Bevacizumab|bevacizumab
511147|NCT00240110|Bipolar|bipolar
511148|NCT00240110|Cocaine|cocaine
511149|NCT00240110|Comorbidity|comorbidity
511150|NCT00240123|ERCP|ercp
511151|NCT00240123|EUS|eus
511152|NCT00240136|Early, severe|early, severe
511153|NCT00240162|Myeloma|myeloma
511154|NCT00240162|PTK|ptk
511155|NCT00240188|Hernia|hernia
511156|NCT00240188|Incisional|incisional
511157|NCT00240188|Laparoscopic|laparoscopic
511158|NCT00240188|Mesh|mesh
511159|NCT00240188|Repair|repair
511160|NCT00240188|Ventral|ventral
511161|NCT00240214|Kidney transplants|kidney transplants
511162|NCT00240227|Alcoholism|alcoholism
511163|NCT00240227|Cocaine Dependence|cocaine dependence
511164|NCT00240227|Prazosin|prazosin
511165|NCT00240227|Substance use disorders|substance use disorders
511166|NCT00240253|diabetes|diabetes
511167|NCT00240253|Amylin|amylin
511168|NCT00240253|Symlin|symlin
511169|NCT00240253|pramlintide|pramlintide
511170|NCT00240253|insulin glargine|insulin glargine
511171|NCT00240266|Metabolic Syndrome|metabolic syndrome
511172|NCT00240266|Dyslipaemia|dyslipaemia
511083|NCT00239720|PsA|psa
511173|NCT00240279|high blood cholesterol levels|high blood cholesterol levels
511273|NCT00247572|Drug Use Disorders|drug use disorders
511174|NCT00240292|Ischaemic or non-ischaemic systolic congestive heart failure|ischaemic or non-ischaemic systolic congestive heart failure
511175|NCT00240305|Metabolic Syndrome|metabolic syndrome
511176|NCT00240305|Dyslipidaemia|dyslipidaemia
511177|NCT00240318|Coronary Artery Disease|coronary artery disease
511178|NCT00240331|End Stage Renal Failure|end stage renal failure
511179|NCT00240344|High risk patients|high risk patients
511180|NCT00240344|Crestor|crestor
511181|NCT00240344|Rosuvastatin|rosuvastatin
511182|NCT00240344|LDL cholesterol|ldl cholesterol
511183|NCT00240344|observational|observational
511185|NCT00240396|Tibia|tibia
511186|NCT00240396|femur|femur
511187|NCT00240396|humerus|humerus
511188|NCT00240396|narcotics|narcotics
511189|NCT00240396|bimodal|bimodal
511190|NCT00240396|analgesia|analgesia
511191|NCT00240396|long-bone|long-bone
511192|NCT00240396|NSAIDS|nsaids
511193|NCT00246363|HIV|hiv
511194|NCT00246363|Hepatitis C|hepatitis c
511195|NCT00246389|muscle spasm|muscle spasm
511196|NCT00246389|cyclobenzaprine hydrochloride|cyclobenzaprine hydrochloride
511197|NCT00246415|Alcohol Dependence|alcohol dependence
511198|NCT00246415|Alcohol Abuse|alcohol abuse
511199|NCT00246415|Memantine|memantine
511200|NCT00246415|Alcohol Treatment|alcohol treatment
511201|NCT00246428|Motivational Interviewing|motivational interviewing
511202|NCT00246428|Alcohol Abuse|alcohol abuse
511203|NCT00246428|Alcohol Dependence|alcohol dependence
511204|NCT00246428|Emergency Care Setting|emergency care setting
511205|NCT00246441|Pharmacotherapy|pharmacotherapy
511206|NCT00246441|Self medication|self medication
511207|NCT00246454|circadian|circadian
511208|NCT00246454|advanced sleep phase|advanced sleep phase
511209|NCT00246454|delayed sleep phase|delayed sleep phase
511210|NCT00246467|plague|plague
511211|NCT00246480|Respiratory Syncytial Virus Infections, RSV, elderly|respiratory syncytial virus infections, rsv, elderly
511212|NCT00246493|Coronary|coronary
511213|NCT00246493|Endothelial|endothelial
511214|NCT00246493|Vascular|vascular
511215|NCT00246493|Atherosclerosis|atherosclerosis
511216|NCT00246493|Arterial|arterial
511217|NCT00246506|Infertility|infertility
511218|NCT00246506|Fertility|fertility
511219|NCT00246506|Reproduction|reproduction
511220|NCT00246506|Advanced Maternal Age|advanced maternal age
511221|NCT00246506|Reproductive Medicine|reproductive medicine
511222|NCT00246506|Reproductive Techniques|reproductive techniques
511223|NCT00246506|Pregnancy|pregnancy
511224|NCT00246519|hypertension|hypertension
511225|NCT00246519|pharmacogenetics|pharmacogenetics
511226|NCT00246519|pharmacogenomics|pharmacogenomics
511227|NCT00246519|beta-blocker|beta-blocker
511228|NCT00246519|atenolol|atenolol
511229|NCT00246519|diuretic|diuretic
511230|NCT00246519|hydrochlorothiazide|hydrochlorothiazide
511231|NCT00246519|blood pressure|blood pressure
511232|NCT00246519|metabolic adverse effects|metabolic adverse effects
511233|NCT00246558|Tight Achilles Tendon|tight achilles tendon
511234|NCT00246558|Hyperpronation of the foot|hyperpronation of the foot
511235|NCT00246584|Hypertension|hypertension
511236|NCT00246584|angiotensin|angiotensin
511237|NCT00246584|renin|renin
511238|NCT00246584|aliskiren|aliskiren
511239|NCT00246597|Anemia|anemia
511240|NCT00246597|Breast cancer|breast cancer
511241|NCT00246597|Hemoglobin|hemoglobin
511242|NCT00246597|Quality of Life|quality of life
511243|NCT00246597|Adjuvant Chemotherapy|adjuvant chemotherapy
511244|NCT00246597|Pure red cell aplasia (PRCA)|pure red cell aplasia (prca)
511245|NCT00246597|Cognitive and executive function|cognitive and executive function
511246|NCT00246610|Non-randomized open-label single-arm study of Nelfinavir plus Combivir in pregnant females infected with HIV-1 virus.|non-randomized open-label single-arm study of nelfinavir plus combivir in pregnant females infected with hiv-1 virus.
511247|NCT00246636|Very high triglycerides|very high triglycerides
511248|NCT00246636|omega-3-acid ethyl esters|omega-3-acid ethyl esters
511249|NCT00246636|fenofibrate|fenofibrate
511250|NCT00246636|Lovaza|lovaza
511251|NCT00246649|Mafosfamide|mafosfamide
511252|NCT00246649|Growth Factor|growth factor
511253|NCT00246649|Stem Cell|stem cell
511254|NCT00246649|Bone Marrow|bone marrow
511255|NCT00246662|Leukemia|leukemia
511256|NCT00246662|Hematologic|hematologic
511257|NCT00246662|Blood|blood
511258|NCT00246662|Cancer|cancer
511259|NCT00246662|Malignancy|malignancy
511260|NCT00246662|Myelodysplastic Syndromes|myelodysplastic syndromes
511261|NCT00247572|d-Amphetamine|d-amphetamine
512636|NCT00252538|Tryptophan|tryptophan
511262|NCT00247572|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
511263|NCT00247572|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
511264|NCT00247572|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
511265|NCT00247572|Amphetamine Abuse|amphetamine abuse
511266|NCT00247572|Amphetamine Dependence|amphetamine dependence
511267|NCT00247572|Amphetamine Addiction|amphetamine addiction
511268|NCT00247572|Amphetamine Users|amphetamine users
511269|NCT00247572|Drug Abuse|drug abuse
511270|NCT00247572|Drug Addiction|drug addiction
511271|NCT00247572|Drug Dependence|drug dependence
511272|NCT00247572|Drug Habituation|drug habituation
511274|NCT00247572|Substance Abuse|substance abuse
511275|NCT00247572|Substance Dependence|substance dependence
511276|NCT00247572|Substance Use Disorders|substance use disorders
511277|NCT00247572|Drug Usage|drug usage
511278|NCT00247572|Substance Addiction|substance addiction
511279|NCT00247572|Drug Abuse, Intravenous|drug abuse, intravenous
511280|NCT00247572|Intravenous Drug Abuse|intravenous drug abuse
511281|NCT00247585|Alcohol|alcohol
511282|NCT00247585|Alcohol abuse|alcohol abuse
511283|NCT00247585|Alcohol consumption|alcohol consumption
511284|NCT00247585|Unhealthy alcohol use|unhealthy alcohol use
511285|NCT00247585|Residual effects|residual effects
511286|NCT00247585|Sleep Stages|sleep stages
511287|NCT00247585|Respiratory Physiology|respiratory physiology
511288|NCT00247611|HIV|hiv
511289|NCT00247611|AIDS|aids
511290|NCT00247611|Antiretroviral Medication Adherence|antiretroviral medication adherence
511291|NCT00247624|Depression|depression
658866|NCT00813826|PHN|phn
511292|NCT00247624|Hypnotics|hypnotics
511293|NCT00247624|Sleep|sleep
511294|NCT00247624|Quality of Life|quality of life
511295|NCT00247624|Insomnia|insomnia
511296|NCT00247624|Suicide|suicide
511297|NCT00247637|Mental Health|mental health
511298|NCT00247637|Psychosis|psychosis
511299|NCT00247637|Genetics|genetics
511300|NCT00247637|Heredity|heredity
511301|NCT00247650|neoadjuvant, postmenopausal women, breast cancer, hormonal therapy, bisphosphonate|neoadjuvant, postmenopausal women, breast cancer, hormonal therapy, bisphosphonate
511302|NCT00247663|Aromatase inhibitor|aromatase inhibitor
511303|NCT00247663|letrozole|letrozole
511304|NCT00247663|breast cancer|breast cancer
511305|NCT00247676|Liver neoplasms, sunitinib, Phase 2|liver neoplasms, sunitinib, phase 2
511306|NCT00247689|Ritalin|ritalin
511307|NCT00247689|Substance Abuse|substance abuse
511308|NCT00247689|Allelic Variants|allelic variants
511309|NCT00247689|Genotype|genotype
511310|NCT00247689|Addiction-Associated Human Gene Variants|addiction-associated human gene variants
511311|NCT00247689|Methylphenidate|methylphenidate
511312|NCT00247702|CYP2C9|cyp2c9
511313|NCT00247702|VKORC1|vkorc1
511314|NCT00247702|polymorphism|polymorphism
511315|NCT00247702|warfarin|warfarin
511316|NCT00247715|uninvestigated dyspepsia|uninvestigated dyspepsia
511317|NCT00247715|cost effectiveness|cost effectiveness
511318|NCT00247715|acid suppressive medicine|acid suppressive medicine
511319|NCT00247715|primary care|primary care
511320|NCT00247715|gastrointestinal complaints|gastrointestinal complaints
511321|NCT00247715|Gastrointestinal drugs|gastrointestinal drugs
511322|NCT00247728|PI-88|pi-88
511323|NCT00247728|post resection hepatoma|post resection hepatoma
511324|NCT00247728|adjuvant therapy|adjuvant therapy
511325|NCT00247728|hepatectomy|hepatectomy
511326|NCT00247728|hepatoma|hepatoma
511327|NCT00247741|spinal anesthesia|spinal anesthesia
511328|NCT00247741|lidocaine|lidocaine
511329|NCT00247741|articaine|articaine
511330|NCT00247741|intrathecal|intrathecal
511331|NCT00247754|Anxiety|anxiety
511332|NCT00247754|Therapy|therapy
511333|NCT00247754|Behaviour|behaviour
511334|NCT00247780|Atrial fibrillation|atrial fibrillation
511335|NCT00247780|Pulmonary vein isolation|pulmonary vein isolation
511336|NCT00247780|Tissue Doppler echocardiography|tissue doppler echocardiography
511337|NCT00247793|immunonutrition|immunonutrition
511338|NCT00247793|preoperative optimization|preoperative optimization
511339|NCT00247793|preoperative enteral nutritional supplement|preoperative enteral nutritional supplement
511340|NCT00247793|high risk|high risk
511341|NCT00247793|cardiac surgery|cardiac surgery
511342|NCT00247793|arginine|arginine
511343|NCT00247793|omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
511344|NCT00247793|nucleotides|nucleotides
511345|NCT00247793|glycine|glycine
511346|NCT00247793|immune enhancing nutritional supplement|immune enhancing nutritional supplement
511347|NCT00247793|immune enhancing formula|immune enhancing formula
511348|NCT00247806|Pilot, pediatric, stem cell transplant, lactose intolerance|pilot, pediatric, stem cell transplant, lactose intolerance
511349|NCT00247819|Substance abuse|substance abuse
511350|NCT00247832|Monitoring, early mobilization, motivation modality, visitation rate, step rates, anxiety, pain|monitoring, early mobilization, motivation modality, visitation rate, step rates, anxiety, pain
511351|NCT00247832|Elective lobectomy|elective lobectomy
511352|NCT00247845|HIV|hiv
511353|NCT00247845|Atazanavir|atazanavir
511354|NCT00247845|quality of life|quality of life
511355|NCT00247845|Treatment Experienced|treatment experienced
511445|NCT00248274|atrial fibrillation|atrial fibrillation
511356|NCT00247858|MRSA, USA300, CMRSA-10, CMRSA-6, soft tissue abscesses|mrsa, usa300, cmrsa-10, cmrsa-6, soft tissue abscesses
511357|NCT00247871|MRSA, USA300, CMRSA-10, CMRSA-6, soft tissue abscesses|mrsa, usa300, cmrsa-10, cmrsa-6, soft tissue abscesses
511358|NCT00247884|Injection drug users|injection drug users
511359|NCT00247884|pegylated interferon|pegylated interferon
511360|NCT00247884|ribavirin,|ribavirin,
511361|NCT00247884|HCV|hcv
511362|NCT00247910|hypertension, ambulatory BP, office resting BP, hydrochlorothiazide, stress reduction, self-help, psychotherapy, efficacy|hypertension, ambulatory bp, office resting bp, hydrochlorothiazide, stress reduction, self-help, psychotherapy, efficacy
511363|NCT00247923|Endometrial polyps.|endometrial polyps.
511364|NCT00247923|Angiogenesis.|angiogenesis.
511365|NCT00247923|Asymptomatic.|asymptomatic.
511366|NCT00247923|Symptoms.|symptoms.
511367|NCT00247923|Malignancy.|malignancy.
511368|NCT00247923|Treatment efficiency.|treatment efficiency.
511369|NCT00247923|Vaginal bleeding.|vaginal bleeding.
511370|NCT00247936|Adenocarcinoma, Esophagectomy|adenocarcinoma, esophagectomy
511371|NCT00247949|carbon dioxide|carbon dioxide
511372|NCT00247949|monitoring|monitoring
511373|NCT00247949|major surgery|major surgery
511374|NCT00247949|repeated blood gas testing|repeated blood gas testing
511375|NCT00247949|carbon dioxide monitoring|carbon dioxide monitoring
511376|NCT00247962|Ankylosing Spondylitis (AS)|ankylosing spondylitis (as)
511377|NCT00247975|L-carnitine|l-carnitine
511378|NCT00247975|Breast cancer|breast cancer
511379|NCT00247975|Anthracycline Cardiotoxicity|anthracycline cardiotoxicity
511380|NCT00247975|Primary prevention|primary prevention
511381|NCT00247975|Anthracycline induced cardiotoxicity|anthracycline induced cardiotoxicity
511382|NCT00247975|Left Ventricular Ejection Fraction|left ventricular ejection fraction
511384|NCT00247988|Relapsed|relapsed
511385|NCT00248014|CLASS II|class ii
511386|NCT00248014|FUNCTIONAL APPLIANCE|functional appliance
511387|NCT00248014|MANDIBULAR ADVANCEMENT STABILITY|mandibular advancement stability
511388|NCT00248027|early intervention,program evaluation|early intervention,program evaluation
511389|NCT00248040|Kidney transplantation|kidney transplantation
511390|NCT00248040|Reperfusion Injury|reperfusion injury
511391|NCT00248040|Survival|survival
511392|NCT00248053|Familial adenomatous polyposis patient with 5 or more adenomatous polyps in the colon or ileoanal pouch|familial adenomatous polyposis patient with 5 or more adenomatous polyps in the colon or ileoanal pouch
511393|NCT00248066|Coronary artery disease|coronary artery disease
511394|NCT00248066|Restenosis|restenosis
511395|NCT00248066|Coronary stent restenosis|coronary stent restenosis
511396|NCT00248079|Coronary Disease|coronary disease
511397|NCT00248092|d-Amphetamine|d-amphetamine
511398|NCT00248092|Diethylpropion|diethylpropion
511399|NCT00248092|Diethylpropion Hydrochloride|diethylpropion hydrochloride
511400|NCT00248092|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
511401|NCT00248092|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
511402|NCT00248092|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
511403|NCT00248092|Amphetamine Abuse|amphetamine abuse
511404|NCT00248092|Amphetamine Dependence|amphetamine dependence
511405|NCT00248092|Amphetamine Addiction|amphetamine addiction
511406|NCT00248092|Amphetamine Users|amphetamine users
511407|NCT00248092|Drug Abuse|drug abuse
511408|NCT00248092|Drug Addiction|drug addiction
511409|NCT00248092|Drug Dependence|drug dependence
511410|NCT00248092|Drug Habituation|drug habituation
511411|NCT00248092|Drug Use Disorders|drug use disorders
511412|NCT00248092|Substance Abuse|substance abuse
511413|NCT00248092|Substance Dependence|substance dependence
511414|NCT00248092|Substance Use Disorders|substance use disorders
511415|NCT00248092|Drug Usage|drug usage
511416|NCT00248092|Substance Addiction|substance addiction
511417|NCT00248105|Arthritis|arthritis
511418|NCT00248105|Physical Activity|physical activity
511419|NCT00248118|Randomized|randomized
511420|NCT00248118|Double-blind|double-blind
511421|NCT00248118|Placebo-controlled|placebo-controlled
511422|NCT00248131|Diabetic retinopathy, octreotide acetate in microspheres|diabetic retinopathy, octreotide acetate in microspheres
511423|NCT00248144|Herpes labialis|herpes labialis
511424|NCT00248157|Diabetic retinopathy|diabetic retinopathy
511425|NCT00248157|Octreotide acetate in microspheres|octreotide acetate in microspheres
511426|NCT00248170|Breast cancer|breast cancer
511427|NCT00248170|letrozole|letrozole
511428|NCT00248170|anastrozole|anastrozole
511429|NCT00248170|adjuvant|adjuvant
511430|NCT00248170|postmenopausal|postmenopausal
511431|NCT00248170|FACE|face
511432|NCT00248209|Female Orgasmic Disorder|female orgasmic disorder
511433|NCT00248209|Female Sexual Dysfunction|female sexual dysfunction
511434|NCT00248222|Exercise|exercise
511435|NCT00248222|Rehabilitation|rehabilitation
511436|NCT00248222|Aerobic training|aerobic training
511437|NCT00248235|exercise|exercise
511438|NCT00248235|rehabilitation|rehabilitation
511439|NCT00248235|head and neck neoplasms|head and neck neoplasms
511440|NCT00248248|Consolidation|consolidation
511441|NCT00248248|Ovarian cancer|ovarian cancer
511442|NCT00248248|DOXIL|doxil
511443|NCT00248248|Hand-foot syndrome|hand-foot syndrome
511444|NCT00248261|ziprasidone, sertraline, PTSD|ziprasidone, sertraline, ptsd
511446|NCT00248274|genetics|genetics
511447|NCT00248300|ventilator-associated pneumonia|ventilator-associated pneumonia
511448|NCT00248300|hospital acquired pneumonia|hospital acquired pneumonia
511449|NCT00248313|Kidney Disease|kidney disease
511450|NCT00248326|atrial fibrillation|atrial fibrillation
511451|NCT00248326|genetics|genetics
511452|NCT00248326|genetic polymorphisms|genetic polymorphisms
511453|NCT00248339|Hepatitis C|hepatitis c
511454|NCT00248339|Peginterferon|peginterferon
511455|NCT00248339|Ribavirin|ribavirin
511456|NCT00248339|Procrit|procrit
511457|NCT00248339|Epoetin-alpha|epoetin-alpha
511458|NCT00248352|Coronary Artery Disease|coronary artery disease
511459|NCT00248352|Diabetes Mellitus|diabetes mellitus
511460|NCT00248352|Type 2|type 2
511461|NCT00248352|Chronic Disease|chronic disease
511462|NCT00248365|Chronic GvHD|chronic gvhd
511463|NCT00248365|Extensive chronic GvHD|extensive chronic gvhd
511464|NCT00248365|Resistant chronic GvHD|resistant chronic gvhd
511465|NCT00248378|Multiple Sclerosis|multiple sclerosis
511466|NCT00248378|Cannabis|cannabis
511467|NCT00248378|Spasticity|spasticity
511468|NCT00248378|Tolerability|tolerability
511469|NCT00248391|adenoid hypertrophy|adenoid hypertrophy
511470|NCT00248391|feeding position|feeding position
511471|NCT00248391|supine|supine
511472|NCT00248391|upright|upright
511473|NCT00248391|pneumonia|pneumonia
511474|NCT00248391|wheezing|wheezing
511475|NCT00248391|otitis|otitis
511476|NCT00248391|adenoid|adenoid
511477|NCT00248391|tonsil|tonsil
511478|NCT00248391|caries|caries
511479|NCT00248404|colorectal cancer|colorectal cancer
511480|NCT00248404|ovarian cancer|ovarian cancer
511481|NCT00248404|lung cancer|lung cancer
511482|NCT00248404|breast cancer|breast cancer
511483|NCT00248404|small bowel cancer|small bowel cancer
511484|NCT00248404|Advanced, recurrent, or metastatic solid tumors of any type|advanced, recurrent, or metastatic solid tumors of any type
511485|NCT00248404|TS overexpression confirmed by fresh biopsy (RTPCR)|ts overexpression confirmed by fresh biopsy (rtpcr)
511486|NCT00248404|Suitable for experimental monotherapy|suitable for experimental monotherapy
511487|NCT00248430|graft versus host disease|graft versus host disease
511488|NCT00248430|stage II multiple myeloma|stage ii multiple myeloma
511489|NCT00248430|stage III multiple myeloma|stage iii multiple myeloma
511490|NCT00248430|refractory multiple myeloma|refractory multiple myeloma
511491|NCT00248430|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
511492|NCT00248430|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
511493|NCT00248430|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
511494|NCT00248430|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
511495|NCT00248430|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
511496|NCT00248430|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
511497|NCT00248430|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
511498|NCT00248430|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
511499|NCT00248430|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
511500|NCT00248430|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
511501|NCT00248430|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
511502|NCT00248430|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
511503|NCT00248430|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
511504|NCT00248430|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
511505|NCT00248430|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
511506|NCT00248430|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
511507|NCT00248430|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
511508|NCT00248430|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
511509|NCT00248443|Haematology and cancer patients|haematology and cancer patients
511510|NCT00248443|Acute respiratory failure|acute respiratory failure
511511|NCT00248443|Bronchoalveolar lavage|bronchoalveolar lavage
511512|NCT00248443|Non invasive diagnostic tools|non invasive diagnostic tools
511513|NCT00248443|Mechanical ventilation|mechanical ventilation
511514|NCT00248443|Intensive Care|intensive care
511515|NCT00248469|Community randomised trial|community randomised trial
511516|NCT00248469|Sexual behavior|sexual behavior
511517|NCT00248469|Intervention|intervention
511518|NCT00248469|Evaluation|evaluation
511519|NCT00248469|Sexual health education|sexual health education
511520|NCT00248469|Youth-friendly health services|youth-friendly health services
511521|NCT00248469|Adolescents|adolescents
511522|NCT00248469|Behavior change|behavior change
511523|NCT00248469|HIV Seronegativity|hiv seronegativity
511525|NCT00248482|extensive stage small cell lung cancer|extensive stage small cell lung cancer
511526|NCT00248482|recurrent small cell lung cancer|recurrent small cell lung cancer
511527|NCT00248495|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
511528|NCT00248495|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
511529|NCT00248495|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
511530|NCT00248495|stage I non-small cell lung cancer|stage i non-small cell lung cancer
511531|NCT00248521|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
511532|NCT00248534|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
511533|NCT00248547|nausea and vomiting|nausea and vomiting
511534|NCT00248547|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
511535|NCT00248547|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
511536|NCT00248547|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
511537|NCT00248547|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
511538|NCT00248547|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
511539|NCT00248547|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
511540|NCT00248547|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
511541|NCT00248547|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
511542|NCT00248547|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
511543|NCT00248547|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
511544|NCT00248547|chronic eosinophilic leukemia|chronic eosinophilic leukemia
511545|NCT00248547|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
511546|NCT00248547|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
511547|NCT00248547|chronic neutrophilic leukemia|chronic neutrophilic leukemia
511548|NCT00248547|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
510959|NCT00246298|HIV|hiv
511549|NCT00248547|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
511550|NCT00248547|disseminated neuroblastoma|disseminated neuroblastoma
511551|NCT00248547|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
511552|NCT00248547|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
511553|NCT00248547|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
511554|NCT00248547|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
511555|NCT00248547|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
511556|NCT00248547|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
511557|NCT00248547|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
511558|NCT00248547|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
511559|NCT00248547|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
511560|NCT00248547|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
511561|NCT00248547|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
511562|NCT00248547|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
511563|NCT00248547|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
511564|NCT00248547|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
511565|NCT00248547|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
511566|NCT00248547|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
511567|NCT00248547|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
511568|NCT00248547|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
511569|NCT00248547|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
511570|NCT00248547|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
511571|NCT00248547|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
511572|NCT00248547|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
511573|NCT00248547|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
511574|NCT00248547|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
511575|NCT00248547|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
511576|NCT00248547|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
511577|NCT00248547|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
511578|NCT00248547|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
511579|NCT00248547|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
511580|NCT00248547|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
511581|NCT00248547|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
511582|NCT00248547|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
511583|NCT00248547|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
511584|NCT00248547|recurrent neuroblastoma|recurrent neuroblastoma
511585|NCT00248547|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
511586|NCT00248547|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
511587|NCT00248547|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
511588|NCT00248547|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
511589|NCT00248547|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
511590|NCT00248547|refractory hairy cell leukemia|refractory hairy cell leukemia
511591|NCT00248547|refractory multiple myeloma|refractory multiple myeloma
511592|NCT00248547|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
511593|NCT00248547|secondary acute myeloid leukemia|secondary acute myeloid leukemia
511594|NCT00248547|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
511595|NCT00248547|splenic marginal zone lymphoma|splenic marginal zone lymphoma
511596|NCT00248547|stage I multiple myeloma|stage i multiple myeloma
511597|NCT00248547|stage II multiple myeloma|stage ii multiple myeloma
511598|NCT00248547|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
511599|NCT00248547|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
511600|NCT00248547|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
511601|NCT00248547|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
511671|NCT00248690|Subarachnoid hemorrhage|subarachnoid hemorrhage
511602|NCT00248547|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
511603|NCT00248547|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
511604|NCT00248547|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
511605|NCT00248547|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
511606|NCT00248547|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
752461|NCT01173081|fracture healing|fracture healing
511607|NCT00248547|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
511608|NCT00248547|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
511609|NCT00248547|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
511610|NCT00248547|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
511611|NCT00248547|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
511612|NCT00248547|stage III multiple myeloma|stage iii multiple myeloma
511613|NCT00248547|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
511614|NCT00248547|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
511615|NCT00248547|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
511616|NCT00248547|stage IIIA breast cancer|stage iiia breast cancer
511617|NCT00248547|stage IIIB breast cancer|stage iiib breast cancer
511618|NCT00248547|stage IIIC breast cancer|stage iiic breast cancer
511619|NCT00248547|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
511620|NCT00248547|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
511621|NCT00248547|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
511622|NCT00248547|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
511623|NCT00248547|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
511624|NCT00248547|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
511625|NCT00248547|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
511626|NCT00248547|stage IV breast cancer|stage iv breast cancer
511627|NCT00248547|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
511628|NCT00248547|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
511629|NCT00248547|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
511630|NCT00248547|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
511631|NCT00248547|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
511632|NCT00248547|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
511633|NCT00248547|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
511634|NCT00248547|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
511635|NCT00248547|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
511636|NCT00248560|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
511637|NCT00248560|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
511638|NCT00248560|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
511639|NCT00248560|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
511640|NCT00248560|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
511641|NCT00248560|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
511642|NCT00248560|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
511643|NCT00248560|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
511644|NCT00248560|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
511645|NCT00248560|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
511646|NCT00248560|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
511647|NCT00248560|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
511648|NCT00248560|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
511649|NCT00248560|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
511650|NCT00248612|Venlafaxine|venlafaxine
511651|NCT00248612|Alcoholism|alcoholism
511652|NCT00248612|Anxiety Disorders|anxiety disorders
511653|NCT00248612|Alcohol-Use Disorders|alcohol-use disorders
511654|NCT00248612|Alcohol Abuse|alcohol abuse
511655|NCT00248612|Alcohol Dependence|alcohol dependence
511656|NCT00248612|Cognitive Behavioral Treatment|cognitive behavioral treatment
511657|NCT00248625|acute liver failure|acute liver failure
511658|NCT00248625|hepatic encephalopathy|hepatic encephalopathy
511659|NCT00248625|acetaminophen toxicity|acetaminophen toxicity
511660|NCT00248625|N-acetylcysteine|n-acetylcysteine
511661|NCT00248651|Bloating|bloating
511662|NCT00248651|Early Fullness|early fullness
511664|NCT00248651|Upper Abdominal Discomfort|upper abdominal discomfort
511665|NCT00248651|dyspepsia|dyspepsia
511666|NCT00248651|stomach pain|stomach pain
511667|NCT00248651|stomach discomfort|stomach discomfort
511668|NCT00248664|Cystitis, Interstitial|cystitis, interstitial
511669|NCT00248664|Case-Control Studies|case-control studies
511670|NCT00248664|Risk Factors|risk factors
15445|NCT03191929|Depression|depression
511672|NCT00248690|Intracranial hypertension|intracranial hypertension
511673|NCT00248690|Intracranial pressure|intracranial pressure
511674|NCT00248690|Diagnostic techniques and procedures|diagnostic techniques and procedures
511675|NCT00248690|Compliance|compliance
511676|NCT00248690|Treatment outcome|treatment outcome
511089|NCT00239746|NSAIDS|nsaids
511677|NCT00248690|Intensive care, surgical|intensive care, surgical
511678|NCT00248703|Disseminating tumor cells,breast cancer,docetaxel,adjuvant|disseminating tumor cells,breast cancer,docetaxel,adjuvant
511679|NCT00248742|IBD, psychological, stress management|ibd, psychological, stress management
511680|NCT00248755|cystic fibrosis|cystic fibrosis
511681|NCT00248755|mucociliary clearance|mucociliary clearance
511682|NCT00248755|nuclear medicine|nuclear medicine
511683|NCT00248768|Depression|depression
511684|NCT00248768|Parkinson Disease|parkinson disease
511685|NCT00248768|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
511686|NCT00248781|Activities of daily living|activities of daily living
511687|NCT00248781|Aging|aging
511688|NCT00248781|Exercise|exercise
511689|NCT00248781|Weight lifting|weight lifting
511690|NCT00248794|Cognitive Impairment|cognitive impairment
511691|NCT00248794|Rehabilitation|rehabilitation
511692|NCT00248807|Blood Pressure, Low|blood pressure, low
511693|NCT00248807|Hypotension, Postural|hypotension, postural
511694|NCT00248807|Injuries, Spinal Cord|injuries, spinal cord
511695|NCT00248807|Spinal Cord Transection|spinal cord transection
511696|NCT00248807|Spinal Cord Trauma|spinal cord trauma
511697|NCT00248820|Contrast-enhanced Ultrasound|contrast-enhanced ultrasound
511698|NCT00248820|Ultrasound Contrast agent, microbubbles|ultrasound contrast agent, microbubbles
511699|NCT00248820|Ovarian tumor|ovarian tumor
511700|NCT00248820|vascularization|vascularization
511701|NCT00248846|Angioplasty patients|angioplasty patients
511702|NCT00248846|Behavior change|behavior change
511703|NCT00248846|Physical activity|physical activity
511704|NCT00248846|Risk reduction|risk reduction
511705|NCT00248859|Coronary artery disease|coronary artery disease
511706|NCT00248859|Depressive symptoms|depressive symptoms
511707|NCT00248859|Latino American|latino american
511708|NCT00248872|African-American|african-american
511709|NCT00248872|Hypertension|hypertension
511710|NCT00248872|Medication adherence|medication adherence
511711|NCT00248872|Risk reduction|risk reduction
511712|NCT00248885|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
511713|NCT00248885|Perioperative complications|perioperative complications
511714|NCT00248885|Neurocognitive function|neurocognitive function
511715|NCT00248885|Quality of life|quality of life
511716|NCT00248885|Blood pressure|blood pressure
511717|NCT00248898|nonagenarians|nonagenarians
511718|NCT00248898|quality of life|quality of life
511719|NCT00248898|cardiothoracic surgery|cardiothoracic surgery
511720|NCT00248898|long term survival|long term survival
511721|NCT00248911|Breast cancer|breast cancer
511722|NCT00248911|Gynecologic cancers|gynecologic cancers
511723|NCT00248911|Meditation|meditation
511724|NCT00248911|Stress-reduction|stress-reduction
511725|NCT00248911|Cognitive-affective behavioral learning|cognitive-affective behavioral learning
511726|NCT00248924|Social service intervention|social service intervention
511727|NCT00248924|Social support|social support
511728|NCT00248924|Elderly|elderly
511729|NCT00248924|Homebound|homebound
511730|NCT00248924|Quality of life|quality of life
511731|NCT00248937|African-American|african-american
511732|NCT00248937|Hypertension|hypertension
511733|NCT00248937|Medication adherence|medication adherence
511734|NCT00248937|Risk reduction|risk reduction
511735|NCT00248950|Angioplasty|angioplasty
511736|NCT00248950|Behavior Change|behavior change
511737|NCT00248963|Oral Contraceptive|oral contraceptive
511738|NCT00248976|Angioplasty|angioplasty
511739|NCT00248976|Motivating behavior change|motivating behavior change
511740|NCT00248976|Reducing risk factors|reducing risk factors
511741|NCT00248976|Enhancing quality of life|enhancing quality of life
511742|NCT00248976|Improving treatment outcomes|improving treatment outcomes
511743|NCT00248989|Skin aging|skin aging
511744|NCT00248989|Menopausal symptoms|menopausal symptoms
511745|NCT00249002|Vascular Access Graft Failure|vascular access graft failure
511746|NCT00249002|Venous Neointimal Hyperplasia(VNH)|venous neointimal hyperplasia(vnh)
511747|NCT00249002|Hemodialysis|hemodialysis
511748|NCT00249015|aerobic exercise|aerobic exercise
511749|NCT00249015|resistance exercise|resistance exercise
511750|NCT00249015|physical fitness|physical fitness
511751|NCT00249015|body composition|body composition
511752|NCT00249015|quality of life|quality of life
511753|NCT00249015|rehabilitation|rehabilitation
511754|NCT00249015|psychosocial oncology|psychosocial oncology
511755|NCT00249015|adherence|adherence
511756|NCT00249041|Rheumatoid Arthritis, Enbrel liquid, antibodies|rheumatoid arthritis, enbrel liquid, antibodies
511757|NCT00249067|Congestive Heart Failure, Left-to-Right Shunt|congestive heart failure, left-to-right shunt
511758|NCT00249080|3T MRI|3t mri
511759|NCT00249080|neurodegenerative disease|neurodegenerative disease
511760|NCT00249080|Alzheimer's disease|alzheimer's disease
511761|NCT00249080|spectroscopy|spectroscopy
511762|NCT00249080|Normal, healthy subject without memory complaint|normal, healthy subject without memory complaint
511763|NCT00249080|Not pregnant|not pregnant
511764|NCT00249080|MR compatible|mr compatible
511765|NCT00249119|chronic schizophrenia|chronic schizophrenia
511184|NCT00240396|fracture|fracture
511766|NCT00249119|psychotic disorders|psychotic disorders
511767|NCT00249119|risperidone|risperidone
511768|NCT00249119|antipsychotic agents|antipsychotic agents
511769|NCT00249132|chronic schizophrenia|chronic schizophrenia
511770|NCT00249132|psychotic disorder|psychotic disorder
511771|NCT00249132|risperidone|risperidone
511772|NCT00249132|antipsychotic agents|antipsychotic agents
511773|NCT00249145|Dementia|dementia
511774|NCT00249145|Alzheimer's Disease|alzheimer's disease
511775|NCT00249145|vascular dementia|vascular dementia
511776|NCT00249145|mixed dementia, risperidone|mixed dementia, risperidone
511777|NCT00249145|nursing home|nursing home
511778|NCT00249158|Dementia|dementia
511779|NCT00249158|Alzheimer's Disease|alzheimer's disease
511780|NCT00249158|vascular dementia|vascular dementia
511781|NCT00249158|mixed dementia|mixed dementia
511782|NCT00249158|risperidone|risperidone
511783|NCT00249158|nursing home|nursing home
511784|NCT00249171|acute schizophrenia|acute schizophrenia
511785|NCT00249171|psychosis|psychosis
511786|NCT00249171|risperidone|risperidone
511787|NCT00249171|lorazepam, antipsychotic agents|lorazepam, antipsychotic agents
511788|NCT00249171|emergency treatment|emergency treatment
511789|NCT00249197|skin infection|skin infection
511790|NCT00249197|bacterial infection|bacterial infection
511791|NCT00249197|levofloxacin|levofloxacin
511792|NCT00249197|quinolones|quinolones
511794|NCT00249197|infection|infection
511795|NCT00249210|Sinusitis|sinusitis
511796|NCT00249210|respiratory tract diseases|respiratory tract diseases
511797|NCT00249210|nose diseases|nose diseases
511798|NCT00249210|respiratory tract infections|respiratory tract infections
511799|NCT00249210|paranasal sinus diseases|paranasal sinus diseases
511800|NCT00249210|antibacterial agents|antibacterial agents
511801|NCT00249210|quinolones|quinolones
511802|NCT00249210|levofloxacin|levofloxacin
511803|NCT00249223|chronic schizophrenia, psychotic disorder, risperidone, long-acting injectable, intramuscular injection, antipsychotic agents|chronic schizophrenia, psychotic disorder, risperidone, long-acting injectable, intramuscular injection, antipsychotic agents
511804|NCT00249236|risperidone|risperidone
511805|NCT00249236|antipsychotic agents|antipsychotic agents
511806|NCT00249236|bipolar disorders|bipolar disorders
511807|NCT00249236|manic episode|manic episode
511808|NCT00249249|hypercholesterolemia|hypercholesterolemia
511809|NCT00249249|dyslipidemia|dyslipidemia
511810|NCT00249249|kowa|kowa
511811|NCT00249249|KRE|kre
511812|NCT00249249|pitavastatin|pitavastatin
511813|NCT00249249|NK-104|nk-104
511814|NCT00249275|significant refractive errors|significant refractive errors
511815|NCT00249275|children|children
511816|NCT00249275|spectacles|spectacles
511817|NCT00249275|Africa|africa
511818|NCT00249288|Schizophrenia|schizophrenia
511819|NCT00249288|Negative Symptoms|negative symptoms
511820|NCT00249288|Folate|folate
511821|NCT00249301|Breast Cancer|breast cancer
511822|NCT00249301|Colon Cancer|colon cancer
511823|NCT00249301|Pancreatic Cancer|pancreatic cancer
511824|NCT00249301|Bladder Cancer|bladder cancer
511825|NCT00249314|South Asians|south asians
511826|NCT00249314|European Caucasians|european caucasians
511827|NCT00249314|ethnic differences|ethnic differences
511828|NCT00249314|body composition|body composition
511829|NCT00249314|body fat distribution|body fat distribution
511830|NCT00249314|adipose tissue|adipose tissue
511831|NCT00249314|visceral fat|visceral fat
511832|NCT00249314|myocellular lipids|myocellular lipids
511833|NCT00249314|skeletal muscle|skeletal muscle
511834|NCT00249327|HIV testing|hiv testing
511835|NCT00249327|HIV disclosure|hiv disclosure
511836|NCT00249327|HIV Seronegativity|hiv seronegativity
511837|NCT00249340|behavioral weight loss treatment|behavioral weight loss treatment
511838|NCT00249340|brief behavioral treatment|brief behavioral treatment
511839|NCT00249340|commercial weight loss programs|commercial weight loss programs
511840|NCT00249340|Weight Watchers|weight watchers
511841|NCT00249353|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
511842|NCT00249353|ADHD|adhd
511843|NCT00249353|Concerta|concerta
511844|NCT00249366|Alcohol withdrawal|alcohol withdrawal
511845|NCT00249366|Symptom-triggered therapy|symptom-triggered therapy
511846|NCT00249366|Fixed-schedule therapy|fixed-schedule therapy
511847|NCT00249366|CIWA-Ar|ciwa-ar
511848|NCT00249366|Lorazepam (drug)|lorazepam (drug)
511849|NCT00249379|Alcohol dependence|alcohol dependence
511850|NCT00249379|Acamprosate(drug)|acamprosate(drug)
511851|NCT00249379|Drug Court|drug court
511852|NCT00249379|Probation|probation
511853|NCT00249379|Parole|parole
511854|NCT00249379|Criminal justice|criminal justice
511855|NCT00249392|ocular diseases|ocular diseases
511856|NCT00249392|risk factors|risk factors
511857|NCT00249392|genetic factors|genetic factors
511858|NCT00249405|Clinical trial|clinical trial
511859|NCT00249405|Alcoholism|alcoholism
511861|NCT00249405|Pharmacogenetics|pharmacogenetics
511862|NCT00249405|Citalopram|citalopram
511863|NCT00249405|Genotype|genotype
511864|NCT00249405|Therapy compliance|therapy compliance
511865|NCT00249405|Serotonin inhibitor|serotonin inhibitor
511866|NCT00249405|Alcoholism/alcohol abuse therapy|alcoholism/alcohol abuse therapy
511867|NCT00249418|Contingency Management|contingency management
511868|NCT00249418|Substance Abuse Treatment|substance abuse treatment
511869|NCT00249457|Behavior Therapy|behavior therapy
511870|NCT00249457|Cocaine Abuse|cocaine abuse
511871|NCT00249457|Cocaine Dependence|cocaine dependence
511872|NCT00249457|Contingency Management|contingency management
511873|NCT00249457|Heroin Dependence|heroin dependence
511874|NCT00249457|Methadone|methadone
511875|NCT00249457|Opioid Dependence|opioid dependence
511876|NCT00249470|HIV|hiv
511877|NCT00249470|HIV risk behaviors|hiv risk behaviors
511878|NCT00249470|Heroin|heroin
511879|NCT00249470|Cocaine|cocaine
511880|NCT00249470|Methadone|methadone
511881|NCT00249470|Opioid Dependence|opioid dependence
511882|NCT00249470|Cocaine Abuse|cocaine abuse
511883|NCT00249470|Contingency management|contingency management
511884|NCT00249470|alcohol & drug use|alcohol & drug use
511885|NCT00249470|sexual risk behaviors|sexual risk behaviors
511886|NCT00249483|Cocaine Addiction|cocaine addiction
511887|NCT00249483|Cocaine Dependence|cocaine dependence
511888|NCT00249496|cocaine|cocaine
511889|NCT00249496|opioids|opioids
511890|NCT00249496|contingency management|contingency management
511891|NCT00249496|sexual risk|sexual risk
511892|NCT00249496|HIV|hiv
511893|NCT00249509|marijuana dependence|marijuana dependence
511894|NCT00249522|contingency management|contingency management
511895|NCT00249522|substance abuse treatment|substance abuse treatment
511896|NCT00249535|Substance Abuse|substance abuse
511897|NCT00249535|Contingency Management|contingency management
511898|NCT00249548|contingency management|contingency management
511899|NCT00249548|substance abuse|substance abuse
511900|NCT00249574|heroin addiction|heroin addiction
511901|NCT00249600|contingency management|contingency management
511902|NCT00249600|substance abuse|substance abuse
511903|NCT00249613|gender-responsive substance abuse treatment|gender-responsive substance abuse treatment
511904|NCT00249626|Contingency management|contingency management
511905|NCT00249626|substance abuse treatment|substance abuse treatment
511906|NCT00249639|Contingency Management|contingency management
511907|NCT00249639|Substance Abuse Treatment|substance abuse treatment
511908|NCT00249652|End stage liver disease|end stage liver disease
511909|NCT00249652|End stage renal disease|end stage renal disease
511910|NCT00249652|Substance-Related Disorders|substance-related disorders
511911|NCT00249678|Behavior Therapy|behavior therapy
511912|NCT00249678|methamphetamine|methamphetamine
511913|NCT00249691|cocaine addiction|cocaine addiction
511914|NCT00249691|cocaine dependence|cocaine dependence
511915|NCT00249717|Contingency management|contingency management
511916|NCT00249717|Substance abuse treatment|substance abuse treatment
511917|NCT00249743|fall prevention|fall prevention
511918|NCT00249743|fall risk management|fall risk management
511919|NCT00249743|RCT|rct
511920|NCT00249743|cost|cost
511921|NCT00249756|Criminal Justice|criminal justice
511922|NCT00249769|Japanese Encephalitis|japanese encephalitis
511923|NCT00249769|Japanese B Encephalitis|japanese b encephalitis
511924|NCT00249769|Japanese B Viral Encephalitis|japanese b viral encephalitis
511925|NCT00249769|Viral Encephalitis, Japanese B|viral encephalitis, japanese b
511926|NCT00249782|rosacea, Papulopustular Rosacea,erythema, dapsone|rosacea, papulopustular rosacea,erythema, dapsone
511927|NCT00249795|Atrial fibrillation|atrial fibrillation
511928|NCT00249795|Cardiovascular disease|cardiovascular disease
511929|NCT00249795|angiotensin II blocker|angiotensin ii blocker
511930|NCT00249808|Candidates for systemic therapy for psoriasis|candidates for systemic therapy for psoriasis
511931|NCT00249834|Healthy female partners of infertile couples justifying Assisted Reproductive Technology (ART) treatment.|healthy female partners of infertile couples justifying assisted reproductive technology (art) treatment.
511932|NCT00249847|Hot flashes, vasomotor symptoms, estrogen, paroxetine|hot flashes, vasomotor symptoms, estrogen, paroxetine
511933|NCT00249860|Subjects with chronic hepatitis C who have never previously received interferon therapy.|subjects with chronic hepatitis c who have never previously received interferon therapy.
511934|NCT00249873|Atrial fibrillation|atrial fibrillation
511935|NCT00249873|Anticoagulant therapy|anticoagulant therapy
511936|NCT00249873|Thromboembolic prevention|thromboembolic prevention
511937|NCT00249899|Hyperlipidemia|hyperlipidemia
511938|NCT00249899|Drug Therapy|drug therapy
511939|NCT00249912|Hyperlipidemia|hyperlipidemia
511940|NCT00249912|Drug Therapy|drug therapy
511941|NCT00249925|Home modification|home modification
511942|NCT00249925|Occupational Therapy|occupational therapy
511943|NCT00249925|Physical Therapy|physical therapy
511944|NCT00249925|Home care|home care
511945|NCT00249938|Antilipemic agents|antilipemic agents
511946|NCT00249938|hyperlipidemia|hyperlipidemia
511947|NCT00249951|nephrocalcinosis|nephrocalcinosis
511948|NCT00249951|premature infants|premature infants
511949|NCT00249951|hypocitraturia|hypocitraturia
511950|NCT00249951|alcaline citrate therapy|alcaline citrate therapy
511951|NCT00249951|Nephrocalcinosis in premature infants|nephrocalcinosis in premature infants
511383|NCT00247988|Ovarian|ovarian
511952|NCT00249964|Extensive or recurrent small cell lung cancer Phase I|extensive or recurrent small cell lung cancer phase i
753945|NCT01178359|cardiac arrest|cardiac arrest
511953|NCT00249964|Paclitaxel, Carboplatin, Temozolomide|paclitaxel, carboplatin, temozolomide
511955|NCT00249977|solid tumors|solid tumors
511956|NCT00249977|DNA repair|dna repair
511957|NCT00249990|Uterus|uterus
511958|NCT00249990|Recurrent disease|recurrent disease
511959|NCT00249990|Treatment|treatment
511960|NCT00249990|9-Nitrocamptothecin|9-nitrocamptothecin
511961|NCT00249990|Endometrium|endometrium
511962|NCT00250003|Elderly|elderly
511963|NCT00250003|Preventive home visits|preventive home visits
511964|NCT00250016|Endometrium|endometrium
511965|NCT00250016|Tissue|tissue
511966|NCT00250016|L9NC|l9nc
511967|NCT00250029|Colorectal Cancer|colorectal cancer
511968|NCT00250029|Pilot Study|pilot study
511969|NCT00250029|Oxaliplatin|oxaliplatin
511971|NCT00250055|Non-Invasive diagnosis of cervical tissue|non-invasive diagnosis of cervical tissue
511972|NCT00250055|Los Alamos/NIH|los alamos/nih
511973|NCT00250068|Phase II|phase ii
511974|NCT00250068|Aerosol Delivery|aerosol delivery
511975|NCT00250068|NSCLC|nsclc
511976|NCT00250068|9-Nitrocamptothecin|9-nitrocamptothecin
511977|NCT00250081|Cerebral Palsy|cerebral palsy
511978|NCT00250081|Tendon Transfer|tendon transfer
511979|NCT00250081|Botulinum Toxin Type A|botulinum toxin type a
511980|NCT00250081|Occupational Therapy|occupational therapy
511981|NCT00250081|Child|child
511982|NCT00250094|Phase I|phase i
511983|NCT00250094|Ovarian Cancer|ovarian cancer
511984|NCT00250094|Ovary|ovary
511985|NCT00250094|Cancer|cancer
511986|NCT00250120|NSCLC|nsclc
511987|NCT00250120|L9NC|l9nc
511988|NCT00250120|Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin|aerosolized liposomal 9-nitro-20 (s)-camptothecin
511989|NCT00250133|selective decontamination of the digestive tract|selective decontamination of the digestive tract
511990|NCT00250146|Celiac Disease|celiac disease
511991|NCT00250146|Gluten|gluten
511992|NCT00250146|Toxicity|toxicity
511993|NCT00250146|Small bowel morphometry|small bowel morphometry
511994|NCT00250159|Congenital Adrenal Hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
511995|NCT00250159|Familial Male Precocious Puberty (FMPP)|familial male precocious puberty (fmpp)
511996|NCT00250159|21-hydroxylast deficiency|21-hydroxylast deficiency
511997|NCT00250159|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
511998|NCT00250159|CAH|cah
511999|NCT00250159|Familial Male Precocious Puberty|familial male precocious puberty
512000|NCT00250159|FMPP|fmpp
512001|NCT00243308|Anti-inflammatory agents|anti-inflammatory agents
512002|NCT00243308|unstable plaque|unstable plaque
512003|NCT00243308|acute coronary syndrome|acute coronary syndrome
512004|NCT00243321|brachytherapy|brachytherapy
512005|NCT00243321|intensity-modulated radiation therapy|intensity-modulated radiation therapy
512006|NCT00243321|prostate specific antigen|prostate specific antigen
512007|NCT00243334|Ambulatory Care Information Systems|ambulatory care information systems
512008|NCT00243334|Clinical Decision Support Systems|clinical decision support systems
512009|NCT00243334|Medication Systems|medication systems
512010|NCT00243334|Medication Errors|medication errors
512011|NCT00243334|Reminder Systems|reminder systems
512012|NCT00243334|Drug Monitoring|drug monitoring
512013|NCT00243334|Preventive Health Services|preventive health services
512014|NCT00243334|Time and Motion Studies|time and motion studies
512015|NCT00243334|Efficiency|efficiency
512016|NCT00243334|Cost-Benefit Analysis|cost-benefit analysis
512017|NCT00243347|RECENTIN|recentin
512018|NCT00243360|Urinary tract infections,|urinary tract infections,
512019|NCT00243360|antibiotic use,|antibiotic use,
512020|NCT00243360|long term care facilities|long term care facilities
512021|NCT00243373|Patient safety|patient safety
512022|NCT00243373|Medication safety|medication safety
512023|NCT00243373|Barcode technology|barcode technology
512024|NCT00243399|Fanconi anemia|fanconi anemia
512025|NCT00243399|FA|fa
512026|NCT00243412|Rituxan|rituxan
512027|NCT00243412|RA|ra
512028|NCT00243425|Major Depressive Disorder;|major depressive disorder;
512029|NCT00243425|African Americans;|african americans;
512030|NCT00243425|Disparities;|disparities;
512031|NCT00243425|Quality Improvement;|quality improvement;
512032|NCT00243425|Patient Centered Care;|patient centered care;
512033|NCT00243425|Primary Care;|primary care;
512034|NCT00243425|Patient-Physician Relationship;|patient-physician relationship;
512035|NCT00243477|Coronary Artery Bypass|coronary artery bypass
512036|NCT00243477|Surgery|surgery
512234|NCT00250666|Sepsis|sepsis
512037|NCT00243490|Photodynamic therapy|photodynamic therapy
512038|NCT00243490|Malignant glioma|malignant glioma
512039|NCT00243490|Photosan|photosan
512040|NCT00243503|Breast Cancer Metastatic|breast cancer metastatic
512041|NCT00243516|Acute Coronary Syndrome|acute coronary syndrome
512042|NCT00243516|Emergency Department|emergency department
512043|NCT00243516|Chest Pain Evaluation Unit|chest pain evaluation unit
512044|NCT00243516|Overtesting|overtesting
512045|NCT00243516|Chest Pain Protocol|chest pain protocol
512046|NCT00243516|Myocardial Infarction|myocardial infarction
511524|NCT00248469|HIV|hiv
512047|NCT00243516|Medical Malpractice|medical malpractice
512048|NCT00243529|Dendritic cells|dendritic cells
512049|NCT00243529|Melanoma|melanoma
512050|NCT00243529|Vaccine|vaccine
511954|NCT00249977|Phase I|phase i
512052|NCT00243529|RNA|rna
512053|NCT00243529|Peptides|peptides
512054|NCT00243542|Acne, G6PD deficiency, Dapsone|acne, g6pd deficiency, dapsone
512055|NCT00243555|peanut hypersensitivity|peanut hypersensitivity
512056|NCT00243555|chemokines|chemokines
512057|NCT00243555|cytokines|cytokines
512058|NCT00243555|RNA,messenger|rna,messenger
512059|NCT00243555|monocytes|monocytes
512060|NCT00243568|HIV Infections|hiv infections
512061|NCT00243568|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
512062|NCT00243568|CCR5/CXCR4 mixed tropism|ccr5/cxcr4 mixed tropism
512063|NCT00243568|R5/X4 mixed tropism|r5/x4 mixed tropism
512064|NCT00243568|CCR5 inhibitor|ccr5 inhibitor
512065|NCT00243568|vicriviroc|vicriviroc
512066|NCT00243568|treatment-experienced|treatment-experienced
512067|NCT00243594|Dendritic cells|dendritic cells
512068|NCT00243594|Immunotherapy|immunotherapy
512069|NCT00243594|Vaccination|vaccination
512070|NCT00243594|Melanoma|melanoma
512071|NCT00243594|Peptides|peptides
512072|NCT00243594|MRI|mri
512073|NCT00243594|Scintigraphy|scintigraphy
512074|NCT00243594|Immune response|immune response
512075|NCT00243607|climacteric symptoms|climacteric symptoms
512076|NCT00243607|breast cancer|breast cancer
512077|NCT00243607|hydrotherapy|hydrotherapy
512078|NCT00243620|Chronic leg ulcers; wound healing; wound care; Vacuum Assisted Closure; topical negative Pressure|chronic leg ulcers; wound healing; wound care; vacuum assisted closure; topical negative pressure
512079|NCT00243633|focal liver lesions|focal liver lesions
512080|NCT00243633|contrast-enhanced ultrasound sonography|contrast-enhanced ultrasound sonography
512081|NCT00243633|cirrhosis|cirrhosis
512082|NCT00243633|suspected liver metastases|suspected liver metastases
512083|NCT00243633|suspected liver cirrhosis|suspected liver cirrhosis
512084|NCT00243646|Radiation therapy|radiation therapy
512085|NCT00243646|Brachytherapy|brachytherapy
512086|NCT00243646|Prostatic neoplasm|prostatic neoplasm
512087|NCT00243659|Hemophilia A|hemophilia a
512088|NCT00243659|bleeding disorder|bleeding disorder
512089|NCT00243685|Chemosensitivity|chemosensitivity
512090|NCT00243685|Chemotherapy|chemotherapy
512091|NCT00243685|Lung cancer|lung cancer
512092|NCT00243685|Ovarian Cancer|ovarian cancer
512093|NCT00243685|Breast Cancer|breast cancer
512094|NCT00243685|Sarcoma|sarcoma
512095|NCT00243685|Apoptosis|apoptosis
512096|NCT00243685|MiCK Assay|mick assay
512097|NCT00243685|New Technology|new technology
512098|NCT00243685|Patients with pathological diagnoses of breast, lung, and ovarian adenocarcinomas and soft tissue sarcoma|patients with pathological diagnoses of breast, lung, and ovarian adenocarcinomas and soft tissue sarcoma
512099|NCT00243698|Contrast-enhanced Ultrasound Sonography|contrast-enhanced ultrasound sonography
512100|NCT00243698|Ultrasound Contrast agents, microbubbles|ultrasound contrast agents, microbubbles
512101|NCT00243698|Breast tumors|breast tumors
512102|NCT00243724|immunohistochemical|immunohistochemical
512103|NCT00243724|erosive esophagitis|erosive esophagitis
512104|NCT00243724|Acid reflux disease|acid reflux disease
512105|NCT00243737|Malaria|malaria
512106|NCT00243737|falciparum|falciparum
512107|NCT00243737|Mefloquine|mefloquine
512108|NCT00243737|Artesunate|artesunate
512109|NCT00243737|Artemisinin|artemisinin
512110|NCT00243750|ankylosing spondylitis|ankylosing spondylitis
512111|NCT00243750|trial|trial
512112|NCT00243750|methotrexate|methotrexate
512113|NCT00243763|Refractory Multiple Myeloma or|refractory multiple myeloma or
512114|NCT00243763|Relapsed Multiple Myeloma|relapsed multiple myeloma
512115|NCT00243789|Duchenne|duchenne
512116|NCT00243789|Genetic|genetic
512117|NCT00243789|Muscular Dystrophy|muscular dystrophy
512118|NCT00243789|DMD|dmd
512119|NCT00243802|Atrial Fibrillation|atrial fibrillation
512120|NCT00243802|Oxidative Stress|oxidative stress
512121|NCT00243802|Atrial Flutter|atrial flutter
512122|NCT00243815|randomized controlled trial|randomized controlled trial
512123|NCT00243815|prophylactic nonsteroidal antiflammatory drug|prophylactic nonsteroidal antiflammatory drug
512124|NCT00243815|IUD removal|iud removal
512125|NCT00243828|Noninvasive Mechanical Ventilation|noninvasive mechanical ventilation
512126|NCT00243828|Acute Respiratory Failure|acute respiratory failure
512127|NCT00243828|Intubation|intubation
512128|NCT00250172|Dosimetry|dosimetry
512129|NCT00250172|Pharmacokinetics|pharmacokinetics
512130|NCT00250172|Compartment Analysis|compartment analysis
512131|NCT00250172|Reproducibility|reproducibility
512436|NCT00251459|AMD|amd
512132|NCT00250172|Healthy Volunteer|healthy volunteer
512133|NCT00250172|HV|hv
512134|NCT00250185|Ischemia Tolerance|ischemia tolerance
512135|NCT00250185|Endothelial Function|endothelial function
512136|NCT00250185|Forearm Blood Flow|forearm blood flow
512137|NCT00250185|Muscle Recovery|muscle recovery
512138|NCT00250185|Inflammation|inflammation
512139|NCT00250185|Healthy Volunteer|healthy volunteer
512140|NCT00250185|HV|hv
512141|NCT00250198|T Cell|t cell
512142|NCT00250198|Lymphocyte|lymphocyte
512143|NCT00250198|Lamina Propria|lamina propria
512144|NCT00250198|Colonoscopy|colonoscopy
512145|NCT00250198|Placebo|placebo
512146|NCT00250198|Crohn's Disease|crohn's disease
512147|NCT00250198|Crohns Disease|crohns disease
512249|NCT00250744|delayed nausea and vomiting|delayed nausea and vomiting
512148|NCT00250211|magnetic resonance imaging, functional|magnetic resonance imaging, functional
512149|NCT00250211|radiation therapy|radiation therapy
512150|NCT00250211|temozolomide|temozolomide
512151|NCT00250211|functional imaging|functional imaging
512152|NCT00250211|concurrent chemoradiation|concurrent chemoradiation
512153|NCT00250224|Radiotherapy|radiotherapy
512154|NCT00250224|image guided|image guided
512156|NCT00250237|Post-operative delirium|post-operative delirium
512157|NCT00250237|hip fracture|hip fracture
512158|NCT00250263|rhinitis|rhinitis
512159|NCT00250263|asthma|asthma
512160|NCT00250263|atopy|atopy
512161|NCT00250263|house dust mite|house dust mite
512162|NCT00250263|immunotherapy|immunotherapy
512163|NCT00250263|SLIT|slit
512164|NCT00250289|malodor|malodor
512165|NCT00250289|halitosis|halitosis
512166|NCT00250289|herbal formulation|herbal formulation
512167|NCT00250289|natural medicinals|natural medicinals
512168|NCT00250289|slow release delivery system|slow release delivery system
512169|NCT00250354|conduct disorder|conduct disorder
512170|NCT00250354|oppositional deficit disorder|oppositional deficit disorder
512171|NCT00250354|disruptive behavior disorder not otherwise specified|disruptive behavior disorder not otherwise specified
512172|NCT00250354|ADHD|adhd
512173|NCT00250354|risperidone|risperidone
512174|NCT00250354|antipsychotropic agents|antipsychotropic agents
512175|NCT00250354|children|children
512176|NCT00250367|risperidone|risperidone
512177|NCT00250367|antipsychotic agents|antipsychotic agents
512178|NCT00250367|bipolar disorders|bipolar disorders
512179|NCT00250367|manic episode|manic episode
512180|NCT00250380|Aspirin|aspirin
512181|NCT00250380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
512182|NCT00250393|Parkinson's disease|parkinson's disease
512183|NCT00250393|monotherapy|monotherapy
512184|NCT00250406|urolithiasis|urolithiasis
512185|NCT00250406|ureteral stent|ureteral stent
512186|NCT00250406|triclosan|triclosan
512187|NCT00250406|drug eluting|drug eluting
512188|NCT00250445|Arcoxia|arcoxia
512189|NCT00250471|GP IIb/IIIa inhibitors|gp iib/iiia inhibitors
512190|NCT00250471|eptifibatide|eptifibatide
512191|NCT00250471|Anti-thrombotic agents|anti-thrombotic agents
512192|NCT00250484|analgesia|analgesia
512193|NCT00250484|electric stimulation therapy|electric stimulation therapy
512194|NCT00250484|electric stimulation|electric stimulation
512195|NCT00250484|pain|pain
512196|NCT00250484|safety|safety
512197|NCT00250497|Adolescent|adolescent
512198|NCT00250497|Girls|girls
512199|NCT00250497|Physical Activity|physical activity
512200|NCT00250497|Exercise|exercise
512201|NCT00250497|Diet|diet
512202|NCT00250497|Body image|body image
512203|NCT00250549|HIV|hiv
512204|NCT00250549|Prevention|prevention
512205|NCT00250549|Rapid HIV testing|rapid hiv testing
512206|NCT00250562|Hypertension|hypertension
512207|NCT00250562|Angiotensin II receptor blocker|angiotensin ii receptor blocker
512208|NCT00250562|fixed combination|fixed combination
512209|NCT00250562|diuretics|diuretics
512210|NCT00250575|Schizophrenia, treatment-resistant, clozapine|schizophrenia, treatment-resistant, clozapine
512211|NCT00250588|Asthma|asthma
512212|NCT00250588|Child|child
512213|NCT00250588|Problem-solving|problem-solving
512214|NCT00250588|Quality of Life|quality of life
512215|NCT00250588|Barriers to Care|barriers to care
512216|NCT00250601|depression|depression
512217|NCT00250601|antidepressive agents|antidepressive agents
512218|NCT00250601|controlled clinical trial|controlled clinical trial
512219|NCT00250614|depression|depression
512220|NCT00250614|antidepressive agents|antidepressive agents
512221|NCT00250614|controlled clinical trial|controlled clinical trial
512222|NCT00250627|depression|depression
512223|NCT00250627|antidepressive agents|antidepressive agents
512224|NCT00250627|controlled clinical trial|controlled clinical trial
512225|NCT00250640|Primary Pulmonary hypertension|primary pulmonary hypertension
512226|NCT00250653|depression|depression
512227|NCT00250653|antidepressive agents|antidepressive agents
512228|NCT00250653|clinical trial|clinical trial
512229|NCT00250666|Biological Markers|biological markers
512230|NCT00250666|Procalcitonin|procalcitonin
512231|NCT00250666|Critical Care|critical care
512232|NCT00250666|Diagnosis, Differential|diagnosis, differential
512233|NCT00250666|Prospective Study|prospective study
512235|NCT00250666|Antibiotic stewardship|antibiotic stewardship
512236|NCT00250666|Antimicrobial resistance|antimicrobial resistance
512237|NCT00250679|COPD|copd
512238|NCT00250679|chronic bronchitis|chronic bronchitis
512239|NCT00250679|emphysema|emphysema
512240|NCT00250705|Aripiprazole|aripiprazole
512241|NCT00250718|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
512242|NCT00250718|Phase II|phase ii
511663|NCT00248651|Nausea|nausea
512243|NCT00250718|Lymphoid malignancies|lymphoid malignancies
512244|NCT00250731|diabetes|diabetes
512245|NCT00250731|relationship|relationship
512246|NCT00250731|social support|social support
512247|NCT00250731|behavior change|behavior change
512248|NCT00250731|telemedicine|telemedicine
512649|NCT00252629|Sleep apnea|sleep apnea
512250|NCT00250744|Emetogenic Chemotherapy|emetogenic chemotherapy
512251|NCT00250744|Pilot Trial|pilot trial
512252|NCT00250757|prostate|prostate
512253|NCT00250757|NMR Spectroscopy|nmr spectroscopy
512254|NCT00250770|Corpus Uteri|corpus uteri
512255|NCT00250770|Endometrium|endometrium
512256|NCT00250770|Cancer|cancer
512257|NCT00250783|Corpus Uteri|corpus uteri
512258|NCT00250783|Endometrium|endometrium
512259|NCT00250783|Cancer|cancer
512260|NCT00250796|Phase II|phase ii
512261|NCT00250796|Hepatocellular carcinoma|hepatocellular carcinoma
512262|NCT00250822|Liver|liver
512263|NCT00250822|hepatocellular|hepatocellular
512264|NCT00250822|Gem-Ox|gem-ox
512265|NCT00250822|Cancer|cancer
512266|NCT00250835|Resectable Rectal Cancer|resectable rectal cancer
512267|NCT00250835|Radiation|radiation
512268|NCT00250835|Neoadjuvant|neoadjuvant
512269|NCT00250835|Rectum|rectum
512270|NCT00250835|GI - Colorectal Neoadjuvant|gi - colorectal neoadjuvant
512271|NCT00250835|Cancer|cancer
512272|NCT00250848|Lung Diseases|lung diseases
512273|NCT00250848|Cancer|cancer
512274|NCT00250887|recurrent Glioblastoma, Gefitinib|recurrent glioblastoma, gefitinib
512275|NCT00250900|Otitis|otitis
512276|NCT00250900|Antibiotic|antibiotic
512277|NCT00250900|Prescription|prescription
512278|NCT00250913|motor activity|motor activity
512279|NCT00250913|determinants|determinants
512280|NCT00250913|psychology|psychology
512281|NCT00250913|health care costs|health care costs
512282|NCT00250913|quality of life|quality of life
512283|NCT00250913|Angioplasty|angioplasty
512284|NCT00250926|bortezomib|bortezomib
512285|NCT00250926|dexamethasone|dexamethasone
512286|NCT00250926|rituximab|rituximab
512287|NCT00250939|Glycogen Storage Disease Type II|glycogen storage disease type ii
512288|NCT00250939|GSD-II|gsd-ii
512289|NCT00250939|Pompe Disease|pompe disease
512290|NCT00250952|Clinical Practice Variations|clinical practice variations
512291|NCT00250978|Advanced Non Small Cell Lung Cancer|advanced non small cell lung cancer
512292|NCT00250991|stroke|stroke
512293|NCT00250991|integrilin|integrilin
512294|NCT00250991|eptifibatide|eptifibatide
512295|NCT00250991|activase|activase
512296|NCT00250991|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
512297|NCT00250991|rt-PA|rt-pa
512298|NCT00250991|recombinant t-PA|recombinant t-pa
512299|NCT00250991|SPOTRIAS|spotrias
512300|NCT00251004|Renal transplantation, kidney, and organ transplant|renal transplantation, kidney, and organ transplant
512301|NCT00251004|Renal transplant rejection|renal transplant rejection
512302|NCT00251017|single nucleotide polymorphisms (SNPs)|single nucleotide polymorphisms (snps)
512303|NCT00251017|personalized medicines|personalized medicines
512304|NCT00251017|Subjects 16 years of age or older, of either sex.|subjects 16 years of age or older, of either sex.
512305|NCT00251017|Subjects have a medication including vancomycin|subjects have a medication including vancomycin
512306|NCT00251043|Pregnancy|pregnancy
512307|NCT00251043|Antepartum Depression|antepartum depression
512308|NCT00251043|Major Depression|major depression
512309|NCT00251069|glucosamine sulphate, osteoarthritis, cholesterol,|glucosamine sulphate, osteoarthritis, cholesterol,
512310|NCT00251082|hormone replacement|hormone replacement
512311|NCT00251082|vasomotoric symptoms|vasomotoric symptoms
512312|NCT00251082|bleeding pattern|bleeding pattern
512313|NCT00251095|Metastatic Breast Cancer|metastatic breast cancer
512314|NCT00251108|'traumatic brain injury'|'traumatic brain injury'
512315|NCT00251108|'head injury'|'head injury'
512316|NCT00251108|'brain injuries'|'brain injuries'
512317|NCT00251108|'exercise therapy'|'exercise therapy'
512318|NCT00251108|'physical fitness'|'physical fitness'
512319|NCT00251121|Electrophysiological study|electrophysiological study
512320|NCT00251121|paroxysmal tachycardia|paroxysmal tachycardia
512321|NCT00251134|myocardial infarction|myocardial infarction
512322|NCT00251134|omega 3-fatty acids|omega 3-fatty acids
512323|NCT00251147|rotator cuff|rotator cuff
512325|NCT00251147|arthroscopic|arthroscopic
512326|NCT00251147|mini-open|mini-open
512327|NCT00251147|acromioplasty|acromioplasty
512328|NCT00251147|quality of life|quality of life
512329|NCT00251147|shoulder|shoulder
512330|NCT00251160|Multi-directional instability|multi-directional instability
512332|NCT00251160|Ligamentous laxity|ligamentous laxity
512333|NCT00251160|Multi-directional laxity|multi-directional laxity
512334|NCT00251160|MDL-AII|mdl-aii
512335|NCT00251160|Shoulder instability|shoulder instability
512336|NCT00251160|electrothermal capsulorrhaphy, ETAC|electrothermal capsulorrhaphy, etac
512337|NCT00251160|inferior capsular shift, ICS|inferior capsular shift, ics
512338|NCT00251160|capsular redundancy|capsular redundancy
512339|NCT00251212|Alcohol|alcohol
512340|NCT00251212|Violence|violence
512341|NCT00251212|Alcohol consumption|alcohol consumption
512342|NCT00251212|Alcohol, drinking|alcohol, drinking
512343|NCT00251225|prostate|prostate
512344|NCT00251238|Raynaud´s phenomenon|raynaud´s phenomenon
512345|NCT00251238|Vasospastic attacks|vasospastic attacks
512346|NCT00251238|Ginkgo biloba|ginkgo biloba
512347|NCT00251251|Congestive heart failure|congestive heart failure
512744|NCT00246818|Stress Reduction|stress reduction
512348|NCT00251251|Multicentre randomized controlled trial|multicentre randomized controlled trial
512350|NCT00251251|Cardiac resynchronization|cardiac resynchronization
512351|NCT00251251|Sudden death/mortality|sudden death/mortality
512352|NCT00251251|Hospitalization|hospitalization
512353|NCT00251251|ICD indication|icd indication
512354|NCT00251251|NYHA Class II|nyha class ii
512355|NCT00251251|LVEF </equal to 30%|lvef </equal to 30%
512356|NCT00251251|QRS >/equal to 120 ms|qrs >/equal to 120 ms
512357|NCT00251264|Shoulder instability|shoulder instability
512358|NCT00251264|Traumatic|traumatic
512359|NCT00251264|Anterior|anterior
512360|NCT00251264|Unidirectional|unidirectional
512361|NCT00251264|Open stabilization|open stabilization
512362|NCT00251264|Arthroscopic|arthroscopic
512363|NCT00251264|Bankart repair|bankart repair
512364|NCT00251264|Shoulder instability, traumatic|shoulder instability, traumatic
512365|NCT00251264|Anterior, unidirectional instability|anterior, unidirectional instability
512366|NCT00251264|Bankart|bankart
512367|NCT00251277|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
512368|NCT00251277|TTP|ttp
512369|NCT00251277|Hematology|hematology
512370|NCT00251290|transient ischemic attack|transient ischemic attack
512371|NCT00251290|sleep apnea|sleep apnea
512372|NCT00251303|Clinical Trial|clinical trial
512373|NCT00251303|Glutamate Antagonist|glutamate antagonist
512374|NCT00251303|Pediatrics|pediatrics
512375|NCT00251303|Basal Ganglia|basal ganglia
512376|NCT00251303|Neuropsychological|neuropsychological
512377|NCT00251303|Obsessive Compulsive Disorder|obsessive compulsive disorder
512378|NCT00251303|OCD|ocd
512379|NCT00251303|Riluzole|riluzole
512380|NCT00251303|Rilutek|rilutek
512381|NCT00251316|Thyroid Neoplasm|thyroid neoplasm
512382|NCT00251316|I-131|i-131
512383|NCT00251316|Radiation Dose|radiation dose
512384|NCT00251316|Radiation Effect|radiation effect
512385|NCT00251316|Pharmaceutical Adjuvant|pharmaceutical adjuvant
512386|NCT00251316|Thyroid Cancer|thyroid cancer
512387|NCT00251329|Neoadjuvant|neoadjuvant
512388|NCT00251329|Breast Cancer|breast cancer
512389|NCT00251329|pCR|pcr
512390|NCT00251329|Capecitabine|capecitabine
512391|NCT00251329|Carboplatin|carboplatin
512392|NCT00251329|Docetaxel|docetaxel
512393|NCT00251342|Postnatal depression|postnatal depression
512394|NCT00251342|Randomized controlled trial|randomized controlled trial
512395|NCT00251342|Screening|screening
512396|NCT00251342|Outcome|outcome
512397|NCT00251342|Edinburgh Postnatal Depression Scale|edinburgh postnatal depression scale
512398|NCT00251355|gemcitabine|gemcitabine
512399|NCT00251355|5-fluorouracil|5-fluorouracil
512400|NCT00251355|5-FU|5-fu
512401|NCT00251355|unresectable pancreatic cancer|unresectable pancreatic cancer
512402|NCT00251355|non-metastatic pancreatic cancer|non-metastatic pancreatic cancer
512403|NCT00251368|leukemia|leukemia
512404|NCT00251368|9-Aminocamptothecin|9-aminocamptothecin
512405|NCT00251368|AML|aml
512406|NCT00251368|ALL|all
512407|NCT00251368|refractory leukemia|refractory leukemia
512408|NCT00251368|relapsed leukemia|relapsed leukemia
512409|NCT00251381|Oropharyngeal Neoplasms|oropharyngeal neoplasms
512410|NCT00251381|Cetuximab|cetuximab
512411|NCT00251381|Concomitant-boost accelerated radiotherapy|concomitant-boost accelerated radiotherapy
512412|NCT00251394|B-Cell follicular non-Hodgkin's lymphoma|b-cell follicular non-hodgkin's lymphoma
512413|NCT00251394|Rituxan|rituxan
512414|NCT00251394|Rituximab|rituximab
512415|NCT00251394|1018 ISS|1018 iss
512416|NCT00251394|CD 20 +|cd 20 +
512417|NCT00251407|Advanced solid tumor malignancy|advanced solid tumor malignancy
512418|NCT00251407|cisplatin|cisplatin
512419|NCT00251407|CPT-11|cpt-11
512420|NCT00251407|taxotere|taxotere
512421|NCT00251420|copd|copd
512422|NCT00251420|asthma|asthma
512423|NCT00251420|QoL|qol
512424|NCT00251420|Perceived health status|perceived health status
512425|NCT00251420|Trait anxiety|trait anxiety
512426|NCT00251433|ErbB1|erbb1
512427|NCT00251433|ErbB2|erbb2
512428|NCT00251433|trastuzumab (Herceptin)|trastuzumab (herceptin)
512429|NCT00251433|lapatinib|lapatinib
512430|NCT00251433|Stage IV breast cancer|stage iv breast cancer
512431|NCT00251433|metastatic breast cancer|metastatic breast cancer
512432|NCT00251433|overexpression of ErbB2 receptors|overexpression of erbb2 receptors
512433|NCT00251433|docetaxel (Taxotere)|docetaxel (taxotere)
512434|NCT00251459|SAILOR|sailor
512435|NCT00251459|CNV|cnv
512437|NCT00251459|CNV secondary to AMD|cnv secondary to amd
512438|NCT00251485|Metastatic 1st line colorectal cancer|metastatic 1st line colorectal cancer
512439|NCT00251498|Metastatic 1st line NSCLC|metastatic 1st line nsclc
660405|NCT00811382|CRT|crt
511793|NCT00249197|skin|skin
512440|NCT00251537|Pilot study|pilot study
512441|NCT00251537|Randomized|randomized
512442|NCT00251537|Placebo-controlled|placebo-controlled
512443|NCT00251537|Double-blind|double-blind
512444|NCT00251537|Effect on viral load|effect on viral load
512445|NCT00251537|LTB4|ltb4
512446|NCT00251537|HIV-1 infection|hiv-1 infection
512447|NCT00251563|Cancer,Risk factors|cancer,risk factors
512448|NCT00251589|Relapsed Non-Small-Cell Lung Cancer|relapsed non-small-cell lung cancer
512449|NCT00251589|Refractory Non-Small-Cell Lung Cancer|refractory non-small-cell lung cancer
512450|NCT00251602|heart rate variability|heart rate variability
512451|NCT00251602|gene response|gene response
512452|NCT00251615|vascular surgery|vascular surgery
512453|NCT00251615|vascular aging|vascular aging
512454|NCT00251615|arterial aging|arterial aging
512455|NCT00251615|surgical tissue|surgical tissue
512456|NCT00251615|Aging|aging
512457|NCT00251628|Tonsils|tonsils
512458|NCT00251628|Tonsillectomy|tonsillectomy
512459|NCT00251654|complications|complications
512460|NCT00251654|adverse events|adverse events
512461|NCT00251654|regional anesthesia|regional anesthesia
512462|NCT00251654|adverse effects|adverse effects
512463|NCT00251680|Hyperlipidemia|hyperlipidemia
512464|NCT00251680|Drug Therapy|drug therapy
512465|NCT00251693|Erosive Esophagitis|erosive esophagitis
512466|NCT00251706|atrial fibrillation|atrial fibrillation
512467|NCT00251706|atrial flutter|atrial flutter
512468|NCT00251706|amiodarone|amiodarone
512469|NCT00251706|post-operative|post-operative
512470|NCT00251706|coronary artery bypass surgery|coronary artery bypass surgery
512471|NCT00251706|valve replacement or repair|valve replacement or repair
512472|NCT00251719|Erosive Esophagitis|erosive esophagitis
512473|NCT00251732|acid reflux studies|acid reflux studies
512474|NCT00251732|efficacy of PPI therapy|efficacy of ppi therapy
512475|NCT00251732|failing PPI therapy|failing ppi therapy
512476|NCT00251732|GERD|gerd
512477|NCT00251732|Acid Reflux Disease|acid reflux disease
512478|NCT00251745|Non-Erosive Gastroesophageal Reflux Disease (GERD)|non-erosive gastroesophageal reflux disease (gerd)
512479|NCT00251745|Heartburn|heartburn
512480|NCT00251758|Non-Erosive Gastroesophageal Reflux Disease(GERD),heartburn|non-erosive gastroesophageal reflux disease(gerd),heartburn
512481|NCT00251771|Thrombolytic therapy|thrombolytic therapy
512482|NCT00251771|Postphlebitic syndrome|postphlebitic syndrome
512483|NCT00251771|Venous thrombosis|venous thrombosis
512484|NCT00251797|Phase I|phase i
512485|NCT00251797|Brain cancer|brain cancer
512486|NCT00251797|Recurrent CNS tumors|recurrent cns tumors
512487|NCT00251810|general anaesthesia|general anaesthesia
512488|NCT00251810|depth of hypnosis|depth of hypnosis
512489|NCT00251810|Cerebral State Monitor|cerebral state monitor
512491|NCT00251810|Bispectral Index|bispectral index
512492|NCT00251810|BIS|bis
512493|NCT00251823|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
512494|NCT00251836|Kidney donation|kidney donation
512495|NCT00251836|Organ Donation|organ donation
512496|NCT00251836|Vascular anatomy|vascular anatomy
512497|NCT00251836|Adrenal Insufficiency|adrenal insufficiency
512498|NCT00251849|Intermittent Claudication|intermittent claudication
512499|NCT00251862|Colorectal cancer screening|colorectal cancer screening
512500|NCT00251862|Shared decision-making|shared decision-making
512501|NCT00251862|Decision aid|decision aid
512502|NCT00251875|patient portals|patient portals
512503|NCT00251875|electronic health records|electronic health records
512504|NCT00251875|family history|family history
512505|NCT00251875|health maintenance|health maintenance
512506|NCT00251875|medications|medications
512507|NCT00251875|diabetes|diabetes
512508|NCT00251888|cervix cancer|cervix cancer
512509|NCT00251888|advanced cervix cancer|advanced cervix cancer
512510|NCT00251888|radiochemotherapy|radiochemotherapy
512511|NCT00251888|pelvic radiotherapy|pelvic radiotherapy
512512|NCT00251888|campto|campto
512513|NCT00251888|cisplatin|cisplatin
512514|NCT00251888|irinotecan|irinotecan
512515|NCT00251888|cisplatyl|cisplatyl
512516|NCT00251888|maximum dose search|maximum dose search
512517|NCT00251901|Gastroesophageal reflux disease|gastroesophageal reflux disease
512518|NCT00251901|GERD|gerd
512519|NCT00251927|Acid reflux disease|acid reflux disease
512520|NCT00251927|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
512521|NCT00251966|Prevention of gastroduodenal lesions|prevention of gastroduodenal lesions
512522|NCT00251966|erosive oesophagitis|erosive oesophagitis
512523|NCT00251966|upper GI symptoms|upper gi symptoms
512524|NCT00252018|Nutritional supplement|nutritional supplement
512525|NCT00252018|Prevention|prevention
512526|NCT00252018|Endothelial function|endothelial function
512527|NCT00252018|Flow mediated dilation|flow mediated dilation
512528|NCT00252031|Borderline Personality Disorder|borderline personality disorder
512529|NCT00252031|BPD|bpd
583946|NCT00514007|Colorectal cancer|colorectal cancer
512530|NCT00252031|Dialectical Behavior Therapy|dialectical behavior therapy
512531|NCT00252031|DBT|dbt
512532|NCT00252057|rehospitalization|rehospitalization
511860|NCT00249405|Alcohol|alcohol
512533|NCT00252057|readmission|readmission
512534|NCT00252057|adverse events|adverse events
512535|NCT00252057|discharge|discharge
512536|NCT00252070|arthritis|arthritis
512537|NCT00252070|exercise|exercise
512538|NCT00252070|function|function
512539|NCT00252070|pain|pain
512540|NCT00252083|Seropositive|seropositive
512541|NCT00252083|MSM|msm
512542|NCT00252083|Hispanic|hispanic
512543|NCT00252083|Popular Opinion Leader|popular opinion leader
512544|NCT00252083|HIV|hiv
512545|NCT00252096|Diagnosis|diagnosis
512546|NCT00252096|Chlamydia trachomatis|chlamydia trachomatis
512547|NCT00252096|Neisseria gonorrhoeae|neisseria gonorrhoeae
512548|NCT00252096|Nucleic acid amplification test|nucleic acid amplification test
512549|NCT00252096|Rectum|rectum
512550|NCT00252096|Pharynx|pharynx
512551|NCT00252109|HIV|hiv
512552|NCT00252109|Seropositive|seropositive
512553|NCT00252109|MSM|msm
512554|NCT00252109|African American|african american
512555|NCT00252109|Popular Opinion Leader|popular opinion leader
512556|NCT00252135|Moderate to severe asthma|moderate to severe asthma
512557|NCT00252148|HIV Preventive Vaccine|hiv preventive vaccine
512558|NCT00252161|Neoadjuvant Therapy|neoadjuvant therapy
512559|NCT00252161|Stomach Neoplasms|stomach neoplasms
512560|NCT00252161|Cisplatin|cisplatin
512561|NCT00252161|S-1(combination)|s-1(combination)
512562|NCT00252174|MDMA|mdma
512563|NCT00252174|cancer|cancer
512564|NCT00252174|anxiety|anxiety
512565|NCT00252174|psychotherapy|psychotherapy
512566|NCT00252174|quality of life|quality of life
512567|NCT00252187|Heart failure|heart failure
512568|NCT00252187|Natriuretic peptides|natriuretic peptides
512569|NCT00252187|B-type natriuretic peptide|b-type natriuretic peptide
512570|NCT00252187|Kidney|kidney
512571|NCT00252187|Nesiritide|nesiritide
512572|NCT00252187|Natrecor|natrecor
512573|NCT00252187|CHF|chf
512574|NCT00252226|Quetiapine|quetiapine
512575|NCT00252226|bipolar spectrum disorders|bipolar spectrum disorders
512576|NCT00252239|stroke|stroke
512577|NCT00252239|tenecteplase|tenecteplase
512578|NCT00252239|TNK|tnk
512579|NCT00252239|ischemic|ischemic
512580|NCT00252239|tissue plasminogen activator|tissue plasminogen activator
512581|NCT00252239|tPA|tpa
512582|NCT00252291|bronchial|bronchial
512583|NCT00252291|hyperresponsiveness|hyperresponsiveness
512584|NCT00252304|Child, severe pneumonia, Zinc, Nepal, therapeutic|child, severe pneumonia, zinc, nepal, therapeutic
512585|NCT00252317|Aortic stenosis|aortic stenosis
512586|NCT00252317|ACE-inhibitores|ace-inhibitores
512587|NCT00252330|major depressive disorder|major depressive disorder
512588|NCT00252330|depression|depression
512589|NCT00252330|major depressive episode|major depressive episode
512590|NCT00252330|antidepressive agents|antidepressive agents
512591|NCT00252343|anxiety disorder|anxiety disorder
512592|NCT00252356|major depressive disorder|major depressive disorder
512593|NCT00252356|depression|depression
512594|NCT00252356|major depressive episode|major depressive episode
512595|NCT00252356|antidepressive agents|antidepressive agents
512596|NCT00252382|Lung|lung
512597|NCT00252382|Squamous Cell|squamous cell
512598|NCT00252382|Large Cell|large cell
512599|NCT00252382|Adenocarcinoma|adenocarcinoma
512600|NCT00252382|Carcinoma|carcinoma
512601|NCT00252382|Cancer|cancer
512602|NCT00252395|medication error|medication error
512603|NCT00252395|electronic prescribing|electronic prescribing
512604|NCT00252395|patient safety|patient safety
512605|NCT00252408|Fracture|fracture
512606|NCT00252408|Osteoporosis|osteoporosis
512607|NCT00252408|Bone mineral density|bone mineral density
512608|NCT00252408|Hormone replacement therapy|hormone replacement therapy
512609|NCT00252408|Estrogen|estrogen
512610|NCT00252408|Breast cancer|breast cancer
512611|NCT00252421|osteoporosis|osteoporosis
512612|NCT00252421|bone mineral density|bone mineral density
512613|NCT00252421|nitrates|nitrates
512614|NCT00252434|high-risk sexual behavior|high-risk sexual behavior
512615|NCT00252434|methamphetamine use|methamphetamine use
512616|NCT00252434|drug craving|drug craving
512617|NCT00252434|addiction behaviors|addiction behaviors
512618|NCT00252486|Bipolar|bipolar
512619|NCT00252486|Omega-3 Fatty acids|omega-3 fatty acids
512620|NCT00252499|beta cell function|beta cell function
512621|NCT00252499|fenofibrate|fenofibrate
512622|NCT00252499|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
512623|NCT00252499|rosiglitazone|rosiglitazone
512624|NCT00252499|insulin sensitivity|insulin sensitivity
512625|NCT00252512|Contingency management interventions|contingency management interventions
512626|NCT00252512|Substance use disorders treatment|substance use disorders treatment
512627|NCT00252512|Treatment effectiveness|treatment effectiveness
512628|NCT00252512|Randomized clinical trial|randomized clinical trial
512629|NCT00252512|Behavioral research|behavioral research
512630|NCT00252538|Cortisol|cortisol
512631|NCT00252538|Depression|depression
512633|NCT00252538|Interferon|interferon
512634|NCT00252538|Polymorphism|polymorphism
512635|NCT00252538|Serotonin|serotonin
512637|NCT00252551|spondylolisthesis, decompressive surgery, osteosynthesis|spondylolisthesis, decompressive surgery, osteosynthesis
512638|NCT00252577|Lithium|lithium
512639|NCT00252577|Pharmacogenetics|pharmacogenetics
512640|NCT00252590|Psychotherapy motivational intervention|psychotherapy motivational intervention
512641|NCT00252603|Autism|autism
512642|NCT00252603|Childhood Autism|childhood autism
512643|NCT00252616|Mechanical ventilation|mechanical ventilation
512644|NCT00252616|acute respiratory failure|acute respiratory failure
512645|NCT00252616|early nutrition|early nutrition
512646|NCT00252629|Fatigue|fatigue
512647|NCT00252629|Functional Somatic Syndrome|functional somatic syndrome
512648|NCT00252629|Gulf War Syndrome|gulf war syndrome
512650|NCT00252629|Upper Airway Resistance Syndrome|upper airway resistance syndrome
512651|NCT00252642|Hepatitis C|hepatitis c
512652|NCT00252642|Interferon|interferon
512653|NCT00252642|Cirrhosis|cirrhosis
512654|NCT00252642|Liver Disease|liver disease
512655|NCT00252642|Portal Hypertension|portal hypertension
512656|NCT00252642|Portal Pressure|portal pressure
512657|NCT00252668|Rheumatoid Arthritis|rheumatoid arthritis
512658|NCT00252681|randomized|randomized
512659|NCT00252681|controlled|controlled
512660|NCT00252681|trial|trial
512661|NCT00252681|necrotizing|necrotizing
512662|NCT00252681|enterocolitis|enterocolitis
512663|NCT00252681|premature|premature
512664|NCT00252681|infants|infants
512665|NCT00252681|laparotomy|laparotomy
512666|NCT00252681|peritoneal|peritoneal
512667|NCT00252681|drainage|drainage
512668|NCT00252694|Diabetes mellitus type 2|diabetes mellitus type 2
512669|NCT00252720|Diabetes mellitus type 1|diabetes mellitus type 1
512670|NCT00252733|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
512671|NCT00252746|NSCLC|nsclc
512672|NCT00252746|Non Small Cell Lung Cancer|non small cell lung cancer
512673|NCT00252785|Asthma|asthma
512674|NCT00252798|Non Small Cell Lung Cancer|non small cell lung cancer
512675|NCT00252850|Parkinson's Disease|parkinson's disease
512676|NCT00252850|Gene Transfer|gene transfer
512677|NCT00252889|Metastatic cancer|metastatic cancer
512678|NCT00252889|Metastatic gastric and esophagus adenocarcinoma|metastatic gastric and esophagus adenocarcinoma
512679|NCT00252889|Unresectable pancreatic cancer|unresectable pancreatic cancer
512680|NCT00252889|Unresectable head and neck cancer|unresectable head and neck cancer
512681|NCT00252889|Cancer of undetermined primary|cancer of undetermined primary
512682|NCT00252902|tobacco; emergency department; motivation; counseling|tobacco; emergency department; motivation; counseling
512683|NCT00252928|sodium dichloroisocyanurate|sodium dichloroisocyanurate
512684|NCT00252928|water purification|water purification
512685|NCT00252928|disinfection|disinfection
512686|NCT00252928|Ghana|ghana
512687|NCT00252941|prostate cancer|prostate cancer
512688|NCT00252941|brachytherapy|brachytherapy
512689|NCT00252941|urethral stenting|urethral stenting
512690|NCT00252954|Spinal cord injury|spinal cord injury
512691|NCT00252954|Neuropathic pain|neuropathic pain
512692|NCT00252954|Spasms|spasms
512693|NCT00252967|Reactive Oxgen Speers|reactive oxgen speers
512694|NCT00252967|Atrial Fibrillation|atrial fibrillation
512695|NCT00252967|Oxidative Stress|oxidative stress
512696|NCT00252967|Inflammation|inflammation
512697|NCT00252980|Cannabis|cannabis
512698|NCT00252980|Dependence|dependence
512699|NCT00252980|Marijuana|marijuana
512824|NCT00247052|NSAID|nsaid
512700|NCT00252980|Substance Abuse Treatment|substance abuse treatment
512701|NCT00252980|Psychotherapy,|psychotherapy,
512702|NCT00252993|Nausea|nausea
512703|NCT00252993|Vomiting|vomiting
512704|NCT00252993|Chronic Functional Vomiting|chronic functional vomiting
512705|NCT00252993|Functional Vomiting|functional vomiting
512706|NCT00252993|Cyclic Vomiting|cyclic vomiting
512707|NCT00253006|NO|no
512708|NCT00253006|mRNA-expression|mrna-expression
512709|NCT00253006|pathophysiology|pathophysiology
512710|NCT00253006|painful bladder syndrome|painful bladder syndrome
512711|NCT00253019|birth control|birth control
512712|NCT00253019|continuation|continuation
512713|NCT00253019|abortion|abortion
512714|NCT00253019|contraception|contraception
512715|NCT00246701|omega-3-acid ethyl esters|omega-3-acid ethyl esters
512716|NCT00246701|simvastatin|simvastatin
512717|NCT00246701|Lovaza|lovaza
512718|NCT00246701|High triglycerides|high triglycerides
512719|NCT00246714|endotoxin tolerance|endotoxin tolerance
512720|NCT00246714|humans|humans
512721|NCT00246714|cross-tolerance|cross-tolerance
512722|NCT00246714|pro and anti-inflammatory cytokines|pro and anti-inflammatory cytokines
512723|NCT00246740|Doxycycline|doxycycline
512724|NCT00246740|coronary artery bypass grafting|coronary artery bypass grafting
512725|NCT00246753|adenocarcinoma of the prostate|adenocarcinoma of the prostate
512726|NCT00246753|recurrent prostate cancer|recurrent prostate cancer
512727|NCT00246753|stage I prostate cancer|stage i prostate cancer
512728|NCT00246753|stage II prostate cancer|stage ii prostate cancer
512729|NCT00246753|stage III prostate cancer|stage iii prostate cancer
512730|NCT00246753|stage IV prostate cancer|stage iv prostate cancer
512731|NCT00246766|Maternal's movements recorded by a specific sensor|maternal's movements recorded by a specific sensor
512835|NCT00247104|Endometritis|endometritis
512732|NCT00246766|Parameters of fetal distress (umbilical and cerebral Doppler) and new-born parameters.|parameters of fetal distress (umbilical and cerebral doppler) and new-born parameters.
512733|NCT00246779|transfusion|transfusion
512734|NCT00246779|cardiac surgery|cardiac surgery
512735|NCT00246779|modified ultrafiltration|modified ultrafiltration
512736|NCT00246779|Cardiopulmonary bypass|cardiopulmonary bypass
512737|NCT00246792|School-based intervention|school-based intervention
512738|NCT00246792|Learning disabilities|learning disabilities
512739|NCT00246792|ecological intervention|ecological intervention
512740|NCT00246805|Permanent atrial fibrillation|permanent atrial fibrillation
512741|NCT00246805|VVI(R) pacing|vvi(r) pacing
512742|NCT00246805|rate regularization|rate regularization
512743|NCT00246818|Mind-Body|mind-body
512745|NCT00246818|Complementary Medicine|complementary medicine
512746|NCT00246818|Quality of Life|quality of life
512747|NCT00246818|Well-being|well-being
512748|NCT00246818|Psychoneuroimmunology|psychoneuroimmunology
512749|NCT00246818|Tai Chi|tai chi
512750|NCT00246818|Aerobic Exercise|aerobic exercise
512751|NCT00246818|Cancer Survivor|cancer survivor
512752|NCT00246831|fMRI|fmri
512753|NCT00246831|Self-Agency|self-agency
512754|NCT00246831|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
512755|NCT00246831|Voluntary Movement|voluntary movement
512756|NCT00246831|Healthy Volunteer|healthy volunteer
512757|NCT00246831|HV|hv
512758|NCT00246844|Transplant|transplant
512759|NCT00246844|Diabetes|diabetes
512760|NCT00246844|C-Peptide|c-peptide
512761|NCT00246844|B Cell|b cell
512762|NCT00246844|Immunosuppression|immunosuppression
512763|NCT00246844|Type 1 Diabetes|type 1 diabetes
512764|NCT00246844|Pancreas Transplant|pancreas transplant
512765|NCT00246857|Apoptosis|apoptosis
512766|NCT00246857|T-cell|t-cell
512767|NCT00246857|Autoimmunity|autoimmunity
512768|NCT00246857|Immunodeficiency|immunodeficiency
512769|NCT00246857|B-Cell|b-cell
512770|NCT00246857|Inherited Lymphhocyte Homeostasis|inherited lymphhocyte homeostasis
512771|NCT00246857|Genetic Disease|genetic disease
512772|NCT00246870|Seizures|seizures
512773|NCT00246870|Development|development
512774|NCT00246870|Pediatric|pediatric
512775|NCT00246870|Benzodiazepine Receptors|benzodiazepine receptors
512776|NCT00246870|Neurotransmission|neurotransmission
512777|NCT00246870|Succinic Semialdehyde Dehydrogenase|succinic semialdehyde dehydrogenase
512778|NCT00246870|Deficiency|deficiency
512779|NCT00246870|SSADH Deficiency|ssadh deficiency
512780|NCT00246870|Healthy Volunteer|healthy volunteer
512781|NCT00246870|HV|hv
512782|NCT00246883|Endothelial Progenitor Cells|endothelial progenitor cells
512783|NCT00246883|Nitric Oxide|nitric oxide
512784|NCT00246883|Brachial Artery Reactivity|brachial artery reactivity
512785|NCT00246883|Physical Fitness|physical fitness
512786|NCT00246883|C-reactive Protein|c-reactive protein
512787|NCT00246883|Exercise|exercise
512788|NCT00246883|Vascular Function|vascular function
512789|NCT00246909|Gastroesophageal Reflux|gastroesophageal reflux
512790|NCT00246909|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
512791|NCT00246909|Pantoprazole|pantoprazole
512792|NCT00246922|Asthma|asthma
512793|NCT00246922|Roflumilast|roflumilast
512794|NCT00246922|phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
512795|NCT00246935|COPD|copd
512796|NCT00246935|Phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
512797|NCT00246935|Roflumilast|roflumilast
512798|NCT00246948|Physical therapy|physical therapy
512799|NCT00246961|Adjuvant|adjuvant
512800|NCT00246974|bladder cancer|bladder cancer
512801|NCT00246974|Transitionel cell cancer of the urothelium|transitionel cell cancer of the urothelium
512802|NCT00247000|Cardiovascular Diseases|cardiovascular diseases
512803|NCT00247000|Heart Disease|heart disease
512804|NCT00247000|Heart Failure,Congestive|heart failure,congestive
512805|NCT00247000|Health Outcomes|health outcomes
512806|NCT00247000|Disease Management|disease management
512807|NCT00247000|Telehomecare|telehomecare
512808|NCT00247000|Home Telehealth|home telehealth
512809|NCT00247013|automated telephone system|automated telephone system
512810|NCT00247013|breast cancer|breast cancer
512811|NCT00247013|cancer prevention|cancer prevention
512812|NCT00247013|intervention|intervention
512813|NCT00247013|mammography|mammography
512814|NCT00247013|screening|screening
512815|NCT00247026|myelodysplasia|myelodysplasia
512816|NCT00247026|curcumin|curcumin
512817|NCT00247026|coenzyme Q10|coenzyme q10
512818|NCT00247026|cytopenia|cytopenia
512819|NCT00247039|neutropenia|neutropenia
512820|NCT00247039|fever|fever
512821|NCT00247039|garlic|garlic
512822|NCT00247039|infection|infection
512823|NCT00247052|post operative pericardial effusion|post operative pericardial effusion
512825|NCT00247078|black|black
512826|NCT00247078|widow|widow
512827|NCT00247078|spider|spider
512828|NCT00247078|antivenom|antivenom
512829|NCT00247091|HIV|hiv
512830|NCT00247091|measles|measles
512831|NCT00247091|measles vaccine|measles vaccine
512832|NCT00247091|children|children
512833|NCT00247091|Zambia|zambia
512834|NCT00247104|Urinary tract infection|urinary tract infection
512836|NCT00247104|Respiratory Distress Syndrome|respiratory distress syndrome
512837|NCT00247104|Necrotizing enterocolitis|necrotizing enterocolitis
512838|NCT00247104|Intraventricular hemorrhage|intraventricular hemorrhage
512839|NCT00247104|Latent period|latent period
512840|NCT00247104|Neonatal infection|neonatal infection
512841|NCT00247117|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
512842|NCT00247117|insulin resistance|insulin resistance
512843|NCT00247117|metformin|metformin
512844|NCT00247130|Omeprazole|omeprazole
512845|NCT00247130|Ranitidine|ranitidine
512847|NCT00247130|Hemostasis|hemostasis
512848|NCT00247130|Peptic ulcer|peptic ulcer
512849|NCT00247143|Protease Inhibitor|protease inhibitor
512850|NCT00247143|Antiretroviral Agents|antiretroviral agents
512851|NCT00247143|Treatment Experienced|treatment experienced
512853|NCT00247156|eye contact|eye contact
512854|NCT00247156|Noncommunicable|noncommunicable
512855|NCT00247169|cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
512856|NCT00247169|progesterone|progesterone
512857|NCT00247182|Stepped Care|stepped care
512858|NCT00247182|Brief Motivational Intervention|brief motivational intervention
512859|NCT00247182|Minimal Intervention|minimal intervention
512860|NCT00247182|Treatment response|treatment response
512861|NCT00247182|College Students|college students
512862|NCT00247195|Major Depression|major depression
512863|NCT00247195|MDD|mdd
512864|NCT00247195|Hispanic|hispanic
512865|NCT00247195|Primary Care|primary care
512866|NCT00247195|Cultural Congruence|cultural congruence
512867|NCT00247208|Coronary artery bypass|coronary artery bypass
512868|NCT00247208|Stents|stents
512869|NCT00247208|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
512870|NCT00247208|Coronary Restenosis|coronary restenosis
512871|NCT00247208|Paclitaxel|paclitaxel
512872|NCT00247221|Alcohol|alcohol
512873|NCT00247221|Substance abuse|substance abuse
512874|NCT00247221|Adolescent|adolescent
512875|NCT00247221|Family functioning|family functioning
512876|NCT00247260|HCC|hcc
512877|NCT00247260|Primary Liver Cancer|primary liver cancer
512878|NCT00247273|randomized controlled trial, osteoporosis, risedronate|randomized controlled trial, osteoporosis, risedronate
512879|NCT00247286|urodynamic stress incontinence|urodynamic stress incontinence
512880|NCT00247286|weighted vaginal cones|weighted vaginal cones
512881|NCT00247286|pelvic floor biofeedback|pelvic floor biofeedback
512882|NCT00247286|randomized controlled trial|randomized controlled trial
512883|NCT00247299|Vascular lesions|vascular lesions
512884|NCT00247299|Intense pulse light|intense pulse light
512885|NCT00247299|phototermolysis|phototermolysis
512886|NCT00247299|wavelength|wavelength
512887|NCT00247299|filters|filters
512888|NCT00247299|non coherent|non coherent
512889|NCT00247312|Prostate cancer|prostate cancer
512890|NCT00247312|brachytherapy|brachytherapy
512891|NCT00247312|palladium 103|palladium 103
512892|NCT00247312|I-125|i-125
512893|NCT00247325|Kidney failure|kidney failure
512894|NCT00247325|Contrast media|contrast media
512895|NCT00247325|Iodixanol|iodixanol
512896|NCT00247325|Ioxaglate|ioxaglate
512897|NCT00247338|parenteral nutrition|parenteral nutrition
512898|NCT00247338|low calorie|low calorie
512899|NCT00247338|low nitrogen|low nitrogen
512900|NCT00247338|gastrointestinal neoplasms|gastrointestinal neoplasms
512901|NCT00247338|gastrointestinal diseases|gastrointestinal diseases
512902|NCT00247338|gastrectomy|gastrectomy
512903|NCT00247338|colectomy|colectomy
512904|NCT00247338|rectectomy|rectectomy
512905|NCT00247338|operations|operations
512906|NCT00247364|RLS|rls
512907|NCT00247377|Morbid Obesity|morbid obesity
512908|NCT00247377|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
512909|NCT00247377|Laparoscopic Gastric Banding|laparoscopic gastric banding
512910|NCT00247390|Chronic Insomnia|chronic insomnia
512911|NCT00247390|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
512912|NCT00247390|Drug Therapy|drug therapy
512913|NCT00247403|Intracranial cancer|intracranial cancer
512914|NCT00247403|Cancer|cancer
512915|NCT00247403|2DG|2dg
512916|NCT00247403|2-deoxyglucose|2-deoxyglucose
512917|NCT00247403|Intracranial metastatic cancer|intracranial metastatic cancer
512918|NCT00247416|Untreated|untreated
512919|NCT00247416|Lung|lung
512920|NCT00247416|Cancer|cancer
512921|NCT00247416|non-small cell|non-small cell
512922|NCT00247416|gemcitabine|gemcitabine
512923|NCT00247416|gemzar|gemzar
512924|NCT00247416|carboplatin|carboplatin
512925|NCT00247416|dexamethasone|dexamethasone
512926|NCT00247429|depression|depression
512927|NCT00247429|anxiety|anxiety
512928|NCT00247429|elderly|elderly
512929|NCT00247442|Mammography screening|mammography screening
512930|NCT00247442|Breast cancer screening|breast cancer screening
512931|NCT00247442|Screening outcomes|screening outcomes
512932|NCT00247442|Decision aid|decision aid
512933|NCT00247442|Decision support tool|decision support tool
512934|NCT00247442|Informed choice|informed choice
512935|NCT00247455|Human nutrition|human nutrition
512936|NCT00247455|Dietary fibre|dietary fibre
512937|NCT00247455|Insulin resistance|insulin resistance
512938|NCT00247455|Obesity|obesity
512939|NCT00247455|Glucose|glucose
512940|NCT00247455|Colonic fermentation|colonic fermentation
512941|NCT00247455|Short chain fatty acids|short chain fatty acids
512942|NCT00247455|GLP-1|glp-1
512943|NCT00247455|Appetite|appetite
512944|NCT00247455|Abdominal fat|abdominal fat
512945|NCT00247481|Metastatic Breast Cancer|metastatic breast cancer
512946|NCT00247494|HIV-1|hiv-1
512947|NCT00247494|atherosclerosis|atherosclerosis
512948|NCT00247494|immunomodulation|immunomodulation
512949|NCT00247507|Anemia|anemia
512950|NCT00247507|atherosclerosis|atherosclerosis
512951|NCT00247507|End-stage renal disease|end-stage renal disease
512952|NCT00247507|Erythropoietin|erythropoietin
512953|NCT00247507|Hemodialysis|hemodialysis
512954|NCT00247507|Oxidative stress|oxidative stress
512955|NCT00247507|Pro-inflammation|pro-inflammation
512956|NCT00247520|Seasonal allergic rhinitis (SAR), rhinoconjunctivitis, allergy|seasonal allergic rhinitis (sar), rhinoconjunctivitis, allergy
512957|NCT00247533|coronary disease|coronary disease
512958|NCT00247533|cerebrovascular disorders|cerebrovascular disorders
512959|NCT00247533|angiography|angiography
512960|NCT00247533|cerebral ischemia|cerebral ischemia
512961|NCT00247533|intracranial atherosclerosis|intracranial atherosclerosis
512962|NCT00247533|Coronary artery disease|coronary artery disease
512963|NCT00247533|cerebral artery stenosis|cerebral artery stenosis
512964|NCT00247533|percutaneous coronary balloon angioplasty|percutaneous coronary balloon angioplasty
512965|NCT00247533|coronary artery bypass surgery|coronary artery bypass surgery
512966|NCT00247533|ischemic stroke|ischemic stroke
512967|NCT00247533|electrocardiograph|electrocardiograph
512968|NCT00247533|electroencephalograph|electroencephalograph
512969|NCT00247533|Nuclear brain scan|nuclear brain scan
512970|NCT00247533|cognition decline|cognition decline
512971|NCT00247533|atrial fibrillation|atrial fibrillation
512972|NCT00247533|undetermined ischemic stroke|undetermined ischemic stroke
512973|NCT00247546|Falls|falls
512974|NCT00247546|Accidental falls|accidental falls
512975|NCT00247546|Prevention|prevention
512976|NCT00247546|Aged|aged
512977|NCT00247546|Multifactorial trial|multifactorial trial
512978|NCT00247559|crow's feet|crow's feet
512979|NCT00247559|cosmesis|cosmesis
512980|NCT00247559|ageing|ageing
512981|NCT00253045|Motivational Interviewing|motivational interviewing
512982|NCT00253045|antiretroviral therapy|antiretroviral therapy
512983|NCT00253045|medication adherence|medication adherence
512984|NCT00253045|risk reduction behaviors|risk reduction behaviors
512985|NCT00253045|women|women
512987|NCT00253045|AIDS|aids
512988|NCT00253058|Allergic|allergic
512989|NCT00253058|pediatric|pediatric
512990|NCT00253058|Rhinitis|rhinitis
512991|NCT00253058|Perennial|perennial
512992|NCT00253071|Prophylactic treatment|prophylactic treatment
512993|NCT00253071|Pharmacological treatment|pharmacological treatment
512994|NCT00253071|Psychological treatment|psychological treatment
512995|NCT00253097|stroke recurrence|stroke recurrence
512996|NCT00253097|risk factors|risk factors
512997|NCT00253097|health behavior|health behavior
512998|NCT00253097|intervention|intervention
512999|NCT00253097|tertiary prevention|tertiary prevention
513000|NCT00253110|Schizophrenia, Psychotic Disorders|schizophrenia, psychotic disorders
513001|NCT00253110|Haloperidol|haloperidol
513002|NCT00253110|Risperidone|risperidone
513003|NCT00253110|Schizoaffective disorder|schizoaffective disorder
513004|NCT00253123|Dementia|dementia
513005|NCT00253123|Alzheimer's disease|alzheimer's disease
513006|NCT00253123|vascular dementia|vascular dementia
513007|NCT00253123|mixed dementia|mixed dementia
513008|NCT00253123|risperidone|risperidone
513009|NCT00253123|nursing home|nursing home
513010|NCT00253136|schizophrenia|schizophrenia
513011|NCT00253136|schizoaffective disorder|schizoaffective disorder
513012|NCT00253136|psychotic disorder|psychotic disorder
513013|NCT00253136|risperidone|risperidone
513014|NCT00253136|long-acting injectable|long-acting injectable
513015|NCT00253136|intramuscular injection|intramuscular injection
513016|NCT00253136|antipsychotic agents|antipsychotic agents
513017|NCT00253149|risperidone|risperidone
513018|NCT00253149|antipsychotic agents|antipsychotic agents
513019|NCT00253149|bipolar disorders|bipolar disorders
513020|NCT00253149|manic episode|manic episode
513021|NCT00253162|risperidone|risperidone
513022|NCT00253162|antipsychotic agents|antipsychotic agents
513023|NCT00253162|bipolar disorders|bipolar disorders
513024|NCT00253162|manic episode|manic episode
513025|NCT00253175|topiramate|topiramate
513027|NCT00253175|migraine prevention|migraine prevention
513028|NCT00253175|migraine|migraine
513029|NCT00253188|Alzheimer's disease|alzheimer's disease
513030|NCT00253188|dementia|dementia
513031|NCT00253188|brain disease|brain disease
513032|NCT00253188|memory loss|memory loss
513033|NCT00253188|galantamine|galantamine
513034|NCT00253188|placebo|placebo
513035|NCT00253188|caregiver|caregiver
513036|NCT00253188|quality of life|quality of life
513037|NCT00253188|resource utilization|resource utilization
513038|NCT00253201|Alzheimer's disease|alzheimer's disease
513039|NCT00253201|dementia|dementia
513040|NCT00253201|brain disease|brain disease
513041|NCT00253201|memory loss|memory loss
513042|NCT00253201|galantamine|galantamine
513043|NCT00253201|placebo|placebo
513044|NCT00253201|caregiver|caregiver
513045|NCT00253201|quality of life|quality of life
513046|NCT00253201|resource utilization|resource utilization
513047|NCT00253214|Alzheimer's disease|alzheimer's disease
513048|NCT00253214|dementia|dementia
513049|NCT00253214|galantamine hydrobromide|galantamine hydrobromide
513051|NCT00253214|once-daily dosing|once-daily dosing
513052|NCT00253227|Alzheimer's disease|alzheimer's disease
513053|NCT00253227|dementia|dementia
513054|NCT00253227|brain disease|brain disease
513055|NCT00253227|memory loss|memory loss
513056|NCT00253227|galantamine|galantamine
513057|NCT00253227|placebo|placebo
513058|NCT00253253|orchidopexy, long-term outcome, congenital|orchidopexy, long-term outcome, congenital
513059|NCT00253266|Treatment resistant depression|treatment resistant depression
513060|NCT00253266|Augmentation|augmentation
513061|NCT00253266|Pharmacogenetics|pharmacogenetics
513062|NCT00253279|Protein Synthesis Rate|protein synthesis rate
513063|NCT00253279|Burn Injury|burn injury
513064|NCT00253279|PET Scan|pet scan
513065|NCT00253292|Burns|burns
513066|NCT00253292|Trauma|trauma
513067|NCT00253292|Outcomes|outcomes
513068|NCT00253292|Quality of Life|quality of life
513069|NCT00253305|tinea unguium|tinea unguium
513070|NCT00253305|onychomycosis|onychomycosis
513071|NCT00253318|Neoplasm Metastasis|neoplasm metastasis
513072|NCT00253318|Breast Cancer|breast cancer
513073|NCT00253318|Docetaxel|docetaxel
513074|NCT00253318|RAD001|rad001
513075|NCT00253318|Taxotere|taxotere
513076|NCT00253331|Raynaud's|raynaud's
513077|NCT00253331|sclerderma|sclerderma
513078|NCT00253331|systemic sclerosis|systemic sclerosis
513079|NCT00253331|autoimmune disease|autoimmune disease
513080|NCT00253344|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
513081|NCT00253357|Heart Failure|heart failure
513082|NCT00253357|Congestive Heart Failure|congestive heart failure
513083|NCT00253357|Fluid overload|fluid overload
513084|NCT00253357|Left sided heart failure|left sided heart failure
513085|NCT00253357|Pacemaker|pacemaker
513086|NCT00253357|Defibrillator|defibrillator
513087|NCT00253760|redox|redox
513088|NCT00253760|sulfur amino acids|sulfur amino acids
513089|NCT00253760|glutathione|glutathione
513090|NCT00253760|aging|aging
513091|NCT00253773|sulfer amino acids|sulfer amino acids
513092|NCT00253773|redox status|redox status
513093|NCT00253786|diabetes|diabetes
513094|NCT00253786|nephropathy|nephropathy
513095|NCT00253812|colonoscopy, sigmoidoscopy, chromoendoscopy, autofluorescence, narrow band imaging, colorectal cancer, polyp, adenoma,rectal remnant, FAP|colonoscopy, sigmoidoscopy, chromoendoscopy, autofluorescence, narrow band imaging, colorectal cancer, polyp, adenoma,rectal remnant, fap
513096|NCT00253838|revision hip arthroplasty|revision hip arthroplasty
513097|NCT00253838|bone mineral density|bone mineral density
513099|NCT00253851|Osteoarthritis|osteoarthritis
513100|NCT00253851|Total Knee Arthroplasty|total knee arthroplasty
513101|NCT00253864|shoulder surgery|shoulder surgery
513102|NCT00253864|prospective database|prospective database
513103|NCT00253864|long term outcome|long term outcome
513104|NCT00253877|osteoarthritis|osteoarthritis
513105|NCT00253877|hip resurfacing|hip resurfacing
513106|NCT00253890|sleep quality|sleep quality
513107|NCT00253890|methadone|methadone
513108|NCT00253890|substance use|substance use
513109|NCT00253903|Primary Insomnia|primary insomnia
513110|NCT00253903|Sleeplessness|sleeplessness
513111|NCT00253903|Early Awakening|early awakening
513112|NCT00253903|Chronic Insomnia|chronic insomnia
513113|NCT00253929|adenosine|adenosine
513114|NCT00253929|polymorphisms|polymorphisms
513115|NCT00253929|blood flow|blood flow
513116|NCT00253929|adenosine A2a receptor|adenosine a2a receptor
513117|NCT00253929|AMP deaminase|amp deaminase
513118|NCT00253968|Primary Insomnia|primary insomnia
513119|NCT00253968|Sleeplessness|sleeplessness
513120|NCT00253968|Early Awakening|early awakening
513121|NCT00253968|Chronic Insomnia|chronic insomnia
513122|NCT00253981|Pain, Intractable|pain, intractable
513123|NCT00253981|Infrared Rays|infrared rays
513124|NCT00253981|Leg|leg
513125|NCT00254007|depression|depression
513126|NCT00254007|traumatic brain injury|traumatic brain injury
513127|NCT00254007|serotonin transporter|serotonin transporter
513128|NCT00254007|genetic polymorphisms|genetic polymorphisms
513129|NCT00254007|citalopram|citalopram
513130|NCT00254020|stroke|stroke
513131|NCT00254020|depression|depression
513132|NCT00254020|cytokines|cytokines
513133|NCT00254020|serotonin|serotonin
513134|NCT00254020|citalopram|citalopram
513135|NCT00254033|Alzheimer's Disease|alzheimer's disease
513136|NCT00254033|Apathy|apathy
513137|NCT00254033|Brain Reward System|brain reward system
513138|NCT00254033|Dopamine|dopamine
513139|NCT00254033|Dextroamphetamine Challenge|dextroamphetamine challenge
513140|NCT00254033|Methylphenidate|methylphenidate
513141|NCT00254046|HIV|hiv
513142|NCT00254046|HIV-1|hiv-1
513143|NCT00254046|TMC125|tmc125
513247|NCT00254410|Cyclophosphamide|cyclophosphamide
513144|NCT00254059|OSAHS, OSA, CPAP, polysomnography, overnight oximetry, Obstructive sleep apnea, apnea hypopnea index, AHI, Obstructive Sleep Apnea Hypopnea Syndrome|osahs, osa, cpap, polysomnography, overnight oximetry, obstructive sleep apnea, apnea hypopnea index, ahi, obstructive sleep apnea hypopnea syndrome
513145|NCT00254072|Morbid Obesity|morbid obesity
513146|NCT00254072|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
513147|NCT00254072|Staple Line Hemorrhage|staple line hemorrhage
513148|NCT00254085|Type 2 diabtes|type 2 diabtes
513149|NCT00254085|Postprandial hyperglycemia|postprandial hyperglycemia
513150|NCT00254085|Insulin treatment|insulin treatment
513151|NCT00254111|osteoarthritis|osteoarthritis
513152|NCT00254111|hand|hand
513153|NCT00254111|laser|laser
513154|NCT00254111|device|device
513155|NCT00254111|hand pain|hand pain
513156|NCT00254111|stiffness|stiffness
513157|NCT00254124|obesity|obesity
513158|NCT00254124|type 2 diabetes mellitus|type 2 diabetes mellitus
513159|NCT00254124|portion control|portion control
513160|NCT00254137|capecitabine|capecitabine
513161|NCT00254137|irinotecan|irinotecan
513162|NCT00254137|cetuximab|cetuximab
513163|NCT00254137|oxaliplatin|oxaliplatin
513164|NCT00254137|colorectal cancer|colorectal cancer
513165|NCT00254176|Neonate|neonate
513166|NCT00254176|Glutathione|glutathione
513167|NCT00254176|Cysteine|cysteine
513168|NCT00254176|Sepsis|sepsis
513169|NCT00254176|Stable Isotope|stable isotope
513170|NCT00254189|Ovulation|ovulation
513171|NCT00254189|Oral Contraceptive|oral contraceptive
513172|NCT00254202|Schizophrenia|schizophrenia
513173|NCT00254202|Atypical antipsychotic|atypical antipsychotic
513174|NCT00254202|psychosis|psychosis
513175|NCT00254215|overweight|overweight
513176|NCT00254215|obesity|obesity
513177|NCT00254215|glycemic index|glycemic index
513178|NCT00254215|glycemic load|glycemic load
513179|NCT00254215|high protein diet|high protein diet
513180|NCT00254215|blood cholesterol|blood cholesterol
513181|NCT00254228|Balance|balance
513182|NCT00254228|Vestibular|vestibular
513183|NCT00254228|Electrotactile|electrotactile
513184|NCT00254228|BrainPort|brainport
513185|NCT00254228|Sensory substitution|sensory substitution
513186|NCT00254228|Tongue|tongue
513187|NCT00254241|Schizophrenia|schizophrenia
513188|NCT00254254|diabetes|diabetes
513189|NCT00254254|adolescents|adolescents
513190|NCT00254254|exenatide|exenatide
513191|NCT00254254|Amylin|amylin
513192|NCT00254254|Lilly|lilly
513193|NCT00254267|Gastrointestinal Stromal Tumor, Imatinib Mesylate Resistance, Phase2 study, AMG 706|gastrointestinal stromal tumor, imatinib mesylate resistance, phase2 study, amg 706
513194|NCT00254280|Warts|warts
513195|NCT00254280|Intense pulsed light|intense pulsed light
513196|NCT00254280|RCT|rct
513197|NCT00254280|Recalcitrant hand and foot warts|recalcitrant hand and foot warts
513198|NCT00254306|Ecstasy|ecstasy
513199|NCT00254306|D2 Dopamine Receptor|d2 dopamine receptor
513200|NCT00254306|IBZM|ibzm
513201|NCT00254306|MDMA|mdma
513202|NCT00254332|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
513203|NCT00254332|Sezary Syndrome|sezary syndrome
513204|NCT00254332|Mycosis Fungoides|mycosis fungoides
513205|NCT00254332|Denileukin Diftitox|denileukin diftitox
513206|NCT00254345|biofilm|biofilm
513207|NCT00254345|adhesion|adhesion
513208|NCT00254345|liquid polish|liquid polish
513209|NCT00254345|bonding resin|bonding resin
513210|NCT00254345|PMMA Polymethylmetacrylate|pmma polymethylmetacrylate
513211|NCT00254345|provisional crown|provisional crown
513212|NCT00254345|no antibiotics treatment three months prior to experiment|no antibiotics treatment three months prior to experiment
513213|NCT00254345|no mouth rinse with oral solutions one month prior to experiment|no mouth rinse with oral solutions one month prior to experiment
513214|NCT00254358|Nicotine|nicotine
513215|NCT00254358|Dopamine|dopamine
513216|NCT00254358|IBZM|ibzm
513217|NCT00254384|Non-Small Cell Lung Cancer|non-small cell lung cancer
513218|NCT00254384|Lung Cancer|lung cancer
513219|NCT00254384|Cisplatin|cisplatin
513220|NCT00254384|Platinol|platinol
513221|NCT00254384|Platinol-AQ|platinol-aq
513222|NCT00254384|CDDP|cddp
513223|NCT00254384|Docetaxel|docetaxel
513224|NCT00254384|Taxotere|taxotere
513225|NCT00254384|Erlotinib|erlotinib
513226|NCT00254384|Tarceva|tarceva
513228|NCT00254384|NSCLC|nsclc
513229|NCT00254397|Melanoma|melanoma
513230|NCT00254397|Uveal Melanoma|uveal melanoma
513231|NCT00254397|Peptide Vaccine|peptide vaccine
513232|NCT00254397|LHRH-agonist|lhrh-agonist
513233|NCT00254397|Leuprolide|leuprolide
513234|NCT00254397|Lupron|lupron
513235|NCT00254397|MAGE-3 Peptide|mage-3 peptide
513236|NCT00254397|MAGE-3|mage-3
513237|NCT00254397|GP100 Peptide|gp100 peptide
513238|NCT00254397|Melanoma vaccines|melanoma vaccines
513239|NCT00254397|Tumor fighting immune cells|tumor fighting immune cells
513240|NCT00254397|T cells|t cells
513241|NCT00254397|Skin Cancer|skin cancer
513242|NCT00254397|Eye Cancer|eye cancer
513243|NCT00254410|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
513244|NCT00254410|Untreated|untreated
513245|NCT00254410|Fludarabine|fludarabine
513246|NCT00254410|Fludara|fludara
513248|NCT00254410|Cytoxan|cytoxan
513249|NCT00254410|Mitoxantrone|mitoxantrone
513250|NCT00254410|Novantrone|novantrone
513251|NCT00254410|Rituximab|rituximab
513252|NCT00254410|Rituxan|rituxan
513253|NCT00254410|Pegylated Filgrastim|pegylated filgrastim
513254|NCT00254410|Neupogen|neupogen
513255|NCT00254423|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
513257|NCT00254423|Dasatinib|dasatinib
513258|NCT00254423|BMS-354825|bms-354825
513259|NCT00254436|Epoetin Alfa|epoetin alfa
513260|NCT00254436|Epogen|epogen
513261|NCT00254436|Erythropoietin|erythropoietin
513262|NCT00254462|ADHD|adhd
513263|NCT00254462|Atomoxetine|atomoxetine
513264|NCT00254475|Valsartan|valsartan
513265|NCT00254475|simvastatin|simvastatin
513266|NCT00254475|hypertension|hypertension
513267|NCT00254475|hypercholesterolemia|hypercholesterolemia
513268|NCT00254475|angiotensin II receptor blocker|angiotensin ii receptor blocker
513269|NCT00254501|diabetes|diabetes
513270|NCT00254527|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
513271|NCT00254527|Children|children
513272|NCT00254527|Colonization|colonization
513273|NCT00254527|Risk Factor|risk factor
513274|NCT00254540|Ph2, RCC, SU011248, SUNITINIB|ph2, rcc, su011248, sunitinib
513275|NCT00254566|Azithromycin SR; Moxifloxacin; Acute exacerbation of chronic bronchitis (AECB)|azithromycin sr; moxifloxacin; acute exacerbation of chronic bronchitis (aecb)
513276|NCT00254579|refractory melanoma|refractory melanoma
513277|NCT00254579|malignant melanoma|malignant melanoma
513278|NCT00254592|Inflammatory|inflammatory
513279|NCT00254592|Breast Cancer|breast cancer
513280|NCT00254592|Female|female
513281|NCT00254592|Neo-adjuvant|neo-adjuvant
513282|NCT00254592|HER-2 positive|her-2 positive
513283|NCT00254592|Hormone receptor|hormone receptor
513284|NCT00254605|imaging|imaging
513285|NCT00254605|adaptive optics scanning laser ophthalmoscope|adaptive optics scanning laser ophthalmoscope
513286|NCT00254605|optical coherence tomography|optical coherence tomography
513287|NCT00254605|electroretinography|electroretinography
513288|NCT00254618|ulcerative colitis; pharmacokinetics; pediatrics|ulcerative colitis; pharmacokinetics; pediatrics
513289|NCT00254631|long bone fracture|long bone fracture
513290|NCT00254631|open fractures|open fractures
513291|NCT00254631|closed fractures|closed fractures
513292|NCT00254631|trauma|trauma
513293|NCT00254644|phonological treatment|phonological treatment
513294|NCT00254644|language|language
513295|NCT00254644|fMRI|fmri
513296|NCT00254657|Fibromyalgia|fibromyalgia
513297|NCT00254657|Fibro|fibro
513298|NCT00254657|Keppra|keppra
513299|NCT00254657|Levetiracetam|levetiracetam
513300|NCT00254670|Alcohol|alcohol
513301|NCT00254670|Naltrexone|naltrexone
513302|NCT00254683|Rectal Cancer|rectal cancer
513303|NCT00254683|Positron Emission Tomography|positron emission tomography
513304|NCT00254683|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
513305|NCT00254683|Computed Tomography|computed tomography
513306|NCT00254683|Neoadjuvant Therapy|neoadjuvant therapy
513307|NCT00254683|Chemotherapy|chemotherapy
513308|NCT00254683|Radiotherapy|radiotherapy
513309|NCT00254696|bacterial infection|bacterial infection
513310|NCT00254709|kidney transplant|kidney transplant
513311|NCT00254709|elderly|elderly
513312|NCT00254722|Traumatic Brain Injury|traumatic brain injury
513313|NCT00254722|Stem Cell|stem cell
513314|NCT00254735|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
513315|NCT00254748|Borderline personality disorder|borderline personality disorder
513316|NCT00254761|cannabis|cannabis
513317|NCT00254761|marijuana|marijuana
513318|NCT00254761|neuropathy|neuropathy
513319|NCT00254761|antinociception|antinociception
513320|NCT00254761|mood|mood
513321|NCT00254761|cognition|cognition
513322|NCT00254774|Bipolar Disorder I or II with Rapid Cycling|bipolar disorder i or ii with rapid cycling
513323|NCT00254787|Schizophrenia|schizophrenia
513324|NCT00254800|diabetes|diabetes
513325|NCT00254800|exenatide|exenatide
513326|NCT00254800|Amylin|amylin
513327|NCT00254800|Lilly|lilly
513328|NCT00254813|Schizophrenia|schizophrenia
513329|NCT00254813|Schizoaffective disorder|schizoaffective disorder
513330|NCT00254826|Yellow Fever Virus Vaccination|yellow fever virus vaccination
513331|NCT00254839|Oral malodor|oral malodor
513332|NCT00254839|Dental implants|dental implants
513333|NCT00254852|Primary lumbar fusion|primary lumbar fusion
513334|NCT00254852|Demineralized Bone Matrix|demineralized bone matrix
513335|NCT00254852|DBM|dbm
513336|NCT00254852|Optecure|optecure
513337|NCT00254852|Allograft|allograft
513338|NCT00254852|Autograft|autograft
513339|NCT00254852|Lumbar fusion|lumbar fusion
512632|NCT00252538|Hepatitis C|hepatitis c
513340|NCT00254852|Interbody fusion|interbody fusion
513341|NCT00254852|Instrumented fusion|instrumented fusion
513342|NCT00254852|Non-instrumented fusion|non-instrumented fusion
513343|NCT00254852|Exactech|exactech
513344|NCT00254852|Spinal fusion|spinal fusion
513345|NCT00254865|Transdermal contraception|transdermal contraception
513346|NCT00254865|contraceptive|contraceptive
513347|NCT00254865|hormonal, steroid contraception|hormonal, steroid contraception
513348|NCT00254865|ethinyl estradiol|ethinyl estradiol
513349|NCT00254865|progesterone|progesterone
513350|NCT00254865|EVRA|evra
513351|NCT00254865|CILEST|cilest
513352|NCT00254878|ADHD, Methylphenidate hydrochloride, modified-release|adhd, methylphenidate hydrochloride, modified-release
513449|NCT00255398|Minimal Change Disease|minimal change disease
513450|NCT00255398|Diabetic Nephropathy|diabetic nephropathy
513451|NCT00255398|Mass Spectrometry|mass spectrometry
513353|NCT00254891|advanced carcinoma, non-small cell lung, Phase III, Paclitaxel, Taxol, Carboplatin, Paraplatin, PF-3512676, immunotherapy, immune modulator|advanced carcinoma, non-small cell lung, phase iii, paclitaxel, taxol, carboplatin, paraplatin, pf-3512676, immunotherapy, immune modulator
513354|NCT00254904|advanced carcinoma, non-small cell lung, Phase III, Gemcitabine, Gemzar, Cisplatin, Platinol, PF-3512676, immunotherapy, immune modulator|advanced carcinoma, non-small cell lung, phase iii, gemcitabine, gemzar, cisplatin, platinol, pf-3512676, immunotherapy, immune modulator
513355|NCT00254917|Pentaxim|pentaxim
513356|NCT00254930|learning disorder|learning disorder
513357|NCT00254930|children|children
513358|NCT00254930|behaviour disorder|behaviour disorder
513359|NCT00254930|risperidone|risperidone
513360|NCT00254956|Diseases|diseases
513361|NCT00254956|respiratory tract diseases|respiratory tract diseases
513362|NCT00254956|respiratory hypersensitivity|respiratory hypersensitivity
513363|NCT00254956|asthma|asthma
513364|NCT00254969|Diphteria|diphteria
513365|NCT00254969|tetanus|tetanus
513366|NCT00254969|haemophilus influenzae type b|haemophilus influenzae type b
513367|NCT00254969|poliomyelitis|poliomyelitis
513368|NCT00254969|pertussis|pertussis
513369|NCT00254995|Meningitis|meningitis
513370|NCT00254995|Meningococcal disease|meningococcal disease
513371|NCT00254995|Menactra vaccine|menactra vaccine
513372|NCT00255008|chronic hepatitis C|chronic hepatitis c
513373|NCT00255008|pegylated interferon alfa-2b|pegylated interferon alfa-2b
513374|NCT00255008|ribavirin|ribavirin
513375|NCT00255008|Asia|asia
513376|NCT00255021|Diphteria|diphteria
513377|NCT00255021|Tetanus|tetanus
513378|NCT00255021|Pertussis|pertussis
513379|NCT00255021|Poliomyelitis|poliomyelitis
513380|NCT00255021|Haemophilus influenzae type b|haemophilus influenzae type b
513381|NCT00255021|acellular|acellular
513382|NCT00255034|chronic hepatitis C|chronic hepatitis c
513383|NCT00255034|pegylated interferon alfa-2b|pegylated interferon alfa-2b
513384|NCT00255034|ribavirin|ribavirin
513385|NCT00255034|Australia|australia
513386|NCT00255047|Pertussis|pertussis
513387|NCT00255047|Whooping cough|whooping cough
513388|NCT00255047|Filamentous Haemagglutinin|filamentous haemagglutinin
513389|NCT00255047|Fimbriae Types 2 and 3;|fimbriae types 2 and 3;
513390|NCT00255047|Pertactin|pertactin
513391|NCT00255047|Diphtheria|diphtheria
513392|NCT00255047|Tetanus|tetanus
513393|NCT00255047|Poliovirus Types 1, 2, and 3.|poliovirus types 1, 2, and 3.
513395|NCT00255099|HIV-1|hiv-1
513396|NCT00255099|TMC125|tmc125
513397|NCT00255112|SAD|sad
513398|NCT00255112|treatment|treatment
513399|NCT00255112|cognitive behavior therapy|cognitive behavior therapy
513400|NCT00255112|family|family
513401|NCT00255112|children|children
513402|NCT00255112|anxiety|anxiety
513403|NCT00255125|Estrogen Receptor|estrogen receptor
513404|NCT00255125|Isoflavones|isoflavones
513405|NCT00255125|Prostate Neoplasm|prostate neoplasm
513406|NCT00255125|Soy Supplementation|soy supplementation
513407|NCT00255138|Cancer|cancer
513408|NCT00255138|Cognitive Late Effects|cognitive late effects
513409|NCT00255138|Stimulants|stimulants
513410|NCT00255138|Atomoxetine|atomoxetine
513411|NCT00255138|Attention|attention
513412|NCT00255138|Children|children
513413|NCT00255151|Erosive Esophagitis|erosive esophagitis
513414|NCT00255164|Erosive Esophagitis|erosive esophagitis
513415|NCT00255177|Hepatitis C|hepatitis c
513416|NCT00255190|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
513417|NCT00255229|irinotecan|irinotecan
513418|NCT00255229|5FU|5fu
513419|NCT00255229|amino acids|amino acids
513420|NCT00255229|heat shock protein|heat shock protein
513421|NCT00255242|Cystic Fibrosis|cystic fibrosis
513422|NCT00255242|Airway Inflammation|airway inflammation
513423|NCT00255242|Cytokines|cytokines
513424|NCT00255242|Simvastatin|simvastatin
513425|NCT00255242|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
513426|NCT00255242|Rho GTP-ase|rho gtp-ase
513427|NCT00255255|Asthma|asthma
513428|NCT00255307|cold|cold
513429|NCT00255307|flu|flu
513430|NCT00255307|respiratory tract infection|respiratory tract infection
752462|NCT01173094|Critical limb ischemia|critical limb ischemia
513431|NCT00255320|healthy volunteers, headache, migraine, hemodynamics, VIP, SPECT, ultrasound|healthy volunteers, headache, migraine, hemodynamics, vip, spect, ultrasound
513432|NCT00255346|targeted therapy|targeted therapy
513433|NCT00255346|leukemia|leukemia
513434|NCT00255346|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
513435|NCT00255346|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
513436|NCT00255346|Agnogenic myeloid metaplasia - myelofibrosis (MMM)|agnogenic myeloid metaplasia - myelofibrosis (mmm)
513437|NCT00255346|Hypereosinophilic syndrome (HES)|hypereosinophilic syndrome (hes)
513438|NCT00255346|Polycythemia vera (PV)|polycythemia vera (pv)
513439|NCT00255346|Mastocytosis|mastocytosis
513440|NCT00255346|CMML|cmml
513441|NCT00255385|Zinc|zinc
513442|NCT00255385|Iron|iron
513443|NCT00255385|Probiotics|probiotics
513444|NCT00255385|Prebiotics|prebiotics
513445|NCT00255385|Child health|child health
513446|NCT00255385|Milk fortification|milk fortification
513447|NCT00255385|Randomized controlled trial|randomized controlled trial
513448|NCT00255398|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
513394|NCT00255099|HIV|hiv
513452|NCT00255398|Proteinuria|proteinuria
513453|NCT00255398|Idiopathic Nephrotic Syndrome|idiopathic nephrotic syndrome
513454|NCT00255398|Glomerular Disease|glomerular disease
513455|NCT00255398|FSG|fsg
513456|NCT00255398|Kidney Disease|kidney disease
513457|NCT00255411|Conversion Disorder|conversion disorder
513458|NCT00255411|Somatoform Disorder|somatoform disorder
513459|NCT00255411|Involuntary Movement|involuntary movement
513460|NCT00255411|Childhood Abuse|childhood abuse
513461|NCT00255411|Depression|depression
513462|NCT00255411|Psychogenic Movement Disorder|psychogenic movement disorder
513464|NCT00255411|Non-Epileptic Seizure|non-epileptic seizure
513465|NCT00255411|NES|nes
513466|NCT00255411|Healthy Volunteer|healthy volunteer
513467|NCT00255411|HV|hv
513468|NCT00255450|anemia|anemia
513469|NCT00255502|Pediatric hypertension|pediatric hypertension
513470|NCT00255528|Pediatric hypertension|pediatric hypertension
513471|NCT00255554|Borderline Personality Disorder|borderline personality disorder
513472|NCT00255554|BPD|bpd
513473|NCT00255554|Dialectical Behavior Therapy|dialectical behavior therapy
513474|NCT00255554|DBT|dbt
513475|NCT00255554|Escitalopram|escitalopram
513476|NCT00255554|Lexapro|lexapro
513477|NCT00255567|Visceral Leishmaniasis|visceral leishmaniasis
513478|NCT00255567|Combination|combination
513479|NCT00255580|neuropathy|neuropathy
513480|NCT00255580|cannabis|cannabis
513481|NCT00255580|marijuana|marijuana
513482|NCT00255580|HIV|hiv
513483|NCT00255580|DSPN|dspn
513484|NCT00255593|Kidney|kidney
513485|NCT00255593|Transplantation|transplantation
513486|NCT00255593|Immunosuppression|immunosuppression
513487|NCT00255593|Rituximab|rituximab
513488|NCT00255606|adenocarcinoma of the prostate|adenocarcinoma of the prostate
513489|NCT00255606|stage IV prostate cancer|stage iv prostate cancer
513490|NCT00255606|recurrent prostate cancer|recurrent prostate cancer
513491|NCT00255619|Continuous ambulatory peritoneal dialysis (CAPD)|continuous ambulatory peritoneal dialysis (capd)
513492|NCT00255619|Peritonitis|peritonitis
513493|NCT00255619|ANDY-disc® (Fresenius Medical care)|andy-disc® (fresenius medical care)
513494|NCT00255619|Ultra® (Baxter)|ultra® (baxter)
513495|NCT00255619|Twin bag System|twin bag system
513496|NCT00255671|radiation toxicity|radiation toxicity
513497|NCT00255671|tumors metastatic to brain|tumors metastatic to brain
513498|NCT00255671|adult anaplastic astrocytoma|adult anaplastic astrocytoma
513499|NCT00255671|adult anaplastic ependymoma|adult anaplastic ependymoma
513500|NCT00255671|adult anaplastic meningioma|adult anaplastic meningioma
513501|NCT00255671|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
513502|NCT00255671|adult brain stem glioma|adult brain stem glioma
513503|NCT00255671|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
513504|NCT00255671|adult choroid plexus tumor|adult choroid plexus tumor
513505|NCT00255671|adult craniopharyngioma|adult craniopharyngioma
513506|NCT00255671|adult diffuse astrocytoma|adult diffuse astrocytoma
513507|NCT00255671|adult ependymoblastoma|adult ependymoblastoma
513508|NCT00255671|adult ependymoma|adult ependymoma
513509|NCT00255671|adult giant cell glioblastoma|adult giant cell glioblastoma
513510|NCT00255671|adult gliosarcoma|adult gliosarcoma
513511|NCT00255671|adult medulloblastoma|adult medulloblastoma
513512|NCT00255671|adult melanocytic lesion|adult melanocytic lesion
513513|NCT00255671|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
513514|NCT00255671|adult meningioma|adult meningioma
513515|NCT00255671|adult myxopapillary ependymoma|adult myxopapillary ependymoma
513516|NCT00255671|adult oligodendroglioma|adult oligodendroglioma
513517|NCT00255671|adult papillary meningioma|adult papillary meningioma
513518|NCT00255671|adult pineoblastoma|adult pineoblastoma
513519|NCT00255671|adult pineocytoma|adult pineocytoma
513520|NCT00255671|adult subependymoma|adult subependymoma
513521|NCT00255671|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
513522|NCT00255671|adult grade I meningioma|adult grade i meningioma
513523|NCT00255671|adult grade II meningioma|adult grade ii meningioma
513524|NCT00255671|adult grade III meningioma|adult grade iii meningioma
513525|NCT00255671|adult mixed glioma|adult mixed glioma
513526|NCT00255671|recurrent adult brain tumor|recurrent adult brain tumor
513527|NCT00255671|adult pilocytic astrocytoma|adult pilocytic astrocytoma
513528|NCT00255671|adult glioblastoma|adult glioblastoma
513529|NCT00255671|ACTH-producing pituitary tumor|acth-producing pituitary tumor
513530|NCT00255671|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
513531|NCT00255671|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
513532|NCT00255671|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
513533|NCT00255671|recurrent pituitary tumor|recurrent pituitary tumor
513534|NCT00255671|TSH producing pituitary tumor|tsh producing pituitary tumor
515186|NCT00264277|Duration|duration
513535|NCT00255684|graft versus host disease|graft versus host disease
513536|NCT00255684|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
513537|NCT00255684|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
513538|NCT00255684|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
513539|NCT00255684|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
515392|NCT00265174|GLIOMA|glioma
513540|NCT00255684|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
513541|NCT00255684|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
513542|NCT00255684|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
513543|NCT00255684|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
513544|NCT00255684|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
513545|NCT00255684|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
513546|NCT00255684|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
513547|NCT00255684|acute undifferentiated leukemia|acute undifferentiated leukemia
513548|NCT00255684|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
513549|NCT00255684|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
513550|NCT00255684|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
513551|NCT00255684|refractory anemia with excess blasts|refractory anemia with excess blasts
513552|NCT00255684|refractory anemia|refractory anemia
513553|NCT00255684|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
513554|NCT00255684|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
513555|NCT00255684|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
513556|NCT00255684|primary myelofibrosis|primary myelofibrosis
513557|NCT00255684|refractory hairy cell leukemia|refractory hairy cell leukemia
513558|NCT00255684|stage I multiple myeloma|stage i multiple myeloma
513559|NCT00255684|stage II multiple myeloma|stage ii multiple myeloma
513560|NCT00255684|stage III multiple myeloma|stage iii multiple myeloma
513561|NCT00255684|refractory multiple myeloma|refractory multiple myeloma
513562|NCT00255684|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
513563|NCT00255684|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
513564|NCT00255684|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
513565|NCT00255684|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
513566|NCT00255684|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
513567|NCT00255684|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
513568|NCT00255684|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
513569|NCT00255684|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
513570|NCT00255684|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
513571|NCT00255684|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
513572|NCT00255684|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
513573|NCT00255684|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
513574|NCT00255684|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
513575|NCT00255684|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
513576|NCT00255684|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
513577|NCT00255684|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
513578|NCT00255684|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
513579|NCT00255684|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
513580|NCT00255684|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
513581|NCT00255684|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
513582|NCT00255684|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
513583|NCT00255684|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
513584|NCT00255684|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
513585|NCT00255684|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
513586|NCT00255684|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
513587|NCT00255684|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
661865|NCT00823407|MDA|mda
512986|NCT00253045|HIV|hiv
513588|NCT00255684|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
513589|NCT00255684|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
513590|NCT00255684|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
513591|NCT00255684|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
513592|NCT00255684|splenic marginal zone lymphoma|splenic marginal zone lymphoma
513593|NCT00255684|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
513594|NCT00255684|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
513595|NCT00255684|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
513596|NCT00255684|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
513597|NCT00255684|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
513598|NCT00255684|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
513599|NCT00255684|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
513600|NCT00255684|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
513601|NCT00255684|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
513602|NCT00255684|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
513603|NCT00255684|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
513604|NCT00255684|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
513605|NCT00255684|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
513606|NCT00255684|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
513607|NCT00255684|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
513608|NCT00255684|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
513609|NCT00255684|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
513610|NCT00255684|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
513611|NCT00255684|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
513612|NCT00255684|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
513613|NCT00255684|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
513614|NCT00255684|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
513615|NCT00255684|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
513616|NCT00255684|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
513617|NCT00255684|secondary acute myeloid leukemia|secondary acute myeloid leukemia
513618|NCT00255684|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
513619|NCT00255684|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
513620|NCT00255684|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
513621|NCT00255684|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
513622|NCT00255684|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
513623|NCT00255684|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
513624|NCT00255684|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
513625|NCT00255684|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
513626|NCT00255684|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
513627|NCT00255684|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
513628|NCT00255684|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
513629|NCT00255684|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
513630|NCT00255684|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
513631|NCT00255684|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
513632|NCT00255697|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
513633|NCT00255697|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
513634|NCT00255710|graft versus host disease|graft versus host disease
513635|NCT00255710|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
513636|NCT00255710|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
513637|NCT00255710|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
513638|NCT00255710|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
513639|NCT00255710|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
513640|NCT00255710|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
513641|NCT00255710|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
513642|NCT00255710|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
513643|NCT00255710|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
752463|NCT01173094|Diabetes Mellitus|diabetes mellitus
662022|NCT00823641|HAM/TSP|ham/tsp
513026|NCT00253175|migraine headache|migraine headache
513644|NCT00255710|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
513645|NCT00255710|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
513646|NCT00255710|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
513647|NCT00255710|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
513648|NCT00255710|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
513649|NCT00255710|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
513650|NCT00255710|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
513651|NCT00255710|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
513652|NCT00255710|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
513653|NCT00255710|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
513654|NCT00255710|stage II multiple myeloma|stage ii multiple myeloma
513655|NCT00255710|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
513963|NCT00257348|Advanced Cervical Carcinoma|advanced cervical carcinoma
513656|NCT00255710|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
513657|NCT00255710|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
513658|NCT00255710|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
513659|NCT00255710|stage III multiple myeloma|stage iii multiple myeloma
513660|NCT00255710|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
513661|NCT00255710|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
513662|NCT00255710|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
513663|NCT00255710|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
513664|NCT00255710|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
513665|NCT00255710|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
513666|NCT00255710|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
513667|NCT00255710|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
513668|NCT00255710|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
513669|NCT00255710|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
513670|NCT00255710|refractory anemia with excess blasts|refractory anemia with excess blasts
513671|NCT00255710|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
513672|NCT00255710|primary systemic amyloidosis|primary systemic amyloidosis
513673|NCT00255710|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
513674|NCT00255710|secondary acute myeloid leukemia|secondary acute myeloid leukemia
513675|NCT00255710|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
513676|NCT00255710|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
513677|NCT00255723|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
513678|NCT00255723|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
513679|NCT00255723|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
513680|NCT00255723|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
513681|NCT00255749|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
513682|NCT00255749|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
513683|NCT00255749|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
513684|NCT00255749|anemia|anemia
513685|NCT00255749|extramedullary plasmacytoma|extramedullary plasmacytoma
513686|NCT00255749|isolated plasmacytoma of bone|isolated plasmacytoma of bone
513687|NCT00255749|refractory multiple myeloma|refractory multiple myeloma
513688|NCT00255749|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
513689|NCT00255749|primary systemic amyloidosis|primary systemic amyloidosis
513690|NCT00255749|stage I multiple myeloma|stage i multiple myeloma
513691|NCT00255749|stage II multiple myeloma|stage ii multiple myeloma
513692|NCT00255749|stage III multiple myeloma|stage iii multiple myeloma
513693|NCT00255749|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
513694|NCT00255749|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
513695|NCT00255749|anaplastic large cell lymphoma|anaplastic large cell lymphoma
513696|NCT00255749|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
513697|NCT00255749|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
513698|NCT00255749|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
513699|NCT00255749|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
513700|NCT00255749|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
513701|NCT00255749|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
513702|NCT00255749|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
513703|NCT00255749|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
513704|NCT00255749|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
513705|NCT00255749|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
513706|NCT00255749|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
513707|NCT00255749|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
513708|NCT00255749|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
513709|NCT00255749|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
513710|NCT00255749|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
513711|NCT00255749|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
513712|NCT00255749|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
513713|NCT00255749|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
513714|NCT00255749|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
513715|NCT00255749|splenic marginal zone lymphoma|splenic marginal zone lymphoma
513716|NCT00255749|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
513717|NCT00255749|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
513718|NCT00255749|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
513719|NCT00255749|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
513720|NCT00255749|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
513721|NCT00255749|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
513722|NCT00255749|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
513723|NCT00255749|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
513724|NCT00255749|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
513725|NCT00255749|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
513726|NCT00255749|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
513727|NCT00255749|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
513728|NCT00255749|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
513729|NCT00255749|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
516843|NCT00269737|patch|patch
513730|NCT00255749|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
513731|NCT00255749|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
513732|NCT00255749|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
513733|NCT00255749|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
513734|NCT00255749|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
513735|NCT00255749|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
513736|NCT00255749|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
513737|NCT00255749|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
513738|NCT00255749|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
513739|NCT00255749|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
513740|NCT00255749|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
513741|NCT00255749|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
513742|NCT00255749|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
513743|NCT00255749|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
513744|NCT00255749|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
513745|NCT00255749|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
513746|NCT00255749|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
513747|NCT00255749|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
513748|NCT00255749|Waldenström macroglobulinemia|waldenström macroglobulinemia
513848|NCT00256113|antidepressive agents|antidepressive agents
513749|NCT00255749|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
513750|NCT00255749|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
513751|NCT00255749|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
513752|NCT00255749|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
513753|NCT00255749|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
513754|NCT00255749|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
513755|NCT00255749|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
513756|NCT00255749|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
513757|NCT00255749|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
513758|NCT00255749|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
513759|NCT00255749|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
513760|NCT00255749|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
513761|NCT00255749|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
513762|NCT00255749|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
585511|NCT00513097|Cancer Prevention|cancer prevention
513763|NCT00255749|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
513227|NCT00254384|OSI-774|osi-774
513764|NCT00255749|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
513765|NCT00255749|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
513766|NCT00255749|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
513767|NCT00255749|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
513768|NCT00255749|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
513769|NCT00255749|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
513770|NCT00255749|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
513771|NCT00255749|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
513772|NCT00255749|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
513773|NCT00255749|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
513774|NCT00255749|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
513775|NCT00255749|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
513776|NCT00255749|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
513777|NCT00255749|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
513778|NCT00255749|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
513779|NCT00255749|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
513780|NCT00255749|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
513781|NCT00255749|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
513782|NCT00255749|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
513783|NCT00255749|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
513784|NCT00255749|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
513785|NCT00255749|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
513786|NCT00255749|stage I mantle cell lymphoma|stage i mantle cell lymphoma
513787|NCT00255749|stage I marginal zone lymphoma|stage i marginal zone lymphoma
513788|NCT00255749|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
513789|NCT00255749|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
513790|NCT00255749|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
513791|NCT00255749|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
513792|NCT00255749|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
513793|NCT00255749|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
513794|NCT00255749|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
513795|NCT00255749|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
513796|NCT00255749|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
513797|NCT00255749|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
513798|NCT00255749|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
513799|NCT00255749|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
513800|NCT00255749|refractory hairy cell leukemia|refractory hairy cell leukemia
513801|NCT00255749|prolymphocytic leukemia|prolymphocytic leukemia
513802|NCT00255749|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
513803|NCT00255749|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
513804|NCT00255775|non-small cell lung cancer|non-small cell lung cancer
513805|NCT00255775|small cell lung cancer|small cell lung cancer
513806|NCT00255788|recurrent breast cancer|recurrent breast cancer
513807|NCT00255788|stage IV breast cancer|stage iv breast cancer
513809|NCT00255801|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
513810|NCT00255801|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
513811|NCT00255801|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
513812|NCT00255801|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
513813|NCT00255801|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
513814|NCT00255801|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
513815|NCT00255801|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
513816|NCT00255801|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
513817|NCT00255801|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
513818|NCT00255801|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
513819|NCT00255814|liver metastases|liver metastases
513820|NCT00255840|Treatment Naive|treatment naive
513821|NCT00255866|Assisted Living Facilities|assisted living facilities
513822|NCT00255866|Aged|aged
513823|NCT00255866|Elderly|elderly
513824|NCT00255866|Caregivers|caregivers
513825|NCT00255879|Schizophrenia|schizophrenia
513826|NCT00255879|Neuroleptic|neuroleptic
513827|NCT00255879|Tardive dyskinesia|tardive dyskinesia
513828|NCT00255892|HIV|hiv
513829|NCT00255905|Depression|depression
513830|NCT00255905|Insomnia|insomnia
513831|NCT00255918|Evoked Potentials|evoked potentials
513832|NCT00255918|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine
513833|NCT00255918|DMXB-A|dmxb-a
513834|NCT00255918|Receptors, Nicotinic|receptors, nicotinic
513835|NCT00255931|Heart Failure|heart failure
513836|NCT00255931|Biofeedback-Relaxation|biofeedback-relaxation
513837|NCT00255931|Cognitive Behavioral Therapy|cognitive behavioral therapy
513838|NCT00255944|HIV Prevention|hiv prevention
513839|NCT00255944|Internet Intervention|internet intervention
513840|NCT00255944|STDs|stds
513841|NCT00255957|Stroke, HES, Coagulation, Kinetics, Hemorehology|stroke, hes, coagulation, kinetics, hemorehology
513842|NCT00255970|Periodontal Treatment of Intraosseous Vertical Defects|periodontal treatment of intraosseous vertical defects
513843|NCT00255983|bronchitis|bronchitis
513844|NCT00255983|AECB|aecb
513845|NCT00256009|Late abortion|late abortion
513846|NCT00256087|Nosocomial rates in critically ill patients|nosocomial rates in critically ill patients
513849|NCT00256113|controlled clinical trial|controlled clinical trial
513850|NCT00256152|Atrial fibrillation|atrial fibrillation
513851|NCT00256152|Pacemaker|pacemaker
513852|NCT00256152|AF suppression pacing|af suppression pacing
513853|NCT00256152|Indications for Pacemaker Implantation due to sinus node or atrio-ventricular node disease|indications for pacemaker implantation due to sinus node or atrio-ventricular node disease
513854|NCT00256165|Aortic valve replacement|aortic valve replacement
513855|NCT00256178|Hyperlipidemia|hyperlipidemia
513856|NCT00256178|Drug Therapy|drug therapy
513857|NCT00256191|taxanes|taxanes
513858|NCT00256191|multidrug resistance|multidrug resistance
513859|NCT00256191|mutant tubulin binding|mutant tubulin binding
513860|NCT00256191|Hodgkin's or Non-Hodgkin's Lymphoma|hodgkin's or non-hodgkin's lymphoma
513861|NCT00256204|Parkinson's|parkinson's
513862|NCT00256204|Rasagiline Mesylate|rasagiline mesylate
513863|NCT00256256|type 2 diabetes|type 2 diabetes
513864|NCT00256256|GLP-1|glp-1
513865|NCT00256256|PET|pet
513866|NCT00256256|brain|brain
513867|NCT00256256|heart|heart
513868|NCT00256269|Esophageal Cancer|esophageal cancer
513869|NCT00256269|Gastroesophageal junction cancer|gastroesophageal junction cancer
513870|NCT00256282|Metastatic Melanoma|metastatic melanoma
513871|NCT00250510|Obesity treatment|obesity treatment
513872|NCT00250510|Insurance reimbursement|insurance reimbursement
513873|NCT00250510|Health care utilization|health care utilization
513875|NCT00250523|trauma|trauma
513876|NCT00250523|critical illness|critical illness
513877|NCT00250523|injury|injury
513878|NCT00256295|Cancer of the Head and Neck|cancer of the head and neck
513879|NCT00256308|Head and Neck Cancer|head and neck cancer
513880|NCT00256321|Gastric Carcinoma|gastric carcinoma
513881|NCT00256321|Gastroesophageal junction Carcinoma|gastroesophageal junction carcinoma
513882|NCT00256334|Colon Cancer|colon cancer
513883|NCT00256334|Resveratrol|resveratrol
513884|NCT00256334|Clinical Trial|clinical trial
513885|NCT00256334|WnT signaling|wnt signaling
513886|NCT00256334|Grapes|grapes
513887|NCT00256334|Cancer prevention|cancer prevention
513888|NCT00256360|breast cancer|breast cancer
513889|NCT00256360|adjuvant|adjuvant
513890|NCT00256360|dose dense|dose dense
513891|NCT00256360|docetaxel|docetaxel
513892|NCT00256360|pegfilgrastim|pegfilgrastim
513893|NCT00256373|Low Back Pain|low back pain
513894|NCT00256373|Dynamic Back-Muscle exercise Treatment|dynamic back-muscle exercise treatment
513895|NCT00256373|Interdisciplinary Treatment|interdisciplinary treatment
513896|NCT00256373|Roland Morris Disability Questionnaire|roland morris disability questionnaire
513897|NCT00256373|SF-36|sf-36
513898|NCT00256373|Low Back Pain Rating Scale|low back pain rating scale
513899|NCT00256386|Baseline|baseline
513900|NCT00256386|Laboratory|laboratory
513901|NCT00256386|Drug|drug
513902|NCT00256425|glioma|glioma
513903|NCT00256425|brain tumor|brain tumor
513904|NCT00256425|cognit|cognit
513905|NCT00256425|neuropsycholog|neuropsycholog
513906|NCT00256425|attention|attention
513907|NCT00256425|memory|memory
513908|NCT00256425|executive function|executive function
513909|NCT00256425|rehabilitation|rehabilitation
513910|NCT00256425|remediation|remediation
513911|NCT00256425|training|training
513912|NCT00256438|Depression|depression
513913|NCT00256438|Transcranial Direct Current Stimulation|transcranial direct current stimulation
513914|NCT00256451|Naltrexone|naltrexone
513915|NCT00256451|Endophenotype|endophenotype
513916|NCT00256464|PTSD|ptsd
513917|NCT00256490|Diffuse large B cells lymphoma|diffuse large b cells lymphoma
513918|NCT00256490|PET/CT|pet/ct
513919|NCT00256490|FDG|fdg
513920|NCT00256503|Primary Insomnia|primary insomnia
513921|NCT00256503|Insomnia|insomnia
513922|NCT00256503|Sleep|sleep
513923|NCT00256516|Diet Therapy|diet therapy
513924|NCT00256529|dysphagia|dysphagia
513925|NCT00256529|eosinophilic esophagitis|eosinophilic esophagitis
513926|NCT00256542|interstitial cystitis|interstitial cystitis
513927|NCT00256542|pelvic pain|pelvic pain
513928|NCT00256542|urgency|urgency
513929|NCT00256542|frequency|frequency
513930|NCT00256542|Pelvic Pain and/or Urgency of Bladder Origin|pelvic pain and/or urgency of bladder origin
513931|NCT00256568|Medical Errors|medical errors
513932|NCT00256568|Medication Errors|medication errors
513933|NCT00256568|Prescriptions, Drug|prescriptions, drug
513934|NCT00256568|Pharmacies|pharmacies
513935|NCT00256568|Ambulatory Care Facilities|ambulatory care facilities
513936|NCT00256581|myocardial perfusion|myocardial perfusion
513938|NCT00256594|Medical Errors|medical errors
513939|NCT00256594|Medication Errors|medication errors
513940|NCT00256594|Prescriptions, Drug|prescriptions, drug
513941|NCT00256620|Cardiopulmonary bypass|cardiopulmonary bypass
513942|NCT00256620|Coronary artery disease|coronary artery disease
513943|NCT00256620|Cardiac morbidity|cardiac morbidity
513944|NCT00256620|Neurologic morbidity|neurologic morbidity
513945|NCT00256620|Neurocognitive function|neurocognitive function
513946|NCT00256620|Autoregulation|autoregulation
513947|NCT00257283|Chronic renal failure|chronic renal failure
513948|NCT00257283|Hemodialysis|hemodialysis
513949|NCT00257283|OMACOR (omega-3-acid ethyl ester 90)|omacor (omega-3-acid ethyl ester 90)
513950|NCT00257283|intervention study|intervention study
513951|NCT00257283|cardiovascular events|cardiovascular events
513952|NCT00257283|mortality|mortality
513953|NCT00257309|Acute myocardial infarction|acute myocardial infarction
513954|NCT00257309|Elderly|elderly
513955|NCT00257309|Thrombolysis|thrombolysis
513956|NCT00257309|Primary angioplasty|primary angioplasty
513957|NCT00257309|Randomized trial|randomized trial
513958|NCT00257309|Efficacy|efficacy
513959|NCT00257309|Safety|safety
513960|NCT00257322|Metastatic colon cancer|metastatic colon cancer
513961|NCT00257322|Metastatic rectal cancer|metastatic rectal cancer
513962|NCT00257335|Carcinoma of the head and neck|carcinoma of the head and neck
513964|NCT00257348|Recurrent Cervical Carcinoma|recurrent cervical carcinoma
513965|NCT00257387|Kidney|kidney
513966|NCT00257387|Kidney Transplant|kidney transplant
513967|NCT00257400|major depressive disorder|major depressive disorder
513968|NCT00257400|psychotherapy|psychotherapy
513969|NCT00257400|childhood sexual abuse|childhood sexual abuse
513970|NCT00257400|trauma|trauma
513971|NCT00257426|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
513972|NCT00257426|advanced adult primary liver cancer|advanced adult primary liver cancer
514100|NCT00258089|quinolones|quinolones
513973|NCT00257426|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
513974|NCT00257426|recurrent adult primary liver cancer|recurrent adult primary liver cancer
513975|NCT00257439|Vitamin B12|vitamin b12
513976|NCT00257439|Folic Acid|folic acid
513977|NCT00257465|melanoma|melanoma
513978|NCT00257465|metastatic|metastatic
513979|NCT00257465|vaccine|vaccine
513980|NCT00257465|immunotherapy|immunotherapy
513981|NCT00257465|autologous|autologous
513982|NCT00257478|Treatment Efficacy|treatment efficacy
513983|NCT00257478|Treatment Effectiveness|treatment effectiveness
513984|NCT00257478|Disease Management|disease management
513985|NCT00257478|Treatment|treatment
513986|NCT00257478|Safety|safety
513987|NCT00257517|Congenital heart disease|congenital heart disease
513988|NCT00257517|Single ventricle|single ventricle
513989|NCT00257517|Infant feeding|infant feeding
513990|NCT00257543|sickle cell disease|sickle cell disease
513991|NCT00257543|bone marrow transplant|bone marrow transplant
513992|NCT00257569|Atopic|atopic
513993|NCT00257569|Pediatric|pediatric
513994|NCT00257569|Dermatitis|dermatitis
513995|NCT00257582|cetirizine|cetirizine
513996|NCT00257582|various type of cutaneous disease accompanied with Pruritus|various type of cutaneous disease accompanied with pruritus
513997|NCT00257582|pediatrics|pediatrics
513998|NCT00257595|Perennial Allergic Rhinitis pediatric|perennial allergic rhinitis pediatric
513999|NCT00257608|NSCLC|nsclc
514000|NCT00257608|Lung Cancer|lung cancer
514001|NCT00257608|ATLAS|atlas
514002|NCT00257608|Avastin|avastin
514003|NCT00257608|Tarceva|tarceva
514004|NCT00257621|HIV-1 protease inhibitor GW640385 ritonavir RTV|hiv-1 protease inhibitor gw640385 ritonavir rtv
514005|NCT00257634|lateral epicondylitis|lateral epicondylitis
514006|NCT00257634|iontophoresis|iontophoresis
514007|NCT00257634|dexamethasone|dexamethasone
514008|NCT00257673|Cognition|cognition
514009|NCT00257673|Alzheimer's|alzheimer's
514010|NCT00257673|Cognitive impairment|cognitive impairment
514011|NCT00257686|Kowa|kowa
514012|NCT00257686|Hypercholesterolemia|hypercholesterolemia
514013|NCT00257686|combined|combined
514014|NCT00257686|dyslipidemia|dyslipidemia
514015|NCT00257686|elderly|elderly
514016|NCT00257686|pitavastatin|pitavastatin
514017|NCT00257686|NK-104|nk-104
514018|NCT00257699|Crohn's Disease|crohn's disease
514019|NCT00257699|Randomized|randomized
514020|NCT00257699|Ciprofloxacin|ciprofloxacin
514021|NCT00257699|Metronidazole|metronidazole
514022|NCT00257699|Antibiotic|antibiotic
514023|NCT00257712|Alzheimer's disease|alzheimer's disease
514024|NCT00257712|cognition disorders|cognition disorders
514025|NCT00257725|ADHD|adhd
514026|NCT00257725|Attention-deficit/hyperactivity disorder (ADHD)|attention-deficit/hyperactivity disorder (adhd)
514027|NCT00257764|Swallowing disorder|swallowing disorder
514028|NCT00257764|Stroke|stroke
514029|NCT00257764|Standardized swallowing therapy|standardized swallowing therapy
514030|NCT00257764|Randomized controlled trial|randomized controlled trial
514031|NCT00257790|Fever|fever
514032|NCT00257790|Neutropenia|neutropenia
514033|NCT00257790|Tobramycin|tobramycin
514034|NCT00257790|Aminoglycoside|aminoglycoside
514035|NCT00257790|Penicillin|penicillin
514036|NCT00257803|Oxytocin, bolus, postpartum hemorrhage|oxytocin, bolus, postpartum hemorrhage
514037|NCT00257816|Cervical Cancer|cervical cancer
514038|NCT00257829|Cervical Cancer|cervical cancer
514039|NCT00257855|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
514040|NCT00257855|Neuroprotection|neuroprotection
514041|NCT00257855|Axonal loss|axonal loss
514042|NCT00257855|Brain atrophy|brain atrophy
514044|NCT00257855|Lamotrigine|lamotrigine
514045|NCT00257855|Sodium Channel Blockers|sodium channel blockers
514046|NCT00257881|Tumor|tumor
514047|NCT00257894|Baclofen|baclofen
514048|NCT00257894|Conditioning, Classical|conditioning, classical
514049|NCT00257894|Nicotine|nicotine
514050|NCT00257894|Smoking|smoking
514051|NCT00257907|Latent Tuberculosis|latent tuberculosis
514053|NCT00257907|Antigen Specific T-Cells|antigen specific t-cells
514054|NCT00257907|Lymphocyte Proliferation Assay|lymphocyte proliferation assay
514055|NCT00257907|HIV|hiv
514056|NCT00257907|LPA|lpa
514057|NCT00257920|Stage 5 Chronic Kidney Disease (CKD)|stage 5 chronic kidney disease (ckd)
514058|NCT00257933|Corticosteroids|corticosteroids
514059|NCT00257933|Treatment|treatment
514060|NCT00257933|Pediatric|pediatric
514061|NCT00257946|Diaphragm|diaphragm
514062|NCT00257946|Hernia|hernia
514063|NCT00257946|Congenital|congenital
514064|NCT00257972|Bipolar Mania|bipolar mania
514221|NCT00258401|stage I uterine sarcoma|stage i uterine sarcoma
514065|NCT00257985|Familial hemiplegic migraine type 1 and 2|familial hemiplegic migraine type 1 and 2
514066|NCT00257985|GTN|gtn
514067|NCT00257985|middle cerebral artery|middle cerebral artery
514068|NCT00257985|superficial temporal artery|superficial temporal artery
514069|NCT00257985|headache|headache
514070|NCT00257985|genotype|genotype
514071|NCT00258011|MPS I Disease|mps i disease
514072|NCT00258024|IPT-SP, pregnancy, malaria,Ghana|ipt-sp, pregnancy, malaria,ghana
514073|NCT00258037|Physiotherapy|physiotherapy
514074|NCT00258037|Stroke|stroke
514075|NCT00258037|Urinary Incontinence|urinary incontinence
514076|NCT00258037|quality of Life|quality of life
514077|NCT00258050|lapatinib|lapatinib
514078|NCT00258050|midazolam|midazolam
514079|NCT00258050|pharmacokinetics|pharmacokinetics
514080|NCT00258063|Transdermal contraception|transdermal contraception
514081|NCT00258063|contraceptive|contraceptive
514082|NCT00258063|hormonal, steroid contraception|hormonal, steroid contraception
514083|NCT00258063|ethinyl estradiol|ethinyl estradiol
514084|NCT00258063|progesterone|progesterone
514085|NCT00258063|EVRA|evra
514086|NCT00258063|CILEST|cilest
514087|NCT00258063|ORTHO EVRA|ortho evra
514088|NCT00258076|Transdermal contraception|transdermal contraception
514089|NCT00258076|contraceptive|contraceptive
514090|NCT00258076|hormonal, steroid contraception|hormonal, steroid contraception
514091|NCT00258076|ethinyl estradiol|ethinyl estradiol
514092|NCT00258076|progesterone|progesterone
514093|NCT00258076|EVRA|evra
514094|NCT00258089|levofloxacin|levofloxacin
514095|NCT00258089|urinary tract infections|urinary tract infections
514096|NCT00258089|bacterial infections|bacterial infections
514097|NCT00258089|bacteriuria|bacteriuria
514098|NCT00258089|urinary anti-infective agents|urinary anti-infective agents
514099|NCT00258089|urinary infections|urinary infections
514101|NCT00258102|levofloxacin|levofloxacin
514102|NCT00258102|urinary tract infections|urinary tract infections
514103|NCT00258102|bacterial infections|bacterial infections
514104|NCT00258102|bacteriuria|bacteriuria
514105|NCT00258102|urinary anti-infective agents|urinary anti-infective agents
514106|NCT00258102|urinary infections|urinary infections
514107|NCT00258102|quinolones|quinolones
514108|NCT00258115|Obesity|obesity
514109|NCT00258115|Metabolic Syndrome|metabolic syndrome
514110|NCT00258115|Diabetes|diabetes
514111|NCT00258115|Inflammation|inflammation
514112|NCT00258167|Family members|family members
514113|NCT00258167|Illness burden|illness burden
514114|NCT00258167|Mental Disorders|mental disorders
514115|NCT00258167|Family intervention|family intervention
514116|NCT00258180|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
514117|NCT00258180|gastrointestinal complications|gastrointestinal complications
514118|NCT00258180|diarrhea|diarrhea
514119|NCT00258193|C-IBS|c-ibs
514120|NCT00258193|IBS-C|ibs-c
514121|NCT00258193|Constipation-predominant Irritable Bowel Syndrome|constipation-predominant irritable bowel syndrome
585512|NCT00513097|Smoking Cessation|smoking cessation
514122|NCT00258193|Constipation Predominant Irritable Bowel Syndrome|constipation predominant irritable bowel syndrome
514123|NCT00258193|Irritable Bowel Syndrome|irritable bowel syndrome
514124|NCT00258193|IBS|ibs
515393|NCT00265174|MGMT|mgmt
514125|NCT00258193|Transit|transit
514126|NCT00258193|Scintigraphy|scintigraphy
514127|NCT00258193|Gastroenterology|gastroenterology
514128|NCT00258193|Gastrointestinal|gastrointestinal
514129|NCT00258193|GC|gc
514130|NCT00258193|MD-1100 Acetate|md-1100 acetate
514131|NCT00258193|MD-1100|md-1100
514132|NCT00258193|linaclotide|linaclotide
514133|NCT00258193|linaclotide acetate|linaclotide acetate
514134|NCT00258206|stage I multiple myeloma|stage i multiple myeloma
514135|NCT00258206|stage II multiple myeloma|stage ii multiple myeloma
514136|NCT00258206|stage III multiple myeloma|stage iii multiple myeloma
514137|NCT00258206|refractory multiple myeloma|refractory multiple myeloma
514138|NCT00258232|adenocarcinoma of the colon|adenocarcinoma of the colon
514139|NCT00258232|adenocarcinoma of the rectum|adenocarcinoma of the rectum
514140|NCT00258232|recurrent colon cancer|recurrent colon cancer
514141|NCT00258232|recurrent rectal cancer|recurrent rectal cancer
514142|NCT00258232|stage IV colon cancer|stage iv colon cancer
514143|NCT00258232|stage IV rectal cancer|stage iv rectal cancer
514144|NCT00258245|stage II multiple myeloma|stage ii multiple myeloma
514145|NCT00258245|stage III multiple myeloma|stage iii multiple myeloma
514146|NCT00258245|refractory multiple myeloma|refractory multiple myeloma
514147|NCT00258245|stage I multiple myeloma|stage i multiple myeloma
514148|NCT00258258|refractory multiple myeloma|refractory multiple myeloma
514149|NCT00258271|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
514150|NCT00258271|adult acute basophilic leukemia|adult acute basophilic leukemia
514151|NCT00258271|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
514152|NCT00258271|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
514153|NCT00258271|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
514154|NCT00258271|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
514155|NCT00258271|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
514156|NCT00258271|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
514157|NCT00258271|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
514158|NCT00258271|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
514159|NCT00258271|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
514160|NCT00258271|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
514161|NCT00258271|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
514162|NCT00258284|recurrent prostate cancer|recurrent prostate cancer
514163|NCT00258284|stage IV prostate cancer|stage iv prostate cancer
514164|NCT00258284|adenocarcinoma of the prostate|adenocarcinoma of the prostate
514165|NCT00258297|stage I esophageal cancer|stage i esophageal cancer
514166|NCT00258297|stage II esophageal cancer|stage ii esophageal cancer
514167|NCT00258297|stage III esophageal cancer|stage iii esophageal cancer
514168|NCT00258297|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
514169|NCT00258297|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
514170|NCT00258310|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
514171|NCT00258310|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
514172|NCT00258310|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
514173|NCT00258310|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
514174|NCT00258310|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
514175|NCT00258310|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
514176|NCT00258310|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
514177|NCT00258310|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
514178|NCT00258310|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
514179|NCT00258310|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
514180|NCT00258310|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
514181|NCT00258310|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
514182|NCT00258310|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
514183|NCT00258310|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
514184|NCT00258310|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
514185|NCT00258310|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
514186|NCT00258310|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
514187|NCT00258310|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
514188|NCT00258310|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
514189|NCT00258310|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
514190|NCT00258323|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
513847|NCT00256113|depression|depression
514191|NCT00258323|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
514192|NCT00258323|stage II esophageal cancer|stage ii esophageal cancer
514193|NCT00258323|stage III esophageal cancer|stage iii esophageal cancer
514194|NCT00258323|stage IV esophageal cancer|stage iv esophageal cancer
514195|NCT00258336|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
514196|NCT00258336|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
514197|NCT00258336|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
514198|NCT00258336|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
514199|NCT00258336|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
514200|NCT00258336|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
514201|NCT00258336|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
514202|NCT00258336|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
514203|NCT00258336|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
514204|NCT00258336|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
514205|NCT00258336|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
514206|NCT00258336|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
514207|NCT00258362|recurrent endometrial carcinoma|recurrent endometrial carcinoma
514208|NCT00258362|stage III endometrial carcinoma|stage iii endometrial carcinoma
514209|NCT00258362|stage IV endometrial carcinoma|stage iv endometrial carcinoma
514210|NCT00258375|stage IIIA breast cancer|stage iiia breast cancer
514211|NCT00258375|stage IIIB breast cancer|stage iiib breast cancer
514212|NCT00258375|stage IIIC breast cancer|stage iiic breast cancer
514213|NCT00258375|stage IV breast cancer|stage iv breast cancer
514214|NCT00258375|recurrent breast cancer|recurrent breast cancer
514215|NCT00258388|adenocarcinoma of the prostate|adenocarcinoma of the prostate
514216|NCT00258388|recurrent prostate cancer|recurrent prostate cancer
514217|NCT00258388|stage IV prostate cancer|stage iv prostate cancer
514218|NCT00258401|diarrhea|diarrhea
514219|NCT00258401|radiation toxicity|radiation toxicity
514220|NCT00258401|recurrent uterine sarcoma|recurrent uterine sarcoma
514222|NCT00258401|stage II uterine sarcoma|stage ii uterine sarcoma
514223|NCT00258401|stage III uterine sarcoma|stage iii uterine sarcoma
514224|NCT00258401|stage IV uterine sarcoma|stage iv uterine sarcoma
514225|NCT00258401|recurrent prostate cancer|recurrent prostate cancer
514226|NCT00258401|stage I prostate cancer|stage i prostate cancer
514227|NCT00258401|stage II prostate cancer|stage ii prostate cancer
514228|NCT00258401|stage III prostate cancer|stage iii prostate cancer
514229|NCT00258401|stage IV prostate cancer|stage iv prostate cancer
514230|NCT00258401|recurrent cervical cancer|recurrent cervical cancer
514231|NCT00258401|stage 0 cervical cancer|stage 0 cervical cancer
514232|NCT00258401|stage IA cervical cancer|stage ia cervical cancer
514233|NCT00258401|stage IB cervical cancer|stage ib cervical cancer
514234|NCT00258401|stage IIA cervical cancer|stage iia cervical cancer
514235|NCT00258401|stage IIB cervical cancer|stage iib cervical cancer
514236|NCT00258401|stage III cervical cancer|stage iii cervical cancer
514237|NCT00258401|stage IVA cervical cancer|stage iva cervical cancer
514238|NCT00258401|stage IVB cervical cancer|stage ivb cervical cancer
514239|NCT00258427|Fanconi anemia|fanconi anemia
514240|NCT00258440|fatigue|fatigue
514241|NCT00258440|anemia|anemia
514242|NCT00258440|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
514243|NCT00258453|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
514244|NCT00258453|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
514245|NCT00258453|perioperative/postoperative complications|perioperative/postoperative complications
514246|NCT00258453|weight changes|weight changes
514247|NCT00258453|childhood craniopharyngioma|childhood craniopharyngioma
514248|NCT00258466|adenocarcinoma of the prostate|adenocarcinoma of the prostate
514249|NCT00258466|stage I prostate cancer|stage i prostate cancer
514250|NCT00258466|stage II prostate cancer|stage ii prostate cancer
514251|NCT00258466|stage III prostate cancer|stage iii prostate cancer
514252|NCT00258479|Nicotine Dependence|nicotine dependence
514253|NCT00258479|Nicotine Use Disorder|nicotine use disorder
514254|NCT00258479|Tobacco Dependence|tobacco dependence
514255|NCT00258492|Restless legs syndrome|restless legs syndrome
514256|NCT00258492|Insomnia|insomnia
514257|NCT00258492|Daytime sleepiness|daytime sleepiness
514258|NCT00258492|Exercise|exercise
514259|NCT00258505|Spreading depression|spreading depression
514260|NCT00258505|Seizures|seizures
514261|NCT00258505|Blood-brain barrier|blood-brain barrier
514262|NCT00258518|Critically ill patients|critically ill patients
514263|NCT00258544|Lung|lung
514264|NCT00258544|Fibrosis|fibrosis
514265|NCT00258544|Idiopathic|idiopathic
514266|NCT00258544|Microarray|microarray
514267|NCT00258544|Tissue|tissue
514268|NCT00258544|Biopsy|biopsy
514269|NCT00258557|HIV|hiv
514270|NCT00258557|Anti-Retroviral agents|anti-retroviral agents
514271|NCT00258557|HIV-1|hiv-1
514272|NCT00258557|TMC114/r|tmc114/r
514273|NCT00258557|Treatment naïve patients|treatment naïve patients
514274|NCT00258570|"Lung[A04.400]"|"lung[a04.400]"
514275|NCT00258583|"Lung[A04.400]"|"lung[a04.400]"
514276|NCT00258596|drug-eluting stent|drug-eluting stent
514277|NCT00258596|chronic total occlusion|chronic total occlusion
514278|NCT00258596|sirolimus-eluting stent|sirolimus-eluting stent
514279|NCT00258596|zotarolimus-eluting stent|zotarolimus-eluting stent
514280|NCT00258596|QCA|qca
514281|NCT00258609|Botulinum toxin type A,|botulinum toxin type a,
514282|NCT00258609|Dysport®,Dysport|dysport®,dysport
514283|NCT00258609|Migraine without aura,|migraine without aura,
514284|NCT00258609|Migraine prophylaxis.|migraine prophylaxis.
514285|NCT00258622|Peripheral neuropathic pain|peripheral neuropathic pain
514286|NCT00258622|Neuropathic pain|neuropathic pain
514287|NCT00258622|Chronic pain|chronic pain
514288|NCT00258635|Allergy|allergy
514289|NCT00258635|Specific Immunotherapy|specific immunotherapy
514290|NCT00258661|Pneumonia|pneumonia
514291|NCT00258661|Osteopathic|osteopathic
514292|NCT00258661|Manipulation|manipulation
514293|NCT00258661|Multi-center|multi-center
514294|NCT00258661|Elderly|elderly
514295|NCT00258674|Diabetes|diabetes
514296|NCT00258674|Care coordination|care coordination
514297|NCT00258674|Case management|case management
514298|NCT00258674|Physician profiling|physician profiling
514299|NCT00258687|GVAX|gvax
514300|NCT00258687|GM-CSF|gm-csf
514301|NCT00258687|Adenoviral mediated gene transfer|adenoviral mediated gene transfer
514302|NCT00258687|Pediatric Melanoma|pediatric melanoma
514303|NCT00258713|Randomized Controlled Trials|randomized controlled trials
514304|NCT00258713|Immunosuppression|immunosuppression
514305|NCT00258713|Adult|adult
514306|NCT00258713|Chronic Disease|chronic disease
514307|NCT00258713|Dermatologic Agents|dermatologic agents
514308|NCT00258713|Female|female
514309|NCT00258713|Humans|humans
514310|NCT00258713|Male|male
514311|NCT00258713|Middle Aged|middle aged
514312|NCT00258713|Severity of Illness Index|severity of illness index
514313|NCT00258713|Treatment Outcome|treatment outcome
514314|NCT00258713|Quality of Life|quality of life
514315|NCT00258713|Double-Blind Method|double-blind method
514417|NCT00259025|Tachycardia, ventricular|tachycardia, ventricular
514316|NCT00258726|Measels, Mumps, Varicella, Rubella, vaccine, children|measels, mumps, varicella, rubella, vaccine, children
514317|NCT00258752|Prevention|prevention
514318|NCT00258752|Adolescent|adolescent
514319|NCT00258765|zoledronic acid|zoledronic acid
514320|NCT00258765|prostate cancer|prostate cancer
514321|NCT00258765|high risk|high risk
514322|NCT00258765|PSA|psa
514323|NCT00258765|docetaxel|docetaxel
514324|NCT00258791|Psychiatric disorders|psychiatric disorders
514325|NCT00258791|ECT|ect
514326|NCT00258791|Headache|headache
514327|NCT00258791|Ibuprofen|ibuprofen
514328|NCT00258817|Fluzone®|fluzone®
514329|NCT00258817|Influenza Virus Vaccine|influenza virus vaccine
514330|NCT00258830|Influenza vaccine|influenza vaccine
514331|NCT00258843|IMOVAX;|imovax;
514332|NCT00258843|poliomyelitis|poliomyelitis
514333|NCT00258856|Meningitis|meningitis
514334|NCT00258856|Meningococcal infection|meningococcal infection
514335|NCT00258856|Neisseria meningitidis|neisseria meningitidis
514336|NCT00258856|Menactra®|menactra®
514337|NCT00258856|Menomune®|menomune®
514338|NCT00258869|prospective studies|prospective studies
514339|NCT00258869|biological assay|biological assay
514340|NCT00258869|body weights and measures|body weights and measures
514341|NCT00258869|chemistry, analytical|chemistry, analytical
514342|NCT00258869|microchip analytical procedures|microchip analytical procedures
514343|NCT00258869|spectrum analysis, mass|spectrum analysis, mass
514344|NCT00258869|molecular diagnostic techniques|molecular diagnostic techniques
514345|NCT00258869|microbiological techniques|microbiological techniques
514346|NCT00258869|drug administration schedule|drug administration schedule
514347|NCT00258869|data collection|data collection
514348|NCT00258869|statistics|statistics
514349|NCT00258869|gene expression profiling|gene expression profiling
514350|NCT00258869|sequence analysis|sequence analysis
514351|NCT00258869|human experimentation|human experimentation
514352|NCT00258869|immunoassay|immunoassay
514353|NCT00258869|Trauma severity indices|trauma severity indices
514354|NCT00258869|Glasgow Coma score|glasgow coma score
514355|NCT00258869|Outcome assessment|outcome assessment
514356|NCT00258869|mortality|mortality
514357|NCT00258869|computer models|computer models
514358|NCT00258869|decision modeling|decision modeling
514359|NCT00258869|linear models|linear models
514360|NCT00258869|logistic models|logistic models
514361|NCT00258869|immunologic model|immunologic model
514362|NCT00258869|mathematical model|mathematical model
514363|NCT00258869|non-linear models|non-linear models
514364|NCT00258869|early diagnosis|early diagnosis
514365|NCT00258869|diagnosis, computer assisted|diagnosis, computer assisted
514366|NCT00258869|medical informatics|medical informatics
514367|NCT00258869|prognosis|prognosis
514368|NCT00258869|registries|registries
514369|NCT00258869|computational biology|computational biology
514370|NCT00258869|systems biology|systems biology
514371|NCT00258882|Tetanus Toxoid,|tetanus toxoid,
514372|NCT00258882|acellular pertussis,|acellular pertussis,
514373|NCT00258882|diphtheria toxoid|diphtheria toxoid
514374|NCT00258895|DAPTACEL®|daptacel®
514375|NCT00258895|Pentacel™|pentacel™
514376|NCT00258895|Diphtheria|diphtheria
514378|NCT00258895|Pertussis|pertussis
514379|NCT00258895|Whooping cough|whooping cough
514380|NCT00258895|Acellular Pertussis Vaccine Adsorbed|acellular pertussis vaccine adsorbed
514381|NCT00258908|ADACEL™|adacel™
514382|NCT00258908|Tetanus|tetanus
514383|NCT00258908|Diphteria|diphteria
514384|NCT00258908|Acellular pertussis|acellular pertussis
514385|NCT00258934|Influenza|influenza
514386|NCT00258934|Orthomyxoviruses|orthomyxoviruses
514387|NCT00258934|Inactivated|inactivated
514388|NCT00258934|Split-virion influenza vaccine|split-virion influenza vaccine
514389|NCT00258934|adults|adults
514390|NCT00258934|Myxovirus Infection|myxovirus infection
514391|NCT00258934|Orthomyxovirus Infection|orthomyxovirus infection
514392|NCT00258947|Smallpox|smallpox
514393|NCT00258947|Orthopoxvirus|orthopoxvirus
514394|NCT00258947|Poxvirus|poxvirus
514395|NCT00258947|Vaccina Virus|vaccina virus
514396|NCT00258947|LISTER Strain|lister strain
514397|NCT00258947|Bioterrorism|bioterrorism
514398|NCT00258960|HER2 positive breast cancer|her2 positive breast cancer
514399|NCT00258960|Metastatic breast cancer|metastatic breast cancer
514400|NCT00258973|Hand held Ultrasound|hand held ultrasound
514401|NCT00258973|Office practice|office practice
514402|NCT00258973|Atherosclerosis prevention|atherosclerosis prevention
514403|NCT00258973|Ultrasound training|ultrasound training
514404|NCT00258986|Living donors|living donors
514405|NCT00258986|Nephrectomy|nephrectomy
514406|NCT00258986|Kidney transplantation|kidney transplantation
514407|NCT00258986|Randomized Controlled Trial|randomized controlled trial
514408|NCT00258986|Laparoscopy|laparoscopy
514409|NCT00258999|Skin Cholesterol|skin cholesterol
514410|NCT00258999|Carotid Plaque|carotid plaque
514411|NCT00258999|Carotid Intima-Media Thickness|carotid intima-media thickness
514412|NCT00259012|GERD|gerd
514413|NCT00259012|Infant|infant
514414|NCT00259025|Renal failure, chronic|renal failure, chronic
514415|NCT00259025|Death, sudden, cardiac|death, sudden, cardiac
514416|NCT00259025|Heart rate variability|heart rate variability
514418|NCT00259025|Ventricular premature complexes|ventricular premature complexes
514419|NCT00259025|Ventricular repolarization|ventricular repolarization
514420|NCT00259025|Eicosapentaenoic acid|eicosapentaenoic acid
514421|NCT00259025|Docosahexaenoic acid|docosahexaenoic acid
514422|NCT00259038|Carperitide|carperitide
514423|NCT00259038|Atrial Natriuretic Peptide|atrial natriuretic peptide
514424|NCT00259038|Treatment efficacy|treatment efficacy
514425|NCT00259038|Safety|safety
514426|NCT00259038|Heart failure, Congestive|heart failure, congestive
514427|NCT00259038|Pulmonary Artery Catheterization|pulmonary artery catheterization
514428|NCT00259103|relaxin|relaxin
514429|NCT00259103|pregnancy|pregnancy
514430|NCT00259103|cervical ripening|cervical ripening
514431|NCT00259103|normal pregnancy at least at 40 weeks of gestation|normal pregnancy at least at 40 weeks of gestation
514432|NCT00259116|Congestive heart failure|congestive heart failure
514433|NCT00259116|Relaxin|relaxin
514434|NCT00259116|Cardiac hemodynamics|cardiac hemodynamics
514435|NCT00259142|home management of fever, malaria, Uganda|home management of fever, malaria, uganda
514436|NCT00259155|Irritable bowel syndrome, Bacterial overgrowth|irritable bowel syndrome, bacterial overgrowth
514437|NCT00259168|Postprandial endothelial function|postprandial endothelial function
514438|NCT00259181|chlorhexidine gluconate|chlorhexidine gluconate
514439|NCT00259181|polymethylmethacrylate|polymethylmethacrylate
514440|NCT00259181|Anti-Bacterial Agents|anti-bacterial agents
514441|NCT00259194|Coronary angiography|coronary angiography
514442|NCT00259194|Complications|complications
514443|NCT00259194|Observation|observation
514444|NCT00259207|Pulmonary valve regurgitation|pulmonary valve regurgitation
514445|NCT00259207|Valve replacement|valve replacement
514446|NCT00259207|Hybrid procedure|hybrid procedure
514447|NCT00259220|Bleeding|bleeding
514448|NCT00259220|Endoscopy|endoscopy
514449|NCT00259220|Gastric tube|gastric tube
514450|NCT00259220|Erythromycin|erythromycin
514451|NCT00259220|Randomized|randomized
514452|NCT00259259|Appetite regulation|appetite regulation
514453|NCT00259259|Hormones|hormones
514454|NCT00259259|Energy intake|energy intake
514455|NCT00259337|Diphteria|diphteria
514456|NCT00259337|Tetanus|tetanus
514457|NCT00259337|Polio|polio
514458|NCT00259337|Acellular Pertussis|acellular pertussis
514459|NCT00259337|Hib|hib
514460|NCT00259337|Haemophilus influenzae type B|haemophilus influenzae type b
514461|NCT00259350|Central venous catheter|central venous catheter
514462|NCT00259350|Skin disinfection|skin disinfection
514463|NCT00259350|Antisepsis|antisepsis
514464|NCT00259350|Nosocomial infection|nosocomial infection
514465|NCT00259350|Catheter infection|catheter infection
514466|NCT00259376|Atrial Fibrillation|atrial fibrillation
514467|NCT00259376|Atrial Flutter|atrial flutter
514468|NCT00259376|Arrhythmia|arrhythmia
514469|NCT00259376|Anti-Arrhythmia agents|anti-arrhythmia agents
514470|NCT00259389|Treatment Experienced|treatment experienced
514471|NCT00259389|Adherence|adherence
514472|NCT00259389|Compliance|compliance
514473|NCT00259389|Directly Observed Therapy|directly observed therapy
514474|NCT00259389|DOT|dot
514475|NCT00259389|Treatment Naive|treatment naive
514476|NCT00259415|Support groups|support groups
514477|NCT00259415|Alzheimer's Disease|alzheimer's disease
514478|NCT00259428|Atrial Fibrillation|atrial fibrillation
514479|NCT00259428|Atrial Flutter|atrial flutter
514480|NCT00259428|Arrhythmia|arrhythmia
514481|NCT00259428|Anti-Arrhythmia agents|anti-arrhythmia agents
514482|NCT00259441|Kidney failure|kidney failure
514483|NCT00259441|Contrast media|contrast media
514484|NCT00259441|Prevention|prevention
514485|NCT00259441|Simvastatin|simvastatin
514486|NCT00259454|Caregivers|caregivers
514487|NCT00259454|in-home care occupational therapy|in-home care occupational therapy
514488|NCT00259467|Activity, Dementia, Caregiving|activity, dementia, caregiving
514489|NCT00259493|Coronary Artery Disease|coronary artery disease
514490|NCT00259493|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
514491|NCT00259493|Off-pump CABG|off-pump cabg
514492|NCT00259493|Cardiac CT|cardiac ct
514493|NCT00259493|Bypass Graft CT angiography|bypass graft ct angiography
514494|NCT00259506|Recurrent depression|recurrent depression
514495|NCT00259506|Mental Health|mental health
514496|NCT00259519|premature or preterm birth|premature or preterm birth
514497|NCT00259519|chorioamnionitis|chorioamnionitis
514498|NCT00259519|neonatal sepsis|neonatal sepsis
514499|NCT00259519|labour|labour
514500|NCT00259519|Cesarean Section|cesarean section
514501|NCT00259519|delivery|delivery
514502|NCT00259519|length of stay|length of stay
514503|NCT00259519|pregnancy|pregnancy
514504|NCT00259545|retarded phosphatidylcholine|retarded phosphatidylcholine
514505|NCT00259545|chronic active|chronic active
514506|NCT00259545|steroid|steroid
514507|NCT00259558|Ulcerative Colitis|ulcerative colitis
514508|NCT00259558|Dose Finding|dose finding
514509|NCT00259558|Phosphatidylcholine|phosphatidylcholine
514510|NCT00259571|remission|remission
514511|NCT00259571|mesalazin|mesalazin
514512|NCT00259571|non-inferiority study|non-inferiority study
514513|NCT00259571|relapse|relapse
514514|NCT00259597|nuclear morphology|nuclear morphology
514515|NCT00259597|image analysis|image analysis
514516|NCT00259597|lipid peroxidation|lipid peroxidation
514517|NCT00259597|diet|diet
514518|NCT00259597|proliferative breast disease|proliferative breast disease
514519|NCT00259610|RA|ra
514520|NCT00259610|painful joints|painful joints
514521|NCT00259610|swollen joints|swollen joints
514522|NCT00259623|Cardiac surgery|cardiac surgery
514523|NCT00259623|Radiofrequency ablation|radiofrequency ablation
514524|NCT00259623|Atrial fibrillation|atrial fibrillation
514525|NCT00259662|cancer--ovarian|cancer--ovarian
514526|NCT00259662|cancer--endometria|cancer--endometria
514527|NCT00259662|deep vein thrombosis|deep vein thrombosis
514528|NCT00259662|statin therapy in perioperative period|statin therapy in perioperative period
514529|NCT00259688|Preeclampsia|preeclampsia
514530|NCT00259688|Sleep Apnea|sleep apnea
514531|NCT00259688|CPAP|cpap
514532|NCT00259701|endothelium|endothelium
514533|NCT00259701|iontophoresis|iontophoresis
514534|NCT00259701|acetylcholine|acetylcholine
514535|NCT00259701|nitroglycerin|nitroglycerin
514536|NCT00259701|vasodilation|vasodilation
514537|NCT00259714|hypertension|hypertension
514538|NCT00259714|hemodialysis|hemodialysis
514539|NCT00259714|sodium|sodium
514540|NCT00259714|dialysate|dialysate
514541|NCT00259714|hemodynamics|hemodynamics
514542|NCT00259727|Amprenavir|amprenavir
514543|NCT00259727|Glucagon|glucagon
514544|NCT00259727|HIV Protease inhibitors|hiv protease inhibitors
514545|NCT00259727|Indinavir|indinavir
514546|NCT00259727|Lopinavir|lopinavir
514547|NCT00259727|Ritonavir|ritonavir
514548|NCT00259740|Multiple Myeloma, Relapsed, Plateau-Phase|multiple myeloma, relapsed, plateau-phase
514549|NCT00259753|Wet Age-Related Macular Degeneration|wet age-related macular degeneration
514550|NCT00259779|COPD|copd
514551|NCT00253370|Sorafenib|sorafenib
514552|NCT00253370|Docetaxel|docetaxel
514553|NCT00253370|Cisplatin|cisplatin
514554|NCT00253370|gastric cancer|gastric cancer
514555|NCT00253370|gastroesophageal junction adenocarcinoma|gastroesophageal junction adenocarcinoma
514556|NCT00253383|transitional care planning|transitional care planning
514557|NCT00253383|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
514558|NCT00253383|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
514559|NCT00253383|extensive stage small cell lung cancer|extensive stage small cell lung cancer
514560|NCT00253383|stage IV breast cancer|stage iv breast cancer
514561|NCT00253383|recurrent breast cancer|recurrent breast cancer
514562|NCT00253383|male breast cancer|male breast cancer
514563|NCT00253383|stage IIIB anal cancer|stage iiib anal cancer
514564|NCT00253383|stage IV anal cancer|stage iv anal cancer
663295|NCT00821561|cornea|cornea
513937|NCT00256581|Imaging|imaging
514565|NCT00253383|carcinoma of the appendix|carcinoma of the appendix
514566|NCT00253383|stage III colon cancer|stage iii colon cancer
514567|NCT00253383|stage IV colon cancer|stage iv colon cancer
514568|NCT00253383|stage III rectal cancer|stage iii rectal cancer
514569|NCT00253383|stage IV rectal cancer|stage iv rectal cancer
514570|NCT00253383|stage III esophageal cancer|stage iii esophageal cancer
514571|NCT00253383|stage IV esophageal cancer|stage iv esophageal cancer
514572|NCT00253383|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
514573|NCT00253383|unresectable gallbladder cancer|unresectable gallbladder cancer
514574|NCT00253383|stage III gastric cancer|stage iii gastric cancer
514575|NCT00253383|stage IV gastric cancer|stage iv gastric cancer
514576|NCT00253383|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
514577|NCT00253383|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
514578|NCT00253383|gastrointestinal stromal tumor|gastrointestinal stromal tumor
514579|NCT00253383|advanced adult primary liver cancer|advanced adult primary liver cancer
514580|NCT00253383|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
514581|NCT00253383|stage III pancreatic cancer|stage iii pancreatic cancer
514582|NCT00253383|recurrent small intestine cancer|recurrent small intestine cancer
514583|NCT00253383|small intestine adenocarcinoma|small intestine adenocarcinoma
514584|NCT00253383|small intestine leiomyosarcoma|small intestine leiomyosarcoma
514585|NCT00253383|small intestine lymphoma|small intestine lymphoma
514586|NCT00253383|stage IV bladder cancer|stage iv bladder cancer
514587|NCT00253383|stage IV renal cell cancer|stage iv renal cell cancer
514588|NCT00253383|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
514589|NCT00253383|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
514590|NCT00253383|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
514591|NCT00253383|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
514592|NCT00253383|anterior urethral cancer|anterior urethral cancer
514593|NCT00253383|posterior urethral cancer|posterior urethral cancer
514594|NCT00253383|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
514595|NCT00253383|stage IV penile cancer|stage iv penile cancer
514596|NCT00253383|stage IV prostate cancer|stage iv prostate cancer
514597|NCT00253383|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
514598|NCT00253383|stage IV endometrial carcinoma|stage iv endometrial carcinoma
514599|NCT00253383|fallopian tube cancer|fallopian tube cancer
514600|NCT00253383|ovarian sarcoma|ovarian sarcoma
514601|NCT00253383|ovarian stromal cancer|ovarian stromal cancer
514602|NCT00253383|stage IV pancreatic cancer|stage iv pancreatic cancer
514604|NCT00253396|clinical trial|clinical trial
514605|NCT00253396|pain measurement|pain measurement
514606|NCT00253396|heparin|heparin
514607|NCT00253396|heparin, low-molecular-weight|heparin, low-molecular-weight
514608|NCT00253396|Anticoagulants|anticoagulants
753946|NCT01178359|ventricular fibrillation|ventricular fibrillation
514609|NCT00253409|localized malignant mesothelioma|localized malignant mesothelioma
516844|NCT00269750|Ditropan®|ditropan®
514610|NCT00253422|recurrent breast cancer|recurrent breast cancer
514611|NCT00253422|stage IV breast cancer|stage iv breast cancer
514612|NCT00253422|stage IIIB breast cancer|stage iiib breast cancer
514613|NCT00253422|stage IIIC breast cancer|stage iiic breast cancer
514614|NCT00253435|recurrent neuroblastoma|recurrent neuroblastoma
514615|NCT00253448|adult glioblastoma|adult glioblastoma
514616|NCT00253448|adult giant cell glioblastoma|adult giant cell glioblastoma
514617|NCT00253448|adult gliosarcoma|adult gliosarcoma
514618|NCT00253461|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
514619|NCT00253461|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
514620|NCT00253461|extensive stage small cell lung cancer|extensive stage small cell lung cancer
514621|NCT00253461|recurrent small cell lung cancer|recurrent small cell lung cancer
514622|NCT00253461|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
514623|NCT00253461|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
514624|NCT00253461|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
514625|NCT00253461|tumors metastatic to brain|tumors metastatic to brain
514626|NCT00253474|neoplasm of uncertain malignant potential|neoplasm of uncertain malignant potential
514627|NCT00253474|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
514628|NCT00253487|adult glioblastoma|adult glioblastoma
514629|NCT00253487|adult anaplastic astrocytoma|adult anaplastic astrocytoma
514630|NCT00253487|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
514631|NCT00253487|adult giant cell glioblastoma|adult giant cell glioblastoma
514632|NCT00253487|adult gliosarcoma|adult gliosarcoma
514633|NCT00253500|stage II breast cancer|stage ii breast cancer
514634|NCT00253500|stage I breast cancer|stage i breast cancer
514635|NCT00253500|stage IIIA breast cancer|stage iiia breast cancer
514636|NCT00253500|stage IIIB breast cancer|stage iiib breast cancer
514637|NCT00253513|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
514638|NCT00253513|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
514639|NCT00253513|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
514640|NCT00253513|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
514641|NCT00253513|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
514642|NCT00253513|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
514643|NCT00253513|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
514644|NCT00253513|secondary acute myeloid leukemia|secondary acute myeloid leukemia
514645|NCT00253513|myelodysplastic syndromes|myelodysplastic syndromes
514646|NCT00253513|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
514647|NCT00253539|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
514648|NCT00253539|breast cancer|breast cancer
514649|NCT00253552|graft versus host disease|graft versus host disease
514650|NCT00253552|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
514651|NCT00253552|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
514652|NCT00253552|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
514653|NCT00253552|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
514654|NCT00253552|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
514655|NCT00253552|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
514656|NCT00253552|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
514657|NCT00253552|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
514658|NCT00253552|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
514659|NCT00253552|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
514660|NCT00253552|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
514661|NCT00253552|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
514662|NCT00253552|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
514663|NCT00253552|chronic eosinophilic leukemia|chronic eosinophilic leukemia
514664|NCT00253552|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
514665|NCT00253552|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
514666|NCT00253552|chronic neutrophilic leukemia|chronic neutrophilic leukemia
514667|NCT00253552|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
514668|NCT00253552|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
514729|NCT00253552|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
515187|NCT00264290|HIV|hiv
514669|NCT00253552|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
514670|NCT00253552|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
514671|NCT00253552|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
514672|NCT00253552|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
514673|NCT00253552|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
514674|NCT00253552|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
514675|NCT00253552|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
516845|NCT00269750|OROS®|oros®
514676|NCT00253552|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
514677|NCT00253552|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
514678|NCT00253552|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
514679|NCT00253552|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
514680|NCT00253552|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
514681|NCT00253552|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
514682|NCT00253552|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
514683|NCT00253552|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
514684|NCT00253552|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
514685|NCT00253552|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
514686|NCT00253552|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
514687|NCT00253552|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
514688|NCT00253552|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
514689|NCT00253552|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
514690|NCT00253552|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
514691|NCT00253552|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
514692|NCT00253552|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
583428|NCT00511745|Erosive or ulcerate Gastroesophageal Reflux|erosive or ulcerate gastroesophageal reflux
514693|NCT00253552|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
514694|NCT00253552|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
514695|NCT00253552|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
514696|NCT00253552|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
514697|NCT00253552|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
514698|NCT00253552|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
514699|NCT00253552|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
514700|NCT00253552|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
514701|NCT00253552|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
514702|NCT00253552|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
514703|NCT00253552|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
514704|NCT00253552|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
514705|NCT00253552|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
514706|NCT00253552|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
514707|NCT00253552|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
514708|NCT00253552|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
514709|NCT00253552|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
514710|NCT00253552|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
514711|NCT00253552|refractory hairy cell leukemia|refractory hairy cell leukemia
514712|NCT00253552|refractory multiple myeloma|refractory multiple myeloma
514713|NCT00253552|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
514714|NCT00253552|secondary acute myeloid leukemia|secondary acute myeloid leukemia
514715|NCT00253552|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
514716|NCT00253552|splenic marginal zone lymphoma|splenic marginal zone lymphoma
514717|NCT00253552|stage I multiple myeloma|stage i multiple myeloma
514718|NCT00253552|stage II multiple myeloma|stage ii multiple myeloma
514719|NCT00253552|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
514720|NCT00253552|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
514721|NCT00253552|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
514722|NCT00253552|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
514723|NCT00253552|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
514724|NCT00253552|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
514725|NCT00253552|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
514726|NCT00253552|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
514727|NCT00253552|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
514728|NCT00253552|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
514730|NCT00253552|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
514731|NCT00253552|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
514732|NCT00253552|stage III multiple myeloma|stage iii multiple myeloma
514733|NCT00253552|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
514734|NCT00253552|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
514735|NCT00253552|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
753947|NCT01178359|nitrite|nitrite
514736|NCT00253552|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
514737|NCT00253552|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
514738|NCT00253552|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
514739|NCT00253552|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
514740|NCT00253552|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
514741|NCT00253552|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
514742|NCT00253552|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
514743|NCT00253552|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
514744|NCT00253552|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
514745|NCT00253552|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
514746|NCT00253552|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
514747|NCT00253552|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
514748|NCT00253552|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
514749|NCT00253565|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
514750|NCT00253591|stage I non-small cell lung cancer|stage i non-small cell lung cancer
514751|NCT00253591|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
514752|NCT00253591|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
514753|NCT00253591|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
514754|NCT00253643|prostate cancer|prostate cancer
514755|NCT00253643|precancerous condition|precancerous condition
514756|NCT00253669|thromboembolism|thromboembolism
663665|NCT00829647|CLL|cll
514757|NCT00253669|adult anaplastic astrocytoma|adult anaplastic astrocytoma
514758|NCT00253669|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
514759|NCT00253669|adult glioblastoma|adult glioblastoma
514760|NCT00253669|adult giant cell glioblastoma|adult giant cell glioblastoma
514761|NCT00253669|adult gliosarcoma|adult gliosarcoma
514762|NCT00253708|depression|depression
514763|NCT00253708|nausea and vomiting|nausea and vomiting
514764|NCT00253708|pain|pain
514765|NCT00253708|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
514766|NCT00253708|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
514767|NCT00253708|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
514768|NCT00253708|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
514769|NCT00253708|extensive stage small cell lung cancer|extensive stage small cell lung cancer
514770|NCT00253708|stage III gastric cancer|stage iii gastric cancer
514771|NCT00253708|stage III esophageal cancer|stage iii esophageal cancer
514772|NCT00253708|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
514773|NCT00253708|stage III colon cancer|stage iii colon cancer
514774|NCT00253708|stage IV renal cell cancer|stage iv renal cell cancer
514775|NCT00253708|stage IV bladder cancer|stage iv bladder cancer
514776|NCT00253708|stage IV prostate cancer|stage iv prostate cancer
514777|NCT00253708|stage IV breast cancer|stage iv breast cancer
514778|NCT00253708|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
514779|NCT00253708|advanced adult primary liver cancer|advanced adult primary liver cancer
514780|NCT00253708|stage IV melanoma|stage iv melanoma
514781|NCT00253708|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
514782|NCT00253708|ovarian sarcoma|ovarian sarcoma
514783|NCT00253708|ovarian stromal cancer|ovarian stromal cancer
514784|NCT00253708|recurrent small cell lung cancer|recurrent small cell lung cancer
514785|NCT00253708|recurrent adult primary liver cancer|recurrent adult primary liver cancer
514786|NCT00253708|recurrent colon cancer|recurrent colon cancer
514787|NCT00253708|recurrent esophageal cancer|recurrent esophageal cancer
514788|NCT00253708|recurrent gastric cancer|recurrent gastric cancer
514789|NCT00253708|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
514790|NCT00253708|recurrent bladder cancer|recurrent bladder cancer
514791|NCT00253708|recurrent breast cancer|recurrent breast cancer
514792|NCT00253708|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
514793|NCT00253708|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
514794|NCT00253708|recurrent prostate cancer|recurrent prostate cancer
514795|NCT00253708|recurrent renal cell cancer|recurrent renal cell cancer
514796|NCT00253708|recurrent melanoma|recurrent melanoma
514797|NCT00253721|adult anaplastic astrocytoma|adult anaplastic astrocytoma
514798|NCT00253721|adult brain stem glioma|adult brain stem glioma
514799|NCT00253721|adult diffuse astrocytoma|adult diffuse astrocytoma
514800|NCT00253721|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
514801|NCT00253721|adult medulloblastoma|adult medulloblastoma
514802|NCT00253721|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
514803|NCT00253721|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
514804|NCT00253721|adult oligodendroglioma|adult oligodendroglioma
514805|NCT00253721|adult pineoblastoma|adult pineoblastoma
514806|NCT00253721|tumors metastatic to brain|tumors metastatic to brain
514807|NCT00253721|adult mixed glioma|adult mixed glioma
514808|NCT00253721|recurrent adult brain tumor|recurrent adult brain tumor
514809|NCT00253721|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
514810|NCT00253734|Influenza|influenza
514812|NCT00259805|epilepsy|epilepsy
514813|NCT00259805|Rasmussens|rasmussens
514814|NCT00259805|rituximab|rituximab
514815|NCT00259805|autoimmune|autoimmune
514816|NCT00259818|Refractory|refractory
514817|NCT00259818|Solid Tumors|solid tumors
514818|NCT00259831|cold|cold
514819|NCT00259831|influenza|influenza
514820|NCT00259844|Colorectal|colorectal
514821|NCT00259844|Liver Metastases|liver metastases
514822|NCT00259844|Vaccine|vaccine
514823|NCT00259844|Colorectal Liver Metastases|colorectal liver metastases
514824|NCT00259857|Fracture|fracture
514825|NCT00259857|Bone Mineral Density|bone mineral density
514826|NCT00259857|DXA|dxa
514827|NCT00259870|Schizophrenia|schizophrenia
514828|NCT00259870|PANSS|panss
514829|NCT00259870|Acute|acute
514830|NCT00259870|Cognition|cognition
514831|NCT00259883|depressive episodes|depressive episodes
514832|NCT00259883|paroxetine|paroxetine
514833|NCT00259883|PAXIL|paxil
514834|NCT00259883|depression|depression
514835|NCT00259883|benzodiazepine|benzodiazepine
514836|NCT00259883|combination|combination
514837|NCT00259896|exenatide|exenatide
514838|NCT00259896|pharmacokinetics|pharmacokinetics
514839|NCT00259896|pharmacodynamics|pharmacodynamics
514840|NCT00259909|Patient reported outcomes|patient reported outcomes
514841|NCT00259909|acute exacerbation of chronic obstructive pulmonary disease (AECOPD)|acute exacerbation of chronic obstructive pulmonary disease (aecopd)
514842|NCT00259909|COPD|copd
514843|NCT00259922|constipation|constipation
514844|NCT00259922|gastrointestinal|gastrointestinal
514845|NCT00259922|opioids|opioids
514846|NCT00259922|pain|pain
514847|NCT00259922|non-cancer pain|non-cancer pain
514848|NCT00259922|opioid-induced|opioid-induced
514849|NCT00259922|bowel dysfunction|bowel dysfunction
514850|NCT00259935|Any Solid Tumor|any solid tumor
514851|NCT00259948|HR variability, CVA, Myocardial infarction, aerobic exercise training|hr variability, cva, myocardial infarction, aerobic exercise training
514852|NCT00259974|Anti-MAG monoclonal gammopathy|anti-mag monoclonal gammopathy
514853|NCT00259974|Polyneuropathy|polyneuropathy
514854|NCT00259974|Rituximab|rituximab
514855|NCT00259987|relapsed adenocarcinoma|relapsed adenocarcinoma
514856|NCT00259987|esophagus|esophagus
514857|NCT00259987|tumors|tumors
514858|NCT00259987|GE junction|ge junction
514859|NCT00259987|cancer|cancer
514860|NCT00259987|lapatinib|lapatinib
514861|NCT00259987|gastric cardia|gastric cardia
514862|NCT00260000|mild PKU|mild pku
514863|NCT00260000|Y414C|y414c
514864|NCT00260000|5,6,7,8-tetrahydrobiopterin, BH4|5,6,7,8-tetrahydrobiopterin, bh4
514865|NCT00260000|treatment without protein restriction|treatment without protein restriction
514866|NCT00260013|chronic mental illness|chronic mental illness
514867|NCT00260026|Lung Cancer|lung cancer
514868|NCT00260052|traumatic brain injury|traumatic brain injury
514869|NCT00260065|Myelodysplastic Syndrome|myelodysplastic syndrome
514870|NCT00260065|Decitabine|decitabine
514871|NCT00260065|Dacogen|dacogen
514872|NCT00260065|MGI Pharma|mgi pharma
514873|NCT00260078|Treatment Experienced|treatment experienced
514874|NCT00260078|Pharmacokinetics|pharmacokinetics
514875|NCT00260078|PK|pk
514876|NCT00260091|Infertility|infertility
514877|NCT00260091|Advanced maternal age|advanced maternal age
514878|NCT00260091|Pregnancy|pregnancy
514879|NCT00260091|Reproductive health|reproductive health
514880|NCT00260091|Fertility treatment|fertility treatment
514881|NCT00260091|Reproduction|reproduction
514882|NCT00260117|Exercise|exercise
514883|NCT00260117|Physical activity|physical activity
514884|NCT00260117|walking|walking
514885|NCT00260117|running|running
514886|NCT00262704|physician intervention|physician intervention
514887|NCT00262704|diabetes mellitus|diabetes mellitus
514888|NCT00262704|primary care|primary care
514889|NCT00262704|quality improvement|quality improvement
514890|NCT00262704|disease management|disease management
514891|NCT00262717|HIV drug resistance testing|hiv drug resistance testing
514892|NCT00262717|Treatment Experienced|treatment experienced
514893|NCT00262730|adult glioblastoma|adult glioblastoma
514894|NCT00262730|adult giant cell glioblastoma|adult giant cell glioblastoma
514895|NCT00262730|adult gliosarcoma|adult gliosarcoma
514896|NCT00262743|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
514897|NCT00262743|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
514898|NCT00262743|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
514899|NCT00262743|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
514900|NCT00262769|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
514984|NCT00263133|visually evoked potentials|visually evoked potentials
514901|NCT00262769|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
514902|NCT00262769|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
514903|NCT00262769|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
514904|NCT00262769|recurrent gallbladder cancer|recurrent gallbladder cancer
514905|NCT00262769|unresectable gallbladder cancer|unresectable gallbladder cancer
514906|NCT00262769|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
514907|NCT00262769|metastatic gallbladder cancer|metastatic gallbladder cancer
514908|NCT00262782|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
514909|NCT00262782|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
514910|NCT00262782|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
514911|NCT00262782|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
514912|NCT00262795|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
514913|NCT00262795|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
514914|NCT00262795|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
514915|NCT00262795|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
514916|NCT00262795|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
514917|NCT00262808|stage II colon cancer|stage ii colon cancer
514918|NCT00262808|stage III colon cancer|stage iii colon cancer
514919|NCT00262808|adenocarcinoma of the colon|adenocarcinoma of the colon
514920|NCT00262860|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
514921|NCT00262873|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
514922|NCT00262873|refractory anemia with excess blasts|refractory anemia with excess blasts
514923|NCT00262873|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
514924|NCT00262873|refractory anemia|refractory anemia
514925|NCT00262873|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
514377|NCT00258895|Tetanus|tetanus
514926|NCT00262873|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
583429|NCT00511745|Rabeprazole|rabeprazole
514927|NCT00262886|recurrent renal cell cancer|recurrent renal cell cancer
514928|NCT00262886|stage IV renal cell cancer|stage iv renal cell cancer
514929|NCT00262899|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
514930|NCT00262899|ductal breast carcinoma in situ|ductal breast carcinoma in situ
514931|NCT00262899|breast cancer in situ|breast cancer in situ
514932|NCT00262899|stage IA breast cancer|stage ia breast cancer
514933|NCT00262899|stage IB breast cancer|stage ib breast cancer
514934|NCT00262899|stage II breast cancer|stage ii breast cancer
514935|NCT00262899|stage IIIA breast cancer|stage iiia breast cancer
514936|NCT00262925|MOAD|moad
514937|NCT00262925|Methotrexate|methotrexate
514938|NCT00262925|Vincristine|vincristine
514939|NCT00262925|L-asparaginase|l-asparaginase
514940|NCT00262925|Dexamethasone|dexamethasone
514941|NCT00262925|Subcutaneous Campath|subcutaneous campath
514942|NCT00262938|stage I endometrial carcinoma|stage i endometrial carcinoma
514943|NCT00262938|stage II endometrial carcinoma|stage ii endometrial carcinoma
514944|NCT00262938|weight changes|weight changes
514945|NCT00262951|stage I pancreatic cancer|stage i pancreatic cancer
514946|NCT00262951|stage II pancreatic cancer|stage ii pancreatic cancer
514947|NCT00262951|stage III pancreatic cancer|stage iii pancreatic cancer
514948|NCT00262951|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
514949|NCT00262964|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
514950|NCT00262964|obesity|obesity
514951|NCT00262964|fatty liver disease|fatty liver disease
514952|NCT00262977|diabetes mellitus|diabetes mellitus
514953|NCT00262977|cardiovascular diseases|cardiovascular diseases
514954|NCT00262977|aspirin|aspirin
514955|NCT00262977|quality of healthcare|quality of healthcare
514956|NCT00262990|Epithelial ovarian cancer|epithelial ovarian cancer
514957|NCT00262990|fallopian tube cancer|fallopian tube cancer
514958|NCT00262990|peritoneal cancer|peritoneal cancer
514959|NCT00262990|primary cancer|primary cancer
514960|NCT00262990|recurrent cancer|recurrent cancer
514961|NCT00262990|doxorubicin|doxorubicin
514962|NCT00262990|taxane chemotherapy|taxane chemotherapy
514963|NCT00262990|platinum chemotherapy|platinum chemotherapy
514964|NCT00262990|Patupilone|patupilone
514965|NCT00262990|taxane platinum resistant|taxane platinum resistant
514966|NCT00263042|Myocardial infarction|myocardial infarction
514967|NCT00263042|cerebrovascular accident|cerebrovascular accident
514968|NCT00263042|obesity|obesity
514969|NCT00263068|IDIOPATHIC RESTLESS LEGS SYNDROME|idiopathic restless legs syndrome
514970|NCT00263081|Hyperlipidemia|hyperlipidemia
514971|NCT00263081|Dyslipidemia|dyslipidemia
514972|NCT00263081|Drug Therapy|drug therapy
514973|NCT00263094|Fasting|fasting
514974|NCT00263094|Headache|headache
514975|NCT00263094|Cox 2 Inhibitors|cox 2 inhibitors
514976|NCT00263094|Pain|pain
514977|NCT00263094|Prophylaxis|prophylaxis
514978|NCT00263107|telerounding|telerounding
514979|NCT00263107|minimally invasive surgery|minimally invasive surgery
514980|NCT00263133|Depression|depression
514981|NCT00263133|SSRI|ssri
514982|NCT00263133|Sertraline|sertraline
514983|NCT00263133|synaptic plasticity|synaptic plasticity
514985|NCT00263172|internet|internet
514986|NCT00263172|weight management|weight management
514987|NCT00263172|behavior therapy|behavior therapy
514988|NCT00263172|self-help|self-help
514989|NCT00263172|commercial program|commercial program
514990|NCT00263172|obesity|obesity
514991|NCT00263211|Breast Cancer|breast cancer
514992|NCT00263211|Metastatic|metastatic
514993|NCT00263211|Platelet|platelet
514994|NCT00263237|T Cell|t cell
514995|NCT00263237|Lymphocyte|lymphocyte
514996|NCT00263237|Lamina Propria|lamina propria
514997|NCT00263237|Malabsorption|malabsorption
514998|NCT00263237|Colonoscopy|colonoscopy
514999|NCT00263237|Common Variable Immunodeficiency|common variable immunodeficiency
515001|NCT00263237|Gastrointestinal Inflammation|gastrointestinal inflammation
515002|NCT00263250|inguinal hernia|inguinal hernia
515003|NCT00263250|asymptomatic|asymptomatic
515004|NCT00263250|watchful waiting|watchful waiting
515005|NCT00263250|tension-free hernia repair|tension-free hernia repair
515006|NCT00263302|dexamethasone, diuretic, congestive heart failure|dexamethasone, diuretic, congestive heart failure
515007|NCT00263315|aspergillosis|aspergillosis
515008|NCT00263315|mycosis|mycosis
515009|NCT00263315|neutropenia|neutropenia
515010|NCT00263315|primary prevention|primary prevention
515011|NCT00263315|hematologic diseases|hematologic diseases
515012|NCT00263315|amphotericin B|amphotericin b
515013|NCT00263315|AmBisome|ambisome
515014|NCT00263315|liposomal amphotericin B|liposomal amphotericin b
515015|NCT00263328|immunosuppression|immunosuppression
515016|NCT00263328|JAK3 inhibitor|jak3 inhibitor
515017|NCT00263328|kidney transplant|kidney transplant
515018|NCT00263328|tofacitinib|tofacitinib
515019|NCT00263328|Xeljanz|xeljanz
515020|NCT00263328|CP-690|cp-690
515021|NCT00263328|550|550
515022|NCT00263328|tacromilus|tacromilus
515023|NCT00263328|mycophenolate mofetil|mycophenolate mofetil
515024|NCT00263341|Contraceptive agents|contraceptive agents
515025|NCT00263341|Female contraception|female contraception
515026|NCT00263341|Progestins|progestins
515027|NCT00263367|Autism|autism
515028|NCT00263367|Oxidative Stress|oxidative stress
515029|NCT00263367|Hyperbaric Oxygen|hyperbaric oxygen
515030|NCT00263367|Reduced Glutathione|reduced glutathione
515031|NCT00263367|Lipid Peroxides|lipid peroxides
515032|NCT00263380|COPD|copd
515033|NCT00263380|cytokines|cytokines
515034|NCT00263380|corticosteroids|corticosteroids
515035|NCT00263380|beta agonists|beta agonists
515036|NCT00263380|synergistic effect|synergistic effect
515037|NCT00263393|Myocardial Infarction|myocardial infarction
515038|NCT00263393|Angina Pectoris|angina pectoris
515039|NCT00263393|Cerebrovascular Accident|cerebrovascular accident
515040|NCT00263393|Diabetes Mellitus|diabetes mellitus
515041|NCT00263393|Cluster randomized design|cluster randomized design
515042|NCT00263393|Community-based intervention trial|community-based intervention trial
515043|NCT00263393|Primary Healthcare intervention|primary healthcare intervention
515044|NCT00263393|Lifestyle advice|lifestyle advice
515045|NCT00263419|Diabetes Type 2|diabetes type 2
515046|NCT00263419|Late Complications|late complications
515047|NCT00263419|Stress relief management|stress relief management
515048|NCT00263419|psychosocial stress|psychosocial stress
515049|NCT00263445|Growth hormone dosing|growth hormone dosing
515050|NCT00263445|IGF-I|igf-i
515051|NCT00263458|HIV|hiv
515052|NCT00263458|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
515053|NCT00263458|buprenorphine|buprenorphine
515054|NCT00263458|opioid dependence|opioid dependence
515055|NCT00263458|opioid-related disorders|opioid-related disorders
515056|NCT00263458|integrated care|integrated care
515057|NCT00263458|primary care|primary care
515058|NCT00263484|Steroids, Fluorinated|steroids, fluorinated
515059|NCT00263484|Thalidomide|thalidomide
515060|NCT00263484|Bisphosphonates|bisphosphonates
515061|NCT00263497|Postinjury chronic pain|postinjury chronic pain
515062|NCT00263497|Transtibial amputation|transtibial amputation
515063|NCT00263497|Physical rehabilitation|physical rehabilitation
515064|NCT00263497|Immediate temporary prosthesis|immediate temporary prosthesis
515065|NCT00263523|Serotonin|serotonin
515066|NCT00263523|Positron Emission Tomograhy|positron emission tomograhy
515067|NCT00263523|Brain|brain
515068|NCT00263523|Neurochemistry|neurochemistry
515069|NCT00263523|Neurotransmitter|neurotransmitter
515070|NCT00263523|Healthy Volunteer|healthy volunteer
515071|NCT00263523|HV|hv
515072|NCT00263536|Obesity|obesity
515073|NCT00263536|Adiposity|adiposity
515074|NCT00263536|Binge Eating|binge eating
515075|NCT00263536|Social Functioning|social functioning
515076|NCT00263536|Eating Disorders|eating disorders
515077|NCT00263536|Prevention|prevention
515078|NCT00263536|Adolescence|adolescence
515079|NCT00263536|Adolescent Weight Gain|adolescent weight gain
515080|NCT00263536|Overweight|overweight
515081|NCT00263549|House dust mite,|house dust mite,
515082|NCT00263549|Allergy|allergy
515083|NCT00263562|Sickle cell disease|sickle cell disease
515084|NCT00263562|vaso-occlusive crisis|vaso-occlusive crisis
515085|NCT00263562|steroid treatment|steroid treatment
515086|NCT00263575|EN3267|en3267
515087|NCT00263575|Breakthrough Pain|breakthrough pain
515088|NCT00263575|Safety Study|safety study
515089|NCT00263575|Fentanyl Tablets|fentanyl tablets
515090|NCT00263588|breast cancer brain metastases ErbB2 positive HER2 positive|breast cancer brain metastases erbb2 positive her2 positive
515091|NCT00263601|Allergovit|allergovit
515092|NCT00263601|Grass pollen allergy|grass pollen allergy
515093|NCT00263627|specific immunotherapy|specific immunotherapy
515094|NCT00263627|birch pollen allergy|birch pollen allergy
515095|NCT00263627|Allergovit|allergovit
515096|NCT00263640|House dust mite|house dust mite
515097|NCT00263640|Bronchial Asthma|bronchial asthma
515099|NCT00263640|House Dust Mite Allergy|house dust mite allergy
515100|NCT00263731|lung cancer|lung cancer
515101|NCT00263731|non-small cell lung cancer|non-small cell lung cancer
515102|NCT00263731|small cell lung cancer|small cell lung cancer
515103|NCT00263731|cancer metabolism|cancer metabolism
515104|NCT00263822|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
515105|NCT00263822|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
515106|NCT00263822|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
515107|NCT00263822|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
515108|NCT00263822|primary peritoneal cavity cancer|primary peritoneal cavity cancer
515109|NCT00263822|fallopian tube cancer|fallopian tube cancer
515110|NCT00263861|neurotoxicity|neurotoxicity
515111|NCT00263861|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
515112|NCT00263887|alpha 1 proteinase inhibitor|alpha 1 proteinase inhibitor
515113|NCT00263887|alpha1 proteinase inhibitor|alpha1 proteinase inhibitor
515114|NCT00263887|congenital emphysema|congenital emphysema
514603|NCT00253396|warfarin|warfarin
515115|NCT00263887|replacement therapy|replacement therapy
515116|NCT00263900|Influenza A|influenza a
515117|NCT00263900|Influenza B|influenza b
515118|NCT00263900|RSV|rsv
515119|NCT00263926|Wasp venom allergy,|wasp venom allergy,
515120|NCT00263926|specific immunotherapy|specific immunotherapy
515121|NCT00263939|chronic disease|chronic disease
515122|NCT00263939|patient education|patient education
515123|NCT00263939|self-efficacy|self-efficacy
515124|NCT00263939|self-management|self-management
515125|NCT00263952|Bee venom allergy|bee venom allergy
515126|NCT00263952|Specific immunotherapy|specific immunotherapy
515127|NCT00263978|Venous occlusive disease|venous occlusive disease
515128|NCT00263978|VOD|vod
515129|NCT00264004|Advanced Solid Tumours|advanced solid tumours
515130|NCT00264004|phase II|phase ii
515131|NCT00264004|Hypertension|hypertension
515132|NCT00264004|RECENTIN|recentin
515133|NCT00264056|malignant melanoma|malignant melanoma
515134|NCT00264056|hyperthermia|hyperthermia
515135|NCT00264056|chemotherapy|chemotherapy
515136|NCT00264069|Adherence|adherence
515137|NCT00264069|Compliance|compliance
515138|NCT00264069|Schizophrenia|schizophrenia
515139|NCT00264069|Bipolar Disorder|bipolar disorder
515140|NCT00264069|Depression|depression
515141|NCT00264069|Personality Disorders|personality disorders
515142|NCT00264069|Registry|registry
515143|NCT00264095|Anemia|anemia
515144|NCT00264095|Blood loss|blood loss
515145|NCT00264095|Transfusion|transfusion
515146|NCT00264095|Blood transfusion|blood transfusion
515147|NCT00264095|Erythropoietin|erythropoietin
515148|NCT00264095|Surgery|surgery
515149|NCT00264095|Surgical blood loss|surgical blood loss
515150|NCT00264095|Tumor|tumor
515151|NCT00264095|Cancer|cancer
515152|NCT00264095|Surgical resection|surgical resection
515153|NCT00264095|Tumor resection|tumor resection
515154|NCT00264108|Antineoplastic agents|antineoplastic agents
515155|NCT00264108|Chemotherapy|chemotherapy
515156|NCT00264108|Cost-effectiveness|cost-effectiveness
515157|NCT00264108|Epoetin alfa|epoetin alfa
515158|NCT00264108|Darbepoetin alfa|darbepoetin alfa
515159|NCT00264121|congenital, high scrotal|congenital, high scrotal
515160|NCT00264134|Non-Small Cell Lung Cancer|non-small cell lung cancer
515161|NCT00264147|Arcoxia|arcoxia
515162|NCT00264160|AMN107|amn107
515163|NCT00264160|CML|cml
515164|NCT00264160|Bcr Abl|bcr abl
515165|NCT00264160|cytogenetic response|cytogenetic response
515166|NCT00264160|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
515167|NCT00264160|imatinib mesylate|imatinib mesylate
515168|NCT00264199|Chronic Congestive heart failure|chronic congestive heart failure
515169|NCT00264199|Ischemic heart disease|ischemic heart disease
515170|NCT00264199|insulin resistance|insulin resistance
515171|NCT00264225|osteoarthritis, pain|osteoarthritis, pain
515172|NCT00264251|HIV|hiv
515173|NCT00264251|Body composition|body composition
515174|NCT00264251|Weight reduction|weight reduction
515175|NCT00264251|Insulin resistance/sensitivity|insulin resistance/sensitivity
515176|NCT00264251|Exercise|exercise
515177|NCT00264251|Diet|diet
515178|NCT00264251|Visceral adiposity|visceral adiposity
515179|NCT00264264|Closure device|closure device
515180|NCT00264264|Stenting|stenting
515181|NCT00264264|Percutaneous coronary intervention|percutaneous coronary intervention
515182|NCT00264277|D-dimer|d-dimer
515183|NCT00264277|Recurrence|recurrence
515184|NCT00264277|Venous Thromboembolism|venous thromboembolism
515185|NCT00264277|Anticoagulation|anticoagulation
515188|NCT00264290|CMV|cmv
515189|NCT00264290|T Cell activation|t cell activation
515190|NCT00264290|Valganciclovir|valganciclovir
515191|NCT00264303|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
515192|NCT00264303|CUTE Levocetirizine Xyzal®|cute levocetirizine xyzal®
515193|NCT00264316|bone marrow cell transfer|bone marrow cell transfer
515194|NCT00264316|acute myocardial infarction|acute myocardial infarction
515195|NCT00264316|left ventricular function|left ventricular function
515197|NCT00264342|Tobacco|tobacco
515198|NCT00264342|Nicotine|nicotine
515199|NCT00264355|cyclosporine|cyclosporine
515200|NCT00264355|metabolites|metabolites
516847|NCT00269750|oxybutynin|oxybutynin
515201|NCT00264355|metabolic pattern|metabolic pattern
515202|NCT00264355|genotypes|genotypes
515203|NCT00264368|Renal replacement therapy|renal replacement therapy
515204|NCT00264368|CMV disease|cmv disease
515205|NCT00264381|Superficial Thrombophlebitis|superficial thrombophlebitis
515207|NCT00264381|Fragmin|fragmin
515208|NCT00264381|Ibuprofen|ibuprofen
515209|NCT00264381|Superficial Thrombus|superficial thrombus
515210|NCT00264381|Superficial Phlebitis|superficial phlebitis
515211|NCT00264381|phlebitis|phlebitis
515212|NCT00264394|Computer generated reminder system|computer generated reminder system
515213|NCT00264394|quality control|quality control
515214|NCT00264394|dyslipidemia|dyslipidemia
515215|NCT00264394|antiretroviral therapy|antiretroviral therapy
515216|NCT00264394|HIV infection|hiv infection
515217|NCT00264407|Hearing Loss, Central|hearing loss, central
515218|NCT00264407|Presbycusis|presbycusis
515219|NCT00264407|Hearing Loss, Sensorineural|hearing loss, sensorineural
515220|NCT00264407|Hearing Loss, Cochlear|hearing loss, cochlear
515221|NCT00264407|Hearing Loss, Bilateral|hearing loss, bilateral
515222|NCT00264407|Sex Steroid Hormones|sex steroid hormones
515223|NCT00264407|Estradiol|estradiol
515224|NCT00264420|bone metastases|bone metastases
515225|NCT00264420|breast cancer|breast cancer
515226|NCT00264420|lung cancer|lung cancer
515227|NCT00264420|prostate cancer|prostate cancer
515228|NCT00264420|zoledronic acid|zoledronic acid
515229|NCT00264420|radiation therapy|radiation therapy
515230|NCT00264433|Cancer; Tumors; Neoplasms; Anticarcinogenic Agents; Antineoplastic Agents|cancer; tumors; neoplasms; anticarcinogenic agents; antineoplastic agents
515231|NCT00264433|Cadherins; Non-Small-Cell Lung Carcinoma; Esophageal Cancer; Gastric Cancer; Renal Cell Carcinoma; Hepatocellular Carcinoma; Adrenocortical Carcinoma|cadherins; non-small-cell lung carcinoma; esophageal cancer; gastric cancer; renal cell carcinoma; hepatocellular carcinoma; adrenocortical carcinoma
515232|NCT00264446|Cancer; Tumors; Neoplasms; Anticarcinogenic Agents; Antineoplastic Agents;|cancer; tumors; neoplasms; anticarcinogenic agents; antineoplastic agents;
515233|NCT00264446|Dihydrouracil dehydrogenase (NADP); Colorectal Carcinoma; Liver Cancer|dihydrouracil dehydrogenase (nadp); colorectal carcinoma; liver cancer
515234|NCT00264459|Sublingual immunotherapy|sublingual immunotherapy
515235|NCT00264459|Rhinoconjunctivitis|rhinoconjunctivitis
515236|NCT00264459|Rhinitis|rhinitis
515237|NCT00264459|Asthma|asthma
515238|NCT00264472|Cancer|cancer
515239|NCT00264472|Tumors|tumors
515240|NCT00264472|Neoplasms|neoplasms
515241|NCT00264472|Anticarcinogenic Agents|anticarcinogenic agents
515242|NCT00264472|Antineoplastic Agents|antineoplastic agents
515243|NCT00264472|Dihydrouracil Dehydrogenase (NADP)|dihydrouracil dehydrogenase (nadp)
515244|NCT00264485|Postoperative pain|postoperative pain
515245|NCT00264485|patient-controlled analgesia|patient-controlled analgesia
515246|NCT00264498|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
515247|NCT00264498|NSCLC|nsclc
515248|NCT00264498|Lung Cancer|lung cancer
515249|NCT00264511|Hyperbaric oxygen|hyperbaric oxygen
515250|NCT00264511|Crush injury|crush injury
515251|NCT00264511|Tibial fracture|tibial fracture
515252|NCT00264511|Gustillo 3|gustillo 3
515253|NCT00264511|soft tissue injury|soft tissue injury
515254|NCT00264511|complications|complications
515255|NCT00264511|outcomes|outcomes
515256|NCT00264511|randomised controlled trial|randomised controlled trial
515257|NCT00264524|Rheumatic heart disease, HLA, Genetics, Taiwan|rheumatic heart disease, hla, genetics, taiwan
515258|NCT00264537|Rheumatoid Arthritis|rheumatoid arthritis
515259|NCT00264537|Methotrexate Naïve|methotrexate naïve
515260|NCT00264537|subcutaneous injection|subcutaneous injection
515261|NCT00264550|Rheumatoid Arthritis|rheumatoid arthritis
515262|NCT00264550|Golimumab|golimumab
515263|NCT00264550|Methotrexate|methotrexate
515264|NCT00264550|Fully Human anti-TNFa monoclonal antibody|fully human anti-tnfa monoclonal antibody
515265|NCT00264550|Simpony|simpony
515266|NCT00264576|influenza|influenza
515267|NCT00264576|flu|flu
515268|NCT00264589|vascular function|vascular function
515269|NCT00264589|cardiac function|cardiac function
515270|NCT00264589|individualized training|individualized training
515271|NCT00264589|ultrasonography|ultrasonography
515272|NCT00264589|body composition|body composition
515273|NCT00264602|Lymphatic mapping|lymphatic mapping
515274|NCT00264602|nodal targeting|nodal targeting
515275|NCT00264602|indocyanine green|indocyanine green
515276|NCT00264602|near infrared imaging|near infrared imaging
515277|NCT00264615|once daily dosing|once daily dosing
515278|NCT00264615|seizure|seizure
515279|NCT00264615|pharmacokinetics|pharmacokinetics
515280|NCT00264615|epilepsy|epilepsy
515281|NCT00264628|NK1-antagonist|nk1-antagonist
515282|NCT00264628|Depression|depression
515283|NCT00264628|Fibromyalgia|fibromyalgia
515284|NCT00264628|GW679769|gw679769
515285|NCT00264628|Outpatient|outpatient
515286|NCT00264641|Hypoglycemia|hypoglycemia
515287|NCT00264641|Cognitive impairment|cognitive impairment
515289|NCT00264641|CalCAP|calcap
515290|NCT00264654|Social|social
515291|NCT00264654|(SAD)|(sad)
515292|NCT00264654|Anxiety|anxiety
515293|NCT00264654|Disorder|disorder
515294|NCT00264667|Dyslipidaemia|dyslipidaemia
515295|NCT00264680|Validation of questionnaire|validation of questionnaire
515296|NCT00264680|qolie-10|qolie-10
515297|NCT00264680|epilepsy|epilepsy
515298|NCT00264680|lamotrigine|lamotrigine
515299|NCT00264680|quality of life|quality of life
515300|NCT00264719|A drug is administered to initiate breastfeeding|a drug is administered to initiate breastfeeding
515301|NCT00264732|cervical lesions|cervical lesions
515302|NCT00264732|cervical dysplasia|cervical dysplasia
515303|NCT00264732|Human papilloma virus|human papilloma virus
515304|NCT00264732|abnormal Pap|abnormal pap
515305|NCT00264732|High-grade cervical intraepithelial lesions (CIN 2/3)|high-grade cervical intraepithelial lesions (cin 2/3)
515306|NCT00264745|Caregiver|caregiver
515307|NCT00264745|Stroke|stroke
515308|NCT00264758|randomized controlled clinical trial|randomized controlled clinical trial
515309|NCT00264758|hemodialysis|hemodialysis
515310|NCT00264758|end stage renal disease|end stage renal disease
583430|NCT00511745|Gastroesophageal reflux|gastroesophageal reflux
515311|NCT00264771|Fiji, Group A streptococcus, rheumatic, glomerulonephritis|fiji, group a streptococcus, rheumatic, glomerulonephritis
515312|NCT00264784|Streptococcus, Group A, Fiji, epidemiology|streptococcus, group a, fiji, epidemiology
515313|NCT00264810|Responsive Stimulation|responsive stimulation
515314|NCT00264810|Brain Stimulator|brain stimulator
515315|NCT00264810|Epilepsy|epilepsy
515316|NCT00264810|Seizures|seizures
515317|NCT00264823|HIV|hiv
515318|NCT00264823|Mental Illness|mental illness
515319|NCT00264849|Asthma|asthma
515320|NCT00264849|omalizumab|omalizumab
515321|NCT00264849|Severe persistent allergic asthma|severe persistent allergic asthma
515322|NCT00264888|Duchenne muscular dystrophy|duchenne muscular dystrophy
515323|NCT00264888|Nonsense mutation|nonsense mutation
515324|NCT00264888|Premature stop codon|premature stop codon
515325|NCT00264914|Inappropriate ADH Syndrome|inappropriate adh syndrome
515326|NCT00264914|Hyponatremia|hyponatremia
515327|NCT00264927|Inappropriate ADH Syndrome|inappropriate adh syndrome
515328|NCT00264927|Hyponatremia|hyponatremia
515329|NCT00264953|Hodgkin´s lymphoma|hodgkin´s lymphoma
515330|NCT00264953|intermediate stages|intermediate stages
515331|NCT00264966|Mild asthma|mild asthma
515332|NCT00264979|Colorectal cancer|colorectal cancer
515333|NCT00264979|Sequential or simultaneous surgery|sequential or simultaneous surgery
515334|NCT00264979|Synchronous hepatic metastases|synchronous hepatic metastases
515335|NCT00264992|embryo implantation, in vitro fertilization,|embryo implantation, in vitro fertilization,
515336|NCT00264992|cytokine expression|cytokine expression
515337|NCT00265005|alteplase|alteplase
515338|NCT00265005|occluded central venous catheter|occluded central venous catheter
515339|NCT00265005|occluded arterial catheter|occluded arterial catheter
515340|NCT00265005|occluded PICC|occluded picc
515341|NCT00265005|neonates|neonates
515342|NCT00265005|infants|infants
515343|NCT00265018|Hodgkin´s lymphoma|hodgkin´s lymphoma
515344|NCT00265018|early stages|early stages
515345|NCT00265031|Hodgkin´s Lymphoma|hodgkin´s lymphoma
515346|NCT00265031|advanced stages|advanced stages
515347|NCT00265044|Behavior Change|behavior change
515348|NCT00265044|patient Education|patient education
515349|NCT00265057|Cancer;|cancer;
515350|NCT00265057|Tumors;|tumors;
515351|NCT00265057|Neoplasms;|neoplasms;
515352|NCT00265057|Anticarcinogenic Agents;|anticarcinogenic agents;
515353|NCT00265057|Antineoplastic Agents;|antineoplastic agents;
515354|NCT00265057|Cadherins;|cadherins;
515355|NCT00265057|Non-Small-Cell Lung Carcinoma;|non-small-cell lung carcinoma;
515356|NCT00265057|Ovarian Cancer|ovarian cancer
515357|NCT00265083|Spondylitis|spondylitis
515358|NCT00265083|subcutaneous injection|subcutaneous injection
515359|NCT00265083|Bechterew's Disease|bechterew's disease
515360|NCT00265083|Spondyloarthritis|spondyloarthritis
515361|NCT00265083|Spondyloarthropathy|spondyloarthropathy
515362|NCT00265096|Psoriatic Arthritis|psoriatic arthritis
515363|NCT00265096|Spondyloarthritis|spondyloarthritis
515364|NCT00265096|Spondyloarthropathy|spondyloarthropathy
515365|NCT00265096|subcutaneous injection|subcutaneous injection
515366|NCT00265109|body dysmorphic disorder|body dysmorphic disorder
515367|NCT00265109|levetiracetam|levetiracetam
515368|NCT00265122|Crohn Disease|crohn disease
515369|NCT00265122|Biologic|biologic
515370|NCT00265122|Infusion|infusion
515371|NCT00265122|Injection|injection
515372|NCT00265122|CNTO 1275|cnto 1275
515373|NCT00265122|Ustekinumab|ustekinumab
515374|NCT00265122|C01275|c01275
515375|NCT00265122|IL-12p40|il-12p40
515376|NCT00265135|Renal cell carcinoma|renal cell carcinoma
515377|NCT00265135|CNTO 328|cnto 328
515378|NCT00265135|Infusions|infusions
515379|NCT00265135|Renal cell cancer|renal cell cancer
515380|NCT00265148|rosiglitazone|rosiglitazone
515381|NCT00265148|cognition|cognition
515382|NCT00265148|cerebral glucose metabolism|cerebral glucose metabolism
515383|NCT00265148|positron emission tomography (PET)|positron emission tomography (pet)
515384|NCT00265148|Alzheimer's Disease|alzheimer's disease
515385|NCT00265161|influenza vaccine|influenza vaccine
515386|NCT00265161|effectiveness|effectiveness
515387|NCT00265161|health care worker|health care worker
515388|NCT00265161|OBSERVATIONAL STUDY|observational study
515390|NCT00265174|LOH|loh
515391|NCT00265174|METHYLATION|methylation
515394|NCT00265187|child, bronchiolitis,|child, bronchiolitis,
515396|NCT00265200|bone metastasis|bone metastasis
515397|NCT00265200|lung cancer|lung cancer
515398|NCT00265200|non-small cell lung cancer|non-small cell lung cancer
515399|NCT00265200|small cell lung cancer|small cell lung cancer
515400|NCT00265200|bone metabolic markers|bone metabolic markers
515401|NCT00265200|tartrate resistant acid phosphatase|tartrate resistant acid phosphatase
515402|NCT00265213|breast conservative surgery|breast conservative surgery
515403|NCT00265213|shoulder functional outcome questionnaire|shoulder functional outcome questionnaire
515404|NCT00265213|disability questionnaire|disability questionnaire
515405|NCT00265226|India|india
515406|NCT00265226|Pulmonary Tuberculosis|pulmonary tuberculosis
515407|NCT00265226|Category-II tuberculosis|category-ii tuberculosis
515408|NCT00265226|Immunomodulator|immunomodulator
515409|NCT00265226|Mycobacterium w|mycobacterium w
515410|NCT00265226|Revised National Tuberculosis Control Programme|revised national tuberculosis control programme
515411|NCT00265226|Category-II Pulmonary Tuberculosis|category-ii pulmonary tuberculosis
515412|NCT00265239|Edaravone|edaravone
515413|NCT00265239|Randomized Control Trial|randomized control trial
515414|NCT00265239|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
515415|NCT00265239|Coronary Angioplasty|coronary angioplasty
515416|NCT00256659|Medical inpatients|medical inpatients
515417|NCT00256659|Social Work|social work
515418|NCT00256659|Physical therapy|physical therapy
515419|NCT00256659|Occupational therapy|occupational therapy
515420|NCT00256659|Psychiatry|psychiatry
515421|NCT00256659|Early intervention|early intervention
515422|NCT00256659|Iatrogenic complications|iatrogenic complications
515423|NCT00256672|Spinal Cord Injury|spinal cord injury
515424|NCT00256672|TLSO brace|tlso brace
515425|NCT00256672|Spine curvature|spine curvature
515426|NCT00256672|Child|child
515427|NCT00256672|Effectiveness of bracing|effectiveness of bracing
515428|NCT00256685|Menopause|menopause
515429|NCT00256698|Hormone|hormone
515430|NCT00256698|receptor|receptor
515431|NCT00256698|positive|positive
515432|NCT00256698|breast|breast
515433|NCT00256698|cancer|cancer
515434|NCT00256698|first|first
515435|NCT00256698|relapse|relapse
515436|NCT00256711|Locally advanced or metastatic NSCLC.|locally advanced or metastatic nsclc.
515437|NCT00256711|Stage IIIb or Stage IV lung cancer|stage iiib or stage iv lung cancer
515438|NCT00256724|hypotension|hypotension
515439|NCT00256724|hypovolemia|hypovolemia
515440|NCT00256724|dehydration|dehydration
515441|NCT00256724|sepsis|sepsis
515442|NCT00256724|blood loss|blood loss
515443|NCT00256737|Maintenance of healed erosive esophagitis|maintenance of healed erosive esophagitis
515444|NCT00256776|Multiple Myeloma|multiple myeloma
515445|NCT00256776|Velcade|velcade
515446|NCT00256776|Autologous transplantation|autologous transplantation
515447|NCT00256776|Relapse|relapse
515448|NCT00256776|Disease progress|disease progress
515449|NCT00256789|NSCLC, Non-Small Cell Lung Cancer,Weekly Radiation, Taxotere|nsclc, non-small cell lung cancer,weekly radiation, taxotere
515450|NCT00256802|Headache|headache
515451|NCT00256802|migraine|migraine
515452|NCT00256802|MR-angiography|mr-angiography
515453|NCT00256802|healthy volunteers|healthy volunteers
515454|NCT00256802|GTN|gtn
515455|NCT00256802|Middle cerebral artery|middle cerebral artery
515456|NCT00256815|Hypofractionated chest radiation|hypofractionated chest radiation
515457|NCT00256815|Oral Navelbine|oral navelbine
515458|NCT00256828|HIV infection|hiv infection
515459|NCT00256828|Highly active antiretroviral therapy|highly active antiretroviral therapy
515460|NCT00256828|Treatment Naive|treatment naive
515461|NCT00256841|Hypofractionated Chest Radiation|hypofractionated chest radiation
515462|NCT00256841|Taxotere|taxotere
515463|NCT00256841|5-FU|5-fu
515464|NCT00256854|RLS|rls
515465|NCT00256854|Ropinirole|ropinirole
515466|NCT00256854|Restless Legs Syndrome|restless legs syndrome
515467|NCT00256867|Type 2 diabetes Type II|type 2 diabetes type ii
515468|NCT00256880|Pazopanib(GW786034)|pazopanib(gw786034)
515469|NCT00256880|Solid Tumors|solid tumors
515470|NCT00256880|Myeloma|myeloma
515471|NCT00256893|pain intensity|pain intensity
515472|NCT00256893|numerical rating scale|numerical rating scale
515473|NCT00256893|fibromyalgia|fibromyalgia
515474|NCT00256906|lateral ventricles|lateral ventricles
515475|NCT00256906|fetal ventriculomegaly|fetal ventriculomegaly
515476|NCT00256919|GW856553|gw856553
515477|NCT00256919|biomarkers|biomarkers
515478|NCT00256919|CRP|crp
515479|NCT00256919|rheumatoid arthritis|rheumatoid arthritis
515876|NCT00268047|pediatric|pediatric
515480|NCT00256932|bowel dysfunction|bowel dysfunction
515481|NCT00256932|constipation|constipation
515482|NCT00256932|gastrointestinal|gastrointestinal
515483|NCT00256932|opioids|opioids
515484|NCT00256932|pain|pain
515485|NCT00256932|non-cancer pain|non-cancer pain
515486|NCT00256932|Opioid-induced|opioid-induced
515487|NCT00256945|biofilm formation|biofilm formation
515488|NCT00256945|dental plaque|dental plaque
515489|NCT00256945|surface roughness|surface roughness
515490|NCT00256945|dental restoration|dental restoration
515491|NCT00256945|dental materials|dental materials
515492|NCT00256984|Obstructive Defecation Syndrome|obstructive defecation syndrome
515493|NCT00256984|Colorectal Surgery|colorectal surgery
515494|NCT00256984|Defecography|defecography
515495|NCT00256984|Constipation|constipation
515496|NCT00256984|Rectocele|rectocele
515497|NCT00256984|Intussusception|intussusception
515498|NCT00256984|Quality of Life|quality of life
515499|NCT00256997|Schizophrenia|schizophrenia
515500|NCT00256997|Risperidone|risperidone
515501|NCT00256997|Risperdal Consta|risperdal consta
515502|NCT00257010|Migraine|migraine
515503|NCT00257010|Almotriptan Malate|almotriptan malate
515504|NCT00257010|Headache|headache
515505|NCT00257010|Triptan|triptan
515506|NCT00257023|Schizophrenia|schizophrenia
515507|NCT00257023|Risperidone|risperidone
583431|NCT00511758|Cervical Dysplasia|cervical dysplasia
515508|NCT00257023|Positive and Negative Syndrome Scale (PANSS)|positive and negative syndrome scale (panss)
515509|NCT00257023|Clinical Global Impression (CGI)|clinical global impression (cgi)
515510|NCT00257023|Positron Emission Tomography (PET)|positron emission tomography (pet)
515511|NCT00257036|Infectious skin diseases|infectious skin diseases
515512|NCT00257036|skin diseases|skin diseases
515513|NCT00257036|bacterial skin diseases|bacterial skin diseases
515514|NCT00257036|cellulitis|cellulitis
515515|NCT00257036|quinolones|quinolones
515516|NCT00257036|levofloxacin|levofloxacin
515517|NCT00257049|Pneumonia|pneumonia
515518|NCT00257049|lung inflammation|lung inflammation
515519|NCT00257049|bacterial pneumonia|bacterial pneumonia
515520|NCT00257049|lung diseases|lung diseases
515521|NCT00257049|respiratory tract infections|respiratory tract infections
515522|NCT00257049|antibacterial agents|antibacterial agents
515523|NCT00257049|quinolones|quinolones
515524|NCT00257049|levofloxacin|levofloxacin
515525|NCT00257062|Infectious skin diseases|infectious skin diseases
515526|NCT00257062|skin diseases|skin diseases
515527|NCT00257062|bacterial skin diseases|bacterial skin diseases
515528|NCT00257062|antibacterial agents|antibacterial agents
515529|NCT00257062|quinolones|quinolones
515530|NCT00257062|levofloxacin|levofloxacin
515531|NCT00257075|risperidone|risperidone
515532|NCT00257075|antipsychotic agents|antipsychotic agents
515533|NCT00257075|bipolar disorders|bipolar disorders
515534|NCT00257075|manic episode|manic episode
515535|NCT00257088|development|development
515536|NCT00257088|epidemiology|epidemiology
515537|NCT00257088|risk factors|risk factors
515538|NCT00257088|randomized field trials|randomized field trials
515539|NCT00257114|Multiple Myeloma|multiple myeloma
515540|NCT00257114|Retreatment|retreatment
515541|NCT00257114|VELCADE|velcade
515542|NCT00257127|Vaccination|vaccination
515543|NCT00257140|Bronchitis|bronchitis
515544|NCT00257140|chronic bronchitis|chronic bronchitis
515545|NCT00257140|lung diseases|lung diseases
515546|NCT00257140|respiratory tract infections|respiratory tract infections
515547|NCT00257140|bronchial diseases|bronchial diseases
515548|NCT00257140|antibacterial agents|antibacterial agents
515549|NCT00257140|quinolones|quinolones
515550|NCT00257140|levofloxacin|levofloxacin
515551|NCT00257153|Acute myocardial infarction|acute myocardial infarction
515552|NCT00257153|primary angioplasty|primary angioplasty
515553|NCT00257153|myocardial reperfusion|myocardial reperfusion
515554|NCT00257153|thrombus aspiration|thrombus aspiration
515555|NCT00257179|Tissue factor|tissue factor
515556|NCT00257179|Lung cancer|lung cancer
515557|NCT00257179|Tissue factor protein inhibitor|tissue factor protein inhibitor
515558|NCT00257179|Factor VII|factor vii
515559|NCT00257179|Factor X|factor x
515560|NCT00257192|Adolescent Subjects With Schizophrenia|adolescent subjects with schizophrenia
515561|NCT00257231|Immunity, innate|immunity, innate
515562|NCT00257231|Inflammation|inflammation
515563|NCT00257231|Genomics|genomics
515564|NCT00257231|Proteomics|proteomics
515565|NCT00257244|Immunity, innate|immunity, innate
515566|NCT00257244|Inflammation|inflammation
515567|NCT00257244|Genomics|genomics
515568|NCT00257244|Proteomics|proteomics
515569|NCT00257257|Type 2 diabetes mellitus|type 2 diabetes mellitus
515570|NCT00257270|Chronic|chronic
515571|NCT00257270|Tinnitus|tinnitus
515572|NCT00257270|Acoustic trauma|acoustic trauma
515573|NCT00257270|Psychophysics|psychophysics
515574|NCT00257270|Loudness match|loudness match
515575|NCT00257270|gabapentin|gabapentin
515576|NCT00265252|osteonecrosis|osteonecrosis
515577|NCT00265252|total hip replacement|total hip replacement
515578|NCT00265265|Cocaine Dependence|cocaine dependence
515579|NCT00265291|Depression|depression
515580|NCT00265291|mood disorders|mood disorders
515581|NCT00265291|affective disorders|affective disorders
515582|NCT00265291|pharmacogenetics|pharmacogenetics
515583|NCT00265291|pharmacogenomics|pharmacogenomics
515584|NCT00265304|Osteoarthritis|osteoarthritis
515585|NCT00265317|Non-small cell lung cancer|non-small cell lung cancer
515586|NCT00265317|sunitinib|sunitinib
515587|NCT00265317|erlotinib|erlotinib
515588|NCT00265317|Phase 2|phase 2
515589|NCT00265330|Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)|children and adolescents with bipolar i disorder (manic or mixed)
515590|NCT00265356|Positron Emission Tomography (PET)|positron emission tomography (pet)
518924|NCT00270283|HIV|hiv
515591|NCT00265356|Diagnostic Investigation|diagnostic investigation
515592|NCT00265356|Colorectal cancer|colorectal cancer
515593|NCT00265356|Liver metastases|liver metastases
515594|NCT00265356|Liver surgery|liver surgery
515595|NCT00265382|Adolescent Subjects|adolescent subjects
515596|NCT00265408|Cervicocephalic Arterial Dissection|cervicocephalic arterial dissection
515597|NCT00265421|Suture Techniques|suture techniques
515598|NCT00265447|knee osteoarthritis|knee osteoarthritis
515599|NCT00265447|exercise|exercise
515600|NCT00265447|aerobic exercise|aerobic exercise
515601|NCT00265447|strengthening exercise|strengthening exercise
515602|NCT00265447|exercise prescription|exercise prescription
515603|NCT00265447|rehabilitation|rehabilitation
515604|NCT00265447|physical disability|physical disability
515605|NCT00265447|physical function|physical function
515606|NCT00265447|physical activity|physical activity
515607|NCT00265447|physical fitness|physical fitness
515608|NCT00265460|smoking cessation,|smoking cessation,
515609|NCT00265460|nicotine,|nicotine,
515610|NCT00265460|smokeless tobacco,|smokeless tobacco,
515611|NCT00265460|cigarettes|cigarettes
515612|NCT00265486|Divers|divers
515613|NCT00265486|Brain|brain
515614|NCT00265486|Flow|flow
515615|NCT00265486|Blood|blood
515616|NCT00265486|EPO|epo
515617|NCT00265486|Dive|dive
515618|NCT00265486|reflex|reflex
515619|NCT00265499|Coronary Artery Bypass|coronary artery bypass
515620|NCT00265499|Skeletonization|skeletonization
515621|NCT00265499|Internal Thoracic Artery|internal thoracic artery
515622|NCT00265499|Flow|flow
515623|NCT00265499|Length|length
515624|NCT00265499|Pain|pain
515625|NCT00265512|Telemedicine|telemedicine
515626|NCT00265512|Aftercare|aftercare
515627|NCT00265525|Randomized Control Trial|randomized control trial
515628|NCT00265525|Exercise Intervention|exercise intervention
515629|NCT00265525|Prevention|prevention
515630|NCT00265525|Rehabilitation|rehabilitation
515631|NCT00265538|Hypertension|hypertension
515632|NCT00265538|Diuretics|diuretics
515633|NCT00265538|Drug Therapy|drug therapy
515634|NCT00265538|Anti-Hypertensive Agents|anti-hypertensive agents
515635|NCT00265538|Patient Intervention|patient intervention
515636|NCT00265551|Schizophrenia|schizophrenia
515637|NCT00265564|outcomes assessment|outcomes assessment
515638|NCT00265564|substance use disorders|substance use disorders
515639|NCT00265564|stress disorders, post-traumatic|stress disorders, post-traumatic
515640|NCT00265564|screening|screening
515641|NCT00265590|Aniridia|aniridia
515642|NCT00265590|PAX6|pax6
515643|NCT00265590|Keratopathy|keratopathy
515644|NCT00265590|Limbal Stem Cell Deficiency|limbal stem cell deficiency
515645|NCT00265590|Molecular Genetics|molecular genetics
515646|NCT00267033|Neoplasm Metastasis|neoplasm metastasis
515647|NCT00267033|Bone Neoplasms|bone neoplasms
515648|NCT00267033|Pain|pain
515649|NCT00267033|Radiotherapy|radiotherapy
515650|NCT00267033|Vertebroplasty|vertebroplasty
515651|NCT00267033|Combined modality therapy|combined modality therapy
515652|NCT00267046|Sarcoma|sarcoma
515653|NCT00267046|Soft Tissue Sarcoma|soft tissue sarcoma
515654|NCT00267046|Oral Mucositis|oral mucositis
515655|NCT00267046|Doxorubicin|doxorubicin
515656|NCT00267046|Adriamycin|adriamycin
515657|NCT00267046|Ifosfamide|ifosfamide
515658|NCT00267046|Palifermin|palifermin
515659|NCT00267046|Vincristine|vincristine
515660|NCT00267046|Cisplatin|cisplatin
515661|NCT00267046|Placebo|placebo
515662|NCT00267059|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
515663|NCT00267059|Lenalidomide|lenalidomide
515664|NCT00267059|Revlimid|revlimid
515665|NCT00267059|CLL|cll
515666|NCT00267072|Ovarian Cancer|ovarian cancer
515667|NCT00267085|Chronic Myeloid Leukemia|chronic myeloid leukemia
515668|NCT00267085|Minimal Residual Disease|minimal residual disease
515669|NCT00267085|Peptide Vaccine|peptide vaccine
515670|NCT00267098|Atrioventricular block|atrioventricular block
515671|NCT00267098|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
515672|NCT00267098|Pacemaker|pacemaker
515673|NCT00267098|Defibrillator|defibrillator
515674|NCT00267098|NYHA Class I, II or III Heart failure|nyha class i, ii or iii heart failure
515675|NCT00267111|Infant,newborn|infant,newborn
515676|NCT00267111|Topical anesthesia|topical anesthesia
515677|NCT00267111|Intramuscular injection|intramuscular injection
515678|NCT00267124|cognitive decline|cognitive decline
515679|NCT00267124|dementia|dementia
515680|NCT00267124|neuroimaging|neuroimaging
515681|NCT00267137|Pacemaker, Atrial Fibrillation/Therapy|pacemaker, atrial fibrillation/therapy
515682|NCT00267150|Simultaneous Pancreas-Kidney Transplantation|simultaneous pancreas-kidney transplantation
515683|NCT00267150|mycophenolate|mycophenolate
515684|NCT00267150|GI problems|gi problems
515685|NCT00267163|Alzheimer's disease|alzheimer's disease
515686|NCT00267163|Mild Cognitive Impairment|mild cognitive impairment
515687|NCT00267176|Osteoarthritis,|osteoarthritis,
515688|NCT00267176|hypertension,|hypertension,
515689|NCT00267176|lumiracoxib,|lumiracoxib,
515690|NCT00267176|ibuprofen,|ibuprofen,
515691|NCT00267176|24-hour blood pressure profile|24-hour blood pressure profile
519527|NCT00282867|insulin|insulin
515692|NCT00267189|Liver transplantation, everolimus, calcineurin inhibitor, renal function|liver transplantation, everolimus, calcineurin inhibitor, renal function
515693|NCT00267202|Allergic Asthma, IgE, immunotherapy, omalizumab|allergic asthma, ige, immunotherapy, omalizumab
515694|NCT00267215|Lumiracoxib|lumiracoxib
515695|NCT00267215|osteoarthritis|osteoarthritis
515696|NCT00267228|Anorexia Nervosa|anorexia nervosa
515697|NCT00267228|Eating disorder|eating disorder
515698|NCT00267228|Quality of life|quality of life
515699|NCT00267241|ARDS|ards
515700|NCT00267241|ALI|ali
515701|NCT00267241|respiratory mechanics|respiratory mechanics
515702|NCT00267241|gas exchange|gas exchange
515703|NCT00267241|assisted ventilation|assisted ventilation
515704|NCT00267293|fever treatment|fever treatment
515705|NCT00267293|children|children
515706|NCT00267332|Sedation|sedation
515707|NCT00267332|Pain|pain
515708|NCT00267332|modafinil|modafinil
515709|NCT00267332|opioids|opioids
515710|NCT00267371|Migraine headache|migraine headache
515711|NCT00267371|Patent Foramen Ovale|patent foramen ovale
515712|NCT00267371|Patent Foramen Ovale Closure|patent foramen ovale closure
515713|NCT00267384|Aminoglycosides|aminoglycosides
515714|NCT00267397|infant|infant
515715|NCT00267397|prenatal|prenatal
515716|NCT00267397|birth defects|birth defects
515717|NCT00267397|22Q11 deletion|22q11 deletion
515718|NCT00267410|HIV|hiv
515719|NCT00267410|Adaptation|adaptation
515720|NCT00267410|Behavioral interventions|behavioral interventions
515721|NCT00267410|Seropositive|seropositive
515722|NCT00267410|MSM|msm
515723|NCT00267410|HIV Seronegativity|hiv seronegativity
515724|NCT00267423|pediatric|pediatric
515725|NCT00267423|cardiac|cardiac
515726|NCT00267423|electrophysiology|electrophysiology
515727|NCT00267423|epicardial biventricular pacing|epicardial biventricular pacing
515728|NCT00267436|adaptation|adaptation
515729|NCT00267436|HIV prevention|hiv prevention
515730|NCT00267436|HIV positive|hiv positive
515731|NCT00267436|evidence based interventions|evidence based interventions
515732|NCT00267436|HIV Seronegativity|hiv seronegativity
515733|NCT00267449|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
515734|NCT00267449|Mammography|mammography
515735|NCT00267449|Breast Cancer|breast cancer
515736|NCT00267462|pediatric|pediatric
515737|NCT00267462|cardiac|cardiac
515738|NCT00267462|hypertrophic Myopathy|hypertrophic myopathy
515739|NCT00267475|eosinophilic esophagitis|eosinophilic esophagitis
515740|NCT00267475|eosinophilic gastritis|eosinophilic gastritis
515741|NCT00267475|eosinophilic enteritis|eosinophilic enteritis
515742|NCT00267475|eosinophilic colitis|eosinophilic colitis
515743|NCT00267475|eosinophilic gastroenteritis|eosinophilic gastroenteritis
515744|NCT00267488|Hycamtin|hycamtin
515745|NCT00267488|endometrial cancer|endometrial cancer
515746|NCT00267488|topotecan|topotecan
515747|NCT00267501|Eosinophilic Disorders|eosinophilic disorders
515748|NCT00267514|Hemodialysis|hemodialysis
515749|NCT00267527|Treatment Experienced|treatment experienced
515750|NCT00267527|HIV Visceral Obesity|hiv visceral obesity
515751|NCT00267540|Vitamin D|vitamin d
515752|NCT00267540|adolescent girls|adolescent girls
515753|NCT00267540|bone accretion|bone accretion
515754|NCT00267540|bone turn over|bone turn over
515755|NCT00267540|vitamin D status|vitamin d status
515756|NCT00267540|Vitamin D insufficiency in young girls|vitamin d insufficiency in young girls
515757|NCT00267553|Atamestane|atamestane
515758|NCT00267553|Breast neoplasms|breast neoplasms
515759|NCT00267553|Combined hormonal therapy|combined hormonal therapy
515760|NCT00267553|Complete estrogen blockade|complete estrogen blockade
515761|NCT00267553|Ductal breast carcinoma|ductal breast carcinoma
515762|NCT00267553|Estrogen blocker|estrogen blocker
515763|NCT00267553|Fareston®|fareston®
515764|NCT00267553|Femara®|femara®
515765|NCT00267553|First line therapy|first line therapy
515766|NCT00267553|Letrozole|letrozole
515767|NCT00267553|Lobular breast carcinoma|lobular breast carcinoma
515768|NCT00267553|Locally advanced breast cancer|locally advanced breast cancer
515769|NCT00267553|Locally recurrent breast cancer|locally recurrent breast cancer
515770|NCT00267553|Maximal estrogen inhibition|maximal estrogen inhibition
515771|NCT00267553|Metastatic breast cancer|metastatic breast cancer
515772|NCT00267553|Neoplasms, Hormone-dependent|neoplasms, hormone-dependent
515773|NCT00267553|Receptor-positive|receptor-positive
515774|NCT00267553|Stage IIIA breast cancer|stage iiia breast cancer
515775|NCT00267553|Stage IIIB breast cancer|stage iiib breast cancer
515776|NCT00267553|Stage IV breast cancer|stage iv breast cancer
515777|NCT00267553|Toremifene|toremifene
515778|NCT00267631|children, obesity, emergency medicine|children, obesity, emergency medicine
515779|NCT00267644|Children, dehydration, Ultrasound|children, dehydration, ultrasound
515780|NCT00267670|Fatty Liver Disease|fatty liver disease
515781|NCT00267670|Liver|liver
515782|NCT00267670|NASH|nash
515783|NCT00267670|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
515784|NCT00267670|Nonalcoholic Fatty Liver Disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
515785|NCT00267670|Pentoxifylline|pentoxifylline
515786|NCT00267696|ovarian cancer|ovarian cancer
515787|NCT00267696|platinum sensitive cancer|platinum sensitive cancer
515788|NCT00267696|fallopian tube cancer|fallopian tube cancer
515789|NCT00267696|peritoneal cancer|peritoneal cancer
515790|NCT00267735|pregnancy|pregnancy
515791|NCT00267735|repeat cesarean|repeat cesarean
515792|NCT00267735|vaginal birth after cesarean|vaginal birth after cesarean
515793|NCT00267800|Lung disease, Interstitial|lung disease, interstitial
515794|NCT00267800|Sarcoidosis|sarcoidosis
515795|NCT00267800|Pulmonary fibrosis|pulmonary fibrosis
515796|NCT00267813|craving|craving
515797|NCT00267813|nicotine|nicotine
515798|NCT00267813|imaging|imaging
515799|NCT00267813|FDG|fdg
515800|NCT00267813|PET|pet
515801|NCT00267813|smoking|smoking
515802|NCT00267813|Bupropion|bupropion
515803|NCT00267826|Anti-CD20 antibody treatment|anti-cd20 antibody treatment
515804|NCT00267826|Atopic dermatitis|atopic dermatitis
515805|NCT00267826|B cells|b cells
515806|NCT00267826|Cytokines|cytokines
515807|NCT00267826|Immunopathology|immunopathology
515808|NCT00267839|exercise|exercise
515809|NCT00267839|intervention|intervention
515810|NCT00267839|elderly woman|elderly woman
515811|NCT00267839|risk factors|risk factors
515812|NCT00267839|health costs|health costs
515813|NCT00267839|Osteoporosis|osteoporosis
515814|NCT00267839|cardiovascular diseases|cardiovascular diseases
515815|NCT00267839|diabetes|diabetes
515816|NCT00267839|Higher Age|higher age
515817|NCT00267852|Arthritis|arthritis
515818|NCT00267865|HIV|hiv
515819|NCT00267865|AIDS-Related-Primary Central Nervous System Lymphoma|aids-related-primary central nervous system lymphoma
515820|NCT00267865|High Dose Methotrexate|high dose methotrexate
515821|NCT00267865|Rituximab|rituximab
515822|NCT00267865|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
515823|NCT00267865|AIDS Related-Primary Central Nervous System Lymphoma|aids related-primary central nervous system lymphoma
515824|NCT00267865|AR-PCNSL|ar-pcnsl
515825|NCT00267891|Healthy Control Subjects|healthy control subjects
515826|NCT00267891|Aggression|aggression
515827|NCT00267891|Prefrontal Cortex Function|prefrontal cortex function
515828|NCT00267891|Children and Adolescents|children and adolescents
515829|NCT00267891|Healthy Volunteer|healthy volunteer
515830|NCT00267891|HV|hv
515831|NCT00267904|Normal Physiology|normal physiology
515832|NCT00267904|Catecholamines|catecholamines
515833|NCT00267904|Catechols|catechols
515834|NCT00267904|Healthy Volunteer|healthy volunteer
515835|NCT00267904|HV|hv
515836|NCT00267930|AFib|afib
515837|NCT00267930|AF|af
515838|NCT00267956|Psoriatic arthritis|psoriatic arthritis
515839|NCT00267956|CNTO 1275|cnto 1275
515840|NCT00267956|Ustekinumab|ustekinumab
515841|NCT00267956|Interleukin-23, IL-12, IL-23|interleukin-23, il-12, il-23
515842|NCT00267956|Monoclonal antibodies|monoclonal antibodies
515843|NCT00267969|Ustekinumab|ustekinumab
515844|NCT00267969|CNTO1275|cnto1275
515845|NCT00267969|Plaque type Psoriasis|plaque type psoriasis
515846|NCT00267969|Interleukin-23|interleukin-23
515847|NCT00267969|IL-23|il-23
515848|NCT00267969|Psoriasis|psoriasis
515849|NCT00267969|Interleukin 12|interleukin 12
515850|NCT00267969|IL-12|il-12
515851|NCT00267982|pediatric|pediatric
515852|NCT00267982|cardiac|cardiac
515853|NCT00267982|Radiofrequency Ablation|radiofrequency ablation
515854|NCT00267982|Ectopic Atrial Tachycardia|ectopic atrial tachycardia
515855|NCT00267995|Pediatric|pediatric
515856|NCT00267995|cardiac|cardiac
515857|NCT00267995|Ross procedure|ross procedure
515858|NCT00267995|Aortic valve replacement|aortic valve replacement
515859|NCT00267995|Proximal buttressing technique|proximal buttressing technique
515860|NCT00268008|aortic valve replacement|aortic valve replacement
515861|NCT00268008|mitral valve replacement|mitral valve replacement
515862|NCT00268008|valvular stenosis|valvular stenosis
515863|NCT00268008|Ross procedure|ross procedure
515864|NCT00268008|Homograft valves|homograft valves
515865|NCT00268008|Bio-prosthetic valves|bio-prosthetic valves
515866|NCT00268008|Mechanical valves|mechanical valves
515867|NCT00268021|pediatric|pediatric
515868|NCT00268021|biventricular pacemaker|biventricular pacemaker
515869|NCT00268021|automated implantable cardioverter defibrillator|automated implantable cardioverter defibrillator
515870|NCT00268021|AICD|aicd
515871|NCT00268034|pediatric|pediatric
515872|NCT00268034|cardiac|cardiac
515873|NCT00268034|aneurysms|aneurysms
515874|NCT00268034|left ventricular aneurysms|left ventricular aneurysms
515875|NCT00268034|surgical repair for LV aneurysms|surgical repair for lv aneurysms
515877|NCT00268047|cardiac|cardiac
515878|NCT00268047|surgery|surgery
515879|NCT00268047|transplantation|transplantation
515880|NCT00268047|pulmonary vascular resistance in Fontan patients|pulmonary vascular resistance in fontan patients
515881|NCT00268060|pediatric|pediatric
515882|NCT00268060|cardiac|cardiac
515883|NCT00268060|Long QT Syndrome|long qt syndrome
515884|NCT00268060|Pacemaker|pacemaker
515885|NCT00268060|Herg mutation|herg mutation
515886|NCT00268073|Pediatric|pediatric
515887|NCT00268073|cardiac|cardiac
515888|NCT00268073|neo-aortic insufficience|neo-aortic insufficience
515889|NCT00268073|Norwood standard Stage I procedure|norwood standard stage i procedure
515890|NCT00268073|Norwood Sano procedure|norwood sano procedure
515891|NCT00268086|constrictive pericarditis|constrictive pericarditis
515892|NCT00268086|adult congenital patients|adult congenital patients
515893|NCT00268086|pulmonary insufficiency|pulmonary insufficiency
515894|NCT00268099|pediatric|pediatric
515895|NCT00268099|cardiac|cardiac
515896|NCT00268099|repair of right to left shunt lesions|repair of right to left shunt lesions
515897|NCT00268099|Tetralogy of Fallot defects|tetralogy of fallot defects
515898|NCT00268112|pediatric|pediatric
515899|NCT00268112|cardiac|cardiac
515900|NCT00268112|ALCAPA|alcapa
515901|NCT00268112|Tissue Doppler Imaging|tissue doppler imaging
515902|NCT00268125|Breast Neoplasm|breast neoplasm
515903|NCT00268125|FEC100|fec100
515904|NCT00268125|Chemotherapy|chemotherapy
515905|NCT00268125|acupression|acupression
515906|NCT00268125|bracelet|bracelet
515907|NCT00268125|nausea|nausea
515908|NCT00268125|vomiting|vomiting
515909|NCT00268138|amine fluoride|amine fluoride
515910|NCT00268138|white spot lesions|white spot lesions
515912|NCT00268151|non-small cell lung cancer|non-small cell lung cancer
515913|NCT00268151|oxaliplatin|oxaliplatin
515914|NCT00268151|capecitabine|capecitabine
515915|NCT00268151|XELOX-RT|xelox-rt
515916|NCT00268177|Airways|airways
515917|NCT00268177|Pulmonary|pulmonary
515918|NCT00268177|Obstructive|obstructive
515919|NCT00268177|Chronic|chronic
515920|NCT00268177|inflammation|inflammation
515921|NCT00268177|salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
515922|NCT00268203|expanded access study|expanded access study
515923|NCT00268203|refractory low-grade non-Hodgkin's Lymphoma|refractory low-grade non-hodgkin's lymphoma
515924|NCT00268203|Bexxar®|bexxar®
515925|NCT00268203|Iodine I 131 Tositumomab|iodine i 131 tositumomab
515926|NCT00268203|EAP|eap
515927|NCT00268203|relapsed low-grade non-Hodgkin's lymphoma|relapsed low-grade non-hodgkin's lymphoma
515928|NCT00268216|mortality|mortality
515929|NCT00268216|TORCH|torch
515930|NCT00268216|SERETIDE|seretide
515931|NCT00268216|ADVAIR|advair
515932|NCT00268216|COPD|copd
515933|NCT00268229|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
515934|NCT00268229|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
515935|NCT00268229|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
515936|NCT00268229|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
515937|NCT00268229|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
515938|NCT00268229|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
515939|NCT00268229|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
515940|NCT00268229|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
515941|NCT00268229|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
515942|NCT00268229|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
515943|NCT00268229|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
515944|NCT00268229|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
515945|NCT00268229|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
515946|NCT00268229|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
515947|NCT00268242|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
515948|NCT00268242|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
515949|NCT00268242|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
515950|NCT00268242|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
515951|NCT00268242|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
515952|NCT00268242|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
515953|NCT00268242|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
515954|NCT00268242|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
515955|NCT00268242|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
515956|NCT00268242|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
515957|NCT00268242|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
515958|NCT00268242|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
515959|NCT00268242|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
753948|NCT01178372|hepatic encephalopathy|hepatic encephalopathy
515960|NCT00268242|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
515961|NCT00268255|stage I non-small cell lung cancer|stage i non-small cell lung cancer
515962|NCT00268255|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
515963|NCT00268255|adenosquamous cell lung cancer|adenosquamous cell lung cancer
515964|NCT00268255|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
515965|NCT00268255|large cell lung cancer|large cell lung cancer
515966|NCT00268255|squamous cell lung cancer|squamous cell lung cancer
515967|NCT00268255|adenocarcinoma of the lung|adenocarcinoma of the lung
515968|NCT00268281|cardiac resynchronization therapy|cardiac resynchronization therapy
516052|NCT00268697|Drug Therapy|drug therapy
752464|NCT01173094|Diabetes foot|diabetes foot
515969|NCT00268294|cardiac resynchronization therapy, atrial arrhythmia|cardiac resynchronization therapy, atrial arrhythmia
515970|NCT00268307|Cell therapy|cell therapy
515971|NCT00268320|congestive heart failure, atrial arrhythmia, cardiac resynchronization therapy, implantable cardioverter defibrillator|congestive heart failure, atrial arrhythmia, cardiac resynchronization therapy, implantable cardioverter defibrillator
515972|NCT00268333|adenocarcinoma of the colon|adenocarcinoma of the colon
515973|NCT00268333|adenocarcinoma of the rectum|adenocarcinoma of the rectum
515974|NCT00268333|stage IV colon cancer|stage iv colon cancer
515975|NCT00268333|stage III colon cancer|stage iii colon cancer
515976|NCT00268333|stage III rectal cancer|stage iii rectal cancer
515977|NCT00268333|stage IV rectal cancer|stage iv rectal cancer
515978|NCT00268346|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
515979|NCT00268346|recurrent esophageal cancer|recurrent esophageal cancer
515980|NCT00268346|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
515981|NCT00268346|stage IV esophageal cancer|stage iv esophageal cancer
515982|NCT00268359|adult anaplastic astrocytoma|adult anaplastic astrocytoma
515983|NCT00268359|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
515985|NCT00268359|adult gliosarcoma|adult gliosarcoma
515986|NCT00268359|recurrent adult brain tumor|recurrent adult brain tumor
515987|NCT00268359|adult giant cell glioblastoma|adult giant cell glioblastoma
515988|NCT00268372|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
515989|NCT00268372|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
515990|NCT00268398|adenocarcinoma of the colon|adenocarcinoma of the colon
515991|NCT00268398|stage IV colon cancer|stage iv colon cancer
515992|NCT00268398|adenocarcinoma of the rectum|adenocarcinoma of the rectum
515993|NCT00268398|stage IV rectal cancer|stage iv rectal cancer
515994|NCT00268398|resectable metastases|resectable metastases
515995|NCT00268411|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
515996|NCT00268411|stage IV pancreatic cancer|stage iv pancreatic cancer
515997|NCT00268437|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
515998|NCT00268437|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
515999|NCT00268437|stage III esophageal cancer|stage iii esophageal cancer
516000|NCT00268437|stage II esophageal cancer|stage ii esophageal cancer
516001|NCT00268450|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
516002|NCT00268450|stage III bladder cancer|stage iii bladder cancer
516003|NCT00268450|stage II bladder cancer|stage ii bladder cancer
516004|NCT00268450|recurrent bladder cancer|recurrent bladder cancer
516005|NCT00268463|liver metastases|liver metastases
516006|NCT00268463|stage IV colon cancer|stage iv colon cancer
516007|NCT00268463|stage IV rectal cancer|stage iv rectal cancer
516008|NCT00268463|adenocarcinoma of the colon|adenocarcinoma of the colon
516009|NCT00268463|adenocarcinoma of the rectum|adenocarcinoma of the rectum
516010|NCT00268476|stage III prostate cancer|stage iii prostate cancer
516011|NCT00268476|stage IV prostate cancer|stage iv prostate cancer
516012|NCT00268476|recurrent prostate cancer|recurrent prostate cancer
516013|NCT00268476|adenocarcinoma of the prostate|adenocarcinoma of the prostate
516014|NCT00268489|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
516015|NCT00268489|squamous cell lung cancer|squamous cell lung cancer
516016|NCT00268489|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
516017|NCT00268489|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
516018|NCT00268502|fatigue|fatigue
516019|NCT00268502|depression|depression
516020|NCT00268502|spiritual concerns|spiritual concerns
516021|NCT00268502|sexual dysfunction|sexual dysfunction
516022|NCT00268502|sleep disorders|sleep disorders
516023|NCT00268502|cancer survivor|cancer survivor
516024|NCT00268502|stage IA breast cancer|stage ia breast cancer
516025|NCT00268502|stage IB breast cancer|stage ib breast cancer
516026|NCT00268502|stage II breast cancer|stage ii breast cancer
516027|NCT00268502|stage IIIA breast cancer|stage iiia breast cancer
516028|NCT00268502|stage IIIB breast cancer|stage iiib breast cancer
516029|NCT00268502|stage IIIC breast cancer|stage iiic breast cancer
516030|NCT00268541|exercise|exercise
516031|NCT00268541|physical activity|physical activity
516032|NCT00268541|insulin resistance|insulin resistance
516033|NCT00268541|adipose tissue|adipose tissue
516034|NCT00268541|gene expression|gene expression
516035|NCT00268554|adenosine|adenosine
516036|NCT00268554|caffeine|caffeine
516037|NCT00268554|dipyridamole|dipyridamole
516038|NCT00268580|Asthma|asthma
516039|NCT00268580|Care map|care map
753949|NCT01178372|lactulose|lactulose
516040|NCT00268580|Clinical pathway|clinical pathway
516041|NCT00268580|Education|education
516042|NCT00268580|Emergency department|emergency department
516043|NCT00268593|heparanase|heparanase
516044|NCT00268593|angiogenesis|angiogenesis
516045|NCT00268606|fibromyalgia|fibromyalgia
516046|NCT00268606|cognitive-behavioral therapy|cognitive-behavioral therapy
516047|NCT00268606|tailored treatment|tailored treatment
516048|NCT00268658|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
516049|NCT00268658|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
516050|NCT00268658|Arthroscopy|arthroscopy
516051|NCT00268697|Hyperlipidemia|hyperlipidemia
516053|NCT00268762|stroke|stroke
516054|NCT00268762|thrombin inhibition|thrombin inhibition
516055|NCT00268762|thrombolysis|thrombolysis
516056|NCT00268762|bleeding|bleeding
516057|NCT00268762|outcome|outcome
516058|NCT00268775|community pharmacy services|community pharmacy services
516060|NCT00268775|outcome assessment|outcome assessment
516061|NCT00268775|benzodiazepines therapeutic use|benzodiazepines therapeutic use
516062|NCT00268788|multifocal motor neuropathy|multifocal motor neuropathy
516063|NCT00268788|subcutaneous|subcutaneous
516064|NCT00268788|IVIG|ivig
516065|NCT00268788|gammaglobulin|gammaglobulin
516066|NCT00268827|Kaletra|kaletra
516067|NCT00268827|Comparison|comparison
516068|NCT00268827|Quality of Life|quality of life
516069|NCT00268827|African American|african american
516070|NCT00268840|Pancreas or biliary cancer|pancreas or biliary cancer
516071|NCT00268853|lymphoma|lymphoma
516073|NCT00268853|large cell|large cell
516074|NCT00268853|phase II|phase ii
516075|NCT00268853|CHOP R|chop r
516076|NCT00268853|CPOP R|cpop r
516077|NCT00268853|non Hodgkins|non hodgkins
516078|NCT00268879|Irritable bowel syndrome|irritable bowel syndrome
516079|NCT00268879|Constipation-predominant irritable bowel syndrome|constipation-predominant irritable bowel syndrome
516080|NCT00268892|Prostate Cancer|prostate cancer
516081|NCT00268892|Androgen ablation therapy|androgen ablation therapy
516082|NCT00268918|PTK787|ptk787
516083|NCT00268918|Metastatic breast cancer|metastatic breast cancer
516084|NCT00268918|Refractory gynecological cancer|refractory gynecological cancer
516085|NCT00268931|premature birth|premature birth
516086|NCT00268931|motor skills|motor skills
516087|NCT00268931|learning|learning
516088|NCT00268931|reaching|reaching
516089|NCT00268944|Glycogen Storage Disease Type II|glycogen storage disease type ii
516090|NCT00268944|GSD-II|gsd-ii
516091|NCT00268944|Pompe Disease|pompe disease
516092|NCT00268957|Chronic|chronic
516093|NCT00268957|Hemodialysis|hemodialysis
516094|NCT00268957|Kidney|kidney
516095|NCT00268957|Hyperphosphatemia|hyperphosphatemia
516096|NCT00268957|Chronic kidney disease|chronic kidney disease
516097|NCT00268957|Chronic Renal Insufficiency|chronic renal insufficiency
516098|NCT00268970|Advanced non-small cell lung cancer (NSCLC)|advanced non-small cell lung cancer (nsclc)
516099|NCT00268983|rituximab|rituximab
516100|NCT00268983|tositumomab and iodine I 131 tositumomab|tositumomab and iodine i 131 tositumomab
516101|NCT00268983|non-Hodgkins lymphoma|non-hodgkins lymphoma
516102|NCT00268983|radioimmunotherapy|radioimmunotherapy
516103|NCT00268983|anti-B1 antibody|anti-b1 antibody
516104|NCT00268983|Bexxar|bexxar
516105|NCT00268983|NHL|nhl
516106|NCT00268983|Tositumomab|tositumomab
516107|NCT00268996|Coronary artery disease|coronary artery disease
516108|NCT00268996|Lipoprotein-associated Phospholipase A2|lipoprotein-associated phospholipase a2
516109|NCT00268996|palpography|palpography
516110|NCT00268996|hs-CRP|hs-crp
516111|NCT00268996|endothelial function|endothelial function
516112|NCT00268996|intravascular ultrasound|intravascular ultrasound
516113|NCT00269009|Tobacco use|tobacco use
516114|NCT00269022|SB-705498 acute migraine single dose TRPV1 combination inpatient outpatient study|sb-705498 acute migraine single dose trpv1 combination inpatient outpatient study
516115|NCT00269035|SB-773812|sb-773812
516116|NCT00269035|SPECT|spect
516117|NCT00269035|D2 RO|d2 ro
516118|NCT00269035|pharmacokinetics|pharmacokinetics
516119|NCT00269035|schizophrenic patients|schizophrenic patients
516120|NCT00269035|5HT2A RO|5ht2a ro
516121|NCT00269048|CHD|chd
516122|NCT00269048|Lp-PLA2|lp-pla2
516123|NCT00269048|SB-480848|sb-480848
516124|NCT00269061|pioglitazone|pioglitazone
516125|NCT00269061|diabetes|diabetes
516126|NCT00269061|fluid|fluid
516127|NCT00269087|Chronic Bronchitis|chronic bronchitis
516128|NCT00269087|COPD|copd
516129|NCT00269087|Emphysema|emphysema
516130|NCT00269100|Debridement|debridement
516131|NCT00269126|COPD|copd
516132|NCT00269126|Chronic Bronchitis|chronic bronchitis
516133|NCT00269126|Emphysema|emphysema
516134|NCT00269139|Behavioral crisis|behavioral crisis
516135|NCT00269139|Perception of social crisis|perception of social crisis
516136|NCT00269139|Repetition compulsion|repetition compulsion
516137|NCT00269139|Intrusive mental events|intrusive mental events
516138|NCT00269139|Uncontrollable urges|uncontrollable urges
516139|NCT00269178|malaria|malaria
516240|NCT00260247|Quinidine|quinidine
516140|NCT00269178|knowledge attitudes and practice (KAP)|knowledge attitudes and practice (kap)
516141|NCT00269178|bednets|bednets
516142|NCT00269178|peer health education|peer health education
516143|NCT00269191|Arcoxia|arcoxia
516144|NCT00269230|cardiac resynchronization therapy, left ventricular Lead, Heart Failure|cardiac resynchronization therapy, left ventricular lead, heart failure
516145|NCT00269295|Typhoid fever, S typhi, vaccine|typhoid fever, s typhi, vaccine
516146|NCT00269308|Randomized|randomized
516147|NCT00269308|Clinical Trial|clinical trial
516148|NCT00269308|Neck Pain|neck pain
516149|NCT00269308|Chiropractic|chiropractic
516150|NCT00269308|Manual Therapies|manual therapies
516151|NCT00269308|Exercise|exercise
516152|NCT00269321|Randomized|randomized
516153|NCT00269321|Clinical Trial|clinical trial
516154|NCT00269321|Low Back Pain|low back pain
516155|NCT00269321|Chiropractic|chiropractic
516156|NCT00269321|Manual Therapies|manual therapies
516157|NCT00269321|Exercise|exercise
516158|NCT00269334|antidepressant,major depression,CYP2D6,CYP2C19,SSRI|antidepressant,major depression,cyp2d6,cyp2c19,ssri
516159|NCT00269347|Chiropractic|chiropractic
516160|NCT00269347|Manual Therapy|manual therapy
516161|NCT00269347|Exercise|exercise
516162|NCT00269347|Randomized|randomized
516163|NCT00269347|Clinical Trial|clinical trial
516164|NCT00269347|Back Pain|back pain
516165|NCT00269360|Chiropractic|chiropractic
516166|NCT00269360|Manual Therapies|manual therapies
516167|NCT00269360|Exercise|exercise
516168|NCT00269360|Randomized|randomized
516169|NCT00269360|Clinical Trial|clinical trial
516170|NCT00269360|Neck Pain|neck pain
516171|NCT00269373|Unknown primary tumor|unknown primary tumor
516173|NCT00269386|Clarithromycin|clarithromycin
516174|NCT00269386|Crohn's|crohn's
516175|NCT00269399|Clostridium difficile-associated Diarrhea (CDAD)|clostridium difficile-associated diarrhea (cdad)
516176|NCT00269399|CDAD|cdad
516177|NCT00269399|C diff|c diff
516178|NCT00269412|Irritable bowel syndrome|irritable bowel syndrome
516179|NCT00269425|Cardiovascular disease|cardiovascular disease
516180|NCT00269425|Nutrition|nutrition
516181|NCT00269425|Mediterranean diet|mediterranean diet
516182|NCT00269425|Low fat diet|low fat diet
516183|NCT00269425|American Heart Association diet|american heart association diet
516184|NCT00269425|Monounsaturated fats|monounsaturated fats
516185|NCT00269425|Omega-3 fats|omega-3 fats
516186|NCT00269425|Outcomes|outcomes
516187|NCT00269477|Meningitis|meningitis
516188|NCT00269477|Meningococcal infection|meningococcal infection
516189|NCT00269477|Neisseria meningitidis|neisseria meningitidis
516190|NCT00269477|Menactra®|menactra®
516191|NCT00269477|Menomune®|menomune®
516192|NCT00269490|Post-Traumatic Stress Disorder|post-traumatic stress disorder
516193|NCT00269490|Yoga Nidra|yoga nidra
516194|NCT00269516|Parkinson's disease|parkinson's disease
516195|NCT00269529|postoperative pain|postoperative pain
516196|NCT00269529|knee arthroplasty|knee arthroplasty
516197|NCT00269529|analgesia|analgesia
516198|NCT00269529|infiltration|infiltration
516199|NCT00269529|femoral nerve block|femoral nerve block
516200|NCT00269542|zinc supplementation|zinc supplementation
516201|NCT00269542|hospitalisations|hospitalisations
516202|NCT00269542|children|children
516203|NCT00269542|mortality|mortality
516204|NCT00269542|iron folic acid|iron folic acid
516205|NCT00269555|Prostate|prostate
516206|NCT00269555|Cancer|cancer
516207|NCT00269555|Prostate Specific Antigen|prostate specific antigen
516208|NCT00269555|C04.588.945.440.770|c04.588.945.440.770
516209|NCT00269568|medical abortion|medical abortion
516210|NCT00269568|mifepristone|mifepristone
516211|NCT00269568|misoprostol|misoprostol
516212|NCT00269581|migraine|migraine
516213|NCT00269581|tension headaches|tension headaches
516214|NCT00269581|chronic daily headaches|chronic daily headaches
516215|NCT00260143|HIV+ men|hiv+ men
516216|NCT00260143|Treatment Experienced|treatment experienced
516217|NCT00260156|Type 2 diabetes|type 2 diabetes
516218|NCT00260156|vildagliptin|vildagliptin
516219|NCT00260169|Treatment Preferences|treatment preferences
516220|NCT00260169|Public sector|public sector
516221|NCT00260169|Latino|latino
516222|NCT00260182|Depressive Disorder|depressive disorder
516223|NCT00260182|Family|family
516224|NCT00260182|Genetics|genetics
516225|NCT00260195|Trauma|trauma
516226|NCT00260195|Violence|violence
516227|NCT00260195|Adolescent|adolescent
516228|NCT00260195|Schools|schools
516229|NCT00260195|Cognitive behavioral therapy|cognitive behavioral therapy
516230|NCT00260208|Liver transplant, adults, hepatitis C, liver fibrosis, cyclosporine microemulsion, tacrolimus|liver transplant, adults, hepatitis c, liver fibrosis, cyclosporine microemulsion, tacrolimus
516231|NCT00260221|Virtual Reality Hypnosis|virtual reality hypnosis
516232|NCT00260234|Transplantation, Pancreatic Islets|transplantation, pancreatic islets
516233|NCT00260234|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
516234|NCT00260234|Insulin Dependent|insulin dependent
516235|NCT00260234|Islet Transplant|islet transplant
516236|NCT00260247|CYP3A4|cyp3a4
516237|NCT00260247|Induction|induction
516238|NCT00260247|Oxcarbazepine|oxcarbazepine
516239|NCT00260247|Carbamazepine|carbamazepine
516241|NCT00260247|Human|human
516242|NCT00260247|In vivo|in vivo
516243|NCT00260273|Preventive Therapy|preventive therapy
516244|NCT00260273|Psychoses|psychoses
516245|NCT00260273|Cognitive Behaviour Therapy|cognitive behaviour therapy
516246|NCT00260286|LH pulsatility|lh pulsatility
516247|NCT00260286|energy availability|energy availability
516248|NCT00260286|exercise|exercise
516249|NCT00260286|diet|diet
516250|NCT00260286|gynecological age|gynecological age
516251|NCT00260299|cholesterol defects|cholesterol defects
516252|NCT00260299|Mevalonic Aciduria|mevalonic aciduria
516253|NCT00260299|Mevalonate Kinase Deficiency|mevalonate kinase deficiency
516254|NCT00260299|HIDS|hids
583432|NCT00511758|Digital Imaging|digital imaging
516255|NCT00260299|Hyperimmunoglobulinemia with periodic fever syndrome|hyperimmunoglobulinemia with periodic fever syndrome
516257|NCT00260299|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
516258|NCT00260299|Periodic Fever Syndromes, hereditary|periodic fever syndromes, hereditary
516259|NCT00260299|mevalonic acid|mevalonic acid
516260|NCT00260299|mevalonate kinase|mevalonate kinase
516261|NCT00260299|cholesterol, dietary|cholesterol, dietary
516262|NCT00260299|Hyper IgD|hyper igd
516263|NCT00260299|Multiple malformations|multiple malformations
516264|NCT00260299|Fever|fever
516265|NCT00260312|inactived|inactived
516266|NCT00260312|polio|polio
516267|NCT00260312|vaccine|vaccine
516268|NCT00260312|cuba|cuba
516269|NCT00260312|trial|trial
516270|NCT00260312|randomized|randomized
516271|NCT00260312|eradication|eradication
516272|NCT00260325|pretreatment|pretreatment
516273|NCT00260325|healthy volunteers|healthy volunteers
516274|NCT00260338|myocardial ischemia|myocardial ischemia
516275|NCT00260338|stem cell|stem cell
516276|NCT00260338|mesenchymal|mesenchymal
516277|NCT00260338|myocardial perfusion|myocardial perfusion
516278|NCT00260351|rabies;|rabies;
516279|NCT00260351|rabies post-exposure;|rabies post-exposure;
516280|NCT00260351|category III|category iii
516281|NCT00260364|Recurrent carcinoma of the pancreas|recurrent carcinoma of the pancreas
516282|NCT00260364|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
516283|NCT00260364|Stage II carcinoma of the pancreas|stage ii carcinoma of the pancreas
516284|NCT00260364|Stage III carcinoma of the pancreas|stage iii carcinoma of the pancreas
516285|NCT00260364|Stage IVA carcinoma of the pancreas|stage iva carcinoma of the pancreas
516286|NCT00260364|Stage IVB carcinoma of the pancreas|stage ivb carcinoma of the pancreas
516287|NCT00260377|Aspirin treatment|aspirin treatment
516288|NCT00260377|Aspirin resistance|aspirin resistance
516289|NCT00260377|Coronary bypass surgery|coronary bypass surgery
516290|NCT00260390|Dysthymic Disorder|dysthymic disorder
516291|NCT00260390|HPG hypofunctioning|hpg hypofunctioning
516292|NCT00260390|Testosterone replacement|testosterone replacement
516293|NCT00260416|Acute myocardial infarction|acute myocardial infarction
516294|NCT00260416|Symptom duration|symptom duration
516295|NCT00260416|Primary angioplasty|primary angioplasty
516296|NCT00260416|Infarct size|infarct size
516297|NCT00260416|Myocardial scintigraphy|myocardial scintigraphy
516298|NCT00260429|Dupuytren's contracture|dupuytren's contracture
516299|NCT00260429|fixed flexion contracture|fixed flexion contracture
516300|NCT00260442|sarcopenia|sarcopenia
516301|NCT00260442|resistance training|resistance training
516302|NCT00260442|strength training|strength training
516303|NCT00260442|skeletal muscle|skeletal muscle
516304|NCT00260442|elderly|elderly
516305|NCT00260442|cholesterol|cholesterol
516306|NCT00260442|aging|aging
516307|NCT00260442|cardiovascular disease|cardiovascular disease
516308|NCT00260442|nutrition|nutrition
516309|NCT00260442|inflammation|inflammation
516310|NCT00260442|lipids|lipids
516311|NCT00260468|Major depression|major depression
516312|NCT00260468|Magnetic resonance imaging|magnetic resonance imaging
516313|NCT00260468|White matter lesions|white matter lesions
516314|NCT00260468|Perfusion|perfusion
516315|NCT00260468|Diffusion|diffusion
516316|NCT00260468|Magnetization transfer|magnetization transfer
516317|NCT00260468|Vascular risk factors|vascular risk factors
516318|NCT00260481|Methamphetamine Dependence|methamphetamine dependence
516319|NCT00260481|Pharmacotherapy|pharmacotherapy
516320|NCT00260494|Cardiac Surgical Procedures|cardiac surgical procedures
516321|NCT00260494|open saphenous vein graft harvest wounds|open saphenous vein graft harvest wounds
516322|NCT00260494|Postoperative Complications|postoperative complications
516323|NCT00260494|Surgical Wound Infection|surgical wound infection
516324|NCT00260494|Surgical Wound Dehiscence|surgical wound dehiscence
516325|NCT00260520|Low molecular weight heparin|low molecular weight heparin
516326|NCT00260520|Preeclampsia|preeclampsia
516327|NCT00260520|Fetal Growth Restriction|fetal growth restriction
516328|NCT00260520|Thrombophilia|thrombophilia
516329|NCT00260520|Factor V Leiden|factor v leiden
516330|NCT00260520|G20210A prothrombin gene mutation|g20210a prothrombin gene mutation
516331|NCT00260546|Ventricular dyssynchrony|ventricular dyssynchrony
516332|NCT00260559|Esophagectomy|esophagectomy
516333|NCT00260559|Esophageal Cancer|esophageal cancer
516334|NCT00260559|Quality of Life|quality of life
516335|NCT00260559|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
753950|NCT01178372|probiotics|probiotics
516336|NCT00260559|Laparoscopic Transhiatal Esophagectomy|laparoscopic transhiatal esophagectomy
516337|NCT00260559|Open Esophagectomy|open esophagectomy
516338|NCT00260559|Karnofsky Score|karnofsky score
516339|NCT00260559|Dysphagia score|dysphagia score
516340|NCT00260559|Heartburn Scale|heartburn scale
516341|NCT00260559|Nutrition Score|nutrition score
516342|NCT00260572|GERD|gerd
516343|NCT00260572|nissen|nissen
516344|NCT00260572|fundoplication|fundoplication
516345|NCT00260572|reflux|reflux
516346|NCT00260572|toupet|toupet
516347|NCT00260572|QOL|qol
516348|NCT00260572|dyspepsia|dyspepsia
516349|NCT00260572|heartburn|heartburn
516350|NCT00260572|Patients with reflux symptoms for at least 6 months|patients with reflux symptoms for at least 6 months
516351|NCT00260572|Patients scheduled for lap nissen or toupet fundoplication|patients scheduled for lap nissen or toupet fundoplication
516352|NCT00260572|Reflux diagnosed by either endoscopy, upper GI, or 24hr. pH (numeric scale used to specify the acidity of gastric contents)|reflux diagnosed by either endoscopy, upper gi, or 24hr. ph (numeric scale used to specify the acidity of gastric contents)
516353|NCT00260572|On or starting treatment with PPI or pro-motility agents|on or starting treatment with ppi or pro-motility agents
516354|NCT00260585|gastroesophageal reflux disease|gastroesophageal reflux disease
516356|NCT00260585|hiatal hernia|hiatal hernia
516357|NCT00260585|achalasia|achalasia
516358|NCT00260585|Barrett's metaplasia|barrett's metaplasia
516359|NCT00260585|Anti-Reflux Surgery|anti-reflux surgery
516360|NCT00260585|Known/suspected esophageal/gastroesophageal junction tumor|known/suspected esophageal/gastroesophageal junction tumor
516361|NCT00260585|Esophageal disorders such as Barrett's metaplasia|esophageal disorders such as barrett's metaplasia
516362|NCT00260585|Symptomatic gastroesophageal reflux disease|symptomatic gastroesophageal reflux disease
516363|NCT00260598|Non-small cell lung cancer|non-small cell lung cancer
516364|NCT00260598|Head and neck squamous cell cancer|head and neck squamous cell cancer
516365|NCT00260598|White light bronchoscopy|white light bronchoscopy
516366|NCT00260598|Imaging Elastic Scattering Spectroscopy (IESS)|imaging elastic scattering spectroscopy (iess)
516367|NCT00260598|Fluorescence Bronchoscopy|fluorescence bronchoscopy
516368|NCT00260598|COPD|copd
516369|NCT00260598|Helium-Cadmium Laser Bronchoscopy|helium-cadmium laser bronchoscopy
516370|NCT00260598|Autofluorescence spectra of dysplasia & cancer in situ (CIS)|autofluorescence spectra of dysplasia & cancer in situ (cis)
516371|NCT00260598|Severe Chronic Obstructive Pulmonary Disorders(COPD)|severe chronic obstructive pulmonary disorders(copd)
516372|NCT00260611|prostate|prostate
516373|NCT00260624|agitation|agitation
516374|NCT00260624|dementia|dementia
516375|NCT00260624|Alzheimer's Disease|alzheimer's disease
516376|NCT00260637|Prostatitis|prostatitis
516377|NCT00260650|heart failure, congestive|heart failure, congestive
516378|NCT00260650|self-care|self-care
516379|NCT00260650|quality of life|quality of life
516380|NCT00260650|health behavior|health behavior
516381|NCT00260663|Hearing Impaired Rehabilitation|hearing impaired rehabilitation
516382|NCT00260663|Hearing Aids|hearing aids
516383|NCT00260663|Randomized Controlled Trials|randomized controlled trials
516384|NCT00260663|Cost Effectiveness|cost effectiveness
516385|NCT00260663|Quality of life|quality of life
516386|NCT00260663|Patient Compliance|patient compliance
516387|NCT00260676|brain death|brain death
516388|NCT00260676|lung transplantation|lung transplantation
516389|NCT00260676|organ donors|organ donors
516390|NCT00260676|potential organ donors|potential organ donors
516391|NCT00260689|Immunosuppression|immunosuppression
516392|NCT00260689|T-cells|t-cells
516393|NCT00260689|Hematopoiesis|hematopoiesis
516394|NCT00260689|Autoimmunity|autoimmunity
516395|NCT00260689|Thrombocytopenia|thrombocytopenia
516396|NCT00260689|Severe Aplastic Anemia|severe aplastic anemia
516397|NCT00260689|SAA|saa
516398|NCT00260702|Phenotype|phenotype
516399|NCT00260702|Monoclonal|monoclonal
516400|NCT00260702|Immunoglobulin|immunoglobulin
516401|NCT00260702|Immunodeficiency|immunodeficiency
516402|NCT00260702|Dermatitis|dermatitis
516403|NCT00260702|Job's Syndrome|job's syndrome
516404|NCT00260702|Hyper-IgE Syndrome|hyper-ige syndrome
516405|NCT00260702|HIES|hies
516406|NCT00260715|Risk behavior|risk behavior
516407|NCT00260715|Sexually Transmitted Diseases|sexually transmitted diseases
516408|NCT00260728|vascular access|vascular access
516409|NCT00260728|hemodialysis|hemodialysis
516410|NCT00260741|cannabis|cannabis
516411|NCT00260741|marijuana|marijuana
516412|NCT00260741|Multiple Sclerosis|multiple sclerosis
516413|NCT00260741|Spasticity|spasticity
516414|NCT00260754|Risk behavior|risk behavior
516415|NCT00260754|Sexually transmitted diseases|sexually transmitted diseases
516416|NCT00260780|sexually transmitted diseases|sexually transmitted diseases
516417|NCT00260780|Risk Behavior|risk behavior
516418|NCT00260793|Ropinirole|ropinirole
516419|NCT00260793|Parkinson's disease|parkinson's disease
516420|NCT00260793|dopamine agonist|dopamine agonist
516421|NCT00260819|Hypoxia-induced pulmonary artery hypertension|hypoxia-induced pulmonary artery hypertension
516422|NCT00260819|High-altitude pulmonary oedema|high-altitude pulmonary oedema
516423|NCT00260819|ETA receptor antagonist|eta receptor antagonist
516424|NCT00260832|Acute Myeloid Leukemia|acute myeloid leukemia
516425|NCT00260832|Dacogen|dacogen
516426|NCT00260832|Decitabine|decitabine
516427|NCT00260832|Poor or intermediate-risk cytogenetics|poor or intermediate-risk cytogenetics
516428|NCT00260858|Glycemic index|glycemic index
516429|NCT00260858|Nutrition|nutrition
516430|NCT00260858|Carbohydrates|carbohydrates
516431|NCT00260858|Glycemic responses|glycemic responses
516432|NCT00260858|Methodology|methodology
516433|NCT00260858|Healthy human subjects|healthy human subjects
516434|NCT00260871|lung adenocarcinoma|lung adenocarcinoma
516435|NCT00260871|genetic epidemiology|genetic epidemiology
516436|NCT00260871|environmental factors|environmental factors
516437|NCT00260871|genetic map|genetic map
516438|NCT00260871|coordination center|coordination center
516545|NCT00261326|Simvastatin|simvastatin
516439|NCT00260897|avascular necrosis of the femoral head|avascular necrosis of the femoral head
516440|NCT00260897|genotyping|genotyping
516441|NCT00260897|linkage analysis|linkage analysis
516442|NCT00260897|pathogenesis|pathogenesis
516443|NCT00260897|therapy|therapy
516444|NCT00260923|hypertension|hypertension
516445|NCT00260923|aliskiren|aliskiren
516446|NCT00260923|blood pressure|blood pressure
516447|NCT00260936|HIV|hiv
516448|NCT00260936|AIDS|aids
516449|NCT00260936|Adolescent Males|adolescent males
516450|NCT00260936|HIV positive|hiv positive
516451|NCT00260936|Treatment Naive|treatment naive
516452|NCT00260936|Treatment Experienced|treatment experienced
516453|NCT00260949|rotator cuff tear|rotator cuff tear
516454|NCT00260949|arthroscopic repair|arthroscopic repair
516455|NCT00260962|Pilot Project,|pilot project,
516456|NCT00260962|Clinical Trial,|clinical trial,
516457|NCT00260962|Treatment Outcome,|treatment outcome,
516458|NCT00260962|Psychopharmacology|psychopharmacology
516459|NCT00260975|breast cancer|breast cancer
516460|NCT00260975|chemotherapy|chemotherapy
516461|NCT00260975|hormonal therapy|hormonal therapy
516462|NCT00260975|cognitive function|cognitive function
516463|NCT00260975|chemo fog|chemo fog
516464|NCT00260988|Prophylaxis|prophylaxis
516465|NCT00260988|Thromboembolic disease|thromboembolic disease
516466|NCT00260988|End stage renal disease|end stage renal disease
516467|NCT00260988|Hemodialysis|hemodialysis
516468|NCT00260988|Pharmacokinetics|pharmacokinetics
516469|NCT00260988|Low Molecular Weight Heparin|low molecular weight heparin
516470|NCT00260988|Innohep|innohep
516471|NCT00260988|Tinzaparin|tinzaparin
516472|NCT00260988|Fragmin|fragmin
516473|NCT00260988|Dalteparin|dalteparin
516474|NCT00260988|Anti Xa|anti xa
516475|NCT00260988|INR|inr
516476|NCT00260988|Oral anticoagulation|oral anticoagulation
516477|NCT00260988|warfarin|warfarin
516478|NCT00260988|Coumadin|coumadin
516479|NCT00261001|Transcutaneous|transcutaneous
516480|NCT00261001|Vaccination|vaccination
516481|NCT00261001|Safety|safety
516482|NCT00261001|Immunogenicity|immunogenicity
516483|NCT00261001|HIV|hiv
516484|NCT00261001|Treatment Experienced|treatment experienced
516485|NCT00261014|Recurrent|recurrent
516486|NCT00261014|Idiopathic|idiopathic
516487|NCT00261014|Deep Vein Thrombosis|deep vein thrombosis
516488|NCT00261014|Pulmonary Embolism|pulmonary embolism
516489|NCT00261014|Clinical Prediction Rule|clinical prediction rule
516490|NCT00261014|Venous Thromboembolism|venous thromboembolism
516491|NCT00261014|Risk Factors|risk factors
516492|NCT00261027|ovarian cancer|ovarian cancer
516493|NCT00261040|Osteoarthritis|osteoarthritis
516494|NCT00261040|Total Hip Arthroplasty|total hip arthroplasty
516495|NCT00261040|Minimally Invasive Surgery|minimally invasive surgery
516496|NCT00261066|functional outcome|functional outcome
516497|NCT00261066|orthopaedic surgery|orthopaedic surgery
516498|NCT00261118|colitis|colitis
516499|NCT00261118|rituximab|rituximab
516500|NCT00261131|cerebral palsy|cerebral palsy
516501|NCT00261131|spasticity|spasticity
516502|NCT00261131|diplegia|diplegia
516503|NCT00261157|nephrectomy|nephrectomy
516504|NCT00261157|Safety|safety
516505|NCT00261157|Laparoscopy|laparoscopy
516506|NCT00261157|telerounding|telerounding
516507|NCT00261157|prostatectomy|prostatectomy
516508|NCT00261170|smoking|smoking
516509|NCT00261196|Frozen Shoulder|frozen shoulder
516510|NCT00261209|Flexor Tendon Adhesions|flexor tendon adhesions
516511|NCT00261209|Zone II of the Hand|zone ii of the hand
516512|NCT00261222|Amodiaquine|amodiaquine
516513|NCT00261222|Efficacy|efficacy
516514|NCT00261222|Malaria|malaria
516515|NCT00261222|Burkina Faso|burkina faso
516516|NCT00261235|Rehabilitation, Vocational|rehabilitation, vocational
516517|NCT00261235|Virtues|virtues
516518|NCT00261235|Employment, supported|employment, supported
516519|NCT00261235|veterans|veterans
516520|NCT00261235|Mentally Ill Persons|mentally ill persons
516521|NCT00261248|Phase 2|phase 2
516522|NCT00261248|Vaccine|vaccine
516523|NCT00261248|Urinary Tract Infection|urinary tract infection
516524|NCT00261248|Vaginal Mucosal|vaginal mucosal
516525|NCT00261261|children|children
516526|NCT00261261|anxiety|anxiety
516527|NCT00261261|behavioral preparation|behavioral preparation
516528|NCT00261261|family|family
516529|NCT00261261|surgery|surgery
516530|NCT00261261|parents|parents
516172|NCT00269373|PET-CT|pet-ct
516531|NCT00261274|transfusion; red blood cells|transfusion; red blood cells
516532|NCT00261287|Hay Fever|hay fever
516533|NCT00261287|Allergic Rhinitis|allergic rhinitis
516534|NCT00261287|Perennial Allergic Rhinitis|perennial allergic rhinitis
516535|NCT00261287|Ciclesonide|ciclesonide
516536|NCT00261300|Gastric acid|gastric acid
666012|NCT00838435|PKU|pku
516537|NCT00261300|GERD|gerd
516538|NCT00261300|Gastroesophageal reflux disease|gastroesophageal reflux disease
516539|NCT00261300|Pantoprazole|pantoprazole
583433|NCT00511758|Colposcopy|colposcopy
516540|NCT00261300|Proton pump inhibitor|proton pump inhibitor
516541|NCT00261313|Breast cancer|breast cancer
516542|NCT00261313|Doses dense chemotherapy|doses dense chemotherapy
516543|NCT00261313|Growth factor support|growth factor support
516544|NCT00261313|Adjuvant Breast Cancer|adjuvant breast cancer
516546|NCT00261326|Optic Neuritis|optic neuritis
516547|NCT00261326|Multiple Sclerosis|multiple sclerosis
516548|NCT00261339|Gastroesophageal Reflux|gastroesophageal reflux
516549|NCT00261339|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
516550|NCT00261339|Pantoprazole|pantoprazole
516551|NCT00261378|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
516552|NCT00261391|Arteriovenous Malformation|arteriovenous malformation
516553|NCT00261391|Lymphatic Malformation|lymphatic malformation
516554|NCT00261391|Gorham|gorham
516555|NCT00261430|Schizophrenia|schizophrenia
516556|NCT00261430|acceptance|acceptance
516557|NCT00261430|motivational enhancement therapy|motivational enhancement therapy
516558|NCT00261430|long-acting risperidone|long-acting risperidone
516559|NCT00261430|intramuscular injection|intramuscular injection
516560|NCT00261430|Treatment Guidebook|treatment guidebook
516561|NCT00261430|GAIN Acceptance Approach|gain acceptance approach
516562|NCT00261443|Bipolar I Disorder with a recent manic or mixed episode|bipolar i disorder with a recent manic or mixed episode
516563|NCT00261456|Prostate cancer|prostate cancer
516564|NCT00261456|BRCA1|brca1
516565|NCT00261456|BRCA2|brca2
516566|NCT00261456|prostate screening|prostate screening
516568|NCT00261456|prostate biopsy|prostate biopsy
516569|NCT00261469|Migraine|migraine
516570|NCT00261469|Headache|headache
516571|NCT00261482|contraception|contraception
516572|NCT00261482|female contraception|female contraception
516573|NCT00261482|hormonal contraception|hormonal contraception
516574|NCT00261482|transdermal contraception|transdermal contraception
516575|NCT00261482|EVRA|evra
516576|NCT00261482|estrogen|estrogen
516577|NCT00261482|progestin|progestin
516578|NCT00261482|ethinyl estradiol|ethinyl estradiol
516579|NCT00261482|norelgestromin|norelgestromin
516580|NCT00261495|chronic noncancer pain|chronic noncancer pain
516581|NCT00261495|pain|pain
516582|NCT00261495|analgesia|analgesia
516583|NCT00261495|analgesic opioid|analgesic opioid
516584|NCT00261495|oxycodone|oxycodone
516585|NCT00261495|hydromorphone|hydromorphone
516586|NCT00261508|Risperidone|risperidone
516587|NCT00261508|child development disorders|child development disorders
516588|NCT00261508|pervasive development disorders|pervasive development disorders
516589|NCT00261508|autistic disorder|autistic disorder
516590|NCT00261508|autism|autism
516591|NCT00261508|developmental disabilities|developmental disabilities
516592|NCT00261508|antipsychotropic agents|antipsychotropic agents
516593|NCT00261521|Kidney failure, Chronic|kidney failure, chronic
516594|NCT00261521|End-stage renal disease|end-stage renal disease
516595|NCT00261521|Kidney failure|kidney failure
516596|NCT00261521|Anemia|anemia
516597|NCT00261521|Dialysis|dialysis
516598|NCT00261521|Epoetin|epoetin
516599|NCT00261521|Erythropoetin|erythropoetin
516600|NCT00261521|Epoetin alfa|epoetin alfa
516601|NCT00261534|Chemotherapy|chemotherapy
516602|NCT00261547|Kidney transplantation|kidney transplantation
516603|NCT00261547|HLA|hla
516604|NCT00261560|ankle sprain|ankle sprain
516605|NCT00261560|acetaminophen extended release, ibuprofen|acetaminophen extended release, ibuprofen
516606|NCT00261573|"Alzheimer's disease with cerebrovascular disease (mixed dementia)"|"alzheimer's disease with cerebrovascular disease (mixed dementia)"
516607|NCT00261573|probable vascular dementia|probable vascular dementia
516608|NCT00261573|galantamine|galantamine
516609|NCT00261586|aspirin|aspirin
516610|NCT00261586|analgesics|analgesics
516611|NCT00261586|cyclooxygenase activity|cyclooxygenase activity
516612|NCT00261586|non-steroidal antiinflammatory drugs|non-steroidal antiinflammatory drugs
516613|NCT00261599|Colonoscopy|colonoscopy
516614|NCT00261599|Sedation|sedation
516615|NCT00261599|AQUAVAN|aquavan
516616|NCT00261599|Fospropofol disodium|fospropofol disodium
516617|NCT00261599|Colon polyps|colon polyps
516618|NCT00261599|Endoscopic outcomes|endoscopic outcomes
516619|NCT00261599|Endoscopic sedation|endoscopic sedation
516620|NCT00261599|Endoscopy|endoscopy
516621|NCT00261612|relapsed or chemotherapy-refractory disease|relapsed or chemotherapy-refractory disease
516622|NCT00261625|peritoneal dialysis|peritoneal dialysis
516623|NCT00261625|artery calcification|artery calcification
516624|NCT00261625|bone mineral density|bone mineral density
516625|NCT00261638|Mental Health Promotion|mental health promotion
516626|NCT00261638|Mental Health Index|mental health index
516823|NCT00269659|Regional cardiac function|regional cardiac function
516627|NCT00261638|Taiwan Mental Health Index scale|taiwan mental health index scale
516628|NCT00261638|psychophysical health|psychophysical health
516629|NCT00261638|education years over 9 years|education years over 9 years
752465|NCT01173133|Free Flap|free flap
752466|NCT01173133|Surgery|surgery
515984|NCT00268359|adult glioblastoma|adult glioblastoma
516630|NCT00261638|normal people, especially joining Mental Health Foundation Promotions|normal people, especially joining mental health foundation promotions
516632|NCT00261677|cancer|cancer
516633|NCT00261677|solid tumor|solid tumor
516634|NCT00261677|Hodgkin's Disease|hodgkin's disease
583434|NCT00511758|Cervix|cervix
516635|NCT00261677|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
516636|NCT00261677|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
516637|NCT00261677|Quality of Life|quality of life
516638|NCT00261677|hemoglobin|hemoglobin
516639|NCT00261677|Epoetin alfa|epoetin alfa
516640|NCT00261690|Virtual Reality Distraction|virtual reality distraction
516641|NCT00261716|clinical trial|clinical trial
516642|NCT00261716|employment|employment
516643|NCT00261716|schizoaffective disorder|schizoaffective disorder
516644|NCT00261716|schizophrenia|schizophrenia
516645|NCT00261729|Paroxetine|paroxetine
516646|NCT00261729|Prazosin|prazosin
516647|NCT00261729|Sleep Disorders|sleep disorders
516648|NCT00261729|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
516649|NCT00261742|perianal|perianal
516650|NCT00261742|dermatitis|dermatitis
516651|NCT00261742|streptococcus pyogenes|streptococcus pyogenes
516652|NCT00261755|Acupuncture|acupuncture
516653|NCT00261755|pain relief|pain relief
516654|NCT00261755|labour|labour
516655|NCT00261755|randomized controlled trial|randomized controlled trial
516656|NCT00261755|TENS|tens
516657|NCT00261768|Aging|aging
516658|NCT00261768|hearing aids|hearing aids
516659|NCT00261768|hearing loss, sensorineural|hearing loss, sensorineural
516660|NCT00261768|speech recognition|speech recognition
516661|NCT00261781|Treadmill|treadmill
516662|NCT00261781|Walking|walking
516663|NCT00261781|Exercise|exercise
516664|NCT00261781|Automaticity|automaticity
516665|NCT00261781|Quality of Life|quality of life
516666|NCT00261794|cognition|cognition
516667|NCT00261794|schizophrenia|schizophrenia
516668|NCT00261794|treatment|treatment
516669|NCT00261807|severe|severe
516670|NCT00261807|skin|skin
516671|NCT00261807|infections|infections
516672|NCT00261820|Kidney Transplant|kidney transplant
516673|NCT00261833|Alpha1-proteinase inhibitor deficiency|alpha1-proteinase inhibitor deficiency
516674|NCT00261833|Emphysema|emphysema
516675|NCT00261833|Chronic augmentation and maintenance therapy|chronic augmentation and maintenance therapy
516676|NCT00261846|Leukemia|leukemia
516677|NCT00261846|tyrosine kinase inhibitor|tyrosine kinase inhibitor
516678|NCT00261846|philadelphia chromosome|philadelphia chromosome
516679|NCT00261846|Myeloid|myeloid
516680|NCT00261846|Philadelphia Positive|philadelphia positive
516681|NCT00261859|hazardous drinking|hazardous drinking
516682|NCT00261872|Alcoholism|alcoholism
516683|NCT00261872|Attention Deficit Disorder|attention deficit disorder
516684|NCT00261872|ADHD|adhd
516685|NCT00261898|Sleep Deprivation|sleep deprivation
516686|NCT00261898|Obesity|obesity
516687|NCT00261898|Metabolic Syndrome|metabolic syndrome
516688|NCT00261898|Hormones|hormones
516689|NCT00261898|Public Health|public health
516690|NCT00261898|Overweight|overweight
516691|NCT00261898|Sleep|sleep
516692|NCT00261911|Meridia|meridia
516693|NCT00261911|Sibutramine|sibutramine
516694|NCT00261911|Obesity|obesity
516695|NCT00261911|Adolescent|adolescent
516697|NCT00261924|Thrombocytopenic patients|thrombocytopenic patients
516698|NCT00261950|Cinacalcet HCl, Cinacalcet, Amgen (AMG) 073, Sensipar, Mimpara, Calcimimetic|cinacalcet hcl, cinacalcet, amgen (amg) 073, sensipar, mimpara, calcimimetic
516699|NCT00261976|Rheumatoid arthritis|rheumatoid arthritis
516700|NCT00261976|Crohn's disease|crohn's disease
516701|NCT00261976|Psoriasis|psoriasis
516702|NCT00261989|pulse oximetry readings|pulse oximetry readings
516703|NCT00261989|pediatrics|pediatrics
516704|NCT00261989|cardiac|cardiac
516705|NCT00261989|congenital heart disease|congenital heart disease
516706|NCT00262054|coronary disease|coronary disease
516707|NCT00262093|preeclampsia|preeclampsia
516708|NCT00262093|sFlt1|sflt1
516709|NCT00262093|PlGF|plgf
516710|NCT00262093|parity|parity
516711|NCT00262093|angiogenesis|angiogenesis
516712|NCT00262106|Administration, intravaginal|administration, intravaginal
516713|NCT00262106|Anti-infective agents|anti-infective agents
516714|NCT00262106|Double blind method|double blind method
516715|NCT00262106|Drug evaluation|drug evaluation
516716|NCT00262106|Female|female
516717|NCT00262106|Gels|gels
516718|NCT00262106|HIV infections/prevention and control|hiv infections/prevention and control
516719|NCT00262106|Microbicide|microbicide
516846|NCT00269750|urge|urge
516720|NCT00262106|Naphthalenesulfonates/administration and dosage|naphthalenesulfonates/administration and dosage
516721|NCT00262106|Polymers/administration and dosage|polymers/administration and dosage
516722|NCT00262106|Sexual behavior|sexual behavior
752467|NCT01173133|Ischemia|ischemia
516723|NCT00262106|Vaginal creams, foams and jellies|vaginal creams, foams and jellies
516724|NCT00262106|HIV Seronegativity|hiv seronegativity
516725|NCT00262106|Genital Herpes Infections|genital herpes infections
516059|NCT00268775|patient care|patient care
516726|NCT00262119|Physiological pacing|physiological pacing
516727|NCT00262119|Antitachycardia pacing therapies|antitachycardia pacing therapies
516728|NCT00262145|glucose|glucose
516729|NCT00262145|lipid|lipid
516730|NCT00262145|diabetes|diabetes
516731|NCT00262145|overweight|overweight
516732|NCT00262158|smoking status|smoking status
516733|NCT00262158|cigarette consumption|cigarette consumption
516734|NCT00262184|Post-Menopausal osteopenia|post-menopausal osteopenia
516735|NCT00262197|Diabetes mellitus|diabetes mellitus
516736|NCT00262197|Medical error rates|medical error rates
516737|NCT00262197|Pharmacotherapy|pharmacotherapy
516738|NCT00262223|Co-morbid alcohol dependence and PTSD|co-morbid alcohol dependence and ptsd
516739|NCT00262223|Alcohol and other drug use disorders|alcohol and other drug use disorders
516740|NCT00262223|Treatment outcome|treatment outcome
516741|NCT00262236|Hypertension, Aliskiren, Atenolol, Blood Pressure|hypertension, aliskiren, atenolol, blood pressure
516742|NCT00262327|antiangiogenesis|antiangiogenesis
516743|NCT00262327|endostatin|endostatin
516744|NCT00262327|adenovirus|adenovirus
516745|NCT00262327|gene therapy|gene therapy
516746|NCT00262327|cancer|cancer
516747|NCT00262340|Asthma|asthma
516748|NCT00262340|Pediatrics|pediatrics
516749|NCT00262340|Airway|airway
516750|NCT00262340|Inflammation|inflammation
516751|NCT00262379|Chronic hepatitis C|chronic hepatitis c
516752|NCT00262379|peginterferon|peginterferon
516753|NCT00262379|ribavirin|ribavirin
516754|NCT00262379|epoetin beta|epoetin beta
516755|NCT00262392|heterotopic ossification,|heterotopic ossification,
516756|NCT00262392|prevention,|prevention,
516757|NCT00262392|high risk,|high risk,
516758|NCT00262392|bisphosphonates,|bisphosphonates,
516759|NCT00262392|radiotherapy|radiotherapy
516760|NCT00262431|Tracheostomy|tracheostomy
516761|NCT00262431|Tracheostomy timing|tracheostomy timing
516762|NCT00262431|Ventilator associated pneumonia|ventilator associated pneumonia
516763|NCT00262431|Mechanical ventilation|mechanical ventilation
516764|NCT00262457|electrical stimulation|electrical stimulation
516765|NCT00262457|Pressure Ulcers|pressure ulcers
516766|NCT00262457|Spinal Cord Injury|spinal cord injury
516767|NCT00262470|tachycardia|tachycardia
516768|NCT00262470|sinus tachycardia|sinus tachycardia
516769|NCT00262470|postural tachycardia syndrome (POTS)|postural tachycardia syndrome (pots)
516770|NCT00262496|Botox|botox
516771|NCT00262496|Overactive bladder|overactive bladder
516772|NCT00262496|Incontinence|incontinence
516773|NCT00262496|Spinal Cord Injury|spinal cord injury
516774|NCT00262509|Rehabilitation|rehabilitation
516775|NCT00262509|Sensory Aid|sensory aid
516776|NCT00262522|Human Immunodeficiency Virus Infections|human immunodeficiency virus infections
516777|NCT00262548|Obesity|obesity
516778|NCT00262548|Menopause|menopause
516779|NCT00262561|Intermittent Claudication|intermittent claudication
516780|NCT00262561|Aspirin resistance|aspirin resistance
516781|NCT00262561|Clopidogrel resistance|clopidogrel resistance
516782|NCT00262574|endothelial disfunction|endothelial disfunction
516783|NCT00262574|BNP|bnp
516784|NCT00262574|PCI|pci
516785|NCT00262574|coronary artery disease|coronary artery disease
516786|NCT00262587|Sport|sport
516787|NCT00262587|Asthma|asthma
516788|NCT00262587|Treatment|treatment
516789|NCT00262587|Airway inflammation|airway inflammation
516790|NCT00262613|Sodium Pyruvate|sodium pyruvate
516791|NCT00262613|COPD|copd
516792|NCT00262613|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
516793|NCT00262639|Alcoholism|alcoholism
516794|NCT00262639|Alcohol Dependence|alcohol dependence
516795|NCT00262639|Alcohol Withdrawal|alcohol withdrawal
516796|NCT00262639|Treatment|treatment
516797|NCT00262639|Pharmacotherapy|pharmacotherapy
516798|NCT00262652|sodium pyruvate|sodium pyruvate
516799|NCT00262652|anti-inflammatory|anti-inflammatory
516800|NCT00262652|bronchodilation|bronchodilation
516801|NCT00262652|asthma|asthma
516802|NCT00262652|asthmatics|asthmatics
516803|NCT00269594|Skin|skin
516804|NCT00269594|Picking|picking
516805|NCT00269594|Pick|pick
516806|NCT00269594|Neurotic Excoriation|neurotic excoriation
516807|NCT00269607|Substance abuse|substance abuse
516808|NCT00269607|Treatment|treatment
516809|NCT00269607|Relapse prevention|relapse prevention
516810|NCT00269607|opioid antagonist|opioid antagonist
516811|NCT00269620|contraceptive vaginal ring|contraceptive vaginal ring
516812|NCT00269620|contraceptive patch|contraceptive patch
516813|NCT00269620|oral contraceptives|oral contraceptives
516814|NCT00269620|acceptability|acceptability
516815|NCT00269633|Seasonal Affective Disorder|seasonal affective disorder
516816|NCT00269646|Diet|diet
516817|NCT00269646|Low-carbohydrate|low-carbohydrate
516818|NCT00269646|Insulin|insulin
516819|NCT00269646|Dietary fiber|dietary fiber
516820|NCT00269646|Diabetes|diabetes
516821|NCT00269646|Cardiovascular disease|cardiovascular disease
516822|NCT00269659|Left Bundle Branch Block|left bundle branch block
516824|NCT00269659|Global cardiac function|global cardiac function
516825|NCT00269659|Mechanical asynchrony|mechanical asynchrony
516826|NCT00269659|Echocardiography|echocardiography
516827|NCT00269659|2D echocardiography|2d echocardiography
516828|NCT00269659|Tissue Doppler Imaging|tissue doppler imaging
516829|NCT00269659|Real-time 3D echocardiography|real-time 3d echocardiography
516830|NCT00269659|Cardiovascular Magnetic Resonance Imaging-tagging|cardiovascular magnetic resonance imaging-tagging
516831|NCT00269672|vaccine|vaccine
516832|NCT00269685|Septic shock|septic shock
516833|NCT00269685|catecholamine|catecholamine
516834|NCT00269685|vasopressin|vasopressin
516835|NCT00269685|tonometria|tonometria
516836|NCT00269685|lactate|lactate
516837|NCT00269724|urinary incontinence|urinary incontinence
516838|NCT00269724|oxybutynin|oxybutynin
516839|NCT00269724|OROS®|oros®
516840|NCT00269737|fentanyl|fentanyl
516841|NCT00269737|pain|pain
516842|NCT00269737|Cancer|cancer
516848|NCT00269750|mixed urinary incontinence|mixed urinary incontinence
516849|NCT00269763|patch|patch
516850|NCT00269763|pain|pain
516851|NCT00269763|fentanyl|fentanyl
516852|NCT00269763|narcotic|narcotic
516853|NCT00269763|Cancer|cancer
516854|NCT00269776|ADHD|adhd
516855|NCT00269776|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
516856|NCT00269776|OROS|oros
516857|NCT00269776|children|children
516858|NCT00269776|methylphenidate|methylphenidate
516859|NCT00269776|Ritalin|ritalin
516860|NCT00269789|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
516861|NCT00269789|OROS®|oros®
516862|NCT00269789|Ritalin®|ritalin®
516863|NCT00269789|children|children
516864|NCT00269789|methylphenidate|methylphenidate
516865|NCT00269789|ADHD|adhd
516866|NCT00269802|ADHD|adhd
516867|NCT00269802|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
516868|NCT00269802|OROS®|oros®
516869|NCT00269802|Ritalin®|ritalin®
516870|NCT00269802|children|children
516871|NCT00269802|methylphenidate|methylphenidate
516872|NCT00269815|ADHD|adhd
516873|NCT00269815|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
516874|NCT00269815|OROS®|oros®
516875|NCT00269815|children|children
516876|NCT00269815|methylphenidate|methylphenidate
516877|NCT00269828|Non-small cell lung cancer|non-small cell lung cancer
516878|NCT00269828|NSCLC|nsclc
516879|NCT00269828|PS 2|ps 2
516880|NCT00269828|female|female
516881|NCT00269828|chemotherapy|chemotherapy
516882|NCT00269841|fistulae|fistulae
516883|NCT00269841|Crohn's Disease|crohn's disease
516884|NCT00269854|Crohn's Disease|crohn's disease
516885|NCT00269867|Rheumatoid Arthritis|rheumatoid arthritis
516886|NCT00269867|infliximab|infliximab
516887|NCT00269867|methotrexate|methotrexate
516888|NCT00269880|Angioplasty, Transluminal, Percutaneous coronary|angioplasty, transluminal, percutaneous coronary
516889|NCT00269893|Abciximab|abciximab
516890|NCT00269893|Angina, unstable|angina, unstable
516891|NCT00269893|Angioplasty, transluminal, Percutaneous coronary|angioplasty, transluminal, percutaneous coronary
516892|NCT00269906|Angina, unstable|angina, unstable
516893|NCT00269906|Angioplasty, transluminal, percutaneous coronary|angioplasty, transluminal, percutaneous coronary
516894|NCT00269906|Abciximab|abciximab
516895|NCT00269919|Schizophrenia|schizophrenia
516896|NCT00269919|Risperidone|risperidone
516897|NCT00269919|Risperidal Consta|risperidal consta
516898|NCT00269932|Bronchitis|bronchitis
516899|NCT00269932|chronic bronchitis|chronic bronchitis
516900|NCT00269932|lung diseases|lung diseases
516901|NCT00269932|respiratory tract infections|respiratory tract infections
516902|NCT00269932|bronchial diseases|bronchial diseases
516903|NCT00269932|antibacterial agents|antibacterial agents
516904|NCT00269932|quinolones|quinolones
516905|NCT00269932|levofloxacin|levofloxacin
516906|NCT00269945|Anemia|anemia
516907|NCT00269945|AIDS|aids
516908|NCT00269945|HIV|hiv
516909|NCT00269945|Zidovudine|zidovudine
516910|NCT00269945|Quality of Life|quality of life
516911|NCT00269945|erythropoietin|erythropoietin
516912|NCT00269945|epoetin alfa|epoetin alfa
516913|NCT00272363|Glaucoma|glaucoma
516914|NCT00272376|Myopia|myopia
516915|NCT00272376|Nearsightedness|nearsightedness
516916|NCT00272402|physician decision support|physician decision support
516917|NCT00272402|diabetes mellitus|diabetes mellitus
516918|NCT00272402|electronic medical records|electronic medical records
516919|NCT00272402|office systems redesign|office systems redesign
516920|NCT00272415|INO4136g|ino4136g
516921|NCT00272415|inotek|inotek
516922|NCT00272415|Parp|parp
516923|NCT00272415|Temodar|temodar
516924|NCT00272428|Prevention trial|prevention trial
516925|NCT00272428|Antioxydant vitamins and minerals|antioxydant vitamins and minerals
516926|NCT00272428|Cancer|cancer
516927|NCT00272428|Ischemic disease|ischemic disease
516928|NCT00272428|Mortality|mortality
516929|NCT00272428|Health related quality of life|health related quality of life
516930|NCT00272454|cilostazol|cilostazol
516931|NCT00272454|aspirin|aspirin
517327|NCT00274352|sarcoidosis|sarcoidosis
516932|NCT00272454|cerebral infarction|cerebral infarction
516933|NCT00272467|Helicobacter pylori|helicobacter pylori
516934|NCT00272467|Stomach ulcer|stomach ulcer
516935|NCT00272467|Rebamipide|rebamipide
516936|NCT00272467|Omeprazole|omeprazole
516937|NCT00272480|HAM/TSP|ham/tsp
516938|NCT00272480|HTLV-I-associated myelopathy|htlv-i-associated myelopathy
516939|NCT00272480|zidovudine|zidovudine
516940|NCT00272480|lamivudine|lamivudine
516941|NCT00272480|antiretroviral therapy|antiretroviral therapy
516942|NCT00272493|Treatment Experienced|treatment experienced
516943|NCT00272493|Treatment Naive|treatment naive
516945|NCT00272519|AIDS|aids
516946|NCT00272519|Adolescent|adolescent
516947|NCT00272519|HIV Positive|hiv positive
516948|NCT00272545|Anorexia Nervosa|anorexia nervosa
516949|NCT00272545|Bulimia Nervosa|bulimia nervosa
516950|NCT00272545|Cognitive Behavioral Therapy|cognitive behavioral therapy
516951|NCT00272558|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
516952|NCT00272558|Chemotherapy|chemotherapy
516953|NCT00272571|ECPT, endothelial progenitor cells|ecpt, endothelial progenitor cells
516954|NCT00272584|Psychosis, schizophrenia, schizoaffective, clozapine, risperidone|psychosis, schizophrenia, schizoaffective, clozapine, risperidone
516955|NCT00272597|Psychosis|psychosis
516956|NCT00272597|schizophrenia|schizophrenia
516957|NCT00272597|schizoaffective|schizoaffective
516958|NCT00272597|risperidone|risperidone
516959|NCT00272610|Skin Aging|skin aging
516960|NCT00272610|Bateman's Purpura|bateman's purpura
516961|NCT00272623|Catheter, Indwelling|catheter, indwelling
516962|NCT00272623|Indwelling Catheter|indwelling catheter
516963|NCT00272623|Indwelling Catheters|indwelling catheters
516964|NCT00272623|Implantable Catheters|implantable catheters
516965|NCT00272623|Catheter, Implantable|catheter, implantable
516966|NCT00272623|Catheters, Implantable|catheters, implantable
516967|NCT00272623|Implantable Catheter|implantable catheter
516968|NCT00272623|In-Dwelling Catheters|in-dwelling catheters
516969|NCT00272623|Catheter, In-Dwelling|catheter, in-dwelling
516970|NCT00272623|Catheters, In-Dwelling|catheters, in-dwelling
516971|NCT00272623|In Dwelling Catheters|in dwelling catheters
516972|NCT00272623|In-Dwelling Catheter|in-dwelling catheter
516973|NCT00272623|Venous Reservoirs|venous reservoirs
516974|NCT00272623|Reservoir, Venous|reservoir, venous
516975|NCT00272623|Reservoirs, Venous|reservoirs, venous
516976|NCT00272623|Venous Reservoir|venous reservoir
516977|NCT00272623|Vascular Access Ports|vascular access ports
516978|NCT00272623|Access Port, Vascular|access port, vascular
516979|NCT00272623|Access Ports, Vascular|access ports, vascular
516980|NCT00272623|Port, Vascular Access|port, vascular access
516981|NCT00272623|Ports, Vascular Access|ports, vascular access
516982|NCT00272623|Vascular Access Port|vascular access port
516983|NCT00272636|atrial fibrillation|atrial fibrillation
516984|NCT00272636|catheter ablation|catheter ablation
516985|NCT00272636|amiodarone|amiodarone
516986|NCT00272636|cardioversion|cardioversion
516987|NCT00272649|Kidney cancer|kidney cancer
516988|NCT00272649|Renal cancer|renal cancer
516989|NCT00272662|anemia|anemia
516990|NCT00272662|cancer|cancer
516991|NCT00272662|chemotherapy|chemotherapy
516992|NCT00272662|chemotherapy induced anemia|chemotherapy induced anemia
516993|NCT00272662|CIA|cia
516994|NCT00272662|hemoglobin|hemoglobin
516995|NCT00272662|Hb|hb
516996|NCT00272662|Hgb|hgb
516997|NCT00272662|erythropoietin|erythropoietin
516998|NCT00272662|EPO|epo
516999|NCT00272662|erythropoiesis stimulating agent|erythropoiesis stimulating agent
517000|NCT00272662|ESA|esa
517001|NCT00272662|Hematide|hematide
517002|NCT00272662|Omontys|omontys
517003|NCT00272662|peginesatide|peginesatide
517004|NCT00272662|red blood cell|red blood cell
517005|NCT00272662|red blood cell production|red blood cell production
517006|NCT00272675|Nosocomial infection,|nosocomial infection,
517007|NCT00272675|Decontamination,|decontamination,
517008|NCT00272675|Randomized placebo-controlled trial,|randomized placebo-controlled trial,
517009|NCT00272675|Cardiac surgery,|cardiac surgery,
517010|NCT00272675|Chlorhexidine,|chlorhexidine,
517011|NCT00272675|Prevention|prevention
517012|NCT00272714|breast pain, tenderness, benign breast conditions|breast pain, tenderness, benign breast conditions
517013|NCT00272727|Asthma|asthma
517014|NCT00272727|dialog tool|dialog tool
517015|NCT00272727|compliance|compliance
517016|NCT00272740|breast cancer|breast cancer
517017|NCT00272740|fulvestrant|fulvestrant
517018|NCT00272740|Faslodex|faslodex
517019|NCT00272740|hormonotherapy|hormonotherapy
517020|NCT00272740|aromatase inhibitor failure|aromatase inhibitor failure
517021|NCT00272740|Advanced breast cancer|advanced breast cancer
517022|NCT00272766|Ocular histoplasmosis|ocular histoplasmosis
517023|NCT00272766|Macugen|macugen
517024|NCT00272766|Photodynamic therapy with Visudyne|photodynamic therapy with visudyne
517025|NCT00272766|Best-corrected visual acuity scores between 20/40-20/200|best-corrected visual acuity scores between 20/40-20/200
517026|NCT00272766|classic or occult choroidal neovascularization|classic or occult choroidal neovascularization
516355|NCT00260585|GERD|gerd
517027|NCT00272779|HIV|hiv
517028|NCT00272779|Treatment Naive|treatment naive
517328|NCT00274352|adalimumab|adalimumab
517029|NCT00272805|chronic heart failure|chronic heart failure
517030|NCT00272805|left ventricular systolic dysfunction|left ventricular systolic dysfunction
517031|NCT00272818|Colitis|colitis
517032|NCT00272818|Esophagitis|esophagitis
517033|NCT00272818|CD23|cd23
517034|NCT00272831|Diabetic nephropathy|diabetic nephropathy
517035|NCT00272831|Macroalbuminuria|macroalbuminuria
517037|NCT00272844|cholesterol|cholesterol
517038|NCT00272844|Smith-Lemli-Opitz syndrome|smith-lemli-opitz syndrome
517039|NCT00272844|mental retardation|mental retardation
517040|NCT00272844|sterols|sterols
517041|NCT00272844|congenital anomalies|congenital anomalies
517042|NCT00272883|central core|central core
517043|NCT00272883|centronuclear|centronuclear
517044|NCT00272883|multiminicore|multiminicore
517045|NCT00272883|multicore|multicore
517046|NCT00272883|minicore|minicore
517047|NCT00272883|congenital fiber type disproportion|congenital fiber type disproportion
517048|NCT00272883|myotubular|myotubular
517049|NCT00272883|nemaline|nemaline
517050|NCT00272883|congenital myopathy|congenital myopathy
517051|NCT00272883|neuromuscular|neuromuscular
517052|NCT00272883|rigid spine|rigid spine
517053|NCT00272896|Migraine|migraine
517054|NCT00272896|VIP|vip
517055|NCT00272896|Transcranial Doppler|transcranial doppler
517056|NCT00272896|Headache|headache
517057|NCT00272909|Acute Ischemic Stroke|acute ischemic stroke
517058|NCT00272909|9-Hour window MRI|9-hour window mri
517059|NCT00272909|Serotonin receptor agonist|serotonin receptor agonist
517060|NCT00272922|Biomaterials|biomaterials
517061|NCT00272922|Paraesophageal Hernia|paraesophageal hernia
517062|NCT00272922|Laparoscopy|laparoscopy
517063|NCT00272935|menopause|menopause
517064|NCT00272935|vasomotor symptoms|vasomotor symptoms
517065|NCT00272948|Venoocclusive disease|venoocclusive disease
517066|NCT00272948|Pediatric|pediatric
517067|NCT00272948|myeloablative conditioning|myeloablative conditioning
517068|NCT00272948|stem cell transplant|stem cell transplant
517069|NCT00272974|AE adverse event|ae adverse event
517070|NCT00272974|DCF data collection forms|dcf data collection forms
517071|NCT00272974|IRB Institutional Review Board|irb institutional review board
517072|NCT00272974|SAE serious adverse event|sae serious adverse event
517073|NCT00272987|trastuzumab|trastuzumab
517074|NCT00272987|ErbB2|erbb2
517075|NCT00272987|paclitaxel|paclitaxel
517076|NCT00272987|Herceptin|herceptin
517077|NCT00272987|Taxol|taxol
517078|NCT00272987|ErbB1|erbb1
517079|NCT00272987|metastatic breast cancer|metastatic breast cancer
517080|NCT00272987|Stage IV breast cancer|stage iv breast cancer
517081|NCT00272987|lapatinib|lapatinib
517082|NCT00273013|asthma|asthma
517083|NCT00273013|allergen challenge|allergen challenge
517084|NCT00273026|Asthma Advair|asthma advair
517085|NCT00273039|Social Anxiety Disorder|social anxiety disorder
517086|NCT00273039|Anxiety|anxiety
517087|NCT00273039|Psychiatry|psychiatry
517088|NCT00273052|hypertension|hypertension
517089|NCT00273065|Local Anesthetic|local anesthetic
517090|NCT00273065|Neosaxitoxin|neosaxitoxin
517091|NCT00273078|Speech,|speech,
517092|NCT00273078|tongue,|tongue,
517093|NCT00273078|pressure,|pressure,
517094|NCT00273078|transducer,|transducer,
517095|NCT00273078|complete denture|complete denture
517096|NCT00273117|transnasal gastroscopy|transnasal gastroscopy
517097|NCT00273117|tachycardia|tachycardia
517098|NCT00273117|hypoxemia|hypoxemia
517099|NCT00273130|transnasal gastroscopy, stress response, ischaemia|transnasal gastroscopy, stress response, ischaemia
517100|NCT00273182|Heart Failure|heart failure
517101|NCT00273182|Cardiomyopathy|cardiomyopathy
517102|NCT00273182|Cardiac pacing|cardiac pacing
517103|NCT00273182|Cardiac resynchronization therapy|cardiac resynchronization therapy
517104|NCT00273195|Implantable Cardioverter Defibrillator, Anti-tachycardia pacing (ATP)|implantable cardioverter defibrillator, anti-tachycardia pacing (atp)
517105|NCT00273208|breast cancer|breast cancer
517106|NCT00273208|fatigue|fatigue
517107|NCT00273221|Glaucoma|glaucoma
517108|NCT00273221|Cataract|cataract
517109|NCT00273234|Venous|venous
517110|NCT00273234|Ulcer|ulcer
517111|NCT00273234|autologous|autologous
517112|NCT00273234|platelet|platelet
517113|NCT00273234|healing|healing
517114|NCT00273273|HIV|hiv
517115|NCT00273273|Atazanavir|atazanavir
517116|NCT00273273|ritonavir|ritonavir
517117|NCT00273273|tenofovir|tenofovir
517118|NCT00273273|Adolescent|adolescent
517119|NCT00273273|Treatment Experienced|treatment experienced
517120|NCT00273286|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
517121|NCT00273286|Diabetes Mellitus, Juvenile-Onset|diabetes mellitus, juvenile-onset
517122|NCT00273286|IDDM|iddm
517123|NCT00273286|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
517124|NCT00273299|hypertension|hypertension
517125|NCT00273299|high blood pressure|high blood pressure
517126|NCT00273299|valsartan/hydrochlorozide|valsartan/hydrochlorozide
517127|NCT00273299|severe hypertension|severe hypertension
517128|NCT00273312|Advanced unresectable metastatic hepatocellular carcinoma|advanced unresectable metastatic hepatocellular carcinoma
517129|NCT00273312|Liver cancer|liver cancer
517873|NCT00266773|CBT|cbt
517130|NCT00273325|NICHD Neonatal Research Network|nichd neonatal research network
517131|NCT00273325|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
517132|NCT00273325|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
517133|NCT00273325|Prematurity|prematurity
517134|NCT00273325|Pneumococcal Vaccines|pneumococcal vaccines
517135|NCT00273325|Vaccines, Conjugate|vaccines, conjugate
517136|NCT00273325|Immunogenicity|immunogenicity
517137|NCT00273325|Vaccine Response|vaccine response
517138|NCT00273325|Heptavalent pneumococcal conjugate vaccine (PCV-7)|heptavalent pneumococcal conjugate vaccine (pcv-7)
517139|NCT00273325|pneumococcal polysaccharide, type 6B|pneumococcal polysaccharide, type 6b
517140|NCT00273325|Pneumococcal polysaccharide, type 14|pneumococcal polysaccharide, type 14
517141|NCT00273325|Pneumococcal polysaccharide, type 19F,|pneumococcal polysaccharide, type 19f,
517142|NCT00273325|Pneumococcal polysaccharide, 23F|pneumococcal polysaccharide, 23f
517143|NCT00273325|Pneumococcal polysaccharide, 18C|pneumococcal polysaccharide, 18c
517144|NCT00273325|Pneumococcal polysaccharide, 4|pneumococcal polysaccharide, 4
517244|NCT00273767|protein S-100|protein s-100
517145|NCT00273325|Pneumococcal polysaccharide, 9V|pneumococcal polysaccharide, 9v
517146|NCT00273338|Androgen-independent Prostate Cancer (AIPC)|androgen-independent prostate cancer (aipc)
517147|NCT00273338|Prostate Cancer|prostate cancer
517149|NCT00273338|calcitriol|calcitriol
517150|NCT00273338|Taxotere|taxotere
517151|NCT00273338|docetaxel|docetaxel
517152|NCT00273351|Parkinson|parkinson
517153|NCT00273351|family history|family history
517154|NCT00273351|diagnosis|diagnosis
517155|NCT00273364|stem cell, autoimmune disease, multiple sclerosis|stem cell, autoimmune disease, multiple sclerosis
517156|NCT00273377|Anesthesia|anesthesia
517157|NCT00273377|Oxygen|oxygen
517158|NCT00273377|Carbon dioxide|carbon dioxide
517159|NCT00273377|Hypercapnia|hypercapnia
517160|NCT00273377|Hypercarbia|hypercarbia
517161|NCT00273377|Dexamethasone|dexamethasone
517162|NCT00273377|Steroid|steroid
517163|NCT00273377|Postoperative nausea and vomiting (PONV)|postoperative nausea and vomiting (ponv)
517165|NCT00273403|Minority Groups|minority groups
517166|NCT00273403|Health Services Accessibility|health services accessibility
517167|NCT00273403|Quality of Life|quality of life
517168|NCT00273494|N2 disease|n2 disease
517169|NCT00273494|Non-small cell lung cancer|non-small cell lung cancer
517170|NCT00273494|Surgery|surgery
517171|NCT00273494|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
517172|NCT00273507|Non-small cell lung cancer|non-small cell lung cancer
517173|NCT00273507|neoadjuvant|neoadjuvant
517174|NCT00273507|resection|resection
517175|NCT00273546|Head and Neck Cancer|head and neck cancer
517176|NCT00273546|Induction|induction
517177|NCT00273546|Chemotherapy|chemotherapy
517178|NCT00273546|Chemoradiotherapy|chemoradiotherapy
517179|NCT00273559|Renal Transplantation|renal transplantation
517180|NCT00273572|Obesity|obesity
517181|NCT00273572|Women|women
517182|NCT00273572|Arab|arab
517183|NCT00273572|Metabolic syndrome|metabolic syndrome
517184|NCT00273572|Lifestyle intervention|lifestyle intervention
517185|NCT00273572|Quality of life|quality of life
517186|NCT00273585|Fecal occult blood testing|fecal occult blood testing
517187|NCT00273585|Flexible sigmoidoscopy|flexible sigmoidoscopy
517188|NCT00273585|Colonoscopy|colonoscopy
517189|NCT00273585|Self-efficacy|self-efficacy
517190|NCT00273598|Scoliosis|scoliosis
517191|NCT00273598|spinal disease|spinal disease
517192|NCT00273598|pediatrics|pediatrics
517193|NCT00273598|Adolescents|adolescents
517194|NCT00273598|Universal Spinal Instrumentation System|universal spinal instrumentation system
517195|NCT00273598|Moss Miami Spinal Instrumentation System|moss miami spinal instrumentation system
517196|NCT00273598|Orthopedic Surgery|orthopedic surgery
517197|NCT00273611|vitamin D deficiency|vitamin d deficiency
517198|NCT00273611|geriatric patients|geriatric patients
517199|NCT00273624|Therapy-resistant depression|therapy-resistant depression
517200|NCT00273624|add-on therapy depression|add-on therapy depression
517201|NCT00273637|heart failure|heart failure
517202|NCT00273637|peripartum cardiomyopathy|peripartum cardiomyopathy
517203|NCT00273637|pregnancy-associated cardiomyopathy|pregnancy-associated cardiomyopathy
517204|NCT00273637|pregnancy complications|pregnancy complications
517205|NCT00273637|nonischemic cardiomyopathy|nonischemic cardiomyopathy
517206|NCT00273650|Autism|autism
517207|NCT00273650|Placebo|placebo
517208|NCT00273650|B12|b12
517209|NCT00273650|Controlled|controlled
517210|NCT00273650|Complementary Alternative Medicine|complementary alternative medicine
517211|NCT00273650|Vitamin Supplement|vitamin supplement
517212|NCT00273663|cerebral blood flow|cerebral blood flow
517213|NCT00273663|electrical stimulation|electrical stimulation
517214|NCT00273663|Computed Tomography Scanner, X-Ray|computed tomography scanner, x-ray
517215|NCT00273663|Brain Mapping|brain mapping
517216|NCT00273676|Community-acquired pneumonia|community-acquired pneumonia
517217|NCT00273676|Treatment|treatment
517218|NCT00273676|Antibiotics|antibiotics
517219|NCT00273702|Gambling|gambling
517220|NCT00273702|Gambler|gambler
517221|NCT00273702|Gamble|gamble
517222|NCT00273702|Pathological|pathological
517223|NCT00273715|Comparative|comparative
517224|NCT00273715|Randomized|randomized
517225|NCT00273715|Suture|suture
517226|NCT00273715|Staples, surgical|staples, surgical
517227|NCT00273715|Skin|skin
517228|NCT00273715|Surgical procedures, operative|surgical procedures, operative
517229|NCT00273715|Orthopedics|orthopedics
517230|NCT00273715|Joint, hip|joint, hip
517164|NCT00273403|HIV|hiv
517231|NCT00273715|Surgical procedures of Hip, Operative|surgical procedures of hip, operative
517233|NCT00273728|shock, septic|shock, septic
517234|NCT00273728|infusion, intravenous|infusion, intravenous
517235|NCT00273728|mortality|mortality
517236|NCT00273741|palliative care|palliative care
517237|NCT00273741|methylphenidate|methylphenidate
517238|NCT00273754|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
517239|NCT00273754|Tonsillectomy and Adenoidectomy (T&A)|tonsillectomy and adenoidectomy (t&a)
517240|NCT00273754|Postoperative Complications|postoperative complications
517241|NCT00273754|Recovery|recovery
517242|NCT00273767|troponin T|troponin t
517243|NCT00273767|CK-MB|ck-mb
517245|NCT00273767|Cardiopulmonary Bypass|cardiopulmonary bypass
517246|NCT00273767|Erythropoietin|erythropoietin
517247|NCT00273780|Patient compliance|patient compliance
517248|NCT00273806|Behavioral risk factors|behavioral risk factors
517249|NCT00273806|Primary Care|primary care
517250|NCT00273806|Health services research|health services research
517251|NCT00273819|Congestive heart failure, LV dysfunction|congestive heart failure, lv dysfunction
517252|NCT00273832|Chest pain|chest pain
517253|NCT00273832|Angina pectoris|angina pectoris
517254|NCT00273832|Emergency medicine|emergency medicine
517255|NCT00273832|Spiral computed tomography|spiral computed tomography
517256|NCT00273832|Length of stay|length of stay
517257|NCT00273832|Cost analysis|cost analysis
517258|NCT00273845|case management|case management
517259|NCT00273845|substance abuse treatment|substance abuse treatment
517260|NCT00273845|linkage|linkage
517261|NCT00273858|Rheumatoid Arthritis|rheumatoid arthritis
517262|NCT00273858|Ankylosing Spondylitis|ankylosing spondylitis
517263|NCT00273858|Psoriatic Arthritis|psoriatic arthritis
517264|NCT00273871|kidney transplant|kidney transplant
517266|NCT00273884|Secondary AML|secondary aml
517267|NCT00273884|Leukemia|leukemia
517268|NCT00273897|Dementia Treatment|dementia treatment
517269|NCT00273897|Hand Function|hand function
517270|NCT00273897|Clinical Trials|clinical trials
517271|NCT00273897|Dementia|dementia
517272|NCT00273897|Cortical Syndrome|cortical syndrome
517273|NCT00273897|CBS|cbs
517274|NCT00273897|Apraxia|apraxia
517275|NCT00273910|Disease Free Survival|disease free survival
517276|NCT00273910|gp 100:209-217 (210m)|gp 100:209-217 (210m)
517277|NCT00273910|Immunologic Response|immunologic response
517278|NCT00273910|Adjuvant Therapy|adjuvant therapy
517279|NCT00273910|Cutaneous Melanoma|cutaneous melanoma
517280|NCT00273910|Melanoma|melanoma
517281|NCT00273949|Lactulose|lactulose
517282|NCT00273949|Prebiotics|prebiotics
517283|NCT00273949|Nosocomial infection|nosocomial infection
517284|NCT00273949|children|children
517285|NCT00273949|infants|infants
517286|NCT00274157|Peripheral Vascular Disease|peripheral vascular disease
517287|NCT00274157|Intermittent Claudication|intermittent claudication
517288|NCT00274157|Catheter-based Arterial Revascularization|catheter-based arterial revascularization
517289|NCT00274157|Peripheral angioplasty|peripheral angioplasty
517290|NCT00274157|Peripheral stenting|peripheral stenting
517291|NCT00274157|Functional capacity|functional capacity
517292|NCT00274157|Quality of life|quality of life
517293|NCT00274170|Migraine|migraine
517294|NCT00274170|Octreotide|octreotide
517295|NCT00274170|Prochlorperazine|prochlorperazine
517296|NCT00274196|fractures, occult|fractures, occult
517297|NCT00274196|hip|hip
517298|NCT00274196|ultrasound examination|ultrasound examination
517299|NCT00274196|MRI|mri
517300|NCT00274196|sensitivity|sensitivity
517301|NCT00274196|specificity|specificity
517302|NCT00274209|Ulcerative colitis|ulcerative colitis
517303|NCT00274209|Crohn's disease|crohn's disease
517304|NCT00274209|Chromoendoscopy|chromoendoscopy
517305|NCT00274209|Dysplasia|dysplasia
517306|NCT00274209|Neoplasia|neoplasia
517307|NCT00274222|COPD, nebulized budesonide, systemic corticosteroids|copd, nebulized budesonide, systemic corticosteroids
517308|NCT00274235|Malaria|malaria
517309|NCT00274235|Prevention|prevention
517310|NCT00274235|Pregnancy|pregnancy
517311|NCT00274235|Low birthweight|low birthweight
517312|NCT00274235|Anemia|anemia
517313|NCT00274235|Africa|africa
517314|NCT00274261|contraception|contraception
517315|NCT00274300|DNA vaccine|dna vaccine
517316|NCT00274300|immunotherapy|immunotherapy
517317|NCT00274300|Herpes Simplex Virus Type 2 (HSV2)|herpes simplex virus type 2 (hsv2)
517318|NCT00274300|Particle Mediated Epidermal Delivery|particle mediated epidermal delivery
517319|NCT00274313|Cystic Fibrosis|cystic fibrosis
517320|NCT00274326|Hyponatremia|hyponatremia
517321|NCT00274339|Laryngopharyngeal Reflux|laryngopharyngeal reflux
666970|NCT00846547|Autism|autism
517322|NCT00274339|Prevacid|prevacid
517323|NCT00274339|Lifestyle changes|lifestyle changes
517324|NCT00274339|Reflux Finding Score|reflux finding score
517325|NCT00274339|Reflux Symptom Index|reflux symptom index
517326|NCT00274339|Laryngoscopy|laryngoscopy
517329|NCT00274352|skin diseases|skin diseases
517330|NCT00274365|general practitioners, psychiatry, videoconference|general practitioners, psychiatry, videoconference
517331|NCT00274378|radius fracture|radius fracture
517332|NCT00274378|fracture fixation|fracture fixation
517333|NCT00274378|homologous bone transplantation|homologous bone transplantation
517334|NCT00274404|infectious mononucleosis|infectious mononucleosis
517335|NCT00274404|Epstein-Barr virus|epstein-barr virus
517336|NCT00274404|valacyclovir|valacyclovir
517337|NCT00274404|quantitative PCR|quantitative pcr
517338|NCT00274456|Metastatic breast cancer, nab paclitaxel, docetaxel,|metastatic breast cancer, nab paclitaxel, docetaxel,
517339|NCT00274469|oncology|oncology
517341|NCT00274469|breast cancer|breast cancer
517342|NCT00274495|Genotype 1|genotype 1
517343|NCT00274495|Metabolic syndrome|metabolic syndrome
517344|NCT00274495|Insulin resistance|insulin resistance
517345|NCT00274625|Biomaterials|biomaterials
517346|NCT00274625|Bariatric Surgery|bariatric surgery
517347|NCT00274625|Hernia, Prevention of|hernia, prevention of
517348|NCT00274625|Obesity|obesity
517349|NCT00274625|Bypass Surgery|bypass surgery
517350|NCT00274625|Incisional Hernia|incisional hernia
517351|NCT00274625|Ventral Hernia|ventral hernia
517352|NCT00274651|CTCL|ctcl
517353|NCT00274651|PTCL|ptcl
517354|NCT00274651|lymphoma|lymphoma
517355|NCT00274651|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
517356|NCT00274651|Cutaneous T-Cell Lymphomas (CTCL)|cutaneous t-cell lymphomas (ctcl)
517357|NCT00274651|Peripheral T-Cell Lymphomas (PTCL)|peripheral t-cell lymphomas (ptcl)
517358|NCT00274651|Other Types of Non-Hodgkin's Lymphoma|other types of non-hodgkin's lymphoma
517359|NCT00274651|belinostat|belinostat
517360|NCT00274664|Amblyopia|amblyopia
517361|NCT00274664|Occlusion dose monitoring|occlusion dose monitoring
517362|NCT00274664|Refractive adaptation|refractive adaptation
517363|NCT00274664|Dose-response|dose-response
517364|NCT00274677|Bipolar Disorder|bipolar disorder
517365|NCT00274690|Neurokinin-1 Receptor Antagonist|neurokinin-1 receptor antagonist
517366|NCT00274690|GW679769|gw679769
517367|NCT00274690|Post-operative Nausea|post-operative nausea
517368|NCT00274690|NK-1 Receptor Antagonist|nk-1 receptor antagonist
517369|NCT00274690|PONV|ponv
517370|NCT00274690|Post-discharge Nausea and Vomiting|post-discharge nausea and vomiting
517371|NCT00274690|PDNV|pdnv
517372|NCT00274690|Vomiting|vomiting
517373|NCT00274703|anti IL-5|anti il-5
517374|NCT00274703|oesophagitis|oesophagitis
517375|NCT00274703|eosinophils|eosinophils
517376|NCT00274703|mepolizumab|mepolizumab
517377|NCT00274703|adults|adults
517378|NCT00274729|Dietary intervention|dietary intervention
517379|NCT00274729|High-carbohydrate diet|high-carbohydrate diet
517380|NCT00274729|High-fat diet|high-fat diet
517381|NCT00274729|Moderate-fat diet|moderate-fat diet
517382|NCT00274729|Obesity|obesity
517383|NCT00274729|Weight maintenance|weight maintenance
517384|NCT00274729|Body composition|body composition
517385|NCT00274729|Glucose metabolism|glucose metabolism
517386|NCT00274729|Cardiovascular disease|cardiovascular disease
517387|NCT00274729|Appetite regulation|appetite regulation
517388|NCT00274729|Energy expenditure|energy expenditure
517389|NCT00274742|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
517390|NCT00274742|Cancer immunotherapy|cancer immunotherapy
517391|NCT00274742|Monoclonal antibody|monoclonal antibody
517392|NCT00274742|anti-CD19|anti-cd19
517393|NCT00274742|anti-CD3|anti-cd3
517394|NCT00274742|BiTE|bite
517395|NCT00274742|Blinatumomab|blinatumomab
517396|NCT00274755|adult anaplastic astrocytoma|adult anaplastic astrocytoma
517397|NCT00274755|adult diffuse astrocytoma|adult diffuse astrocytoma
517398|NCT00274755|adult glioblastoma|adult glioblastoma
517399|NCT00274755|adult giant cell glioblastoma|adult giant cell glioblastoma
517400|NCT00274755|adult gliosarcoma|adult gliosarcoma
517401|NCT00274755|adult pilocytic astrocytoma|adult pilocytic astrocytoma
517402|NCT00274755|adult anaplastic ependymoma|adult anaplastic ependymoma
517403|NCT00274755|adult ependymoma|adult ependymoma
517404|NCT00274755|adult myxopapillary ependymoma|adult myxopapillary ependymoma
517405|NCT00274755|adult subependymoma|adult subependymoma
517406|NCT00274755|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
517407|NCT00274755|adult oligodendroglioma|adult oligodendroglioma
517408|NCT00274755|adult mixed glioma|adult mixed glioma
517409|NCT00274768|stage IV breast cancer|stage iv breast cancer
517410|NCT00274768|male breast cancer|male breast cancer
517411|NCT00274768|recurrent breast cancer|recurrent breast cancer
517412|NCT00274781|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
517413|NCT00274781|refractory anemia with excess blasts|refractory anemia with excess blasts
517414|NCT00274781|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
517415|NCT00274781|secondary acute myeloid leukemia|secondary acute myeloid leukemia
517416|NCT00274781|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
517417|NCT00274781|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
517418|NCT00274781|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
583947|NCT00514020|adenocarcinoma of the stomach|adenocarcinoma of the stomach
517419|NCT00274794|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
15446|NCT03191929|Post-traumatic Stress Disorder|post-traumatic stress disorder
517420|NCT00274794|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
517421|NCT00274794|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
517422|NCT00274794|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
517423|NCT00274794|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
517424|NCT00274794|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
517425|NCT00274794|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
517426|NCT00274794|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
517427|NCT00274794|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
517428|NCT00274794|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
517429|NCT00274794|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
517430|NCT00274794|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
517431|NCT00274794|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
517432|NCT00274794|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
517433|NCT00274794|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
517434|NCT00274794|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
517435|NCT00274794|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
517436|NCT00274794|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
517437|NCT00274794|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
517438|NCT00274794|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
517439|NCT00274794|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
517440|NCT00274794|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
517441|NCT00274794|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
517442|NCT00274794|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
517443|NCT00274794|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
517444|NCT00274794|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
517445|NCT00274794|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
517446|NCT00274794|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
517447|NCT00274794|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
517448|NCT00274794|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
517449|NCT00274794|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
517450|NCT00274794|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
517451|NCT00274794|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
517452|NCT00274794|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
517453|NCT00274794|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
517454|NCT00274794|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
517455|NCT00274794|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
517456|NCT00274794|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
517457|NCT00274794|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
517458|NCT00274794|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
517459|NCT00274794|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
517460|NCT00274794|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
517461|NCT00274794|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
517462|NCT00274794|splenic marginal zone lymphoma|splenic marginal zone lymphoma
517463|NCT00274794|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
517464|NCT00274794|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
517465|NCT00274794|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
517466|NCT00274794|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
517467|NCT00274794|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
517468|NCT00274794|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
517469|NCT00274807|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
517470|NCT00274807|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
752468|NCT01173133|Outcome|outcome
517471|NCT00274807|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
517472|NCT00274807|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
517473|NCT00274807|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
517474|NCT00274807|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
517475|NCT00274820|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
517476|NCT00274820|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
517477|NCT00274820|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
517478|NCT00274820|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
518387|NCT00277290|Cancer|cancer
517479|NCT00274820|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
517480|NCT00274820|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
517481|NCT00274820|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
517482|NCT00274833|adult glioblastoma|adult glioblastoma
517483|NCT00274833|adult giant cell glioblastoma|adult giant cell glioblastoma
517484|NCT00274833|adult gliosarcoma|adult gliosarcoma
517485|NCT00274846|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
517486|NCT00274846|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
517487|NCT00274846|secondary acute myeloid leukemia|secondary acute myeloid leukemia
517488|NCT00274846|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
517489|NCT00274846|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
517490|NCT00274846|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
518164|NCT00276276|lung cancer|lung cancer
517491|NCT00274846|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
517492|NCT00274846|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
517493|NCT00260130|obesity|obesity
517494|NCT00260130|food intake|food intake
517495|NCT00260130|human|human
517496|NCT00260130|energy balance|energy balance
517497|NCT00260130|beverage|beverage
517498|NCT00265616|Refractory status epilepticus,|refractory status epilepticus,
517499|NCT00265616|coma-induction,|coma-induction,
517500|NCT00265616|treatment,|treatment,
517501|NCT00265616|propofol,|propofol,
517502|NCT00265616|barbiturates,|barbiturates,
517503|NCT00265616|efficacy,|efficacy,
517504|NCT00265616|safety.|safety.
517505|NCT00265629|Atrial fibrillation|atrial fibrillation
517506|NCT00265642|Hepatitis C, Chronic|hepatitis c, chronic
517507|NCT00265642|irbesartan|irbesartan
517508|NCT00265681|smokeless tobacco cessation|smokeless tobacco cessation
517509|NCT00265681|chewing tobacco|chewing tobacco
517510|NCT00265681|oral tobacco|oral tobacco
517511|NCT00265681|smokeless tobacco|smokeless tobacco
517512|NCT00265681|telephone|telephone
517513|NCT00265681|counseling|counseling
517514|NCT00265707|Hypertension|hypertension
517515|NCT00265707|Hypotension|hypotension
517516|NCT00265720|African Americans|african americans
517517|NCT00265720|Colorectal Cancer Screening|colorectal cancer screening
517518|NCT00265720|Colorectal Cancer|colorectal cancer
517519|NCT00265720|Colorectal Cancer and African Americans|colorectal cancer and african americans
517520|NCT00265720|Cancer Disparities|cancer disparities
517521|NCT00265733|male breast cancer|male breast cancer
517522|NCT00265733|recurrent breast cancer|recurrent breast cancer
517523|NCT00265733|stage IV breast cancer|stage iv breast cancer
517524|NCT00265746|metformin|metformin
517525|NCT00265746|gestational diabetes|gestational diabetes
517526|NCT00265746|lifestyle|lifestyle
517527|NCT00265759|stage II breast cancer|stage ii breast cancer
517528|NCT00265759|stage IIIA breast cancer|stage iiia breast cancer
517529|NCT00265759|stage IIIB breast cancer|stage iiib breast cancer
517530|NCT00265759|stage IIIC breast cancer|stage iiic breast cancer
517531|NCT00265759|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
517532|NCT00265772|enteral nutrition|enteral nutrition
517533|NCT00265772|steroids|steroids
517534|NCT00265772|mucosal healing|mucosal healing
517535|NCT00265785|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
517536|NCT00265785|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
517537|NCT00265785|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
517538|NCT00265785|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
517539|NCT00265811|stage III colon cancer|stage iii colon cancer
517540|NCT00265811|adenocarcinoma of the colon|adenocarcinoma of the colon
517541|NCT00265824|stage IV colon cancer|stage iv colon cancer
517542|NCT00265824|stage IV rectal cancer|stage iv rectal cancer
517543|NCT00265824|adenocarcinoma of the colon|adenocarcinoma of the colon
517544|NCT00265824|adenocarcinoma of the rectum|adenocarcinoma of the rectum
517545|NCT00265824|chemotherapy|chemotherapy
517546|NCT00265837|graft versus host disease|graft versus host disease
517547|NCT00265837|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
517548|NCT00265837|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
516944|NCT00272519|HIV|hiv
517549|NCT00265837|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
517550|NCT00265837|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
517551|NCT00265837|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
517552|NCT00265837|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
517553|NCT00265837|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
517554|NCT00265837|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
517555|NCT00265837|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
517556|NCT00265837|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
517557|NCT00265837|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
517558|NCT00265837|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
517559|NCT00265837|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
517560|NCT00265837|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
517561|NCT00265837|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
517562|NCT00265837|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
517563|NCT00265837|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
517564|NCT00265837|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
517565|NCT00265837|secondary acute myeloid leukemia|secondary acute myeloid leukemia
517566|NCT00265837|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
517567|NCT00265837|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
517568|NCT00265837|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
517569|NCT00265837|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
518165|NCT00276276|resistant|resistant
517570|NCT00265837|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
517571|NCT00265837|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
517572|NCT00265837|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
517573|NCT00265837|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
517574|NCT00265837|stage I multiple myeloma|stage i multiple myeloma
517575|NCT00265837|stage II multiple myeloma|stage ii multiple myeloma
517576|NCT00265837|stage III multiple myeloma|stage iii multiple myeloma
517577|NCT00265837|refractory multiple myeloma|refractory multiple myeloma
517578|NCT00265837|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
517579|NCT00265837|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
517580|NCT00265837|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
517581|NCT00265837|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
517582|NCT00265837|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
517583|NCT00265837|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
517584|NCT00265837|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
517585|NCT00265837|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
517586|NCT00265837|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
517587|NCT00265837|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
517588|NCT00265837|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
517589|NCT00265837|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
517590|NCT00265837|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
517591|NCT00265837|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
517592|NCT00265837|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
517593|NCT00265837|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
517594|NCT00265837|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
517595|NCT00265837|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
517596|NCT00265837|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
517597|NCT00265837|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
517598|NCT00265837|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
517599|NCT00265837|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
517600|NCT00265837|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
517601|NCT00265837|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
517602|NCT00265837|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
517603|NCT00265837|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
517604|NCT00265837|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
517605|NCT00265837|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
517036|NCT00272831|Pletaal|pletaal
517606|NCT00265837|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
517607|NCT00265837|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
517608|NCT00265837|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
517609|NCT00265837|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
517610|NCT00265837|splenic marginal zone lymphoma|splenic marginal zone lymphoma
517611|NCT00265837|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
517612|NCT00265837|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
517613|NCT00265837|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
517614|NCT00265837|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
517615|NCT00265837|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
517616|NCT00265837|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
517617|NCT00265837|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
518388|NCT00277290|Recurrent|recurrent
517618|NCT00265837|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
517619|NCT00265837|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
517620|NCT00265837|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
517621|NCT00265837|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
517622|NCT00265837|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
517623|NCT00265837|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
517624|NCT00265837|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
517625|NCT00265837|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
517626|NCT00265837|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
517627|NCT00265837|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
517628|NCT00265837|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
517629|NCT00265837|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
517630|NCT00265837|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
517631|NCT00265837|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
518166|NCT00276276|small cel|small cel
517632|NCT00265837|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
517633|NCT00265837|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
517634|NCT00265837|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
517635|NCT00265850|recurrent colon cancer|recurrent colon cancer
517636|NCT00265850|stage III colon cancer|stage iii colon cancer
517637|NCT00265850|stage III rectal cancer|stage iii rectal cancer
517638|NCT00265850|stage IV colon cancer|stage iv colon cancer
517639|NCT00265850|recurrent rectal cancer|recurrent rectal cancer
517640|NCT00265850|stage IV rectal cancer|stage iv rectal cancer
517641|NCT00265850|adenocarcinoma of the colon|adenocarcinoma of the colon
517642|NCT00265850|adenocarcinoma of the rectum|adenocarcinoma of the rectum
517643|NCT00265863|malignant ascites|malignant ascites
517644|NCT00265876|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
517645|NCT00265876|stage III pancreatic cancer|stage iii pancreatic cancer
517646|NCT00265876|recurrent pancreatic cancer|recurrent pancreatic cancer
517647|NCT00265876|stage IV pancreatic cancer|stage iv pancreatic cancer
517648|NCT00265889|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
517649|NCT00265889|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
517650|NCT00265889|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
517651|NCT00265902|Kaposi sarcoma|kaposi sarcoma
517652|NCT00265915|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
517653|NCT00265915|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
517654|NCT00265915|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
517655|NCT00265915|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
517656|NCT00265915|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
517657|NCT00265915|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
517658|NCT00265915|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
517659|NCT00265928|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
517660|NCT00265928|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
517661|NCT00265928|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
517662|NCT00265928|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
517663|NCT00265928|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
517664|NCT00265928|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
517665|NCT00265928|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
517666|NCT00265928|splenic marginal zone lymphoma|splenic marginal zone lymphoma
517667|NCT00265928|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
517668|NCT00265928|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
517669|NCT00265928|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
517670|NCT00265941|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
517671|NCT00265941|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
517672|NCT00265941|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
517673|NCT00265941|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
517674|NCT00265941|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
517675|NCT00265941|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
517676|NCT00265980|Leptin|leptin
517677|NCT00265980|Obesity|obesity
517678|NCT00265980|Energy|energy
517679|NCT00265980|Autonomics|autonomics
517680|NCT00265980|Neuroendocrine|neuroendocrine
517681|NCT00266019|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
517682|NCT00266019|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
517683|NCT00266019|Fatty liver|fatty liver
517684|NCT00266019|Cirrhosis|cirrhosis
517685|NCT00266019|Obesity|obesity
517686|NCT00266019|Weight Reduction|weight reduction
517687|NCT00266019|Weight Management|weight management
517688|NCT00266045|Deep Vein Thrombosis|deep vein thrombosis
517689|NCT00266045|Pulmonary Embolism|pulmonary embolism
517690|NCT00266045|D-dimer|d-dimer
517691|NCT00266045|Recurrence|recurrence
517692|NCT00266045|Duration of Anticoagulation|duration of anticoagulation
517693|NCT00266045|Vitamin K Antagonists|vitamin k antagonists
517694|NCT00266058|healthy|healthy
517695|NCT00266058|controls|controls
517696|NCT00266058|research|research
517697|NCT00266058|clinical|clinical
517698|NCT00266058|study|study
517699|NCT00266058|pharmacokinetic|pharmacokinetic
517701|NCT00266058|HIV|hiv
517702|NCT00266058|malaria|malaria
517703|NCT00266071|skin|skin
517704|NCT00266071|pressure|pressure
517705|NCT00266071|age|age
517706|NCT00266084|Cervix|cervix
517707|NCT00266084|Uterus|uterus
517708|NCT00266084|Dysplasia|dysplasia
517709|NCT00266084|Cancer|cancer
517710|NCT00266084|Collector|collector
517711|NCT00266097|stage III pancreatic cancer|stage iii pancreatic cancer
517712|NCT00266097|stage IV pancreatic cancer|stage iv pancreatic cancer
517713|NCT00266097|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
517714|NCT00266097|unresectable gallbladder cancer|unresectable gallbladder cancer
518402|NCT00277368|Seizure|seizure
517715|NCT00266097|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
517716|NCT00266097|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
517717|NCT00266097|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
517718|NCT00266097|recurrent pancreatic cancer|recurrent pancreatic cancer
517719|NCT00266097|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
517720|NCT00266097|recurrent gallbladder cancer|recurrent gallbladder cancer
517721|NCT00266110|stage IV breast cancer|stage iv breast cancer
517722|NCT00266110|recurrent breast cancer|recurrent breast cancer
517723|NCT00266123|Kidney Failure|kidney failure
517724|NCT00266123|Kidney Transplant|kidney transplant
517725|NCT00266136|AML treatment, de-novo, secondary, high-risk MDS, chemotherapy, autologous SCT, adult|aml treatment, de-novo, secondary, high-risk mds, chemotherapy, autologous sct, adult
517726|NCT00266149|Pharmacokinetics|pharmacokinetics
517727|NCT00266149|Lamotrigine|lamotrigine
517728|NCT00266149|Oral Contraceptives|oral contraceptives
517730|NCT00266149|Glucuronidation.|glucuronidation.
517731|NCT00266162|Heart Defects, Congenital|heart defects, congenital
517732|NCT00266162|Eisenmenger Complex|eisenmenger complex
517733|NCT00266162|Hypertension, Pulmonary|hypertension, pulmonary
517734|NCT00266162|Pulmonary Heart Disease|pulmonary heart disease
517735|NCT00266162|Pulmonary Circulation|pulmonary circulation
517736|NCT00266162|Vascular Resistance|vascular resistance
517737|NCT00266175|Pulmonary heart disease|pulmonary heart disease
517738|NCT00266175|Pulmonary hypertension|pulmonary hypertension
517739|NCT00266175|Stent implantation|stent implantation
517740|NCT00266175|Balloon dilatation|balloon dilatation
517741|NCT00266175|Surgery|surgery
517742|NCT00266188|Heart Defects, Congenital|heart defects, congenital
517743|NCT00266188|Tetralogy of Fallot|tetralogy of fallot
517744|NCT00266188|Heart Septal Defects, Ventricular|heart septal defects, ventricular
517745|NCT00266188|Pulmonary Valve Diseases|pulmonary valve diseases
517746|NCT00266188|Magnetic Resonance Imaging|magnetic resonance imaging
517747|NCT00266188|Heart Catheterization|heart catheterization
517748|NCT00266188|Echocardiography|echocardiography
517749|NCT00266201|Heart Defects, Congenital|heart defects, congenital
517750|NCT00266201|Right Ventricular Dysfunction|right ventricular dysfunction
517751|NCT00266201|Low Cardiac Output|low cardiac output
517752|NCT00266201|Biochemical markers|biochemical markers
517753|NCT00266201|Neurohumoral activity|neurohumoral activity
517754|NCT00266214|lidocaine patch 5%|lidocaine patch 5%
517755|NCT00266214|Lidoderm|lidoderm
517756|NCT00266214|carpal tunnel syndrome|carpal tunnel syndrome
517757|NCT00266214|pain|pain
517758|NCT00266214|nerve compression injury|nerve compression injury
517759|NCT00266214|topical analgesic|topical analgesic
517760|NCT00266266|Human Papilloma Virus|human papilloma virus
517761|NCT00266292|Fish oil|fish oil
517762|NCT00266292|Polyunsaturated fatty acid|polyunsaturated fatty acid
517763|NCT00266292|Immune function|immune function
517764|NCT00266292|Endothelial function|endothelial function
517765|NCT00266292|Cardiovascular risk factors|cardiovascular risk factors
517766|NCT00266305|n-3 LCPUFA|n-3 lcpufa
517767|NCT00266305|Infant development|infant development
517768|NCT00266305|Visual acuity|visual acuity
517769|NCT00266305|Immune function|immune function
517770|NCT00266305|Breast milk|breast milk
517771|NCT00266318|Hepatitis C Nonresponder|hepatitis c nonresponder
517772|NCT00266318|Genotype 1|genotype 1
517773|NCT00266318|Interferon Alfacon-1|interferon alfacon-1
517774|NCT00266318|Consensus Interferon|consensus interferon
517775|NCT00266318|CIFN|cifn
517776|NCT00266318|Infergen|infergen
517777|NCT00266318|Ribavirin|ribavirin
517778|NCT00266331|Breast cancer|breast cancer
517779|NCT00266331|Radiation skin protection|radiation skin protection
517780|NCT00266396|Total Hip Arthroplasty|total hip arthroplasty
517782|NCT00266396|Total Knee Arthroplasty|total knee arthroplasty
517783|NCT00266396|TKA|tka
517784|NCT00266396|Total Hip Replacement|total hip replacement
517785|NCT00266396|THR|thr
517786|NCT00266396|Total Knee Replacement|total knee replacement
517787|NCT00266396|TKR|tkr
517788|NCT00266435|Asymptomatic subjects|asymptomatic subjects
517789|NCT00266435|Moderate to high risk for cardiovascular event|moderate to high risk for cardiovascular event
517791|NCT00266448|eradication|eradication
517792|NCT00266448|chlorhexidine|chlorhexidine
517793|NCT00266461|Postoperative Ileus|postoperative ileus
517794|NCT00266474|Cystic Fibrosis with Chronic Rhinosinusitis|cystic fibrosis with chronic rhinosinusitis
517795|NCT00266487|Homocysteine|homocysteine
517796|NCT00266487|B vitamins|b vitamins
517797|NCT00266487|Folic acid|folic acid
517798|NCT00266487|Randomized trial|randomized trial
517799|NCT00266487|Secondary prevention|secondary prevention
517800|NCT00266500|Adipose Tissue|adipose tissue
517801|NCT00266500|Weight Gain|weight gain
517802|NCT00266500|Overweight|overweight
517803|NCT00266500|Thermogenesis|thermogenesis
517804|NCT00266500|Deep Body Temperature|deep body temperature
517805|NCT00266500|Adult|adult
517806|NCT00266500|Exercise|exercise
517807|NCT00266513|CD40 Ligand|cd40 ligand
517808|NCT00266513|Nemo|nemo
517809|NCT00266513|Genetics|genetics
517811|NCT00266513|Ectodermal Dysplasia|ectodermal dysplasia
517812|NCT00266513|CVID|cvid
517813|NCT00266513|Hyper-IgM Syndrome|hyper-igm syndrome
517814|NCT00266513|Primary Immune Deficiency Disorders|primary immune deficiency disorders
517815|NCT00266513|Common Variable Immune Deficiency|common variable immune deficiency
517816|NCT00266526|Allergy|allergy
517817|NCT00266526|Birch pollen|birch pollen
517818|NCT00266526|Recombinant|recombinant
517819|NCT00266539|Postoperative pain|postoperative pain
517820|NCT00266539|patient-controlled analgesia|patient-controlled analgesia
517821|NCT00266552|conduct disorder|conduct disorder
517822|NCT00266552|oppositional defiant disorder|oppositional defiant disorder
517823|NCT00266552|disruptive behavior disorder not otherwise specified|disruptive behavior disorder not otherwise specified
517824|NCT00266552|ADHD|adhd
517825|NCT00266552|risperidone|risperidone
517826|NCT00266552|antipsychotropic agents|antipsychotropic agents
517827|NCT00266552|children|children
517828|NCT00266578|Eosinophilic Esophagitis|eosinophilic esophagitis
517829|NCT00266591|Epilepsy|epilepsy
517830|NCT00266591|Seizures|seizures
517831|NCT00266591|Topiramate|topiramate
517832|NCT00266591|Prophylaxis|prophylaxis
517833|NCT00266591|Antiepileptic|antiepileptic
517834|NCT00266591|Epileptic seizures|epileptic seizures
517835|NCT00266591|Partial seizure disorder|partial seizure disorder
517836|NCT00266591|Brain disease|brain disease
517837|NCT00266604|Epilepsy|epilepsy
517838|NCT00266604|seizures|seizures
517839|NCT00266604|new-onset epilepsy|new-onset epilepsy
517840|NCT00266604|epilepsy relapse|epilepsy relapse
517841|NCT00266604|epilepsy monotherapy|epilepsy monotherapy
517842|NCT00266617|Anemia|anemia
517843|NCT00266617|chemotherapy|chemotherapy
517844|NCT00266617|epoetin alfa|epoetin alfa
517845|NCT00266617|epogen|epogen
517846|NCT00266617|erythropoietin|erythropoietin
517847|NCT00266617|neoplasms|neoplasms
517848|NCT00266617|cancer|cancer
517849|NCT00266669|Raynaud's Phenomenon|raynaud's phenomenon
517850|NCT00266669|Raynaud's Disease|raynaud's disease
517851|NCT00266669|Scleroderma|scleroderma
517852|NCT00266669|Raynaud's Disease Secondary to Scleroderma|raynaud's disease secondary to scleroderma
517853|NCT00266669|Raynaud's Disease Secondary to Other Autoimmune Disease|raynaud's disease secondary to other autoimmune disease
517854|NCT00266682|Bradycardia|bradycardia
517855|NCT00266708|renal transplant|renal transplant
517856|NCT00266708|post-transplant osteoporosis|post-transplant osteoporosis
517857|NCT00266721|Pancrelipase|pancrelipase
517858|NCT00266721|Abdominal bloating|abdominal bloating
517859|NCT00266721|Abdominal pain|abdominal pain
517860|NCT00266721|Eructation|eructation
517861|NCT00266734|Adenoviral conjunctivitis|adenoviral conjunctivitis
517862|NCT00266734|Viral conjunctivitis|viral conjunctivitis
517863|NCT00266734|conjunctivitis|conjunctivitis
517864|NCT00266747|Anxiety|anxiety
517865|NCT00266747|Anti-Anxiety Agents|anti-anxiety agents
517866|NCT00266747|Controlled Clinical Trial|controlled clinical trial
517867|NCT00266773|Chronic Pain|chronic pain
517868|NCT00266773|Cognitive Therapy|cognitive therapy
517869|NCT00266773|Cognitive Behavioral Therapy|cognitive behavioral therapy
517870|NCT00266773|Recurrence|recurrence
517871|NCT00266773|Relapse Prevention|relapse prevention
517872|NCT00266773|Educational Technology|educational technology
517874|NCT00266773|CST|cst
517875|NCT00266773|IVR|ivr
517876|NCT00266773|TIVR|tivr
517877|NCT00266812|temozolomide|temozolomide
517878|NCT00266812|radiotherapy|radiotherapy
517879|NCT00266838|Lacrimal Obstruction|lacrimal obstruction
517881|NCT00266851|Randomized clinical trial|randomized clinical trial
517882|NCT00266851|Asthma|asthma
517883|NCT00266851|Adults|adults
517884|NCT00266851|Azithromycin|azithromycin
517885|NCT00266864|Spinal Cord Injury|spinal cord injury
517886|NCT00266864|Testosterone Replacement Therapy|testosterone replacement therapy
517887|NCT00266864|Dual Energy X ray Absorptiometry|dual energy x ray absorptiometry
517888|NCT00266864|Lean Tissue Mass|lean tissue mass
517889|NCT00266877|Lung Cancer|lung cancer
517890|NCT00266903|adult|adult
517891|NCT00266903|congenital heart disease|congenital heart disease
517892|NCT00266903|Eisenmenger's Syndrome|eisenmenger's syndrome
517893|NCT00266903|Bosentan|bosentan
517894|NCT00266903|Sitaxsetan|sitaxsetan
517895|NCT00266903|Sildenafil|sildenafil
517896|NCT00266916|adult|adult
517897|NCT00266916|congenital heart disease|congenital heart disease
517898|NCT00266916|percutaneous occlusion|percutaneous occlusion
517899|NCT00266916|percutaneous balloon valvotomy|percutaneous balloon valvotomy
517900|NCT00266916|balloon angioplasty|balloon angioplasty
517901|NCT00266916|complex cyanotic congenital heart defects (CCHD)|complex cyanotic congenital heart defects (cchd)
517902|NCT00266929|odontoid fx|odontoid fx
517903|NCT00266929|surgical intervention|surgical intervention
517904|NCT00266929|conservative treatment|conservative treatment
517905|NCT00266929|nonunion|nonunion
517906|NCT00266929|odontoid fractures|odontoid fractures
517907|NCT00266929|surgical treatment|surgical treatment
517908|NCT00266942|Fontan procedure|fontan procedure
517909|NCT00266942|single ventricle physiology|single ventricle physiology
517910|NCT00266942|intra-atrial|intra-atrial
517911|NCT00266942|extracardiac technique|extracardiac technique
517912|NCT00266955|pediatric|pediatric
517914|NCT00266955|ADHD|adhd
517915|NCT00266955|Adderall|adderall
517916|NCT00266955|Straterra|straterra
517917|NCT00266968|pediatric|pediatric
517918|NCT00266968|cardiac|cardiac
517919|NCT00266968|single ventricle|single ventricle
517920|NCT00266994|Thrombosis|thrombosis
517921|NCT00267007|Peripheral neuropathy|peripheral neuropathy
517922|NCT00267007|Chemotherapy-induced|chemotherapy-induced
517923|NCT00267007|Hemoglobin level|hemoglobin level
517924|NCT00267007|Cancer|cancer
517925|NCT00267007|Taxane|taxane
517926|NCT00267007|Platinum-based chemotherapy|platinum-based chemotherapy
517927|NCT00274859|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
517928|NCT00274872|recurrent rectal cancer|recurrent rectal cancer
517929|NCT00274872|stage IV rectal cancer|stage iv rectal cancer
517930|NCT00274872|recurrent colon cancer|recurrent colon cancer
517931|NCT00274872|stage IV colon cancer|stage iv colon cancer
517932|NCT00274872|adenocarcinoma of the colon|adenocarcinoma of the colon
517933|NCT00274872|adenocarcinoma of the rectum|adenocarcinoma of the rectum
517934|NCT00274885|neurotoxicity|neurotoxicity
517935|NCT00274885|carcinoma of the appendix|carcinoma of the appendix
517936|NCT00274885|recurrent anal cancer|recurrent anal cancer
517937|NCT00274885|stage I anal cancer|stage i anal cancer
517938|NCT00274885|stage II anal cancer|stage ii anal cancer
517939|NCT00274885|stage IIIA anal cancer|stage iiia anal cancer
517940|NCT00274885|stage IIIB anal cancer|stage iiib anal cancer
517941|NCT00274885|stage IV anal cancer|stage iv anal cancer
517942|NCT00274885|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
517943|NCT00274885|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
517944|NCT00274885|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
517945|NCT00274885|localized gallbladder cancer|localized gallbladder cancer
517946|NCT00274885|recurrent gallbladder cancer|recurrent gallbladder cancer
517947|NCT00274885|unresectable gallbladder cancer|unresectable gallbladder cancer
517948|NCT00274885|recurrent gastric cancer|recurrent gastric cancer
517949|NCT00274885|stage IV gastric cancer|stage iv gastric cancer
517950|NCT00274885|recurrent colon cancer|recurrent colon cancer
517951|NCT00274885|recurrent rectal cancer|recurrent rectal cancer
517952|NCT00274885|recurrent esophageal cancer|recurrent esophageal cancer
517953|NCT00274885|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
517954|NCT00274885|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
517955|NCT00274885|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
517956|NCT00274885|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
517810|NCT00266513|Hyper-IGM|hyper-igm
517957|NCT00274885|gastrointestinal stromal tumor|gastrointestinal stromal tumor
517958|NCT00274885|advanced adult primary liver cancer|advanced adult primary liver cancer
517959|NCT00274885|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
517960|NCT00274885|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
517961|NCT00274885|recurrent adult primary liver cancer|recurrent adult primary liver cancer
517962|NCT00274885|recurrent pancreatic cancer|recurrent pancreatic cancer
517963|NCT00274885|stage I pancreatic cancer|stage i pancreatic cancer
517964|NCT00274885|stage II pancreatic cancer|stage ii pancreatic cancer
517965|NCT00274885|stage III pancreatic cancer|stage iii pancreatic cancer
517966|NCT00274885|recurrent small intestine cancer|recurrent small intestine cancer
517967|NCT00274885|small intestine adenocarcinoma|small intestine adenocarcinoma
517968|NCT00274885|small intestine leiomyosarcoma|small intestine leiomyosarcoma
517969|NCT00274885|small intestine lymphoma|small intestine lymphoma
517970|NCT00274885|stage IV pancreatic cancer|stage iv pancreatic cancer
517971|NCT00274885|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
517972|NCT00274885|metastatic gallbladder cancer|metastatic gallbladder cancer
517973|NCT00274885|stage IA gastric cancer|stage ia gastric cancer
517974|NCT00274885|stage IB gastric cancer|stage ib gastric cancer
517975|NCT00274885|stage IIA gastric cancer|stage iia gastric cancer
519006|NCT00270530|HIV|hiv
517976|NCT00274885|stage IIB gastric cancer|stage iib gastric cancer
517977|NCT00274885|stage IIIA gastric cancer|stage iiia gastric cancer
517978|NCT00274885|stage IIIB gastric cancer|stage iiib gastric cancer
517979|NCT00274885|stage IIIC gastric cancer|stage iiic gastric cancer
517980|NCT00274885|stage I colon cancer|stage i colon cancer
517981|NCT00274885|stage IIA colon cancer|stage iia colon cancer
517982|NCT00274885|stage IIB colon cancer|stage iib colon cancer
517983|NCT00274885|stage IIIA colon cancer|stage iiia colon cancer
517984|NCT00274885|stage IIIB colon cancer|stage iiib colon cancer
517985|NCT00274885|stage IIIC colon cancer|stage iiic colon cancer
517986|NCT00274885|stage IVA colon cancer|stage iva colon cancer
517987|NCT00274885|stage IVB colon cancer|stage ivb colon cancer
517988|NCT00274885|stage I rectal cancer|stage i rectal cancer
517989|NCT00274885|stage IIA rectal cancer|stage iia rectal cancer
517990|NCT00274885|stage IIB rectal cancer|stage iib rectal cancer
517991|NCT00274885|stage IIC rectal cancer|stage iic rectal cancer
517992|NCT00274885|stage IIIA rectal cancer|stage iiia rectal cancer
517993|NCT00274885|stage IIIB rectal cancer|stage iiib rectal cancer
517994|NCT00274885|stage IIIC rectal cancer|stage iiic rectal cancer
517995|NCT00274885|stage IVA rectal cancer|stage iva rectal cancer
517996|NCT00274885|stage IVB rectal cancer|stage ivb rectal cancer
517997|NCT00274885|stage IA esophageal cancer|stage ia esophageal cancer
517998|NCT00274885|stage IB esophageal cancer|stage ib esophageal cancer
517999|NCT00274885|stage IIA esophageal cancer|stage iia esophageal cancer
518000|NCT00274885|stage IIB esophageal cancer|stage iib esophageal cancer
518001|NCT00274885|stage IIIA esophageal cancer|stage iiia esophageal cancer
518002|NCT00274885|stage IIIB esophageal cancer|stage iiib esophageal cancer
518003|NCT00274885|stage IIIC esophageal cancer|stage iiic esophageal cancer
518004|NCT00274885|stage IV esophageal cancer|stage iv esophageal cancer
518005|NCT00274898|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
518006|NCT00274898|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
518007|NCT00274898|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
518008|NCT00274898|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
518009|NCT00274911|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
518010|NCT00274924|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
518011|NCT00274924|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
518012|NCT00274924|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
518013|NCT00274924|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
518014|NCT00274950|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
518015|NCT00274950|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
518016|NCT00274950|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
518017|NCT00274950|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
518018|NCT00274950|childhood teratoma|childhood teratoma
518019|NCT00274950|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
518020|NCT00274963|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
518021|NCT00274963|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
518022|NCT00274976|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
518023|NCT00274976|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
518024|NCT00274976|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
518025|NCT00274989|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
518026|NCT00274989|relapsed refractory chronic lymphocytic leukemia|relapsed refractory chronic lymphocytic leukemia
518027|NCT00274989|previously untreated chronic lymphocytic leukemia|previously untreated chronic lymphocytic leukemia
518028|NCT00275002|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
518029|NCT00275002|recurrent childhood brain tumor|recurrent childhood brain tumor
518030|NCT00275015|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
518031|NCT00275015|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
518032|NCT00275015|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
518033|NCT00275015|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
518034|NCT00275015|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
518035|NCT00275015|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
518036|NCT00275041|recurrent breast cancer|recurrent breast cancer
518037|NCT00275041|stage IV breast cancer|stage iv breast cancer
518038|NCT00275041|male breast cancer|male breast cancer
518039|NCT00275054|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
518040|NCT00275054|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
518041|NCT00275054|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
518042|NCT00275054|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
518043|NCT00275067|adult anaplastic astrocytoma|adult anaplastic astrocytoma
518044|NCT00275067|adult gliosarcoma|adult gliosarcoma
518045|NCT00275067|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
518046|NCT00275067|adult mixed glioma|adult mixed glioma
518047|NCT00275067|adult glioblastoma|adult glioblastoma
518048|NCT00275067|adult giant cell glioblastoma|adult giant cell glioblastoma
518049|NCT00275067|recurrent adult brain tumor|recurrent adult brain tumor
518050|NCT00275106|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
518051|NCT00275106|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
518052|NCT00275106|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
518053|NCT00275106|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
518054|NCT00275119|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
518055|NCT00275119|stage II pancreatic cancer|stage ii pancreatic cancer
518056|NCT00275119|stage III pancreatic cancer|stage iii pancreatic cancer
518057|NCT00275119|recurrent pancreatic cancer|recurrent pancreatic cancer
518058|NCT00275132|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
518059|NCT00275132|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
518061|NCT00275158|Glomerular Filtration Rate (GFR)|glomerular filtration rate (gfr)
518062|NCT00275158|Inulin clearance|inulin clearance
518063|NCT00275158|Hypertension|hypertension
518064|NCT00275158|L-Arginine|l-arginine
518065|NCT00275158|Nitric Oxide|nitric oxide
518067|NCT00275158|Endothelin|endothelin
518068|NCT00275158|ADMA|adma
518069|NCT00275171|Nontoxic nodular goiter|nontoxic nodular goiter
518070|NCT00275171|131I therapy|131i therapy
518071|NCT00275171|thyroid radioiodine uptake|thyroid radioiodine uptake
518072|NCT00275171|optimal time-interval|optimal time-interval
518073|NCT00275171|reduced 131I activity|reduced 131i activity
518074|NCT00275171|goiter reduction|goiter reduction
518075|NCT00275184|Bowel preparation|bowel preparation
518076|NCT00275184|capsule endoscopy|capsule endoscopy
518077|NCT00275184|randomised|randomised
518078|NCT00275184|Citramag|citramag
518079|NCT00275184|Senna|senna
518080|NCT00275184|Metoclopramide|metoclopramide
518081|NCT00275184|Patients referred for Capsule endoscopy|patients referred for capsule endoscopy
518082|NCT00275184|occult/overt gastrointestinal bleeding|occult/overt gastrointestinal bleeding
518083|NCT00275184|other suspected small bowel pathology|other suspected small bowel pathology
518084|NCT00275925|partial epilepsy, oxcarbazepine, adults|partial epilepsy, oxcarbazepine, adults
518085|NCT00275938|hepatitis B virus|hepatitis b virus
518086|NCT00275938|e antigen|e antigen
518087|NCT00275938|interferon|interferon
518088|NCT00275938|ribavirin|ribavirin
518089|NCT00275951|Combination|combination
518090|NCT00275951|Chemotherapy|chemotherapy
518091|NCT00275951|Gastric cancer|gastric cancer
518092|NCT00275977|"Stem cell"|"stem cell"
518093|NCT00275977|"autologous bone marrow transplantation"|"autologous bone marrow transplantation"
518094|NCT00275977|"Myocardial infarction"|"myocardial infarction"
518095|NCT00275990|coronary thrombectomy|coronary thrombectomy
518096|NCT00275990|thrombectomy for acute myocardial infarction|thrombectomy for acute myocardial infarction
518097|NCT00275990|C14.280.647.500|c14.280.647.500
518098|NCT00275990|C14.907.553.355.500|c14.907.553.355.500
518099|NCT00276003|Lymphoma-Non Hodgkins|lymphoma-non hodgkins
518100|NCT00276003|Phase II|phase ii
518101|NCT00276003|Gemcitabine|gemcitabine
518102|NCT00276003|Irinotecan|irinotecan
518103|NCT00276029|Asthma|asthma
518104|NCT00276029|Refractory|refractory
518105|NCT00276042|AOM|aom
518106|NCT00276055|Soft Tissue Sarcoma|soft tissue sarcoma
518107|NCT00276055|Phase I|phase i
518108|NCT00276055|Gemcitabine|gemcitabine
518109|NCT00276055|Docetaxel|docetaxel
518110|NCT00276055|Bevacizumab|bevacizumab
518111|NCT00276055|vascular endothelial growth factor|vascular endothelial growth factor
518112|NCT00276068|Vulvar vestibulitis|vulvar vestibulitis
518113|NCT00276068|Vulvodynia|vulvodynia
518114|NCT00276068|Desipramine|desipramine
518115|NCT00276068|Lidocaine|lidocaine
518116|NCT00276068|Genetics|genetics
518117|NCT00276081|Hot flashes|hot flashes
518118|NCT00276081|postmenopausal|postmenopausal
518119|NCT00276081|climacteric symptoms|climacteric symptoms
518120|NCT00276081|hormone replacement therapy|hormone replacement therapy
518121|NCT00276081|gabapentin|gabapentin
518122|NCT00276094|Urogenital atrophy|urogenital atrophy
518123|NCT00276094|Vaginal atrophy|vaginal atrophy
518124|NCT00276094|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
518125|NCT00276094|Menopausal symptoms|menopausal symptoms
518127|NCT00276107|Healthy Infants|healthy infants
518128|NCT00276120|Breast|breast
518129|NCT00276120|Cancer|cancer
518130|NCT00276120|Young|young
518131|NCT00276120|Women|women
518132|NCT00276133|small dense LDL|small dense ldl
518133|NCT00276146|dipyridamole|dipyridamole
518134|NCT00276146|magnesium|magnesium
518135|NCT00276146|sickle cell|sickle cell
518136|NCT00276146|anemia|anemia
518137|NCT00276146|red blood cells|red blood cells
518138|NCT00276159|Leukemia|leukemia
518139|NCT00276159|Lymphoma|lymphoma
518140|NCT00276159|Myeloma|myeloma
518141|NCT00276159|Hematology|hematology
518142|NCT00276159|852A|852a
518143|NCT00276159|IRM|irm
518144|NCT00276159|Oncology|oncology
518145|NCT00276185|spasticity ;|spasticity ;
518146|NCT00276185|Botulinum toxin ;|botulinum toxin ;
518147|NCT00276185|Upper limb ;|upper limb ;
518148|NCT00276185|motor function.|motor function.
519713|NCT00283660|Child|child
518149|NCT00276185|spastic hemiplegia after stoke|spastic hemiplegia after stoke
518150|NCT00276198|Clinical trial, controlled|clinical trial, controlled
518151|NCT00276198|Micronutrients|micronutrients
518152|NCT00276198|Dietary Supplementation|dietary supplementation
518154|NCT00276211|MRI diffusion mamma cancer|mri diffusion mamma cancer
518155|NCT00276224|iron deficiency schistosomiasis soil transmitted helminths|iron deficiency schistosomiasis soil transmitted helminths
518156|NCT00276237|Congenital Heart Disease|congenital heart disease
518157|NCT00276237|Pulmonary Valve Replacement|pulmonary valve replacement
518158|NCT00276263|Schizophrenia prodrome|schizophrenia prodrome
518159|NCT00276263|Sarcosine|sarcosine
518160|NCT00276263|Psychosis|psychosis
518161|NCT00276263|NMDA receptor|nmda receptor
518162|NCT00276263|Prevention|prevention
518163|NCT00276276|relapsed|relapsed
518167|NCT00276276|topotecan (HYCAMTIN)|topotecan (hycamtin)
518168|NCT00276289|nephrolithiasis|nephrolithiasis
518169|NCT00276289|hypercalciuria|hypercalciuria
518170|NCT00276289|hypokalemia|hypokalemia
518171|NCT00276289|thiazide diuretics|thiazide diuretics
518172|NCT00276341|cognitive impairment|cognitive impairment
518173|NCT00276445|allergy|allergy
518174|NCT00276445|Allergy conjunctivitis|allergy conjunctivitis
518175|NCT00276445|beta-1-3glucan|beta-1-3glucan
518176|NCT00276445|Th1/Th2|th1/th2
518177|NCT00276497|Impaired glucose tolerance|impaired glucose tolerance
518178|NCT00276497|Intervention|intervention
518179|NCT00276497|Prevention|prevention
518180|NCT00276523|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
518181|NCT00276523|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
518182|NCT00276523|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
518183|NCT00276523|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
518184|NCT00276523|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
518185|NCT00276523|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
518186|NCT00276523|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
518187|NCT00276523|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
518188|NCT00276523|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
518189|NCT00276523|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
518190|NCT00276523|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
518191|NCT00276523|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
518192|NCT00276523|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
518193|NCT00276523|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
518194|NCT00276523|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
518195|NCT00276523|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
518196|NCT00276536|stage IV melanoma|stage iv melanoma
518197|NCT00276536|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
518198|NCT00276549|adenocarcinoma of the prostate|adenocarcinoma of the prostate
518199|NCT00276549|stage IV prostate cancer|stage iv prostate cancer
518200|NCT00276575|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
518201|NCT00276588|adenocarcinoma of the lung|adenocarcinoma of the lung
518202|NCT00276588|adenosquamous cell lung cancer|adenosquamous cell lung cancer
518203|NCT00276588|large cell lung cancer|large cell lung cancer
518204|NCT00276588|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
518205|NCT00276588|squamous cell lung cancer|squamous cell lung cancer
518206|NCT00276588|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
518207|NCT00276588|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
518208|NCT00276601|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
518209|NCT00276601|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
518210|NCT00276601|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
518211|NCT00276601|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
518212|NCT00276601|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
518213|NCT00276614|stage IV renal cell cancer|stage iv renal cell cancer
518214|NCT00276614|recurrent renal cell cancer|recurrent renal cell cancer
518215|NCT00276614|papillary renal cell carcinoma|papillary renal cell carcinoma
518216|NCT00276627|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
518217|NCT00276640|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
518218|NCT00276640|untreated childhood brain stem glioma|untreated childhood brain stem glioma
518219|NCT00276640|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
518220|NCT00276640|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
518221|NCT00276640|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
518222|NCT00276640|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
518223|NCT00276640|childhood oligodendroglioma|childhood oligodendroglioma
518224|NCT00276640|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
518225|NCT00276640|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
518226|NCT00276640|childhood spinal cord neoplasm|childhood spinal cord neoplasm
518227|NCT00276666|untreated childhood medulloblastoma|untreated childhood medulloblastoma
518228|NCT00276679|recurrent neuroblastoma|recurrent neuroblastoma
518229|NCT00276679|disseminated neuroblastoma|disseminated neuroblastoma
518230|NCT00276679|localized unresectable neuroblastoma|localized unresectable neuroblastoma
518231|NCT00276692|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
518232|NCT00276705|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
518233|NCT00276705|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
518234|NCT00276705|advanced adult primary liver cancer|advanced adult primary liver cancer
518235|NCT00276705|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
518236|NCT00276705|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
518237|NCT00276705|stage I childhood liver cancer|stage i childhood liver cancer
518238|NCT00276705|stage II childhood liver cancer|stage ii childhood liver cancer
518239|NCT00276705|stage III childhood liver cancer|stage iii childhood liver cancer
518240|NCT00276705|stage IV childhood liver cancer|stage iv childhood liver cancer
518241|NCT00276718|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
518242|NCT00276718|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
518243|NCT00276718|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
518244|NCT00276718|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
518245|NCT00276718|childhood teratoma|childhood teratoma
518246|NCT00276731|localized resectable neuroblastoma|localized resectable neuroblastoma
518247|NCT00276731|localized unresectable neuroblastoma|localized unresectable neuroblastoma
518248|NCT00276731|regional neuroblastoma|regional neuroblastoma
518249|NCT00276744|recurrent pancreatic cancer|recurrent pancreatic cancer
518250|NCT00276744|stage III pancreatic cancer|stage iii pancreatic cancer
518251|NCT00276744|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
518252|NCT00276744|stage I pancreatic cancer|stage i pancreatic cancer
518253|NCT00276744|stage II pancreatic cancer|stage ii pancreatic cancer
518254|NCT00276757|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
518255|NCT00276770|adult anaplastic astrocytoma|adult anaplastic astrocytoma
518256|NCT00276770|adult anaplastic ependymoma|adult anaplastic ependymoma
518257|NCT00276770|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
518258|NCT00276770|adult diffuse astrocytoma|adult diffuse astrocytoma
518259|NCT00276770|adult glioblastoma|adult glioblastoma
518260|NCT00276770|adult giant cell glioblastoma|adult giant cell glioblastoma
518261|NCT00276770|adult gliosarcoma|adult gliosarcoma
518262|NCT00276770|adult ependymoma|adult ependymoma
518263|NCT00276770|adult oligodendroglioma|adult oligodendroglioma
518264|NCT00276770|recurrent adult brain tumor|recurrent adult brain tumor
518265|NCT00276770|adult mixed glioma|adult mixed glioma
518266|NCT00276783|primary central nervous system lymphoma|primary central nervous system lymphoma
518267|NCT00276783|tumors metastatic to brain|tumors metastatic to brain
518268|NCT00276783|recurrent adult brain tumor|recurrent adult brain tumor
518269|NCT00276783|adult giant cell glioblastoma|adult giant cell glioblastoma
518270|NCT00276783|adult gliosarcoma|adult gliosarcoma
518271|NCT00276783|adult mixed glioma|adult mixed glioma
518272|NCT00276783|adult anaplastic astrocytoma|adult anaplastic astrocytoma
518273|NCT00276783|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
518274|NCT00276783|adult glioblastoma|adult glioblastoma
518275|NCT00276796|cervical squamous cell carcinoma|cervical squamous cell carcinoma
518276|NCT00276796|stage III cervical cancer|stage iii cervical cancer
518277|NCT00276796|recurrent cervical cancer|recurrent cervical cancer
518278|NCT00276796|cervical adenocarcinoma|cervical adenocarcinoma
518279|NCT00276796|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
518280|NCT00276796|cervical small cell carcinoma|cervical small cell carcinoma
518281|NCT00276796|stage IVA cervical cancer|stage iva cervical cancer
518282|NCT00276796|stage IVB cervical cancer|stage ivb cervical cancer
518283|NCT00276809|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
518284|NCT00276809|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
518285|NCT00276809|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
518286|NCT00276809|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
518287|NCT00276809|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
518288|NCT00276822|stage I breast cancer|stage i breast cancer
518289|NCT00276822|stage II breast cancer|stage ii breast cancer
518290|NCT00276822|stage IIIA breast cancer|stage iiia breast cancer
518291|NCT00276822|stage IIIB breast cancer|stage iiib breast cancer
518292|NCT00276822|stage IIIC breast cancer|stage iiic breast cancer
518293|NCT00276822|stage IV breast cancer|stage iv breast cancer
518294|NCT00276835|recurrent renal cell cancer|recurrent renal cell cancer
518295|NCT00276835|clear cell renal cell carcinoma|clear cell renal cell carcinoma
518296|NCT00276835|stage IV renal cell cancer|stage iv renal cell cancer
518297|NCT00276835|recurrent melanoma|recurrent melanoma
518298|NCT00276835|stage IV melanoma|stage iv melanoma
518299|NCT00276848|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
518300|NCT00276848|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
518301|NCT00276861|adenocarcinoma of the colon|adenocarcinoma of the colon
518302|NCT00276861|recurrent colon cancer|recurrent colon cancer
518303|NCT00276861|stage IV colon cancer|stage iv colon cancer
518304|NCT00276874|Cocaine Addiction|cocaine addiction
518305|NCT00276874|Cocaine Dependence|cocaine dependence
518306|NCT00276887|Somatization Disorder|somatization disorder
518307|NCT00276887|Multiple Medically Unexplained Symptoms|multiple medically unexplained symptoms
518308|NCT00276887|Cognitive Behavior Therapy|cognitive behavior therapy
518309|NCT00276887|Mental Health|mental health
518310|NCT00276900|Postpartum Depression|postpartum depression
518403|NCT00277381|Adherence|adherence
518311|NCT00276900|Recurrent Depression|recurrent depression
518312|NCT00276926|Hypereosinophilic Syndrome|hypereosinophilic syndrome
518313|NCT00276926|Eosinophilic leukemias|eosinophilic leukemias
518314|NCT00276926|STI571 (Gleevec)|sti571 (gleevec)
518315|NCT00276926|PDGF receptor alpha|pdgf receptor alpha
518316|NCT00276926|Familiar hypereosinophilia|familiar hypereosinophilia
518317|NCT00276926|Myeloproliferative disorder (MPD) with eosinophilia|myeloproliferative disorder (mpd) with eosinophilia
518318|NCT00276926|myeloproliferative disorders/myelodysplastic syndromes|myeloproliferative disorders/myelodysplastic syndromes
518319|NCT00276939|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
518320|NCT00276939|Diet, Vegetarian|diet, vegetarian
518321|NCT00276939|Diet, Fat-Restricted|diet, fat-restricted
518322|NCT00276939|Glycemic Index|glycemic index
518323|NCT00276952|Gonyautoxins|gonyautoxins
518324|NCT00276952|Tension-type Headache|tension-type headache
518325|NCT00276952|Human Treatment|human treatment
518326|NCT00276965|Bipolar II Depression|bipolar ii depression
518327|NCT00276978|Therapy-resistant Depression|therapy-resistant depression
518328|NCT00276978|add-on therapy depression|add-on therapy depression
518450|NCT00277680|uterine fibroids|uterine fibroids
518329|NCT00276991|Prolonged Viral Suppression|prolonged viral suppression
518330|NCT00276991|HIV Infections|hiv infections
518331|NCT00277017|Combination Therapy|combination therapy
518332|NCT00277017|5-Fluorouracil|5-fluorouracil
518333|NCT00277017|Interferon-a Interleukin-2|interferon-a interleukin-2
518334|NCT00277017|Thalidomide|thalidomide
518335|NCT00277017|Renal Cell Carcinoma|renal cell carcinoma
518336|NCT00277030|Respiratory Distress Syndrome|respiratory distress syndrome
518337|NCT00277030|Surfactant|surfactant
518338|NCT00277030|Nasal CPAP|nasal cpap
518340|NCT00277043|Test Dose|test dose
518341|NCT00277056|leukemia|leukemia
518342|NCT00277069|Breast metastatic|breast metastatic
518343|NCT00277082|Metastatic or Recurrent Cancer of the Endometrium or the Lung (NSCLC)|metastatic or recurrent cancer of the endometrium or the lung (nsclc)
518344|NCT00277082|Aerosolized Liposomal 9-Nitro 20|aerosolized liposomal 9-nitro 20
518345|NCT00277082|Camptothecin (L9NC)|camptothecin (l9nc)
518346|NCT00277095|Urinary Incontinence|urinary incontinence
518347|NCT00277108|postpartum depression|postpartum depression
518348|NCT00277108|postnatal depression|postnatal depression
518349|NCT00277108|PPD|ppd
518350|NCT00277121|Lipid disorder|lipid disorder
518351|NCT00277121|Gene mutation|gene mutation
518352|NCT00277147|Typhoid Fever|typhoid fever
518353|NCT00277147|Immunogenicity|immunogenicity
518354|NCT00277147|Safety|safety
518355|NCT00277147|Vaccine|vaccine
518356|NCT00277147|Conjugate|conjugate
518357|NCT00277147|Healthy Volunteer|healthy volunteer
518358|NCT00277173|Medication Safety|medication safety
518359|NCT00277173|Adverse Drug Events|adverse drug events
518360|NCT00277173|Preventable Adverse Drug Events|preventable adverse drug events
518361|NCT00277173|Culture of Safety|culture of safety
518362|NCT00277173|Failure Modes and Effects Analysis|failure modes and effects analysis
518363|NCT00277173|Teambuilding|teambuilding
518364|NCT00277186|Arthroplasty|arthroplasty
518365|NCT00277186|Health services research|health services research
518366|NCT00277186|Intent to treat|intent to treat
518367|NCT00277186|Randomized|randomized
518368|NCT00277186|Controlled|controlled
518369|NCT00277212|Bipolar I Disorder with a recent manic or mixed episode|bipolar i disorder with a recent manic or mixed episode
518370|NCT00277238|HCV|hcv
518371|NCT00277238|Hepatitis c virus|hepatitis c virus
518372|NCT00277238|Virus diseases|virus diseases
518373|NCT00277238|Interferon-alpha|interferon-alpha
518374|NCT00277238|Interferons|interferons
518375|NCT00277238|Liver diseases|liver diseases
518376|NCT00277251|Crohn's disease|crohn's disease
518377|NCT00277251|systemic-onset juvenile rheumatoid arthritis|systemic-onset juvenile rheumatoid arthritis
518378|NCT00277251|juvenile dermatomyositis|juvenile dermatomyositis
518379|NCT00277251|systemic lupus erythematosus (SLE)|systemic lupus erythematosus (sle)
518380|NCT00277251|Mixed connective tissue disease (MCTD)|mixed connective tissue disease (mctd)
518381|NCT00277251|vasculitis|vasculitis
518382|NCT00277277|Telemedicine|telemedicine
518383|NCT00277277|Biobehavioral weight loss program|biobehavioral weight loss program
518384|NCT00277277|Body Mass Index|body mass index
518385|NCT00277277|Blood Glucose|blood glucose
518386|NCT00277277|Diabetes Management|diabetes management
518389|NCT00277290|Platinum-resistant|platinum-resistant
518390|NCT00277290|Platinum-sensitive|platinum-sensitive
518391|NCT00277303|Colon Cancer|colon cancer
518392|NCT00277316|Kidney cancer|kidney cancer
518393|NCT00277316|Metastatic|metastatic
518394|NCT00277342|lipid induced hepatic insulin resistance|lipid induced hepatic insulin resistance
518395|NCT00277342|polymorphisms liver fatty-acid-binding-protein|polymorphisms liver fatty-acid-binding-protein
518396|NCT00277342|gluconeogenesis|gluconeogenesis
518397|NCT00277342|glycogenolysis|glycogenolysis
518398|NCT00277342|endogenous glucose production|endogenous glucose production
518399|NCT00277355|Study of Minocycline in Huntington's Disease|study of minocycline in huntington's disease
518400|NCT00277368|Epilepsy|epilepsy
518401|NCT00277368|Headache|headache
518404|NCT00277381|Hypertension|hypertension
518405|NCT00277381|Telemedicine|telemedicine
518406|NCT00277394|Acute, symptomatic and objectively confirmed DVT|acute, symptomatic and objectively confirmed dvt
518407|NCT00277407|NAET|naet
518408|NCT00277407|Chiropractic procedures|chiropractic procedures
518409|NCT00277407|Acupuncture/acupressure|acupuncture/acupressure
518410|NCT00277407|Treatment of Autism by holistic procedures|treatment of autism by holistic procedures
518411|NCT00277407|Food and Vaccination allergy|food and vaccination allergy
518412|NCT00277433|Atopic Dermatitis|atopic dermatitis
518413|NCT00277433|Eczema|eczema
518414|NCT00277433|Genetics|genetics
518415|NCT00277433|Histamine|histamine
518416|NCT00277446|Asthma|asthma
518417|NCT00277446|Soy isoflavones|soy isoflavones
518418|NCT00277446|Eosinophils|eosinophils
518419|NCT00277446|Exhaled nitric oxide|exhaled nitric oxide
518420|NCT00277472|Hypertension|hypertension
518421|NCT00277472|High blood pressure|high blood pressure
518422|NCT00277472|diuretics|diuretics
518423|NCT00277472|valsartan|valsartan
518424|NCT00277524|Pacemaker|pacemaker
518425|NCT00277524|Defibrillator|defibrillator
518426|NCT00277524|Cardiac Resynchronization|cardiac resynchronization
518427|NCT00277524|Dysynchrony|dysynchrony
518428|NCT00277524|Heart failure|heart failure
518429|NCT00277524|Arrhythmia|arrhythmia
518430|NCT00277524|Tachycardia|tachycardia
518431|NCT00277524|Bradycardia|bradycardia
518432|NCT00277537|Mannitol|mannitol
518433|NCT00277550|Constipation, Tegaserod, Dyspepsia|constipation, tegaserod, dyspepsia
518434|NCT00277563|Carpal Tunnel Syndrome|carpal tunnel syndrome
518435|NCT00277563|Neuropathic Pain|neuropathic pain
518436|NCT00277563|Neuromodulation|neuromodulation
518437|NCT00277563|PEMF|pemf
518438|NCT00277563|Magnetic Field Therapy|magnetic field therapy
518439|NCT00277563|Magnetotherapy|magnetotherapy
518440|NCT00277576|DNA vaccine|dna vaccine
518441|NCT00277576|immunotherapy|immunotherapy
518442|NCT00277576|Hepatitis B Virus|hepatitis b virus
518443|NCT00277576|Particle Mediated Epidermal Delivery|particle mediated epidermal delivery
518444|NCT00277615|Children|children
518445|NCT00277615|Bladder volume|bladder volume
518446|NCT00277615|Ultrasound|ultrasound
518447|NCT00277641|Binge Eating Disorder Associated with Obesity|binge eating disorder associated with obesity
668693|NCT00851383|HIV|hiv
517880|NCT00266838|Epiphora|epiphora
518448|NCT00277654|Bipolar Disorder with Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder|bipolar disorder with concurrent moderately severe anxiety and lifetime panic or generalized anxiety disorder
518449|NCT00277667|currently experiencing hypomania or mild mania|currently experiencing hypomania or mild mania
518451|NCT00277680|leiomyoma|leiomyoma
518452|NCT00277680|laparoscopy|laparoscopy
518453|NCT00277680|menorrhagia|menorrhagia
518454|NCT00277693|hemodialysis|hemodialysis
518455|NCT00277693|aldosterone|aldosterone
518456|NCT00277693|heart failure|heart failure
518457|NCT00277693|spironolactone|spironolactone
518458|NCT00277706|periodontitis|periodontitis
518459|NCT00277706|bone regeneration|bone regeneration
518460|NCT00277706|Parathyroid Hormone|parathyroid hormone
518461|NCT00277706|moderate to advanced periodontitis|moderate to advanced periodontitis
518462|NCT00277745|periodontitis|periodontitis
518463|NCT00277745|microfluidics|microfluidics
518464|NCT00277745|saliva diagnostics|saliva diagnostics
518465|NCT00277758|Interleukin-2|interleukin-2
518466|NCT00277771|technology in weight loss|technology in weight loss
518467|NCT00277771|standard behavioral therapy for obesity|standard behavioral therapy for obesity
518468|NCT00277784|Age Related Macular Degeneration|age related macular degeneration
518469|NCT00277784|Ultrasound|ultrasound
518470|NCT00277784|OCT|oct
518471|NCT00277784|Eye|eye
518472|NCT00277797|Low Back Pain|low back pain
518473|NCT00277810|Alzheimer's Disease|alzheimer's disease
518474|NCT00277810|Cholinesterase Inhibitors|cholinesterase inhibitors
518475|NCT00277810|Outpatients|outpatients
518476|NCT00277823|Depression|depression
518477|NCT00277823|Adult|adult
518478|NCT00277823|Outpatients|outpatients
518479|NCT00277836|malignant tumor|malignant tumor
518480|NCT00277849|Sickle|sickle
518481|NCT00277849|Hemoglobinopathy|hemoglobinopathy
518482|NCT00277849|Thalassemia|thalassemia
518483|NCT00277849|G6PD|g6pd
518484|NCT00277849|Plasmodium|plasmodium
518485|NCT00277849|Erythrocyte Variant|erythrocyte variant
518486|NCT00277849|Hemoglobin Variant|hemoglobin variant
518487|NCT00277849|Healthy Volunteer|healthy volunteer
518488|NCT00277849|HV|hv
518489|NCT00277862|chronic hepatitis C;|chronic hepatitis c;
518490|NCT00277862|peg-interferon alfa-2b;|peg-interferon alfa-2b;
518491|NCT00277862|ribavirin,|ribavirin,
518492|NCT00277862|rapid virologic response,|rapid virologic response,
518493|NCT00277862|sustained virological response|sustained virological response
518494|NCT00277875|Cardiovascular|cardiovascular
518495|NCT00277875|Flow-Mediated Vasodilation (FMD)|flow-mediated vasodilation (fmd)
518496|NCT00277875|Pulse Perfusion-Mediated Vasodilation (PPMV)|pulse perfusion-mediated vasodilation (ppmv)
518497|NCT00277875|Endothelial Function|endothelial function
518498|NCT00277875|Heart Failure|heart failure
518499|NCT00277875|Local Distensibility|local distensibility
518500|NCT00277875|Arterial Stiffening|arterial stiffening
520029|NCT00285090|Calcium|calcium
518501|NCT00277875|Augmentation Index (AI)|augmentation index (ai)
518502|NCT00277875|Aging|aging
518503|NCT00277875|Isolated Systolic Hypertension|isolated systolic hypertension
518504|NCT00277875|Advanced Glycation Endproducts|advanced glycation endproducts
518505|NCT00277875|Vascular Stiffness|vascular stiffness
518506|NCT00277888|Dialysis|dialysis
518507|NCT00277888|Hemodialysis|hemodialysis
518508|NCT00277888|Catheterization|catheterization
518509|NCT00277901|cardiac|cardiac
518510|NCT00277901|pediatric|pediatric
518511|NCT00277901|MRI|mri
518512|NCT00277901|Tetralogy of Fallot TOF|tetralogy of fallot tof
518513|NCT00277901|Aortic Coarctation|aortic coarctation
518514|NCT00277927|Pediatric|pediatric
518515|NCT00277927|Cardiac|cardiac
518516|NCT00277927|Valvar Pulmonary Stenosis|valvar pulmonary stenosis
518517|NCT00277940|Pediatric|pediatric
518518|NCT00277940|Cardiac|cardiac
518519|NCT00277940|Neoaortic Elastic Properties|neoaortic elastic properties
518520|NCT00277940|Aortic Arch Reconstruction|aortic arch reconstruction
518521|NCT00277953|Pediatric|pediatric
518522|NCT00277953|Cardiac|cardiac
518523|NCT00277953|Tracheal Dimensions|tracheal dimensions
518524|NCT00277953|MRI|mri
518525|NCT00277966|Pediatric|pediatric
518526|NCT00277966|Cardiac Catheterization|cardiac catheterization
518527|NCT00277966|Fluoroscopy time|fluoroscopy time
518528|NCT00277979|pediatric|pediatric
518529|NCT00277979|cardiac|cardiac
518530|NCT00277979|Infantile Pompe's Disease|infantile pompe's disease
518531|NCT00277979|3D Echocardiography|3d echocardiography
518532|NCT00277992|Pediatric|pediatric
518533|NCT00277992|Cardiac|cardiac
518534|NCT00277992|Norwood operation modification|norwood operation modification
518535|NCT00277992|GT/Nissen operation|gt/nissen operation
518536|NCT00277992|Po feed|po feed
518537|NCT00277992|GT fed|gt fed
518538|NCT00278005|pediatric|pediatric
518539|NCT00278005|DiGeorge Syndrome|digeorge syndrome
518540|NCT00278005|Congenital heart defects|congenital heart defects
518541|NCT00278005|Infections|infections
518542|NCT00278005|Cardiac surgery|cardiac surgery
518543|NCT00278031|Retinoblastoma|retinoblastoma
518544|NCT00278031|Quality of life|quality of life
518545|NCT00278044|Search as text words in Annotation & Scope Note|search as text words in annotation & scope note
518546|NCT00278057|Blood pressure;|blood pressure;
518547|NCT00278057|chronic renal failure;|chronic renal failure;
518548|NCT00278057|diabetes mellitus;|diabetes mellitus;
518549|NCT00278057|dialysis fluid; glucose;|dialysis fluid; glucose;
518550|NCT00278057|hemodialysis;|hemodialysis;
518551|NCT00278057|hypertension;|hypertension;
518552|NCT00278057|uremia.|uremia.
518553|NCT00278070|Metronomic-therapy|metronomic-therapy
518554|NCT00278070|vinorelbine|vinorelbine
518555|NCT00278070|Recurrent Breast Cancer|recurrent breast cancer
518556|NCT00278070|Recurrent Non Small Cell Lung Cancer|recurrent non small cell lung cancer
518557|NCT00278070|Metastatic prostate cancer|metastatic prostate cancer
518558|NCT00278083|Pharmacology|pharmacology
518559|NCT00278083|Asthma|asthma
518560|NCT00278083|TNF-alpha|tnf-alpha
518561|NCT00278096|disability|disability
518562|NCT00278096|occupational therapy|occupational therapy
518563|NCT00278109|stage I breast cancer|stage i breast cancer
518564|NCT00278109|stage II breast cancer|stage ii breast cancer
518565|NCT00278122|stage III melanoma|stage iii melanoma
518566|NCT00278122|stage IV melanoma|stage iv melanoma
518567|NCT00278122|recurrent melanoma|recurrent melanoma
518568|NCT00278135|Cognition|cognition
518569|NCT00278135|Memory|memory
518570|NCT00278135|Nutrition|nutrition
518571|NCT00278135|Omega-3|omega-3
518572|NCT00278135|DHA|dha
518573|NCT00278148|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
518574|NCT00278148|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
518575|NCT00278161|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
518576|NCT00278161|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
518577|NCT00278161|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
518578|NCT00278161|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
518579|NCT00278161|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
518580|NCT00278161|small lymphocytic lymphoma|small lymphocytic lymphoma
518581|NCT00278161|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
519913|NCT00284557|Obesity|obesity
518582|NCT00278161|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
518583|NCT00278161|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
518584|NCT00278161|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
518585|NCT00278161|splenic marginal zone lymphoma|splenic marginal zone lymphoma
518586|NCT00278161|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
518587|NCT00278161|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
518588|NCT00278161|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
518589|NCT00278161|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
518590|NCT00278161|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
518591|NCT00278161|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
518592|NCT00278161|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
518593|NCT00278161|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
518594|NCT00278161|stage I mantle cell lymphoma|stage i mantle cell lymphoma
518595|NCT00278161|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
518596|NCT00278161|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
518597|NCT00278161|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
518598|NCT00278161|prolymphocytic leukemia|prolymphocytic leukemia
518599|NCT00278161|stage I marginal zone lymphoma|stage i marginal zone lymphoma
518600|NCT00278161|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
518601|NCT00278161|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
518602|NCT00278161|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
518603|NCT00278161|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
518604|NCT00278161|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
518605|NCT00278161|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
518606|NCT00278161|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
518607|NCT00278161|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
518608|NCT00278161|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
518609|NCT00278161|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
518610|NCT00278161|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
518611|NCT00278161|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
518612|NCT00278161|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
518613|NCT00278161|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
518614|NCT00278161|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
518615|NCT00278161|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
518066|NCT00275158|cGMP|cgmp
518616|NCT00278161|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
518617|NCT00278161|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
518618|NCT00278161|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
518619|NCT00278161|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
518620|NCT00278174|stage IV renal cell cancer|stage iv renal cell cancer
518621|NCT00278174|recurrent renal cell cancer|recurrent renal cell cancer
518622|NCT00278174|clear cell renal cell carcinoma|clear cell renal cell carcinoma
583948|NCT00514020|stage IV gastric cancer|stage iv gastric cancer
518623|NCT00278187|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
518624|NCT00278187|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
518625|NCT00278187|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
518626|NCT00278200|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
518627|NCT00278213|prolymphocytic leukemia|prolymphocytic leukemia
518628|NCT00278213|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
518629|NCT00278213|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
518630|NCT00278213|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
518631|NCT00278213|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
518632|NCT00278213|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
518633|NCT00278213|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
518634|NCT00278226|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
518635|NCT00278239|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
518636|NCT00278239|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
518637|NCT00278239|cognitive/functional effects|cognitive/functional effects
518638|NCT00278239|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
518639|NCT00278252|recurrent childhood ependymoma|recurrent childhood ependymoma
518640|NCT00278252|childhood infratentorial ependymoma|childhood infratentorial ependymoma
518641|NCT00278252|childhood supratentorial ependymoma|childhood supratentorial ependymoma
518642|NCT00278265|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
518644|NCT00278265|neutropenia|neutropenia
518645|NCT00278278|untreated childhood brain stem glioma|untreated childhood brain stem glioma
518796|NCT00270010|Quality of Life|quality of life
518646|NCT00278278|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
518647|NCT00278278|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
518648|NCT00278278|childhood spinal cord neoplasm|childhood spinal cord neoplasm
518649|NCT00278304|cervical adenocarcinoma|cervical adenocarcinoma
518650|NCT00278304|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
518651|NCT00278304|cervical squamous cell carcinoma|cervical squamous cell carcinoma
518652|NCT00278304|stage IB cervical cancer|stage ib cervical cancer
518653|NCT00278304|stage IIA cervical cancer|stage iia cervical cancer
518654|NCT00278304|stage IIB cervical cancer|stage iib cervical cancer
518655|NCT00278304|stage III cervical cancer|stage iii cervical cancer
518656|NCT00278304|stage IVA cervical cancer|stage iva cervical cancer
518657|NCT00278304|stage IVB cervical cancer|stage ivb cervical cancer
518658|NCT00278369|recurrent renal cell cancer|recurrent renal cell cancer
518659|NCT00278369|stage IV renal cell cancer|stage iv renal cell cancer
518922|NCT00270283|Quality of Life|quality of life
518660|NCT00278369|clear cell renal cell carcinoma|clear cell renal cell carcinoma
518661|NCT00278408|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
518662|NCT00278408|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
518663|NCT00278408|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
518664|NCT00278408|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
518665|NCT00278408|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
518666|NCT00278408|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
518667|NCT00278408|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
518668|NCT00278408|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
518669|NCT00278408|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
518670|NCT00278408|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
518671|NCT00278408|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
518672|NCT00278408|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
518673|NCT00278408|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
518674|NCT00278408|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
518675|NCT00278408|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
518676|NCT00278408|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
518677|NCT00278408|anaplastic large cell lymphoma|anaplastic large cell lymphoma
518678|NCT00278408|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
518126|NCT00276107|Vaccine|vaccine
518679|NCT00278408|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
518680|NCT00278408|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
518681|NCT00278408|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
518682|NCT00278408|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
518683|NCT00278408|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
518684|NCT00278408|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
518685|NCT00278408|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
518686|NCT00278408|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
518687|NCT00278408|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
518688|NCT00278408|stage I mantle cell lymphoma|stage i mantle cell lymphoma
518689|NCT00278408|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
518690|NCT00278408|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
518691|NCT00278408|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
518692|NCT00278408|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
518693|NCT00278408|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
518694|NCT00278408|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
518695|NCT00278408|stage I marginal zone lymphoma|stage i marginal zone lymphoma
518696|NCT00278408|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
518697|NCT00278408|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
518698|NCT00278421|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
518699|NCT00278421|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
518700|NCT00278421|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
518701|NCT00278421|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
518702|NCT00278421|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
518703|NCT00278421|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
518704|NCT00278421|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
518705|NCT00278421|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
518706|NCT00278421|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
518707|NCT00278421|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
518708|NCT00278421|anaplastic large cell lymphoma|anaplastic large cell lymphoma
518709|NCT00278421|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
518710|NCT00278421|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
518711|NCT00278421|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
518712|NCT00278421|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
518713|NCT00278421|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
518714|NCT00278421|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
518715|NCT00278421|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
518716|NCT00278421|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
518717|NCT00278421|stage I mantle cell lymphoma|stage i mantle cell lymphoma
518718|NCT00278421|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
518719|NCT00278421|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
518720|NCT00278421|stage I marginal zone lymphoma|stage i marginal zone lymphoma
518721|NCT00278421|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
518722|NCT00278421|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
518723|NCT00278421|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
518724|NCT00278421|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
518725|NCT00278421|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
518726|NCT00278421|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
518727|NCT00278421|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
518728|NCT00278421|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
518729|NCT00278421|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
518730|NCT00278421|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
518731|NCT00278421|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
518732|NCT00278421|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
518733|NCT00278421|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
518734|NCT00278421|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
518735|NCT00278434|cervical cancer|cervical cancer
518736|NCT00278434|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
518737|NCT00278434|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
518738|NCT00278447|Alcohol|alcohol
518739|NCT00278447|Alcohol use|alcohol use
518740|NCT00278447|Alcohol dependence|alcohol dependence
518741|NCT00278447|Drug|drug
518742|NCT00278447|Drug use|drug use
518743|NCT00278447|Drug dependence|drug dependence
518744|NCT00278447|Utilization|utilization
518745|NCT00278447|Hospitalization|hospitalization
518746|NCT00278447|Primary care|primary care
518747|NCT00278447|Chronic disease management|chronic disease management
518748|NCT00278447|Care management|care management
518749|NCT00278447|Comorbidity|comorbidity
518750|NCT00278460|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
518751|NCT00278460|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
518752|NCT00278460|adenocarcinoma of the lung|adenocarcinoma of the lung
518753|NCT00278460|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
518754|NCT00278460|large cell lung cancer|large cell lung cancer
518755|NCT00278460|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
518756|NCT00278460|squamous cell lung cancer|squamous cell lung cancer
518757|NCT00278473|Primarily Inattentive|primarily inattentive
518758|NCT00278473|Hyperactive Impulsive Type|hyperactive impulsive type
518759|NCT00278473|Combined Type|combined type
518760|NCT00278473|ADHD|adhd
518761|NCT00278473|Adults|adults
518762|NCT00278473|Psychological|psychological
518763|NCT00278473|Cognitive Behavioral Therapy|cognitive behavioral therapy
518764|NCT00278473|CBT|cbt
518765|NCT00269958|hip replacement|hip replacement
518766|NCT00269958|hip replacement surgery|hip replacement surgery
518767|NCT00269958|surgery|surgery
518768|NCT00269958|anemia|anemia
518769|NCT00269958|transfusions|transfusions
518770|NCT00269958|blood transfusions|blood transfusions
518771|NCT00269971|hip replacement|hip replacement
518772|NCT00269971|hip replacement surgery|hip replacement surgery
518773|NCT00269971|surgery|surgery
518774|NCT00269971|anemia|anemia
518775|NCT00269971|transfusions|transfusions
518776|NCT00269971|blood|blood
518777|NCT00269971|blood transfusions|blood transfusions
518778|NCT00269984|Anemia|anemia
518779|NCT00269984|Blood transfusion|blood transfusion
518780|NCT00269984|Epoetin alfa|epoetin alfa
518781|NCT00269984|Erythropoietin|erythropoietin
518782|NCT00269984|Neoplasm|neoplasm
518783|NCT00269984|Epogen|epogen
518784|NCT00269984|Cancer|cancer
518785|NCT00269997|Anemia|anemia
518786|NCT00269997|chemotherapy|chemotherapy
518787|NCT00269997|epoetin alfa|epoetin alfa
518788|NCT00269997|epogen|epogen
518789|NCT00269997|erythropoietin|erythropoietin
518790|NCT00269997|neoplasms|neoplasms
518791|NCT00269997|cancer|cancer
518792|NCT00270010|Anemia|anemia
518793|NCT00270010|AIDS|aids
518794|NCT00270010|HIV|hiv
518795|NCT00270010|Zidovudine|zidovudine
518797|NCT00270010|erythropoietin|erythropoietin
518798|NCT00270010|epoetin alfa|epoetin alfa
518799|NCT00270023|Blood transfusion|blood transfusion
518800|NCT00270023|epoetin alfa|epoetin alfa
518801|NCT00270023|epogen|epogen
518802|NCT00270023|erythropoietin|erythropoietin
518803|NCT00270023|orthopedic procedures|orthopedic procedures
518804|NCT00270023|orthopedic surgery|orthopedic surgery
518805|NCT00270023|cardiovascular surgical procedures|cardiovascular surgical procedures
518806|NCT00270023|breast reduction|breast reduction
518807|NCT00270036|Blood transfusion|blood transfusion
518808|NCT00270036|epoetin alfa|epoetin alfa
518809|NCT00270036|epogen|epogen
518810|NCT00270036|erythropoietin|erythropoietin
518811|NCT00270036|orthopedic procedures|orthopedic procedures
518812|NCT00270036|orthopedic surgery|orthopedic surgery
518813|NCT00270049|Anemia|anemia
518814|NCT00270049|cancer|cancer
518815|NCT00270049|leukemia|leukemia
518923|NCT00270283|Zidovudine|zidovudine
518816|NCT00270049|chronic lymphocytic leukemia|chronic lymphocytic leukemia
518817|NCT00270049|lymphocytic leukemia|lymphocytic leukemia
518818|NCT00270049|epoetin alfa|epoetin alfa
518819|NCT00270049|erythropoietin|erythropoietin
518820|NCT00270049|red blood cells|red blood cells
518821|NCT00270049|transfusions|transfusions
518822|NCT00270049|quality of life|quality of life
518823|NCT00270062|anemia|anemia
518824|NCT00270062|blood transfusion|blood transfusion
518825|NCT00270062|epoetin alfa|epoetin alfa
518826|NCT00270062|erythropoietin|erythropoietin
518827|NCT00270062|surgery|surgery
518828|NCT00270062|blood donation|blood donation
518829|NCT00270062|blood|blood
518830|NCT00270075|epogen|epogen
518831|NCT00270075|erythropoietin|erythropoietin
518832|NCT00270075|orthopedic procedures|orthopedic procedures
518833|NCT00270075|orthopedic surgery|orthopedic surgery
518834|NCT00270075|cardiovascular surgical procedures|cardiovascular surgical procedures
518835|NCT00270075|Blood transfusion|blood transfusion
518836|NCT00270075|epoetin alfa|epoetin alfa
518837|NCT00270088|Anemia|anemia
518838|NCT00270088|blood transfusion|blood transfusion
518839|NCT00270088|epoetin alfa|epoetin alfa
518840|NCT00270088|epogen|epogen
518841|NCT00270088|erythropoietin|erythropoietin
518842|NCT00270088|orthopedic procedures|orthopedic procedures
518843|NCT00270088|orthopedic surgery|orthopedic surgery
518844|NCT00270101|anemia|anemia
518845|NCT00270101|cancer|cancer
518846|NCT00270101|quality of life|quality of life
518847|NCT00270101|chemotherapy|chemotherapy
518848|NCT00270101|hemoglobin|hemoglobin
518849|NCT00270101|multiple myeloma|multiple myeloma
518850|NCT00270101|transfusion|transfusion
518851|NCT00270101|epoetin alfa|epoetin alfa
518852|NCT00270101|epoetin|epoetin
518853|NCT00270101|erythropoietin|erythropoietin
518854|NCT00270114|Anemia|anemia
518855|NCT00270114|blood transfusion, autologous|blood transfusion, autologous
518856|NCT00270114|epoetin alfa|epoetin alfa
518858|NCT00270114|erythropoietin|erythropoietin
518859|NCT00270114|orthopedic procedures|orthopedic procedures
518860|NCT00270114|orthopedic surgery|orthopedic surgery
518861|NCT00270127|Anemia|anemia
518862|NCT00270127|cancer|cancer
518863|NCT00270127|quality of life|quality of life
518864|NCT00270127|chemotherapy|chemotherapy
518865|NCT00270127|hemoglobin|hemoglobin
518866|NCT00270127|transfusion|transfusion
518867|NCT00270127|epoetin alfa|epoetin alfa
518868|NCT00270127|epoetin|epoetin
518869|NCT00270127|erythropoietin|erythropoietin
518870|NCT00270140|anemia|anemia
518871|NCT00270140|blood transfusion|blood transfusion
518872|NCT00270140|epoetin alfa|epoetin alfa
518873|NCT00270140|erythropoietin|erythropoietin
518874|NCT00270140|surgery|surgery
518875|NCT00270140|blood donation|blood donation
518876|NCT00270140|blood|blood
518877|NCT00270153|renal transplant, ACE inhibitor|renal transplant, ace inhibitor
518878|NCT00270166|cancer|cancer
518879|NCT00270166|malignancy|malignancy
518880|NCT00270166|red cell transfusion|red cell transfusion
518881|NCT00270166|epoetin alfa|epoetin alfa
518882|NCT00270166|epoetin|epoetin
518883|NCT00270166|erythropoietin|erythropoietin
518884|NCT00270166|red blood cells|red blood cells
518885|NCT00270179|Anemia|anemia
518886|NCT00270179|blood transfusion|blood transfusion
518887|NCT00270179|epoetin alfa|epoetin alfa
518888|NCT00270179|erythropoietin|erythropoietin
518889|NCT00270179|surgery|surgery
518890|NCT00270179|self-blood donation|self-blood donation
518891|NCT00270192|Breastfeeding|breastfeeding
518892|NCT00270192|exclusive|exclusive
518893|NCT00270192|education|education
518894|NCT00270192|counseling|counseling
518895|NCT00270205|Treatment Experienced|treatment experienced
518896|NCT00270205|HIV Therapeutic Vaccine|hiv therapeutic vaccine
518897|NCT00270218|HIV Seronegativity|hiv seronegativity
518898|NCT00270218|Adenoviral Vector Vaccine|adenoviral vector vaccine
518899|NCT00270218|DNA Plasmid Vaccine|dna plasmid vaccine
518900|NCT00270231|within-subjects, crossover, laboratory study|within-subjects, crossover, laboratory study
518901|NCT00270231|Naltrexone vs. Placebo|naltrexone vs. placebo
518902|NCT00270244|Major Depression|major depression
518903|NCT00270244|Dysthymic Disorder|dysthymic disorder
518904|NCT00270244|Adjustment Disorder With Depressed Mood|adjustment disorder with depressed mood
518905|NCT00270244|Depressive Disorder Not Otherwise Specified|depressive disorder not otherwise specified
518906|NCT00270244|Adolescent|adolescent
518907|NCT00270244|Psychotherapy|psychotherapy
518908|NCT00270257|HIV Seronegativity|hiv seronegativity
518909|NCT00270257|Opiate Addiction|opiate addiction
518910|NCT00270257|Opiate Dependence|opiate dependence
518911|NCT00270270|erythropoietin|erythropoietin
518912|NCT00270270|Anemia|anemia
518913|NCT00270270|Quality of Life|quality of life
518914|NCT00270270|epoetin alfa|epoetin alfa
518915|NCT00270270|HIV|hiv
518916|NCT00270270|Zidovudine|zidovudine
518917|NCT00270270|AIDS|aids
518918|NCT00270283|Anemia|anemia
518919|NCT00270283|AIDS|aids
518920|NCT00270283|erythropoietin|erythropoietin
518921|NCT00270283|epoetin alfa|epoetin alfa
518925|NCT00270296|Treatment Naive|treatment naive
518926|NCT00270296|MTCT|mtct
518927|NCT00270296|HIV Seronegativity|hiv seronegativity
518928|NCT00270309|lower urinary tract symptoms, self-management|lower urinary tract symptoms, self-management
518929|NCT00270322|total knee replacement|total knee replacement
518930|NCT00270322|orthopedic surgery|orthopedic surgery
518931|NCT00270322|post operative analgesia|post operative analgesia
518932|NCT00270322|continuous epidural|continuous epidural
518933|NCT00270322|patients controlled analgesia|patients controlled analgesia
518934|NCT00270322|morphine|morphine
518935|NCT00270322|combined spinal epidural anesthesia|combined spinal epidural anesthesia
518936|NCT00270322|anesthesia|anesthesia
518937|NCT00270322|analgesia|analgesia
518938|NCT00270322|epidural marcaine|epidural marcaine
518939|NCT00270322|epidural fentanyl|epidural fentanyl
518940|NCT00270322|pain|pain
518941|NCT00270348|Asthma|asthma
518942|NCT00270348|Safety|safety
518943|NCT00270348|Pediatrics|pediatrics
518944|NCT00270361|Heart Failure|heart failure
518945|NCT00270361|Renal Dysfunction|renal dysfunction
518946|NCT00270361|Cardiomyopathy|cardiomyopathy
518947|NCT00270361|Heart Decompensation|heart decompensation
518948|NCT00270361|Dyspnea Paroxsymal|dyspnea paroxsymal
518949|NCT00270361|Outpatient Therapy.|outpatient therapy.
518950|NCT00270374|Congestive heart failure|congestive heart failure
518951|NCT00270374|CHF|chf
518952|NCT00270374|Left-sided heart failure|left-sided heart failure
518953|NCT00270374|Right-sided heart failure|right-sided heart failure
518954|NCT00270374|Systolic Heart Failure|systolic heart failure
518955|NCT00270387|Acutely Decompensated Congestive Heart Failure|acutely decompensated congestive heart failure
518956|NCT00270387|Heart Failure|heart failure
518957|NCT00270387|Renal Impairment|renal impairment
518958|NCT00270387|Kidney Failure|kidney failure
518959|NCT00270387|Myocardial Infarction.|myocardial infarction.
518960|NCT00270400|Heart Failure|heart failure
518961|NCT00270400|Renal Dysfunction|renal dysfunction
518962|NCT00270400|Cardiomyopathy|cardiomyopathy
518963|NCT00270400|Heart Decompensation|heart decompensation
518964|NCT00270400|Dyspnea Paroxsymal.|dyspnea paroxsymal.
518965|NCT00270413|breast cancer|breast cancer
518966|NCT00270413|metastatic|metastatic
518967|NCT00270413|taxanes|taxanes
518968|NCT00270413|SU11248|su11248
518969|NCT00270426|Advanced Chronic Renal Insufficiency|advanced chronic renal insufficiency
518970|NCT00270426|Benazepril|benazepril
518971|NCT00270439|Obesity|obesity
518972|NCT00270439|Omentectomy|omentectomy
518973|NCT00270439|Diabetes Mellitus Type 2|diabetes mellitus type 2
518974|NCT00270439|Laparoscopic|laparoscopic
518975|NCT00270439|Dyslipidemia|dyslipidemia
518976|NCT00270452|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
518977|NCT00270452|Wilm's tumor-1|wilm's tumor-1
518978|NCT00270452|Proteinase-3|proteinase-3
518979|NCT00270452|Vaccine Therapy|vaccine therapy
518980|NCT00270452|Acute Myeloid Leukemia|acute myeloid leukemia
518981|NCT00270452|Chronic Myeloid Leukemias|chronic myeloid leukemias
518982|NCT00270452|Myelodysplastic Syndrome|myelodysplastic syndrome
518983|NCT00270452|MDS|mds
518984|NCT00270465|HIV-positive|hiv-positive
518985|NCT00270465|Treatment Interruption|treatment interruption
518986|NCT00270465|Therapeutic Vaccine|therapeutic vaccine
518987|NCT00270465|HIV/AIDS|hiv/aids
518988|NCT00270465|Virologic Response|virologic response
518989|NCT00270465|HIV Positive|hiv positive
518990|NCT00270478|Erythropoietin Therapy|erythropoietin therapy
518991|NCT00270478|Fetal Hemoglobin Induction|fetal hemoglobin induction
518992|NCT00270478|Sickle Cell Disease|sickle cell disease
518993|NCT00270478|Pulmonary Hypertension|pulmonary hypertension
518994|NCT00270478|Chronic Kidney Disease|chronic kidney disease
518995|NCT00270478|SCD|scd
518996|NCT00270504|Memokath|memokath
518997|NCT00270504|Urethral stricture|urethral stricture
518998|NCT00270504|urethral stent|urethral stent
518999|NCT00270504|Bulbar urethral stricture|bulbar urethral stricture
519000|NCT00270530|Malaria|malaria
519001|NCT00270530|Placental diseases|placental diseases
519002|NCT00270530|Birth complications|birth complications
519003|NCT00270530|Plasmodium falciparum|plasmodium falciparum
519004|NCT00270530|Zambia|zambia
519005|NCT00270530|HIV-seropositive|hiv-seropositive
519007|NCT00270543|Stomach Neoplasms|stomach neoplasms
519008|NCT00270556|Treatment Experienced|treatment experienced
519009|NCT00270608|Hypertension|hypertension
519010|NCT00270608|Peripheral vascular disease|peripheral vascular disease
519011|NCT00270608|Diabetes|diabetes
519012|NCT00270608|Total body fat percentage|total body fat percentage
519013|NCT00270634|Randomized Controlled Trials|randomized controlled trials
519014|NCT00270634|Immunosuppression|immunosuppression
519015|NCT00270634|Adult|adult
519016|NCT00270634|Kidney Transplantation|kidney transplantation
519017|NCT00270634|Treatment Outcome|treatment outcome
519018|NCT00270647|cancer|cancer
519019|NCT00270647|prostate cancer|prostate cancer
519020|NCT00270647|colorectal cancer|colorectal cancer
519021|NCT00270647|cardiovascular disease|cardiovascular disease
519022|NCT00270647|eye disease|eye disease
519023|NCT00270647|cognitive decline|cognitive decline
519024|NCT00270660|retraction pockets ear|retraction pockets ear
519025|NCT00270660|unsafe otitis media|unsafe otitis media
519026|NCT00270660|otitis media complications|otitis media complications
519027|NCT00270673|Lactate|lactate
519028|NCT00270673|Tissue hypoxia|tissue hypoxia
519029|NCT00270673|Intensive care|intensive care
519030|NCT00270673|Goal- directed therapy|goal- directed therapy
519031|NCT00270686|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
519032|NCT00270686|Stickler Syndrome|stickler syndrome
519033|NCT00270686|Marfan Syndrome|marfan syndrome
519034|NCT00270686|Genetics|genetics
519035|NCT00270686|Aneurysm|aneurysm
519036|NCT00270699|Dengue Vaccine|dengue vaccine
519037|NCT00270699|Dengue Virus|dengue virus
519038|NCT00270699|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
519039|NCT00270699|Dengue Shock Syndrome|dengue shock syndrome
519040|NCT00270712|kidney|kidney
519041|NCT00270712|transplant|transplant
519042|NCT00270712|dysfunction|dysfunction
519043|NCT00270712|chronic|chronic
519044|NCT00270712|deterioration|deterioration
519045|NCT00270712|loss of function|loss of function
519046|NCT00270725|HIV|hiv
519047|NCT00270725|AIDS|aids
519048|NCT00270725|Labor productivity|labor productivity
519049|NCT00270725|Antiretroviral therapy|antiretroviral therapy
519050|NCT00270725|South Africa|south africa
519051|NCT00270738|urinary incontinence|urinary incontinence
519052|NCT00270738|transversus abdominis|transversus abdominis
519053|NCT00270738|pelvic floor muscles|pelvic floor muscles
519054|NCT00270738|randomized controlled trial|randomized controlled trial
519055|NCT00270751|Video-Assisted Thoracoscopic Surgery|video-assisted thoracoscopic surgery
519056|NCT00270751|Spontaneous pneumothorax|spontaneous pneumothorax
519057|NCT00270751|Pleurectomy|pleurectomy
519058|NCT00270751|Pleural abrasion|pleural abrasion
519059|NCT00270751|Minocycline|minocycline
519060|NCT00270764|HIV/AIDS|hiv/aids
519061|NCT00270764|Antiretroviral therapy|antiretroviral therapy
519062|NCT00270764|Quality of life|quality of life
519063|NCT00270764|South Africa|south africa
519064|NCT00270764|Treatment Naive|treatment naive
519065|NCT00270777|Controlled trial|controlled trial
519066|NCT00270777|Snake bite|snake bite
519067|NCT00270777|Safety|safety
519068|NCT00270777|Antivenom|antivenom
519069|NCT00270790|Head and Neck cancer|head and neck cancer
519070|NCT00270803|Marijuana, FDG, PET, maze, THC, motor coordination.|marijuana, fdg, pet, maze, thc, motor coordination.
519071|NCT00270816|Multiple Sclerosis|multiple sclerosis
519072|NCT00270816|Interferon-ß-1b|interferon-ß-1b
519073|NCT00270816|Therapy|therapy
519074|NCT00270829|renal function|renal function
519075|NCT00270842|Education|education
519076|NCT00270842|Exercise|exercise
519077|NCT00270842|Gait|gait
519078|NCT00270842|Peripheral Nervous System|peripheral nervous system
519079|NCT00270842|Postural Balance|postural balance
519080|NCT00270842|Self Efficacy|self efficacy
519081|NCT00270842|Tai Chi Chuan|tai chi chuan
519082|NCT00270855|Body Composition|body composition
519083|NCT00270855|Exercise|exercise
519084|NCT00270855|Glucose Tolerance|glucose tolerance
519085|NCT00270855|Insulin Sensitivity|insulin sensitivity
519086|NCT00270855|Functional Electric Stimulation|functional electric stimulation
519087|NCT00270868|Double guide wire technique|double guide wire technique
519088|NCT00270868|Difficult selective biliary cannulation|difficult selective biliary cannulation
519089|NCT00270868|ERCP|ercp
519090|NCT00270868|Attempts of cannulation|attempts of cannulation
519091|NCT00270868|Post-ERCP complications.|post-ercp complications.
519092|NCT00270881|cord blood transplantation|cord blood transplantation
519093|NCT00270881|myeloablative regimen|myeloablative regimen
519094|NCT00270881|hematologic malignancies|hematologic malignancies
519095|NCT00270894|neoadjuvant chemotherapy|neoadjuvant chemotherapy
519096|NCT00270894|HER2 positive breast cancer|her2 positive breast cancer
519097|NCT00270894|stage II - III breast cancer|stage ii - iii breast cancer
519098|NCT00270907|Metastatic Breast Cancer|metastatic breast cancer
519099|NCT00270907|Breast Cancer|breast cancer
519100|NCT00270907|CT-2103|ct-2103
519101|NCT00270907|Gemcitabine|gemcitabine
519102|NCT00270907|Xyotax|xyotax
519103|NCT00270907|Gemzar|gemzar
519104|NCT00270920|Initiation, Maintenance, Breastfeeding|initiation, maintenance, breastfeeding
519105|NCT00270933|defibrillators|defibrillators
519107|NCT00270933|ventricular tachycardia|ventricular tachycardia
519108|NCT00270933|ventricular fibrillation|ventricular fibrillation
519109|NCT00270946|Venous leg ulcer|venous leg ulcer
519110|NCT00270946|OrCel|orcel
519111|NCT00270946|Compression therapy|compression therapy
519112|NCT00270959|PTSD|ptsd
519113|NCT00270972|Venous leg ulcer|venous leg ulcer
519114|NCT00270972|Venous insufficiency|venous insufficiency
519115|NCT00270972|OrCel|orcel
519116|NCT00270985|almonds|almonds
519117|NCT00270985|pre-diabetes|pre-diabetes
519118|NCT00270985|inflammatory|inflammatory
519120|NCT00270998|Stress urinary incontinence|stress urinary incontinence
519121|NCT00271024|Smoking|smoking
519122|NCT00271024|Smoking Cessation|smoking cessation
519123|NCT00271037|Pelvic organ prolapse|pelvic organ prolapse
519124|NCT00271037|Stress urinary incontinence|stress urinary incontinence
519125|NCT00271037|Surgery|surgery
519126|NCT00271037|Colpocleisis|colpocleisis
519127|NCT00271037|Urinary retention|urinary retention
519128|NCT00271050|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
519129|NCT00271050|external beam radiotherapy (EBRT)|external beam radiotherapy (ebrt)
519130|NCT00271050|radio-immunotherapy (RIT)|radio-immunotherapy (rit)
519131|NCT00271050|Zevalin|zevalin
519132|NCT00271063|Refractory or Relapsed Acute Lymphocytic Leukemia|refractory or relapsed acute lymphocytic leukemia
519133|NCT00271076|CAD|cad
519134|NCT00271076|CEA|cea
519135|NCT00271076|CAS|cas
519136|NCT00271076|IVUS|ivus
519137|NCT00271076|symptomatic|symptomatic
519138|NCT00271076|asymptomatic|asymptomatic
519139|NCT00271076|Cerebral Protection Device|cerebral protection device
519140|NCT00271076|TIA|tia
519141|NCT00271076|Stroke|stroke
519142|NCT00271076|plaque morphology|plaque morphology
519143|NCT00271102|Cystocele, prolapse, anterior repair, colporrhaphy|cystocele, prolapse, anterior repair, colporrhaphy
519144|NCT00271115|Kangaroo holding|kangaroo holding
519145|NCT00271115|Kangaroo care|kangaroo care
519146|NCT00271115|Maternal stress levels|maternal stress levels
519147|NCT00271115|Premature birth|premature birth
519148|NCT00271128|NT-proBNP|nt-probnp
519149|NCT00271128|Heart failure|heart failure
519150|NCT00271128|Dyspnea|dyspnea
519151|NCT00271141|Parkinson's disease|parkinson's disease
519152|NCT00271141|Oxidative stress|oxidative stress
519153|NCT00271141|Marker|marker
519154|NCT00271154|Heart Failure|heart failure
519155|NCT00271154|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
519156|NCT00271154|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
519157|NCT00271167|Cardiac surgery|cardiac surgery
519158|NCT00271167|PARP inhibitor|parp inhibitor
519159|NCT00271167|PARP inhibition|parp inhibition
519160|NCT00271167|Bypass surgery|bypass surgery
519161|NCT00271167|CPB surgery|cpb surgery
519162|NCT00271167|Cardiopulmonary bypass|cardiopulmonary bypass
519163|NCT00271167|Coronary revascularization|coronary revascularization
519164|NCT00271167|Cardiac valve replacement|cardiac valve replacement
519165|NCT00271180|Cardiac Pacing|cardiac pacing
519166|NCT00271180|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
519167|NCT00271180|pacemaker|pacemaker
519168|NCT00271180|Sinus Bradycardia|sinus bradycardia
519169|NCT00271206|Nicotine Dependence|nicotine dependence
519170|NCT00271206|Tobacco Dependence|tobacco dependence
519171|NCT00271219|opiate addiction|opiate addiction
519172|NCT00271219|opiate dependence|opiate dependence
519173|NCT00271219|substance abuse|substance abuse
519174|NCT00271219|addiction|addiction
519175|NCT00271219|substance addiction|substance addiction
519176|NCT00271219|pregnancy|pregnancy
519177|NCT00271219|buprenorphine|buprenorphine
519178|NCT00271219|methadone|methadone
519179|NCT00271219|fetal|fetal
519180|NCT00271219|neonatal|neonatal
519181|NCT00271219|post-partum|post-partum
519182|NCT00271232|Heart Failure, Cardiac Resynchronization|heart failure, cardiac resynchronization
519183|NCT00271245|cirrhosis|cirrhosis
519184|NCT00271245|liver disease|liver disease
519185|NCT00271245|selenium|selenium
519186|NCT00271245|selenoproteins|selenoproteins
519187|NCT00271245|selenoprotein P|selenoprotein p
519188|NCT00271245|biomarkers|biomarkers
519189|NCT00271297|pelvic floor|pelvic floor
519190|NCT00271297|exercise therapy|exercise therapy
519191|NCT00271297|prevention|prevention
519192|NCT00271297|ultrasonography|ultrasonography
519193|NCT00271297|risk factors|risk factors
519194|NCT00271336|NEC|nec
519195|NCT00271336|Premature Infants|premature infants
519196|NCT00271336|TNF|tnf
519197|NCT00271336|Pentoxifylline|pentoxifylline
519198|NCT00271349|Eosinophilic Esophagitis|eosinophilic esophagitis
519199|NCT00271349|Budesonide|budesonide
519200|NCT00271362|Exercise|exercise
519201|NCT00271362|Physical function|physical function
519202|NCT00271362|Prosthetic mobility|prosthetic mobility
519203|NCT00271362|Rehabilitation|rehabilitation
519204|NCT00271375|Age|age
519205|NCT00271375|Caregivers|caregivers
519206|NCT00271375|Family|family
519207|NCT00271375|Intervention Studies|intervention studies
519208|NCT00271388|Galvanic Vestibular Stimulation|galvanic vestibular stimulation
519209|NCT00271388|Hemispatial Neglect|hemispatial neglect
519211|NCT00271401|Stents|stents
519212|NCT00271401|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
519213|NCT00271414|chronic pain|chronic pain
519214|NCT00271414|opioid|opioid
519215|NCT00271414|fentanyl|fentanyl
519216|NCT00271414|transdermal|transdermal
519217|NCT00271414|Duragesic|duragesic
519218|NCT00271414|morphine|morphine
519219|NCT00271427|Thyroiditis|thyroiditis
519220|NCT00271427|Autoimmune|autoimmune
519221|NCT00271427|Hashimoto's|hashimoto's
519222|NCT00271427|TPOAb|tpoab
519223|NCT00271427|Selenium|selenium
519224|NCT00271440|chlorhexidine|chlorhexidine
519225|NCT00271440|neonatal|neonatal
519226|NCT00271440|skin flora|skin flora
519227|NCT00271440|skin cleansing|skin cleansing
519228|NCT00271440|bacterial colonization|bacterial colonization
519229|NCT00271453|chronic pain|chronic pain
519230|NCT00271453|opioid|opioid
519231|NCT00271453|fentanyl|fentanyl
519232|NCT00271453|transdermal|transdermal
519233|NCT00271453|Durogesic|durogesic
519234|NCT00271453|morphine|morphine
519235|NCT00271466|opioid|opioid
519236|NCT00271466|fentanyl|fentanyl
519237|NCT00271466|Duragesic|duragesic
519238|NCT00271466|transdermal|transdermal
519239|NCT00271466|chronic pain|chronic pain
519240|NCT00271466|morphine|morphine
519241|NCT00271479|Meningitis|meningitis
519242|NCT00271479|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
519243|NCT00271479|Neisseria meningitidis|neisseria meningitidis
519244|NCT00271479|Outbreaks|outbreaks
519245|NCT00271479|Vaccine|vaccine
519246|NCT00271479|Africa|africa
519247|NCT00271479|Uganda|uganda
519248|NCT00271479|Prevention of Neisseria meningitidis infections|prevention of neisseria meningitidis infections
519249|NCT00271479|In outbreak contexts in developing countries|in outbreak contexts in developing countries
519250|NCT00271505|Non-Small Cell Lung Cancer|non-small cell lung cancer
519251|NCT00271505|Lung Cancer|lung cancer
518643|NCT00278265|anemia|anemia
519252|NCT00271505|Bevacizumab|bevacizumab
519253|NCT00271505|Carboplatin|carboplatin
519254|NCT00271505|Docetaxel|docetaxel
519255|NCT00271505|Avastin|avastin
519256|NCT00271505|NSCLC|nsclc
519257|NCT00271505|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
519258|NCT00271505|rhuMAb-VEGF|rhumab-vegf
519259|NCT00271505|Paraplatin®|paraplatin®
519260|NCT00271505|Taxotere|taxotere
519261|NCT00271531|bacterial infection, pneumonia, ventilation, children|bacterial infection, pneumonia, ventilation, children
519262|NCT00271544|heart failure|heart failure
519263|NCT00271544|cardiac pacing|cardiac pacing
519264|NCT00271544|left ventricular lead|left ventricular lead
519265|NCT00271544|cardiac resynchronization therapy|cardiac resynchronization therapy
519266|NCT00271557|Heart Failure|heart failure
519267|NCT00271557|Renal Dysfunction|renal dysfunction
519268|NCT00271557|Cardiomyopathy|cardiomyopathy
519269|NCT00271557|Heart Decompensation|heart decompensation
519270|NCT00271557|Dyspnea Paroxysmal.|dyspnea paroxysmal.
519271|NCT00271583|emergency contraception|emergency contraception
519272|NCT00271583|antiprogestin|antiprogestin
519273|NCT00271596|Huntington Disease|huntington disease
519274|NCT00271596|Citalopram|citalopram
519275|NCT00271596|Celexa|celexa
519276|NCT00271596|Chorea|chorea
519277|NCT00271596|Focus|focus
519278|NCT00271596|ADD|add
519279|NCT00271596|ADHD|adhd
519280|NCT00271596|HD|hd
519281|NCT00271596|SSRI|ssri
519282|NCT00271609|AVASTIN|avastin
519283|NCT00271609|Recurrence|recurrence
519284|NCT00271609|Chemotherapy|chemotherapy
519285|NCT00271609|Anti-Angiogenesis|anti-angiogenesis
519286|NCT00271609|Radiotherapy|radiotherapy
519287|NCT00271609|Brain Tumor|brain tumor
519288|NCT00271609|Malignant Glioma|malignant glioma
519289|NCT00271622|Screening|screening
519290|NCT00271622|Pediatric|pediatric
519291|NCT00271622|Pervasive Developmental Disorder|pervasive developmental disorder
519292|NCT00271622|Early Development|early development
519293|NCT00271622|Children|children
519294|NCT00271622|Autism Spectrum Disorders|autism spectrum disorders
519295|NCT00271622|Healthy Volunteer|healthy volunteer
519296|NCT00271622|HV|hv
519297|NCT00271635|Charcot-Marie-Tooth Disease|charcot-marie-tooth disease
519298|NCT00271635|Hereditary Motor and Sensory Neuropathies|hereditary motor and sensory neuropathies
519299|NCT00271635|Ascorbic Acid|ascorbic acid
519300|NCT00271635|Vitamin C|vitamin c
519301|NCT00271661|presbyopia; breast cancer survivors|presbyopia; breast cancer survivors
519302|NCT00271687|exercise|exercise
519303|NCT00271687|exercise therapy|exercise therapy
519304|NCT00271687|activities of daily living|activities of daily living
519305|NCT00271687|quality of life|quality of life
519306|NCT00271700|Diabetes Mellitus|diabetes mellitus
519307|NCT00271700|Outcome Assessment (Healthcare)|outcome assessment (healthcare)
519308|NCT00271700|Inpatients|inpatients
519309|NCT00271700|Hospital Information Systems|hospital information systems
519310|NCT00271700|Education|education
519311|NCT00271713|bone structure|bone structure
519312|NCT00271713|ibandronate|ibandronate
519313|NCT00271726|distal radius fracture|distal radius fracture
519314|NCT00271726|extraarticular Colles fracture|extraarticular colles fracture
519315|NCT00271739|Telemedicine|telemedicine
519316|NCT00271739|Diabetes Mellitus|diabetes mellitus
519317|NCT00271752|Procalcitonin|procalcitonin
519318|NCT00271752|Sepsis|sepsis
519319|NCT00271752|Intensive Care Unit|intensive care unit
519320|NCT00271752|Sepsis and Complications|sepsis and complications
519321|NCT00271752|Organ Failure|organ failure
519322|NCT00271765|Myocardial infarction|myocardial infarction
519323|NCT00271765|Coronary angioplasty|coronary angioplasty
519324|NCT00271765|PARP inhibitor|parp inhibitor
519325|NCT00271765|PARP inhibition|parp inhibition
519326|NCT00271765|Heart Attack|heart attack
519327|NCT00271778|Otitis media suppurative|otitis media suppurative
519328|NCT00271778|surgery ear|surgery ear
519329|NCT00271791|Vestibular Neuronitis|vestibular neuronitis
519330|NCT00271791|Vestibular Function Tests|vestibular function tests
519331|NCT00271791|Vestibular Adaptation|vestibular adaptation
519332|NCT00271791|Steroids|steroids
519333|NCT00271804|Myelodysplastic syndrome|myelodysplastic syndrome
519334|NCT00271804|Myelodysplasia|myelodysplasia
519336|NCT00271804|Velcade|velcade
519337|NCT00271804|Thalidomide|thalidomide
519338|NCT00271804|Bortezomib|bortezomib
519339|NCT00271830|renal|renal
519340|NCT00271830|transplant|transplant
519341|NCT00271830|sexual dysfunction|sexual dysfunction
519342|NCT00271830|male|male
519343|NCT00271830|dialysis free|dialysis free
519344|NCT00271856|HIV|hiv
519345|NCT00271856|Meditation|meditation
519346|NCT00271856|Stress|stress
519347|NCT00271856|Randomized Controlled Trial|randomized controlled trial
519348|NCT00271856|Complementary Therapies|complementary therapies
519349|NCT00271856|MBSR|mbsr
519350|NCT00271856|Not on ART medications|not on art medications
519351|NCT00271869|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
519352|NCT00271869|graft-versus-host disease|graft-versus-host disease
519353|NCT00271869|treatment|treatment
519354|NCT00271882|Adolescent Females|adolescent females
519355|NCT00271882|HIV positive|hiv positive
519356|NCT00271882|PTSD|ptsd
519357|NCT00271882|Sexual Abuse|sexual abuse
519358|NCT00271908|HIV|hiv
519359|NCT00271908|AIDS|aids
519360|NCT00271908|Adolescent|adolescent
519361|NCT00271908|Community|community
519362|NCT00271908|Structural Changes|structural changes
519363|NCT00271908|HIV Seronegativity|hiv seronegativity
519364|NCT00271921|eating disorders|eating disorders
519365|NCT00271921|anorexia nervosa|anorexia nervosa
519366|NCT00271921|body fat distribution|body fat distribution
519367|NCT00271921|metabolic syndrome|metabolic syndrome
519368|NCT00271921|visceral adipose tissue|visceral adipose tissue
519369|NCT00271960|Pregnancy|pregnancy
519370|NCT00271960|Birth Weight|birth weight
519371|NCT00271960|Gestational Age|gestational age
519372|NCT00271960|Preterm Delivery|preterm delivery
519373|NCT00271960|HIV Seronegativity|hiv seronegativity
519374|NCT00271986|Peritoneal microdialysis|peritoneal microdialysis
519375|NCT00271986|Low anterior resection|low anterior resection
519376|NCT00271986|Recto-sigmoid cancer|recto-sigmoid cancer
519377|NCT00271986|Anastomotic leakage|anastomotic leakage
519378|NCT00271999|randomized controlled clinical trial|randomized controlled clinical trial
519379|NCT00271999|hemodialysis|hemodialysis
519380|NCT00271999|End Stage Renal Disease|end stage renal disease
519381|NCT00272025|Bipolar Depression|bipolar depression
519382|NCT00272025|Escitalopram|escitalopram
519383|NCT00272025|Mood Stabilizer|mood stabilizer
519384|NCT00272025|Atypical Antipsychotic|atypical antipsychotic
519385|NCT00272051|Neurotoxicity syndromes|neurotoxicity syndromes
519386|NCT00272051|Paresthesia|paresthesia
519387|NCT00272051|Oxaliplatin|oxaliplatin
519388|NCT00272051|Xaliproden|xaliproden
519389|NCT00272103|functional dyspepsia|functional dyspepsia
519390|NCT00272103|non ulcer dyspepsia|non ulcer dyspepsia
519391|NCT00272103|drug treatment|drug treatment
519392|NCT00272116|zinc|zinc
519393|NCT00272116|diarrhea|diarrhea
519394|NCT00272116|severe diarrhea|severe diarrhea
519395|NCT00272116|recurrent diarrhea|recurrent diarrhea
519396|NCT00272116|acute lower respiratory infection|acute lower respiratory infection
519397|NCT00272116|pneumonia|pneumonia
519398|NCT00272142|mortality|mortality
519399|NCT00272142|hospitalization|hospitalization
519400|NCT00272142|diarrhea|diarrhea
519401|NCT00272142|respiratory infection|respiratory infection
519402|NCT00272142|low birth weight|low birth weight
519403|NCT00272142|morbidity|morbidity
519404|NCT00272168|Cognitive behavioral therapy|cognitive behavioral therapy
519405|NCT00272168|Social Skills training|social skills training
519406|NCT00272168|Vocational Rehabilitation|vocational rehabilitation
519407|NCT00272194|Endotracheal Intubation|endotracheal intubation
519408|NCT00272194|Supraglottic Airway|supraglottic airway
519409|NCT00272207|Fibromyalgia|fibromyalgia
519410|NCT00272207|Cannabinoids|cannabinoids
519411|NCT00272207|Nabilone|nabilone
519412|NCT00272207|Cesamet|cesamet
519413|NCT00272207|Pain|pain
519414|NCT00272220|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
519415|NCT00272220|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
519416|NCT00272220|Randomized Controlled Trials|randomized controlled trials
519417|NCT00272220|Africa|africa
519418|NCT00272220|Adherence|adherence
519419|NCT00272220|Treatment Naive|treatment naive
519420|NCT00272233|Inflammation Mediators [D23.469]|inflammation mediators [d23.469]
519421|NCT00272233|Cardiovascular Physiologic Phenomena [G09.330.553]|cardiovascular physiologic phenomena [g09.330.553]
519422|NCT00272246|dystonia|dystonia
519423|NCT00272272|Fall Prevention, Music Therapy, Geriatric, Nursing Home|fall prevention, music therapy, geriatric, nursing home
519424|NCT00272285|Serotonin antagonists|serotonin antagonists
519425|NCT00272285|Randomized controlled trial|randomized controlled trial
519426|NCT00272285|Combination drug therapy|combination drug therapy
519427|NCT00272285|Double-blind method|double-blind method
519428|NCT00272311|Primary prevention|primary prevention
519429|NCT00272311|Cardiovascular diseases|cardiovascular diseases
519430|NCT00272311|Aspirin|aspirin
519431|NCT00272311|Metabolic Syndrome X|metabolic syndrome x
519432|NCT00272311|Atherosclerosis|atherosclerosis
519433|NCT00272324|Colorectal neoplasms|colorectal neoplasms
519434|NCT00272324|Adenomatous polyps|adenomatous polyps
519435|NCT00272337|Cardiovascular diseases|cardiovascular diseases
519436|NCT00272337|Aspirin|aspirin
519437|NCT00272337|Atherosclerosis|atherosclerosis
519438|NCT00272337|Myocardial Infarction|myocardial infarction
519439|NCT00272350|Brain|brain
519440|NCT00272350|Tumor|tumor
519441|NCT00272350|Therapy|therapy
519442|NCT00272350|Progression|progression
519443|NCT00272350|Antiangiogenesis|antiangiogenesis
519444|NCT00272350|Brain Tumor|brain tumor
519445|NCT00272350|Malignant Glioma|malignant glioma
519446|NCT00278538|Stem cell, Autoimmune disease, Systemic Lupus Erythematosus|stem cell, autoimmune disease, systemic lupus erythematosus
519447|NCT00278681|zinc|zinc
519448|NCT00278681|diarrhea|diarrhea
519449|NCT00278681|hospitalization|hospitalization
519450|NCT00278681|programme|programme
519451|NCT00278694|Oxaliplatin, radiation|oxaliplatin, radiation
519452|NCT00278707|Canavan Disease|canavan disease
519453|NCT00278707|Aspartoacylase Deficiency|aspartoacylase deficiency
519454|NCT00278707|NAA|naa
519455|NCT00278707|Acetate|acetate
519456|NCT00278707|Glyceryltriacetate|glyceryltriacetate
519457|NCT00278733|Randomized controlled trial|randomized controlled trial
519458|NCT00278733|brief intervention|brief intervention
519459|NCT00278733|university students|university students
519460|NCT00278733|physician advice|physician advice
519461|NCT00278733|high risk drinking|high risk drinking
519462|NCT00278746|zinc|zinc
519463|NCT00278746|diarrhea|diarrhea
519464|NCT00278746|cluster randomization|cluster randomization
519465|NCT00278746|hospitalization|hospitalization
519466|NCT00278759|rapid viral diagnosis|rapid viral diagnosis
519467|NCT00278759|respiratory infection|respiratory infection
519468|NCT00278759|pediatric emergency department|pediatric emergency department
519469|NCT00278759|febrile respiratory infection|febrile respiratory infection
519470|NCT00278785|interviews|interviews
519471|NCT00278785|brief intervention|brief intervention
519472|NCT00278785|drinking|drinking
519473|NCT00278785|alcohol|alcohol
519474|NCT00278785|injuries|injuries
519475|NCT00278785|wounds|wounds
519476|NCT00278785|intervention studies|intervention studies
519477|NCT00278798|tracehelectomy|tracehelectomy
519478|NCT00278798|radical hysterectomy|radical hysterectomy
519479|NCT00278811|Mental Health Services|mental health services
519480|NCT00278811|Suicide|suicide
519481|NCT00278811|Suicide ideation|suicide ideation
519482|NCT00278824|Chronic Pain|chronic pain
519483|NCT00278824|Pain|pain
519484|NCT00278837|Meditation|meditation
519485|NCT00278837|Stress-reduction|stress-reduction
519486|NCT00278837|Cognitive-affective behavior learning|cognitive-affective behavior learning
519487|NCT00282711|Diagnostic Techniques, Radioisotope|diagnostic techniques, radioisotope
519488|NCT00282711|Radionuclide Imaging|radionuclide imaging
519489|NCT00282711|Diagnostic Techniques, Cardiovascular|diagnostic techniques, cardiovascular
519490|NCT00282711|Heart Function tests|heart function tests
519491|NCT00282724|Lamellar ichthyosis|lamellar ichthyosis
519492|NCT00282724|Liarozole|liarozole
519493|NCT00282724|Investigator's Global Assessment|investigator's global assessment
519494|NCT00282724|Scaling|scaling
519495|NCT00282750|"Surgery[MeSH]"|"surgery[mesh]"
519496|NCT00282750|"Surgical Sponges[MeSH]"|"surgical sponges[mesh]"
519497|NCT00282750|"Automatic Data Processing[MeSH]"|"automatic data processing[mesh]"
519498|NCT00282776|Postpartum Depression|postpartum depression
519499|NCT00282776|Telephone Care Management|telephone care management
519500|NCT00282776|Screening for Postpartum Depression|screening for postpartum depression
519501|NCT00282802|Parkinson's Disease|parkinson's disease
519502|NCT00282802|twins|twins
519503|NCT00282802|SPECT|spect
15447|NCT03191929|Health Information Technology (HIT)|health information technology (hit)
15450|NCT03191916|Parkinson's Disease|parkinson's disease
15645|NCT03191019|Women|women
519504|NCT00282802|National Academy of Sciences/National Resource Council (NAS/NRC) World War II Veteran Twins Cohort Registry|national academy of sciences/national resource council (nas/nrc) world war ii veteran twins cohort registry
519506|NCT00282802|World War II Veteran Twins|world war ii veteran twins
519507|NCT00282815|obstructive sleep apnea|obstructive sleep apnea
519508|NCT00282815|stroke|stroke
519509|NCT00282815|OSA|osa
519510|NCT00282815|CPAP|cpap
519511|NCT00282815|continuous positive airway pressure|continuous positive airway pressure
519512|NCT00282828|Social Anxiety Disorder|social anxiety disorder
519513|NCT00282828|Pharmacotherapy|pharmacotherapy
519514|NCT00282828|Genetics|genetics
519515|NCT00282828|Treatment Refractory|treatment refractory
519516|NCT00282841|stroke|stroke
519517|NCT00282841|ultrasound|ultrasound
519518|NCT00282841|occlusion|occlusion
519519|NCT00282841|blockage|blockage
519520|NCT00282841|contrast solution|contrast solution
519521|NCT00282854|epilepsy|epilepsy
519522|NCT00282854|Rolandic epilepsy|rolandic epilepsy
519523|NCT00282867|stroke|stroke
519524|NCT00282867|acute ischemic stroke|acute ischemic stroke
519525|NCT00282867|hyperglycemia|hyperglycemia
519526|NCT00282867|glucose|glucose
519528|NCT00282867|insulin and potassium therapy|insulin and potassium therapy
519529|NCT00282867|GIK|gik
519530|NCT00282893|aneurysm|aneurysm
519531|NCT00282893|vasospasm|vasospasm
519532|NCT00282893|subarachnoid hemorrhage|subarachnoid hemorrhage
519533|NCT00282893|transluminal ballooning|transluminal ballooning
519534|NCT00282971|Type 2 diabetes melllitus|type 2 diabetes melllitus
519535|NCT00283010|cognitive enhancement|cognitive enhancement
519536|NCT00283010|memory|memory
519537|NCT00283010|auditory memory|auditory memory
519538|NCT00283010|speech|speech
519539|NCT00283010|computerized|computerized
519540|NCT00283010|cognitive decline|cognitive decline
519541|NCT00283023|All selective craniotomy|all selective craniotomy
519542|NCT00283075|intraabdominal cancer (carcinomas)|intraabdominal cancer (carcinomas)
670185|NCT00855920|Gout|gout
518857|NCT00270114|epogen|epogen
519543|NCT00283075|agarose macrobeads|agarose macrobeads
519544|NCT00283075|mouse kidney cancer cells|mouse kidney cancer cells
519545|NCT00283075|cancer cell growth inhibition|cancer cell growth inhibition
519546|NCT00283088|stroke|stroke
519547|NCT00283088|hypothermia|hypothermia
519548|NCT00283088|cooling|cooling
519549|NCT00283088|tissue plasminogen activator|tissue plasminogen activator
519550|NCT00283088|tPA|tpa
519551|NCT00283088|thrombolysis|thrombolysis
519552|NCT00283101|Antigens, CD40|antigens, cd40
519553|NCT00283101|Antibody, Monoclonal|antibody, monoclonal
519554|NCT00283101|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
519555|NCT00283101|Hematologic Diseases|hematologic diseases
519556|NCT00283101|Immunoproliferatic Disorders|immunoproliferatic disorders
519557|NCT00283101|Lymphatic Diseases|lymphatic diseases
519558|NCT00283101|Lymphoproliferative Disorders|lymphoproliferative disorders
519559|NCT00283101|Leukemia|leukemia
519560|NCT00283114|Lintuzumab|lintuzumab
519561|NCT00283114|Antigens, CD33|antigens, cd33
519562|NCT00283114|Antibodies, Monoclonal|antibodies, monoclonal
519563|NCT00283114|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
519564|NCT00283114|Myelodysplastic Syndromes|myelodysplastic syndromes
519565|NCT00283114|Hematologic Diseases|hematologic diseases
519566|NCT00283114|Myeloproliferative Disorders|myeloproliferative disorders
519567|NCT00283114|Leukemia|leukemia
519568|NCT00283127|Chlamydia trachomatis|chlamydia trachomatis
519569|NCT00283127|Mass screening|mass screening
519570|NCT00283127|Home sampling|home sampling
519571|NCT00283127|Urine test|urine test
519572|NCT00283153|Traumatic Brain Injury|traumatic brain injury
519573|NCT00283153|Stroke|stroke
519574|NCT00283153|Emotion Recognition|emotion recognition
519575|NCT00283153|Affect|affect
519576|NCT00283153|Interventions|interventions
519577|NCT00283166|Palliative Care|palliative care
519578|NCT00283179|Aripiprazole|aripiprazole
519579|NCT00283179|Risperidone|risperidone
519580|NCT00283179|Schizophrenia|schizophrenia
519581|NCT00283179|Schizoaffective disorder|schizoaffective disorder
519582|NCT00283192|Menopausal Symptoms|menopausal symptoms
519583|NCT00283192|Hot flashes|hot flashes
519584|NCT00283205|Menopausal Symptoms|menopausal symptoms
519585|NCT00283205|Hot Flashes|hot flashes
519586|NCT00283205|Yoga|yoga
519587|NCT00283231|Hot Flashes|hot flashes
519588|NCT00283231|Menopausal Symptoms|menopausal symptoms
519589|NCT00283231|Paced respiration|paced respiration
519590|NCT00283231|RESPeRATE|resperate
519591|NCT00283244|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
519592|NCT00283244|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
519593|NCT00283257|Problem solving|problem solving
519594|NCT00283257|psychosocial support|psychosocial support
519595|NCT00283270|Mental health|mental health
519596|NCT00283270|Screening|screening
519597|NCT00283270|Elderly|elderly
519598|NCT00283270|Chinese|chinese
519599|NCT00283270|Problem-solving counselling|problem-solving counselling
519600|NCT00283283|Influenza|influenza
519601|NCT00283296|manual wheelchair|manual wheelchair
519602|NCT00283296|assistive technology|assistive technology
519604|NCT00283309|Corticosteroids|corticosteroids
519605|NCT00283309|Riluzole|riluzole
519606|NCT00283309|Memantine|memantine
519607|NCT00283309|Memory|memory
519608|NCT00283322|Heparin Induced Thrombocytopenia|heparin induced thrombocytopenia
519610|NCT00283322|HITT|hitt
519611|NCT00283322|Thrombosis|thrombosis
519612|NCT00283322|Thromboembolism|thromboembolism
519613|NCT00283348|Renal Transplantation|renal transplantation
519614|NCT00283348|Immunosuppression|immunosuppression
519615|NCT00283348|Chronic Rejection|chronic rejection
519616|NCT00283374|Metabolic Syndrome|metabolic syndrome
519617|NCT00283374|Obesity|obesity
519618|NCT00283374|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
519619|NCT00283374|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
519620|NCT00283374|Bariatric Surgery|bariatric surgery
519621|NCT00283387|Primary Hyperoxaluria|primary hyperoxaluria
519622|NCT00283400|subarachnoid hemorrhage|subarachnoid hemorrhage
519623|NCT00283400|SAH|sah
519624|NCT00283400|human albumin|human albumin
519625|NCT00283400|HA|ha
519626|NCT00283400|cerebral vasospasm|cerebral vasospasm
519627|NCT00283400|aneurysm|aneurysm
519628|NCT00283400|neuroprotective|neuroprotective
519629|NCT00283413|Covered Stent System|covered stent system
519630|NCT00283413|Saphenous Vein Graft|saphenous vein graft
519631|NCT00283413|Coronary Artery Bypass[MeSH]|coronary artery bypass[mesh]
519632|NCT00283413|Stents[MeSH]|stents[mesh]
519634|NCT00283439|chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
519635|NCT00283439|CIT|cit
519636|NCT00283439|ICE|ice
519637|NCT00283439|RICE|rice
519638|NCT00283439|Hodgkin's Lymphoma|hodgkin's lymphoma
519639|NCT00283439|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
519640|NCT00283439|CHOP|chop
519641|NCT00283439|ESHAP|eshap
519642|NCT00283439|DHAP|dhap
519643|NCT00283439|R-CHOP|r-chop
519644|NCT00283439|R-ESHAP|r-eshap
519645|NCT00283439|R-DHAP|r-dhap
519646|NCT00283452|Physical activity maintenance|physical activity maintenance
519647|NCT00283452|Interactive phone and mail-based intervention|interactive phone and mail-based intervention
519648|NCT00283452|Older adults|older adults
519649|NCT00283465|Anemia|anemia
519650|NCT00283465|cancer|cancer
519651|NCT00283465|neoplasm|neoplasm
519652|NCT00283465|transfusion|transfusion
519653|NCT00283465|quality of life|quality of life
519654|NCT00283465|tumor response|tumor response
519655|NCT00283465|survival|survival
519656|NCT00283465|chemotherapy|chemotherapy
519657|NCT00283465|hemoglobin|hemoglobin
519658|NCT00283465|standard care|standard care
519659|NCT00283465|epoetin alfa|epoetin alfa
519660|NCT00283465|epoetin|epoetin
519661|NCT00283465|erythropoietin|erythropoietin
519662|NCT00283478|Advanced stage|advanced stage
519663|NCT00283478|Lung cancer|lung cancer
519664|NCT00283491|Iron absorption|iron absorption
519665|NCT00283491|Organic acids|organic acids
519666|NCT00283491|Lactobacillus|lactobacillus
519667|NCT00283491|Probiotic|probiotic
519668|NCT00283517|Risperidone long-acting injection|risperidone long-acting injection
519669|NCT00283517|Antipsychotic medication|antipsychotic medication
519670|NCT00283517|Schizophrenia|schizophrenia
519671|NCT00283517|Treatment retention|treatment retention
519672|NCT00283517|Observational study|observational study
519673|NCT00283530|Cancer|cancer
519674|NCT00283530|Cancer receiving chemotherapy|cancer receiving chemotherapy
519675|NCT00283530|Tumor biopsy|tumor biopsy
519676|NCT00283543|Glioma|glioma
519677|NCT00283543|Gliadel Wafer|gliadel wafer
519678|NCT00283556|High Dose Irinotecan|high dose irinotecan
519679|NCT00283556|CPT-11|cpt-11
519680|NCT00283556|Camptosar|camptosar
519681|NCT00283556|Malignant Glioma|malignant glioma
519682|NCT00283556|Unresectable|unresectable
519683|NCT00283569|Glioma|glioma
519684|NCT00283595|Anorexia Nervosa|anorexia nervosa
519685|NCT00283595|Eating disorder|eating disorder
519686|NCT00283595|Bone|bone
519687|NCT00283595|Growth hormone|growth hormone
519688|NCT00283595|Osteopenia|osteopenia
519689|NCT00283595|Osteoporosis|osteoporosis
519690|NCT00283608|stage I breast cancer|stage i breast cancer
519691|NCT00283608|stage II breast cancer|stage ii breast cancer
519692|NCT00283608|stage IIIA breast cancer|stage iiia breast cancer
519693|NCT00283608|stage IIIB breast cancer|stage iiib breast cancer
519694|NCT00283608|stage IIIC breast cancer|stage iiic breast cancer
519695|NCT00283621|Aranesp|aranesp
519696|NCT00283621|Darbepoetin Alfa|darbepoetin alfa
519697|NCT00283621|Pegfilgrastim|pegfilgrastim
519698|NCT00283621|Neulasta|neulasta
519699|NCT00283621|Sarcoma|sarcoma
519700|NCT00283621|Adriamycin|adriamycin
519701|NCT00283621|Doxorubicin Hydrocholoride|doxorubicin hydrocholoride
519702|NCT00283621|Adriamycin PFS|adriamycin pfs
519703|NCT00283621|Adriamycin RDF|adriamycin rdf
519704|NCT00283621|Ifosfamide|ifosfamide
519705|NCT00283647|lead exposure|lead exposure
519706|NCT00283647|magnetic resonance imaging|magnetic resonance imaging
519707|NCT00283647|magnetic resonance spectroscopy|magnetic resonance spectroscopy
519708|NCT00283647|functional magnetic resonance|functional magnetic resonance
519709|NCT00283647|brain development|brain development
519710|NCT00283660|Zinc|zinc
519711|NCT00283660|Dietary Supplements|dietary supplements
519712|NCT00283660|Nutritional Supplements|nutritional supplements
519714|NCT00283660|Mental Health|mental health
519715|NCT00283660|School|school
519716|NCT00283660|Guatemala|guatemala
519717|NCT00283686|polycystic kidney disease|polycystic kidney disease
519718|NCT00283686|polycystic|polycystic
519719|NCT00283686|kidney|kidney
519720|NCT00283686|disease|disease
519721|NCT00283686|adpkd|adpkd
519722|NCT00283686|halt|halt
519724|NCT00283686|blood pressure|blood pressure
519725|NCT00283686|bp|bp
519726|NCT00283686|hypertension|hypertension
519727|NCT00283686|renal|renal
519728|NCT00283686|renin-angiotensin-aldosterone-system|renin-angiotensin-aldosterone-system
519729|NCT00283686|RAAS|raas
519730|NCT00283699|neurocysticercosis|neurocysticercosis
519731|NCT00283699|albendazole|albendazole
519732|NCT00283699|tape worm|tape worm
519733|NCT00283712|Skin Diseases|skin diseases
519734|NCT00283712|Autoimmune Diseases|autoimmune diseases
519735|NCT00283725|Dementia|dementia
519736|NCT00283725|Alzheimer's Disease|alzheimer's disease
519737|NCT00283725|Acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
519738|NCT00283725|Galantamine|galantamine
519739|NCT00283725|Nursing Home Admission|nursing home admission
519740|NCT00283738|migraine|migraine
519741|NCT00283738|aura|aura
519742|NCT00283738|Patent Foramen Ovale (PFO)|patent foramen ovale (pfo)
519743|NCT00283738|cardiac defects|cardiac defects
519744|NCT00283738|Heart Septal Defects, Atrial|heart septal defects, atrial
519745|NCT00283738|Cephalalgia|cephalalgia
519746|NCT00283777|insulin|insulin
519747|NCT00283777|glucose|glucose
519748|NCT00283777|body weight|body weight
519119|NCT00270985|CRP|crp
519749|NCT00283777|chromium|chromium
519750|NCT00283816|Polycystic Ovary Syndrome|polycystic ovary syndrome
519751|NCT00283816|Overweight Adolescent Girls|overweight adolescent girls
519752|NCT00283816|Irregular Menstrual Cycles|irregular menstrual cycles
519753|NCT00283829|Immunotherapy|immunotherapy
519754|NCT00283842|neuropathic pain|neuropathic pain
519755|NCT00283842|diabetic peripheral neuropathy|diabetic peripheral neuropathy
519756|NCT00283855|Rheumatoid Arthritis|rheumatoid arthritis
519757|NCT00283855|Self-Management|self-management
519758|NCT00283855|Internet|internet
519759|NCT00283868|stroke|stroke
519760|NCT00283868|digital video|digital video
519761|NCT00283868|SPOTRIAS|spotrias
519762|NCT00283881|Haptic Skills|haptic skills
519763|NCT00283881|Implicit Tactile Learning|implicit tactile learning
519764|NCT00283881|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
519765|NCT00283881|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
519766|NCT00283881|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
519767|NCT00283881|Stroke|stroke
519768|NCT00283881|Healthy Volunteer|healthy volunteer
519769|NCT00283881|HV|hv
519770|NCT00283894|Obesity|obesity
519771|NCT00283894|Leptin|leptin
519772|NCT00283894|Sleep Attacks|sleep attacks
519773|NCT00283894|Energy Metabolism|energy metabolism
519774|NCT00283894|Healthy Control|healthy control
519775|NCT00283894|Narcolepsy|narcolepsy
519776|NCT00283894|Healthy Volunteer|healthy volunteer
519777|NCT00283894|HV|hv
519778|NCT00283907|Electroencephalogram (EEG)|electroencephalogram (eeg)
519779|NCT00283907|Sense of Agency|sense of agency
519780|NCT00283907|Coherence|coherence
519781|NCT00283907|Voluntary Movement|voluntary movement
519782|NCT00283907|Self-Agency|self-agency
519783|NCT00283907|Healthy Volunteer|healthy volunteer
519784|NCT00283907|HV|hv
519785|NCT00283920|Pharmacokinetics|pharmacokinetics
519786|NCT00283920|Compartmental Analysis|compartmental analysis
519787|NCT00283920|Distribution Volume|distribution volume
519788|NCT00283920|Identitiability|identitiability
519789|NCT00283920|Healthy Volunteer|healthy volunteer
519790|NCT00283920|HV|hv
519791|NCT00283946|zolpidem|zolpidem
519792|NCT00283946|sleep initiation and maintenance disorders Hypnotics and sedatives|sleep initiation and maintenance disorders hypnotics and sedatives
519793|NCT00283946|double-blind study|double-blind study
519794|NCT00283946|comparative study|comparative study
519795|NCT00283972|Health Outcome Study|health outcome study
519796|NCT00283985|NK/T-cell lymphoma|nk/t-cell lymphoma
519797|NCT00283985|Lymphoma|lymphoma
519798|NCT00283985|L-asparaginase|l-asparaginase
519799|NCT00283985|Nasal NK-cell lymphoma|nasal nk-cell lymphoma
519800|NCT00283985|Nasal-type NK-cell Lymphoma|nasal-type nk-cell lymphoma
519801|NCT00283998|Odontoid|odontoid
519802|NCT00283998|Type II fractures|type ii fractures
519803|NCT00283998|Elderly patients|elderly patients
519804|NCT00283998|Surgical vs. conservative treatment|surgical vs. conservative treatment
519805|NCT00284011|SAMe|same
519806|NCT00284011|AdoMet|adomet
519807|NCT00284011|Methylation|methylation
519808|NCT00284011|Homocysteine|homocysteine
519809|NCT00284011|Dietary Supplement|dietary supplement
519810|NCT00284011|S-Adenosyl-L-Methionine|s-adenosyl-l-methionine
519811|NCT00284024|breastfeeding|breastfeeding
519812|NCT00284024|domperidone|domperidone
519813|NCT00284024|efficacy|efficacy
519814|NCT00284024|randomized controlled trial|randomized controlled trial
519815|NCT00284024|compliance|compliance
519914|NCT00284557|Pediatrics|pediatrics
519816|NCT00284037|obstructive sleep apnea,|obstructive sleep apnea,
519817|NCT00284037|baroreceptors|baroreceptors
519818|NCT00284050|DME|dme
519819|NCT00284050|Diabetic macular edema|diabetic macular edema
519820|NCT00284050|ranibizumab|ranibizumab
519821|NCT00284050|Diabetic macular edema with center involvement|diabetic macular edema with center involvement
519822|NCT00284063|spinal manipulation, zygapophysial joints|spinal manipulation, zygapophysial joints
519823|NCT00284089|Subfoveal CNV, AMD, ranibizumab|subfoveal cnv, amd, ranibizumab
519824|NCT00284102|gas exchange|gas exchange
519825|NCT00284102|dead space|dead space
519826|NCT00284102|respiratory failure|respiratory failure
519827|NCT00284102|ALI/ARDS patients|ali/ards patients
519828|NCT00284115|Gait trainer|gait trainer
519829|NCT00284115|Hemiplegia|hemiplegia
519830|NCT00284115|Rehabilitation|rehabilitation
519831|NCT00284115|Stroke|stroke
519832|NCT00284128|Cardiovascular Disease C14|cardiovascular disease c14
519833|NCT00284128|vascular disease C14.907|vascular disease c14.907
519834|NCT00284128|hypertension C14.907.489|hypertension c14.907.489
519835|NCT00284141|lung|lung
519836|NCT00284141|cancer|cancer
519837|NCT00284141|non-small-cell lung cancer|non-small-cell lung cancer
519838|NCT00284141|metastatic|metastatic
519839|NCT00284141|carcinoma|carcinoma
519840|NCT00284141|lung neoplasm|lung neoplasm
519841|NCT00284141|lung diseases|lung diseases
519842|NCT00284141|angiogenesis|angiogenesis
519843|NCT00284141|anti-angiogenesis|anti-angiogenesis
754055|NCT01178749|Symptom Distress|symptom distress
670593|NCT00857623|PDN|pdn
519844|NCT00284141|anti-angiogenesis inhibitors|anti-angiogenesis inhibitors
519845|NCT00284141|cancer and other neoplasms|cancer and other neoplasms
519846|NCT00284141|respiratory tract|respiratory tract
519847|NCT00284141|(lung and bronchial) diseases|(lung and bronchial) diseases
519848|NCT00284154|Extensive stage|extensive stage
519849|NCT00284154|Relapsed|relapsed
519850|NCT00284167|tailored|tailored
519851|NCT00284167|web-based|web-based
519852|NCT00284167|weight management|weight management
519853|NCT00284167|obesity|obesity
519854|NCT00284167|efficacy|efficacy
519855|NCT00284180|Breast Neoplasms|breast neoplasms
519856|NCT00284180|Breast Cancer|breast cancer
519857|NCT00284180|Vinflunine|vinflunine
519858|NCT00284180|Vinca Alkaloid|vinca alkaloid
519859|NCT00284180|Javlor|javlor
519860|NCT00284206|methamphetamine, cognition, outpatient, risperidone|methamphetamine, cognition, outpatient, risperidone
519861|NCT00284219|rTMS, smoking, dopamine, acotinine|rtms, smoking, dopamine, acotinine
519862|NCT00284232|HbA1c|hba1c
519863|NCT00284232|Self-monitoring blood glucose (SMBG)|self-monitoring blood glucose (smbg)
519864|NCT00284232|Diabetes treatment|diabetes treatment
519865|NCT00284232|quality of care|quality of care
519866|NCT00284245|Chronic Pain|chronic pain
519867|NCT00284245|Pain|pain
519868|NCT00284245|Computer Analysis|computer analysis
519869|NCT00284245|Pain Diagrams|pain diagrams
519870|NCT00284258|Colorectal Cancer|colorectal cancer
519871|NCT00284271|Hodgkin´s Lymphoma|hodgkin´s lymphoma
519872|NCT00284271|eldery patients|eldery patients
519873|NCT00284271|primary diagnosis|primary diagnosis
519874|NCT00284310|Wrist surgery: 4-corner arthrodesis or proximal row carpectomy|wrist surgery: 4-corner arthrodesis or proximal row carpectomy
519875|NCT00284323|Acute Myocardial Infarction|acute myocardial infarction
519876|NCT00284323|PCI|pci
519877|NCT00284323|Adenosine|adenosine
519878|NCT00284323|Postconditioning|postconditioning
519879|NCT00284336|breast cancer|breast cancer
519880|NCT00284336|elderly|elderly
519881|NCT00284336|adjuvant chemotherapy|adjuvant chemotherapy
519882|NCT00284336|Caelyx|caelyx
519883|NCT00284401|Reversed prosthesis|reversed prosthesis
519884|NCT00284440|Visual field progression|visual field progression
519885|NCT00284440|Choroidal blood flow|choroidal blood flow
519886|NCT00284453|ventricular|ventricular
519887|NCT00284453|arrhythmias|arrhythmias
519888|NCT00284453|ICD|icd
519889|NCT00284453|VT storm|vt storm
519890|NCT00284453|ICD patients with VT storm|icd patients with vt storm
519891|NCT00284466|coronary artery disease|coronary artery disease
519892|NCT00284466|cardiac catheterization|cardiac catheterization
519893|NCT00284466|CT coronary angiography|ct coronary angiography
519894|NCT00284466|coronary angiography|coronary angiography
519895|NCT00284479|walking intervention|walking intervention
519896|NCT00284479|cardiovascular risk|cardiovascular risk
519897|NCT00284479|inflammatory markers|inflammatory markers
519898|NCT00284479|aerobic fitness|aerobic fitness
519899|NCT00284479|fatness|fatness
519900|NCT00284492|Women|women
519901|NCT00284492|Acupuncture|acupuncture
519902|NCT00284492|Menopause|menopause
519903|NCT00284492|Hot flashes|hot flashes
519904|NCT00284492|Health related quality of life|health related quality of life
519905|NCT00284505|cytokine|cytokine
519906|NCT00284505|arachnoiditis|arachnoiditis
519907|NCT00284505|neuropathic pain|neuropathic pain
519908|NCT00284505|tumor necrosis factor|tumor necrosis factor
519909|NCT00284531|cardiac transplantation|cardiac transplantation
519910|NCT00284531|allograft rejection|allograft rejection
519911|NCT00284531|anti-CD25|anti-cd25
519912|NCT00284557|Behavioral/Social|behavioral/social
519915|NCT00284557|Preventive Medicine|preventive medicine
519916|NCT00284570|pediatrics|pediatrics
519917|NCT00284570|congenital heart disease|congenital heart disease
519918|NCT00284570|cardiac|cardiac
519919|NCT00284570|cardiopulmonary bypass|cardiopulmonary bypass
519920|NCT00284570|infection|infection
519921|NCT00284570|sepsis|sepsis
519922|NCT00284570|postoperative|postoperative
519923|NCT00284570|marker for infection|marker for infection
519924|NCT00284570|inflammation|inflammation
519925|NCT00284570|cardiac surgery|cardiac surgery
519926|NCT00284583|Morton's Neuroma|morton's neuroma
519927|NCT00284583|Alcohol|alcohol
519928|NCT00284583|Steroid|steroid
519929|NCT00284596|Opening wedge high tibial osteotomy|opening wedge high tibial osteotomy
519930|NCT00284596|Radio Sterometric Analysis|radio sterometric analysis
519931|NCT00284596|Locking screw fixation|locking screw fixation
519932|NCT00284609|Type 2 diabetes,|type 2 diabetes,
519933|NCT00284609|rehabilitation,|rehabilitation,
519934|NCT00284609|quality of life,|quality of life,
519935|NCT00284609|glycaemic control,|glycaemic control,
519936|NCT00284609|lifestyle intervention,|lifestyle intervention,
519937|NCT00284609|patient education,|patient education,
519938|NCT00284609|physical training,|physical training,
519939|NCT00284609|group visits,|group visits,
519940|NCT00284609|reminders|reminders
519941|NCT00284622|HTO|hto
519942|NCT00284622|Arthroscopy|arthroscopy
519943|NCT00284622|Osteoarthritis|osteoarthritis
519944|NCT00284622|Alignement|alignement
519945|NCT00284622|Varus gonarthrosis|varus gonarthrosis
519946|NCT00284648|Achilles tendon|achilles tendon
519947|NCT00284648|Rupture|rupture
519948|NCT00284648|Non-operative|non-operative
519949|NCT00284648|Operative|operative
519950|NCT00284661|Meniscal repair|meniscal repair
519951|NCT00284661|Meniscal suturing|meniscal suturing
519952|NCT00284661|Meniscal tear|meniscal tear
519953|NCT00284687|bone marrow transplantation|bone marrow transplantation
519955|NCT00284700|Helicobacter pylori|helicobacter pylori
519956|NCT00284700|Iron deficiency anemia|iron deficiency anemia
519957|NCT00284700|children|children
519958|NCT00284726|Cytokines in lung transplantation|cytokines in lung transplantation
519959|NCT00284726|Cold storage solutions|cold storage solutions
519960|NCT00284726|Ischemic reperfusion injury|ischemic reperfusion injury
519961|NCT00284752|Prostate|prostate
519962|NCT00284752|Cancer|cancer
519963|NCT00284752|Metastatic|metastatic
519964|NCT00284778|lung cancer|lung cancer
519965|NCT00284778|second line treatment|second line treatment
519966|NCT00284778|cost-minimization trial|cost-minimization trial
519967|NCT00284778|Pharmaco-economic study|pharmaco-economic study
519968|NCT00284778|docetaxel|docetaxel
519969|NCT00284778|pemetrexed|pemetrexed
519970|NCT00284804|relapsed or refractory Hodgkin's Disease|relapsed or refractory hodgkin's disease
519971|NCT00284830|Right Ventricular Pacing|right ventricular pacing
519972|NCT00284830|Persistent Atrial Fibrillation|persistent atrial fibrillation
519973|NCT00284830|Atrioventricular Conduction|atrioventricular conduction
519974|NCT00284830|Heart Failure Hospitalization|heart failure hospitalization
519975|NCT00284830|Cardiovascular Health Care Utilization|cardiovascular health care utilization
519976|NCT00284830|Sinus-node Disease|sinus-node disease
519977|NCT00284830|Minimized Ventricular Pacing|minimized ventricular pacing
519978|NCT00284843|Streptococcus, Fiji, pyoderma, scabies, rheumatic disease|streptococcus, fiji, pyoderma, scabies, rheumatic disease
519979|NCT00284869|LPS|lps
519980|NCT00284869|ethnicity|ethnicity
519981|NCT00284869|neutrophils|neutrophils
519982|NCT00284869|TNF|tnf
519983|NCT00284882|Streptococcus, Fiji, pyoderma, pharyngitis, scabies|streptococcus, fiji, pyoderma, pharyngitis, scabies
519984|NCT00284895|Obesity|obesity
519985|NCT00284895|Bariatric Surgery|bariatric surgery
519986|NCT00284895|Weight Loss Surgery|weight loss surgery
519987|NCT00284895|Asthma|asthma
519988|NCT00284908|S-Tenatoprazole-Na|s-tenatoprazole-na
519989|NCT00284908|Pharmacokinetic|pharmacokinetic
519990|NCT00284908|intragastric pH recording|intragastric ph recording
519991|NCT00284908|dose-response|dose-response
519992|NCT00284921|kidney transplant, hepatitis C, enteric-coated mycophenolate sodium|kidney transplant, hepatitis c, enteric-coated mycophenolate sodium
519993|NCT00284934|Dose optimization|dose optimization
519994|NCT00284934|immune suppressive regimen|immune suppressive regimen
519995|NCT00284934|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
519996|NCT00284934|EC-MPS|ec-mps
519997|NCT00284934|renal transplantation|renal transplantation
519998|NCT00284934|kidney|kidney
519999|NCT00284934|transplant|transplant
520000|NCT00284934|maintenance patients|maintenance patients
520001|NCT00284934|Renal transplantation in maintenance|renal transplantation in maintenance
520002|NCT00284947|Side effects|side effects
520003|NCT00284947|calcineurin inhibitors|calcineurin inhibitors
520004|NCT00284947|maintenance|maintenance
520005|NCT00284947|basiliximab|basiliximab
15646|NCT03191006|effect|effect
520006|NCT00284947|Kidney maintenance transplant|kidney maintenance transplant
520007|NCT00284960|erectile dysfunction|erectile dysfunction
520008|NCT00284960|metabolic syndrome|metabolic syndrome
520009|NCT00284960|insulin resistance|insulin resistance
520010|NCT00284960|etiology|etiology
520011|NCT00284973|malaria|malaria
520012|NCT00284986|GVHD|gvhd
520013|NCT00284986|Graft vs Host Disease|graft vs host disease
520014|NCT00284986|Graft versus Host Disease|graft versus host disease
520015|NCT00285012|smoking cessation|smoking cessation
520016|NCT00285012|smoking cessation in COPD|smoking cessation in copd
520017|NCT00285025|Alzheimer disease|alzheimer disease
520018|NCT00285025|nerve growth factors|nerve growth factors
520019|NCT00285025|Clinical Trial|clinical trial
520020|NCT00285038|Deep vein thrombosis|deep vein thrombosis
520021|NCT00285038|Gynecological cancer|gynecological cancer
520022|NCT00285051|emesis, nausea,|emesis, nausea,
520023|NCT00285064|MDCT|mdct
520024|NCT00285064|viability|viability
520025|NCT00285077|Alzheimer disease|alzheimer disease
520026|NCT00285077|nerve growth factors|nerve growth factors
520027|NCT00285077|Clinical Trial|clinical trial
520028|NCT00285090|Burn Injury|burn injury
520030|NCT00285090|Vitamin D|vitamin d
520031|NCT00285090|Bone Mineral Density|bone mineral density
520032|NCT00285103|Antisense, mRNA antagonist, Bcl-2, CLL|antisense, mrna antagonist, bcl-2, cll
520033|NCT00285142|rosiglitazone|rosiglitazone
520034|NCT00285142|insulin secretion|insulin secretion
520035|NCT00285142|clinical trial|clinical trial
520036|NCT00285142|healthy|healthy
520037|NCT00285142|persons|persons
520038|NCT00285155|bupropion|bupropion
520039|NCT00285155|repeated dose|repeated dose
520040|NCT00285155|healthy volunteers|healthy volunteers
520041|NCT00285155|cognitive function|cognitive function
520042|NCT00285155|behaviour|behaviour
520043|NCT00285155|tolerance|tolerance
520044|NCT00285155|Persons|persons
520045|NCT00285168|Osteoporosis|osteoporosis
520046|NCT00285168|Fractures, Bone|fractures, bone
520047|NCT00285168|Bone Mineral Density|bone mineral density
520048|NCT00285181|persons|persons
520049|NCT00285207|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
520050|NCT00285207|High-grade Cervical Intraepithelial Neoplasia|high-grade cervical intraepithelial neoplasia
520051|NCT00285207|High-grade Squamous Intraepithelial Lesions (HSIL)|high-grade squamous intraepithelial lesions (hsil)
520052|NCT00285207|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
520053|NCT00285207|High-Grade Cervical Intraepithelial Lesions (CIN 2/3)|high-grade cervical intraepithelial lesions (cin 2/3)
520055|NCT00275210|Chemotherapy,adjuvant|chemotherapy,adjuvant
520056|NCT00275210|Colonic Neoplasms|colonic neoplasms
520057|NCT00275223|adipose tissue|adipose tissue
520058|NCT00275223|adipocytokines|adipocytokines
520059|NCT00275236|Idiopthic Restless Legs Syndrome|idiopthic restless legs syndrome
520060|NCT00275249|Chronic Pain|chronic pain
520061|NCT00275262|Bone marrow transplantation|bone marrow transplantation
520062|NCT00275262|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
520063|NCT00275262|Hodgkin's disease|hodgkin's disease
520064|NCT00275262|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
520065|NCT00275262|multiple myeloma|multiple myeloma
520067|NCT00275275|Parkinson's|parkinson's
520068|NCT00275288|Borderline Personality Disorder|borderline personality disorder
520069|NCT00275288|BPD|bpd
520070|NCT00275288|amygdala|amygdala
520071|NCT00275288|facial expression response|facial expression response
520072|NCT00275288|MRI|mri
520073|NCT00275301|Borderline Personality Disorder|borderline personality disorder
520074|NCT00275301|BPD|bpd
520075|NCT00275301|PET|pet
520076|NCT00275301|olanzapine|olanzapine
520077|NCT00275301|brain|brain
520078|NCT00275314|transplantation|transplantation
520079|NCT00275327|antibiotics|antibiotics
520080|NCT00275340|Pain|pain
520081|NCT00275340|Depressive Symptoms|depressive symptoms
520082|NCT00275340|Coronary Artery Bypass|coronary artery bypass
520083|NCT00275340|Convalescence|convalescence
520084|NCT00275340|Quality of Life|quality of life
520085|NCT00275340|Human Activities|human activities
520086|NCT00275366|cuff, rotator|cuff, rotator
520087|NCT00275366|Rotator cuff|rotator cuff
520088|NCT00275379|Cystitis|cystitis
520089|NCT00275392|Dizziness|dizziness
520090|NCT00275392|Geriatrics|geriatrics
520091|NCT00275392|Rehabilitation|rehabilitation
520092|NCT00275392|Vestibular rehabilitation|vestibular rehabilitation
520093|NCT00275405|Effects of Garlic|effects of garlic
520094|NCT00275418|Crohn's disease|crohn's disease
520095|NCT00275418|remission|remission
520096|NCT00275418|beta carotene|beta carotene
520097|NCT00275431|cancer|cancer
520098|NCT00275431|AT-101|at-101
520099|NCT00275431|AT101|at101
520100|NCT00275431|B-cell malignancies|b-cell malignancies
520101|NCT00275431|Non-Hodgkin|non-hodgkin
520102|NCT00275431|lymphoma|lymphoma
520103|NCT00275431|lukemia|lukemia
520104|NCT00275496|SLND|slnd
520105|NCT00275496|Sentinel|sentinel
520106|NCT00275496|Melanoma|melanoma
520107|NCT00275496|Surgical|surgical
520108|NCT00275509|kidney|kidney
520109|NCT00275509|transplantation|transplantation
520110|NCT00275509|positive crossmatch|positive crossmatch
520111|NCT00275509|antibody mediated rejection|antibody mediated rejection
520112|NCT00275509|rejection|rejection
520113|NCT00275509|induction|induction
520115|NCT00275509|trial|trial
520116|NCT00275535|kidney transplantation|kidney transplantation
520215|NCT00285558|peer group|peer group
520117|NCT00275535|immunosuppression|immunosuppression
520118|NCT00275535|calcineurin inhibitor|calcineurin inhibitor
520119|NCT00275535|sirolimus|sirolimus
520120|NCT00275535|chronic allograft nephropathy|chronic allograft nephropathy
520121|NCT00275561|Eosinophilic Esophagitis|eosinophilic esophagitis
520122|NCT00275561|Fluticasone|fluticasone
520123|NCT00275561|Dysphagia|dysphagia
520124|NCT00275730|indometacine|indometacine
520125|NCT00275730|retinal blood flow|retinal blood flow
520126|NCT00275730|choroidal blood flow|choroidal blood flow
520127|NCT00275756|Ocular Physiology|ocular physiology
520128|NCT00275756|Brimonidine|brimonidine
520129|NCT00275756|Timoptic|timoptic
520130|NCT00275756|Dorzolamide|dorzolamide
520131|NCT00275756|ocular blood flow|ocular blood flow
520132|NCT00275756|Regional Blood Flow|regional blood flow
520133|NCT00275769|Arrhythmia|arrhythmia
520134|NCT00275769|Bradycardia|bradycardia
520135|NCT00275769|Cardiac Pacemaker Artificial|cardiac pacemaker artificial
520136|NCT00275795|NST-NAET testing|nst-naet testing
520137|NCT00275795|Food Ssensitivities|food ssensitivities
520138|NCT00275795|Eczema|eczema
520139|NCT00275795|Acne|acne
520140|NCT00275795|Indigestion|indigestion
520141|NCT00275821|Age-related macular degeneration, ranibizumab|age-related macular degeneration, ranibizumab
520142|NCT00275834|obesity treatment|obesity treatment
520143|NCT00275834|weight loss|weight loss
520144|NCT00275834|antiobesity drugs|antiobesity drugs
520145|NCT00275834|zonisamide|zonisamide
520146|NCT00285246|combat disorders|combat disorders
520147|NCT00285246|stress, psychological|stress, psychological
520148|NCT00285246|somatoform disorders|somatoform disorders
520149|NCT00285246|life change events|life change events
520150|NCT00285246|utilization|utilization
520151|NCT00285259|cytomegalovirus infection|cytomegalovirus infection
520152|NCT00285259|infectious disease|infectious disease
520153|NCT00285259|viremia|viremia
520154|NCT00285259|cytomegalovirus disease|cytomegalovirus disease
520155|NCT00285259|stem cell transplant|stem cell transplant
520156|NCT00285259|allogeneic|allogeneic
520157|NCT00285259|bone marrow transplant|bone marrow transplant
520158|NCT00285259|hematopoietic cell transplant|hematopoietic cell transplant
520159|NCT00285259|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
520160|NCT00285259|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
520161|NCT00285259|Acute Myelogenous Leukemia|acute myelogenous leukemia
520162|NCT00285259|Hodgkin's Lymphoma|hodgkin's lymphoma
520163|NCT00285259|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
520164|NCT00285259|Myelodysplastic Syndrome|myelodysplastic syndrome
520165|NCT00285285|Point-of-care Testing|point-of-care testing
520166|NCT00285285|Pediatric Emergency Department|pediatric emergency department
520167|NCT00285285|Length of Stay|length of stay
520168|NCT00285285|Efficiency|efficiency
520169|NCT00285298|proteinuria|proteinuria
520170|NCT00285298|Kidney failure, chronic|kidney failure, chronic
520171|NCT00285324|Glioma|glioma
520172|NCT00285324|Glioblastoma Multiforme|glioblastoma multiforme
520173|NCT00285324|Brain Cancer|brain cancer
520174|NCT00285324|Diffusion-Weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
520175|NCT00285324|Brain Tumor|brain tumor
520176|NCT00285337|Myelopathy|myelopathy
520177|NCT00285337|Laminectomy|laminectomy
520178|NCT00285337|Laminoplasty|laminoplasty
520179|NCT00285337|Decompression of Spinal Cord|decompression of spinal cord
520180|NCT00285337|Cervical Spondylosis|cervical spondylosis
520181|NCT00285350|myasthenia gravis|myasthenia gravis
520182|NCT00285363|cancer|cancer
520183|NCT00285363|quality of life|quality of life
520184|NCT00285363|adolescents|adolescents
520185|NCT00285376|Depression. Genetics, Pharmacogenetics|depression. genetics, pharmacogenetics
520186|NCT00285389|Mantle cell lymphoma|mantle cell lymphoma
520187|NCT00285389|Chemotherapy|chemotherapy
520188|NCT00285389|Autologous PBSCT|autologous pbsct
520189|NCT00285389|Molecular evaluation|molecular evaluation
520190|NCT00285402|Migraine|migraine
520191|NCT00285402|Migraine prophylaxis|migraine prophylaxis
520192|NCT00285402|Migraine prevention|migraine prevention
520193|NCT00285402|Chronic migraine treatment|chronic migraine treatment
520194|NCT00285415|Advanced endometrial adenocarcinoma, stage III A, B, C|advanced endometrial adenocarcinoma, stage iii a, b, c
520195|NCT00285428|treatment|treatment
520196|NCT00285428|NHL|nhl
520197|NCT00285428|CD20+ B-cell NHL|cd20+ b-cell nhl
520198|NCT00285428|Lymphoma|lymphoma
520199|NCT00285441|HIV|hiv
520200|NCT00285467|kidney, parathyroid hormone, vitamin d|kidney, parathyroid hormone, vitamin d
520201|NCT00285493|low back pain|low back pain
520202|NCT00285506|Healthy Volunteers|healthy volunteers
520203|NCT00285519|Morning hypertension|morning hypertension
520204|NCT00285532|Blood Lead|blood lead
520205|NCT00285532|Pesticides|pesticides
520206|NCT00285532|Community-based|community-based
520207|NCT00285532|Sampling Kits|sampling kits
520208|NCT00285545|Blood Supply|blood supply
520209|NCT00285545|Mesentery|mesentery
520210|NCT00285558|obesity|obesity
520211|NCT00285558|adolescent|adolescent
520212|NCT00285558|weight loss|weight loss
520213|NCT00285558|body mass index|body mass index
520214|NCT00285558|evaluation studies|evaluation studies
520216|NCT00285558|behavior therapy|behavior therapy
520217|NCT00285558|diet|diet
520218|NCT00285558|exercise|exercise
520219|NCT00285558|self efficacy|self efficacy
520220|NCT00285558|parents|parents
520221|NCT00285584|HIV infection|hiv infection
520222|NCT00285584|Depression|depression
520223|NCT00285584|Men who have sex with men|men who have sex with men
520224|NCT00285584|Drug abuse|drug abuse
520225|NCT00285766|Depression|depression
520226|NCT00285792|Preschool, Physical Activity|preschool, physical activity
520227|NCT00285805|Rosiglitazone|rosiglitazone
520228|NCT00285805|Furosemide|furosemide
520229|NCT00285805|Amiloride|amiloride
520230|NCT00285805|Epithelial sodium channel|epithelial sodium channel
520231|NCT00285805|Sodium excretion|sodium excretion
520232|NCT00285844|obesity|obesity
520233|NCT00285844|insulin resistance|insulin resistance
520234|NCT00285844|thiazolidinedione|thiazolidinedione
520235|NCT00285844|weight loss|weight loss
520236|NCT00285844|adipose tissue|adipose tissue
520237|NCT00285844|metabolic syndrome|metabolic syndrome
520238|NCT00285844|diabetes prevention|diabetes prevention
519609|NCT00283322|HIT|hit
520239|NCT00285844|cardiovascular disease prevention|cardiovascular disease prevention
520240|NCT00285857|duct cytology|duct cytology
520241|NCT00285883|Invirase|invirase
520242|NCT00285883|HIV|hiv
520243|NCT00285883|DOT|dot
520244|NCT00285883|Treatment Experienced|treatment experienced
520245|NCT00285896|GLP-1|glp-1
520246|NCT00285896|fasting|fasting
520247|NCT00285896|hypoglycaemia|hypoglycaemia
520248|NCT00285909|Moderate alcohol consumption|moderate alcohol consumption
520249|NCT00285909|Alcohol dehydrogenase 1c polymorphism|alcohol dehydrogenase 1c polymorphism
520250|NCT00285909|PPAR-gamma activated gene expression|ppar-gamma activated gene expression
520251|NCT00285922|myocardial infarction|myocardial infarction
520252|NCT00285922|electrocardiography|electrocardiography
520253|NCT00285922|myocardial ischemia|myocardial ischemia
520254|NCT00285922|emergency medicine|emergency medicine
520255|NCT00285922|monitoring, physiologic|monitoring, physiologic
520256|NCT00285935|Major Depressive Disorder|major depressive disorder
520257|NCT00285935|MDD|mdd
520258|NCT00285935|Neurobiology|neurobiology
520259|NCT00285935|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
520260|NCT00285935|SSRI|ssri
520261|NCT00285935|Depression|depression
520262|NCT00285961|Fractures of the wrist, forearm, elbow, ankle, foot|fractures of the wrist, forearm, elbow, ankle, foot
520263|NCT00285961|Distortions of the wrist, elbow, ankle|distortions of the wrist, elbow, ankle
520264|NCT00285961|Wounds without tendon injuries|wounds without tendon injuries
520265|NCT00286026|Chlamydia trachomatis|chlamydia trachomatis
520266|NCT00286065|Pain|pain
520267|NCT00286065|Fentanyl|fentanyl
520268|NCT00286065|Analgesics|analgesics
520269|NCT00286065|Opioid|opioid
520270|NCT00286065|Inhalation|inhalation
520271|NCT00286078|Headache|headache
520272|NCT00286078|Migraine|migraine
520273|NCT00286078|Refractory|refractory
520274|NCT00286078|Chronic|chronic
520275|NCT00286078|Pain|pain
520276|NCT00286091|Hormone refractory prostate cancer|hormone refractory prostate cancer
520277|NCT00286091|androgen independent|androgen independent
520278|NCT00286091|ADT|adt
520279|NCT00286091|bone metastasis|bone metastasis
520280|NCT00286104|Ventriculitis|ventriculitis
520281|NCT00286104|External ventricular catheter|external ventricular catheter
520282|NCT00286104|Antibiotic-impregnated|antibiotic-impregnated
520283|NCT00286117|Breast Cancer|breast cancer
520284|NCT00286130|metastatic colorectal cancer|metastatic colorectal cancer
520285|NCT00286130|FOLFOX 6|folfox 6
520286|NCT00286130|FOLFIRI|folfiri
520287|NCT00286156|ADPKD|adpkd
520288|NCT00286169|Extensive-disease small-cell lung cancer (ED-SCLC)|extensive-disease small-cell lung cancer (ed-sclc)
520289|NCT00286182|Heart Failure|heart failure
520290|NCT00286182|Elderly|elderly
520291|NCT00286182|Diastolic Dysfunction|diastolic dysfunction
520292|NCT00286182|Anemia|anemia
520293|NCT00286182|Ventricular End Diastolic Volume|ventricular end diastolic volume
520294|NCT00286182|Aged|aged
520295|NCT00286208|Medical abortion|medical abortion
520296|NCT00286208|mifepristone|mifepristone
520297|NCT00286208|misoprostol|misoprostol
520298|NCT00286234|triglycerides|triglycerides
520299|NCT00286234|HDL-cholesterol|hdl-cholesterol
520300|NCT00286234|insulin resistance|insulin resistance
520301|NCT00286234|omega-3 fatty acids|omega-3 fatty acids
520302|NCT00286234|niacin|niacin
520303|NCT00286260|polyneuropathy|polyneuropathy
520304|NCT00286260|neuropathic pain|neuropathic pain
520305|NCT00286260|levetiracetam|levetiracetam
520306|NCT00286273|kidney failure, acute|kidney failure, acute
520307|NCT00286273|venovenous hemofiltration|venovenous hemofiltration
520308|NCT00286273|hemorrhage|hemorrhage
520309|NCT00286273|heparin, low-molecular-weight|heparin, low-molecular-weight
520310|NCT00286273|nadroparin|nadroparin
520311|NCT00286273|citrates|citrates
520312|NCT00286286|Laparoscopy|laparoscopy
520313|NCT00286286|Laparoscopic Surgical Procedures|laparoscopic surgical procedures
520314|NCT00286286|Laparoscopic Surgery|laparoscopic surgery
520315|NCT00286286|Gastric Bypass|gastric bypass
520316|NCT00286286|Drug Delivery Systems|drug delivery systems
520317|NCT00286286|Pain Measurement|pain measurement
520318|NCT00286299|Schizophrenia|schizophrenia
520319|NCT00286299|Cardiovascular disease|cardiovascular disease
520320|NCT00286299|Aerobic capacity|aerobic capacity
520321|NCT00286299|Mortality|mortality
520322|NCT00286299|Exercise|exercise
520323|NCT00286312|Acute myocardial infarction|acute myocardial infarction
520324|NCT00286312|Primary angioplasty|primary angioplasty
520325|NCT00286312|Reperfusion damage|reperfusion damage
520326|NCT00286312|Atorvastatin|atorvastatin
520327|NCT00286312|Placebo|placebo
520328|NCT00286312|Early left ventricular remodelling|early left ventricular remodelling
520329|NCT00286312|Late left ventricular remodelling|late left ventricular remodelling
520330|NCT00286312|Cardiac MRI|cardiac mri
520331|NCT00286312|Statin|statin
520332|NCT00286312|Transluminal, Percutaneous Coronary|transluminal, percutaneous coronary
520333|NCT00286312|Angioplasty|angioplasty
520334|NCT00286338|Fluid therapy|fluid therapy
520335|NCT00286338|Monitoring|monitoring
520336|NCT00286403|Acute Tubular Necrosis|acute tubular necrosis
520337|NCT00286403|antioxidants|antioxidants
520338|NCT00286403|Fenoldopam|fenoldopam
520339|NCT00286416|AERD|aerd
520340|NCT00286416|aspirin|aspirin
520341|NCT00286416|allergy|allergy
520342|NCT00286416|omalizumab|omalizumab
520343|NCT00286429|Glucose Metabolism Disorder|glucose metabolism disorder
520344|NCT00286429|Dysmetabolic Syndrome|dysmetabolic syndrome
520346|NCT00286429|Diabetes Mellitus|diabetes mellitus
520347|NCT00286429|Lipoatrophic|lipoatrophic
520348|NCT00286429|Dyslipidemia|dyslipidemia
520349|NCT00286429|Drug Therapy|drug therapy
520350|NCT00286442|Glucose Metabolism Disorder|glucose metabolism disorder
520351|NCT00286442|Dysmetabolic Syndrome|dysmetabolic syndrome
520352|NCT00286442|Type II Diabetes|type ii diabetes
520353|NCT00286442|Diabetes Mellitus|diabetes mellitus
520354|NCT00286442|Lipoatrophic|lipoatrophic
520355|NCT00286442|Dyslipidemia|dyslipidemia
520356|NCT00286442|Drug Therapy|drug therapy
520357|NCT00286455|Glucose Metabolism Disorder|glucose metabolism disorder
520358|NCT00286455|Dysmetabolic Syndrome|dysmetabolic syndrome
520359|NCT00286455|Type II Diabetes; Diabetes Mellitus|type ii diabetes; diabetes mellitus
520360|NCT00286455|Lipoatrophic|lipoatrophic
520361|NCT00286455|Dyslipidemia|dyslipidemia
520362|NCT00286455|Drug Therapy|drug therapy
520363|NCT00286468|Glucose Metabolism Disorder|glucose metabolism disorder
520364|NCT00286468|Dysmetabolic Syndrome|dysmetabolic syndrome
520365|NCT00286468|Type II Diabetes|type ii diabetes
520366|NCT00286468|Diabetes Mellitus|diabetes mellitus
520367|NCT00286468|Lipoatrophic|lipoatrophic
520368|NCT00286468|Dyslipidemia|dyslipidemia
520369|NCT00286468|Drug Therapy|drug therapy
520370|NCT00286481|Hyperlipidemia|hyperlipidemia
520371|NCT00286481|Drug Therapy|drug therapy
520372|NCT00286494|Glucose Metabolism Disorder|glucose metabolism disorder
520373|NCT00286494|Dysmetabolic Syndrome|dysmetabolic syndrome
520374|NCT00286494|Type II Diabetes|type ii diabetes
520375|NCT00286494|Diabetes Mellitus|diabetes mellitus
520376|NCT00286494|Lipoatrophic|lipoatrophic
520377|NCT00286494|Dyslipidemia|dyslipidemia
520378|NCT00286494|Drug Therapy|drug therapy
520379|NCT00286507|Full thickness macular hole|full thickness macular hole
520380|NCT00286507|Internal limiting membrane (ILM)|internal limiting membrane (ilm)
520381|NCT00286507|Vitreo retinal surgery|vitreo retinal surgery
520382|NCT00286507|Vitrectomy|vitrectomy
520383|NCT00286520|Constipation|constipation
520384|NCT00286520|Fecal incontinence|fecal incontinence
520385|NCT00286520|Spinal cord injury|spinal cord injury
520386|NCT00286520|transanal irrigation|transanal irrigation
520387|NCT00286520|quality of life|quality of life
520388|NCT00286533|Implant|implant
520389|NCT00286546|Testosterone|testosterone
520390|NCT00286546|Major Depression|major depression
520391|NCT00286546|Men|men
520392|NCT00286559|Coronary artery disease|coronary artery disease
520393|NCT00286559|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
520394|NCT00286559|SPECT|spect
520395|NCT00286559|Adenosin|adenosin
520396|NCT00286572|insulin-dependent diabetes mellitus|insulin-dependent diabetes mellitus
520397|NCT00286572|non-insulin-dependent diabetes mellitus|non-insulin-dependent diabetes mellitus
520398|NCT00286572|coronary artery disease|coronary artery disease
520399|NCT00286572|long-term mortality|long-term mortality
520400|NCT00286585|preconditioning|preconditioning
520401|NCT00286585|cardiac protection|cardiac protection
520402|NCT00286585|morbidity|morbidity
520403|NCT00286585|mortality|mortality
520404|NCT00286585|major non-cardiac surgery|major non-cardiac surgery
520405|NCT00286585|cardiac mortality and morbidity|cardiac mortality and morbidity
520406|NCT00286585|high cardiac perioperative risk|high cardiac perioperative risk
520407|NCT00286598|foot ulcer|foot ulcer
520408|NCT00286598|diabetes mellitus|diabetes mellitus
520409|NCT00286598|motor activity|motor activity
520410|NCT00286598|randomized controlled trial|randomized controlled trial
520411|NCT00286598|prevention|prevention
520412|NCT00286611|Amifostine|amifostine
520414|NCT00286637|CSLO|cslo
520415|NCT00286637|SLP|slp
520416|NCT00286637|Perimetry|perimetry
520417|NCT00286637|electrophysiology|electrophysiology
520418|NCT00286637|glaucoma|glaucoma
520419|NCT00286637|macular degeneration|macular degeneration
520420|NCT00286637|retinopathy|retinopathy
520421|NCT00286637|diabetes|diabetes
520422|NCT00286637|macular hole|macular hole
520423|NCT00286650|Paracetamol|paracetamol
520424|NCT00286663|AIH, Autoimmune Hepatitis|aih, autoimmune hepatitis
520425|NCT00286702|splints|splints
520426|NCT00286702|Occupational Therapy|occupational therapy
520427|NCT00286728|self-help groups|self-help groups
520428|NCT00286728|referral and consultation|referral and consultation
520429|NCT00286741|Diabetes|diabetes
520430|NCT00286741|Hypertension|hypertension
520431|NCT00286741|Randomized controlled trials|randomized controlled trials
520432|NCT00286741|cost-effectiveness|cost-effectiveness
520433|NCT00286741|health services|health services
520434|NCT00286754|Hypertension|hypertension
671283|NCT00860028|Smoking|smoking
520435|NCT00286754|Behavior modification|behavior modification
520436|NCT00286754|Randomized controlled trial|randomized controlled trial
520437|NCT00286754|Treatment effectiveness|treatment effectiveness
520438|NCT00286754|Telemedicine|telemedicine
520439|NCT00286754|Prevention|prevention
520440|NCT00286767|Opportunistic Infections|opportunistic infections
520441|NCT00286767|Immune Restoration Disease|immune restoration disease
520442|NCT00286767|Mycobacterial Infections|mycobacterial infections
520443|NCT00286767|HIV-1 Infection|hiv-1 infection
520444|NCT00286767|HIV|hiv
520445|NCT00286767|ART Naive|art naive
520446|NCT00286780|AT101|at101
520447|NCT00286780|AT-101|at-101
520448|NCT00286780|cancer|cancer
520449|NCT00286780|lymphoctic|lymphoctic
520450|NCT00286780|lukemia|lukemia
520451|NCT00286780|Rituximab|rituximab
520452|NCT00286793|at-101|at-101
520453|NCT00286793|at101|at101
520454|NCT00286793|cancer|cancer
520455|NCT00286793|hormone refractory|hormone refractory
520456|NCT00286793|prostate|prostate
520457|NCT00286793|docetaxel|docetaxel
520458|NCT00286793|prednisone|prednisone
520459|NCT00286819|early breast cancer,|early breast cancer,
520460|NCT00286819|Fluorouracil|fluorouracil
520461|NCT00286832|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
520462|NCT00286832|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
520463|NCT00286832|PET|pet
520464|NCT00286832|Prognosis|prognosis
520465|NCT00286845|Chemosensitivity|chemosensitivity
520466|NCT00286845|Acute Myeloid Leukemia|acute myeloid leukemia
520467|NCT00286845|Apoptosis|apoptosis
520468|NCT00286845|MiCK Assay|mick assay
520469|NCT00286910|AQP-2|aqp-2
520470|NCT00286910|NPHS2-gene|nphs2-gene
520471|NCT00286923|migraine|migraine
520472|NCT00286923|chronic headache|chronic headache
520473|NCT00286923|hyperexcitability|hyperexcitability
520474|NCT00286923|Magnetic stimulation|magnetic stimulation
520475|NCT00286936|Hip fracture|hip fracture
520476|NCT00286936|delirium|delirium
520477|NCT00286936|sleep disturbance|sleep disturbance
520478|NCT00286936|hypnotic|hypnotic
520479|NCT00286949|Parkinson's disease|parkinson's disease
520480|NCT00286949|executive dysfunction|executive dysfunction
520481|NCT00286949|impairment|impairment
520482|NCT00286949|motor skills|motor skills
520483|NCT00286949|cognitive|cognitive
520484|NCT00286962|Diabetes mellitus, type 1|diabetes mellitus, type 1
520485|NCT00286962|insulin infusion systems|insulin infusion systems
520486|NCT00286962|continuous intraperitoneal insulin infusion|continuous intraperitoneal insulin infusion
520487|NCT00286962|cross-over studies|cross-over studies
520488|NCT00286975|Leadership skills|leadership skills
520489|NCT00286975|Management skills|management skills
520490|NCT00286975|Postgraduate medical education|postgraduate medical education
520491|NCT00286988|Preventative|preventative
520492|NCT00286988|Open-Label|open-label
520493|NCT00286988|Safety/Efficacy|safety/efficacy
520494|NCT00287001|Acquired bilateral nevus of Ota-like macules|acquired bilateral nevus of ota-like macules
520495|NCT00287001|Postinflammatory hyperpigmentation|postinflammatory hyperpigmentation
520496|NCT00287001|Cold air cooling|cold air cooling
520497|NCT00287014|Rift valley fever, Kenya|rift valley fever, kenya
520498|NCT00287027|psychotic disorders|psychotic disorders
520499|NCT00287027|family burden|family burden
520500|NCT00287027|long acting injectible antipsychotic medication|long acting injectible antipsychotic medication
520501|NCT00287040|Breast Cancer|breast cancer
520502|NCT00287040|Mammography|mammography
520503|NCT00287053|divalproex sodium|divalproex sodium
520504|NCT00287053|valproic acid|valproic acid
520505|NCT00287053|food intake|food intake
520506|NCT00287053|energy expenditure|energy expenditure
520507|NCT00287053|posture allocation|posture allocation
15647|NCT03191006|insoles|insoles
520508|NCT00287053|None, the population of study is healthy|none, the population of study is healthy
520509|NCT00287092|Haemophilus influenzae type b;|haemophilus influenzae type b;
520510|NCT00287092|Corynebacterium diphtheriae;|corynebacterium diphtheriae;
520512|NCT00287092|Bordetella pertussis;|bordetella pertussis;
520513|NCT00287092|poliovirus types 1, 2 and 3;|poliovirus types 1, 2 and 3;
520514|NCT00287092|Vero cell;|vero cell;
520515|NCT00287092|Influenza;|influenza;
520516|NCT00287092|Diphtheria|diphtheria
520517|NCT00287105|Chemotherapy|chemotherapy
520518|NCT00287105|Leukemia|leukemia
520519|NCT00287105|Children|children
520520|NCT00287105|Philadelphia chromosome|philadelphia chromosome
520521|NCT00287105|Protein-tyrosine kinase inhibitor|protein-tyrosine kinase inhibitor
520522|NCT00287131|melanoma|melanoma
520523|NCT00287131|metastatic melanoma|metastatic melanoma
520524|NCT00287131|adoptive immunotherapy|adoptive immunotherapy
520525|NCT00287131|IL-2|il-2
520526|NCT00287144|Hypothyroidism|hypothyroidism
520527|NCT00287157|Traumatic Brain Injury|traumatic brain injury
520528|NCT00287157|Actigraphy|actigraphy
520529|NCT00287157|Spasticity, Cognition and Functioning|spasticity, cognition and functioning
520530|NCT00287170|Crohn's Disease|crohn's disease
520531|NCT00287170|Local Ileal Delivery|local ileal delivery
520532|NCT00287170|Delayed-Release Formulations|delayed-release formulations
520533|NCT00287170|6-Mercaptopurine|6-mercaptopurine
520534|NCT00287170|Calcitriol|calcitriol
520535|NCT00287196|Melanoma|melanoma
520536|NCT00287196|Lymph node disease|lymph node disease
520537|NCT00287196|Adjuvant radiotherapy|adjuvant radiotherapy
520538|NCT00287196|Lymphoedema|lymphoedema
520539|NCT00287209|RASCABG 1 - study|rascabg 1 - study
520540|NCT00287209|Postoperative atrial fibrillation|postoperative atrial fibrillation
520541|NCT00287209|Randomized, controlled trial|randomized, controlled trial
520543|NCT00287222|Inoperable and Metastatic Hepatocellular Carcinoma|inoperable and metastatic hepatocellular carcinoma
520544|NCT00287235|Hepatic Encephalopathy|hepatic encephalopathy
520545|NCT00287235|End Stage Liver Disease|end stage liver disease
520546|NCT00287235|Cirrhosis|cirrhosis
520548|NCT00287235|Albumin Dialysis|albumin dialysis
520549|NCT00287248|Alzheimer|alzheimer
520550|NCT00287248|Alzheimer disease|alzheimer disease
520551|NCT00287248|Alzheimer disease (AD)|alzheimer disease (ad)
520552|NCT00287261|myelofibrosis|myelofibrosis
520553|NCT00287261|D009191|d009191
520554|NCT00287287|Lenalidomide|lenalidomide
520555|NCT00287287|Clinical Trials phase II|clinical trials phase ii
520556|NCT00287287|Carcinomas, thyroid|carcinomas, thyroid
520557|NCT00287287|Radioiodine-Unresponsive Papillary & Follicular Thyroid Carcinomas|radioiodine-unresponsive papillary & follicular thyroid carcinomas
520558|NCT00287300|Malaria|malaria
520559|NCT00287300|Pregnancy|pregnancy
520560|NCT00287300|Efficacy|efficacy
520561|NCT00287300|Azithromycin|azithromycin
520562|NCT00287300|Artesunate|artesunate
520563|NCT00287313|Unstable INRs|unstable inrs
520564|NCT00287313|Warfarin|warfarin
520565|NCT00287313|Vitamin K|vitamin k
520566|NCT00287326|Epidural|epidural
520567|NCT00287326|Bupivacaine|bupivacaine
520568|NCT00287326|Clonidine|clonidine
520569|NCT00287339|Cough|cough
520570|NCT00287339|GERD|gerd
520571|NCT00287352|First episode psychosis|first episode psychosis
520572|NCT00287391|Insomnia|insomnia
520573|NCT00287391|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
520574|NCT00287391|Sleep Disturbance|sleep disturbance
520575|NCT00287404|type 2 diabetes|type 2 diabetes
520576|NCT00287404|hyperlipidemia|hyperlipidemia
520577|NCT00287404|dyslipidemia|dyslipidemia
520578|NCT00287404|fasting lipids|fasting lipids
520579|NCT00287404|postprandial lipids|postprandial lipids
520580|NCT00287404|Non-HDL cholesterol|non-hdl cholesterol
520581|NCT00287404|NMR lipoanalysis|nmr lipoanalysis
520582|NCT00287404|ATP III guidelines|atp iii guidelines
520583|NCT00287417|Nucal translucency|nucal translucency
520584|NCT00287417|Down syndrome|down syndrome
520585|NCT00287417|MSS|mss
520586|NCT00287417|Risk assessment|risk assessment
520587|NCT00287469|Hepatitis E|hepatitis e
520588|NCT00287469|clinical hepatitis|clinical hepatitis
520589|NCT00287469|vaccine|vaccine
520590|NCT00287469|efficacy|efficacy
520591|NCT00287469|Nepal|nepal
520592|NCT00287482|Treatment side effects|treatment side effects
520593|NCT00287482|Quality of Life|quality of life
520594|NCT00287482|Transition|transition
520595|NCT00287482|Survivorship|survivorship
520596|NCT00287495|AIDS|aids
520597|NCT00287495|HIV|hiv
520598|NCT00287495|Antiangiogenesis|antiangiogenesis
520599|NCT00287495|VEGF|vegf
520600|NCT00287495|AIDS Malignancy|aids malignancy
520601|NCT00287495|Kaposi Sarcoma|kaposi sarcoma
520602|NCT00287495|KS|ks
520603|NCT00287508|Carotid stenting|carotid stenting
520604|NCT00287508|Carotid endarterectomy|carotid endarterectomy
520605|NCT00287508|Carotid artery disease with severe narrowing of the artery|carotid artery disease with severe narrowing of the artery
520606|NCT00287508|Stroke prevention|stroke prevention
520607|NCT00287508|cerebral infarction|cerebral infarction
520608|NCT00287521|open|open
520609|NCT00287521|angle|angle
520610|NCT00287521|glaucoma|glaucoma
520611|NCT00287521|ocular|ocular
520612|NCT00287521|hypertension|hypertension
520613|NCT00287534|Early Breast Cancer|early breast cancer
520614|NCT00287586|Testosterone Replacement|testosterone replacement
520615|NCT00287586|Heart Disease|heart disease
520616|NCT00287586|Vascular Disease|vascular disease
520617|NCT00287586|Risk Factors for Cardiovascular Disease|risk factors for cardiovascular disease
520618|NCT00287586|Cholesterol|cholesterol
520619|NCT00287586|Obesity|obesity
520620|NCT00287586|Blood pressure|blood pressure
520621|NCT00287586|Quality of Life|quality of life
520622|NCT00287599|Surgical wound infections|surgical wound infections
520623|NCT00287599|Real-time PCR|real-time pcr
520624|NCT00287599|Rapid identification of bacteria|rapid identification of bacteria
520625|NCT00287599|Cloning|cloning
520626|NCT00287599|16S rRNA sequencing|16s rrna sequencing
520627|NCT00287612|GERD|gerd
520628|NCT00287612|Hiatal Hernia|hiatal hernia
520629|NCT00287612|Recurrence|recurrence
520630|NCT00287625|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
520631|NCT00287625|Pulmonary rehabilitation|pulmonary rehabilitation
519954|NCT00284687|CMV disease|cmv disease
520632|NCT00287638|Obstructive sleep apnea|obstructive sleep apnea
520633|NCT00287651|Pulsatile intravenous insulin|pulsatile intravenous insulin
520634|NCT00287651|Oral carbohydrate loading|oral carbohydrate loading
520635|NCT00287651|Respiratory Quotients|respiratory quotients
520636|NCT00287651|Hypoglycemia|hypoglycemia
520637|NCT00287664|hepatorenal syndrome|hepatorenal syndrome
520639|NCT00287664|albumin|albumin
520640|NCT00287664|cirrhosis|cirrhosis
520641|NCT00287677|Growth Hormone|growth hormone
520642|NCT00287677|HIV-1|hiv-1
520643|NCT00287677|Vaccination|vaccination
520644|NCT00287677|Thymopoiesis|thymopoiesis
520645|NCT00287677|HIV-specific responses|hiv-specific responses
520646|NCT00287677|Treatment Experienced|treatment experienced
520647|NCT00287690|arteries|arteries
520648|NCT00287690|blood flow|blood flow
520649|NCT00287690|coronary artery disease|coronary artery disease
520650|NCT00287690|diet|diet
520651|NCT00287703|Major depression|major depression
520652|NCT00287703|Treatment resistant|treatment resistant
520653|NCT00287703|PEMF|pemf
520654|NCT00287703|AQT|aqt
520655|NCT00287703|Hamilton|hamilton
520656|NCT00287716|Idiopathic|idiopathic
520657|NCT00287716|Pulmonary|pulmonary
520658|NCT00287716|Fibrosis|fibrosis
520659|NCT00287716|Lung|lung
520660|NCT00287716|Pirfenidone|pirfenidone
520661|NCT00287716|InterMune|intermune
520662|NCT00287729|Idiopathic|idiopathic
520663|NCT00287729|Pulmonary|pulmonary
520664|NCT00287729|Fibrosis|fibrosis
520665|NCT00287729|Lung|lung
520666|NCT00287729|Pirfenidone|pirfenidone
520667|NCT00287729|InterMune|intermune
520668|NCT00287742|risperidone|risperidone
520669|NCT00287742|antipsychotic agents|antipsychotic agents
520670|NCT00287742|Alzheimer's disease|alzheimer's disease
520671|NCT00287742|dementia|dementia
520672|NCT00287742|psychosis|psychosis
520673|NCT00287755|gastric cancer|gastric cancer
520675|NCT00287755|chemosensitivity|chemosensitivity
520676|NCT00287755|adjuvant|adjuvant
520677|NCT00287768|gastric cancer|gastric cancer
520678|NCT00287768|advanced gastric cancer|advanced gastric cancer
520679|NCT00287768|S-1|s-1
520680|NCT00287768|docetaxel|docetaxel
520681|NCT00287768|phase III study|phase iii study
520682|NCT00287781|Migraine|migraine
520683|NCT00287781|Lidocaine|lidocaine
520684|NCT00287781|Headache|headache
520685|NCT00287794|rheumatoid arthritis|rheumatoid arthritis
520686|NCT00287794|sleep disturbance|sleep disturbance
520687|NCT00287807|Diabetes mellitus, type 2|diabetes mellitus, type 2
520688|NCT00287807|Blood Glucose Self-Monitoring|blood glucose self-monitoring
520689|NCT00287807|life style|life style
520690|NCT00287820|schizophrenia|schizophrenia
520691|NCT00287820|diabetes|diabetes
520692|NCT00287820|metabolic syndrome|metabolic syndrome
520693|NCT00287820|hyperglycemia|hyperglycemia
520694|NCT00287820|glucose|glucose
520695|NCT00287820|insulin|insulin
520696|NCT00287820|lipids|lipids
520697|NCT00287820|IL-6|il-6
520698|NCT00287820|prolactin|prolactin
520699|NCT00287846|desmoid tumor|desmoid tumor
520700|NCT00287859|fallopian tube cancer|fallopian tube cancer
520701|NCT00287859|peritoneal cavity cancer|peritoneal cavity cancer
520702|NCT00287859|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
520703|NCT00287872|stage II multiple myeloma|stage ii multiple myeloma
520704|NCT00287872|stage III multiple myeloma|stage iii multiple myeloma
520705|NCT00287885|recurrent cervical cancer|recurrent cervical cancer
520706|NCT00287885|stage III cervical cancer|stage iii cervical cancer
520707|NCT00287885|stage IVA cervical cancer|stage iva cervical cancer
520708|NCT00287885|stage IVB cervical cancer|stage ivb cervical cancer
520709|NCT00287885|stage III endometrial carcinoma|stage iii endometrial carcinoma
520710|NCT00287885|recurrent endometrial carcinoma|recurrent endometrial carcinoma
520711|NCT00287885|stage IV endometrial carcinoma|stage iv endometrial carcinoma
520712|NCT00287885|fallopian tube cancer|fallopian tube cancer
520713|NCT00287885|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
520714|NCT00287885|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
520715|NCT00287885|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
520716|NCT00287885|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
520717|NCT00287885|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
520718|NCT00287885|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
520719|NCT00287885|recurrent uterine sarcoma|recurrent uterine sarcoma
520720|NCT00287885|stage III uterine sarcoma|stage iii uterine sarcoma
520721|NCT00287885|stage IV uterine sarcoma|stage iv uterine sarcoma
520722|NCT00287885|stage III vaginal cancer|stage iii vaginal cancer
520723|NCT00287885|recurrent vaginal cancer|recurrent vaginal cancer
520724|NCT00287885|stage IVA vaginal cancer|stage iva vaginal cancer
520725|NCT00287885|stage IVB vaginal cancer|stage ivb vaginal cancer
520726|NCT00287885|stage III vulvar cancer|stage iii vulvar cancer
520727|NCT00287885|recurrent vulvar cancer|recurrent vulvar cancer
520728|NCT00287885|stage IV vulvar cancer|stage iv vulvar cancer
520054|NCT00275210|Oxaliplatin|oxaliplatin
520729|NCT00287885|ovarian sarcoma|ovarian sarcoma
520730|NCT00287885|ovarian stromal cancer|ovarian stromal cancer
520731|NCT00287885|peritoneal cavity cancer|peritoneal cavity cancer
520732|NCT00287898|breast cancer|breast cancer
520733|NCT00287911|cervical adenocarcinoma|cervical adenocarcinoma
520734|NCT00287911|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
520735|NCT00287911|cervical squamous cell carcinoma|cervical squamous cell carcinoma
520736|NCT00287911|stage IB cervical cancer|stage ib cervical cancer
520737|NCT00287911|stage IIA cervical cancer|stage iia cervical cancer
520738|NCT00287911|stage IIB cervical cancer|stage iib cervical cancer
520739|NCT00287911|stage III cervical cancer|stage iii cervical cancer
520740|NCT00287911|stage IVA cervical cancer|stage iva cervical cancer
520741|NCT00287924|childhood infratentorial ependymoma|childhood infratentorial ependymoma
520742|NCT00287924|childhood supratentorial ependymoma|childhood supratentorial ependymoma
520743|NCT00287924|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
520744|NCT00287950|disseminated neuroblastoma|disseminated neuroblastoma
520745|NCT00287950|localized resectable neuroblastoma|localized resectable neuroblastoma
520746|NCT00287950|localized unresectable neuroblastoma|localized unresectable neuroblastoma
520747|NCT00287950|regional neuroblastoma|regional neuroblastoma
520748|NCT00287950|stage 4S neuroblastoma|stage 4s neuroblastoma
520749|NCT00287963|adenocarcinoma of the lung|adenocarcinoma of the lung
520750|NCT00287963|adenosquamous cell lung cancer|adenosquamous cell lung cancer
520751|NCT00287963|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
520752|NCT00287963|combined type small cell lung cancer|combined type small cell lung cancer
520753|NCT00287963|intermediate type small cell lung cancer|intermediate type small cell lung cancer
520754|NCT00287963|large cell lung cancer|large cell lung cancer
520755|NCT00287963|lymphocyte-like type small cell lung cancer|lymphocyte-like type small cell lung cancer
520756|NCT00287963|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
520757|NCT00287963|recurrent small cell lung cancer|recurrent small cell lung cancer
520758|NCT00287963|squamous cell lung cancer|squamous cell lung cancer
520759|NCT00287976|childhood hepatoblastoma|childhood hepatoblastoma
520760|NCT00287976|recurrent childhood liver cancer|recurrent childhood liver cancer
520761|NCT00287989|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
520762|NCT00287989|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
520763|NCT00287989|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
520764|NCT00288002|inflammatory breast cancer|inflammatory breast cancer
520765|NCT00288002|stage II breast cancer|stage ii breast cancer
520766|NCT00288002|stage IIIA breast cancer|stage iiia breast cancer
520767|NCT00288002|stage IIIB breast cancer|stage iiib breast cancer
520768|NCT00288002|stage IIIC breast cancer|stage iiic breast cancer
520769|NCT00288002|stage IA breast cancer|stage ia breast cancer
520770|NCT00288002|stage IB breast cancer|stage ib breast cancer
520771|NCT00288002|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
520772|NCT00288002|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
520773|NCT00288002|HER2-negative breast cancer|her2-negative breast cancer
520774|NCT00288002|HER2-positive breast cancer|her2-positive breast cancer
520775|NCT00288015|adult angiosarcoma|adult angiosarcoma
520776|NCT00288015|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
520777|NCT00288015|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
520778|NCT00288015|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
520779|NCT00288015|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
520780|NCT00288015|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
520781|NCT00288028|stage I multiple myeloma|stage i multiple myeloma
520782|NCT00288028|stage II multiple myeloma|stage ii multiple myeloma
520783|NCT00288028|stage III multiple myeloma|stage iii multiple myeloma
520784|NCT00288028|refractory multiple myeloma|refractory multiple myeloma
520785|NCT00288054|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
520786|NCT00288054|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
520787|NCT00288054|adenocarcinoma of the lung|adenocarcinoma of the lung
520788|NCT00288054|large cell lung cancer|large cell lung cancer
520789|NCT00288054|squamous cell lung cancer|squamous cell lung cancer
520790|NCT00288080|stage III prostate cancer|stage iii prostate cancer
520791|NCT00288080|stage IIB prostate cancer|stage iib prostate cancer
520792|NCT00288080|stage IIA prostate cancer|stage iia prostate cancer
520793|NCT00288080|stage IV prostate cancer|stage iv prostate cancer
520794|NCT00288106|recurrent prostate cancer|recurrent prostate cancer
520795|NCT00288106|stage I prostate cancer|stage i prostate cancer
520796|NCT00288106|stage II prostate cancer|stage ii prostate cancer
520797|NCT00288106|stage III prostate cancer|stage iii prostate cancer
520798|NCT00288106|stage IV prostate cancer|stage iv prostate cancer
520799|NCT00288119|Barrett's Esophagus|barrett's esophagus
520800|NCT00288132|Diabetes|diabetes
520801|NCT00288132|self-management|self-management
520802|NCT00288132|telemedicine|telemedicine
520803|NCT00288132|retinal|retinal
520804|NCT00288132|screening|screening
520805|NCT00288145|worksite|worksite
520806|NCT00288145|weight gain prevention (among adults)|weight gain prevention (among adults)
520807|NCT00288145|obesity (among adults)|obesity (among adults)
520808|NCT00288145|physical activity|physical activity
520809|NCT00288145|nutrition|nutrition
520810|NCT00288210|Myocardial Infarction|myocardial infarction
520811|NCT00288210|Stents|stents
520812|NCT00288210|Sirolimus|sirolimus
520813|NCT00288210|abciximab|abciximab
520814|NCT00288236|Type 2 diabetes mellitus|type 2 diabetes mellitus
520815|NCT00278850|Vulvar vestibulitis|vulvar vestibulitis
520816|NCT00278850|Treatment|treatment
520817|NCT00278850|Education|education
520818|NCT00278863|Stomach cancer|stomach cancer
520819|NCT00278863|Palliative chemotherapy|palliative chemotherapy
520820|NCT00278863|Capecitabine|capecitabine
520822|NCT00278876|GIST|gist
520823|NCT00278876|Imatinib|imatinib
520824|NCT00278876|Adjuvant therapy|adjuvant therapy
520825|NCT00278876|Kit mutation|kit mutation
520826|NCT00278889|Colorectal Cancer|colorectal cancer
520827|NCT00278889|phase II|phase ii
520828|NCT00278889|metastatic colorectal cancer|metastatic colorectal cancer
520829|NCT00278889|AZD2171|azd2171
520830|NCT00278889|RECENTIN|recentin
520831|NCT00278902|ErbB2+ Breast Cancer|erbb2+ breast cancer
520832|NCT00278902|HER2+ Breast Cancer|her2+ breast cancer
520833|NCT00278915|Progressive Precocious Puberty|progressive precocious puberty
520834|NCT00278915|PPP|ppp
520835|NCT00278915|McCune-Albright Syndrome|mccune-albright syndrome
520836|NCT00278915|MAS|mas
520837|NCT00278928|Hypertriglyceridemia|hypertriglyceridemia
520838|NCT00278928|Infant, Premature|infant, premature
520839|NCT00278941|Seroquel SR™|seroquel sr™
520840|NCT00278941|Major Depressive Disorder|major depressive disorder
520841|NCT00278954|Primary Antibody Deficiency|primary antibody deficiency
520842|NCT00278954|Common variable hypogammaglobulinemia|common variable hypogammaglobulinemia
520843|NCT00278954|X-linked hypogammaglobulinemia|x-linked hypogammaglobulinemia
520844|NCT00278954|Hypogammaglobulinemia|hypogammaglobulinemia
520845|NCT00278954|Immunodeficiency with hyper-IgM|immunodeficiency with hyper-igm
520846|NCT00278954|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
520847|NCT00278967|colonoscopy|colonoscopy
520848|NCT00278967|preparation|preparation
520849|NCT00278993|Prostate cancer|prostate cancer
520850|NCT00278993|metastatic disease|metastatic disease
520851|NCT00279006|DES (drug eluting stents)|des (drug eluting stents)
520852|NCT00279006|CAD (cornary artery disease)|cad (cornary artery disease)
520853|NCT00279006|stent retrieval|stent retrieval
520854|NCT00279019|GSK233705|gsk233705
520855|NCT00279019|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
520856|NCT00279019|COPD|copd
520857|NCT00279032|GW406381|gw406381
520858|NCT00279032|peripheral nerve injury|peripheral nerve injury
520859|NCT00279032|patients|patients
520860|NCT00279032|allodynia|allodynia
520861|NCT00279032|hyperalgesia|hyperalgesia
520862|NCT00279032|randomised|randomised
520863|NCT00279032|placebo-controlled|placebo-controlled
520864|NCT00279045|type 2 diabetes monotherapy treatment naive|type 2 diabetes monotherapy treatment naive
520865|NCT00279071|dystocia|dystocia
520866|NCT00279071|stimulation|stimulation
520867|NCT00279071|acupuncture|acupuncture
520868|NCT00279071|oxytocin|oxytocin
520869|NCT00279084|Anaemia|anaemia
520870|NCT00279084|Chronic kidney disease|chronic kidney disease
520871|NCT00279084|Type 2 diabetes|type 2 diabetes
520872|NCT00279084|Randomized trial|randomized trial
520873|NCT00279097|Intracranial pressure|intracranial pressure
520874|NCT00279097|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
520875|NCT00279097|Neurosurgery|neurosurgery
520876|NCT00279110|HIV|hiv
520877|NCT00279110|Antiretroviral therapy|antiretroviral therapy
520878|NCT00279110|Heroin dependence|heroin dependence
520879|NCT00279110|Methadone|methadone
520880|NCT00279110|Buprenorphine|buprenorphine
520881|NCT00279136|Bronchial hyperresponsiveness,|bronchial hyperresponsiveness,
520882|NCT00279136|lung function,|lung function,
520883|NCT00279136|airway inflammation,|airway inflammation,
520884|NCT00279136|deep inspiration,|deep inspiration,
520885|NCT00279136|bronchial biopsies|bronchial biopsies
520886|NCT00279136|airway smooth muscle|airway smooth muscle
520887|NCT00279149|Telemedicine|telemedicine
520888|NCT00279149|TELESTROKE|telestroke
520889|NCT00279149|symptoms of ischemic stroke since less than 3 hours|symptoms of ischemic stroke since less than 3 hours
520890|NCT00279175|Acute myocardial infarction|acute myocardial infarction
520891|NCT00279188|Bronchial hyperresponsiveness|bronchial hyperresponsiveness
520892|NCT00279188|Atopy|atopy
520893|NCT00279188|Inhaled steroids|inhaled steroids
521187|NCT00280800|auto CPAP|auto cpap
520894|NCT00279188|Exacerbations|exacerbations
520895|NCT00279188|Lung function decline|lung function decline
520896|NCT00279188|Prognosis|prognosis
520897|NCT00279201|diabetes|diabetes
520898|NCT00279201|type 2|type 2
520899|NCT00279227|coronary artery disease|coronary artery disease
520900|NCT00279227|epicardial adipose tissue|epicardial adipose tissue
520901|NCT00279227|epicardial fat|epicardial fat
520902|NCT00279227|obesity|obesity
520903|NCT00279240|Impaired glucose tolerance|impaired glucose tolerance
520904|NCT00279240|Intervention|intervention
520905|NCT00279240|Prevention|prevention
520906|NCT00279253|clonidine|clonidine
520907|NCT00279253|glaucoma|glaucoma
523143|NCT00295360|ABCG2|abcg2
520908|NCT00279266|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
520909|NCT00279266|Peripheral Neuropathy|peripheral neuropathy
520910|NCT00279266|Diabetes Mellitus|diabetes mellitus
520911|NCT00279279|Implantable cardioverter defibrillator (ICD)|implantable cardioverter defibrillator (icd)
520912|NCT00279279|Sudden Cardiac Death|sudden cardiac death
520913|NCT00279279|Primary Prevention|primary prevention
520914|NCT00279292|Pancreatic neoplasm|pancreatic neoplasm
520915|NCT00279305|Newly diagnosed type 1 diabetes|newly diagnosed type 1 diabetes
520916|NCT00279305|New Onset type 1 diabetes|new onset type 1 diabetes
520917|NCT00279305|Preservation of insulin secretion|preservation of insulin secretion
520918|NCT00279305|Type 1 diabetes|type 1 diabetes
520919|NCT00279305|Juvenile Onset Diabetes|juvenile onset diabetes
520920|NCT00279305|Insulin Dependent Diabetes|insulin dependent diabetes
520922|NCT00279318|Environment|environment
520923|NCT00279318|Exposures|exposures
520924|NCT00279318|Diet|diet
520925|NCT00279318|Toxins|toxins
520926|NCT00279318|Psychosocial|psychosocial
520927|NCT00279318|Infectious Agents|infectious agents
520928|NCT00279318|Bacterial|bacterial
520929|NCT00279318|Viral|viral
520930|NCT00279318|Immunizations|immunizations
520931|NCT00279318|Autoantibody|autoantibody
520932|NCT00279331|HIV Seronegativity|hiv seronegativity
520933|NCT00279331|Men who have Sex with Men|men who have sex with men
520934|NCT00279331|MSM|msm
520935|NCT00279331|Peru|peru
520936|NCT00279331|Ecuador|ecuador
520937|NCT00279331|Incidence|incidence
520938|NCT00279331|Prevalence|prevalence
520939|NCT00279331|Drug resistance, viral|drug resistance, viral
520940|NCT00279357|NBI|nbi
520941|NCT00279357|high risk group for adenomas|high risk group for adenomas
520942|NCT00279370|SSRI Exposure|ssri exposure
520943|NCT00279370|Pregnancy|pregnancy
520944|NCT00279370|Infant Development|infant development
520945|NCT00279383|Intra-operatively treated patients with hemostatic supporting agents/techniques in addition to the standard surgical procedures|intra-operatively treated patients with hemostatic supporting agents/techniques in addition to the standard surgical procedures
520946|NCT00279409|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
520947|NCT00279409|ADHD|adhd
520948|NCT00279409|Treatment resistant|treatment resistant
520949|NCT00279409|Partial responder|partial responder
520950|NCT00279409|Non-responder|non-responder
520951|NCT00279409|Atypical Antipsychotic|atypical antipsychotic
520952|NCT00279422|Intravenous, Steroid-Refractory, Ulcerative Colitis|intravenous, steroid-refractory, ulcerative colitis
520953|NCT00279435|Intravenous, Steroid-Refractory, Ulcerative Colitis|intravenous, steroid-refractory, ulcerative colitis
520954|NCT00279461|Rheumatoid Arthritis|rheumatoid arthritis
520955|NCT00279461|Vitamin D|vitamin d
520956|NCT00279474|cancer patients|cancer patients
520957|NCT00279474|family|family
520958|NCT00279474|cognitive behavior|cognitive behavior
520959|NCT00279474|distress|distress
520960|NCT00279487|Patients undergoing total knee replacement who received pain management by the following modality:|patients undergoing total knee replacement who received pain management by the following modality:
520961|NCT00279487|IV PCA opioid|iv pca opioid
520962|NCT00279487|Local femoral nerve block with 1.5% Mepivacaine & 0.5% Ropivacaine|local femoral nerve block with 1.5% mepivacaine & 0.5% ropivacaine
520963|NCT00279513|homeopathy|homeopathy
520964|NCT00279513|hallux valgus|hallux valgus
520965|NCT00279513|pain|pain
520966|NCT00279513|traumeel s|traumeel s
520967|NCT00279526|Depression|depression
520968|NCT00279526|Health services utilization|health services utilization
520969|NCT00279526|Elderly|elderly
520970|NCT00279526|Primary Care|primary care
520971|NCT00279539|Cardiovascular|cardiovascular
520972|NCT00279539|Gene Therapy|gene therapy
520973|NCT00279539|DNA|dna
520974|NCT00279539|Stem Cells|stem cells
520975|NCT00279539|Congestive Heart Failure|congestive heart failure
520976|NCT00279539|Coronary Artery Disease|coronary artery disease
520977|NCT00279539|CHF|chf
520978|NCT00279539|Cardiomyopathy|cardiomyopathy
520979|NCT00279552|Vitamin B12 deficiency|vitamin b12 deficiency
520980|NCT00279552|Vitamin B12 malabsorption|vitamin b12 malabsorption
520981|NCT00279552|Intrinsic factor|intrinsic factor
520982|NCT00279552|Holotranscobalamin|holotranscobalamin
520983|NCT00279565|buprenorphine|buprenorphine
520984|NCT00279565|methadone|methadone
520985|NCT00279565|Peg-Intron|peg-intron
520986|NCT00279565|Rebetol|rebetol
520987|NCT00279578|haemophilia A|haemophilia a
520988|NCT00279578|thrombelastography|thrombelastography
520989|NCT00279578|recombinant factor VIII|recombinant factor viii
520990|NCT00279578|thrombin generation|thrombin generation
520991|NCT00279630|Tibialis Posterior Tendinopathy|tibialis posterior tendinopathy
520992|NCT00279643|Laser|laser
520993|NCT00279643|immunohistochemical staining|immunohistochemical staining
520345|NCT00286429|Type II Diabetes|type ii diabetes
520994|NCT00279643|Laser Hair Removal|laser hair removal
520995|NCT00279643|follicular stem cells|follicular stem cells
520996|NCT00279643|keratin 15|keratin 15
520997|NCT00279656|Frail elderly|frail elderly
520998|NCT00279656|Pharmaceutical services|pharmaceutical services
520999|NCT00279656|Drug therapy|drug therapy
521000|NCT00279656|Geriatrics|geriatrics
521001|NCT00279656|Randomized controlled trial|randomized controlled trial
521002|NCT00279656|Hospitals, teaching|hospitals, teaching
521003|NCT00279669|Retinopathy of Prematurity|retinopathy of prematurity
521004|NCT00279669|Ultrasound|ultrasound
521005|NCT00279669|Eye|eye
521006|NCT00279682|depression|depression
521007|NCT00279682|suicide|suicide
521008|NCT00279682|geriatric|geriatric
521009|NCT00279682|elderly|elderly
521010|NCT00279682|primary care|primary care
521011|NCT00279695|Glaucoma|glaucoma
521012|NCT00279695|Accommodation|accommodation
521013|NCT00279695|Ocular Tumors|ocular tumors
521014|NCT00279695|Age-Related Macular Degeneration|age-related macular degeneration
521015|NCT00279695|Ultrasound|ultrasound
521016|NCT00279695|Eye|eye
521017|NCT00279708|Granulomatous Inflammation|granulomatous inflammation
521018|NCT00279708|Steroid-Sparing|steroid-sparing
521019|NCT00279708|Pulmonary Function|pulmonary function
521020|NCT00279708|Sarcoidosis, Pulmonary|sarcoidosis, pulmonary
521021|NCT00279708|Statins (Atorvastatin)|statins (atorvastatin)
521022|NCT00279708|Biomarkers|biomarkers
521023|NCT00279708|Nitric Oxide|nitric oxide
521024|NCT00279708|Disease Activity|disease activity
521025|NCT00279708|Quality of Life|quality of life
521026|NCT00279708|Corticosteroids|corticosteroids
521027|NCT00279708|Pulmonary Sarcoidosis|pulmonary sarcoidosis
521028|NCT00279708|Sarcoidosis|sarcoidosis
521029|NCT00279721|thyroid neoplasms|thyroid neoplasms
521030|NCT00279721|intensity modulated radiation|intensity modulated radiation
521031|NCT00279721|radiotherapy|radiotherapy
521032|NCT00279734|Rheumatoid Arthritis|rheumatoid arthritis
521033|NCT00279773|Acute|acute
521034|NCT00279773|Myeloid|myeloid
521035|NCT00279773|Leukemia|leukemia
521036|NCT00279786|pediatric|pediatric
521037|NCT00279799|Sexually Transmitted Diseases, HIV, condom use, adolescents|sexually transmitted diseases, hiv, condom use, adolescents
521038|NCT00279812|Immune response|immune response
521039|NCT00279812|Selenomethionine|selenomethionine
521040|NCT00279812|Selenium enriched foods|selenium enriched foods
521041|NCT00279812|Selenium status|selenium status
521042|NCT00279812|Selenium biomarkers|selenium biomarkers
521043|NCT00279851|idiopathic seizure|idiopathic seizure
521044|NCT00279851|hypoglycemia|hypoglycemia
521045|NCT00279851|hyperammonemia/hyperinsulinism syndrome|hyperammonemia/hyperinsulinism syndrome
521046|NCT00280215|Primary Hyperoxaluria|primary hyperoxaluria
521047|NCT00280228|ADHD|adhd
521048|NCT00280228|Oppositional Defiant Disorder|oppositional defiant disorder
521049|NCT00280228|Conduct Disorder|conduct disorder
521050|NCT00280228|Substance Use|substance use
521051|NCT00280228|Drug and Alcohol Use|drug and alcohol use
521052|NCT00280241|Chronic|chronic
521053|NCT00280241|Lymphocytic|lymphocytic
521054|NCT00280241|Leukemia|leukemia
521055|NCT00280241|Fludarabine|fludarabine
521056|NCT00280241|Cyclophosphamide|cyclophosphamide
521057|NCT00280241|Rituximab|rituximab
521058|NCT00280254|Heart Failure|heart failure
521059|NCT00280254|Hemodynamics|hemodynamics
521060|NCT00280254|Echocardiography|echocardiography
521061|NCT00280267|hip fracture|hip fracture
521062|NCT00280267|testosterone|testosterone
521063|NCT00280267|muscle weakness|muscle weakness
521064|NCT00280267|frail elderly|frail elderly
521065|NCT00280267|aging|aging
521066|NCT00280280|spasticity|spasticity
521067|NCT00280280|Botox|botox
521068|NCT00280280|baclofen|baclofen
521069|NCT00280293|Bipolar Disorder|bipolar disorder
521070|NCT00280293|Cocaine Dependence|cocaine dependence
521071|NCT00280293|Dual Diagnosis|dual diagnosis
521072|NCT00280319|randomized controlled trial|randomized controlled trial
521073|NCT00280319|depression|depression
521074|NCT00280319|Uganda|uganda
521075|NCT00280319|adolescents|adolescents
521076|NCT00280332|colonic adenoma, colonic advanced neoplasm|colonic adenoma, colonic advanced neoplasm
521077|NCT00280345|pigmentary glaucoma|pigmentary glaucoma
521078|NCT00280345|primary open angle glaucoma|primary open angle glaucoma
521079|NCT00280345|cataract|cataract
521080|NCT00280345|trabeculectomy|trabeculectomy
15648|NCT03191006|children|children
521081|NCT00280345|cataract surgery|cataract surgery
521083|NCT00280358|Formoterol|formoterol
521084|NCT00280358|PK Study|pk study
521085|NCT00280358|Pharmacokinetics|pharmacokinetics
521086|NCT00280371|COPD|copd
521087|NCT00280371|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
521088|NCT00280371|formoterol|formoterol
521188|NCT00280800|treatment|treatment
521089|NCT00280397|Cancer, solid tumors|cancer, solid tumors
521090|NCT00280423|Cognition|cognition
521091|NCT00280423|Polysomnography|polysomnography
521092|NCT00280423|Primary Insomnia|primary insomnia
521093|NCT00280423|Electroencephalography|electroencephalography
521094|NCT00280423|Sleep|sleep
521095|NCT00280436|Polysomnography|polysomnography
521096|NCT00280436|Electroencephalography|electroencephalography
521097|NCT00280436|Primary Insomnia|primary insomnia
521098|NCT00280436|Cognition|cognition
521099|NCT00280436|Sleep|sleep
521100|NCT00280449|people living with HIV|people living with hiv
521101|NCT00280449|quality of life|quality of life
521102|NCT00280462|Nifedipine|nifedipine
521103|NCT00280462|Choroidal blood flow|choroidal blood flow
523793|NCT00288821|Metastasis|metastasis
521104|NCT00280462|Choroidal autoregulation|choroidal autoregulation
521105|NCT00280462|Isometric exercise|isometric exercise
521106|NCT00280475|Randomized Controlled Trials|randomized controlled trials
521107|NCT00280475|Brain Neoplasms/Secondary|brain neoplasms/secondary
521108|NCT00280475|Brain Neoplasms/Radiotherapy|brain neoplasms/radiotherapy
521109|NCT00280475|Radiosurgery|radiosurgery
521110|NCT00280488|Motivational Interviewing|motivational interviewing
521111|NCT00280488|Alcohol Abuse|alcohol abuse
521112|NCT00280488|Alcohol Dependence|alcohol dependence
521113|NCT00280488|Emergency Care Setting|emergency care setting
521114|NCT00280501|Sulpiride|sulpiride
521115|NCT00280501|Quetiapine|quetiapine
521116|NCT00280501|Light/dark transition|light/dark transition
521117|NCT00280501|Choroidal blood flow|choroidal blood flow
521118|NCT00280514|abscess|abscess
521119|NCT00280514|penetration|penetration
521120|NCT00280514|antibiotics|antibiotics
521121|NCT00280514|cefpirome|cefpirome
521122|NCT00280514|moxifloxacin|moxifloxacin
521123|NCT00280514|abdominal cyst|abdominal cyst
521124|NCT00280527|NAFLD|nafld
521125|NCT00280527|NASH|nash
521126|NCT00280527|Obesity|obesity
521127|NCT00280527|Bariatric Surgery|bariatric surgery
521128|NCT00280527|Weight Reduction|weight reduction
521129|NCT00280540|Hypertension|hypertension
521130|NCT00280540|High blood pressure|high blood pressure
521131|NCT00280540|Blood pressure control|blood pressure control
521132|NCT00280540|Blood pressure reduction|blood pressure reduction
521133|NCT00280540|Valsartan|valsartan
521134|NCT00280553|analgesia|analgesia
521135|NCT00280553|laparoscopic surgical procedures|laparoscopic surgical procedures
521136|NCT00280553|length of stay|length of stay
521137|NCT00280592|Prophylaxis|prophylaxis
521138|NCT00280592|Cranberry|cranberry
521139|NCT00280592|Neurogenic bladder|neurogenic bladder
521140|NCT00280657|Acne papulopustulosa|acne papulopustulosa
521141|NCT00280683|Airway Inflammation|airway inflammation
521142|NCT00280683|Moderate persistent asthma|moderate persistent asthma
521143|NCT00280683|Severe Persistent Asthma|severe persistent asthma
521144|NCT00280696|Epilepsies, Partial,|epilepsies, partial,
521145|NCT00280696|Keppra, levetiracetam|keppra, levetiracetam
521146|NCT00280709|Bile duct|bile duct
521147|NCT00280709|Bile duct obstruction|bile duct obstruction
521148|NCT00280709|Biliary stent|biliary stent
521149|NCT00280709|Metal stent|metal stent
521150|NCT00280709|ERCP|ercp
521151|NCT00280709|Patency|patency
521152|NCT00280709|Complication|complication
521153|NCT00280709|Stent occlusion|stent occlusion
521154|NCT00280722|Randomised|randomised
521155|NCT00280722|Intervention|intervention
521156|NCT00280722|Leaflet|leaflet
521157|NCT00280722|Information|information
521158|NCT00280722|Awareness|awareness
521159|NCT00280722|Behaviour|behaviour
521160|NCT00280722|Research|research
521161|NCT00280735|stage I non-small cell lung cancer|stage i non-small cell lung cancer
521162|NCT00280735|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
521163|NCT00280735|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
521164|NCT00280748|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
521165|NCT00280748|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
521166|NCT00280748|tumors metastatic to brain|tumors metastatic to brain
521167|NCT00280761|adenocarcinoma of the rectum|adenocarcinoma of the rectum
521168|NCT00280761|recurrent rectal cancer|recurrent rectal cancer
521169|NCT00280761|stage II rectal cancer|stage ii rectal cancer
521170|NCT00280761|stage III rectal cancer|stage iii rectal cancer
521171|NCT00280761|stage IV rectal cancer|stage iv rectal cancer
521172|NCT00280774|corticosteroid|corticosteroid
521173|NCT00280774|prednisone|prednisone
521174|NCT00280774|memantine|memantine
521175|NCT00280774|Patients who are taking a corticosteroid for a|patients who are taking a corticosteroid for a
521176|NCT00280774|pulmonary illness|pulmonary illness
521177|NCT00280774|rheumatic illness|rheumatic illness
521178|NCT00280774|kidney transplant|kidney transplant
521179|NCT00280787|unresectable|unresectable
521180|NCT00280787|induction|induction
521181|NCT00280787|radiotherapy|radiotherapy
521182|NCT00280787|ZD1839|zd1839
521183|NCT00280800|randomized|randomized
521184|NCT00280800|controlled|controlled
521185|NCT00280800|double blind|double blind
521186|NCT00280800|effectiveness|effectiveness
521189|NCT00280800|sleep apnea|sleep apnea
521190|NCT00280813|treatment|treatment
520542|NCT00287209|Amiodarone|amiodarone
521191|NCT00280813|dual diagnosis|dual diagnosis
521192|NCT00280826|OCT|oct
521193|NCT00280826|Retinal Disease|retinal disease
521194|NCT00280826|Adhesion Molecule|adhesion molecule
521195|NCT00280826|Ocular Inflammation|ocular inflammation
521196|NCT00280826|Raptiva|raptiva
521197|NCT00280826|Macular Edema|macular edema
521198|NCT00280826|Uveitis|uveitis
521199|NCT00280826|Immunosuppression|immunosuppression
521200|NCT00280852|anaplastic thyroid cancer|anaplastic thyroid cancer
521201|NCT00280852|chemotherapy|chemotherapy
521202|NCT00280852|radiotherapy|radiotherapy
521203|NCT00280865|Tesaglitazar|tesaglitazar
521204|NCT00280865|type 2 diabetes|type 2 diabetes
521205|NCT00280878|Lymphoma|lymphoma
521206|NCT00280878|CD20+|cd20+
521207|NCT00280891|head and neck|head and neck
521208|NCT00280891|cancer|cancer
521209|NCT00280891|palliation|palliation
521210|NCT00280891|radiotherapy|radiotherapy
521211|NCT00280904|Hydrocephalus|hydrocephalus
521212|NCT00280904|Shunt|shunt
521213|NCT00280917|Rheumatoid Arthritis|rheumatoid arthritis
521214|NCT00280917|RA|ra
521215|NCT00280930|letrozole|letrozole
521216|NCT00280930|breast cancer|breast cancer
521217|NCT00280930|menopause|menopause
521218|NCT00280943|All NC LTC facilities having ten residents with a hip fracture or osteoporosis on the MDS will be invited to participate in the trial|all nc ltc facilities having ten residents with a hip fracture or osteoporosis on the mds will be invited to participate in the trial
521219|NCT00280969|HIV infection|hiv infection
521220|NCT00280969|treatment|treatment
521221|NCT00280969|efavirenz|efavirenz
521222|NCT00280969|atazanavir|atazanavir
521223|NCT00280969|ritonavir|ritonavir
521224|NCT00280982|dendritic cells, immunotherapy, vaccination, mesothelioma|dendritic cells, immunotherapy, vaccination, mesothelioma
521225|NCT00280995|LDL-cholesterol|ldl-cholesterol
521226|NCT00280995|apoB-100|apob-100
521227|NCT00280995|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
521228|NCT00281008|LDL-cholesterol|ldl-cholesterol
521229|NCT00281008|apoB-100|apob-100
521230|NCT00281008|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
521231|NCT00281021|non-small cell lung cancer|non-small cell lung cancer
521232|NCT00281021|Erlotinib|erlotinib
521233|NCT00281021|Digoxin|digoxin
521234|NCT00281034|brain infarction|brain infarction
521235|NCT00281034|SF-36|sf-36
521236|NCT00281034|HRQOL|hrqol
521237|NCT00281034|Japan|japan
521238|NCT00281034|Post-stroke syndrome|post-stroke syndrome
521239|NCT00281047|Helicobacter pylori (H. pylori)|helicobacter pylori (h. pylori)
521240|NCT00281047|FP-10|fp-10
521241|NCT00281047|amoxicillin|amoxicillin
521242|NCT00281047|clarithromycin|clarithromycin
521243|NCT00281047|lansoprazole|lansoprazole
521244|NCT00281060|endovascular|endovascular
521245|NCT00281060|balloon angioplasty|balloon angioplasty
521246|NCT00281060|stents|stents
521247|NCT00281073|Intra-Cardiac Echocardiography|intra-cardiac echocardiography
521248|NCT00281073|Cardioversion|cardioversion
521249|NCT00281099|ICD|icd
521250|NCT00281099|Pacing|pacing
521251|NCT00281099|Heart Failure|heart failure
521252|NCT00281125|Non-Small Cell Lung Cancer|non-small cell lung cancer
521253|NCT00281125|Pleural Mesothelioma|pleural mesothelioma
521254|NCT00281190|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
521255|NCT00281190|COPD|copd
521256|NCT00281203|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
521257|NCT00281203|COPD|copd
521258|NCT00281216|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
521259|NCT00281216|COPD|copd
521260|NCT00281229|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
521261|NCT00281229|COPD|copd
521262|NCT00281242|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
521263|NCT00281242|COPD|copd
521264|NCT00281281|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
521265|NCT00281281|vancomycin|vancomycin
521266|NCT00281294|Arthritis, Rheumatoid|arthritis, rheumatoid
521267|NCT00281307|Rhinitis|rhinitis
521268|NCT00281307|Vitamin E|vitamin e
521269|NCT00281307|Intranasal|intranasal
521270|NCT00281346|Doppler echocardiography|doppler echocardiography
521271|NCT00281346|coronary stenosis|coronary stenosis
521272|NCT00281346|Coronary angiography|coronary angiography
521273|NCT00281359|cerebral palsy|cerebral palsy
521274|NCT00281359|dynamic splinting|dynamic splinting
521275|NCT00281359|contractures|contractures
521276|NCT00281359|heat therapy|heat therapy
521277|NCT00281372|sexual dysfunction|sexual dysfunction
521278|NCT00281372|male|male
521284|NCT00281385|exercise|exercise
521285|NCT00281385|pedometer|pedometer
521286|NCT00281385|training|training
521287|NCT00281398|homelessness|homelessness
521288|NCT00281398|Attitudes of medical trainees towards the homeless|attitudes of medical trainees towards the homeless
521289|NCT00281411|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
521290|NCT00281411|Endovascular aneurysm repair|endovascular aneurysm repair
583535|NCT00512096|Platinol-AQ|platinol-aq
520638|NCT00287664|terlipressin|terlipressin
521291|NCT00281411|Magnetic Resonance Angiography|magnetic resonance angiography
521292|NCT00281411|Computed Tomography Angiography|computed tomography angiography
521293|NCT00281411|Endoleak|endoleak
521294|NCT00281424|exercise adherence|exercise adherence
521295|NCT00281424|cardiac patients|cardiac patients
521296|NCT00281424|walking|walking
521297|NCT00281437|exercise|exercise
521298|NCT00281437|adherence|adherence
521299|NCT00281437|lifestyle|lifestyle
521301|NCT00281437|autonomy|autonomy
521302|NCT00281463|wheelchair|wheelchair
521308|NCT00281489|Recall|recall
521309|NCT00281489|Awareness|awareness
521310|NCT00281489|BIS|bis
521311|NCT00281489|Anesthesia|anesthesia
521312|NCT00281489|Explicit Recall|explicit recall
521313|NCT00281502|Hepatic Encephalopathy|hepatic encephalopathy
521314|NCT00281502|Hepatitis C|hepatitis c
521315|NCT00281502|Liver Cirrhosis|liver cirrhosis
521316|NCT00281502|Bacterial Overgrowth|bacterial overgrowth
521317|NCT00281528|First Line Metastatic Breast Cancer|first line metastatic breast cancer
521318|NCT00281541|Treatment Efficacy|treatment efficacy
521319|NCT00281541|Treatment Effectiveness|treatment effectiveness
521320|NCT00281541|Disease Management|disease management
521321|NCT00281541|Treatment|treatment
521322|NCT00281541|Safety|safety
521323|NCT00281541|Malignant Melanoma|malignant melanoma
521324|NCT00281554|Investigational Therapies|investigational therapies
521325|NCT00281554|Atrial Fibrillation|atrial fibrillation
521326|NCT00281554|Treatment Efficacy|treatment efficacy
521327|NCT00281554|Treatment Effectiveness|treatment effectiveness
521328|NCT00281554|Safety|safety
521329|NCT00281554|RSD1235|rsd1235
521330|NCT00281606|Lopinavir|lopinavir
521331|NCT00281606|antiretroviral therapy|antiretroviral therapy
521332|NCT00281606|cross-over|cross-over
521333|NCT00281606|tolerability|tolerability
521334|NCT00281619|Pediatric Kidney Transplant|pediatric kidney transplant
521335|NCT00281619|Kidney Transplant|kidney transplant
521336|NCT00281619|CellCept|cellcept
521337|NCT00281619|Mycophenolate mofetil|mycophenolate mofetil
521338|NCT00281619|Mycophenolic Acid|mycophenolic acid
521339|NCT00281619|MPA|mpa
521340|NCT00281632|Pazopanib|pazopanib
521341|NCT00281632|Fallopian tube cancer|fallopian tube cancer
521342|NCT00281632|Ovarian epithelial cancer|ovarian epithelial cancer
521343|NCT00281632|Peritoneal cancer|peritoneal cancer
521344|NCT00281658|ErbB2 positive|erbb2 positive
521345|NCT00281658|Her2+|her2+
521346|NCT00281658|metastatic breast cancer|metastatic breast cancer
521347|NCT00281658|FISH positive|fish positive
521348|NCT00281658|Stage IV|stage iv
521349|NCT00281671|Nesiritide|nesiritide
521350|NCT00281671|Natriuretic Peptide, Brain|natriuretic peptide, brain
521351|NCT00281671|Heart Defects, Congenital|heart defects, congenital
521352|NCT00281671|Cardiopulmonary Bypass|cardiopulmonary bypass
521353|NCT00281671|Diuretics|diuretics
521360|NCT00281697|Ribbon 2|ribbon 2
521361|NCT00281697|Avastin|avastin
521362|NCT00281697|MBC|mbc
521363|NCT00281697|Breast cancer|breast cancer
521364|NCT00281710|AQP-2|aqp-2
521365|NCT00281710|Methylprednisolone|methylprednisolone
521366|NCT00281710|Urinary concentrating ability|urinary concentrating ability
521367|NCT00281723|Aphthous|aphthous
521368|NCT00281723|oral|oral
521369|NCT00281736|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
521370|NCT00281736|recurrent esophageal cancer|recurrent esophageal cancer
521371|NCT00281736|stage 0 esophageal cancer|stage 0 esophageal cancer
521372|NCT00281736|stage I esophageal cancer|stage i esophageal cancer
521373|NCT00281736|precancerous condition|precancerous condition
521374|NCT00281749|ALZHEIMER'S D-SE|alzheimer's d-se
521375|NCT00281749|PARKINSON'S D-SE|parkinson's d-se
521376|NCT00281749|FRAILTY|frailty
521377|NCT00281762|AQP-2|aqp-2
521378|NCT00281762|NSAID|nsaid
521379|NCT00281762|Urinary concentrating ability|urinary concentrating ability
521380|NCT00281788|stage I esophageal cancer|stage i esophageal cancer
521381|NCT00281788|stage II esophageal cancer|stage ii esophageal cancer
521382|NCT00281788|stage III esophageal cancer|stage iii esophageal cancer
521383|NCT00281801|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
521384|NCT00281801|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
521306|NCT00281476|statins|statins
521385|NCT00281801|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
521386|NCT00281801|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
521387|NCT00281801|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
521388|NCT00281801|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
521389|NCT00281801|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
521390|NCT00281801|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
521391|NCT00281801|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
521392|NCT00281801|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
521393|NCT00281801|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
521886|NCT00288262|melatonin|melatonin
521394|NCT00281801|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
521395|NCT00281801|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
523794|NCT00288834|stroke|stroke
521396|NCT00281801|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
521397|NCT00281801|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
583533|NCT00512096|TanyN2-3M0 Squamous Cell Carcinoma of the Penis|tanyn2-3m0 squamous cell carcinoma of the penis
521398|NCT00281801|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
521399|NCT00281801|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
521400|NCT00281801|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
521401|NCT00281801|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
521402|NCT00281801|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
521403|NCT00281801|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
521404|NCT00281801|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
521405|NCT00281801|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
521406|NCT00281801|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
521407|NCT00281801|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
521408|NCT00281801|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
521409|NCT00281801|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
521410|NCT00281801|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
521411|NCT00281801|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
521412|NCT00281801|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
521413|NCT00281801|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
521414|NCT00281801|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
521415|NCT00281801|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
521416|NCT00281801|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
521417|NCT00281801|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
521418|NCT00281801|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
521419|NCT00281801|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
521420|NCT00281801|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
521421|NCT00281801|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
521422|NCT00281801|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
521423|NCT00281801|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
521424|NCT00281801|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
521425|NCT00281801|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
521426|NCT00281801|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
521427|NCT00281801|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
521428|NCT00281801|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
521429|NCT00281801|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
521430|NCT00281801|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
521431|NCT00281801|refractory hairy cell leukemia|refractory hairy cell leukemia
521432|NCT00281801|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
521433|NCT00281801|secondary acute myeloid leukemia|secondary acute myeloid leukemia
521434|NCT00281801|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
521435|NCT00281801|splenic marginal zone lymphoma|splenic marginal zone lymphoma
521436|NCT00281801|stage I multiple myeloma|stage i multiple myeloma
521437|NCT00281801|stage II multiple myeloma|stage ii multiple myeloma
521438|NCT00281801|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
521439|NCT00281801|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
521440|NCT00281801|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
521441|NCT00281801|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
521442|NCT00281801|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
521443|NCT00281801|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
521444|NCT00281801|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
521445|NCT00281801|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
521446|NCT00281801|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
521447|NCT00281801|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
521448|NCT00281801|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
521449|NCT00281801|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
521450|NCT00281801|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
521451|NCT00281801|stage III multiple myeloma|stage iii multiple myeloma
521452|NCT00281801|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
521453|NCT00281801|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
521454|NCT00281801|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
521455|NCT00281801|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
521456|NCT00281801|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
521457|NCT00281801|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
521458|NCT00281801|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
521459|NCT00281801|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
521460|NCT00281801|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
521461|NCT00281801|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
521462|NCT00281801|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
521463|NCT00281801|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
521464|NCT00281801|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
521465|NCT00281801|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
521466|NCT00281801|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
521467|NCT00281814|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
521468|NCT00281814|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
521469|NCT00281814|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
521470|NCT00281814|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
521471|NCT00281814|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
521472|NCT00281814|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
521473|NCT00281814|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
521474|NCT00281814|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
521475|NCT00281814|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
521476|NCT00281814|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
521477|NCT00281814|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
521478|NCT00281814|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
521479|NCT00281814|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
521480|NCT00281814|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
521481|NCT00281814|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
521482|NCT00281814|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
521483|NCT00281814|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
521484|NCT00281814|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
521485|NCT00281814|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
521486|NCT00281814|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
521487|NCT00281814|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
521488|NCT00281814|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
521489|NCT00281814|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
521490|NCT00281814|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
521491|NCT00281814|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
521492|NCT00281814|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
521493|NCT00281814|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
521494|NCT00281814|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
521495|NCT00281814|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
521496|NCT00281814|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
521497|NCT00281814|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
521498|NCT00281814|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
521499|NCT00281814|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
521500|NCT00281814|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
521501|NCT00281814|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
521502|NCT00281814|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
521503|NCT00281814|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
15653|NCT03190954|C-11 Raclopride|c-11 raclopride
521504|NCT00281814|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
521505|NCT00281814|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
521506|NCT00281814|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
521507|NCT00281814|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
521508|NCT00281814|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
521509|NCT00281814|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
521510|NCT00281814|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
521511|NCT00281814|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
521512|NCT00281814|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
521513|NCT00281814|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
521514|NCT00281814|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
521515|NCT00281814|refractory hairy cell leukemia|refractory hairy cell leukemia
521516|NCT00281814|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
521517|NCT00281814|secondary acute myeloid leukemia|secondary acute myeloid leukemia
521518|NCT00281814|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
521519|NCT00281814|splenic marginal zone lymphoma|splenic marginal zone lymphoma
521520|NCT00281814|stage I multiple myeloma|stage i multiple myeloma
521521|NCT00281814|stage II multiple myeloma|stage ii multiple myeloma
521522|NCT00281814|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
521523|NCT00281814|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
521524|NCT00281814|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
521525|NCT00281814|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
521526|NCT00281814|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
521527|NCT00281814|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
521528|NCT00281814|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
521529|NCT00281814|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
521530|NCT00281814|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
521531|NCT00281814|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
521532|NCT00281814|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
521533|NCT00281814|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
521534|NCT00281814|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
521535|NCT00281814|stage III multiple myeloma|stage iii multiple myeloma
521536|NCT00281814|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
521537|NCT00281814|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
521538|NCT00281814|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
521539|NCT00281814|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
521540|NCT00281814|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
521541|NCT00281814|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
521542|NCT00281814|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
521543|NCT00281814|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
521544|NCT00281814|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
521545|NCT00281814|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
521546|NCT00281814|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
521547|NCT00281814|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
521548|NCT00281814|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
521549|NCT00281814|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
521550|NCT00281814|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
521551|NCT00281827|adenocarcinoma of the lung|adenocarcinoma of the lung
521552|NCT00281827|squamous cell lung cancer|squamous cell lung cancer
521553|NCT00281827|large cell lung cancer|large cell lung cancer
521554|NCT00281827|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
521555|NCT00281827|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
521556|NCT00281840|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
521557|NCT00281840|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
521558|NCT00281840|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
521559|NCT00281840|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
521560|NCT00281840|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
521561|NCT00281840|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
521562|NCT00281840|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
521563|NCT00281840|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
521564|NCT00281840|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
521565|NCT00281840|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
521566|NCT00281853|neurotoxicity|neurotoxicity
521567|NCT00281853|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
15654|NCT03190954|[11C] NNC-112|[11c] nnc-112
521568|NCT00281866|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
521569|NCT00281866|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
521570|NCT00281866|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
521571|NCT00281866|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
521572|NCT00281866|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
521573|NCT00281866|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
521574|NCT00281866|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
521575|NCT00281866|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
583534|NCT00512096|Cisplatin|cisplatin
521576|NCT00281866|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
521577|NCT00281866|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
521578|NCT00281866|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
521637|NCT00281879|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
521579|NCT00281866|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
521774|NCT00282191|mental retardation|mental retardation
521580|NCT00281866|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
521581|NCT00281866|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
521582|NCT00281879|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
521583|NCT00281879|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
521584|NCT00281879|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
521585|NCT00281879|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
521586|NCT00281879|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
521587|NCT00281879|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
521588|NCT00281879|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
521589|NCT00281879|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
521590|NCT00281879|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
521591|NCT00281879|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
521592|NCT00281879|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
521593|NCT00281879|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
521594|NCT00281879|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
521595|NCT00281879|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
521596|NCT00281879|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
521597|NCT00281879|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
521598|NCT00281879|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
521599|NCT00281879|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
521600|NCT00281879|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
521601|NCT00281879|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
521602|NCT00281879|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
521603|NCT00281879|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
521604|NCT00281879|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
521605|NCT00281879|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
521606|NCT00281879|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
521607|NCT00281879|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
521608|NCT00281879|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
521609|NCT00281879|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
521610|NCT00281879|secondary acute myeloid leukemia|secondary acute myeloid leukemia
521611|NCT00281879|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
521612|NCT00281879|refractory anemia with excess blasts|refractory anemia with excess blasts
521613|NCT00281879|refractory anemia|refractory anemia
521614|NCT00281879|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
521615|NCT00281879|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
521616|NCT00281879|chronic eosinophilic leukemia|chronic eosinophilic leukemia
521617|NCT00281879|primary myelofibrosis|primary myelofibrosis
521618|NCT00281879|chronic neutrophilic leukemia|chronic neutrophilic leukemia
521619|NCT00281879|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
521620|NCT00281879|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
521621|NCT00281879|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
521622|NCT00281879|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
521623|NCT00281879|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
521624|NCT00281879|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
521625|NCT00281879|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
521626|NCT00281879|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
521627|NCT00281879|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
521628|NCT00281879|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
521629|NCT00281879|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
521630|NCT00281879|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
521631|NCT00281879|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
521632|NCT00281879|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
521633|NCT00281879|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
521634|NCT00281879|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
521635|NCT00281879|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
521636|NCT00281879|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
522386|NCT00293124|Glivec|glivec
521638|NCT00281879|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
521639|NCT00281879|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
521640|NCT00281879|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
521641|NCT00281879|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
521642|NCT00281879|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
521643|NCT00281879|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
521644|NCT00281879|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
521645|NCT00281879|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
521646|NCT00281879|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
521647|NCT00281879|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
521648|NCT00281879|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
521649|NCT00281879|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
521650|NCT00281879|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
521651|NCT00281879|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
521652|NCT00281879|refractory hairy cell leukemia|refractory hairy cell leukemia
521653|NCT00281879|refractory multiple myeloma|refractory multiple myeloma
521654|NCT00281879|splenic marginal zone lymphoma|splenic marginal zone lymphoma
521655|NCT00281879|stage I multiple myeloma|stage i multiple myeloma
521656|NCT00281879|stage II multiple myeloma|stage ii multiple myeloma
521657|NCT00281879|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
521658|NCT00281879|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
521659|NCT00281879|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
521660|NCT00281879|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
521661|NCT00281879|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
521662|NCT00281879|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
521663|NCT00281879|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
521664|NCT00281879|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
521665|NCT00281879|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
521666|NCT00281879|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
521667|NCT00281879|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
521668|NCT00281879|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
521669|NCT00281879|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
521670|NCT00281879|stage III multiple myeloma|stage iii multiple myeloma
521671|NCT00281879|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
521672|NCT00281879|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
521673|NCT00281879|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
521674|NCT00281879|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
521675|NCT00281879|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
521676|NCT00281879|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
521677|NCT00281879|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
521678|NCT00281879|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
521679|NCT00281879|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
521680|NCT00281879|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
521681|NCT00281879|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
521682|NCT00281879|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
521683|NCT00281879|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
521684|NCT00281879|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
521685|NCT00281879|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
521686|NCT00281879|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
753952|NCT01178385|Asperger's Syndrome|asperger's syndrome
521687|NCT00281879|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
521688|NCT00281879|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
521689|NCT00281879|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
521690|NCT00281879|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
521691|NCT00281879|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
521692|NCT00281879|unusual cancers of childhood|unusual cancers of childhood
521693|NCT00281879|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
521694|NCT00281892|anemia|anemia
521695|NCT00281892|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
521696|NCT00281892|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
521697|NCT00281892|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
521780|NCT00282217|Kidney Transplant|kidney transplant
521698|NCT00281892|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
521699|NCT00281892|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
521700|NCT00281892|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
521701|NCT00281905|untreated childhood brain stem glioma|untreated childhood brain stem glioma
521702|NCT00281905|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
521703|NCT00281905|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
521704|NCT00281905|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
521705|NCT00281905|childhood choroid plexus tumor|childhood choroid plexus tumor
521706|NCT00281905|childhood infratentorial ependymoma|childhood infratentorial ependymoma
521707|NCT00281905|childhood supratentorial ependymoma|childhood supratentorial ependymoma
521708|NCT00281905|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
521709|NCT00281905|untreated childhood medulloblastoma|untreated childhood medulloblastoma
521710|NCT00281905|childhood oligodendroglioma|childhood oligodendroglioma
521711|NCT00281905|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
521712|NCT00281905|disseminated neuroblastoma|disseminated neuroblastoma
521713|NCT00281905|localized resectable neuroblastoma|localized resectable neuroblastoma
521714|NCT00281905|localized unresectable neuroblastoma|localized unresectable neuroblastoma
521715|NCT00281905|regional neuroblastoma|regional neuroblastoma
521716|NCT00281905|stage 4S neuroblastoma|stage 4s neuroblastoma
521717|NCT00281918|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
521718|NCT00281918|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
521719|NCT00281918|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
521720|NCT00281918|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
521721|NCT00281918|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
521722|NCT00281931|prolymphocytic leukemia|prolymphocytic leukemia
521723|NCT00281970|stage I non-small cell lung cancer|stage i non-small cell lung cancer
521724|NCT00281970|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
521725|NCT00281970|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
521726|NCT00281970|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
521727|NCT00281983|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
521728|NCT00281983|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
521729|NCT00281983|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
521730|NCT00281983|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
521731|NCT00281983|Waldenström macroglobulinemia|waldenström macroglobulinemia
521732|NCT00281996|recurrent pancreatic cancer|recurrent pancreatic cancer
521733|NCT00281996|stage III pancreatic cancer|stage iii pancreatic cancer
521734|NCT00281996|stage IV pancreatic cancer|stage iv pancreatic cancer
521735|NCT00282009|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
521736|NCT00282022|recurrent small cell lung cancer|recurrent small cell lung cancer
521737|NCT00282022|extensive stage small cell lung cancer|extensive stage small cell lung cancer
521738|NCT00282022|limited stage small cell lung cancer|limited stage small cell lung cancer
521739|NCT00282035|breast cancer|breast cancer
521740|NCT00282035|breast tumour|breast tumour
521741|NCT00282035|DCIS|dcis
521742|NCT00282035|female|female
521743|NCT00282035|breast conserving surgery|breast conserving surgery
521744|NCT00282035|irradiation|irradiation
521745|NCT00282035|whole breast irradiation|whole breast irradiation
521746|NCT00282035|3D CRT accelerated partial breast irradiation|3d crt accelerated partial breast irradiation
521747|NCT00282035|cosmetic outcome|cosmetic outcome
521748|NCT00282035|quality of life|quality of life
521749|NCT00282061|3 conditions in a within-subject design:|3 conditions in a within-subject design:
521750|NCT00282061|1-ad-lib sleep wake|1-ad-lib sleep wake
521751|NCT00282061|2-forced morning wake-up|2-forced morning wake-up
521752|NCT00282061|3- ad-lib sleep wake after treatment with melatonin|3- ad-lib sleep wake after treatment with melatonin
521753|NCT00282087|early stage|early stage
521300|NCT00281437|choice|choice
521754|NCT00282087|high grade|high grade
521755|NCT00282087|uterine leiomyosarcoma|uterine leiomyosarcoma
521756|NCT00282087|adjuvant treatment|adjuvant treatment
521757|NCT00282113|Probiotic|probiotic
521758|NCT00282113|Prebiotic|prebiotic
521760|NCT00282113|Premature infants|premature infants
521761|NCT00282113|commensal flora|commensal flora
521762|NCT00282126|Calcium balance|calcium balance
521763|NCT00282152|Early Stage Parkinson's Disease|early stage parkinson's disease
521764|NCT00282152|Parkinson's Disease|parkinson's disease
521765|NCT00282152|Deep Brain Stimulation|deep brain stimulation
521766|NCT00282152|PD|pd
521767|NCT00282152|DBS|dbs
521768|NCT00282178|Metabolic|metabolic
521769|NCT00282178|Hypertension|hypertension
521770|NCT00282178|Abdominal obesity|abdominal obesity
521771|NCT00282178|Insulin sensitivity|insulin sensitivity
521772|NCT00282178|Hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
521773|NCT00282191|spasticity|spasticity
521775|NCT00282204|Hypnosis|hypnosis
521776|NCT00282204|Hypnotherapy|hypnotherapy
521777|NCT00282204|Childbirth|childbirth
521778|NCT00282204|Analgesia|analgesia
521779|NCT00282217|Kidney Failure|kidney failure
521781|NCT00282217|Graft Rejection|graft rejection
521782|NCT00282217|Kidney Transplantation|kidney transplantation
521783|NCT00282230|Malononitrilamide|malononitrilamide
521784|NCT00282230|immunosuppression|immunosuppression
521785|NCT00282230|treatment efficacy|treatment efficacy
521786|NCT00282230|treatment outcome|treatment outcome
521787|NCT00282243|Pharmacokinetics|pharmacokinetics
521788|NCT00282243|Therapy|therapy
521789|NCT00282243|Immunosuppression|immunosuppression
521790|NCT00282243|Drugs, Investigational|drugs, investigational
521791|NCT00282243|Adult|adult
521792|NCT00282256|Child|child
521793|NCT00282256|Pharmacokinetics|pharmacokinetics
521794|NCT00282256|Immunosuppression Drugs|immunosuppression drugs
521795|NCT00282256|Hepatic transplant|hepatic transplant
521796|NCT00282256|Liver Transplantation|liver transplantation
521797|NCT00282269|Traumatic Brain Injury|traumatic brain injury
521798|NCT00282269|Children|children
521799|NCT00282269|Hypothermia|hypothermia
521800|NCT00282269|Outcome|outcome
521801|NCT00282269|Intensive Care|intensive care
521802|NCT00282269|Magnetic resonance Imaging|magnetic resonance imaging
521803|NCT00282282|non-myeloablative peripheral blood stem cell|non-myeloablative peripheral blood stem cell
521804|NCT00282282|PBSCT|pbsct
521805|NCT00282282|tacrolimus|tacrolimus
521806|NCT00282282|sirolimus|sirolimus
521807|NCT00282295|tetanus|tetanus
521808|NCT00282295|pertussis|pertussis
521809|NCT00282295|Prophylaxis|prophylaxis
521810|NCT00282295|meningococcus|meningococcus
521811|NCT00282295|diptheria|diptheria
521812|NCT00282308|RA|ra
521813|NCT00282308|Rituxan|rituxan
521814|NCT00282308|SIERRA|sierra
521815|NCT00282334|Telemedicine|telemedicine
521816|NCT00282334|Blood pressure|blood pressure
521817|NCT00282334|Quality of life|quality of life
521818|NCT00282334|Cost-effectiveness|cost-effectiveness
521819|NCT00282347|Class IV LN|class iv ln
521820|NCT00282347|Lupus|lupus
521821|NCT00282347|LUNAR|lunar
521822|NCT00282347|LN|ln
521823|NCT00282360|coronary artery disease|coronary artery disease
521824|NCT00282360|diabetes mellitus|diabetes mellitus
521825|NCT00282399|Myelodysplastic Syndrome|myelodysplastic syndrome
521826|NCT00282399|MGI Pharma|mgi pharma
521827|NCT00282399|Decitabine|decitabine
521828|NCT00282399|Dacogen|dacogen
521829|NCT00282464|Bipolar I Depression|bipolar i depression
521830|NCT00282477|cyclist|cyclist
521831|NCT00282490|Overactive bladder|overactive bladder
521832|NCT00282490|Children|children
521833|NCT00282490|Nerve stimulation|nerve stimulation
521834|NCT00282490|TENS|tens
521835|NCT00282503|aGvHD|agvhd
521836|NCT00282516|asthma|asthma
521837|NCT00282516|telemedicine|telemedicine
521838|NCT00282516|case management|case management
521839|NCT00282516|clinic|clinic
521840|NCT00282516|children|children
521841|NCT00282516|pediatric|pediatric
521842|NCT00282529|lymphedema, screening, treatment|lymphedema, screening, treatment
521843|NCT00282542|Hepatocytes|hepatocytes
521844|NCT00282555|Esophagitis, Reflux|esophagitis, reflux
521845|NCT00282555|S-Tenatoprazole-Na|s-tenatoprazole-na
521846|NCT00282555|Heartburn|heartburn
521847|NCT00282555|Esophageal endoscopy|esophageal endoscopy
521848|NCT00282568|Pharmacokinetics|pharmacokinetics
521849|NCT00282568|Therapy|therapy
521850|NCT00282568|Immunosuppression|immunosuppression
521851|NCT00282568|Drugs, Investigational|drugs, investigational
521852|NCT00282568|Adult|adult
521853|NCT00282581|HIV|hiv
521854|NCT00282581|Smallpox|smallpox
521855|NCT00282581|MVA|mva
521856|NCT00282594|Intensive Insulin Therapy|intensive insulin therapy
521857|NCT00282594|General Surgical|general surgical
521858|NCT00282594|Vascular Surgical|vascular surgical
521859|NCT00282594|Tight Glycemic Control|tight glycemic control
521860|NCT00282607|Erectile Dysfunction|erectile dysfunction
521861|NCT00282620|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
521862|NCT00282620|Magnesium|magnesium
521863|NCT00282620|Electrocardiogram|electrocardiogram
521864|NCT00282620|Ventricular Arrhythmia|ventricular arrhythmia
521865|NCT00282633|Cesarean Delivery|cesarean delivery
521866|NCT00282633|Wound closure|wound closure
521867|NCT00282633|Suture|suture
521868|NCT00282633|Alternative therapy|alternative therapy
521870|NCT00282646|critical limb ischemia|critical limb ischemia
521871|NCT00282646|peripheral arterial occlusive disease|peripheral arterial occlusive disease
521872|NCT00282646|[C14.907.137]|[c14.907.137]
521873|NCT00282659|Hemodynamics|hemodynamics
521874|NCT00282659|Hypertension|hypertension
521875|NCT00282659|Dyslipidemia|dyslipidemia
521876|NCT00282659|Diabetes|diabetes
521877|NCT00282659|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
521878|NCT00282659|Blood Pressure|blood pressure
521879|NCT00282672|Barrett's Esophagus|barrett's esophagus
521880|NCT00282672|Dysplasia|dysplasia
521881|NCT00282672|Radiofrequency Ablation|radiofrequency ablation
521882|NCT00282685|Patients with symmetric peripheral diabetic neuropathy|patients with symmetric peripheral diabetic neuropathy
521883|NCT00288249|Breast Cancer|breast cancer
521884|NCT00288249|Breast Neoplasms|breast neoplasms
521885|NCT00288262|hot flashes|hot flashes
521887|NCT00288262|depression|depression
521888|NCT00288262|sleep|sleep
521889|NCT00288262|luteinizing hormone|luteinizing hormone
521890|NCT00288262|postmenopause|postmenopause
521891|NCT00288275|Ovarian Cancer|ovarian cancer
521892|NCT00288275|Fallopian Tube Cancer|fallopian tube cancer
521893|NCT00288275|Peritoneal Cancer|peritoneal cancer
521894|NCT00288275|Assay|assay
521895|NCT00288275|Chemotherapy|chemotherapy
521896|NCT00288275|Recurrent|recurrent
521897|NCT00288275|Refractory|refractory
521898|NCT00288275|Persistent|persistent
521899|NCT00288275|Chemoresponse|chemoresponse
521900|NCT00288275|Sensitivity|sensitivity
521901|NCT00288275|Precision Therapeutics|precision therapeutics
521902|NCT00288301|diet|diet
521903|NCT00288301|physical activity|physical activity
521904|NCT00288301|weight management|weight management
521905|NCT00288314|PTSD|ptsd
521906|NCT00288314|MRI, Functional|mri, functional
521907|NCT00288314|Anxiety|anxiety
521908|NCT00288314|Working Memory|working memory
521909|NCT00288314|Processing speed|processing speed
521910|NCT00288327|diet|diet
521911|NCT00288327|physical activity|physical activity
521912|NCT00288327|smoking cessation|smoking cessation
521913|NCT00288340|psychotic disorders|psychotic disorders
521914|NCT00288340|auditory hallucinations|auditory hallucinations
521915|NCT00288340|brain structure|brain structure
521916|NCT00288340|psychiatric disorder with auditory hallucinations (at least one every 20 minutes)|psychiatric disorder with auditory hallucinations (at least one every 20 minutes)
521917|NCT00288340|schizophrenia/schizoaffective disorder without auditory hallucinations|schizophrenia/schizoaffective disorder without auditory hallucinations
521918|NCT00288353|schizophrenia|schizophrenia
521919|NCT00288353|schizoaffective disorder|schizoaffective disorder
521920|NCT00288353|bipolar disorder|bipolar disorder
521921|NCT00288353|metabolic syndrome|metabolic syndrome
521922|NCT00288366|schizophrenia|schizophrenia
521923|NCT00288366|schizoaffective disorder|schizoaffective disorder
521924|NCT00288366|bipolar disorder|bipolar disorder
521925|NCT00288366|metabolic syndrome|metabolic syndrome
521926|NCT00288379|Asthma|asthma
521927|NCT00288379|allergen challenge|allergen challenge
521928|NCT00288379|airway responsiveness|airway responsiveness
521929|NCT00288379|airway inflammation|airway inflammation
521930|NCT00288379|Symbicort®|symbicort®
521931|NCT00288405|Intracranial|intracranial
521932|NCT00288405|Wide-neck|wide-neck
521933|NCT00288405|Saccular|saccular
521934|NCT00288405|Aneurysms|aneurysms
521935|NCT00288418|Colonization of the catheter|colonization of the catheter
521936|NCT00288418|Catheter related bloodstream infection|catheter related bloodstream infection
521937|NCT00288431|cancer|cancer
521938|NCT00288431|sarcoma|sarcoma
521939|NCT00288444|Advanced malignancies.|advanced malignancies.
521940|NCT00288496|mechanical bowel preparation, colorectal surgery, anastomotic dehiscence|mechanical bowel preparation, colorectal surgery, anastomotic dehiscence
521941|NCT00288535|coronary bifurcation ; PCI; modified T-Stenting; sirolimus stent|coronary bifurcation ; pci; modified t-stenting; sirolimus stent
521942|NCT00288561|ARMD, ranibizumab, verteporfin|armd, ranibizumab, verteporfin
521943|NCT00288574|Depression|depression
521944|NCT00291044|pregnancy, genital herpes|pregnancy, genital herpes
521945|NCT00291057|Pediculosis|pediculosis
521946|NCT00291057|Head Lice|head lice
521947|NCT00291070|ADHD|adhd
521948|NCT00291070|attention|attention
521949|NCT00291070|insomnia|insomnia
521950|NCT00291070|hyperactivity|hyperactivity
521951|NCT00291070|anxiety|anxiety
521953|NCT00291083|nipple aspirate fluid|nipple aspirate fluid
521954|NCT00291083|breast atypia|breast atypia
521955|NCT00291083|high risk for breast cancer|high risk for breast cancer
521956|NCT00291083|breast epithelial hyperplasia|breast epithelial hyperplasia
521957|NCT00291083|Ki-67|ki-67
521958|NCT00291083|hormones plus chemoprevention|hormones plus chemoprevention
521959|NCT00291083|chemoprevention|chemoprevention
521960|NCT00291096|breast atypia|breast atypia
521961|NCT00291096|fine needle aspiration|fine needle aspiration
521962|NCT00291096|high risk for breast cancer|high risk for breast cancer
521963|NCT00291096|breast epithelial hyperplasia|breast epithelial hyperplasia
521952|NCT00291083|NAF|naf
521964|NCT00291109|breast atypia|breast atypia
521965|NCT00291109|breast epithelial hyperplasia|breast epithelial hyperplasia
521967|NCT00291109|RTPCR|rtpcr
521968|NCT00291109|microdissection|microdissection
521969|NCT00291122|breast atypia|breast atypia
521970|NCT00291122|breast epithelial hyperplasia|breast epithelial hyperplasia
521971|NCT00291122|ki-67|ki-67
521972|NCT00291122|RTPCR|rtpcr
521973|NCT00291122|microdissection|microdissection
521974|NCT00291135|breast atypia|breast atypia
521975|NCT00291135|open label pilot study|open label pilot study
521976|NCT00291135|letrozole|letrozole
521977|NCT00291135|fine needle aspiration|fine needle aspiration
521978|NCT00291135|high risk for breast cancer|high risk for breast cancer
521979|NCT00291135|breast epithelial hyperplasia|breast epithelial hyperplasia
521980|NCT00291135|Ki-67|ki-67
521981|NCT00291135|hormones plus chemoprevention|hormones plus chemoprevention
521982|NCT00291135|chemoprevention|chemoprevention
521983|NCT00291148|Neuropathic pain|neuropathic pain
521984|NCT00291148|Multiple Sclerosis|multiple sclerosis
521985|NCT00291148|pregabalin|pregabalin
521986|NCT00291148|paroxetine|paroxetine
521987|NCT00291161|Delivery of Health Care, Integrated|delivery of health care, integrated
521988|NCT00291161|United States Department of Veterans Affairs|united states department of veterans affairs
521989|NCT00291161|Dementia|dementia
521990|NCT00291161|Patient Care Management|patient care management
521991|NCT00291174|Ventricular Arrhythmia|ventricular arrhythmia
521992|NCT00291174|Myocardial Infarction|myocardial infarction
521993|NCT00291174|Ventricular Dysfunction|ventricular dysfunction
521994|NCT00291174|Coronary Artery Disease|coronary artery disease
521995|NCT00291174|Structural Heart Disease|structural heart disease
521996|NCT00291174|Arrhythmia|arrhythmia
521997|NCT00291174|Cardiomyopathies|cardiomyopathies
521998|NCT00291200|Psychosis|psychosis
521999|NCT00291200|Basic Symptoms|basic symptoms
522000|NCT00291226|schizophrenia prodrome|schizophrenia prodrome
522001|NCT00291265|Bradykinesia|bradykinesia
522003|NCT00291265|Speech|speech
522004|NCT00291265|Rigidity|rigidity
522005|NCT00291265|Neurodegeneration|neurodegeneration
522006|NCT00291265|Parkinson Disease|parkinson disease
522007|NCT00291265|PD|pd
522008|NCT00291278|Endometriosis|endometriosis
522009|NCT00291278|Bone Mineral Density|bone mineral density
522010|NCT00291278|Osteopenia|osteopenia
522011|NCT00291278|Osteoporosis|osteoporosis
522012|NCT00291278|DEXA Scan|dexa scan
522013|NCT00291278|Menopause|menopause
522014|NCT00291278|Screening|screening
522015|NCT00291278|Healthy Volunteer|healthy volunteer
522016|NCT00291278|HV|hv
522017|NCT00291304|Magnetic Resonance Imaging|magnetic resonance imaging
522018|NCT00291304|Pathology|pathology
522019|NCT00291317|pediatric spinal cord injury|pediatric spinal cord injury
522020|NCT00291317|FES cycling|fes cycling
522021|NCT00291317|bone mineral density|bone mineral density
522022|NCT00291317|quality of life|quality of life
522023|NCT00291343|hepatitis B|hepatitis b
522024|NCT00291343|meningococcal vaccine|meningococcal vaccine
522025|NCT00291343|pertussis|pertussis
522026|NCT00291343|Prophylaxis diphtheria|prophylaxis diphtheria
522027|NCT00291343|meningococcal serogroups A and C diseases|meningococcal serogroups a and c diseases
522028|NCT00291343|tetanus|tetanus
522029|NCT00291343|Haemophilus influenzae type b|haemophilus influenzae type b
522030|NCT00291356|Diabetes|diabetes
522031|NCT00291356|sodium dependent glucose transporter|sodium dependent glucose transporter
522032|NCT00291356|SGLT2|sglt2
522033|NCT00291356|GSK189075|gsk189075
522034|NCT00291356|GSK189074|gsk189074
522035|NCT00291356|SGLT1|sglt1
522036|NCT00291356|GW869683|gw869683
522037|NCT00291369|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
522038|NCT00291369|Interleukin-2|interleukin-2
522039|NCT00291369|Interferon alfa|interferon alfa
522040|NCT00291369|Cytokines|cytokines
522041|NCT00291369|Survival|survival
522042|NCT00291382|Total asthma control|total asthma control
522043|NCT00291382|airway hyper-responsiveness|airway hyper-responsiveness
522044|NCT00291382|adult|adult
522045|NCT00291382|Asthma|asthma
522046|NCT00291421|Alzheimer's Disease|alzheimer's disease
522047|NCT00291421|Dementia|dementia
522048|NCT00291421|Brain Disease|brain disease
522049|NCT00291421|Memory Loss|memory loss
522050|NCT00291421|Caregiver|caregiver
522051|NCT00291421|Primary Caregiver|primary caregiver
522052|NCT00291421|Observation|observation
522053|NCT00291421|galantamine|galantamine
522054|NCT00291421|donepezil|donepezil
522055|NCT00291421|rivastigmine|rivastigmine
522056|NCT00291421|Quality of life|quality of life
522057|NCT00291434|Head and neck cancer|head and neck cancer
522058|NCT00291434|Fractionation|fractionation
522059|NCT00291434|Radiotherapy|radiotherapy
522060|NCT00291434|Conventional fractionation|conventional fractionation
522061|NCT00291434|Hyperfractionation|hyperfractionation
522062|NCT00291434|Accelerated fractionation|accelerated fractionation
522063|NCT00291460|COPD|copd
522064|NCT00291460|respiratory failure|respiratory failure
522002|NCT00291265|Tremor|tremor
522065|NCT00291460|inspiratory muscle training|inspiratory muscle training
522066|NCT00291499|symptomatic OA of the hand|symptomatic oa of the hand
522067|NCT00291512|HIV|hiv
522068|NCT00291512|STDs|stds
522069|NCT00291512|Methamphetamine abuse|methamphetamine abuse
522070|NCT00291512|MSM|msm
522071|NCT00291525|valve|valve
522072|NCT00291525|prosthesis|prosthesis
522073|NCT00291525|antithrombotics|antithrombotics
522074|NCT00291525|randomized|randomized
522075|NCT00291564|Observational|observational
522076|NCT00291564|Heart Failure|heart failure
522077|NCT00291564|Continuous Cardiac Resynchronization Therapy|continuous cardiac resynchronization therapy
522078|NCT00291577|advanced|advanced
522079|NCT00291577|sunitinib (Sutent)|sunitinib (sutent)
522080|NCT00291577|docetaxel|docetaxel
522081|NCT00291577|Phase 1B|phase 1b
522082|NCT00291590|diabetes|diabetes
522083|NCT00291590|behavioral change|behavioral change
522084|NCT00291590|chronic care model|chronic care model
522085|NCT00291590|stage of change|stage of change
522086|NCT00291590|Medicaid|medicaid
522087|NCT00291590|Dual eligible|dual eligible
522088|NCT00291590|ethnic|ethnic
522089|NCT00291590|self-care|self-care
522090|NCT00291603|dialysis|dialysis
522091|NCT00291603|Renal Dialysis|renal dialysis
522092|NCT00291603|inflammation|inflammation
522093|NCT00291603|quality of life|quality of life
522094|NCT00291603|End Stage Kidney Failure|end stage kidney failure
522095|NCT00291616|chronic hepatitis B, pegylated interferon, thymosin alpha|chronic hepatitis b, pegylated interferon, thymosin alpha
522096|NCT00291629|Myocardial infarction|myocardial infarction
522097|NCT00291629|revascularization|revascularization
522098|NCT00291629|drug eluting stents|drug eluting stents
522099|NCT00291642|Levocetirizine, Xyzal, Rhinitis, Allergic, Seasonal, Ragweed|levocetirizine, xyzal, rhinitis, allergic, seasonal, ragweed
522100|NCT00291655|NEWLY DIAGNOSED EPILEPSY|newly diagnosed epilepsy
522101|NCT00291655|LEVETIRACETAM|levetiracetam
522102|NCT00291655|KEPPRA|keppra
522103|NCT00291655|N01175 (NCT00175903)|n01175 (nct00175903)
522104|NCT00291668|Crohn's Disease|crohn's disease
522105|NCT00291668|CDP870, Certolizumab pegol|cdp870, certolizumab pegol
522106|NCT00291681|Inflammatory Bowel Disease|inflammatory bowel disease
522107|NCT00291681|B cell selection|b cell selection
522108|NCT00291694|breast atypia|breast atypia
522109|NCT00291694|double-blind randomized clinical trial|double-blind randomized clinical trial
522110|NCT00291694|RCT|rct
522111|NCT00291694|celecoxib|celecoxib
522112|NCT00291694|COX-2 inhibitor|cox-2 inhibitor
522113|NCT00291694|placebo|placebo
522114|NCT00291694|high risk for breast cancer|high risk for breast cancer
522115|NCT00291694|breast epithelial hyperplasia|breast epithelial hyperplasia
522116|NCT00291694|ki-67|ki-67
522117|NCT00291694|chemoprevention|chemoprevention
522118|NCT00291707|head|head
522119|NCT00291707|neck|neck
522120|NCT00291707|Cetuximab|cetuximab
522121|NCT00291707|Pemetrexed|pemetrexed
522122|NCT00291720|Aldosterone|aldosterone
522123|NCT00291720|Spironolactone|spironolactone
522124|NCT00291720|Chronic Kidney Disease|chronic kidney disease
522125|NCT00291720|Arterial Stiffness|arterial stiffness
522126|NCT00291733|Levetiracetam|levetiracetam
522127|NCT00291733|Levodopa-induced dyskinesias|levodopa-induced dyskinesias
522128|NCT00291733|Parkinson's|parkinson's
522129|NCT00291746|GERD|gerd
522130|NCT00291772|Type 1 Diabetes|type 1 diabetes
522131|NCT00291772|hypoglycemia|hypoglycemia
522132|NCT00291772|hyperglycemia|hyperglycemia
522133|NCT00291785|colorectal cancer|colorectal cancer
522134|NCT00291785|camptothecin|camptothecin
522135|NCT00291798|pilot study|pilot study
522136|NCT00291798|exemestane|exemestane
522137|NCT00291798|endocrinotherapy|endocrinotherapy
522138|NCT00291798|mamma carcinoma|mamma carcinoma
522139|NCT00291798|neoadjuvant|neoadjuvant
522140|NCT00291798|ABCSG|abcsg
522141|NCT00291798|17|17
522142|NCT00291811|AMD3100|amd3100
522143|NCT00291811|G-CSF|g-csf
522144|NCT00291824|Cardiovascular risks|cardiovascular risks
522145|NCT00291824|Motivational interviewing|motivational interviewing
522146|NCT00291824|Behavior change|behavior change
522147|NCT00291824|Primary care setting|primary care setting
522148|NCT00291837|ovarian|ovarian
522149|NCT00291837|CT-2106|ct-2106
522150|NCT00291850|NSCLC|nsclc
522151|NCT00291863|end stage renal failure|end stage renal failure
522152|NCT00291863|peritoneal dialysis|peritoneal dialysis
522153|NCT00291863|simvastatin|simvastatin
522154|NCT00291863|endothelium|endothelium
522155|NCT00291863|vasodilation|vasodilation
522156|NCT00291876|HAVRIX™|havrix™
522157|NCT00291876|Hepatitis A|hepatitis a
522158|NCT00291902|CHD|chd
522159|NCT00291902|coronary heart disease|coronary heart disease
522160|NCT00291902|atherosclerosis|atherosclerosis
522161|NCT00291902|inflammation|inflammation
522162|NCT00291915|early arthritis, methotrexate, adalimumab|early arthritis, methotrexate, adalimumab
522163|NCT00291941|Dialysis|dialysis
522164|NCT00291941|Pre-dialysis|pre-dialysis
522165|NCT00291941|Hepatitis B vaccine|hepatitis b vaccine
522166|NCT00291941|Prophylaxis|prophylaxis
522167|NCT00291954|Dialysis|dialysis
753953|NCT01178385|Treatment|treatment
522168|NCT00291954|Pre-dialysis|pre-dialysis
522169|NCT00291954|Hepatitis B vaccine|hepatitis b vaccine
522170|NCT00291954|Prophylaxis hepatitis B infection|prophylaxis hepatitis b infection
522171|NCT00291980|Dialysis|dialysis
522172|NCT00291980|Pre-dialysis|pre-dialysis
522173|NCT00291980|Hepatitis B vaccine|hepatitis b vaccine
522174|NCT00291980|Prophylaxis hepatitis B infection|prophylaxis hepatitis b infection
522175|NCT00291993|Obstructive sleep apnea|obstructive sleep apnea
522176|NCT00291993|Vasoactive hormones|vasoactive hormones
522177|NCT00291993|Blood pressure|blood pressure
522178|NCT00292006|clinical scaphoid fracture|clinical scaphoid fracture
522179|NCT00292006|pediatric|pediatric
522180|NCT00292032|cardiac arrest|cardiac arrest
522181|NCT00292032|diagnosis|diagnosis
522182|NCT00292032|genetics|genetics
522183|NCT00292032|testing|testing
522184|NCT00292045|NY-ESO-1 protein, immunization, advanced prostate cancer|ny-eso-1 protein, immunization, advanced prostate cancer
522185|NCT00292058|Telepsychiatry|telepsychiatry
522186|NCT00292058|Videoconference|videoconference
522187|NCT00292058|Psychiatric consultation|psychiatric consultation
522188|NCT00292058|Equivalence trial|equivalence trial
522189|NCT00292084|Hepatitis C|hepatitis c
522190|NCT00292084|Celgosivir|celgosivir
522191|NCT00292084|HCV|hcv
522192|NCT00292084|Genotype 1|genotype 1
522193|NCT00292084|Non-responders|non-responders
522194|NCT00292084|End of Treatment Response|end of treatment response
522195|NCT00292084|Sustained Viral Response|sustained viral response
522196|NCT00292097|Respiratory failure|respiratory failure
522197|NCT00292097|Tracheostomy|tracheostomy
522198|NCT00292097|Percutaneous dilatation tracheostomy|percutaneous dilatation tracheostomy
522199|NCT00292097|Endotracheal Conversion|endotracheal conversion
522200|NCT00292097|Traumatic brain injury|traumatic brain injury
522201|NCT00292110|HIV|hiv
522202|NCT00292110|Opiate Substitution|opiate substitution
522203|NCT00292110|Pharmacokinetics|pharmacokinetics
522204|NCT00292110|ECG|ecg
522205|NCT00292110|Polydrug Abuse|polydrug abuse
522206|NCT00292136|Cocaine Dependence|cocaine dependence
522207|NCT00292136|Drug Relapse|drug relapse
522208|NCT00292136|Pharmacokinetics|pharmacokinetics
522209|NCT00292136|EMA|ema
522210|NCT00292136|Polydrug Abuse|polydrug abuse
522211|NCT00292162|Chronic Heart Failure|chronic heart failure
522212|NCT00292162|Atrial Fibrillation|atrial fibrillation
522213|NCT00292162|Radiofrequency Ablation|radiofrequency ablation
522214|NCT00292175|colonoscopy, narrow band imaging (NBI), ulcerative colitis|colonoscopy, narrow band imaging (nbi), ulcerative colitis
522215|NCT00292188|Phase 4, post-traumatic neuropathic pain, neuropathic pain, Nep, post surgical pain, nerve injury, phantom limb pain, international|phase 4, post-traumatic neuropathic pain, neuropathic pain, nep, post surgical pain, nerve injury, phantom limb pain, international
522216|NCT00292201|Asthma|asthma
522217|NCT00292201|Statin|statin
522218|NCT00292214|paracetamol|paracetamol
522219|NCT00292214|acetaminophen|acetaminophen
522220|NCT00292214|pharmacokinetic|pharmacokinetic
522221|NCT00292214|intravenous|intravenous
522222|NCT00292214|oral|oral
522223|NCT00292214|analgesia|analgesia
522224|NCT00292214|pain|pain
522225|NCT00292214|opioid|opioid
522226|NCT00292227|advanced-stage idiopathic Parkinson's disease|advanced-stage idiopathic parkinson's disease
522227|NCT00292240|brief motivational intervention; teens; substance use|brief motivational intervention; teens; substance use
522228|NCT00292253|MS|ms
522229|NCT00292266|Relapsing-remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
522230|NCT00292266|Rebif®|rebif®
522231|NCT00292266|Avonex®|avonex®
522232|NCT00292266|interferon-beta-1a|interferon-beta-1a
522233|NCT00292279|Impact of Omega 3 fatty acid on outcome|impact of omega 3 fatty acid on outcome
522234|NCT00292279|Omega-3 fatty acid|omega-3 fatty acid
522235|NCT00292279|Carcinoma surgery|carcinoma surgery
522236|NCT00292279|Digestive System|digestive system
522237|NCT00292279|Parenteral Nutrition|parenteral nutrition
522238|NCT00292279|Fat Emulsions, Intravenous|fat emulsions, intravenous
522239|NCT00292279|Clinical outcome|clinical outcome
522240|NCT00292279|SIRS|sirs
522241|NCT00292279|Infectious complication|infectious complication
522242|NCT00292279|Postoperative hospital stay|postoperative hospital stay
522243|NCT00292279|Cost of postoperative period|cost of postoperative period
522244|NCT00292279|Post-operative nutritional cost & total treatment cost|post-operative nutritional cost & total treatment cost
522245|NCT00292305|PCI|pci
522246|NCT00292305|Bifurcation lesion|bifurcation lesion
522247|NCT00292318|adequate relief|adequate relief
522248|NCT00292318|anorectal manometry|anorectal manometry
522249|NCT00292318|biofeedback therapy|biofeedback therapy
522250|NCT00292318|fecal incontinence|fecal incontinence
522251|NCT00292331|gastric varices|gastric varices
522252|NCT00292331|liver cirrhosis|liver cirrhosis
522253|NCT00292331|hepatocelluar carcinoma|hepatocelluar carcinoma
522254|NCT00292331|rebleeding|rebleeding
522255|NCT00292331|long-term|long-term
522256|NCT00292344|Travelers' diarrhea|travelers' diarrhea
522257|NCT00292344|rifaximin|rifaximin
522258|NCT00292344|loperamide|loperamide
522259|NCT00292344|enterotoxigenic E. coli|enterotoxigenic e. coli
522260|NCT00292370|Atypical Antipsychotics|atypical antipsychotics
522261|NCT00292370|Controlled Trial|controlled trial
522262|NCT00292370|Paroxetine|paroxetine
522263|NCT00292370|Quetiapine|quetiapine
522264|NCT00292370|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
583536|NCT00512096|Platinol|platinol
522265|NCT00292370|Treatment refractory|treatment refractory
522266|NCT00292370|Treatment resistant|treatment resistant
522267|NCT00292383|Cardiac Pacing, artificial|cardiac pacing, artificial
522268|NCT00292383|Atrial Fibrillation|atrial fibrillation
522269|NCT00292383|Heart failure|heart failure
522270|NCT00292383|Pacemaker leads|pacemaker leads
522271|NCT00292383|Lead position|lead position
522272|NCT00292383|Higher degree AV-Block|higher degree av-block
522273|NCT00292422|Arthritis, Rheumatoid|arthritis, rheumatoid
522274|NCT00292422|Methotrexate|methotrexate
522275|NCT00292422|Antirheumatic Agents|antirheumatic agents
522276|NCT00292461|Epilepsy|epilepsy
522277|NCT00292461|seizures|seizures
522278|NCT00292474|coronary artery disease|coronary artery disease
522279|NCT00292474|percutaneous coronary interventions|percutaneous coronary interventions
523024|NCT00294788|bioadjuvant|bioadjuvant
522280|NCT00292474|stent implant|stent implant
522281|NCT00292474|drug-coated stent|drug-coated stent
522282|NCT00292500|CABG, anastomotic device; myocardial revascularization|cabg, anastomotic device; myocardial revascularization
522283|NCT00292526|Chemotherapy induced cardiotoxicity|chemotherapy induced cardiotoxicity
522284|NCT00292526|Troponin|troponin
522285|NCT00292526|Heart failure|heart failure
522286|NCT00292539|Pacemaker|pacemaker
522287|NCT00292539|NYHA class|nyha class
522288|NCT00292539|Ejection fraction|ejection fraction
522289|NCT00292539|Heart Failure|heart failure
522290|NCT00292552|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
522291|NCT00292552|longitudinal|longitudinal
522293|NCT00292578|Allergy|allergy
522294|NCT00292578|Sugar Intolerance|sugar intolerance
522295|NCT00292578|Fatigue|fatigue
522296|NCT00292591|vitamin D|vitamin d
522297|NCT00292591|cholecalciferol|cholecalciferol
522298|NCT00292591|pregnancy|pregnancy
522299|NCT00292591|bone mineral density|bone mineral density
522300|NCT00292656|Allergy|allergy
522301|NCT00292708|Antibiotics|antibiotics
522302|NCT00292708|Prophylaxis|prophylaxis
522303|NCT00292708|Surgical wound infection|surgical wound infection
522304|NCT00292773|Anovulation|anovulation
522305|NCT00292773|Obesity|obesity
522306|NCT00292773|bariatric surgery|bariatric surgery
522307|NCT00292786|Functional Electrical Stimulation|functional electrical stimulation
522308|NCT00292786|FES|fes
522309|NCT00292786|Walking|walking
522310|NCT00292786|Practice|practice
522311|NCT00292786|Coordination|coordination
522312|NCT00292786|Posture|posture
522313|NCT00292799|Polycystic ovary syndrome|polycystic ovary syndrome
522314|NCT00292799|Obesity|obesity
522315|NCT00292799|metformin|metformin
522316|NCT00292799|orlistat|orlistat
522317|NCT00292812|Infant nutrition|infant nutrition
522318|NCT00292812|Nucleotides|nucleotides
522319|NCT00292812|Infant formula|infant formula
522320|NCT00292825|vasovagal syncope|vasovagal syncope
522321|NCT00292825|syncope|syncope
522322|NCT00292825|cardioinhibitory syncope|cardioinhibitory syncope
522323|NCT00292825|neurocardiogenic syncope|neurocardiogenic syncope
522324|NCT00292825|pacing|pacing
522325|NCT00292825|closed loop pacing|closed loop pacing
522326|NCT00292825|tilt table|tilt table
522327|NCT00292838|Eosinophilic bronchitis with asthma|eosinophilic bronchitis with asthma
522328|NCT00292838|Eosinophilic bronchitis without asthma|eosinophilic bronchitis without asthma
522329|NCT00292864|Cancer|cancer
522330|NCT00292864|Carcinoma|carcinoma
522331|NCT00292864|Adenocarcinoma|adenocarcinoma
522332|NCT00292864|Tumor|tumor
522333|NCT00292864|Advanced solid tumors|advanced solid tumors
522334|NCT00292877|1. Eosinophilic bronchitis, 2. Asthma, 3. Steroid dependent asthma, 4. Sputum eosinophils, 5. SB-240563 (Mepolizumab)|1. eosinophilic bronchitis, 2. asthma, 3. steroid dependent asthma, 4. sputum eosinophils, 5. sb-240563 (mepolizumab)
522335|NCT00292890|injection devices|injection devices
522336|NCT00292890|injection technique|injection technique
522337|NCT00292890|insulin needles|insulin needles
522338|NCT00292890|insulin administration|insulin administration
522339|NCT00292903|Perinatal Depression|perinatal depression
522340|NCT00292903|Interpersonal Psychotherapy|interpersonal psychotherapy
522341|NCT00292916|whole body vibration|whole body vibration
522342|NCT00292916|exercise|exercise
522343|NCT00292916|elderly woman|elderly woman
522344|NCT00292916|Bone Mineral Density|bone mineral density
522345|NCT00292916|falls|falls
522346|NCT00292916|higher age|higher age
522347|NCT00292929|artesunate|artesunate
522348|NCT00292929|artemisinin|artemisinin
522349|NCT00292929|falciparum|falciparum
522350|NCT00292942|artesunate|artesunate
522351|NCT00292942|artemisinin|artemisinin
522352|NCT00292942|falciparum|falciparum
522353|NCT00292955|Cervical Cancer, Cetuximab, Phase II Clinical Trials|cervical cancer, cetuximab, phase ii clinical trials
522354|NCT00292955|Stage IB2-IVB Carcinoma of the Cervix|stage ib2-ivb carcinoma of the cervix
522355|NCT00292968|Health Behavior|health behavior
522356|NCT00292968|Prevention|prevention
522357|NCT00292968|Informatics|informatics
522358|NCT00292968|Electronic Health Record|electronic health record
522359|NCT00292981|C1 Inhibitor|c1 inhibitor
522360|NCT00292981|Hereditary angioedema|hereditary angioedema
522361|NCT00292981|Acute HAE attack|acute hae attack
522362|NCT00292994|Metabolic Syndrome|metabolic syndrome
522363|NCT00292994|Hyperlipidemia|hyperlipidemia
522364|NCT00292994|Type 2 diabetes mellitus|type 2 diabetes mellitus
522365|NCT00292994|Insulin resistance|insulin resistance
522366|NCT00292994|Weight loss|weight loss
522367|NCT00292994|Obesity|obesity
522368|NCT00292994|Exercise|exercise
522369|NCT00292994|Hypertension|hypertension
522370|NCT00293020|Breakthrough Pain in Cancer Patients|breakthrough pain in cancer patients
522371|NCT00293033|Breakthrough Pain in Cancer Patients|breakthrough pain in cancer patients
522372|NCT00293046|Allergy|allergy
522373|NCT00293059|Dysfunctional Uterine Bleeding|dysfunctional uterine bleeding
522374|NCT00293072|Rituximab, ANCA, vasculitis, lupus,|rituximab, anca, vasculitis, lupus,
522375|NCT00293085|NSCLC|nsclc
522376|NCT00293085|Docetaxel|docetaxel
522377|NCT00293098|Iron overload|iron overload
522378|NCT00293098|Thalassemia|thalassemia
522379|NCT00293098|Iron induced heart disease|iron induced heart disease
522380|NCT00293098|deferoxamine (Desferal)|deferoxamine (desferal)
522381|NCT00293098|Deferiprone|deferiprone
522382|NCT00293111|Multiple Myeloma|multiple myeloma
522383|NCT00293111|Relapsed Multiple Myeloma|relapsed multiple myeloma
522384|NCT00293111|Refractory Multiple Myeloma|refractory multiple myeloma
522385|NCT00293124|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
522387|NCT00293137|Chronic systolic heart failure|chronic systolic heart failure
522388|NCT00293137|Heart Failure|heart failure
522389|NCT00293150|diastolic heart failure|diastolic heart failure
522390|NCT00293150|heart failure|heart failure
522391|NCT00293176|Cognitive impairment|cognitive impairment
522392|NCT00293176|Memory Loss|memory loss
522393|NCT00293189|hip fracture|hip fracture
522394|NCT00293189|epidemiology|epidemiology
522395|NCT00293189|genetics|genetics
522396|NCT00293189|p2x7|p2x7
522397|NCT00293202|etanercept|etanercept
522398|NCT00293202|malnutrition|malnutrition
522399|NCT00293202|inflammation|inflammation
522400|NCT00293202|hemodialysis|hemodialysis
522401|NCT00293228|Latent tuberculosis|latent tuberculosis
522402|NCT00293228|biomarkers|biomarkers
522403|NCT00293228|isoniazid|isoniazid
522405|NCT00293228|PPD positive individuals|ppd positive individuals
522406|NCT00293241|Pacemaker or ICD replacement|pacemaker or icd replacement
522407|NCT00293254|Treatment Experienced|treatment experienced
522408|NCT00293267|Treatment Experienced|treatment experienced
522409|NCT00293280|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
522410|NCT00293280|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
522411|NCT00293280|adenocarcinoma of the lung|adenocarcinoma of the lung
522412|NCT00293280|adenosquamous cell lung cancer|adenosquamous cell lung cancer
522413|NCT00293280|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
522414|NCT00293280|large cell lung cancer|large cell lung cancer
522415|NCT00293280|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
522416|NCT00293280|squamous cell lung cancer|squamous cell lung cancer
522417|NCT00293293|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
522418|NCT00293293|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
522419|NCT00293293|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
522420|NCT00293293|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
522421|NCT00293293|peritoneal cavity cancer|peritoneal cavity cancer
522422|NCT00293319|recurrent neuroblastoma|recurrent neuroblastoma
522423|NCT00293332|stage I non-small cell lung cancer|stage i non-small cell lung cancer
522424|NCT00293332|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
522425|NCT00293332|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
522426|NCT00293358|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
522427|NCT00293358|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
522428|NCT00293358|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
522429|NCT00293358|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
522430|NCT00293358|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
522431|NCT00293371|adenocarcinoma of the prostate|adenocarcinoma of the prostate
522432|NCT00293371|recurrent prostate cancer|recurrent prostate cancer
522433|NCT00293371|stage IV prostate cancer|stage iv prostate cancer
674153|NCT00872794|Hip|hip
522434|NCT00293384|nausea and vomiting|nausea and vomiting
522435|NCT00293384|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
522436|NCT00293384|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
522437|NCT00293384|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
522438|NCT00293384|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
522439|NCT00293384|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
522440|NCT00293384|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
522441|NCT00293384|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
583537|NCT00512096|CDDP|cddp
754058|NCT01178762|Chlamydial Conjunctivitis|chlamydial conjunctivitis
522442|NCT00293384|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
522443|NCT00293384|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
522444|NCT00293384|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
522445|NCT00293384|chronic eosinophilic leukemia|chronic eosinophilic leukemia
522446|NCT00293384|primary myelofibrosis|primary myelofibrosis
522447|NCT00293384|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
522448|NCT00293384|chronic neutrophilic leukemia|chronic neutrophilic leukemia
522449|NCT00293384|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
522450|NCT00293384|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
522451|NCT00293384|disseminated neuroblastoma|disseminated neuroblastoma
522452|NCT00293384|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
522453|NCT00293384|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
522454|NCT00293384|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
522455|NCT00293384|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
522456|NCT00293384|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
522457|NCT00293384|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
522458|NCT00293384|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
522645|NCT00293579|head and neck cancer|head and neck cancer
522459|NCT00293384|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
522460|NCT00293384|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
522461|NCT00293384|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
522462|NCT00293384|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
522463|NCT00293384|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
522464|NCT00293384|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
522465|NCT00293384|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
522466|NCT00293384|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
522467|NCT00293384|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
522468|NCT00293384|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
522469|NCT00293384|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
522470|NCT00293384|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
522471|NCT00293384|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
522472|NCT00293384|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
522473|NCT00293384|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
522474|NCT00293384|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
522475|NCT00293384|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
522476|NCT00293384|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
522477|NCT00293384|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
522478|NCT00293384|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
522479|NCT00293384|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
522480|NCT00293384|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
522481|NCT00293384|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
522482|NCT00293384|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
522483|NCT00293384|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
522484|NCT00293384|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
522485|NCT00293384|recurrent neuroblastoma|recurrent neuroblastoma
522486|NCT00293384|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
522487|NCT00293384|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
522488|NCT00293384|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
522489|NCT00293384|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
522490|NCT00293384|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
522491|NCT00293384|refractory hairy cell leukemia|refractory hairy cell leukemia
522492|NCT00293384|refractory multiple myeloma|refractory multiple myeloma
522493|NCT00293384|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
522494|NCT00293384|secondary acute myeloid leukemia|secondary acute myeloid leukemia
522495|NCT00293384|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
522496|NCT00293384|splenic marginal zone lymphoma|splenic marginal zone lymphoma
522497|NCT00293384|stage I multiple myeloma|stage i multiple myeloma
522498|NCT00293384|stage II multiple myeloma|stage ii multiple myeloma
522499|NCT00293384|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
522500|NCT00293384|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
583538|NCT00512096|Ifosfamide|ifosfamide
522501|NCT00293384|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
522502|NCT00293384|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
754059|NCT01178775|fatigue|fatigue
522503|NCT00293384|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
522504|NCT00293384|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
522505|NCT00293384|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
522506|NCT00293384|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
522507|NCT00293384|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
522508|NCT00293384|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
522509|NCT00293384|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
522510|NCT00293384|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
522511|NCT00293384|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
522512|NCT00293384|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
522513|NCT00293384|stage III multiple myeloma|stage iii multiple myeloma
522514|NCT00293384|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
523025|NCT00294788|probiotic|probiotic
522515|NCT00293384|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
522516|NCT00293384|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
522517|NCT00293384|stage IIIA breast cancer|stage iiia breast cancer
522518|NCT00293384|stage IIIB breast cancer|stage iiib breast cancer
522519|NCT00293384|stage IIIC breast cancer|stage iiic breast cancer
522520|NCT00293384|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
522521|NCT00293384|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
522522|NCT00293384|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
522523|NCT00293384|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
522524|NCT00293384|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
522525|NCT00293384|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
522526|NCT00293384|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
522527|NCT00293384|stage IV breast cancer|stage iv breast cancer
522528|NCT00293384|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
522529|NCT00293384|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
522530|NCT00293384|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
522531|NCT00293384|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
522532|NCT00293384|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
522533|NCT00293384|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
522534|NCT00293384|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
522535|NCT00293384|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
522536|NCT00293397|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
522537|NCT00293397|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
522538|NCT00293410|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
522539|NCT00293410|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
522540|NCT00293410|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
522541|NCT00293410|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
522542|NCT00293410|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
522543|NCT00293410|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
522544|NCT00293410|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
522545|NCT00293410|secondary acute myeloid leukemia|secondary acute myeloid leukemia
522546|NCT00293410|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
522547|NCT00293410|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
522548|NCT00293410|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
522549|NCT00293410|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
522550|NCT00293410|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
522551|NCT00293410|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
522552|NCT00293410|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
674401|NCT00873717|elderly|elderly
522553|NCT00293410|acute undifferentiated leukemia|acute undifferentiated leukemia
522554|NCT00293410|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
522555|NCT00293410|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
522556|NCT00293410|adult acute basophilic leukemia|adult acute basophilic leukemia
522557|NCT00293410|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
522558|NCT00293410|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
522559|NCT00293410|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
522560|NCT00293410|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
522561|NCT00293410|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
583539|NCT00512096|Ifex|ifex
583540|NCT00512096|Paclitaxel|paclitaxel
522562|NCT00293410|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
522563|NCT00293410|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
522564|NCT00293410|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
522565|NCT00293410|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
522566|NCT00293410|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
522567|NCT00293410|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
522568|NCT00293410|childhood acute basophilic leukemia|childhood acute basophilic leukemia
522569|NCT00293410|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
522570|NCT00293410|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
522571|NCT00293410|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
522572|NCT00293410|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
522573|NCT00293410|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
522574|NCT00293410|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
522575|NCT00293410|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
523026|NCT00294788|HAI|hai
522576|NCT00293410|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
522577|NCT00293410|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
522578|NCT00293410|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
522579|NCT00293423|adult glioblastoma|adult glioblastoma
522580|NCT00293423|recurrent adult brain tumor|recurrent adult brain tumor
522581|NCT00293436|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
522582|NCT00293436|advanced adult primary liver cancer|advanced adult primary liver cancer
522583|NCT00293436|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
522584|NCT00293462|mucositis|mucositis
522585|NCT00293462|radiation toxicity|radiation toxicity
522644|NCT00293540|Hormone Receptor-Positive Breast Cancer|hormone receptor-positive breast cancer
523142|NCT00295360|bile acids|bile acids
522586|NCT00293462|recurrent squamous and basal cell carcinoma of the hypopharynx,larynx,lip,nasopharynx|recurrent squamous and basal cell carcinoma of the hypopharynx,larynx,lip,nasopharynx
522587|NCT00293462|oropharynx, paranasal sinus and nasal cavity|oropharynx, paranasal sinus and nasal cavity
522588|NCT00293462|stage I-IV lymphoepithelioma of the nasopharynx|stage i-iv lymphoepithelioma of the nasopharynx
522589|NCT00293462|stage I-IV lymphoepithelioma of the oropharynx|stage i-iv lymphoepithelioma of the oropharynx
522590|NCT00293462|Recurrent and stage I-IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent and stage i-iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
522591|NCT00293462|Recurrent and stage I-IV inverted papilloma of the paranasal sinus and nasal cavity|recurrent and stage i-iv inverted papilloma of the paranasal sinus and nasal cavity
522592|NCT00293462|Recurrent and stage I-IV midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent and stage i-iv midline lethal granuloma of the paranasal sinus and nasal cavity
522593|NCT00293462|untreated, current,metastatic squamous neck cancer with occult primary|untreated, current,metastatic squamous neck cancer with occult primary
522594|NCT00293462|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
522595|NCT00293462|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
522596|NCT00293462|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
522597|NCT00293462|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
522598|NCT00293462|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
522599|NCT00293462|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
522600|NCT00293462|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
522601|NCT00293462|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
522602|NCT00293462|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
522603|NCT00293462|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
522604|NCT00293462|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
522605|NCT00293462|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
754056|NCT01178749|Quality of Life|quality of life
522606|NCT00293462|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
522607|NCT00293462|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
522608|NCT00293462|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
522609|NCT00293462|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
522610|NCT00293462|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
522611|NCT00293462|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
522612|NCT00293462|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
522613|NCT00293462|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
522614|NCT00293462|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
583541|NCT00512096|Taxol|taxol
522615|NCT00293462|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
522616|NCT00293462|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
522617|NCT00293462|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
522618|NCT00293462|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
522619|NCT00293462|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
522620|NCT00293462|tongue cancer|tongue cancer
522621|NCT00293488|anaplastic large cell lymphoma|anaplastic large cell lymphoma
522622|NCT00293488|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
522623|NCT00293488|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
522624|NCT00293488|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
522625|NCT00293488|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
522626|NCT00293488|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
522627|NCT00293488|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
522628|NCT00293488|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
522629|NCT00293488|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
523027|NCT00294788|immunity|immunity
522630|NCT00293488|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
522631|NCT00293488|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
522632|NCT00293488|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
522633|NCT00293488|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
522634|NCT00293488|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
522635|NCT00293488|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
522636|NCT00293488|splenic marginal zone lymphoma|splenic marginal zone lymphoma
522637|NCT00293501|clear cell renal cell carcinoma|clear cell renal cell carcinoma
522638|NCT00293501|stage IV renal cell cancer|stage iv renal cell cancer
522639|NCT00293501|recurrent renal cell cancer|recurrent renal cell cancer
522640|NCT00293514|standard surgical treatment for air leakage in pulmonary lobectomy|standard surgical treatment for air leakage in pulmonary lobectomy
522641|NCT00293527|Metastatic|metastatic
522642|NCT00293540|metastatic|metastatic
522643|NCT00293540|secondary|secondary
522646|NCT00293592|Heart surgery|heart surgery
522647|NCT00293592|Cardiopulmonary bypass|cardiopulmonary bypass
522648|NCT00293592|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
522649|NCT00293605|aseptic loosening|aseptic loosening
522650|NCT00293605|femoral stem design|femoral stem design
522651|NCT00293618|Implementation of prediction rules|implementation of prediction rules
522652|NCT00293618|Decision Support Systems, Clinical|decision support systems, clinical
522653|NCT00293618|PONV|ponv
522654|NCT00293618|Emesis|emesis
522655|NCT00293618|Nausea|nausea
522656|NCT00293618|Vomiting|vomiting
522657|NCT00293618|Postoperative|postoperative
522658|NCT00293618|Implementation|implementation
522659|NCT00293618|prediction rule|prediction rule
522660|NCT00293618|impact study|impact study
522661|NCT00293618|decision support|decision support
522662|NCT00293618|clinical decision support|clinical decision support
522663|NCT00293644|Pregnancy Complications|pregnancy complications
522664|NCT00293644|Hyperemesis Gravidarum|hyperemesis gravidarum
522665|NCT00293644|Diclectin|diclectin
522666|NCT00293644|doxylamine succinate|doxylamine succinate
522667|NCT00293644|pyridoxine hydrochloride|pyridoxine hydrochloride
522668|NCT00293683|cesarean|cesarean
522669|NCT00293683|closure|closure
522670|NCT00293683|skin|skin
522671|NCT00293683|staple|staple
522672|NCT00293683|absorbable|absorbable
522673|NCT00293683|metal|metal
522674|NCT00279942|Fibromyalgia|fibromyalgia
522675|NCT00279942|Dietary Supplements|dietary supplements
522676|NCT00279942|Rheumatologic Diseases|rheumatologic diseases
522677|NCT00279942|Complementary and Alternative Medicine|complementary and alternative medicine
522678|NCT00279955|Heart Failure, Congestive|heart failure, congestive
522679|NCT00279955|Implantable Cardioverter-Defibrillators|implantable cardioverter-defibrillators
522680|NCT00279968|ICD|icd
522681|NCT00279968|Registry|registry
522682|NCT00279968|Ventricular tachycardia|ventricular tachycardia
522683|NCT00279968|Ventricular Fibrillation|ventricular fibrillation
522684|NCT00279981|Atrial fibrillation|atrial fibrillation
522685|NCT00279981|Stroke|stroke
522686|NCT00279981|Pacemaker|pacemaker
522687|NCT00279981|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
522688|NCT00279981|Resynchronization systems|resynchronization systems
522689|NCT00279994|Intermittent claudication|intermittent claudication
522690|NCT00279994|Exercise therapy|exercise therapy
522691|NCT00279994|Therapy feedback|therapy feedback
522692|NCT00279994|Accelerometer|accelerometer
522693|NCT00279994|Physiotherapy|physiotherapy
522694|NCT00279994|PAD;|pad;
522695|NCT00279994|peripheral arterial disease according to Fontaine stage II)|peripheral arterial disease according to fontaine stage ii)
522696|NCT00280007|hepatocellular carcinoma|hepatocellular carcinoma
522698|NCT00280007|transarterial chemoembolisation|transarterial chemoembolisation
522699|NCT00280007|portal hypertension|portal hypertension
522700|NCT00280007|angiogenesis|angiogenesis
522701|NCT00280007|VEGF|vegf
522702|NCT00280007|bevacizumab|bevacizumab
522703|NCT00280020|sleep disorders|sleep disorders
522704|NCT00280020|meditation|meditation
522705|NCT00280020|cognitive behavior therapy|cognitive behavior therapy
522706|NCT00280033|H5N1, Influenza, vaccine, parent protocol|h5n1, influenza, vaccine, parent protocol
522707|NCT00280059|Epilepsy|epilepsy
522708|NCT00280059|partial seizures|partial seizures
754060|NCT01178775|meaning|meaning
522709|NCT00280059|pregabalin monotherapy|pregabalin monotherapy
522710|NCT00280059|lamotrigine comparator|lamotrigine comparator
522711|NCT00280059|double-blind and randomized trial|double-blind and randomized trial
522712|NCT00280072|Renal Failure, Acute|renal failure, acute
522713|NCT00280072|Acute Kidney Failure|acute kidney failure
522714|NCT00280072|Acute Renal Failure|acute renal failure
522715|NCT00280072|Acute Tubular Necrosis|acute tubular necrosis
522717|NCT00280072|Renal Dialysis|renal dialysis
522718|NCT00280072|Acute Kidney Injury|acute kidney injury
522719|NCT00280111|rotavirus|rotavirus
522720|NCT00280111|vaccine|vaccine
522721|NCT00280111|safety|safety
522722|NCT00280111|immunogenicity|immunogenicity
522723|NCT00280111|infants|infants
522724|NCT00280137|Quality of Life|quality of life
523028|NCT00294788|vaccine|vaccine
522725|NCT00280137|Pediatric Systemic Lupus Erythematosus|pediatric systemic lupus erythematosus
522726|NCT00280150|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
522727|NCT00280150|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
522728|NCT00280150|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
522729|NCT00280150|squamous cell lung cancer|squamous cell lung cancer
522730|NCT00280163|Genomics, cardiac surgery|genomics, cardiac surgery
522731|NCT00280176|recurrent rectal cancer|recurrent rectal cancer
522732|NCT00280176|stage II rectal cancer|stage ii rectal cancer
522733|NCT00280176|stage III rectal cancer|stage iii rectal cancer
522734|NCT00280176|stage IV rectal cancer|stage iv rectal cancer
522735|NCT00280176|adenocarcinoma of the rectum|adenocarcinoma of the rectum
522736|NCT00280189|Radiofrequency ablation|radiofrequency ablation
522737|NCT00280189|Pulmonary malignancies|pulmonary malignancies
522738|NCT00280189|Primary lung cancer|primary lung cancer
522739|NCT00280189|Pulmonary metastasis|pulmonary metastasis
522740|NCT00280189|Primary lung tumors|primary lung tumors
522741|NCT00280189|Secondary lung tumors|secondary lung tumors
522742|NCT00280189|Coagulation necrosis of soft tissue tumors|coagulation necrosis of soft tissue tumors
522743|NCT00280202|Non-small cell lung cancer|non-small cell lung cancer
522744|NCT00280202|Carcinogenesis|carcinogenesis
522745|NCT00280202|Genomic changes leading to malignant phenotypes in NSCLC.|genomic changes leading to malignant phenotypes in nsclc.
522746|NCT00280202|Simultaneous mutagenesis of epithelial cells.|simultaneous mutagenesis of epithelial cells.
522747|NCT00280202|Chromosomal abnormalities/mutations in bronchial tissues.|chromosomal abnormalities/mutations in bronchial tissues.
522748|NCT00280202|Detect micrometastases in histologically neg. lymph nodes|detect micrometastases in histologically neg. lymph nodes
522749|NCT00285623|Collection of all thromboembolic events,|collection of all thromboembolic events,
522750|NCT00285623|immunological events and drug interactions leading to thromboembolic events or major|immunological events and drug interactions leading to thromboembolic events or major
522751|NCT00285623|bleeding after exposure to TachoSil®.|bleeding after exposure to tachosil®.
522752|NCT00285636|Long Term Follow-Up|long term follow-up
522753|NCT00285649|Spinal Manipulation|spinal manipulation
522755|NCT00285662|Malaria|malaria
522756|NCT00285662|Anemia|anemia
522757|NCT00285662|Prevention|prevention
522758|NCT00285662|Infant|infant
522759|NCT00285662|Artesunate|artesunate
522760|NCT00285662|SP|sp
522761|NCT00285662|Amodiaquine|amodiaquine
522762|NCT00285662|Papua New Guinea|papua new guinea
522763|NCT00285675|Calcitriol, DN-101, Androgen Independent Prostate Cancer (AIPC), Prostate Cancer, Non Small Cell Lung Cancer (NSCLC)|calcitriol, dn-101, androgen independent prostate cancer (aipc), prostate cancer, non small cell lung cancer (nsclc)
522764|NCT00285688|H. Pylori, Clarithromycin resistant, gene|h. pylori, clarithromycin resistant, gene
522292|NCT00292552|eclipse|eclipse
522765|NCT00285714|3D computer assisted imaging|3d computer assisted imaging
522766|NCT00285714|maxillofacial surgery|maxillofacial surgery
522767|NCT00285714|cephalometry|cephalometry
522768|NCT00285714|normative value|normative value
522769|NCT00285753|psychosocial intervention|psychosocial intervention
522770|NCT00285753|mild cognitive impairment|mild cognitive impairment
522771|NCT00285753|support group|support group
522772|NCT00285753|caregivers|caregivers
522773|NCT00285753|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
522774|NCT00285753|Cognitive Impairment No Dementia (CIND)|cognitive impairment no dementia (cind)
522775|NCT00293696|biomarker study|biomarker study
522776|NCT00293696|Patients with clinically localised prostate cancer|patients with clinically localised prostate cancer
522777|NCT00293709|Arthritis|arthritis
522778|NCT00293722|Arthritis|arthritis
522779|NCT00293735|Preeclampsia|preeclampsia
522780|NCT00293735|Pregnancy|pregnancy
522781|NCT00293735|Hypertension|hypertension
522782|NCT00293735|Eclampsia|eclampsia
522783|NCT00293735|HELLP Syndrome|hellp syndrome
522784|NCT00293735|Seizures|seizures
522785|NCT00293735|Prevention|prevention
522786|NCT00293748|Genomics|genomics
522787|NCT00293748|Statins|statins
522788|NCT00293748|Coronary Heart Disease|coronary heart disease
522789|NCT00293748|Stroke|stroke
522790|NCT00293748|Inflammation|inflammation
522791|NCT00293748|Gene Expression|gene expression
522792|NCT00293748|Vascular Risk|vascular risk
522793|NCT00293748|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
522794|NCT00293748|Atorvastatin|atorvastatin
522754|NCT00285662|IPTi|ipti
522795|NCT00293748|Vascular Disease|vascular disease
522796|NCT00293748|Vascular Disease Risk|vascular disease risk
522797|NCT00293761|open-angle|open-angle
522798|NCT00293761|glaucoma|glaucoma
522799|NCT00293761|ocular|ocular
522800|NCT00293761|hypertension|hypertension
522801|NCT00293774|Prospective|prospective
522802|NCT00293774|Conventional therapy|conventional therapy
522803|NCT00293774|Registry|registry
522804|NCT00293774|Metal-on-metal|metal-on-metal
522805|NCT00293774|Ceramic-on-ceramic|ceramic-on-ceramic
522806|NCT00293774|Hip Arthroplasty|hip arthroplasty
522807|NCT00293787|Open-angle|open-angle
522808|NCT00293787|glaucoma|glaucoma
522810|NCT00293787|hypertension|hypertension
522811|NCT00293800|Open-angle|open-angle
522812|NCT00293800|glaucoma|glaucoma
522813|NCT00293800|ocular|ocular
522814|NCT00293800|hypertension|hypertension
522815|NCT00293813|Post Menopausal|post menopausal
522816|NCT00293813|Osteoporosis|osteoporosis
522817|NCT00293813|MicroCT|microct
522818|NCT00293813|Amgen|amgen
522819|NCT00293813|denosumab|denosumab
522820|NCT00293813|Extreme CT|extreme ct
522821|NCT00293813|XCT|xct
522822|NCT00293813|Fosamax|fosamax
522823|NCT00293813|Alendronate|alendronate
522824|NCT00293826|ACR criteria|acr criteria
522825|NCT00293826|methotrexate|methotrexate
522826|NCT00293826|DMARDs|dmards
522827|NCT00293826|patient reported outcomes|patient reported outcomes
522828|NCT00293826|joint assessment|joint assessment
522829|NCT00293839|bladder|bladder
522830|NCT00293839|overactive|overactive
522831|NCT00293852|Heart failure, Congestive|heart failure, congestive
522832|NCT00293852|Metabolic Syndrome X|metabolic syndrome x
522833|NCT00293852|Ambulatory Care|ambulatory care
522834|NCT00293852|Health behavior|health behavior
522835|NCT00293865|Breast infiltrative cancer|breast infiltrative cancer
522836|NCT00293891|Treatment Outcome|treatment outcome
522837|NCT00293891|Tacrolimus|tacrolimus
522838|NCT00293891|Safety|safety
522839|NCT00293891|Psoriasis|psoriasis
522840|NCT00293904|Allergy|allergy
522841|NCT00293904|Grass Pollen|grass pollen
522842|NCT00293904|Systemic Immunotherapy|systemic immunotherapy
522843|NCT00293917|Treatment Outcome|treatment outcome
522844|NCT00293917|Tacrolimus|tacrolimus
522845|NCT00293917|Safety|safety
522846|NCT00293917|Psoriasis|psoriasis
522847|NCT00293930|Treatment Outcome|treatment outcome
522848|NCT00293930|Tacrolimus|tacrolimus
522849|NCT00293930|Safety|safety
522850|NCT00293930|Psoriasis|psoriasis
522851|NCT00293943|Atrial fibrillation|atrial fibrillation
522852|NCT00293943|Pulmonary vein ablation|pulmonary vein ablation
522853|NCT00293943|Linear lesions|linear lesions
522854|NCT00293956|hypothyroxinemia|hypothyroxinemia
522855|NCT00293956|full term infants|full term infants
522856|NCT00293956|near term infants|near term infants
522857|NCT00293956|respiratory distress|respiratory distress
522858|NCT00293956|thyroid disease|thyroid disease
522859|NCT00293969|Pain|pain
522860|NCT00293969|Morphine|morphine
522861|NCT00293982|Patient satisfaction|patient satisfaction
522862|NCT00293982|Patient expectations|patient expectations
522863|NCT00293982|Pediatric emergency department|pediatric emergency department
522864|NCT00294008|Schizophrenia|schizophrenia
522865|NCT00294008|Treatment adherence|treatment adherence
522866|NCT00294008|Antipsychotic agents|antipsychotic agents
522867|NCT00294008|Risperidone|risperidone
522868|NCT00294008|Long-acting injectable|long-acting injectable
522869|NCT00294008|Risperdal tablet|risperdal tablet
522870|NCT00294008|Risperidal Consta|risperidal consta
522871|NCT00294242|pregnancy|pregnancy
522872|NCT00294242|membranes sweeping|membranes sweeping
522873|NCT00294242|prelabor rupture of membranes|prelabor rupture of membranes
522874|NCT00294255|mixed mania|mixed mania
522875|NCT00294255|depression|depression
522876|NCT00294255|irritability|irritability
522877|NCT00294268|obesity|obesity
522878|NCT00294268|CBT|cbt
522879|NCT00294268|motivational enhancement therapy|motivational enhancement therapy
522880|NCT00294268|weight loss maintenance|weight loss maintenance
522881|NCT00294281|Pain|pain
522882|NCT00294281|Tenderness|tenderness
522883|NCT00294281|Depression|depression
522884|NCT00294281|Work Disability|work disability
522885|NCT00294281|Physical Function|physical function
522886|NCT00294281|Quality of Life|quality of life
522887|NCT00294281|Chronic Pain|chronic pain
522888|NCT00294294|vaccine|vaccine
522889|NCT00294294|infant|infant
522890|NCT00294307|Nursing Models of Care|nursing models of care
522891|NCT00294307|Collaborative Care|collaborative care
522892|NCT00294307|Care Management|care management
522893|NCT00294307|Transitional Care|transitional care
522894|NCT00294307|Advanced Practice Nurse Care Interventions|advanced practice nurse care interventions
522895|NCT00294307|Cognitive Impairment|cognitive impairment
522896|NCT00294307|Dementia|dementia
522897|NCT00294307|Delirium|delirium
522898|NCT00294320|Aldara|aldara
522899|NCT00294320|Actinic Keratosis|actinic keratosis
522900|NCT00294346|Social Anxiety Disorder|social anxiety disorder
522901|NCT00294346|Social Phobia|social phobia
522902|NCT00294359|colorectal neoplasm|colorectal neoplasm
522903|NCT00294385|Breast Cancer|breast cancer
522904|NCT00294385|Docetaxel|docetaxel
522905|NCT00294398|Asthma, Controller Medications|asthma, controller medications
522906|NCT00294424|Waiting time|waiting time
522907|NCT00294424|Total hip replacement|total hip replacement
522908|NCT00294424|Total knee replacement|total knee replacement
522909|NCT00294424|Quality of life|quality of life
522911|NCT00294424|Harris Hip Score|harris hip score
522912|NCT00294424|Knee Score|knee score
522913|NCT00294424|Pain measurement|pain measurement
522914|NCT00294424|Cost-effectiveness|cost-effectiveness
522915|NCT00294424|Medication|medication
522916|NCT00294424|Health services|health services
522917|NCT00294424|Social services|social services
522918|NCT00294424|Randomized Controlled Trial|randomized controlled trial
522919|NCT00294437|Prostate Cancer|prostate cancer
522920|NCT00294437|Zometa|zometa
522921|NCT00294463|postmenopause|postmenopause
522922|NCT00294463|endometrium|endometrium
522923|NCT00294463|Gene Expression Profiling|gene expression profiling
522924|NCT00294463|Histology, Comparative|histology, comparative
522925|NCT00294463|Hormone Replacement Therapy|hormone replacement therapy
522926|NCT00294463|Hormones|hormones
522927|NCT00294476|IVIg|ivig
522928|NCT00294476|Cancer|cancer
522929|NCT00294476|Melanoma|melanoma
522930|NCT00294489|HCV|hcv
522931|NCT00294489|Fibrosis|fibrosis
522932|NCT00294489|Breath test|breath test
522933|NCT00294528|osteoarthritis, knee|osteoarthritis, knee
522934|NCT00294528|total knee arthroplasty|total knee arthroplasty
522935|NCT00294528|range of motion|range of motion
522936|NCT00294528|satisfaction|satisfaction
522937|NCT00294541|sickle cell disease|sickle cell disease
522938|NCT00294541|sickle cell anemia|sickle cell anemia
522939|NCT00294554|Parkinson's Disease|parkinson's disease
522940|NCT00294554|Cognitive Impairment|cognitive impairment
522941|NCT00294554|Dementia|dementia
522942|NCT00294554|Memory|memory
522943|NCT00294567|Hypertension|hypertension
522944|NCT00294567|PCI|pci
522945|NCT00294567|Calcium Channel Blockers|calcium channel blockers
522946|NCT00294567|IVUS|ivus
522947|NCT00294567|Plaque|plaque
522948|NCT00294580|Malaria|malaria
522949|NCT00294580|Cognition|cognition
522950|NCT00294580|Prevention & control|prevention & control
522951|NCT00294580|Anemia|anemia
522952|NCT00294580|Chemoprophylaxis|chemoprophylaxis
522953|NCT00294580|Mortality|mortality
522954|NCT00294580|Children|children
522955|NCT00294580|Randomized controlled trial|randomized controlled trial
522956|NCT00294580|Education|education
522957|NCT00294580|Long-term effects|long-term effects
522958|NCT00294580|The Gambia|the gambia
522959|NCT00294580|Africa, West|africa, west
522960|NCT00294593|Down syndrome|down syndrome
522961|NCT00294593|folinic acid therapy|folinic acid therapy
522962|NCT00294593|cognitive functions|cognitive functions
522963|NCT00294606|vasopressor agents|vasopressor agents
522964|NCT00294606|carotid endarterectomy|carotid endarterectomy
522965|NCT00294606|cardiac function|cardiac function
522966|NCT00294606|transesophageal echocardiography|transesophageal echocardiography
522967|NCT00294606|wall motion abnormalities|wall motion abnormalities
522968|NCT00294619|Growth hormone deficiency|growth hormone deficiency
522969|NCT00294632|Mantle Cell Lymphoma|mantle cell lymphoma
675043|NCT00869245|ACS|acs
522970|NCT00294632|B-Cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
522971|NCT00294632|Transformed Large Cell Lymphoma|transformed large cell lymphoma
522972|NCT00294632|Follicular Lymphoma|follicular lymphoma
522973|NCT00294632|Lymphoma|lymphoma
522974|NCT00294632|MCL|mcl
522975|NCT00294632|Lenalidomide|lenalidomide
522976|NCT00294632|CC-5013|cc-5013
522977|NCT00294632|Revlimid™|revlimid™
522978|NCT00294632|Rituximab|rituximab
522979|NCT00294632|Rituxan|rituxan
522980|NCT00294645|Remote Follow Up|remote follow up
522981|NCT00294645|Diagnostic|diagnostic
522982|NCT00294645|Bradycardia|bradycardia
522983|NCT00294658|myasthenia gravis|myasthenia gravis
522984|NCT00294658|thymectomy|thymectomy
522985|NCT00294658|prednisone|prednisone
522986|NCT00294658|corticosteroid|corticosteroid
522987|NCT00294658|extended transsternal thymectomy|extended transsternal thymectomy
522988|NCT00294658|ETTX|ettx
522989|NCT00294658|MG|mg
522990|NCT00294658|thymus|thymus
522992|NCT00294671|familial amyloid polyneuropathy|familial amyloid polyneuropathy
522993|NCT00294671|familial amyloidosis|familial amyloidosis
522994|NCT00294671|diflunisal|diflunisal
522995|NCT00294671|amyloidosis|amyloidosis
522996|NCT00294671|transthyretin|transthyretin
522997|NCT00294671|peripheral neuropathy|peripheral neuropathy
522998|NCT00294671|autonomic neuropathy|autonomic neuropathy
522999|NCT00294671|amyloid cardiomyopathy|amyloid cardiomyopathy
523000|NCT00294684|biliary atresia|biliary atresia
523001|NCT00294684|hepatoportoenterostomy|hepatoportoenterostomy
523002|NCT00294684|corticosteroids|corticosteroids
523003|NCT00294697|polymorphisms|polymorphisms
523004|NCT00294697|innate immune response|innate immune response
523005|NCT00294697|immunomonitoring|immunomonitoring
523006|NCT00294697|immuno paralysis|immuno paralysis
523007|NCT00294710|Hypertension, aliskiren, hydrochlorothiazide, amlodipine|hypertension, aliskiren, hydrochlorothiazide, amlodipine
523008|NCT00294736|lung cancer|lung cancer
523009|NCT00294736|erlotinib|erlotinib
523010|NCT00294736|NSCLC|nsclc
523011|NCT00294736|smokers|smokers
523012|NCT00294749|Prostate,|prostate,
523013|NCT00294749|Infection,|infection,
523014|NCT00294749|Biopsy,|biopsy,
523015|NCT00294749|Antibiotic,|antibiotic,
523016|NCT00294749|Prophylaxis|prophylaxis
523017|NCT00294762|NSCLC|nsclc
523018|NCT00294762|Erlotinib|erlotinib
523019|NCT00294762|Tarceva|tarceva
523020|NCT00294762|Lung Cancer|lung cancer
523021|NCT00294775|diastolic dysfunction|diastolic dysfunction
523022|NCT00294775|Reverse Remodelling|reverse remodelling
523023|NCT00294788|Influenza|influenza
523029|NCT00294788|Immune response to influenza vaccine|immune response to influenza vaccine
523030|NCT00294801|knee osteoarthritis|knee osteoarthritis
523031|NCT00294814|Cardiac Surgery|cardiac surgery
523032|NCT00294814|CABG|cabg
523033|NCT00294814|Microemboli|microemboli
523034|NCT00294814|Transcranial Doppler|transcranial doppler
523035|NCT00294814|Cognitive Decline|cognitive decline
523036|NCT00294814|Anastomotic Device|anastomotic device
523037|NCT00294814|Proximal Anastomosis|proximal anastomosis
523038|NCT00294814|Coronary Artery Bypass Graft (CABG)|coronary artery bypass graft (cabg)
523039|NCT00294827|Liver transplantation|liver transplantation
523040|NCT00294853|Coronary calcium score|coronary calcium score
523041|NCT00294853|Coronary artery disease|coronary artery disease
523042|NCT00294853|Cardiac transplantation|cardiac transplantation
523043|NCT00294853|Coronary calcium score in heart transplanted patients|coronary calcium score in heart transplanted patients
523044|NCT00294853|Coronary artery disease in heart transplanted patients|coronary artery disease in heart transplanted patients
523045|NCT00294866|End Stage Renal Disease|end stage renal disease
523046|NCT00294866|Inflammation|inflammation
523047|NCT00294892|HIV|hiv
523048|NCT00294892|mother to child transmission; MTCT|mother to child transmission; mtct
523049|NCT00294892|nevirapine resistance|nevirapine resistance
523050|NCT00294892|pharmacokinetics|pharmacokinetics
523051|NCT00294892|Treatment Naive|treatment naive
523052|NCT00294905|COPD|copd
523053|NCT00294905|smoking cessation|smoking cessation
523054|NCT00294905|implementation|implementation
523055|NCT00294905|patient counseling|patient counseling
523056|NCT00294905|general practice|general practice
523057|NCT00294918|Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)|human immunodeficiency virus-associated adipose redistribution syndrome (hars)
523058|NCT00294918|Human Immunodeficiency Virus Infections|human immunodeficiency virus infections
523059|NCT00294918|Serostim®|serostim®
523060|NCT00294918|recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
523061|NCT00294931|Lung Cancer, Small Cell|lung cancer, small cell
523062|NCT00294931|Extensive|extensive
523063|NCT00294996|Metastatic Her2+ Breast cancer|metastatic her2+ breast cancer
523064|NCT00294996|Myocet|myocet
523065|NCT00294996|liposomal doxorubicin|liposomal doxorubicin
523066|NCT00294996|trastuzumab|trastuzumab
675195|NCT00875667|MCL|mcl
523067|NCT00295022|Levocetirizine|levocetirizine
523068|NCT00295022|Xyzal|xyzal
523069|NCT00295022|Rhinitis|rhinitis
523070|NCT00295022|Allergic|allergic
523071|NCT00295022|Seasonal|seasonal
523072|NCT00295022|Ragweed|ragweed
523073|NCT00295048|treatment|treatment
523074|NCT00295048|cognition|cognition
523075|NCT00295048|schizophrenia|schizophrenia
523076|NCT00295061|alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
523077|NCT00295061|alpha 1-Antitrypsin|alpha 1-antitrypsin
523078|NCT00295061|pulmonary emphysema|pulmonary emphysema
523079|NCT00295074|traumatic brain injury|traumatic brain injury
523080|NCT00295074|head injury|head injury
523081|NCT00295074|concussion|concussion
523082|NCT00295074|neuropsychologic test|neuropsychologic test
523083|NCT00295087|Premature Ovarian Failure|premature ovarian failure
523084|NCT00295087|X-Chromosome Inactivation|x-chromosome inactivation
523085|NCT00295100|Tamoxifen|tamoxifen
523086|NCT00295100|Prevention|prevention
523087|NCT00295100|Breast Cancer|breast cancer
523089|NCT00295113|Pulmonary arterial pressure|pulmonary arterial pressure
523090|NCT00295113|COPD|copd
523091|NCT00295113|Cardiac output|cardiac output
523092|NCT00295113|pulmonary and cardiac functions|pulmonary and cardiac functions
523093|NCT00295113|pulmonary arterial pressure measurements|pulmonary arterial pressure measurements
523094|NCT00295126|Edentulous|edentulous
523095|NCT00295126|Tooth Loss|tooth loss
523096|NCT00295126|APC|apc
523097|NCT00295126|Autologous platelet concentrate|autologous platelet concentrate
523098|NCT00295139|treatment|treatment
523099|NCT00295139|dual diagnosis|dual diagnosis
523100|NCT00295152|elderly/aged|elderly/aged
523101|NCT00295152|occupational therapy|occupational therapy
523102|NCT00295152|daily activities|daily activities
523103|NCT00295152|caregivers|caregivers
523104|NCT00295152|sense of competence|sense of competence
523105|NCT00295191|end-stage renal disease|end-stage renal disease
523106|NCT00295191|hemodialysis|hemodialysis
523107|NCT00295191|cardiovascular morbidity and mortality|cardiovascular morbidity and mortality
523108|NCT00295191|high flux dialyser|high flux dialyser
523109|NCT00295191|ultrapure dialysate|ultrapure dialysate
523110|NCT00295191|coronary vascular calcifications|coronary vascular calcifications
523111|NCT00295191|carotid intima-media thickness|carotid intima-media thickness
523112|NCT00295191|atherosclerosis|atherosclerosis
523113|NCT00295204|Syncope|syncope
523114|NCT00295204|pre-syncope|pre-syncope
523115|NCT00295204|palpitations|palpitations
523116|NCT00295217|Fibroids|fibroids
523117|NCT00295217|Uterine Leiomyomas|uterine leiomyomas
523118|NCT00295217|ExAblate|exablate
523119|NCT00295217|MrgFUS|mrgfus
523120|NCT00295230|respiratory distress syndrome|respiratory distress syndrome
523121|NCT00295230|very low birth weight infant|very low birth weight infant
523122|NCT00295230|mechanical ventilation|mechanical ventilation
523676|NCT00296504|pro-drug|pro-drug
523123|NCT00295256|randomized trial|randomized trial
523124|NCT00295256|diabetes|diabetes
523125|NCT00295256|pregnancy|pregnancy
523126|NCT00295282|Ulcerative Colitis|ulcerative colitis
523127|NCT00295282|UC|uc
523128|NCT00295282|Colitis|colitis
523129|NCT00295295|vibration|vibration
523130|NCT00295295|bone density|bone density
523131|NCT00295308|Opioid Dependence|opioid dependence
523132|NCT00295308|Clonidine|clonidine
523133|NCT00295308|Buprenorphine|buprenorphine
523134|NCT00295308|Opioid Abstinence|opioid abstinence
523135|NCT00295308|Relapse|relapse
523136|NCT00295334|adherence|adherence
523137|NCT00295334|glycemic control|glycemic control
523138|NCT00295360|cholestasis|cholestasis
523139|NCT00295360|BCRP|bcrp
523140|NCT00295360|multidrug resistance|multidrug resistance
523141|NCT00295360|duodenum|duodenum
523144|NCT00295373|Hypercholesterolemia|hypercholesterolemia
523145|NCT00295373|Exercise|exercise
523146|NCT00295373|Statin|statin
523147|NCT00295373|Rosuvastatin|rosuvastatin
523148|NCT00295373|TLR4|tlr4
523149|NCT00295373|Inflammation|inflammation
523150|NCT00295399|cerebrovascular accident|cerebrovascular accident
523151|NCT00295399|traumatic brain injury|traumatic brain injury
523152|NCT00295399|stroke|stroke
523153|NCT00295399|telerehabilitation|telerehabilitation
523154|NCT00295425|psoriasis|psoriasis
523155|NCT00295425|randomized clinical trial|randomized clinical trial
523156|NCT00295425|cyclosporine A|cyclosporine a
523157|NCT00295425|mycophenolate mofetil|mycophenolate mofetil
523158|NCT00295425|immunosuppression|immunosuppression
523159|NCT00295438|robot-based tele-echography|robot-based tele-echography
523160|NCT00295438|tele-medicine|tele-medicine
523161|NCT00295464|Antenatal glucocorticoid|antenatal glucocorticoid
523162|NCT00295464|Premature birth|premature birth
523163|NCT00295477|HIV|hiv
523164|NCT00295477|Treatment Experienced|treatment experienced
523165|NCT00295490|double blind randomised controlled trial|double blind randomised controlled trial
523166|NCT00295490|phase II|phase ii
523167|NCT00295490|Devil's Claw|devil's claw
523168|NCT00295490|osteoarthritis of the knee|osteoarthritis of the knee
523169|NCT00295490|osteoarthritis of the hip|osteoarthritis of the hip
523170|NCT00295503|mesothelioma|mesothelioma
523171|NCT00295503|bevacizumab|bevacizumab
523172|NCT00295503|chemotherapy|chemotherapy
523173|NCT00295516|Rhesus|rhesus
523174|NCT00295516|Isoimmunization|isoimmunization
523175|NCT00295516|Red Cell Alloimmunization|red cell alloimmunization
523176|NCT00295516|Fetal Hemolytic Anemia|fetal hemolytic anemia
523177|NCT00295516|Erythroblastosis fetalis|erythroblastosis fetalis
523178|NCT00295529|Primary health care|primary health care
523179|NCT00295529|Breast neoplasm|breast neoplasm
523180|NCT00295529|Education|education
523181|NCT00295542|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
523182|NCT00295542|cardiovascular risk|cardiovascular risk
523183|NCT00295542|chronotherapy|chronotherapy
523184|NCT00295542|circadian pattern|circadian pattern
523185|NCT00295555|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
523186|NCT00295555|doxazosin|doxazosin
523187|NCT00295555|alpha1-adrenergic antagonists|alpha1-adrenergic antagonists
523188|NCT00295555|sympathetic nervous activity|sympathetic nervous activity
523189|NCT00295555|diabetic nephropathy|diabetic nephropathy
523190|NCT00295555|essential hypertension|essential hypertension
523191|NCT00295555|power spectral analysis|power spectral analysis
523192|NCT00295555|morning surge|morning surge
523193|NCT00295568|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
523194|NCT00295568|Motor Learning|motor learning
523196|NCT00295568|Tracking Motor Task|tracking motor task
523197|NCT00295568|Healthy Volunteer|healthy volunteer
523198|NCT00295568|HV|hv
523199|NCT00295581|Human|human
523200|NCT00295581|Clinical Trial|clinical trial
523201|NCT00295581|Mosquito|mosquito
523202|NCT00295581|Healthy Volunteer|healthy volunteer
523203|NCT00295581|HV|hv
523204|NCT00295594|Tacrolimus|tacrolimus
523205|NCT00295594|Liver Transplantation|liver transplantation
523206|NCT00295594|Treatment Outcome|treatment outcome
754061|NCT01178775|education|education
523207|NCT00295594|Immunosuppression|immunosuppression
523208|NCT00295607|Tacrolimus|tacrolimus
523209|NCT00295607|Liver Transplantation|liver transplantation
523210|NCT00295607|Immunosuppression|immunosuppression
523211|NCT00295607|Adult|adult
523212|NCT00295607|Treatment Outcome|treatment outcome
523213|NCT00295620|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
523214|NCT00295646|ABCSG|abcsg
523215|NCT00295646|12|12
523216|NCT00295646|Phase 3|phase 3
523217|NCT00295646|breast cancer|breast cancer
523218|NCT00295646|anastrozole|anastrozole
523219|NCT00295646|tamoxifen|tamoxifen
523220|NCT00295646|zoledronic acid|zoledronic acid
523221|NCT00295646|premenopausal|premenopausal
523222|NCT00295646|hormone receptor-positive|hormone receptor-positive
523223|NCT00295646|Stage I|stage i
523224|NCT00295646|Stage II|stage ii
523225|NCT00295646|bone mineral density|bone mineral density
523226|NCT00295646|BMD|bmd
523227|NCT00295646|bisphosphonate|bisphosphonate
523228|NCT00295646|zoledronate|zoledronate
523229|NCT00295659|Gestational Diabetes|gestational diabetes
523230|NCT00295659|Screening|screening
523231|NCT00295659|Cost-effectiveness|cost-effectiveness
523232|NCT00295659|obstetrical outcomes|obstetrical outcomes
523233|NCT00295672|Non-Small-Cell Lung,radiotherapy, Chemotherapy, vinorelbine|non-small-cell lung,radiotherapy, chemotherapy, vinorelbine
523234|NCT00295685|Reflux|reflux
523235|NCT00295685|GERD|gerd
523236|NCT00295698|HIV|hiv
523237|NCT00295698|Lymphatic filariasis|lymphatic filariasis
523238|NCT00295698|Diethylcarbamazine|diethylcarbamazine
523239|NCT00295698|Interaction|interaction
523240|NCT00295698|Tanzania|tanzania
523241|NCT00295711|bicifadine|bicifadine
523242|NCT00295711|chronic low back pain|chronic low back pain
523243|NCT00295724|bicifadine|bicifadine
523795|NCT00288834|dysphagia|dysphagia
523244|NCT00295724|chronic low back pain|chronic low back pain
523245|NCT00295737|allergic rhinitis|allergic rhinitis
523246|NCT00295750|Prostate Cancer|prostate cancer
523247|NCT00295763|papillary thyroid cancer|papillary thyroid cancer
523248|NCT00295763|follicular thyroid cancer|follicular thyroid cancer
523249|NCT00295763|recombinant human TSH|recombinant human tsh
523250|NCT00295763|Thyrogen|thyrogen
523251|NCT00295763|thyroid stimulating hormone|thyroid stimulating hormone
523252|NCT00295763|thyroid remnant ablation|thyroid remnant ablation
523253|NCT00295763|radioiodine|radioiodine
523254|NCT00295776|Inclusion Criteria:Minimum of 4 on the Likert Pain Scale.If currently taking TCA and/or Gabapentin, need to have been on stable dose for minimum of 4 weeks.|inclusion criteria:minimum of 4 on the likert pain scale.if currently taking tca and/or gabapentin, need to have been on stable dose for minimum of 4 weeks.
523255|NCT00295776|Exclusion Criteria:|exclusion criteria:
523256|NCT00295776|Currently on any antiepilepic drugs (AED), except for Gabapentin.|currently on any antiepilepic drugs (aed), except for gabapentin.
523257|NCT00295776|Currently taking opioid or unwilling to washout prior to the study,|currently taking opioid or unwilling to washout prior to the study,
523258|NCT00295776|Pregnant and lactating,|pregnant and lactating,
523259|NCT00295776|Have active severe systemic disease,|have active severe systemic disease,
523260|NCT00295776|History of Stevens-Johnson syndrome or TEN,|history of stevens-johnson syndrome or ten,
523261|NCT00295789|cervical cancer|cervical cancer
523262|NCT00295789|palliative chemotherapy|palliative chemotherapy
523263|NCT00295789|recurrent|recurrent
523264|NCT00295789|persistent|persistent
523265|NCT00295789|stageⅣb|stageⅳb
523266|NCT00295789|cisplatin|cisplatin
523267|NCT00295789|carboplatin|carboplatin
523268|NCT00295789|paclitaxel|paclitaxel
523269|NCT00295802|Prostate Cancer|prostate cancer
523270|NCT00295802|HIFU|hifu
523271|NCT00295802|EDAP|edap
523272|NCT00295802|Low Risk, Localized Prostate Cancer|low risk, localized prostate cancer
523273|NCT00295828|VEGF|vegf
523274|NCT00295828|iris neovascularization|iris neovascularization
523275|NCT00295828|diabetic retinopathy|diabetic retinopathy
523276|NCT00295828|Macugen|macugen
523277|NCT00295841|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
523278|NCT00295841|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
523279|NCT00295841|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
523280|NCT00295841|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
523281|NCT00295841|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
523282|NCT00295841|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
523283|NCT00295841|adult acute basophilic leukemia|adult acute basophilic leukemia
523284|NCT00295841|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
523285|NCT00295841|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
523286|NCT00295841|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
523287|NCT00295841|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
523288|NCT00295841|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
523289|NCT00295841|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
523290|NCT00295841|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
523291|NCT00295841|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
523292|NCT00295841|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
523293|NCT00295841|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
523294|NCT00295854|Interstitial Cystitis|interstitial cystitis
523295|NCT00295854|urgency|urgency
523296|NCT00295854|frequency|frequency
523297|NCT00295854|MN-001|mn-001
523298|NCT00295854|Global Response Assessment|global response assessment
523299|NCT00295854|bladder pain/urgency|bladder pain/urgency
523300|NCT00295854|O'Leary Sant IC Symptom and Problem Index|o'leary sant ic symptom and problem index
523301|NCT00295867|stage I breast cancer|stage i breast cancer
523302|NCT00295867|stage II breast cancer|stage ii breast cancer
523303|NCT00295867|stage IIIA breast cancer|stage iiia breast cancer
523304|NCT00295867|stage IIIB breast cancer|stage iiib breast cancer
523305|NCT00295867|stage IIIC breast cancer|stage iiic breast cancer
523677|NCT00296504|antiretroviral therapy|antiretroviral therapy
523306|NCT00295880|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
523307|NCT00295880|adult acute myeloid leukemia|adult acute myeloid leukemia
523308|NCT00295880|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
523309|NCT00295880|secondary acute myeloid leukemia|secondary acute myeloid leukemia
523310|NCT00295880|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
523311|NCT00295880|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
523312|NCT00295880|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
523313|NCT00295880|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
523314|NCT00295880|refractory anemia with excess blasts|refractory anemia with excess blasts
523315|NCT00295880|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
523316|NCT00295880|myelodysplastic syndromes|myelodysplastic syndromes
523317|NCT00295880|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
523991|NCT00289783|Infants|infants
523318|NCT00295880|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
523319|NCT00295880|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
523320|NCT00295880|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
523321|NCT00295880|grade 3 follicular lymphoma|grade 3 follicular lymphoma
523322|NCT00295880|mantle cell lymphoma|mantle cell lymphoma
523323|NCT00295880|childhood large cell lymphoma|childhood large cell lymphoma
523324|NCT00295880|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
523325|NCT00295880|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
523326|NCT00295880|acute lymphoblastic leukemia|acute lymphoblastic leukemia
523327|NCT00295880|refractory anemia|refractory anemia
523328|NCT00295880|refractory cytopenia|refractory cytopenia
523329|NCT00295880|childhood acute myeloid leukemia|childhood acute myeloid leukemia
523330|NCT00295880|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
523331|NCT00295880|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
523332|NCT00295880|chronic eosinophilic leukemia|chronic eosinophilic leukemia
522697|NCT00280007|TACE|tace
523333|NCT00295880|chronic neutrophilic leukemia|chronic neutrophilic leukemia
523334|NCT00295880|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
523335|NCT00295880|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
523336|NCT00295893|inflammatory breast cancer|inflammatory breast cancer
523337|NCT00295893|stage II breast cancer|stage ii breast cancer
523338|NCT00295893|stage IIIA breast cancer|stage iiia breast cancer
523339|NCT00295893|stage IIIB breast cancer|stage iiib breast cancer
523340|NCT00295893|stage IIIC breast cancer|stage iiic breast cancer
523341|NCT00295893|male breast cancer|male breast cancer
523342|NCT00295893|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
523343|NCT00295893|invasive ductal breast carcinoma with predominant intraductal component|invasive ductal breast carcinoma with predominant intraductal component
523344|NCT00295893|invasive ductal breast carcinoma|invasive ductal breast carcinoma
523345|NCT00295893|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
523346|NCT00295893|comedo ductal breast carcinoma|comedo ductal breast carcinoma
523347|NCT00295893|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
523348|NCT00295893|invasive lobular breast carcinoma|invasive lobular breast carcinoma
523349|NCT00295893|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
523350|NCT00295893|papillary ductal breast carcinoma|papillary ductal breast carcinoma
523351|NCT00295893|tubular ductal breast carcinoma|tubular ductal breast carcinoma
523353|NCT00295906|skin cancer|skin cancer
523354|NCT00295919|recurrent neuroblastoma|recurrent neuroblastoma
523355|NCT00295932|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
523356|NCT00295932|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
523357|NCT00295932|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
523358|NCT00295932|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
523359|NCT00295932|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
523360|NCT00295932|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
523361|NCT00295932|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
523362|NCT00295932|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
523363|NCT00295932|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
523364|NCT00295932|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
523365|NCT00295932|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
523366|NCT00295932|splenic marginal zone lymphoma|splenic marginal zone lymphoma
523368|NCT00295945|perioperative/postoperative complications|perioperative/postoperative complications
523369|NCT00295945|stage III cervical cancer|stage iii cervical cancer
523370|NCT00295945|recurrent cervical cancer|recurrent cervical cancer
523371|NCT00295945|stage IB cervical cancer|stage ib cervical cancer
523372|NCT00295945|stage IIB cervical cancer|stage iib cervical cancer
523373|NCT00295945|stage IVB cervical cancer|stage ivb cervical cancer
523374|NCT00295945|stage IA cervical cancer|stage ia cervical cancer
523375|NCT00295945|stage IIA cervical cancer|stage iia cervical cancer
523376|NCT00295945|stage IVA cervical cancer|stage iva cervical cancer
523377|NCT00295945|stage I endometrial carcinoma|stage i endometrial carcinoma
523378|NCT00295945|stage II endometrial carcinoma|stage ii endometrial carcinoma
523379|NCT00295945|stage III endometrial carcinoma|stage iii endometrial carcinoma
523380|NCT00295945|stage IV endometrial carcinoma|stage iv endometrial carcinoma
523381|NCT00295945|recurrent endometrial carcinoma|recurrent endometrial carcinoma
523382|NCT00295945|stage I uterine sarcoma|stage i uterine sarcoma
523383|NCT00295945|stage II uterine sarcoma|stage ii uterine sarcoma
523384|NCT00295945|stage III uterine sarcoma|stage iii uterine sarcoma
523385|NCT00295945|stage IV uterine sarcoma|stage iv uterine sarcoma
523386|NCT00295945|recurrent uterine sarcoma|recurrent uterine sarcoma
523387|NCT00295945|ovarian sarcoma|ovarian sarcoma
523388|NCT00295945|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
523389|NCT00295945|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
523390|NCT00295945|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
524093|NCT00290212|Women|women
523391|NCT00295945|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
523392|NCT00295945|ovarian stromal cancer|ovarian stromal cancer
523393|NCT00295945|recurrent fallopian tube cancer|recurrent fallopian tube cancer
523394|NCT00295945|stage IA fallopian tube cancer|stage ia fallopian tube cancer
523395|NCT00295945|stage IB fallopian tube cancer|stage ib fallopian tube cancer
523396|NCT00295945|stage IC fallopian tube cancer|stage ic fallopian tube cancer
523397|NCT00295945|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
523398|NCT00295945|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
523399|NCT00295945|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
523400|NCT00295945|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
523401|NCT00295945|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
523402|NCT00295945|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
523403|NCT00295945|stage IV fallopian tube cancer|stage iv fallopian tube cancer
523404|NCT00295945|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
523405|NCT00295945|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
523406|NCT00295945|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
523407|NCT00295945|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
523408|NCT00295945|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
523409|NCT00295945|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
523410|NCT00295945|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
523411|NCT00295945|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
523412|NCT00295945|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
523413|NCT00295945|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
523414|NCT00295945|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
523415|NCT00295945|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
523416|NCT00295945|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
523417|NCT00295945|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
523418|NCT00295945|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
523419|NCT00295945|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
523420|NCT00295945|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
523421|NCT00295945|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
523422|NCT00295958|recurrent melanoma|recurrent melanoma
523423|NCT00295958|stage IV melanoma|stage iv melanoma
523424|NCT00295958|skin cancer|skin cancer
523425|NCT00295971|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
523426|NCT00295971|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
523427|NCT00295971|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
523428|NCT00295971|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
523429|NCT00295971|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
523430|NCT00295971|secondary acute myeloid leukemia|secondary acute myeloid leukemia
523431|NCT00295971|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
523432|NCT00295971|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
523433|NCT00295971|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
523434|NCT00295971|refractory anemia with excess blasts|refractory anemia with excess blasts
523435|NCT00295971|severe congenital neutropenia|severe congenital neutropenia
754062|NCT01178775|walking program|walking program
523436|NCT00295971|congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
523437|NCT00295971|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
523438|NCT00295971|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
523439|NCT00295984|classic Kaposi sarcoma|classic kaposi sarcoma
523440|NCT00295984|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
523441|NCT00295997|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
523442|NCT00295997|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
523443|NCT00295997|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
523444|NCT00295997|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
523445|NCT00295997|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
523678|NCT00296504|LEXIVA|lexiva
523446|NCT00295997|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
523447|NCT00295997|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
523448|NCT00295997|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
523449|NCT00295997|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
523450|NCT00295997|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
523451|NCT00295997|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
523452|NCT00295997|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
523453|NCT00295997|chronic eosinophilic leukemia|chronic eosinophilic leukemia
523454|NCT00295997|primary myelofibrosis|primary myelofibrosis
523455|NCT00295997|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
523456|NCT00295997|chronic neutrophilic leukemia|chronic neutrophilic leukemia
523457|NCT00295997|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
523458|NCT00295997|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
523459|NCT00295997|essential thrombocythemia|essential thrombocythemia
523460|NCT00295997|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
523461|NCT00295997|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
523463|NCT00295997|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
523464|NCT00295997|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
523465|NCT00295997|prolymphocytic leukemia|prolymphocytic leukemia
523466|NCT00295997|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
523467|NCT00295997|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
523468|NCT00295997|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
523469|NCT00295997|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
523470|NCT00295997|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
523471|NCT00295997|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
523472|NCT00295997|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
523473|NCT00295997|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
523474|NCT00295997|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
523475|NCT00295997|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
523476|NCT00295997|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
523477|NCT00295997|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
523478|NCT00295997|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
523479|NCT00295997|refractory multiple myeloma|refractory multiple myeloma
523480|NCT00295997|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
523481|NCT00295997|secondary acute myeloid leukemia|secondary acute myeloid leukemia
523482|NCT00295997|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
523483|NCT00295997|stage II multiple myeloma|stage ii multiple myeloma
523484|NCT00295997|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
523485|NCT00295997|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
523486|NCT00295997|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
523487|NCT00295997|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
523488|NCT00295997|stage III multiple myeloma|stage iii multiple myeloma
523489|NCT00295997|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
523490|NCT00295997|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
523491|NCT00295997|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
523492|NCT00295997|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
523493|NCT00295997|recurrent renal cell cancer|recurrent renal cell cancer
523494|NCT00295997|stage IV renal cell cancer|stage iv renal cell cancer
523495|NCT00295997|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
523496|NCT00295997|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
523497|NCT00295997|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
523498|NCT00295997|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
523499|NCT00295997|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
523500|NCT00296010|stage I breast cancer|stage i breast cancer
523502|NCT00296010|stage IIIA breast cancer|stage iiia breast cancer
523503|NCT00296023|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
523504|NCT00296023|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
523505|NCT00296023|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
523506|NCT00296023|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
523507|NCT00296023|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
523508|NCT00296023|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
523509|NCT00296023|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
523510|NCT00296023|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
523511|NCT00296023|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
523512|NCT00296023|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
523513|NCT00296023|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
523514|NCT00296023|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
523515|NCT00296023|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
523516|NCT00296023|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
523517|NCT00296023|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
523518|NCT00296023|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
523519|NCT00296023|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
523520|NCT00296023|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
523521|NCT00296023|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
523522|NCT00296023|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
523523|NCT00296023|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
523524|NCT00296023|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
523525|NCT00296023|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
523526|NCT00296023|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
523527|NCT00296023|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
523528|NCT00296023|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
523529|NCT00296023|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
523530|NCT00296023|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
522991|NCT00294658|thymoma|thymoma
523531|NCT00296023|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
523532|NCT00296023|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
523533|NCT00296023|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
523534|NCT00296023|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
523535|NCT00296023|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
523536|NCT00296023|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
523537|NCT00296023|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
523538|NCT00296023|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
523539|NCT00296023|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
523540|NCT00296023|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
583542|NCT00512109|vascular risk|vascular risk
523541|NCT00296023|splenic marginal zone lymphoma|splenic marginal zone lymphoma
523542|NCT00296023|stage II multiple myeloma|stage ii multiple myeloma
523543|NCT00296023|stage III multiple myeloma|stage iii multiple myeloma
523544|NCT00296023|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
523545|NCT00296023|primary myelofibrosis|primary myelofibrosis
523546|NCT00296023|polycythemia vera|polycythemia vera
523547|NCT00296023|prolymphocytic leukemia|prolymphocytic leukemia
523548|NCT00296023|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
523549|NCT00296023|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
523550|NCT00296023|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
523551|NCT00296023|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
523552|NCT00296023|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
523553|NCT00296023|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
523554|NCT00296023|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
523555|NCT00296023|refractory anemia with excess blasts|refractory anemia with excess blasts
523556|NCT00296023|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
523557|NCT00296023|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
523558|NCT00296023|secondary acute myeloid leukemia|secondary acute myeloid leukemia
523559|NCT00296023|Waldenström macroglobulinemia|waldenström macroglobulinemia
523560|NCT00296023|essential thrombocythemia|essential thrombocythemia
523561|NCT00296023|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
523562|NCT00296023|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
523563|NCT00296023|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
523564|NCT00296023|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
523565|NCT00296023|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
523566|NCT00296023|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
523567|NCT00296023|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
523568|NCT00296023|stage I multiple myeloma|stage i multiple myeloma
523569|NCT00296036|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
523570|NCT00296036|stage I breast cancer|stage i breast cancer
523571|NCT00296036|stage II breast cancer|stage ii breast cancer
523572|NCT00296036|stage IIIA breast cancer|stage iiia breast cancer
523573|NCT00296036|stage IIIB breast cancer|stage iiib breast cancer
523574|NCT00296036|stage IIIC breast cancer|stage iiic breast cancer
523575|NCT00296036|stage IV breast cancer|stage iv breast cancer
523576|NCT00296036|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
523577|NCT00296049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
523579|NCT00296049|neutropenia|neutropenia
523580|NCT00296049|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
523581|NCT00296062|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
523582|NCT00296062|stage III colon cancer|stage iii colon cancer
523583|NCT00296062|stage IV colon cancer|stage iv colon cancer
523584|NCT00296062|stage III rectal cancer|stage iii rectal cancer
523585|NCT00296062|stage IV rectal cancer|stage iv rectal cancer
523586|NCT00296062|recurrent colon cancer|recurrent colon cancer
523587|NCT00296062|recurrent rectal cancer|recurrent rectal cancer
523588|NCT00296088|Mechanical Ventilation|mechanical ventilation
523589|NCT00296088|Critical Care|critical care
523590|NCT00296088|Respiratory Failure|respiratory failure
523591|NCT00296101|Physical Inactivity|physical inactivity
523592|NCT00296114|Cancer|cancer
523593|NCT00296114|Pancreas|pancreas
523594|NCT00296153|Human immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
523595|NCT00296153|Highly Active Antiviral Therapy (HAART)|highly active antiviral therapy (haart)
523596|NCT00296153|Ischemic Heart Disease|ischemic heart disease
523597|NCT00296153|OMACOR|omacor
523598|NCT00296153|Triglycerides|triglycerides
523599|NCT00296153|Endothelial function|endothelial function
523600|NCT00296153|Treatment Experienced|treatment experienced
523601|NCT00296166|Atrial fibrillation|atrial fibrillation
523602|NCT00296166|Permanent Atrial fibrillation|permanent atrial fibrillation
523603|NCT00296166|catheter ablation|catheter ablation
523604|NCT00296166|thoracoscopy|thoracoscopy
523605|NCT00296166|Arrhythmia|arrhythmia
523606|NCT00296166|Heart|heart
523607|NCT00296192|Rotigotine|rotigotine
523608|NCT00296192|Rotigotine nasal spray|rotigotine nasal spray
523609|NCT00296192|Efficacy, safety and tolerability|efficacy, safety and tolerability
523610|NCT00296192|Parkinson's disease|parkinson's disease
523611|NCT00296205|Multiple Sclerosis|multiple sclerosis
523612|NCT00296205|Cyclophosphamide|cyclophosphamide
523613|NCT00296205|autoimmune|autoimmune
523614|NCT00296231|premature infants|premature infants
523615|NCT00296231|very low birthweight infants|very low birthweight infants
523616|NCT00296231|high frequency ventilation|high frequency ventilation
523617|NCT00296231|nasal ventilation|nasal ventilation
523618|NCT00296244|steroid-free immunosuppression|steroid-free immunosuppression
523619|NCT00296244|liver transplantation|liver transplantation
523620|NCT00296283|Relatives|relatives
523621|NCT00296283|Bipolar Disorder|bipolar disorder
523622|NCT00296283|Psychoeducation|psychoeducation
523623|NCT00296296|kidney Transplant|kidney transplant
523624|NCT00296296|Type II Diabetes|type ii diabetes
523625|NCT00296296|Diabetic Nephropathy|diabetic nephropathy
523626|NCT00296296|Immunosuppression|immunosuppression
523627|NCT00296296|Cyclosporin|cyclosporin
523628|NCT00296296|Tacrolimus|tacrolimus
523629|NCT00296309|Tacrolimus|tacrolimus
523630|NCT00296309|Kidney Transplantation|kidney transplantation
523631|NCT00296309|Immunosuppression|immunosuppression
523632|NCT00296309|Adult|adult
523633|NCT00296309|Treatment Outcomes|treatment outcomes
523634|NCT00296322|stomach cancer|stomach cancer
523635|NCT00296322|adjuvant chemotherapy|adjuvant chemotherapy
523636|NCT00296322|mitomycin|mitomycin
523637|NCT00296322|cisplatin|cisplatin
523638|NCT00296322|doxifluridine|doxifluridine
523639|NCT00296335|Stomach cancer|stomach cancer
523640|NCT00296335|Adjuvant chemotherapy|adjuvant chemotherapy
523641|NCT00296335|Mitomycin|mitomycin
523642|NCT00296335|Cisplatin|cisplatin
523643|NCT00296335|Doxifluridine|doxifluridine
523644|NCT00296348|Tacrolimus|tacrolimus
523645|NCT00296348|Kidney Transplantation|kidney transplantation
523646|NCT00296348|Child|child
523647|NCT00296348|Treatment Outcome|treatment outcome
523648|NCT00296348|Immunosuppression|immunosuppression
523649|NCT00296361|Tacrolimus|tacrolimus
523650|NCT00296361|Kidney Transplantation|kidney transplantation
523651|NCT00296361|Immunosuppression|immunosuppression
523652|NCT00296361|Adult|adult
523653|NCT00296361|Treatment Outcomes|treatment outcomes
523654|NCT00296374|Hyperlipidemia|hyperlipidemia
523655|NCT00296374|Proteinuria|proteinuria
523656|NCT00296374|Diabetes Mellitus|diabetes mellitus
523657|NCT00296400|Hyperlipidemia|hyperlipidemia
523658|NCT00296400|Proteinuria|proteinuria
523659|NCT00296400|Diabetes Mellitus|diabetes mellitus
523660|NCT00296413|epilepsy|epilepsy
523661|NCT00296413|menstrual cycle|menstrual cycle
523662|NCT00296413|valproate|valproate
523663|NCT00296413|lamotrigine|lamotrigine
523664|NCT00296413|oral contraceptive|oral contraceptive
523665|NCT00296426|Adverse Drug Event|adverse drug event
523666|NCT00296426|Inpatients|inpatients
523667|NCT00296426|Outcome assessment|outcome assessment
523668|NCT00296452|cancer|cancer
523669|NCT00296452|nutrition|nutrition
523670|NCT00296491|Allergic Rhinitis|allergic rhinitis
523671|NCT00296491|Asthma|asthma
523672|NCT00296504|antiretroviral therapy naive subjects|antiretroviral therapy naive subjects
523673|NCT00296504|fosamprenavir|fosamprenavir
523674|NCT00296504|HIV-1|hiv-1
523675|NCT00296504|protease inhibitor|protease inhibitor
523679|NCT00296504|AGENERASE|agenerase
523680|NCT00296504|GW433908|gw433908
523681|NCT00296504|amprenavir|amprenavir
523682|NCT00296517|depression|depression
523683|NCT00296517|double-blind|double-blind
523684|NCT00296517|placebo-controlled|placebo-controlled
523685|NCT00296517|bupropion hydrochloride|bupropion hydrochloride
523686|NCT00296517|SSRI|ssri
523687|NCT00296517|comparative study|comparative study
523688|NCT00296517|non-responder|non-responder
523689|NCT00296530|Asthma|asthma
523690|NCT00296530|Allergic Rhinitis|allergic rhinitis
523691|NCT00296543|hemodialysis|hemodialysis
523692|NCT00296543|sudden cardiac death|sudden cardiac death
523693|NCT00296556|Ulcerative colitis|ulcerative colitis
523694|NCT00296556|EP4 agonist|ep4 agonist
523695|NCT00296556|PGE2|pge2
525626|NCT00305149|BEACOPP|beacopp
523696|NCT00296608|stage II rectal cancer|stage ii rectal cancer
523697|NCT00296608|stage III rectal cancer|stage iii rectal cancer
523698|NCT00296608|adenocarcinoma of the rectum|adenocarcinoma of the rectum
523699|NCT00296621|glutamine|glutamine
523700|NCT00296621|nutrition|nutrition
523195|NCT00295568|Accuracy|accuracy
523701|NCT00296621|children|children
523702|NCT00296621|pediatrics|pediatrics
523703|NCT00296621|randomized controlled clinical trial|randomized controlled clinical trial
523704|NCT00296621|therapy|therapy
523705|NCT00296621|supplement|supplement
523706|NCT00296621|oral administration|oral administration
523707|NCT00296621|handicap|handicap
523708|NCT00296634|H5N1, Influenza, vaccine|h5n1, influenza, vaccine
523709|NCT00296660|Acute Infection|acute infection
523710|NCT00296673|Rehabilitation, Side Bridge test, Muscular endurance|rehabilitation, side bridge test, muscular endurance
523711|NCT00296686|Major Depression|major depression
523712|NCT00296686|Refractory Depression|refractory depression
523713|NCT00296686|Tranylcypromine|tranylcypromine
523714|NCT00296686|Dextroamphetamine|dextroamphetamine
523715|NCT00296686|Triiodothyronine|triiodothyronine
523716|NCT00296699|Atypical Depression|atypical depression
523717|NCT00296699|Major Depressive Disorder|major depressive disorder
523718|NCT00296699|Dysthymic Disorder|dysthymic disorder
523719|NCT00296699|Atypical Features|atypical features
523720|NCT00296699|Duloxetine|duloxetine
523721|NCT00296712|Major Depression|major depression
523722|NCT00296712|Dysthymia|dysthymia
523723|NCT00296712|Depression NOS|depression nos
523724|NCT00296712|Escitalopram|escitalopram
523725|NCT00296712|Bupropion|bupropion
523726|NCT00296712|Dual Therapy|dual therapy
523727|NCT00296712|Combination Therapy|combination therapy
523728|NCT00296725|Major Depression|major depression
523729|NCT00296725|Dysthymia|dysthymia
523730|NCT00296725|Depression NOS|depression nos
523731|NCT00296725|Dichotic Listening|dichotic listening
523732|NCT00296725|Fluoxetine|fluoxetine
523733|NCT00296725|Imipramine|imipramine
523734|NCT00296725|Placebo|placebo
523735|NCT00296725|Predictors|predictors
523736|NCT00288587|Heart Failure|heart failure
523737|NCT00288587|Congestive Heart Failure|congestive heart failure
523738|NCT00288587|CHF|chf
523739|NCT00288600|Immunoglobulins, Intravenous|immunoglobulins, intravenous
523740|NCT00288600|Hyperbilirubinemia|hyperbilirubinemia
523741|NCT00288600|Erythroblastosis, Fetal|erythroblastosis, fetal
523742|NCT00288600|Exchange Transfusion, Whole Blood|exchange transfusion, whole blood
523743|NCT00288613|ESRD|esrd
523744|NCT00288613|Daily Hemodialysis|daily hemodialysis
523745|NCT00288613|Hemodialysis|hemodialysis
523746|NCT00288613|Kidney Failure|kidney failure
523747|NCT00288613|Kidney Disease|kidney disease
523748|NCT00288626|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
523749|NCT00288626|HCT- autologous hematopoietic cell transplant|hct- autologous hematopoietic cell transplant
523750|NCT00288626|HDIT-high-dose immunosuppressive therapy|hdit-high-dose immunosuppressive therapy
523751|NCT00288626|BEAM -Carmustine (BCNU), Etoposide (VP-16), Cytarabine (ara-C), and Melphalan|beam -carmustine (bcnu), etoposide (vp-16), cytarabine (ara-c), and melphalan
523752|NCT00288639|Pregabalin for partial seizures|pregabalin for partial seizures
523753|NCT00288665|Myocardial infarction|myocardial infarction
523754|NCT00288665|aspiration|aspiration
523755|NCT00288665|thrombectomy|thrombectomy
523756|NCT00288665|ventricular remodeling|ventricular remodeling
523757|NCT00288678|Diabetic shared care|diabetic shared care
523758|NCT00288678|Health manager|health manager
523759|NCT00288678|Prospective Study|prospective study
523760|NCT00288678|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
523761|NCT00288691|Treatment-resistant menorrhagia|treatment-resistant menorrhagia
523762|NCT00288704|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
523763|NCT00288704|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
523765|NCT00288704|NLRP-3|nlrp-3
523766|NCT00288704|PYPAF1|pypaf1
523767|NCT00288704|Cryopyrin|cryopyrin
523768|NCT00288704|CAPS|caps
523769|NCT00288704|Interleukin-1|interleukin-1
523770|NCT00288730|Heart Failure|heart failure
523771|NCT00288730|Renal Dysfunction|renal dysfunction
523772|NCT00288730|Cardiomyopathy|cardiomyopathy
523773|NCT00288730|Heart Decompensation|heart decompensation
523774|NCT00288730|Dyspnea Paroxysmal|dyspnea paroxysmal
523775|NCT00288756|arrythmias|arrythmias
523776|NCT00288769|Recurrent aphthous stomatitis|recurrent aphthous stomatitis
523777|NCT00288769|vitamin B12|vitamin b12
523778|NCT00288782|Mirtazapine|mirtazapine
523779|NCT00288782|Antidepressant|antidepressant
523780|NCT00288782|Positron Emission Tomography|positron emission tomography
523781|NCT00288795|Fatigue|fatigue
523782|NCT00288795|Polarity|polarity
523783|NCT00288795|Massage|massage
523784|NCT00288808|Blood|blood
523785|NCT00288808|Coagulation|coagulation
523786|NCT00288808|PT/InR|pt/inr
523787|NCT00288808|Warfarin|warfarin
523788|NCT00288808|Mechanical Valve|mechanical valve
523789|NCT00288821|Gynaecological malignancy|gynaecological malignancy
523790|NCT00288821|Diagnostic Accuracy|diagnostic accuracy
523791|NCT00288821|DWIBS|dwibs
523792|NCT00288821|Lymph Nodes|lymph nodes
523796|NCT00288834|rehabilitation|rehabilitation
523797|NCT00288834|biofeedback|biofeedback
523798|NCT00288847|Patella Dislocation|patella dislocation
523799|NCT00288847|Surface EMG|surface emg
523800|NCT00288847|Gender difference|gender difference
523801|NCT00288860|telemedicine|telemedicine
523802|NCT00288860|treatment compliance|treatment compliance
523803|NCT00288860|mental health|mental health
523804|NCT00288873|Vitamin D deficiency|vitamin d deficiency
523805|NCT00288873|Secondary hyperparathyroidism|secondary hyperparathyroidism
523806|NCT00288873|Obesity|obesity
523807|NCT00288886|Compliance|compliance
523808|NCT00288886|Aftercare|aftercare
523809|NCT00288886|Reinforcement, social|reinforcement, social
523810|NCT00288886|Alcoholics Anonymous|alcoholics anonymous
523811|NCT00288886|Support Groups|support groups
523812|NCT00288886|Treatment Outcome|treatment outcome
523813|NCT00288899|Informed Consent|informed consent
523814|NCT00288899|Medical Record Systems, computerized|medical record systems, computerized
523815|NCT00288899|Comprehension|comprehension
523816|NCT00288899|Anxiety|anxiety
523817|NCT00288899|Personal Satisfactin|personal satisfactin
523818|NCT00288912|Self-Care|self-care
523819|NCT00288912|Telemedicine|telemedicine
523820|NCT00288912|Pain|pain
523821|NCT00288912|Veterans|veterans
523822|NCT00288938|Suspicious mole|suspicious mole
523823|NCT00288938|Congenital Nevus|congenital nevus
523824|NCT00288938|Skin Cancer|skin cancer
523825|NCT00288938|Moles|moles
523826|NCT00288938|Pigmented lesion|pigmented lesion
523827|NCT00288938|LCMN|lcmn
523828|NCT00288964|balloon|balloon
523829|NCT00288964|fiber|fiber
523830|NCT00288964|respiratory|respiratory
523831|NCT00288964|oxygenator|oxygenator
523832|NCT00288964|Heart Failure|heart failure
523833|NCT00288964|ARDS|ards
523834|NCT00288964|COPD|copd
523835|NCT00288977|Diabetes|diabetes
523836|NCT00288977|Islet Transplantation|islet transplantation
523837|NCT00288990|MS|ms
523838|NCT00289016|gene transfer|gene transfer
523839|NCT00289016|gene therapy|gene therapy
523840|NCT00289016|oncolytic virus|oncolytic virus
523841|NCT00289016|GM-CSF|gm-csf
523842|NCT00289016|melanoma|melanoma
523843|NCT00289042|atrial fibrillation|atrial fibrillation
523844|NCT00289042|atrial thrombus|atrial thrombus
523845|NCT00289042|cardioversion|cardioversion
523846|NCT00289042|enoxaparin|enoxaparin
523847|NCT00289042|low molecular weight heparin|low molecular weight heparin
523848|NCT00289042|transesophageal echocardiography|transesophageal echocardiography
523849|NCT00289055|Peripheral Artery Occlusive Disease|peripheral artery occlusive disease
523850|NCT00289068|cataract surgery|cataract surgery
523851|NCT00289068|phacoemulsification sleeve|phacoemulsification sleeve
523852|NCT00289081|Total Knee Replacement|total knee replacement
523853|NCT00289107|Total Knee Replacement|total knee replacement
523854|NCT00289107|Knee Prosthesis|knee prosthesis
523855|NCT00289120|urolithiasis, cola|urolithiasis, cola
523856|NCT00289133|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
523857|NCT00289146|kidney cancer, immunology|kidney cancer, immunology
523858|NCT00289159|aged 18-50|aged 18-50
523859|NCT00289159|remitting evolution|remitting evolution
523860|NCT00289159|less than two years of evolution|less than two years of evolution
523861|NCT00289159|MS patients|ms patients
523862|NCT00289185|Coccidiosis|coccidiosis
523863|NCT00289185|Parasitic Diseases|parasitic diseases
523864|NCT00289185|Malaria, Falciparum|malaria, falciparum
523865|NCT00289185|Malaria|malaria
523866|NCT00289198|GW685698X|gw685698x
523867|NCT00289198|perennial allergic rhinitis|perennial allergic rhinitis
523868|NCT00289198|allergic rhinitis|allergic rhinitis
523869|NCT00289211|Hereditary angioedema|hereditary angioedema
523870|NCT00289211|HAE|hae
523871|NCT00289211|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
523872|NCT00289211|C1INH-nf|c1inh-nf
523873|NCT00289224|bivalent killed whole cell oral cholera vaccine|bivalent killed whole cell oral cholera vaccine
523874|NCT00289224|double blind randomized clinical trial|double blind randomized clinical trial
523875|NCT00289237|Lifestyle intervention|lifestyle intervention
523876|NCT00289237|Behavioural changes|behavioural changes
523877|NCT00289237|CHD|chd
523878|NCT00289237|Type 2 diabetes|type 2 diabetes
523879|NCT00289250|Malaria|malaria
523880|NCT00289250|Gametocytes|gametocytes
523881|NCT00289250|Asymptomatic carriers|asymptomatic carriers
523882|NCT00289263|metastatic breast cancer|metastatic breast cancer
523883|NCT00289263|maintenance chemotherapy|maintenance chemotherapy
523884|NCT00289276|Cardiomyopathy|cardiomyopathy
523885|NCT00289276|Ventricular Ejection Fraction|ventricular ejection fraction
523886|NCT00289276|Congestive Heart Failure|congestive heart failure
523887|NCT00289276|Impedance|impedance
523888|NCT00289289|Atrial Fibrillation|atrial fibrillation
523889|NCT00289289|Atrial Tachyarrhythmia|atrial tachyarrhythmia
523890|NCT00289289|Arrhythmia|arrhythmia
523891|NCT00289289|Bradycardia|bradycardia
523892|NCT00289289|Cardiac Pacemaker|cardiac pacemaker
523893|NCT00289289|IPG Indication|ipg indication
523894|NCT00289289|Pacing|pacing
523895|NCT00289302|Heart Failure|heart failure
523896|NCT00289302|Cardiac pacing|cardiac pacing
523897|NCT00289302|Cardiac resynchronization therapy|cardiac resynchronization therapy
676412|NCT00880399|MDD|mdd
523352|NCT00295906|melanoma|melanoma
523898|NCT00289302|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
523899|NCT00289354|chromium|chromium
523900|NCT00289354|chromium picolinate|chromium picolinate
523901|NCT00289354|type 2 diabetes mellitus|type 2 diabetes mellitus
523902|NCT00289354|HbA1c|hba1c
523903|NCT00289354|hyperglycemia|hyperglycemia
523904|NCT00289354|cholesterol|cholesterol
523905|NCT00289380|Nutritional Risk Screening(NRS)|nutritional risk screening(nrs)
523906|NCT00289380|Malnutrition|malnutrition
523907|NCT00289380|Overweight|overweight
523908|NCT00289380|Obesity|obesity
523909|NCT00289380|Clinical nutritional support|clinical nutritional support
523910|NCT00289380|Clinical outcome|clinical outcome
523911|NCT00289380|Cost effectiveness|cost effectiveness
523912|NCT00289380|Complication|complication
523913|NCT00289380|Infective complications|infective complications
523914|NCT00289406|hypertension|hypertension
523915|NCT00289419|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
523916|NCT00289419|Anesthetics, Local|anesthetics, local
523917|NCT00289419|Pain, Postoperative|pain, postoperative
523918|NCT00289458|older adults, falls, arthritis, aquatic, exercise|older adults, falls, arthritis, aquatic, exercise
523919|NCT00289471|Sensitivity and specificity|sensitivity and specificity
523920|NCT00289471|Physician's practice patterns|physician's practice patterns
523921|NCT00289471|Health Care costs|health care costs
523922|NCT00289471|Quality of Health Care|quality of health care
523924|NCT00289497|Charcot|charcot
523925|NCT00289497|foot|foot
523926|NCT00289497|ulceration|ulceration
523927|NCT00289497|neuropathy|neuropathy
523928|NCT00289523|Major Depressive Disorder, Depressive Disorder, Unipolar Depression, Antidepressants, Electroencephalography|major depressive disorder, depressive disorder, unipolar depression, antidepressants, electroencephalography
523929|NCT00289549|CLL|cll
523930|NCT00289549|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
523931|NCT00289549|leukemia|leukemia
523932|NCT00289549|Advanced, fludarabine-refractory CLL|advanced, fludarabine-refractory cll
523933|NCT00289562|B-cell|b-cell
523934|NCT00289562|leukemia|leukemia
523935|NCT00289562|B-lymphoblastic leukemia|b-lymphoblastic leukemia
523936|NCT00289562|lymphoma|lymphoma
523937|NCT00289562|B-All|b-all
523938|NCT00289575|Femur head aseptic osteonecrosis|femur head aseptic osteonecrosis
523939|NCT00289575|Bone reconstruction|bone reconstruction
523940|NCT00289575|Macroporous biphasic calcium phosphate granules|macroporous biphasic calcium phosphate granules
523941|NCT00289588|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
523942|NCT00289588|Staphylococcus aureus|staphylococcus aureus
523943|NCT00289588|MRSA|mrsa
523944|NCT00289588|CA-MRSA|ca-mrsa
523945|NCT00289601|aspirin|aspirin
523946|NCT00289601|clopidogrel|clopidogrel
523947|NCT00289601|resistance|resistance
523948|NCT00289601|angioplasty|angioplasty
523949|NCT00289601|percutaneous coronary intervention|percutaneous coronary intervention
523950|NCT00289601|myocardial infarction|myocardial infarction
523951|NCT00289614|contrast induced nephropathy|contrast induced nephropathy
523952|NCT00289627|Previously treated melanoma|previously treated melanoma
523953|NCT00289627|Unresectable Stage III|unresectable stage iii
523955|NCT00289640|Stage III (unresectable)|stage iii (unresectable)
523956|NCT00289640|Stage IV melanoma|stage iv melanoma
523957|NCT00289653|nicotine dependence,|nicotine dependence,
523958|NCT00289653|transdermal nicotine patch,|transdermal nicotine patch,
523959|NCT00289653|smoking while receiving nicotine replacement,|smoking while receiving nicotine replacement,
523960|NCT00289653|comorbidities|comorbidities
523961|NCT00289666|Sleep Disorder|sleep disorder
523962|NCT00289666|CPAP|cpap
523963|NCT00289705|Obesity|obesity
523964|NCT00289705|Surgery|surgery
523965|NCT00289705|Adolescent|adolescent
523966|NCT00289705|Roux-en-Y gastric bypass|roux-en-y gastric bypass
523967|NCT00289705|Laparoscopic|laparoscopic
523968|NCT00289718|Combined Hepatitis A and B vaccine|combined hepatitis a and b vaccine
523969|NCT00289718|Hepatitis A|hepatitis a
523970|NCT00289718|Hepatitis B|hepatitis b
523971|NCT00289731|Combined hepatitis A and hepatitis B vaccine|combined hepatitis a and hepatitis b vaccine
523972|NCT00289731|Hepatitis B|hepatitis b
523973|NCT00289731|Hepatitis A|hepatitis a
524076|NCT00290147|Dengue|dengue
523974|NCT00289731|Monovalent hepatitis A and hepatitis B vaccines|monovalent hepatitis a and hepatitis b vaccines
523975|NCT00289744|Hepatitis B|hepatitis b
523976|NCT00289744|TWINRIX™ ADULT|twinrix™ adult
523977|NCT00289744|Hepatitis A|hepatitis a
523978|NCT00289757|Havrix™|havrix™
523979|NCT00289757|Hepatitis A|hepatitis a
523980|NCT00289770|TWINRIX™ ADULT|twinrix™ adult
523981|NCT00289770|Hepatitis A|hepatitis a
523982|NCT00289770|Hepatitis B|hepatitis b
523983|NCT00289783|Primary and booster vaccination|primary and booster vaccination
523984|NCT00289783|Neisseria meningitidis|neisseria meningitidis
523985|NCT00289783|Hib disease|hib disease
523986|NCT00289783|Meningococcal vaccine|meningococcal vaccine
523987|NCT00289783|Meningococcal disease|meningococcal disease
523988|NCT00289783|Children|children
523989|NCT00289783|Immunogenicity|immunogenicity
523990|NCT00289783|Safety|safety
523992|NCT00289822|chronic heart failure|chronic heart failure
523993|NCT00289822|myocardial infarction|myocardial infarction
523994|NCT00289835|Coronary Artery Bypass Grafting|coronary artery bypass grafting
523995|NCT00289835|Drug Eluting Stent|drug eluting stent
523996|NCT00289835|Saphenous Vein Graft|saphenous vein graft
523997|NCT00289861|Schizophrenia|schizophrenia
523998|NCT00289861|risperidone|risperidone
523999|NCT00289861|prolactin|prolactin
524000|NCT00289861|clozapine|clozapine
524001|NCT00289913|Hepatitis A virus|hepatitis a virus
524002|NCT00289926|low libido|low libido
524003|NCT00289926|lack of wellbeing|lack of wellbeing
524004|NCT00289939|women|women
524005|NCT00289939|women's health|women's health
524007|NCT00289939|risk factors|risk factors
524008|NCT00289939|risk behaviors|risk behaviors
524009|NCT00289939|prevention|prevention
524010|NCT00289939|motivational interviewing|motivational interviewing
524011|NCT00289939|domestic violence|domestic violence
524012|NCT00289939|partner violence|partner violence
524013|NCT00289939|behavioral trial|behavioral trial
524014|NCT00289939|community justice|community justice
524015|NCT00289939|criminal justice|criminal justice
524016|NCT00289952|HIV infections|hiv infections
524017|NCT00289952|Histone deacetylase Inhibitor|histone deacetylase inhibitor
524018|NCT00289952|HIV Reservoirs|hiv reservoirs
524019|NCT00289952|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
524020|NCT00289952|Valproic Acid|valproic acid
524021|NCT00289952|Treatment Experienced|treatment experienced
524022|NCT00289965|Alcohol Abuse|alcohol abuse
524023|NCT00289965|Alcohol Drinking|alcohol drinking
524024|NCT00289965|Intervention Studies|intervention studies
524025|NCT00289965|Computer-Assisted Instruction|computer-assisted instruction
524026|NCT00289965|College Students|college students
524027|NCT00289978|Multiple Sclerosis|multiple sclerosis
524028|NCT00289978|FTY720|fty720
524029|NCT00289978|Fingolimod|fingolimod
524030|NCT00290004|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
524031|NCT00290004|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
524032|NCT00290004|Leukemia|leukemia
524033|NCT00290004|Lymphoma|lymphoma
524034|NCT00290004|Motexafin Gadolinium|motexafin gadolinium
524035|NCT00290004|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
524036|NCT00290004|Relapsed Small Lymphocytic Lymphoma|relapsed small lymphocytic lymphoma
524037|NCT00290004|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
524038|NCT00290004|Refractory Small Lymphocytic Lymphoma|refractory small lymphocytic lymphoma
524039|NCT00290030|acute urinary retention|acute urinary retention
524040|NCT00290030|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
524041|NCT00290043|Insulin glulisine|insulin glulisine
524042|NCT00290043|Diabetes mellitus Type 1|diabetes mellitus type 1
524043|NCT00290043|Postprandial Period|postprandial period
524044|NCT00290043|Pharmacokinetics|pharmacokinetics
524045|NCT00290043|Glucodynamics|glucodynamics
524046|NCT00290056|CHD|chd
524047|NCT00290056|Arrhythmia|arrhythmia
524048|NCT00290056|ICD|icd
524049|NCT00290056|Omega-3 PUFA|omega-3 pufa
524050|NCT00290056|Nutrition|nutrition
524051|NCT00290069|Renal function|renal function
524052|NCT00290069|Serum creatinine|serum creatinine
524053|NCT00290069|Immunosuppression|immunosuppression
524054|NCT00290069|Rejection|rejection
524055|NCT00290082|sedation|sedation
524056|NCT00290082|midazolam|midazolam
524057|NCT00290082|loxapine|loxapine
524058|NCT00290082|agitation|agitation
524059|NCT00290082|emergency department|emergency department
524060|NCT00290082|toxicological analysis|toxicological analysis
524061|NCT00290095|Multiple Myeloma|multiple myeloma
524062|NCT00290095|Quality of Life|quality of life
524063|NCT00290095|Response Shift|response shift
524064|NCT00290095|Clinically Important Difference|clinically important difference
524066|NCT00290108|Propofol|propofol
524067|NCT00290108|hemodynamic|hemodynamic
524068|NCT00290108|pharmacokinetic|pharmacokinetic
524069|NCT00290121|Schizophrenia|schizophrenia
524070|NCT00290121|Atypical antipsychotics|atypical antipsychotics
524071|NCT00290121|Weight gain|weight gain
524072|NCT00290121|Appetite|appetite
524073|NCT00290121|fMRI|fmri
524074|NCT00290134|Hypogonadism|hypogonadism
524075|NCT00290134|Testosterone|testosterone
524077|NCT00290147|DNA vaccine|dna vaccine
524078|NCT00290160|Hyperkalemia|hyperkalemia
524079|NCT00290160|Protein|protein
524080|NCT00290160|Hyperglycemia|hyperglycemia
524081|NCT00290160|ELBW|elbw
524082|NCT00290173|pre term labor|pre term labor
524083|NCT00290173|therapy|therapy
524084|NCT00290173|maintenance|maintenance
524085|NCT00290186|Cerebral Palsy|cerebral palsy
524086|NCT00290186|Spastic Cerebral Palsy|spastic cerebral palsy
524087|NCT00290186|CP|cp
524088|NCT00290186|Hyperbaric|hyperbaric
524089|NCT00290186|HBOT|hbot
524090|NCT00290199|Fetal Membranes, Premature Rupture|fetal membranes, premature rupture
524091|NCT00290199|Labor, Induced|labor, induced
524092|NCT00290199|Foley Catheter|foley catheter
524094|NCT00290212|Bone density|bone density
524095|NCT00290212|Menopause|menopause
524096|NCT00290212|Dietary Supplements|dietary supplements
524097|NCT00290212|Vitamin K2|vitamin k2
524098|NCT00290225|Posttraumatic stress disorder|posttraumatic stress disorder
524099|NCT00290225|depression|depression
524100|NCT00290225|disaster mental health|disaster mental health
524101|NCT00290225|yoga|yoga
524102|NCT00290225|Breathwork|breathwork
524103|NCT00290225|exposure treatments|exposure treatments
524104|NCT00290238|Chronic Low Back Pain|chronic low back pain
524105|NCT00290238|Lower Extremity Pain|lower extremity pain
524106|NCT00290238|Central Sensitization|central sensitization
524107|NCT00290238|Percutaneous Neuromodulation Therapy|percutaneous neuromodulation therapy
524108|NCT00290251|Endometrium|endometrium
524109|NCT00290251|Progesterone|progesterone
524111|NCT00290251|Fibroid|fibroid
524112|NCT00290251|Hysterectomy|hysterectomy
524113|NCT00290251|Leiomyoma|leiomyoma
524114|NCT00290251|Uterine Fibroids|uterine fibroids
524115|NCT00290251|Fibroids|fibroids
524116|NCT00290290|Prevention|prevention
524117|NCT00290290|Antiseptic Preoperative Scrub|antiseptic preoperative scrub
524118|NCT00290290|Postoperative Wound Infection|postoperative wound infection
524119|NCT00290316|Hepatocellular carcinoma|hepatocellular carcinoma
524120|NCT00290316|Cholangiocarcinoma|cholangiocarcinoma
524121|NCT00290316|Metastasis|metastasis
524122|NCT00290316|Liver neoplasm|liver neoplasm
524123|NCT00290329|Safety|safety
524124|NCT00290329|Meningococcal disease|meningococcal disease
524125|NCT00290329|Meningitidis serogroups A, C,W & Y diseases|meningitidis serogroups a, c,w & y diseases
524126|NCT00290329|Meningococcal vaccine|meningococcal vaccine
524127|NCT00290368|Nasal allergen challenge|nasal allergen challenge
524128|NCT00290368|Allergic rhinitis|allergic rhinitis
524129|NCT00290368|Timothy grass pollen|timothy grass pollen
524130|NCT00290368|inflammatory mediators|inflammatory mediators
524131|NCT00290381|Allergic rhinitis|allergic rhinitis
524132|NCT00290394|Blood Pressure,|blood pressure,
524133|NCT00290394|rosiglitazone,Diabetes Mellitus, Type 2,|rosiglitazone,diabetes mellitus, type 2,
524134|NCT00290407|chronic lymphocytic leukemia|chronic lymphocytic leukemia
524135|NCT00290407|small lymphocytic lymphoma|small lymphocytic lymphoma
524136|NCT00290407|rituximab|rituximab
524137|NCT00290407|beta-glucan|beta-glucan
524138|NCT00290420|malaria|malaria
524139|NCT00290420|Plasmodium vivax|plasmodium vivax
524140|NCT00290420|pregnancy|pregnancy
524141|NCT00290420|chemoprophylaxis|chemoprophylaxis
524142|NCT00290433|Lymphoma|lymphoma
524143|NCT00290433|Peripheral T Cell|peripheral t cell
524144|NCT00290433|HCVIDDOXIL Regimen|hcviddoxil regimen
524145|NCT00290433|ARA-C|ara-c
524146|NCT00290433|Cytosar|cytosar
524147|NCT00290433|DepoCyt|depocyt
524148|NCT00290433|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
524149|NCT00290433|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
524150|NCT00290433|Doxorubicin hydrochloride|doxorubicin hydrochloride
524151|NCT00290433|Doxil|doxil
524152|NCT00290433|Cyclophosphamide|cyclophosphamide
524153|NCT00290433|Cytoxan|cytoxan
524154|NCT00290433|Neosar|neosar
524155|NCT00290433|Dexamethasone|dexamethasone
524156|NCT00290433|Decadron|decadron
524157|NCT00290433|Mesna|mesna
524158|NCT00290433|Methotrexate|methotrexate
524159|NCT00290433|Vincristine|vincristine
524160|NCT00290433|G-CSF|g-csf
524161|NCT00290433|Filgrastim|filgrastim
524162|NCT00290433|Neupogen|neupogen
524163|NCT00290459|Gynecologic Disease|gynecologic disease
524164|NCT00290459|Gynecologic Cancer|gynecologic cancer
524165|NCT00290459|Prognostic Markers|prognostic markers
524166|NCT00290485|non-resectable tumor|non-resectable tumor
524167|NCT00290485|high-risk tumor|high-risk tumor
524168|NCT00290485|metastasis|metastasis
524169|NCT00290485|Response Evaluation Criteria in Solid Tumors (RECIST)|response evaluation criteria in solid tumors (recist)
524170|NCT00290485|Gleevec|gleevec
524171|NCT00290485|Imatinib mesylate|imatinib mesylate
524172|NCT00290498|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
524173|NCT00290498|B-Cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
524174|NCT00290498|Lymphoma|lymphoma
524175|NCT00290498|Cyclophosphamide|cyclophosphamide
524176|NCT00290498|Cytarabine|cytarabine
524177|NCT00290498|Doxorubicin|doxorubicin
524178|NCT00290498|Hyper-CVAD|hyper-cvad
524179|NCT00290498|Methotrexate|methotrexate
524180|NCT00290498|Prednisone|prednisone
524181|NCT00290498|Rituximab|rituximab
524182|NCT00290498|Vincristine|vincristine
524183|NCT00290498|R-CHOP|r-chop
524184|NCT00290498|R-HCVAD|r-hcvad
524185|NCT00290498|Dexamethasone|dexamethasone
524186|NCT00290498|Decadron|decadron
524187|NCT00290498|Leucovorin|leucovorin
524188|NCT00290498|Ara-C|ara-c
524189|NCT00290498|Cytosar|cytosar
524190|NCT00290498|Cytoxan|cytoxan
524191|NCT00290498|DepoCyt|depocyt
524192|NCT00290498|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
524194|NCT00290498|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
524195|NCT00290498|Neosar|neosar
524196|NCT00290511|Follicular Lymphoma|follicular lymphoma
524197|NCT00290511|Zevalin|zevalin
524198|NCT00290511|Ibritumomab Tiuxetan|ibritumomab tiuxetan
524199|NCT00290511|IDEC-Y2B8|idec-y2b8
524200|NCT00290511|Fludarabine|fludarabine
524201|NCT00290511|Fludara|fludara
524202|NCT00290511|Dexamethasone|dexamethasone
524203|NCT00290511|Mitoxantrone|mitoxantrone
524204|NCT00290511|Rituximab|rituximab
524205|NCT00290511|Rituxan|rituxan
524206|NCT00290511|R-FND|r-fnd
524207|NCT00290511|Fludarabine Phosphate|fludarabine phosphate
524208|NCT00290511|Decadron|decadron
524209|NCT00290524|Oral alimentation following colorectal surgery|oral alimentation following colorectal surgery
524210|NCT00290524|anastomosis|anastomosis
524211|NCT00290524|laparoscopy|laparoscopy
524212|NCT00290524|hospitalization stay|hospitalization stay
524213|NCT00290537|Non-Small Cell Lung Cancer|non-small cell lung cancer
524214|NCT00290537|Lung Cancer|lung cancer
524215|NCT00290537|Carboplatin|carboplatin
524216|NCT00290537|Paclitaxel|paclitaxel
524217|NCT00290537|ZD6474|zd6474
524218|NCT00290537|NSCLC|nsclc
524219|NCT00290550|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
524220|NCT00290550|NSCLC|nsclc
524221|NCT00290576|Digestive and Nutritional Effects|digestive and nutritional effects
524222|NCT00290576|Safety and Growth|safety and growth
524223|NCT00290576|Feeding Tolerance|feeding tolerance
524224|NCT00290589|low back pain|low back pain
524225|NCT00290589|emergency department|emergency department
524226|NCT00290589|corticosteroids|corticosteroids
524227|NCT00290602|Acute respiratory distress syndrome|acute respiratory distress syndrome
524228|NCT00290602|corticosteroids|corticosteroids
524229|NCT00290602|postoperative complications|postoperative complications
524230|NCT00290602|cytokines|cytokines
524231|NCT00290615|adenocarcinoma of the colon|adenocarcinoma of the colon
524232|NCT00290615|recurrent colon cancer|recurrent colon cancer
524233|NCT00290615|stage IV colon cancer|stage iv colon cancer
524234|NCT00290615|adenocarcinoma of the rectum|adenocarcinoma of the rectum
524235|NCT00290615|recurrent rectal cancer|recurrent rectal cancer
524236|NCT00290615|stage IV rectal cancer|stage iv rectal cancer
524237|NCT00290628|graft versus host disease|graft versus host disease
524238|NCT00290628|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
524239|NCT00290628|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
524240|NCT00290628|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
524241|NCT00290628|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
524242|NCT00290628|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
524243|NCT00290628|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
524244|NCT00290628|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
524245|NCT00290628|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
524246|NCT00290628|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
524247|NCT00290628|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
751944|NCT01171300|adenocarcinoma of the rectum|adenocarcinoma of the rectum
524248|NCT00290628|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
524249|NCT00290628|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
524250|NCT00290628|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
524251|NCT00290628|chronic eosinophilic leukemia|chronic eosinophilic leukemia
524252|NCT00290628|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
524253|NCT00290628|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
524254|NCT00290628|chronic neutrophilic leukemia|chronic neutrophilic leukemia
524255|NCT00290628|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
524256|NCT00290628|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
524257|NCT00290628|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
524258|NCT00290628|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
524259|NCT00290628|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
524260|NCT00290628|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
524261|NCT00290628|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
524262|NCT00290628|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
524263|NCT00290628|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
524264|NCT00290628|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
524265|NCT00290628|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
524266|NCT00290628|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
524267|NCT00290628|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
524268|NCT00290628|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
524269|NCT00290628|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
524270|NCT00290628|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
524271|NCT00290628|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
524272|NCT00290628|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
524273|NCT00290628|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
524274|NCT00290628|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
524275|NCT00290628|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
524276|NCT00290628|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
524277|NCT00290628|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
524278|NCT00290628|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
583543|NCT00512109|perioperative|perioperative
524279|NCT00290628|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
524280|NCT00290628|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
524281|NCT00290628|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
524282|NCT00290628|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
524283|NCT00290628|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
524284|NCT00290628|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
524285|NCT00290628|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
524286|NCT00290628|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
524287|NCT00290628|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
524288|NCT00290628|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
524289|NCT00290628|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
524290|NCT00290628|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
524291|NCT00290628|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
524292|NCT00290628|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
524293|NCT00290628|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
524294|NCT00290628|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
524295|NCT00290628|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
524296|NCT00290628|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
524297|NCT00290628|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
524298|NCT00290628|refractory hairy cell leukemia|refractory hairy cell leukemia
524299|NCT00290628|refractory multiple myeloma|refractory multiple myeloma
524300|NCT00290628|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
524301|NCT00290628|secondary acute myeloid leukemia|secondary acute myeloid leukemia
524302|NCT00290628|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
524303|NCT00290628|splenic marginal zone lymphoma|splenic marginal zone lymphoma
524304|NCT00290628|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
524305|NCT00290628|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
524306|NCT00290628|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
524307|NCT00290628|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
751945|NCT01171300|rectum|rectum
751946|NCT01171326|topical|topical
524308|NCT00290628|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
524309|NCT00290628|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
524310|NCT00290628|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
524311|NCT00290628|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
524312|NCT00290628|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
524313|NCT00290628|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
524314|NCT00290628|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
524315|NCT00290628|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
524316|NCT00290628|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
524317|NCT00290628|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
524318|NCT00290628|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
524319|NCT00290628|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
524320|NCT00290628|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
524321|NCT00290628|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
524322|NCT00290628|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
524323|NCT00290628|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
524324|NCT00290628|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
524325|NCT00290628|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
524326|NCT00290628|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
524327|NCT00290628|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
677029|NCT00884091|Chinese|chinese
524328|NCT00290628|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
524329|NCT00290628|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
524330|NCT00290628|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
524331|NCT00290628|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
524332|NCT00290628|Diamond-Blackfan anemia|diamond-blackfan anemia
524333|NCT00290628|Fanconi anemia|fanconi anemia
524334|NCT00290628|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
524335|NCT00290641|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
524336|NCT00290641|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
524337|NCT00290641|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
524338|NCT00290641|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
524339|NCT00290641|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
524340|NCT00290641|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
583544|NCT00512109|vascular events|vascular events
524341|NCT00290641|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
524342|NCT00290641|secondary acute myeloid leukemia|secondary acute myeloid leukemia
524343|NCT00290641|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
524344|NCT00290641|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
524345|NCT00290641|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
524346|NCT00290641|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
524347|NCT00290641|refractory anemia with excess blasts|refractory anemia with excess blasts
524348|NCT00290641|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
524349|NCT00290641|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
524350|NCT00290641|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
524351|NCT00290641|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
524352|NCT00290641|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
524353|NCT00290641|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
524354|NCT00290641|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
524355|NCT00290641|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
524356|NCT00290641|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
524357|NCT00290641|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
524358|NCT00290641|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
524359|NCT00290641|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
524360|NCT00290641|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
524361|NCT00290641|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
524362|NCT00290641|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
524363|NCT00290641|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
524364|NCT00290641|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
524365|NCT00290641|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
524366|NCT00290641|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
524367|NCT00290641|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
524368|NCT00290641|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
524369|NCT00290641|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
524370|NCT00290641|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
524371|NCT00290641|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
524372|NCT00290641|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
524373|NCT00290641|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
524374|NCT00290641|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
524375|NCT00290641|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
524376|NCT00290641|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
524377|NCT00290641|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
524378|NCT00290641|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
524379|NCT00290641|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
524380|NCT00290641|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
524381|NCT00290641|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
524382|NCT00290641|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
524383|NCT00290641|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
524384|NCT00290641|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
524385|NCT00290641|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
524386|NCT00290641|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
524387|NCT00290641|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
524388|NCT00290641|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
524389|NCT00290641|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
524390|NCT00290641|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
524391|NCT00290641|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
524392|NCT00290641|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
524393|NCT00290641|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
524394|NCT00290641|chronic eosinophilic leukemia|chronic eosinophilic leukemia
524395|NCT00290641|chronic neutrophilic leukemia|chronic neutrophilic leukemia
524396|NCT00290641|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
524397|NCT00290641|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
524398|NCT00290641|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
524399|NCT00290641|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
524400|NCT00290641|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
524401|NCT00290641|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
524402|NCT00290641|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
524403|NCT00290641|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
524404|NCT00290641|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
524405|NCT00290641|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
524406|NCT00290641|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
524407|NCT00290641|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
524408|NCT00290641|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
524409|NCT00290641|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
524410|NCT00290641|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
524411|NCT00290641|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
524412|NCT00290641|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
524413|NCT00290641|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
524414|NCT00290641|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
524415|NCT00290641|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
524416|NCT00290641|stage I mantle cell lymphoma|stage i mantle cell lymphoma
524417|NCT00290641|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
524418|NCT00290641|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
524419|NCT00290641|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
524420|NCT00290641|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
524421|NCT00290641|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
524422|NCT00290641|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
524423|NCT00290641|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
524424|NCT00290641|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
524425|NCT00290654|ductal breast carcinoma in situ|ductal breast carcinoma in situ
524426|NCT00290654|breast cancer in situ|breast cancer in situ
524427|NCT00290667|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
524428|NCT00290667|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
524429|NCT00290667|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
524430|NCT00290667|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
524431|NCT00290667|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
524432|NCT00290667|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
524433|NCT00290667|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
524434|NCT00290667|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
524435|NCT00290667|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
524436|NCT00290667|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
524437|NCT00290667|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
524438|NCT00290667|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
524439|NCT00290667|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
524440|NCT00290667|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
524441|NCT00290667|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
524442|NCT00290667|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
524443|NCT00290667|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
523923|NCT00289484|Mood disorder|mood disorder
524444|NCT00290667|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
524622|NCT00297076|GW873140|gw873140
524445|NCT00290667|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
524446|NCT00290667|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
524447|NCT00290667|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
524448|NCT00290667|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
524449|NCT00290667|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
524450|NCT00290667|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
524451|NCT00290667|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
524452|NCT00290667|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
524453|NCT00290667|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
524454|NCT00290667|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
524455|NCT00290667|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
524456|NCT00290667|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
524457|NCT00290667|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
524458|NCT00290667|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
524459|NCT00290667|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
524460|NCT00290667|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
524461|NCT00290667|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
524462|NCT00290667|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
524463|NCT00290667|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
524464|NCT00290667|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
524465|NCT00290667|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
524466|NCT00290667|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
524467|NCT00290680|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
524468|NCT00290693|recurrent pancreatic cancer|recurrent pancreatic cancer
524469|NCT00290693|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
524470|NCT00290693|stage IV pancreatic cancer|stage iv pancreatic cancer
524471|NCT00290706|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
524472|NCT00290706|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
524473|NCT00290706|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
524474|NCT00290706|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
524475|NCT00290706|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
524476|NCT00290706|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
524477|NCT00290706|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
524478|NCT00290719|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
524479|NCT00290719|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
524480|NCT00290719|stage II esophageal cancer|stage ii esophageal cancer
524481|NCT00290719|stage III esophageal cancer|stage iii esophageal cancer
524482|NCT00290732|stage I breast cancer|stage i breast cancer
524483|NCT00290732|stage II breast cancer|stage ii breast cancer
524484|NCT00290732|stage IIIA breast cancer|stage iiia breast cancer
524485|NCT00290732|stage IIIC breast cancer|stage iiic breast cancer
524486|NCT00290732|stage IV breast cancer|stage iv breast cancer
524487|NCT00290732|breast cancer in situ|breast cancer in situ
524488|NCT00290732|ductal breast carcinoma in situ|ductal breast carcinoma in situ
524489|NCT00290745|breast cancer in situ|breast cancer in situ
524490|NCT00290745|ductal breast carcinoma in situ|ductal breast carcinoma in situ
524491|NCT00290771|imatinib mesylate|imatinib mesylate
524492|NCT00290771|hydroxyurea|hydroxyurea
524493|NCT00290771|protein tyrosine kinases|protein tyrosine kinases
524495|NCT00290771|glioblastoma multiforme|glioblastoma multiforme
524496|NCT00290771|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
524498|NCT00290771|MacDonald criteria|macdonald criteria
524499|NCT00290823|Taenia|taenia
524500|NCT00290823|Seizures|seizures
524501|NCT00290823|Tapeworm|tapeworm
524502|NCT00290823|Parasite|parasite
524503|NCT00290862|Osteoporosis|osteoporosis
524504|NCT00290862|Spine fracture|spine fracture
524505|NCT00290862|Back Pain|back pain
524506|NCT00290862|Vertebroplasty|vertebroplasty
524507|NCT00290862|Vertebral compression fractures related to osteoporosis|vertebral compression fractures related to osteoporosis
524508|NCT00290875|cspine injury|cspine injury
524509|NCT00290875|radiography|radiography
524510|NCT00290875|clinical impact|clinical impact
524511|NCT00290875|dissemination|dissemination
524512|NCT00290888|Rotator Cuff Tear|rotator cuff tear
524513|NCT00290888|Tendon Repair|tendon repair
524514|NCT00290888|Acromioplasty|acromioplasty
524515|NCT00290888|Arthroscopy|arthroscopy
524516|NCT00290888|Orthopedic Surgery|orthopedic surgery
524517|NCT00290927|HMR1964, insulin glulisine, Diabetes Mellitus, Type 2|hmr1964, insulin glulisine, diabetes mellitus, type 2
524518|NCT00290940|Diabetes mellitus, Type 2|diabetes mellitus, type 2
524519|NCT00290940|High blood sugar|high blood sugar
524520|NCT00290940|Hyperglycemia|hyperglycemia
524725|NCT00300976|Lipids|lipids
524521|NCT00290940|Antihyperglycemic agents|antihyperglycemic agents
524522|NCT00290940|CS-917|cs-917
524523|NCT00290953|Metastases|metastases
524524|NCT00290966|docetaxel|docetaxel
524525|NCT00290966|stomach neoplasm|stomach neoplasm
524526|NCT00290979|HMR1964, insulin glulisine, Diabetes Mellitus, Type 1|hmr1964, insulin glulisine, diabetes mellitus, type 1
524527|NCT00290992|urate oxidase, hyperuricemia, lymphoma, leukemia|urate oxidase, hyperuricemia, lymphoma, leukemia
524528|NCT00291005|Prostate cancer|prostate cancer
524529|NCT00291005|HRPC|hrpc
524530|NCT00291005|AIPC|aipc
524531|NCT00291005|Hormone refractory|hormone refractory
524532|NCT00291005|Androgen independent|androgen independent
524533|NCT00291005|Docetaxel|docetaxel
524534|NCT00291005|Taxotere|taxotere
524535|NCT00291005|prednisolone|prednisolone
524536|NCT00291018|ProDisc|prodisc
524537|NCT00291018|ProDisc-C|prodisc-c
524538|NCT00291018|Spinal Fusion|spinal fusion
524539|NCT00291018|Anterior cervical diskectomy|anterior cervical diskectomy
524540|NCT00291018|Cervical spine|cervical spine
524541|NCT00291018|Disc disease|disc disease
524542|NCT00291018|Implant|implant
524543|NCT00291018|Degenerative disc disease|degenerative disc disease
524544|NCT00291018|Intervertebral disc|intervertebral disc
524545|NCT00291031|nightmare|nightmare
524546|NCT00291031|sleep disorder|sleep disorder
524547|NCT00291031|sleep|sleep
524548|NCT00291031|imagery rehearsal|imagery rehearsal
524549|NCT00291031|anxiety disorders|anxiety disorders
524550|NCT00291031|mood disorders|mood disorders
524551|NCT00291031|personality disorders|personality disorders
524552|NCT00296764|Happy Puppet Syndrome|happy puppet syndrome
524553|NCT00296764|Developmental Disorders|developmental disorders
524554|NCT00296777|Major Depression|major depression
524555|NCT00296777|Dysthymia|dysthymia
524556|NCT00296777|f-MRI|f-mri
524557|NCT00296777|Escitalopram|escitalopram
524558|NCT00296777|Bupropion|bupropion
524559|NCT00296777|Imipramine|imipramine
524560|NCT00296777|Neuropsychologic test|neuropsychologic test
524561|NCT00296777|Dichotic listening|dichotic listening
524562|NCT00296777|EEG|eeg
524563|NCT00296777|ERP|erp
524564|NCT00296803|metabolic syndrome|metabolic syndrome
524565|NCT00296829|Influenza;|influenza;
524566|NCT00296829|Orthomyxoviruses;|orthomyxoviruses;
524567|NCT00296829|Inactivated Split-virion influenza vaccine;|inactivated split-virion influenza vaccine;
524568|NCT00296829|Elderly.|elderly.
524569|NCT00296842|posttraumatic stress disorder|posttraumatic stress disorder
524570|NCT00296842|children|children
524571|NCT00296842|injury|injury
524572|NCT00296842|road traffic accident|road traffic accident
524573|NCT00296855|Peripheral artery disease|peripheral artery disease
524574|NCT00296868|reflex sympathetic dystrophy|reflex sympathetic dystrophy
524575|NCT00296868|ascorbic acid|ascorbic acid
524576|NCT00296868|primary prevention|primary prevention
524577|NCT00296868|radius fractures|radius fractures
524578|NCT00296881|Periodontitis|periodontitis
524579|NCT00296881|Photodynamic Disinfection|photodynamic disinfection
524580|NCT00296881|PERIOWAVE|periowave
524581|NCT00296881|Scaling and Root Planing|scaling and root planing
524582|NCT00296881|SRP|srp
524583|NCT00296907|cancer|cancer
524584|NCT00296907|siblings|siblings
524585|NCT00296907|behavior|behavior
524586|NCT00296907|psychological adaptation|psychological adaptation
524587|NCT00296907|intervention|intervention
524588|NCT00296920|Deep Brain Stimulation|deep brain stimulation
524589|NCT00296920|Treatment failure|treatment failure
524590|NCT00296933|Major Depression|major depression
524591|NCT00296933|Antidepressant|antidepressant
524592|NCT00296933|Pharmacotherapy|pharmacotherapy
524593|NCT00296933|Memory functioning|memory functioning
524594|NCT00296933|Memory Impairment|memory impairment
524595|NCT00296946|Sialorrhoea|sialorrhoea
524596|NCT00296959|Dyskinesia|dyskinesia
524597|NCT00296959|AMPA receptor antagonists|ampa receptor antagonists
524598|NCT00296972|peg interferon|peg interferon
524599|NCT00296972|ribavirin|ribavirin
524600|NCT00296972|HAART|haart
524601|NCT00296972|HIV|hiv
524602|NCT00296972|Chronic Hepatitis C|chronic hepatitis c
524603|NCT00296972|Treatment Experienced|treatment experienced
524604|NCT00296985|Cardiac surgery|cardiac surgery
524605|NCT00296985|Cellsaver|cellsaver
524606|NCT00296985|Neurocognitive Function|neurocognitive function
524607|NCT00296985|Neuronal Protection|neuronal protection
524608|NCT00296985|Quality of Life|quality of life
524609|NCT00297037|oral lichen planus, pimecrolimus 1% cream|oral lichen planus, pimecrolimus 1% cream
524610|NCT00297050|Influenza Virus|influenza virus
524611|NCT00297050|Avian Influenza|avian influenza
524612|NCT00297050|Normal Volunteers|normal volunteers
524613|NCT00297050|Neuraminidase Inhibitor|neuraminidase inhibitor
524614|NCT00297050|Viral Disease|viral disease
524615|NCT00297050|Healthy Volunteer|healthy volunteer
524110|NCT00290251|Estrogen|estrogen
524616|NCT00297050|HV|hv
524617|NCT00297063|rosiglitazone|rosiglitazone
524618|NCT00297063|vandia|vandia
524619|NCT00297063|Type 2 diabetes mellitus|type 2 diabetes mellitus
524620|NCT00297063|diabetes;|diabetes;
524621|NCT00297076|HIV-1|hiv-1
524623|NCT00297076|CCR5 antagonist|ccr5 antagonist
524624|NCT00297076|experienced|experienced
524625|NCT00297076|Treatment Experienced|treatment experienced
524626|NCT00297089|Lung Cancer|lung cancer
524627|NCT00297089|ABT-751|abt-751
524628|NCT00297089|NSCLC|nsclc
524629|NCT00297089|Alimta|alimta
524630|NCT00297089|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
524631|NCT00297089|pemetrexed|pemetrexed
524632|NCT00297102|Roflumilast|roflumilast
524633|NCT00297102|COPD|copd
524634|NCT00297102|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
524635|NCT00300560|ESBL-producing E.coli Infections|esbl-producing e.coli infections
524636|NCT00300560|ESBL-producing Klebsiella pneumoniae Infections|esbl-producing klebsiella pneumoniae infections
524637|NCT00300560|Colistin|colistin
524638|NCT00300573|dexelvucitabine|dexelvucitabine
524639|NCT00300573|DFC|dfc
525627|NCT00305149|PET|pet
524640|NCT00300573|Treatment Experienced|treatment experienced
524641|NCT00300573|HIV-1|hiv-1
524642|NCT00300586|Non-small cell lung cancer ;|non-small cell lung cancer ;
524643|NCT00300586|metastatic ;|metastatic ;
524644|NCT00300586|chemotherapy ;|chemotherapy ;
524645|NCT00300586|erlotinib|erlotinib
524646|NCT00300625|Syncope|syncope
524647|NCT00300625|Near syncope|near syncope
524648|NCT00300625|San Francisco Syncope rule|san francisco syncope rule
524649|NCT00300638|Alcoholism|alcoholism
524650|NCT00300638|Emotion|emotion
524651|NCT00300638|Cognition|cognition
524652|NCT00300638|Brain scans|brain scans
524653|NCT00300651|Cognitive Behavioral Therapy|cognitive behavioral therapy
524654|NCT00300651|Schizophrenia|schizophrenia
524655|NCT00300651|Cognitive Biases|cognitive biases
524656|NCT00300651|Efficacy|efficacy
524657|NCT00300677|Pharmacokinetics|pharmacokinetics
524658|NCT00300677|Voriconazole|voriconazole
524659|NCT00300677|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
524660|NCT00300690|Lower extremity bypass surgery|lower extremity bypass surgery
524661|NCT00300690|femoro-popliteal bypass|femoro-popliteal bypass
524662|NCT00300690|Dacron material|dacron material
524663|NCT00300690|PTFE material|ptfe material
524664|NCT00300703|Cardiac Arrest|cardiac arrest
524665|NCT00300716|Multiple Sclerosis|multiple sclerosis
524666|NCT00300716|Cognitive impairment|cognitive impairment
524667|NCT00300716|Memantine|memantine
524668|NCT00300716|Placebo|placebo
524669|NCT00300716|Neuropsychological tests|neuropsychological tests
524670|NCT00300716|Quality of life|quality of life
524671|NCT00300716|Fatigue|fatigue
524672|NCT00300729|Cyclooxygenase-2 inhibitors|cyclooxygenase-2 inhibitors
524673|NCT00300729|Celecoxib|celecoxib
524674|NCT00300729|Carcinoma, non-small-cell lung|carcinoma, non-small-cell lung
524675|NCT00300729|Antineoplastic agents|antineoplastic agents
524676|NCT00300729|Therapy, palliative|therapy, palliative
524677|NCT00300729|Survival|survival
524678|NCT00300742|drinking|drinking
524679|NCT00300742|eating|eating
524680|NCT00300742|obesity|obesity
524681|NCT00300742|alcohol|alcohol
524682|NCT00300742|binge eating|binge eating
524683|NCT00300755|GERD|gerd
524684|NCT00300755|Children|children
524685|NCT00300755|Child|child
524686|NCT00300755|Child, Preschool|child, preschool
524687|NCT00300768|onchocerciasis|onchocerciasis
524688|NCT00300768|onchocerca volvulus|onchocerca volvulus
524689|NCT00300768|river blindness|river blindness
524690|NCT00300768|ivermectin|ivermectin
524691|NCT00300768|moxidectin|moxidectin
524692|NCT00300781|phase 2|phase 2
524693|NCT00300781|HER2+ breast cancer|her2+ breast cancer
524694|NCT00300781|monotherapy neratinib|monotherapy neratinib
524695|NCT00300807|Hepatitis C|hepatitis c
524696|NCT00300807|Monoclonal Antibody|monoclonal antibody
524697|NCT00300807|failed IFN/RBV treatment|failed ifn/rbv treatment
524698|NCT00300820|Bipolar Disorder|bipolar disorder
524699|NCT00300820|Affected Adults and Adult Siblings|affected adults and adult siblings
524700|NCT00300820|Interest in Genetic Counseling|interest in genetic counseling
524702|NCT00300820|Genes|genes
524703|NCT00300820|Familial|familial
524704|NCT00300820|Education|education
524705|NCT00300820|Testing|testing
524706|NCT00300820|BP|bp
524707|NCT00300820|Adult Siblings|adult siblings
524708|NCT00300885|Non-Small Cell Lung Cancer|non-small cell lung cancer
524709|NCT00300885|NSCLC|nsclc
524710|NCT00300898|contained lumbar herniated disc|contained lumbar herniated disc
524711|NCT00300898|nucleoplasty|nucleoplasty
524712|NCT00300898|percutaneous decompression|percutaneous decompression
524713|NCT00300898|Dekompressor|dekompressor
524714|NCT00300898|intervertebral electrothermal disc decompression|intervertebral electrothermal disc decompression
524715|NCT00300898|IDET|idet
524716|NCT00300911|Natriuretic Peptide, Brain|natriuretic peptide, brain
524717|NCT00300911|Heart Failure, Congestive|heart failure, congestive
524718|NCT00300950|Pancreas Cancer|pancreas cancer
524719|NCT00300950|resected pancreas cancer|resected pancreas cancer
524720|NCT00300950|non-metastatic pancreas cancer|non-metastatic pancreas cancer
524721|NCT00300963|psychosis|psychosis
524722|NCT00300963|cognition|cognition
524723|NCT00300976|Blood glucose|blood glucose
524724|NCT00300976|Blood pressure|blood pressure
524726|NCT00301002|safety|safety
524727|NCT00301002|effectiveness|effectiveness
524728|NCT00301002|Alefacept|alefacept
524729|NCT00301002|Palmar|palmar
524730|NCT00301002|Plantar|plantar
524731|NCT00301002|Pustulosis|pustulosis
524732|NCT00301028|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
524733|NCT00301028|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
524734|NCT00301028|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
524735|NCT00301028|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
524736|NCT00301028|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
524737|NCT00301041|invasive ductal breast carcinoma|invasive ductal breast carcinoma
525628|NCT00305149|Gallium|gallium
524738|NCT00301041|invasive lobular breast carcinoma|invasive lobular breast carcinoma
524739|NCT00301041|stage I breast cancer|stage i breast cancer
524740|NCT00301041|stage II breast cancer|stage ii breast cancer
524741|NCT00301041|stage IIIA breast cancer|stage iiia breast cancer
524742|NCT00301054|Anaemia|anaemia
524743|NCT00301054|Malaria|malaria
524744|NCT00301054|Rural Area in Ghana|rural area in ghana
524745|NCT00301067|stage IV melanoma|stage iv melanoma
524746|NCT00301067|recurrent melanoma|recurrent melanoma
524747|NCT00301080|pain|pain
524748|NCT00301080|neurotoxicity|neurotoxicity
524749|NCT00301080|breast cancer|breast cancer
524750|NCT00301093|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
524751|NCT00301093|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
524752|NCT00301106|stage IV breast cancer|stage iv breast cancer
524753|NCT00301106|liver metastases|liver metastases
524754|NCT00301119|small cell lung cancer|small cell lung cancer
524755|NCT00301119|non-small cell lung cancer|non-small cell lung cancer
524756|NCT00301119|smoker lung cancer screening|smoker lung cancer screening
524757|NCT00301119|low dose spiral CT screening|low dose spiral ct screening
524758|NCT00301145|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
524759|NCT00301158|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
524760|NCT00301171|Wheezing|wheezing
524761|NCT00301184|HIV Seronegativity|hiv seronegativity
524762|NCT00301184|HIV Preventive Vaccine|hiv preventive vaccine
524763|NCT00301184|HIV DNA Vaccine|hiv dna vaccine
524764|NCT00301184|Modified Vaccinia Ankara Vaccine|modified vaccinia ankara vaccine
524765|NCT00301197|Childhood obesity|childhood obesity
524766|NCT00301197|intervention|intervention
524768|NCT00301197|weight loss|weight loss
524769|NCT00301197|behavior therapy|behavior therapy
524770|NCT00301197|peer group|peer group
524771|NCT00301197|social support network|social support network
524772|NCT00301197|child|child
524773|NCT00301197|clinical research|clinical research
524774|NCT00301197|human subject|human subject
524775|NCT00301236|ADHD, children, CADS-T, Dexmethylphenidate-HCl, extended release|adhd, children, cads-t, dexmethylphenidate-hcl, extended release
524776|NCT00301249|Diabetes|diabetes
524777|NCT00301249|Nephropathy|nephropathy
524778|NCT00301249|Diabetic Nephropathy|diabetic nephropathy
524779|NCT00301249|Genome Scan|genome scan
524780|NCT00301249|Genetic Research|genetic research
524781|NCT00301353|early menopause|early menopause
524782|NCT00301353|isoflavones/phyto-estrogens|isoflavones/phyto-estrogens
524783|NCT00301353|bone metabolism|bone metabolism
524784|NCT00301353|bone mineral density|bone mineral density
524785|NCT00301353|hormones|hormones
524786|NCT00301366|alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
524787|NCT00301366|alpha 1-Antitrypsin|alpha 1-antitrypsin
524788|NCT00301366|pulmonary emphysema|pulmonary emphysema
524789|NCT00301379|Cholangiocarcinoma|cholangiocarcinoma
524790|NCT00301379|Observational|observational
524791|NCT00301392|Glucose intolerance|glucose intolerance
524792|NCT00301392|Diabetes mellitus|diabetes mellitus
524793|NCT00301392|Statins,HMG-CoA|statins,hmg-coa
524794|NCT00301405|prostatitis|prostatitis
524795|NCT00301405|pelvic pain|pelvic pain
524796|NCT00301418|Glioblastoma Multiforme|glioblastoma multiforme
524797|NCT00301418|Anaplastic Astrocytoma|anaplastic astrocytoma
524798|NCT00301418|High Grade Glial Neoplasms|high grade glial neoplasms
524799|NCT00301418|Brain Tumor|brain tumor
524800|NCT00301431|Fibromyalgia|fibromyalgia
524801|NCT00301431|Adults|adults
524802|NCT00301431|Outpatients|outpatients
524803|NCT00301431|Adult|adult
524804|NCT00301431|Double-Blind Method|double-blind method
524805|NCT00301444|phantom limb pain|phantom limb pain
524806|NCT00301444|limb amputation|limb amputation
524807|NCT00301457|Hormone Sensitive Primary Breast Cancer|hormone sensitive primary breast cancer
524808|NCT00301457|Adjuvant Treatment|adjuvant treatment
524809|NCT00301457|Aromatase Inhibitor|aromatase inhibitor
524810|NCT00301470|Ureter, obstruction|ureter, obstruction
524811|NCT00301470|Diagnostic techniques, urological|diagnostic techniques, urological
524812|NCT00301470|MRI, functional|mri, functional
524813|NCT00301483|multiple trauma|multiple trauma
524814|NCT00301483|bleeding injuries|bleeding injuries
524815|NCT00301483|gunshot wounds|gunshot wounds
524816|NCT00301483|stab wounds|stab wounds
524817|NCT00301483|penetrating injuries|penetrating injuries
524818|NCT00301483|blunt trauma|blunt trauma
524819|NCT00301483|multiple wounds|multiple wounds
524820|NCT00301522|Coronary|coronary
524821|NCT00301522|Artery|artery
524822|NCT00301522|Stenosis|stenosis
524823|NCT00301522|Drug-eluting|drug-eluting
524824|NCT00301522|stent|stent
524825|NCT00301522|restenosis|restenosis
524826|NCT00301522|revascularization|revascularization
524827|NCT00301535|Coronary Artery Bypass Graft|coronary artery bypass graft
524828|NCT00301535|memory loss after cardiac surgery|memory loss after cardiac surgery
524829|NCT00301535|side effects of bypass|side effects of bypass
524830|NCT00301548|antineoplastic protocols|antineoplastic protocols
524831|NCT00301548|neoadjuvant therapy|neoadjuvant therapy
524832|NCT00301548|perioperative chemotherapy|perioperative chemotherapy
524833|NCT00301548|fluorouracil|fluorouracil
524834|NCT00301561|Antiretroviral treatment|antiretroviral treatment
524835|NCT00301561|Expanded access|expanded access
524836|NCT00301561|Africa|africa
524837|NCT00301561|Treatment Naive|treatment naive
524838|NCT00301574|Alzheimer's disease|alzheimer's disease
524839|NCT00301574|Cognitive dysfunction|cognitive dysfunction
524840|NCT00301587|spina bifida|spina bifida
524841|NCT00301587|birth defects|birth defects
524842|NCT00301587|folic acid|folic acid
524843|NCT00301587|nervous system diseases|nervous system diseases
524844|NCT00301587|folate|folate
524845|NCT00301587|Vitamin B|vitamin b
524846|NCT00301600|Crescentic IgA nephropathy|crescentic iga nephropathy
524847|NCT00301600|Mycophenolate mofetil|mycophenolate mofetil
524848|NCT00301600|Cyclophosphamide|cyclophosphamide
524849|NCT00301600|treatment|treatment
524850|NCT00301613|Henoch-Schonlein purpura nephritis Mycophenolate mofetil|henoch-schonlein purpura nephritis mycophenolate mofetil
524851|NCT00301613|Cyclophosphamide|cyclophosphamide
524852|NCT00301613|treatment|treatment
524853|NCT00301626|tobacco|tobacco
524854|NCT00301626|nicotine|nicotine
524855|NCT00301626|smoking reduction|smoking reduction
524856|NCT00301652|ANCA|anca
524857|NCT00301652|vasculitis|vasculitis
524858|NCT00301652|mycophenolate mofetil|mycophenolate mofetil
524859|NCT00301652|cyclophosphamide|cyclophosphamide
524860|NCT00301652|treatment|treatment
524861|NCT00301678|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
524862|NCT00301691|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
524863|NCT00301730|lung metastases|lung metastases
524864|NCT00301730|stage IV breast cancer|stage iv breast cancer
524865|NCT00301730|recurrent breast cancer|recurrent breast cancer
524866|NCT00301782|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
524867|NCT00301782|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
524868|NCT00301782|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
524869|NCT00301782|testicular choriocarcinoma|testicular choriocarcinoma
524870|NCT00301782|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
524871|NCT00301782|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
524872|NCT00301782|testicular embryonal carcinoma|testicular embryonal carcinoma
524873|NCT00301782|testicular yolk sac tumor|testicular yolk sac tumor
524874|NCT00301782|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
524875|NCT00301782|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
524876|NCT00301782|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
524877|NCT00301782|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
524878|NCT00301782|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
751947|NCT01171326|minocycline|minocycline
524879|NCT00301782|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
524880|NCT00301782|stage I extragonadal non-seminomatous germ cell tumor|stage i extragonadal non-seminomatous germ cell tumor
524881|NCT00301782|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
524882|NCT00301782|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
524883|NCT00301782|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
524884|NCT00301782|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
524885|NCT00301782|testicular immature teratoma|testicular immature teratoma
524886|NCT00301782|testicular mature teratoma|testicular mature teratoma
524887|NCT00301782|adult teratoma|adult teratoma
677880|NCT00887328|MRI|mri
524888|NCT00301808|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
524889|NCT00301808|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
524890|NCT00301821|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
524891|NCT00301821|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
524892|NCT00301821|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
524893|NCT00301821|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
524894|NCT00301834|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
525396|NCT00303121|Therapy|therapy
524895|NCT00301834|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
524896|NCT00301834|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
524897|NCT00301834|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
524898|NCT00301834|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
524899|NCT00301834|congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
524900|NCT00301834|Diamond-Blackfan anemia|diamond-blackfan anemia
524901|NCT00301834|severe congenital neutropenia|severe congenital neutropenia
524902|NCT00301834|secondary acute myeloid leukemia|secondary acute myeloid leukemia
524903|NCT00301834|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
524904|NCT00301834|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
524905|NCT00301847|tumors metastatic to brain|tumors metastatic to brain
524906|NCT00301847|recurrent renal cell cancer|recurrent renal cell cancer
524907|NCT00301847|stage IV renal cell cancer|stage iv renal cell cancer
524908|NCT00301860|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
524909|NCT00301860|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
524910|NCT00301860|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
524911|NCT00301860|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
524912|NCT00301860|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
524913|NCT00301860|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
524914|NCT00301860|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
524915|NCT00301860|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
524916|NCT00301860|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
524917|NCT00301860|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
524918|NCT00301860|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
524919|NCT00301860|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
524920|NCT00301860|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
524921|NCT00301873|osteoporosis|osteoporosis
524922|NCT00301873|adult anaplastic astrocytoma|adult anaplastic astrocytoma
524923|NCT00301873|adult giant cell glioblastoma|adult giant cell glioblastoma
524924|NCT00301873|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
524925|NCT00301873|adult gliosarcoma|adult gliosarcoma
524926|NCT00301873|adult mixed glioma|adult mixed glioma
524927|NCT00301873|recurrent adult brain tumor|recurrent adult brain tumor
524928|NCT00301873|adult glioblastoma|adult glioblastoma
524929|NCT00301886|pain|pain
524930|NCT00301886|hypercalcemia of malignancy|hypercalcemia of malignancy
524931|NCT00301886|stage IV breast cancer|stage iv breast cancer
524932|NCT00301886|bone metastases|bone metastases
524933|NCT00301886|recurrent breast cancer|recurrent breast cancer
524934|NCT00301899|recurrent breast cancer|recurrent breast cancer
524935|NCT00301899|male breast cancer|male breast cancer
524936|NCT00301899|stage IIIA breast cancer|stage iiia breast cancer
524937|NCT00301899|stage IIIB breast cancer|stage iiib breast cancer
524938|NCT00301899|stage IIIC breast cancer|stage iiic breast cancer
524939|NCT00301899|stage IV breast cancer|stage iv breast cancer
524940|NCT00301912|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
524941|NCT00301912|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
524942|NCT00301912|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
524943|NCT00301912|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
524944|NCT00301912|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
524945|NCT00301912|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
524946|NCT00301912|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
524947|NCT00301912|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
524948|NCT00301912|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
524949|NCT00301912|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
524950|NCT00301912|secondary acute myeloid leukemia|secondary acute myeloid leukemia
524951|NCT00301912|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
524952|NCT00301912|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
524953|NCT00301912|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
524954|NCT00301912|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
524955|NCT00301912|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
524956|NCT00301912|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
524957|NCT00301912|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
524958|NCT00301912|anemia|anemia
524959|NCT00301912|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
524960|NCT00301912|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
524961|NCT00301912|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
524962|NCT00301912|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
524963|NCT00301912|stage II multiple myeloma|stage ii multiple myeloma
525708|NCT00305448|oncology|oncology
524964|NCT00301912|stage III multiple myeloma|stage iii multiple myeloma
524965|NCT00301912|refractory multiple myeloma|refractory multiple myeloma
524966|NCT00301912|polycythemia vera|polycythemia vera
524967|NCT00301912|essential thrombocythemia|essential thrombocythemia
524968|NCT00301912|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
524969|NCT00301912|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
583545|NCT00512109|cohort study|cohort study
524970|NCT00301912|splenic marginal zone lymphoma|splenic marginal zone lymphoma
524971|NCT00301912|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
524972|NCT00301912|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
524973|NCT00301912|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
524974|NCT00301912|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
524975|NCT00301912|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
524976|NCT00301912|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
524977|NCT00301912|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
524978|NCT00301912|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
524979|NCT00301912|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
524980|NCT00301912|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
524981|NCT00301912|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
524982|NCT00301912|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
524983|NCT00301912|chronic eosinophilic leukemia|chronic eosinophilic leukemia
524984|NCT00301912|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
524985|NCT00301912|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
524986|NCT00301912|chronic neutrophilic leukemia|chronic neutrophilic leukemia
524987|NCT00301912|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
524988|NCT00301912|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
524989|NCT00301912|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
524990|NCT00301912|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
524991|NCT00301912|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
524992|NCT00301912|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
524993|NCT00301912|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
524994|NCT00301912|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
524995|NCT00301912|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
524996|NCT00301912|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
524997|NCT00301912|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
524998|NCT00301912|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
524999|NCT00301912|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
525000|NCT00301912|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
525001|NCT00301912|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
525002|NCT00301912|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
525003|NCT00301912|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
525004|NCT00301912|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
525005|NCT00301912|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
525006|NCT00301912|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
525007|NCT00301912|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
525008|NCT00301912|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
525009|NCT00301912|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
525010|NCT00301912|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
525011|NCT00301912|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
525012|NCT00301912|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
525013|NCT00301912|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
525014|NCT00301912|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
525015|NCT00301912|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
525016|NCT00301912|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
525017|NCT00301912|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
525018|NCT00301912|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
525019|NCT00301912|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
525020|NCT00301912|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
525021|NCT00301912|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
525022|NCT00301912|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
525023|NCT00301912|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
525024|NCT00301912|stage I multiple myeloma|stage i multiple myeloma
525025|NCT00301912|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
525026|NCT00301925|stage I breast cancer|stage i breast cancer
525027|NCT00301925|stage II breast cancer|stage ii breast cancer
525028|NCT00301925|stage IIIA breast cancer|stage iiia breast cancer
525029|NCT00301925|male breast cancer|male breast cancer
525030|NCT00301951|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
525031|NCT00301951|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
525032|NCT00301951|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
525033|NCT00301951|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
525034|NCT00301951|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
525035|NCT00301951|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
525036|NCT00301951|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
525037|NCT00301951|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
525038|NCT00301951|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
525112|NCT00302146|Glucocerebrosidase|glucocerebrosidase
525039|NCT00301951|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
525040|NCT00301951|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
525041|NCT00301951|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
525042|NCT00301951|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
525043|NCT00301951|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
525044|NCT00301951|anaplastic large cell lymphoma|anaplastic large cell lymphoma
525045|NCT00301951|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
525046|NCT00301951|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
525047|NCT00301951|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
525048|NCT00301951|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
525049|NCT00301951|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
525050|NCT00301951|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
525051|NCT00301951|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
525052|NCT00301951|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
525053|NCT00301951|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
525054|NCT00301951|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
525055|NCT00301951|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
525056|NCT00301951|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
525057|NCT00301951|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
525058|NCT00301951|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
525059|NCT00301951|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
525060|NCT00301951|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
525061|NCT00301951|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
525062|NCT00301951|refractory multiple myeloma|refractory multiple myeloma
525063|NCT00301951|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
525064|NCT00301951|secondary acute myeloid leukemia|secondary acute myeloid leukemia
525065|NCT00301951|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
525066|NCT00301951|splenic marginal zone lymphoma|splenic marginal zone lymphoma
525067|NCT00301951|stage I multiple myeloma|stage i multiple myeloma
525068|NCT00301951|stage II multiple myeloma|stage ii multiple myeloma
525069|NCT00301951|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
525070|NCT00301951|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
525071|NCT00301951|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
525072|NCT00301951|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
525073|NCT00301951|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
751948|NCT01171326|foam|foam
525074|NCT00301951|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
525075|NCT00301951|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
525076|NCT00301951|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
525077|NCT00301951|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
525078|NCT00301951|stage III multiple myeloma|stage iii multiple myeloma
525079|NCT00301951|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
525080|NCT00301951|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
525081|NCT00301951|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
525082|NCT00301951|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
525083|NCT00301951|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
525084|NCT00301951|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
525085|NCT00301951|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
525086|NCT00301951|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
525087|NCT00301951|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
525088|NCT00301951|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
525089|NCT00301990|stage IV renal cell cancer|stage iv renal cell cancer
525090|NCT00301990|recurrent renal cell cancer|recurrent renal cell cancer
525091|NCT00301990|clear cell renal cell carcinoma|clear cell renal cell carcinoma
525092|NCT00302016|Chronic myeloid leukemia|chronic myeloid leukemia
525093|NCT00302016|AMN 107|amn 107
525094|NCT00302016|Imatinib resistant or intolerant|imatinib resistant or intolerant
525095|NCT00302016|nilotinib|nilotinib
525096|NCT00302016|enact|enact
583546|NCT00512109|surgery|surgery
525097|NCT00302029|Cytomegalovirus, risk factors, seroprevalence|cytomegalovirus, risk factors, seroprevalence
525098|NCT00302068|Exercise|exercise
525099|NCT00302081|Hepatitis C, Chronic|hepatitis c, chronic
525100|NCT00302081|Genotype 2 and Genotype 3|genotype 2 and genotype 3
525101|NCT00302107|Mirtazapine|mirtazapine
525102|NCT00302107|PTSD|ptsd
525103|NCT00302107|Veterans|veterans
525104|NCT00302107|antidepressant|antidepressant
525105|NCT00302120|Magnetic Resonance Imaging|magnetic resonance imaging
525106|NCT00302120|Breast Neoplasms|breast neoplasms
525107|NCT00302120|Diagnostic Trial|diagnostic trial
525108|NCT00302133|Alcoholism Bipolar Disorder Pharmacotherapy Naltrexone|alcoholism bipolar disorder pharmacotherapy naltrexone
525109|NCT00302146|Lysosomal Storage Disorder|lysosomal storage disorder
525110|NCT00302146|Carrier|carrier
525111|NCT00302146|L-Dopa Uptake|l-dopa uptake
525113|NCT00302146|Pathogenesis|pathogenesis
525114|NCT00302146|Carbidopa|carbidopa
525115|NCT00302146|Gaucher Disease|gaucher disease
525116|NCT00302146|Parkinson Disease|parkinson disease
525117|NCT00302146|[O-15]-Water|[o-15]-water
525118|NCT00302146|6-[F-18]Fluoro-L-dopa|6-[f-18]fluoro-l-dopa
525119|NCT00302146|Healthy Volunteer|healthy volunteer
525121|NCT00302159|Chemotherapy|chemotherapy
525122|NCT00302159|Radiation|radiation
525123|NCT00302159|Brain Tumor|brain tumor
525124|NCT00302159|GBM|gbm
525125|NCT00302159|Radiosensitizer|radiosensitizer
525126|NCT00302159|Glioblastoma|glioblastoma
525127|NCT00302159|Glioblastoma Multiforme|glioblastoma multiforme
525128|NCT00302172|Cancer|cancer
525129|NCT00302172|solid tumor|solid tumor
525130|NCT00302172|metastatic|metastatic
525131|NCT00302172|primary tumor|primary tumor
525132|NCT00302185|Palliative Care|palliative care
525133|NCT00302185|Acupuncture|acupuncture
525134|NCT00302185|Symptom Management|symptom management
525135|NCT00302185|Quality of Life|quality of life
525136|NCT00302198|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
525137|NCT00302211|PAH|pah
525138|NCT00302211|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
525139|NCT00302224|safety|safety
525140|NCT00302224|type 2 diabetes|type 2 diabetes
525141|NCT00302237|carotid, stenting, angioplasty|carotid, stenting, angioplasty
525142|NCT00302250|Cardiovascular|cardiovascular
525143|NCT00302250|Flow-mediated vasodilation (FMD)|flow-mediated vasodilation (fmd)
525144|NCT00302250|Pulse perfusion-mediated vasodilation (PPMV)|pulse perfusion-mediated vasodilation (ppmv)
525145|NCT00302250|Endothelial function|endothelial function
525146|NCT00302250|Heart failure|heart failure
525147|NCT00302263|Green tea|green tea
525148|NCT00302263|capsaicin|capsaicin
525149|NCT00302263|tyrosine|tyrosine
525150|NCT00302263|caffeine|caffeine
525151|NCT00302263|energy expenditure|energy expenditure
525152|NCT00302263|catecholamines|catecholamines
525153|NCT00302276|Body fat loss|body fat loss
525154|NCT00302276|energy expenditure|energy expenditure
525155|NCT00302276|capsaicin|capsaicin
525156|NCT00302276|caffeine|caffeine
525157|NCT00302276|green tea|green tea
525158|NCT00302276|calcium|calcium
525159|NCT00302276|fecal fat|fecal fat
525160|NCT00302276|fecal energy|fecal energy
525161|NCT00302289|green tea|green tea
525162|NCT00302289|caffeine|caffeine
525163|NCT00302289|tyrosine|tyrosine
525164|NCT00302289|energy expenditure|energy expenditure
525165|NCT00302289|energy intake|energy intake
525166|NCT00302302|Blood glucose|blood glucose
525167|NCT00302302|Insulin|insulin
525168|NCT00302302|Triglyceride|triglyceride
525170|NCT00302302|GLP-1|glp-1
525171|NCT00302302|L-arabinose|l-arabinose
525172|NCT00302302|Appetite|appetite
525173|NCT00302302|Energy intake|energy intake
525174|NCT00302315|postcesarean physiotherapy|postcesarean physiotherapy
525175|NCT00302315|incisional pain|incisional pain
525176|NCT00302315|functional activity|functional activity
525177|NCT00302315|connective tissue manipulation|connective tissue manipulation
525178|NCT00302315|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
525179|NCT00302341|Pulmonary disease|pulmonary disease
525180|NCT00302341|Dyspnea|dyspnea
525181|NCT00302341|Hypoxemia|hypoxemia
525182|NCT00302341|AIDS|aids
525183|NCT00302341|Pneumocystis jiroveci|pneumocystis jiroveci
525184|NCT00302393|healthy volunteers|healthy volunteers
525185|NCT00302419|Acute myocardial infarction|acute myocardial infarction
525186|NCT00302419|primary angioplasty|primary angioplasty
525187|NCT00302419|streptokinase|streptokinase
525188|NCT00302419|microvasculature|microvasculature
525189|NCT00302432|smoking reduction|smoking reduction
525190|NCT00302432|group therapy|group therapy
525191|NCT00302432|cigarette holders|cigarette holders
525192|NCT00302432|"Flowers Menthol"|"flowers menthol"
525193|NCT00302458|healthy volunteers|healthy volunteers
525194|NCT00302510|lipoprotein glomerulopathy|lipoprotein glomerulopathy
525195|NCT00302510|treatment|treatment
525196|NCT00302510|immunoadsorption|immunoadsorption
525197|NCT00302510|apolipoprotein E|apolipoprotein e
525198|NCT00302523|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
525199|NCT00302523|Treatment|treatment
525200|NCT00302523|Tacrolimus|tacrolimus
525201|NCT00302523|Cyclophosphamide|cyclophosphamide
525202|NCT00302536|Idiopathic Focal Segmental Glomerulosclerosis|idiopathic focal segmental glomerulosclerosis
525203|NCT00302536|Treatment|treatment
525204|NCT00302536|Steroids|steroids
525205|NCT00302549|Tacrolimus|tacrolimus
525206|NCT00302549|Cyclophosphamide|cyclophosphamide
525207|NCT00302549|Treatment|treatment
525208|NCT00302549|Lupus Nephritis|lupus nephritis
525209|NCT00302562|laryngeal cancer|laryngeal cancer
525210|NCT00302562|hypopharyngeal cancer|hypopharyngeal cancer
525211|NCT00302562|CXCR4|cxcr4
525212|NCT00302562|CXCL12|cxcl12
525213|NCT00302562|matrix metalloproteinases(MMPs)|matrix metalloproteinases(mmps)
525214|NCT00302562|metastasis|metastasis
525215|NCT00302575|Substance-Related Disorders|substance-related disorders
525216|NCT00302575|Prisoners|prisoners
525217|NCT00302588|metastatic carcinoma|metastatic carcinoma
525218|NCT00302588|cervical lymph nodes|cervical lymph nodes
525219|NCT00302588|unknown primary|unknown primary
525220|NCT00302588|diagnosis|diagnosis
525221|NCT00302588|result|result
525222|NCT00302601|Pulmonary embolism|pulmonary embolism
525223|NCT00302601|Right heart strain|right heart strain
525224|NCT00302601|Lung scintigraphy|lung scintigraphy
525225|NCT00302601|Pulmonary angiography|pulmonary angiography
525226|NCT00302614|obstructive sleep apnea|obstructive sleep apnea
525227|NCT00302614|snoring|snoring
525228|NCT00302614|collapsibility|collapsibility
525229|NCT00302614|upper airway|upper airway
525230|NCT00302627|bisphosphonates|bisphosphonates
525231|NCT00302627|vitamin D|vitamin d
525232|NCT00302627|calcium supplement|calcium supplement
525233|NCT00302627|corticosteroid therapy|corticosteroid therapy
525234|NCT00302627|fractures|fractures
525235|NCT00302666|Contraception, Bleeding pattern|contraception, bleeding pattern
525236|NCT00302679|Colonoscopy|colonoscopy
525237|NCT00302679|Sigmoidoscopy|sigmoidoscopy
525238|NCT00302679|Colon cancer screening|colon cancer screening
525239|NCT00302679|Pain|pain
525240|NCT00302679|Screening|screening
525241|NCT00302705|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
525242|NCT00302705|Valsartan|valsartan
525243|NCT00302705|Enalapril|enalapril
525244|NCT00302705|Missing dose|missing dose
525245|NCT00302718|Physician Incentive Plan|physician incentive plan
525246|NCT00302718|Quality of Health Care|quality of health care
525247|NCT00302718|Reimbursement, Incentive|reimbursement, incentive
525248|NCT00302718|Randomized Controlled Trial|randomized controlled trial
525249|NCT00302718|Physicians|physicians
525250|NCT00302718|Reward|reward
525251|NCT00302744|Anxiety|anxiety
525252|NCT00302744|Depression|depression
525253|NCT00302744|Mood|mood
525254|NCT00302744|Cancer|cancer
525255|NCT00302744|Quality of Life|quality of life
525256|NCT00302744|Psychiatric|psychiatric
525257|NCT00302744|Psilocybin|psilocybin
525258|NCT00302744|Alternative|alternative
525259|NCT00302744|Los Angeles|los angeles
525260|NCT00302757|NHL|nhl
525261|NCT00302757|low and high grade non-Hodgkin lymphoma|low and high grade non-hodgkin lymphoma
525262|NCT00302770|Patients with SAD|patients with sad
525263|NCT00302783|Education, Medical|education, medical
525264|NCT00302783|Education, Competency-Based|education, competency-based
525265|NCT00302783|Multi-Source Feedback|multi-source feedback
525266|NCT00302783|Communication|communication
525267|NCT00302783|Professionalism|professionalism
525268|NCT00302796|Low Back Pain,|low back pain,
525269|NCT00302809|Flavonoids|flavonoids
525270|NCT00302809|Arterial stiffness|arterial stiffness
525271|NCT00302809|Blood pressure|blood pressure
525272|NCT00302809|Endothelium|endothelium
525273|NCT00302809|Inflammation|inflammation
525274|NCT00302822|HIV infections|hiv infections
525275|NCT00302822|Fuzeon|fuzeon
525276|NCT00302822|Truvada|truvada
525277|NCT00302822|AIDS|aids
525278|NCT00302822|Treatment Naive|treatment naive
525279|NCT00302835|Analgesics|analgesics
525280|NCT00302835|Chronic Kidney Failure|chronic kidney failure
525281|NCT00302848|Venous thromboembolism|venous thromboembolism
525282|NCT00302848|Drospirenone|drospirenone
525283|NCT00302861|B-Cll|b-cll
525284|NCT00302874|diabetes|diabetes
525285|NCT00302874|hyperglycemia|hyperglycemia
525286|NCT00302874|hospital|hospital
525287|NCT00302874|medicine ward|medicine ward
525288|NCT00302887|fibromyalgia|fibromyalgia
525289|NCT00302887|connective tissue manipulation|connective tissue manipulation
525290|NCT00302887|ultrasound therapy|ultrasound therapy
525291|NCT00302887|high voltage pulsed galvanic stimulation|high voltage pulsed galvanic stimulation
525292|NCT00302900|Blood Donation|blood donation
525293|NCT00302900|Syncope|syncope
525294|NCT00302900|Vasovagal Reactions|vasovagal reactions
525295|NCT00302913|Clopidogrel|clopidogrel
525296|NCT00302913|Coronary Artery Disease|coronary artery disease
525297|NCT00302913|Dose-Response Relationship, Drug|dose-response relationship, drug
525298|NCT00302913|Drug Resistance|drug resistance
525299|NCT00302913|PCI|pci
525300|NCT00302926|Weight loss|weight loss
525301|NCT00302926|obesity|obesity
525302|NCT00302926|energy restriction|energy restriction
525303|NCT00302939|Aging|aging
525304|NCT00302952|Arthritis, Rheumatoid|arthritis, rheumatoid
525305|NCT00302965|Plasma|plasma
525306|NCT00302965|Trauma|trauma
525307|NCT00302965|Critical Care|critical care
525308|NCT00302978|Height phobia|height phobia
525309|NCT00302978|fear of heights|fear of heights
525310|NCT00302978|specific phobia|specific phobia
525311|NCT00302991|Observational|observational
525312|NCT00302991|cross-sectional|cross-sectional
525313|NCT00302991|health-related quality of life|health-related quality of life
525314|NCT00302991|adverse effects|adverse effects
525315|NCT00302991|Baker´s AEP scale validation|baker´s aep scale validation
525316|NCT00302991|epilepsy|epilepsy
525317|NCT00303030|Fecal incontinence|fecal incontinence
525318|NCT00303030|Biofeedback|biofeedback
525319|NCT00303030|Patient Satisfaction|patient satisfaction
525418|NCT00303173|psychophysiology|psychophysiology
525320|NCT00303030|Quality of LifeTreatment Outcome|quality of lifetreatment outcome
525321|NCT00303030|Injections|injections
525322|NCT00303043|Hemodynamic monitoring|hemodynamic monitoring
525323|NCT00303043|Mixed venous saturation|mixed venous saturation
525324|NCT00303043|Critically ill patients|critically ill patients
525325|NCT00303056|Osteoarthritis|osteoarthritis
525326|NCT00303056|knee|knee
525327|NCT00303069|S. aureus;|s. aureus;
525328|NCT00303069|Vaccine|vaccine
525329|NCT00303069|FIM|fim
525330|NCT00303082|Probiotics|probiotics
525331|NCT00303082|Bacterial Vaginosis|bacterial vaginosis
525332|NCT00303082|Premature birth|premature birth
525333|NCT00303082|Intra-uterine Infection|intra-uterine infection
525334|NCT00303082|Periventricular leukomalacia|periventricular leukomalacia
525335|NCT00294034|Registry|registry
525336|NCT00294034|Pacemaker|pacemaker
525337|NCT00294034|Diagnostics|diagnostics
525338|NCT00294047|Vaccine|vaccine
525339|NCT00294047|Human papillomavirus|human papillomavirus
525340|NCT00294047|Cervical Cancer|cervical cancer
525341|NCT00294047|Cervical Infection|cervical infection
525342|NCT00294060|Pacemaker|pacemaker
525343|NCT00294060|Bradycardia|bradycardia
525344|NCT00294073|femoral block|femoral block
525345|NCT00294073|fascia iliaca block|fascia iliaca block
525346|NCT00294073|ACL repair|acl repair
525347|NCT00294073|post-operative analgesia|post-operative analgesia
525348|NCT00294073|knee surgery|knee surgery
525349|NCT00294073|ACL damage|acl damage
525350|NCT00294073|knee damage|knee damage
525351|NCT00294086|valsartan,|valsartan,
525352|NCT00294086|chronic heart failure,|chronic heart failure,
525353|NCT00294099|A/H5N1, Influenza, Vaccine|a/h5n1, influenza, vaccine
525354|NCT00294112|mesenchymal stem cells|mesenchymal stem cells
525355|NCT00294125|Medical Food|medical food
525356|NCT00294125|Botanicals|botanicals
525357|NCT00294125|Phytochemicals|phytochemicals
525358|NCT00294151|breast cancer|breast cancer
525359|NCT00294151|prostate cancer|prostate cancer
525360|NCT00294151|vertebral metastasis|vertebral metastasis
525361|NCT00294151|vertebroplasty|vertebroplasty
525362|NCT00294151|vertebral metastasis from breast cancer|vertebral metastasis from breast cancer
525363|NCT00294151|vertebral metastasis from prostate cancer|vertebral metastasis from prostate cancer
525364|NCT00294164|Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)|human immunodeficiency virus-associated adipose redistribution syndrome (hars)
525365|NCT00294164|Human Immunodeficiency Virus Infections|human immunodeficiency virus infections
525366|NCT00294164|recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
525367|NCT00294164|Serostim®|serostim®
525368|NCT00294164|Placebo|placebo
678680|NCT00889590|GCT|gct
751949|NCT01171326|phase II|phase ii
525369|NCT00294177|Trophoblastic Neoplasms|trophoblastic neoplasms
525370|NCT00294177|Chorionic Gonadotropin|chorionic gonadotropin
525371|NCT00294177|Molecular Conformation|molecular conformation
525373|NCT00294190|Extensive stage|extensive stage
525374|NCT00294190|Small Cell Lung Cancer|small cell lung cancer
525375|NCT00294203|Digestive System Surgical Procedures|digestive system surgical procedures
525376|NCT00294203|Post-Operative Care|post-operative care
525377|NCT00294203|Fatigue|fatigue
525378|NCT00294203|Quality of Life|quality of life
525379|NCT00294203|Erythrocyte Transfusion|erythrocyte transfusion
525380|NCT00294203|Esophagectomy|esophagectomy
525381|NCT00294203|Gastric Cancer|gastric cancer
525382|NCT00294203|Hepatectomy|hepatectomy
525383|NCT00294203|Pancreatic Cancer|pancreatic cancer
525384|NCT00294203|Rectum|rectum
525385|NCT00294216|Omacor|omacor
525386|NCT00294216|Omega-3 PUFA|omega-3 pufa
525387|NCT00294216|Endarterectomy|endarterectomy
525388|NCT00294216|Carotid Plaque stability|carotid plaque stability
525389|NCT00294216|Structural changes|structural changes
525390|NCT00294216|inflammation|inflammation
525391|NCT00294229|Low back pain|low back pain
525392|NCT00294229|Spinal manipulative therapy|spinal manipulative therapy
525393|NCT00294229|Randomised controlled trial|randomised controlled trial
525394|NCT00303121|Glaucoma|glaucoma
525395|NCT00303121|Compliance|compliance
525397|NCT00303121|Administration technique|administration technique
525398|NCT00303134|islet cell|islet cell
525399|NCT00303134|diabetes|diabetes
525400|NCT00303134|transplant|transplant
525401|NCT00303134|immunosuppression|immunosuppression
525402|NCT00303134|autoimmunity|autoimmunity
525403|NCT00303134|alloimmunity|alloimmunity
525404|NCT00303147|Expressive Writing|expressive writing
525405|NCT00303147|Written Emotional Expression|written emotional expression
525406|NCT00303147|Caregiver Stress|caregiver stress
525407|NCT00303147|Cognition|cognition
525408|NCT00303160|heliobacter pylori infection|heliobacter pylori infection
525409|NCT00303160|reactive oxygen species|reactive oxygen species
525410|NCT00303160|antioxidants|antioxidants
525411|NCT00303173|Pre-eclampsia|pre-eclampsia
525412|NCT00303173|hypertension|hypertension
525413|NCT00303173|blood pressure|blood pressure
525414|NCT00303173|pregnancy|pregnancy
525415|NCT00303173|randomized clinical trial|randomized clinical trial
525416|NCT00303173|guided imagery|guided imagery
525417|NCT00303173|relaxation|relaxation
525419|NCT00303173|mind-body|mind-body
525420|NCT00303186|Rheumatoid Arthritis|rheumatoid arthritis
525421|NCT00303199|Multiple Myeloma|multiple myeloma
525423|NCT00303199|Cancer study|cancer study
525424|NCT00303199|Failed treatment|failed treatment
525425|NCT00303212|heart failure|heart failure
525426|NCT00303212|CHF|chf
525427|NCT00303212|telemedicine|telemedicine
525428|NCT00303212|disease management|disease management
525429|NCT00303225|Biodefense|biodefense
525430|NCT00303225|Smallpox|smallpox
525431|NCT00303225|Monkeypox|monkeypox
525432|NCT00303225|Vaccinia|vaccinia
525433|NCT00303225|Prophylaxis|prophylaxis
525434|NCT00303225|Healthy Volunteer|healthy volunteer
525435|NCT00303225|HV|hv
525436|NCT00303238|Inflammation|inflammation
525437|NCT00303238|Interleukin-1|interleukin-1
525438|NCT00303238|C-reactive protein|c-reactive protein
525439|NCT00303238|Genotype|genotype
525440|NCT00303238|Rose Hips|rose hips
525441|NCT00303238|Blueberry|blueberry
525442|NCT00303238|Blackberry|blackberry
525443|NCT00303238|Aframomum melegueta|aframomum melegueta
525444|NCT00303238|Resveravine|resveravine
525445|NCT00303251|Locally Advanced or Metastatic Melanoma|locally advanced or metastatic melanoma
525446|NCT00303264|functional dyspepsia|functional dyspepsia
525447|NCT00303264|cholecystokinin|cholecystokinin
525448|NCT00303264|CCK|cck
525449|NCT00303264|gastrointestinal|gastrointestinal
525450|NCT00303264|intestinal transit|intestinal transit
525451|NCT00303264|GI motility|gi motility
525452|NCT00303264|bloating|bloating
525453|NCT00303264|upper GI discomfort|upper gi discomfort
525454|NCT00303264|upper GI|upper gi
525455|NCT00303264|early satiety|early satiety
525456|NCT00303264|nausea|nausea
525457|NCT00303264|belching|belching
525458|NCT00303264|retching|retching
525459|NCT00303264|vomiting|vomiting
525460|NCT00303264|GERD|gerd
525461|NCT00303277|Alzheimer's disease|alzheimer's disease
525462|NCT00303277|beta-amyloid|beta-amyloid
525463|NCT00303277|statins|statins
525464|NCT00303290|Early Chronic Phase CML|early chronic phase cml
525465|NCT00303290|Peg Interferon Alpha 2b|peg interferon alpha 2b
525466|NCT00303290|Peg Intron|peg intron
525467|NCT00303290|Ara-C|ara-c
525468|NCT00303290|Cytosine Arabinoside|cytosine arabinoside
525469|NCT00303303|Snake envenomation|snake envenomation
525470|NCT00303303|Antivenins|antivenins
525471|NCT00303303|Disability evaluation|disability evaluation
525472|NCT00303303|Activities of daily living|activities of daily living
525473|NCT00303316|Diphtheria|diphtheria
525474|NCT00303316|Tetanus|tetanus
525475|NCT00303316|Pertussis|pertussis
525476|NCT00303316|whooping cough|whooping cough
525477|NCT00303316|Haemophilus influenzae type b|haemophilus influenzae type b
525478|NCT00303316|Hepatitis B|hepatitis b
525479|NCT00303316|Poliomyelitis|poliomyelitis
525480|NCT00303329|β-thalassemia|β-thalassemia
525481|NCT00303329|rare chronic anemia|rare chronic anemia
525482|NCT00303329|iron overload|iron overload
525483|NCT00303329|deferasirox|deferasirox
525484|NCT00303329|chronic anemias|chronic anemias
525485|NCT00303329|transfusional hemosiderosis|transfusional hemosiderosis
525486|NCT00303342|sleep|sleep
525487|NCT00303342|arousal|arousal
525488|NCT00303342|stress|stress
525489|NCT00303342|cortisol|cortisol
525490|NCT00303342|catecholamines|catecholamines
525491|NCT00303355|jugular venous pulse|jugular venous pulse
525492|NCT00303368|Neurofibromatosis (NF1)|neurofibromatosis (nf1)
525493|NCT00303368|Tibial Dysplasia (TD)|tibial dysplasia (td)
525494|NCT00303394|Type 2 Diabetes, IL-1, inflammation, glucotoxicity, insulin|type 2 diabetes, il-1, inflammation, glucotoxicity, insulin
525495|NCT00303420|catheter|catheter
525496|NCT00303420|hemodialysis|hemodialysis
525497|NCT00303420|dysfunction|dysfunction
525498|NCT00303420|thrombolytic|thrombolytic
525499|NCT00303420|alteplase|alteplase
525500|NCT00303433|Prevention|prevention
525501|NCT00303433|Post-Operative tates|post-operative tates
525502|NCT00303433|Delirium|delirium
525503|NCT00303433|Namenda|namenda
525504|NCT00304798|Transient Ischemic Attack (TIA).|transient ischemic attack (tia).
525505|NCT00304798|Stroke.|stroke.
525506|NCT00304798|Hospital admission.|hospital admission.
525507|NCT00304811|MRSA|mrsa
525508|NCT00304811|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
525509|NCT00304824|Glaucoma|glaucoma
525510|NCT00304824|Olfactory functions|olfactory functions
525511|NCT00304824|Sniffing Sticks Test|sniffing sticks test
525512|NCT00304837|Nonhealing leg ulcers|nonhealing leg ulcers
525513|NCT00304837|Ischemic rest pain|ischemic rest pain
525514|NCT00304850|polyamines|polyamines
525515|NCT00304850|pain|pain
525516|NCT00304850|breast cancer|breast cancer
525517|NCT00304850|mastectomy|mastectomy
525518|NCT00304850|post operative pain|post operative pain
525519|NCT00304863|CDAD|cdad
525520|NCT00304863|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
525521|NCT00304876|Clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
525522|NCT00304889|Clostridium difficile|clostridium difficile
525523|NCT00304902|MRSA|mrsa
525524|NCT00304902|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
525525|NCT00304902|Staphylococcus aureus Bacteremia|staphylococcus aureus bacteremia
525526|NCT00304915|HIV, depression|hiv, depression
525527|NCT00304915|patient care management|patient care management
525528|NCT00304915|patient care team|patient care team
525529|NCT00304941|Breast Cancer|breast cancer
525530|NCT00304941|Family History|family history
525531|NCT00304941|Pre/Post Menopausal|pre/post menopausal
525532|NCT00304941|Prevention|prevention
525533|NCT00304941|Risk-Factor|risk-factor
525534|NCT00304941|Body-Mass-Index|body-mass-index
525535|NCT00304941|BRCA1|brca1
525536|NCT00304941|Insulin|insulin
525537|NCT00304941|Genetic Counseling|genetic counseling
525538|NCT00304941|Penetrance|penetrance
525539|NCT00304941|Risk Assessment|risk assessment
525540|NCT00304941|Healthy Volunteer|healthy volunteer
525541|NCT00304941|HV|hv
525542|NCT00304954|Age-Related Macular Degeneration|age-related macular degeneration
525543|NCT00304954|Rapamycin|rapamycin
525544|NCT00304954|Remicade|remicade
525545|NCT00304954|Daclizumab|daclizumab
525546|NCT00304954|Immunosuppression|immunosuppression
525547|NCT00304954|Infliximab|infliximab
525548|NCT00304954|Choroidal Neovascularization|choroidal neovascularization
525549|NCT00304954|Sirolimus|sirolimus
525550|NCT00304954|AMD|amd
525551|NCT00304954|Ocular Inflammation|ocular inflammation
525552|NCT00304967|Cataract|cataract
525553|NCT00304967|Normal Lenses|normal lenses
525554|NCT00304967|Lens Crystallines|lens crystallines
525555|NCT00304967|Dynamic or Quasielastic Light Scattering (DLS)|dynamic or quasielastic light scattering (dls)
525556|NCT00304967|Eye Examinations|eye examinations
525557|NCT00304967|Healthy Volunteer|healthy volunteer
525558|NCT00304967|HV|hv
525559|NCT00304967|Eye Examination|eye examination
525560|NCT00304993|fenofibrate|fenofibrate
525561|NCT00304993|niacin|niacin
525562|NCT00304993|rosiglitazone|rosiglitazone
525563|NCT00304993|LDL phenotype pattern B|ldl phenotype pattern b
525564|NCT00304993|small, dense LDL|small, dense ldl
525565|NCT00304993|insulin resistance|insulin resistance
525566|NCT00304993|Metabolic Syndrome|metabolic syndrome
525567|NCT00305006|cerebral palsy|cerebral palsy
525568|NCT00305006|constraint-induced therapy|constraint-induced therapy
525569|NCT00305006|constraint-induced movement therapy|constraint-induced movement therapy
525570|NCT00305006|CP|cp
525571|NCT00305006|hemiplegia|hemiplegia
525572|NCT00305006|hand|hand
525573|NCT00305006|forced use|forced use
525574|NCT00305006|motor control|motor control
525575|NCT00305006|children|children
525576|NCT00305006|HABIT|habit
525577|NCT00305006|Hand-arm bimanual intensive therapy|hand-arm bimanual intensive therapy
525578|NCT00305006|Bilateral training|bilateral training
525579|NCT00305006|Bimanual training|bimanual training
525580|NCT00305006|functional therapy|functional therapy
525581|NCT00305006|physical therapy|physical therapy
525582|NCT00305006|occupational therapy|occupational therapy
525583|NCT00305006|intensive|intensive
525584|NCT00305006|pediatric|pediatric
525585|NCT00305006|development|development
525586|NCT00305006|upper extremity|upper extremity
525587|NCT00305006|hemiplegic|hemiplegic
525588|NCT00305045|Major Depressive Disorder|major depressive disorder
525589|NCT00305045|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
525590|NCT00305045|Treatment resistance|treatment resistance
525591|NCT00305058|Elderly|elderly
525592|NCT00305058|Hydromorphone|hydromorphone
525593|NCT00305058|Morphine|morphine
525594|NCT00305058|Pain|pain
525595|NCT00305058|Acute|acute
525596|NCT00305058|Emergency Department|emergency department
525597|NCT00305071|pyuria|pyuria
525598|NCT00305071|urinary tract infections|urinary tract infections
525599|NCT00305071|Vaccinium macrocarpon|vaccinium macrocarpon
525600|NCT00305084|NGR-hTNF|ngr-htnf
525601|NCT00305084|doxorubicin|doxorubicin
525602|NCT00305084|solid tumors|solid tumors
525603|NCT00305097|coffee|coffee
525604|NCT00305097|caffeine|caffeine
525605|NCT00305097|glucose tolerance|glucose tolerance
525606|NCT00305097|body weight|body weight
525607|NCT00305097|insulin sensitivity|insulin sensitivity
525608|NCT00305097|randomized controlled trial|randomized controlled trial
525609|NCT00305110|Pain|pain
525610|NCT00305110|Acute|acute
525611|NCT00305110|Emergency Department|emergency department
525612|NCT00305110|Severe|severe
525613|NCT00305110|Hydromorphone|hydromorphone
525614|NCT00305110|Dilaudid|dilaudid
525615|NCT00305110|Adult|adult
525616|NCT00305123|Pharyngitis, Mali, Group A Streptococcus, Children|pharyngitis, mali, group a streptococcus, children
525617|NCT00305136|thoracotomy|thoracotomy
525618|NCT00305136|post-operative pain|post-operative pain
525619|NCT00305136|chronic pain|chronic pain
525620|NCT00305136|endogenous analgesia|endogenous analgesia
525621|NCT00305136|temporal summation|temporal summation
525622|NCT00305136|central sensitization|central sensitization
525623|NCT00305136|prediction|prediction
525624|NCT00305136|Patients Who Should Undergo Thoracotomy|patients who should undergo thoracotomy
525625|NCT00305149|Hodgkin Lymphoma|hodgkin lymphoma
525629|NCT00305149|Tailored therapy|tailored therapy
525630|NCT00305162|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
525631|NCT00305162|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
525632|NCT00305162|non-ST-segment elevation myocardial infarction (NSTEMI)|non-st-segment elevation myocardial infarction (nstemi)
525633|NCT00305162|ST-segment elevation myocardial infarction (STEMI)|st-segment elevation myocardial infarction (stemi)
525634|NCT00305175|Hydroxyurea|hydroxyurea
525635|NCT00305175|Sickle Cell Anemia|sickle cell anemia
525636|NCT00305188|Neurotoxicity syndromes|neurotoxicity syndromes
525637|NCT00305188|Paresthesia|paresthesia
525638|NCT00305188|Oxaliplatin|oxaliplatin
525639|NCT00305188|Xaliproden|xaliproden
525640|NCT00305201|Mucocutaneous Lymph Node Syndrome|mucocutaneous lymph node syndrome
525641|NCT00305201|Kawasaki disease|kawasaki disease
525642|NCT00305201|Endothelial dysfunction|endothelial dysfunction
525643|NCT00305201|Pravastatin|pravastatin
525644|NCT00305201|Statin therapy|statin therapy
525645|NCT00305214|Myocardial Infarction|myocardial infarction
525646|NCT00305214|Microvolt T Wave Alternans Test|microvolt t wave alternans test
525647|NCT00305214|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
525648|NCT00305214|Ventricular Arrhythmia|ventricular arrhythmia
525649|NCT00305227|urinary tract infection|urinary tract infection
525650|NCT00305227|cystitis|cystitis
525651|NCT00305227|Lactobacillus|lactobacillus
525652|NCT00305227|probiotic|probiotic
525653|NCT00305227|prevention|prevention
525654|NCT00305240|Myocardial Infarction|myocardial infarction
525655|NCT00305240|Microvolt T Wave Alternans Test|microvolt t wave alternans test
525656|NCT00305240|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
525657|NCT00305240|Ventricular Arrythmias|ventricular arrythmias
525658|NCT00305253|maternal mortality|maternal mortality
525659|NCT00305253|obstetric hemorrhage|obstetric hemorrhage
525660|NCT00305266|CIDP|cidp
525661|NCT00305266|IVIG|ivig
525662|NCT00305266|gammaglobulin|gammaglobulin
525663|NCT00305266|Chronic Inflammatory Demyelinating Polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
525664|NCT00305305|Agenesis Corpus Callosum|agenesis corpus callosum
525665|NCT00305305|Polymicrogyria|polymicrogyria
525666|NCT00305305|Dandy-Walker|dandy-walker
525667|NCT00305305|Brain Malformation|brain malformation
525668|NCT00305305|Autism|autism
525669|NCT00305305|Epilepsy|epilepsy
525670|NCT00305305|Mental Retardation|mental retardation
525672|NCT00305305|Agenesis of the Corpus Callosum (complete or partial)|agenesis of the corpus callosum (complete or partial)
525673|NCT00305305|Confirmed by a brain MRI.|confirmed by a brain mri.
525677|NCT00305331|Peripheral edema|peripheral edema
525679|NCT00305331|Ropinirole|ropinirole
525680|NCT00305344|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
525681|NCT00305344|Umbilical Cord|umbilical cord
525682|NCT00305344|Regeneration|regeneration
525683|NCT00305344|Insulin|insulin
525684|NCT00305344|Islets of Langerhans|islets of langerhans
525685|NCT00305357|Post-Herpetic Neuralgia|post-herpetic neuralgia
525686|NCT00305357|Acute Herpes Zoster|acute herpes zoster
525687|NCT00305370|clinical trial|clinical trial
525688|NCT00305370|aripiprazole|aripiprazole
525689|NCT00305370|methylphenidate|methylphenidate
525690|NCT00305370|Bipolar Disorder|bipolar disorder
525691|NCT00305370|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
525692|NCT00305370|ADHD|adhd
525693|NCT00305383|Viramidine|viramidine
525694|NCT00305383|Peginterferon alfa-2b|peginterferon alfa-2b
525695|NCT00305383|Valeant|valeant
525696|NCT00305383|Hepatitis C|hepatitis c
525697|NCT00305383|Rapid virologic response|rapid virologic response
525698|NCT00305383|HCV RNA|hcv rna
525700|NCT00305396|immunosuppression|immunosuppression
525701|NCT00305396|sirolimus|sirolimus
525702|NCT00305396|Thymoglobulin|thymoglobulin
525703|NCT00305409|Crohn's|crohn's
525704|NCT00305409|TNF-alpha|tnf-alpha
525705|NCT00305409|Synbiotic|synbiotic
525706|NCT00305409|Probiotic|probiotic
525707|NCT00305435|AMG 531, ITP, Phase 2, Japanese|amg 531, itp, phase 2, japanese
525709|NCT00305448|cancer|cancer
525710|NCT00305448|breast cancer|breast cancer
525711|NCT00305461|Asthma|asthma
525712|NCT00305461|Quality of Life|quality of life
525713|NCT00305461|Ciclesonide|ciclesonide
525714|NCT00305474|Negative symptoms|negative symptoms
525715|NCT00305474|neuropsychological deficits|neuropsychological deficits
525716|NCT00305474|Cognitive function|cognitive function
525717|NCT00305474|diagnostic|diagnostic
525718|NCT00305474|prevention|prevention
525719|NCT00305487|Hay Fever|hay fever
525720|NCT00305487|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
525721|NCT00305487|Nasal spray|nasal spray
525722|NCT00305487|Ciclesonide|ciclesonide
525723|NCT00305487|Allergic Rhinitis|allergic rhinitis
525724|NCT00305500|OCD|ocd
525725|NCT00305500|Escitalopram|escitalopram
525729|NCT00305513|PET scan|pet scan
525730|NCT00305513|patients post right hemispheric CVA (stroke)|patients post right hemispheric cva (stroke)
525731|NCT00305539|Giant Cell Arteritis|giant cell arteritis
525733|NCT00305539|Anti-TNF|anti-tnf
525734|NCT00305539|Multicenter-randomized-trial|multicenter-randomized-trial
525735|NCT00305539|Proved GCA according to ACR criteria (HUNDER et al 1990)|proved gca according to acr criteria (hunder et al 1990)
525736|NCT00305552|Randomized controlled trial|randomized controlled trial
525737|NCT00305552|Thalidomide vs placebo|thalidomide vs placebo
525738|NCT00305552|skin sarcoidosis|skin sarcoidosis
525739|NCT00305552|Thalidomide|thalidomide
525740|NCT00305565|Depression|depression
525741|NCT00305565|Chronic Depression|chronic depression
525742|NCT00305565|Bipolar Disorder|bipolar disorder
525743|NCT00305578|Bipolar|bipolar
525744|NCT00305578|Depression|depression
525745|NCT00305578|Incomplete Response|incomplete response
525746|NCT00305591|magnetic resonance imaging|magnetic resonance imaging
525747|NCT00305591|magnetic resonance spectroscopy|magnetic resonance spectroscopy
525748|NCT00305591|functional magnetic resonance imaging|functional magnetic resonance imaging
525749|NCT00305591|cirrhosis|cirrhosis
525750|NCT00305591|hepatic encephalopathy|hepatic encephalopathy
525751|NCT00305591|l-ornithine l-aspartate|l-ornithine l-aspartate
525752|NCT00305617|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
525753|NCT00305617|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
525754|NCT00305630|Corticosteroids|corticosteroids
525755|NCT00305630|Triamcinolone|triamcinolone
525756|NCT00305630|Photodynamic therapy|photodynamic therapy
525757|NCT00305630|Choroidal neovascularization|choroidal neovascularization
525758|NCT00305630|Age-related macular degeneration|age-related macular degeneration
525759|NCT00305643|Hand-Foot Syndrome|hand-foot syndrome
525760|NCT00305643|cancer-related problem/condition|cancer-related problem/condition
525761|NCT00305643|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
525762|NCT00305643|pain|pain
525763|NCT00305643|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
525764|NCT00305643|stage IV breast cancer|stage iv breast cancer
525765|NCT00305643|male breast cancer|male breast cancer
525766|NCT00305643|recurrent breast cancer|recurrent breast cancer
525767|NCT00305643|stage IV colon cancer|stage iv colon cancer
525768|NCT00305643|stage IV rectal cancer|stage iv rectal cancer
525769|NCT00305643|recurrent colon cancer|recurrent colon cancer
525770|NCT00305643|recurrent rectal cancer|recurrent rectal cancer
525771|NCT00305643|Celecoxib|celecoxib
525775|NCT00305669|adenocarcinoma of the prostate|adenocarcinoma of the prostate
525776|NCT00305669|stage I prostate cancer|stage i prostate cancer
525777|NCT00305669|stage IIB prostate cancer|stage iib prostate cancer
525778|NCT00305669|stage IIA prostate cancer|stage iia prostate cancer
525779|NCT00305669|stage III prostate cancer|stage iii prostate cancer
525780|NCT00305708|thrombocytopenia|thrombocytopenia
525781|NCT00305708|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
525782|NCT00305708|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
525783|NCT00305708|Diamond-Blackfan anemia|diamond-blackfan anemia
525784|NCT00305708|congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
525785|NCT00305708|Fanconi anemia|fanconi anemia
525786|NCT00305708|severe congenital neutropenia|severe congenital neutropenia
525787|NCT00305708|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
525788|NCT00305747|recurrent prostate cancer|recurrent prostate cancer
525789|NCT00305747|stage I prostate cancer|stage i prostate cancer
525790|NCT00305747|stage II prostate cancer|stage ii prostate cancer
525791|NCT00305747|stage III prostate cancer|stage iii prostate cancer
525792|NCT00305747|adenocarcinoma of the prostate|adenocarcinoma of the prostate
525793|NCT00305747|stage IV prostate cancer|stage iv prostate cancer
525794|NCT00305760|stage III pancreatic cancer|stage iii pancreatic cancer
525795|NCT00305760|recurrent pancreatic cancer|recurrent pancreatic cancer
525796|NCT00305760|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
525797|NCT00305760|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
525798|NCT00305760|stage IV pancreatic cancer|stage iv pancreatic cancer
525799|NCT00305786|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
525800|NCT00305786|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
525801|NCT00305786|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
525802|NCT00305799|neurotoxicity|neurotoxicity
525803|NCT00305799|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
525804|NCT00305812|stage I multiple myeloma|stage i multiple myeloma
525805|NCT00305812|stage II multiple myeloma|stage ii multiple myeloma
525806|NCT00305812|stage III multiple myeloma|stage iii multiple myeloma
525813|NCT00305838|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
525814|NCT00305838|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
525815|NCT00305838|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
525816|NCT00305838|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
525817|NCT00305838|recurrent fallopian tube cancer|recurrent fallopian tube cancer
525818|NCT00305838|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
525819|NCT00305838|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
525820|NCT00305838|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
525821|NCT00305838|stage IV fallopian tube cancer|stage iv fallopian tube cancer
525822|NCT00305838|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
525823|NCT00305838|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
525824|NCT00305838|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
525825|NCT00305838|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
525826|NCT00305838|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
525828|NCT00305851|pain|pain
525829|NCT00305851|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
525830|NCT00305851|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
525831|NCT00305851|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
525832|NCT00305851|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
525833|NCT00305851|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
525834|NCT00305851|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
525835|NCT00305851|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
525836|NCT00305851|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
525837|NCT00305851|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
525838|NCT00305851|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
525839|NCT00305851|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
525840|NCT00305851|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
525841|NCT00305851|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
525842|NCT00305851|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
525843|NCT00305851|chronic eosinophilic leukemia|chronic eosinophilic leukemia
525844|NCT00305851|primary myelofibrosis|primary myelofibrosis
525845|NCT00305851|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
525846|NCT00305851|chronic neutrophilic leukemia|chronic neutrophilic leukemia
525847|NCT00305851|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
525848|NCT00305851|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
525849|NCT00305851|disseminated neuroblastoma|disseminated neuroblastoma
525850|NCT00305851|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
679285|NCT00891306|AAV|aav
525851|NCT00305851|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
525852|NCT00305851|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
525853|NCT00305851|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
525854|NCT00305851|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
525855|NCT00305851|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
525856|NCT00305851|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
525857|NCT00305851|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
525858|NCT00305851|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
525859|NCT00305851|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
525860|NCT00305851|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
525861|NCT00305851|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
525862|NCT00305851|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
525863|NCT00305851|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
525864|NCT00305851|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
525865|NCT00305851|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
525866|NCT00305851|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
525867|NCT00305851|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
525868|NCT00305851|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
525869|NCT00305851|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
526130|NCT00306670|Anti-Factor VIII inhibitors|anti-factor viii inhibitors
525870|NCT00305851|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
525871|NCT00305851|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
525872|NCT00305851|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
525873|NCT00305851|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
525874|NCT00305851|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
525875|NCT00305851|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
525876|NCT00305851|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
525877|NCT00305851|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
525878|NCT00305851|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
525879|NCT00305851|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
525880|NCT00305851|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
525881|NCT00305851|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
525882|NCT00305851|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
525883|NCT00305851|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
525884|NCT00305851|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
525885|NCT00305851|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
525886|NCT00305851|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
525887|NCT00305851|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
525888|NCT00305851|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
525889|NCT00305851|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
525890|NCT00305851|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
525891|NCT00305851|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
525892|NCT00305851|recurrent neuroblastoma|recurrent neuroblastoma
525893|NCT00305851|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
525894|NCT00305851|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
525895|NCT00305851|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
525896|NCT00305851|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
525897|NCT00305851|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
525898|NCT00305851|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
525899|NCT00305851|refractory hairy cell leukemia|refractory hairy cell leukemia
525900|NCT00305851|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
525901|NCT00305851|secondary acute myeloid leukemia|secondary acute myeloid leukemia
525902|NCT00305851|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
525903|NCT00305851|splenic marginal zone lymphoma|splenic marginal zone lymphoma
525904|NCT00305851|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
525905|NCT00305851|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
525906|NCT00305851|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
525907|NCT00305851|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
751950|NCT01171326|impetigo|impetigo
751951|NCT01171339|elderly|elderly
525908|NCT00305851|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
525909|NCT00305851|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
525910|NCT00305851|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
525911|NCT00305851|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
525912|NCT00305851|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
525913|NCT00305851|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
525914|NCT00305851|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
525915|NCT00305851|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
525916|NCT00305851|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
525917|NCT00305851|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
525918|NCT00305851|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
525919|NCT00305851|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
525920|NCT00305851|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
525921|NCT00305851|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
525922|NCT00305851|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
525923|NCT00305851|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
525924|NCT00305851|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
525925|NCT00305851|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
525926|NCT00305851|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
525927|NCT00305851|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
525928|NCT00305851|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
525929|NCT00305851|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
525930|NCT00305851|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
525931|NCT00305851|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
525932|NCT00305851|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
525933|NCT00305851|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
525934|NCT00305851|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
525935|NCT00305851|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
525936|NCT00305851|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
525937|NCT00305851|Ewing sarcoma|ewing sarcoma
525938|NCT00305851|childhood brain tumor|childhood brain tumor
525939|NCT00305851|adult brain tumor|adult brain tumor
525940|NCT00305851|osteosarcoma|osteosarcoma
525942|NCT00305903|Alzheimer's,|alzheimer's,
525943|NCT00305903|Rivastigmine,|rivastigmine,
525944|NCT00305903|Memantine|memantine
525945|NCT00305916|MSCT|msct
525946|NCT00305916|Idiopathic Cardiomyopathy|idiopathic cardiomyopathy
525947|NCT00305916|Sinus rhythm|sinus rhythm
525948|NCT00305929|Treatment of localized prostate cancer|treatment of localized prostate cancer
525949|NCT00305929|Localized prostate cancer|localized prostate cancer
525950|NCT00305942|Lung Cancer|lung cancer
525951|NCT00305942|Carcinoma, Small Cell|carcinoma, small cell
525952|NCT00305955|amblyopia|amblyopia
525953|NCT00305955|bilateral amblyopia|bilateral amblyopia
525954|NCT00305955|refractive error|refractive error
525955|NCT00305968|Quality of life|quality of life
525956|NCT00305968|Gastrointestinal symptoms|gastrointestinal symptoms
525957|NCT00305968|Health related costs|health related costs
525958|NCT00306007|Pregnancy|pregnancy
525959|NCT00306007|Unplanned pregnancy|unplanned pregnancy
525960|NCT00306007|Psychosocial|psychosocial
525961|NCT00306007|Measure|measure
525962|NCT00306020|Skin ulcers|skin ulcers
525963|NCT00306020|Topical morphine|topical morphine
525964|NCT00306020|Chronic pain|chronic pain
525965|NCT00306020|Cancer|cancer
525966|NCT00306033|myasthenia gravis|myasthenia gravis
525967|NCT00306033|immunoglobulin|immunoglobulin
525968|NCT00306033|intravenous immunoglobulin|intravenous immunoglobulin
525969|NCT00306033|treatment|treatment
525970|NCT00306046|PETScan|petscan
525971|NCT00306046|Positron-Emission Tomography|positron-emission tomography
525972|NCT00306046|Bisphosphonate|bisphosphonate
525973|NCT00306046|Biochemical Markers|biochemical markers
525974|NCT00306046|Paget's Disease of Bone (monostotic and polyostotic)|paget's disease of bone (monostotic and polyostotic)
525975|NCT00306085|Peripheral arterial disease,|peripheral arterial disease,
525976|NCT00306085|blood marrow cells,|blood marrow cells,
525977|NCT00306085|therapeutic angiogenesis.|therapeutic angiogenesis.
525978|NCT00306098|Transplantation, Islets of Langerhans|transplantation, islets of langerhans
525979|NCT00306111|stem cell transplantation|stem cell transplantation
525980|NCT00306111|stem cell mobilization|stem cell mobilization
525981|NCT00306111|high-dose therapy|high-dose therapy
525982|NCT00306124|Dementia|dementia
525983|NCT00306124|Mild Cognitive Impairment|mild cognitive impairment
525984|NCT00306124|MCI|mci
525985|NCT00306124|levodopa|levodopa
525986|NCT00306124|learning|learning
525987|NCT00306124|enhancement|enhancement
525988|NCT00306150|Prevention of blood loss|prevention of blood loss
525989|NCT00306150|Blood Loss, Surgical|blood loss, surgical
525990|NCT00306150|Blood Loss, Postoperative|blood loss, postoperative
525991|NCT00306163|Asthma|asthma
679418|NCT00892190|MDS|mds
525992|NCT00306163|AMP|amp
525993|NCT00306163|Ciclesonide|ciclesonide
525994|NCT00306163|Fluticasone propionate|fluticasone propionate
525995|NCT00306176|rosiglitazone,exercise,cardiovascular risk factors|rosiglitazone,exercise,cardiovascular risk factors
525996|NCT00306189|RANKL|rankl
525997|NCT00306189|RANK|rank
525998|NCT00306189|denosumab|denosumab
525999|NCT00306189|AMG 162|amg 162
526000|NCT00306189|osteoporosis|osteoporosis
526001|NCT00306189|bone turnover|bone turnover
526002|NCT00306189|bone mineral density|bone mineral density
526003|NCT00306189|Japanese|japanese
526004|NCT00306202|Relapsed and Refractory Leukemia|relapsed and refractory leukemia
526005|NCT00306215|double-blind|double-blind
526006|NCT00306215|placebo-controlled|placebo-controlled
526007|NCT00306215|multicenter|multicenter
526008|NCT00306215|efficacy|efficacy
526009|NCT00306215|safety|safety
583547|NCT00512122|early parenteral nutrition|early parenteral nutrition
526010|NCT00306228|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
526012|NCT00306228|Early routine percutaneous coronary intervention|early routine percutaneous coronary intervention
526013|NCT00306228|tirofiban|tirofiban
526014|NCT00306228|paclitaxel|paclitaxel
526015|NCT00306241|Cervical neoplasia|cervical neoplasia
526016|NCT00306241|Cervical cancer|cervical cancer
526017|NCT00306241|Double-blind|double-blind
526018|NCT00306241|HPV-16/18 L1 VLP AS04|hpv-16/18 l1 vlp as04
526019|NCT00306241|HPV|hpv
526020|NCT00306241|AS04|as04
526021|NCT00306267|Anemia|anemia
526022|NCT00306267|non-chemotherapy-induced|non-chemotherapy-induced
526023|NCT00306267|non-radiation therapy-induced|non-radiation therapy-induced
526024|NCT00306267|cancer|cancer
526025|NCT00306267|non-myeloid|non-myeloid
526026|NCT00306280|Helicobacter pylori|helicobacter pylori
526027|NCT00306280|phototherapy|phototherapy
526028|NCT00306280|peptic ulcer|peptic ulcer
526029|NCT00306280|gastric cancer|gastric cancer
526030|NCT00306293|Recurrent Genital Herpes|recurrent genital herpes
526031|NCT00306319|Tuberculosis|tuberculosis
526032|NCT00306332|Allogeneic Stem cell transplantation|allogeneic stem cell transplantation
526033|NCT00306332|T-cell depletion|t-cell depletion
526034|NCT00306332|B-cell depletion|b-cell depletion
526346|NCT00297180|weight loss|weight loss
526035|NCT00306332|Immunomagnetic selection|immunomagnetic selection
526036|NCT00306345|Outreach|outreach
526037|NCT00306345|Major general surgery|major general surgery
526038|NCT00306345|Intensive care|intensive care
526039|NCT00306345|Serious adverse events|serious adverse events
526040|NCT00306358|absorption test|absorption test
526041|NCT00306358|cobalamin|cobalamin
526042|NCT00306358|holotranscobalamin|holotranscobalamin
526043|NCT00306358|vitamin B12|vitamin b12
526044|NCT00306371|diode|diode
526045|NCT00306371|laser|laser
526046|NCT00306371|acne|acne
526047|NCT00306371|acne scar|acne scar
526048|NCT00306384|Glucose Metabolism Disorder|glucose metabolism disorder
526049|NCT00306384|Dysmetabolic Syndrome|dysmetabolic syndrome
526050|NCT00306384|Type II Diabetes|type ii diabetes
526051|NCT00306384|Diabetes Mellitus,|diabetes mellitus,
526052|NCT00306384|Lipoatrophic|lipoatrophic
526053|NCT00306384|Dyslipidemia|dyslipidemia
526054|NCT00306384|Drug Therapy|drug therapy
526055|NCT00306397|Kidney transplantation|kidney transplantation
526056|NCT00306397|Steroid free|steroid free
526057|NCT00306397|Calcineurin inhibitor free|calcineurin inhibitor free
526058|NCT00306397|Tacrolimus|tacrolimus
526059|NCT00306397|Sirolimus|sirolimus
526060|NCT00306410|Vitamin D deficiency|vitamin d deficiency
526061|NCT00306410|HIV/AIDS|hiv/aids
526062|NCT00306410|HAART|haart
526063|NCT00306410|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
526064|NCT00306410|insulin resistance|insulin resistance
526065|NCT00306410|bone density|bone density
526066|NCT00306423|exercise|exercise
526067|NCT00306436|Diabetes|diabetes
526068|NCT00306436|renal deficiency|renal deficiency
526069|NCT00306436|hypertension|hypertension
526070|NCT00306449|Weight gain|weight gain
526071|NCT00306449|obesity|obesity
526072|NCT00306449|overweight|overweight
526073|NCT00306449|young adults|young adults
526074|NCT00306449|lipid disorders|lipid disorders
526075|NCT00306449|insulin resistance|insulin resistance
526076|NCT00306449|randomized controled study|randomized controled study
526077|NCT00306462|Premature Labor|premature labor
526078|NCT00306462|Premature Birth|premature birth
526079|NCT00306462|Magnesium sulfate|magnesium sulfate
526080|NCT00306462|Nifedipine|nifedipine
526081|NCT00306475|schizophrenia, cognition, mood stabilizer|schizophrenia, cognition, mood stabilizer
526082|NCT00306488|Retinal Pigment Epithelium|retinal pigment epithelium
526083|NCT00306488|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
526084|NCT00306488|Visual Acuity Decrease|visual acuity decrease
526085|NCT00306488|Intra-ocular Pressure|intra-ocular pressure
526086|NCT00306488|Autofluorescence of Retina|autofluorescence of retina
526087|NCT00306488|Age-Related Macular Degeneration|age-related macular degeneration
526088|NCT00306488|AMD|amd
526089|NCT00306501|Training|training
526090|NCT00306501|Cortical Stimulation|cortical stimulation
526091|NCT00306501|Sensory Stimulation|sensory stimulation
526092|NCT00306501|Brain Imaging|brain imaging
526093|NCT00306501|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
526094|NCT00306501|Swallowing|swallowing
526095|NCT00306501|Dysphagia|dysphagia
526096|NCT00306501|Stroke|stroke
526097|NCT00306501|CVA|cva
526098|NCT00306501|Cerebral Vascular Accident|cerebral vascular accident
526099|NCT00306501|Healthy Volunteer|healthy volunteer
526100|NCT00306501|HV|hv
526101|NCT00306514|metastatic malignant melanoma of the skin|metastatic malignant melanoma of the skin
526102|NCT00306527|Influenza|influenza
526103|NCT00306527|adult/elderly|adult/elderly
526104|NCT00306527|flu cell culture|flu cell culture
526105|NCT00306527|vaccine|vaccine
526106|NCT00306579|Ischemic Stroke|ischemic stroke
526107|NCT00306579|Myocardial ischemia|myocardial ischemia
526108|NCT00306579|Myocardial necrosis|myocardial necrosis
526109|NCT00306592|Multiple Sclerosis|multiple sclerosis
526111|NCT00306605|Emotional experiences|emotional experiences
526112|NCT00306605|fathers|fathers
526113|NCT00306605|stress|stress
526114|NCT00306605|depressive symptomatology|depressive symptomatology
526115|NCT00306605|NICU|nicu
526116|NCT00306605|preterm birth|preterm birth
526117|NCT00306631|Advanced and Metastatic Breast Cancer|advanced and metastatic breast cancer
526118|NCT00306644|rosiglitazone|rosiglitazone
526119|NCT00306644|Type 2 diabetes|type 2 diabetes
526120|NCT00306644|intima media thickness|intima media thickness
526121|NCT00306644|Insulin resistance|insulin resistance
526122|NCT00306657|Glaucoma Open-Angle|glaucoma open-angle
526123|NCT00306657|Normal tension glaucoma progressive|normal tension glaucoma progressive
526124|NCT00306657|chronic open angle glaucoma progressive|chronic open angle glaucoma progressive
526125|NCT00306657|optic nerve sheath fenestration|optic nerve sheath fenestration
526126|NCT00306657|cerebrospinal fluid|cerebrospinal fluid
526127|NCT00306657|Beta-Trace Protein|beta-trace protein
526128|NCT00306670|Acquired Hemophilia A|acquired hemophilia a
526129|NCT00306670|Anti-Factor VIII antibodies|anti-factor viii antibodies
526236|NCT00307021|Coccidiosis|coccidiosis
526131|NCT00306670|Hemophilia A|hemophilia a
526132|NCT00306670|Factor VIII inhibitors|factor viii inhibitors
526133|NCT00306683|Hypothalamic-pituitary lesions|hypothalamic-pituitary lesions
526134|NCT00306683|Craniopharyngioma|craniopharyngioma
526135|NCT00306683|Obesity|obesity
526136|NCT00306683|Diazoxide|diazoxide
526137|NCT00306683|Hyperinsulinemia|hyperinsulinemia
526138|NCT00306683|Pediatric neurosurgery|pediatric neurosurgery
526139|NCT00306683|Oncology|oncology
526140|NCT00306683|Pituitary|pituitary
526141|NCT00306683|Hypothalamus|hypothalamus
526142|NCT00306696|rosiglitazone|rosiglitazone
526143|NCT00306696|fluid retention|fluid retention
526144|NCT00306696|Type 2 diabetes|type 2 diabetes
526145|NCT00306696|diuretics|diuretics
526146|NCT00306709|obesity|obesity
526147|NCT00306709|behavior change|behavior change
526148|NCT00306709|cultural adaptations|cultural adaptations
526149|NCT00306709|weight loss|weight loss
526150|NCT00306722|Bronchoscopy|bronchoscopy
526151|NCT00306722|Sedation|sedation
526152|NCT00306722|AQUAVAN|aquavan
526153|NCT00306722|fospropofol disodium|fospropofol disodium
526154|NCT00306722|Flexible bronchoscopy|flexible bronchoscopy
526155|NCT00306735|Multiple Myeloma|multiple myeloma
526156|NCT00306735|Stem Cell Transplantation|stem cell transplantation
526157|NCT00306735|CINV|cinv
526158|NCT00306748|Chronic Constipation|chronic constipation
526159|NCT00306748|Chronic Idiopathic Constipation|chronic idiopathic constipation
526160|NCT00306748|Constipation|constipation
526161|NCT00306748|CIC|cic
526162|NCT00306748|CC|cc
526163|NCT00306748|MD-1100|md-1100
526164|NCT00306748|MD-1100 Acetate|md-1100 acetate
526165|NCT00306748|Microbia|microbia
526166|NCT00306748|Microbia, Inc.|microbia, inc.
526167|NCT00306748|linaclotide|linaclotide
526168|NCT00306748|linaclotide acetate|linaclotide acetate
526169|NCT00306774|osteoarthritis|osteoarthritis
526170|NCT00306774|vitamin D|vitamin d
526171|NCT00306774|knee pain|knee pain
526172|NCT00306774|cartilage loss|cartilage loss
526173|NCT00306774|WOMAC|womac
526174|NCT00306774|MRI|mri
526175|NCT00306774|cartilage volume|cartilage volume
526176|NCT00306774|OA|oa
526177|NCT00306774|physical function|physical function
526178|NCT00306774|web-based|web-based
526179|NCT00306774|internet-based|internet-based
526180|NCT00306787|Herpes simplex|herpes simplex
526181|NCT00306787|genital herpes|genital herpes
526182|NCT00306787|famciclovir|famciclovir
526183|NCT00306787|valacyclovir|valacyclovir
526184|NCT00306787|Recurrent genital herpes|recurrent genital herpes
526185|NCT00306800|Methyl aminolevulinate|methyl aminolevulinate
526186|NCT00306800|Photodynamic therapy|photodynamic therapy
526187|NCT00306800|Aktilite CL128 LED light source|aktilite cl128 led light source
526188|NCT00306800|Multiple Actinic Keratosis|multiple actinic keratosis
526189|NCT00306813|refractory or relapsed multiple myeloma|refractory or relapsed multiple myeloma
679695|NCT00893373|AML|aml
526190|NCT00306813|CC-5013|cc-5013
526191|NCT00306813|Revlimid|revlimid
526192|NCT00306813|lenalidomide|lenalidomide
526193|NCT00306813|RAD|rad
526194|NCT00306826|Impaired glucose tolerance|impaired glucose tolerance
526195|NCT00306839|Tissucol|tissucol
526196|NCT00306839|Tisseel|tisseel
526197|NCT00306839|Lichtenstein|lichtenstein
526198|NCT00306839|hernia|hernia
526199|NCT00306839|inguinal|inguinal
526200|NCT00306852|Glaucoma|glaucoma
526201|NCT00306852|Trabeculectomy|trabeculectomy
526202|NCT00306852|Tube shunt surgery|tube shunt surgery
526203|NCT00306865|Neurotransmitter|neurotransmitter
526204|NCT00306865|Neuroimaging|neuroimaging
526205|NCT00306865|Movement Disorder|movement disorder
526206|NCT00306865|Focal Hand Dystonia|focal hand dystonia
526207|NCT00306865|FHD|fhd
526208|NCT00306865|HV|hv
526209|NCT00306891|Advanced solid tumours|advanced solid tumours
526210|NCT00306891|Advanced cancer|advanced cancer
526211|NCT00306891|tumor|tumor
526212|NCT00306891|tumour|tumour
526213|NCT00306891|RECENTIN|recentin
526214|NCT00306904|Macular|macular
526215|NCT00306904|Edema|edema
526216|NCT00306904|Diabetic|diabetic
526217|NCT00306904|Retinopathy|retinopathy
526218|NCT00306917|Total Hip Replacement|total hip replacement
526219|NCT00306930|Total Hip Replacement|total hip replacement
526220|NCT00306930|post-traumatic arthritis|post-traumatic arthritis
526221|NCT00306956|Infant|infant
526222|NCT00306956|Newborn|newborn
526223|NCT00306956|pacifier|pacifier
526224|NCT00306956|dummies|dummies
526225|NCT00306956|breastfeeding|breastfeeding
526226|NCT00306956|Sudden Infant Death|sudden infant death
526227|NCT00306956|SIDS|sids
526228|NCT00306956|Pacifiers|pacifiers
526229|NCT00306969|mycosis fungoides, Sézary Syndrome|mycosis fungoides, sézary syndrome
526230|NCT00306982|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
526231|NCT00306995|prophylaxis of pandemic influenza|prophylaxis of pandemic influenza
526232|NCT00307008|Prophylaxis Invasive pneumococcal diseases and pneumonia|prophylaxis invasive pneumococcal diseases and pneumonia
526233|NCT00307021|Parasitic Diseases|parasitic diseases
526234|NCT00307021|Malaria, Falciparum|malaria, falciparum
526235|NCT00307021|Malaria|malaria
526237|NCT00307034|Primary vaccination|primary vaccination
526238|NCT00307034|Pneumococcal disease|pneumococcal disease
526239|NCT00307034|Safety|safety
526240|NCT00307034|Booster vaccination|booster vaccination
526241|NCT00307034|Immunogenicity|immunogenicity
526242|NCT00307034|Pneumococcal vaccine|pneumococcal vaccine
526243|NCT00307034|Dose comparison|dose comparison
526244|NCT00307047|Stents|stents
526245|NCT00307047|Angioplasty|angioplasty
526246|NCT00307047|Total coronary occlusion|total coronary occlusion
526247|NCT00307047|coronary restenosis|coronary restenosis
526248|NCT00307047|stent thrombosis|stent thrombosis
526249|NCT00307073|Pacemaker|pacemaker
526250|NCT00307073|Managed Ventricular Pacing|managed ventricular pacing
526251|NCT00307073|Ventricular Pacing|ventricular pacing
526252|NCT00307099|bacterial diseases|bacterial diseases
526253|NCT00307112|Group A streptococcus, Nicaragua, Rheumatic Heart Disease|group a streptococcus, nicaragua, rheumatic heart disease
526254|NCT00307125|Organ Transplantation|organ transplantation
526255|NCT00307125|Graft function/survival|graft function/survival
526256|NCT00307125|Immunosuppression|immunosuppression
526257|NCT00307125|anti-CD20 (rituximab)|anti-cd20 (rituximab)
526258|NCT00307138|Coronary artery bypass, Off-pump|coronary artery bypass, off-pump
526259|NCT00307138|Hetastarch|hetastarch
526260|NCT00307138|Plasma substitutes|plasma substitutes
526261|NCT00307138|Equivalence|equivalence
526262|NCT00307151|Treatment Naive|treatment naive
526263|NCT00307151|Mother-To-Child Transmission|mother-to-child transmission
526264|NCT00307151|MTCT|mtct
526265|NCT00307151|Pediatrics|pediatrics
526266|NCT00307151|Viral resistance|viral resistance
526267|NCT00307164|Treatment Experienced|treatment experienced
526268|NCT00307164|Uridine|uridine
526269|NCT00307177|influenza vaccine, baculovirus, immunogenicity, lymphoma|influenza vaccine, baculovirus, immunogenicity, lymphoma
526270|NCT00307190|BED|bed
526271|NCT00307203|Bupropion|bupropion
526272|NCT00307203|Zyban|zyban
526273|NCT00307203|Wellbutrin|wellbutrin
526274|NCT00307203|Smoking cessation|smoking cessation
526275|NCT00307203|Schizophrenia|schizophrenia
526276|NCT00307203|Schizoaffective disorder|schizoaffective disorder
526277|NCT00307203|Cognitive Behavioral Therapy|cognitive behavioral therapy
526278|NCT00307216|First Episode Psychosis|first episode psychosis
526279|NCT00307216|Early Psychosis|early psychosis
526280|NCT00307216|Psychosocial Intervention|psychosocial intervention
526281|NCT00307229|metastatic breast cancer|metastatic breast cancer
526282|NCT00307229|recurrent breast cancer|recurrent breast cancer
526283|NCT00307242|Adefovir Dipivoxil|adefovir dipivoxil
526284|NCT00307242|Lamivudine|lamivudine
526285|NCT00307242|Hepatitis B|hepatitis b
526286|NCT00307255|unspecified adult solid tumor|unspecified adult solid tumor
526287|NCT00307255|protocol specific|protocol specific
525699|NCT00305396|Kidney transplantation|kidney transplantation
526288|NCT00307255|Paclitaxel|paclitaxel
526289|NCT00307255|Abraxane|abraxane
526290|NCT00307255|Gemcitabine|gemcitabine
526291|NCT00307255|Gemzar|gemzar
526292|NCT00307255|Phase I|phase i
526293|NCT00307255|Lineberger|lineberger
526294|NCT00307268|ADHD Effectiveness|adhd effectiveness
526295|NCT00307294|Prostate|prostate
526296|NCT00307294|Androgen|androgen
526297|NCT00307294|AIPC|aipc
526298|NCT00307294|Doxil|doxil
526299|NCT00297115|Roflumilast|roflumilast
526300|NCT00297115|COPD|copd
526301|NCT00297115|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
526302|NCT00297128|pilot study|pilot study
526303|NCT00297128|rectal|rectal
526304|NCT00297128|cancer|cancer
526305|NCT00297128|phase II|phase ii
526306|NCT00297128|preoperative|preoperative
526307|NCT00297128|chemoradiation|chemoradiation
526308|NCT00297128|capecitabine|capecitabine
526309|NCT00297128|cetuximab|cetuximab
526310|NCT00297128|operable|operable
526311|NCT00297128|T4|t4
526312|NCT00297128|ABCSG|abcsg
526313|NCT00297128|TAKO|tako
526314|NCT00297128|R03|r03
526315|NCT00297128|96|96
526316|NCT00297128|06|06
526317|NCT00297141|Preoperative|preoperative
526318|NCT00297141|Radiochemotherapy|radiochemotherapy
526319|NCT00297141|Newly Diagnosed|newly diagnosed
526320|NCT00297141|Primary Operable|primary operable
526321|NCT00297141|Locally Advanced|locally advanced
526322|NCT00297141|Rectal Carcinoma|rectal carcinoma
526323|NCT00297141|T3|t3
526324|NCT00297141|Lower Rectum|lower rectum
526325|NCT00297141|Middle Rectum|middle rectum
526326|NCT00297141|ABCSG|abcsg
526327|NCT00297141|TAKO|tako
526328|NCT00297141|95|95
526329|NCT00297141|05|05
526330|NCT00297154|Heart failure, congestive|heart failure, congestive
526331|NCT00297154|Metabolic Syndrome X|metabolic syndrome x
526332|NCT00297154|Obesity|obesity
526333|NCT00297167|CF|cf
526334|NCT00297167|Cystic Fibrosis|cystic fibrosis
526335|NCT00297167|EPI|epi
526336|NCT00297167|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
526337|NCT00297167|Pancreatic|pancreatic
526338|NCT00297167|Enzyme|enzyme
526339|NCT00297167|PEP|pep
526340|NCT00297180|hunger|hunger
526341|NCT00297180|obesity|obesity
526342|NCT00297180|sodium-dependent glucose transporter|sodium-dependent glucose transporter
526343|NCT00297180|GW869682|gw869682
526344|NCT00297180|body composition|body composition
526345|NCT00297180|SGLT2 inhibitor|sglt2 inhibitor
526347|NCT00297193|Crohn's Disease|crohn's disease
526348|NCT00297193|HSCT|hsct
526349|NCT00297193|Autologous|autologous
526350|NCT00297193|EBMT|ebmt
526351|NCT00297193|ECCO|ecco
526352|NCT00297206|pharmacokinetics herpes varicella herpes labialis Epstein-Barr virus|pharmacokinetics herpes varicella herpes labialis epstein-barr virus
526353|NCT00297219|Hemodialysis|hemodialysis
526354|NCT00297219|Coronary artery calcification|coronary artery calcification
526355|NCT00297219|Adynamic bone disease|adynamic bone disease
526356|NCT00297219|Dialysate calcium|dialysate calcium
526357|NCT00297219|Bone mineral density|bone mineral density
526358|NCT00297219|Bone histomorphometry|bone histomorphometry
526359|NCT00297232|Multiple Sclerosis|multiple sclerosis
526360|NCT00297232|MS|ms
526361|NCT00297245|gastrodin|gastrodin
526362|NCT00297258|Sarcoma|sarcoma
526363|NCT00297258|Synovial sarcoma|synovial sarcoma
526364|NCT00297258|Pazopanib(GW786034)|pazopanib(gw786034)
526365|NCT00297258|Adipocytic tumors|adipocytic tumors
526366|NCT00297258|Leiomyosarcoma|leiomyosarcoma
526367|NCT00297258|Phase II|phase ii
526368|NCT00297271|Dementia|dementia
526369|NCT00297271|Mild Cognitive Impairment|mild cognitive impairment
526370|NCT00297271|Patient Registries|patient registries
526371|NCT00297271|Prospective Studies|prospective studies
526372|NCT00297271|Longitudinal Studies|longitudinal studies
526373|NCT00297271|Australia|australia
526374|NCT00297271|Cholinesterase Inhibitors|cholinesterase inhibitors
526375|NCT00297271|Observational|observational
526376|NCT00297271|Non-randomized|non-randomized
526377|NCT00297284|systemic lupus erythematosus|systemic lupus erythematosus
526378|NCT00297284|cognitive efficiency|cognitive efficiency
526379|NCT00297284|cognitive dysfunction|cognitive dysfunction
526380|NCT00297284|cognition|cognition
526381|NCT00297284|memory|memory
526382|NCT00297284|attention|attention
526383|NCT00297284|modafinil|modafinil
526384|NCT00297284|provigil|provigil
526385|NCT00297297|Solitary solid and scintigraphically cold thyroid nodules|solitary solid and scintigraphically cold thyroid nodules
526386|NCT00297310|Tacrolimus|tacrolimus
526387|NCT00297310|Kidney transplantation|kidney transplantation
526388|NCT00297310|Transplantation|transplantation
526389|NCT00297310|Kidney failure|kidney failure
526390|NCT00297310|chronic|chronic
526391|NCT00297310|P-Glycoprotein|p-glycoprotein
526392|NCT00297323|Seizures|seizures
526393|NCT00297323|Epilepsy|epilepsy
679951|NCT00894387|CHF|chf
526394|NCT00297323|Topiramate|topiramate
526395|NCT00297323|Epilepsy in Children|epilepsy in children
526396|NCT00297336|Topiramate|topiramate
526397|NCT00297336|Migraine|migraine
526398|NCT00297336|Headache|headache
526399|NCT00297336|Chronic headache|chronic headache
526400|NCT00297336|Chronic migraine|chronic migraine
526401|NCT00297349|Seizures|seizures
526402|NCT00297349|Epilepsy|epilepsy
526403|NCT00297349|Tonic-clonic|tonic-clonic
526404|NCT00297349|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
526405|NCT00297349|Focal Epilepsy|focal epilepsy
526406|NCT00297349|Topiramate|topiramate
526407|NCT00297349|Epilepsy in Children|epilepsy in children
526408|NCT00297362|Alzheimer Disease|alzheimer disease
526409|NCT00297362|Dementia|dementia
526410|NCT00297362|Brain Disease|brain disease
526411|NCT00297362|Memory Loss|memory loss
526412|NCT00297362|Caregiver|caregiver
526413|NCT00297362|Galantamine hydrobromide|galantamine hydrobromide
526414|NCT00297362|Nervous System Diseases|nervous system diseases
526415|NCT00297362|Mental Disorders|mental disorders
526416|NCT00297375|treatment|treatment
526418|NCT00297375|acute|acute
526419|NCT00297375|migraine|migraine
526420|NCT00297375|headache|headache
526421|NCT00297388|schizophrenia|schizophrenia
526422|NCT00297388|schizoaffective disorder|schizoaffective disorder
526423|NCT00297388|long-acting risperidone|long-acting risperidone
526424|NCT00297388|intramuscular injection risperidone|intramuscular injection risperidone
526425|NCT00297388|risperidone|risperidone
526426|NCT00297414|Mild Cognitive Impairment|mild cognitive impairment
526427|NCT00297414|Dementia|dementia
526428|NCT00297414|Galantamine|galantamine
526429|NCT00297414|Memory disorders|memory disorders
526430|NCT00297414|Isolated memory impairment|isolated memory impairment
526431|NCT00297414|Alzheimer's disease|alzheimer's disease
526432|NCT00297427|urinary incontinence|urinary incontinence
526433|NCT00297440|Smoking|smoking
526434|NCT00297440|Exercise|exercise
526435|NCT00297440|Adolescent|adolescent
526436|NCT00297440|Girls|girls
526437|NCT00297466|tobacco use|tobacco use
526438|NCT00297466|smoking cessation|smoking cessation
526439|NCT00297466|emergency department|emergency department
526440|NCT00297479|Tobacco Cessation|tobacco cessation
526441|NCT00297479|Smoking Cessation|smoking cessation
526442|NCT00297492|Smoking Cessation|smoking cessation
526443|NCT00297492|Tobacco|tobacco
526742|NCT00299182|Neosar|neosar
526444|NCT00297505|Cocaine; citalopram; impulsivity; serotonin|cocaine; citalopram; impulsivity; serotonin
526445|NCT00297518|Adult Periodontitis|adult periodontitis
526446|NCT00297518|Chronic Periodontitis|chronic periodontitis
526447|NCT00297518|PDD|pdd
526448|NCT00297518|PDT|pdt
526449|NCT00297518|Photodynamic Disinfection|photodynamic disinfection
526450|NCT00297518|SRP|srp
526451|NCT00297518|Scaling and Root Planing|scaling and root planing
526452|NCT00297531|Chronic Periodontitis|chronic periodontitis
526453|NCT00297531|Periodontitis|periodontitis
526454|NCT00297531|Photodynamic disinfection|photodynamic disinfection
526455|NCT00297531|PDD|pdd
526456|NCT00297531|PDT|pdt
526457|NCT00297531|Periowave|periowave
526458|NCT00297531|Scaling and Root Planing|scaling and root planing
526459|NCT00297531|SRP|srp
526460|NCT00297544|impotence|impotence
526461|NCT00297544|endothelial function|endothelial function
526462|NCT00297544|autonomic nervous system|autonomic nervous system
526463|NCT00297570|CML|cml
526464|NCT00297570|Imatinib|imatinib
526465|NCT00297570|Pegylated Interferon|pegylated interferon
526466|NCT00297570|Philadelphia Positive CML|philadelphia positive cml
526467|NCT00297596|Metastatic|metastatic
526468|NCT00297596|HER2/neu+|her2/neu+
526469|NCT00297609|Resuscitation medication errors|resuscitation medication errors
526470|NCT00297609|critical care|critical care
526471|NCT00297609|pediatrics|pediatrics
526472|NCT00297609|clinical decision support systems|clinical decision support systems
526473|NCT00297609|computerized physician order entry|computerized physician order entry
526474|NCT00297635|Hyperglycemia|hyperglycemia
526475|NCT00297635|Insulin Infusion Systems|insulin infusion systems
526476|NCT00297635|Blood Glucose Self-Monitoring|blood glucose self-monitoring
526477|NCT00298051|Iron-deficiency anemia|iron-deficiency anemia
526478|NCT00298051|Umbilical cord clamping|umbilical cord clamping
526479|NCT00298051|Infant|infant
526480|NCT00298064|Cervical cancer|cervical cancer
526481|NCT00298064|EGFR|egfr
526482|NCT00298064|cervical|cervical
526483|NCT00298064|genomic|genomic
526484|NCT00298064|DNA|dna
526485|NCT00298064|markers|markers
526486|NCT00298064|prognostic|prognostic
526487|NCT00298064|gene|gene
526488|NCT00298064|epidermal growth factor|epidermal growth factor
526489|NCT00298077|Infection|infection
526490|NCT00298077|transplant recipients|transplant recipients
526491|NCT00298090|Oxygenation|oxygenation
526492|NCT00298103|Antibiotic resistant|antibiotic resistant
526493|NCT00298103|Infection|infection
526494|NCT00298142|Cervicogenic Headache|cervicogenic headache
526495|NCT00298142|Migraine|migraine
526496|NCT00298142|Tension Type Headache|tension type headache
526497|NCT00298168|Delayed Graft Function|delayed graft function
526498|NCT00298207|high blood pressure|high blood pressure
526499|NCT00298207|hypertension|hypertension
526500|NCT00298207|adult|adult
526501|NCT00298207|African Americans|african americans
526502|NCT00298207|Walking|walking
526503|NCT00298220|Family Practice|family practice
526504|NCT00298220|Intervention Studies|intervention studies
526505|NCT00298220|Prevention and Control|prevention and control
526506|NCT00298233|Antibody Response|antibody response
526507|NCT00298233|Antiviral Efficacy|antiviral efficacy
526509|NCT00298233|Severe Respiratory Distress|severe respiratory distress
526510|NCT00298233|Viral Replication and Shedding|viral replication and shedding
526511|NCT00298246|Neurodevelopmental Disorders|neurodevelopmental disorders
526512|NCT00298246|Neurological Disorder|neurological disorder
526513|NCT00298246|Children- Onset|children- onset
526514|NCT00298246|Children|children
526515|NCT00298246|Pervasive Developmental Disorder|pervasive developmental disorder
526516|NCT00298246|PDD|pdd
526517|NCT00298246|Autism|autism
526518|NCT00298246|Healthy Volunteer|healthy volunteer
526520|NCT00298285|mechanical valve replacement|mechanical valve replacement
526522|NCT00298298|lung cancer|lung cancer
526523|NCT00298298|non-small cell lung cancere|non-small cell lung cancere
526524|NCT00298298|vaccine|vaccine
526525|NCT00298298|immunotherapy|immunotherapy
526526|NCT00298324|GvHD|gvhd
526527|NCT00298324|graft versus host disease|graft versus host disease
526528|NCT00298324|extensive|extensive
526529|NCT00298324|myfortic|myfortic
526530|NCT00298350|Phase 2|phase 2
526531|NCT00298350|Phase II|phase ii
526532|NCT00298350|Randomized|randomized
526533|NCT00298350|Controlled|controlled
526534|NCT00298350|Comparator|comparator
526535|NCT00298350|Partially Blind|partially blind
526536|NCT00298350|Protease Inhibitors|protease inhibitors
526537|NCT00298350|Integrase Inhibitors|integrase inhibitors
526538|NCT00298350|Antiviral Agents|antiviral agents
526539|NCT00298350|Antiretroviral Agents|antiretroviral agents
526540|NCT00298350|ART|art
526541|NCT00298350|ARV|arv
526542|NCT00298350|Highly Activity Antiretroviral Therapy|highly activity antiretroviral therapy
526543|NCT00298350|HAART|haart
526544|NCT00298350|Treatment Experienced|treatment experienced
526545|NCT00298363|Hepatitis; Hepatitis B virus; Tenofovir|hepatitis; hepatitis b virus; tenofovir
526546|NCT00298376|Cow’s milk allergy,|cow’s milk allergy,
526547|NCT00298376|food allergy|food allergy
526743|NCT00299182|AD|ad
526548|NCT00298376|oral tolerance,|oral tolerance,
526549|NCT00298376|infant,|infant,
526550|NCT00298376|regulatory T cells,|regulatory t cells,
526551|NCT00298376|intestinal microflora|intestinal microflora
526552|NCT00298389|macrophage|macrophage
526553|NCT00298389|phagocytosis|phagocytosis
526554|NCT00298389|exacerbation|exacerbation
526555|NCT00298402|macrophage|macrophage
526557|NCT00298402|CT scan|ct scan
526558|NCT00298415|2-years survival|2-years survival
526559|NCT00298428|stent|stent
526560|NCT00298428|percutaneous coronary intervention|percutaneous coronary intervention
526561|NCT00298428|platelet aggregation|platelet aggregation
526562|NCT00298428|clopidogrel|clopidogrel
526563|NCT00298428|shear|shear
526564|NCT00298428|metabolic syndrome|metabolic syndrome
526565|NCT00298441|intravenous iron administration|intravenous iron administration
526566|NCT00298454|renal failure|renal failure
526567|NCT00298454|oliguric|oliguric
526568|NCT00298454|critically ill|critically ill
526569|NCT00298454|furosemide|furosemide
526570|NCT00298467|ALCL|alcl
526571|NCT00298467|csALCL|csalcl
526572|NCT00298467|pcALCL|pcalcl
526573|NCT00298467|Lymphoma|lymphoma
526574|NCT00298467|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
526575|NCT00298467|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
526576|NCT00298467|classic systemci Anaplastic Large Cell Lymphoma (csALCL)|classic systemci anaplastic large cell lymphoma (csalcl)
526577|NCT00298467|primary cutaneous Anaplastic Large Cell Lymphoma (pcALCL)|primary cutaneous anaplastic large cell lymphoma (pcalcl)
526578|NCT00298480|preterm labor|preterm labor
526579|NCT00298480|transvaginal ultrasound|transvaginal ultrasound
526580|NCT00298480|dynamic cervical change|dynamic cervical change
526581|NCT00298493|ICU|icu
526582|NCT00298493|Sedation strategies|sedation strategies
526583|NCT00298493|Daily sedative interruption|daily sedative interruption
526584|NCT00298493|Sedation protocols|sedation protocols
526585|NCT00298506|Tacrolimus|tacrolimus
526586|NCT00298506|Mycophenolate mofetil|mycophenolate mofetil
526587|NCT00298506|Cyclophosphamide|cyclophosphamide
526588|NCT00298506|Lupus nephritis|lupus nephritis
526589|NCT00298506|Treatment|treatment
526590|NCT00298532|Pediatrics|pediatrics
526591|NCT00298532|Seizure|seizure
526592|NCT00298532|Trauma|trauma
526593|NCT00298532|Respiratory|respiratory
526594|NCT00298532|Cardiac|cardiac
526595|NCT00298532|Arrest|arrest
526596|NCT00298558|cognition disorder|cognition disorder
526597|NCT00298558|cognitive behavior therapy|cognitive behavior therapy
526598|NCT00298558|functional ability|functional ability
526599|NCT00298571|Cesarean Delivery|cesarean delivery
526600|NCT00298571|Post-operative|post-operative
526601|NCT00298571|Pain|pain
526602|NCT00298571|Local Anesthetic|local anesthetic
526603|NCT00298584|Diagnostic techniques, urological|diagnostic techniques, urological
526604|NCT00298584|urinary catheterization|urinary catheterization
526605|NCT00298584|Aspiration|aspiration
526606|NCT00298584|Neonates|neonates
526607|NCT00298584|Neonatal Intensive Care Unit|neonatal intensive care unit
526608|NCT00298584|Infant, Newborn|infant, newborn
526609|NCT00298584|Infant, Premature|infant, premature
526610|NCT00298584|Infant, Low-birth weight|infant, low-birth weight
526611|NCT00298610|Uncomplicated Malaria|uncomplicated malaria
526612|NCT00298610|GMP artesunate|gmp artesunate
526613|NCT00298649|pesticide safety|pesticide safety
526614|NCT00298649|migrant and seasonal farmworkers|migrant and seasonal farmworkers
526615|NCT00298649|Latino/Hispanic|latino/hispanic
526616|NCT00298649|agricultural health|agricultural health
526617|NCT00298649|occupational health|occupational health
526618|NCT00298662|Multiple Sclerosis|multiple sclerosis
526619|NCT00298662|Betaseron-Prograf|betaseron-prograf
526620|NCT00298662|patients of Multiple Sclerosis|patients of multiple sclerosis
526621|NCT00298662|Secondary Progressive type|secondary progressive type
526622|NCT00298662|Relapsing-Remitting type|relapsing-remitting type
526623|NCT00298701|Allergy|allergy
526624|NCT00298714|Hepatitis C, Chronic|hepatitis c, chronic
526625|NCT00298727|Knowledge transfer|knowledge transfer
526626|NCT00298727|Clinical decision-making|clinical decision-making
526627|NCT00298727|Outcome measures|outcome measures
526628|NCT00298779|patients with advanced solid tumors or Non-Hodgkins's Lymphoma|patients with advanced solid tumors or non-hodgkins's lymphoma
526629|NCT00298792|Cognitive Behavioral Treatment|cognitive behavioral treatment
526630|NCT00298792|Alcohol Dependence|alcohol dependence
526631|NCT00298792|Functional Analysis|functional analysis
526632|NCT00298792|Experience Sampling|experience sampling
526633|NCT00298792|Interactive Voice Response|interactive voice response
526634|NCT00298805|Migraine|migraine
526635|NCT00298805|Headache|headache
526636|NCT00298805|Depression|depression
526637|NCT00298805|Quality of Life|quality of life
526638|NCT00298818|Epilepsy|epilepsy
526639|NCT00298818|Mental Retardation|mental retardation
526640|NCT00298818|Developmental Disabilities|developmental disabilities
526641|NCT00298844|Type 2 diabetes mellitus|type 2 diabetes mellitus
526642|NCT00298844|Macrovascular disease|macrovascular disease
526643|NCT00298844|Diastolic dysfunction|diastolic dysfunction
526644|NCT00298844|Intima media thickness|intima media thickness
526949|NCT00299819|Lupus|lupus
526645|NCT00298844|Single- photon emission computed tomography (SPECT)|single- photon emission computed tomography (spect)
526647|NCT00298857|Obesity|obesity
526648|NCT00298857|Pharmacokinetics|pharmacokinetics
526649|NCT00298870|pulmonary tuberculosis|pulmonary tuberculosis
526650|NCT00298870|isoniazid|isoniazid
526651|NCT00298870|arylamine N-acetyltransferase 2|arylamine n-acetyltransferase 2
526652|NCT00298870|pharmacogenomics|pharmacogenomics
526653|NCT00298870|genetic polymorphisms|genetic polymorphisms
526654|NCT00298870|individualized medicine|individualized medicine
526655|NCT00298870|drug-induced hepatotoxity|drug-induced hepatotoxity
526656|NCT00298883|Renal|renal
526657|NCT00298883|Transplant|transplant
526658|NCT00298883|PRA|pra
526659|NCT00298896|Lung|lung
526660|NCT00298896|Squamous Cell|squamous cell
526661|NCT00298896|Small Cell|small cell
526662|NCT00298896|Carcinoma|carcinoma
526663|NCT00298896|Cancer|cancer
526664|NCT00298896|Small Cell Lung Cancer|small cell lung cancer
526665|NCT00298922|Cystic Fibrosis|cystic fibrosis
526666|NCT00298922|Burkholderia cepacia complex|burkholderia cepacia complex
526667|NCT00298935|Randomized Controlled Trial|randomized controlled trial
526668|NCT00298935|Pregnant Women|pregnant women
526669|NCT00298974|Osteoarthritis of the hip or knee|osteoarthritis of the hip or knee
526670|NCT00298987|Chronic Myeloid Leukemia Accelerated and Blast Phase|chronic myeloid leukemia accelerated and blast phase
526671|NCT00298987|Leukemia, Acute, Philadelphia-Positive|leukemia, acute, philadelphia-positive
526672|NCT00299013|Ulcerative colitis|ulcerative colitis
526673|NCT00299026|Coronary Artery Disease|coronary artery disease
526674|NCT00299026|Percutaneous Coronary Intervention|percutaneous coronary intervention
526675|NCT00299026|Stent Implant|stent implant
526676|NCT00299026|Drug-coated Stent|drug-coated stent
526677|NCT00299039|Randomized controlled trial|randomized controlled trial
526678|NCT00299039|Clinical trial|clinical trial
526679|NCT00299039|Breast tumor surgery|breast tumor surgery
526680|NCT00299039|Outpatient surgery|outpatient surgery
526681|NCT00299039|Analgesia|analgesia
526682|NCT00299039|Outpatient analgesia|outpatient analgesia
526683|NCT00299039|Post surgical analgesia|post surgical analgesia
526684|NCT00299039|≥ 18 and ≤ 70 years of age|≥ 18 and ≤ 70 years of age
526685|NCT00299039|Elective outpatient breast surgery for:|elective outpatient breast surgery for:
526686|NCT00299039|lumpectomy/quadrantectomy +/- Sentinel Lymph Node Biopsy|lumpectomy/quadrantectomy +/- sentinel lymph node biopsy
526687|NCT00299039|lumpectomy/quadrantectomy with Axillary Node Dissection|lumpectomy/quadrantectomy with axillary node dissection
754057|NCT01178762|Oral Azithromycin|oral azithromycin
526011|NCT00306228|Thrombolysis|thrombolysis
526688|NCT00299039|simple mastectomy +/- Sentinel Lymph Node Biopsy|simple mastectomy +/- sentinel lymph node biopsy
526689|NCT00299039|Modified Radical mastectomy|modified radical mastectomy
526690|NCT00299052|Tibia|tibia
526691|NCT00299052|Fracture|fracture
526692|NCT00299052|DBM|dbm
526693|NCT00299065|Asthma, bronchial|asthma, bronchial
526694|NCT00299065|Asthma, exercise-induced|asthma, exercise-induced
526695|NCT00299065|Anti-asthmatic agents|anti-asthmatic agents
526696|NCT00299091|Therapeutic drug monitoring|therapeutic drug monitoring
526697|NCT00299091|Treatment Naive|treatment naive
526698|NCT00299091|Treatment Experienced|treatment experienced
526699|NCT00299091|HIV|hiv
526700|NCT00299104|Rituxan|rituxan
526701|NCT00299104|MTX|mtx
526702|NCT00299104|RA|ra
526703|NCT00299104|IMAGE|image
526704|NCT00299104|WA17047|wa17047
526705|NCT00299117|Smoking cessation|smoking cessation
526706|NCT00299117|Stress|stress
526707|NCT00299117|Nicotine dependence|nicotine dependence
526708|NCT00299117|Complication, postoperative|complication, postoperative
526709|NCT00299130|RA|ra
526710|NCT00299130|Rituxan|rituxan
526711|NCT00299130|SERENE|serene
526712|NCT00299143|SIPA|sipa
526713|NCT00299143|acute coronary syndrome|acute coronary syndrome
526714|NCT00299156|Myelodysplastic Syndrome|myelodysplastic syndrome
526715|NCT00299156|MDS|mds
526716|NCT00299156|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
526717|NCT00299156|CMML|cmml
526718|NCT00299156|Clofarabine|clofarabine
526719|NCT00299156|Clofarex|clofarex
526720|NCT00299156|Clolar|clolar
526721|NCT00299156|Chemotherapy|chemotherapy
526722|NCT00299169|N of 1 trial|n of 1 trial
526723|NCT00299169|diabetes mellitus|diabetes mellitus
526724|NCT00299169|HMG CoA Reductase Inhibitors|hmg coa reductase inhibitors
526725|NCT00299169|cardiovascular disease|cardiovascular disease
526726|NCT00299182|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
526727|NCT00299182|Lymphoma|lymphoma
526728|NCT00299182|Mantle Cell Lymphoma|mantle cell lymphoma
526729|NCT00299182|AMG 531|amg 531
526730|NCT00299182|Romiplostim|romiplostim
526731|NCT00299182|Placebo|placebo
526732|NCT00299182|R-HyperCVAD|r-hypercvad
526733|NCT00299182|R-Ara-C/MTX|r-ara-c/mtx
526734|NCT00299182|Cyclophosphamide|cyclophosphamide
526735|NCT00299182|Cytarabine|cytarabine
526736|NCT00299182|Dexamethasone|dexamethasone
526737|NCT00299182|Doxorubicin|doxorubicin
526738|NCT00299182|Methotrexate|methotrexate
526739|NCT00299182|Rituximab|rituximab
526740|NCT00299182|Vincristine|vincristine
526741|NCT00299182|Decadron|decadron
526744|NCT00299182|Hydroxydaunomycin hydrocholoride|hydroxydaunomycin hydrocholoride
526745|NCT00299182|Ara-C|ara-c
526746|NCT00299182|Cytosar|cytosar
526747|NCT00299182|DepoCyt|depocyt
527151|NCT00307307|niacin|niacin
526748|NCT00299182|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
526749|NCT00299195|Oral Leukoplakia|oral leukoplakia
526750|NCT00299195|Benign Neoplasms|benign neoplasms
526751|NCT00299195|Chemoprevention|chemoprevention
526752|NCT00299195|Pan-cyclooxygenase (COX) inhibitor|pan-cyclooxygenase (cox) inhibitor
526753|NCT00299195|sulindac|sulindac
526754|NCT00299195|04-099|04-099
526755|NCT00299208|Malaria|malaria
526756|NCT00299221|immunosuppression|immunosuppression
526757|NCT00299221|steroid withdrawal|steroid withdrawal
526758|NCT00299221|rejection|rejection
526759|NCT00299221|coronary disease|coronary disease
526760|NCT00299221|cytomegalovirus infection|cytomegalovirus infection
526761|NCT00299234|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
526762|NCT00299247|Malaria, Plasmodium falciparum, drug resistance, Colombia|malaria, plasmodium falciparum, drug resistance, colombia
526763|NCT00299260|cytomegalovirus, glycoprotein B vaccine, allograft|cytomegalovirus, glycoprotein b vaccine, allograft
526764|NCT00299273|Obesity;|obesity;
526765|NCT00299273|Low calorie high fat/protein diet;|low calorie high fat/protein diet;
526766|NCT00299273|Low-carbohydrate diet|low-carbohydrate diet
526767|NCT00299273|Weight Loss|weight loss
526768|NCT00299286|Ki67|ki67
526769|NCT00299286|Molecular|molecular
526770|NCT00299286|antiproliferative|antiproliferative
526771|NCT00299312|Loss of Purposeful Hand Use Syndrome|loss of purposeful hand use syndrome
526772|NCT00299312|Loss of Communication|loss of communication
526773|NCT00299312|Stereotypic Hand Movements|stereotypic hand movements
526774|NCT00299312|MECP2 mutation|mecp2 mutation
526775|NCT00299312|MECP2 duplication|mecp2 duplication
526776|NCT00299312|CDKL5 mutation|cdkl5 mutation
526777|NCT00299312|FOXG1 mutation|foxg1 mutation
526778|NCT00299338|HIV|hiv
526779|NCT00299338|AIDS|aids
526780|NCT00299338|CD4|cd4
526781|NCT00299338|HAART|haart
526782|NCT00299338|antiretroviral|antiretroviral
526783|NCT00299338|treatment failure|treatment failure
526784|NCT00299338|resistance|resistance
526785|NCT00299338|CCR4|ccr4
526786|NCT00299338|CXCR5|cxcr5
526787|NCT00299338|gp120|gp120
526788|NCT00299338|gp41|gp41
526110|NCT00306592|MS|ms
526789|NCT00299338|cholesterol|cholesterol
526790|NCT00299338|lipid rafts|lipid rafts
526791|NCT00299338|intracellular fluid|intracellular fluid
526792|NCT00299338|receptors|receptors
526793|NCT00299338|chemokine|chemokine
526794|NCT00299338|antigens|antigens
526795|NCT00299338|Treatment Experienced|treatment experienced
526796|NCT00299364|Climacteric symptoms|climacteric symptoms
526797|NCT00299364|Black Cohosh|black cohosh
526798|NCT00299364|Efficacy|efficacy
526799|NCT00299364|Safety|safety
526800|NCT00299377|STEMI|stemi
526801|NCT00299377|infarct size|infarct size
526802|NCT00299377|primary PCI|primary pci
526804|NCT00299377|ST-elevation myocardial infarction|st-elevation myocardial infarction
526805|NCT00299390|Sagopilone|sagopilone
526806|NCT00299390|Epothilone|epothilone
526807|NCT00299390|SCLC|sclc
526808|NCT00299390|Small Cell Lung Cancer|small cell lung cancer
526809|NCT00299390|Lung Cancer|lung cancer
526810|NCT00299403|Depressive disorder,|depressive disorder,
526811|NCT00299403|Antidepressant effect,|antidepressant effect,
526812|NCT00299403|rTMS,|rtms,
526813|NCT00299403|ECT,|ect,
526814|NCT00299403|cognition,|cognition,
526815|NCT00299403|Saliva cortisol|saliva cortisol
526816|NCT00299403|noninferiority trial|noninferiority trial
526817|NCT00299416|Stroke|stroke
526818|NCT00299416|Nonhemorrhagic|nonhemorrhagic
526819|NCT00299416|hypothermia|hypothermia
526820|NCT00299429|Stent|stent
526821|NCT00299429|drug-eluting stent|drug-eluting stent
526822|NCT00299429|Minimally invasive bypass surgery|minimally invasive bypass surgery
526823|NCT00299429|left anterior descending|left anterior descending
526824|NCT00299442|behavior|behavior
526825|NCT00299442|conduct|conduct
526826|NCT00299442|child|child
526827|NCT00299442|parenting|parenting
526828|NCT00299442|self-help|self-help
526829|NCT00299442|media-based|media-based
526830|NCT00299468|hypertension|hypertension
526831|NCT00299468|home care|home care
526832|NCT00299468|patient activation|patient activation
526833|NCT00299468|stages-of-change|stages-of-change
526834|NCT00299481|Tissue Bank|tissue bank
526835|NCT00299481|Endometrial neoplasm|endometrial neoplasm
526836|NCT00299481|uterine cervical neoplasm|uterine cervical neoplasm
526837|NCT00299481|ovarian neoplasm|ovarian neoplasm
526838|NCT00299481|leiomyoma|leiomyoma
526840|NCT00299481|RNA|rna
526841|NCT00299481|Protein|protein
526842|NCT00299481|Serum|serum
526843|NCT00299494|Lymphoma|lymphoma
526844|NCT00299494|NHL|nhl
526845|NCT00299507|exudative AMD|exudative amd
526846|NCT00299507|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
526847|NCT00299520|skin infection|skin infection
527249|NCT00308139|exenatide|exenatide
526848|NCT00299520|complicated skin infection|complicated skin infection
526849|NCT00299520|skin structure infection|skin structure infection
526850|NCT00299546|Rheumatoid Arthritis|rheumatoid arthritis
527152|NCT00307307|MR imaging|mr imaging
526851|NCT00299546|Anti-TNFa agents|anti-tnfa agents
526852|NCT00299546|subcutaneous injection|subcutaneous injection
526853|NCT00299559|common cold|common cold
526854|NCT00299559|organic chemicals|organic chemicals
526855|NCT00299559|menthol|menthol
526856|NCT00299559|cineole|cineole
526857|NCT00299559|camphor|camphor
526858|NCT00299559|etheric oils|etheric oils
526859|NCT00299559|alternative medicine|alternative medicine
526860|NCT00299559|smart textiles|smart textiles
526861|NCT00299572|alendronate|alendronate
526862|NCT00299572|peritoneal dialysis|peritoneal dialysis
526863|NCT00299572|vascular calcification|vascular calcification
526864|NCT00299572|bone mineral density|bone mineral density
526865|NCT00299585|dental implant|dental implant
526866|NCT00299585|dental implantation|dental implantation
526867|NCT00299585|osseointegration|osseointegration
526868|NCT00299585|bone cement|bone cement
526869|NCT00299585|osteoconductivity|osteoconductivity
526870|NCT00299585|brushite|brushite
526871|NCT00299585|calcium phosphate|calcium phosphate
526872|NCT00299585|bone augmentation|bone augmentation
526873|NCT00299585|primary stability|primary stability
526874|NCT00299585|immediate implantation|immediate implantation
526875|NCT00299585|Mandibular Ridge Augmentation|mandibular ridge augmentation
526876|NCT00299585|Maxillary Ridge Augmentation|maxillary ridge augmentation
526877|NCT00299585|synthetic implants for rebuilding the alveolar ridge|synthetic implants for rebuilding the alveolar ridge
526878|NCT00299598|antibacterial|antibacterial
526879|NCT00299598|composite|composite
526880|NCT00299598|polyethylenimine|polyethylenimine
526881|NCT00299598|nanoparticle|nanoparticle
526883|NCT00299611|Anxiety|anxiety
526884|NCT00299611|Pharmacotherapy|pharmacotherapy
526885|NCT00299611|Sertraline|sertraline
526886|NCT00299611|Levetiracetam|levetiracetam
526887|NCT00299624|venous thromboembolism risk,|venous thromboembolism risk,
526888|NCT00299624|elderly,|elderly,
526889|NCT00299624|hypercoagulability|hypercoagulability
526890|NCT00299624|fibrinolysis|fibrinolysis
526891|NCT00299624|microparticles|microparticles
526892|NCT00299650|ARDS|ards
526893|NCT00299650|mortality|mortality
680555|NCT00896935|cancer|cancer
526894|NCT00299650|mechanical ventilation|mechanical ventilation
526895|NCT00299650|pneumonia|pneumonia
526896|NCT00299650|muscle relaxants|muscle relaxants
526897|NCT00299663|group A streptococcal infection|group a streptococcal infection
526898|NCT00299663|genital tract|genital tract
526899|NCT00299663|CARRIER|carrier
526900|NCT00299663|patients with GAS isolation|patients with gas isolation
526901|NCT00299663|Streptococcus Group A|streptococcus group a
526902|NCT00299676|Alzheimer's Disease|alzheimer's disease
526903|NCT00299676|Dementia|dementia
526904|NCT00299676|Post Marketing|post marketing
526905|NCT00299676|Prospective Studies|prospective studies
526906|NCT00299676|Longitudinal Studies|longitudinal studies
526907|NCT00299676|New Zealand|new zealand
526908|NCT00299676|Cholinesterase Inhibitors|cholinesterase inhibitors
526909|NCT00299676|Observational|observational
526910|NCT00299676|Outcomes|outcomes
526911|NCT00299689|Melanoma|melanoma
526912|NCT00299689|Metastatic|metastatic
526913|NCT00299689|Stage IV|stage iv
526914|NCT00299689|Ontak|ontak
526915|NCT00299702|Schizophrenia|schizophrenia
526916|NCT00299702|Relapse|relapse
526917|NCT00299702|Remission|remission
526918|NCT00299702|Treatment Outcome|treatment outcome
526919|NCT00299702|long-acting injectable|long-acting injectable
526920|NCT00299715|Affective psychosis|affective psychosis
526921|NCT00299715|mixed-state|mixed-state
526922|NCT00299715|bipolar disorder|bipolar disorder
526923|NCT00299715|manic disorder|manic disorder
526924|NCT00299715|manic-depressive|manic-depressive
526925|NCT00299715|psychosis|psychosis
526926|NCT00299715|mania|mania
526927|NCT00299715|manic state|manic state
526928|NCT00299715|paliperidone|paliperidone
526929|NCT00299715|paliperidone ER.|paliperidone er.
526930|NCT00299728|NY-ESO-1|ny-eso-1
526931|NCT00299728|Vaccine|vaccine
526932|NCT00299728|Adjuvant or metastatic setting|adjuvant or metastatic setting
526933|NCT00299728|Several tumor types eligible|several tumor types eligible
526934|NCT00299741|Sutent|sutent
526935|NCT00299741|Sunitinib|sunitinib
526936|NCT00299741|Bone|bone
526937|NCT00299741|Metastatic|metastatic
526938|NCT00299741|Hormone-refractory|hormone-refractory
526939|NCT00299741|Biomarkers|biomarkers
526940|NCT00299754|Low dose misoprostol|low dose misoprostol
526941|NCT00299754|dinoprostone|dinoprostone
526942|NCT00299754|cervical priming|cervical priming
526943|NCT00299780|Mobilization|mobilization
526944|NCT00299780|Stem Cell|stem cell
526945|NCT00299780|Parathyroid Hormone|parathyroid hormone
526946|NCT00299793|Epilepsy|epilepsy
526947|NCT00299793|Quality of life|quality of life
526948|NCT00299806|Hypertension, aliskiren, blood pressure, rennin|hypertension, aliskiren, blood pressure, rennin
526950|NCT00299832|Hypertension, aliskiren, blood pressure, rennin|hypertension, aliskiren, blood pressure, rennin
526951|NCT00299845|gastroesophageal reflux|gastroesophageal reflux
526952|NCT00299845|children|children
526953|NCT00299845|lansoprazole|lansoprazole
526954|NCT00299845|cytochrome P450 2C19 (CYP2C19)|cytochrome p450 2c19 (cyp2c19)
526955|NCT00299845|pharmacogenomics|pharmacogenomics
526956|NCT00299845|genetic polymorphisms|genetic polymorphisms
526957|NCT00299845|individualized medicine|individualized medicine
526958|NCT00299845|pharmacokinetics/dynamics|pharmacokinetics/dynamics
526959|NCT00299858|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
526960|NCT00299858|Theophylline|theophylline
526961|NCT00299858|Exercise testing|exercise testing
526962|NCT00299871|Type 2 diabetes|type 2 diabetes
526963|NCT00299884|Randomized|randomized
526964|NCT00299884|non-blinded|non-blinded
526965|NCT00299884|prospective|prospective
526966|NCT00299884|open-label|open-label
526967|NCT00299884|LDL-C|ldl-c
526968|NCT00299884|HDL-C|hdl-c
526969|NCT00299897|HIV|hiv
526970|NCT00299897|AIDS|aids
526971|NCT00299897|Treatment Resistance|treatment resistance
526972|NCT00299897|Treatment Failure|treatment failure
526973|NCT00299897|Mutations|mutations
526974|NCT00299897|GP120|gp120
526975|NCT00299897|Entry Inhibitors|entry inhibitors
526976|NCT00299897|HAART|haart
526977|NCT00299897|antiretroviral|antiretroviral
526978|NCT00299897|antiviral|antiviral
526979|NCT00299897|ARV|arv
526980|NCT00299897|CCR5|ccr5
526981|NCT00299897|CXCR4|cxcr4
526982|NCT00299897|receptors|receptors
526983|NCT00299897|intracellular fluid|intracellular fluid
526984|NCT00299897|lipid rafts|lipid rafts
526985|NCT00299897|cholesterol|cholesterol
526986|NCT00299897|chemokine|chemokine
526987|NCT00299897|Treatment Experienced|treatment experienced
526988|NCT00299923|drug therapy|drug therapy
526989|NCT00299923|Interferon|interferon
526990|NCT00299936|hepatitis C|hepatitis c
526991|NCT00299936|chronic hepatitis C|chronic hepatitis c
526992|NCT00299936|ribavirin|ribavirin
526993|NCT00299936|WIN-R|win-r
526994|NCT00299962|gene therapy|gene therapy
526995|NCT00299962|immunotherapy|immunotherapy
526996|NCT00299975|Randomized Controlled Trials|randomized controlled trials
526997|NCT00299975|Medicine, Chinese Traditional|medicine, chinese traditional
526998|NCT00299975|Medicine, Herbal|medicine, herbal
526999|NCT00299975|Constipation|constipation
527000|NCT00299988|Immunotherapy|immunotherapy
527001|NCT00299988|Amyloid beta protein|amyloid beta protein
527002|NCT00299988|Antibodies|antibodies
527003|NCT00299988|Alzheimer's|alzheimer's
527004|NCT00299988|Dementia|dementia
527005|NCT00300001|Cancer|cancer
527006|NCT00300001|Symptom Management|symptom management
527007|NCT00300001|Supportive Symptom Interventions|supportive symptom interventions
527008|NCT00300001|Symptom Severity|symptom severity
527009|NCT00300001|quality of life|quality of life
527010|NCT00300001|Home-based symptom monitoring|home-based symptom monitoring
527011|NCT00300014|Post vitrectomy|post vitrectomy
527012|NCT00300014|Recurrent diabetic vitreous hemorrhage|recurrent diabetic vitreous hemorrhage
527013|NCT00300014|Intravitreal triamcinolone injection|intravitreal triamcinolone injection
527014|NCT00300027|Advanced Gastrointestinal Malignancies|advanced gastrointestinal malignancies
527015|NCT00300040|Amputation|amputation
527016|NCT00300040|Lower limb|lower limb
527017|NCT00300040|Critical Limb Ischemia|critical limb ischemia
527018|NCT00300040|residual limb|residual limb
527019|NCT00300040|Peripheral Vascular Disease|peripheral vascular disease
527020|NCT00300040|re-amputation|re-amputation
527021|NCT00300040|Lower Limb Ischemia|lower limb ischemia
527022|NCT00300040|PVD|pvd
527024|NCT00300066|Glomerular Filtration Rate|glomerular filtration rate
527025|NCT00300066|Serum Cystatin C|serum cystatin c
527026|NCT00300066|Body Composition|body composition
527027|NCT00300066|bioelectrical impedance spectroscopy|bioelectrical impedance spectroscopy
527028|NCT00300079|Ocular Hypertension Patients|ocular hypertension patients
527029|NCT00300105|Patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study GALLANT 4|patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study gallant 4
527030|NCT00300131|Bioabsorbable|bioabsorbable
527031|NCT00300131|Coronary Stent|coronary stent
527032|NCT00300131|Everolimus|everolimus
527033|NCT00300131|drug eluting stents|drug eluting stents
527034|NCT00300131|stents|stents
527035|NCT00300131|angioplasty|angioplasty
527036|NCT00300131|coronary artery disease|coronary artery disease
527037|NCT00300131|total coronary occlusion|total coronary occlusion
527038|NCT00300131|coronary artery restenosis|coronary artery restenosis
527039|NCT00300131|stent thrombosis|stent thrombosis
527040|NCT00300131|vascular disease|vascular disease
527041|NCT00300131|myocardial ischemia|myocardial ischemia
527042|NCT00300131|coronary artery stenosis|coronary artery stenosis
527043|NCT00300157|Left main coronary artery stenosis, stent, Taxus|left main coronary artery stenosis, stent, taxus
527044|NCT00300157|Unprotected left main coronary artery disease|unprotected left main coronary artery disease
527555|NCT00309712|statin|statin
527045|NCT00300157|Percutaneous coronary intervention with Taxus stent|percutaneous coronary intervention with taxus stent
527046|NCT00300170|HIV|hiv
527047|NCT00300170|race|race
527153|NCT00307320|pregnancy|pregnancy
527048|NCT00300170|unstable housing|unstable housing
527049|NCT00300170|health services accessibility|health services accessibility
527050|NCT00300170|health services utilization|health services utilization
527051|NCT00300170|substance abuse|substance abuse
527052|NCT00300170|AIDS|aids
527053|NCT00300170|health services research|health services research
527054|NCT00300170|social support|social support
527055|NCT00300170|depression|depression
527056|NCT00300170|trust|trust
527057|NCT00300170|discrimination|discrimination
527058|NCT00300183|HIV|hiv
527059|NCT00300183|health services accessibility|health services accessibility
527060|NCT00300183|health services research|health services research
527061|NCT00300183|homeless|homeless
527062|NCT00300183|social support|social support
527063|NCT00300183|AIDS|aids
527064|NCT00300183|substance abuse|substance abuse
527065|NCT00300183|mental health|mental health
527066|NCT00300183|quality of life|quality of life
527067|NCT00300183|outreach|outreach
527068|NCT00300183|harm reduction|harm reduction
527069|NCT00300196|Stroke|stroke
527070|NCT00300196|Fibrinogen|fibrinogen
527071|NCT00300196|Reperfusion|reperfusion
527072|NCT00300196|Thrombolysis|thrombolysis
527073|NCT00300222|dermal assessment|dermal assessment
527074|NCT00300222|pain measurement|pain measurement
527075|NCT00300222|diary|diary
527076|NCT00300222|PHN|phn
527077|NCT00300222|shingles|shingles
527078|NCT00300222|neuropathy|neuropathy
527079|NCT00300222|analgesics|analgesics
527080|NCT00300222|capsaicin|capsaicin
527081|NCT00300222|postherpetic neuralgia|postherpetic neuralgia
527082|NCT00300235|Sickle Cell Anemia|sickle cell anemia
527083|NCT00300248|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
527084|NCT00300248|Acute Lung Injury|acute lung injury
527085|NCT00300248|Respiratory Failure|respiratory failure
527086|NCT00300248|ARDS, Human|ards, human
527087|NCT00300261|Heart Failure|heart failure
527088|NCT00300274|Everolimus|everolimus
527089|NCT00300274|heart transplant|heart transplant
527090|NCT00300274|heart disease|heart disease
680669|NCT00897286|gliomas|gliomas
527091|NCT00300274|transplantation|transplantation
527092|NCT00300274|heart IVUS assessment at 12 months|heart ivus assessment at 12 months
527093|NCT00300274|rate of graft loss|rate of graft loss
527094|NCT00300274|acute rejection episodes|acute rejection episodes
527095|NCT00300274|survival|survival
527096|NCT00300287|Type 2 diabetes|type 2 diabetes
527097|NCT00300287|Vildagliptin|vildagliptin
527098|NCT00300300|ACL computer-assisted surgery graft|acl computer-assisted surgery graft
527099|NCT00300352|Coronary artery disease|coronary artery disease
527100|NCT00300352|Folic acid|folic acid
527101|NCT00300352|Endothelial function|endothelial function
527102|NCT00300365|HDL cholesterol|hdl cholesterol
527103|NCT00300365|Metabolic syndrome|metabolic syndrome
527104|NCT00300378|Depression|depression
527105|NCT00300378|Adult|adult
527106|NCT00300378|Outpatients|outpatients
527107|NCT00300391|Delirium|delirium
527108|NCT00300391|Mechanical ventilation|mechanical ventilation
527109|NCT00300391|Intensive care|intensive care
527110|NCT00300391|Haloperidol|haloperidol
527111|NCT00300404|Schizophrenia|schizophrenia
527112|NCT00300404|Psychosis|psychosis
527113|NCT00300404|Depression|depression
527114|NCT00300404|Affective Disorder|affective disorder
527115|NCT00300417|Flavivirus|flavivirus
527116|NCT00300417|Mosquito|mosquito
527117|NCT00300417|Immunity|immunity
527118|NCT00300417|Preventive|preventive
527120|NCT00300417|West Nile Virus|west nile virus
527121|NCT00300417|Vaccine|vaccine
527122|NCT00300417|Healthy Volunteer|healthy volunteer
527123|NCT00300417|HV|hv
527124|NCT00300456|Dyslipidemia|dyslipidemia
527125|NCT00300456|Coronary Heart Disease|coronary heart disease
527126|NCT00300456|Mixed Dyslipidemia|mixed dyslipidemia
527127|NCT00300469|Mixed Dyslipidemia|mixed dyslipidemia
527128|NCT00300469|Coronary Heart Disease|coronary heart disease
527129|NCT00300469|Dyslipidemia|dyslipidemia
527130|NCT00300482|Dyslipidemia|dyslipidemia
527131|NCT00300482|Coronary Heart Disease|coronary heart disease
527132|NCT00300482|Mixed Dyslipidemia|mixed dyslipidemia
527133|NCT00300495|Atrial fibrillation|atrial fibrillation
527134|NCT00300495|Lung cancer|lung cancer
527135|NCT00300495|Pulmonary resection|pulmonary resection
527136|NCT00300495|Post-operative complications|post-operative complications
527137|NCT00300508|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
527138|NCT00300521|hepatocellular carcinoma|hepatocellular carcinoma
527139|NCT00300521|liver transplantation|liver transplantation
527140|NCT00300521|adenovirus-thymidine kinase enzyme|adenovirus-thymidine kinase enzyme
527141|NCT00300521|gene therapy|gene therapy
527142|NCT00300521|immunosuppression|immunosuppression
527143|NCT00300534|Diagnosis|diagnosis
527144|NCT00300547|colorectal cancer|colorectal cancer
527145|NCT00300547|polyps|polyps
527146|NCT00300547|Virtual colonoscopy|virtual colonoscopy
527147|NCT00300547|synchronous carcinoma|synchronous carcinoma
527148|NCT00300547|MR colonography|mr colonography
527149|NCT00307307|atherosclerosis|atherosclerosis
527150|NCT00307307|HDL cholesterol|hdl cholesterol
527154|NCT00307320|stress|stress
527155|NCT00307320|anxiety|anxiety
527156|NCT00307333|very low birth weight infants|very low birth weight infants
527157|NCT00307333|heart rate characteristics|heart rate characteristics
527158|NCT00307346|Movement-Related Potential|movement-related potential
527159|NCT00307346|Electroencephalogram|electroencephalogram
527160|NCT00307346|Psychogenic Movement Disorders|psychogenic movement disorders
527161|NCT00307346|Psychogenic Movement Disorder|psychogenic movement disorder
527162|NCT00307346|Healthy Volunteer|healthy volunteer
527163|NCT00307346|HV|hv
527164|NCT00307385|Motor Recovery|motor recovery
527165|NCT00307385|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
527166|NCT00307385|Homeostatic Plasticity|homeostatic plasticity
527167|NCT00307385|Ipsilesional Primary Motor Cortex|ipsilesional primary motor cortex
527168|NCT00307385|Paretic Fingers Motor Sequence|paretic fingers motor sequence
527169|NCT00307385|Motor Cortex|motor cortex
527170|NCT00307385|Motor Function|motor function
527171|NCT00307385|Motor Learning|motor learning
527172|NCT00307385|Premotor Cortex|premotor cortex
527173|NCT00307385|Primary Motor Cortex|primary motor cortex
527174|NCT00307385|Stroke|stroke
527175|NCT00307385|Healthy Volunteer|healthy volunteer
527176|NCT00307385|HV|hv
527177|NCT00307398|AMD|amd
527178|NCT00307398|Dry AMD|dry amd
527179|NCT00307398|Drusen|drusen
527180|NCT00307398|CNV|cnv
527181|NCT00307411|Metabolic syndrome|metabolic syndrome
527182|NCT00307437|Moderate to Severe Plaque-Type Psoriasis|moderate to severe plaque-type psoriasis
527183|NCT00307437|interleukin 23|interleukin 23
527184|NCT00307437|IL-12|il-12
527185|NCT00307437|interleukin-12|interleukin-12
527186|NCT00307437|interleukin-23|interleukin-23
527187|NCT00307437|CNTO1275|cnto1275
527188|NCT00307437|biologic|biologic
527189|NCT00307437|Psoriasis|psoriasis
527190|NCT00307437|CNTO 1275|cnto 1275
527191|NCT00307437|IL23|il23
527192|NCT00307437|interleukin 12|interleukin 12
527193|NCT00307437|IL-23|il-23
526521|NCT00298285|warfarin|warfarin
527194|NCT00307437|IL12|il12
527195|NCT00307437|ustekinumab|ustekinumab
527196|NCT00307450|Dyskinesias|dyskinesias
527197|NCT00307450|Parkinson's disease|parkinson's disease
527198|NCT00307450|Levetiracetam|levetiracetam
527199|NCT00307450|Treatment|treatment
527200|NCT00307463|end-stage renal disease|end-stage renal disease
527201|NCT00307463|hemodialysis|hemodialysis
527202|NCT00307463|volume control|volume control
527203|NCT00307463|ultrafiltration|ultrafiltration
527204|NCT00307463|inflammation|inflammation
527205|NCT00307463|cardiovascular disease|cardiovascular disease
527206|NCT00307463|left ventricular hypertrophy|left ventricular hypertrophy
527207|NCT00307463|dietary salt restriction|dietary salt restriction
527208|NCT00307476|Fecal Incontinence|fecal incontinence
527209|NCT00307476|Fecal Containment Devices|fecal containment devices
527210|NCT00307476|Skin Integrity|skin integrity
527211|NCT00307502|protease inhibitors|protease inhibitors
527212|NCT00307502|non-nucleoside analog reverse transcriptase inhibitors|non-nucleoside analog reverse transcriptase inhibitors
527213|NCT00307502|pharmacokinetic models|pharmacokinetic models
527214|NCT00307502|treatment experienced|treatment experienced
527216|NCT00307580|CVADS|cvads
527217|NCT00307593|Systemic ANCA+ vascularizes|systemic anca+ vascularizes
527218|NCT00307593|Relapse|relapse
527219|NCT00307593|Corticosteroids|corticosteroids
527220|NCT00307593|Immunosuppressant|immunosuppressant
527221|NCT00307593|Infliximab/rituximab|infliximab/rituximab
527222|NCT00307593|Patients with relapsing or refractory forms of ANCA|patients with relapsing or refractory forms of anca
527223|NCT00307593|associated vasculitides Microscopic polyangiitis|associated vasculitides microscopic polyangiitis
527224|NCT00307606|Mastectomy|mastectomy
527225|NCT00307606|Seroma|seroma
527226|NCT00307606|Breast cancer|breast cancer
527227|NCT00307606|Glucocorticoid|glucocorticoid
527228|NCT00307619|Binge-Eating Disorder|binge-eating disorder
527229|NCT00307632|Contraception|contraception
527230|NCT00307632|Hormonal patch|hormonal patch
527231|NCT00307632|Norelgestromine|norelgestromine
527232|NCT00307632|Ethinyl estradiol|ethinyl estradiol
527233|NCT00307645|ANCA associated systemic vasculitis|anca associated systemic vasculitis
527234|NCT00307645|Maintenance therapy|maintenance therapy
527235|NCT00307645|Azathioprine|azathioprine
527236|NCT00307645|Mycophenolate mofetil|mycophenolate mofetil
527237|NCT00307658|ANCA associated Vasculitides|anca associated vasculitides
527238|NCT00307658|Relapse|relapse
527239|NCT00307658|intravenous Immunoglobulins|intravenous immunoglobulins
527240|NCT00307658|Corticosteroid|corticosteroid
527241|NCT00307658|Immunosuppressant|immunosuppressant
527242|NCT00308100|Liver Transplantation|liver transplantation
527243|NCT00308113|Muscular dystrophy|muscular dystrophy
527244|NCT00308113|Duchenne|duchenne
527245|NCT00308113|CoQ10|coq10
527246|NCT00308113|prednisone|prednisone
527247|NCT00308126|Abdominal operation|abdominal operation
527248|NCT00308139|diabetes|diabetes
527250|NCT00308139|long acting release|long acting release
527251|NCT00308139|LAR|lar
527252|NCT00308139|Amylin|amylin
527253|NCT00308139|Lilly|lilly
527254|NCT00308152|Colonoscopy|colonoscopy
527255|NCT00308152|Rehydration|rehydration
527256|NCT00308152|Sedation|sedation
527257|NCT00308165|Recurrent Primary Malignant Brain Tumors|recurrent primary malignant brain tumors
527258|NCT00308165|Brain Tumors|brain tumors
527259|NCT00308165|Neoplasms, Brain|neoplasms, brain
527260|NCT00308165|Brain Cancer|brain cancer
527261|NCT00308165|Brain cancer treatment|brain cancer treatment
527262|NCT00308165|Topotecan|topotecan
527263|NCT00308178|Abraxane|abraxane
527264|NCT00308178|dose-dense chemotherapy|dose-dense chemotherapy
527266|NCT00308191|COPD|copd
527267|NCT00308191|Formoterol|formoterol
527268|NCT00308191|Tiotropium|tiotropium
527269|NCT00308204|discoid lupus|discoid lupus
527270|NCT00308204|lupus|lupus
527271|NCT00308204|discoid lupus erythematosus|discoid lupus erythematosus
527272|NCT00308204|lupus of the scalp|lupus of the scalp
527273|NCT00308217|Heart Disease, Congenital|heart disease, congenital
527274|NCT00308217|Single Ventricle|single ventricle
527275|NCT00308217|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
527276|NCT00308230|Congenital, BNP|congenital, bnp
527277|NCT00308243|Cystic Fibrosis|cystic fibrosis
527278|NCT00308243|Sodium Pyruvate|sodium pyruvate
527279|NCT00308243|Reactive Oxygen Species|reactive oxygen species
527280|NCT00308243|Inflammation of Lung|inflammation of lung
527281|NCT00308256|Type1 diabetes;|type1 diabetes;
527282|NCT00308256|nurse-counselling;|nurse-counselling;
527283|NCT00308256|adolescent|adolescent
527284|NCT00308269|Cancer|cancer
527285|NCT00308269|Phase I|phase i
527286|NCT00308269|EC145|ec145
527287|NCT00308269|Recurrent|recurrent
527288|NCT00308269|Refractory|refractory
527289|NCT00308269|Solid Tumors|solid tumors
527290|NCT00308269|Experimental|experimental
527291|NCT00308334|Domperidone|domperidone
527292|NCT00308334|breast milk|breast milk
527293|NCT00308334|breast milk composition|breast milk composition
527294|NCT00308334|preterm infant|preterm infant
527295|NCT00308334|neonate|neonate
527296|NCT00308334|nutrition|nutrition
527297|NCT00308360|Hostility|hostility
527298|NCT00308360|Impulsivity|impulsivity
527299|NCT00308360|Aggression|aggression
527300|NCT00308386|Nurse Case Management|nurse case management
527301|NCT00308386|Diabetes|diabetes
527302|NCT00308386|Hypertension|hypertension
527303|NCT00308386|Hyperlipidemia|hyperlipidemia
527304|NCT00308386|Behavior therapy|behavior therapy
527305|NCT00308386|Motivational interviewing|motivational interviewing
527306|NCT00308412|Respiratory Tract Infection|respiratory tract infection
527307|NCT00308425|Renal transplantation, EC-MPS|renal transplantation, ec-mps
527308|NCT00308438|Crohn Disease|crohn disease
527309|NCT00308438|Crohn's Disease|crohn's disease
527310|NCT00308451|chromium|chromium
527311|NCT00308451|chromium picolinate|chromium picolinate
527265|NCT00308178|taxol|taxol
527312|NCT00308451|type 2 diabetes mellitus|type 2 diabetes mellitus
527313|NCT00308451|fructosamine|fructosamine
527314|NCT00308451|glycemic control|glycemic control
527316|NCT00308477|eye diseases|eye diseases
527317|NCT00308503|Primary Insomnia|primary insomnia
527318|NCT00308503|Sleep Maintenance Insomnia|sleep maintenance insomnia
527319|NCT00308503|Awakening|awakening
527320|NCT00308516|Rectal Cancer|rectal cancer
527321|NCT00308516|Cancer of the Rectum|cancer of the rectum
527322|NCT00308516|Colorectal Cancer|colorectal cancer
527323|NCT00308516|Bevacizumab|bevacizumab
527324|NCT00308529|Carcinoma Small Cell Lung|carcinoma small cell lung
527325|NCT00308529|Lung Cancer|lung cancer
527326|NCT00308542|eye diseases|eye diseases
527327|NCT00308542|diabetic eye problems|diabetic eye problems
527328|NCT00308555|Cannabis|cannabis
527329|NCT00308555|Morphine|morphine
527330|NCT00308555|Oxycodone|oxycodone
527331|NCT00308555|Marijuana|marijuana
527332|NCT00308555|chronic pain|chronic pain
527333|NCT00308568|screening colonoscopy|screening colonoscopy
527334|NCT00308568|adherence|adherence
527335|NCT00308581|Crohn's Disease|crohn's disease
527336|NCT00308581|Certolizumab pegol|certolizumab pegol
527337|NCT00308594|cervical radiculopathy|cervical radiculopathy
527338|NCT00308594|dexamethasone|dexamethasone
527339|NCT00308594|corticosteroid|corticosteroid
527340|NCT00308594|oral|oral
527341|NCT00308607|melanoma|melanoma
527342|NCT00308607|metastatic|metastatic
527343|NCT00308607|bevacizumab|bevacizumab
527345|NCT00308620|chloroquine|chloroquine
527346|NCT00308620|disease progression|disease progression
527347|NCT00308620|inflammation|inflammation
527348|NCT00308620|treatment naive|treatment naive
527349|NCT00308633|Cardiac Rehabilitation|cardiac rehabilitation
527350|NCT00308633|Apoptosis|apoptosis
527351|NCT00308633|Gene Expression|gene expression
527352|NCT00308633|Nitric Oxide|nitric oxide
527353|NCT00308633|Reactive Oxygen Species|reactive oxygen species
527354|NCT00308633|Coronary Artery Disease|coronary artery disease
527355|NCT00308633|CAD|cad
527356|NCT00308685|Asthma|asthma
527556|NCT00309712|fibrate|fibrate
527357|NCT00308685|Pediatric asthma|pediatric asthma
527358|NCT00308698|recombinant human erythropoietin|recombinant human erythropoietin
527359|NCT00308698|adiponectin|adiponectin
527360|NCT00308698|mortality|mortality
527361|NCT00308711|Cervical ripening|cervical ripening
527362|NCT00308711|Induction of labor|induction of labor
527363|NCT00308711|Dinoprostone vaginal insert|dinoprostone vaginal insert
527364|NCT00308711|Cervidil|cervidil
527365|NCT00308711|Misoprostol vaginal insert|misoprostol vaginal insert
527366|NCT00308711|Modified Bishop's Score|modified bishop's score
527367|NCT00308711|PGE2|pge2
527368|NCT00308711|PGE1|pge1
527369|NCT00308711|Uterine Hyperstimulation|uterine hyperstimulation
527370|NCT00308711|Cesarean section|cesarean section
527371|NCT00308724|Generalized Anxiety Disorder|generalized anxiety disorder
527372|NCT00308724|Geriatric|geriatric
527373|NCT00308763|Smoking Cessation|smoking cessation
527374|NCT00308763|Nicotine Dependence|nicotine dependence
527375|NCT00308789|Continuous Positive Airway Pressure|continuous positive airway pressure
527376|NCT00308789|Infant,newborn|infant,newborn
527377|NCT00308789|Artificial respiration|artificial respiration
527378|NCT00308802|Kidney|kidney
527379|NCT00308802|Transplant|transplant
527380|NCT00308802|Rejection|rejection
527381|NCT00308802|Kidney Disease|kidney disease
527382|NCT00308802|Kidney Failure|kidney failure
527383|NCT00308802|End Stage Renal Disease|end stage renal disease
527384|NCT00308815|Resuscitation|resuscitation
527385|NCT00308815|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
527386|NCT00308815|cardiac arrest|cardiac arrest
527387|NCT00308815|CPR|cpr
527388|NCT00308841|"Objective: To evaluate the efficacy of intrauterine lidocaine instillation in reducing patient discomfort during the removal of a lost IUD"|"objective: to evaluate the efficacy of intrauterine lidocaine instillation in reducing patient discomfort during the removal of a lost iud"
527389|NCT00308854|AK|ak
527390|NCT00308854|PDT|pdt
527391|NCT00308867|PDT|pdt
527392|NCT00308867|AK|ak
527393|NCT00308867|Cryosurgery|cryosurgery
527394|NCT00308880|Tranexamic acid|tranexamic acid
527395|NCT00308880|head neck surgery|head neck surgery
527396|NCT00308893|Antidepressants|antidepressants
527397|NCT00308893|escitalopram|escitalopram
527398|NCT00308893|Genetic polymorphism|genetic polymorphism
527399|NCT00308906|infection|infection
527400|NCT00308906|renal dysfunction|renal dysfunction
527401|NCT00308906|aminoglycoside|aminoglycoside
527402|NCT00308906|protein|protein
527403|NCT00308906|child|child
527404|NCT00308932|fluticasone|fluticasone
527405|NCT00308932|asthma therapy|asthma therapy
527406|NCT00308932|spacer inhaler|spacer inhaler
527407|NCT00308932|HFA-134a|hfa-134a
527408|NCT00308945|Glaucoma|glaucoma
527409|NCT00308945|Blood flow|blood flow
527410|NCT00308945|Choroid|choroid
527411|NCT00308945|Retina|retina
527412|NCT00308945|Prostaglandin analogues|prostaglandin analogues
527413|NCT00308958|cystic fibrosis|cystic fibrosis
527414|NCT00308958|chest physiotherapy|chest physiotherapy
527415|NCT00308958|airway clearance|airway clearance
527416|NCT00308958|bronchiectasis|bronchiectasis
527418|NCT00308984|Intraoperative Awareness|intraoperative awareness
527419|NCT00308984|Pediatric Anesthesia|pediatric anesthesia
527420|NCT00308997|Auditory Hallucinations|auditory hallucinations
527421|NCT00308997|Schizophrenia|schizophrenia
527422|NCT00308997|Schizoaffective Disorder|schizoaffective disorder
527423|NCT00308997|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
527424|NCT00308997|Wernicke's Area|wernicke's area
527425|NCT00308997|Superior Temporal Gyrus|superior temporal gyrus
527426|NCT00309010|Focal Hand Dystonia|focal hand dystonia
527427|NCT00309010|Motor Planning|motor planning
527428|NCT00309010|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
527429|NCT00309010|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
527430|NCT00309010|FHD|fhd
527431|NCT00309010|Writer's Cramp|writer's cramp
527432|NCT00309010|Healthy Volunteer|healthy volunteer
527433|NCT00309010|HV|hv
527434|NCT00309023|Advanced Solid Tumors|advanced solid tumors
527435|NCT00309036|Allergy|allergy
527436|NCT00309036|Grass pollen|grass pollen
527437|NCT00309036|Recombinant|recombinant
527438|NCT00309062|Allergy|allergy
527439|NCT00309062|Birch pollen|birch pollen
527440|NCT00309062|Recombinant|recombinant
527441|NCT00309075|Stenosis of the calf and/or pedal arteries|stenosis of the calf and/or pedal arteries
527442|NCT00309088|Tacrolimus|tacrolimus
527443|NCT00309088|Myasthenia Gravis|myasthenia gravis
527444|NCT00309101|Tacrolimus|tacrolimus
527445|NCT00309101|Myasthenia Gravis|myasthenia gravis
527446|NCT00309114|UTI|uti
527447|NCT00309114|SCI|sci
527448|NCT00309114|E coli|e coli
527449|NCT00309114|Prevention|prevention
527450|NCT00309127|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
527451|NCT00309127|DM Nephropathy|dm nephropathy
527452|NCT00309127|Structured care|structured care
527453|NCT00309179|Advanced colorectal cancer|advanced colorectal cancer
527454|NCT00309192|Diabetes, Macular Edema, Triamcinolone|diabetes, macular edema, triamcinolone
527455|NCT00309205|HIV seronegativity|hiv seronegativity
527456|NCT00309218|Pediatric renal transplantation|pediatric renal transplantation
527457|NCT00309218|Steroid withdrawal|steroid withdrawal
527780|NCT00310323|phenotyping|phenotyping
527458|NCT00309218|Mycophenolate Mofetil|mycophenolate mofetil
527459|NCT00309218|Cyclosporine A|cyclosporine a
527460|NCT00309218|Stable graft function|stable graft function
527461|NCT00309218|children|children
527462|NCT00309218|renal transplantation|renal transplantation
527463|NCT00309231|diabetes mellitus|diabetes mellitus
527464|NCT00309231|islet transplantation|islet transplantation
527465|NCT00309270|Campath-1H, low-dose immunosuppression, T regulatives cells|campath-1h, low-dose immunosuppression, t regulatives cells
527466|NCT00309296|smoking cessation|smoking cessation
527467|NCT00309296|smoking reduction|smoking reduction
527468|NCT00309296|nicotine replacement therapy|nicotine replacement therapy
527469|NCT00309322|Soft Tissue Anesthesia (Numbness)|soft tissue anesthesia (numbness)
527470|NCT00309335|Soft Tissue Anesthesia (Numbness)|soft tissue anesthesia (numbness)
527471|NCT00309361|Soft Tissue Anesthesia (Numbness)|soft tissue anesthesia (numbness)
527473|NCT00309374|Statins|statins
527474|NCT00309374|leukocyte mRNA expression profiles|leukocyte mrna expression profiles
527475|NCT00309387|Cataract|cataract
527476|NCT00309387|Nutritional supplements|nutritional supplements
527477|NCT00309400|History|history
527478|NCT00309400|Phenylketonuria|phenylketonuria
527479|NCT00309400|Galactosemia|galactosemia
527480|NCT00309400|Screening|screening
527481|NCT00309400|Treatment|treatment
527482|NCT00309413|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
527483|NCT00309426|atherosclerosis|atherosclerosis
527484|NCT00309452|First episode psychosis|first episode psychosis
527485|NCT00309452|Specialized care|specialized care
527486|NCT00309452|Phase-specific treatment|phase-specific treatment
527487|NCT00309452|Schizophrenia|schizophrenia
527488|NCT00309452|Disorders with psychotic features|disorders with psychotic features
527489|NCT00309465|Diabetes|diabetes
527490|NCT00309465|Insulin Glargine|insulin glargine
527491|NCT00309465|Surgery|surgery
527492|NCT00309478|Cyclophosphamide|cyclophosphamide
527493|NCT00309478|Methotrexate|methotrexate
527494|NCT00309478|Fluorouracil|fluorouracil
526839|NCT00299481|DNA|dna
527495|NCT00309478|Goserelin|goserelin
527496|NCT00309478|Tamoxifen|tamoxifen
527497|NCT00309478|Breast cancer|breast cancer
527498|NCT00309491|Tamoxifen|tamoxifen
527499|NCT00309491|Aminoglutethimide|aminoglutethimide
527500|NCT00309491|Breast cancer|breast cancer
527501|NCT00309504|magnetic resonance imaging|magnetic resonance imaging
527502|NCT00309504|magnetic resonance spectroscopy|magnetic resonance spectroscopy
527503|NCT00309517|Fluorouracil|fluorouracil
527504|NCT00309517|Leucovorin|leucovorin
527505|NCT00309517|MAb 17-1A|mab 17-1a
527506|NCT00309517|Rectal cancer|rectal cancer
527507|NCT00309530|Fluorouracil|fluorouracil
527508|NCT00309530|Levamisol|levamisol
527509|NCT00309530|Interferon|interferon
527510|NCT00309530|Colon cancer|colon cancer
527511|NCT00309543|Fluorouracil|fluorouracil
527512|NCT00309543|Leucovorin|leucovorin
527513|NCT00309543|Colon cancer|colon cancer
527514|NCT00309556|Epirubicin|epirubicin
527515|NCT00309556|Docetaxel|docetaxel
527516|NCT00309556|Capecitabine|capecitabine
527517|NCT00309556|Herceptin|herceptin
527518|NCT00309556|Breast cancer|breast cancer
527519|NCT00309569|Cyclophosphamide|cyclophosphamide
527520|NCT00309569|Methotrexate|methotrexate
527521|NCT00309569|Fluorouracil|fluorouracil
527522|NCT00309569|Epirubicine|epirubicine
527523|NCT00309569|Breast Cancer|breast cancer
527524|NCT00309621|Hand Dermatoses,|hand dermatoses,
527525|NCT00309621|hand dermatitis|hand dermatitis
527526|NCT00309621|hand eczema|hand eczema
527527|NCT00309621|chronic hand dermatitis|chronic hand dermatitis
527528|NCT00309621|retinoid|retinoid
527529|NCT00309634|prophylaxis of pandemic influenza|prophylaxis of pandemic influenza
527530|NCT00309647|prophylaxis of pandemic influenza|prophylaxis of pandemic influenza
527531|NCT00309660|PPARgamma ligand|ppargamma ligand
527532|NCT00309660|Rosiglitazone|rosiglitazone
527533|NCT00309660|Enema|enema
527534|NCT00309673|tuberculosis, tuberculin, childhood, pain|tuberculosis, tuberculin, childhood, pain
527535|NCT00309686|Affective psychosis|affective psychosis
527536|NCT00309686|bipolar disorder|bipolar disorder
527537|NCT00309686|manic disorder|manic disorder
527538|NCT00309686|manic-depressive psychosis|manic-depressive psychosis
527539|NCT00309686|mania|mania
527540|NCT00309686|manic state|manic state
527541|NCT00309686|paliperidone|paliperidone
527542|NCT00309686|paliperidone ER|paliperidone er
527543|NCT00309686|adjunctive therapy|adjunctive therapy
527544|NCT00309699|Affective psychosis|affective psychosis
527545|NCT00309699|mixed-state|mixed-state
527546|NCT00309699|bipolar disorder|bipolar disorder
527547|NCT00309699|manic disorder|manic disorder
527548|NCT00309699|manic-depressive psychosis|manic-depressive psychosis
527549|NCT00309699|mania|mania
527550|NCT00309699|manic state|manic state
527551|NCT00309699|paliperidone|paliperidone
527552|NCT00309699|paliperidone ER.|paliperidone er.
527553|NCT00309712|diabetes|diabetes
527554|NCT00309712|combination lipid treatment|combination lipid treatment
527557|NCT00309712|hypercholesteremia|hypercholesteremia
527558|NCT00309712|mixed dyslipidemia|mixed dyslipidemia
527559|NCT00309725|Alzheimer's Disease|alzheimer's disease
527560|NCT00309725|cardiac arrhythmias|cardiac arrhythmias
527561|NCT00309738|Kowa|kowa
527563|NCT00309738|Hypercholesterolemia|hypercholesterolemia
527564|NCT00309738|combined dyslipidemia|combined dyslipidemia
527565|NCT00309738|dyslipidemia|dyslipidemia
527566|NCT00309738|pitavastatin|pitavastatin
527567|NCT00309738|NK-104|nk-104
527568|NCT00309738|simvastatin|simvastatin
527569|NCT00309751|Kowa|kowa
527570|NCT00309751|Type II Diabetes Mellitus|type ii diabetes mellitus
527571|NCT00309751|Combined Dyslipidemia|combined dyslipidemia
527572|NCT00309751|pitavastatin|pitavastatin
527573|NCT00309751|NK-104|nk-104
527574|NCT00309751|Atorvastatin|atorvastatin
527575|NCT00309777|hypercholesterolemia|hypercholesterolemia
527576|NCT00309777|kowa|kowa
527577|NCT00309777|dyslipidemia|dyslipidemia
527578|NCT00309777|pitavastatin|pitavastatin
527579|NCT00309777|NK-104|nk-104
527580|NCT00309777|Primary Hypercholesterolemia or Combined Dyslipidemia|primary hypercholesterolemia or combined dyslipidemia
527581|NCT00309790|exercise stress test|exercise stress test
527582|NCT00309803|Carotid artery|carotid artery
527583|NCT00309803|distal protection device|distal protection device
527584|NCT00309816|Exercise stress test|exercise stress test
527585|NCT00309842|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
527586|NCT00309842|primary myelofibrosis|primary myelofibrosis
527587|NCT00309842|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
527588|NCT00309842|myelodysplastic syndromes|myelodysplastic syndromes
527589|NCT00309842|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
527590|NCT00309842|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
527591|NCT00309842|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
527592|NCT00309842|recurrent lymphoblastic lymphoma|recurrent lymphoblastic lymphoma
527593|NCT00309842|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
527594|NCT00309842|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
527595|NCT00309842|recurrent follicular lymphoma|recurrent follicular lymphoma
527596|NCT00309842|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
527597|NCT00309842|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
527598|NCT00309842|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
527599|NCT00309842|refractory multiple myeloma|refractory multiple myeloma
527600|NCT00309842|chronic myelogenous leukemia|chronic myelogenous leukemia
527601|NCT00309842|secondary acute myeloid leukemia|secondary acute myeloid leukemia
527602|NCT00309842|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
527603|NCT00309842|multiple myeloma|multiple myeloma
527604|NCT00309842|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
527605|NCT00309842|refractory anemia with excess blasts|refractory anemia with excess blasts
527606|NCT00309842|refractory anemia|refractory anemia
527607|NCT00309842|Burkitt lymphoma|burkitt lymphoma
527608|NCT00309842|childhood large cell lymphoma|childhood large cell lymphoma
527609|NCT00309842|adult Burkitt lymphoma|adult burkitt lymphoma
527610|NCT00309842|mantle cell lymphoma|mantle cell lymphoma
527611|NCT00309842|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
527612|NCT00309842|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
527613|NCT00309868|heart catheterization|heart catheterization
527614|NCT00309868|echocardiogram|echocardiogram
527615|NCT00309868|nesiritide|nesiritide
527616|NCT00309881|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
527617|NCT00309881|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
527618|NCT00309881|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
527619|NCT00309881|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
527620|NCT00309881|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
527621|NCT00309894|adenocarcinoma of the prostate|adenocarcinoma of the prostate
527622|NCT00309894|recurrent prostate cancer|recurrent prostate cancer
527623|NCT00309920|stage IIIA breast cancer|stage iiia breast cancer
527624|NCT00309920|stage IIIC breast cancer|stage iiic breast cancer
527625|NCT00309933|cognitive/functional effects|cognitive/functional effects
527626|NCT00309933|spiritual concerns|spiritual concerns
527627|NCT00309933|sexuality and reproductive issues|sexuality and reproductive issues
527628|NCT00309933|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
527629|NCT00309933|cancer survivor|cancer survivor
527630|NCT00309933|stage I breast cancer|stage i breast cancer
527631|NCT00309933|stage II breast cancer|stage ii breast cancer
527632|NCT00309933|stage IIIA breast cancer|stage iiia breast cancer
527633|NCT00309933|stage IIIB breast cancer|stage iiib breast cancer
527634|NCT00309933|stage IIIC breast cancer|stage iiic breast cancer
527635|NCT00309972|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
527636|NCT00309972|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
527637|NCT00309985|metastatic hormone-sensitive prostate cancer|metastatic hormone-sensitive prostate cancer
527638|NCT00309985|docetaxel|docetaxel
527783|NCT00310323|child|child
527639|NCT00309998|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
527980|NCT00303628|Bevacizumab|bevacizumab
527640|NCT00309998|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
527641|NCT00309998|adenocarcinoma of the lung|adenocarcinoma of the lung
527642|NCT00309998|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
527643|NCT00309998|large cell lung cancer|large cell lung cancer
527644|NCT00309998|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
527645|NCT00310011|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
527646|NCT00310011|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
527647|NCT00310011|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
527648|NCT00310011|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
527649|NCT00310011|stage IV bladder cancer|stage iv bladder cancer
527650|NCT00310011|recurrent bladder cancer|recurrent bladder cancer
527651|NCT00310050|stage II pancreatic cancer|stage ii pancreatic cancer
527652|NCT00310050|stage III pancreatic cancer|stage iii pancreatic cancer
527653|NCT00310050|stage IV pancreatic cancer|stage iv pancreatic cancer
527654|NCT00310063|nausea and vomiting|nausea and vomiting
527655|NCT00310063|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
527656|NCT00310076|carcinoma of the appendix|carcinoma of the appendix
527657|NCT00310076|stage II colon cancer|stage ii colon cancer
527658|NCT00310076|stage III colon cancer|stage iii colon cancer
527659|NCT00310076|stage IV colon cancer|stage iv colon cancer
527660|NCT00310076|recurrent colon cancer|recurrent colon cancer
527661|NCT00310076|stage II rectal cancer|stage ii rectal cancer
527662|NCT00310076|stage III rectal cancer|stage iii rectal cancer
527663|NCT00310076|stage IV rectal cancer|stage iv rectal cancer
527664|NCT00310076|recurrent rectal cancer|recurrent rectal cancer
527023|NCT00300053|angina|angina
527665|NCT00310089|stage IIIA breast cancer|stage iiia breast cancer
527666|NCT00310089|stage IIIB breast cancer|stage iiib breast cancer
527667|NCT00310089|stage IIIC breast cancer|stage iiic breast cancer
527668|NCT00310089|inflammatory breast cancer|inflammatory breast cancer
527669|NCT00310115|non-small cell lung cancer|non-small cell lung cancer
527670|NCT00310115|small cell lung cancer|small cell lung cancer
527671|NCT00310115|bladder cancer|bladder cancer
527672|NCT00310115|cervical cancer|cervical cancer
527673|NCT00310115|esophageal cancer|esophageal cancer
527674|NCT00310115|gastric cancer|gastric cancer
527675|NCT00310115|renal cell carcinoma|renal cell carcinoma
527676|NCT00310115|adult primary liver cancer|adult primary liver cancer
527677|NCT00310115|pancreatic cancer|pancreatic cancer
527678|NCT00310115|hypopharyngeal cancer|hypopharyngeal cancer
527679|NCT00310115|lip and oral cavity cancer|lip and oral cavity cancer
527680|NCT00310115|laryngeal cancer|laryngeal cancer
527681|NCT00310115|nasopharyngeal cancer|nasopharyngeal cancer
527682|NCT00310115|oropharyngeal cancer|oropharyngeal cancer
527683|NCT00310115|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
527684|NCT00310115|adult acute myeloid leukemia|adult acute myeloid leukemia
527685|NCT00310115|tobacco use disorder|tobacco use disorder
527686|NCT00310128|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
527687|NCT00310128|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
527688|NCT00310128|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
527689|NCT00310128|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
527690|NCT00310128|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
527691|NCT00310128|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
527692|NCT00310128|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
527693|NCT00310128|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
527694|NCT00310128|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
527695|NCT00310128|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
527696|NCT00310128|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
527697|NCT00310128|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
527698|NCT00310128|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
527699|NCT00310128|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
527700|NCT00310128|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
527701|NCT00310128|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
527702|NCT00310128|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
527703|NCT00310128|contiguous stage II adult Burkitt's lymphoma|contiguous stage ii adult burkitt's lymphoma
527704|NCT00310128|noncontiguous stage II adult Burkitt's lymphoma|noncontiguous stage ii adult burkitt's lymphoma
527705|NCT00310128|recurrent adult Burkitt's lymphoma|recurrent adult burkitt's lymphoma
527706|NCT00310128|stage I adult Burkitt's lymphoma|stage i adult burkitt's lymphoma
527707|NCT00310128|stage III adult Burkitt's lymphoma|stage iii adult burkitt's lymphoma
527708|NCT00310128|stage IV adult Burkitt's lymphoma|stage iv adult burkitt's lymphoma
527709|NCT00310128|anaplastic large cell lymphoma|anaplastic large cell lymphoma
528490|NCT00319137|GW274150|gw274150
527710|NCT00310128|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
527711|NCT00310128|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
527712|NCT00310128|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
527713|NCT00310128|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
527714|NCT00310128|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
527715|NCT00310128|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
527716|NCT00310128|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
527717|NCT00310128|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
527718|NCT00310128|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
527719|NCT00310128|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
527720|NCT00310128|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
527721|NCT00310128|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
527722|NCT00310128|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
527723|NCT00310128|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
527724|NCT00310128|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
527725|NCT00310128|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
527726|NCT00310128|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
527727|NCT00310128|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
527728|NCT00310141|non-small cell lung cancer|non-small cell lung cancer
527729|NCT00310141|small cell lung cancer|small cell lung cancer
527119|NCT00300417|West Nile Fever|west nile fever
527730|NCT00310154|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
527731|NCT00310154|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
527732|NCT00310154|adenosquamous cell lung cancer|adenosquamous cell lung cancer
527733|NCT00310154|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
527734|NCT00310154|large cell lung cancer|large cell lung cancer
527735|NCT00310154|squamous cell lung cancer|squamous cell lung cancer
527736|NCT00310154|adenocarcinoma of the lung|adenocarcinoma of the lung
527737|NCT00310167|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
527738|NCT00310167|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
527739|NCT00310167|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
527740|NCT00310167|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
527741|NCT00310167|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
527742|NCT00310167|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
527743|NCT00310167|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
527744|NCT00310167|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
527745|NCT00310167|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
527746|NCT00310167|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
527747|NCT00310167|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
527748|NCT00310167|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
527749|NCT00310167|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
527750|NCT00310167|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
527751|NCT00310167|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
527752|NCT00310167|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
527753|NCT00310167|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
527754|NCT00310167|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
527755|NCT00310167|Marginal zone lymphoma|marginal zone lymphoma
527756|NCT00310206|Influenza, pandemic, H5N1, vaccine|influenza, pandemic, h5n1, vaccine
527757|NCT00310219|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
527758|NCT00310219|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
527759|NCT00310219|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
527760|NCT00310219|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
527761|NCT00310232|Quality of Life|quality of life
527762|NCT00310232|Blood transfusion|blood transfusion
527763|NCT00310245|CD4-guided STI|cd4-guided sti
527764|NCT00310245|Keywords:|keywords:
527766|NCT00310245|Clinical outcome|clinical outcome
527767|NCT00310245|Resistance|resistance
527768|NCT00310245|Costs|costs
527769|NCT00310245|Prognostic factors|prognostic factors
527770|NCT00310245|pulse therapy|pulse therapy
527771|NCT00310245|treatment experienced|treatment experienced
527772|NCT00310245|treatment interruption|treatment interruption
527773|NCT00310271|DNA vaccine, immunotherapy, HSV-2, PMED|dna vaccine, immunotherapy, hsv-2, pmed
527774|NCT00310284|Insomnia|insomnia
527775|NCT00310284|Sleep|sleep
527776|NCT00310310|Continuous positive airway pressure|continuous positive airway pressure
527777|NCT00310310|Patient compliance|patient compliance
527778|NCT00310310|Self-care|self-care
527779|NCT00310323|sleep apnea|sleep apnea
527784|NCT00310349|pneumococcal vaccine|pneumococcal vaccine
527785|NCT00310349|clinical trial|clinical trial
527786|NCT00310349|Indigenous|indigenous
527787|NCT00310349|Maternal|maternal
527788|NCT00310349|Streptococcus pneumoniae|streptococcus pneumoniae
527789|NCT00310362|telephone|telephone
527790|NCT00310362|telemedicine|telemedicine
527791|NCT00310362|mass screening|mass screening
527792|NCT00310362|patient education|patient education
527793|NCT00310362|Patient compliance|patient compliance
527794|NCT00310375|Epilepsy|epilepsy
527795|NCT00310375|Partial Seizures|partial seizures
527796|NCT00310375|Potassium Channels|potassium channels
527797|NCT00310375|Anticonvulsant|anticonvulsant
527798|NCT00310375|Complex Partial Seizures|complex partial seizures
527799|NCT00310375|Epilepsies, Partial|epilepsies, partial
527800|NCT00310375|RTG115098|rtg115098
527801|NCT00310388|Partial Seizures|partial seizures
527802|NCT00310388|Epilepsy|epilepsy
527803|NCT00310388|RTG115097|rtg115097
527804|NCT00310388|Complex Partial Seizures|complex partial seizures
527805|NCT00310388|Anticonvulsant|anticonvulsant
527806|NCT00310388|Potassium Channels|potassium channels
527807|NCT00310388|Epilepsies, Partial|epilepsies, partial
527808|NCT00310401|brain death|brain death
527809|NCT00310401|organ donor|organ donor
527810|NCT00310401|pulmonary edema|pulmonary edema
527811|NCT00310401|albuterol|albuterol
527812|NCT00310401|hypoxia|hypoxia
527813|NCT00310401|lung transplantation|lung transplantation
527814|NCT00310401|infiltrates|infiltrates
527815|NCT00310414|Imaging Studies|imaging studies
527816|NCT00310414|Botulinum Toxin|botulinum toxin
527817|NCT00310414|Writer's Cramp|writer's cramp
527818|NCT00310414|Focal Hand Dystonia|focal hand dystonia
527819|NCT00310414|FHD|fhd
527820|NCT00310414|Writer Cramp|writer cramp
527821|NCT00310414|Healthy Volunteer|healthy volunteer
527822|NCT00310414|HV|hv
527823|NCT00310427|Anxiety|anxiety
527824|NCT00310427|Alcohol Dependence|alcohol dependence
527825|NCT00310427|Alcoholism|alcoholism
527826|NCT00310440|Degenerative disc disease|degenerative disc disease
527827|NCT00310440|P-15 Bone Putty|p-15 bone putty
527828|NCT00310440|Bone graft|bone graft
527829|NCT00310440|Cervical discectomy|cervical discectomy
527830|NCT00310440|Cervical spine|cervical spine
527831|NCT00310479|Magnetic Resonance Imaging|magnetic resonance imaging
527832|NCT00310479|prostate cancer imaging|prostate cancer imaging
527833|NCT00310479|3T MRS|3t mrs
527834|NCT00310479|functional imaging|functional imaging
527835|NCT00310505|visceral leishmaniasis|visceral leishmaniasis
527836|NCT00310505|amphotericin B|amphotericin b
527837|NCT00310505|Kala-azar|kala-azar
527838|NCT00310570|distal|distal
527839|NCT00310570|interphalangeal|interphalangeal
527840|NCT00310570|extensor tendon|extensor tendon
527841|NCT00310570|avulsion|avulsion
527842|NCT00310583|tactile hyperalgesia|tactile hyperalgesia
527843|NCT00310583|neuropathic pain|neuropathic pain
527844|NCT00310583|enriched design|enriched design
527845|NCT00310583|peripheral nerve lesion|peripheral nerve lesion
527846|NCT00310583|plexus lesion|plexus lesion
527847|NCT00310583|radicular lesion|radicular lesion
527848|NCT00310583|spinal lesion|spinal lesion
527849|NCT00310583|polyneuropathy|polyneuropathy
527850|NCT00310583|postzosteric neuralgia|postzosteric neuralgia
527851|NCT00310596|ECG safety|ecg safety
583548|NCT00512122|critical illness|critical illness
527852|NCT00310609|Structural abnormalities of the aortic arch and cerebral branches|structural abnormalities of the aortic arch and cerebral branches
527853|NCT00297648|Certolizumab pegol|certolizumab pegol
527854|NCT00297648|Crohn's disease|crohn's disease
527855|NCT00297648|Mucosal healing|mucosal healing
527856|NCT00297661|Coronary Revascularization|coronary revascularization
527981|NCT00303641|Cardiopulmonary bypass|cardiopulmonary bypass
527857|NCT00297661|Sirolimus-eluting stents|sirolimus-eluting stents
527858|NCT00297661|Paclitaxel-eluting stents|paclitaxel-eluting stents
527859|NCT00297674|clarithromycin|clarithromycin
527860|NCT00297674|sepsis|sepsis
527861|NCT00297674|immunomodulation|immunomodulation
527862|NCT00297687|Vaccines|vaccines
527863|NCT00297687|Healthy Adults|healthy adults
527864|NCT00297687|Health|health
527865|NCT00297687|Adult|adult
527866|NCT00297687|Meningococcal Vaccines|meningococcal vaccines
527867|NCT00297700|Smoking|smoking
527868|NCT00297700|Dental|dental
527869|NCT00297700|Cessation|cessation
527870|NCT00297700|Prevention|prevention
527871|NCT00297700|Control|control
527872|NCT00297700|Quitline|quitline
527873|NCT00297700|5A-Model|5a-model
527874|NCT00297700|Cost-effective|cost-effective
527875|NCT00297726|Osteoarthritis, Knee|osteoarthritis, knee
527876|NCT00297726|Osteoarthritis, Hip|osteoarthritis, hip
527877|NCT00297726|Osteoarthritis, Ankle|osteoarthritis, ankle
527878|NCT00297726|Arthritis|arthritis
527879|NCT00297726|Self-Management|self-management
527880|NCT00297739|Aggression|aggression
527881|NCT00297739|ADHD|adhd
527882|NCT00297739|Antipsychotic|antipsychotic
527883|NCT00297752|facial burns|facial burns
527884|NCT00297752|cerium flammazine|cerium flammazine
527885|NCT00297752|quality of life|quality of life
527886|NCT00297752|randomised clinical trial|randomised clinical trial
527887|NCT00297765|Renal Transplantation|renal transplantation
527888|NCT00297765|Therapeutics|therapeutics
527889|NCT00297765|Treatment Outcome|treatment outcome
527890|NCT00297765|Safety|safety
527891|NCT00297791|rectal cancer|rectal cancer
527892|NCT00297791|laparoscopic technique|laparoscopic technique
527893|NCT00297791|open technique|open technique
527894|NCT00297791|clinical trial|clinical trial
527895|NCT00297791|multicenter study|multicenter study
527896|NCT00297791|randomized controlled trial|randomized controlled trial
527897|NCT00297791|Tumor Below 15cm|tumor below 15cm
527898|NCT00297791|curative surgical resection|curative surgical resection
527899|NCT00297791|no evidence for distant metastases|no evidence for distant metastases
527900|NCT00297804|Coronary Artery Disease|coronary artery disease
527901|NCT00297804|Percutaneous Coronary Intervention|percutaneous coronary intervention
527902|NCT00297804|Stent Implant|stent implant
527903|NCT00297804|Drug-coated Stent|drug-coated stent
527904|NCT00297817|Meningococcal Disease; Meningococcal Meningitis; Vaccine|meningococcal disease; meningococcal meningitis; vaccine
527905|NCT00297830|Heart Transplantation|heart transplantation
527906|NCT00297830|Liver Transplantation|liver transplantation
527907|NCT00297830|Immunosuppression|immunosuppression
527908|NCT00297830|Bone Density/drug effects|bone density/drug effects
527909|NCT00297830|Alendronate|alendronate
527910|NCT00297830|Zoledronic acid|zoledronic acid
527911|NCT00297830|Comparative study|comparative study
527912|NCT00297830|Humans|humans
527913|NCT00297856|Boostrix|boostrix
527914|NCT00297882|Efficacy|efficacy
527915|NCT00297882|Safety|safety
527916|NCT00297882|Children|children
527917|NCT00297882|Cameroon|cameroon
527918|NCT00297895|sentinel lymph node dissection|sentinel lymph node dissection
527919|NCT00297895|complete lymph node dissection|complete lymph node dissection
527920|NCT00297895|surgical|surgical
527921|NCT00297908|Ethanol levels|ethanol levels
527922|NCT00297908|Dermal absorbtion|dermal absorbtion
527923|NCT00297934|dual-task|dual-task
527924|NCT00297934|postural control|postural control
527925|NCT00297934|cognitive|cognitive
527926|NCT00297947|schizophrenia|schizophrenia
527927|NCT00297947|quetiapine|quetiapine
527928|NCT00297947|schizoaffective disorder|schizoaffective disorder
527929|NCT00298012|Methotrexate|methotrexate
527930|NCT00298012|Magnetic Resonance Imaging|magnetic resonance imaging
527931|NCT00298012|Anterior uveitis|anterior uveitis
527932|NCT00298025|Infertility|infertility
527933|NCT00298025|Cetrotide|cetrotide
527934|NCT00298025|Antagon|antagon
527935|NCT00298025|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
527936|NCT00298025|Human Menopausal Gonadotropin (hMG)|human menopausal gonadotropin (hmg)
527937|NCT00298025|Recombinant Human Choriogonadotropin (r-hCG)|recombinant human choriogonadotropin (r-hcg)
527938|NCT00303446|Motor Neuron|motor neuron
527939|NCT00303446|Androgen Receptor|androgen receptor
527940|NCT00303446|Polyglutamine|polyglutamine
527941|NCT00303446|X-Linked|x-linked
527942|NCT00303446|Ligand Dependency|ligand dependency
527943|NCT00303446|Spinal and Bulbar Muscular Atrophy|spinal and bulbar muscular atrophy
527944|NCT00303446|SBMA|sbma
527945|NCT00303446|Kennedy Disease|kennedy disease
527946|NCT00303459|sildenafil|sildenafil
527947|NCT00303459|Combination Drug Therapy|combination drug therapy
527948|NCT00303459|bosentan|bosentan
527949|NCT00303459|Pulmonary Hypertension|pulmonary hypertension
527950|NCT00303459|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
527951|NCT00303459|Multicenter Study|multicenter study
527952|NCT00303459|Antihypertensive Agents|antihypertensive agents
527953|NCT00303459|Tracleer|tracleer
527954|NCT00303459|endothelin receptor antagonist|endothelin receptor antagonist
527955|NCT00303459|Randomized Controlled Trial|randomized controlled trial
527956|NCT00303459|Phosphodiesterase type 5 inhibitor (PDE5i)|phosphodiesterase type 5 inhibitor (pde5i)
527957|NCT00303459|Outcome Assessment|outcome assessment
527958|NCT00303472|MDS|mds
527959|NCT00303472|Myelodysplastic Syndromes|myelodysplastic syndromes
527960|NCT00303472|Refractory Cytopenias|refractory cytopenias
527961|NCT00303472|Thrombocytopenia|thrombocytopenia
527962|NCT00303511|adult|adult
527963|NCT00303511|pacemaker|pacemaker
527964|NCT00303511|bradycardia|bradycardia
527965|NCT00303511|tachycardia|tachycardia
527966|NCT00303511|heart failure|heart failure
527967|NCT00303537|hepatitis|hepatitis
527968|NCT00303537|metformin|metformin
527969|NCT00303537|non-alcoholic fatty liver (NAFLD)|non-alcoholic fatty liver (nafld)
527970|NCT00303537|non-alcoholic steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
527971|NCT00303537|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
527972|NCT00303550|skin infection|skin infection
527973|NCT00303550|complicated skin infection|complicated skin infection
527974|NCT00303550|skin structure infection|skin structure infection
527975|NCT00303550|Complicated Skin and Skin Structure Infection|complicated skin and skin structure infection
527976|NCT00303576|HIV-1|hiv-1
527977|NCT00303576|HIV Seronegativity|hiv seronegativity
527978|NCT00303615|ER (-) and PR (-)|er (-) and pr (-)
527979|NCT00303628|Rectal cancer|rectal cancer
527982|NCT00303641|Inflammatory reaction|inflammatory reaction
527983|NCT00303654|recurrent bladder cancer|recurrent bladder cancer
527984|NCT00303654|stage I bladder cancer|stage i bladder cancer
527985|NCT00303654|stage II bladder cancer|stage ii bladder cancer
527986|NCT00303654|stage III bladder cancer|stage iii bladder cancer
527987|NCT00303654|stage IV bladder cancer|stage iv bladder cancer
527988|NCT00303667|NK cells|nk cells
527989|NCT00303667|natural killer cells|natural killer cells
527990|NCT00303667|immunotherapy|immunotherapy
527991|NCT00303667|hematopoietic cell transplant|hematopoietic cell transplant
527992|NCT00303667|acute myelogenous leukemia|acute myelogenous leukemia
527993|NCT00303706|CABG, Endoscopic, Radial Artery|cabg, endoscopic, radial artery
527994|NCT00303706|Radial Artery Conduit|radial artery conduit
527995|NCT00303706|Coronary Artery Bypass Surgery|coronary artery bypass surgery
527996|NCT00303706|Endoscopic technique|endoscopic technique
527997|NCT00303719|leukemia|leukemia
527998|NCT00303719|lymphoma|lymphoma
527999|NCT00303719|myeloma|myeloma
528000|NCT00303732|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
528001|NCT00303732|recurrent renal cell cancer|recurrent renal cell cancer
528002|NCT00303732|stage IV renal cell cancer|stage iv renal cell cancer
528003|NCT00303745|adenocarcinoma of the colon|adenocarcinoma of the colon
528004|NCT00303745|recurrent colon cancer|recurrent colon cancer
528005|NCT00303745|stage IV colon cancer|stage iv colon cancer
528006|NCT00303745|adenocarcinoma of the rectum|adenocarcinoma of the rectum
528007|NCT00303745|recurrent rectal cancer|recurrent rectal cancer
528008|NCT00303745|stage IV rectal cancer|stage iv rectal cancer
528009|NCT00303758|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
528010|NCT00303758|recurrent pancreatic cancer|recurrent pancreatic cancer
528011|NCT00303758|stage IV pancreatic cancer|stage iv pancreatic cancer
528012|NCT00303771|adenocarcinoma of the rectum|adenocarcinoma of the rectum
528013|NCT00303771|stage IV rectal cancer|stage iv rectal cancer
528014|NCT00303771|stage IV colon cancer|stage iv colon cancer
528015|NCT00303771|adenocarcinoma of the colon|adenocarcinoma of the colon
528016|NCT00303771|recurrent colon cancer|recurrent colon cancer
528017|NCT00303771|recurrent rectal cancer|recurrent rectal cancer
528018|NCT00303784|hot flashes|hot flashes
528019|NCT00303784|anemia|anemia
528020|NCT00303784|osteoporosis|osteoporosis
528021|NCT00303784|cardiovascular complications|cardiovascular complications
528022|NCT00303784|recurrent prostate cancer|recurrent prostate cancer
528023|NCT00303784|stage III prostate cancer|stage iii prostate cancer
528024|NCT00303784|stage IV prostate cancer|stage iv prostate cancer
528025|NCT00303784|adenocarcinoma of the prostate|adenocarcinoma of the prostate
528026|NCT00303810|childhood infratentorial ependymoma|childhood infratentorial ependymoma
528027|NCT00303810|childhood supratentorial ependymoma|childhood supratentorial ependymoma
528028|NCT00303810|untreated childhood medulloblastoma|untreated childhood medulloblastoma
528029|NCT00303810|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
528030|NCT00303810|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
528031|NCT00303875|recurrent prostate cancer|recurrent prostate cancer
528032|NCT00303875|stage I prostate cancer|stage i prostate cancer
528033|NCT00303875|stage IIB prostate cancer|stage iib prostate cancer
528034|NCT00303875|stage IIA prostate cancer|stage iia prostate cancer
528035|NCT00303875|stage III prostate cancer|stage iii prostate cancer
528036|NCT00303875|stage IV prostate cancer|stage iv prostate cancer
528037|NCT00303875|recurrent breast cancer|recurrent breast cancer
528038|NCT00303875|stage I breast cancer|stage i breast cancer
528039|NCT00303875|stage II breast cancer|stage ii breast cancer
528040|NCT00303875|stage IIIA breast cancer|stage iiia breast cancer
528041|NCT00303875|stage IIIB breast cancer|stage iiib breast cancer
528042|NCT00303875|stage IIIC breast cancer|stage iiic breast cancer
528043|NCT00303875|stage IV breast cancer|stage iv breast cancer
528044|NCT00303875|recurrent colon cancer|recurrent colon cancer
528045|NCT00303875|stage I colon cancer|stage i colon cancer
528046|NCT00303875|stage II colon cancer|stage ii colon cancer
528047|NCT00303875|stage III colon cancer|stage iii colon cancer
528048|NCT00303875|stage IV colon cancer|stage iv colon cancer
528049|NCT00303875|recurrent rectal cancer|recurrent rectal cancer
528050|NCT00303875|stage I rectal cancer|stage i rectal cancer
528051|NCT00303875|stage II rectal cancer|stage ii rectal cancer
528052|NCT00303875|stage III rectal cancer|stage iii rectal cancer
528053|NCT00303875|stage IV rectal cancer|stage iv rectal cancer
528054|NCT00303888|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
528055|NCT00303888|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
528056|NCT00303888|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
528057|NCT00303888|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
528058|NCT00303888|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
528059|NCT00303888|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
528060|NCT00303888|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
528061|NCT00303888|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
528062|NCT00303888|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
528584|NCT00319488|Wheezing|wheezing
528063|NCT00303888|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
528064|NCT00303888|recurrent fallopian tube cancer|recurrent fallopian tube cancer
528065|NCT00303888|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
528066|NCT00303888|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
528067|NCT00303888|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
528068|NCT00303888|stage IV fallopian tube cancer|stage iv fallopian tube cancer
528069|NCT00303901|lung metastases|lung metastases
528070|NCT00303901|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
528071|NCT00303901|recurrent small cell lung cancer|recurrent small cell lung cancer
528072|NCT00303901|stage I non-small cell lung cancer|stage i non-small cell lung cancer
528073|NCT00303901|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
528074|NCT00303901|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
528075|NCT00303901|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
528076|NCT00303901|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
528077|NCT00303901|extensive stage small cell lung cancer|extensive stage small cell lung cancer
528078|NCT00303901|limited stage small cell lung cancer|limited stage small cell lung cancer
528079|NCT00303901|pulmonary carcinoid tumor|pulmonary carcinoid tumor
528081|NCT00303914|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
528082|NCT00303914|cognitive/functional effects|cognitive/functional effects
528083|NCT00303914|recurrent breast cancer|recurrent breast cancer
528084|NCT00303914|stage I breast cancer|stage i breast cancer
528085|NCT00303914|stage II breast cancer|stage ii breast cancer
527562|NCT00309738|KRE|kre
528086|NCT00303914|stage IIIA breast cancer|stage iiia breast cancer
528087|NCT00303914|stage IIIB breast cancer|stage iiib breast cancer
528088|NCT00303914|stage IIIC breast cancer|stage iiic breast cancer
528089|NCT00303914|stage IV breast cancer|stage iv breast cancer
528090|NCT00303914|recurrent colon cancer|recurrent colon cancer
528091|NCT00303914|stage I colon cancer|stage i colon cancer
528092|NCT00303914|stage II colon cancer|stage ii colon cancer
528093|NCT00303914|stage III colon cancer|stage iii colon cancer
528094|NCT00303914|stage IV colon cancer|stage iv colon cancer
528095|NCT00303914|recurrent rectal cancer|recurrent rectal cancer
528096|NCT00303914|stage I rectal cancer|stage i rectal cancer
528097|NCT00303914|stage II rectal cancer|stage ii rectal cancer
528098|NCT00303914|stage III rectal cancer|stage iii rectal cancer
528099|NCT00303914|stage IV rectal cancer|stage iv rectal cancer
528100|NCT00303914|extensive stage small cell lung cancer|extensive stage small cell lung cancer
528101|NCT00303914|limited stage small cell lung cancer|limited stage small cell lung cancer
528102|NCT00303914|recurrent small cell lung cancer|recurrent small cell lung cancer
528103|NCT00303914|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
528104|NCT00303914|stage I non-small cell lung cancer|stage i non-small cell lung cancer
528105|NCT00303914|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
528106|NCT00303914|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
528107|NCT00303914|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
528108|NCT00303914|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
528109|NCT00303914|recurrent prostate cancer|recurrent prostate cancer
528110|NCT00303914|stage I prostate cancer|stage i prostate cancer
528111|NCT00303914|stage IIB prostate cancer|stage iib prostate cancer
528112|NCT00303914|stage IIA prostate cancer|stage iia prostate cancer
528113|NCT00303914|stage III prostate cancer|stage iii prostate cancer
528114|NCT00303914|stage IV prostate cancer|stage iv prostate cancer
528115|NCT00303914|male breast cancer|male breast cancer
528116|NCT00303914|pulmonary carcinoid tumor|pulmonary carcinoid tumor
528117|NCT00303927|recurrent pancreatic cancer|recurrent pancreatic cancer
528118|NCT00303927|stage IV pancreatic cancer|stage iv pancreatic cancer
528119|NCT00303940|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
528120|NCT00303940|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
528121|NCT00303940|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
528122|NCT00303940|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
528123|NCT00303940|recurrent osteosarcoma|recurrent osteosarcoma
528124|NCT00303940|recurrent neuroblastoma|recurrent neuroblastoma
528125|NCT00303940|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
528126|NCT00303940|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
528127|NCT00303940|recurrent childhood liver cancer|recurrent childhood liver cancer
528128|NCT00303940|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
528129|NCT00303940|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
528130|NCT00303940|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
528131|NCT00303940|recurrent childhood ependymoma|recurrent childhood ependymoma
528132|NCT00303940|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
528133|NCT00303940|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
528134|NCT00303940|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
528135|NCT00303940|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
528136|NCT00303940|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
528137|NCT00303940|childhood choroid plexus tumor|childhood choroid plexus tumor
528138|NCT00303940|childhood craniopharyngioma|childhood craniopharyngioma
528139|NCT00303940|childhood infratentorial ependymoma|childhood infratentorial ependymoma
528140|NCT00303940|childhood supratentorial ependymoma|childhood supratentorial ependymoma
528141|NCT00303940|childhood oligodendroglioma|childhood oligodendroglioma
528142|NCT00303940|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
528143|NCT00303940|recurrent childhood brain tumor|recurrent childhood brain tumor
528144|NCT00303940|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
528145|NCT00303940|childhood grade I meningioma|childhood grade i meningioma
528146|NCT00303940|childhood grade II meningioma|childhood grade ii meningioma
528147|NCT00303940|childhood grade III meningioma|childhood grade iii meningioma
528148|NCT00303940|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
528149|NCT00303940|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
528150|NCT00303940|childhood teratoma|childhood teratoma
528151|NCT00303979|Systolic Heart Failure|systolic heart failure
528152|NCT00303979|Quality of Care|quality of care
528153|NCT00303979|Outcomes|outcomes
528154|NCT00303979|Evidence-based Guidelines|evidence-based guidelines
528155|NCT00303979|Recommended Therapies|recommended therapies
528156|NCT00303992|stage IV breast cancer|stage iv breast cancer
528157|NCT00303992|recurrent breast cancer|recurrent breast cancer
528158|NCT00304005|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
528159|NCT00304005|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
528160|NCT00304005|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
528161|NCT00304018|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
528162|NCT00304018|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
528163|NCT00304018|secondary acute myeloid leukemia|secondary acute myeloid leukemia
528164|NCT00304018|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
528165|NCT00304018|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
528166|NCT00304018|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
528167|NCT00304018|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
528168|NCT00304018|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
528169|NCT00304018|refractory multiple myeloma|refractory multiple myeloma
528170|NCT00304018|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
528171|NCT00304018|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
528172|NCT00304018|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
528173|NCT00304018|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
528174|NCT00304018|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
528175|NCT00304018|stage II multiple myeloma|stage ii multiple myeloma
528176|NCT00304018|stage III multiple myeloma|stage iii multiple myeloma
528177|NCT00304018|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
528178|NCT00304018|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
528179|NCT00304018|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
528180|NCT00304018|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
528181|NCT00304018|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
528182|NCT00304018|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
528183|NCT00304018|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
528184|NCT00304018|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
528185|NCT00304018|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
528186|NCT00304018|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
528187|NCT00304018|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
528188|NCT00304018|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
528308|NCT00304655|Schizophrenia|schizophrenia
528189|NCT00304018|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
528190|NCT00304018|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
528191|NCT00304018|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
528192|NCT00304018|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
528193|NCT00304018|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
528194|NCT00304018|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
528195|NCT00304018|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
528196|NCT00304018|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
528197|NCT00304018|stage I multiple myeloma|stage i multiple myeloma
528198|NCT00304031|adult glioblastoma|adult glioblastoma
528199|NCT00304031|adult giant cell glioblastoma|adult giant cell glioblastoma
528200|NCT00304031|adult gliosarcoma|adult gliosarcoma
528201|NCT00304083|adult neurofibrosarcoma|adult neurofibrosarcoma
528202|NCT00304083|childhood neurofibrosarcoma|childhood neurofibrosarcoma
528203|NCT00304083|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
528689|NCT00319943|training|training
528204|NCT00304083|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
528400|NCT00310856|vaccine|vaccine
528205|NCT00304083|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
528206|NCT00304083|neurofibromatosis type 1|neurofibromatosis type 1
528207|NCT00304096|recurrent breast cancer|recurrent breast cancer
528208|NCT00304096|stage IIIA breast cancer|stage iiia breast cancer
528209|NCT00304096|stage IIIB breast cancer|stage iiib breast cancer
528210|NCT00304096|stage IIIC breast cancer|stage iiic breast cancer
528211|NCT00304096|stage IV breast cancer|stage iv breast cancer
528212|NCT00304096|male breast cancer|male breast cancer
528213|NCT00304096|invasive lobular breast carcinoma|invasive lobular breast carcinoma
528214|NCT00304135|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
528215|NCT00304135|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
528216|NCT00304135|unresectable gallbladder cancer|unresectable gallbladder cancer
528217|NCT00304148|Renal Insufficiency Chronic|renal insufficiency chronic
528218|NCT00304161|Depression|depression
528219|NCT00304161|Parkinson's Disease|parkinson's disease
528220|NCT00304161|Atomoxetine|atomoxetine
528221|NCT00304187|Binge-Eating Disorder|binge-eating disorder
528222|NCT00304200|Metastatic Malignant Melanoma|metastatic malignant melanoma
528223|NCT00304213|hypogonadism|hypogonadism
528224|NCT00304213|testosterone|testosterone
528225|NCT00304213|aging|aging
528226|NCT00304213|Total testosterone < 300 ng/dL|total testosterone < 300 ng/dl
527781|NCT00310323|cytochrome P450|cytochrome p450
528227|NCT00304213|Bioavailable testosterone < 70 ng/dL|bioavailable testosterone < 70 ng/dl
528228|NCT00304226|Valsartan,|valsartan,
528229|NCT00304226|amlodipine,|amlodipine,
528230|NCT00304226|hydrochlorothiazide|hydrochlorothiazide
528231|NCT00304239|Methyl aminolevulinate|methyl aminolevulinate
528232|NCT00304239|Photodynamic therapy|photodynamic therapy
528233|NCT00304239|Aktilite CL128 LED light source|aktilite cl128 led light source
528234|NCT00304239|Multiple Actinic Keratosis|multiple actinic keratosis
528235|NCT00304265|Pertussis,|pertussis,
528236|NCT00304265|Diphtheria,|diphtheria,
528237|NCT00304265|Tetanus,|tetanus,
528238|NCT00304265|Poliomyelitis|poliomyelitis
528239|NCT00304278|Head and Neck Cancer|head and neck cancer
528240|NCT00304278|Erlotinib|erlotinib
528241|NCT00304278|RADPLAT|radplat
528242|NCT00304291|Novantrone|novantrone
528243|NCT00304304|child care centers|child care centers
528244|NCT00304304|asthma triggers|asthma triggers
528245|NCT00304304|community-based research|community-based research
528246|NCT00304317|calculi|calculi
528247|NCT00304317|ureteral calculi|ureteral calculi
528248|NCT00304317|ureter|ureter
528249|NCT00304330|gram negative infection|gram negative infection
528250|NCT00304356|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
528251|NCT00304369|Clostridium difficile|clostridium difficile
528252|NCT00304382|Pneumococcus|pneumococcus
528253|NCT00304382|Pneumococcal pneumonia|pneumococcal pneumonia
751952|NCT01171339|multimorbidity|multimorbidity
528254|NCT00304395|Community Acquired Pneumonia|community acquired pneumonia
528255|NCT00304395|CAP|cap
528256|NCT00304408|Clostridium difficile|clostridium difficile
528257|NCT00304421|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
528258|NCT00304421|Proton Pump Inhibitors|proton pump inhibitors
528259|NCT00304421|Gastric pH|gastric ph
528260|NCT00304421|Gastric Acid Secretion|gastric acid secretion
528261|NCT00304434|Adverse effects|adverse effects
528262|NCT00304434|Antiviral|antiviral
528263|NCT00304434|Clinical trial|clinical trial
528264|NCT00304434|Oseltamivir|oseltamivir
528265|NCT00304434|Pharmacokinetics|pharmacokinetics
528266|NCT00304434|Probenecid|probenecid
528267|NCT00304447|Leukemia|leukemia
528268|NCT00304447|Mylotarg|mylotarg
528269|NCT00304447|Safety|safety
528270|NCT00304447|Adverse Events|adverse events
528271|NCT00304460|Serum Protein Levels|serum protein levels
528272|NCT00304460|Lymphocyte Phenotypes|lymphocyte phenotypes
528273|NCT00304460|Predictive Analysis|predictive analysis
528274|NCT00304460|Serum Cytokines|serum cytokines
528275|NCT00304460|Kidney Cancer|kidney cancer
528276|NCT00304460|Renal Cell Cancer|renal cell cancer
528277|NCT00304460|Melanoma|melanoma
528278|NCT00304460|Metastatic Melanoma|metastatic melanoma
528279|NCT00304473|Schizophrenia|schizophrenia
528280|NCT00304499|OROS®|oros®
528281|NCT00304499|middle age|middle age
528282|NCT00304499|elderly|elderly
528283|NCT00304499|oxybutynin|oxybutynin
528284|NCT00304499|urinary incontinenence|urinary incontinenence
528285|NCT00304499|women|women
528286|NCT00304525|Anti-angiogenesis therapy|anti-angiogenesis therapy
528287|NCT00304525|Kinase inhibitor therapy|kinase inhibitor therapy
528288|NCT00304525|Raf inhibitor|raf inhibitor
528289|NCT00304525|Locally Advanced Melanoma|locally advanced melanoma
528290|NCT00304538|diabetes|diabetes
528291|NCT00304551|CHC with compensated LC|chc with compensated lc
528292|NCT00304564|Posturography, Fall Prevention, Geriatrics, Nolwenn Effect|posturography, fall prevention, geriatrics, nolwenn effect
528293|NCT00304577|Strabismus|strabismus
528294|NCT00304577|Esotropia|esotropia
528295|NCT00304577|Surgical techniques|surgical techniques
528296|NCT00304603|Obesity|obesity
528297|NCT00304603|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
528298|NCT00304603|Topiramate|topiramate
528299|NCT00304603|Pharmacogenomics|pharmacogenomics
528300|NCT00304603|DNA Polymorphism|dna polymorphism
528301|NCT00304616|Schizophrenia|schizophrenia
528302|NCT00304616|Aripiprazole|aripiprazole
528303|NCT00304629|Alzheimer's disease|alzheimer's disease
528304|NCT00304629|cholinesterase inhibitors|cholinesterase inhibitors
528305|NCT00304629|galantamine|galantamine
528306|NCT00304642|HIV-1|hiv-1
528307|NCT00304642|HIV Seronegativity|hiv seronegativity
528309|NCT00304655|Schizoaffective disorder|schizoaffective disorder
528310|NCT00304655|Aripiprazole|aripiprazole
528311|NCT00304668|HIV-1|hiv-1
528312|NCT00304668|HIV Seronegativity|hiv seronegativity
528313|NCT00304681|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
528314|NCT00304681|OROS* Methylphenidate|oros* methylphenidate
528315|NCT00304694|NPC|npc
528316|NCT00304694|Induction chemotherapy|induction chemotherapy
528317|NCT00304694|Therapeutic response|therapeutic response
528318|NCT00304694|18F-FDG PET|18f-fdg pet
528319|NCT00304720|Lymphoma|lymphoma
528320|NCT00304720|Leukemia|leukemia
528321|NCT00304733|neuropathic foot ulcerations - total contact cast - custom -made footwear - off-loading|neuropathic foot ulcerations - total contact cast - custom -made footwear - off-loading
528322|NCT00304759|prostate cancer|prostate cancer
528323|NCT00304759|localized prostate cancer|localized prostate cancer
528324|NCT00304759|intermediate risk|intermediate risk
528325|NCT00304759|prostate specific antigen|prostate specific antigen
528326|NCT00304759|PSA|psa
528327|NCT00304759|radiation fractionation|radiation fractionation
528328|NCT00304759|shorter schedule|shorter schedule
528329|NCT00304759|quality of life|quality of life
528330|NCT00304772|Candida|candida
528331|NCT00304772|bloodstream infection|bloodstream infection
528332|NCT00304772|fluconazole|fluconazole
528333|NCT00304772|micafungin|micafungin
528334|NCT00304772|randomized controlled trial|randomized controlled trial
528335|NCT00310622|HyperQ|hyperq
528336|NCT00310622|Ischemia|ischemia
528337|NCT00310622|dobutamine|dobutamine
528338|NCT00310635|Prevention of meningococcal infection|prevention of meningococcal infection
528339|NCT00310648|Influenza, elderly, vaccine|influenza, elderly, vaccine
528340|NCT00310661|sarizotan|sarizotan
528341|NCT00310661|neuroleptic-induced tardive dyskinesia|neuroleptic-induced tardive dyskinesia
528342|NCT00310674|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
528343|NCT00310674|meningococcal vaccines|meningococcal vaccines
528344|NCT00310674|conjugate|conjugate
528345|NCT00310674|Immunology|immunology
528346|NCT00310674|infant|infant
528347|NCT00310687|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
528348|NCT00310687|vaccines|vaccines
528349|NCT00310687|conjugate|conjugate
528350|NCT00310687|immunology|immunology
528351|NCT00310687|antibody persistence|antibody persistence
528352|NCT00310700|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
528353|NCT00310700|vaccines, conjugate|vaccines, conjugate
528354|NCT00310700|immunology|immunology
528355|NCT00310700|infant|infant
528356|NCT00310700|antibody persistence|antibody persistence
528357|NCT00310713|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
528358|NCT00310713|vaccines|vaccines
528359|NCT00310713|conjugate|conjugate
528360|NCT00310713|immunology|immunology
528361|NCT00310713|children|children
528362|NCT00310713|antibody persistence|antibody persistence
528363|NCT00310726|Mother to Child Transmission of HIV|mother to child transmission of hiv
528364|NCT00310726|Postnatal HIV transmission|postnatal hiv transmission
528365|NCT00310726|HIV|hiv
528366|NCT00310726|Breastfeeding|breastfeeding
528367|NCT00310726|Perinatal HIV Transmission|perinatal hiv transmission
528368|NCT00310726|HIV Seronegativity|hiv seronegativity
528369|NCT00310765|abdominal pain|abdominal pain
528370|NCT00310765|surgical adhesions|surgical adhesions
528371|NCT00310778|High sodium diet|high sodium diet
528372|NCT00310778|Low sodium diet|low sodium diet
528373|NCT00310778|Renin-angiotensin system blockers|renin-angiotensin system blockers
528374|NCT00310778|AT1 receptor (AT1R) antagonist|at1 receptor (at1r) antagonist
528375|NCT00310778|ACE inhibition|ace inhibition
528376|NCT00310791|anorexia nervosa|anorexia nervosa
528377|NCT00310791|adolescents|adolescents
528378|NCT00310791|dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
528379|NCT00310791|dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
528380|NCT00310791|osteoporosis|osteoporosis
528381|NCT00310804|Influenza|influenza
528382|NCT00310804|Flu|flu
528383|NCT00310804|Cell-Derived|cell-derived
528384|NCT00310804|Egg-Derived|egg-derived
528385|NCT00310804|Healthy Adults|healthy adults
528386|NCT00310804|Safety|safety
528387|NCT00310804|Immunogenicity|immunogenicity
528388|NCT00310804|Vaccination|vaccination
528389|NCT00310817|meningitis|meningitis
528390|NCT00310817|children|children
528391|NCT00310817|vaccine|vaccine
528392|NCT00310830|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
528393|NCT00310830|Pulmonary hypertension|pulmonary hypertension
528394|NCT00310830|Sickle Cell Disease|sickle cell disease
528395|NCT00310830|Sickle cell anemia|sickle cell anemia
528396|NCT00310830|ASSET|asset
528397|NCT00310830|ASSET-1|asset-1
528398|NCT00310856|meningitis|meningitis
528399|NCT00310856|children|children
528401|NCT00310869|Preterm Birth|preterm birth
528402|NCT00310869|Prematurity|prematurity
528403|NCT00310869|NIDCAP|nidcap
528404|NCT00310869|Adolescence|adolescence
528405|NCT00310869|Developmental Care|developmental care
528406|NCT00310869|Follow-up|follow-up
528407|NCT00310869|Neurobehavior|neurobehavior
528408|NCT00310882|breast cancer|breast cancer
528409|NCT00310882|digitalis like compounds|digitalis like compounds
528410|NCT00310882|prognostic factor|prognostic factor
528411|NCT00310895|Refractory|refractory
528412|NCT00310895|Relapsed|relapsed
528413|NCT00310908|Renal|renal
528414|NCT00310908|Colic|colic
528415|NCT00310908|Calculi|calculi
528416|NCT00310908|Treatment|treatment
528417|NCT00310934|heroin dependence|heroin dependence
528418|NCT00310934|methadone|methadone
528419|NCT00310934|buprenorphine|buprenorphine
528420|NCT00310934|contingency management|contingency management
528421|NCT00310934|relapse prevention|relapse prevention
528422|NCT00310947|Coronary artery disease|coronary artery disease
528423|NCT00310947|Coronary flow reserve|coronary flow reserve
528424|NCT00310947|Heart failure|heart failure
528425|NCT00310947|prospective randomised|prospective randomised
528426|NCT00318799|prevention of unintended pregnancies|prevention of unintended pregnancies
528427|NCT00318812|Randomized controlled trial (RCT)|randomized controlled trial (rct)
528428|NCT00318812|Prospective Studies|prospective studies
528429|NCT00318812|ferric oxide, saccharated|ferric oxide, saccharated
528430|NCT00318812|Peptides|peptides
528431|NCT00318812|Heme|heme
528432|NCT00318812|Iron|iron
528433|NCT00318812|Erythropoietin,|erythropoietin,
528434|NCT00318812|Recombinant|recombinant
528435|NCT00318812|Ferritin|ferritin
528436|NCT00318812|Transferrin|transferrin
528437|NCT00318812|Treatment Outcome|treatment outcome
528438|NCT00318825|Pain|pain
528439|NCT00318825|Colonoscopy|colonoscopy
528440|NCT00318825|Sedation|sedation
528441|NCT00318851|Carotid Artery stenting|carotid artery stenting
528442|NCT00318851|Stroke|stroke
528443|NCT00318864|depression|depression
528444|NCT00318864|cardiovascular risk|cardiovascular risk
528445|NCT00318864|mechanisms|mechanisms
528446|NCT00318877|Obesity|obesity
528447|NCT00318877|Physical activity|physical activity
528448|NCT00318890|Chemotherapy and Radiotherapy for Head and Neck Cancer|chemotherapy and radiotherapy for head and neck cancer
528449|NCT00318890|Chemotherapy, Radiotherapy Squamous Cell Carcinoma Head Neck|chemotherapy, radiotherapy squamous cell carcinoma head neck
528450|NCT00318903|Chemotherapy for cancer of the esophagus|chemotherapy for cancer of the esophagus
528451|NCT00318903|Radiotherapy for cancer of the esophagus|radiotherapy for cancer of the esophagus
528452|NCT00318903|Surgery for cancer of the esophagus|surgery for cancer of the esophagus
751953|NCT01171339|polypharmacy|polypharmacy
528453|NCT00318903|Chemotherapy, radiotherapy, surgery for esophageal cancer|chemotherapy, radiotherapy, surgery for esophageal cancer
528454|NCT00318929|Treatment Efficacy|treatment efficacy
528455|NCT00318929|pharmacokinetics|pharmacokinetics
528456|NCT00318942|Sepsis|sepsis
528457|NCT00318942|Multiple Trauma|multiple trauma
528458|NCT00318942|Hypovolemic Shock|hypovolemic shock
528459|NCT00318955|Dexmedetomidine, Sedation, Extubation, Phase 4|dexmedetomidine, sedation, extubation, phase 4
528460|NCT00318968|Acid Reflux|acid reflux
528461|NCT00318968|Nexium|nexium
528462|NCT00318968|Esomeprazole|esomeprazole
528463|NCT00318981|Medication trial|medication trial
528464|NCT00318981|ADHD|adhd
528465|NCT00318981|Concerta|concerta
528466|NCT00318981|Efficacy trial|efficacy trial
528467|NCT00319020|bosentan|bosentan
528468|NCT00319020|pulmonary arterial hypertension|pulmonary arterial hypertension
528469|NCT00319020|children|children
528470|NCT00319020|FUTURE 1|future 1
528471|NCT00319033|interstitial lung disease|interstitial lung disease
528472|NCT00319033|scleroderma|scleroderma
528473|NCT00319033|bosentan|bosentan
528474|NCT00319046|Type 1 Gaucher Disease|type 1 gaucher disease
528475|NCT00319046|miglustat|miglustat
528476|NCT00319046|enzyme replacement therapy|enzyme replacement therapy
528477|NCT00319085|Arthroplasty,|arthroplasty,
528478|NCT00319085|Hip,|hip,
528479|NCT00319085|Pre-heating,|pre-heating,
528480|NCT00319085|Radiostereometric analysis,|radiostereometric analysis,
528481|NCT00319085|Dual-Energy Radiographic Absorptiometry,|dual-energy radiographic absorptiometry,
528482|NCT00319098|Adjuvanted pandemic influenza candidate vaccine|adjuvanted pandemic influenza candidate vaccine
528483|NCT00319098|Influenza|influenza
528484|NCT00319111|pulmonary hypertension|pulmonary hypertension
528485|NCT00319111|bosentan|bosentan
528486|NCT00319111|BENEFIT|benefit
528487|NCT00319111|CTEPH|cteph
528488|NCT00319111|inoperable chronic thromboembolic pulmonary hypertension (CTEPH)|inoperable chronic thromboembolic pulmonary hypertension (cteph)
528489|NCT00319124|Hip Osteoarthritis, muscle strength, range of motion, aerobic capacity, functional capacity, health-related quality of life|hip osteoarthritis, muscle strength, range of motion, aerobic capacity, functional capacity, health-related quality of life
528491|NCT00319137|Nitric Oxide|nitric oxide
528492|NCT00319137|acute migraine|acute migraine
528493|NCT00319150|Erythropoetin resistance|erythropoetin resistance
528494|NCT00319150|End Stage Renal Disease on hemodialysis|end stage renal disease on hemodialysis
528495|NCT00319163|oral contraceptive|oral contraceptive
528496|NCT00319163|therapeutic equivalency|therapeutic equivalency
528497|NCT00319163|contraceptives, oral, combined|contraceptives, oral, combined
528498|NCT00319176|Pregnancy|pregnancy
528499|NCT00319176|Enoxaparin|enoxaparin
528500|NCT00319176|Anticoagulation|anticoagulation
528501|NCT00319189|Nateglinide|nateglinide
528502|NCT00319189|Renal|renal
528503|NCT00319189|Kidney|kidney
528504|NCT00319189|Transplantation|transplantation
528505|NCT00319189|Diabets|diabets
528506|NCT00319189|Glucose|glucose
528507|NCT00319202|Impaired fasting glucose|impaired fasting glucose
528508|NCT00319202|Abdominal obesity|abdominal obesity
528509|NCT00319202|HOMA|homa
528510|NCT00319202|Angiotensin-receptor blocker|angiotensin-receptor blocker
528511|NCT00319215|ramelteon|ramelteon
528512|NCT00319215|zopiclone|zopiclone
528513|NCT00319215|driving|driving
528514|NCT00319215|memory|memory
528515|NCT00319215|balance|balance
528516|NCT00319215|psychomotor|psychomotor
528517|NCT00319228|AT-III deficiency|at-iii deficiency
528518|NCT00319228|AT-III concentrate|at-iii concentrate
528519|NCT00319228|Bleeding disorders|bleeding disorders
528520|NCT00319228|Blood disorders|blood disorders
528521|NCT00319241|parenting intervention|parenting intervention
528522|NCT00319241|substance abuse treatment|substance abuse treatment
528523|NCT00319241|mother-child relations|mother-child relations
528524|NCT00319241|parent-child relations|parent-child relations
528525|NCT00319241|child abuse and neglect|child abuse and neglect
528526|NCT00319254|Advanced Breast Cancer|advanced breast cancer
528527|NCT00319267|bosentan|bosentan
528528|NCT00319267|children|children
528529|NCT00319267|pharmacokinetics|pharmacokinetics
528530|NCT00319267|pulmonary arterial hypertension|pulmonary arterial hypertension
528531|NCT00319280|Osteoarthritis, Knee|osteoarthritis, knee
528532|NCT00319280|Osteotomy|osteotomy
528533|NCT00319280|Healing|healing
528534|NCT00319280|Roentgen Stereometric Analysis|roentgen stereometric analysis
528535|NCT00319306|Respiratory Tract Diseases|respiratory tract diseases
528536|NCT00319306|Bronchial Diseases|bronchial diseases
528537|NCT00319306|Anti-asthmatic agents|anti-asthmatic agents
528538|NCT00319306|Anti-asthmatic drugs|anti-asthmatic drugs
528539|NCT00319306|Bronchodilators|bronchodilators
528540|NCT00319319|major depressive disorder,|major depressive disorder,
528541|NCT00319319|serotonin selective reuptake inhibitor,|serotonin selective reuptake inhibitor,
528542|NCT00319319|mecamylamine,|mecamylamine,
528543|NCT00319319|controlled trial,|controlled trial,
528544|NCT00319319|cigarette smoking|cigarette smoking
528545|NCT00319332|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
528546|NCT00319332|follicular lymphoma|follicular lymphoma
528547|NCT00319332|BEXXAR|bexxar
528548|NCT00319332|ZEVALIN|zevalin
528549|NCT00319332|Iodine I 131 Tositumomab|iodine i 131 tositumomab
528550|NCT00319332|Ibritumomab Tiuxetan|ibritumomab tiuxetan
583549|NCT00512122|respiratory failure|respiratory failure
528551|NCT00319332|Follicular, mixed small-cleaved and large-cell|follicular, mixed small-cleaved and large-cell
528552|NCT00319332|Diffuse large cell non-Hodgkin's lymphoma following or concurrent with a diagnosis of follicular lymphoma|diffuse large cell non-hodgkin's lymphoma following or concurrent with a diagnosis of follicular lymphoma
528553|NCT00319345|Traumatic brain injury|traumatic brain injury
528554|NCT00319345|Intracranial pressure|intracranial pressure
528555|NCT00319345|Osmotherapy|osmotherapy
528556|NCT00319345|Glasgow outcome score|glasgow outcome score
528557|NCT00319345|Mannitol|mannitol
528558|NCT00319345|Sodium-Lactate|sodium-lactate
528559|NCT00319358|chronic pancreatitis|chronic pancreatitis
528560|NCT00319358|antioxidant supplementation|antioxidant supplementation
528561|NCT00319358|oxidative stress|oxidative stress
528562|NCT00319371|vasospasm|vasospasm
528563|NCT00319371|circadian|circadian
528564|NCT00319371|sleep-disorders|sleep-disorders
528565|NCT00319384|congestive heart failure|congestive heart failure
528566|NCT00319384|heart failure|heart failure
528567|NCT00319384|ultrafiltration therapy|ultrafiltration therapy
528568|NCT00319384|fluid overload|fluid overload
528569|NCT00319397|vascular resistance|vascular resistance
528570|NCT00319397|vasomotion|vasomotion
528571|NCT00319397|coronary disorder|coronary disorder
528572|NCT00319397|hemodynamics|hemodynamics
528573|NCT00319397|physical fitness|physical fitness
528574|NCT00319410|Menorrhagia|menorrhagia
528575|NCT00319410|intrauterine diagnosis|intrauterine diagnosis
528576|NCT00319410|visual analogue scale|visual analogue scale
528577|NCT00319423|Hip Osteoarthritis, Exercise therapy, Patient Education|hip osteoarthritis, exercise therapy, patient education
528578|NCT00319436|parenting intervention|parenting intervention
528579|NCT00319436|family intervention|family intervention
528580|NCT00319436|maternal substance abuse|maternal substance abuse
528581|NCT00319436|mother-child relations|mother-child relations
528582|NCT00319436|parent-child relations|parent-child relations
528583|NCT00319462|point A, cervical cancer, radiotherapy|point a, cervical cancer, radiotherapy
528585|NCT00319488|Respiratory Tract Illness|respiratory tract illness
528586|NCT00319501|Acute Repetitive Seizures|acute repetitive seizures
528588|NCT00319501|Diazepam|diazepam
528589|NCT00319501|Cluster Seizures|cluster seizures
528590|NCT00319527|long term outcome|long term outcome
528591|NCT00319527|living kidney donor|living kidney donor
528592|NCT00319540|Depression|depression
528593|NCT00319540|psychoeducation|psychoeducation
528594|NCT00319540|RCT|rct
528595|NCT00319540|primary health services|primary health services
528596|NCT00319553|Tetanus|tetanus
528597|NCT00319553|diphtheria|diphtheria
528598|NCT00319553|acellular pertussis|acellular pertussis
528599|NCT00319566|Coronary Heart Disease|coronary heart disease
528600|NCT00319566|Hormone replacement therapy|hormone replacement therapy
528601|NCT00319566|Estrogen|estrogen
528602|NCT00319566|Postmenopausal women|postmenopausal women
528603|NCT00319579|living kidney donors|living kidney donors
528604|NCT00319579|prospective|prospective
528605|NCT00319579|medical|medical
528606|NCT00319579|psychosocial|psychosocial
528607|NCT00319592|Japanese encephalitis|japanese encephalitis
528608|NCT00319592|ChimeriVax™-JE|chimerivax™-je
528609|NCT00319592|JE-VAX®|je-vax®
528610|NCT00319605|Cross sectional study|cross sectional study
528080|NCT00303914|pain|pain
528611|NCT00319605|acceptability|acceptability
528612|NCT00319605|levetiracetam|levetiracetam
528613|NCT00319605|oral solution|oral solution
528614|NCT00319605|Keppra|keppra
528615|NCT00319631|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
528616|NCT00319657|Kidney Transplantation|kidney transplantation
528617|NCT00319657|Blood Stem Cell Transplantation|blood stem cell transplantation
528618|NCT00319670|constipation|constipation
528619|NCT00319670|pediatric|pediatric
528620|NCT00319683|Cancer|cancer
528621|NCT00319683|Tumors|tumors
528622|NCT00319683|Neoplasms|neoplasms
528623|NCT00319683|Anticarcinogenic Agents|anticarcinogenic agents
528624|NCT00319683|Antineoplastic Agents|antineoplastic agents
528625|NCT00319683|Dihydrouracil Dehydrogenase (NADP)|dihydrouracil dehydrogenase (nadp)
528626|NCT00319696|systemic sclerosis|systemic sclerosis
528627|NCT00319696|digital ulcers|digital ulcers
528628|NCT00319696|bosentan|bosentan
528629|NCT00319696|open label|open label
528630|NCT00319696|finger ulcers|finger ulcers
528631|NCT00319709|depression|depression
528632|NCT00319709|antidepressive agents|antidepressive agents
528633|NCT00319709|controlled clinical trial|controlled clinical trial
528634|NCT00319722|autism|autism
528635|NCT00319722|pervasive developmental disorder|pervasive developmental disorder
528636|NCT00319722|evoked potentials|evoked potentials
528637|NCT00319722|EEG|eeg
528638|NCT00319722|Coherence|coherence
528639|NCT00319748|Breast|breast
528640|NCT00319748|Ovarian|ovarian
528641|NCT00319748|Endometrial|endometrial
528642|NCT00319748|Cervical|cervical
528643|NCT00319748|Metastatic|metastatic
528645|NCT00319748|IRM|irm
528646|NCT00319748|Oncology|oncology
528647|NCT00319748|Metastatic Cervical Cancer|metastatic cervical cancer
528648|NCT00319748|Metastatic Ovarian Cancer|metastatic ovarian cancer
528649|NCT00319748|Metastatic Breast Cancer|metastatic breast cancer
528650|NCT00319748|Metastatic Endometrial Cancer|metastatic endometrial cancer
528651|NCT00319761|glomerulonephritis|glomerulonephritis
528652|NCT00319761|proteinuria|proteinuria
528653|NCT00319761|chronic kidney diseases|chronic kidney diseases
528654|NCT00319774|End-stage renal disease|end-stage renal disease
528655|NCT00319774|Hemodialysis|hemodialysis
528656|NCT00319774|Hypertension|hypertension
528657|NCT00319774|Hypotension|hypotension
528658|NCT00319774|Blood volume|blood volume
528659|NCT00319774|Hypervolemia|hypervolemia
528660|NCT00319774|Quality of life|quality of life
528661|NCT00319774|Biofeedback system|biofeedback system
528662|NCT00319826|Staphylococcus aureus, S. aureus, bacteremia, sepsis|staphylococcus aureus, s. aureus, bacteremia, sepsis
528663|NCT00319839|Head cancer|head cancer
528664|NCT00319839|Neck cancer|neck cancer
528665|NCT00319852|Diphteria;|diphteria;
528666|NCT00319852|Tetanus;|tetanus;
528667|NCT00319852|Pertussis;|pertussis;
528668|NCT00319852|Poliomyelitis;|poliomyelitis;
528669|NCT00319852|acellular|acellular
528670|NCT00319865|Multiple Myeloma Relapsed|multiple myeloma relapsed
528671|NCT00319891|Alzheimer's|alzheimer's
528672|NCT00319891|AD|ad
528673|NCT00319891|Mild Cognitive Impairment|mild cognitive impairment
528674|NCT00319891|Dementia|dementia
528675|NCT00319891|Cognitive remediation|cognitive remediation
528676|NCT00319891|computer-based training|computer-based training
528677|NCT00319904|Schizophrenia|schizophrenia
528678|NCT00319904|DNA|dna
528679|NCT00319917|Tacrolimus|tacrolimus
528680|NCT00319917|Rheumatoid Arthritis|rheumatoid arthritis
528681|NCT00319917|Tacrolimus anhydrous|tacrolimus anhydrous
528682|NCT00319930|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
528684|NCT00319930|ZAP-70|zap-70
528685|NCT00319930|Hsp90 inhibitor|hsp90 inhibitor
528686|NCT00319943|Cognitive remediation|cognitive remediation
528687|NCT00319943|Cognitive impairment|cognitive impairment
528688|NCT00319943|computer|computer
528690|NCT00319956|premature infant|premature infant
528691|NCT00319956|respiratory distress syndrome|respiratory distress syndrome
528692|NCT00319956|mechanical ventilation|mechanical ventilation
528693|NCT00319969|small cell lung cancer|small cell lung cancer
528694|NCT00319969|amrubicin|amrubicin
528695|NCT00319982|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
528696|NCT00319982|Left ventricular hypertrophy|left ventricular hypertrophy
528697|NCT00319982|Diltiazem|diltiazem
528698|NCT00320021|Diabetic nephropathy|diabetic nephropathy
528699|NCT00320021|Advanced Glycation Endproduct Inhibitor|advanced glycation endproduct inhibitor
528700|NCT00320021|Pyridorin|pyridorin
528701|NCT00320021|Pyridoxamine|pyridoxamine
528702|NCT00320034|levalbuterol|levalbuterol
528703|NCT00320034|asthma|asthma
528704|NCT00320034|allergen provocation|allergen provocation
528705|NCT00320034|airway inflammation|airway inflammation
528706|NCT00320034|clinical trial|clinical trial
528707|NCT00320047|Binge Eating Disorder|binge eating disorder
528708|NCT00320060|Diabetic nephropathy|diabetic nephropathy
528709|NCT00320060|Advanced Glycation Endproduct Inhibitor|advanced glycation endproduct inhibitor
528710|NCT00320060|Pyridorin|pyridorin
528711|NCT00320060|Pyridoxamine|pyridoxamine
528712|NCT00320073|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
528713|NCT00320099|septic shock|septic shock
528714|NCT00320099|adrenal insufficiency|adrenal insufficiency
528715|NCT00320099|glucose control|glucose control
528716|NCT00320099|mineralocorticoids|mineralocorticoids
528717|NCT00320112|telemedicine|telemedicine
528718|NCT00320112|case management|case management
528719|NCT00320112|insulin|insulin
528720|NCT00320112|self-care|self-care
528721|NCT00320125|Dairy|dairy
528722|NCT00320125|Calcium|calcium
528723|NCT00320125|Pregnancy|pregnancy
528724|NCT00320125|Fetus|fetus
528725|NCT00320125|Bone mineralization|bone mineralization
528726|NCT00320138|PTSD|ptsd
528727|NCT00320138|Posttraumatic Stress|posttraumatic stress
528728|NCT00320138|Acupuncture|acupuncture
528729|NCT00320138|Randomized Controlled Trial|randomized controlled trial
528730|NCT00320138|Complementary medicine|complementary medicine
528731|NCT00320138|Alternative medicine|alternative medicine
528732|NCT00320138|Chinese medicine|chinese medicine
528733|NCT00320138|military healthcare|military healthcare
528734|NCT00320151|chronic lung disease|chronic lung disease
528735|NCT00320164|Healthy Volunteers|healthy volunteers
528736|NCT00320177|Binge Eating|binge eating
528737|NCT00320177|Food Intake|food intake
528738|NCT00320177|Obesity|obesity
528739|NCT00320177|Melanocortin-4 Receptor Gene|melanocortin-4 receptor gene
528740|NCT00320177|Child|child
528741|NCT00320177|Macronutrient Composition|macronutrient composition
583550|NCT00512122|kidney failure|kidney failure
583551|NCT00512122|hepatic failure|hepatic failure
528742|NCT00320190|Chronic phase CML, with a suboptimal response after treatment with imatinib|chronic phase cml, with a suboptimal response after treatment with imatinib
528744|NCT00320203|glaucoma|glaucoma
528745|NCT00320216|Psoriasis|psoriasis
528746|NCT00320216|CNTO 1275|cnto 1275
528747|NCT00320216|Ustekinumab|ustekinumab
528748|NCT00320216|Stelara|stelara
528749|NCT00320216|Interleukin-12|interleukin-12
528750|NCT00320216|IL-12|il-12
528751|NCT00320216|Interleukin-23|interleukin-23
528752|NCT00320216|IL-23|il-23
528753|NCT00320229|angioplasty|angioplasty
528754|NCT00320229|stent|stent
528755|NCT00320229|abciximab|abciximab
528756|NCT00320229|Platelet Glycoprotein GPIIb-IIIa Complex|platelet glycoprotein gpiib-iiia complex
528757|NCT00320229|myocardial infarction|myocardial infarction
528758|NCT00320242|Parkinson's disease|parkinson's disease
528759|NCT00320242|laser cane|laser cane
528760|NCT00320242|freezing of gait|freezing of gait
528761|NCT00320242|visual cues|visual cues
528762|NCT00320255|anticoagulant|anticoagulant
528763|NCT00320268|MDD|mdd
528764|NCT00320268|Quetiapine fumarate, sustained release|quetiapine fumarate, sustained release
528765|NCT00320268|Depression|depression
528766|NCT00320281|Botox|botox
528767|NCT00320307|Human Immunodeficiency Virus|human immunodeficiency virus
528768|NCT00320307|HIV|hiv
528769|NCT00320307|Abacavir regime|abacavir regime
528770|NCT00320307|ABC|abc
528771|NCT00320320|No prior chemotherapy|no prior chemotherapy
528772|NCT00320333|COPD|copd
528773|NCT00320333|rehabilitation|rehabilitation
528774|NCT00320333|health services research|health services research
528775|NCT00320346|Pandemic|pandemic
528776|NCT00320346|Influenza|influenza
528777|NCT00320346|Prevention|prevention
528778|NCT00320346|Vaccine|vaccine
528779|NCT00320346|Prevention of Pandemic Influenza|prevention of pandemic influenza
528780|NCT00320359|First-line Cisplatin|first-line cisplatin
528781|NCT00320359|Small Cell Lung Cancer|small cell lung cancer
528782|NCT00320359|topotecan|topotecan
528783|NCT00320359|etoposide|etoposide
528784|NCT00320359|Extensive Disease|extensive disease
528785|NCT00320372|Major Depressive Disorder|major depressive disorder
528786|NCT00320372|Treatment-resistant Depression|treatment-resistant depression
528787|NCT00320385|lapatinib|lapatinib
528788|NCT00320385|GW572016|gw572016
528789|NCT00320385|ErbB2|erbb2
528790|NCT00320385|EGFR|egfr
528791|NCT00320385|ErbB1|erbb1
528792|NCT00320385|MBC|mbc
528793|NCT00320385|FISH amplification|fish amplification
529192|NCT00321438|GW873140|gw873140
528794|NCT00320385|Metastatic Breast Cancer|metastatic breast cancer
528795|NCT00320385|dual tyrosine kinase inhibitor|dual tyrosine kinase inhibitor
528796|NCT00320385|Her-2/neu|her-2/neu
528797|NCT00320398|Fondaparinux|fondaparinux
528798|NCT00320398|Hip Replacement Arthroplasty|hip replacement arthroplasty
528799|NCT00320398|VTE|vte
528800|NCT00320398|THR|thr
528801|NCT00320398|MOSLL|mosll
528802|NCT00320398|pentasaccharide|pentasaccharide
528803|NCT00320398|Xa factor|xa factor
528804|NCT00320411|Stage IV breast cancer|stage iv breast cancer
528805|NCT00320411|Herceptin|herceptin
528806|NCT00320411|metastatic breast cancer|metastatic breast cancer
528807|NCT00320411|ErbB1|erbb1
528808|NCT00320411|ErbB2|erbb2
528809|NCT00320411|trastuzumab|trastuzumab
528810|NCT00320411|lapatinib|lapatinib
528811|NCT00320424|Xa factor|xa factor
528812|NCT00320424|VTE|vte
528813|NCT00320424|MOSLL|mosll
528814|NCT00320424|pentasaccharide|pentasaccharide
528815|NCT00320437|trauma|trauma
528816|NCT00320437|anxiety|anxiety
528817|NCT00320437|antenatal|antenatal
528818|NCT00320437|mothers|mothers
528819|NCT00320437|children|children
528820|NCT00320437|Gene x Environment Interaction|gene x environment interaction
528821|NCT00320450|SB-681323|sb-681323
528822|NCT00320450|CRP|crp
528823|NCT00320450|Rheumatoid Arthritis SB-681323 CRP RA|rheumatoid arthritis sb-681323 crp ra
528824|NCT00320450|Rheumatoid Arthritis|rheumatoid arthritis
528825|NCT00320450|RA|ra
528826|NCT00320476|Multiple myeloma|multiple myeloma
528827|NCT00320541|Breast Cancer|breast cancer
528828|NCT00320541|Cancer of Breast|cancer of breast
528829|NCT00320541|Cancer of the breast|cancer of the breast
528830|NCT00320541|Breast Neoplasms|breast neoplasms
528831|NCT00320567|osteoporosis|osteoporosis
528832|NCT00320567|anorexia nervosa|anorexia nervosa
528833|NCT00320567|pediatric|pediatric
528834|NCT00320580|Metrorrhagia|metrorrhagia
528835|NCT00320580|oral contraception|oral contraception
528836|NCT00320580|breakthrough bleeding|breakthrough bleeding
528837|NCT00320580|spotting|spotting
528838|NCT00320593|Myopia|myopia
528839|NCT00320593|Progressive Addition Lenses (PALs)|progressive addition lenses (pals)
528840|NCT00320593|Single Vision Lenses (SVLs)|single vision lenses (svls)
528841|NCT00320593|Accommodative lags|accommodative lags
528842|NCT00320593|Near esophoria|near esophoria
528843|NCT00320593|Refractive error|refractive error
528844|NCT00320606|allograft function|allograft function
528845|NCT00320606|anti-rejection|anti-rejection
528846|NCT00320606|immunosuppression withdrawal|immunosuppression withdrawal
528847|NCT00320606|liver transplant|liver transplant
528848|NCT00320606|liver transplantation|liver transplantation
528849|NCT00320606|living donor transplant|living donor transplant
528850|NCT00320619|Aminocaproic Acids|aminocaproic acids
528851|NCT00320619|Blood Transfusion|blood transfusion
528852|NCT00320632|Major Depressive Disorder|major depressive disorder
528854|NCT00320658|Plasmodium falciparum|plasmodium falciparum
528855|NCT00320671|First-episode|first-episode
528856|NCT00320671|Schizoaffective Disorder|schizoaffective disorder
528857|NCT00320671|Schizophreniform Disorder|schizophreniform disorder
528858|NCT00320671|Psychotic Disorder Not Otherwise Specified NOS|psychotic disorder not otherwise specified nos
528859|NCT00320671|Aripiprazole|aripiprazole
528860|NCT00320671|Clozapine|clozapine
528861|NCT00320671|Risperidone|risperidone
528862|NCT00320684|Serotonin Transporter|serotonin transporter
528863|NCT00320684|Positron-Emission Tomography|positron-emission tomography
528864|NCT00320697|schizophrenia|schizophrenia
528865|NCT00320697|smoking cessation|smoking cessation
528866|NCT00320697|relapse prevention|relapse prevention
528867|NCT00320697|nicotine|nicotine
528868|NCT00320697|bupropion|bupropion
528869|NCT00320697|cognitive behavioral therapy|cognitive behavioral therapy
528870|NCT00320697|nicotine replacement therapy|nicotine replacement therapy
528871|NCT00320710|Breast cancer|breast cancer
528872|NCT00320710|zoledronic acid|zoledronic acid
528873|NCT00320710|bone metastases|bone metastases
528874|NCT00320723|schizophrenia|schizophrenia
528875|NCT00320723|smoking cessation|smoking cessation
528876|NCT00320723|nicotine|nicotine
528877|NCT00320723|patch|patch
528878|NCT00320723|bupropion|bupropion
528879|NCT00320723|nicotine replacement therapy|nicotine replacement therapy
528880|NCT00320723|cognitive behavioral therapy|cognitive behavioral therapy
528881|NCT00320736|schizophrenia|schizophrenia
528882|NCT00320736|cognitive function|cognitive function
528883|NCT00320736|cholinergic medication|cholinergic medication
528884|NCT00320736|nicotinic receptor agonist|nicotinic receptor agonist
528885|NCT00320749|Advanced Pancreatic Cancer|advanced pancreatic cancer
528886|NCT00320762|Glaucoma|glaucoma
528887|NCT00320762|Pterygium|pterygium
528888|NCT00320762|collagen matrix|collagen matrix
528889|NCT00320762|OculusGen|oculusgen
528890|NCT00320762|trabeculectomy|trabeculectomy
528891|NCT00320762|Anti scarring|anti scarring
528892|NCT00320762|pterygium recurrence|pterygium recurrence
528893|NCT00320762|tissue engineering|tissue engineering
528894|NCT00320762|Aeon Astron|aeon astron
528895|NCT00320775|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
528896|NCT00320788|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
528897|NCT00320801|Chronic pain|chronic pain
528898|NCT00320801|osteoarthritis|osteoarthritis
528899|NCT00320801|transdermal|transdermal
528900|NCT00320827|Apoptosis|apoptosis
528901|NCT00320827|Death receptor 5|death receptor 5
528902|NCT00320827|Cancer|cancer
528903|NCT00320827|Advanced solid malignancies and lymphomas (without leukemic component)|advanced solid malignancies and lymphomas (without leukemic component)
528904|NCT00320840|preterm infants|preterm infants
528905|NCT00320840|twins|twins
528906|NCT00320840|motherhood|motherhood
528907|NCT00320840|internal resources|internal resources
528908|NCT00320840|familial resources|familial resources
528909|NCT00320853|Diabetes|diabetes
528910|NCT00320853|Vitamin D|vitamin d
528911|NCT00320853|Insulin sensitivity|insulin sensitivity
528912|NCT00320853|Insulin secretion|insulin secretion
528913|NCT00320866|Hypodermoclysis|hypodermoclysis
528914|NCT00320866|Evaluation of Symptoms|evaluation of symptoms
528915|NCT00320879|diabetes|diabetes
528916|NCT00320879|microalbuminuria|microalbuminuria
528917|NCT00320879|angiotensin II receptor blockade|angiotensin ii receptor blockade
528918|NCT00320879|irbesartan|irbesartan
528919|NCT00320879|dose-response|dose-response
528920|NCT00320879|randomized|randomized
528921|NCT00320879|double-blind|double-blind
528922|NCT00320879|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
528923|NCT00320879|clinical|clinical
528924|NCT00320879|hypertension|hypertension
528925|NCT00320892|Death Rattle|death rattle
528926|NCT00320892|Noise level|noise level
528927|NCT00320892|Primary Care|primary care
528928|NCT00320905|Cardiac Rehabilitation|cardiac rehabilitation
528929|NCT00320905|Cognitive functioning|cognitive functioning
528930|NCT00320905|Cardiovascular disease|cardiovascular disease
528931|NCT00320918|Unresectable/metastatic cholangiocarcinoma|unresectable/metastatic cholangiocarcinoma
528933|NCT00320918|Chart Review|chart review
528934|NCT00320931|Coronary artery disease|coronary artery disease
528935|NCT00320931|PET CT scan|pet ct scan
528936|NCT00320931|Stress test|stress test
528937|NCT00320931|Rubudium|rubudium
528938|NCT00320957|Glaucoma|glaucoma
528939|NCT00320957|Pterygium|pterygium
528940|NCT00320957|collagen matrix|collagen matrix
528942|NCT00320957|trabeculectomy|trabeculectomy
528943|NCT00320957|Anti scarring|anti scarring
528944|NCT00320957|pterygium recurrence|pterygium recurrence
528945|NCT00320957|tissue engineering|tissue engineering
528946|NCT00320957|Aeon Astron|aeon astron
528947|NCT00320957|ologen|ologen
528948|NCT00320970|TGF-Beta 1|tgf-beta 1
528949|NCT00320970|Angiotensin II|angiotensin ii
528950|NCT00320970|Advanced glycation end products|advanced glycation end products
528951|NCT00320983|Cancer|cancer
528952|NCT00320983|Cervix|cervix
528953|NCT00320996|Pelvic mass|pelvic mass
528954|NCT00321009|Myocardial Infarction|myocardial infarction
528955|NCT00321009|Left Ventricular Mural Thrombus|left ventricular mural thrombus
528956|NCT00321009|Low Molecular Weight Heparin|low molecular weight heparin
528957|NCT00321009|Enoxaparin|enoxaparin
528958|NCT00321009|Warfarin|warfarin
528959|NCT00321009|Echocardiograms|echocardiograms
528960|NCT00321022|Transient Ischemic Attack (TIA)|transient ischemic attack (tia)
528961|NCT00321022|Diagnostic Protocol|diagnostic protocol
528962|NCT00321022|Observational Medicine|observational medicine
528963|NCT00321022|Emergency Department Observational Unit|emergency department observational unit
528964|NCT00321035|Glaucoma|glaucoma
528965|NCT00321035|Pterygium|pterygium
528966|NCT00321035|collagen matrix|collagen matrix
528967|NCT00321035|oculusgen|oculusgen
528968|NCT00321035|ologen|ologen
528969|NCT00321035|trabeculectomy|trabeculectomy
528970|NCT00321035|anti scarring|anti scarring
528971|NCT00321035|prevent recurrence|prevent recurrence
528972|NCT00321035|tissue engineering|tissue engineering
528973|NCT00321035|Aeon Astron|aeon astron
528974|NCT00321048|breast cancer|breast cancer
528975|NCT00321048|SPECT|spect
528976|NCT00321048|ABC device|abc device
528977|NCT00321048|Invasive adenocarcinoma of the left breast|invasive adenocarcinoma of the left breast
528978|NCT00321048|Ductal Carcinoma In Situ of the left breast|ductal carcinoma in situ of the left breast
528979|NCT00321061|HIV Negative|hiv negative
528980|NCT00321061|Healthy|healthy
528981|NCT00321061|Immunity|immunity
528982|NCT00321061|Preventive|preventive
528983|NCT00321061|Virus|virus
528984|NCT00321061|Healthy Volunteer|healthy volunteer
528985|NCT00321061|HV|hv
528986|NCT00321074|IMMUNOSUPPRESSION|immunosuppression
528987|NCT00321074|TACROLIMUS|tacrolimus
528988|NCT00321074|MARGINAL LIVERS|marginal livers
528989|NCT00321074|PHARMACOKINETICS|pharmacokinetics
528990|NCT00321087|Movement Disorder|movement disorder
528991|NCT00321100|metastatic|metastatic
528992|NCT00321100|colorectal|colorectal
528993|NCT00321100|cancer|cancer
528994|NCT00321100|initial therapy|initial therapy
528995|NCT00321113|MARGINAL KIDNEY|marginal kidney
528996|NCT00321113|TACROLIMUS|tacrolimus
528997|NCT00321113|IMMUNOSUPPRESSION|immunosuppression
528998|NCT00321113|ELDERLY RECEPIENTS|elderly recepients
528999|NCT00321126|Zinc|zinc
529000|NCT00321126|Shigella|shigella
529001|NCT00321126|Children|children
529002|NCT00321126|Bangladesh|bangladesh
529003|NCT00321139|biomarkers|biomarkers
529004|NCT00321139|oxidative stress|oxidative stress
529005|NCT00321139|intravascular ultrasound|intravascular ultrasound
529006|NCT00321165|nutrition|nutrition
529007|NCT00321165|parenteral|parenteral
529008|NCT00321165|infection|infection
529009|NCT00321165|katheter|katheter
529010|NCT00321165|taurolidine|taurolidine
529011|NCT00321165|acridine orange|acridine orange
529012|NCT00321165|prevention|prevention
529013|NCT00321178|Mycobacterium ulcerans|mycobacterium ulcerans
529014|NCT00321178|Buruli ulcer|buruli ulcer
529015|NCT00321178|Ghana|ghana
529016|NCT00321178|randomized comparison|randomized comparison
529017|NCT00321178|streptomycin|streptomycin
682741|NCT00900549|ICD|icd
529018|NCT00321178|rifampicin|rifampicin
529019|NCT00321178|clarithromycin|clarithromycin
529020|NCT00321204|Atrial Fibrillation|atrial fibrillation
529021|NCT00321204|Atrial Flutter|atrial flutter
529022|NCT00321204|Cardiac Surgery|cardiac surgery
529023|NCT00321204|Thiazolidinediones|thiazolidinediones
529024|NCT00321217|rheumatoid arthritis|rheumatoid arthritis
529025|NCT00321217|pharmacogenetics|pharmacogenetics
529026|NCT00321217|anti-TNF|anti-tnf
529027|NCT00321217|high throughput genotyping|high throughput genotyping
529028|NCT00321230|Colon cleansing|colon cleansing
529029|NCT00321243|triage|triage
529030|NCT00321256|islet transplantation|islet transplantation
529031|NCT00321256|brittle diabetes|brittle diabetes
529032|NCT00321256|severe hypoglycemia|severe hypoglycemia
529033|NCT00321256|type 1 diabetes mellitus|type 1 diabetes mellitus
529034|NCT00321269|Home Monitoring|home monitoring
529035|NCT00321269|Heart Failure|heart failure
529036|NCT00321269|Depression|depression
529037|NCT00321282|Atrial Fibrillation|atrial fibrillation
529038|NCT00321282|Coronary Artery Bypass Graft|coronary artery bypass graft
529039|NCT00321282|Risk Stratification|risk stratification
529040|NCT00307671|Systemic necrotizing vasculitides|systemic necrotizing vasculitides
529041|NCT00307671|corticosteroids; azathioprine; mycophenolate mofetil;|corticosteroids; azathioprine; mycophenolate mofetil;
529043|NCT00307671|Elderly patients|elderly patients
529044|NCT00307671|Randomized controlled trial|randomized controlled trial
529045|NCT00307684|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
529046|NCT00307684|Adult|adult
529047|NCT00307684|Long term safety|long term safety
529048|NCT00307684|Efficacy|efficacy
529049|NCT00307684|Quality of life|quality of life
529050|NCT00307697|Letter intervention|letter intervention
529051|NCT00307697|Depression|depression
529052|NCT00307697|Anxiety|anxiety
529053|NCT00307697|Primary health care|primary health care
529054|NCT00307710|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
529055|NCT00307710|Influenza Vaccination|influenza vaccination
529056|NCT00307710|Trivalent Baculovirus-Expressed Influenza HA vaccine|trivalent baculovirus-expressed influenza ha vaccine
529057|NCT00307710|Antineoplastic Therapy|antineoplastic therapy
529058|NCT00307723|EBRT|ebrt
529059|NCT00307723|advanced pancreatic cancer|advanced pancreatic cancer
529060|NCT00307736|Fluorouracil|fluorouracil
529061|NCT00307736|bevacizumab|bevacizumab
529062|NCT00307736|erlotinib|erlotinib
529063|NCT00307736|external beam radiation therapy|external beam radiation therapy
529064|NCT00307736|EBRT|ebrt
529065|NCT00307749|Neuropathy|neuropathy
529066|NCT00307749|Nerve Conduction|nerve conduction
529067|NCT00307762|Stroke|stroke
529068|NCT00307762|Physiotherapy|physiotherapy
529069|NCT00307762|Effectiveness|effectiveness
529070|NCT00307762|Gait trainer|gait trainer
529071|NCT00307775|oestradiol, faecal incontinence, post menopausal|oestradiol, faecal incontinence, post menopausal
529072|NCT00307775|post menopausal women with faecal incontinence|post menopausal women with faecal incontinence
529073|NCT00307788|Psychiatric Comorbidity|psychiatric comorbidity
529074|NCT00307788|Acupuncture|acupuncture
529075|NCT00307788|expectancy|expectancy
529076|NCT00307801|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
529077|NCT00307814|Anemia|anemia
529078|NCT00307814|Low Blood Count|low blood count
529079|NCT00307814|Chronic Kidney Failure|chronic kidney failure
529080|NCT00307814|Chronic Kidney Disease|chronic kidney disease
529081|NCT00307814|epoetin alfa|epoetin alfa
529082|NCT00307814|recombinant human erythropoietin|recombinant human erythropoietin
529083|NCT00307827|Steroid-Refractory|steroid-refractory
529084|NCT00307827|IVSR-UC|ivsr-uc
529085|NCT00307827|Ulcerative Colitis|ulcerative colitis
529086|NCT00307840|hemodialysis; secondary hyperparathyroidism; hypercalcemia; hyperphosphatemia; vitamin D|hemodialysis; secondary hyperparathyroidism; hypercalcemia; hyperphosphatemia; vitamin d
529087|NCT00307853|homeopathy|homeopathy
529088|NCT00307853|pain|pain
529089|NCT00307853|traumeel s|traumeel s
529090|NCT00307853|total knee arthroplasty|total knee arthroplasty
529091|NCT00307853|total hip arthroplasty|total hip arthroplasty
529189|NCT00321412|Inflammatory Bowel Disease|inflammatory bowel disease
529190|NCT00321412|Fistula|fistula
529092|NCT00307866|Known or suspected focal liver lesions detected by spiral CT|known or suspected focal liver lesions detected by spiral ct
529093|NCT00307879|Myocardial infarction|myocardial infarction
529094|NCT00307879|revascularization|revascularization
529095|NCT00307879|granulocyte colony stimulating factor (G-CSF)|granulocyte colony stimulating factor (g-csf)
529096|NCT00307892|Homeopathy|homeopathy
529097|NCT00307892|Traumeel S|traumeel s
529098|NCT00307892|Arthroscopy|arthroscopy
529099|NCT00307892|Pain management|pain management
529100|NCT00307892|Post-operative pain following arthroscopy|post-operative pain following arthroscopy
529101|NCT00307905|homeopathy|homeopathy
529102|NCT00307905|pain|pain
529103|NCT00307905|traumeel s|traumeel s
529104|NCT00307905|Fracture of neck of femur|fracture of neck of femur
529105|NCT00307905|Surgical correction of fracture of neck of hip|surgical correction of fracture of neck of hip
529106|NCT00307918|acupuncture, intraocular pressure, glaucoma|acupuncture, intraocular pressure, glaucoma
529107|NCT00307931|Certolizumab pegol|certolizumab pegol
529108|NCT00307931|Cimzia|cimzia
529109|NCT00307931|Crohn's disease|crohn's disease
529110|NCT00307931|Greek patients|greek patients
529111|NCT00307944|Acid Reflux|acid reflux
529112|NCT00307944|Obstructive Sleep Apnea|obstructive sleep apnea
529113|NCT00307944|Daytime Sleepiness|daytime sleepiness
529114|NCT00307957|Obstructive Sleep Apnea|obstructive sleep apnea
529115|NCT00307957|Daytime Sleepiness|daytime sleepiness
529116|NCT00307957|Pillar Palatal Implants|pillar palatal implants
529117|NCT00307970|fluticasone|fluticasone
529118|NCT00307970|asthma therapy|asthma therapy
529119|NCT00307970|spacer inhaler|spacer inhaler
529120|NCT00307970|HFA-134a|hfa-134a
529121|NCT00307996|CoQ10|coq10
529122|NCT00307996|hemodialysis|hemodialysis
529123|NCT00307996|oxidative marker|oxidative marker
529124|NCT00307996|antioxidant|antioxidant
529125|NCT00308009|Pelvic Organ Prolapse|pelvic organ prolapse
529126|NCT00308009|Urinary stress incontinence|urinary stress incontinence
529127|NCT00308009|Surgery|surgery
529128|NCT00308022|Acute Lung Injury|acute lung injury
529129|NCT00308022|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
529130|NCT00308022|High Frequency Percussive Ventilation|high frequency percussive ventilation
529131|NCT00308022|Ventilator Associated Pneumonia|ventilator associated pneumonia
529133|NCT00308048|Pegylated interferon|pegylated interferon
529134|NCT00308048|Pegylated interferon alfa 2b|pegylated interferon alfa 2b
529135|NCT00308048|Hepatitis C|hepatitis c
529136|NCT00308048|Genotype 2|genotype 2
529137|NCT00308048|Genotype 3|genotype 3
529138|NCT00308048|Rapid virological response|rapid virological response
529139|NCT00308048|Short treatment|short treatment
529140|NCT00308048|14 weeks treatment|14 weeks treatment
529141|NCT00308048|health related quality of life|health related quality of life
529142|NCT00308048|sick leave|sick leave
529143|NCT00308048|Injecting drug use|injecting drug use
529144|NCT00308061|Plasmodium falciparum|plasmodium falciparum
529145|NCT00308061|malaria|malaria
529146|NCT00308061|merozoite surface protein-1|merozoite surface protein-1
529147|NCT00308074|behavioral problems|behavioral problems
529148|NCT00308074|aggression|aggression
529149|NCT00308074|autism|autism
529150|NCT00308074|aripiprazole|aripiprazole
529151|NCT00308087|Sargramostim|sargramostim
529152|NCT00308087|Leukine|leukine
529153|NCT00308087|NHL|nhl
529154|NCT00321295|Bi-ventricular pacing|bi-ventricular pacing
529155|NCT00321295|Cardiac Surgery|cardiac surgery
529156|NCT00321295|Cardiomyopahty|cardiomyopahty
529157|NCT00321295|Heart Failure|heart failure
529158|NCT00321308|advanced carcinoma, non-small cell lung cancer, phase II, pemetrexed, Alimta, PF-3512676, immunotherapy, immunomodulator|advanced carcinoma, non-small cell lung cancer, phase ii, pemetrexed, alimta, pf-3512676, immunotherapy, immunomodulator
529159|NCT00321321|Type 2 diabetes mellitus|type 2 diabetes mellitus
529160|NCT00321321|Glucose dependent insulinotropic polypeptide|glucose dependent insulinotropic polypeptide
529161|NCT00321321|Sulfonylurea compounds|sulfonylurea compounds
529162|NCT00321321|insulin secretion|insulin secretion
529163|NCT00321321|Sulfonylurea receptor subunit-SUR1|sulfonylurea receptor subunit-sur1
529164|NCT00321321|Impaired incretin effect|impaired incretin effect
529165|NCT00321334|non-small cell lung cancer|non-small cell lung cancer
529166|NCT00321334|Chemotherapy|chemotherapy
529167|NCT00321334|surgery|surgery
529168|NCT00321334|neo-adjuvant|neo-adjuvant
529169|NCT00321334|adjuvant|adjuvant
529170|NCT00321334|RCT|rct
529171|NCT00321347|Cancer|cancer
529172|NCT00321347|Pain|pain
529173|NCT00321347|Lidocaine|lidocaine
529174|NCT00321360|propofol|propofol
529175|NCT00321360|sedation|sedation
529176|NCT00321373|Influenza|influenza
529177|NCT00321373|Influenza vaccine|influenza vaccine
529178|NCT00321386|Glaucoma|glaucoma
529179|NCT00321386|Open Angle|open angle
529180|NCT00321386|Normal Tension|normal tension
529181|NCT00321399|CORONARY ANATOMY|coronary anatomy
529182|NCT00321399|Coronary Artery Disease|coronary artery disease
529183|NCT00321399|SPECT|spect
529185|NCT00321399|PET/CT|pet/ct
529186|NCT00321399|CTA|cta
529187|NCT00321412|Crohn's disease|crohn's disease
529188|NCT00321412|IBD|ibd
529191|NCT00321438|HIV-1|hiv-1
529193|NCT00321438|CCR5 antagonist|ccr5 antagonist
529194|NCT00321438|experienced|experienced
529195|NCT00321438|treatment experienced|treatment experienced
529196|NCT00321451|insomnia|insomnia
529197|NCT00321451|cognitive behavior therapy|cognitive behavior therapy
529198|NCT00321464|Fractures|fractures
529199|NCT00321464|Compressions|compressions
529200|NCT00321464|Bisphosphonates|bisphosphonates
529201|NCT00321464|Bone metastases|bone metastases
529202|NCT00321464|Breast cancer|breast cancer
529203|NCT00321464|Skeletal|skeletal
529204|NCT00321464|Radiation|radiation
529205|NCT00321464|Surgery to Bone|surgery to bone
529206|NCT00321477|Overactive Bladder|overactive bladder
529207|NCT00321490|MDD|mdd
529208|NCT00321490|Quetiapine fumarate, sustained release|quetiapine fumarate, sustained release
529209|NCT00321490|Depression|depression
528587|NCT00319501|ARS|ars
529210|NCT00321503|acid reflux|acid reflux
529211|NCT00321503|LPR|lpr
529212|NCT00321503|gastroesophageal reflux|gastroesophageal reflux
529213|NCT00321503|GERD|gerd
529214|NCT00321503|pH probe|ph probe
529215|NCT00321503|proton pump inhibitor|proton pump inhibitor
529216|NCT00321503|PPI|ppi
529217|NCT00321516|Bipolar type I Disorder|bipolar type i disorder
529218|NCT00321529|Cervical spine instability|cervical spine instability
529219|NCT00321529|Penning Study|penning study
529220|NCT00321542|Computed tomography|computed tomography
529221|NCT00321542|Diabetes mellitus|diabetes mellitus
529222|NCT00321542|Coronary atherosclerosis|coronary atherosclerosis
529223|NCT00321542|Non-invasive imaging|non-invasive imaging
529224|NCT00321555|Biologic Therapy|biologic therapy
529225|NCT00321555|Monoclonal Antibody|monoclonal antibody
529226|NCT00321555|Immunotherapy|immunotherapy
529227|NCT00321555|Pseudomonas Exotoxin|pseudomonas exotoxin
529228|NCT00321555|Targeted Therapy|targeted therapy
529229|NCT00321555|Hairy Cell Leukemia|hairy cell leukemia
529230|NCT00321555|HCL|hcl
529231|NCT00321568|Multiple Sclerosis|multiple sclerosis
529232|NCT00321568|Magnetic Resonance|magnetic resonance
529234|NCT00321568|Magnetic Field|magnetic field
529235|NCT00321568|MS|ms
529236|NCT00321581|VEGFR2|vegfr2
529237|NCT00321581|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
529238|NCT00321581|Antiangiogenesis|antiangiogenesis
529239|NCT00321581|Solid Tumors|solid tumors
529240|NCT00321581|Childhood Cancer|childhood cancer
529241|NCT00321581|Solid Tumor|solid tumor
529242|NCT00321581|Recurrent Solid Tumor|recurrent solid tumor
529243|NCT00321581|Treatment Resistant Solid Tumor|treatment resistant solid tumor
529244|NCT00321581|Acute Myelogenous Leukemia|acute myelogenous leukemia
529245|NCT00321581|AML|aml
529246|NCT00321620|Bone metastases|bone metastases
529247|NCT00321620|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
529248|NCT00321620|Skeletal|skeletal
529249|NCT00321620|Fractures|fractures
529250|NCT00321620|Compressions|compressions
529251|NCT00321620|Bisphosphonates|bisphosphonates
529252|NCT00321633|stage IV breast cancer|stage iv breast cancer
529253|NCT00321633|recurrent breast cancer|recurrent breast cancer
529254|NCT00321633|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
529255|NCT00321633|BRCA1 mutation carrier|brca1 mutation carrier
529256|NCT00321633|BRCA2 mutation carrier|brca2 mutation carrier
529257|NCT00327392|Arthroscopy|arthroscopy
529258|NCT00327392|AV Shunt|av shunt
529259|NCT00327392|Bunion|bunion
529260|NCT00327392|Dilatation and Curettage|dilatation and curettage
529261|NCT00327392|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
529262|NCT00327392|Hysteroscopy|hysteroscopy
529263|NCT00327392|Lithotripsy|lithotripsy
529264|NCT00327392|Rotator Cuff/ Shoulder|rotator cuff/ shoulder
529265|NCT00327392|Transesophageal Echocardiography|transesophageal echocardiography
529266|NCT00327392|Ureteroscopy|ureteroscopy
529267|NCT00327392|AQUAVAN|aquavan
529268|NCT00327392|Sedation|sedation
529269|NCT00327405|POAG|poag
529270|NCT00327405|Primary Open Angle Glaucoma|primary open angle glaucoma
529271|NCT00327405|Trabeculectomy|trabeculectomy
529272|NCT00327405|Combined Phacotrabeculectomy|combined phacotrabeculectomy
529273|NCT00327405|Combined Glaucoma Cataract Surgery|combined glaucoma cataract surgery
529274|NCT00327405|Releasable Suture|releasable suture
529275|NCT00327405|Ocular Compresssion|ocular compresssion
529276|NCT00327431|Hypertension|hypertension
529277|NCT00327431|Blood Pressure|blood pressure
529278|NCT00327431|Psychosocial Factors|psychosocial factors
529279|NCT00327444|Ovarian neoplasm|ovarian neoplasm
529280|NCT00327444|Ascites|ascites
529281|NCT00327444|Angiogenesis inhibitor|angiogenesis inhibitor
529282|NCT00327444|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
529283|NCT00327444|Recombinant fusion protein|recombinant fusion protein
529284|NCT00327457|colorectal cancer screening|colorectal cancer screening
529285|NCT00327457|sigmoidoscopy|sigmoidoscopy
529286|NCT00327457|colonoscopy|colonoscopy
529287|NCT00327470|neovascular age related macular degeneration|neovascular age related macular degeneration
529288|NCT00327470|choroidal neovascularization|choroidal neovascularization
529289|NCT00327483|Transplant|transplant
529290|NCT00327483|Medication error|medication error
529291|NCT00327483|Patient Safety|patient safety
529292|NCT00327483|Information technology|information technology
529293|NCT00327509|mRNA|mrna
529294|NCT00327509|glaucoma|glaucoma
529295|NCT00327561|Inflammation|inflammation
529296|NCT00327561|Periodontitis|periodontitis
529297|NCT00327561|Endothelial function|endothelial function
529298|NCT00327561|Atherosclerosis|atherosclerosis
529299|NCT00327561|Controlled trial|controlled trial
529300|NCT00327587|hypertension|hypertension
529301|NCT00327587|valsartan|valsartan
529302|NCT00327587|amlodipine|amlodipine
529303|NCT00327587|HCTZ|hctz
529304|NCT00327613|PEX|pex
529305|NCT00327613|glaucoma|glaucoma
529306|NCT00327613|MMP|mmp
529307|NCT00327613|DNA degradation|dna degradation
683056|NCT00894855|Beach|beach
529308|NCT00327613|POAG|poag
529309|NCT00327613|Healthy subjects|healthy subjects
529310|NCT00327626|Fasting plasma glucose|fasting plasma glucose
529311|NCT00327626|HbA1c|hba1c
529312|NCT00327626|Oral antidiabetic agent(s)|oral antidiabetic agent(s)
529313|NCT00327652|carcinoma|carcinoma
529314|NCT00327652|liver|liver
529315|NCT00327652|hepatic|hepatic
529316|NCT00327652|metastasis|metastasis
529317|NCT00327652|Listeria|listeria
529318|NCT00327665|pneumonia|pneumonia
529319|NCT00327665|pneumococcal vaccine|pneumococcal vaccine
529320|NCT00327665|elderly subjects|elderly subjects
529321|NCT00327665|invasive pneumococcal diseases|invasive pneumococcal diseases
529322|NCT00327665|Prophylaxis|prophylaxis
529323|NCT00327678|ALL,|all,
529324|NCT00327678|young patients,|young patients,
529325|NCT00327678|chemotherapy,|chemotherapy,
529326|NCT00327678|Mabtera,|mabtera,
529327|NCT00327678|Imatinib,|imatinib,
529328|NCT00327678|allogeneic transplant|allogeneic transplant
529329|NCT00327691|Major cardiovascular event|major cardiovascular event
529330|NCT00327691|Major Coronary event|major coronary event
529331|NCT00327691|Revascularization|revascularization
529332|NCT00327704|Septic Shock|septic shock
529333|NCT00327717|Epilepsy|epilepsy
529334|NCT00327717|Partial seizures|partial seizures
529335|NCT00327730|Muscle|muscle
529336|NCT00327730|Spasm|spasm
529337|NCT00327730|Back|back
529338|NCT00327730|Pain|pain
529339|NCT00327743|Cancer Alternative Therapies|cancer alternative therapies
529340|NCT00327743|Metastatic Breast Cancer|metastatic breast cancer
529341|NCT00327756|Depression|depression
529342|NCT00327756|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
529343|NCT00327756|Mitochondrial Enhancer|mitochondrial enhancer
529344|NCT00327756|Manic Depressive|manic depressive
529345|NCT00327756|Bioenergetics|bioenergetics
529346|NCT00327756|Bipolar Disorder|bipolar disorder
529347|NCT00327756|Manic Depression|manic depression
529348|NCT00327769|Advanced breast cancer|advanced breast cancer
529350|NCT00327769|anastrozole|anastrozole
529351|NCT00327782|pediatric|pediatric
529352|NCT00327782|palliative care|palliative care
529353|NCT00327782|end stage heart failure|end stage heart failure
529354|NCT00327795|congenital heart disease|congenital heart disease
529355|NCT00327795|pediatric|pediatric
529356|NCT00327795|surgical outcomes|surgical outcomes
529357|NCT00327808|Smokers|smokers
529358|NCT00327808|Adults|adults
529359|NCT00327808|Inflammatory markers|inflammatory markers
529360|NCT00327873|breathlessness|breathlessness
529361|NCT00327873|shortness of breath|shortness of breath
529362|NCT00327873|end-of-life care|end-of-life care
529363|NCT00327873|hospice|hospice
529364|NCT00327886|pediatric|pediatric
529365|NCT00327886|Glenn operation|glenn operation
529366|NCT00327886|Cyanosis|cyanosis
529367|NCT00327899|pediatric|pediatric
529368|NCT00327899|congestive heart failure|congestive heart failure
529369|NCT00327899|inotropes|inotropes
529370|NCT00327912|Obesity|obesity
529371|NCT00327912|Surgery|surgery
529372|NCT00327912|Gastric bypass|gastric bypass
529373|NCT00327912|Biliopancreatic diversion with Duodenal switch|biliopancreatic diversion with duodenal switch
529374|NCT00327912|Laparoscopy|laparoscopy
529375|NCT00327925|Ovarian|ovarian
529376|NCT00327925|Cancer|cancer
529377|NCT00327925|Antibodies|antibodies
529378|NCT00327925|Ovarian Cancer Associated Antibodies|ovarian cancer associated antibodies
529379|NCT00327938|Remifentanil|remifentanil
529380|NCT00327938|Skin Conductance|skin conductance
529381|NCT00327938|Anesthesia|anesthesia
529382|NCT00327938|Analgesics, Opioid|analgesics, opioid
529383|NCT00327951|pediatric|pediatric
529384|NCT00327951|cardiac|cardiac
529385|NCT00327951|weight gain pre-operative|weight gain pre-operative
529386|NCT00327951|trisomy 21|trisomy 21
529387|NCT00327951|complete atrioventricular canal|complete atrioventricular canal
529388|NCT00327964|malaria|malaria
529389|NCT00327964|fever|fever
529390|NCT00327964|Uganda|uganda
529391|NCT00327964|children|children
529392|NCT00327964|rapid diagnostic tests|rapid diagnostic tests
529393|NCT00327964|RDTs|rdts
529394|NCT00327964|Africa|africa
529395|NCT00327977|hypoxemia|hypoxemia
529396|NCT00327977|palliative neonatal surgery|palliative neonatal surgery
529397|NCT00327990|ibandronate|ibandronate
529398|NCT00327990|osteoporosis|osteoporosis
529399|NCT00327990|preference|preference
529400|NCT00327990|case-finding|case-finding
529401|NCT00327990|post-menopausal|post-menopausal
529402|NCT00327990|alendronate|alendronate
529403|NCT00328016|hypertension|hypertension
529404|NCT00328016|high blood pressure|high blood pressure
529405|NCT00328016|meditation|meditation
529406|NCT00328029|Busulfan|busulfan
529407|NCT00328029|pharmacokinetic|pharmacokinetic
529408|NCT00328029|respiratory function assessment|respiratory function assessment
529409|NCT00328029|Busulfan pharmacokinetic and respiratory function tests|busulfan pharmacokinetic and respiratory function tests
529410|NCT00328042|Self-care|self-care
529411|NCT00328042|Quality of Life|quality of life
529412|NCT00328042|Chronic disease|chronic disease
529413|NCT00328055|functional ability|functional ability
529414|NCT00328055|patient care management|patient care management
529415|NCT00328055|communication|communication
529416|NCT00328055|literacy|literacy
529417|NCT00328068|ASAS classification|asas classification
529418|NCT00328068|ASAS diagnostic criteria|asas diagnostic criteria
529419|NCT00328068|spondyloarthritis|spondyloarthritis
529420|NCT00328068|spondyloarthropathy|spondyloarthropathy
529421|NCT00328068|spondylitis, ankylosing|spondylitis, ankylosing
529422|NCT00328068|modified New York criteria for AS|modified new york criteria for as
529423|NCT00328068|ESSG criteria for SpA|essg criteria for spa
529424|NCT00328068|Amor criteria for SpA|amor criteria for spa
529425|NCT00328068|arthritis|arthritis
529426|NCT00328068|enthesitis|enthesitis
529427|NCT00328068|magnetic resonance imaging|magnetic resonance imaging
529429|NCT00328081|Weight gain|weight gain
529430|NCT00328081|Anti-obesity medication|anti-obesity medication
529431|NCT00328081|Anti-obesity management strategies|anti-obesity management strategies
529432|NCT00328081|Body Weight|body weight
529433|NCT00328094|Tight|tight
529434|NCT00328094|Glycemic|glycemic
529436|NCT00328094|outcomes|outcomes
529437|NCT00328094|peripheral vascular disease|peripheral vascular disease
529438|NCT00328094|infection|infection
529439|NCT00328094|cardiovascular|cardiovascular
529440|NCT00328094|morbidity|morbidity
529441|NCT00328094|mortality|mortality
529442|NCT00328107|Influenza|influenza
529443|NCT00328120|Advanced breast cancer|advanced breast cancer
529444|NCT00328120|Faslodex|faslodex
529445|NCT00328133|recombinant Factor VIIa|recombinant factor viia
529446|NCT00328133|traumatic hemorrhage|traumatic hemorrhage
529447|NCT00328133|hemorrhagic shock|hemorrhagic shock
529448|NCT00328133|coagulopathy|coagulopathy
529449|NCT00328146|pediatric|pediatric
529450|NCT00328146|cardiac|cardiac
529428|NCT00328081|Obesity|obesity
529451|NCT00328146|re-operative surgery|re-operative surgery
529453|NCT00328159|long-chain FAO enzyme defects|long-chain fao enzyme defects
529454|NCT00328159|inborn errors of metabolism|inborn errors of metabolism
529455|NCT00328159|carnitine palmitoyltransferase 1 (CPT1),|carnitine palmitoyltransferase 1 (cpt1),
529456|NCT00328159|carnitine-acylcarnitine translocase (CAT),|carnitine-acylcarnitine translocase (cat),
529457|NCT00328159|carnitine palmitoyltransferase 2 (CPT2),|carnitine palmitoyltransferase 2 (cpt2),
529458|NCT00328159|very-long chain acyl-CoA dehydrogenase (VLCAD),|very-long chain acyl-coa dehydrogenase (vlcad),
529459|NCT00328159|L-3-hydroxy-acyl-CoA dehydrogenase (LCHAD)|l-3-hydroxy-acyl-coa dehydrogenase (lchad)
529460|NCT00328159|or trifunctional protein (MTP).|or trifunctional protein (mtp).
529461|NCT00328185|pediatric|pediatric
529462|NCT00328185|heart disease|heart disease
529463|NCT00328185|orthotopic heart transplantation|orthotopic heart transplantation
529464|NCT00328185|allograft fibrosis|allograft fibrosis
529465|NCT00328198|CAMPATH|campath
529466|NCT00328198|Alemtuzumab|alemtuzumab
529467|NCT00328198|Leukemia|leukemia
529468|NCT00328198|MabCampath|mabcampath
529469|NCT00328198|Chronic|chronic
529470|NCT00328198|Subcutaneous|subcutaneous
529471|NCT00328198|CLL|cll
529472|NCT00328198|C-CLL|c-cll
529473|NCT00328198|Relapsed|relapsed
529474|NCT00328198|Refractory|refractory
529475|NCT00328198|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
529476|NCT00328224|ritalin|ritalin
529477|NCT00328224|ADHA|adha
529478|NCT00328224|dental status|dental status
529479|NCT00328224|periodontal status|periodontal status
529480|NCT00328224|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
529481|NCT00328224|Dental trauma|dental trauma
529482|NCT00328237|Cord Blood Transplant|cord blood transplant
529483|NCT00328237|Umbilical cord blood transplant|umbilical cord blood transplant
529484|NCT00328237|Transplant|transplant
529485|NCT00328237|Fludarabine|fludarabine
529486|NCT00328237|Total Body Irradiation|total body irradiation
529487|NCT00328237|Cyclophosphamide|cyclophosphamide
529488|NCT00328250|Internet|internet
529489|NCT00328250|CBT|cbt
529490|NCT00328250|Insomnia|insomnia
529491|NCT00328250|Sleep|sleep
529492|NCT00328263|Bio-K+CL1285|bio-k+cl1285
529493|NCT00328263|Probiotics|probiotics
529494|NCT00328263|Antibiotics-associated diarrhea|antibiotics-associated diarrhea
529590|NCT00328692|renal impairment|renal impairment
529495|NCT00328263|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
529496|NCT00328263|Lactobacillus acidophilus|lactobacillus acidophilus
529497|NCT00328263|Clostridium Difficile|clostridium difficile
529498|NCT00328289|Dialysis associated hypotension|dialysis associated hypotension
529499|NCT00328289|Urea removal|urea removal
529500|NCT00328302|Diabetes|diabetes
529501|NCT00328302|Kidney function|kidney function
529502|NCT00328302|24 ambulatory blood pressure|24 ambulatory blood pressure
529503|NCT00328302|Kidney biopsy|kidney biopsy
529504|NCT00328315|Myocardial Perfusion SPECT|myocardial perfusion spect
529505|NCT00328341|traumatic brain injury|traumatic brain injury
529506|NCT00328341|hemorrhagic shock|hemorrhagic shock
529507|NCT00328341|multisystem trauma|multisystem trauma
528853|NCT00320632|MDD|mdd
529508|NCT00328341|under resuscitation|under resuscitation
529509|NCT00328341|tissue oxygen monitoring|tissue oxygen monitoring
529510|NCT00328367|schizophrenia|schizophrenia
529511|NCT00328367|aripiprazole|aripiprazole
529512|NCT00328367|clozapine|clozapine
529513|NCT00328380|Travelers' Diarrhea|travelers' diarrhea
529514|NCT00328380|Xifaxan|xifaxan
529515|NCT00328380|Rifaximin|rifaximin
529516|NCT00328380|Escherichia coli|escherichia coli
529517|NCT00328380|E coli|e coli
529518|NCT00328380|EAEC|eaec
529519|NCT00328380|Enteroaggregative E coli|enteroaggregative e coli
529520|NCT00328380|ETEC|etec
529521|NCT00328380|Enterotoxigenic E coli|enterotoxigenic e coli
529522|NCT00328393|Hypertension|hypertension
529523|NCT00328419|Photoprotection,|photoprotection,
529524|NCT00328419|Parenteral nutrition|parenteral nutrition
529525|NCT00328419|Oxidant stress|oxidant stress
529526|NCT00328419|Infant, Premature|infant, premature
529527|NCT00328432|early breast cancer|early breast cancer
529528|NCT00328432|double-blind randomized placebo-controlled|double-blind randomized placebo-controlled
529529|NCT00328432|RCT|rct
529530|NCT00328432|pre-surgical model|pre-surgical model
529531|NCT00328432|DCIS model|dcis model
529532|NCT00328432|COX-2 inhibitor|cox-2 inhibitor
529533|NCT00328432|celecoxib|celecoxib
529534|NCT00328432|Ki-67 placebo|ki-67 placebo
529535|NCT00328445|Curriculum|curriculum
529536|NCT00328445|Classroom management|classroom management
529537|NCT00328445|School-wide climate|school-wide climate
529538|NCT00328445|Parent involvement|parent involvement
529539|NCT00328458|CNS and head and neck cancers|cns and head and neck cancers
529540|NCT00328458|Histologically confirmed CNS malignancy head and neck|histologically confirmed cns malignancy head and neck
529541|NCT00328458|there is on standard therapy or|there is on standard therapy or
529542|NCT00328458|have failed standard therapy|have failed standard therapy
529543|NCT00328471|patient care management|patient care management
529544|NCT00328471|cerebrovascular accident|cerebrovascular accident
529546|NCT00328484|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
529547|NCT00328484|Exercise|exercise
529548|NCT00328484|Emphysema|emphysema
529549|NCT00328484|Chronic Bronchitis|chronic bronchitis
529550|NCT00328510|Stereotactic radiotherapy|stereotactic radiotherapy
529551|NCT00328536|flow-mediated vasodilatation|flow-mediated vasodilatation
529552|NCT00328536|endothelial dysfunction|endothelial dysfunction
529553|NCT00328536|omega-3 fatty acids|omega-3 fatty acids
529554|NCT00328536|type 2 diabetes mellitus|type 2 diabetes mellitus
529555|NCT00328536|postprandial state|postprandial state
529556|NCT00328549|Natural History,|natural history,
529557|NCT00328549|Hepatitis C Infection|hepatitis c infection
529558|NCT00328549|Ribavirin|ribavirin
529559|NCT00328549|Pegylated Interferon|pegylated interferon
529560|NCT00328549|Interferon|interferon
529561|NCT00328562|Advanced NSCLC|advanced nsclc
529562|NCT00328562|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
529563|NCT00328562|Stage IV NSCLC|stage iv nsclc
529564|NCT00328575|Brain metastases|brain metastases
529565|NCT00328575|Parenchymal|parenchymal
529566|NCT00328575|Neoplasm|neoplasm
529567|NCT00328575|IMRT|imrt
529568|NCT00328575|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
529569|NCT00328588|Treatment Efficacy|treatment efficacy
529570|NCT00328588|Treatment Effectiveness|treatment effectiveness
529571|NCT00328588|Disease Management|disease management
529572|NCT00328588|Treatment|treatment
529573|NCT00328588|Safety|safety
529574|NCT00328614|Locally advanced prostate cancer|locally advanced prostate cancer
529575|NCT00328614|positive lymph nodes|positive lymph nodes
529576|NCT00328627|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
529577|NCT00328627|Drug Therapy|drug therapy
529578|NCT00328627|Diabetes Mellitus, Non Insulin Dependent|diabetes mellitus, non insulin dependent
529579|NCT00328627|Glucose Intolerance|glucose intolerance
529580|NCT00328627|Hyperglycemia|hyperglycemia
529581|NCT00328640|CVA|cva
529582|NCT00328640|Ischemic stroke|ischemic stroke
529583|NCT00328653|vernal keratoconjunctivitis (VKC), eye, allergy, cyclosporin|vernal keratoconjunctivitis (vkc), eye, allergy, cyclosporin
529584|NCT00328679|abdominal|abdominal
529585|NCT00328679|stomach|stomach
529586|NCT00328679|dyspepsia|dyspepsia
529587|NCT00328679|food allergy|food allergy
529588|NCT00328692|heart failure|heart failure
529589|NCT00328692|diuretic|diuretic
529591|NCT00328692|renal function|renal function
529592|NCT00328705|Sensing|sensing
529593|NCT00328705|Capture Management|capture management
529594|NCT00328705|Heart Failure|heart failure
529595|NCT00328705|ICD Indication|icd indication
529596|NCT00328718|Persistent Asthma|persistent asthma
529597|NCT00328718|pediatric asthmatic|pediatric asthmatic
529598|NCT00328718|asthma control|asthma control
529599|NCT00328731|Allergy|allergy
529600|NCT00328731|NAET|naet
529601|NCT00328744|Weight|weight
529602|NCT00328744|Dietary intake|dietary intake
529603|NCT00328744|Energy|energy
528941|NCT00320957|OculusGen|oculusgen
529604|NCT00328744|Hedonics|hedonics
529605|NCT00328744|Behavioral|behavioral
529606|NCT00328744|Sensory-specific satiety|sensory-specific satiety
529607|NCT00328744|Monotony|monotony
529608|NCT00328757|gynecologic cancer|gynecologic cancer
529609|NCT00328757|cervical cancer|cervical cancer
529610|NCT00328757|ovarian cancer|ovarian cancer
529611|NCT00328757|endometrial cancer|endometrial cancer
529612|NCT00328757|radical abdominal hysterectomy|radical abdominal hysterectomy
529613|NCT00328757|pelvic lymphadenectomy|pelvic lymphadenectomy
529614|NCT00328757|surgical staging|surgical staging
529615|NCT00328757|postoperative feeding|postoperative feeding
529616|NCT00328757|Early-stage gynecologic cancer patients|early-stage gynecologic cancer patients
529617|NCT00328770|liver transplant|liver transplant
529618|NCT00328770|hepatocellular carcinoma|hepatocellular carcinoma
529619|NCT00328770|sirolimus|sirolimus
529620|NCT00328783|Breast cancer|breast cancer
529621|NCT00328783|Active Breathing Control|active breathing control
529622|NCT00328783|Active Breathing Coordinator|active breathing coordinator
529623|NCT00328783|ABC|abc
529624|NCT00328796|Perineal|perineal
529625|NCT00328796|repair|repair
529626|NCT00328796|episiotomies|episiotomies
529627|NCT00328796|midwives|midwives
529628|NCT00328796|pain relief|pain relief
529629|NCT00328796|Episiotomy|episiotomy
529630|NCT00328822|Primary insomnia|primary insomnia
529631|NCT00328822|Quetiapine|quetiapine
529632|NCT00328822|Randomized controlled trial|randomized controlled trial
529633|NCT00328822|Double blind|double blind
529634|NCT00328835|Optic Nerve|optic nerve
529635|NCT00328835|Glaucoma|glaucoma
529636|NCT00328848|patient care management|patient care management
529637|NCT00328848|chronic disease|chronic disease
529638|NCT00328861|Adoptive Cell Therapy|adoptive cell therapy
529639|NCT00328861|Cutaneous Melanoma|cutaneous melanoma
529640|NCT00328861|Clinical Response|clinical response
529641|NCT00328861|Rate of Repopulation|rate of repopulation
529642|NCT00328861|Toxicity Profile|toxicity profile
529643|NCT00328861|Metastatic Melanoma|metastatic melanoma
529644|NCT00328861|Metastatic Kidney Cancer|metastatic kidney cancer
529645|NCT00328874|Progressive Supranuclear Palsy|progressive supranuclear palsy
529646|NCT00328874|Coenzyme Q10|coenzyme q10
529647|NCT00328887|Esophageal Neoplasms|esophageal neoplasms
529648|NCT00328900|Galvanic skin response|galvanic skin response
529649|NCT00328900|Anesthesia|anesthesia
529650|NCT00328900|Atropine|atropine
529651|NCT00328913|satiety|satiety
529652|NCT00328913|food intake|food intake
529653|NCT00328913|mood|mood
529654|NCT00328913|wellness|wellness
529655|NCT00328913|weight management|weight management
529656|NCT00328926|Hypogonadotropic Hypogonadism (LH <1.2 IU/L)|hypogonadotropic hypogonadism (lh <1.2 iu/l)
529657|NCT00328926|Placebo|placebo
529658|NCT00328926|Luveris® 75 IU|luveris® 75 iu
529659|NCT00328926|Luveris® 25 IU|luveris® 25 iu
529660|NCT00328926|Recombinant human chorionic gonadotropin (r-hCG)|recombinant human chorionic gonadotropin (r-hcg)
529661|NCT00328939|ARIXTRA|arixtra
529662|NCT00328939|prevention of DVT|prevention of dvt
529663|NCT00328952|schizophrenia|schizophrenia
529664|NCT00328952|auditory verbal hallucination|auditory verbal hallucination
529665|NCT00328952|antipsychotic treatment|antipsychotic treatment
529666|NCT00328965|Korean patients|korean patients
529667|NCT00328965|Type 2 diabetes|type 2 diabetes
529668|NCT00328965|Endothelial function|endothelial function
529669|NCT00328965|lacidipine|lacidipine
529670|NCT00328965|Essential hypertension|essential hypertension
529671|NCT00328978|schizophrenia|schizophrenia
529672|NCT00328978|schizoaffective disorders|schizoaffective disorders
529673|NCT00328991|wart|wart
529674|NCT00328991|common wart|common wart
529675|NCT00328991|verruca vulgaris|verruca vulgaris
529676|NCT00328991|verruca plantaris|verruca plantaris
529677|NCT00328991|plantar wart|plantar wart
529678|NCT00328991|duct tape|duct tape
529679|NCT00328991|occlusion therapy|occlusion therapy
529680|NCT00329004|Solid Tumors|solid tumors
529681|NCT00329017|SNPs|snps
529682|NCT00329017|single nucleotide polymorphism|single nucleotide polymorphism
529683|NCT00329017|breast atypia|breast atypia
529684|NCT00329017|breast epithelial hyperplasia|breast epithelial hyperplasia
529685|NCT00329017|high risk for breast cancer|high risk for breast cancer
529686|NCT00329030|Large B-Cell Lymphoma|large b-cell lymphoma
529687|NCT00329030|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
529688|NCT00329043|Prostate Cancer|prostate cancer
529689|NCT00329043|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
529690|NCT00329043|Ductal Adenocarcinoma of the Prostate|ductal adenocarcinoma of the prostate
529691|NCT00329043|Hormonal Ablation|hormonal ablation
529692|NCT00329043|Radical Prostatectomy|radical prostatectomy
529693|NCT00329043|LHRH Agonist|lhrh agonist
529694|NCT00329043|Lupron|lupron
529695|NCT00329043|Leuprolide|leuprolide
529696|NCT00329043|Sunitinib Malate|sunitinib malate
529697|NCT00329043|SU011248|su011248
529698|NCT00329056|Parkinson's disease|parkinson's disease
683561|NCT00903422|MDS|mds
529042|NCT00307671|cyclophosphamide|cyclophosphamide
529699|NCT00329056|MitoQ|mitoq
529700|NCT00329056|UPDRS|updrs
529701|NCT00329069|statin|statin
529702|NCT00329069|atorvastatin|atorvastatin
529703|NCT00329069|hypercholesterolemia|hypercholesterolemia
529704|NCT00329069|coronary artery disease|coronary artery disease
529705|NCT00329069|monocyte|monocyte
529706|NCT00329069|collateral formation|collateral formation
529707|NCT00329069|arteriogenesis|arteriogenesis
529708|NCT00329069|chemotaxis|chemotaxis
529709|NCT00329069|migration|migration
529710|NCT00329069|growth factors|growth factors
529711|NCT00329069|vascular endothelial growth factor A|vascular endothelial growth factor a
529712|NCT00329069|placenta growth factor 1|placenta growth factor 1
529713|NCT00329069|hepatocyte growth factor|hepatocyte growth factor
529714|NCT00329069|monocyte chemotactic protein 1|monocyte chemotactic protein 1
529715|NCT00329095|Glaucoma|glaucoma
529716|NCT00329095|Compliance|compliance
529717|NCT00329121|SCCIS|sccis
529718|NCT00329121|Bowens disease|bowens disease
529719|NCT00329121|PEP005|pep005
529720|NCT00329121|Topical|topical
529721|NCT00329121|Dermatology|dermatology
529722|NCT00329121|Cutaneous Squamous Cell Carcinoma in situ|cutaneous squamous cell carcinoma in situ
529723|NCT00329147|Healthy Subjects|healthy subjects
529724|NCT00329147|Major Depressive Disorder|major depressive disorder
529725|NCT00329147|Depression|depression
529726|NCT00329186|Healthy Subjects|healthy subjects
529727|NCT00329186|Major Depressive Disorder|major depressive disorder
529728|NCT00329186|Depression|depression
529729|NCT00329186|Cytochrome P-450 CYP2D6|cytochrome p-450 cyp2d6
529730|NCT00329186|Pharmacokinetics|pharmacokinetics
529731|NCT00329186|Health|health
529732|NCT00329199|Depression|depression
529733|NCT00329199|Adolescents|adolescents
529734|NCT00329199|Family Therapy|family therapy
529735|NCT00329199|Primary Care|primary care
529736|NCT00329199|Family Conflict|family conflict
529737|NCT00329212|Pharmacokinetics|pharmacokinetics
529738|NCT00329212|Bioavailability|bioavailability
529739|NCT00329212|Therapeutic Equivalency|therapeutic equivalency
529740|NCT00329225|Type 2 Diabetes Mellitus Thiazolidinediones Insulin|type 2 diabetes mellitus thiazolidinediones insulin
529741|NCT00329251|HIV|hiv
529742|NCT00329251|Viral load|viral load
529743|NCT00329251|Vaccines|vaccines
529744|NCT00329251|Immunotherapy|immunotherapy
529746|NCT00329264|anxiety|anxiety
529747|NCT00329277|age-related macular degeneration|age-related macular degeneration
529748|NCT00329277|preferred retinal locus|preferred retinal locus
529749|NCT00329277|macular perimetry|macular perimetry
529750|NCT00329290|pregnancy|pregnancy
529751|NCT00329290|anticoagulation|anticoagulation
529752|NCT00329290|enoxaparin|enoxaparin
529753|NCT00329290|prosthetic heart valves|prosthetic heart valves
529754|NCT00329303|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
529755|NCT00329303|anti TNF α|anti tnf α
529756|NCT00329303|CDP 870|cdp 870
529757|NCT00329303|Cimzia®|cimzia®
529758|NCT00329303|certolizumab pegol|certolizumab pegol
529759|NCT00329303|retreatment|retreatment
529760|NCT00329316|Pre-term labor|pre-term labor
529761|NCT00329316|progesterone|progesterone
529762|NCT00329329|Advanced solid malignancies|advanced solid malignancies
529763|NCT00329342|Low back pain;|low back pain;
529764|NCT00329342|Return to work;|return to work;
529765|NCT00329342|Posture|posture
529766|NCT00329355|menstrual migraine|menstrual migraine
529767|NCT00329355|headache|headache
529768|NCT00329355|early intervention|early intervention
529769|NCT00329355|dysmenorrhea|dysmenorrhea
529770|NCT00329368|Cancer|cancer
529771|NCT00329368|Vaccine|vaccine
529772|NCT00329368|Phase I|phase i
529773|NCT00329368|FolateImmune|folateimmune
529774|NCT00329368|Recurrent|recurrent
529775|NCT00329368|Refractory|refractory
529776|NCT00329368|Experimental|experimental
529777|NCT00329381|Allergic|allergic
529778|NCT00329381|Asthma|asthma
529779|NCT00329381|Immunotherapy|immunotherapy
529780|NCT00329394|Ketamine|ketamine
529781|NCT00329394|Analgesia|analgesia
529782|NCT00329394|Alcool-dependent|alcool-dependent
529783|NCT00329394|carcinological surgery|carcinological surgery
529784|NCT00329407|Alcoholism|alcoholism
529785|NCT00329407|Heavy Drinking|heavy drinking
529786|NCT00329407|Alcohol Dependence|alcohol dependence
529787|NCT00329420|Crohn's Disease|crohn's disease
529788|NCT00329420|CDP870|cdp870
529789|NCT00329420|Certolizumab pegol|certolizumab pegol
529790|NCT00329420|CZP|czp
529791|NCT00329433|Deep venous thrombosis|deep venous thrombosis
529792|NCT00329433|DVT|dvt
530102|NCT00311909|TSSL|tssl
529793|NCT00329433|Heparin induced thrombocytopenia|heparin induced thrombocytopenia
529794|NCT00329433|HIT|hit
529795|NCT00329433|Direct thrombin inhibitor|direct thrombin inhibitor
529796|NCT00329446|GAD|gad
529797|NCT00329446|anxiety|anxiety
529798|NCT00329459|menstrual migraine|menstrual migraine
529799|NCT00329459|headache|headache
683755|NCT00904332|HV|hv
529132|NCT00308048|Interferon|interferon
529800|NCT00329459|early intervention|early intervention
529801|NCT00329459|dysmenorrhea|dysmenorrhea
529802|NCT00329485|Elevated BNP Levels in CHF patients|elevated bnp levels in chf patients
529803|NCT00329498|ascorbic acid|ascorbic acid
529804|NCT00329511|pregnancy|pregnancy
529805|NCT00329511|hypertension|hypertension
529806|NCT00329511|compliance|compliance
529807|NCT00329511|clonidine patch|clonidine patch
529808|NCT00329511|methyldopa|methyldopa
529809|NCT00329524|Tinnitus|tinnitus
529810|NCT00329524|TMS|tms
529811|NCT00329524|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
529812|NCT00329537|Crohn's Disease|crohn's disease
529813|NCT00329537|Sargramostim|sargramostim
529814|NCT00329537|CDAI|cdai
529815|NCT00329537|Moderately to severely active Crohn's Disease|moderately to severely active crohn's disease
529816|NCT00329550|Certolizumab pegol|certolizumab pegol
529817|NCT00329550|Cimzia|cimzia
529818|NCT00329550|CZP|czp
529819|NCT00329563|Cardiac Arrest|cardiac arrest
529820|NCT00329563|Hypothermia|hypothermia
529821|NCT00329589|Malignancies of the central nervous system, head and neck area|malignancies of the central nervous system, head and neck area
529822|NCT00329589|and cervix|and cervix
529823|NCT00329602|Moderate|moderate
529824|NCT00329602|Restless Legs Syndrome|restless legs syndrome
529825|NCT00329602|Severe|severe
529826|NCT00329602|ropinirole|ropinirole
529827|NCT00329615|Cancer cachexia|cancer cachexia
529828|NCT00329615|Tumor host metabolism|tumor host metabolism
529829|NCT00329628|Prevention|prevention
529830|NCT00329628|Thromboembolism|thromboembolism
529831|NCT00329654|Burn wounds, light therapy|burn wounds, light therapy
529833|NCT00329667|mitral|mitral
529834|NCT00329667|aortic|aortic
529835|NCT00329667|valvular disease|valvular disease
529836|NCT00329680|Sepsis|sepsis
529837|NCT00329680|Severe Sepsis|severe sepsis
529838|NCT00329680|Septic Shock|septic shock
529839|NCT00329680|Enteral Nutrition|enteral nutrition
529840|NCT00329680|Antioxidants|antioxidants
529841|NCT00329680|EPA|epa
529842|NCT00329680|GLA|gla
529843|NCT00329680|Nutrition|nutrition
529844|NCT00329680|Intensive Care|intensive care
529845|NCT00329680|ICU|icu
529846|NCT00329706|mild cognitive impairment|mild cognitive impairment
529847|NCT00329706|Alzheimer's disease|alzheimer's disease
529848|NCT00329706|dementia|dementia
529849|NCT00329706|FDG|fdg
529850|NCT00329706|PET|pet
529851|NCT00329745|Rotavirus Gastroenteritis|rotavirus gastroenteritis
529852|NCT00329745|Human rotavirus vaccine, efficacy, infants|human rotavirus vaccine, efficacy, infants
529853|NCT00329758|moderate head injury|moderate head injury
529855|NCT00329758|statin|statin
529856|NCT00329758|amnesia|amnesia
529857|NCT00329758|orientation|orientation
529858|NCT00329784|peanut allergy|peanut allergy
529859|NCT00329784|egg allergy|egg allergy
529860|NCT00329784|eczema|eczema
529861|NCT00329784|peanut|peanut
529862|NCT00329784|allergy|allergy
529863|NCT00329784|allergies|allergies
529864|NCT00329784|allergic reaction|allergic reaction
529865|NCT00329784|anaphylaxis|anaphylaxis
529866|NCT00329784|infants|infants
529867|NCT00329784|children|children
529868|NCT00329797|osteoporosis|osteoporosis
529869|NCT00329797|adenocarcinoma of the prostate|adenocarcinoma of the prostate
529870|NCT00329797|stage IIB prostate cancer|stage iib prostate cancer
529871|NCT00329797|stage IIA prostate cancer|stage iia prostate cancer
529872|NCT00329797|stage III prostate cancer|stage iii prostate cancer
529873|NCT00329797|stage IV prostate cancer|stage iv prostate cancer
529874|NCT00329823|Hidradenitis suppurativa, etanercept|hidradenitis suppurativa, etanercept
529875|NCT00329849|Meningitis|meningitis
529876|NCT00329849|children|children
529877|NCT00329849|vaccine|vaccine
529878|NCT00329849|safety|safety
529879|NCT00329849|efficacy|efficacy
529880|NCT00329862|Laparoscopic Adjustable Gastric Banding|laparoscopic adjustable gastric banding
529881|NCT00329862|Truncal Vagotomy|truncal vagotomy
529882|NCT00329862|Lap Band|lap band
529883|NCT00329862|Lap Banding|lap banding
529884|NCT00329862|Obesity Surgery|obesity surgery
529885|NCT00329862|Bariatric surgery|bariatric surgery
529886|NCT00329862|Weight Loss Surgery|weight loss surgery
529887|NCT00329888|Endoscopic papillary balloon dilatation|endoscopic papillary balloon dilatation
529888|NCT00329888|Endoscopic sphincterotomy|endoscopic sphincterotomy
529889|NCT00329901|Meningitis|meningitis
529890|NCT00329901|healthy subject|healthy subject
529891|NCT00329901|vaccine|vaccine
529892|NCT00310960|infantile esotropia|infantile esotropia
529893|NCT00310960|acquired non-accommodative esotropia|acquired non-accommodative esotropia
529894|NCT00310960|acquired partially accommodative esotropia|acquired partially accommodative esotropia
529895|NCT00310973|HIV|hiv
529896|NCT00310973|Prevention|prevention
529897|NCT00310973|Risk Behavior Reduction|risk behavior reduction
529898|NCT00310973|Roma|roma
529899|NCT00310973|Bulgaria|bulgaria
529900|NCT00310973|HIV seronegativity|hiv seronegativity
683896|NCT00904644|HIV|hiv
529233|NCT00321568|MRI|mri
529901|NCT00310986|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
529902|NCT00310986|meditation|meditation
529903|NCT00310986|breathing meditation|breathing meditation
529904|NCT00310986|Anapanasathi|anapanasathi
529905|NCT00310986|randomized controlled trial|randomized controlled trial
529906|NCT00310986|nonpharmacologic treatment|nonpharmacologic treatment
529907|NCT00310986|complementary and alternative medicine|complementary and alternative medicine
529908|NCT00310999|Cervical Vertebrae|cervical vertebrae
529909|NCT00310999|Intubation, Intratracheal|intubation, intratracheal
529910|NCT00310999|Laryngoscopes|laryngoscopes
529911|NCT00310999|Fluoroscopy|fluoroscopy
529912|NCT00311012|Hypertension, Aliskiren|hypertension, aliskiren
529914|NCT00311025|physical therapy|physical therapy
529915|NCT00311025|rehabilitation|rehabilitation
529916|NCT00311025|exercise|exercise
529917|NCT00311025|longterm follow-up|longterm follow-up
529918|NCT00311038|ONO-1101|ono-1101
529919|NCT00311038|Landiolol Hydrochloride|landiolol hydrochloride
529920|NCT00311038|Multi-slice CT|multi-slice ct
529921|NCT00311038|Coronary Artery Disease|coronary artery disease
529922|NCT00311051|Asthma|asthma
529923|NCT00311051|Allergens|allergens
529924|NCT00311051|house dust mites|house dust mites
529925|NCT00311051|Ramatroban|ramatroban
529926|NCT00311051|Montelukast|montelukast
529927|NCT00311051|Bronchial Provocation Tests|bronchial provocation tests
529928|NCT00311090|Deep Venous Thrombosis|deep venous thrombosis
529929|NCT00311103|Elderly|elderly
529930|NCT00311103|Disability|disability
529931|NCT00311103|Musculoskeletal diseases|musculoskeletal diseases
529932|NCT00311116|Vitamin E|vitamin e
529933|NCT00311116|Cancer|cancer
529934|NCT00311116|pediatrics|pediatrics
529935|NCT00311116|supportive care|supportive care
529936|NCT00311116|oral mucositis|oral mucositis
529937|NCT00311116|Bayesian analysis|bayesian analysis
529938|NCT00311116|N-of-1 trial|n-of-1 trial
529940|NCT00311142|Sleep pattern|sleep pattern
529941|NCT00311142|newborn|newborn
529942|NCT00311142|actigraphy|actigraphy
529943|NCT00311142|delivery mode|delivery mode
529944|NCT00311142|Parents' approval|parents' approval
529945|NCT00311155|Olmesartan medoxomil|olmesartan medoxomil
529946|NCT00311155|Hypertension|hypertension
529947|NCT00311181|ICD|icd
529948|NCT00311181|Defibrillation|defibrillation
529949|NCT00311181|ULV|ulv
529950|NCT00311181|Tuned|tuned
529951|NCT00311194|Heart failure|heart failure
529952|NCT00311194|Education|education
529953|NCT00311194|CD-ROM|cd-rom
529954|NCT00311194|Randomization|randomization
529955|NCT00311194|Hospitalization|hospitalization
529956|NCT00311194|Readmission|readmission
529958|NCT00311194|Knowledge|knowledge
529959|NCT00311207|diagnostic kit|diagnostic kit
529960|NCT00311207|immunochromatography test|immunochromatography test
529961|NCT00311207|PCR detection kit|pcr detection kit
529962|NCT00311207|luminex|luminex
529963|NCT00311220|tuberculosis|tuberculosis
529964|NCT00311220|latent tuberculosis|latent tuberculosis
529965|NCT00311220|tuberculin skin test|tuberculin skin test
529966|NCT00311220|quantiferon TB-RD1|quantiferon tb-rd1
529967|NCT00311220|contact screening|contact screening
529968|NCT00311220|elderly|elderly
529969|NCT00311233|child|child
529970|NCT00311233|psychosocial|psychosocial
529971|NCT00311233|predictors|predictors
529972|NCT00311233|cohort|cohort
529973|NCT00311233|recurrent|recurrent
529974|NCT00311246|Sarcoidosis|sarcoidosis
529975|NCT00311246|Humira|humira
529976|NCT00311246|Adalimumab|adalimumab
529977|NCT00311246|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors
529978|NCT00311272|dendritic cells|dendritic cells
529979|NCT00311272|antigens, neoplasm|antigens, neoplasm
529980|NCT00311285|Electromyography|electromyography
529981|NCT00311285|Glucocorticoids|glucocorticoids
529982|NCT00311285|Heart Rate|heart rate
529983|NCT00311285|Physical workload|physical workload
529984|NCT00311285|Mental workload|mental workload
529985|NCT00311285|Ergonomics|ergonomics
529986|NCT00311285|Laparoscopy|laparoscopy
529987|NCT00311285|Workload|workload
529988|NCT00311285|Biomechanics|biomechanics
529989|NCT00311298|tuberculosis|tuberculosis
529990|NCT00311298|hiv|hiv
529991|NCT00311298|diabetes|diabetes
529992|NCT00311298|protein-energy|protein-energy
529993|NCT00311298|micronutrients|micronutrients
529994|NCT00311311|Kidney transplant|kidney transplant
529995|NCT00311311|Renal transplant|renal transplant
529996|NCT00311311|Immunosuppression|immunosuppression
529997|NCT00311311|Atherosclerosis|atherosclerosis
529998|NCT00311311|Graft Rejection|graft rejection
529999|NCT00311324|behavioral intervention|behavioral intervention
530000|NCT00311337|VELCADE|velcade
530001|NCT00311337|bortezomib|bortezomib
530002|NCT00311337|maintenance treatment|maintenance treatment
530003|NCT00311337|multiple myeloma|multiple myeloma
530004|NCT00311337|primary disease|primary disease
530005|NCT00311350|Safety|safety
530006|NCT00311350|Health|health
683905|NCT00904670|ADHD|adhd
530007|NCT00311350|Pharmacokinetics|pharmacokinetics
530008|NCT00311350|ileus|ileus
530009|NCT00311389|Glaucoma|glaucoma
530010|NCT00311389|POAG|poag
530011|NCT00311389|OAG|oag
530012|NCT00311389|OHT|oht
530013|NCT00311415|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
530014|NCT00311415|meningococcal vaccines|meningococcal vaccines
530015|NCT00311415|conjugate|conjugate
530016|NCT00311415|immunology|immunology
530017|NCT00311415|infant|infant
530018|NCT00311415|antibody persistence|antibody persistence
530019|NCT00311428|Influenza|influenza
530020|NCT00311428|Children|children
530021|NCT00311428|Vaccine|vaccine
530022|NCT00311441|TBE, children, vaccine|tbe, children, vaccine
530023|NCT00311467|renal cell cancer|renal cell cancer
530024|NCT00311480|influenza|influenza
530025|NCT00311480|pandemic influenza|pandemic influenza
530026|NCT00311480|influenza vaccine|influenza vaccine
530027|NCT00311480|adjuvanted influenza vaccine|adjuvanted influenza vaccine
530028|NCT00311493|TBE|tbe
530029|NCT00311493|vaccine|vaccine
530030|NCT00311493|adults|adults
530031|NCT00311506|Pulmozyme|pulmozyme
530032|NCT00311519|Subcutaneous hydration|subcutaneous hydration
530033|NCT00311519|Hylenex|hylenex
530034|NCT00311519|Hyaluronidase|hyaluronidase
530035|NCT00311545|recurrent renal cell cancer|recurrent renal cell cancer
530036|NCT00311545|stage IV renal cell cancer|stage iv renal cell cancer
530037|NCT00311545|stage III renal cell cancer|stage iii renal cell cancer
530038|NCT00311558|stage IV melanoma|stage iv melanoma
530039|NCT00311558|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
530040|NCT00311558|recurrent melanoma|recurrent melanoma
530041|NCT00311571|bedrest|bedrest
530042|NCT00311571|spaceflight|spaceflight
530043|NCT00311571|Weightlessness|weightlessness
530044|NCT00311571|Countermeasure|countermeasure
530045|NCT00311584|recurrent neuroblastoma|recurrent neuroblastoma
530046|NCT00311597|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
530047|NCT00311610|recurrent colon cancer|recurrent colon cancer
530048|NCT00311610|stage IV colon cancer|stage iv colon cancer
530049|NCT00311610|recurrent rectal cancer|recurrent rectal cancer
530050|NCT00311610|stage IV rectal cancer|stage iv rectal cancer
530051|NCT00311623|stage III prostate cancer|stage iii prostate cancer
530052|NCT00311623|stage I prostate cancer|stage i prostate cancer
530053|NCT00311623|stage IIB prostate cancer|stage iib prostate cancer
530054|NCT00311623|stage IIA prostate cancer|stage iia prostate cancer
530055|NCT00311623|adenocarcinoma of the prostate|adenocarcinoma of the prostate
530056|NCT00311636|stage I breast cancer|stage i breast cancer
530057|NCT00311636|stage II breast cancer|stage ii breast cancer
530058|NCT00311636|stage IIIA breast cancer|stage iiia breast cancer
530059|NCT00311636|stage IIIB breast cancer|stage iiib breast cancer
530060|NCT00311636|stage IIIC breast cancer|stage iiic breast cancer
530061|NCT00311649|H5N1, Influenza|h5n1, influenza
530062|NCT00311675|influenza, A/H5N1, vaccine|influenza, a/h5n1, vaccine
530063|NCT00311688|IL-2|il-2
530064|NCT00311688|Immunomodulatory Therapies|immunomodulatory therapies
530065|NCT00311701|Influenza, pediatric|influenza, pediatric
530066|NCT00311714|Influenza, United Kingdom|influenza, united kingdom
530067|NCT00311727|Cell-Mediated Immune Responses, Influenza, A/H5N1, Vaccine, sub-study|cell-mediated immune responses, influenza, a/h5n1, vaccine, sub-study
530068|NCT00311740|Hypertension,|hypertension,
530069|NCT00311740|Valsartan,|valsartan,
530070|NCT00311740|Hydrochlorothiazide|hydrochlorothiazide
530071|NCT00311753|heparin, thromboprophylaxis, medical patients, acutely ill|heparin, thromboprophylaxis, medical patients, acutely ill
530072|NCT00311753|Acutely ill non surgical patients|acutely ill non surgical patients
530073|NCT00311753|Immobilization|immobilization
530074|NCT00311766|Epidermolysis Bullosa|epidermolysis bullosa
530075|NCT00311766|cutaneous wound-healing|cutaneous wound-healing
530076|NCT00311766|chronic wound-healing|chronic wound-healing
530077|NCT00311766|Thymosin Beta 4|thymosin beta 4
530078|NCT00311766|laminin-5|laminin-5
530079|NCT00311779|Pediculosis capitis|pediculosis capitis
530080|NCT00311779|Head Lice|head lice
530081|NCT00311779|Crawlers|crawlers
530082|NCT00311779|Ova|ova
530083|NCT00311792|training|training
530084|NCT00311792|teaching|teaching
530085|NCT00311792|curriculum|curriculum
530086|NCT00311831|Pediatrics|pediatrics
530087|NCT00311831|Gastroenteritis|gastroenteritis
530088|NCT00311831|Education|education
530089|NCT00311857|Cetuximab|cetuximab
530090|NCT00311883|Cystic Fibrosis|cystic fibrosis
530091|NCT00311883|Induced sputum|induced sputum
530092|NCT00311883|Lung inflammation|lung inflammation
530093|NCT00311896|Cancer|cancer
530094|NCT00311896|Thrombosis|thrombosis
530095|NCT00311896|Catheter|catheter
530096|NCT00311896|Bemiparin|bemiparin
530097|NCT00311896|Prophylaxis|prophylaxis
530098|NCT00311909|Tourette Syndrome|tourette syndrome
530099|NCT00311909|Deep Brain Stimulation|deep brain stimulation
530100|NCT00311909|Video assessment|video assessment
530101|NCT00311909|YGTSS|ygtss
530103|NCT00311922|Diabetes|diabetes
530104|NCT00311922|Education|education
530105|NCT00311922|Health Literacy|health literacy
530106|NCT00311935|Hernia|hernia
530107|NCT00311935|Inguinal|inguinal
530108|NCT00311935|Groin|groin
530109|NCT00311935|Laparoscopic|laparoscopic
530110|NCT00311935|Open|open
530111|NCT00311935|Abdominal wall|abdominal wall
530112|NCT00311948|Teen smokers|teen smokers
530113|NCT00311948|Quithelper|quithelper
530114|NCT00311948|Tobacco|tobacco
530115|NCT00311948|Tobacco Website|tobacco website
530116|NCT00311948|Website Intervention|website intervention
530117|NCT00311948|Tobacco counseling|tobacco counseling
530118|NCT00311948|Tobacco abstinence|tobacco abstinence
530119|NCT00311961|COPD|copd
530120|NCT00311961|Exacerbations|exacerbations
530121|NCT00311961|Corticosteroids|corticosteroids
530122|NCT00311961|Oral|oral
530123|NCT00311961|Intravenous|intravenous
530124|NCT00311961|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
530125|NCT00311974|Dihydralazine|dihydralazine
530126|NCT00311974|Sympathetic activation|sympathetic activation
530127|NCT00311974|Fractional sodium excretion|fractional sodium excretion
530128|NCT00311987|Hypercholesterolemia|hypercholesterolemia
530129|NCT00311987|Thyroid hormone|thyroid hormone
530130|NCT00311987|Diiodothyropropionic acid|diiodothyropropionic acid
530131|NCT00311987|Therapy|therapy
530132|NCT00312000|colorectal|colorectal
530133|NCT00312000|cancer|cancer
530134|NCT00312000|capecitabine|capecitabine
530135|NCT00312000|irinotecan|irinotecan
530136|NCT00312000|oxaliplatin|oxaliplatin
530137|NCT00312013|low molecular weight heparin|low molecular weight heparin
530138|NCT00312013|nadroparin|nadroparin
530139|NCT00312013|non-small cell lung cancer|non-small cell lung cancer
530141|NCT00312013|prostate cancer|prostate cancer
530142|NCT00312013|pancreatic cancer|pancreatic cancer
530143|NCT00312026|Plaque Psoriasis|plaque psoriasis
530144|NCT00312026|Hands|hands
530145|NCT00312026|Feet|feet
530146|NCT00312026|Hand|hand
530147|NCT00312039|HIV-1|hiv-1
530148|NCT00312039|treatment experienced|treatment experienced
530149|NCT00312052|Coronary Artery Disease|coronary artery disease
530150|NCT00312065|servocontrolled|servocontrolled
530151|NCT00312065|radiant warmer|radiant warmer
530152|NCT00312065|thermistor|thermistor
530153|NCT00312065|heat shield|heat shield
530154|NCT00312078|Minimal Hepatic Encephalopathy|minimal hepatic encephalopathy
530155|NCT00312078|Cirrhosis|cirrhosis
530156|NCT00312091|Pharmacokinetics|pharmacokinetics
530157|NCT00312091|Treatment Experienced|treatment experienced
530158|NCT00312117|contrast induced nephropathy|contrast induced nephropathy
530159|NCT00312117|sodium bicarbonate|sodium bicarbonate
530160|NCT00312117|cardiac catheterization|cardiac catheterization
530161|NCT00312130|Vildaglptin|vildaglptin
530162|NCT00312130|Pre-diabetes|pre-diabetes
530163|NCT00312143|De novo Kidney Transplant recipients, enteric-coated mycophenolate sodium|de novo kidney transplant recipients, enteric-coated mycophenolate sodium
530164|NCT00312169|HIV|hiv
530165|NCT00312169|NNRTI|nnrti
530166|NCT00312169|Incomplete virologic suppression|incomplete virologic suppression
530167|NCT00312169|treatment experienced|treatment experienced
530168|NCT00312195|Chronic pain|chronic pain
530169|NCT00312195|opioid|opioid
530170|NCT00312195|transdermal|transdermal
530171|NCT00312195|Butrans™ [BTDS]|butrans™ [btds]
530172|NCT00312221|Osteoarthritis, opioid, transdermal|osteoarthritis, opioid, transdermal
530173|NCT00313222|CTEPH|cteph
530174|NCT00313222|bosentan|bosentan
530175|NCT00313235|Dendritic Vaccine|dendritic vaccine
530176|NCT00313235|Melanoma|melanoma
530177|NCT00313235|Cyclophosphamide (CPA)|cyclophosphamide (cpa)
530178|NCT00313248|Breast Cancer|breast cancer
530179|NCT00313248|Metastatic Breast Cancer|metastatic breast cancer
530180|NCT00313326|Adaptive Support ventilation|adaptive support ventilation
530181|NCT00313326|Weaning|weaning
530182|NCT00313339|myocardial infarction|myocardial infarction
530183|NCT00313339|bone marrow|bone marrow
530184|NCT00313339|cd34+|cd34+
530185|NCT00313339|stem cells|stem cells
530186|NCT00313352|adult|adult
530187|NCT00313352|cardiac|cardiac
530188|NCT00313352|transposition of great arteries|transposition of great arteries
530189|NCT00313352|beta-adrenergic blockers|beta-adrenergic blockers
530190|NCT00313378|Thoracotomy|thoracotomy
530191|NCT00313378|Neuropathic pain|neuropathic pain
530192|NCT00313378|Nerve trauma|nerve trauma
530193|NCT00313378|Ketamine|ketamine
530194|NCT00313378|NMDA receptors|nmda receptors
530195|NCT00313404|Norovirus|norovirus
530196|NCT00313404|Gastroenteritis|gastroenteritis
530197|NCT00313404|Clinical Trial|clinical trial
530198|NCT00313404|Stomach flu|stomach flu
530199|NCT00313417|Creatine|creatine
530200|NCT00313417|major depressive disorders|major depressive disorders
530201|NCT00313430|Urine concentration ability|urine concentration ability
530202|NCT00313430|chronic renal insufficiency|chronic renal insufficiency
530203|NCT00313430|hypertension|hypertension
530204|NCT00313430|aquaporin2|aquaporin2
530205|NCT00313430|Patients with chronic renal insufficiency|patients with chronic renal insufficiency
529545|NCT00328484|COPD|copd
530206|NCT00313430|Patients with hypertension|patients with hypertension
530291|NCT00313677|B3GNT1|b3gnt1
530207|NCT00313430|Healthy volunteers|healthy volunteers
530208|NCT00313443|Anti-Arrhythmia Agents|anti-arrhythmia agents
530209|NCT00313443|Amiodarone, chronic treatment|amiodarone, chronic treatment
530210|NCT00313443|Amiodarone, adverse effects|amiodarone, adverse effects
530211|NCT00313443|Biopsy, Fine-Needle, Adipose tissue|biopsy, fine-needle, adipose tissue
530212|NCT00313443|Drug concentrations in tissues|drug concentrations in tissues
530213|NCT00313443|Drug accumulation in tissues|drug accumulation in tissues
530214|NCT00313469|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
530215|NCT00313469|Elderly|elderly
530216|NCT00313469|Anticoagulants|anticoagulants
530217|NCT00313495|Huntington disease, observational, family members, biomarker|huntington disease, observational, family members, biomarker
530218|NCT00313508|stage IV melanoma|stage iv melanoma
530219|NCT00313508|recurrent melanoma|recurrent melanoma
530220|NCT00313508|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
530221|NCT00313508|recurrent intraocular melanoma|recurrent intraocular melanoma
530222|NCT00313508|metastatic intraocular melanoma|metastatic intraocular melanoma
530223|NCT00313508|extraocular extension melanoma|extraocular extension melanoma
530224|NCT00313508|iris melanoma|iris melanoma
530225|NCT00313521|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
530226|NCT00313521|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
530227|NCT00313534|recurrent prostate cancer|recurrent prostate cancer
530228|NCT00313534|stage IIB prostate cancer|stage iib prostate cancer
530229|NCT00313534|stage IIA prostate cancer|stage iia prostate cancer
530230|NCT00313534|stage III prostate cancer|stage iii prostate cancer
530231|NCT00313534|stage I prostate cancer|stage i prostate cancer
530232|NCT00313547|Blood pressure|blood pressure
530233|NCT00313547|Hypertension|hypertension
530234|NCT00313547|Renin|renin
530235|NCT00313547|Aldosterone|aldosterone
530236|NCT00313547|Heart rate variability|heart rate variability
530237|NCT00313560|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
530238|NCT00313560|stage I pancreatic cancer|stage i pancreatic cancer
530239|NCT00313560|stage II pancreatic cancer|stage ii pancreatic cancer
530240|NCT00313573|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
530241|NCT00313573|pain|pain
530242|NCT00313573|depression|depression
530243|NCT00313599|recurrent breast cancer|recurrent breast cancer
530244|NCT00313599|stage IV breast cancer|stage iv breast cancer
530245|NCT00313599|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
530246|NCT00313599|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
530247|NCT00313599|recurrent prostate cancer|recurrent prostate cancer
530248|NCT00313599|stage IV prostate cancer|stage iv prostate cancer
530249|NCT00313599|recurrent bladder cancer|recurrent bladder cancer
530250|NCT00313599|stage IV bladder cancer|stage iv bladder cancer
530251|NCT00313599|recurrent gastric cancer|recurrent gastric cancer
530252|NCT00313599|stage IV gastric cancer|stage iv gastric cancer
530253|NCT00313599|recurrent esophageal cancer|recurrent esophageal cancer
530254|NCT00313599|stage IV esophageal cancer|stage iv esophageal cancer
530255|NCT00313599|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
530256|NCT00313599|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
530257|NCT00313599|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
530258|NCT00313599|ovarian choriocarcinoma|ovarian choriocarcinoma
530259|NCT00313599|ovarian dysgerminoma|ovarian dysgerminoma
530260|NCT00313599|ovarian embryonal carcinoma|ovarian embryonal carcinoma
530261|NCT00313599|ovarian yolk sac tumor|ovarian yolk sac tumor
530262|NCT00313599|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
530263|NCT00313599|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
530264|NCT00313599|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
530265|NCT00313599|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
530266|NCT00313599|recurrent extragonadal seminoma|recurrent extragonadal seminoma
530267|NCT00313599|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
530268|NCT00313599|stage IV extragonadal seminoma|stage iv extragonadal seminoma
530269|NCT00313599|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
530270|NCT00313625|stage I multiple myeloma|stage i multiple myeloma
530271|NCT00313625|stage II multiple myeloma|stage ii multiple myeloma
530272|NCT00313625|stage III multiple myeloma|stage iii multiple myeloma
530273|NCT00313625|refractory multiple myeloma|refractory multiple myeloma
530274|NCT00313677|muscular dystrophy|muscular dystrophy
530275|NCT00313677|MD|md
530276|NCT00313677|fukutin-related protein gene|fukutin-related protein gene
530277|NCT00313677|limb girdle|limb girdle
530278|NCT00313677|FKRP gene|fkrp gene
530279|NCT00313677|congenital muscular dystrophy|congenital muscular dystrophy
530280|NCT00313677|childhood onset LGMD|childhood onset lgmd
530281|NCT00313677|adult onset LGMD|adult onset lgmd
530282|NCT00313677|POMT1|pomt1
530283|NCT00313677|POMT2|pomt2
530284|NCT00313677|POMGnT|pomgnt
530285|NCT00313677|LARGE|large
530286|NCT00313677|alpha dystroglycan|alpha dystroglycan
530287|NCT00313677|dystroglycanopathy|dystroglycanopathy
530288|NCT00313677|ISPD|ispd
530289|NCT00313677|DPM|dpm
530290|NCT00313677|GMPPB|gmppb
530292|NCT00313677|B3GALNT2|b3galnt2
530293|NCT00313677|GTDC2|gtdc2
530294|NCT00313677|TMEM5|tmem5
530295|NCT00313677|Fukutin|fukutin
530296|NCT00313677|DAG1|dag1
530297|NCT00313677|POMK|pomk
530298|NCT00313690|Lung Cancer|lung cancer
530299|NCT00313703|headache|headache
530300|NCT00313703|emergency department|emergency department
530301|NCT00313703|migraine|migraine
530302|NCT00313703|recurrent headache|recurrent headache
530303|NCT00313716|anemia|anemia
530304|NCT00313716|traumatic brain injury|traumatic brain injury
530305|NCT00313716|recombinant human erythropoietin|recombinant human erythropoietin
530306|NCT00313716|rhEpo|rhepo
530307|NCT00313716|erythropoietin|erythropoietin
530308|NCT00313716|TBI|tbi
530309|NCT00313716|Epo|epo
530310|NCT00313729|adult oligodendroglioma|adult oligodendroglioma
530311|NCT00313729|adult mixed glioma|adult mixed glioma
530312|NCT00313729|adult diffuse astrocytoma|adult diffuse astrocytoma
530313|NCT00313729|adult pilocytic astrocytoma|adult pilocytic astrocytoma
530314|NCT00313729|adult pineal gland astrocytoma|adult pineal gland astrocytoma
530315|NCT00313755|colonoscopy, narrow band imaging,|colonoscopy, narrow band imaging,
530316|NCT00313755|high definition endoscopy|high definition endoscopy
530317|NCT00313755|colorectal cancer|colorectal cancer
530318|NCT00313755|dysplasia|dysplasia
530319|NCT00313755|hereditary non-polyposis colorectal cancer|hereditary non-polyposis colorectal cancer
530320|NCT00313755|Lynch Syndrome|lynch syndrome
530321|NCT00313755|HNPCC|hnpcc
530322|NCT00313768|advanced carcinoma, non-small cell lung, Phase II, paclitaxel, Taxol, carboplatin, Paraplatin, bevacizumab, Avastin, PF-3512676, immunotherapy, immunomodulator|advanced carcinoma, non-small cell lung, phase ii, paclitaxel, taxol, carboplatin, paraplatin, bevacizumab, avastin, pf-3512676, immunotherapy, immunomodulator
530323|NCT00313781|randomized|randomized
530324|NCT00313781|non-comparative|non-comparative
530325|NCT00313781|efficacy|efficacy
530326|NCT00313807|contrast nephropathy|contrast nephropathy
530327|NCT00313807|renal failure|renal failure
530328|NCT00313807|Travasol|travasol
530329|NCT00313820|Post-stroke pain, pregabalin|post-stroke pain, pregabalin
530330|NCT00313833|Chronic pain|chronic pain
530331|NCT00313833|elderly|elderly
530332|NCT00313833|supervised living|supervised living
530333|NCT00313833|opioid|opioid
530334|NCT00313833|transdermal|transdermal
530335|NCT00313846|Chronic pain|chronic pain
530336|NCT00313846|opioid|opioid
530337|NCT00313846|transdermal|transdermal
530338|NCT00313846|osteoarthritis|osteoarthritis
530339|NCT00313859|colorectal cancer|colorectal cancer
530340|NCT00313859|metastatic|metastatic
530341|NCT00313872|gastric cancer|gastric cancer
530342|NCT00313872|chemotherapy|chemotherapy
530344|NCT00313872|docetaxel|docetaxel
530345|NCT00313898|quality of sexual life, Mild erectile dysfunction|quality of sexual life, mild erectile dysfunction
530346|NCT00313911|Diphtheria|diphtheria
530347|NCT00313911|Tetanus|tetanus
530348|NCT00313911|Pertussis|pertussis
530349|NCT00313911|Recombinant Hepatitis B|recombinant hepatitis b
530350|NCT00313911|Poliomyelitis|poliomyelitis
530351|NCT00313911|Haemophilus influenzae type b|haemophilus influenzae type b
530352|NCT00313911|Tetanus protein|tetanus protein
530353|NCT00313924|URGENCY FREQUENCY SYNDROME|urgency frequency syndrome
530354|NCT00313924|URGE INCONTINENCE|urge incontinence
530355|NCT00313950|measles|measles
530356|NCT00313950|rubella|rubella
530357|NCT00313950|mumps|mumps
530358|NCT00313950|hepatitis A|hepatitis a
530359|NCT00313963|Anemia, Sickle Cell|anemia, sickle cell
530360|NCT00313963|Magnesium Sulfate|magnesium sulfate
530361|NCT00313963|pediatric|pediatric
530362|NCT00313976|Multiple Sclerosis|multiple sclerosis
530363|NCT00313976|Early secondary progressive Multiple Sclerosis|early secondary progressive multiple sclerosis
530364|NCT00314002|Massive pulmonary embolism|massive pulmonary embolism
530365|NCT00314002|Catheter thrombectomy|catheter thrombectomy
530366|NCT00314028|African American|african american
530367|NCT00314028|Men|men
530368|NCT00314028|Sexually Transmitted Diseases|sexually transmitted diseases
530369|NCT00314028|Condoms|condoms
530370|NCT00314041|Infant|infant
530371|NCT00314041|Conjugate vaccine|conjugate vaccine
530372|NCT00314041|Meningococcal|meningococcal
530373|NCT00314041|Antibody|antibody
530374|NCT00314041|Immune memory|immune memory
530375|NCT00314041|Health|health
530376|NCT00314041|Meningococcal Vaccines|meningococcal vaccines
530377|NCT00314054|Hepatitis C|hepatitis c
530378|NCT00314054|Hepatic Impairment|hepatic impairment
530379|NCT00314054|Healthy Volunteer|healthy volunteer
530380|NCT00314054|Phase 1|phase 1
530381|NCT00314054|Hepacivirus|hepacivirus
530382|NCT00314067|Quality of Health Care|quality of health care
530383|NCT00314067|Primary Health Care|primary health care
530384|NCT00314067|Education|education
530385|NCT00314067|E-Learning|e-learning
530386|NCT00314067|Alcohol-related Disorders|alcohol-related disorders
530387|NCT00314080|Botulism|botulism
530388|NCT00314080|Botulinum anti-toxin|botulinum anti-toxin
530695|NCT00315172|Pediatric|pediatric
530389|NCT00314080|Repetitive nerve stimulation|repetitive nerve stimulation
530390|NCT00314080|Respiratory failure|respiratory failure
530698|NCT00315172|Exercise|exercise
530391|NCT00314093|Clinical Response|clinical response
530392|NCT00314093|Stage IV Melanoma|stage iv melanoma
530393|NCT00314093|Immunotoxin|immunotoxin
530394|NCT00314093|T Regulatory Cells|t regulatory cells
530395|NCT00314093|CD25+ Cells|cd25+ cells
530396|NCT00314093|Metastatic Melanoma|metastatic melanoma
530397|NCT00314106|Clinical Response|clinical response
530398|NCT00314106|Stage IV Melanoma|stage iv melanoma
530399|NCT00314106|Adoptive Cell Therapy|adoptive cell therapy
530400|NCT00314106|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
530401|NCT00314106|Immunologic Response|immunologic response
530402|NCT00314106|Metastatic Melanoma|metastatic melanoma
530403|NCT00314119|Tumor Imaging|tumor imaging
530405|NCT00314119|Neurofibromatosis|neurofibromatosis
530406|NCT00314132|Japanese Encephalitis|japanese encephalitis
530407|NCT00314132|Encephalitis virus|encephalitis virus
530408|NCT00314132|ChimeriVax™-JE Vaccine|chimerivax™-je vaccine
530409|NCT00314171|open-angle glaucoma|open-angle glaucoma
530410|NCT00314171|ocular hypertension|ocular hypertension
530411|NCT00314184|Bipolar I disorder.|bipolar i disorder.
530412|NCT00314197|automated counseling system|automated counseling system
530413|NCT00314197|telephone-based intervention|telephone-based intervention
530414|NCT00314197|behavior change|behavior change
530415|NCT00314210|Generalised Anxiety Disorder|generalised anxiety disorder
530416|NCT00314236|Cartilage repair|cartilage repair
530417|NCT00314236|Cartilage|cartilage
530418|NCT00314236|Knee|knee
530419|NCT00314236|Knee Pain|knee pain
530420|NCT00314236|Microfracture|microfracture
530421|NCT00314236|arthroscopy|arthroscopy
530422|NCT00314236|bone marrow stimulation|bone marrow stimulation
530423|NCT00314236|Chondrogenesis|chondrogenesis
530424|NCT00314236|Scaffold|scaffold
530425|NCT00314236|Chitosan|chitosan
530426|NCT00314236|A02.165.165|a02.165.165
530427|NCT00314236|A10.165.382.332|a10.165.382.332
530428|NCT00314236|G07.574.500.325.377.625.180|g07.574.500.325.377.625.180
530429|NCT00314236|A10.165.382.400|a10.165.382.400
530430|NCT00314236|Articular Cartilage Repair|articular cartilage repair
530431|NCT00314249|Fibromyalgia|fibromyalgia
530432|NCT00314262|Skin Lesions|skin lesions
530433|NCT00314262|Premalignant Lesion|premalignant lesion
530434|NCT00314275|Pharmacokinetics|pharmacokinetics
530435|NCT00314275|Coronary Artery Disease|coronary artery disease
530437|NCT00314275|Drug Eluting Stent|drug eluting stent
530438|NCT00314288|Parkinson's Disease|parkinson's disease
530439|NCT00314288|Dyskinesia|dyskinesia
530440|NCT00314288|L-dopa-induced dyskinesia|l-dopa-induced dyskinesia
530441|NCT00314301|cerebral palsy|cerebral palsy
530442|NCT00314301|resistance|resistance
530443|NCT00314301|movement|movement
530444|NCT00314301|biomechanics|biomechanics
530445|NCT00314314|Bipolar Disorder, memory, executive functioning|bipolar disorder, memory, executive functioning
530446|NCT00314327|first episode|first episode
530447|NCT00314327|schizophrenia|schizophrenia
530448|NCT00314327|risperidone|risperidone
530449|NCT00314340|Chronic Pain|chronic pain
530450|NCT00314340|Opioids|opioids
530451|NCT00314353|NSABP|nsabp
530452|NCT00314353|bevacizumab|bevacizumab
530453|NCT00314353|capecitabine|capecitabine
530454|NCT00314353|oxaliplatin|oxaliplatin
530455|NCT00314353|irinotecan|irinotecan
530456|NCT00314353|rectal cancer|rectal cancer
530457|NCT00314353|colon cancer|colon cancer
530458|NCT00314353|colorectal cancer|colorectal cancer
530459|NCT00314366|stem cell|stem cell
530460|NCT00314366|autologous|autologous
530461|NCT00314366|ischemia|ischemia
530462|NCT00314379|Diabetes|diabetes
530463|NCT00314379|Endothelial Function|endothelial function
530464|NCT00314379|Haptoglobin|haptoglobin
530465|NCT00314392|Experimental pain|experimental pain
530466|NCT00314392|Placebo analgesia|placebo analgesia
530467|NCT00314392|Heart rate variability|heart rate variability
530468|NCT00314392|Skin conductance|skin conductance
530469|NCT00314405|sentinel lymph node|sentinel lymph node
530470|NCT00314405|SLN|sln
530471|NCT00314405|probe|probe
530472|NCT00314405|breast cancer|breast cancer
530473|NCT00314405|lymphoscintigraphy|lymphoscintigraphy
530474|NCT00314405|methylene blue dye|methylene blue dye
530475|NCT00314418|Colonoscopy|colonoscopy
530476|NCT00314418|technique|technique
530477|NCT00314418|time|time
530478|NCT00314418|duration|duration
530479|NCT00314418|position|position
530480|NCT00314418|abdominal pressure|abdominal pressure
530481|NCT00314431|neonatal chronic lung disease|neonatal chronic lung disease
530482|NCT00314431|bronchopulmonary dysplasia|bronchopulmonary dysplasia
530483|NCT00314431|prematurity|prematurity
530484|NCT00314431|telephone follow up|telephone follow up
530485|NCT00314431|care coordination|care coordination
530486|NCT00314431|children with special health care needs|children with special health care needs
530487|NCT00314444|Psychogenic|psychogenic
530488|NCT00314444|Psychogenic Movement Disorders|psychogenic movement disorders
529832|NCT00329667|heart valve|heart valve
530489|NCT00314457|pain control|pain control
530490|NCT00314457|intra-articular pain control device|intra-articular pain control device
530491|NCT00314457|ACL repair|acl repair
530492|NCT00314457|Bankart Repair|bankart repair
530493|NCT00314483|Mesenchymal stem cells|mesenchymal stem cells
530494|NCT00314483|GVHD|gvhd
530495|NCT00314483|Treatment|treatment
530496|NCT00314483|Steroid refractory GVHD|steroid refractory gvhd
530497|NCT00314509|Asthma|asthma
530498|NCT00314509|Ciclesonide|ciclesonide
530499|NCT00314509|Formoterol Fumarate|formoterol fumarate
530500|NCT00314509|Long-acting beta2-agonists|long-acting beta2-agonists
530501|NCT00314509|LABA|laba
530502|NCT00314509|Steroids|steroids
530503|NCT00314548|ARDS|ards
530504|NCT00314548|pulmonary hypertension|pulmonary hypertension
530505|NCT00314548|prostacyclins|prostacyclins
530506|NCT00314561|Rosiglitazone|rosiglitazone
530507|NCT00314561|Pioglitazone|pioglitazone
530508|NCT00314561|FMD|fmd
530509|NCT00314561|PWV|pwv
530510|NCT00314561|atherosclerosis|atherosclerosis
530511|NCT00314574|Persistent Asthma|persistent asthma
530512|NCT00314574|EXTRA|extra
530513|NCT00314574|Xolair|xolair
530514|NCT00314574|Difficult Breathing|difficult breathing
530515|NCT00314587|fracture|fracture
530516|NCT00314587|forearm|forearm
530517|NCT00314587|midshaft|midshaft
530518|NCT00314587|child|child
530519|NCT00314587|treatment|treatment
530520|NCT00314600|Fracture|fracture
530522|NCT00314600|Midshaft|midshaft
530523|NCT00314600|Child|child
530524|NCT00314600|Cast|cast
530525|NCT00314613|Schizophreniform; Schizophrenia; Schizoaffective Disorders|schizophreniform; schizophrenia; schizoaffective disorders
530526|NCT00314626|Antiviral efficacy|antiviral efficacy
530527|NCT00314626|Tolerability|tolerability
530528|NCT00314626|Immunologic response|immunologic response
530529|NCT00314626|Virologic response|virologic response
530530|NCT00314626|HIV|hiv
530531|NCT00314652|Osteoarthritis|osteoarthritis
530532|NCT00314652|chronic pain|chronic pain
530533|NCT00314652|opioid|opioid
530534|NCT00314652|transdermal|transdermal
530535|NCT00314665|Sarcoidosis|sarcoidosis
530536|NCT00314665|Chronic Uveitis|chronic uveitis
530537|NCT00314665|Uveitis|uveitis
530538|NCT00314665|Thalidomide|thalidomide
530539|NCT00314678|Ovarian|ovarian
530540|NCT00314678|Peritoneal|peritoneal
530541|NCT00314691|fetal DNA|fetal dna
530542|NCT00314691|prenatal diagnosis|prenatal diagnosis
530543|NCT00314691|maternal plasma|maternal plasma
530544|NCT00314691|Diagnostic potential of cell-free fetal DNA circulating in maternal blood|diagnostic potential of cell-free fetal dna circulating in maternal blood
530545|NCT00314704|shock|shock
530546|NCT00314704|hypotension|hypotension
530547|NCT00314704|circulatory failure|circulatory failure
530548|NCT00314704|septic shock|septic shock
530549|NCT00314704|cardiogenic shock|cardiogenic shock
530550|NCT00314743|Patients with Non-Hodgkins Lymphoma or Multiple Myeloma|patients with non-hodgkins lymphoma or multiple myeloma
530552|NCT00314756|nodular basal cell carcinoma|nodular basal cell carcinoma
530553|NCT00314756|curettage|curettage
530554|NCT00314769|Transcranial Direct Current Stimulation (TDCS)|transcranial direct current stimulation (tdcs)
530555|NCT00314769|Motor Learning|motor learning
530556|NCT00314769|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
530557|NCT00314769|Cortical Re-Organization|cortical re-organization
530558|NCT00314769|Neuroplasticity|neuroplasticity
530559|NCT00314769|Neurorehabilitation|neurorehabilitation
530560|NCT00314769|TBI|tbi
530561|NCT00314769|Stroke|stroke
530562|NCT00314769|Healthy Volunteer|healthy volunteer
530563|NCT00314769|HV|hv
530564|NCT00314782|metastatic hormone-refractory prostate cancer (HRPC)|metastatic hormone-refractory prostate cancer (hrpc)
530565|NCT00314795|pure red cell aplasia|pure red cell aplasia
530566|NCT00314795|PRCA|prca
530567|NCT00314795|chronic kidney disease|chronic kidney disease
530568|NCT00314795|CKD|ckd
530569|NCT00314795|chronic renal failure|chronic renal failure
530570|NCT00314795|CRF|crf
530571|NCT00314795|anemia|anemia
530572|NCT00314795|erythropoietin|erythropoietin
530573|NCT00314795|EPO|epo
530574|NCT00314795|erythropoiesis stimulating agent|erythropoiesis stimulating agent
530575|NCT00314795|ESA|esa
530576|NCT00314795|hemoglobin|hemoglobin
530577|NCT00314795|Hb|hb
530578|NCT00314795|Hgb|hgb
530579|NCT00314795|red blood cell|red blood cell
530580|NCT00314795|red blood cell production|red blood cell production
530581|NCT00314808|primary gliomas|primary gliomas
530582|NCT00314808|brain tumors|brain tumors
530583|NCT00314808|vomiting|vomiting
530584|NCT00314808|appetite suppression|appetite suppression
530585|NCT00314808|appetite|appetite
530586|NCT00314821|bipolar disorder, ropinirole, depression|bipolar disorder, ropinirole, depression
530587|NCT00314834|hemodialysis|hemodialysis
530588|NCT00314834|intradialytic parenteral nutrition|intradialytic parenteral nutrition
530589|NCT00314834|oral supplementation|oral supplementation
530590|NCT00314834|survival|survival
530591|NCT00314834|hospitalization|hospitalization
529939|NCT00311116|prophylaxis|prophylaxis
530592|NCT00314834|serum albumin|serum albumin
530593|NCT00314834|prealbumin|prealbumin
531757|NCT00312689|stenosis|stenosis
530594|NCT00314834|transthyretin|transthyretin
530595|NCT00314847|Myocardial infarction|myocardial infarction
530596|NCT00314847|Cardiogenic shock|cardiogenic shock
530597|NCT00314847|Extracorporeal Life Support-Impella|extracorporeal life support-impella
530598|NCT00314860|Restless Legs Syndrome|restless legs syndrome
530599|NCT00314873|Thymic malignancy|thymic malignancy
530600|NCT00314873|Thymic Carcinoma|thymic carcinoma
530602|NCT00314886|Fiber|fiber
530603|NCT00314886|Irritable Bowel Syndrome|irritable bowel syndrome
530604|NCT00314886|Colonic Flora|colonic flora
530605|NCT00314899|Malaria, Plasmodium falciparum, Kenya, immunity|malaria, plasmodium falciparum, kenya, immunity
530606|NCT00314925|advanced carcinoma|advanced carcinoma
530607|NCT00314925|carcinoid|carcinoid
530608|NCT00314925|neuroendocrine features|neuroendocrine features
530609|NCT00314925|oncolytic virus|oncolytic virus
530610|NCT00314925|phase I study|phase i study
530611|NCT00314925|dose escalation study|dose escalation study
530612|NCT00314925|rhabdomyosarcoma|rhabdomyosarcoma
530613|NCT00314925|alveolar rhabdomyosarcoma|alveolar rhabdomyosarcoma
530614|NCT00314925|medulloblastoma|medulloblastoma
530615|NCT00314925|rhabdoid|rhabdoid
530616|NCT00314925|glioblastoma|glioblastoma
530617|NCT00314925|ewing's sarcoma|ewing's sarcoma
530618|NCT00314925|pediatric oncologies|pediatric oncologies
530619|NCT00314925|neuroblastoma|neuroblastoma
530620|NCT00314925|wilms' tumor|wilms' tumor
530621|NCT00314925|retinoblastoma|retinoblastoma
530622|NCT00314925|Large cell lung cancer|large cell lung cancer
530623|NCT00314951|CDAD, Clostridium difficile, diarrhea|cdad, clostridium difficile, diarrhea
530624|NCT00314951|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
530625|NCT00314977|Large resectable breast cancer|large resectable breast cancer
530626|NCT00314977|Locally advanced breast cancer|locally advanced breast cancer
530627|NCT00314977|Neoadjuvant therapy|neoadjuvant therapy
530628|NCT00314990|Venous thrombosis|venous thrombosis
530629|NCT00314990|Deep-vein thrombosis|deep-vein thrombosis
530630|NCT00314990|Pulmonary embolism|pulmonary embolism
530631|NCT00314990|Homocysteine|homocysteine
530632|NCT00314990|B-vitamins|b-vitamins
530633|NCT00314990|Folate|folate
530634|NCT00314990|Vitamin B12|vitamin b12
530635|NCT00314990|Vitamin B6|vitamin b6
530636|NCT00315003|Otitis Media|otitis media
530637|NCT00315003|Suppurative|suppurative
530638|NCT00315003|Purulent|purulent
530639|NCT00315003|Ketolide|ketolide
530640|NCT00315003|Azithromycin|azithromycin
530641|NCT00315003|Telithromycin|telithromycin
530642|NCT00315003|Controlled Clinical Trials|controlled clinical trials
530643|NCT00315016|albuminuria|albuminuria
530644|NCT00315016|eplerenone|eplerenone
530645|NCT00315016|ACE inhibition|ace inhibition
530646|NCT00315016|renal function|renal function
530601|NCT00314886|Diet|diet
530647|NCT00315016|endothelial function|endothelial function
530648|NCT00315029|Implementation|implementation
530649|NCT00315029|Single embryo transfer|single embryo transfer
530650|NCT00315029|ICSI|icsi
530652|NCT00315029|prevention|prevention
530653|NCT00315042|Tonsillitis|tonsillitis
530654|NCT00315042|pharyngitis|pharyngitis
530655|NCT00315042|penicillin|penicillin
530656|NCT00315042|telithromycin|telithromycin
530657|NCT00315042|ketolides|ketolides
530658|NCT00315042|clinical trials|clinical trials
530659|NCT00315055|Hepatitis B|hepatitis b
530660|NCT00315055|Polio|polio
530661|NCT00315055|Diphtheria|diphtheria
530662|NCT00315055|Pertussis|pertussis
530663|NCT00315055|H influenzae type b|h influenzae type b
530664|NCT00315068|arrythmia|arrythmia
530665|NCT00315068|atrial fibrillation|atrial fibrillation
530666|NCT00315068|proteins|proteins
530667|NCT00315081|Schizophrenia|schizophrenia
530668|NCT00315081|Hyperprolactinemia|hyperprolactinemia
530669|NCT00315081|Risperidone|risperidone
530670|NCT00315081|Bromocriptin|bromocriptin
530671|NCT00315094|home parenteral nutrition|home parenteral nutrition
530672|NCT00315120|Randomized controlled trial|randomized controlled trial
530673|NCT00315120|Low back pain|low back pain
530674|NCT00315120|Spinal manipulative therapy|spinal manipulative therapy
530675|NCT00315120|Spinal manipulation|spinal manipulation
530676|NCT00315120|Osteopathic manipulation|osteopathic manipulation
530677|NCT00315120|Osteopathic medicine|osteopathic medicine
530678|NCT00315120|Physical therapy modalities|physical therapy modalities
530679|NCT00315133|Diabetes mellitus|diabetes mellitus
530680|NCT00315133|Stem cells|stem cells
530681|NCT00315133|Autologous stem cell transplantation|autologous stem cell transplantation
530682|NCT00315133|Autoimmune diseases|autoimmune diseases
530683|NCT00315146|Body Composition|body composition
530684|NCT00315146|Sarcopenia|sarcopenia
530685|NCT00315146|Weight loss trials|weight loss trials
530686|NCT00315146|Intervention studies|intervention studies
530687|NCT00315146|Elderly|elderly
530688|NCT00315159|Squamous|squamous
530689|NCT00315159|Cell|cell
530690|NCT00315159|Carcinoma|carcinoma
684596|NCT00905398|Acute|acute
530691|NCT00315159|Vulva|vulva
530692|NCT00315159|Sentinel Node|sentinel node
530693|NCT00315172|Adipose Tissue|adipose tissue
530694|NCT00315172|Weight Gain|weight gain
530696|NCT00315172|Body Composition|body composition
530697|NCT00315172|Thermogenesis|thermogenesis
530699|NCT00315172|Healthy Volunteer|healthy volunteer
530700|NCT00315172|HV|hv
530701|NCT00315185|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
530702|NCT00315185|First Line Treatment|first line treatment
530703|NCT00315198|amblyopia|amblyopia
530704|NCT00315198|patching|patching
530705|NCT00315198|visual activities|visual activities
530706|NCT00315211|Small Cell Lung Cancer Recurrent|small cell lung cancer recurrent
530707|NCT00315224|Isolated systolic Hypertension|isolated systolic hypertension
530708|NCT00315224|exercise|exercise
530709|NCT00315224|pulse pressure|pulse pressure
530710|NCT00315224|endothelium|endothelium
530711|NCT00315250|Parkinson|parkinson
530712|NCT00315263|DNA|dna
530713|NCT00315263|Genomics|genomics
530714|NCT00315263|SNPs|snps
530715|NCT00315263|Neonatology|neonatology
530716|NCT00315263|Chronic Lung Disease|chronic lung disease
530717|NCT00315263|Periventricular Brain Injury|periventricular brain injury
530718|NCT00315263|Hypoxic Respiratory Failure|hypoxic respiratory failure
530719|NCT00315276|ADHD|adhd
530720|NCT00315289|Nasolacrimal duct obstruction|nasolacrimal duct obstruction
530721|NCT00315289|Simple probing|simple probing
530722|NCT00315289|Balloon catheter dilation|balloon catheter dilation
530723|NCT00315289|Nasolacrimal intubation|nasolacrimal intubation
530724|NCT00315302|Amblyopia|amblyopia
530725|NCT00315302|Atropine|atropine
530726|NCT00315302|Plano lens|plano lens
530727|NCT00315315|Nasolacrimal duct obstruction|nasolacrimal duct obstruction
530728|NCT00315315|Balloon catheter nasolacrimal duct dilation|balloon catheter nasolacrimal duct dilation
530729|NCT00315315|Nasolacrimal intubation|nasolacrimal intubation
530730|NCT00315315|Simple Nasolacrimal duct probing|simple nasolacrimal duct probing
530731|NCT00315328|Amblyopia|amblyopia
530732|NCT00315328|Atropine|atropine
530733|NCT00315328|Patching|patching
530734|NCT00315354|obesity|obesity
530735|NCT00315354|nutrition|nutrition
530736|NCT00315367|Multiple Sclerosis|multiple sclerosis
530737|NCT00315367|Memory impairment|memory impairment
530738|NCT00315380|EGPA|egpa
530740|NCT00315393|GPA|gpa
530741|NCT00315393|MPA|mpa
530742|NCT00315393|WG|wg
530743|NCT00315406|PAN|pan
530744|NCT00315406|Periarteritis Nodosa|periarteritis nodosa
530745|NCT00315419|Large Granular Lymphocyte Leukemia|large granular lymphocyte leukemia
530746|NCT00315419|Amegakaryocytic Thrombocytopenic Purpura|amegakaryocytic thrombocytopenic purpura
530747|NCT00315419|Idiopathic Pure Red Cell Aplasia|idiopathic pure red cell aplasia
530748|NCT00315419|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
15655|NCT03190954|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
15656|NCT03190954|Dopamine D1 Receptor|dopamine d1 receptor
530749|NCT00315432|Natural History, Hepatitis C Infection, HIV Infection, HCV/HIV co-infection Ribavirin, Pegylated Interferon, Interferon|natural history, hepatitis c infection, hiv infection, hcv/hiv co-infection ribavirin, pegylated interferon, interferon
530750|NCT00315445|chronic back pain|chronic back pain
530751|NCT00315445|opioid|opioid
530752|NCT00315445|transdermal|transdermal
530753|NCT00315458|osteoarthritis|osteoarthritis
530754|NCT00315458|opioid|opioid
530755|NCT00315458|transdermal|transdermal
530756|NCT00315471|Vasculitis|vasculitis
530757|NCT00315484|Anemia|anemia
530758|NCT00315484|chemotherapy|chemotherapy
530759|NCT00315484|hemoglobin level|hemoglobin level
530760|NCT00315484|recombinant human erythropoietin|recombinant human erythropoietin
530761|NCT00315484|epoetin alfa|epoetin alfa
530762|NCT00315484|darbepoetin alfa|darbepoetin alfa
530763|NCT00315497|Giant Cell Arteritis|giant cell arteritis
530764|NCT00315510|Ischemia-reperfusion|ischemia-reperfusion
530765|NCT00315510|Annexin A5|annexin a5
530766|NCT00315523|Levocetirizine|levocetirizine
530767|NCT00315523|Xyzal|xyzal
530768|NCT00315523|Rhinitis|rhinitis
530769|NCT00315523|Allergic|allergic
530770|NCT00315523|Seasonal|seasonal
530771|NCT00315523|Ragweed|ragweed
530772|NCT00315549|Tonsillitis|tonsillitis
530773|NCT00315549|pharyngitis|pharyngitis
530774|NCT00315549|penicillin|penicillin
530775|NCT00315549|telithromycin|telithromycin
530776|NCT00315549|ketolides|ketolides
530777|NCT00315549|clinical trials|clinical trials
530778|NCT00315562|stroke|stroke
530779|NCT00315562|carotid stenosis|carotid stenosis
530780|NCT00315562|carotid endarterectomy|carotid endarterectomy
530781|NCT00315562|timing|timing
530782|NCT00315575|Dementia|dementia
530783|NCT00315575|brain circulation|brain circulation
530784|NCT00315575|disease /disorder proneness /risk|disease /disorder proneness /risk
530785|NCT00315575|neuropathology|neuropathology
530786|NCT00315575|neurophysiology|neurophysiology
530787|NCT00315575|aging|aging
684708|NCT00908011|HIV|hiv
530140|NCT00312013|cancer survival|cancer survival
530788|NCT00315575|apolipoprotein E|apolipoprotein e
530789|NCT00315575|genotype|genotype
530790|NCT00315575|hemodynamics|hemodynamics
530791|NCT00315575|memory|memory
530792|NCT00315575|temporal lobe /cortex|temporal lobe /cortex
530793|NCT00315588|Islet Transplantation|islet transplantation
530794|NCT00315601|Telithromycin (drug)|telithromycin (drug)
530795|NCT00315601|Azithromycin (drug)|azithromycin (drug)
530796|NCT00315601|Bronchoalveolar lavage (procedure)|bronchoalveolar lavage (procedure)
530797|NCT00315601|Pharmacokinetics|pharmacokinetics
530798|NCT00315614|Islet Transplantation|islet transplantation
530799|NCT00315627|Islet Transplantation|islet transplantation
530800|NCT00315640|Elevated IOP due to intravitreal triamcinolone therapy|elevated iop due to intravitreal triamcinolone therapy
530801|NCT00315653|Bladder Cancer|bladder cancer
530802|NCT00315653|Cancer of Bladder|cancer of bladder
530803|NCT00315653|Bladder Tumors|bladder tumors
530804|NCT00315653|Cancer of the Bladder|cancer of the bladder
530805|NCT00315653|Neoplasms, Bladder|neoplasms, bladder
530806|NCT00315666|Chronic tension-type headache|chronic tension-type headache
530807|NCT00315679|recurrent aphthous stomatitis|recurrent aphthous stomatitis
530808|NCT00315679|recurrent mouth ulcers|recurrent mouth ulcers
530809|NCT00315679|pentoxifylline|pentoxifylline
530810|NCT00315679|clinical trial|clinical trial
530811|NCT00315679|double blind|double blind
530812|NCT00315679|placebo controlled|placebo controlled
530813|NCT00315679|randomized|randomized
530814|NCT00315692|Ovarian Neoplasms|ovarian neoplasms
530815|NCT00315705|clofarabine|clofarabine
530816|NCT00315705|acute leukemia|acute leukemia
530818|NCT00315705|AML|aml
530819|NCT00315705|clolar|clolar
530820|NCT00315705|CLO218|clo218
530821|NCT00315718|Hintonia latiflora extract|hintonia latiflora extract
530822|NCT00315718|Diabetes mellitus type 2|diabetes mellitus type 2
530823|NCT00315718|HbA1c|hba1c
530824|NCT00315718|Safety|safety
530825|NCT00315718|Liver function tests|liver function tests
530826|NCT00315731|Bexxar|bexxar
530827|NCT00315731|tositumomab and iodine I 131 tositumomab therapeutic regiment|tositumomab and iodine i 131 tositumomab therapeutic regiment
530828|NCT00315731|fission|fission
530829|NCT00315731|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
530830|NCT00315731|Iodine I 131 Tositumomab|iodine i 131 tositumomab
530831|NCT00315731|pharmacokinetics|pharmacokinetics
530832|NCT00315731|tellurium|tellurium
530833|NCT00315744|moderate asthma|moderate asthma
530834|NCT00315744|fluticasone|fluticasone
530835|NCT00315744|children|children
530836|NCT00315744|salmeterol|salmeterol
530837|NCT00315744|steroid-sparing|steroid-sparing
530838|NCT00315744|Asthma|asthma
530839|NCT00315770|overweight|overweight
530840|NCT00315770|Metabolic syndrome|metabolic syndrome
530841|NCT00315783|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
530842|NCT00315783|echocardiography|echocardiography
530843|NCT00315783|magnetic resonance imaging|magnetic resonance imaging
530844|NCT00315796|Mind-Body Intervention|mind-body intervention
530845|NCT00315796|Distraction|distraction
530846|NCT00315796|Biophilic|biophilic
530847|NCT00315796|Cancer|cancer
530848|NCT00315796|pain|pain
530849|NCT00315796|Bedscapes|bedscapes
530850|NCT00315796|procedures|procedures
530851|NCT00315796|bone marrow aspirate|bone marrow aspirate
530852|NCT00315796|bone marrow biopsy|bone marrow biopsy
530853|NCT00315809|leprosy, Philippines|leprosy, philippines
530854|NCT00315822|Surgery|surgery
530855|NCT00315822|colon|colon
530856|NCT00315835|postoperative pain|postoperative pain
530857|NCT00315835|opioid|opioid
530858|NCT00315835|transdermal|transdermal
530859|NCT00315848|chronic pain|chronic pain
530860|NCT00315848|osteoarthritis|osteoarthritis
530861|NCT00315848|opioid|opioid
530862|NCT00315848|transdermal|transdermal
530863|NCT00315861|ovarian carcinoma|ovarian carcinoma
530864|NCT00315861|endometrial carcinoma|endometrial carcinoma
530865|NCT00315861|cervical carcinoma|cervical carcinoma
530866|NCT00315861|lung carcinoma|lung carcinoma
530867|NCT00315874|chronic back pain|chronic back pain
530868|NCT00315874|opioid|opioid
530869|NCT00315874|transdermal|transdermal
530870|NCT00315887|low back pain|low back pain
530871|NCT00315887|opioid|opioid
530872|NCT00315887|transdermal|transdermal
530873|NCT00315900|Seroquel|seroquel
530874|NCT00315900|Depakote ER|depakote er
530875|NCT00315900|Nursing Home|nursing home
530876|NCT00315900|Quetiapine|quetiapine
530877|NCT00315900|Divalproex ER|divalproex er
530878|NCT00315900|Agitation|agitation
530879|NCT00315913|Labor|labor
530880|NCT00315913|Dysfunctional Labor|dysfunctional labor
530881|NCT00315913|Labor Arrest|labor arrest
530882|NCT00315913|Primary Cesarean Section Prevention|primary cesarean section prevention
530883|NCT00315926|Cardiac morbidity|cardiac morbidity
530884|NCT00315926|Melatonin|melatonin
530885|NCT00315926|Surgery|surgery
530886|NCT00315926|Postoperative|postoperative
530887|NCT00315939|Diabetes|diabetes
530888|NCT00315939|hypoglycemic episodes|hypoglycemic episodes
530889|NCT00315952|type 1 diabetes mellitus|type 1 diabetes mellitus
530890|NCT00315952|inhaled insulin|inhaled insulin
530891|NCT00315952|Positron Emission Tomography|positron emission tomography
530892|NCT00315965|Diffusion|diffusion
530893|NCT00315965|Membrane diffusing capacity|membrane diffusing capacity
530894|NCT00315965|Alveolar capillary gas diffusion|alveolar capillary gas diffusion
530895|NCT00315965|Transfer factor|transfer factor
531758|NCT00312689|bacteria|bacteria
530896|NCT00315965|Nitric oxide diffusion|nitric oxide diffusion
530897|NCT00315978|Risk Assessment|risk assessment
530898|NCT00315978|Decision Support Technique|decision support technique
530899|NCT00315978|Physician-Patient Relations|physician-patient relations
530900|NCT00315978|Prevention and Control|prevention and control
530901|NCT00315991|BG perception|bg perception
530902|NCT00315991|hypoglycemic awareness|hypoglycemic awareness
530903|NCT00315991|pediatric T1DM|pediatric t1dm
530904|NCT00316004|Traumatic|traumatic
530905|NCT00316004|Brain injury|brain injury
530906|NCT00316017|Trauma|trauma
530907|NCT00316017|Shock|shock
530908|NCT00316030|AML|aml
530909|NCT00316030|Acute Myeloid Leukemia|acute myeloid leukemia
530910|NCT00316030|Bexarotene|bexarotene
530911|NCT00316030|Leukemia|leukemia
530912|NCT00316043|Urinary tract infections|urinary tract infections
530913|NCT00316043|Renal failure|renal failure
530914|NCT00316043|Renal scarring|renal scarring
530915|NCT00316043|Prevention|prevention
530916|NCT00316043|Primary Care|primary care
530917|NCT00316043|General Practice|general practice
530918|NCT00316043|Intervention Studies|intervention studies
530919|NCT00316043|Children|children
530920|NCT00316056|Genetic Literacy|genetic literacy
530921|NCT00316056|Learning|learning
530922|NCT00316056|Genetic Knowledge|genetic knowledge
530923|NCT00316056|Public Understanding of Science|public understanding of science
530924|NCT00316056|Science Education|science education
530925|NCT00316056|Healthy Volunteer|healthy volunteer
530926|NCT00316056|HV|hv
530927|NCT00316290|ADHD|adhd
530928|NCT00316290|Cognitive Behavioral Therapy|cognitive behavioral therapy
530929|NCT00316290|Parent Training|parent training
530930|NCT00316303|Serious Mental Illness|serious mental illness
530931|NCT00316303|Dual Diagnosis|dual diagnosis
530932|NCT00316303|Mental Disorders|mental disorders
530933|NCT00316303|Substance-Related Disorders|substance-related disorders
530934|NCT00316316|OCD|ocd
530935|NCT00316342|Low back pain|low back pain
530936|NCT00316342|Industrial workers|industrial workers
530937|NCT00316342|Recurrent back pain|recurrent back pain
530938|NCT00316342|Back supports|back supports
530939|NCT00316342|Back health education|back health education
530940|NCT00316342|Rehabilitation|rehabilitation
530941|NCT00316355|Anxiety|anxiety
530942|NCT00316355|Behavior therapy|behavior therapy
530943|NCT00316355|Cognitive-behavioral therapy|cognitive-behavioral therapy
530944|NCT00316355|Stepped care|stepped care
530945|NCT00316355|Cost-effectiveness|cost-effectiveness
530946|NCT00316368|Bi-Ventricular pacing post coronary artery bypass graft|bi-ventricular pacing post coronary artery bypass graft
530947|NCT00316368|coronary artery bypass graft|coronary artery bypass graft
530948|NCT00316381|stem cells|stem cells
530949|NCT00316381|acute myocardial infarction|acute myocardial infarction
530950|NCT00316381|regeneration|regeneration
15657|NCT03190954|D2 Receptors|d2 receptors
530951|NCT00316381|left ventricular ejection fraction|left ventricular ejection fraction
530952|NCT00316394|Preventive Health Care|preventive health care
530953|NCT00316394|Annual Health Check-up|annual health check-up
530954|NCT00316394|Primary Care|primary care
530956|NCT00316459|Healthy|healthy
530957|NCT00316459|Cardiac|cardiac
530958|NCT00316459|Pharmacokinetics|pharmacokinetics
530959|NCT00316472|Hyperphosphatemia|hyperphosphatemia
530960|NCT00316472|End Stage Renal Disease|end stage renal disease
530961|NCT00316472|Renal Osteodystrophy|renal osteodystrophy
530962|NCT00316485|Bone|bone
530963|NCT00316485|Microbiology|microbiology
530964|NCT00316485|Dental Pulp Stem Cell|dental pulp stem cell
530965|NCT00316485|Wisdom Teeth|wisdom teeth
530966|NCT00316485|Biopsy|biopsy
530967|NCT00316485|Third Molar Extraction|third molar extraction
530968|NCT00316498|Eye Movement|eye movement
530969|NCT00316498|Niemann Pick C|niemann pick c
530970|NCT00316511|advanced solid malignancies|advanced solid malignancies
530971|NCT00316511|B-cell lymphoma|b-cell lymphoma
530972|NCT00316511|Aroplatin|aroplatin
530973|NCT00316511|L-NDDP|l-nddp
530974|NCT00316511|MTD|mtd
530975|NCT00316511|advanced solid malignancies or B-cell lymphoma|advanced solid malignancies or b-cell lymphoma
530976|NCT00316524|Smallpox|smallpox
530977|NCT00316524|Vaccination|vaccination
530978|NCT00316524|Prevention|prevention
530979|NCT00316537|diabetes|diabetes
530980|NCT00316537|foot ulcers|foot ulcers
530981|NCT00316537|nicotine gel|nicotine gel
530982|NCT00316537|wound healing|wound healing
530983|NCT00316550|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
530984|NCT00316563|cannabinoids|cannabinoids
530985|NCT00316563|taste disorders|taste disorders
530986|NCT00316563|olfaction disorders|olfaction disorders
530987|NCT00316563|cancer|cancer
530988|NCT00316563|palliative medicine|palliative medicine
530989|NCT00316563|caloric intake|caloric intake
530990|NCT00316563|appetite|appetite
530991|NCT00316563|reward|reward
530992|NCT00316563|tetrahydrocannabinol/therapeutic use|tetrahydrocannabinol/therapeutic use
530993|NCT00316563|anorexia/drug therapy|anorexia/drug therapy
530994|NCT00316563|quality of life|quality of life
530995|NCT00316563|chemosensory changes/drug therapy|chemosensory changes/drug therapy
530996|NCT00316576|Kidney failure, Acute|kidney failure, acute
530997|NCT00316576|Genetic Polymorphism|genetic polymorphism
530998|NCT00316576|Angiotensin-converting enzyme|angiotensin-converting enzyme
530999|NCT00316589|HIV|hiv
531000|NCT00316589|treatment experienced|treatment experienced
531001|NCT00316589|treatment vaccinia naive|treatment vaccinia naive
531002|NCT00316602|Atopic dermatitis|atopic dermatitis
531003|NCT00316602|Smallpox|smallpox
531004|NCT00316602|Vaccination|vaccination
531005|NCT00316615|influenza|influenza
531006|NCT00316615|non elderly adult and elderly|non elderly adult and elderly
531007|NCT00316615|vaccine|vaccine
531008|NCT00316628|influenza|influenza
531009|NCT00316628|elderly|elderly
531010|NCT00316628|vaccine|vaccine
531011|NCT00316654|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
531012|NCT00316654|vaccines, conjugate|vaccines, conjugate
531013|NCT00316654|immunology|immunology
531014|NCT00316654|child|child
531015|NCT00316654|antibody persistence|antibody persistence
531016|NCT00316667|epidemiology|epidemiology
531017|NCT00316667|risk factors|risk factors
531018|NCT00316693|HPV Vaccine Efficacy|hpv vaccine efficacy
531019|NCT00316706|Prophylaxis HPV-16/18 infections and cervical neoplasia|prophylaxis hpv-16/18 infections and cervical neoplasia
531020|NCT00316719|treatment naive|treatment naive
531021|NCT00316719|CHB|chb
531022|NCT00316719|adefovir|adefovir
531023|NCT00316719|monotherapy|monotherapy
531024|NCT00316732|Avodart|avodart
531025|NCT00316732|IPSS|ipss
531026|NCT00316732|BPH|bph
531027|NCT00316732|dutasteride|dutasteride
531028|NCT00316732|EQ-5D|eq-5d
531029|NCT00316732|Observational|observational
531030|NCT00316745|irinotecan|irinotecan
531031|NCT00316745|S-1|s-1
531032|NCT00316745|Oxaliplatin|oxaliplatin
531033|NCT00316745|l-leucovorin|l-leucovorin
531034|NCT00316745|Fluorouracil|fluorouracil
531035|NCT00316745|Metastatic colorectal cancer|metastatic colorectal cancer
531036|NCT00316745|phase III|phase iii
531037|NCT00316784|osteoarthritis; knee; IDEA-033|osteoarthritis; knee; idea-033
531038|NCT00316797|SPECT|spect
531039|NCT00316797|Nuclear Medicine|nuclear medicine
531040|NCT00316810|Campath 1H|campath 1h
531041|NCT00316810|Alemtuzumab|alemtuzumab
531042|NCT00316810|Tacrolimus|tacrolimus
531043|NCT00316810|Pancreas-kidney transplantation|pancreas-kidney transplantation
531044|NCT00316810|immunosuppression|immunosuppression
531045|NCT00316810|prevention of acute rejection|prevention of acute rejection
531046|NCT00316823|thyroid cancer|thyroid cancer
531047|NCT00316836|stage I breast cancer|stage i breast cancer
531048|NCT00316836|stage II breast cancer|stage ii breast cancer
531049|NCT00316836|stage IIIA breast cancer|stage iiia breast cancer
531050|NCT00316862|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
531051|NCT00316862|stage II esophageal cancer|stage ii esophageal cancer
531052|NCT00316862|stage III esophageal cancer|stage iii esophageal cancer
531053|NCT00316875|stage IV breast cancer|stage iv breast cancer
531054|NCT00316875|recurrent breast cancer|recurrent breast cancer
531056|NCT00316888|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
531057|NCT00316888|stage I anal cancer|stage i anal cancer
531058|NCT00316888|stage II anal cancer|stage ii anal cancer
531059|NCT00316888|stage IIIA anal cancer|stage iiia anal cancer
531060|NCT00316888|stage IIIB anal cancer|stage iiib anal cancer
531061|NCT00316888|basaloid carcinoma of the anus|basaloid carcinoma of the anus
531062|NCT00316888|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
531063|NCT00316901|stage IV renal cell cancer|stage iv renal cell cancer
531064|NCT00316901|stage IV melanoma|stage iv melanoma
531065|NCT00316901|recurrent melanoma|recurrent melanoma
531066|NCT00316901|recurrent renal cell cancer|recurrent renal cell cancer
531067|NCT00316914|neurotoxicity|neurotoxicity
531068|NCT00316914|stage II colon cancer|stage ii colon cancer
531069|NCT00316914|stage III colon cancer|stage iii colon cancer
531070|NCT00316914|adenocarcinoma of the colon|adenocarcinoma of the colon
531071|NCT00316914|stage II rectal cancer|stage ii rectal cancer
531072|NCT00316914|stage III rectal cancer|stage iii rectal cancer
531073|NCT00316914|stage IV rectal cancer|stage iv rectal cancer
531074|NCT00316914|stage IV colon cancer|stage iv colon cancer
531075|NCT00316914|adenocarcinoma of the rectum|adenocarcinoma of the rectum
531076|NCT00316927|adenocarcinoma of the prostate|adenocarcinoma of the prostate
531077|NCT00316927|stage III prostate cancer|stage iii prostate cancer
531078|NCT00316927|stage IV prostate cancer|stage iv prostate cancer
531079|NCT00316940|stage I multiple myeloma|stage i multiple myeloma
531080|NCT00316940|stage II multiple myeloma|stage ii multiple myeloma
531081|NCT00316940|stage III multiple myeloma|stage iii multiple myeloma
531082|NCT00316940|refractory multiple myeloma|refractory multiple myeloma
531083|NCT00316966|Nutritional status, dietary intervention, health care use, costs|nutritional status, dietary intervention, health care use, costs
531084|NCT00316979|migraine|migraine
531085|NCT00316979|transcranial magnetic stimulation|transcranial magnetic stimulation
531086|NCT00316979|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
531087|NCT00316979|rTMS|rtms
531088|NCT00316992|Insomnia|insomnia
531089|NCT00316992|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
531090|NCT00316992|Drug Therapy|drug therapy
531091|NCT00317005|hemodialysis|hemodialysis
531092|NCT00317005|chronic uremia|chronic uremia
531093|NCT00317005|hyperhomocysteinemia|hyperhomocysteinemia
531094|NCT00317005|folate|folate
531095|NCT00317018|depression|depression
531096|NCT00317018|quality improvement|quality improvement
531097|NCT00317018|implementation|implementation
531098|NCT00317018|translation|translation
531099|NCT00317018|evidence-based practice|evidence-based practice
531100|NCT00317018|collaborative care|collaborative care
531101|NCT00317018|adoption|adoption
531102|NCT00317018|sustainability|sustainability
531103|NCT00317018|cost-effectiveness|cost-effectiveness
531104|NCT00317018|rural|rural
531105|NCT00317031|Alcoholism|alcoholism
531106|NCT00317031|Drug Therapy|drug therapy
531107|NCT00317044|Moderate to severe Asthma|moderate to severe asthma
531108|NCT00317044|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
531109|NCT00317044|esomeprazole|esomeprazole
531111|NCT00317057|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
531112|NCT00317057|Outpatient management|outpatient management
531113|NCT00317057|nurse-lead patient education|nurse-lead patient education
531114|NCT00317070|PBS/IC|pbs/ic
531115|NCT00317070|Painful bladder syndrome including Interstitial cystitis|painful bladder syndrome including interstitial cystitis
531116|NCT00317083|Cough Reflex|cough reflex
531117|NCT00317083|Citric acid|citric acid
531118|NCT00317083|Obesity|obesity
531119|NCT00317083|Sleep apnea syndrome|sleep apnea syndrome
531120|NCT00317096|Drug Therapy|drug therapy
531121|NCT00317096|Maintenance|maintenance
531122|NCT00317096|rituximab|rituximab
531123|NCT00317109|meningococcal serogroups A and C diseases|meningococcal serogroups a and c diseases
531124|NCT00317109|tetanus|tetanus
531125|NCT00317109|hepatitis B|hepatitis b
531126|NCT00317109|pertussis|pertussis
531127|NCT00317109|Haemophilus influenzae type b|haemophilus influenzae type b
531128|NCT00317109|meningococcal vaccine|meningococcal vaccine
531129|NCT00317109|Prophylaxis diphtheria|prophylaxis diphtheria
531130|NCT00317148|Hot Flashes|hot flashes
531131|NCT00317148|Menopause|menopause
531132|NCT00317148|Quality of Life|quality of life
531133|NCT00317148|Hot flushes|hot flushes
531134|NCT00317213|Smoking|smoking
531135|NCT00317213|Nicotine|nicotine
531136|NCT00317213|Withdrawal|withdrawal
531137|NCT00317213|Phospholipids|phospholipids
531138|NCT00317213|Cell membrane fluidity|cell membrane fluidity
531139|NCT00317213|Smoking cessation|smoking cessation
531140|NCT00317226|Anemia|anemia
531142|NCT00317226|Chronic Kidney Disease|chronic kidney disease
531143|NCT00317226|Iron|iron
531144|NCT00317226|Maintenance Dose|maintenance dose
531145|NCT00317239|Anemia|anemia
531146|NCT00317239|Chronic Kidney Disease|chronic kidney disease
531147|NCT00317239|Iron|iron
531148|NCT00317252|contrast induced nephropathy|contrast induced nephropathy
531149|NCT00317252|contrast nephropathy|contrast nephropathy
531150|NCT00317252|contrast media|contrast media
531151|NCT00317252|kidney diseases|kidney diseases
531152|NCT00317252|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
531153|NCT00317265|coronary artery disease|coronary artery disease
531154|NCT00317265|coronary bypass surgery|coronary bypass surgery
531155|NCT00317265|complete arterial coronary surgery|complete arterial coronary surgery
531156|NCT00317265|internal mammary artery|internal mammary artery
531157|NCT00317278|Massage|massage
531158|NCT00317278|immune system|immune system
531159|NCT00317278|preterm infants|preterm infants
531160|NCT00317291|Acupuncture|acupuncture
531161|NCT00317291|HIV|hiv
531162|NCT00317291|AIDS|aids
531163|NCT00317291|Symptom management|symptom management
531164|NCT00317291|Non-invasive|non-invasive
531165|NCT00317291|Complementary Therapies|complementary therapies
531166|NCT00317291|Treatment Experienced|treatment experienced
531167|NCT00317304|Hot flashes|hot flashes
531168|NCT00317304|vasomotor symptoms|vasomotor symptoms
531169|NCT00317304|menopause|menopause
531170|NCT00317304|mindfulness based stress reduction|mindfulness based stress reduction
531171|NCT00317304|meditation|meditation
531172|NCT00317317|IVF|ivf
531173|NCT00317317|Acupuncture|acupuncture
531174|NCT00317317|Pregnant|pregnant
531175|NCT00317343|Patients candidate to a PCI with a planned anticoagulation regime other than unfractionated heparin in monotherapy|patients candidate to a pci with a planned anticoagulation regime other than unfractionated heparin in monotherapy
531176|NCT00317356|OPC-6535|opc-6535
685192|NCT00910013|TKR|tkr
530521|NCT00314600|Forearm|forearm
531177|NCT00317356|ulcerative colitis|ulcerative colitis
531178|NCT00317369|OPC-6535|opc-6535
531179|NCT00317369|Crohn's disease|crohn's disease
531180|NCT00317382|lumbar puncture|lumbar puncture
531181|NCT00317382|headache|headache
531182|NCT00317382|traumatic tap|traumatic tap
531183|NCT00317395|Non ST elevation Acute Coronary Syndrome|non st elevation acute coronary syndrome
531184|NCT00317395|Early invasive strategy|early invasive strategy
531185|NCT00317395|Percutaneous Coronary Intervention|percutaneous coronary intervention
531186|NCT00317408|anaplastic large cell lymphoma|anaplastic large cell lymphoma
531286|NCT00317694|Hyperphosphatemia|hyperphosphatemia
531187|NCT00317408|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
531188|NCT00317408|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
531189|NCT00317408|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
531190|NCT00317421|Phosphodiesterase 5|phosphodiesterase 5
531191|NCT00317421|Sildenafil|sildenafil
531192|NCT00317421|Hypertension|hypertension
531193|NCT00317421|Blood pressure|blood pressure
531194|NCT00317421|Arterial stiffness|arterial stiffness
531195|NCT00317421|Endothelial function|endothelial function
531196|NCT00317434|ovarian cancer|ovarian cancer
531197|NCT00317447|Sciatica|sciatica
531198|NCT00317447|Lower back pain|lower back pain
531199|NCT00317447|Prednisone|prednisone
531200|NCT00317447|Randomized, controlled clinical trial|randomized, controlled clinical trial
531201|NCT00317460|Drug Abuse|drug abuse
531202|NCT00317460|Drug Addiction|drug addiction
531203|NCT00317460|Drug Dependence|drug dependence
531204|NCT00317460|Drug Use Disorders|drug use disorders
531205|NCT00317460|Drug Use Disorder|drug use disorder
531206|NCT00317460|Substance Abuse|substance abuse
531207|NCT00317460|Substance Use Disorder|substance use disorder
531208|NCT00317460|Buprenorphine|buprenorphine
531209|NCT00317460|Opiate Addiction|opiate addiction
531210|NCT00317473|Vaccine|vaccine
531211|NCT00317473|Phase 1|phase 1
531212|NCT00317473|Plasmodium falciparum|plasmodium falciparum
531213|NCT00317473|Malaria|malaria
531214|NCT00317473|Merozoite surface protein-1|merozoite surface protein-1
531215|NCT00317473|MSP-1|msp-1
531216|NCT00317473|Falciparum malaria protein 1|falciparum malaria protein 1
531217|NCT00317473|FMP-1|fmp-1
531218|NCT00317473|AS02A|as02a
531219|NCT00317486|pulmonary arterial hypertension|pulmonary arterial hypertension
531220|NCT00317486|Eisenmenger physiology|eisenmenger physiology
531221|NCT00317486|bosentan|bosentan
531222|NCT00317512|Hemoglobin Based Oxygen carrier|hemoglobin based oxygen carrier
531223|NCT00317512|HBOC 201|hboc 201
531224|NCT00317512|Percutaneous Revascularization|percutaneous revascularization
531225|NCT00317512|Percutaneous Coronary Intervention|percutaneous coronary intervention
531226|NCT00317512|Non ST-segment Elevation Myocardial Infarction|non st-segment elevation myocardial infarction
531227|NCT00317512|Tissue Oxygenation|tissue oxygenation
531228|NCT00317512|Transluminal Percutaneous Coronary Angioplasty|transluminal percutaneous coronary angioplasty
531229|NCT00317525|Refractive error|refractive error
531230|NCT00317525|Asthenopia|asthenopia
531231|NCT00317538|Rheumatoid Arthritis|rheumatoid arthritis
531232|NCT00317538|Switching|switching
531233|NCT00317538|Structural Damage|structural damage
531235|NCT00317551|Aberration control|aberration control
531236|NCT00317551|Accommodative facility|accommodative facility
531237|NCT00317551|Accommodative response|accommodative response
531238|NCT00317551|Peripheral refraction|peripheral refraction
531239|NCT00317551|Accommodative convergence to accommodation ratio|accommodative convergence to accommodation ratio
531241|NCT00317564|High Risk Pregnancy|high risk pregnancy
531242|NCT00317564|Multiple Sclerosis|multiple sclerosis
531243|NCT00317577|Low-pressure glaucoma|low-pressure glaucoma
531244|NCT00317577|Normal tension glaucoma|normal tension glaucoma
531245|NCT00317577|Neuroprotection|neuroprotection
531246|NCT00317577|Brimonidine|brimonidine
531247|NCT00317577|Visual field progression|visual field progression
531248|NCT00317590|Diagnosis|diagnosis
531249|NCT00317590|Rapid Diagnostic Test|rapid diagnostic test
531250|NCT00317590|Management|management
531251|NCT00317590|Attributable Fraction|attributable fraction
531252|NCT00317590|Threshold|threshold
531253|NCT00317603|autologous vaccination|autologous vaccination
531254|NCT00317603|GM-CSF|gm-csf
531255|NCT00317603|adenoviral mediated gene transfer|adenoviral mediated gene transfer
531256|NCT00317603|Stage IV breast cancer|stage iv breast cancer
531257|NCT00317616|FALS|fals
531258|NCT00317616|SOD1|sod1
531259|NCT00317616|familial|familial
531260|NCT00317616|genetic testing|genetic testing
531261|NCT00317616|genetic counseling|genetic counseling
531262|NCT00317616|ALS|als
531263|NCT00317616|C9ORF72|c9orf72
531264|NCT00317616|TARDBP|tardbp
531265|NCT00317616|VCP|vcp
531266|NCT00317616|FUS|fus
531267|NCT00317616|PFN1|pfn1
531268|NCT00317629|leishmaniasis|leishmaniasis
531269|NCT00317629|nitric oxide|nitric oxide
531270|NCT00317629|treatment|treatment
685361|NCT00902564|GAD|gad
530651|NCT00315029|IVF|ivf
531271|NCT00317629|donor|donor
531272|NCT00317629|controlled trial|controlled trial
531273|NCT00317642|acute myelogenous leukemia|acute myelogenous leukemia
531274|NCT00317642|acute myeloid leukemia|acute myeloid leukemia
531275|NCT00317642|relapsed AML|relapsed aml
531276|NCT00317642|refractory AML|refractory aml
531277|NCT00317642|clofarabine|clofarabine
531278|NCT00317642|cytarabine|cytarabine
531279|NCT00317642|CLO341|clo341
531280|NCT00317642|clolar|clolar
531281|NCT00317655|back pain|back pain
531282|NCT00317681|Cutaneous lupus erythematosus|cutaneous lupus erythematosus
531283|NCT00317681|Tacrolimus ointment|tacrolimus ointment
531284|NCT00317681|Topical treatment|topical treatment
531285|NCT00317681|Skin lesions|skin lesions
531287|NCT00317694|Phosphate binder|phosphate binder
531288|NCT00317707|cardiovascular risk|cardiovascular risk
531289|NCT00317707|cardiovascular diseases|cardiovascular diseases
531290|NCT00317707|cardiovascular prevention|cardiovascular prevention
531291|NCT00317707|polyunsaturated fatty acids|polyunsaturated fatty acids
531292|NCT00317707|diabetes|diabetes
531293|NCT00317707|hypertension|hypertension
531294|NCT00317707|hypercholesterolemia|hypercholesterolemia
531296|NCT00317720|Breast Cancer|breast cancer
531297|NCT00317720|Metastatic Breast Cancer|metastatic breast cancer
531298|NCT00317720|Trastuzumab|trastuzumab
531299|NCT00317720|RAD001|rad001
531300|NCT00317720|Herceptin|herceptin
531301|NCT00317733|Ketoprofen|ketoprofen
531302|NCT00317733|Transfersome|transfersome
531303|NCT00317733|Osteoarthritis, Knee|osteoarthritis, knee
531304|NCT00317746|HIV/HCV Co-infection|hiv/hcv co-infection
531305|NCT00317746|Depression|depression
531306|NCT00317746|Citalopram|citalopram
531307|NCT00317759|stage IV melanoma|stage iv melanoma
531308|NCT00317759|recurrent melanoma|recurrent melanoma
531309|NCT00317772|Epithelial Ovarian Cancer|epithelial ovarian cancer
531310|NCT00317772|Peritoneal Cancer|peritoneal cancer
531311|NCT00317772|Fallopian Tube Cancer|fallopian tube cancer
531312|NCT00317772|Epidermal Growth Factor|epidermal growth factor
531313|NCT00317772|Platinum Hypersensitivity|platinum hypersensitivity
531314|NCT00317772|Hycamtin|hycamtin
531315|NCT00317772|Gefitinib|gefitinib
531316|NCT00317772|Iressa|iressa
531317|NCT00317772|Topotecan|topotecan
531318|NCT00317772|EGFR|egfr
531319|NCT00317785|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
531320|NCT00317785|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
531321|NCT00317785|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
531322|NCT00317785|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
531323|NCT00317785|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
531324|NCT00317785|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
531325|NCT00317785|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
531326|NCT00317785|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
531327|NCT00317785|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
531328|NCT00317785|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
531329|NCT00317785|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
531330|NCT00317785|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
531331|NCT00317785|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
531332|NCT00317785|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
531333|NCT00317785|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
531334|NCT00317785|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
531335|NCT00317785|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
531336|NCT00317785|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
531337|NCT00317785|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
531338|NCT00317785|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
531339|NCT00317785|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
531340|NCT00317785|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
531341|NCT00317785|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
531342|NCT00317785|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
531343|NCT00317785|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
531344|NCT00317785|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
531345|NCT00317785|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
530739|NCT00315380|CSS|css
531346|NCT00317785|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
531347|NCT00317785|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
531348|NCT00317785|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
531349|NCT00317785|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
531350|NCT00317785|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
531351|NCT00317785|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
531352|NCT00317785|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
531353|NCT00317785|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
531354|NCT00317785|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
531355|NCT00317785|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
531356|NCT00317785|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
531357|NCT00317785|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
531756|NCT00312689|lacrimal|lacrimal
531358|NCT00317785|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
531359|NCT00317785|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
531360|NCT00317785|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
531361|NCT00317785|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
531362|NCT00317785|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
531363|NCT00317785|secondary acute myeloid leukemia|secondary acute myeloid leukemia
531364|NCT00317785|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
531365|NCT00317785|splenic marginal zone lymphoma|splenic marginal zone lymphoma
531366|NCT00317785|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
531367|NCT00317785|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
583552|NCT00512122|muscle strength|muscle strength
531368|NCT00317785|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
531369|NCT00317785|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
531370|NCT00317785|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
531371|NCT00317785|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
531372|NCT00317785|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
531373|NCT00317785|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
531374|NCT00317785|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
531375|NCT00317785|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
531376|NCT00317785|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
531377|NCT00317785|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
531378|NCT00317785|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
531379|NCT00317785|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
531380|NCT00317785|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
531381|NCT00317785|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
531382|NCT00317785|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
531383|NCT00317785|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
531384|NCT00317785|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
531385|NCT00317785|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
531386|NCT00317785|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
531387|NCT00317785|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
531388|NCT00317785|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
531389|NCT00317785|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
531390|NCT00317785|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
531391|NCT00317785|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
15744|NCT03190317|electronic medical record|electronic medical record
531392|NCT00317798|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
531393|NCT00317798|stage I multiple myeloma|stage i multiple myeloma
531394|NCT00317798|stage II multiple myeloma|stage ii multiple myeloma
531395|NCT00317798|stage III multiple myeloma|stage iii multiple myeloma
531396|NCT00317798|refractory multiple myeloma|refractory multiple myeloma
531397|NCT00317811|stage I multiple myeloma|stage i multiple myeloma
531398|NCT00317811|stage II multiple myeloma|stage ii multiple myeloma
531399|NCT00317811|stage III multiple myeloma|stage iii multiple myeloma
531400|NCT00317837|Fracture of Femoral Neck|fracture of femoral neck
531401|NCT00317876|Fanconi anemia|fanconi anemia
531403|NCT00317902|Anemia|anemia
531404|NCT00317902|erythropoetin|erythropoetin
531405|NCT00317902|Epoetin alfa|epoetin alfa
531406|NCT00317902|erythropoetin recombinant|erythropoetin recombinant
531407|NCT00317902|HIV, AIDS|hiv, aids
531537|NCT00318448|Pediatric Psychology|pediatric psychology
531408|NCT00317928|Polycystic Ovary Syndrome|polycystic ovary syndrome
531409|NCT00317928|Metformin|metformin
531410|NCT00317928|Metabolic Syndrome|metabolic syndrome
531411|NCT00317928|Hyperandrogenism|hyperandrogenism
531412|NCT00317928|Ovulation|ovulation
531413|NCT00317941|Multiple Sclerosis|multiple sclerosis
531414|NCT00317941|RRMS|rrms
531415|NCT00317954|Diabetic nephropathy|diabetic nephropathy
531416|NCT00317954|Spironolactone|spironolactone
531417|NCT00317954|Aldosterone antagonism|aldosterone antagonism
531418|NCT00317954|Renoprotection|renoprotection
531419|NCT00317967|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
531420|NCT00317967|Statin therapy|statin therapy
531421|NCT00317967|Regression|regression
531422|NCT00317967|Heart failure|heart failure
531423|NCT00317967|Arrhythmias|arrhythmias
531424|NCT00317967|Sudden cardiac death|sudden cardiac death
531425|NCT00317980|Cutaneous leishmaniasis|cutaneous leishmaniasis
531426|NCT00317980|Leishmania braziliensis|leishmania braziliensis
531427|NCT00317980|Pentavalent antimony|pentavalent antimony
531428|NCT00317980|Meglumine antimoniate|meglumine antimoniate
531429|NCT00318006|chronic|chronic
531430|NCT00318006|nasal|nasal
531431|NCT00318006|sinus|sinus
531432|NCT00318006|symptoms|symptoms
531433|NCT00318019|Energy|energy
531434|NCT00318019|Energy Level|energy level
531435|NCT00318032|Randomised control trial|randomised control trial
531436|NCT00318032|Screening|screening
531437|NCT00318032|Intensive management|intensive management
531438|NCT00318032|Diabetes mellitus|diabetes mellitus
531439|NCT00318032|Type 2 diabetes|type 2 diabetes
531440|NCT00318045|Refractive error|refractive error
531441|NCT00318045|Asthenopia|asthenopia
531442|NCT00318071|Stroke|stroke
531443|NCT00318071|Ischemic|ischemic
531444|NCT00318071|Thrombus|thrombus
531445|NCT00318071|Embolectomy|embolectomy
531446|NCT00318071|Thrombectomy|thrombectomy
531447|NCT00318071|Merci|merci
531448|NCT00318071|Concentric|concentric
531449|NCT00318071|Embolus|embolus
531450|NCT00318071|Embolism|embolism
531451|NCT00318071|Mechanical|mechanical
531452|NCT00318084|Gastroesophageal reflux disease|gastroesophageal reflux disease
531453|NCT00318084|Heartburn|heartburn
531457|NCT00318097|McCune Albright Syndrome|mccune albright syndrome
531458|NCT00318097|Histamine regulation|histamine regulation
531459|NCT00318110|Metastatic|metastatic
531461|NCT00318110|Cell|cell
531462|NCT00318110|Carcinoma|carcinoma
531463|NCT00318110|Unrelated|unrelated
531464|NCT00318110|Donor|donor
531465|NCT00318110|Transplant|transplant
531466|NCT00318110|stage IV|stage iv
531467|NCT00318110|clear cell|clear cell
531468|NCT00318123|Simplification therapy|simplification therapy
531469|NCT00318123|Efficacy|efficacy
531470|NCT00318123|Safety|safety
531471|NCT00318123|Virological effectiveness|virological effectiveness
531472|NCT00318123|Immunological effectiveness|immunological effectiveness
531473|NCT00318123|HIV|hiv
531474|NCT00318136|BRIDGE|bridge
531475|NCT00318136|NSCLC|nsclc
531476|NCT00318136|Lung Cancer|lung cancer
531477|NCT00318136|Avastin|avastin
531478|NCT00318162|autism|autism
531479|NCT00318162|PDD|pdd
531480|NCT00318162|LDN|ldn
531481|NCT00318162|naltrexone|naltrexone
531482|NCT00318175|Systemic Scleroderma|systemic scleroderma
531483|NCT00318175|Dermal Sclerosis|dermal sclerosis
531484|NCT00318175|Bosentan|bosentan
531485|NCT00318175|Endothelin Receptor Antagonist|endothelin receptor antagonist
531486|NCT00318175|Rodnan Skin Score|rodnan skin score
531487|NCT00318188|scleroderma|scleroderma
531488|NCT00318188|HAQ|haq
531489|NCT00318188|Intensive care reeducation, readaptation|intensive care reeducation, readaptation
531490|NCT00318201|Healthy Subjects|healthy subjects
531491|NCT00318214|toe ulcer|toe ulcer
531492|NCT00318214|heel ulcer|heel ulcer
531493|NCT00318214|foot ulcer|foot ulcer
531494|NCT00318214|diabetic feet|diabetic feet
531495|NCT00318214|diabetic foot|diabetic foot
531496|NCT00318214|complications of diabetes|complications of diabetes
531497|NCT00318227|Postoperative care|postoperative care
531498|NCT00318227|Cardiac Surgery|cardiac surgery
531499|NCT00318227|Blood Transfusion|blood transfusion
531500|NCT00318240|High Intensity Focused Ultrasound|high intensity focused ultrasound
531502|NCT00318240|Locally recurrent prostate cancer.|locally recurrent prostate cancer.
531503|NCT00318253|Cranberry juice|cranberry juice
531504|NCT00318253|Antiadhesion|antiadhesion
531505|NCT00318253|Urinary tract infection|urinary tract infection
531506|NCT00318253|vaginosis|vaginosis
531507|NCT00318266|Detection of Bladder Cancer using NMP22 Urine Test Kit|detection of bladder cancer using nmp22 urine test kit
531508|NCT00318279|Surgical education|surgical education
531509|NCT00318279|Vascular anastomosis|vascular anastomosis
531510|NCT00318279|Simulator|simulator
531511|NCT00318279|Randomized controlled trial|randomized controlled trial
531512|NCT00318292|preemptive analgesia|preemptive analgesia
531513|NCT00318292|paracervical block|paracervical block
531514|NCT00318292|vaginal hysterectomy|vaginal hysterectomy
531515|NCT00318318|Premarin,|premarin,
531516|NCT00318318|HRT,|hrt,
531517|NCT00318318|RNA,|rna,
531518|NCT00318318|Gene Expression.|gene expression.
531519|NCT00318318|Postmenopausal Women|postmenopausal women
531520|NCT00318331|Glutamine|glutamine
531521|NCT00318331|Critical Illness|critical illness
531522|NCT00318331|Enteral Feeding|enteral feeding
531523|NCT00318331|Blood Volume Analysis|blood volume analysis
531524|NCT00318357|Cardiac Resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
531525|NCT00318357|All-cause mortality|all-cause mortality
531526|NCT00318357|Long-term follow-up|long-term follow-up
531527|NCT00318370|Ovarian Cancer|ovarian cancer
531528|NCT00318370|Primary Fallopian Tube Cancer|primary fallopian tube cancer
531529|NCT00318370|Peritoneal Cancer|peritoneal cancer
531530|NCT00318383|Vaccine|vaccine
531531|NCT00318383|Immunogenicity|immunogenicity
531532|NCT00318383|Randomized Controlled Trial|randomized controlled trial
531533|NCT00318396|THA|tha
531534|NCT00318409|Methamphetamine|methamphetamine
531535|NCT00318409|HIV|hiv
531536|NCT00318448|Child Psychology|child psychology
531538|NCT00318448|Insomnia|insomnia
531539|NCT00318448|Sleeplessness|sleeplessness
531540|NCT00318474|Proteinuria|proteinuria
531541|NCT00318474|Immunoglobulin A|immunoglobulin a
531542|NCT00318487|Dental implants|dental implants
531543|NCT00318500|Endometriosis|endometriosis
531544|NCT00318500|Dysmenorrhea|dysmenorrhea
531545|NCT00318500|Pelvic pain|pelvic pain
531546|NCT00318500|Dyspareunia|dyspareunia
531547|NCT00318513|breast cancer|breast cancer
531548|NCT00318513|lymphedema|lymphedema
531549|NCT00318513|extremity|extremity
531550|NCT00318513|women|women
531551|NCT00318539|Obsessive Compulsive Disorder|obsessive compulsive disorder
531555|NCT00318565|Heart Disease|heart disease
531556|NCT00318565|Atrial Flutter|atrial flutter
531557|NCT00318565|Typical Atrial Flutter|typical atrial flutter
531558|NCT00318578|convulsive status epilepticus|convulsive status epilepticus
531559|NCT00318578|outcome|outcome
531560|NCT00318578|prognosis factors|prognosis factors
531561|NCT00318578|seizure duration|seizure duration
531562|NCT00318578|adult|adult
531563|NCT00318578|electroencephalogram|electroencephalogram
531564|NCT00318578|intensive care unit|intensive care unit
531565|NCT00318604|plasma circulating DNA|plasma circulating dna
531566|NCT00318604|hean and neck cancers|hean and neck cancers
531567|NCT00318604|esophageal cancer|esophageal cancer
531568|NCT00318604|localized head and neck cancers|localized head and neck cancers
531569|NCT00318604|localized esophageal cancer|localized esophageal cancer
531570|NCT00318617|peroxisome proliferator activated receptors,|peroxisome proliferator activated receptors,
531571|NCT00318617|PPARs,|ppars,
531572|NCT00318617|Heart Failure,|heart failure,
531573|NCT00318617|cardiac energetics,|cardiac energetics,
531574|NCT00318617|MRI,|mri,
531575|NCT00318617|GW501516X|gw501516x
531576|NCT00318617|fatty acid metabolism,|fatty acid metabolism,
531577|NCT00318630|Asthma AVANDIA Inflammation|asthma avandia inflammation
531578|NCT00318643|Non-invasive bladder cancer|non-invasive bladder cancer
531579|NCT00318643|Chemophase|chemophase
531580|NCT00318643|Intravesical administration|intravesical administration
531581|NCT00318643|Superficial Bladder Cancer|superficial bladder cancer
531582|NCT00318656|type 2 diabetes|type 2 diabetes
531583|NCT00318656|rosiglitazone|rosiglitazone
531584|NCT00318656|metformin|metformin
531585|NCT00318656|glimepiride|glimepiride
531586|NCT00318656|glycemia|glycemia
531587|NCT00318669|Anxiety|anxiety
531588|NCT00318669|SAD|sad
531589|NCT00318669|Social|social
531590|NCT00318669|Disorder|disorder
531591|NCT00318682|biopsy|biopsy
531592|NCT00318682|FIBROSCAN|fibroscan
531593|NCT00318695|Probiotics|probiotics
531594|NCT00318695|Eczema|eczema
531595|NCT00318695|Asthma|asthma
531596|NCT00318695|Allergic Rhinitis|allergic rhinitis
531597|NCT00318695|Prevention|prevention
531598|NCT00318695|Immunological responses|immunological responses
531599|NCT00318721|Leishmania donovani|leishmania donovani
531600|NCT00318721|cluster-randomised control trial|cluster-randomised control trial
531601|NCT00318721|Long Lasting Impregnated Nets|long lasting impregnated nets
531602|NCT00318721|Bednets|bednets
531603|NCT00318721|Sandflies|sandflies
531604|NCT00318747|Amb a 1-Immunostimulatory Oligodeoxyribonucleotide Conjugate|amb a 1-immunostimulatory oligodeoxyribonucleotide conjugate
531606|NCT00318747|Amb a I Protein|amb a i protein
531607|NCT00318747|Ragweed Allergy|ragweed allergy
531608|NCT00318747|Hay Fever|hay fever
531609|NCT00318747|Wheeze|wheeze
531610|NCT00318747|Immunotherapy|immunotherapy
531611|NCT00318747|Tolerance|tolerance
531612|NCT00318747|Immunostimulatory|immunostimulatory
531613|NCT00318747|Ragweed Season|ragweed season
531614|NCT00318747|Asthma|asthma
531615|NCT00318747|Asthmatics|asthmatics
531616|NCT00318747|Asthmatic|asthmatic
531617|NCT00318760|Drug Cue|drug cue
531618|NCT00318760|Relapse|relapse
531619|NCT00318760|Stress|stress
531620|NCT00318760|Craving|craving
531621|NCT00318773|PMS|pms
531622|NCT00318773|PMDD|pmdd
531623|NCT00318773|sertraline|sertraline
531624|NCT00318773|antidepressant|antidepressant
531625|NCT00318773|extended treatment|extended treatment
531626|NCT00318773|relapse|relapse
531627|NCT00312234|Muscular Disease|muscular disease
531628|NCT00312234|Fibromyalgia|fibromyalgia
531629|NCT00312234|Exercise Therapy|exercise therapy
531630|NCT00312234|Qigong|qigong
531631|NCT00312234|Aerobic Exercise|aerobic exercise
531632|NCT00312234|pediatrics|pediatrics
531633|NCT00312247|Walking|walking
531634|NCT00312247|Muscle Strength|muscle strength
531635|NCT00312247|Energy Cost|energy cost
531636|NCT00312247|Quality of Life|quality of life
531637|NCT00312260|Pain|pain
531638|NCT00312260|Analgesia|analgesia
531639|NCT00312260|Gabapentin|gabapentin
531640|NCT00312260|Amitriptyline|amitriptyline
531641|NCT00312260|Pediatrics|pediatrics
531642|NCT00312273|Heart Arrest|heart arrest
531643|NCT00312273|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
531644|NCT00312273|Aminophylline|aminophylline
531645|NCT00312273|Bradycardia|bradycardia
531646|NCT00312273|Humans|humans
531647|NCT00312273|Emergency Medical Services|emergency medical services
531648|NCT00312286|Cervical Neoplasms|cervical neoplasms
531649|NCT00312286|Drug Therapy|drug therapy
531650|NCT00312286|Human Papillomavirus|human papillomavirus
531651|NCT00312286|Cervical Human Papillomavirus|cervical human papillomavirus
531652|NCT00312286|Cervical Dysplasia|cervical dysplasia
531653|NCT00312286|Chemoprevention|chemoprevention
531654|NCT00312286|High Risk Cervical Human Papillomavirus|high risk cervical human papillomavirus
531655|NCT00312286|Atypical Squamous Cells of Undetermined Significance|atypical squamous cells of undetermined significance
531656|NCT00312286|Low Grade Intraepithelial Lesions|low grade intraepithelial lesions
531657|NCT00312299|Double-Blind Method|double-blind method
531658|NCT00312299|Clinical Trials, Randomized|clinical trials, randomized
531659|NCT00312299|Lenses, Intraocular|lenses, intraocular
531660|NCT00312299|Prospective Studies|prospective studies
531661|NCT00312299|PMMA|pmma
531662|NCT00312299|Visual acuity|visual acuity
531663|NCT00312312|Asthma|asthma
531664|NCT00312312|Allergic rhinitis|allergic rhinitis
531665|NCT00312312|Atopy|atopy
531666|NCT00312312|Exhaled nitric oxide|exhaled nitric oxide
531667|NCT00312312|Specific immunotherapy|specific immunotherapy
531668|NCT00312312|Atopic diseases|atopic diseases
531669|NCT00312325|Optic nerve head blood flow|optic nerve head blood flow
531670|NCT00312325|Choroidal blood flow|choroidal blood flow
531671|NCT00312325|Prednisolone|prednisolone
531672|NCT00312325|Graves´ Ophthalmopathy|graves´ ophthalmopathy
531673|NCT00312325|optic neuritis|optic neuritis
531674|NCT00312351|AMD|amd
531675|NCT00312351|Age-Related Macular Degeneration|age-related macular degeneration
531676|NCT00312351|Macular Degeneration|macular degeneration
531677|NCT00312351|Macugen|macugen
531678|NCT00312351|pegaptanib sodium|pegaptanib sodium
531679|NCT00312351|ERG|erg
531680|NCT00312351|specular microscopy|specular microscopy
531681|NCT00312351|Age-Related Mcular Degeneration (AMD)|age-related mcular degeneration (amd)
531682|NCT00312364|toe ulcer|toe ulcer
531683|NCT00312364|heel ulcer|heel ulcer
531684|NCT00312364|foot ulcer|foot ulcer
531685|NCT00312364|diabetic feet|diabetic feet
531686|NCT00312364|diabetic foot|diabetic foot
531687|NCT00312364|complications of diabetes|complications of diabetes
531688|NCT00312377|Non-small cell lung cancer|non-small cell lung cancer
531689|NCT00312377|NSCLC|nsclc
531690|NCT00312390|Amblyopia|amblyopia
531691|NCT00312390|Retinal vessel diameters|retinal vessel diameters
531692|NCT00312390|Retinal blood flow|retinal blood flow
531693|NCT00312390|Flicker|flicker
531694|NCT00312403|Glaucoma|glaucoma
531695|NCT00312403|Gene Polymorphism|gene polymorphism
531696|NCT00312403|Metalloproteinase|metalloproteinase
531697|NCT00312416|Choroidal blood flow|choroidal blood flow
531698|NCT00312416|Clonidin|clonidin
531699|NCT00312416|Brimonidin|brimonidin
531700|NCT00312429|Hematological Malignancies|hematological malignancies
531701|NCT00312429|Leukemia|leukemia
531702|NCT00312429|Lymphoma|lymphoma
531703|NCT00312429|Myelodysplasia|myelodysplasia
531704|NCT00312429|Multiple Myeloma|multiple myeloma
531705|NCT00312442|Prostate cancer after radiation therapy|prostate cancer after radiation therapy
531706|NCT00312455|Substance abuse|substance abuse
531707|NCT00312455|Depression|depression
531708|NCT00312455|Aggression|aggression
531709|NCT00312468|AIDS|aids
531710|NCT00312507|Meconium Aspiration Syndrome|meconium aspiration syndrome
531711|NCT00312507|Surfactant|surfactant
531712|NCT00312507|Bronchoalveolar Lavage|bronchoalveolar lavage
531713|NCT00312507|newborns|newborns
531714|NCT00312533|knee|knee
531715|NCT00312533|injection|injection
531716|NCT00312533|function|function
531717|NCT00312533|osteoarthritis|osteoarthritis
531718|NCT00312546|Virus Latency|virus latency
531719|NCT00312546|Valproic Acid|valproic acid
531720|NCT00312546|Histone Deacetylase|histone deacetylase
531721|NCT00312559|Parkinson's Disease|parkinson's disease
531722|NCT00312572|Osteoarthritis, opioid, transdermal|osteoarthritis, opioid, transdermal
531723|NCT00312585|pregnancy|pregnancy
531724|NCT00312585|acupuncture|acupuncture
531725|NCT00312598|schizophrenia|schizophrenia
531727|NCT00312598|weight|weight
531728|NCT00312598|aripiprazole|aripiprazole
531729|NCT00312598|antipsychotic|antipsychotic
531110|NCT00317044|GERD|gerd
531730|NCT00312598|Mood Disorders with psychotic features|mood disorders with psychotic features
531731|NCT00312611|Gastric pacing device|gastric pacing device
531732|NCT00312611|Obesity|obesity
531733|NCT00312624|ICD implantation|icd implantation
531734|NCT00312624|cardiac MRI|cardiac mri
531735|NCT00312624|cardiomyopathy|cardiomyopathy
531736|NCT00312624|ventricular arrhythmias|ventricular arrhythmias
531737|NCT00312624|LVEF 35% or less|lvef 35% or less
531738|NCT00312624|indication for ICD implantation as part of standard of care|indication for icd implantation as part of standard of care
531739|NCT00312637|Breast Cancer Staging|breast cancer staging
531740|NCT00312650|ovarian cancer|ovarian cancer
531741|NCT00312650|recurrent|recurrent
531742|NCT00312650|progressive|progressive
531743|NCT00312663|Vaccine|vaccine
531744|NCT00312663|Phase I/II|phase i/ii
531745|NCT00312663|Malaria|malaria
531746|NCT00312663|Liver Stage Antigen -1|liver stage antigen -1
531747|NCT00312663|Falciparum Malaria Protein -11|falciparum malaria protein -11
531748|NCT00312663|AS01B|as01b
531749|NCT00312663|adjuvant|adjuvant
531750|NCT00312676|Tolerability|tolerability
531751|NCT00312676|Depakote DR|depakote dr
531752|NCT00312676|Depakote ER|depakote er
531753|NCT00312676|Elderly|elderly
531754|NCT00312676|Conversion|conversion
531755|NCT00312689|congenital|congenital
531759|NCT00312689|microbiological|microbiological
531760|NCT00312702|Vaccine|vaccine
531761|NCT00312702|Malaria|malaria
531762|NCT00312702|Liver Stage Antigen-1|liver stage antigen-1
531763|NCT00312702|Falciparum Malaria Protein-11|falciparum malaria protein-11
531764|NCT00312702|AS02A|as02a
531765|NCT00312702|adjuvant|adjuvant
531766|NCT00312715|Deiodinase|deiodinase
531767|NCT00312715|Levothyroxine|levothyroxine
531768|NCT00312715|Liothyronine|liothyronine
531769|NCT00312715|Lipid Metabolism|lipid metabolism
531770|NCT00312715|Healthy Volunteer|healthy volunteer
531771|NCT00312715|HV|hv
531772|NCT00312728|Brain Cancer|brain cancer
531773|NCT00312728|Brain Metastases|brain metastases
531774|NCT00312728|Avastin|avastin
531775|NCT00312728|NSCLC|nsclc
531776|NCT00312728|Lung Cancer|lung cancer
531777|NCT00312728|PASSPORT|passport
531778|NCT00312741|community-acquired pneumonia|community-acquired pneumonia
531779|NCT00312741|microbiological tests|microbiological tests
531780|NCT00312741|urinary antigen|urinary antigen
531781|NCT00312741|selection of antibiotic treatment|selection of antibiotic treatment
531782|NCT00312767|Agalsidase beta|agalsidase beta
531783|NCT00312767|alpha Galactosidase A|alpha galactosidase a
531784|NCT00312767|aGAL|agal
531785|NCT00312767|rh aGAL|rh agal
531786|NCT00312767|Fabry|fabry
531787|NCT00312767|GL3|gl3
531788|NCT00312767|Fabrazyme|fabrazyme
531789|NCT00312767|dialysis|dialysis
531790|NCT00312767|hemodialysis|hemodialysis
531791|NCT00312780|albuminuria|albuminuria
531792|NCT00312780|diabetic nephropathy|diabetic nephropathy
531793|NCT00312780|diabetes|diabetes
531794|NCT00312793|Anterior Cruciate Ligament reconstruction surgery|anterior cruciate ligament reconstruction surgery
531795|NCT00312806|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
531796|NCT00312806|GERD|gerd
531797|NCT00312806|Pantoprazole|pantoprazole
531798|NCT00312806|ReQuestTM|requesttm
531799|NCT00312819|Non-small cel lung cancer|non-small cel lung cancer
531800|NCT00312819|chemotherapy|chemotherapy
531801|NCT00312819|randomized phaseII|randomized phaseii
531802|NCT00312819|disulfiram|disulfiram
531803|NCT00312819|antiangiogenesis|antiangiogenesis
531804|NCT00312819|placebo|placebo
531805|NCT00312832|HIV|hiv
531806|NCT00312832|d4T|d4t
531807|NCT00312832|TDF|tdf
531808|NCT00312832|lipoatrophy|lipoatrophy
531809|NCT00312832|treatment experienced|treatment experienced
531810|NCT00312832|HIV-infection|hiv-infection
531811|NCT00312845|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
531812|NCT00312858|Hepatitis A Virus|hepatitis a virus
531813|NCT00312871|Chronic renal failure|chronic renal failure
531814|NCT00312871|Anemia|anemia
531815|NCT00312871|Renal replacement therapy|renal replacement therapy
531816|NCT00312871|Epoetin|epoetin
531817|NCT00312871|Epoetin alfa|epoetin alfa
531818|NCT00312871|erythropoietin|erythropoietin
531819|NCT00312871|Chronic kidney failure|chronic kidney failure
531820|NCT00312871|end-stage renal disease|end-stage renal disease
531821|NCT00312884|telemonitoring|telemonitoring
531822|NCT00312884|heart failure|heart failure
531823|NCT00312884|randomised|randomised
531824|NCT00312884|hospitalisation|hospitalisation
531825|NCT00312884|HomMed|hommed
531826|NCT00312897|Adolescents|adolescents
531827|NCT00312897|Depression|depression
531828|NCT00312897|Fish Oil|fish oil
531829|NCT00312897|Omega-3 Fatty Acids|omega-3 fatty acids
531830|NCT00312897|Psychiatry|psychiatry
531831|NCT00312910|Cirrhosis|cirrhosis
531832|NCT00312910|Probiotics|probiotics
531833|NCT00312910|Hepatic encephalopathy|hepatic encephalopathy
531834|NCT00312910|Ammonia|ammonia
531835|NCT00312923|HIV|hiv
531836|NCT00312923|lipids|lipids
531837|NCT00312923|dyslipidemia|dyslipidemia
531838|NCT00312923|policosanol|policosanol
531839|NCT00312923|treatment experienced|treatment experienced
531840|NCT00312936|Medication adherence|medication adherence
531841|NCT00312936|Medication compliance|medication compliance
531842|NCT00312936|Quality of Life|quality of life
531843|NCT00312936|Stress reduction|stress reduction
531844|NCT00312936|mindfulness based stress reduction|mindfulness based stress reduction
531845|NCT00312936|HIV/AIDS|hiv/aids
531846|NCT00312936|treatment experienced|treatment experienced
531847|NCT00312949|Patient participation|patient participation
531848|NCT00312949|Patient education|patient education
531849|NCT00312949|Consumer involvement|consumer involvement
531850|NCT00312962|Schizoaffective Disorder|schizoaffective disorder
531851|NCT00312962|Cognitive Remediation|cognitive remediation
531852|NCT00312962|fMRI|fmri
531853|NCT00312988|Ovarian cancer|ovarian cancer
531854|NCT00313014|Low back pain|low back pain
531855|NCT00313014|opioid|opioid
531856|NCT00313014|transdermal|transdermal
531857|NCT00313014|Butrans|butrans
531858|NCT00313040|physical activity|physical activity
531859|NCT00313040|sedentary|sedentary
531860|NCT00313040|behavioral medicine|behavioral medicine
531861|NCT00313040|motivational interviewing|motivational interviewing
531862|NCT00313066|CTGF|ctgf
531863|NCT00313066|fibrogenic cytokine|fibrogenic cytokine
531864|NCT00313066|FGF|fgf
531865|NCT00313066|pleural fibrosis|pleural fibrosis
531866|NCT00313092|OSAS|osas
531867|NCT00313092|glaucoma|glaucoma
531868|NCT00313092|MMP|mmp
531869|NCT00313105|smoking cessation|smoking cessation
531870|NCT00313105|smokeless tobacco|smokeless tobacco
531871|NCT00313105|nicotine patch|nicotine patch
531872|NCT00313105|nicotine buccal tablets|nicotine buccal tablets
531873|NCT00313105|retreatment|retreatment
531874|NCT00313105|adherence|adherence
531875|NCT00313118|oxidative stress parameters|oxidative stress parameters
531876|NCT00313131|bacterial vaginosis|bacterial vaginosis
531877|NCT00313131|vaginal candidiasis|vaginal candidiasis
531878|NCT00313131|trichomoniasis|trichomoniasis
531879|NCT00313131|vaginitis|vaginitis
531880|NCT00313131|Ghana|ghana
531881|NCT00313131|Togo|togo
531882|NCT00313131|Mali|mali
531883|NCT00313131|Guinea|guinea
531884|NCT00313157|Atrial fibrillation|atrial fibrillation
531885|NCT00313170|oncology|oncology
531886|NCT00313170|cancer|cancer
531887|NCT00313170|breast cancer|breast cancer
531888|NCT00313183|Type 1 Diabetes|type 1 diabetes
531889|NCT00313183|pediatric|pediatric
531890|NCT00313183|pramlintide|pramlintide
531891|NCT00313183|Symlin|symlin
531892|NCT00313183|Amylin|amylin
531893|NCT00313196|Pulmonary Hypertension|pulmonary hypertension
531894|NCT00313196|Sickle Cell Disease|sickle cell disease
531895|NCT00313196|Sickle cell anemia|sickle cell anemia
531896|NCT00313196|bosentan|bosentan
531897|NCT00313196|ASSET|asset
531898|NCT00313196|ASSET-2|asset-2
531899|NCT00313209|Roflumilast|roflumilast
531900|NCT00313209|Salmeterol|salmeterol
531901|NCT00313209|COPD|copd
531902|NCT00313209|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
531903|NCT00329914|Preterm delivery|preterm delivery
531904|NCT00329914|Prevention|prevention
531905|NCT00329914|Twins|twins
531906|NCT00329914|Progesterone|progesterone
531907|NCT00329927|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
531908|NCT00329940|Letrozole|letrozole
531909|NCT00329940|breast cancer|breast cancer
531910|NCT00329940|critical musculoskeletal|critical musculoskeletal
531911|NCT00329940|postmenopausal|postmenopausal
531912|NCT00329940|rheumatologic tolerance|rheumatologic tolerance
531913|NCT00329966|Influenza|influenza
531914|NCT00329966|adult|adult
531915|NCT00329966|elderly|elderly
531916|NCT00329966|vaccine|vaccine
531917|NCT00329979|aortic stenosis|aortic stenosis
531918|NCT00329979|radial|radial
531919|NCT00329979|femoral|femoral
531920|NCT00329979|vascular access site|vascular access site
531921|NCT00329979|embolism|embolism
531922|NCT00329979|cerebral|cerebral
531923|NCT00329979|MRI|mri
531924|NCT00329979|stroke|stroke
531925|NCT00330005|psychotherapy|psychotherapy
531926|NCT00330005|bipolar disorder|bipolar disorder
531927|NCT00330005|psychodynamic|psychodynamic
531928|NCT00330005|psychoeducation|psychoeducation
531929|NCT00330005|illness management|illness management
531930|NCT00330005|controlled trial|controlled trial
531931|NCT00330005|pilot study|pilot study
531932|NCT00330018|BMT|bmt
531933|NCT00330018|CMV|cmv
531934|NCT00330018|GVHD|gvhd
531935|NCT00330070|8-week treatment|8-week treatment
531936|NCT00330070|oral tablets|oral tablets
531937|NCT00330070|persistent moderate to severe asthma|persistent moderate to severe asthma
531938|NCT00330070|AQLQ|aqlq
531939|NCT00330070|asthma control|asthma control
531940|NCT00330070|quality of life|quality of life
531941|NCT00330096|bone loss, osteoporosis, prevention, hesperidin|bone loss, osteoporosis, prevention, hesperidin
531942|NCT00330109|glioma|glioma
531943|NCT00330109|machine learning|machine learning
531944|NCT00330109|advanced diagnostic imaging|advanced diagnostic imaging
531945|NCT00330122|radius articular displaced fractures|radius articular displaced fractures
531946|NCT00330122|fore locked plate|fore locked plate
531947|NCT00330122|external radiocarpal fixer|external radiocarpal fixer
531948|NCT00330135|hip osteoarthritis|hip osteoarthritis
531949|NCT00330135|Hyaluronic acid|hyaluronic acid
531950|NCT00330135|Viscosupplementation|viscosupplementation
531951|NCT00330135|intra-articular injections|intra-articular injections
531952|NCT00330148|trypanosomiasis|trypanosomiasis
531953|NCT00330148|gambiense|gambiense
531954|NCT00330148|combination drug therapy|combination drug therapy
531955|NCT00330148|sleeping sickness|sleeping sickness
531956|NCT00330148|Uganda|uganda
531957|NCT00330174|Alcoholism|alcoholism
531958|NCT00330174|Mood|mood
531959|NCT00330174|Anxiety|anxiety
531960|NCT00330174|Acamprosate|acamprosate
531961|NCT00330187|nicotine dependence|nicotine dependence
531962|NCT00330187|bupropion SR|bupropion sr
531963|NCT00330187|smoking cessation|smoking cessation
531964|NCT00330187|adolescents|adolescents
531965|NCT00330187|contingency management|contingency management
531966|NCT00330200|Fasting plasma glucose|fasting plasma glucose
531967|NCT00330200|HbA1c|hba1c
531968|NCT00330200|Metabolism|metabolism
531969|NCT00330213|transthoracic|transthoracic
532077|NCT00330616|WELLBUTRIN|wellbutrin
531970|NCT00330213|echocardiography|echocardiography
531972|NCT00330213|cognac|cognac
531973|NCT00330213|coronary reactivity|coronary reactivity
531974|NCT00330226|schizophrenia|schizophrenia
531975|NCT00330226|bipolar disorder|bipolar disorder
531976|NCT00330226|atypical antipsychotics|atypical antipsychotics
531977|NCT00330226|mood stabilizers|mood stabilizers
531978|NCT00330226|biological markers|biological markers
531979|NCT00330239|Substance Abuse|substance abuse
531980|NCT00330239|Trauma|trauma
531981|NCT00330239|Dependence|dependence
531982|NCT00330252|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
531983|NCT00330252|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
531984|NCT00330252|Alemtuzumab|alemtuzumab
531985|NCT00330252|Campath|campath
531986|NCT00330252|Rituximab|rituximab
531987|NCT00330252|Rituxan|rituxan
531988|NCT00330278|Cesarean section|cesarean section
531989|NCT00330278|Antibiotic prophylaxis|antibiotic prophylaxis
531990|NCT00330278|Cefazolin|cefazolin
531991|NCT00330408|Adherence|adherence
531992|NCT00330408|GP training|gp training
531993|NCT00330408|Medication Event Monitoring System(MEMS)|medication event monitoring system(mems)
531994|NCT00330408|Antihypertensive Medication|antihypertensive medication
531995|NCT00330408|Hypertension|hypertension
531996|NCT00330434|Alcohol|alcohol
531997|NCT00330434|Bupropion|bupropion
531998|NCT00330434|Chlorzoxazone|chlorzoxazone
531999|NCT00330434|Interaction|interaction
532000|NCT00330434|Induction|induction
532001|NCT00330434|Depression|depression
532002|NCT00330434|Smoking|smoking
532003|NCT00330434|Drinking|drinking
532004|NCT00330434|Cytochrome P450 Enzyme|cytochrome p450 enzyme
532005|NCT00330434|CYP2B6|cyp2b6
532006|NCT00330434|CYP2E1|cyp2e1
532007|NCT00330434|Pharmacogenetics|pharmacogenetics
532008|NCT00330434|Pharmacokinetics|pharmacokinetics
532009|NCT00330434|Pharmacodynamics|pharmacodynamics
532010|NCT00330434|Boston|boston
532011|NCT00330434|Tufts University|tufts university
532012|NCT00330447|pregnancy|pregnancy
532013|NCT00330447|in utero|in utero
532014|NCT00330447|chemotherapy|chemotherapy
532015|NCT00330447|radiotherapy|radiotherapy
532016|NCT00330447|cancer|cancer
532017|NCT00330447|offspring|offspring
532018|NCT00330447|neonatal|neonatal
532019|NCT00330447|long term|long term
532020|NCT00330447|follow up|follow up
532021|NCT00330447|cancer during pregnancy|cancer during pregnancy
532022|NCT00330447|chemotherapy and radiotherapy during pregnancy|chemotherapy and radiotherapy during pregnancy
532023|NCT00330447|long term follow up of children|long term follow up of children
532024|NCT00330460|Osteoporosis|osteoporosis
532025|NCT00330460|Osteopenia|osteopenia
532026|NCT00330460|AMG 162|amg 162
532027|NCT00330460|Fracture - hip|fracture - hip
532028|NCT00330460|Postmenopausal|postmenopausal
532029|NCT00330486|Acamprosate|acamprosate
532030|NCT00330486|Addiction|addiction
532031|NCT00330486|Alcoholism|alcoholism
532032|NCT00330486|Alcohol dependence|alcohol dependence
532033|NCT00330486|Bipolar disorder|bipolar disorder
532034|NCT00330486|Depression|depression
532035|NCT00330486|Impulsivity|impulsivity
532036|NCT00330486|Mania|mania
532037|NCT00330486|Substance abuse|substance abuse
532038|NCT00330499|Locally invasive|locally invasive
532039|NCT00330499|Bladder cancer|bladder cancer
532040|NCT00330499|Chemoradiotherapy|chemoradiotherapy
532041|NCT00330499|Efficacy|efficacy
532042|NCT00330499|Organ conservation|organ conservation
532043|NCT00330512|regional anestesia|regional anestesia
532044|NCT00330512|cesarean section|cesarean section
532045|NCT00330512|hypotention|hypotention
532046|NCT00330512|newborn|newborn
532047|NCT00330538|Osteoporosis|osteoporosis
532048|NCT00330538|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
532049|NCT00330551|Schizoaffective Disorder, Depressed Type|schizoaffective disorder, depressed type
532050|NCT00330551|Schizophreniform Disorder|schizophreniform disorder
532051|NCT00330551|First-episode Schizophrenia|first-episode schizophrenia
532052|NCT00330551|Injectable Risperidone|injectable risperidone
532053|NCT00330564|VHL Syndrome|vhl syndrome
532054|NCT00330564|Von Hippel-Lindau Syndrome|von hippel-lindau syndrome
532055|NCT00330564|VHL Disease|vhl disease
532056|NCT00330564|Kidney|kidney
532057|NCT00330564|Retina|retina
532058|NCT00330564|Brain|brain
532059|NCT00330564|Spinal cord|spinal cord
532060|NCT00330564|Pancreas|pancreas
532061|NCT00330564|Inner ear|inner ear
532062|NCT00330564|Cysts|cysts
532063|NCT00330564|Tumors|tumors
532064|NCT00330564|Sunitinib Malate|sunitinib malate
532065|NCT00330564|SU011248|su011248
532066|NCT00330564|Sutent|sutent
532068|NCT00330564|Sunitinib|sunitinib
532069|NCT00330564|Renal cell carcinoma|renal cell carcinoma
532070|NCT00330564|Hemangioblastoma|hemangioblastoma
532071|NCT00330564|Endothelium|endothelium
532072|NCT00330590|Central Venous|central venous
532073|NCT00330590|Ultrasonography|ultrasonography
532074|NCT00330590|Catheterization|catheterization
532075|NCT00330603|Cough|cough
532076|NCT00330603|Gastroesophageal Reflux|gastroesophageal reflux
532078|NCT00330616|elderly|elderly
532079|NCT00330616|depression|depression
532080|NCT00330616|Pharmacokinetics|pharmacokinetics
532081|NCT00330642|Streptococcus Group B|streptococcus group b
532082|NCT00330642|Pregnancy|pregnancy
532083|NCT00330655|Binge eating|binge eating
532084|NCT00330655|Obesity|obesity
532085|NCT00330655|Eating disorder|eating disorder
532086|NCT00330668|Insulin-like Growth Factor Deficiency|insulin-like growth factor deficiency
532087|NCT00330668|IGF-1|igf-1
532088|NCT00330668|Short Stature|short stature
532089|NCT00330681|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
532090|NCT00330681|free radical scavenger|free radical scavenger
532091|NCT00330694|Physical Therapy|physical therapy
532092|NCT00330694|Organisation of care|organisation of care
532093|NCT00330707|bladder cancer|bladder cancer
532094|NCT00330707|BCG|bcg
532095|NCT00330707|interferon alpha|interferon alpha
532096|NCT00330720|Personal Emergency Response System|personal emergency response system
532097|NCT00330720|Anxiety|anxiety
532098|NCT00330720|Fear of Falling|fear of falling
532099|NCT00330720|RCT|rct
532100|NCT00330733|Cardiovascular Disease|cardiovascular disease
532101|NCT00330733|Inflammation|inflammation
532102|NCT00330733|Insulin Resistance|insulin resistance
532103|NCT00330733|Type 2 DM|type 2 dm
532104|NCT00330746|elderly|elderly
532105|NCT00330746|chemotherapy|chemotherapy
532106|NCT00330746|targeted therapy|targeted therapy
532107|NCT00330746|combination therapy|combination therapy
532108|NCT00330746|sequential therapy|sequential therapy
532109|NCT00330746|randomized phase II|randomized phase ii
532110|NCT00330746|one year survival|one year survival
532111|NCT00330759|Bone metastases|bone metastases
532112|NCT00330759|lytic bone lesions|lytic bone lesions
532113|NCT00330759|advanced cancer|advanced cancer
532114|NCT00330759|multiple myeloma|multiple myeloma
532115|NCT00330759|lymphoma|lymphoma
532116|NCT00330759|solid tumors|solid tumors
532117|NCT00330759|skeletal related events|skeletal related events
532118|NCT00330759|skeletal fractures|skeletal fractures
532119|NCT00330759|spinal cord compressions, radiation to bone|spinal cord compressions, radiation to bone
532120|NCT00330759|surgery to bone, bisphosphonates|surgery to bone, bisphosphonates
532121|NCT00330759|denosumab|denosumab
532122|NCT00330772|Cardiac Surger|cardiac surger
532123|NCT00330772|Coronary Artery Bypass Grafting|coronary artery bypass grafting
532124|NCT00330772|Graft patency|graft patency
532125|NCT00330772|Aspirin|aspirin
532126|NCT00330772|Clopidogrel|clopidogrel
532127|NCT00330772|Hemorrhage|hemorrhage
532128|NCT00330772|Transfusion|transfusion
532129|NCT00330798|Photorefractive Keratectomy|photorefractive keratectomy
532137|NCT00330850|Aura|aura
532138|NCT00330863|Relapse|relapse
532139|NCT00330863|Prevention|prevention
532140|NCT00330863|Schizophrenia|schizophrenia
532141|NCT00330863|Injectable Medication|injectable medication
532142|NCT00330876|pitavastatin|pitavastatin
532143|NCT00330876|hypercholesterolemia|hypercholesterolemia
532144|NCT00330876|combined dyslipidemia|combined dyslipidemia
532145|NCT00330889|Rheumatoid Arthritis|rheumatoid arthritis
532146|NCT00330902|malaria|malaria
532147|NCT00330902|subpatent parasitaemia|subpatent parasitaemia
532148|NCT00330902|dry season|dry season
532149|NCT00330902|primaquine|primaquine
532150|NCT00330902|Plasmodium falciparum infection detected by PCR|plasmodium falciparum infection detected by pcr
532151|NCT00330954|viral response genes|viral response genes
532152|NCT00330967|Fat Emulsions, Intravenous|fat emulsions, intravenous
686482|NCT00907348|NHL|nhl
531454|NCT00318084|Acid-related diseases|acid-related diseases
531455|NCT00318084|Acid reflux disease|acid reflux disease
531456|NCT00318084|Nexium|nexium
531460|NCT00318110|Renal|renal
532153|NCT00330967|Free Fatty Acids|free fatty acids
532154|NCT00330967|Glucose Clamp Technique|glucose clamp technique
532155|NCT00330967|Inflammation|inflammation
532156|NCT00330967|Insulin Resistance|insulin resistance
532157|NCT00330967|Muscle, Skeletal|muscle, skeletal
532158|NCT00330967|NF-Kappa B|nf-kappa b
532159|NCT00330980|Cognition|cognition
532160|NCT00330980|Statins|statins
532161|NCT00330980|Serotonin|serotonin
532162|NCT00330980|Cholesterol|cholesterol
532163|NCT00330993|mifepristone|mifepristone
532164|NCT00330993|misoprostol|misoprostol
532165|NCT00330993|medical abortion|medical abortion
532166|NCT00330993|buccal administration|buccal administration
532167|NCT00331006|Blood Coagulation Factor Inhibitors|blood coagulation factor inhibitors
532168|NCT00331019|Streptococcus Group B|streptococcus group b
532169|NCT00331019|Pregnancy|pregnancy
532170|NCT00331032|VivaGel™, sexually transmitted, microbicide, herpes simplex|vivagel™, sexually transmitted, microbicide, herpes simplex
532171|NCT00331045|Opioids|opioids
532172|NCT00331045|cancer|cancer
532173|NCT00331045|constipation|constipation
532174|NCT00331058|Severe Asthma bronchoscopy|severe asthma bronchoscopy
532175|NCT00331071|Contraception|contraception
532176|NCT00331071|Hormonal contraception|hormonal contraception
532183|NCT00331097|intermediate risk|intermediate risk
532184|NCT00331097|high risk|high risk
532185|NCT00331123|Surgical menopause|surgical menopause
532186|NCT00331123|HSDD|hsdd
532187|NCT00331136|malaria|malaria
532188|NCT00331136|pyronaridine|pyronaridine
532189|NCT00331136|artesunate|artesunate
532190|NCT00331136|falciparum|falciparum
532191|NCT00331136|ACT|act
532192|NCT00331149|safety|safety
532193|NCT00331149|efficacy|efficacy
532194|NCT00331149|L-dopa|l-dopa
532195|NCT00331149|ropinirole PR|ropinirole pr
532196|NCT00331149|Parkinson's disease|parkinson's disease
532197|NCT00331149|ropinirole IR|ropinirole ir
532198|NCT00331149|adjunctive therapy|adjunctive therapy
532199|NCT00331149|superiority|superiority
532200|NCT00331149|REQUIP|requip
532201|NCT00331149|health outcomes|health outcomes
532209|NCT00331188|Esophageal Variceal Bleeding|esophageal variceal bleeding
532210|NCT00331188|Portal Hypertension|portal hypertension
532211|NCT00331188|Hepatic Cirrhosis|hepatic cirrhosis
532212|NCT00331188|Cirrhosis|cirrhosis
532213|NCT00331188|Liver Cirrhosis|liver cirrhosis
532214|NCT00331188|Somatostatin Analog|somatostatin analog
532215|NCT00331188|Vapreotide|vapreotide
532216|NCT00331188|Acute Esophageal Variceal Bleeding|acute esophageal variceal bleeding
532217|NCT00331201|NEC|nec
532218|NCT00331214|Surgical menopause|surgical menopause
532219|NCT00331214|HSDD|hsdd
532220|NCT00331227|flavonoids|flavonoids
532221|NCT00331227|food supplements|food supplements
532222|NCT00331227|endothelial function|endothelial function
532223|NCT00331227|no conditions allowed, healthy volunteers only|no conditions allowed, healthy volunteers only
532224|NCT00331253|Indocyanine Green-Mediated Photothrombosis|indocyanine green-mediated photothrombosis
532225|NCT00331253|Neovascular|neovascular
532226|NCT00331253|Age-Related Macular Degeneration|age-related macular degeneration
532227|NCT00331279|polycystic ovary syndrome|polycystic ovary syndrome
532228|NCT00331279|insulin resistance|insulin resistance
532229|NCT00331279|cinnamon|cinnamon
532230|NCT00331292|Asthma bronchoscopy|asthma bronchoscopy
532231|NCT00331305|Exercise|exercise
532232|NCT00331318|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
532233|NCT00331318|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
532234|NCT00331318|Motor Learning|motor learning
532235|NCT00331318|Brain Plasticity|brain plasticity
532236|NCT00331318|Healthy Volunteer|healthy volunteer
532237|NCT00331318|HV|hv
532238|NCT00331331|Uveitis|uveitis
532239|NCT00331331|Intermediate Uveitis|intermediate uveitis
532240|NCT00331331|Pars Planitis|pars planitis
532241|NCT00331331|Macular Edema|macular edema
532242|NCT00331331|Vasculitis|vasculitis
532243|NCT00331331|Ocular Inflammatory Disease|ocular inflammatory disease
532244|NCT00331357|acute idiopathic thrombocytopenic purpura|acute idiopathic thrombocytopenic purpura
532245|NCT00331357|paediatric|paediatric
532246|NCT00331357|quality of life|quality of life
532247|NCT00331409|stage III renal cell cancer|stage iii renal cell cancer
532248|NCT00331409|stage IV renal cell cancer|stage iv renal cell cancer
532249|NCT00331409|clear cell renal cell carcinoma|clear cell renal cell carcinoma
532250|NCT00331409|recurrent renal cell cancer|recurrent renal cell cancer
532251|NCT00331422|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
532252|NCT00331422|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
532253|NCT00331422|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
532254|NCT00331422|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
532255|NCT00331422|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
532256|NCT00331422|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
532257|NCT00331422|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
532258|NCT00331422|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
532259|NCT00331422|peritoneal cavity cancer|peritoneal cavity cancer
532260|NCT00331422|fallopian tube cancer|fallopian tube cancer
532261|NCT00331422|Brenner tumor|brenner tumor
532262|NCT00331435|AMD|amd
532263|NCT00331435|PCV|pcv
532264|NCT00331435|PDT|pdt
532265|NCT00331448|Treatment Experienced|treatment experienced
532266|NCT00331448|Lipoatrophy|lipoatrophy
532267|NCT00331448|Lipohypertrophy|lipohypertrophy
532268|NCT00331448|Glucose|glucose
532269|NCT00331448|Cholesterol|cholesterol
532270|NCT00331448|Triglycerides|triglycerides
532271|NCT00331448|MRI|mri
532272|NCT00331448|DXA|dxa
532273|NCT00331448|Carotid IMT|carotid imt
532274|NCT00331448|LDL|ldl
532275|NCT00331448|HDL|hdl
532276|NCT00331474|BCG|bcg
532277|NCT00331474|HIV|hiv
532278|NCT00331474|Immune responses|immune responses
532279|NCT00331474|Delayed vaccination|delayed vaccination
532280|NCT00331474|Infant morbidity|infant morbidity
532281|NCT00331474|Nutritional status|nutritional status
532282|NCT00331474|Morbidity|morbidity
532283|NCT00331474|Mortality|mortality
532284|NCT00331487|Glucose Metabolism Disorder|glucose metabolism disorder
532285|NCT00331487|Dysmetabolic Syndrome|dysmetabolic syndrome
532286|NCT00331487|Type II Diabetes|type ii diabetes
532287|NCT00331487|Diabetes Mellitus|diabetes mellitus
532288|NCT00331487|Lipoatrophic|lipoatrophic
532289|NCT00331487|Dyslipidemia|dyslipidemia
532290|NCT00331487|Drug Therapy|drug therapy
532291|NCT00331526|adult glioblastoma|adult glioblastoma
532292|NCT00331526|adult gliosarcoma|adult gliosarcoma
532293|NCT00331526|adult giant cell glioblastoma|adult giant cell glioblastoma
532294|NCT00331539|Cochlear implant|cochlear implant
532295|NCT00331539|threshold (T) measurement|threshold (t) measurement
532296|NCT00331539|comfort (C) level|comfort (c) level
532297|NCT00331539|profound hearing loss|profound hearing loss
532298|NCT00331539|auditory stimuli|auditory stimuli
532299|NCT00331539|profound hearing loss patients eligible for the study should be capable of providing reliable|profound hearing loss patients eligible for the study should be capable of providing reliable
532300|NCT00331539|subjective counted thresholds and has good NRT recordings, implanted with|subjective counted thresholds and has good nrt recordings, implanted with
532301|NCT00331539|the Nucleus Freedom system|the nucleus freedom system
532302|NCT00331565|Bariatric surgery|bariatric surgery
532303|NCT00331565|Bioavailability|bioavailability
532304|NCT00331565|Bioequivalence|bioequivalence
532305|NCT00331565|Atorvastatin|atorvastatin
532306|NCT00331565|CYP's|cyp's
532307|NCT00331565|P-gp|p-gp
532308|NCT00331565|OATP|oatp
532309|NCT00331630|stage I breast cancer|stage i breast cancer
532310|NCT00331630|stage II breast cancer|stage ii breast cancer
532311|NCT00331630|stage IIIA breast cancer|stage iiia breast cancer
532312|NCT00331630|stage IIIB breast cancer|stage iiib breast cancer
532313|NCT00331630|stage IIIC breast cancer|stage iiic breast cancer
532314|NCT00331656|noninvasive|noninvasive
532315|NCT00331656|positive|positive
532316|NCT00331656|cuirass|cuirass
532317|NCT00331656|ventilation|ventilation
532318|NCT00331656|respiratory|respiratory
532319|NCT00331656|failure|failure
532320|NCT00331669|deep brain stimulation|deep brain stimulation
532321|NCT00331669|pallidum|pallidum
532322|NCT00331669|tardive dystonia|tardive dystonia
532323|NCT00331669|randomized|randomized
532324|NCT00331669|double blind|double blind
532325|NCT00331669|multicenter|multicenter
532326|NCT00331695|Progesterone|progesterone
532327|NCT00331695|Preterm delivery|preterm delivery
532328|NCT00331695|Preterm labor|preterm labor
532329|NCT00331695|Cervical length|cervical length
532330|NCT00331695|ultrasonography|ultrasonography
532331|NCT00331708|Malaria|malaria
532332|NCT00331708|Efficacy|efficacy
532333|NCT00331708|Pharmacokinetic|pharmacokinetic
532334|NCT00331708|Gametocyte|gametocyte
532335|NCT00331708|Molecular markers|molecular markers
532336|NCT00331708|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
532337|NCT00331708|Artesunate|artesunate
532338|NCT00331708|Artemisinin|artemisinin
532339|NCT00331721|Acute Ischemic Stroke|acute ischemic stroke
532340|NCT00331760|stage I endometrial carcinoma|stage i endometrial carcinoma
532341|NCT00331760|stage II endometrial carcinoma|stage ii endometrial carcinoma
532342|NCT00331760|stage III endometrial carcinoma|stage iii endometrial carcinoma
532343|NCT00331760|endometrial adenoacanthoma|endometrial adenoacanthoma
532344|NCT00331760|endometrial adenocarcinoma|endometrial adenocarcinoma
532345|NCT00331760|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
532346|NCT00331760|stage IB cervical cancer|stage ib cervical cancer
532347|NCT00331760|stage IIA cervical cancer|stage iia cervical cancer
532348|NCT00331760|stage IIB cervical cancer|stage iib cervical cancer
532349|NCT00331760|cervical adenocarcinoma|cervical adenocarcinoma
532350|NCT00331760|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
532351|NCT00331760|cervical squamous cell carcinoma|cervical squamous cell carcinoma
532352|NCT00331773|adenocarcinoma of the prostate|adenocarcinoma of the prostate
532353|NCT00331773|stage IIB prostate cancer|stage iib prostate cancer
532354|NCT00331773|stage IIA prostate cancer|stage iia prostate cancer
532355|NCT00331786|colon cancer|colon cancer
532356|NCT00331786|rectal cancer|rectal cancer
532357|NCT00331799|Depression|depression
532358|NCT00331799|Pharmacotherapy|pharmacotherapy
532359|NCT00331799|Duloxetine|duloxetine
532360|NCT00331812|Hypermetabolism|hypermetabolism
532361|NCT00331812|Mitochondrial abnormalities|mitochondrial abnormalities
532362|NCT00331812|Oxidant/antioxidant status|oxidant/antioxidant status
532363|NCT00331825|Schizophrenia, EPS, risperidone, olanzapine|schizophrenia, eps, risperidone, olanzapine
532364|NCT00331838|Prevention|prevention
532365|NCT00331838|Venous Thrombosis|venous thrombosis
532366|NCT00331838|Orthopedic Surgery|orthopedic surgery
533048|NCT00323518|hematologic|hematologic
532367|NCT00331864|AMD, ranibizumab|amd, ranibizumab
532368|NCT00331877|family|family
532369|NCT00331877|end-of-life|end-of-life
532370|NCT00331877|intensive care unit|intensive care unit
532371|NCT00331890|Neuroprotection|neuroprotection
532372|NCT00331890|Acute ischemic stroke|acute ischemic stroke
532373|NCT00331890|Cerebral infarction|cerebral infarction
532374|NCT00331929|Asthma|asthma
532375|NCT00331929|Allergy|allergy
532376|NCT00331929|Respiratory|respiratory
532377|NCT00331929|Pollution|pollution
532378|NCT00331929|Children|children
532379|NCT00331929|Air pollution|air pollution
532380|NCT00331942|Breast|breast
532381|NCT00331942|Cancer|cancer
532382|NCT00331942|Associated|associated
532383|NCT00331942|Antibodies|antibodies
532384|NCT00332033|Fibroids|fibroids
532385|NCT00332033|Leiomyoma|leiomyoma
532386|NCT00332033|Pirfenidone|pirfenidone
532387|NCT00332033|Misoprostol|misoprostol
532388|NCT00332033|Non-Surgical|non-surgical
532389|NCT00332033|Collagen|collagen
532390|NCT00332033|Uterus|uterus
532391|NCT00332033|Uterine Fibroids|uterine fibroids
532392|NCT00332033|Uterine Leiomyoma|uterine leiomyoma
532393|NCT00332046|fMRI placebo GW679769 Social Anxiety Disorder SAD|fmri placebo gw679769 social anxiety disorder sad
532394|NCT00332098|Childhood Mood Disorders|childhood mood disorders
532395|NCT00332098|Family Treatment|family treatment
532396|NCT00332098|Psychoeducation|psychoeducation
532397|NCT00332098|Pharmacotherapy|pharmacotherapy
532398|NCT00332098|Family Functioning|family functioning
532399|NCT00332098|Psychosocial Intervention|psychosocial intervention
532400|NCT00332111|transplant|transplant
532401|NCT00332111|pancreas|pancreas
532402|NCT00332150|parents|parents
532403|NCT00332150|newborn|newborn
532404|NCT00332150|clinical trials|clinical trials
532405|NCT00332163|STEPP|stepp
532406|NCT00332163|STEP|step
532407|NCT00332163|STEEP|steep
532408|NCT00332163|mCRC|mcrc
532409|NCT00332163|Skin Toxicities|skin toxicities
532410|NCT00332163|Skin Rash|skin rash
532411|NCT00332163|Metastatic Colorectal Cancer|metastatic colorectal cancer
532412|NCT00332163|Anti-EGFr Skin Rash|anti-egfr skin rash
532413|NCT00332163|colon cancer|colon cancer
532414|NCT00332163|colorectal cancer|colorectal cancer
532415|NCT00332163|rectal cancer|rectal cancer
532416|NCT00332176|Hepatitis C|hepatitis c
532417|NCT00332176|Celgosivir|celgosivir
532418|NCT00332176|HCV|hcv
532419|NCT00332176|Genotype 1|genotype 1
532420|NCT00332176|Treatment-naive|treatment-naive
532421|NCT00332176|Early viral kinetics|early viral kinetics
532422|NCT00332189|PKU|pku
532423|NCT00332215|Cystic Fibrosis|cystic fibrosis
532424|NCT00332215|Antioxidants|antioxidants
532425|NCT00332215|Inhalational therapy|inhalational therapy
532426|NCT00332215|Induced sputum|induced sputum
532427|NCT00332215|Airway inflammation|airway inflammation
532428|NCT00332228|opiate dependence|opiate dependence
532429|NCT00332228|heroin dependence|heroin dependence
532430|NCT00332228|naltrexone|naltrexone
532431|NCT00332228|cognitive behavioral therapy|cognitive behavioral therapy
532432|NCT00332241|Serious behavioral problems in children and adolescents with AD|serious behavioral problems in children and adolescents with ad
532433|NCT00332241|Behavioral Problems|behavioral problems
532434|NCT00332254|Anterior cruciate ligament tear|anterior cruciate ligament tear
532435|NCT00332254|Meniscus tear|meniscus tear
532436|NCT00332254|Chondral injury|chondral injury
532437|NCT00332267|Sepsis|sepsis
532438|NCT00332267|Hypoxia|hypoxia
532439|NCT00332267|Altitude Sickness|altitude sickness
532440|NCT00332267|Endotoxin|endotoxin
532441|NCT00332267|Cytokines|cytokines
532442|NCT00332267|Cerebral blood flow|cerebral blood flow
532443|NCT00332267|Cerebral metabolism|cerebral metabolism
532444|NCT00332267|Reactive oxygen species|reactive oxygen species
532445|NCT00332280|solid tumors|solid tumors
532446|NCT00332280|clinical benefit|clinical benefit
532447|NCT00332280|quality of life|quality of life
686800|NCT00918983|BPH|bph
532448|NCT00332280|esophageal cancer|esophageal cancer
532449|NCT00332280|colon cancer|colon cancer
532450|NCT00332280|pancreatic cancer|pancreatic cancer
532451|NCT00332280|gastric cancer|gastric cancer
532452|NCT00332280|liver cancer|liver cancer
532453|NCT00332280|gall bladder cancer|gall bladder cancer
532454|NCT00332280|prostate cancer|prostate cancer
532455|NCT00332280|gynecological cancer|gynecological cancer
532456|NCT00332280|lung cancer|lung cancer
532457|NCT00332280|Tumors of GI tract, prostate and gynaecological|tumors of gi tract, prostate and gynaecological
532458|NCT00332306|Once daily antiretroviral treatment|once daily antiretroviral treatment
532459|NCT00332306|Concomitant antituberculosis treatment|concomitant antituberculosis treatment
532460|NCT00332306|HIV Infections|hiv infections
532461|NCT00332319|spinal cord injury|spinal cord injury
532462|NCT00332319|urgency|urgency
532463|NCT00332319|Overactive bladder|overactive bladder
532464|NCT00332319|neurogenic|neurogenic
532465|NCT00332319|neurometry|neurometry
532466|NCT00332319|frequency|frequency
532467|NCT00332319|urge incontinence|urge incontinence
532468|NCT00332332|Phase IV|phase iv
532469|NCT00332332|Psoriasis|psoriasis
532470|NCT00332332|Inflammation|inflammation
532471|NCT00332371|Intensive Care|intensive care
532472|NCT00332371|Shock, Septic|shock, septic
532473|NCT00332371|Adsorption|adsorption
532474|NCT00332371|Sorption Detoxification|sorption detoxification
532475|NCT00332410|Voriconazole|voriconazole
532476|NCT00332410|renal transplant|renal transplant
532477|NCT00332410|kidney function|kidney function
532478|NCT00332410|kidneys|kidneys
532479|NCT00332449|early breast feeding|early breast feeding
532480|NCT00332449|hypoglycemia|hypoglycemia
532481|NCT00332449|newborn|newborn
532482|NCT00332462|Liver transplantation, Cyclosporine|liver transplantation, cyclosporine
532483|NCT00332514|pharmacist intervention|pharmacist intervention
532484|NCT00332514|post-discharge telephone call|post-discharge telephone call
532485|NCT00332514|black hole|black hole
532486|NCT00332579|Compulsive Shoplifting|compulsive shoplifting
532487|NCT00332579|Kleptomania|kleptomania
532488|NCT00332579|Compulsive Stealing|compulsive stealing
532489|NCT00332592|Necrotizing Enterocolitis|necrotizing enterocolitis
532490|NCT00332592|Intragastric microdialysis|intragastric microdialysis
532491|NCT00332592|Peritoneal microdialysis|peritoneal microdialysis
532492|NCT00332592|Infants|infants
532493|NCT00332605|Methamphetamine Dependence|methamphetamine dependence
532494|NCT00332618|MULTICENTER|multicenter
532495|NCT00332618|CONTROLLED|controlled
532496|NCT00332618|PARALLEL GROUPS|parallel groups
532497|NCT00332631|Cardiac surgery,|cardiac surgery,
532498|NCT00332631|Cardiopulmonary bypass,|cardiopulmonary bypass,
532499|NCT00332631|Oxidative stress,|oxidative stress,
532500|NCT00332631|Acute renal dysfunction,|acute renal dysfunction,
532501|NCT00332631|N-acetylcysteine|n-acetylcysteine
532502|NCT00332670|(Non-seasonal) Depression|(non-seasonal) depression
532503|NCT00332670|bright light therapy|bright light therapy
532504|NCT00332670|randomized controlled trial|randomized controlled trial
532505|NCT00332670|suprachiasmatic nucleus|suprachiasmatic nucleus
532506|NCT00332670|HPA-axis|hpa-axis
532507|NCT00332670|DHEA|dhea
532508|NCT00332670|melatonin|melatonin
532509|NCT00332670|actigraphy|actigraphy
532510|NCT00332670|elderly|elderly
532511|NCT00332670|self-efficacy|self-efficacy
532512|NCT00332670|social support|social support
532513|NCT00332683|Dysphagia|dysphagia
532514|NCT00332683|spine surgery|spine surgery
532515|NCT00332683|cuff pressure|cuff pressure
532516|NCT00332696|bowel obstruction,|bowel obstruction,
532517|NCT00332696|peritoneal carcinomatosis|peritoneal carcinomatosis
532518|NCT00332696|Octreotide|octreotide
532519|NCT00332696|inoperable|inoperable
532520|NCT00332709|Breast cancer|breast cancer
532521|NCT00332709|postmenopausal|postmenopausal
532522|NCT00332709|bone mineral density|bone mineral density
532523|NCT00332709|Zoledronic acid|zoledronic acid
532524|NCT00332709|Letrozole|letrozole
532525|NCT00332709|extended adjuvant treatment.|extended adjuvant treatment.
532526|NCT00332709|Postmenopausal women with primary hormone receptor positive breast cancer|postmenopausal women with primary hormone receptor positive breast cancer
532527|NCT00332735|spinal|spinal
532528|NCT00332735|anesthesia|anesthesia
532530|NCT00332735|bupivacaine|bupivacaine
532531|NCT00332735|outpatient|outpatient
532532|NCT00332735|surgery|surgery
532533|NCT00332735|limbs|limbs
532534|NCT00332787|Major Depressive Disorder|major depressive disorder
532535|NCT00332800|Stroke-Nutritional Supplementation-Functional Recovery|stroke-nutritional supplementation-functional recovery
532536|NCT00332813|HIV Risk Behavior|hiv risk behavior
532537|NCT00332813|Pregnancy|pregnancy
532538|NCT00332813|Drug Abuse|drug abuse
532539|NCT00332826|Inhaled insulin|inhaled insulin
532540|NCT00332826|Diabetes Type I and II with Asthma|diabetes type i and ii with asthma
532541|NCT00332839|enteric-coated mycophenolate sodium, everolimus, CNI-free regimen|enteric-coated mycophenolate sodium, everolimus, cni-free regimen
532542|NCT00332852|Postive breast cancer|postive breast cancer
532543|NCT00332852|postmenopausal|postmenopausal
532544|NCT00332852|disease free survival|disease free survival
532545|NCT00332852|letrozole|letrozole
532546|NCT00332852|early adjuvant treatment|early adjuvant treatment
532547|NCT00332852|primary hormone receptor|primary hormone receptor
532548|NCT00332865|Head and neck cancer|head and neck cancer
532549|NCT00332865|Radiotherapy|radiotherapy
532550|NCT00332865|Dysphagia|dysphagia
532551|NCT00332865|Exercise|exercise
532552|NCT00332865|Deglutition|deglutition
532553|NCT00332865|Randomized controlled trial|randomized controlled trial
532554|NCT00332865|Quality of life|quality of life
532555|NCT00332865|Tube feeding|tube feeding
532556|NCT00332878|Behavioral Intervention|behavioral intervention
532558|NCT00332878|HSV2|hsv2
532559|NCT00332891|Anxiety|anxiety
532560|NCT00332891|Anti-Anxiety Agents|anti-anxiety agents
532561|NCT00332891|controlled Clinical Trials|controlled clinical trials
532562|NCT00332904|betablocker|betablocker
532563|NCT00332904|aldosterone antagonist|aldosterone antagonist
532564|NCT00332904|peripheral haemodynamics|peripheral haemodynamics
532565|NCT00332904|cardiac haemodynamics|cardiac haemodynamics
532566|NCT00332904|oxygenation|oxygenation
532567|NCT00332917|Parkinson's disease|parkinson's disease
532569|NCT00332930|Therapeutic vaccine|therapeutic vaccine
532570|NCT00332943|colorectal polyps|colorectal polyps
532571|NCT00332943|colorectal cancer|colorectal cancer
532572|NCT00332943|Virtual colonoscopy|virtual colonoscopy
532573|NCT00332943|Fecal tagging|fecal tagging
532574|NCT00332943|MR colonography|mr colonography
532575|NCT00332969|Open label|open label
532576|NCT00332969|phase II|phase ii
532577|NCT00332969|disease|disease
532578|NCT00332969|clinical trial|clinical trial
532579|NCT00332969|Octreotide|octreotide
532580|NCT00332969|thymoma|thymoma
532581|NCT00332969|cancer|cancer
532582|NCT00332969|tumor|tumor
532583|NCT00332982|best practices, performance improvement, intensive care, measurement|best practices, performance improvement, intensive care, measurement
532584|NCT00332995|HIV Seronegativity|hiv seronegativity
532585|NCT00333008|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
532586|NCT00333008|CDOP|cdop
532587|NCT00333008|Dose Dense|dose dense
532588|NCT00333008|Anne Arbor Stage I-IV|anne arbor stage i-iv
532589|NCT00333008|Any IPI score|any ipi score
533273|NCT00325624|Glucometer|glucometer
532590|NCT00333021|Fondaparinux Abdominal surgery Japanese VTE|fondaparinux abdominal surgery japanese vte
532591|NCT00333034|Psoriasis|psoriasis
532592|NCT00316069|Erythropoiesis|erythropoiesis
532593|NCT00316069|Leukapheresis|leukapheresis
532594|NCT00316069|G-CSF|g-csf
532595|NCT00316069|Mobilization|mobilization
532596|NCT00316069|Stem Cells|stem cells
532597|NCT00316069|Apheresis|apheresis
532598|NCT00316069|Blood Donation|blood donation
532599|NCT00316069|Healthy Volunteer|healthy volunteer
532600|NCT00316069|HV|hv
532601|NCT00316108|Carotid|carotid
532602|NCT00316108|Carotid Artery Stenting|carotid artery stenting
532603|NCT00316108|Stent|stent
532604|NCT00316108|Carotid Endarterectomy|carotid endarterectomy
532605|NCT00316108|Stroke|stroke
532606|NCT00316108|Transient Ischemic Attack|transient ischemic attack
532607|NCT00316108|Stenosis|stenosis
532608|NCT00316108|Atherosclerotic Disease|atherosclerotic disease
532609|NCT00316121|One or Two Level Degenerative Disc Disease|one or two level degenerative disc disease
532610|NCT00316134|Pleural Diseases|pleural diseases
532611|NCT00316134|Pleural Effusion|pleural effusion
532612|NCT00316134|Pleural Effusion, Malignant|pleural effusion, malignant
532613|NCT00316134|Pleural Neoplasms|pleural neoplasms
532614|NCT00316134|Neoplasms, Pleural|neoplasms, pleural
532615|NCT00316147|diphtheria|diphtheria
532616|NCT00316147|tetanus|tetanus
532617|NCT00316147|poliomyelitis|poliomyelitis
532618|NCT00316147|pertussis|pertussis
532619|NCT00316147|hepatitis B|hepatitis b
532620|NCT00316147|Prophylaxis|prophylaxis
532621|NCT00316147|Haemophilus influenza type b diseases|haemophilus influenza type b diseases
532622|NCT00316160|sexual dysfunction|sexual dysfunction
532623|NCT00316160|Depression|depression
532624|NCT00316160|MDD|mdd
532625|NCT00316173|HYCAMTIN|hycamtin
532626|NCT00316173|ovarian cancer|ovarian cancer
532627|NCT00316173|recurrent|recurrent
532628|NCT00316173|relapsed|relapsed
532629|NCT00316173|carboplatin|carboplatin
532630|NCT00316173|topotecan|topotecan
532631|NCT00316173|potentially platinum-sensitive|potentially platinum-sensitive
532632|NCT00316186|chemonaive|chemonaive
532633|NCT00316186|small cell lung cancer|small cell lung cancer
532634|NCT00316186|untreated|untreated
532635|NCT00316186|Lung cancer|lung cancer
532636|NCT00316186|HYCAMTIN|hycamtin
532637|NCT00316186|first-line|first-line
532638|NCT00316186|extensive disease|extensive disease
532639|NCT00316212|Coronary Artery Bypass Graft Surgery involving Cardiopulmonary Bypass|coronary artery bypass graft surgery involving cardiopulmonary bypass
532640|NCT00316251|Somatosensory dysfunction|somatosensory dysfunction
532641|NCT00316264|Respiratory Syncytial Virus|respiratory syncytial virus
532642|NCT00316264|Premature and under 6 mos. of age|premature and under 6 mos. of age
532643|NCT00316264|Chronic Lung Disease over 6 mos. of age|chronic lung disease over 6 mos. of age
532644|NCT00316264|palivizumab|palivizumab
531971|NCT00330213|red wine|red wine
532645|NCT00316264|motavizumab|motavizumab
532646|NCT00316264|RSV|rsv
532647|NCT00316277|Opiate Analgesic Dependence|opiate analgesic dependence
532648|NCT00321646|prostate cancer|prostate cancer
532649|NCT00321646|bevacizumab|bevacizumab
532650|NCT00321646|docetaxel|docetaxel
532651|NCT00321646|radical prostatectomy|radical prostatectomy
532652|NCT00321659|fibromyalgia|fibromyalgia
532653|NCT00321659|self-management|self-management
532654|NCT00321659|exercise|exercise
532655|NCT00321659|patient education|patient education
532656|NCT00321672|Analgesics|analgesics
532657|NCT00321672|Capsaicin|capsaicin
532658|NCT00321672|Neuropathic pain|neuropathic pain
532659|NCT00321672|Neuropathy|neuropathy
532660|NCT00321672|Distal sensory polyneuropathy|distal sensory polyneuropathy
532661|NCT00321672|Peripheral neuropathy|peripheral neuropathy
532662|NCT00321672|Dermal assessment|dermal assessment
532663|NCT00321672|Pain measurement|pain measurement
532664|NCT00321698|adenocarcinoma of the prostate|adenocarcinoma of the prostate
532665|NCT00321698|stage II prostate cancer|stage ii prostate cancer
532666|NCT00321698|stage III prostate cancer|stage iii prostate cancer
532667|NCT00321711|MDS|mds
532668|NCT00321711|Myelodysplastic Syndromes|myelodysplastic syndromes
532669|NCT00321711|Refractory Cytopenias|refractory cytopenias
532670|NCT00321711|Thrombocytopenia|thrombocytopenia
532671|NCT00321737|Erosive Esophagitis|erosive esophagitis
532672|NCT00321750|Oral erosive lichen planus|oral erosive lichen planus
532673|NCT00321750|pimecrolimus cream|pimecrolimus cream
532674|NCT00321763|Influenza|influenza
532675|NCT00321763|Influenza vaccine|influenza vaccine
532676|NCT00321789|self care|self care
532677|NCT00321789|social support|social support
532678|NCT00321802|atrial fibrillation|atrial fibrillation
532679|NCT00321802|statin therapy|statin therapy
532680|NCT00321802|CRP levels|crp levels
532681|NCT00321802|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
532682|NCT00321815|advanced carcinoma non-small cell lung EGFR positive Erlotinib Tarceva PF-3512676 Phase II immunotherapy immune modulator|advanced carcinoma non-small cell lung egfr positive erlotinib tarceva pf-3512676 phase ii immunotherapy immune modulator
532683|NCT00321828|adenocarcinoma of the colon|adenocarcinoma of the colon
532684|NCT00321828|stage IV colon cancer|stage iv colon cancer
532685|NCT00321867|rectocele|rectocele
532686|NCT00321867|pelvic prolapse|pelvic prolapse
532687|NCT00321867|graft|graft
532688|NCT00321867|surgical repair|surgical repair
532689|NCT00321880|fatigue|fatigue
532690|NCT00321880|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
532691|NCT00321880|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
532692|NCT00321880|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
532693|NCT00321880|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
532694|NCT00321880|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
532695|NCT00321880|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
532696|NCT00321880|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
532697|NCT00321880|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
532698|NCT00321880|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
532699|NCT00321880|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
532700|NCT00321893|Small cell lung cancer|small cell lung cancer
532701|NCT00321893|Non-small cell lung cancer|non-small cell lung cancer
532702|NCT00321893|Budesonide|budesonide
532703|NCT00321893|Entocort EC|entocort ec
532704|NCT00321893|Pulmicort Respules|pulmicort respules
532705|NCT00321893|Rhinocort aqua|rhinocort aqua
532706|NCT00321893|Aerosol budesonide treatment|aerosol budesonide treatment
532707|NCT00321893|Smoking|smoking
532708|NCT00321906|Rejection in lung transplant|rejection in lung transplant
532709|NCT00321945|Atrial Fibrillation|atrial fibrillation
532710|NCT00321945|Atrial Flutter|atrial flutter
532711|NCT00321945|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
532712|NCT00321945|Angiotensin Receptor Blocker|angiotensin receptor blocker
532713|NCT00321958|Barrett Esophagus|barrett esophagus
532714|NCT00321958|Esophageal Neoplasm|esophageal neoplasm
532715|NCT00321958|Deglutition disorders|deglutition disorders
532716|NCT00321958|Cryotherapy|cryotherapy
532717|NCT00321958|Cryosurgery|cryosurgery
532718|NCT00321958|GERD|gerd
532719|NCT00321958|Neoplasm|neoplasm
532720|NCT00321958|Esophagus|esophagus
532721|NCT00321958|Endoscopy, Digestive System|endoscopy, digestive system
532722|NCT00321971|Anxiety|anxiety
532723|NCT00321971|Mild Cognitive Impairment|mild cognitive impairment
532724|NCT00321971|MCI|mci
532725|NCT00321971|Cognitive Impairment|cognitive impairment
532726|NCT00321971|Alzheimer's Disease|alzheimer's disease
532727|NCT00321971|Caregiver Burden|caregiver burden
532728|NCT00321971|Caregiver Stress|caregiver stress
532729|NCT00321971|Family Dementia Caregiving|family dementia caregiving
532730|NCT00321971|Spousal Dementia Caregiving|spousal dementia caregiving
532731|NCT00321984|Gastroesophageal Reflux Disease(GERD)|gastroesophageal reflux disease(gerd)
532732|NCT00321984|Heartburn|heartburn
532733|NCT00321997|AMD|amd
532734|NCT00321997|Age-Related Macular Degeneration|age-related macular degeneration
532735|NCT00321997|Macular Degeneration|macular degeneration
532736|NCT00321997|Macugen|macugen
532737|NCT00321997|pegaptanib sodium|pegaptanib sodium
532738|NCT00322010|mechanical ventilation|mechanical ventilation
532739|NCT00322010|physical therapy|physical therapy
532740|NCT00322010|occupational therapy|occupational therapy
532741|NCT00322010|mobilization|mobilization
532742|NCT00322010|clinical protocols|clinical protocols
532743|NCT00322010|ICU acquired weakness|icu acquired weakness
532744|NCT00322010|critical illness myopathy|critical illness myopathy
532745|NCT00322010|muscle atrophy|muscle atrophy
532746|NCT00322010|intensive care unit|intensive care unit
532747|NCT00322010|randomized controlled trial|randomized controlled trial
532748|NCT00322023|Negative symptoms|negative symptoms
532749|NCT00322023|NMDA|nmda
532750|NCT00322023|Glutamate|glutamate
532751|NCT00322023|Glycine|glycine
532752|NCT00322036|Alzheimer Disease|alzheimer disease
532753|NCT00322036|Dementia|dementia
532754|NCT00322049|Dengue, Vaccine, Thailand|dengue, vaccine, thailand
532755|NCT00322062|Colon cleansing|colon cleansing
532756|NCT00322114|prostate cancer|prostate cancer
532757|NCT00322127|Hematopoietic Stem Cells|hematopoietic stem cells
533150|NCT00325039|Surgery|surgery
532758|NCT00322127|Stem Cell Mobilization|stem cell mobilization
532759|NCT00322127|CXCR4|cxcr4
532760|NCT00322127|SDF-1|sdf-1
532761|NCT00322127|Healthy Volunteer|healthy volunteer
532762|NCT00322127|HV|hv
532763|NCT00322140|Metastatic|metastatic
532764|NCT00322140|Triterpenoids|triterpenoids
532765|NCT00322140|2-Cyano-3,12-Dioxooleana-1,9(11)Dien-28oic Acid|2-cyano-3,12-dioxooleana-1,9(11)dien-28oic acid
532766|NCT00322140|Dose-Limiting|dose-limiting
532767|NCT00322140|Pharmacokinetic|pharmacokinetic
532768|NCT00322140|Solid Tumor|solid tumor
532769|NCT00322140|Lymphoma|lymphoma
532770|NCT00322153|memantine|memantine
532771|NCT00322153|Alzheimer's disease|alzheimer's disease
532772|NCT00322153|moderate to severe Alzheimer's disease|moderate to severe alzheimer's disease
532773|NCT00322166|accidental falls|accidental falls
532774|NCT00322166|vitamin D|vitamin d
532775|NCT00322166|parathyroid hormone|parathyroid hormone
532776|NCT00322166|osteoporosis|osteoporosis
532777|NCT00322179|Microarray Analysis|microarray analysis
532778|NCT00322179|Obesity|obesity
532779|NCT00322179|Chronic Hepatitis C|chronic hepatitis c
532780|NCT00322192|Stroke rehabilitation|stroke rehabilitation
532781|NCT00322192|Physical Therapy|physical therapy
532782|NCT00322244|Osteoarthritis|osteoarthritis
532783|NCT00322244|Massage therapy|massage therapy
532784|NCT00322270|Occluded Central Venous Access Devices|occluded central venous access devices
532785|NCT00322270|Occluded Catheters|occluded catheters
532786|NCT00322270|Thrombosis|thrombosis
532787|NCT00322270|thrombosis, catheter|thrombosis, catheter
532788|NCT00322270|alfimeprase|alfimeprase
532789|NCT00322270|thrombotic occlusion|thrombotic occlusion
532790|NCT00322270|thrombosis, CVAD|thrombosis, cvad
532791|NCT00322270|thrombosis, catheters|thrombosis, catheters
532792|NCT00322283|oglemilast|oglemilast
532793|NCT00322283|asthma|asthma
532794|NCT00322283|exercise|exercise
532795|NCT00322283|prevention|prevention
532796|NCT00322283|prophylaxis|prophylaxis
532797|NCT00322296|Parapsoriasis|parapsoriasis
532798|NCT00322296|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
532799|NCT00322296|Mycosis fungoides|mycosis fungoides
532800|NCT00322296|Bexarotene|bexarotene
532801|NCT00322296|Retinoids|retinoids
532802|NCT00322309|Cocaine|cocaine
532803|NCT00322309|Substance Abuse|substance abuse
532804|NCT00322322|L-carnitine supplementation|l-carnitine supplementation
532805|NCT00322322|Hemodialysis|hemodialysis
532806|NCT00322322|Anaemia|anaemia
532807|NCT00322322|Erythropoietin responsiveness|erythropoietin responsiveness
532808|NCT00322335|H.influenzae type b Disease|h.influenzae type b disease
532809|NCT00322348|oncology|oncology
532810|NCT00322348|cancer|cancer
532811|NCT00322348|breast cancer|breast cancer
532812|NCT00322387|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
532813|NCT00322387|Multiple Myeloma|multiple myeloma
532814|NCT00322387|Stem cell mobilization|stem cell mobilization
532815|NCT00322400|Clinical trial|clinical trial
532816|NCT00322400|AMG 706|amg 706
532817|NCT00322400|Anti-angiogenesis|anti-angiogenesis
532819|NCT00322400|Metastatic|metastatic
532820|NCT00322400|Breast Cancer|breast cancer
532821|NCT00322400|VEGF|vegf
532822|NCT00322400|Angiogenesis Inhibitor|angiogenesis inhibitor
532823|NCT00322400|Oral|oral
532824|NCT00322400|Multi-kinase Inhibitor|multi-kinase inhibitor
532825|NCT00322400|Anti-tumor|anti-tumor
532826|NCT00322400|PDGF receptor|pdgf receptor
532827|NCT00322400|Paclitaxel|paclitaxel
532828|NCT00322400|Docetaxel|docetaxel
532829|NCT00322400|Targeted Therapy|targeted therapy
532830|NCT00322400|Oncology|oncology
532831|NCT00322400|Amgen|amgen
532832|NCT00322400|c-Kit|c-kit
532833|NCT00322413|Epoetin alfa|epoetin alfa
532834|NCT00322413|Epoetin omega|epoetin omega
532835|NCT00322413|Comparative efficacy trial|comparative efficacy trial
532836|NCT00322413|Renal anemia|renal anemia
532837|NCT00322426|Freezing of Gait|freezing of gait
532838|NCT00322426|Parkinson's Disease|parkinson's disease
532839|NCT00322426|Sensory Cues|sensory cues
532840|NCT00322439|plaque Psoriasis patients|plaque psoriasis patients
532841|NCT00322439|TNF-inhibitor naïve|tnf-inhibitor naïve
532842|NCT00322452|NSCLC|nsclc
532843|NCT00322452|Gefitinib|gefitinib
532844|NCT00322465|non-gonococcal urethritis, doxycycline, azithromycin, sexually transmitted, tinidazole|non-gonococcal urethritis, doxycycline, azithromycin, sexually transmitted, tinidazole
532845|NCT00322491|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
532846|NCT00322491|Multiple Myeloma|multiple myeloma
532847|NCT00322491|Stem cell mobilization|stem cell mobilization
532848|NCT00322543|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
532849|NCT00322543|Drug eluting stent (DES)|drug eluting stent (des)
532850|NCT00322556|Immunoglobulin Intravenous|immunoglobulin intravenous
532851|NCT00322556|Agammaglobulinemia|agammaglobulinemia
532852|NCT00322556|Hypogammaglobulinemia|hypogammaglobulinemia
532853|NCT00322556|Common variable immunodeficiency|common variable immunodeficiency
532854|NCT00322556|Immunoglobulin G|immunoglobulin g
532855|NCT00322556|Children|children
532856|NCT00322569|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
532857|NCT00322569|Drug eluting stent (DES)|drug eluting stent (des)
532858|NCT00322582|familial cardiomyopathy|familial cardiomyopathy
532859|NCT00322582|genetics analysis|genetics analysis
532862|NCT00322608|Solid Tumors|solid tumors
532863|NCT00322608|Lymphomas|lymphomas
532864|NCT00322673|acute myeloid leukemia|acute myeloid leukemia
532865|NCT00322673|AML|aml
532866|NCT00322686|oglemilast|oglemilast
532867|NCT00322686|asthma|asthma
532868|NCT00322686|allergen|allergen
532869|NCT00322686|prevention|prevention
532870|NCT00322686|prophylaxis|prophylaxis
532871|NCT00322686|Allergen-Induced Asthma|allergen-induced asthma
532872|NCT00322699|Bladder Cancer|bladder cancer
532873|NCT00322699|Photodynamic Therapy|photodynamic therapy
532874|NCT00322699|Photofrin|photofrin
532875|NCT00322699|Photosensitization|photosensitization
532876|NCT00322699|Photoradiation|photoradiation
532877|NCT00322738|malaria, Plasmodium falciparum, Gambia, larvicides, vector|malaria, plasmodium falciparum, gambia, larvicides, vector
533274|NCT00325637|CHERISH|cherish
532878|NCT00322764|manic depression|manic depression
532879|NCT00322764|bipolar disorder|bipolar disorder
532880|NCT00322764|depression|depression
532881|NCT00322764|uridine|uridine
532882|NCT00322764|RG2417|rg2417
532883|NCT00322777|Major depression|major depression
532884|NCT00322777|Spirituality|spirituality
532885|NCT00322777|Randomized clinical trial|randomized clinical trial
532886|NCT00322803|panic disorder|panic disorder
532887|NCT00322803|proof of concept|proof of concept
532888|NCT00322816|Malaria, Plasmodium falciparum, Gambia, larvicides|malaria, plasmodium falciparum, gambia, larvicides
532889|NCT00322829|Group B Streptococcus, Strepotococcus agalactiae, detection|group b streptococcus, strepotococcus agalactiae, detection
532890|NCT00322842|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
532891|NCT00322842|Multiple Myeloma|multiple myeloma
532892|NCT00322842|Stem cell mobilization|stem cell mobilization
532893|NCT00322868|Prescription drugs|prescription drugs
532894|NCT00322868|Administration, oral|administration, oral
532895|NCT00322868|Durable medical equipment|durable medical equipment
532896|NCT00322868|Kinetics|kinetics
532897|NCT00322881|carboplatin|carboplatin
532898|NCT00322881|paclitaxel|paclitaxel
532899|NCT00322881|elderly women|elderly women
532900|NCT00322894|Breast cancer|breast cancer
532901|NCT00322894|Risk factors|risk factors
532902|NCT00322894|Treatment|treatment
532903|NCT00322894|Clinico-pathologic|clinico-pathologic
532904|NCT00322894|Outcomes|outcomes
532905|NCT00322894|Tissue repository|tissue repository
532906|NCT00322894|Registry|registry
532907|NCT00322907|malaria|malaria
532908|NCT00322907|treatment|treatment
532909|NCT00322907|cotrifazid|cotrifazid
532910|NCT00322907|clinical trial|clinical trial
532911|NCT00322907|efficacy|efficacy
532912|NCT00322920|cervical cancer|cervical cancer
532913|NCT00322920|topotecan|topotecan
532914|NCT00322920|Stage IVB cervical cancer|stage ivb cervical cancer
532915|NCT00322920|Persistent or recurrent cervical cancer|persistent or recurrent cervical cancer
532916|NCT00322933|intermittent renal replacement therapy|intermittent renal replacement therapy
532917|NCT00322933|continuous renal replacement therapy|continuous renal replacement therapy
532918|NCT00322933|acute renal failure|acute renal failure
532919|NCT00322933|renal recovery|renal recovery
532920|NCT00322933|mortality|mortality
532921|NCT00322946|Dengue Fever|dengue fever
532922|NCT00322946|Dengue Vaccine|dengue vaccine
532923|NCT00322946|Dengue Virus|dengue virus
532924|NCT00322946|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
532925|NCT00322946|Dengue Shock Syndrome|dengue shock syndrome
532926|NCT00322959|dendritic cells|dendritic cells
532927|NCT00322959|Tai-Chi-Chuan|tai-chi-chuan
532928|NCT00322972|Bacterial Infections|bacterial infections
532929|NCT00322972|Chlamydia Infections|chlamydia infections
532930|NCT00322972|Eye Diseases|eye diseases
532931|NCT00322985|T-cell lymphoma|t-cell lymphoma
532932|NCT00322985|lenalidomide|lenalidomide
532933|NCT00323024|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
532934|NCT00323024|Pulmonary Hypertension|pulmonary hypertension
532935|NCT00323024|Idiopathic PAH|idiopathic pah
532936|NCT00323024|PH associated with connective tissue disease (CTD)|ph associated with connective tissue disease (ctd)
532937|NCT00323024|PH associated with interstitial lung disease (ILD)|ph associated with interstitial lung disease (ild)
532938|NCT00323024|PH associated with congestive heart failure (CHF)|ph associated with congestive heart failure (chf)
532939|NCT00323024|PH associated with chronic obstructive pulmonary disease (COPD)|ph associated with chronic obstructive pulmonary disease (copd)
532940|NCT00323037|heart failure|heart failure
532941|NCT00323063|recurrent breast cancer|recurrent breast cancer
532942|NCT00323063|stage IV breast cancer|stage iv breast cancer
532943|NCT00323063|male breast cancer|male breast cancer
532944|NCT00323063|stage IIIA breast cancer|stage iiia breast cancer
532945|NCT00323063|stage IIIB breast cancer|stage iiib breast cancer
532946|NCT00323063|stage IIIC breast cancer|stage iiic breast cancer
532947|NCT00323089|microcoil|microcoil
532948|NCT00323089|subcentimetre nodules|subcentimetre nodules
532949|NCT00323115|immunotherapy|immunotherapy
532950|NCT00323115|cancer vaccine|cancer vaccine
532951|NCT00323115|glioblastoma multiforme|glioblastoma multiforme
532952|NCT00323141|Hernia umbilicalis|hernia umbilicalis
532953|NCT00323154|Morphine, analgesia|morphine, analgesia
532954|NCT00323167|Variant Cystic Fibrosis|variant cystic fibrosis
532955|NCT00323167|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
532956|NCT00323193|Behavioral interventions|behavioral interventions
532957|NCT00323193|Mental Illness|mental illness
532958|NCT00323193|Obesity|obesity
532959|NCT00323193|Psycho-educational interventions|psycho-educational interventions
532960|NCT00323193|Weight management|weight management
532961|NCT00323206|melanoma|melanoma
532962|NCT00323206|electroporation|electroporation
532963|NCT00323206|IL-12|il-12
532964|NCT00323206|gene therapy|gene therapy
532965|NCT00323206|gene transfer|gene transfer
532966|NCT00323219|Cellulitis, RCT, emergency Department, Double-blind, Equivalence trial, Moxifloxacin, Cefazolin, Probenecid.|cellulitis, rct, emergency department, double-blind, equivalence trial, moxifloxacin, cefazolin, probenecid.
532967|NCT00323232|DHS, Intertrochanteric|dhs, intertrochanteric
532968|NCT00323245|Randomized clinical trial|randomized clinical trial
532969|NCT00323245|osteoporosis|osteoporosis
532970|NCT00323245|urinary incontinence|urinary incontinence
532971|NCT00323245|physiotherapy|physiotherapy
532972|NCT00323245|education|education
532973|NCT00323258|Heart disease|heart disease
532974|NCT00323258|Coronary disease|coronary disease
532975|NCT00323258|Patient compliance|patient compliance
532976|NCT00323258|Treatment refusal|treatment refusal
532977|NCT00323258|Pharmacists|pharmacists
532978|NCT00323258|Continuity of patient care|continuity of patient care
532979|NCT00323258|Evidence-based medicine|evidence-based medicine
532980|NCT00323258|Patient education|patient education
532981|NCT00323258|Adherence|adherence
532982|NCT00323271|Chronic pain|chronic pain
532983|NCT00323271|Cognitive behavioral therapy|cognitive behavioral therapy
532984|NCT00323271|Multiple sclerosis|multiple sclerosis
532985|NCT00323271|Randomized controlled trial|randomized controlled trial
532986|NCT00323284|Open angle|open angle
532987|NCT00323284|Glaucoma|glaucoma
532988|NCT00323284|Cataract|cataract
532989|NCT00323284|Surgery|surgery
532990|NCT00323310|disease of the central nervous system (brain or spine)|disease of the central nervous system (brain or spine)
532991|NCT00323323|Untreated|untreated
532992|NCT00323323|CD-20 Negative|cd-20 negative
532993|NCT00323323|Large B-Cell Lymphomas|large b-cell lymphomas
532994|NCT00323349|Glucose Tolerance Test|glucose tolerance test
532995|NCT00323349|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
532996|NCT00323349|Motivation|motivation
532997|NCT00323349|Communication|communication
532998|NCT00323349|Health Behavior|health behavior
532999|NCT00323362|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
533000|NCT00323362|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
533001|NCT00323375|Malaria|malaria
533002|NCT00323375|Aminoquinolines|aminoquinolines
533003|NCT00323375|Drug Resistance|drug resistance
533004|NCT00323375|Chloroquine Resistance|chloroquine resistance
533005|NCT00323401|Pregnancy|pregnancy
533006|NCT00323401|Parturition|parturition
533007|NCT00323401|Depression|depression
533008|NCT00323401|Randomized|randomized
533009|NCT00323401|Antenatal classes|antenatal classes
533010|NCT00323414|PUFA|pufa
533011|NCT00323414|NASH|nash
533012|NCT00323414|Fatty Liver|fatty liver
533013|NCT00323414|Insulin resistance|insulin resistance
533014|NCT00323414|Metabolic syndrome|metabolic syndrome
533015|NCT00323414|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
533016|NCT00323414|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
533017|NCT00323414|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
533018|NCT00323427|Audiology|audiology
533019|NCT00323427|Coping behaviors|coping behaviors
533020|NCT00323427|Counseling|counseling
533021|NCT00323427|Hearing aids|hearing aids
533022|NCT00323427|Hearing impairment|hearing impairment
533023|NCT00323427|Patient-centered care|patient-centered care
533024|NCT00323427|Psychological adaptation|psychological adaptation
533025|NCT00323427|Psychological adjustment|psychological adjustment
533026|NCT00323427|Rehabilitation|rehabilitation
533027|NCT00323427|Social adjustment|social adjustment
533028|NCT00323427|Aural Rehabilitation|aural rehabilitation
533029|NCT00323440|Familial Mediterranean fever|familial mediterranean fever
533030|NCT00323440|Inflammation|inflammation
533031|NCT00323440|Attacks|attacks
533032|NCT00323440|Remission|remission
533033|NCT00323440|RNA|rna
533034|NCT00323440|Cytokines|cytokines
533035|NCT00323440|Inflammatory proteins|inflammatory proteins
533036|NCT00323440|MEFV|mefv
533037|NCT00323440|mutations|mutations
533038|NCT00323440|Colchicine|colchicine
533039|NCT00323440|Treatment|treatment
533040|NCT00323440|microarray RNA analysis|microarray rna analysis
533041|NCT00323453|Appendectomy|appendectomy
533042|NCT00323453|Surgery|surgery
533043|NCT00323453|Infection|infection
533044|NCT00323479|breast cancer treatment|breast cancer treatment
533045|NCT00323479|joint disorders|joint disorders
533046|NCT00323492|HIV 1 Infection|hiv 1 infection
533047|NCT00323518|oral mucositis|oral mucositis
533049|NCT00323518|autologous stem cell transplant|autologous stem cell transplant
533050|NCT00323518|velafermin|velafermin
533051|NCT00323518|stomatitis|stomatitis
533052|NCT00323518|oncology - supportive care|oncology - supportive care
533053|NCT00323518|mouth diseases|mouth diseases
533054|NCT00323531|thoracoscopy|thoracoscopy
533055|NCT00323531|fibrinolysis|fibrinolysis
533056|NCT00323531|empyema|empyema
533057|NCT00323531|children|children
533058|NCT00323544|HIV 1|hiv 1
533059|NCT00323544|HIV 1 infection|hiv 1 infection
533060|NCT00323557|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
533061|NCT00323557|Leukemia|leukemia
533062|NCT00323557|Sargramostim|sargramostim
533063|NCT00323557|Pneumococcal Pneumonia|pneumococcal pneumonia
533064|NCT00323557|Pneumococcal Vaccine|pneumococcal vaccine
533065|NCT00323557|Prevnar|prevnar
533066|NCT00323557|GM-CSF|gm-csf
533067|NCT00323557|CLL|cll
533068|NCT00323583|Cancer|cancer
533069|NCT00323583|Pancreatic Cancer|pancreatic cancer
533070|NCT00323583|Cancer Alternative Therapies|cancer alternative therapies
533071|NCT00323583|Living with Cancer|living with cancer
533072|NCT00323609|Kyphoplasty|kyphoplasty
533073|NCT00323609|Vertebroplasty|vertebroplasty
533074|NCT00323609|Balloon Kyphoplasty|balloon kyphoplasty
533075|NCT00323609|Inflatable Bone Tamp|inflatable bone tamp
533076|NCT00323609|Spine|spine
533077|NCT00323609|Back Pain|back pain
533078|NCT00323609|Vertebral Compression Fracture|vertebral compression fracture
533079|NCT00323609|Vertebral Body Compression Fracture|vertebral body compression fracture
533080|NCT00323635|nocturia|nocturia
533081|NCT00323635|urinary incontinence|urinary incontinence
533082|NCT00323635|overactive bladder|overactive bladder
533083|NCT00323635|tolterodine|tolterodine
533084|NCT00323635|sleep|sleep
533085|NCT00323635|sleep disorder|sleep disorder
533086|NCT00323635|menopause|menopause
533087|NCT00323635|midlife women|midlife women
533088|NCT00323635|psychological tests|psychological tests
533089|NCT00323661|Pacing|pacing
533090|NCT00323661|Rate-adaptive|rate-adaptive
533091|NCT00323661|Quality of life|quality of life
533092|NCT00323661|Cognitive performance|cognitive performance
533093|NCT00323661|Atrial fibrillation|atrial fibrillation
533094|NCT00323661|Pacemaker sensor|pacemaker sensor
533095|NCT00323674|Hernia Inguinalis|hernia inguinalis
533096|NCT00323687|HIV-1 Infection|hiv-1 infection
533097|NCT00323700|ADHD|adhd
533098|NCT00323700|Effectiveness|effectiveness
533099|NCT00323700|ODD|odd
533100|NCT00323713|Chronic renal insufficiency|chronic renal insufficiency
533101|NCT00323713|CKD stage 4|ckd stage 4
533102|NCT00323713|CKD stage 5|ckd stage 5
533103|NCT00323713|Protein intake|protein intake
533104|NCT00323713|Low protein diet|low protein diet
533105|NCT00323713|Very low protein diet|very low protein diet
533106|NCT00323713|Ketoanalogs|ketoanalogs
533107|NCT00323713|Renal death|renal death
533108|NCT00323739|kidney cancer|kidney cancer
533109|NCT00323739|bevacizumab|bevacizumab
533110|NCT00324831|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
533111|NCT00324831|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
533112|NCT00324831|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
533113|NCT00324831|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
533114|NCT00324857|Osteoarthritis, Knee|osteoarthritis, knee
533116|NCT00324857|ethnicity|ethnicity
532568|NCT00332930|HIV|hiv
533117|NCT00324857|knee replacement|knee replacement
533118|NCT00324883|sodium intake|sodium intake
533119|NCT00324883|sodium excretion|sodium excretion
533120|NCT00324883|chloride excretion|chloride excretion
533121|NCT00324883|creatinine|creatinine
533122|NCT00324883|hypertension|hypertension
533123|NCT00324896|Parkinson's|parkinson's
533124|NCT00324896|insomnia|insomnia
533125|NCT00324896|drug|drug
533126|NCT00324896|eszopiclone|eszopiclone
533127|NCT00324896|placebo|placebo
533128|NCT00324922|Vancomycin|vancomycin
533129|NCT00324922|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
533130|NCT00324948|Female sexual arousal disorder|female sexual arousal disorder
533131|NCT00324948|Female sexual dysfunction|female sexual dysfunction
533132|NCT00324961|adefovir dipivoxil|adefovir dipivoxil
533133|NCT00324961|e Antigen negative|e antigen negative
533134|NCT00324961|chronic hepatitis B|chronic hepatitis b
533135|NCT00324961|Chinese|chinese
533136|NCT00324974|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
533137|NCT00324974|infant|infant
533138|NCT00324974|lansoprazole oral suspension|lansoprazole oral suspension
533139|NCT00324974|PPI|ppi
533140|NCT00325013|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
533141|NCT00325013|PSC|psc
533142|NCT00325013|DHA|dha
533143|NCT00325013|Docosahexaenoic Acid|docosahexaenoic acid
533144|NCT00325026|Preterm gestation|preterm gestation
533145|NCT00325026|Cervical ripening|cervical ripening
533146|NCT00325026|Labor induction|labor induction
533147|NCT00325026|Misoprostol|misoprostol
533148|NCT00325026|Foley bulb|foley bulb
533149|NCT00325039|Urinary Incontinence, Stress|urinary incontinence, stress
533151|NCT00325065|Amygdala|amygdala
533153|NCT00325065|Memory|memory
533154|NCT00325065|Threat|threat
533155|NCT00325065|Peptides|peptides
533156|NCT00325065|Neuropeptides|neuropeptides
533157|NCT00325065|Oxytocin|oxytocin
533158|NCT00325065|Vasopressin|vasopressin
533159|NCT00325065|Mood Disorder|mood disorder
533160|NCT00325078|Remicade|remicade
533161|NCT00325078|Crohn's Disease|crohn's disease
533162|NCT00325078|IBD|ibd
533163|NCT00325078|CGD Infection|cgd infection
533164|NCT00325078|Infliximab|infliximab
533165|NCT00325078|Chorionic Granulomatous Disease|chorionic granulomatous disease
533166|NCT00325078|CGD|cgd
533167|NCT00325078|Inflammatory Bowel Disease|inflammatory bowel disease
533168|NCT00325091|Writer's Cramp|writer's cramp
533169|NCT00325091|Electroencephalogram (EEG)|electroencephalogram (eeg)
533170|NCT00325091|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
533171|NCT00325091|Fine Motor Skills|fine motor skills
533172|NCT00325091|Focal Hand Dystonia|focal hand dystonia
533173|NCT00325091|Writer Cramp|writer cramp
533174|NCT00325091|Healthy Volunteer|healthy volunteer
533175|NCT00325091|HV|hv
533176|NCT00325104|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
533177|NCT00325104|Gastrinoma|gastrinoma
533178|NCT00325104|Prolacinoma|prolacinoma
533179|NCT00325104|Medullary Thyroid Cancer|medullary thyroid cancer
533180|NCT00325104|Insulinoma|insulinoma
533181|NCT00325104|MEN1|men1
533182|NCT00325104|MEN2A|men2a
533183|NCT00325104|Familial Primary Hyperparathytoidism|familial primary hyperparathytoidism
533184|NCT00325117|Type 2 diabetes|type 2 diabetes
533185|NCT00325117|Vildagliptin|vildagliptin
533186|NCT00325117|HbA1c|hba1c
533187|NCT00325169|Cross-over|cross-over
533188|NCT00325169|Tiotropium|tiotropium
533189|NCT00325169|Triple|triple
533190|NCT00325169|COPD|copd
533191|NCT00325169|SERETIDE 50/500|seretide 50/500
533192|NCT00325169|Dyspnoea|dyspnoea
533193|NCT00325169|Impulse oscillometry|impulse oscillometry
533194|NCT00325169|Plethysmography|plethysmography
533195|NCT00325182|Alcoholism|alcoholism
533196|NCT00325221|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
533197|NCT00325221|telemedicine|telemedicine
533198|NCT00325221|Home Monitoring|home monitoring
533199|NCT00325221|psychosomatic|psychosomatic
533200|NCT00325221|ventricular tachyarrhythmia|ventricular tachyarrhythmia
533201|NCT00325221|quality of life|quality of life
533202|NCT00325221|Electric Countershock|electric countershock
533203|NCT00325247|ZINC SUPPLEMENTATION|zinc supplementation
533204|NCT00325247|ACUTE DIARRHOEA|acute diarrhoea
533205|NCT00325247|UNDER FIVE CHILDREN|under five children
533206|NCT00325247|RURAL BANGLADESH|rural bangladesh
533207|NCT00325260|influenza|influenza
533208|NCT00325260|non-inferiority|non-inferiority
533209|NCT00325260|Influvac|influvac
533210|NCT00325260|Agrippal|agrippal
533211|NCT00325260|healthy subjects|healthy subjects
533212|NCT00325273|Lactobacillus rhamnosus|lactobacillus rhamnosus
533152|NCT00325065|Emotion|emotion
533213|NCT00325273|Atopic dermatitis|atopic dermatitis
533214|NCT00325273|Allergic rhinitis|allergic rhinitis
533215|NCT00325273|Asthma|asthma
533216|NCT00325273|Infant|infant
533217|NCT00325273|Pregnancy|pregnancy
533218|NCT00325312|Neck Pain|neck pain
533219|NCT00325312|Complementary Therapies|complementary therapies
687784|NCT00912483|VTE|vte
533220|NCT00325312|Subcutaneous Carbon Dioxide Insufflations|subcutaneous carbon dioxide insufflations
533221|NCT00325312|Acute Treatment|acute treatment
533222|NCT00325325|Kidney Transplantation|kidney transplantation
533223|NCT00325338|Allergy|allergy
533224|NCT00325338|Specific Immunotherapy|specific immunotherapy
533225|NCT00325338|Ragweed|ragweed
533226|NCT00325338|Environmental Exposure Chamber|environmental exposure chamber
533227|NCT00325351|Ovarian cancer|ovarian cancer
533228|NCT00325351|Ovarian neoplasms, epithelium|ovarian neoplasms, epithelium
533229|NCT00325377|low back pain|low back pain
533230|NCT00325377|pain|pain
533231|NCT00325377|magnetism|magnetism
533232|NCT00325377|electromagnetic fields|electromagnetic fields
533233|NCT00325377|visual analogue pain scale|visual analogue pain scale
533234|NCT00325390|SR25990C|sr25990c
533235|NCT00325390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
533236|NCT00325390|NSTEACS|nsteacs
533237|NCT00325403|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
533238|NCT00325416|melphalan|melphalan
533239|NCT00325416|topotecan|topotecan
533240|NCT00325416|topoisomerase|topoisomerase
533241|NCT00325416|bone marrow transplant|bone marrow transplant
533242|NCT00325416|drug sequence|drug sequence
533243|NCT00325429|Type 2 diabetes|type 2 diabetes
533244|NCT00325429|Vildagliptin|vildagliptin
533245|NCT00325429|HbA1c|hba1c
533246|NCT00325442|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
533247|NCT00325468|bone loss|bone loss
533248|NCT00325468|osteoporosis|osteoporosis
533249|NCT00325494|Pancreatic Cancer|pancreatic cancer
533250|NCT00325494|Mesothelioma|mesothelioma
533251|NCT00325494|Ovarian Cancer|ovarian cancer
533252|NCT00325494|Non-Small Cell Lung Cancer|non-small cell lung cancer
533253|NCT00325494|Mesothelin|mesothelin
533254|NCT00325507|Renal cell cancer|renal cell cancer
533255|NCT00325507|requiring IL-2 treatment|requiring il-2 treatment
533256|NCT00325507|Locally advanced or metastatic renal cell carcinoma|locally advanced or metastatic renal cell carcinoma
533257|NCT00325533|Blood Pressure, High|blood pressure, high
533258|NCT00325533|Blacks|blacks
533259|NCT00325533|African Americans|african americans
533260|NCT00325546|Obesity|obesity
533261|NCT00325585|Human Immunodeficiency Viruses|human immunodeficiency viruses
533262|NCT00325585|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
533263|NCT00325585|Substance Abuse|substance abuse
533264|NCT00325585|Sexually Transmitted Disease, Viral|sexually transmitted disease, viral
533265|NCT00325585|Intervention Studies|intervention studies
533266|NCT00325585|Women's Health|women's health
533267|NCT00325611|Palliative care|palliative care
533268|NCT00325611|End of life care|end of life care
533269|NCT00325624|Blood Pressure|blood pressure
533270|NCT00325624|Diabetes mellitus|diabetes mellitus
533271|NCT00325624|Hypertension|hypertension
533272|NCT00325624|Home Care|home care
533275|NCT00325637|Ischemic Stroke|ischemic stroke
533276|NCT00325650|Prediabetic state|prediabetic state
533277|NCT00325650|Impaired fasting glucose|impaired fasting glucose
533278|NCT00325650|Impaired glucose Tolerance|impaired glucose tolerance
533279|NCT00325663|acupuncture|acupuncture
533280|NCT00325663|double-blind|double-blind
533281|NCT00325663|sham control|sham control
533282|NCT00325663|osteoarthritis|osteoarthritis
533283|NCT00325663|pain|pain
533284|NCT00325676|GERD|gerd
533285|NCT00325676|Pantoprazole|pantoprazole
533286|NCT00325676|Complete Remission|complete remission
533287|NCT00325702|HIV|hiv
533288|NCT00325702|prevention|prevention
533289|NCT00325728|Chronic Insomnia|chronic insomnia
533290|NCT00325728|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
533291|NCT00325728|Drug Therapy|drug therapy
533292|NCT00325728|Alzheimer disease|alzheimer disease
533293|NCT00325741|Lupus|lupus
533294|NCT00325741|Systemic Lupus Erythematosus|systemic lupus erythematosus
533295|NCT00325741|Blood Stem Cell Transplantation|blood stem cell transplantation
533296|NCT00325754|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
533297|NCT00325754|COPD|copd
533298|NCT00325767|mucociliary clearance|mucociliary clearance
533299|NCT00325767|beta-adrenergic drugs|beta-adrenergic drugs
533300|NCT00325767|inhalation|inhalation
533301|NCT00325767|aerosol|aerosol
533302|NCT00325780|Kowa|kowa
533303|NCT00325780|Hypercholesterolemia|hypercholesterolemia
533304|NCT00325780|dyslipidemia|dyslipidemia
533305|NCT00325780|pitavastatin|pitavastatin
533306|NCT00325780|NK-104|nk-104
533307|NCT00325780|Hypercholesterolemia or combined dyslipidemia|hypercholesterolemia or combined dyslipidemia
533308|NCT00325793|nicardipine|nicardipine
533309|NCT00325793|hypertension|hypertension
533310|NCT00325793|intracerebral hemorrhage|intracerebral hemorrhage
533311|NCT00325793|ischemic stroke|ischemic stroke
533312|NCT00325819|Acetaminophen|acetaminophen
533314|NCT00325819|Immunization|immunization
533315|NCT00325832|Hypertension|hypertension
533316|NCT00325832|Blood Pressure|blood pressure
533317|NCT00325832|Systolic Pressure|systolic pressure
533318|NCT00325832|Diastolic Pressure|diastolic pressure
533319|NCT00325832|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
533320|NCT00325845|Investigational|investigational
533321|NCT00325845|Therapeutic|therapeutic
533322|NCT00325845|Efficacy|efficacy
533323|NCT00325845|Safety|safety
533324|NCT00325845|Outcomes|outcomes
533325|NCT00325845|Lumbar facet joint arthrosis|lumbar facet joint arthrosis
533326|NCT00325845|Lumbar facet joint arthropathy|lumbar facet joint arthropathy
533327|NCT00325858|osteoarthritis pain|osteoarthritis pain
533328|NCT00325858|knee|knee
533329|NCT00325858|hip|hip
533330|NCT00325858|extended-release analgesia|extended-release analgesia
533331|NCT00325858|opioid|opioid
533332|NCT00325884|coronary artery disease|coronary artery disease
533333|NCT00325884|bifurcation lesions|bifurcation lesions
533334|NCT00325884|percutaneous interventions|percutaneous interventions
533335|NCT00325884|stenting|stenting
533336|NCT00325884|outcomes|outcomes
533337|NCT00325884|death|death
533338|NCT00325884|myocardial infarction|myocardial infarction
533339|NCT00325910|Diabetes|diabetes
533340|NCT00325910|Heart Failure|heart failure
533341|NCT00325910|Mortality|mortality
533342|NCT00325910|Hospitalization|hospitalization
533343|NCT00325910|Feasability|feasability
533344|NCT00325923|Decision making|decision making
533345|NCT00325923|Decision support|decision support
533346|NCT00325923|Decisional conflict|decisional conflict
533347|NCT00325923|Menopause|menopause
533348|NCT00325923|Natural health products|natural health products
533349|NCT00325923|Herbs|herbs
533350|NCT00325923|Complementary medicine|complementary medicine
533351|NCT00325923|Complementary therapies|complementary therapies
533352|NCT00325936|metabolic syndrome|metabolic syndrome
533353|NCT00325936|Hypertension|hypertension
533355|NCT00325936|cilnidipine|cilnidipine
533356|NCT00325962|Hypertension|hypertension
533357|NCT00325962|Type 2 Diabetes|type 2 diabetes
533358|NCT00325962|6R-BH4|6r-bh4
533359|NCT00325962|BH4|bh4
533360|NCT00325962|BH4 deficiency|bh4 deficiency
533361|NCT00325962|sapropterin dihydrochloride|sapropterin dihydrochloride
533362|NCT00325962|endothelial dysfunction|endothelial dysfunction
533363|NCT00325962|NO|no
533364|NCT00325962|Nitric Oxide|nitric oxide
533365|NCT00325975|Smallpox|smallpox
533366|NCT00325975|Variola|variola
533367|NCT00325975|Orthopoxvirus|orthopoxvirus
533368|NCT00325975|Virus|virus
533369|NCT00325975|Immunogenicity|immunogenicity
533370|NCT00325975|Smallpox Vaccine|smallpox vaccine
533371|NCT00325988|Neuroimmunology|neuroimmunology
533372|NCT00325988|Demyelinating Disease|demyelinating disease
533373|NCT00325988|Genetics|genetics
533374|NCT00325988|Proteins|proteins
533375|NCT00326001|Transvenous Catheter Ablation|transvenous catheter ablation
533376|NCT00326001|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
533377|NCT00326001|Atrial flutter|atrial flutter
533378|NCT00326001|Catheter Ablation|catheter ablation
533379|NCT00326014|Open angle|open angle
533380|NCT00326014|Glaucoma|glaucoma
533381|NCT00326014|Cataract|cataract
533382|NCT00326014|Surgery|surgery
533383|NCT00326027|GERD|gerd
533384|NCT00326027|Pantoprazole|pantoprazole
533385|NCT00326027|NERD|nerd
533386|NCT00326040|Open angle|open angle
533387|NCT00326040|Glaucoma|glaucoma
533388|NCT00326040|Refractory|refractory
533389|NCT00326040|Surgery|surgery
533390|NCT00326053|Asthma Reoccurrence|asthma reoccurrence
533391|NCT00326053|Acute Asthma|acute asthma
533392|NCT00326053|Patient Discharge|patient discharge
533393|NCT00326053|Emergency Service, Hospital|emergency service, hospital
533394|NCT00326053|Asthma Exacerbation|asthma exacerbation
533395|NCT00326053|Asthma Relapse|asthma relapse
533396|NCT00326066|Open angle|open angle
533397|NCT00326066|Glaucoma|glaucoma
533398|NCT00326066|Surgery|surgery
533399|NCT00326066|Cataract|cataract
533400|NCT00326079|Open angle|open angle
533401|NCT00326079|Glaucoma|glaucoma
533402|NCT00326079|Surgery|surgery
533403|NCT00326105|MDD|mdd
533404|NCT00326105|Depression|depression
533405|NCT00326118|Meningococcal serogroup C diseases|meningococcal serogroup c diseases
533406|NCT00326118|H.influenzae type b diseases|h.influenzae type b diseases
533407|NCT00326144|MDD|mdd
533408|NCT00326144|Depression|depression
533409|NCT00326157|antifungal primary prophylaxis treatment|antifungal primary prophylaxis treatment
533410|NCT00326157|allogeneic stem-cell transplantation|allogeneic stem-cell transplantation
533411|NCT00326157|antifungal primary prophylaxis treatment of high risk patients undergoing allogeneic stem-cell transplantation|antifungal primary prophylaxis treatment of high risk patients undergoing allogeneic stem-cell transplantation
533412|NCT00326170|Combination Chemotherapy|combination chemotherapy
533413|NCT00326170|MDS|mds
533414|NCT00326170|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
533416|NCT00326170|Acute myelogenous leukemia|acute myelogenous leukemia
533417|NCT00326170|valproic acid|valproic acid
533418|NCT00326170|VPA|vpa
533419|NCT00326170|Depakene|depakene
533420|NCT00326170|5-azacytidine|5-azacytidine
533421|NCT00326170|5-aza|5-aza
533422|NCT00326170|Azacitidine|azacitidine
533423|NCT00326170|5-AZC|5-azc
533424|NCT00326170|Vidaza|vidaza
533425|NCT00326170|AZA-CR|aza-cr
533426|NCT00326170|Ladakamycin|ladakamycin
533427|NCT00326170|NSC-102816|nsc-102816
533428|NCT00326170|All-trans retinoic acid|all-trans retinoic acid
533429|NCT00326170|ATRA|atra
533430|NCT00326170|Tretinoin|tretinoin
533431|NCT00326170|Vesanoid|vesanoid
533432|NCT00326196|CABG|cabg
533433|NCT00326196|Coronary Disease|coronary disease
533434|NCT00326196|Diabetes|diabetes
533435|NCT00326196|PCI|pci
533436|NCT00326209|UC|uc
533437|NCT00326209|Ulcerative colitis|ulcerative colitis
533438|NCT00326209|Inflammatory bowel disease|inflammatory bowel disease
533439|NCT00326209|IBD|ibd
533440|NCT00326222|Patient Education as a Topic|patient education as a topic
533441|NCT00326222|Self-Management Program|self-management program
533442|NCT00326222|Health promotion|health promotion
533443|NCT00326222|Self Efficacy|self efficacy
533444|NCT00326222|Quality of life|quality of life
533445|NCT00326235|Opioid withdrawal|opioid withdrawal
533446|NCT00326235|Buspirone|buspirone
533447|NCT00326235|Methadone taper|methadone taper
533448|NCT00326248|postoperative nausea and vomiting PONV antiemetics NK-1 5HT3 casopitant mesylate ZOFRAN ondansetron hydrochloride|postoperative nausea and vomiting ponv antiemetics nk-1 5ht3 casopitant mesylate zofran ondansetron hydrochloride
533449|NCT00326287|Community-Acquired Pneumonia|community-acquired pneumonia
533450|NCT00326287|Cephalosporins|cephalosporins
533451|NCT00326287|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
533452|NCT00326300|Attention Deficit Hyperactivity Disorder, ADHD, Attention Deficit Disorder Adult|attention deficit hyperactivity disorder, adhd, attention deficit disorder adult
533453|NCT00326313|Group B streptococci|group b streptococci
533455|NCT00326313|morbidity|morbidity
533456|NCT00326313|mortality|mortality
533457|NCT00326339|R935788|r935788
533458|NCT00326339|Rheumatoid Arthritis|rheumatoid arthritis
533459|NCT00326339|Syk Kinase|syk kinase
533460|NCT00326352|Sedation|sedation
533461|NCT00326352|Propofol|propofol
533462|NCT00326352|Remifentanil|remifentanil
533463|NCT00326352|recovery|recovery
533464|NCT00326365|mechanical ventilation|mechanical ventilation
533465|NCT00326365|secretions|secretions
533466|NCT00326365|viscosity|viscosity
533467|NCT00326365|homeopathy|homeopathy
533468|NCT00326365|kalium bichromate|kalium bichromate
533469|NCT00326365|extubation|extubation
533470|NCT00326391|Attention Deficit Disorder with Hyperactivity, ADHD, Attention Deficit Disorder Adult|attention deficit disorder with hyperactivity, adhd, attention deficit disorder adult
533471|NCT00326404|Oral Contraceptives|oral contraceptives
533472|NCT00326404|Adolescents|adolescents
533473|NCT00326404|Compliance|compliance
533474|NCT00326417|Severe Aplastic Anemia|severe aplastic anemia
533475|NCT00326430|Social Phobia|social phobia
533476|NCT00326430|Cognitive Therapy|cognitive therapy
533477|NCT00326430|Interpersonal Therapy|interpersonal therapy
533478|NCT00326430|Efficacy|efficacy
535816|NCT00333762|wheelchairs|wheelchairs
533479|NCT00326430|Process-Outcome|process-outcome
533480|NCT00326443|Salmonella, vaccine, typhoid fever, S. Typhi|salmonella, vaccine, typhoid fever, s. typhi
533481|NCT00326456|ovarian cancer|ovarian cancer
533482|NCT00326456|chemotherapy|chemotherapy
533483|NCT00326456|first-line|first-line
533484|NCT00326482|Drug Toxicity|drug toxicity
533485|NCT00326482|Steatohepatitis|steatohepatitis
533486|NCT00326482|Hepatotoxicity|hepatotoxicity
533487|NCT00326482|Liver Biopsy|liver biopsy
533488|NCT00326482|Elevated transaminases|elevated transaminases
533489|NCT00326482|HIV|hiv
533490|NCT00326482|Liver Fibrosis|liver fibrosis
533491|NCT00326495|Sorafenib|sorafenib
533492|NCT00326495|Cetuximab|cetuximab
533493|NCT00326495|Advanced Cancer|advanced cancer
533494|NCT00326495|Phase II|phase ii
533495|NCT00326495|Colorectal Cancer|colorectal cancer
533496|NCT00326495|Colon Cancer|colon cancer
533497|NCT00326495|Rectal Cancer|rectal cancer
533498|NCT00326495|CRC|crc
533499|NCT00326495|Metastatic Colorectal Cancer|metastatic colorectal cancer
533500|NCT00326508|T Lymphocytes|t lymphocytes
533501|NCT00326508|IL-2 Conjugate|il-2 conjugate
533502|NCT00326508|CD25|cd25
533503|NCT00326508|T Regulatory Cells|t regulatory cells
533504|NCT00326508|Autoimmunity|autoimmunity
533505|NCT00326508|Uveitis|uveitis
533506|NCT00326508|Daclizumab|daclizumab
533507|NCT00326508|Denileukin Diftitox|denileukin diftitox
533508|NCT00326508|Immune Tolerance|immune tolerance
533509|NCT00326508|T Cell|t cell
533510|NCT00326521|Pregnant Women|pregnant women
533511|NCT00326521|Epidural Anesthesia|epidural anesthesia
533512|NCT00326521|Fever|fever
533513|NCT00326521|Chorioamnionitis|chorioamnionitis
533514|NCT00326521|Intrauterine pressure catheter|intrauterine pressure catheter
533515|NCT00326521|Pregnancy|pregnancy
533516|NCT00326534|Sarcoidosis|sarcoidosis
533517|NCT00326534|Rickettsia|rickettsia
533518|NCT00326534|Serological reactions|serological reactions
533519|NCT00326534|Polymerase chain reaction|polymerase chain reaction
532860|NCT00322595|Anxiety|anxiety
533520|NCT00326560|Pterygium excision|pterygium excision
533521|NCT00326560|Cut and paste|cut and paste
533522|NCT00326560|Tisseel fibrin glue|tisseel fibrin glue
533523|NCT00326560|Conjunctival autograft|conjunctival autograft
533524|NCT00326573|Diabetes|diabetes
533525|NCT00326573|Teenagers|teenagers
533526|NCT00326573|Motivational Interviewing|motivational interviewing
533527|NCT00326599|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
533528|NCT00326599|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
533529|NCT00326599|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
533530|NCT00326599|squamous cell lung cancer|squamous cell lung cancer
533531|NCT00326612|Seizures|seizures
533532|NCT00326638|prostate, IMRT, tomotherapy, radiation, cancer|prostate, imrt, tomotherapy, radiation, cancer
533533|NCT00326651|infertility|infertility
533534|NCT00326651|pregnancy|pregnancy
533535|NCT00326651|conception|conception
533536|NCT00326651|conceive|conceive
533537|NCT00326651|conceiving|conceiving
533538|NCT00326651|trying to conceive|trying to conceive
533539|NCT00326651|get pregnant|get pregnant
533540|NCT00326651|conception kit|conception kit
533541|NCT00326651|conception cap|conception cap
533542|NCT00326651|fertility|fertility
533543|NCT00326651|Women who are actively trying to become pregnant|women who are actively trying to become pregnant
533544|NCT00326677|Depression Prevention|depression prevention
533545|NCT00326677|Prevention of Depression|prevention of depression
533546|NCT00326677|Depression in the Elderly|depression in the elderly
533547|NCT00326677|Late Life Depression|late life depression
533548|NCT00326677|Depression in Old Age|depression in old age
533670|NCT00327106|hip fracture|hip fracture
533549|NCT00326677|Treatment of Depression in Primary Care Patients|treatment of depression in primary care patients
533550|NCT00326677|Sub syndromal depression|sub syndromal depression
533645|NCT00327067|Hemoglobin|hemoglobin
533551|NCT00326677|Minor Depression|minor depression
533552|NCT00326690|Congestive Heart Failure|congestive heart failure
533553|NCT00326690|Coronary Artery Disease|coronary artery disease
533554|NCT00326690|Ischemic Cardiomyopathy|ischemic cardiomyopathy
533555|NCT00326690|Idiopathic Cardiomyopathy|idiopathic cardiomyopathy
533556|NCT00326703|hypoxia|hypoxia
533557|NCT00326703|hypobaric|hypobaric
533558|NCT00326703|altitude|altitude
533559|NCT00326716|HIV-1 infected pregnant women, either treatment naive or on ATV/RTV combined with ZDV/3TC|hiv-1 infected pregnant women, either treatment naive or on atv/rtv combined with zdv/3tc
533560|NCT00326729|burns|burns
533561|NCT00326729|thermal injury|thermal injury
533562|NCT00326729|hemodynamics|hemodynamics
533563|NCT00326729|microcirculation|microcirculation
533564|NCT00326742|Alcoholism|alcoholism
533565|NCT00326742|Risk factors|risk factors
533566|NCT00326742|Adolescence|adolescence
533567|NCT00326742|Stress test|stress test
533568|NCT00326742|HPA system|hpa system
533569|NCT00326742|Family adversity|family adversity
533570|NCT00326742|Candidate genes|candidate genes
533571|NCT00326742|Cortisol|cortisol
533572|NCT00326742|Adrenocorticotrophin|adrenocorticotrophin
533768|NCT00333177|First-Episode Schizophrenia|first-episode schizophrenia
533573|NCT00326781|Nicotine nasal spray + counseling|nicotine nasal spray + counseling
533574|NCT00326781|Transdermal nicotine + counseling|transdermal nicotine + counseling
533575|NCT00326794|Nonsurgical proximal humerus fracture|nonsurgical proximal humerus fracture
533576|NCT00326794|Rehabilitation|rehabilitation
533577|NCT00326794|Physiotherapy|physiotherapy
533578|NCT00326794|randomised controlled trial|randomised controlled trial
533579|NCT00326807|naltrexone|naltrexone
533580|NCT00326807|alcohol|alcohol
533581|NCT00326807|gambling|gambling
533582|NCT00326807|concurrent|concurrent
533583|NCT00326820|hypercalcemia of malignancy|hypercalcemia of malignancy
533584|NCT00326820|stage IV breast cancer|stage iv breast cancer
533585|NCT00326820|bone metastases|bone metastases
533586|NCT00326820|recurrent breast cancer|recurrent breast cancer
533587|NCT00326820|male breast cancer|male breast cancer
533588|NCT00326833|Vitamin B12 deficiency|vitamin b12 deficiency
533589|NCT00326833|Vitamin B12 absorption|vitamin b12 absorption
533590|NCT00326833|Holotranscobalamin|holotranscobalamin
533591|NCT00326859|analgesia strategies|analgesia strategies
533592|NCT00326859|pain|pain
533593|NCT00326859|extensive dressing change|extensive dressing change
533594|NCT00326885|Ascites|ascites
533595|NCT00326885|Epithelial Cancer|epithelial cancer
533596|NCT00326885|Epithelial Carcinoma|epithelial carcinoma
533597|NCT00326885|Epithelial Ovarian Cancer|epithelial ovarian cancer
533598|NCT00326885|Epithelial Ovarian Carcinoma|epithelial ovarian carcinoma
533599|NCT00326885|Fallopian Tube Cancer|fallopian tube cancer
533600|NCT00326885|Fallopian Tube Carcinoma|fallopian tube carcinoma
533601|NCT00326885|Malignant Ascites|malignant ascites
533602|NCT00326885|Ovarian Cancer|ovarian cancer
533603|NCT00326885|Ovarian Carcinoma|ovarian carcinoma
533604|NCT00326885|Ovarian Epithelial Cancer|ovarian epithelial cancer
533605|NCT00326885|Ovarian Epithelial Carcinoma|ovarian epithelial carcinoma
533606|NCT00326885|Peritoneal Cancer|peritoneal cancer
533607|NCT00326885|Peritoneal Carcinoma|peritoneal carcinoma
533608|NCT00326885|Recurrent Ascites|recurrent ascites
533609|NCT00326885|Recurrent Malignant Ascites|recurrent malignant ascites
533610|NCT00326885|Recurrent Symptomatic Malignant Ascites|recurrent symptomatic malignant ascites
533611|NCT00326885|Symptomatic Malignant Ascites|symptomatic malignant ascites
533612|NCT00326885|Symptomatic Ascites|symptomatic ascites
533613|NCT00326885|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
533614|NCT00326885|Ovarian Neoplasms|ovarian neoplasms
533615|NCT00326885|Fallopian Tube Neoplasms|fallopian tube neoplasms
533616|NCT00326885|Peritoneal Neoplasms|peritoneal neoplasms
533617|NCT00326898|Sorafenib|sorafenib
533618|NCT00326898|Sunitinib|sunitinib
533619|NCT00326898|Renal Carcinoma|renal carcinoma
533620|NCT00326924|Transfusion|transfusion
533621|NCT00326950|Cancer|cancer
533622|NCT00326950|Tumors|tumors
533623|NCT00326950|Phase I|phase i
533624|NCT00326950|E7389|e7389
533625|NCT00326976|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
533626|NCT00326976|Myocardial Revascularization|myocardial revascularization
533627|NCT00326989|Extracorporal shock wave therapy|extracorporal shock wave therapy
533628|NCT00326989|Cell therapy|cell therapy
533629|NCT00327002|Low HDL|low hdl
533630|NCT00327002|Metabolic syndrome|metabolic syndrome
533631|NCT00327002|low HDL Cholesterol in setting of metabolic syndrome|low hdl cholesterol in setting of metabolic syndrome
533632|NCT00327028|Bronchial asthma|bronchial asthma
533633|NCT00327028|Phenytoin, Diphenine|phenytoin, diphenine
533634|NCT00327028|Antiepileptic drugs|antiepileptic drugs
533635|NCT00327028|Efficacy|efficacy
533636|NCT00327041|Aspirin|aspirin
533637|NCT00327041|Clopidogrel|clopidogrel
533638|NCT00327041|Balloon Angioplasty|balloon angioplasty
533639|NCT00327041|Coronary Thrombosis|coronary thrombosis
533640|NCT00327054|Dyslipidaemia|dyslipidaemia
533641|NCT00327054|Herbal medicine|herbal medicine
533642|NCT00327054|Home remedy|home remedy
533643|NCT00327054|Alternative medicine|alternative medicine
533644|NCT00327054|Metabolic syndrome|metabolic syndrome
533646|NCT00327067|Iron Supplementation|iron supplementation
533647|NCT00327067|Donor Retention|donor retention
533648|NCT00327067|Iron Stores|iron stores
533649|NCT00327067|Ferritin|ferritin
533650|NCT00327067|Transferrin Saturation|transferrin saturation
533651|NCT00327067|Healthy Volunteer|healthy volunteer
533652|NCT00327067|HV|hv
533653|NCT00327067|Blood Donors|blood donors
533654|NCT00327080|HIV|hiv
533655|NCT00327080|AIDS|aids
533656|NCT00327080|Pulmonary Hypertension|pulmonary hypertension
533657|NCT00327080|Blood Flow Studies|blood flow studies
533658|NCT00327080|Right Heart Catheterization|right heart catheterization
533659|NCT00327080|HIV Infection|hiv infection
533660|NCT00327080|HIV Associated Pulmonary Hypertension|hiv associated pulmonary hypertension
533661|NCT00327080|Healthy Volunteer|healthy volunteer
533662|NCT00327080|HV|hv
533663|NCT00327093|Colorectal cancer,|colorectal cancer,
533664|NCT00327093|immunohistochemistry,|immunohistochemistry,
533665|NCT00327093|monoclonal antibodies,|monoclonal antibodies,
533666|NCT00327093|predictive model,|predictive model,
533667|NCT00327093|antiangiogenic agents,|antiangiogenic agents,
533668|NCT00327093|medical imaging|medical imaging
533669|NCT00327093|Colorectal cancer with liver metastases|colorectal cancer with liver metastases
533671|NCT00327106|transfusion|transfusion
533672|NCT00327106|tranexamic acid|tranexamic acid
533673|NCT00327106|fondaparinux|fondaparinux
533674|NCT00327119|EGFR|egfr
533675|NCT00327119|Fully human|fully human
533676|NCT00327119|Monoclonal antibody|monoclonal antibody
533677|NCT00327119|Panitumumab|panitumumab
533678|NCT00327119|ABX-EGF|abx-egf
533679|NCT00327119|AMG954|amg954
533680|NCT00327119|Colorectal Cancer|colorectal cancer
533681|NCT00327119|Japan|japan
533682|NCT00327132|Early-stage Lg/Hg Gastric MALT Lymphoma|early-stage lg/hg gastric malt lymphoma
533683|NCT00327132|Eradication of Helicobacter pylori (Hp)|eradication of helicobacter pylori (hp)
533684|NCT00327145|HCTZ|hctz
533685|NCT00327145|hypertension|hypertension
533686|NCT00327145|valsartan|valsartan
533687|NCT00327145|amlodipine|amlodipine
533688|NCT00327158|Reaming|reaming
533689|NCT00327158|fracture|fracture
533690|NCT00327158|emboli|emboli
533691|NCT00327171|ovarian cancer|ovarian cancer
533692|NCT00327171|angiogenesis|angiogenesis
533693|NCT00327171|angiogenesis inhibition|angiogenesis inhibition
533694|NCT00327171|VEGF-Trap fusion recombinant protein|vegf-trap fusion recombinant protein
533695|NCT00327171|Cancer and other neoplasms|cancer and other neoplasms
533696|NCT00327197|bronchoscopy|bronchoscopy
533697|NCT00327197|Sputum induction|sputum induction
533698|NCT00327197|Prednisolone|prednisolone
533699|NCT00327197|Asthma|asthma
533700|NCT00327197|biomarkers|biomarkers
533701|NCT00327210|BGAT|bgat
533702|NCT00327210|Blood Glucose Awareness Training|blood glucose awareness training
533703|NCT00327210|Diabetes|diabetes
533704|NCT00327210|T1DM|t1dm
533705|NCT00327210|Internet|internet
533706|NCT00327210|Web|web
533707|NCT00327210|Intervention|intervention
533708|NCT00327210|Treatment|treatment
533709|NCT00327210|Behavior|behavior
533710|NCT00327210|Education|education
533711|NCT00327210|Awareness|awareness
533712|NCT00327223|Metastatic cancer|metastatic cancer
533713|NCT00327223|Disseminated malignant disease|disseminated malignant disease
533714|NCT00327236|Paraneoplastic Neurologic Syndromes|paraneoplastic neurologic syndromes
533715|NCT00327262|chronic myeloid leukemia|chronic myeloid leukemia
533716|NCT00327262|Ph+|ph+
533717|NCT00327262|bcr/abl+|bcr/abl+
533718|NCT00327262|imatinib|imatinib
533719|NCT00327288|Hormone refractory prostate cancer|hormone refractory prostate cancer
533720|NCT00327301|POAG|poag
533721|NCT00327301|Parkinson's disease|parkinson's disease
533722|NCT00327301|cellular proteome|cellular proteome
533723|NCT00327301|human leucocytes|human leucocytes
533724|NCT00327301|vasospasm|vasospasm
533725|NCT00327301|POAG patients|poag patients
533726|NCT00327301|Patients with Parkinson's disease|patients with parkinson's disease
533727|NCT00327301|Healthy subjects|healthy subjects
533728|NCT00327340|Metastatic hormone refractory prostate cancer (HRPC)|metastatic hormone refractory prostate cancer (hrpc)
533729|NCT00327353|Asthma|asthma
533730|NCT00327353|Salmeterol|salmeterol
533731|NCT00327353|Formoterol|formoterol
533732|NCT00327353|Airway resistance|airway resistance
533733|NCT00327366|Menstrual Cycle|menstrual cycle
533734|NCT00327366|Light Therapy|light therapy
533735|NCT00327366|Sex Hormones|sex hormones
533736|NCT00327366|Ovulation|ovulation
533737|NCT00327379|Bloodloss|bloodloss
533738|NCT00327379|Transfusion Requirements in Patients Undergoing Elective Spinal Fusion Surgery|transfusion requirements in patients undergoing elective spinal fusion surgery
533739|NCT00333047|Metastatic breast cancer|metastatic breast cancer
533740|NCT00333047|Aromatase inhibitor|aromatase inhibitor
533742|NCT00333073|urinary incontinence|urinary incontinence
533743|NCT00333073|Bulkamid|bulkamid
533744|NCT00333086|Endometrial Cancer|endometrial cancer
533745|NCT00333086|Aromatase inhibitor|aromatase inhibitor
533746|NCT00333086|Letrozole|letrozole
533747|NCT00333099|Enteral nutrition|enteral nutrition
533748|NCT00333099|immunonutrients|immunonutrients
533749|NCT00333099|head and neck cancer|head and neck cancer
533750|NCT00333099|esophageal cancer|esophageal cancer
533751|NCT00333099|chemoradiotherapy|chemoradiotherapy
533752|NCT00333099|H&N or esophageal cancer patients with a chemoradiotherapy treatment.|h&n or esophageal cancer patients with a chemoradiotherapy treatment.
533753|NCT00333112|Treatment Outcome|treatment outcome
533754|NCT00333112|Urology|urology
533755|NCT00333112|Solifenacin succinate|solifenacin succinate
533756|NCT00333112|Urinary Incontinence|urinary incontinence
533757|NCT00333138|FTY720|fty720
533758|NCT00333138|MS|ms
533759|NCT00333138|Multiple Sclerosis|multiple sclerosis
533760|NCT00333138|RRMS|rrms
533761|NCT00333164|intracranial arteriosclerosis|intracranial arteriosclerosis
533762|NCT00333164|cilostazol|cilostazol
533763|NCT00333164|Platelete aggrigation inhibitors dual antiplatelet therapy|platelete aggrigation inhibitors dual antiplatelet therapy
533764|NCT00333164|Drug therapy, combination|drug therapy, combination
533765|NCT00333164|Clinical trials|clinical trials
533766|NCT00333177|Schizoaffective Disorder, Depressed Type|schizoaffective disorder, depressed type
533767|NCT00333177|Schizophreniform Disorder|schizophreniform disorder
533870|NCT00334230|HV|hv
533769|NCT00333177|Supported Employment|supported employment
533770|NCT00333177|Cognitive Remediation|cognitive remediation
533771|NCT00333177|Health Behavior Training|health behavior training
533772|NCT00333177|Antipsychotic Medication|antipsychotic medication
533773|NCT00333190|stem cell transplant|stem cell transplant
533774|NCT00333190|graft versus host disease|graft versus host disease
533775|NCT00333190|GVHD|gvhd
533776|NCT00333190|CD+8 T cell depletion|cd+8 t cell depletion
533777|NCT00333203|epimacular membrane|epimacular membrane
533778|NCT00333229|Breast Cancer|breast cancer
533779|NCT00333229|premenopausal|premenopausal
533780|NCT00333229|Bone Mineral density|bone mineral density
533781|NCT00333229|Cancer therapy induced bone loss|cancer therapy induced bone loss
533782|NCT00333229|zoledronic acid|zoledronic acid
533783|NCT00333242|Pain|pain
533784|NCT00333242|opioid|opioid
533785|NCT00333242|hyperalgesia|hyperalgesia
533786|NCT00333242|methadone|methadone
533787|NCT00333281|Healthy Volunteers|healthy volunteers
533788|NCT00333307|relaxin|relaxin
533789|NCT00333307|preeclampsia|preeclampsia
533790|NCT00333320|acute myocardial infarction|acute myocardial infarction
533791|NCT00333320|postconditioning|postconditioning
533792|NCT00333320|coronary reserve|coronary reserve
533793|NCT00333320|ejection fraction|ejection fraction
533794|NCT00333333|Thrombocytopenia|thrombocytopenia
533795|NCT00333333|Small for Gestational Age (SGA)|small for gestational age (sga)
533796|NCT00333333|Preeclampsia|preeclampsia
533797|NCT00334061|Penumbra|penumbra
533798|NCT00334061|Ischemic|ischemic
533799|NCT00334061|Stroke|stroke
533800|NCT00334061|Intervention|intervention
533801|NCT00334061|Neurovascular|neurovascular
533802|NCT00334061|Thrombus|thrombus
533803|NCT00334061|Embolectomy|embolectomy
533804|NCT00334061|Ischemic stroke|ischemic stroke
533807|NCT00334074|CML|cml
533808|NCT00334074|Relapsed|relapsed
533809|NCT00334074|Refractory|refractory
533810|NCT00334074|Chemo treatment|chemo treatment
533811|NCT00334074|Clofarabine|clofarabine
533812|NCT00334074|Cytarabine|cytarabine
533813|NCT00334074|standard or poor cytogenetic risk AML|standard or poor cytogenetic risk aml
533814|NCT00334074|untreated high-risk (>10% blasts) MDS|untreated high-risk (>10% blasts) mds
533815|NCT00334074|CML in accelerated phase or blast crisis|cml in accelerated phase or blast crisis
533816|NCT00334074|Elderly AML patients with risk of anthracycline toxicity|elderly aml patients with risk of anthracycline toxicity
533817|NCT00334087|primary dental prevention|primary dental prevention
533818|NCT00334087|early childhood caries|early childhood caries
533819|NCT00334087|prenatal oral care|prenatal oral care
533820|NCT00334100|Exercise|exercise
533821|NCT00334100|multiple sclerosis|multiple sclerosis
533822|NCT00334100|treadmill|treadmill
533823|NCT00334113|Diabetes Mellitus|diabetes mellitus
533824|NCT00334113|Exercise|exercise
533825|NCT00334113|Obesity|obesity
533826|NCT00334113|Telemedicine|telemedicine
533827|NCT00334126|Schizophrenia|schizophrenia
533828|NCT00334126|Antipsychotic|antipsychotic
533829|NCT00334126|paliperidone|paliperidone
533830|NCT00334126|quetiapine|quetiapine
533831|NCT00334126|Seroquel|seroquel
533832|NCT00334126|placebo|placebo
533833|NCT00334139|serum bone markers|serum bone markers
533834|NCT00334139|bone metastasis|bone metastasis
533835|NCT00334139|prostate cancer|prostate cancer
533836|NCT00334139|breast cancer|breast cancer
533837|NCT00334139|quality of life|quality of life
533838|NCT00334139|bisphosphonates|bisphosphonates
533839|NCT00334152|NK-1|nk-1
533840|NCT00334152|antiemetics|antiemetics
533841|NCT00334152|casopitant mesylate|casopitant mesylate
533842|NCT00334152|postoperative nausea and vomiting|postoperative nausea and vomiting
533843|NCT00334152|ondansetron hydrochloride|ondansetron hydrochloride
533844|NCT00334152|5HT3|5ht3
533845|NCT00334152|ZOFRAN|zofran
533846|NCT00334152|PONV|ponv
533847|NCT00334178|Migraine|migraine
533848|NCT00334178|Migraine prophylaxis|migraine prophylaxis
533849|NCT00334191|Cardiac surgery,|cardiac surgery,
533850|NCT00334191|Cardiopulmonary bypass,|cardiopulmonary bypass,
533851|NCT00334191|Oxidative stress,|oxidative stress,
533852|NCT00334191|Acute renal dysfunction,|acute renal dysfunction,
533853|NCT00334191|Sodium Bicarbonate|sodium bicarbonate
533854|NCT00334204|Platelet Function Analyser-100 (PFA-100)|platelet function analyser-100 (pfa-100)
533855|NCT00334204|renal failure|renal failure
533856|NCT00334204|kidney biopsy|kidney biopsy
533857|NCT00334204|bleeding|bleeding
533858|NCT00334204|hematoma|hematoma
533859|NCT00334217|Psychology: cognitive aspects|psychology: cognitive aspects
533860|NCT00334217|Substance-Related Disorders|substance-related disorders
533861|NCT00334217|treatment efficacy|treatment efficacy
533862|NCT00334230|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
533863|NCT00334230|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
533864|NCT00334230|Locomotion|locomotion
533865|NCT00334230|Cortical Reorganization|cortical reorganization
533866|NCT00334230|Rehabilitation|rehabilitation
533867|NCT00334230|fMRI|fmri
533868|NCT00334230|Stroke|stroke
533869|NCT00334230|Healthy Volunteer|healthy volunteer
533871|NCT00334243|in vitro fertilization|in vitro fertilization
533872|NCT00334243|infertile|infertile
533873|NCT00334243|infertility|infertility
533874|NCT00334243|pregnancy|pregnancy
533875|NCT00334243|pregnancy rates|pregnancy rates
533876|NCT00334243|microflare protocol|microflare protocol
533877|NCT00334243|antagonist protocol|antagonist protocol
533878|NCT00334243|demi-halt protocol|demi-halt protocol
533879|NCT00334243|poor responders|poor responders
533880|NCT00334243|low antral follicle count|low antral follicle count
533881|NCT00334243|Infertile Patients undergoing in vitro fertilization (IVF)|infertile patients undergoing in vitro fertilization (ivf)
533882|NCT00334243|Patients with a previous poor response to ovarian stimulation|patients with a previous poor response to ovarian stimulation
533883|NCT00334243|Patients with an antral follicle count of less than 10|patients with an antral follicle count of less than 10
533884|NCT00334256|PMTCT|pmtct
533885|NCT00334256|Resistance|resistance
533886|NCT00334256|HIV infection|hiv infection
533887|NCT00334256|Pregnancy|pregnancy
533888|NCT00334269|obesity|obesity
533889|NCT00334269|physical activity|physical activity
533890|NCT00334269|daily energy intake|daily energy intake
533891|NCT00334269|nutrition|nutrition
533892|NCT00334269|healthy lifestyle|healthy lifestyle
533893|NCT00334269|Aboriginal|aboriginal
533894|NCT00334269|body fat|body fat
533895|NCT00334269|exercise|exercise
533896|NCT00334269|education|education
533897|NCT00334269|family|family
533898|NCT00334269|body mass index|body mass index
533899|NCT00334269|knowledge|knowledge
533900|NCT00334269|randomized controlled trial|randomized controlled trial
533901|NCT00334269|community|community
533902|NCT00334269|intervention|intervention
533903|NCT00334269|Six Nations Indian Reserve|six nations indian reserve
533904|NCT00334269|household|household
533905|NCT00334269|health counselling|health counselling
533906|NCT00334282|Metastatic|metastatic
533907|NCT00334282|Anti-angiogenesis|anti-angiogenesis
533908|NCT00334282|GW786034|gw786034
533909|NCT00334282|Pazopanib|pazopanib
533910|NCT00334295|Recurrent or metastatic endometrial carcinoma|recurrent or metastatic endometrial carcinoma
533912|NCT00334321|Tomotherapy|tomotherapy
533913|NCT00334321|Post-Hysterectomy|post-hysterectomy
533914|NCT00334321|Endometrial Cancer|endometrial cancer
533915|NCT00334334|Streptococcus pneumonia, vaccine|streptococcus pneumonia, vaccine
533916|NCT00334373|Myocardial infarction|myocardial infarction
533917|NCT00334373|Magnetic Resonance Imaging|magnetic resonance imaging
533918|NCT00334373|Coronary Angioplasty|coronary angioplasty
533919|NCT00334386|Hypertension|hypertension
533920|NCT00334386|Anti-hypertensive effect|anti-hypertensive effect
533921|NCT00334386|Diuretic|diuretic
533922|NCT00334399|alpa-glucosidase inhibitor,Biguanide|alpa-glucosidase inhibitor,biguanide
533923|NCT00334438|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
533924|NCT00334438|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
533925|NCT00334438|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
533926|NCT00334438|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
533927|NCT00334438|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
533929|NCT00334451|Remote Monitoring|remote monitoring
533930|NCT00334451|Implantable Device|implantable device
533931|NCT00334464|warfarin metabolism|warfarin metabolism
533932|NCT00334464|CYP2C0|cyp2c0
533933|NCT00334464|anticoagulation|anticoagulation
533934|NCT00334464|genotyping|genotyping
533935|NCT00334464|DVT|dvt
533936|NCT00334464|PE|pe
533937|NCT00334477|erectile dysfunction|erectile dysfunction
533938|NCT00334477|chronic renal dysfunction|chronic renal dysfunction
533939|NCT00334477|tadalafil|tadalafil
533940|NCT00334490|Pulmonary Hypertension|pulmonary hypertension
533941|NCT00334490|Sildenafil|sildenafil
533943|NCT00334490|Cardiac Surgery|cardiac surgery
533944|NCT00334490|Cardiopulmonary Bypass|cardiopulmonary bypass
533945|NCT00334503|alpa-glucosidase inhibitor,Biguanide|alpa-glucosidase inhibitor,biguanide
533946|NCT00334516|Motor Neuron Disease|motor neuron disease
533947|NCT00334516|Cognitive Testing|cognitive testing
533948|NCT00334516|Movement-Related Potential|movement-related potential
533949|NCT00334516|MRI|mri
533950|NCT00334516|Neuropsychologic Testing|neuropsychologic testing
533951|NCT00334516|Primary Lateral Sclerosis|primary lateral sclerosis
533952|NCT00334516|PLS|pls
533953|NCT00334516|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
533954|NCT00334516|ALS|als
533955|NCT00334516|Healthy Volunteer|healthy volunteer
533956|NCT00334516|HV|hv
533957|NCT00334529|Tamiflu|tamiflu
533958|NCT00334529|Flu|flu
533959|NCT00334529|Antiviral|antiviral
533960|NCT00334529|Neuraminidase Inhibitor|neuraminidase inhibitor
533961|NCT00334529|Pharmacokinetic Trial|pharmacokinetic trial
533962|NCT00334529|Healthy Volunteer|healthy volunteer
533963|NCT00334529|HV|hv
533964|NCT00334542|breast cancer|breast cancer
533965|NCT00334542|ductal breast carcinoma in situ|ductal breast carcinoma in situ
533966|NCT00334542|breast cancer in situ|breast cancer in situ
533967|NCT00334542|stage I breast cancer|stage i breast cancer
533968|NCT00334542|stage II breast cancer|stage ii breast cancer
533969|NCT00334542|stage IIIA breast cancer|stage iiia breast cancer
533970|NCT00334542|stage IIIB breast cancer|stage iiib breast cancer
533971|NCT00334542|stage IIIC breast cancer|stage iiic breast cancer
533972|NCT00334555|trichomoniasis|trichomoniasis
533973|NCT00334555|partner notification|partner notification
533974|NCT00334568|AVANDIA|avandia
533975|NCT00334568|Alzheimers Disease|alzheimers disease
533976|NCT00334594|epithelial mesothelioma|epithelial mesothelioma
533977|NCT00334594|sarcomatous mesothelioma|sarcomatous mesothelioma
533978|NCT00334594|stage IA malignant mesothelioma|stage ia malignant mesothelioma
533979|NCT00334594|stage IB malignant mesothelioma|stage ib malignant mesothelioma
533980|NCT00334594|stage II malignant mesothelioma|stage ii malignant mesothelioma
533981|NCT00334594|stage III malignant mesothelioma|stage iii malignant mesothelioma
533982|NCT00334607|HRV vaccine|hrv vaccine
533983|NCT00334607|diarrhoea|diarrhoea
533984|NCT00334607|rotavirus|rotavirus
533985|NCT00334620|randomised double-blinded trial|randomised double-blinded trial
533986|NCT00334620|rehabilitation|rehabilitation
533987|NCT00334620|radon spa therapy|radon spa therapy
533988|NCT00334620|long-term effectiveness|long-term effectiveness
533989|NCT00334633|bacterial vaginosis|bacterial vaginosis
533990|NCT00334633|tinidazole|tinidazole
533991|NCT00334646|cyclophosphamide|cyclophosphamide
533992|NCT00334646|CINV|cinv
533993|NCT00334646|Chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
533994|NCT00334659|HIV-1 Infection|hiv-1 infection
533995|NCT00334672|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
533996|NCT00334711|Permanent Neonatal Diabetes|permanent neonatal diabetes
688822|NCT00925587|CKD|ckd
533997|NCT00334711|Kir6.2|kir6.2
533998|NCT00334711|KCNJ11|kcnj11
533999|NCT00334711|Infancy onset diabetes|infancy onset diabetes
534000|NCT00334711|Sulfonylurea|sulfonylurea
534001|NCT00334724|Cardiovascular disease|cardiovascular disease
534002|NCT00334724|Vascular disease|vascular disease
534003|NCT00334724|Hypertension|hypertension
534004|NCT00334724|Home blood pressure measurement|home blood pressure measurement
534005|NCT00334737|erythropoietin|erythropoietin
534006|NCT00334737|darbepoetin|darbepoetin
534007|NCT00334737|transfusions|transfusions
534008|NCT00334737|neonates|neonates
534009|NCT00334737|outcomes|outcomes
534010|NCT00334737|neurodevelopment|neurodevelopment
534011|NCT00334750|Glaucoma, Open-Angle Ocular Hypertension Risk factors Canadian|glaucoma, open-angle ocular hypertension risk factors canadian
534012|NCT00334763|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
534013|NCT00334763|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
534014|NCT00334763|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
534015|NCT00334763|squamous cell lung cancer|squamous cell lung cancer
534016|NCT00334776|recurrent melanoma|recurrent melanoma
534017|NCT00334776|stage IV melanoma|stage iv melanoma
534018|NCT00334776|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
534019|NCT00334776|iris melanoma|iris melanoma
534020|NCT00334776|recurrent intraocular melanoma|recurrent intraocular melanoma
534021|NCT00334776|extraocular extension melanoma|extraocular extension melanoma
534023|NCT00334828|septic shock|septic shock
534024|NCT00334828|sepsis|sepsis
534025|NCT00334854|childhood synovial sarcoma|childhood synovial sarcoma
534026|NCT00334854|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
534027|NCT00334854|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
534028|NCT00334854|childhood angiosarcoma|childhood angiosarcoma
534029|NCT00334854|childhood epithelioid sarcoma|childhood epithelioid sarcoma
534030|NCT00334854|childhood fibrosarcoma|childhood fibrosarcoma
534031|NCT00334854|childhood leiomyosarcoma|childhood leiomyosarcoma
534032|NCT00334854|childhood liposarcoma|childhood liposarcoma
534033|NCT00334854|childhood neurofibrosarcoma|childhood neurofibrosarcoma
534034|NCT00334854|localized childhood malignant fibrous histiocytoma of bone|localized childhood malignant fibrous histiocytoma of bone
534035|NCT00334854|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
534036|NCT00334854|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
534037|NCT00334854|chondrosarcoma|chondrosarcoma
534038|NCT00334867|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
534039|NCT00334880|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
534040|NCT00334880|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
534041|NCT00334880|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
534042|NCT00334906|memantine|memantine
534043|NCT00334906|Alzheimer's disease|alzheimer's disease
534045|NCT00334906|moderate Alzheimer's disease|moderate alzheimer's disease
534046|NCT00334919|Diabetes|diabetes
534047|NCT00334919|Pre-Diabetes|pre-diabetes
534048|NCT00334919|Anti-Inflammatory Diet|anti-inflammatory diet
534049|NCT00334919|Diet Study|diet study
534050|NCT00334919|Inflammation|inflammation
534051|NCT00334919|Diabetic Diet|diabetic diet
534052|NCT00334932|refractory multiple myeloma|refractory multiple myeloma
534053|NCT00334932|stage I multiple myeloma|stage i multiple myeloma
534054|NCT00334932|stage II multiple myeloma|stage ii multiple myeloma
534055|NCT00334932|stage III multiple myeloma|stage iii multiple myeloma
534056|NCT00334945|Fibroblast Growth Factors|fibroblast growth factors
534057|NCT00334945|Bone development|bone development
534058|NCT00334971|African-American|african-american
534059|NCT00334971|estradiol|estradiol
534060|NCT00334971|luteinizing hormone|luteinizing hormone
534061|NCT00334971|follicle stimulating hormone|follicle stimulating hormone
534062|NCT00334971|androstenedione|androstenedione
534063|NCT00334971|aromatase|aromatase
534064|NCT00334971|inhibins|inhibins
534065|NCT00334971|ovarian|ovarian
534066|NCT00334971|Healthy volunteers|healthy volunteers
534067|NCT00334971|Fragile X|fragile x
534068|NCT00334984|childhood fibrosarcoma|childhood fibrosarcoma
534069|NCT00334984|childhood neurofibrosarcoma|childhood neurofibrosarcoma
534070|NCT00334984|childhood synovial sarcoma|childhood synovial sarcoma
534071|NCT00334984|chondrosarcoma|chondrosarcoma
534072|NCT00334984|localized osteosarcoma|localized osteosarcoma
534073|NCT00334984|metastatic osteosarcoma|metastatic osteosarcoma
534074|NCT00334984|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
534075|NCT00334984|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
534076|NCT00334984|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
534077|NCT00334984|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
534078|NCT00334984|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
533454|NCT00326313|virulent|virulent
534079|NCT00334984|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
534080|NCT00334984|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
534081|NCT00334984|childhood angiosarcoma|childhood angiosarcoma
534082|NCT00334984|childhood epithelioid sarcoma|childhood epithelioid sarcoma
534083|NCT00334984|childhood leiomyosarcoma|childhood leiomyosarcoma
534084|NCT00334984|childhood liposarcoma|childhood liposarcoma
534085|NCT00334984|localized childhood malignant fibrous histiocytoma of bone|localized childhood malignant fibrous histiocytoma of bone
534086|NCT00334984|metastatic childhood malignant fibrous histiocytoma of bone|metastatic childhood malignant fibrous histiocytoma of bone
534087|NCT00334984|childhood malignant mesenchymoma|childhood malignant mesenchymoma
534088|NCT00334984|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
534089|NCT00334984|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
534090|NCT00334997|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
534091|NCT00334997|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
534092|NCT00334997|stage 0 laryngeal cancer|stage 0 laryngeal cancer
534093|NCT00335010|Nitroglycerine|nitroglycerine
534094|NCT00335010|gastroesophageal anastomosis|gastroesophageal anastomosis
534095|NCT00335010|microvascular bloodflow|microvascular bloodflow
534096|NCT00335010|microvascular hemoglobinsaturation|microvascular hemoglobinsaturation
534097|NCT00335023|postpartum hemorrhage|postpartum hemorrhage
534098|NCT00335023|red blood cell transfusion|red blood cell transfusion
534099|NCT00335023|health related quality of life|health related quality of life
534100|NCT00335036|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
534101|NCT00335036|Ventricular Arrhythmia|ventricular arrhythmia
534102|NCT00335036|Sudden Cardiac Death|sudden cardiac death
534103|NCT00335036|Congenital Heart Disease|congenital heart disease
534104|NCT00335036|Pediatric Electrophysiology|pediatric electrophysiology
534105|NCT00335049|myopia progression|myopia progression
534106|NCT00335049|bifocal|bifocal
534107|NCT00335062|Autoimmune thyroid disease|autoimmune thyroid disease
534108|NCT00335062|Children and Adolescents|children and adolescents
534109|NCT00335062|TSH Receptor Antibodies|tsh receptor antibodies
534110|NCT00335088|Prophylaxis,|prophylaxis,
534111|NCT00335088|Intraocular surgery|intraocular surgery
534112|NCT00335088|Lacrimal sac|lacrimal sac
534113|NCT00335088|Eye lid|eye lid
534114|NCT00335088|No conditions|no conditions
534115|NCT00335101|Coronary Artery Disease (CAD), Renal Impairment, Serum creatinine (SCr), Iodixanol, Ioversol, Iopromide, Contrast Induced Nephropathy (CIN)|coronary artery disease (cad), renal impairment, serum creatinine (scr), iodixanol, ioversol, iopromide, contrast induced nephropathy (cin)
534116|NCT00335114|cyclosporine, dry eye syndrome, contact lens|cyclosporine, dry eye syndrome, contact lens
534117|NCT00335140|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
534118|NCT00335153|severe motor fluctuations|severe motor fluctuations
534119|NCT00335153|levodopa|levodopa
534120|NCT00335153|levodopa/carbidopa intestinal gel|levodopa/carbidopa intestinal gel
534121|NCT00335153|efficacy|efficacy
534122|NCT00335153|dyskinesia|dyskinesia
534123|NCT00335153|Parkinson's Disease|parkinson's disease
534124|NCT00335153|carbidopa|carbidopa
534125|NCT00335153|DUOPA|duopa
534126|NCT00335166|Parkinson Disease|parkinson disease
534127|NCT00335179|Actinic keratosis|actinic keratosis
534128|NCT00335179|AK|ak
534129|NCT00335179|imiquimod|imiquimod
534130|NCT00335179|confocal microscopy|confocal microscopy
534131|NCT00335179|gene microarray|gene microarray
534132|NCT00335192|Intracellular concentrations|intracellular concentrations
534133|NCT00335192|Plasma concentration|plasma concentration
534134|NCT00335192|Abacavir|abacavir
534135|NCT00335192|Tenofovir|tenofovir
534136|NCT00335192|Lamivudine (3TC)|lamivudine (3tc)
536205|NCT00346346|Immunity|immunity
534137|NCT00335192|Pharmacokinetic interactions|pharmacokinetic interactions
534138|NCT00335205|ropinirole|ropinirole
534139|NCT00335205|dopamine|dopamine
534140|NCT00335205|D2|d2
534141|NCT00335205|depression|depression
534142|NCT00335205|bipolar|bipolar
534143|NCT00335218|Early postmenopausal state|early postmenopausal state
534144|NCT00335218|Climacteric symptoms|climacteric symptoms
534145|NCT00335218|Hormone replacement therapy|hormone replacement therapy
534146|NCT00335231|Post-cataract surgery endophthalmitis|post-cataract surgery endophthalmitis
534147|NCT00335257|Drospirenone|drospirenone
534148|NCT00335257|Safety|safety
534149|NCT00335257|INAS|inas
534150|NCT00335270|HIV Type 1|hiv type 1
534151|NCT00335296|PFO|pfo
534152|NCT00335296|Migraine|migraine
534153|NCT00335296|Stroke|stroke
534154|NCT00335296|TIA (transient ischemic attack)|tia (transient ischemic attack)
534155|NCT00335296|Decompression Illness|decompression illness
534156|NCT00335309|chronic rhinosinusitis|chronic rhinosinusitis
534157|NCT00335309|sinus irrigation|sinus irrigation
534158|NCT00335322|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
534159|NCT00335335|Coronary|coronary
534160|NCT00335335|Angiography|angiography
534161|NCT00335335|X-ray|x-ray
534162|NCT00335335|CAD|cad
534163|NCT00335348|Multiple Myeloma|multiple myeloma
534164|NCT00335348|Relapse|relapse
534165|NCT00335348|Bortezomib|bortezomib
534166|NCT00335348|Dexamethasone|dexamethasone
534167|NCT00335348|Maintenance|maintenance
534168|NCT00335361|Male Contraceptive Devices|male contraceptive devices
534169|NCT00335361|Intra Vas Device (IVD)|intra vas device (ivd)
534170|NCT00335361|Male Sterilization|male sterilization
534171|NCT00335361|Vasectomy|vasectomy
534172|NCT00335361|Intra Vas Deferens Occlusion|intra vas deferens occlusion
534173|NCT00335361|Vas Occlusion|vas occlusion
534174|NCT00335374|Parkinson's disease|parkinson's disease
534175|NCT00335413|Renal autoregulation|renal autoregulation
534176|NCT00335413|Glomerular filtration rate|glomerular filtration rate
534177|NCT00335413|Type 1 diabetes|type 1 diabetes
534178|NCT00335452|platelet aggregation inhibitors|platelet aggregation inhibitors
534179|NCT00335452|acute coronary disease|acute coronary disease
534180|NCT00335452|percutaneous coronary|percutaneous coronary
534181|NCT00335478|neutropenia|neutropenia
534182|NCT00335478|infection|infection
534183|NCT00335478|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
534184|NCT00335478|fever, sweats, and hot flashes|fever, sweats, and hot flashes
534185|NCT00335491|small cell lung cancer|small cell lung cancer
534186|NCT00335491|non-small cell lung cancer|non-small cell lung cancer
534187|NCT00335491|colon cancer|colon cancer
534188|NCT00335491|prostate cancer|prostate cancer
534189|NCT00335491|breast cancer|breast cancer
534190|NCT00335491|male breast cancer|male breast cancer
534191|NCT00335491|fatigue|fatigue
534192|NCT00335491|lymphoma|lymphoma
534193|NCT00335491|ovarian epithelial cancer|ovarian epithelial cancer
534194|NCT00335491|bladder cancer|bladder cancer
534195|NCT00335491|esophageal cancer|esophageal cancer
534196|NCT00335517|Lumbar surgery|lumbar surgery
534197|NCT00335517|Surgery L3-S1|surgery l3-s1
534198|NCT00335517|DepoDur|depodur
534199|NCT00335517|Post-operative pain|post-operative pain
534200|NCT00335517|Pain control|pain control
534201|NCT00335517|Pain relief|pain relief
534202|NCT00335543|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
534203|NCT00335543|stage I pancreatic cancer|stage i pancreatic cancer
534204|NCT00335543|stage II pancreatic cancer|stage ii pancreatic cancer
534205|NCT00335543|stage III pancreatic cancer|stage iii pancreatic cancer
534206|NCT00335569|Infertility, sterility, hCG, IVF|infertility, sterility, hcg, ivf
534207|NCT00335582|alpha 2 agonists|alpha 2 agonists
534208|NCT00335582|cardiac events|cardiac events
534209|NCT00335582|non cardiac surgery|non cardiac surgery
534210|NCT00335595|colorectal cancer|colorectal cancer
534211|NCT00335595|Bevacizumab|bevacizumab
534212|NCT00335595|capecitabine|capecitabine
534213|NCT00335595|oxaliplatin|oxaliplatin
534214|NCT00335621|COPD|copd
534215|NCT00335621|ipratropium|ipratropium
534216|NCT00335621|tiotropium|tiotropium
534217|NCT00335634|Prostate Cancer|prostate cancer
534218|NCT00335634|Radical Prostatectomy|radical prostatectomy
534219|NCT00335634|Sexual Dysfunction|sexual dysfunction
534220|NCT00335634|Intimacy|intimacy
534221|NCT00335634|Adaptation|adaptation
534222|NCT00335634|Psychosocial Oncology|psychosocial oncology
534223|NCT00335647|stage III multiple myeloma|stage iii multiple myeloma
534224|NCT00335647|refractory multiple myeloma|refractory multiple myeloma
534225|NCT00335647|stage II multiple myeloma|stage ii multiple myeloma
534226|NCT00335660|Idiopathic Detrusor Overactivity|idiopathic detrusor overactivity
534227|NCT00335660|NK-1 Receptor Antagonist|nk-1 receptor antagonist
534228|NCT00335660|Neurokinin|neurokinin
534229|NCT00335660|Urge Incontinence|urge incontinence
534230|NCT00335686|Mitochondrial toxicity|mitochondrial toxicity
534231|NCT00335686|Lopinavir-rtv|lopinavir-rtv
534232|NCT00335686|Nevirapine|nevirapine
534233|NCT00335686|DNA mitochondrial/DNA nuclear|dna mitochondrial/dna nuclear
534323|NCT00336180|Drinking behavior|drinking behavior
534234|NCT00335699|Hypercholesterolemia with nondiabetic metabolic syndrome|hypercholesterolemia with nondiabetic metabolic syndrome
534235|NCT00335712|ONO-5129|ono-5129
534236|NCT00335712|type 2 diabetes mellitus|type 2 diabetes mellitus
534237|NCT00335725|Ovarian stimulation|ovarian stimulation
534238|NCT00335725|Infertility|infertility
534239|NCT00335725|ICSI|icsi
534241|NCT00335751|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
534242|NCT00335751|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
534243|NCT00335751|localized osteosarcoma|localized osteosarcoma
534244|NCT00335751|metastatic osteosarcoma|metastatic osteosarcoma
534245|NCT00335751|recurrent osteosarcoma|recurrent osteosarcoma
534246|NCT00335751|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
534247|NCT00335751|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
534248|NCT00335751|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
534249|NCT00335816|stage II rectal cancer|stage ii rectal cancer
534250|NCT00335816|stage III rectal cancer|stage iii rectal cancer
534251|NCT00335816|adenocarcinoma of the rectum|adenocarcinoma of the rectum
534252|NCT00335829|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
534253|NCT00335829|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
534254|NCT00335829|advanced adult primary liver cancer|advanced adult primary liver cancer
534255|NCT00335829|recurrent adult primary liver cancer|recurrent adult primary liver cancer
534256|NCT00335855|Device, influenza|device, influenza
534257|NCT00335868|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
534258|NCT00335868|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
534259|NCT00335868|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
534260|NCT00335868|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
534261|NCT00335881|Prophylaxis for hepatitis B disease|prophylaxis for hepatitis b disease
534262|NCT00335894|Infertility|infertility
534263|NCT00335894|IVF|ivf
534264|NCT00335894|ART|art
534265|NCT00335894|hMG|hmg
534266|NCT00335907|Clinical trial|clinical trial
534267|NCT00335907|Controlled clinical trial|controlled clinical trial
534268|NCT00335907|Shock, Septic|shock, septic
534269|NCT00335920|Sudden Hearing Loss|sudden hearing loss
534270|NCT00335920|intratympanic|intratympanic
534271|NCT00335920|steroids|steroids
534272|NCT00335933|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
534273|NCT00335959|adenocarcinoma of the stomach|adenocarcinoma of the stomach
534274|NCT00335959|stage I gastric cancer|stage i gastric cancer
534275|NCT00335959|stage II gastric cancer|stage ii gastric cancer
534276|NCT00335959|stage III gastric cancer|stage iii gastric cancer
534277|NCT00335972|Carotid Endarterectomy patients|carotid endarterectomy patients
534278|NCT00335985|polymyositis, dermatomyositis|polymyositis, dermatomyositis
534279|NCT00335985|High-dose intravenous immunoglobulin|high-dose intravenous immunoglobulin
534280|NCT00335985|Venoglobulin-IH|venoglobulin-ih
534281|NCT00335985|Steroid-resistant polymyositis(PM) and dermatomyositis(DM)|steroid-resistant polymyositis(pm) and dermatomyositis(dm)
534282|NCT00336011|pacemaker|pacemaker
534283|NCT00336011|magnetic resonance imaging|magnetic resonance imaging
534284|NCT00336011|safety|safety
534285|NCT00336050|Air Pollution|air pollution
534286|NCT00336050|Pulmonary Function|pulmonary function
534287|NCT00336076|Mast cell disease|mast cell disease
534288|NCT00336076|Anaphylaxis|anaphylaxis
534289|NCT00336076|c-kit|c-kit
534290|NCT00336076|Mutation|mutation
534291|NCT00336076|Mastocytosis (suspected or proven)|mastocytosis (suspected or proven)
534292|NCT00336089|fatigue|fatigue
534293|NCT00336089|pain|pain
534294|NCT00336089|cancer survivor|cancer survivor
534295|NCT00336089|breast cancer in situ|breast cancer in situ
534296|NCT00336089|inflammatory breast cancer|inflammatory breast cancer
534297|NCT00336089|stage IA breast cancer|stage ia breast cancer
534298|NCT00336089|stage IB breast cancer|stage ib breast cancer
534299|NCT00336089|stage II breast cancer|stage ii breast cancer
534300|NCT00336089|stage IIIA breast cancer|stage iiia breast cancer
534301|NCT00336089|stage IIIB breast cancer|stage iiib breast cancer
534302|NCT00336089|stage IIIC breast cancer|stage iiic breast cancer
534303|NCT00336089|stage IV breast cancer|stage iv breast cancer
534304|NCT00336089|recurrent breast cancer|recurrent breast cancer
534305|NCT00336102|fatigue|fatigue
534306|NCT00336102|hypothyroidism|hypothyroidism
534307|NCT00336102|stage I breast cancer|stage i breast cancer
534308|NCT00336102|stage II breast cancer|stage ii breast cancer
534309|NCT00336102|stage IIIA breast cancer|stage iiia breast cancer
534310|NCT00336102|stage IIIB breast cancer|stage iiib breast cancer
534311|NCT00336115|pertussis|pertussis
534312|NCT00336115|bone marrow transplant|bone marrow transplant
534313|NCT00336128|infant|infant
534314|NCT00336128|kindergarten|kindergarten
534315|NCT00336128|obesity|obesity
534316|NCT00336128|adiposity|adiposity
534317|NCT00336167|carnitine palmitoyl transferase 2 deficiency|carnitine palmitoyl transferase 2 deficiency
534318|NCT00336167|Fatty acid oxidation|fatty acid oxidation
534319|NCT00336167|Mitochondria|mitochondria
534320|NCT00336180|Adolescent|adolescent
534321|NCT00336180|Adolescent behavior|adolescent behavior
534322|NCT00336180|Adolescent development|adolescent development
534324|NCT00336180|Health behavior|health behavior
534325|NCT00336180|Reproductive Behavior|reproductive behavior
534326|NCT00336180|Sexual Behavior|sexual behavior
534327|NCT00336180|South Africa|south africa
534328|NCT00336193|home visitation|home visitation
534329|NCT00336193|family outcomes|family outcomes
534330|NCT00336193|competency training|competency training
534331|NCT00336206|Low dose Alemtuzumab|low dose alemtuzumab
534332|NCT00336206|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
534333|NCT00336206|B-Cell|b-cell
534334|NCT00336219|GERD|gerd
534335|NCT00336219|Pantoprazole|pantoprazole
534336|NCT00336232|Vitamin K metabolism|vitamin k metabolism
534337|NCT00336232|Bone health|bone health
534338|NCT00336232|Metabolism|metabolism
534339|NCT00336245|Contraception|contraception
534340|NCT00336245|Women|women
534341|NCT00336245|HIV/AIDS|hiv/aids
534343|NCT00336245|IUCD|iucd
534344|NCT00336258|Deep Vein Thrombosis|deep vein thrombosis
534345|NCT00336258|Cancer|cancer
534346|NCT00336258|US- Doppler|us- doppler
534347|NCT00336258|Procoagulant Microparticles|procoagulant microparticles
533741|NCT00333047|Letrozole|letrozole
534348|NCT00336258|Asymptomatic|asymptomatic
534349|NCT00336271|coffee|coffee
534350|NCT00336271|caffeine|caffeine
534351|NCT00336271|healthy subjects|healthy subjects
534352|NCT00336284|Telemonitoring|telemonitoring
534353|NCT00336284|ICD|icd
534354|NCT00336284|Reduction of office follow-ups|reduction of office follow-ups
534355|NCT00336297|screening|screening
534356|NCT00336297|screening methods|screening methods
534357|NCT00336297|intimate partner violence|intimate partner violence
534358|NCT00336310|Diabetes Mellitus|diabetes mellitus
534359|NCT00336310|Treatment|treatment
534360|NCT00336310|Repaglinide|repaglinide
534361|NCT00336323|diabetic|diabetic
534362|NCT00336323|macular|macular
534363|NCT00336323|edema|edema
534364|NCT00336323|avastin|avastin
534365|NCT00336323|bevacizumab|bevacizumab
534366|NCT00336323|anti-VEGF|anti-vegf
534367|NCT00336323|retinal thickness|retinal thickness
534368|NCT00336323|visual acuity|visual acuity
534369|NCT00336323|DME|dme
534370|NCT00336349|diabetes mellitus|diabetes mellitus
534371|NCT00336349|neuropathic pain|neuropathic pain
534372|NCT00336362|Beta Thalassemia Major|beta thalassemia major
534373|NCT00336362|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
534374|NCT00336362|Gene Transfer Techniques|gene transfer techniques
534375|NCT00336388|Malaria|malaria
534376|NCT00336401|anesthesia|anesthesia
534377|NCT00336401|non cardiac surgery|non cardiac surgery
534378|NCT00336401|cardiac outcomes|cardiac outcomes
534379|NCT00336414|Juvenile Systemic Lupus Erythematosus nephritis|juvenile systemic lupus erythematosus nephritis
534380|NCT00336414|randomised actively controlled clinical trial|randomised actively controlled clinical trial
534381|NCT00336414|cyclophosphamide|cyclophosphamide
534382|NCT00336414|prednisone|prednisone
534383|NCT00336414|azathioprine|azathioprine
534384|NCT00336414|methylprednisolone|methylprednisolone
534385|NCT00336427|MRSA|mrsa
534386|NCT00336427|Colonization|colonization
534387|NCT00336427|Pregnancy|pregnancy
534388|NCT00336427|Neonates|neonates
534389|NCT00336453|Influenza|influenza
534390|NCT00336466|Cardiac bypass surgery|cardiac bypass surgery
534391|NCT00336492|Ulcerative colitis|ulcerative colitis
534392|NCT00336492|inflammatory bowel disease|inflammatory bowel disease
534393|NCT00336492|children|children
534394|NCT00336505|Pneumonia|pneumonia
534395|NCT00336505|Respiratory|respiratory
534396|NCT00336505|Infection|infection
534397|NCT00336505|Infectious|infectious
534398|NCT00336505|Advanced|advanced
534399|NCT00336505|Life|life
534400|NCT00336505|Sciences|sciences
534401|NCT00336505|Lung|lung
534402|NCT00336505|Pulmonary|pulmonary
534403|NCT00336505|Cethromycin|cethromycin
534404|NCT00336505|Restanza|restanza
534405|NCT00336505|Clarithromycin|clarithromycin
534406|NCT00336505|Biaxin|biaxin
534407|NCT00336531|prophylactic itraconazole|prophylactic itraconazole
534408|NCT00336531|Relapsed pediatric solid tumors|relapsed pediatric solid tumors
534409|NCT00336531|Embryonal brain tumor|embryonal brain tumor
534410|NCT00336544|Pneumonia|pneumonia
534411|NCT00336544|Respiratory|respiratory
534412|NCT00336544|Infection|infection
534413|NCT00336544|Infectious|infectious
534414|NCT00336544|Advanced|advanced
534415|NCT00336544|Life|life
534416|NCT00336544|Sciences|sciences
534417|NCT00336544|Lung|lung
534418|NCT00336544|Pulmonary|pulmonary
534419|NCT00336544|Cethromycin|cethromycin
534420|NCT00336544|Clarithromycin|clarithromycin
534421|NCT00336544|Biaxin|biaxin
534422|NCT00336557|High-Dose Interferon|high-dose interferon
534423|NCT00336557|Neutralizing Antibodies|neutralizing antibodies
534424|NCT00336570|Oxidative Stress|oxidative stress
534425|NCT00336570|Endothelial Function|endothelial function
534426|NCT00336570|Flow Mediated Dilation|flow mediated dilation
534427|NCT00336583|oxaliplatin|oxaliplatin
534428|NCT00336583|ESHAOX|eshaox
534429|NCT00336583|refractory|refractory
534430|NCT00336583|relapsed|relapsed
534431|NCT00336583|non-hodgkin's lymphoma|non-hodgkin's lymphoma
534432|NCT00336596|middle cerebral artery occlusion|middle cerebral artery occlusion
534433|NCT00336596|intracranial embolism and thrombosis|intracranial embolism and thrombosis
534434|NCT00336596|ultrasound enhanced thrombolysis|ultrasound enhanced thrombolysis
534435|NCT00336596|Patients receiving iv thrombolytic therapy (t-PA)|patients receiving iv thrombolytic therapy (t-pa)
534436|NCT00323752|Blood loss, Erythropoetin|blood loss, erythropoetin
534437|NCT00323765|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
534438|NCT00323765|Cervical Dystonia|cervical dystonia
534439|NCT00323765|Plasticity|plasticity
534440|NCT00323765|Healthy Volunteer|healthy volunteer
534441|NCT00323765|HV|hv
534442|NCT00323778|hyalgan|hyalgan
534443|NCT00323778|knee|knee
534444|NCT00323778|osteoarthritis|osteoarthritis
534445|NCT00323778|MRI|mri
534446|NCT00323791|recurrent renal cell cancer|recurrent renal cell cancer
534447|NCT00323791|clear cell renal cell carcinoma|clear cell renal cell carcinoma
534448|NCT00323791|papillary renal cell carcinoma|papillary renal cell carcinoma
534449|NCT00323791|stage IV renal cell cancer|stage iv renal cell cancer
534450|NCT00323804|Maintenance therapy|maintenance therapy
534451|NCT00323804|Non-responder patients|non-responder patients
534452|NCT00323804|Ribavirin/peginterferon combination therapy|ribavirin/peginterferon combination therapy
534453|NCT00323804|Hepatitis C, Chronic|hepatitis c, chronic
534454|NCT00323830|gastric cancer|gastric cancer
534455|NCT00323830|radiotherapy|radiotherapy
534456|NCT00323830|postoperative therapy|postoperative therapy
534457|NCT00323830|chemotherapy|chemotherapy
534458|NCT00323843|Kidney stone|kidney stone
534459|NCT00323843|ureteropyeloscopy|ureteropyeloscopy
534460|NCT00323843|renal pelvic pressure|renal pelvic pressure
534461|NCT00323856|Hemophilia A|hemophilia a
534462|NCT00323856|Plasma-derived treatment|plasma-derived treatment
534463|NCT00323856|Factor VIII|factor viii
534464|NCT00323856|Inhibitor|inhibitor
534465|NCT00323882|Prostate Cancer|prostate cancer
534466|NCT00323882|Oncology|oncology
534467|NCT00323882|Prostate|prostate
534468|NCT00323882|Cancer|cancer
534469|NCT00323882|Metastatic|metastatic
534470|NCT00323882|Hormone|hormone
534471|NCT00323882|PSA|psa
534472|NCT00323882|Metastatic Hormone-Refractory Prostate Cancer (HRPC)|metastatic hormone-refractory prostate cancer (hrpc)
534473|NCT00323908|Breast Cancer|breast cancer
534474|NCT00323908|prevention|prevention
534475|NCT00323908|tissue sampling|tissue sampling
534477|NCT00323908|steroid and carcinogen metabolism|steroid and carcinogen metabolism
534478|NCT00323934|metastatic solid tumor|metastatic solid tumor
534479|NCT00323934|aggressive non Hodgkin's Lymphoma|aggressive non hodgkin's lymphoma
534480|NCT00323934|Phase I|phase i
534481|NCT00323934|Advanced Solid Tumors|advanced solid tumors
534482|NCT00323947|ADHD|adhd
534483|NCT00323947|Seizures|seizures
534484|NCT00323947|Methylphenidate|methylphenidate
534485|NCT00323947|Stimulant|stimulant
534486|NCT00323960|Juvenile dermatomyositis|juvenile dermatomyositis
534487|NCT00323960|randomised actively controlled clinical trial|randomised actively controlled clinical trial
534488|NCT00323960|prednisone|prednisone
534489|NCT00323960|cyclosporine|cyclosporine
534490|NCT00323960|methotrexate|methotrexate
534491|NCT00323960|effectiveness|effectiveness
534492|NCT00323973|Chagas, Heart failure, Cardiomiopathy|chagas, heart failure, cardiomiopathy
534493|NCT00323986|COPD|copd
534494|NCT00323986|tracheotomy|tracheotomy
534495|NCT00323986|azithromycin|azithromycin
534496|NCT00323986|exacerbation|exacerbation
534497|NCT00323986|hospitalisation|hospitalisation
534498|NCT00323986|exhaled breath condensate|exhaled breath condensate
534499|NCT00323999|Hysteroscopic resection|hysteroscopic resection
534500|NCT00323999|Menorrhagia|menorrhagia
534501|NCT00323999|fibroids|fibroids
534502|NCT00323999|polyps|polyps
534503|NCT00324012|Adrenocortical Carcinoma|adrenocortical carcinoma
534504|NCT00324012|cisplatin|cisplatin
534505|NCT00324012|taxotere|taxotere
534506|NCT00324025|Cryptococcal meningitis|cryptococcal meningitis
534507|NCT00324038|OA|oa
534508|NCT00324038|Elderly|elderly
534509|NCT00324038|Pain|pain
534510|NCT00324038|OA of the hips and/or knees|oa of the hips and/or knees
534511|NCT00324064|Growth hormone deficiency|growth hormone deficiency
534512|NCT00324077|Chronic phase chronic myelogenous leukemia (CML)|chronic phase chronic myelogenous leukemia (cml)
534513|NCT00324103|HIV|hiv
534514|NCT00324103|Chronic Infection|chronic infection
534515|NCT00324103|Clinical Trial|clinical trial
534516|NCT00324103|Structured Treatment Interruption|structured treatment interruption
534517|NCT00324129|Leukemia|leukemia
534518|NCT00324129|Myelodysplastic Syndromes|myelodysplastic syndromes
534519|NCT00324129|Phase I|phase i
534520|NCT00324142|Bacterial vaginosis|bacterial vaginosis
534521|NCT00324142|Tinidazole|tinidazole
534522|NCT00324142|Vaginitis|vaginitis
534523|NCT00324155|Stage IIIc N3 (unresectable)|stage iiic n3 (unresectable)
534524|NCT00324155|Stage IV melanoma|stage iv melanoma
534525|NCT00324168|Bacterial Infections|bacterial infections
534526|NCT00324168|Eye Diseases|eye diseases
534527|NCT00324168|Bacterial Keratitis|bacterial keratitis
534528|NCT00324168|Visual Acuity|visual acuity
534529|NCT00324181|normal-tension glaucoma|normal-tension glaucoma
534530|NCT00324181|psychopathology|psychopathology
534531|NCT00324181|Hong Kong|hong kong
534532|NCT00324194|Leukemia|leukemia
534533|NCT00324194|Myelodysplastic Syndromes|myelodysplastic syndromes
534534|NCT00324194|Phase I|phase i
534535|NCT00324207|Type 1 diabetes mellitus|type 1 diabetes mellitus
534536|NCT00324207|Insulin mRNA|insulin mrna
534537|NCT00324220|Phase I/II|phase i/ii
534538|NCT00324233|Residual urine|residual urine
534539|NCT00324233|Hematuria|hematuria
534540|NCT00324233|Ultra sound|ultra sound
534541|NCT00324246|vaginal infection|vaginal infection
534542|NCT00324246|color appearance|color appearance
534543|NCT00324246|new developed indicator strips (NEW NORMA-SENSE)|new developed indicator strips (new norma-sense)
534544|NCT00324246|in-vitro|in-vitro
534545|NCT00324246|vaginal secretion|vaginal secretion
533928|NCT00334451|Heart Failure|heart failure
534546|NCT00324246|elevated pH|elevated ph
534547|NCT00324272|Groin dissection|groin dissection
534548|NCT00324272|Axilla (or axillary) dissection|axilla (or axillary) dissection
534549|NCT00324272|Lymph node dissection|lymph node dissection
534550|NCT00324272|Lymphadenectomy|lymphadenectomy
534551|NCT00324272|Seroma|seroma
534552|NCT00324272|Wound drainage|wound drainage
534553|NCT00324272|Fibrin sealant|fibrin sealant
534554|NCT00324272|Malignant melanoma|malignant melanoma
534555|NCT00324272|Squamous cell carcinoma|squamous cell carcinoma
534556|NCT00324285|Diarrhoea|diarrhoea
534557|NCT00324285|severe malnutrition|severe malnutrition
534558|NCT00324285|amylase resistant starch|amylase resistant starch
534559|NCT00324285|ORS|ors
534560|NCT00324298|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
15745|NCT03190317|personal health record|personal health record
534561|NCT00324298|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
534562|NCT00324324|infection|infection
534563|NCT00324324|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
534564|NCT00324324|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
534565|NCT00324324|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
534566|NCT00324324|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
534567|NCT00324324|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
534568|NCT00324324|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
534569|NCT00324324|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
534570|NCT00324324|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
534571|NCT00324324|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
534572|NCT00324324|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
534573|NCT00324324|chronic eosinophilic leukemia|chronic eosinophilic leukemia
534574|NCT00324324|primary myelofibrosis|primary myelofibrosis
534575|NCT00324324|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
534576|NCT00324324|chronic neutrophilic leukemia|chronic neutrophilic leukemia
534577|NCT00324324|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
534578|NCT00324324|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
534579|NCT00324324|disseminated neuroblastoma|disseminated neuroblastoma
534580|NCT00324324|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
534581|NCT00324324|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
534582|NCT00324324|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
534583|NCT00324324|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
535198|NCT00342225|Mothers|mothers
534584|NCT00324324|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
534585|NCT00324324|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
534586|NCT00324324|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
534587|NCT00324324|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
534588|NCT00324324|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
534589|NCT00324324|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
534590|NCT00324324|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
534591|NCT00324324|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
534592|NCT00324324|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
534593|NCT00324324|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
534594|NCT00324324|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
534595|NCT00324324|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
534596|NCT00324324|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
534597|NCT00324324|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
534598|NCT00324324|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
534599|NCT00324324|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
534600|NCT00324324|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
534601|NCT00324324|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
534602|NCT00324324|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
534603|NCT00324324|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
534604|NCT00324324|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
534605|NCT00324324|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
534606|NCT00324324|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
534022|NCT00334828|Severe sepsis|severe sepsis
534607|NCT00324324|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
534608|NCT00324324|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
534609|NCT00324324|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
534610|NCT00324324|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
534611|NCT00324324|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
534612|NCT00324324|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
534613|NCT00324324|recurrent neuroblastoma|recurrent neuroblastoma
534614|NCT00324324|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
534615|NCT00324324|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
534616|NCT00324324|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
534617|NCT00324324|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
534618|NCT00324324|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
534619|NCT00324324|refractory hairy cell leukemia|refractory hairy cell leukemia
534620|NCT00324324|refractory multiple myeloma|refractory multiple myeloma
15848|NCT03189680|posture|posture
534621|NCT00324324|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
534622|NCT00324324|secondary acute myeloid leukemia|secondary acute myeloid leukemia
534623|NCT00324324|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
534624|NCT00324324|splenic marginal zone lymphoma|splenic marginal zone lymphoma
534625|NCT00324324|stage I multiple myeloma|stage i multiple myeloma
534626|NCT00324324|stage II multiple myeloma|stage ii multiple myeloma
534627|NCT00324324|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
534628|NCT00324324|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
534629|NCT00324324|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
534630|NCT00324324|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
534631|NCT00324324|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
534632|NCT00324324|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
534633|NCT00324324|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
534634|NCT00324324|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
534635|NCT00324324|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
534636|NCT00324324|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
534637|NCT00324324|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
534638|NCT00324324|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
534639|NCT00324324|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
534640|NCT00324324|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
534641|NCT00324324|stage III multiple myeloma|stage iii multiple myeloma
534642|NCT00324324|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
534643|NCT00324324|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
534644|NCT00324324|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
534645|NCT00324324|stage IIIA breast cancer|stage iiia breast cancer
534646|NCT00324324|stage IIIB breast cancer|stage iiib breast cancer
534647|NCT00324324|stage IIIC breast cancer|stage iiic breast cancer
534648|NCT00324324|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
534649|NCT00324324|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
534650|NCT00324324|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
534651|NCT00324324|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
534652|NCT00324324|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
534653|NCT00324324|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
534654|NCT00324324|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
534655|NCT00324324|stage IV breast cancer|stage iv breast cancer
534656|NCT00324324|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
534657|NCT00324324|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
534658|NCT00324324|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
534659|NCT00324324|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
534660|NCT00324324|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
534661|NCT00324324|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
534662|NCT00324324|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
534663|NCT00324324|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
535720|NCT00344214|HIV|hiv
534664|NCT00324350|Diabetes Mellitus|diabetes mellitus
534665|NCT00324350|Fracture|fracture
534666|NCT00324350|Falls|falls
534667|NCT00324350|Height Loss|height loss
534668|NCT00324363|exenatide|exenatide
534669|NCT00324363|diabetes|diabetes
534670|NCT00324363|Amylin|amylin
534671|NCT00324363|Lilly|lilly
534672|NCT00324363|China|china
534673|NCT00324389|Interferon, Gene Expression in Liver, Lymphocytes, High Density Oligonucleotide Microarray Expression Analysis, African American, Hepatitis C|interferon, gene expression in liver, lymphocytes, high density oligonucleotide microarray expression analysis, african american, hepatitis c
534674|NCT00324402|brain natriuretic peptide|brain natriuretic peptide
534675|NCT00324402|pregnancy|pregnancy
534676|NCT00324402|biomarker|biomarker
534677|NCT00324415|stage I anal cancer|stage i anal cancer
534678|NCT00324415|stage II anal cancer|stage ii anal cancer
534679|NCT00324415|stage IIIA anal cancer|stage iiia anal cancer
534680|NCT00324415|stage IIIB anal cancer|stage iiib anal cancer
534681|NCT00324415|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
534682|NCT00324415|basaloid carcinoma of the anus|basaloid carcinoma of the anus
534683|NCT00324415|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
534684|NCT00324428|TMS|tms
534685|NCT00324428|Visceral Pain|visceral pain
534686|NCT00324428|Analgesia|analgesia
534687|NCT00324428|Pancreatic Cancer|pancreatic cancer
534688|NCT00324428|Cancer|cancer
534689|NCT00324428|Electric stimulation therapy|electric stimulation therapy
534690|NCT00324428|Electric stimulation|electric stimulation
534691|NCT00324428|Pain|pain
534692|NCT00324428|Safety|safety
534693|NCT00324441|Fibromyalgia|fibromyalgia
534694|NCT00324441|Rehabilitation|rehabilitation
534695|NCT00324441|Physical Medicine|physical medicine
534696|NCT00324441|Whole-Body Hyperthermia|whole-body hyperthermia
534697|NCT00324441|Water-Filtered Near Infrared|water-filtered near infrared
534698|NCT00324454|motor neuron disease|motor neuron disease
534699|NCT00324454|amyotrophic lateral sclerosis primary lateral|amyotrophic lateral sclerosis primary lateral
534700|NCT00324454|sclerosis; progressive muscular atrophy|sclerosis; progressive muscular atrophy
534701|NCT00324454|cramps|cramps
534702|NCT00324454|spasticity|spasticity
534703|NCT00324467|NON-HODGKIN'S LYMPHOMA|non-hodgkin's lymphoma
534704|NCT00324467|POSITRON EMISSION TOMOGRAPHY|positron emission tomography
534705|NCT00324467|PET|pet
534706|NCT00324467|DLBCL|dlbcl
534707|NCT00324467|R-CHOP|r-chop
534708|NCT00324467|R-ICE|r-ice
534709|NCT00324493|Severe Hemophilia|severe hemophilia
534710|NCT00324493|Musculoskeletal Function|musculoskeletal function
534711|NCT00324493|Factor Replacement|factor replacement
534712|NCT00324519|second trimester|second trimester
534713|NCT00324519|pregnancy termination|pregnancy termination
534714|NCT00324519|misoprostol|misoprostol
534715|NCT00324519|foley bulb|foley bulb
534716|NCT00324545|Obesity|obesity
534717|NCT00324545|Diets|diets
534718|NCT00324545|Heart Disease|heart disease
534719|NCT00324545|Randomized controlled trial|randomized controlled trial
534720|NCT00324545|Ischemia.|ischemia.
534721|NCT00324558|Bemiparin|bemiparin
534722|NCT00324558|small cell lung carcinoma|small cell lung carcinoma
534723|NCT00324584|type 1 diabetes mellitus|type 1 diabetes mellitus
534724|NCT00324584|telecare|telecare
534725|NCT00324584|telemedicine|telemedicine
534726|NCT00324584|insulin pump therapy|insulin pump therapy
534727|NCT00324597|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
534728|NCT00324597|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
534729|NCT00324597|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
534730|NCT00324597|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
534731|NCT00324597|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
534732|NCT00324597|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
534801|NCT00324662|Electric Countershock|electric countershock
534733|NCT00324597|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
534734|NCT00324597|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
534735|NCT00324597|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
534736|NCT00324597|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
534737|NCT00324597|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
534738|NCT00324597|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
534739|NCT00324597|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
534740|NCT00324597|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
534741|NCT00324597|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
534742|NCT00324597|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
534743|NCT00324597|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
534744|NCT00324597|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
534745|NCT00324597|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
534746|NCT00324597|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
534747|NCT00324597|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
534748|NCT00324597|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
534749|NCT00324597|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
534750|NCT00324597|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
534751|NCT00324597|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
534752|NCT00324597|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
534753|NCT00324597|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
534240|NCT00335725|FSH|fsh
534754|NCT00324597|splenic marginal zone lymphoma|splenic marginal zone lymphoma
534755|NCT00324597|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
534756|NCT00324597|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
534757|NCT00324597|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
534758|NCT00324597|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
534759|NCT00324597|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
534760|NCT00324597|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
534761|NCT00324597|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
534762|NCT00324597|Waldenström macroglobulinemia|waldenström macroglobulinemia
534763|NCT00324597|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
534764|NCT00324597|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
534765|NCT00324597|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
534766|NCT00324597|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
534767|NCT00324597|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
534768|NCT00324597|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
534769|NCT00324597|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
534770|NCT00324597|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
534771|NCT00324597|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
534772|NCT00324597|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
534773|NCT00324597|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
534774|NCT00324597|adenocarcinoma of the lung|adenocarcinoma of the lung
534775|NCT00324597|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
534776|NCT00324597|large cell lung cancer|large cell lung cancer
534777|NCT00324597|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
534778|NCT00324597|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
534779|NCT00324597|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
534780|NCT00324597|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
534781|NCT00324597|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
534782|NCT00324597|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
534783|NCT00324597|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
534784|NCT00324597|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
534785|NCT00324597|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
534786|NCT00324597|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
534787|NCT00324597|anaplastic large cell lymphoma|anaplastic large cell lymphoma
534788|NCT00324597|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
534789|NCT00324597|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
534790|NCT00324597|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
534791|NCT00324610|fluoropyrimidines|fluoropyrimidines
534792|NCT00324610|metastases|metastases
534793|NCT00324610|pharmacokinetics|pharmacokinetics
534794|NCT00324610|phase 1-2 study|phase 1-2 study
534795|NCT00324623|stage IV melanoma|stage iv melanoma
534796|NCT00324623|recurrent melanoma|recurrent melanoma
534797|NCT00324649|HIV-1|hiv-1
534798|NCT00324662|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
534799|NCT00324662|Ventricular tachyarrhythmia|ventricular tachyarrhythmia
534800|NCT00324662|Supraventricular tachyarrhythmia|supraventricular tachyarrhythmia
534802|NCT00324675|type 2 diabetes,|type 2 diabetes,
534803|NCT00324675|glomerular filtration rate,|glomerular filtration rate,
534804|NCT00324675|renal plasma flow,|renal plasma flow,
534805|NCT00324675|endothelial dysfunction,|endothelial dysfunction,
534806|NCT00324675|proteinuria,|proteinuria,
534807|NCT00324675|diabetic nephropathy|diabetic nephropathy
534808|NCT00324688|HIV-1|hiv-1
534809|NCT00324688|Methadone|methadone
534810|NCT00324688|HIV-1 infection|hiv-1 infection
534811|NCT00324701|Mental Health|mental health
534812|NCT00324701|Geriatric Medicine|geriatric medicine
534813|NCT00324701|Depression|depression
534814|NCT00324701|Health Service Delivery|health service delivery
534815|NCT00324701|Aged|aged
534816|NCT00324714|osteoporosis|osteoporosis
534817|NCT00324714|ductal breast carcinoma in situ|ductal breast carcinoma in situ
534818|NCT00324714|breast cancer in situ|breast cancer in situ
534819|NCT00324727|liver metastases|liver metastases
534820|NCT00324727|extraocular extension melanoma|extraocular extension melanoma
534821|NCT00324727|stage IV melanoma|stage iv melanoma
534822|NCT00324727|recurrent melanoma|recurrent melanoma
535721|NCT00344214|STDs|stds
534823|NCT00324727|recurrent intraocular melanoma|recurrent intraocular melanoma
534824|NCT00324727|metastatic intraocular melanoma|metastatic intraocular melanoma
534825|NCT00324727|iris melanoma|iris melanoma
534826|NCT00324727|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
534827|NCT00324753|cancer|cancer
534342|NCT00336245|IUD|iud
534828|NCT00324753|screening|screening
534829|NCT00324753|communication|communication
534830|NCT00324753|prevention|prevention
534831|NCT00324779|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
534832|NCT00324779|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
534833|NCT00324779|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
534834|NCT00324779|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
534835|NCT00324779|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
534836|NCT00324779|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
534837|NCT00324779|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
534838|NCT00324779|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
534839|NCT00324779|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
534840|NCT00324779|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
534841|NCT00324779|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
534842|NCT00324779|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
534843|NCT00324779|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
534844|NCT00324779|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
534845|NCT00324818|bacterial vaginosis|bacterial vaginosis
534846|NCT00324818|treatment|treatment
534847|NCT00330291|PTSD|ptsd
534848|NCT00330291|Xyrem|xyrem
534849|NCT00330291|Sleep problems|sleep problems
534850|NCT00330304|Tuberculosis|tuberculosis
534852|NCT00330304|HIV|hiv
534853|NCT00330304|prophylaxis|prophylaxis
534854|NCT00330304|mortality|mortality
534855|NCT00330317|Letrozole|letrozole
534856|NCT00330317|Breast Conserving Surgery|breast conserving surgery
534857|NCT00330317|NeoAdjuvant|neoadjuvant
534858|NCT00330317|Early Breast Cancer|early breast cancer
534859|NCT00330330|Fasting plasma glucose|fasting plasma glucose
534860|NCT00330330|HbA1c|hba1c
534861|NCT00330343|morphine|morphine
534862|NCT00330343|naloxone|naloxone
534863|NCT00330343|pediatrics|pediatrics
534864|NCT00330343|adverse effects|adverse effects
534865|NCT00330343|pain|pain
534866|NCT00330356|Dietary Salt|dietary salt
534867|NCT00330356|Blood Pressure|blood pressure
534868|NCT00330356|Normotensives|normotensives
534869|NCT00336622|Carpal Tunnel Syndrome|carpal tunnel syndrome
534870|NCT00336622|Splints|splints
534871|NCT00336635|smallpox, vaccine, immunity|smallpox, vaccine, immunity
534872|NCT00336648|Pancreatic Neoplasms|pancreatic neoplasms
534873|NCT00336648|Bevacizumab|bevacizumab
534874|NCT00336648|Gemcitabine|gemcitabine
534875|NCT00336648|Radiation Therapy|radiation therapy
534876|NCT00336648|adenocarcinoma of the pancreatic head|adenocarcinoma of the pancreatic head
534877|NCT00336648|adenocarcinoma of the uncinate process|adenocarcinoma of the uncinate process
534878|NCT00336661|Periodontitis|periodontitis
534879|NCT00336661|Chronic Periodontitis|chronic periodontitis
534880|NCT00336661|Gingivitis|gingivitis
534881|NCT00336661|PERIOWAVE|periowave
534882|NCT00336661|Photodynamic Disinfection|photodynamic disinfection
534883|NCT00336674|Type 1 diabetes|type 1 diabetes
534884|NCT00336687|Thrombopenia|thrombopenia
534885|NCT00336687|Reanimation|reanimation
534886|NCT00336687|Thrombopenia in reanimation|thrombopenia in reanimation
534887|NCT00336700|Pancreas|pancreas
534888|NCT00336700|Cancer|cancer
534889|NCT00336700|Pancreatic|pancreatic
534890|NCT00336713|depression|depression
534891|NCT00336713|antidepressive agents|antidepressive agents
534892|NCT00336713|controlled clinical trial|controlled clinical trial
535196|NCT00342212|HV|hv
534893|NCT00336739|Gastric acidity determination|gastric acidity determination
534894|NCT00336739|Calcium sensing receptor|calcium sensing receptor
534895|NCT00336752|undisplaced ,unstable wEBER B ankle fractures|undisplaced ,unstable weber b ankle fractures
534896|NCT00336752|operative intervention|operative intervention
534897|NCT00336752|non operative intervention|non operative intervention
534898|NCT00336765|solid tumors|solid tumors
534899|NCT00336791|Breast Cancer|breast cancer
534900|NCT00336791|Gene Expression|gene expression
534901|NCT00336791|Fluorouracil|fluorouracil
534902|NCT00336791|Cyclophosphamide|cyclophosphamide
534903|NCT00336791|Doxorubicin|doxorubicin
534904|NCT00336791|Paclitaxel|paclitaxel
534905|NCT00336817|Liver transplantation|liver transplantation
534906|NCT00336817|mycophenolate mofetil|mycophenolate mofetil
534907|NCT00336817|gastrointestinal|gastrointestinal
534908|NCT00336817|adverse effects|adverse effects
534909|NCT00336830|Cardiac Rehabilitation|cardiac rehabilitation
534910|NCT00336830|Improving Cardiac Rehabilitation Participation|improving cardiac rehabilitation participation
534911|NCT00336830|coronary angioplasty|coronary angioplasty
534912|NCT00336830|coronary artery bypass surgery|coronary artery bypass surgery
534913|NCT00336843|Zevalin|zevalin
534914|NCT00336843|B-cell non-Hodgkin's lymphoma|b-cell non-hodgkin's lymphoma
534915|NCT00336843|autologous stem cell transplantation|autologous stem cell transplantation
534916|NCT00336843|BuCyE regimen|bucye regimen
534917|NCT00336856|Colon Cancer|colon cancer
534918|NCT00336882|traumatic brain injury|traumatic brain injury
534919|NCT00336882|propofol|propofol
534920|NCT00336882|oxidative stress|oxidative stress
534921|NCT00336882|microdialysis|microdialysis
534922|NCT00336895|Liver transplantation|liver transplantation
534923|NCT00336895|mycophenolate mofetil|mycophenolate mofetil
534924|NCT00336895|gastrointestinal|gastrointestinal
534925|NCT00336895|adverse effects|adverse effects
534926|NCT00336908|Intensive Care,Neonatal|intensive care,neonatal
534927|NCT00336908|Parenteral nutrition|parenteral nutrition
534928|NCT00336908|Fat emulsions,Intravenous|fat emulsions,intravenous
534929|NCT00336934|adenocarcinoma of the prostate|adenocarcinoma of the prostate
534930|NCT00336934|recurrent prostate cancer|recurrent prostate cancer
534931|NCT00336934|stage I prostate cancer|stage i prostate cancer
534932|NCT00336934|stage II prostate cancer|stage ii prostate cancer
534933|NCT00336934|stage III prostate cancer|stage iii prostate cancer
534934|NCT00336934|stage IV prostate cancer|stage iv prostate cancer
534935|NCT00336947|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
534936|NCT00336947|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
534937|NCT00336947|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
534938|NCT00336947|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
534939|NCT00336947|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
534940|NCT00336947|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
534941|NCT00336947|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
534942|NCT00336947|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
534943|NCT00336947|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
534944|NCT00336947|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
534945|NCT00336960|stage II rectal cancer|stage ii rectal cancer
534946|NCT00336960|stage III rectal cancer|stage iii rectal cancer
534947|NCT00336960|adenocarcinoma of the rectum|adenocarcinoma of the rectum
534949|NCT00341536|Pilot|pilot
534950|NCT00341536|Cohort|cohort
534951|NCT00341536|Environmental|environmental
534952|NCT00341536|Chronic Disease|chronic disease
534953|NCT00341549|Linkage|linkage
534954|NCT00341549|Genetics|genetics
534955|NCT00341549|Mapping|mapping
534956|NCT00341549|Gene|gene
534957|NCT00341549|Susceptibility|susceptibility
534958|NCT00341549|Myopia|myopia
534959|NCT00341549|Nearsightedness|nearsightedness
534960|NCT00341549|Refraction|refraction
534961|NCT00341549|Eye|eye
534962|NCT00341562|Gene Expression Profiling|gene expression profiling
534963|NCT00341562|Vascular Disease|vascular disease
534964|NCT00341575|Family Systems|family systems
534965|NCT00341575|Communication|communication
534966|NCT00341575|Information Diffusion|information diffusion
534967|NCT00341575|Social Networks|social networks
534968|NCT00341575|Family Dynamics|family dynamics
534969|NCT00341588|Testicular Cancer|testicular cancer
534970|NCT00341588|Epidemiology|epidemiology
534971|NCT00341588|Testicular Germ Cell Cancer|testicular germ cell cancer
534972|NCT00341588|TGCT|tgct
534973|NCT00341588|Healthy Volunteer|healthy volunteer
534974|NCT00341601|Mycobacterium Tuberculosis|mycobacterium tuberculosis
534975|NCT00341601|TLR-2|tlr-2
534976|NCT00341601|Recurrent Tuberculosis|recurrent tuberculosis
534977|NCT00341601|Phenolic Glycolipid|phenolic glycolipid
534978|NCT00341601|mRNA Expression Profiles|mrna expression profiles
534979|NCT00341614|Exercise|exercise
534980|NCT00341614|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
534981|NCT00341614|Postmenopause|postmenopause
534982|NCT00341614|Diet|diet
534983|NCT00341627|Bone Tumor|bone tumor
534984|NCT00341627|Familial Chordoma|familial chordoma
534985|NCT00341627|Gene Mapping|gene mapping
534986|NCT00341627|Genetics|genetics
534987|NCT00341627|Sporadic Chordoma|sporadic chordoma
534988|NCT00341640|Teen Pregnancy|teen pregnancy
534989|NCT00341653|Asthma|asthma
534990|NCT00341653|Pulmonary Function|pulmonary function
534991|NCT00341653|Air Pollution|air pollution
534992|NCT00341653|Genetic Polymorphism|genetic polymorphism
534993|NCT00341653|Environmental Tobacco Agents|environmental tobacco agents
534994|NCT00341666|Immune Regulation|immune regulation
534995|NCT00341666|Co-Infection|co-infection
534996|NCT00341666|Filariasis|filariasis
534997|NCT00341666|Immunology|immunology
534998|NCT00341666|Filarial Infection|filarial infection
534999|NCT00341679|Autoimmune Diseases|autoimmune diseases
535000|NCT00341679|Genetic Risk Factors|genetic risk factors
535001|NCT00341679|Polymyositis|polymyositis
535002|NCT00341679|Dermatomyositis|dermatomyositis
535003|NCT00341679|Connective Tissue Disorders|connective tissue disorders
534476|NCT00323908|polymorphisms|polymorphisms
535004|NCT00341679|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
535005|NCT00341679|Inclusion Body Myositis|inclusion body myositis
535006|NCT00341679|Pathogenesis|pathogenesis
535007|NCT00341679|Environmental Risk Factor|environmental risk factor
535008|NCT00341679|IIM|iim
535009|NCT00341692|Mammary|mammary
535010|NCT00341692|Development|development
535011|NCT00341692|Cancer|cancer
535012|NCT00341692|Risk|risk
535013|NCT00341692|Genes|genes
535014|NCT00341705|AIDS|aids
535015|NCT00341705|Cancer|cancer
535016|NCT00341705|Hepatitis C Virus|hepatitis c virus
535017|NCT00341705|HIV|hiv
535018|NCT00341705|Natural History|natural history
535019|NCT00341705|Hemophilia|hemophilia
535020|NCT00341705|Hepatitis C|hepatitis c
535021|NCT00341718|Interview|interview
535022|NCT00341718|Genetics|genetics
535023|NCT00341731|Cystic Ovaries|cystic ovaries
535024|NCT00341731|Environmental Factors|environmental factors
535025|NCT00341731|Heritability|heritability
535026|NCT00341731|Hyperandrogenism|hyperandrogenism
535027|NCT00341731|Twin Study|twin study
535028|NCT00341744|Vision|vision
535029|NCT00341744|Aids|aids
535030|NCT00341757|Family Reports|family reports
535031|NCT00341757|Cancer|cancer
535032|NCT00341757|Questionnaire|questionnaire
535033|NCT00341757|Validity|validity
535034|NCT00341757|Surveillance|surveillance
535035|NCT00341783|Plasmodium|plasmodium
535036|NCT00341783|Falciparum|falciparum
535037|NCT00341783|Screening|screening
535038|NCT00341783|Malaria|malaria
535039|NCT00341796|AIDS|aids
535040|NCT00341796|HIV|hiv
535041|NCT00341796|Perinatal|perinatal
535042|NCT00341796|Transmission|transmission
535043|NCT00341796|Antiretroviral|antiretroviral
535044|NCT00341796|Outcomes|outcomes
535045|NCT00341809|Natural Killer Cells|natural killer cells
535046|NCT00341809|Autoimmune Disease|autoimmune disease
535047|NCT00341809|Chronic Inflammation|chronic inflammation
535048|NCT00341809|Two-Locus Interaction|two-locus interaction
535049|NCT00341809|Allele/Haplotype Analysis|allele/haplotype analysis
535050|NCT00341822|Amniocentesis|amniocentesis
535051|NCT00341822|Chorionic Villus Sampling|chorionic villus sampling
535052|NCT00341822|Fertility|fertility
535053|NCT00341822|Genetic Counseling|genetic counseling
535054|NCT00341822|Decisional Conflict|decisional conflict
535055|NCT00341822|Prenatal Testing|prenatal testing
535056|NCT00341822|Questionnaire|questionnaire
535057|NCT00341835|Linkage Analysis|linkage analysis
535058|NCT00341835|Cancer Susceptibility Alleles|cancer susceptibility alleles
535059|NCT00341835|Cancer Genetics|cancer genetics
535060|NCT00341835|Linkage Mapping|linkage mapping
535061|NCT00341835|Linkage Disequilibrium|linkage disequilibrium
535062|NCT00341848|Apoptosis|apoptosis
535063|NCT00341848|Environment|environment
535064|NCT00341848|Infection|infection
535065|NCT00341848|Inflammation|inflammation
535066|NCT00341848|Leiomyoma|leiomyoma
535067|NCT00341848|Uterine Leiomyoma|uterine leiomyoma
535068|NCT00341848|Uterus|uterus
535069|NCT00341861|Bladder Cancer|bladder cancer
535070|NCT00341861|Occupational and Environmental Risks|occupational and environmental risks
535071|NCT00341861|Lifestyle Factors|lifestyle factors
535072|NCT00341861|Epidemiology|epidemiology
535073|NCT00341861|Genetic Susceptibility|genetic susceptibility
535074|NCT00341874|DNA Mutations|dna mutations
535075|NCT00341874|Genetic Variation|genetic variation
535076|NCT00341874|GENETIC LINKAGE|genetic linkage
535077|NCT00341874|Gene Expression Patterns|gene expression patterns
535078|NCT00341874|Hereditary Hearing Disorder|hereditary hearing disorder
535079|NCT00341887|Screening|screening
535080|NCT00341887|AIDS|aids
535081|NCT00341887|Antiretrovirals|antiretrovirals
535082|NCT00341887|Military|military
535083|NCT00341887|Force readiness|force readiness
535084|NCT00341900|Chromosome Translocations|chromosome translocations
535197|NCT00342225|Observation|observation
535085|NCT00341900|Cosmic Radiation|cosmic radiation
535086|NCT00341900|Airline Flight Crew|airline flight crew
535087|NCT00341900|Airlines|airlines
535088|NCT00341900|Flight Crew|flight crew
535089|NCT00341900|Occupational Exposure|occupational exposure
535090|NCT00341913|Research|research
535091|NCT00341913|Repository|repository
535092|NCT00341913|Registry|registry
535093|NCT00341913|Surveillance|surveillance
535094|NCT00341913|Databases|databases
535095|NCT00341939|Drug Therapy|drug therapy
535096|NCT00341939|Pharmacogenetics|pharmacogenetics
535097|NCT00341939|Cancer|cancer
535098|NCT00341939|Pharmacodynamics|pharmacodynamics
535099|NCT00341939|Parmacokinetics|parmacokinetics
535100|NCT00341952|Case-Control Study|case-control study
535101|NCT00341952|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
535102|NCT00341965|DDT|ddt
535103|NCT00341965|DDE|dde
535104|NCT00341965|Androgen Levels|androgen levels
535105|NCT00341965|Farming|farming
535106|NCT00341965|Antiandrogen|antiandrogen
535107|NCT00341991|DNA Repair|dna repair
535108|NCT00341991|Genes|genes
535109|NCT00341991|Pigmentation|pigmentation
535110|NCT00341991|Skin Cancer|skin cancer
535111|NCT00341991|Sun Exposure|sun exposure
535112|NCT00342004|Shanghai|shanghai
535113|NCT00342004|Residential History|residential history
535114|NCT00342004|Exposure Assessment|exposure assessment
535115|NCT00342004|Cohort Study|cohort study
535116|NCT00342004|Molecular Epidemiology|molecular epidemiology
535117|NCT00342017|Filarial Infections|filarial infections
535118|NCT00342017|Helminths|helminths
535119|NCT00342017|Tuberculosis|tuberculosis
535120|NCT00342017|Filarial Infection|filarial infection
535121|NCT00342030|Respiratory|respiratory
535122|NCT00342030|Polymorphism|polymorphism
535123|NCT00342030|Fruit|fruit
535124|NCT00342030|COPD|copd
535125|NCT00342030|Prospective|prospective
535126|NCT00342030|Diet|diet
535127|NCT00342043|Sickle Trait|sickle trait
535128|NCT00342043|Fetal Hemoglobin|fetal hemoglobin
535129|NCT00342043|Hemoglobin C|hemoglobin c
535130|NCT00342043|Beta-Thalassemia|beta-thalassemia
535131|NCT00342043|Artesunate-Amodiaquine|artesunate-amodiaquine
535132|NCT00342056|Pharmacogenetics|pharmacogenetics
535133|NCT00342056|Transporter Proteins|transporter proteins
535134|NCT00342056|Drug Exposure|drug exposure
535135|NCT00342056|Imatinib|imatinib
535136|NCT00342056|Retrospective|retrospective
535137|NCT00342056|Cancer|cancer
535138|NCT00342069|Decision Making|decision making
535139|NCT00342069|Genetic Counseling|genetic counseling
535140|NCT00342069|Pregnancy Options|pregnancy options
535141|NCT00342069|Attitudes Toward Reproductive Options|attitudes toward reproductive options
535142|NCT00342069|Beliefs About Down Syndrome Risk|beliefs about down syndrome risk
535143|NCT00342069|Down Syndrome Risk|down syndrome risk
535144|NCT00342069|Pregnancy|pregnancy
535145|NCT00342082|Zidovudine|zidovudine
535146|NCT00342082|HIV|hiv
535147|NCT00342082|Cord Blood|cord blood
535148|NCT00342095|Autoimmune Diseases|autoimmune diseases
535149|NCT00342095|Estrogen|estrogen
535150|NCT00342095|Silica|silica
535151|NCT00342095|Pesticides|pesticides
535152|NCT00342095|Major Histocompatibility Complex|major histocompatibility complex
535153|NCT00342095|Genetic Susceptibility|genetic susceptibility
535154|NCT00342121|Cancer|cancer
535155|NCT00342121|NHL|nhl
535156|NCT00342121|Pesticides|pesticides
535157|NCT00342121|Atrazine|atrazine
535158|NCT00342121|Organophosphates|organophosphates
535159|NCT00342121|Cancer Risk|cancer risk
535160|NCT00342121|Normal Control|normal control
535161|NCT00342134|Demyelination|demyelination
535162|NCT00342134|Inflammation|inflammation
535163|NCT00342134|Immunosuppression|immunosuppression
535164|NCT00342134|Autoimmunity|autoimmunity
535165|NCT00342134|Bone Marrow|bone marrow
535166|NCT00342134|Multiple Sclerosis|multiple sclerosis
535167|NCT00342147|EBV|ebv
535168|NCT00342147|NPC|npc
535169|NCT00342160|AIDS|aids
535170|NCT00342160|HIV Infectiousness|hiv infectiousness
535171|NCT00342160|Immunity|immunity
535172|NCT00342160|CTL|ctl
535173|NCT00342160|Epidemiology|epidemiology
535174|NCT00342173|Cervix|cervix
535175|NCT00342173|Natural History|natural history
535176|NCT00342173|Neoplasia|neoplasia
535177|NCT00342173|HPV|hpv
535178|NCT00342173|Costa Rica|costa rica
535179|NCT00342186|China|china
535180|NCT00342186|Cancer|cancer
535181|NCT00342186|Hepatitis B|hepatitis b
535182|NCT00342186|Genetics|genetics
535183|NCT00342186|Liver Disease|liver disease
535184|NCT00342186|HBV|hbv
535185|NCT00342199|Incidence|incidence
535186|NCT00342199|Prevalence|prevalence
535187|NCT00342199|Immunity|immunity
535188|NCT00342199|Bacteriology|bacteriology
535189|NCT00342199|Pathogenesis|pathogenesis
535190|NCT00342212|Walking|walking
535191|NCT00342212|Jogging|jogging
535192|NCT00342212|Bridging Study|bridging study
535193|NCT00342212|Data Comparability|data comparability
535194|NCT00342212|Healthy Adults|healthy adults
535195|NCT00342212|Healthy Volunteer|healthy volunteer
535199|NCT00342225|Description|description
535200|NCT00342251|Macular Degeneration|macular degeneration
535201|NCT00342251|Retinal Images|retinal images
535202|NCT00342251|Risk Factors|risk factors
535203|NCT00342251|Linkage Analysis|linkage analysis
535204|NCT00342251|Gene|gene
535205|NCT00342251|Mutation|mutation
535206|NCT00342264|Lung Cancer|lung cancer
535207|NCT00342264|Smoking|smoking
535208|NCT00342264|Diesel Exhaust|diesel exhaust
535209|NCT00342277|Premature Rupture of Membranes|premature rupture of membranes
535210|NCT00342277|Genetic Risk Factors|genetic risk factors
535211|NCT00342277|Tissue Specific Expression|tissue specific expression
535212|NCT00342277|Quantitative Real Time PCR|quantitative real time pcr
535213|NCT00342277|Preterm Birth|preterm birth
535214|NCT00342277|Expression Profiling|expression profiling
535215|NCT00342277|Microarrays|microarrays
535216|NCT00342290|Pathophysiological Volume Measurement|pathophysiological volume measurement
535217|NCT00342290|Power Doppler Ultrasound|power doppler ultrasound
535218|NCT00342290|Prediction of Adverse Pregnancy Outcome|prediction of adverse pregnancy outcome
535219|NCT00342290|Subchorionic Hemorrhage|subchorionic hemorrhage
535220|NCT00342303|Premature Infants|premature infants
535221|NCT00342303|Fatty Acid Metabolism|fatty acid metabolism
535222|NCT00342303|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
535223|NCT00342303|Infant Formula|infant formula
535224|NCT00342303|Gas-chromatography|gas-chromatography
535225|NCT00342303|Mass Spectrometry|mass spectrometry
535226|NCT00342316|Acute Myeloid Leukemia|acute myeloid leukemia
535227|NCT00342316|Stem Cell Transplantation|stem cell transplantation
535228|NCT00342316|Reduced Intensity Conditioning|reduced intensity conditioning
535229|NCT00342316|Survival|survival
535230|NCT00342316|Relapse|relapse
535231|NCT00342329|Case-Control|case-control
535232|NCT00342329|Hydrocarbons|hydrocarbons
535233|NCT00342329|Metals|metals
535234|NCT00342329|Silica|silica
535235|NCT00342329|Tobacco Smoke|tobacco smoke
535236|NCT00342329|Lupus Nephritis|lupus nephritis
535237|NCT00342329|Environmental Exposures|environmental exposures
535238|NCT00342329|Occupational Exposures|occupational exposures
535239|NCT00342342|Genetics|genetics
535240|NCT00342355|Protease Inhibitors|protease inhibitors
535241|NCT00342355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
535242|NCT00342355|AIDS|aids
535243|NCT00342355|Opportunistic Infections|opportunistic infections
535244|NCT00342355|Resource-Poor|resource-poor
535245|NCT00342368|CPAP|cpap
535246|NCT00342368|ARDS|ards
535247|NCT00342368|ALI|ali
535248|NCT00342368|Hypoxemia|hypoxemia
535249|NCT00342368|Intubation|intubation
535250|NCT00342381|Motor fatigue|motor fatigue
535251|NCT00342381|Cognitive fatigue|cognitive fatigue
535252|NCT00342394|Biological Monitoring|biological monitoring
535253|NCT00342394|Exposure Determinants|exposure determinants
535254|NCT00342394|Exposure Validation|exposure validation
535255|NCT00342394|Occupational Exposure|occupational exposure
535256|NCT00342394|Pesticides|pesticides
535257|NCT00342394|Agriculture|agriculture
535258|NCT00342407|Cancer Risk|cancer risk
535259|NCT00342407|Cosmic Radiation|cosmic radiation
535260|NCT00342407|Airlines|airlines
535261|NCT00342407|Flight Attendants|flight attendants
535262|NCT00342407|Circadian Rhythm|circadian rhythm
535263|NCT00342433|Androgens|androgens
535265|NCT00342433|Tissue|tissue
535266|NCT00342446|GONADOTROPIN|gonadotropin
535267|NCT00342446|CLOMIPHENE|clomiphene
535268|NCT00342446|Ovulation-Stimulating Drugs|ovulation-stimulating drugs
535269|NCT00342472|Esophageal Cancer|esophageal cancer
535270|NCT00342472|Polycyclic Aromatic Hydrocarbons|polycyclic aromatic hydrocarbons
535271|NCT00342485|Cellular Immunity|cellular immunity
535272|NCT00342485|HIV-infected|hiv-infected
535273|NCT00342485|Immune Deficiency|immune deficiency
535274|NCT00342485|Cancer|cancer
535275|NCT00342485|Transplantation|transplantation
535277|NCT00342498|Hormone|hormone
535278|NCT00342498|Resistance|resistance
535279|NCT00342498|Skeleton|skeleton
535280|NCT00342511|Pap|pap
535281|NCT00342511|Hybrid Capture 2|hybrid capture 2
535282|NCT00342511|HSIL|hsil
535283|NCT00342511|Colposcopy|colposcopy
535284|NCT00342511|CIN|cin
535285|NCT00342511|Specimen Collection|specimen collection
535286|NCT00342524|IVIG|ivig
535287|NCT00342524|Plasmapheresis|plasmapheresis
535288|NCT00342524|Blood Collection|blood collection
535289|NCT00342524|Immune Globulin|immune globulin
535290|NCT00342524|Severe Acute Respiratory Syndrome|severe acute respiratory syndrome
535291|NCT00342524|SARS|sars
535292|NCT00342537|Pathology|pathology
535293|NCT00342537|Genetics|genetics
535294|NCT00342537|Testicular Cancer|testicular cancer
535295|NCT00342537|Familial|familial
535296|NCT00342537|Cancer Epidemiology|cancer epidemiology
535297|NCT00342550|Pregnancy|pregnancy
535298|NCT00342550|Preterm Birth|preterm birth
535299|NCT00342550|Pregnancy Complications|pregnancy complications
535300|NCT00342563|mecamylamine|mecamylamine
535301|NCT00342563|treatment|treatment
535695|NCT00344149|Response|response
535302|NCT00342563|alcohol dependence|alcohol dependence
535304|NCT00342576|Filarial Parasites|filarial parasites
535305|NCT00342576|Wuchereria Bancrofti|wuchereria bancrofti
535306|NCT00342576|Brugia Malayi|brugia malayi
535307|NCT00342576|Diethylcarbamazine (DEC)|diethylcarbamazine (dec)
535308|NCT00342576|Ivermectin|ivermectin
535309|NCT00342589|Pneumocystis|pneumocystis
535310|NCT00342589|HIV|hiv
535311|NCT00342589|Oral Wash|oral wash
535312|NCT00342589|PCR|pcr
535313|NCT00342589|Drug Resistance|drug resistance
535314|NCT00342602|JC Virus|jc virus
535315|NCT00342602|Opportunistic Infection|opportunistic infection
535316|NCT00342602|Single Nucleotide Polymorphism|single nucleotide polymorphism
535317|NCT00342602|Genotype|genotype
535318|NCT00342602|Sequencing|sequencing
535319|NCT00342628|Antibody|antibody
535320|NCT00342628|Reactions|reactions
535321|NCT00342628|Vaccine|vaccine
535322|NCT00342628|Conjugate Vaccine|conjugate vaccine
535323|NCT00342628|Typhoid Fever|typhoid fever
535324|NCT00342628|Trial|trial
690662|NCT00929370|CSF|csf
535325|NCT00342628|Safety|safety
535326|NCT00342628|Immunogenicity|immunogenicity
535327|NCT00342628|Comparability|comparability
535328|NCT00342628|DTP|dtp
535329|NCT00342641|Lymphoma|lymphoma
535330|NCT00342641|Multiple Myeloma|multiple myeloma
535331|NCT00342641|Thyroiditis|thyroiditis
535332|NCT00342641|Cohort Study|cohort study
535333|NCT00342641|Record linkage study|record linkage study
535334|NCT00342641|Hepatitis C|hepatitis c
535335|NCT00342654|Epidemiology|epidemiology
535336|NCT00342654|Cancer|cancer
535337|NCT00342654|Environment|environment
535338|NCT00342654|Genetics|genetics
535339|NCT00342654|Nutrition|nutrition
535340|NCT00342667|Preterm Birth|preterm birth
535341|NCT00342667|Predictors of Outcome|predictors of outcome
535342|NCT00342667|Neonatal/Infant Complications|neonatal/infant complications
535343|NCT00342667|Neurologic Development|neurologic development
535344|NCT00342667|(SqrRoot) mniotic Fluid|(sqrroot) mniotic fluid
535345|NCT00342667|Cerebral Palsy|cerebral palsy
535346|NCT00342667|Risk Factors|risk factors
535347|NCT00342693|Radiation|radiation
535348|NCT00342693|Screening|screening
535349|NCT00342693|Cancer|cancer
535350|NCT00342693|Nodules|nodules
535351|NCT00342693|Nuclear|nuclear
535352|NCT00342693|Thyroid Screening|thyroid screening
535353|NCT00342693|Thyroid Gland|thyroid gland
535354|NCT00342706|Teen Pregnancy|teen pregnancy
535355|NCT00342706|Short Inter-Pregnancy Intervals|short inter-pregnancy intervals
535356|NCT00342732|Genetics|genetics
535357|NCT00342732|Fat Intake|fat intake
535358|NCT00342732|Pima Indians|pima indians
535359|NCT00342732|Weight Control|weight control
535360|NCT00342732|Appetite Control|appetite control
535361|NCT00342758|Asthma|asthma
535362|NCT00342758|Wheeze|wheeze
535364|NCT00342758|Diet|diet
535365|NCT00342758|Infection|infection
535366|NCT00342771|Tobacco Use|tobacco use
535367|NCT00342771|Tumor Biology|tumor biology
535368|NCT00342771|Biomarker|biomarker
535369|NCT00342771|Risk Factor|risk factor
535370|NCT00342771|Health Disparity|health disparity
535371|NCT00342784|Mutation|mutation
535372|NCT00342784|Cancer Genetics|cancer genetics
535373|NCT00342797|second primary cancer|second primary cancer
535374|NCT00342797|retinoblastoma|retinoblastoma
535375|NCT00342797|RB1 germline mutation|rb1 germline mutation
535376|NCT00342810|Eye Diseases|eye diseases
535377|NCT00342823|Linkage Analysis|linkage analysis
535378|NCT00342823|Canidate Gene Analysis|canidate gene analysis
535379|NCT00342823|Genome Scan|genome scan
535380|NCT00342823|L. Chagasi|l. chagasi
535381|NCT00342823|Visceral Leishmania|visceral leishmania
535383|NCT00342836|Immunohistochemistry|immunohistochemistry
535384|NCT00342836|Myoinositol|myoinositol
535385|NCT00342836|Bronchial Specimens|bronchial specimens
535386|NCT00342836|Phosphorylation|phosphorylation
535387|NCT00342849|Clinical Trial|clinical trial
535388|NCT00342849|Low-level Lead Poisoning|low-level lead poisoning
535389|NCT00342849|Chelation|chelation
535390|NCT00342849|Developmental Assessment|developmental assessment
535391|NCT00342849|Succimer|succimer
535392|NCT00342862|Pregnancy|pregnancy
535393|NCT00342862|Amevive|amevive
535394|NCT00342862|alefacept|alefacept
535395|NCT00342862|Registry|registry
535396|NCT00342862|Psoriasis|psoriasis
535397|NCT00342875|Bladder Cancer|bladder cancer
535398|NCT00342875|Exposure|exposure
535399|NCT00342875|Drinking Water|drinking water
535400|NCT00342888|Childhood Cancer|childhood cancer
535401|NCT00342888|Pesticides|pesticides
535402|NCT00342888|Polychlorinated Biphenyls|polychlorinated biphenyls
535403|NCT00342888|Organochlorines|organochlorines
535404|NCT00342888|Polybrominated Diphenyl Ethers|polybrominated diphenyl ethers
535405|NCT00342927|American Indians|american indians
535406|NCT00342927|Complications|complications
535407|NCT00342927|Genetics|genetics
535408|NCT00342927|Linkage|linkage
535409|NCT00342927|Type 2 Diabetes|type 2 diabetes
535410|NCT00342927|Diabetic Kidney Disease|diabetic kidney disease
535411|NCT00342940|influenza|influenza
535412|NCT00342940|influenza vaccine|influenza vaccine
535413|NCT00342940|flu|flu
535414|NCT00342940|vaccination|vaccination
535415|NCT00342940|immunogenicity|immunogenicity
535416|NCT00342953|saline|saline
535417|NCT00342953|silicone|silicone
535418|NCT00342953|Breast Implants|breast implants
535419|NCT00342953|augmentation mammoplasty|augmentation mammoplasty
535420|NCT00342953|visk|visk
535421|NCT00342966|Metabolism|metabolism
535422|NCT00342966|Tracer Studies|tracer studies
535423|NCT00342966|Chemoprevention|chemoprevention
535424|NCT00342966|Selenomethionine|selenomethionine
535425|NCT00342966|Plasma Selenoproteins|plasma selenoproteins
535426|NCT00342992|Vitamin E|vitamin e
535427|NCT00342992|Micronutrients|micronutrients
535428|NCT00342992|Genetics|genetics
535429|NCT00342992|Smoking|smoking
535430|NCT00342992|Biomarkers|biomarkers
535431|NCT00343005|Blood-Stage|blood-stage
535432|NCT00343005|Investigational|investigational
535433|NCT00343005|Endemic|endemic
535434|NCT00343005|Malaria|malaria
535435|NCT00343005|Vaccine|vaccine
535436|NCT00343018|Preschoolers|preschoolers
535437|NCT00343018|Young Children|young children
535438|NCT00343018|Eyewitness|eyewitness
535439|NCT00343018|Memory|memory
535440|NCT00343031|Insecticides|insecticides
535441|NCT00343031|Children|children
535442|NCT00343031|Women|women
535443|NCT00343031|Infection|infection
535444|NCT00343031|DDT|ddt
535445|NCT00343031|Contaminant|contaminant
535446|NCT00343044|platinum resistant ovarian cancer|platinum resistant ovarian cancer
535447|NCT00343044|recurrent ovarian cancer|recurrent ovarian cancer
535448|NCT00343044|platinum resistant cancer|platinum resistant cancer
535449|NCT00343083|Head and Neck Neoplasms|head and neck neoplasms
535450|NCT00343096|intranasal|intranasal
535451|NCT00343096|buccal|buccal
535452|NCT00343096|lorazepam|lorazepam
535453|NCT00343096|paediatric|paediatric
535454|NCT00343096|convulsions|convulsions
535455|NCT00343122|liver|liver
535456|NCT00343122|cirrhosis|cirrhosis
535457|NCT00343122|hepatopulmonary syndrome|hepatopulmonary syndrome
535458|NCT00343135|Skin|skin
535459|NCT00343135|AUGMENTIN|augmentin
535460|NCT00343135|1gm|1gm
535461|NCT00343135|Soft|soft
535462|NCT00343135|tissue|tissue
535463|NCT00343135|Infections|infections
535464|NCT00343161|Nexium|nexium
535465|NCT00343174|stroke|stroke
535466|NCT00343174|vascular diseases|vascular diseases
535467|NCT00343187|Tarceva|tarceva
535468|NCT00343187|Rash|rash
535469|NCT00343187|EGFR-1 Rash|egfr-1 rash
535470|NCT00343187|erlotinib|erlotinib
535471|NCT00343187|Aczone|aczone
535472|NCT00343187|Dapsone|dapsone
535473|NCT00343187|Non-small Cell Lung Cancer|non-small cell lung cancer
535474|NCT00343187|subjects treated with Tarceva for non-small cell lung cancer (NSCLC) who subsequently develop a rash suspected to be related to Tarceva|subjects treated with tarceva for non-small cell lung cancer (nsclc) who subsequently develop a rash suspected to be related to tarceva
535475|NCT00343213|Prognostic value of p16INK4a|prognostic value of p16ink4a
535477|NCT00343213|LSIL|lsil
535478|NCT00343213|HPV|hpv
535479|NCT00343226|Basiliximab, transplantation, liver, renal function|basiliximab, transplantation, liver, renal function
535480|NCT00343265|Preterm birth|preterm birth
535481|NCT00343265|Multiple pregnancy|multiple pregnancy
535482|NCT00343265|Vaginal progesterone|vaginal progesterone
535483|NCT00343265|Preterm birth in multiple pregnancy|preterm birth in multiple pregnancy
535484|NCT00343278|Valaciclovir Hydrochloride|valaciclovir hydrochloride
535485|NCT00343278|hemodialysis patient|hemodialysis patient
535486|NCT00343278|ALDH|aldh
535487|NCT00343278|pharmacokinetics|pharmacokinetics
535488|NCT00343278|Japanese|japanese
535489|NCT00343291|Non-Small Cell Lung Cancer|non-small cell lung cancer
535490|NCT00343291|Malignant pleural effusions|malignant pleural effusions
535491|NCT00343304|Stroke.Robot.Ergometer.Group OT|stroke.robot.ergometer.group ot
535492|NCT00343317|puerperal sepsis|puerperal sepsis
535493|NCT00343317|HIV infection|hiv infection
535494|NCT00343317|prophylactic antibiotics|prophylactic antibiotics
535495|NCT00343356|Bladder neoplasm;|bladder neoplasm;
535496|NCT00343356|Carcinoma;|carcinoma;
535497|NCT00343356|Epirubicin;|epirubicin;
535498|NCT00343356|BCG;|bcg;
535499|NCT00343356|Perfusion|perfusion
535500|NCT00343369|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
535501|NCT00343369|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
535502|NCT00343369|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
535503|NCT00343369|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
535504|NCT00343382|sexuality and reproductive issues|sexuality and reproductive issues
535505|NCT00343382|sexual dysfunction|sexual dysfunction
535506|NCT00343382|recurrent breast cancer|recurrent breast cancer
535507|NCT00343382|stage I breast cancer|stage i breast cancer
535508|NCT00343382|stage II breast cancer|stage ii breast cancer
535509|NCT00343382|stage IIIA breast cancer|stage iiia breast cancer
535510|NCT00343382|stage IIIB breast cancer|stage iiib breast cancer
535511|NCT00343382|stage IIIC breast cancer|stage iiic breast cancer
535512|NCT00343382|stage IV breast cancer|stage iv breast cancer
535513|NCT00343395|rosiglitazone|rosiglitazone
535514|NCT00343395|metformin|metformin
535516|NCT00343395|inflammation|inflammation
535517|NCT00343408|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
535518|NCT00343408|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
535519|NCT00343408|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
535520|NCT00343408|recurrent colon cancer|recurrent colon cancer
535521|NCT00343408|stage III colon cancer|stage iii colon cancer
535522|NCT00343408|stage IV colon cancer|stage iv colon cancer
535523|NCT00343408|recurrent rectal cancer|recurrent rectal cancer
535524|NCT00343408|stage III rectal cancer|stage iii rectal cancer
535525|NCT00343408|stage IV rectal cancer|stage iv rectal cancer
535526|NCT00343421|Diphtheria|diphtheria
535527|NCT00343421|Tetanus|tetanus
535528|NCT00343421|Pertussis|pertussis
535529|NCT00343421|Poliomyelitis|poliomyelitis
535530|NCT00343421|Haemophilus influenzae type b|haemophilus influenzae type b
535531|NCT00343421|Pneumococcal infections|pneumococcal infections
535532|NCT00343434|stage I breast cancer|stage i breast cancer
535533|NCT00343434|stage II breast cancer|stage ii breast cancer
535534|NCT00343434|stage IIIA breast cancer|stage iiia breast cancer
535535|NCT00343434|stage IIIB breast cancer|stage iiib breast cancer
535536|NCT00343434|stage IIIC breast cancer|stage iiic breast cancer
535537|NCT00343434|obesity|obesity
535538|NCT00343447|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
535539|NCT00343447|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
535540|NCT00343447|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
535541|NCT00343447|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
535542|NCT00343460|nausea and vomiting|nausea and vomiting
535543|NCT00343460|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
535544|NCT00343473|Fuch's dystrophy|fuch's dystrophy
535545|NCT00343473|corneal disorders|corneal disorders
535546|NCT00343473|cornea|cornea
535547|NCT00343473|lasik|lasik
535548|NCT00343473|refractive surgery|refractive surgery
535549|NCT00343486|Overactive Bladder|overactive bladder
535550|NCT00343499|atrial fibrillation|atrial fibrillation
535551|NCT00343499|valsartan|valsartan
535552|NCT00343499|sinus rhythm|sinus rhythm
535553|NCT00343499|persistent atrial fibrillation undergoing electrical cardioversion to restore normal sinus rhythm|persistent atrial fibrillation undergoing electrical cardioversion to restore normal sinus rhythm
535554|NCT00343512|inflammatory breast cancer|inflammatory breast cancer
535555|NCT00343512|stage II breast cancer|stage ii breast cancer
535556|NCT00343512|stage IIIA breast cancer|stage iiia breast cancer
535557|NCT00343512|stage IIIB breast cancer|stage iiib breast cancer
535558|NCT00343512|stage IIIC breast cancer|stage iiic breast cancer
535560|NCT00343525|monoclonal antibody|monoclonal antibody
535561|NCT00343525|phase 1|phase 1
535515|NCT00343395|hs-CRP|hs-crp
535562|NCT00343551|Hypertension, ambulatory blood pressure, missed dose, aliskiren|hypertension, ambulatory blood pressure, missed dose, aliskiren
535563|NCT00343577|proteinuria|proteinuria
535564|NCT00343577|ARBs|arbs
535565|NCT00343577|agalsidase-beta|agalsidase-beta
535566|NCT00343577|MDRD estimated GFR|mdrd estimated gfr
535567|NCT00343577|Chronic kidney disease|chronic kidney disease
535568|NCT00343603|maculopathy|maculopathy
535569|NCT00343616|cognitive/functional effects|cognitive/functional effects
535570|NCT00343616|fatigue|fatigue
535571|NCT00343616|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
535572|NCT00343616|stage I breast cancer|stage i breast cancer
535573|NCT00343616|stage II breast cancer|stage ii breast cancer
535574|NCT00343616|stage IIIA breast cancer|stage iiia breast cancer
535575|NCT00343629|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
535576|NCT00343642|Crohn's disease|crohn's disease
535577|NCT00343642|Fructooligosaccharide|fructooligosaccharide
535578|NCT00343642|Inulin|inulin
535579|NCT00343642|Diet|diet
535580|NCT00343642|Treatment|treatment
535581|NCT00343642|Bacterial flora|bacterial flora
535582|NCT00343642|Oxidative stress|oxidative stress
535583|NCT00343655|Hypercholesterolemia|hypercholesterolemia
535584|NCT00343668|advanced gastric cancer|advanced gastric cancer
535585|NCT00343668|First-line therapy|first-line therapy
535586|NCT00343668|S-1|s-1
535587|NCT00343668|irinotecan|irinotecan
535588|NCT00343681|Influenza|influenza
535589|NCT00343681|Orthomyxoviridae Infections|orthomyxoviridae infections
535590|NCT00343681|Orthomyxoviruses|orthomyxoviruses
535591|NCT00343681|Split-virion influenza vaccine|split-virion influenza vaccine
535592|NCT00343707|Social Anxiety Disorder|social anxiety disorder
535593|NCT00343707|brain imaging|brain imaging
535594|NCT00343707|Positron Emission Tomography|positron emission tomography
535595|NCT00343707|antidepressant|antidepressant
535596|NCT00343720|VELCADE|velcade
535597|NCT00343720|Alimta|alimta
535598|NCT00343720|locally advanced|locally advanced
535599|NCT00343720|metastatic|metastatic
535600|NCT00343720|non-small cell lung cancer|non-small cell lung cancer
535601|NCT00343720|complete response|complete response
535602|NCT00343720|partial response|partial response
535603|NCT00343720|Locally Advanced or Metastatic Non-Small Cell Lung Cancer|locally advanced or metastatic non-small cell lung cancer
535604|NCT00343733|diabetic peripheral neuropathy|diabetic peripheral neuropathy
535605|NCT00343733|postherpetic neuralgia|postherpetic neuralgia
535606|NCT00343733|traumatic injury|traumatic injury
535607|NCT00343733|complex regional pain syndrome|complex regional pain syndrome
535608|NCT00343733|back pain|back pain
535609|NCT00343733|neck pain|neck pain
535610|NCT00343733|fibromyalgia|fibromyalgia
535611|NCT00343733|chronic pancreatitis|chronic pancreatitis
535612|NCT00343733|osteoarthritis|osteoarthritis
535613|NCT00343746|macular degeneration|macular degeneration
535614|NCT00343746|glaucoma|glaucoma
535615|NCT00343746|diabetic retinopathy|diabetic retinopathy
535616|NCT00343746|retinopathy, eye diseases|retinopathy, eye diseases
534948|NCT00341536|Diet|diet
535617|NCT00343759|Breast cancer|breast cancer
535618|NCT00343759|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
535619|NCT00343759|Lapatinib|lapatinib
535620|NCT00343759|Biologic response modifiers|biologic response modifiers
535621|NCT00343759|Magnetic resonance imaging|magnetic resonance imaging
535622|NCT00343759|Treatment-naive, operable|treatment-naive, operable
535623|NCT00343811|Attention-Deficit/Hyper Activity Disorder|attention-deficit/hyper activity disorder
535624|NCT00343811|ADHD|adhd
535625|NCT00343824|Burn wounds - Silver Dressings - Bacterial Control|burn wounds - silver dressings - bacterial control
535626|NCT00343850|idiopathic chronic inflammatory disease of large intestine|idiopathic chronic inflammatory disease of large intestine
535627|NCT00343850|ulcerative colitis|ulcerative colitis
535628|NCT00343850|inactive ulcerative colitis|inactive ulcerative colitis
535629|NCT00343850|chronic disease of large intestine|chronic disease of large intestine
535630|NCT00343850|medication adherence|medication adherence
535631|NCT00343850|Asacol|asacol
535632|NCT00343850|mesalamine|mesalamine
535633|NCT00343876|hs-CRP|hs-crp
535634|NCT00343876|aspirin|aspirin
535635|NCT00343876|clopidogrel|clopidogrel
535636|NCT00343889|Diphtheria|diphtheria
535637|NCT00343889|Tetanus|tetanus
535638|NCT00343889|Pertussis|pertussis
535639|NCT00343889|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
535640|NCT00343889|Haemophilus influenzae type b|haemophilus influenzae type b
535641|NCT00343889|Haemophilus Influenzae|haemophilus influenzae
535642|NCT00343902|Hawthorn|hawthorn
535643|NCT00343902|Crataegus|crataegus
535644|NCT00343902|Herbs|herbs
535645|NCT00343915|Persistence|persistence
535646|NCT00343915|Hepatitis B vaccine|hepatitis b vaccine
535647|NCT00343941|HIV-1 infection|hiv-1 infection
535648|NCT00343941|Tucaresol|tucaresol
535649|NCT00343941|Viral suppression|viral suppression
535650|NCT00343954|sickle cell disease|sickle cell disease
535651|NCT00343993|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
535652|NCT00343993|acute lung injury|acute lung injury
535653|NCT00343993|acute respiratory distress syndrome|acute respiratory distress syndrome
15849|NCT03189680|quality of life|quality of life
535654|NCT00344006|Malaria CDA COARTEM Africa pediatrics children|malaria cda coartem africa pediatrics children
535655|NCT00344019|Acute coronary syndrome|acute coronary syndrome
535656|NCT00344019|Percutaneous coronary intervention|percutaneous coronary intervention
535657|NCT00344019|Peri-procedure myocardial infarction|peri-procedure myocardial infarction
535658|NCT00344032|Double-blind|double-blind
535659|NCT00344032|Human Papillomavirus|human papillomavirus
535660|NCT00344032|Phase IIIb|phase iiib
535661|NCT00344032|Controlled|controlled
535662|NCT00344032|Randomized|randomized
535663|NCT00344032|India|india
535664|NCT00344045|Subjects with postoperative pain after Total Hip Arthroplasty|subjects with postoperative pain after total hip arthroplasty
535665|NCT00344058|pregnancy|pregnancy
535666|NCT00344058|preeclampsia|preeclampsia
535667|NCT00344058|treatment|treatment
535668|NCT00344071|Clinical|clinical
535669|NCT00344071|Tissue|tissue
535670|NCT00344071|Photographs|photographs
535671|NCT00344071|Women|women
535672|NCT00344071|Case-Control|case-control
535673|NCT00344084|Leishmania Major|leishmania major
535674|NCT00344084|Phlebotomus Duboscqi|phlebotomus duboscqi
535675|NCT00344084|Dermatology|dermatology
535676|NCT00344084|Vector-Transmitted Disease|vector-transmitted disease
535677|NCT00344084|Africa|africa
535678|NCT00344084|Cutaneous Leishmaniasis|cutaneous leishmaniasis
535679|NCT00344084|CL|cl
535680|NCT00344097|soy protein|soy protein
535681|NCT00344097|pain|pain
535682|NCT00344097|thoracotomy|thoracotomy
535683|NCT00344110|Hypertension, aliskiren, blood pressure, renin|hypertension, aliskiren, blood pressure, renin
535684|NCT00344123|HIV|hiv
535685|NCT00344136|Blood Pressure, High|blood pressure, high
535686|NCT00344136|Stroke|stroke
535687|NCT00344136|Hypertension|hypertension
535688|NCT00344136|Diabetes Mellitus|diabetes mellitus
535689|NCT00344136|Obesity|obesity
535690|NCT00344136|Cerebrovascular Accident|cerebrovascular accident
535691|NCT00344136|Atherosclerosis|atherosclerosis
535692|NCT00344149|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
535693|NCT00344149|Rituximab|rituximab
535694|NCT00344149|Splenectomy|splenectomy
535696|NCT00344149|Treatment|treatment
535697|NCT00344149|treatment of Idiopathic Thrombocytopenic Purpura|treatment of idiopathic thrombocytopenic purpura
535698|NCT00344162|Epidemiology|epidemiology
535699|NCT00344162|Population|population
535700|NCT00344162|Pregnancy|pregnancy
535701|NCT00344162|Preeclampsia|preeclampsia
535702|NCT00344175|hypercholesterolemia|hypercholesterolemia
535703|NCT00344175|dyslipidemia|dyslipidemia
535704|NCT00344175|CHD|chd
535705|NCT00344175|pitavastatin|pitavastatin
535706|NCT00344175|simvastatin|simvastatin
535707|NCT00344175|2 or more risk factors for coronary heart disease|2 or more risk factors for coronary heart disease
535708|NCT00344175|combined dyslipidemia|combined dyslipidemia
535709|NCT00344188|Cutaneous|cutaneous
535710|NCT00344188|Visceral|visceral
535711|NCT00344188|PCR|pcr
535712|NCT00344188|Mucocutaneous|mucocutaneous
535713|NCT00344188|Biopsy|biopsy
535714|NCT00344188|Leishmanial Infection|leishmanial infection
535715|NCT00344188|Leishmaniasis|leishmaniasis
535716|NCT00344201|Pterygium|pterygium
535717|NCT00344201|Fibrin adhesive|fibrin adhesive
535718|NCT00344201|Conjunctival graft|conjunctival graft
535719|NCT00344201|Ocular surface reconstruction|ocular surface reconstruction
535722|NCT00344214|Methamphetamine|methamphetamine
535723|NCT00344227|neovascularization|neovascularization
535724|NCT00344227|age-related macular degeneration|age-related macular degeneration
535725|NCT00344227|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
535726|NCT00344227|antigen-binding fragment (Fab)|antigen-binding fragment (fab)
535727|NCT00344227|antiangiogenesis|antiangiogenesis
535728|NCT00344227|optical coherence tomography (OCT)|optical coherence tomography (oct)
535729|NCT00333385|Ceftazidime|ceftazidime
535730|NCT00333385|Continuous infusion|continuous infusion
535731|NCT00333385|Antibiotic course|antibiotic course
535732|NCT00333398|CSL Influenza Vaccine, influenza, vaccine, immunogenicity|csl influenza vaccine, influenza, vaccine, immunogenicity
535733|NCT00333424|HIV|hiv
535734|NCT00333424|Human Immunodeficiency Virus|human immunodeficiency virus
535735|NCT00333424|Prophylactic vaccine|prophylactic vaccine
535736|NCT00333437|Scleroderma, Systemic|scleroderma, systemic
535737|NCT00333489|valsartan|valsartan
535738|NCT00333489|amlodipine|amlodipine
535739|NCT00333489|hypertension|hypertension
535740|NCT00333502|Cancer, Neoplasms, Solid Tumor, Ovarian Cancer, Lung Cancer,|cancer, neoplasms, solid tumor, ovarian cancer, lung cancer,
535741|NCT00333502|Non Small Cell Lung Cancer, Pancreatic Cancer,|non small cell lung cancer, pancreatic cancer,
535742|NCT00333502|Breast Cancer, Colon Cancer, Endometrial Cancer,|breast cancer, colon cancer, endometrial cancer,
535743|NCT00333502|Kidney (Renal Cell) Cancer, Melanoma, Prostate Cancer,|kidney (renal cell) cancer, melanoma, prostate cancer,
535744|NCT00333502|Skin Cancer, Thyroid Cancer,|skin cancer, thyroid cancer,
535745|NCT00333502|Solid Malignancies|solid malignancies
535746|NCT00333515|Chemical nerve agent intoxication|chemical nerve agent intoxication
535747|NCT00333528|Chemical Nerve Agent Intoxication|chemical nerve agent intoxication
535748|NCT00333528|Chemical Warfare Agents|chemical warfare agents
535749|NCT00333528|Chemical Terrorism|chemical terrorism
535750|NCT00333541|Contraceptive behavior|contraceptive behavior
535751|NCT00333541|Internet Use|internet use
535752|NCT00333541|Adolescent pregnancy|adolescent pregnancy
535753|NCT00333541|Unintended pregnancy|unintended pregnancy
535755|NCT00333554|docosahexaenoic acid|docosahexaenoic acid
535756|NCT00333554|omega-3 fatty acid|omega-3 fatty acid
535757|NCT00333554|fish oil|fish oil
535758|NCT00333554|pregnancy|pregnancy
535759|NCT00333554|infancy|infancy
535760|NCT00333554|prevention|prevention
535761|NCT00333554|"at risk for developing type 1 diabetes"|"at risk for developing type 1 diabetes"
535762|NCT00333554|juvenile diabetes|juvenile diabetes
535763|NCT00333554|T1D|t1d
535764|NCT00333554|diabetes mellitus|diabetes mellitus
535765|NCT00333554|Type 1 diabetes TrialNet|type 1 diabetes trialnet
535766|NCT00333554|TrialNet|trialnet
535767|NCT00333554|dietary supplementation|dietary supplementation
535768|NCT00333554|nutrition|nutrition
535769|NCT00333567|arthroscopic knee surgery|arthroscopic knee surgery
535770|NCT00333567|cyclooxygenase-2 inhibitors|cyclooxygenase-2 inhibitors
535771|NCT00333567|lumiracoxib|lumiracoxib
535772|NCT00333567|COX189|cox189
535773|NCT00333567|Ambulatory arthroscopic knee surgery|ambulatory arthroscopic knee surgery
535774|NCT00333580|Ethnography|ethnography
535775|NCT00333580|Psychometrics|psychometrics
535776|NCT00333580|Qualitative Research|qualitative research
535777|NCT00333593|Dialysis|dialysis
535778|NCT00333593|Large pore dialyser|large pore dialyser
535779|NCT00333593|Cytokines|cytokines
535780|NCT00333593|Noradrenaline|noradrenaline
535781|NCT00333619|sleep disorders|sleep disorders
535782|NCT00333619|rehabilitation|rehabilitation
535783|NCT00333619|rehabilitation outcomes|rehabilitation outcomes
535784|NCT00333632|Sleep|sleep
535785|NCT00333632|Dexmedetomidine|dexmedetomidine
535786|NCT00333632|Postoperative care|postoperative care
535787|NCT00333632|Sedation|sedation
535788|NCT00333645|Liver transplantation|liver transplantation
535789|NCT00333645|Invasive fungal infection|invasive fungal infection
535790|NCT00333645|Invasive aspergillosis|invasive aspergillosis
535791|NCT00333645|Prophylaxis|prophylaxis
535792|NCT00333645|Caspofungin|caspofungin
535793|NCT00333658|psychotherapy, group|psychotherapy, group
535794|NCT00333658|rehabilitation, vocational|rehabilitation, vocational
535795|NCT00333658|treatment outcome|treatment outcome
535796|NCT00333671|Macular oedema|macular oedema
535797|NCT00333671|Diabetes|diabetes
535798|NCT00333671|Pathogenesis|pathogenesis
535799|NCT00333671|Osmolality|osmolality
535800|NCT00333671|Retinal thickness|retinal thickness
535801|NCT00333697|Deep vein thrombosis|deep vein thrombosis
535802|NCT00333697|Duplex ultrasound|duplex ultrasound
535803|NCT00333697|Pulmonary embolism|pulmonary embolism
535804|NCT00333710|Rehabilitation|rehabilitation
535805|NCT00333710|Telecommunication|telecommunication
535806|NCT00333723|Rosiglitazone|rosiglitazone
535807|NCT00333723|Glyburide|glyburide
535808|NCT00333723|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
535809|NCT00333723|African American|african american
535810|NCT00333723|Hispanic|hispanic
535811|NCT00333736|Injection site reactions|injection site reactions
535812|NCT00333736|enfuvirtide administration|enfuvirtide administration
535813|NCT00333749|children|children
535814|NCT00333762|aging|aging
535815|NCT00333762|blindness|blindness
535817|NCT00333762|spinal cord injury|spinal cord injury
535818|NCT00333788|Crohn's Disease|crohn's disease
535819|NCT00333788|Certolizumab pegol|certolizumab pegol
535820|NCT00333788|CDP870|cdp870
535821|NCT00333788|Cimzia|cimzia
535822|NCT00333801|Posttraumatic Stress Disorder|posttraumatic stress disorder
535823|NCT00333801|Veterans|veterans
535824|NCT00333801|Vocational Rehabilitation|vocational rehabilitation
535825|NCT00333801|Supported Employment|supported employment
535826|NCT00333801|Individual Placement and Support|individual placement and support
535827|NCT00333827|Dilated Cardiomyopathy|dilated cardiomyopathy
535828|NCT00333827|stem cells|stem cells
535829|NCT00333827|Therapeutics|therapeutics
535830|NCT00333827|Randomized Controlled Trials|randomized controlled trials
535831|NCT00333840|CML|cml
535832|NCT00333840|STI571|sti571
535833|NCT00333840|imatinib|imatinib
535834|NCT00333840|interferon|interferon
535835|NCT00333840|interferon alpha|interferon alpha
535836|NCT00333840|cytosine arabinoside|cytosine arabinoside
535837|NCT00333840|chronic myeloid leukemia|chronic myeloid leukemia
535838|NCT00333840|Philadelphia chromosome positive|philadelphia chromosome positive
535839|NCT00333879|Rehabilitation|rehabilitation
535840|NCT00333879|Sensory Aid|sensory aid
535841|NCT00333892|primary HIV infection|primary hiv infection
535842|NCT00333892|chronic HIV infection|chronic hiv infection
535843|NCT00333905|Exercise|exercise
535844|NCT00333905|Exercise Therapy|exercise therapy
535845|NCT00333918|Cataract Extraction|cataract extraction
535846|NCT00333918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
535847|NCT00333931|Impulsive Aggression|impulsive aggression
535848|NCT00333931|Posttraumatic Stress Disorder|posttraumatic stress disorder
535849|NCT00333944|Organophosphorus poisoning|organophosphorus poisoning
535850|NCT00333944|Atropine|atropine
535851|NCT00333944|Pralidoxime|pralidoxime
535852|NCT00333944|Intermediate syndrome.|intermediate syndrome.
535853|NCT00333957|capsule endoscopy|capsule endoscopy
535854|NCT00333970|cognition|cognition
535855|NCT00333970|neuropsychology|neuropsychology
535856|NCT00333970|Rehabilitation|rehabilitation
535857|NCT00333970|treatment efficacy|treatment efficacy
535858|NCT00333970|cognitive remediation|cognitive remediation
535859|NCT00334009|Cardiac Surgery|cardiac surgery
535860|NCT00334009|Cardiopulmonary Bypass|cardiopulmonary bypass
535861|NCT00334009|COMT-Polymorphism|comt-polymorphism
535862|NCT00334009|Vasoplegia|vasoplegia
535863|NCT00334009|Catecholamines|catecholamines
535864|NCT00334009|Acute Renal Failure|acute renal failure
535865|NCT00334022|Fuzeon|fuzeon
535866|NCT00334022|Viral Decay|viral decay
535867|NCT00334048|Medication-induced sexual dysfunction|medication-induced sexual dysfunction
535868|NCT00334048|SSRI-induced sexual dysfunction|ssri-induced sexual dysfunction
535869|NCT00334048|Anorgasmia|anorgasmia
535870|NCT00334048|Delayed ejaculation|delayed ejaculation
535871|NCT00334048|Sexual dysfunction|sexual dysfunction
535872|NCT00334048|Antidepressant-induced sexual dysfunction|antidepressant-induced sexual dysfunction
535873|NCT00334048|Requip|requip
535874|NCT00334048|Ropinirole|ropinirole
535875|NCT00334048|Dopamine agonist|dopamine agonist
535876|NCT00334048|Serotonin reuptake inhibitor|serotonin reuptake inhibitor
535877|NCT00334048|Sexual dysfunction, physiological, medication-induced|sexual dysfunction, physiological, medication-induced
535878|NCT00344240|type 2 diabetes|type 2 diabetes
535879|NCT00344240|exercise|exercise
535880|NCT00344240|activity guidance|activity guidance
535881|NCT00344240|health education|health education
535882|NCT00344253|Uveitis|uveitis
535883|NCT00344253|Macular Edema|macular edema
535884|NCT00344253|Interferon|interferon
535885|NCT00344253|Multiple Sclerosis|multiple sclerosis
535886|NCT00344253|Encephalomyelitis disseminata (ED)|encephalomyelitis disseminata (ed)
535887|NCT00344266|Obesity|obesity
535888|NCT00344266|Adipose Tissue|adipose tissue
535889|NCT00344266|Microarrays|microarrays
535890|NCT00344266|Cytokines|cytokines
535891|NCT00344266|Eicosanoids|eicosanoids
535892|NCT00344266|Gene Expression|gene expression
535893|NCT00344266|Adipokines|adipokines
535894|NCT00344266|Inflammation|inflammation
535895|NCT00344266|Weight Loss|weight loss
535896|NCT00344266|Lipid Products|lipid products
535897|NCT00344279|Coinfection|coinfection
535898|NCT00344279|AIDS|aids
535899|NCT00344279|Lymphatic Filariasis|lymphatic filariasis
535900|NCT00344279|Diethylcarbamazine (DEC)|diethylcarbamazine (dec)
535901|NCT00344279|Albendazole|albendazole
535276|NCT00342498|DNA|dna
535902|NCT00344292|Polymorphism, Genetic|polymorphism, genetic
535903|NCT00344292|Coronary Artery Disease|coronary artery disease
535904|NCT00344292|Coronary Arteriosclerosis|coronary arteriosclerosis
535905|NCT00344292|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
535906|NCT00344292|SNPs|snps
535907|NCT00344305|children, FluMist, shedding,|children, flumist, shedding,
535908|NCT00344318|Immunogenicity|immunogenicity
535909|NCT00344318|Safety|safety
535910|NCT00344318|Pneumococcal vaccine|pneumococcal vaccine
535911|NCT00344318|Pneumococcal disease|pneumococcal disease
535912|NCT00344331|Lysosomal Storage|lysosomal storage
535913|NCT00344331|Biomarkers|biomarkers
535914|NCT00344331|Longitudinal|longitudinal
535915|NCT00344331|Niemann Pick Type C|niemann pick type c
535917|NCT00344331|Lysosomal Storage Disorder|lysosomal storage disorder
535918|NCT00344344|Asthma|asthma
535919|NCT00344344|Cockroach|cockroach
535920|NCT00344344|Dust Mite|dust mite
535921|NCT00344344|Extermination|extermination
535922|NCT00344344|Targeted Cleaning|targeted cleaning
535923|NCT00344344|Allergy|allergy
535924|NCT00344344|Prevention|prevention
535925|NCT00344370|Pitavastatin|pitavastatin
535926|NCT00344370|Type II Diabetes Mellitus|type ii diabetes mellitus
535927|NCT00344370|Combined Dyslipidemia|combined dyslipidemia
535928|NCT00344383|oral contraceptive|oral contraceptive
535929|NCT00344383|breakthrough bleeding|breakthrough bleeding
535930|NCT00344383|spotting|spotting
535931|NCT00344409|darbepoetin alfa|darbepoetin alfa
535932|NCT00344409|anemia|anemia
535933|NCT00344409|cancer patients|cancer patients
535934|NCT00344409|platinum containing chemotherapy|platinum containing chemotherapy
535935|NCT00344422|Anthracyclines|anthracyclines
535936|NCT00344422|Liposomes|liposomes
535937|NCT00344422|Liposomal|liposomal
535938|NCT00344422|Vincristine|vincristine
535939|NCT00344422|Doxorubicin|doxorubicin
535940|NCT00344422|Dexamethasone|dexamethasone
535941|NCT00344422|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
535942|NCT00344422|DOXIL|doxil
535943|NCT00344422|drug resistant myeloma|drug resistant myeloma
535944|NCT00344435|Hemophilia|hemophilia
535945|NCT00344435|Antibody|antibody
535946|NCT00344435|Mutations|mutations
535947|NCT00344435|SNP|snp
535948|NCT00344435|clotting|clotting
535949|NCT00344448|Adhesion Molecule|adhesion molecule
535950|NCT00344448|Interventional Study|interventional study
535951|NCT00344448|Immunomodulation|immunomodulation
535952|NCT00344448|Autoimmunity|autoimmunity
535953|NCT00344448|Sjogren Syndrome|sjogren syndrome
535954|NCT00344448|SS|ss
535955|NCT00344474|Prevention|prevention
535956|NCT00344474|Addiction|addiction
535957|NCT00344474|Personality|personality
535958|NCT00344474|Adolescents|adolescents
535959|NCT00344474|Binge Drinking|binge drinking
535960|NCT00344474|Alcohol Abuse|alcohol abuse
535961|NCT00344474|Comorbidity|comorbidity
535962|NCT00344474|Depression|depression
535964|NCT00344474|Antisocial Behaviour|antisocial behaviour
535965|NCT00344500|Antipsychotic|antipsychotic
535966|NCT00344500|Bipolar|bipolar
535967|NCT00344500|Diabetes|diabetes
535968|NCT00344500|Mental Illness|mental illness
535969|NCT00344500|Nutrition|nutrition
535970|NCT00344500|Obesity|obesity
535971|NCT00344500|Schizoaffective|schizoaffective
535972|NCT00344500|Schizophrenia|schizophrenia
535973|NCT00344500|Weight Gain|weight gain
535974|NCT00344500|Weight Loss|weight loss
535975|NCT00344513|registry|registry
535976|NCT00344513|OPTIMIZE|optimize
535977|NCT00344513|Heart failure|heart failure
535978|NCT00344513|OPTIMIZE-HF|optimize-hf
535979|NCT00344526|AL amyloidosis|al amyloidosis
535980|NCT00344526|Autologous stem cell transplantation|autologous stem cell transplantation
535981|NCT00344526|Melphalan|melphalan
535982|NCT00344526|Dexamethasone|dexamethasone
535983|NCT00344539|asexual blood stage vaccine, Plasmodium falciparum malaria|asexual blood stage vaccine, plasmodium falciparum malaria
535984|NCT00344578|Higher Order Abberations|higher order abberations
535985|NCT00344591|HIV|hiv
535986|NCT00344591|AIDS|aids
535987|NCT00345631|Closure Device|closure device
535988|NCT00345631|Angiography|angiography
535989|NCT00345631|Angioplasty|angioplasty
535990|NCT00345631|Hemostasis|hemostasis
535991|NCT00345631|Heart Catheterization|heart catheterization
535992|NCT00345631|Peripheral Angiography|peripheral angiography
535993|NCT00345631|Femoral Closure|femoral closure
535994|NCT00345631|Vascular Closure|vascular closure
535995|NCT00345631|Coronary Angiography|coronary angiography
535996|NCT00345644|Postmenopausal|postmenopausal
535997|NCT00345657|Hyperlipidemia|hyperlipidemia
535998|NCT00345657|Dyslipidemia|dyslipidemia
535999|NCT00345657|Niacin|niacin
536000|NCT00345657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
536001|NCT00345657|Combination lipid therapy|combination lipid therapy
536002|NCT00345657|Lovastatin|lovastatin
536003|NCT00345670|Lower respiratory tract illness|lower respiratory tract illness
536004|NCT00345670|RSV and PIV3 infection|rsv and piv3 infection
535363|NCT00342758|Environment|environment
536005|NCT00345683|H. influenzae type B vaccine|h. influenzae type b vaccine
536006|NCT00345683|Infants|infants
536007|NCT00345683|Neisseria meningitidis|neisseria meningitidis
536008|NCT00345683|Vaccines, conjugate|vaccines, conjugate
536009|NCT00345683|Meningococcal vaccines|meningococcal vaccines
536010|NCT00345683|Prophylaxis|prophylaxis
536011|NCT00345683|Comparative study|comparative study
536012|NCT00345683|Safety|safety
536013|NCT00345683|Humans|humans
536014|NCT00345696|Capecitabine|capecitabine
536015|NCT00345696|Oxaliplatin|oxaliplatin
536016|NCT00345696|Bevacizumab|bevacizumab
536017|NCT00345696|First line|first line
536018|NCT00345709|Ovarian Cancer|ovarian cancer
536019|NCT00345709|Peritoneal Cancer|peritoneal cancer
536020|NCT00345709|Fallopian Tube Cancer|fallopian tube cancer
536021|NCT00345709|Elizabeth Registry|elizabeth registry
536022|NCT00345709|Questionnaire|questionnaire
536023|NCT00345709|Registry|registry
536024|NCT00345709|Survey|survey
536025|NCT00345722|Strawberry|strawberry
536026|NCT00345722|Almond|almond
536027|NCT00345722|Soy protein|soy protein
536028|NCT00345722|viscous dietary fibre|viscous dietary fibre
536029|NCT00345722|plant sterols|plant sterols
536030|NCT00345722|portfolio diet|portfolio diet
536031|NCT00345722|blood lipids|blood lipids
536032|NCT00345722|compliance|compliance
536033|NCT00345722|blood pressure|blood pressure
536034|NCT00345735|Cancer pain with breakthrough pain episodes|cancer pain with breakthrough pain episodes
536035|NCT00345761|Advanced and/or metastatic colorectal cancer|advanced and/or metastatic colorectal cancer
536036|NCT00345774|Pulmonary Hypertension|pulmonary hypertension
536037|NCT00345774|PH|ph
536038|NCT00345774|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
536039|NCT00345774|PAH|pah
536040|NCT00345774|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
536042|NCT00345774|PRX-08066|prx-08066
536043|NCT00345774|Predix|predix
536044|NCT00345787|Osteoarthritic Pain|osteoarthritic pain
536045|NCT00345800|Endocrine Evaluation cataplexy|endocrine evaluation cataplexy
536046|NCT00345800|sodium oxybate (xyrem)|sodium oxybate (xyrem)
536047|NCT00345813|adenocarcinoma of the prostate|adenocarcinoma of the prostate
536048|NCT00345813|stage I prostate cancer|stage i prostate cancer
536049|NCT00345813|stage IIB prostate cancer|stage iib prostate cancer
536050|NCT00345813|stage IIA prostate cancer|stage iia prostate cancer
536051|NCT00345813|stage III prostate cancer|stage iii prostate cancer
536052|NCT00345813|stage IV prostate cancer|stage iv prostate cancer
536053|NCT00345826|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
536054|NCT00345826|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
536055|NCT00345826|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
536056|NCT00345826|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
536057|NCT00345826|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
536058|NCT00345826|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
536059|NCT00345839|Cinacalcet HCl|cinacalcet hcl
536060|NCT00345839|Cinacalcet|cinacalcet
536061|NCT00345839|AMG 073|amg 073
536062|NCT00345839|Sensipar|sensipar
536063|NCT00345839|Mimpara|mimpara
536064|NCT00345839|Calcimimetic|calcimimetic
536065|NCT00345839|Hemodialysis|hemodialysis
536066|NCT00345839|CKD|ckd
536067|NCT00345839|Secondary hyperparathyroidism (HPT)|secondary hyperparathyroidism (hpt)
536068|NCT00345852|twin to twin transfusion syndrome|twin to twin transfusion syndrome
536069|NCT00345852|fetoscopic selective laser photocoagulation|fetoscopic selective laser photocoagulation
536070|NCT00345852|amnioreduction|amnioreduction
536071|NCT00345865|Hodgkin lymphoma|hodgkin lymphoma
536072|NCT00345865|non-Hodgkin lymphoma|non-hodgkin lymphoma
536073|NCT00345865|HIV-associated lymphoma|hiv-associated lymphoma
536074|NCT00345878|HPV-16/18 L1 VLP AS04|hpv-16/18 l1 vlp as04
536075|NCT00345878|Cervical neoplasia|cervical neoplasia
536076|NCT00345878|Cervical cancer|cervical cancer
536077|NCT00345878|Human Papillomavirus (HPV)|human papillomavirus (hpv)
536078|NCT00345878|Double-blind|double-blind
536079|NCT00345878|AS04|as04
536080|NCT00345891|Lung neoplasms|lung neoplasms
536081|NCT00345891|Family|family
536082|NCT00345891|Stress|stress
536083|NCT00345904|influenza, vaccine|influenza, vaccine
536084|NCT00345904|prophylaxis of influenza|prophylaxis of influenza
536085|NCT00345917|Retinitis Pigmentosa|retinitis pigmentosa
536086|NCT00345917|Retinal Transplant|retinal transplant
536087|NCT00345917|Fetal Tissue|fetal tissue
536088|NCT00345917|Early treatment diabetic retinopathy study|early treatment diabetic retinopathy study
536089|NCT00345917|20/200 or worse.|20/200 or worse.
536090|NCT00345930|Complementary and alternative medicine|complementary and alternative medicine
536091|NCT00345930|Complementary therapies|complementary therapies
536092|NCT00345930|Alternative therapies|alternative therapies
536093|NCT00345930|Prescription Drugs|prescription drugs
536094|NCT00345930|Non prescription Drugs|non prescription drugs
536095|NCT00345930|Liver Disease|liver disease
536096|NCT00345930|Chemical Ind|chemical ind
536097|NCT00345930|Phenotype|phenotype
536098|NCT00345930|Proteomics|proteomics
536099|NCT00345930|Metabolomics|metabolomics
536100|NCT00345930|Cholestatic Liver Injury|cholestatic liver injury
536101|NCT00345930|Hepatocellular Liver Injury|hepatocellular liver injury
536102|NCT00345930|Mixed Liver Injury|mixed liver injury
536103|NCT00345930|Matched Case Control Studies|matched case control studies
536104|NCT00345930|Genotype|genotype
536105|NCT00345930|Liver Dis|liver dis
536106|NCT00345930|Chem Ind|chem ind
536107|NCT00345943|Eating Disorders|eating disorders
536108|NCT00345943|Bulimia Nervosa|bulimia nervosa
536109|NCT00345943|Bulimia|bulimia
536110|NCT00345943|fMRI|fmri
536111|NCT00345943|Magnetic Resonance Imaging|magnetic resonance imaging
536112|NCT00345956|Prophylaxis against gastroenteritis caused by Rotavirus|prophylaxis against gastroenteritis caused by rotavirus
536113|NCT00345969|Testosterone Replacement Therapy|testosterone replacement therapy
536114|NCT00345969|Physical Frailty|physical frailty
536115|NCT00345969|Hip Fracture|hip fracture
536116|NCT00345982|Schizophrenia|schizophrenia
536117|NCT00345982|Treatment-resistant|treatment-resistant
536118|NCT00345982|sertindole|sertindole
536119|NCT00345982|clozapine|clozapine
536120|NCT00346008|melanoma|melanoma
536121|NCT00346008|recurrent melanoma|recurrent melanoma
536122|NCT00346008|stage I melanoma|stage i melanoma
536123|NCT00346008|stage II melanoma|stage ii melanoma
536124|NCT00346008|stage III melanoma|stage iii melanoma
536125|NCT00346008|stage IV melanoma|stage iv melanoma
536126|NCT00346021|Children's behavior towards hat use|children's behavior towards hat use
536127|NCT00346060|Dry age related macular degeneration.|dry age related macular degeneration.
536128|NCT00346060|Retinal Transplant|retinal transplant
536129|NCT00346060|Fetal Tissue|fetal tissue
536130|NCT00346060|Early treatment diabetic retinopathy study|early treatment diabetic retinopathy study
536131|NCT00346060|20/200 or worse.|20/200 or worse.
536132|NCT00346073|Prophylaxis for diphtheria, tetanus, pertussis|prophylaxis for diphtheria, tetanus, pertussis
536133|NCT00346073|Immunogenicity, booster, dTpa|immunogenicity, booster, dtpa
536134|NCT00346086|CpG oligonucleotide vaccine|cpg oligonucleotide vaccine
536135|NCT00346086|ragweed immunotherapy|ragweed immunotherapy
536136|NCT00346099|NSABP|nsabp
536137|NCT00346099|panitumumab|panitumumab
536138|NCT00346099|rectal cancer|rectal cancer
536139|NCT00346099|colorectal cancer|colorectal cancer
536140|NCT00346099|oxaliplatin|oxaliplatin
536141|NCT00346099|capecitabine|capecitabine
536142|NCT00346099|combined modality therapy|combined modality therapy
536143|NCT00346099|combined pelvic radiation therapy|combined pelvic radiation therapy
536144|NCT00346099|Rectal cancer with or without metastasis|rectal cancer with or without metastasis
536145|NCT00346112|ICD|icd
536146|NCT00346112|distress|distress
536147|NCT00346112|anxiety|anxiety
536148|NCT00346112|quality-of-life|quality-of-life
536149|NCT00346125|soft tissue sarcoma|soft tissue sarcoma
536150|NCT00346125|Malignant fibrous histiocytoma|malignant fibrous histiocytoma
536151|NCT00346125|Liposarcoma|liposarcoma
536152|NCT00346125|Fibrosarcoma|fibrosarcoma
536153|NCT00346125|Leiomyosarcoma|leiomyosarcoma
536154|NCT00346125|Synovial sarcoma|synovial sarcoma
536155|NCT00346125|Malignant peripheral nerve sheath tumor (MPNST)|malignant peripheral nerve sheath tumor (mpnst)
536156|NCT00346125|Epithelioid sarcoma|epithelioid sarcoma
536157|NCT00346151|renal transplantation|renal transplantation
536158|NCT00346151|kidney transplantation|kidney transplantation
536159|NCT00346151|renal allograft recipient|renal allograft recipient
536160|NCT00346151|anti-rejection drugs|anti-rejection drugs
536161|NCT00346151|immunosuppression protocol|immunosuppression protocol
536162|NCT00346151|immunosuppression withdrawal|immunosuppression withdrawal
536163|NCT00346177|heart|heart
536164|NCT00346177|stem Cells|stem cells
536165|NCT00346177|low EF|low ef
536166|NCT00346177|heart attack|heart attack
536167|NCT00346177|cardiomyopathy|cardiomyopathy
536168|NCT00346177|congestive heart failure|congestive heart failure
536169|NCT00346177|cardiovascular disease|cardiovascular disease
536170|NCT00346177|Heart Failure|heart failure
536171|NCT00346177|Low Ejection Fraction|low ejection fraction
536172|NCT00346229|stage III B breast cancer|stage iii b breast cancer
536173|NCT00346229|stage III C breast cancer|stage iii c breast cancer
536174|NCT00346229|stage IV breast cancer|stage iv breast cancer
536175|NCT00346229|inflammatory breast cancer|inflammatory breast cancer
536176|NCT00346229|recurrent breast cancer|recurrent breast cancer
536177|NCT00346242|thalassemia|thalassemia
536178|NCT00346242|zoledronic acid|zoledronic acid
536179|NCT00346242|skeletal events|skeletal events
536180|NCT00346255|stage I multiple myeloma|stage i multiple myeloma
536181|NCT00346255|stage II multiple myeloma|stage ii multiple myeloma
536182|NCT00346255|stage III multiple myeloma|stage iii multiple myeloma
536183|NCT00346281|unresectable pancreatic cancer|unresectable pancreatic cancer
536184|NCT00346281|brachytherapy|brachytherapy
536185|NCT00346281|32P|32p
536186|NCT00346281|BioSilicon|biosilicon
536187|NCT00346281|locally advanced|locally advanced
536188|NCT00346281|gemcitabine|gemcitabine
535559|NCT00343525|HCV|hcv
536189|NCT00346281|intratumourally|intratumourally
536190|NCT00346281|unresectable|unresectable
536191|NCT00346294|Rheumatoid Arthritis|rheumatoid arthritis
536192|NCT00346294|Device|device
536193|NCT00346294|Auto-injector|auto-injector
536194|NCT00346294|SureClick|sureclick
536195|NCT00346294|Enbrel|enbrel
536196|NCT00346294|Etanercept|etanercept
536197|NCT00346320|stage I non-small cell lung cancer|stage i non-small cell lung cancer
536198|NCT00346320|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
536199|NCT00346320|adenocarcinoma of the lung|adenocarcinoma of the lung
536200|NCT00346320|adenosquamous cell lung cancer|adenosquamous cell lung cancer
536201|NCT00346320|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
536202|NCT00346320|large cell lung cancer|large cell lung cancer
536203|NCT00346320|squamous cell lung cancer|squamous cell lung cancer
536204|NCT00346333|Retinitis Pigmentosa, Inherited Retinal Degeneration|retinitis pigmentosa, inherited retinal degeneration
536206|NCT00346346|Memory|memory
536207|NCT00346346|ELISPOT|elispot
536208|NCT00346346|Malaria|malaria
536209|NCT00346346|Prospective|prospective
536210|NCT00346359|graft versus host disease|graft versus host disease
536211|NCT00346359|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
536212|NCT00346359|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
536213|NCT00346359|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
536214|NCT00346359|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
536215|NCT00346359|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
536216|NCT00346359|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
536217|NCT00346359|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
536218|NCT00346359|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
536219|NCT00346359|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
536220|NCT00346359|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
536221|NCT00346359|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
536222|NCT00346359|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
536223|NCT00346359|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
536224|NCT00346359|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
536225|NCT00346359|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
536226|NCT00346359|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
536227|NCT00346359|secondary acute myeloid leukemia|secondary acute myeloid leukemia
536228|NCT00346359|chronic eosinophilic leukemia|chronic eosinophilic leukemia
536229|NCT00346359|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
536230|NCT00346359|chronic neutrophilic leukemia|chronic neutrophilic leukemia
536231|NCT00346359|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
536232|NCT00346359|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
536233|NCT00346359|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
536234|NCT00346359|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
536235|NCT00346359|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
536236|NCT00346359|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
536237|NCT00346372|Ocular Melanoma|ocular melanoma
536238|NCT00346372|Optical Coherence Tomography|optical coherence tomography
536239|NCT00346372|Eye Tumor|eye tumor
536240|NCT00346372|Choroidal Melanoma|choroidal melanoma
536241|NCT00346372|Uveal Melanoma|uveal melanoma
536242|NCT00346385|recurrent small cell lung cancer|recurrent small cell lung cancer
536243|NCT00346385|merkel cell carcinoma|merkel cell carcinoma
536244|NCT00346385|ovarian cancer|ovarian cancer
536245|NCT00346398|asthma|asthma
536246|NCT00346398|allergen|allergen
536247|NCT00346398|allergic disease|allergic disease
536248|NCT00346398|allergen immunotherapy|allergen immunotherapy
536249|NCT00346398|allergic sensitization|allergic sensitization
536250|NCT00346398|atopic dermatitis|atopic dermatitis
536251|NCT00346398|eczema|eczema
536252|NCT00346398|food allergy|food allergy
536253|NCT00346398|oral mucosal immunoprophylaxis (OMIP)|oral mucosal immunoprophylaxis (omip)
536254|NCT00346411|rheumatoid arthritis|rheumatoid arthritis
536255|NCT00346411|mood|mood
536256|NCT00346411|adherence|adherence
536257|NCT00346411|medication|medication
536258|NCT00346424|occluded central catheter|occluded central catheter
536259|NCT00346424|central venous access devices dysfunction|central venous access devices dysfunction
536260|NCT00346424|withdrawal occlusion|withdrawal occlusion
536261|NCT00346424|Thrombosis|thrombosis
536262|NCT00346424|Venous thrombosis|venous thrombosis
536263|NCT00346437|angina|angina
536264|NCT00346437|FGF-4|fgf-4
536265|NCT00346437|angiogenesis|angiogenesis
536266|NCT00346437|adenovector|adenovector
536267|NCT00346437|growth factor|growth factor
536268|NCT00346437|myocardial ischemia|myocardial ischemia
536269|NCT00346437|revascularization|revascularization
536270|NCT00346450|Culture|culture
536271|NCT00346450|Conjunctiva|conjunctiva
536272|NCT00346450|transplantation|transplantation
536273|NCT00346450|pterygium|pterygium
536274|NCT00346450|ocular surface|ocular surface
536275|NCT00346463|Allopurinol|allopurinol
536276|NCT00346463|Fetal Growth Retardation|fetal growth retardation
536277|NCT00346463|Oxidative Stress|oxidative stress
536278|NCT00346463|Placental Insufficiency|placental insufficiency
536279|NCT00346476|TB|tb
536280|NCT00346476|Transmission|transmission
536281|NCT00346476|Genetic Diversity|genetic diversity
536282|NCT00346476|Genetic Testing|genetic testing
536283|NCT00346476|RFLP|rflp
536284|NCT00346489|Trabeculectomy|trabeculectomy
536285|NCT00346489|5-fluorouracil|5-fluorouracil
536286|NCT00346489|Mitomycin C|mitomycin c
536287|NCT00346515|carotid artery|carotid artery
536288|NCT00346515|carotid stenosis|carotid stenosis
536289|NCT00346515|carotid stenting|carotid stenting
536290|NCT00346515|embolic protection|embolic protection
536291|NCT00346541|glaucoma|glaucoma
536397|NCT00346996|diabetes|diabetes
536292|NCT00346541|polymorphism, genetic|polymorphism, genetic
536293|NCT00346554|COPD|copd
536294|NCT00346554|Sleep disorders|sleep disorders
536295|NCT00346554|pulmonary rehabilitation|pulmonary rehabilitation
536296|NCT00346567|mother-to-child-transmission|mother-to-child-transmission
536297|NCT00346567|PMTCT|pmtct
536298|NCT00346567|HIV|hiv
536299|NCT00346567|resistance|resistance
536300|NCT00346567|NNRTI|nnrti
536301|NCT00346606|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
536302|NCT00346606|Desloratadine|desloratadine
536303|NCT00346606|Denosin|denosin
536304|NCT00346606|Levocetirizine|levocetirizine
536305|NCT00346632|AML|aml
536306|NCT00346632|ALL|all
536307|NCT00346632|MDS|mds
536308|NCT00346632|CML|cml
536309|NCT00346632|Kinase Inhibitor|kinase inhibitor
536310|NCT00346645|NON-SMALL CELL LUNG CANCER METASTATIC|non-small cell lung cancer metastatic
536311|NCT00346658|Osteoporosis|osteoporosis
536312|NCT00346658|bone density|bone density
536313|NCT00346658|magnesium|magnesium
536314|NCT00346658|vitamin D|vitamin d
536315|NCT00346671|Reiki|reiki
536316|NCT00346671|Stress|stress
536317|NCT00346671|CAM|cam
536318|NCT00346684|Lymphoma|lymphoma
536319|NCT00346684|LPHD|lphd
536320|NCT00346684|Rituximab|rituximab
536321|NCT00346697|AIDS|aids
536323|NCT00346697|HAART|haart
536324|NCT00346697|Lipids|lipids
536325|NCT00346697|Triglycerides|triglycerides
536326|NCT00346697|Cholesterol|cholesterol
536327|NCT00346697|omega-3 fatty acids|omega-3 fatty acids
536328|NCT00346697|bone turnover|bone turnover
536329|NCT00346697|inflammation|inflammation
536330|NCT00346697|insulin resistance|insulin resistance
536331|NCT00346710|communication|communication
536332|NCT00346710|patient experience|patient experience
536333|NCT00346710|fellowship training|fellowship training
536334|NCT00346723|Influenza, Vaccine, CHMP criteria|influenza, vaccine, chmp criteria
536335|NCT00346736|Alternative medicine|alternative medicine
536336|NCT00346736|Traditional Chinese medicine|traditional chinese medicine
536337|NCT00346736|Acupuncture|acupuncture
536338|NCT00346736|Autistic Spectrum Disorder|autistic spectrum disorder
536339|NCT00346736|Autism|autism
536340|NCT00346736|Children|children
536341|NCT00346749|Inflammation|inflammation
536342|NCT00346749|FEV1|fev1
536343|NCT00346749|Sputum|sputum
536344|NCT00346762|Former Plasma Donors|former plasma donors
536345|NCT00346762|Commercial Plasma Donors|commercial plasma donors
536346|NCT00346762|Long-Term Nonprogressors|long-term nonprogressors
536347|NCT00346762|Host Factors|host factors
536348|NCT00346762|Viral Factors|viral factors
536349|NCT00346762|HIV|hiv
536350|NCT00346775|questionnaire|questionnaire
536351|NCT00346775|nasal spray|nasal spray
536352|NCT00346775|Seasonal allergic rhinitis|seasonal allergic rhinitis
536353|NCT00346775|nasal spray questionnaire|nasal spray questionnaire
536354|NCT00346775|allergic rhinitis|allergic rhinitis
536355|NCT00346801|Non-Small Cell Lung Cancer|non-small cell lung cancer
536356|NCT00346801|Lung Cancer|lung cancer
536357|NCT00346801|Celecoxib|celecoxib
536358|NCT00346801|Cisplatin|cisplatin
536359|NCT00346801|Platinol|platinol
536360|NCT00346801|CPT-11|cpt-11
536361|NCT00346801|Irinotecan|irinotecan
536362|NCT00346801|SC-58635|sc-58635
536363|NCT00346801|Celebrex|celebrex
536364|NCT00346801|Radiation Therapy|radiation therapy
536365|NCT00346814|Retinopathy of prematurity|retinopathy of prematurity
536366|NCT00346814|antiangiogenic therapy|antiangiogenic therapy
536367|NCT00346840|Labor induction|labor induction
536368|NCT00346840|cervical ripening|cervical ripening
536369|NCT00346840|misoprostol|misoprostol
536370|NCT00346840|vaginal insert|vaginal insert
536371|NCT00346853|Dark adaptation inhibition|dark adaptation inhibition
536372|NCT00346853|Stargardt macular dystrophy|stargardt macular dystrophy
536373|NCT00346853|4-Methylpyrazole (4-MP)|4-methylpyrazole (4-mp)
536374|NCT00346853|Antizol|antizol
536375|NCT00346853|Fomepizole|fomepizole
535754|NCT00333554|DHA|dha
536376|NCT00346879|fondaparinux for prevention of blood clots|fondaparinux for prevention of blood clots
536377|NCT00346892|Prophylaxis rotavirus|prophylaxis rotavirus
536378|NCT00346905|GERD|gerd
536379|NCT00346905|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
536380|NCT00346905|Reflux|reflux
536381|NCT00346905|Enteryx|enteryx
536382|NCT00346918|ADPKD|adpkd
536383|NCT00346918|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
536384|NCT00346918|Sirolimus|sirolimus
536385|NCT00346918|volumetry|volumetry
536386|NCT00346931|glaucoma|glaucoma
536387|NCT00346931|cataract|cataract
536388|NCT00346931|surgery|surgery
536389|NCT00346931|intraocular pressure|intraocular pressure
536390|NCT00346931|phacoemulsification|phacoemulsification
536391|NCT00346931|trabeculotomy|trabeculotomy
536392|NCT00346970|Metabolic Syndrome|metabolic syndrome
536393|NCT00346970|High Density Lipoprotein|high density lipoprotein
536394|NCT00346970|Extended-Release Niacin|extended-release niacin
536395|NCT00346970|Endothelial Function|endothelial function
536396|NCT00346970|Endothelial Progenitor Cells|endothelial progenitor cells
536398|NCT00346996|insulin|insulin
536399|NCT00346996|insulin analogues|insulin analogues
536400|NCT00346996|hypoglycaemia|hypoglycaemia
536401|NCT00346996|severe hypoglycaemia|severe hypoglycaemia
536402|NCT00347009|Cirrhosis|cirrhosis
536403|NCT00347009|Advanced Fibrosis|advanced fibrosis
536404|NCT00347009|Chronic Hepatitis B|chronic hepatitis b
536405|NCT00347009|Adefovir Dipivoxil|adefovir dipivoxil
536406|NCT00347022|Multislice computed tomography (MSCT)indications|multislice computed tomography (msct)indications
536407|NCT00347048|Ulcerative colitis|ulcerative colitis
536408|NCT00347048|tacrolimus|tacrolimus
536409|NCT00347048|FK506|fk506
536410|NCT00347048|treatment outcome|treatment outcome
536411|NCT00347061|Benign Prostatic Hyperplasiam|benign prostatic hyperplasiam
536412|NCT00347061|Adrenergic alpha-antagonist|adrenergic alpha-antagonist
536413|NCT00347074|Keratoconus, corneal topography, ocular aberrometry, visual outcome, contact lens wear, quality of life|keratoconus, corneal topography, ocular aberrometry, visual outcome, contact lens wear, quality of life
536414|NCT00347087|Insulin sensitivity|insulin sensitivity
536415|NCT00347087|chronic heart failure|chronic heart failure
536416|NCT00347087|metabolism|metabolism
536417|NCT00347113|P. falciparum|p. falciparum
536418|NCT00347113|malaria|malaria
536419|NCT00347113|schistosome infections|schistosome infections
536420|NCT00347113|soil-transmitted helminths infection|soil-transmitted helminths infection
536421|NCT00347113|anaemia|anaemia
536422|NCT00347113|immune response|immune response
536423|NCT00347113|Tanzania|tanzania
536424|NCT00347126|Glaucoma|glaucoma
536425|NCT00347126|Latanoprost|latanoprost
536426|NCT00347126|Travoprost|travoprost
536427|NCT00347126|Intraocular pressure|intraocular pressure
536428|NCT00347126|Hyperemia|hyperemia
536429|NCT00347139|Tolerability|tolerability
536430|NCT00347139|Pharmacodynamics|pharmacodynamics
536431|NCT00347139|Safety|safety
536432|NCT00347139|Pharmacokinetics|pharmacokinetics
536433|NCT00347139|GW642444|gw642444
536434|NCT00347139|Asthmatic patients|asthmatic patients
536435|NCT00347139|Efficacy|efficacy
536436|NCT00347152|Intellectual disabilities|intellectual disabilities
536437|NCT00347152|development disabilities|development disabilities
536438|NCT00347152|behavior disorders|behavior disorders
536439|NCT00347152|stable epilepsy|stable epilepsy
536440|NCT00347165|macular degeneration|macular degeneration
536441|NCT00347165|angiogenesis|angiogenesis
536442|NCT00347165|antibodies|antibodies
536443|NCT00347178|Asymptomatic Narrow Angles|asymptomatic narrow angles
536444|NCT00347178|Primary Angle Closure Suspects|primary angle closure suspects
536445|NCT00347178|Laser Peripheral Iridotomy|laser peripheral iridotomy
536446|NCT00347178|Randomised Controlled Trial|randomised controlled trial
536447|NCT00347191|Corneal thickness|corneal thickness
536448|NCT00347191|Intraocular pressure|intraocular pressure
536449|NCT00347191|Instrumentation|instrumentation
536450|NCT00347191|Glaucoma|glaucoma
536451|NCT00347191|Keratoconus|keratoconus
536452|NCT00347204|PRK|prk
536453|NCT00347204|laser vision correction|laser vision correction
536454|NCT00347204|surface ablation|surface ablation
536455|NCT00347204|pain|pain
536456|NCT00347204|wound healing|wound healing
536457|NCT00347204|corneal haze|corneal haze
536458|NCT00347217|Cholesterol|cholesterol
536459|NCT00347217|rosuvastatin|rosuvastatin
536460|NCT00347217|LDL-C goal|ldl-c goal
536461|NCT00347217|observational study|observational study
536462|NCT00347217|primary prevention|primary prevention
536463|NCT00347217|secondary prevention|secondary prevention
536464|NCT00347230|Intacs ring segments|intacs ring segments
536465|NCT00347230|Keratoconus|keratoconus
536466|NCT00347269|Anxiety Disorders|anxiety disorders
536467|NCT00347269|Post-traumatic Stress Disorder|post-traumatic stress disorder
536468|NCT00347269|Generalized Anxiety Disorder|generalized anxiety disorder
536469|NCT00347269|Panic Disorder|panic disorder
535916|NCT00344331|NPC|npc
536470|NCT00347269|Social Anxiety Disorder|social anxiety disorder
536471|NCT00347269|Stress|stress
536472|NCT00347269|Stress Disorders, Traumatic|stress disorders, traumatic
536473|NCT00347269|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
536474|NCT00347269|Mental Health Disorders|mental health disorders
536475|NCT00347282|Post enucleation socket syndrome|post enucleation socket syndrome
536476|NCT00347282|Multi-slice computed tomography scan|multi-slice computed tomography scan
536477|NCT00347282|Prospective studies|prospective studies
536478|NCT00347282|Tomography, X Ray Computed|tomography, x ray computed
536479|NCT00347308|brow ptosis, facial aesthetics, browlift, facelift|brow ptosis, facial aesthetics, browlift, facelift
536480|NCT00347321|Percutaneous tracheostomy|percutaneous tracheostomy
536481|NCT00347321|Endotracheal intubation|endotracheal intubation
536482|NCT00347321|Mechanical ventilation|mechanical ventilation
536483|NCT00347321|Cardiac surgery|cardiac surgery
536484|NCT00347321|Ventilator-free days|ventilator-free days
536485|NCT00347334|Torticollis|torticollis
536486|NCT00347334|infant home positioning|infant home positioning
536487|NCT00347334|head control|head control
536488|NCT00347360|carvedilol|carvedilol
536489|NCT00347360|hypertension|hypertension
536490|NCT00347360|lisinopril|lisinopril
536491|NCT00347360|factorial|factorial
536492|NCT00347373|conjugated linoleic acid|conjugated linoleic acid
536493|NCT00347373|obesity|obesity
536494|NCT00347373|body composition|body composition
536495|NCT00347373|body fat mass|body fat mass
536496|NCT00347373|lean body mass|lean body mass
536497|NCT00347386|Infants|infants
536498|NCT00347386|India|india
536499|NCT00347386|Zinc|zinc
536500|NCT00347386|Bacterial illness|bacterial illness
536501|NCT00347386|Treatment|treatment
536502|NCT00347399|macular degeneration|macular degeneration
536503|NCT00347399|antibodies|antibodies
536504|NCT00347399|angiogenesis inhibitor|angiogenesis inhibitor
536505|NCT00347412|NSCLC|nsclc
536506|NCT00347412|Stage IIIb|stage iiib
536507|NCT00347412|Stage IV|stage iv
536508|NCT00347412|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
536509|NCT00347412|NSCLC Stage IIIb with malignant pleural/pericardial effusion|nsclc stage iiib with malignant pleural/pericardial effusion
536510|NCT00347412|NSCLC Stage IV|nsclc stage iv
536511|NCT00347425|Switch Study|switch study
536512|NCT00347425|Schizophrenia|schizophrenia
536513|NCT00347425|Atypical Antipsychotics|atypical antipsychotics
536514|NCT00347438|breast cancer|breast cancer
536515|NCT00347438|neoadjuvant|neoadjuvant
536516|NCT00347438|locally advanced|locally advanced
536517|NCT00347451|myopia|myopia
536518|NCT00347451|optical coherence tomography|optical coherence tomography
536519|NCT00347464|Kleinfelter|kleinfelter
536520|NCT00347477|cardiac arrest|cardiac arrest
536521|NCT00347477|hypothermia|hypothermia
536522|NCT00347477|neurologic outcome|neurologic outcome
536523|NCT00347477|edema|edema
536524|NCT00347516|IOL formula|iol formula
536525|NCT00347516|High myopia|high myopia
536526|NCT00347516|axial length|axial length
15850|NCT03189641|Drug eluting stents|drug eluting stents
536527|NCT00347529|DNA vaccine, influenza, immunogenicity, tolerability, PMED, pandemic|dna vaccine, influenza, immunogenicity, tolerability, pmed, pandemic
536528|NCT00347542|Vitamin D|vitamin d
536529|NCT00347542|Diabetes|diabetes
536530|NCT00347542|Insulin sensitivity|insulin sensitivity
536531|NCT00347542|Obesity|obesity
536532|NCT00347555|malaria, falciparum, Plasmodium falciparum malaria, vaccine|malaria, falciparum, plasmodium falciparum malaria, vaccine
536533|NCT00347568|decision aids|decision aids
536534|NCT00347568|high risk|high risk
536535|NCT00347568|breast cancer|breast cancer
536536|NCT00347568|breast cancer prevention|breast cancer prevention
536537|NCT00347581|convergence insufficiency|convergence insufficiency
536538|NCT00347581|base-in prism|base-in prism
536539|NCT00347581|orthoptics|orthoptics
536540|NCT00347581|vision therapy|vision therapy
536541|NCT00347594|Corneal surface topography|corneal surface topography
536542|NCT00347594|Ocular aberrations|ocular aberrations
536543|NCT00347607|trachoma|trachoma
536544|NCT00347607|chlamydia trachomatis|chlamydia trachomatis
536545|NCT00347607|surveillance|surveillance
536546|NCT00347607|azithromycin|azithromycin
536547|NCT00347659|Lung volume reduction|lung volume reduction
536548|NCT00347659|Bronchoscopy|bronchoscopy
536549|NCT00347659|Emphysema|emphysema
536550|NCT00347659|COPD|copd
536551|NCT00347659|NETT|nett
536552|NCT00347659|Lung disease|lung disease
536553|NCT00347659|COLD|cold
536554|NCT00347659|BLVR|blvr
536555|NCT00347672|Bird Flu|bird flu
536556|NCT00347685|chronic non-malignant pain; chronic pain; non-malignant|chronic non-malignant pain; chronic pain; non-malignant
536557|NCT00347685|pain; moderate pain; severe pain|pain; moderate pain; severe pain
536558|NCT00347698|diabetic retinopathy|diabetic retinopathy
536559|NCT00347698|bevacizumab|bevacizumab
536560|NCT00347698|photocoagulation|photocoagulation
97190|NCT02681913|minimally invasive mitral valve replacement (mini-MVR)|minimally invasive mitral valve replacement (mini-mvr)
536561|NCT00347724|chronic low back pain; chronic pain; low back pain; extended-release analgesia; opioid|chronic low back pain; chronic pain; low back pain; extended-release analgesia; opioid
536562|NCT00347750|Lopinavir|lopinavir
536563|NCT00347750|Pharmacokinetic|pharmacokinetic
536564|NCT00347750|Pharmacodynamic|pharmacodynamic
536668|NCT00337051|Sevoflurane|sevoflurane
536565|NCT00347750|Ethiopian population|ethiopian population
536566|NCT00347750|Caucasian population|caucasian population
536567|NCT00347763|trachoma|trachoma
536568|NCT00347763|chlamydia|chlamydia
536569|NCT00347763|flies|flies
536570|NCT00347763|permethrin|permethrin
536571|NCT00347776|trichiasis|trichiasis
536572|NCT00347776|azithromycin|azithromycin
536573|NCT00347776|trichiasis surgery|trichiasis surgery
536574|NCT00347776|topical tetracycline|topical tetracycline
536575|NCT00347789|glaucoma|glaucoma
536576|NCT00347789|trabeculectomy|trabeculectomy
536577|NCT00347789|filtering bleb revision|filtering bleb revision
536578|NCT00347789|intraocular pressure|intraocular pressure
536579|NCT00347789|needling procedure|needling procedure
536580|NCT00347789|mitomycin C|mitomycin c
536581|NCT00347828|Antibiotic prophylaxis|antibiotic prophylaxis
536582|NCT00347828|Vigamox|vigamox
536583|NCT00347828|Moxifloxacin|moxifloxacin
536584|NCT00347828|Zymar|zymar
536585|NCT00347828|Gatifloxacin|gatifloxacin
536586|NCT00347828|Preoperative antibiotic|preoperative antibiotic
536587|NCT00347828|Eye infection|eye infection
536588|NCT00347854|Normal, healthy eyes (other than correction for visual acuity)|normal, healthy eyes (other than correction for visual acuity)
536589|NCT00347867|IUGR|iugr
536590|NCT00347867|PET|pet
536591|NCT00347867|Pregnancy|pregnancy
536592|NCT00347867|Viagra|viagra
536593|NCT00347867|Sildenafil citrate|sildenafil citrate
536594|NCT00347880|Bronchiolitis|bronchiolitis
536595|NCT00347880|ANP|anp
536596|NCT00347880|BNP|bnp
536597|NCT00347880|Atrial Natriuretic Peptide|atrial natriuretic peptide
536598|NCT00347880|Brain Natriuretic Peptide|brain natriuretic peptide
536599|NCT00347880|Vasopressin|vasopressin
536600|NCT00347880|ADH|adh
536601|NCT00347880|Pediatric|pediatric
536602|NCT00347880|Respiratory Distress|respiratory distress
536603|NCT00347880|Fluid Balance|fluid balance
536604|NCT00347893|Primary open angle glaucoma|primary open angle glaucoma
536605|NCT00347893|Ocular hypertension|ocular hypertension
536606|NCT00347893|Pseudo-exfoliative glaucoma|pseudo-exfoliative glaucoma
536607|NCT00347893|Pigment Dispersion glaucoma|pigment dispersion glaucoma
536608|NCT00347893|selective laser trabeculoplasty|selective laser trabeculoplasty
536609|NCT00347893|intraocular pressure|intraocular pressure
536610|NCT00347919|GW786034|gw786034
536611|NCT00347919|Quality of Life|quality of life
536612|NCT00347919|GW572016|gw572016
536613|NCT00347919|Lapatinib|lapatinib
536614|NCT00347919|Pazopanib|pazopanib
536615|NCT00347919|Metastatic|metastatic
536616|NCT00347919|Breast cancer|breast cancer
536617|NCT00347919|Genetics|genetics
536618|NCT00347919|FISH|fish
536619|NCT00347919|Advanced|advanced
536620|NCT00347945|convergence insufficiency, vision therapy, orthoptics|convergence insufficiency, vision therapy, orthoptics
536621|NCT00347958|Tetanus,|tetanus,
536622|NCT00347958|Diphtheria,|diphtheria,
536623|NCT00347958|Pertussis|pertussis
536624|NCT00347971|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
536625|NCT00347971|interleukin-21|interleukin-21
536626|NCT00347971|rituximab|rituximab
536627|NCT00347971|Immunotherapy|immunotherapy
536628|NCT00348010|osteoarthritis|osteoarthritis
536629|NCT00348010|knee pain|knee pain
536630|NCT00348010|extended release analgesia|extended release analgesia
536632|NCT00348036|Major Depression|major depression
536633|NCT00348036|Trauma|trauma
536634|NCT00348036|Primary Care|primary care
536635|NCT00348036|Low-Income Patients|low-income patients
536636|NCT00348049|LASIK|lasik
536637|NCT00348049|PRK|prk
536638|NCT00348049|Myopia|myopia
536639|NCT00348075|Neurovision|neurovision
536640|NCT00348075|Adult myopia|adult myopia
536641|NCT00348075|Therapy|therapy
536642|NCT00348088|Metastatic|metastatic
536643|NCT00348088|Melanoma|melanoma
536644|NCT00348088|Untreated|untreated
536645|NCT00348088|Biomarker|biomarker
536646|NCT00348101|Patients undergoing major vascular surgery having documented CAD or risk factors for CAD|patients undergoing major vascular surgery having documented cad or risk factors for cad
536647|NCT00348114|autologous|autologous
536648|NCT00348114|transplantation ex-vivo expanded limbal epithelium|transplantation ex-vivo expanded limbal epithelium
536649|NCT00348114|limbal deficiency|limbal deficiency
536650|NCT00348127|Neurovision|neurovision
536651|NCT00348127|Myopia Therapy|myopia therapy
536652|NCT00348140|adjunctive therapy|adjunctive therapy
536653|NCT00348140|moderate|moderate
536654|NCT00348140|Alzheimer's disease|alzheimer's disease
536655|NCT00348140|apolipoprotein E|apolipoprotein e
536656|NCT00348140|mild|mild
536657|NCT00348140|rosiglitazone|rosiglitazone
536658|NCT00348140|cognition|cognition
536659|NCT00336973|Plaque Psoriasis|plaque psoriasis
536660|NCT00336973|Raptiva|raptiva
536661|NCT00336973|Anti-TNF|anti-tnf
536041|NCT00345774|COPD|copd
536662|NCT00337051|Renal transplantation|renal transplantation
536663|NCT00337051|renal allograft|renal allograft
536664|NCT00337051|end-stage renal disease|end-stage renal disease
536665|NCT00337051|renal failure|renal failure
536666|NCT00337051|general anaesthesia|general anaesthesia
536667|NCT00337051|inhaled anaesthetic|inhaled anaesthetic
536669|NCT00337051|ischemia|ischemia
536670|NCT00337051|reperfusion|reperfusion
536671|NCT00337051|ischemic lesions|ischemic lesions
536672|NCT00337064|Breast cancer treatment|breast cancer treatment
536673|NCT00337064|Partial breast radiation|partial breast radiation
536674|NCT00337064|Radiation Therapy|radiation therapy
536675|NCT00337064|Adjuvant Treatment|adjuvant treatment
536676|NCT00337077|Eribulin Mesylate|eribulin mesylate
536677|NCT00337077|metastatic hormone refractory prostate cancer|metastatic hormone refractory prostate cancer
536678|NCT00337077|Halichondrin B Analog|halichondrin b analog
536679|NCT00337090|Over Active Bladder|over active bladder
536680|NCT00337090|Urinary incontinence|urinary incontinence
536682|NCT00337090|Symptomatic Over Active Bladder|symptomatic over active bladder
536683|NCT00337129|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
536684|NCT00337129|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
536685|NCT00337129|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
536686|NCT00337129|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
536687|NCT00337129|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
536688|NCT00337129|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
536689|NCT00337129|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
536690|NCT00337129|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
536691|NCT00337129|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
536692|NCT00337129|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
583553|NCT00512122|rehabilitation|rehabilitation
536693|NCT00337129|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
536694|NCT00337129|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
536695|NCT00337129|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
536696|NCT00337129|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
536697|NCT00337142|gestational diabetes|gestational diabetes
536698|NCT00337142|newborn|newborn
536699|NCT00337142|hypoglycemia|hypoglycemia
536700|NCT00337155|Recurrent Prostate Cancer|recurrent prostate cancer
536701|NCT00337155|metastatic Cancer|metastatic cancer
536702|NCT00337168|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
536703|NCT00337168|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
536704|NCT00337168|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
536705|NCT00337168|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
536706|NCT00337168|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
536707|NCT00337181|HIV-1|hiv-1
536681|NCT00337090|YM178|ym178
536708|NCT00337181|Natural History|natural history
536709|NCT00337181|HIV vaccine|hiv vaccine
536710|NCT00337181|Thailand|thailand
536711|NCT00337207|adult glioblastoma|adult glioblastoma
536712|NCT00337207|adult gliosarcoma|adult gliosarcoma
536713|NCT00337207|recurrent adult brain tumor|recurrent adult brain tumor
536714|NCT00337207|adult anaplastic astrocytoma|adult anaplastic astrocytoma
536715|NCT00337207|adult giant cell glioblastoma|adult giant cell glioblastoma
536716|NCT00337220|allograft|allograft
536717|NCT00337220|graft|graft
536718|NCT00337233|fatigue|fatigue
536719|NCT00337233|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
536720|NCT00337233|recurrent breast cancer|recurrent breast cancer
536721|NCT00337233|stage I breast cancer|stage i breast cancer
536722|NCT00337233|stage II breast cancer|stage ii breast cancer
536723|NCT00337233|stage IIIA breast cancer|stage iiia breast cancer
536724|NCT00337233|stage IIIB breast cancer|stage iiib breast cancer
536725|NCT00337233|stage IIIC breast cancer|stage iiic breast cancer
536726|NCT00337233|stage IV breast cancer|stage iv breast cancer
536727|NCT00337233|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
536728|NCT00337233|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
536729|NCT00337233|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
536730|NCT00337233|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
536731|NCT00337233|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
536732|NCT00337233|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
536733|NCT00337233|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
536734|NCT00337233|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
97192|NCT02681874|stress|stress
536735|NCT00337233|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
536736|NCT00337233|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
536737|NCT00337246|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
536738|NCT00337246|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
536739|NCT00337246|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
536740|NCT00337246|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
536741|NCT00337246|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
536742|NCT00337259|marginal zone lymphoma|marginal zone lymphoma
536743|NCT00337259|gemcitabine|gemcitabine
536744|NCT00337272|chronic insomnia|chronic insomnia
536745|NCT00337285|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
536746|NCT00337285|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
536747|NCT00337285|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
536748|NCT00337298|Diabetes|diabetes
536749|NCT00337298|Retinopathy|retinopathy
536750|NCT00337298|Blood Pressure|blood pressure
536751|NCT00337298|Amlodipine|amlodipine
536752|NCT00337298|Lisinopril|lisinopril
536753|NCT00337324|Diabetic neuropathy|diabetic neuropathy
536754|NCT00337324|Complications of diabetes|complications of diabetes
536755|NCT00337324|Neuropathies|neuropathies
536756|NCT00337324|Electromagnetic stimulation|electromagnetic stimulation
536757|NCT00337324|Neuropathic pain|neuropathic pain
536758|NCT00337337|Diabetes|diabetes
536759|NCT00337337|rice|rice
536760|NCT00337337|fiber|fiber
536761|NCT00337350|Schizophrenia|schizophrenia
536762|NCT00337350|Glucose Metabolism|glucose metabolism
536763|NCT00337350|Insulin Resistance|insulin resistance
536764|NCT00337389|Metastatic|metastatic
536765|NCT00337389|Colorectal|colorectal
536766|NCT00337389|Cancer|cancer
536767|NCT00337389|CoFactor|cofactor
536768|NCT00337389|Stage IV|stage iv
536769|NCT00337402|Gastrostomy|gastrostomy
536770|NCT00337402|Quality of life|quality of life
536771|NCT00337441|Chronic Anemia|chronic anemia
536772|NCT00337441|Anemia|anemia
536773|NCT00337441|Chronic Diseases|chronic diseases
536774|NCT00337441|Elderly|elderly
536775|NCT00337441|Epoetin alfa|epoetin alfa
536776|NCT00337441|Fatigue|fatigue
536777|NCT00337441|Quality of life|quality of life
536778|NCT00337441|Mobility|mobility
536779|NCT00337454|Imatinib resistant or intolerant CML|imatinib resistant or intolerant cml
536780|NCT00337454|Treatment resistant or intolerant Ph+ALL|treatment resistant or intolerant ph+all
536781|NCT00337467|HIV-Infected Patients Evidencing Virologic Suppression|hiv-infected patients evidencing virologic suppression
536782|NCT00337480|acute coronary syndrome|acute coronary syndrome
536783|NCT00337480|cardiovascular risk factors|cardiovascular risk factors
536784|NCT00337480|smoking habits|smoking habits
536785|NCT00337480|obesity|obesity
536786|NCT00337480|sedentary lifestyle|sedentary lifestyle
536787|NCT00337480|overweight|overweight
536788|NCT00337480|education|education
536789|NCT00337480|follow up after hospitalization|follow up after hospitalization
536790|NCT00337506|the efficacy and safety of Velcade plus dexamethasone|the efficacy and safety of velcade plus dexamethasone
536791|NCT00337506|Multiple Myeloma|multiple myeloma
536792|NCT00337519|chronic lymphocytic leukemia|chronic lymphocytic leukemia
536793|NCT00337519|reduced intensity conditioning|reduced intensity conditioning
536794|NCT00337519|alemtuzumab|alemtuzumab
536795|NCT00337519|allogeneic stem cell transplantation|allogeneic stem cell transplantation
536796|NCT00337545|Metastatic|metastatic
536797|NCT00337545|Refractory|refractory
536798|NCT00337558|treatment outcomes|treatment outcomes
536799|NCT00337558|Overactive bladder|overactive bladder
536800|NCT00337558|Solifenacin succinate|solifenacin succinate
536801|NCT00337558|urinary incontinence|urinary incontinence
536802|NCT00337558|urge incontinence|urge incontinence
536803|NCT00337558|frequency|frequency
536804|NCT00337571|Serious behavioral problems in children and adolescents with AD|serious behavioral problems in children and adolescents with ad
536805|NCT00337584|out patient surgery|out patient surgery
536806|NCT00337584|quality improvement|quality improvement
536807|NCT00337597|Normal saline|normal saline
536808|NCT00337597|Dextrose 5% in water|dextrose 5% in water
536809|NCT00337597|neurostimulation|neurostimulation
536810|NCT00337597|Continuous regional analgesia after total knee arthroplasty|continuous regional analgesia after total knee arthroplasty
536811|NCT00337623|Cataracts|cataracts
536812|NCT00337623|Corticosteroids|corticosteroids
536813|NCT00337623|Scheimpflug|scheimpflug
536814|NCT00337623|Lens autofluorescence|lens autofluorescence
536816|NCT00337636|INCL|incl
536817|NCT00337636|LINCL|lincl
536818|NCT00337636|Batten disease|batten disease
536819|NCT00337636|Infantile Neuronal Ceroid Lipofuscinosis (INCL)|infantile neuronal ceroid lipofuscinosis (incl)
536820|NCT00337636|Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL)|late infantile neuronal ceroid lipofuscinosis (lincl)
536821|NCT00337688|Cerebral Palsy|cerebral palsy
536822|NCT00337688|Spasticity|spasticity
536823|NCT00337688|Joystick|joystick
536824|NCT00337688|Wheelchair|wheelchair
97193|NCT02681874|nutrition|nutrition
536825|NCT00337688|rehabilitation|rehabilitation
536826|NCT00337714|Central venous catheter,|central venous catheter,
536827|NCT00337714|bloodstream infections,|bloodstream infections,
536828|NCT00337714|intensive care unit|intensive care unit
536829|NCT00337753|Gambling|gambling
536830|NCT00337766|Blood Loss|blood loss
536831|NCT00337766|Postoperative Blood loss|postoperative blood loss
536832|NCT00337805|colloid|colloid
536833|NCT00337805|crystalloid|crystalloid
536834|NCT00337805|hemodynamics|hemodynamics
536835|NCT00337805|flow-directed|flow-directed
536836|NCT00337805|resuscitation|resuscitation
536837|NCT00337818|Non-inferiority|non-inferiority
536838|NCT00337818|Immunogenicity|immunogenicity
536839|NCT00337818|HPV Vaccine Consistency|hpv vaccine consistency
536840|NCT00337870|Pediatric Anxiety|pediatric anxiety
536841|NCT00337870|Pediatric Pain|pediatric pain
536842|NCT00337870|Emergency room procedures|emergency room procedures
536843|NCT00337883|Glioblastoma Multiforme|glioblastoma multiforme
536844|NCT00337883|glioma|glioma
536845|NCT00337883|Grade IV glioma|grade iv glioma
536846|NCT00337896|vaccine, influenza, A/H5N1, CMI, sub-study|vaccine, influenza, a/h5n1, cmi, sub-study
536847|NCT00337909|cognitive enhancement|cognitive enhancement
536848|NCT00337909|memory|memory
536849|NCT00337909|auditory memory|auditory memory
536850|NCT00337909|speech|speech
536851|NCT00337909|computerized|computerized
536852|NCT00337922|EPZICOM|epzicom
536853|NCT00337922|Lamivudine|lamivudine
536854|NCT00337922|Abacavir|abacavir
536855|NCT00337922|pharmacokinetics|pharmacokinetics
536856|NCT00337922|Japanese|japanese
536857|NCT00337935|Long Term Care Facilities|long term care facilities
536858|NCT00337935|subcutaneous injections|subcutaneous injections
536859|NCT00337935|PROCRIT|procrit
536860|NCT00337935|Epoetin alfa|epoetin alfa
536861|NCT00337935|Anemia|anemia
536862|NCT00337948|Anemia|anemia
536863|NCT00337948|Epoetin Alfa|epoetin alfa
536864|NCT00337948|Chemotherapy|chemotherapy
536865|NCT00337948|Anemia due to Cancer|anemia due to cancer
536866|NCT00337961|Optic Nerve Sheath Fenestration|optic nerve sheath fenestration
536867|NCT00337974|cognitive enhancement|cognitive enhancement
536868|NCT00337974|memory|memory
536869|NCT00337974|auditory memory|auditory memory
536870|NCT00337974|speech|speech
536871|NCT00337974|computerized|computerized
536872|NCT00338000|Chronic renal failure|chronic renal failure
536873|NCT00338000|left ventricular hypertrophy|left ventricular hypertrophy
536874|NCT00338000|epoetin alfa|epoetin alfa
536875|NCT00338013|sleep|sleep
536876|NCT00338026|Solid Tumors|solid tumors
536877|NCT00338026|Thallion|thallion
536878|NCT00338026|TLN-4601|tln-4601
536879|NCT00338026|Ecopia|ecopia
536880|NCT00338026|ECO-4601|eco-4601
536881|NCT00338026|Patients with histologically confirmed solid tumors:|patients with histologically confirmed solid tumors:
536882|NCT00338026|High Grade Glioma|high grade glioma
536883|NCT00338026|Colorectal|colorectal
536884|NCT00338026|Lung|lung
536885|NCT00338026|Breast|breast
536886|NCT00338026|Ovarian|ovarian
536887|NCT00338026|Pancreatic|pancreatic
536888|NCT00338026|Prostate|prostate
536889|NCT00338039|Pancreatic Cancer|pancreatic cancer
536890|NCT00338039|Cetuximab|cetuximab
536891|NCT00338039|C225|c225
536892|NCT00338039|Erbitux|erbitux
536893|NCT00338039|Gemcitabine|gemcitabine
536894|NCT00338039|Oxaliplatin|oxaliplatin
536895|NCT00338039|Eloxatin|eloxatin
536896|NCT00338039|Capecitabine|capecitabine
536897|NCT00338039|Xeloda|xeloda
536898|NCT00338052|Contraception|contraception
536899|NCT00338065|Intraocular Pressure|intraocular pressure
536900|NCT00338091|Renal Insufficiency,Chronic|renal insufficiency,chronic
536901|NCT00338091|Disease Progression|disease progression
536902|NCT00338091|Proteinuria|proteinuria
536903|NCT00338091|Dose-Response Relationship,Drug|dose-response relationship,drug
536904|NCT00338091|Benazepril|benazepril
536905|NCT00338091|Losartan|losartan
536906|NCT00338104|insulin|insulin
536907|NCT00338104|glargine|glargine
536908|NCT00338104|intravenous|intravenous
536909|NCT00338104|subcutaneous|subcutaneous
536910|NCT00338104|hospital|hospital
536911|NCT00338104|diabetes|diabetes
536912|NCT00338104|glucose|glucose
536913|NCT00338104|inpatient|inpatient
536914|NCT00338117|Dementia|dementia
536915|NCT00338117|neurodegenerative disorder|neurodegenerative disorder
536916|NCT00338117|impairment of memory|impairment of memory
536917|NCT00338117|galantamine|galantamine
536918|NCT00338117|galanthamine|galanthamine
536919|NCT00338117|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
536920|NCT00338117|Mini Mental State Examination score|mini mental state examination score
536921|NCT00338130|Melanoma|melanoma
536922|NCT00338130|Phase II|phase ii
536923|NCT00338130|AZD6244|azd6244
536924|NCT00338130|temozolomide|temozolomide
536925|NCT00338143|Plaque psoriasis|plaque psoriasis
536926|NCT00338143|Antipsoriatic|antipsoriatic
536927|NCT00338156|Left Ventricle Remodelling|left ventricle remodelling
536928|NCT00338156|Collagen markers|collagen markers
536929|NCT00338156|Neurohormones|neurohormones
536930|NCT00338156|Cardiac MRI|cardiac mri
536931|NCT00338182|Solid tumor|solid tumor
536932|NCT00338195|Caffeine dependence|caffeine dependence
536933|NCT00338195|Caffeine withdrawal|caffeine withdrawal
536934|NCT00338208|low vision|low vision
536935|NCT00338208|glaucoma|glaucoma
536936|NCT00338221|Diarrhea, Malnutrition, Brazil|diarrhea, malnutrition, brazil
536937|NCT00338234|anemia|anemia
536938|NCT00338234|intensive care|intensive care
536939|NCT00338234|cardiac surgery|cardiac surgery
536940|NCT00338234|iron metabolism|iron metabolism
536941|NCT00338234|hepcidin|hepcidin
536942|NCT00338247|advanced|advanced
536943|NCT00338247|TYKERB|tykerb
536944|NCT00338247|HER2 positive|her2 positive
536945|NCT00338247|Stage IIIc|stage iiic
536946|NCT00338247|ErbB2 positive|erbb2 positive
536947|NCT00338247|GW572016|gw572016
536948|NCT00338247|metastatic|metastatic
536949|NCT00338247|Stage IIIb|stage iiib
536950|NCT00338247|breast cancer|breast cancer
536951|NCT00338273|Bipolar I disorder with major depressive episode|bipolar i disorder with major depressive episode
536952|NCT00338286|anemia|anemia
536953|NCT00338286|metastatic breast cancer|metastatic breast cancer
536954|NCT00338286|Hemoglobin|hemoglobin
536955|NCT00338286|progression-free survival (PFS)|progression-free survival (pfs)
536956|NCT00338286|erythropoiesis-stimulating agents (ESA)|erythropoiesis-stimulating agents (esa)
536957|NCT00338299|Anemia|anemia
536958|NCT00338299|hemoglobin|hemoglobin
536959|NCT00338299|chemotherapy|chemotherapy
536960|NCT00338299|subcutaneous injection|subcutaneous injection
536961|NCT00338299|Epoetin alfa|epoetin alfa
536962|NCT00338962|SSRI|ssri
536963|NCT00338962|treatment|treatment
536964|NCT00338962|naltrexone|naltrexone
536965|NCT00338962|alcohol dependence|alcohol dependence
536966|NCT00338962|Desipramine|desipramine
536967|NCT00338962|depression|depression
536968|NCT00338962|PTSD|ptsd
536969|NCT00338975|Psychotic Disorders|psychotic disorders
536970|NCT00338975|Schizoaffective Disorder|schizoaffective disorder
536971|NCT00338975|Cognitive Behavioral Therapy|cognitive behavioral therapy
536972|NCT00338975|Social Skills Training|social skills training
536973|NCT00338988|Gastrointestinal|gastrointestinal
536974|NCT00338988|Capecitabine|capecitabine
536975|NCT00338988|Oxaliplatin|oxaliplatin
536976|NCT00338988|Carcinoma of the Gallbladder|carcinoma of the gallbladder
583554|NCT00512122|overfeeding|overfeeding
583654|NCT00512564|Hepcidin|hepcidin
536977|NCT00338988|Carcinoma of the Intrahepatic or Extrahepatic Biliary Tract|carcinoma of the intrahepatic or extrahepatic biliary tract
536979|NCT00338988|Eloxatin|eloxatin
536980|NCT00339001|Erythropoietin|erythropoietin
536981|NCT00339001|Iron|iron
536982|NCT00339001|Retinopathy of prematurity|retinopathy of prematurity
536983|NCT00339027|child care centers|child care centers
536984|NCT00339027|community based research|community based research
536985|NCT00339027|behavioral health|behavioral health
536986|NCT00339027|health literacy|health literacy
536987|NCT00339027|unmet healthcare needs|unmet healthcare needs
536989|NCT00339053|thoracic aortic aneurysm|thoracic aortic aneurysm
536990|NCT00339053|immunonutrition|immunonutrition
536991|NCT00339053|respiratory failure|respiratory failure
536992|NCT00339053|lenght of stay ICU|lenght of stay icu
536993|NCT00339066|Late-Life Depression|late-life depression
536994|NCT00339092|HIV|hiv
536995|NCT00339092|ART|art
536996|NCT00339105|Acute|acute
536997|NCT00339105|Coronary|coronary
536998|NCT00339105|Syndrome|syndrome
536999|NCT00339105|HyperQ|hyperq
537000|NCT00339105|High|high
537001|NCT00339105|Frequency|frequency
537002|NCT00339105|ECG|ecg
537003|NCT00339105|chest|chest
537004|NCT00339105|pain|pain
537005|NCT00339131|radiopharmaceutical|radiopharmaceutical
537006|NCT00339131|radiation dosimetry|radiation dosimetry
537007|NCT00339131|iodine|iodine
537008|NCT00339131|MIBG|mibg
537009|NCT00339131|iobenguane|iobenguane
537010|NCT00339131|Ultratrace|ultratrace
537011|NCT00339131|neuroendocrine tumors|neuroendocrine tumors
537012|NCT00339144|Solid tumors (including relapsed disease) that are refractory to standard therapies or for which no effective standard therapy exists|solid tumors (including relapsed disease) that are refractory to standard therapies or for which no effective standard therapy exists
537013|NCT00339157|IDIOPATHIC JUVENILE ARTHRITIS|idiopathic juvenile arthritis
537014|NCT00339157|PEDIATRICS|pediatrics
537015|NCT00339157|ORPHAN DISEASE|orphan disease
537016|NCT00339157|INTERLEUKIN - 1|interleukin - 1
537017|NCT00339157|RECEPTORS , INTERLEUKINS|receptors , interleukins
537018|NCT00339157|ANTAGONISTS|antagonists
537019|NCT00339170|Schizoaffective Disorder|schizoaffective disorder
537020|NCT00339170|Schizophrenic Disorders|schizophrenic disorders
537021|NCT00339170|Psychotic Disorders|psychotic disorders
537022|NCT00339170|Cognition|cognition
537023|NCT00339183|Oncology|oncology
537024|NCT00339183|Cancer|cancer
537025|NCT00339183|Metastatic Colorectal Cancer|metastatic colorectal cancer
537026|NCT00339183|EGFr|egfr
537027|NCT00339183|Panitumumab|panitumumab
537028|NCT00339183|Clinical Trial|clinical trial
537029|NCT00339183|Amgen|amgen
537030|NCT00339196|AML|aml
537031|NCT00339196|MDS High risk|mds high risk
537032|NCT00339196|Demethylating agents|demethylating agents
537033|NCT00339196|HDAC Inhibitors|hdac inhibitors
537034|NCT00339209|Genetic Polymorphisms|genetic polymorphisms
537035|NCT00339209|Acute Rejection|acute rejection
537036|NCT00339209|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
537037|NCT00339209|Transplant Rejection|transplant rejection
537038|NCT00339209|Innate Immunity|innate immunity
537039|NCT00339209|Lung Transplantation Rejection|lung transplantation rejection
537040|NCT00339222|Genetics|genetics
537041|NCT00339222|Kindreds|kindreds
537042|NCT00339222|Mediterranean Population|mediterranean population
537043|NCT00339222|Nevi|nevi
537044|NCT00339222|Pigmentation|pigmentation
537045|NCT00339222|Melanoma-Prone Families|melanoma-prone families
537046|NCT00339222|Sun Exposure|sun exposure
537047|NCT00339222|Melanoma|melanoma
537048|NCT00339235|Preterm Birth Prevention|preterm birth prevention
537049|NCT00339235|Preterm Birth|preterm birth
537050|NCT00339235|Pregnancy|pregnancy
537051|NCT00339235|Pregnancy Complications|pregnancy complications
537052|NCT00339248|Hyperplasia|hyperplasia
537053|NCT00339248|Atypia|atypia
537054|NCT00339248|Polymorphism|polymorphism
537055|NCT00339248|Progression|progression
537056|NCT00339248|Epidemiology|epidemiology
537057|NCT00339261|Cardiovascular|cardiovascular
537058|NCT00339261|Renal|renal
537059|NCT00339261|Autoimmune Disease|autoimmune disease
537060|NCT00339261|Genetics|genetics
537061|NCT00339261|Mortality|mortality
537062|NCT00339274|Repositories|repositories
537063|NCT00339274|Pathology|pathology
537064|NCT00339274|Belarus|belarus
537065|NCT00339274|Russia|russia
537066|NCT00339274|Ukraine|ukraine
537067|NCT00339287|Inflammation|inflammation
537068|NCT00339287|Innate Immunity|innate immunity
537069|NCT00339287|Macrophages|macrophages
537070|NCT00339287|Neutrophils|neutrophils
537071|NCT00339287|Pathogenesis|pathogenesis
537072|NCT00339300|Etiology|etiology
537073|NCT00339300|Brain Cancer|brain cancer
537074|NCT00339300|Epidemiology|epidemiology
537075|NCT00339300|Brain Tumors|brain tumors
537076|NCT00339300|Glioma|glioma
537077|NCT00339313|Obesity|obesity
537078|NCT00339313|Etiology|etiology
537079|NCT00339313|Macronutrient Selection|macronutrient selection
537080|NCT00339313|Taste Preference|taste preference
537081|NCT00339313|Mixed Meal Test|mixed meal test
537082|NCT00339326|Human Herpes virus 8 (HHV8)|human herpes virus 8 (hhv8)
537083|NCT00339326|Kaposis sarcoma (KS)|kaposis sarcoma (ks)
537084|NCT00339326|Kaposi Sarcoma|kaposi sarcoma
537085|NCT00339326|Karposi Sarcoma-Associated Herpesvirus|karposi sarcoma-associated herpesvirus
537086|NCT00339326|KSHV|kshv
537087|NCT00339326|KS|ks
537088|NCT00339339|Dental Materials|dental materials
537089|NCT00339339|Resins|resins
537090|NCT00339339|BisDMA|bisdma
537091|NCT00339339|Absorption|absorption
537092|NCT00339339|Systemic|systemic
537093|NCT00339352|Brain|brain
537094|NCT00339352|Exposures|exposures
537095|NCT00339352|Genetics|genetics
537096|NCT00339352|Glioma|glioma
537097|NCT00339352|Occupations|occupations
537098|NCT00339365|Infants|infants
537099|NCT00339365|Toddlers|toddlers
537100|NCT00339365|Attachment|attachment
537101|NCT00339365|Maltreatment|maltreatment
537102|NCT00339365|Foster Care|foster care
537103|NCT00339378|Record Linkage|record linkage
537104|NCT00339378|Retrospective|retrospective
537105|NCT00339378|Cohort|cohort
537106|NCT00339378|Registries|registries
537107|NCT00339378|Agricultural|agricultural
537108|NCT00339391|Adjustment|adjustment
537109|NCT00339391|Environmental Complexity|environmental complexity
537110|NCT00339391|Mental Illness|mental illness
537111|NCT00339391|Non-literate|non-literate
537112|NCT00339391|West Africa|west africa
537113|NCT00339391|Stress|stress
537114|NCT00339391|Knowledge|knowledge
537115|NCT00339391|Mental Health|mental health
537116|NCT00339391|AIDS|aids
537117|NCT00339404|Genotyping|genotyping
537118|NCT00339404|Linkage Analysis|linkage analysis
537119|NCT00339404|Cancer|cancer
537120|NCT00339404|Hereditary Melanoma|hereditary melanoma
537121|NCT00339417|Lymphatic Filariasis|lymphatic filariasis
537122|NCT00339417|Chemotherapy|chemotherapy
537123|NCT00339430|Genotyping|genotyping
537124|NCT00339430|HIV|hiv
537125|NCT00339430|HPV|hpv
537126|NCT00339430|HCV|hcv
537127|NCT00339430|HBV|hbv
537128|NCT00339443|Buccal Cells|buccal cells
537129|NCT00339443|Concordance|concordance
537130|NCT00339443|DNA Yields|dna yields
537131|NCT00339443|pH Meter|ph meter
537132|NCT00339443|Urine pH|urine ph
537133|NCT00339443|Calibration|calibration
537134|NCT00339456|Therapy|therapy
537135|NCT00339456|Africa|africa
537136|NCT00339456|Structured|structured
537137|NCT00339456|Interruption|interruption
537138|NCT00339456|Antiretroviral|antiretroviral
537139|NCT00339456|HIV|hiv
537140|NCT00339469|Prevention|prevention
537141|NCT00339469|Colorectal Neoplasms|colorectal neoplasms
537142|NCT00339469|Insulin Resistance|insulin resistance
537143|NCT00339469|Inflammation Obesity|inflammation obesity
537144|NCT00339469|Adenoma|adenoma
537145|NCT00339482|Epidemiology|epidemiology
537146|NCT00339482|Type 2 Diabetes|type 2 diabetes
537147|NCT00339482|Vascular Complications|vascular complications
537148|NCT00339482|Retinopathy|retinopathy
537149|NCT00339482|Nephropathy|nephropathy
537150|NCT00339482|Genetics|genetics
537151|NCT00339495|Prostate|prostate
537152|NCT00339495|Screening Trail|screening trail
537153|NCT00339495|Ovarian|ovarian
537154|NCT00339495|Lung|lung
537155|NCT00339495|Colorectal|colorectal
537156|NCT00339508|Linkage Analysis|linkage analysis
537157|NCT00339508|Cancer Genetics|cancer genetics
537158|NCT00339508|Software|software
537159|NCT00339508|Bug Reports|bug reports
537160|NCT00339508|Computer Programs|computer programs
537161|NCT00339508|Data Analysis|data analysis
537162|NCT00339521|Asthma|asthma
537163|NCT00339521|Mexico|mexico
537164|NCT00339521|Candidate Genes|candidate genes
537165|NCT00339521|Triads|triads
537166|NCT00339521|Polymorphism|polymorphism
537167|NCT00339534|African Men|african men
537168|NCT00339534|Case-Control Study|case-control study
537169|NCT00339534|Prostate Cancer|prostate cancer
537170|NCT00339534|Cancer|cancer
537171|NCT00339547|Leiomyomas|leiomyomas
537172|NCT00339547|Ultrasound|ultrasound
537173|NCT00339547|Hysterectomy|hysterectomy
537174|NCT00339547|Epidemiology|epidemiology
537175|NCT00339547|Hyperinsulinemia|hyperinsulinemia
537176|NCT00339560|Ampulla of Vater|ampulla of vater
537177|NCT00339560|Gallbaldder|gallbaldder
537178|NCT00339560|Cancer|cancer
537179|NCT00339560|Extrahepatic Bile Duct|extrahepatic bile duct
537180|NCT00339573|Asthma|asthma
537181|NCT00339573|Dust Mite|dust mite
537182|NCT00339573|Cockroach|cockroach
537183|NCT00339573|Lead Toxicity|lead toxicity
537184|NCT00339573|Allergy|allergy
537185|NCT00339586|Non-small cell lung cancer|non-small cell lung cancer
537186|NCT00339586|tyrosine kinase inhibition|tyrosine kinase inhibition
537187|NCT00339586|first-line treatment|first-line treatment
537188|NCT00339586|mutant EGFR-gene|mutant egfr-gene
537189|NCT00339599|Atherosclerosis|atherosclerosis
537190|NCT00339599|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
537191|NCT00339599|Monocyte Chemotactic Protein-1|monocyte chemotactic protein-1
537192|NCT00339599|Inflammation|inflammation
537193|NCT00339599|Eotaxin|eotaxin
537194|NCT00339612|Perinatal|perinatal
537195|NCT00339612|HIV|hiv
537196|NCT00339612|AIDS|aids
537197|NCT00339625|Intervention|intervention
537198|NCT00339625|Diet|diet
537199|NCT00339625|Colon|colon
537200|NCT00339638|Epidemiology|epidemiology
537201|NCT00339638|Risk Prediction|risk prediction
537202|NCT00339638|Biomarkers|biomarkers
537203|NCT00339638|Nested Case Control|nested case control
537204|NCT00339651|Precursors|precursors
537205|NCT00339651|Endometrial Cancer|endometrial cancer
537206|NCT00339651|Hyperplasia|hyperplasia
537207|NCT00339651|Progression|progression
537208|NCT00339664|Pharmacokinetics|pharmacokinetics
537209|NCT00339664|Quantify|quantify
537210|NCT00339664|HPLC|hplc
537211|NCT00339664|LC/MS|lc/ms
537212|NCT00339664|Pharmacodynamics|pharmacodynamics
537213|NCT00339677|Measurement Error|measurement error
537214|NCT00339677|Dietary Assessment|dietary assessment
537215|NCT00339677|Dietary Intake|dietary intake
537216|NCT00339677|Energy|energy
537217|NCT00339677|Protein|protein
537218|NCT00339690|Asthma|asthma
537219|NCT00339690|Allergy|allergy
537220|NCT00339690|Intervention|intervention
537221|NCT00339690|Behaviors|behaviors
537222|NCT00339690|Test-Kit|test-kit
537223|NCT00339690|Dust Mites Allergen|dust mites allergen
537224|NCT00339703|Resistin|resistin
537225|NCT00339703|Asthma|asthma
537226|NCT00339703|CRP|crp
537227|NCT00339703|Diabetes|diabetes
537228|NCT00339703|FIZZ|fizz
537229|NCT00339716|Cohort|cohort
537230|NCT00339716|Radiation|radiation
537231|NCT00339716|In Utero|in utero
537232|NCT00339729|Children|children
537233|NCT00339729|Behavior|behavior
537234|NCT00339729|Epidemiology|epidemiology
537235|NCT00339729|Lead|lead
537236|NCT00339729|Learning Disorder|learning disorder
537237|NCT00339742|Esophageal Cancer|esophageal cancer
537238|NCT00339742|Case-Control Study|case-control study
537239|NCT00339742|Environmental Risk Factors|environmental risk factors
537240|NCT00339742|Genetic Risk Factors|genetic risk factors
537241|NCT00339768|Helicobacter Pylori|helicobacter pylori
537242|NCT00339768|Gastric Cancer Prevention|gastric cancer prevention
537243|NCT00339768|Precancerous Gastric Lesions|precancerous gastric lesions
537244|NCT00339781|Fetomaternal Microchimerism|fetomaternal microchimerism
537245|NCT00339781|Cell Trafficking|cell trafficking
537246|NCT00339781|Discordant Twins|discordant twins
537247|NCT00339781|Maternofetal Microchimerism|maternofetal microchimerism
537248|NCT00339781|Diabetes Type I|diabetes type i
537249|NCT00339781|Twins|twins
537250|NCT00339794|Racial Profiling|racial profiling
537251|NCT00339794|Genomics|genomics
537252|NCT00339794|Genetic Testing|genetic testing
537253|NCT00339794|Family History|family history
537254|NCT00339794|Family Physician|family physician
537255|NCT00339807|Retrovirus|retrovirus
537256|NCT00339807|Caribbean|caribbean
537257|NCT00339807|Transmission|transmission
537258|NCT00339807|Genetic|genetic
537259|NCT00339807|Viral Markers|viral markers
537260|NCT00339807|HTLV-1|htlv-1
537261|NCT00339833|Salsalate|salsalate
537262|NCT00339833|Insulin Resistance|insulin resistance
537263|NCT00339833|Diabetes Mellitus|diabetes mellitus
537264|NCT00339833|Inflammation|inflammation
537265|NCT00339833|Diabetes|diabetes
537266|NCT00339833|HCV|hcv
537267|NCT00339846|Craniosynostosis|craniosynostosis
537373|NCT00340210|Biomarkers|biomarkers
537268|NCT00339846|Craniofrontonasal Syndrome|craniofrontonasal syndrome
537269|NCT00339846|CFNS|cfns
537270|NCT00339859|Molecular Epidemiology of Lung Cancer|molecular epidemiology of lung cancer
537271|NCT00339859|Health Disparities|health disparities
537272|NCT00339872|healthy subjects|healthy subjects
537273|NCT00339885|Type 2 Diabetes|type 2 diabetes
537274|NCT00339898|Minimal Residual Disease|minimal residual disease
537275|NCT00339898|Ewings Sarcoma|ewings sarcoma
537276|NCT00339911|Repository|repository
537277|NCT00339911|Phlebotomy|phlebotomy
537278|NCT00339911|Venipuncture|venipuncture
537279|NCT00339911|Anemia|anemia
537280|NCT00339911|Occupational Health Services|occupational health services
537281|NCT00339924|Clinical Decision-Making|clinical decision-making
537282|NCT00339924|Physician Bias|physician bias
537283|NCT00339924|Genetics|genetics
537284|NCT00339924|Race|race
537285|NCT00339924|Ethnicity|ethnicity
537538|NCT00340665|Isoflavones|isoflavones
537286|NCT00339924|Human Genetic Variation|human genetic variation
537287|NCT00339937|Human Herpes virus 8 (HHV8)|human herpes virus 8 (hhv8)
537288|NCT00339937|Kaposi sarcoma (KS)|kaposi sarcoma (ks)
537289|NCT00339950|Colorectal adenoma|colorectal adenoma
537290|NCT00339950|Screening|screening
537291|NCT00339950|Polyp|polyp
537292|NCT00339950|Diet|diet
537293|NCT00339950|Nutrition|nutrition
537294|NCT00339950|Polymorphism|polymorphism
537295|NCT00339950|Cooking|cooking
537296|NCT00339950|Risk Factors|risk factors
537297|NCT00339963|Microarray|microarray
537305|NCT00339976|Case-Control Study|case-control study
537306|NCT00339976|Death Certificates|death certificates
537307|NCT00339976|National Death Index|national death index
537308|NCT00339976|Cause of Death Information|cause of death information
537309|NCT00339976|Lead Exposure|lead exposure
537310|NCT00339976|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
537312|NCT00339989|Molecular Markers|molecular markers
537313|NCT00339989|Human Papillomavirus|human papillomavirus
537314|NCT00339989|Cervix|cervix
537315|NCT00339989|Cancer|cancer
537316|NCT00339989|Microarray|microarray
537317|NCT00340002|Fetal Anatomy|fetal anatomy
537318|NCT00340002|Pregnancy|pregnancy
537319|NCT00340002|Prenatal Diagnosis|prenatal diagnosis
537320|NCT00340015|Cancer|cancer
537321|NCT00340015|Mortality|mortality
537322|NCT00340015|Lifestyle Factors|lifestyle factors
537323|NCT00340015|Cohort|cohort
537324|NCT00340028|Ovulation|ovulation
537325|NCT00340028|Diary Record|diary record
537326|NCT00340028|Urine Collection|urine collection
537327|NCT00340028|Leutinizing Hormone|leutinizing hormone
537328|NCT00340028|Blood Collection|blood collection
537329|NCT00340028|Pregnancy|pregnancy
537330|NCT00340054|brain tumor|brain tumor
537331|NCT00340080|Abacavir|abacavir
537332|NCT00340080|Pharmacogenetics|pharmacogenetics
537333|NCT00340080|hypersensitivity|hypersensitivity
537341|NCT00340106|Infant Health Study|infant health study
537342|NCT00340106|Environmental Tobacco Smoke|environmental tobacco smoke
537343|NCT00340106|Infant Health|infant health
537344|NCT00340119|CHOICE Cohort|choice cohort
537345|NCT00340119|End Stage Renal Disease|end stage renal disease
537346|NCT00340119|Epidemiology|epidemiology
537347|NCT00340119|Prevention|prevention
537348|NCT00340119|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
537349|NCT00340119|ESRD|esrd
537356|NCT00340158|Mammary|mammary
537357|NCT00340158|Diagnosis|diagnosis
537358|NCT00340158|Aggressive|aggressive
537359|NCT00340158|Pathology|pathology
537360|NCT00340158|Epidemiology|epidemiology
537361|NCT00340171|Intrauterine Growth Retardation|intrauterine growth retardation
537362|NCT00340171|Macrosomia|macrosomia
537363|NCT00340171|Fetal Volume|fetal volume
537364|NCT00340171|Fetal Anatomy|fetal anatomy
537365|NCT00340171|Prediction of Birthweight|prediction of birthweight
537366|NCT00340171|3D Ultrasonography|3d ultrasonography
537367|NCT00340171|Fetus|fetus
537368|NCT00340171|Prenatal Diagnosis|prenatal diagnosis
537369|NCT00340184|concurrent|concurrent
537370|NCT00340184|chemoradiation|chemoradiation
537371|NCT00340184|paclitaxel|paclitaxel
537372|NCT00340184|carboplatin|carboplatin
537381|NCT00340223|Disease Progression|disease progression
537382|NCT00340223|RNA|rna
537383|NCT00340249|Premature Rupture of the Membranes (PROM)|premature rupture of the membranes (prom)
537384|NCT00340249|Preterm Delivery|preterm delivery
537385|NCT00340249|In-Utero Fetal Demise|in-utero fetal demise
537386|NCT00340249|Chorioamnionitis|chorioamnionitis
537387|NCT00340249|Spontaneous Abortion|spontaneous abortion
537388|NCT00340262|Supplemental Hormone Use|supplemental hormone use
537389|NCT00340262|Osteoporosis|osteoporosis
537390|NCT00340262|Endogenous Sex Hormones|endogenous sex hormones
537391|NCT00340275|Bacterial Vaginosis|bacterial vaginosis
537392|NCT00340275|Vaginal Infection|vaginal infection
537393|NCT00340275|Vaginitis|vaginitis
537394|NCT00340275|Cohort Study|cohort study
537395|NCT00340275|Sexually Transmitted Disease|sexually transmitted disease
537402|NCT00340301|Polymorphism|polymorphism
537403|NCT00340301|Neurodegenerative Diseases|neurodegenerative diseases
537404|NCT00340301|ALS|als
537405|NCT00340314|symptomatic|symptomatic
537406|NCT00340314|paroxysmal|paroxysmal
537407|NCT00340314|atrial fibrillation|atrial fibrillation
537408|NCT00340327|healthy subjects|healthy subjects
537409|NCT00340340|Population-Based Case Control Study|population-based case control study
537410|NCT00340340|Lung Cancer|lung cancer
537411|NCT00340340|Epidemiology|epidemiology
537412|NCT00340340|Smoking|smoking
537413|NCT00340340|Smokers|smokers
537414|NCT00340340|Genetics|genetics
537415|NCT00340353|Gene Expression|gene expression
537416|NCT00340353|Drug Sensitivity|drug sensitivity
537417|NCT00340353|TFE3|tfe3
537418|NCT00340353|ASPL-TFE3|aspl-tfe3
537419|NCT00340353|NOD-SCID Mice|nod-scid mice
537420|NCT00340353|Sarcoma|sarcoma
537421|NCT00340353|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
537422|NCT00340353|ASPS|asps
537423|NCT00340366|Homocysteine|homocysteine
537424|NCT00340366|Vitamin B12|vitamin b12
537425|NCT00340366|Birth Defects|birth defects
537426|NCT00340366|Pregnancy|pregnancy
537427|NCT00340366|Folate|folate
537428|NCT00340366|Irish Individuals|irish individuals
537429|NCT00340379|Psychotic|psychotic
537430|NCT00340392|Mammary Stem Cells|mammary stem cells
537431|NCT00340392|Breast Cancer|breast cancer
537432|NCT00340392|Cancer Stem Cells|cancer stem cells
537433|NCT00340392|Gene Expression Profiling|gene expression profiling
537434|NCT00340405|Blood|blood
537435|NCT00340405|Lung Cancer|lung cancer
537436|NCT00340405|Occupational Exposure|occupational exposure
537437|NCT00340405|Radon|radon
537438|NCT00340405|Arsenic|arsenic
537439|NCT00340418|Bronchoalveolar Lavage|bronchoalveolar lavage
537440|NCT00340418|Acute Rejection|acute rejection
537441|NCT00340418|Chronic Rejection|chronic rejection
537442|NCT00340418|Genetic Polymorphisms|genetic polymorphisms
537443|NCT00340418|Innate Immunity|innate immunity
537444|NCT00340418|Lung Transplantation|lung transplantation
537445|NCT00340418|Lung Allograft Rejection|lung allograft rejection
537446|NCT00340431|Human|human
537447|NCT00340431|Clinical Trial|clinical trial
537448|NCT00340431|Mosquito|mosquito
537449|NCT00340444|Linkage|linkage
537450|NCT00340444|Covariates|covariates
537451|NCT00340444|Association|association
537453|NCT00340444|Inflammatory Bowel Disease|inflammatory bowel disease
537454|NCT00340444|Ulcerative Colitis|ulcerative colitis
537455|NCT00340444|Crohn's Disease|crohn's disease
537456|NCT00340457|Case-Control Study|case-control study
537457|NCT00340457|Renal Cell Carcinoma|renal cell carcinoma
537458|NCT00340457|Kidney Cancer|kidney cancer
537459|NCT00340457|Diet|diet
537460|NCT00340457|Occupation|occupation
537461|NCT00340470|Injury|injury
537462|NCT00340470|Motor Vehicle|motor vehicle
537463|NCT00340470|Parenting|parenting
537464|NCT00340470|Randomized Trial|randomized trial
537465|NCT00340470|Behavioral Intervention|behavioral intervention
537466|NCT00340483|Smoking Cessation|smoking cessation
537467|NCT00340483|Young Adults|young adults
537468|NCT00340483|Quit Smoking|quit smoking
537469|NCT00340483|Email|email
537470|NCT00340483|Social Marketing|social marketing
537471|NCT00340496|Schwannoma|schwannoma
537472|NCT00340496|Meningioma|meningioma
537473|NCT00340496|Follow-Up|follow-up
537474|NCT00340496|Radiation Therapy|radiation therapy
537475|NCT00340496|Cohort|cohort
537476|NCT00340509|Genetics|genetics
537477|NCT00340509|Population|population
537478|NCT00340509|CHD Risk|chd risk
537479|NCT00340509|Epidemiology|epidemiology
537480|NCT00340509|Gene Mapping|gene mapping
537482|NCT00340522|Brain Tumor|brain tumor
537483|NCT00340522|Embryonal Tumor|embryonal tumor
537484|NCT00340522|Tumor Array|tumor array
537485|NCT00340522|Childhood Cancer|childhood cancer
537486|NCT00340522|Plexiform Neurofibromas|plexiform neurofibromas
537487|NCT00340522|Drug Screening|drug screening
537488|NCT00340522|Immunohistochemistry|immunohistochemistry
537489|NCT00340535|Disinfection byproducts|disinfection byproducts
537490|NCT00340535|Genetic Variation|genetic variation
537491|NCT00340535|Trihalomethanes|trihalomethanes
537492|NCT00340548|Genotyping|genotyping
537493|NCT00340548|Polymorphisms|polymorphisms
537494|NCT00340548|Co-Infection|co-infection
537495|NCT00340548|Chemokines|chemokines
537496|NCT00340548|Associations|associations
537498|NCT00340548|HCV|hcv
537499|NCT00340548|Hepatitis C|hepatitis c
537500|NCT00340548|Hemophilia|hemophilia
537501|NCT00340561|Test Track|test track
537502|NCT00340561|Distraction|distraction
537503|NCT00340561|Motor Vehicle|motor vehicle
537504|NCT00340561|Learning|learning
537505|NCT00340561|Inexperience|inexperience
537506|NCT00340574|Human|human
537507|NCT00340574|Clinical Trial|clinical trial
537508|NCT00340574|Mosquito|mosquito
537509|NCT00340574|Healthy Volunteer|healthy volunteer
537510|NCT00340574|HV|hv
537511|NCT00340587|Zona Pellucida|zona pellucida
537512|NCT00340587|Human Eggs|human eggs
537513|NCT00340587|ZP1, ZP2, ZP3|zp1, zp2, zp3
537514|NCT00340587|Fertilization|fertilization
537515|NCT00340600|Cancer|cancer
537516|NCT00340600|DES|des
537517|NCT00340600|Endocrine Disrupting Chemicals|endocrine disrupting chemicals
537518|NCT00340600|In Utero|in utero
537519|NCT00340613|Type 1 Diabetes|type 1 diabetes
537520|NCT00340613|Poorly controlled glucose|poorly controlled glucose
537521|NCT00340613|adolescents|adolescents
537522|NCT00340626|Whole Genome Sequencing|whole genome sequencing
537523|NCT00340626|Cleft Palate|cleft palate
537524|NCT00340639|Adherence|adherence
537525|NCT00340639|Chronic Illness|chronic illness
537526|NCT00340639|Adolescent|adolescent
537527|NCT00340639|Family|family
537528|NCT00340639|Self-Regulation|self-regulation
537529|NCT00340652|Soy|soy
537530|NCT00340652|Isoflavones|isoflavones
537531|NCT00340652|Infant Formula|infant formula
537532|NCT00340652|Sexual Development|sexual development
537533|NCT00340652|Hormone|hormone
537534|NCT00340665|Soy|soy
537535|NCT00340665|Infant Formula|infant formula
537536|NCT00340665|Sexual Development|sexual development
537537|NCT00340665|Hormone|hormone
537539|NCT00340678|Angiotensin II Receptor Antagonist|angiotensin ii receptor antagonist
537540|NCT00340678|Therapeutic Trial|therapeutic trial
537541|NCT00340678|Glomerular Filtration Rate|glomerular filtration rate
537542|NCT00340678|Kidney Biopsy|kidney biopsy
537543|NCT00340678|Non-Insulin Dependent Diabetes Mellitus|non-insulin dependent diabetes mellitus
537544|NCT00340691|Parasite|parasite
537545|NCT00340691|Chemotherapy|chemotherapy
537546|NCT00340691|Wuchereria Bancrofti|wuchereria bancrofti
537547|NCT00340704|tamsulosin|tamsulosin
537548|NCT00340704|pediatric|pediatric
537549|NCT00340704|neurogenic bladder|neurogenic bladder
537550|NCT00340717|Methylation|methylation
537551|NCT00340717|Genes|genes
537552|NCT00340717|Screening|screening
537553|NCT00340717|Prospective|prospective
537554|NCT00340717|Diagnosis|diagnosis
537555|NCT00340730|Health Education|health education
537556|NCT00340730|Mentoring|mentoring
537557|NCT00340730|Parenting|parenting
537558|NCT00340730|Social Skills Training|social skills training
537559|NCT00340730|Violence|violence
537560|NCT00340730|Intervention|intervention
537561|NCT00340730|Youth Injury|youth injury
537566|NCT00340743|Comet Assay|comet assay
537567|NCT00340743|Diet|diet
537568|NCT00340743|Healthy Volunteer|healthy volunteer
537569|NCT00340756|GCMS|gcms
537570|NCT00340756|LCMS-MS|lcms-ms
537571|NCT00340769|Cytokines|cytokines
537572|NCT00340769|Inflammation|inflammation
537573|NCT00340769|mRNA Stability|mrna stability
537574|NCT00340769|Pygmy|pygmy
537575|NCT00340769|Zinc Finger Proteins|zinc finger proteins
537576|NCT00340769|Ethnic Group|ethnic group
537577|NCT00340782|Menstrual Cycles|menstrual cycles
537578|NCT00340782|Early Pregnancy|early pregnancy
537579|NCT00340782|Reproductive Hormones|reproductive hormones
537580|NCT00340782|Stress|stress
537581|NCT00340782|Adrenal Function|adrenal function
537582|NCT00340795|Media Analysis|media analysis
537583|NCT00340795|Nutrition|nutrition
537584|NCT00340795|Physical Activity|physical activity
537585|NCT00340795|After-School|after-school
537586|NCT00340795|Exercise|exercise
537587|NCT00340808|Endometrial Cancer|endometrial cancer
537593|NCT00340834|FTY720|fty720
537594|NCT00340834|Interferon|interferon
537595|NCT00340834|RRMS|rrms
537596|NCT00340834|Multiple Sclerosis|multiple sclerosis
537597|NCT00340834|Efficacy|efficacy
537598|NCT00340847|Molecular Profiling|molecular profiling
537599|NCT00340847|In Situ Hybridization|in situ hybridization
537600|NCT00340847|SAGE|sage
537601|NCT00340847|Tumor Markers|tumor markers
537602|NCT00340847|IHC|ihc
537603|NCT00340847|Lung Cancer|lung cancer
537604|NCT00340847|Genetics|genetics
537605|NCT00340860|Ultrasound|ultrasound
537606|NCT00340860|Biobank|biobank
537607|NCT00340860|Urine|urine
537608|NCT00340860|Blood|blood
537609|NCT00340860|Exposure|exposure
537610|NCT00340860|Norway Mother and Child Study|norway mother and child study
537611|NCT00340873|Molecular Epidemiology|molecular epidemiology
537612|NCT00340873|Cross-Sectional|cross-sectional
537613|NCT00340873|Gene-Enviroment Interaction|gene-enviroment interaction
537614|NCT00340886|Genetic Susceptibility|genetic susceptibility
537615|NCT00340886|Single Nucleotide Polymorphism|single nucleotide polymorphism
537616|NCT00340886|Environmental Risk Factor|environmental risk factor
537617|NCT00340886|Allelic Variants|allelic variants
537618|NCT00340886|Ascertainment by Genotype|ascertainment by genotype
537624|NCT00340912|Skin Biopsy|skin biopsy
537625|NCT00340938|Adherence|adherence
537626|NCT00340938|Education|education
537627|NCT00340938|Problem Solving|problem solving
537628|NCT00340938|Motivation|motivation
537629|NCT00340938|Locus of Responsibility|locus of responsibility
537630|NCT00340951|Regulatory T Cells|regulatory t cells
537631|NCT00340951|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
537632|NCT00340951|Genetic Polymorphism|genetic polymorphism
537633|NCT00340951|Innate Immunity|innate immunity
537634|NCT00340951|Transplantation|transplantation
537635|NCT00340951|Lung Transplantation|lung transplantation
537636|NCT00340964|Photography|photography
537637|NCT00340964|Self-Esteem|self-esteem
537638|NCT00340964|Perceived Social Stigma|perceived social stigma
537639|NCT00340964|Hopefulness|hopefulness
537640|NCT00340964|Cleft Lip and Palate|cleft lip and palate
537641|NCT00340964|Hemifacial Microsomia|hemifacial microsomia
537642|NCT00340964|Treacher Collins Syndrome|treacher collins syndrome
537643|NCT00340964|Mobius Syndrome|mobius syndrome
537644|NCT00340964|Apert Syndrome|apert syndrome
537645|NCT00340964|Videography|videography
537646|NCT00340964|Craniofacial Differences|craniofacial differences
537647|NCT00340964|Self -Esteem|self -esteem
537648|NCT00340977|Birth Defects|birth defects
537649|NCT00340977|Case-Control Studies|case-control studies
537650|NCT00340977|Genetic Susceptibility|genetic susceptibility
537651|NCT00340990|Tuberculosis|tuberculosis
537652|NCT00340990|HIV|hiv
537653|NCT00340990|CD4+ T Cell|cd4+ t cell
537654|NCT00340990|Interferon-Gamma|interferon-gamma
537655|NCT00340990|Lymphocyte Proliferation|lymphocyte proliferation
537656|NCT00341003|Plasmodium Falciparum|plasmodium falciparum
537657|NCT00341003|Hemoglobin E|hemoglobin e
537658|NCT00341003|Mefloquine|mefloquine
537659|NCT00341003|Artemisinin|artemisinin
537660|NCT00341003|Piperaquine|piperaquine
537661|NCT00341003|Malaria|malaria
537662|NCT00341016|Radiation|radiation
537663|NCT00341029|Longitudinal Study|longitudinal study
537664|NCT00341029|Chromosomal Effects|chromosomal effects
537665|NCT00341029|Sister Chromatid Exchanges|sister chromatid exchanges
537666|NCT00341029|Micronuclei|micronuclei
537667|NCT00341029|Stimulants|stimulants
537668|NCT00341029|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
537669|NCT00341029|ADHD|adhd
537670|NCT00341042|Normal Values|normal values
537588|NCT00340808|Epidemiology|epidemiology
537671|NCT00341042|Complete Blood Count|complete blood count
537672|NCT00341042|HIV|hiv
537673|NCT00341042|Tuberculosis|tuberculosis
537674|NCT00341042|Flow Cytometry|flow cytometry
537675|NCT00341055|Anemia|anemia
537676|NCT00341055|Hemoglobin|hemoglobin
537677|NCT00341055|Chemotherapy|chemotherapy
537678|NCT00341055|Epoetin alfa|epoetin alfa
537679|NCT00341068|Birth Defects|birth defects
537680|NCT00341068|Genetics|genetics
537681|NCT00341068|Folic Acid|folic acid
537682|NCT00341068|Gene-Environment Interactions|gene-environment interactions
537683|NCT00341068|Neural Tube Defects|neural tube defects
537684|NCT00341068|Cleft Lip|cleft lip
537685|NCT00341068|Cleft Palate|cleft palate
537686|NCT00341068|Mutations|mutations
537687|NCT00341081|Short Tandem Repeat|short tandem repeat
537688|NCT00341081|Molecular Epidemiology|molecular epidemiology
537689|NCT00341081|Viral Infection|viral infection
537690|NCT00341081|Mixture Detection|mixture detection
537691|NCT00341081|Intervention & Education|intervention & education
537692|NCT00341081|Intervention|intervention
537693|NCT00341081|Education|education
537694|NCT00341094|Cohort|cohort
537695|NCT00341094|Radiation|radiation
537696|NCT00341094|In Utero|in utero
537697|NCT00341094|Genomic|genomic
537698|NCT00341107|Cancer|cancer
537699|NCT00341107|Genes|genes
537700|NCT00341107|Screening|screening
537701|NCT00341107|Primary Care|primary care
537702|NCT00341107|Inherited Susceptibility|inherited susceptibility
537703|NCT00341120|Genotypes|genotypes
537704|NCT00341120|Mutation|mutation
537705|NCT00341120|Folate|folate
537706|NCT00341120|Male Infertility|male infertility
537707|NCT00341120|Nutrition|nutrition
537708|NCT00341133|Laterality|laterality
537709|NCT00341133|Heterotaxy|heterotaxy
537710|NCT00341133|Holoprosencephaly|holoprosencephaly
537711|NCT00341133|Genetic Testing|genetic testing
537712|NCT00341133|Congential Cardiac Malformations|congential cardiac malformations
537713|NCT00341133|Disturbed Internal Organ Positioning|disturbed internal organ positioning
537714|NCT00341146|Cancer|cancer
537715|NCT00341146|Catonese Chinese|catonese chinese
537716|NCT00341146|Genetic Predisposition|genetic predisposition
537717|NCT00341146|Genotyping|genotyping
537718|NCT00341146|Triad analysis|triad analysis
537719|NCT00341146|Nasopharyngeal Cancer|nasopharyngeal cancer
537721|NCT00341159|Breast|breast
537722|NCT00341159|BRCA1|brca1
537723|NCT00341159|BRCA2|brca2
536978|NCT00338988|Xeloda|xeloda
537724|NCT00341159|Inherited|inherited
537725|NCT00341159|Association|association
537726|NCT00341159|Breast Cancer|breast cancer
537727|NCT00341159|Population-Based|population-based
537728|NCT00341159|Cancer Susceptibility Alleles|cancer susceptibility alleles
537729|NCT00341172|Retinitis|retinitis
537730|NCT00341172|Cytomegalovirus|cytomegalovirus
537731|NCT00341172|HIV-1|hiv-1
537732|NCT00341172|Polymorphisms|polymorphisms
537733|NCT00341172|HAART|haart
537734|NCT00341185|Biodosimetry|biodosimetry
537735|NCT00341185|Dose Reconstruction|dose reconstruction
537736|NCT00341185|Radioactive Fallout|radioactive fallout
537737|NCT00341185|Thyroid Screening|thyroid screening
537738|NCT00341185|Ultrasound|ultrasound
537739|NCT00341198|Rheumatoid Arthritis|rheumatoid arthritis
537740|NCT00341198|Lupus|lupus
537741|NCT00341198|Scleroderma|scleroderma
537742|NCT00341198|Sjogren's Syndrome|sjogren's syndrome
537743|NCT00341198|Farming|farming
537744|NCT00341198|Autoimmune Disease|autoimmune disease
537745|NCT00341198|Exposure|exposure
537747|NCT00341211|Cancer|cancer
537748|NCT00341211|Epidemiology|epidemiology
537749|NCT00341211|Immunology|immunology
537750|NCT00341211|Virology|virology
537751|NCT00341224|Aggression|aggression
537752|NCT00341224|Violence|violence
537753|NCT00341224|Adolescents|adolescents
537754|NCT00341224|Randomized Trial|randomized trial
537755|NCT00341224|Behavioral Intervention|behavioral intervention
537756|NCT00341237|Polymorphism|polymorphism
537757|NCT00341237|Genotype|genotype
537758|NCT00341237|Phenotype|phenotype
537759|NCT00341237|Environmental Factor|environmental factor
537760|NCT00341237|Single Nucleotide Polymorphism|single nucleotide polymorphism
537761|NCT00341250|Blood Stage|blood stage
537762|NCT00341250|Investigational|investigational
537763|NCT00341250|Endemic|endemic
537764|NCT00341250|Malaria|malaria
537765|NCT00341263|Twins|twins
537766|NCT00341263|Clinical Research|clinical research
537767|NCT00341263|Endocrinology|endocrinology
537768|NCT00341263|Breast Cancer|breast cancer
537769|NCT00341263|Biochemical Epidemiology|biochemical epidemiology
537770|NCT00341276|Esophageal Cancer|esophageal cancer
537771|NCT00341276|Genetics|genetics
537772|NCT00341276|Polymorphism|polymorphism
537773|NCT00341276|Susceptibility Genes|susceptibility genes
537774|NCT00341276|Tumor|tumor
537775|NCT00341289|Submersion|submersion
537776|NCT00341289|Epidemiology|epidemiology
537777|NCT00341289|Fatal|fatal
537778|NCT00341289|Child|child
537779|NCT00341289|Swim|swim
537780|NCT00341289|Drowning|drowning
537781|NCT00341289|Survey|survey
537782|NCT00341302|HIV|hiv
537783|NCT00341302|AIDS|aids
537784|NCT00341302|Perinatal|perinatal
537785|NCT00341302|Transmission|transmission
537786|NCT00341302|Antiretroviral|antiretroviral
537787|NCT00341302|Outcomes|outcomes
537788|NCT00341315|Epidemiology|epidemiology
537789|NCT00341315|DDT|ddt
537790|NCT00341315|BMI|bmi
537791|NCT00341315|Serum|serum
537792|NCT00341315|Case-Control Study|case-control study
537793|NCT00341328|India|india
537794|NCT00341328|Pulmonary Tuberculosis|pulmonary tuberculosis
537795|NCT00341328|Category-I Pulmonary Tuberculosis|category-i pulmonary tuberculosis
537796|NCT00341328|Immunomodulator|immunomodulator
537797|NCT00341328|Mycobacterium w|mycobacterium w
537798|NCT00341341|Smoking|smoking
537799|NCT00341341|Smoking Cessation|smoking cessation
537800|NCT00341341|GSTM1|gstm1
537801|NCT00341341|Glutathione S. Transferase|glutathione s. transferase
537802|NCT00341341|Lung Cancer|lung cancer
537803|NCT00341341|Smokers|smokers
537804|NCT00341341|Genetic Risk Communication|genetic risk communication
537805|NCT00341354|Pneumonia|pneumonia
537806|NCT00341354|Bacterial Infection|bacterial infection
537807|NCT00341354|Nosocomial Infection|nosocomial infection
537808|NCT00341354|Trachea|trachea
537809|NCT00341354|Biofilm|biofilm
537810|NCT00341354|Mucus Shaver|mucus shaver
537811|NCT00341367|Analgesic|analgesic
537812|NCT00341367|Back Pain|back pain
537813|NCT00341367|Lumbar Disc|lumbar disc
537814|NCT00341367|Nerve|nerve
537815|NCT00341367|Radiculopathy|radiculopathy
537816|NCT00341380|Cancer|cancer
537817|NCT00341380|Lung Cancer|lung cancer
537818|NCT00341380|Surgical Resection|surgical resection
537819|NCT00341380|Non-Small Cell Lung Cancer|non-small cell lung cancer
537820|NCT00341380|NSCLC|nsclc
537821|NCT00341393|HIV Infection|hiv infection
537822|NCT00341393|AIDS|aids
537823|NCT00341393|Viral Load|viral load
537824|NCT00341393|Retroviral Treatment|retroviral treatment
537825|NCT00341393|Uganda|uganda
537826|NCT00341406|Obesity|obesity
537827|NCT00341406|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
537828|NCT00341406|Adipose Cell Turn Over|adipose cell turn over
537829|NCT00341419|ABC Transporter|abc transporter
537830|NCT00341419|ABCC6|abcc6
537831|NCT00341419|Slkin Laxity|slkin laxity
537832|NCT00341419|Genetic Association|genetic association
537833|NCT00341419|Angiod Streaks|angiod streaks
537834|NCT00341419|Pseudoxanthoma Elasticum|pseudoxanthoma elasticum
537835|NCT00341419|PXE|pxe
537836|NCT00341432|NRT Study|nrt study
537837|NCT00341432|Smoking Cessation|smoking cessation
537838|NCT00341445|Environmental Intervention|environmental intervention
537839|NCT00341445|Indoor Allergens|indoor allergens
537840|NCT00341445|Environment|environment
537841|NCT00341458|Breast Cancer|breast cancer
537842|NCT00341458|Environment|environment
537843|NCT00341458|Genetics|genetics
537844|NCT00341458|Epidemiology|epidemiology
537845|NCT00341471|School|school
537846|NCT00341471|Sixth Grade|sixth grade
537847|NCT00341471|Curricular|curricular
537848|NCT00341471|Howard University|howard university
537849|NCT00341471|D.C.|d.c.
537850|NCT00341471|Adolescent Pregnancy|adolescent pregnancy
537851|NCT00341471|Intervention|intervention
537852|NCT00341484|Genetics|genetics
537853|NCT00341484|Liver Cancer|liver cancer
537854|NCT00341484|HIV|hiv
537855|NCT00341497|Leukoplakia|leukoplakia
537856|NCT00341497|Oral Mucosa|oral mucosa
537857|NCT00341497|Biomarkers|biomarkers
537858|NCT00341510|Risk Behavior|risk behavior
537859|NCT00341510|Health Status|health status
537860|NCT00341510|Adolescence|adolescence
537861|NCT00341510|Positive Health Behaviors|positive health behaviors
537862|NCT00341510|Social Support|social support
537863|NCT00341510|Health Behavior|health behavior
537864|NCT00341510|Survey|survey
537865|NCT00341523|Cytology|cytology
537866|NCT00341523|Endoscopy|endoscopy
537867|NCT00341523|Esophageal Cancer|esophageal cancer
537868|NCT00341523|Early Detection|early detection
537869|NCT00341523|Treatment|treatment
537870|NCT00348153|Uveitis|uveitis
537871|NCT00348153|Adalimumab|adalimumab
537872|NCT00348153|TNF alpha|tnf alpha
537873|NCT00348179|Vascular abnormalities|vascular abnormalities
537874|NCT00348179|Type 1 diabetes|type 1 diabetes
537875|NCT00348179|Healthy control subjects|healthy control subjects
537876|NCT00348192|Alzheimer's Disease|alzheimer's disease
537877|NCT00348192|cognition global functioning|cognition global functioning
537878|NCT00348192|symptomatic|symptomatic
537879|NCT00348192|SB-742457|sb-742457
537880|NCT00348218|Neurovision|neurovision
537881|NCT00348218|Myopia Therapy|myopia therapy
537882|NCT00348231|diabetes mellitus, biphasic insulin analogue|diabetes mellitus, biphasic insulin analogue
537883|NCT00348270|Cataract|cataract
537884|NCT00348270|Intraocular lens|intraocular lens
537885|NCT00348270|Aberration|aberration
537886|NCT00348270|Wavefront|wavefront
537887|NCT00348296|Scleroderma, Systemic|scleroderma, systemic
537888|NCT00348309|apolipoprotein E|apolipoprotein e
537889|NCT00348309|Alzheimer's disease|alzheimer's disease
537890|NCT00348309|cognition|cognition
537891|NCT00348309|rosiglitazone|rosiglitazone
537892|NCT00348309|adjunctive therapy|adjunctive therapy
537893|NCT00348361|Hay fever|hay fever
537894|NCT00348361|biomarkers|biomarkers
537895|NCT00348374|type two diabetes, insulin, HbA1c|type two diabetes, insulin, hba1c
537896|NCT00348387|Imovax polio|imovax polio
537897|NCT00348387|poliomyelitis|poliomyelitis
537898|NCT00348413|Graves ophthalmopathy/therapy|graves ophthalmopathy/therapy
537899|NCT00348413|Randomized controlled trial|randomized controlled trial
537900|NCT00348413|Methylprednisolone|methylprednisolone
537901|NCT00348413|Methotrexate|methotrexate
537902|NCT00348426|Food Borne Botulism|food borne botulism
537903|NCT00348452|osteoarthritis pain; knee; hip; extended release analgesia; opioid|osteoarthritis pain; knee; hip; extended release analgesia; opioid
537904|NCT00348465|Brachytherapy|brachytherapy
537905|NCT00348465|Prostate volume|prostate volume
537906|NCT00348478|trachoma|trachoma
537907|NCT00348478|chlamydia trachomatis|chlamydia trachomatis
537909|NCT00348478|health education|health education
537910|NCT00348478|face washing|face washing
537911|NCT00349089|Non-small cell lung cancer|non-small cell lung cancer
537912|NCT00349089|adjuvant therapy|adjuvant therapy
537913|NCT00349089|clinical feasibility rate|clinical feasibility rate
537914|NCT00349102|Non-small-cell lung cancer|non-small-cell lung cancer
537915|NCT00349102|Breath-hold|breath-hold
537916|NCT00349102|Radiation pneumonitis|radiation pneumonitis
537917|NCT00349102|Serum cytokines|serum cytokines
537918|NCT00349102|LENT-SOMA scale|lent-soma scale
537919|NCT00349102|Non-metastatic non-small-cell lung cancer|non-metastatic non-small-cell lung cancer
537920|NCT00349128|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
537921|NCT00349141|Pandemic influenza|pandemic influenza
537922|NCT00349167|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
537923|NCT00349180|Total Hip Replacement|total hip replacement
537924|NCT00349180|Enoxaparin|enoxaparin
537925|NCT00349193|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
537926|NCT00349219|first-line|first-line
537927|NCT00349219|second-line|second-line
537928|NCT00349219|targeted therapy|targeted therapy
537929|NCT00349232|childhood obesity|childhood obesity
537930|NCT00349232|lifestyle intervention|lifestyle intervention
537931|NCT00349232|school health program|school health program
537932|NCT00349232|special primary education|special primary education
537933|NCT00349245|Endotracheal|endotracheal
537934|NCT00349245|Awake fiberoptic intubation|awake fiberoptic intubation
537935|NCT00349245|Dexmedetomidine|dexmedetomidine
537936|NCT00349245|Remifentanil|remifentanil
537937|NCT00349258|OHSS|ohss
537938|NCT00349258|PCOS|pcos
537939|NCT00349258|Previous high response|previous high response
537940|NCT00349258|GnRH antagonist|gnrh antagonist
537941|NCT00349258|GnRH agonist|gnrh agonist
537942|NCT00349258|IVF|ivf
537943|NCT00349271|Chagas Cardiomyopathy|chagas cardiomyopathy
537944|NCT00349271|Dilated Cardiomyopathy|dilated cardiomyopathy
537945|NCT00349271|stem cells|stem cells
537946|NCT00349271|Therapeutics|therapeutics
537947|NCT00349271|Randomized Controlled Trials|randomized controlled trials
537948|NCT00349284|Hyperlipidemia Combined and features of the metabolic syndrome, efficacy combination fenofibrate ezetimibe|hyperlipidemia combined and features of the metabolic syndrome, efficacy combination fenofibrate ezetimibe
537949|NCT00349323|Community directed treatment,|community directed treatment,
537950|NCT00349323|soil-transmitted helminth infections,|soil-transmitted helminth infections,
537951|NCT00349323|treatment coverage,|treatment coverage,
537952|NCT00349323|Zambia|zambia
537953|NCT00349375|Hyperlipidemia Combined, efficacy combination fenofibrate simvastatin|hyperlipidemia combined, efficacy combination fenofibrate simvastatin
537954|NCT00349388|Mesalamine|mesalamine
537955|NCT00349388|Ulcerative Colitis|ulcerative colitis
537956|NCT00349401|pain|pain
537957|NCT00349401|chronic pain|chronic pain
537958|NCT00349401|morphine|morphine
537959|NCT00349401|ketorolac|ketorolac
537960|NCT00349414|Advanced glaucoma|advanced glaucoma
537961|NCT00349414|Refractory glaucoma|refractory glaucoma
537962|NCT00349414|Cyclophotocoagulation|cyclophotocoagulation
537963|NCT00349414|Transscleral cyclophotocoagulation|transscleral cyclophotocoagulation
537964|NCT00349414|Micropulse transscleral cyclophotocoagulation|micropulse transscleral cyclophotocoagulation
537965|NCT00349427|Insulin|insulin
537966|NCT00349427|BRL49653 /rosiglitazone|brl49653 /rosiglitazone
538565|NCT00338702|Foot|foot
537967|NCT00349427|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
537968|NCT00349440|Dry eye|dry eye
537969|NCT00349453|Deferiprone|deferiprone
537971|NCT00349453|Desferrioxamine|desferrioxamine
537972|NCT00349453|Hemochromatosis|hemochromatosis
537973|NCT00349453|Iron overload|iron overload
537974|NCT00349453|Thalassemia|thalassemia
537975|NCT00349466|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
537976|NCT00349466|KCS|kcs
537977|NCT00349466|Dry Eye|dry eye
537978|NCT00349479|stroke|stroke
537979|NCT00349479|tissue plasminogen activator|tissue plasminogen activator
537980|NCT00349479|t-PA|t-pa
537981|NCT00349479|barrier assessment and interactive educational intervention|barrier assessment and interactive educational intervention
537982|NCT00349479|BA-IEI|ba-iei
537983|NCT00349492|Small Cell Lung Cancer|small cell lung cancer
537984|NCT00349492|Extensive Disease|extensive disease
537985|NCT00349492|Chemotherapy|chemotherapy
537986|NCT00349492|Randomisation|randomisation
537987|NCT00349505|previous treatment surgery + 6 cycles of platinum based chemotherapy|previous treatment surgery + 6 cycles of platinum based chemotherapy
537988|NCT00349518|Chronic and Advanced Phase CML and|chronic and advanced phase cml and
537989|NCT00349518|Philadelphia Chromosome Positive ALL with imatinib intolerance or resistance|philadelphia chromosome positive all with imatinib intolerance or resistance
537990|NCT00349544|Neck pain|neck pain
537991|NCT00349544|Cervicalgia|cervicalgia
537992|NCT00349544|Quality of life|quality of life
537993|NCT00349544|Disability|disability
537994|NCT00349557|Prostate Cancer|prostate cancer
537995|NCT00349557|High-Risk Prostate Cancer|high-risk prostate cancer
537996|NCT00349557|1st line therapy|1st line therapy
537997|NCT00349570|thrombus|thrombus
537998|NCT00349570|aspiration catheter|aspiration catheter
537999|NCT00349596|Hypomethylating agent|hypomethylating agent
538000|NCT00349596|Chemotherapy|chemotherapy
538001|NCT00349596|Relapsed or refractory ALL|relapsed or refractory all
538002|NCT00349596|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
538003|NCT00349622|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
538004|NCT00349622|ALS|als
538005|NCT00349622|ceftriaxone|ceftriaxone
538006|NCT00349622|cephalosporin antibiotic|cephalosporin antibiotic
538007|NCT00349622|motor neurons|motor neurons
538008|NCT00349635|Weight loss and diet.|weight loss and diet.
538009|NCT00349648|subacromial|subacromial
538010|NCT00349648|impingement|impingement
538011|NCT00349648|acromioplasty|acromioplasty
538012|NCT00349648|physiotherapy|physiotherapy
538013|NCT00349661|clopidogrel|clopidogrel
538014|NCT00349661|omeprazole|omeprazole
538015|NCT00349674|Wegener's granulomatosis,|wegener's granulomatosis,
538016|NCT00349674|microscopic polyangiitis,|microscopic polyangiitis,
538017|NCT00349674|ANCA-associated vasculitis,|anca-associated vasculitis,
538018|NCT00349674|methotrexate,|methotrexate,
538019|NCT00349674|azathioprine|azathioprine
538020|NCT00349700|healing|healing
538021|NCT00349700|skin|skin
538022|NCT00349700|infection|infection
538023|NCT00349700|wound therapy|wound therapy
537298|NCT00339963|Lymphoma|lymphoma
537299|NCT00339963|Gene Expression|gene expression
537300|NCT00339963|Molecular Diagnosis|molecular diagnosis
537301|NCT00339963|Prognosis|prognosis
537302|NCT00339963|Leukemia|leukemia
537303|NCT00339963|Myeloma|myeloma
537304|NCT00339963|Lymphoid Malignancy|lymphoid malignancy
537311|NCT00339976|ALS|als
538024|NCT00349713|Plasmodium falciparum Malaria, Mali, adjuvant|plasmodium falciparum malaria, mali, adjuvant
538025|NCT00349726|NICHD Neonatal Research Network|nichd neonatal research network
538026|NCT00349726|Pharmacokinetics|pharmacokinetics
538027|NCT00349726|Inositol|inositol
538028|NCT00349726|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
538029|NCT00349726|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
538030|NCT00349726|Prematurity|prematurity
538031|NCT00349739|age related macular degeneration|age related macular degeneration
538032|NCT00349752|certolizumab pegol|certolizumab pegol
538033|NCT00349752|Cimzia|cimzia
538034|NCT00349752|Crohn's Disease|crohn's disease
538035|NCT00349752|Inflammatory Bowel Disease|inflammatory bowel disease
538036|NCT00349765|cardiovascular disease|cardiovascular disease
538037|NCT00349765|saturated fat|saturated fat
538038|NCT00349765|trans fat|trans fat
538039|NCT00349765|polyunsaturated fat|polyunsaturated fat
538040|NCT00349765|diet|diet
538041|NCT00349765|intramyocellular lipid|intramyocellular lipid
538042|NCT00349791|Natural Menopause|natural menopause
538043|NCT00349804|temperature|temperature
538044|NCT00349804|Temperature Homeostasis|temperature homeostasis
538045|NCT00349869|inflammatory arthritis|inflammatory arthritis
538046|NCT00349869|rheumatoid arthritis|rheumatoid arthritis
538047|NCT00349869|knee osteoarthritis|knee osteoarthritis
538048|NCT00349869|arthritis|arthritis
538049|NCT00349869|yoga|yoga
538050|NCT00349895|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
538051|NCT00349895|Stent implantation|stent implantation
538052|NCT00349908|Atherosclerosis,Wide Neck Aneurysm|atherosclerosis,wide neck aneurysm
538053|NCT00349921|pain|pain
538054|NCT00349921|chronic pain|chronic pain
538055|NCT00349921|clonidine|clonidine
538056|NCT00349921|adenosine|adenosine
538057|NCT00349921|complex regional pain syndrome|complex regional pain syndrome
538058|NCT00349921|CRPS|crps
538059|NCT00349921|a2-adrenergic agonists|a2-adrenergic agonists
538060|NCT00349921|alpha2-adrenergic agonists|alpha2-adrenergic agonists
538061|NCT00349934|Metastatic breast cancer|metastatic breast cancer
538062|NCT00349934|IMP321|imp321
538063|NCT00349934|hLAG-3Ig|hlag-3ig
538064|NCT00349934|LAG-3|lag-3
538065|NCT00349934|CD223|cd223
538066|NCT00349934|Chemotherapy|chemotherapy
538067|NCT00349934|Paclitaxel|paclitaxel
538068|NCT00349934|Combination therapy|combination therapy
538069|NCT00349960|Erythropoiesis stimulating agent|erythropoiesis stimulating agent
538070|NCT00349960|Dosing frequency|dosing frequency
538071|NCT00349960|Hemodialysis|hemodialysis
538072|NCT00349960|Therapeutic equivalence|therapeutic equivalence
538073|NCT00349973|Schizophrenia|schizophrenia
538074|NCT00349973|Positive symptoms|positive symptoms
538075|NCT00349973|Negative symptoms|negative symptoms
538076|NCT00349973|Cognitive deficits|cognitive deficits
15851|NCT03189641|Coronary artery disease|coronary artery disease
538077|NCT00349999|Vibrio cholerae, Cholera, Bangladesh, esophagogastroduodenoscopy, sub-study|vibrio cholerae, cholera, bangladesh, esophagogastroduodenoscopy, sub-study
538079|NCT00350012|visual|visual
538080|NCT00350012|spatial neglect|spatial neglect
538081|NCT00350025|urothelial|urothelial
538082|NCT00350025|urologic|urologic
538083|NCT00350025|neoplasm|neoplasm
538084|NCT00350025|advanced|advanced
538085|NCT00350025|metastatic|metastatic
538086|NCT00350051|Prostate cancer|prostate cancer
538087|NCT00350051|Metastatic androgen-independent prostate cancer|metastatic androgen-independent prostate cancer
538088|NCT00350064|Metabolic Syndrome|metabolic syndrome
538089|NCT00350064|Obesity|obesity
538090|NCT00350064|Exercise|exercise
538091|NCT00350064|Diabetes|diabetes
538092|NCT00350064|Physical Activity|physical activity
538093|NCT00350077|Burns|burns
538094|NCT00350090|Anemia|anemia
538095|NCT00350090|Neoplasms|neoplasms
538096|NCT00350090|Hemoglobin values|hemoglobin values
538390|NCT00351403|Genotype 1|genotype 1
538097|NCT00350116|plaque psoriasis|plaque psoriasis
538098|NCT00350116|Vitamin B12|vitamin b12
538100|NCT00350129|vasospasm|vasospasm
538101|NCT00350129|RVA|rva
538102|NCT00350129|LDF|ldf
538103|NCT00350129|vasospastic subjects|vasospastic subjects
538104|NCT00350129|non-vasospastic subjects|non-vasospastic subjects
538105|NCT00350142|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
538106|NCT00350142|pancreas cancer|pancreas cancer
537497|NCT00340548|HIV|hiv
538107|NCT00350142|locally advanced|locally advanced
538108|NCT00350142|local control|local control
538109|NCT00350142|Gemcitabine|gemcitabine
538110|NCT00350155|Video capsule endoscopy, healthy volunteers, naproxen, omeprazole, lumiracoxib, small bowel|video capsule endoscopy, healthy volunteers, naproxen, omeprazole, lumiracoxib, small bowel
538111|NCT00350168|Blood pressure|blood pressure
538112|NCT00350168|Venous pressure|venous pressure
538113|NCT00350168|Systolic pressure|systolic pressure
538114|NCT00350168|Diastolic pressure|diastolic pressure
538115|NCT00350168|Pulse pressure|pulse pressure
538116|NCT00350194|Fatty Acids, Omega-3|fatty acids, omega-3
538117|NCT00350220|Single ventricle|single ventricle
538118|NCT00350220|Bidirectional Glenn|bidirectional glenn
538119|NCT00350220|Fontan|fontan
538120|NCT00350220|Congenital cardiac disease|congenital cardiac disease
538121|NCT00350220|Red blood cell transfusion|red blood cell transfusion
538122|NCT00350220|oxygen utilization|oxygen utilization
538123|NCT00350220|lactate level|lactate level
538124|NCT00350220|hemoglobin level|hemoglobin level
538125|NCT00350233|Bone Tumors|bone tumors
538126|NCT00350233|Bone Cancer|bone cancer
538127|NCT00350233|Prostate Cancer|prostate cancer
538128|NCT00350233|lung cancer|lung cancer
538129|NCT00350272|HIV-1 treatment naive|hiv-1 treatment naive
538130|NCT00350285|cannabis|cannabis
538131|NCT00350285|marijuana|marijuana
538132|NCT00350298|Monoclonal antibody,|monoclonal antibody,
538133|NCT00350298|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
538134|NCT00350350|XEROSTOMIA|xerostomia
538135|NCT00350350|MOUTH DRYNESS|mouth dryness
538136|NCT00350350|ELDERLY|elderly
538137|NCT00350350|ORAL LUBRICANT|oral lubricant
538138|NCT00350376|asthma|asthma
538139|NCT00350376|allergies|allergies
538140|NCT00350376|Xolair|xolair
538141|NCT00350376|Advair|advair
538142|NCT00350389|Falls, Older persons|falls, older persons
538143|NCT00350402|Parkinson's disease|parkinson's disease
538144|NCT00350402|PD|pd
538145|NCT00350402|masked faces|masked faces
538146|NCT00350402|diminished facial expressivity|diminished facial expressivity
538147|NCT00350402|diminished facial expression|diminished facial expression
538148|NCT00350402|high intensity respiratory muscle strength training|high intensity respiratory muscle strength training
538149|NCT00350402|MST|mst
538150|NCT00350415|ulcerative colitis, inflammatory bowel disease|ulcerative colitis, inflammatory bowel disease
538151|NCT00350428|Acute primary angle closure|acute primary angle closure
538152|NCT00350428|Laser preipheral iridotomy|laser preipheral iridotomy
538153|NCT00350428|Phacoemulsification|phacoemulsification
538154|NCT00350441|Sildenafil Citrate|sildenafil citrate
538155|NCT00350441|Cardiopulmonary bypass|cardiopulmonary bypass
538156|NCT00350441|Open heart surgery|open heart surgery
538157|NCT00350467|Schizophrenia|schizophrenia
538158|NCT00350467|DSM-IV|dsm-iv
538159|NCT00350467|PANSS|panss
538160|NCT00350467|informed consent|informed consent
538161|NCT00350480|acute uterine bleeding|acute uterine bleeding
538162|NCT00350519|Hemostasis, Surgical|hemostasis, surgical
538163|NCT00350519|Epoetin alfa|epoetin alfa
538164|NCT00350519|Surgery|surgery
538165|NCT00350519|Abdomen|abdomen
538166|NCT00350519|Pelvis|pelvis
538167|NCT00350519|PROCRIT|procrit
538168|NCT00350519|pRBC|prbc
538169|NCT00350519|Blood transfusion|blood transfusion
538170|NCT00350519|Packed red blood cell transfusion|packed red blood cell transfusion
538171|NCT00350532|pain, chronic pain|pain, chronic pain
538172|NCT00350532|acetylcholine|acetylcholine
538173|NCT00350532|clonidine|clonidine
538174|NCT00350532|a2-adrenergic agonists|a2-adrenergic agonists
538175|NCT00350532|alpha2-adrenergic agonists|alpha2-adrenergic agonists
538176|NCT00350571|behavior therapy|behavior therapy
538177|NCT00350571|counseling|counseling
538178|NCT00350571|drug abuse therapy|drug abuse therapy
538179|NCT00350571|outpatient care|outpatient care
538180|NCT00350571|therapy compliance|therapy compliance
538181|NCT00350571|clinical trial phase I|clinical trial phase i
538182|NCT00350571|coping|coping
538183|NCT00350571|outcomes research|outcomes research
538184|NCT00350571|satisfaction|satisfaction
538185|NCT00350571|social psychology|social psychology
538186|NCT00350571|patient oriented research|patient oriented research
538187|NCT00350584|Mindfulness|mindfulness
538188|NCT00350584|Psychoeducation|psychoeducation
538189|NCT00350584|Telehealth Intervention|telehealth intervention
538190|NCT00350597|Malignant Melanoma|malignant melanoma
538191|NCT00350597|Adjuvant Therapy|adjuvant therapy
538192|NCT00350597|Cytokine Therapy|cytokine therapy
538193|NCT00350597|Immunologic Testing|immunologic testing
538194|NCT00350610|cognitive behavior therapy|cognitive behavior therapy
538195|NCT00350610|computer assisted instruction|computer assisted instruction
538196|NCT00350610|drug abuse therapy|drug abuse therapy
538197|NCT00350610|educational resource design and development|educational resource design and development
538198|NCT00350623|AIDS|aids
538199|NCT00350636|OAB, anticholineric, oxybutynin, urge urinary incontinence|oab, anticholineric, oxybutynin, urge urinary incontinence
538200|NCT00350649|behavior modification|behavior modification
538201|NCT00350649|cognitive behavioral therapy|cognitive behavioral therapy
538202|NCT00350649|combination therapy|combination therapy
538203|NCT00350649|drug abuse therapy|drug abuse therapy
538204|NCT00350649|drug addition|drug addition
538205|NCT00350649|human therapy evaluation|human therapy evaluation
538206|NCT00350649|psychotherapy|psychotherapy
538207|NCT00350649|clinical trial phase II|clinical trial phase ii
538208|NCT00350649|coping|coping
538209|NCT00350649|drug and alcohol abstinence|drug and alcohol abstinence
538210|NCT00350649|longitudinal human study|longitudinal human study
538211|NCT00350649|outcomes research|outcomes research
538212|NCT00350649|outpatient care|outpatient care
538213|NCT00350649|psychological reinforcement|psychological reinforcement
538214|NCT00350649|therapy compliance|therapy compliance
538215|NCT00350649|behavior and social research tag|behavior and social research tag
538216|NCT00350649|human subjects|human subjects
538217|NCT00350649|neuropsychological test|neuropsychological test
538218|NCT00350649|patient oriented research|patient oriented research
538219|NCT00350662|Deferiprone|deferiprone
538221|NCT00350662|Desferrioxamine|desferrioxamine
538222|NCT00350662|Hemochromatosis|hemochromatosis
538223|NCT00350662|Iron overload|iron overload
538224|NCT00350662|Thalassemia|thalassemia
538225|NCT00350688|Bladder,|bladder,
538226|NCT00350688|Cancer,|cancer,
538227|NCT00350688|Chemoradiation,|chemoradiation,
538228|NCT00350688|IMRT,|imrt,
538229|NCT00350688|tomotherapy|tomotherapy
538230|NCT00350701|DM type 2|dm type 2
538231|NCT00350701|Hypogonadism|hypogonadism
538232|NCT00350701|Testosterone|testosterone
538233|NCT00350701|AndroGel|androgel
538234|NCT00350714|HCV (Hepatitis C Virus)|hcv (hepatitis c virus)
538235|NCT00350714|MBT (Methacetin Breath Test)|mbt (methacetin breath test)
538236|NCT00350714|Hepatitis C Virus Patients|hepatitis c virus patients
538237|NCT00350727|relapsed|relapsed
538239|NCT00350727|Pazopanib|pazopanib
538240|NCT00350727|glioblastoma|glioblastoma
538241|NCT00350753|Cholangiocarcinoma|cholangiocarcinoma
538242|NCT00350766|Myocardial Infarction|myocardial infarction
538243|NCT00350766|Myocardial Ischemia|myocardial ischemia
538244|NCT00350766|Ventricular Remodeling|ventricular remodeling
538245|NCT00350766|Bone Marrow Cell Transplantation|bone marrow cell transplantation
538246|NCT00350766|Stem cells|stem cells
538247|NCT00350779|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
538248|NCT00350805|Schizophrenia|schizophrenia
538249|NCT00350805|Time perception|time perception
538250|NCT00350805|Cortical synchronization|cortical synchronization
538251|NCT00350805|Electroencephalography|electroencephalography
538252|NCT00350818|Acute Myelogenous Leukemia|acute myelogenous leukemia
538253|NCT00350818|Myelodysplastic Syndrome|myelodysplastic syndrome
538254|NCT00350818|Allogeneic Transplantation|allogeneic transplantation
538255|NCT00350818|Leukemia|leukemia
538256|NCT00350818|Azacitidine|azacitidine
538257|NCT00350818|Vidaza|vidaza
538258|NCT00350831|Solid tumor|solid tumor
538259|NCT00350844|Sickle Cell Disease|sickle cell disease
538260|NCT00350844|Pulmonary Hypertension|pulmonary hypertension
538261|NCT00350870|disulfiram|disulfiram
538262|NCT00350870|cognitive behavioral therapy|cognitive behavioral therapy
538263|NCT00350870|contingency management|contingency management
538264|NCT00350870|drug abuse therapy|drug abuse therapy
538265|NCT00350870|educational/resource design/development|educational/resource design/development
538266|NCT00350883|Cognitive Therapy|cognitive therapy
538267|NCT00350883|Negative Symptoms|negative symptoms
538268|NCT00350883|Functional Outcomes|functional outcomes
538269|NCT00350883|Schizophrenia|schizophrenia
538270|NCT00350883|Schizoaffective Disorder|schizoaffective disorder
538271|NCT00350896|trapezotrapezoidial|trapezotrapezoidial
538272|NCT00350896|scaphotrapezial|scaphotrapezial
538273|NCT00350896|thumb|thumb
538277|NCT00350909|drug abuse|drug abuse
538278|NCT00350935|fMRI|fmri
538279|NCT00350935|Visual perception|visual perception
538280|NCT00350935|Attention|attention
538281|NCT00350948|Ovary|ovary
538282|NCT00350961|Cholangiocarcinoma|cholangiocarcinoma
538283|NCT00350961|Fixed dose rate|fixed dose rate
538284|NCT00350961|Gemcitabine|gemcitabine
538285|NCT00350961|Oxaliplatin|oxaliplatin
538286|NCT00350961|Capecitabine|capecitabine
538287|NCT00350987|Procalcitonin, guidelines, LRTI, non-inferiority|procalcitonin, guidelines, lrti, non-inferiority
538288|NCT00350987|COLD|cold
538289|NCT00351000|Schizophrenia|schizophrenia
538290|NCT00351000|Ziprasidone|ziprasidone
538291|NCT00351000|Diabetes|diabetes
538292|NCT00351000|Insulin Resistance|insulin resistance
538293|NCT00351013|malaria|malaria
538298|NCT00351026|methadone|methadone
538299|NCT00351026|HIV|hiv
538300|NCT00351052|Pimecrolimus, Atopic Dermatitis, Eczema, Pediatric|pimecrolimus, atopic dermatitis, eczema, pediatric
538301|NCT00351065|erectile dysfunction, PDE-5 inhibitor|erectile dysfunction, pde-5 inhibitor
538302|NCT00351078|Cystic fibrosis|cystic fibrosis
538303|NCT00351078|Nonsense mutation|nonsense mutation
538304|NCT00351078|Premature stop codon|premature stop codon
538305|NCT00351078|CF|cf
538306|NCT00351078|PTC124|ptc124
538307|NCT00351104|Sprain|sprain
538308|NCT00351104|Strain|strain
538309|NCT00351104|Pain|pain
538310|NCT00351104|Ankle Pain|ankle pain
538311|NCT00351104|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
538312|NCT00351117|St. John's Wort|st. john's wort
538313|NCT00351117|Selective Serotonin Receptor Inhibitor|selective serotonin receptor inhibitor
538314|NCT00351117|Microvasculature|microvasculature
538315|NCT00351117|Natural Health Products|natural health products
538316|NCT00351130|Hypertension,|hypertension,
538317|NCT00351130|stage 1 hypertension,|stage 1 hypertension,
538318|NCT00351130|stage 2 hypertension,|stage 2 hypertension,
538319|NCT00351130|valsartan,|valsartan,
538320|NCT00351130|amlodipine,|amlodipine,
538321|NCT00351143|QoL|qol
538322|NCT00351143|Asthma|asthma
538323|NCT00351143|asthma compliance enhancement|asthma compliance enhancement
538324|NCT00351143|Salmeterol/fluticasone|salmeterol/fluticasone
538325|NCT00351143|Total control|total control
538326|NCT00351143|SERETIDE|seretide
538327|NCT00351143|FEV1|fev1
538328|NCT00351156|Gaucher Disease|gaucher disease
538329|NCT00351156|Gaucher Disease, Type 1|gaucher disease, type 1
538330|NCT00351156|Gaucher Disease, Type 2|gaucher disease, type 2
538331|NCT00351156|Gaucher Disease, Type 3|gaucher disease, type 3
538332|NCT00351156|Neuronopathic Gaucher Disease|neuronopathic gaucher disease
538333|NCT00351156|Non-Neuronopathic Gaucher Disease|non-neuronopathic gaucher disease
538334|NCT00351156|Lysosomal Storage Disease|lysosomal storage disease
538335|NCT00351156|Metabolism, Inborn Errors|metabolism, inborn errors
538336|NCT00351156|Metabolic Diseases|metabolic diseases
538337|NCT00351156|Sphingolipidoses|sphingolipidoses
538338|NCT00351156|Genetic Diseases, Inborn|genetic diseases, inborn
538339|NCT00351169|Major Depressive Disorder|major depressive disorder
538340|NCT00351169|MDD|mdd
538341|NCT00351182|Scrub typhus|scrub typhus
538342|NCT00351182|Telithromycin|telithromycin
538343|NCT00351182|Doxycycline|doxycycline
538344|NCT00351182|5 day Course of Telithromycin versus Doxycycline for the Treatment of Mild to Moderate Scrub Typhus|5 day course of telithromycin versus doxycycline for the treatment of mild to moderate scrub typhus
538345|NCT00351195|Hepatocellular carcinoma|hepatocellular carcinoma
538346|NCT00351195|Etoposide|etoposide
538347|NCT00351195|Oxaliplatin|oxaliplatin
538348|NCT00351195|Capecitabine|capecitabine
538349|NCT00351208|Spinal cord stimulation|spinal cord stimulation
538350|NCT00351208|Spinal cord stimulation efficacy|spinal cord stimulation efficacy
538351|NCT00351208|Spinal cord stimulators|spinal cord stimulators
538352|NCT00351208|Stimulation frequencies|stimulation frequencies
538353|NCT00351208|Stimulation pulse-widths|stimulation pulse-widths
538354|NCT00351208|Varying settings|varying settings
538355|NCT00351234|Diabetes Mellitus Type I,|diabetes mellitus type i,
538356|NCT00351234|Hypoglycemia,|hypoglycemia,
538357|NCT00351234|Carnitine|carnitine
538358|NCT00351247|Myocardial Infarction|myocardial infarction
538359|NCT00351247|Primary PCI|primary pci
538360|NCT00351247|Postconditioning|postconditioning
538361|NCT00351247|MRI|mri
538362|NCT00351260|Bifurcation|bifurcation
538363|NCT00351260|Coronary|coronary
538364|NCT00351260|Stenosis|stenosis
538365|NCT00351260|Stent|stent
538366|NCT00351260|drug elution|drug elution
538367|NCT00351273|Chlamydia|chlamydia
538368|NCT00351286|peripheral arterial disease|peripheral arterial disease
538369|NCT00351286|peripheral vascular disease|peripheral vascular disease
538370|NCT00351286|claudication|claudication
538371|NCT00351299|Delirium|delirium
538372|NCT00351299|Agitation|agitation
538373|NCT00351299|Sedation|sedation
538374|NCT00351299|Dexmedetomidine|dexmedetomidine
538375|NCT00351299|Surgical|surgical
538376|NCT00351312|Pressure ulcers|pressure ulcers
538377|NCT00351312|socks|socks
538378|NCT00351312|foot pressure|foot pressure
538379|NCT00351351|Kidney Stones|kidney stones
538380|NCT00351351|Renal Calculi|renal calculi
538381|NCT00351364|atherosclerosis|atherosclerosis
538382|NCT00351364|inflammation|inflammation
538383|NCT00351364|leukotriene blockade|leukotriene blockade
538384|NCT00351364|endothelial function|endothelial function
538385|NCT00351377|Autoimmune disease, mycophenolate, GI problems|autoimmune disease, mycophenolate, gi problems
538389|NCT00351403|Chronic HCV infection|chronic hcv infection
538391|NCT00351403|Individually adapted therapy|individually adapted therapy
538392|NCT00351403|Peginterferon alfa-2b|peginterferon alfa-2b
538393|NCT00351403|Ribavirin|ribavirin
538394|NCT00351403|Sustained viral response (SVR)|sustained viral response (svr)
538395|NCT00351416|GnRH deficiency|gnrh deficiency
538396|NCT00351416|GnRH antagonist|gnrh antagonist
538397|NCT00351416|Letrozole|letrozole
538398|NCT00351416|GnRH|gnrh
538399|NCT00351416|FSH|fsh
538400|NCT00351416|LH|lh
538401|NCT00351416|Inhibins|inhibins
538402|NCT00351429|Glaucoma|glaucoma
538403|NCT00351429|Trabeculectomy|trabeculectomy
538404|NCT00351429|Sutures|sutures
538405|NCT00351442|Host Resistance|host resistance
538406|NCT00351455|hernia|hernia
538407|NCT00351455|incisional hernia|incisional hernia
538408|NCT00351455|ventral hernia|ventral hernia
97194|NCT02681874|health|health
537746|NCT00341211|AIDS|aids
538409|NCT00351455|umbilical hernia|umbilical hernia
538410|NCT00351468|eltrombopag olamine|eltrombopag olamine
538411|NCT00351468|SB-497115-GR|sb-497115-gr
538412|NCT00351468|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
538413|NCT00351468|thrombocytopenia|thrombocytopenia
538414|NCT00351468|ITP|itp
538415|NCT00351468|platelets|platelets
538416|NCT00351481|IVF|ivf
538417|NCT00351481|endometrial receptivity|endometrial receptivity
538418|NCT00351481|embryo implantation|embryo implantation
538419|NCT00351481|recurrent implantation failure|recurrent implantation failure
538420|NCT00351494|embolization|embolization
538421|NCT00351494|contrast enhanced ultrasound|contrast enhanced ultrasound
538422|NCT00351494|myoma|myoma
538423|NCT00351494|uterine artery|uterine artery
538424|NCT00351494|microvascularisation|microvascularisation
538425|NCT00351507|Vildagliptin|vildagliptin
538426|NCT00351507|Type 2 diabetes|type 2 diabetes
538427|NCT00351520|Anthoponotic Cutaneous leishmaniasis|anthoponotic cutaneous leishmaniasis
538428|NCT00351520|Glucantime|glucantime
538429|NCT00351520|Miltefosine|miltefosine
538430|NCT00351533|Respiratory distress syndrome, adult|respiratory distress syndrome, adult
538431|NCT00351533|Acute lung injury|acute lung injury
538432|NCT00351533|Acute respiratory distress syndrome|acute respiratory distress syndrome
538433|NCT00351533|ARDS, human|ards, human
538434|NCT00351533|Fish oils|fish oils
538435|NCT00351533|Fatty Acids, Omega-3|fatty acids, omega-3
538436|NCT00351533|Docosahexaenoic Acids|docosahexaenoic acids
538437|NCT00351533|Eicosapentaenoic Acid|eicosapentaenoic acid
538438|NCT00351546|Vildagliptin|vildagliptin
538439|NCT00351546|Type 2 diabetes|type 2 diabetes
538440|NCT00351546|Insulin sensitivity|insulin sensitivity
538441|NCT00351546|Insulin action|insulin action
538443|NCT00351559|rejection|rejection
538444|NCT00351559|biopsy|biopsy
538445|NCT00351559|gene|gene
538446|NCT00351559|expression|expression
538447|NCT00351559|cardiac|cardiac
538448|NCT00351559|heart|heart
538449|NCT00351559|transplant|transplant
538450|NCT00351572|colon cancer|colon cancer
538451|NCT00351585|Vildagliptin|vildagliptin
538452|NCT00351585|Type 2 diabetes|type 2 diabetes
538453|NCT00351585|Insulin secretion|insulin secretion
538454|NCT00351585|Beta cell|beta cell
538455|NCT00338312|Natural Menopause|natural menopause
538456|NCT00338312|HSDD|hsdd
538457|NCT00338325|Pediatric Anxiety|pediatric anxiety
538458|NCT00338325|Pediatric Pain|pediatric pain
538459|NCT00338338|essential hypertension|essential hypertension
538460|NCT00338338|Amlodipine|amlodipine
538461|NCT00338338|blood pressure|blood pressure
538462|NCT00338338|lacidipine|lacidipine
538463|NCT00338364|Pediatric pain|pediatric pain
538464|NCT00338364|Pediatric anxiety|pediatric anxiety
538465|NCT00338364|Painful procedures|painful procedures
538466|NCT00338377|Melanoma|melanoma
538467|NCT00338377|Regional nodal disease|regional nodal disease
538468|NCT00338377|Dendritic Cell Immunization|dendritic cell immunization
538469|NCT00338377|Lymphodepletion|lymphodepletion
538470|NCT00338377|Adoptive Cell Transfer|adoptive cell transfer
538471|NCT00338377|T Cells|t cells
538472|NCT00338377|Vaccine|vaccine
538473|NCT00338377|Cyclosphosphamide|cyclosphosphamide
538474|NCT00338377|Cytoxan|cytoxan
538475|NCT00338377|Neosar|neosar
538476|NCT00338377|Dendritic Cells|dendritic cells
538477|NCT00338377|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
538478|NCT00338377|TIL Cells|til cells
538479|NCT00338377|MART Peptide|mart peptide
538480|NCT00338377|Fludarabine|fludarabine
538482|NCT00338377|Fludara|fludara
538483|NCT00338377|Proleukin|proleukin
538484|NCT00338377|IL-2|il-2
538485|NCT00338377|Interleukin-2|interleukin-2
538486|NCT00338377|Leptomeningeal disease|leptomeningeal disease
538487|NCT00338390|Antiretrovirals|antiretrovirals
538488|NCT00338390|CD4 cell count|cd4 cell count
538489|NCT00338390|toxicity|toxicity
538490|NCT00338403|CPAP pressure of -5cm/water during cold, dry air exposure|cpap pressure of -5cm/water during cold, dry air exposure
538491|NCT00338403|CPAP pressure of 0cm/water during cold, dry air exposure|cpap pressure of 0cm/water during cold, dry air exposure
538492|NCT00338403|CPAP pressure of 5cm/water during cold, dry air exposure|cpap pressure of 5cm/water during cold, dry air exposure
538493|NCT00338403|CPAP pressure of 10cm/water during cold, dry air exposure|cpap pressure of 10cm/water during cold, dry air exposure
538494|NCT00338416|Chemotherapy Induced Anemia|chemotherapy induced anemia
538495|NCT00338416|PROCRIT (Epoetin alfa)|procrit (epoetin alfa)
538496|NCT00338416|Chemotherapy|chemotherapy
538497|NCT00338416|Epoetin alfa|epoetin alfa
538498|NCT00338429|sleep onset latency|sleep onset latency
538499|NCT00338429|bedtime resistance|bedtime resistance
538500|NCT00338442|Immune compromised|immune compromised
538501|NCT00338442|Varicella Zoster Virus ( VZV) Infection|varicella zoster virus ( vzv) infection
538502|NCT00338442|Pediatric|pediatric
538503|NCT00338455|Congestive heart failure|congestive heart failure
538504|NCT00338455|cardiac transplantation|cardiac transplantation
538505|NCT00338455|renal insufficiency|renal insufficiency
538506|NCT00338455|renal failure|renal failure
538507|NCT00338455|dialysis|dialysis
538508|NCT00338455|ultrafiltration|ultrafiltration
538509|NCT00338455|vasodilator|vasodilator
538510|NCT00338455|Natrecor (nesiritide)|natrecor (nesiritide)
538512|NCT00338468|Elderly|elderly
538513|NCT00338468|Hemoglobin level|hemoglobin level
538514|NCT00338468|Chronic Kidney Disease|chronic kidney disease
538515|NCT00338507|Chronic Bronchitis|chronic bronchitis
538516|NCT00338507|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
538517|NCT00338520|Cerebral malaria, phenylalanine, Tanzania|cerebral malaria, phenylalanine, tanzania
538518|NCT00338533|childhood glaucoma|childhood glaucoma
538519|NCT00338546|Cocaine|cocaine
538520|NCT00338546|Sympathetic nerve activity|sympathetic nerve activity
538521|NCT00338546|Blood pressure|blood pressure
538522|NCT00338546|Cutaneous vasoconstriction|cutaneous vasoconstriction
538523|NCT00338546|Coronary vasoconstriction|coronary vasoconstriction
538524|NCT00338559|Strabismus|strabismus
538525|NCT00338559|LMA|lma
538526|NCT00338559|ET Tube|et tube
538527|NCT00338559|POV|pov
538528|NCT00338572|Inflammation|inflammation
538529|NCT00338572|Blood Pressure, High|blood pressure, high
538530|NCT00338585|PAO|pao
538531|NCT00338585|acute peripheral arterial occlusion|acute peripheral arterial occlusion
538532|NCT00338585|thrombolysis|thrombolysis
538533|NCT00338585|blood clot|blood clot
538534|NCT00338585|leg attack|leg attack
538535|NCT00338585|alfimeprase|alfimeprase
538536|NCT00338585|thrombus|thrombus
538537|NCT00338585|embolism|embolism
538539|NCT00338585|claudication|claudication
538540|NCT00338585|thrombolytic|thrombolytic
538541|NCT00338585|thrombosis|thrombosis
538542|NCT00338585|plasminogen activator|plasminogen activator
538543|NCT00338585|arterial flow|arterial flow
538544|NCT00338598|glycine|glycine
538545|NCT00338598|treatment|treatment
538546|NCT00338598|alcohol dependence|alcohol dependence
538547|NCT00338598|schizophrenia|schizophrenia
538548|NCT00338611|vision therapy|vision therapy
538549|NCT00338611|orthoptics|orthoptics
538550|NCT00338611|pencil push-up therapy|pencil push-up therapy
538551|NCT00338624|lower urinary tract symptoms|lower urinary tract symptoms
538552|NCT00338624|DITROPAN XL|ditropan xl
538553|NCT00338624|oxybutynin extended release tablets|oxybutynin extended release tablets
538554|NCT00338663|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
538555|NCT00338663|knee immobilization|knee immobilization
538556|NCT00338663|postoperative pain|postoperative pain
538557|NCT00338676|Aortic stenosis|aortic stenosis
538558|NCT00338676|Elderly|elderly
538559|NCT00338689|infant formula|infant formula
538560|NCT00338689|protein content|protein content
538561|NCT00338689|growth|growth
538562|NCT00338689|obesity|obesity
538563|NCT00338689|breast feeding|breast feeding
538564|NCT00338702|Diabetic|diabetic
538566|NCT00338702|Ulcer|ulcer
538567|NCT00338702|Autologous|autologous
538568|NCT00338702|Platelet|platelet
538569|NCT00338702|Gel|gel
538570|NCT00338715|Effectiveness|effectiveness
538571|NCT00338715|Pulmonary Vein Isolation Procedure|pulmonary vein isolation procedure
538572|NCT00338715|Coronary Artery Bypass Surgery|coronary artery bypass surgery
538573|NCT00338715|Atrial Fibrillation|atrial fibrillation
538574|NCT00338728|Breast Cancer|breast cancer
538575|NCT00338728|Letrozole|letrozole
538576|NCT00338728|Imatinib Mesylate|imatinib mesylate
538577|NCT00338728|Gleevec|gleevec
538578|NCT00338728|Femara|femara
538579|NCT00338767|AIDS|aids
538580|NCT00338767|DOT|dot
538581|NCT00338767|Directly Observed Therapy|directly observed therapy
538582|NCT00338780|Chronic Hepatitis B|chronic hepatitis b
538583|NCT00338780|Lamivudine|lamivudine
538584|NCT00338780|HBeAg negative|hbeag negative
538585|NCT00338793|Tuberculosis;|tuberculosis;
538586|NCT00338793|Pleural effusion;|pleural effusion;
538587|NCT00338793|Corticosteroids.|corticosteroids.
538588|NCT00338806|Prevention|prevention
538589|NCT00338806|Mood Disorders|mood disorders
538590|NCT00338806|Unipolar Depression|unipolar depression
538591|NCT00338819|DVT prevention|dvt prevention
538592|NCT00338819|Hemodynamic study|hemodynamic study
538594|NCT00338819|CECT|cect
538595|NCT00338832|Lifestyle Intervention|lifestyle intervention
538596|NCT00338832|Schizoaffective Disorder|schizoaffective disorder
538597|NCT00338845|STDs|stds
538598|NCT00338897|Venous Thromboembolism|venous thromboembolism
538599|NCT00338897|Prevention|prevention
538600|NCT00338897|Arthroplasty|arthroplasty
538601|NCT00338897|Replacement|replacement
538602|NCT00338897|Hip|hip
538603|NCT00338897|orthopedic surgery|orthopedic surgery
538604|NCT00338910|healthy volunteers|healthy volunteers
538605|NCT00338936|Hypertension|hypertension
538606|NCT00338936|Valsartan|valsartan
538607|NCT00338936|Hydrochlorothiazide|hydrochlorothiazide
538608|NCT00338949|Ziprasidone|ziprasidone
538609|NCT00338949|Olanzapine|olanzapine
538610|NCT00338949|Risperidone|risperidone
538611|NCT00338949|Schizoaffective Disorder|schizoaffective disorder
538612|NCT00338949|Insulin Sensitivity|insulin sensitivity
694724|NCT00948857|POF|pof
537970|NCT00349453|L1|l1
538613|NCT00338949|Visceral Adiposity|visceral adiposity
538614|NCT00338949|Metabolic Syndrome|metabolic syndrome
538615|NCT00344604|Patients who have undergone routine LASIK as a primary refractive procedure for myopia, hyperopia, or astigmatism.|patients who have undergone routine lasik as a primary refractive procedure for myopia, hyperopia, or astigmatism.
538616|NCT00344617|Choroidal neovascularisation|choroidal neovascularisation
538617|NCT00344617|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
538618|NCT00344617|Intravitreal injection|intravitreal injection
538619|NCT00344617|Avastin|avastin
538620|NCT00344643|Comparison of Daily wear versus Extended wear in bacterial binding and corneal epithelial thickness|comparison of daily wear versus extended wear in bacterial binding and corneal epithelial thickness
538621|NCT00344656|Eating Disorders|eating disorders
538622|NCT00344656|Anorexia Nervosa|anorexia nervosa
538623|NCT00344669|underweight|underweight
538624|NCT00344669|preschool|preschool
538625|NCT00344669|mass deworming|mass deworming
538626|NCT00344682|memantine|memantine
538627|NCT00344682|Namenda|namenda
538628|NCT00344682|augmentation|augmentation
538629|NCT00344682|add-on|add-on
538630|NCT00344682|depression|depression
538631|NCT00344682|MDD (major depressive disorder)|mdd (major depressive disorder)
538632|NCT00344682|unipolar depression|unipolar depression
538633|NCT00344682|NMDA|nmda
538634|NCT00344682|ketamine|ketamine
538635|NCT00344682|uncompetitive NMDA receptor antagonist|uncompetitive nmda receptor antagonist
538636|NCT00344708|Tissue-Cultured Human Amniotic Epithelial Cells onto damaged corneal surface|tissue-cultured human amniotic epithelial cells onto damaged corneal surface
538637|NCT00344721|Meibomian Gland Syndrome|meibomian gland syndrome
538638|NCT00344721|Blepharitis|blepharitis
538639|NCT00344734|Nitric oxide|nitric oxide
538640|NCT00344734|Renal hemodynamics|renal hemodynamics
538641|NCT00344747|intervention program|intervention program
538642|NCT00344747|diet|diet
538643|NCT00344747|physical activity|physical activity
538644|NCT00344747|adolescents|adolescents
538645|NCT00344747|obesity|obesity
538646|NCT00344773|Locally advanced (IIIB) pulmonary adenocarcinoma with EGFR mutation|locally advanced (iiib) pulmonary adenocarcinoma with egfr mutation
538647|NCT00344773|Metastatic (IV) pulmonary adenocarcinoma with EGFR mutation|metastatic (iv) pulmonary adenocarcinoma with egfr mutation
538648|NCT00344773|Recurrent pulmonary adenocarcinoma with EGFR mutation|recurrent pulmonary adenocarcinoma with egfr mutation
538649|NCT00344786|CLL|cll
538650|NCT00344786|CNF2024|cnf2024
538651|NCT00344786|Hsp90 inhibitor|hsp90 inhibitor
538652|NCT00344799|Choroidal Melanoma|choroidal melanoma
538653|NCT00344799|Choroidal Malignant Melanoma|choroidal malignant melanoma
538654|NCT00344799|Ocular Melanoma|ocular melanoma
538655|NCT00344799|Uveal Melanoma|uveal melanoma
538656|NCT00344825|B- Chronic Lymphocytic Leukemia|b- chronic lymphocytic leukemia
538657|NCT00344838|LADARWave™|ladarwave™
538658|NCT00344838|WaveScan Wavefront™ Systems|wavescan wavefront™ systems
538659|NCT00344851|menstrual cyclicity|menstrual cyclicity
538660|NCT00344851|insulin resistance|insulin resistance
538661|NCT00344851|body fat distribution|body fat distribution
538662|NCT00344851|pancreatic ß-cell function|pancreatic ß-cell function
538663|NCT00344851|inflammatory markers|inflammatory markers
538664|NCT00344851|liver function tests|liver function tests
538665|NCT00344864|Contact Lenses Higher Order Aberrations|contact lenses higher order aberrations
538666|NCT00344877|Epilepsy|epilepsy
538667|NCT00344877|Temporal Lobe Epilepsy|temporal lobe epilepsy
538668|NCT00344877|Cortical Excitability|cortical excitability
538669|NCT00344877|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
538670|NCT00344877|Memory Testing|memory testing
538671|NCT00344877|Seizures|seizures
538672|NCT00344877|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
538673|NCT00344877|Memory|memory
538674|NCT00344877|Plasticity|plasticity
538675|NCT00344890|Cervical fusion|cervical fusion
538676|NCT00344890|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
538677|NCT00344890|ACDF|acdf
538678|NCT00344903|Atherosclerosis|atherosclerosis
538679|NCT00344903|Heart Failure|heart failure
538680|NCT00344903|Ventricular Hypertrophy|ventricular hypertrophy
538681|NCT00344903|Myocardial Infarction|myocardial infarction
538682|NCT00344903|Screening|screening
538683|NCT00344903|Hypertension|hypertension
538684|NCT00344903|Diabetes|diabetes
538685|NCT00344903|Obesity|obesity
538686|NCT00344903|Metabolic Syndrome|metabolic syndrome
538687|NCT00344916|Renal hemodynamics|renal hemodynamics
538688|NCT00344916|Nitric oxide|nitric oxide
538689|NCT00344955|HMG-COA reductase inhibition|hmg-coa reductase inhibition
538690|NCT00344955|GFR|gfr
538691|NCT00344955|RPF|rpf
538692|NCT00344955|FE|fe
538693|NCT00344955|CL|cl
538694|NCT00344981|Cell Cycle Agents|cell cycle agents
538695|NCT00344994|Restless Legs Syndrome|restless legs syndrome
538696|NCT00344994|Mirapex (pramipexole)|mirapex (pramipexole)
538697|NCT00344994|Requip(Ropinirole)|requip(ropinirole)
538698|NCT00344994|Dopamine Agonist|dopamine agonist
538699|NCT00345007|Retinal detachment|retinal detachment
538700|NCT00345007|Macular function|macular function
538701|NCT00345007|Multifocal electrophysiology|multifocal electrophysiology
538702|NCT00345020|Deep Lamellar Endotheliam Keratoplasty|deep lamellar endotheliam keratoplasty
538703|NCT00345033|Glucose Metabolism|glucose metabolism
538704|NCT00345046|Glaucoma|glaucoma
538705|NCT00345046|Cataract|cataract
538706|NCT00345059|second line|second line
538707|NCT00345059|monochemotherapy|monochemotherapy
538708|NCT00345059|combination chemotherapy|combination chemotherapy
538709|NCT00345059|platinum refractory|platinum refractory
538710|NCT00345059|previously treated|previously treated
538711|NCT00345072|Menopause|menopause
538712|NCT00345072|Decision aids|decision aids
538713|NCT00345072|Internet|internet
538714|NCT00345072|Hormone Replacement Therapy|hormone replacement therapy
538715|NCT00345072|Breast Cancer|breast cancer
538716|NCT00345072|Cardiovascular Disease|cardiovascular disease
538717|NCT00345072|Osteoporosis|osteoporosis
538718|NCT00345098|Depression, Antidepressive agents|depression, antidepressive agents
538719|NCT00345098|Clinical Trial|clinical trial
538720|NCT00345098|Phase III|phase iii
538721|NCT00345098|Multicenter study|multicenter study
538722|NCT00345111|Restor IOL versus Conventional IOL|restor iol versus conventional iol
538723|NCT00345124|urinary aquaporin-2|urinary aquaporin-2
538724|NCT00345124|ENaC|enac
538725|NCT00345124|fractional sodium excretion|fractional sodium excretion
538726|NCT00345124|High/low sodium diet|high/low sodium diet
538727|NCT00345137|Renal hemodynamics|renal hemodynamics
538728|NCT00345137|Nitric oxide|nitric oxide
538729|NCT00345150|hypertension|hypertension
538730|NCT00345150|nitric oxide|nitric oxide
538731|NCT00345150|renal hemodynamics|renal hemodynamics
538732|NCT00345163|Glioblastoma Multiforme|glioblastoma multiforme
538733|NCT00345163|Avastin|avastin
538734|NCT00345163|Brain Cancer|brain cancer
538735|NCT00345163|GBM|gbm
538736|NCT00345176|age-related macular degeneration|age-related macular degeneration
538737|NCT00345176|AMD|amd
538738|NCT00345176|lutein|lutein
538739|NCT00345176|zeaxanthin|zeaxanthin
538740|NCT00345176|docosahexaenoic acid|docosahexaenoic acid
538741|NCT00345176|eicosapentaenoic acid|eicosapentaenoic acid
538742|NCT00345189|Hsp90 inhibitor|hsp90 inhibitor
538743|NCT00345189|CNF2024|cnf2024
538744|NCT00345189|Advanced Solid Tumors|advanced solid tumors
538745|NCT00345202|HMG-COA reductase inhibition|hmg-coa reductase inhibition
538746|NCT00345202|GFR|gfr
538747|NCT00345202|RPF|rpf
538748|NCT00345202|FE|fe
538749|NCT00345202|CL|cl
538750|NCT00345215|Urinary Aquaporin 2|urinary aquaporin 2
538751|NCT00345215|High/low Sodium Diet|high/low sodium diet
538752|NCT00345215|Fractional Sodium Excretion|fractional sodium excretion
538753|NCT00345228|High myopia|high myopia
538754|NCT00345228|Choroidal neovascularisation|choroidal neovascularisation
538755|NCT00345228|Lacquer crack|lacquer crack
538756|NCT00345228|Fundus fluorescein angiography|fundus fluorescein angiography
538757|NCT00345228|Indocyanine green angiography|indocyanine green angiography
538758|NCT00345228|Axial length|axial length
538759|NCT00345241|Blepharitis|blepharitis
538760|NCT00345267|Asthma|asthma
538761|NCT00345267|Children|children
538762|NCT00345267|Integrated Care Pathway|integrated care pathway
538763|NCT00345267|Evidence based medicine|evidence based medicine
538764|NCT00345267|Prescribing errors|prescribing errors
538765|NCT00345280|Cystic fibrosis|cystic fibrosis
538766|NCT00345280|eye|eye
538767|NCT00345280|inflammation|inflammation
538768|NCT00345280|apoptosis|apoptosis
538769|NCT00345280|C11+|c11+
538770|NCT00345293|Prostate Cancer|prostate cancer
538771|NCT00345306|endometrial preparation|endometrial preparation
538772|NCT00345306|Utrogestan|utrogestan
538773|NCT00345306|Endometrin|endometrin
538774|NCT00345319|rabies|rabies
538775|NCT00345319|vaccine|vaccine
538776|NCT00345319|post-exposure prophylaxis|post-exposure prophylaxis
538777|NCT00345345|Neutropenia|neutropenia
538778|NCT00345345|Monoclonal Antibody Therapy|monoclonal antibody therapy
538779|NCT00345345|Anti-CD52|anti-cd52
538780|NCT00345345|T-LGL Leukemia|t-lgl leukemia
538781|NCT00345345|LGL Leukemia|lgl leukemia
538782|NCT00345345|Anemia|anemia
538783|NCT00345345|Immunosuppression|immunosuppression
538784|NCT00345345|Chronic T Cell Lymphocytosis with Neutropenia|chronic t cell lymphocytosis with neutropenia
538785|NCT00345345|Leukemia|leukemia
538786|NCT00345358|Booster vaccination|booster vaccination
538787|NCT00345358|Catch-up vaccination|catch-up vaccination
538788|NCT00345358|Pneumococcal vaccine|pneumococcal vaccine
538789|NCT00345358|Immunogenicity|immunogenicity
538790|NCT00345358|Safety|safety
538791|NCT00345358|Pneumococcal disease|pneumococcal disease
538792|NCT00345371|methamphetamine addiction|methamphetamine addiction
538793|NCT00345384|Dexmedetomidine|dexmedetomidine
538794|NCT00345384|Sedation|sedation
538795|NCT00345384|Opioid|opioid
538796|NCT00345384|Respiratory depression|respiratory depression
538797|NCT00345397|cecostomy|cecostomy
538798|NCT00345397|colonoscopy|colonoscopy
538799|NCT00345397|colostomy|colostomy
538800|NCT00345397|constipation|constipation
538801|NCT00345397|endoscopy, gastrointestinal|endoscopy, gastrointestinal
538802|NCT00345397|fecal incontinence|fecal incontinence
538803|NCT00345397|percutaneous|percutaneous
538804|NCT00345397|quality of life|quality of life
538805|NCT00345397|spinal cord injury|spinal cord injury
538806|NCT00345410|obesity and dyslipidemia|obesity and dyslipidemia
538807|NCT00345436|Insulin Sensitivity|insulin sensitivity
538808|NCT00345436|Moderate intensity|moderate intensity
538809|NCT00345436|Insulin Resistance|insulin resistance
538810|NCT00345436|Exercise Intervention|exercise intervention
538811|NCT00345449|cystic fibrosis,|cystic fibrosis,
538812|NCT00345449|lung disease,|lung disease,
538813|NCT00345449|lung transplantation,|lung transplantation,
538814|NCT00345449|decision aid|decision aid
538815|NCT00345462|Influenza, Vaccine, CHMP criteria|influenza, vaccine, chmp criteria
538816|NCT00345475|Birth Defects|birth defects
538817|NCT00345475|Epilepsy|epilepsy
538818|NCT00345475|High Risk Pregnancy|high risk pregnancy
538819|NCT00345501|contrast media|contrast media
538820|NCT00345501|contrast nephropathy|contrast nephropathy
538821|NCT00345514|Children|children
538822|NCT00345514|Self-efficacy|self-efficacy
538823|NCT00345514|Organization|organization
538824|NCT00345514|Process of care|process of care
538825|NCT00345527|Problem gambling|problem gambling
538826|NCT00345527|Clinically significant anger|clinically significant anger
538827|NCT00345540|Platinum Resistant Tumors of Ovarian Origin|platinum resistant tumors of ovarian origin
538828|NCT00345553|Biliary Atresia|biliary atresia
538829|NCT00345553|Cholestasis|cholestasis
538830|NCT00345566|cerebral palsy|cerebral palsy
538831|NCT00345566|protein composition|protein composition
538832|NCT00345566|gastric emptying rate|gastric emptying rate
538833|NCT00345566|tube feeding|tube feeding
538834|NCT00345579|Prophylaxis|prophylaxis
538835|NCT00345579|Neisseria meningitidis Vaccines, conjugate|neisseria meningitidis vaccines, conjugate
538836|NCT00345579|Infants|infants
538837|NCT00345579|Meningococcal vaccines|meningococcal vaccines
538838|NCT00345579|H. influenzae type B vaccine|h. influenzae type b vaccine
538839|NCT00345579|Humans|humans
538840|NCT00345579|Safety|safety
538841|NCT00345605|Argininosuccinic Acid Lyase Deficiency|argininosuccinic acid lyase deficiency
538842|NCT00345605|ASA|asa
538843|NCT00345618|Deep venous thrombosis|deep venous thrombosis
538844|NCT00345618|pulmonary embolism|pulmonary embolism
538845|NCT00345618|anticoagulant drugs|anticoagulant drugs
538846|NCT00351598|Tumour Volume|tumour volume
538847|NCT00351598|Prognostic value|prognostic value
538848|NCT00351611|epilepsy partial seizure treatment with pregabalin or placebo|epilepsy partial seizure treatment with pregabalin or placebo
538849|NCT00351611|vision testing|vision testing
538850|NCT00351624|DHA supplementation|dha supplementation
538851|NCT00351624|Cognitive function|cognitive function
538852|NCT00351624|Preschool children|preschool children
538853|NCT00351624|Attention and behavior|attention and behavior
538854|NCT00351624|Healthy Children|healthy children
538855|NCT00351637|Sublingual methadone|sublingual methadone
538856|NCT00351637|iatrogenic|iatrogenic
538957|NCT00352222|iliac arteries|iliac arteries
538857|NCT00351637|treatment related incident breakthrough pain|treatment related incident breakthrough pain
538858|NCT00351637|feasibility study|feasibility study
538859|NCT00351637|Phase II/open-label|phase ii/open-label
538860|NCT00351637|inpatients|inpatients
538861|NCT00351637|Safety/efficacy|safety/efficacy
538862|NCT00351637|Cancer related breakthrough pain|cancer related breakthrough pain
538863|NCT00351637|previously receiving opioids|previously receiving opioids
538864|NCT00351637|speak English|speak english
538865|NCT00351650|Imaging|imaging
538866|NCT00351650|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
538867|NCT00351650|Islet|islet
538868|NCT00351650|B Cell Mass|b cell mass
538869|NCT00351650|Pet Scan|pet scan
538870|NCT00351650|Type 1 Diabetes|type 1 diabetes
538872|NCT00351650|Pancreas|pancreas
538873|NCT00351650|Healthy Volunteer|healthy volunteer
538874|NCT00351650|HV|hv
538875|NCT00351663|Venous Thrombosis|venous thrombosis
538876|NCT00351663|Critical Illness|critical illness
538877|NCT00351663|Blood Coagulation|blood coagulation
538878|NCT00351663|Factor Xa|factor xa
538879|NCT00351676|Drug Therapy|drug therapy
538880|NCT00351676|Hospitals, Teaching|hospitals, teaching
538881|NCT00351676|Hospitals, Community|hospitals, community
538882|NCT00351676|Interprofessional relations|interprofessional relations
538883|NCT00351676|Patient Care Team|patient care team
538884|NCT00351676|Pharmacists|pharmacists
539066|NCT00352469|OCD|ocd
538885|NCT00351676|Pharmacy Service, Hospital|pharmacy service, hospital
538886|NCT00351676|Comparative Study|comparative study
538887|NCT00351676|Hospitalization|hospitalization
538888|NCT00351689|Probiotic bacteria|probiotic bacteria
538889|NCT00351689|cutaneous immune homeostasis|cutaneous immune homeostasis
538890|NCT00351689|UV radiation|uv radiation
538891|NCT00351689|dietary supplement|dietary supplement
538892|NCT00351702|Preventive therapy|preventive therapy
538893|NCT00351715|Sublingual Methadone|sublingual methadone
538894|NCT00351715|Cancer related breakthrough pain|cancer related breakthrough pain
538895|NCT00351715|feasibility study|feasibility study
538896|NCT00351715|Phase II/open label|phase ii/open label
538238|NCT00350727|lapatinib|lapatinib
538897|NCT00351715|Outpatients|outpatients
538898|NCT00351715|Safety/ efficacy|safety/ efficacy
538899|NCT00351715|previously receiving opioids|previously receiving opioids
538900|NCT00351715|speak English|speak english
538902|NCT00351767|Diabetes|diabetes
538903|NCT00351767|Dabetic Feet|dabetic feet
538904|NCT00351780|fractional flow reserve|fractional flow reserve
538905|NCT00351780|bifurcation|bifurcation
538906|NCT00351780|stent|stent
538907|NCT00351806|acute intracerebral infarction|acute intracerebral infarction
538908|NCT00351819|Testosterone|testosterone
538909|NCT00351819|Pain|pain
538910|NCT00351819|Opioid|opioid
538911|NCT00351819|Hypogonadism|hypogonadism
538912|NCT00351832|Type 2 diabetes|type 2 diabetes
538913|NCT00351832|Vildagliptin|vildagliptin
538914|NCT00351832|Hemoglobin A1c|hemoglobin a1c
538915|NCT00351858|Breast Cancer|breast cancer
538916|NCT00351858|investigational drug|investigational drug
538917|NCT00351858|drug therapy|drug therapy
538918|NCT00351858|Antineoplastic Protocols|antineoplastic protocols
538919|NCT00351858|Immunotherapy|immunotherapy
538920|NCT00351858|Metastatic breast cancer|metastatic breast cancer
538921|NCT00351858|Advanced breast cancer|advanced breast cancer
538922|NCT00351858|Stage III to IV breast cancer|stage iii to iv breast cancer
538923|NCT00351858|Hormonal therapy refractory|hormonal therapy refractory
538924|NCT00351858|Failure of hormonal therapy|failure of hormonal therapy
538925|NCT00351858|Her-2/neu expressing breast cancer|her-2/neu expressing breast cancer
538926|NCT00351858|low to moderate Her-2/neu expression|low to moderate her-2/neu expression
538928|NCT00351884|Type 2 diabetes|type 2 diabetes
538929|NCT00351884|vildagliptin|vildagliptin
538930|NCT00351884|Hemoglobin A1c|hemoglobin a1c
538931|NCT00351910|Major Depressive Disorder|major depressive disorder
538932|NCT00351910|MDD|mdd
538933|NCT00352157|Soy|soy
538934|NCT00352157|Dermatology|dermatology
538935|NCT00352157|Skin|skin
538936|NCT00352157|Hair|hair
538937|NCT00352157|Finger Nails|finger nails
538938|NCT00352157|Weight Loss|weight loss
538939|NCT00352157|Body Mass Index|body mass index
538940|NCT00352157|Photoaging of Skin|photoaging of skin
538941|NCT00352157|Skin Wrinkling|skin wrinkling
538942|NCT00352170|calcium|calcium
538943|NCT00352170|vitamin D|vitamin d
538944|NCT00352170|secondary hyperparathyroidism|secondary hyperparathyroidism
538945|NCT00352170|osteoporotic fractures|osteoporotic fractures
538946|NCT00352183|Hyperlipidemia Combined|hyperlipidemia combined
538947|NCT00352183|Combination of fenofibrate and simvastatin|combination of fenofibrate and simvastatin
538948|NCT00352196|Asperger's Disorder|asperger's disorder
538949|NCT00352196|Risperidone|risperidone
538950|NCT00352196|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
538951|NCT00352196|Social Skills|social skills
538952|NCT00352209|Cyclophosphamide|cyclophosphamide
538953|NCT00352209|Preparative Regimens|preparative regimens
538954|NCT00352209|Risk Factors|risk factors
538955|NCT00352209|Chart Review|chart review
538956|NCT00352209|Incidence|incidence
538958|NCT00352222|implantation|implantation
538959|NCT00352222|treatment of atherosclerotic disease|treatment of atherosclerotic disease
538960|NCT00352222|stenosed|stenosed
538961|NCT00352222|occlusive|occlusive
538962|NCT00352235|Chronic hepatitis C|chronic hepatitis c
538963|NCT00352235|KRN7000|krn7000
538964|NCT00352235|a-GalCer|a-galcer
538965|NCT00352235|immunotherapy|immunotherapy
538966|NCT00352235|Natural Killer T cells|natural killer t cells
538967|NCT00352235|interferon|interferon
538968|NCT00352248|Alternative Medicine (AM)|alternative medicine (am)
538969|NCT00352248|Traditional Chinese Medicine|traditional chinese medicine
15950|NCT03188887|NIgA|niga
538970|NCT00352248|Tongue Acupuncture|tongue acupuncture
538971|NCT00352248|Autistic Spectrum Disorder|autistic spectrum disorder
538972|NCT00352248|Autism|autism
538973|NCT00352248|Children|children
538974|NCT00352261|Barrett's Esophagus|barrett's esophagus
538975|NCT00352287|Visceral fat|visceral fat
538976|NCT00352287|Impaired glucose tolerance|impaired glucose tolerance
538977|NCT00352287|Insulin resistance|insulin resistance
538978|NCT00352287|Growth hormone|growth hormone
538979|NCT00352287|Thiazolidinedione|thiazolidinedione
538980|NCT00352313|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
538981|NCT00352313|adult gliosarcoma|adult gliosarcoma
538982|NCT00352313|adult mixed glioma|adult mixed glioma
538983|NCT00352313|adult anaplastic astrocytoma|adult anaplastic astrocytoma
538984|NCT00352313|recurrent adult brain tumor|recurrent adult brain tumor
538985|NCT00352313|adult glioblastoma|adult glioblastoma
538986|NCT00352313|adult giant cell glioblastoma|adult giant cell glioblastoma
538987|NCT00352339|Schizophrenia|schizophrenia
538988|NCT00352339|Switching|switching
538989|NCT00352339|Early stage|early stage
538990|NCT00352339|Risperidone|risperidone
538991|NCT00352339|Aripirazole|aripirazole
538992|NCT00352352|Traditional Chinese Medicine (TCM)|traditional chinese medicine (tcm)
538993|NCT00352352|Alternative Medicine (AM)|alternative medicine (am)
538994|NCT00352352|Tongue Acupuncture (TAC)|tongue acupuncture (tac)
538995|NCT00352352|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
538996|NCT00352352|Autism|autism
538997|NCT00352352|Children|children
538998|NCT00352378|Primary|primary
538999|NCT00352391|Non-Small Cell Lung Cancer|non-small cell lung cancer
539000|NCT00352391|Head And Neck Cancer|head and neck cancer
539001|NCT00352391|Lung Cancer|lung cancer
539002|NCT00352391|Bronchoscopy|bronchoscopy
539003|NCT00352391|Laryngoscopy|laryngoscopy
539004|NCT00352391|NSCLC|nsclc
539005|NCT00352391|Disease Free Survival|disease free survival
539006|NCT00352391|Current Smoker|current smoker
539007|NCT00352391|Former Smoker|former smoker
539008|NCT00352404|Endomicroscopy|endomicroscopy
539009|NCT00352404|Chromoendoscopy|chromoendoscopy
539010|NCT00352404|Chromoscopy|chromoscopy
539011|NCT00352404|Ulcerative Colitis|ulcerative colitis
539012|NCT00352404|Intraepithelial Neoplasia|intraepithelial neoplasia
539013|NCT00352430|Nitric Oxide|nitric oxide
539014|NCT00352430|PDE Inhibitors|pde inhibitors
539015|NCT00352430|Pulmonary Hypertension|pulmonary hypertension
539016|NCT00352430|Sickle Cell|sickle cell
539017|NCT00352430|Thalassemia|thalassemia
539018|NCT00352430|Sickle Cell Anemia|sickle cell anemia
539019|NCT00352443|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
539020|NCT00352443|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
539021|NCT00352443|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
539022|NCT00352443|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
539023|NCT00352443|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
539024|NCT00352443|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
539025|NCT00352443|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
539026|NCT00352443|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
539027|NCT00352443|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
539028|NCT00352443|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
539029|NCT00352443|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
539030|NCT00352443|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
539031|NCT00352443|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
539032|NCT00352443|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
539033|NCT00352443|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
539034|NCT00352443|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
539035|NCT00352443|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
539036|NCT00352443|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
539037|NCT00352443|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
539038|NCT00352443|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
539039|NCT00352443|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
539040|NCT00352443|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
539041|NCT00352443|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
539135|NCT00352664|Advanced Cancer|advanced cancer
539042|NCT00352443|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
539043|NCT00352443|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
539044|NCT00352443|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
539045|NCT00352443|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
539046|NCT00352443|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
539047|NCT00352443|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
539048|NCT00352443|splenic marginal zone lymphoma|splenic marginal zone lymphoma
539049|NCT00352443|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
539050|NCT00352443|anaplastic large cell lymphoma|anaplastic large cell lymphoma
539051|NCT00352443|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
539052|NCT00352443|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
539054|NCT00352456|Facial Affect|facial affect
539055|NCT00352456|Instrumental Learning|instrumental learning
539056|NCT00352456|Psychopathy|psychopathy
539057|NCT00352456|Emotion|emotion
539058|NCT00352456|Orbitofrontal Cortex|orbitofrontal cortex
539059|NCT00352456|Healthy Volunteer|healthy volunteer
539061|NCT00352469|Alcoholism|alcoholism
539062|NCT00352469|Anxiety|anxiety
539063|NCT00352469|GAD|gad
539064|NCT00352469|PTSD|ptsd
539065|NCT00352469|Panic Disorder|panic disorder
539067|NCT00352482|Pulmonary Hypertension|pulmonary hypertension
539068|NCT00352482|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
539069|NCT00352495|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
539070|NCT00352495|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
539071|NCT00352495|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
539072|NCT00352495|childhood oligodendroglioma|childhood oligodendroglioma
539073|NCT00352495|neurofibromatosis type 1|neurofibromatosis type 1
695242|NCT00950248|MS|ms
538442|NCT00351559|allograft|allograft
539074|NCT00352495|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
539075|NCT00352495|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
539076|NCT00352508|Internet, dietary advice, saturated fat|internet, dietary advice, saturated fat
539077|NCT00352521|adult anaplastic astrocytoma|adult anaplastic astrocytoma
539078|NCT00352521|adult mixed glioma|adult mixed glioma
539079|NCT00352521|adult giant cell glioblastoma|adult giant cell glioblastoma
539080|NCT00352521|adult gliosarcoma|adult gliosarcoma
539081|NCT00352521|recurrent adult brain tumor|recurrent adult brain tumor
539082|NCT00352521|adult glioblastoma|adult glioblastoma
539083|NCT00352521|adult anaplastic ependymoma|adult anaplastic ependymoma
539084|NCT00352521|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
539085|NCT00352521|adult pineal gland astrocytoma|adult pineal gland astrocytoma
539086|NCT00352547|Immunosuppresant|immunosuppresant
539087|NCT00352547|Genetic Polymorphism|genetic polymorphism
539088|NCT00352547|Drug Metabolism|drug metabolism
539089|NCT00352547|Pharmacogenetics|pharmacogenetics
539090|NCT00352547|Rapamycin|rapamycin
539091|NCT00352560|Patients with Paroxysmal Atrial Fibrillation (PAF)|patients with paroxysmal atrial fibrillation (paf)
539092|NCT00352573|Ethics, Clinical|ethics, clinical
539093|NCT00352573|Physician's Role|physician's role
539094|NCT00352573|Health Care Rationing|health care rationing
539095|NCT00352573|Knowledge, Attitudes, Practices|knowledge, attitudes, practices
539097|NCT00352573|Survey|survey
539098|NCT00352573|Ethics|ethics
539099|NCT00352586|Classical Conditioning|classical conditioning
539100|NCT00352586|Learning|learning
539101|NCT00352586|NMDA|nmda
539102|NCT00352586|Startle|startle
539103|NCT00352586|Eyeblink|eyeblink
539104|NCT00352586|Anxiety|anxiety
539105|NCT00352586|Fear Conditioning|fear conditioning
539106|NCT00352586|Fear Potentiated Startle|fear potentiated startle
539107|NCT00352586|Extinction|extinction
539108|NCT00352586|D-cycloserine|d-cycloserine
539109|NCT00352586|Healthy Volunteer|healthy volunteer
539110|NCT00352586|HV|hv
539111|NCT00352586|Normal Control|normal control
539112|NCT00352599|Neurofibromatosis Type 1|neurofibromatosis type 1
539113|NCT00352599|NF1|nf1
539114|NCT00352599|Lovastatin|lovastatin
539115|NCT00352599|statin|statin
539116|NCT00352612|clinical trial|clinical trial
539117|NCT00352612|randomized|randomized
539118|NCT00352612|blinded|blinded
539119|NCT00352612|controlled|controlled
539120|NCT00352625|Tendonitis|tendonitis
539121|NCT00352625|Bursitis|bursitis
539122|NCT00352625|Pain|pain
539123|NCT00352625|Shoulder Pain|shoulder pain
539124|NCT00352625|Elbow Pain|elbow pain
539125|NCT00352625|Knee Pain|knee pain
539126|NCT00352625|Tendon Injury|tendon injury
539127|NCT00352625|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
539128|NCT00352638|colon cancer|colon cancer
539129|NCT00352638|rectal cancer|rectal cancer
539130|NCT00352651|Acute Herpes Zoster (AHZ)|acute herpes zoster (ahz)
539131|NCT00352651|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
539132|NCT00352651|Pregabalin|pregabalin
539133|NCT00352651|Lyrica|lyrica
539134|NCT00352651|Pain|pain
539136|NCT00352664|Cancer Pain|cancer pain
539137|NCT00352664|Donepezil|donepezil
539138|NCT00352664|Sedation|sedation
539139|NCT00352664|Placebo|placebo
539140|NCT00352703|Oral mucositis|oral mucositis
539141|NCT00352703|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
539142|NCT00352703|conditioning chemotherapy|conditioning chemotherapy
539143|NCT00352703|autologous PBSCT|autologous pbsct
539144|NCT00352703|multiple myeloma (MM)|multiple myeloma (mm)
539145|NCT00352703|Melphalan|melphalan
539146|NCT00352729|Burns|burns
539147|NCT00352729|ACell|acell
539148|NCT00352729|Donor Site|donor site
539149|NCT00352742|Multiple myeloma|multiple myeloma
539150|NCT00352742|bortezomib|bortezomib
539151|NCT00352742|ATN-224|atn-224
539152|NCT00352742|refractory|refractory
539153|NCT00352742|relapsed|relapsed
539154|NCT00352742|antiangiogenic|antiangiogenic
539155|NCT00352768|Fluvoxamine Maleate|fluvoxamine maleate
539157|NCT00352768|Children and Adolescents|children and adolescents
539158|NCT00352781|nicotine replacement therapy|nicotine replacement therapy
539159|NCT00352781|smoking cessation|smoking cessation
539160|NCT00352794|Combination chemotherapy|combination chemotherapy
539161|NCT00352794|Myelofibrosis (MF)|myelofibrosis (mf)
539162|NCT00352807|Cataract|cataract
539163|NCT00352820|Caregiver|caregiver
539164|NCT00352820|Brain cancer|brain cancer
539165|NCT00352820|Glioma|glioma
539166|NCT00352820|Questionnaire|questionnaire
539167|NCT00352820|Survey|survey
539168|NCT00352820|Interview|interview
539169|NCT00352833|gastric cancer|gastric cancer
539170|NCT00352833|investigational drug|investigational drug
539171|NCT00352833|adjuvant therapy|adjuvant therapy
538538|NCT00338585|thromboembolism|thromboembolism
539172|NCT00352833|intraoperative|intraoperative
539173|NCT00352833|intraperitoneal|intraperitoneal
539174|NCT00352833|EpCAM-positive tumor|epcam-positive tumor
539175|NCT00352846|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
539176|NCT00352846|Lymphoma|lymphoma
539177|NCT00352846|Zoledronic Acid|zoledronic acid
539178|NCT00352846|Zoledronate|zoledronate
539179|NCT00352846|Zometa|zometa
539180|NCT00352846|Vitamin D|vitamin d
539181|NCT00352846|Calcium Carbonate|calcium carbonate
539182|NCT00352846|Bone Loss|bone loss
539183|NCT00352859|Cancer|cancer
539184|NCT00352859|Renal Cell Cancer|renal cell cancer
539185|NCT00352859|RCC|rcc
539186|NCT00352872|Pharmacogenetics|pharmacogenetics
539187|NCT00352872|Toxicity|toxicity
539188|NCT00352872|Pre-Menopausal|pre-menopausal
539189|NCT00352872|Women|women
539190|NCT00352872|Doxorubicin|doxorubicin
539191|NCT00352872|Cyclophosphamide|cyclophosphamide
539192|NCT00352872|Breast Cancer|breast cancer
539193|NCT00352872|Chemotherapy|chemotherapy
539194|NCT00352885|Cancer|cancer
539195|NCT00352885|IL-2 therapy|il-2 therapy
539196|NCT00352885|Antidepressant|antidepressant
539197|NCT00352885|Immune system|immune system
539198|NCT00352885|Neuroendocrine response|neuroendocrine response
539199|NCT00352911|HIV-1|hiv-1
539200|NCT00352924|Cancer|cancer
539201|NCT00352924|Pesticides|pesticides
539202|NCT00352924|Agriculture|agriculture
539203|NCT00352937|Coronary Arteriosclerosis|coronary arteriosclerosis
539204|NCT00352937|Tomography, X-Ray Computed|tomography, x-ray computed
539205|NCT00352937|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
539206|NCT00352950|NSCLC, Lung cancer|nsclc, lung cancer
539207|NCT00352950|Panitumumab|panitumumab
539208|NCT00352950|Sirolimus|sirolimus
539209|NCT00352950|mTOR|mtor
539210|NCT00352950|Monoclonal antibody|monoclonal antibody
539211|NCT00352963|Open, phase 3, Infanrix hexa™, Hib-MenC, co-administered|open, phase 3, infanrix hexa™, hib-menc, co-administered
539212|NCT00352976|Bone Marrow transplant|bone marrow transplant
539213|NCT00352976|stem cell transplant|stem cell transplant
539214|NCT00352976|cord blood transplant|cord blood transplant
539215|NCT00352976|total body irradiation|total body irradiation
539216|NCT00352976|thymic shielding|thymic shielding
539217|NCT00353002|Pain|pain
539218|NCT00353002|Ametop|ametop
539219|NCT00353002|Liposomal Lidocaine|liposomal lidocaine
539220|NCT00353002|Venous cannulation|venous cannulation
539221|NCT00353015|Gastrointestinal cancer|gastrointestinal cancer
539222|NCT00353015|high grade gastrointestinal neuroendocrine carcinoma|high grade gastrointestinal neuroendocrine carcinoma
539223|NCT00353015|High grade neuroendocrine carcinoma of unknown primary site|high grade neuroendocrine carcinoma of unknown primary site
539224|NCT00353015|Cisplatin|cisplatin
539225|NCT00353015|Platinol-AQ|platinol-aq
539226|NCT00353015|Platinol|platinol
539227|NCT00353015|CDDP|cddp
539228|NCT00353015|CPT-11|cpt-11
539229|NCT00353015|Irinotecan|irinotecan
539230|NCT00353028|Fluvoxamine Maleate|fluvoxamine maleate
539231|NCT00353028|Depression|depression
539232|NCT00353028|Children and Adolescents|children and adolescents
539233|NCT00353041|topical|topical
539234|NCT00353041|anesthetic|anesthetic
539235|NCT00353041|pain|pain
539236|NCT00353054|Caltrate|caltrate
539237|NCT00353054|Lipoproteins|lipoproteins
539238|NCT00353054|Glucose|glucose
539239|NCT00353054|Insulin|insulin
539240|NCT00353054|Blood pressure|blood pressure
539241|NCT00353054|Body fat|body fat
539242|NCT00353054|Body weight|body weight
539243|NCT00353054|Women|women
539244|NCT00353054|Diet|diet
539245|NCT00353054|Macronutrients|macronutrients
539246|NCT00353067|unstable angina|unstable angina
539247|NCT00353067|myocardial infarction|myocardial infarction
539248|NCT00353067|coronary thrombosis|coronary thrombosis
539249|NCT00353067|coronary atherosclerosis|coronary atherosclerosis
539250|NCT00353080|Prevention of postmenopausal osteoporosis|prevention of postmenopausal osteoporosis
539251|NCT00353093|deep vein thrombosis,D-dimer,ultrasonography|deep vein thrombosis,d-dimer,ultrasonography
539252|NCT00353106|Graft-Versus-Host Disease|graft-versus-host disease
539253|NCT00353106|GVHD|gvhd
539254|NCT00353106|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
539255|NCT00353106|cGVHD|cgvhd
539256|NCT00353106|Interview|interview
539257|NCT00353106|Questionnaire|questionnaire
539258|NCT00353106|Survey|survey
539259|NCT00353106|Caregiver|caregiver
539260|NCT00353119|Palmoplantar pustulosis|palmoplantar pustulosis
539261|NCT00353119|Psoriasis|psoriasis
539262|NCT00353119|Etanercept|etanercept
539263|NCT00353145|Unknown Primary Neoplasms|unknown primary neoplasms
539264|NCT00353145|UPC|upc
539265|NCT00353145|Unknown Primary Cancer|unknown primary cancer
539266|NCT00353145|Questionnaire|questionnaire
539267|NCT00353145|Gemcitabine|gemcitabine
539268|NCT00353145|Gemcitabine Hydrochloride|gemcitabine hydrochloride
539269|NCT00353145|Gemzar|gemzar
539270|NCT00353145|Oxaliplatin|oxaliplatin
539271|NCT00353145|Eloxatin|eloxatin
539272|NCT00353145|Gemox|gemox
539273|NCT00353158|Phototesting|phototesting
539274|NCT00353158|UVR/UVA|uvr/uva
539275|NCT00353158|Sunburn|sunburn
539276|NCT00353158|Doxycycline|doxycycline
539277|NCT00353158|Voriconazole|voriconazole
539278|NCT00353158|Phototoxicity|phototoxicity
539279|NCT00353158|Healthy Volunteer|healthy volunteer
539280|NCT00353158|HV|hv
539281|NCT00353171|Smoking|smoking
539282|NCT00353171|PCB|pcb
539283|NCT00353171|DDE|dde
539284|NCT00353171|Menstrual Cycle|menstrual cycle
539285|NCT00353171|NC Infant Feeding Study|nc infant feeding study
539286|NCT00353184|Acute|acute
539287|NCT00353184|Asthma|asthma
539288|NCT00353184|Child|child
539289|NCT00353184|Pediatric|pediatric
539290|NCT00353184|Emergency|emergency
539291|NCT00353184|Oral|oral
539292|NCT00353184|Montelukast|montelukast
539293|NCT00353184|Forced Expiratory Volume in One Second|forced expiratory volume in one second
539294|NCT00353184|FEV1|fev1
539295|NCT00353197|IVF|ivf
539296|NCT00353197|embryos|embryos
539297|NCT00353197|research|research
539298|NCT00353197|donation|donation
539299|NCT00353197|surplus|surplus
539300|NCT00353197|stem cells|stem cells
539301|NCT00353210|IVF|ivf
539302|NCT00353210|embryos|embryos
539303|NCT00353210|research|research
539304|NCT00353210|donation|donation
539305|NCT00353210|surplus|surplus
539306|NCT00353210|stem cells|stem cells
539307|NCT00353210|abnormal embryo|abnormal embryo
539308|NCT00353210|screening|screening
539309|NCT00353223|Heart Failure|heart failure
539310|NCT00353223|Functional Impairment|functional impairment
539311|NCT00353223|Health-Related Quality of Life|health-related quality of life
539312|NCT00353223|Telemedicine|telemedicine
539313|NCT00353236|delivery of preterm infant and/or twins|delivery of preterm infant and/or twins
539314|NCT00353249|Cognitive Behavioral Therapy|cognitive behavioral therapy
539316|NCT00353249|Homeless Women|homeless women
539317|NCT00353275|Strict glycemic control|strict glycemic control
539318|NCT00353301|Carcinoma, Renal Cell|carcinoma, renal cell
539319|NCT00353301|Receptor, Epidermal Growth Factor|receptor, epidermal growth factor
539320|NCT00353301|mTOR protein|mtor protein
539321|NCT00353301|Sirolimus|sirolimus
539322|NCT00353301|Erlotinib|erlotinib
539323|NCT00353327|HIV|hiv
539324|NCT00353327|Passive immunotherapy|passive immunotherapy
539325|NCT00353340|sodium bicarbonate,|sodium bicarbonate,
539326|NCT00353340|n-acetylcisteine,|n-acetylcisteine,
539327|NCT00353340|contrast nephropathy,|contrast nephropathy,
539328|NCT00353340|cardiac catheterisation|cardiac catheterisation
539329|NCT00353353|no specific conditions|no specific conditions
539330|NCT00353366|safety|safety
539331|NCT00353366|Post-marketing surveillance (PMS)|post-marketing surveillance (pms)
539332|NCT00353366|Rotarix|rotarix
539333|NCT00353366|oral|oral
539334|NCT00353366|Filipino|filipino
539335|NCT00353366|Rotavirus|rotavirus
539336|NCT00353366|Gastroenteritis|gastroenteritis
539337|NCT00353366|Human Rotavirus (HRV) vaccine|human rotavirus (hrv) vaccine
539338|NCT00353405|Adolescents|adolescents
539339|NCT00353405|Sexually Transmitted Infections|sexually transmitted infections
539340|NCT00353405|Gonorrhea|gonorrhea
539341|NCT00353405|Chlamydia Infections|chlamydia infections
539342|NCT00353431|Hyperglycaemia|hyperglycaemia
539343|NCT00353431|algorithm|algorithm
539344|NCT00353431|emergency|emergency
539345|NCT00353431|s.c. insulin therapy|s.c. insulin therapy
539346|NCT00353431|Emergency patient|emergency patient
539347|NCT00353444|head injury|head injury
539348|NCT00353444|transcranial Doppler|transcranial doppler
539349|NCT00353444|pulsatility index|pulsatility index
539350|NCT00353444|vasospasm in head injury|vasospasm in head injury
539351|NCT00353457|Adjuvant therapy|adjuvant therapy
539352|NCT00353457|Rectal cancer|rectal cancer
539353|NCT00353457|Capecitabine|capecitabine
539354|NCT00353457|Oxaliplatin|oxaliplatin
539355|NCT00353457|Cetuximab|cetuximab
539356|NCT00353457|Erbitux|erbitux
539357|NCT00353470|PD|pd
539358|NCT00353470|CBT|cbt
539359|NCT00353470|PFPP|pfpp
539360|NCT00353483|Breast Cancer|breast cancer
539361|NCT00353483|Neoadjuvant|neoadjuvant
539362|NCT00353496|Non functioning entero-pancreatic tumours|non functioning entero-pancreatic tumours
539363|NCT00353535|glomerulosclerosis, focal|glomerulosclerosis, focal
539364|NCT00353535|pretransplant immunosuppression|pretransplant immunosuppression
539365|NCT00353535|total lymphoid irradiation|total lymphoid irradiation
539367|NCT00353535|recurrence|recurrence
539368|NCT00353548|Bulimia Nervosa|bulimia nervosa
539369|NCT00353548|Binge Eating Disorder|binge eating disorder
539370|NCT00353548|Obesity|obesity
539371|NCT00353548|Anorexia Nervosa|anorexia nervosa
539372|NCT00353574|Resistant Hypertension|resistant hypertension
539373|NCT00353587|insulin sensitizer|insulin sensitizer
539374|NCT00353587|type 2 diabetes|type 2 diabetes
539375|NCT00353587|diabetes|diabetes
539376|NCT00353587|glucose control|glucose control
539377|NCT00353600|Proteinuria|proteinuria
539378|NCT00353600|Renal Failure|renal failure
539379|NCT00353600|Angiotension Converting Enzyme Inhibitor|angiotension converting enzyme inhibitor
539380|NCT00353600|Glomerular Filtration Rate|glomerular filtration rate
539381|NCT00353613|Antibiotic prophylaxis|antibiotic prophylaxis
539382|NCT00353626|Amputation|amputation
539383|NCT00353626|trans tibial|trans tibial
539384|NCT00353626|prosthesis|prosthesis
539385|NCT00353626|motion analysis|motion analysis
539387|NCT00353639|Telomerase|telomerase
539388|NCT00353639|TERT|tert
539389|NCT00353639|TERC|terc
539390|NCT00353639|SBDS|sbds
539391|NCT00353639|DNA Helicase|dna helicase
539392|NCT00353639|Inflammatory Bowel Disease|inflammatory bowel disease
539393|NCT00353639|IBD|ibd
539394|NCT00353652|Blood Pressure, High|blood pressure, high
539395|NCT00353665|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
539396|NCT00353665|motor neuron disease|motor neuron disease
539397|NCT00353665|memantine|memantine
539398|NCT00353665|clinical trial|clinical trial
539399|NCT00353678|Hip replacement|hip replacement
539400|NCT00353678|Arthroplasty|arthroplasty
539401|NCT00353678|Prevention|prevention
539402|NCT00353678|Thromboembolism|thromboembolism
539403|NCT00353678|Treatment outcomes|treatment outcomes
539404|NCT00353678|Arthroplasty, replacement, hip|arthroplasty, replacement, hip
539405|NCT00353704|Intervertebral disk displacement|intervertebral disk displacement
539406|NCT00353704|disk prolapse|disk prolapse
539407|NCT00353704|pregabalin|pregabalin
539408|NCT00353717|breast|breast
539409|NCT00353717|basal like|basal like
539410|NCT00353717|carcinoma|carcinoma
539411|NCT00353717|metastatic|metastatic
539412|NCT00353717|EGFR|egfr
539413|NCT00353730|Serial Analysis of Gene Expression|serial analysis of gene expression
539414|NCT00353730|Carotid Artery Plaque|carotid artery plaque
539415|NCT00353730|Atherosclerosis|atherosclerosis
539416|NCT00353743|infected abortion|infected abortion
539417|NCT00353743|treatment period|treatment period
539418|NCT00353743|doxycycline|doxycycline
539419|NCT00353743|metronidazole|metronidazole
539420|NCT00353743|placebo|placebo
539421|NCT00353769|scalp laceration|scalp laceration
539422|NCT00353769|tissue adhesive|tissue adhesive
539423|NCT00353769|wound care|wound care
539424|NCT00353769|cost effectiveness|cost effectiveness
539425|NCT00353782|Dyslipidemia|dyslipidemia
539426|NCT00353782|Hypertriglyceridemia|hypertriglyceridemia
539427|NCT00353782|Hyperalphalipoproteinemia|hyperalphalipoproteinemia
539428|NCT00353782|Atheroembolism|atheroembolism
539429|NCT00353782|Atherosclerosis|atherosclerosis
539430|NCT00353782|Dyslipoproteinemia|dyslipoproteinemia
539431|NCT00353782|Hypercholesterolemia|hypercholesterolemia
539432|NCT00353782|hypoalphalipoproteinemia|hypoalphalipoproteinemia
539433|NCT00353795|MESA|mesa
539434|NCT00353795|MRI|mri
539435|NCT00353795|Cardiovascular|cardiovascular
539436|NCT00353795|Cardiac|cardiac
539437|NCT00353795|Coronary|coronary
539438|NCT00353795|Atherosclerosis|atherosclerosis
539439|NCT00353821|Tumor Necrosis Factor Alpha (TNF-Alpha)|tumor necrosis factor alpha (tnf-alpha)
539440|NCT00353821|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
539441|NCT00353821|Interleukin-10 (IL-10)|interleukin-10 (il-10)
539442|NCT00353821|Interleukin-6 (IL-6)|interleukin-6 (il-6)
539443|NCT00353821|Interleukin-1 (IL-1 Ra)|interleukin-1 (il-1 ra)
539444|NCT00353821|Interleukin-1 Receptor Antagonist (IL-1 Ra)|interleukin-1 receptor antagonist (il-1 ra)
539445|NCT00353821|Vitamin D Receptor (VitD R)|vitamin d receptor (vitd r)
539446|NCT00353834|endothelial dysfunction|endothelial dysfunction
539447|NCT00353834|subclinical inflammation|subclinical inflammation
539448|NCT00353834|flow mediated brachial artery dilation|flow mediated brachial artery dilation
539449|NCT00353834|pulse wave analysis|pulse wave analysis
539450|NCT00353834|glucagon like polypeptide mimetics|glucagon like polypeptide mimetics
539451|NCT00353834|type 2 diabetes mellitus|type 2 diabetes mellitus
539452|NCT00353847|acupuncture, RCTs, chronic LBP|acupuncture, rcts, chronic lbp
539453|NCT00353860|Leukemia|leukemia
539454|NCT00353860|Transplant - Mortality|transplant - mortality
539455|NCT00353860|Immunosuppression|immunosuppression
539456|NCT00353860|Radiation|radiation
539457|NCT00353860|Cure|cure
539458|NCT00353860|Peripheral Blood Stem Cells|peripheral blood stem cells
539459|NCT00353860|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
539386|NCT00353639|Ulcera|ulcera
539460|NCT00353860|Graft-Versus-Host Disease|graft-versus-host disease
539461|NCT00353860|Cyclosporine|cyclosporine
539462|NCT00353860|Fludarabine|fludarabine
539463|NCT00353873|FLIXOTIDE|flixotide
539464|NCT00353873|asthmatics children 4-11 years|asthmatics children 4-11 years
539465|NCT00353873|SERETIDE|seretide
539466|NCT00353873|asthma-control|asthma-control
539467|NCT00353886|Retrospective|retrospective
539468|NCT00353886|Epilepsy|epilepsy
539469|NCT00353886|Antiepileptic Drugs|antiepileptic drugs
539470|NCT00353886|Behavioral Development|behavioral development
539471|NCT00353886|Intellectual Development|intellectual development
539472|NCT00353899|Magnetic Resonance Imaging|magnetic resonance imaging
539473|NCT00353899|Pediatric|pediatric
539474|NCT00353899|Normal Volunteer|normal volunteer
539475|NCT00353899|Electrocardiogram|electrocardiogram
539476|NCT00353899|Cardiac|cardiac
539477|NCT00353899|Healthy Volunteer|healthy volunteer
539478|NCT00353899|HV|hv
539479|NCT00353912|Blood|blood
539480|NCT00353912|Venous|venous
539481|NCT00353912|Systolic|systolic
539482|NCT00353912|Diastolic|diastolic
539483|NCT00353912|Pulse|pulse
539484|NCT00353912|Pressure|pressure
539485|NCT00353925|Hypertrophy|hypertrophy
539486|NCT00353925|LVH|lvh
539487|NCT00353925|Cardiac|cardiac
539488|NCT00353925|Blood Pressure|blood pressure
539489|NCT00353925|Papillary Muscle|papillary muscle
539490|NCT00353938|PTSD, MDMA, psychotherapy, Switzerland|ptsd, mdma, psychotherapy, switzerland
539491|NCT00353951|primary care|primary care
539492|NCT00353951|lower respiratory tract infection|lower respiratory tract infection
539493|NCT00353951|antibiotics|antibiotics
539494|NCT00353951|cough|cough
539495|NCT00353977|Cytomegalovirus|cytomegalovirus
539496|NCT00353977|Vaccine|vaccine
539497|NCT00353977|CMV|cmv
539498|NCT00353977|Immunization|immunization
539499|NCT00353977|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
539500|NCT00353977|Stem Cell Allotransplant|stem cell allotransplant
539501|NCT00353990|insulin|insulin
539502|NCT00353990|bioavailability|bioavailability
539503|NCT00353990|duodenum|duodenum
539504|NCT00353990|infusion|infusion
539505|NCT00353990|healthy|healthy
539506|NCT00353990|diabetes|diabetes
539507|NCT00353990|absorption|absorption
539508|NCT00354003|Parkinson|parkinson
539509|NCT00354003|Imaging|imaging
539510|NCT00354016|influenza|influenza
539511|NCT00354016|vaccine|vaccine
539512|NCT00354029|hemorrhoids|hemorrhoids
539513|NCT00354029|hemorrhoidectomy|hemorrhoidectomy
539514|NCT00354029|S (+) ketamine|s (+) ketamine
539515|NCT00354029|pain|pain
539516|NCT00354042|GW597901X|gw597901x
539517|NCT00354042|Asthma|asthma
539518|NCT00354042|Crossover|crossover
539519|NCT00354042|dose ascending|dose ascending
539520|NCT00354042|repeat dose|repeat dose
539521|NCT00354042|inhaled|inhaled
539522|NCT00354068|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
539523|NCT00354068|adult giant cell glioblastoma|adult giant cell glioblastoma
539524|NCT00354068|adult gliosarcoma|adult gliosarcoma
539525|NCT00354068|adult mixed glioma|adult mixed glioma
539526|NCT00354068|adult anaplastic astrocytoma|adult anaplastic astrocytoma
539527|NCT00354068|recurrent adult brain tumor|recurrent adult brain tumor
539528|NCT00354068|adult glioblastoma|adult glioblastoma
539529|NCT00354081|Coronary Artery Disease|coronary artery disease
539530|NCT00354081|Myocardial Infarction|myocardial infarction
539531|NCT00354081|Cerebrovascular Stroke|cerebrovascular stroke
539532|NCT00354081|Homocysteine|homocysteine
539533|NCT00354081|Folic Acid|folic acid
539534|NCT00354081|Vitamin B 12|vitamin b 12
539535|NCT00354081|Vitamin B 6|vitamin b 6
539536|NCT00354133|Parkinson Disease|parkinson disease
539537|NCT00354133|Deep Brain Stimulation|deep brain stimulation
539538|NCT00354133|PDQ-39|pdq-39
539539|NCT00354146|Farnesyl transferase inhibitor|farnesyl transferase inhibitor
539540|NCT00354146|relapsed or refractory acute myeloid leukemia|relapsed or refractory acute myeloid leukemia
539541|NCT00354159|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
539542|NCT00354159|Intracardiac pressures|intracardiac pressures
539543|NCT00354172|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
539544|NCT00354172|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
539545|NCT00354172|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
539625|NCT00354445|pegaptanib sodium|pegaptanib sodium
539546|NCT00354172|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
539547|NCT00354172|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
539548|NCT00354172|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
539549|NCT00354172|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
539550|NCT00354172|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
539551|NCT00354172|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
539552|NCT00354172|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
539553|NCT00354172|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
15951|NCT03188887|Kidney biopsy|kidney biopsy
539554|NCT00354172|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
539555|NCT00354172|secondary acute myeloid leukemia|secondary acute myeloid leukemia
539556|NCT00354172|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
539557|NCT00354172|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
539558|NCT00354198|rapidly progressive glomerulonephritis|rapidly progressive glomerulonephritis
539559|NCT00354198|pentoxifylline|pentoxifylline
539560|NCT00354211|Cardiac Output|cardiac output
539561|NCT00354211|Hemodynamic Phenomena|hemodynamic phenomena
539562|NCT00354224|recurrent gastric cancer|recurrent gastric cancer
539563|NCT00354224|stage III gastric cancer|stage iii gastric cancer
538927|NCT00351871|HCV|hcv
539564|NCT00354224|stage IV gastric cancer|stage iv gastric cancer
539565|NCT00354237|diabetes mellitus|diabetes mellitus
539566|NCT00354237|cardiac rehabilitation|cardiac rehabilitation
539567|NCT00354237|insulin|insulin
539568|NCT00354263|Healthy male volunteers|healthy male volunteers
539569|NCT00354263|IMP321|imp321
539570|NCT00354263|Adjuvant|adjuvant
539571|NCT00354263|Monotherapy|monotherapy
539572|NCT00354263|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
539573|NCT00354276|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
539574|NCT00354276|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
539575|NCT00354276|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
539576|NCT00354276|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
539577|NCT00354276|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
539578|NCT00354276|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
539579|NCT00354276|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
539580|NCT00354276|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
539581|NCT00354276|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
539582|NCT00354276|adult acute basophilic leukemia|adult acute basophilic leukemia
539583|NCT00354276|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
539584|NCT00354276|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
539585|NCT00354276|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
583555|NCT00512122|Reduced Oral Intake|reduced oral intake
539586|NCT00354276|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
539587|NCT00354302|osteoporosis|osteoporosis
539588|NCT00354302|stage I breast cancer|stage i breast cancer
539589|NCT00354302|stage II breast cancer|stage ii breast cancer
539590|NCT00354302|stage IIIA breast cancer|stage iiia breast cancer
539591|NCT00354315|Shared decision making|shared decision making
539592|NCT00354315|Optimal drug prescription|optimal drug prescription
539593|NCT00354328|HCM|hcm
539594|NCT00354328|Echocardiography|echocardiography
539595|NCT00354328|Diastolic Dysfunction|diastolic dysfunction
539596|NCT00354328|Enalapril|enalapril
539597|NCT00354354|COPD|copd
539598|NCT00354354|Combivent|combivent
539599|NCT00354354|Exercise|exercise
539600|NCT00354354|Bronchodilator|bronchodilator
539601|NCT00354354|Kinetics|kinetics
539602|NCT00354367|Crohn Disease|crohn disease
539603|NCT00354367|Certolizumab pegol|certolizumab pegol
539604|NCT00354367|Fistula|fistula
539605|NCT00354380|Malaria|malaria
539606|NCT00354380|Africa|africa
539607|NCT00354380|Methalyne-blue|methalyne-blue
539608|NCT00354380|Artesunate|artesunate
539609|NCT00354380|Amodiaquine|amodiaquine
539610|NCT00354393|localized malignant mesothelioma|localized malignant mesothelioma
539611|NCT00354393|sarcomatous mesothelioma|sarcomatous mesothelioma
539612|NCT00354393|advanced malignant mesothelioma|advanced malignant mesothelioma
539613|NCT00354393|epithelial mesothelioma|epithelial mesothelioma
539614|NCT00354406|Abciximab|abciximab
539615|NCT00354406|Magnetic Resonance Imaging|magnetic resonance imaging
539616|NCT00354406|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
539617|NCT00354432|recurrent prostate cancer|recurrent prostate cancer
539618|NCT00354432|stage I prostate cancer|stage i prostate cancer
539619|NCT00354432|stage IIB prostate cancer|stage iib prostate cancer
539620|NCT00354432|stage IIA prostate cancer|stage iia prostate cancer
539621|NCT00354432|stage III prostate cancer|stage iii prostate cancer
539622|NCT00354432|stage IV prostate cancer|stage iv prostate cancer
539623|NCT00354432|hot flashes|hot flashes
539624|NCT00354445|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
539626|NCT00354445|subfoveal CNV|subfoveal cnv
539627|NCT00354445|macugen|macugen
539628|NCT00354458|heart failure|heart failure
539629|NCT00354458|diuretic|diuretic
539630|NCT00354458|renal impairment|renal impairment
539631|NCT00354458|renal function|renal function
539632|NCT00354484|anemia|anemia
539633|NCT00354484|postpartum|postpartum
539634|NCT00354497|prostate cancer|prostate cancer
539635|NCT00354510|atopic dermatitis|atopic dermatitis
539636|NCT00354510|GW842470X|gw842470x
539637|NCT00354510|PDE4 inhibitor|pde4 inhibitor
539638|NCT00354523|Solid Tumor|solid tumor
539639|NCT00354523|Thyroid Cancer|thyroid cancer
15952|NCT03188887|GFR|gfr
539640|NCT00354523|Medullary Thyroid Cancer|medullary thyroid cancer
539641|NCT00354523|MTC|mtc
539642|NCT00354523|Advanced Metastatic Medullary Thyroid Carcinoma|advanced metastatic medullary thyroid carcinoma
539643|NCT00354523|Capecitabine|capecitabine
539644|NCT00354523|Dacarbazine|dacarbazine
539645|NCT00354523|Imatinib|imatinib
539646|NCT00354523|Gleevec|gleevec
539647|NCT00354523|Imatinib Mesylate|imatinib mesylate
539648|NCT00354523|DTIC-Dome|dtic-dome
539649|NCT00354523|Xeloda|xeloda
539053|NCT00352456|Amygdala|amygdala
539650|NCT00354536|GSK716155|gsk716155
539651|NCT00354536|albiglutide|albiglutide
539652|NCT00354536|pharmacodynamics|pharmacodynamics
539653|NCT00354536|pharmacokinetics|pharmacokinetics
539654|NCT00354549|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
539655|NCT00354549|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
539656|NCT00354549|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
539657|NCT00354549|adenocarcinoma of the lung|adenocarcinoma of the lung
539658|NCT00354549|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
539659|NCT00354549|large cell lung cancer|large cell lung cancer
539660|NCT00354562|Lung Cancer|lung cancer
539661|NCT00354562|Non-Small Cell Lung Cancer|non-small cell lung cancer
539662|NCT00354562|NSCLC|nsclc
539663|NCT00354562|ABT-751|abt-751
539664|NCT00354562|docetaxel|docetaxel
539665|NCT00354562|Taxotere|taxotere
539666|NCT00354575|Constipation;|constipation;
539667|NCT00354575|Chinese herb;|chinese herb;
539668|NCT00354575|Long-term care;|long-term care;
539669|NCT00354575|Integrative Chinese Medicine and Western Medicine;|integrative chinese medicine and western medicine;
539670|NCT00354588|chronic renal failure|chronic renal failure
539671|NCT00354588|arterial stiffness|arterial stiffness
539672|NCT00354588|arterial wave reflections|arterial wave reflections
539673|NCT00354601|fallopian tube cancer|fallopian tube cancer
539674|NCT00354601|peritoneal cavity cancer|peritoneal cavity cancer
539675|NCT00354601|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
539676|NCT00354601|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
539677|NCT00354601|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
539678|NCT00354601|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
539679|NCT00354601|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
539680|NCT00354601|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
539681|NCT00354627|HIV-1|hiv-1
539682|NCT00354627|Early Access Program (EAP)|early access program (eap)
539683|NCT00354627|TMC125|tmc125
539684|NCT00354627|treatment-experienced|treatment-experienced
539685|NCT00354627|failing multiple antiretroviral (ARV) regimens|failing multiple antiretroviral (arv) regimens
539686|NCT00354627|limited to no treatment options|limited to no treatment options
539687|NCT00354640|breast cancer|breast cancer
539688|NCT00354640|breast cancer in situ|breast cancer in situ
539689|NCT00354640|ductal breast carcinoma in situ|ductal breast carcinoma in situ
539690|NCT00354640|stage I breast cancer|stage i breast cancer
539691|NCT00354640|stage II breast cancer|stage ii breast cancer
539692|NCT00354640|stage IIIA breast cancer|stage iiia breast cancer
539693|NCT00354640|stage IIIB breast cancer|stage iiib breast cancer
539694|NCT00354640|stage IIIC breast cancer|stage iiic breast cancer
539695|NCT00354653|HBeAg|hbeag
539696|NCT00354653|HBV|hbv
539697|NCT00354653|CHRONIC HEPATITIS|chronic hepatitis
539698|NCT00354653|lamivudine|lamivudine
539699|NCT00354666|inhaled|inhaled
539700|NCT00354666|asthmatic subjects|asthmatic subjects
539701|NCT00354666|GSK159797|gsk159797
539702|NCT00354666|safety and tolerability|safety and tolerability
539703|NCT00354666|efficacy|efficacy
539704|NCT00354666|dry powder|dry powder
539705|NCT00354679|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
539706|NCT00354679|recurrent esophageal cancer|recurrent esophageal cancer
539707|NCT00354679|stage III esophageal cancer|stage iii esophageal cancer
539708|NCT00354679|stage II esophageal cancer|stage ii esophageal cancer
539709|NCT00348491|Dental surgery|dental surgery
539710|NCT00348491|acute pain|acute pain
539711|NCT00348491|lumiracoxib|lumiracoxib
539712|NCT00348491|celecoxib|celecoxib
539713|NCT00348491|Moderate to severe pain following dental surgery|moderate to severe pain following dental surgery
539714|NCT00348530|Systolic heart failure; Therapy; Cardiomyopathy|systolic heart failure; therapy; cardiomyopathy
539715|NCT00348543|age-related macula degeneration|age-related macula degeneration
539716|NCT00348543|prophylactic laser treatment|prophylactic laser treatment
539897|NCT00354783|Walking|walking
539717|NCT00348543|exudative complication|exudative complication
539718|NCT00348569|CT|ct
539719|NCT00348569|Coronary|coronary
539720|NCT00348569|Cardiac|cardiac
539721|NCT00348569|Angiography|angiography
539722|NCT00348569|X-ray|x-ray
539723|NCT00348569|CAD|cad
539724|NCT00348569|Chest pain|chest pain
539725|NCT00348595|Prostate Cancer|prostate cancer
539726|NCT00348608|Coronary|coronary
539727|NCT00348608|Angiography|angiography
539728|NCT00348608|X-ray|x-ray
539729|NCT00348608|CAD|cad
539730|NCT00348621|cataract surgery|cataract surgery
539731|NCT00348621|refractive correction|refractive correction
539732|NCT00348621|low vision services|low vision services
539733|NCT00348621|nursing home|nursing home
539734|NCT00348621|visual impairment|visual impairment
539735|NCT00348634|Constipation, Tegaserod, orocecal transit, colonic transit, gastric emptying|constipation, tegaserod, orocecal transit, colonic transit, gastric emptying
539736|NCT00348647|Prevention|prevention
539737|NCT00348647|Exercise|exercise
539738|NCT00348647|Overuse|overuse
539096|NCT00352573|Questionnaires|questionnaires
539739|NCT00348647|Anterior knee pain syndrome|anterior knee pain syndrome
539740|NCT00348647|Exertional lower leg pain|exertional lower leg pain
539741|NCT00348647|Prospective|prospective
539742|NCT00348647|Risk factors|risk factors
539743|NCT00348647|Hip|hip
539744|NCT00348660|Screening for Hepatitis C in Pregnancy|screening for hepatitis c in pregnancy
539745|NCT00348686|LVH|lvh
539746|NCT00348725|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
539747|NCT00348738|radiotherapy|radiotherapy
539748|NCT00348738|clinical trial|clinical trial
539749|NCT00348738|erythropoietin|erythropoietin
539750|NCT00348738|cervix cancer|cervix cancer
539751|NCT00348738|Phase III|phase iii
539752|NCT00348738|2 Arms|2 arms
539753|NCT00348764|lauromacrogol|lauromacrogol
539754|NCT00348764|Sclerotherapy|sclerotherapy
539755|NCT00348777|Visual analogic Scale of pain|visual analogic scale of pain
539756|NCT00348777|Womac indice|womac indice
539757|NCT00348777|SF-36 quality of life|sf-36 quality of life
539758|NCT00348777|Hydrotherapy|hydrotherapy
539759|NCT00348790|adult grade I meningioma|adult grade i meningioma
539760|NCT00348790|adult grade II meningioma|adult grade ii meningioma
539761|NCT00348790|adult grade III meningioma|adult grade iii meningioma
539762|NCT00348790|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
539763|NCT00348790|adult anaplastic meningioma|adult anaplastic meningioma
539764|NCT00348790|adult papillary meningioma|adult papillary meningioma
539765|NCT00348790|adult melanocytic lesion|adult melanocytic lesion
539766|NCT00348790|recurrent adult brain tumor|recurrent adult brain tumor
539767|NCT00348816|stage I prostate cancer|stage i prostate cancer
539768|NCT00348816|stage IIB prostate cancer|stage iib prostate cancer
539769|NCT00348816|stage IIA prostate cancer|stage iia prostate cancer
539770|NCT00348816|stage III prostate cancer|stage iii prostate cancer
539771|NCT00348816|stage IV prostate cancer|stage iv prostate cancer
539772|NCT00348829|CHF|chf
539773|NCT00348829|mitral insufficiency|mitral insufficiency
539774|NCT00348829|conductance catheter|conductance catheter
539775|NCT00348829|mitral valve repair|mitral valve repair
539776|NCT00348842|Immunotherapy|immunotherapy
539777|NCT00348855|High Blood Pressure|high blood pressure
539778|NCT00348855|High cardiovascular risk|high cardiovascular risk
539779|NCT00348855|Type 2 diabetes|type 2 diabetes
539780|NCT00348855|Reaching goals|reaching goals
539781|NCT00348868|HIV Infection|hiv infection
539782|NCT00348868|Opioid dependence|opioid dependence
539783|NCT00348868|DSM-IV criteria for opioid dependence|dsm-iv criteria for opioid dependence
539784|NCT00348881|Diphtheria|diphtheria
539785|NCT00348881|Tetanus|tetanus
539786|NCT00348881|Pertussis|pertussis
539787|NCT00348881|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
539788|NCT00348881|Haemophilus influenzae type b|haemophilus influenzae type b
539789|NCT00348907|doppler|doppler
539790|NCT00348907|CIVIQ quality of life|civiq quality of life
539791|NCT00348907|Hydrotherapy|hydrotherapy
539792|NCT00348907|anticoagulants|anticoagulants
539793|NCT00348920|Aortic Valve|aortic valve
539794|NCT00348920|Aortic Stenosis|aortic stenosis
539795|NCT00348920|High Spinal Anesthesia|high spinal anesthesia
539796|NCT00348920|Total Spinal Anesthesia|total spinal anesthesia
539797|NCT00348920|Stress Response|stress response
539798|NCT00348920|Inflammatory Mediators|inflammatory mediators
539799|NCT00348920|Renal Function|renal function
539800|NCT00348920|Hemodynamic Stability|hemodynamic stability
539801|NCT00348933|Developmental Delay|developmental delay
539802|NCT00348933|Mental Retardation|mental retardation
539803|NCT00348933|Ataxia|ataxia
539804|NCT00348933|Microcephaly|microcephaly
539805|NCT00348933|Seizures|seizures
539806|NCT00348946|Klinefelter syndrome|klinefelter syndrome
539807|NCT00348946|androgen|androgen
539808|NCT00348946|androgen oxandrolone|androgen oxandrolone
539809|NCT00348959|Haematological Malignancies|haematological malignancies
539810|NCT00348959|Autologous Stem Cell Transplantation|autologous stem cell transplantation
539811|NCT00348959|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
539812|NCT00348959|Quality of Life|quality of life
539813|NCT00348959|Life Threatening Illness|life threatening illness
539814|NCT00348959|Art in Health Care|art in health care
539815|NCT00348959|Randomised Controlled Trial|randomised controlled trial
539816|NCT00348959|Mixed Methods Research|mixed methods research
539817|NCT00348972|Glargine|glargine
539818|NCT00348972|prediabetes|prediabetes
539819|NCT00348972|impaired glucose tolerance|impaired glucose tolerance
539820|NCT00348972|impaired fasting glucose|impaired fasting glucose
539821|NCT00348998|adenocarcinoma of the prostate|adenocarcinoma of the prostate
539822|NCT00348998|stage IIB prostate cancer|stage iib prostate cancer
539823|NCT00348998|stage IIA prostate cancer|stage iia prostate cancer
539824|NCT00348998|stage III prostate cancer|stage iii prostate cancer
539825|NCT00348998|stage IV prostate cancer|stage iv prostate cancer
539826|NCT00349011|menopause|menopause
539827|NCT00349011|genetic counseling|genetic counseling
539828|NCT00349011|breast cancer|breast cancer
539829|NCT00349011|tamoxifen|tamoxifen
539830|NCT00349011|chemoprevention|chemoprevention
539831|NCT00349024|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
539832|NCT00349024|pain|pain
539833|NCT00349024|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
539834|NCT00349024|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
539835|NCT00349024|chondrosarcoma|chondrosarcoma
539836|NCT00349024|osteosarcoma|osteosarcoma
539837|NCT00349024|childhood soft tissue sarcoma|childhood soft tissue sarcoma
539838|NCT00349024|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
539839|NCT00349024|neuroblastoma|neuroblastoma
539840|NCT00349024|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
539841|NCT00349024|childhood large cell lymphoma|childhood large cell lymphoma
539842|NCT00349024|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
539843|NCT00349024|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
539844|NCT00349024|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
539845|NCT00349024|childhood brain stem glioma|childhood brain stem glioma
539846|NCT00349024|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
539847|NCT00349024|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
539848|NCT00349024|childhood cerebral astrocytoma/malignant glioma|childhood cerebral astrocytoma/malignant glioma
539849|NCT00349024|childhood choroid plexus tumor|childhood choroid plexus tumor
539850|NCT00349024|childhood craniopharyngioma|childhood craniopharyngioma
539851|NCT00349024|childhood ependymoma|childhood ependymoma
539852|NCT00349024|childhood medulloblastoma|childhood medulloblastoma
539853|NCT00349024|childhood meningioma|childhood meningioma
539854|NCT00349024|childhood oligodendroglioma|childhood oligodendroglioma
539855|NCT00349024|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
539856|NCT00349024|childhood spinal cord neoplasm|childhood spinal cord neoplasm
539857|NCT00349024|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
539858|NCT00349024|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
539859|NCT00349024|chordoma|chordoma
539860|NCT00349024|mucositis|mucositis
539861|NCT00349024|Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)|ewing sarcoma/peripheral primitive neuroectodermal tumor (pnet)
539862|NCT00349037|DNA vaccine|dna vaccine
539863|NCT00349037|influenza|influenza
539864|NCT00349037|immunogenicity|immunogenicity
539865|NCT00349037|tolerability|tolerability
539867|NCT00349037|efficacy|efficacy
539868|NCT00349037|challenge virus|challenge virus
539869|NCT00349050|trigeminal neuralgia|trigeminal neuralgia
539870|NCT00349050|neuropathic pain|neuropathic pain
539871|NCT00349050|complex regional pain syndrome|complex regional pain syndrome
539872|NCT00349050|reflex sympathetic dystrophy|reflex sympathetic dystrophy
539873|NCT00349050|pain|pain
539874|NCT00349050|chronic pain|chronic pain
539875|NCT00349050|transcranial magnetic stimulation|transcranial magnetic stimulation
539877|NCT00349050|laboratory pain assessment|laboratory pain assessment
539878|NCT00354705|Colon Cancer|colon cancer
539879|NCT00354705|Adenocarcinoma of the Colon|adenocarcinoma of the colon
539880|NCT00354705|Cancer Recurrence|cancer recurrence
539881|NCT00354705|Survey|survey
539882|NCT00354705|Chemotherapy|chemotherapy
539883|NCT00354705|Surgery|surgery
539884|NCT00354731|nephrotic syndrome, pentoxifylline, corticosteroid|nephrotic syndrome, pentoxifylline, corticosteroid
539885|NCT00354744|adult rhabdomyosarcoma|adult rhabdomyosarcoma
539886|NCT00354744|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
539887|NCT00354744|adult malignant mesenchymoma|adult malignant mesenchymoma
539888|NCT00354744|childhood malignant mesenchymoma|childhood malignant mesenchymoma
539889|NCT00354744|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
539890|NCT00354744|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
539891|NCT00354757|gastroesophageal reflux disease, proton-pump inhibitor test|gastroesophageal reflux disease, proton-pump inhibitor test
539892|NCT00354770|Trichotillomania|trichotillomania
539893|NCT00354770|Hair-pulling|hair-pulling
539894|NCT00354783|Very low birth weight premature infants|very low birth weight premature infants
539895|NCT00354783|Kicking|kicking
539896|NCT00354783|Stepping|stepping
539898|NCT00354783|Motor development|motor development
539899|NCT00354783|Kinematics|kinematics
539900|NCT00354796|bleeding|bleeding
539901|NCT00354796|anticoagulation|anticoagulation
539902|NCT00354796|LMWH|lmwh
539903|NCT00354796|Enoxaparin|enoxaparin
539904|NCT00354809|cognition|cognition
539905|NCT00354809|Primary Insomnia|primary insomnia
539906|NCT00354809|sleep|sleep
539907|NCT00354809|polysomnography|polysomnography
539908|NCT00354822|Zevalin|zevalin
539909|NCT00354822|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
539910|NCT00354861|Healthy volunteers|healthy volunteers
539911|NCT00354861|IMP321|imp321
539912|NCT00354861|Adjuvant|adjuvant
539913|NCT00354861|Pharmacodynamics|pharmacodynamics
539315|NCT00353249|CBT|cbt
539914|NCT00354874|GW642444 asthmatic subjects safety tolerability PD and PK|gw642444 asthmatic subjects safety tolerability pd and pk
539915|NCT00354887|Gastrointestinal Cancer|gastrointestinal cancer
539916|NCT00354887|Small Bowel Cancer|small bowel cancer
539917|NCT00354887|Ampulla of Vater|ampulla of vater
539918|NCT00354887|Capecitabine|capecitabine
539920|NCT00354887|Oxaliplatin|oxaliplatin
539921|NCT00354887|Eloxatin|eloxatin
539922|NCT00354900|breast cancer|breast cancer
539923|NCT00354900|fibrinolysis|fibrinolysis
539924|NCT00354900|urokinase-type plasminogen activator|urokinase-type plasminogen activator
539925|NCT00354900|plasminogen activator inhibitor|plasminogen activator inhibitor
539926|NCT00354900|aprotinin|aprotinin
539927|NCT00354900|plasmin/alpha-2-antiplasmin complex|plasmin/alpha-2-antiplasmin complex
539928|NCT00354913|adult grade I meningioma|adult grade i meningioma
539929|NCT00354913|adult grade II meningioma|adult grade ii meningioma
539930|NCT00354913|adult grade III meningioma|adult grade iii meningioma
539931|NCT00354913|adult papillary meningioma|adult papillary meningioma
539932|NCT00354913|adult anaplastic meningioma|adult anaplastic meningioma
539933|NCT00354913|recurrent adult brain tumor|recurrent adult brain tumor
539934|NCT00354913|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
539935|NCT00354913|Imatinib|imatinib
539936|NCT00354913|Imatinib mesylate|imatinib mesylate
539937|NCT00354913|Hydroxyurea|hydroxyurea
539939|NCT00354913|Hydrea|hydrea
539940|NCT00354913|Hydroxycarbamide|hydroxycarbamide
539941|NCT00354913|Gleevec|gleevec
539942|NCT00354913|Meningioma|meningioma
539943|NCT00354926|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
539944|NCT00354926|rituximab|rituximab
539945|NCT00354926|humanized monoclonal antibody|humanized monoclonal antibody
539946|NCT00354926|anti-CD20 monoclonal antibody|anti-cd20 monoclonal antibody
539947|NCT00354952|Healthy volunteers|healthy volunteers
539948|NCT00354952|Antibiotic exposure|antibiotic exposure
539949|NCT00354952|Resistance selection|resistance selection
539950|NCT00354965|ABS|abs
539951|NCT00354965|Acute Bacterial|acute bacterial
539952|NCT00354965|Sinusitis|sinusitis
539953|NCT00354965|Bacterial Sinusitis|bacterial sinusitis
539954|NCT00354978|Colorectal Cancer|colorectal cancer
539955|NCT00354978|FOLFIRI|folfiri
539956|NCT00354978|Irinotecan|irinotecan
539957|NCT00354978|CPT-11|cpt-11
539958|NCT00354978|Leucovorin|leucovorin
539959|NCT00354978|LV|lv
539960|NCT00354978|Folinic Acid|folinic acid
539961|NCT00354978|Fluorouracil|fluorouracil
539962|NCT00354978|5-FU|5-fu
539963|NCT00354978|Adrucil|adrucil
539964|NCT00354978|Efudex|efudex
539965|NCT00354978|Bevacizumab|bevacizumab
539966|NCT00354978|Avastin|avastin
539967|NCT00354978|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
539968|NCT00354978|rhuMAb-VEGF|rhumab-vegf
539969|NCT00355004|colon cancer|colon cancer
539970|NCT00355004|rectal cancer|rectal cancer
539971|NCT00355043|Zinc treatment|zinc treatment
539972|NCT00355043|Bronchiolitis|bronchiolitis
539973|NCT00355043|Wheezing|wheezing
539974|NCT00355043|Children aged 2 months to 23 months|children aged 2 months to 23 months
539975|NCT00355043|Diagnosed case of acute bronchiolitis|diagnosed case of acute bronchiolitis
539976|NCT00357110|Breast neoplasms|breast neoplasms
539977|NCT00357110|breast cancer|breast cancer
539978|NCT00357110|early breast cancer|early breast cancer
539979|NCT00357110|oncology|oncology
539980|NCT00357110|cancer|cancer
539981|NCT00357110|breast cancer micrometastasis|breast cancer micrometastasis
539982|NCT00357110|fulvestrant|fulvestrant
539983|NCT00357123|abdominal sepsis|abdominal sepsis
539984|NCT00357123|sepsis|sepsis
539985|NCT00357123|rosuvastatin|rosuvastatin
539986|NCT00357214|bone turnover|bone turnover
539987|NCT00357214|calcium excretion|calcium excretion
539988|NCT00357214|nitrogen excretion|nitrogen excretion
539989|NCT00357214|potassium bicarbonate|potassium bicarbonate
539990|NCT00357214|muscle loss|muscle loss
539991|NCT00357214|muscle atrophy|muscle atrophy
539992|NCT00357214|bone loss|bone loss
539993|NCT00357227|Atrial fibrillation|atrial fibrillation
539994|NCT00357227|Stroke|stroke
539995|NCT00357227|Vascular Dementia|vascular dementia
539996|NCT00357227|Mild Cognitive Impairment|mild cognitive impairment
539997|NCT00357240|Protease inhibitor|protease inhibitor
539998|NCT00357253|untreated childhood brain stem glioma|untreated childhood brain stem glioma
539999|NCT00357253|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
540000|NCT00357253|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
540001|NCT00357266|Uveitis|uveitis
540002|NCT00357266|Interleukin 2|interleukin 2
540003|NCT00357266|Interleukin 2 Receptor|interleukin 2 receptor
540004|NCT00357266|Microarrays|microarrays
540005|NCT00357266|Genetic Expression|genetic expression
540006|NCT00357266|Daclizumab|daclizumab
540007|NCT00357266|HAT|hat
540008|NCT00357266|Zenapax|zenapax
540009|NCT00357266|Proteins|proteins
540010|NCT00357266|RNA|rna
540011|NCT00357266|Ocular Inflammatory Disease|ocular inflammatory disease
540012|NCT00357331|postmenopausal osteopenia|postmenopausal osteopenia
540013|NCT00357331|treatment|treatment
540014|NCT00357331|bone loss|bone loss
540015|NCT00357344|Obesity|obesity
540016|NCT00357344|Gray Matter|gray matter
540017|NCT00357344|Eating Behavior|eating behavior
540018|NCT00357344|Brain MRI|brain mri
540019|NCT00357344|Body Weight Regulation|body weight regulation
540020|NCT00357357|Alzheimer's disease|alzheimer's disease
540021|NCT00357396|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
540022|NCT00357396|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
540023|NCT00357409|GABA|gaba
540024|NCT00357409|Occipital|occipital
540025|NCT00357409|Vision|vision
540026|NCT00357409|Plasticity|plasticity
540028|NCT00357409|Blind|blind
540029|NCT00357422|HCC, operation, percutaneous ethanol injection|hcc, operation, percutaneous ethanol injection
540030|NCT00357435|Cornea|cornea
540031|NCT00357435|Genetics|genetics
540032|NCT00357435|Dystrophy|dystrophy
540033|NCT00357435|Gene|gene
540034|NCT00357435|Mapping|mapping
540035|NCT00357435|Molecular|molecular
540036|NCT00357435|Bietti|bietti
540037|NCT00357435|Fleck|fleck
540038|NCT00357435|Positional Cloning|positional cloning
540039|NCT00357435|Linkage|linkage
540040|NCT00357461|stage IV melanoma|stage iv melanoma
540041|NCT00357461|recurrent melanoma|recurrent melanoma
540042|NCT00357474|HCC, TACE, PEIT|hcc, tace, peit
540043|NCT00357487|Sentinel lymph node|sentinel lymph node
540044|NCT00357487|Breast cancer|breast cancer
540045|NCT00357487|Lymphoscintigraphy|lymphoscintigraphy
540046|NCT00357487|Probe|probe
540047|NCT00357487|Operative gamma camera|operative gamma camera
540048|NCT00357487|Breast cancer and sentinel lymph node biopsy|breast cancer and sentinel lymph node biopsy
540049|NCT00357487|Use of lymphoscintigraphy|use of lymphoscintigraphy
540050|NCT00357487|Use of intraoperative gamma camera|use of intraoperative gamma camera
540051|NCT00357487|Use of intraoperative probe|use of intraoperative probe
540052|NCT00357500|Metronomic|metronomic
540053|NCT00357500|antiangiogenic|antiangiogenic
540054|NCT00357513|Cerebrovascular Disease|cerebrovascular disease
540055|NCT00357513|Gene Chip|gene chip
540056|NCT00357513|Inflammation|inflammation
540057|NCT00357513|Pathophysiology Stroke|pathophysiology stroke
540058|NCT00357513|Stroke Genomics|stroke genomics
540059|NCT00357513|Stroke Subtypes|stroke subtypes
540060|NCT00357513|Neuroimaging|neuroimaging
540061|NCT00357513|Clinical Outcome Measures|clinical outcome measures
540062|NCT00357513|Stroke|stroke
540064|NCT00357513|Healthy Volunteer|healthy volunteer
540065|NCT00357513|HV|hv
540066|NCT00357513|Normal Control|normal control
540067|NCT00357526|vaginal ring|vaginal ring
540068|NCT00357526|Oral contraceptive pills|oral contraceptive pills
540069|NCT00357526|Teenagers|teenagers
540070|NCT00357526|Young women|young women
540071|NCT00357526|Patient satisfaction|patient satisfaction
540072|NCT00357552|Treatment Experienced|treatment experienced
540073|NCT00357565|MDS|mds
540074|NCT00357565|AML|aml
540075|NCT00357578|Macrophages|macrophages
540076|NCT00357578|Biopsy|biopsy
540077|NCT00357578|Genetic Analysis|genetic analysis
540078|NCT00357578|Geographic Atrophy|geographic atrophy
540079|NCT00357578|Choroidal Neovascularization|choroidal neovascularization
540080|NCT00357578|Fibroblast|fibroblast
540081|NCT00357578|Disciform|disciform
540082|NCT00357578|Age-Related Macular Degeneration|age-related macular degeneration
540083|NCT00357591|Heart Failure|heart failure
540084|NCT00357591|Acute Decompensation|acute decompensation
540085|NCT00357591|Chronic Heart Failure|chronic heart failure
540086|NCT00357604|HIV|hiv
540087|NCT00357604|Protease Inhibitor|protease inhibitor
540088|NCT00357617|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
540089|NCT00357617|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
540090|NCT00357617|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
540091|NCT00357617|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
540092|NCT00357617|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
540093|NCT00357617|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
540094|NCT00357617|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
540095|NCT00357617|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
540182|NCT00357994|levodopa|levodopa
540096|NCT00357617|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
540097|NCT00357617|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
540098|NCT00357617|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
540099|NCT00357617|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
540100|NCT00357617|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
540101|NCT00357617|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
15953|NCT03188887|Corticotherapy|corticotherapy
540102|NCT00357617|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
540103|NCT00357617|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
540104|NCT00357617|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
540105|NCT00357617|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
540106|NCT00357617|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
540107|NCT00357617|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
540108|NCT00357630|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
540109|NCT00357630|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
540208|NCT00358072|Risk-oriented therapy|risk-oriented therapy
540110|NCT00357630|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
540111|NCT00357630|pain|pain
540112|NCT00357643|calcium|calcium
540113|NCT00357643|vitamin D|vitamin d
540114|NCT00357643|bone loss|bone loss
540115|NCT00357656|Hemophilia A (severe or moderately severe)|hemophilia a (severe or moderately severe)
540116|NCT00357669|Unverricht-Lundborg disease|unverricht-lundborg disease
540117|NCT00357669|Baltic myoclonus|baltic myoclonus
540118|NCT00357669|progressive myoclonic epilepsies|progressive myoclonic epilepsies
540119|NCT00357669|myoclonus|myoclonus
540120|NCT00357669|brivaracetam|brivaracetam
540121|NCT00357682|esophageal cancer|esophageal cancer
540122|NCT00357682|Barrett's esophagus|barrett's esophagus
540123|NCT00357695|Praxis|praxis
540124|NCT00357695|Grasping|grasping
540125|NCT00357695|Premotor Cortex|premotor cortex
540126|NCT00357695|Visuo-Motor Integration|visuo-motor integration
540127|NCT00357695|Motor Imagination|motor imagination
540128|NCT00357734|lung cancer|lung cancer
540129|NCT00357734|breast cancer|breast cancer
540130|NCT00357747|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
540131|NCT00357760|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
540132|NCT00357760|VEGF Trap|vegf trap
540133|NCT00357786|Lysosomal Disease|lysosomal disease
540134|NCT00357786|Glycolipid|glycolipid
540136|NCT00357786|Peripheral Neuropathy|peripheral neuropathy
540137|NCT00357786|Storage Disorder|storage disorder
540138|NCT00357799|Venipuncture|venipuncture
540139|NCT00357799|Randomized Controlled Trial|randomized controlled trial
540140|NCT00357799|Intravenous Access|intravenous access
540141|NCT00357799|Children|children
540142|NCT00357799|Emergency Department Nursing|emergency department nursing
540143|NCT00357799|VeinViewer|veinviewer
540144|NCT00357799|Pediatrics|pediatrics
540145|NCT00357799|Emergency Nursing|emergency nursing
540146|NCT00357812|Herpes Simplex Virus Type 1|herpes simplex virus type 1
540147|NCT00357812|Herpes Simplex Keratitis|herpes simplex keratitis
540148|NCT00357812|Cornea|cornea
540149|NCT00357812|Dendretic Ulcer|dendretic ulcer
540150|NCT00357812|In vivo Confocal Microscopy|in vivo confocal microscopy
540151|NCT00357812|Nested Multi-plex PCR|nested multi-plex pcr
540152|NCT00357812|Monoclonal Antibody|monoclonal antibody
540153|NCT00357812|Glycoprotein D|glycoprotein d
540154|NCT00357812|Glycoprotein C|glycoprotein c
540155|NCT00357838|normal healthy women|normal healthy women
540156|NCT00357851|pancreatitis, blood loss|pancreatitis, blood loss
540157|NCT00357890|type 1 diabetes|type 1 diabetes
540158|NCT00357890|diabetes|diabetes
540159|NCT00357890|new onset|new onset
540160|NCT00357890|CSII|csii
540161|NCT00357890|insulin glargine|insulin glargine
540162|NCT00357890|insulin sensitivity|insulin sensitivity
540163|NCT00357890|beta cell function|beta cell function
540164|NCT00357890|beta cell preservation|beta cell preservation
540165|NCT00357903|Rheumatoid Arthritis, Etanercept, Long-term Safety, Enbrel|rheumatoid arthritis, etanercept, long-term safety, enbrel
540166|NCT00357916|PEP005|pep005
540167|NCT00357916|Safety|safety
540168|NCT00357929|permissive hypercarbia|permissive hypercarbia
540169|NCT00357929|weaning from mechanical ventilation|weaning from mechanical ventilation
540170|NCT00357942|Morphine|morphine
540171|NCT00357942|Mouthwash|mouthwash
540172|NCT00357942|Mucositis|mucositis
540173|NCT00357942|Pain|pain
540174|NCT00357942|Cancer|cancer
540175|NCT00357942|Child|child
540176|NCT00357942|Adolescent|adolescent
540177|NCT00357981|Contraceptive patch|contraceptive patch
540178|NCT00357981|menstruation|menstruation
540179|NCT00357981|economics|economics
540180|NCT00357994|carbidopa|carbidopa
540181|NCT00357994|levodopa-carbidopa|levodopa-carbidopa
540183|NCT00357994|levodopa/carbidopa suspension|levodopa/carbidopa suspension
540184|NCT00357994|dyskinesia|dyskinesia
540185|NCT00357994|Duodopa|duodopa
540186|NCT00357994|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
540187|NCT00357994|Severe Motor Fluctuations|severe motor fluctuations
540188|NCT00357994|DUOPA|duopa
540189|NCT00358007|Kilovoltage Imaging|kilovoltage imaging
540190|NCT00358007|Cone-beam CT|cone-beam ct
540191|NCT00358007|CBCT|cbct
540192|NCT00358007|radiation therapy|radiation therapy
540193|NCT00358007|head and neck neoplasms|head and neck neoplasms
540194|NCT00358020|MYELOMA, THALIDOMIDE, BORTEZOMIB|myeloma, thalidomide, bortezomib
540195|NCT00358046|Hyperphosphatemia|hyperphosphatemia
540196|NCT00358046|Chronic kidney disease|chronic kidney disease
540197|NCT00358046|Dialysis|dialysis
540198|NCT00358046|Hyperphosphatemia in CKD patients on dialysis|hyperphosphatemia in ckd patients on dialysis
540199|NCT00358059|diabetes mellitus|diabetes mellitus
540200|NCT00358059|adolescence|adolescence
540201|NCT00358059|adherence|adherence
540202|NCT00358059|glycemic control|glycemic control
540203|NCT00358059|adaptation|adaptation
540204|NCT00358059|communication|communication
540205|NCT00358072|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
540206|NCT00358072|Adult patients|adult patients
540207|NCT00358072|Minimal residual disease|minimal residual disease
540209|NCT00358085|Endovascular|endovascular
540210|NCT00358085|Vascular Surgical Procedures|vascular surgical procedures
540211|NCT00358085|Aneurysm|aneurysm
540212|NCT00358085|Expertise Based Methodology|expertise based methodology
540213|NCT00358098|PET|pet
540214|NCT00358098|hormone positive breast cancer|hormone positive breast cancer
540215|NCT00358111|high-grade disease|high-grade disease
540216|NCT00358111|Cervical examination|cervical examination
540217|NCT00358111|targeting biopsies|targeting biopsies
540218|NCT00358111|dysplasia|dysplasia
540219|NCT00358111|cancer|cancer
540220|NCT00358137|Blood Pressure, High|blood pressure, high
540221|NCT00358150|Type 1 Gaucher Disease|type 1 gaucher disease
540222|NCT00358150|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
540223|NCT00358163|angiogenesis|angiogenesis
540224|NCT00358163|taxane|taxane
540225|NCT00358163|tyrosine kinase|tyrosine kinase
540226|NCT00358163|pharmacokinetics|pharmacokinetics
540227|NCT00358163|Vatalanib|vatalanib
540228|NCT00358163|Taxol|taxol
540229|NCT00358176|Treatment osteoporosis postmenopausal|treatment osteoporosis postmenopausal
540230|NCT00358189|deep brain stimulation|deep brain stimulation
540231|NCT00358189|gait|gait
540232|NCT00358189|manual dexterity|manual dexterity
540233|NCT00358189|parkinson's disease|parkinson's disease
540234|NCT00358202|intramuscular antibiotics|intramuscular antibiotics
540235|NCT00358202|nursing home acquired pneumonia|nursing home acquired pneumonia
540236|NCT00358202|nhap|nhap
540237|NCT00358202|pharmacoeconomics|pharmacoeconomics
540238|NCT00358202|cefepime|cefepime
540239|NCT00358202|ceftriaxone|ceftriaxone
540240|NCT00358215|Survival study|survival study
540241|NCT00358215|morbidity and mortality|morbidity and mortality
540242|NCT00358215|heart failure hospitalization|heart failure hospitalization
540243|NCT00358215|all-cause death|all-cause death
540244|NCT00358215|patient-reported outcomes|patient-reported outcomes
540245|NCT00358215|Kansas City Cardiomyopathy questionnaire|kansas city cardiomyopathy questionnaire
540246|NCT00358215|anemia treatment|anemia treatment
540247|NCT00358228|Smoking cessation|smoking cessation
540248|NCT00358228|Abstinence|abstinence
540249|NCT00358241|Nerve block, postoperative pain, analgesia|nerve block, postoperative pain, analgesia
540250|NCT00358267|Inferior Turbinate Reduction|inferior turbinate reduction
540251|NCT00358267|Partial Resection of Inferior Turbinates (PRIT)|partial resection of inferior turbinates (prit)
540252|NCT00358267|Radiofrequency Ablation (RFA)|radiofrequency ablation (rfa)
540253|NCT00358267|NOSE scale|nose scale
540254|NCT00358267|Nasal Obstruction|nasal obstruction
540255|NCT00358280|Patients ASA category I ～ II|patients asa category i ～ ii
540256|NCT00358280|Unilateral Lower limb surgery|unilateral lower limb surgery
540257|NCT00358280|Spinal Anesthesia|spinal anesthesia
540258|NCT00358293|Multiple Sclerosis|multiple sclerosis
540259|NCT00358293|Spasticity|spasticity
540260|NCT00358293|Sublingual Tizanidine|sublingual tizanidine
540261|NCT00358293|Ashworth Scores|ashworth scores
540262|NCT00358293|Spasticity in Multiple Sclerosis Patients|spasticity in multiple sclerosis patients
540263|NCT00358306|Endothelium|endothelium
540264|NCT00358306|Chronic Kidney Disease|chronic kidney disease
540265|NCT00358306|Acute Kidney Injury|acute kidney injury
540266|NCT00358306|Hemolytic-uremic syndrome (HUS)|hemolytic-uremic syndrome (hus)
540267|NCT00358319|Valproic Acid (VPA)|valproic acid (vpa)
540268|NCT00358319|Karenitecin|karenitecin
540269|NCT00358319|Malignant Melanoma|malignant melanoma
540270|NCT00358319|Histone deacetylases (HDAC)inhibitors|histone deacetylases (hdac)inhibitors
540271|NCT00358319|Topoisomerase I inhibitor|topoisomerase i inhibitor
540272|NCT00358319|metastatic|metastatic
540273|NCT00358332|malaria, vaccine, Mali, children|malaria, vaccine, mali, children
540274|NCT00358345|AMD|amd
540275|NCT00358358|COPD|copd
540276|NCT00358358|Impulse Oscillometry System|impulse oscillometry system
540277|NCT00358358|Computerized Tomography|computerized tomography
540278|NCT00358371|bioavailability flucloxacillin|bioavailability flucloxacillin
540279|NCT00358384|tolerability|tolerability
540280|NCT00358384|safety|safety
540281|NCT00358384|angiogenesis|angiogenesis
540282|NCT00358384|vascular endothelial growth factor|vascular endothelial growth factor
540283|NCT00358384|pharmacodynamics|pharmacodynamics
540284|NCT00358384|pharmacokinetics|pharmacokinetics
696802|NCT00947544|UCD|ucd
540285|NCT00358384|microplaque|microplaque
540286|NCT00358384|VEGF|vegf
540287|NCT00358384|GW786034|gw786034
540288|NCT00358397|Solid Tumor|solid tumor
540289|NCT00358397|Clostridial|clostridial
540290|NCT00358397|Spore-forming bacteria|spore-forming bacteria
540291|NCT00358397|hypoxia|hypoxia
540292|NCT00358397|anaerobes|anaerobes
540293|NCT00358397|Clostridium novyi|clostridium novyi
540294|NCT00358397|Bacteria|bacteria
540295|NCT00358397|Bacteriolytic|bacteriolytic
540296|NCT00358397|Tumor lysis|tumor lysis
540297|NCT00358397|Necrosis|necrosis
540298|NCT00358397|Colon Cancer|colon cancer
540299|NCT00358397|Lung Cancer|lung cancer
540301|NCT00358397|Bladder Cancer|bladder cancer
540302|NCT00358397|Rectal Cancer|rectal cancer
540303|NCT00358397|Gastric Cancer|gastric cancer
540304|NCT00358397|Pancreatic Cancer|pancreatic cancer
540305|NCT00358397|Experimental Therapy|experimental therapy
540306|NCT00358397|Solid Tumors|solid tumors
540307|NCT00358410|Functional Dyspepsia|functional dyspepsia
540308|NCT00358410|Barostat|barostat
540309|NCT00358410|Stomach|stomach
540310|NCT00358423|CME|cme
540311|NCT00358423|Pegaptanib|pegaptanib
540312|NCT00358423|Post-Surgical Ocular Inflammation|post-surgical ocular inflammation
540313|NCT00358436|COPD|copd
540314|NCT00358436|Lung function|lung function
540315|NCT00358436|Exacerbations|exacerbations
540316|NCT00358436|Quality of Life|quality of life
540317|NCT00358449|eosinophilic|eosinophilic
540318|NCT00358449|mepolizumab|mepolizumab
540319|NCT00358449|esophagitis|esophagitis
540320|NCT00358462|NGU, M genitalium, Ureaplasma, azithromycin, doxycycline|ngu, m genitalium, ureaplasma, azithromycin, doxycycline
540321|NCT00358475|perennial allergic rhinitis|perennial allergic rhinitis
540322|NCT00358488|Safety|safety
540323|NCT00358488|Asthmatic patients|asthmatic patients
540324|NCT00358488|GSK159797|gsk159797
540325|NCT00358488|Efficacy|efficacy
540326|NCT00358501|Defibrotide|defibrotide
540327|NCT00358501|Severe veno occlusive disease|severe veno occlusive disease
540328|NCT00358501|Multi organ failure|multi organ failure
540329|NCT00358501|Stem cell transplant|stem cell transplant
540330|NCT00358501|Liver|liver
540331|NCT00358501|Regimen related toxicity|regimen related toxicity
540332|NCT00358501|Day 100 survival|day 100 survival
540333|NCT00358514|Tibia|tibia
540334|NCT00358514|fracture|fracture
540335|NCT00358514|compartment syndrome|compartment syndrome
540336|NCT00358514|fasciotomy|fasciotomy
540337|NCT00358540|sarcoma|sarcoma
540338|NCT00358540|thrombocytopenia|thrombocytopenia
540339|NCT00358540|eltrombopag|eltrombopag
540340|NCT00358540|thrombopoiesis|thrombopoiesis
540341|NCT00358553|Human Volunteers|human volunteers
540342|NCT00358566|Advanced|advanced
540343|NCT00358566|Unresesctable|unresesctable
540344|NCT00358566|Adenocarcinoma|adenocarcinoma
540345|NCT00358566|Pancreatic cancer|pancreatic cancer
540346|NCT00358579|Vasopressin|vasopressin
540347|NCT00358579|Adrenaline|adrenaline
540348|NCT00358579|Survival|survival
540349|NCT00358579|Return of spontaneous of circulation|return of spontaneous of circulation
540350|NCT00358592|surgical instruments|surgical instruments
540351|NCT00358592|cesarean section|cesarean section
540352|NCT00358592|obesity|obesity
540353|NCT00358605|OSAHS|osahs
540354|NCT00358605|Oral Appliance|oral appliance
540355|NCT00358605|Hypopnoea Syndrome|hypopnoea syndrome
540356|NCT00358618|Randomized|randomized
540357|NCT00358618|double-blind|double-blind
540358|NCT00358618|3-group clinical interventional study|3-group clinical interventional study
540359|NCT00358631|depression|depression
540360|NCT00358631|antidepressive agents|antidepressive agents
540361|NCT00358631|controlled clinical trial|controlled clinical trial
540362|NCT00358644|Acute Myeloid Leukemia|acute myeloid leukemia
540363|NCT00358644|AML|aml
540364|NCT00358644|Decitabine|decitabine
540365|NCT00358644|Dacogen|dacogen
540366|NCT00358644|MGI PHARMA, INC.|mgi pharma, inc.
540367|NCT00358683|certolizunab pegol|certolizunab pegol
540368|NCT00358683|long term safety follow-up|long term safety follow-up
540369|NCT00358683|Chrohn's disease|chrohn's disease
540370|NCT00358683|infliximab failures patients|infliximab failures patients
540371|NCT00358683|Greek population|greek population
540372|NCT00358696|tenofovir|tenofovir
540373|NCT00358696|didanosine|didanosine
540374|NCT00358696|hiv|hiv
540375|NCT00358696|hepatitis c virus infection|hepatitis c virus infection
540376|NCT00358696|treatment|treatment
540377|NCT00358709|Cognitive-behavioral therapy|cognitive-behavioral therapy
540378|NCT00358709|symptom management|symptom management
540379|NCT00358709|first psychotic episode|first psychotic episode
540380|NCT00358735|SAFE|safe
540381|NCT00358735|CECT|cect
540382|NCT00358735|SFT|sft
540383|NCT00358735|ActiveCare|activecare
540384|NCT00358735|ActiveCare+SFT|activecare+sft
540385|NCT00358735|Deep Vein Thrombosis prevention|deep vein thrombosis prevention
540386|NCT00358735|Total Hip Replacement|total hip replacement
540387|NCT00358735|Total Hip Arthroplasty|total hip arthroplasty
540388|NCT00358735|Low Molecular Weight Heparin|low molecular weight heparin
540389|NCT00358735|MCS|mcs
540390|NCT00358748|Preterm|preterm
540391|NCT00358748|hypotension|hypotension
540392|NCT00358748|steroids|steroids
540393|NCT00358748|hydrocortisone|hydrocortisone
540394|NCT00358761|Lone Star Tick|lone star tick
540395|NCT00358761|Borrelia|borrelia
540396|NCT00358761|Skin Biopsy|skin biopsy
540397|NCT00358761|Spirochete|spirochete
540398|NCT00358761|Erythema Migrans|erythema migrans
540399|NCT00358761|Southern Tick-Assoicated Rash Illness|southern tick-assoicated rash illness
540400|NCT00358761|STARI|stari
540401|NCT00358774|homeopathic|homeopathic
540402|NCT00358774|common cold|common cold
540403|NCT00358774|Research Subjects|research subjects
540404|NCT00358787|Supracondylar fracture|supracondylar fracture
540405|NCT00358787|humerus|humerus
540406|NCT00358787|ulnar nerve injury|ulnar nerve injury
540407|NCT00358787|Baumann's angle|baumann's angle
540408|NCT00358787|Supracondylar fracture of the humerus|supracondylar fracture of the humerus
540409|NCT00358800|OSAHS and REMStar Auto with C-Flex|osahs and remstar auto with c-flex
540410|NCT00358813|emesis|emesis
540411|NCT00358813|renal impairment|renal impairment
540412|NCT00358813|GW679769|gw679769
540413|NCT00358813|kidney problems|kidney problems
540414|NCT00358839|Familial hemiplegic migraine type 1 and 2|familial hemiplegic migraine type 1 and 2
540415|NCT00358839|CGRP|cgrp
540416|NCT00358839|middle cerebral artery|middle cerebral artery
540417|NCT00358839|superficial temporal artery|superficial temporal artery
540418|NCT00358839|headache|headache
540419|NCT00358839|genotype|genotype
540420|NCT00358839|Healthy Volunteers|healthy volunteers
540421|NCT00358852|Schizophrenia|schizophrenia
540422|NCT00358852|Mental disorder|mental disorder
540423|NCT00358852|Schizoaffective disorder|schizoaffective disorder
540424|NCT00358852|Schizophreniform disorder|schizophreniform disorder
540425|NCT00358852|Epidemiological study|epidemiological study
540426|NCT00358852|Scale validation|scale validation
540427|NCT00358852|Relapse|relapse
540428|NCT00358852|Short Term Hospitalization|short term hospitalization
540429|NCT00358852|PRE-COG|pre-cog
540430|NCT00358852|RISSCH4075|rissch4075
540431|NCT00358865|Virtual Reality|virtual reality
540433|NCT00358865|Projected system|projected system
540434|NCT00358878|Ascites|ascites
540435|NCT00358878|Liver Cirrhosis|liver cirrhosis
540436|NCT00358891|Prematurity|prematurity
540437|NCT00358891|Chronic Lung Disease|chronic lung disease
540438|NCT00358891|Respiratory Health|respiratory health
540439|NCT00358891|Neurodevelopment|neurodevelopment
540440|NCT00358891|Preschool|preschool
540441|NCT00358891|Influencing Factors|influencing factors
540442|NCT00358904|Hill Sachs|hill sachs
540443|NCT00358904|Weber osteotomy|weber osteotomy
540444|NCT00358904|shoulder dislocation|shoulder dislocation
540445|NCT00358930|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
540446|NCT00358943|Gaucher Disease|gaucher disease
540447|NCT00358943|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
540448|NCT00358956|medullary thyroid cancer|medullary thyroid cancer
540449|NCT00358956|MTC|mtc
540450|NCT00358956|hereditary medullary thyroid cancer|hereditary medullary thyroid cancer
540451|NCT00358956|thyroid cancer|thyroid cancer
540452|NCT00358969|borderline personality disorder|borderline personality disorder
540453|NCT00358969|guanfacine|guanfacine
540454|NCT00358969|impulsivity|impulsivity
540455|NCT00358969|aggression|aggression
540456|NCT00358969|affective instability|affective instability
540457|NCT00358982|Relapsed or Refractory Hodgkin's Lymphoma|relapsed or refractory hodgkin's lymphoma
540458|NCT00358982|Phase II|phase ii
540459|NCT00358995|Cognitive Behavioral Therapy|cognitive behavioral therapy
540460|NCT00358995|Primary Obsessions|primary obsessions
540461|NCT00358995|Obsessive Compulsive Disorder|obsessive compulsive disorder
540462|NCT00358995|Compulsive Disorder|compulsive disorder
540463|NCT00359008|AMD|amd
540464|NCT00359008|CNV|cnv
540465|NCT00359008|PHP|php
540466|NCT00359021|HIV-1|hiv-1
540467|NCT00359021|treatment experienced|treatment experienced
540468|NCT00359021|virologic failure|virologic failure
540469|NCT00359034|Doppler ultrasound|doppler ultrasound
540470|NCT00359034|pulsewave velocity|pulsewave velocity
540471|NCT00359034|intrauterine growth restriction|intrauterine growth restriction
540472|NCT00359034|Fetal Pulsewave Velocity|fetal pulsewave velocity
540473|NCT00359047|Osteoporosis|osteoporosis
540474|NCT00359047|Fragility fracture|fragility fracture
540475|NCT00359047|Women|women
540476|NCT00359047|Randomised control trial|randomised control trial
540477|NCT00359047|Patient education|patient education
540478|NCT00359047|Diagnosis|diagnosis
540479|NCT00359047|Treatment|treatment
540480|NCT00359060|Physical activity|physical activity
540481|NCT00359060|Sex steroid hormones|sex steroid hormones
540482|NCT00359060|Breast cancer risk|breast cancer risk
540483|NCT00359060|Intervention study|intervention study
540484|NCT00359060|Postmenopausal women|postmenopausal women
540485|NCT00359073|asthma|asthma
539866|NCT00349037|PMED|pmed
540486|NCT00359073|leukotrienes|leukotrienes
540487|NCT00359073|rhinovirus|rhinovirus
540488|NCT00359086|Relapsed and Refractory Lymphoma|relapsed and refractory lymphoma
540489|NCT00359086|Phase II|phase ii
540490|NCT00359099|Hepatic Medicine|hepatic medicine
540491|NCT00359099|Surgery|surgery
540492|NCT00359112|Type 2 diabetes|type 2 diabetes
540493|NCT00359112|overweight|overweight
540494|NCT00359112|AVANDAMET|avandamet
540495|NCT00359112|metformin|metformin
540496|NCT00359112|sulphonylurea|sulphonylurea
540497|NCT00359125|bipolar|bipolar
540498|NCT00359125|RU-486|ru-486
540499|NCT00359125|mifepristone|mifepristone
540500|NCT00359125|neurocognition|neurocognition
540501|NCT00359125|mood|mood
540502|NCT00359125|cortisol|cortisol
540503|NCT00359125|HPA axis|hpa axis
540504|NCT00359138|Histamine H1 Antagonists|histamine h1 antagonists
540505|NCT00359138|Anti-Allergic Agents|anti-allergic agents
540506|NCT00359151|Perioperative care of total arthroplasty assessing opioid consumption|perioperative care of total arthroplasty assessing opioid consumption
540507|NCT00359164|AMD|amd
540508|NCT00359164|Avastin|avastin
540509|NCT00359164|Visudyne|visudyne
540510|NCT00359164|Medical condition being studied AMD|medical condition being studied amd
540511|NCT00359177|emesis liver problems hepatic impairment GW679769|emesis liver problems hepatic impairment gw679769
540512|NCT00359190|lapatinib|lapatinib
540513|NCT00359190|breast cancer|breast cancer
540514|NCT00359190|treatment-naive|treatment-naive
540515|NCT00359203|syncope|syncope
540516|NCT00359203|implantable loop recorder|implantable loop recorder
540517|NCT00359216|Hypopnea Syndrome|hypopnea syndrome
540518|NCT00359242|Infant Sleep|infant sleep
540519|NCT00359242|Infant Diet|infant diet
540520|NCT00359242|Infant Temperament|infant temperament
540521|NCT00359242|Rapid Infant weight gain|rapid infant weight gain
540522|NCT00359242|Infant Development|infant development
540523|NCT00359242|Parenting Competence|parenting competence
540524|NCT00359242|infant weight gain|infant weight gain
540525|NCT00359255|Exercise|exercise
540526|NCT00359255|rehabilitation|rehabilitation
540527|NCT00359255|upper limb|upper limb
540528|NCT00359255|inpatient|inpatient
540529|NCT00359255|RCT|rct
540530|NCT00359255|activities of daily living|activities of daily living
540531|NCT00359268|Polymerase Chain Reaction|polymerase chain reaction
540532|NCT00359268|Random Priming|random priming
540533|NCT00359268|Nucleic Acid|nucleic acid
540534|NCT00359268|Viral Genome|viral genome
540535|NCT00359268|Virus|virus
540536|NCT00359268|Identification|identification
540537|NCT00359281|healthy volunteers|healthy volunteers
540538|NCT00359294|Tumor|tumor
540539|NCT00359294|Lymphoma|lymphoma
540540|NCT00359294|Zalypsis|zalypsis
540541|NCT00359294|PharmaMar|pharmamar
540542|NCT00359294|PM00104|pm00104
540543|NCT00359307|Genetic|genetic
540544|NCT00359307|Longitudinal|longitudinal
540545|NCT00359307|Prospective|prospective
540546|NCT00359307|Epidemiology|epidemiology
540547|NCT00359307|Heart Attack|heart attack
540548|NCT00359320|Pancreaticoduodenectomy|pancreaticoduodenectomy
540549|NCT00359320|Pancreaticojejunostomy|pancreaticojejunostomy
540550|NCT00359320|Pancreatic Cancer|pancreatic cancer
540551|NCT00359346|Plasmapheresis|plasmapheresis
540552|NCT00359346|Auto-antibodies|auto-antibodies
540553|NCT00359346|Autonomic Nervous System|autonomic nervous system
540554|NCT00359346|Dysautonomia|dysautonomia
540555|NCT00359346|Sympathetic Nervous System|sympathetic nervous system
540556|NCT00359346|Autonomic Failure|autonomic failure
540557|NCT00359359|Small Cell Lung Cancer|small cell lung cancer
540558|NCT00359372|Chronic Heart Failure|chronic heart failure
540559|NCT00359372|Cardiac Resynchronization|cardiac resynchronization
540560|NCT00359372|Magnetic Resonance Imaging|magnetic resonance imaging
540561|NCT00359372|Biventricular Pacing|biventricular pacing
540562|NCT00359372|Heart Function|heart function
540563|NCT00359372|CRT|crt
540564|NCT00359385|primary hyperparathyroidism|primary hyperparathyroidism
540565|NCT00359385|hyperparathyroidism|hyperparathyroidism
540566|NCT00359385|PHPT|phpt
540567|NCT00359385|PTH|pth
540568|NCT00359385|hypercalcemia|hypercalcemia
540569|NCT00359385|bone density|bone density
540570|NCT00359385|osteoporosis|osteoporosis
540571|NCT00359385|bone turnover|bone turnover
540572|NCT00359385|DXA|dxa
540573|NCT00359385|pQCT|pqct
540574|NCT00359385|cQCT|cqct
540575|NCT00359385|alendronate|alendronate
540576|NCT00359385|Fosamax|fosamax
540577|NCT00359385|parathyroid hormone|parathyroid hormone
540578|NCT00359385|parathyroid surgery|parathyroid surgery
540579|NCT00359385|parathyroidectomy|parathyroidectomy
540580|NCT00359385|Silverberg|silverberg
540581|NCT00359385|Rubin|rubin
540582|NCT00359385|Bilezikian|bilezikian
540583|NCT00359385|treatment|treatment
540584|NCT00359398|Cardiopulmonary bypass|cardiopulmonary bypass
540585|NCT00359398|Blood component removal|blood component removal
540586|NCT00359411|Epstein-Barr Virus|epstein-barr virus
540587|NCT00359411|B-Cell Lymphoma|b-cell lymphoma
540588|NCT00359411|Herpes Virus|herpes virus
540589|NCT00359411|Infectious Mononucleosis|infectious mononucleosis
540590|NCT00359424|acute ischemic stroke|acute ischemic stroke
540591|NCT00359424|rt-PA|rt-pa
540592|NCT00359424|thrombolytic|thrombolytic
540593|NCT00359424|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
540594|NCT00359424|recanalization|recanalization
540595|NCT00359424|blood clot|blood clot
540596|NCT00359424|stroke|stroke
540597|NCT00359424|clot-dissolving|clot-dissolving
540598|NCT00359424|Activase®|activase®
540599|NCT00359424|Actilyse®|actilyse®
540600|NCT00359424|Concentric Merci® Retriever|concentric merci® retriever
540601|NCT00359424|EKOS® Micro-Infusion catheter (MicroLysus)|ekos® micro-infusion catheter (microlysus)
540602|NCT00359424|The Penumbra System™|the penumbra system™
540603|NCT00359424|Standard microcatheter|standard microcatheter
540604|NCT00359450|Locally advanced or metastatic non-small cell lung cancer|locally advanced or metastatic non-small cell lung cancer
540605|NCT00359463|hepatitis C-associated thrombocytopenia|hepatitis c-associated thrombocytopenia
540606|NCT00359463|chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
540607|NCT00359463|thrombocytopenia|thrombocytopenia
540608|NCT00359463|hepatic impairment|hepatic impairment
540889|NCT00362167|Neuropathic|neuropathic
540609|NCT00359463|chronic immune thrombocytopenia purpura|chronic immune thrombocytopenia purpura
540610|NCT00359476|Locally advanced/metastatic gastric adenocarcinoma|locally advanced/metastatic gastric adenocarcinoma
540611|NCT00359476|adenocarcinoma-gastroesophageal junction|adenocarcinoma-gastroesophageal junction
540612|NCT00359476|Gastric Adenocarcinoma|gastric adenocarcinoma
540613|NCT00359515|Archived Samples|archived samples
540614|NCT00359515|Mutation Screening|mutation screening
540615|NCT00359515|Genotype-Phenotype Correlation|genotype-phenotype correlation
540616|NCT00359515|Pediatric Developmental Disorder|pediatric developmental disorder
540617|NCT00359515|Cataracts|cataracts
540618|NCT00359515|Mutation Detection|mutation detection
540619|NCT00359515|Lowe Syndrome|lowe syndrome
540620|NCT00359515|Genotype|genotype
540621|NCT00359541|CYP2C9|cyp2c9
540622|NCT00359541|CYP2C19|cyp2c19
540623|NCT00359541|Pharmacology|pharmacology
540624|NCT00359541|Genotype|genotype
540625|NCT00359541|Metabolism|metabolism
540626|NCT00359554|Influenza|influenza
540627|NCT00359567|nausea and vomiting|nausea and vomiting
540628|NCT00359580|Ancestry|ancestry
540629|NCT00359593|Stroke|stroke
540630|NCT00359593|Rehabilitation|rehabilitation
540631|NCT00359593|Knowledge translation|knowledge translation
540632|NCT00359593|Evidence based practice|evidence based practice
540633|NCT00359593|Outcomes|outcomes
540634|NCT00359606|DNA Methylation|dna methylation
540635|NCT00359606|Advanced Cancer|advanced cancer
540636|NCT00359606|Methyltransferase Inhibitor|methyltransferase inhibitor
540637|NCT00359606|Epigenetics|epigenetics
540638|NCT00359606|Gene Re-Expression|gene re-expression
540639|NCT00351936|Schizophrenia|schizophrenia
540640|NCT00351936|Diabetes|diabetes
540641|NCT00351936|Obesity|obesity
540642|NCT00351936|Olanzapine|olanzapine
540643|NCT00351936|Insulin Resistance|insulin resistance
540644|NCT00351949|Advanced or metastatic renal cell carcinoma|advanced or metastatic renal cell carcinoma
540645|NCT00351949|IMP321|imp321
540646|NCT00351949|Monotherapy|monotherapy
540647|NCT00351949|LAG-3|lag-3
540648|NCT00351949|CD223|cd223
540649|NCT00351962|lung neoplasms|lung neoplasms
540650|NCT00351962|metastatic lung cancer|metastatic lung cancer
540651|NCT00351962|stereotactic radiation|stereotactic radiation
540652|NCT00351988|Lung Cancer|lung cancer
540653|NCT00351988|Non-Small Cell Lung Cancer|non-small cell lung cancer
540654|NCT00351988|Breast Cancer|breast cancer
540655|NCT00351988|Psychosocial|psychosocial
540656|NCT00351988|Behavioral|behavioral
540657|NCT00351988|Caregiver|caregiver
540658|NCT00351988|Interview|interview
540659|NCT00351988|Questionnaire|questionnaire
540660|NCT00351988|Minority Caregiver|minority caregiver
540661|NCT00351988|Non-Minority Caregiver|non-minority caregiver
540662|NCT00351988|Survey|survey
540663|NCT00352001|refractory anemia with excess blasts|refractory anemia with excess blasts
540664|NCT00352001|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
540665|NCT00352001|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
540666|NCT00352001|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
540667|NCT00352001|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
540668|NCT00352014|Monitoring of antiplatelet therapy|monitoring of antiplatelet therapy
540669|NCT00352014|antiplatelet therapy|antiplatelet therapy
540670|NCT00352014|platelet function assays|platelet function assays
540671|NCT00352014|Aspirin|aspirin
540672|NCT00352014|Clopidogrel|clopidogrel
540673|NCT00352014|elective PCI|elective pci
540674|NCT00352027|Hodgkin's Disease|hodgkin's disease
540675|NCT00352053|Phase 3|phase 3
540676|NCT00352053|Randomized, Double-Blind|randomized, double-blind
540677|NCT00352053|Control|control
540678|NCT00352053|Treatment-Experienced|treatment-experienced
540679|NCT00352053|OBR|obr
540063|NCT00357513|CVA|cva
540680|NCT00352053|Optimized background regimen|optimized background regimen
540681|NCT00352053|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
540682|NCT00352053|HAART|haart
540683|NCT00352053|HIV|hiv
540684|NCT00352053|HIV-1|hiv-1
540685|NCT00352053|AIDS Virus|aids virus
540686|NCT00352053|Human Immunodeficiency Virus|human immunodeficiency virus
540687|NCT00352053|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
540688|NCT00352053|Virus|virus
540689|NCT00352053|Human Immunodeficiency|human immunodeficiency
540690|NCT00352053|Pediatrics|pediatrics
540691|NCT00352066|Human Immunodeficiency Virus|human immunodeficiency virus
540692|NCT00352066|anti-retroviral therapy|anti-retroviral therapy
540693|NCT00352066|nucleoside analogue|nucleoside analogue
540694|NCT00352066|reverse transcriptase|reverse transcriptase
540695|NCT00352066|apricitabine|apricitabine
540696|NCT00352066|tipranavir|tipranavir
540697|NCT00352066|bioequivalence|bioequivalence
540698|NCT00352066|drug-drug interaction|drug-drug interaction
540699|NCT00352066|pharmacokinetics|pharmacokinetics
540700|NCT00352079|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
540701|NCT00352079|stage 0 bladder cancer|stage 0 bladder cancer
540702|NCT00352079|stage I bladder cancer|stage i bladder cancer
540703|NCT00352079|recurrent bladder cancer|recurrent bladder cancer
540704|NCT00352092|Kidney disease|kidney disease
540705|NCT00352092|Renal transplant|renal transplant
540706|NCT00352092|HLA Identical|hla identical
540707|NCT00352092|Living Donor|living donor
540708|NCT00352092|Corticosteroid free|corticosteroid free
540709|NCT00352092|Calcineurin sparing|calcineurin sparing
540710|NCT00352092|Adults|adults
540711|NCT00352105|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
540712|NCT00352105|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
540713|NCT00352105|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
583949|NCT00514020|recurrent gastric cancer|recurrent gastric cancer
540714|NCT00352105|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
540715|NCT00352105|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
540716|NCT00352105|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
540717|NCT00352105|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
540718|NCT00352105|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
540719|NCT00352118|oral complications of radiation therapy|oral complications of radiation therapy
540720|NCT00352118|oral complications of chemotherapy|oral complications of chemotherapy
540721|NCT00352118|mucositis|mucositis
540722|NCT00352118|xerostomia|xerostomia
540723|NCT00352118|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
540724|NCT00352118|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
540725|NCT00352118|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
540726|NCT00352118|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
540727|NCT00352118|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
540728|NCT00352118|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
540729|NCT00352118|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
540730|NCT00352118|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
540731|NCT00352131|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
540732|NCT00352131|stage II pancreatic cancer|stage ii pancreatic cancer
540733|NCT00352131|stage III pancreatic cancer|stage iii pancreatic cancer
540734|NCT00352131|stage IV pancreatic cancer|stage iv pancreatic cancer
540735|NCT00352131|recurrent pancreatic cancer|recurrent pancreatic cancer
540736|NCT00359619|HPV vaccine|hpv vaccine
540737|NCT00359632|Optic neuropathy following long-term linezolid use|optic neuropathy following long-term linezolid use
540738|NCT00359645|Screening|screening
540739|NCT00359645|Upper aerodigestive tract cancer|upper aerodigestive tract cancer
540740|NCT00359645|Alcohol|alcohol
540741|NCT00359645|Tobacco|tobacco
540742|NCT00359645|Randomized trial|randomized trial
540743|NCT00359658|Cyclosporine|cyclosporine
540744|NCT00359658|Glucocorticoids|glucocorticoids
540745|NCT00359658|renal insufficiency, chronic|renal insufficiency, chronic
540746|NCT00359658|long-term care|long-term care
540747|NCT00359684|Cystinosis|cystinosis
540748|NCT00359684|Cystine|cystine
540749|NCT00359684|Lysomal Storage Disease|lysomal storage disease
540750|NCT00359684|Mutation Analysis|mutation analysis
540751|NCT00359684|Metabolic Disease|metabolic disease
540752|NCT00359710|Multiracial Populations|multiracial populations
540753|NCT00359710|Human Genetic Variation|human genetic variation
540754|NCT00359710|Family History|family history
540755|NCT00359710|Admixture|admixture
540756|NCT00359710|Physician-Patient Communication|physician-patient communication
540757|NCT00359710|Ancestry|ancestry
540135|NCT00357786|Stroke|stroke
540758|NCT00359710|Self-Identified Multiracial Adults|self-identified multiracial adults
540759|NCT00359710|Interview|interview
540760|NCT00359723|Parkinson's disease|parkinson's disease
540761|NCT00359723|PD|pd
540762|NCT00359723|methylphenidate|methylphenidate
540763|NCT00359723|Ritalin|ritalin
540764|NCT00359723|MPD|mpd
540765|NCT00359736|alveolitis, fibrosing|alveolitis, fibrosing
540766|NCT00359736|exercise, aerobic|exercise, aerobic
540767|NCT00359736|fibrosis, pulmonary|fibrosis, pulmonary
540768|NCT00359736|hypertension, pulmonary|hypertension, pulmonary
540769|NCT00359762|exenatide|exenatide
540770|NCT00359762|diabetes|diabetes
540771|NCT00359762|Amylin|amylin
540772|NCT00359762|Lilly|lilly
540773|NCT00359762|glimepiride|glimepiride
540774|NCT00359775|Coping|coping
540775|NCT00359775|psychosocial|psychosocial
540776|NCT00359775|Quality of Life|quality of life
540777|NCT00359775|problem solving|problem solving
540778|NCT00359801|Large Simple Trial|large simple trial
540779|NCT00359814|Cyclosporine|cyclosporine
540780|NCT00359814|renal insufficiency, chronic|renal insufficiency, chronic
540781|NCT00359814|long-term care|long-term care
540782|NCT00359840|darbepoetin alfa|darbepoetin alfa
540783|NCT00359840|anemia|anemia
540784|NCT00359840|cancer patients|cancer patients
540785|NCT00359840|chemotherapy|chemotherapy
540786|NCT00359853|Norfloxacin, primary prophylaxis, SBP|norfloxacin, primary prophylaxis, sbp
540787|NCT00359879|diabetes|diabetes
540788|NCT00359879|exenatide|exenatide
540789|NCT00359879|Lilly|lilly
540991|NCT00362622|Travalert|travalert
540791|NCT00359905|Benign prostatic hyperplasia|benign prostatic hyperplasia
540792|NCT00359905|alpha-blockers|alpha-blockers
540793|NCT00359918|infarction|infarction
540794|NCT00359918|facilitated PCI|facilitated pci
540795|NCT00359918|primary PCI|primary pci
540796|NCT00359918|infarct size|infarct size
540797|NCT00359918|fibrinolysis|fibrinolysis
540798|NCT00359918|ST-elevation myocardial infarction (STEMI)|st-elevation myocardial infarction (stemi)
540799|NCT00359931|Neural Networks|neural networks
540800|NCT00359931|Mathematical Modeling|mathematical modeling
540801|NCT00359931|Auditory Processing|auditory processing
540802|NCT00359931|Tinnitis|tinnitis
540803|NCT00359931|Hearing Loss|hearing loss
540804|NCT00359944|Alzheimer|alzheimer
540805|NCT00359944|Dementia|dementia
540806|NCT00359957|Pediatric obesity|pediatric obesity
540807|NCT00359957|Physical activity|physical activity
540808|NCT00359957|Visceral fat|visceral fat
540809|NCT00359957|Weight|weight
540810|NCT00359970|Diarrhea|diarrhea
540811|NCT00359970|Travel|travel
540812|NCT00359970|Travelers' diarrhea|travelers' diarrhea
540813|NCT00359970|Azithromycin|azithromycin
540814|NCT00359970|Loperamide|loperamide
540815|NCT00359970|Treatment|treatment
540816|NCT00359970|Antibiotic|antibiotic
540817|NCT00361816|Maternal Effect Gene|maternal effect gene
540818|NCT00361816|Embryonic Development|embryonic development
540819|NCT00361816|Infertility|infertility
540820|NCT00361829|Development|development
540821|NCT00361829|Childhood Growth|childhood growth
540822|NCT00361842|Colorectal cancer|colorectal cancer
540823|NCT00361842|Colorectal carcinoma|colorectal carcinoma
540824|NCT00361842|Colonic cancer|colonic cancer
540825|NCT00361842|Rectal cancer|rectal cancer
540826|NCT00361855|MI|mi
540827|NCT00361868|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
540828|NCT00361907|Pulsatile intravenous insulin|pulsatile intravenous insulin
540829|NCT00361907|Oral carbohydrate loading|oral carbohydrate loading
540830|NCT00361907|Respiratory Quotients|respiratory quotients
540831|NCT00361907|Hypoglycemia|hypoglycemia
540832|NCT00361907|Diabetic Complications|diabetic complications
540833|NCT00361907|Circulating vascular and inflammatory markers|circulating vascular and inflammatory markers
540834|NCT00361920|steroid resistant asthma|steroid resistant asthma
540835|NCT00361946|Type 2 diabetes|type 2 diabetes
540836|NCT00361946|Lean|lean
540837|NCT00361946|Obese|obese
540838|NCT00361959|fluticasone propionate/salmeterol combination|fluticasone propionate/salmeterol combination
540839|NCT00361959|tiotropium|tiotropium
540840|NCT00361959|SERETIDE|seretide
540841|NCT00361959|COPD exacerbation|copd exacerbation
540842|NCT00361985|Gastric bypass|gastric bypass
540843|NCT00361985|Anastomotic stricture|anastomotic stricture
540844|NCT00361985|Morbid obesity|morbid obesity
540845|NCT00361985|Bariatric surgery|bariatric surgery
540846|NCT00361985|Omeprazole|omeprazole
540847|NCT00361998|Uncomplicated Cystitis|uncomplicated cystitis
540848|NCT00361998|Nitrofurantoin Macrocrystals|nitrofurantoin macrocrystals
540849|NCT00362050|malaria, falciparum|malaria, falciparum
540850|NCT00362050|uncomplicated Plasmodium falciparum malaria|uncomplicated plasmodium falciparum malaria
540851|NCT00362063|growth hormone|growth hormone
540852|NCT00362076|Perception|perception
540853|NCT00362076|Development|development
540854|NCT00362076|Cognition|cognition
540855|NCT00362076|Vision|vision
540856|NCT00362076|Infants|infants
697489|NCT00956878|Cancer|cancer
540857|NCT00362076|Autonomic Function|autonomic function
540858|NCT00362076|Cardiac Vagal Tone|cardiac vagal tone
540859|NCT00362076|Categorization|categorization
540860|NCT00362076|Habituation|habituation
540861|NCT00362076|Motion-Carried Information|motion-carried information
540862|NCT00362089|n-3 fatty acids|n-3 fatty acids
540863|NCT00362089|n-6 fatty acids|n-6 fatty acids
540864|NCT00362089|long chain polyunsaturated fatty acids|long chain polyunsaturated fatty acids
540865|NCT00362089|pregnancy|pregnancy
540866|NCT00362089|lactation|lactation
540867|NCT00362089|breast feeding|breast feeding
540868|NCT00362089|breast milk|breast milk
540869|NCT00362089|adipose tissue|adipose tissue
540870|NCT00362089|newborn|newborn
540871|NCT00362089|fetal development|fetal development
15954|NCT03188861|mental health conditions in ACSC patients|mental health conditions in acsc patients
540872|NCT00362102|EGFR-detectable metastatic colorectal carcinoma with documented progressive disease to irinotecan-based chemotherapy and failure|egfr-detectable metastatic colorectal carcinoma with documented progressive disease to irinotecan-based chemotherapy and failure
540873|NCT00362115|hypertension|hypertension
540874|NCT00362115|blood pressure|blood pressure
540875|NCT00362115|diastolic blood pressure|diastolic blood pressure
540876|NCT00362115|drug therapy|drug therapy
540877|NCT00362128|Blood Pressure, High|blood pressure, high
540879|NCT00362128|Tobacco Use Disorder|tobacco use disorder
540880|NCT00362141|levetiracetam|levetiracetam
540881|NCT00362141|status|status
540882|NCT00362141|epilepticus|epilepticus
540883|NCT00362167|Clinical Experience|clinical experience
540884|NCT00362167|Educational Training|educational training
540885|NCT00362167|Pain Syndromes|pain syndromes
540886|NCT00362167|Analgesia|analgesia
540887|NCT00362167|Pain Medicine|pain medicine
540888|NCT00362167|Therapy|therapy
540890|NCT00362167|Chronic Pain|chronic pain
540891|NCT00362167|Acute Pain|acute pain
540892|NCT00362167|Analgesics|analgesics
540893|NCT00362167|Medication|medication
540894|NCT00362167|Evaluation|evaluation
540895|NCT00362180|LDL-cholesterol|ldl-cholesterol
540896|NCT00362180|apoB-100|apob-100
540897|NCT00362180|apoB-48|apob-48
540898|NCT00362180|triglyceride|triglyceride
540899|NCT00362180|HeFH|hefh
540900|NCT00362180|FHBL|fhbl
540901|NCT00362193|Diabetes|diabetes
540902|NCT00362193|Chronic disease management|chronic disease management
540903|NCT00362193|Relapse|relapse
540904|NCT00362206|Hyperlipidemia Combined, efficacy combination fenofibrate simvastatin versus pravastatin|hyperlipidemia combined, efficacy combination fenofibrate simvastatin versus pravastatin
540905|NCT00362206|Hyperlipidemia Combined|hyperlipidemia combined
540906|NCT00362219|topical|topical
540907|NCT00362219|morphine|morphine
540908|NCT00362219|pain|pain
540909|NCT00362219|skin-wound|skin-wound
540910|NCT00362219|skin-graft|skin-graft
540911|NCT00362219|peripheral analgesia|peripheral analgesia
540912|NCT00362219|burn|burn
540913|NCT00362232|Prevention of venous thromboembolism|prevention of venous thromboembolism
540914|NCT00362245|Amikacin|amikacin
540915|NCT00362245|Pharmacokinetics|pharmacokinetics
540916|NCT00362245|Pharmacodynamics|pharmacodynamics
540917|NCT00362245|Intra-Thecal injection|intra-thecal injection
540918|NCT00362271|Healthy Subjects|healthy subjects
540919|NCT00362284|Alzheimer's disease|alzheimer's disease
540920|NCT00362284|coping|coping
540921|NCT00362284|quality of life|quality of life
540922|NCT00362284|caregiving|caregiving
540923|NCT00362310|classical kaposi's sarcoma|classical kaposi's sarcoma
540924|NCT00362310|treatment|treatment
540925|NCT00362310|HIV protease inhibitor indinavir|hiv protease inhibitor indinavir
540926|NCT00362323|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
540927|NCT00362336|Hepatitis B|hepatitis b
540928|NCT00362336|Polio|polio
540929|NCT00362336|Diphtheria|diphtheria
540930|NCT00362336|Pertussis|pertussis
540931|NCT00362336|H. influenzae type b|h. influenzae type b
540932|NCT00362349|ITP|itp
540933|NCT00362349|IVIg|ivig
540934|NCT00362349|Platelet count|platelet count
540935|NCT00362349|Bleeding|bleeding
540936|NCT00362362|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
540937|NCT00362362|Primary Lateral Sclerosis|primary lateral sclerosis
540938|NCT00362362|Genetics|genetics
540939|NCT00362362|Blood Sample|blood sample
540940|NCT00362362|PLS|pls
540941|NCT00362362|ALS|als
540942|NCT00362375|Adult|adult
540943|NCT00362375|*HIV Infections/pc [Prevention & Control]|*hiv infections/pc [prevention & control]
540944|NCT00362375|Female|female
540945|NCT00362375|Humans|humans
540946|NCT00362375|Risk-Taking|risk-taking
540947|NCT00362375|Safe Sex|safe sex
540948|NCT00362375|Sexual Behavior|sexual behavior
540949|NCT00362375|HIV Testing|hiv testing
540950|NCT00362388|Coronary artery disease|coronary artery disease
540951|NCT00362388|Ischemic heart disease|ischemic heart disease
540952|NCT00362388|Angiogenesis|angiogenesis
540953|NCT00362388|Cells|cells
540954|NCT00362388|Cardiac surgery|cardiac surgery
540955|NCT00362401|Psychoacoustics|psychoacoustics
540956|NCT00362401|Quality of Life|quality of life
540957|NCT00362401|Heart Valve Prosthesis|heart valve prosthesis
540958|NCT00362414|Stroke|stroke
540959|NCT00362427|Hepatitis B|hepatitis b
540960|NCT00362427|Pertussis|pertussis
540961|NCT00362427|Diphtheria|diphtheria
540962|NCT00362427|Tetanus|tetanus
540963|NCT00362427|H. influenzae type b|h. influenzae type b
540964|NCT00362427|Polio|polio
540965|NCT00362440|HIV lipodystrophy|hiv lipodystrophy
540966|NCT00362440|Leptin|leptin
540967|NCT00362440|Fat wasting|fat wasting
540968|NCT00362440|Pioglitazone|pioglitazone
540969|NCT00362440|Insulin resistance|insulin resistance
540970|NCT00362466|Leukemia (chronic myeloid leukemia - chronic phase)|leukemia (chronic myeloid leukemia - chronic phase)
540971|NCT00362479|pregnancy prevention|pregnancy prevention
540972|NCT00362479|oral contraceptives|oral contraceptives
540973|NCT00362492|TKR|tkr
540974|NCT00362492|Ultrasonography|ultrasonography
540975|NCT00362492|asymptomatic deep venous thrombosis|asymptomatic deep venous thrombosis
540976|NCT00362492|extended duration prophylaxis|extended duration prophylaxis
540977|NCT00362492|short duration prophylaxis|short duration prophylaxis
540978|NCT00362518|atherosclerosis|atherosclerosis
540979|NCT00362518|vitamin C|vitamin c
540980|NCT00362518|vitamin E|vitamin e
540981|NCT00362544|antifungal prophylaxis|antifungal prophylaxis
540982|NCT00362544|allogeneic stem-cell transplantation|allogeneic stem-cell transplantation
540983|NCT00362544|acute leukaemia|acute leukaemia
540984|NCT00362544|antifungal prophylaxis treatment of allogeneic stem-cell transplantation and acute leukaemia|antifungal prophylaxis treatment of allogeneic stem-cell transplantation and acute leukaemia
540985|NCT00362570|Newly diagnosed|newly diagnosed
540986|NCT00362583|Cancer pain with breakthrough pain episodes|cancer pain with breakthrough pain episodes
540987|NCT00362596|Acyclovir|acyclovir
540989|NCT00362596|HSV|hsv
540990|NCT00362609|Safety|safety
540992|NCT00362622|open angle glaucoma|open angle glaucoma
540994|NCT00362661|cortisol|cortisol
540995|NCT00362661|memory|memory
540996|NCT00362661|treatment|treatment
540997|NCT00362687|HIV, HAART|hiv, haart
540998|NCT00362726|HIV|hiv
540999|NCT00362752|norfloxacin|norfloxacin
541000|NCT00362752|hepatopulmonary syndrome|hepatopulmonary syndrome
541001|NCT00362765|Type 2 Diabetes|type 2 diabetes
541002|NCT00362765|Dyslipidemia|dyslipidemia
541003|NCT00362765|Hyperinsulinemic|hyperinsulinemic
541005|NCT00362765|Metformin|metformin
541006|NCT00362765|Fenofibrate|fenofibrate
541007|NCT00362791|voluntary counseling and testing|voluntary counseling and testing
541008|NCT00362791|HIV/STD prevention counseling|hiv/std prevention counseling
541009|NCT00362791|HIV/STD prevention intervention|hiv/std prevention intervention
541010|NCT00362791|counseling efficacy|counseling efficacy
541011|NCT00362804|tetrabenazine|tetrabenazine
541012|NCT00362804|partial response|partial response
541013|NCT00362804|psychosis|psychosis
541014|NCT00362804|schizophrenia|schizophrenia
541015|NCT00362804|schizoaffective disorder|schizoaffective disorder
541016|NCT00362804|partial response to antipsychotics|partial response to antipsychotics
541017|NCT00362817|Recurrent|recurrent
541018|NCT00362817|Symptomatic|symptomatic
541019|NCT00362843|11C-Leucine|11c-leucine
541020|NCT00362843|Positron Emission Tomography (PET)|positron emission tomography (pet)
541021|NCT00362843|Cerebral Protein Synthesis|cerebral protein synthesis
541022|NCT00362843|Propofol|propofol
541023|NCT00362843|Fragile X|fragile x
541024|NCT00362843|Fragile X Syndrome|fragile x syndrome
541025|NCT00362869|Enteroaggregative Escherichia coli, diarrhea, challenge|enteroaggregative escherichia coli, diarrhea, challenge
541026|NCT00362908|Obesity|obesity
541027|NCT00362908|Hypertension|hypertension
541028|NCT00362908|Insulin Resistance|insulin resistance
541029|NCT00362921|adult glioblastoma multiforme|adult glioblastoma multiforme
541030|NCT00362921|adult gliosarcoma|adult gliosarcoma
541031|NCT00362921|recurrent adult brain tumor|recurrent adult brain tumor
541032|NCT00362934|Hyperlipidemia Combined|hyperlipidemia combined
541033|NCT00362934|efficacy combination fenofibrate simvastatin versus atorvastatin|efficacy combination fenofibrate simvastatin versus atorvastatin
541034|NCT00362947|Superficial vein thrombosis|superficial vein thrombosis
541035|NCT00362947|thrombophlebitis|thrombophlebitis
541036|NCT00362947|LMWH|lmwh
541037|NCT00362947|parnaparin|parnaparin
541038|NCT00362960|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
541039|NCT00362960|Diabetic Nephropathy|diabetic nephropathy
541040|NCT00362960|Inflammatory Markers|inflammatory markers
541041|NCT00362960|Proteinuria|proteinuria
541042|NCT00362960|Renal Disease|renal disease
541043|NCT00362973|male breast cancer|male breast cancer
541044|NCT00362973|recurrent breast cancer|recurrent breast cancer
541045|NCT00362973|stage I breast cancer|stage i breast cancer
541046|NCT00362973|stage II breast cancer|stage ii breast cancer
541047|NCT00362973|stage IIIA breast cancer|stage iiia breast cancer
541048|NCT00362973|stage IIIB breast cancer|stage iiib breast cancer
541049|NCT00362973|stage IIIC breast cancer|stage iiic breast cancer
541050|NCT00362973|stage IV breast cancer|stage iv breast cancer
541051|NCT00362986|dermatologic complications|dermatologic complications
541052|NCT00362986|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
541053|NCT00362999|Allergic|allergic
541054|NCT00362999|Rhinitis|rhinitis
541055|NCT00362999|Pharmacogenetics|pharmacogenetics
541056|NCT00362999|Histamine|histamine
541057|NCT00363012|stage IIIA breast cancer|stage iiia breast cancer
541058|NCT00363012|stage IIIB breast cancer|stage iiib breast cancer
541059|NCT00363012|stage IIIC breast cancer|stage iiic breast cancer
541060|NCT00363012|stage IV breast cancer|stage iv breast cancer
541061|NCT00363012|male breast cancer|male breast cancer
541062|NCT00363025|Acute myeloid leukemia|acute myeloid leukemia
541063|NCT00363025|Older patients|older patients
541064|NCT00363025|Patient aged 65 years or more|patient aged 65 years or more
541065|NCT00363038|Bruising|bruising
541066|NCT00363038|Topical 20% arnica|topical 20% arnica
541067|NCT00363051|Pancreatic|pancreatic
541069|NCT00363051|Islet Cell|islet cell
541070|NCT00363051|Carcinoma|carcinoma
541071|NCT00363051|Neuroendocrine|neuroendocrine
541072|NCT00363051|Endocrine|endocrine
541073|NCT00363051|Atypical Carcinoid|atypical carcinoid
541074|NCT00363051|RADIANT1|radiant1
541075|NCT00363051|RADIANT-1|radiant-1
541076|NCT00363077|Influenza vaccine|influenza vaccine
541077|NCT00363077|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
541078|NCT00363090|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
541079|NCT00363090|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
541080|NCT00363090|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
541081|NCT00363090|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
541082|NCT00363090|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
541176|NCT00363467|Busulfan|busulfan
541083|NCT00363090|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
541084|NCT00363090|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
541085|NCT00363090|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
541086|NCT00363090|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
541087|NCT00363090|anaplastic large cell lymphoma|anaplastic large cell lymphoma
541088|NCT00363090|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
541089|NCT00363090|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
541090|NCT00363090|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
541091|NCT00363116|Kidney transplant|kidney transplant
541092|NCT00363116|Pancreas transplant|pancreas transplant
541093|NCT00363116|Daclizumab|daclizumab
541094|NCT00363116|Tacrolimus|tacrolimus
541095|NCT00363116|Mycophenolate mofetil|mycophenolate mofetil
541096|NCT00363116|Steroids|steroids
541097|NCT00363116|Immunosuppression|immunosuppression
541098|NCT00363116|Acute allograft rejection|acute allograft rejection
541099|NCT00363129|neurotoxicity|neurotoxicity
541100|NCT00363129|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
541101|NCT00363142|HIV-1 LEXIVA Ritonavir Once-daily|hiv-1 lexiva ritonavir once-daily
541102|NCT00363155|chronic|chronic
541103|NCT00363155|hepatitis b|hepatitis b
541104|NCT00363168|Hemorrhagic Choroidal Neovascularization|hemorrhagic choroidal neovascularization
541105|NCT00363181|Insulin resistance|insulin resistance
541106|NCT00363181|Metabolic problems|metabolic problems
541107|NCT00363181|Weight gain|weight gain
541108|NCT00363181|Mental health problems|mental health problems
541109|NCT00363181|Mental disorders|mental disorders
541110|NCT00363181|Antipsychotic medication|antipsychotic medication
541111|NCT00363181|Olanzapine|olanzapine
541112|NCT00363194|Pazopanib GW786034 Advanced cancer Metastatic cancer|pazopanib gw786034 advanced cancer metastatic cancer
541113|NCT00363207|behavior|behavior
541114|NCT00363207|local anesthesia|local anesthesia
541115|NCT00363207|behavior after dental local anesthesia|behavior after dental local anesthesia
541116|NCT00363220|Infection|infection
541117|NCT00363220|E coli|e coli
541118|NCT00363220|Klebsiella|klebsiella
541119|NCT00363220|ESBL|esbl
541120|NCT00363233|type 2 diabetes|type 2 diabetes
541121|NCT00363233|lignans|lignans
541122|NCT00363233|flaxseed|flaxseed
541123|NCT00363233|cholesterol|cholesterol
541124|NCT00363246|Elderly|elderly
541125|NCT00363246|Fall risk|fall risk
541126|NCT00363246|Veterans|veterans
541127|NCT00363246|WheelChairs|wheelchairs
541128|NCT00363246|Injury|injury
541129|NCT00363285|adenocarcinoma of the prostate|adenocarcinoma of the prostate
541130|NCT00363285|stage III prostate cancer|stage iii prostate cancer
541131|NCT00363285|stage IV prostate cancer|stage iv prostate cancer
541132|NCT00363298|D-amphetamine, dextro-amphetamine, stimulant drug|d-amphetamine, dextro-amphetamine, stimulant drug
541133|NCT00363311|Dutasteride Prostate Cancer Expectant management REDEEM|dutasteride prostate cancer expectant management redeem
541134|NCT00363324|stem cell|stem cell
541135|NCT00363324|acute myocardial infarction|acute myocardial infarction
541136|NCT00363337|Adults|adults
541137|NCT00363337|Bipolar Depression|bipolar depression
541138|NCT00363337|Bipolar Disorder|bipolar disorder
541139|NCT00363337|Bipolar I|bipolar i
541140|NCT00363337|Bipolar II|bipolar ii
541141|NCT00363337|Depression|depression
541142|NCT00363363|Pediatrics|pediatrics
541143|NCT00363363|Fontan Procedure|fontan procedure
541144|NCT00363363|Physical Activity|physical activity
541145|NCT00363363|Physical Fitness|physical fitness
541146|NCT00363363|Congenital Heart Defects|congenital heart defects
541147|NCT00363363|exercise rehabilitation|exercise rehabilitation
541148|NCT00363376|olanzapine|olanzapine
541149|NCT00363376|zonisamide|zonisamide
541150|NCT00363376|weight gain|weight gain
541151|NCT00363376|bipolar disorder|bipolar disorder
541152|NCT00363376|psychotic disorders|psychotic disorders
541153|NCT00363389|Hysteroscopy|hysteroscopy
541154|NCT00363389|Misoprostol|misoprostol
541155|NCT00363389|Uterine hemorrhage|uterine hemorrhage
541156|NCT00363389|Uterine cervix|uterine cervix
541157|NCT00363389|Dilatation|dilatation
541158|NCT00363402|Cystic Fibrosis|cystic fibrosis
541159|NCT00363428|pulmonary complications|pulmonary complications
541160|NCT00363428|perioperative/postoperative complications|perioperative/postoperative complications
541161|NCT00363428|tobacco use disorder|tobacco use disorder
541162|NCT00363428|non-small cell lung cancer|non-small cell lung cancer
541163|NCT00363428|small cell lung cancer|small cell lung cancer
541164|NCT00363441|head and neck neoplasms|head and neck neoplasms
541165|NCT00363441|squamous cell cancer|squamous cell cancer
541166|NCT00363441|intensity modulated radiotherapy|intensity modulated radiotherapy
541167|NCT00363454|Phase I|phase i
541168|NCT00363454|Pharmacokinetics|pharmacokinetics
541169|NCT00363454|TCN-PM|tcn-pm
541170|NCT00363454|VD-0002|vd-0002
541171|NCT00363454|Immunohistochemistry|immunohistochemistry
541172|NCT00363454|Serum tumor marker|serum tumor marker
541173|NCT00363454|Akt phosphorylation|akt phosphorylation
541174|NCT00363454|Ex vivo testing|ex vivo testing
541175|NCT00363454|metastatic|metastatic
541177|NCT00363467|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
541178|NCT00363467|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
541179|NCT00363467|Dendritic cells|dendritic cells
541180|NCT00363467|Bone marrow transplantation|bone marrow transplantation
541181|NCT00363467|PBSC mobilization|pbsc mobilization
541182|NCT00363467|Autologous stem cells|autologous stem cells
541184|NCT00363480|Asthma Control Test|asthma control test
541185|NCT00363480|SERETIDE|seretide
541186|NCT00363506|nutritional|nutritional
541187|NCT00363506|C10.228.140.546.399.750|c10.228.140.546.399.750
541188|NCT00363519|MK-0431|mk-0431
541189|NCT00363519|ONO-5435|ono-5435
541190|NCT00363519|Type 2 diabetes mellitus|type 2 diabetes mellitus
541191|NCT00363532|migraine with out aura|migraine with out aura
541192|NCT00363545|Prophylaxis against gastroenteritis caused by Rotavirus|prophylaxis against gastroenteritis caused by rotavirus
541193|NCT00363558|skin graft|skin graft
541194|NCT00363558|fixation|fixation
541195|NCT00363558|cyanoacrylate glue|cyanoacrylate glue
541196|NCT00363558|skin staples|skin staples
541197|NCT00363584|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
541198|NCT00363584|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
541199|NCT00363584|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
541200|NCT00363584|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
541201|NCT00363584|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
541202|NCT00363584|anaplastic carcinoma of the gallbladder|anaplastic carcinoma of the gallbladder
541203|NCT00363584|localized gallbladder cancer|localized gallbladder cancer
541204|NCT00363584|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
541205|NCT00363584|squamous cell carcinoma of the gallbladder|squamous cell carcinoma of the gallbladder
541206|NCT00363584|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
541207|NCT00363597|dyspepsia|dyspepsia
541208|NCT00363597|gastrointestinal disease|gastrointestinal disease
541209|NCT00363597|indigestion|indigestion
541210|NCT00363610|Advanced and/or Metastatic Solid Tumors and Lymphoma|advanced and/or metastatic solid tumors and lymphoma
541211|NCT00363636|relapsed|relapsed
541212|NCT00363636|NHL|nhl
541213|NCT00363636|pharmacokinetics|pharmacokinetics
541214|NCT00363636|antibody|antibody
541215|NCT00363636|safety|safety
541216|NCT00363636|galiximab|galiximab
541217|NCT00363636|efficacy|efficacy
541218|NCT00363636|rituximab|rituximab
541219|NCT00363636|refractory|refractory
541220|NCT00363649|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
541221|NCT00363649|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
541222|NCT00363675|Hand Burns|hand burns
541223|NCT00363675|Pediatrics|pediatrics
541224|NCT00363688|Non life threatening allergic reaction|non life threatening allergic reaction
541225|NCT00363688|oral challenge|oral challenge
541226|NCT00363688|penicillin|penicillin
541227|NCT00363688|skin testing|skin testing
541228|NCT00363701|Protonpumpinhibitors|protonpumpinhibitors
541229|NCT00363701|withdrawal|withdrawal
541230|NCT00363701|longterm treatment|longterm treatment
541231|NCT00363701|dyspepsia|dyspepsia
541232|NCT00363701|functional dyspepsia|functional dyspepsia
541233|NCT00363701|gastrooesophageal reflux|gastrooesophageal reflux
541234|NCT00363701|upper endoscopy|upper endoscopy
541235|NCT00363727|dyskinesia|dyskinesia
541236|NCT00363727|SINEMET|sinemet
541237|NCT00363727|Parkinson's disease|parkinson's disease
541238|NCT00363727|controlled release ropinirole|controlled release ropinirole
541239|NCT00363740|GW685698X|gw685698x
541240|NCT00363740|allergic rhinitis|allergic rhinitis
541241|NCT00363740|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
541242|NCT00363753|Transient ischemic attack|transient ischemic attack
541243|NCT00363753|Stroke|stroke
541244|NCT00363753|Aspirin|aspirin
541245|NCT00363753|Clopidogrel|clopidogrel
541246|NCT00363779|Large Granular Lymphocyte (LGL)|large granular lymphocyte (lgl)
541247|NCT00363779|LGL|lgl
541248|NCT00363779|Leukemia|leukemia
541249|NCT00363779|Cyclosporine|cyclosporine
541250|NCT00363779|Microarray|microarray
541251|NCT00363779|Gene Expression|gene expression
541252|NCT00363779|Cyclosporin|cyclosporin
541253|NCT00363779|Large Granular Lymphocyte Leukemia|large granular lymphocyte leukemia
541254|NCT00363779|LGL Leukemia|lgl leukemia
541255|NCT00363792|Healthy subjects|healthy subjects
541256|NCT00363805|lung cancer|lung cancer
541257|NCT00363805|prevention|prevention
541258|NCT00363805|green tea|green tea
541259|NCT00363805|former smokers|former smokers
541260|NCT00363818|Endothelial function|endothelial function
541261|NCT00363818|Platelet function|platelet function
541262|NCT00363818|Coronary artery disease|coronary artery disease
541263|NCT00363818|Thrombosis|thrombosis
541264|NCT00363818|Aggregation|aggregation
541265|NCT00363844|MK-0431|mk-0431
541266|NCT00363844|ONO-5435|ono-5435
541267|NCT00363844|Type 2 diabetes mellitus|type 2 diabetes mellitus
541268|NCT00363857|fatigue|fatigue
541269|NCT00363857|sleep|sleep
541673|NCT00356070|Strattera,|strattera,
541270|NCT00363857|sleep disorder|sleep disorder
541271|NCT00363857|Legs|legs
541272|NCT00363857|RLS|rls
541273|NCT00363857|Restless Legs Syndrome|restless legs syndrome
541274|NCT00363857|Ropinirole|ropinirole
541275|NCT00363870|Influenza vaccine|influenza vaccine
541276|NCT00363870|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
541277|NCT00363896|COPD|copd
541278|NCT00363896|Lung function|lung function
541279|NCT00363896|Exacerbations|exacerbations
541280|NCT00363896|Quality of Life|quality of life
541281|NCT00363909|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
541282|NCT00363909|hot flashes|hot flashes
541283|NCT00363909|breast cancer|breast cancer
541284|NCT00363922|Coronary Artery Bypass [E04.100.376.719.332]|coronary artery bypass [e04.100.376.719.332]
541285|NCT00363948|MK-0431|mk-0431
541286|NCT00363948|ONO-5435|ono-5435
541287|NCT00363948|Type 2 diabetes mellitus|type 2 diabetes mellitus
541288|NCT00363961|End stage renal disease|end stage renal disease
541289|NCT00363961|Maintenance dialysis|maintenance dialysis
541290|NCT00363961|Resistance exercise|resistance exercise
541291|NCT00363961|Muscle wasting|muscle wasting
541292|NCT00363961|Disability|disability
541293|NCT00363974|AML|aml
541294|NCT00363974|leukemia|leukemia
541295|NCT00363974|relapse|relapse
541296|NCT00363974|refractory|refractory
541297|NCT00363974|antisense|antisense
541298|NCT00363974|oligonucleotide|oligonucleotide
541299|NCT00363987|nephropathy with type 2 diabetes|nephropathy with type 2 diabetes
541300|NCT00364000|haemodialysis|haemodialysis
541301|NCT00364000|hyperphosphatemia|hyperphosphatemia
541302|NCT00364000|sevelamer|sevelamer
541303|NCT00364000|calcium acetate|calcium acetate
541304|NCT00364013|Oncology|oncology
541305|NCT00364013|Cancer|cancer
541306|NCT00364013|metastatic colorectal cancer|metastatic colorectal cancer
541307|NCT00364013|EGFr|egfr
541308|NCT00364013|Panitumumab|panitumumab
541309|NCT00364013|Clinical Trail|clinical trail
541310|NCT00364013|Amgen|amgen
541311|NCT00364052|Valganciclovir, Oral Ganciclovir, Liver transplant|valganciclovir, oral ganciclovir, liver transplant
541312|NCT00364078|Cross-sectional correlational study|cross-sectional correlational study
541313|NCT00364078|Uncertainty|uncertainty
541314|NCT00364078|Locus of Control|locus of control
541315|NCT00364078|Quality of life|quality of life
541316|NCT00364078|Transitoriness|transitoriness
541317|NCT00364078|Cancer care|cancer care
541318|NCT00364091|allergic conjunctivitis, ophthalmology, multicenter, controlled|allergic conjunctivitis, ophthalmology, multicenter, controlled
541319|NCT00364104|Iron deficiency|iron deficiency
541320|NCT00364104|Helicobacter infection|helicobacter infection
541321|NCT00364104|Epidemiology|epidemiology
541322|NCT00364117|150 discharges|150 discharges
541323|NCT00364117|adults|adults
541324|NCT00364117|Internal Medicine|internal medicine
541325|NCT00364143|Cancer|cancer
541326|NCT00364143|Advanced Solid Tumor|advanced solid tumor
541327|NCT00364143|Oncology|oncology
541328|NCT00364169|constipation|constipation
541329|NCT00364169|cancer|cancer
541330|NCT00364169|surgery|surgery
541331|NCT00364169|intervention|intervention
541332|NCT00364169|nursing|nursing
541333|NCT00364169|postoperative|postoperative
541334|NCT00364182|Hemophilia B|hemophilia b
541335|NCT00364182|BeneFIX|benefix
541336|NCT00364195|Metastatic breast cancer|metastatic breast cancer
541337|NCT00364195|Tesmilifene|tesmilifene
541338|NCT00364195|DPPE|dppe
541339|NCT00364234|Renal Osteodystrophy|renal osteodystrophy
541340|NCT00364247|Acute pain|acute pain
541341|NCT00364247|bunionectomy|bunionectomy
541342|NCT00364260|Anemia|anemia
541343|NCT00364260|epoetin alfa|epoetin alfa
541344|NCT00364273|Asthma|asthma
541345|NCT00364286|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
541346|NCT00364286|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
541347|NCT00364286|Prolymphocytic Leukemia|prolymphocytic leukemia
541348|NCT00364286|Leukemia|leukemia
541349|NCT00364286|Lymphoma|lymphoma
541350|NCT00364286|Dasatinib|dasatinib
541351|NCT00364286|BMS-354825|bms-354825
541352|NCT00364299|Ventilator-associated pneumonia|ventilator-associated pneumonia
541353|NCT00364299|Mechanical ventilation|mechanical ventilation
541354|NCT00364299|Tracheal tube cuff pressure|tracheal tube cuff pressure
541355|NCT00364312|behavior therapy|behavior therapy
541356|NCT00364312|dietary control|dietary control
541357|NCT00364312|exercise|exercise
541358|NCT00364312|diabetes mellitus|diabetes mellitus
541359|NCT00364312|behavior modification|behavior modification
541360|NCT00364312|blood glucose|blood glucose
541361|NCT00364312|clinical trial|clinical trial
541362|NCT00364312|diabetes education|diabetes education
541363|NCT00364312|health behavior|health behavior
541364|NCT00364312|health care service utilization|health care service utilization
541365|NCT00364312|obesity|obesity
541366|NCT00364312|quality of life|quality of life
541367|NCT00364325|Heart failure, congestive|heart failure, congestive
541368|NCT00364325|Heart decompensation|heart decompensation
541369|NCT00364338|gourmet healthy cooking|gourmet healthy cooking
541370|NCT00364338|quality of life|quality of life
541777|NCT00356512|Clamp|clamp
541371|NCT00364338|preimenopause|preimenopause
541372|NCT00364338|weight|weight
541373|NCT00364338|lipids|lipids
541374|NCT00355056|Migraine|migraine
541375|NCT00355056|PFO|pfo
541376|NCT00355056|Migraine Headache|migraine headache
541377|NCT00355056|patent foramen ovale|patent foramen ovale
541379|NCT00355069|asthma|asthma
541380|NCT00355069|translational research|translational research
541381|NCT00355069|health information technology|health information technology
541382|NCT00355082|epilepsy|epilepsy
541383|NCT00355082|lamotrigine|lamotrigine
541384|NCT00355082|Lamictal|lamictal
541385|NCT00355082|monotherapy|monotherapy
541386|NCT00355095|multiple sclerosis|multiple sclerosis
541387|NCT00355095|add-on Therapy|add-on therapy
541388|NCT00355095|erythropoietin|erythropoietin
541389|NCT00355095|methylprednisolone|methylprednisolone
541390|NCT00355095|autoimmune optic neuritis|autoimmune optic neuritis
541391|NCT00355108|Rendu Osler syndrome|rendu osler syndrome
541392|NCT00355108|Epistaxis|epistaxis
541393|NCT00355108|Tranexamic acid|tranexamic acid
541394|NCT00355108|clinical trial|clinical trial
541395|NCT00355121|Meningococcal meningitis|meningococcal meningitis
541396|NCT00355121|Tetanus|tetanus
541397|NCT00355121|Diphtheria|diphtheria
541398|NCT00355121|Pertussis|pertussis
541399|NCT00355121|Poliomyelitis|poliomyelitis
541400|NCT00355121|Neisseria meningitidis|neisseria meningitidis
541401|NCT00355134|fingolimod|fingolimod
541402|NCT00355134|FTY720|fty720
541403|NCT00355134|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
541405|NCT00355134|RRMS|rrms
541406|NCT00355147|Ischemic stroke|ischemic stroke
541407|NCT00355147|Preventive medicine|preventive medicine
541408|NCT00355147|Transient Ischemic Attack|transient ischemic attack
541409|NCT00355147|Neurology|neurology
541410|NCT00355147|Risk management|risk management
541411|NCT00355160|Headache|headache
541412|NCT00355160|Sinusitis|sinusitis
541413|NCT00355160|Rhinitis|rhinitis
541414|NCT00355160|Facial Pain|facial pain
541415|NCT00355186|acute myocardial infarction|acute myocardial infarction
541416|NCT00355186|MRI|mri
541417|NCT00355186|bone marrow cells|bone marrow cells
541418|NCT00355186|stem cells|stem cells
541419|NCT00355186|remodeling|remodeling
541420|NCT00355199|DLBCL|dlbcl
541421|NCT00355199|R-HDS|r-hds
541422|NCT00355199|R-CHOP14|r-chop14
541423|NCT00355212|percutaneous ethanol injection|percutaneous ethanol injection
541424|NCT00355212|radiofrequency|radiofrequency
541425|NCT00355212|liver cirrhosis|liver cirrhosis
541426|NCT00355212|carcinoma, hepatocellular|carcinoma, hepatocellular
541427|NCT00355225|insecticide-treated bednets|insecticide-treated bednets
541428|NCT00355225|malaria|malaria
541429|NCT00355225|africa|africa
541430|NCT00355225|social marketing|social marketing
541431|NCT00355225|ante-natal care|ante-natal care
541432|NCT00355225|ITN coverage|itn coverage
541433|NCT00355225|ITn use|itn use
541434|NCT00355251|Atorvastatin|atorvastatin
541435|NCT00355251|Viral replication|viral replication
541436|NCT00355251|HIV-1|hiv-1
541437|NCT00355251|plasma cholesterol|plasma cholesterol
541438|NCT00355251|Cell membrane cholesterol|cell membrane cholesterol
541439|NCT00355277|Tricyclic antidepressants|tricyclic antidepressants
541440|NCT00355277|Neuropathic pain|neuropathic pain
541441|NCT00355277|Local anaesthesia|local anaesthesia
541442|NCT00355277|Transcutaneous|transcutaneous
541443|NCT00355290|Chronic Oral Anticoagulation|chronic oral anticoagulation
541643|NCT00355940|sensor|sensor
541444|NCT00355303|Premature rupture of membranes at term|premature rupture of membranes at term
541445|NCT00355303|Induction of labour|induction of labour
541446|NCT00355303|Misoprostol|misoprostol
541447|NCT00355303|PGE2 gel|pge2 gel
541448|NCT00355303|Immediate induction with PGE2 gel|immediate induction with pge2 gel
541449|NCT00355303|Immediate induction with Misoprostol|immediate induction with misoprostol
541450|NCT00355316|Breast Cancer|breast cancer
541451|NCT00355316|Peripheral|peripheral
541452|NCT00355316|Blood|blood
541453|NCT00355329|Traditional Chinese Medicine (TCM)|traditional chinese medicine (tcm)
541454|NCT00355329|Autism|autism
541455|NCT00355329|Autistic Spectrum Disorder|autistic spectrum disorder
541456|NCT00355329|Tongue Acupuncture (TAC)|tongue acupuncture (tac)
541457|NCT00355329|18F-fluorodeoxyglucose Positron Emission Tomography (PET)|18f-fluorodeoxyglucose positron emission tomography (pet)
541458|NCT00355329|children|children
541459|NCT00355342|Osteoporosis|osteoporosis
541460|NCT00355342|Bone Mineral Density|bone mineral density
541461|NCT00355342|Osteopenia|osteopenia
541462|NCT00355342|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
541463|NCT00355342|COPD|copd
541464|NCT00355355|Hepatocellular carcinoma|hepatocellular carcinoma
541465|NCT00355355|HCC|hcc
541466|NCT00355355|Liver Neoplasms|liver neoplasms
541467|NCT00355355|Talaporfin Sodium (LS11)|talaporfin sodium (ls11)
541468|NCT00355355|Light emitting diodes (LEDs)|light emitting diodes (leds)
541469|NCT00355355|Light activation|light activation
541470|NCT00355368|intubation|intubation
541471|NCT00355368|intensive care|intensive care
541472|NCT00355368|neuromuscular depolarizing agents|neuromuscular depolarizing agents
541473|NCT00355368|neuromuscular nondepolarizing agents|neuromuscular nondepolarizing agents
541474|NCT00355368|neuromuscular blocking agents|neuromuscular blocking agents
541475|NCT00355381|Information Services|information services
541476|NCT00355381|Randomized Controlled Trials|randomized controlled trials
541477|NCT00355381|Medical Records Systems, Computerized|medical records systems, computerized
541478|NCT00355381|Internet|internet
541479|NCT00355381|Librarians|librarians
541480|NCT00355381|Breast Neoplasms|breast neoplasms
541481|NCT00355381|Patient Satisfaction|patient satisfaction
541482|NCT00355381|Health Personnel|health personnel
541483|NCT00355381|Costs and Cost Analysis|costs and cost analysis
541484|NCT00355381|Premature Birth|premature birth
541485|NCT00355407|Aranesp|aranesp
541486|NCT00355407|allogeneic stem cell transplant|allogeneic stem cell transplant
541487|NCT00355433|urinary incontinence|urinary incontinence
541488|NCT00355433|urodynamics|urodynamics
541489|NCT00355433|temperature|temperature
541490|NCT00355446|Cataract|cataract
541491|NCT00355446|Human Aqueous|human aqueous
541492|NCT00355459|Meibomian Gland Dystrophy|meibomian gland dystrophy
541493|NCT00355472|Adult T-Cell Leukemia|adult t-cell leukemia
541494|NCT00355472|ATL|atl
541495|NCT00355472|Adult Peripheral T-Cell Lymphoma|adult peripheral t-cell lymphoma
541496|NCT00355472|PTCL|ptcl
541497|NCT00355485|Acne|acne
541498|NCT00355485|Microdermabrasion|microdermabrasion
541499|NCT00355498|functional magnetic resonance imaging|functional magnetic resonance imaging
541500|NCT00355498|positron emission tomography|positron emission tomography
541501|NCT00355498|beta-amyloid|beta-amyloid
541502|NCT00355498|tau|tau
541503|NCT00355511|heart failure, congestive|heart failure, congestive
541504|NCT00355511|patient care team|patient care team
541505|NCT00355511|randomized controlled trial|randomized controlled trial
541506|NCT00355511|disease management|disease management
541507|NCT00355511|drug therapy|drug therapy
541508|NCT00355511|diet therapy|diet therapy
541509|NCT00355511|hospitalization|hospitalization
541510|NCT00355511|mortality|mortality
541511|NCT00355524|HIV-1|hiv-1
541512|NCT00355524|Darunavir|darunavir
541513|NCT00355524|Ritonavir|ritonavir
541514|NCT00355524|TMC114|tmc114
541515|NCT00355550|Mild Cognitive Impairment|mild cognitive impairment
541516|NCT00355550|Cognition disorders|cognition disorders
541517|NCT00355550|nutritional supplement|nutritional supplement
541518|NCT00355550|dietary supplement|dietary supplement
541519|NCT00355576|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
541520|NCT00355576|Celecoxib|celecoxib
541521|NCT00355576|Creatine|creatine
541522|NCT00355576|Minocycline|minocycline
541523|NCT00355576|Combination|combination
541524|NCT00355576|Selection|selection
541525|NCT00355576|ALS|als
541526|NCT00355576|Motor Neuron Disease|motor neuron disease
541527|NCT00355589|Hypertension|hypertension
541528|NCT00355589|High Blood Pressure|high blood pressure
541529|NCT00355589|Diuretic|diuretic
541530|NCT00355589|Angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
541531|NCT00355589|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
541532|NCT00355602|Antibiotics|antibiotics
541533|NCT00355602|Controlled Clinical Trial|controlled clinical trial
541534|NCT00355615|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
541535|NCT00355628|Pain|pain
541536|NCT00355628|Cancer|cancer
541537|NCT00355628|Neoplasm|neoplasm
541538|NCT00355628|Continual Reassessment Method|continual reassessment method
541539|NCT00355628|Pain Associated with Cancer/Neoplasms|pain associated with cancer/neoplasms
541540|NCT00355641|Ropinirole|ropinirole
541541|NCT00355641|Restless Legs Syndrome|restless legs syndrome
541542|NCT00355641|RLS|rls
541543|NCT00355654|Diphtheria|diphtheria
541544|NCT00355654|Tetanus|tetanus
541545|NCT00355654|Pertussis|pertussis
541546|NCT00355654|Poliomyelitis|poliomyelitis
541547|NCT00355654|Haemophilus influenzae type b|haemophilus influenzae type b
541548|NCT00355654|Hepatitis B|hepatitis b
541549|NCT00355667|diuretics|diuretics
541550|NCT00355667|furosemide|furosemide
541551|NCT00355667|azosemide|azosemide
541552|NCT00355667|congestive heart failure|congestive heart failure
541553|NCT00355680|Retina|retina
541555|NCT00355680|Retinal Vessels|retinal vessels
541556|NCT00355680|Laser Coagulation|laser coagulation
541557|NCT00355693|Anxiety|anxiety
541558|NCT00355693|Dental|dental
541559|NCT00355693|Oral|oral
541560|NCT00355693|Surgery|surgery
541561|NCT00355693|Colonoscopy|colonoscopy
541562|NCT00355693|Propofol|propofol
541563|NCT00355693|Sedation|sedation
541564|NCT00355693|Effect|effect
541565|NCT00355693|Reaction|reaction
541566|NCT00355706|chronic low back pain|chronic low back pain
541567|NCT00355706|thoracic facet joint|thoracic facet joint
541568|NCT00355706|nerve block|nerve block
541569|NCT00355719|Nevirapine|nevirapine
541570|NCT00355719|Atazanavir|atazanavir
541571|NCT00355719|Pharmacokinetics|pharmacokinetics
541572|NCT00355719|Interactions|interactions
541573|NCT00355732|Respiration|respiration
541574|NCT00355732|COPD|copd
541575|NCT00355732|Mechanical Ventilation|mechanical ventilation
541576|NCT00355732|Ventilator Weaning|ventilator weaning
541577|NCT00355732|Respiratory Failure|respiratory failure
541578|NCT00355732|ICU|icu
541579|NCT00355732|Pressure Support Ventilation|pressure support ventilation
541580|NCT00355745|Breast|breast
541581|NCT00355745|tumor|tumor
541582|NCT00355745|ultrasound|ultrasound
541583|NCT00355745|biopsy|biopsy
541584|NCT00355745|Breast mammographic or ultrasound findings|breast mammographic or ultrasound findings
541585|NCT00355758|Prostate Cancer Detection by Serum Proteomic Profiling|prostate cancer detection by serum proteomic profiling
541586|NCT00355771|allergic rhinitis|allergic rhinitis
541587|NCT00355771|histamine antagonist|histamine antagonist
541588|NCT00355771|sleep disorder|sleep disorder
541589|NCT00355784|growth hormone|growth hormone
541590|NCT00355784|overfeeding|overfeeding
541591|NCT00355784|energy expenditure|energy expenditure
541592|NCT00355784|protein metabolism|protein metabolism
541593|NCT00355784|lipid metabolism|lipid metabolism
541594|NCT00355797|Bradycardia|bradycardia
541595|NCT00355797|Sinus Node Dysfunction|sinus node dysfunction
541596|NCT00355797|Chronotropic incompetence|chronotropic incompetence
541597|NCT00355797|Pacemaker|pacemaker
541598|NCT00355797|Rate adaptive|rate adaptive
541599|NCT00355810|Probiotics|probiotics
541600|NCT00355823|electric field|electric field
541601|NCT00355823|wound current|wound current
541602|NCT00355823|wound healing|wound healing
541603|NCT00355823|bioelectric field|bioelectric field
541604|NCT00355823|chronic ulcer|chronic ulcer
541605|NCT00355823|diabetic|diabetic
541606|NCT00355823|Diabetes|diabetes
541607|NCT00355823|aging|aging
541608|NCT00355836|Motor Imagery|motor imagery
541609|NCT00355836|Stroke|stroke
541610|NCT00355836|Neuro-rehabilitation|neuro-rehabilitation
541611|NCT00355836|health psychology|health psychology
541612|NCT00355836|neuroscience|neuroscience
541613|NCT00355836|randomised controlled trial|randomised controlled trial
541614|NCT00355862|Sirolimus|sirolimus
541615|NCT00355862|mTOR|mtor
541616|NCT00355862|HCC-recurrence free survival|hcc-recurrence free survival
541617|NCT00355862|Liver transplant recipients|liver transplant recipients
541618|NCT00355862|HCC recurrence free survival|hcc recurrence free survival
541619|NCT00355875|newborn|newborn
541620|NCT00355875|preterm|preterm
541621|NCT00355875|resuscitation|resuscitation
541622|NCT00355875|oxidative injury|oxidative injury
541623|NCT00355875|protein carbonyl|protein carbonyl
541624|NCT00355888|Cancer|cancer
541625|NCT00355888|Advanced or Metastatic Solid Tumor|advanced or metastatic solid tumor
541626|NCT00355901|Ulcerative Colitis|ulcerative colitis
541627|NCT00355901|Colitis|colitis
541628|NCT00355901|Steroid-Refractory|steroid-refractory
541629|NCT00355901|Visilizumab|visilizumab
541630|NCT00355901|Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)|intravenous steroid-refractory ulcerative colitis (ivsr-uc)
541631|NCT00355914|Lumbar Facet Joint Nerve Block|lumbar facet joint nerve block
541632|NCT00355927|Deep brain stimulation|deep brain stimulation
541004|NCT00362765|Clamp|clamp
541633|NCT00355927|Microelectrode recordings|microelectrode recordings
541634|NCT00355927|Basal Ganglia|basal ganglia
541635|NCT00355927|Sedation|sedation
541636|NCT00355927|Propofol|propofol
541637|NCT00355940|endovascular|endovascular
541638|NCT00355940|aortic|aortic
541639|NCT00355940|repair|repair
541640|NCT00355940|navigation|navigation
541641|NCT00355940|DynaCT|dynact
541642|NCT00355940|position|position
541644|NCT00355953|Post-Menopausal Women|post-menopausal women
541645|NCT00355953|Osteoporosis|osteoporosis
541646|NCT00355953|Phytoestrogen|phytoestrogen
541647|NCT00355953|Genistein|genistein
541648|NCT00355966|Premature rupture of membranes|premature rupture of membranes
541649|NCT00355966|Induction of labour with Misoprostol|induction of labour with misoprostol
541650|NCT00355966|Induction of labour with PGE2 gel|induction of labour with pge2 gel
541651|NCT00355979|Obesity, intragastric balloon, Pharmacotherapy|obesity, intragastric balloon, pharmacotherapy
541652|NCT00355992|Myocardial Ischemia|myocardial ischemia
541653|NCT00355992|Chest pain|chest pain
541782|NCT00356551|Parent involvement|parent involvement
541654|NCT00355992|Ischemia Modified Albumin|ischemia modified albumin
541655|NCT00355992|Acute Coronary Syndrome|acute coronary syndrome
541656|NCT00356005|falciparum malaria|falciparum malaria
541657|NCT00356005|therapy|therapy
541658|NCT00356005|azithromycin|azithromycin
541659|NCT00356005|artesunate|artesunate
541660|NCT00356005|Coartem|coartem
541661|NCT00356005|Bangladesh|bangladesh
541662|NCT00356018|Epilepsy|epilepsy
541663|NCT00356018|Compliance|compliance
541664|NCT00356031|Avastin|avastin
541665|NCT00356044|Transradial access|transradial access
541666|NCT00356044|Femoral access|femoral access
541667|NCT00356044|Femoral vs radial access|femoral vs radial access
541668|NCT00356057|atrial fibrillation|atrial fibrillation
541669|NCT00356057|AV node ablation|av node ablation
541670|NCT00356057|pacemaker|pacemaker
541671|NCT00356057|congestive heart failure|congestive heart failure
541672|NCT00356070|Attention Deficit Hyperactivity Disorder, treatment,|attention deficit hyperactivity disorder, treatment,
541679|NCT00356122|advanced|advanced
541680|NCT00356122|recurrent|recurrent
541681|NCT00356122|metastatic|metastatic
541682|NCT00356122|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
541683|NCT00356148|breast cancer|breast cancer
541684|NCT00356148|breast surgery|breast surgery
541685|NCT00356148|clean wound|clean wound
541686|NCT00356148|overweight|overweight
541687|NCT00356148|prophylaxis|prophylaxis
541688|NCT00356148|antibiotics|antibiotics
541689|NCT00356161|colorectal neoplasms|colorectal neoplasms
541690|NCT00356161|hepatocellular carcinoma|hepatocellular carcinoma
541691|NCT00356161|gallbladder cancer|gallbladder cancer
541692|NCT00356161|bile duct cancer|bile duct cancer
541693|NCT00356161|hepatic arterial infusion|hepatic arterial infusion
541694|NCT00356174|Food Allergy|food allergy
541695|NCT00356213|morbid obesity|morbid obesity
541696|NCT00356213|bariatric surgery|bariatric surgery
541697|NCT00356213|sleeve-gastrectomy|sleeve-gastrectomy
541698|NCT00356213|Roux-Y-gastric bypass|roux-y-gastric bypass
541699|NCT00356213|outcome|outcome
541700|NCT00356213|weight loss|weight loss
541701|NCT00356226|norepinephrine|norepinephrine
541702|NCT00356226|renin|renin
541703|NCT00356226|aldosterone|aldosterone
541704|NCT00356226|hemodynamics|hemodynamics
541705|NCT00356226|spironolactone|spironolactone
541706|NCT00356239|Defibrillators, Implantable|defibrillators, implantable
541707|NCT00356239|Heart Failure, Congestive|heart failure, congestive
541708|NCT00356239|Magnetic Resonance Imaging|magnetic resonance imaging
541714|NCT00356278|D-Cycloserine|d-cycloserine
541715|NCT00356278|Virtual Reality|virtual reality
541716|NCT00356278|Exposure Therapy|exposure therapy
541717|NCT00356278|Veterans|veterans
541718|NCT00356278|Cognitive Behavior Therapy|cognitive behavior therapy
541719|NCT00356278|Translational Research|translational research
541720|NCT00356291|HIV|hiv
541721|NCT00356291|AIDS|aids
541722|NCT00356291|Prevention|prevention
541723|NCT00356291|Serious Mental Illness|serious mental illness
541724|NCT00356304|Dysthymia|dysthymia
541725|NCT00356304|Major Depression|major depression
541726|NCT00356304|Hispanics|hispanics
541727|NCT00356304|Latinos|latinos
541728|NCT00356304|Motivational Interviewing|motivational interviewing
541729|NCT00356304|Adherence|adherence
541730|NCT00356317|Culture|culture
541731|NCT00356317|Family|family
541732|NCT00356317|Therapy|therapy
541733|NCT00356330|pacemaker|pacemaker
541734|NCT00356330|magnetic resonance imaging|magnetic resonance imaging
541735|NCT00356330|safety|safety
541736|NCT00356343|NMES|nmes
541737|NCT00356343|Cerebral Palsy|cerebral palsy
541738|NCT00356343|Spastic Diplegia|spastic diplegia
541739|NCT00356343|Electrical Stimulation|electrical stimulation
541740|NCT00356343|Children|children
541741|NCT00356369|Immunogenicity|immunogenicity
541742|NCT00356369|Healthy|healthy
541743|NCT00356369|Persistence|persistence
541744|NCT00356369|Meningococcal vaccine|meningococcal vaccine
541745|NCT00356369|Non-inferiority|non-inferiority
541746|NCT00356369|Meningococcal A C W Y Diseases|meningococcal a c w y diseases
541747|NCT00356369|meningococcal serogroups A, C, W & Y diseases|meningococcal serogroups a, c, w & y diseases
541748|NCT00356382|probiotic|probiotic
541749|NCT00356382|Lactobacillus (L.) casei|lactobacillus (l.) casei
541750|NCT00356382|cultured dairy drink|cultured dairy drink
541751|NCT00356382|Health|health
541752|NCT00356395|endothelial function, insulin resistance, adipocytokines|endothelial function, insulin resistance, adipocytokines
541753|NCT00356408|CDP870|cdp870
541754|NCT00356408|certolizumab pegol|certolizumab pegol
541755|NCT00356408|Crohn's Disease|crohn's disease
541756|NCT00356434|deep vein thrombosis|deep vein thrombosis
541757|NCT00356434|thrombophilia|thrombophilia
541758|NCT00356434|pregnancy|pregnancy
541759|NCT00356434|thromboprophylaxis|thromboprophylaxis
541760|NCT00356434|decreased mobility|decreased mobility
541761|NCT00356434|hospitalization|hospitalization
541762|NCT00356473|Rheumatoid arthritis|rheumatoid arthritis
541763|NCT00356473|Atherosclerosis|atherosclerosis
541764|NCT00356473|High density lipoprotein (HDL) cholesterol|high density lipoprotein (hdl) cholesterol
541765|NCT00356473|Statins|statins
541766|NCT00356473|HDL anti-inflammatory properties|hdl anti-inflammatory properties
541767|NCT00356473|Atorvastatin|atorvastatin
541768|NCT00356486|Chronic Hepatitis C|chronic hepatitis c
541769|NCT00356486|Co-infection|co-infection
541770|NCT00356486|Induction dose|induction dose
541771|NCT00356486|HIV|hiv
541772|NCT00356486|HIV Infections|hiv infections
541773|NCT00356512|Phosphate|phosphate
541774|NCT00356512|Vitamin D|vitamin d
541775|NCT00356512|Hypoparathyroidism|hypoparathyroidism
541776|NCT00356512|Phosphatonin|phosphatonin
541778|NCT00356551|Teen pregnancy|teen pregnancy
541779|NCT00356551|Family strengthening|family strengthening
541780|NCT00356551|Substance abuse prevention|substance abuse prevention
541781|NCT00356551|Depression prevention|depression prevention
541783|NCT00356564|Prophylaxis for hepatitis B disease|prophylaxis for hepatitis b disease
541784|NCT00356590|Rheumatoid Arthritis|rheumatoid arthritis
541786|NCT00356590|Long-term Safety|long-term safety
541787|NCT00356590|Enbrel|enbrel
541788|NCT00356603|Migraine|migraine
541789|NCT00356603|Sumatriptan Succinate Injection Kit|sumatriptan succinate injection kit
541790|NCT00356603|Cluster Headache|cluster headache
541791|NCT00356603|self-injection|self-injection
541792|NCT00356616|Antiretroviral treatment|antiretroviral treatment
541793|NCT00356616|virological failure|virological failure
541794|NCT00356616|HIV|hiv
541795|NCT00356629|bronchopulmonary ignition|bronchopulmonary ignition
541796|NCT00356629|condensate of exhaled air|condensate of exhaled air
541797|NCT00356629|Mucoviscidosis|mucoviscidosis
541798|NCT00356629|Asthma|asthma
541799|NCT00356642|PK|pk
541800|NCT00356642|GW842470X|gw842470x
541801|NCT00356642|safety|safety
541802|NCT00356642|tolerability|tolerability
541803|NCT00356642|PD|pd
541804|NCT00356642|Atopic Dermatitis|atopic dermatitis
541805|NCT00356655|Depressive disorder|depressive disorder
541806|NCT00356655|Patient compliance|patient compliance
541807|NCT00356655|Antidepressive Agents|antidepressive agents
541808|NCT00356655|Patient education|patient education
541809|NCT00356655|Community pharmacy services|community pharmacy services
541810|NCT00356655|Counseling|counseling
541811|NCT00356668|HFNC|hfnc
541812|NCT00356668|NCPAP|ncpap
541813|NCT00356668|nasal continuous positive airway pressure|nasal continuous positive airway pressure
541814|NCT00356668|humidified high flow nasal cannula|humidified high flow nasal cannula
541815|NCT00356668|esophageal pressure|esophageal pressure
541816|NCT00356668|gas flow|gas flow
541817|NCT00356681|AMG 706|amg 706
541818|NCT00356681|Paclitaxel|paclitaxel
541819|NCT00356681|Metastatic Breast Cancer|metastatic breast cancer
541820|NCT00356681|Antiangiogenic|antiangiogenic
541821|NCT00356681|Bevacizumab|bevacizumab
541822|NCT00356707|Body Mass Index|body mass index
541823|NCT00356733|cardiorenal syndrome|cardiorenal syndrome
541824|NCT00356733|erythropoietin|erythropoietin
541825|NCT00356733|Heart Failure, Congestive|heart failure, congestive
541826|NCT00356733|Renal Insufficiency, Chronic|renal insufficiency, chronic
541827|NCT00356746|Perioperative inflammatory response|perioperative inflammatory response
541828|NCT00356746|General anesthesia|general anesthesia
541829|NCT00356746|Toll-Like Receptors|toll-like receptors
541830|NCT00356759|warfarin|warfarin
541831|NCT00356759|prothrombin time|prothrombin time
541832|NCT00356759|monitoring|monitoring
541833|NCT00356785|lifestyle|lifestyle
541834|NCT00356785|diet|diet
541835|NCT00356785|exercise|exercise
541836|NCT00356785|physical activity|physical activity
541837|NCT00356785|obesity|obesity
541838|NCT00356798|pandemic|pandemic
541839|NCT00356798|influenza|influenza
541840|NCT00356798|H5N1|h5n1
541841|NCT00356798|vaccine|vaccine
541842|NCT00356811|Lapatinib|lapatinib
541843|NCT00356811|Metastatic breast cancer|metastatic breast cancer
541844|NCT00356811|Paclitaxel|paclitaxel
541183|NCT00363480|Asthma|asthma
541845|NCT00356811|ErbB2-amplification|erbb2-amplification
541846|NCT00356811|GW572016|gw572016
541847|NCT00356824|Child|child
541848|NCT00356863|Intervention|intervention
541849|NCT00356863|Awareness|awareness
541850|NCT00356863|Cardiac Rehabilitation (CR)|cardiac rehabilitation (cr)
541851|NCT00356863|Coronary Artery Patients|coronary artery patients
541852|NCT00356863|Coronary Artery Bypass Grafting Surgery (CABG)|coronary artery bypass grafting surgery (cabg)
541853|NCT00356915|Nail fungus|nail fungus
541854|NCT00356915|Onychomycosis|onychomycosis
541855|NCT00356915|Itraconazole|itraconazole
541856|NCT00356915|Toenail|toenail
542096|NCT00364650|Probiotics|probiotics
541857|NCT00356928|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
541858|NCT00356928|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
541859|NCT00356928|secondary acute myeloid leukemia|secondary acute myeloid leukemia
541860|NCT00356928|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
541861|NCT00356928|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
541862|NCT00356941|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
541863|NCT00356941|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
541864|NCT00356941|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
541865|NCT00356941|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
541866|NCT00356954|Kidney failure|kidney failure
541867|NCT00356954|Contrast media|contrast media
541868|NCT00356954|Antioxidant|antioxidant
541869|NCT00356954|Prevention|prevention
541870|NCT00356967|smoking|smoking
541871|NCT00356967|cessation|cessation
541872|NCT00356967|tobacco|tobacco
541873|NCT00356967|smoking cessation|smoking cessation
541874|NCT00356967|tobacco use cessation|tobacco use cessation
541875|NCT00356980|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
541876|NCT00356993|nicotine replacement therapy|nicotine replacement therapy
541877|NCT00356993|smoking cessation|smoking cessation
541878|NCT00357006|Schizophrenia|schizophrenia
541880|NCT00357006|Psychosis|psychosis
541881|NCT00357058|Deafferentiation-Induced Plasticity|deafferentiation-induced plasticity
541882|NCT00357058|fMRI|fmri
541883|NCT00357058|Cortical Reorganization|cortical reorganization
541884|NCT00357058|Tactile Performance|tactile performance
541885|NCT00357058|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
541886|NCT00357058|Tactile Discrimination|tactile discrimination
541887|NCT00357058|Plasticity|plasticity
541888|NCT00357058|Healthy Volunteer|healthy volunteer
541889|NCT00357058|HV|hv
541890|NCT00357058|Normal Control|normal control
541891|NCT00357071|Autoimmunity|autoimmunity
541892|NCT00357071|Cell Mediated Immunity|cell mediated immunity
541893|NCT00357071|S Antigen|s antigen
541894|NCT00357071|Cell Proliferation|cell proliferation
541895|NCT00357071|Uveitis|uveitis
541896|NCT00357071|Cell Proliferation Assays|cell proliferation assays
541897|NCT00357071|Auto-Antibody|auto-antibody
541898|NCT00357071|Auto-Antigens|auto-antigens
541899|NCT00357084|graft versus host disease|graft versus host disease
541900|NCT00357084|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
541901|NCT00357084|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
541902|NCT00357084|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
541903|NCT00357084|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
541904|NCT00357084|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
541905|NCT00357084|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
541906|NCT00357084|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
541907|NCT00357084|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
541908|NCT00357084|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
541909|NCT00357084|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
541910|NCT00357084|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
541911|NCT00357084|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
541912|NCT00357084|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
541913|NCT00357084|chronic eosinophilic leukemia|chronic eosinophilic leukemia
541914|NCT00357084|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
541915|NCT00357084|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
541916|NCT00357084|chronic neutrophilic leukemia|chronic neutrophilic leukemia
541917|NCT00357084|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
541918|NCT00357084|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
541919|NCT00357084|disseminated neuroblastoma|disseminated neuroblastoma
541920|NCT00357084|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
541921|NCT00357084|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
541922|NCT00357084|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
541923|NCT00357084|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
541924|NCT00357084|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
541925|NCT00357084|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
541926|NCT00357084|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
541927|NCT00357084|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
541928|NCT00357084|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
541929|NCT00357084|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
541930|NCT00357084|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
541931|NCT00357084|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
541932|NCT00357084|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
541933|NCT00357084|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
541934|NCT00357084|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
541935|NCT00357084|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
541936|NCT00357084|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
541937|NCT00357084|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
15955|NCT03188861|multimorbidity|multimorbidity
541938|NCT00357084|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
541939|NCT00357084|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
541940|NCT00357084|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
541941|NCT00357084|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
541942|NCT00357084|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
541943|NCT00357084|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
541944|NCT00357084|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
541945|NCT00357084|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
541946|NCT00357084|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
541947|NCT00357084|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
541948|NCT00357084|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
541949|NCT00357084|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
541950|NCT00357084|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
541951|NCT00357084|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
541952|NCT00357084|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
541953|NCT00357084|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
541954|NCT00357084|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
541955|NCT00357084|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
541956|NCT00357084|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
541957|NCT00357084|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
541958|NCT00357084|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
541959|NCT00357084|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
541960|NCT00357084|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
541961|NCT00357084|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
541962|NCT00357084|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
541963|NCT00357084|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
541964|NCT00357084|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
541965|NCT00357084|refractory hairy cell leukemia|refractory hairy cell leukemia
541966|NCT00357084|refractory multiple myeloma|refractory multiple myeloma
541967|NCT00357084|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
541968|NCT00357084|secondary acute myeloid leukemia|secondary acute myeloid leukemia
541969|NCT00357084|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
541970|NCT00357084|splenic marginal zone lymphoma|splenic marginal zone lymphoma
541971|NCT00357084|stage I multiple myeloma|stage i multiple myeloma
541972|NCT00357084|stage II multiple myeloma|stage ii multiple myeloma
541973|NCT00357084|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
541974|NCT00357084|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
541975|NCT00357084|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
541976|NCT00357084|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
541977|NCT00357084|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
541978|NCT00357084|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
541979|NCT00357084|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
541980|NCT00357084|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
541981|NCT00357084|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
541378|NCT00355069|pediatric|pediatric
541982|NCT00357084|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
541983|NCT00357084|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
541984|NCT00357084|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
541985|NCT00357084|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
541986|NCT00357084|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
541987|NCT00357084|stage III multiple myeloma|stage iii multiple myeloma
541988|NCT00357084|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
541989|NCT00357084|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
541990|NCT00357084|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
541991|NCT00357084|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
541992|NCT00357084|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
542095|NCT00364650|Immunosuppression|immunosuppression
541993|NCT00357084|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
541994|NCT00357084|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
541995|NCT00357084|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
541996|NCT00357084|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
541997|NCT00357084|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
541998|NCT00357084|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
541999|NCT00357084|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
542000|NCT00357084|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
542001|NCT00357084|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
542002|NCT00357084|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
542003|NCT00357084|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
542004|NCT00357084|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
542005|NCT00357084|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
542007|NCT00357097|ropinirole|ropinirole
542008|NCT00357097|depression|depression
542010|NCT00357097|placebo|placebo
542011|NCT00357097|mood|mood
542012|NCT00357097|double-blind|double-blind
542013|NCT00357097|restless legs syndrome|restless legs syndrome
542014|NCT00357097|germany|germany
542015|NCT00364351|Non Small Cell Lung Cancer|non small cell lung cancer
542016|NCT00364351|NSCLC|nsclc
542017|NCT00364390|CABG|cabg
542018|NCT00364390|Anginera|anginera
542019|NCT00364390|CAD|cad
542020|NCT00364403|Glycemic index|glycemic index
542021|NCT00364403|Glycemic load|glycemic load
542022|NCT00364403|Low fat|low fat
542023|NCT00364403|Impaired glucose tolerance|impaired glucose tolerance
542024|NCT00364403|Large for gestational age infant|large for gestational age infant
542025|NCT00364403|Excessive body weight|excessive body weight
542026|NCT00364416|Heart Failure, congestive|heart failure, congestive
542027|NCT00364416|Heart decompensation|heart decompensation
542028|NCT00364429|schizophrenic patients|schizophrenic patients
542029|NCT00364429|SPET|spet
542030|NCT00364429|NMDA receptor|nmda receptor
542031|NCT00364429|ligand [123]I-CNS 1261|ligand [123]i-cns 1261
542032|NCT00364442|asthma|asthma
542033|NCT00364455|Hormone refractory prostate cancer|hormone refractory prostate cancer
542034|NCT00364455|Anemia|anemia
542035|NCT00364455|Quality-of-life|quality-of-life
542036|NCT00364468|pegfilgrastim|pegfilgrastim
542037|NCT00364468|neutropenia|neutropenia
542038|NCT00364468|cancer patients|cancer patients
542039|NCT00364468|lymphoma|lymphoma
542040|NCT00364481|apnea|apnea
542041|NCT00364481|tongue|tongue
542042|NCT00364481|exercises|exercises
542043|NCT00364481|reflux|reflux
542044|NCT00364481|airway|airway
542045|NCT00364481|upper|upper
542046|NCT00364481|fatigue|fatigue
542047|NCT00364494|Hematocrit|hematocrit
542048|NCT00364494|Hemodilution|hemodilution
542049|NCT00364494|Blood Transfusion|blood transfusion
542050|NCT00364494|Cardiopulmonary Bypass|cardiopulmonary bypass
542051|NCT00364494|Multiple Organ Failure|multiple organ failure
542052|NCT00364494|Surgery, Cardiac|surgery, cardiac
542053|NCT00364494|Kidney Failure|kidney failure
542054|NCT00364494|Cardiac Surgical Procedures|cardiac surgical procedures
542055|NCT00364520|Hematologic Diseases|hematologic diseases
542056|NCT00364520|Benzene|benzene
542057|NCT00364520|Genetic Polymorphisms|genetic polymorphisms
542058|NCT00364533|Arthralgia|arthralgia
542059|NCT00364533|Pain|pain
542060|NCT00364533|Pain Assessment|pain assessment
542061|NCT00364533|Hip Replacement|hip replacement
542062|NCT00364533|Tapentadol|tapentadol
542063|NCT00364546|Osteoarthritis|osteoarthritis
542064|NCT00364546|Pain|pain
542065|NCT00364546|Low Back Pain|low back pain
542066|NCT00364546|Hip Pain|hip pain
542067|NCT00364546|Knee Pain|knee pain
542068|NCT00364546|Backache|backache
542069|NCT00364546|tapentadol|tapentadol
542070|NCT00364559|intracerebral hemorrhage|intracerebral hemorrhage
542071|NCT00364559|statins|statins
542072|NCT00364559|rosuvastatin|rosuvastatin
542073|NCT00364559|stroke|stroke
542074|NCT00364572|sciatica|sciatica
542075|NCT00364572|low back pain|low back pain
542076|NCT00364572|epidural|epidural
542077|NCT00364572|tumor necrosis factor|tumor necrosis factor
542078|NCT00364598|Anginera|anginera
542079|NCT00364598|LVAD|lvad
542080|NCT00364598|Transplant|transplant
542081|NCT00364598|Histology|histology
542082|NCT00364598|LVAD implantation as a bridge to transplant|lvad implantation as a bridge to transplant
542083|NCT00364624|lung cancer|lung cancer
542084|NCT00364624|adrenal insufficiency|adrenal insufficiency
542085|NCT00364637|Sevoflurane|sevoflurane
542086|NCT00364637|Anesthesia|anesthesia
542087|NCT00364637|Troponin|troponin
542088|NCT00364637|Myocardial Preconditioning|myocardial preconditioning
542089|NCT00364637|Surgery, Cardiac|surgery, cardiac
542090|NCT00364637|Stents|stents
542091|NCT00364637|Non-cardiac Surgery|non-cardiac surgery
542092|NCT00364637|Surgery|surgery
542093|NCT00364650|Renal transplantation|renal transplantation
542094|NCT00364650|Diarrhea|diarrhea
542097|NCT00364663|NSCLC|nsclc
542098|NCT00364663|staging|staging
542099|NCT00364663|18F-FDG PET|18f-fdg pet
542100|NCT00364663|decision tree model|decision tree model
542101|NCT00364663|cost-effectiveness|cost-effectiveness
542102|NCT00364676|Vinorelbine|vinorelbine
542103|NCT00364676|solid tumors|solid tumors
542104|NCT00364676|Hodgkins|hodgkins
542105|NCT00364676|Non hodgkins|non hodgkins
542106|NCT00364676|Lymphoma|lymphoma
542107|NCT00364676|Advanced solid tumors|advanced solid tumors
542108|NCT00365612|HIV|hiv
542109|NCT00365612|HIV-1|hiv-1
542111|NCT00365612|Human Immunodeficiency Virus|human immunodeficiency virus
542112|NCT00365612|HIV-1 Infection|hiv-1 infection
542113|NCT00365625|Psoriasis|psoriasis
542114|NCT00365625|JAM3 protein, human|jam3 protein, human
542115|NCT00365625|Cell Adhesion Molecules|cell adhesion molecules
542116|NCT00365625|Skin|skin
542117|NCT00365625|Inflammation|inflammation
542118|NCT00365625|Lymphocytes|lymphocytes
542119|NCT00365638|PCOS|pcos
542120|NCT00365638|statin|statin
542121|NCT00365638|testosterone|testosterone
542123|NCT00365651|obesity|obesity
542124|NCT00365651|overweight|overweight
542125|NCT00365690|AIDS|aids
542126|NCT00365690|Older Adults|older adults
542127|NCT00365690|Telephone|telephone
542128|NCT00365690|Telemedicine|telemedicine
542129|NCT00365703|Infant, Premature|infant, premature
542130|NCT00365703|Tube feeding|tube feeding
542131|NCT00365716|HPV 6/11/16/18 infection and related genital disease|hpv 6/11/16/18 infection and related genital disease
542132|NCT00365729|genitoanal HPV infection|genitoanal hpv infection
542133|NCT00365729|HIV infection|hiv infection
542134|NCT00365742|red yeast rice|red yeast rice
542135|NCT00365742|pharmaceutical grade fish oil|pharmaceutical grade fish oil
542136|NCT00365742|simvastatin|simvastatin
542137|NCT00365742|primary prevention|primary prevention
542138|NCT00365755|disseminated neuroblastoma|disseminated neuroblastoma
542139|NCT00365768|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
542140|NCT00365768|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
542141|NCT00365768|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
542142|NCT00365768|stage I Wilms tumor|stage i wilms tumor
542143|NCT00365768|stage II Wilms tumor|stage ii wilms tumor
542144|NCT00365768|stage III Wilms tumor|stage iii wilms tumor
542145|NCT00365768|stage IV Wilms tumor|stage iv wilms tumor
542146|NCT00365768|stage V Wilms tumor|stage v wilms tumor
542147|NCT00365768|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
542148|NCT00365768|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
542149|NCT00365768|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
542150|NCT00365768|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
542151|NCT00365768|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
542152|NCT00365768|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
542153|NCT00365768|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
542154|NCT00365768|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
542155|NCT00365768|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
542156|NCT00365768|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
542157|NCT00365768|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
542158|NCT00365768|childhood Burkitt lymphoma|childhood burkitt lymphoma
542159|NCT00365768|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
542160|NCT00365768|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
542161|NCT00365768|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
542162|NCT00365768|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
542163|NCT00365768|localized Ewing sarcoma/PNET|localized ewing sarcoma/pnet
542164|NCT00365768|metastatic Ewing sarcoma/PNET|metastatic ewing sarcoma/pnet
542165|NCT00365768|neurotoxicity|neurotoxicity
542166|NCT00365768|peripheral neuropathy|peripheral neuropathy
542167|NCT00365781|Injection Site Reaction|injection site reaction
542168|NCT00365781|Subcutaneous administration|subcutaneous administration
542169|NCT00365781|Dermatological effects|dermatological effects
542170|NCT00365781|Antisense|antisense
542171|NCT00365794|Aging|aging
542172|NCT00365794|Older men|older men
542173|NCT00365794|Abdominal obesity|abdominal obesity
542174|NCT00365794|Central obesity|central obesity
542175|NCT00365794|Insulin resistance|insulin resistance
542176|NCT00365794|Low testosterone|low testosterone
542177|NCT00365807|Obesity|obesity
542178|NCT00365807|Overweight|overweight
542179|NCT00365807|Behavioral treatment|behavioral treatment
542180|NCT00365807|Family involvement|family involvement
542181|NCT00365820|Opioid, constipation, tegaserod|opioid, constipation, tegaserod
542182|NCT00365820|Opioid-induced constipation|opioid-induced constipation
542183|NCT00365833|Transplantation|transplantation
542184|NCT00365833|Cardiovascular|cardiovascular
542185|NCT00365833|Renal|renal
542186|NCT00365846|prevent kidney rejection|prevent kidney rejection
542386|NCT00366782|Bovine|bovine
542187|NCT00365859|Serious behavioral problems in children and adolescents with AD|serious behavioral problems in children and adolescents with ad
542188|NCT00365859|behavioral problems|behavioral problems
542189|NCT00365872|Sarcoma|sarcoma
542190|NCT00365872|Intratumoral injection|intratumoral injection
542191|NCT00365872|Dendritic cells|dendritic cells
542192|NCT00365872|Neo-adjuvant treatment|neo-adjuvant treatment
542193|NCT00365872|Immunotherapy|immunotherapy
542194|NCT00365872|Pheresis|pheresis
542195|NCT00365872|Radiation|radiation
542196|NCT00365885|Medical Informatics|medical informatics
542197|NCT00365885|Decision Support Systems, Clinical|decision support systems, clinical
542198|NCT00365885|Community Health Services|community health services
542199|NCT00365885|Costs and Cost analysis|costs and cost analysis
542200|NCT00365898|Chronic non-malignant pain, opioid|chronic non-malignant pain, opioid
542201|NCT00365911|No specific condition|no specific condition
542202|NCT00365924|12 month therapy with postmenopausal women with osteoporosis to examine changes in bone quality parameters|12 month therapy with postmenopausal women with osteoporosis to examine changes in bone quality parameters
542203|NCT00365937|immunotherapy|immunotherapy
542204|NCT00365937|adjuvants|adjuvants
542206|NCT00365937|Montanide ISA51 VG|montanide isa51 vg
542207|NCT00365937|tumor-specific peptides|tumor-specific peptides
542208|NCT00365950|Duration of anticoagulation|duration of anticoagulation
542209|NCT00365950|Deep vein thrombosis and/or pulmonary embolism|deep vein thrombosis and/or pulmonary embolism
542210|NCT00365963|lung cancer, caregivers, support, resources, education|lung cancer, caregivers, support, resources, education
542211|NCT00365976|Insomnia|insomnia
542212|NCT00365976|Low Back Pain|low back pain
542213|NCT00365976|Hypnotics|hypnotics
542214|NCT00365976|Eszopiclone|eszopiclone
542215|NCT00365976|Pain|pain
542216|NCT00365976|Disability|disability
542217|NCT00365989|Fibroids|fibroids
542218|NCT00365989|leiomyoma|leiomyoma
542219|NCT00365989|neoplasm|neoplasm
542220|NCT00365989|benign tumors|benign tumors
542221|NCT00366002|Darifenacin,Overactive Bladder,antimuscarinic,M3 muscarinic receptor antagonist|darifenacin,overactive bladder,antimuscarinic,m3 muscarinic receptor antagonist
542222|NCT00366015|Coronary Artery Disease|coronary artery disease
542223|NCT00366015|PCI|pci
542224|NCT00366015|Drug eluting stents|drug eluting stents
542225|NCT00366015|Coronary Hybrid Revascularization|coronary hybrid revascularization
542226|NCT00366015|Robotic CABG|robotic cabg
542227|NCT00366028|Organization Innovation|organization innovation
542228|NCT00366028|Diffusion of Innovation|diffusion of innovation
542229|NCT00366028|Evidence-based Medicine|evidence-based medicine
542230|NCT00366028|Infection Control|infection control
542231|NCT00366067|Bronchial asthma|bronchial asthma
542232|NCT00366067|Phenytoin|phenytoin
542233|NCT00366067|Antiepileptic drugs|antiepileptic drugs
542234|NCT00366067|Efficacy|efficacy
542235|NCT00366080|GSK189254 H3 Histamine Narcolepsy|gsk189254 h3 histamine narcolepsy
542236|NCT00366093|Menopause|menopause
542237|NCT00366093|Perimenopause|perimenopause
542238|NCT00366106|Relapsed Multiple Myeloma|relapsed multiple myeloma
542239|NCT00366106|Refractory Multiple Myeloma|refractory multiple myeloma
542240|NCT00366119|hypertension|hypertension
542241|NCT00366119|ramipril|ramipril
542242|NCT00366119|blood pressure|blood pressure
542243|NCT00366119|artery stiffness|artery stiffness
542244|NCT00366119|BNP|bnp
542245|NCT00366119|CRP|crp
542246|NCT00366132|Diabetic|diabetic
542247|NCT00366132|Foot Ulcers|foot ulcers
542248|NCT00366132|TRT|trt
542249|NCT00366132|DermaGold|dermagold
542250|NCT00366132|Shockwave|shockwave
542251|NCT00366132|ESWT|eswt
542252|NCT00366132|Diabetes Mellitus|diabetes mellitus
542253|NCT00366145|acute GVHD|acute gvhd
542254|NCT00366145|steroid refractory GVHD|steroid refractory gvhd
542255|NCT00366145|severe steroid refractory acute GVHD|severe steroid refractory acute gvhd
542256|NCT00366145|steroid refractory|steroid refractory
542257|NCT00366145|Steroid Refractory Acute Graft Versus Host Disease|steroid refractory acute graft versus host disease
541674|NCT00356070|rehabilitation|rehabilitation
541675|NCT00356122|Lung|lung
541676|NCT00356122|non-small cell|non-small cell
541677|NCT00356122|chemotherapy|chemotherapy
541678|NCT00356122|tumor|tumor
542258|NCT00366158|Patients with intact AV conduction|patients with intact av conduction
542259|NCT00366171|Schizophrenia|schizophrenia
542260|NCT00366184|Neuromodulation|neuromodulation
542261|NCT00366184|Stroke|stroke
542262|NCT00366184|Motor Cortex|motor cortex
542263|NCT00366184|Motor Learning|motor learning
542264|NCT00366184|L-Dopa|l-dopa
542265|NCT00366184|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
542266|NCT00366184|Levodopa|levodopa
542267|NCT00366184|Healthy Volunteer|healthy volunteer
542268|NCT00366184|HV|hv
542269|NCT00366197|Rapid Shallow Breathing Index|rapid shallow breathing index
542270|NCT00366197|Mechanical Ventilation|mechanical ventilation
542271|NCT00366210|stroke|stroke
542272|NCT00366210|rehabilitation|rehabilitation
542273|NCT00366210|physical therapy|physical therapy
542274|NCT00366210|occupational therapy|occupational therapy
542275|NCT00366210|arm|arm
542276|NCT00366223|infection|infection
542277|NCT00366223|candida|candida
542278|NCT00366236|Amebiasis|amebiasis
542279|NCT00366236|Entamoeba histolytica|entamoeba histolytica
542280|NCT00366249|Diabetic foot infection|diabetic foot infection
542281|NCT00366249|Osteomyelitis|osteomyelitis
542282|NCT00366249|Diabetes Complications|diabetes complications
542283|NCT00366249|Foot ulcer|foot ulcer
542284|NCT00366249|Skin infection|skin infection
542285|NCT00366262|Health|health
542286|NCT00366275|follicular lymphoma|follicular lymphoma
542287|NCT00366275|rituximab|rituximab
542288|NCT00366275|immunochemotherapy|immunochemotherapy
542289|NCT00366275|peripheral blood stem cells (PBSC) mobilization|peripheral blood stem cells (pbsc) mobilization
542290|NCT00366275|in vivo purging|in vivo purging
542291|NCT00366275|autotransplant|autotransplant
542292|NCT00366275|bcl-2 rearrangement|bcl-2 rearrangement
542293|NCT00366275|molecular response|molecular response
542294|NCT00366288|Healthy|healthy
542295|NCT00366288|Safety|safety
542296|NCT00366301|type 2 diabetes|type 2 diabetes
542297|NCT00366301|insulin|insulin
542298|NCT00366301|insulin injection|insulin injection
542299|NCT00366301|metformin|metformin
542300|NCT00366301|C-reactive protein|c-reactive protein
542301|NCT00366301|insulin sensitivity|insulin sensitivity
542302|NCT00366301|glycemic control|glycemic control
542303|NCT00366301|inflammation|inflammation
542304|NCT00366314|Blood samples|blood samples
542305|NCT00366314|Medication administration|medication administration
542306|NCT00366314|CICU|cicu
542307|NCT00366314|PICU|picu
542308|NCT00366314|NICU|nicu
542309|NCT00366327|Schizophrenia|schizophrenia
542310|NCT00366340|safety|safety
542311|NCT00366340|Vaccine|vaccine
542312|NCT00366353|Mechanical Ventilation|mechanical ventilation
542313|NCT00366353|Spontaneous Breathing Trial|spontaneous breathing trial
542314|NCT00366353|Sedation|sedation
542315|NCT00366392|Low Vision|low vision
542316|NCT00366392|Optical Aids|optical aids
542317|NCT00366405|cataract|cataract
542319|NCT00366418|Monoclonal Antibody Therapy|monoclonal antibody therapy
542320|NCT00366418|Anti CD20|anti cd20
542321|NCT00366418|Biologic Response Modifier Therapy|biologic response modifier therapy
542322|NCT00366418|Fractionated-Dose|fractionated-dose
542323|NCT00366418|Low-Dose|low-dose
542324|NCT00366418|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
542325|NCT00366431|OIBD|oibd
542327|NCT00366431|Opioid|opioid
542328|NCT00366431|Constipation|constipation
542329|NCT00366431|Laxative|laxative
542330|NCT00366444|Bunionectomy|bunionectomy
542331|NCT00366444|Bunion surgery|bunion surgery
542332|NCT00366444|Post-operative pain|post-operative pain
542333|NCT00366483|healthy young volunteers|healthy young volunteers
542334|NCT00366483|healthy elderly volunteers|healthy elderly volunteers
542335|NCT00366483|Alzheimer's disease|alzheimer's disease
542336|NCT00366483|5HT1A antagonist|5ht1a antagonist
542337|NCT00366483|Health|health
542338|NCT00366483|Pharmacokinetics|pharmacokinetics
542339|NCT00366509|Vac A Toxin|vac a toxin
542340|NCT00366509|Lung|lung
542341|NCT00366509|Bronchoscopy|bronchoscopy
542342|NCT00366509|Endoscopy|endoscopy
542343|NCT00366509|Cytotoxin|cytotoxin
542344|NCT00366509|Pulmonary Disease|pulmonary disease
542345|NCT00366509|Lung Disease|lung disease
542346|NCT00366509|Genetic Disease|genetic disease
542347|NCT00366509|Oropharyngeal Disease|oropharyngeal disease
542348|NCT00366509|Pulmonary Fibrosis|pulmonary fibrosis
542349|NCT00366509|Asthma|asthma
542350|NCT00366522|Safety|safety
542351|NCT00366522|Healthy|healthy
542352|NCT00366522|healthy subjects|healthy subjects
542353|NCT00366535|Muscle Pain|muscle pain
542354|NCT00366535|Fibrositis Allodynia|fibrositis allodynia
542355|NCT00366535|Stiffness|stiffness
541785|NCT00356590|Etanercept|etanercept
542356|NCT00366535|Tender Points|tender points
542357|NCT00366535|Fibromyalgia|fibromyalgia
542358|NCT00366548|Vaccine|vaccine
542359|NCT00366548|Infant|infant
542360|NCT00366561|neonates|neonates
542361|NCT00366561|neurological complications|neurological complications
542362|NCT00366561|surgery|surgery
542363|NCT00366600|Breast Cancer|breast cancer
542364|NCT00366600|Health|health
542365|NCT00366600|Pharmacokinetics|pharmacokinetics
542366|NCT00366600|healthy subjects|healthy subjects
542367|NCT00366613|Cataract|cataract
542368|NCT00366613|Cataract Extraction|cataract extraction
542369|NCT00366626|Alcohol dependence|alcohol dependence
542370|NCT00366626|Alcoholism|alcoholism
542371|NCT00366626|Craving|craving
542372|NCT00366626|Genetic|genetic
542373|NCT00366639|Heart failure, congestive|heart failure, congestive
542374|NCT00366639|Heart decompensation|heart decompensation
542375|NCT00366652|Healthy|healthy
542376|NCT00366678|Safety|safety
542377|NCT00366678|Vaccine|vaccine
542378|NCT00366691|cataract|cataract
542379|NCT00366704|Schizophrenia|schizophrenia
542380|NCT00366717|Cancer under chemotherapy|cancer under chemotherapy
542381|NCT00366730|Amebiasis|amebiasis
542382|NCT00366730|Entamoeba histolytica|entamoeba histolytica
542383|NCT00366756|Vision|vision
542384|NCT00366756|Visual Acuity|visual acuity
542385|NCT00366782|Respiratory Tract Disease|respiratory tract disease
542387|NCT00366782|Chimeric Vaccine|chimeric vaccine
542388|NCT00366821|cardiac|cardiac
542389|NCT00366821|pediatric|pediatric
542390|NCT00366821|genetic|genetic
542391|NCT00366834|Anthracycline|anthracycline
542392|NCT00366834|Cyclophosphamide|cyclophosphamide
542393|NCT00366834|Moderately|moderately
542394|NCT00366834|Nausea|nausea
542395|NCT00366834|Emetogenic|emetogenic
542396|NCT00366834|Vomiting|vomiting
542397|NCT00366847|cardiac|cardiac
542399|NCT00366847|pediatrics|pediatrics
542401|NCT00366860|isoflavones|isoflavones
542402|NCT00366860|bone resorption|bone resorption
542318|NCT00366418|CLL|cll
542403|NCT00366860|osteogenesis|osteogenesis
542404|NCT00366860|diet|diet
542405|NCT00366860|hyperlipidemia|hyperlipidemia
542406|NCT00366873|Infant|infant
542407|NCT00366873|Term|term
542408|NCT00366886|cardiac|cardiac
542409|NCT00366886|pediatric|pediatric
542410|NCT00366886|surgery|surgery
542411|NCT00366886|blood markers|blood markers
542412|NCT00366899|Vaccine|vaccine
542413|NCT00366899|Infants|infants
542414|NCT00366912|work of breathing|work of breathing
542415|NCT00366912|pressure time product|pressure time product
542416|NCT00366912|muscle pressures|muscle pressures
542417|NCT00366938|Osteoarthritis, lumiracoxib, celecoxib, Cox-2|osteoarthritis, lumiracoxib, celecoxib, cox-2
542418|NCT00366951|Cervical Ripening|cervical ripening
542419|NCT00366951|Labor, Induced|labor, induced
542420|NCT00366951|Balloon Dilation|balloon dilation
542421|NCT00366951|Oxytocin|oxytocin
542422|NCT00366977|Cessation|cessation
542423|NCT00366977|Smoking|smoking
542424|NCT00366977|Quitline|quitline
542425|NCT00366977|Policies|policies
542426|NCT00366977|Counseling|counseling
542427|NCT00366990|Arterial Stiffening|arterial stiffening
542428|NCT00367003|Depression, Unipolar, Bipolar-II, DBS, Imaging|depression, unipolar, bipolar-ii, dbs, imaging
542429|NCT00367029|Physical Activity|physical activity
542430|NCT00367055|Beta cell function|beta cell function
542431|NCT00367055|Type 2 diabetes|type 2 diabetes
542432|NCT00367055|Combination treatment|combination treatment
542433|NCT00367068|Cerebral palsy|cerebral palsy
542434|NCT00367068|Spasticity|spasticity
542435|NCT00367068|Child|child
542436|NCT00367068|Baclofen|baclofen
542437|NCT00367068|Intrathecal injection|intrathecal injection
542438|NCT00367081|Toxoplasmic Encephalitis|toxoplasmic encephalitis
542439|NCT00367081|AIDS|aids
542440|NCT00367094|Hypertension, benazepril, hydrochlorothiazide, fixed combination|hypertension, benazepril, hydrochlorothiazide, fixed combination
542441|NCT00367107|Autism spectrum disorders|autism spectrum disorders
542442|NCT00367107|long-term outcomes|long-term outcomes
542443|NCT00367107|caregiver burden|caregiver burden
542444|NCT00367107|birth cohort|birth cohort
542445|NCT00367107|nested case-control study|nested case-control study
542446|NCT00367133|diabetic|diabetic
542447|NCT00367133|macular|macular
542448|NCT00367133|edema|edema
542449|NCT00367133|intravitreal|intravitreal
542450|NCT00367133|triamcinolone|triamcinolone
542451|NCT00367133|laser|laser
542452|NCT00367133|photocoagulation|photocoagulation
542453|NCT00367133|DME|dme
542454|NCT00367146|liver transplantation|liver transplantation
542455|NCT00367146|children|children
542456|NCT00367146|immunosuppression|immunosuppression
542457|NCT00367146|mycophenolatmofetil|mycophenolatmofetil
542458|NCT00367146|calcineurin inhibitor|calcineurin inhibitor
542459|NCT00367146|kidney disease|kidney disease
97690|NCT02678520|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
541879|NCT00357006|Estrogen|estrogen
542460|NCT00367159|Vesico-ureteral reflux, autologous adipocytes, adipocytes graft|vesico-ureteral reflux, autologous adipocytes, adipocytes graft
542461|NCT00367172|human immunodeficiency virus|human immunodeficiency virus
542462|NCT00367172|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
542463|NCT00367172|substance abuse|substance abuse
542464|NCT00367172|directly administered antiretroviral therapy|directly administered antiretroviral therapy
542465|NCT00367172|adherence, directly observed therapy|adherence, directly observed therapy
542466|NCT00367185|Multiple myeloma|multiple myeloma
542467|NCT00367185|Elderly patients|elderly patients
542468|NCT00367185|Thalidomide|thalidomide
542469|NCT00367185|Autologous transplantation|autologous transplantation
542470|NCT00367211|Gastric Ulcers|gastric ulcers
542471|NCT00367211|NSAID|nsaid
542472|NCT00367211|Arthritis|arthritis
542473|NCT00367224|vitiligo|vitiligo
542474|NCT00367224|tolerance|tolerance
542475|NCT00367224|ultraviolet B.|ultraviolet b.
542476|NCT00367263|Asthma|asthma
542477|NCT00367276|Females requiring contraceptives|females requiring contraceptives
542478|NCT00367302|addiction|addiction
542479|NCT00367302|jail|jail
542480|NCT00367302|opiates|opiates
542481|NCT00367302|buprenorphine|buprenorphine
542482|NCT00367302|clinical trial|clinical trial
542483|NCT00367315|Osteoarthritis, lumiracoxib, celecoxib, cyclooxygenase-2 inhibitors|osteoarthritis, lumiracoxib, celecoxib, cyclooxygenase-2 inhibitors
542484|NCT00367328|Hidradenitis Supperativa|hidradenitis supperativa
542485|NCT00367341|Depression, Treatment, Imaging|depression, treatment, imaging
542486|NCT00367354|Imaging Technology|imaging technology
542487|NCT00367354|Cardiology|cardiology
542488|NCT00367367|embryo transfer|embryo transfer
542489|NCT00367367|hysteroscopy|hysteroscopy
542490|NCT00367367|curettage|curettage
542491|NCT00367367|iv-vitro fertilization|iv-vitro fertilization
542492|NCT00367367|molecular markers|molecular markers
542493|NCT00367367|endometrial receptivity|endometrial receptivity
542494|NCT00367367|endometrial dating|endometrial dating
542495|NCT00367380|Malaria|malaria
542496|NCT00367380|Sporozoite|sporozoite
542497|NCT00367380|Challenge Model|challenge model
542498|NCT00367380|Plasmodium vivax|plasmodium vivax
542499|NCT00367380|Human Volunteers|human volunteers
16144|NCT03187795|Neurogenic Bladder|neurogenic bladder
16145|NCT03187795|Rehabilitation|rehabilitation
542500|NCT00367393|Pimecrolimus, skin atrophy, dermoscopy, atopic dermatitis, eczema|pimecrolimus, skin atrophy, dermoscopy, atopic dermatitis, eczema
542501|NCT00367432|Epilepsies|epilepsies
542502|NCT00367432|Partial|partial
542503|NCT00367432|Keppra|keppra
542504|NCT00367432|levetiracetam|levetiracetam
542505|NCT00367458|Viremia|viremia
542506|NCT00367458|Statin|statin
542507|NCT00367458|HIV Replication|hiv replication
542508|NCT00367458|Cholesterol|cholesterol
542509|NCT00367458|Lipid Raft|lipid raft
542510|NCT00367458|HIV Infection|hiv infection
542511|NCT00367458|HIV Positive|hiv positive
542512|NCT00367471|metastatic|metastatic
542513|NCT00367471|paclitaxel|paclitaxel
542514|NCT00367471|lapatinib|lapatinib
542515|NCT00367471|trastuzumab|trastuzumab
542516|NCT00367471|carboplatin|carboplatin
542517|NCT00367471|breast cancer|breast cancer
542518|NCT00367497|aggressive non-Hodgkin's lymphoma|aggressive non-hodgkin's lymphoma
542519|NCT00367497|salvage chemotherapy|salvage chemotherapy
542520|NCT00367497|rituximab|rituximab
542521|NCT00367523|Echocardiogram|echocardiogram
542522|NCT00367523|Nigeria|nigeria
542523|NCT00367523|Screening|screening
542524|NCT00367523|Sickle Cell Disease|sickle cell disease
542525|NCT00367523|Genetics|genetics
542526|NCT00367536|Health|health
542527|NCT00367549|Labor|labor
542528|NCT00367549|instrumental delivery|instrumental delivery
542529|NCT00367549|nutrition|nutrition
542530|NCT00367549|epidural anesthesia|epidural anesthesia
542531|NCT00367549|oxytocin|oxytocin
542532|NCT00367562|IGA NEPHROPATHY|iga nephropathy
542533|NCT00367562|STEROIDS|steroids
542534|NCT00367562|ENALAPRIL|enalapril
542535|NCT00367562|VALSARTAN|valsartan
542536|NCT00367562|PROTEINURIA|proteinuria
542537|NCT00367562|IMMUNOGLOBULIN A NEPHROPATHY (IGA NEPHROPATHY)|immunoglobulin a nephropathy (iga nephropathy)
542538|NCT00367575|alcoholism|alcoholism
542539|NCT00367575|drinking|drinking
542540|NCT00367575|randomized|randomized
542541|NCT00367575|internet personalized alcohol feedback|internet personalized alcohol feedback
542542|NCT00367588|chemotherapy|chemotherapy
542543|NCT00367588|diet|diet
542544|NCT00367588|hematological malignancy|hematological malignancy
542545|NCT00367588|infection prevention|infection prevention
542546|NCT00367588|protective isolation|protective isolation
542547|NCT00367588|Patients with cytopenia due to intensive chemotherapy for hematological malignancy|patients with cytopenia due to intensive chemotherapy for hematological malignancy
542548|NCT00367614|Adolescents|adolescents
542549|NCT00367614|GERD|gerd
542550|NCT00367627|Children|children
542551|NCT00367627|Malnutrition|malnutrition
542552|NCT00367627|Ascaris Lumbricoides|ascaris lumbricoides
97691|NCT02678520|Hormone|hormone
542553|NCT00367627|Trichuris trichiura Morbidity|trichuris trichiura morbidity
542554|NCT00367627|Helminthiasis|helminthiasis
542555|NCT00367627|Children 2-5 years|children 2-5 years
542556|NCT00367627|Stool RME +ve for helminthiasis|stool rme +ve for helminthiasis
542557|NCT00367640|Sublingual immunotherapy|sublingual immunotherapy
542558|NCT00367640|Grass pollen tablet|grass pollen tablet
542559|NCT00367640|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
542560|NCT00367679|pazopanib|pazopanib
542561|NCT00367679|I-ELCAP|i-elcap
542562|NCT00367679|non-small cell lung cancer|non-small cell lung cancer
542563|NCT00367679|antiangiogenesis|antiangiogenesis
542564|NCT00367679|NSCLC|nsclc
542565|NCT00367679|GW786034|gw786034
542566|NCT00367692|Scleritis|scleritis
542567|NCT00367731|HIV|hiv
542568|NCT00367731|AIDS|aids
542569|NCT00367731|Neurological complications|neurological complications
542570|NCT00367731|HAART|haart
542571|NCT00367744|mitochondria|mitochondria
542572|NCT00367744|HIV|hiv
542573|NCT00367744|lipoatrophy|lipoatrophy
542574|NCT00367757|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
542575|NCT00367757|persistent atrial fibrillation|persistent atrial fibrillation
542576|NCT00367757|high burden of atrial fibrillation|high burden of atrial fibrillation
542577|NCT00367757|atrial fibrillation ablation|atrial fibrillation ablation
542578|NCT00367757|Pulmonary vein isolation|pulmonary vein isolation
542579|NCT00367757|AF trigger|af trigger
542580|NCT00367757|complex fractionated electrograms|complex fractionated electrograms
542581|NCT00367757|CFE|cfe
542582|NCT00367757|CFAE|cfae
542583|NCT00367757|complex fractionated atrial electrograms|complex fractionated atrial electrograms
542584|NCT00367757|refractory antiarrhythmic medication|refractory antiarrhythmic medication
542585|NCT00367757|PVAI|pvai
542586|NCT00367757|Ensite NavX|ensite navx
542587|NCT00367757|NavX|navx
542588|NCT00367757|CoolPath catheter|coolpath catheter
542589|NCT00367757|irrigated ablation catheter|irrigated ablation catheter
542590|NCT00367757|high burden of paroxysmal or persistent atrial fibrillation|high burden of paroxysmal or persistent atrial fibrillation
542591|NCT00367757|candidates for AF ablation|candidates for af ablation
542592|NCT00367757|symptomatic AF|symptomatic af
542593|NCT00367757|AF is refractory to at least one antiarrhythmic medication|af is refractory to at least one antiarrhythmic medication
542594|NCT00367770|bosentan|bosentan
542595|NCT00367770|PAH related to Eisenmenger physiology|pah related to eisenmenger physiology
542596|NCT00367770|Tracleer|tracleer
16146|NCT03187769|Alkermes|alkermes
542606|NCT00367822|dopamine agonist|dopamine agonist
542607|NCT00367822|lisuride|lisuride
542608|NCT00367822|ropinirole|ropinirole
542609|NCT00367848|suspected fractures in the ankle and wrist|suspected fractures in the ankle and wrist
542610|NCT00367861|GIST|gist
542621|NCT00367900|Lifestyle|lifestyle
542622|NCT00367900|Neurodegenerative Diseases|neurodegenerative diseases
542623|NCT00367900|Elderly Population|elderly population
542624|NCT00367900|Public Health|public health
542625|NCT00367900|Parkinson Disease|parkinson disease
542626|NCT00367900|Environment|environment
542627|NCT00367913|pulmonary disease|pulmonary disease
542628|NCT00367913|Treatment of Opportunist Mycobacteria|treatment of opportunist mycobacteria
542629|NCT00367913|Clarithromycin|clarithromycin
542630|NCT00367913|Ciprofloxacin|ciprofloxacin
542631|NCT00367913|M.vaccae|m.vaccae
542632|NCT00367913|Pulmonary diseases caused by Opportunist Mycobacteria|pulmonary diseases caused by opportunist mycobacteria
542633|NCT00367926|ginseng|ginseng
542634|NCT00367926|polysaccharides|polysaccharides
542635|NCT00367926|postprandial glycemia|postprandial glycemia
542636|NCT00367926|area under the glucose curve|area under the glucose curve
542637|NCT00367926|peak incremental glucose|peak incremental glucose
542638|NCT00367939|Hypertension|hypertension
542640|NCT00367952|apricitabine|apricitabine
542641|NCT00367952|drug resistance|drug resistance
542642|NCT00367952|reverse transcriptase|reverse transcriptase
542643|NCT00367952|lamivudine|lamivudine
542644|NCT00367965|Insomnia related to rheumatoid arthritis (RA)|insomnia related to rheumatoid arthritis (ra)
542645|NCT00367978|Hypertension, diabetes, African-American, amlodipine/benazepril|hypertension, diabetes, african-american, amlodipine/benazepril
542646|NCT00367991|Platelet function tests|platelet function tests
542647|NCT00367991|Erythropoietin|erythropoietin
542648|NCT00367991|Myocardial infarction|myocardial infarction
542649|NCT00368004|Coloboma|coloboma
542650|NCT00368004|Genetics|genetics
542651|NCT00368004|Optic Nerve Coloboma|optic nerve coloboma
542652|NCT00368004|Chorioretinal Coloboma|chorioretinal coloboma
542653|NCT00368004|Iris Coloboma|iris coloboma
542654|NCT00368004|Uveal Coloboma|uveal coloboma
542655|NCT00368030|Insomnia related to major depressive disorder.|insomnia related to major depressive disorder.
542656|NCT00368043|Pituitary|pituitary
542657|NCT00368043|Adrenal|adrenal
542658|NCT00368043|Growth|growth
542659|NCT00368043|Cortisol|cortisol
542660|NCT00368043|Stress Response|stress response
542661|NCT00368043|Adoption|adoption
542662|NCT00368043|Thyroid Hormone|thyroid hormone
542663|NCT00368043|Psychosocial Adjustment|psychosocial adjustment
542006|NCT00357097|randomised|randomised
542664|NCT00368043|Healthy Volunteer|healthy volunteer
542665|NCT00368043|HV|hv
542666|NCT00368069|Epilepsy|epilepsy
542667|NCT00368069|Keppra® XR|keppra® xr
542668|NCT00368069|Levetiracetam XR|levetiracetam xr
542669|NCT00368069|Extended release|extended release
542678|NCT00368095|DM|dm
542679|NCT00368095|HT|ht
542680|NCT00368095|Dyslipidemia|dyslipidemia
542681|NCT00368095|Obesity|obesity
542682|NCT00368095|Cardiovascular disease|cardiovascular disease
542683|NCT00368095|Cerebrovascular disease|cerebrovascular disease
542684|NCT00368095|Myocardial infarction|myocardial infarction
542685|NCT00368095|stroke|stroke
542686|NCT00368095|Metabolic syndrome|metabolic syndrome
542687|NCT00368095|CVD-CAD|cvd-cad
542688|NCT00359983|Humans|humans
542689|NCT00359983|Meningococcal vaccines|meningococcal vaccines
542690|NCT00359983|Immunogenicity|immunogenicity
542691|NCT00359983|Vaccines|vaccines
542692|NCT00359983|H. influenzae type b vaccine|h. influenzae type b vaccine
542693|NCT00359983|Conjugate|conjugate
542694|NCT00359983|Toddlers|toddlers
542695|NCT00359983|Comparative study|comparative study
542696|NCT00359983|Neisseria meningitidis|neisseria meningitidis
542697|NCT00359996|diabetes|diabetes
542698|NCT00359996|quality improvement|quality improvement
542699|NCT00359996|community health center|community health center
542700|NCT00359996|health disparities|health disparities
542701|NCT00360009|Parkinson's disease|parkinson's disease
542702|NCT00360009|Parkinson disease|parkinson disease
542703|NCT00360009|PD|pd
542704|NCT00360009|deep brain stimulation|deep brain stimulation
542705|NCT00360009|DBS|dbs
542706|NCT00360009|subthalamic nucleus|subthalamic nucleus
542707|NCT00360009|STN|stn
542708|NCT00360009|globus pallidus interna|globus pallidus interna
542710|NCT00360009|mood|mood
542711|NCT00360009|motor symptoms|motor symptoms
542712|NCT00360009|cognition|cognition
542713|NCT00360009|emotion|emotion
542714|NCT00360009|memory|memory
542715|NCT00360009|attention|attention
542716|NCT00360009|tremor|tremor
542717|NCT00360009|rigidity|rigidity
542718|NCT00360009|bradykinesia|bradykinesia
542719|NCT00360048|oxytocin|oxytocin
542720|NCT00360048|tnf|tnf
542721|NCT00360048|sepsis|sepsis
542722|NCT00360048|lps|lps
542723|NCT00360061|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
542724|NCT00360061|Adolescents|adolescents
542725|NCT00360061|Cognitive Behaviour Therapy|cognitive behaviour therapy
542726|NCT00360074|secondary hypothyroidism|secondary hypothyroidism
542727|NCT00360074|body weight adjusted thyroxin dose|body weight adjusted thyroxin dose
542728|NCT00360074|triiodothyronine supplementation|triiodothyronine supplementation
542729|NCT00360087|Treatment Study|treatment study
542730|NCT00360087|Sickle Cell Anemia|sickle cell anemia
542731|NCT00360087|6-Minute Walk|6-minute walk
542732|NCT00360087|Right Heart Catheterization|right heart catheterization
542733|NCT00360087|Tracleer|tracleer
542734|NCT00360087|Sickle Cell|sickle cell
542735|NCT00360087|SCD|scd
542736|NCT00360126|Lamictal|lamictal
542737|NCT00360126|lamotrigine|lamotrigine
542738|NCT00360126|Open-Label Extension Study|open-label extension study
542739|NCT00360126|Bipolar Disorder|bipolar disorder
542740|NCT00360139|Sculptra|sculptra
542741|NCT00360139|lipoatrophy|lipoatrophy
542742|NCT00360139|emaciation|emaciation
542743|NCT00360139|facial|facial
542744|NCT00360139|dermal filler|dermal filler
542745|NCT00360139|poly-L-lactic acid|poly-l-lactic acid
542746|NCT00360139|Dermik|dermik
542747|NCT00360139|SpaMD|spamd
542748|NCT00360139|Sanofi|sanofi
542749|NCT00360139|Facial lipoatrophy|facial lipoatrophy
542750|NCT00360139|Facial emaciation|facial emaciation
542751|NCT00360152|Breast Cancer|breast cancer
542752|NCT00360152|Axilla|axilla
542753|NCT00360152|Ultrasound|ultrasound
542754|NCT00360152|FNA|fna
542755|NCT00360152|Molecular Analysis|molecular analysis
542756|NCT00360178|hypertension|hypertension
542757|NCT00360178|valsartan|valsartan
542758|NCT00360178|amlodipine|amlodipine
542759|NCT00360178|hydrochlorothiazide|hydrochlorothiazide
542760|NCT00360204|Infant health|infant health
542761|NCT00360204|parenting competence|parenting competence
542762|NCT00360204|Home nurse visit|home nurse visit
542763|NCT00360204|maternal post-partum care|maternal post-partum care
542764|NCT00360204|postpartum health utilization|postpartum health utilization
542765|NCT00360204|Breastfeeding|breastfeeding
542766|NCT00360217|Omega-3|omega-3
542767|NCT00360217|Triglyceride|triglyceride
542768|NCT00360217|Hyperlipidemia|hyperlipidemia
542769|NCT00360217|Coronary Artery Disease|coronary artery disease
542770|NCT00360217|Fatty Acids|fatty acids
542771|NCT00360217|Safety|safety
542772|NCT00360217|Fish Oil|fish oil
542773|NCT00360217|Docosohexanoic Acid|docosohexanoic acid
542774|NCT00360230|Malaria|malaria
542775|NCT00360230|Plasmodium falciparum|plasmodium falciparum
542776|NCT00360230|Vaccine|vaccine
542777|NCT00360230|Prophylaxis Plasmodium falciparum malaria|prophylaxis plasmodium falciparum malaria
542778|NCT00360256|Depression|depression
542779|NCT00360256|Amplichip P450 tests|amplichip p450 tests
542780|NCT00360256|Antidepressants|antidepressants
542781|NCT00360282|Migraine|migraine
542782|NCT00360282|Triptans|triptans
542783|NCT00360282|Motion Sickness|motion sickness
542784|NCT00360334|diabetes|diabetes
542785|NCT00360334|exenatide|exenatide
542786|NCT00360334|insulin glargine|insulin glargine
542787|NCT00360334|Lilly|lilly
542788|NCT00360334|Amylin|amylin
542789|NCT00360360|Neoplasm, Unknown Primary|neoplasm, unknown primary
542790|NCT00360373|bariatric|bariatric
542791|NCT00360373|obesity|obesity
542792|NCT00360373|insulin resistance|insulin resistance
542793|NCT00360373|gastric bypass|gastric bypass
542794|NCT00360373|adolescent|adolescent
542795|NCT00360399|Escitalopram|escitalopram
542796|NCT00360399|Duloxetine|duloxetine
542797|NCT00360399|Cognitive Behavioral Therapy|cognitive behavioral therapy
542798|NCT00360399|PET|pet
542799|NCT00360399|fMRI|fmri
542800|NCT00360425|anemia|anemia
542801|NCT00360425|intravenous iron|intravenous iron
542802|NCT00360425|pharmacokinetics|pharmacokinetics
542803|NCT00360425|QTc|qtc
542804|NCT00360438|Leukemia|leukemia
542805|NCT00360438|Lymphoma|lymphoma
542806|NCT00360438|Tumor Lysis Syndrome|tumor lysis syndrome
542807|NCT00360438|TLS|tls
542808|NCT00360438|Rasburicase|rasburicase
542809|NCT00360438|Elitek|elitek
542810|NCT00360451|Prevention|prevention
542811|NCT00360451|Child|child
542812|NCT00360451|Adolescent|adolescent
542813|NCT00360451|Parent|parent
542814|NCT00360477|Kidney stone removal surgery|kidney stone removal surgery
16147|NCT03187769|ALKS 3831|alks 3831
542815|NCT00360490|Idiopathic Menorrhagia|idiopathic menorrhagia
542816|NCT00360503|Cystic fibrosis|cystic fibrosis
542817|NCT00360503|Antibiotic resistance|antibiotic resistance
542818|NCT00360503|Microbiology|microbiology
542819|NCT00360516|healthy volunteers|healthy volunteers
542820|NCT00360568|carbidopa|carbidopa
542821|NCT00360568|severe motor fluctuations|severe motor fluctuations
542822|NCT00360568|intestinal gel|intestinal gel
542823|NCT00360568|levodopa|levodopa
542824|NCT00360568|efficacy|efficacy
542825|NCT00360568|levodopa carbidopa intestinal gel|levodopa carbidopa intestinal gel
542826|NCT00360568|dyskinesia|dyskinesia
542827|NCT00360568|Parkinson's Disease|parkinson's disease
542828|NCT00360568|Duodopa|duodopa
542829|NCT00360568|levodopa-carbidopa|levodopa-carbidopa
542830|NCT00360568|DUOPA|duopa
542831|NCT00360581|Smoking abstinence|smoking abstinence
542832|NCT00360594|alcoholism|alcoholism
542833|NCT00360633|Parkinson's Disease|parkinson's disease
542834|NCT00360633|Impulse control disorder|impulse control disorder
542835|NCT00360633|Dopamine agonist withdrawal syndrome|dopamine agonist withdrawal syndrome
542836|NCT00360633|Anxiety|anxiety
542837|NCT00360633|Depression|depression
542838|NCT00360633|Healthcare Utilization|healthcare utilization
542839|NCT00360633|Disability|disability
542840|NCT00360633|Quality of life|quality of life
542841|NCT00360633|Cognitive function|cognitive function
542842|NCT00360633|Psychosis|psychosis
542843|NCT00360633|Apathy|apathy
542844|NCT00360633|Dyskinesias|dyskinesias
542845|NCT00360633|Wearing off|wearing off
542846|NCT00360646|LIVER DIS|liver dis
542847|NCT00360646|CHEM IND|chem ind
542848|NCT00360646|Drugs|drugs
542849|NCT00360646|Drug induced liver injury|drug induced liver injury
542850|NCT00360646|phenotype|phenotype
542851|NCT00360646|cholestatic liver injury|cholestatic liver injury
542852|NCT00360646|hepatocellular liver injury|hepatocellular liver injury
542853|NCT00360646|mixed liver injury|mixed liver injury
542854|NCT00360646|genotype|genotype
542855|NCT00360659|Obstructive sleep Apnea|obstructive sleep apnea
542856|NCT00360659|Hypertension|hypertension
542857|NCT00360659|Vasoactive hormones|vasoactive hormones
542858|NCT00360672|Acute Myelogenous Leukemia|acute myelogenous leukemia
542859|NCT00360672|Myelodysplastic Syndrome|myelodysplastic syndrome
542860|NCT00360685|Tacrolimus|tacrolimus
542861|NCT00360685|Methotrexate|methotrexate
542862|NCT00360685|Mycophenolate mofetil|mycophenolate mofetil
542863|NCT00360685|Mucositis|mucositis
542864|NCT00360685|Acute graft-versus-host disease (aGVHD)|acute graft-versus-host disease (agvhd)
542865|NCT00360685|Engraftment|engraftment
542866|NCT00360685|hemolytic/uremic syndrome (HUS)|hemolytic/uremic syndrome (hus)
542867|NCT00360685|Thrombotic thrombocytopenic purpura (TTP)|thrombotic thrombocytopenic purpura (ttp)
542868|NCT00360711|Moral Distress|moral distress
542869|NCT00360711|Nondirectiveness|nondirectiveness
542870|NCT00360711|Ethical Dilemma|ethical dilemma
542871|NCT00360724|dysthymia|dysthymia
542872|NCT00360724|dysthymic disorder|dysthymic disorder
542873|NCT00360724|chronic depression|chronic depression
542874|NCT00360724|chronic low-grade depression|chronic low-grade depression
542875|NCT00360724|atypical depression|atypical depression
542876|NCT00360724|minor depression|minor depression
542877|NCT00360724|depression NOS|depression nos
542878|NCT00360724|depression|depression
542879|NCT00360724|depressive disorder|depressive disorder
542880|NCT00360724|mood disorder|mood disorder
542881|NCT00360724|unipolar depression|unipolar depression
542882|NCT00360724|low-grade depression|low-grade depression
542883|NCT00360737|Clinical Trials|clinical trials
542884|NCT00360737|Investigational Drug|investigational drug
542885|NCT00360737|Healthy Volunteers|healthy volunteers
542886|NCT00360737|Botulinum Antitoxin|botulinum antitoxin
542887|NCT00360737|Phoenix, Arizona|phoenix, arizona
542888|NCT00360750|intraocular retinoblastoma|intraocular retinoblastoma
542889|NCT00360750|extraocular retinoblastoma|extraocular retinoblastoma
542890|NCT00360789|STROKE REHABILITATION|stroke rehabilitation
542891|NCT00360789|pHYSICAL THERAPY|physical therapy
542892|NCT00360802|chronic low back pain|chronic low back pain
542893|NCT00360802|cognitive-behavioral therapy|cognitive-behavioral therapy
542894|NCT00360802|Mindful Based Stress Reduction|mindful based stress reduction
542895|NCT00360802|pain clinics|pain clinics
542896|NCT00360802|anxiety|anxiety
542897|NCT00360802|quality of life|quality of life
542898|NCT00360802|chronic pain|chronic pain
542899|NCT00360828|Recurrent Anaplastic Astrocytoma|recurrent anaplastic astrocytoma
542900|NCT00360828|Mixed Malignant Glioma|mixed malignant glioma
542901|NCT00360828|Oligodendroglioma|oligodendroglioma
542902|NCT00360828|Irinotecan|irinotecan
542903|NCT00360828|Brain tumor|brain tumor
542904|NCT00360828|Nitrosoureas|nitrosoureas
542905|NCT00360828|Brain and nervous system|brain and nervous system
542906|NCT00360841|auricular|auricular
542907|NCT00360841|acupuncture|acupuncture
542908|NCT00360854|untreated childhood brain stem glioma|untreated childhood brain stem glioma
542909|NCT00360854|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
542910|NCT00360854|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
16148|NCT03187769|Olanzapine|olanzapine
542911|NCT00360854|recurrent childhood ependymoma|recurrent childhood ependymoma
542912|NCT00360854|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
542913|NCT00360854|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
543257|NCT00361725|EPCR|epcr
542914|NCT00360854|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
542915|NCT00360854|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
542916|NCT00360854|childhood choroid plexus tumor|childhood choroid plexus tumor
542917|NCT00360854|childhood craniopharyngioma|childhood craniopharyngioma
542918|NCT00360854|childhood grade I meningioma|childhood grade i meningioma
542919|NCT00360854|childhood grade II meningioma|childhood grade ii meningioma
542920|NCT00360854|childhood grade III meningioma|childhood grade iii meningioma
542921|NCT00360854|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
542922|NCT00360854|childhood infratentorial ependymoma|childhood infratentorial ependymoma
542923|NCT00360854|childhood supratentorial ependymoma|childhood supratentorial ependymoma
542924|NCT00360854|recurrent childhood brain tumor|recurrent childhood brain tumor
542925|NCT00360854|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
542926|NCT00360854|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
542927|NCT00360867|Extension study|extension study
542928|NCT00360867|solid tumors|solid tumors
542929|NCT00360906|RRMS|rrms
542930|NCT00360906|Omega-3|omega-3
542931|NCT00360906|Treatment|treatment
542932|NCT00360919|casomorphin|casomorphin
542933|NCT00360919|cheese|cheese
542934|NCT00360919|craving|craving
542935|NCT00360919|casein|casein
542936|NCT00360919|milk|milk
542937|NCT00360932|facial lipoatrophy|facial lipoatrophy
542938|NCT00360932|HIV/AIDs|hiv/aids
542939|NCT00360945|childhood oligodendroglioma|childhood oligodendroglioma
542940|NCT00360945|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
542941|NCT00360945|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
542942|NCT00360945|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
542943|NCT00360945|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
542944|NCT00360945|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
542945|NCT00360945|recurrent childhood brain tumor|recurrent childhood brain tumor
542946|NCT00360958|ultrafiltration|ultrafiltration
542947|NCT00360958|heart failure|heart failure
542948|NCT00360958|fluid overload|fluid overload
542949|NCT00360971|mucositis|mucositis
542950|NCT00360971|pain|pain
542951|NCT00360971|radiation toxicity|radiation toxicity
542952|NCT00360971|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
542953|NCT00360971|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
542954|NCT00360971|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
542955|NCT00360971|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
542956|NCT00360971|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
542957|NCT00360971|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
542326|NCT00366431|OIC|oic
542958|NCT00360971|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
542959|NCT00360971|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
542960|NCT00360984|CSII|csii
542961|NCT00360984|insulin analog|insulin analog
542962|NCT00360984|severe hypoglycaemia|severe hypoglycaemia
542963|NCT00360984|altered hypoglycaemia awareness|altered hypoglycaemia awareness
542964|NCT00360984|diabetes quality of life|diabetes quality of life
542965|NCT00360984|CGMS|cgms
542966|NCT00360997|Stroke rehabilitation|stroke rehabilitation
542967|NCT00360997|Physical therapy|physical therapy
542968|NCT00361010|Keppra|keppra
542969|NCT00361010|Epilepsy|epilepsy
542970|NCT00361010|Childhood Absence Epilepsy|childhood absence epilepsy
542971|NCT00361010|Seizures|seizures
542972|NCT00361023|Angiotensin type 1 receptor blocker (ARB)|angiotensin type 1 receptor blocker (arb)
542973|NCT00361023|losartan|losartan
542974|NCT00361023|type 2 diabetes|type 2 diabetes
542975|NCT00361023|insulin sensitivity and secretion|insulin sensitivity and secretion
542976|NCT00361023|glucose metabolism|glucose metabolism
542977|NCT00361036|Leiomyoma|leiomyoma
542978|NCT00361036|Leiomyomatosis|leiomyomatosis
542979|NCT00361036|Uterine Neoplasms|uterine neoplasms
542980|NCT00361036|BeadBlock|beadblock
542981|NCT00361036|Embsophere|embsophere
542982|NCT00361036|Embolization|embolization
542983|NCT00361036|Uterine fibroid embolization|uterine fibroid embolization
542984|NCT00361049|graft versus host disease|graft versus host disease
542985|NCT00361049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
542986|NCT00361049|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
543086|NCT00361127|exercise capacity|exercise capacity
542987|NCT00361049|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
585513|NCT00513097|Smoking Prevention|smoking prevention
16149|NCT03187769|Samidorphan|samidorphan
542988|NCT00361049|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
542989|NCT00361049|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
542990|NCT00361049|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
542991|NCT00361049|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
542992|NCT00361049|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
542993|NCT00361049|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
542994|NCT00361049|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
542995|NCT00361049|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
542996|NCT00361049|chronic eosinophilic leukemia|chronic eosinophilic leukemia
542997|NCT00361049|primary myelofibrosis|primary myelofibrosis
542998|NCT00361049|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
542999|NCT00361049|chronic neutrophilic leukemia|chronic neutrophilic leukemia
543000|NCT00361049|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
543001|NCT00361049|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
543002|NCT00361049|disseminated neuroblastoma|disseminated neuroblastoma
543003|NCT00361049|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
543004|NCT00361049|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
543005|NCT00361049|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
543006|NCT00361049|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
543007|NCT00361049|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
543008|NCT00361049|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
543009|NCT00361049|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
543010|NCT00361049|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
543011|NCT00361049|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
543012|NCT00361049|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
543013|NCT00361049|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
543014|NCT00361049|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
543015|NCT00361049|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
543016|NCT00361049|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
543017|NCT00361049|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
543018|NCT00361049|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
543019|NCT00361049|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
543020|NCT00361049|secondary acute myeloid leukemia|secondary acute myeloid leukemia
543021|NCT00361049|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
542400|NCT00366860|soy|soy
543022|NCT00361049|splenic marginal zone lymphoma|splenic marginal zone lymphoma
543023|NCT00361049|stage I multiple myeloma|stage i multiple myeloma
543024|NCT00361049|stage II multiple myeloma|stage ii multiple myeloma
543025|NCT00361049|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
543026|NCT00361049|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
543027|NCT00361049|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
543028|NCT00361049|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
543029|NCT00361049|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
543030|NCT00361049|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
543031|NCT00361049|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
543032|NCT00361049|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
543033|NCT00361049|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
543034|NCT00361049|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
543035|NCT00361049|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
543036|NCT00361049|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
543037|NCT00361049|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
543038|NCT00361049|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
543039|NCT00361049|stage III multiple myeloma|stage iii multiple myeloma
543040|NCT00361049|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
543041|NCT00361049|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
543042|NCT00361049|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
543043|NCT00361049|stage IIIA breast cancer|stage iiia breast cancer
543044|NCT00361049|stage IIIB breast cancer|stage iiib breast cancer
543045|NCT00361049|stage IIIC breast cancer|stage iiic breast cancer
543046|NCT00361049|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
543047|NCT00361049|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
543048|NCT00361049|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
543049|NCT00361049|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
543143|NCT00361374|Boston|boston
543050|NCT00361049|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
543051|NCT00361049|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
543052|NCT00361049|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
543053|NCT00361049|stage IV breast cancer|stage iv breast cancer
543054|NCT00361049|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
543055|NCT00361049|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
543056|NCT00361049|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
543057|NCT00361049|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
543058|NCT00361049|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
543059|NCT00361049|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
543060|NCT00361049|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
543061|NCT00361049|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
543062|NCT00361062|aggressive|aggressive
543063|NCT00361062|SSRI's|ssri's
543064|NCT00361062|simulation|simulation
543065|NCT00361062|behavioral|behavioral
543066|NCT00361062|Side Effects, Psychological|side effects, psychological
543067|NCT00361062|adverse effects|adverse effects
543068|NCT00361062|Serotonin Reuptake Inhibitors|serotonin reuptake inhibitors
543069|NCT00361062|aggressive behavior|aggressive behavior
543070|NCT00361062|computer simulation|computer simulation
543071|NCT00361075|Perimenopause|perimenopause
543072|NCT00361075|Abdominal adipose tissue|abdominal adipose tissue
543073|NCT00361075|Women's health|women's health
543074|NCT00361075|Cholesterol|cholesterol
543075|NCT00361075|Lipid Metabolism|lipid metabolism
543076|NCT00361088|Velcade (PS-341)|velcade (ps-341)
543077|NCT00361088|Bortezomib|bortezomib
543078|NCT00361088|Zarnestra (R115777)|zarnestra (r115777)
543079|NCT00361088|Tipifarnib|tipifarnib
543080|NCT00361101|HIV|hiv
543081|NCT00361101|X4 tropic virus|x4 tropic virus
543082|NCT00361127|Heart failure|heart failure
543083|NCT00361127|pulmonary edema|pulmonary edema
543084|NCT00361127|ACE-inhibitors|ace-inhibitors
543085|NCT00361127|lung diffusion|lung diffusion
543087|NCT00361127|Chronic heart failure|chronic heart failure
543088|NCT00361140|Busulfan|busulfan
543089|NCT00361140|Fludarabine|fludarabine
543090|NCT00361140|Chimerism|chimerism
543091|NCT00361140|Allogeneic stem cell transplantation (HCT)|allogeneic stem cell transplantation (hct)
543092|NCT00361140|Myelodysplastic Syndromes|myelodysplastic syndromes
543093|NCT00361140|Leukemia Myeloproliferative disorders (MPD)|leukemia myeloproliferative disorders (mpd)
543094|NCT00361140|Leukemia, Lymphocytic|leukemia, lymphocytic
543095|NCT00361140|Myeloma|myeloma
543096|NCT00361140|Lymphoma|lymphoma
543097|NCT00361140|AUC|auc
543098|NCT00361140|Hematologic malignancies|hematologic malignancies
543099|NCT00361166|Schizophrenia|schizophrenia
543100|NCT00361166|psychosis|psychosis
543101|NCT00361166|delusions|delusions
700279|NCT00960349|PhI|phi
543102|NCT00361166|hallucination|hallucination
543103|NCT00361179|Observation|observation
543104|NCT00361179|Post-treatment|post-treatment
543105|NCT00361192|temporal arteritis|temporal arteritis
543106|NCT00361192|duplex of temporal artery|duplex of temporal artery
543107|NCT00361192|biopsy of temporal artery|biopsy of temporal artery
543108|NCT00361205|Parkinson's Disease, pharmacology, compliance, dopaminergic|parkinson's disease, pharmacology, compliance, dopaminergic
543109|NCT00361218|depression|depression
543110|NCT00361218|biology|biology
543111|NCT00361231|Avastin|avastin
543112|NCT00361231|GEMOX|gemox
543113|NCT00361244|Sutent|sutent
543114|NCT00361257|Treatment Experienced|treatment experienced
543115|NCT00361270|Biofeedback|biofeedback
543116|NCT00361270|Hypnosis|hypnosis
543117|NCT00361270|Low Back Pain, Recurrent|low back pain, recurrent
543118|NCT00361270|Pain beliefs|pain beliefs
543119|NCT00361270|Pain coping strategies|pain coping strategies
543120|NCT00361270|Pain intensity|pain intensity
543121|NCT00361270|Pain interference|pain interference
543122|NCT00361270|Pain quality|pain quality
543123|NCT00361270|Self-help treatment|self-help treatment
543124|NCT00361270|Sleep dysfunction|sleep dysfunction
543125|NCT00361296|refractory anemia with excess blasts|refractory anemia with excess blasts
543126|NCT00361296|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
543127|NCT00361296|refractory anemia|refractory anemia
543128|NCT00361296|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
543129|NCT00361296|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
543130|NCT00361296|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
543131|NCT00361296|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
543132|NCT00361309|liver cancer|liver cancer
543133|NCT00361309|HCC|hcc
543134|NCT00361335|Rheumatoid arthritis|rheumatoid arthritis
543135|NCT00361335|Golimumab|golimumab
543136|NCT00361335|Methotrexate|methotrexate
543137|NCT00361335|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
543138|NCT00361335|Immunology|immunology
543139|NCT00361348|Palifermin|palifermin
543140|NCT00361348|drug interaction|drug interaction
543141|NCT00361374|Depression|depression
543142|NCT00361374|Omega-3|omega-3
543144|NCT00361387|Sarcoidosis|sarcoidosis
543145|NCT00361387|Sarcoid|sarcoid
543146|NCT00361400|pregnancy|pregnancy
543147|NCT00361400|hormonal contraception|hormonal contraception
543148|NCT00361413|Stem cell transplantation|stem cell transplantation
543149|NCT00361413|GVHD|gvhd
543150|NCT00361413|Graft Versus Host Disease|graft versus host disease
543151|NCT00361426|COPD|copd
543152|NCT00361426|Respiration Rate|respiration rate
543153|NCT00361426|Monitoring|monitoring
543154|NCT00361478|exercise|exercise
543155|NCT00361478|postnatal depression|postnatal depression
543156|NCT00361478|psychological health|psychological health
543157|NCT00361478|well-being|well-being
543158|NCT00361491|Depression|depression
543159|NCT00361491|antidepressive disorders|antidepressive disorders
543160|NCT00361491|controlled clinical trial|controlled clinical trial
543161|NCT00361504|Osteoarthritis|osteoarthritis
543162|NCT00361504|Pain|pain
543163|NCT00361504|Low Back Pain|low back pain
543164|NCT00361504|Hip Pain|hip pain
543165|NCT00361504|Knee Pain|knee pain
543166|NCT00361504|Backache|backache
543167|NCT00361504|Tapentadol|tapentadol
543168|NCT00361517|GM monitoring|gm monitoring
543169|NCT00361517|Immunocompromised|immunocompromised
543170|NCT00361517|hematological disorder|hematological disorder
543171|NCT00361517|Allogenic HSCT recipients|allogenic hsct recipients
543172|NCT00361517|Aspergillus PCR assay|aspergillus pcr assay
543173|NCT00361530|stroke|stroke
543174|NCT00361530|brain ischemia|brain ischemia
543175|NCT00361530|cerebrovascular accident|cerebrovascular accident
543176|NCT00361530|statin|statin
543177|NCT00361530|hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
543178|NCT00361530|cholesterol|cholesterol
543179|NCT00361530|hypercholesterolemia|hypercholesterolemia
543180|NCT00361530|hyperlipidemia|hyperlipidemia
543181|NCT00361530|multicenter studies|multicenter studies
543182|NCT00361530|prospective studies|prospective studies
543183|NCT00361530|endpoint determination|endpoint determination
543184|NCT00361530|randomized controlled trials|randomized controlled trials
543185|NCT00361530|recurrence|recurrence
543186|NCT00361530|pravastatin|pravastatin
543187|NCT00361530|plaque|plaque
543188|NCT00361530|tunica intima|tunica intima
543189|NCT00361530|tunica media|tunica media
543190|NCT00361530|ultrasonography|ultrasonography
543191|NCT00361530|carotid arteries|carotid arteries
543192|NCT00361543|Schizophrenia|schizophrenia
543193|NCT00361543|Mental Illness|mental illness
543194|NCT00361543|SERM|serm
543195|NCT00361543|Raloxifene|raloxifene
543196|NCT00361543|Cognition|cognition
543197|NCT00361556|low back pain|low back pain
543198|NCT00361556|disability|disability
543199|NCT00361556|health education|health education
543200|NCT00361556|primary care|primary care
543201|NCT00361569|vaginal atrophy|vaginal atrophy
543202|NCT00361569|vaginal dryness|vaginal dryness
543203|NCT00361569|vaginal itching|vaginal itching
543204|NCT00361569|vaginal pain|vaginal pain
543205|NCT00361582|Osteoarthritis|osteoarthritis
543206|NCT00361582|tapentadol|tapentadol
543207|NCT00361582|knee-replacement|knee-replacement
543208|NCT00361582|hip replacement|hip replacement
543209|NCT00361582|pain|pain
543210|NCT00361595|osteoporosis|osteoporosis
543211|NCT00361595|zoledronic acid|zoledronic acid
543212|NCT00361595|forteo|forteo
543213|NCT00361608|diabetes|diabetes
543214|NCT00361608|hypoglycemia|hypoglycemia
543215|NCT00361608|monitor|monitor
543216|NCT00361608|children with Type I Diabetes|children with type i diabetes
543217|NCT00361621|VELCADE|velcade
543218|NCT00361634|Etanercept|etanercept
543219|NCT00361634|Enbrel|enbrel
543220|NCT00361634|DCE-MRI|dce-mri
543221|NCT00361634|RA|ra
543222|NCT00361660|Motor skills|motor skills
543223|NCT00361660|Occupational Therapy|occupational therapy
543224|NCT00361660|Physical Therapy Techniques|physical therapy techniques
543225|NCT00361660|Rehabilitation|rehabilitation
543226|NCT00361660|Upper Extremity|upper extremity
543227|NCT00361660|Stroke|stroke
543228|NCT00361673|Health Disparities|health disparities
543229|NCT00361673|Built Environments|built environments
543230|NCT00361686|tramadol|tramadol
543231|NCT00361686|remifentanyl|remifentanyl
543232|NCT00361686|patient controlled analgesia|patient controlled analgesia
543233|NCT00361686|abortion|abortion
543234|NCT00361699|stroke|stroke
543235|NCT00361699|brain ischemia|brain ischemia
543236|NCT00361699|cerebrovascular accident|cerebrovascular accident
543237|NCT00361699|statin|statin
543238|NCT00361699|hydroxymethylglutaryl-CoA reductase inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
543239|NCT00361699|cholesterol|cholesterol
543240|NCT00361699|hypercholesterolemia|hypercholesterolemia
543241|NCT00361699|hyperlipidemia|hyperlipidemia
543242|NCT00361699|multicenter studies|multicenter studies
543243|NCT00361699|prospective studies|prospective studies
543244|NCT00361699|endpoint determination|endpoint determination
543245|NCT00361699|randomized controlled trials|randomized controlled trials
543246|NCT00361699|recurrence|recurrence
543276|NCT00368121|Multiple Myeloma|multiple myeloma
543277|NCT00368121|Cetuximab|cetuximab
543278|NCT00368134|Type 2 Diabetes|type 2 diabetes
543279|NCT00368134|Vildagliptin|vildagliptin
543280|NCT00368134|HbA1c|hba1c
543281|NCT00368147|Hemodialysis|hemodialysis
543282|NCT00368147|Arteriovenous Fistula|arteriovenous fistula
543283|NCT00368147|Arteriovenous Graft|arteriovenous graft
543284|NCT00368147|Left Ventricular Hypertrophy|left ventricular hypertrophy
543285|NCT00368147|Brain Natriuretic Peptide|brain natriuretic peptide
543286|NCT00368160|Next day driving|next day driving
543287|NCT00368199|single photon emission computer tomography (SPECT)|single photon emission computer tomography (spect)
543288|NCT00368199|transcranial sonography|transcranial sonography
543289|NCT00368199|transcranial duplex scanning|transcranial duplex scanning
543290|NCT00368199|parkinson's disease|parkinson's disease
543291|NCT00368199|atypical parkinson syndromes|atypical parkinson syndromes
543292|NCT00368199|parkinsonism|parkinsonism
543293|NCT00368199|parkinsonian|parkinsonian
543294|NCT00368199|diagnostic|diagnostic
543295|NCT00368199|progressive supranuclear paralysis|progressive supranuclear paralysis
543296|NCT00368212|Somatization|somatization
543297|NCT00368212|Refractory Symptoms|refractory symptoms
543298|NCT00368225|Viral Hepatitis|viral hepatitis
543299|NCT00368225|Hepatitis C|hepatitis c
543301|NCT00368225|Liver Transplant|liver transplant
543302|NCT00368225|Renal Transplant|renal transplant
543303|NCT00368225|Kidney Transplant|kidney transplant
543304|NCT00368238|Platelet function tests|platelet function tests
543305|NCT00368238|Erythropoietin|erythropoietin
543306|NCT00368238|Aspirin|aspirin
543307|NCT00368238|Clopidogrel|clopidogrel
543308|NCT00368251|Unverricht-Lundborg Disease|unverricht-lundborg disease
543309|NCT00368251|Baltic Myoclonus|baltic myoclonus
543310|NCT00368251|Progressive Myoclonic Epilepsies|progressive myoclonic epilepsies
543311|NCT00368251|Myoclonus|myoclonus
543312|NCT00368251|Brivaracetam|brivaracetam
543313|NCT00368264|lupus|lupus
543314|NCT00368264|nephritis|nephritis
543315|NCT00368264|membraneous|membraneous
543316|NCT00368264|proteinuria|proteinuria
543318|NCT00368264|infliximab|infliximab
543319|NCT00368264|azathioprine|azathioprine
543320|NCT00368264|autoantibodies|autoantibodies
543321|NCT00368277|Systolic hypertension|systolic hypertension
543322|NCT00368277|hypertension|hypertension
543323|NCT00368277|aliskiren|aliskiren
543324|NCT00368277|blood pressure|blood pressure
543325|NCT00368277|ramipril|ramipril
543326|NCT00368277|HTN|htn
543327|NCT00368290|cocaine dependence|cocaine dependence
543328|NCT00368290|hiv prevention|hiv prevention
543329|NCT00368303|Major Depression|major depression
542709|NCT00360009|GPi|gpi
543330|NCT00368303|paroxetine controlled release (CR)|paroxetine controlled release (cr)
543331|NCT00368303|paroxetine immediate release (IR)|paroxetine immediate release (ir)
543332|NCT00368316|Dysentery|dysentery
543333|NCT00368316|S. sonnei|s. sonnei
543334|NCT00368316|Antibody Response|antibody response
543335|NCT00368316|Protection|protection
543346|NCT00368381|sepsis|sepsis
543347|NCT00368381|septicemia|septicemia
543348|NCT00368381|sepsis syndrome|sepsis syndrome
543349|NCT00368381|adrenal insufficiency|adrenal insufficiency
543350|NCT00368381|adrenal cortex hormones|adrenal cortex hormones
543351|NCT00368381|hydrocortisone|hydrocortisone
543352|NCT00368381|fludrocortisone|fludrocortisone
543353|NCT00368394|Insulin glulisine|insulin glulisine
543354|NCT00368394|Euglycaemic clamp|euglycaemic clamp
543355|NCT00368394|Diabetes mellitus Type 1|diabetes mellitus type 1
543356|NCT00368407|308-nm excimer laser|308-nm excimer laser
543357|NCT00368407|vitiligo|vitiligo
543358|NCT00368420|ovarian cancer|ovarian cancer
543300|NCT00368225|HCV|hcv
543360|NCT00368420|surgery|surgery
543361|NCT00368433|Sensory Processing|sensory processing
543362|NCT00368433|Electromyogram|electromyogram
543363|NCT00368433|Tic Disorder|tic disorder
543364|NCT00368433|Tourette Syndrome|tourette syndrome
543365|NCT00368433|Tourette's Syndrome|tourette's syndrome
543366|NCT00368433|Healthy Volunteer|healthy volunteer
543367|NCT00368433|HV|hv
543368|NCT00368446|Nontuberculous Mycobacterial Infection|nontuberculous mycobacterial infection
543369|NCT00368446|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
543370|NCT00368446|Cystic Fibrosis|cystic fibrosis
543371|NCT00368446|Pseudohypoaldosteronism|pseudohypoaldosteronism
543372|NCT00368446|Chronic Granulomatous Disease|chronic granulomatous disease
543373|NCT00368446|Mycobacterial Infection|mycobacterial infection
543374|NCT00368446|PCD|pcd
543375|NCT00368446|CF|cf
543376|NCT00368446|PHA|pha
543377|NCT00368446|Healthy Volunteer|healthy volunteer
543378|NCT00368446|HV|hv
543379|NCT00369681|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
543380|NCT00369681|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
543381|NCT00369681|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
543382|NCT00369681|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
543383|NCT00369681|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
543384|NCT00369681|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
543385|NCT00369694|Esophageal varices|esophageal varices
543386|NCT00369694|Portal Hypertension|portal hypertension
543387|NCT00369694|Melena|melena
543388|NCT00369694|Hematemesis|hematemesis
543389|NCT00369694|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
543390|NCT00369694|Terlipressin|terlipressin
543391|NCT00369694|Efficacy|efficacy
543392|NCT00369694|Safety|safety
543393|NCT00369707|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
543394|NCT00369720|Prematurity|prematurity
543395|NCT00369720|Resuscitation|resuscitation
543396|NCT00369720|Room Air|room air
543397|NCT00369733|Aranesp|aranesp
543398|NCT00369733|Anemia|anemia
543399|NCT00369733|Kidney Disease|kidney disease
543400|NCT00369733|Hemoglobin|hemoglobin
543401|NCT00369733|darbepoetin alfa|darbepoetin alfa
543402|NCT00369733|QoL|qol
543403|NCT00369746|Depression|depression
543404|NCT00369746|Alcohol Abuse|alcohol abuse
543405|NCT00369746|Alcohol Dependence|alcohol dependence
543406|NCT00369759|Acute Lower Respiratory Infection|acute lower respiratory infection
543407|NCT00369759|Retractions|retractions
543408|NCT00369759|Bronchiolitis or pneumonia|bronchiolitis or pneumonia
543409|NCT00369759|Wheezing|wheezing
543410|NCT00369759|Rales|rales
543411|NCT00369759|Crackles|crackles
543412|NCT00369772|Aranesp|aranesp
543413|NCT00369772|Anemia|anemia
543414|NCT00369772|Kidney Disease|kidney disease
543415|NCT00369772|Hemoglobin|hemoglobin
543416|NCT00369772|darbepoetin alfa|darbepoetin alfa
543417|NCT00369772|QoL|qol
543418|NCT00369785|cognitive/functional effects|cognitive/functional effects
543419|NCT00369785|fatigue|fatigue
543420|NCT00369785|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
543421|NCT00369785|radiation toxicity|radiation toxicity
543422|NCT00369785|tumors metastatic to brain|tumors metastatic to brain
543423|NCT00369785|adult brain stem glioma|adult brain stem glioma
543424|NCT00369785|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
543425|NCT00369785|adult choroid plexus tumor|adult choroid plexus tumor
543426|NCT00369785|adult craniopharyngioma|adult craniopharyngioma
543427|NCT00369785|adult mixed glioma|adult mixed glioma
543428|NCT00369785|adult anaplastic meningioma|adult anaplastic meningioma
543429|NCT00369785|meningeal melanocytoma|meningeal melanocytoma
543430|NCT00369785|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
543431|NCT00369785|adult grade I meningioma|adult grade i meningioma
543432|NCT00369785|adult grade II meningioma|adult grade ii meningioma
543433|NCT00369785|adult grade III meningioma|adult grade iii meningioma
543434|NCT00369785|adult papillary meningioma|adult papillary meningioma
543435|NCT00369785|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
543436|NCT00369785|adult oligodendroglioma|adult oligodendroglioma
543437|NCT00369785|adult pineoblastoma|adult pineoblastoma
543438|NCT00369785|adult pineocytoma|adult pineocytoma
543439|NCT00369785|adult anaplastic astrocytoma|adult anaplastic astrocytoma
543440|NCT00369785|adult diffuse astrocytoma|adult diffuse astrocytoma
543441|NCT00369785|adult glioblastoma|adult glioblastoma
543442|NCT00369785|adult giant cell glioblastoma|adult giant cell glioblastoma
543443|NCT00369785|adult gliosarcoma|adult gliosarcoma
543444|NCT00369785|adult pilocytic astrocytoma|adult pilocytic astrocytoma
543445|NCT00369785|adult ependymoblastoma|adult ependymoblastoma
543446|NCT00369785|adult medulloblastoma|adult medulloblastoma
543447|NCT00369785|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
543448|NCT00369785|adult anaplastic ependymoma|adult anaplastic ependymoma
543449|NCT00369785|adult ependymoma|adult ependymoma
543450|NCT00369785|adult myxopapillary ependymoma|adult myxopapillary ependymoma
543451|NCT00369785|adult subependymoma|adult subependymoma
543452|NCT00369798|Unipolar Depression|unipolar depression
543453|NCT00369798|Phosphorylation|phosphorylation
543454|NCT00369798|Affinity States|affinity states
543455|NCT00369798|Compartment Analysis|compartment analysis
543456|NCT00369798|(R)-(11)C Rolipram|(r)-(11)c rolipram
543457|NCT00369798|Depression|depression
543458|NCT00369798|Major Depressive Disorder|major depressive disorder
543459|NCT00369798|MDD|mdd
543460|NCT00369798|Healthy Volunteer|healthy volunteer
543461|NCT00369798|HV|hv
543462|NCT00369811|Cholecystectomy, postoperative|cholecystectomy, postoperative
543463|NCT00369824|HPV|hpv
543464|NCT00369824|HPV, diptheria, pertussis, tetanus, meningitis|hpv, diptheria, pertussis, tetanus, meningitis
543465|NCT00369850|osteoporosis|osteoporosis
543466|NCT00369850|stage I breast cancer|stage i breast cancer
543467|NCT00369850|stage II breast cancer|stage ii breast cancer
543468|NCT00369850|stage IIIA breast cancer|stage iiia breast cancer
543469|NCT00369863|Cystoid macular edema|cystoid macular edema
543470|NCT00369863|Diabetic macular edema|diabetic macular edema
543471|NCT00369863|Hard exudates|hard exudates
543472|NCT00369863|Intravitreal triamcinolone|intravitreal triamcinolone
543473|NCT00369863|Macular thickness|macular thickness
543474|NCT00369876|Burns|burns
543475|NCT00369876|Anorexia|anorexia
543476|NCT00369876|Neuropeptide|neuropeptide
543477|NCT00369876|Leptin|leptin
543478|NCT00369876|Adiponectin|adiponectin
543479|NCT00369876|Gherlin|gherlin
543480|NCT00369889|Thymoma|thymoma
543481|NCT00369889|Thymic Cancer|thymic cancer
543482|NCT00369902|pain|pain
543483|NCT00369902|acupuncture|acupuncture
543484|NCT00369915|Cholinergic|cholinergic
543485|NCT00369915|Unipolar|unipolar
543486|NCT00369915|Bipolar|bipolar
543487|NCT00369915|Depression|depression
543488|NCT00369915|Muscarinic|muscarinic
543489|NCT00369915|Scopolamine|scopolamine
543490|NCT00369915|Major Depressive Disorder|major depressive disorder
543491|NCT00369915|MDD|mdd
543492|NCT00369915|Bipolar Disorder|bipolar disorder
543493|NCT00369915|BP|bp
543494|NCT00369954|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
543495|NCT00369954|fallopian tube cancer|fallopian tube cancer
543496|NCT00369954|peritoneal cavity cancer|peritoneal cavity cancer
543497|NCT00369967|Contraception|contraception
543498|NCT00369967|Adolescents|adolescents
543499|NCT00369967|Contraceptive vaginal ring|contraceptive vaginal ring
543500|NCT00369967|Quick start|quick start
543501|NCT00369993|asthma|asthma
543502|NCT00369993|spacer|spacer
543503|NCT00370006|cytomegalovirus|cytomegalovirus
543504|NCT00370006|vaccine|vaccine
543505|NCT00370006|T cell|t cell
543506|NCT00370006|antibodies|antibodies
543507|NCT00370019|Premature Ovarian Failure|premature ovarian failure
543508|NCT00370019|Ovulation|ovulation
543509|NCT00370019|Fertility|fertility
543510|NCT00370019|Estrogen Replacement|estrogen replacement
543511|NCT00370019|Follicle Function|follicle function
543512|NCT00370019|Premature Menopause|premature menopause
543513|NCT00370019|POF|pof
543514|NCT00370032|mucosal blood flow d-IBS|mucosal blood flow d-ibs
543515|NCT00370058|ect|ect
543516|NCT00370058|depression|depression
543517|NCT00370058|homocysteine|homocysteine
543518|NCT00370058|mthfr genotype|mthfr genotype
543519|NCT00370071|MS|ms
543520|NCT00370097|Asthma infants FLOVENT spacer|asthma infants flovent spacer
543521|NCT00370123|endometriosis|endometriosis
543522|NCT00370123|apoptosis|apoptosis
543523|NCT00370123|regulatory T cells|regulatory t cells
543524|NCT00370188|problem gambling|problem gambling
543525|NCT00370188|topiramate|topiramate
543526|NCT00370201|retinal detachment|retinal detachment
543527|NCT00370201|proliferative vitreoretinopathy|proliferative vitreoretinopathy
543528|NCT00370214|Pulmonary arterial hypertension|pulmonary arterial hypertension
543529|NCT00370214|Lung diseases|lung diseases
543530|NCT00370214|Heart diseases|heart diseases
543531|NCT00370214|Pulmonary circulation|pulmonary circulation
543532|NCT00370214|Vascular resistance|vascular resistance
543533|NCT00370214|PAH|pah
543534|NCT00370214|Hypertension|hypertension
543535|NCT00370227|Streptococcus pneumonia, pneumococcal conjugate vaccine|streptococcus pneumonia, pneumococcal conjugate vaccine
543536|NCT00370240|Female|female
543537|NCT00370240|Anesthetics,local|anesthetics,local
543538|NCT00370253|hepatorenal syndrome|hepatorenal syndrome
543539|NCT00370253|ascites|ascites
543540|NCT00370253|portal hypertension|portal hypertension
543541|NCT00370253|cirrhosis|cirrhosis
543542|NCT00370266|Macular edema|macular edema
543543|NCT00370266|Branch retinal vein occlusion|branch retinal vein occlusion
543544|NCT00370266|Intravitreal triamcinolone|intravitreal triamcinolone
543545|NCT00370266|Macular thickness|macular thickness
543546|NCT00370266|Retinal neovascularization|retinal neovascularization
543547|NCT00370279|Pseudophakic retinal detachment,|pseudophakic retinal detachment,
543548|NCT00370279|Aphakic retinal detachment,|aphakic retinal detachment,
543549|NCT00370279|Scleral buckling,|scleral buckling,
543550|NCT00370279|Primary vitrectomy,|primary vitrectomy,
543551|NCT00370279|Proliferative vitreoretinopathy|proliferative vitreoretinopathy
543552|NCT00370305|11ß-hydroxysteroid dehydrogenase|11ß-hydroxysteroid dehydrogenase
543554|NCT00370305|insulin sensitivity|insulin sensitivity
543555|NCT00370305|Impaired glucose tolerance|impaired glucose tolerance
543556|NCT00370318|Pneumococcal Disease|pneumococcal disease
543557|NCT00370331|ITP|itp
543558|NCT00370331|idiopathic|idiopathic
543559|NCT00370331|platelets|platelets
543560|NCT00370331|purpura|purpura
543561|NCT00370331|thrombocytopenia|thrombocytopenia
543562|NCT00370331|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
543563|NCT00370331|thrombocytopenic|thrombocytopenic
543564|NCT00370344|Gallbladder diseases|gallbladder diseases
543565|NCT00370344|gallstones|gallstones
543566|NCT00370344|cholecystectomy|cholecystectomy
543567|NCT00370344|minilaparotomy|minilaparotomy
543568|NCT00370344|laparoscopy|laparoscopy
543569|NCT00370357|Microbicide|microbicide
543570|NCT00370357|SPL7013|spl7013
543571|NCT00370357|VivaGel|vivagel
543572|NCT00370370|Bevacizumab,|bevacizumab,
543573|NCT00370370|Triamcinolone|triamcinolone
543574|NCT00370370|Age-related macular degeneration|age-related macular degeneration
543575|NCT00370370|Choroidal neovascular membrane|choroidal neovascular membrane
543576|NCT00370383|Non Small Cell Lung Cancer|non small cell lung cancer
543577|NCT00370383|PATIENTS ≥ 70 YEARS WITH UNRESECTABLE STAGE 3 OR 4 NSCLC|patients ≥ 70 years with unresectable stage 3 or 4 nsclc
543578|NCT00370396|Streptococcus pneumonia, pneumococcal conjugate vaccine|streptococcus pneumonia, pneumococcal conjugate vaccine
543579|NCT00370409|Rebleeding|rebleeding
543580|NCT00370409|Diabetic vitreous hemorrhage|diabetic vitreous hemorrhage
543581|NCT00370409|Cryotherapy|cryotherapy
543582|NCT00370422|Cystoid macular edema|cystoid macular edema
543583|NCT00370422|Diabetic macular edema|diabetic macular edema
543584|NCT00370422|Hard exudates|hard exudates
543585|NCT00370422|Intravitreal bevacizumab|intravitreal bevacizumab
543586|NCT00370422|Intravitreal triamcinolone|intravitreal triamcinolone
543587|NCT00370422|Macular thickness|macular thickness
543588|NCT00370435|rheumatoid arthritis|rheumatoid arthritis
543589|NCT00370435|safety|safety
543590|NCT00370435|GW274150|gw274150
543591|NCT00370435|pharmacokinetics|pharmacokinetics
543592|NCT00370435|tolerability|tolerability
543593|NCT00370461|Basic Cardiac Life Support|basic cardiac life support
543594|NCT00370461|Termination of Resuscitation|termination of resuscitation
543595|NCT00370461|Emergency Medical Services|emergency medical services
543596|NCT00370461|Primary Care Paramedics|primary care paramedics
543597|NCT00370461|Out of Hospital Cardiac Arrest|out of hospital cardiac arrest
543598|NCT00370474|Bi-V lead|bi-v lead
543599|NCT00370474|Magnetic Navigation|magnetic navigation
543600|NCT00370474|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
543601|NCT00370487|Abortion|abortion
543602|NCT00370487|Midlevel providers|midlevel providers
543603|NCT00370487|South Africa|south africa
543604|NCT00370487|Viet Nam|viet nam
543605|NCT00370500|Schizophrenia|schizophrenia
543606|NCT00370500|Dopamine transporter gene|dopamine transporter gene
543607|NCT00370500|DNA methylation|dna methylation
543608|NCT00370500|Epigenetics|epigenetics
543609|NCT00370513|liver cancer|liver cancer
543610|NCT00370513|pazopanib|pazopanib
543611|NCT00370513|hepatocellular cancer|hepatocellular cancer
543612|NCT00370526|heart failure|heart failure
543613|NCT00370526|resynchronization|resynchronization
543615|NCT00370526|Bi-V pacemaker|bi-v pacemaker
543616|NCT00370526|LV lead placement|lv lead placement
543617|NCT00370526|hemodynamic assessment|hemodynamic assessment
543618|NCT00370526|CRT Outcomes|crt outcomes
543619|NCT00370539|Photodynamic therapy,|photodynamic therapy,
543620|NCT00370539|Bevacizumab,|bevacizumab,
543621|NCT00370539|Triamcinolone,|triamcinolone,
543622|NCT00370539|Age-related macular degeneration,|age-related macular degeneration,
543623|NCT00370539|Choroidal neovascular membrane|choroidal neovascular membrane
543624|NCT00370578|STEMI, THROMBUS, ASPIRATION DEVICE, NO REFLOW|stemi, thrombus, aspiration device, no reflow
543625|NCT00370591|Inhaled corticosteroids|inhaled corticosteroids
543626|NCT00370591|Asthma|asthma
543627|NCT00370604|Parturient|parturient
543628|NCT00370604|Obstetrics|obstetrics
543629|NCT00370604|Pregnancy|pregnancy
543630|NCT00370604|Labour|labour
543631|NCT00370604|Labor|labor
543632|NCT00370604|Headache|headache
543633|NCT00370604|Epidural|epidural
543634|NCT00370604|Analgesia|analgesia
543635|NCT00370604|Anesthesia|anesthesia
543636|NCT00370604|Anaesthesia|anaesthesia
543637|NCT00370617|chronic hepatitis C|chronic hepatitis c
543638|NCT00370617|insulin resistance|insulin resistance
543639|NCT00370617|therapy|therapy
543640|NCT00370630|CRVO|crvo
543641|NCT00370630|Intravitreal Avastin|intravitreal avastin
543642|NCT00370630|Intravitreal triamcinolone|intravitreal triamcinolone
543643|NCT00370643|hyperglycaemia|hyperglycaemia
543644|NCT00370643|open heart surgery|open heart surgery
543645|NCT00370643|intensive care unit|intensive care unit
543646|NCT00370656|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
543647|NCT00370669|Bevacizumab|bevacizumab
543648|NCT00370669|CSME|csme
543650|NCT00370669|Triamcinolone acetonide|triamcinolone acetonide
543651|NCT00370695|Chronic back pain|chronic back pain
543652|NCT00370695|Intractable neuropathic back pain|intractable neuropathic back pain
543653|NCT00370695|Lumbar radiculopathy|lumbar radiculopathy
543654|NCT00370695|Spinal cord stimulation|spinal cord stimulation
543655|NCT00370708|Cesarean|cesarean
543656|NCT00370708|Oral|oral
543657|NCT00370708|Intake|intake
543658|NCT00370721|Proliferative diabetic retinopathy(PDR)|proliferative diabetic retinopathy(pdr)
543659|NCT00370721|Pan retinal photocoagulation (PRP)|pan retinal photocoagulation (prp)
543660|NCT00370721|Vitreous hemorrhage|vitreous hemorrhage
543661|NCT00370721|Traction retinal detachment|traction retinal detachment
543662|NCT00370721|Neovascularization on disc (NVD)|neovascularization on disc (nvd)
543663|NCT00370721|Neovascularization elsewhere (NVE)|neovascularization elsewhere (nve)
543664|NCT00370721|Fibrous proliferation on disc (FPD)|fibrous proliferation on disc (fpd)
543665|NCT00370721|Fibrous proliferaiton elsewhere (FPE)|fibrous proliferaiton elsewhere (fpe)
543666|NCT00370734|botulinum toxin|botulinum toxin
543667|NCT00370734|thyroid eye disease|thyroid eye disease
543668|NCT00370734|lid retraction|lid retraction
543670|NCT00370760|Oral colchicine|oral colchicine
543671|NCT00370760|Dexamethasone|dexamethasone
543672|NCT00370760|low molecular weight heparin|low molecular weight heparin
543673|NCT00370760|5-FU|5-fu
543674|NCT00370773|Failed Back Surgery Syndrome|failed back surgery syndrome
543675|NCT00370773|Back Pain|back pain
543676|NCT00370773|Chronic Pain|chronic pain
543677|NCT00370773|Spinal Cord Stimulation|spinal cord stimulation
543678|NCT00370786|Choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
543679|NCT00370786|Bevacizumab|bevacizumab
543680|NCT00370786|Non AMD|non amd
543681|NCT00370786|High myopia|high myopia
543682|NCT00370786|angioid streaks|angioid streaks
543683|NCT00370786|Ocular histoplasmosis|ocular histoplasmosis
543684|NCT00370786|Idiopathic|idiopathic
543685|NCT00370799|Caudal Epidural injections|caudal epidural injections
543686|NCT00370799|lumbar disc herniation|lumbar disc herniation
543687|NCT00370799|spinal stenosis|spinal stenosis
543688|NCT00370799|discogenic pain|discogenic pain
543689|NCT00370799|post-lumbar laminectomy syndrome|post-lumbar laminectomy syndrome
543690|NCT00370812|amniotic membrane transplantation|amniotic membrane transplantation
543691|NCT00370812|ocular chemical burns|ocular chemical burns
543692|NCT00370825|Visceral leishmaniasis|visceral leishmaniasis
543693|NCT00370825|miltefosine|miltefosine
543694|NCT00370825|AmBisome|ambisome
543695|NCT00370825|Combination|combination
543696|NCT00370838|Tics|tics
543697|NCT00370838|Tourette syndrome|tourette syndrome
543698|NCT00370838|levetiracetam|levetiracetam
543699|NCT00370838|clonidine|clonidine
543700|NCT00370851|intravitreal Avastin|intravitreal avastin
543701|NCT00370851|BRVO|brvo
543702|NCT00370851|Macular edema|macular edema
543703|NCT00370864|Pandemic|pandemic
543704|NCT00370864|Influenza|influenza
543705|NCT00370864|Prevention|prevention
543706|NCT00370864|Vaccine|vaccine
543707|NCT00370864|Prevention of Pandemic Influenza|prevention of pandemic influenza
543708|NCT00370877|Post-partum hemorrhage|post-partum hemorrhage
543709|NCT00370877|Arterial embolization|arterial embolization
543710|NCT00370877|Surgery|surgery
543711|NCT00370877|Hysterectomy|hysterectomy
543712|NCT00370877|Activated recombinant human factor VII|activated recombinant human factor vii
543713|NCT00370890|nasopharyngeal cancer|nasopharyngeal cancer
543714|NCT00370890|adjuvant chemotherapy|adjuvant chemotherapy
543715|NCT00370890|EBV DNA|ebv dna
543716|NCT00370890|PET CT scan|pet ct scan
543717|NCT00370903|cesarean|cesarean
543718|NCT00370903|planned|planned
543719|NCT00370903|emergent|emergent
543720|NCT00370903|postpartum depression|postpartum depression
543721|NCT00370916|Clinical Decision Support Systems|clinical decision support systems
543722|NCT00370916|Continuity of Patient Care|continuity of patient care
543723|NCT00370916|Medication Errors|medication errors
543724|NCT00370916|Drug Adverse Effects|drug adverse effects
543725|NCT00370942|GW823093C|gw823093c
543726|NCT00370942|diabetes|diabetes
543727|NCT00370942|type 2 diabetes mellitus|type 2 diabetes mellitus
543728|NCT00370942|DPP-IV inhibitor|dpp-iv inhibitor
543729|NCT00370955|Phacoemulsification|phacoemulsification
543730|NCT00370955|Corneal endothelial cell loss|corneal endothelial cell loss
543731|NCT00370955|Hydrodynamic parameters|hydrodynamic parameters
543732|NCT00370955|Total ultrasound energy|total ultrasound energy
543733|NCT00370955|Total infused fluids|total infused fluids
543734|NCT00370968|Children|children
543735|NCT00370968|India|india
543736|NCT00370968|Hospital|hospital
543737|NCT00370968|Zinc|zinc
543738|NCT00370968|Malnutrition|malnutrition
543739|NCT00370968|Treatment|treatment
543740|NCT00370981|investigational drug|investigational drug
543741|NCT00370981|ejaculation|ejaculation
543742|NCT00370994|post-lumbar surgery syndrome|post-lumbar surgery syndrome
543743|NCT00370994|percutaneous lumbar epidural adhesiolysis|percutaneous lumbar epidural adhesiolysis
543744|NCT00370994|hypertonic saline neurolysis|hypertonic saline neurolysis
543745|NCT00371020|silicone oil|silicone oil
543746|NCT00371020|PVR|pvr
543747|NCT00371020|retinal redetachment|retinal redetachment
543748|NCT00371020|low molecular weight heparin|low molecular weight heparin
543750|NCT00371046|preterm labor|preterm labor
543751|NCT00371046|transvaginal ultrasound cervical length|transvaginal ultrasound cervical length
543752|NCT00371046|fetal fibronectin|fetal fibronectin
543754|NCT00371059|Agitation|agitation
543755|NCT00371059|Dementia|dementia
543756|NCT00371059|Alzheimer's|alzheimer's
543757|NCT00371072|Aphakic Glaucoma|aphakic glaucoma
543758|NCT00371072|trabeculectomy with mitomycin- C|trabeculectomy with mitomycin- c
543759|NCT00371072|Ahmed glaucoma implant|ahmed glaucoma implant
543760|NCT00371085|heart failure|heart failure
543761|NCT00371085|quality improvement|quality improvement
543762|NCT00371085|patient education|patient education
543763|NCT00371085|health care economics|health care economics
543764|NCT00371098|influenza vaccination|influenza vaccination
543765|NCT00371098|coronary artery disease|coronary artery disease
543766|NCT00371098|prevention|prevention
543767|NCT00371098|acute coronary syndromes|acute coronary syndromes
543768|NCT00371111|Resistant uveitic cystoid macular edema|resistant uveitic cystoid macular edema
543769|NCT00371111|intravitreal triamcinolone|intravitreal triamcinolone
543770|NCT00371111|intravitreal bevacizumab|intravitreal bevacizumab
543771|NCT00371124|Myopia treatment|myopia treatment
543772|NCT00371124|Atropine|atropine
543773|NCT00371137|FMS|fms
543774|NCT00371137|Fibro|fibro
543775|NCT00371137|pain|pain
543776|NCT00371137|Body pain|body pain
543777|NCT00371137|tenderness|tenderness
543778|NCT00371137|joint pain|joint pain
543779|NCT00371137|stiffness|stiffness
543780|NCT00371137|muscular pain|muscular pain
544313|NCT00365430|Hospital|hospital
543781|NCT00371163|Identification of genes by microarray analyses.|identification of genes by microarray analyses.
543782|NCT00371176|Cognitive Behavior Therapy|cognitive behavior therapy
543783|NCT00371176|Cognitive enhancers|cognitive enhancers
543784|NCT00371176|Combat Disorders|combat disorders
543785|NCT00371176|D-Cycloserine|d-cycloserine
543786|NCT00371176|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
543787|NCT00371189|circumsporozoite, malaria, vaccine|circumsporozoite, malaria, vaccine
543788|NCT00371202|keratoconus, penetrating keratoplasty,|keratoconus, penetrating keratoplasty,
543789|NCT00371202|deep lamellar keratoplasty|deep lamellar keratoplasty
543790|NCT00371202|big bubble technique|big bubble technique
543791|NCT00371215|hemostasis|hemostasis
543792|NCT00371215|grafting, skin|grafting, skin
543793|NCT00371215|hemostatics|hemostatics
543794|NCT00371215|phase 2|phase 2
543795|NCT00371228|cord clamping|cord clamping
543796|NCT00371228|hematocrit|hematocrit
543797|NCT00371228|hemoglobin|hemoglobin
543798|NCT00371228|timing|timing
543799|NCT00371241|ECMO|ecmo
543800|NCT00371241|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
543801|NCT00371241|cytokines|cytokines
543802|NCT00371241|chemokines|chemokines
543803|NCT00371254|Recurrent, locally-advanced, or 'triple negative' metastatic breast cancer|recurrent, locally-advanced, or 'triple negative' metastatic breast cancer
543804|NCT00371267|cognitive behavioral therapy|cognitive behavioral therapy
543805|NCT00371267|pain|pain
543806|NCT00371280|hydroxyapatite|hydroxyapatite
543807|NCT00371280|peg|peg
543808|NCT00371280|prosthetic motility|prosthetic motility
543809|NCT00371280|orbital implant|orbital implant
543810|NCT00371293|Sleep Apnea|sleep apnea
543811|NCT00371293|C-Reactive Protein|c-reactive protein
543812|NCT00371293|Obesity|obesity
543813|NCT00371293|Insulin Resistance|insulin resistance
543814|NCT00371293|Arterial stiffness|arterial stiffness
543815|NCT00371306|Diabetes|diabetes
543816|NCT00371306|Pregnancy|pregnancy
543817|NCT00371319|lupus|lupus
543818|NCT00371319|nephritis|nephritis
543819|NCT00371319|tacrolimus|tacrolimus
543820|NCT00371319|mycophenolate mofetil|mycophenolate mofetil
543821|NCT00371332|chronic periodontitis, mouth|chronic periodontitis, mouth
543822|NCT00371332|Moderate to advanced chronic periodontitis|moderate to advanced chronic periodontitis
701133|NCT00971971|ICU|icu
543823|NCT00371345|Recurrent, locally-advanced, or metastatic breast cancer|recurrent, locally-advanced, or metastatic breast cancer
543824|NCT00371371|clinical trial|clinical trial
543825|NCT00371371|chronic critical limb ischemia|chronic critical limb ischemia
543826|NCT00371371|leg pain|leg pain
543827|NCT00371371|cell therapy|cell therapy
543828|NCT00371371|bone marrow|bone marrow
543829|NCT00371371|mononuclear|mononuclear
543830|NCT00371371|progenitor cell|progenitor cell
543831|NCT00371371|stem cell|stem cell
543832|NCT00371371|critical limb ischemia|critical limb ischemia
543833|NCT00371371|nonhealing leg ulcer|nonhealing leg ulcer
543834|NCT00371384|massage|massage
543835|NCT00371384|back pain|back pain
543836|NCT00371384|effectiveness|effectiveness
543837|NCT00371397|yoga|yoga
543838|NCT00371397|immune function|immune function
543839|NCT00371397|stress|stress
543840|NCT00371397|health|health
543841|NCT00371397|mood|mood
543842|NCT00371397|skin barrier repair|skin barrier repair
543843|NCT00371410|Vitrectomy|vitrectomy
543941|NCT00371878|Bronchoalveolar lavage|bronchoalveolar lavage
543844|NCT00371410|Intravitreal triamcinolone acetonide|intravitreal triamcinolone acetonide
543845|NCT00371410|Macular focal laser photocoagulation|macular focal laser photocoagulation
543846|NCT00371410|Best-corrected visual acuity|best-corrected visual acuity
543847|NCT00371410|Central macular thickness|central macular thickness
543848|NCT00371436|Counseling|counseling
543849|NCT00371436|Education|education
543850|NCT00371436|Evaluation studies|evaluation studies
543851|NCT00371436|Quality of health care|quality of health care
543852|NCT00371436|Rehabilitation of hearing impaired|rehabilitation of hearing impaired
543853|NCT00371436|Triage|triage
543854|NCT00371449|hearing loss|hearing loss
543855|NCT00371449|hearing aids|hearing aids
543856|NCT00371462|intervention study|intervention study
543857|NCT00371462|technology|technology
543858|NCT00371462|weight loss|weight loss
543859|NCT00371488|ErbB2|erbb2
543860|NCT00371488|Stage IV breast cancer|stage iv breast cancer
543861|NCT00371488|ErbB1|erbb1
543862|NCT00371488|breast cancer|breast cancer
543863|NCT00371488|lapatinib|lapatinib
543864|NCT00371488|Herceptin|herceptin
543865|NCT00371488|trastuzumab|trastuzumab
543866|NCT00371501|lupus|lupus
543867|NCT00371501|atherosclerosis|atherosclerosis
543868|NCT00371501|thrombosis|thrombosis
543869|NCT00371501|statin|statin
543870|NCT00371501|lipid|lipid
543871|NCT00371527|Bronchitis|bronchitis
543872|NCT00371527|Acute bronchitis|acute bronchitis
543873|NCT00371527|Ipratropium|ipratropium
543874|NCT00371527|Cough|cough
543875|NCT00371527|Metered dose inhaler|metered dose inhaler
543876|NCT00371527|Antibiotic prescriptions|antibiotic prescriptions
543877|NCT00371527|Sputum production|sputum production
543878|NCT00371540|Africa|africa
543879|NCT00371540|Antiretrovirals|antiretrovirals
543880|NCT00371553|relapsed or cisplatin-refractory germ cell cancer|relapsed or cisplatin-refractory germ cell cancer
543881|NCT00371553|germ cell cancer|germ cell cancer
543882|NCT00371553|SU011248 (Sunitinib)|su011248 (sunitinib)
543883|NCT00371566|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
543884|NCT00371566|lapatinib|lapatinib
543885|NCT00371566|ErbB1/ErbB2 inhibitor|erbb1/erbb2 inhibitor
543886|NCT00371566|apoptosis|apoptosis
543887|NCT00371579|rosuvastatin|rosuvastatin
543888|NCT00371579|hepatitis C|hepatitis c
543889|NCT00371579|geranylgeranylation|geranylgeranylation
543890|NCT00371579|HCV-RNA load|hcv-rna load
543891|NCT00371592|Treatment Naive|treatment naive
543892|NCT00371605|Voriconazole|voriconazole
543893|NCT00371605|Liver Transplant|liver transplant
543894|NCT00371605|Fungal Infection|fungal infection
543895|NCT00371618|Fluoroscopy|fluoroscopy
543896|NCT00371618|Interventional Pain Management Procedures|interventional pain management procedures
543897|NCT00371631|biofilm|biofilm
543898|NCT00371631|clinical trial|clinical trial
543899|NCT00371631|Escherichia coli|escherichia coli
543900|NCT00371631|urinary catheter|urinary catheter
543901|NCT00371644|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
543902|NCT00371644|Cognitive Processing Therapy|cognitive processing therapy
543903|NCT00371644|Military sexual trauma|military sexual trauma
543904|NCT00371644|Psychology, Military|psychology, military
543905|NCT00371644|Veterans|veterans
543906|NCT00371644|Rape|rape
543907|NCT00371644|Veterans, psychology|veterans, psychology
543908|NCT00371644|Healthcare utilization|healthcare utilization
543909|NCT00371657|obesity|obesity
543910|NCT00371657|small for gestation age|small for gestation age
543911|NCT00371657|intrauterine growth restriction|intrauterine growth restriction
543912|NCT00371670|Knee, osteoarthritis, pain, disease modifying|knee, osteoarthritis, pain, disease modifying
543913|NCT00371683|Prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery|prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery
543914|NCT00371722|Cesarean section|cesarean section
543915|NCT00371722|Appendectomy|appendectomy
543916|NCT00371735|Malaria CDA LAPDAP Africa|malaria cda lapdap africa
543917|NCT00371761|Hepatitis B virus|hepatitis b virus
543918|NCT00371761|Pegylated interferon alfa-2b (PegIntron)|pegylated interferon alfa-2b (pegintron)
543919|NCT00371774|Psoriasis|psoriasis
543920|NCT00371774|Plaque Psoriasis|plaque psoriasis
543921|NCT00371774|Amevive®|amevive®
543922|NCT00371774|alefacept|alefacept
543923|NCT00371800|Cinnamon|cinnamon
543924|NCT00371800|Type 1 Diabetes|type 1 diabetes
543925|NCT00371800|Adolescent|adolescent
543926|NCT00371800|HbA1c|hba1c
543927|NCT00371826|Renal transplantation|renal transplantation
543928|NCT00371826|everolimus|everolimus
543929|NCT00371826|Immunosuppressants|immunosuppressants
543930|NCT00371839|Hearing Loss|hearing loss
543931|NCT00371839|Hearing Aids|hearing aids
543932|NCT00371839|Rehabilitation of hearing impaired|rehabilitation of hearing impaired
543933|NCT00371865|Behavior therapy|behavior therapy
543934|NCT00371865|Chronic pain|chronic pain
543935|NCT00371865|Cognitive therapy|cognitive therapy
543936|NCT00371865|Meditation|meditation
543937|NCT00371865|Mindfulness|mindfulness
543938|NCT00371865|Psychotherapy|psychotherapy
543939|NCT00371878|Vaccine|vaccine
543940|NCT00371878|Lung|lung
543942|NCT00371878|Lymphocyte|lymphocyte
543943|NCT00371878|Immunoglobulin|immunoglobulin
543945|NCT00371878|Streptococcus pneumoniae|streptococcus pneumoniae
543947|NCT00371904|Rituximab|rituximab
543949|NCT00371904|sensitised|sensitised
543950|NCT00371904|antibody|antibody
543951|NCT00371904|rejection|rejection
543952|NCT00371943|variceal bleeding,band ligation, beta-blocker|variceal bleeding,band ligation, beta-blocker
543953|NCT00371943|had history of esophageal variceal bleeding|had history of esophageal variceal bleeding
543954|NCT00371956|raloxifene|raloxifene
543955|NCT00371956|estrogen|estrogen
543956|NCT00371956|receptor|receptor
543957|NCT00371956|modulation|modulation
543958|NCT00371956|osteoporosis|osteoporosis
543959|NCT00371956|steroid|steroid
543960|NCT00371956|Steroids|steroids
543961|NCT00371969|Unsafe drinking|unsafe drinking
543962|NCT00371969|Human Immunodeficiency Virus|human immunodeficiency virus
543963|NCT00371969|Motivational Interviewing|motivational interviewing
543964|NCT00371982|Fish oil|fish oil
543965|NCT00371982|Type 2 diabetic women|type 2 diabetic women
543966|NCT00371982|adiposity|adiposity
543967|NCT00371982|adipose tissue inflammation|adipose tissue inflammation
543968|NCT00371982|PAI-1|pai-1
543969|NCT00371982|Insulin sensitivity|insulin sensitivity
543970|NCT00371995|Visceral leishmaniasis|visceral leishmaniasis
543971|NCT00371995|kala-azar|kala-azar
543972|NCT00371995|miltefosine|miltefosine
543973|NCT00371995|AmBisome|ambisome
543974|NCT00372021|non arthritic ischemic optic neuropathy|non arthritic ischemic optic neuropathy
543975|NCT00372021|anterior ischemic optic neuropathy|anterior ischemic optic neuropathy
543976|NCT00372021|Optic nerve Neurotomy|optic nerve neurotomy
543977|NCT00372034|contact lenses|contact lenses
543978|NCT00372034|intolerance|intolerance
543979|NCT00372034|punctal plugs|punctal plugs
543980|NCT00372034|tear volume|tear volume
543981|NCT00372034|Intolerance to contact lens wear due to dryness symptoms|intolerance to contact lens wear due to dryness symptoms
543982|NCT00372099|Postmenopausal women|postmenopausal women
543983|NCT00372099|bone microarchitecture|bone microarchitecture
543984|NCT00372099|peripheral quantitative micro-CT|peripheral quantitative micro-ct
543985|NCT00372099|salmon calcitonin|salmon calcitonin
543986|NCT00372112|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
543987|NCT00372112|COPD|copd
543988|NCT00372125|Prader-Willi syndrome|prader-willi syndrome
543989|NCT00372125|Growth hormone|growth hormone
543990|NCT00372125|Body composition|body composition
543991|NCT00372138|Abdominal aortic aneurysms|abdominal aortic aneurysms
543992|NCT00372138|Endoleaks|endoleaks
543993|NCT00372138|Prevention|prevention
543994|NCT00372151|Schizophrenia|schizophrenia
543995|NCT00372151|Schizoaffective disorders|schizoaffective disorders
543996|NCT00372151|Theonine|theonine
543997|NCT00372151|Augmentation|augmentation
543998|NCT00372164|ASIPP|asipp
543999|NCT00372164|Guidelines|guidelines
544000|NCT00372177|monoclonal antibody|monoclonal antibody
544001|NCT00372177|diagnostics|diagnostics
544002|NCT00372177|RA|ra
544003|NCT00372177|Immunoglobulins|immunoglobulins
544004|NCT00372177|molecular target|molecular target
544005|NCT00372177|Tc99m-pertechnetate|tc99m-pertechnetate
544006|NCT00372177|Fab-fragment of Anti-human CD4|fab-fragment of anti-human cd4
544007|NCT00372177|Radiopharmaceutical|radiopharmaceutical
544008|NCT00372177|chronic inflammatory diseases|chronic inflammatory diseases
544009|NCT00372177|active Rheumatoid Arthritis|active rheumatoid arthritis
544010|NCT00372190|Pelvic organ prolapse|pelvic organ prolapse
544011|NCT00372190|recurrence|recurrence
544012|NCT00372190|mesh|mesh
544013|NCT00372190|complications|complications
544014|NCT00372190|treatment|treatment
544015|NCT00364689|Encephalopathy, Hepatic|encephalopathy, hepatic
544016|NCT00364689|Portosystemic Encephalopathy|portosystemic encephalopathy
544017|NCT00364689|Encephalopathy, Hepatocerebral|encephalopathy, hepatocerebral
544018|NCT00364689|Encephalopathy, Portal-Systemic|encephalopathy, portal-systemic
544019|NCT00364689|Encephalopathy, Portosystemic|encephalopathy, portosystemic
544020|NCT00364689|Hepatic Coma|hepatic coma
544021|NCT00364689|Hepatic Stupor|hepatic stupor
544022|NCT00364689|Hepatocerebral Encephalopathy|hepatocerebral encephalopathy
544023|NCT00364689|Portal-Systemic Encephalopathy|portal-systemic encephalopathy
544024|NCT00364702|Virtual Reality|virtual reality
544025|NCT00364702|ADHD|adhd
544026|NCT00364702|Methylphenidate|methylphenidate
544027|NCT00364715|Nuclear localization, annexin A1, oral SCC|nuclear localization, annexin a1, oral scc
544028|NCT00364754|Tesmilifene|tesmilifene
544029|NCT00364754|DPPE|dppe
544030|NCT00364754|Breast cancer|breast cancer
544031|NCT00364754|Cyclophosphamide|cyclophosphamide
544032|NCT00364754|Epirubicin|epirubicin
544033|NCT00364754|Pharmacokinetic|pharmacokinetic
544034|NCT00364767|Moderate alcohol consumption|moderate alcohol consumption
544035|NCT00364767|Fat and carbohydrate oxidative capacity|fat and carbohydrate oxidative capacity
544036|NCT00364767|Postprandial glycemic response|postprandial glycemic response
544037|NCT00364793|HIV, Pediatric|hiv, pediatric
544038|NCT00364806|Migraine|migraine
544039|NCT00364806|Headache|headache
544040|NCT00364819|Primary Biliary Cirrhosis|primary biliary cirrhosis
544041|NCT00364845|Quality of Life|quality of life
544042|NCT00364845|Chronic Kidney Disease|chronic kidney disease
544043|NCT00364845|Anemia|anemia
544044|NCT00364858|Type 1 Gaucher Disease|type 1 gaucher disease
544045|NCT00364858|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
544046|NCT00364871|Obesity|obesity
544047|NCT00364884|chronic kidney disease|chronic kidney disease
544048|NCT00364910|Myocardial Infarction (MI)|myocardial infarction (mi)
544049|NCT00364910|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
544050|NCT00364910|Adherence|adherence
544051|NCT00364910|Depression|depression
544052|NCT00364923|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
544053|NCT00364923|T-cell Lymphoma|t-cell lymphoma
544054|NCT00364923|Lymphoma|lymphoma
544055|NCT00364923|PDX|pdx
544056|NCT00364923|Pralatrexate|pralatrexate
544057|NCT00364923|Vitamin B12|vitamin b12
544058|NCT00364923|Folic acid|folic acid
544059|NCT00364936|palliative care|palliative care
544060|NCT00364936|hospice|hospice
544061|NCT00364936|end-of-life|end-of-life
544062|NCT00364936|symptom control|symptom control
544063|NCT00364936|evaluation|evaluation
544064|NCT00364936|effectiveness|effectiveness
544065|NCT00364949|Polycystic Ovary Syndrome|polycystic ovary syndrome
544066|NCT00364949|PCOS|pcos
544067|NCT00364949|Pregnant|pregnant
544068|NCT00364949|Cord Blood|cord blood
544069|NCT00364962|NPC|npc
544070|NCT00364962|Nasopharyngectomy|nasopharyngectomy
544071|NCT00364962|KTP laser|ktp laser
544072|NCT00364962|recurrence|recurrence
544073|NCT00364975|gourmet healthy cooking|gourmet healthy cooking
544074|NCT00364975|quality of life|quality of life
544075|NCT00364975|adjuvant chemotherapy|adjuvant chemotherapy
544076|NCT00364975|weight|weight
544077|NCT00364975|breast cancer|breast cancer
544078|NCT00364988|pioglitazone|pioglitazone
544079|NCT00364988|losartan|losartan
544080|NCT00364988|proteinuria|proteinuria
544081|NCT00364988|end stage renal disease (ESRD)|end stage renal disease (esrd)
544082|NCT00365014|aplastic anemia|aplastic anemia
544083|NCT00365014|myelodysplastic syndromes|myelodysplastic syndromes
544084|NCT00365014|cytopenias|cytopenias
544085|NCT00365014|acute myeloid leukemia|acute myeloid leukemia
544086|NCT00365014|myelodysplastic/myeloproliferative diseases|myelodysplastic/myeloproliferative diseases
544087|NCT00365014|benzene poisoning|benzene poisoning
544088|NCT00365027|GNRH agonist|gnrh agonist
544089|NCT00365027|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
544090|NCT00365027|Embryo cryopreservation|embryo cryopreservation
544091|NCT00365040|myopia|myopia
544092|NCT00365040|excimer laser|excimer laser
544093|NCT00365092|Insertion of tympanostomy tubes|insertion of tympanostomy tubes
544094|NCT00365092|Otitis media with effusion|otitis media with effusion
544095|NCT00365092|Child development|child development
544096|NCT00365092|Literacy|literacy
544097|NCT00365092|Attention|attention
544098|NCT00365092|Middle-ear effusion|middle-ear effusion
544099|NCT00365092|Educational status|educational status
544100|NCT00365092|Behavior|behavior
544101|NCT00365092|Social behavior|social behavior
544102|NCT00365092|Achievement|achievement
544103|NCT00365105|pain|pain
544104|NCT00365105|bone metastases|bone metastases
544105|NCT00365105|extensive stage small cell lung cancer|extensive stage small cell lung cancer
544106|NCT00365105|recurrent breast cancer|recurrent breast cancer
544107|NCT00365105|stage IV breast cancer|stage iv breast cancer
544108|NCT00365105|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
544109|NCT00365105|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
544110|NCT00365105|recurrent prostate cancer|recurrent prostate cancer
544111|NCT00365105|stage IV prostate cancer|stage iv prostate cancer
544112|NCT00365118|Port wine stains|port wine stains
544113|NCT00365118|naevus flammeus|naevus flammeus
544114|NCT00365131|Type I Gaucher disease|type i gaucher disease
544115|NCT00365131|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
544116|NCT00365144|stage IV pancreatic cancer|stage iv pancreatic cancer
544117|NCT00365144|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
544118|NCT00365144|recurrent pancreatic cancer|recurrent pancreatic cancer
544119|NCT00365183|Non Small Cell Lung Cancer|non small cell lung cancer
544120|NCT00365183|Lung Cancer|lung cancer
544121|NCT00365183|Metastatic Lung Cancer|metastatic lung cancer
544122|NCT00365183|Inoperable Lung Cancer|inoperable lung cancer
544123|NCT00365183|Advanced Lung Cancer|advanced lung cancer
544124|NCT00365183|Large Cell Lung Cancer|large cell lung cancer
544125|NCT00365183|Adenocarcinoma, lung|adenocarcinoma, lung
544126|NCT00365183|Squamous Cell Carcinoma, lung|squamous cell carcinoma, lung
544127|NCT00365183|Squamous Cell Lung Cancer|squamous cell lung cancer
544128|NCT00365183|Large Cell Carcinoma, lung|large cell carcinoma, lung
544129|NCT00365183|Cancer of the Lung|cancer of the lung
544130|NCT00365183|Carcinoma|carcinoma
544131|NCT00365183|Bronchogenic|bronchogenic
544132|NCT00365196|Autonomic Nervous System|autonomic nervous system
544133|NCT00365222|Temozolomide|temozolomide
544134|NCT00365222|Temodar|temodar
544135|NCT00365222|Glioblastoma|glioblastoma
544136|NCT00365222|Gliosarcoma|gliosarcoma
544137|NCT00365222|Brain Tumor|brain tumor
544138|NCT00365222|Quality of Life|quality of life
544140|NCT00365248|Surgical resection of the liver with or without segmental transplantation|surgical resection of the liver with or without segmental transplantation
544141|NCT00365261|pain|pain
544142|NCT00365261|fatigue|fatigue
544143|NCT00365261|sleep|sleep
544144|NCT00365261|bone marrow transplant|bone marrow transplant
544145|NCT00365261|cancer|cancer
544146|NCT00365274|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
544148|NCT00365274|murine monoclonal antibody|murine monoclonal antibody
544149|NCT00365274|mAb|mab
544150|NCT00365274|SGN-30|sgn-30
544151|NCT00365274|CHOP|chop
544152|NCT00365274|Cyclophosphamide|cyclophosphamide
544153|NCT00365274|Doxorubicin Hydrochloride|doxorubicin hydrochloride
544154|NCT00365274|Vincristine|vincristine
544155|NCT00365274|Prednisone|prednisone
544156|NCT00365274|anaplastic large cell lymphoma|anaplastic large cell lymphoma
544157|NCT00365274|Lymphoma|lymphoma
544158|NCT00365274|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
544159|NCT00365274|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
544160|NCT00365274|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
544161|NCT00365274|Neoplasms by Histologic Type|neoplasms by histologic type
544162|NCT00365274|Neoplasms|neoplasms
544163|NCT00365274|Lymphoproliferative Disorders|lymphoproliferative disorders
544164|NCT00365274|Lymphatic Diseases|lymphatic diseases
544165|NCT00365274|Immunoproliferative Disorders|immunoproliferative disorders
544166|NCT00365274|Immune System Diseases|immune system diseases
544167|NCT00365274|Lymphoma, B-Cell|lymphoma, b-cell
544168|NCT00365274|Lymphoma, T-Cell|lymphoma, t-cell
544169|NCT00365274|Antibodies|antibodies
544170|NCT00365274|Antibodies, Monoclonal|antibodies, monoclonal
544171|NCT00365274|Immunologic Factors|immunologic factors
544172|NCT00365274|Physiological Effects of Drugs|physiological effects of drugs
544173|NCT00365274|Pharmacologic Actions|pharmacologic actions
544174|NCT00365274|Immunosuppressive Agents|immunosuppressive agents
544175|NCT00365274|Antirheumatic Agents|antirheumatic agents
544176|NCT00365274|Therapeutic Uses|therapeutic uses
544177|NCT00365274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
544178|NCT00365274|Alkylating Agents|alkylating agents
544179|NCT00365274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
544180|NCT00365274|Antineoplastic Agents|antineoplastic agents
544181|NCT00365274|Myeloablative Agonists|myeloablative agonists
544182|NCT00365274|Antibiotics|antibiotics
544183|NCT00365274|Antineoplastic|antineoplastic
544184|NCT00365287|stage IV breast cancer|stage iv breast cancer
544185|NCT00365287|recurrent renal cell cancer|recurrent renal cell cancer
544186|NCT00365287|stage III renal cell cancer|stage iii renal cell cancer
544187|NCT00365287|stage IV renal cell cancer|stage iv renal cell cancer
544188|NCT00365287|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
544189|NCT00365287|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
544190|NCT00365287|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
544191|NCT00365287|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
544192|NCT00365287|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
544193|NCT00365287|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
544194|NCT00365287|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
544195|NCT00365287|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
544290|NCT00365326|bone marrow|bone marrow
544196|NCT00365287|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
544197|NCT00365287|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
544198|NCT00365287|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
544199|NCT00365287|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
544200|NCT00365287|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
544201|NCT00365287|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
544202|NCT00365287|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
544203|NCT00365287|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
544204|NCT00365287|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
544205|NCT00365287|stage I multiple myeloma|stage i multiple myeloma
544206|NCT00365287|stage II multiple myeloma|stage ii multiple myeloma
544207|NCT00365287|stage III multiple myeloma|stage iii multiple myeloma
544208|NCT00365287|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
544209|NCT00365287|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
544210|NCT00365287|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
544211|NCT00365287|refractory anemia|refractory anemia
544212|NCT00365287|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
544213|NCT00365287|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
544214|NCT00365287|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
544215|NCT00365287|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
544216|NCT00365287|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
544217|NCT00365287|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
544218|NCT00365287|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
544219|NCT00365287|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
544220|NCT00365287|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
544221|NCT00365287|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
544222|NCT00365287|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
544223|NCT00365287|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
544224|NCT00365287|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
544225|NCT00365287|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
544226|NCT00365287|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
544227|NCT00365287|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
544228|NCT00365287|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
544229|NCT00365287|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
544230|NCT00365287|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
544231|NCT00365287|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
544232|NCT00365287|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
544233|NCT00365287|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
544234|NCT00365287|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
544235|NCT00365287|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
544236|NCT00365287|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
544237|NCT00365287|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
544238|NCT00365287|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
544239|NCT00365287|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
544240|NCT00365287|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
544241|NCT00365287|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
544242|NCT00365287|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
544243|NCT00365287|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
544244|NCT00365287|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
544245|NCT00365287|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
544246|NCT00365287|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
544247|NCT00365287|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
544248|NCT00365287|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
544249|NCT00365287|refractory multiple myeloma|refractory multiple myeloma
544250|NCT00365287|secondary acute myeloid leukemia|secondary acute myeloid leukemia
544251|NCT00365287|splenic marginal zone lymphoma|splenic marginal zone lymphoma
544252|NCT00365287|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
544253|NCT00365287|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
544254|NCT00365287|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
544255|NCT00365287|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
544256|NCT00365287|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
544257|NCT00365287|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
543669|NCT00370760|PVR|pvr
544258|NCT00365287|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
544259|NCT00365287|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
544260|NCT00365287|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
544261|NCT00365287|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
544262|NCT00365287|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
544263|NCT00365287|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
544264|NCT00365287|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
544265|NCT00365287|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
544266|NCT00365287|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
544267|NCT00365287|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
544268|NCT00365287|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
544269|NCT00365287|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
544270|NCT00365287|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
544271|NCT00365287|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
544272|NCT00365287|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
544273|NCT00365287|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
544274|NCT00365287|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
544275|NCT00365287|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
544721|NCT00373269|Diabetes|diabetes
544276|NCT00365287|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
16243|NCT03187275|Quality of Life (QOL)|quality of life (qol)
544277|NCT00365287|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
544278|NCT00365287|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
544279|NCT00365287|refractory anemia with excess blasts|refractory anemia with excess blasts
544280|NCT00365287|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
544282|NCT00365300|Infants|infants
544283|NCT00365300|Gastroesophageal Reflux|gastroesophageal reflux
544284|NCT00365313|celecoxib|celecoxib
544285|NCT00365313|oesomeprazole|oesomeprazole
544286|NCT00365313|arthritis|arthritis
544287|NCT00365313|ulcer bleeding|ulcer bleeding
544288|NCT00365326|AC133|ac133
544289|NCT00365326|coronary|coronary
544291|NCT00365326|autologous|autologous
544292|NCT00365326|coronary artery disease|coronary artery disease
544293|NCT00365339|HIV|hiv
544294|NCT00365339|Protease Inhibitor|protease inhibitor
544295|NCT00365404|Behavioral change|behavioral change
544296|NCT00365404|Weight management|weight management
544297|NCT00365404|Physical activity|physical activity
544298|NCT00365417|NSABP|nsabp
544299|NCT00365417|Doxorubicin|doxorubicin
544300|NCT00365417|Cyclophosphamide|cyclophosphamide
544301|NCT00365417|Bevacizumab|bevacizumab
544302|NCT00365417|Capecitabine|capecitabine
544303|NCT00365417|Docetaxel|docetaxel
544304|NCT00365417|Breast cancer|breast cancer
544305|NCT00365417|Locally advanced|locally advanced
544306|NCT00365417|Neoadjuvant|neoadjuvant
544307|NCT00365417|Locally advanced breast cancer|locally advanced breast cancer
544308|NCT00365430|Patient safety|patient safety
544309|NCT00365430|Adverse event|adverse event
544310|NCT00365430|Prevention|prevention
544311|NCT00365430|Knowledge|knowledge
544312|NCT00365430|Inpatient|inpatient
544314|NCT00365430|Nursing home|nursing home
544315|NCT00365430|Long term care|long term care
544316|NCT00365430|Nurse|nurse
544317|NCT00365443|anogenital warts|anogenital warts
544318|NCT00365443|premalignancy|premalignancy
544319|NCT00365443|HPV|hpv
544320|NCT00365443|Human papillomavirus|human papillomavirus
544321|NCT00365456|Lumbar Spine Bone Mineral Density (BMD)|lumbar spine bone mineral density (bmd)
544322|NCT00365469|Probiotics|probiotics
544323|NCT00365469|Eczema|eczema
544324|NCT00365469|Asthma|asthma
544325|NCT00365469|Allergic Rhinitis|allergic rhinitis
544326|NCT00365469|Prevention|prevention
544327|NCT00365469|Immunological responses|immunological responses
544328|NCT00365482|Epilepsy|epilepsy
544329|NCT00365482|Bipolar Disorder|bipolar disorder
544330|NCT00365495|Type 2 diabetes|type 2 diabetes
544331|NCT00365495|physical training|physical training
544332|NCT00365495|mitochondrial function|mitochondrial function
544333|NCT00365508|bladder cancer|bladder cancer
544334|NCT00365508|cervical cancer|cervical cancer
544335|NCT00365508|esophageal cancer|esophageal cancer
544336|NCT00365508|gastric cancer|gastric cancer
544337|NCT00365508|renal cell carcinoma|renal cell carcinoma
544338|NCT00365508|adult primary liver cancer|adult primary liver cancer
544339|NCT00365508|non-small cell lung cancer|non-small cell lung cancer
544340|NCT00365508|small cell lung cancer|small cell lung cancer
544341|NCT00365508|pancreatic cancer|pancreatic cancer
544342|NCT00365508|hypopharyngeal cancer|hypopharyngeal cancer
544343|NCT00365508|laryngeal cancer|laryngeal cancer
544344|NCT00365508|lip and oral cavity cancer|lip and oral cavity cancer
543753|NCT00371046|preterm birth|preterm birth
544345|NCT00365508|nasopharyngeal cancer|nasopharyngeal cancer
544346|NCT00365508|oropharyngeal cancer|oropharyngeal cancer
544347|NCT00365508|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
544348|NCT00365508|adult acute myeloid leukemia|adult acute myeloid leukemia
544349|NCT00365508|tongue cancer|tongue cancer
544350|NCT00365508|tobacco use disorder|tobacco use disorder
544351|NCT00365521|Organ transplant patients receiving immunosuppressive therapy|organ transplant patients receiving immunosuppressive therapy
544352|NCT00365534|First colonoscopy examination|first colonoscopy examination
544353|NCT00365547|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
544354|NCT00365547|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
544355|NCT00365547|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
544356|NCT00365547|adenocarcinoma of the lung|adenocarcinoma of the lung
544357|NCT00365547|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
544358|NCT00365547|large cell lung cancer|large cell lung cancer
544359|NCT00365586|Pain|pain
544360|NCT00365586|Osteoarthritis|osteoarthritis
544361|NCT00365586|Knee|knee
544362|NCT00365586|NSAID|nsaid
544363|NCT00365599|Breast cancer|breast cancer
544364|NCT00365599|Suberoylanilide hydroxamic acid (SAHA)|suberoylanilide hydroxamic acid (saha)
544365|NCT00365599|Vorinostat|vorinostat
544366|NCT00365599|Tamoxifen|tamoxifen
544367|NCT00365599|Anti-hormonal therapy|anti-hormonal therapy
544368|NCT00365599|Estrogen receptor positive|estrogen receptor positive
544369|NCT00365599|Progesterone receptor positive|progesterone receptor positive
544370|NCT00365599|Metastatic disease|metastatic disease
545031|NCT00374439|depression|depression
544371|NCT00365599|Aromatase inhibitors (Ais)|aromatase inhibitors (ais)
544372|NCT00365599|Histone deacetylase (HDAC) inhibitors|histone deacetylase (hdac) inhibitors
544373|NCT00365599|Selective estrogen receptor modulators(SERMS)|selective estrogen receptor modulators(serms)
544374|NCT00372203|Non-small cell lung cancer|non-small cell lung cancer
544376|NCT00372203|EBUS|ebus
544377|NCT00372203|Endobronchial ultrasound|endobronchial ultrasound
544378|NCT00372203|mediastinoscopy|mediastinoscopy
544379|NCT00372216|myocardial infarction|myocardial infarction
544380|NCT00372216|Clopidogrel|clopidogrel
544381|NCT00372216|primary PCI|primary pci
544382|NCT00372216|TIMI-flow|timi-flow
544383|NCT00372216|STEMI within 6 hrs.|stemi within 6 hrs.
544384|NCT00372242|Mal-nutrition|mal-nutrition
544385|NCT00372242|Morbidity|morbidity
544386|NCT00372242|Nutrition Education|nutrition education
544387|NCT00372242|Complementary Feeding|complementary feeding
544388|NCT00372242|Weight gain|weight gain
544389|NCT00372242|Height|height
544390|NCT00372268|Comparison of four conditionings of the insufflated gas during laparoscopy and their consequences on the core temperature and the post-operative pain.|comparison of four conditionings of the insufflated gas during laparoscopy and their consequences on the core temperature and the post-operative pain.
544391|NCT00372268|Women with womb pathology needing laparoscopic surgery|women with womb pathology needing laparoscopic surgery
544392|NCT00372268|No emergency|no emergency
544393|NCT00372268|Aged over 18 years|aged over 18 years
544394|NCT00372281|MRI, CLIAVIST, MACROPHAGE, INFECTION, SPINE|mri, cliavist, macrophage, infection, spine
544395|NCT00372294|Toxoplasmosis|toxoplasmosis
544396|NCT00372294|Chorioretinitis|chorioretinitis
544397|NCT00372294|Intravitreal Clindamycin|intravitreal clindamycin
544398|NCT00372294|Dexamethasone in chorioretinitis|dexamethasone in chorioretinitis
544399|NCT00372294|Toxoplasmic|toxoplasmic
544400|NCT00372320|Adenovirus|adenovirus
544401|NCT00372320|Aquaporin-1|aquaporin-1
544402|NCT00372320|Gene Transfer|gene transfer
544403|NCT00372320|Radiation-Induced Salivary Hypofunction|radiation-induced salivary hypofunction
544404|NCT00372320|Salivary Gland|salivary gland
544405|NCT00372320|Xerostomia|xerostomia
544406|NCT00372320|Salivary Dysfunction|salivary dysfunction
544407|NCT00372320|Hyposalivation|hyposalivation
544408|NCT00372320|Dry mouth|dry mouth
544409|NCT00372320|head and neck cancer|head and neck cancer
544410|NCT00372320|side effects radiation damage|side effects radiation damage
544411|NCT00372333|musculoskeletal pain; soft tissue inflammation; IDEA-033|musculoskeletal pain; soft tissue inflammation; idea-033
544412|NCT00372359|Attention Deficit Disorder|attention deficit disorder
544413|NCT00372359|Hyperactivity|hyperactivity
544414|NCT00372359|Methylphenidate|methylphenidate
544415|NCT00372372|corticosteroids, bone mineral, risedronate, bisphosphonate|corticosteroids, bone mineral, risedronate, bisphosphonate
544416|NCT00372398|scleroderma|scleroderma
544417|NCT00372398|sclerosis|sclerosis
544418|NCT00372398|atherosclerosis|atherosclerosis
544419|NCT00372411|Stroke|stroke
544420|NCT00372411|Rehabilitation|rehabilitation
544421|NCT00372411|Single-blind|single-blind
544422|NCT00372411|Clinical Trial|clinical trial
544423|NCT00372411|Randomized controlled trial|randomized controlled trial
544424|NCT00372411|Upper extremity|upper extremity
544425|NCT00372411|Robotics|robotics
544426|NCT00372424|Breast cancer over-expressing HER2. First-line treatment with sunitinib/docetaxel/trastuzumab.|breast cancer over-expressing her2. first-line treatment with sunitinib/docetaxel/trastuzumab.
544427|NCT00372437|Refractory solid tumors|refractory solid tumors
544428|NCT00372437|Phase I/II|phase i/ii
544429|NCT00372437|Refractory and solid tumors|refractory and solid tumors
544430|NCT00372450|recurrent esophageal cancer|recurrent esophageal cancer
544431|NCT00372450|stage III esophageal cancer|stage iii esophageal cancer
544432|NCT00372450|stage IV esophageal cancer|stage iv esophageal cancer
544433|NCT00372450|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
544434|NCT00372450|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
544435|NCT00372450|gastrointestinal complications|gastrointestinal complications
544436|NCT00372463|diabetes|diabetes
544437|NCT00372463|type 2 diabetes|type 2 diabetes
544438|NCT00372463|type II diabetes|type ii diabetes
544439|NCT00372463|diabetes mellitus|diabetes mellitus
544440|NCT00372463|diabetes type 2|diabetes type 2
544441|NCT00372463|diabetes type II|diabetes type ii
544442|NCT00372463|diabetes education|diabetes education
544443|NCT00372463|patient education|patient education
544444|NCT00372463|workshop|workshop
544445|NCT00372463|class|class
544446|NCT00372463|education|education
544447|NCT00372463|online|online
544448|NCT00372463|on-line|on-line
544449|NCT00372463|internet|internet
544450|NCT00372463|web|web
544451|NCT00372476|Breast cancer|breast cancer
544452|NCT00372476|Tyrosine inhibitor|tyrosine inhibitor
544453|NCT00372476|Chemotherapy|chemotherapy
544454|NCT00372476|Imatinib|imatinib
544455|NCT00372489|anemia|anemia
544456|NCT00372489|chronic kidney disease|chronic kidney disease
544458|NCT00372489|chronic renal failure|chronic renal failure
544459|NCT00372489|CRF|crf
544460|NCT00372489|dialysis|dialysis
544461|NCT00372489|erythropoietin|erythropoietin
544462|NCT00372489|EPO|epo
544463|NCT00372489|erythropoiesis stimulating agent|erythropoiesis stimulating agent
544466|NCT00372489|hemodialysis|hemodialysis
544467|NCT00372489|hemoglobin|hemoglobin
544468|NCT00372489|Hb|hb
544469|NCT00372489|Hgb|hgb
544470|NCT00372489|Omontys|omontys
544471|NCT00372489|peginesatide|peginesatide
544472|NCT00372489|red blood cell|red blood cell
544473|NCT00372489|red blood cell production|red blood cell production
544474|NCT00372502|sepsis|sepsis
544475|NCT00372502|shock|shock
544476|NCT00372502|emergency department|emergency department
544477|NCT00372502|resuscitation|resuscitation
544478|NCT00372515|epidermal growth factor|epidermal growth factor
544479|NCT00372515|EGFR|egfr
544480|NCT00372515|lung cancer|lung cancer
544481|NCT00372515|Iressa|iressa
544482|NCT00372515|Gefitinib|gefitinib
544483|NCT00372593|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
544484|NCT00372593|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
544485|NCT00372593|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
544486|NCT00372593|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
544487|NCT00372593|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
544488|NCT00372593|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
544489|NCT00372593|adult acute basophilic leukemia|adult acute basophilic leukemia
544490|NCT00372593|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
544491|NCT00372593|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
544492|NCT00372593|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
544493|NCT00372593|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
544494|NCT00372593|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
544495|NCT00372593|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
544496|NCT00372593|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
544497|NCT00372593|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
544498|NCT00372593|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
544499|NCT00372593|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
544500|NCT00372593|childhood acute basophilic leukemia|childhood acute basophilic leukemia
544501|NCT00372593|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
544502|NCT00372593|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
544503|NCT00372593|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
544504|NCT00372593|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
544505|NCT00372593|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
544506|NCT00372593|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
544507|NCT00372593|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
544508|NCT00372593|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
544509|NCT00372593|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
544510|NCT00372606|Obesity|obesity
544511|NCT00372606|Overweight|overweight
544512|NCT00372606|Hispanics|hispanics
543948|NCT00371904|donor|donor
544513|NCT00372606|Online|online
544514|NCT00372606|Weight Loss|weight loss
544515|NCT00372619|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
544516|NCT00372619|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
544517|NCT00372619|acute undifferentiated leukemia|acute undifferentiated leukemia
544518|NCT00372619|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
544519|NCT00372619|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
544520|NCT00372619|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
544636|NCT00372983|chronic HCV|chronic hcv
544521|NCT00372619|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
544522|NCT00372619|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
544523|NCT00372619|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
544524|NCT00372619|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
544525|NCT00372619|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
544526|NCT00372619|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
544527|NCT00372619|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
544528|NCT00372619|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
544529|NCT00372619|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
544530|NCT00372619|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
544531|NCT00372619|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
544532|NCT00372619|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
544533|NCT00372619|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
544534|NCT00372619|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
544535|NCT00372619|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
544536|NCT00372619|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
544537|NCT00372632|Pregnancy malaria prevention|pregnancy malaria prevention
544539|NCT00372658|hysterosalpingogram|hysterosalpingogram
544540|NCT00372658|intracervical local anesthesia|intracervical local anesthesia
544541|NCT00372658|pain perception|pain perception
544542|NCT00372658|visual analogue scale|visual analogue scale
544543|NCT00372671|Cardiac Rehabilitation|cardiac rehabilitation
544544|NCT00372671|Improving Cardiac Rehabilitation Participation|improving cardiac rehabilitation participation
544545|NCT00372684|Plasmodium falciparum|plasmodium falciparum
544547|NCT00372684|Imported malaria|imported malaria
544548|NCT00372684|Severe malaria|severe malaria
544549|NCT00372684|Uncomplicated malaria|uncomplicated malaria
544550|NCT00372684|Intensive Care Units|intensive care units
544551|NCT00372684|Polymorphism, Genetic|polymorphism, genetic
544552|NCT00372684|Parasitic Sensitivity Tests|parasitic sensitivity tests
544553|NCT00372684|Inflammation Mediators|inflammation mediators
544554|NCT00372697|acromegaly|acromegaly
544555|NCT00372697|octreotide acetate|octreotide acetate
544556|NCT00372697|partial responder patients|partial responder patients
544557|NCT00372710|Breast cancer|breast cancer
544558|NCT00372710|Palliation|palliation
544559|NCT00372710|Bone metastasis|bone metastasis
544560|NCT00372710|Zoledronic acid|zoledronic acid
544561|NCT00372723|toxic epidermal necrlysis|toxic epidermal necrlysis
544562|NCT00372723|ten|ten
544563|NCT00372736|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
544564|NCT00372749|Alcohol dependence|alcohol dependence
544565|NCT00372749|Craving|craving
544566|NCT00372749|Disulfiram|disulfiram
544567|NCT00372749|Cue exposure|cue exposure
544568|NCT00372762|Insulin resistance|insulin resistance
544569|NCT00372762|heart failure|heart failure
544570|NCT00372762|diuretic therapy|diuretic therapy
544571|NCT00372775|brain metastases|brain metastases
544572|NCT00372775|Sunitinib|sunitinib
544573|NCT00372775|Phase 2|phase 2
544574|NCT00372788|NSCLC|nsclc
544575|NCT00372788|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
544576|NCT00372788|AZD6244|azd6244
544577|NCT00372801|Osteoarthritis|osteoarthritis
544578|NCT00372801|Ibuprofen|ibuprofen
544579|NCT00372801|COX2|cox2
544580|NCT00372801|VAS|vas
544581|NCT00372801|knee|knee
544582|NCT00372801|single dose|single dose
544583|NCT00372814|diabetes|diabetes
544584|NCT00372814|regimen adherence|regimen adherence
544585|NCT00372814|metabolic control|metabolic control
544586|NCT00372814|adolescents|adolescents
544587|NCT00372814|family therapy|family therapy
544588|NCT00372840|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
544589|NCT00372840|stage I breast cancer|stage i breast cancer
544590|NCT00372840|stage II breast cancer|stage ii breast cancer
544591|NCT00372840|stage IIIA breast cancer|stage iiia breast cancer
544592|NCT00372840|stage IIIA colon cancer|stage iiia colon cancer
544593|NCT00372840|stage I prostate cancer|stage i prostate cancer
544594|NCT00372840|stage IIB prostate cancer|stage iib prostate cancer
544595|NCT00372840|stage IIA prostate cancer|stage iia prostate cancer
544596|NCT00372840|stage III prostate cancer|stage iii prostate cancer
544597|NCT00372840|stage I non-small cell lung cancer|stage i non-small cell lung cancer
544598|NCT00372840|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
544599|NCT00372840|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
544600|NCT00372840|limited stage small cell lung cancer|limited stage small cell lung cancer
544601|NCT00372840|stage I rectal cancer|stage i rectal cancer
544602|NCT00372840|stage IIA rectal cancer|stage iia rectal cancer
544603|NCT00372840|stage IIB rectal cancer|stage iib rectal cancer
544604|NCT00372840|stage IIC rectal cancer|stage iic rectal cancer
544605|NCT00372840|stage IIIA rectal cancer|stage iiia rectal cancer
544606|NCT00372840|pulmonary carcinoid tumor|pulmonary carcinoid tumor
544607|NCT00372840|stage I thymoma|stage i thymoma
544608|NCT00372840|stage II thymoma|stage ii thymoma
544609|NCT00372840|stage III thymoma|stage iii thymoma
544610|NCT00372840|stage I colon cancer|stage i colon cancer
544611|NCT00372840|stage IIA colon cancer|stage iia colon cancer
544612|NCT00372840|stage IIB colon cancer|stage iib colon cancer
544613|NCT00372840|stage IIC colon cancer|stage iic colon cancer
544614|NCT00372840|stage IA malignant mesothelioma|stage ia malignant mesothelioma
544615|NCT00372840|stage IB malignant mesothelioma|stage ib malignant mesothelioma
544616|NCT00372840|stage II malignant mesothelioma|stage ii malignant mesothelioma
544617|NCT00372840|stage III malignant mesothelioma|stage iii malignant mesothelioma
544618|NCT00372879|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
544619|NCT00372879|vitamin E|vitamin e
544620|NCT00372879|muscle cramp|muscle cramp
544621|NCT00372892|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
544622|NCT00372892|Rituximab|rituximab
544623|NCT00372892|Feasibility study|feasibility study
544624|NCT00372905|follicular lymphoma|follicular lymphoma
544625|NCT00372944|advanced pancreatic cancer|advanced pancreatic cancer
544626|NCT00372944|metastatic pancreatic cancer|metastatic pancreatic cancer
544627|NCT00372944|AZD6244|azd6244
544628|NCT00372957|pharmacodynamics|pharmacodynamics
544629|NCT00372957|Diabetes|diabetes
544630|NCT00372957|pharmacokinetics|pharmacokinetics
544631|NCT00372970|gastroparesis|gastroparesis
544632|NCT00372970|vomiting|vomiting
544633|NCT00372970|nausea|nausea
544634|NCT00372970|bloating|bloating
544635|NCT00372970|dyspepsia|dyspepsia
544637|NCT00372983|Failed treatment|failed treatment
544638|NCT00372983|genotype 1|genotype 1
544639|NCT00372983|failed treatment with pegylated interferon plus ribavirin|failed treatment with pegylated interferon plus ribavirin
544640|NCT00373009|Low back pain|low back pain
544641|NCT00373009|Primary prevention|primary prevention
544642|NCT00373009|Secondary prevention|secondary prevention
544643|NCT00373009|Lumbar stabilization|lumbar stabilization
544644|NCT00373009|Psychosocial education|psychosocial education
544645|NCT00373022|depression|depression
544646|NCT00373022|anxiety disorder|anxiety disorder
544647|NCT00373022|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
544648|NCT00373022|stage II colon cancer|stage ii colon cancer
544649|NCT00373022|stage III colon cancer|stage iii colon cancer
544650|NCT00373022|stage II rectal cancer|stage ii rectal cancer
544651|NCT00373022|stage III rectal cancer|stage iii rectal cancer
544652|NCT00373035|prostate cancer|prostate cancer
544653|NCT00373048|HIV-1 malaria Clinical Trial|hiv-1 malaria clinical trial
544654|NCT00373061|Expect|expect
544655|NCT00373074|Spinal Puncture Headache|spinal puncture headache
544656|NCT00373087|Parkinson's disease|parkinson's disease
544657|NCT00373087|Catechol O-methyltransferase|catechol o-methyltransferase
544658|NCT00373087|Entacapone|entacapone
544659|NCT00373087|pharmacogenetic|pharmacogenetic
544660|NCT00373100|Zinc|zinc
544661|NCT00373100|placebo|placebo
544662|NCT00373100|severe pneumonia|severe pneumonia
544663|NCT00373100|children|children
544664|NCT00373113|advanced breast cancer|advanced breast cancer
544665|NCT00373113|metastatic breast cancer|metastatic breast cancer
544666|NCT00373113|treatment resistant|treatment resistant
544667|NCT00373113|treatment failure|treatment failure
544668|NCT00373126|nicotine|nicotine
544669|NCT00373126|schizophrenia|schizophrenia
544670|NCT00373126|reward|reward
544671|NCT00373126|withdrawal|withdrawal
544672|NCT00373139|Pregnancy,|pregnancy,
544673|NCT00373139|Screening,|screening,
544674|NCT00373139|Whole Blood|whole blood
544675|NCT00373152|stage I breast cancer|stage i breast cancer
544676|NCT00373152|stage II breast cancer|stage ii breast cancer
544677|NCT00373152|stage IIIA breast cancer|stage iiia breast cancer
544678|NCT00373152|stage IIIC breast cancer|stage iiic breast cancer
544679|NCT00373152|stage IV breast cancer|stage iv breast cancer
544680|NCT00373165|Renal Transplantation|renal transplantation
544681|NCT00373165|CMV|cmv
544682|NCT00373165|Ganciclovir|ganciclovir
544683|NCT00373165|Prophylaxis|prophylaxis
544684|NCT00373165|Preemptive Therapy|preemptive therapy
544685|NCT00373165|Graft Survival|graft survival
544686|NCT00373165|Proteomics|proteomics
544147|NCT00365274|NHL|nhl
544687|NCT00373178|rosiglitazone|rosiglitazone
544688|NCT00373178|metformin|metformin
544689|NCT00373191|stage I breast cancer|stage i breast cancer
544690|NCT00373191|stage II breast cancer|stage ii breast cancer
544691|NCT00373191|stage IIIA breast cancer|stage iiia breast cancer
544692|NCT00373191|stage IIIB breast cancer|stage iiib breast cancer
544693|NCT00373191|stage IIIC breast cancer|stage iiic breast cancer
544694|NCT00373191|ductal breast carcinoma in situ|ductal breast carcinoma in situ
544695|NCT00373204|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
544696|NCT00373204|Non-small cell lung cancer|non-small cell lung cancer
544697|NCT00373204|Lung cancer|lung cancer
544698|NCT00373204|Metastatic lung cancer|metastatic lung cancer
544699|NCT00373204|Second line treatment for advanced lung cancer|second line treatment for advanced lung cancer
544700|NCT00373204|Cancer|cancer
544701|NCT00373204|Advanced lung cancer|advanced lung cancer
544702|NCT00373217|fallopian tube cancer|fallopian tube cancer
544703|NCT00373217|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
544704|NCT00373217|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
544705|NCT00373217|primary peritoneal cavity cancer|primary peritoneal cavity cancer
544706|NCT00373230|weight loss|weight loss
544707|NCT00373230|telemedicine|telemedicine
544708|NCT00373230|african-american|african-american
544709|NCT00373230|rural|rural
544710|NCT00373243|hepatic impairment pharmacokinetics|hepatic impairment pharmacokinetics
544711|NCT00373256|Breast cancer|breast cancer
544712|NCT00373256|advanced|advanced
544713|NCT00373256|sunitinib|sunitinib
544714|NCT00373256|bevacizumab|bevacizumab
544715|NCT00373256|paclitaxel|paclitaxel
544716|NCT00373256|Phase 3|phase 3
544717|NCT00373269|Acute ischemic stroke|acute ischemic stroke
544718|NCT00373269|Stroke|stroke
544719|NCT00373269|Hyperglycemia|hyperglycemia
544720|NCT00373269|Procoagulation|procoagulation
544722|NCT00373269|Blood coagulation|blood coagulation
544723|NCT00373282|PVR|pvr
544724|NCT00373282|Retinal detachment|retinal detachment
544725|NCT00373282|Silicone oil|silicone oil
544726|NCT00373282|Triamcinolone|triamcinolone
544727|NCT00373295|Baclofen|baclofen
544728|NCT00373295|Marijuana Dependence|marijuana dependence
544729|NCT00373295|Marijuana Withdrawal|marijuana withdrawal
544730|NCT00373308|Quality of Life|quality of life
544731|NCT00373334|gastroesophageal reflux disease|gastroesophageal reflux disease
544732|NCT00373334|GERD|gerd
544733|NCT00373334|heartburn|heartburn
544734|NCT00373360|pulmonary hypertension|pulmonary hypertension
544735|NCT00373360|PAH|pah
544736|NCT00373360|Remodulin|remodulin
544737|NCT00373360|treprostinil|treprostinil
544738|NCT00373360|Quality of Life|quality of life
544739|NCT00373360|Rapid Switch|rapid switch
544740|NCT00373373|Sorafenib|sorafenib
544741|NCT00373373|Acute Myeloid Leukemia|acute myeloid leukemia
544742|NCT00373373|Flt3|flt3
544743|NCT00373373|AML|aml
544744|NCT00373373|Kinase Inhibitor|kinase inhibitor
544745|NCT00373386|growth hormone|growth hormone
544746|NCT00373386|endothelial function|endothelial function
544747|NCT00373399|Cannabinoids|cannabinoids
544748|NCT00373399|Risk taking|risk taking
544749|NCT00373399|Decision making|decision making
544750|NCT00373412|cytomegalovirus|cytomegalovirus
544751|NCT00373412|vaccine|vaccine
544752|NCT00373412|T cell|t cell
544753|NCT00373412|antibodies|antibodies
544754|NCT00373425|Adjuvant Non-small Cell Lung Cancer|adjuvant non-small cell lung cancer
544755|NCT00373425|Tarceva|tarceva
544756|NCT00373425|Early-stage Lung Cancer|early-stage lung cancer
544757|NCT00373425|Adjuvant|adjuvant
544758|NCT00373425|RADIANT|radiant
544759|NCT00373425|NSCLC|nsclc
544760|NCT00373425|EGFR-positive tumor|egfr-positive tumor
544761|NCT00373425|Stage IB Non-small Cell Lung Cancer|stage ib non-small cell lung cancer
544762|NCT00373425|Stage II Non-small Cell Lung Cancer|stage ii non-small cell lung cancer
544863|NCT00373789|Detrusor Overactivity|detrusor overactivity
544763|NCT00373425|Stage IIIA Non-small Cell Lung Cancer|stage iiia non-small cell lung cancer
544764|NCT00373438|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
544765|NCT00373438|tracheal occlusion|tracheal occlusion
544766|NCT00373438|fetus|fetus
544767|NCT00373438|fetal surgery|fetal surgery
544768|NCT00373438|fetoscopy|fetoscopy
544769|NCT00373438|ECMO|ecmo
544770|NCT00373451|NSTEMI|nstemi
544771|NCT00373464|Postoperative pain|postoperative pain
544772|NCT00373464|Opioid|opioid
544773|NCT00373464|Etoricoxib|etoricoxib
544774|NCT00373464|Ketorolac|ketorolac
544775|NCT00373464|Laparoscopic Surgery|laparoscopic surgery
544776|NCT00373464|Surgical Procedures, Gynecologic|surgical procedures, gynecologic
544777|NCT00373477|Depression|depression
544778|NCT00373477|Primary Care|primary care
544779|NCT00373477|Care Manager|care manager
544780|NCT00373503|Lofexidine|lofexidine
544781|NCT00373503|Oral THC|oral thc
544782|NCT00373503|Cannabinoids|cannabinoids
544783|NCT00373516|psoriasis|psoriasis
544784|NCT00373516|topical therapy|topical therapy
544785|NCT00373529|Acute myelogenous leukemia|acute myelogenous leukemia
544786|NCT00373529|Acute myeloid leukemia|acute myeloid leukemia
544787|NCT00373529|newly Diagnosed AML|newly diagnosed aml
544788|NCT00373529|Clofarabine|clofarabine
544789|NCT00373529|CLASSIC II|classic ii
544790|NCT00373529|CLO243|clo243
544791|NCT00373542|Restless Legs Syndrome|restless legs syndrome
544792|NCT00373542|ropinirole|ropinirole
544793|NCT00373542|polysomnography|polysomnography
544795|NCT00373542|PSG|psg
544796|NCT00373555|Sarcoidosis|sarcoidosis
544797|NCT00373555|mediastinal adenopathy|mediastinal adenopathy
544798|NCT00373555|bronchoscopy|bronchoscopy
544799|NCT00373555|Transbronchial needle aspiration|transbronchial needle aspiration
544800|NCT00373555|endobronchial ultrasonography|endobronchial ultrasonography
544801|NCT00373568|mucosal|mucosal
544802|NCT00373568|miltefosine|miltefosine
544803|NCT00373581|Vigabatrin|vigabatrin
544804|NCT00373581|GABA levels|gaba levels
544805|NCT00373581|Smoked cocaine|smoked cocaine
544806|NCT00373594|Cold agglutinin disease|cold agglutinin disease
544807|NCT00373594|Hemolytic|hemolytic
544808|NCT00373594|Anemia|anemia
544809|NCT00373594|Lymphoproliferative disease|lymphoproliferative disease
544810|NCT00373594|Monoclonal antibodies|monoclonal antibodies
544811|NCT00373594|Rituximab|rituximab
544812|NCT00373594|Fludarabine|fludarabine
544813|NCT00373607|Non complicated malaria|non complicated malaria
544814|NCT00373607|Microscopy|microscopy
544815|NCT00373607|Adult|adult
544816|NCT00373607|Children|children
544817|NCT00373620|endometrial cancer|endometrial cancer
544818|NCT00373620|high risk|high risk
544819|NCT00373620|weekly paclitaxel|weekly paclitaxel
544820|NCT00373620|Cuncurrent chemoradiation|cuncurrent chemoradiation
544821|NCT00373633|THoracic Surgery|thoracic surgery
544822|NCT00373633|thoracic epidural|thoracic epidural
544823|NCT00373633|epidural|epidural
544824|NCT00373633|thoracotomy|thoracotomy
544825|NCT00373633|intercostal nerve block|intercostal nerve block
544826|NCT00373633|intercostal|intercostal
544827|NCT00373633|nerve block|nerve block
544828|NCT00373646|MALT Lymphoma|malt lymphoma
544829|NCT00373646|thalidomide|thalidomide
544830|NCT00373646|disseminated MALT Lymphoma or at relapse following HP-eradication|disseminated malt lymphoma or at relapse following hp-eradication
544831|NCT00373646|or chemotherapy or radiation|or chemotherapy or radiation
544832|NCT00373659|Neovascularization|neovascularization
544833|NCT00373659|Age-related macular degeneration|age-related macular degeneration
544834|NCT00373659|Ranibizumab (Lucentis)|ranibizumab (lucentis)
544835|NCT00373659|Optical coherence tomography|optical coherence tomography
544836|NCT00373659|Intravitreal injection|intravitreal injection
544837|NCT00373672|schizophrenia|schizophrenia
544838|NCT00373672|cognition|cognition
544839|NCT00373685|GI events in patients with moderate GI risk treated with NSAIDS|gi events in patients with moderate gi risk treated with nsaids
544840|NCT00373698|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
544841|NCT00373698|Delivery of Health Care, Integrated|delivery of health care, integrated
544842|NCT00373698|Primary Health Care|primary health care
544843|NCT00373698|Veterans|veterans
544844|NCT00373698|Depression|depression
544845|NCT00373724|sacroiliac joint|sacroiliac joint
544846|NCT00373724|low back pain|low back pain
544847|NCT00373724|radiofrequency|radiofrequency
544848|NCT00373750|Native American health|native american health
544849|NCT00373750|Teen pregnancy|teen pregnancy
544850|NCT00373750|Family strengthening|family strengthening
544851|NCT00373750|Substance abuse prevention|substance abuse prevention
544852|NCT00373750|Injury prevention|injury prevention
544853|NCT00373763|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
544854|NCT00373763|tracheal occlusion|tracheal occlusion
544855|NCT00373763|fetus|fetus
544856|NCT00373763|fetal surgery|fetal surgery
544857|NCT00373763|fetoscopy|fetoscopy
544858|NCT00373776|mucosal|mucosal
544859|NCT00373776|leishmaniasis|leishmaniasis
544860|NCT00373776|miltefosine|miltefosine
544861|NCT00373789|Botulinum Toxin A|botulinum toxin a
544862|NCT00373789|Urinary Incontinence|urinary incontinence
544864|NCT00373815|acute GVHD|acute gvhd
544865|NCT00373815|Immunosuppression|immunosuppression
544866|NCT00373828|Chest Pain|chest pain
544867|NCT00373828|Chest Wall|chest wall
544868|NCT00373828|Angina Pectoris|angina pectoris
544869|NCT00373828|Atypical Chest Pain|atypical chest pain
544870|NCT00373828|Physical Examination|physical examination
544871|NCT00373828|Myocardial Perfusion Imaging|myocardial perfusion imaging
544872|NCT00373828|Observational Study|observational study
544873|NCT00373828|Non-Cardiac Chest Pain|non-cardiac chest pain
544874|NCT00373828|Ischemic Heart Disease|ischemic heart disease
544875|NCT00373841|Lung|lung
544876|NCT00373841|Fibrosis|fibrosis
544877|NCT00373841|Idiopathic|idiopathic
544878|NCT00373841|Biomarkers|biomarkers
544879|NCT00373841|Genomics|genomics
544880|NCT00373841|Longitudinal|longitudinal
544881|NCT00373854|Hypoglycemia|hypoglycemia
544882|NCT00373854|Endothelial function|endothelial function
544883|NCT00373867|Secondary prevention|secondary prevention
544884|NCT00373867|Physical therapy|physical therapy
702584|NCT00976833|ICU|icu
544885|NCT00373867|Fear-avoidance beliefs|fear-avoidance beliefs
544886|NCT00373867|Disability|disability
544887|NCT00373880|Aripiprazole|aripiprazole
544888|NCT00373880|Cocaine abuse|cocaine abuse
544889|NCT00373893|Pain|pain
544890|NCT00373893|Hyperalgesia|hyperalgesia
544891|NCT00373893|capsaicin|capsaicin
544892|NCT00373906|MALT Lymphoma, Bortezomib|malt lymphoma, bortezomib
544893|NCT00373932|Exercise|exercise
544894|NCT00373932|Physical Activity|physical activity
544895|NCT00373932|Adherence|adherence
544896|NCT00373945|HLA-B*5701|hla-b*5701
544897|NCT00373945|pharmacogenetic marker|pharmacogenetic marker
544898|NCT00373945|hypersensitivity to abacavir,|hypersensitivity to abacavir,
544899|NCT00373945|retrospective analysis|retrospective analysis
544900|NCT00373971|Activities of daily living|activities of daily living
544901|NCT00373971|Elderly|elderly
544902|NCT00373971|Nutrition|nutrition
544903|NCT00373971|Postoperative|postoperative
544904|NCT00373971|Hip fractures|hip fractures
544905|NCT00373971|Hip replacement|hip replacement
544906|NCT00373971|Knee replacement|knee replacement
544907|NCT00373984|shoulder|shoulder
544908|NCT00373984|thoracotomy|thoracotomy
544909|NCT00374010|end-of-life decision making|end-of-life decision making
544910|NCT00374010|advance care planning|advance care planning
544911|NCT00374023|Zinc|zinc
544912|NCT00374023|vitamin A|vitamin a
544913|NCT00374023|immunity|immunity
544914|NCT00374023|morbidity|morbidity
544915|NCT00374023|height gain|height gain
544916|NCT00374023|weight gain|weight gain
544917|NCT00374023|Children aged between 1 and 3 years|children aged between 1 and 3 years
544918|NCT00374023|Weight for age between 70% and 61% of NCHS standard|weight for age between 70% and 61% of nchs standard
544919|NCT00374023|Acute diarrhoeal Patients|acute diarrhoeal patients
544920|NCT00374023|No signs of vitamin A deficiency|no signs of vitamin a deficiency
544921|NCT00374023|Who has not received measles vaccine|who has not received measles vaccine
544922|NCT00374036|chemotherapy|chemotherapy
544923|NCT00374036|stomach cancer metastatic|stomach cancer metastatic
544924|NCT00374036|Capecitabine|capecitabine
544925|NCT00374036|Irinotecan|irinotecan
544926|NCT00374049|Prostate|prostate
544927|NCT00374049|vaccine|vaccine
544928|NCT00374049|immunosuppression|immunosuppression
544929|NCT00374049|dendritic cells|dendritic cells
544930|NCT00374062|Mohs Surgery|mohs surgery
544931|NCT00374075|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
544932|NCT00374075|Valproic Acid|valproic acid
544933|NCT00374088|N-acetylcysteine|n-acetylcysteine
544934|NCT00374088|Myocardial dysfunction|myocardial dysfunction
544935|NCT00374088|Transposition of the Great Arteries|transposition of the great arteries
544936|NCT00374101|PPIs,|ppis,
544937|NCT00374101|endoscopic therapy,|endoscopic therapy,
544938|NCT00374101|peptic ulcers,|peptic ulcers,
544939|NCT00374101|upper gastrointestinal bleeding,|upper gastrointestinal bleeding,
544940|NCT00374101|non-variceal upper gastrointestinal bleeding|non-variceal upper gastrointestinal bleeding
544941|NCT00374114|cervical|cervical
544942|NCT00374114|dysplasia|dysplasia
544943|NCT00374127|Marijuana|marijuana
544944|NCT00374127|Comparison between joints and blunts|comparison between joints and blunts
544945|NCT00374127|Pharmacokinetic effects|pharmacokinetic effects
544946|NCT00374140|small cell|small cell
544947|NCT00374140|lung|lung
544948|NCT00374153|Alcohol|alcohol
544949|NCT00374153|Drinking|drinking
544950|NCT00374153|College|college
544951|NCT00374153|Motivational|motivational
544952|NCT00374153|Feedback|feedback
544953|NCT00374153|Assessment|assessment
544954|NCT00374166|Anti-anxiety agents|anti-anxiety agents
544955|NCT00374166|antidepressive agents|antidepressive agents
544956|NCT00374166|controlled clinical trial|controlled clinical trial
544957|NCT00374192|Menopause|menopause
544958|NCT00374192|Insomnia|insomnia
544959|NCT00374192|Depression|depression
544960|NCT00374192|Anxiety|anxiety
544961|NCT00374192|Sleep|sleep
544962|NCT00374192|Lunesta|lunesta
544963|NCT00374192|Quality of Life|quality of life
544964|NCT00374205|Ghana|ghana
544965|NCT00374205|Effectiveness|effectiveness
544966|NCT00374205|Safety|safety
544967|NCT00374205|Drug-Resistance|drug-resistance
544969|NCT00374205|Coartem|coartem
544970|NCT00374205|Arsucam|arsucam
544971|NCT00374218|Carbohydrate|carbohydrate
544972|NCT00374218|Glycemic index|glycemic index
544973|NCT00374218|Randomized|randomized
544974|NCT00374218|Double-blind|double-blind
544975|NCT00374218|Glucose|glucose
544976|NCT00374218|Insulin|insulin
544977|NCT00374218|C-reactive protein|c-reactive protein
544978|NCT00374231|Liver|liver
544979|NCT00374231|Transplant|transplant
544980|NCT00374231|Corticosteroid withdrawal|corticosteroid withdrawal
544981|NCT00374231|Tacrolimus|tacrolimus
544982|NCT00374231|CellCept|cellcept
544983|NCT00374231|MMF|mmf
544984|NCT00374231|Mycophenolate mofetil|mycophenolate mofetil
544985|NCT00374244|schizophrenia|schizophrenia
544986|NCT00374244|pimozide|pimozide
544987|NCT00374244|clozapine|clozapine
544988|NCT00374257|NB-UVB|nb-uvb
544989|NCT00374257|cGVHD|cgvhd
544990|NCT00374270|Diabetes (type I and type II)|diabetes (type i and type ii)
544991|NCT00374283|Monitoring|monitoring
544992|NCT00374283|Polyomavirus|polyomavirus
544993|NCT00374283|Kidney|kidney
544994|NCT00374283|Pancreas|pancreas
544995|NCT00374283|Transplant|transplant
544996|NCT00374296|Leukemia|leukemia
544997|NCT00374296|MDS|mds
544998|NCT00374296|Phase II|phase ii
544999|NCT00374296|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
545000|NCT00374296|High Risk Myelodysplastic Syndromes (MDS)|high risk myelodysplastic syndromes (mds)
545001|NCT00374309|Hemorrhagic Fever|hemorrhagic fever
545002|NCT00374309|Healthy|healthy
545003|NCT00374309|Immunity|immunity
545004|NCT00374309|T -Cells|t -cells
545005|NCT00374309|Filovirus|filovirus
545006|NCT00374309|Healthy Volunteer|healthy volunteer
545007|NCT00374309|HV|hv
545008|NCT00374322|Breast Cancer|breast cancer
545009|NCT00374322|ErbB2-overexpressing|erbb2-overexpressing
545010|NCT00374322|early-stage breast cancer|early-stage breast cancer
545011|NCT00374322|adjuvant|adjuvant
545012|NCT00374335|prospective cohort study|prospective cohort study
545013|NCT00374348|Schizophrenia with OCD|schizophrenia with ocd
545014|NCT00374348|Schizophrenia with-comorbid symptoms of Obsessive Compulsive Disorder(OCD)|schizophrenia with-comorbid symptoms of obsessive compulsive disorder(ocd)
545015|NCT00374361|insulin sensitivity|insulin sensitivity
545016|NCT00374361|endothelial function|endothelial function
545017|NCT00374361|adolescence|adolescence
545019|NCT00374361|puberty|puberty
545020|NCT00374374|probiotic|probiotic
545021|NCT00374387|Healthy women|healthy women
545022|NCT00374400|Kidney|kidney
545023|NCT00374400|Transplant|transplant
545024|NCT00374400|Paired donation|paired donation
545025|NCT00374400|Living donor|living donor
545026|NCT00374413|DDD|ddd
545027|NCT00374413|artificial disc|artificial disc
545028|NCT00374426|depression|depression
545029|NCT00374426|diabetes mellitus|diabetes mellitus
545030|NCT00374426|depression recurrence|depression recurrence
545032|NCT00374439|adolescents|adolescents
545033|NCT00374439|prevention|prevention
545035|NCT00374452|hypertension|hypertension
545036|NCT00374452|practice guidelines|practice guidelines
545037|NCT00374452|quality of health care|quality of health care
545038|NCT00374452|decision support systems|decision support systems
545039|NCT00374452|evidence-based medicine|evidence-based medicine
545040|NCT00374452|medical informatics|medical informatics
545041|NCT00374465|Dilated Cardiomyopathy|dilated cardiomyopathy
545042|NCT00374465|Heart Failure|heart failure
545043|NCT00374478|Scopolamine|scopolamine
545044|NCT00374478|Antiemetic|antiemetic
545045|NCT00374478|Task performance and analysis|task performance and analysis
545046|NCT00374478|Psychomotor vigilance test|psychomotor vigilance test
545048|NCT00374491|Bone Screw|bone screw
545049|NCT00374491|Knee|knee
545050|NCT00374517|Mycobacterium Tuberculosis|mycobacterium tuberculosis
545051|NCT00374517|Pimonidazole Hydrochloride|pimonidazole hydrochloride
545052|NCT00374517|Recurrent Tuberculosis|recurrent tuberculosis
545053|NCT00374517|Hypoxyprobe|hypoxyprobe
545054|NCT00374517|mRNA Expression|mrna expression
545055|NCT00374517|Pulmonary Tuberculosis|pulmonary tuberculosis
545056|NCT00374543|Bipolar Disorder|bipolar disorder
545057|NCT00374543|Generalized Anxiety Disorder|generalized anxiety disorder
545058|NCT00374543|Double-blind|double-blind
545059|NCT00374543|Placebo-controlled|placebo-controlled
545060|NCT00374543|Ziprasidone|ziprasidone
545061|NCT00374556|eszopiclone|eszopiclone
545062|NCT00374556|insomnia|insomnia
545063|NCT00374569|Gymnastics, Computerized Dynamic Posturography, Balance|gymnastics, computerized dynamic posturography, balance
545064|NCT00374582|Bioelectric impedance analysis|bioelectric impedance analysis
545065|NCT00374582|BIA|bia
545066|NCT00374582|ESLD|esld
545067|NCT00374582|LVP|lvp
545068|NCT00374582|Large volume paracentesis|large volume paracentesis
545069|NCT00374582|Ascites|ascites
545070|NCT00374582|Liver|liver
545071|NCT00374582|Hepatic|hepatic
545072|NCT00374595|Kidney Transplant|kidney transplant
545073|NCT00374595|Vascular Risk|vascular risk
545074|NCT00374595|inflammation|inflammation
545075|NCT00374595|Diabetes|diabetes
545076|NCT00374595|Insulin resistance|insulin resistance
545077|NCT00374595|Chronic kidney disease|chronic kidney disease
545078|NCT00374608|pediatric|pediatric
545079|NCT00374608|congenital complete heart block|congenital complete heart block
545080|NCT00374608|dual chamber pacemaker|dual chamber pacemaker
545081|NCT00374647|Renal|renal
545082|NCT00374647|Kidney|kidney
545083|NCT00374647|Transplant|transplant
545084|NCT00374660|Irofulven|irofulven
545085|NCT00374660|Oxaliplatin|oxaliplatin
545086|NCT00374673|TMS|tms
545087|NCT00374673|chronic pain|chronic pain
545088|NCT00374673|fibromyalgia|fibromyalgia
545089|NCT00374673|IBS|ibs
545090|NCT00374673|burning mouth syndrome|burning mouth syndrome
545091|NCT00374673|predictive factors|predictive factors
545092|NCT00374686|cytomegalovirus|cytomegalovirus
544457|NCT00372489|CKD|ckd
545093|NCT00374686|kidney|kidney
545094|NCT00374686|transplantation|transplantation
545095|NCT00374686|valganciclovir|valganciclovir
545096|NCT00374686|preemptive|preemptive
545097|NCT00374699|Velcade|velcade
545098|NCT00374699|Bortezomib|bortezomib
545099|NCT00374699|CHOP|chop
545100|NCT00374699|Peripheral T-cell lymphomas(PTCLs)|peripheral t-cell lymphomas(ptcls)
545101|NCT00374699|natural killer (NK)-cell lymphomas|natural killer (nk)-cell lymphomas
545102|NCT00374712|Phosphate|phosphate
545103|NCT00374712|Dialysis|dialysis
545104|NCT00374712|Klotho|klotho
545105|NCT00374712|Hemodialysis|hemodialysis
545106|NCT00374725|Ulcerative Colitis|ulcerative colitis
545107|NCT00374725|Probiotic|probiotic
545108|NCT00374725|Placebo controlled trial|placebo controlled trial
545109|NCT00374725|Lactobacillus rhamnosus|lactobacillus rhamnosus
545110|NCT00374725|Lactobacillus acidophilus|lactobacillus acidophilus
545111|NCT00374738|Guided Imagery for Trauma (GIFT)|guided imagery for trauma (gift)
545112|NCT00374738|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
585514|NCT00513097|Focus Groups|focus groups
545113|NCT00374738|Military Sexual Trauma (MST)|military sexual trauma (mst)
545114|NCT00374738|Military Sexual Trauma - related PTSD|military sexual trauma - related ptsd
545115|NCT00374751|Samarium|samarium
545116|NCT00374751|Kyphoplasty|kyphoplasty
545117|NCT00374751|Pain management|pain management
545118|NCT00374751|Bone metastases|bone metastases
545119|NCT00374751|Histologically proven malignancy in the primary site|histologically proven malignancy in the primary site
545120|NCT00374751|Radiographic evidence of bone metastasis|radiographic evidence of bone metastasis
545121|NCT00374751|Significant pain equal or more than score 5|significant pain equal or more than score 5
545122|NCT00374751|Karnofsky Performance status >40|karnofsky performance status >40
545123|NCT00374751|The patient must sign a study specific informed consent|the patient must sign a study specific informed consent
545124|NCT00374764|Autism, Applied Behavioral Analysis, Risperidone|autism, applied behavioral analysis, risperidone
545125|NCT00374777|Insomnia|insomnia
545126|NCT00374777|schizophrenia|schizophrenia
545127|NCT00374777|manic-depressive psychosis|manic-depressive psychosis
545128|NCT00374777|zolpidem|zolpidem
545129|NCT00374790|Lead toxicity|lead toxicity
545130|NCT00374803|Kidney|kidney
545131|NCT00374803|Transplant|transplant
545132|NCT00374803|Corticosteroid|corticosteroid
545133|NCT00374803|Myfortic|myfortic
545134|NCT00374829|randomised prospective trial|randomised prospective trial
545135|NCT00374829|medication refill compliance|medication refill compliance
545136|NCT00374829|hypertension|hypertension
545137|NCT00374829|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
545138|NCT00374829|information technology based patient support system|information technology based patient support system
545139|NCT00374829|process of care, quality of life, pharmacoeconomics|process of care, quality of life, pharmacoeconomics
545140|NCT00374829|multidisciplinary patient management|multidisciplinary patient management
545141|NCT00374842|Influenza vaccine|influenza vaccine
545142|NCT00374842|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
545143|NCT00374894|2,3-dimercaptosuccinic acid|2,3-dimercaptosuccinic acid
545144|NCT00374894|Blood Lead Levels|blood lead levels
545145|NCT00374894|children|children
545146|NCT00374894|multi-nutrients|multi-nutrients
545147|NCT00374920|bipolar|bipolar
545148|NCT00374920|mania|mania
545149|NCT00374920|mixed|mixed
545150|NCT00374933|AML|aml
545151|NCT00374933|ALL|all
545152|NCT00374933|MDS|mds
545153|NCT00374933|Allogeneic transplant|allogeneic transplant
545154|NCT00374933|Acute Myelogenous Leukemia|acute myelogenous leukemia
545155|NCT00374933|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
545156|NCT00374933|Myelodysplastic Syndrome|myelodysplastic syndrome
545157|NCT00374933|Adoptive cell therapy|adoptive cell therapy
545158|NCT00374933|Non-myeloablative|non-myeloablative
545159|NCT00374959|Prevention of pneumonia|prevention of pneumonia
545160|NCT00374959|ceftriaxone|ceftriaxone
545161|NCT00374959|continuous aspiration|continuous aspiration
545162|NCT00374959|subglottic secretions|subglottic secretions
545163|NCT00374959|Mechanical ventilation with Endotracheal intubation.|mechanical ventilation with endotracheal intubation.
545164|NCT00374959|Absence of infection|absence of infection
545165|NCT00374985|chemoradiation|chemoradiation
545166|NCT00374985|docetaxel|docetaxel
545167|NCT00374985|oxaliplatin|oxaliplatin
545168|NCT00374985|gastric|gastric
545169|NCT00374985|neoadjuvant|neoadjuvant
545170|NCT00374985|radiochemotherapy|radiochemotherapy
545171|NCT00374998|Malaria|malaria
545172|NCT00374998|Vaccine|vaccine
545173|NCT00374998|Prime-boost|prime-boost
545174|NCT00375011|MELD-Model of End Stage Liver Disease score|meld-model of end stage liver disease score
545175|NCT00375011|CTP-Child-Turcotte-Pugh score|ctp-child-turcotte-pugh score
545176|NCT00375011|MEGX-monoethylglycinexylidide-resultant of metabolism of lidocaine|megx-monoethylglycinexylidide-resultant of metabolism of lidocaine
545177|NCT00375011|HCC-Hepatocellular carcinoma|hcc-hepatocellular carcinoma
545178|NCT00375011|HCV-Hepatitis C virus|hcv-hepatitis c virus
544538|NCT00372645|Healthy|healthy
545179|NCT00375011|NASH-Non-alcoholic Steatohepatitis|nash-non-alcoholic steatohepatitis
545180|NCT00375024|Patient navigation|patient navigation
545181|NCT00375024|Breast cancer|breast cancer
545182|NCT00375024|Colon cancer|colon cancer
545183|NCT00375024|Questionnaire|questionnaire
545184|NCT00375037|hand washing|hand washing
545185|NCT00375037|cluster randomized trial|cluster randomized trial
545186|NCT00375037|performance feedback|performance feedback
545187|NCT00375037|healthcare workers|healthcare workers
545188|NCT00375037|Hand hygiene|hand hygiene
545189|NCT00375037|hand washing adherence|hand washing adherence
545190|NCT00375063|left main stenosis|left main stenosis
545191|NCT00375063|Percutaneous Coronary Intervention|percutaneous coronary intervention
545192|NCT00375063|Coronary Artery Bypass Grafting|coronary artery bypass grafting
545193|NCT00368459|raloxifene, women|raloxifene, women
545194|NCT00368472|Refractory|refractory
545195|NCT00368472|Partial|partial
545196|NCT00368472|Seizures|seizures
545197|NCT00368485|diaphragm electrical activity|diaphragm electrical activity
545198|NCT00368485|non invasive ventilation|non invasive ventilation
545199|NCT00368485|patient ventilator interaction|patient ventilator interaction
545200|NCT00368498|teicoplanin|teicoplanin
545201|NCT00368511|Fall Prevention|fall prevention
545202|NCT00368511|Dynamic Posturography|dynamic posturography
545203|NCT00368511|Nolwenn Effect|nolwenn effect
545204|NCT00368511|Music Listening|music listening
545205|NCT00368524|cocaine dependence|cocaine dependence
545206|NCT00368524|mental disorder|mental disorder
545207|NCT00368524|dual diagnoses|dual diagnoses
545208|NCT00368524|homelessness|homelessness
545209|NCT00368537|skin infection|skin infection
545210|NCT00368537|antibiotics|antibiotics
545211|NCT00368550|Alcohol Drinking|alcohol drinking
545212|NCT00368550|Alcohol Dependence|alcohol dependence
545213|NCT00368550|Sertraline Pharmacotherapy|sertraline pharmacotherapy
545214|NCT00368550|Alcoholism Subtypes|alcoholism subtypes
545215|NCT00368550|Early- versus Late-Onset Alcoholism|early- versus late-onset alcoholism
545216|NCT00368576|SB-480848|sb-480848
545217|NCT00368576|methacholine challenge|methacholine challenge
545218|NCT00368576|asthma|asthma
545219|NCT00368576|inhaled steroid|inhaled steroid
545220|NCT00368589|atherosclerotic plaque|atherosclerotic plaque
545221|NCT00368589|USPIO|uspio
545222|NCT00368589|Atheroma|atheroma
545223|NCT00368589|thrombo-embolic stroke|thrombo-embolic stroke
545224|NCT00368589|magnetic resonance imaging|magnetic resonance imaging
545225|NCT00368589|Ultra small Super-Paramagnetic Iron Oxide|ultra small super-paramagnetic iron oxide
545226|NCT00368615|melanoma|melanoma
545227|NCT00368615|malignant melanoma|malignant melanoma
545228|NCT00368628|acute ischemic stroke|acute ischemic stroke
545229|NCT00368628|sleep apnea|sleep apnea
545230|NCT00368628|continuous positive airway pressure|continuous positive airway pressure
545231|NCT00368667|Anorexia Nervosa|anorexia nervosa
545232|NCT00368667|Body Composition|body composition
545233|NCT00368667|Metabolic Rate|metabolic rate
545234|NCT00368680|Respiratory Distress Syndrome|respiratory distress syndrome
545235|NCT00368680|Early Bubble CPAP|early bubble cpap
545236|NCT00368680|Mechanical Ventilation|mechanical ventilation
545237|NCT00368680|Surfactant|surfactant
545238|NCT00368706|solifenacin|solifenacin
545239|NCT00368706|Overactive bladder|overactive bladder
545240|NCT00368706|Urinary incontinence|urinary incontinence
545241|NCT00368706|Treatment outcomes|treatment outcomes
545242|NCT00368706|VESIcare|vesicare
545243|NCT00368732|Congenital Heart Defects|congenital heart defects
545244|NCT00368758|Meteorism|meteorism
545245|NCT00368758|Bloating|bloating
545246|NCT00368758|Irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
545247|NCT00368758|Probiotics|probiotics
545248|NCT00368758|Bowel gas|bowel gas
545249|NCT00368771|Irritable Bowel Syndrome|irritable bowel syndrome
545250|NCT00368771|Abdominal Pain|abdominal pain
545251|NCT00368771|Abdominal Discomfort|abdominal discomfort
545252|NCT00368771|Diarrhea|diarrhea
545253|NCT00368771|Constipation|constipation
545255|NCT00368797|Gene Therapy|gene therapy
545257|NCT00368797|CLI|cli
545258|NCT00368810|Children|children
545259|NCT00368810|Cross-Sectional|cross-sectional
545260|NCT00368810|Glycosylphosphatidylinositol|glycosylphosphatidylinositol
545261|NCT00368810|Cytokines|cytokines
545262|NCT00368810|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
545263|NCT00368810|Malaria|malaria
545264|NCT00368823|point of care|point of care
545265|NCT00368823|evidence based medicine|evidence based medicine
545266|NCT00368836|Capnography|capnography
545267|NCT00368836|Thromboembolism|thromboembolism
545268|NCT00368836|Arthroplasty|arthroplasty
545269|NCT00368836|D-dimer|d-dimer
545270|NCT00368849|Huntington Disease|huntington disease
545271|NCT00368849|Chorea|chorea
545272|NCT00368849|Attention|attention
545273|NCT00368849|ADHD|adhd
545275|NCT00368849|Strattera|strattera
545276|NCT00368849|Atomoxetine|atomoxetine
545277|NCT00368862|Alcoholism|alcoholism
545278|NCT00368862|Depression|depression
545279|NCT00368862|Efficacy study|efficacy study
545280|NCT00368862|Memantine|memantine
545281|NCT00368862|Escitalopram|escitalopram
545282|NCT00368901|Aranesp|aranesp
545283|NCT00368901|Anemia|anemia
545284|NCT00368901|Kidney Disease|kidney disease
545285|NCT00368901|Hemoglobin|hemoglobin
545286|NCT00368901|darbepoetin alfa|darbepoetin alfa
545287|NCT00368901|QoL|qol
545288|NCT00368914|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
545289|NCT00368940|Memory Deficits|memory deficits
545290|NCT00368940|Geriatric Depression|geriatric depression
545291|NCT00368940|Cognitive Impairment|cognitive impairment
545292|NCT00368940|Executive Dysfunction|executive dysfunction
545293|NCT00368940|Disability|disability
545294|NCT00368940|Problem Solving Therapy|problem solving therapy
545295|NCT00368966|Pneumococcal|pneumococcal
545296|NCT00368966|Pediatric|pediatric
545297|NCT00368966|Vaccine|vaccine
545298|NCT00368979|Benign Prostatic Hyperplasia BPH dutasteride|benign prostatic hyperplasia bph dutasteride
545299|NCT00369005|Transfusions|transfusions
545300|NCT00369005|Erythrocyte|erythrocyte
545301|NCT00369005|Anemia|anemia
545302|NCT00369005|Brain|brain
545303|NCT00369005|Infant, Premature|infant, premature
545304|NCT00369018|photodynamic therapy|photodynamic therapy
545305|NCT00369018|methyl aminolevulinate|methyl aminolevulinate
545306|NCT00369018|hexaminolevulinate|hexaminolevulinate
545307|NCT00369018|dose-finding|dose-finding
545308|NCT00369018|cervical dysplasia|cervical dysplasia
545309|NCT00369031|HIV|hiv
545310|NCT00369031|vaccine|vaccine
545311|NCT00369031|nasal immunization|nasal immunization
545312|NCT00369044|decompensated heart failure|decompensated heart failure
545313|NCT00369044|prednisone|prednisone
545314|NCT00369044|diuretics|diuretics
545315|NCT00369044|diuresis|diuresis
545316|NCT00369057|Intraocular pressure|intraocular pressure
545317|NCT00369057|Prostatectomy|prostatectomy
545318|NCT00369057|Robotic|robotic
545319|NCT00369057|Glaucoma|glaucoma
545320|NCT00369057|Carbon dioxide|carbon dioxide
545321|NCT00369070|AMG 706|amg 706
545322|NCT00369070|Bevacizumab|bevacizumab
545323|NCT00369070|Paclitaxel and Carboplatin|paclitaxel and carboplatin
545324|NCT00369070|Randomized|randomized
545325|NCT00369070|Non-Small Cell Lung Cancer|non-small cell lung cancer
545326|NCT00369083|Frail elderly|frail elderly
545327|NCT00369083|Hospital at home|hospital at home
545254|NCT00368771|IBS|ibs
545328|NCT00369096|Peritoneal Dialysis|peritoneal dialysis
545329|NCT00369096|Bemiparin|bemiparin
545330|NCT00369096|Icodextrin|icodextrin
545331|NCT00369096|Peritoneal Transport Disorders|peritoneal transport disorders
545332|NCT00369109|recurrent colon cancer|recurrent colon cancer
545333|NCT00369109|stage III colon cancer|stage iii colon cancer
545334|NCT00369109|stage IV colon cancer|stage iv colon cancer
545335|NCT00369109|recurrent rectal cancer|recurrent rectal cancer
545336|NCT00369109|stage III rectal cancer|stage iii rectal cancer
545337|NCT00369109|stage IV rectal cancer|stage iv rectal cancer
545338|NCT00369109|recurrent pancreatic cancer|recurrent pancreatic cancer
545339|NCT00369109|stage II pancreatic cancer|stage ii pancreatic cancer
545340|NCT00369109|stage III pancreatic cancer|stage iii pancreatic cancer
545341|NCT00369109|stage IV pancreatic cancer|stage iv pancreatic cancer
545342|NCT00369109|recurrent breast cancer|recurrent breast cancer
545343|NCT00369109|stage IIIA breast cancer|stage iiia breast cancer
545344|NCT00369109|stage IIIB breast cancer|stage iiib breast cancer
545345|NCT00369109|stage IIIC breast cancer|stage iiic breast cancer
545346|NCT00369109|stage IV breast cancer|stage iv breast cancer
545347|NCT00369135|work|work
545348|NCT00369135|Musculoskeletal Disorders|musculoskeletal disorders
545349|NCT00369148|glinides|glinides
545350|NCT00369148|premixed insulin|premixed insulin
545351|NCT00369148|combination therapy|combination therapy
545352|NCT00369148|glycemic control|glycemic control
545353|NCT00369213|Crossover trial|crossover trial
545354|NCT00369213|condom failure|condom failure
545355|NCT00369213|additional spermicidal lubricant|additional spermicidal lubricant
545356|NCT00369226|Velcade|velcade
545357|NCT00369226|Bortezomib|bortezomib
545358|NCT00369226|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
545359|NCT00369226|GVHD|gvhd
545360|NCT00369239|Early psychosis|early psychosis
545361|NCT00369239|premorbid functioning|premorbid functioning
545362|NCT00369239|Scale for Assessment of Insight|scale for assessment of insight
545363|NCT00369239|Risperdal Consta|risperdal consta
545364|NCT00369239|risperidone long acting injectable|risperidone long acting injectable
545365|NCT00369252|Nimotuzumab|nimotuzumab
545366|NCT00369252|TheraCIM|theracim
545367|NCT00369252|H-R3|h-r3
545368|NCT00369252|Solid tumours|solid tumours
545369|NCT00369252|EGFR|egfr
545370|NCT00369252|Monoclonal antibody|monoclonal antibody
545371|NCT00369265|Gastroesophageal reflux|gastroesophageal reflux
545372|NCT00369265|Laryngitis|laryngitis
545373|NCT00369265|Hoarseness|hoarseness
545374|NCT00369265|Dysphonia|dysphonia
545375|NCT00369265|Proton pump inhibitor|proton pump inhibitor
545376|NCT00369278|Renal transplantation, mycophenolate|renal transplantation, mycophenolate
545377|NCT00369304|Health|health
545378|NCT00369330|atrial fibrillation|atrial fibrillation
545379|NCT00369330|early cardioversion|early cardioversion
545380|NCT00369330|electrical cardioversion|electrical cardioversion
545381|NCT00369343|Major Depressive Disorder|major depressive disorder
545382|NCT00369343|vasomotor symptoms|vasomotor symptoms
545383|NCT00369343|menopause|menopause
545384|NCT00369343|diabetic neuropathy|diabetic neuropathy
545385|NCT00369343|fibromyalgia|fibromyalgia
545386|NCT00369382|Heart Transplant|heart transplant
545387|NCT00369382|Kidney Failure|kidney failure
545388|NCT00369395|melanoma|melanoma
545389|NCT00369395|antibody|antibody
545390|NCT00369395|angiogenesis|angiogenesis
545391|NCT00369395|volociximab|volociximab
545392|NCT00369408|Randomized Trial|randomized trial
545393|NCT00369408|Medication for Heavy Drinking|medication for heavy drinking
545394|NCT00369408|Naltrexone Treatment|naltrexone treatment
545395|NCT00369408|Daily vs. Targeted Administration|daily vs. targeted administration
545396|NCT00369421|Dietary Therapy|dietary therapy
545397|NCT00369421|Biochemical Defects|biochemical defects
545398|NCT00369421|Enzyme Defects|enzyme defects
545399|NCT00369421|Transport|transport
545400|NCT00369421|Rare Diseases|rare diseases
545401|NCT00369421|Varied Disorders|varied disorders
545402|NCT00369421|Screening|screening
545403|NCT00369421|Relatives|relatives
545404|NCT00369447|Non small cell lung cancer|non small cell lung cancer
545405|NCT00369447|NSCLC|nsclc
545406|NCT00369447|Nimotuzumab|nimotuzumab
545407|NCT00369447|TheraCIM|theracim
545408|NCT00369447|h-R3|h-r3
545409|NCT00369447|YM BioSciences|ym biosciences
545410|NCT00369447|Radiation|radiation
545411|NCT00369447|Non small cell lung cancer, Stage IIb, III and IV|non small cell lung cancer, stage iib, iii and iv
545412|NCT00369460|recurrent pancreatic cancer|recurrent pancreatic cancer
545413|NCT00369460|stage III pancreatic cancer|stage iii pancreatic cancer
545414|NCT00369460|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
545415|NCT00369460|stage IV pancreatic cancer|stage iv pancreatic cancer
545416|NCT00369473|rheumatoid arthritis|rheumatoid arthritis
545417|NCT00369486|diabetic|diabetic
545418|NCT00369486|macular|macular
545419|NCT00369486|edema|edema
545420|NCT00369486|peribulbar|peribulbar
545421|NCT00369486|triamcinolone|triamcinolone
545422|NCT00369486|acetonide|acetonide
545423|NCT00369486|laser|laser
545424|NCT00369486|photocoagulation|photocoagulation
545425|NCT00369486|intraocular|intraocular
545426|NCT00369486|DME|dme
545427|NCT00369512|Phase II|phase ii
545428|NCT00369512|Erlotinib|erlotinib
545429|NCT00369512|Radiotherapy|radiotherapy
545430|NCT00369512|Squamous Cell Carcinomas|squamous cell carcinomas
545431|NCT00369512|Cutaneous|cutaneous
545432|NCT00369512|Stage III|stage iii
545433|NCT00369538|Podocyte - podocyturia - microparticles - angiotensin receptor antagonist - glomerulosclerosis|podocyte - podocyturia - microparticles - angiotensin receptor antagonist - glomerulosclerosis
545434|NCT00369538|Patients presenting with stable glomerular nephropathy with proteinuria, normal or slightly altered renal function, with hypertension|patients presenting with stable glomerular nephropathy with proteinuria, normal or slightly altered renal function, with hypertension
545435|NCT00369564|neurotoxicity|neurotoxicity
545436|NCT00369564|peripheral neuropathy|peripheral neuropathy
545437|NCT00369564|stage I Wilms tumor|stage i wilms tumor
545438|NCT00369564|stage II Wilms tumor|stage ii wilms tumor
545439|NCT00369564|stage III Wilms tumor|stage iii wilms tumor
545440|NCT00369564|stage IV Wilms tumor|stage iv wilms tumor
545441|NCT00369564|stage V Wilms tumor|stage v wilms tumor
545442|NCT00369564|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
545443|NCT00369564|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
545444|NCT00369564|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
545445|NCT00369564|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
545446|NCT00369564|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
545447|NCT00369564|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
545448|NCT00369564|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
545449|NCT00369564|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
545450|NCT00369564|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
545451|NCT00369564|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
545452|NCT00369564|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
545453|NCT00369564|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
545543|NCT00375245|melanoma|melanoma
545454|NCT00369564|childhood Burkitt lymphoma|childhood burkitt lymphoma
545455|NCT00369564|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
545456|NCT00369564|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
545457|NCT00369564|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
545458|NCT00369564|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
545459|NCT00369564|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
545460|NCT00369577|Agitation|agitation
545461|NCT00369577|Schizophrenia|schizophrenia
545462|NCT00369603|Alzheimer's Disease|alzheimer's disease
545463|NCT00369603|fMRI|fmri
545464|NCT00369603|Functional Neuroimaging|functional neuroimaging
545465|NCT00369603|Allosteric Nicotinic Receptor Modulation|allosteric nicotinic receptor modulation
545466|NCT00369603|Acetylcholinesterase Inhibition|acetylcholinesterase inhibition
545467|NCT00369603|Head to head|head to head
545468|NCT00369603|Dose escalation|dose escalation
545469|NCT00369603|Biomarker|biomarker
545470|NCT00369629|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
545471|NCT00369629|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
545472|NCT00369629|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
545473|NCT00369629|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
545474|NCT00369629|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
545475|NCT00369629|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
545476|NCT00369629|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
585516|NCT00513110|Adenosine|adenosine
545477|NCT00369629|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
545478|NCT00369629|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
545479|NCT00369629|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
545480|NCT00369642|Cognitive-behavioral therapy|cognitive-behavioral therapy
545481|NCT00369642|Children|children
545482|NCT00369642|Obsessive-compulsive disorder|obsessive-compulsive disorder
545483|NCT00369642|Intensive Cognitive-behavioral therapy|intensive cognitive-behavioral therapy
545484|NCT00369642|Weekly Cognitive-behavioral therapy|weekly cognitive-behavioral therapy
545485|NCT00369668|Rehabilitation|rehabilitation
545486|NCT00369668|Physical Therapy Techniques|physical therapy techniques
545487|NCT00369668|Occupational Therapy|occupational therapy
545488|NCT00369668|Upper Extremity; Motor skills|upper extremity; motor skills
545489|NCT00375089|Early-onset Morbid Obesity|early-onset morbid obesity
545490|NCT00375102|acupuncture|acupuncture
545491|NCT00375102|relaxation response|relaxation response
545492|NCT00375102|homeless|homeless
545493|NCT00375102|veterans|veterans
545494|NCT00375102|randomized trials|randomized trials
545495|NCT00375128|Malaria|malaria
545496|NCT00375128|Vaccine|vaccine
545497|NCT00375128|Prime-boost|prime-boost
545498|NCT00375128|Challenge|challenge
545499|NCT00375154|Acute respiratory failure|acute respiratory failure
545500|NCT00375154|Prehospital care|prehospital care
545501|NCT00375154|Noninvasive ventilation|noninvasive ventilation
545502|NCT00375154|Emergency|emergency
545503|NCT00375167|Recovery, Hope, Empowerment, Randomized Control Trial|recovery, hope, empowerment, randomized control trial
545504|NCT00375180|food|food
545505|NCT00375180|diet|diet
545506|NCT00375180|mucositis|mucositis
545507|NCT00375180|xerostomia|xerostomia
545508|NCT00375180|dysphagia|dysphagia
545509|NCT00375180|taste|taste
545510|NCT00375180|smell|smell
545511|NCT00375180|head and neck|head and neck
545512|NCT00375180|radiation|radiation
545513|NCT00375180|chemotherapy|chemotherapy
545514|NCT00375193|small cell lung cancer|small cell lung cancer
545515|NCT00375193|amrubicin|amrubicin
545516|NCT00375206|PowderMed, DNA vaccine, influenza|powdermed, dna vaccine, influenza
545517|NCT00375219|Chronic Myeloid Leukemia|chronic myeloid leukemia
545519|NCT00375219|HHT|hht
545520|NCT00375219|Homoharringtonine|homoharringtonine
545521|NCT00375219|Omacetaxine|omacetaxine
545522|NCT00375219|T315i|t315i
545523|NCT00375219|ChemGenex|chemgenex
545524|NCT00375219|ChemGenex Pharmaceuticals|chemgenex pharmaceuticals
545525|NCT00375232|Exercise-Induced Bronchospasm|exercise-induced bronchospasm
545526|NCT00375232|Asthma|asthma
545527|NCT00375232|Cardiopulmonary Stress Test|cardiopulmonary stress test
545528|NCT00375232|Eucapnic Voluntary Hyperventilation|eucapnic voluntary hyperventilation
545529|NCT00375232|Induced sputum|induced sputum
545530|NCT00375245|phase I|phase i
545531|NCT00375245|metastatic|metastatic
545532|NCT00375245|advanced cancer|advanced cancer
545533|NCT00375245|lung cancer|lung cancer
545534|NCT00375245|renal cancer|renal cancer
545535|NCT00375245|kidney cancer|kidney cancer
545536|NCT00375245|head and neck cancer|head and neck cancer
545537|NCT00375245|bladder cancer|bladder cancer
545538|NCT00375245|breast cancer|breast cancer
545539|NCT00375245|colorectal cancer|colorectal cancer
545540|NCT00375245|esophagus|esophagus
545541|NCT00375245|GIST|gist
545542|NCT00375245|liver cancer|liver cancer
545544|NCT00375245|mesothelioma|mesothelioma
545545|NCT00375245|lymphoma|lymphoma
545546|NCT00375245|ovary cancer|ovary cancer
545547|NCT00375245|ovarian cancer|ovarian cancer
545548|NCT00375245|pancreas cancer|pancreas cancer
545549|NCT00375245|pancreatic cancer|pancreatic cancer
545550|NCT00375245|prostate cancer|prostate cancer
545551|NCT00375245|stomach cancer|stomach cancer
545552|NCT00375245|thyroid cancer|thyroid cancer
545553|NCT00375245|Metastatic solid tumor|metastatic solid tumor
545554|NCT00375258|Adult trauma patients with ongoing significant haemorrhage or at risk of significant haemorrhage|adult trauma patients with ongoing significant haemorrhage or at risk of significant haemorrhage
545555|NCT00375271|Monitoring, Intraoperative|monitoring, intraoperative
545556|NCT00375271|Hemodynamic Processes|hemodynamic processes
545557|NCT00375271|Treatment Protocols|treatment protocols
545558|NCT00375297|antidepressants|antidepressants
545559|NCT00375297|sexual dysfunction|sexual dysfunction
545560|NCT00375297|women|women
545561|NCT00375297|sildenafil|sildenafil
545562|NCT00375297|PDE5 inhibitors|pde5 inhibitors
545563|NCT00375297|serotonin reuptake inhibitor antidepressants|serotonin reuptake inhibitor antidepressants
545564|NCT00375310|Phase I|phase i
545565|NCT00375310|Pancreas Cancer|pancreas cancer
545566|NCT00375310|Chemo-radiotherapy|chemo-radiotherapy
545567|NCT00375323|factor VIII inhibitor|factor viii inhibitor
545568|NCT00375336|Aortic valve|aortic valve
545569|NCT00375336|Calcification|calcification
545570|NCT00375336|Endothelial dysfunction|endothelial dysfunction
545571|NCT00375336|Calcium metabolism|calcium metabolism
545572|NCT00375336|Coronary artery disease|coronary artery disease
545573|NCT00375349|fatty liver|fatty liver
545574|NCT00375349|statin|statin
545575|NCT00375349|non-alcoholic|non-alcoholic
545576|NCT00375362|nitroglycerin|nitroglycerin
545577|NCT00375362|morphine|morphine
545578|NCT00375362|patient controlled analgesia|patient controlled analgesia
545579|NCT00375362|total knee arthroplasty|total knee arthroplasty
545580|NCT00375375|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
545581|NCT00375375|Hepatic encephalopathy|hepatic encephalopathy
545582|NCT00375375|Subclinical hepatic encephalopathy|subclinical hepatic encephalopathy
545583|NCT00375375|Health related quality of life|health related quality of life
545584|NCT00375388|Type 2 diabetes mellitus|type 2 diabetes mellitus
545585|NCT00375388|Metformin on top of insulin therapy|metformin on top of insulin therapy
545586|NCT00375388|Randomized placebo-controlled trial|randomized placebo-controlled trial
545587|NCT00375388|Diabetes regulation|diabetes regulation
545588|NCT00375388|Daily dose of insulin|daily dose of insulin
545589|NCT00375388|Body Weight|body weight
545590|NCT00375388|Patients with type 2 diabetes|patients with type 2 diabetes
545591|NCT00375388|Intensive insulin therapy|intensive insulin therapy
545592|NCT00375388|Age: 30-80 years|age: 30-80 years
545593|NCT00375388|Body mass index|body mass index
545594|NCT00375388|Lipids|lipids
545595|NCT00375388|Blood Pressure|blood pressure
545596|NCT00375388|Endothelial function|endothelial function
545597|NCT00375388|Low grade inflammation|low grade inflammation
545598|NCT00375388|Fibrinolysis|fibrinolysis
545599|NCT00375388|Microvascular complications|microvascular complications
545600|NCT00375388|Macrovascular complications|macrovascular complications
545601|NCT00375414|Enteral tube feeding,|enteral tube feeding,
545602|NCT00375414|endoscopic gastropexy,|endoscopic gastropexy,
545603|NCT00375414|percutaneous endoscopic gastrostomy,|percutaneous endoscopic gastrostomy,
545604|NCT00375414|PEG|peg
545605|NCT00375648|Prostate|prostate
545606|NCT00375648|Cancer|cancer
545607|NCT00375648|Bone metastases|bone metastases
545608|NCT00375648|Zoledronic acid|zoledronic acid
545609|NCT00375648|Bone metastases-related pain|bone metastases-related pain
545610|NCT00375648|Prostate cancer|prostate cancer
545611|NCT00375661|hepatocellular carcinoma|hepatocellular carcinoma
545612|NCT00375687|Prostate cancer|prostate cancer
545613|NCT00375700|food|food
545614|NCT00375700|diet|diet
545615|NCT00375700|oral supplement|oral supplement
545616|NCT00375700|head and neck cancer|head and neck cancer
545617|NCT00375700|radiation|radiation
545618|NCT00375713|Dermatitis|dermatitis
545619|NCT00375713|Eczema|eczema
545620|NCT00375713|Pruritus|pruritus
545621|NCT00375713|Xyzal|xyzal
545622|NCT00375713|Zyrtec|zyrtec
545623|NCT00375713|Levocetirizine|levocetirizine
545624|NCT00375713|Cetirizine|cetirizine
545625|NCT00375726|Dengue Fever|dengue fever
545626|NCT00375726|Dengue Vaccine|dengue vaccine
545627|NCT00375726|Dengue Virus|dengue virus
545628|NCT00375726|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
545629|NCT00375726|Dengue Shock Syndrome|dengue shock syndrome
545630|NCT00375739|Actinic Keratosis|actinic keratosis
545631|NCT00375739|Topical|topical
545632|NCT00375739|Solar Keratosis|solar keratosis
545633|NCT00375739|Sun Spots|sun spots
545634|NCT00375739|Dermatology|dermatology
545635|NCT00375752|Breast cancer|breast cancer
545636|NCT00375752|Anti tumor potential|anti tumor potential
545637|NCT00375752|Letrozole|letrozole
545638|NCT00375752|Zoledronic acid|zoledronic acid
545639|NCT00375752|Neoadjuvant treatment|neoadjuvant treatment
545640|NCT00375752|Hormone responsive breast cancer|hormone responsive breast cancer
545641|NCT00375765|Dutasteride|dutasteride
545642|NCT00375765|BPH|bph
545643|NCT00375765|Prostate cancer|prostate cancer
545644|NCT00375765|Gene expression|gene expression
545645|NCT00375765|PSA|psa
703594|NCT00980174|men|men
545646|NCT00375778|Parkinson's Disease|parkinson's disease
545647|NCT00375778|Positron Emission Tomography|positron emission tomography
545648|NCT00375778|Memantine|memantine
545649|NCT00375778|NMDA antagonists|nmda antagonists
545650|NCT00375778|Cerebral Blood Flow|cerebral blood flow
545651|NCT00375778|Cerebral Metabolic Rate of Oxygen|cerebral metabolic rate of oxygen
545652|NCT00375791|Relapsed Multiple Myeloma|relapsed multiple myeloma
545653|NCT00375791|Refractory Multiple Myeloma|refractory multiple myeloma
545654|NCT00375804|Endometrial Cancer|endometrial cancer
545655|NCT00375856|arthroplasty|arthroplasty
545656|NCT00375856|knee|knee
545657|NCT00375856|computer-assist|computer-assist
545658|NCT00375856|gait|gait
545659|NCT00375856|Total knee arthroplasty|total knee arthroplasty
545660|NCT00375856|knee prostheses|knee prostheses
545661|NCT00375869|Neuroprotection|neuroprotection
545662|NCT00375869|neuron specific enolase|neuron specific enolase
545663|NCT00375869|CSF glutamate levels|csf glutamate levels
545664|NCT00375869|Darbepoetin Alfa|darbepoetin alfa
545665|NCT00375895|Cyclosporin|cyclosporin
545666|NCT00375895|Peginterferon|peginterferon
545667|NCT00375895|Ribavirin|ribavirin
545668|NCT00375895|Chronic hepatitis C|chronic hepatitis c
545669|NCT00375895|Liver transplantation|liver transplantation
545670|NCT00375908|Neonatal Encephalopathy|neonatal encephalopathy
545671|NCT00375908|Hypoxic-Ischemic Brain Injury|hypoxic-ischemic brain injury
545672|NCT00375908|Umbilical Cord Blood|umbilical cord blood
545673|NCT00375908|Proteomics|proteomics
545674|NCT00375921|diet|diet
545675|NCT00375921|food|food
545676|NCT00375921|taste|taste
545677|NCT00375921|smell|smell
545678|NCT00375921|head and neck|head and neck
545679|NCT00375921|radiation|radiation
545680|NCT00375921|chemotherapy|chemotherapy
545681|NCT00375934|Bunionectomy|bunionectomy
545682|NCT00375934|Bunion surgery|bunion surgery
545683|NCT00375934|Post-operative pain|post-operative pain
545684|NCT00375947|exercise|exercise
545685|NCT00375947|hand disability|hand disability
545686|NCT00375947|arthritis|arthritis
545687|NCT00375947|AUSCAN|auscan
545688|NCT00375960|Pain associated with diabetes Type I or Type II|pain associated with diabetes type i or type ii
545689|NCT00375960|Neuropathic Pain due to diabetes|neuropathic pain due to diabetes
545690|NCT00375960|Diabetic peripheral neuropathic pain|diabetic peripheral neuropathic pain
545691|NCT00375960|Pain|pain
545692|NCT00375960|Diabetes with burning sensation in the arms and/or legs|diabetes with burning sensation in the arms and/or legs
545693|NCT00375960|Diabetes with tingling sensation in the arms and/or legs|diabetes with tingling sensation in the arms and/or legs
545694|NCT00375960|Neuropathic Pain Due to Diabetes Type I or Type II|neuropathic pain due to diabetes type i or type ii
545695|NCT00375973|Fatigue|fatigue
545696|NCT00375973|Fatigue syndrome, chronic|fatigue syndrome, chronic
545697|NCT00375973|Chronic fatigue syndrome|chronic fatigue syndrome
545699|NCT00375973|Fibromyalgia|fibromyalgia
545700|NCT00375986|Cesarean delivery|cesarean delivery
545701|NCT00375986|Placental removal|placental removal
545702|NCT00375986|Blood loss|blood loss
545703|NCT00376012|Chemotherapy for TB in HIV infection|chemotherapy for tb in hiv infection
545704|NCT00376025|Kashin-Beck Disease|kashin-beck disease
545705|NCT00376025|Kashin-Beck Osteoarthropathy|kashin-beck osteoarthropathy
545706|NCT00376038|GSK189074|gsk189074
545707|NCT00376038|T2DM|t2dm
545708|NCT00376038|GSK189075|gsk189075
545709|NCT00376038|Glucophage|glucophage
545710|NCT00376038|Obesity|obesity
545711|NCT00376038|Diabetes|diabetes
545712|NCT00376038|Metformin|metformin
545713|NCT00376038|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
545714|NCT00376038|Drug Interaction|drug interaction
545715|NCT00376051|frontotemporal lobar degeneration|frontotemporal lobar degeneration
545716|NCT00376051|frontotemporal dementia|frontotemporal dementia
545717|NCT00376051|serotonin|serotonin
545718|NCT00376051|dementia|dementia
545719|NCT00376051|behavioural disturbances|behavioural disturbances
545720|NCT00376064|Growth hormone (GH)|growth hormone (gh)
545721|NCT00376064|IGF-1|igf-1
545722|NCT00376064|Acromegaly|acromegaly
545723|NCT00376064|Pituitary adenoma|pituitary adenoma
545724|NCT00376064|Brain tumor|brain tumor
545725|NCT00376064|Brain cancer|brain cancer
545726|NCT00376064|Octreotide acetate|octreotide acetate
545727|NCT00376077|Thrombocytopenia|thrombocytopenia
545728|NCT00376077|pediatric|pediatric
545729|NCT00376077|methylprednisolone|methylprednisolone
545730|NCT00376077|intracranial hemorrhage|intracranial hemorrhage
545731|NCT00376077|intravenous immune globulin|intravenous immune globulin
545732|NCT00376090|MVA vector|mva vector
545733|NCT00376090|Immunogenicity|immunogenicity
545734|NCT00376090|HIV vaccine|hiv vaccine
545735|NCT00376090|HIV preventative vaccine|hiv preventative vaccine
545736|NCT00376103|Brain Tumor|brain tumor
545737|NCT00376103|GBM|gbm
545738|NCT00376103|Glioblastoma Multiforme|glioblastoma multiforme
545739|NCT00376103|Glioblastoma|glioblastoma
545740|NCT00376103|Brachytherapy|brachytherapy
545741|NCT00376103|Temozolomide|temozolomide
545742|NCT00376103|Temodar|temodar
545743|NCT00376116|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
545744|NCT00376116|Pacemaker|pacemaker
545745|NCT00376116|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
545746|NCT00376116|Heart failure|heart failure
545747|NCT00376116|Predictor|predictor
545748|NCT00376116|Mortality|mortality
545749|NCT00376116|Rehospitalization|rehospitalization
545750|NCT00376116|Telemedicine|telemedicine
545751|NCT00376116|Home Monitoring|home monitoring
545752|NCT00376142|Intention|intention
545753|NCT00376142|Behaviour|behaviour
545754|NCT00376142|Evidence-based practice|evidence-based practice
545755|NCT00376142|Intervention|intervention
545756|NCT00376155|malaria|malaria
545757|NCT00376155|prevention|prevention
545758|NCT00376155|intermittent|intermittent
545759|NCT00376155|drugs|drugs
545760|NCT00376181|type 2 diabetes|type 2 diabetes
545761|NCT00376181|hypertension|hypertension
545762|NCT00376181|blood pressure|blood pressure
545763|NCT00376181|diastolic blood pressure|diastolic blood pressure
545764|NCT00376194|Pervasive Developmental Disorder|pervasive developmental disorder
545765|NCT00376194|Alternative Therapy|alternative therapy
545766|NCT00376194|Autism|autism
545767|NCT00376194|Asperger's Disorder|asperger's disorder
545768|NCT00376194|Clinical Trial|clinical trial
545769|NCT00376194|Autism Spectrum Disorder|autism spectrum disorder
545770|NCT00376194|ASD|asd
545771|NCT00376194|Asperger Disorder|asperger disorder
545772|NCT00376207|Cerebral infarct|cerebral infarct
545773|NCT00376207|physical exercise|physical exercise
545774|NCT00376207|insulin sensitivity|insulin sensitivity
545775|NCT00376207|low grade chronic inflammation|low grade chronic inflammation
545776|NCT00376207|intervention|intervention
545777|NCT00376207|HOMA|homa
545778|NCT00376207|PASE|pase
545779|NCT00376220|Bipolar|bipolar
545780|NCT00376220|Depression|depression
545781|NCT00376233|Schizophrenia,|schizophrenia,
545782|NCT00376233|Cannabinoids,|cannabinoids,
545783|NCT00376233|Arachidonic Acid,|arachidonic acid,
545784|NCT00376233|Niacin,|niacin,
545785|NCT00376233|Prostaglandins|prostaglandins
545786|NCT00376259|lamivudine resistance|lamivudine resistance
545787|NCT00376259|Hepatitis B virus|hepatitis b virus
545788|NCT00376272|atrial fibrillation,atrial remodeling,dysrhythmias,valsartan|atrial fibrillation,atrial remodeling,dysrhythmias,valsartan
545789|NCT00376298|incontinence|incontinence
545790|NCT00376298|prostate cancer|prostate cancer
545791|NCT00376298|interstitial cystitis|interstitial cystitis
545792|NCT00376311|Lequesne's algo-functional score|lequesne's algo-functional score
545793|NCT00376311|Biomarkers of joint metabolism|biomarkers of joint metabolism
545794|NCT00376324|pharmacokinetics|pharmacokinetics
545795|NCT00376324|human bone|human bone
545796|NCT00376337|Invasive Aspergillosis|invasive aspergillosis
545797|NCT00376337|Salvage Therapy|salvage therapy
545798|NCT00376337|Micafungin|micafungin
546374|NCT00377871|Biological|biological
545799|NCT00376350|Low Back Pain|low back pain
545800|NCT00376350|Chronic|chronic
545801|NCT00376350|Manipulation|manipulation
545802|NCT00376350|Chiropractic|chiropractic
545803|NCT00376350|Massage|massage
545804|NCT00376363|glaucoma|glaucoma
545805|NCT00376363|Ahmed implant|ahmed implant
545806|NCT00376363|Baerveldt implant|baerveldt implant
545807|NCT00376376|levofloxacin|levofloxacin
545808|NCT00376376|pharmacodynamic|pharmacodynamic
545809|NCT00376376|bactericidal|bactericidal
545810|NCT00376402|Pandemic|pandemic
545811|NCT00376402|Influenza|influenza
545812|NCT00376402|Prevention|prevention
545813|NCT00376402|Vaccine|vaccine
545814|NCT00376402|Prevention of Pandemic Influenza|prevention of pandemic influenza
545815|NCT00376415|Lessertia frutescens|lessertia frutescens
545816|NCT00376415|Sutherlandia frutescens|sutherlandia frutescens
545817|NCT00376415|Phase 1 clinical trial|phase 1 clinical trial
545818|NCT00376415|Human safety study|human safety study
545819|NCT00376428|Cystic Fibrosis Transmembrane Conductance Regulator|cystic fibrosis transmembrane conductance regulator
545820|NCT00376428|Premature termination codon|premature termination codon
545821|NCT00376428|Gentamicin-induced readthrough|gentamicin-induced readthrough
545822|NCT00376441|vaginal|vaginal
545823|NCT00376441|incontinence|incontinence
545824|NCT00376441|sexual function|sexual function
545825|NCT00376454|neuropathic pain|neuropathic pain
545826|NCT00376467|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
545827|NCT00376467|Philadelphia positive|philadelphia positive
545828|NCT00376467|Adult|adult
545829|NCT00376467|Elderly|elderly
545830|NCT00376467|Imatinib|imatinib
545831|NCT00376480|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
545832|NCT00376480|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
545833|NCT00376480|refractory anemia with excess blasts|refractory anemia with excess blasts
545834|NCT00376480|refractory anemia|refractory anemia
545835|NCT00376480|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
97893|NCT02677038|Pancreatic Cancer|pancreatic cancer
545836|NCT00376480|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
545837|NCT00376480|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
545838|NCT00376480|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
545839|NCT00376480|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
545840|NCT00376480|secondary acute myeloid leukemia|secondary acute myeloid leukemia
545841|NCT00376480|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
545842|NCT00376480|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
545843|NCT00376480|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
545844|NCT00376480|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
545845|NCT00376480|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
545846|NCT00376480|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
545847|NCT00376480|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
545848|NCT00376493|Abortion|abortion
545849|NCT00376493|Infection|infection
545850|NCT00376493|Antibiotics|antibiotics
545851|NCT00376493|Treatment|treatment
545852|NCT00376493|Pregnancy complications|pregnancy complications
545853|NCT00376506|Aspiration|aspiration
545854|NCT00376506|Rehabilitation|rehabilitation
545855|NCT00376506|Swallowing Disorders|swallowing disorders
545857|NCT00376506|Parkinson's Disease|parkinson's disease
545858|NCT00376506|Dysphagia|dysphagia
545859|NCT00376506|Parkinson Disease|parkinson disease
545860|NCT00376506|PD|pd
545861|NCT00376519|graft versus host disease|graft versus host disease
545862|NCT00376519|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
545863|NCT00376519|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
545864|NCT00376519|secondary acute myeloid leukemia|secondary acute myeloid leukemia
545865|NCT00376519|refractory anemia with excess blasts|refractory anemia with excess blasts
545866|NCT00376519|myelodysplastic syndromes|myelodysplastic syndromes
545867|NCT00376519|chronic myelogenous leukemia|chronic myelogenous leukemia
545868|NCT00376519|refractory anemia|refractory anemia
545869|NCT00376519|prolymphocytic leukemia|prolymphocytic leukemia
545870|NCT00376519|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
545871|NCT00376519|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
545872|NCT00376519|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
545873|NCT00376519|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
545874|NCT00376519|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
545875|NCT00376519|follicular lymphoma|follicular lymphoma
545876|NCT00376519|mantle cell lymphoma|mantle cell lymphoma
545877|NCT00376519|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
545878|NCT00376519|secondary myelofibrosis|secondary myelofibrosis
545879|NCT00376519|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
545880|NCT00376519|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
545881|NCT00376519|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
545882|NCT00376519|marginal zone lymphoma|marginal zone lymphoma
545883|NCT00376519|diffuse large cell lymphoma|diffuse large cell lymphoma
545884|NCT00376519|anaplastic large cell lymphoma|anaplastic large cell lymphoma
545885|NCT00376519|lymphoblastic lymphoma|lymphoblastic lymphoma
545886|NCT00376519|immunoblastic large cell lymphoma|immunoblastic large cell lymphoma
545887|NCT00376519|multiple myeloma|multiple myeloma
545888|NCT00376532|Cardiac Ischemia|cardiac ischemia
545889|NCT00376532|Cardiac Arrhythmia|cardiac arrhythmia
545890|NCT00376532|Defibrillator|defibrillator
545891|NCT00376532|Matrix Metalloproteinase|matrix metalloproteinase
545892|NCT00376532|Genetic Polymorphism|genetic polymorphism
545893|NCT00376545|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
545894|NCT00376545|Visuomotor|visuomotor
545895|NCT00376545|Occipital Cortex|occipital cortex
545896|NCT00376545|Prefrontal Cortex|prefrontal cortex
545897|NCT00376545|Healthy Volunteer|healthy volunteer
545898|NCT00376545|HV|hv
545899|NCT00376558|cocaine dependence|cocaine dependence
545900|NCT00376571|PCI|pci
545901|NCT00376571|Bifurcation lesion|bifurcation lesion
545902|NCT00376584|Primary Hypercholesteremia|primary hypercholesteremia
545903|NCT00376584|Mixed Hyperlipidemia|mixed hyperlipidemia
545904|NCT00376597|lymphedema|lymphedema
545905|NCT00376597|stage IA breast cancer|stage ia breast cancer
545906|NCT00376597|stage IB breast cancer|stage ib breast cancer
545907|NCT00376597|stage II breast cancer|stage ii breast cancer
545908|NCT00376597|stage IIIA breast cancer|stage iiia breast cancer
545909|NCT00376597|stage IIIB breast cancer|stage iiib breast cancer
545910|NCT00376597|stage IIIC breast cancer|stage iiic breast cancer
545911|NCT00376649|crohns|crohns
545912|NCT00376649|quality of life|quality of life
545913|NCT00376649|lifestyle changing|lifestyle changing
545914|NCT00376649|remmision|remmision
545915|NCT00376662|HRT|hrt
545916|NCT00376662|Etidronate|etidronate
545917|NCT00376662|Fractures|fractures
545918|NCT00376662|Osteoporosis|osteoporosis
545919|NCT00376662|Asthma|asthma
545920|NCT00376662|Glucocorticoids|glucocorticoids
545921|NCT00376675|fatigue|fatigue
545922|NCT00376675|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
545923|NCT00376701|Choroidal Neovascularization|choroidal neovascularization
545924|NCT00376701|Photodynamic Therapy|photodynamic therapy
545925|NCT00376701|Age Related Macular Degeneration|age related macular degeneration
545926|NCT00376701|Triamcinolone Acetonide|triamcinolone acetonide
545927|NCT00376701|Avastin|avastin
545928|NCT00376701|Visudyne|visudyne
545929|NCT00376714|plethysmography|plethysmography
545930|NCT00376714|muscarinic receptor antagonist|muscarinic receptor antagonist
545931|NCT00376714|COPD|copd
545932|NCT00376714|repeat dosing|repeat dosing
545933|NCT00376727|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
545934|NCT00376740|breast cancer, postmenopausal, letrozole, zoledronic acid, adjuvant,bone mineral density|breast cancer, postmenopausal, letrozole, zoledronic acid, adjuvant,bone mineral density
545935|NCT00376753|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
545936|NCT00376753|Writer's Cramp|writer's cramp
545937|NCT00376753|Electromyogram|electromyogram
545938|NCT00376753|Focal Hand Dystonia|focal hand dystonia
545939|NCT00376753|FHD|fhd
545940|NCT00376753|Healthy Volunteer|healthy volunteer
545941|NCT00376753|HV|hv
545942|NCT00376766|Cluster seizure|cluster seizure
545943|NCT00376766|seizure clustering|seizure clustering
545944|NCT00376766|repetitive seizure|repetitive seizure
545945|NCT00376766|Drug resistant epilepsy|drug resistant epilepsy
545946|NCT00376766|Levetiracetam|levetiracetam
545947|NCT00376766|keppra|keppra
545948|NCT00376779|Haemophilus influenzae type b|haemophilus influenzae type b
545949|NCT00376779|Double-blind|double-blind
545950|NCT00376779|Finland|finland
545951|NCT00376779|randomized|randomized
545952|NCT00376779|phase 2|phase 2
545953|NCT00376779|GSK Biologicals|gsk biologicals
545954|NCT00376779|DTPa-HBV-IPV/Hib|dtpa-hbv-ipv/hib
545955|NCT00376792|stage IIB prostate cancer|stage iib prostate cancer
545956|NCT00376792|stage IIA prostate cancer|stage iia prostate cancer
545957|NCT00376792|stage III prostate cancer|stage iii prostate cancer
545958|NCT00376792|adenocarcinoma of the prostate|adenocarcinoma of the prostate
545959|NCT00376805|stage IV breast cancer|stage iv breast cancer
545960|NCT00376805|male breast cancer|male breast cancer
545961|NCT00376805|recurrent breast cancer|recurrent breast cancer
545962|NCT00376818|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
545963|NCT00376818|adult anaplastic astrocytoma|adult anaplastic astrocytoma
545964|NCT00376818|adult anaplastic ependymoma|adult anaplastic ependymoma
545965|NCT00376818|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
545966|NCT00376818|adult giant cell glioblastoma|adult giant cell glioblastoma
545967|NCT00376818|adult gliosarcoma|adult gliosarcoma
545968|NCT00376818|adult medulloblastoma|adult medulloblastoma
545969|NCT00376818|adult anaplastic meningioma|adult anaplastic meningioma
545970|NCT00376818|adult papillary meningioma|adult papillary meningioma
545971|NCT00376818|adult mixed glioma|adult mixed glioma
545972|NCT00376818|recurrent adult brain tumor|recurrent adult brain tumor
546375|NCT00377871|aortic|aortic
545973|NCT00376818|adult glioblastoma|adult glioblastoma
545974|NCT00376818|adult grade III meningioma|adult grade iii meningioma
545975|NCT00376831|colonoscopy|colonoscopy
545976|NCT00376831|conscious sedation|conscious sedation
545977|NCT00376831|midazolam|midazolam
545978|NCT00376831|ketamine|ketamine
545979|NCT00376831|fentanyl|fentanyl
545980|NCT00376844|stage I endometrial carcinoma|stage i endometrial carcinoma
545981|NCT00376857|Indocyanine green, toxicity, epiretinal membrane, visual field defect|indocyanine green, toxicity, epiretinal membrane, visual field defect
545982|NCT00376870|PCI|pci
545983|NCT00376870|STENT|stent
545984|NCT00376870|Coronary|coronary
545985|NCT00376870|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
545986|NCT00376883|multiple myeloma|multiple myeloma
545987|NCT00376883|pamidronate prophylaxis|pamidronate prophylaxis
545988|NCT00376883|dose comparison|dose comparison
545989|NCT00376883|quality of life|quality of life
545990|NCT00376883|skeletal event|skeletal event
545991|NCT00376883|response|response
545992|NCT00376883|survival|survival
545993|NCT00376896|IBS fMRI|ibs fmri
545994|NCT00376909|breast cancer|breast cancer
545995|NCT00376909|cervical cancer|cervical cancer
545996|NCT00376909|colon cancer|colon cancer
545997|NCT00376909|rectal cancer|rectal cancer
545998|NCT00376922|pain|pain
545999|NCT00376922|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
546000|NCT00376922|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
546001|NCT00376922|acute undifferentiated leukemia|acute undifferentiated leukemia
546002|NCT00376922|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
546003|NCT00376922|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
546004|NCT00376922|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
546005|NCT00376922|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
546006|NCT00376922|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
546007|NCT00376922|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
546008|NCT00376922|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
546009|NCT00376922|chronic eosinophilic leukemia|chronic eosinophilic leukemia
546010|NCT00376922|primary myelofibrosis|primary myelofibrosis
546011|NCT00376922|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
546012|NCT00376922|chronic neutrophilic leukemia|chronic neutrophilic leukemia
546013|NCT00376922|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
546014|NCT00376922|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
546015|NCT00376922|essential thrombocythemia|essential thrombocythemia
546016|NCT00376922|extramedullary plasmacytoma|extramedullary plasmacytoma
546017|NCT00376922|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
546018|NCT00376922|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
546019|NCT00376922|polycythemia vera|polycythemia vera
546020|NCT00376922|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
546021|NCT00376922|primary systemic amyloidosis|primary systemic amyloidosis
546022|NCT00376922|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
546023|NCT00376922|prolymphocytic leukemia|prolymphocytic leukemia
546024|NCT00376922|secondary acute myeloid leukemia|secondary acute myeloid leukemia
546025|NCT00376922|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
546026|NCT00376922|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
546027|NCT00376922|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
546028|NCT00376922|stage III multiple myeloma|stage iii multiple myeloma
546029|NCT00376922|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
546030|NCT00376922|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
546031|NCT00376922|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
546032|NCT00376922|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
546033|NCT00376922|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
546034|NCT00376922|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
546035|NCT00376922|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
546036|NCT00376922|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
546037|NCT00376922|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
546038|NCT00376922|mast cell leukemia|mast cell leukemia
546039|NCT00376922|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
546040|NCT00376922|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
546041|NCT00376922|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
546042|NCT00376922|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
546043|NCT00376922|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
546044|NCT00376922|refractory hairy cell leukemia|refractory hairy cell leukemia
546045|NCT00376922|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
546046|NCT00376922|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
546376|NCT00377871|heart|heart
546047|NCT00376922|untreated hairy cell leukemia|untreated hairy cell leukemia
546048|NCT00376922|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
546049|NCT00376922|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
546050|NCT00376922|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
546051|NCT00376922|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
546052|NCT00376922|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
546053|NCT00376922|anaplastic large cell lymphoma|anaplastic large cell lymphoma
546054|NCT00376922|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
546055|NCT00376922|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
546056|NCT00376922|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
546057|NCT00376922|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
546058|NCT00376922|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
546059|NCT00376922|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
546060|NCT00376922|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
546061|NCT00376922|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
546062|NCT00376922|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
546063|NCT00376922|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
546064|NCT00376922|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
546065|NCT00376922|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
546066|NCT00376922|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
546067|NCT00376922|Waldenström macroglobulinemia|waldenström macroglobulinemia
545518|NCT00375219|CML|cml
546068|NCT00376922|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
546069|NCT00376922|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
546070|NCT00376922|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
546071|NCT00376922|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
546313|NCT00377572|anti-IgE|anti-ige
546072|NCT00376922|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
546073|NCT00376922|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
546074|NCT00376922|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
546075|NCT00376922|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
546076|NCT00376922|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
546077|NCT00376922|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
546078|NCT00376922|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
546079|NCT00376922|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
546080|NCT00376922|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
546081|NCT00376922|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
546082|NCT00376922|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
546083|NCT00376922|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
546084|NCT00376922|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
546085|NCT00376922|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
546086|NCT00376922|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
546087|NCT00376922|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
546088|NCT00376922|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
546089|NCT00376922|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
546090|NCT00376922|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
546091|NCT00376922|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
546092|NCT00376922|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
546093|NCT00376922|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
546094|NCT00376922|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
546095|NCT00376922|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
546096|NCT00376922|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
546097|NCT00376922|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
546098|NCT00376922|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
546099|NCT00376922|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
546100|NCT00376922|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
546101|NCT00376922|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
546102|NCT00376922|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
546103|NCT00376922|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
546104|NCT00376922|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
546105|NCT00376922|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
546106|NCT00376922|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
546107|NCT00376922|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
546108|NCT00376922|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
546109|NCT00376922|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
546110|NCT00376922|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
546111|NCT00376922|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
546112|NCT00376922|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
546113|NCT00376922|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
546114|NCT00376922|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
546115|NCT00376922|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
546116|NCT00376922|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
546117|NCT00376922|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
546118|NCT00376922|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
546119|NCT00376922|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
546120|NCT00376922|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
546121|NCT00376922|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
546122|NCT00376922|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
546123|NCT00376922|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
546124|NCT00376922|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
546125|NCT00376922|stage I mantle cell lymphoma|stage i mantle cell lymphoma
546126|NCT00376922|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
546127|NCT00376922|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
546128|NCT00376922|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
546129|NCT00376922|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
546130|NCT00376922|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
546314|NCT00377585|Elderly|elderly
546131|NCT00376922|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
546132|NCT00376922|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
546133|NCT00376922|splenic marginal zone lymphoma|splenic marginal zone lymphoma
546134|NCT00376922|stage I marginal zone lymphoma|stage i marginal zone lymphoma
546135|NCT00376922|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
546136|NCT00376922|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
546137|NCT00376922|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
546138|NCT00376922|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
546139|NCT00376922|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
546140|NCT00376922|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
546141|NCT00376922|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
546142|NCT00376922|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
546143|NCT00376922|isolated plasmacytoma of bone|isolated plasmacytoma of bone
546144|NCT00376922|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
546145|NCT00376922|refractory multiple myeloma|refractory multiple myeloma
546146|NCT00376922|stage I multiple myeloma|stage i multiple myeloma
546147|NCT00376922|stage II multiple myeloma|stage ii multiple myeloma
546148|NCT00376922|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
546149|NCT00376922|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
546150|NCT00376935|Treatment Experienced|treatment experienced
546151|NCT00376948|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
546152|NCT00376948|stage III pancreatic cancer|stage iii pancreatic cancer
546153|NCT00376948|stage IV pancreatic cancer|stage iv pancreatic cancer
546154|NCT00376948|recurrent pancreatic cancer|recurrent pancreatic cancer
546155|NCT00376961|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
546156|NCT00376961|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
546157|NCT00376961|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
546158|NCT00376961|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
546159|NCT00376974|glaucoma|glaucoma
546160|NCT00376974|compliance|compliance
546161|NCT00376974|intraocular pressure|intraocular pressure
546163|NCT00376987|renal cell carcinoma|renal cell carcinoma
546164|NCT00376987|bladder cancer|bladder cancer
546165|NCT00376987|cervical cancer|cervical cancer
546166|NCT00376987|esophageal cancer|esophageal cancer
546167|NCT00376987|gastric cancer|gastric cancer
546168|NCT00376987|adult acute myeloid leukemia|adult acute myeloid leukemia
546169|NCT00376987|pancreatic cancer|pancreatic cancer
546170|NCT00376987|hypopharyngeal cancer|hypopharyngeal cancer
546171|NCT00376987|lip and oral cavity cancer|lip and oral cavity cancer
546172|NCT00376987|laryngeal cancer|laryngeal cancer
546173|NCT00376987|nasopharyngeal cancer|nasopharyngeal cancer
546174|NCT00376987|oropharyngeal cancer|oropharyngeal cancer
546175|NCT00376987|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
546176|NCT00376987|non-small cell lung cancer|non-small cell lung cancer
546177|NCT00376987|small cell lung cancer|small cell lung cancer
546178|NCT00376987|adult primary liver cancer|adult primary liver cancer
546162|NCT00376974|video|video
546179|NCT00376987|tongue cancer|tongue cancer
546180|NCT00376987|tobacco use disorder|tobacco use disorder
546181|NCT00377026|weight loss|weight loss
546182|NCT00377026|postpartum|postpartum
546183|NCT00377026|weight retention|weight retention
546184|NCT00377039|ACR 1990 Fibromyalgia|acr 1990 fibromyalgia
546185|NCT00377039|Fibromyalgia Impact Questionnaire|fibromyalgia impact questionnaire
546186|NCT00377052|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
546187|NCT00377078|recombinant human lactoferrin|recombinant human lactoferrin
546188|NCT00377091|pulmonary embolism|pulmonary embolism
546189|NCT00377091|venous thromboembolism|venous thromboembolism
546190|NCT00377091|pharmacoeconomic|pharmacoeconomic
546191|NCT00377091|heparin|heparin
546192|NCT00377091|unfractionated heparin|unfractionated heparin
546193|NCT00377091|fondaparinux|fondaparinux
546194|NCT00377091|length of stay|length of stay
546195|NCT00377091|costs|costs
546196|NCT00377091|bleeding|bleeding
546197|NCT00377091|thrombosis|thrombosis
546198|NCT00377130|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
546199|NCT00377130|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
546200|NCT00377143|warfarin|warfarin
546201|NCT00377143|pharmacogenomic|pharmacogenomic
546202|NCT00377143|CYP2C9|cyp2c9
546203|NCT00377143|VKORC1|vkorc1
546204|NCT00377143|polymorphism, single nucleotide|polymorphism, single nucleotide
546205|NCT00377156|cognitive/functional effects|cognitive/functional effects
546206|NCT00377156|tumors metastatic to brain|tumors metastatic to brain
546207|NCT00377156|stage IV breast cancer|stage iv breast cancer
546208|NCT00377156|stage IV prostate cancer|stage iv prostate cancer
546209|NCT00377156|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
546210|NCT00377156|male breast cancer|male breast cancer
546211|NCT00377156|recurrent breast cancer|recurrent breast cancer
546212|NCT00377156|recurrent prostate cancer|recurrent prostate cancer
546417|NCT00377988|Progestin|progestin
546213|NCT00377156|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
546214|NCT00377169|Treatment Experienced|treatment experienced
546215|NCT00377195|Marginal Zone Lymphoma|marginal zone lymphoma
546216|NCT00377195|Involved field radiotherapy|involved field radiotherapy
546217|NCT00377195|H. pylori|h. pylori
546218|NCT00377208|Blood Pressure, High|blood pressure, high
546219|NCT00377247|Carcinoma|carcinoma
546220|NCT00377247|Head|head
546221|NCT00377247|Neck|neck
546222|NCT00377247|Oral Cavity|oral cavity
546223|NCT00377247|Oropharynx|oropharynx
546224|NCT00377247|Mouth|mouth
546225|NCT00377260|acute otitis media, infants, children|acute otitis media, infants, children
546226|NCT00377286|Osteoarthritis|osteoarthritis
546227|NCT00377286|Knee Pain|knee pain
546228|NCT00377286|Glucosamine|glucosamine
546229|NCT00377286|MRI|mri
546230|NCT00377286|CTX-II|ctx-ii
546231|NCT00377286|Biomarkers|biomarkers
546232|NCT00377286|Skin quality|skin quality
546233|NCT00377299|Amphetamine Abuse|amphetamine abuse
546234|NCT00377299|Amphetamine Dependence|amphetamine dependence
546235|NCT00377299|Bipolar Disorder|bipolar disorder
546236|NCT00377299|Major Depressive Disorder|major depressive disorder
546237|NCT00377299|Citicoline|citicoline
546238|NCT00377312|Endocrine System Diseases|endocrine system diseases
546239|NCT00377312|MusculoSkeletal System Disease|musculoskeletal system disease
546240|NCT00377312|Hormone|hormone
546241|NCT00377312|Physiologic Properties|physiologic properties
546242|NCT00377338|Bronchoscopy|bronchoscopy
546243|NCT00377338|Diagnostic imaging|diagnostic imaging
546244|NCT00377338|Laser scanning confocal microscopy|laser scanning confocal microscopy
546245|NCT00377338|Pulmonary Alveoli|pulmonary alveoli
546246|NCT00377338|Healthy volunteers|healthy volunteers
546247|NCT00377338|Diffuse peripheral lung disease|diffuse peripheral lung disease
546248|NCT00377338|Focal peripheral lung disease|focal peripheral lung disease
546249|NCT00377351|Public Health|public health
546250|NCT00377351|Elderly Population|elderly population
546251|NCT00377351|Neurodegenerative Diseases|neurodegenerative diseases
546252|NCT00377351|Exposure|exposure
546253|NCT00377351|Lifestyle|lifestyle
546254|NCT00377364|Acetaminophen|acetaminophen
546255|NCT00377364|corticosteroids|corticosteroids
546256|NCT00377364|prednisone|prednisone
546257|NCT00377377|GH release|gh release
546258|NCT00377377|Pharmacokinetics|pharmacokinetics
546259|NCT00377377|Safety|safety
546260|NCT00377390|Immunoglobulin|immunoglobulin
546261|NCT00377390|IgE|ige
546262|NCT00377390|Omalizumab|omalizumab
546263|NCT00377403|rhinosinusitis, sinusitis, amoxicillin|rhinosinusitis, sinusitis, amoxicillin
546264|NCT00377416|Gene Transfer Techniques|gene transfer techniques
546265|NCT00377416|Gene Therapy|gene therapy
546266|NCT00377429|Epithelial Cancer|epithelial cancer
546267|NCT00377429|Epithelial Carcinoma|epithelial carcinoma
546268|NCT00377429|Epithelial Ovarian Cancer|epithelial ovarian cancer
546269|NCT00377429|Epithelial Ovarian Carcinoma|epithelial ovarian carcinoma
546270|NCT00377429|Fallopian Tube Cancer|fallopian tube cancer
546271|NCT00377429|Fallopian Tube Carcinoma|fallopian tube carcinoma
546272|NCT00377429|Ovarian Cancer|ovarian cancer
546273|NCT00377429|Ovarian Carcinoma|ovarian carcinoma
546377|NCT00377871|valve|valve
546274|NCT00377429|Ovarian Epithelial Cancer|ovarian epithelial cancer
546275|NCT00377429|Ovarian Epithelial Carcinoma|ovarian epithelial carcinoma
546276|NCT00377429|Peritoneal Cancer|peritoneal cancer
546277|NCT00377429|Peritoneal Carcinoma|peritoneal carcinoma
546278|NCT00377429|Advanced Epithelial Ovarian Cancer|advanced epithelial ovarian cancer
546279|NCT00377455|scleroderma|scleroderma
546280|NCT00377455|systemic sclerosis|systemic sclerosis
546281|NCT00377455|bosentan|bosentan
546282|NCT00377455|pulmonary hypertension|pulmonary hypertension
546283|NCT00377455|PHAROS|pharos
546284|NCT00377455|PHROS|phros
546285|NCT00377455|exercise echocardiogram|exercise echocardiogram
546286|NCT00377468|THC|thc
546287|NCT00377468|CRPS|crps
546288|NCT00377468|Pain|pain
546289|NCT00377468|Complex Regional Pain Syndrome|complex regional pain syndrome
546290|NCT00377468|Neuropathic Pain|neuropathic pain
546291|NCT00377468|Chronic|chronic
546292|NCT00377468|Prevention|prevention
546293|NCT00377494|malaria, Plasmodium falciparum, vaccine, Ghana|malaria, plasmodium falciparum, vaccine, ghana
546294|NCT00377507|catechin|catechin
546295|NCT00377507|elderly|elderly
546296|NCT00377507|mouth washing|mouth washing
546297|NCT00377507|disabled|disabled
546298|NCT00377507|colonized|colonized
546299|NCT00377533|wheelchairs|wheelchairs
546300|NCT00377533|caregivers|caregivers
546301|NCT00377533|skills|skills
546302|NCT00377546|Retinal Surgery|retinal surgery
546303|NCT00377559|Breast cancer|breast cancer
546304|NCT00377559|metastatic|metastatic
546305|NCT00377559|cardiotoxicity|cardiotoxicity
546306|NCT00377559|liposomal|liposomal
546307|NCT00377559|doxorubicin|doxorubicin
546308|NCT00377559|docetaxel|docetaxel
546309|NCT00377559|HER2/neu negative metastatic breast cancer|her2/neu negative metastatic breast cancer
546310|NCT00377572|Immunoglobulins|immunoglobulins
546311|NCT00377572|Immunoglobulin E|immunoglobulin e
546312|NCT00377572|omalizumab|omalizumab
546315|NCT00377585|Improved vaccine|improved vaccine
546316|NCT00377585|Influenza|influenza
546317|NCT00377585|Influenza disease|influenza disease
546318|NCT00377598|Herpes Zoster|herpes zoster
546319|NCT00377598|Neuralgia|neuralgia
546320|NCT00377598|Drug Therapy|drug therapy
546321|NCT00377611|Influenza vaccine|influenza vaccine
546322|NCT00377676|diabetes|diabetes
546323|NCT00377676|diabetes mellitus|diabetes mellitus
546324|NCT00377689|Accidental falls|accidental falls
546325|NCT00377689|Cerebrovascular accident|cerebrovascular accident
546326|NCT00377689|Balance|balance
546327|NCT00377689|ADL|adl
546328|NCT00377689|Self efficacy|self efficacy
546329|NCT00377689|Quality of Life|quality of life
546330|NCT00377689|Gait parameters|gait parameters
546331|NCT00377702|Coronary Heart Disease|coronary heart disease
546332|NCT00377702|Risk Factors|risk factors
546333|NCT00377702|Heart Failure|heart failure
546334|NCT00377715|Dimebon, Alzheimer's Disease, Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog)|dimebon, alzheimer's disease, alzheimer's disease assessment scale-cognitive subscale (adas-cog)
546335|NCT00377728|Seasonal Allergic Rhinitis Inflammation Vienna CHallenge Chamber|seasonal allergic rhinitis inflammation vienna challenge chamber
546336|NCT00377754|dengue virus, immunity, hemorrhagic fever, Philippines|dengue virus, immunity, hemorrhagic fever, philippines
546337|NCT00377767|Chronic Care Model|chronic care model
546338|NCT00377767|Obesity|obesity
546339|NCT00377767|Overweight|overweight
546340|NCT00377767|Children|children
546341|NCT00377767|Body Mass Index|body mass index
546342|NCT00377767|Primary Care|primary care
546343|NCT00377780|Breast cancer|breast cancer
546344|NCT00377780|metastatic|metastatic
546345|NCT00377780|cardiotoxicity|cardiotoxicity
546346|NCT00377780|liposomal|liposomal
546347|NCT00377780|doxorubicin|doxorubicin
546348|NCT00377780|trastuzumab|trastuzumab
546349|NCT00377780|docetaxel|docetaxel
546350|NCT00377780|HER2/neu positive metastatic breast cancer|her2/neu positive metastatic breast cancer
546351|NCT00377806|Superficial thrombophlebitis, diclofenac gel, non steroidal antiinflammatory drugs|superficial thrombophlebitis, diclofenac gel, non steroidal antiinflammatory drugs
546352|NCT00377819|RANKL|rankl
546353|NCT00377819|RANK|rank
546354|NCT00377819|denosumab|denosumab
546355|NCT00377819|AMG 162|amg 162
546356|NCT00377819|osteoporosis|osteoporosis
546357|NCT00377819|bone turnover|bone turnover
546358|NCT00377819|bone mineral density|bone mineral density
546359|NCT00377819|clinical trial|clinical trial
546360|NCT00377819|postmenopausal osteoporosis|postmenopausal osteoporosis
546361|NCT00377819|alendronate|alendronate
546362|NCT00377819|total hip bone mineral density|total hip bone mineral density
546363|NCT00377832|Fetal tachycardia|fetal tachycardia
546364|NCT00377832|Fever in labor|fever in labor
546365|NCT00377832|Acetaminophen|acetaminophen
546366|NCT00377832|Non reassuring fetal status|non reassuring fetal status
546367|NCT00377845|self test|self test
546368|NCT00377845|PAP smear|pap smear
546369|NCT00377845|tampon test|tampon test
546370|NCT00377845|cervical dysplasia|cervical dysplasia
546371|NCT00377858|diabetes|diabetes
546372|NCT00377858|type 2|type 2
546373|NCT00377871|Stentless|stentless
546378|NCT00377871|prosthesis|prosthesis
546379|NCT00377871|artificial|artificial
546380|NCT00377884|THA|tha
546381|NCT00377897|critical leg ischemia|critical leg ischemia
546382|NCT00377897|PAD|pad
546383|NCT00377897|cell therapy|cell therapy
546384|NCT00377910|Chronic Achilles tendinopathy|chronic achilles tendinopathy
546385|NCT00377910|Polidocanol|polidocanol
546386|NCT00377910|Ultrasound|ultrasound
546387|NCT00377910|Efficacy|efficacy
546388|NCT00377910|RCT|rct
546389|NCT00377923|pharmacodynamic and pharmacokinetic study|pharmacodynamic and pharmacokinetic study
546390|NCT00377923|Progesterone|progesterone
546391|NCT00377923|healthy volunteers|healthy volunteers
546392|NCT00377923|Endometrial decidualisation|endometrial decidualisation
546393|NCT00377936|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
546394|NCT00377936|Locally advanced|locally advanced
546395|NCT00377936|Metastatic|metastatic
546396|NCT00377949|Systemic Sclerosis|systemic sclerosis
546397|NCT00377949|Scleroderma|scleroderma
546398|NCT00377949|Pulmonary Hypertension|pulmonary hypertension
546399|NCT00377949|PHAROS|pharos
546400|NCT00377949|PHROS|phros
546401|NCT00377949|Exercise Echocardiogram|exercise echocardiogram
545856|NCT00376506|Stroke|stroke
546402|NCT00377949|Pulmonary Functional Tests|pulmonary functional tests
546403|NCT00377949|Six minute walk tests|six minute walk tests
546404|NCT00377949|6 minute walk tests|6 minute walk tests
546405|NCT00377949|Right heart catheterization|right heart catheterization
546406|NCT00377962|thoracic transplant recipients|thoracic transplant recipients
546407|NCT00377962|everolimus|everolimus
546408|NCT00377962|immunosuppressants|immunosuppressants
546409|NCT00377975|UCP-1|ucp-1
546410|NCT00377975|ephedrine|ephedrine
546411|NCT00377975|caffeine|caffeine
546412|NCT00377975|pioglitazone|pioglitazone
546413|NCT00377988|Contraception|contraception
546414|NCT00377988|Hormonal contraception|hormonal contraception
546415|NCT00377988|Oral contraception|oral contraception
546416|NCT00377988|Ethinyl estradiol|ethinyl estradiol
546418|NCT00377988|Transdermal|transdermal
546419|NCT00377988|Thrombosis|thrombosis
546420|NCT00377988|Venous thromboembolism|venous thromboembolism
546421|NCT00378001|Infertility, FSH, IVF, Ovarian stimulation|infertility, fsh, ivf, ovarian stimulation
546422|NCT00378014|Liver transplantation, everolimus, CNI|liver transplantation, everolimus, cni
546423|NCT00378027|Pulmonary Embolism|pulmonary embolism
546424|NCT00378027|PE|pe
546425|NCT00378027|Outpatient|outpatient
546426|NCT00378027|Anticoagulation|anticoagulation
546427|NCT00378053|Radiation|radiation
546428|NCT00378053|Exposure|exposure
546429|NCT00378053|Hand|hand
546430|NCT00378053|Orthopaedic|orthopaedic
546431|NCT00378053|Surgeons|surgeons
546432|NCT00378092|Schizophrenia|schizophrenia
546433|NCT00378092|Risperidone|risperidone
546434|NCT00378092|Risperdal consta|risperdal consta
546435|NCT00378105|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
546436|NCT00378118|HIV-1|hiv-1
546437|NCT00378118|HIV-2|hiv-2
546438|NCT00372541|ceftriaxone|ceftriaxone
546439|NCT00372541|chloramphenicol|chloramphenicol
546440|NCT00372541|severe pneumonia|severe pneumonia
546441|NCT00372541|children|children
546442|NCT00378157|autism|autism
546443|NCT00378157|joint attention|joint attention
546444|NCT00378157|intervention|intervention
546445|NCT00378157|joint engagement|joint engagement
546446|NCT00378157|language|language
546447|NCT00378170|intubation|intubation
546448|NCT00378170|difficulty|difficulty
546449|NCT00378170|Macintosh|macintosh
546450|NCT00378170|dental damage|dental damage
546451|NCT00378170|complications|complications
546452|NCT00378183|weight loss|weight loss
546453|NCT00378183|behavioral therapy|behavioral therapy
546454|NCT00378183|risperidone|risperidone
546455|NCT00378183|switching antipsychotics|switching antipsychotics
546456|NCT00378183|schizoaffective disorder|schizoaffective disorder
546457|NCT00378183|Risperdal|risperdal
546458|NCT00378183|schizophrenia|schizophrenia
546459|NCT00378183|olanzapine|olanzapine
546460|NCT00378183|Zyprexa|zyprexa
546461|NCT00378196|Idiopathic Parafoveal Telangiectasia (IPT)|idiopathic parafoveal telangiectasia (ipt)
546462|NCT00378196|Also Known As Idiopathic Juxtafoveal Telangiectasia (IJFT)|also known as idiopathic juxtafoveal telangiectasia (ijft)
546463|NCT00378209|relapsed multiple myeloma|relapsed multiple myeloma
546464|NCT00378209|refractory multiple myeloma|refractory multiple myeloma
546465|NCT00378222|Myeloma previously untreated|myeloma previously untreated
546466|NCT00378222|Single autologous transplantation|single autologous transplantation
546467|NCT00378222|Double autologous transplantation|double autologous transplantation
546468|NCT00378222|Complete response|complete response
546469|NCT00378235|neurosurgery, craniotomy|neurosurgery, craniotomy
546470|NCT00378235|convection-enhanced delivery|convection-enhanced delivery
546471|NCT00378235|CNS interstitial infusion|cns interstitial infusion
546472|NCT00378235|recombinant toxins|recombinant toxins
546473|NCT00378235|malignant glioma, recurrent|malignant glioma, recurrent
546474|NCT00378235|catheter,|catheter,
546475|NCT00378235|intratumoral therapy|intratumoral therapy
546476|NCT00378235|positive pressure microinfusion|positive pressure microinfusion
546477|NCT00378248|Personality disorders,|personality disorders,
546478|NCT00378248|Day treatment,|day treatment,
546479|NCT00378248|Group psychotherapy,|group psychotherapy,
546480|NCT00378248|Combined psychotherapy,|combined psychotherapy,
546481|NCT00378248|Outcome,|outcome,
546482|NCT00378248|Attachment pattern|attachment pattern
546483|NCT00378261|Rheumatoid Arthritis|rheumatoid arthritis
546484|NCT00378274|Neuropathic pain|neuropathic pain
546485|NCT00378274|Chronic pain|chronic pain
546486|NCT00378274|Depression|depression
546487|NCT00378274|Anxiety|anxiety
546488|NCT00378287|Acid Reflux|acid reflux
546489|NCT00378287|Proton Pump Inhibitor|proton pump inhibitor
546490|NCT00378287|GERD|gerd
546491|NCT00378300|Atopic Dermatitis|atopic dermatitis
546492|NCT00378300|Probiotics|probiotics
546493|NCT00378300|T Regulatory Cells|t regulatory cells
546494|NCT00378313|NSABP|nsabp
546495|NCT00378313|gemcitabine|gemcitabine
546496|NCT00378313|epirubicin|epirubicin
546497|NCT00378313|paclitaxel|paclitaxel
546498|NCT00378313|Taxol|taxol
546499|NCT00378313|breast cancer|breast cancer
546500|NCT00378313|neoadjuvant chemotherapy|neoadjuvant chemotherapy
546501|NCT00378313|primary chemotherapy|primary chemotherapy
546502|NCT00378326|paraneoplastic syndrome|paraneoplastic syndrome
546503|NCT00378339|arthrosis|arthrosis
546504|NCT00378339|gold|gold
546505|NCT00378352|Acute Myocardial Infarction|acute myocardial infarction
546506|NCT00378352|Left Ventricular Remodeling|left ventricular remodeling
546507|NCT00378352|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
546508|NCT00378352|Endothelial Progenitor Cells|endothelial progenitor cells
546509|NCT00378352|Infarct Size|infarct size
546510|NCT00378365|Acute promyelocytic leukaemia|acute promyelocytic leukaemia
546511|NCT00378365|ATRA|atra
546512|NCT00378365|Idarubicin|idarubicin
546513|NCT00378365|Arsenic trioxide|arsenic trioxide
546514|NCT00378365|Patient with a newly acute promyelocytic leukaemia (APL)|patient with a newly acute promyelocytic leukaemia (apl)
546515|NCT00378365|Unmapped MeSH term|unmapped mesh term
546516|NCT00378391|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
546517|NCT00378391|upstream abciximab|upstream abciximab
546518|NCT00378391|guideline adherence|guideline adherence
546519|NCT00378391|hospital networking|hospital networking
546520|NCT00378404|NSCLC|nsclc
546521|NCT00378404|Non-Small Cell Lung Cancer|non-small cell lung cancer
546522|NCT00378404|Non-Small Cell|non-small cell
546523|NCT00378404|Lung Cancer|lung cancer
546524|NCT00378404|Docetaxel|docetaxel
546525|NCT00378404|Radiation|radiation
546526|NCT00378404|Metastatic|metastatic
546527|NCT00378404|Recurrent|recurrent
546528|NCT00378417|Otitis Media|otitis media
546529|NCT00378417|Pneumococcal Infections|pneumococcal infections
546530|NCT00378417|Pneumococcal Vaccines|pneumococcal vaccines
546531|NCT00378417|Proportional Hazards Models|proportional hazards models
546532|NCT00378417|Prospective Studies|prospective studies
546533|NCT00378417|Streptococcus pneumoniae|streptococcus pneumoniae
546534|NCT00378417|Vaccines, Conjugate|vaccines, conjugate
546535|NCT00378469|Hepcidin|hepcidin
546536|NCT00378469|Hemojuvelin|hemojuvelin
546537|NCT00378469|Iron|iron
546538|NCT00378469|Healthy volunteers|healthy volunteers
546539|NCT00378612|trials|trials
546540|NCT00378612|stents|stents
546541|NCT00378612|coronary occlusions|coronary occlusions
546542|NCT00378638|lymph|lymph
546543|NCT00378638|node|node
546544|NCT00378638|positive|positive
546545|NCT00378638|breast|breast
546546|NCT00378638|cancer|cancer
546547|NCT00378638|metastases|metastases
546548|NCT00378638|angiogenesis|angiogenesis
546549|NCT00378638|bevacizumab|bevacizumab
546550|NCT00378638|chemotherapy|chemotherapy
546551|NCT00378651|Intubation, Endotracheal|intubation, endotracheal
546552|NCT00378651|Anesthesia, General|anesthesia, general
546553|NCT00378664|urinary incontinence|urinary incontinence
546554|NCT00378664|spinal cord injury|spinal cord injury
546555|NCT00378664|spina bifida|spina bifida
546556|NCT00378677|Powder inhalation|powder inhalation
546557|NCT00378677|Side effects|side effects
546558|NCT00378677|Nephrotoxicity|nephrotoxicity
546559|NCT00378677|Calcineurin inhibitor|calcineurin inhibitor
546560|NCT00378677|Bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
546561|NCT00378677|Forced Expiratory Volume|forced expiratory volume
546562|NCT00378690|Prostate Cancer|prostate cancer
546563|NCT00378690|Prostate Specific Antigen|prostate specific antigen
546564|NCT00378716|stage II colon cancer|stage ii colon cancer
546565|NCT00378716|stage III colon cancer|stage iii colon cancer
546566|NCT00378716|adenocarcinoma of the colon|adenocarcinoma of the colon
546567|NCT00378729|PCOS|pcos
546568|NCT00378729|FERTILOSCOPY|fertiloscopy
546569|NCT00378729|Ovarian hyperstimulation|ovarian hyperstimulation
546570|NCT00378729|Multiple pregnancies|multiple pregnancies
546571|NCT00378729|Patient with PCOS (Rotterdam criteria)|patient with pcos (rotterdam criteria)
546572|NCT00378729|Failure of treatment with Clomiphene Citrate|failure of treatment with clomiphene citrate
546573|NCT00378729|Age between 18 and 36 years old|age between 18 and 36 years old
546574|NCT00378729|Spermogram must be normal|spermogram must be normal
546575|NCT00378729|Permeability of Fallopian tubes|permeability of fallopian tubes
546576|NCT00378742|Glaucoma|glaucoma
546577|NCT00378742|Gene|gene
546578|NCT00378742|Phenotype-Genotype correlation|phenotype-genotype correlation
546579|NCT00378742|Molecular Diagnosis|molecular diagnosis
546580|NCT00378742|Retinal Degeneration|retinal degeneration
546581|NCT00378742|Inherited Eye Disease|inherited eye disease
546582|NCT00378742|Retinitis Pigmentosa|retinitis pigmentosa
546583|NCT00378742|Macular Dystrophy|macular dystrophy
546584|NCT00378742|Congenital Glaucoma|congenital glaucoma
546585|NCT00378755|velcade|velcade
546586|NCT00378755|myeloma|myeloma
546587|NCT00378755|VAD regimen|vad regimen
546588|NCT00378755|Transplantation, Autologous|transplantation, autologous
546589|NCT00378768|stage I multiple myeloma|stage i multiple myeloma
546590|NCT00378768|stage II multiple myeloma|stage ii multiple myeloma
546591|NCT00378768|stage III multiple myeloma|stage iii multiple myeloma
546592|NCT00378768|refractory multiple myeloma|refractory multiple myeloma
546593|NCT00378781|infection|infection
546594|NCT00378781|poor vascular access|poor vascular access
546595|NCT00378781|thromboembolism|thromboembolism
546596|NCT00378781|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
546597|NCT00378781|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
546598|NCT00378781|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
546599|NCT00378781|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
546600|NCT00378781|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
546601|NCT00378781|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
546602|NCT00378781|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
546603|NCT00378781|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
546604|NCT00378781|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
546605|NCT00378781|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
546606|NCT00378781|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
546607|NCT00378781|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
546608|NCT00378781|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
546609|NCT00378781|chronic eosinophilic leukemia|chronic eosinophilic leukemia
546610|NCT00378781|primary myelofibrosis|primary myelofibrosis
546611|NCT00378781|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
546612|NCT00378781|chronic neutrophilic leukemia|chronic neutrophilic leukemia
585517|NCT00513110|Caffeine|caffeine
546613|NCT00378781|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
546614|NCT00378781|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
546615|NCT00378781|disseminated neuroblastoma|disseminated neuroblastoma
546616|NCT00378781|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
546617|NCT00378781|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
546618|NCT00378781|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
546619|NCT00378781|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
546620|NCT00378781|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
546621|NCT00378781|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
546622|NCT00378781|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
546623|NCT00378781|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
546624|NCT00378781|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
546625|NCT00378781|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
546626|NCT00378781|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
546627|NCT00378781|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
546628|NCT00378781|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
546629|NCT00378781|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
546630|NCT00378781|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
546631|NCT00378781|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
546632|NCT00378781|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
546633|NCT00378781|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
546634|NCT00378781|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
546635|NCT00378781|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
546636|NCT00378781|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
546637|NCT00378781|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
546638|NCT00378781|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
546639|NCT00378781|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
546640|NCT00378781|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
546641|NCT00378781|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
546642|NCT00378781|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
546643|NCT00378781|recurrent breast cancer|recurrent breast cancer
546644|NCT00378781|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
546645|NCT00378781|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
546646|NCT00378781|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
546647|NCT00378781|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
546648|NCT00378781|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
546649|NCT00378781|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
546650|NCT00378781|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
546851|NCT00379002|incontinence|incontinence
546651|NCT00378781|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
546652|NCT00378781|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
546653|NCT00378781|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
546654|NCT00378781|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
546655|NCT00378781|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
546656|NCT00378781|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
546657|NCT00378781|recurrent neuroblastoma|recurrent neuroblastoma
546658|NCT00378781|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
546659|NCT00378781|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
546660|NCT00378781|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
546661|NCT00378781|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
546662|NCT00378781|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
546663|NCT00378781|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
546664|NCT00378781|refractory hairy cell leukemia|refractory hairy cell leukemia
546665|NCT00378781|refractory multiple myeloma|refractory multiple myeloma
547194|NCT00380458|Pain|pain
546666|NCT00378781|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
546667|NCT00378781|secondary acute myeloid leukemia|secondary acute myeloid leukemia
546668|NCT00378781|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
546669|NCT00378781|splenic marginal zone lymphoma|splenic marginal zone lymphoma
546670|NCT00378781|stage I multiple myeloma|stage i multiple myeloma
546671|NCT00378781|stage II multiple myeloma|stage ii multiple myeloma
546672|NCT00378781|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
546673|NCT00378781|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
546674|NCT00378781|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
546675|NCT00378781|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
546676|NCT00378781|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
546677|NCT00378781|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
546678|NCT00378781|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
546679|NCT00378781|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
546680|NCT00378781|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
546681|NCT00378781|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
546682|NCT00378781|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
546683|NCT00378781|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
546684|NCT00378781|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
546685|NCT00378781|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
546686|NCT00378781|stage III multiple myeloma|stage iii multiple myeloma
546687|NCT00378781|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
546688|NCT00378781|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
546689|NCT00378781|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
546690|NCT00378781|stage IIIA breast cancer|stage iiia breast cancer
546691|NCT00378781|stage IIIB breast cancer|stage iiib breast cancer
546692|NCT00378781|stage IIIC breast cancer|stage iiic breast cancer
546693|NCT00378781|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
546694|NCT00378781|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
546695|NCT00378781|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
546696|NCT00378781|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
546697|NCT00378781|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
546698|NCT00378781|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
546699|NCT00378781|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
546700|NCT00378781|stage IV breast cancer|stage iv breast cancer
546701|NCT00378781|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
546702|NCT00378781|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
546703|NCT00378781|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
546704|NCT00378781|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
546705|NCT00378781|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
546706|NCT00378781|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
546707|NCT00378781|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
546708|NCT00378781|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
546709|NCT00378781|acute undifferentiated leukemia|acute undifferentiated leukemia
546711|NCT00378781|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
546712|NCT00378781|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
546713|NCT00378781|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
546714|NCT00378781|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
546715|NCT00378781|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
546716|NCT00378781|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
546717|NCT00378781|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
546718|NCT00378781|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
546719|NCT00378781|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
546720|NCT00378781|prolymphocytic leukemia|prolymphocytic leukemia
546721|NCT00378781|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
546722|NCT00378781|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
546723|NCT00378781|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
546724|NCT00378781|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
546725|NCT00378781|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
546726|NCT00378781|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
546727|NCT00378781|anaplastic large cell lymphoma|anaplastic large cell lymphoma
546728|NCT00378781|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
546729|NCT00378781|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
546730|NCT00378781|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
546731|NCT00378781|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
546732|NCT00378781|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
546733|NCT00378781|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
546891|NCT00379158|home-fortification|home-fortification
546734|NCT00378781|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
546735|NCT00378781|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
546736|NCT00378781|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
546737|NCT00378781|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
546738|NCT00378781|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
546739|NCT00378781|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
546740|NCT00378781|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
546741|NCT00378781|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
546742|NCT00378781|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
546743|NCT00378781|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
546744|NCT00378781|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
546745|NCT00378781|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
546746|NCT00378781|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
546747|NCT00378781|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
546748|NCT00378781|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
546749|NCT00378781|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
546750|NCT00378781|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
546751|NCT00378781|stage I mantle cell lymphoma|stage i mantle cell lymphoma
546752|NCT00378781|stage I marginal zone lymphoma|stage i marginal zone lymphoma
546753|NCT00378781|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
546754|NCT00378781|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
546755|NCT00378781|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
546756|NCT00378781|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
546757|NCT00378781|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
546758|NCT00378781|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
546759|NCT00378781|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
546760|NCT00378781|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
546761|NCT00378781|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
546762|NCT00378781|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
546763|NCT00378781|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
546764|NCT00378781|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
546765|NCT00378781|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
546766|NCT00378781|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
546767|NCT00378781|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
546768|NCT00378781|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
546769|NCT00378781|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
546852|NCT00379015|stage IIIB breast cancer|stage iiib breast cancer
546770|NCT00378781|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
546771|NCT00378781|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
546772|NCT00378781|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
546773|NCT00378781|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
546774|NCT00378781|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
546775|NCT00378781|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
546776|NCT00378781|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
546777|NCT00378781|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
546778|NCT00378781|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
546779|NCT00378781|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
546780|NCT00378781|intraocular lymphoma|intraocular lymphoma
546781|NCT00378781|stage I melanoma|stage i melanoma
546782|NCT00378781|stage II melanoma|stage ii melanoma
546783|NCT00378781|stage III melanoma|stage iii melanoma
546784|NCT00378781|stage IV melanoma|stage iv melanoma
546785|NCT00378781|recurrent melanoma|recurrent melanoma
546786|NCT00378781|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
546787|NCT00378781|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
546788|NCT00378781|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
546789|NCT00378781|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
546790|NCT00378781|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
546791|NCT00378781|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
546792|NCT00378781|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
546793|NCT00378781|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
546794|NCT00378781|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
546795|NCT00378781|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
546796|NCT00378781|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
546797|NCT00378781|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
546798|NCT00378781|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
546799|NCT00378781|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
546800|NCT00378781|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
546801|NCT00378781|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
546802|NCT00378781|recurrent uterine sarcoma|recurrent uterine sarcoma
546803|NCT00378781|stage I uterine sarcoma|stage i uterine sarcoma
546804|NCT00378781|stage II uterine sarcoma|stage ii uterine sarcoma
546805|NCT00378781|stage III uterine sarcoma|stage iii uterine sarcoma
546806|NCT00378781|stage IV uterine sarcoma|stage iv uterine sarcoma
546807|NCT00378781|localized osteosarcoma|localized osteosarcoma
546808|NCT00378781|metastatic osteosarcoma|metastatic osteosarcoma
546809|NCT00378781|recurrent osteosarcoma|recurrent osteosarcoma
546810|NCT00378781|chondrosarcoma|chondrosarcoma
546811|NCT00378781|small intestine leiomyosarcoma|small intestine leiomyosarcoma
546812|NCT00378781|recurrent small intestine cancer|recurrent small intestine cancer
546813|NCT00378781|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
546814|NCT00378820|Children|children
546816|NCT00378820|Casein|casein
546817|NCT00378820|Milk minerals|milk minerals
546818|NCT00378820|Growth factors|growth factors
546819|NCT00378820|IGF-I|igf-i
546820|NCT00378820|Insulin|insulin
546821|NCT00378833|Primary Hypercholesterolemia or Mixed Hyperlipidemia|primary hypercholesterolemia or mixed hyperlipidemia
546822|NCT00378846|fever, sweats, and hot flashes|fever, sweats, and hot flashes
546823|NCT00378859|Children|children
546824|NCT00378859|Milk|milk
546825|NCT00378859|Meat|meat
546826|NCT00378859|Animal Protein|animal protein
546827|NCT00378859|Growth Factors|growth factors
546828|NCT00378859|IGF-I|igf-i
546829|NCT00378859|IGFBP-3|igfbp-3
546830|NCT00378859|Insulin|insulin
546831|NCT00378885|HIV-prevention|hiv-prevention
546832|NCT00378885|Internet Prevention intervention|internet prevention intervention
546833|NCT00378885|Online randomized controlled trial|online randomized controlled trial
546834|NCT00378885|Effect evaluation|effect evaluation
546835|NCT00378885|MSM|msm
546836|NCT00378885|Steady relationships|steady relationships
546837|NCT00378937|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
546838|NCT00378937|pain|pain
546839|NCT00378950|Congestive Heart Failure|congestive heart failure
546840|NCT00378976|HIV infection|hiv infection
546841|NCT00378976|HIV shedding|hiv shedding
546842|NCT00378976|HSV suppression|hsv suppression
546843|NCT00378976|Co-infected|co-infected
546844|NCT00378976|MSM|msm
546845|NCT00378976|Reactivation|reactivation
546846|NCT00378976|Valacyclovir|valacyclovir
546847|NCT00379002|Interstitial Cystitis|interstitial cystitis
546848|NCT00379002|Sexual Dysfunction|sexual dysfunction
546849|NCT00379002|Vulvodynia|vulvodynia
546853|NCT00379015|stage IIIC breast cancer|stage iiic breast cancer
546854|NCT00379015|stage IV breast cancer|stage iv breast cancer
546855|NCT00379028|COPD|copd
546856|NCT00379041|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
546857|NCT00379041|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
546858|NCT00379054|social support, smoking, smoking cessation, intervention,|social support, smoking, smoking cessation, intervention,
546859|NCT00379054|telephone counseling|telephone counseling
546860|NCT00379067|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
546861|NCT00379067|Nocturia|nocturia
546862|NCT00379067|Actigraphy|actigraphy
546863|NCT00379067|Tamsulosin|tamsulosin
546864|NCT00379093|Alcohol|alcohol
546865|NCT00379093|Comorbidity|comorbidity
546866|NCT00379093|Aging|aging
546867|NCT00379093|Brief Advice|brief advice
546868|NCT00379093|Randomized Trial|randomized trial
546869|NCT00379106|Supportive|supportive
546870|NCT00379106|Mastectomy|mastectomy
546871|NCT00379106|Quality of Life|quality of life
546872|NCT00379106|Arm Function|arm function
546873|NCT00379119|adenocarcinoma of the prostate|adenocarcinoma of the prostate
546874|NCT00379119|recurrent prostate cancer|recurrent prostate cancer
546875|NCT00379119|stage I prostate cancer|stage i prostate cancer
546876|NCT00379119|stage IIB prostate cancer|stage iib prostate cancer
546877|NCT00379119|stage IIA prostate cancer|stage iia prostate cancer
546878|NCT00379119|stage III prostate cancer|stage iii prostate cancer
546879|NCT00379132|Glioma|glioma
546880|NCT00379132|prostatic|prostatic
546881|NCT00379132|breast|breast
546882|NCT00379132|non-small cell lung|non-small cell lung
546883|NCT00379132|melanoma|melanoma
546884|NCT00379132|colorectal|colorectal
546885|NCT00379132|pancreatic|pancreatic
546886|NCT00379145|uterine leiomyosarcoma|uterine leiomyosarcoma
546887|NCT00379145|recurrent uterine sarcoma|recurrent uterine sarcoma
546888|NCT00379145|stage III uterine sarcoma|stage iii uterine sarcoma
546889|NCT00379145|stage IV uterine sarcoma|stage iv uterine sarcoma
546890|NCT00379158|multiple micronutrient supplements|multiple micronutrient supplements
546892|NCT00379158|complementary foods|complementary foods
546893|NCT00379158|infants|infants
546894|NCT00379158|Ghana|ghana
546895|NCT00379171|Children|children
546896|NCT00379171|Complementary feeding|complementary feeding
546897|NCT00379171|Breast feeding|breast feeding
546898|NCT00379171|Cow's milk|cow's milk
546899|NCT00379171|Formula|formula
546900|NCT00379171|Protein|protein
546901|NCT00379171|LCPUFA|lcpufa
546902|NCT00379171|Fish oil|fish oil
546903|NCT00379171|Lipid profile|lipid profile
546904|NCT00379171|Intestinal inflammation|intestinal inflammation
546905|NCT00379171|Intestinal microbiota|intestinal microbiota
546906|NCT00379184|arthritis|arthritis
546907|NCT00379197|stage IV breast cancer, estrogen receptor positive|stage iv breast cancer, estrogen receptor positive
546908|NCT00379197|recurrent breast cancer|recurrent breast cancer
546909|NCT00379197|hormone-refractory, metastatic breast cancer|hormone-refractory, metastatic breast cancer
546910|NCT00379210|Attention|attention
546912|NCT00379210|event-related potentials|event-related potentials
546913|NCT00379210|fMRI|fmri
546914|NCT00379210|functional magnetic resonance imaging|functional magnetic resonance imaging
546915|NCT00379210|MBSR|mbsr
546916|NCT00379210|Mindfulness Based Stress Reduction|mindfulness based stress reduction
546917|NCT00379210|Mindfulness Meditation Training|mindfulness meditation training
546918|NCT00379210|MMT|mmt
546919|NCT00379223|retinal vein occlusion|retinal vein occlusion
546920|NCT00379223|vitrectomy|vitrectomy
546921|NCT00379223|surgery|surgery
546922|NCT00379223|retinal disorders|retinal disorders
546923|NCT00379223|vascular diseases|vascular diseases
546924|NCT00379236|osteoarthritis|osteoarthritis
546925|NCT00379236|knee|knee
546926|NCT00379249|hypercholesterolemia|hypercholesterolemia
546927|NCT00379249|statin|statin
546928|NCT00379249|compliance|compliance
546929|NCT00379262|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
546930|NCT00379262|Chemoradiotherapy|chemoradiotherapy
546931|NCT00379262|Accelerated Fractionation|accelerated fractionation
546932|NCT00379275|Sarcoidosis|sarcoidosis
546933|NCT00379275|Uveitis|uveitis
546934|NCT00379275|Pulmonary Sarcoidosis|pulmonary sarcoidosis
546935|NCT00379275|HLA-Typing|hla-typing
546936|NCT00379275|Cytokines|cytokines
546937|NCT00379275|Serum Markers|serum markers
546938|NCT00379301|Atrial Fibrillation|atrial fibrillation
546939|NCT00379301|A-Fib|a-fib
546940|NCT00379301|AF|af
546941|NCT00379301|Persistent|persistent
546942|NCT00379301|Permanent|permanent
546943|NCT00379301|Pulmonary Vein Isolation|pulmonary vein isolation
546944|NCT00379301|Ablation|ablation
546945|NCT00379314|Incontinence|incontinence
546946|NCT00379314|Urinary|urinary
546947|NCT00379314|Female|female
546948|NCT00379314|Surgery|surgery
546949|NCT00379314|Complications|complications
546950|NCT00379327|Pregnancy|pregnancy
546951|NCT00379327|Acupuncture|acupuncture
546952|NCT00379327|Pregnancy Outcome|pregnancy outcome
546953|NCT00379327|Randomized Controlled Trial|randomized controlled trial
546954|NCT00379327|Double-Blind Method|double-blind method
546955|NCT00379353|Advanced Cancers|advanced cancers
546956|NCT00379353|Anorexia|anorexia
546957|NCT00379353|Fatigue|fatigue
546958|NCT00379353|Thalidomide|thalidomide
546959|NCT00379353|Placebo|placebo
546960|NCT00379366|Randomized Controlled Trials|randomized controlled trials
546961|NCT00379366|Renal Dialysis|renal dialysis
546962|NCT00379366|Graft Occlusion, Vascular|graft occlusion, vascular
546963|NCT00379366|Angioplasty|angioplasty
546964|NCT00379366|Vascular Patency|vascular patency
546965|NCT00379366|Radiation, Ionizing|radiation, ionizing
546966|NCT00379379|electroacupuncture, plasma glucose, plasma insulin|electroacupuncture, plasma glucose, plasma insulin
546967|NCT00379392|Stroke|stroke
546968|NCT00379392|Mental Imagery|mental imagery
546969|NCT00379392|Constraint Induced Therapy|constraint induced therapy
546970|NCT00379405|Saquinavir/ritonavir|saquinavir/ritonavir
546971|NCT00379405|Single therapy|single therapy
546972|NCT00379405|Virological efficacy|virological efficacy
546973|NCT00379405|Safety|safety
546974|NCT00379405|HIV-1|hiv-1
546975|NCT00379444|tobacco, intervention, tobacco cessation, ALaska Natives,|tobacco, intervention, tobacco cessation, alaska natives,
546976|NCT00379444|Native Americans, pregnancy, women|native americans, pregnancy, women
546977|NCT00379457|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
546978|NCT00379457|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
546979|NCT00379457|childhood malignant mesenchymoma|childhood malignant mesenchymoma
546980|NCT00379457|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
546981|NCT00379457|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
546982|NCT00379457|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
546983|NCT00379470|Brain tumor|brain tumor
546984|NCT00379470|Treatment|treatment
546985|NCT00379470|Minimal toxicity|minimal toxicity
546987|NCT00379470|Glioblastoma|glioblastoma
546988|NCT00379470|Recurrent|recurrent
546989|NCT00379470|TTFields|ttfields
546990|NCT00379483|Transfusional iron overload|transfusional iron overload
546991|NCT00379483|Deferasirox|deferasirox
546992|NCT00379496|Fibromyalgia|fibromyalgia
546993|NCT00379496|Acupuncture|acupuncture
546994|NCT00379496|Randomized study|randomized study
546995|NCT00379509|recurrent breast cancer|recurrent breast cancer
546996|NCT00379509|stage IIIA breast cancer|stage iiia breast cancer
546997|NCT00379509|stage IIIB breast cancer|stage iiib breast cancer
546998|NCT00379509|stage IIIC breast cancer|stage iiic breast cancer
546999|NCT00379509|stage IV breast cancer|stage iv breast cancer
547000|NCT00379509|male breast cancer|male breast cancer
547001|NCT00379522|hemorrhagic|hemorrhagic
547002|NCT00379522|shock|shock
547003|NCT00379522|traumatic|traumatic
547004|NCT00379522|shock treatment|shock treatment
547005|NCT00379522|vasopressin|vasopressin
547006|NCT00379522|Circulatory Collapse|circulatory collapse
547007|NCT00379522|Hypovolemic Shock|hypovolemic shock
547008|NCT00379535|pregnancy , lack of iodine|pregnancy , lack of iodine
547009|NCT00379535|lack of iodine during pregnancy|lack of iodine during pregnancy
547010|NCT00379561|Prostate Cancer|prostate cancer
547011|NCT00379561|Recurrent Prostate Cancer|recurrent prostate cancer
547012|NCT00379561|Non-Metastatic prostate cancer|non-metastatic prostate cancer
547013|NCT00379561|Recurrent Localized Prostate Cancer with Biochemical Failure|recurrent localized prostate cancer with biochemical failure
547014|NCT00379574|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
547015|NCT00379574|Bortezomib|bortezomib
547016|NCT00379574|CHOP|chop
547017|NCT00379574|Lenograstim|lenograstim
547018|NCT00379587|Rituximab|rituximab
547019|NCT00379587|Chronic GVHD|chronic gvhd
547020|NCT00379600|Anti-inflammatory treatment|anti-inflammatory treatment
547021|NCT00379600|Rheumatoid Arthritis|rheumatoid arthritis
547022|NCT00379626|Paraphilia|paraphilia
547023|NCT00379626|Hormonal treatment|hormonal treatment
547024|NCT00379626|Cognitive treatment|cognitive treatment
547025|NCT00379639|Pancreatic cancer|pancreatic cancer
547026|NCT00379639|advanced solid tumors|advanced solid tumors
547027|NCT00379652|Community Health Centers|community health centers
547028|NCT00379652|Diabetes|diabetes
547029|NCT00379652|Blood Pressure, High|blood pressure, high
547030|NCT00379665|Lung|lung
547031|NCT00379665|Chemotherapy|chemotherapy
547032|NCT00379665|Cisplatin|cisplatin
547033|NCT00379665|Intratumoral|intratumoral
547034|NCT00379665|Bronchoscope|bronchoscope
547035|NCT00379665|Brachytherapy|brachytherapy
547036|NCT00379678|atopic dermatitis|atopic dermatitis
547037|NCT00379691|spinal|spinal
547038|NCT00379691|Cesarean section|cesarean section
547039|NCT00379691|hypotension|hypotension
547040|NCT00379691|nausea|nausea
547041|NCT00379691|vomiting|vomiting
547042|NCT00379691|phenylephrine|phenylephrine
547043|NCT00379704|Tissue factor|tissue factor
547044|NCT00379704|Obesity|obesity
547045|NCT00379704|Adipose tissue|adipose tissue
547046|NCT00379704|Microparticles|microparticles
547047|NCT00379717|helical tomotherapy|helical tomotherapy
547048|NCT00379717|dose escalation|dose escalation
547049|NCT00379717|chemotherapy|chemotherapy
547050|NCT00379730|CT scan|ct scan
547051|NCT00379730|breathing tests|breathing tests
547052|NCT00379730|lung function tests|lung function tests
547053|NCT00379730|biomarkers|biomarkers
547054|NCT00379730|prednisolone|prednisolone
547055|NCT00379730|IOS|ios
547056|NCT00379730|COPD|copd
547057|NCT00379730|clinical outcomes|clinical outcomes
547058|NCT00379756|Erectile dysfunction, impotence|erectile dysfunction, impotence
547059|NCT00379769|diabetes|diabetes
547060|NCT00379769|CV outcomes|cv outcomes
547061|NCT00379769|rosiglitazone|rosiglitazone
547062|NCT00379769|Type II diabetes|type ii diabetes
547063|NCT00379769|sulfonylurea|sulfonylurea
547064|NCT00379769|RECORD|record
547065|NCT00379769|metformin|metformin
547066|NCT00379795|CNV|cnv
547067|NCT00379795|Lucentis|lucentis
547068|NCT00379795|AMD|amd
547069|NCT00379795|Age-related macular degeneration|age-related macular degeneration
547070|NCT00379795|RVO|rvo
547071|NCT00379808|coronary heart disease|coronary heart disease
547072|NCT00379808|montelukast|montelukast
547073|NCT00379808|inflammation|inflammation
547074|NCT00379821|chloroquine, malaria, Plasmodium falciparum, Malawi, children|chloroquine, malaria, plasmodium falciparum, malawi, children
547075|NCT00379834|glaucoma|glaucoma
547076|NCT00379834|diurnal|diurnal
547077|NCT00379834|intraocular pressure|intraocular pressure
547078|NCT00379847|hyponatremia|hyponatremia
547079|NCT00379847|hypervolemic|hypervolemic
547080|NCT00379847|euvolemic|euvolemic
547081|NCT00379847|treatment outcomes|treatment outcomes
547082|NCT00379847|YM087|ym087
547083|NCT00379886|ECT|ect
547084|NCT00379886|Depression|depression
547085|NCT00379886|Anesthiticum|anesthiticum
547086|NCT00379886|Propofol|propofol
547087|NCT00379886|Thiopental|thiopental
547088|NCT00379899|calcification|calcification
547089|NCT00379899|vascular calcification|vascular calcification
547090|NCT00379899|coronary vascular calcification|coronary vascular calcification
547091|NCT00379899|chronic kidney disease|chronic kidney disease
547092|NCT00379899|end stage renal disease|end stage renal disease
547093|NCT00379899|dialysis|dialysis
547094|NCT00379925|Physical Activity|physical activity
547095|NCT00379925|Exercise|exercise
547096|NCT00379925|Dietary Habits|dietary habits
547097|NCT00379938|Parvovirus B-19, Parvoviridae, vaccine|parvovirus b-19, parvoviridae, vaccine
547098|NCT00379990|iNOS|inos
547099|NCT00379990|Exhaled NO|exhaled no
547100|NCT00379990|Rheumatoid arthritis|rheumatoid arthritis
547101|NCT00380016|Angioplasty|angioplasty
547102|NCT00380016|Stent|stent
547103|NCT00380016|Coronary Artery Disease|coronary artery disease
547104|NCT00380016|Peripheral Artery Disease|peripheral artery disease
547105|NCT00380016|Percutaneous Coronary Intervention|percutaneous coronary intervention
547106|NCT00380016|CAD|cad
547107|NCT00380016|PAD|pad
547108|NCT00380016|Cardiovascular Disease|cardiovascular disease
547109|NCT00380029|stage II bladder cancer|stage ii bladder cancer
547110|NCT00380029|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
547111|NCT00380042|Cortical Electrical Stimulation|cortical electrical stimulation
547112|NCT00380042|Treatment Resistant Depression|treatment resistant depression
547113|NCT00380042|Major Depressive Disorder|major depressive disorder
547114|NCT00380055|Cancer Screening|cancer screening
547115|NCT00380055|Navigators|navigators
547116|NCT00380055|Community Outreach|community outreach
547117|NCT00380055|Behavioral Change|behavioral change
547118|NCT00380055|Access|access
547119|NCT00380081|Insomnia|insomnia
547120|NCT00380094|ACS|acs
547121|NCT00380094|NSTEMI|nstemi
547122|NCT00380094|Myeloperoxidase|myeloperoxidase
547123|NCT00380094|nonST segment elevation myocardial infarction|nonst segment elevation myocardial infarction
547124|NCT00380107|Minor surgery|minor surgery
547125|NCT00380107|Volume optimization|volume optimization
547126|NCT00380107|Volume deficit|volume deficit
547127|NCT00380107|Epidural anesthesia|epidural anesthesia
547128|NCT00380133|COPD SB-681323 prednisolone biomarkers|copd sb-681323 prednisolone biomarkers
547129|NCT00380146|Malaria|malaria
547130|NCT00380146|Intermittent presumptive treatment|intermittent presumptive treatment
547131|NCT00380146|IPT|ipt
547132|NCT00380146|Pharmacokinetic|pharmacokinetic
547133|NCT00380146|Efficacy|efficacy
547134|NCT00380146|Gametocyte|gametocyte
547135|NCT00380146|Molecular markers|molecular markers
547136|NCT00380159|Extension study to ACH443-014A|extension study to ach443-014a
547137|NCT00380172|AMD|amd
547138|NCT00380172|Macular Degeneration|macular degeneration
547139|NCT00380172|Retinal Degeneration|retinal degeneration
547140|NCT00380185|Peripheral Arterial Disease|peripheral arterial disease
547141|NCT00380185|Atherosclerosis|atherosclerosis
547142|NCT00380211|Thimerosal reduced content|thimerosal reduced content
547143|NCT00380211|Immunogenicity, safety, reactogenicity|immunogenicity, safety, reactogenicity
547144|NCT00380211|Young and elderly adults|young and elderly adults
547145|NCT00380211|Influenza vaccine|influenza vaccine
547146|NCT00380224|schizophrenia|schizophrenia
547147|NCT00380237|Bird Flu|bird flu
547148|NCT00380237|Avian Flu|avian flu
547149|NCT00380276|Alzheimer's|alzheimer's
547150|NCT00380276|Dementia|dementia
547151|NCT00380276|Dementia of Alzheimer Type|dementia of alzheimer type
547152|NCT00380289|Essential hypertension|essential hypertension
547153|NCT00380289|Glucose metabolism|glucose metabolism
547154|NCT00380289|Thiazides|thiazides
546850|NCT00379002|Pelvic Pain|pelvic pain
547155|NCT00380289|Beta blockers|beta blockers
547156|NCT00380302|Alzheimer's disease|alzheimer's disease
547157|NCT00380302|symptomatic|symptomatic
547158|NCT00380302|cognition|cognition
547159|NCT00380315|Cough|cough
547160|NCT00380315|Chronic bronchitis|chronic bronchitis
547161|NCT00380315|PNDs|pnds
547162|NCT00380315|Post Nasal Drip syndrome|post nasal drip syndrome
547163|NCT00380315|GERD|gerd
547164|NCT00380315|gastroesophageal reflux disease|gastroesophageal reflux disease
547165|NCT00380315|bronchiectasis|bronchiectasis
547166|NCT00380328|Pharmacokinetic|pharmacokinetic
547167|NCT00380328|healthy subjects|healthy subjects
547168|NCT00380354|allergen|allergen
547169|NCT00380354|methacholine|methacholine
547170|NCT00380354|GSK256066|gsk256066
547171|NCT00380354|mild asthmatics|mild asthmatics
547172|NCT00380354|repeat dose|repeat dose
547173|NCT00380354|challenge|challenge
547174|NCT00380354|late asthmatic response|late asthmatic response
547175|NCT00380380|Vildagliptin, type 2 diabetes, gastric emptying|vildagliptin, type 2 diabetes, gastric emptying
547176|NCT00380393|Malaria|malaria
547177|NCT00380393|Plasmodium|plasmodium
547178|NCT00380393|RTS|rts
547179|NCT00380393|S/AS01|s/as01
547180|NCT00380393|Falciparum|falciparum
547181|NCT00380406|Gonadotropin releasing hormone agonist|gonadotropin releasing hormone agonist
547182|NCT00380406|GnRH|gnrh
547183|NCT00380406|Fertility|fertility
547184|NCT00380406|Fertility preservation|fertility preservation
547185|NCT00380406|Oncology|oncology
547186|NCT00380406|Cancer|cancer
547187|NCT00380406|Chemotherapy|chemotherapy
547188|NCT00380419|Pregnancy|pregnancy
547189|NCT00380419|Postpartum Depression|postpartum depression
547190|NCT00380445|Vildagliptin, Type 2 diabetes|vildagliptin, type 2 diabetes
547191|NCT00380458|Obstructive|obstructive
547192|NCT00380458|Sleep|sleep
547193|NCT00380458|Apnea|apnea
547195|NCT00380458|UPPP|uppp
547196|NCT00380458|Tonsillectomy|tonsillectomy
547197|NCT00380458|Narcotics|narcotics
547198|NCT00380471|bath PUVA|bath puva
547199|NCT00380497|Pediatrics|pediatrics
547200|NCT00380497|Colonoscopy|colonoscopy
547201|NCT00380497|Bowel cleanout|bowel cleanout
547202|NCT00380497|Poly-Ethylene Glycol|poly-ethylene glycol
547203|NCT00380497|Pico-Salax|pico-salax
547204|NCT00380510|Family Physicians|family physicians
547205|NCT00380510|Adolescents|adolescents
547206|NCT00380510|Preventive Care|preventive care
547207|NCT00380510|Health Behavior|health behavior
547208|NCT00380536|Peer-led Education|peer-led education
547209|NCT00380549|osteoarthritis, hip replacement|osteoarthritis, hip replacement
547210|NCT00380562|Quality of life|quality of life
547211|NCT00380562|Cognitive Functioning|cognitive functioning
547212|NCT00380562|Activities of Daily Living|activities of daily living
547213|NCT00380562|Disability prevention|disability prevention
547214|NCT00380575|hyponatremia|hyponatremia
547215|NCT00380575|hypervolemic|hypervolemic
547216|NCT00380575|euvolemic|euvolemic
547217|NCT00380575|vasopressins|vasopressins
547218|NCT00380575|YM087|ym087
547219|NCT00380614|Acute Hepatitis B, Lamivudine|acute hepatitis b, lamivudine
547220|NCT00380640|Pediatrics|pediatrics
547221|NCT00380640|Epidermolysis Bullosa|epidermolysis bullosa
547222|NCT00380640|Trimethoprim|trimethoprim
547223|NCT00380640|Wound Healing|wound healing
547224|NCT00380731|Social Anxiety Disorder|social anxiety disorder
547225|NCT00380731|Magnetic Resonance Imaging|magnetic resonance imaging
547226|NCT00380731|Cognitive Behavior Therapy|cognitive behavior therapy
547227|NCT00380757|cardiac arrest|cardiac arrest
547228|NCT00380757|CPR|cpr
547229|NCT00380757|resuscitation|resuscitation
547230|NCT00380757|fatigue|fatigue
547231|NCT00380757|quality|quality
547232|NCT00380770|HIV|hiv
547233|NCT00380770|AIDS|aids
547234|NCT00380770|Kaposi's sarcoma|kaposi's sarcoma
547235|NCT00380770|Human herpesvirus 8|human herpesvirus 8
547236|NCT00380796|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
547237|NCT00380796|COPD|copd
547238|NCT00380822|alpa-glucosidase inhibitor|alpa-glucosidase inhibitor
547239|NCT00380835|metastatic breast cancer|metastatic breast cancer
547240|NCT00380835|amrubicin|amrubicin
547241|NCT00380848|sleep apnea|sleep apnea
547242|NCT00380848|end stage renal disease|end stage renal disease
547243|NCT00380848|hemodiafiltration|hemodiafiltration
547244|NCT00380861|Total Knee Replacement|total knee replacement
547245|NCT00380861|Flexion|flexion
547246|NCT00380861|Range of Motion|range of motion
547247|NCT00380861|Activities of Daily Living|activities of daily living
547248|NCT00380861|Implant design|implant design
547249|NCT00380861|Subject Satisfaction|subject satisfaction
547250|NCT00380861|Non-inflammatory arthritis|non-inflammatory arthritis
547251|NCT00380874|Pain|pain
547252|NCT00380874|chemotherapy|chemotherapy
547253|NCT00380887|bioavailability|bioavailability
547255|NCT00380887|marketed product|marketed product
547256|NCT00380887|Premarin|premarin
547257|NCT00380887|Medroxyprogesterone acetate|medroxyprogesterone acetate
547259|NCT00380887|Postmenopausal|postmenopausal
547260|NCT00380887|vasomotor symptoms|vasomotor symptoms
547261|NCT00380926|polyunsatturated fatty acids|polyunsatturated fatty acids
547262|NCT00380926|nutrition|nutrition
547263|NCT00380926|low-dose allergen challenge|low-dose allergen challenge
547264|NCT00380926|exhaled nitric oxide|exhaled nitric oxide
547265|NCT00380952|IDC|idc
547266|NCT00380952|DCIS|dcis
547267|NCT00380952|ILC|ilc
547268|NCT00380965|Chemotherapy-induced|chemotherapy-induced
547269|NCT00380965|neuropathy|neuropathy
547270|NCT00380965|cancer|cancer
547271|NCT00380978|labor pain|labor pain
547272|NCT00380978|cesarean section|cesarean section
547273|NCT00380978|epidural analgesia|epidural analgesia
547274|NCT00380978|opioid analgesics|opioid analgesics
547275|NCT00380978|local anesthetics|local anesthetics
547276|NCT00380978|labor induced|labor induced
547277|NCT00381004|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
547278|NCT00381004|Leukemia|leukemia
547279|NCT00381004|Cyclophosphamide|cyclophosphamide
547280|NCT00381004|Fludarabine|fludarabine
547281|NCT00381004|Sargramostim|sargramostim
547282|NCT00381004|Rituximab|rituximab
547283|NCT00381004|GM-CSF|gm-csf
547284|NCT00381004|FCR|fcr
547285|NCT00381030|beta-Adrenergic Blockers|beta-adrenergic blockers
547286|NCT00381030|Disease Management|disease management
547287|NCT00381043|Alcohol Dependence|alcohol dependence
547288|NCT00381043|Family Medicine Setting|family medicine setting
547289|NCT00381043|University of North Carolina at Chapel Hill|university of north carolina at chapel hill
547290|NCT00381056|labor and delivery care|labor and delivery care
547291|NCT00381056|teamwork training|teamwork training
547292|NCT00381056|crew resource management|crew resource management
547293|NCT00381056|cluster-randomized trial|cluster-randomized trial
547294|NCT00381069|Recreation Centers|recreation centers
547295|NCT00381069|Families|families
547296|NCT00381069|Obesity Prevention|obesity prevention
547297|NCT00381082|Pediculus|pediculus
547298|NCT00381082|capitis|capitis
547299|NCT00381082|lice|lice
547300|NCT00381108|BPH|bph
547301|NCT00375427|Breast cancer|breast cancer
547302|NCT00375427|Zoledronic acid|zoledronic acid
547303|NCT00375427|Skeletal related events (SRE)|skeletal related events (sre)
547304|NCT00375440|Tranexamic Acid|tranexamic acid
547305|NCT00375440|Revision Total Hip Replacement|revision total hip replacement
547306|NCT00375440|Reduction in Blood Loss|reduction in blood loss
547307|NCT00375453|Paclitaxel|paclitaxel
547308|NCT00375453|Advanced Solid Tumors|advanced solid tumors
547309|NCT00375466|Hemorrhage|hemorrhage
547310|NCT00375466|Transfusion|transfusion
547311|NCT00375466|Blood components|blood components
547312|NCT00375466|Fibrinolysis|fibrinolysis
547313|NCT00375466|Platelet activation|platelet activation
547314|NCT00375492|diabetes|diabetes
547315|NCT00375492|overweight|overweight
547316|NCT00375492|obesity|obesity
547317|NCT00375492|weight loss|weight loss
547318|NCT00375492|exenatide|exenatide
547319|NCT00375492|Amylin|amylin
547320|NCT00375492|Lilly|lilly
547321|NCT00375505|Breast Cancer|breast cancer
547322|NCT00375505|Premenopausal|premenopausal
547323|NCT00375505|Bone mineral density|bone mineral density
547324|NCT00375505|Cancer therapy induced bone loss|cancer therapy induced bone loss
547325|NCT00375505|zoledronic acid|zoledronic acid
547326|NCT00375518|Thoracic Surgery|thoracic surgery
547327|NCT00375518|Cardiopulmonary complications|cardiopulmonary complications
547328|NCT00375518|Atorvastatin|atorvastatin
547329|NCT00375531|Post Traumatic Stress Disorder|post traumatic stress disorder
547330|NCT00375531|Mindfulness Meditation|mindfulness meditation
547331|NCT00375544|Laser Therapy, Low-Level|laser therapy, low-level
547332|NCT00375544|Osteoarthritis|osteoarthritis
547333|NCT00375544|Phototherapy|phototherapy
547334|NCT00375544|Osteoarthritis, knee|osteoarthritis, knee
547335|NCT00375544|Light-emitting diode|light-emitting diode
547336|NCT00375583|Lymphatic Filariasis|lymphatic filariasis
547337|NCT00375583|Diethylcarbamazine|diethylcarbamazine
547338|NCT00375583|Microfilariae|microfilariae
547339|NCT00375583|Helminths|helminths
547340|NCT00375583|Nematode|nematode
547341|NCT00375609|Prevention of Venous Thromboembolism|prevention of venous thromboembolism
547342|NCT00375622|HHT|hht
547343|NCT00375622|Epistaxis|epistaxis
547344|NCT00375622|Tamoxifen|tamoxifen
547345|NCT00375622|Hemoglobin|hemoglobin
547346|NCT00375635|mFPSA|mfpsa
547347|NCT00375635|Uremic toxins|uremic toxins
547348|NCT00375635|Protein bound toxins|protein bound toxins
547349|NCT00375635|Uremia|uremia
547350|NCT00375635|Chronic hemodialysis|chronic hemodialysis
547351|NCT00381121|Tissue Biobank|tissue biobank
547352|NCT00381121|molecular markers|molecular markers
547353|NCT00381121|molecular pathways|molecular pathways
547354|NCT00381134|double-blind|double-blind
547355|NCT00381134|placebo-controlled|placebo-controlled
547357|NCT00381134|blood pressure|blood pressure
547358|NCT00381134|urine albumin to creatinine ratio|urine albumin to creatinine ratio
547359|NCT00381134|placebo|placebo
547360|NCT00381160|weight loss|weight loss
547361|NCT00381160|obesity|obesity
547362|NCT00381160|sugar-sweetened beverages|sugar-sweetened beverages
547363|NCT00381160|diet|diet
547364|NCT00381160|adolescence|adolescence
547365|NCT00381173|MGI PHARMA|mgi pharma
547366|NCT00381173|ZYC3-002|zyc3-002
547367|NCT00381173|ZYC300|zyc300
547368|NCT00381173|plasmid DNA|plasmid dna
547369|NCT00381173|cyclophosphamide|cyclophosphamide
547370|NCT00381173|Cytoxan|cytoxan
547371|NCT00381173|advanced breast cancer|advanced breast cancer
547372|NCT00381173|advanced ovarian cancer|advanced ovarian cancer
547373|NCT00381173|hormone refractory prostate cancer|hormone refractory prostate cancer
547374|NCT00381173|advanced colon cancer|advanced colon cancer
547375|NCT00381173|advanced renal cancer|advanced renal cancer
547376|NCT00381173|advanced stage malignancies|advanced stage malignancies
547377|NCT00381173|immune therapy|immune therapy
547378|NCT00381173|gene therapy|gene therapy
547379|NCT00381173|biologic therapy|biologic therapy
547380|NCT00381173|T-regulatory cells|t-regulatory cells
547381|NCT00381173|cancer vaccine|cancer vaccine
547382|NCT00381173|vaccine|vaccine
547383|NCT00381173|Advanced stage malignancies-ovary, breast, colon, prostate|advanced stage malignancies-ovary, breast, colon, prostate
547384|NCT00381186|impaired glucose tolerance|impaired glucose tolerance
547385|NCT00381186|type 2 diabetes|type 2 diabetes
547386|NCT00381199|fibromyalgia|fibromyalgia
547388|NCT00381199|chronic pain|chronic pain
547389|NCT00381199|sleep|sleep
547390|NCT00381199|insomnia|insomnia
547391|NCT00381199|diffuse widespread pain|diffuse widespread pain
547392|NCT00381199|antidepressant|antidepressant
547393|NCT00381212|Immunotherapeutic injection|immunotherapeutic injection
547394|NCT00381225|radio-frequency|radio-frequency
547395|NCT00381225|ablation|ablation
547396|NCT00381225|ultra-sound|ultra-sound
547397|NCT00381225|guidance|guidance
547398|NCT00381225|papillary|papillary
547399|NCT00381225|thyroid|thyroid
547400|NCT00381225|cancer|cancer
547401|NCT00381238|Alzheimer's Disease|alzheimer's disease
547402|NCT00381238|Rosiglitazone|rosiglitazone
547403|NCT00381251|vaginal atrophy|vaginal atrophy
547404|NCT00381251|postmenopausal osteoporosis|postmenopausal osteoporosis
547405|NCT00381251|menopause|menopause
547406|NCT00381251|hot flashes|hot flashes
547407|NCT00381277|nephrolithiasis|nephrolithiasis
547408|NCT00381277|citrate|citrate
547409|NCT00381277|oxalate|oxalate
547410|NCT00381290|Arthritis|arthritis
547411|NCT00381290|Arthritis, Degenerative|arthritis, degenerative
547412|NCT00381290|Knee Health|knee health
547413|NCT00381290|Obesity|obesity
547414|NCT00381290|Overweight|overweight
547415|NCT00381290|Osteoarthritis|osteoarthritis
547416|NCT00381290|Weight Loss|weight loss
547417|NCT00381290|Diet|diet
547418|NCT00381290|Exercise|exercise
547419|NCT00381290|Knee Pain|knee pain
547421|NCT00381303|AIDS|aids
547422|NCT00381303|Immunodeficiency Virus, Human|immunodeficiency virus, human
547423|NCT00381303|Females|females
547424|NCT00381303|Women|women
547425|NCT00381303|PREZISTA|prezista
547426|NCT00381303|darunavir|darunavir
547427|NCT00381303|TMC114|tmc114
547428|NCT00381303|Protease Inhibitor|protease inhibitor
547429|NCT00381329|Motivational Interviewing|motivational interviewing
547430|NCT00381329|Structured Brief Advice|structured brief advice
547431|NCT00381329|Adolescent Smoking|adolescent smoking
547432|NCT00381329|Behavioral Intervention|behavioral intervention
547433|NCT00381329|Smoking|smoking
547434|NCT00381329|Primary Care|primary care
547435|NCT00381329|Tobacco|tobacco
547436|NCT00381342|diabetes|diabetes
547437|NCT00381342|exenatide|exenatide
547438|NCT00381342|Amylin|amylin
547439|NCT00381342|Lilly|lilly
547440|NCT00381342|monotherapy|monotherapy
547441|NCT00381355|asthma|asthma
547442|NCT00381355|children|children
547443|NCT00381355|written action plan|written action plan
547444|NCT00381355|education|education
547445|NCT00381355|guided self-management|guided self-management
547446|NCT00381355|efficacy|efficacy
547447|NCT00381355|compliance|compliance
547448|NCT00381355|b2-agonists|b2-agonists
547449|NCT00381355|inhaled corticosteroids|inhaled corticosteroids
547450|NCT00381355|oral steroids|oral steroids
547451|NCT00381355|relapse|relapse
547452|NCT00381355|randomised controlled trial|randomised controlled trial
547453|NCT00381355|emergency department|emergency department
547454|NCT00381368|breast cancer|breast cancer
547455|NCT00381368|skeletal metastases|skeletal metastases
547456|NCT00381368|bisphosphonate therapy|bisphosphonate therapy
547457|NCT00381368|Breast cancer with painful skeletal metastases|breast cancer with painful skeletal metastases
547458|NCT00381381|Alzheimer's disease|alzheimer's disease
547459|NCT00381394|amphotericin B|amphotericin b
547460|NCT00381394|safety|safety
547461|NCT00381394|tolerability and pharmacokinetics of oral sitamaquine|tolerability and pharmacokinetics of oral sitamaquine
547462|NCT00381394|Visceral leishmaniasis|visceral leishmaniasis
547463|NCT00381407|ADHD|adhd
547464|NCT00381407|Organizational Skills|organizational skills
547465|NCT00381407|Contingency Management|contingency management
547466|NCT00381433|HCV|hcv
547467|NCT00381433|Hepatitis C virus|hepatitis c virus
547468|NCT00381446|corneal staining|corneal staining
547469|NCT00381446|contact lens care|contact lens care
547470|NCT00381446|multipurpose solution|multipurpose solution
547471|NCT00382226|Glaucoma|glaucoma
547472|NCT00382239|diabetes|diabetes
547473|NCT00382239|exenatide|exenatide
547474|NCT00382239|LY2148568|ly2148568
547475|NCT00382239|Lilly|lilly
547476|NCT00382239|Amylin|amylin
547477|NCT00382239|Japan|japan
547478|NCT00382252|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
547479|NCT00382252|lung metastases|lung metastases
547480|NCT00382265|urolithiasis|urolithiasis
547481|NCT00382265|renal colic|renal colic
547482|NCT00382265|kidney stones|kidney stones
547483|NCT00382265|urinary stone disease|urinary stone disease
547484|NCT00382278|Stem cell|stem cell
547485|NCT00382278|Liver cirrhosis|liver cirrhosis
547486|NCT00382278|Cellular therapy|cellular therapy
547487|NCT00382278|Autologous|autologous
547488|NCT00382278|Bone marrow|bone marrow
547489|NCT00382291|OCD|ocd
547490|NCT00382291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation
547491|NCT00382291|Placebos|placebos
547492|NCT00382291|Cognitive Behavior Therapy|cognitive behavior therapy
547494|NCT00382291|Activation Syndrome|activation syndrome
547495|NCT00382291|Psychometrics|psychometrics
547496|NCT00382304|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
547497|NCT00382304|C. difficile|c. difficile
547498|NCT00382304|CDAD|cdad
547499|NCT00382304|Clostridium difficile|clostridium difficile
547500|NCT00382304|Clostridium difficile Disease|clostridium difficile disease
547501|NCT00382304|Clostridium Enterocolitis|clostridium enterocolitis
547502|NCT00382304|Antibiotic-Associated Colitis|antibiotic-associated colitis
547503|NCT00382304|Infectious diarrhea|infectious diarrhea
547504|NCT00382317|MSCT indications|msct indications
547505|NCT00382330|Vulva|vulva
547506|NCT00382343|Prevention|prevention
547507|NCT00382343|Pyelonephritis|pyelonephritis
547508|NCT00382343|Renal scars|renal scars
547509|NCT00382343|Vesico-ureteral reflux|vesico-ureteral reflux
547510|NCT00382343|Dimercaptosuccinic acid renal scan (DMSA)|dimercaptosuccinic acid renal scan (dmsa)
547511|NCT00382356|Benign Prostatic Enlargement|benign prostatic enlargement
547512|NCT00382356|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
547513|NCT00382356|Dutasteride|dutasteride
547514|NCT00382356|5-alpha reductase inhibitors|5-alpha reductase inhibitors
547515|NCT00382356|Hormonal therapy|hormonal therapy
547516|NCT00382369|familial vocal cord paralysis|familial vocal cord paralysis
547517|NCT00382369|genetic screening|genetic screening
547518|NCT00382382|Autism|autism
547519|NCT00382382|Asperger Syndrome|asperger syndrome
547520|NCT00382382|Restricted repetitive behavior|restricted repetitive behavior
547521|NCT00382382|Stereotyped patterns of behavior|stereotyped patterns of behavior
547522|NCT00382382|Typically Developing children|typically developing children
547523|NCT00382382|Human Volunteers|human volunteers
547524|NCT00382395|Glaucoma shunt|glaucoma shunt
547525|NCT00382395|Ocular implant|ocular implant
547526|NCT00382395|Gold|gold
547527|NCT00382395|trabeculectomy|trabeculectomy
547528|NCT00382408|Acute respiratory disease prevention|acute respiratory disease prevention
547529|NCT00382408|Adenovirus|adenovirus
547530|NCT00382421|Myocardial Ischemia|myocardial ischemia
547531|NCT00382421|Randomized Controlled Trials|randomized controlled trials
547532|NCT00382421|Drug Therapy|drug therapy
547533|NCT00382434|emergency pharmacist|emergency pharmacist
547534|NCT00382434|emergency medicine|emergency medicine
547535|NCT00382434|emergency department|emergency department
547536|NCT00382434|medical error|medical error
547537|NCT00382434|adverse event|adverse event
547538|NCT00382434|pharmacist|pharmacist
547539|NCT00382434|patient safety|patient safety
547540|NCT00382447|breath actuated nebulizer|breath actuated nebulizer
547541|NCT00382447|nebulizer|nebulizer
547542|NCT00382473|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
547543|NCT00382473|Overweight|overweight
547544|NCT00382473|Fatty acid oxidation|fatty acid oxidation
547545|NCT00382473|Mitochondria|mitochondria
547546|NCT00382473|Exercise|exercise
547547|NCT00382486|Intestinal transplant|intestinal transplant
547548|NCT00382486|Bone marrow|bone marrow
547549|NCT00382486|Irradiation of allograft|irradiation of allograft
547550|NCT00382499|Intravenous Lidocaine|intravenous lidocaine
547551|NCT00382499|Lidocaine Infusion|lidocaine infusion
547552|NCT00382499|Total Abdominal Hysterectomy|total abdominal hysterectomy
547553|NCT00382499|Analgesia|analgesia
547554|NCT00382499|Anesthesia|anesthesia
547555|NCT00382499|Adjunct|adjunct
547556|NCT00382512|Moderate Plaque Psoriasis|moderate plaque psoriasis
547557|NCT00382525|Bradyarrhythmia|bradyarrhythmia
547558|NCT00382525|Atrial Fibrillation|atrial fibrillation
547559|NCT00382525|Ventricular Tachycardia|ventricular tachycardia
547560|NCT00382525|Ventricular Fibrillation|ventricular fibrillation
546911|NCT00379210|ERP|erp
547562|NCT00382525|Pacemaker|pacemaker
547563|NCT00382525|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
547564|NCT00382525|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
547565|NCT00382525|Loop recorder|loop recorder
547566|NCT00382525|Registry|registry
547567|NCT00382538|mifepristone|mifepristone
547568|NCT00382538|induction|induction
547569|NCT00382538|abortion|abortion
547570|NCT00382538|injection, intra-amniotic|injection, intra-amniotic
547571|NCT00382551|Alcohol|alcohol
547572|NCT00382551|Red wine|red wine
547573|NCT00382551|Endothelial function|endothelial function
547574|NCT00382551|Flow-mediated vasodilation|flow-mediated vasodilation
547575|NCT00382551|Cardiovascular disease|cardiovascular disease
547576|NCT00382564|Imaging|imaging
547577|NCT00382564|Arteriosclerosis|arteriosclerosis
547578|NCT00382564|Hardening of the arteries|hardening of the arteries
547579|NCT00382564|MRA|mra
547580|NCT00382564|Narrowing of Vessels|narrowing of vessels
547581|NCT00382564|Noninvasive Plaque Imaging|noninvasive plaque imaging
547582|NCT00382564|Atherosclerotic Disease|atherosclerotic disease
547583|NCT00382564|Plaque|plaque
547584|NCT00382564|Arteries|arteries
547585|NCT00382564|Diabetes|diabetes
547586|NCT00382564|Hypertension|hypertension
547587|NCT00382590|Acute Myelogenous Leukemia|acute myelogenous leukemia
547588|NCT00382590|AML|aml
547589|NCT00382590|Myelodysplastic Syndrome|myelodysplastic syndrome
547590|NCT00382590|Leukemia|leukemia
547591|NCT00382590|MDS|mds
547592|NCT00382590|Azacytidine|azacytidine
547593|NCT00382590|5-Azacytidine|5-azacytidine
547594|NCT00382590|5-aza|5-aza
547595|NCT00382590|Vidaza|vidaza
547596|NCT00382590|5-AZC|5-azc
547597|NCT00382590|AZA-CR|aza-cr
547598|NCT00382590|Ladakamycin|ladakamycin
547599|NCT00382590|Ara-C|ara-c
547600|NCT00382590|Cytarabine|cytarabine
547601|NCT00382590|Cytosar|cytosar
547602|NCT00382590|DepoCyt|depocyt
547603|NCT00382590|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
547604|NCT00382590|Valproic Acid|valproic acid
547605|NCT00382590|VPA|vpa
547606|NCT00382590|Depakene|depakene
547607|NCT00382603|Contact Lens Care|contact lens care
547608|NCT00382616|behavioral problems|behavioral problems
547609|NCT00382616|learning problems|learning problems
547610|NCT00382616|inattentive|inattentive
547611|NCT00382616|impulsive|impulsive
547612|NCT00382616|hyperactive|hyperactive
547613|NCT00382616|children|children
547614|NCT00382616|phosphatidylserine|phosphatidylserine
547615|NCT00382616|long-chain polyunsaturated fatty acid|long-chain polyunsaturated fatty acid
547616|NCT00382616|eicosapentaenoic acid|eicosapentaenoic acid
547617|NCT00382616|docosahexaenoic acid|docosahexaenoic acid
547618|NCT00382616|omega3:omega6 ratio|omega3:omega6 ratio
547619|NCT00382616|eicosapentaenoic acid:arachidonic acid ratio|eicosapentaenoic acid:arachidonic acid ratio
547620|NCT00382616|Test of Variables of Attention|test of variables of attention
547621|NCT00382616|ADHD index scores|adhd index scores
547622|NCT00382629|Multiple sclerosis|multiple sclerosis
547623|NCT00382629|MS|ms
547624|NCT00382629|Bayhill|bayhill
547625|NCT00382629|BHT-3009|bht-3009
547626|NCT00382629|immunotherapy|immunotherapy
547627|NCT00382642|alcoholism, alcohol disorder, drinking,alcohol|alcoholism, alcohol disorder, drinking,alcohol
547628|NCT00382655|Prevention|prevention
547629|NCT00382655|Emergency Medical Services|emergency medical services
547630|NCT00382655|Emergency Medical Technicians|emergency medical technicians
547631|NCT00382668|hepatically impaired|hepatically impaired
547632|NCT00382681|Contact Lens Care|contact lens care
547633|NCT00382694|Myeloma|myeloma
547634|NCT00382694|Induction therapy|induction therapy
547635|NCT00382694|High-dose melphalan|high-dose melphalan
547636|NCT00382694|Autologous stem cell support|autologous stem cell support
547637|NCT00382694|Fludarabine|fludarabine
547638|NCT00382694|Cyclophosphamide|cyclophosphamide
547639|NCT00382694|Dexamethasone|dexamethasone
547640|NCT00382694|Safety|safety
547641|NCT00382694|Toxicity|toxicity
547642|NCT00382707|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
547643|NCT00382707|low frequency|low frequency
547644|NCT00382707|frontal lobe epilepsy|frontal lobe epilepsy
547645|NCT00382707|brain excitability|brain excitability
547646|NCT00382707|electromyography|electromyography
547647|NCT00382733|Solid Tumors|solid tumors
547648|NCT00382746|Congestive|congestive
547649|NCT00382746|Heart|heart
547650|NCT00382746|Failure|failure
547651|NCT00382746|CHF|chf
547652|NCT00382772|HRV vaccine|hrv vaccine
547653|NCT00382772|Diarrhoea|diarrhoea
547654|NCT00382772|Rotavirus|rotavirus
547655|NCT00382785|online|online
547656|NCT00382785|support|support
547657|NCT00382785|breast cancer|breast cancer
547658|NCT00382811|Recurrent Ovarian Epithelial Cancer|recurrent ovarian epithelial cancer
547659|NCT00382811|Stage IV Ovarian Epithelial Cancer|stage iv ovarian epithelial cancer
547660|NCT00382811|Peritoneal Cavity Cancer|peritoneal cavity cancer
546986|NCT00379470|GBM|gbm
547661|NCT00382811|Stage III Ovarian Epithelial Cancer|stage iii ovarian epithelial cancer
547662|NCT00382824|Progressive Supranuclear Palsy|progressive supranuclear palsy
547663|NCT00382824|Atypical Parkinsonism|atypical parkinsonism
547665|NCT00382837|Lupus,|lupus,
547666|NCT00382837|Antibody,|antibody,
547667|NCT00382837|B-Cell immunotherapy|b-cell immunotherapy
547668|NCT00382850|Nissen fundoplication|nissen fundoplication
547669|NCT00382850|gastroesophageal reflux|gastroesophageal reflux
547670|NCT00382863|heart failure|heart failure
547671|NCT00382863|cardiac support|cardiac support
547672|NCT00382863|Paracor|paracor
547673|NCT00382863|HeartNet|heartnet
547674|NCT00382863|PEERLESS-HF|peerless-hf
547675|NCT00382876|apnea, hypoxia, car seat, car bed|apnea, hypoxia, car seat, car bed
547676|NCT00382889|Anti-Asthmatic Agents|anti-asthmatic agents
547677|NCT00382889|corticosteroids|corticosteroids
547678|NCT00382889|symptom-driven|symptom-driven
547679|NCT00382889|beclomethasone|beclomethasone
547680|NCT00382889|salbutamol|salbutamol
547681|NCT00382902|Contact Lens Care|contact lens care
547682|NCT00382915|Smoking|smoking
547683|NCT00382915|Topography|topography
547684|NCT00382915|Nicotine|nicotine
547685|NCT00382928|Randomized Controlled Trials|randomized controlled trials
547686|NCT00382928|Defibrillators|defibrillators
547687|NCT00382928|Medical Devices|medical devices
547688|NCT00382954|Acute Myelogenous Leukemia|acute myelogenous leukemia
547690|NCT00382954|Relapse|relapse
547691|NCT00382954|Elderly|elderly
547692|NCT00382954|Velcade|velcade
547693|NCT00382954|Idarubicin|idarubicin
547694|NCT00382954|Bortezomib|bortezomib
547695|NCT00382967|Parkinsonian Syndromes, Parkinsonism, DaTSCAN, SPECT, clinical management, quality of life, movement disorder|parkinsonian syndromes, parkinsonism, datscan, spect, clinical management, quality of life, movement disorder
547696|NCT00382967|Clinically uncertain Parkinsonian Syndromes|clinically uncertain parkinsonian syndromes
547697|NCT00382980|influenza, vaccine, A/H5N1, aluminum hydroxide, Vero cell|influenza, vaccine, a/h5n1, aluminum hydroxide, vero cell
547698|NCT00382993|migraine with or without aura|migraine with or without aura
547699|NCT00382993|naproxen sodium|naproxen sodium
547700|NCT00382993|combination product|combination product
547701|NCT00382993|sumatriptan succinate|sumatriptan succinate
547702|NCT00382993|poor response|poor response
547703|NCT00382993|short acting triptan|short acting triptan
547704|NCT00382993|migraine, acute|migraine, acute
547705|NCT00383006|Psychotherapy, Group|psychotherapy, group
547706|NCT00383006|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
547707|NCT00383006|Ambulatory Care|ambulatory care
547708|NCT00383045|Buprenorphine|buprenorphine
547709|NCT00383045|Naltrexone|naltrexone
547710|NCT00383045|HIV risk reduction behavior|hiv risk reduction behavior
547711|NCT00383045|Counseling|counseling
547712|NCT00383058|obesity|obesity
547713|NCT00383058|green tea|green tea
547714|NCT00383071|Apheresis|apheresis
547715|NCT00383071|Avian Flu|avian flu
547716|NCT00383071|Healthy Volunteers|healthy volunteers
547717|NCT00383071|Infectious Diseases|infectious diseases
547718|NCT00383071|IVIG|ivig
547719|NCT00383071|Healthy Volunteer|healthy volunteer
547720|NCT00383071|HV|hv
547721|NCT00383084|Pain|pain
547722|NCT00383084|Physical Activity|physical activity
547723|NCT00383084|Fatigue|fatigue
547724|NCT00383084|Lifestyle Activity|lifestyle activity
547725|NCT00383097|CTLs|ctls
547726|NCT00383097|LMP1|lmp1
547727|NCT00383097|LMP2|lmp2
547728|NCT00383097|CYTOTOXIC T-LYMPHOCYTES|cytotoxic t-lymphocytes
547729|NCT00383097|CD45|cd45
547730|NCT00383097|ANTIBODY|antibody
547731|NCT00383097|EBV-POSITIVE HODGKIN'S|ebv-positive hodgkin's
547732|NCT00383097|NON-HODGKIN'S LYMPHOMA|non-hodgkin's lymphoma
547733|NCT00383110|Diabetes|diabetes
547734|NCT00383110|Health Outcomes|health outcomes
547735|NCT00383110|Racial Preference|racial preference
547736|NCT00383110|Clinical Trial|clinical trial
547737|NCT00383110|Ethnic Differences|ethnic differences
547738|NCT00383123|Fluarix|fluarix
547739|NCT00383123|Influenza|influenza
547740|NCT00383136|STEMI|stemi
547741|NCT00383136|Primary Angioplasty|primary angioplasty
547742|NCT00383136|Abciximab|abciximab
547743|NCT00383136|Tirofiban|tirofiban
547744|NCT00383162|Combination Product|combination product
547745|NCT00383162|naproxen sodium|naproxen sodium
547746|NCT00383162|sumatriptan succinate|sumatriptan succinate
547747|NCT00383162|short acting triptan|short acting triptan
547748|NCT00383162|migraine, acute|migraine, acute
547749|NCT00383162|Poor response|poor response
547750|NCT00383175|Ocular Accommodation|ocular accommodation
547751|NCT00383175|Reading|reading
547752|NCT00383188|Arthritis, Rheumatoid|arthritis, rheumatoid
547753|NCT00383201|Contact Lens Care|contact lens care
547754|NCT00383214|Lupus,|lupus,
547755|NCT00383214|antibody,|antibody,
547756|NCT00383214|B-cell immunotherapy|b-cell immunotherapy
547757|NCT00383279|recurrent cervical cancer|recurrent cervical cancer
547758|NCT00383279|stage 0 cervical cancer|stage 0 cervical cancer
547759|NCT00383279|stage IA cervical cancer|stage ia cervical cancer
547760|NCT00383279|stage IB cervical cancer|stage ib cervical cancer
547761|NCT00383279|stage IIA cervical cancer|stage iia cervical cancer
547762|NCT00383279|stage IIB cervical cancer|stage iib cervical cancer
547763|NCT00383279|stage III cervical cancer|stage iii cervical cancer
547764|NCT00383279|stage IVA cervical cancer|stage iva cervical cancer
547765|NCT00383279|stage IVB cervical cancer|stage ivb cervical cancer
547766|NCT00383279|recurrent uterine sarcoma|recurrent uterine sarcoma
547767|NCT00383279|stage I uterine sarcoma|stage i uterine sarcoma
547768|NCT00383279|stage II uterine sarcoma|stage ii uterine sarcoma
547769|NCT00383279|stage III uterine sarcoma|stage iii uterine sarcoma
547770|NCT00383279|stage IV uterine sarcoma|stage iv uterine sarcoma
547771|NCT00383279|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
547772|NCT00383279|ovarian sarcoma|ovarian sarcoma
547773|NCT00383279|ovarian stromal cancer|ovarian stromal cancer
547774|NCT00383279|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
547775|NCT00383279|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
547776|NCT00383279|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
547777|NCT00383279|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
547778|NCT00383279|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
547779|NCT00383279|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
547780|NCT00383279|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
547781|NCT00383279|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
547782|NCT00383279|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
547783|NCT00383279|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
547784|NCT00383305|neonatal|neonatal
547785|NCT00383305|hypoxic|hypoxic
547786|NCT00383305|ischemic|ischemic
547787|NCT00383305|encephalopathy|encephalopathy
547789|NCT00383305|birth asphyxia|birth asphyxia
547790|NCT00383305|neonatal encephalopathy|neonatal encephalopathy
547791|NCT00383305|Asphyxia Neonatorum|asphyxia neonatorum
547792|NCT00383305|hypothermia, therapeutic|hypothermia, therapeutic
547793|NCT00383305|brain cooling|brain cooling
547794|NCT00383305|selective head cooling|selective head cooling
547795|NCT00383318|Neonate|neonate
547796|NCT00383318|Hyperbilirubinemia|hyperbilirubinemia
547797|NCT00383318|Jaundice|jaundice
547798|NCT00383318|G6PD Deficiency|g6pd deficiency
547799|NCT00383318|Gilbert's Syndrome|gilbert's syndrome
547800|NCT00383344|Crohn Disease|crohn disease
547801|NCT00383344|Positron Emission Tomography|positron emission tomography
547802|NCT00383344|Colonoscopy|colonoscopy
547803|NCT00383357|Performance|performance
547804|NCT00383357|Gait stability|gait stability
547805|NCT00383357|sedative|sedative
547806|NCT00383357|hypnotic|hypnotic
547807|NCT00383357|quality of life|quality of life
547808|NCT00383357|sleep disorder|sleep disorder
547809|NCT00383357|wakefulness|wakefulness
547810|NCT00383357|sleeping pills|sleeping pills
547811|NCT00383357|Cognitive function|cognitive function
547812|NCT00383409|breast|breast
547813|NCT00383409|cancer|cancer
547814|NCT00383409|fatigue|fatigue
547815|NCT00383409|multivitamins|multivitamins
547816|NCT00383448|Stem cell transplantation|stem cell transplantation
547817|NCT00383448|Inborn errors of metabolism|inborn errors of metabolism
547818|NCT00383448|Adrenoleukodystrophy (ALD)|adrenoleukodystrophy (ald)
547819|NCT00383448|Metachromatic leukodystrophy (MLD)|metachromatic leukodystrophy (mld)
547820|NCT00383448|Globoid cell leukodystrophy (GLD or Krabbe)|globoid cell leukodystrophy (gld or krabbe)
547821|NCT00383448|Tay Sachs|tay sachs
547822|NCT00383448|Sandhoff|sandhoff
547823|NCT00383448|Sanfilippo syndrome|sanfilippo syndrome
547824|NCT00383448|Mucopolysaccharidosis III (MPS-III)|mucopolysaccharidosis iii (mps-iii)
547825|NCT00383448|GM1 gangliosidosis|gm1 gangliosidosis
547826|NCT00383448|I-cell|i-cell
547827|NCT00383448|mucolipidosis|mucolipidosis
547828|NCT00383461|tobacco use disorder|tobacco use disorder
547829|NCT00383513|Lupus|lupus
547830|NCT00383513|Antibody|antibody
547831|NCT00383513|B-Cell Immunotherapy|b-cell immunotherapy
547832|NCT00383526|Influenza|influenza
547833|NCT00383526|Orthomyxoviruses|orthomyxoviruses
547834|NCT00383526|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
547835|NCT00383526|elderly|elderly
547836|NCT00383539|Influenza|influenza
547837|NCT00383539|Orthomyxoviruses|orthomyxoviruses
547838|NCT00383539|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
547839|NCT00383539|Adults|adults
547840|NCT00383578|Type 2 diabetes|type 2 diabetes
547841|NCT00383578|vildagliptin|vildagliptin
547842|NCT00383578|hemoglobin A1c|hemoglobin a1c
547843|NCT00383578|metformin|metformin
547844|NCT00383617|pre-radiographic|pre-radiographic
547845|NCT00383617|screening|screening
547846|NCT00383617|early diagnosis|early diagnosis
547847|NCT00383630|End Stage Heart Failure|end stage heart failure
547848|NCT00383630|LVAD|lvad
547849|NCT00383630|Bone Marrow Transplantation|bone marrow transplantation
547850|NCT00383630|Stem Cell Transplantation|stem cell transplantation
547851|NCT00383656|gonadotropin releasing hormone|gonadotropin releasing hormone
706714|NCT00994955|SRT|srt
547852|NCT00383656|GnRH deficiency|gnrh deficiency
547853|NCT00383656|hypothalamic amenorrhea|hypothalamic amenorrhea
547953|NCT00384137|Tacrolimus|tacrolimus
547854|NCT00383656|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
547855|NCT00383656|Kallman's syndrome|kallman's syndrome
547856|NCT00383656|infertility|infertility
547857|NCT00383669|HIV|hiv
547858|NCT00383669|AIDS|aids
547859|NCT00383669|Disease Progression|disease progression
547860|NCT00383669|Multivitamins|multivitamins
547861|NCT00383669|Anti-Retroviral Therapy|anti-retroviral therapy
547862|NCT00383669|HAART|haart
547863|NCT00383669|Tanzania|tanzania
547864|NCT00383669|Africa|africa
547865|NCT00383682|postamputation pain|postamputation pain
547866|NCT00383682|phantom pain|phantom pain
547867|NCT00383682|stump pain|stump pain
547868|NCT00383682|neuroma pain|neuroma pain
547869|NCT00383682|opioid|opioid
547870|NCT00383682|mexiletine|mexiletine
547871|NCT00383695|adenocarcinoma of the rectum|adenocarcinoma of the rectum
547872|NCT00383695|stage I rectal cancer|stage i rectal cancer
547873|NCT00383695|stage II rectal cancer|stage ii rectal cancer
547874|NCT00383695|stage III rectal cancer|stage iii rectal cancer
547875|NCT00383734|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
547876|NCT00383734|polylactic acid|polylactic acid
547877|NCT00383734|polyacrylamide gels|polyacrylamide gels
547878|NCT00383747|cognition|cognition
547879|NCT00383747|nicotine|nicotine
547880|NCT00383747|schizophrenia|schizophrenia
547881|NCT00383773|retinal vein occlusion|retinal vein occlusion
547882|NCT00383773|rTPA|rtpa
547883|NCT00383786|PTSD|ptsd
547884|NCT00383786|Substance P|substance p
547885|NCT00383786|Treatment Study|treatment study
547886|NCT00383786|Placebo|placebo
547887|NCT00383786|Controlled|controlled
547888|NCT00383786|Post Traumatic Stress Disorder|post traumatic stress disorder
547889|NCT00383799|Ventricular tachycardia|ventricular tachycardia
547890|NCT00383812|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
547891|NCT00383812|Intravitreal Bevacizumab|intravitreal bevacizumab
547892|NCT00383825|conjunctival autografts|conjunctival autografts
547893|NCT00383825|amniotic membrane|amniotic membrane
547894|NCT00383825|indocyanine green angiography|indocyanine green angiography
547895|NCT00383825|pterygium surgery|pterygium surgery
547896|NCT00383838|brief motivational intervention; teens; substance use|brief motivational intervention; teens; substance use
547897|NCT00383851|ATN-224|atn-224
547898|NCT00383851|Temozolomide|temozolomide
547899|NCT00383851|Combination|combination
547900|NCT00383851|Sequential|sequential
547901|NCT00383851|Anti-angiogenic|anti-angiogenic
547902|NCT00383851|Copper|copper
547903|NCT00383864|liver fibrosis|liver fibrosis
547904|NCT00383864|portal pressure|portal pressure
547905|NCT00383864|antiviral therapy|antiviral therapy
547906|NCT00383890|American Society of Anesthesiologists (ASA)|american society of anesthesiologists (asa)
547907|NCT00383890|Mallampati Score|mallampati score
547908|NCT00383890|Ramsay Sedation Scale (RSS)|ramsay sedation scale (rss)
547909|NCT00383916|healthy|healthy
547910|NCT00383929|Blood pressure reduction|blood pressure reduction
547911|NCT00383929|combination therapy|combination therapy
547912|NCT00383929|candesartan cilexetil|candesartan cilexetil
547913|NCT00383929|hydrochlorothiazide|hydrochlorothiazide
547914|NCT00383942|Pregnancy|pregnancy
547915|NCT00383942|Extra amniotic saline infusion|extra amniotic saline infusion
547916|NCT00383942|Misoprostol|misoprostol
547917|NCT00383942|Labor induction|labor induction
547918|NCT00383981|malondialdehyde optoelectronic vitamin complex|malondialdehyde optoelectronic vitamin complex
547919|NCT00383994|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
547920|NCT00383994|CLL|cll
547921|NCT00383994|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
547922|NCT00383994|B-Cell Lymphoma|b-cell lymphoma
547923|NCT00383994|Lymphoma|lymphoma
547924|NCT00383994|granulocyte-macrophage colony-stimulating factor|granulocyte-macrophage colony-stimulating factor
547925|NCT00383994|Leukemia|leukemia
547926|NCT00383994|NK Cells|nk cells
547927|NCT00383994|Rituximab|rituximab
547928|NCT00383994|GM-CSF|gm-csf
547929|NCT00383994|Non-myeloablative Allogeneic Stem Cell Transplantation|non-myeloablative allogeneic stem cell transplantation
547930|NCT00383994|Stem Cell Transplant|stem cell transplant
547931|NCT00384007|back pain|back pain
547932|NCT00384007|herniated disc|herniated disc
547933|NCT00384007|leg pain|leg pain
547934|NCT00384007|pinched nerves|pinched nerves
547935|NCT00384007|sciatica|sciatica
547936|NCT00384007|radiculopathy|radiculopathy
547937|NCT00384020|Major Depression Disorder|major depression disorder
547938|NCT00384020|Antidepressant|antidepressant
547939|NCT00384020|Pharmacogenomics|pharmacogenomics
547940|NCT00384020|Cytochrome P450|cytochrome p450
547941|NCT00384020|Serotonin Transporter|serotonin transporter
547942|NCT00384033|MDD|mdd
547943|NCT00384033|Major Depressive Disorder|major depressive disorder
547944|NCT00384033|Depression|depression
547945|NCT00384072|postmenopausal|postmenopausal
547946|NCT00384072|women|women
547947|NCT00384072|SERM|serm
547948|NCT00384072|osteoporosis|osteoporosis
547949|NCT00384098|Psoriasis|psoriasis
547950|NCT00384124|Bowens disease|bowens disease
547951|NCT00384124|Squamous cell carcinoma in situ of the skin|squamous cell carcinoma in situ of the skin
547952|NCT00384124|imiquimod|imiquimod
547955|NCT00384150|galiximab|galiximab
547956|NCT00384150|antibody|antibody
547957|NCT00384150|refractory|refractory
547958|NCT00384150|follicular|follicular
547959|NCT00384150|relapsed|relapsed
547961|NCT00384150|rituximab|rituximab
547962|NCT00384150|retreatment|retreatment
547963|NCT00384163|cardiac|cardiac
547964|NCT00384163|adult|adult
547965|NCT00384163|PVR|pvr
547966|NCT00384176|Metastatic Colorectal Cancer|metastatic colorectal cancer
547967|NCT00384176|RECENTIN|recentin
547968|NCT00384189|Asthma|asthma
547969|NCT00384189|Ciclesonide|ciclesonide
547970|NCT00384189|children|children
547971|NCT00384202|Tacrolimus|tacrolimus
547972|NCT00384202|Liver Transplantation|liver transplantation
547973|NCT00384228|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
547974|NCT00384228|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
547975|NCT00384241|Blood Pressure, High|blood pressure, high
547976|NCT00384241|Stress|stress
547977|NCT00384241|Inflammation|inflammation
547978|NCT00384254|Tobacco.|tobacco.
547979|NCT00384254|Cessation.|cessation.
547980|NCT00384254|Dental patients.|dental patients.
547981|NCT00384254|Dentists.|dentists.
547982|NCT00384254|Hygienists.|hygienists.
547983|NCT00384254|Dental assistants.|dental assistants.
547984|NCT00384254|Health care providers.|health care providers.
547985|NCT00384254|Behavioral intervention.|behavioral intervention.
547986|NCT00384254|Tobacco intervention.|tobacco intervention.
547987|NCT00384254|Cigarettes.|cigarettes.
547988|NCT00384254|Smokeless tobacco.|smokeless tobacco.
547989|NCT00384254|Smoking intervention.|smoking intervention.
547990|NCT00384267|malaria, infants, preterm babies, neonates, Mali|malaria, infants, preterm babies, neonates, mali
547991|NCT00384306|COPD|copd
547992|NCT00384306|prednisolone|prednisolone
547993|NCT00384306|bone biopsy|bone biopsy
547994|NCT00384306|tetracycline labelling|tetracycline labelling
547995|NCT00384319|resuscitation|resuscitation
547996|NCT00384319|hypothermia|hypothermia
547997|NCT00384332|Bipolar Depression|bipolar depression
547998|NCT00384332|Weight gain bipolar medicine|weight gain bipolar medicine
547999|NCT00384332|side effects olanzapine|side effects olanzapine
548000|NCT00384332|gastrointestinal hormones bipolar medicine|gastrointestinal hormones bipolar medicine
548001|NCT00384345|bright light treatment|bright light treatment
548002|NCT00384345|exercise|exercise
548003|NCT00384345|body fat index|body fat index
548004|NCT00384345|mood|mood
548005|NCT00384345|sleep|sleep
548006|NCT00384345|fatigue|fatigue
548007|NCT00384358|Fractures|fractures
548008|NCT00384371|back|back
548009|NCT00384371|pain|pain
548010|NCT00384384|Dialysis|dialysis
548011|NCT00384384|Serum potassium|serum potassium
548012|NCT00384384|18b glycyrrhetinic acid|18b glycyrrhetinic acid
548013|NCT00384384|insulin sensitivity|insulin sensitivity
548014|NCT00384397|Menactra vaccine|menactra vaccine
548015|NCT00384397|Meningococcal meningitis|meningococcal meningitis
548016|NCT00384397|Measles|measles
548017|NCT00384397|Mumps|mumps
548018|NCT00384397|Rubella|rubella
548019|NCT00384397|Varicella virus|varicella virus
548020|NCT00384397|Haemophilus influenzae type b|haemophilus influenzae type b
548021|NCT00384397|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
548022|NCT00384410|Pain|pain
548023|NCT00384410|Insomnia|insomnia
548024|NCT00384410|Nabilone|nabilone
548025|NCT00384423|Alzheimer's Disease|alzheimer's disease
548026|NCT00384423|AD|ad
548027|NCT00384423|PRX-03140|prx-03140
548028|NCT00384423|Dementia|dementia
548029|NCT00384423|Epix|epix
548030|NCT00384423|Predix|predix
548031|NCT00384423|Cognition enhancing|cognition enhancing
548032|NCT00384436|Major Depressive Disorder|major depressive disorder
548033|NCT00384449|Eales|eales
548034|NCT00384462|Premature infants (32-35 weeks GA) <6 months of age at the start of the RSV season who are not receiving palivizumab and do not have CLD of prematurity|premature infants (32-35 weeks ga) <6 months of age at the start of the rsv season who are not receiving palivizumab and do not have cld of prematurity
548035|NCT00384462|Respiratory Syncytial Viruses|respiratory syncytial viruses
548036|NCT00384475|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
548037|NCT00384475|Ciclesonide|ciclesonide
548038|NCT00384475|Hay Fever|hay fever
548039|NCT00384475|SAR|sar
548040|NCT00384488|Diabetes mellitus|diabetes mellitus
548041|NCT00384488|Weight control|weight control
548042|NCT00384488|Healthy eating|healthy eating
548043|NCT00384488|Physical Activity|physical activity
548044|NCT00384501|keratoconus|keratoconus
548045|NCT00384501|Intacs|intacs
548046|NCT00384514|Coronary Artery disease with chronic stable angina|coronary artery disease with chronic stable angina
548047|NCT00384527|Clostridium difficile|clostridium difficile
752411|NCT01172912|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
547387|NCT00381199|cannabinoid|cannabinoid
548048|NCT00384540|-Heart Transplant, Allograft Vasculopathy, Dobutamine Stress Echocardiography, Brain Natriuretic Peptide|-heart transplant, allograft vasculopathy, dobutamine stress echocardiography, brain natriuretic peptide
548049|NCT00384540|Vasculopathy|vasculopathy
548050|NCT00384579|back|back
548051|NCT00384579|pain|pain
548052|NCT00384592|heartburn|heartburn
548055|NCT00384592|GERD|gerd
548056|NCT00384592|GORD|gord
548057|NCT00384618|Kidney, Antioxidants, Statin, Carotid IMT|kidney, antioxidants, statin, carotid imt
548058|NCT00384631|Neovascular|neovascular
548059|NCT00384631|Glaucoma|glaucoma
548060|NCT00384631|Bevacizumab|bevacizumab
548061|NCT00384631|Avastin|avastin
548062|NCT00384631|Intravitreal|intravitreal
548063|NCT00384631|IOP|iop
548064|NCT00384644|heart failure|heart failure
548065|NCT00384644|sepsis|sepsis
548066|NCT00384644|septic shock|septic shock
548067|NCT00384644|cardiogenic shock|cardiogenic shock
548068|NCT00384657|chronic heart failure|chronic heart failure
548069|NCT00384657|chronic kidney disease|chronic kidney disease
548070|NCT00384657|anemia|anemia
548071|NCT00384657|intravenous iron|intravenous iron
548072|NCT00384670|dengue|dengue
548073|NCT00384670|vaccine|vaccine
548075|NCT00378495|miltefosine|miltefosine
548076|NCT00378495|kala azar|kala azar
548077|NCT00378495|Brazil|brazil
548078|NCT00378508|immune therapy|immune therapy
548079|NCT00378508|autoimmunity|autoimmunity
548080|NCT00378508|insulin secretion|insulin secretion
548081|NCT00378508|diabetes mellitus|diabetes mellitus
548082|NCT00378521|Raynaud's|raynaud's
548083|NCT00378521|Nitroglycerin|nitroglycerin
548084|NCT00378521|topical gel|topical gel
548085|NCT00378521|cold hands|cold hands
548086|NCT00378521|painful hands|painful hands
548087|NCT00378521|scleroderma|scleroderma
548088|NCT00378534|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
548089|NCT00378534|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
548090|NCT00378534|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
548091|NCT00378534|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
548092|NCT00378534|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
548093|NCT00378534|Leukemia|leukemia
548094|NCT00378534|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
548096|NCT00378534|Acute Myeloid Leukemia|acute myeloid leukemia
548097|NCT00378534|AML|aml
548098|NCT00378534|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
548099|NCT00378534|CLL|cll
548100|NCT00378534|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
548101|NCT00378534|ALL|all
548102|NCT00378534|Myelodysplasia Syndrome|myelodysplasia syndrome
548103|NCT00378547|Tonsillectomy|tonsillectomy
548104|NCT00378547|pregabalin|pregabalin
548105|NCT00378547|dexamethasone|dexamethasone
548106|NCT00378547|multimodal postoperative analgesia|multimodal postoperative analgesia
548107|NCT00384683|Endothelial Dysfunction|endothelial dysfunction
548108|NCT00384683|Endothelial Cells|endothelial cells
548109|NCT00384683|Perioperative Outcome|perioperative outcome
548110|NCT00384683|Blood Sample|blood sample
548111|NCT00384696|Risk Perception|risk perception
548112|NCT00384696|Smoking Cessation|smoking cessation
548113|NCT00384696|Nicotine Replacement Therapy|nicotine replacement therapy
548114|NCT00384696|Questionnaire|questionnaire
548115|NCT00384696|Nicotine|nicotine
548116|NCT00384709|Elderly|elderly
548117|NCT00384709|Hospitalization|hospitalization
548118|NCT00384709|Geriatrics|geriatrics
548119|NCT00384709|Mortality|mortality
548120|NCT00384709|Readmission|readmission
548121|NCT00384709|Length of Stay|length of stay
548122|NCT00384722|Left ventricular lead|left ventricular lead
548123|NCT00384722|Pacing|pacing
548124|NCT00384722|Heart Failure|heart failure
548125|NCT00384735|bone tumor|bone tumor
548126|NCT00384735|soft tissue tumor|soft tissue tumor
548127|NCT00384748|Cerebrovascular Accident|cerebrovascular accident
548128|NCT00384748|Rehabilitation|rehabilitation
548129|NCT00384748|Telemedicine|telemedicine
548130|NCT00384774|Migraine|migraine
548131|NCT00384787|HIV Seronegativity|hiv seronegativity
548132|NCT00384787|Adenoviral Vector Vaccine|adenoviral vector vaccine
548133|NCT00384787|DNA Plasmid Vaccine|dna plasmid vaccine
548134|NCT00384787|HIV Preventive Vaccine|hiv preventive vaccine
548135|NCT00384826|Adenocarcinoma, Bronchiolo-Alveolar|adenocarcinoma, bronchiolo-alveolar
548136|NCT00384852|Fracture|fracture
548137|NCT00384852|Humerus|humerus
548138|NCT00384865|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
548139|NCT00384891|Superficial urothelial cell carcinoma of bladder|superficial urothelial cell carcinoma of bladder
548140|NCT00384891|NMIBC|nmibc
548141|NCT00384891|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
548142|NCT00384891|Hyperthermia|hyperthermia
548143|NCT00384891|Bladder instillation|bladder instillation
548144|NCT00384891|Mitomycin C|mitomycin c
548145|NCT00384891|RITE|rite
548146|NCT00384891|SHTC|shtc
548147|NCT00384891|Intravesical|intravesical
548148|NCT00384943|postpartum depression|postpartum depression
547493|NCT00382291|Child Psychiatry|child psychiatry
548149|NCT00384943|exercise|exercise
548150|NCT00384956|MDS either de novo or secondary, fitting any of the WHO classifications.|mds either de novo or secondary, fitting any of the who classifications.
548151|NCT00384969|RAD001|rad001
548152|NCT00384969|Sorafenib|sorafenib
548354|NCT00386256|exercise|exercise
548153|NCT00384969|Renal Cell Carcinoma|renal cell carcinoma
548155|NCT00384982|Bone marrow-derived stem cells|bone marrow-derived stem cells
548156|NCT00384982|Acute myocardial infarction|acute myocardial infarction
548157|NCT00384995|Contrast Induced Nephropathy|contrast induced nephropathy
548158|NCT00384995|Chronic Kidney Disease|chronic kidney disease
548159|NCT00384995|Acute Renal Failure|acute renal failure
548160|NCT00384995|End-stage Renal Disease|end-stage renal disease
548161|NCT00384995|Cardiovascular diseases|cardiovascular diseases
548162|NCT00384995|Coronary catheterization|coronary catheterization
548163|NCT00384995|Percutaneous coronary intervention|percutaneous coronary intervention
548164|NCT00384995|Intra-arterial angiography|intra-arterial angiography
548165|NCT00384995|Bicarbonate|bicarbonate
548167|NCT00385008|Combination product, sumatriptan succinate, naproxen sodium, absorption, pharmacokinetics, disintegration, gastric transit, gastric scintigraphy|combination product, sumatriptan succinate, naproxen sodium, absorption, pharmacokinetics, disintegration, gastric transit, gastric scintigraphy
548168|NCT00385528|Case complexity|case complexity
548169|NCT00385528|INTERMED|intermed
548170|NCT00385528|Consultation liaison psychiatry|consultation liaison psychiatry
548171|NCT00385528|depression|depression
548172|NCT00385541|pain|pain
548173|NCT00385541|morphine|morphine
548174|NCT00385541|hydromorphone|hydromorphone
548175|NCT00385541|nausea|nausea
548176|NCT00385541|vomiting|vomiting
548177|NCT00385541|pruritis|pruritis
548178|NCT00385554|Microbicide|microbicide
548179|NCT00385554|HIV prevention|hiv prevention
548180|NCT00385554|Botswana|botswana
548181|NCT00385554|Preventing acquisition of HIV infection|preventing acquisition of hiv infection
548182|NCT00385554|HIV Seronegativity|hiv seronegativity
548183|NCT00385567|AIDS|aids
548184|NCT00385567|Treatment Experienced|treatment experienced
548185|NCT00385606|prolonged continuous infusion|prolonged continuous infusion
548186|NCT00385606|Cox-2 inhibitors|cox-2 inhibitors
548187|NCT00385632|Treatment Experienced|treatment experienced
548188|NCT00385645|HIV seronegativity|hiv seronegativity
548189|NCT00385658|Dyslipidemia|dyslipidemia
548190|NCT00385658|metabolic syndrome|metabolic syndrome
548191|NCT00385658|fluvastatin|fluvastatin
548192|NCT00385658|fenofibrate|fenofibrate
548193|NCT00385658|simvastatin|simvastatin
548194|NCT00385658|ezetimibe|ezetimibe
548195|NCT00385684|Agitation|agitation
548196|NCT00385684|Alzheimer Disease|alzheimer disease
548197|NCT00385684|Analgesics|analgesics
548198|NCT00385684|Dementia|dementia
548199|NCT00385684|Narcotics|narcotics
548200|NCT00385684|Opioid|opioid
548201|NCT00385684|Pain|pain
548202|NCT00385684|Palliative Care|palliative care
548203|NCT00385684|Psychomotor|psychomotor
548204|NCT00385684|Suffering, Physical|suffering, physical
548205|NCT00385697|Randomized|randomized
548206|NCT00385697|Double Blind|double blind
548207|NCT00385697|Parallel Group|parallel group
548208|NCT00385697|Controlled Clinical Trial|controlled clinical trial
548209|NCT00385710|Progressive supranuclear palsy (PSP)|progressive supranuclear palsy (psp)
548210|NCT00385723|affect|affect
548211|NCT00385723|inflammation|inflammation
548212|NCT00385736|Moderate to Severe Ulcerative Colitis|moderate to severe ulcerative colitis
548213|NCT00385736|Double-blind|double-blind
548214|NCT00385736|Adalimumab|adalimumab
548215|NCT00385736|Induction of Clinical Remission|induction of clinical remission
548216|NCT00385749|Implanted cardioverter defibrillator|implanted cardioverter defibrillator
548217|NCT00385749|congestive heart failure|congestive heart failure
548218|NCT00385749|right ventricular lead placement|right ventricular lead placement
548219|NCT00385749|select site pacing|select site pacing
548220|NCT00385762|Human volunteers|human volunteers
548221|NCT00385775|Cancer|cancer
548222|NCT00385775|solid tumours|solid tumours
548223|NCT00385775|refractory|refractory
548224|NCT00385775|antisense|antisense
548225|NCT00385775|oligonucleotide|oligonucleotide
548226|NCT00385788|Hodgkin's Disease|hodgkin's disease
548227|NCT00385788|Stem Cell Transplantation|stem cell transplantation
548228|NCT00385788|Antithymocyte Globulin|antithymocyte globulin
548229|NCT00385788|Gemcitabine|gemcitabine
548230|NCT00385788|Gemzar|gemzar
548231|NCT00385788|Fludarabine|fludarabine
548232|NCT00385788|Fludarabine Phosphate|fludarabine phosphate
548233|NCT00385788|Melphalan|melphalan
548234|NCT00385788|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
548235|NCT00385788|AST|ast
548236|NCT00385788|SCT|sct
548237|NCT00385788|ATG|atg
548238|NCT00385788|Thymoglobulin|thymoglobulin
548239|NCT00385801|cocaine|cocaine
548240|NCT00385801|dependence|dependence
548241|NCT00385801|risperidal|risperidal
548242|NCT00385801|MRI|mri
548243|NCT00385827|Cancer|cancer
707141|NCT00996320|Adult|adult
548244|NCT00385827|Prostate|prostate
548245|NCT00385827|IL-6|il-6
548246|NCT00385827|Mitoxantrone|mitoxantrone
548247|NCT00385827|Metastatic prostate cancer|metastatic prostate cancer
548248|NCT00385840|Influenza vaccine|influenza vaccine
548249|NCT00385840|Influenza|influenza
548250|NCT00385853|PTK|ptk
548251|NCT00385853|temozolomide|temozolomide
548252|NCT00385853|glioblastoma|glioblastoma
548166|NCT00384995|Saline|saline
548253|NCT00385866|Patient Navigator|patient navigator
548254|NCT00385866|Community health|community health
548255|NCT00385866|Communication|communication
548256|NCT00385892|Healthy volonteers|healthy volonteers
548257|NCT00385892|Abdominal binder|abdominal binder
548258|NCT00385892|IAP|iap
548259|NCT00385892|MAP|map
548260|NCT00385892|APP|app
548261|NCT00385918|Cardiovascular Fitness|cardiovascular fitness
548262|NCT00385918|Exercise|exercise
548263|NCT00385918|Gait|gait
548264|NCT00385918|Spinal Cord Injury|spinal cord injury
548265|NCT00385918|Treadmill Training|treadmill training
548266|NCT00385931|Hypertension|hypertension
548267|NCT00385931|high cholesterol|high cholesterol
548268|NCT00385931|valsartan|valsartan
548269|NCT00385931|simvastatin|simvastatin
548270|NCT00385957|Treatment Naive|treatment naive
548271|NCT00385983|thyroidectomy|thyroidectomy
548272|NCT00385983|thyroid neoplasm|thyroid neoplasm
548273|NCT00385983|postoperative complications|postoperative complications
548274|NCT00385983|cost effectiveness|cost effectiveness
548275|NCT00385996|Carcinoma,non-small cell lung|carcinoma,non-small cell lung
548276|NCT00385996|preoperative|preoperative
548277|NCT00385996|Tarceva|tarceva
548278|NCT00385996|Response rate|response rate
548279|NCT00386009|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
548280|NCT00386009|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
548281|NCT00386022|Gonadotropin-releasing hormone|gonadotropin-releasing hormone
548282|NCT00386022|Estrogens|estrogens
548283|NCT00386022|postmenopausal women|postmenopausal women
548284|NCT00386022|Pituitary hormones|pituitary hormones
548285|NCT00386035|Treatment Experienced|treatment experienced
548286|NCT00386048|Cognitive Behavioral Therapy|cognitive behavioral therapy
548287|NCT00386048|Pediatric Sickle Cell Disease|pediatric sickle cell disease
548288|NCT00386048|Pain Management|pain management
548289|NCT00386061|Obesity|obesity
548290|NCT00386061|risk factors|risk factors
548291|NCT00386074|NaFeEDTA|nafeedta
548292|NCT00386074|electrolytic iron|electrolytic iron
548293|NCT00386074|efficacy|efficacy
548294|NCT00386074|whole maize flour|whole maize flour
548295|NCT00386074|phytate|phytate
548296|NCT00386074|school-age children|school-age children
548297|NCT00386074|controlled trial|controlled trial
548298|NCT00386074|Africa|africa
548299|NCT00386087|Breast Cancer|breast cancer
548300|NCT00386087|Cancer of the Breast|cancer of the breast
548301|NCT00386100|Fasting Plasma Glucose|fasting plasma glucose
548302|NCT00386100|Dual energy X ray absorptiometry (DXA)|dual energy x ray absorptiometry (dxa)
548303|NCT00386100|Drug-naive|drug-naive
548304|NCT00386100|Type 2 diabetes mellitus|type 2 diabetes mellitus
548305|NCT00386100|Bone Mineral Density|bone mineral density
548306|NCT00386100|Hyperglycemia|hyperglycemia
548307|NCT00386100|HbA1c|hba1c
548308|NCT00386113|Influenza|influenza
548309|NCT00386113|improved vaccine|improved vaccine
548310|NCT00386113|elderly|elderly
548311|NCT00386126|Heart Failure|heart failure
548312|NCT00386126|Anemia|anemia
548313|NCT00386126|Treatment|treatment
548314|NCT00386139|Diastolic|diastolic
548315|NCT00386139|systolic|systolic
548316|NCT00386139|hypertension|hypertension
548317|NCT00386139|aliskiren|aliskiren
548318|NCT00386139|blood pressure|blood pressure
548319|NCT00386139|hydrochlorothiazide, HCTZ|hydrochlorothiazide, hctz
548320|NCT00386152|Anemia|anemia
548321|NCT00386152|Cancer|cancer
548322|NCT00386152|Chemotherapy-Induced Anemia|chemotherapy-induced anemia
548323|NCT00386152|Epoetin alfa|epoetin alfa
548324|NCT00386152|Darbepoetin alfa|darbepoetin alfa
548325|NCT00386178|vitamin E|vitamin e
548326|NCT00386178|gamma tocopherol|gamma tocopherol
548327|NCT00386178|moderate to severe asthma|moderate to severe asthma
548328|NCT00386178|healthy subjects|healthy subjects
548329|NCT00386191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
548330|NCT00386191|Ischemic cerebrovascular disease|ischemic cerebrovascular disease
548331|NCT00386204|Q-switched Ruby laser|q-switched ruby laser
548332|NCT00386217|Cervical Cancer|cervical cancer
548333|NCT00386217|Breast Cancer|breast cancer
548334|NCT00386217|Hodgkin's Disease|hodgkin's disease
548335|NCT00386217|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
548336|NCT00386217|Female Infertility|female infertility
548337|NCT00386217|Telephone Survey|telephone survey
548338|NCT00386230|transmission|transmission
548339|NCT00386230|infant|infant
548340|NCT00386230|HIV|hiv
548341|NCT00386230|pregnancy|pregnancy
548342|NCT00386230|HIV-1 infection|hiv-1 infection
548343|NCT00386230|HIV Seronegativity|hiv seronegativity
547689|NCT00382954|AML|aml
548344|NCT00386243|analgesia|analgesia
548345|NCT00386243|analgesics|analgesics
548346|NCT00386243|cognitive behavioral therapy|cognitive behavioral therapy
548347|NCT00386243|Pain|pain
548348|NCT00386243|self-management|self-management
548349|NCT00386243|stepped care|stepped care
548350|NCT00386243|musculoskeletal pain|musculoskeletal pain
548351|NCT00386256|telehealth|telehealth
548352|NCT00386256|telerehabilitation|telerehabilitation
548353|NCT00386256|deconditioning|deconditioning
548355|NCT00386269|codeine phosphate analgesia|codeine phosphate analgesia
548356|NCT00386282|Mifepristone|mifepristone
548357|NCT00386282|Misoprostol|misoprostol
548358|NCT00386282|Buccal administration|buccal administration
548359|NCT00386308|Heavy Menstrual Bleeding|heavy menstrual bleeding
548360|NCT00386308|Menorrhagia|menorrhagia
548361|NCT00386321|Zevalin|zevalin
548362|NCT00386321|Zevalin plus CHOP|zevalin plus chop
548363|NCT00386321|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
548364|NCT00386321|First line Diffuse large B-cell lymphoma|first line diffuse large b-cell lymphoma
548365|NCT00386334|insomnia|insomnia
548366|NCT00386334|chronic|chronic
548367|NCT00386334|primary|primary
548368|NCT00386347|HIV|hiv
548369|NCT00386347|repeat dose|repeat dose
548370|NCT00386347|pharmacokinetics|pharmacokinetics
548371|NCT00386347|bioavailability|bioavailability
548372|NCT00386347|single-dose|single-dose
548373|NCT00386347|food effect|food effect
548374|NCT00386373|Chronic Myeloid Leukemia|chronic myeloid leukemia
548375|NCT00386373|CML|cml
548376|NCT00386373|ALL|all
548377|NCT00386373|AML|aml
548378|NCT00386373|Leukemia|leukemia
548379|NCT00386373|Imatinib Mesylate|imatinib mesylate
548380|NCT00386373|Gleevec|gleevec
548381|NCT00386373|Philadelphia-Positive|philadelphia-positive
548382|NCT00386373|Bone marrow transplant|bone marrow transplant
548383|NCT00386373|BMT|bmt
548384|NCT00386373|Stem cell transplant|stem cell transplant
548385|NCT00386373|SCT|sct
548386|NCT00386386|hydration|hydration
548387|NCT00386386|prehospital|prehospital
548388|NCT00386386|mass casualty incident|mass casualty incident
548389|NCT00386399|Advanced Pancreatic Cancer|advanced pancreatic cancer
548390|NCT00386399|Mutated BRCA2 Gene|mutated brca2 gene
548391|NCT00386399|Recurrent Pancreatic Cancer|recurrent pancreatic cancer
548392|NCT00386412|Cytomegalovirus infection|cytomegalovirus infection
548393|NCT00386451|Intravenous chemotherapy|intravenous chemotherapy
548394|NCT00386464|bipap|bipap
548395|NCT00386464|lou gehrigs disease|lou gehrigs disease
548396|NCT00386464|motor neuron disease|motor neuron disease
548397|NCT00386464|respiratory muscles|respiratory muscles
548398|NCT00386477|Povidone iodine|povidone iodine
548399|NCT00386477|postoperative infection|postoperative infection
548400|NCT00386477|presurgical cleansing|presurgical cleansing
548401|NCT00386516|cholangiocarcinoma|cholangiocarcinoma
548402|NCT00386516|bile duct|bile duct
548403|NCT00386516|biliary|biliary
548404|NCT00386516|intra-hepatic|intra-hepatic
548405|NCT00386516|extra-hepatic|extra-hepatic
548406|NCT00386516|gall bladder|gall bladder
548407|NCT00386516|cancer|cancer
548408|NCT00386516|carcinoma|carcinoma
548409|NCT00386516|metastatic|metastatic
548410|NCT00386516|metastasis|metastasis
548411|NCT00386516|advanced|advanced
548412|NCT00386516|recurrent|recurrent
548413|NCT00386529|low dose aspirin|low dose aspirin
548414|NCT00386529|Hypertension|hypertension
548415|NCT00386529|administration time dependent effect|administration time dependent effect
548416|NCT00386542|vaccination|vaccination
548417|NCT00386542|influenza vaccine|influenza vaccine
548418|NCT00386542|jet injection|jet injection
548419|NCT00386542|intradermal injection|intradermal injection
548420|NCT00386542|infancy|infancy
548421|NCT00386542|children|children
548422|NCT00386542|dose-sparing|dose-sparing
548423|NCT00386542|cutaneous vaccination|cutaneous vaccination
548424|NCT00386542|Dominican Republic|dominican republic
548425|NCT00386542|pandemic preparedness|pandemic preparedness
548426|NCT00386542|jet injector|jet injector
548427|NCT00386542|reduced dosage|reduced dosage
548428|NCT00386542|immunogenicity|immunogenicity
548429|NCT00386542|reactogenicity|reactogenicity
548430|NCT00386542|safety|safety
548431|NCT00386542|needle-free|needle-free
548432|NCT00386542|immune response|immune response
548433|NCT00386542|hemagglutination inhibition|hemagglutination inhibition
548434|NCT00386542|Infant|infant
548435|NCT00386594|Barrett Esophagus|barrett esophagus
548436|NCT00386594|High grade dysplasia|high grade dysplasia
548437|NCT00386594|Carcinoma in situ|carcinoma in situ
548438|NCT00386594|825A|825a
548439|NCT00386607|Hypertension, aliskiren, valsartan, HCTZ, blood pressure|hypertension, aliskiren, valsartan, hctz, blood pressure
548440|NCT00386620|Breast Cancer|breast cancer
548441|NCT00386620|Cancer Control|cancer control
548442|NCT00386620|Spousal Relationships|spousal relationships
548443|NCT00386620|Questionnaire|questionnaire
548444|NCT00386620|Interview|interview
548445|NCT00386620|Pain|pain
547788|NCT00383305|HIE|hie
548446|NCT00386633|Vaccine|vaccine
548447|NCT00386633|Safety|safety
548448|NCT00386633|T-cell epitope|t-cell epitope
548449|NCT00386633|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
548450|NCT00386633|HIV Preventive Vaccine|hiv preventive vaccine
548451|NCT00386646|Dry eye syndromes therapy|dry eye syndromes therapy
548452|NCT00386672|Calcium|calcium
548453|NCT00386672|Vitamin D|vitamin d
548454|NCT00386672|Weight Loss|weight loss
548455|NCT00386672|Overweight|overweight
548456|NCT00386672|Obesity|obesity
548457|NCT00386672|Lite Orange Juice|lite orange juice
548458|NCT00386685|Cancer|cancer
548460|NCT00386685|metastatic breast cancer|metastatic breast cancer
548462|NCT00386698|improved vaccine,|improved vaccine,
548463|NCT00386698|influenza disease|influenza disease
548464|NCT00386698|elderly|elderly
548465|NCT00386711|suicide|suicide
548466|NCT00386711|depressed patients|depressed patients
548467|NCT00386711|primary care|primary care
548468|NCT00386724|Pain|pain
548469|NCT00386724|Neurostimulation|neurostimulation
548470|NCT00386724|Leg Pain|leg pain
548471|NCT00386724|Back Pain|back pain
548472|NCT00386737|Asthma|asthma
548473|NCT00386737|Breath Testing|breath testing
548474|NCT00386737|Laser Spectroscopy|laser spectroscopy
548475|NCT00386737|eNO|eno
548476|NCT00386737|Nitric Oxide|nitric oxide
548477|NCT00386737|Lower Airway Inflammation|lower airway inflammation
548478|NCT00386737|Carbon Dioxide|carbon dioxide
548479|NCT00386737|CO2|co2
548480|NCT00386750|Malaria|malaria
548482|NCT00386750|co-artemether|co-artemether
548483|NCT00386750|auditory|auditory
548484|NCT00386750|Plasmodium falciparum|plasmodium falciparum
548485|NCT00386750|marsh fever|marsh fever
548486|NCT00386750|Plasmodium infections|plasmodium infections
548487|NCT00386750|remittent fever|remittent fever
548488|NCT00386750|paludism|paludism
548489|NCT00386750|artemether|artemether
548490|NCT00386750|artemisinins|artemisinins
548491|NCT00386750|benflumetol|benflumetol
548492|NCT00386750|lumefantrine|lumefantrine
548493|NCT00386763|Marsh fever|marsh fever
548494|NCT00386763|Plasmodium infections|plasmodium infections
548495|NCT00386763|Remittent fever|remittent fever
548496|NCT00386763|Paludism|paludism
548497|NCT00386763|Artemether|artemether
548498|NCT00386763|Artemisinins|artemisinins
548499|NCT00386763|Malaria|malaria
548500|NCT00386763|Benflumetol|benflumetol
548501|NCT00386763|Lumefantrine|lumefantrine
548502|NCT00386776|computers|computers
548503|NCT00386776|diagnosis|diagnosis
548504|NCT00386776|medical records|medical records
548505|NCT00386776|physician patient relations|physician patient relations
548506|NCT00386776|medical history taking|medical history taking
548507|NCT00386776|medical informatics applications|medical informatics applications
548508|NCT00386789|Typhoid Fever|typhoid fever
548509|NCT00386789|Serological Survey|serological survey
548510|NCT00386789|Follow-Up|follow-up
548511|NCT00386789|Protection|protection
548512|NCT00386802|Neutropenia|neutropenia
548513|NCT00386802|Antifungals|antifungals
548797|NCT00387738|Vaccine|vaccine
548514|NCT00386828|colorectal cancer|colorectal cancer
548515|NCT00386828|advanced colorectal cancer|advanced colorectal cancer
548516|NCT00386841|Major depression|major depression
548517|NCT00386841|First degree relatives|first degree relatives
548518|NCT00386841|Escitalopram|escitalopram
548519|NCT00386841|Cortisol|cortisol
548520|NCT00386841|Cognition|cognition
548521|NCT00386841|Personality|personality
548522|NCT00386841|Endo-phenotype|endo-phenotype
548523|NCT00386854|exercise|exercise
548524|NCT00386854|lipid metabolism|lipid metabolism
548525|NCT00386854|lipoproteins|lipoproteins
548526|NCT00386854|insulin resistance|insulin resistance
548527|NCT00386854|inflammation|inflammation
548528|NCT00386867|medical abortion|medical abortion
548529|NCT00386867|mifepristone|mifepristone
548530|NCT00386867|misoprostol|misoprostol
548531|NCT00386867|buccal administration|buccal administration
548532|NCT00386906|Melanoma|melanoma
548533|NCT00386906|Conjunctival Melanoma|conjunctival melanoma
548534|NCT00386906|Malignant Melanoma of the Conjunctiva|malignant melanoma of the conjunctiva
548535|NCT00386906|Malignant Melanoma of the Eyelid|malignant melanoma of the eyelid
548536|NCT00386906|Sebaceous Cell Carcinoma|sebaceous cell carcinoma
548537|NCT00386906|Sebaceous Cell Carcinoma of the Conjunctiva|sebaceous cell carcinoma of the conjunctiva
548538|NCT00386906|Sebaceous Cell Carcinoma of the Eyelid|sebaceous cell carcinoma of the eyelid
548539|NCT00386906|Sentinel Lymph Node|sentinel lymph node
548540|NCT00386906|Lymphatic Mapping|lymphatic mapping
548541|NCT00386906|Eyelid|eyelid
548542|NCT00386906|Eyelid Lesion|eyelid lesion
548543|NCT00386945|Tobacco|tobacco
548544|NCT00386945|Cessation.|cessation.
548545|NCT00386945|Chiropractic patients.|chiropractic patients.
548546|NCT00386945|Doctors of Chiropractic.|doctors of chiropractic.
548547|NCT00386945|Health care providers.|health care providers.
548548|NCT00386945|Behavioral intervention.|behavioral intervention.
548549|NCT00386945|Tobacco intervention.|tobacco intervention.
548550|NCT00386945|Cigarettes.|cigarettes.
548551|NCT00386945|Smokeless tobacco.|smokeless tobacco.
548552|NCT00386945|Smoking intervention.|smoking intervention.
548553|NCT00386958|corneal ulcers|corneal ulcers
548554|NCT00386958|bacterial keratitis|bacterial keratitis
548555|NCT00386958|childhood blindness|childhood blindness
548556|NCT00386958|povidone-iodine|povidone-iodine
548557|NCT00386971|L-carnitine|l-carnitine
548558|NCT00386971|HIV|hiv
548559|NCT00386971|TGRL metabolism|tgrl metabolism
548560|NCT00386971|postprandial|postprandial
548561|NCT00386971|HIV Treatment Experienced|hiv treatment experienced
548562|NCT00386984|hepatocellular carcinoma; Sandostatin-LAR; RCT|hepatocellular carcinoma; sandostatin-lar; rct
548459|NCT00386685|Breast|breast
548563|NCT00387023|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
548564|NCT00387023|Orbital Lymphoma|orbital lymphoma
548565|NCT00387023|Rituximab|rituximab
548566|NCT00387023|Rituxan|rituxan
548567|NCT00387023|Zevalin|zevalin
548568|NCT00387023|Ibritumomab tiuxetan|ibritumomab tiuxetan
548569|NCT00387023|IDEC-Y2B8|idec-y2b8
548570|NCT00387023|Eye|eye
548571|NCT00387049|Anxiety Sensitivity|anxiety sensitivity
548572|NCT00387062|Breast Cancer|breast cancer
548573|NCT00387062|Cognitive Impairment|cognitive impairment
548574|NCT00387062|Chemofog|chemofog
548575|NCT00387062|Chemobrain|chemobrain
548576|NCT00387062|Post-chemotherapy cognitive impairment|post-chemotherapy cognitive impairment
548577|NCT00387075|Parkinson Disease|parkinson disease
548578|NCT00387075|SPECT imaging|spect imaging
548579|NCT00387101|Diabetic Foot Ulcer|diabetic foot ulcer
548581|NCT00387101|Debridement|debridement
548582|NCT00387101|Dermal-LSR|dermal-lsr
548583|NCT00387101|Standard of Care|standard of care
548584|NCT00387114|C-reactive protein|c-reactive protein
548585|NCT00387114|nitrotyrosine|nitrotyrosine
548586|NCT00387114|oxidative stress|oxidative stress
548587|NCT00387114|resistin|resistin
548588|NCT00387114|vitamin C|vitamin c
548589|NCT00387127|Neck Cancer|neck cancer
548590|NCT00387127|Locally advanced head and neck cancer|locally advanced head and neck cancer
548591|NCT00387127|locally advanced|locally advanced
548592|NCT00387127|Head and Neck cancer|head and neck cancer
548593|NCT00387127|lapatinib|lapatinib
548594|NCT00387127|EGFR/ErbB2 inhibitor|egfr/erbb2 inhibitor
548595|NCT00387127|Head Cancer|head cancer
548596|NCT00387140|Dental Pain, Postoperative|dental pain, postoperative
548597|NCT00387153|Oncology|oncology
548598|NCT00387153|Cancer|cancer
548599|NCT00387153|Blood Cancers|blood cancers
548600|NCT00387166|Type 2 Diabetes|type 2 diabetes
548601|NCT00387166|Cardiovascular|cardiovascular
548602|NCT00387166|Blood Pressure|blood pressure
548603|NCT00387166|Hispanic|hispanic
548604|NCT00387166|Women|women
548605|NCT00387166|Social Context|social context
548606|NCT00387166|Psychosocial|psychosocial
548607|NCT00387179|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
548608|NCT00387192|Von Willebrand Disease|von willebrand disease
548609|NCT00387192|Factor VIII|factor viii
548610|NCT00387192|Von Willebrand Factor|von willebrand factor
548611|NCT00387192|Pharmacokinetics|pharmacokinetics
548612|NCT00387205|chronic administration|chronic administration
548613|NCT00387205|monotherapy and combination therapies|monotherapy and combination therapies
548614|NCT00387205|solid|solid
548615|NCT00387205|lapatinib (TYKERB, TYVERB)|lapatinib (tykerb, tyverb)
548616|NCT00387205|malignant tumor|malignant tumor
548617|NCT00387205|Pazopanib|pazopanib
548618|NCT00387205|GW786034|gw786034
548619|NCT00387205|cancer|cancer
548620|NCT00387205|safety|safety
548621|NCT00387218|Exercise|exercise
548622|NCT00387218|Physical Functional Ability|physical functional ability
548623|NCT00387218|Spinal Range of Motion|spinal range of motion
548624|NCT00387218|Balance|balance
548625|NCT00387218|Economy of Movement|economy of movement
548626|NCT00387218|Aerobic Conditioning|aerobic conditioning
548627|NCT00387218|Quality of Life|quality of life
548628|NCT00387218|Adherence|adherence
548629|NCT00387231|Myocardial Ischemia|myocardial ischemia
548630|NCT00387231|Randomized Controlled Trials|randomized controlled trials
548631|NCT00387231|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
548632|NCT00387231|Drug Therapy|drug therapy
548633|NCT00387244|Pain;|pain;
548634|NCT00387244|Back Pain;|back pain;
548635|NCT00387244|Neurostimulation|neurostimulation
548636|NCT00387257|platelet aggregation|platelet aggregation
548637|NCT00387257|SB-659032|sb-659032
548638|NCT00387257|rilapladib|rilapladib
548639|NCT00387270|Huntington's disease|huntington's disease
548640|NCT00387270|Dimebon|dimebon
548641|NCT00387270|dose-escalation|dose-escalation
548642|NCT00387270|Phase 1-2a|phase 1-2a
548643|NCT00387270|randomized|randomized
548644|NCT00387270|controlled|controlled
548645|NCT00387270|double-blind|double-blind
548646|NCT00387270|Unified Huntington's Disease Rating Scale|unified huntington's disease rating scale
548648|NCT00387283|West Nile virus|west nile virus
548649|NCT00387283|WNV meningoencephalitis|wnv meningoencephalitis
548650|NCT00387309|Bowel|bowel
548651|NCT00387322|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
548652|NCT00387322|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
548653|NCT00387322|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
548654|NCT00387322|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
548655|NCT00387348|fatigue|fatigue
548656|NCT00387348|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
548657|NCT00387348|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
548658|NCT00387348|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
549006|NCT00381849|Kidney calculi|kidney calculi
548659|NCT00387348|extensive stage small cell lung cancer|extensive stage small cell lung cancer
548660|NCT00387348|advanced adult primary liver cancer|advanced adult primary liver cancer
548662|NCT00387348|stage III pancreatic cancer|stage iii pancreatic cancer
548663|NCT00387348|stage IV pancreatic cancer|stage iv pancreatic cancer
548664|NCT00387348|stage IV esophageal cancer|stage iv esophageal cancer
548665|NCT00387348|stage IV gastric cancer|stage iv gastric cancer
548666|NCT00387348|stage IVA colon cancer|stage iva colon cancer
548667|NCT00387348|stage IVB colon cancer|stage ivb colon cancer
548668|NCT00387348|stage IVA rectal cancer|stage iva rectal cancer
548669|NCT00387348|stage IVB rectal cancer|stage ivb rectal cancer
548670|NCT00387348|unresectable gallbladder cancer|unresectable gallbladder cancer
548671|NCT00387348|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
548672|NCT00387361|Post-Operative Nausea|post-operative nausea
548674|NCT00387361|Anesthesia|anesthesia
548675|NCT00387361|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
548676|NCT00387361|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
548677|NCT00387361|Manipulation, Osteopathic|manipulation, osteopathic
548678|NCT00387361|Osteopathy|osteopathy
548679|NCT00387361|Texas College of Osteopathic Medicine|texas college of osteopathic medicine
548680|NCT00387387|pharmacokinetics|pharmacokinetics
548681|NCT00387387|colorectal cancer|colorectal cancer
548682|NCT00387387|pazopanib|pazopanib
548683|NCT00387387|capecitabine|capecitabine
548684|NCT00387387|CapeOx|capeox
548685|NCT00387387|5-fluorouracil|5-fluorouracil
548686|NCT00387387|oxaliplatin|oxaliplatin
548687|NCT00387387|combination therapy|combination therapy
548688|NCT00387387|FOLFOX 6|folfox 6
548689|NCT00387400|adult giant cell glioblastoma|adult giant cell glioblastoma
548690|NCT00387400|adult gliosarcoma|adult gliosarcoma
548691|NCT00387400|recurrent adult brain tumor|recurrent adult brain tumor
548692|NCT00387400|adult glioblastoma|adult glioblastoma
548693|NCT00387413|Duloxetine|duloxetine
548694|NCT00387413|GSK189254|gsk189254
548695|NCT00387413|Healthy volunteers|healthy volunteers
548696|NCT00387413|Phase I.|phase i.
548697|NCT00387413|Electrical hyperalgesia model|electrical hyperalgesia model
548698|NCT00387439|Anal incontinence|anal incontinence
548699|NCT00387439|Gastroenterology|gastroenterology
548700|NCT00387439|Anoperineal physiotherapy|anoperineal physiotherapy
548701|NCT00387439|Randomized clinical trial|randomized clinical trial
548702|NCT00387452|Aging|aging
548703|NCT00387452|Type 2 diabetes|type 2 diabetes
548704|NCT00387452|exercise|exercise
548705|NCT00387452|aerobic training|aerobic training
548706|NCT00387452|strength training|strength training
548707|NCT00387452|glucose metabolism arterial baroreceptors|glucose metabolism arterial baroreceptors
548708|NCT00387452|heart rate variability|heart rate variability
548709|NCT00387452|cerebral autoregulation|cerebral autoregulation
548710|NCT00387452|tilt table study|tilt table study
548711|NCT00387452|transcranial Doppler|transcranial doppler
548712|NCT00387452|autonomic nervous system|autonomic nervous system
548713|NCT00387478|Allergy|allergy
548714|NCT00387478|Specific Immunotherapy|specific immunotherapy
548715|NCT00387478|Tree|tree
548716|NCT00387478|Environmental Exposure Chamber|environmental exposure chamber
548717|NCT00387504|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
548718|NCT00387517|Diastolic|diastolic
548719|NCT00387517|systolic|systolic
548720|NCT00387517|hypertension|hypertension
548721|NCT00387517|aliskiren|aliskiren
548722|NCT00387517|blood pressure|blood pressure
548723|NCT00387517|hydrochlorothiazide|hydrochlorothiazide
548724|NCT00387517|HCTZ|hctz
548725|NCT00387530|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
548726|NCT00387530|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
548727|NCT00387530|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
548728|NCT00387530|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
548729|NCT00387530|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
548730|NCT00387530|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
548731|NCT00387530|recurrent gastric cancer|recurrent gastric cancer
548732|NCT00387556|ketamine|ketamine
548733|NCT00387556|children|children
548734|NCT00387556|emesis|emesis
548735|NCT00387569|Toddlers|toddlers
548736|NCT00387569|Vaccine|vaccine
548095|NCT00378534|CML|cml
548737|NCT00387569|Safety|safety
548738|NCT00387582|Diabetes|diabetes
548739|NCT00387582|Macular Edema|macular edema
548740|NCT00387582|Diabetic Retinopathy|diabetic retinopathy
548741|NCT00387582|Lucentis|lucentis
548742|NCT00387582|Ranibizumab|ranibizumab
548743|NCT00387595|Family History|family history
548744|NCT00387595|CAD|cad
548745|NCT00387595|CAC|cac
548746|NCT00387595|cIMT|cimt
548747|NCT00387595|CV Risk Factors|cv risk factors
548748|NCT00387608|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
548749|NCT00387608|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
548750|NCT00387608|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
548751|NCT00387608|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
548752|NCT00387608|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
548753|NCT00387608|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
548754|NCT00387608|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
548755|NCT00387608|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
548756|NCT00387608|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
548757|NCT00387608|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
548758|NCT00387608|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
548759|NCT00387608|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
548760|NCT00387608|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
548761|NCT00387621|heart failure|heart failure
548762|NCT00387621|diastolic dysfunction|diastolic dysfunction
548763|NCT00387621|systolic dysfunction|systolic dysfunction
548764|NCT00387621|preclinical|preclinical
548765|NCT00387621|natriuretic peptide|natriuretic peptide
548766|NCT00387621|B-type natriuretic peptide|b-type natriuretic peptide
548767|NCT00387621|cyclic guanosine monophosphate|cyclic guanosine monophosphate
548768|NCT00387634|tick born encephalitis, TBE, adults|tick born encephalitis, tbe, adults
548769|NCT00387647|myeloid|myeloid
548770|NCT00387647|acute|acute
548771|NCT00387647|monocytic|monocytic
548772|NCT00387660|extensive stage small cell lung cancer|extensive stage small cell lung cancer
548773|NCT00387660|limited stage small cell lung cancer|limited stage small cell lung cancer
548774|NCT00387660|recurrent small cell lung cancer|recurrent small cell lung cancer
548775|NCT00387673|electrical stimulation|electrical stimulation
548776|NCT00387673|hand|hand
548777|NCT00387673|Rehabilitation|rehabilitation
548778|NCT00387673|spinal cord injury|spinal cord injury
548779|NCT00387699|limited stage small cell lung cancer|limited stage small cell lung cancer
548780|NCT00387712|exercise|exercise
548781|NCT00387712|inflammation|inflammation
548782|NCT00387712|motor performance|motor performance
548783|NCT00387712|skeletal muscle|skeletal muscle
548784|NCT00387712|chronic stroke survivors|chronic stroke survivors
548785|NCT00387712|treadmill exercise|treadmill exercise
548786|NCT00387725|Adolescent|adolescent
548787|NCT00387725|Meningococcal|meningococcal
548788|NCT00387725|Safety|safety
548789|NCT00387738|Ragweed|ragweed
548790|NCT00387738|Allergy|allergy
548791|NCT00387738|Allergic|allergic
548792|NCT00387738|Rhinitis|rhinitis
548793|NCT00387738|Hay Fever|hay fever
548794|NCT00387738|Seasonal|seasonal
548795|NCT00387738|Treatment|treatment
548796|NCT00387738|Immunotherapy|immunotherapy
548798|NCT00387764|renal cell carcinoma|renal cell carcinoma
548799|NCT00387764|pazopanib|pazopanib
548800|NCT00387764|anti-angiogenic therapy|anti-angiogenic therapy
548801|NCT00387764|open label|open label
548802|NCT00387777|Buprenorphine|buprenorphine
548803|NCT00387777|Transdermal patch|transdermal patch
548804|NCT00387777|multidose|multidose
548805|NCT00387777|Centrally acting analgesic|centrally acting analgesic
548806|NCT00387777|Plasma level|plasma level
548807|NCT00387777|Healthy volunteers|healthy volunteers
548808|NCT00387855|suicide|suicide
548809|NCT00387855|depression|depression
548810|NCT00387868|Thymoma|thymoma
548811|NCT00387868|Thymic carcinoma|thymic carcinoma
548812|NCT00387868|Preoperative chemotherapy and radiation|preoperative chemotherapy and radiation
548813|NCT00387868|Response rate|response rate
548814|NCT00387881|sumatriptan succinate,|sumatriptan succinate,
548815|NCT00387881|naproxen sodium,|naproxen sodium,
548816|NCT00387881|parallel group,|parallel group,
548817|NCT00387881|double-blind,|double-blind,
548818|NCT00387881|placebo-controlled,|placebo-controlled,
548819|NCT00387881|Combination product,|combination product,
548820|NCT00387881|migrainous headache|migrainous headache
548821|NCT00387881|Probable migraine, a sub-type of Migraine|probable migraine, a sub-type of migraine
548822|NCT00387881|probable migraine,|probable migraine,
548823|NCT00387894|adult glioblastoma|adult glioblastoma
548824|NCT00387894|adult gliosarcoma|adult gliosarcoma
548825|NCT00387894|recurrent adult brain tumor|recurrent adult brain tumor
548826|NCT00387907|Herceptin|herceptin
548827|NCT00387907|Taxane|taxane
548828|NCT00387907|Breast Cancer|breast cancer
548829|NCT00387933|recurrent adult brain tumor|recurrent adult brain tumor
548830|NCT00387933|adult glioblastoma|adult glioblastoma
548831|NCT00387933|adult anaplastic astrocytoma|adult anaplastic astrocytoma
548832|NCT00387933|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
548833|NCT00387933|adult gliosarcoma|adult gliosarcoma
548834|NCT00387933|adult giant cell glioblastoma|adult giant cell glioblastoma
548835|NCT00387933|adult anaplastic ependymoma|adult anaplastic ependymoma
548836|NCT00387933|adult brain stem glioma|adult brain stem glioma
548837|NCT00387933|adult mixed glioma|adult mixed glioma
548838|NCT00387933|adult pineal gland astrocytoma|adult pineal gland astrocytoma
548839|NCT00387946|smoking|smoking
548840|NCT00387946|cessation|cessation
548841|NCT00387946|tobacco|tobacco
548842|NCT00387959|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
549215|NCT00388388|Remodeling|remodeling
548843|NCT00387959|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
548844|NCT00387959|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
548845|NCT00387959|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
548846|NCT00387959|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
548847|NCT00387959|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
548848|NCT00387959|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
548849|NCT00387959|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
548850|NCT00387959|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
548851|NCT00387959|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
548852|NCT00387959|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
548853|NCT00387959|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
548854|NCT00387959|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
548960|NCT00381758|Methylphenidate|methylphenidate
548855|NCT00387959|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
548856|NCT00387959|splenic marginal zone lymphoma|splenic marginal zone lymphoma
548857|NCT00387959|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
548858|NCT00387959|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
548859|NCT00387959|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
548860|NCT00387959|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
548861|NCT00387959|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
548862|NCT00387959|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
548863|NCT00387959|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
548864|NCT00387959|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
548865|NCT00387959|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
548866|NCT00387959|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
548867|NCT00387959|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
548868|NCT00387959|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
548869|NCT00387959|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
548870|NCT00387959|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
548871|NCT00387959|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
548872|NCT00387959|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
548873|NCT00387959|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
548955|NCT00381706|stage IV esophageal cancer|stage iv esophageal cancer
548874|NCT00387959|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
548875|NCT00387959|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
548876|NCT00387959|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
548877|NCT00387972|Type 2 diabetes mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
548878|NCT00387972|glycosylated hemoglobin (HbA1c)|glycosylated hemoglobin (hba1c)
548880|NCT00387972|diabetes treatment|diabetes treatment
548881|NCT00387972|glycemic control|glycemic control
548882|NCT00387998|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
548883|NCT00388011|Post surgical pain|post surgical pain
548884|NCT00388011|Bunionectomy|bunionectomy
548885|NCT00388011|Hammer Toe Syndrome|hammer toe syndrome
548886|NCT00388011|Morphine|morphine
548887|NCT00388024|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
548888|NCT00388024|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
548889|NCT00388024|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
548890|NCT00388024|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
548891|NCT00388024|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
548892|NCT00388024|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
548893|NCT00388024|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
548894|NCT00388024|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
548895|NCT00388024|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
548896|NCT00388024|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
548897|NCT00388024|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
548898|NCT00388024|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
548899|NCT00388024|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
548900|NCT00388024|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
548901|NCT00388024|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
548902|NCT00388024|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
548903|NCT00388024|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
549007|NCT00381849|Supersaturation|supersaturation
548904|NCT00388024|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
548905|NCT00388050|Decision aid, diabetes, primary care|decision aid, diabetes, primary care
548906|NCT00381472|Parkinson's Disease|parkinson's disease
548908|NCT00381472|Adjunctive Therapy with L-dopa|adjunctive therapy with l-dopa
548909|NCT00381511|pulmonary embolism,|pulmonary embolism,
548910|NCT00381511|deferred diagnosis,|deferred diagnosis,
548911|NCT00381511|protective anticoagulation|protective anticoagulation
548912|NCT00381511|anticoagulants|anticoagulants
548913|NCT00381524|human immunodeficiency virus|human immunodeficiency virus
548914|NCT00381524|behavior change|behavior change
548915|NCT00381537|childhood epilepsy|childhood epilepsy
548916|NCT00381537|Active childhood epilepsy|active childhood epilepsy
548917|NCT00381563|Bracing|bracing
548918|NCT00381563|Patellofemoral|patellofemoral
548919|NCT00381563|Osteoarthritis|osteoarthritis
548920|NCT00381576|Resistance training|resistance training
548921|NCT00381576|Strength training|strength training
548922|NCT00381576|Training adaptations|training adaptations
548924|NCT00381589|clozapine-induced hypersalivation|clozapine-induced hypersalivation
548925|NCT00381602|End stage renal disease|end stage renal disease
548926|NCT00381602|Hemodialysis|hemodialysis
548927|NCT00381602|Malnutrition|malnutrition
548928|NCT00381602|End stage renal disease (ESRD)|end stage renal disease (esrd)
548929|NCT00381615|Meningococcal disease|meningococcal disease
548930|NCT00381615|prevention|prevention
548931|NCT00381615|vaccination|vaccination
548932|NCT00381628|Anatomy|anatomy
548933|NCT00381628|cells|cells
548934|NCT00381628|epithelial cells|epithelial cells
548935|NCT00381628|blood cells|blood cells
548936|NCT00381628|cystic fibrosis|cystic fibrosis
548937|NCT00381628|equipment and supplies|equipment and supplies
548938|NCT00381628|disposable equipment|disposable equipment
548939|NCT00381628|reagent kits|reagent kits
548940|NCT00381654|Solid Tumors|solid tumors
548941|NCT00381654|Tyrosine Kinases|tyrosine kinases
548942|NCT00381667|safety|safety
548943|NCT00381667|GW642444M|gw642444m
548944|NCT00381667|Single Dose|single dose
548945|NCT00381667|pharmacodynamics|pharmacodynamics
548946|NCT00381667|pharmacokinetics|pharmacokinetics
548947|NCT00381667|GW642444H|gw642444h
548948|NCT00381667|tolerability|tolerability
548949|NCT00381693|primary myelofibrosis|primary myelofibrosis
548950|NCT00381693|polycythemia vera|polycythemia vera
548951|NCT00381693|essential thrombocythemia|essential thrombocythemia
548952|NCT00381693|secondary myelofibrosis|secondary myelofibrosis
548953|NCT00381706|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
548954|NCT00381706|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
548956|NCT00381706|recurrent esophageal cancer|recurrent esophageal cancer
548957|NCT00381732|Impotence|impotence
548958|NCT00381732|erectile dysfunction|erectile dysfunction
548959|NCT00381758|ADHD|adhd
548961|NCT00381758|Metadate CD|metadate cd
548962|NCT00381758|Concerta|concerta
548963|NCT00381758|COMACS|comacs
548964|NCT00381758|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
548965|NCT00381771|Globus Pharyngeus|globus pharyngeus
548966|NCT00381771|Xerostomia|xerostomia
548967|NCT00381771|Salivary Hypofunction|salivary hypofunction
548968|NCT00381771|Pharyngoxerosis|pharyngoxerosis
548969|NCT00381784|YMSM|ymsm
548970|NCT00381784|HIV/AIDS|hiv/aids
548971|NCT00381784|Condom use|condom use
548972|NCT00381784|Drug users|drug users
548973|NCT00381784|Minority women|minority women
548974|NCT00381810|Rituxan|rituxan
548975|NCT00381810|SLE|sle
548976|NCT00381810|Lupus|lupus
548977|NCT00381823|Pregnant women|pregnant women
548978|NCT00381823|Intervention Studies|intervention studies
548979|NCT00381823|African Americans|african americans
548980|NCT00381823|Infant Mortality|infant mortality
548981|NCT00381823|Environmental Tobacco Smoke Pollution|environmental tobacco smoke pollution
548982|NCT00381823|Depression|depression
548983|NCT00381823|Partner Abuse|partner abuse
548984|NCT00381823|Tobacco Smoke|tobacco smoke
548985|NCT00381836|Prostate Cancer|prostate cancer
548986|NCT00381836|Anemia|anemia
548987|NCT00381836|Blood transfusion|blood transfusion
548988|NCT00381836|Cancer|cancer
548989|NCT00381836|Critical illness|critical illness
548990|NCT00381836|Drug efficacy|drug efficacy
548991|NCT00381836|Drug safety|drug safety
548992|NCT00381836|Drug tolerability|drug tolerability
548993|NCT00381836|Erythropoietin|erythropoietin
548994|NCT00381836|Fatigue|fatigue
548995|NCT00381836|Hemoglobin|hemoglobin
548996|NCT00381836|Human|human
548997|NCT00381836|Male|male
548998|NCT00381836|Multicenter study|multicenter study
548999|NCT00381836|Quality of life|quality of life
549000|NCT00381836|Questionnaire|questionnaire
549001|NCT00381836|Randomized controlled trial|randomized controlled trial
549002|NCT00381836|Recombinant erythropoietin|recombinant erythropoietin
549003|NCT00381849|Cystone|cystone
549004|NCT00381849|Uricare|uricare
549005|NCT00381849|Computerized tomography|computerized tomography
549008|NCT00381849|Nephrolithiasis|nephrolithiasis
549009|NCT00381849|Quantitative CT|quantitative ct
549010|NCT00381862|nausea and vomiting|nausea and vomiting
549011|NCT00381862|recurrent colon cancer|recurrent colon cancer
549012|NCT00381862|stage IV colon cancer|stage iv colon cancer
549013|NCT00381862|recurrent rectal cancer|recurrent rectal cancer
549014|NCT00381862|stage IV rectal cancer|stage iv rectal cancer
549015|NCT00381875|HIV infection|hiv infection
549016|NCT00381888|thromboembolism|thromboembolism
549017|NCT00381888|cervical cancer|cervical cancer
549018|NCT00381888|endometrial cancer|endometrial cancer
549019|NCT00381888|ovarian epithelial cancer|ovarian epithelial cancer
549020|NCT00381888|ovarian germ cell tumor|ovarian germ cell tumor
549021|NCT00381888|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
549022|NCT00381888|ovarian sarcoma|ovarian sarcoma
549023|NCT00381888|ovarian stromal cancer|ovarian stromal cancer
549024|NCT00381888|uterine sarcoma|uterine sarcoma
549025|NCT00381888|vaginal cancer|vaginal cancer
549026|NCT00381888|vulvar cancer|vulvar cancer
549027|NCT00381888|fallopian tube cancer|fallopian tube cancer
549028|NCT00381901|stage II breast cancer|stage ii breast cancer
549029|NCT00381901|stage IIIA breast cancer|stage iiia breast cancer
549030|NCT00381901|stage IIIB breast cancer|stage iiib breast cancer
549031|NCT00381901|stage IA breast cancer|stage ia breast cancer
549032|NCT00381901|stage IB breast cancer|stage ib breast cancer
549033|NCT00381901|recurrent breast cancer|recurrent breast cancer
549034|NCT00381901|stage IIIC breast cancer|stage iiic breast cancer
549036|NCT00381914|Vitamin D|vitamin d
549037|NCT00381914|Dose-response|dose-response
549038|NCT00381927|Breast Cancer Risk|breast cancer risk
549039|NCT00381927|Counseling|counseling
549040|NCT00381927|Prevention|prevention
549042|NCT00381927|BRCA1 mutation|brca1 mutation
549043|NCT00381927|BRCA2 mutation|brca2 mutation
549044|NCT00381927|Tamoxifen|tamoxifen
549045|NCT00381966|Prostate Cancer|prostate cancer
549046|NCT00381966|Brachytherapy|brachytherapy
549047|NCT00381979|Depression|depression
549048|NCT00381979|Anxiety|anxiety
549049|NCT00381979|Adolescents|adolescents
549050|NCT00381979|Treatment|treatment
549051|NCT00381979|Supportive Expressive Therapy|supportive expressive therapy
549052|NCT00381992|sexual risk behavior|sexual risk behavior
549053|NCT00381992|diabetes mellitus|diabetes mellitus
549054|NCT00381992|hypertension|hypertension
549055|NCT00381992|obesity|obesity
549056|NCT00381992|human immunodeficiency virus|human immunodeficiency virus
549057|NCT00381992|hyperlipidemia|hyperlipidemia
549058|NCT00381992|chlamydia|chlamydia
549059|NCT00382018|recurrent breast cancer|recurrent breast cancer
549060|NCT00382018|stage IV breast cancer|stage iv breast cancer
549061|NCT00382044|Kidney Failure, Chronic|kidney failure, chronic
549062|NCT00382044|Dialysis|dialysis
549063|NCT00382044|Anemia|anemia
549064|NCT00382044|epoetin|epoetin
549065|NCT00382057|Testosterone|testosterone
549066|NCT00382057|Insulin resistance|insulin resistance
549067|NCT00382057|Insulin sensitivity|insulin sensitivity
549068|NCT00382057|Metabolic disorders|metabolic disorders
549069|NCT00382070|stage I breast cancer|stage i breast cancer
549070|NCT00382070|stage II breast cancer|stage ii breast cancer
549071|NCT00382070|stage IIIA breast cancer|stage iiia breast cancer
549072|NCT00382083|Mammogram|mammogram
549073|NCT00382083|Pain|pain
549074|NCT00382083|Discomfort|discomfort
549075|NCT00382083|Breast|breast
549076|NCT00382083|Pre-medication|pre-medication
549077|NCT00382096|Type 2 diabetes|type 2 diabetes
549078|NCT00382096|vildagliptin|vildagliptin
549079|NCT00382096|metformin|metformin
549080|NCT00382096|hemoglobin A1c|hemoglobin a1c
549081|NCT00382122|Glaucoma|glaucoma
549082|NCT00382122|Ocular hypertension|ocular hypertension
549083|NCT00382122|Dry eye|dry eye
549084|NCT00382122|Ocular surface disease|ocular surface disease
549085|NCT00382135|Impotence|impotence
549086|NCT00382135|erectile dysfunction|erectile dysfunction
549087|NCT00382135|semen|semen
549088|NCT00382135|sperm|sperm
548481|NCT00386750|hearing|hearing
549089|NCT00382135|Healthy male volunteers|healthy male volunteers
549219|NCT00388401|Postoperative Ileus|postoperative ileus
549090|NCT00382135|men with mild erectile dysfunction|men with mild erectile dysfunction
549091|NCT00382148|TOPS|tops
549092|NCT00382148|Peanut allergy|peanut allergy
549093|NCT00382148|Peanut-induced allergy|peanut-induced allergy
549094|NCT00382148|Allergy|allergy
549095|NCT00382161|impotence|impotence
549096|NCT00382161|erectile dysfunction|erectile dysfunction
549097|NCT00382161|cardiovascular risk factor|cardiovascular risk factor
549098|NCT00382161|statin|statin
549099|NCT00382174|pressure ulcers|pressure ulcers
549100|NCT00382174|cutaneous wound- healing|cutaneous wound- healing
549101|NCT00382174|chronic wound-healing|chronic wound-healing
549102|NCT00382174|Thymosin Beta 4|thymosin beta 4
549103|NCT00382174|laminin-5|laminin-5
549104|NCT00382187|influenza|influenza
549105|NCT00382187|pandemic influenza|pandemic influenza
549106|NCT00382187|influenza vaccine|influenza vaccine
549107|NCT00382187|adjuvanted influenza vaccine|adjuvanted influenza vaccine
549108|NCT00382187|H5N1 influenza antigen|h5n1 influenza antigen
549109|NCT00382187|MF59|mf59
549110|NCT00382187|Pandemic influenza disease|pandemic influenza disease
549111|NCT00382200|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
549112|NCT00382200|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
549113|NCT00388063|Neuroendocrine|neuroendocrine
549114|NCT00388063|Carcinoma|carcinoma
549115|NCT00388063|Atiprimod|atiprimod
549116|NCT00388063|Carcinoid|carcinoid
549117|NCT00388076|Pazopanib|pazopanib
549118|NCT00388076|paclitaxel|paclitaxel
549119|NCT00388076|carboplatin|carboplatin
549120|NCT00388076|lapatinib|lapatinib
549121|NCT00388076|TAXOL|taxol
549122|NCT00388076|TYKERB|tykerb
549123|NCT00388076|PARAPLATIN|paraplatin
549124|NCT00388089|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
549125|NCT00388089|extensive stage small cell lung cancer|extensive stage small cell lung cancer
549126|NCT00388089|recurrent small cell lung cancer|recurrent small cell lung cancer
549127|NCT00388115|ductal breast carcinoma in situ|ductal breast carcinoma in situ
549128|NCT00388115|stage I breast cancer|stage i breast cancer
549129|NCT00388115|stage II breast cancer|stage ii breast cancer
549130|NCT00388115|breast cancer in situ|breast cancer in situ
549131|NCT00388128|Intermittent Claudication|intermittent claudication
549133|NCT00388128|Caffeine|caffeine
549134|NCT00388128|Walking capacity|walking capacity
549137|NCT00388128|Growth factor|growth factor
549138|NCT00388141|Preterm Infant;|preterm infant;
549139|NCT00388141|NIDCAP;|nidcap;
549140|NCT00388141|Neonatal Care,|neonatal care,
549141|NCT00388141|Intervention Study;|intervention study;
549142|NCT00388141|Growth and Development;|growth and development;
549143|NCT00388141|Maternal Self-esteem.|maternal self-esteem.
549144|NCT00388141|Maternal Social support|maternal social support
549145|NCT00388141|NICU|nicu
549146|NCT00388154|Endometrial Cancer|endometrial cancer
549147|NCT00388154|Gemcitabine|gemcitabine
549148|NCT00388154|Gemzar|gemzar
549149|NCT00388154|Gemcitabine Hydrochloride|gemcitabine hydrochloride
549150|NCT00388154|Cisplatin|cisplatin
549151|NCT00388154|Platinol-AQ|platinol-aq
549152|NCT00388154|Platinol|platinol
549153|NCT00388154|CDDP|cddp
549154|NCT00388167|Invader fungal infection (IFI)|invader fungal infection (ifi)
549155|NCT00388167|Invasive Aspergillosis (AI)|invasive aspergillosis (ai)
549156|NCT00388167|Invasive Candidiasis (CI)|invasive candidiasis (ci)
549157|NCT00388167|Caspofungin acetate|caspofungin acetate
549158|NCT00388180|cholesterol|cholesterol
549159|NCT00388180|inflammation|inflammation
549160|NCT00388180|fat|fat
549161|NCT00388193|ALL (L3)|all (l3)
549162|NCT00388193|BURKITT's LYMPHOMA|burkitt's lymphoma
549163|NCT00388193|RITUXIMAB|rituximab
549164|NCT00388206|NSCLC|nsclc
549165|NCT00388206|Avastin|avastin
549166|NCT00388206|anti-VEGF|anti-vegf
549167|NCT00388206|lung cancer|lung cancer
549168|NCT00388206|colorectal cancer|colorectal cancer
549169|NCT00388206|ARIES|aries
549170|NCT00388206|Colon Cancer|colon cancer
549171|NCT00388219|Buprenorphine|buprenorphine
549172|NCT00388219|Transdermal patch|transdermal patch
549173|NCT00388219|Centrally acting analgesic|centrally acting analgesic
549174|NCT00388219|Plasma level|plasma level
549175|NCT00388219|Healthy volunteers|healthy volunteers
549176|NCT00388232|COPD|copd
549177|NCT00388232|prevalence|prevalence
549178|NCT00388232|smoke|smoke
549179|NCT00388232|biomass|biomass
549180|NCT00388232|occupational|occupational
549181|NCT00388232|Malatya|malatya
549182|NCT00388232|Turkey|turkey
549183|NCT00388245|PCI|pci
549184|NCT00388245|CABG|cabg
549185|NCT00388245|Ejection Fraction|ejection fraction
549186|NCT00388245|Myocardial Revascularization|myocardial revascularization
549187|NCT00388258|Postoperative ileus|postoperative ileus
549188|NCT00388271|Alpha-blocker|alpha-blocker
549189|NCT00388271|Alfuzosin|alfuzosin
549190|NCT00388271|Xatral|xatral
548580|NCT00387101|Diabetes Mellitus|diabetes mellitus
549191|NCT00388271|ESWL|eswl
549192|NCT00388284|hemostasis|hemostasis
549193|NCT00388284|arterial sealing|arterial sealing
549194|NCT00388297|Subclinical Hypothyroidism|subclinical hypothyroidism
549195|NCT00388297|Hypothyroxinemia|hypothyroxinemia
549196|NCT00388297|Thyroid|thyroid
549197|NCT00388297|Pregnancy|pregnancy
549198|NCT00388297|Intellectual Development|intellectual development
549199|NCT00388310|cellulitis|cellulitis
549200|NCT00388310|furuncles|furuncles
549201|NCT00388310|carbuncles|carbuncles
549202|NCT00388310|abscess|abscess
549203|NCT00388323|Alcohol|alcohol
549204|NCT00388323|Hepatitis|hepatitis
549205|NCT00388323|Cirrhosis|cirrhosis
549206|NCT00388323|Inflammation|inflammation
549207|NCT00388323|Cytokines|cytokines
549208|NCT00388323|ADIPOKINES|adipokines
549209|NCT00388323|Adipose tissue|adipose tissue
549210|NCT00388336|Anemia|anemia
549211|NCT00388336|Neoplasms, Hemoglobin values|neoplasms, hemoglobin values
549212|NCT00388336|PROCRIT|procrit
549213|NCT00388336|Epoetin alfa|epoetin alfa
549214|NCT00388362|GVHD|gvhd
549216|NCT00388388|Resistance arteries|resistance arteries
549217|NCT00388388|angiotensin receptor blocker|angiotensin receptor blocker
549218|NCT00388388|thiazide diuretic|thiazide diuretic
549220|NCT00388505|tobramycin|tobramycin
549221|NCT00388531|Acute Lymphoblastic Leucemia|acute lymphoblastic leucemia
549222|NCT00388531|Aggressive Non-Hodgkin-Lymphoma|aggressive non-hodgkin-lymphoma
549223|NCT00388531|CNS relapse|cns relapse
549224|NCT00388531|Cytarabine liposome|cytarabine liposome
549226|NCT00388570|adult|adult
549227|NCT00388570|paediatric|paediatric
549228|NCT00388570|NIOX MINO®|niox mino®
549229|NCT00388570|NIOX®|niox®
549230|NCT00388570|nitric oxide|nitric oxide
549231|NCT00388570|airway inflammation|airway inflammation
549232|NCT00388570|open−label|open−label
549233|NCT00388570|single−cohort|single−cohort
549234|NCT00388583|Influenza|influenza
549235|NCT00388583|Orthomyxoviruses|orthomyxoviruses
549236|NCT00388583|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
549237|NCT00388583|Elderly.|elderly.
549238|NCT00388596|SB-751689|sb-751689
549239|NCT00388596|osteoporosis|osteoporosis
549240|NCT00388596|drug interaction|drug interaction
549241|NCT00388596|ketoconazole|ketoconazole
549242|NCT00388596|atorvastatin|atorvastatin
549243|NCT00388596|rosuvastatin|rosuvastatin
549244|NCT00388622|Heart failure|heart failure
549245|NCT00388622|Adherence|adherence
549246|NCT00388622|Compliance|compliance
549247|NCT00388622|Pharmacy|pharmacy
549248|NCT00388622|Pharmacist|pharmacist
549249|NCT00388622|Health-related quality of life|health-related quality of life
549250|NCT00388622|Clinical exacerbation|clinical exacerbation
549251|NCT00388622|Costs|costs
549252|NCT00388635|Multiple Myeloma|multiple myeloma
549253|NCT00388635|Patients over 65 years old|patients over 65 years old
549254|NCT00388648|Dialysis|dialysis
549255|NCT00388648|Vegan Diet|vegan diet
549256|NCT00388648|Mortality|mortality
549257|NCT00388648|Morbidity|morbidity
549258|NCT00388648|Treatment outcome|treatment outcome
549259|NCT00388661|sleep problems|sleep problems
549260|NCT00388661|quality of life|quality of life
549261|NCT00388661|melatonin|melatonin
549262|NCT00388661|sleep apnea|sleep apnea
549263|NCT00388661|medication|medication
549264|NCT00388661|preload|preload
549265|NCT00388661|nutritional status|nutritional status
549266|NCT00388661|ProBNP|probnp
549267|NCT00388674|Chronic Hepatitis B Virus|chronic hepatitis b virus
549268|NCT00388687|Hypoxia|hypoxia
549269|NCT00388687|FAZA|faza
549270|NCT00388687|PET|pet
549271|NCT00388687|Radiochemotherapy|radiochemotherapy
549272|NCT00388700|Colorectal cancer, DAVANAT, colon cancer, 5-FU|colorectal cancer, davanat, colon cancer, 5-fu
549273|NCT00388713|Radiation therapy|radiation therapy
549274|NCT00388713|Radiation-Induced Atherosclerosis|radiation-induced atherosclerosis
549275|NCT00388713|Carotid Artery Diseases|carotid artery diseases
549276|NCT00388713|Breast Cancer|breast cancer
549277|NCT00388713|Intima Media thickening Ultrasound|intima media thickening ultrasound
549278|NCT00388726|Locally recurrent breast cancer|locally recurrent breast cancer
549279|NCT00388726|metastatic breast cancer|metastatic breast cancer
549280|NCT00388739|Pediatric Asthma|pediatric asthma
549281|NCT00388739|Pulmicort|pulmicort
549282|NCT00388739|TEDAS ED|tedas ed
549283|NCT00388739|Acute exacerbation of asthma|acute exacerbation of asthma
549284|NCT00388739|Chronic asthma|chronic asthma
549285|NCT00388752|Acupuncture|acupuncture
549286|NCT00388752|Phantom limb pain|phantom limb pain
549287|NCT00388752|Residual limb pain|residual limb pain
549288|NCT00388752|amputation|amputation
549289|NCT00388752|amputee|amputee
549290|NCT00388752|traumatic|traumatic
549291|NCT00388752|surgical|surgical
549292|NCT00388752|Traumatic amputation upper extremity|traumatic amputation upper extremity
549293|NCT00388752|Traumatic amputation lower extremity|traumatic amputation lower extremity
548673|NCT00387361|Nausea|nausea
549294|NCT00388752|Surgical amputation upper extremity|surgical amputation upper extremity
549295|NCT00388752|Surgical amputation lower extremity|surgical amputation lower extremity
549296|NCT00388765|bronchoscopy|bronchoscopy
549297|NCT00388765|sample bank|sample bank
549298|NCT00388765|research study volunteer|research study volunteer
549299|NCT00388791|symptomatology|symptomatology
549300|NCT00388791|Schein questionnaire|schein questionnaire
549301|NCT00388791|fluoresceien staining|fluoresceien staining
549302|NCT00388804|Prostate Cancer|prostate cancer
549303|NCT00388804|External Beam Radiotherapy|external beam radiotherapy
549304|NCT00388804|Radiation Therapy|radiation therapy
549305|NCT00388804|Hormone Therapy|hormone therapy
549306|NCT00388804|Bicalutamide|bicalutamide
549307|NCT00388804|Casodex|casodex
549308|NCT00388804|Leuprolide|leuprolide
549309|NCT00388804|Lupron|lupron
549310|NCT00388804|Goserelin|goserelin
549311|NCT00388804|Zoladex|zoladex
549312|NCT00388804|Flutamide|flutamide
549313|NCT00388804|EBRT|ebrt
549314|NCT00388817|Hypertension|hypertension
549315|NCT00388817|Blood pressure|blood pressure
549316|NCT00388817|Adherence|adherence
549317|NCT00388817|Compliance|compliance
549318|NCT00388817|Pharmacist|pharmacist
549319|NCT00388817|Pharmacy|pharmacy
549320|NCT00388817|Costs|costs
549321|NCT00388830|Gallbladder|gallbladder
549322|NCT00388830|Ultrasound|ultrasound
549323|NCT00388830|Emergency Medicine|emergency medicine
549324|NCT00388843|carotid atherosclerosis|carotid atherosclerosis
549325|NCT00388843|magnetic resonance imaging|magnetic resonance imaging
549327|NCT00388843|ultrasound|ultrasound
549328|NCT00388843|inflammation|inflammation
549329|NCT00388843|statins|statins
549330|NCT00388843|vulnerable plaque|vulnerable plaque
549331|NCT00388843|stroke|stroke
549332|NCT00388856|antioxidant supplementation|antioxidant supplementation
549333|NCT00388856|preeclampsia|preeclampsia
549334|NCT00388856|prevention|prevention
549335|NCT00388869|renal artery|renal artery
549336|NCT00388869|calcium|calcium
549337|NCT00388869|CT|ct
549338|NCT00388869|hypertension|hypertension
549339|NCT00388895|Acute lymphoblastic Leukemia|acute lymphoblastic leukemia
549340|NCT00388908|vertebral fractures|vertebral fractures
549341|NCT00388908|osteoporosis|osteoporosis
549342|NCT00388908|prevention|prevention
549343|NCT00388908|case-finding|case-finding
549344|NCT00388908|quality improvement|quality improvement
549345|NCT00388921|Vitamin A|vitamin a
549346|NCT00388921|Children|children
549347|NCT00388921|Severe malnutrition|severe malnutrition
549348|NCT00388921|Retinol|retinol
549349|NCT00388921|Retinol binding protein|retinol binding protein
549350|NCT00388921|Diarrhoea|diarrhoea
549351|NCT00388921|ALRI|alri
549352|NCT00388921|Age 6-59 months|age 6-59 months
549353|NCT00388921|Either sex|either sex
549354|NCT00388921|Severe malnutrition as defined by the presence of any of the followings:|severe malnutrition as defined by the presence of any of the followings:
549355|NCT00388921|Bipedal oedema|bipedal oedema
549356|NCT00388921|Weight (measured after correction of dehydration) for height Z score <-3 of the National Center for Health Statistics (NCHS) reference|weight (measured after correction of dehydration) for height z score <-3 of the national center for health statistics (nchs) reference
549357|NCT00388921|Written informed consent of respective parents/ guardians for participation of the children in the study.|written informed consent of respective parents/ guardians for participation of the children in the study.
549358|NCT00388921|Children having diarrhoea (watery or invasive) or cough and cold or both for the last 48 hours.|children having diarrhoea (watery or invasive) or cough and cold or both for the last 48 hours.
549359|NCT00388934|Percutaneous coronary intervention|percutaneous coronary intervention
549360|NCT00388934|Angina pectoris|angina pectoris
549361|NCT00388934|Stent|stent
549362|NCT00388947|vaginal prolapse|vaginal prolapse
549363|NCT00388947|cystocele|cystocele
549364|NCT00388947|rectocele|rectocele
549365|NCT00388947|enterocele|enterocele
549366|NCT00388947|apical prolapse|apical prolapse
549367|NCT00388947|vaginal vault prolapse|vaginal vault prolapse
549368|NCT00388960|small cell lung cancer|small cell lung cancer
549369|NCT00388960|amrubicin|amrubicin
549370|NCT00388973|Major Depressive Disorder|major depressive disorder
549371|NCT00388973|MDD|mdd
549372|NCT00388999|Multiple Myeloma|multiple myeloma
549373|NCT00388999|Stem Cell Transplant|stem cell transplant
549374|NCT00388999|rhMBL|rhmbl
549375|NCT00389012|rehabilitation|rehabilitation
549376|NCT00389012|hemiplegic gait|hemiplegic gait
549377|NCT00389012|exercise therapy|exercise therapy
549378|NCT00389012|physical therapy|physical therapy
549379|NCT00389025|Subject with clinical history of seasonal allergic conjunctivitis|subject with clinical history of seasonal allergic conjunctivitis
549380|NCT00389038|headache|headache
549381|NCT00389038|coping skills training|coping skills training
549382|NCT00389038|amitriptyline|amitriptyline
549383|NCT00389038|attention control|attention control
549384|NCT00389051|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
549385|NCT00389051|Malignant lymphoma|malignant lymphoma
549386|NCT00389064|Generalised Anxiety Disorder|generalised anxiety disorder
549387|NCT00389064|GAD|gad
549388|NCT00389077|perifosine|perifosine
549389|NCT00389077|solid tumors|solid tumors
549390|NCT00389077|lymphomas|lymphomas
549391|NCT00389077|anticancer agent|anticancer agent
549392|NCT00389090|temozolomide resistant|temozolomide resistant
549393|NCT00389090|anaplastic glioma|anaplastic glioma
549394|NCT00389090|anaplastic astrocytoma|anaplastic astrocytoma
549395|NCT00389090|anaplastic oligodendroglioma|anaplastic oligodendroglioma
549396|NCT00389090|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
549397|NCT00389129|Platelets|platelets
549398|NCT00389129|Aspirin Resistance|aspirin resistance
549399|NCT00389129|Platelet aggregation|platelet aggregation
549400|NCT00389142|pelvic pain|pelvic pain
549401|NCT00389142|urinary frequency|urinary frequency
549402|NCT00389142|painful bladder|painful bladder
549403|NCT00389142|urinary urgency|urinary urgency
549404|NCT00389155|Advanced or metastatic transitional cell carcinoma of the urothelium|advanced or metastatic transitional cell carcinoma of the urothelium
549405|NCT00389168|Hypertension|hypertension
549406|NCT00389168|Cardiac hypertrophy|cardiac hypertrophy
549407|NCT00389168|Angiotensin|angiotensin
549408|NCT00389168|Human|human
549409|NCT00389181|Unruptured brain arteriovenous malformation|unruptured brain arteriovenous malformation
549410|NCT00389181|AVM|avm
549411|NCT00389181|BAVM|bavm
549412|NCT00389181|Stroke|stroke
549413|NCT00389181|Intracranial Hemorrhage|intracranial hemorrhage
549414|NCT00389194|HIV-1 infection|hiv-1 infection
549415|NCT00389194|fat distribution|fat distribution
549416|NCT00389194|lipodystrophy|lipodystrophy
549419|NCT00389194|Treatment Experienced|treatment experienced
549420|NCT00389220|Coronary Disease|coronary disease
549421|NCT00389220|Coronary Stenosis|coronary stenosis
549422|NCT00389220|Angioplasty|angioplasty
549423|NCT00389220|Coronary Restenosis|coronary restenosis
549424|NCT00389220|Drug Eluting Stent|drug eluting stent
549425|NCT00389246|obesity|obesity
549426|NCT00389246|genetic consultation|genetic consultation
549427|NCT00389246|randomized controlled trial|randomized controlled trial
549428|NCT00389259|Insecticides|insecticides
549429|NCT00389259|Organophosphate|organophosphate
549430|NCT00389259|Scopolamine|scopolamine
549431|NCT00389259|randomized control study|randomized control study
549432|NCT00389259|Organophosphate or carbamate intoxication|organophosphate or carbamate intoxication
549433|NCT00389285|Carcinoma, renal cell|carcinoma, renal cell
549434|NCT00389285|interleukin-21|interleukin-21
549435|NCT00389285|sorafenib|sorafenib
549436|NCT00389285|Immunotherapy|immunotherapy
549437|NCT00389298|Chronic hepatitis C|chronic hepatitis c
549438|NCT00389298|Viral kinetics|viral kinetics
549439|NCT00389298|Phase II|phase ii
549440|NCT00389298|Pharmacokinetics (PK)|pharmacokinetics (pk)
549441|NCT00389298|Safety and tolerability|safety and tolerability
549442|NCT00389311|Microbicide|microbicide
549443|NCT00389311|Safety|safety
549444|NCT00389311|HIV prevention|hiv prevention
549445|NCT00389311|HIV Seronegativity|hiv seronegativity
549446|NCT00389324|Primary immune deficiency|primary immune deficiency
549447|NCT00389337|Sepsis|sepsis
549448|NCT00389337|SIRS|sirs
549449|NCT00389337|Biomarkers|biomarkers
549450|NCT00389337|xMAP|xmap
549451|NCT00389389|Advanced Solid Malignancies|advanced solid malignancies
549452|NCT00389389|Advanced solid tumors|advanced solid tumors
549453|NCT00389389|Cancer|cancer
549454|NCT00389389|Phase I|phase i
549455|NCT00389389|Solid tumors|solid tumors
549456|NCT00389389|Solid malignancies|solid malignancies
549457|NCT00389402|lipids|lipids
549458|NCT00389402|lipodystrophy|lipodystrophy
549459|NCT00389402|fat distribution|fat distribution
549460|NCT00389402|hiv-1|hiv-1
549461|NCT00389402|antiretroviral therapy|antiretroviral therapy
549462|NCT00389402|Treatment Naive|treatment naive
549463|NCT00389415|Type 2 Diabetes|type 2 diabetes
549464|NCT00389415|Vildagliptin|vildagliptin
549465|NCT00389415|HbA1c|hba1c
549466|NCT00389428|Hematologic malignancies|hematologic malignancies
549467|NCT00389428|Malignancies, hematologic|malignancies, hematologic
549468|NCT00389428|Hematopoietic malignancies|hematopoietic malignancies
549469|NCT00389441|VEGFR inhibitor|vegfr inhibitor
549470|NCT00389441|tyrosine kinase inhibitor|tyrosine kinase inhibitor
549471|NCT00389441|anti-angiogenic|anti-angiogenic
549472|NCT00389441|carcinoma|carcinoma
549473|NCT00389441|papillary|papillary
549474|NCT00389441|follicular|follicular
549475|NCT00389441|medullary|medullary
549476|NCT00389441|anaplastic|anaplastic
549477|NCT00389454|Acetaminophen|acetaminophen
549478|NCT00389454|Fever|fever
549479|NCT00389454|cerebro spinal fluid|cerebro spinal fluid
549480|NCT00389454|Infants|infants
549481|NCT00389467|stroke|stroke
549482|NCT00389467|ischemic stroke|ischemic stroke
549483|NCT00389467|blood clot|blood clot
549484|NCT00389467|Merci Retriever|merci retriever
549485|NCT00389467|Penumbra System|penumbra system
549486|NCT00389467|embolectomy|embolectomy
549487|NCT00389467|magnetic resonance imaging|magnetic resonance imaging
549489|NCT00389467|CT|ct
548879|NCT00387972|denagliptin|denagliptin
549490|NCT00389467|SPOTRIAS|spotrias
549491|NCT00389480|Solid Tumors|solid tumors
549492|NCT00389480|Solid Malignancies|solid malignancies
549493|NCT00389480|Phase I|phase i
549494|NCT00389493|OCD|ocd
549495|NCT00389493|Augmentation|augmentation
549496|NCT00389493|Antipsychotics|antipsychotics
549497|NCT00389493|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
549498|NCT00389506|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
549499|NCT00389506|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
549500|NCT00389506|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
549501|NCT00389506|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
549502|NCT00389519|Hypertension/*etiology|hypertension/*etiology
549503|NCT00389519|Blood Pressure|blood pressure
549504|NCT00389519|Pediatric|pediatric
549505|NCT00389519|Adolescent|adolescent
549506|NCT00389519|Child|child
549507|NCT00389532|Influenza|influenza
549508|NCT00389532|Influenza Vaccine|influenza vaccine
549509|NCT00389558|Skin colonization|skin colonization
549510|NCT00389558|Antiseptic|antiseptic
549511|NCT00389558|Epicutaneocavous catheter dressing|epicutaneocavous catheter dressing
549512|NCT00389558|Infant|infant
549513|NCT00389584|cognitive/functional effects|cognitive/functional effects
549514|NCT00389584|poor performance status|poor performance status
549515|NCT00389584|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
549516|NCT00389584|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
549517|NCT00389584|adult tumors metastatic to brain|adult tumors metastatic to brain
549518|NCT00389584|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
549519|NCT00389584|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
549520|NCT00389597|degenerative disc disease|degenerative disc disease
549521|NCT00389597|cervical arthroplasty|cervical arthroplasty
549523|NCT00389597|multilevel|multilevel
549524|NCT00389597|anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
549525|NCT00389610|stage I pancreatic cancer|stage i pancreatic cancer
549526|NCT00389610|stage II pancreatic cancer|stage ii pancreatic cancer
549527|NCT00389610|stage III pancreatic cancer|stage iii pancreatic cancer
549528|NCT00389610|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
549529|NCT00389636|Diabetes|diabetes
549531|NCT00389636|Extremity|extremity
549532|NCT00389636|Ulcer|ulcer
549533|NCT00389636|Wound|wound
549534|NCT00389636|Gauze|gauze
549535|NCT00389649|congestive heart failure|congestive heart failure
549536|NCT00389649|pacemaker|pacemaker
549537|NCT00389649|heart rate|heart rate
549538|NCT00389688|stage I non-small cell lung cancer|stage i non-small cell lung cancer
549539|NCT00389688|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
549540|NCT00389701|stage I multiple myeloma|stage i multiple myeloma
549541|NCT00389701|stage II multiple myeloma|stage ii multiple myeloma
549542|NCT00389701|stage III multiple myeloma|stage iii multiple myeloma
549543|NCT00389701|refractory multiple myeloma|refractory multiple myeloma
549544|NCT00389714|pedodontics|pedodontics
549545|NCT00389714|carious|carious
549546|NCT00389714|dental restoration|dental restoration
549547|NCT00389714|antibacterial|antibacterial
549548|NCT00389714|nanoparticles|nanoparticles
549549|NCT00389753|Scars|scars
549550|NCT00389753|Hydratation|hydratation
549551|NCT00389753|After Treatment|after treatment
549552|NCT00389766|localized unresectable neuroblastoma|localized unresectable neuroblastoma
549553|NCT00389766|recurrent neuroblastoma|recurrent neuroblastoma
549554|NCT00389766|regional neuroblastoma|regional neuroblastoma
549555|NCT00389766|localized resectable neuroblastoma|localized resectable neuroblastoma
549556|NCT00389766|disseminated neuroblastoma|disseminated neuroblastoma
549557|NCT00389805|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
549558|NCT00389805|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
549559|NCT00389805|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
549560|NCT00389805|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
549561|NCT00389818|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
549562|NCT00389818|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
549563|NCT00389818|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
549564|NCT00389818|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
549565|NCT00389818|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
549566|NCT00389818|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
549567|NCT00389818|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
549568|NCT00389818|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
549569|NCT00389818|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
549570|NCT00389818|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
708876|NCT00992758|NHL|nhl
549571|NCT00389818|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
549572|NCT00389818|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
549573|NCT00389818|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
549574|NCT00389818|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
549575|NCT00389818|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
549576|NCT00389818|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
549577|NCT00389818|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
549578|NCT00389818|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
549579|NCT00389831|Rotigotine|rotigotine
549580|NCT00389831|Rotigotine nasal spray|rotigotine nasal spray
549581|NCT00389831|Efficacy, safety and tolerability|efficacy, safety and tolerability
549582|NCT00389831|Restless Legs Syndrome|restless legs syndrome
549583|NCT00389844|hip fracture|hip fracture
549584|NCT00389844|exercise|exercise
549585|NCT00389844|motivation|motivation
549586|NCT00389857|Influenza|influenza
549587|NCT00389857|Influenza Virus Vaccine|influenza virus vaccine
549588|NCT00389857|Fluzone®|fluzone®
549589|NCT00389870|recurrent colon cancer|recurrent colon cancer
549590|NCT00389870|stage IV colon cancer|stage iv colon cancer
549591|NCT00389870|recurrent rectal cancer|recurrent rectal cancer
549592|NCT00389870|stage IV rectal cancer|stage iv rectal cancer
549593|NCT00389870|adenocarcinoma of the colon|adenocarcinoma of the colon
549594|NCT00389870|adenocarcinoma of the rectum|adenocarcinoma of the rectum
549595|NCT00389883|supratentorial brain tumors|supratentorial brain tumors
549596|NCT00389883|propofol|propofol
549597|NCT00389883|sevoflurane|sevoflurane
549598|NCT00389883|remifentanil|remifentanil
549599|NCT00389883|sufentanil.|sufentanil.
549600|NCT00389909|Premature infants|premature infants
549601|NCT00389909|Apnea|apnea
549602|NCT00389909|Doxapram|doxapram
549603|NCT00389909|pharmacokinetics|pharmacokinetics
549604|NCT00389922|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
549605|NCT00389935|Gastrointestinal Bleeding|gastrointestinal bleeding
549606|NCT00389935|Arteriovenous Malformation|arteriovenous malformation
549607|NCT00389935|Angiodysplasia|angiodysplasia
549608|NCT00389935|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
549609|NCT00389935|Obscure Bleeding|obscure bleeding
549610|NCT00389948|Heartburn, frequent heartburn, proton pump inhibitor, lansoprazole|heartburn, frequent heartburn, proton pump inhibitor, lansoprazole
549611|NCT00390013|Vulvar Pain|vulvar pain
549612|NCT00390026|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
549613|NCT00390026|Bevacizumab|bevacizumab
549614|NCT00390026|Photodynamic therapy|photodynamic therapy
549615|NCT00390039|Pain, postoperative|pain, postoperative
549616|NCT00390039|Surgery, orthopedic|surgery, orthopedic
549617|NCT00390039|Morphine|morphine
549618|NCT00390065|Follow-up|follow-up
549619|NCT00390065|Premature infants|premature infants
549620|NCT00390065|Nitric Oxide|nitric oxide
549621|NCT00390065|Respiratory function testing|respiratory function testing
549622|NCT00390065|Neurodevelopmental outcomes|neurodevelopmental outcomes
549623|NCT00390078|Vaccine|vaccine
549624|NCT00390078|Safety|safety
549625|NCT00390078|T-cell epitope|t-cell epitope
549626|NCT00390078|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
549627|NCT00390078|HIV Therapeutic Vaccine|hiv therapeutic vaccine
549628|NCT00390091|Lupus|lupus
549629|NCT00390091|Nephritis|nephritis
549630|NCT00390091|Kidney|kidney
549631|NCT00390091|SLE|sle
549632|NCT00390091|Systemic Lupus Erythematosus|systemic lupus erythematosus
549633|NCT00390091|Nephritis, Lupus|nephritis, lupus
549634|NCT00390104|Neuromuscular Disease|neuromuscular disease
549635|NCT00390104|Muscle weakness|muscle weakness
549636|NCT00390104|Muscle atrophy|muscle atrophy
549637|NCT00390117|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
549638|NCT00390117|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
549639|NCT00390117|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
549640|NCT00390117|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
549641|NCT00390117|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
549642|NCT00390117|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
549643|NCT00390117|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
549644|NCT00390117|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
549645|NCT00390117|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
549646|NCT00390117|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
549647|NCT00390117|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
549648|NCT00390117|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
549649|NCT00390117|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
549035|NCT00381914|Infants|infants
549650|NCT00390117|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
549651|NCT00390117|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
549652|NCT00390117|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
549653|NCT00390117|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
549654|NCT00390117|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
549655|NCT00390117|splenic marginal zone lymphoma|splenic marginal zone lymphoma
549656|NCT00390130|Vaccination|vaccination
549657|NCT00390130|Pediatrics|pediatrics
549658|NCT00390130|Pain|pain
549659|NCT00390143|Immunogenicity|immunogenicity
549660|NCT00390143|Meningococcal vaccine|meningococcal vaccine
549661|NCT00390143|Conjugate vaccine|conjugate vaccine
549662|NCT00390143|Persistence|persistence
549663|NCT00390156|refractory|refractory
549664|NCT00390156|prior treatment|prior treatment
549665|NCT00390156|solid tumors|solid tumors
549666|NCT00390156|phase I|phase i
549667|NCT00390156|phase 1|phase 1
549668|NCT00390169|breast neoplasms|breast neoplasms
549669|NCT00390169|stress|stress
549670|NCT00390169|personality|personality
549671|NCT00390169|psychology|psychology
549672|NCT00390182|GI tumors|gi tumors
549673|NCT00390182|Locally Advanced|locally advanced
549674|NCT00390182|Metastatic|metastatic
549675|NCT00390182|Hepatobiliary|hepatobiliary
549676|NCT00390182|Ovary|ovary
549677|NCT00390195|Hepatocellular carcinoma|hepatocellular carcinoma
549678|NCT00390195|RAD001|rad001
549679|NCT00390195|Rapamycin|rapamycin
549680|NCT00390195|Randomize|randomize
549681|NCT00390195|Phase I|phase i
549682|NCT00390195|Phase II|phase ii
549683|NCT00390195|Pharmacokinetics|pharmacokinetics
549684|NCT00390208|Macular Degeneration|macular degeneration
549685|NCT00390208|Degenerative changes in the macula lutea of the retina.|degenerative changes in the macula lutea of the retina.
549686|NCT00390208|Maculopathy, Age-Related|maculopathy, age-related
549687|NCT00390208|Age-Related Maculopathies|age-related maculopathies
549688|NCT00390208|Age-Related Maculopathy|age-related maculopathy
549689|NCT00390208|Maculopathies, Age-Related|maculopathies, age-related
549690|NCT00390208|RETINAL DEGENERATION|retinal degeneration
549691|NCT00390208|ARMD|armd
549692|NCT00390208|AMD|amd
549693|NCT00390208|Lucentis|lucentis
549694|NCT00390208|Visudyne|visudyne
549695|NCT00390208|Photodynamic Therapy|photodynamic therapy
549696|NCT00390208|Verteporfin|verteporfin
549697|NCT00390208|Ranibizumab|ranibizumab
549698|NCT00390208|Intravitreal Dexamethasone|intravitreal dexamethasone
549699|NCT00390221|MS|ms
549700|NCT00390221|multiple sclerosis|multiple sclerosis
549701|NCT00390273|diabetes|diabetes
549702|NCT00390273|metformin|metformin
549703|NCT00390273|hyperlactatemia|hyperlactatemia
549704|NCT00390286|Telemedicine|telemedicine
549705|NCT00390312|Post operative pain|post operative pain
549706|NCT00390312|Third molar extraction|third molar extraction
549707|NCT00390312|Dental surgery|dental surgery
549708|NCT00390312|Morphine|morphine
549709|NCT00390338|recurrent melanoma|recurrent melanoma
549710|NCT00390338|stage IV melanoma|stage iv melanoma
549711|NCT00390338|stage IIIA melanoma|stage iiia melanoma
549712|NCT00390338|stage IIIB melanoma|stage iiib melanoma
549713|NCT00390338|stage IIIC melanoma|stage iiic melanoma
549714|NCT00390351|Optical coherence tomography|optical coherence tomography
549715|NCT00390364|adenocarcinoma of the colon|adenocarcinoma of the colon
549716|NCT00390364|adenocarcinoma of the rectum|adenocarcinoma of the rectum
549717|NCT00390364|recurrent colon cancer|recurrent colon cancer
549718|NCT00390364|stage III colon cancer|stage iii colon cancer
549719|NCT00390364|stage IV colon cancer|stage iv colon cancer
549720|NCT00390364|recurrent rectal cancer|recurrent rectal cancer
549721|NCT00390364|stage III rectal cancer|stage iii rectal cancer
549722|NCT00390364|stage IV rectal cancer|stage iv rectal cancer
549723|NCT00390377|x-ray diffraction|x-ray diffraction
549724|NCT00390377|hair|hair
549725|NCT00390377|breast cancer|breast cancer
549726|NCT00390377|synchrotron|synchrotron
549727|NCT00390390|Heartburn, frequent heartburn, proton pump inhibitor, lansoprazole|heartburn, frequent heartburn, proton pump inhibitor, lansoprazole
549728|NCT00390403|adult glioblastoma|adult glioblastoma
549729|NCT00390403|adult gliosarcoma|adult gliosarcoma
549730|NCT00390403|adult giant cell glioblastoma|adult giant cell glioblastoma
549731|NCT00390416|Metastatic|metastatic
549732|NCT00390416|Gastroesophageal|gastroesophageal
549733|NCT00390416|Docetaxel|docetaxel
549734|NCT00390416|Cisplatin|cisplatin
549735|NCT00390416|Fluorouracil|fluorouracil
549736|NCT00390416|Bevacizumab|bevacizumab
549737|NCT00390416|Metastatic Gastroesophageal Adenocarcinoma|metastatic gastroesophageal adenocarcinoma
549738|NCT00390416|06-096|06-096
549739|NCT00390429|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
549740|NCT00390429|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
549741|NCT00390429|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
549135|NCT00388128|ABI|abi
549742|NCT00390429|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
549743|NCT00390442|cardiogenic pulmonary edema|cardiogenic pulmonary edema
549744|NCT00390442|non invasive ventilation|non invasive ventilation
549745|NCT00390442|CPAP|cpap
549746|NCT00390468|Tandutinib|tandutinib
549747|NCT00390468|MLN518|mln518
549748|NCT00390468|CT53518|ct53518
549749|NCT00390468|pain|pain
549750|NCT00390468|adenocarcinoma of the prostate|adenocarcinoma of the prostate
549751|NCT00390468|recurrent prostate cancer|recurrent prostate cancer
549752|NCT00390468|stage IV prostate cancer|stage iv prostate cancer
549753|NCT00390468|bone metastases|bone metastases
549754|NCT00390468|hormone-based castration|hormone-based castration
549755|NCT00390481|Carotid Occlusion|carotid occlusion
549756|NCT00390481|Cognition|cognition
549757|NCT00390494|Fibroids|fibroids
549758|NCT00390494|Leiomyoma|leiomyoma
549759|NCT00390494|Hysterectomy|hysterectomy
549760|NCT00390494|Myomectomy|myomectomy
549761|NCT00390494|Uterine Fibroid Embolization|uterine fibroid embolization
549762|NCT00390494|Questionnaire|questionnaire
549763|NCT00390507|Acceleromyography|acceleromyography
549764|NCT00390507|TOF-Watch|tof-watch
549765|NCT00390507|Posttetanic count|posttetanic count
549766|NCT00390507|Train of four|train of four
549767|NCT00390507|Neuromuscular blockade|neuromuscular blockade
549768|NCT00390520|Type 2 diabetes|type 2 diabetes
549770|NCT00390520|glucagon|glucagon
549771|NCT00390520|hypoglycemia|hypoglycemia
549772|NCT00390533|Anxiety|anxiety
549773|NCT00390533|clinical trials|clinical trials
549774|NCT00390559|Nicotine Replacement Therapy|nicotine replacement therapy
549775|NCT00390559|Tobacco Smoking|tobacco smoking
549776|NCT00390559|Smoking stimuli|smoking stimuli
549777|NCT00390559|Gender|gender
549778|NCT00390572|sleep|sleep
549779|NCT00390572|consultation and referral|consultation and referral
549780|NCT00390572|outcome assessment|outcome assessment
549781|NCT00390572|primary care|primary care
549782|NCT00390585|Renal Insufficiency|renal insufficiency
751954|NCT01171339|multimedication|multimedication
549783|NCT00390585|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
549784|NCT00390585|Contrast media|contrast media
549785|NCT00390598|colonoscopy|colonoscopy
549786|NCT00390598|large bowel preparation|large bowel preparation
549787|NCT00390598|bowel cleansing|bowel cleansing
549788|NCT00390598|randomized controlled trial|randomized controlled trial
549789|NCT00390611|Ovarian Cancer|ovarian cancer
549790|NCT00390624|Urodilatin|urodilatin
549791|NCT00390624|Mannitol|mannitol
549792|NCT00390624|Acute Kidney Failure|acute kidney failure
549793|NCT00390637|Diogenes|diogenes
549794|NCT00390637|Diet Intervention|diet intervention
549796|NCT00390637|Glycemic Index|glycemic index
549797|NCT00390637|Protein|protein
549798|NCT00390650|Anxiety|anxiety
549799|NCT00390650|clinical trials|clinical trials
549800|NCT00390663|Paediatric|paediatric
549801|NCT00390663|Epistaxis|epistaxis
549802|NCT00390663|Nose bleed|nose bleed
549803|NCT00390663|Naseptin|naseptin
549804|NCT00390676|cancer|cancer
549805|NCT00390676|tumors|tumors
549806|NCT00390676|anticarcinogenic agents|anticarcinogenic agents
549807|NCT00390676|antineoplastic agents|antineoplastic agents
549808|NCT00390676|cadherins|cadherins
549809|NCT00390676|solid tumors|solid tumors
549810|NCT00390702|Ventricular septal defect|ventricular septal defect
549811|NCT00390702|VSD|vsd
549812|NCT00390715|Acute Myeloblastic Leukemia|acute myeloblastic leukemia
549813|NCT00390741|hip fracture|hip fracture
549814|NCT00390741|bone mineral density|bone mineral density
549815|NCT00390741|exercise|exercise
549816|NCT00390754|pregnancy|pregnancy
549817|NCT00390754|unintended|unintended
549818|NCT00390754|menses|menses
549819|NCT00390767|Peripheral arterial disease|peripheral arterial disease
549820|NCT00390767|Peripheral vascular disease|peripheral vascular disease
549821|NCT00390767|Claudication|claudication
549822|NCT00390767|Cell therapy|cell therapy
549823|NCT00390767|Gene therapy|gene therapy
549824|NCT00390767|Endothelial cells|endothelial cells
549825|NCT00390767|Smooth muscle cells|smooth muscle cells
549826|NCT00390767|Angiogenesis|angiogenesis
549827|NCT00390780|Miconazole Lauriad|miconazole lauriad
549828|NCT00390780|Oropharyngeal candidiasis|oropharyngeal candidiasis
549829|NCT00390780|HIV patients|hiv patients
549830|NCT00390780|Mycology|mycology
549831|NCT00390780|Clinical picture of Oropharyngeal candidiasis|clinical picture of oropharyngeal candidiasis
549832|NCT00390780|Candida culture positive|candida culture positive
549833|NCT00390780|Treatment Experienced|treatment experienced
549834|NCT00390793|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
549835|NCT00390793|Leukemia|leukemia
549836|NCT00390793|ALL|all
549837|NCT00390793|Philadelphia-Positive ALL|philadelphia-positive all
549838|NCT00390793|BCR-ABL Positive ALL|bcr-abl positive all
549839|NCT00390793|Dasatinib|dasatinib
549840|NCT00390793|Hyper-CVAD|hyper-cvad
549841|NCT00390793|Cyclophosphamide|cyclophosphamide
549842|NCT00390793|Cytoxan|cytoxan
549225|NCT00388570|Asthma|asthma
549843|NCT00390793|Vincristine|vincristine
549844|NCT00390793|Vincasar|vincasar
549845|NCT00390793|Doxorubicin|doxorubicin
549846|NCT00390793|Adriamycin|adriamycin
549847|NCT00390793|Dexamethasone|dexamethasone
549848|NCT00390793|Decadron|decadron
549849|NCT00390793|Sprycel|sprycel
549850|NCT00390806|Brain metastases from Non-Small Cell Lung Cancer|brain metastases from non-small cell lung cancer
549851|NCT00390806|Brain metastases brain tumor lung cancer oral chemotherapy HYCAMTIN topotecan NSCLC WBRT whole brain radiation|brain metastases brain tumor lung cancer oral chemotherapy hycamtin topotecan nsclc wbrt whole brain radiation
549852|NCT00390819|Community acquired pneumonia|community acquired pneumonia
549853|NCT00390832|STEMI|stemi
549854|NCT00390845|MAP kinase|map kinase
549855|NCT00390845|SB681323|sb681323
549856|NCT00390845|neuropathic pain|neuropathic pain
549857|NCT00390845|patients|patients
549858|NCT00390845|P38|p38
549859|NCT00390845|nerve trauma|nerve trauma
549860|NCT00390858|β-thalassemia major|β-thalassemia major
549861|NCT00390858|iron overload|iron overload
549862|NCT00390858|deferasirox|deferasirox
549863|NCT00390858|pediatric rare anemia|pediatric rare anemia
549864|NCT00390871|Patient|patient
549865|NCT00390871|Must be|must be
549866|NCT00390871|Under|under
549867|NCT00390884|Fluzone®|fluzone®
549868|NCT00390884|Influenza|influenza
549869|NCT00390884|Influenza virus infection|influenza virus infection
549870|NCT00390884|Influenza vaccine|influenza vaccine
549871|NCT00390897|chronic myeloid leukaemia|chronic myeloid leukaemia
549873|NCT00390897|Interferon|interferon
549874|NCT00390910|Pneumococcal vaccine|pneumococcal vaccine
549875|NCT00390910|Preterm|preterm
549876|NCT00390910|Safety|safety
549877|NCT00390910|Pneumococcal disease|pneumococcal disease
549878|NCT00390910|Immunogenicity|immunogenicity
549879|NCT00390923|smoking|smoking
549880|NCT00390923|nicotine dependence|nicotine dependence
549881|NCT00390923|double-blind|double-blind
549882|NCT00390923|placebo-controlled|placebo-controlled
549883|NCT00390923|randomized|randomized
549884|NCT00390923|full substitution therapy|full substitution therapy
549885|NCT00390923|selegiline|selegiline
549886|NCT00390949|HIV prevention|hiv prevention
549887|NCT00390949|Zimbabwe|zimbabwe
549888|NCT00390949|Core groups|core groups
549889|NCT00390949|Peer education|peer education
549890|NCT00390949|Syndromic management|syndromic management
549891|NCT00390949|Commercial sex workers|commercial sex workers
549892|NCT00390949|Condom distribution|condom distribution
549893|NCT00390949|HIV Seronegativity|hiv seronegativity
549894|NCT00390962|copeptin|copeptin
549895|NCT00390962|vasopressin|vasopressin
549896|NCT00390962|Adh|adh
549897|NCT00390962|SIADH|siadh
549898|NCT00390962|diabetes insipidus|diabetes insipidus
549899|NCT00390962|stroke|stroke
549900|NCT00390962|risk factors|risk factors
549901|NCT00390962|Neurological patients with ischemic and hemorrhagic stroke and patients undergoing intracranial surgery.|neurological patients with ischemic and hemorrhagic stroke and patients undergoing intracranial surgery.
549902|NCT00390975|Tegaserod|tegaserod
549903|NCT00390975|diabetes|diabetes
549904|NCT00390975|diabetic gastroparesis|diabetic gastroparesis
549905|NCT00390975|gastric emptying|gastric emptying
549906|NCT00390975|gastric retention|gastric retention
549907|NCT00390975|electrogastrography|electrogastrography
549908|NCT00390988|blood count|blood count
549909|NCT00390988|capillary|capillary
549910|NCT00390988|venous|venous
549911|NCT00390988|Adult|adult
549912|NCT00390988|reference values|reference values
549913|NCT00391001|mania|mania
549914|NCT00391001|bipolar disorder|bipolar disorder
549915|NCT00391001|taurine|taurine
549916|NCT00391001|adolescents|adolescents
549917|NCT00385021|Advanced|advanced
549918|NCT00385021|metastatic|metastatic
549919|NCT00385021|colorectal|colorectal
549920|NCT00385021|cancer|cancer
549921|NCT00385021|Avastin|avastin
549922|NCT00385034|randomized controlled trial|randomized controlled trial
549923|NCT00385034|RCT|rct
549924|NCT00385034|partner violence|partner violence
549925|NCT00385034|IPV|ipv
549926|NCT00385034|screening|screening
549927|NCT00385034|family practice|family practice
549928|NCT00385034|computer|computer
549929|NCT00385047|malaria|malaria
549930|NCT00385047|vaccine|vaccine
549931|NCT00385047|AMA-1 (apical membrane antigen-1)|ama-1 (apical membrane antigen-1)
549932|NCT00385047|efficacy|efficacy
549933|NCT00385086|Sciatica|sciatica
549934|NCT00385086|Pain|pain
549935|NCT00385086|TNF-alpha|tnf-alpha
549936|NCT00385086|Discectomy|discectomy
549937|NCT00385086|Fibrosis|fibrosis
549938|NCT00385086|Spine|spine
549939|NCT00385099|IBS|ibs
549940|NCT00385099|stress|stress
549941|NCT00385099|CRF1|crf1
549942|NCT00385112|Cardiology|cardiology
549943|NCT00385112|Echocardiograms|echocardiograms
549944|NCT00385112|Surgery|surgery
549945|NCT00385112|Valve Disease|valve disease
549946|NCT00385112|Heart Valve Disease|heart valve disease
549947|NCT00385125|relapsed|relapsed
549326|NCT00388843|atherosclerosis|atherosclerosis
549948|NCT00385125|refractory|refractory
549949|NCT00385125|CD 20 positive|cd 20 positive
549950|NCT00385138|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
549951|NCT00385138|ACS|acs
549952|NCT00385151|Post conditioning|post conditioning
549953|NCT00385164|lung neoplasms|lung neoplasms
549954|NCT00385164|positron emissions tomography|positron emissions tomography
549955|NCT00385164|radiotherapy planning|radiotherapy planning
549956|NCT00385190|SAD|sad
549957|NCT00385203|cancer|cancer
549958|NCT00385203|tumour|tumour
549959|NCT00385203|advanced cancer|advanced cancer
549960|NCT00385203|Metastatic Gastro-Intestinal Stromal Tumours|metastatic gastro-intestinal stromal tumours
549961|NCT00385203|gastro-intestinal cancer|gastro-intestinal cancer
549962|NCT00385203|RECENTIN|recentin
549963|NCT00385216|Third Molar|third molar
549964|NCT00385216|Pain|pain
549965|NCT00385229|Asphyxia neonatorum|asphyxia neonatorum
549966|NCT00385229|Birth Injury|birth injury
549967|NCT00385229|Meconium Aspiration Syndrome|meconium aspiration syndrome
549968|NCT00385242|coronary artery disease|coronary artery disease
549969|NCT00385242|left ventricular dysfunction|left ventricular dysfunction
549970|NCT00385242|positron emission tomography|positron emission tomography
549971|NCT00385242|viable myocardium|viable myocardium
549972|NCT00385242|revascularization|revascularization
549973|NCT00385242|cost effectiveness|cost effectiveness
549974|NCT00385255|Immunogenicity,|immunogenicity,
549975|NCT00385255|Influenza|influenza
549976|NCT00385255|Co-administration,|co-administration,
549977|NCT00385255|Tdap,|tdap,
549978|NCT00385268|cocaine|cocaine
549979|NCT00385281|proteomic profiling, influenza, vaccine, FluMist|proteomic profiling, influenza, vaccine, flumist
549980|NCT00385294|Genetic|genetic
549981|NCT00385294|pain|pain
549982|NCT00385294|obstetrical|obstetrical
549983|NCT00385307|Depression|depression
549984|NCT00385307|Clinical Trials|clinical trials
549985|NCT00385307|Major Depressive Disorder|major depressive disorder
549986|NCT00385333|Mitochondrion|mitochondrion
549987|NCT00385333|Retina|retina
549988|NCT00385333|Mitochondria|mitochondria
549989|NCT00385333|Metabolism|metabolism
549990|NCT00385333|In Vivo Imaging|in vivo imaging
549991|NCT00385333|Age-Related Macular Degeneration|age-related macular degeneration
549992|NCT00385333|AMD|amd
549993|NCT00385333|Diabetic Retinopathy|diabetic retinopathy
549994|NCT00385333|DR|dr
549995|NCT00385333|Hippel-Lindau Disease|hippel-lindau disease
549996|NCT00385333|VHL|vhl
549997|NCT00385346|Expressive writing|expressive writing
549998|NCT00385346|Male infertility|male infertility
549999|NCT00385372|low pseudoallergen diet|low pseudoallergen diet
550000|NCT00385372|elimination diet|elimination diet
550001|NCT00385372|provocation diet|provocation diet
550002|NCT00385372|oral provocation|oral provocation
550003|NCT00385372|natural food ingredients|natural food ingredients
550004|NCT00385372|food additives|food additives
550005|NCT00385372|flavours|flavours
550006|NCT00385398|tumors metastatic to brain|tumors metastatic to brain
550007|NCT00385398|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
550008|NCT00385437|Driving safety|driving safety
550009|NCT00385437|maintenance of wakefulness test|maintenance of wakefulness test
550010|NCT00385437|major depressive disorder|major depressive disorder
550011|NCT00385437|mirtazapine|mirtazapine
550012|NCT00385463|Asthma|asthma
550013|NCT00385463|Rhinitis|rhinitis
550014|NCT00385463|Allergic Asthma|allergic asthma
550015|NCT00385476|Advanced Cancer|advanced cancer
550016|NCT00385476|Medication Knowledge|medication knowledge
550017|NCT00385476|Emergency Center|emergency center
550018|NCT00385476|Questionnaire|questionnaire
550019|NCT00385476|Survey|survey
550020|NCT00385502|toenail|toenail
550021|NCT00385502|fungus|fungus
550022|NCT00385502|onychomycosis|onychomycosis
550023|NCT00385502|antifungal|antifungal
550024|NCT00385502|anti-fungal|anti-fungal
550025|NCT00385502|nail|nail
550026|NCT00391014|Acute myeloid Leukemia|acute myeloid leukemia
550027|NCT00391014|Allogeneic haematopoietic progenitor cell transplant|allogeneic haematopoietic progenitor cell transplant
550028|NCT00391014|Acute Invasive Aspergillosis|acute invasive aspergillosis
550029|NCT00391027|type 2 diabetes, insulin, glycemic control|type 2 diabetes, insulin, glycemic control
550030|NCT00391040|diabetes mellitus, structured treatment and teaching, education,|diabetes mellitus, structured treatment and teaching, education,
550031|NCT00391040|elderly patients, geriatrics|elderly patients, geriatrics
550032|NCT00391053|Influenza|influenza
550033|NCT00391053|Orthomyxoviruses|orthomyxoviruses
550034|NCT00391053|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
550035|NCT00391053|Adults|adults
550036|NCT00391066|CD23+/CD20+ B-cell CLL|cd23+/cd20+ b-cell cll
550037|NCT00391066|CLL|cll
550038|NCT00391079|Central Neuropathic Pain|central neuropathic pain
550039|NCT00391105|intubation|intubation
550040|NCT00391105|Sedation|sedation
550041|NCT00391105|Analgesia|analgesia
550042|NCT00391105|preterm neonate|preterm neonate
709446|NCT01002040|HIV|hiv
549417|NCT00389194|lipids|lipids
550043|NCT00391105|remifentanil|remifentanil
550044|NCT00391105|morphine|morphine
550045|NCT00391105|respiratory distress syndrome|respiratory distress syndrome
550046|NCT00391131|PID|pid
550047|NCT00391131|SCIG|scig
550048|NCT00391131|Ig|ig
550049|NCT00391131|Quality of Life|quality of life
550050|NCT00391131|Serious Bacterial Infections|serious bacterial infections
550051|NCT00391144|Pattern Dystrophy|pattern dystrophy
550052|NCT00391144|Choroidal Neovascularization|choroidal neovascularization
550053|NCT00391144|Intravitreal Avastin Injection|intravitreal avastin injection
550054|NCT00391157|Múltiple Myeloma|múltiple myeloma
550055|NCT00391157|Transplant|transplant
550056|NCT00391157|Patients <65 years.|patients <65 years.
550057|NCT00391170|Oral Chronic GVHD|oral chronic gvhd
550058|NCT00391170|Topical Dexamethasone|topical dexamethasone
550059|NCT00391170|Tissue Markers|tissue markers
550060|NCT00391170|Salivary Proteomics|salivary proteomics
550061|NCT00391170|Quality of Life|quality of life
550062|NCT00391170|Oral Chronic Graft Versus Host Disease|oral chronic graft versus host disease
550063|NCT00391170|Oral Pain|oral pain
550064|NCT00391170|Mouth Pain|mouth pain
550065|NCT00391183|Gallbladder cancer|gallbladder cancer
550066|NCT00391183|Quality of life|quality of life
550067|NCT00391183|Stenting|stenting
550068|NCT00391183|Survival|survival
550069|NCT00391183|Performance status|performance status
550070|NCT00391222|Bipolar I Disorder|bipolar i disorder
550071|NCT00391222|Intramuscular injection|intramuscular injection
550072|NCT00391222|prevention of mood episodes|prevention of mood episodes
550073|NCT00391222|long acting injectable|long acting injectable
550074|NCT00391222|risperidone|risperidone
550075|NCT00391235|bipolar disorder|bipolar disorder
550076|NCT00391235|magnetic resonance imaging|magnetic resonance imaging
550077|NCT00391235|white matter|white matter
550078|NCT00391235|diffusion tensor imaging|diffusion tensor imaging
550079|NCT00391235|children|children
550080|NCT00391235|adolescents|adolescents
550081|NCT00391248|non-small cell lung cancer|non-small cell lung cancer
551025|NCT00397995|Distal|distal
550082|NCT00391248|palliative radiation|palliative radiation
550083|NCT00391248|tarceva|tarceva
550084|NCT00391248|palliative thoracic radiation therapy|palliative thoracic radiation therapy
550085|NCT00391261|weight gain|weight gain
550086|NCT00391261|obesity|obesity
550087|NCT00391261|metabolism|metabolism
550088|NCT00391287|Red-Cell Aplasia due to Chronic Kidney Failure|red-cell aplasia due to chronic kidney failure
550089|NCT00391287|Aplastic Anemia|aplastic anemia
550090|NCT00391287|Recombinant Erythropoietin|recombinant erythropoietin
550091|NCT00391287|Surveillance Registry|surveillance registry
550093|NCT00391300|melanoma|melanoma
550094|NCT00391300|basal cell carcinoma of the skin|basal cell carcinoma of the skin
550095|NCT00391300|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
550096|NCT00391313|Chikungunya|chikungunya
550097|NCT00391313|Chikungunya disease|chikungunya disease
550098|NCT00391326|Bivalirudin|bivalirudin
550099|NCT00391326|Heparin|heparin
550100|NCT00391326|Bleeding|bleeding
550101|NCT00391326|TIMI flow|timi flow
550102|NCT00391326|STEMI|stemi
550103|NCT00391339|Bryophyllum p.|bryophyllum p.
550104|NCT00391339|Nifedipine|nifedipine
550105|NCT00391339|Tocolysis|tocolysis
550106|NCT00391625|Gaucher disease, Enzyme Replacement Therapy|gaucher disease, enzyme replacement therapy
550107|NCT00391638|HIV and Hepatitis B coinfection|hiv and hepatitis b coinfection
550108|NCT00391638|Peg interferon|peg interferon
550109|NCT00391638|tenofovir|tenofovir
550110|NCT00391638|emtricitabine|emtricitabine
550111|NCT00391638|Hepatitis B e Antigens|hepatitis b e antigens
550112|NCT00391638|Treatment Experienced|treatment experienced
550113|NCT00391651|UTI|uti
550114|NCT00391664|Endometrial cancer|endometrial cancer
550115|NCT00391664|Ovarian Cancer|ovarian cancer
550116|NCT00391664|Cervical Cancer|cervical cancer
550117|NCT00391664|Genital Cancer|genital cancer
550118|NCT00391664|Vulvar Cancer|vulvar cancer
550119|NCT00391664|Vaginal Cancer|vaginal cancer
550120|NCT00391664|Other Gynecological Cancers|other gynecological cancers
550121|NCT00391677|Cognitive Rehabilitation|cognitive rehabilitation
550122|NCT00391677|Behavior Therapy|behavior therapy
550123|NCT00391690|Serum bone marker|serum bone marker
550124|NCT00391690|Prostate cancer|prostate cancer
550125|NCT00391690|Bisphosphonates|bisphosphonates
550126|NCT00391690|Early detection of metastasis|early detection of metastasis
550127|NCT00391703|Cystic fibrosis|cystic fibrosis
550128|NCT00391703|mucoviscidosis|mucoviscidosis
550129|NCT00391703|electrostimulation|electrostimulation
550130|NCT00391703|retraining|retraining
550131|NCT00391716|Alcohol|alcohol
550132|NCT00391716|Alcohol treatment|alcohol treatment
550133|NCT00391716|Alcoholism|alcoholism
550134|NCT00391716|Alcohol Dependence|alcohol dependence
550135|NCT00391729|ADHD|adhd
550136|NCT00391742|Brief intervention|brief intervention
550137|NCT00391742|Motivational Interviewing|motivational interviewing
549522|NCT00389597|Mobi C|mobi c
550138|NCT00391742|Primary care|primary care
550139|NCT00391742|Stepped-care|stepped-care
550140|NCT00391755|Migraine Headache|migraine headache
550141|NCT00391768|influenza, oseltamivir, Tamiflu®, antiviral, children, infants|influenza, oseltamivir, tamiflu®, antiviral, children, infants
550142|NCT00391781|mechanical infertility|mechanical infertility
550143|NCT00391781|hysterosalpingogram|hysterosalpingogram
550144|NCT00391781|hysterosalpingography|hysterosalpingography
550145|NCT00391794|Memory|memory
550146|NCT00391794|Alzheimer's disease|alzheimer's disease
550147|NCT00391794|Dementia|dementia
550148|NCT00391794|Support Group|support group
550149|NCT00391794|Psychosocial|psychosocial
550150|NCT00391807|Contraception|contraception
550151|NCT00391820|constipation|constipation
550152|NCT00391820|chronic|chronic
550153|NCT00391820|bowel function|bowel function
550154|NCT00391833|Alzheimer's disease, Ginseng, CD34|alzheimer's disease, ginseng, cd34
550155|NCT00391846|Heart Failure|heart failure
550156|NCT00391846|Ventricular Dysfunction|ventricular dysfunction
550157|NCT00391846|NTproBNP|ntprobnp
550158|NCT00391859|Pharmacist-initiated Intervention Trial in OsteoArthritis|pharmacist-initiated intervention trial in osteoarthritis
550159|NCT00391872|ACS|acs
550160|NCT00391872|Acute coronary syndrome|acute coronary syndrome
550161|NCT00391872|Heart attack|heart attack
550162|NCT00391872|Unstable angina|unstable angina
550163|NCT00391872|Coronary artery disease|coronary artery disease
550164|NCT00391898|Parkinson's disease, adults, levodopa/carbidopa/entacapone, wearing-off, activities of daily living|parkinson's disease, adults, levodopa/carbidopa/entacapone, wearing-off, activities of daily living
550165|NCT00391911|Rhabdomyolysis|rhabdomyolysis
550166|NCT00391911|CRRT|crrt
550167|NCT00391911|N-Acetylcysteine|n-acetylcysteine
550168|NCT00391924|Dehydroepiandrosterone|dehydroepiandrosterone
550169|NCT00391924|Fatigue|fatigue
550170|NCT00391924|Quality of life|quality of life
550171|NCT00391924|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
550172|NCT00391924|Sjogren's Syndrome|sjogren's syndrome
550173|NCT00391924|Bone mineral density|bone mineral density
550174|NCT00391937|"resurfacing hip [MESH]"|"resurfacing hip [mesh]"
550175|NCT00391937|"conventional position method"|"conventional position method"
550176|NCT00391937|"surgery, computer-assisted [MESH]"|"surgery, computer-assisted [mesh]"
551026|NCT00397995|Child|child
550177|NCT00391950|Prostate cancer|prostate cancer
550178|NCT00391950|Cancer treatment induced bone loss (CTIBL)|cancer treatment induced bone loss (ctibl)
550179|NCT00391950|Androgen deprivation therapy (ADT)|androgen deprivation therapy (adt)
550180|NCT00391976|Cystic fibrosis|cystic fibrosis
550181|NCT00391989|Ph+ Acute Lymphoblastic Leukaemia|ph+ acute lymphoblastic leukaemia
550182|NCT00391989|Dasatinib|dasatinib
550183|NCT00391989|targeted therapy|targeted therapy
550184|NCT00391989|Patients with Ph positive and or BCR ABL positive ALL|patients with ph positive and or bcr abl positive all
550185|NCT00392002|GERD|gerd
550186|NCT00392015|Malaria Vaccine|malaria vaccine
550187|NCT00392015|Adenovirus|adenovirus
550188|NCT00392015|Plasmodium falciparum|plasmodium falciparum
550189|NCT00392028|Ertapenem|ertapenem
550190|NCT00392028|Bone drug level|bone drug level
550191|NCT00392028|Blood drug level|blood drug level
550192|NCT00392028|Tissue drug level|tissue drug level
550193|NCT00392041|Fibromyalgia|fibromyalgia
550194|NCT00392041|Insomnia|insomnia
550195|NCT00392041|Sleep|sleep
550196|NCT00392041|Eszopiclone|eszopiclone
550197|NCT00392041|Lunesta|lunesta
550198|NCT00392054|Atrial Fibrillation|atrial fibrillation
550199|NCT00392054|Paroxysmal|paroxysmal
550321|NCT00392678|Type 2 Diabetes|type 2 diabetes
550200|NCT00392054|Pulmonary Vein Isolation|pulmonary vein isolation
550201|NCT00392054|Ablation Catheter|ablation catheter
550202|NCT00392054|Anti-arrhythmic Drug Therapy|anti-arrhythmic drug therapy
550203|NCT00392054|First Line Therapy|first line therapy
550204|NCT00392093|Systemic lupus erythematosus|systemic lupus erythematosus
550205|NCT00392093|Menopause hormonal therapy|menopause hormonal therapy
550206|NCT00392093|Menopausal symptoms|menopausal symptoms
550207|NCT00392093|Bone mineral density|bone mineral density
550208|NCT00392106|atrial fibrillation|atrial fibrillation
550209|NCT00392106|arrhythmia|arrhythmia
550210|NCT00392106|AF ablation|af ablation
550211|NCT00392106|antiarrhythmic agent|antiarrhythmic agent
550212|NCT00392106|catheter ablation|catheter ablation
550213|NCT00392106|pulmonary veins|pulmonary veins
550214|NCT00392119|MR-guided therapy|mr-guided therapy
550215|NCT00392119|Laser interstitial thermal therapy|laser interstitial thermal therapy
550216|NCT00392119|brain metastasis|brain metastasis
550217|NCT00392119|Magnetic Resonance Thermal imaging (MRTI)|magnetic resonance thermal imaging (mrti)
550219|NCT00392145|Pediatrics|pediatrics
550220|NCT00392145|Gastroenteritis|gastroenteritis
550221|NCT00392145|Dehydration|dehydration
550222|NCT00392145|IV Rehydration|iv rehydration
550223|NCT00392184|accelerated partial breast irradiation|accelerated partial breast irradiation
550224|NCT00392184|multicatheter brachytherapy|multicatheter brachytherapy
550225|NCT00392184|high dose rate brachytherapy|high dose rate brachytherapy
550226|NCT00392184|pulsed dose rate brachytherapy|pulsed dose rate brachytherapy
550227|NCT00392197|OPC-14597|opc-14597
550228|NCT00392197|Schizophrenia|schizophrenia
550229|NCT00392236|Schizoaffective Disorder|schizoaffective disorder
550230|NCT00392249|Schizophrenia|schizophrenia
550231|NCT00392249|Drug adherence|drug adherence
550232|NCT00392262|Moderate essential hypertension (WHO grade II)|moderate essential hypertension (who grade ii)
550233|NCT00392275|Cataract|cataract
550234|NCT00392275|Aqueous absorption|aqueous absorption
550235|NCT00392275|Funtioning Filtering Blebs|funtioning filtering blebs
550236|NCT00392288|Bronchial Asthma|bronchial asthma
550237|NCT00392301|wound healing|wound healing
550238|NCT00392301|skin|skin
550239|NCT00392301|graft donor site|graft donor site
550240|NCT00392301|donor site|donor site
550241|NCT00392301|transepidermal water loss|transepidermal water loss
550242|NCT00392314|hodgkin lymphoma|hodgkin lymphoma
550243|NCT00392314|PET/CT|pet/ct
550244|NCT00392314|Therapy|therapy
550245|NCT00392340|recurrent neuroblastoma|recurrent neuroblastoma
550246|NCT00392340|disseminated neuroblastoma|disseminated neuroblastoma
550247|NCT00392366|MRI guided Laser Therapy|mri guided laser therapy
550248|NCT00392366|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
550249|NCT00392366|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
550250|NCT00392366|Liver Metastasis|liver metastasis
550251|NCT00392379|Tobacco use disorder|tobacco use disorder
550252|NCT00392379|Tobacco cessation|tobacco cessation
550253|NCT00392392|Breast Cancer|breast cancer
550254|NCT00392405|Contrast Induced Nephropathy|contrast induced nephropathy
550255|NCT00392418|iron deficiency anemia|iron deficiency anemia
550256|NCT00392418|hematologic disease|hematologic disease
550257|NCT00392418|infancy|infancy
550258|NCT00392418|pediatrics|pediatrics
550259|NCT00392418|Sprinkles®|sprinkles®
550260|NCT00392418|iron|iron
550261|NCT00392418|micronutrient|micronutrient
550262|NCT00392457|Idiopathic Hypogonadotropic Hypogonadism|idiopathic hypogonadotropic hypogonadism
550263|NCT00392457|Kallmann Syndrome|kallmann syndrome
550264|NCT00392457|Agonadal|agonadal
550265|NCT00392470|adenocarcinoma of the rectum|adenocarcinoma of the rectum
550266|NCT00392470|stage III rectal cancer|stage iii rectal cancer
550267|NCT00392470|stage IV rectal cancer|stage iv rectal cancer
550268|NCT00392483|Heading Health Plan Implementation|heading health plan implementation
550269|NCT00392483|Computer-Assisted Instruction|computer-assisted instruction
550270|NCT00392483|General Practice|general practice
550271|NCT00392483|Dementia|dementia
550272|NCT00392509|critical limb ischemia|critical limb ischemia
550273|NCT00392509|cell therapy for angiogenesis|cell therapy for angiogenesis
550274|NCT00392509|aldehyde dehydrogenase-bright cells|aldehyde dehydrogenase-bright cells
550275|NCT00392509|peripheral artery disease|peripheral artery disease
550276|NCT00392509|peripheral vascular disease|peripheral vascular disease
550277|NCT00392509|leg pain|leg pain
550280|NCT00392509|CLI|cli
550281|NCT00392509|amputation|amputation
550282|NCT00392509|limb salvage|limb salvage
550283|NCT00392522|Anxiety|anxiety
550284|NCT00392522|Cough|cough
550285|NCT00392522|Number of general anaesthesias (due to procedure failure)|number of general anaesthesias (due to procedure failure)
550286|NCT00392522|Patients satisfaction|patients satisfaction
550287|NCT00392522|Chest physician satisfaction|chest physician satisfaction
550288|NCT00392535|adenocarcinoma of the prostate|adenocarcinoma of the prostate
550289|NCT00392535|stage IIB prostate cancer|stage iib prostate cancer
550290|NCT00392535|stage IIA prostate cancer|stage iia prostate cancer
550291|NCT00392535|stage III prostate cancer|stage iii prostate cancer
550292|NCT00392548|GBM|gbm
550293|NCT00392548|glioblastoma|glioblastoma
550294|NCT00392548|urine|urine
550295|NCT00392548|VEGF|vegf
550296|NCT00392548|radiation|radiation
550297|NCT00392548|Patients must be enrolled to an RTOG GBM study that prescribes 6000 cGy of radiation therapy.|patients must be enrolled to an rtog gbm study that prescribes 6000 cgy of radiation therapy.
550298|NCT00392574|Gastroenteritis|gastroenteritis
550299|NCT00392587|Pharmacodynamics|pharmacodynamics
550300|NCT00392587|Pharmacokinetics|pharmacokinetics
550301|NCT00392587|Tolerability|tolerability
550302|NCT00392587|COPD|copd
550303|NCT00392587|Safety|safety
550304|NCT00392639|Heart arrest|heart arrest
550305|NCT00392639|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
550306|NCT00392639|Humans|humans
550307|NCT00392639|Hypothermia|hypothermia
550308|NCT00392639|Brain diseases|brain diseases
550309|NCT00392639|Hypoxia-ischemia|hypoxia-ischemia
550310|NCT00392639|Cost Benefit Analysis|cost benefit analysis
550311|NCT00392639|Prospective study|prospective study
550312|NCT00392639|Comparative study|comparative study
550313|NCT00392639|Treatment outcome|treatment outcome
550314|NCT00392639|Hypothermia for|hypothermia for
550315|NCT00392639|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
550316|NCT00392639|from cardiac origin|from cardiac origin
550317|NCT00392639|successfully resuscitated|successfully resuscitated
550318|NCT00392665|SCCHN|scchn
550319|NCT00392665|erlotinib|erlotinib
550320|NCT00392665|tarceva|tarceva
550322|NCT00392678|Inflammation|inflammation
550323|NCT00392678|Obesity|obesity
550324|NCT00392678|Metabolic Syndrome|metabolic syndrome
550325|NCT00392691|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
550326|NCT00392691|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
550327|NCT00392691|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
550328|NCT00392691|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
550329|NCT00392691|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
550330|NCT00392691|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
550331|NCT00392691|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
550332|NCT00392691|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
550333|NCT00392691|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
550334|NCT00392691|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
550335|NCT00392691|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
550336|NCT00392691|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
550337|NCT00392691|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
550338|NCT00392691|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
550339|NCT00392691|splenic marginal zone lymphoma|splenic marginal zone lymphoma
550340|NCT00392691|Waldenström macroglobulinemia|waldenström macroglobulinemia
550341|NCT00392717|lipoprotein metabolism|lipoprotein metabolism
550347|NCT00392730|Parenteral Nutrition|parenteral nutrition
550348|NCT00392730|Prematurity|prematurity
550349|NCT00392743|Bolus|bolus
550350|NCT00392743|11C-Raclopride|11c-raclopride
550351|NCT00392743|Schizophrenia|schizophrenia
550352|NCT00392743|123I-IBZM|123i-ibzm
550353|NCT00392743|SPECT|spect
550354|NCT00392743|Receptor Occupancy|receptor occupancy
550355|NCT00392743|PET|pet
550356|NCT00392743|MRI|mri
550357|NCT00392743|Antipsychotics|antipsychotics
550358|NCT00392743|Bolus/Infusion|bolus/infusion
550363|NCT00392769|Endometrial Cancer|endometrial cancer
550364|NCT00392769|Progressive or Recurrent Endometrial Cancer|progressive or recurrent endometrial cancer
550365|NCT00392769|Cetuximab|cetuximab
550366|NCT00392769|C225|c225
550367|NCT00392769|Erbitux™|erbitux™
550368|NCT00392769|IMC-C225|imc-c225
550369|NCT00392769|Epidermal growth factor receptor|epidermal growth factor receptor
550370|NCT00392769|EGFR|egfr
550371|NCT00392769|Endometrioid Tumor|endometrioid tumor
550372|NCT00392769|Serous Tumor|serous tumor
550373|NCT00392769|Clear cell Tumor|clear cell tumor
550374|NCT00392769|Mixed malignant Mullerian Tumors|mixed malignant mullerian tumors
550375|NCT00392782|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
550376|NCT00392782|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
550377|NCT00392782|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
550378|NCT00392782|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
550379|NCT00392782|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
550380|NCT00392782|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
550381|NCT00392782|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
550382|NCT00392782|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
550383|NCT00392782|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
550384|NCT00392782|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
550385|NCT00392782|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
550386|NCT00392782|secondary acute myeloid leukemia|secondary acute myeloid leukemia
550387|NCT00392782|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
550388|NCT00392782|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
550389|NCT00392782|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
550390|NCT00392782|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
550391|NCT00392782|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
550392|NCT00392795|Critical Care|critical care
550393|NCT00392795|Delirium|delirium
550394|NCT00392795|Long-term cognitive impairment|long-term cognitive impairment
550395|NCT00392795|mechanical ventilation|mechanical ventilation
550396|NCT00392795|Critical illness|critical illness
550397|NCT00392795|dementia|dementia
550398|NCT00392795|sedatives and analgesics|sedatives and analgesics
550399|NCT00392795|aging|aging
550400|NCT00392808|Meningococcal vaccine|meningococcal vaccine
550401|NCT00392808|Immunization, secondary|immunization, secondary
550402|NCT00392808|vaccines conjugated|vaccines conjugated
550403|NCT00392808|Meningococcal disease|meningococcal disease
550404|NCT00392834|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
550405|NCT00392834|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
550406|NCT00392834|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
549769|NCT00390520|vildagliptin|vildagliptin
550407|NCT00392834|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
550408|NCT00392834|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
550409|NCT00392834|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
550410|NCT00392847|Child mental disorder|child mental disorder
550411|NCT00392847|Home visit|home visit
550412|NCT00392847|Postnatal depression|postnatal depression
550413|NCT00392847|Social Support|social support
550414|NCT00392847|Random selection|random selection
550415|NCT00392860|Wheelchair|wheelchair
550416|NCT00392860|Handrims|handrims
550417|NCT00392860|Rehabilitation|rehabilitation
550418|NCT00392860|Upper extremity|upper extremity
550419|NCT00392873|Amenorrhea|amenorrhea
550420|NCT00392873|Energy deficiency|energy deficiency
550421|NCT00392873|Resting energy expenditure|resting energy expenditure
550422|NCT00392873|Bone metabolism|bone metabolism
550423|NCT00392873|Bone mineral density|bone mineral density
550424|NCT00392873|Exercise|exercise
550425|NCT00392886|untreated childhood medulloblastoma|untreated childhood medulloblastoma
585518|NCT00513110|AMPD1 polymorphism|ampd1 polymorphism
550426|NCT00392886|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
550427|NCT00392886|childhood infratentorial ependymoma|childhood infratentorial ependymoma
550428|NCT00392886|childhood supratentorial ependymoma|childhood supratentorial ependymoma
550429|NCT00392886|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
550430|NCT00392886|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
550685|NCT00393809|diphtheria toxin|diphtheria toxin
550431|NCT00392886|childhood oligodendroglioma|childhood oligodendroglioma
550432|NCT00392886|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
550433|NCT00392886|childhood choroid plexus tumor|childhood choroid plexus tumor
550434|NCT00392886|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
550435|NCT00392886|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
550436|NCT00392886|untreated childhood pineoblastoma|untreated childhood pineoblastoma
550437|NCT00392899|stage II colon cancer|stage ii colon cancer
550438|NCT00392899|stage II rectal cancer|stage ii rectal cancer
550439|NCT00392899|adenocarcinoma of the colon|adenocarcinoma of the colon
550440|NCT00392899|adenocarcinoma of the rectum|adenocarcinoma of the rectum
550441|NCT00392912|testosterone|testosterone
550442|NCT00392912|hypogonadal|hypogonadal
550443|NCT00392912|cerebral glucose metabolism|cerebral glucose metabolism
550444|NCT00392912|PET scan|pet scan
550445|NCT00392912|Alzheimer's disease|alzheimer's disease
550446|NCT00392925|overweight|overweight
550447|NCT00392925|obesity|obesity
550448|NCT00392925|pramlintide|pramlintide
550449|NCT00392925|leptin|leptin
550450|NCT00392925|Amylin|amylin
550451|NCT00392938|recurrent prostate cancer|recurrent prostate cancer
550452|NCT00392938|stage IV prostate cancer|stage iv prostate cancer
550453|NCT00392938|bone metastases|bone metastases
550454|NCT00392951|ALPS|alps
550455|NCT00392951|Autoimmune|autoimmune
550456|NCT00392951|Cytopenias|cytopenias
550457|NCT00392951|Treatment|treatment
550458|NCT00392951|Sirolimus|sirolimus
550459|NCT00392951|Rapamycin|rapamycin
550460|NCT00392951|Lymph Nodes|lymph nodes
550461|NCT00392951|Spleen|spleen
550462|NCT00392951|Hemolytic Anemia|hemolytic anemia
550463|NCT00392951|Immune Thrombocytopenia|immune thrombocytopenia
550464|NCT00392951|Neutropenia|neutropenia
550465|NCT00392951|ITP|itp
550466|NCT00392951|Lupus|lupus
550467|NCT00392964|Antacids|antacids
550468|NCT00392964|Proton pump inhibitors|proton pump inhibitors
550469|NCT00392964|aspirin|aspirin
550470|NCT00392964|ischemic heart disease|ischemic heart disease
550471|NCT00392964|Dyspepsia|dyspepsia
550472|NCT00392977|Manganese|manganese
550473|NCT00392977|Neonatal Intensive Care|neonatal intensive care
550474|NCT00392977|MRI|mri
550475|NCT00392977|Parenteral Nutrition|parenteral nutrition
550476|NCT00392977|Prematurity|prematurity
550477|NCT00392990|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
550478|NCT00392990|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
550479|NCT00392990|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
550480|NCT00392990|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
550481|NCT00392990|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
550482|NCT00392990|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
550483|NCT00393003|Anesthesia|anesthesia
550484|NCT00393003|Sedation|sedation
550485|NCT00393029|Tumor Regression|tumor regression
550486|NCT00393029|In Vivo Cell Survival|in vivo cell survival
550487|NCT00393029|Toxicity Profile|toxicity profile
550488|NCT00393029|Metastatic Renal Cell Cancer|metastatic renal cell cancer
550489|NCT00393029|Cancer|cancer
550490|NCT00393029|Metastatic Cancer|metastatic cancer
550491|NCT00393042|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
549872|NCT00390897|Glivec|glivec
550492|NCT00393042|sleep|sleep
550493|NCT00393042|side effects|side effects
550494|NCT00393042|stimulants|stimulants
550495|NCT00393094|Brain Tumor|brain tumor
550496|NCT00393094|Chemotherapy|chemotherapy
550497|NCT00393094|Progression|progression
550498|NCT00393094|Radiotherapy|radiotherapy
550499|NCT00393094|Antiangiogenesis|antiangiogenesis
550500|NCT00393094|Glioma|glioma
550501|NCT00393107|follicular lymphoma|follicular lymphoma
550502|NCT00393107|non-Hodgkin lymphoma|non-hodgkin lymphoma
550503|NCT00393107|Fludarabine|fludarabine
550504|NCT00393107|Cyclophosphamide|cyclophosphamide
550505|NCT00393107|Rituximab|rituximab
550506|NCT00393107|combination|combination
550507|NCT00393107|immuno-chemotherapy|immuno-chemotherapy
550508|NCT00393107|relapsed|relapsed
550509|NCT00393120|HIV-infection|hiv-infection
550510|NCT00393120|viral load|viral load
550511|NCT00393120|CCR5|ccr5
550512|NCT00393120|viral tropism|viral tropism
550513|NCT00393120|HIV-1 infection|hiv-1 infection
550514|NCT00393120|Treatment Naive|treatment naive
550515|NCT00393146|Rheumatoid arthritis|rheumatoid arthritis
550516|NCT00393146|MRI|mri
550517|NCT00393159|Effusion|effusion
550518|NCT00393159|Otitis|otitis
550519|NCT00393159|Media|media
550521|NCT00393159|Popper|popper
550522|NCT00393159|Children|children
550523|NCT00393172|exercise|exercise
550524|NCT00393172|breast cancer|breast cancer
550525|NCT00393172|prevention|prevention
550526|NCT00393172|obesity|obesity
550527|NCT00393172|estrogen metabolism|estrogen metabolism
550528|NCT00393172|oxidative stress|oxidative stress
550529|NCT00393172|IGF-1|igf-1
550530|NCT00393185|Immunosuppression|immunosuppression
550531|NCT00393185|Primary Biliary Cirrhosis|primary biliary cirrhosis
550532|NCT00393185|Allogeneic Hematopoietic Stem Cell|allogeneic hematopoietic stem cell
550533|NCT00393198|Intrauterine System|intrauterine system
550534|NCT00393198|Contraception|contraception
550535|NCT00393198|Menorrhagia|menorrhagia
550536|NCT00393224|Epidemiology|epidemiology
550537|NCT00393224|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
550538|NCT00393224|Genetic|genetic
550539|NCT00393224|Viruses|viruses
550540|NCT00393224|Cancer|cancer
550541|NCT00393224|NPC|npc
550542|NCT00393250|Hypnosis|hypnosis
550543|NCT00393250|Symptom Management|symptom management
550544|NCT00393250|Pain Management|pain management
550545|NCT00393250|Sickle Cell Disease|sickle cell disease
550546|NCT00393250|Pain|pain
550547|NCT00393276|Treatment Experienced|treatment experienced
550548|NCT00393276|Treatment Naive|treatment naive
550549|NCT00393276|Immunizations|immunizations
550550|NCT00393289|Calcium absorption|calcium absorption
550551|NCT00393289|D-vitamin status|d-vitamin status
550552|NCT00393289|Whole body calcium retention|whole body calcium retention
550553|NCT00393289|Calcium intake|calcium intake
550554|NCT00393289|PTH status|pth status
550555|NCT00393302|HIV testing in pregnant women|hiv testing in pregnant women
550556|NCT00393315|in stent restenosis|in stent restenosis
550557|NCT00393315|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
550558|NCT00393315|pepcad|pepcad
550559|NCT00393315|drug eluting balloon|drug eluting balloon
550560|NCT00393341|Breast Cancer|breast cancer
550561|NCT00393367|Asthma|asthma
550562|NCT00393367|Acute|acute
550563|NCT00393367|Treatment|treatment
550564|NCT00393367|Children|children
550565|NCT00393367|Pediatric|pediatric
550566|NCT00393367|Inhaled corticosteroid|inhaled corticosteroid
550567|NCT00393367|Budesonide|budesonide
550568|NCT00393367|Budesonide inhalation suspension|budesonide inhalation suspension
550569|NCT00393367|Asthma score|asthma score
550570|NCT00393367|Emergency|emergency
550571|NCT00393367|Emergency Department|emergency department
550572|NCT00393367|Asthma flare|asthma flare
550573|NCT00393367|Clinical trial|clinical trial
550574|NCT00393367|Randomized clinical trial|randomized clinical trial
550575|NCT00393367|Randomized trial|randomized trial
550576|NCT00393367|Pulmonary index score|pulmonary index score
550577|NCT00393367|Hospitalization|hospitalization
550578|NCT00393367|Moderate asthma|moderate asthma
550579|NCT00393367|Severe asthma|severe asthma
550580|NCT00393367|Mixing budesonide|mixing budesonide
550581|NCT00393367|Budesonide admixture|budesonide admixture
550582|NCT00393367|Albuterol|albuterol
550583|NCT00393367|Continuous albuterol|continuous albuterol
550584|NCT00393367|Ipratropium bromide|ipratropium bromide
550585|NCT00393380|Myelogenous Leukemia, Chronic|myelogenous leukemia, chronic
550586|NCT00393380|Myelodysplasia|myelodysplasia
550587|NCT00393380|Parathyroid Hormone|parathyroid hormone
550588|NCT00393380|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
550589|NCT00393393|osteoarthritis|osteoarthritis
550590|NCT00393393|knee|knee
550591|NCT00393393|hylan|hylan
550592|NCT00393406|Objective Risk|objective risk
550593|NCT00393406|Gail Model|gail model
550594|NCT00393406|Subjective Risk|subjective risk
550595|NCT00393406|Medical Risk-Reducing Strategies|medical risk-reducing strategies
550596|NCT00393406|Physical Activity, Diet, Alcohol Use|physical activity, diet, alcohol use
550597|NCT00393406|Breast Cancer Risk|breast cancer risk
550598|NCT00393419|hypertension|hypertension
550599|NCT00393419|hyperlipidemia|hyperlipidemia
550600|NCT00393419|adherence|adherence
550601|NCT00393419|pharmacist|pharmacist
550602|NCT00393419|elderly|elderly
550603|NCT00393419|medication|medication
550604|NCT00393432|Action Observation|action observation
550605|NCT00393432|Motor Memory|motor memory
550606|NCT00393432|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
552414|NCT00395135|Obesity|obesity
550607|NCT00393432|Use-Dependent Plasticity|use-dependent plasticity
550608|NCT00393432|Healthy Volunteer|healthy volunteer
550609|NCT00393432|HV|hv
550610|NCT00393445|GLP-1|glp-1
550611|NCT00393445|Exendin(9-39)|exendin(9-39)
550612|NCT00393445|Insulin|insulin
550613|NCT00393445|Glucagon|glucagon
550614|NCT00393445|Human physiology|human physiology
550615|NCT00393458|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
550616|NCT00393458|COPD|copd
550617|NCT00393458|indacaterol|indacaterol
550618|NCT00393458|long-acting β2 agonist|long-acting β2 agonist
550619|NCT00393471|Arthritis|arthritis
550620|NCT00393471|Rheumatoid|rheumatoid
550621|NCT00393471|Safety|safety
550622|NCT00393497|Breast Cancer|breast cancer
550623|NCT00393497|lymphedema|lymphedema
550624|NCT00393510|Diabetic Foot Ulcer|diabetic foot ulcer
550625|NCT00393510|Traditional Chinese Medicine|traditional chinese medicine
550626|NCT00393536|Depression|depression
550627|NCT00393536|Guidelines|guidelines
550628|NCT00393536|Educational outreach visiting|educational outreach visiting
550629|NCT00393536|Prescribing|prescribing
550630|NCT00393549|Median Neuropathy at the wrist (MNW)|median neuropathy at the wrist (mnw)
550631|NCT00393562|excessive sleepiness|excessive sleepiness
550632|NCT00393562|hypersomnolence|hypersomnolence
550633|NCT00393562|Parkinson's disease|parkinson's disease
550634|NCT00393575|HIV Prevention|hiv prevention
550635|NCT00393575|HIV positive communities|hiv positive communities
550636|NCT00393588|Brain|brain
550637|NCT00393588|Cognitive Deficits|cognitive deficits
550638|NCT00393588|Cognitive Testing|cognitive testing
550639|NCT00393588|MRI|mri
550640|NCT00393588|Multiple Sclerosis|multiple sclerosis
550641|NCT00393588|MS|ms
550642|NCT00393588|Healthy Volunteer|healthy volunteer
550643|NCT00393588|HV|hv
550644|NCT00393601|Cystectomy|cystectomy
550645|NCT00393614|CSWS, interiktal epileptiform activity|csws, interiktal epileptiform activity
550646|NCT00393627|Dementia|dementia
550647|NCT00393627|Sleep disturbance|sleep disturbance
550648|NCT00393627|Behavioral strategies|behavioral strategies
550649|NCT00393627|Alzheimer's Disease|alzheimer's disease
550650|NCT00393627|Adult Family Homes|adult family homes
550651|NCT00393640|Early Initiation of lactogenesis II|early initiation of lactogenesis ii
550652|NCT00393653|osteoarthritis|osteoarthritis
550653|NCT00393653|gastroesophageal reflux disease|gastroesophageal reflux disease
550654|NCT00393653|practice-based research|practice-based research
550655|NCT00393653|N-of-1 trial|n-of-1 trial
550656|NCT00393653|prescription|prescription
550657|NCT00393653|single-patient trial|single-patient trial
550658|NCT00393666|Absence|absence
550659|NCT00393666|Epilepsy|epilepsy
550660|NCT00393666|Seizure|seizure
550661|NCT00393666|Brain|brain
550662|NCT00393679|Children 6-59 months|children 6-59 months
550663|NCT00393679|P.falciparum|p.falciparum
550664|NCT00393679|Haemoglobin|haemoglobin
550665|NCT00393679|Informed consent|informed consent
550666|NCT00393679|ACT|act
550667|NCT00393692|Age-related macular degeneration|age-related macular degeneration
550668|NCT00393692|Geographic atrophy|geographic atrophy
550669|NCT00393692|drusen|drusen
550670|NCT00393705|diabetes|diabetes
550671|NCT00393705|type 2|type 2
550672|NCT00393731|labor|labor
550673|NCT00393731|induction|induction
550674|NCT00393731|misoprostol|misoprostol
550675|NCT00393731|oxytocin|oxytocin
550676|NCT00393757|Malaria, Plasmodium falciparum, Kenya|malaria, plasmodium falciparum, kenya
550677|NCT00393770|Risk of type 2 diabetes|risk of type 2 diabetes
550678|NCT00393783|Breast Cancer|breast cancer
550679|NCT00393783|Metastatic|metastatic
550680|NCT00393783|HER2|her2
550681|NCT00393783|04-101|04-101
550682|NCT00393809|transitional cell carcinoma|transitional cell carcinoma
550683|NCT00393809|H19 gene|h19 gene
550684|NCT00393809|plasmid|plasmid
550686|NCT00393822|KGF|kgf
550687|NCT00393822|Palifermin|palifermin
550688|NCT00393822|Oral Mucositis|oral mucositis
550689|NCT00393822|Clinical Trial|clinical trial
550690|NCT00393822|Amgen|amgen
550691|NCT00393822|Oncology|oncology
550692|NCT00393822|Colon Cancer|colon cancer
550693|NCT00393848|Hip Replacement Arthroplasty|hip replacement arthroplasty
550694|NCT00393848|Hip Replacement Surgery|hip replacement surgery
550695|NCT00393848|Hip Surgery|hip surgery
550696|NCT00393848|Hip Rehabilitation|hip rehabilitation
550697|NCT00393848|Avascular Necrosis|avascular necrosis
550698|NCT00393848|Knee replacement surgery|knee replacement surgery
550699|NCT00393848|Total knee arthroplasty|total knee arthroplasty
550700|NCT00393861|Germ Cell Tumor|germ cell tumor
550701|NCT00393861|Germ Cell Cancer|germ cell cancer
550702|NCT00393874|Anxiety D/O|anxiety d/o
550703|NCT00393874|Mood D/O|mood d/o
550704|NCT00393887|Inguinal hernia|inguinal hernia
550705|NCT00393887|polypropylene|polypropylene
550706|NCT00393887|Biodesign IHM|biodesign ihm
550707|NCT00393887|lichtenstein|lichtenstein
550708|NCT00393900|otitis media|otitis media
550709|NCT00393900|tympanostomy tube|tympanostomy tube
550710|NCT00393900|eustachian tube function|eustachian tube function
550711|NCT00393900|gas exchange|gas exchange
550712|NCT00393900|tympanostomy tubes|tympanostomy tubes
550713|NCT00393913|Sleep Apnea|sleep apnea
550714|NCT00393913|Sleep-Disordered Breathing|sleep-disordered breathing
550715|NCT00393913|Snoring|snoring
550716|NCT00393926|Robotics|robotics
550717|NCT00393926|Rehabilitation|rehabilitation
550718|NCT00393926|Upper Extremity|upper extremity
550719|NCT00393926|CVA|cva
550720|NCT00393939|advanced breast cancer|advanced breast cancer
550721|NCT00393939|sunitinib|sunitinib
550722|NCT00393939|docetaxel|docetaxel
550723|NCT00393939|Phase 3|phase 3
550724|NCT00393952|Asthma|asthma
550725|NCT00393952|Fluticasone Propionate|fluticasone propionate
550726|NCT00393952|Formoterol Fumarate|formoterol fumarate
550727|NCT00393952|Pressurized metered dose inhaler|pressurized metered dose inhaler
550728|NCT00393952|Hydrofluoroalkane|hydrofluoroalkane
550729|NCT00393952|Moderate-Severe Asthma|moderate-severe asthma
550730|NCT00393965|Metastases|metastases
550731|NCT00393965|Refractory|refractory
550732|NCT00393965|Brain|brain
550733|NCT00393978|Bipolar mania|bipolar mania
550734|NCT00393978|Cannabis consumption|cannabis consumption
550735|NCT00393991|Asthma|asthma
550736|NCT00393991|Fluticasone Propionate|fluticasone propionate
550737|NCT00393991|Formoterol Fumarate|formoterol fumarate
550738|NCT00393991|Pressurized metered dose inhaler|pressurized metered dose inhaler
550739|NCT00393991|Hydrofluoroalkane|hydrofluoroalkane
550740|NCT00393991|Mild to Moderate Asthma|mild to moderate asthma
550741|NCT00394004|Decision Making|decision making
550742|NCT00394004|Health Disparities|health disparities
550743|NCT00394004|Hispanic|hispanic
550744|NCT00394004|African-American|african-american
550745|NCT00394004|Clinical Trials|clinical trials
550746|NCT00394004|HIV Positive|hiv positive
550747|NCT00394017|Heading Health Plan Implementation|heading health plan implementation
550846|NCT00394316|Gene Therapy|gene therapy
550748|NCT00394017|Computer-Assisted Instruction|computer-assisted instruction
550749|NCT00394017|General Practice|general practice
550750|NCT00394017|Dementia|dementia
550751|NCT00394017|education|education
550752|NCT00394030|GSK716155 pharmacodynamics pharmacokinetics injection site|gsk716155 pharmacodynamics pharmacokinetics injection site
550753|NCT00394043|Carpal Tunnel Sydrome|carpal tunnel sydrome
550754|NCT00394043|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
550755|NCT00394043|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
550756|NCT00394043|Physical Medicine|physical medicine
550757|NCT00394056|placebo|placebo
550758|NCT00394056|balanced|balanced
550759|NCT00394056|paroxetine|paroxetine
550760|NCT00394056|repeated dose|repeated dose
550761|NCT00394056|Hearing Loss|hearing loss
550762|NCT00394056|loudness|loudness
550763|NCT00394056|combination|combination
550764|NCT00394056|Tinnitus|tinnitus
550765|NCT00394056|vestipitant (GW597599)|vestipitant (gw597599)
550766|NCT00394056|randomised|randomised
550767|NCT00394056|annoyance|annoyance
550768|NCT00394056|crossover|crossover
550769|NCT00394082|Metastatic breast cancer, Abraxane, Bevacizumab|metastatic breast cancer, abraxane, bevacizumab
550770|NCT00394095|Bipolar Disorder|bipolar disorder
550771|NCT00394095|Weight Gain|weight gain
550772|NCT00394121|Asthma|asthma
550773|NCT00394121|Fluticasone Propionate|fluticasone propionate
550774|NCT00394121|Formoterol Fumarate|formoterol fumarate
550775|NCT00394121|Pressurized metered does inhaler|pressurized metered does inhaler
550776|NCT00394121|Hydrofluoroalkane|hydrofluoroalkane
550777|NCT00394121|Mild to moderate-severe asthma|mild to moderate-severe asthma
550778|NCT00394134|Melanoma|melanoma
550779|NCT00394134|Sun Exposure|sun exposure
550780|NCT00394134|Sun Protection|sun protection
550781|NCT00394134|Interview|interview
550782|NCT00394147|advanced|advanced
550783|NCT00394147|head|head
550784|NCT00394147|neck|neck
550785|NCT00394147|cancer|cancer
550786|NCT00388427|advanced cancer|advanced cancer
550787|NCT00388427|solid tumor|solid tumor
550788|NCT00388427|solid malignancies|solid malignancies
550789|NCT00388427|phase I|phase i
550790|NCT00388440|Mumps|mumps
550791|NCT00388440|Singapore|singapore
550792|NCT00388440|Rubella|rubella
550793|NCT00388440|Measles|measles
550794|NCT00388453|Healthy volunteers|healthy volunteers
550795|NCT00388466|whole body vibration|whole body vibration
550796|NCT00388466|muscle function|muscle function
550797|NCT00388466|cystic fibrosis|cystic fibrosis
550798|NCT00388466|mechanography|mechanography
550799|NCT00388466|chair-rising-test|chair-rising-test
550800|NCT00388492|HIV Infected|hiv infected
550801|NCT00394173|IBS|ibs
550802|NCT00394173|diarrhea|diarrhea
550803|NCT00394173|gastrointestinal functional disorder|gastrointestinal functional disorder
550804|NCT00394173|IBS-D|ibs-d
550805|NCT00394186|GW427353|gw427353
550806|NCT00394186|b3-Adrenergic Receptor Agonist|b3-adrenergic receptor agonist
550807|NCT00394186|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
550808|NCT00394186|efficacy|efficacy
550809|NCT00394186|tolerability|tolerability
550810|NCT00394186|pharmacokinetics|pharmacokinetics
550811|NCT00394199|Asthma|asthma
550812|NCT00394199|Fluticasone Propionate|fluticasone propionate
550813|NCT00394199|formoterol fumarate|formoterol fumarate
550814|NCT00394199|Pressurized metered dose inhaler|pressurized metered dose inhaler
550815|NCT00394199|Hydrofluoroalkane|hydrofluoroalkane
550816|NCT00394199|Mild to Moderate Asthma|mild to moderate asthma
550817|NCT00394212|Weight Loss|weight loss
550818|NCT00394212|Transoral Suturing|transoral suturing
550819|NCT00394212|Dilated gastrojejunostomy|dilated gastrojejunostomy
550820|NCT00394212|Inadequate weight loss following primary RYGB|inadequate weight loss following primary rygb
550821|NCT00394225|6-Minute Walk Test|6-minute walk test
550822|NCT00394225|COPD|copd
550823|NCT00394225|Helium-Hyperoxia|helium-hyperoxia
550824|NCT00394225|Exercise|exercise
550825|NCT00394225|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
550826|NCT00394251|Adjuvant therapy|adjuvant therapy
550827|NCT00394251|Bevacizumab|bevacizumab
550828|NCT00394251|Abraxane|abraxane
550829|NCT00394251|Early stage breast cancer|early stage breast cancer
550830|NCT00394264|low back pain|low back pain
550831|NCT00394264|active duty military personnel|active duty military personnel
550832|NCT00394264|manual/manipulative therapy|manual/manipulative therapy
550833|NCT00394264|osteopathic manipulative treatment|osteopathic manipulative treatment
550834|NCT00394264|physical medicine|physical medicine
550835|NCT00394290|Down Syndrome|down syndrome
550836|NCT00394290|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
550837|NCT00394290|Continuous Positive Pressure|continuous positive pressure
550838|NCT00394290|Hypersomnia|hypersomnia
550839|NCT00394303|Open heart surgery|open heart surgery
550840|NCT00394303|Diabetes mellitus|diabetes mellitus
550841|NCT00394303|Hyperglycemia|hyperglycemia
550842|NCT00394303|Surgical site infection|surgical site infection
550843|NCT00394303|Normoglycemia|normoglycemia
550844|NCT00394316|CD34 Stem Cells|cd34 stem cells
550845|NCT00394316|Busulfan|busulfan
550847|NCT00394316|Immune Reconstitution|immune reconstitution
550848|NCT00394316|Engraftment|engraftment
550849|NCT00394316|Chronic Granulomatous Disease (CGD)|chronic granulomatous disease (cgd)
550850|NCT00394316|Gp91 Phox Deficiency|gp91 phox deficiency
550851|NCT00394316|Peripheral Blood Stem Cells|peripheral blood stem cells
550852|NCT00394316|Bone Marrow Transplantation|bone marrow transplantation
550853|NCT00394316|Chronic Granulomatous Disease|chronic granulomatous disease
550855|NCT00394368|asthma|asthma
550856|NCT00394368|combinations|combinations
550857|NCT00394368|inhaled therapy|inhaled therapy
550858|NCT00394368|corticosteroids|corticosteroids
550859|NCT00394368|long acting bronchodilators|long acting bronchodilators
550860|NCT00394368|salmeterol|salmeterol
550861|NCT00394368|beclomethasone|beclomethasone
550862|NCT00394368|formoterol|formoterol
550863|NCT00394368|fluticasone|fluticasone
550864|NCT00394381|acute myeloid leukemia|acute myeloid leukemia
550865|NCT00394381|myelodysplastic syndrome|myelodysplastic syndrome
550866|NCT00394381|autologous CIK cells|autologous cik cells
550867|NCT00394381|autologous peripheral blood stem cell transplant|autologous peripheral blood stem cell transplant
550868|NCT00394407|inpatient|inpatient
550869|NCT00394407|diabetes management|diabetes management
550870|NCT00394407|insulin therapy|insulin therapy
550871|NCT00394433|TPCA|tpca
550872|NCT00394433|Taxotere|taxotere
550873|NCT00394433|Platinum|platinum
550874|NCT00394433|Avastin|avastin
550875|NCT00394433|Camptosar|camptosar
550876|NCT00394433|gastric cancer|gastric cancer
550877|NCT00394446|Solid Tumors|solid tumors
550878|NCT00394446|Refractory|refractory
550879|NCT00394446|Brain|brain
550880|NCT00394459|Anaesthetic techniques|anaesthetic techniques
550881|NCT00394459|epidural|epidural
550882|NCT00394459|catheters|catheters
550883|NCT00394459|paraesthesia|paraesthesia
550884|NCT00394459|side effects|side effects
550885|NCT00394459|Anesthesia, Epidural [E03.155.086.131]|anesthesia, epidural [e03.155.086.131]
550886|NCT00394472|Heartburn|heartburn
550887|NCT00394472|Patient reported symptoms|patient reported symptoms
550888|NCT00394472|Proton pump inhibitor|proton pump inhibitor
550889|NCT00394485|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
550890|NCT00394485|Procaterol|procaterol
550891|NCT00394485|Tiotropium|tiotropium
550892|NCT00394498|Myocardial Infarction|myocardial infarction
550893|NCT00394498|Stem Cells|stem cells
752412|NCT01172912|recurrent extragonadal seminoma|recurrent extragonadal seminoma
710586|NCT01005342|rye|rye
550278|NCT00392509|PVD|pvd
550894|NCT00397449|Malaria, malaria vaccine, randomised, safety, immunogenicity|malaria, malaria vaccine, randomised, safety, immunogenicity
550895|NCT00397462|Osteoporosis|osteoporosis
550896|NCT00397462|Sarcopenia|sarcopenia
550897|NCT00397462|Calf muscle pump|calf muscle pump
550898|NCT00397462|Venous insufficiency|venous insufficiency
550899|NCT00397462|DEXA|dexa
550900|NCT00397462|Soleus muscle|soleus muscle
550901|NCT00397462|APG|apg
550902|NCT00397488|recurrent bladder cancer|recurrent bladder cancer
550903|NCT00397488|stage IV bladder cancer|stage iv bladder cancer
550904|NCT00397488|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
550905|NCT00397488|anterior urethral cancer|anterior urethral cancer
550906|NCT00397488|posterior urethral cancer|posterior urethral cancer
550907|NCT00397488|recurrent urethral cancer|recurrent urethral cancer
550908|NCT00397488|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
550909|NCT00397488|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
550910|NCT00397488|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
550911|NCT00397501|cognitive/functional effects|cognitive/functional effects
550912|NCT00397501|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
550913|NCT00397501|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
550914|NCT00397501|recurrent breast cancer|recurrent breast cancer
550915|NCT00397501|stage IV breast cancer|stage iv breast cancer
550916|NCT00397501|adult tumors metastatic to brain|adult tumors metastatic to brain
550917|NCT00397514|Biventricular pacing|biventricular pacing
550918|NCT00397514|Congenital heart disease|congenital heart disease
550919|NCT00397514|Tissue Doppler echocardiography|tissue doppler echocardiography
550921|NCT00397540|HCC|hcc
550922|NCT00397540|recurrence|recurrence
550923|NCT00397540|PEIT|peit
550924|NCT00397540|RFTA|rfta
550925|NCT00397566|HIV|hiv
550926|NCT00397566|Treatment Experienced|treatment experienced
550927|NCT00397579|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
550928|NCT00397579|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
550929|NCT00397579|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
550930|NCT00397579|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
550931|NCT00397579|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
550932|NCT00397579|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
550933|NCT00397579|secondary acute myeloid leukemia|secondary acute myeloid leukemia
551024|NCT00397995|Forearm|forearm
550934|NCT00397579|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
550935|NCT00397579|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
550936|NCT00397579|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
550937|NCT00397579|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
550938|NCT00397579|blastic plasmacytoid dendritic cell neoplasm|blastic plasmacytoid dendritic cell neoplasm
550939|NCT00397579|plasmacytoid dendritic cell leukemia|plasmacytoid dendritic cell leukemia
550940|NCT00397579|CD123+|cd123+
550941|NCT00397592|Growth Hormone|growth hormone
550942|NCT00397592|Cardiovascular System|cardiovascular system
550943|NCT00397592|Endothelial Progenitor Cells|endothelial progenitor cells
550944|NCT00397605|bipolar|bipolar
550945|NCT00397605|therapeutic potential|therapeutic potential
550946|NCT00397605|neurocognitive performance|neurocognitive performance
550947|NCT00397605|cannabinoids|cannabinoids
550948|NCT00397644|pediatrician|pediatrician
550949|NCT00397644|well-child care visit|well-child care visit
550950|NCT00397644|low-income children|low-income children
550951|NCT00397644|family psychosocial problem|family psychosocial problem
550952|NCT00397657|carotid intima media thickness|carotid intima media thickness
550953|NCT00397657|atherosclerosis|atherosclerosis
550955|NCT00397657|coronary heart disease|coronary heart disease
550956|NCT00397657|HDL-C|hdl-c
550957|NCT00397657|LDL-C|ldl-c
550958|NCT00397696|Parkinson|parkinson
550959|NCT00397696|imaging|imaging
550960|NCT00397696|nicotinic receptors|nicotinic receptors
550961|NCT00397709|Latent tuberculosis infection.|latent tuberculosis infection.
550962|NCT00397709|Isoniazid.|isoniazid.
550963|NCT00397709|Rifampin.|rifampin.
550964|NCT00397709|Clinical trial.|clinical trial.
550965|NCT00397709|treatment of latent tuberculosis infection|treatment of latent tuberculosis infection
550966|NCT00397722|safety|safety
550967|NCT00397722|outpatients with a diagnosis of Social Anxiety disorder (SocAD).|outpatients with a diagnosis of social anxiety disorder (socad).
550968|NCT00397722|effectiveness|effectiveness
550969|NCT00397735|pregnancy|pregnancy
550970|NCT00397735|chorioamnionitis|chorioamnionitis
550971|NCT00397735|preterm labor|preterm labor
550972|NCT00397735|preterm premature rupture of the membranes|preterm premature rupture of the membranes
550342|NCT00392717|cardiovascular disease|cardiovascular disease
550343|NCT00392717|obesity|obesity
550344|NCT00392730|Manganese|manganese
550345|NCT00392730|Neonatal Intensive Care|neonatal intensive care
550346|NCT00392730|MRI|mri
550973|NCT00397735|Intra-amniotic infection|intra-amniotic infection
550974|NCT00397735|Intra-amniotic inflammation|intra-amniotic inflammation
550975|NCT00397748|Phospholipase A2|phospholipase a2
550976|NCT00397748|D2 Receptors|d2 receptors
550977|NCT00397748|Apomorphine|apomorphine
550978|NCT00397748|Trimethobenzamide|trimethobenzamide
550979|NCT00397748|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
550980|NCT00397748|ADHD|adhd
550981|NCT00397748|Healthy Volunteer|healthy volunteer
550982|NCT00397748|HV|hv
550983|NCT00397761|inflammatory breast cancer|inflammatory breast cancer
550984|NCT00397761|stage II breast cancer|stage ii breast cancer
550985|NCT00397761|stage IIIA breast cancer|stage iiia breast cancer
550986|NCT00397761|stage IIIB breast cancer|stage iiib breast cancer
550987|NCT00397774|Palliative care|palliative care
550988|NCT00397774|Physical exercise|physical exercise
550989|NCT00397774|Physical function|physical function
550990|NCT00397800|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
550991|NCT00397800|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
550992|NCT00397800|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
550993|NCT00397800|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
550994|NCT00397800|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
550995|NCT00397800|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
550996|NCT00397800|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
550997|NCT00397800|splenic marginal zone lymphoma|splenic marginal zone lymphoma
550998|NCT00397839|male osteoporosis|male osteoporosis
550999|NCT00397839|osteoporosis|osteoporosis
551000|NCT00397839|bisphonates|bisphonates
551001|NCT00397839|bone|bone
551002|NCT00397852|Fracture|fracture
551003|NCT00397852|Forearm|forearm
551004|NCT00397852|Distal|distal
551005|NCT00397852|Child|child
551006|NCT00397852|Treatment|treatment
551007|NCT00397865|Obesity|obesity
551008|NCT00397865|Overweight|overweight
551009|NCT00397904|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
551010|NCT00397904|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
551011|NCT00397904|recurrent esophageal cancer|recurrent esophageal cancer
551012|NCT00397904|recurrent gastric cancer|recurrent gastric cancer
551013|NCT00397904|adenocarcinoma of the stomach|adenocarcinoma of the stomach
551014|NCT00397904|stage IV esophageal cancer|stage iv esophageal cancer
551015|NCT00397904|stage IV gastric cancer|stage iv gastric cancer
551016|NCT00397930|cancer-related sleep disturbance|cancer-related sleep disturbance
551017|NCT00397930|fatigue|fatigue
551018|NCT00397930|sleep disorders|sleep disorders
551019|NCT00397943|Tuberculosis|tuberculosis
551020|NCT00397969|colon cancer|colon cancer
551021|NCT00397969|rectal cancer|rectal cancer
551022|NCT00397969|precancerous condition|precancerous condition
551023|NCT00397995|Fracture|fracture
551027|NCT00397995|Treatment|treatment
551028|NCT00398008|Buprenorphine|buprenorphine
551029|NCT00398008|Naltrexone|naltrexone
551030|NCT00398008|HIV risk reduction behavior|hiv risk reduction behavior
551031|NCT00398008|Counseling|counseling
551032|NCT00398008|HIV Seronegativity|hiv seronegativity
551033|NCT00398021|constipation|constipation
551034|NCT00398021|bowel habits|bowel habits
551035|NCT00398034|opioids|opioids
551036|NCT00398034|pain|pain
551037|NCT00398034|hypogonadism|hypogonadism
551038|NCT00398034|depression|depression
551039|NCT00398034|fatigue|fatigue
551040|NCT00398034|cognition|cognition
551041|NCT00398034|libido|libido
551042|NCT00398047|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
551043|NCT00398047|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
551044|NCT00398047|refractory anemia with excess blasts|refractory anemia with excess blasts
551045|NCT00398047|refractory anemia|refractory anemia
551046|NCT00398047|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
551047|NCT00398047|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
551048|NCT00398047|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
551049|NCT00398047|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
551050|NCT00398060|life-style counseling|life-style counseling
551051|NCT00398060|type 2 diabetes|type 2 diabetes
551052|NCT00398060|prediabetes|prediabetes
551053|NCT00398060|physical activity|physical activity
551054|NCT00398060|diet|diet
551055|NCT00398060|cognitive-behavioral|cognitive-behavioral
551056|NCT00398073|stage II melanoma|stage ii melanoma
551057|NCT00398073|stage III melanoma|stage iii melanoma
551058|NCT00398073|stage IV melanoma|stage iv melanoma
551059|NCT00398073|recurrent melanoma|recurrent melanoma
551060|NCT00398073|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
551061|NCT00398073|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
551062|NCT00398073|recurrent intraocular melanoma|recurrent intraocular melanoma
551063|NCT00398073|metastatic intraocular melanoma|metastatic intraocular melanoma
551064|NCT00398086|Metastatic Pancreatic Cancer, Abraxane, Gemcitabine|metastatic pancreatic cancer, abraxane, gemcitabine
551065|NCT00398125|GSK364735|gsk364735
551066|NCT00398125|HIV-1|hiv-1
551067|NCT00398125|integrase inhibitor|integrase inhibitor
551068|NCT00398138|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
551069|NCT00398138|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
551070|NCT00398138|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
551071|NCT00398138|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
551072|NCT00398138|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
551073|NCT00398138|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
551074|NCT00398138|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
551169|NCT00398528|Multiple Sclerosis|multiple sclerosis
551075|NCT00398138|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
551076|NCT00398138|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
551077|NCT00398138|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
551078|NCT00398138|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
551079|NCT00398138|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
551080|NCT00398138|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
551081|NCT00398138|advanced malignant mesothelioma|advanced malignant mesothelioma
551082|NCT00398138|recurrent malignant mesothelioma|recurrent malignant mesothelioma
551083|NCT00398138|primary peritoneal cavity cancer|primary peritoneal cavity cancer
551084|NCT00398190|Smoking|smoking
551085|NCT00398190|Tobacco use disorder|tobacco use disorder
551086|NCT00398203|NaviAid™ BGE Device|naviaid™ bge device
551087|NCT00398203|Small Intestine|small intestine
551088|NCT00398203|Intestinal Diseases|intestinal diseases
551089|NCT00398216|Anti-coagulant|anti-coagulant
551090|NCT00398216|hip replacement|hip replacement
551091|NCT00398216|hip replacement surgery|hip replacement surgery
551092|NCT00398216|unilateral hip replacement surgery|unilateral hip replacement surgery
551093|NCT00398216|DeepVein Thrombosis|deepvein thrombosis
551094|NCT00398216|Venous Thromboembolism|venous thromboembolism
551095|NCT00398216|pulmonary embolism|pulmonary embolism
551096|NCT00398216|Prevention of Blood Clots|prevention of blood clots
551097|NCT00398229|In-Vitro Fertilization|in-vitro fertilization
551098|NCT00398229|human chorionic gonadotropin|human chorionic gonadotropin
551099|NCT00398229|frozen-thawed embryo transfer|frozen-thawed embryo transfer
551100|NCT00398229|implantation rate|implantation rate
551101|NCT00398242|fracture|fracture
551102|NCT00398242|forearm|forearm
551103|NCT00398242|midshaft|midshaft
551104|NCT00398242|child|child
551105|NCT00398242|treatment|treatment
551106|NCT00398255|arthritis|arthritis
551107|NCT00398255|self management|self management
551108|NCT00398255|patient education|patient education
551109|NCT00398268|Fracture|fracture
551110|NCT00398268|Forearm|forearm
551111|NCT00398268|Distal|distal
551112|NCT00398268|Child|child
551113|NCT00398268|Treatment|treatment
551114|NCT00398281|prostate cancer|prostate cancer
551115|NCT00398307|Renal Impairment|renal impairment
551116|NCT00398333|Colorectal Neoplasms|colorectal neoplasms
551117|NCT00398333|Eicosapentaenoic Acid|eicosapentaenoic acid
551118|NCT00398333|Quality of Life|quality of life
551119|NCT00398333|Nutritional Status|nutritional status
551120|NCT00398359|Obesity|obesity
551121|NCT00398359|Overweight|overweight
551122|NCT00398359|Children|children
551123|NCT00398359|Behavioral|behavioral
551124|NCT00398359|Motivational|motivational
551125|NCT00398359|Family|family
551126|NCT00398359|Primary care|primary care
551127|NCT00398385|squamous cell lung cancer|squamous cell lung cancer
551128|NCT00398385|adenocarcinoma of the lung|adenocarcinoma of the lung
551129|NCT00398385|adenosquamous cell lung cancer|adenosquamous cell lung cancer
551130|NCT00398385|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
551131|NCT00398385|large cell lung cancer|large cell lung cancer
551132|NCT00398385|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
551133|NCT00398385|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
551134|NCT00398385|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
551135|NCT00398398|gastric cancer|gastric cancer
551136|NCT00398398|chemotherapy|chemotherapy
551138|NCT00398398|capecitabine|capecitabine
551139|NCT00398398|oxaliplatin|oxaliplatin
551140|NCT00398411|prophylaxis|prophylaxis
551141|NCT00398411|bacteremia|bacteremia
551142|NCT00398411|moxifloxacin|moxifloxacin
551143|NCT00398411|stem cell transplantation|stem cell transplantation
550520|NCT00393159|Ear|ear
551144|NCT00398411|Hodgkin disease|hodgkin disease
551145|NCT00398411|non-Hodgkin lymphoma|non-hodgkin lymphoma
551146|NCT00398411|multiple myeloma|multiple myeloma
551147|NCT00398411|solid tumor|solid tumor
551148|NCT00398411|autologous stem cell transplantation|autologous stem cell transplantation
551149|NCT00398424|Impaired Hepatic Function|impaired hepatic function
551150|NCT00398437|tumors metastatic to brain|tumors metastatic to brain
551151|NCT00398437|stage IV breast cancer|stage iv breast cancer
551152|NCT00398450|recurrent melanoma|recurrent melanoma
551153|NCT00398450|stage IV melanoma|stage iv melanoma
551154|NCT00398463|tirofiban|tirofiban
551155|NCT00398463|aspirin resistance|aspirin resistance
551156|NCT00398463|clopidogrel resistance|clopidogrel resistance
551157|NCT00398476|taste|taste
551158|NCT00398476|questionnaire|questionnaire
551159|NCT00398476|preference|preference
551160|NCT00398476|attributes|attributes
551161|NCT00398476|odor|odor
551162|NCT00398476|after taste|after taste
551163|NCT00398476|scent|scent
551164|NCT00398489|stage IIIA breast cancer|stage iiia breast cancer
551165|NCT00398489|stage IIIB breast cancer|stage iiib breast cancer
551166|NCT00398489|stage IIIC breast cancer|stage iiic breast cancer
551167|NCT00398489|stage II breast cancer|stage ii breast cancer
551168|NCT00398489|inflammatory breast cancer|inflammatory breast cancer
551670|NCT00402129|Ethnic Skin|ethnic skin
551170|NCT00398528|Disease Modifying Therapy|disease modifying therapy
551171|NCT00398554|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
551172|NCT00398554|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
551173|NCT00398554|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
551174|NCT00398554|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
551175|NCT00398554|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
551176|NCT00398554|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
551177|NCT00398554|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
551178|NCT00398567|HKI-272|hki-272
551179|NCT00398567|neratinib|neratinib
551180|NCT00398567|trastuzumab|trastuzumab
551181|NCT00398567|Herceptin|herceptin
551182|NCT00398567|breast cancer|breast cancer
551184|NCT00398580|Testosterone|testosterone
551185|NCT00398580|Hypogonadism|hypogonadism
551186|NCT00398580|Dutasteride|dutasteride
551187|NCT00398580|Androgen deficiency|androgen deficiency
551188|NCT00398593|Adherence with therapy|adherence with therapy
551189|NCT00398593|Adherence enhancing intervention|adherence enhancing intervention
551190|NCT00398593|Nonadherence|nonadherence
551191|NCT00398593|Ulcerative colitis|ulcerative colitis
551192|NCT00398645|GW685698X|gw685698x
551193|NCT00398645|Adults|adults
551194|NCT00398645|Pharmacokinetics|pharmacokinetics
551195|NCT00398645|Pharmacogenetics|pharmacogenetics
551196|NCT00398645|Asthma|asthma
551197|NCT00398645|Adolescents|adolescents
551198|NCT00398658|Endophthalmitis|endophthalmitis
551199|NCT00398658|Post-traumatic Endophthalmitis|post-traumatic endophthalmitis
551200|NCT00398658|Bacterial Endophthalmitis|bacterial endophthalmitis
551201|NCT00398658|Prophylaxis of Endophthalmitis|prophylaxis of endophthalmitis
551202|NCT00398658|Intra Ocular Injection of antibiotics|intra ocular injection of antibiotics
551203|NCT00398671|primary successful cardio-pulmonary resuscitation|primary successful cardio-pulmonary resuscitation
551204|NCT00398671|pre-hospital setting|pre-hospital setting
551205|NCT00398684|Thailand|thailand
551206|NCT00398684|Developing countries|developing countries
551207|NCT00398684|prophylaxis|prophylaxis
551208|NCT00398684|mother to child transmission|mother to child transmission
551209|NCT00398684|HIV-1|hiv-1
551210|NCT00398684|HIV-1 infection|hiv-1 infection
551211|NCT00398684|HIV Seronegativity|hiv seronegativity
551212|NCT00398697|perifosine|perifosine
551213|NCT00398697|gemcitabine|gemcitabine
551214|NCT00398710|Waldenström's Macroglobulinemia|waldenström's macroglobulinemia
551215|NCT00398710|Perifosine|perifosine
551216|NCT00398723|Narrowband UBV Phototherapy|narrowband ubv phototherapy
551217|NCT00398723|Skin biopsies|skin biopsies
551218|NCT00398736|Presence of severe sepsis and septic shock, mechanical ventilation|presence of severe sepsis and septic shock, mechanical ventilation
551219|NCT00398749|Anemia|anemia
551220|NCT00398749|Neoplasms|neoplasms
551221|NCT00398749|Antineoplastic agents|antineoplastic agents
551222|NCT00398749|Chemotherapy|chemotherapy
551223|NCT00398749|Efficacy|efficacy
551224|NCT00398749|Epoetin alfa|epoetin alfa
551225|NCT00398775|procalcitonin guided antibiotic discontinuation|procalcitonin guided antibiotic discontinuation
551226|NCT00398775|fever of unknown origin|fever of unknown origin
551227|NCT00398788|Pain|pain
551228|NCT00398801|gastroparesis|gastroparesis
551229|NCT00398814|Perifosine|perifosine
551230|NCT00398814|Sorafenib|sorafenib
551231|NCT00398814|Renal cancer|renal cancer
551232|NCT00398814|Hepatocellular cancer|hepatocellular cancer
551233|NCT00398814|other advanced solid tumors|other advanced solid tumors
551234|NCT00398827|American Society of Anesthesiologists (ASA)|american society of anesthesiologists (asa)
551235|NCT00398827|Observer's Assessment of Alertness Scale (OAA/S)|observer's assessment of alertness scale (oaa/s)
551236|NCT00398827|Aldrete Scoring System|aldrete scoring system
551237|NCT00398827|Surgery or procedure using monitored care anesthesia|surgery or procedure using monitored care anesthesia
551238|NCT00398827|Surgery or procedure at least 30 minutes in duration|surgery or procedure at least 30 minutes in duration
551239|NCT00398840|Cancer|cancer
551240|NCT00398840|Solid Tumors|solid tumors
551241|NCT00398840|advanced solid tumors|advanced solid tumors
551242|NCT00398853|insulin|insulin
551243|NCT00398853|glucose|glucose
551244|NCT00398853|chromium|chromium
551245|NCT00398866|Hyaluronan|hyaluronan
551246|NCT00398866|Carpometacarpal|carpometacarpal
551247|NCT00398866|Outcomes|outcomes
551248|NCT00398866|Carpometacarpal Joints|carpometacarpal joints
551249|NCT00398879|Capecitabine|capecitabine
551250|NCT00398892|Type 2 diabetes mellitus|type 2 diabetes mellitus
551251|NCT00398892|Glycaemic control|glycaemic control
551252|NCT00398892|Lipoic acid|lipoic acid
551253|NCT00398892|Diabetic nephropathy|diabetic nephropathy
551254|NCT00398905|Prevention of venous thromboembolism|prevention of venous thromboembolism
551255|NCT00398944|Guideline based decision support system, Hypertension, Diabetes|guideline based decision support system, hypertension, diabetes
551256|NCT00398957|Analgesia|analgesia
551257|NCT00398970|Endobronchial ultrasonography|endobronchial ultrasonography
551258|NCT00398970|Fluoroscopy|fluoroscopy
551259|NCT00398970|Guide sheath|guide sheath
551260|NCT00398970|Peripheral pulmonary lesion|peripheral pulmonary lesion
551261|NCT00398970|Transbronchial biopsy|transbronchial biopsy
551262|NCT00398983|Acute Myelogenous Leukemia|acute myelogenous leukemia
551263|NCT00398983|AML|aml
551264|NCT00398983|Remission|remission
551265|NCT00398983|Decitabine|decitabine
551266|NCT00398983|Maintenance Therapy|maintenance therapy
551267|NCT00398996|antiretroviral therapy|antiretroviral therapy
551269|NCT00398996|Opportunistic infections|opportunistic infections
551270|NCT00398996|CD4|cd4
551271|NCT00398996|Viral load|viral load
551272|NCT00398996|TB/HIV co infection|tb/hiv co infection
551273|NCT00398996|Treatment Naive|treatment naive
551274|NCT00399009|Circular stapling devices|circular stapling devices
551275|NCT00399009|anastomotic leak|anastomotic leak
551276|NCT00399009|anastomotic dehiscence|anastomotic dehiscence
551277|NCT00399009|rectal cancer|rectal cancer
551278|NCT00399035|Colorectal Cancer|colorectal cancer
551279|NCT00399035|Cediranib|cediranib
551280|NCT00399035|RECENTIN|recentin
551281|NCT00399048|Pain|pain
551282|NCT00399048|Osteoarthritis|osteoarthritis
551283|NCT00399048|knee Osteoarthritis|knee osteoarthritis
551284|NCT00399048|hip Osteoarthritis .|hip osteoarthritis .
551285|NCT00399074|Sickle Cell anemia|sickle cell anemia
551286|NCT00399074|Malaria|malaria
551287|NCT00399074|Presumptive treatment|presumptive treatment
551288|NCT00399074|Sulfadoxine- pyrimethamine|sulfadoxine- pyrimethamine
551289|NCT00399074|Children|children
551290|NCT00399074|Uganda|uganda
551291|NCT00399152|Perifosine|perifosine
551292|NCT00399152|Sunitinib Malate|sunitinib malate
551293|NCT00399152|Renal cancer|renal cancer
551294|NCT00399152|GIST|gist
551295|NCT00399152|advanced cancers|advanced cancers
551296|NCT00399165|Oral Contraception for Men|oral contraception for men
551297|NCT00399165|Contraceptive agent|contraceptive agent
551298|NCT00399178|Osteoarthritis|osteoarthritis
551299|NCT00399178|Norspan versus Tramadol|norspan versus tramadol
551300|NCT00399178|Randomised|randomised
551301|NCT00399178|Efficacy and safety|efficacy and safety
551302|NCT00399178|OA pain of the hip and/or knee|oa pain of the hip and/or knee
551303|NCT00399191|anemia|anemia
551304|NCT00399191|iron deficiency anemia|iron deficiency anemia
551305|NCT00399191|iron deficiency|iron deficiency
551306|NCT00399191|absorption|absorption
551307|NCT00399191|iron absorption|iron absorption
551308|NCT00399191|iron uptake|iron uptake
551309|NCT00399217|subcutaneous ICD|subcutaneous icd
551310|NCT00399217|ICD|icd
551311|NCT00399217|DFT|dft
551312|NCT00399217|Pacing threshold|pacing threshold
551313|NCT00399217|Polarity|polarity
551314|NCT00399243|cluster headache|cluster headache
551315|NCT00399243|sumatriptan|sumatriptan
551316|NCT00399256|contrast-induced nephropathy|contrast-induced nephropathy
551317|NCT00399256|Acetylcysteine|acetylcysteine
551318|NCT00399256|Zinc|zinc
551319|NCT00399256|Cystatin C|cystatin c
551320|NCT00399256|Creatinine|creatinine
551321|NCT00399269|Anemia|anemia
551322|NCT00399282|Rheumatoid arthritis|rheumatoid arthritis
551323|NCT00399282|Health related quality of life|health related quality of life
551324|NCT00399282|Omega 3 fatty acids|omega 3 fatty acids
551325|NCT00399282|Vitamin E|vitamin e
551326|NCT00399295|Analgesia|analgesia
551327|NCT00399308|wound|wound
551328|NCT00399308|leg|leg
551329|NCT00399308|venous|venous
551330|NCT00399308|chronic|chronic
551331|NCT00399308|wound healing|wound healing
551332|NCT00399321|Post menopause women receiving adjuvant care|post menopause women receiving adjuvant care
551333|NCT00399334|Schizophrenia|schizophrenia
551334|NCT00399334|Schizoaffective|schizoaffective
551335|NCT00399334|relapse|relapse
551336|NCT00399334|risk factors|risk factors
551337|NCT00399334|Observational study|observational study
551338|NCT00399334|Antipsychotic medication|antipsychotic medication
551339|NCT00399347|Diabetes Mellitus, prevalence , Ethiopians Jews, Israel|diabetes mellitus, prevalence , ethiopians jews, israel
551340|NCT00399360|HIV|hiv
551341|NCT00399360|Metabolic Syndrome|metabolic syndrome
551342|NCT00399360|Lifestyle Modification|lifestyle modification
551343|NCT00399360|Metformin|metformin
551344|NCT00399360|Treatment Experienced|treatment experienced
551345|NCT00399373|disease management|disease management
551346|NCT00399373|substance abuse|substance abuse
551347|NCT00399386|S ICD|s icd
551348|NCT00399386|ICD|icd
551349|NCT00399386|Ablation|ablation
551350|NCT00399386|EP study|ep study
551351|NCT00399386|Paediatric|paediatric
551352|NCT00399386|ECG|ecg
551353|NCT00399399|Churg-Strauss|churg-strauss
551354|NCT00399399|Vasculitis|vasculitis
551355|NCT00399399|Therapy|therapy
551356|NCT00399399|Cyclophosphamide|cyclophosphamide
551357|NCT00399399|Azathioprine|azathioprine
551358|NCT00399412|S-ICD|s-icd
551359|NCT00399412|ICD|icd
551360|NCT00399412|ECG signals|ecg signals
551361|NCT00399412|Resting|resting
551362|NCT00399425|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
551363|NCT00399425|Bemiparin|bemiparin
551364|NCT00399425|Foot Ulcer, Diabetic|foot ulcer, diabetic
551365|NCT00399425|Diabetic Angiopathies|diabetic angiopathies
551366|NCT00399425|Primary Health Care|primary health care
551671|NCT00402129|Laser|laser
551367|NCT00399438|Diarrhea-predominant irritable bowel syndrome|diarrhea-predominant irritable bowel syndrome
551368|NCT00399451|Sleep Apnea,Obstructive|sleep apnea,obstructive
551369|NCT00399451|apnea-hypopnea index (AHI)|apnea-hypopnea index (ahi)
551370|NCT00399451|polidocanol|polidocanol
551371|NCT00399451|sclerotherapy|sclerotherapy
551372|NCT00399451|pharynges|pharynges
551373|NCT00399464|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
551374|NCT00399464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
551375|NCT00399464|alfuzosin|alfuzosin
551376|NCT00399490|Monoclonal antibody|monoclonal antibody
551377|NCT00399503|Noninvasive assessment|noninvasive assessment
551378|NCT00399503|Combined parameter|combined parameter
551379|NCT00399503|Holter|holter
551380|NCT00399516|Pain|pain
551381|NCT00399516|Neurostimulation|neurostimulation
551382|NCT00399516|Back pain|back pain
551383|NCT00399516|Chronic Pain|chronic pain
551384|NCT00399529|Stage IV HER-2/neu overexpressing breast cancer|stage iv her-2/neu overexpressing breast cancer
551385|NCT00399542|Irritable Bowel Syndrome With Constipation|irritable bowel syndrome with constipation
551386|NCT00399555|Single Ventricle|single ventricle
551387|NCT00399555|Hypoplastic Left Heart|hypoplastic left heart
551388|NCT00399555|Developmental|developmental
551389|NCT00399568|Pain|pain
551390|NCT00399568|Gynecologic|gynecologic
551391|NCT00399568|IV Acetaminophen|iv acetaminophen
551392|NCT00399568|Postoperative|postoperative
551393|NCT00399568|Analgesic|analgesic
551394|NCT00399581|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
551395|NCT00399581|Acute Lung Injury|acute lung injury
551396|NCT00399581|Mechanical Ventilation|mechanical ventilation
551397|NCT00399581|Lung|lung
551398|NCT00399594|Mechanical dyssynchrony|mechanical dyssynchrony
551399|NCT00399594|Biventricular pacing|biventricular pacing
551400|NCT00399594|Cardiac resynchronization therapy|cardiac resynchronization therapy
551401|NCT00399607|colonic neoplasms|colonic neoplasms
551402|NCT00399607|colorectal adenoma|colorectal adenoma
551403|NCT00399607|calcium|calcium
551404|NCT00399607|vitamin D|vitamin d
551504|NCT00391417|estrogen|estrogen
551405|NCT00399620|Periodontitis|periodontitis
551406|NCT00399620|Diabetes|diabetes
551407|NCT00399620|Gingival crevicular fluid|gingival crevicular fluid
551409|NCT00399620|Saliva|saliva
551410|NCT00399620|Chromogranin|chromogranin
551411|NCT00399620|Electrophorèse|electrophorèse
551412|NCT00399620|Western Blot|western blot
551413|NCT00399620|RT-HPLC|rt-hplc
551414|NCT00399633|VIP|vip
551415|NCT00399633|PACAP|pacap
551416|NCT00399633|CGRP|cgrp
551417|NCT00399633|Prostanoids|prostanoids
551418|NCT00399659|Opioid, constipation, tegaserod|opioid, constipation, tegaserod
551419|NCT00399672|HCV|hcv
551420|NCT00399672|injection drug users|injection drug users
551421|NCT00399672|ribavirin|ribavirin
551422|NCT00399672|pegylated interferon|pegylated interferon
551423|NCT00399672|illicit drug users|illicit drug users
551425|NCT00399698|Severe conduct problems|severe conduct problems
551426|NCT00399698|Risperidone|risperidone
551427|NCT00399698|Risperdal|risperdal
551428|NCT00399737|ACE activity|ace activity
551429|NCT00399737|Fermented milk peptides|fermented milk peptides
551430|NCT00399737|Healthy male volunteers|healthy male volunteers
551431|NCT00399763|Adolescent|adolescent
551432|NCT00399763|ADHD|adhd
551433|NCT00399763|SUD|sud
551434|NCT00399776|bone mineral|bone mineral
550854|NCT00394316|CGD|cgd
551435|NCT00399776|antipsychotic therapy|antipsychotic therapy
551436|NCT00399776|bone mineral accrual|bone mineral accrual
551437|NCT00399776|bone mineral content|bone mineral content
551438|NCT00399789|Non-Small-Cell Lung|non-small-cell lung
551439|NCT00399789|Perifosine|perifosine
551440|NCT00399815|Chronic viral hepatitis C|chronic viral hepatitis c
551441|NCT00399815|HCV RNA|hcv rna
551442|NCT00399815|Fibroscan|fibroscan
551443|NCT00399815|Fibrotest|fibrotest
551444|NCT00399815|hepatic elastography by MRI|hepatic elastography by mri
551445|NCT00399841|Pain|pain
551446|NCT00399841|Chronic Pain|chronic pain
551447|NCT00399841|Neurostimulation|neurostimulation
551448|NCT00399867|multiple myeloma|multiple myeloma
551449|NCT00399867|refractory|refractory
551450|NCT00399867|cell adhesion mediated drug resistance|cell adhesion mediated drug resistance
551451|NCT00399880|Clinical Trial|clinical trial
551452|NCT00399880|Behavioral/Social|behavioral/social
551453|NCT00399880|Cardiovascular Disease|cardiovascular disease
551454|NCT00399880|Risk Factors/Analysis|risk factors/analysis
551455|NCT00399893|Childhood obesity|childhood obesity
551456|NCT00399893|Prader-Willi Syndrome|prader-willi syndrome
551457|NCT00399893|Octreotide|octreotide
551458|NCT00399893|Ghrelin|ghrelin
551459|NCT00399893|Weight loss|weight loss
551460|NCT00399893|Body composition|body composition
551461|NCT00399893|Energy expenditure|energy expenditure
551462|NCT00399919|Perhipheral Artery Disease|perhipheral artery disease
551463|NCT00399919|Claudication|claudication
551464|NCT00399919|Exercise|exercise
551465|NCT00399919|Intermittent Claudication due to Peripheral Artery Disease|intermittent claudication due to peripheral artery disease
551466|NCT00399932|metabolic syndrome|metabolic syndrome
551467|NCT00399932|insulin resistance|insulin resistance
551468|NCT00399932|NASH|nash
551469|NCT00399932|hepatic fibrosis|hepatic fibrosis
551470|NCT00399932|Fibroscan|fibroscan
551471|NCT00399932|elastography by MRI|elastography by mri
551472|NCT00399945|Cystic fibrosis, tobramycin, PARI eFlow, PARI LC Plus, nebulizer, pharmacoscintigraphy|cystic fibrosis, tobramycin, pari eflow, pari lc plus, nebulizer, pharmacoscintigraphy
551473|NCT00399971|Idiopathic Aplastic Anemia|idiopathic aplastic anemia
551474|NCT00399971|Has Failed Conventional Immunosuppressive Therapy|has failed conventional immunosuppressive therapy
551475|NCT00399971|Not Eligible For Bone Marrow Transplantation|not eligible for bone marrow transplantation
551476|NCT00399971|C15.378.071.085|c15.378.071.085
551477|NCT00391352|Multiple Sclerosis|multiple sclerosis
551478|NCT00391352|Disease Modifying Therapy|disease modifying therapy
551479|NCT00391365|ankle osteoarthritis|ankle osteoarthritis
551480|NCT00391365|arthritis|arthritis
551481|NCT00391365|arthrodesis|arthrodesis
551482|NCT00391365|arthroplasty|arthroplasty
551483|NCT00391365|Gait|gait
551484|NCT00391365|step count|step count
551485|NCT00391365|walking|walking
551486|NCT00391378|Diffusion-Weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
551487|NCT00391378|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
551488|NCT00391378|Stroke|stroke
551489|NCT00391378|Cognition|cognition
551490|NCT00391378|Heart|heart
551491|NCT00391391|Influenza|influenza
551492|NCT00391391|Orthomyxoviruses|orthomyxoviruses
551493|NCT00391391|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
551494|NCT00391391|Infants|infants
551495|NCT00391391|children.|children.
551496|NCT00391404|Childhood cancer survivors|childhood cancer survivors
551497|NCT00391404|Osteoporosis|osteoporosis
551498|NCT00391404|Bone mineral density|bone mineral density
551499|NCT00391404|Therapy|therapy
551500|NCT00391404|Bisphosphonate|bisphosphonate
551501|NCT00391404|Randomized controlled trial|randomized controlled trial
551502|NCT00391417|hot flush|hot flush
551503|NCT00391417|hot flash|hot flash
551505|NCT00391417|vaginal atrophy|vaginal atrophy
551506|NCT00391430|PTSD|ptsd
551507|NCT00391430|Trauma|trauma
551508|NCT00391430|Sexual Abuse|sexual abuse
551509|NCT00391430|Sexual Assault|sexual assault
551510|NCT00391443|BUILD 3|build 3
551511|NCT00391443|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
551512|NCT00391443|Tracleer|tracleer
551513|NCT00391443|Interstitial Lung Disease|interstitial lung disease
551514|NCT00391443|bosentan|bosentan
551515|NCT00391443|Actelion|actelion
551516|NCT00391456|animal-assisted therapy|animal-assisted therapy
551517|NCT00391456|dog hospital visit|dog hospital visit
551518|NCT00391456|heart failure|heart failure
551519|NCT00391469|cardiac arrest|cardiac arrest
551520|NCT00391469|mild hypothermia|mild hypothermia
551408|NCT00399620|GCF|gcf
551521|NCT00391482|IV Drug Users|iv drug users
551522|NCT00391482|Hepatitis C Virus|hepatitis c virus
551523|NCT00391482|Human Immunodeficiency Virus|human immunodeficiency virus
551524|NCT00391482|Intervention|intervention
551525|NCT00391482|HIV Seronegativity|hiv seronegativity
551527|NCT00391495|Cytokines|cytokines
551528|NCT00391495|CR-P|cr-p
551529|NCT00391508|Ostomy|ostomy
551530|NCT00391508|Peristomal skin|peristomal skin
711438|NCT01007331|IgE|ige
550920|NCT00397540|HBV DNA|hbv dna
551531|NCT00391508|Skin complication|skin complication
551532|NCT00391521|Oncology. All solid Tumour disease.|oncology. all solid tumour disease.
551533|NCT00391534|Epilepsy|epilepsy
551534|NCT00391534|oxcarbazepine|oxcarbazepine
551535|NCT00391547|Gingivitis Disease|gingivitis disease
551536|NCT00391560|refractory leukemia|refractory leukemia
551537|NCT00391586|erlotinib|erlotinib
551538|NCT00391586|NSCLC|nsclc
551539|NCT00391586|chemotherapy|chemotherapy
551540|NCT00391586|platinum|platinum
551541|NCT00391586|lung|lung
551542|NCT00391586|lung cancer|lung cancer
551543|NCT00391599|Cesarean Section,|cesarean section,
551544|NCT00391599|Enema|enema
551545|NCT00391612|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
551546|NCT00391612|Emphysema|emphysema
551547|NCT00391612|Hyperinflation|hyperinflation
551548|NCT00391612|Minimally Invasive|minimally invasive
551549|NCT00399984|Continuing Medical Education|continuing medical education
551550|NCT00399997|Exercise|exercise
551551|NCT00399997|Exercise referral|exercise referral
551552|NCT00399997|Lifestyle diseases|lifestyle diseases
551553|NCT00399997|Sedentary behavior|sedentary behavior
551554|NCT00400010|Expert system|expert system
551555|NCT00400010|Transtheoretical Model of Behavior Change|transtheoretical model of behavior change
551556|NCT00400010|Brief intervention|brief intervention
551557|NCT00400010|General hospital|general hospital
551558|NCT00400023|Advanced Solid Tumors|advanced solid tumors
551559|NCT00400036|cod protein|cod protein
551560|NCT00400036|insulin sensitivity|insulin sensitivity
551561|NCT00400036|plasma lipids|plasma lipids
551562|NCT00400036|glucose tolerance|glucose tolerance
551563|NCT00400036|plasma inflammatory markers|plasma inflammatory markers
551672|NCT00402129|Photobiology|photobiology
551564|NCT00400036|skeletal muscle insulin signaling|skeletal muscle insulin signaling
551565|NCT00400036|type 2 diabetes|type 2 diabetes
551566|NCT00400036|humans|humans
551567|NCT00400062|Critical care|critical care
551568|NCT00400062|delirium|delirium
551569|NCT00400062|long-term cognitive impairment|long-term cognitive impairment
551570|NCT00400062|mechanical ventilation|mechanical ventilation
551571|NCT00400062|critical illness|critical illness
551572|NCT00400062|dementia|dementia
551573|NCT00400062|aging|aging
551574|NCT00400062|sedatives and analgesics|sedatives and analgesics
551575|NCT00400075|Polyarteritis|polyarteritis
551576|NCT00400075|Vasculitis|vasculitis
551577|NCT00400075|Therapy|therapy
551578|NCT00400075|Cyclophosphamide|cyclophosphamide
551579|NCT00400075|Azathioprine|azathioprine
551580|NCT00400088|Major Depressive Disorder|major depressive disorder
551581|NCT00400088|Depression|depression
551582|NCT00400088|Bipolar Disorder|bipolar disorder
551583|NCT00400088|Manic Depressive Illness|manic depressive illness
551584|NCT00400088|Randomized Trial|randomized trial
551585|NCT00400088|Antidepressant Treatment|antidepressant treatment
551586|NCT00400088|Lithium Treatment|lithium treatment
551587|NCT00400101|Malaria|malaria
551588|NCT00400101|Vaccine|vaccine
551589|NCT00400101|Plasmodium|plasmodium
551590|NCT00400101|falciparum|falciparum
551591|NCT00400101|Phase I|phase i
551592|NCT00400101|Peptide|peptide
551593|NCT00400101|Virosome|virosome
551594|NCT00400101|safety|safety
551595|NCT00400101|immunogenicity|immunogenicity
551596|NCT00400114|esophageal|esophageal
551597|NCT00400114|esophagus|esophagus
551598|NCT00400114|cancer|cancer
551599|NCT00400114|sutent|sutent
551600|NCT00400114|sunitinib|sunitinib
551601|NCT00400127|transfemoral amputee|transfemoral amputee
551602|NCT00400127|silicon suspension|silicon suspension
551603|NCT00400127|balance|balance
551604|NCT00400127|gait|gait
551605|NCT00400140|Myopia, defocus|myopia, defocus
551606|NCT00400166|Peer support|peer support
551607|NCT00400166|Psychiatric disability|psychiatric disability
551608|NCT00400166|Mutual support|mutual support
551609|NCT00400166|Psychiatric Rehabilitation|psychiatric rehabilitation
551610|NCT00400179|Gastric Cancer|gastric cancer
551611|NCT00400192|Microchimerism|microchimerism
551612|NCT00400192|Injuries|injuries
551613|NCT00400192|Leukocytes|leukocytes
551614|NCT00400192|Immunologic Techniques|immunologic techniques
551615|NCT00400205|Squamous Cell Carcinoma of the Oral Cavity|squamous cell carcinoma of the oral cavity
551616|NCT00400231|metabolic syndrome|metabolic syndrome
551617|NCT00400231|Triglycerides|triglycerides
551618|NCT00400231|Insulin Resistance|insulin resistance
551619|NCT00400231|inflammation|inflammation
551620|NCT00400231|Cardiovascular Disease|cardiovascular disease
551621|NCT00400231|Elevated triglycerides|elevated triglycerides
551622|NCT00400231|without diabetes|without diabetes
551624|NCT00400244|skills|skills
551625|NCT00400244|french|french
551626|NCT00400257|Heart Failure|heart failure
551627|NCT00400257|BNP|bnp
551628|NCT00400270|Asthma|asthma
551629|NCT00400270|Randomised controlled trial|randomised controlled trial
551630|NCT00400270|Breathing exercises|breathing exercises
551631|NCT00400270|Relaxation exercises|relaxation exercises
551632|NCT00400270|Primary care|primary care
551633|NCT00400322|glioblastoma multiforme|glioblastoma multiforme
551634|NCT00400322|cytomegalovirus infection|cytomegalovirus infection
551635|NCT00400322|antiviral treatment|antiviral treatment
551636|NCT00400322|valganciclovir|valganciclovir
551637|NCT00401986|Refractory Asthma|refractory asthma
551638|NCT00401986|Bronchial Thermoplasty|bronchial thermoplasty
551639|NCT00401986|Alair System|alair system
551640|NCT00401986|RISA (Research in Severe Asthma)|risa (research in severe asthma)
551641|NCT00401999|PET|pet
551642|NCT00401999|C-11 Raclopride|c-11 raclopride
551643|NCT00401999|Dopamine|dopamine
551644|NCT00401999|OPRM1|oprm1
551645|NCT00401999|Alcohol|alcohol
551646|NCT00401999|Healthy Volunteer|healthy volunteer
551647|NCT00401999|HV|hv
551648|NCT00402012|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
551649|NCT00402025|Metastatic|metastatic
551650|NCT00402025|Pancreas|pancreas
551651|NCT00402025|Adenocarcinoma|adenocarcinoma
551652|NCT00402064|bisphosphonates|bisphosphonates
551653|NCT00402064|children|children
551654|NCT00402064|dental|dental
551655|NCT00402064|Osteomyelitis|osteomyelitis
551656|NCT00402064|medication|medication
551657|NCT00402077|overweight|overweight
551658|NCT00402077|obesity|obesity
551659|NCT00402077|pramlintide|pramlintide
551660|NCT00402077|Symlin|symlin
551661|NCT00402077|sibutramine|sibutramine
551662|NCT00402077|Meridia|meridia
551663|NCT00402077|phentermine|phentermine
551664|NCT00402077|Amylin|amylin
551665|NCT00402090|thiopurines|thiopurines
551666|NCT00402090|thiopurine methyl transferase|thiopurine methyl transferase
551667|NCT00402090|toxicity|toxicity
551668|NCT00402090|pharmacogenomics|pharmacogenomics
551669|NCT00402103|Hypertension, aliskiren, amlodipine, HCTZ, blood pressure|hypertension, aliskiren, amlodipine, hctz, blood pressure
551673|NCT00402129|Quality of life|quality of life
551674|NCT00402142|HIV Infection|hiv infection
551675|NCT00402142|Dendritic cell vaccine|dendritic cell vaccine
551676|NCT00402142|Autologous virus|autologous virus
551677|NCT00402142|Heat inactivated|heat inactivated
551678|NCT00402142|HIV Therapeutic Vaccine|hiv therapeutic vaccine
551679|NCT00402155|electroretinogram|electroretinogram
551680|NCT00402155|visual evoked potential|visual evoked potential
551681|NCT00402155|contrast sensitivity|contrast sensitivity
551682|NCT00402181|Myeloma|myeloma
551683|NCT00402181|Intravenous|intravenous
551684|NCT00402181|Monoclonal antibody|monoclonal antibody
551685|NCT00402181|Siltuximab|siltuximab
551686|NCT00402181|Dexamethasone|dexamethasone
551687|NCT00402181|CNTO 328|cnto 328
551688|NCT00402194|Obesity|obesity
551689|NCT00402194|Insulin resistance|insulin resistance
551690|NCT00402194|Impaired glucose tolerance|impaired glucose tolerance
551691|NCT00402194|pre-diabetes|pre-diabetes
551692|NCT00402207|asthma|asthma
551693|NCT00402207|non-invasive inflammometry|non-invasive inflammometry
551694|NCT00402207|exhaled nitric oxide|exhaled nitric oxide
551695|NCT00402207|exhaled breath condensate|exhaled breath condensate
551696|NCT00402207|paediatric|paediatric
551697|NCT00402207|extrafine HFA-beclomethasone|extrafine hfa-beclomethasone
551698|NCT00402207|HFA-fluticasone|hfa-fluticasone
551699|NCT00402246|Randomized Controlled Trials|randomized controlled trials
551700|NCT00402246|Defibrillators|defibrillators
551701|NCT00402246|Remote Consultation|remote consultation
551702|NCT00402259|acute non-variceal upper gastrointestinal bleeding|acute non-variceal upper gastrointestinal bleeding
551703|NCT00402272|drug eluting stents|drug eluting stents
551704|NCT00402272|stents|stents
551705|NCT00402272|Angioplasty|angioplasty
551706|NCT00402272|coronary artery disease|coronary artery disease
551707|NCT00402272|total coronary occlusion|total coronary occlusion
551708|NCT00402272|coronary artery restenosis|coronary artery restenosis
551709|NCT00402272|stent thrombosis|stent thrombosis
551807|NCT00402545|C-TPF|c-tpf
551710|NCT00402272|vascular disease|vascular disease
551711|NCT00402272|myocardial ischemia|myocardial ischemia
551712|NCT00402272|coronary artery stenosis|coronary artery stenosis
551713|NCT00402285|adenocarcinoma of the prostate|adenocarcinoma of the prostate
551714|NCT00402285|stage I prostate cancer|stage i prostate cancer
551715|NCT00402285|stage IIB prostate cancer|stage iib prostate cancer
551716|NCT00402285|stage IIA prostate cancer|stage iia prostate cancer
551717|NCT00402298|PTSD|ptsd
551718|NCT00402298|MDMA|mdma
551719|NCT00402298|psychotherapy|psychotherapy
551720|NCT00402298|Posttraumatic stress disorder|posttraumatic stress disorder
551721|NCT00402298|Israel|israel
551722|NCT00402311|Health Services for the Aged|health services for the aged
551723|NCT00402311|Geriatric Psychiatry|geriatric psychiatry
551724|NCT00402324|Mixed episode associated with Bipolar I|mixed episode associated with bipolar i
551725|NCT00402337|Constipation|constipation
551726|NCT00402337|Chronic Constipation|chronic constipation
551727|NCT00402337|Microbia|microbia
551728|NCT00402337|linaclotide|linaclotide
551729|NCT00402337|linaclotide acetate|linaclotide acetate
551730|NCT00402337|MD-1100|md-1100
551731|NCT00402350|Staccato Fentanyl, Pharmacokinetics, Pharmacodynamics, inhaled fentanyl|staccato fentanyl, pharmacokinetics, pharmacodynamics, inhaled fentanyl
551732|NCT00402363|Lovaza|lovaza
551733|NCT00402363|Omega-3 fatty acids|omega-3 fatty acids
551734|NCT00402363|Omacor|omacor
551735|NCT00402363|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
551736|NCT00402376|End-stage heart failure|end-stage heart failure
551737|NCT00402376|heart failure;|heart failure;
551738|NCT00402376|ventricular assist device;|ventricular assist device;
551739|NCT00402376|statin;|statin;
551740|NCT00402376|heart transplantation;|heart transplantation;
551741|NCT00402376|myocardial function;|myocardial function;
551742|NCT00402376|mitochondrial respiratory function;|mitochondrial respiratory function;
551743|NCT00402389|Perinatal Depression|perinatal depression
551744|NCT00402389|Postpartum Depression|postpartum depression
551745|NCT00402389|Omega-3 Fatty Acids|omega-3 fatty acids
551746|NCT00402389|Eicosapentaenoic Acid (EPA)|eicosapentaenoic acid (epa)
551747|NCT00402389|Docosahexaenoic Acid (DHA)|docosahexaenoic acid (dha)
551748|NCT00402389|Pregnancy|pregnancy
551749|NCT00402389|Psychotherapy|psychotherapy
551750|NCT00402402|Tuberculin skin test|tuberculin skin test
551751|NCT00402402|Quantiferon-TB Gold assay|quantiferon-tb gold assay
551752|NCT00402402|Chronic liver disease|chronic liver disease
551753|NCT00402402|Liver transplantation|liver transplantation
551754|NCT00402402|Latent tuberculosis infection|latent tuberculosis infection
551755|NCT00402415|metastatic|metastatic
551756|NCT00402415|malignancy|malignancy
551757|NCT00402415|advanced solid tumors|advanced solid tumors
551758|NCT00402415|unresectable|unresectable
551759|NCT00402415|Solid Tumors|solid tumors
551760|NCT00402428|Chronic Hepatitis C|chronic hepatitis c
551761|NCT00402428|Hepatitis C|hepatitis c
551762|NCT00402428|CHC|chc
551763|NCT00402428|HepC|hepc
551764|NCT00402428|Genotype 1|genotype 1
551765|NCT00402428|Hepatitis|hepatitis
551766|NCT00402428|HCV|hcv
551767|NCT00402454|HIV|hiv
552250|NCT00404092|caspofungin|caspofungin
551768|NCT00402454|Tuberculosis|tuberculosis
551769|NCT00402454|Prophylaxis|prophylaxis
551770|NCT00402454|AIDS|aids
551771|NCT00402467|Prevention of venous thromboembolism|prevention of venous thromboembolism
551772|NCT00402480|Sickle Cell Anemia with Elevated TCD flow velocity|sickle cell anemia with elevated tcd flow velocity
551773|NCT00402493|Glaucoma|glaucoma
551774|NCT00402493|Ocular Hypertension|ocular hypertension
551775|NCT00402493|Xalatan|xalatan
551776|NCT00402493|Alpahgan|alpahgan
551777|NCT00402493|Ibuprofen|ibuprofen
551778|NCT00402493|Non-Steroidal Anti-Inflammatory|non-steroidal anti-inflammatory
551779|NCT00402493|Brimonidine|brimonidine
551780|NCT00402493|Latanoprost|latanoprost
551781|NCT00402493|Eye Pressure|eye pressure
551782|NCT00402493|Intra-Ocular Pressure|intra-ocular pressure
551783|NCT00402506|coronary|coronary
551784|NCT00402506|surgery|surgery
551785|NCT00402506|ischemia|ischemia
551786|NCT00402506|reperfusion injury|reperfusion injury
551787|NCT00402506|cardiac|cardiac
551788|NCT00402506|heart|heart
551789|NCT00402506|neurological|neurological
551790|NCT00402506|cardiopulmonary bypass|cardiopulmonary bypass
551791|NCT00402506|cardioprotection|cardioprotection
551792|NCT00402506|myocardium|myocardium
551793|NCT00402506|myocardial|myocardial
551794|NCT00402506|myocardial revascularization|myocardial revascularization
551795|NCT00402519|accelerated partial breast irradiation|accelerated partial breast irradiation
551796|NCT00402519|multicatheter brachytherapy|multicatheter brachytherapy
551797|NCT00402519|high dose rate brachytherapy|high dose rate brachytherapy
551798|NCT00402519|pulsed dose rate brachytherapy|pulsed dose rate brachytherapy
551799|NCT00402532|Lung Transplantation|lung transplantation
551800|NCT00402532|Immunosuppression|immunosuppression
551801|NCT00402532|Mortality|mortality
551802|NCT00402532|Graft rejection|graft rejection
551803|NCT00402532|Bronchiolitis obliterans|bronchiolitis obliterans
551804|NCT00402532|Opportunistic infections|opportunistic infections
551805|NCT00402532|Nephrotoxicity|nephrotoxicity
551806|NCT00402545|SCCHN|scchn
551808|NCT00402545|5-FU|5-fu
551809|NCT00402545|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
551810|NCT00402558|Acute Myeloid Leukemia|acute myeloid leukemia
551811|NCT00402558|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
551812|NCT00402558|Myelodysplastic Syndrome|myelodysplastic syndrome
551813|NCT00402558|Leukemia|leukemia
551814|NCT00402558|NK Cells|nk cells
551815|NCT00402558|Natural Killer Cells|natural killer cells
551816|NCT00402558|Fludarabine|fludarabine
551817|NCT00402558|Busulfan|busulfan
551818|NCT00402558|Thymoglobulin|thymoglobulin
551819|NCT00402558|AML|aml
551820|NCT00402558|CML|cml
551821|NCT00402558|MDS|mds
551822|NCT00402558|ATG|atg
551823|NCT00402558|Antithymocyte globulin|antithymocyte globulin
551824|NCT00402558|Busulfex|busulfex
551825|NCT00402558|Myleran®|myleran®
551826|NCT00402558|Fludarabine Phosphate|fludarabine phosphate
551827|NCT00402558|G-CSF|g-csf
551828|NCT00402558|Filgrastim|filgrastim
551829|NCT00402558|Neupogen|neupogen
551830|NCT00402558|Interleukin-2|interleukin-2
551831|NCT00402558|IL-2|il-2
551832|NCT00402558|Aldesleukin|aldesleukin
551833|NCT00402558|Proleukin|proleukin
551834|NCT00402558|Tacrolimus|tacrolimus
551835|NCT00402558|Prograf|prograf
551836|NCT00402558|Methotrexate|methotrexate
551837|NCT00402571|acetaminophen|acetaminophen
551838|NCT00402571|alcohol|alcohol
551839|NCT00402571|liver injury|liver injury
551840|NCT00402597|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
551841|NCT00402597|Myocardial Ischemia|myocardial ischemia
551842|NCT00402597|Rivaroxaban (BAY59-7939)|rivaroxaban (bay59-7939)
551843|NCT00402597|Anti-platelet agents|anti-platelet agents
551844|NCT00402597|Aspirin|aspirin
551845|NCT00402597|Thienopyridine|thienopyridine
551846|NCT00402597|Clopidogrel|clopidogrel
551847|NCT00402610|HIV|hiv
551848|NCT00402610|Tuberculosis|tuberculosis
551849|NCT00402610|Chemoprophylaxis|chemoprophylaxis
551850|NCT00402610|Anergy|anergy
551851|NCT00402610|AIDS|aids
551852|NCT00402623|sarcoidosis|sarcoidosis
551853|NCT00402623|quercetin|quercetin
551854|NCT00402623|supplementation|supplementation
551855|NCT00402623|oxidative stress|oxidative stress
551856|NCT00402623|inflammation|inflammation
551857|NCT00402649|influenza, A/H5N1, avian influenza, vaccine|influenza, a/h5n1, avian influenza, vaccine
551858|NCT00402662|everolimus|everolimus
551859|NCT00402662|imatinib|imatinib
551860|NCT00402675|NSTEMI|nstemi
551861|NCT00402675|infarction|infarction
551862|NCT00402675|treatment|treatment
551863|NCT00402675|percutaneous coronary intervention|percutaneous coronary intervention
551864|NCT00402675|non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
551865|NCT00402688|Chronic Prostatitis|chronic prostatitis
551866|NCT00402688|Prostatitis|prostatitis
551867|NCT00402688|levofloxacin|levofloxacin
551868|NCT00402688|Levaquin|levaquin
551869|NCT00402701|walking|walking
551870|NCT00402701|motor activity|motor activity
551872|NCT00402701|schools|schools
551873|NCT00402701|transportation|transportation
551874|NCT00402701|motor vehicles|motor vehicles
551875|NCT00402714|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
551876|NCT00402740|Carotid|carotid
551877|NCT00402740|Artery|artery
551878|NCT00402740|Disease|disease
551879|NCT00402740|Stent|stent
551880|NCT00402740|PROTECT|protect
551881|NCT00402740|XACT|xact
551882|NCT00402740|EMBOSHIELD|emboshield
551883|NCT00402753|Cancer, Exercise, Health Related Quality of Life, PBSCT|cancer, exercise, health related quality of life, pbsct
551884|NCT00402766|Mesothelioma|mesothelioma
551885|NCT00402766|Pleural Mesothelioma|pleural mesothelioma
551886|NCT00402766|Peritoneal Mesothelioma|peritoneal mesothelioma
551887|NCT00402766|PDGF-R|pdgf-r
551888|NCT00402766|Pemetrexed|pemetrexed
551889|NCT00402766|Alimta|alimta
551890|NCT00402766|Cisplatin|cisplatin
551891|NCT00402766|Imatinib Mesylate|imatinib mesylate
551892|NCT00402766|Gleevec|gleevec
551893|NCT00402766|Platinol|platinol
551894|NCT00402766|Platinol-AQ|platinol-aq
551895|NCT00402766|CDDP|cddp
551896|NCT00402766|Ly231514|ly231514
551897|NCT00402766|Multitargeted Antifolate|multitargeted antifolate
551898|NCT00402766|NSC-698037|nsc-698037
551899|NCT00402766|STI571|sti571
551900|NCT00402766|NSSC-716051|nssc-716051
551901|NCT00402779|Oral Cancer|oral cancer
551902|NCT00402779|Oral IEN Lesion with LOH|oral ien lesion with loh
551903|NCT00402779|Loss of Heterozygosity|loss of heterozygosity
551904|NCT00402779|Intraepithelial Neoplasia|intraepithelial neoplasia
551905|NCT00402779|Placebo|placebo
551906|NCT00402779|Erlotinib|erlotinib
551907|NCT00402779|Tarceva|tarceva
551908|NCT00402779|OSI-774|osi-774
551909|NCT00402792|Acute pain following bunionectomy surgery|acute pain following bunionectomy surgery
551910|NCT00402805|Influenza vaccine|influenza vaccine
551911|NCT00402805|Intradermal|intradermal
551912|NCT00402805|Lung transplantation|lung transplantation
551913|NCT00402818|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
551914|NCT00402844|Multicenter|multicenter
551915|NCT00402844|Pelvic organ prolapse|pelvic organ prolapse
551916|NCT00402844|Prospective|prospective
551917|NCT00402844|Transvaginal mesh|transvaginal mesh
551918|NCT00402857|Parenting Education|parenting education
551919|NCT00402857|Child, Preschool|child, preschool
551920|NCT00402857|Preventive Intervention|preventive intervention
551921|NCT00402857|Primary Health Care|primary health care
551922|NCT00402857|Pediatrics|pediatrics
551923|NCT00402857|Attention Deficit Disorders|attention deficit disorders
551924|NCT00402857|Oppositional Defiant Disorder|oppositional defiant disorder
551925|NCT00402857|Disruptive Behavior Disorder|disruptive behavior disorder
551926|NCT00402896|Lung Cancer|lung cancer
551927|NCT00402896|Non-Small Cell Lung Cancer|non-small cell lung cancer
551928|NCT00402896|Pleural Effusion|pleural effusion
551929|NCT00402896|Indwelling Intrapleural Denver Catheter|indwelling intrapleural denver catheter
551930|NCT00402896|ZD6474|zd6474
551268|NCT00398996|HIV|hiv
551931|NCT00402896|Vascular Endothelial Growth Factor Receptor|vascular endothelial growth factor receptor
551932|NCT00402896|VEGFR|vegfr
551933|NCT00402896|Epidermal Growth factor Receptor|epidermal growth factor receptor
551934|NCT00402896|EGFR|egfr
551935|NCT00402896|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
551936|NCT00402909|Type 2 diabetes,|type 2 diabetes,
551937|NCT00402909|fasting glucose,|fasting glucose,
551938|NCT00402909|postprandial glucose,|postprandial glucose,
551939|NCT00402909|blood sugar,|blood sugar,
551940|NCT00402909|HbA1c,|hba1c,
551941|NCT00402909|insulin,|insulin,
551942|NCT00402909|glargine,|glargine,
551943|NCT00402909|metformin,|metformin,
551944|NCT00402909|thiazolidinedione|thiazolidinedione
551945|NCT00402922|Coronary Heart Disease|coronary heart disease
551946|NCT00402935|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
551947|NCT00402935|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
551948|NCT00402935|sexual dysfunction and infertility|sexual dysfunction and infertility
551949|NCT00402935|sexuality and reproductive issues|sexuality and reproductive issues
551950|NCT00402935|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
551951|NCT00402935|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
551952|NCT00402935|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
551953|NCT00402935|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
551954|NCT00402935|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
551955|NCT00402935|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
551956|NCT00402935|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
551957|NCT00402935|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
551958|NCT00402935|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
551959|NCT00402935|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
551960|NCT00402935|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
551961|NCT00402935|secondary acute myeloid leukemia|secondary acute myeloid leukemia
552415|NCT00395135|Weight loss|weight loss
551962|NCT00402935|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
551963|NCT00402935|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
551964|NCT00402935|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
551965|NCT00402935|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
551966|NCT00402935|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
551967|NCT00402935|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
551968|NCT00402935|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
551969|NCT00402935|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
551970|NCT00402935|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
551971|NCT00402935|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
551972|NCT00402935|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
551973|NCT00402935|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
551974|NCT00402935|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
551975|NCT00402935|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
551976|NCT00402935|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
551977|NCT00402935|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
551978|NCT00402935|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
551979|NCT00402935|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
551980|NCT00402948|High eosinophils level in sputum|high eosinophils level in sputum
551981|NCT00402961|Acupuncture|acupuncture
551982|NCT00402961|Post-Colectomy Ileus|post-colectomy ileus
551983|NCT00402961|Abdominal Surgery|abdominal surgery
551984|NCT00402961|Colon Surgery|colon surgery
551985|NCT00402974|osteocalcin|osteocalcin
551986|NCT00402974|vitamin K|vitamin k
551987|NCT00402974|carboxylation|carboxylation
551988|NCT00402974|healthy children|healthy children
551989|NCT00402987|sore throat|sore throat
551990|NCT00402987|acute pain|acute pain
551991|NCT00403000|recurrent prostate cancer|recurrent prostate cancer
551992|NCT00403013|nerve block/*methods|nerve block/*methods
551993|NCT00403013|Anesthetics, Local/pharmacokinetics|anesthetics, local/pharmacokinetics
551994|NCT00403013|*Brachial Plexus|*brachial plexus
551995|NCT00403026|Bevacizumab (Avastin)|bevacizumab (avastin)
551996|NCT00403026|Intravitreal injection|intravitreal injection
551998|NCT00403026|CRVO|crvo
551999|NCT00403026|BRVO|brvo
552001|NCT00403026|CNVM|cnvm
552002|NCT00403039|Central Retinal Vein Occlusion|central retinal vein occlusion
552003|NCT00403052|colorectal|colorectal
552004|NCT00403052|cancer|cancer
552005|NCT00403052|carcinoma|carcinoma
552006|NCT00403052|metastatic|metastatic
552007|NCT00403052|colon|colon
552008|NCT00403052|rectal|rectal
552010|NCT00403052|cetuximab|cetuximab
552011|NCT00403052|irinotecan|irinotecan
552012|NCT00403052|1018 ISS|1018 iss
552013|NCT00403052|combination therapy|combination therapy
552014|NCT00403065|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
552015|NCT00403065|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
552016|NCT00403065|tumors metastatic to brain|tumors metastatic to brain
552017|NCT00403078|Carotid Artery Stenting (Endovascular)|carotid artery stenting (endovascular)
552018|NCT00403091|Diabetes mellitus|diabetes mellitus
552019|NCT00403091|Internet|internet
552020|NCT00403091|Education, Professional|education, professional
552021|NCT00403091|Quality Indicators, Health Care|quality indicators, health care
552022|NCT00403091|Quality of Health Care|quality of health care
552023|NCT00403091|Hypertension|hypertension
552024|NCT00403091|Hyperlipidemia|hyperlipidemia
552025|NCT00403104|ONO-2506PO|ono-2506po
552026|NCT00403104|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
552027|NCT00403104|ALS|als
552028|NCT00403117|naltrexone|naltrexone
552029|NCT00403117|smoked marijuana|smoked marijuana
552030|NCT00403117|marijuana use|marijuana use
552031|NCT00403143|intraocular lens, colour vision, blue-light filtering|intraocular lens, colour vision, blue-light filtering
552032|NCT00403156|Macular Degeneration|macular degeneration
552033|NCT00403169|stage III renal cell cancer|stage iii renal cell cancer
552034|NCT00403169|stage IV renal cell cancer|stage iv renal cell cancer
552035|NCT00403169|recurrent renal cell cancer|recurrent renal cell cancer
552036|NCT00403182|recurrent breast cancer|recurrent breast cancer
552037|NCT00403182|stage IIIA breast cancer|stage iiia breast cancer
552038|NCT00403182|stage IIIB breast cancer|stage iiib breast cancer
552039|NCT00403182|stage IIIC breast cancer|stage iiic breast cancer
552040|NCT00403182|stage IV breast cancer|stage iv breast cancer
552041|NCT00403195|Ocular Ischemic Syndrome|ocular ischemic syndrome
552042|NCT00403208|Ventilation, Mechanical|ventilation, mechanical
552043|NCT00403208|Sedation|sedation
552044|NCT00403221|Gene therapy|gene therapy
552045|NCT00403221|Prostate cancer|prostate cancer
552046|NCT00403221|Immunology, Angiogenesis inhibition|immunology, angiogenesis inhibition
552047|NCT00403221|Phase I clinical trial|phase i clinical trial
552048|NCT00403234|Postoperative pain|postoperative pain
552049|NCT00403234|opioid|opioid
552050|NCT00403234|transdermal|transdermal
552051|NCT00403234|TKA (total knee arthroplasty)|tka (total knee arthroplasty)
552052|NCT00403247|Schizophrenia|schizophrenia
552053|NCT00403247|Schizoaffective Disorder|schizoaffective disorder
552054|NCT00403247|Homocysteine|homocysteine
552055|NCT00403247|Vitamins|vitamins
552056|NCT00403260|malaria|malaria
552057|NCT00403260|ACT|act
552058|NCT00403260|P falciparum|p falciparum
552059|NCT00403260|pyronaridine|pyronaridine
552060|NCT00403260|artesunate|artesunate
552061|NCT00403273|Painful Knee Arthroplasty|painful knee arthroplasty
552062|NCT00403273|Botulinum Toxin A|botulinum toxin a
552063|NCT00403273|Randomized Controlled Trial|randomized controlled trial
552064|NCT00403273|Pain and Function|pain and function
552065|NCT00403286|Chronic|chronic
552066|NCT00403286|Obstructive|obstructive
552067|NCT00403286|Pulmonary|pulmonary
552068|NCT00403286|Disease|disease
552069|NCT00403286|COPD|copd
552070|NCT00403286|Safety|safety
552071|NCT00403286|Efficacy|efficacy
552072|NCT00403286|Pharmacokinetic|pharmacokinetic
552073|NCT00403286|Dose-finding|dose-finding
552074|NCT00403299|Coronary artery disease|coronary artery disease
552075|NCT00403299|Cardiac transplantation|cardiac transplantation
552076|NCT00403299|Coronary artery disease in heart transplanted patients|coronary artery disease in heart transplanted patients
552077|NCT00403312|Physical Activity|physical activity
552078|NCT00403312|Wellness Programs|wellness programs
552079|NCT00403312|Pharmacological Smoking Cessation|pharmacological smoking cessation
552080|NCT00403325|Central Serous Chorioretinopathy|central serous chorioretinopathy
552081|NCT00403338|myocardial ischemia|myocardial ischemia
552082|NCT00403338|coronary disease|coronary disease
552083|NCT00403338|heart disease|heart disease
552084|NCT00403338|Coronary Stenosis [MeSH heading: C14.280.647.250.285]|coronary stenosis [mesh heading: c14.280.647.250.285]
552085|NCT00403351|Risk|risk
552086|NCT00403351|Coronary artery disease|coronary artery disease
552087|NCT00403351|Heart Rate variability|heart rate variability
552088|NCT00403351|Pulse wave analysis|pulse wave analysis
552089|NCT00403351|BNP|bnp
552090|NCT00403351|CRP|crp
552091|NCT00403364|Helicobacter pylori infection|helicobacter pylori infection
552092|NCT00403364|Treatment|treatment
552093|NCT00403364|Double blind placebo controlled trial|double blind placebo controlled trial
552094|NCT00403377|melanoma|melanoma
552095|NCT00403377|basal cell carcinoma of the skin|basal cell carcinoma of the skin
552096|NCT00403377|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
552097|NCT00403403|SCLC|sclc
552098|NCT00403403|SALUTE|salute
552099|NCT00403403|Lung Cancer|lung cancer
552100|NCT00403403|Avastin|avastin
552101|NCT00403416|AEB071|aeb071
552102|NCT00403416|Tacrolimus|tacrolimus
552103|NCT00403416|Mycophenolic acid|mycophenolic acid
552104|NCT00403416|Basiliximab|basiliximab
552105|NCT00403416|Rejection|rejection
552106|NCT00403416|Kidney function|kidney function
552107|NCT00403416|Immunosuppression|immunosuppression
552108|NCT00403429|oral chemotherapy|oral chemotherapy
552109|NCT00403429|platinum resistant|platinum resistant
552110|NCT00403429|platinum refractory|platinum refractory
552111|NCT00403429|second line|second line
552112|NCT00403442|Macular Degeneration|macular degeneration
552113|NCT00403455|Clinical|clinical
552114|NCT00403455|Genetics|genetics
552115|NCT00403455|Monoamine transporter|monoamine transporter
552116|NCT00403455|Pharmacogenetics|pharmacogenetics
552117|NCT00403455|Post Traumatic Stress Disorder|post traumatic stress disorder
552118|NCT00403481|Hypertension|hypertension
552119|NCT00403481|Angiotensin Receptor Blocker|angiotensin receptor blocker
552120|NCT00403481|Calcium Channel Blocker|calcium channel blocker
552121|NCT00403481|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
552122|NCT00403481|Hydrochlorothiazide|hydrochlorothiazide
552123|NCT00403481|Stage I and II Hypertension|stage i and ii hypertension
552124|NCT00403481|Type II Diabetes|type ii diabetes
552125|NCT00403494|Intermittent Claudication|intermittent claudication
552126|NCT00403494|IC|ic
552127|NCT00403494|Symptomatic Peripheral Arterial Disease|symptomatic peripheral arterial disease
552128|NCT00403494|Peripheral Arterial Disease|peripheral arterial disease
552129|NCT00403494|PAD|pad
552130|NCT00403494|6R-BH4|6r-bh4
552131|NCT00403494|BH4|bh4
552132|NCT00403494|sapropterin dihydrochloride|sapropterin dihydrochloride
552133|NCT00403494|endothelial dysfunction|endothelial dysfunction
552134|NCT00403494|Nitric Oxide|nitric oxide
552135|NCT00403494|NO|no
552136|NCT00403507|Mild Dementia|mild dementia
552137|NCT00403507|Mild Alzheimer|mild alzheimer
552138|NCT00403507|Cognitive Impairment|cognitive impairment
552139|NCT00403507|Cholinesterase Inhibitor|cholinesterase inhibitor
552140|NCT00403507|Exercise|exercise
552141|NCT00403507|Physical activity|physical activity
552142|NCT00403507|Behavior|behavior
552143|NCT00403507|Memory loss|memory loss
552144|NCT00403520|Alzheimer's disease|alzheimer's disease
552145|NCT00403520|Mild cognitive impairment|mild cognitive impairment
552146|NCT00403533|Hepatitis C|hepatitis c
552147|NCT00403533|viral load|viral load
552148|NCT00403533|antiviral therapy|antiviral therapy
552149|NCT00403533|cholesterol|cholesterol
552150|NCT00403533|atorvastatin|atorvastatin
552151|NCT00403546|Schizophrenia|schizophrenia
552152|NCT00403559|seborrheic dermatitis|seborrheic dermatitis
552153|NCT00403572|Preeclampsia|preeclampsia
552154|NCT00403572|Trans cranial Doppler|trans cranial doppler
552155|NCT00403572|Cardiac output|cardiac output
552156|NCT00403572|systemic vascular resistance|systemic vascular resistance
552157|NCT00403572|blood pressure|blood pressure
552158|NCT00403585|Adefovir Dipivoxil(Hepsera)|adefovir dipivoxil(hepsera)
552159|NCT00403585|Chronic Hepatitis B (CHB)|chronic hepatitis b (chb)
552160|NCT00403637|Asthma, indacaterol, long acting β2-agonist|asthma, indacaterol, long acting β2-agonist
552161|NCT00403650|Sarcoidosis|sarcoidosis
552162|NCT00403650|Dyspnea|dyspnea
552163|NCT00403650|Interstitial lung disease|interstitial lung disease
552164|NCT00403663|Body mass index|body mass index
552165|NCT00403663|Combined Spinal-Epidural Anesthesia|combined spinal-epidural anesthesia
552166|NCT00403663|Cesarean section|cesarean section
552167|NCT00403663|Obesity|obesity
552168|NCT00403676|nurse practitioner|nurse practitioner
552169|NCT00403676|rheumatology care|rheumatology care
552170|NCT00403676|outpatient clinic|outpatient clinic
552171|NCT00403676|patient satisfaction|patient satisfaction
552172|NCT00403689|Increased non-specific inflammatory markers|increased non-specific inflammatory markers
552173|NCT00403702|Retinal detachment|retinal detachment
552174|NCT00403702|proliferative vitreoretinopathy|proliferative vitreoretinopathy
552175|NCT00403702|heavier-than-water internal tamponades|heavier-than-water internal tamponades
552176|NCT00403728|Ischemia|ischemia
552177|NCT00403728|Reperfusion|reperfusion
552178|NCT00403728|Myocardial infarction|myocardial infarction
552179|NCT00403728|ciclosporin A|ciclosporin a
552180|NCT00403728|acute myocardial infarction|acute myocardial infarction
552181|NCT00403741|behavior|behavior
552182|NCT00403741|physical activity|physical activity
552183|NCT00403741|motivation|motivation
552184|NCT00403754|asthma|asthma
552185|NCT00403754|QAB149|qab149
552186|NCT00403754|indacaterol|indacaterol
552187|NCT00403754|long acting β2-agonist|long acting β2-agonist
552188|NCT00403754|bronchodilator|bronchodilator
552189|NCT00403767|Atrial Fibrillation|atrial fibrillation
552190|NCT00403767|Stroke|stroke
552191|NCT00403767|Embolism|embolism
552192|NCT00403767|Non-central nervous system systemic embolism|non-central nervous system systemic embolism
552193|NCT00403767|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
552194|NCT00403767|Blood Clot|blood clot
552195|NCT00403767|Rivaroxaban|rivaroxaban
552196|NCT00403767|Warfarin|warfarin
552197|NCT00403767|Anticoagulants|anticoagulants
552198|NCT00403767|Arrhythmias, Cardiac|arrhythmias, cardiac
552199|NCT00403780|Critical limb ischemia|critical limb ischemia
552200|NCT00403780|Pain control|pain control
552201|NCT00403780|Rest pain in lower limb ischemia|rest pain in lower limb ischemia
552202|NCT00403780|pregabalin|pregabalin
552203|NCT00403780|randomized controlled study|randomized controlled study
552204|NCT00403780|Ischemia, therapy|ischemia, therapy
552205|NCT00403780|Lower extremity, blood supply|lower extremity, blood supply
552206|NCT00403780|Pain, prevention & control|pain, prevention & control
552207|NCT00403780|Pain, therapy|pain, therapy
552208|NCT00403806|Adenotonsillectomy|adenotonsillectomy
552209|NCT00403806|Pediatrics|pediatrics
552210|NCT00403806|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
552211|NCT00403806|Pain|pain
552212|NCT00403806|Oral intake|oral intake
552213|NCT00403806|Dexamethasone|dexamethasone
552214|NCT00403806|Dose finding|dose finding
552215|NCT00403845|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
552216|NCT00403845|COPD|copd
552217|NCT00403845|QAB149|qab149
552218|NCT00403845|indacaterol|indacaterol
552219|NCT00403845|long acting β2-agonist|long acting β2-agonist
552220|NCT00403871|Anaesthesia|anaesthesia
552221|NCT00403871|Pregnency|pregnency
552222|NCT00403871|Heart disease|heart disease
552223|NCT00403884|Drusen|drusen
552224|NCT00403884|Geographic atrophy|geographic atrophy
552225|NCT00403884|diabetes|diabetes
552226|NCT00403884|macular edema|macular edema
552227|NCT00403884|laser|laser
552228|NCT00403884|retinal pigment epithelium|retinal pigment epithelium
552229|NCT00403897|Constipation|constipation
552230|NCT00403923|Lactose intolerance|lactose intolerance
552231|NCT00403923|Ulcerative colitis|ulcerative colitis
552232|NCT00403923|Lactose|lactose
552233|NCT00403923|Threshold|threshold
552234|NCT00403936|osteopathic manipulation|osteopathic manipulation
552235|NCT00403936|autonomic nervous system|autonomic nervous system
552236|NCT00403962|anxiety|anxiety
552237|NCT00403962|Social Anxiety Disorder|social anxiety disorder
552239|NCT00404001|Microbia|microbia
552240|NCT00404001|MD-0727|md-0727
552241|NCT00404001|Primary Hypercholesterolemia|primary hypercholesterolemia
552242|NCT00404001|Hypercholesterolemia|hypercholesterolemia
552243|NCT00404001|Hyperlipidemia|hyperlipidemia
552244|NCT00404001|Dyslipidemia|dyslipidemia
552245|NCT00404001|Cholesterol|cholesterol
552247|NCT00404014|MCI following CABG surgery|mci following cabg surgery
552248|NCT00404079|Chronic low back pain|chronic low back pain
552249|NCT00404092|aspergillosis|aspergillosis
552251|NCT00404092|maximum tolerated dose|maximum tolerated dose
552252|NCT00404105|Excimer laser|excimer laser
552253|NCT00404118|long-term care|long-term care
552254|NCT00404118|satisfaction|satisfaction
552255|NCT00404118|cost|cost
552256|NCT00404144|small vessel|small vessel
552257|NCT00404144|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
552258|NCT00404144|pepcad|pepcad
552259|NCT00404144|drug eluting balloon|drug eluting balloon
552260|NCT00404157|Lupus|lupus
552261|NCT00404157|U2970g|u2970g
552262|NCT00404170|imaging|imaging
552263|NCT00404170|Parkinson|parkinson
552264|NCT00404170|progression|progression
552265|NCT00404183|Pain associated with osteoarthritis|pain associated with osteoarthritis
552266|NCT00404222|Acute Pain following Bunionectomy|acute pain following bunionectomy
552267|NCT00404235|stage IV melanoma|stage iv melanoma
552268|NCT00404235|recurrent melanoma|recurrent melanoma
552269|NCT00404248|adult anaplastic astrocytoma|adult anaplastic astrocytoma
552270|NCT00404248|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
552271|NCT00404248|adult giant cell glioblastoma|adult giant cell glioblastoma
552272|NCT00404248|recurrent adult brain tumor|recurrent adult brain tumor
552273|NCT00404248|adult glioblastoma|adult glioblastoma
552274|NCT00404248|adult gliosarcoma|adult gliosarcoma
552275|NCT00404261|Fluticasone Propionate|fluticasone propionate
552276|NCT00404261|healthcare professional satisfaction|healthcare professional satisfaction
552277|NCT00404261|patient satisfaction|patient satisfaction
552278|NCT00404261|metered dose inhaler with counter|metered dose inhaler with counter
552279|NCT00404261|Salmeterol|salmeterol
552280|NCT00404261|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
552281|NCT00404274|healthy human volunteer|healthy human volunteer
552282|NCT00404274|GW679769|gw679769
552283|NCT00404274|warfarin|warfarin
552284|NCT00404274|casopitant|casopitant
552285|NCT00404287|C reactive protein|c reactive protein
552286|NCT00404287|Inflammation|inflammation
552287|NCT00404287|Aortic valve stenosis|aortic valve stenosis
552288|NCT00404287|progression|progression
552289|NCT00404326|Cervical carcinoma|cervical carcinoma
552290|NCT00404326|Epigenetic therapy|epigenetic therapy
552291|NCT00404326|Hydralazine|hydralazine
552292|NCT00404326|Valproate|valproate
552293|NCT00404326|Microarray analysis|microarray analysis
552294|NCT00404339|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
752413|NCT01172912|stage IV extragonadal seminoma|stage iv extragonadal seminoma
552295|NCT00404339|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
552296|NCT00404339|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
552297|NCT00404339|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
552298|NCT00404339|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
552299|NCT00404339|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
552300|NCT00404339|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
552301|NCT00404339|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
552302|NCT00404339|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
552303|NCT00404339|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
552304|NCT00404339|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
552305|NCT00404339|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
552306|NCT00404339|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
552307|NCT00404339|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
552308|NCT00404339|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
552309|NCT00404339|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
552310|NCT00404339|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
552311|NCT00404339|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
552312|NCT00404339|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
585617|NCT00513396|standardized regimen|standardized regimen
552313|NCT00404339|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
552314|NCT00404339|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
552315|NCT00404339|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
552316|NCT00404339|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
552317|NCT00404339|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
552318|NCT00404339|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
552319|NCT00404339|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
552413|NCT00395122|Chiasmal Lesions|chiasmal lesions
552320|NCT00404339|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
552321|NCT00404339|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
552322|NCT00404339|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
552323|NCT00404339|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
552324|NCT00404339|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
552325|NCT00404339|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
552326|NCT00404339|tongue cancer|tongue cancer
552327|NCT00404352|Rebif New Formulation|rebif new formulation
552328|NCT00404352|Clinical Isolated Syndrome|clinical isolated syndrome
552329|NCT00404352|Multiple Sclerosis|multiple sclerosis
552330|NCT00404365|depression|depression
552331|NCT00404365|extensive stage small cell lung cancer|extensive stage small cell lung cancer
552332|NCT00404365|limited stage small cell lung cancer|limited stage small cell lung cancer
552333|NCT00404365|recurrent small cell lung cancer|recurrent small cell lung cancer
552334|NCT00404365|stage I non-small cell lung cancer|stage i non-small cell lung cancer
552335|NCT00404365|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
552336|NCT00404365|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
552337|NCT00404365|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
552338|NCT00404365|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
552339|NCT00404365|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
552340|NCT00404378|Healthy subjects|healthy subjects
552341|NCT00404378|Pharmacokinetics|pharmacokinetics
552342|NCT00404378|Drug interaction|drug interaction
552343|NCT00404378|Ketoconazole|ketoconazole
552344|NCT00404378|Casopitant|casopitant
552345|NCT00404391|Moderate to severe pain following bunionectomy surgery|moderate to severe pain following bunionectomy surgery
552346|NCT00404404|recurrent breast cancer|recurrent breast cancer
552347|NCT00404404|stage IV breast cancer|stage iv breast cancer
552348|NCT00404417|pain|pain
552349|NCT00404417|lumbar|lumbar
552350|NCT00404430|Endothelial function|endothelial function
552351|NCT00404430|Peripheral Arterial Tone|peripheral arterial tone
552352|NCT00404430|Systemic Inflammation|systemic inflammation
552353|NCT00404430|Oxidative Stress|oxidative stress
552354|NCT00404430|Respiratory and peripheral muscular function|respiratory and peripheral muscular function
552355|NCT00404430|Cardiovascular risk|cardiovascular risk
552356|NCT00404430|COPD severity|copd severity
552357|NCT00404443|Acupuncture|acupuncture
552358|NCT00404443|Electroacupuncture|electroacupuncture
552359|NCT00404443|Rheumatoid arthritis|rheumatoid arthritis
552360|NCT00394524|ICU|icu
552361|NCT00394524|hyperglycemia|hyperglycemia
552362|NCT00394524|glucommander|glucommander
552363|NCT00394927|Non-Interventional|non-interventional
552364|NCT00394927|Surveillance|surveillance
552365|NCT00394927|Adverse Effects|adverse effects
552366|NCT00394927|AntiEpileptic Drug treatment|antiepileptic drug treatment
552367|NCT00394940|COPD|copd
552368|NCT00394940|Emphysema|emphysema
552369|NCT00394940|Chronic Bronchitis|chronic bronchitis
552370|NCT00394940|Inflammation|inflammation
552371|NCT00394940|CD14|cd14
552372|NCT00394940|TLR4|tlr4
552373|NCT00394940|Proteomics|proteomics
552374|NCT00394992|Colorectal cancer|colorectal cancer
552375|NCT00394992|Liver metastasis|liver metastasis
552376|NCT00394992|Radical resection|radical resection
552377|NCT00394992|Adjuvant therapy|adjuvant therapy
552378|NCT00394992|Bevacizumab|bevacizumab
552379|NCT00394992|Capecitabine|capecitabine
552380|NCT00394992|Oxaliplatin|oxaliplatin
552381|NCT00394992|Hepatica|hepatica
552382|NCT00395005|Kallikrein|kallikrein
552383|NCT00395005|Cytokines|cytokines
552384|NCT00395005|Proteinuria|proteinuria
552385|NCT00395005|Renal function|renal function
552386|NCT00395005|Chronic kidney disease|chronic kidney disease
552387|NCT00395018|Chronic Hepatitis B Virus, Liver Transplant|chronic hepatitis b virus, liver transplant
552388|NCT00395031|schizophrenia|schizophrenia
552389|NCT00395031|Schizoaffective Disorder|schizoaffective disorder
552390|NCT00395031|metabolic markers|metabolic markers
552391|NCT00395031|ziprasidone|ziprasidone
552392|NCT00395031|diabetes|diabetes
552393|NCT00395044|Cannabis treatment|cannabis treatment
552394|NCT00395044|marijuana treatment|marijuana treatment
552395|NCT00395070|Melanoma|melanoma
552398|NCT00395070|Stage 3|stage 3
552399|NCT00395070|Stage 4|stage 4
552400|NCT00395070|Metastatic|metastatic
552401|NCT00395070|Metastatic Melanoma (Stage 3, Stage 4 Melanoma)|metastatic melanoma (stage 3, stage 4 melanoma)
552402|NCT00395096|Exhaled Nitric Oxide|exhaled nitric oxide
552403|NCT00395096|Asthma|asthma
552404|NCT00395096|Tobacco Smoke|tobacco smoke
552405|NCT00395096|Allergen|allergen
552406|NCT00395109|cancer|cancer
552407|NCT00395109|hypoxia|hypoxia
552408|NCT00395109|PET scan|pet scan
552409|NCT00395109|CT scan|ct scan
552410|NCT00395122|Band Atrophy|band atrophy
552411|NCT00395122|Optical Coherence Tomography|optical coherence tomography
552412|NCT00395122|Scanning Laser Polarimetry|scanning laser polarimetry
552416|NCT00395135|lorcaserin|lorcaserin
552417|NCT00395135|APD356|apd356
552418|NCT00395135|BLOOM|bloom
552419|NCT00395135|Hypertension|hypertension
552420|NCT00395135|Dyslipidemia|dyslipidemia
552421|NCT00395135|Sleep apnea|sleep apnea
552422|NCT00395135|glucose tolerance|glucose tolerance
552423|NCT00395135|cardiovascular disease|cardiovascular disease
552424|NCT00395135|Arena|arena
552425|NCT00395161|sepsis|sepsis
552426|NCT00395161|prevention|prevention
552427|NCT00395161|mineral supplementation|mineral supplementation
552428|NCT00395174|Influenza|influenza
552429|NCT00395200|Multiple Sclerosis|multiple sclerosis
552430|NCT00395200|Safety|safety
552431|NCT00395200|Therapeutics|therapeutics
552432|NCT00395200|Mesenchymal Stem Cells|mesenchymal stem cells
552433|NCT00395200|Multipotent Mesenchymal Stromal Cells|multipotent mesenchymal stromal cells
552434|NCT00395200|Optic Neuritis|optic neuritis
552435|NCT00395213|Anxiety|anxiety
552436|NCT00395213|Major Depression|major depression
552437|NCT00395213|Anorexia|anorexia
552438|NCT00395213|Bulimia|bulimia
552439|NCT00395213|OCD|ocd
552440|NCT00395213|Antidepressant|antidepressant
552441|NCT00395213|SSRI|ssri
552442|NCT00395213|SNRI|snri
552443|NCT00395226|Rosacea|rosacea
552444|NCT00395239|Asthma|asthma
552445|NCT00395239|Inhaled corticosteroid|inhaled corticosteroid
552446|NCT00395239|ICS|ics
552447|NCT00395239|Metabolites|metabolites
552448|NCT00395239|Induced sputum|induced sputum
552449|NCT00395239|Virtual Asthma Clinic|virtual asthma clinic
552450|NCT00395252|pancreatic cancer|pancreatic cancer
552451|NCT00395252|adjuvant chemotherapy|adjuvant chemotherapy
552452|NCT00395252|phase 2|phase 2
552453|NCT00395252|R0 or R1 resected Adenocarcinoma of the Pancreas|r0 or r1 resected adenocarcinoma of the pancreas
552454|NCT00395265|Deep Vein Thrombosis|deep vein thrombosis
552455|NCT00395265|Chronic Venous Insufficiency|chronic venous insufficiency
552456|NCT00395265|Post Thrombotic Syndrome|post thrombotic syndrome
552457|NCT00395265|Blood Coagulation|blood coagulation
552458|NCT00395265|Inflammation|inflammation
552459|NCT00395278|KSHV|kshv
552460|NCT00395278|Kaposi's Sarcoma|kaposi's sarcoma
552462|NCT00395278|Kaposi Sarcoma|kaposi sarcoma
551871|NCT00402701|students|students
552463|NCT00395291|Chronic kidney disease|chronic kidney disease
552464|NCT00395291|End stage renal disease|end stage renal disease
552465|NCT00395317|magnetic resonance imaging|magnetic resonance imaging
552466|NCT00395317|multiple sclerosis|multiple sclerosis
552467|NCT00395317|SB-683699|sb-683699
552468|NCT00395330|Respiratory Function Tests|respiratory function tests
552469|NCT00395330|Oscillometry|oscillometry
552470|NCT00395330|World Trade Center Disaster|world trade center disaster
552472|NCT00395330|Distal Airways|distal airways
552473|NCT00395356|Diet|diet
552474|NCT00395356|Caloric restriction|caloric restriction
552475|NCT00395356|Intermittent diet|intermittent diet
552476|NCT00395356|Obesity|obesity
552477|NCT00395356|Postmenopausal women|postmenopausal women
552478|NCT00395369|aprotinin|aprotinin
552479|NCT00395369|cardiac surgery|cardiac surgery
552480|NCT00395369|neurological dysfunction|neurological dysfunction
552481|NCT00395369|optical coherance tomography|optical coherance tomography
552482|NCT00395382|Vascular calcification|vascular calcification
552483|NCT00395382|Arterial stiffness|arterial stiffness
552484|NCT00395382|Cardiovascular risk|cardiovascular risk
552485|NCT00395382|Bone mineral metabolism|bone mineral metabolism
552486|NCT00395382|Calcium|calcium
552487|NCT00395395|Postmenopausal|postmenopausal
552488|NCT00395395|osteoporosis|osteoporosis
552489|NCT00395395|Pharmacokinetics/dynamics|pharmacokinetics/dynamics
552490|NCT00395395|Calcitonin|calcitonin
552491|NCT00395421|treatment-naive|treatment-naive
552492|NCT00395434|Advanced Solid Tumors|advanced solid tumors
552493|NCT00395434|Advanced Solid Tumours|advanced solid tumours
552494|NCT00395434|Advanced Solid Tumor|advanced solid tumor
552495|NCT00395434|Advanced Solid Tumour|advanced solid tumour
552496|NCT00395434|Advanced|advanced
552497|NCT00395434|Malignant|malignant
552498|NCT00395434|Solid|solid
552499|NCT00395434|Tumors|tumors
552500|NCT00395434|Tumours|tumours
552501|NCT00395434|Tumor|tumor
552502|NCT00395434|Tumour|tumour
552503|NCT00395434|Cancer|cancer
552504|NCT00395434|Malignant Solid Tumors|malignant solid tumors
552505|NCT00395434|Malignant Solid Tumours|malignant solid tumours
552506|NCT00395434|Malignant Solid Tumor|malignant solid tumor
552507|NCT00395434|Malignant Solid Tumour|malignant solid tumour
552508|NCT00395434|Metastatic Cancer|metastatic cancer
552509|NCT00395434|Metastatic Disease|metastatic disease
552510|NCT00395434|Advanced Cancer|advanced cancer
552511|NCT00395434|Vascular Disrupting Agent|vascular disrupting agent
552512|NCT00395434|Anti-angiogenesis agent|anti-angiogenesis agent
552513|NCT00395434|Phase 1|phase 1
552514|NCT00395447|Cardiac Pacemaker|cardiac pacemaker
552515|NCT00395447|Defibrillator|defibrillator
552516|NCT00395447|Replacement|replacement
552517|NCT00395447|Upgrade|upgrade
552518|NCT00395460|Gadovist|gadovist
552519|NCT00395460|Gadavist|gadavist
552520|NCT00395460|Contrast agent|contrast agent
552521|NCT00395460|Brain|brain
552522|NCT00395460|Spine disease|spine disease
552523|NCT00395460|Magnetic Resonance Imaging|magnetic resonance imaging
552524|NCT00395486|rosuvastatin|rosuvastatin
552525|NCT00395486|lipoprotein|lipoprotein
552526|NCT00395486|metabolic syndrome|metabolic syndrome
552527|NCT00395499|Risperidone|risperidone
552528|NCT00395499|9-Hydroxyrisperidone|9-hydroxyrisperidone
552529|NCT00395499|Plasma|plasma
552530|NCT00395499|Saliva|saliva
552531|NCT00395499|children|children
552532|NCT00395512|Glucose Metabolism Disorder|glucose metabolism disorder
552533|NCT00395512|Dysmetabolic Syndrome|dysmetabolic syndrome
552534|NCT00395512|Type II Diabetes|type ii diabetes
552535|NCT00395512|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
552536|NCT00395512|Dyslipidemia|dyslipidemia
552537|NCT00395512|Drug Therapy|drug therapy
552538|NCT00395538|Parathyroid|parathyroid
552539|NCT00395538|Bone Biopsy|bone biopsy
552540|NCT00395538|Calcium-Sensing Receptor|calcium-sensing receptor
552541|NCT00395538|Bone Density|bone density
552542|NCT00395538|Bone Turnover|bone turnover
552543|NCT00395538|Hypoparathyroidism|hypoparathyroidism
552544|NCT00395551|choroidal neovascularization|choroidal neovascularization
552545|NCT00395551|Choroidal Neovascularization Not related to Age-Related Macular Degeneration|choroidal neovascularization not related to age-related macular degeneration
552546|NCT00395564|Urologic Surgery|urologic surgery
552547|NCT00395590|OSA inflammatory cytokines, metabolic syndrome|osa inflammatory cytokines, metabolic syndrome
552548|NCT00395629|Deferasirox|deferasirox
552549|NCT00395629|ICL670A|icl670a
552550|NCT00395629|Iron chelators|iron chelators
552551|NCT00395629|Deferiprone|deferiprone
552552|NCT00395629|Transfusional Hemochromatosis|transfusional hemochromatosis
552553|NCT00395642|Congestive Heart Failure|congestive heart failure
552554|NCT00395642|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
552555|NCT00395642|Home Monitoring|home monitoring
552556|NCT00395642|Telemonitoring|telemonitoring
552557|NCT00395642|Remote Monitoring|remote monitoring
552558|NCT00395655|locally advanced breast cancer|locally advanced breast cancer
551997|NCT00403026|VEGF|vegf
552559|NCT00395655|hydralazine|hydralazine
552560|NCT00395655|magnesium valproate|magnesium valproate
552561|NCT00395655|epigenetic therapy|epigenetic therapy
552562|NCT00395655|gene expression|gene expression
552563|NCT00395668|TETRA|tetra
552564|NCT00395668|EMF|emf
552565|NCT00395668|Human exposure study|human exposure study
552566|NCT00395668|Symptoms|symptoms
552567|NCT00395668|Well-being|well-being
552568|NCT00395668|Cognitive function|cognitive function
552569|NCT00395681|Obesity|obesity
552570|NCT00395681|Propofol|propofol
552571|NCT00395681|Morbidly obese|morbidly obese
552572|NCT00395681|BMI|bmi
552573|NCT00395694|epilepsy|epilepsy
552574|NCT00395694|Incidence of rash|incidence of rash
552575|NCT00395694|safety evaluation for initial dose|safety evaluation for initial dose
552576|NCT00395694|patients with Valproic acid|patients with valproic acid
552577|NCT00395707|Macular Degeneration|macular degeneration
552578|NCT00395707|Age Related Macular Degeneration|age related macular degeneration
552579|NCT00395707|Retinal Angiomatous Proliferations|retinal angiomatous proliferations
552580|NCT00395720|TB|tb
552581|NCT00395720|Tuberculosis|tuberculosis
552582|NCT00395720|HIV|hiv
552583|NCT00395720|Vaccine|vaccine
552584|NCT00395720|MVA85A|mva85a
552585|NCT00395720|HIV Therapeutic Vaccine|hiv therapeutic vaccine
552586|NCT00395733|Gadovist|gadovist
552587|NCT00395733|Gadavist|gadavist
552588|NCT00395733|MRI Imaging|mri imaging
552589|NCT00395733|vascular diseases|vascular diseases
552590|NCT00395733|Chinese|chinese
552591|NCT00395759|contrast sensitivity|contrast sensitivity
552592|NCT00395772|Treatment of venous thromboembolism|treatment of venous thromboembolism
552593|NCT00395785|Carotid stenosis|carotid stenosis
552594|NCT00395785|Intracranial Embolism|intracranial embolism
552595|NCT00395785|Carotid artery|carotid artery
552596|NCT00395785|Carotid stent|carotid stent
552597|NCT00395785|Embolic protection|embolic protection
552598|NCT00395785|TriActiv ProGuard System|triactiv proguard system
552599|NCT00395785|Carotid angioplasty|carotid angioplasty
552600|NCT00395798|cervical intervertebral disc displacement|cervical intervertebral disc displacement
552601|NCT00395798|cervical spondylosis|cervical spondylosis
552602|NCT00395798|radiculopathy|radiculopathy
552603|NCT00395798|neck collar|neck collar
552604|NCT00395798|brace|brace
552605|NCT00395798|physiotherapy|physiotherapy
552606|NCT00395798|treatment|treatment
552607|NCT00395798|rehabilitation|rehabilitation
552608|NCT00395811|Myocardial Infarction|myocardial infarction
552609|NCT00395811|stem cell therapy|stem cell therapy
552610|NCT00395811|Coronary Artery Bypass Grafting|coronary artery bypass grafting
552611|NCT00395824|citrate|citrate
552612|NCT00395824|anticoagulation|anticoagulation
552613|NCT00395824|heparin-coated membrane|heparin-coated membrane
552614|NCT00395837|Aging|aging
552615|NCT00395837|Wellness|wellness
552616|NCT00395837|Aerobic exercise|aerobic exercise
552617|NCT00395837|Prevention|prevention
552618|NCT00395850|cocaine dependence|cocaine dependence
552619|NCT00395850|disulfiram|disulfiram
552620|NCT00395850|clinical trial|clinical trial
552621|NCT00395850|methadone maintenance|methadone maintenance
552622|NCT00395850|pharmacogenetics|pharmacogenetics
552623|NCT00395850|dopamine beta-hydroxylase|dopamine beta-hydroxylase
552624|NCT00395876|TNKase|tnkase
552625|NCT00395876|CVA|cva
552626|NCT00395876|CVAD|cvad
552627|NCT00395876|Central venous access catheter|central venous access catheter
552628|NCT00395876|CVA catheter|cva catheter
552629|NCT00395889|Lung Transplantation|lung transplantation
552630|NCT00395889|Physical Activities in Daily Life|physical activities in daily life
552631|NCT00395889|Pulmonary Rehabilitation|pulmonary rehabilitation
552632|NCT00395889|Functional Status|functional status
552633|NCT00395902|Sensipar|sensipar
552634|NCT00395902|cinacalcet|cinacalcet
552635|NCT00395902|Mimpara|mimpara
552636|NCT00395915|schizophrenia|schizophrenia
552637|NCT00395915|antipsychotics|antipsychotics
552638|NCT00395915|treatment non response|treatment non response
552639|NCT00395915|pragmatic trial|pragmatic trial
552640|NCT00395928|heart|heart
552641|NCT00395928|echocardiography|echocardiography
552642|NCT00395928|diastolic function|diastolic function
552643|NCT00395928|left ventricle|left ventricle
552644|NCT00395928|right ventricle|right ventricle
552645|NCT00395928|cigarette smoking|cigarette smoking
552646|NCT00395928|Smoking|smoking
552647|NCT00395928|Heart Ventricles|heart ventricles
552648|NCT00395928|Diastole|diastole
552649|NCT00395928|Doppler Echocardiography|doppler echocardiography
552650|NCT00395954|Lactose Intolerance|lactose intolerance
552651|NCT00395954|Lactose|lactose
552652|NCT00395954|Threshold|threshold
552653|NCT00395967|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
552654|NCT00395967|Multiple Myeloma|multiple myeloma
552655|NCT00395967|stem cell mobilization|stem cell mobilization
552656|NCT00395967|autologous transplantation|autologous transplantation
552657|NCT00395967|AMD3100|amd3100
552658|NCT00395993|anemia|anemia
552659|NCT00395993|heavy uterine bleeding|heavy uterine bleeding
552660|NCT00395993|menorrhagia|menorrhagia
552661|NCT00395993|Anemia secondary to heavy uterine bleeding|anemia secondary to heavy uterine bleeding
552663|NCT00396032|Hemodialysis|hemodialysis
552664|NCT00396032|Catheter clearance|catheter clearance
552665|NCT00396032|TNKase|tnkase
552666|NCT00396032|Renal Insufficiency|renal insufficiency
552667|NCT00396045|Multiple Myeloma, Lenalidomide, elderly patients|multiple myeloma, lenalidomide, elderly patients
552668|NCT00396071|Type 2 diabetes|type 2 diabetes
552669|NCT00396071|vildagliptin|vildagliptin
552670|NCT00396071|incretin effect|incretin effect
552671|NCT00396071|metformin|metformin
552672|NCT00396084|tuberculosis, linezolid, gatifloxacin, levofloxacin, isoniazid, moxifloxacin, Brazil|tuberculosis, linezolid, gatifloxacin, levofloxacin, isoniazid, moxifloxacin, brazil
552673|NCT00396097|ISS|iss
552674|NCT00396097|human growth hormone|human growth hormone
552675|NCT00396110|cholesterol|cholesterol
552676|NCT00396110|coronary heart disease|coronary heart disease
552677|NCT00396110|rosuvastatin|rosuvastatin
552678|NCT00396110|LDL-C goal|ldl-c goal
552679|NCT00396110|hypercholesterolemia|hypercholesterolemia
552680|NCT00396123|Chronic Kidney Disease|chronic kidney disease
552681|NCT00396123|Anemia|anemia
552682|NCT00396136|Congestive Heart Failure|congestive heart failure
552683|NCT00396136|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
552684|NCT00396136|Left Ventricular Lead|left ventricular lead
552685|NCT00396149|rBet v 1|rbet v 1
552686|NCT00396149|Birch pollen allergy|birch pollen allergy
552687|NCT00396149|Sublingual Immunotherapy|sublingual immunotherapy
552688|NCT00396188|Keratoconus|keratoconus
552689|NCT00396188|LASIK|lasik
552690|NCT00396188|Orthokeratology|orthokeratology
552691|NCT00396188|Pellucid Marginal Degeneration|pellucid marginal degeneration
552692|NCT00396188|Refractive Surgery|refractive surgery
552693|NCT00396188|normal cornea|normal cornea
552694|NCT00396188|post myopic LASIK|post myopic lasik
552695|NCT00396188|post hyperopic LASIK|post hyperopic lasik
552696|NCT00396188|corneal pathologies (e.g. pellucid marginal degeneration)|corneal pathologies (e.g. pellucid marginal degeneration)
552697|NCT00396201|Hodgkin's Disease|hodgkin's disease
552698|NCT00396201|Stem cell mobilization|stem cell mobilization
552699|NCT00396201|apheresis|apheresis
552700|NCT00396214|Schizophrenia|schizophrenia
552701|NCT00396214|weight changes|weight changes
552702|NCT00396227|Type 2 diabetes|type 2 diabetes
552703|NCT00396227|vildagliptin|vildagliptin
552704|NCT00396227|hemoglobin A1c|hemoglobin a1c
552705|NCT00396227|metformin|metformin
552706|NCT00396240|rosuvastatin|rosuvastatin
552707|NCT00396240|hypercholesterolaemia|hypercholesterolaemia
552708|NCT00396240|cholesterol|cholesterol
552709|NCT00396240|LDL-C|ldl-c
552710|NCT00396240|triglyceride|triglyceride
552711|NCT00396240|plasma lipids|plasma lipids
552712|NCT00396240|compliance|compliance
552713|NCT00396253|HD|hd
552714|NCT00396253|TNKase|tnkase
552715|NCT00396253|Hemodialysis|hemodialysis
552716|NCT00396253|Catheter clearance|catheter clearance
552717|NCT00396266|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
552718|NCT00396266|Multiple Myeloma|multiple myeloma
552719|NCT00396266|stem cell mobilization|stem cell mobilization
552720|NCT00396266|AMD3100|amd3100
552721|NCT00396266|autologous transplantation|autologous transplantation
552722|NCT00396279|Giant Cell Tumor of Bone|giant cell tumor of bone
552723|NCT00396292|Anemia|anemia
552724|NCT00396292|postpartum|postpartum
552725|NCT00396292|Postpartum anemia|postpartum anemia
552726|NCT00396305|Influenza, vaccine, efficacy, elderly|influenza, vaccine, efficacy, elderly
552727|NCT00396318|TNKase|tnkase
552728|NCT00396318|CVA|cva
552729|NCT00396318|CVAD|cvad
552730|NCT00396318|Central venous access catheter|central venous access catheter
552731|NCT00396331|Multiple Myeloma|multiple myeloma
552732|NCT00396331|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
552733|NCT00396331|autologous transplantation|autologous transplantation
552734|NCT00396331|AMD3100|amd3100
552735|NCT00396331|stem cell mobilization|stem cell mobilization
552736|NCT00396331|plerixafor|plerixafor
552737|NCT00396344|Systemic sepsis|systemic sepsis
552738|NCT00396357|Type 2 diabetes|type 2 diabetes
552739|NCT00396357|vildagliptin|vildagliptin
552740|NCT00396357|hemoglobin A1c|hemoglobin a1c
552741|NCT00396357|metformin|metformin
552742|NCT00396370|tuberculosis, Bacillus Calmette-Guérin, parent protocol|tuberculosis, bacillus calmette-guérin, parent protocol
552743|NCT00396383|Multiple Myeloma|multiple myeloma
552744|NCT00396383|Stem cell mobilization|stem cell mobilization
552745|NCT00396383|apheresis|apheresis
552746|NCT00396396|Creatinine clearance|creatinine clearance
552747|NCT00396396|Acetylcysteine|acetylcysteine
552748|NCT00396422|psoriasis|psoriasis
552749|NCT00396422|skin|skin
552750|NCT00396422|auto immune|auto immune
552751|NCT00396435|anaemia|anaemia
552752|NCT00396435|renal transplantation|renal transplantation
552753|NCT00396435|kidney failure|kidney failure
552754|NCT00396461|Critical Illness|critical illness
552755|NCT00396461|Fat Emulsions, Intravenous|fat emulsions, intravenous
552756|NCT00396461|Superinfection|superinfection
552757|NCT00396461|Parenteral Nutrition|parenteral nutrition
552758|NCT00396474|Small for gestational age, Insulin Sensitivity Index, growth hormone treatment|small for gestational age, insulin sensitivity index, growth hormone treatment
552759|NCT00396487|Metastatic colorectal cancer|metastatic colorectal cancer
552760|NCT00396487|tailored treatment|tailored treatment
552761|NCT00396487|genetic markers|genetic markers
552762|NCT00396487|gene polymorphism|gene polymorphism
552763|NCT00396487|chemotherapy|chemotherapy
552764|NCT00396500|Deworming|deworming
552765|NCT00396500|Malnutrition|malnutrition
552766|NCT00396500|children|children
552767|NCT00396500|Community|community
552769|NCT00396513|PCOS|pcos
552770|NCT00396513|Statin|statin
552771|NCT00396513|Metformin|metformin
552772|NCT00396513|Testosterone|testosterone
552773|NCT00396513|Menstrual cycle|menstrual cycle
552774|NCT00396513|Lipids|lipids
552775|NCT00396526|Nonsevere pneumonia|nonsevere pneumonia
552776|NCT00396526|treatment|treatment
552777|NCT00396526|underfives|underfives
552778|NCT00396526|children|children
552779|NCT00396526|Community|community
552780|NCT00396526|India|india
552781|NCT00396552|refractory transcranial magnetic stimulation|refractory transcranial magnetic stimulation
552782|NCT00396552|obsessive compulsive disorder|obsessive compulsive disorder
552783|NCT00396552|randomized|randomized
552784|NCT00396552|placebo-controlled|placebo-controlled
552785|NCT00396552|double-blind|double-blind
552786|NCT00396565|Schizophrenia|schizophrenia
552787|NCT00396565|JNS007ER|jns007er
552788|NCT00396565|Positive and Negative Syndrome Scale (PANSS)|positive and negative syndrome scale (panss)
552789|NCT00396565|Paliperidone|paliperidone
552790|NCT00396565|Extended Release Osmotic Controlled-Release Oral Delivery System (OROS) paliperidone|extended release osmotic controlled-release oral delivery system (oros) paliperidone
552791|NCT00396578|aerosolized antibiotics|aerosolized antibiotics
552792|NCT00396578|ventilator associated pneumonia|ventilator associated pneumonia
552793|NCT00396578|clinical pulmonary infection score|clinical pulmonary infection score
552794|NCT00396578|bacterial resistance|bacterial resistance
552795|NCT00396591|Ovarian cancer|ovarian cancer
552796|NCT00396591|malignant ascites|malignant ascites
552797|NCT00396591|angiogenesis|angiogenesis
552798|NCT00396591|angiogenesis inhibition|angiogenesis inhibition
552799|NCT00396591|VEGF-Trap fusion recombinant protein|vegf-trap fusion recombinant protein
552800|NCT00396604|indacaterol|indacaterol
552801|NCT00396604|long acting beta agonist|long acting beta agonist
552802|NCT00396617|Laryngeal or pharyngo-laryngeal's carcinoma,|laryngeal or pharyngo-laryngeal's carcinoma,
552803|NCT00396617|voice prosthesis tracheooesophageal shunt,|voice prosthesis tracheooesophageal shunt,
552804|NCT00396617|titanium beads,|titanium beads,
552805|NCT00396617|cellular colonization|cellular colonization
552806|NCT00396617|Laryngeal or pharyngo-laryngeal's carcinoma|laryngeal or pharyngo-laryngeal's carcinoma
552807|NCT00396630|Transmission|transmission
552808|NCT00396630|Gastroenteritis|gastroenteritis
552809|NCT00396630|Shedding|shedding
552810|NCT00396630|rotavirus|rotavirus
552811|NCT00396630|HRV vaccine|hrv vaccine
552812|NCT00396643|Ultra-High Risk|ultra-high risk
552813|NCT00396643|Psychosis|psychosis
552814|NCT00396643|Schizophrenia|schizophrenia
552815|NCT00396643|Omega-3 fatty acids|omega-3 fatty acids
552817|NCT00396656|hypertension|hypertension
552818|NCT00396656|valsartan|valsartan
552819|NCT00396656|atenolol|atenolol
552820|NCT00396656|hydrochlorothiazide|hydrochlorothiazide
552821|NCT00396656|microcirculation|microcirculation
552822|NCT00396656|arterial compliance|arterial compliance
552823|NCT00396656|pulse wave analysis|pulse wave analysis
552824|NCT00396669|Nicotine|nicotine
552825|NCT00396669|Dopamine|dopamine
552826|NCT00396669|Imaging|imaging
552827|NCT00396669|Raclopride|raclopride
552828|NCT00396669|Addiction|addiction
552829|NCT00396669|Genetics|genetics
552830|NCT00396682|HCC|hcc
552831|NCT00396682|T cell|t cell
552832|NCT00396695|PTSD, traumatic memory|ptsd, traumatic memory
552833|NCT00396708|Robotics|robotics
552834|NCT00396708|Rehabilitation|rehabilitation
552835|NCT00396708|Arm|arm
552836|NCT00396708|Stroke|stroke
552837|NCT00396708|Weakness|weakness
552838|NCT00396708|Outpatient|outpatient
552839|NCT00396708|Chronic|chronic
552840|NCT00396721|Nephropathy, IGA|nephropathy, iga
552841|NCT00396721|Pilot trial|pilot trial
552842|NCT00396721|Sirolimus|sirolimus
552843|NCT00396721|Rapamune|rapamune
552844|NCT00396734|Imaging|imaging
552845|NCT00396734|cocaine|cocaine
552846|NCT00396734|methadone|methadone
552847|NCT00396734|craving|craving
552848|NCT00396734|PET|pet
552849|NCT00396734|FDG|fdg
552850|NCT00396734|D2|d2
552851|NCT00396734|Modafinil|modafinil
552852|NCT00396734|Topiramate|topiramate
552853|NCT00396747|Early rheumatoid arthritis,|early rheumatoid arthritis,
552854|NCT00396747|glucocorticoids,|glucocorticoids,
552855|NCT00396747|pulse therapy,|pulse therapy,
552856|NCT00396747|infliximab,|infliximab,
552857|NCT00396747|TNF blockade|tnf blockade
552858|NCT00396760|cardiac surgery|cardiac surgery
552859|NCT00396760|blood transfusion|blood transfusion
552860|NCT00396760|antifibrinolytics|antifibrinolytics
552861|NCT00396760|aprotinin|aprotinin
552862|NCT00396760|tranexamic acid|tranexamic acid
552863|NCT00396773|electrocoagulation,pregnancy,brian waves|electrocoagulation,pregnancy,brian waves
552864|NCT00396786|Prevention of venous thromboembolism|prevention of venous thromboembolism
552865|NCT00396812|Autoimmune disease|autoimmune disease
552866|NCT00396812|Biologic response modifiers|biologic response modifiers
552867|NCT00396812|Disease-modifying antirheumatic drugs (DMARDS)|disease-modifying antirheumatic drugs (dmards)
552868|NCT00396812|Immune system|immune system
552870|NCT00396812|Rituximab (anti-CD20 monoclonal antibodies)|rituximab (anti-cd20 monoclonal antibodies)
552871|NCT00396825|Care giving|care giving
552872|NCT00396825|Alzheimer's Disease|alzheimer's disease
552873|NCT00396825|Stress management|stress management
552874|NCT00396864|cutaneous lymphoma|cutaneous lymphoma
552875|NCT00396864|marginal zone lymphoma|marginal zone lymphoma
552876|NCT00396877|cyanotic congenital heart disease|cyanotic congenital heart disease
552877|NCT00396877|shunt palliation|shunt palliation
552878|NCT00396877|thrombosis|thrombosis
552879|NCT00396877|clopidogrel|clopidogrel
552880|NCT00396890|Theta Burst Stimulation|theta burst stimulation
552881|NCT00396890|Repetitive TMS (rTMS)|repetitive tms (rtms)
552882|NCT00396890|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
552883|NCT00396890|Primary Motor Cortex|primary motor cortex
552884|NCT00396890|Interhemispheric Disinhibition|interhemispheric disinhibition
552885|NCT00396890|Healthy Volunteer|healthy volunteer
552887|NCT00396903|Anaesthetic techniques|anaesthetic techniques
552888|NCT00396903|epidural catheters|epidural catheters
552889|NCT00396903|paraesthesia|paraesthesia
552890|NCT00396903|side effects.|side effects.
552891|NCT00396916|cancer patients|cancer patients
552892|NCT00396929|Paclitaxel|paclitaxel
552893|NCT00396929|Restenosis|restenosis
552894|NCT00396929|Stent|stent
552895|NCT00396929|Intracoronary Dosis|intracoronary dosis
552896|NCT00396929|Paclitaxel-eluting Stent|paclitaxel-eluting stent
552897|NCT00396942|Electroencephalogram (EEG)|electroencephalogram (eeg)
552898|NCT00396942|Nerve Conduction Study|nerve conduction study
552899|NCT00396942|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
552900|NCT00396942|Motor Evoked Potential|motor evoked potential
552901|NCT00396942|Parkinson Disease|parkinson disease
552903|NCT00396942|Healthy Volunteer|healthy volunteer
552904|NCT00396942|HV|hv
552905|NCT00396955|osteoarthritis|osteoarthritis
552906|NCT00396955|arthritis|arthritis
552907|NCT00396955|pain|pain
552908|NCT00396968|AMD3100|amd3100
552909|NCT00396968|Acute Myelogenous Leukemai|acute myelogenous leukemai
552910|NCT00396968|Myelodysplastic Syndromes|myelodysplastic syndromes
552911|NCT00396968|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
552912|NCT00396981|Intracranial saccular aneurysms|intracranial saccular aneurysms
552913|NCT00396981|Endovascular coiling therapy|endovascular coiling therapy
552914|NCT00396981|Retreatment|retreatment
552915|NCT00396981|Raymond scale|raymond scale
552916|NCT00396981|Matrix|matrix
552917|NCT00396981|GDC|gdc
552918|NCT00396981|Guglielmi Detachable Coil|guglielmi detachable coil
552919|NCT00396994|biomechanics|biomechanics
552920|NCT00396994|osteogenesis|osteogenesis
552921|NCT00396994|osteoporosis|osteoporosis
552922|NCT00396994|bone regeneration|bone regeneration
552923|NCT00397007|tinnitus|tinnitus
552924|NCT00397007|biofeedback|biofeedback
552925|NCT00397007|psychophysiological reactivity|psychophysiological reactivity
552926|NCT00397007|intervention|intervention
552927|NCT00397020|quetiapine|quetiapine
552928|NCT00397020|divalproex|divalproex
552929|NCT00397033|Schizoaffective Disorder|schizoaffective disorder
552930|NCT00397033|antipsychotic|antipsychotic
552931|NCT00397033|paliperidone|paliperidone
552932|NCT00397033|placebo|placebo
552933|NCT00397046|Advanced Malignant Solid Tumors|advanced malignant solid tumors
552934|NCT00397059|Escitalopram|escitalopram
552935|NCT00397059|Pharmacokinetics|pharmacokinetics
552936|NCT00397059|Pharmacodynamics|pharmacodynamics
552937|NCT00397059|CYP2C19|cyp2c19
552938|NCT00397059|Pupillometry|pupillometry
552939|NCT00397059|healthy volunteers|healthy volunteers
552940|NCT00397072|Glioblastoma recurrent,temozolomide, epothilone|glioblastoma recurrent,temozolomide, epothilone
552941|NCT00397098|Anxiety disorders, Relapse prevention|anxiety disorders, relapse prevention
552942|NCT00397111|Morphometry|morphometry
552943|NCT00397111|BOLD|bold
552944|NCT00397111|fMRI|fmri
552945|NCT00397111|Spectrometry|spectrometry
552946|NCT00397111|Relaxometry|relaxometry
552947|NCT00397111|Healthy Volunteer|healthy volunteer
552948|NCT00397111|HV|hv
552949|NCT00397137|Symptomatic haemorrhoids|symptomatic haemorrhoids
552950|NCT00397137|haemorrhoidectomy|haemorrhoidectomy
552951|NCT00397137|stapled anopexy|stapled anopexy
552952|NCT00397150|Infant Nutrition [G06.696.259.750]|infant nutrition [g06.696.259.750]
552953|NCT00397150|Infant Care [N02.421.088.120] +|infant care [n02.421.088.120] +
713315|NCT01012674|MRA|mra
552954|NCT00397150|Diarrhea, Infantile [C23.888.821.214.500]|diarrhea, infantile [c23.888.821.214.500]
552955|NCT00397150|Child Health Services [N02.421.143.130] +|child health services [n02.421.143.130] +
552956|NCT00397150|Counseling [N02.421.143.303]|counseling [n02.421.143.303]
552957|NCT00397150|Growth [G07.574.249] +|growth [g07.574.249] +
552958|NCT00397150|Micronutrients [D11.430]|micronutrients [d11.430]
552959|NCT00397150|Breast Feeding [G06.696.259.750.500]|breast feeding [g06.696.259.750.500]
552960|NCT00397163|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
552961|NCT00397163|Remote ischemic preconditioning|remote ischemic preconditioning
552962|NCT00397163|Troponin-T|troponin-t
552886|NCT00396890|HV|hv
552963|NCT00397189|Primary insomnia as defined by DSM IV criteria|primary insomnia as defined by dsm iv criteria
552964|NCT00397202|Menstruation|menstruation
552966|NCT00397215|influenza|influenza
552967|NCT00397215|vaccine|vaccine
552968|NCT00397228|Parkinson|parkinson
552969|NCT00397228|imaging|imaging
552970|NCT00397228|dopamine transporter|dopamine transporter
552971|NCT00397254|Migraine|migraine
552972|NCT00397254|rizatriptan|rizatriptan
552973|NCT00397267|Dyspnea|dyspnea
552974|NCT00397267|Cough|cough
552975|NCT00397280|Neutrophil|neutrophil
552976|NCT00397280|Immunity|immunity
552977|NCT00397280|Signal Transduction|signal transduction
552978|NCT00397280|Lipopolysaccharide|lipopolysaccharide
552979|NCT00397280|Cholesterol|cholesterol
552980|NCT00397280|Healthy Volunteer|healthy volunteer
552981|NCT00397280|HV|hv
552982|NCT00397293|AT101|at101
552983|NCT00397293|AT-101|at-101
552984|NCT00397293|cancer|cancer
552985|NCT00397293|lung|lung
552986|NCT00397293|small-cell|small-cell
552987|NCT00397293|topotecan|topotecan
552988|NCT00397319|Growth Hormone|growth hormone
552989|NCT00397319|Cardiovascular System|cardiovascular system
552990|NCT00397332|GVHD|gvhd
552991|NCT00397345|Renal|renal
552992|NCT00397345|TroVax|trovax
552993|NCT00397345|survival|survival
552994|NCT00397345|metastatic|metastatic
552995|NCT00397345|Kidney|kidney
552996|NCT00397345|cancer|cancer
552997|NCT00397345|immunotherapy|immunotherapy
552998|NCT00397345|Locally advanced or metastatic, measurable, histologically proven clear cell renal carcinoma.|locally advanced or metastatic, measurable, histologically proven clear cell renal carcinoma.
552999|NCT00397358|Peritoneal Dialysis|peritoneal dialysis
553000|NCT00397358|Hypertriglyceridemia|hypertriglyceridemia
553001|NCT00397358|Extraneal(7.5% icodextrin)Peritoneal Dialysis Solution|extraneal(7.5% icodextrin)peritoneal dialysis solution
553002|NCT00397397|Urinary Calculi|urinary calculi
553003|NCT00397397|Rowatinex|rowatinex
553004|NCT00397397|Alfuzosin|alfuzosin
553005|NCT00397397|Drug Therapy|drug therapy
553006|NCT00397410|hip protectors|hip protectors
553007|NCT00397410|uptake and adherence|uptake and adherence
553008|NCT00397410|Nursing home residents|nursing home residents
553009|NCT00397410|efficacy|efficacy
553010|NCT00397410|prevention|prevention
553011|NCT00397423|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
553012|NCT00397423|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
553013|NCT00397423|Randomized Control Trial Study|randomized control trial study
553014|NCT00404482|uveitis|uveitis
553015|NCT00404482|jia|jia
553016|NCT00404482|Cyclosporine A|cyclosporine a
553017|NCT00404482|MTX|mtx
553018|NCT00404508|Hydralazine|hydralazine
553112|NCT00405379|RSA|rsa
553019|NCT00404508|Magnesium Valproate|magnesium valproate
553020|NCT00404508|Chemotherapy resistance|chemotherapy resistance
553021|NCT00404508|Epigenetic therapy|epigenetic therapy
553022|NCT00404521|Tumor|tumor
553023|NCT00404521|PM02734|pm02734
553024|NCT00404521|PharmaMar|pharmamar
553025|NCT00404534|functional dyspepsia|functional dyspepsia
553026|NCT00404534|Helicobacter pylori|helicobacter pylori
553027|NCT00404534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
553028|NCT00404534|Gastritis|gastritis
553029|NCT00404547|Asthma|asthma
553030|NCT00404547|Alvesco®|alvesco®
553031|NCT00404547|Ciclesonide|ciclesonide
553032|NCT00404560|CTLA4 Mutation|ctla4 mutation
553033|NCT00404560|Recurrent Infections|recurrent infections
553034|NCT00404560|Immunodeficiency|immunodeficiency
553035|NCT00404560|Phagocytes|phagocytes
553036|NCT00404560|PI3K|pi3k
553037|NCT00404560|DOCK8|dock8
553038|NCT00404560|STAT 1|stat 1
553039|NCT00404560|Genetic Mutation|genetic mutation
553040|NCT00404560|Cytokines|cytokines
553041|NCT00404560|Auto-antibodies|auto-antibodies
553042|NCT00404560|Infection Susceptibility|infection susceptibility
553043|NCT00404560|Immune Disorders|immune disorders
553044|NCT00404560|Immune Defects of Phagocytes|immune defects of phagocytes
553045|NCT00404560|Unusual, Chronic Bacterial, Mycobacterial, and Fungal Infections|unusual, chronic bacterial, mycobacterial, and fungal infections
553046|NCT00404573|Schizophrenia|schizophrenia
553047|NCT00404586|GW784568X|gw784568x
553048|NCT00404586|Intranasal|intranasal
553049|NCT00404586|Environmental Challenge Chamber|environmental challenge chamber
553147|NCT00405522|Pediatrics|pediatrics
552397|NCT00395070|TMZ|tmz
553050|NCT00404599|simvastatin, atorvastatin, oxidative stress|simvastatin, atorvastatin, oxidative stress
553051|NCT00404612|uveitis|uveitis
553052|NCT00404612|calcineurin|calcineurin
553053|NCT00404625|Bacteremia caused by ESBL-producing Enterobacteriaceae|bacteremia caused by esbl-producing enterobacteriaceae
553054|NCT00404625|Pneumonia caused by ESBL-producing Enterobacteriaceae|pneumonia caused by esbl-producing enterobacteriaceae
553055|NCT00404625|Abdomen infections due to ESBL-producing Enterobacteriaceae|abdomen infections due to esbl-producing enterobacteriaceae
553056|NCT00404625|Skin infections caused by ESBL-producing Enterobacteriaceae|skin infections caused by esbl-producing enterobacteriaceae
553057|NCT00404625|Urinary infections due to ESBL-producing Enterobacteriaceae|urinary infections due to esbl-producing enterobacteriaceae
553058|NCT00404638|Enuresis Nocturna|enuresis nocturna
553059|NCT00404638|Paula Method|paula method
553060|NCT00404638|Circular muscle exercise|circular muscle exercise
553061|NCT00404638|Sphincter|sphincter
553062|NCT00404651|Diphtheria|diphtheria
553063|NCT00404651|Tetanus|tetanus
553064|NCT00404651|Pertussis|pertussis
553065|NCT00404651|Hepatitis B|hepatitis b
553066|NCT00404651|Poliomyelitis|poliomyelitis
553067|NCT00404651|Invasive Haemophilus influenzae type b.|invasive haemophilus influenzae type b.
553068|NCT00404664|influenza vaccine|influenza vaccine
553069|NCT00404664|influenza immunization|influenza immunization
553070|NCT00404664|reminder letters|reminder letters
553071|NCT00404664|raffle prize|raffle prize
553072|NCT00404690|Gastroschisis|gastroschisis
553073|NCT00404690|Silo|silo
553074|NCT00404690|Operative closure|operative closure
553075|NCT00404729|Glaucoma|glaucoma
553076|NCT00404729|Optic Neuropathy, Ischemic|optic neuropathy, ischemic
553077|NCT00404729|Visual Pathways,|visual pathways,
553078|NCT00404729|Optic nerve|optic nerve
553079|NCT00404729|Neural conduction|neural conduction
553080|NCT00404742|uveitis|uveitis
553081|NCT00404742|calcineurin|calcineurin
553082|NCT00404755|Depression|depression
553083|NCT00404768|Premature Labor|premature labor
553084|NCT00404768|Pre Term Labor|pre term labor
553085|NCT00404768|intravenous|intravenous
553086|NCT00404768|fetal fibronectin|fetal fibronectin
553087|NCT00404781|ischemic heart disease|ischemic heart disease
553088|NCT00404781|acute coronary syndromes|acute coronary syndromes
553089|NCT00404781|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
553090|NCT00404781|platelet function|platelet function
553091|NCT00404781|aspirin|aspirin
553092|NCT00404781|clopidogrel|clopidogrel
553093|NCT00404781|cilostazol|cilostazol
553094|NCT00405301|Tuberculosis|tuberculosis
553095|NCT00405301|Drug Induced Hepatotoxicity|drug induced hepatotoxicity
553096|NCT00405301|Anti-tuberculosis drugs|anti-tuberculosis drugs
553097|NCT00405301|India|india
553098|NCT00405314|respiratory failure|respiratory failure
553099|NCT00405314|non invasive ventilation|non invasive ventilation
553100|NCT00405314|prehospital|prehospital
553101|NCT00405314|endotracheal intubation|endotracheal intubation
553102|NCT00405314|continuous positive airway pressure|continuous positive airway pressure
553103|NCT00405327|tumor vaccine|tumor vaccine
553104|NCT00405327|metastatic solid tumors|metastatic solid tumors
553105|NCT00405327|recurrent tumors|recurrent tumors
553106|NCT00405353|multiple sclerosis|multiple sclerosis
553107|NCT00405353|testosterone|testosterone
553108|NCT00405366|stage II renal cell cancer|stage ii renal cell cancer
553109|NCT00405366|stage III renal cell cancer|stage iii renal cell cancer
553110|NCT00405366|stage IV renal cell cancer|stage iv renal cell cancer
553111|NCT00405379|arthroplasty|arthroplasty
553113|NCT00405379|Osteoarthritis|osteoarthritis
553114|NCT00405379|trabecular metal mesh|trabecular metal mesh
553115|NCT00405392|Ibandronate|ibandronate
553116|NCT00405392|risedronate|risedronate
553117|NCT00405392|Osteoporosis|osteoporosis
553118|NCT00405392|preference|preference
553119|NCT00405405|Head and neck cancer|head and neck cancer
553120|NCT00405405|Parotid gland cancer|parotid gland cancer
553121|NCT00405405|thyroid gland cancer|thyroid gland cancer
553122|NCT00405405|melanoma|melanoma
553123|NCT00405405|Chemoradiotherapy|chemoradiotherapy
553124|NCT00405405|bevacizumab|bevacizumab
553125|NCT00405405|erlotinib|erlotinib
553126|NCT00405431|glaucoma filtering surgery|glaucoma filtering surgery
553127|NCT00405431|restasis|restasis
553128|NCT00405431|conjunctival inflammation|conjunctival inflammation
553129|NCT00405444|Pediatrics|pediatrics
553130|NCT00405444|Pain|pain
553131|NCT00405444|Voiding Cystourethrogram|voiding cystourethrogram
553132|NCT00405444|Catheterization|catheterization
553133|NCT00405444|Fentanyl|fentanyl
553134|NCT00405470|arthroplasty|arthroplasty
553135|NCT00405470|RSA|rsa
553136|NCT00405470|micromotion|micromotion
553137|NCT00405470|osteoarthritis|osteoarthritis
553138|NCT00405483|arthroplasty|arthroplasty
553139|NCT00405483|RSA|rsa
553140|NCT00405483|micromotion|micromotion
553141|NCT00405483|osteoarthritis|osteoarthritis
553142|NCT00405483|minimally invasive|minimally invasive
553143|NCT00405483|ProfemurZ|profemurz
553144|NCT00405509|Upper Respiratory Infection|upper respiratory infection
553145|NCT00405509|Common Cold|common cold
553146|NCT00405522|Lumbar Puncture|lumbar puncture
553148|NCT00405522|Propofol|propofol
553149|NCT00405522|Remifentanil|remifentanil
553150|NCT00405522|sedation|sedation
553151|NCT00405522|Oncology|oncology
553153|NCT00405535|Obsessive Compulsive Disorder|obsessive compulsive disorder
553154|NCT00405535|Glycine|glycine
553155|NCT00405561|Advanced Colorectal Carcinoma|advanced colorectal carcinoma
553156|NCT00405574|prostate|prostate
553157|NCT00405574|PSA|psa
553158|NCT00405574|antiangiogenic|antiangiogenic
553159|NCT00405574|copper|copper
553160|NCT00405574|ATN-224|atn-224
553161|NCT00405600|Lumbar degenerative disease|lumbar degenerative disease
553162|NCT00405600|spinal stenosis|spinal stenosis
553163|NCT00405600|spondylolisthesis|spondylolisthesis
553164|NCT00405600|non instrumented surgery|non instrumented surgery
553165|NCT00405600|instrumented surgery|instrumented surgery
553167|NCT00405613|Aspirin|aspirin
553168|NCT00405613|Bleeding|bleeding
553169|NCT00405613|Clinical Trial|clinical trial
553170|NCT00405613|Dental Extraction|dental extraction
553171|NCT00405626|post partum hemmorhage,Arnica montana,Bellis Perenis|post partum hemmorhage,arnica montana,bellis perenis
553172|NCT00405652|Liver transplantation, mycophenolate, GI problems, Quality of Life|liver transplantation, mycophenolate, gi problems, quality of life
553173|NCT00405665|Cystic Fibrosis|cystic fibrosis
553174|NCT00405665|L-Arginine|l-arginine
553175|NCT00405665|Pediatrics|pediatrics
553176|NCT00405665|pulmonary function|pulmonary function
553177|NCT00405678|Exercise Intervention|exercise intervention
553178|NCT00405678|Breast Cancer|breast cancer
553179|NCT00405678|Neo-Adjuvant Therapy|neo-adjuvant therapy
553180|NCT00405678|Operable Breast Cancer Stage I-II receiving neo-adjuvant chemotherapy|operable breast cancer stage i-ii receiving neo-adjuvant chemotherapy
553181|NCT00405691|Medical Device|medical device
553182|NCT00405691|Spine|spine
553183|NCT00405691|Lumbar Spinal Stenosis|lumbar spinal stenosis
553184|NCT00405691|Degenerative Spondylolisthesis|degenerative spondylolisthesis
553185|NCT00405691|Facet Arthrosis|facet arthrosis
553186|NCT00405691|Back and Leg Pain|back and leg pain
553187|NCT00405691|Spine Research|spine research
553188|NCT00405691|Medical Device Research|medical device research
553190|NCT00405691|Lumbar Treatment|lumbar treatment
553191|NCT00405691|Spinal Treatment|spinal treatment
553192|NCT00405691|Spinal Device|spinal device
553193|NCT00405704|Vesicoureteral Reflux|vesicoureteral reflux
553194|NCT00405704|Urinary Tract Infections|urinary tract infections
553195|NCT00405704|Renal Scarring|renal scarring
553196|NCT00405704|Antibiotic Resistance|antibiotic resistance
553197|NCT00405704|Controlled Clinical Trial|controlled clinical trial
553198|NCT00405704|Trimethoprim-Sulfamethoxazole|trimethoprim-sulfamethoxazole
553199|NCT00405704|Children|children
553200|NCT00405717|ischemic heart disease|ischemic heart disease
553201|NCT00405717|acute coronary syndromes|acute coronary syndromes
553202|NCT00405717|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
553203|NCT00405717|statin|statin
553204|NCT00405717|clopidogrel|clopidogrel
553205|NCT00405730|Cataracts|cataracts
553206|NCT00405743|CP-4055|cp-4055
553207|NCT00405743|ELACYT™|elacyt™
553208|NCT00405743|Cancer|cancer
553209|NCT00405743|Refractory|refractory
553210|NCT00405743|Relapsed|relapsed
553211|NCT00405743|Hematologic Malignancies|hematologic malignancies
553212|NCT00405743|Leukemia|leukemia
553213|NCT00405743|ALL|all
553214|NCT00405743|AML|aml
553215|NCT00405743|AMM|amm
553216|NCT00405743|CLL|cll
553217|NCT00405743|CML|cml
553218|NCT00405743|CMML|cmml
553219|NCT00405743|MDS|mds
553220|NCT00405756|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
553221|NCT00405756|Celgene|celgene
553222|NCT00405756|CC-5013|cc-5013
553223|NCT00405756|Revlimid|revlimid
553224|NCT00405756|Lenalidomide|lenalidomide
553225|NCT00405756|Melphalan|melphalan
553226|NCT00405756|Prednisone|prednisone
553227|NCT00405756|Elderly|elderly
553228|NCT00405769|statin intolerance|statin intolerance
553229|NCT00405769|hyperlipidemia|hyperlipidemia
553230|NCT00405769|lifestyle changes|lifestyle changes
553231|NCT00405769|red yeast rice|red yeast rice
553232|NCT00405782|metastatic breast cancer|metastatic breast cancer
553233|NCT00405782|exercise intervention|exercise intervention
553234|NCT00405795|Pressure Ulcer|pressure ulcer
553235|NCT00405821|AIDS|aids
553236|NCT00405821|HIV Disease Progression|hiv disease progression
553237|NCT00405821|Quality of Life|quality of life
553238|NCT00405821|HIV Viral Load|hiv viral load
553239|NCT00405821|Genital Ulcers|genital ulcers
553240|NCT00405821|HIV|hiv
553241|NCT00405821|Treatment Naive|treatment naive
553242|NCT00405834|Pressure Ulcers|pressure ulcers
553243|NCT00405847|Sleep|sleep
553244|NCT00405847|Critical illness|critical illness
553245|NCT00405847|Cytokine|cytokine
553246|NCT00405873|Primary hepatocellular carcinoma|primary hepatocellular carcinoma
553247|NCT00405873|Liver cancer|liver cancer
713684|NCT01021956|AMD|amd
553248|NCT00405873|Tumour response|tumour response
553249|NCT00405873|Quality of life|quality of life
553251|NCT00405899|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
553252|NCT00405899|Perennial Allergic Rhinitis|perennial allergic rhinitis
553253|NCT00405925|AIDS|aids
553254|NCT00405925|Treatment Naive|treatment naive
553255|NCT00405938|Breast cancer|breast cancer
553256|NCT00405938|Metastatic breast cancer|metastatic breast cancer
553257|NCT00405938|Bevacizumab|bevacizumab
553258|NCT00405938|Anastrozole|anastrozole
553259|NCT00405938|Fulvestrant|fulvestrant
553260|NCT00405977|Neuromuscular block|neuromuscular block
553261|NCT00405977|Magnesium|magnesium
553262|NCT00405977|Rocuronium|rocuronium
553263|NCT00405977|Time course of action|time course of action
553264|NCT00405990|HIV|hiv
553265|NCT00405990|MTCT|mtct
553266|NCT00405990|heterosexual behaviour|heterosexual behaviour
553267|NCT00405990|sexual risk behaviour|sexual risk behaviour
553268|NCT00405990|couple counselling|couple counselling
553269|NCT00405990|Voluntary counselling and testing|voluntary counselling and testing
553270|NCT00405990|HIV Seronegativity|hiv seronegativity
553271|NCT00406003|BRL029060/Paroxetine CR|brl029060/paroxetine cr
553272|NCT00406003|pharmacokinetics|pharmacokinetics
553274|NCT00406016|Acute spinal cord injury;|acute spinal cord injury;
553275|NCT00406042|glaucoma|glaucoma
553276|NCT00406042|trabeculoplasty|trabeculoplasty
553277|NCT00406042|steroids|steroids
553278|NCT00406068|Bladder neoplasm|bladder neoplasm
553279|NCT00406068|Intravesical drug administration|intravesical drug administration
553280|NCT00406068|Neoplasm recurrence, local|neoplasm recurrence, local
553281|NCT00406068|Transitional cell, carcinoma|transitional cell, carcinoma
553282|NCT00406068|Carcinoma in situ|carcinoma in situ
553283|NCT00406068|Mycobacterium|mycobacterium
553284|NCT00406094|NARES|nares
553285|NCT00406094|eosinophils|eosinophils
553286|NCT00406094|nasal symptoms|nasal symptoms
553287|NCT00406107|branch retinal vein occlusion|branch retinal vein occlusion
553288|NCT00406107|macular edema|macular edema
553289|NCT00406107|pegaptanib sodium|pegaptanib sodium
553290|NCT00406107|vascular endothelial growth factor|vascular endothelial growth factor
553291|NCT00406120|eye|eye
553292|NCT00406120|uvea|uvea
553293|NCT00406120|iris|iris
553294|NCT00406120|choroid|choroid
553295|NCT00406120|ciliary body|ciliary body
553296|NCT00406120|melanoma|melanoma
553297|NCT00406120|iris melanoma|iris melanoma
553298|NCT00406120|choroidal melanoma|choroidal melanoma
553299|NCT00406120|ciliary body melanoma|ciliary body melanoma
553300|NCT00406120|uveal melanoma|uveal melanoma
553301|NCT00406120|posterior uveal melanoma|posterior uveal melanoma
553302|NCT00406120|prognosis|prognosis
553303|NCT00406120|metastasis|metastasis
553304|NCT00406120|genetic testing|genetic testing
553305|NCT00406120|molecular testing|molecular testing
553306|NCT00406120|gene expression profiling|gene expression profiling
553307|NCT00406159|Autism|autism
553308|NCT00406159|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
553309|NCT00406159|Behavioral assessments|behavioral assessments
553310|NCT00406185|Registry|registry
553311|NCT00406185|cardiac catheterization laboratory|cardiac catheterization laboratory
553312|NCT00406185|coronary heart disease|coronary heart disease
553313|NCT00406185|cardiovascular disease|cardiovascular disease
553314|NCT00406198|Sepsis syndrom|sepsis syndrom
553315|NCT00406198|severe sepsis|severe sepsis
553316|NCT00406198|septic shock|septic shock
553317|NCT00406198|hemofiltration|hemofiltration
553318|NCT00406198|multiple organ failure|multiple organ failure
553319|NCT00406211|Rubella|rubella
553320|NCT00406211|Varicella|varicella
553321|NCT00406211|Measles|measles
553322|NCT00406211|Mumps|mumps
553323|NCT00406211|Germany|germany
553324|NCT00406211|Austria|austria
553325|NCT00406263|nuclear sclerotic cataract|nuclear sclerotic cataract
553326|NCT00406263|cataract|cataract
553327|NCT00406276|Lung Cancer|lung cancer
553328|NCT00406302|NSCLC|nsclc
553329|NCT00406302|non-small-cell lung cancer|non-small-cell lung cancer
553330|NCT00406315|ziprasidone, quetiapine (Seroquel) switch, open label, flexible dose, schizophrenia, schizoaffective disorder|ziprasidone, quetiapine (seroquel) switch, open label, flexible dose, schizophrenia, schizoaffective disorder
553331|NCT00406380|Telangiectasias|telangiectasias
553332|NCT00406380|Leakage|leakage
553333|NCT00406380|Bevacizumab|bevacizumab
553334|NCT00406380|Telangiectasias secondary to Branch Retinal Vein Occlusion (BRVO)|telangiectasias secondary to branch retinal vein occlusion (brvo)
553335|NCT00406380|Idiopathic juxtafoveal retinal telangiectasias|idiopathic juxtafoveal retinal telangiectasias
553336|NCT00406393|Acute Myelogenous Leukemia|acute myelogenous leukemia
553337|NCT00406393|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
553338|NCT00406393|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
553339|NCT00406419|anti-CD20|anti-cd20
553340|NCT00406419|stage|stage
553341|NCT00406419|CD20|cd20
553342|NCT00406419|RA|ra
553343|NCT00406432|BRL029060/Paroxetine CR|brl029060/paroxetine cr
553344|NCT00406432|pharmacokinetics|pharmacokinetics
553345|NCT00406432|repeat dose|repeat dose
553346|NCT00406445|Metabolism|metabolism
553347|NCT00406445|Li-Fraumeni Syndrome|li-fraumeni syndrome
553348|NCT00406458|Diabetic neuropathy|diabetic neuropathy
553349|NCT00406458|Diabetes Type I or II|diabetes type i or ii
553350|NCT00406458|Mild to moderate sensorimotor diabetic polyneuropathy|mild to moderate sensorimotor diabetic polyneuropathy
553351|NCT00406471|Ischemic|ischemic
553352|NCT00406471|Central|central
553353|NCT00406471|Retinal|retinal
553354|NCT00406471|Vein|vein
553355|NCT00406471|Occlusion|occlusion
553356|NCT00406471|Ranibizumab|ranibizumab
553357|NCT00406471|Lucentis|lucentis
553358|NCT00406471|CRVO|crvo
553359|NCT00406471|ISCRVO|iscrvo
553360|NCT00406484|Methadone|methadone
553361|NCT00406484|Counseling|counseling
553362|NCT00406484|HIV risk reduction|hiv risk reduction
553363|NCT00406484|HIV Seronegativity|hiv seronegativity
553364|NCT00406536|Cystic Fibrosis|cystic fibrosis
553365|NCT00406536|Pancreatic Insufficiency|pancreatic insufficiency
553366|NCT00406536|LYM-X-SORB™|lym-x-sorb™
553368|NCT00406549|Staphylococcus aureus|staphylococcus aureus
553369|NCT00406549|Nasal colonization|nasal colonization
553370|NCT00406549|pre-surgical patients|pre-surgical patients
553371|NCT00406549|Sensitivity|sensitivity
553372|NCT00406549|Specificity|specificity
553373|NCT00406549|Nasal Staphylococcus aureus in pre-surgical patients|nasal staphylococcus aureus in pre-surgical patients
553374|NCT00406562|uncontrolled|uncontrolled
553375|NCT00406575|Congestive heart failure|congestive heart failure
553376|NCT00406575|Relaxin|relaxin
553377|NCT00406575|Hemodynamics|hemodynamics
553378|NCT00406575|Renal function|renal function
553379|NCT00406588|Parkinson Disease|parkinson disease
553380|NCT00406614|High Blood Pressure|high blood pressure
553381|NCT00406627|filariasis, lymphatic filariasis, Egypt|filariasis, lymphatic filariasis, egypt
553383|NCT00406640|Major Depressive Disorder|major depressive disorder
553384|NCT00406640|Depression|depression
553385|NCT00406679|pain, postoperative|pain, postoperative
553386|NCT00406679|surgery, oral|surgery, oral
553387|NCT00406679|surgery, dental|surgery, dental
553388|NCT00406692|Zonisamide|zonisamide
553389|NCT00406692|Alcoholism|alcoholism
553390|NCT00406692|Alcohol|alcohol
553391|NCT00406705|Exercise Tolerance|exercise tolerance
553392|NCT00406705|Dyspnea|dyspnea
553393|NCT00406705|Rehabilitation|rehabilitation
553394|NCT00406705|Helium|helium
553395|NCT00406718|Medication Adherence|medication adherence
553396|NCT00406718|Psychosocial Treatment|psychosocial treatment
553397|NCT00406718|Cognitive Adaptation Training|cognitive adaptation training
553398|NCT00406718|Med-e Monitor|med-e monitor
553399|NCT00406718|Adaptive Function|adaptive function
553400|NCT00406731|Endothelin-1|endothelin-1
553401|NCT00406731|L-NG-Monomethyl Arginine|l-ng-monomethyl arginine
553402|NCT00406731|Optic Nerve Head blood flow|optic nerve head blood flow
553403|NCT00406744|neovascularization|neovascularization
553404|NCT00406757|T-cell|t-cell
553405|NCT00406757|T-ALL|t-all
553406|NCT00406757|T-LBL|t-lbl
553407|NCT00406757|506U78|506u78
553408|NCT00406757|ara-G|ara-g
553409|NCT00406757|ara-GTP|ara-gtp
553410|NCT00406757|Lymphoma|lymphoma
553411|NCT00406757|Leukemia|leukemia
553412|NCT00406770|Obesity|obesity
553413|NCT00406770|Light therapy|light therapy
553414|NCT00406770|Hypocaloric diet|hypocaloric diet
553415|NCT00406783|Allergic Rhinitis|allergic rhinitis
553416|NCT00406783|Intermittent Allergic Rhinitis|intermittent allergic rhinitis
553417|NCT00406809|Sezary syndrome|sezary syndrome
553418|NCT00406809|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
553419|NCT00406809|follicular lymphoma|follicular lymphoma
553420|NCT00406809|marginal zone lymphoma|marginal zone lymphoma
553421|NCT00406809|indolent T-cell lymphoma|indolent t-cell lymphoma
553422|NCT00406809|Navitoclax|navitoclax
553524|NCT00407381|DME|dme
553423|NCT00406809|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
553424|NCT00406809|peripheral T-cell lymphoma|peripheral t-cell lymphoma
553425|NCT00406809|ABT-263|abt-263
553426|NCT00406809|lymphoid malignancies|lymphoid malignancies
553427|NCT00406809|chronic lymphoid leukemia|chronic lymphoid leukemia
553428|NCT00406809|mycosis fungoides|mycosis fungoides
553429|NCT00406809|mantle cell lymphoma|mantle cell lymphoma
553430|NCT00406822|Glaucoma|glaucoma
553431|NCT00406822|collagen matrix|collagen matrix
553432|NCT00406822|OculusGen|oculusgen
553433|NCT00406822|trabeculectomy|trabeculectomy
553434|NCT00406822|tissue engineering|tissue engineering
553435|NCT00406835|Whole Brain Radiation Therapy|whole brain radiation therapy
553436|NCT00406835|Stereotactic Radiosurgery|stereotactic radiosurgery
553437|NCT00406835|Brain metastases|brain metastases
553438|NCT00406861|reaction|reaction
553439|NCT00406861|ENL|enl
553440|NCT00406861|leprosy|leprosy
553441|NCT00406874|infertility|infertility
553442|NCT00406874|semen quality|semen quality
553443|NCT00406874|sexual function|sexual function
553444|NCT00406874|blood pressure|blood pressure
553445|NCT00406874|omega 3 fats|omega 3 fats
553446|NCT00406874|folic acid|folic acid
553447|NCT00406900|uveal melanoma|uveal melanoma
552816|NCT00396643|RCT|rct
553448|NCT00406900|metastatic disease|metastatic disease
553449|NCT00406939|Gene Therapy|gene therapy
553450|NCT00406939|Immunology|immunology
553451|NCT00406939|Phase I Clinical Trial|phase i clinical trial
553452|NCT00406978|MYELOMA|myeloma
553453|NCT00406978|THALIDOMIDE|thalidomide
553454|NCT00406978|DEFIBRODITE|defibrodite
553455|NCT00406991|retinal blood flow|retinal blood flow
553456|NCT00406991|diabetic retinopathy|diabetic retinopathy
553457|NCT00406991|microthrombosis|microthrombosis
553458|NCT00406991|aspirin|aspirin
553459|NCT00406991|clopidogrel|clopidogrel
553460|NCT00407004|acute-on-chronic liver failure, MARS, Prometheus, bilirubin, bile acids, cytokines|acute-on-chronic liver failure, mars, prometheus, bilirubin, bile acids, cytokines
553461|NCT00407043|Dry Eye Disease|dry eye disease
553462|NCT00407043|Lotemax|lotemax
553463|NCT00407043|Restasis|restasis
553464|NCT00407043|Loteprednol|loteprednol
553465|NCT00407043|Cyclosporine|cyclosporine
553466|NCT00407095|Parkinson Disease|parkinson disease
553467|NCT00407108|vitreoretinal surgery|vitreoretinal surgery
553468|NCT00407121|Neovascular Membrane|neovascular membrane
553469|NCT00407121|Uveitis|uveitis
553470|NCT00407121|Bevacizumab|bevacizumab
553471|NCT00407147|bacterial infection|bacterial infection
553472|NCT00407147|empiric antibiotic treatment|empiric antibiotic treatment
553473|NCT00407147|duration antibiotic treatment|duration antibiotic treatment
553474|NCT00407147|reduce antibiotic treatment|reduce antibiotic treatment
553475|NCT00407147|procalcitonin|procalcitonin
553476|NCT00407147|PCT Kryptor|pct kryptor
553477|NCT00407147|sepsis|sepsis
553478|NCT00407147|Intensive Care Unit|intensive care unit
553479|NCT00407147|antibiotic treatment|antibiotic treatment
553480|NCT00407160|Kidney transplant|kidney transplant
553481|NCT00407160|Tolerance induction|tolerance induction
553482|NCT00407160|High PRA kidney recipients|high pra kidney recipients
553484|NCT00407186|gastric cancer|gastric cancer
553485|NCT00407186|surgery|surgery
553486|NCT00407186|adjuvant|adjuvant
553487|NCT00407186|chemotherapy|chemotherapy
553488|NCT00407186|chemoradiotherapy|chemoradiotherapy
553489|NCT00407186|capecitabine|capecitabine
553490|NCT00407186|cisplatin|cisplatin
553491|NCT00407186|epirubicin|epirubicin
553492|NCT00407199|social phobia, anxiety, quetiapine|social phobia, anxiety, quetiapine
553493|NCT00407212|early stage idiopathic Parkinson's disease|early stage idiopathic parkinson's disease
553494|NCT00407238|barrier function, multi-purpose solutions, silicone hydrogel contact lenses|barrier function, multi-purpose solutions, silicone hydrogel contact lenses
553495|NCT00407251|refractory|refractory
553496|NCT00407251|prostate|prostate
553497|NCT00407251|hormone|hormone
553498|NCT00407264|bronchial squamous metaplasia|bronchial squamous metaplasia
553499|NCT00407264|bronchial squamous dysplasia|bronchial squamous dysplasia
553500|NCT00407277|nicotine dependence|nicotine dependence
553501|NCT00407277|smoking|smoking
553502|NCT00407277|nicotine patch|nicotine patch
553503|NCT00407277|double-blind|double-blind
553504|NCT00407277|randomized|randomized
553505|NCT00407277|placebo|placebo
553506|NCT00407277|psychosis|psychosis
553507|NCT00407277|schizophrenia|schizophrenia
553508|NCT00407277|schizophreniform|schizophreniform
553509|NCT00407277|schizoaffective disorder|schizoaffective disorder
553510|NCT00407290|pregnancy|pregnancy
553511|NCT00407290|vaginal delivery|vaginal delivery
553512|NCT00407316|Uveitis|uveitis
553513|NCT00407316|Quality of life|quality of life
553514|NCT00407316|Visual function|visual function
553515|NCT00407329|BPH|bph
553516|NCT00407342|Psoriasis|psoriasis
553517|NCT00407342|biologics|biologics
553518|NCT00407342|alefacept|alefacept
553519|NCT00407342|Narrowband UVB|narrowband uvb
553520|NCT00407342|Phototherapy|phototherapy
553521|NCT00407342|Half-side comparison|half-side comparison
553522|NCT00407355|vein occlusion|vein occlusion
553523|NCT00407355|macular edema|macular edema
553525|NCT00407394|Pneumonia|pneumonia
553526|NCT00407394|Wheezing|wheezing
553527|NCT00407394|Treatment|treatment
553528|NCT00407394|Children|children
553529|NCT00407394|India|india
553530|NCT00407407|Epithelial ovarian|epithelial ovarian
553531|NCT00407407|Primary peritoneal or fallopian tube carcinoma|primary peritoneal or fallopian tube carcinoma
553532|NCT00407407|Abraxane|abraxane
553533|NCT00407407|Carboplatin|carboplatin
553534|NCT00407420|Childhood|childhood
553535|NCT00407420|Obesity|obesity
553536|NCT00407420|Behavior modification|behavior modification
553537|NCT00407420|Insulin resistance|insulin resistance
553538|NCT00407433|Gemcitabine|gemcitabine
553539|NCT00407433|Oxaliplatine|oxaliplatine
553540|NCT00407433|Paediatric solid tumors|paediatric solid tumors
553541|NCT00407433|Other CNS tumors|other cns tumors
553542|NCT00407433|Other miscellaneous solid non-CNS tumours|other miscellaneous solid non-cns tumours
553543|NCT00407446|PDE5 inhibition|pde5 inhibition
553544|NCT00407446|chronic heart failure|chronic heart failure
553545|NCT00407446|endothelial function|endothelial function
553546|NCT00407446|exercise ventilation|exercise ventilation
553547|NCT00407472|Bio-equivalence study in healthy volunteers, indication|bio-equivalence study in healthy volunteers, indication
553548|NCT00407472|of product is growth hormone deficiency|of product is growth hormone deficiency
553549|NCT00407498|P 276-00|p 276-00
553550|NCT00407498|Advanced Refractory Neoplasm|advanced refractory neoplasm
553551|NCT00407498|Maximum Tolerated Dose|maximum tolerated dose
553552|NCT00407498|Dose Limiting Toxicity|dose limiting toxicity
553553|NCT00407498|Pharmacokinetics|pharmacokinetics
553554|NCT00407550|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
553555|NCT00407550|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
553556|NCT00407550|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
553557|NCT00407576|Alzheimer's Disease|alzheimer's disease
553558|NCT00407576|Positron Emission Tomography|positron emission tomography
553559|NCT00407576|Brain|brain
553560|NCT00407576|Neurochemistry|neurochemistry
553561|NCT00407576|Beta-Amyloid Plaques|beta-amyloid plaques
553562|NCT00407576|PET|pet
553563|NCT00407576|MeS-IMPY|mes-impy
553564|NCT00407576|Alzheimer Disease|alzheimer disease
553566|NCT00407576|Dementia|dementia
553567|NCT00407576|Healthy Volunteer|healthy volunteer
553568|NCT00407576|HV|hv
553569|NCT00407602|retinitis pigmentosa|retinitis pigmentosa
553570|NCT00407602|device|device
553571|NCT00407602|retinal implant|retinal implant
553572|NCT00407602|retinal prosthesis|retinal prosthesis
553573|NCT00407602|RP|rp
553574|NCT00407602|outer retinal degeneration|outer retinal degeneration
553575|NCT00407628|Stroke|stroke
553576|NCT00407628|Diffusion spectrum tractography|diffusion spectrum tractography
553577|NCT00407628|Functional MRI (fMRI)|functional mri (fmri)
553578|NCT00407628|Lower extremity|lower extremity
553579|NCT00407641|diabetes mellitus|diabetes mellitus
553580|NCT00407641|chronic hemodialysis|chronic hemodialysis
553581|NCT00407641|anticoagulation|anticoagulation
553582|NCT00407641|outcome|outcome
553583|NCT00407667|hemiparesis|hemiparesis
553584|NCT00407667|rehabilitation|rehabilitation
553585|NCT00407667|upper limb rehabilitation|upper limb rehabilitation
553586|NCT00407667|arm therapy|arm therapy
553587|NCT00407680|Type 2 diabetes mellitus|type 2 diabetes mellitus
553588|NCT00407680|Hypertension|hypertension
553589|NCT00407680|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
553590|NCT00407680|Diabetic nephropathy|diabetic nephropathy
553591|NCT00407693|Dosimetry|dosimetry
553592|NCT00407693|Effective Dose|effective dose
553593|NCT00407693|Radiation-Absorbed Dose|radiation-absorbed dose
553594|NCT00407706|Breast Cancer, FACS, SCM, Malignant, Benign, Lymphocytes|breast cancer, facs, scm, malignant, benign, lymphocytes
553595|NCT00407719|Choroidal Neovascularization|choroidal neovascularization
553596|NCT00407732|hepatitis C|hepatitis c
553597|NCT00407732|mental disorder|mental disorder
553598|NCT00407732|substance use|substance use
553599|NCT00407732|psychosocial intervention|psychosocial intervention
553600|NCT00407745|Pain|pain
553601|NCT00407745|central neuropathic pain|central neuropathic pain
553602|NCT00407758|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
553603|NCT00407758|primary peritoneal cavity cancer|primary peritoneal cavity cancer
553604|NCT00407771|platelet function assay|platelet function assay
553605|NCT00407771|Glycoprotein inhibitors|glycoprotein inhibitors
553606|NCT00407771|percutaneous coronary intervention|percutaneous coronary intervention
553607|NCT00407771|Diabetes Mellitus|diabetes mellitus
553608|NCT00407784|primary aldosteronism|primary aldosteronism
553609|NCT00407784|hypertension|hypertension
553610|NCT00407784|aldosteron-renin ratio|aldosteron-renin ratio
553611|NCT00407784|eplerenone|eplerenone
553612|NCT00407784|aldosteron-receptor antagonist|aldosteron-receptor antagonist
553613|NCT00407784|screening|screening
553614|NCT00394550|laryngomalacia|laryngomalacia
553615|NCT00394550|supraglottoplasty|supraglottoplasty
553616|NCT00394550|Tonsillectomy|tonsillectomy
553617|NCT00394550|Adenoidectomy|adenoidectomy
553618|NCT00394550|obstructive sleep apnea|obstructive sleep apnea
553619|NCT00394550|Laser|laser
553620|NCT00394550|Polysomnogram|polysomnogram
553621|NCT00394550|airway obstruction|airway obstruction
553622|NCT00394563|osteoarthritis monoclonal antibody|osteoarthritis monoclonal antibody
553623|NCT00394576|Kidney School|kidney school
553624|NCT00394576|Short Test of Functional Health Literacy|short test of functional health literacy
553625|NCT00394576|Chronic Kidney Disease Knowledge Assessment Tool of Nutrition|chronic kidney disease knowledge assessment tool of nutrition
553626|NCT00394576|Short Form 12 version 2|short form 12 version 2
553627|NCT00394576|Kidney Disease Self-Management Survey|kidney disease self-management survey
553628|NCT00394576|Three Day Dietary Diary|three day dietary diary
553629|NCT00394602|Gastric Cancer|gastric cancer
553630|NCT00394602|Pancreatic Cancer|pancreatic cancer
553631|NCT00394602|Cervical Cancer|cervical cancer
553632|NCT00394602|Vulvar Cancer|vulvar cancer
553633|NCT00394602|Endometrial Cancer|endometrial cancer
553634|NCT00394602|Anal Cancer|anal cancer
553635|NCT00394602|Quality of Life|quality of life
553636|NCT00394602|Questionnaire|questionnaire
553637|NCT00394602|Interview|interview
553638|NCT00394602|Emesis|emesis
553639|NCT00394602|Nausea|nausea
553640|NCT00394602|Survey|survey
553641|NCT00394628|Glioblastoma Multiforme|glioblastoma multiforme
553642|NCT00394628|Radiotherapy|radiotherapy
553643|NCT00394628|temozolomide|temozolomide
553644|NCT00394628|adjuvant temozolomide|adjuvant temozolomide
553645|NCT00394680|coronary revascularization|coronary revascularization
553646|NCT00394680|stent inmplantation|stent inmplantation
553647|NCT00394680|coronary bypass|coronary bypass
553648|NCT00394693|Primary CBCL including (WHO/EORTC classification 2005)|primary cbcl including (who/eortc classification 2005)
553649|NCT00394693|Primary cutaneous marginal zone B-cell lymphoma|primary cutaneous marginal zone b-cell lymphoma
553650|NCT00394693|Primary cutaneous follicle center B-cell lymphoma|primary cutaneous follicle center b-cell lymphoma
553651|NCT00394693|Primary cutaneous diffuse large B-cell other than leg type|primary cutaneous diffuse large b-cell other than leg type
553652|NCT00394693|Histologically consistent with primary CBCL|histologically consistent with primary cbcl
553653|NCT00394693|Relapse or active disease|relapse or active disease
553654|NCT00394706|cardiac arrest|cardiac arrest
553655|NCT00394706|cardiopulmonary resuscitation|cardiopulmonary resuscitation
553656|NCT00394732|chronic low back pain|chronic low back pain
553657|NCT00394732|total disc replacement|total disc replacement
553658|NCT00394732|multidisciplinary rehabilitation|multidisciplinary rehabilitation
553659|NCT00394732|clinical effects|clinical effects
553660|NCT00394732|cost effectiveness|cost effectiveness
553661|NCT00394732|randomized controlled trial|randomized controlled trial
553662|NCT00394732|multicenter study|multicenter study
553663|NCT00394745|Hypertension, Metabolic Syndrome, lipid subfractions|hypertension, metabolic syndrome, lipid subfractions
553664|NCT00394758|ultrasonic surgical aspiration|ultrasonic surgical aspiration
553665|NCT00394758|CO2 laser surgery|co2 laser surgery
553666|NCT00394758|vulvar dysplasia|vulvar dysplasia
553667|NCT00394758|vaginal dysplasia|vaginal dysplasia
553668|NCT00394758|recurrence|recurrence
553669|NCT00394771|oral contraceptives|oral contraceptives
553670|NCT00394771|breakthrough bleeding|breakthrough bleeding
553671|NCT00394771|spotting|spotting
553672|NCT00394784|gram negative bacteria|gram negative bacteria
553674|NCT00394784|infection|infection
553675|NCT00394823|Hypertension, valsartan, compliance|hypertension, valsartan, compliance
553676|NCT00394836|ofatumumab|ofatumumab
553677|NCT00394836|rituximab|rituximab
553679|NCT00394836|CD20|cd20
553680|NCT00394836|refractory|refractory
553681|NCT00394849|Tonsillectomy|tonsillectomy
553682|NCT00394849|Suturing of tonsillar pillars|suturing of tonsillar pillars
553683|NCT00394849|pain|pain
553684|NCT00394849|postoperative hemorrhage, bleeding|postoperative hemorrhage, bleeding
553685|NCT00394875|Randomized controlled trial|randomized controlled trial
553686|NCT00394875|Delegation, Professional|delegation, professional
553687|NCT00394875|Nurses|nurses
553688|NCT00394888|Hemangioma|hemangioma
553689|NCT00394888|PHACE|phace
553690|NCT00394888|Lumbosacral hemangioma|lumbosacral hemangioma
553691|NCT00394888|Occult Spinal Dysraphism|occult spinal dysraphism
553692|NCT00400335|Testosterone|testosterone
553693|NCT00400335|Men|men
553694|NCT00400335|Hypogonadism|hypogonadism
553695|NCT00400335|Dutasteride|dutasteride
553696|NCT00400335|DHT|dht
553697|NCT00400335|Androgen deficiency|androgen deficiency
553698|NCT00400374|Head and Neck Cancer|head and neck cancer
553699|NCT00400387|recurrent pregnancy loss|recurrent pregnancy loss
553700|NCT00400400|RenalTransplantation|renaltransplantation
553701|NCT00400400|KidneyTransplantation|kidneytransplantation
553702|NCT00400400|MPA|mpa
553703|NCT00400400|EC-MPS|ec-mps
553704|NCT00400413|Neuropsychology|neuropsychology
553705|NCT00400413|fMRI|fmri
553706|NCT00400413|Reading|reading
553707|NCT00400413|Phonology|phonology
553708|NCT00400413|Deafness|deafness
553709|NCT00400426|Palliative radiotherapy|palliative radiotherapy
553710|NCT00400426|Recurrent|recurrent
553711|NCT00400426|Head and neck Neoplasm|head and neck neoplasm
553712|NCT00400426|Quality of life|quality of life
553713|NCT00400452|wheelchair|wheelchair
553714|NCT00400452|skills|skills
553715|NCT00400452|long-term-care|long-term-care
553716|NCT00400452|caregivers|caregivers
553717|NCT00400465|thyroid|thyroid
553718|NCT00400465|thyroidectomy|thyroidectomy
553719|NCT00400465|dressing|dressing
553720|NCT00400478|DLBCL|dlbcl
553721|NCT00400478|NHL 13|nhl 13
553722|NCT00400478|Rituximab|rituximab
553723|NCT00400478|maintenance|maintenance
553724|NCT00400491|diabetes|diabetes
553725|NCT00400491|insulin|insulin
553726|NCT00400491|glycated hemoglobin|glycated hemoglobin
553727|NCT00400491|cholecalciferol|cholecalciferol
553728|NCT00400491|vitamin D|vitamin d
553729|NCT00400504|Thrombelastograph|thrombelastograph
553730|NCT00400504|Cancer|cancer
553731|NCT00400504|Thromboembolism|thromboembolism
553732|NCT00400504|Hypercoagulable|hypercoagulable
553733|NCT00400517|stage III prostate cancer|stage iii prostate cancer
553734|NCT00400517|stage II prostate cancer|stage ii prostate cancer
553735|NCT00400517|adenocarcinoma of the prostate|adenocarcinoma of the prostate
553736|NCT00400517|stage I prostate cancer|stage i prostate cancer
553737|NCT00400517|stage IV prostate cancer|stage iv prostate cancer
553738|NCT00400543|obstructive sleep apnea|obstructive sleep apnea
553739|NCT00400543|arterial stiffness|arterial stiffness
553740|NCT00400543|atherosclerosis|atherosclerosis
553741|NCT00400543|CPAP|cpap
553742|NCT00400543|heart disease|heart disease
553743|NCT00400556|mobilization|mobilization
553744|NCT00400556|ATRA|atra
553745|NCT00400556|G-CSF|g-csf
553746|NCT00400556|filgrastim|filgrastim
553747|NCT00400556|retinoids|retinoids
553748|NCT00400556|stem cell mobilization|stem cell mobilization
553749|NCT00400556|hematopoietic stem and progenitor cells|hematopoietic stem and progenitor cells
553750|NCT00400569|Sunitinib malate|sunitinib malate
553751|NCT00400569|SUTENT|sutent
553752|NCT00400569|SU011248|su011248
553753|NCT00400569|Soft tissue sarcoma|soft tissue sarcoma
553754|NCT00400569|Gastrointestinal stromal tumors (GIST)|gastrointestinal stromal tumors (gist)
553755|NCT00400569|MFH|mfh
553756|NCT00400569|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
553757|NCT00400569|Imatinib mesylate|imatinib mesylate
553673|NCT00394784|culture|culture
553759|NCT00400582|Heart failure|heart failure
553760|NCT00400582|Gene polymorphism|gene polymorphism
553761|NCT00400582|Candesartan|candesartan
553762|NCT00400582|ACE inhibitors|ace inhibitors
553763|NCT00400582|BNP|bnp
553764|NCT00400582|Pharmacogenomics|pharmacogenomics
553765|NCT00400595|peritonitis|peritonitis
553766|NCT00400595|catheter related infection|catheter related infection
553767|NCT00400595|exit site ointments|exit site ointments
553768|NCT00400595|mupirocin|mupirocin
553769|NCT00400595|Polysporin Triple|polysporin triple
553771|NCT00400608|ADVAIR Inhaler|advair inhaler
553772|NCT00400608|Asthma|asthma
553773|NCT00400608|ADVAIR DISKUS|advair diskus
553774|NCT00400621|acetaminophen|acetaminophen
553775|NCT00400621|alcohol|alcohol
553776|NCT00400621|liver injury|liver injury
553777|NCT00400647|kidney transplant|kidney transplant
553778|NCT00400647|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
553779|NCT00400647|quality of life|quality of life
553780|NCT00400647|gastrointestinal symptoms|gastrointestinal symptoms
553781|NCT00400660|GSK615915 asthma surfactant MDI|gsk615915 asthma surfactant mdi
553782|NCT00400673|Acute myelogenous leukemia|acute myelogenous leukemia
553783|NCT00400673|Adult patients|adult patients
553784|NCT00400673|Cytogenetic risk class|cytogenetic risk class
553785|NCT00400673|Clinico-cytogenetic risk model|clinico-cytogenetic risk model
553786|NCT00400673|Risk-oriented therapy|risk-oriented therapy
553787|NCT00400686|anemia|anemia
553788|NCT00400686|stage I multiple myeloma|stage i multiple myeloma
553789|NCT00400686|stage II multiple myeloma|stage ii multiple myeloma
553790|NCT00400686|stage III multiple myeloma|stage iii multiple myeloma
553791|NCT00400686|refractory multiple myeloma|refractory multiple myeloma
553792|NCT00400699|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
553793|NCT00400699|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
553794|NCT00400712|mobility|mobility
553795|NCT00400712|strength|strength
553796|NCT00400712|balance|balance
553797|NCT00400712|function|function
553798|NCT00400712|reintegration|reintegration
553799|NCT00400712|community|community
553800|NCT00400725|maintenance|maintenance
553801|NCT00400725|scalp psoriasis|scalp psoriasis
553802|NCT00400725|Galderma|galderma
553803|NCT00400738|HIV-1 infection|hiv-1 infection
553804|NCT00400738|pharmacokinetics|pharmacokinetics
553805|NCT00400738|protease inhibitor|protease inhibitor
553806|NCT00400738|double boosted protease inhibitors|double boosted protease inhibitors
553807|NCT00400738|PIs|pis
553808|NCT00400738|Treatment Naive|treatment naive
553809|NCT00400751|Health-compromised smokers, family cessation intervention|health-compromised smokers, family cessation intervention
553810|NCT00400764|NHL|nhl
553811|NCT00400764|Follicular NHL|follicular nhl
553812|NCT00400764|Rituxan|rituxan
553813|NCT00400764|Apo2L/TRAIL|apo2l/trail
553814|NCT00400777|Valsartan|valsartan
553815|NCT00400777|hydrochlorothiazide|hydrochlorothiazide
553816|NCT00400777|amlodipine|amlodipine
553817|NCT00400777|hypertension|hypertension
553818|NCT00400777|high blood pressure|high blood pressure
553819|NCT00400790|neurocognitive decline|neurocognitive decline
553820|NCT00400790|coronary artery bypass surgery|coronary artery bypass surgery
553821|NCT00400790|composite morbidity|composite morbidity
553822|NCT00400790|postoperative care cost|postoperative care cost
553823|NCT00400803|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
553824|NCT00400803|Gemcitabine|gemcitabine
553825|NCT00400803|Carboplatin|carboplatin
553826|NCT00400803|Bevacizumab|bevacizumab
553827|NCT00400803|Biological therapy|biological therapy
553828|NCT00400803|Drug therapy|drug therapy
553829|NCT00400816|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
553830|NCT00400816|adult mixed glioma|adult mixed glioma
553831|NCT00400842|SA-001|sa-001
553832|NCT00400842|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
553833|NCT00400842|Pancreatectomy|pancreatectomy
553834|NCT00400855|Asthma|asthma
553189|NCT00405691|Impliant|impliant
553835|NCT00400855|AMP challenge|amp challenge
553836|NCT00400868|rheumatoid arthritis, occupational therapy, joint protection|rheumatoid arthritis, occupational therapy, joint protection
553837|NCT00400881|mechanical ventilation|mechanical ventilation
553838|NCT00400881|weaning|weaning
553839|NCT00400881|respiratory failure|respiratory failure
553840|NCT00400881|spontaneous breathing trial|spontaneous breathing trial
553841|NCT00400894|prostate cancer|prostate cancer
553842|NCT00400894|annexin A3|annexin a3
553843|NCT00400894|early detection|early detection
553844|NCT00400894|exprimate urine|exprimate urine
553845|NCT00400907|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
553846|NCT00400907|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
553847|NCT00400907|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
553848|NCT00400907|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
553849|NCT00400907|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
553850|NCT00400907|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
553851|NCT00400933|Psycho-education|psycho-education
553852|NCT00400933|Eating disorders|eating disorders
553853|NCT00400933|Personality disorders|personality disorders
553854|NCT00400933|Relatives and close friends|relatives and close friends
553855|NCT00400933|Caregiver burden|caregiver burden
553856|NCT00400946|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
553857|NCT00400946|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
553858|NCT00400946|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
553859|NCT00400946|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
553860|NCT00400946|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
553861|NCT00400959|cell therapy|cell therapy
553862|NCT00400959|acute myocardial infarction|acute myocardial infarction
553863|NCT00400972|GlideScope|glidescope
553864|NCT00400972|videolaryngoscopy|videolaryngoscopy
553865|NCT00400972|intubation|intubation
553866|NCT00400972|nasal|nasal
553867|NCT00400972|nasotracheal|nasotracheal
553868|NCT00400972|laryngoscopy|laryngoscopy
553869|NCT00400972|anesthesia|anesthesia
553870|NCT00400985|Heart Failure, Congestive|heart failure, congestive
553871|NCT00400985|Diagnostic|diagnostic
553872|NCT00400985|Ambulatory Monitoring|ambulatory monitoring
553873|NCT00400985|Intrathoracic Impedance|intrathoracic impedance
553874|NCT00400998|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
553875|NCT00400998|Quality of Life|quality of life
553876|NCT00400998|Efficacy|efficacy
553877|NCT00400998|Validation|validation
553878|NCT00400998|Fluticasone Propionate|fluticasone propionate
553879|NCT00401011|Perifosine|perifosine
553880|NCT00401011|Bortezomib|bortezomib
553881|NCT00401011|Dexamethasone|dexamethasone
553882|NCT00401011|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
553883|NCT00401024|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
553884|NCT00401024|adult oligodendroglioma|adult oligodendroglioma
553885|NCT00401024|adult anaplastic astrocytoma|adult anaplastic astrocytoma
553886|NCT00401024|adult giant cell glioblastoma|adult giant cell glioblastoma
553887|NCT00401024|adult gliosarcoma|adult gliosarcoma
553888|NCT00401024|recurrent adult brain tumor|recurrent adult brain tumor
553889|NCT00401024|adult brain stem glioma|adult brain stem glioma
553890|NCT00401024|adult mixed glioma|adult mixed glioma
553891|NCT00401024|adult glioblastoma|adult glioblastoma
553892|NCT00401024|adult pilocytic astrocytoma|adult pilocytic astrocytoma
553893|NCT00401024|adult diffuse astrocytoma|adult diffuse astrocytoma
553894|NCT00401024|adult anaplastic ependymoma|adult anaplastic ependymoma
553895|NCT00401024|adult ependymoma|adult ependymoma
553896|NCT00401024|adult myxopapillary ependymoma|adult myxopapillary ependymoma
553897|NCT00401024|adult subependymoma|adult subependymoma
553898|NCT00401024|adult pineal gland astrocytoma|adult pineal gland astrocytoma
553899|NCT00401024|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
553900|NCT00401050|patellofemoral pain syndrome|patellofemoral pain syndrome
553901|NCT00401050|chiropractic|chiropractic
553902|NCT00401050|knee pain|knee pain
553903|NCT00401050|chiropractic manipulation|chiropractic manipulation
554308|NCT00409318|CRP|crp
553904|NCT00401050|Graston Instrument Soft Tissue Mobilization(GISTM)|graston instrument soft tissue mobilization(gistm)
553905|NCT00401063|Cancer|cancer
553906|NCT00401063|Acupuncture|acupuncture
553907|NCT00401063|Cancer Pain|cancer pain
553908|NCT00401063|Quality of life|quality of life
553909|NCT00401076|SA-001|sa-001
553910|NCT00401076|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
553911|NCT00401076|Chronic Pancreatitis|chronic pancreatitis
553912|NCT00401076|Pancreatectomy|pancreatectomy
553913|NCT00401089|negative symptoms schizophrenia|negative symptoms schizophrenia
553914|NCT00401089|Atypical antipsychotics|atypical antipsychotics
553915|NCT00401089|Neurocognition impairment|neurocognition impairment
553916|NCT00401089|obesity risk factor|obesity risk factor
714504|NCT01009866|GBM|gbm
553917|NCT00401089|Diabetes insulin resistance schizophrenia|diabetes insulin resistance schizophrenia
553918|NCT00401102|self-injurious behavior|self-injurious behavior
553919|NCT00401102|depression|depression
553920|NCT00401102|adolescents|adolescents
553921|NCT00401102|psychotherapy|psychotherapy
553922|NCT00401128|clear cell renal cell carcinoma|clear cell renal cell carcinoma
553923|NCT00401128|recurrent renal cell cancer|recurrent renal cell cancer
553924|NCT00401128|papillary renal cell carcinoma|papillary renal cell carcinoma
554027|NCT00401635|advanced|advanced
553925|NCT00401128|stage IV renal cell cancer|stage iv renal cell cancer
553926|NCT00401141|Systemic lupus|systemic lupus
553927|NCT00401141|B lymphocytes|b lymphocytes
553928|NCT00401141|transcriptomas|transcriptomas
553929|NCT00401154|Spastic Diplegia|spastic diplegia
553930|NCT00401154|Cerebral Palsy|cerebral palsy
553931|NCT00401154|Children|children
553932|NCT00401154|Adolescents|adolescents
553933|NCT00401154|Strengthening|strengthening
553934|NCT00401154|Endurance|endurance
553935|NCT00401167|Alzheimer's disease|alzheimer's disease
553936|NCT00401167|behavioral and psychological symptoms of dementia|behavioral and psychological symptoms of dementia
553937|NCT00401167|severe Alzheimer's disease|severe alzheimer's disease
553938|NCT00401167|memantine|memantine
553939|NCT00401167|agitation|agitation
553940|NCT00401167|aggression|aggression
553941|NCT00401180|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
553942|NCT00401193|Menorrhagia|menorrhagia
553943|NCT00401193|Heavy Menstrual Bleeding|heavy menstrual bleeding
553944|NCT00401206|dexmedetomidine|dexmedetomidine
553945|NCT00401206|sedation|sedation
553946|NCT00401206|bronchoscopy|bronchoscopy
553947|NCT00401206|COPD|copd
553948|NCT00401258|IBS|ibs
553949|NCT00401258|irritable bowel syndrome|irritable bowel syndrome
553950|NCT00401258|irritable bowel|irritable bowel
553951|NCT00401297|Leishmaniasis|leishmaniasis
553952|NCT00401297|L. Viannia|l. viannia
553953|NCT00401297|Leishmania|leishmania
553954|NCT00401297|Colombia|colombia
553955|NCT00401336|Magnetic resonance imaging|magnetic resonance imaging
553956|NCT00401336|Hepatic iron|hepatic iron
553957|NCT00401336|Steatosis|steatosis
553958|NCT00401349|Leishmania|leishmania
553959|NCT00401349|Mif Alleles|mif alleles
553960|NCT00401349|Colombia|colombia
553961|NCT00401349|children|children
553962|NCT00401388|Chemo Insensitive Sarcomas|chemo insensitive sarcomas
553963|NCT00401388|Chondrosarcomas|chondrosarcomas
553964|NCT00401388|Alveolar soft part sarcomas|alveolar soft part sarcomas
553965|NCT00401388|Extra skeletal myxoid chondrosarcomas|extra skeletal myxoid chondrosarcomas
553966|NCT00401388|Perifosine|perifosine
553967|NCT00401414|Warfarin|warfarin
553968|NCT00401414|Thrombosis|thrombosis
553969|NCT00401414|Genetics|genetics
553970|NCT00401414|Nomogram|nomogram
553971|NCT00401414|Pulmonary Embolism|pulmonary embolism
553972|NCT00401414|Deep Vein Thrombosis|deep vein thrombosis
553973|NCT00401414|Dosing|dosing
553974|NCT00401414|INR|inr
553975|NCT00401414|Anticoagulation|anticoagulation
553976|NCT00401414|Therapy|therapy
553977|NCT00401414|Orthopedic Surgery|orthopedic surgery
553978|NCT00401427|HER2 overexpression|her2 overexpression
553979|NCT00401427|combination therapy|combination therapy
553980|NCT00401440|Medical termination of pregnancy|medical termination of pregnancy
553981|NCT00401440|Induction of abortion|induction of abortion
553982|NCT00401440|Misoprostol|misoprostol
553983|NCT00401440|MTP in second trimester|mtp in second trimester
553984|NCT00401440|400 microgram vaginal misoprostol|400 microgram vaginal misoprostol
553985|NCT00401466|prophylactic ICD therapy|prophylactic icd therapy
553986|NCT00401466|home monitoring|home monitoring
553987|NCT00401466|follow-up interval|follow-up interval
553988|NCT00401466|remote follow-up|remote follow-up
553989|NCT00401479|GW427353|gw427353
553990|NCT00401479|b3-Adrenergic Receptor Agonist|b3-adrenergic receptor agonist
553991|NCT00401479|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
553992|NCT00401479|pharmacokinetics|pharmacokinetics
553993|NCT00401479|tolerability|tolerability
553994|NCT00401479|gastrointestinal transit|gastrointestinal transit
553995|NCT00401492|elderly|elderly
553996|NCT00401492|chemotherapy|chemotherapy
553997|NCT00401492|quality of life|quality of life
553998|NCT00401492|ADL|adl
553999|NCT00401492|toxicity|toxicity
554000|NCT00401505|rubella|rubella
554001|NCT00401505|rubella vaccine|rubella vaccine
554002|NCT00401505|postpartum|postpartum
554003|NCT00401505|immunity|immunity
554004|NCT00401518|Spinal Stenosis|spinal stenosis
554005|NCT00401518|Lumbar Spinal Stenosis|lumbar spinal stenosis
554006|NCT00401518|Facet Arthroplasty|facet arthroplasty
554007|NCT00401518|Posterior Fusion|posterior fusion
554008|NCT00401518|Facet Arthritis|facet arthritis
554009|NCT00401531|Hepatitis B|hepatitis b
554010|NCT00401531|Polio|polio
554011|NCT00401531|Diphtheria|diphtheria
554012|NCT00401531|Pertussis|pertussis
554013|NCT00401531|H. influenzae type b|h. influenzae type b
554014|NCT00401544|anemia|anemia
553382|NCT00406640|MDD|mdd
554015|NCT00401544|chemotherapy induced anemia|chemotherapy induced anemia
554016|NCT00401544|darbepoetin alfa|darbepoetin alfa
554017|NCT00401544|cancer|cancer
554018|NCT00401557|Leishmaniasis, Leishmania (Viannia), Colombia|leishmaniasis, leishmania (viannia), colombia
554019|NCT00401570|Antibody|antibody
554020|NCT00401570|Pancreas|pancreas
554021|NCT00401570|Carcinoma|carcinoma
554022|NCT00401570|Cancer|cancer
554023|NCT00401570|Pancreatic|pancreatic
554024|NCT00401583|GW786034 (pazopanib) cytochrome P450 interaction|gw786034 (pazopanib) cytochrome p450 interaction
554025|NCT00401596|ALTO|alto
554026|NCT00401609|elderly|elderly
554028|NCT00401635|recurrent|recurrent
554029|NCT00401635|chemotherapy|chemotherapy
554030|NCT00401635|first-line|first-line
554031|NCT00401648|POC|poc
554032|NCT00401648|photosensitive|photosensitive
554033|NCT00401648|epileptic|epileptic
554034|NCT00401648|brivaracetam|brivaracetam
554035|NCT00401648|PPR|ppr
554036|NCT00401648|AED|aed
554037|NCT00401674|ovarian cancer|ovarian cancer
554038|NCT00401674|elderly|elderly
554039|NCT00401674|weekly chemotherapy|weekly chemotherapy
554040|NCT00401674|first-line|first-line
554041|NCT00401687|Reduced Heart Function|reduced heart function
554042|NCT00401700|influenza|influenza
554043|NCT00401700|influenza vaccine|influenza vaccine
554044|NCT00401700|pregnancy|pregnancy
554045|NCT00401713|submacular membrane|submacular membrane
554046|NCT00401713|transplantation of RPE|transplantation of rpe
554047|NCT00401713|translocation of RPE and Choroid|translocation of rpe and choroid
554048|NCT00401726|Major Depressive Disorder|major depressive disorder
554049|NCT00401726|Depression|depression
585618|NCT00513396|adjuvant therapy|adjuvant therapy
554051|NCT00401752|NSAID-associated gastric ulcer|nsaid-associated gastric ulcer
554052|NCT00401765|Prostatic neoplasm|prostatic neoplasm
554053|NCT00401765|intravenous|intravenous
554054|NCT00401765|docetaxel|docetaxel
554055|NCT00401765|monoclonal antibody|monoclonal antibody
554056|NCT00401778|Lung Cancer|lung cancer
554057|NCT00401804|Multiple Myeloma|multiple myeloma
554058|NCT00401804|renal impairment|renal impairment
554059|NCT00401804|Velcade|velcade
554060|NCT00401830|Fibromyalgia Syndrome|fibromyalgia syndrome
554061|NCT00401830|Lacosamide|lacosamide
554062|NCT00401830|Vimpat|vimpat
554063|NCT00401830|Harkoseride|harkoseride
554064|NCT00401843|multiple myeloma|multiple myeloma
554065|NCT00401843|Monoclonal Antibody|monoclonal antibody
554066|NCT00401843|Intravenous|intravenous
554067|NCT00401843|refractory or relapsed multiple myeloma|refractory or relapsed multiple myeloma
554068|NCT00401843|velcade|velcade
554069|NCT00401843|bortezomib|bortezomib
554070|NCT00401856|Cardiomyopathy|cardiomyopathy
554071|NCT00401856|Fibrosis|fibrosis
554072|NCT00401856|Magnetic-Resonance|magnetic-resonance
554073|NCT00401856|Eplerenone|eplerenone
554074|NCT00401869|vigor|vigor
554075|NCT00401869|function|function
554076|NCT00401869|well-being|well-being
554077|NCT00401869|hand-strength|hand-strength
554078|NCT00401869|surgery|surgery
554079|NCT00401869|anemia|anemia
554080|NCT00401869|transfusion|transfusion
554081|NCT00401869|strength|strength
554082|NCT00401869|quality-of-life|quality-of-life
554083|NCT00401882|Cardiac arrest|cardiac arrest
554084|NCT00401882|Sudden Cardiac Death|sudden cardiac death
554085|NCT00401882|Ventricular Fibrillation|ventricular fibrillation
554086|NCT00401882|Pulseless Ventricular Tachycardia|pulseless ventricular tachycardia
554087|NCT00401882|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
554088|NCT00401895|TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT|transjugular intrahepatic portosystemic shunt
554089|NCT00401895|Covered stents|covered stents
554090|NCT00401895|portal hypertension|portal hypertension
554091|NCT00401895|hepatic encephalopathy|hepatic encephalopathy
554092|NCT00401908|Acute gastrointestinal bleeding|acute gastrointestinal bleeding
554093|NCT00401908|Acute coronary syndrome|acute coronary syndrome
554094|NCT00401934|cholera, Vibrio cholerae, diarrhea, Bangladesh, children|cholera, vibrio cholerae, diarrhea, bangladesh, children
554095|NCT00401947|HCV|hcv
554096|NCT00401947|Chronic|chronic
554097|NCT00401947|Hepatitis|hepatitis
554098|NCT00401960|Enterococcus|enterococcus
554099|NCT00401960|Daptomycin|daptomycin
554100|NCT00401960|Endocarditis|endocarditis
554101|NCT00407797|Lyrica|lyrica
554102|NCT00407797|Epilepsies - Partial|epilepsies - partial
554103|NCT00407823|Child|child
554104|NCT00407823|Septic shock|septic shock
554105|NCT00407823|Resuscitation|resuscitation
554106|NCT00407823|Central venous oxygen saturation|central venous oxygen saturation
554107|NCT00407823|Cardiac output|cardiac output
554108|NCT00407823|Goal-directed therapy|goal-directed therapy
554109|NCT00407836|HIV|hiv
554110|NCT00407836|CD4 T cell level|cd4 t cell level
554111|NCT00407836|CD4 autoimmunity|cd4 autoimmunity
554112|NCT00407836|Viral load|viral load
554113|NCT00407836|T cell vaccination|t cell vaccination
554114|NCT00407836|HIV Therapeutic Vaccine|hiv therapeutic vaccine
554115|NCT00407862|insulin resistance|insulin resistance
553483|NCT00407186|CRITICS|critics
554116|NCT00407862|beta cell function|beta cell function
554117|NCT00407862|endothelial dysfunction|endothelial dysfunction
554118|NCT00407875|Prostate|prostate
554119|NCT00407875|Cancer|cancer
554120|NCT00407875|Radiation|radiation
554121|NCT00407901|Visually Challenged|visually challenged
554122|NCT00407901|Legally Blind|legally blind
554123|NCT00407901|Functional Assessment Questionnaire|functional assessment questionnaire
554124|NCT00407901|Low Functioning|low functioning
554125|NCT00407901|High Functioning|high functioning
554126|NCT00407914|wrinkles|wrinkles
554127|NCT00407914|soft tissue filler|soft tissue filler
554128|NCT00407914|Aquamid|aquamid
554129|NCT00407940|Thrombosis|thrombosis
554130|NCT00407940|Claudication|claudication
554131|NCT00407992|Headache|headache
554132|NCT00407992|Migraine|migraine
554133|NCT00408031|Major depressive disorder|major depressive disorder
554134|NCT00408031|NMDA receptor|nmda receptor
554135|NCT00408031|Treatment-Resistant|treatment-resistant
554136|NCT00408031|D-cycloserine|d-cycloserine
554137|NCT00408057|lipid lowering|lipid lowering
554138|NCT00408057|target achievement|target achievement
554139|NCT00408057|Patients with established cardiovascular disease|patients with established cardiovascular disease
554140|NCT00408070|ovarian cancer|ovarian cancer
554141|NCT00408070|fallopian tube cancer|fallopian tube cancer
554142|NCT00408070|peritoneal cancer|peritoneal cancer
554143|NCT00408096|osteoarthritis|osteoarthritis
554144|NCT00408096|shoulder|shoulder
554145|NCT00408096|resurfacing|resurfacing
554146|NCT00408096|prosthesis|prosthesis
554147|NCT00408109|Avian Influenza|avian influenza
554148|NCT00408109|Healthy|healthy
554149|NCT00408109|Immunity|immunity
554150|NCT00408109|Preventive|preventive
554151|NCT00408109|Bird Flu|bird flu
554152|NCT00408109|Healthy Volunteer|healthy volunteer
554153|NCT00408109|HV|hv
554154|NCT00408135|Respiratory Tract Infections|respiratory tract infections
554155|NCT00408135|Skin Diseases|skin diseases
554156|NCT00408135|Sinusitis|sinusitis
554157|NCT00408798|Treatment of Alopecia areata with intracutaneous injections of Botulinum Toxin A|treatment of alopecia areata with intracutaneous injections of botulinum toxin a
554158|NCT00408824|insulin resistance|insulin resistance
554159|NCT00408824|adipocytokine|adipocytokine
554160|NCT00408824|Metabolic syndrome|metabolic syndrome
554161|NCT00408824|Diabetes|diabetes
554162|NCT00408850|sympathetic nervous system, pioglitazone, metabolic syndrome|sympathetic nervous system, pioglitazone, metabolic syndrome
554163|NCT00408863|Breast cancer|breast cancer
554164|NCT00408863|Tibolone|tibolone
554165|NCT00408863|Climacteric symptoms|climacteric symptoms
554166|NCT00408889|liver transplantation|liver transplantation
554167|NCT00408889|organ failure|organ failure
554168|NCT00408889|outcome|outcome
554169|NCT00408915|Lisuride|lisuride
554170|NCT00408915|Continuous Dopaminergic Stimulation|continuous dopaminergic stimulation
554171|NCT00408915|Motor Fluctuations|motor fluctuations
554172|NCT00408915|Off-Times|off-times
554173|NCT00408915|Troublesome Dyskinesia|troublesome dyskinesia
554174|NCT00408915|Parkinson's Disease with motor fluctuations with OFF periods and/or troublesome dyskinesias of more than four hours per day|parkinson's disease with motor fluctuations with off periods and/or troublesome dyskinesias of more than four hours per day
554175|NCT00408928|Graft-versus-Host Disease|graft-versus-host disease
554176|NCT00408928|bortezomib|bortezomib
554177|NCT00408941|EEG|eeg
554178|NCT00408941|AEP|aep
554179|NCT00408941|Artefacts|artefacts
554180|NCT00408941|Propofol|propofol
554181|NCT00408941|Local Anaesthesia|local anaesthesia
554182|NCT00408967|Ovarian|ovarian
554183|NCT00408967|Cancer|cancer
554184|NCT00408967|Epithelial|epithelial
554185|NCT00408967|Recurrent|recurrent
554186|NCT00408967|Platinum|platinum
554187|NCT00408967|Second-line therapy|second-line therapy
554188|NCT00408967|Maintenance Therapy|maintenance therapy
554189|NCT00408967|Biologic|biologic
554190|NCT00408967|Targeted Therapy|targeted therapy
554191|NCT00408967|Antibody|antibody
554192|NCT00408980|diet|diet
554193|NCT00408980|breast milk fat|breast milk fat
554194|NCT00409032|osteoporosis|osteoporosis
554195|NCT00409032|BMD|bmd
554196|NCT00409032|CTX|ctx
554197|NCT00409032|Post menopausal|post menopausal
554198|NCT00409032|strontium|strontium
554199|NCT00409032|bone turnover|bone turnover
554200|NCT00409032|clinical development|clinical development
554201|NCT00409045|Obstructive Sleep Apnea|obstructive sleep apnea
554202|NCT00409045|Pulmonary Embolism|pulmonary embolism
554309|NCT00409318|Adiponectin|adiponectin
554203|NCT00409045|male and female patients suspected of having a pulmonary embolism.|male and female patients suspected of having a pulmonary embolism.
554204|NCT00409058|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
554205|NCT00409058|Intracranial Edema|intracranial edema
554206|NCT00409058|Brain Edema|brain edema
554207|NCT00409058|Craniocerebral Trauma|craniocerebral trauma
554208|NCT00409058|Head Injury|head injury
554209|NCT00409058|Brain Hemorrhage, Traumatic|brain hemorrhage, traumatic
554210|NCT00409058|Subdural Hematoma|subdural hematoma
554211|NCT00409058|Brain Concussion|brain concussion
554212|NCT00409058|Head Injuries, Closed|head injuries, closed
554213|NCT00409071|Non metastatic breast cancer|non metastatic breast cancer
554214|NCT00409071|Adjuvant chemotherapy|adjuvant chemotherapy
554215|NCT00409071|Nausea|nausea
554216|NCT00409071|Vomiting|vomiting
554217|NCT00409071|Quality of life|quality of life
554218|NCT00409071|Homeopathy|homeopathy
554219|NCT00409084|varices|varices
554220|NCT00409084|band ligation|band ligation
554221|NCT00409084|portal hypertension|portal hypertension
554222|NCT00409084|primary prophylaxis|primary prophylaxis
554223|NCT00409084|cirrhosis|cirrhosis
554224|NCT00409084|beta blockers|beta blockers
554225|NCT00409097|ADMA|adma
554226|NCT00409097|MOF|mof
554227|NCT00409097|Critical illness|critical illness
554228|NCT00409110|Ocular Pulse Amplitude|ocular pulse amplitude
554229|NCT00409110|Dynamic Contour Tonometry|dynamic contour tonometry
554230|NCT00409110|Pulsatility Index|pulsatility index
554231|NCT00409110|Choroidal Laser Doppler Flowmetry|choroidal laser doppler flowmetry
554232|NCT00409110|Finometer|finometer
554233|NCT00409123|vasospastic women|vasospastic women
554234|NCT00409123|controls|controls
554235|NCT00409123|core cooling|core cooling
554236|NCT00409123|core warming|core warming
554237|NCT00409123|external cooling|external cooling
554238|NCT00409123|external warming|external warming
554239|NCT00409123|LDF|ldf
554240|NCT00409123|choroidal blood flow|choroidal blood flow
554241|NCT00409123|temperature|temperature
554242|NCT00409123|vasospastic subjects|vasospastic subjects
554243|NCT00409123|normal subjects|normal subjects
554244|NCT00409136|Alert|alert
554245|NCT00409136|Deep Vein Thrombosis|deep vein thrombosis
554246|NCT00409136|Pulmonary Embolism|pulmonary embolism
554247|NCT00409136|Venous Thromboembolism|venous thromboembolism
554248|NCT00409136|Prophylaxis|prophylaxis
554249|NCT00409136|Anticoagulation|anticoagulation
554250|NCT00409149|Hypertension|hypertension
554251|NCT00409149|Diet|diet
554252|NCT00409149|physical exercise|physical exercise
554253|NCT00409149|naturopathic|naturopathic
554254|NCT00409149|group therapy|group therapy
554255|NCT00409149|Qi Gong|qi gong
554256|NCT00409162|Tattoo removal|tattoo removal
554257|NCT00409175|FAP|fap
554258|NCT00409175|Fx-1006A|fx-1006a
554259|NCT00409175|transthyretin|transthyretin
554260|NCT00409175|TTR|ttr
554261|NCT00409175|amyloid|amyloid
554262|NCT00409175|polyneuropathy|polyneuropathy
554263|NCT00409175|V30M|v30m
554264|NCT00409175|familial|familial
554265|NCT00409175|hereditary|hereditary
554266|NCT00409175|amyloidosis|amyloidosis
554267|NCT00409175|FoldRx|foldrx
554268|NCT00409188|Non-Small Cell Lung Carcinoma;|non-small cell lung carcinoma;
554269|NCT00409188|stage III;|stage iii;
554270|NCT00409188|unresectable;|unresectable;
554271|NCT00409188|vaccine; Tecemotide; L-BLP25;|vaccine; tecemotide; l-blp25;
554272|NCT00409188|Cyclophosphamide;|cyclophosphamide;
554273|NCT00409188|placebo controlled;|placebo controlled;
554274|NCT00409188|randomized;|randomized;
554275|NCT00409188|double blind;|double blind;
554276|NCT00409188|immunotherapy;|immunotherapy;
554277|NCT00409201|schizophrenia|schizophrenia
554278|NCT00409201|reboxetine|reboxetine
554279|NCT00409201|cognitive|cognitive
554280|NCT00409201|behavior|behavior
554281|NCT00409214|Glioma|glioma
554282|NCT00409214|Litx™|litx™
554283|NCT00409214|LS11|ls11
554284|NCT00409214|Glioblastoma multiforme|glioblastoma multiforme
554285|NCT00409214|Anaplastic Astrocytoma|anaplastic astrocytoma
554286|NCT00409214|GBM|gbm
554287|NCT00409214|AA|aa
554288|NCT00409227|swl|swl
554289|NCT00409227|lithotripsy|lithotripsy
554290|NCT00409227|stone disease|stone disease
554291|NCT00409227|urolithiasis|urolithiasis
554292|NCT00409227|nephrolithiasis|nephrolithiasis
554293|NCT00409240|Group Intervention|group intervention
554294|NCT00409240|Pharmacotherapy|pharmacotherapy
554295|NCT00409240|Behavioral Modification|behavioral modification
554296|NCT00409240|Diabetes|diabetes
554297|NCT00409253|PRE-ECLAMPSIA-URAPIDIL-NICARDIPINE|pre-eclampsia-urapidil-nicardipine
554298|NCT00409279|Aging|aging
554299|NCT00409279|Parent / Adult-child interaction|parent / adult-child interaction
554300|NCT00409279|Family caregivers|family caregivers
554301|NCT00409279|Alzheimer's|alzheimer's
554302|NCT00409279|Caregiving|caregiving
554303|NCT00409292|RAD001|rad001
554304|NCT00409292|metastatic pancreatic cancer|metastatic pancreatic cancer
554305|NCT00409318|Inflammation|inflammation
554306|NCT00409318|Visceral adiposity|visceral adiposity
554307|NCT00409318|TNF|tnf
554310|NCT00409318|Insulin resistance|insulin resistance
554311|NCT00409318|metabolic syndrome|metabolic syndrome
554312|NCT00409331|Head and Neck Cancer|head and neck cancer
554313|NCT00409331|HNSCC|hnscc
554314|NCT00409331|Submandibular and Sublingual Salivary Sparing|submandibular and sublingual salivary sparing
554315|NCT00409331|Amifostine|amifostine
554316|NCT00409331|Ethyol|ethyol
714985|NCT01017263|Vyvanse|vyvanse
554317|NCT00409331|Radiation Therapy|radiation therapy
554318|NCT00409344|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
554319|NCT00409344|Dexmedetomidine|dexmedetomidine
554320|NCT00409344|Mechanical ventilation|mechanical ventilation
554321|NCT00409357|urinary tract|urinary tract
554322|NCT00409383|Advanced Melanoma|advanced melanoma
554323|NCT00409383|Normal baseline LDH|normal baseline ldh
554324|NCT00409383|Chemotherapy naive|chemotherapy naive
554325|NCT00409396|Ulcerative|ulcerative
554326|NCT00409396|Colitis|colitis
554327|NCT00409396|PGE-M|pge-m
554328|NCT00409396|fecal calprotectin|fecal calprotectin
554329|NCT00409396|disease biomarkers|disease biomarkers
554330|NCT00409409|Sublingual immunotherapy|sublingual immunotherapy
554331|NCT00409409|Grass pollen tablet|grass pollen tablet
554332|NCT00409409|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
554333|NCT00409422|pediatric obesity|pediatric obesity
554334|NCT00409422|overweight|overweight
554335|NCT00409422|insulin resistance|insulin resistance
554336|NCT00409422|hyperinsulinemia|hyperinsulinemia
554337|NCT00409422|weight management program|weight management program
554338|NCT00409422|family-based|family-based
554339|NCT00409435|Postural tachycardia syndrome (POTS)|postural tachycardia syndrome (pots)
554340|NCT00409448|TBI|tbi
554341|NCT00409448|intracranial edema|intracranial edema
554342|NCT00409448|brain edema|brain edema
554343|NCT00409448|craniocerebral trauma|craniocerebral trauma
554344|NCT00409448|head injury|head injury
554345|NCT00409448|brain hemorrhage, traumatic|brain hemorrhage, traumatic
554346|NCT00409448|subdural hematoma|subdural hematoma
554347|NCT00409448|brain concussion|brain concussion
554348|NCT00409448|head injuries, closed|head injuries, closed
554349|NCT00409448|epidural hematoma|epidural hematoma
554350|NCT00409448|extra-axial hemorrhage|extra-axial hemorrhage
554351|NCT00409448|cortical contusion|cortical contusion
554352|NCT00409487|obstructive sleep apnea|obstructive sleep apnea
554353|NCT00409487|hypertension|hypertension
554354|NCT00409487|ambulatory bloop pressure monitoring|ambulatory bloop pressure monitoring
554355|NCT00409500|Safety, tolerability, pharmacokinetics, AQW051, food, Japanese, healthy male subjects|safety, tolerability, pharmacokinetics, aqw051, food, japanese, healthy male subjects
554356|NCT00409500|Healthy volunteers study|healthy volunteers study
554357|NCT00409526|Iloprost|iloprost
554358|NCT00409526|PPHN|pphn
554359|NCT00409526|Newborn|newborn
554360|NCT00409526|Pulmonary Hypertension|pulmonary hypertension
554361|NCT00409526|Term|term
554362|NCT00409526|Persistent Pulmonary Hypertension of the Newborn|persistent pulmonary hypertension of the newborn
554363|NCT00409565|head and neck cancer|head and neck cancer
554364|NCT00409565|cetuximab|cetuximab
554365|NCT00409565|bevacizumab|bevacizumab
554366|NCT00409565|squamous cell carcinoma|squamous cell carcinoma
554367|NCT00409565|SCCHN|scchn
554368|NCT00409565|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
554369|NCT00409578|Post acute coronary syndrome|post acute coronary syndrome
554370|NCT00409578|Acute|acute
554371|NCT00409578|coronary syndrome|coronary syndrome
554372|NCT00409578|B-type natriuretic peptide|b-type natriuretic peptide
554373|NCT00409578|N-terminal|n-terminal
554374|NCT00409578|pro-B-type natriuretic peptide|pro-b-type natriuretic peptide
554375|NCT00409578|myocardial infarctions|myocardial infarctions
554376|NCT00409591|Thailand|thailand
554377|NCT00409591|Developing Countries|developing countries
554378|NCT00409591|Prophylaxis|prophylaxis
554379|NCT00409591|Mother-to-child transmission|mother-to-child transmission
554380|NCT00409591|HIV-1|hiv-1
554381|NCT00409591|HIV-1 infection|hiv-1 infection
554382|NCT00409591|HIV Seronegativity|hiv seronegativity
554383|NCT00409630|Asthma|asthma
554384|NCT00409643|HYPERTENSION, VALSARTAN, AMLODIPINE, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
554385|NCT00409669|Barraquer tonometer|barraquer tonometer
554386|NCT00409669|Intraocular pressure|intraocular pressure
554387|NCT00409669|Tonometry|tonometry
554388|NCT00409682|Crohn's Disease|crohn's disease
554389|NCT00409695|Acute Graft versus Host Disease|acute graft versus host disease
554390|NCT00409695|aGVHD|agvhd
554391|NCT00409695|Blood And Marrow Transplantation|blood and marrow transplantation
554392|NCT00409695|Thymoglobulin|thymoglobulin
554394|NCT00409708|Attention Deficit Hyperactivity Disorder,|attention deficit hyperactivity disorder,
554395|NCT00409708|ADHD|adhd
554396|NCT00409708|Cytogenetic abnormalities,|cytogenetic abnormalities,
554397|NCT00409708|extended-release methylphenidate,|extended-release methylphenidate,
554398|NCT00409721|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
554400|NCT00409721|Motor Neuron Disease|motor neuron disease
554401|NCT00409721|MND|mnd
554402|NCT00409721|Memantine|memantine
554403|NCT00409734|pyloric|pyloric
554404|NCT00409734|stenosis|stenosis
554405|NCT00409747|Immunology|immunology
554406|NCT00409747|Microglia|microglia
554407|NCT00409747|NF-Kappa-B|nf-kappa-b
554408|NCT00409747|Antibiotic|antibiotic
554409|NCT00409747|Autism|autism
554410|NCT00409747|Minocycline|minocycline
553770|NCT00400608|pediatrics|pediatrics
554411|NCT00409747|Regressive Autism|regressive autism
554412|NCT00409760|HYEPRTENSION, VALSARTAN, AMLODIPINE, high blood pressure|hyeprtension, valsartan, amlodipine, high blood pressure
554413|NCT00409786|Obesity|obesity
554414|NCT00409786|Diabetes|diabetes
554415|NCT00409786|Internet|internet
554416|NCT00409786|Obesity with high cardiovascular risk|obesity with high cardiovascular risk
554417|NCT00409799|Bone graft substitute|bone graft substitute
554418|NCT00409799|Promotion of bone healing|promotion of bone healing
554419|NCT00409838|Rheumatoid Arthritis, with inadequate response to methotrexate|rheumatoid arthritis, with inadequate response to methotrexate
554420|NCT00409851|HYPERTENSION, VALSARTAN, AMLODIPINE,SAFETY|hypertension, valsartan, amlodipine,safety
554421|NCT00409864|Gallbaldder Cancer|gallbaldder cancer
554422|NCT00409864|Endoscopic stenting|endoscopic stenting
554423|NCT00409864|Percutaneous biliary drainage|percutaneous biliary drainage
554424|NCT00409890|Buscopan|buscopan
554425|NCT00409890|Hyoscine|hyoscine
554426|NCT00409890|Shortens|shortens
554427|NCT00409890|Labor|labor
554428|NCT00409890|Stage|stage
554946|NCT00404976|asthma|asthma
554429|NCT00409916|chronic heart failure|chronic heart failure
554430|NCT00409916|heart failure|heart failure
554431|NCT00409916|congestive heart failure|congestive heart failure
554432|NCT00409916|impedance cardiography|impedance cardiography
554433|NCT00409916|ICG|icg
554434|NCT00409916|transthoracic electrical bioimpedance|transthoracic electrical bioimpedance
554435|NCT00409916|non-invasive|non-invasive
554436|NCT00409916|TEB|teb
554437|NCT00409929|Safety, tolerability, pharmacokinetics, pharmacodynamics, AEB071, healthy subjects, transplantation|safety, tolerability, pharmacokinetics, pharmacodynamics, aeb071, healthy subjects, transplantation
554438|NCT00409942|Chronic heart failure|chronic heart failure
554439|NCT00409942|Torasemide prolonged release|torasemide prolonged release
554440|NCT00409942|Myocardial fibrosis|myocardial fibrosis
554441|NCT00409942|Loop diuretics|loop diuretics
554442|NCT00409942|Peptide of procollagen type 1|peptide of procollagen type 1
554443|NCT00409955|Lamellar transplant|lamellar transplant
554444|NCT00409955|Lyophilization|lyophilization
554445|NCT00409955|Corneas storage|corneas storage
554446|NCT00409955|Keratoconus patients|keratoconus patients
554447|NCT00409955|Best corrected visual acuity < 20/60|best corrected visual acuity < 20/60
554448|NCT00409955|Signed the consent inform|signed the consent inform
554449|NCT00409968|Lung Cancer|lung cancer
554450|NCT00409968|Non Small Cell Lung Cancer|non small cell lung cancer
554451|NCT00409968|BATTLE Program|battle program
554452|NCT00409968|Umbrella Trial|umbrella trial
554453|NCT00409968|Tumor Biopsy|tumor biopsy
554454|NCT00409968|NSCLC|nsclc
554455|NCT00409981|in stent restenosis|in stent restenosis
554456|NCT00409981|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
554457|NCT00409981|paccocath|paccocath
554458|NCT00409981|drug eluting balloon|drug eluting balloon
554459|NCT00409994|Colorectal cancer|colorectal cancer
554460|NCT00409994|M-tor inhibitor|m-tor inhibitor
554461|NCT00409994|Rapamycin|rapamycin
554462|NCT00410007|ADPKD|adpkd
554463|NCT00410007|Urinary Aquaporin-2|urinary aquaporin-2
554464|NCT00410007|ENaC|enac
554465|NCT00410007|Fractional sodium excretion|fractional sodium excretion
554466|NCT00410007|High/low sodium diet|high/low sodium diet
554467|NCT00410020|alpha linolenic acid|alpha linolenic acid
554468|NCT00410020|atrial fibrillation|atrial fibrillation
554469|NCT00410020|omega 3 fatty acids|omega 3 fatty acids
554470|NCT00410020|diet|diet
554471|NCT00410020|rapeseed oil|rapeseed oil
554472|NCT00410020|canola oil|canola oil
554473|NCT00410020|cardiovascular diseases|cardiovascular diseases
554474|NCT00410059|Non-Small Cell Lung Cancer|non-small cell lung cancer
554475|NCT00410059|Lung Cancer|lung cancer
554476|NCT00410059|NSCLC|nsclc
554477|NCT00410059|Erlotinib|erlotinib
554478|NCT00410059|Tarceva|tarceva
554479|NCT00410059|OSI-774|osi-774
554480|NCT00410059|Battle Program|battle program
554481|NCT00410098|asthma|asthma
554482|NCT00410098|yoga|yoga
554483|NCT00410098|heat|heat
554484|NCT00410098|humidity|humidity
554485|NCT00410098|bikram|bikram
554486|NCT00410111|sepsis|sepsis
554487|NCT00410111|encephalopathy|encephalopathy
554488|NCT00410111|cerebral perfusion|cerebral perfusion
554489|NCT00410111|electroencephalogram|electroencephalogram
554490|NCT00410124|advanced kidney cancer|advanced kidney cancer
554491|NCT00410124|everolimus|everolimus
554492|NCT00410124|kidney cancer|kidney cancer
554493|NCT00410124|oral therapy|oral therapy
554494|NCT00410150|Status asthmaticus|status asthmaticus
554495|NCT00410150|Asthma|asthma
554496|NCT00410150|Helium|helium
554497|NCT00410150|Children|children
554498|NCT00410163|B-cell|b-cell
554499|NCT00410163|cyclophosphamide|cyclophosphamide
554500|NCT00410163|fludarabine|fludarabine
554501|NCT00410163|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
554502|NCT00410163|Ofatumumab|ofatumumab
554503|NCT00410189|Non-Small Cell Lung Cancer|non-small cell lung cancer
554504|NCT00410189|NSCLC|nsclc
554505|NCT00410189|Lung Cancer|lung cancer
554506|NCT00410189|ZD6474|zd6474
554507|NCT00410189|Zactima|zactima
554508|NCT00410189|Vandetanib|vandetanib
554509|NCT00410189|BATTLE Program|battle program
554510|NCT00410228|safety, tolerability, pharmacokinetics, pharmacodynamics, AHT956|safety, tolerability, pharmacokinetics, pharmacodynamics, aht956
554512|NCT00410241|Cardiovascular Disease|cardiovascular disease
554513|NCT00410241|Volunteers|volunteers
554514|NCT00410241|Genes|genes
554515|NCT00410241|Atherosclerosis|atherosclerosis
554516|NCT00410241|Coronary Artery Calcification|coronary artery calcification
554517|NCT00410241|Cardiovascular|cardiovascular
554518|NCT00410267|glaucoma|glaucoma
554519|NCT00410267|Post operative from selective laser trabeculoplasty|post operative from selective laser trabeculoplasty
554520|NCT00410293|Heart failure|heart failure
554521|NCT00410293|Diagnostic|diagnostic
554522|NCT00410293|Natriuretic peptide|natriuretic peptide
554523|NCT00410293|NT-pro B-type natriuretic peptide|nt-pro b-type natriuretic peptide
554524|NCT00410293|Length of stay|length of stay
554525|NCT00410293|Costs|costs
554526|NCT00410306|Hypogonadism|hypogonadism
554527|NCT00410306|Nebido|nebido
554528|NCT00410306|Testosterone|testosterone
554529|NCT00410306|Observational Study|observational study
554530|NCT00410332|tonsillectomy|tonsillectomy
554531|NCT00410332|pain|pain
554532|NCT00410332|homeopathy|homeopathy
554533|NCT00410332|Traumeel|traumeel
554534|NCT00410358|Gimatecan|gimatecan
554535|NCT00410358|topoisomerase I inhibitor|topoisomerase i inhibitor
554536|NCT00410358|advanced solid tumors|advanced solid tumors
554537|NCT00410371|tolerability|tolerability
554538|NCT00410371|safety|safety
554539|NCT00410371|Pharmacokinetic characteristics|pharmacokinetic characteristics
554540|NCT00410384|Antibodies|antibodies
554541|NCT00410384|Autoimmune Diseases|autoimmune diseases
554542|NCT00410384|Systemic Lupus Erythematosus|systemic lupus erythematosus
554543|NCT00410384|SLE|sle
554544|NCT00410384|Belimumab|belimumab
554545|NCT00410384|Lupus|lupus
554546|NCT00410397|Low back pain|low back pain
554547|NCT00410397|Hip pain|hip pain
554548|NCT00410423|Leukemia|leukemia
554549|NCT00410423|Acute Myeloid Leukemia|acute myeloid leukemia
554550|NCT00410423|Acute Lymphoid / Lymphoblastic Leukemia|acute lymphoid / lymphoblastic leukemia
554551|NCT00410436|Type 1 Diabetes|type 1 diabetes
554552|NCT00410436|Resistance Exercise|resistance exercise
554553|NCT00410436|Aerobic Exercise|aerobic exercise
554554|NCT00410449|End stage renal disease treated by hemodialysis|end stage renal disease treated by hemodialysis
554555|NCT00410449|Hemodialysis vascular access patency|hemodialysis vascular access patency
554556|NCT00410449|Vitamin E|vitamin e
554557|NCT00410449|oxidative markers|oxidative markers
554558|NCT00410449|pentosidine|pentosidine
554559|NCT00410449|hydroxynonenal|hydroxynonenal
554560|NCT00410449|levuglandin|levuglandin
554561|NCT00410462|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
554562|NCT00410462|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
554563|NCT00410462|adult liposarcoma|adult liposarcoma
554564|NCT00410462|adult fibrosarcoma|adult fibrosarcoma
554565|NCT00410462|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
554566|NCT00410462|adult leiomyosarcoma|adult leiomyosarcoma
554567|NCT00410462|adult rhabdomyosarcoma|adult rhabdomyosarcoma
554568|NCT00410462|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
554569|NCT00410462|adult malignant mesenchymoma|adult malignant mesenchymoma
554570|NCT00410462|adult angiosarcoma|adult angiosarcoma
554571|NCT00410462|adult epithelioid sarcoma|adult epithelioid sarcoma
554572|NCT00410462|adult neurofibrosarcoma|adult neurofibrosarcoma
554573|NCT00410462|adult synovial sarcoma|adult synovial sarcoma
554574|NCT00410462|recurrent uterine sarcoma|recurrent uterine sarcoma
554575|NCT00410462|stage IV uterine sarcoma|stage iv uterine sarcoma
554576|NCT00410462|ovarian sarcoma|ovarian sarcoma
554577|NCT00410462|small intestine leiomyosarcoma|small intestine leiomyosarcoma
554578|NCT00410462|recurrent small intestine cancer|recurrent small intestine cancer
554579|NCT00410475|Ionizing Radiation|ionizing radiation
554580|NCT00410475|Cohort Study|cohort study
554581|NCT00410475|Radiation-Induced Neoplasms|radiation-induced neoplasms
554582|NCT00410475|Radiologic Technologists|radiologic technologists
554583|NCT00410475|Ultraviolet Radiation|ultraviolet radiation
554584|NCT00410488|Sarcoma|sarcoma
554585|NCT00410488|Palonosetron|palonosetron
554586|NCT00410488|Aloxi|aloxi
554587|NCT00410488|Nausea|nausea
554588|NCT00410488|Vomiting|vomiting
554589|NCT00410501|Pharmacokinetics, interaction, QAB149, indacaterol, ketoconazole, healthy subjects|pharmacokinetics, interaction, qab149, indacaterol, ketoconazole, healthy subjects
554590|NCT00410514|Beta-3 Receptor Agonist|beta-3 receptor agonist
554591|NCT00410514|YM178|ym178
554592|NCT00410514|Men|men
554593|NCT00410514|Lower Urinary Tract Symptoms|lower urinary tract symptoms
554594|NCT00410514|Bladder Outlet Obstruction|bladder outlet obstruction
554595|NCT00410527|Antibacterials|antibacterials
554596|NCT00410527|Colonization|colonization
554597|NCT00410527|Infection|infection
554598|NCT00410527|Pneumonia|pneumonia
554599|NCT00410527|Resistance|resistance
554600|NCT00410540|Cancer pain|cancer pain
554601|NCT00410540|Oral analgesic|oral analgesic
554602|NCT00410540|OROS hydromorphone HCL|oros hydromorphone hcl
554603|NCT00410540|Morphine sulfate|morphine sulfate
554604|NCT00410566|Acid sphingomyelinase deficiency|acid sphingomyelinase deficiency
554605|NCT00410566|Niemann-Pick disease|niemann-pick disease
554606|NCT00410566|Lysosomal storage disorder|lysosomal storage disorder
554607|NCT00410566|Enzyme replacement therapy|enzyme replacement therapy
554608|NCT00410566|Treatment|treatment
554609|NCT00410579|pain|pain
554610|NCT00410579|fatigue|fatigue
554611|NCT00410579|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
554612|NCT00410579|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
554613|NCT00410579|stage II rectal cancer|stage ii rectal cancer
554614|NCT00410579|stage III rectal cancer|stage iii rectal cancer
554615|NCT00410579|stage II colon cancer|stage ii colon cancer
554616|NCT00410579|stage III colon cancer|stage iii colon cancer
554617|NCT00410579|adenocarcinoma of the colon|adenocarcinoma of the colon
554618|NCT00410592|GERD|gerd
554619|NCT00410592|acid reflux|acid reflux
554620|NCT00410592|heartburn|heartburn
554621|NCT00410592|PPI|ppi
554622|NCT00410592|Hispanic|hispanic
554947|NCT00404976|children|children
554623|NCT00410618|cognitive/functional effects|cognitive/functional effects
554624|NCT00410618|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
554625|NCT00410618|recurrent colon cancer|recurrent colon cancer
554626|NCT00410618|stage I colon cancer|stage i colon cancer
554627|NCT00410618|stage II colon cancer|stage ii colon cancer
554628|NCT00410618|stage III colon cancer|stage iii colon cancer
554629|NCT00410618|stage IV colon cancer|stage iv colon cancer
554630|NCT00410631|localized resectable neuroblastoma|localized resectable neuroblastoma
554631|NCT00410631|localized unresectable neuroblastoma|localized unresectable neuroblastoma
554632|NCT00410631|regional neuroblastoma|regional neuroblastoma
554633|NCT00410631|stage 4S neuroblastoma|stage 4s neuroblastoma
554634|NCT00410631|disseminated neuroblastoma|disseminated neuroblastoma
554635|NCT00410631|recurrent neuroblastoma|recurrent neuroblastoma
554636|NCT00410644|Non-malignant chronic pain|non-malignant chronic pain
554637|NCT00410644|pain|pain
554638|NCT00410644|analgesics|analgesics
554639|NCT00410644|opioid|opioid
554640|NCT00410657|graft versus host disease|graft versus host disease
554641|NCT00410657|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
554642|NCT00410657|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
554643|NCT00410657|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
554644|NCT00410657|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
554645|NCT00410657|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
554646|NCT00410657|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
554647|NCT00410657|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
554648|NCT00410657|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
554649|NCT00410657|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
554650|NCT00410657|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
554651|NCT00410657|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
554652|NCT00410657|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
554653|NCT00410657|chronic eosinophilic leukemia|chronic eosinophilic leukemia
554654|NCT00410657|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
554655|NCT00410657|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
554656|NCT00410657|chronic neutrophilic leukemia|chronic neutrophilic leukemia
554657|NCT00410657|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
554658|NCT00410657|disseminated neuroblastoma|disseminated neuroblastoma
554659|NCT00410657|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
554660|NCT00410657|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
554661|NCT00410657|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
554662|NCT00410657|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
554663|NCT00410657|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
554664|NCT00410657|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
554665|NCT00410657|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
554666|NCT00410657|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
554667|NCT00410657|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
554668|NCT00410657|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
554669|NCT00410657|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
554670|NCT00410657|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
715499|NCT01026454|HSV|hsv
554671|NCT00410657|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
554672|NCT00410657|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
554673|NCT00410657|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
554674|NCT00410657|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
554675|NCT00410657|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
554676|NCT00410657|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
554677|NCT00410657|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
554678|NCT00410657|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
554679|NCT00410657|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
554680|NCT00410657|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
554681|NCT00410657|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
554682|NCT00410657|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
554683|NCT00410657|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
554684|NCT00410657|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
554685|NCT00410657|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
554686|NCT00410657|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
554687|NCT00410657|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
554688|NCT00410657|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
554689|NCT00410657|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
554690|NCT00410657|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
554691|NCT00410657|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
554692|NCT00410657|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
583950|NCT00514046|Multiple Endocrine Neoplasia (MEN)|multiple endocrine neoplasia (men)
554693|NCT00410657|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
554694|NCT00410657|splenic marginal zone lymphoma|splenic marginal zone lymphoma
751955|NCT01171339|medication appropriateness|medication appropriateness
554695|NCT00410657|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
554696|NCT00410657|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
554697|NCT00410657|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
554698|NCT00410657|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
554699|NCT00410657|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
554700|NCT00410657|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
554701|NCT00410657|stage I multiple myeloma|stage i multiple myeloma
554702|NCT00410657|stage II multiple myeloma|stage ii multiple myeloma
554703|NCT00410657|stage III multiple myeloma|stage iii multiple myeloma
554704|NCT00410657|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
554705|NCT00410657|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
554706|NCT00410657|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
554707|NCT00410657|aggressive, noncontiguous stage II adult non-Hodgkin lymphoma|aggressive, noncontiguous stage ii adult non-hodgkin lymphoma
554708|NCT00410657|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
554709|NCT00410657|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
554710|NCT00410657|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
554711|NCT00410657|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
554712|NCT00410657|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
554713|NCT00410657|stage IIIA breast cancer|stage iiia breast cancer
554714|NCT00410657|stage IIIB breast cancer|stage iiib breast cancer
554715|NCT00410657|stage IIIC breast cancer|stage iiic breast cancer
554716|NCT00410657|stage IV breast cancer|stage iv breast cancer
554717|NCT00410657|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
554718|NCT00410657|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
554719|NCT00410657|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
554720|NCT00410670|Gene|gene
554721|NCT00410670|Genetics|genetics
554722|NCT00410670|Family History|family history
554723|NCT00410670|Radiation Therapy|radiation therapy
554724|NCT00410670|Children|children
554725|NCT00410683|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
554726|NCT00410683|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
554727|NCT00410696|High-dose chemotherapy|high-dose chemotherapy
554728|NCT00410696|Growth factor|growth factor
554729|NCT00410696|Pegfilgrastim|pegfilgrastim
554730|NCT00410709|Pediculosis Capitis|pediculosis capitis
554731|NCT00410709|Head Lice|head lice
554732|NCT00410709|Crawlers|crawlers
554733|NCT00410709|Ova|ova
554734|NCT00410709|Nits|nits
554735|NCT00410722|Nutrition|nutrition
554736|NCT00410722|Type 2 Diabetes|type 2 diabetes
554737|NCT00410735|ONO-1078|ono-1078
554738|NCT00410735|chronic sinusitis|chronic sinusitis
554739|NCT00410748|Chronic cancer pain|chronic cancer pain
554740|NCT00410748|chronic pain|chronic pain
554741|NCT00410761|ZD6474|zd6474
554742|NCT00410761|MTC|mtc
555425|NCT00413439|BAL8557|bal8557
554743|NCT00410761|Hereditary Medullary Thyroid Cancer|hereditary medullary thyroid cancer
554744|NCT00410761|Sporadic Medullary Thyroid Cancer|sporadic medullary thyroid cancer
554745|NCT00410761|Medullary Thyroid Cancer|medullary thyroid cancer
554746|NCT00410774|stage III pancreatic cancer|stage iii pancreatic cancer
554747|NCT00410774|stage I pancreatic cancer|stage i pancreatic cancer
554748|NCT00410774|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
554749|NCT00410774|stage II pancreatic cancer|stage ii pancreatic cancer
554750|NCT00410787|Chronic cancer pain|chronic cancer pain
554751|NCT00410787|OROS hydromorphone HCI (slow release)|oros hydromorphone hci (slow release)
554752|NCT00410787|long-term repeated dosing|long-term repeated dosing
554753|NCT00410800|Insulin Resistance|insulin resistance
554754|NCT00410800|Body Composition|body composition
554755|NCT00410800|Kinetic Modeling|kinetic modeling
554756|NCT00410813|stage IV breast cancer|stage iv breast cancer
554757|NCT00410813|male breast cancer|male breast cancer
554758|NCT00410813|recurrent breast cancer|recurrent breast cancer
554759|NCT00410813|bone metastases|bone metastases
554760|NCT00410852|Insulin|insulin
554761|NCT00410852|Hyperglycemia|hyperglycemia
554762|NCT00410852|Hypoglycemia|hypoglycemia
554763|NCT00410852|Intensive care|intensive care
554764|NCT00410852|Critical care|critical care
554765|NCT00410865|Oral Premalignancies|oral premalignancies
554766|NCT00410865|Mouth Cancer|mouth cancer
554767|NCT00410865|Dysplasia/Carcinoma in Situ (CIS) of the Oral Cavity|dysplasia/carcinoma in situ (cis) of the oral cavity
554768|NCT00410865|Dysplasia/Carcinoma in situ (CIS) of the Oral Pharynx|dysplasia/carcinoma in situ (cis) of the oral pharynx
554769|NCT00410865|Advexin|advexin
554770|NCT00410865|Gene Therapy|gene therapy
554771|NCT00410865|INGN 201|ingn 201
554772|NCT00410865|Wild Type p53 Gene Induction|wild type p53 gene induction
554773|NCT00410878|Opioids|opioids
554774|NCT00410878|Chronic cancer pain|chronic cancer pain
554775|NCT00410878|Analgesic|analgesic
554776|NCT00410930|Immunotherapy, major allergen, birch|immunotherapy, major allergen, birch
554777|NCT00410943|Cancer pain|cancer pain
554778|NCT00410943|Oral analgesic|oral analgesic
554779|NCT00410943|OROS hydromorphone HCI|oros hydromorphone hci
554780|NCT00410956|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
554781|NCT00410956|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
554782|NCT00410956|advanced adult primary liver cancer|advanced adult primary liver cancer
554783|NCT00410956|recurrent adult primary liver cancer|recurrent adult primary liver cancer
554784|NCT00410956|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
554785|NCT00410969|resuscitation|resuscitation
554786|NCT00410969|hypothermia|hypothermia
554787|NCT00410982|Lymphoid Malignancies|lymphoid malignancies
554788|NCT00410982|Hodgkin's Disease|hodgkin's disease
554789|NCT00410982|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
554790|NCT00410982|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
554791|NCT00410982|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
554792|NCT00410982|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
554793|NCT00410982|Myeloma|myeloma
554794|NCT00410982|Leukemia|leukemia
554795|NCT00410982|Lymphoma|lymphoma
554796|NCT00410982|Busulfan|busulfan
554797|NCT00410982|Busulfex|busulfex
554798|NCT00410982|Myleran|myleran
554799|NCT00410982|Gemcitabine|gemcitabine
554800|NCT00410982|Gemcitabine Hydrochloride|gemcitabine hydrochloride
554801|NCT00410982|Gemzar|gemzar
554802|NCT00410982|Melphalan|melphalan
554803|NCT00410982|Alkeran|alkeran
554804|NCT00410995|Physically fit volunteers|physically fit volunteers
554805|NCT00411034|Opioids|opioids
554806|NCT00411034|Chronic Cancer Pain|chronic cancer pain
554807|NCT00411034|analgesic|analgesic
554808|NCT00411047|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
554809|NCT00411047|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
554810|NCT00411047|adenocarcinoma of the lung|adenocarcinoma of the lung
554811|NCT00411047|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
554812|NCT00411047|large cell lung cancer|large cell lung cancer
554813|NCT00411060|Rotator Cuff Tear|rotator cuff tear
554814|NCT00411073|darapladib|darapladib
554815|NCT00411073|moxifloxacin|moxifloxacin
554816|NCT00411073|QT study|qt study
554817|NCT00411086|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
554818|NCT00411086|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
554819|NCT00411086|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
554820|NCT00411086|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
554821|NCT00411086|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
554822|NCT00411086|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
554823|NCT00411086|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
554824|NCT00411086|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
554825|NCT00411086|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
554826|NCT00411086|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
554827|NCT00411086|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
554828|NCT00411086|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
554829|NCT00411086|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
554830|NCT00411086|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
554831|NCT00411086|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
554832|NCT00411086|Granulocyte-Macrophage Colony Stimulating Factor|granulocyte-macrophage colony stimulating factor
554833|NCT00411086|GM-CSF|gm-csf
554834|NCT00411086|Rituximab|rituximab
554835|NCT00411086|Rituxan|rituxan
554836|NCT00411099|agomelatine, major depressive disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
554837|NCT00411112|Sentinel node|sentinel node
554838|NCT00411112|Isosulphan blue|isosulphan blue
554839|NCT00411112|Isotopic detection|isotopic detection
554840|NCT00411112|Survival|survival
554841|NCT00411125|Postmenopausal|postmenopausal
554842|NCT00411125|osteoporosis|osteoporosis
554843|NCT00411125|Pharmacokinetics/dynamics|pharmacokinetics/dynamics
554844|NCT00411125|Calcitonin|calcitonin
554845|NCT00411138|endometrial clear cell carcinoma|endometrial clear cell carcinoma
554846|NCT00411138|stage II endometrial carcinoma|stage ii endometrial carcinoma
554847|NCT00411138|stage IA grade 3 endometrial carcinoma|stage ia grade 3 endometrial carcinoma
554848|NCT00411138|stage IB endometrial carcinoma|stage ib endometrial carcinoma
554849|NCT00411138|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
554850|NCT00411138|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
554851|NCT00411138|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
554852|NCT00411151|Adenocarcinoma of esophagogastric junction|adenocarcinoma of esophagogastric junction
554853|NCT00411151|Adenocarcinoma of lower esophagus (Barrett carcinoma)|adenocarcinoma of lower esophagus (barrett carcinoma)
554854|NCT00411164|knee pain|knee pain
554855|NCT00411164|hip pain|hip pain
554856|NCT00411164|opioid|opioid
554857|NCT00411177|end-stage renal disease|end-stage renal disease
554858|NCT00411177|hemodialysis|hemodialysis
554859|NCT00411177|cardiovascular morbidity and mortality|cardiovascular morbidity and mortality
554860|NCT00411177|high flux dialyser|high flux dialyser
554861|NCT00411177|on-line hemodiafiltration|on-line hemodiafiltration
554862|NCT00411177|arterial stiffness|arterial stiffness
554863|NCT00411177|inflammation|inflammation
554864|NCT00411177|life quality|life quality
554865|NCT00411177|left ventricular hypertrophy|left ventricular hypertrophy
554866|NCT00411190|Osteoporosis|osteoporosis
554867|NCT00411190|Osteoarthritis|osteoarthritis
554868|NCT00411190|Postmenopausal|postmenopausal
554869|NCT00411203|Protein kinase C, tamoxifen, acute mania, clinical trial|protein kinase c, tamoxifen, acute mania, clinical trial
554870|NCT00411216|vestibular rehabilitation|vestibular rehabilitation
554871|NCT00411216|vestibular hypofunction|vestibular hypofunction
554872|NCT00411242|agomelatine, major depressive disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
554873|NCT00411255|Blink Reflex|blink reflex
554874|NCT00411255|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
554875|NCT00411255|Dystonia|dystonia
554876|NCT00411255|Blepharospasm|blepharospasm
554877|NCT00411255|BSP|bsp
554878|NCT00411255|Focal Dystonia|focal dystonia
554879|NCT00411268|Chronic low back pain|chronic low back pain
554880|NCT00411268|OROS hydromorphone slow release tablet|oros hydromorphone slow release tablet
554881|NCT00411268|Quality of Life|quality of life
554882|NCT00411281|acute myeloid leukemia/transient myeloproliferative disorder|acute myeloid leukemia/transient myeloproliferative disorder
554883|NCT00411294|ergocalciferol|ergocalciferol
554884|NCT00411294|chronic kidney disease|chronic kidney disease
554885|NCT00411294|secondary hyperparathyroidism|secondary hyperparathyroidism
554886|NCT00411294|vitamin D deficiency|vitamin d deficiency
554887|NCT00411307|Analgesia|analgesia
554888|NCT00411307|Postoperative pain|postoperative pain
554889|NCT00411320|Asthma|asthma
554890|NCT00411320|Smoking|smoking
554891|NCT00411320|Steroid Resistance|steroid resistance
554892|NCT00411320|Corticosteroid insensitivity|corticosteroid insensitivity
554893|NCT00411333|diabetic retinopathy|diabetic retinopathy
554894|NCT00411333|fluorescein angiography|fluorescein angiography
554895|NCT00411333|steroid|steroid
554896|NCT00411333|anti-angiogenesis|anti-angiogenesis
554897|NCT00411346|Asthma|asthma
554898|NCT00411346|Self-Monitoring|self-monitoring
554899|NCT00411346|Cost-effectiveness|cost-effectiveness
554900|NCT00404794|membranous lupus nephritis|membranous lupus nephritis
554901|NCT00404807|Continuous positive airway pressure|continuous positive airway pressure
554902|NCT00404807|cardiovascular diseases|cardiovascular diseases
554903|NCT00404807|sleep apnea syndromes|sleep apnea syndromes
554904|NCT00404807|sleep breathing disorders|sleep breathing disorders
554905|NCT00404807|sham CPAP|sham cpap
715896|NCT01020175|MDS|mds
554393|NCT00409695|ATG|atg
554906|NCT00404820|osteoporosis|osteoporosis
554907|NCT00404820|bisphosphonate|bisphosphonate
554908|NCT00404820|biomarker|biomarker
554909|NCT00404820|zoledronic acid|zoledronic acid
554910|NCT00404820|alendronate|alendronate
554911|NCT00404820|postmenopausal|postmenopausal
554912|NCT00404833|idiopathic membranous nephropathy or focal segmental glomerulosclerosis|idiopathic membranous nephropathy or focal segmental glomerulosclerosis
555426|NCT00413439|ASP9766|asp9766
554913|NCT00404846|Hyperbaric oxygenation therapy|hyperbaric oxygenation therapy
554914|NCT00404846|HBOT|hbot
554915|NCT00404846|Autism|autism
554916|NCT00404859|inflammometry|inflammometry
554917|NCT00404859|exhaled breath condensate|exhaled breath condensate
554918|NCT00404859|fractional exhaled nitric oxide|fractional exhaled nitric oxide
554919|NCT00404859|asthma|asthma
554920|NCT00404859|cystic fibrosis|cystic fibrosis
554921|NCT00404859|monitoring|monitoring
554922|NCT00404859|exacerbations|exacerbations
554923|NCT00404859|paediatric|paediatric
554924|NCT00404872|Stroke|stroke
554925|NCT00404885|uveitis|uveitis
554926|NCT00404885|calcineurin|calcineurin
554927|NCT00404885|inflammation|inflammation
554928|NCT00404898|World Trade Center dust|world trade center dust
554929|NCT00404911|Oppositional Defiant Disorder|oppositional defiant disorder
554930|NCT00404924|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
554931|NCT00404924|Adenocarcinoma|adenocarcinoma
554932|NCT00404924|Squamous Cell Carcinoma|squamous cell carcinoma
554933|NCT00404924|Large Cell Carcinoma|large cell carcinoma
554934|NCT00404950|hyperglycemia|hyperglycemia
554935|NCT00404950|cardiopulmonary bypass|cardiopulmonary bypass
554936|NCT00404950|renal injury|renal injury
554937|NCT00404950|diabetes|diabetes
554938|NCT00404963|GSK376501,|gsk376501,
554939|NCT00404963|First Time in Human,|first time in human,
554940|NCT00404963|Single Dose,|single dose,
554941|NCT00404963|Dose Escalation,|dose escalation,
554942|NCT00404963|Healthy Overweight/Obese Volunteer|healthy overweight/obese volunteer
554943|NCT00404976|inflammometry|inflammometry
554944|NCT00404976|exhaled breath condensate|exhaled breath condensate
554945|NCT00404976|fractional exhaled nitric oxide|fractional exhaled nitric oxide
554948|NCT00404989|HIV|hiv
554950|NCT00404989|Hepatitis|hepatitis
554951|NCT00404989|Pregnancy|pregnancy
554952|NCT00404989|Registry|registry
554953|NCT00405002|Acute respiratory failure|acute respiratory failure
554954|NCT00405015|rosiglitazone|rosiglitazone
554955|NCT00405015|ischemia-reperfusion injury|ischemia-reperfusion injury
554956|NCT00405015|human|human
554957|NCT00405015|Annexin A5 scintigraphy|annexin a5 scintigraphy
554958|NCT00405015|metabolic syndrome|metabolic syndrome
554959|NCT00405067|Cholesterol|cholesterol
554961|NCT00405093|cardiopulmonary bypass|cardiopulmonary bypass
554962|NCT00405093|circulatory arrest|circulatory arrest
554963|NCT00405093|aprotinin|aprotinin
554964|NCT00405093|thoracic aorta surgery|thoracic aorta surgery
554966|NCT00405106|anxiety|anxiety
554967|NCT00405106|myopia progression|myopia progression
554968|NCT00405106|accommodation|accommodation
554969|NCT00405106|vergence|vergence
554970|NCT00405119|tolerance|tolerance
554971|NCT00405119|pharmacodynamics|pharmacodynamics
554972|NCT00405119|ranitidine|ranitidine
554973|NCT00405119|esomeprazole|esomeprazole
554974|NCT00405119|pharmacokinetics|pharmacokinetics
554975|NCT00405119|gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
554976|NCT00405119|AH23844|ah23844
554977|NCT00405145|Epilepsy|epilepsy
554978|NCT00405145|MRI|mri
554979|NCT00405145|EEG|eeg
554980|NCT00405145|Neuroimaging|neuroimaging
554981|NCT00405158|Lactation mastitis|lactation mastitis
554982|NCT00405158|Breast inflammation|breast inflammation
554983|NCT00405158|Breastfeeding|breastfeeding
554984|NCT00405158|Care interventions|care interventions
554985|NCT00405158|Acupuncture treatment|acupuncture treatment
554986|NCT00405158|Antibiotic therapy|antibiotic therapy
554987|NCT00405171|Efavirenz|efavirenz
554988|NCT00405171|Nevirapine|nevirapine
554989|NCT00405171|Dyslipidemia|dyslipidemia
554990|NCT00405171|HIV|hiv
554991|NCT00405184|PID|pid
554992|NCT00405184|IVIg|ivig
554993|NCT00405184|IntragamP|intragamp
554994|NCT00405197|MUFA|mufa
554995|NCT00405197|Mediterranean diet|mediterranean diet
554996|NCT00405197|Insulin resistance|insulin resistance
554997|NCT00405197|metabolic syndrome X|metabolic syndrome x
554998|NCT00405210|hormone-resistant|hormone-resistant
554999|NCT00405210|metastatic prostatic cancer|metastatic prostatic cancer
555000|NCT00405210|pharmacokinetics|pharmacokinetics
555001|NCT00405210|naïve patient|naïve patient
555002|NCT00405236|inflammation|inflammation
555003|NCT00405236|exacerbations|exacerbations
555004|NCT00405249|HIV-1|hiv-1
555005|NCT00405249|Treatment Experienced|treatment experienced
555006|NCT00405262|Pediatrics|pediatrics
555007|NCT00405262|Postoperative Analgesia|postoperative analgesia
555008|NCT00405262|orthopedic surgery|orthopedic surgery
555009|NCT00405262|Iliac Crest Bone Graft|iliac crest bone graft
555010|NCT00405262|Osteotomy|osteotomy
555011|NCT00405262|cleft palate|cleft palate
555012|NCT00405275|antineoplastic|antineoplastic
555013|NCT00405275|antiparasitics|antiparasitics
555014|NCT00405275|antirheumatics|antirheumatics
555015|NCT00405275|chronic diseases|chronic diseases
555016|NCT00405275|clinical trial|clinical trial
555017|NCT00405275|connective tissue|connective tissue
555018|NCT00405275|double-blind|double-blind
555019|NCT00405275|drug treatment|drug treatment
555020|NCT00405275|gastric medications|gastric medications
555021|NCT00405275|joint|joint
555022|NCT00405275|multi-site trial|multi-site trial
555023|NCT00405275|musculoskeletal|musculoskeletal
555024|NCT00405275|randomized|randomized
555025|NCT00405275|rheumatoid arthritis|rheumatoid arthritis
555026|NCT00405288|Hemorrhoids|hemorrhoids
555027|NCT00405288|Pregnancy|pregnancy
555028|NCT00405288|antihemorrhoidal|antihemorrhoidal
555029|NCT00405288|Proctofoam|proctofoam
555030|NCT00405288|infants|infants
555031|NCT00411359|Refractory angina|refractory angina
555032|NCT00411359|Cardiac rehabilitation|cardiac rehabilitation
555033|NCT00411359|Symptomology|symptomology
555034|NCT00411359|Physical ability|physical ability
555035|NCT00411359|Exercise|exercise
555036|NCT00411359|Psychology|psychology
555037|NCT00411359|Quality of life|quality of life
555038|NCT00411359|Risk factors|risk factors
555039|NCT00411372|Questionnaire|questionnaire
555040|NCT00411372|COPD|copd
555041|NCT00411372|Shortness of Breath|shortness of breath
555042|NCT00411385|Chronic Hepatitis C|chronic hepatitis c
555043|NCT00411385|Hepatitis C|hepatitis c
555044|NCT00411385|CHC|chc
555045|NCT00411385|HepC|hepc
555046|NCT00411385|Genotype 1|genotype 1
555047|NCT00411385|Hepatitis|hepatitis
555048|NCT00411385|HCV|hcv
555049|NCT00411398|Anxiety, SNRI, SSRI,GAD,SAD|anxiety, snri, ssri,gad,sad
555050|NCT00411411|GLP-1|glp-1
555051|NCT00411411|GIP|gip
555052|NCT00411411|Incretin hormones|incretin hormones
555053|NCT00411411|DPP-IV inhibitor|dpp-iv inhibitor
555054|NCT00411411|Hyperglycaemic clamp|hyperglycaemic clamp
555055|NCT00411411|Meal test|meal test
555056|NCT00411424|Rheumatoid Arthritis|rheumatoid arthritis
555057|NCT00411424|Randomized Control Trial|randomized control trial
555058|NCT00411424|Treatment outcomes|treatment outcomes
555059|NCT00411424|Monoclonal antibody|monoclonal antibody
555060|NCT00411450|k-ras|k-ras
555061|NCT00411450|biomarker|biomarker
555062|NCT00411450|colorectal|colorectal
555063|NCT00411450|colon|colon
555064|NCT00411450|rectal|rectal
555065|NCT00411450|FOLFOX|folfox
555066|NCT00411450|FOLFIRI|folfiri
555067|NCT00411463|Interpersonal Therapy|interpersonal therapy
555068|NCT00411463|Social Rhythm Therapy|social rhythm therapy
555069|NCT00411463|Bipolar Disorder|bipolar disorder
555071|NCT00411463|Seroquel|seroquel
555072|NCT00411528|Prostate Cancer|prostate cancer
555073|NCT00411528|Hormone Refractory|hormone refractory
555074|NCT00411528|patupilone|patupilone
555075|NCT00411528|docetaxel|docetaxel
555076|NCT00411541|acute lymphoblastic leukemia, maintenance, BFM protocol|acute lymphoblastic leukemia, maintenance, bfm protocol
555077|NCT00411541|intermediate risk childhood acute lymphoblastic leukemia|intermediate risk childhood acute lymphoblastic leukemia
555078|NCT00411567|markers, inflammation, optimal, sub-optimal, corticosteroid, bronchial asthma|markers, inflammation, optimal, sub-optimal, corticosteroid, bronchial asthma
555079|NCT00411580|Mild, moderate Alzheimer's Disease (AD), Aß-specific antibody, CAD106|mild, moderate alzheimer's disease (ad), aß-specific antibody, cad106
555080|NCT00411593|Non-Small Cell Lung Cancer|non-small cell lung cancer
555081|NCT00411593|Lung Cancer|lung cancer
555082|NCT00411593|NSCLC|nsclc
555083|NCT00411593|Bortezomib|bortezomib
555084|NCT00411593|Bevacizumab|bevacizumab
555085|NCT00411606|Healthy|healthy
555086|NCT00411606|Allergy|allergy
555087|NCT00411606|Allergic Rhinoconjunctivitis|allergic rhinoconjunctivitis
555088|NCT00411619|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
555089|NCT00411619|Subendymal Giant Cell Astrocytomas (SEGA'S)|subendymal giant cell astrocytomas (sega's)
555090|NCT00411619|Mammalian Target of Rapamycin (mTOR)|mammalian target of rapamycin (mtor)
555091|NCT00411619|Everolimus (RAD001)|everolimus (rad001)
555092|NCT00411619|Tuberous Sclerosis with Subependymal Giant Cell Astrocytomas|tuberous sclerosis with subependymal giant cell astrocytomas
555093|NCT00411632|Lung Cancer|lung cancer
555094|NCT00411632|Non-Small Cell Lung Cancer|non-small cell lung cancer
555095|NCT00411632|NSCLC|nsclc
555096|NCT00411632|Erlotinib|erlotinib
555097|NCT00411632|Tarceva|tarceva
555098|NCT00411632|Bexarotene|bexarotene
555099|NCT00411632|Targretin|targretin
555100|NCT00411632|OSI-774|osi-774
555101|NCT00411632|Battle Program|battle program
555102|NCT00411645|prevention|prevention
555103|NCT00411645|prophylaxis|prophylaxis
555104|NCT00411645|Cytomegalovirus|cytomegalovirus
555106|NCT00411645|allogeneic stem cell transplant|allogeneic stem cell transplant
555108|NCT00411671|Lung Cancer|lung cancer
555109|NCT00411671|Non-Small Cell Lung Cancer|non-small cell lung cancer
555110|NCT00411671|NSCLC|nsclc
555111|NCT00411671|Sorafenib|sorafenib
555112|NCT00411671|BAY 43-9006|bay 43-9006
555113|NCT00411671|Battle Program|battle program
555114|NCT00411723|multiple sclerosis, chronic-progressive, relapsing-remitting|multiple sclerosis, chronic-progressive, relapsing-remitting
555115|NCT00412646|HIV|hiv
555116|NCT00412646|AIDS|aids
555117|NCT00412646|Dose finding study|dose finding study
555118|NCT00412646|TMC125-C203|tmc125-c203
555119|NCT00412646|Treatment Experienced|treatment experienced
555120|NCT00412659|Sinus, Pilonidal|sinus, pilonidal
555121|NCT00412659|Pilonidal sinus|pilonidal sinus
555122|NCT00412659|Pilonidal cysts|pilonidal cysts
555123|NCT00412659|Pilonidal disease|pilonidal disease
556153|NCT00418951|MDS|mds
555124|NCT00412659|midline excision|midline excision
555125|NCT00412659|Karydakis operation|karydakis operation
555126|NCT00412659|expertise based study|expertise based study
555127|NCT00412659|surgery|surgery
555128|NCT00412659|therapy|therapy
555129|NCT00412672|Myocardial infarction|myocardial infarction
555130|NCT00412672|contrast echocardiography|contrast echocardiography
555131|NCT00412672|collateral circulation|collateral circulation
555132|NCT00412724|diet|diet
555133|NCT00412724|acceptability|acceptability
555134|NCT00412724|palatability|palatability
555135|NCT00412724|food|food
555136|NCT00412724|questionnaire|questionnaire
555137|NCT00412724|Food habits|food habits
555138|NCT00412750|hepatitis B|hepatitis b
555139|NCT00412750|hepatitis B Virus (HBV)|hepatitis b virus (hbv)
555140|NCT00412750|chronic hepatitis B|chronic hepatitis b
555141|NCT00412750|telbivudine|telbivudine
555142|NCT00412750|peginterferon|peginterferon
555143|NCT00412763|Acute hepatitis|acute hepatitis
555144|NCT00412763|Acute viral hepatitis|acute viral hepatitis
555145|NCT00412763|Acute nonviral hepatitis|acute nonviral hepatitis
555146|NCT00412763|Silymarin|silymarin
555147|NCT00412763|Milk Thistle|milk thistle
555148|NCT00412789|Advanced solid tumor|advanced solid tumor
555149|NCT00412789|Patupilone|patupilone
555150|NCT00412802|enoxaparine|enoxaparine
555151|NCT00412802|acute coronary syndrome|acute coronary syndrome
555152|NCT00412802|renal failure|renal failure
555153|NCT00412802|dose adaptation|dose adaptation
555154|NCT00412815|insulin sensitivity|insulin sensitivity
555155|NCT00412815|coronary artery disease|coronary artery disease
555156|NCT00412815|exercise training|exercise training
555157|NCT00412828|Melanoma|melanoma
555158|NCT00412828|CR011-vcMMAE|cr011-vcmmae
555159|NCT00412841|Avascular Necrosis|avascular necrosis
555160|NCT00412841|Lipitor|lipitor
555162|NCT00412867|Cerebral Infarction|cerebral infarction
555163|NCT00412867|acute ischemic stroke|acute ischemic stroke
555164|NCT00412867|Brain ischemia|brain ischemia
555165|NCT00412893|Phase III|phase iii
555166|NCT00412893|Invasive fungal disease|invasive fungal disease
555168|NCT00412893|Filamentous fungi|filamentous fungi
555169|NCT00412893|ASP9766|asp9766
555170|NCT00412893|BAL8557|bal8557
555171|NCT00412893|Isavuconazole|isavuconazole
555172|NCT00412906|Low-grade inflammation|low-grade inflammation
555173|NCT00412906|insulin resistance|insulin resistance
555174|NCT00412906|Metabolism|metabolism
555175|NCT00412906|Type 2 diabetes|type 2 diabetes
555176|NCT00412906|Endotoxemia|endotoxemia
555177|NCT00412906|Fat tissue|fat tissue
555178|NCT00412906|Muscle tissue|muscle tissue
555179|NCT00412906|RT-PCR|rt-pcr
555180|NCT00412919|Myeloma|myeloma
555181|NCT00412919|Relapsed|relapsed
555182|NCT00412919|Refractory|refractory
555183|NCT00412932|Hypertension|hypertension
555184|NCT00412932|Angiotensin Receptor Blocker|angiotensin receptor blocker
555185|NCT00412932|Calcium Channel Blocker|calcium channel blocker
555186|NCT00412932|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
555187|NCT00412932|Hydrochlorothiazide|hydrochlorothiazide
555188|NCT00412932|Stage I and II Hypertension|stage i and ii hypertension
555189|NCT00412971|Recurrence of bladder cancer|recurrence of bladder cancer
555190|NCT00412971|Fluorescence cystoscopy|fluorescence cystoscopy
555191|NCT00412997|advanced solid tumor|advanced solid tumor
555192|NCT00412997|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
555193|NCT00412997|Phase I|phase i
555194|NCT00412997|HDAC inhibitor|hdac inhibitor
555195|NCT00412997|Adult patients|adult patients
555196|NCT00413023|depression|depression
555197|NCT00413023|major depressive disorder|major depressive disorder
555198|NCT00413023|MDD|mdd
555199|NCT00413036|Celgene|celgene
555200|NCT00413036|Revlimid|revlimid
555201|NCT00413036|CC-5013|cc-5013
555202|NCT00413036|Non-hodgkin's lymphoma|non-hodgkin's lymphoma
555203|NCT00413036|Lenalidomide|lenalidomide
555204|NCT00413036|CC5013|cc5013
555205|NCT00413036|NHL|nhl
555206|NCT00413049|Hypertension, valsartan, amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
555207|NCT00413075|Solid tumors|solid tumors
555208|NCT00413075|Adenosarcoma|adenosarcoma
555209|NCT00413075|B-cell lymphoma|b-cell lymphoma
555210|NCT00413075|belinostat|belinostat
555211|NCT00413075|bladder cancer|bladder cancer
555212|NCT00413075|Breast cancer|breast cancer
555213|NCT00413075|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
555214|NCT00413075|Carcinoma, Small Cell|carcinoma, small cell
555215|NCT00413075|Chondrosarcoma|chondrosarcoma
555216|NCT00413075|colorectal cancer|colorectal cancer
555217|NCT00413075|Esophageal Neoplasms|esophageal neoplasms
555218|NCT00413075|Fibrosarcoma|fibrosarcoma
555219|NCT00413075|head and neck cancer|head and neck cancer
555220|NCT00413075|Hemangiosarcoma|hemangiosarcoma
555221|NCT00413075|Hodgkins Disease|hodgkins disease
555222|NCT00413075|kidney cancer|kidney cancer
555223|NCT00413075|Leiomyosarcoma|leiomyosarcoma
555224|NCT00413075|Liposarcoma|liposarcoma
555225|NCT00413075|lung cancer|lung cancer
555226|NCT00413075|lymphoma|lymphoma
555227|NCT00413075|mesothelioma|mesothelioma
556659|NCT00421187|Ambisome|ambisome
555228|NCT00413075|mesothelioma, cystic|mesothelioma, cystic
555229|NCT00413075|Mixed Tumor, Mesodermal|mixed tumor, mesodermal
555230|NCT00413075|Osteosarcoma|osteosarcoma
555231|NCT00413075|Otorhinolaryngologic Neoplasms|otorhinolaryngologic neoplasms
555232|NCT00413075|Ovarian cancer|ovarian cancer
555233|NCT00413075|Parathyroid Neoplasms|parathyroid neoplasms
555234|NCT00413075|Prostate cancer|prostate cancer
555235|NCT00413075|sarcoma|sarcoma
555236|NCT00413075|T-cell lymphoma|t-cell lymphoma
555237|NCT00413075|thyroid cancer|thyroid cancer
555238|NCT00413075|PXD101|pxd101
555239|NCT00413088|renal insufficency|renal insufficency
555240|NCT00413088|low molecular weight heparin|low molecular weight heparin
555241|NCT00413088|pharmacokinetics|pharmacokinetics
555242|NCT00413088|elderly|elderly
555243|NCT00413127|Systemic lidocaine|systemic lidocaine
555244|NCT00413127|peridural lidocaine|peridural lidocaine
555245|NCT00413127|perioperative analgesia|perioperative analgesia
555246|NCT00413127|inflammation|inflammation
555247|NCT00413127|Anesthesia|anesthesia
555248|NCT00413140|childhood disease|childhood disease
555249|NCT00413140|cystic fibrosis|cystic fibrosis
555250|NCT00413140|exhaled breath condensate|exhaled breath condensate
555251|NCT00413140|exhaled nitric oxide|exhaled nitric oxide
555252|NCT00413140|airway inflammation|airway inflammation
555253|NCT00413140|non-invasive inflammatory markers|non-invasive inflammatory markers
555255|NCT00413140|children|children
555256|NCT00413153|HIV|hiv
555257|NCT00413153|Kaletra|kaletra
555258|NCT00413153|Reyataz|reyataz
555259|NCT00413153|Insulin sensitivity|insulin sensitivity
555260|NCT00413153|Lipids|lipids
555261|NCT00413153|Body Composition|body composition
555262|NCT00413153|Receiving Kaletra|receiving kaletra
555263|NCT00413153|Treatment Experienced|treatment experienced
555264|NCT00413166|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
555265|NCT00413166|APL|apl
555266|NCT00413166|ATRA|atra
555267|NCT00413166|All-Trans Retinoic Acid|all-trans retinoic acid
555268|NCT00413166|Arsenic Trioxide|arsenic trioxide
555269|NCT00413166|Theophylline|theophylline
555270|NCT00413166|Gemtuzumab|gemtuzumab
555271|NCT00413179|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
555272|NCT00413179|Chronic Anovulation|chronic anovulation
555273|NCT00413179|Chronic Oligoovulation|chronic oligoovulation
555274|NCT00413179|Infertility|infertility
555275|NCT00413179|Hyperandrogenism|hyperandrogenism
555276|NCT00413179|Metformin|metformin
555277|NCT00413179|Ovulation induction|ovulation induction
555278|NCT00413218|Invasive Candida infections|invasive candida infections
555279|NCT00413218|BAL8557|bal8557
555280|NCT00413218|ASP9766|asp9766
555281|NCT00413218|Isavuconazole|isavuconazole
555282|NCT00413218|Candidemia|candidemia
555283|NCT00413218|Candidemia and other invasive candida infections|candidemia and other invasive candida infections
555284|NCT00413218|Phase III study|phase iii study
555285|NCT00413231|Thoracic Aneurysm|thoracic aneurysm
555286|NCT00413231|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
555287|NCT00413231|Endovascular Stent Graft|endovascular stent graft
555288|NCT00413231|Endograft|endograft
555289|NCT00413231|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
555290|NCT00413231|Endovascular procedure|endovascular procedure
555291|NCT00413231|Descending Thoracic Aneurysm|descending thoracic aneurysm
555292|NCT00413231|Valiant Stent Graft System|valiant stent graft system
555293|NCT00413244|Hypogonadal|hypogonadal
555294|NCT00413244|coronary artery disease|coronary artery disease
555295|NCT00413244|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
555296|NCT00413257|Postoperative Hyperalgesia|postoperative hyperalgesia
555297|NCT00413257|cardiac Surgical Procedures|cardiac surgical procedures
555298|NCT00413257|Nefopam|nefopam
555299|NCT00413257|Randomized Controlled Trials|randomized controlled trials
555300|NCT00413257|Pain and chronic disease|pain and chronic disease
555301|NCT00413270|Imatinib resistant,|imatinib resistant,
555302|NCT00413270|Imatinib intolerant,|imatinib intolerant,
555303|NCT00413270|CML- blast crisis,|cml- blast crisis,
555304|NCT00413270|CML- Accelerated phase,|cml- accelerated phase,
555305|NCT00413270|CML- chronic phase,|cml- chronic phase,
555306|NCT00413270|nilotinib,|nilotinib,
555307|NCT00413270|Chronic myelogenous leukemia,|chronic myelogenous leukemia,
555308|NCT00413270|blast crisis,|blast crisis,
555309|NCT00413270|accelerated phase,|accelerated phase,
555310|NCT00413270|chronic phase|chronic phase
555311|NCT00413283|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
752414|NCT01172912|testicular mature teratoma|testicular mature teratoma
555312|NCT00413283|Chemotherapy Induced Thrombocytopenia|chemotherapy induced thrombocytopenia
555314|NCT00413283|NSCLC|nsclc
555315|NCT00413283|Stage IIIB NSCLC|stage iiib nsclc
555316|NCT00413283|Stage IV NSCLC|stage iv nsclc
555317|NCT00413283|Gemcitabine|gemcitabine
555318|NCT00413283|Carboplatin|carboplatin
555319|NCT00413283|Cisplatin|cisplatin
555320|NCT00413296|PTSD|ptsd
555321|NCT00413296|Anxiety|anxiety
555322|NCT00413296|Pharmacotherapy|pharmacotherapy
555323|NCT00413296|Levetiracetam|levetiracetam
555324|NCT00413296|Relapse prevention|relapse prevention
555325|NCT00413309|Acute Coronary Syndrome|acute coronary syndrome
555326|NCT00413309|Percutaneous Coronary Intervention|percutaneous coronary intervention
555327|NCT00413309|Antiplatelet Therapy|antiplatelet therapy
555328|NCT00413309|PillCam|pillcam
555329|NCT00413309|Endoscopy|endoscopy
555330|NCT00413322|Advanced Solid tumor|advanced solid tumor
555331|NCT00413322|Adenosarcoma|adenosarcoma
555332|NCT00413322|Androgen-independent prostate cancer|androgen-independent prostate cancer
555333|NCT00413322|belinostat|belinostat
555334|NCT00413322|bladder cancer|bladder cancer
555335|NCT00413322|bladder neoplasms|bladder neoplasms
555336|NCT00413322|Breast cancer|breast cancer
555337|NCT00413322|Carcinoma, Bronchogenic|carcinoma, bronchogenic
555464|NCT00413556|Oral tablets|oral tablets
555338|NCT00413322|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
555339|NCT00413322|Carcinoma, Small Cell|carcinoma, small cell
555340|NCT00413322|Carcinosarcoma|carcinosarcoma
555341|NCT00413322|Chondrosarcoma|chondrosarcoma
555342|NCT00413322|Coin Lesion, Pulmonary|coin lesion, pulmonary
555343|NCT00413322|colorectal cancer|colorectal cancer
555344|NCT00413322|Esophageal Neoplasms|esophageal neoplasms
555345|NCT00413322|Facial Neoplasms|facial neoplasms
555346|NCT00413322|Fibrosarcoma|fibrosarcoma
555347|NCT00413322|head and neck cancer|head and neck cancer
555348|NCT00413322|Hemangiosarcoma|hemangiosarcoma
555349|NCT00413322|Histiocytoma, Malignant Fibrous|histiocytoma, malignant fibrous
555350|NCT00413322|kidney cancer|kidney cancer
555351|NCT00413322|Leiomyosarcoma|leiomyosarcoma
555352|NCT00413322|Liposarcoma|liposarcoma
555353|NCT00413322|lung cancer|lung cancer
555354|NCT00413322|lung neoplasms|lung neoplasms
555355|NCT00413322|Lymphangiosarcoma|lymphangiosarcoma
555356|NCT00413322|mesothelioma|mesothelioma
555357|NCT00413322|mesothelioma, cystic|mesothelioma, cystic
555358|NCT00413322|Mixed Tumor, Mesodermal|mixed tumor, mesodermal
555359|NCT00413322|Mouth Neoplasms|mouth neoplasms
555360|NCT00413322|Myosarcoma|myosarcoma
555361|NCT00413322|Myxosarcoma|myxosarcoma
555362|NCT00413322|Osteosarcoma|osteosarcoma
555363|NCT00413322|Otorhinolaryngologic Neoplasms|otorhinolaryngologic neoplasms
555364|NCT00413322|Ovarian cancer|ovarian cancer
555365|NCT00413322|Pancoast's Syndrome|pancoast's syndrome
555366|NCT00413322|Parathyroid Neoplasms|parathyroid neoplasms
555367|NCT00413322|Phyllodes Tumor|phyllodes tumor
555368|NCT00413322|Pulmonary Sclerosing Hemangioma|pulmonary sclerosing hemangioma
555370|NCT00413322|thyroid cancer|thyroid cancer
555371|NCT00413322|Thyroid Neoplasms|thyroid neoplasms
555372|NCT00413322|Tracheal Neoplasms|tracheal neoplasms
555373|NCT00413322|PXD101|pxd101
555374|NCT00413335|Childhood and Adolescent Obesity|childhood and adolescent obesity
555375|NCT00413335|Metabolic phenotype|metabolic phenotype
555376|NCT00413335|Impaired Glucose Tolerance|impaired glucose tolerance
555377|NCT00413335|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
555378|NCT00413335|Insulin Sensitivity|insulin sensitivity
555379|NCT00413335|Insulin Resistance|insulin resistance
555380|NCT00413335|Abdominal fat partitioning|abdominal fat partitioning
555381|NCT00413335|Impaired Glucose Tolerance (IGT)|impaired glucose tolerance (igt)
555382|NCT00413335|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
555383|NCT00413348|Type 2 diabetes|type 2 diabetes
555384|NCT00413348|Probiotics|probiotics
555385|NCT00413348|Insulin-resistance|insulin-resistance
555386|NCT00413348|Inflammation|inflammation
555387|NCT00413348|Hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
555388|NCT00413348|Endotoxin|endotoxin
555389|NCT00413361|Systemic Lupus Erythematosus|systemic lupus erythematosus
555390|NCT00413361|Hydroxychloroquine|hydroxychloroquine
555391|NCT00413374|Lovenox|lovenox
555392|NCT00413374|Enoxaparin|enoxaparin
555393|NCT00413374|Prophylaxis|prophylaxis
555394|NCT00413374|Pulmonary Embolism|pulmonary embolism
555395|NCT00413374|Acute Deep Vein Thrombosis|acute deep vein thrombosis
555396|NCT00413374|Venous Thrombosis|venous thrombosis
555397|NCT00413374|Thrombosis|thrombosis
555398|NCT00413374|Anticoagulation|anticoagulation
555399|NCT00413387|Asthma|asthma
555400|NCT00413387|Combinations|combinations
555401|NCT00413387|Inhaled therapy|inhaled therapy
555402|NCT00413387|Corticosteroids|corticosteroids
555403|NCT00413387|Long acting bronchodilators|long acting bronchodilators
555404|NCT00413387|Beclomethasone|beclomethasone
555405|NCT00413387|Formoterol|formoterol
555406|NCT00413387|Budesonide|budesonide
555407|NCT00413400|Inflammation|inflammation
555408|NCT00413400|Visceral adiposity|visceral adiposity
555410|NCT00413400|Adiponectin|adiponectin
555411|NCT00413400|glucose tolerance|glucose tolerance
555412|NCT00413400|endothelial function|endothelial function
555413|NCT00413400|metabolic syndrome|metabolic syndrome
555414|NCT00413413|Hypertension, valsartan, amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
555415|NCT00413426|Pharmacokinetics|pharmacokinetics
555416|NCT00413426|oral|oral
555417|NCT00413426|single dose|single dose
555418|NCT00413426|table|table
555419|NCT00413426|suspension|suspension
555420|NCT00413426|release|release
555421|NCT00413426|darifenacin|darifenacin
555422|NCT00413426|healthy subjects|healthy subjects
555423|NCT00413426|Healthy volunteers study|healthy volunteers study
555424|NCT00413439|Isavuconazole|isavuconazole
555427|NCT00413439|chemotherapy|chemotherapy
555428|NCT00413439|prophylaxis|prophylaxis
555429|NCT00413439|systemic fungal infection|systemic fungal infection
555430|NCT00413452|Rheumatoid Arthritis|rheumatoid arthritis
555431|NCT00413452|Etanercept|etanercept
555432|NCT00413452|Enbrel|enbrel
555433|NCT00413452|Amgen|amgen
555434|NCT00413465|Renal Plasma Flow|renal plasma flow
555435|NCT00413465|Endotoxemia|endotoxemia
555436|NCT00413465|Type 2 diabetes|type 2 diabetes
555437|NCT00413478|5-Aza|5-aza
555438|NCT00413478|Azacytidine|azacytidine
555439|NCT00413478|Vidaza|vidaza
555440|NCT00413478|CLL|cll
555441|NCT00413478|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
555442|NCT00413478|Richter's transformation|richter's transformation
555443|NCT00413478|Leukemia|leukemia
555444|NCT00413491|Breast Cancer|breast cancer
555445|NCT00413491|BRCA1 gene|brca1 gene
555446|NCT00413491|BRCA2 gene|brca2 gene
555447|NCT00413491|Magnetic Resonance Imaging|magnetic resonance imaging
555448|NCT00413491|Mammography|mammography
555449|NCT00413491|Ultrasonography|ultrasonography
555450|NCT00413504|Fondaparinux|fondaparinux
555451|NCT00413504|Monotherapy|monotherapy
555452|NCT00413504|Deep Vein thrombosis|deep vein thrombosis
555453|NCT00413504|Pulmonary Embolism|pulmonary embolism
555454|NCT00413504|Anticoagulation|anticoagulation
555651|NCT00414375|Perforated Appendicitis|perforated appendicitis
555455|NCT00413517|Naturally occurring myopia with or without astigmatism|naturally occurring myopia with or without astigmatism
555456|NCT00413543|COPD|copd
555457|NCT00413543|exacerbation|exacerbation
555458|NCT00413543|pulmonary rehabilitation|pulmonary rehabilitation
555459|NCT00413543|exercise tolerance|exercise tolerance
555460|NCT00413543|exacerbations|exacerbations
555461|NCT00413543|quality of life|quality of life
555462|NCT00413543|readmissions|readmissions
555463|NCT00413556|Rhinitis|rhinitis
555465|NCT00413556|Ig G4|ig g4
555466|NCT00413556|grass pollen|grass pollen
555468|NCT00413582|Pectus Excavatum|pectus excavatum
555469|NCT00413582|Bar Repair|bar repair
555470|NCT00413582|Pain Control|pain control
555471|NCT00413582|Pectus Excavatum Repair|pectus excavatum repair
555472|NCT00413595|Cerebrovascular Accident|cerebrovascular accident
555473|NCT00413595|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
555474|NCT00413595|Fabry Disease|fabry disease
555475|NCT00413595|Fabry's Disease|fabry's disease
555476|NCT00413595|Anderson-Fabry Disease|anderson-fabry disease
555477|NCT00413595|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
555478|NCT00413595|Stroke, acute|stroke, acute
555479|NCT00413595|Cerebral Stroke|cerebral stroke
555480|NCT00413608|Human|human
555481|NCT00413608|Adults|adults
555482|NCT00413608|Male|male
555483|NCT00413608|Alleles|alleles
555484|NCT00413608|Genotype|genotype
555485|NCT00413608|Platelet Aggregation/drug effects|platelet aggregation/drug effects
555486|NCT00413608|Platelet Aggregation Inhibitors/*pharmacology|platelet aggregation inhibitors/*pharmacology
555487|NCT00413608|Platelet Function Tests|platelet function tests
555488|NCT00413608|Pharmacogenetics|pharmacogenetics
555489|NCT00413608|*Polymorphism, Genetic|*polymorphism, genetic
555490|NCT00413608|Ticlopidine/*analogs & derivatives/pharmacology|ticlopidine/*analogs & derivatives/pharmacology
555491|NCT00413608|Healthy subjects|healthy subjects
555493|NCT00413621|Alzheimer Disease|alzheimer disease
555494|NCT00413621|Amyloid|amyloid
555495|NCT00413621|AD|ad
555496|NCT00413621|Healthy Volunteer|healthy volunteer
555497|NCT00413621|HV|hv
555498|NCT00413647|CardioPET|cardiopet
555499|NCT00413647|Coronary Artery Disease|coronary artery disease
555500|NCT00413647|Electrocardiogram|electrocardiogram
555501|NCT00413647|Radiation Dosimetry|radiation dosimetry
555502|NCT00413660|DMARD therapy|dmard therapy
555503|NCT00413673|Naturally occurring low to moderate myopia, with or without low levels of astigmatism in U.S. Army personnel|naturally occurring low to moderate myopia, with or without low levels of astigmatism in u.s. army personnel
555504|NCT00413686|Mixed solid tumors|mixed solid tumors
555505|NCT00413699|long-term|long-term
555506|NCT00413699|open-label|open-label
555507|NCT00413699|safety|safety
555508|NCT00413712|Supraventricular Tachycardia|supraventricular tachycardia
555509|NCT00413712|Calcium Channel Blockers|calcium channel blockers
555510|NCT00413712|Verapamil|verapamil
716584|NCT01029262|MDS|mds
555511|NCT00413712|Diltiazem|diltiazem
555512|NCT00413712|Adenosine|adenosine
555513|NCT00413725|HIV Seronegativity|hiv seronegativity
555514|NCT00413725|HIV Preventive Vaccine|hiv preventive vaccine
555515|NCT00413725|Adenovirus|adenovirus
555516|NCT00413738|Central venous catheter|central venous catheter
555517|NCT00413738|Catheter related bloodstream infection|catheter related bloodstream infection
555518|NCT00413738|Heparin|heparin
555519|NCT00413738|Chlorhexidine|chlorhexidine
555520|NCT00413738|Sulfadiazine|sulfadiazine
555521|NCT00413751|Large pupils rendering night vision difficulties such as haloes, glare, and monocular diplopia|large pupils rendering night vision difficulties such as haloes, glare, and monocular diplopia
555522|NCT00413790|Heart rate, overactive bladder|heart rate, overactive bladder
555523|NCT00413803|Hemodialysis|hemodialysis
555524|NCT00413803|Nocturnal dialysis|nocturnal dialysis
555525|NCT00413803|Cardiovascular disease|cardiovascular disease
555526|NCT00413803|Quality of Life|quality of life
555527|NCT00413803|left ventricular hypertrophy|left ventricular hypertrophy
555528|NCT00413816|Anemia|anemia
555529|NCT00413816|Critically ill|critically ill
555530|NCT00413829|age related macular degeneration|age related macular degeneration
555531|NCT00413829|anti-VEGF therapy|anti-vegf therapy
555532|NCT00413842|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
555533|NCT00413842|Plasticity|plasticity
555534|NCT00413842|Primary Motor Cortex|primary motor cortex
555535|NCT00413842|Cerebellum|cerebellum
555536|NCT00413842|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
555537|NCT00413842|Healthy Volunteer|healthy volunteer
555538|NCT00413842|HV|hv
555539|NCT00413855|Abdominal pain|abdominal pain
555540|NCT00413855|Appendectomy|appendectomy
555541|NCT00413855|Laparoscopy|laparoscopy
555542|NCT00413855|Chronic appendicitis|chronic appendicitis
555544|NCT00413868|Myopia with our without astigmatism|myopia with our without astigmatism
555545|NCT00413881|Residual refractive error left over from initial LASIK correction.|residual refractive error left over from initial lasik correction.
555546|NCT00413881|Higher Order aberrations measured using a wavefront analyzer.|higher order aberrations measured using a wavefront analyzer.
555547|NCT00413920|Steroids avoidance,|steroids avoidance,
555548|NCT00413920|enteric-coated mycophenolate sodium (EC-MPS),|enteric-coated mycophenolate sodium (ec-mps),
555549|NCT00413920|de novo renal transplantation|de novo renal transplantation
555550|NCT00413933|falls|falls
555551|NCT00413933|prevention|prevention
555552|NCT00413933|elderly|elderly
555553|NCT00413933|multidisciplinary intervention|multidisciplinary intervention
555554|NCT00413933|health care utilization|health care utilization
555555|NCT00413946|Premature infant|premature infant
555556|NCT00413946|developmental outcome|developmental outcome
555557|NCT00413959|NHL|nhl
555558|NCT00413985|Low Birth Weight|low birth weight
555559|NCT00413985|Fortified Human Milk|fortified human milk
555560|NCT00413985|breastfeeding|breastfeeding
555561|NCT00413985|infants|infants
555562|NCT00413985|growth|growth
555563|NCT00413998|Functional ischaemic mitral regurgitation|functional ischaemic mitral regurgitation
555564|NCT00414011|Removal of corneal epithelium followed by excimer laser treatment during prk|removal of corneal epithelium followed by excimer laser treatment during prk
555565|NCT00414024|Opioid, constipation, tegaserod|opioid, constipation, tegaserod
555566|NCT00414037|insomnia|insomnia
555567|NCT00414037|lunesta|lunesta
555568|NCT00414037|eszopiclone|eszopiclone
555569|NCT00414037|pain|pain
555570|NCT00414037|fMRI|fmri
555571|NCT00414063|Fecal Energy|fecal energy
555572|NCT00414063|Urine Energy|urine energy
555573|NCT00414063|Bomb Calorimetry|bomb calorimetry
555574|NCT00414063|Gut Maintenance Flora|gut maintenance flora
555575|NCT00414063|Obesity|obesity
555576|NCT00414063|Energy Metabolism|energy metabolism
555577|NCT00414076|Uterine Leiomyosarcoma|uterine leiomyosarcoma
555578|NCT00414076|Uterine Neoplasm|uterine neoplasm
555579|NCT00414076|Uterine Sarcomas|uterine sarcomas
555580|NCT00414076|Uterine Cancer|uterine cancer
555581|NCT00414076|Uterus|uterus
555582|NCT00414076|LMS|lms
555583|NCT00414076|ER Positivity|er positivity
555584|NCT00414076|Femara|femara
555585|NCT00414076|Letrozole|letrozole
555586|NCT00414102|Chronic Insomnia|chronic insomnia
555587|NCT00414102|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
555588|NCT00414102|Drug Therapy|drug therapy
555589|NCT00414115|Observational controlled study|observational controlled study
555590|NCT00414115|Genomic biomarkers|genomic biomarkers
555591|NCT00414115|Adverse drug reaction|adverse drug reaction
555592|NCT00414115|In children OR adults|in children or adults
555593|NCT00414128|vasculitis|vasculitis
555594|NCT00414128|ANCA|anca
555595|NCT00414128|mycophenolate mofetil|mycophenolate mofetil
555596|NCT00414128|cyclophosphamide|cyclophosphamide
555597|NCT00414128|Anti neutrophil cytoplasm antibody associated vasculitis|anti neutrophil cytoplasm antibody associated vasculitis
555598|NCT00414141|Allergy|allergy
555599|NCT00414141|Allergoid|allergoid
555600|NCT00414141|Specific Immunotherapy|specific immunotherapy
554949|NCT00404989|HBV|hbv
555601|NCT00414154|Group based patient education,|group based patient education,
555602|NCT00414154|multidisciplinary,|multidisciplinary,
555603|NCT00414154|physical activity,|physical activity,
555604|NCT00414154|adherence to treatment,|adherence to treatment,
555605|NCT00414154|quality of life|quality of life
555606|NCT00414167|Binge eating|binge eating
555607|NCT00414167|Obesity|obesity
555608|NCT00414167|Medication|medication
555609|NCT00414167|Craving|craving
555610|NCT00414167|Emotional eating|emotional eating
555611|NCT00414193|AmpC beta-lactamase|ampc beta-lactamase
555612|NCT00414193|Bacteremia|bacteremia
555613|NCT00414193|Piperacillin|piperacillin
555614|NCT00414193|Tazobactam|tazobactam
555615|NCT00414206|AMD|amd
555616|NCT00414206|Wet AMD|wet amd
555617|NCT00414232|Rectal Cancer|rectal cancer
555618|NCT00414232|Chemoradiation|chemoradiation
555619|NCT00414232|Rectal Cancer receiving chemoradiation.|rectal cancer receiving chemoradiation.
555620|NCT00414258|Pain Response|pain response
555621|NCT00414271|gastric cancer, neo-adjuvant chemotherapy|gastric cancer, neo-adjuvant chemotherapy
555622|NCT00414284|HIV/AIDS|hiv/aids
555623|NCT00414284|viremia|viremia
555624|NCT00414284|Kaletra|kaletra
555625|NCT00414284|pharmacokinetics|pharmacokinetics
555626|NCT00414284|viral load|viral load
555627|NCT00414284|LPV/r|lpv/r
555628|NCT00414284|Treatment Experienced|treatment experienced
555629|NCT00414297|CAD|cad
555630|NCT00414297|ECP|ecp
555631|NCT00414297|CFI|cfi
555632|NCT00414297|CPI|cpi
555633|NCT00414297|MPR|mpr
555634|NCT00414310|Decitabine|decitabine
555635|NCT00414310|Dacogen|dacogen
555636|NCT00414310|5-AZA|5-aza
555637|NCT00414310|Valproic Acid|valproic acid
555638|NCT00414310|Myelodysplastic Syndrome|myelodysplastic syndrome
555639|NCT00414310|Acute Myelogenous Leukemia|acute myelogenous leukemia
555640|NCT00414310|MDS|mds
555641|NCT00414310|AML|aml
555642|NCT00414336|Blood Stage|blood stage
555643|NCT00414336|Investigational|investigational
555644|NCT00414336|Endemic|endemic
555645|NCT00414336|Malaria|malaria
555646|NCT00414349|Topical analgesic|topical analgesic
555647|NCT00414349|Multiple dose|multiple dose
555648|NCT00414362|Bacteremia|bacteremia
555649|NCT00414362|Urinary Tract Infections|urinary tract infections
555650|NCT00414362|Fluoroquinolone|fluoroquinolone
555653|NCT00414375|Appendectomy|appendectomy
555654|NCT00414388|AIPC|aipc
555655|NCT00414414|TB|tb
555656|NCT00414414|Tuberculosis|tuberculosis
555657|NCT00414414|HIV|hiv
555658|NCT00414414|Co-infection|co-infection
555659|NCT00414414|Steroid|steroid
555660|NCT00414414|Prednisone|prednisone
555661|NCT00414414|oral corticosteroids|oral corticosteroids
555662|NCT00414414|TB Treatment|tb treatment
555663|NCT00414414|South Africa|south africa
555664|NCT00414427|Knee Osteoarthritis|knee osteoarthritis
555665|NCT00414427|Ultrasonography|ultrasonography
555666|NCT00414427|Corticosteroids|corticosteroids
555667|NCT00414440|end-stage renal disease, ESRD, autosomal dominant polycystic kidney disease, ADPKD, everolimus|end-stage renal disease, esrd, autosomal dominant polycystic kidney disease, adpkd, everolimus
555668|NCT00414453|Neuropathic pain|neuropathic pain
555669|NCT00414453|Chronic pain|chronic pain
555670|NCT00414453|Multiple sclerosis|multiple sclerosis
555671|NCT00414453|Central neuropathic pain|central neuropathic pain
555672|NCT00414453|Peripheral neuropathic pain|peripheral neuropathic pain
555673|NCT00414453|Opioid analgesic|opioid analgesic
555675|NCT00414479|schistosomiasis|schistosomiasis
555676|NCT00414479|anaemia|anaemia
555677|NCT00414479|malaria|malaria
555678|NCT00414479|iron deficiency|iron deficiency
555679|NCT00414492|metastatic colorectal cancer|metastatic colorectal cancer
555680|NCT00414492|liver metastasis|liver metastasis
555681|NCT00414492|tumor margins|tumor margins
555682|NCT00414492|neoadjuvant therapy|neoadjuvant therapy
555683|NCT00414518|Acute Infection|acute infection
555684|NCT00414518|Early HIV Infection|early hiv infection
555685|NCT00414518|Short-Term Antiretroviral Therapy|short-term antiretroviral therapy
555686|NCT00414518|Treatment Interruption|treatment interruption
555687|NCT00414518|Antiretroviral Drug (ARV)|antiretroviral drug (arv)
555688|NCT00414518|ART|art
555689|NCT00414544|Nasolabial folds|nasolabial folds
555690|NCT00414544|Dermal filler|dermal filler
555691|NCT00414544|Injectable dermal filler|injectable dermal filler
555692|NCT00414544|Soft tissue augmentation|soft tissue augmentation
555693|NCT00414557|Musculoskeletal diseases|musculoskeletal diseases
555694|NCT00414557|Joint diseases|joint diseases
555695|NCT00414570|Positron Emission Tomography (PET)|positron emission tomography (pet)
555696|NCT00414570|3'-deoxy-3'(18F)fluorothymidine ([18F]FLT)|3'-deoxy-3'(18f)fluorothymidine ([18f]flt)
555697|NCT00414583|Cerebrovascular Accident|cerebrovascular accident
555698|NCT00414583|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
555699|NCT00414583|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
555700|NCT00414583|Cerebral Stroke|cerebral stroke
555701|NCT00414583|Stroke, Acute|stroke, acute
555702|NCT00414583|Cerebrovascular Stroke|cerebrovascular stroke
555107|NCT00411645|SCT|sct
555703|NCT00414583|Fabry Disease|fabry disease
555704|NCT00414583|Anderson-Fabry Disease|anderson-fabry disease
555705|NCT00414583|Fabry's Disease|fabry's disease
555706|NCT00414609|myocardial infarction, aliskiren, heart failure|myocardial infarction, aliskiren, heart failure
555707|NCT00414609|Post acute myocardial infarction with systolic dysfunction|post acute myocardial infarction with systolic dysfunction
555708|NCT00414622|Alzheimer|alzheimer
555709|NCT00414622|Probable Alzheimer disease|probable alzheimer disease
555710|NCT00414635|HIV/AIDS|hiv/aids
555711|NCT00414635|efavirenz|efavirenz
555712|NCT00414635|tenofovir|tenofovir
555713|NCT00414635|emtricitabine|emtricitabine
555714|NCT00414635|FOTO|foto
555715|NCT00414635|treatment interruption|treatment interruption
555716|NCT00414635|Atripla|atripla
555717|NCT00414635|Truvada|truvada
555718|NCT00414635|Treatment Experienced|treatment experienced
555719|NCT00414648|Lymphangiomyomatosis|lymphangiomyomatosis
555720|NCT00414648|Lung Disease|lung disease
555966|NCT00408551|stage IV colon cancer|stage iv colon cancer
555721|NCT00414661|Observational non-interventional long-term safety|observational non-interventional long-term safety
555722|NCT00414687|Primary or secondary Pulmonary hypertension|primary or secondary pulmonary hypertension
555723|NCT00414687|Iloprost|iloprost
555724|NCT00414687|Inhaled|inhaled
555725|NCT00414687|Long-term treatment|long-term treatment
555726|NCT00414700|Cartilage|cartilage
555727|NCT00414700|Articular|articular
555728|NCT00414700|Femoral|femoral
555729|NCT00414700|Knee|knee
555730|NCT00414713|Upper GI bleeding|upper gi bleeding
555731|NCT00414713|Cirrhosis|cirrhosis
555732|NCT00414713|Portal hypertension|portal hypertension
555733|NCT00414713|Non-variceal bleeding|non-variceal bleeding
555734|NCT00414713|Transfusion|transfusion
555735|NCT00414726|ischemic stroke|ischemic stroke
555736|NCT00414726|normobaric oxygen therapy|normobaric oxygen therapy
555737|NCT00414739|growth of dendritic cells|growth of dendritic cells
555739|NCT00414752|Smoking, abstinence, craving, smoker, AFQ056, nicotine, placebo|smoking, abstinence, craving, smoker, afq056, nicotine, placebo
555740|NCT00414765|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
555741|NCT00414765|Metastatic Melanoma|metastatic melanoma
555742|NCT00414765|Aldesleukin|aldesleukin
555743|NCT00414765|IL-2|il-2
555744|NCT00414778|Safety, pharmacokinetics, oral, single dose, multiple dose, LHT344, Chinese, healthy subjects|safety, pharmacokinetics, oral, single dose, multiple dose, lht344, chinese, healthy subjects
555745|NCT00414804|Pain|pain
555746|NCT00414804|Neurostimulation|neurostimulation
555747|NCT00414817|Inhaled Corticosteroids|inhaled corticosteroids
555748|NCT00414817|ICS|ics
555749|NCT00414817|Adherence|adherence
555750|NCT00414830|prevention|prevention
555751|NCT00414830|health technology assessment|health technology assessment
555752|NCT00414830|population based|population based
555753|NCT00414830|fracture|fracture
555754|NCT00414843|Storage|storage
555755|NCT00414843|Bile|bile
555756|NCT00414843|Biomarkers|biomarkers
555757|NCT00414843|biliary malignancies|biliary malignancies
555758|NCT00414856|GERD|gerd
555759|NCT00414856|gastroesophageal reflux disease|gastroesophageal reflux disease
555760|NCT00414856|meal-induced gastroesophageal reflux events|meal-induced gastroesophageal reflux events
555761|NCT00414869|Liver|liver
555762|NCT00414869|Portal pressure|portal pressure
555763|NCT00414869|Fibrosis|fibrosis
555764|NCT00414869|Nitric oxide|nitric oxide
555765|NCT00414882|TB, tuberculosis, Mycobacterium tuberculosis, Brazil|tb, tuberculosis, mycobacterium tuberculosis, brazil
555766|NCT00414908|Chronic Pancreatitis|chronic pancreatitis
555767|NCT00414908|Pancreatectomy|pancreatectomy
555768|NCT00414908|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
555769|NCT00414921|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
555770|NCT00414921|ADHD|adhd
555771|NCT00414921|clonidine|clonidine
555772|NCT00414921|methylphenidate|methylphenidate
555773|NCT00414921|MPH|mph
555774|NCT00414934|cancer|cancer
555775|NCT00414934|bone scan|bone scan
555776|NCT00414934|NaF bone PET|naf bone pet
555777|NCT00414947|Bioequivalence|bioequivalence
555778|NCT00414947|safety|safety
555779|NCT00414947|LAF237|laf237
555780|NCT00414947|vildagliptin|vildagliptin
555781|NCT00414947|Chinese|chinese
555782|NCT00414947|healthy subjects|healthy subjects
555783|NCT00414960|Healthy|healthy
555784|NCT00414960|Prevention|prevention
555785|NCT00414999|Macular degeneration|macular degeneration
555786|NCT00414999|Vascular diseases|vascular diseases
555787|NCT00414999|Retinal disorders|retinal disorders
555788|NCT00414999|Macular edema|macular edema
555789|NCT00415025|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
555790|NCT00415025|oral complications of radiation therapy|oral complications of radiation therapy
555791|NCT00415025|radiation toxicity|radiation toxicity
555792|NCT00415025|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
555793|NCT00415025|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
555794|NCT00415025|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
555795|NCT00415025|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
555796|NCT00415025|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
555797|NCT00415025|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
555798|NCT00415025|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
555799|NCT00415025|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
555800|NCT00415025|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
555801|NCT00415025|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
555802|NCT00415025|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
555803|NCT00415025|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
555804|NCT00415025|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
555805|NCT00415025|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
555806|NCT00415025|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
555807|NCT00415025|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
555808|NCT00415025|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
555809|NCT00415025|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
555810|NCT00415025|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
555811|NCT00415025|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
555812|NCT00415025|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
555813|NCT00415025|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
555814|NCT00415025|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
555815|NCT00415025|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
555816|NCT00415025|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
555817|NCT00415025|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
555818|NCT00415025|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
555819|NCT00415025|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
555932|NCT00408395|influenza disease|influenza disease
555994|NCT00408603|tumor|tumor
555820|NCT00415025|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
555821|NCT00415025|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
555822|NCT00415025|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
555823|NCT00415025|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
16244|NCT03187262|Waldenström Macroglobulinemia|waldenström macroglobulinemia
16245|NCT03187223|Multiple Myeloma|multiple myeloma
555824|NCT00415025|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
555825|NCT00415025|stage III salivary gland cancer|stage iii salivary gland cancer
555826|NCT00415025|stage IV salivary gland cancer|stage iv salivary gland cancer
555827|NCT00415025|recurrent salivary gland cancer|recurrent salivary gland cancer
555828|NCT00415025|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
555829|NCT00415025|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
555830|NCT00415025|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
555831|NCT00415025|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
555832|NCT00415025|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
555833|NCT00415025|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
555834|NCT00415025|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
555835|NCT00415025|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
555836|NCT00415025|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
555837|NCT00415025|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
555838|NCT00415025|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
555839|NCT00415025|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
555840|NCT00415025|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
555841|NCT00415025|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
555254|NCT00413140|controls|controls
555842|NCT00415025|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
555843|NCT00415025|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
555844|NCT00415025|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
555845|NCT00415025|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
555846|NCT00415038|hypertension|hypertension
555847|NCT00415038|pharmacogenomic|pharmacogenomic
555848|NCT00415038|adducin|adducin
555849|NCT00415038|ouabain|ouabain
555850|NCT00415038|rostafuroxin|rostafuroxin
555851|NCT00415051|Rift Valley Fever, vaccine|rift valley fever, vaccine
555852|NCT00415064|Multiple Myeloma|multiple myeloma
555853|NCT00415064|Perifosine|perifosine
555854|NCT00415064|Lenalidomide|lenalidomide
555855|NCT00415064|Dexamethasone|dexamethasone
555856|NCT00415090|Nevirapine|nevirapine
555857|NCT00415090|Antiretroviral treatment|antiretroviral treatment
555858|NCT00415090|Triple nucleoside therapy|triple nucleoside therapy
555859|NCT00415090|HIV|hiv
555860|NCT00415090|Treatment Experienced|treatment experienced
555861|NCT00415103|Emesis|emesis
555862|NCT00415103|Nausea|nausea
555863|NCT00415103|leukemia|leukemia
555864|NCT00415103|lymphoma|lymphoma
555967|NCT00408551|stage IV rectal cancer|stage iv rectal cancer
555865|NCT00415116|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
555866|NCT00415129|Influenza|influenza
555867|NCT00415129|Orthomyxoviridae Infections|orthomyxoviridae infections
555868|NCT00415129|Influenza Pandemics|influenza pandemics
555869|NCT00415129|A/H5N1 strain|a/h5n1 strain
555870|NCT00415142|Depression|depression
555871|NCT00415142|Major depressive disorders|major depressive disorders
555872|NCT00415142|Controlled clinical trial|controlled clinical trial
555873|NCT00415181|CYP2C8|cyp2c8
555874|NCT00415181|MDR1|mdr1
555875|NCT00415181|Pharmacogenetics|pharmacogenetics
555876|NCT00415181|Paclitaxel|paclitaxel
555877|NCT00408161|Contingency Management|contingency management
555878|NCT00408161|Alcohol Dependence|alcohol dependence
555879|NCT00408174|IBD|ibd
555880|NCT00408174|UC|uc
555881|NCT00408174|Ulcerative Colitis|ulcerative colitis
555882|NCT00408174|Inflammatory Bowel Disease|inflammatory bowel disease
555883|NCT00408187|Randomized Controlled Trials|randomized controlled trials
555884|NCT00408187|Immunosuppression|immunosuppression
555885|NCT00408187|Adult|adult
555886|NCT00408187|Chronic Disease|chronic disease
555887|NCT00408187|Dermatologic Agents|dermatologic agents
555888|NCT00408187|Female|female
555889|NCT00408187|Humans|humans
555890|NCT00408187|Male|male
555891|NCT00408187|Middle Aged|middle aged
555892|NCT00408187|Severity of Illness Index|severity of illness index
555893|NCT00408187|Treatment Outcome|treatment outcome
555894|NCT00408187|Quality of Life|quality of life
555895|NCT00408187|Double-Blind Method|double-blind method
555896|NCT00408200|Atrial fibrillation|atrial fibrillation
555897|NCT00408200|Atrial arrhythmia|atrial arrhythmia
555898|NCT00408239|Factor Xa inhibitor|factor xa inhibitor
555899|NCT00408239|Thromboembolism|thromboembolism
555900|NCT00408239|Arthroplasty|arthroplasty
555901|NCT00408239|Knee Replacement|knee replacement
555902|NCT00408239|Prevention and Control|prevention and control
555903|NCT00408252|recurrent or locally advanced|recurrent or locally advanced
555904|NCT00408252|cytokine failure|cytokine failure
555905|NCT00408265|Nicotine Dependence|nicotine dependence
555906|NCT00408265|Contingency Management|contingency management
555907|NCT00408278|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
555908|NCT00408291|fracture|fracture
555909|NCT00408291|shoulder|shoulder
555910|NCT00408291|bone density|bone density
555911|NCT00408291|healing|healing
555912|NCT00408304|interferon alpha|interferon alpha
555913|NCT00408304|depression|depression
555914|NCT00408304|omega 3|omega 3
555915|NCT00408317|Cystic Fibrosis|cystic fibrosis
555916|NCT00408317|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
555917|NCT00408317|Ultrase® MT20|ultrase® mt20
555918|NCT00408356|Zinc treatment|zinc treatment
555919|NCT00408356|supplementation|supplementation
555920|NCT00408356|Enterotoxigenic E. coli|enterotoxigenic e. coli
555921|NCT00408356|diarrhoea|diarrhoea
555922|NCT00408369|prophylactic|prophylactic
555923|NCT00408369|malaria|malaria
555924|NCT00408369|challenge|challenge
555925|NCT00408382|Lipitor|lipitor
555926|NCT00408382|atorvastatin|atorvastatin
555927|NCT00408382|Hypercholesteremia|hypercholesteremia
555928|NCT00408382|yellow coronary plaque|yellow coronary plaque
555929|NCT00408395|influenza|influenza
555930|NCT00408395|children|children
555931|NCT00408395|vaccine|vaccine
555933|NCT00408408|stage I breast cancer|stage i breast cancer
555934|NCT00408408|stage II breast cancer|stage ii breast cancer
555935|NCT00408408|stage IIIA breast cancer|stage iiia breast cancer
555936|NCT00408434|PPARgamma agonist|ppargamma agonist
555937|NCT00408434|advanced or metastatic malignancies|advanced or metastatic malignancies
555938|NCT00408434|Tumor|tumor
555369|NCT00413322|sarcoma|sarcoma
555939|NCT00408434|Cancer|cancer
555940|NCT00408447|stem cell transplant|stem cell transplant
555941|NCT00408447|sickle cell disease|sickle cell disease
555942|NCT00408447|thalassemia|thalassemia
555943|NCT00408447|moderately ablative|moderately ablative
555944|NCT00408447|cord blood transplant|cord blood transplant
555945|NCT00408447|matched family donor|matched family donor
555946|NCT00408499|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
555947|NCT00408499|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
555948|NCT00408499|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
555949|NCT00408499|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
555950|NCT00408499|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
555951|NCT00408512|treatment|treatment
555952|NCT00408512|adverse events|adverse events
555953|NCT00408512|adherence|adherence
555954|NCT00408512|gene|gene
555955|NCT00408512|polymorphism|polymorphism
555956|NCT00408525|memory loss|memory loss
555957|NCT00408525|memory problems|memory problems
555958|NCT00408525|alzheimer's|alzheimer's
555959|NCT00408525|forgetfulness|forgetfulness
555960|NCT00408525|forgetting|forgetting
555961|NCT00408538|Microbicide|microbicide
555962|NCT00408538|HIV|hiv
555963|NCT00408538|Prevention|prevention
555964|NCT00408538|Rectal|rectal
555965|NCT00408538|HIV Prevention|hiv prevention
555968|NCT00408551|liver metastases|liver metastases
555969|NCT00408551|recurrent colon cancer|recurrent colon cancer
555970|NCT00408551|recurrent rectal cancer|recurrent rectal cancer
555971|NCT00408564|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
555972|NCT00408564|stage II pancreatic cancer|stage ii pancreatic cancer
555973|NCT00408564|stage III pancreatic cancer|stage iii pancreatic cancer
555974|NCT00408577|glucose intolerance|glucose intolerance
555975|NCT00408577|cardiovascular disease|cardiovascular disease
555976|NCT00408577|insulin resistance|insulin resistance
555977|NCT00408577|endothelial dysfunction|endothelial dysfunction
555978|NCT00408590|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
555979|NCT00408590|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
555980|NCT00408590|primary peritoneal cavity cancer|primary peritoneal cavity cancer
555981|NCT00408590|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
555982|NCT00408590|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
555983|NCT00408590|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
555984|NCT00408590|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
555985|NCT00408590|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
555986|NCT00408590|Brenner tumor|brenner tumor
555987|NCT00408603|second line treatment|second line treatment
555988|NCT00408603|platinum resistant|platinum resistant
555989|NCT00408603|ovary|ovary
555990|NCT00408603|ovaries|ovaries
555991|NCT00408603|cancer|cancer
555992|NCT00408603|epithelial|epithelial
555993|NCT00408603|carcinomas|carcinomas
555995|NCT00408629|Ulcerative Colitis|ulcerative colitis
555996|NCT00408629|Adalimumab|adalimumab
555997|NCT00408629|TNF Antagonist|tnf antagonist
555998|NCT00408629|Mayo Score|mayo score
555999|NCT00408642|adherence|adherence
556000|NCT00408642|treatment|treatment
556001|NCT00408642|antiretroviral|antiretroviral
556002|NCT00408642|HAART|haart
556003|NCT00408642|HIV|hiv
556004|NCT00408642|Treatment Naive|treatment naive
556005|NCT00408668|Malaria Vaccine|malaria vaccine
556006|NCT00408707|local infiltration analgesia|local infiltration analgesia
556007|NCT00408707|postoperative pain|postoperative pain
556008|NCT00408707|ropivacaine|ropivacaine
556009|NCT00408720|Spectral OCT|spectral oct
556010|NCT00408720|SLO|slo
556011|NCT00408720|Retinal Imagining|retinal imagining
556012|NCT00408746|stomatognathic system|stomatognathic system
556013|NCT00408746|maxilla|maxilla
556014|NCT00408746|palate|palate
556015|NCT00408746|development|development
556016|NCT00408759|xerostomia|xerostomia
556017|NCT00408759|hypnosis|hypnosis
556018|NCT00408759|dry mouth|dry mouth
556019|NCT00408759|radiotherapy|radiotherapy
556020|NCT00408759|head and neck cancer|head and neck cancer
556021|NCT00408772|liver metastases|liver metastases
556022|NCT00408772|stage IV colon cancer|stage iv colon cancer
556023|NCT00408772|stage IV rectal cancer|stage iv rectal cancer
556024|NCT00408772|adenocarcinoma of the colon|adenocarcinoma of the colon
556025|NCT00408772|adenocarcinoma of the rectum|adenocarcinoma of the rectum
556026|NCT00408772|recurrent colon cancer|recurrent colon cancer
556027|NCT00408772|recurrent rectal cancer|recurrent rectal cancer
556028|NCT00408785|Botulinum Toxin Type A|botulinum toxin type a
556029|NCT00408785|safety|safety
556030|NCT00408785|efficacy|efficacy
556031|NCT00408785|glabellar lines|glabellar lines
556032|NCT00415207|CYP2C8|cyp2c8
556033|NCT00415207|MDR1|mdr1
556034|NCT00415207|Pharmacogenetics|pharmacogenetics
555652|NCT00414375|Abscess|abscess
556035|NCT00415207|Paclitaxel|paclitaxel
556036|NCT00415220|Chiropractic|chiropractic
556037|NCT00415220|Manipulation|manipulation
556038|NCT00415220|Back surgery|back surgery
556039|NCT00415220|Herniated lumbar disc|herniated lumbar disc
556040|NCT00415220|Sciatica|sciatica
556041|NCT00415220|Lumbar microdiscectomy|lumbar microdiscectomy
556042|NCT00415220|Cost-effectiveness|cost-effectiveness
556043|NCT00415233|stage I follicular thyroid cancer|stage i follicular thyroid cancer
556044|NCT00415233|stage I papillary thyroid cancer|stage i papillary thyroid cancer
556045|NCT00415233|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
556046|NCT00415233|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
556047|NCT00415233|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
556048|NCT00415233|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
556049|NCT00415233|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
556050|NCT00415233|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
556051|NCT00415285|Breast|breast
556052|NCT00415285|Cancer|cancer
556053|NCT00415285|Early-Stage|early-stage
556054|NCT00415285|Chemotherapy|chemotherapy
556174|NCT00419133|Kolkata|kolkata
556055|NCT00415298|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
556056|NCT00415298|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
556057|NCT00415298|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
556058|NCT00415298|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
556151|NCT00418951|Myelodysplastic Syndrome|myelodysplastic syndrome
556059|NCT00415298|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
556060|NCT00415298|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
556061|NCT00415298|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
556062|NCT00415298|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
556063|NCT00415298|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
556064|NCT00415298|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
556065|NCT00415298|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
556066|NCT00415298|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
556067|NCT00415298|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
556068|NCT00415298|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
556069|NCT00415298|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
556070|NCT00415311|Liver Transplantation|liver transplantation
556071|NCT00415311|rhMBL|rhmbl
556072|NCT00415337|lung|lung
556073|NCT00415337|neoplasm|neoplasm
556074|NCT00415337|bronchoscopy|bronchoscopy
556075|NCT00415337|ultrasonography|ultrasonography
556076|NCT00415337|histology|histology
556077|NCT00415350|Bronchiectasis|bronchiectasis
556078|NCT00415350|Macrolide|macrolide
556079|NCT00415350|Azithromycin|azithromycin
556080|NCT00415350|Antibiotic prophylaxis|antibiotic prophylaxis
556081|NCT00415350|Immunomodulation|immunomodulation
556082|NCT00415350|Inflammation|inflammation
556083|NCT00415350|Lung function|lung function
556084|NCT00415350|Sputum|sputum
556085|NCT00415350|Bacterial colonization|bacterial colonization
556086|NCT00415376|seizure|seizure
556087|NCT00415376|adult tumors metastatic to brain|adult tumors metastatic to brain
556088|NCT00415376|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
556089|NCT00415389|Stroke|stroke
556090|NCT00415389|interactive educational program|interactive educational program
556091|NCT00415389|acute ischemic stroke|acute ischemic stroke
556093|NCT00415402|morbidity|morbidity
556094|NCT00415402|mortality|mortality
556095|NCT00415402|low birth weight|low birth weight
556096|NCT00415402|supplementation|supplementation
556098|NCT00415402|TH2|th2
556099|NCT00415402|CRP|crp
556100|NCT00415402|Neopterin|neopterin
556101|NCT00415402|immune response|immune response
556102|NCT00415415|Racial Disparities|racial disparities
556103|NCT00415415|Psychosocial Risk Factors|psychosocial risk factors
556104|NCT00415415|Neighborhood Socioeconomic Status|neighborhood socioeconomic status
556105|NCT00415415|CVD|cvd
556106|NCT00415415|CHD|chd
556107|NCT00415441|physiotherapy|physiotherapy
556108|NCT00415441|exercise|exercise
556109|NCT00415441|manual therapy|manual therapy
556110|NCT00415441|shoulder pain|shoulder pain
556111|NCT00415441|rotator cuff|rotator cuff
556112|NCT00415454|Pancreatic Cancer|pancreatic cancer
556113|NCT00415467|Brain Tumor|brain tumor
556114|NCT00415467|Radiation Therapy System|radiation therapy system
556115|NCT00415467|GliaSite RTS|gliasite rts
556116|NCT00415493|rhinitis|rhinitis
556117|NCT00415493|non-allergic rhinitis|non-allergic rhinitis
556118|NCT00415493|rhinomanometry|rhinomanometry
555543|NCT00413855|Appendicopathy|appendicopathy
556119|NCT00415493|cold air|cold air
556120|NCT00415493|triggers: cold, dry air inhalation|triggers: cold, dry air inhalation
556121|NCT00415493|warm, most air inhalation|warm, most air inhalation
556122|NCT00415493|Nonallergic rhinitis; normal controls|nonallergic rhinitis; normal controls
556123|NCT00415519|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
556124|NCT00415519|free radical scavenger|free radical scavenger
556125|NCT00415532|splenectomy|splenectomy
556126|NCT00415532|platelet|platelet
556127|NCT00415532|AMG 531|amg 531
556128|NCT00415532|thrombopoietin|thrombopoietin
556129|NCT00415532|blood disorder|blood disorder
556130|NCT00415532|bleeding disorder|bleeding disorder
556131|NCT00415532|immune thrombocytopenic purpura|immune thrombocytopenic purpura
556132|NCT00415532|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
556133|NCT00415532|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
556134|NCT00415532|TPO|tpo
556135|NCT00415532|thrombopoietic protein|thrombopoietic protein
556136|NCT00415545|Heart Failure|heart failure
556137|NCT00415545|Patient Education|patient education
556138|NCT00418938|EGFR|egfr
556139|NCT00418938|FOLFIRI|folfiri
556140|NCT00418938|2nd Line Therapy|2nd line therapy
556141|NCT00418938|2nd Line mCRC Therapy|2nd line mcrc therapy
556142|NCT00418938|mCRC|mcrc
556143|NCT00418938|Irinotecan|irinotecan
556144|NCT00418938|panitumumab|panitumumab
556145|NCT00418938|bevacizumab|bevacizumab
556146|NCT00418951|Voriconazole|voriconazole
556147|NCT00418951|Vfend|vfend
556148|NCT00418951|Liposomal amphotericin B|liposomal amphotericin b
556149|NCT00418951|Ambisome|ambisome
556150|NCT00418951|Acute Myelogenous Leukemia|acute myelogenous leukemia
556152|NCT00418951|AML|aml
556154|NCT00418964|Anterior cruciate ligament rupture|anterior cruciate ligament rupture
556155|NCT00418964|Anterior cruciate ligament(A02.513.514.100)|anterior cruciate ligament(a02.513.514.100)
556156|NCT00418977|Anorexia Nervosa|anorexia nervosa
556157|NCT00418990|Multivitamin|multivitamin
556158|NCT00418990|Academic performance|academic performance
556159|NCT00419029|combat|combat
556160|NCT00419029|depression|depression
556161|NCT00419029|PTSD|ptsd
556162|NCT00419029|substance abuse|substance abuse
556163|NCT00419042|cancer|cancer
556164|NCT00419042|Lung cancer|lung cancer
556165|NCT00419042|None small-cell lung cancer|none small-cell lung cancer
556166|NCT00419055|percutaneous coronary intervention|percutaneous coronary intervention
556167|NCT00419081|leukemia|leukemia
556168|NCT00419081|lymphoma|lymphoma
556169|NCT00419094|Keppra XR|keppra xr
556170|NCT00419094|conversion to monotherapy|conversion to monotherapy
556171|NCT00419094|partial seizures|partial seizures
556172|NCT00419133|Cholera|cholera
556173|NCT00419133|Vaccine|vaccine
556175|NCT00419133|West Bengal|west bengal
556176|NCT00419133|India|india
556177|NCT00419133|Immunogenicity|immunogenicity
556178|NCT00419133|Safety|safety
556179|NCT00419146|Schizophrenia|schizophrenia
556180|NCT00419146|Schizophreniform disorders|schizophreniform disorders
556181|NCT00419146|Schizoaffective disorder|schizoaffective disorder
556182|NCT00419146|Psychotic disorders|psychotic disorders
556183|NCT00419146|Randomized Controlled Trials|randomized controlled trials
556184|NCT00419146|Longitudinal Studies|longitudinal studies
556185|NCT00419146|Fatty Acids, Omega-3|fatty acids, omega-3
556186|NCT00419146|Eicosapentaenoic Acid|eicosapentaenoic acid
556187|NCT00419146|Vitamins|vitamins
556188|NCT00419146|Antioxidants|antioxidants
556189|NCT00419146|Ascorbic Acid|ascorbic acid
556190|NCT00419146|Alpha-Tocopherol|alpha-tocopherol
556191|NCT00419146|Placebos|placebos
556192|NCT00419146|Antipsychotic Agents|antipsychotic agents
556193|NCT00419146|Oxidative Stress|oxidative stress
556194|NCT00419146|Fatty Acids, Unsaturated|fatty acids, unsaturated
556195|NCT00419146|Phospholipases|phospholipases
556196|NCT00419146|Niacin|niacin
556197|NCT00419146|Adverse effects|adverse effects
556198|NCT00419146|Delusions|delusions
556199|NCT00419146|Hallucinations|hallucinations
556200|NCT00419146|Neuropsychological Tests|neuropsychological tests
556201|NCT00419146|Attention|attention
556202|NCT00419146|Memory|memory
556203|NCT00419146|Hypertriglyceridemia|hypertriglyceridemia
556204|NCT00419146|Models, Statistical|models, statistical
556205|NCT00419159|Colorectal cancer|colorectal cancer
556206|NCT00419159|metastatic colorectal adenocarcinoma|metastatic colorectal adenocarcinoma
556207|NCT00419159|anti-EGFR antibody|anti-egfr antibody
556208|NCT00419172|Pharmacokinetics|pharmacokinetics
556209|NCT00419172|Deferasirox|deferasirox
556210|NCT00419172|Exjade|exjade
556211|NCT00419172|ICL670|icl670
556212|NCT00419172|Rifampicin|rifampicin
556213|NCT00419172|Healthy, Volunteers|healthy, volunteers
556214|NCT00419185|macular hole surgery|macular hole surgery
556215|NCT00419185|indocyanine green|indocyanine green
556216|NCT00419185|trypan blue|trypan blue
556217|NCT00419185|internal limiting membrane|internal limiting membrane
556218|NCT00419198|Ischemia|ischemia
556219|NCT00419198|Reperfusion|reperfusion
556220|NCT00419198|Myocardial infarction|myocardial infarction
556221|NCT00419198|Postconditioning|postconditioning
556222|NCT00419211|Pregnancy, Exercise, Depression|pregnancy, exercise, depression
556223|NCT00419224|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
556224|NCT00419224|Non-myeloabalative|non-myeloabalative
556225|NCT00419224|Influenza vaccination|influenza vaccination
556226|NCT00419224|Humoral immune response|humoral immune response
556227|NCT00419224|Immunogenicity|immunogenicity
556228|NCT00419237|hepatic impairment pharmacokinetics|hepatic impairment pharmacokinetics
556229|NCT00419250|relapsed|relapsed
556230|NCT00419250|refractory|refractory
556231|NCT00419250|fludarabine|fludarabine
556232|NCT00419250|Revlimid|revlimid
556233|NCT00419250|lenalidomide|lenalidomide
556235|NCT00419250|B-cell CLL|b-cell cll
556236|NCT00419250|CC-5013|cc-5013
556237|NCT00419250|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
556238|NCT00419263|influenza|influenza
556239|NCT00419263|flu|flu
556240|NCT00419276|Total knee arthroplasty, postoperative analgesia|total knee arthroplasty, postoperative analgesia
556241|NCT00419276|Primary, unilateral, total knee arthroplasty|primary, unilateral, total knee arthroplasty
556242|NCT00419289|COPD, rehabilitation, quality of life|copd, rehabilitation, quality of life
556243|NCT00419315|alcoholism|alcoholism
556244|NCT00419315|primary care|primary care
556245|NCT00419315|treatment|treatment
556246|NCT00419328|solid tumors NGR-hTNF|solid tumors ngr-htnf
556247|NCT00419341|Immune globulin subcutaneous|immune globulin subcutaneous
556248|NCT00419341|SCIG|scig
556249|NCT00419341|Primary immunodeficiency|primary immunodeficiency
556250|NCT00419341|PID|pid
556251|NCT00419354|Pacemaker|pacemaker
556252|NCT00419354|Tricuspid regurgitation|tricuspid regurgitation
556253|NCT00419380|clogged ear tubes|clogged ear tubes
556254|NCT00419393|Keppra XR|keppra xr
556255|NCT00419393|Levetiracetam XR|levetiracetam xr
556256|NCT00419393|long term|long term
556257|NCT00419393|partial seizures|partial seizures
556258|NCT00419406|UVA1|uva1
556260|NCT00419406|phototherapy|phototherapy
556261|NCT00419406|atopic dermatitis|atopic dermatitis
556262|NCT00419406|SCORAD index|scorad index
556263|NCT00419419|Raynaud's|raynaud's
556264|NCT00419432|Pediatrics|pediatrics
556265|NCT00419432|Cerebral Palsy|cerebral palsy
556266|NCT00419432|Gait Analysis|gait analysis
556267|NCT00419432|Orthopedic Surgery|orthopedic surgery
556268|NCT00419445|Attention Deficit Hyperactivity Disorder in adults|attention deficit hyperactivity disorder in adults
556269|NCT00419458|ventilator weaning|ventilator weaning
556270|NCT00419458|weaning|weaning
556271|NCT00419458|respiratory failure|respiratory failure
556272|NCT00419458|inspiratory muscle strength training|inspiratory muscle strength training
556273|NCT00419471|Depression|depression
556274|NCT00419471|Myocardial infarction|myocardial infarction
556275|NCT00419471|Angina, unstable|angina, unstable
556276|NCT00419497|Paleolithic diet|paleolithic diet
556277|NCT00419497|Mediterranean-style diet|mediterranean-style diet
556278|NCT00419497|Glucose tolerance|glucose tolerance
556279|NCT00419497|Diabetes type 2|diabetes type 2
556280|NCT00419497|Weight loss|weight loss
556281|NCT00419497|Waist|waist
556282|NCT00419510|Genetic counseling|genetic counseling
556283|NCT00419510|BRCA1 and BRCA2|brca1 and brca2
556284|NCT00419510|African American|african american
556285|NCT00419536|LBH|lbh
556286|NCT00419536|LBH589|lbh589
556287|NCT00419536|Prostate Cancer|prostate cancer
556288|NCT00419536|HRPC|hrpc
556289|NCT00419549|ERCP|ercp
556290|NCT00419549|Pancreatitis|pancreatitis
556291|NCT00419549|Nitroglycerine|nitroglycerine
556292|NCT00419549|Valdecoxib|valdecoxib
556293|NCT00419562|oral insulin|oral insulin
556294|NCT00419562|autoantigen|autoantigen
556295|NCT00419562|self tolerance|self tolerance
16247|NCT03187223|Melphalan|melphalan
556296|NCT00419562|oral tolerance|oral tolerance
556297|NCT00419562|DPT-1|dpt-1
556298|NCT00419562|prevention|prevention
556299|NCT00419562|"at risk for developing type 1 diabetes"|"at risk for developing type 1 diabetes"
556300|NCT00419562|juvenile diabetes|juvenile diabetes
556301|NCT00419562|T1D|t1d
556302|NCT00419562|diabetes mellitus|diabetes mellitus
556303|NCT00419562|Type 1 diabetes TrialNet|type 1 diabetes trialnet
556304|NCT00419562|TrialNet|trialnet
556305|NCT00419575|renal|renal
556306|NCT00419575|transplantation|transplantation
556307|NCT00419575|immunosuppression|immunosuppression
556308|NCT00419575|monitoring|monitoring
556309|NCT00419588|infant, premature|infant, premature
556310|NCT00419588|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
556311|NCT00419588|asthma|asthma
556312|NCT00419601|ventilated newborns (≥ 36 SSW)and infants (≤60 days)|ventilated newborns (≥ 36 ssw)and infants (≤60 days)
556313|NCT00419601|of any medical condition|of any medical condition
556314|NCT00419627|proteomics of solid tumors|proteomics of solid tumors
556315|NCT00419640|Sinus node disease|sinus node disease
717722|NCT01027767|MBI|mbi
555738|NCT00414739|prevention|prevention
556316|NCT00419640|AV node disease|av node disease
556317|NCT00419653|schizophrenia fMRI drug therapy amisulpride|schizophrenia fmri drug therapy amisulpride
556318|NCT00419666|Calcitriol|calcitriol
556319|NCT00419666|Psoriasis|psoriasis
556320|NCT00419666|PK|pk
556321|NCT00419666|Adolescents|adolescents
556322|NCT00419679|breast cancer|breast cancer
556323|NCT00419679|hair|hair
556324|NCT00419679|fibre|fibre
556325|NCT00419679|synchrotron|synchrotron
556326|NCT00419679|x-ray diffraction|x-ray diffraction
556327|NCT00419692|formulation,|formulation,
556328|NCT00419692|controlled release for RLS,|controlled release for rls,
556329|NCT00419692|pharmacokinetic,|pharmacokinetic,
556330|NCT00419692|RLS|rls
556331|NCT00419692|food effect,|food effect,
556332|NCT00419692|SK&F101468,|sk&f101468,
556333|NCT00419705|acute stroke|acute stroke
556334|NCT00419705|infrared laser therapy|infrared laser therapy
556335|NCT00419705|clinical trial|clinical trial
556336|NCT00419705|safety|safety
556337|NCT00419705|effectiveness|effectiveness
556338|NCT00419731|nicotine|nicotine
556339|NCT00419731|smoking|smoking
556340|NCT00419731|addiction|addiction
556341|NCT00419744|COPD|copd
556342|NCT00419757|Moderate asthma|moderate asthma
556343|NCT00419757|Severe asthma|severe asthma
556344|NCT00419770|zygomycosis|zygomycosis
556345|NCT00419770|Rhizopus|rhizopus
556346|NCT00419770|iron|iron
556347|NCT00419770|iron-chelation|iron-chelation
556348|NCT00419770|adjunctive therapy|adjunctive therapy
556349|NCT00419783|Allergic rhinitis|allergic rhinitis
556350|NCT00419783|Urticaria|urticaria
556351|NCT00419796|Osteoarthritis, controlled hypertension, lumiracoxib, ibuprofen, high blood pressure|osteoarthritis, controlled hypertension, lumiracoxib, ibuprofen, high blood pressure
556352|NCT00419809|methotrexate,|methotrexate,
556353|NCT00419809|SB-681323,|sb-681323,
556354|NCT00419809|p38 MAP Kinase Inhibitor,|p38 map kinase inhibitor,
556355|NCT00419809|liver function|liver function
556356|NCT00419809|Rheumatoid Arthritis,|rheumatoid arthritis,
556357|NCT00419822|Acupuncture|acupuncture
556358|NCT00419822|Range of Motion|range of motion
556359|NCT00419822|Quality of Life|quality of life
556360|NCT00419835|diabetic nephropathy|diabetic nephropathy
556361|NCT00419835|proteinuria|proteinuria
556362|NCT00419835|CKD progression|ckd progression
556363|NCT00419835|dialysis|dialysis
556364|NCT00419848|Acne|acne
556365|NCT00419848|Azithromycin|azithromycin
556366|NCT00419848|Doxycycline|doxycycline
556367|NCT00419861|Influenza, surveillance, flu, parent protocol|influenza, surveillance, flu, parent protocol
556368|NCT00419874|Blood-brain barrier|blood-brain barrier
556369|NCT00419874|Post traumatic epilepsy|post traumatic epilepsy
556370|NCT00419874|Seizures|seizures
556371|NCT00419887|Safety, tolerability, pharmacokinetics, pharmacodynamics, LAF237, vildagliptin, Chinese, healthy volunteers|safety, tolerability, pharmacokinetics, pharmacodynamics, laf237, vildagliptin, chinese, healthy volunteers
556372|NCT00419900|breast cancer|breast cancer
556373|NCT00419900|diagnosis|diagnosis
556374|NCT00419900|x-ray diffraction|x-ray diffraction
556375|NCT00419900|synchrotron|synchrotron
556376|NCT00419900|hair|hair
556377|NCT00419913|Ovulation Induction|ovulation induction
556378|NCT00419913|In vitro Fertilization|in vitro fertilization
556379|NCT00419913|Pregnancy|pregnancy
556380|NCT00419926|Renal, Kidney, Intensified, Enteric-coated mycophenolate sodium, Transplant|renal, kidney, intensified, enteric-coated mycophenolate sodium, transplant
556381|NCT00419939|Severe traumatic brain injury|severe traumatic brain injury
556779|NCT00411996|rifampicin|rifampicin
556382|NCT00419939|Intensive neurorehabilitation|intensive neurorehabilitation
556383|NCT00419939|"Patient Participation[Professional-Patient Relations"|"patient participation[professional-patient relations"
556384|NCT00419939|Re-learning|re-learning
556385|NCT00419939|Daily life activities|daily life activities
556386|NCT00419939|Rehabilitation|rehabilitation
556387|NCT00419952|Moderate Asthma|moderate asthma
556388|NCT00419952|Severe Asthma|severe asthma
556389|NCT00419991|Tigecycline|tigecycline
556390|NCT00419991|Staphylococcal Infections|staphylococcal infections
556391|NCT00419991|Catheter|catheter
556392|NCT00420017|Amiodarone|amiodarone
556393|NCT00420017|Atrial fibrillation|atrial fibrillation
556394|NCT00420017|Surgical procedures, thoracic|surgical procedures, thoracic
556395|NCT00420030|upfront abciximab|upfront abciximab
556397|NCT00420030|cardiogenic shock|cardiogenic shock
556398|NCT00420043|Food effect|food effect
556399|NCT00420043|bioavailability|bioavailability
556400|NCT00420043|pharmacokinetic|pharmacokinetic
556401|NCT00420043|STI571|sti571
556402|NCT00420043|modified release formulation of STI571|modified release formulation of sti571
556403|NCT00420043|CML|cml
556404|NCT00420043|Chronic Myeloid Leukemia|chronic myeloid leukemia
556405|NCT00420043|Philadelphia Chromosome|philadelphia chromosome
556406|NCT00420043|imatinib|imatinib
556407|NCT00420082|Rhinitis|rhinitis
556408|NCT00420082|Seasonal|seasonal
556409|NCT00420082|Allergic|allergic
556410|NCT00420082|Pollen allergy|pollen allergy
556411|NCT00420082|Environmental Exposure Chamber|environmental exposure chamber
556412|NCT00420082|Challenge Chamber|challenge chamber
556413|NCT00420095|diabetes|diabetes
556414|NCT00420095|type 1|type 1
556415|NCT00420095|type 2|type 2
556416|NCT00420108|Heart Failure, Congestive|heart failure, congestive
556417|NCT00420108|Cardiac Pacemaker, Artificial|cardiac pacemaker, artificial
556418|NCT00420108|Ventricular Pressure|ventricular pressure
556419|NCT00420121|standardized evaluation|standardized evaluation
556420|NCT00420121|core set questionnaire|core set questionnaire
556421|NCT00420121|epidemiological data|epidemiological data
556422|NCT00420121|laboratory analysis|laboratory analysis
556423|NCT00420134|mesenchymal stem cell|mesenchymal stem cell
556424|NCT00420134|end stage liver disease|end stage liver disease
556425|NCT00420134|Cirrhosis|cirrhosis
556426|NCT00420134|stem cell therapy|stem cell therapy
556427|NCT00420147|knee osteoarthritis|knee osteoarthritis
556428|NCT00420147|orthosis|orthosis
556430|NCT00420147|gait|gait
556431|NCT00420160|Smoking cessation|smoking cessation
556432|NCT00420160|Exercise|exercise
556433|NCT00420160|Nicotine Patch|nicotine patch
556434|NCT00420160|Disease Prevention|disease prevention
556435|NCT00420173|cutaneous lupus erythematosus|cutaneous lupus erythematosus
556436|NCT00420173|standardized evaluation|standardized evaluation
556437|NCT00420173|core set questionnaire|core set questionnaire
556438|NCT00420173|epidemiological data|epidemiological data
556439|NCT00420173|laboratory features|laboratory features
556440|NCT00420212|relapsing|relapsing
556441|NCT00420212|oral|oral
556442|NCT00420212|remitting|remitting
556443|NCT00420212|multiple sclerosis|multiple sclerosis
556444|NCT00420225|Cystocele|cystocele
556445|NCT00420225|surgery|surgery
556446|NCT00420225|mesh|mesh
556447|NCT00420225|genital prolapse|genital prolapse
556448|NCT00420238|Axial Ankylosing Spondylitis|axial ankylosing spondylitis
556449|NCT00420238|Adult|adult
556450|NCT00420277|Hip arthroplasty|hip arthroplasty
556451|NCT00420277|Anesthesia, spinal|anesthesia, spinal
556452|NCT00420277|Hypotension|hypotension
556453|NCT00420277|Ischemia|ischemia
556454|NCT00420277|Blood substitutes|blood substitutes
556455|NCT00420277|Plasma expanders|plasma expanders
556456|NCT00420290|inflammation|inflammation
556457|NCT00420290|end stage renal disease|end stage renal disease
556458|NCT00420303|Refractory Heel Enthesitis in Spondylarthropathy|refractory heel enthesitis in spondylarthropathy
556459|NCT00420303|Spondylarthropathy|spondylarthropathy
556460|NCT00420303|Refractory Heel Enthesitis|refractory heel enthesitis
556461|NCT00420316|Intussusception|intussusception
556462|NCT00420316|Gastroenteritis|gastroenteritis
556463|NCT00420316|Finland|finland
556464|NCT00420342|Pre-Hypertension in Postmenopausal Women|pre-hypertension in postmenopausal women
556465|NCT00420355|antiretroviral therapy|antiretroviral therapy
556466|NCT00420355|protease inhibitors|protease inhibitors
556467|NCT00420355|drug interactions|drug interactions
556468|NCT00420355|HIV infection|hiv infection
556469|NCT00420355|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
556470|NCT00420355|Treatment Experienced|treatment experienced
556471|NCT00420368|Infant|infant
556472|NCT00420368|Malnutrition|malnutrition
556473|NCT00420368|Sub-Saharan Africa|sub-saharan africa
556474|NCT00420368|Treatment|treatment
556475|NCT00420368|Growth|growth
556476|NCT00420368|Haemoglobin|haemoglobin
556477|NCT00420368|Fortified spread|fortified spread
556478|NCT00420368|Food supplement|food supplement
556479|NCT00420381|Recurrent Cancer|recurrent cancer
556480|NCT00420394|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
557400|NCT00425607|Lonafarnib|lonafarnib
556481|NCT00420394|Adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
556482|NCT00420394|Adenocarcinoma of stomach and gastroesophageal junction|adenocarcinoma of stomach and gastroesophageal junction
556483|NCT00420433|Breast Cancer|breast cancer
556484|NCT00420433|Bone Metastases|bone metastases
556485|NCT00420433|Radiography|radiography
556486|NCT00420433|X-Ray|x-ray
556487|NCT00420433|Computed Tomography|computed tomography
556488|NCT00420433|CT Scan|ct scan
556489|NCT00420433|Skeletal Scintigraphy|skeletal scintigraphy
556490|NCT00420485|Maximum Tolerated Dose|maximum tolerated dose
556491|NCT00420485|Solid Tumors|solid tumors
556492|NCT00420485|Dose Limiting Toxicity|dose limiting toxicity
556493|NCT00420485|Topoisomerase-1 Inhibitor|topoisomerase-1 inhibitor
556494|NCT00420498|Schizophrenia|schizophrenia
556495|NCT00420498|Prefrontal Cortical Function|prefrontal cortical function
556496|NCT00420498|Smoking|smoking
556497|NCT00420498|Cognition|cognition
556498|NCT00420498|Positive and Negative Symptoms|positive and negative symptoms
556499|NCT00420498|Tobacco|tobacco
556500|NCT00420498|Cigarette Smoking|cigarette smoking
556501|NCT00420498|Dopamine|dopamine
556502|NCT00420511|Type 2 diabetes|type 2 diabetes
556503|NCT00420511|beta-cell function|beta-cell function
556504|NCT00420511|sitagliptin|sitagliptin
556505|NCT00420511|intensive insulin therapy|intensive insulin therapy
556506|NCT00420524|EPO|epo
556507|NCT00420524|Patupilone|patupilone
556508|NCT00420524|Solid Tumors|solid tumors
556509|NCT00420537|Kidney|kidney
556510|NCT00420537|Heart Transplantation|heart transplantation
556511|NCT00420537|Creatinine|creatinine
556512|NCT00420537|Glomerular Filtration Rate|glomerular filtration rate
556513|NCT00420550|Interstitial Cystitis|interstitial cystitis
556514|NCT00420550|Pelvic pain|pelvic pain
556515|NCT00420550|Guided Imagery|guided imagery
556516|NCT00420563|Cancer, palliative treatment|cancer, palliative treatment
556517|NCT00420576|Post-menopausal|post-menopausal
556518|NCT00420576|Traditional Chinese Medicine|traditional chinese medicine
556519|NCT00420576|Randomized|randomized
556520|NCT00420589|Weight loss|weight loss
556521|NCT00420589|Weight regain|weight regain
556522|NCT00420589|Weight maintenance|weight maintenance
556523|NCT00420615|Cancer|cancer
556524|NCT00420615|EPO906|epo906
556525|NCT00420615|Patupilone|patupilone
556526|NCT00420641|GSK372475|gsk372475
556527|NCT00420641|MDD|mdd
556528|NCT00420641|paroxetine|paroxetine
556529|NCT00420641|flexible-dose|flexible-dose
556530|NCT00420641|Major Depressive Disorder|major depressive disorder
556531|NCT00420654|Turner syndrome|turner syndrome
556532|NCT00420654|growth hormone treatment|growth hormone treatment
556533|NCT00420654|positron emission tomography|positron emission tomography
556534|NCT00420654|heart|heart
556535|NCT00420667|unfractionated heparin|unfractionated heparin
556536|NCT00420667|enoxaparin|enoxaparin
556537|NCT00420667|low molecular weight heparin|low molecular weight heparin
556538|NCT00420667|bypass surgery|bypass surgery
556539|NCT00420667|bleeding|bleeding
556540|NCT00420719|ALS|als
556541|NCT00420719|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
556542|NCT00420719|Lou Gehrig's disease|lou gehrig's disease
556543|NCT00420719|Diaphragm for Ventilatory Assist|diaphragm for ventilatory assist
556544|NCT00420719|Diaphragm Pacing|diaphragm pacing
556545|NCT00420758|Infant|infant
556546|NCT00420758|Malnutrition|malnutrition
556547|NCT00420758|Sub-Saharan Africa|sub-saharan africa
556548|NCT00420758|Treatment|treatment
556549|NCT00420758|Growth|growth
556550|NCT00420758|Haemoglobin|haemoglobin
556551|NCT00420758|Fortified spread|fortified spread
556552|NCT00420758|Food supplement|food supplement
556553|NCT00420771|Benzodiazepine|benzodiazepine
556555|NCT00420771|Methadone|methadone
556556|NCT00420784|Genotype 1|genotype 1
556557|NCT00420797|Faecal seepage|faecal seepage
556558|NCT00420797|ileal pouch anal anastomosis (IPAA)|ileal pouch anal anastomosis (ipaa)
556559|NCT00420797|quality of life|quality of life
556560|NCT00420797|faecal incontinence|faecal incontinence
556561|NCT00420797|ileo-anal pouch construction|ileo-anal pouch construction
556562|NCT00420797|phenylephrine hydrochloride gel|phenylephrine hydrochloride gel
556563|NCT00420797|IPAA-related faecal incontinence|ipaa-related faecal incontinence
556565|NCT00420823|First Episode Psychosis|first episode psychosis
556566|NCT00420836|Cystic fibrosis, tobramycin, PARI eFlow, PARI LC Plus, nebulizer, pharmacokinetic|cystic fibrosis, tobramycin, pari eflow, pari lc plus, nebulizer, pharmacokinetic
556567|NCT00420862|Lung neoplasms|lung neoplasms
556568|NCT00420862|Early diagnosis|early diagnosis
556569|NCT00420862|Screening|screening
556570|NCT00420862|Spiral Computed Tomography|spiral computed tomography
556571|NCT00420862|Randomized Controlled Trial|randomized controlled trial
556572|NCT00420875|plantar fasciitis|plantar fasciitis
556573|NCT00420875|plantar fasciosis|plantar fasciosis
556574|NCT00420875|Achilles tendinosis|achilles tendinosis
556575|NCT00420875|Achilles tendinitis|achilles tendinitis
556576|NCT00420875|heel pain|heel pain
556577|NCT00420875|fasciosis|fasciosis
556578|NCT00420875|fasciitis|fasciitis
556579|NCT00420875|tendinosis|tendinosis
556580|NCT00420875|tendinitis|tendinitis
556581|NCT00420875|conservative treatment|conservative treatment
556582|NCT00420901|function|function
556583|NCT00420901|inhibition|inhibition
556584|NCT00420914|Thrombocytopenia|thrombocytopenia
556585|NCT00420914|Platelets|platelets
556586|NCT00420914|Dose|dose
556587|NCT00420914|Bleeding|bleeding
556588|NCT00420927|Early Rheumatoid Arthritis|early rheumatoid arthritis
556589|NCT00420927|Tumor Necrosis Factor Optimization|tumor necrosis factor optimization
556590|NCT00420940|vibration|vibration
556591|NCT00420940|mechanical loading|mechanical loading
556592|NCT00420940|bone mineral density|bone mineral density
556593|NCT00420940|women's health|women's health
556594|NCT00420940|osteoporosis|osteoporosis
556595|NCT00420966|lower respiratory tract infection|lower respiratory tract infection
556596|NCT00420966|respiratory syncytial virus infections|respiratory syncytial virus infections
556598|NCT00420966|outcomes|outcomes
556599|NCT00420966|utilization|utilization
556600|NCT00420966|compliance|compliance
556601|NCT00420992|hip|hip
556602|NCT00420992|knee|knee
556603|NCT00420992|pain|pain
556604|NCT00420992|osteoarthritis|osteoarthritis
556605|NCT00420992|OA|oa
556606|NCT00420992|Kadian|kadian
556607|NCT00420992|Alpharma|alpharma
556608|NCT00420992|naltrexone|naltrexone
556609|NCT00420992|Opioid|opioid
556610|NCT00420992|morphine|morphine
556611|NCT00420992|Embeda|embeda
556612|NCT00420992|ALO-01|alo-01
556613|NCT00421018|Asthma|asthma
556614|NCT00421018|Allergy|allergy
556615|NCT00421018|Cytokines|cytokines
556616|NCT00421018|Glucocorticoids|glucocorticoids
556617|NCT00421018|Inflammation|inflammation
556618|NCT00421018|Nitric Oxide (NO)|nitric oxide (no)
556619|NCT00421018|Quality of Life|quality of life
556620|NCT00421018|Self-Rated Health|self-rated health
556621|NCT00421018|Stress|stress
556622|NCT00421044|EPO|epo
556623|NCT00421044|Patupilone|patupilone
556624|NCT00421044|Solid Tumors|solid tumors
556625|NCT00421057|Breast Cancer|breast cancer
556626|NCT00421057|Cancer-Related Fatigue|cancer-related fatigue
556627|NCT00421057|Fatigue|fatigue
556628|NCT00421057|Exercise|exercise
556629|NCT00421057|Strength Training|strength training
556630|NCT00421057|Endurance Exercise|endurance exercise
556631|NCT00421057|Questionnaire|questionnaire
556632|NCT00421057|Survey|survey
556633|NCT00421070|Aggression|aggression
556634|NCT00421070|Massage|massage
556635|NCT00421070|Stress|stress
556636|NCT00421070|Psychiatric inpatient|psychiatric inpatient
556637|NCT00421083|Erectile dysfunction as a result of traumatic spinal cord injury|erectile dysfunction as a result of traumatic spinal cord injury
556638|NCT00421096|uterine cervical cancer|uterine cervical cancer
556639|NCT00421109|Urticaria|urticaria
556640|NCT00421109|Hives|hives
556641|NCT00421109|Wheals|wheals
556642|NCT00421109|Flare|flare
556643|NCT00421109|Chronic|chronic
556644|NCT00421109|Idiopathic|idiopathic
556645|NCT00421109|Erythema|erythema
556646|NCT00421109|Skin diseases, vascular|skin diseases, vascular
556647|NCT00421109|Hypersensitivity, Immediate|hypersensitivity, immediate
556648|NCT00421109|Allergic|allergic
556649|NCT00421109|Cutaneous|cutaneous
556650|NCT00421122|Chinese patients|chinese patients
556651|NCT00421122|COPD|copd
556652|NCT00421161|olive oil|olive oil
556653|NCT00421161|stasis dermatitis|stasis dermatitis
556654|NCT00421161|Patients with stasis dermatitis for at least six months.|patients with stasis dermatitis for at least six months.
556655|NCT00421174|Etanercept|etanercept
556656|NCT00421174|IPS|ips
556657|NCT00421187|Antibiotic resistant neutropenic fever|antibiotic resistant neutropenic fever
556658|NCT00421187|ARNF|arnf
556660|NCT00421187|Liposomal amphotericin B|liposomal amphotericin b
556661|NCT00421200|Hip arthroplasty|hip arthroplasty
556662|NCT00421200|Anesthesia, spinal|anesthesia, spinal
556663|NCT00421200|Hypotension|hypotension
556664|NCT00421200|Ischemia|ischemia
556665|NCT00421200|Blood substitutes|blood substitutes
556666|NCT00421200|Plasma expanders|plasma expanders
556667|NCT00421213|APL|apl
556668|NCT00421213|Lymphoma|lymphoma
556669|NCT00421213|T-cell Lymphoma|t-cell lymphoma
556670|NCT00421213|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
556671|NCT00421226|Safety, tolerability, pharmacokinetics, pharmacodynamics, ACZ885, Japanese,|safety, tolerability, pharmacokinetics, pharmacodynamics, acz885, japanese,
556672|NCT00421239|hypertensive urgency|hypertensive urgency
556673|NCT00421239|arterial hypertension|arterial hypertension
556674|NCT00421252|clopidogrel|clopidogrel
556675|NCT00421252|hemorrhagic complication|hemorrhagic complication
556676|NCT00421252|vascular complication|vascular complication
556677|NCT00421252|antiplatelet agent|antiplatelet agent
556678|NCT00421252|stenting|stenting
556679|NCT00421252|percutaneous coronary intervention|percutaneous coronary intervention
556680|NCT00421252|risk|risk
556681|NCT00421252|ischemia|ischemia
556682|NCT00421252|troponin|troponin
556683|NCT00421252|sheath size|sheath size
556684|NCT00421265|prostate cancer|prostate cancer
557561|NCT00426192|Mannitol|mannitol
556685|NCT00421265|active surveillance|active surveillance
556686|NCT00421265|indolent features|indolent features
556687|NCT00421317|Ocular, Metastatic melanoma|ocular, metastatic melanoma
556688|NCT00421330|Abdominal aortic aneurysm|abdominal aortic aneurysm
556689|NCT00421330|AAA|aaa
556690|NCT00421330|randomised controlled trial|randomised controlled trial
556691|NCT00421330|Endovascular repair|endovascular repair
556692|NCT00421330|conventional open repair|conventional open repair
556693|NCT00421343|disease/disorder proneness/risk|disease/disorder proneness/risk
556694|NCT00421343|osteoporotic fractures|osteoporotic fractures
556695|NCT00421343|accidental falls|accidental falls
556696|NCT00421343|aging|aging
556697|NCT00421356|amputation, transfemoral, lower extremity, prosthetic knee|amputation, transfemoral, lower extremity, prosthetic knee
556698|NCT00421369|Major depressive disorder|major depressive disorder
556699|NCT00421369|Antidepressants|antidepressants
556700|NCT00421369|Triiodothyronine (T3)|triiodothyronine (t3)
556701|NCT00421369|Thyroid Function|thyroid function
556702|NCT00421369|Augmentation|augmentation
556703|NCT00421369|Thyroid pathway genes|thyroid pathway genes
556704|NCT00421395|NHL|nhl
556705|NCT00421395|B-cell NHL|b-cell nhl
556706|NCT00421395|Non-Hodgkins lymphoma|non-hodgkins lymphoma
556707|NCT00421408|Dietary protein|dietary protein
556708|NCT00421408|Calcium|calcium
556709|NCT00421408|Parathyroid hormone|parathyroid hormone
556710|NCT00421408|Bone markers|bone markers
556711|NCT00421408|Bone mineral density|bone mineral density
556712|NCT00421408|IGF-1|igf-1
556713|NCT00421408|Urine Calcium|urine calcium
556714|NCT00421421|Acute Urinary Retention|acute urinary retention
556715|NCT00421421|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
556716|NCT00421421|Trial Without Catheter|trial without catheter
556717|NCT00421434|Hepatitis C|hepatitis c
556718|NCT00421447|Breast Cancer|breast cancer
556719|NCT00421447|pQCT|pqct
556720|NCT00421447|Anastrozole|anastrozole
556721|NCT00421447|bone geometry|bone geometry
556722|NCT00411736|Cystic Fibrosis|cystic fibrosis
556723|NCT00411736|Pseudomonas aeruginosa|pseudomonas aeruginosa
556724|NCT00411736|Azithromycin|azithromycin
556725|NCT00411736|Intermittent pulmonary infection|intermittent pulmonary infection
556726|NCT00411762|Pancreatic|pancreatic
556727|NCT00411788|HER-2 positive|her-2 positive
556728|NCT00411788|breast cancer|breast cancer
556729|NCT00411788|HER-2 positive breast cancer|her-2 positive breast cancer
556730|NCT00411801|bleeding disorder|bleeding disorder
556731|NCT00411801|universal plasma|universal plasma
556732|NCT00411801|plasma|plasma
556733|NCT00411801|plasma exchange|plasma exchange
556734|NCT00411814|melbourne,|melbourne,
556735|NCT00411814|healthy|healthy
556736|NCT00411814|antibody,|antibody,
556737|NCT00411814|male,|male,
556738|NCT00411814|Safety and pharmacokinetic study,|safety and pharmacokinetic study,
556739|NCT00411814|mild asthmatic patients,|mild asthmatic patients,
556740|NCT00411814|australia|australia
556741|NCT00411814|monoclonal|monoclonal
556742|NCT00411814|female,|female,
556743|NCT00411814|volunteers,|volunteers,
556744|NCT00411827|Cytology|cytology
556745|NCT00411827|Keratomileusis, Laser In Situ|keratomileusis, laser in situ
556746|NCT00411827|Keratectomy, Photorefractive, Excimer Laser|keratectomy, photorefractive, excimer laser
556747|NCT00411840|stem cell therapy|stem cell therapy
556748|NCT00411840|peripheral arterial disease|peripheral arterial disease
556749|NCT00411840|limb ischemia|limb ischemia
583951|NCT00514046|Medullary Thyroid Carcinoma|medullary thyroid carcinoma
556750|NCT00411853|Prostate, Hormone Refractory, Cancer|prostate, hormone refractory, cancer
556751|NCT00411866|safety|safety
556752|NCT00411866|pharmacokinetics,|pharmacokinetics,
556753|NCT00411879|Heart Arrest|heart arrest
556754|NCT00411879|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
556755|NCT00411879|Epinephrine|epinephrine
556756|NCT00411879|Vasopressin|vasopressin
556757|NCT00411879|Adrenal Cortex Hormones|adrenal cortex hormones
556758|NCT00411905|Myelodysplastic syndromes|myelodysplastic syndromes
556759|NCT00411905|IPSS Int-2 and High risk|ipss int-2 and high risk
556760|NCT00411905|Bortezomib|bortezomib
556761|NCT00411905|Low dose Cytarabine|low dose cytarabine
556762|NCT00411905|Bone Marrow diseases|bone marrow diseases
556763|NCT00411944|tacrolimus pharmacokinetics|tacrolimus pharmacokinetics
556764|NCT00411944|CYP3A4 - CYP3A5|cyp3a4 - cyp3a5
556765|NCT00411944|P-glycoprotein|p-glycoprotein
556766|NCT00411944|single nucleotide polymorphisms|single nucleotide polymorphisms
556767|NCT00411944|renal transplantation|renal transplantation
556768|NCT00411944|calcineurin-inhibitor-associated nephrotoxicity|calcineurin-inhibitor-associated nephrotoxicity
556769|NCT00411957|atazanavir/ritonavir|atazanavir/ritonavir
556770|NCT00411957|pharmacokinetic of ATV/r200/100 OD+2NRTIs|pharmacokinetic of atv/r200/100 od+2nrtis
556771|NCT00411970|23 gauge pars plana vitrectomy|23 gauge pars plana vitrectomy
556772|NCT00411970|conjunctival erythema and injection|conjunctival erythema and injection
556773|NCT00411970|20 gauge pars plana vitrectomy|20 gauge pars plana vitrectomy
556774|NCT00411970|vitreous and retinal surgery|vitreous and retinal surgery
556775|NCT00411983|chronic HIV infection|chronic hiv infection
556776|NCT00411983|long term cohort of HIV infection|long term cohort of hiv infection
556777|NCT00411996|indinavir/ritonavir|indinavir/ritonavir
556778|NCT00411996|HIV/TB|hiv/tb
556780|NCT00411996|PK and efficacy of IDV/RTV 600/100 mg BID with rifampicin|pk and efficacy of idv/rtv 600/100 mg bid with rifampicin
556781|NCT00411996|Treatment Naive|treatment naive
556782|NCT00412009|tuberculosis|tuberculosis
556783|NCT00412009|control|control
556784|NCT00412009|treatment|treatment
556785|NCT00412009|adherence|adherence
556786|NCT00412022|early breast cancer|early breast cancer
556787|NCT00412022|adjuvant therapy|adjuvant therapy
556788|NCT00412022|premenopause|premenopause
556789|NCT00412022|premenopausal|premenopausal
556790|NCT00412022|menopausal status|menopausal status
556792|NCT00412022|bone mineral density|bone mineral density
556793|NCT00412022|hormone sensitive|hormone sensitive
556794|NCT00412022|aromatase inhibitors|aromatase inhibitors
556795|NCT00412022|letrozole|letrozole
556796|NCT00412022|disease-free survival|disease-free survival
556797|NCT00412061|Cancer|cancer
556798|NCT00412061|Carcinoid|carcinoid
556799|NCT00412061|Tumor|tumor
556800|NCT00412061|Neuroendocrine|neuroendocrine
556801|NCT00412061|Carcinoma|carcinoma
556802|NCT00412061|Everolimus|everolimus
556803|NCT00412061|Octreotide|octreotide
556234|NCT00419250|CLL|cll
556804|NCT00412074|Breastfeeding|breastfeeding
556805|NCT00412074|Vitamin D|vitamin d
556806|NCT00412074|Vitamin D deficiency|vitamin d deficiency
556807|NCT00412087|vitamin D|vitamin d
556808|NCT00412087|cholecalciferol|cholecalciferol
556809|NCT00412087|pregnant women|pregnant women
556810|NCT00412100|A randomised|a randomised
556811|NCT00412100|double-blind|double-blind
556812|NCT00412100|double-dummy|double-dummy
556813|NCT00412100|parallel-group multicentre study to demonstrate improvement in symptoms of constipation|parallel-group multicentre study to demonstrate improvement in symptoms of constipation
556814|NCT00412100|Moderate to severe, chronic non-malignant pain|moderate to severe, chronic non-malignant pain
556815|NCT00412126|Diabetes Mellitus|diabetes mellitus
556816|NCT00412126|Coronary Restenosis|coronary restenosis
556817|NCT00412126|Insulin|insulin
556818|NCT00412126|Angioplasty|angioplasty
556819|NCT00412139|vascular calcifications|vascular calcifications
556820|NCT00412139|uremic toxins|uremic toxins
556821|NCT00412139|renal osteodystrophy|renal osteodystrophy
556822|NCT00412139|Dialysis|dialysis
556823|NCT00412152|A randomised|a randomised
556824|NCT00412152|double blind|double blind
556825|NCT00412152|parallel group|parallel group
556826|NCT00412152|multicentre study to demonstrate improvement in symptoms of constipation in subjects with non malignant pain|multicentre study to demonstrate improvement in symptoms of constipation in subjects with non malignant pain
556827|NCT00412152|Moderate to severe chronic non-malignant pain|moderate to severe chronic non-malignant pain
556828|NCT00412165|Prevention of Type 2 Diabetes|prevention of type 2 diabetes
556829|NCT00412165|Adolescents|adolescents
556830|NCT00412165|Obesity|obesity
556831|NCT00412165|Overweight|overweight
556832|NCT00412165|Internet Technology|internet technology
556833|NCT00412165|Cell Phone|cell phone
556834|NCT00412178|Internet|internet
556835|NCT00412178|mobile communication|mobile communication
556836|NCT00412178|glucose monitoring|glucose monitoring
556837|NCT00412191|healthy volunteers|healthy volunteers
556838|NCT00412191|bioequivalence|bioequivalence
556839|NCT00412191|food effects|food effects
556840|NCT00412204|double-blind|double-blind
556841|NCT00412204|placebo-controlled|placebo-controlled
556842|NCT00412204|crossover|crossover
556843|NCT00412204|effects of tiotropium bromide|effects of tiotropium bromide
556844|NCT00412204|gas exchange|gas exchange
556845|NCT00412204|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
556846|NCT00412204|exercise.|exercise.
556847|NCT00412230|Pre-eclampsia|pre-eclampsia
556848|NCT00412230|Gestational diabetes|gestational diabetes
556849|NCT00412230|Insulin resistance|insulin resistance
556850|NCT00412230|hypertension in pregnancy|hypertension in pregnancy
556851|NCT00412243|Burkitt's Lymphoma|burkitt's lymphoma
556852|NCT00412243|Lymphoblastic Lymphoma|lymphoblastic lymphoma
556853|NCT00412243|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
556854|NCT00412243|Clofarabine|clofarabine
556855|NCT00412243|Clofarex|clofarex
556857|NCT00412243|Cyclophosphamide|cyclophosphamide
556858|NCT00412243|Neosar|neosar
556859|NCT00412243|Cytoxan|cytoxan
556860|NCT00412256|Treatment|treatment
556861|NCT00412256|Disease activity|disease activity
556862|NCT00412256|Clinical trial|clinical trial
556863|NCT00412269|Insulin Sensitivity|insulin sensitivity
556864|NCT00412269|Total abdominal fat|total abdominal fat
556865|NCT00412269|Visceral abdominal fat|visceral abdominal fat
556866|NCT00412269|Reproductive Hormones|reproductive hormones
556867|NCT00412269|Menopause|menopause
556868|NCT00412269|Diabetes|diabetes
556869|NCT00412269|Fat Distribution|fat distribution
556870|NCT00412269|Sex Hormones|sex hormones
556871|NCT00412295|Naturally occuring myopia with or without astigmatism.|naturally occuring myopia with or without astigmatism.
556872|NCT00412295|Wavefront errors|wavefront errors
556873|NCT00412308|spinal cord injury|spinal cord injury
556874|NCT00412308|ventilator dependency|ventilator dependency
556875|NCT00412308|ventilator weaning|ventilator weaning
556876|NCT00412308|tidal volume|tidal volume
556877|NCT00412321|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
556878|NCT00412321|Multiple Myeloma|multiple myeloma
556879|NCT00412321|Castleman's disease|castleman's disease
556880|NCT00412321|intravenous|intravenous
556881|NCT00412321|IL-6|il-6
556882|NCT00412347|hyperglycemia|hyperglycemia
556883|NCT00412347|diabetes|diabetes
556884|NCT00412347|insulin drip|insulin drip
556885|NCT00412347|hypoglycemia|hypoglycemia
556886|NCT00412347|general wards|general wards
556887|NCT00412360|Double cord blood|double cord blood
556888|NCT00412373|Schizoaffective Disorder|schizoaffective disorder
556889|NCT00412373|antipsychotic|antipsychotic
556890|NCT00412373|paliperidone|paliperidone
556892|NCT00412386|Pediatric|pediatric
556893|NCT00412386|Congenital Heart Disease|congenital heart disease
556894|NCT00412386|Imaging|imaging
556895|NCT00412399|Employment|employment
556896|NCT00412399|Negative workplace events|negative workplace events
556897|NCT00412399|Healthy controls|healthy controls
556898|NCT00412399|Fatigue|fatigue
556259|NCT00419406|N-B UVB|n-b uvb
556899|NCT00412399|Physical activity|physical activity
556900|NCT00412412|Cancer of Breast|cancer of breast
556901|NCT00412412|Cancer of the Breast|cancer of the breast
556902|NCT00412425|Melanoma|melanoma
556903|NCT00412425|Nausea|nausea
556904|NCT00412425|Vomiting|vomiting
556905|NCT00412425|Palonosetron|palonosetron
556906|NCT00412425|Cisplatin|cisplatin
556907|NCT00412425|Vinblastine|vinblastine
556908|NCT00412425|Loss of Appetite|loss of appetite
556909|NCT00412425|Weight loss|weight loss
556910|NCT00412438|Atrial Fibrillation|atrial fibrillation
556911|NCT00412451|Diabetic Macular Edema|diabetic macular edema
556912|NCT00412451|PVD|pvd
556913|NCT00412451|DME|dme
556914|NCT00412451|Diabetic Retinopathy|diabetic retinopathy
556915|NCT00412464|fondaparinux|fondaparinux
556916|NCT00412464|thrombosis|thrombosis
556917|NCT00412464|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
556918|NCT00412464|pediatrics|pediatrics
556919|NCT00412477|HIV|hiv
556920|NCT00412477|Lfn-p24|lfn-p24
556921|NCT00412477|Anthrax|anthrax
556922|NCT00412477|IM|im
556923|NCT00412477|HIV-1|hiv-1
556924|NCT00412477|HIV Preventive Vaccine|hiv preventive vaccine
556925|NCT00412490|Oral Cavity Cancer|oral cavity cancer
556926|NCT00412490|Body Image|body image
556927|NCT00412490|Smoking|smoking
556928|NCT00412490|Appearance|appearance
556929|NCT00412490|Questionnaire|questionnaire
556930|NCT00412490|Interview|interview
556931|NCT00412516|Japanese Encephalitis|japanese encephalitis
556932|NCT00412516|Japanese B Encephalitis|japanese b encephalitis
556933|NCT00412516|Japanese B Viral Encephalitis|japanese b viral encephalitis
556934|NCT00412516|Viral Encephalitis, Japanese B|viral encephalitis, japanese b
556935|NCT00412529|HBeAg-positive, chronic hepatitis B|hbeag-positive, chronic hepatitis b
556936|NCT00412529|telbivudine|telbivudine
556937|NCT00412529|entecavir|entecavir
556938|NCT00412529|viral kinetics|viral kinetics
556939|NCT00412542|Glioblastoma Multiforme|glioblastoma multiforme
556940|NCT00412542|Glioma|glioma
556941|NCT00412542|Thalidomide|thalidomide
556942|NCT00412542|Thalomid|thalomid
556943|NCT00412542|CPT-11|cpt-11
556944|NCT00412542|Irinotecan|irinotecan
556945|NCT00412542|malignant glioma|malignant glioma
556946|NCT00412568|Naturally occuring myopia with or without astigmatism.|naturally occuring myopia with or without astigmatism.
556947|NCT00412581|Melanoma|melanoma
556948|NCT00412581|Lenalidomide|lenalidomide
556949|NCT00412581|Dacarbazine|dacarbazine
556950|NCT00412581|CC-5013|cc-5013
556951|NCT00412581|Revlimid|revlimid
556952|NCT00412581|DTIC|dtic
556953|NCT00412594|Hairy Cell Leukemia|hairy cell leukemia
556954|NCT00412594|Leukemia|leukemia
556955|NCT00412594|2CDA|2cda
556956|NCT00412594|2-chlorodeoxyadenosine|2-chlorodeoxyadenosine
556957|NCT00412594|Rituximab|rituximab
556958|NCT00412594|Rituxan|rituxan
556959|NCT00412594|HCL|hcl
556960|NCT00412607|Ventricular Tachycardia|ventricular tachycardia
556961|NCT00412607|Heart Diseases|heart diseases
556962|NCT00412607|Arrhythmia|arrhythmia
556963|NCT00412633|Obesity|obesity
556964|NCT00412633|Men|men
556965|NCT00412633|Overweight|overweight
556966|NCT00421460|Nebido in hypogonadism with erectile dysfunction|nebido in hypogonadism with erectile dysfunction
556967|NCT00421473|HIV|hiv
556968|NCT00421473|Malaria prophylaxis|malaria prophylaxis
556969|NCT00421473|Treatment Experienced|treatment experienced
556970|NCT00421486|Oral human papillomavirus infection|oral human papillomavirus infection
556971|NCT00421486|HIV-infection|hiv-infection
556972|NCT00421486|High-risk HPV viral load|high-risk hpv viral load
556973|NCT00421486|Oral human papillomavirus infection in HIV-positive men|oral human papillomavirus infection in hiv-positive men
556974|NCT00421486|Treatment Experienced|treatment experienced
556975|NCT00421486|Treatment Naive|treatment naive
556976|NCT00421512|Renal cell carcinoma|renal cell carcinoma
556977|NCT00421512|Metastatic|metastatic
556978|NCT00421512|Kidney Cancer|kidney cancer
556979|NCT00421512|Bevacizumab|bevacizumab
556980|NCT00421512|Sunitinib|sunitinib
556981|NCT00421525|multiple myeloma|multiple myeloma
556982|NCT00421525|Myeloma, Plasma-Cell|myeloma, plasma-cell
556983|NCT00421525|PLASMACYTOMA|plasmacytoma
556984|NCT00421538|Deep vein Thrombosis|deep vein thrombosis
556985|NCT00421538|Calf vein thrombosis|calf vein thrombosis
556986|NCT00421538|Low-molecular weight heparin|low-molecular weight heparin
556987|NCT00421538|Placebo|placebo
556988|NCT00421538|Elastic contention|elastic contention
556989|NCT00421538|Compression Ultrasonography|compression ultrasonography
556990|NCT00421551|HIV Infections|hiv infections
556991|NCT00421551|darunavir|darunavir
556992|NCT00421551|Ritonavir|ritonavir
556993|NCT00421551|HIV Protease Inhibitors|hiv protease inhibitors
556994|NCT00421551|treatment experienced|treatment experienced
556995|NCT00421564|Menopausal|menopausal
556996|NCT00421564|Traditional Chinese Medicine|traditional chinese medicine
556997|NCT00421577|Caries Diagnosis|caries diagnosis
556998|NCT00421577|Replica technique|replica technique
556999|NCT00421590|Randomized, partially blind, placebo controlled, crossover, drug interaction with concomitant antacid, pharmacokinetics, pharmacodynamics, SMC021|randomized, partially blind, placebo controlled, crossover, drug interaction with concomitant antacid, pharmacokinetics, pharmacodynamics, smc021
557000|NCT00421603|Cocaine|cocaine
557001|NCT00421603|Adderall|adderall
557002|NCT00421603|Topiramate|topiramate
557003|NCT00421603|ADHD|adhd
557004|NCT00421616|Calorimetry|calorimetry
557005|NCT00421616|Overweight|overweight
557006|NCT00421616|Weight loss|weight loss
557007|NCT00421616|Appetite|appetite
557008|NCT00421629|health insurance|health insurance
557009|NCT00421629|hospitalization insurance|hospitalization insurance
557010|NCT00421629|community based health insurance|community based health insurance
557011|NCT00421629|health care access|health care access
557012|NCT00421629|developing countries|developing countries
557013|NCT00421629|randomized controlled trials|randomized controlled trials
557014|NCT00421668|HIV|hiv
557015|NCT00421668|Tanzania|tanzania
557016|NCT00421668|Micronutrients|micronutrients
557017|NCT00421668|Infants/children|infants/children
557018|NCT00421668|Infectious Disease|infectious disease
557019|NCT00421668|Growth faltering|growth faltering
557020|NCT00421681|Aging|aging
557021|NCT00421681|exercise|exercise
557022|NCT00421681|health behavior|health behavior
557023|NCT00421707|Irritable Bowel Syndrome safety|irritable bowel syndrome safety
557024|NCT00421720|remifentanil|remifentanil
557025|NCT00421720|sufentanil|sufentanil
557026|NCT00421720|propofol|propofol
557027|NCT00421720|analgesia|analgesia
557028|NCT00421720|sedation|sedation
557029|NCT00421720|mechanically ventilated|mechanically ventilated
557030|NCT00421720|intensive care|intensive care
557031|NCT00421720|pharmacoeconomic|pharmacoeconomic
557032|NCT00421720|weaning|weaning
557033|NCT00421720|delirium|delirium
557034|NCT00421720|randomized|randomized
557035|NCT00421720|Germany|germany
557036|NCT00421733|Type 2 Diabetic Nephropathy|type 2 diabetic nephropathy
557037|NCT00421759|Sensory loss|sensory loss
557038|NCT00421759|psychomotor function|psychomotor function
557039|NCT00421759|balance|balance
557040|NCT00421759|gait|gait
557041|NCT00421772|cerebral ventriculomegaly|cerebral ventriculomegaly
557043|NCT00421772|neuropsychological outcome|neuropsychological outcome
557044|NCT00421785|N-acetylcysteine|n-acetylcysteine
557045|NCT00421785|Peritoneal Dialysis|peritoneal dialysis
557046|NCT00421785|ADMA|adma
557047|NCT00424203|cognitive/functional effects|cognitive/functional effects
557048|NCT00424203|depression|depression
557049|NCT00424203|malnutrition|malnutrition
557050|NCT00424203|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
557051|NCT00424203|stage IA breast cancer|stage ia breast cancer
558491|NCT00418847|Miglustat|miglustat
557052|NCT00424203|stage IB breast cancer|stage ib breast cancer
557053|NCT00424203|stage II breast cancer|stage ii breast cancer
557054|NCT00424203|stage IIIA breast cancer|stage iiia breast cancer
557055|NCT00424203|stage IIIB breast cancer|stage iiib breast cancer
557056|NCT00424203|stage IIIC breast cancer|stage iiic breast cancer
557057|NCT00424203|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
557058|NCT00424203|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
557059|NCT00424216|Mood|mood
557060|NCT00424216|Emotion|emotion
557061|NCT00424216|Judgment|judgment
557062|NCT00424216|Cortex|cortex
557063|NCT00424216|Brain Stimulation|brain stimulation
557064|NCT00424216|Healthy Volunteer|healthy volunteer
557065|NCT00424216|HV|hv
557066|NCT00424229|MDS INT-2MDS HIGH RISKDELETION 5q[31]Lenalidomide|mds int-2mds high riskdeletion 5q[31]lenalidomide
557067|NCT00424242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
557068|NCT00424242|tumors metastatic to brain|tumors metastatic to brain
557069|NCT00424242|leptomeningeal metastases|leptomeningeal metastases
557070|NCT00424242|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
557071|NCT00424242|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
557072|NCT00424242|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
557073|NCT00424242|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
557074|NCT00424242|chronic eosinophilic leukemia|chronic eosinophilic leukemia
557075|NCT00424242|primary myelofibrosis|primary myelofibrosis
557076|NCT00424242|chronic neutrophilic leukemia|chronic neutrophilic leukemia
557077|NCT00424242|essential thrombocythemia|essential thrombocythemia
557078|NCT00424242|polycythemia vera|polycythemia vera
557079|NCT00424242|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
751956|NCT01171339|medication appropriateness index|medication appropriateness index
557080|NCT00424242|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
557081|NCT00424242|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
557082|NCT00424242|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
557083|NCT00424242|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
557084|NCT00424242|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
557085|NCT00424242|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
557086|NCT00424242|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
557087|NCT00424242|secondary acute myeloid leukemia|secondary acute myeloid leukemia
557088|NCT00424242|acute undifferentiated leukemia|acute undifferentiated leukemia
557090|NCT00424242|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
557091|NCT00424242|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
557092|NCT00424242|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
557093|NCT00424242|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
557094|NCT00424242|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
557095|NCT00424242|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
557096|NCT00424242|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
557097|NCT00424242|refractory hairy cell leukemia|refractory hairy cell leukemia
557098|NCT00424242|prolymphocytic leukemia|prolymphocytic leukemia
557099|NCT00424242|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
557100|NCT00424242|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
557101|NCT00424242|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
557102|NCT00424242|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
557103|NCT00424242|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
557104|NCT00424242|intraocular lymphoma|intraocular lymphoma
557105|NCT00424242|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
557106|NCT00424242|refractory multiple myeloma|refractory multiple myeloma
557107|NCT00424242|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
557108|NCT00424242|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
557109|NCT00424242|anaplastic large cell lymphoma|anaplastic large cell lymphoma
557110|NCT00424242|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
557111|NCT00424242|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
557112|NCT00424242|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
557113|NCT00424242|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
557114|NCT00424242|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
557115|NCT00424242|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
557116|NCT00424242|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
557117|NCT00424242|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
557118|NCT00424242|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
557119|NCT00424242|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
557120|NCT00424242|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
557295|NCT00425152|stage II colon cancer|stage ii colon cancer
557121|NCT00424242|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
557122|NCT00424242|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
557123|NCT00424242|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
557124|NCT00424242|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
557125|NCT00424242|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
557126|NCT00424242|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
557127|NCT00424242|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
557128|NCT00424242|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
557129|NCT00424242|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
557130|NCT00424242|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
557131|NCT00424242|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
557132|NCT00424242|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
557133|NCT00424242|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
557134|NCT00424242|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
557135|NCT00424242|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
557136|NCT00424242|splenic marginal zone lymphoma|splenic marginal zone lymphoma
557137|NCT00424242|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
557223|NCT00424723|neuroendocrine tumors|neuroendocrine tumors
557138|NCT00424242|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
557139|NCT00424242|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
557140|NCT00424242|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
557141|NCT00424242|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
557142|NCT00424242|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
557143|NCT00424242|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
557144|NCT00424242|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
557145|NCT00424242|secondary myelofibrosis|secondary myelofibrosis
557146|NCT00424242|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
556554|NCT00420771|Gabapentin|gabapentin
557147|NCT00424242|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
557266|NCT00424970|pulmonary hypertension|pulmonary hypertension
557148|NCT00424242|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
557149|NCT00424242|stage III multiple myeloma|stage iii multiple myeloma
557150|NCT00424242|primary systemic amyloidosis|primary systemic amyloidosis
557151|NCT00424242|extramedullary plasmacytoma|extramedullary plasmacytoma
557152|NCT00424242|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
557153|NCT00424242|isolated plasmacytoma of bone|isolated plasmacytoma of bone
557154|NCT00424255|Cancer of the Head and Neck|cancer of the head and neck
557157|NCT00424255|Head and neck cancer|head and neck cancer
557158|NCT00424255|High-risk head and neck cancer|high-risk head and neck cancer
557159|NCT00424255|Post-surgery|post-surgery
557160|NCT00424255|Head cancer|head cancer
557161|NCT00424268|COPD|copd
557162|NCT00424268|Roflumilast|roflumilast
557163|NCT00424281|Arixtra, fondaparinux, vasopressor, venous thrombolism|arixtra, fondaparinux, vasopressor, venous thrombolism
557164|NCT00424320|Acute kidney failure|acute kidney failure
557165|NCT00424320|Contrast-induced nephropathy|contrast-induced nephropathy
557166|NCT00424320|Non-ionic contrast media|non-ionic contrast media
557167|NCT00424320|Ionic contrast media|ionic contrast media
557168|NCT00424320|Iopamidol|iopamidol
557169|NCT00424320|Percutaneous coronary intervention|percutaneous coronary intervention
557170|NCT00424320|Coronariography|coronariography
557171|NCT00424346|Active Rheumatoid Arthritis|active rheumatoid arthritis
557172|NCT00424346|anti-interleukin-1beta monoclonal antibody|anti-interleukin-1beta monoclonal antibody
557173|NCT00424346|methotrexate|methotrexate
557174|NCT00424359|Mulitple Sclerosis|mulitple sclerosis
557175|NCT00424359|Ambulation|ambulation
557176|NCT00424385|AIPC, Prostate cancer|aipc, prostate cancer
557177|NCT00424385|prostate|prostate
557178|NCT00424424|Postoperative Dental Pain|postoperative dental pain
557179|NCT00424450|contrast ultrasound|contrast ultrasound
557180|NCT00424450|muscle perfusion|muscle perfusion
557181|NCT00424463|Amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
557182|NCT00424476|Autoimmune Diseases|autoimmune diseases
557183|NCT00424476|Lupus|lupus
557184|NCT00424476|SLE|sle
557185|NCT00424476|Systemic Lupus Erythematosus|systemic lupus erythematosus
557186|NCT00424476|Belimumab|belimumab
557187|NCT00424476|Antibodies|antibodies
557188|NCT00424489|Refractory Myasthenia Gravis|refractory myasthenia gravis
557189|NCT00424489|Autologous Stem Cell Transplantation|autologous stem cell transplantation
557190|NCT00424489|Cyclophosphamide and ATG|cyclophosphamide and atg
557191|NCT00424515|Imatinib|imatinib
557192|NCT00424515|Gleevec|gleevec
557193|NCT00424528|COPD including chronic bronchitis and emphysema|copd including chronic bronchitis and emphysema
557194|NCT00424541|Pharmacokinetics, pharmacodynamics, safety, RAS profile, SPP100, aliskiren, Japanese, essential hypertension|pharmacokinetics, pharmacodynamics, safety, ras profile, spp100, aliskiren, japanese, essential hypertension
557296|NCT00425152|stage III colon cancer|stage iii colon cancer
557195|NCT00424541|Mild to moderate essential hypertension|mild to moderate essential hypertension
557196|NCT00424567|Fracture|fracture
557197|NCT00424567|non union fracture|non union fracture
557198|NCT00424567|ununited fracture|ununited fracture
557199|NCT00424567|pseudarthrosis|pseudarthrosis
557200|NCT00424606|High risk node negative|high risk node negative
557201|NCT00424619|Vitamin D|vitamin d
557202|NCT00424619|Hip fracture|hip fracture
557203|NCT00424619|Optimal level|optimal level
557204|NCT00424619|Deficiency|deficiency
557205|NCT00424619|Functional muscle strength|functional muscle strength
557206|NCT00424645|Hematologic Malignancy|hematologic malignancy
557207|NCT00424645|Solid Tumor|solid tumor
557208|NCT00424645|Glucarpidase|glucarpidase
557209|NCT00424645|Voraxaze|voraxaze
557210|NCT00424645|Delayed Methotrexate Clearance|delayed methotrexate clearance
557211|NCT00424645|Placebo|placebo
557212|NCT00424658|breathing disorders|breathing disorders
557213|NCT00424684|TB|tb
557214|NCT00424684|Chronic Liver Disease|chronic liver disease
557215|NCT00424697|Brain imaging,|brain imaging,
557216|NCT00424697|fMRI,|fmri,
557217|NCT00424697|stimulation,|stimulation,
557218|NCT00424697|pharmacodynamics,|pharmacodynamics,
557219|NCT00424697|tolerability,|tolerability,
557220|NCT00424697|healthy subjects|healthy subjects
557221|NCT00424710|choroidal neovascularization|choroidal neovascularization
557222|NCT00424723|pemetrexed|pemetrexed
557224|NCT00424723|metastatic neuroendocrine tumors|metastatic neuroendocrine tumors
557225|NCT00424736|blunt trauma, pediatric patient, imaging, computer tomography|blunt trauma, pediatric patient, imaging, computer tomography
557226|NCT00424749|Antineutrophil cytoplasmic antibody associated vasculitis|antineutrophil cytoplasmic antibody associated vasculitis
557227|NCT00424749|Glomerulonephritis|glomerulonephritis
557228|NCT00424749|Rituximab|rituximab
557229|NCT00424762|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
557230|NCT00424762|Congestive Heart Failure|congestive heart failure
557231|NCT00424762|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
718942|NCT01039519|GIST|gist
557232|NCT00424762|intracellular cardiomyocyte triglycerides|intracellular cardiomyocyte triglycerides
557233|NCT00424762|thiazolidinedione|thiazolidinedione
557234|NCT00424762|rosiglitazone|rosiglitazone
557235|NCT00424762|nuclear magnetic resonance|nuclear magnetic resonance
557236|NCT00424775|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
557237|NCT00424788|multiple sclerosis (MS)|multiple sclerosis (ms)
557238|NCT00424814|HIV mother to child prevention|hiv mother to child prevention
557239|NCT00424814|HIV Infections|hiv infections
557241|NCT00424814|Combivir|combivir
557242|NCT00424814|HIV Seronegativity|hiv seronegativity
557243|NCT00424827|pancreatic cancer, gemcitabine, 5-FU, cetuximab, radiation|pancreatic cancer, gemcitabine, 5-fu, cetuximab, radiation
557244|NCT00424840|lung cancer, Carboplatin, bortezomib, Bevacizumab|lung cancer, carboplatin, bortezomib, bevacizumab
557245|NCT00424866|Peripheral Arterial Disease|peripheral arterial disease
557246|NCT00424866|Ischemia|ischemia
557247|NCT00424866|Intermittent Claudication|intermittent claudication
557248|NCT00424918|Dance|dance
557249|NCT00424918|Peers|peers
557250|NCT00424918|middle school-based|middle school-based
557251|NCT00424918|feasibility|feasibility
557252|NCT00424931|narcolepsy|narcolepsy
557253|NCT00424931|sleepiness|sleepiness
557254|NCT00424944|Malaria|malaria
557255|NCT00424944|Vaccine|vaccine
557256|NCT00424944|GMZ2|gmz2
557257|NCT00424944|Safety|safety
557258|NCT00424944|African|african
557259|NCT00424944|immunogenicity|immunogenicity
557260|NCT00424957|Ammonia|ammonia
557261|NCT00424957|Astrocytes|astrocytes
557262|NCT00424957|Citric acid cycle|citric acid cycle
557263|NCT00424957|Alpha ketoglutarate dehydrogenase|alpha ketoglutarate dehydrogenase
557264|NCT00424970|high altitude|high altitude
557265|NCT00424970|hypoxia|hypoxia
557267|NCT00424970|polycythemia|polycythemia
557268|NCT00424970|hypoventilation|hypoventilation
557269|NCT00424983|Multiple myeloma|multiple myeloma
557270|NCT00424983|breast cancer|breast cancer
557271|NCT00424983|zoledronic acid|zoledronic acid
557272|NCT00424983|pharmacokinetics|pharmacokinetics
557273|NCT00425009|Berberine|berberine
557274|NCT00425009|Type 2 diabetes|type 2 diabetes
557275|NCT00425009|Treatment|treatment
557276|NCT00425022|lung cancer|lung cancer
557277|NCT00425022|video-assisted thoracic surgery|video-assisted thoracic surgery
557279|NCT00425074|slow release ASA|slow release asa
557280|NCT00425074|platelet functionalism|platelet functionalism
557281|NCT00425074|secondary cardiovascular prevention|secondary cardiovascular prevention
557282|NCT00425113|Mycobacterium Tuberculosis|mycobacterium tuberculosis
557283|NCT00425113|Anaerobic|anaerobic
557284|NCT00425113|FDG-PET-HRCT|fdg-pet-hrct
557285|NCT00425113|HRCT|hrct
557286|NCT00425113|Lesion Matrix|lesion matrix
557287|NCT00425113|Tuberculosis|tuberculosis
557288|NCT00425113|TB|tb
557289|NCT00425126|Delayed Graft Function|delayed graft function
557290|NCT00425126|Kidney Transplantation|kidney transplantation
557291|NCT00425139|Cancer|cancer
557292|NCT00425139|Video game|video game
557293|NCT00425139|Adolescent|adolescent
557294|NCT00425139|Young adult|young adult
557740|NCT00426764|romidepsin|romidepsin
557297|NCT00425178|Chronic wounds|chronic wounds
557298|NCT00425178|Diabetes|diabetes
557299|NCT00425178|Ulcers|ulcers
557300|NCT00425178|Arterial bypass|arterial bypass
557301|NCT00425178|Angioplasty|angioplasty
557302|NCT00425178|Diabetic ulcers|diabetic ulcers
557303|NCT00425243|primary insomnia|primary insomnia
557304|NCT00425243|chronic insomnia|chronic insomnia
557305|NCT00425269|lifestyle intervention|lifestyle intervention
557306|NCT00425269|Type 2 Diabetes|type 2 diabetes
557307|NCT00425269|Metabolic syndrome|metabolic syndrome
557308|NCT00425269|Pakistani women|pakistani women
557309|NCT00425269|dietary change|dietary change
557310|NCT00425269|Physical activity|physical activity
557311|NCT00425269|Norway|norway
557312|NCT00425282|RWJ-333369|rwj-333369
557313|NCT00425282|anticonvulsants|anticonvulsants
557314|NCT00425282|antiepileptic drugs|antiepileptic drugs
557315|NCT00425308|Everolimus, calcineurine inhibitor, renal transplantation in maintenance, chronic allograft nephropathy|everolimus, calcineurine inhibitor, renal transplantation in maintenance, chronic allograft nephropathy
557316|NCT00425321|Arthritis|arthritis
557317|NCT00425321|Joints|joints
557318|NCT00425321|Auto immune|auto immune
557319|NCT00425334|Blood loss|blood loss
557320|NCT00425334|Ischemia|ischemia
557321|NCT00425334|Hemoglobin|hemoglobin
557322|NCT00425334|Blood Substitutes|blood substitutes
557323|NCT00425334|Plasma Expanders|plasma expanders
557324|NCT00425347|Multiple myeloma, MM, plasma cell myeloma, cancer|multiple myeloma, mm, plasma cell myeloma, cancer
557325|NCT00425360|stage III pancreatic cancer|stage iii pancreatic cancer
557326|NCT00425360|stage IV pancreatic cancer|stage iv pancreatic cancer
557327|NCT00425360|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
557328|NCT00425360|recurrent pancreatic cancer|recurrent pancreatic cancer
557329|NCT00425373|Hypertension, Valsartan, Amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
557330|NCT00425386|stage III renal cell cancer|stage iii renal cell cancer
557331|NCT00425386|stage IV renal cell cancer|stage iv renal cell cancer
557332|NCT00425386|clear cell renal cell carcinoma|clear cell renal cell carcinoma
557333|NCT00425386|recurrent renal cell cancer|recurrent renal cell cancer
557334|NCT00425399|Schizophrenia|schizophrenia
557335|NCT00425399|Shiatsu|shiatsu
557336|NCT00425425|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
557337|NCT00425425|stage IIA esophageal cancer|stage iia esophageal cancer
557338|NCT00425425|stage IIB esophageal cancer|stage iib esophageal cancer
557339|NCT00425425|stage IIIA esophageal cancer|stage iiia esophageal cancer
557340|NCT00425425|stage IIIB esophageal cancer|stage iiib esophageal cancer
557341|NCT00425425|stage IIIC esophageal cancer|stage iiic esophageal cancer
557342|NCT00425451|Periodontitis|periodontitis
557343|NCT00425451|Dental Care|dental care
557344|NCT00425451|Efficacy|efficacy
557345|NCT00425451|Safety|safety
557346|NCT00425477|refractory anemia with excess blasts|refractory anemia with excess blasts
557347|NCT00425477|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
557348|NCT00425477|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
557349|NCT00425477|secondary acute myeloid leukemia|secondary acute myeloid leukemia
557350|NCT00425477|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
557351|NCT00425477|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
557352|NCT00425477|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
557353|NCT00425477|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
557354|NCT00425477|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
557355|NCT00425477|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
557356|NCT00425477|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
557357|NCT00425477|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
557358|NCT00425477|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
557359|NCT00425477|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
557360|NCT00425477|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
557361|NCT00425477|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
557362|NCT00425477|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
557363|NCT00425477|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
557364|NCT00425477|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
557365|NCT00425477|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
557366|NCT00425477|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
557367|NCT00425477|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
557368|NCT00425477|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
557369|NCT00425477|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
557370|NCT00425503|Prostate Cancer|prostate cancer
557371|NCT00425503|Bortezomib|bortezomib
557372|NCT00425503|Radical Prostatectomy|radical prostatectomy
557373|NCT00425503|Phase 2 Clinical Trial|phase 2 clinical trial
557374|NCT00425516|neoadjuvant chemotherapy|neoadjuvant chemotherapy
557375|NCT00425516|breast cancer|breast cancer
557376|NCT00425516|sequential treatment|sequential treatment
557377|NCT00425542|Pulmonary embolism|pulmonary embolism
557378|NCT00425542|Outpatient care|outpatient care
557379|NCT00425542|Prognosis|prognosis
557380|NCT00425555|Cutaneous T-Cell Lymphoma, adults|cutaneous t-cell lymphoma, adults
557381|NCT00425555|Mycosis Fungoides|mycosis fungoides
557382|NCT00425555|Sézary Syndrome|sézary syndrome
557383|NCT00425555|CTCL|ctcl
557384|NCT00425568|hypogonadism|hypogonadism
557385|NCT00425568|low testosterone level|low testosterone level
557386|NCT00425568|gonadal deficiency|gonadal deficiency
557387|NCT00425581|N-terminal pro-BNP,|n-terminal pro-bnp,
557388|NCT00425581|Cardiac Troponin-T,|cardiac troponin-t,
557389|NCT00425581|Very low birth weight infants|very low birth weight infants
557390|NCT00425581|hemodynamic instability|hemodynamic instability
557391|NCT00425581|myocardial dysfunction|myocardial dysfunction
557392|NCT00425594|colonoscopy|colonoscopy
557393|NCT00425594|bowel preparation|bowel preparation
557394|NCT00425594|prep|prep
557395|NCT00425607|Hutchinson-Gilford Progeria Syndrome|hutchinson-gilford progeria syndrome
557396|NCT00425607|HGPS|hgps
557397|NCT00425607|Progeria|progeria
557398|NCT00425607|FTI|fti
557399|NCT00425607|Farnesyltransferase Inhibitor|farnesyltransferase inhibitor
557401|NCT00425620|Chronic Sinusitis|chronic sinusitis
557402|NCT00425620|Chronic Rhinosinusitis|chronic rhinosinusitis
557403|NCT00425633|Homeopathic|homeopathic
557404|NCT00425633|Potassium|potassium
557405|NCT00425633|Dichromate|dichromate
557407|NCT00425633|Bichromicum|bichromicum
557408|NCT00425633|Mechanical|mechanical
557409|NCT00425633|Ventilation|ventilation
556856|NCT00412243|Clolar|clolar
557410|NCT00425633|Secretions|secretions
557411|NCT00425646|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
557412|NCT00425646|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
557414|NCT00425646|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
557415|NCT00425646|large cell lung cancer|large cell lung cancer
557416|NCT00425646|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
557417|NCT00425659|Health utility|health utility
557418|NCT00425659|Home sleep study|home sleep study
557419|NCT00425685|cardiopulmonary resuscitation, ECMO, shock, survival, heart failure, transplantation, heart assist device.|cardiopulmonary resuscitation, ecmo, shock, survival, heart failure, transplantation, heart assist device.
557420|NCT00425711|Acamprosate|acamprosate
557421|NCT00425711|Alcohol Dependence|alcohol dependence
557422|NCT00425711|Driving Under the Influence|driving under the influence
557423|NCT00425711|Drug Court|drug court
557424|NCT00425711|DUI Court|dui court
557425|NCT00425724|proteinuria|proteinuria
557426|NCT00425724|nephritis|nephritis
557427|NCT00425724|nephrotic syndrome|nephrotic syndrome
557428|NCT00425724|glomerulonephritis|glomerulonephritis
557429|NCT00425737|Oral live attenuated human rotavirus vaccine|oral live attenuated human rotavirus vaccine
557430|NCT00425737|Gastroenteritis|gastroenteritis
557431|NCT00425750|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
557432|NCT00425750|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
557433|NCT00425750|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
557434|NCT00425750|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
557435|NCT00425750|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
557436|NCT00425750|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
557437|NCT00425750|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
557438|NCT00425750|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
557439|NCT00425763|malaria|malaria
557440|NCT00425763|efficacy|efficacy
557441|NCT00425763|intermittent preventive therapy in infants|intermittent preventive therapy in infants
557442|NCT00425763|drug resistance|drug resistance
557443|NCT00425776|Breast cancer|breast cancer
557444|NCT00425776|Acupuncture|acupuncture
557445|NCT00425776|Post-menopausal hot flushes|post-menopausal hot flushes
557446|NCT00425776|Se-estradiol|se-estradiol
557447|NCT00425776|Se-endorphine|se-endorphine
557448|NCT00425789|Deep Chemical Peeling|deep chemical peeling
557449|NCT00425789|Hyperbaric Therapy|hyperbaric therapy
557450|NCT00425789|post-deep peel|post-deep peel
557451|NCT00425802|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
557452|NCT00425802|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
557453|NCT00425802|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
557454|NCT00425802|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
557455|NCT00425802|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
557456|NCT00425802|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
557457|NCT00425802|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
557458|NCT00425802|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
557459|NCT00425802|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
557460|NCT00425802|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
558584|NCT00427050|Dermatology|dermatology
557461|NCT00425802|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
557462|NCT00425802|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
557463|NCT00425802|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
557464|NCT00425802|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
557465|NCT00425802|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
557466|NCT00425802|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
557467|NCT00425802|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
557468|NCT00425802|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
557469|NCT00425802|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
557470|NCT00425802|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
557471|NCT00425802|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
557472|NCT00425802|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
557473|NCT00425802|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
557474|NCT00425802|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
557475|NCT00425802|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
557476|NCT00425802|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
557477|NCT00425802|splenic marginal zone lymphoma|splenic marginal zone lymphoma
557478|NCT00425802|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
557479|NCT00425802|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
557480|NCT00425802|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
557481|NCT00425802|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
557482|NCT00425802|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
557483|NCT00425802|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
557484|NCT00425802|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
557485|NCT00425802|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
557486|NCT00425815|Cognition|cognition
557487|NCT00425815|Ampakines|ampakines
557488|NCT00425815|Schizophrenia|schizophrenia
557489|NCT00425841|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
557490|NCT00425841|stage III pancreatic cancer|stage iii pancreatic cancer
557491|NCT00425841|stage II pancreatic cancer|stage ii pancreatic cancer
557492|NCT00425867|PAR1 gene|par1 gene
557493|NCT00425867|polymorphisms|polymorphisms
557494|NCT00425867|abortions|abortions
557495|NCT00425867|reccurent abortions|reccurent abortions
557496|NCT00425867|premature delivery|premature delivery
557497|NCT00425880|Pregnancy|pregnancy
557498|NCT00425880|Asthma|asthma
557499|NCT00425880|Tobacco Abuse|tobacco abuse
557500|NCT00425880|Exhaled Nitric Oxide|exhaled nitric oxide
557501|NCT00425893|influenza|influenza
557502|NCT00425893|masks|masks
557503|NCT00425893|transmission|transmission
557504|NCT00425893|hand hygiene|hand hygiene
557505|NCT00425893|non-pharmacologic interventions|non-pharmacologic interventions
557506|NCT00425906|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
557507|NCT00425906|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
557508|NCT00425906|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
557509|NCT00425906|anorexia|anorexia
557510|NCT00425906|pain|pain
557511|NCT00425919|Type 2 Diabetes|type 2 diabetes
557512|NCT00425919|Diabetes|diabetes
557513|NCT00425932|Magnetic Resonance Imaging|magnetic resonance imaging
557514|NCT00425932|Rituximab|rituximab
557515|NCT00425932|Low Field MRI|low field mri
557516|NCT00425932|Biomarkers|biomarkers
557517|NCT00425958|year and more after TBI|year and more after tbi
557518|NCT00425958|good vision|good vision
557519|NCT00425958|at least one functinal hand|at least one functinal hand
557520|NCT00425958|cap[able od doing shopping during everyday life|cap[able od doing shopping during everyday life
557522|NCT00425984|Male circumcision|male circumcision
557523|NCT00425984|Sexually transmitted infections|sexually transmitted infections
557524|NCT00425984|Sexual risk behaviors|sexual risk behaviors
557525|NCT00425984|Adult males|adult males
557526|NCT00425984|Haemophilus ducreyi|haemophilus ducreyi
557527|NCT00425984|Human papillomavirus|human papillomavirus
557528|NCT00425984|Rakai|rakai
557529|NCT00425984|Uganda|uganda
557530|NCT00425984|HIV seronegativity|hiv seronegativity
557531|NCT00425984|HPV|hpv
557532|NCT00425984|STI|sti
557533|NCT00425997|Hypertension, valsartan/HCTZ, amlodipine and HCTZ|hypertension, valsartan/hctz, amlodipine and hctz
557534|NCT00426010|Placebo effect|placebo effect
557535|NCT00426010|Caffeine|caffeine
557536|NCT00426010|Systolic BP|systolic bp
557537|NCT00426010|VAS|vas
557538|NCT00426023|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
557539|NCT00426023|Cyclosporine|cyclosporine
557540|NCT00426023|Children|children
557541|NCT00426023|Clinical trial|clinical trial
557542|NCT00426036|Open-label study, healthy subjects, stable impaired renal function, licarbazepine, pharmacokinetics, metabolism, safety.|open-label study, healthy subjects, stable impaired renal function, licarbazepine, pharmacokinetics, metabolism, safety.
557543|NCT00426049|Coronary artery disease|coronary artery disease
557544|NCT00426049|Stents|stents
557545|NCT00426049|Immunosuppressive Agents|immunosuppressive agents
557546|NCT00426049|Coronary restenosis|coronary restenosis
557547|NCT00426049|Safety|safety
557548|NCT00426062|Squamous Cell Carcinoma of Tongue and mouth floor|squamous cell carcinoma of tongue and mouth floor
557549|NCT00426075|Deep vein thrombosis of the lower extremities|deep vein thrombosis of the lower extremities
557550|NCT00426101|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
557551|NCT00426127|Pancreatic|pancreatic
557552|NCT00426127|Docetaxel|docetaxel
557553|NCT00426127|Doxorubicin|doxorubicin
557554|NCT00426127|Enoxaparin|enoxaparin
557555|NCT00426140|EPO|epo
557556|NCT00426140|Patupilone|patupilone
557557|NCT00426140|Solid Tumors|solid tumors
557558|NCT00426179|Imatinib, allergic inflammation, out of allergy season, repeated nasal allergen, seasonal allergic rhinitis, sensitive, Timothy grass pollen, c-kit inhibition|imatinib, allergic inflammation, out of allergy season, repeated nasal allergen, seasonal allergic rhinitis, sensitive, timothy grass pollen, c-kit inhibition
557559|NCT00426192|Immunedefense Suppression|immunedefense suppression
557560|NCT00426192|Cardiopulmonary Bypass|cardiopulmonary bypass
557562|NCT00426192|Hemofiltration|hemofiltration
557563|NCT00426192|Cytokines|cytokines
557564|NCT00426192|Receptors, Surface CD14|receptors, surface cd14
557565|NCT00426205|GM-CSF|gm-csf
557566|NCT00426205|GVAX|gvax
557042|NCT00421772|prenatal diagnostic|prenatal diagnostic
557567|NCT00426205|Cancer vaccine|cancer vaccine
557568|NCT00426205|blood stem cell transplantation|blood stem cell transplantation
557569|NCT00426205|MDS|mds
557570|NCT00426205|AML|aml
557571|NCT00426205|CML|cml
557572|NCT00426218|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
557573|NCT00426218|Immunogenicity|immunogenicity
557574|NCT00426218|Pharmacokinetics|pharmacokinetics
557575|NCT00426218|Anti-IL-1ß Monoclonal Antibody|anti-il-1ß monoclonal antibody
557576|NCT00426218|ACZ885|acz885
557577|NCT00426218|SJIA|sjia
557578|NCT00426218|Pediatrics|pediatrics
557579|NCT00426231|Randomized Controlled Trials|randomized controlled trials
557580|NCT00426231|Health Education|health education
557581|NCT00426231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
557582|NCT00426231|Patient Nonadherence|patient nonadherence
557583|NCT00426244|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
557584|NCT00426244|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
557585|NCT00426244|Pregnancy|pregnancy
557586|NCT00426244|Physiologic|physiologic
557587|NCT00426244|Gait|gait
557588|NCT00426244|Low back pain|low back pain
557589|NCT00426244|Heart rate variability|heart rate variability
557590|NCT00426257|Ovarian Cancer|ovarian cancer
557591|NCT00426257|stage III|stage iii
557592|NCT00426257|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
557593|NCT00426257|debulking surgery|debulking surgery
557594|NCT00426257|HIPEC|hipec
557595|NCT00426283|Eosinophilic Esophagitis|eosinophilic esophagitis
557596|NCT00426296|HIV|hiv
557597|NCT00426296|Reyataz|reyataz
557598|NCT00426296|atazanavir|atazanavir
557599|NCT00426296|Norvir|norvir
557600|NCT00426296|ritonavir|ritonavir
557601|NCT00426296|Boosted|boosted
557602|NCT00426296|Lipodystrophy|lipodystrophy
557603|NCT00426296|Treatment Experienced|treatment experienced
557604|NCT00426322|maxillary sinus augmentation|maxillary sinus augmentation
557606|NCT00426322|bovine bone mineral|bovine bone mineral
557607|NCT00426322|dental implants|dental implants
557608|NCT00426335|breast|breast
557609|NCT00426335|cancer|cancer
557610|NCT00426335|cognitive behaviour therapy|cognitive behaviour therapy
557611|NCT00426335|psychological|psychological
557612|NCT00426348|IgA nephropathy|iga nephropathy
557614|NCT00426348|valsartan|valsartan
557615|NCT00426348|treatment|treatment
557616|NCT00426348|antioxidant|antioxidant
557617|NCT00426348|IGA nephropathy：a kind of glomerulonephritis,which IgA is the dominant immunodeposit in mesangial areas|iga nephropathy：a kind of glomerulonephritis,which iga is the dominant immunodeposit in mesangial areas
557618|NCT00426361|Human Papillomavirus|human papillomavirus
557619|NCT00426374|HIV|hiv
557620|NCT00426374|AIDS|aids
557621|NCT00426374|Troponin|troponin
557622|NCT00426374|natriuretic peptide|natriuretic peptide
557623|NCT00426374|heart failure|heart failure
557624|NCT00426374|heart disease children|heart disease children
557625|NCT00426374|HIV pediatric|hiv pediatric
557626|NCT00426374|AIDS pediatric|aids pediatric
557627|NCT00426413|ketosis-prone diabetes|ketosis-prone diabetes
557628|NCT00426413|diabetic ketoacidosis|diabetic ketoacidosis
557629|NCT00426413|obesity|obesity
557630|NCT00426413|insulin dependence|insulin dependence
557631|NCT00426413|mechanisms|mechanisms
557632|NCT00426439|malaria|malaria
557633|NCT00426439|Plasmodium falciparum|plasmodium falciparum
557634|NCT00426439|children|children
557635|NCT00426439|Guinea-Bissau|guinea-bissau
557636|NCT00426439|artemether|artemether
557637|NCT00426439|lumefantrine|lumefantrine
557638|NCT00426439|chloroquine|chloroquine
557639|NCT00426439|Coartem|coartem
557814|NCT00416624|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
557640|NCT00426452|Vascular endothelial growth factor receptor (VEGF-R) tyrosine kinase inhibitor|vascular endothelial growth factor receptor (vegf-r) tyrosine kinase inhibitor
557641|NCT00426452|Vatalinib|vatalinib
557642|NCT00426452|Proton-pump inhibitors|proton-pump inhibitors
557643|NCT00426452|Omeprazole|omeprazole
557644|NCT00426452|Healthy Postmenopausal Female Volunteers|healthy postmenopausal female volunteers
557645|NCT00426465|Motor Practice|motor practice
557646|NCT00426465|Magnetic Stimulation|magnetic stimulation
557647|NCT00426465|Stroke|stroke
557648|NCT00426465|Spacing Effect|spacing effect
557649|NCT00426465|Massed Practice|massed practice
557650|NCT00426465|Healthy Volunteer|healthy volunteer
557651|NCT00426465|HV|hv
557652|NCT00426478|AMPM, SBP, DBP, Valsartan plus Hydrochlorothiazide, Amlodipine, high blood pressure|ampm, sbp, dbp, valsartan plus hydrochlorothiazide, amlodipine, high blood pressure
557653|NCT00426504|Head,|head,
557654|NCT00426504|Neck,|neck,
557655|NCT00426504|Cancer,|cancer,
557656|NCT00426504|Tomotherapy,|tomotherapy,
557657|NCT00426504|IMRT,|imrt,
557658|NCT00426517|MUD Transplant|mud transplant
557659|NCT00426517|Transplant|transplant
557660|NCT00426517|AlloPBSC|allopbsc
557661|NCT00426517|HLA Matched Transplant|hla matched transplant
557662|NCT00426517|BMT|bmt
557663|NCT00426517|Congenital Immunodeficiency|congenital immunodeficiency
557664|NCT00426517|Bone Marrow Transplant|bone marrow transplant
557155|NCT00424255|Neck cancer|neck cancer
557665|NCT00426530|HER2-overexpressing metastatic breast cancer|her2-overexpressing metastatic breast cancer
557666|NCT00426530|Breast cancer|breast cancer
557667|NCT00426530|Cancer of the breast|cancer of the breast
557668|NCT00426530|Human mammary carcinoma|human mammary carcinoma
557669|NCT00426530|HER-2|her-2
557670|NCT00426530|metastatic|metastatic
557671|NCT00426530|everolimus|everolimus
557672|NCT00426530|trastuzumab|trastuzumab
557673|NCT00426530|vinorelbine|vinorelbine
557674|NCT00426543|Clinical trial|clinical trial
557675|NCT00426543|Intervention study|intervention study
557676|NCT00426543|Double-blind randomised controlled study|double-blind randomised controlled study
557677|NCT00426556|Breast cancer|breast cancer
557678|NCT00426556|Cancer of the breast|cancer of the breast
557679|NCT00426556|Human mammary carcinoma|human mammary carcinoma
557680|NCT00426556|HER-2|her-2
557681|NCT00426556|Metastatic|metastatic
557682|NCT00426556|everolimus|everolimus
557683|NCT00426556|trastuzumab|trastuzumab
557684|NCT00426556|paclitaxel|paclitaxel
557685|NCT00426582|Cancer|cancer
557686|NCT00426582|maximum tolerated dose|maximum tolerated dose
557687|NCT00426582|dose-limiting toxicity|dose-limiting toxicity
557688|NCT00426582|patupilone|patupilone
557689|NCT00426582|carboplatin|carboplatin
557690|NCT00426582|pharmacokinetics|pharmacokinetics
557691|NCT00426608|cortisol,|cortisol,
557692|NCT00426608|Healthy volunteers|healthy volunteers
557693|NCT00426608|GSK561679,|gsk561679,
557694|NCT00426608|HPA axis,|hpa axis,
557695|NCT00426608|hormones,|hormones,
557696|NCT00426621|Knee osteoarthritis, degenerative joint disease, knee pain, joint pain, topical NSAID,|knee osteoarthritis, degenerative joint disease, knee pain, joint pain, topical nsaid,
557697|NCT00426621|diclofenac sodium|diclofenac sodium
557698|NCT00426634|Asthma|asthma
557699|NCT00426634|Allergens|allergens
557700|NCT00426634|Mold|mold
557701|NCT00426634|Asthma Counselor|asthma counselor
557702|NCT00426634|Environmental Remediation|environmental remediation
557703|NCT00426647|Osteoarthritis|osteoarthritis
557704|NCT00426647|Pain|pain
557705|NCT00426647|Norspan|norspan
557706|NCT00426647|Buprenorphine|buprenorphine
557707|NCT00426647|Tramadol|tramadol
557708|NCT00426660|HIV Infections|hiv infections
557709|NCT00426673|partial onset seizures, phenytoin, dilatin, brivaracetam, interaction|partial onset seizures, phenytoin, dilatin, brivaracetam, interaction
557710|NCT00426686|thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
557711|NCT00426686|prognostic factors|prognostic factors
557712|NCT00426686|ADAMTS13|adamts13
557713|NCT00426699|enterovirus|enterovirus
557714|NCT00426699|meningitis|meningitis
557715|NCT00426699|sepsis|sepsis
557716|NCT00426699|myocarditis|myocarditis
557717|NCT00426699|kidney|kidney
557718|NCT00426699|urine|urine
557719|NCT00426699|glomerulonephritis|glomerulonephritis
557720|NCT00426712|Chronic kidney failure|chronic kidney failure
557721|NCT00426712|Chronic kidney disease|chronic kidney disease
557722|NCT00426712|Hemodialysis|hemodialysis
557723|NCT00426712|HBV vaccine|hbv vaccine
557724|NCT00426712|Hepatitis B vaccine|hepatitis b vaccine
557725|NCT00426712|Hepatitis B|hepatitis b
557726|NCT00426712|Hepatitis|hepatitis
557728|NCT00426712|Prevention & Control|prevention & control
557729|NCT00426725|labor|labor
557730|NCT00426725|pain|pain
557731|NCT00426725|relief|relief
557732|NCT00426725|labour|labour
557733|NCT00426725|device|device
557734|NCT00426751|Eptifibatide|eptifibatide
557735|NCT00426751|ST-elevation Myocardial Infarction|st-elevation myocardial infarction
557736|NCT00426751|STEMI|stemi
557737|NCT00426751|Abciximab|abciximab
557738|NCT00426764|peripheral T-cell lymphoma|peripheral t-cell lymphoma
557739|NCT00426764|T-cell lymphoma|t-cell lymphoma
557741|NCT00416468|Aliskiren , Valsartan, bioavailability, hypertension|aliskiren , valsartan, bioavailability, hypertension
557742|NCT00416468|Healthy male and female subjects|healthy male and female subjects
557743|NCT00416481|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
557744|NCT00416494|adenocarcinoma of the colon|adenocarcinoma of the colon
557745|NCT00416494|recurrent colon cancer|recurrent colon cancer
557746|NCT00416494|stage IV colon cancer|stage iv colon cancer
557747|NCT00416494|adenocarcinoma of the rectum|adenocarcinoma of the rectum
557748|NCT00416494|recurrent rectal cancer|recurrent rectal cancer
557749|NCT00416494|stage IV rectal cancer|stage iv rectal cancer
557750|NCT00416507|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
557751|NCT00416507|stage III pancreatic cancer|stage iii pancreatic cancer
557752|NCT00416507|stage II pancreatic cancer|stage ii pancreatic cancer
557753|NCT00416520|Chronic Kidney Disease|chronic kidney disease
557754|NCT00416520|Dialysis|dialysis
557755|NCT00416520|Hyperphosphatemia|hyperphosphatemia
557756|NCT00416520|Phosphate binder|phosphate binder
557757|NCT00416533|recurrent prostate cancer|recurrent prostate cancer
557758|NCT00416533|stage III prostate cancer|stage iii prostate cancer
557759|NCT00416533|stage IV prostate cancer|stage iv prostate cancer
557760|NCT00416533|adenocarcinoma of the prostate|adenocarcinoma of the prostate
557761|NCT00416546|Healthy Caucasians|healthy caucasians
557762|NCT00416546|Healthy Japanese subjects|healthy japanese subjects
557763|NCT00416546|Immunosuppressant|immunosuppressant
557764|NCT00416546|early T-cell activation blockers|early t-cell activation blockers
557765|NCT00416546|inhibition of protein kinase C|inhibition of protein kinase c
557766|NCT00416559|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
753080|NCT01175382|Behavioral Medicine|behavioral medicine
557767|NCT00416559|localized resectable neuroblastoma|localized resectable neuroblastoma
557768|NCT00416559|localized unresectable neuroblastoma|localized unresectable neuroblastoma
557769|NCT00416559|regional neuroblastoma|regional neuroblastoma
557770|NCT00416572|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
557771|NCT00416572|stage I breast cancer|stage i breast cancer
557772|NCT00416572|stage II breast cancer|stage ii breast cancer
557773|NCT00416585|acne|acne
557774|NCT00416585|isotretinoin|isotretinoin
557775|NCT00416585|calcium. vitamin D|calcium. vitamin d
557776|NCT00416611|High blood pressure|high blood pressure
557777|NCT00416611|Awareness|awareness
557778|NCT00416611|Treatment|treatment
557779|NCT00416611|Effective Control|effective control
557780|NCT00416611|Coronary heart disease risk reduction|coronary heart disease risk reduction
557781|NCT00416611|Hypertension|hypertension
557782|NCT00416624|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
557783|NCT00416624|extramedullary plasmacytoma|extramedullary plasmacytoma
557784|NCT00416624|isolated plasmacytoma of bone|isolated plasmacytoma of bone
557785|NCT00416624|refractory multiple myeloma|refractory multiple myeloma
557786|NCT00416624|stage I multiple myeloma|stage i multiple myeloma
557787|NCT00416624|stage II multiple myeloma|stage ii multiple myeloma
557788|NCT00416624|stage III multiple myeloma|stage iii multiple myeloma
557789|NCT00416624|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
557790|NCT00416624|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
557791|NCT00416624|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
557792|NCT00416624|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
557793|NCT00416624|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
557794|NCT00416624|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
557795|NCT00416624|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
557796|NCT00416624|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
557797|NCT00416624|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
557798|NCT00416624|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
557799|NCT00416624|anaplastic large cell lymphoma|anaplastic large cell lymphoma
557800|NCT00416624|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
557801|NCT00416624|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
557802|NCT00416624|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
557803|NCT00416624|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
557804|NCT00416624|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
557805|NCT00416624|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
557806|NCT00416624|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
557807|NCT00416624|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
557808|NCT00416624|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
557809|NCT00416624|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
557810|NCT00416624|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
557811|NCT00416624|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
557812|NCT00416624|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
557813|NCT00416624|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
558675|NCT00427479|Screening|screening
557815|NCT00416624|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
557816|NCT00416624|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
557817|NCT00416624|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
557818|NCT00416624|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
557819|NCT00416624|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
557820|NCT00416624|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
557821|NCT00416624|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
557822|NCT00416624|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
557823|NCT00416624|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
557824|NCT00416624|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
557825|NCT00416624|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
557278|NCT00425035|Renal Cancer|renal cancer
557826|NCT00416624|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
557827|NCT00416624|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
557963|NCT00416767|WDHA syndrome|wdha syndrome
557828|NCT00416624|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
557829|NCT00416624|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
557830|NCT00416624|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
557831|NCT00416624|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
557832|NCT00416624|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
558145|NCT00417339|hemodialysis|hemodialysis
557833|NCT00416624|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
557834|NCT00416624|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
557835|NCT00416624|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
557836|NCT00416624|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
557837|NCT00416624|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
557838|NCT00416624|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
557839|NCT00416624|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
557840|NCT00416624|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
557841|NCT00416624|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
557842|NCT00416624|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
557843|NCT00416624|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
557844|NCT00416624|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
557845|NCT00416624|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
557846|NCT00416624|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
557847|NCT00416624|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
557848|NCT00416624|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
557849|NCT00416624|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
557850|NCT00416624|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
557851|NCT00416624|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
557852|NCT00416624|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
557853|NCT00416624|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
557854|NCT00416624|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
557855|NCT00416624|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
557856|NCT00416624|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
557857|NCT00416624|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
557858|NCT00416624|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
557859|NCT00416624|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
557860|NCT00416624|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
557861|NCT00416624|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
557862|NCT00416624|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
557863|NCT00416624|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
557864|NCT00416624|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
557865|NCT00416624|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
557866|NCT00416624|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
557867|NCT00416624|stage I mantle cell lymphoma|stage i mantle cell lymphoma
557868|NCT00416624|stage I marginal zone lymphoma|stage i marginal zone lymphoma
557869|NCT00416624|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
557870|NCT00416624|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
557871|NCT00416624|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
557872|NCT00416624|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
558099|NCT00417170|endothelial dysfunction|endothelial dysfunction
557873|NCT00416624|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
557874|NCT00416624|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
557875|NCT00416624|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
557876|NCT00416624|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
557877|NCT00416624|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
557878|NCT00416624|splenic marginal zone lymphoma|splenic marginal zone lymphoma
557879|NCT00416624|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
557880|NCT00416624|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
557881|NCT00416624|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
557882|NCT00416624|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
557883|NCT00416624|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
557884|NCT00416624|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
557885|NCT00416624|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
557886|NCT00416624|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
557887|NCT00416624|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
557888|NCT00416624|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
557889|NCT00416624|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
557890|NCT00416624|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
557891|NCT00416624|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
557892|NCT00416624|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
557893|NCT00416624|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
557894|NCT00416624|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
557895|NCT00416624|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
557896|NCT00416624|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
557897|NCT00416624|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
557898|NCT00416624|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
557899|NCT00416624|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
557900|NCT00416624|refractory hairy cell leukemia|refractory hairy cell leukemia
557901|NCT00416624|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
557902|NCT00416624|prolymphocytic leukemia|prolymphocytic leukemia
557904|NCT00416624|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
557905|NCT00416624|primary systemic amyloidosis|primary systemic amyloidosis
557906|NCT00416624|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
557907|NCT00416624|acute undifferentiated leukemia|acute undifferentiated leukemia
557908|NCT00416624|mast cell leukemia|mast cell leukemia
557909|NCT00416624|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
557910|NCT00416624|untreated hairy cell leukemia|untreated hairy cell leukemia
557911|NCT00416637|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
557912|NCT00416650|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
557913|NCT00416650|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
557914|NCT00416650|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
557915|NCT00416650|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
557916|NCT00416663|Stem cells|stem cells
557917|NCT00416663|Progenitor cells|progenitor cells
557918|NCT00416663|Angina Pectoris|angina pectoris
557919|NCT00416663|Heart Failure|heart failure
557920|NCT00416663|Angiogenesis|angiogenesis
557921|NCT00416676|localized resectable neuroblastoma|localized resectable neuroblastoma
557922|NCT00416676|localized unresectable neuroblastoma|localized unresectable neuroblastoma
557923|NCT00416676|regional neuroblastoma|regional neuroblastoma
557924|NCT00416689|nausea and vomiting|nausea and vomiting
557925|NCT00416689|pulmonary carcinoid tumor|pulmonary carcinoid tumor
557926|NCT00416689|recurrent breast cancer|recurrent breast cancer
557927|NCT00416689|stage I breast cancer|stage i breast cancer
557928|NCT00416689|stage II breast cancer|stage ii breast cancer
557929|NCT00416689|stage IIIA breast cancer|stage iiia breast cancer
557930|NCT00416689|stage IIIB breast cancer|stage iiib breast cancer
557931|NCT00416689|stage IIIC breast cancer|stage iiic breast cancer
557932|NCT00416689|stage IV breast cancer|stage iv breast cancer
557933|NCT00416689|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
557934|NCT00416689|stage I non-small cell lung cancer|stage i non-small cell lung cancer
557935|NCT00416689|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
557936|NCT00416689|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
557937|NCT00416689|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
557938|NCT00416689|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
557939|NCT00416689|extensive stage small cell lung cancer|extensive stage small cell lung cancer
557940|NCT00416689|limited stage small cell lung cancer|limited stage small cell lung cancer
557941|NCT00416689|recurrent small cell lung cancer|recurrent small cell lung cancer
557942|NCT00416702|safety study, pharmacokinetic effects, healthy subjects, hepatic impairment, liver|safety study, pharmacokinetic effects, healthy subjects, hepatic impairment, liver
557943|NCT00416702|Subjects with mild and moderate hepatic impairment and healthy subjects|subjects with mild and moderate hepatic impairment and healthy subjects
557944|NCT00416728|Aliskiren , Valsartan , bioavailability, hypertension|aliskiren , valsartan , bioavailability, hypertension
557945|NCT00416728|Healthy male and female subjects|healthy male and female subjects
557946|NCT00416741|Metabolic Syndrome|metabolic syndrome
557947|NCT00416741|Obesity|obesity
557948|NCT00416741|Hyperlipidemia|hyperlipidemia
557949|NCT00416741|High blood pressure|high blood pressure
557950|NCT00416741|Diabetes|diabetes
557951|NCT00416754|breast cancer|breast cancer
557952|NCT00416754|stage I breast cancer|stage i breast cancer
557953|NCT00416754|stage II breast cancer|stage ii breast cancer
557954|NCT00416754|stage IIIA breast cancer|stage iiia breast cancer
557955|NCT00416754|stage IIIB breast cancer|stage iiib breast cancer
557956|NCT00416754|stage IIIC breast cancer|stage iiic breast cancer
557957|NCT00416754|stage IV breast cancer|stage iv breast cancer
557958|NCT00416767|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
557959|NCT00416767|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
557960|NCT00416767|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
557961|NCT00416767|gastrinoma|gastrinoma
557962|NCT00416767|insulinoma|insulinoma
557964|NCT00416767|glucagonoma|glucagonoma
557965|NCT00416767|pancreatic polypeptide tumor|pancreatic polypeptide tumor
557966|NCT00416767|somatostatinoma|somatostatinoma
557967|NCT00416767|recurrent islet cell carcinoma|recurrent islet cell carcinoma
557968|NCT00416780|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
557969|NCT00416780|recurrent breast cancer|recurrent breast cancer
557970|NCT00416780|stage I breast cancer|stage i breast cancer
557971|NCT00416780|stage II breast cancer|stage ii breast cancer
557972|NCT00416780|stage IV breast cancer|stage iv breast cancer
557973|NCT00416819|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
557974|NCT00416819|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
557975|NCT00416832|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
557976|NCT00416832|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
557977|NCT00416832|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
557978|NCT00416832|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
557979|NCT00416845|pharmacodynamic effects, cardiac effects, healthy subjects, synthetic sphingosine 1 phosphate (S1P) receptor modulator|pharmacodynamic effects, cardiac effects, healthy subjects, synthetic sphingosine 1 phosphate (s1p) receptor modulator
557980|NCT00416845|Healthy male and female subjects|healthy male and female subjects
557981|NCT00416858|stage III esophageal cancer|stage iii esophageal cancer
557982|NCT00416871|stage IV renal cell cancer|stage iv renal cell cancer
557983|NCT00416871|recurrent renal cell cancer|recurrent renal cell cancer
557984|NCT00416884|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
557985|NCT00416884|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
557986|NCT00416884|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
557987|NCT00416897|stage I multiple myeloma|stage i multiple myeloma
557988|NCT00416897|stage II multiple myeloma|stage ii multiple myeloma
557989|NCT00416897|stage III multiple myeloma|stage iii multiple myeloma
557990|NCT00416897|renal failure|renal failure
557991|NCT00416910|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
557992|NCT00416910|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
557993|NCT00416910|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
557994|NCT00416910|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
557995|NCT00416910|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
557996|NCT00416923|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
557997|NCT00416923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
557998|NCT00416923|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
557999|NCT00416923|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
558000|NCT00416923|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
558001|NCT00416923|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
558002|NCT00416923|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
558003|NCT00416923|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
558004|NCT00416923|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
558005|NCT00416923|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
558006|NCT00416923|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
558007|NCT00416923|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
558008|NCT00416923|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
558009|NCT00416923|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
558010|NCT00416923|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
558011|NCT00416923|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
558012|NCT00416923|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
558013|NCT00416923|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
558014|NCT00416923|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
558015|NCT00416923|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
558016|NCT00416923|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
558017|NCT00416923|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
558018|NCT00416923|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
558019|NCT00416923|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
558020|NCT00416923|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
558021|NCT00416923|leptomeningeal metastases|leptomeningeal metastases
558022|NCT00416923|intraocular lymphoma|intraocular lymphoma
558023|NCT00416923|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
558024|NCT00416923|Waldenström macroglobulinemia|waldenström macroglobulinemia
558025|NCT00416923|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
558026|NCT00416923|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
558027|NCT00416923|splenic marginal zone lymphoma|splenic marginal zone lymphoma
558028|NCT00416949|anaplastic thyroid cancer|anaplastic thyroid cancer
558029|NCT00416949|insular thyroid cancer|insular thyroid cancer
558030|NCT00416949|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
558031|NCT00416949|recurrent thyroid cancer|recurrent thyroid cancer
558032|NCT00416949|stage I follicular thyroid cancer|stage i follicular thyroid cancer
558033|NCT00416949|stage I papillary thyroid cancer|stage i papillary thyroid cancer
558034|NCT00416949|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
558035|NCT00416949|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
558036|NCT00416949|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
558037|NCT00416949|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
558038|NCT00416949|stage IVA follicular thyroid cancer|stage iva follicular thyroid cancer
558039|NCT00416949|stage IVB follicular thyroid cancer|stage ivb follicular thyroid cancer
558040|NCT00416949|stage IVC follicular thyroid cancer|stage ivc follicular thyroid cancer
558041|NCT00416949|stage IVA papillary thyroid cancer|stage iva papillary thyroid cancer
558042|NCT00416949|stage IVB papillary thyroid cancer|stage ivb papillary thyroid cancer
558043|NCT00416949|stage IVC papillary thyroid cancer|stage ivc papillary thyroid cancer
558044|NCT00416962|Oseltamivir, amantidine, Symmetrel, Tamiflu|oseltamivir, amantidine, symmetrel, tamiflu
558046|NCT00416988|melanoma|melanoma
558047|NCT00416988|weight changes|weight changes
558048|NCT00417001|sedation|sedation
558049|NCT00417001|colonoscopy|colonoscopy
558050|NCT00417001|Aroma therapy|aroma therapy
558051|NCT00417014|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
558052|NCT00417014|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
558053|NCT00417014|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
558054|NCT00417014|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
558055|NCT00417014|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
558056|NCT00417027|Patient controlled epidural analgesia|patient controlled epidural analgesia
558057|NCT00417027|Labor analgesia|labor analgesia
558058|NCT00417027|Epidural analgesia|epidural analgesia
558059|NCT00417040|adenocarcinoma of the prostate|adenocarcinoma of the prostate
558060|NCT00417040|recurrent prostate cancer|recurrent prostate cancer
558061|NCT00417040|stage IV prostate cancer|stage iv prostate cancer
558062|NCT00417053|disseminated neuroblastoma|disseminated neuroblastoma
558063|NCT00417053|localized resectable neuroblastoma|localized resectable neuroblastoma
558064|NCT00417053|localized unresectable neuroblastoma|localized unresectable neuroblastoma
558065|NCT00417053|regional neuroblastoma|regional neuroblastoma
558066|NCT00417053|stage 4S neuroblastoma|stage 4s neuroblastoma
558067|NCT00417066|poor responders|poor responders
558068|NCT00417066|GnRH antagonist|gnrh antagonist
558069|NCT00417066|GnRH agonist|gnrh agonist
558070|NCT00417066|flare up|flare up
558071|NCT00417066|short protocol|short protocol
558073|NCT00417079|Prostate|prostate
558074|NCT00417092|coronary artery bypass grafting|coronary artery bypass grafting
558075|NCT00417092|reduced left ventricular function|reduced left ventricular function
558076|NCT00417092|postoperative pacing|postoperative pacing
558077|NCT00417092|cardiac resynchronization|cardiac resynchronization
558078|NCT00417105|hemodialysis|hemodialysis
558079|NCT00417105|dialysis adequacy|dialysis adequacy
558080|NCT00417105|chronic kidney disease|chronic kidney disease
558081|NCT00417118|Anxiety|anxiety
558082|NCT00417118|clinical trials|clinical trials
558083|NCT00417131|Islet transplantation,|islet transplantation,
558084|NCT00417131|coagulation,|coagulation,
558085|NCT00417131|graft destruction,|graft destruction,
558086|NCT00417131|islet imaging|islet imaging
558087|NCT00417144|OHSS|ohss
558088|NCT00417144|PCOS|pcos
558089|NCT00417144|GnRH antagonist|gnrh antagonist
558090|NCT00417144|GnRH agonist|gnrh agonist
558091|NCT00417157|GnRH antagonist|gnrh antagonist
558092|NCT00417157|Poor responders|poor responders
558093|NCT00417157|Oocyte donation|oocyte donation
558094|NCT00417157|Modified natural cycle|modified natural cycle
558095|NCT00417170|High Blood pressure|high blood pressure
558096|NCT00417170|Hypertension|hypertension
558097|NCT00417170|metabolic syndrome|metabolic syndrome
558098|NCT00417170|insulin resistance|insulin resistance
558201|NCT00417534|Genetics|genetics
558100|NCT00417170|pre-diabetic|pre-diabetic
558101|NCT00417170|amlodipine,|amlodipine,
558102|NCT00417170|aliskiren,|aliskiren,
558103|NCT00417170|IGT,|igt,
558104|NCT00417170|IFG,|ifg,
558105|NCT00417170|MBF|mbf
558106|NCT00417183|GnRH antagonist|gnrh antagonist
558107|NCT00417183|GnRH agonist|gnrh agonist
557613|NCT00426348|probucol|probucol
558108|NCT00417183|Long protocol|long protocol
558109|NCT00417183|Flexible|flexible
558110|NCT00417196|pharmacodynamic effects, safety, healthy subjects,|pharmacodynamic effects, safety, healthy subjects,
558111|NCT00417196|Healthy male and female subjects|healthy male and female subjects
558112|NCT00417209|advanced pancreatic cancer|advanced pancreatic cancer
558113|NCT00417235|catheter related infection|catheter related infection
558114|NCT00417235|catheter dressing|catheter dressing
558115|NCT00417235|prevention|prevention
558116|NCT00417235|Chlorhexidine impregnated dressings|chlorhexidine impregnated dressings
558117|NCT00417235|Infection|infection
558118|NCT00417235|catheterization|catheterization
558119|NCT00417261|ATF936, AXT914, healthy subjects, pharmacokinetics, parathyroid hormone, osteoporosis|atf936, axt914, healthy subjects, pharmacokinetics, parathyroid hormone, osteoporosis
558120|NCT00417261|Healthy male and female subjects|healthy male and female subjects
558121|NCT00417274|Cancer of Prostate|cancer of prostate
558122|NCT00417274|Prostate Cancer|prostate cancer
558123|NCT00417274|Cancer of the Prostate|cancer of the prostate
558124|NCT00417274|Neoplasms, Prostate|neoplasms, prostate
558125|NCT00417274|Neoplasms, Prostatic|neoplasms, prostatic
558126|NCT00417274|Prostate Neoplasms|prostate neoplasms
558127|NCT00417274|Prostatic Cancer|prostatic cancer
558128|NCT00417274|Androgen-Independent Prostate Cancer|androgen-independent prostate cancer
558130|NCT00417287|Cancer|cancer
558131|NCT00417287|Carcinoma|carcinoma
558132|NCT00417300|PTSD|ptsd
558133|NCT00417300|Cognitive Behavioral Treatment|cognitive behavioral treatment
558134|NCT00417300|Child Sexual Abuse|child sexual abuse
558135|NCT00417313|knee pain|knee pain
558136|NCT00417313|acupuncture /acupressure|acupuncture /acupressure
558137|NCT00417313|alternative medicine|alternative medicine
558138|NCT00417313|analgesia|analgesia
558139|NCT00417313|arthritis therapy|arthritis therapy
558140|NCT00417313|chronic pain|chronic pain
558141|NCT00417313|functional ability|functional ability
558142|NCT00417326|ONO-5046Na|ono-5046na
558143|NCT00417326|acute respiratory failure|acute respiratory failure
558144|NCT00417326|community-acquired pneumonia|community-acquired pneumonia
558146|NCT00417339|dialysis adequacy|dialysis adequacy
558147|NCT00417339|uremic retention solute|uremic retention solute
558148|NCT00417352|no intervention|no intervention
558149|NCT00417352|bracing restricted forearm and wrist movement|bracing restricted forearm and wrist movement
558150|NCT00417352|bracing with added mass near elbow|bracing with added mass near elbow
558151|NCT00417352|bracing with added mass near wrist|bracing with added mass near wrist
558152|NCT00417365|odor|odor
558153|NCT00417365|douching|douching
558155|NCT00417365|vaginitis|vaginitis
558156|NCT00417365|vaginal|vaginal
558157|NCT00417365|yeast|yeast
558158|NCT00417365|ecosystem|ecosystem
558159|NCT00417365|Lactobacilli|lactobacilli
558160|NCT00417365|Nugent|nugent
558161|NCT00417365|Amsel|amsel
558162|NCT00417378|ACS|acs
558163|NCT00417404|preterm|preterm
558164|NCT00417404|nutrition|nutrition
558165|NCT00417404|vitamin A|vitamin a
558166|NCT00417404|electroretinogram|electroretinogram
558167|NCT00417404|conjunctiva|conjunctiva
558168|NCT00417404|vitamin A status|vitamin a status
558169|NCT00417404|conjunctival health|conjunctival health
558170|NCT00417417|Endothelium|endothelium
558171|NCT00417417|Inflammation|inflammation
558172|NCT00417417|Nitric Oxide|nitric oxide
558173|NCT00417417|Rilonacept|rilonacept
558174|NCT00417417|Cytokines|cytokines
558175|NCT00417417|Coronary Artery Disease|coronary artery disease
558176|NCT00417417|CAD|cad
558177|NCT00417417|Atherosclerosis|atherosclerosis
558178|NCT00417443|epidural|epidural
558179|NCT00417443|clonidine|clonidine
558180|NCT00417443|hyperalgesia|hyperalgesia
558181|NCT00417443|laparotomy|laparotomy
558182|NCT00417456|Acne|acne
558183|NCT00417456|Telemedicine|telemedicine
558184|NCT00417456|Dermatology|dermatology
558185|NCT00417482|Risperidone treatment, psychosis, agitation, aggression,|risperidone treatment, psychosis, agitation, aggression,
558186|NCT00417482|discontinuation, placebo|discontinuation, placebo
558187|NCT00417495|adenocarcinoma, breast, multifocal lesions, surgery|adenocarcinoma, breast, multifocal lesions, surgery
558188|NCT00417508|function|function
558189|NCT00417508|elderly|elderly
558190|NCT00417508|ADL|adl
558191|NCT00417508|nutritional supplementation|nutritional supplementation
558192|NCT00417508|Quality of life|quality of life
558193|NCT00417508|handgrip strength|handgrip strength
558194|NCT00417508|Body Composition|body composition
558195|NCT00417521|Adolescents|adolescents
558196|NCT00417521|Anorexia|anorexia
558197|NCT00417521|Eating disorder|eating disorder
558198|NCT00417521|Family therapy|family therapy
558199|NCT00417534|Coronary Disease|coronary disease
558200|NCT00417534|Inflammation|inflammation
558202|NCT00417534|HLA Antigens|hla antigens
558203|NCT00417534|Aortic Valve|aortic valve
558204|NCT00417547|Self Concept|self concept
558205|NCT00417547|Eating Disorder|eating disorder
557727|NCT00426712|HBV|hbv
558206|NCT00417547|Body Mass Index|body mass index
558207|NCT00417547|Dressing|dressing
558208|NCT00417547|Islamic Veil|islamic veil
558209|NCT00417560|Influenza A/H5N1|influenza a/h5n1
558210|NCT00417560|vaccine|vaccine
558211|NCT00417560|avian influenza H5N1|avian influenza h5n1
558212|NCT00417560|H5N1|h5n1
558213|NCT00417573|Immunodeficiency|immunodeficiency
558214|NCT00417573|Gammaglobulin|gammaglobulin
558215|NCT00417573|IgG subclass deficiency with recurrent infections|igg subclass deficiency with recurrent infections
558216|NCT00417586|Stroke|stroke
558217|NCT00417599|Prevention of overweight|prevention of overweight
558218|NCT00417599|Prevention of obesity|prevention of obesity
558219|NCT00417599|Treatment of overweight|treatment of overweight
558220|NCT00417599|Treatment of obesity|treatment of obesity
558221|NCT00417612|Rickets, Hypophosphatemia|rickets, hypophosphatemia
558316|NCT00417989|Sensor|sensor
558222|NCT00417612|Rickets, Vitamin D-Resistant|rickets, vitamin d-resistant
558223|NCT00417612|Rickets, X-linked hypophosphatemic|rickets, x-linked hypophosphatemic
558224|NCT00417625|Coronary Artery Perfusion|coronary artery perfusion
558225|NCT00417625|MRI|mri
558226|NCT00417625|Fractional Flow Reserve|fractional flow reserve
558227|NCT00417625|Coronary Flow Reserve|coronary flow reserve
558228|NCT00417625|Collateral Artery Perfusion|collateral artery perfusion
558229|NCT00417625|Cardiovascular Disease|cardiovascular disease
558230|NCT00417625|Coronary Artery Disease|coronary artery disease
558231|NCT00417625|CAD|cad
558232|NCT00417638|myocardial infarction|myocardial infarction
558233|NCT00417638|acute intervention|acute intervention
558234|NCT00417638|percutaneous intervention|percutaneous intervention
558235|NCT00417638|endovascular cooling|endovascular cooling
558236|NCT00417638|endovascular rewarming|endovascular rewarming
558237|NCT00417651|Bacterial|bacterial
558238|NCT00417651|contamination|contamination
558239|NCT00417651|gastrotomy|gastrotomy
558240|NCT00417651|Complications|complications
558241|NCT00417664|cardiac surgery|cardiac surgery
558242|NCT00417664|valvular surgery|valvular surgery
558243|NCT00417664|delirium|delirium
558244|NCT00417664|postoperative delirium|postoperative delirium
558245|NCT00417664|cognitive dysfunction|cognitive dysfunction
558246|NCT00417664|altered mental status|altered mental status
558247|NCT00417677|Advanced Renal Carcinoma|advanced renal carcinoma
558249|NCT00417690|Acute Flare|acute flare
558250|NCT00417690|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
558251|NCT00417690|Ileocecal distribution|ileocecal distribution
558252|NCT00417703|Intraocular Pressure|intraocular pressure
558253|NCT00417703|Intravitreous Injection|intravitreous injection
558254|NCT00417703|Ranibizumab|ranibizumab
558255|NCT00417716|Diffuse Diabetic Macular Edema|diffuse diabetic macular edema
558256|NCT00417716|Intravitreal Bevacizumab|intravitreal bevacizumab
558257|NCT00417716|Anti-VEGF drugs|anti-vegf drugs
558258|NCT00417729|Diabetes|diabetes
558259|NCT00417729|Acarobse|acarobse
558260|NCT00417729|Metformin|metformin
558261|NCT00417729|oxidative stress|oxidative stress
558262|NCT00417729|Mean amplitude Glycemic Excursion|mean amplitude glycemic excursion
558263|NCT00417729|Meal test|meal test
558264|NCT00417742|headache|headache
558265|NCT00417742|migraine headache|migraine headache
558266|NCT00417742|tension headache|tension headache
558267|NCT00417755|Nutritional intake|nutritional intake
558268|NCT00417755|Mechanical ventilation|mechanical ventilation
558269|NCT00417755|Enteral feeding|enteral feeding
558270|NCT00417768|tissue plasminogen activator|tissue plasminogen activator
558271|NCT00417768|intraabdominal|intraabdominal
558272|NCT00417768|abscess|abscess
558273|NCT00417768|percutaneous drainage|percutaneous drainage
558274|NCT00417781|ADHD, adolescence, family study, endophenotype, outcome|adhd, adolescence, family study, endophenotype, outcome
558275|NCT00417794|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
558276|NCT00417794|ADHD|adhd
558277|NCT00417794|fetal alcohol syndrome|fetal alcohol syndrome
558278|NCT00417794|FAS|fas
558279|NCT00417794|FASD|fasd
558280|NCT00417794|atomoxetine hcl|atomoxetine hcl
558281|NCT00417807|refractory desmoplastic small round cell tumors|refractory desmoplastic small round cell tumors
558282|NCT00417807|PDGF-R|pdgf-r
558283|NCT00417820|Safety, tolerability, pharmacodynamics, single administration, BCT194, healthy volunteers, psoriasis|safety, tolerability, pharmacodynamics, single administration, bct194, healthy volunteers, psoriasis
558284|NCT00417846|Age-Related Macular Degeneration|age-related macular degeneration
558285|NCT00417846|Optical Coherence Tomography, OCT|optical coherence tomography, oct
558286|NCT00417846|Preferential Hyperacuity Perimeter, PHP|preferential hyperacuity perimeter, php
558287|NCT00417846|Amsler Grid|amsler grid
558288|NCT00417872|Clostridium difficile|clostridium difficile
558289|NCT00417898|Stroke|stroke
558290|NCT00417898|Cerebral Ischemia|cerebral ischemia
558291|NCT00417898|Tissue Plasminogen Activator|tissue plasminogen activator
558292|NCT00417898|Aspirin|aspirin
558293|NCT00417898|Human|human
557903|NCT00416624|anemia|anemia
558294|NCT00417898|Cerebral Reperfusion|cerebral reperfusion
558295|NCT00417911|multiple myeloma|multiple myeloma
558296|NCT00417911|autologous stem cell transplantation|autologous stem cell transplantation
558297|NCT00417911|high-dose melphalan|high-dose melphalan
558298|NCT00417911|bortezomib|bortezomib
558299|NCT00417911|consolidation|consolidation
558300|NCT00417911|event free survival|event free survival
558301|NCT00417911|phase III|phase iii
558302|NCT00417924|Patient education|patient education
558303|NCT00417924|Patient satisfaction|patient satisfaction
558304|NCT00417924|Eye health|eye health
558305|NCT00417950|diabetes|diabetes
558306|NCT00417950|acarbose|acarbose
558307|NCT00417950|alcohol|alcohol
558308|NCT00417950|inflammation|inflammation
558309|NCT00417950|oxidative stress|oxidative stress
558310|NCT00417950|Mild diabetes mellitus|mild diabetes mellitus
558311|NCT00417963|Carotid|carotid
558312|NCT00417963|Artery|artery
558313|NCT00417963|Stenosis|stenosis
558314|NCT00417976|Advanced Pancreatic Cancer|advanced pancreatic cancer
558315|NCT00417989|Glycemic control|glycemic control
558317|NCT00418002|Single-rising dose , multiple rising dose, elderly, cognitive, , pharmacokinetic, impairment.|single-rising dose , multiple rising dose, elderly, cognitive, , pharmacokinetic, impairment.
558318|NCT00418002|Healthy elderly male and female subjects|healthy elderly male and female subjects
558319|NCT00418015|µ-opioid receptor|µ-opioid receptor
558320|NCT00418015|neuraxial labor analgesia|neuraxial labor analgesia
558321|NCT00418015|pharmacogenetics|pharmacogenetics
558322|NCT00418028|capecitabine|capecitabine
558324|NCT00418028|breast cancer|breast cancer
558325|NCT00418067|Coronary Artery Disease|coronary artery disease
558326|NCT00418067|Stent|stent
558327|NCT00418093|mullerian carcinoma|mullerian carcinoma
558328|NCT00418106|Premature birth|premature birth
558329|NCT00418106|Pumping breast milk|pumping breast milk
558330|NCT00418106|Kangaroo holding|kangaroo holding
558331|NCT00418132|SSc|ssc
558332|NCT00418132|Systemic Sclerosis|systemic sclerosis
558333|NCT00418132|Progressive Systemic Sclerosis|progressive systemic sclerosis
558334|NCT00418145|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
558335|NCT00418158|Pulmonary complications|pulmonary complications
558336|NCT00418184|ADHD|adhd
558337|NCT00418184|inattentive|inattentive
558338|NCT00418184|impulsive|impulsive
558339|NCT00418184|hyperactive|hyperactive
558340|NCT00418184|poor academic performance|poor academic performance
558341|NCT00418184|poor self-discipline|poor self-discipline
558342|NCT00418184|low self-esteem|low self-esteem
558343|NCT00418197|spinal stenosis|spinal stenosis
558344|NCT00418197|low back pain|low back pain
558345|NCT00418197|spondylolisthesis|spondylolisthesis
558346|NCT00418197|lumbar spinal stenosis|lumbar spinal stenosis
558347|NCT00418197|leg pain|leg pain
558348|NCT00418197|spinal diseases|spinal diseases
558349|NCT00418210|Accelerated Partial Breast Irradiation|accelerated partial breast irradiation
558350|NCT00418210|Conformal Radiation Therapy|conformal radiation therapy
558351|NCT00418210|Feasibility|feasibility
558352|NCT00418210|Early breast cancer|early breast cancer
558353|NCT00418223|Urinary retention|urinary retention
558354|NCT00418223|Child birth|child birth
558355|NCT00418223|Catheterization|catheterization
558356|NCT00418223|Ultrasound|ultrasound
558357|NCT00418249|Androgenetic Alopecia|androgenetic alopecia
558358|NCT00418249|Telogen effluvium|telogen effluvium
558359|NCT00418249|Chronic telogen effluvium|chronic telogen effluvium
558360|NCT00418249|Menopause|menopause
558361|NCT00418249|Female Androgenetic Alopecia (FAGA)|female androgenetic alopecia (faga)
558362|NCT00418262|fetal alcohol syndrome|fetal alcohol syndrome
558363|NCT00418262|attention deficit disorder|attention deficit disorder
558364|NCT00418262|attention deficit disorder with hyperactivity|attention deficit disorder with hyperactivity
558365|NCT00418262|ADD|add
558366|NCT00418262|FAS|fas
558367|NCT00418262|FASD|fasd
558368|NCT00418262|ADHD|adhd
558369|NCT00418275|Cerebrovascular Stroke|cerebrovascular stroke
558370|NCT00418288|GLP-1|glp-1
558371|NCT00418288|glucose metabolism|glucose metabolism
558372|NCT00418288|Type 2 diabetes|type 2 diabetes
558373|NCT00418288|brain|brain
558374|NCT00418288|PET|pet
558375|NCT00418301|Pain|pain
558376|NCT00418301|Neurostimulation|neurostimulation
558377|NCT00418327|Tarceva|tarceva
558378|NCT00418327|refractory and relapsed malignant brain tumors|refractory and relapsed malignant brain tumors
558379|NCT00418327|newly diagnosed brain stem glioma|newly diagnosed brain stem glioma
558380|NCT00418340|Irritable Bowel Syndrome,|irritable bowel syndrome,
558381|NCT00418340|Visceral hypersensitivity,|visceral hypersensitivity,
558382|NCT00418340|probiotic therapy,|probiotic therapy,
558383|NCT00418340|immune response|immune response
558384|NCT00418353|Antenatal corticosteroids|antenatal corticosteroids
558385|NCT00418353|Betamethasone|betamethasone
558386|NCT00418353|Dexamethasone|dexamethasone
558387|NCT00418353|Premature|premature
558388|NCT00418366|Mild, moderate, severe renal insufficiency|mild, moderate, severe renal insufficiency
558389|NCT00418366|End stage renal disease|end stage renal disease
558390|NCT00418379|Sublingual immunotherapy|sublingual immunotherapy
558391|NCT00418379|Grass pollen tablet|grass pollen tablet
558392|NCT00418379|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
558393|NCT00418392|pneumothorax, aspiration, minocycline, pleurodesis|pneumothorax, aspiration, minocycline, pleurodesis
558394|NCT00418405|Arthritis, Rheumatoid|arthritis, rheumatoid
558395|NCT00418405|Cohort Studies|cohort studies
558396|NCT00418418|Cell transplantation|cell transplantation
558397|NCT00418418|Heart failure|heart failure
558398|NCT00418418|Clinical trials|clinical trials
558399|NCT00418444|Breast cancer,group psychotherapy,RCT,women's mental health|breast cancer,group psychotherapy,rct,women's mental health
558400|NCT00418457|Breast Cancer|breast cancer
558401|NCT00418457|Anesthesia; regional|anesthesia; regional
558402|NCT00418457|cancer recurrence|cancer recurrence
558403|NCT00418457|Anesthesia; inhalational|anesthesia; inhalational
558404|NCT00418457|Analgesia; opioid|analgesia; opioid
558405|NCT00418470|Cystic fibrosis|cystic fibrosis
558406|NCT00418470|Catheterization, peripheral|catheterization, peripheral
558407|NCT00418470|Phlebitis|phlebitis
558408|NCT00418470|Anti-Bacterial Agents|anti-bacterial agents
558409|NCT00418470|Osmolar Concentration|osmolar concentration
558410|NCT00418483|thrombolytic|thrombolytic
558411|NCT00418483|thrombolysis|thrombolysis
558412|NCT00418483|acute peripheral arterial occlusion|acute peripheral arterial occlusion
558413|NCT00418483|peripheral vascular disease|peripheral vascular disease
558414|NCT00418483|thrombosis|thrombosis
558415|NCT00418483|endovascular|endovascular
558416|NCT00418496|Unresectable|unresectable
558417|NCT00418496|Metastatic|metastatic
558418|NCT00418509|Dose proportionality|dose proportionality
558419|NCT00418509|pharmacokinetics|pharmacokinetics
558420|NCT00418509|mometasone|mometasone
558421|NCT00418509|formoterol|formoterol
558422|NCT00418509|Healthy volunteers study|healthy volunteers study
558423|NCT00418522|Insulin Glargine Diabetes HbA1c|insulin glargine diabetes hba1c
558424|NCT00418535|Lymphoma, NK/T-Cell|lymphoma, nk/t-cell
558426|NCT00418561|MLD|mld
558427|NCT00418561|Metazym|metazym
558428|NCT00418574|Ovarian cancer|ovarian cancer
558429|NCT00418574|Abagovomab|abagovomab
558430|NCT00418587|Vitamin D|vitamin d
558431|NCT00418587|Lupus|lupus
558432|NCT00418600|Secondary Hyperparathyroidism|secondary hyperparathyroidism
558433|NCT00418600|Hectorol® (doxercalciferol capsules)|hectorol® (doxercalciferol capsules)
558434|NCT00418600|Hectorol® (doxercalciferol injection)|hectorol® (doxercalciferol injection)
558436|NCT00418626|hepatic impairment|hepatic impairment
558437|NCT00418626|Child-Pugh scale|child-pugh scale
558438|NCT00418626|PK|pk
558439|NCT00418626|healthy, subject(s)|healthy, subject(s)
558440|NCT00418626|Subjects with impaired hepatic function and healthy subjects|subjects with impaired hepatic function and healthy subjects
558441|NCT00418639|Chronic Hepatitis C|chronic hepatitis c
558442|NCT00418652|Normal Controls|normal controls
558443|NCT00418665|Revlimid|revlimid
558444|NCT00418665|Lenalidomide|lenalidomide
558445|NCT00418665|Low Platelet Count|low platelet count
558446|NCT00418665|Low Risk Myelodysplastic Syndrome|low risk myelodysplastic syndrome
558447|NCT00418665|Intermediate 1 Myelodysplastic Syndrome|intermediate 1 myelodysplastic syndrome
558448|NCT00418665|MDS|mds
558449|NCT00418665|Myelodysplastic Syndrome|myelodysplastic syndrome
558450|NCT00418691|Brain Tumor|brain tumor
558451|NCT00418691|Methylphenidate|methylphenidate
558452|NCT00418691|Ritalin|ritalin
558453|NCT00418691|Modafinil|modafinil
558454|NCT00418691|Provigil|provigil
558455|NCT00418691|Fatigue|fatigue
558456|NCT00418691|Concentration|concentration
558457|NCT00418704|cancer|cancer
558458|NCT00418704|Lung cancer|lung cancer
558459|NCT00418704|None small-cell lung cancer|none small-cell lung cancer
558460|NCT00418730|androgenetic alopecia|androgenetic alopecia
558461|NCT00418730|male pattern hair loss|male pattern hair loss
558462|NCT00418730|male pattern baldness|male pattern baldness
558463|NCT00418730|androgenetic alopecia or male pattern hair loss|androgenetic alopecia or male pattern hair loss
558464|NCT00418743|cancer|cancer
558465|NCT00418743|Lung cancer|lung cancer
558466|NCT00418743|small-cell lung cancer|small-cell lung cancer
558467|NCT00418756|nilotinib|nilotinib
558468|NCT00418756|Rifampin|rifampin
558469|NCT00418756|PK|pk
558470|NCT00418756|healthy subjects|healthy subjects
558471|NCT00418769|nilotinib|nilotinib
558472|NCT00418769|bioavailability|bioavailability
558473|NCT00418769|tablet|tablet
558474|NCT00418769|capsule|capsule
558475|NCT00418769|PK|pk
558476|NCT00418769|healthy, subject(s),|healthy, subject(s),
558477|NCT00418795|Acute Intermittent Porphyria|acute intermittent porphyria
558478|NCT00418795|treatment|treatment
558479|NCT00418795|Acute attack|acute attack
558480|NCT00418808|motor|motor
558481|NCT00418808|development|development
558482|NCT00418808|multiple pregnancies|multiple pregnancies
558483|NCT00418808|general movement|general movement
558484|NCT00418808|video recording|video recording
558485|NCT00418847|pediatrics|pediatrics
558486|NCT00418847|lysosomal storage diseases|lysosomal storage diseases
558487|NCT00418847|Gangliosidoses GM2|gangliosidoses gm2
558488|NCT00418847|Tay-Sachs disease|tay-sachs disease
558489|NCT00418847|Sandhoff disease|sandhoff disease
558490|NCT00418847|Infantile GM2-activator deficiency|infantile gm2-activator deficiency
558492|NCT00418860|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
558493|NCT00418860|Stent thrombosis|stent thrombosis
558494|NCT00418860|Zotarolimus-eluting stent|zotarolimus-eluting stent
558495|NCT00418873|schizophrenia|schizophrenia
558496|NCT00418873|zotepine|zotepine
558497|NCT00418873|risperidone|risperidone
558498|NCT00418873|second generation antipsychotic|second generation antipsychotic
558499|NCT00418886|NSCLC|nsclc
558500|NCT00418886|Non Small Cell Lung Cancer|non small cell lung cancer
558501|NCT00418899|Brain Tumor|brain tumor
558502|NCT00418899|Glioma|glioma
558503|NCT00418899|Linkage Study|linkage study
558504|NCT00418899|Survey|survey
558505|NCT00418899|Gliogene|gliogene
558506|NCT00418899|High-risk familial brain tumor pedigrees|high-risk familial brain tumor pedigrees
558507|NCT00426777|prostate cancer|prostate cancer
558508|NCT00426777|prostatic adenoma|prostatic adenoma
558509|NCT00426777|prostatic neoplasm|prostatic neoplasm
558510|NCT00426816|primary insomnia|primary insomnia
558511|NCT00426816|PSG sleep recordings|psg sleep recordings
558512|NCT00426816|daytime cognitive function|daytime cognitive function
558513|NCT00426816|Insomnia|insomnia
558514|NCT00426816|SB-649868|sb-649868
558515|NCT00426829|Liver Cancer|liver cancer
558516|NCT00426829|Biliary Tract|biliary tract
558517|NCT00426829|Hepatocellular Carcinoma|hepatocellular carcinoma
558518|NCT00426829|Cholangiocarcinoma|cholangiocarcinoma
558519|NCT00426829|Bevacizumab|bevacizumab
558520|NCT00426829|Proton Therapy|proton therapy
558521|NCT00426829|Radiation Therapy|radiation therapy
558524|NCT00426829|Proton RT|proton rt
558525|NCT00426829|Avastin|avastin
558526|NCT00426829|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
558527|NCT00426829|rhuMAb-VEGF|rhumab-vegf
558528|NCT00426842|Blood pressure|blood pressure
558529|NCT00426842|Orthostatic hypotension|orthostatic hypotension
558530|NCT00426842|Spinal Cord Injury|spinal cord injury
558531|NCT00426842|Sympathetic vascular control|sympathetic vascular control
558532|NCT00426842|Midodrine|midodrine
558533|NCT00426855|Lymphoma, Non-Hodgkin, Low-Grade|lymphoma, non-hodgkin, low-grade
558534|NCT00426868|ADRC|adrc
558535|NCT00426868|Stem Cells|stem cells
558536|NCT00426868|chronic ischemia|chronic ischemia
558537|NCT00426868|heart disease|heart disease
558538|NCT00426868|coronary artery disease|coronary artery disease
558539|NCT00426868|inducible reversible ischemia|inducible reversible ischemia
558540|NCT00426881|Exercise|exercise
558541|NCT00426881|Resistance training|resistance training
558542|NCT00426894|surveillance cultures|surveillance cultures
558543|NCT00426894|children|children
558544|NCT00426894|cardiac surgery|cardiac surgery
558545|NCT00426894|perioperative prophylaxis|perioperative prophylaxis
558546|NCT00426907|Osteoarthritis, Knee|osteoarthritis, knee
558547|NCT00426907|Osteotomy|osteotomy
558548|NCT00426907|Healing|healing
558549|NCT00426907|Rehabilitation|rehabilitation
558550|NCT00426907|Roentgen Stereometric Analysis|roentgen stereometric analysis
558551|NCT00426920|pharmacokinetics|pharmacokinetics
558552|NCT00426920|pharmacodynamics|pharmacodynamics
558553|NCT00426920|inhaled|inhaled
558554|NCT00426920|recombinant human insulin|recombinant human insulin
558555|NCT00426933|cSSSI|csssi
558556|NCT00426933|MRSA|mrsa
558557|NCT00426946|Depression Children Reboxetine|depression children reboxetine
558558|NCT00426946|A diagnosis of major depressive disorder or a dysthimic disorder according to DSM-IV-TR.|a diagnosis of major depressive disorder or a dysthimic disorder according to dsm-iv-tr.
558559|NCT00426946|Drug naïve or without chronic medication for at least one month.|drug naïve or without chronic medication for at least one month.
558560|NCT00426946|Only children who agree to participate and whose parents will sign and informed consent form will be included.|only children who agree to participate and whose parents will sign and informed consent form will be included.
558561|NCT00426959|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
558562|NCT00426959|PSA of less than 10 ng/mL|psa of less than 10 ng/ml
558563|NCT00426959|Combined Gleason score 6 or less|combined gleason score 6 or less
558564|NCT00426959|International Prostate Symptom Score (IPSS) must <or= to 18|international prostate symptom score (ipss) must <or= to 18
558565|NCT00426985|Tendonitis|tendonitis
558566|NCT00426985|Bursitis|bursitis
558567|NCT00426985|Pain|pain
558568|NCT00426985|Shoulder Pain|shoulder pain
558569|NCT00426985|Elbow Pain|elbow pain
558570|NCT00426985|Knee Pain|knee pain
558571|NCT00426985|Tendon Injury|tendon injury
558572|NCT00426985|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
558573|NCT00426998|Choroidal neovascularization due to age-related macular degeneration|choroidal neovascularization due to age-related macular degeneration
558574|NCT00427024|renal transplantation|renal transplantation
558575|NCT00427024|acute rejection|acute rejection
558576|NCT00427024|transport|transport
558577|NCT00427024|transporter|transporter
720927|NCT01051349|MS|ms
558578|NCT00427024|acute rejection after renal transplantation|acute rejection after renal transplantation
558579|NCT00427037|Vitamin D deficiency|vitamin d deficiency
558580|NCT00427037|Chronic Kidney Disease|chronic kidney disease
558581|NCT00427050|Actinic Keratoses (AK)|actinic keratoses (ak)
558582|NCT00427050|PEP005|pep005
558583|NCT00427050|Topical|topical
558585|NCT00427063|retinal vessels|retinal vessels
558586|NCT00427063|tortuosity|tortuosity
558587|NCT00427076|vancomycin|vancomycin
558588|NCT00427076|cotrimoxazole|cotrimoxazole
558589|NCT00427076|trimethoprim/ sulfamethoxazole|trimethoprim/ sulfamethoxazole
558590|NCT00427076|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
558591|NCT00427076|Health care association infections|health care association infections
558592|NCT00427076|MRSA bacteremia or other microbiologically documented MRSA infections (defined clinically by CDC criteria)|mrsa bacteremia or other microbiologically documented mrsa infections (defined clinically by cdc criteria)
558593|NCT00427076|Suspected neurosurgical meningitis|suspected neurosurgical meningitis
558594|NCT00427076|Sepsis during hemodialysis, catheter-associated and catheter-related infections|sepsis during hemodialysis, catheter-associated and catheter-related infections
558595|NCT00427076|Ventilator-associated pneumonia|ventilator-associated pneumonia
558596|NCT00427076|Surgical site infection in the presence of a foreign body|surgical site infection in the presence of a foreign body
558597|NCT00427089|Colon cleansing|colon cleansing
558598|NCT00427089|Polyethylene Glycol|polyethylene glycol
558599|NCT00427089|Sodium Phosphate|sodium phosphate
558600|NCT00427102|Oral MRX-1024|oral mrx-1024
558601|NCT00427102|High-Dose Cisplatin Chemotherapy|high-dose cisplatin chemotherapy
558602|NCT00427102|Standard Radiation Therapy|standard radiation therapy
558603|NCT00427297|HIV-1|hiv-1
558605|NCT00427297|nevirapine|nevirapine
558606|NCT00427297|HAART|haart
558607|NCT00427297|Resistance|resistance
558608|NCT00427297|Treatment Naive|treatment naive
558609|NCT00427310|stage I colon cancer|stage i colon cancer
558610|NCT00427310|stage II colon cancer|stage ii colon cancer
558611|NCT00427310|stage III colon cancer|stage iii colon cancer
558612|NCT00427310|adenocarcinoma of the colon|adenocarcinoma of the colon
558613|NCT00427323|sleep|sleep
558614|NCT00427323|aging|aging
558615|NCT00427323|biological rhythm|biological rhythm
558616|NCT00427323|melatonin|melatonin
558618|NCT00427323|early morning awakening|early morning awakening
558619|NCT00427323|daytime sleepiness|daytime sleepiness
558620|NCT00427323|difficulty maintaining sleep|difficulty maintaining sleep
558621|NCT00427323|sleep maintenance insomnia|sleep maintenance insomnia
558622|NCT00427336|Severe Aplastic Anemia|severe aplastic anemia
558623|NCT00427336|Bone Marrow Failure|bone marrow failure
558624|NCT00427336|Stem Cell Transplantation|stem cell transplantation
558625|NCT00427336|Fludarabine|fludarabine
558626|NCT00427336|Cyclophosphamide|cyclophosphamide
558627|NCT00427336|Antithymocyte Globulin|antithymocyte globulin
558628|NCT00427336|SAA|saa
558629|NCT00427336|ATG|atg
558630|NCT00427336|Cytoxan|cytoxan
558631|NCT00427336|Neosar|neosar
558632|NCT00427336|Fludarabine Phosphate|fludarabine phosphate
558633|NCT00427336|Thymoglobulin|thymoglobulin
558634|NCT00427349|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
558635|NCT00427349|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
558636|NCT00427349|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
558637|NCT00427349|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
558638|NCT00427349|gastrinoma|gastrinoma
558639|NCT00427349|insulinoma|insulinoma
558640|NCT00427349|WDHA syndrome|wdha syndrome
558641|NCT00427349|glucagonoma|glucagonoma
558642|NCT00427349|pancreatic polypeptide tumor|pancreatic polypeptide tumor
558643|NCT00427349|somatostatinoma|somatostatinoma
558644|NCT00427349|recurrent islet cell carcinoma|recurrent islet cell carcinoma
558645|NCT00427349|neuroendocrine tumor|neuroendocrine tumor
558646|NCT00427375|Rectal cancer surgery|rectal cancer surgery
558647|NCT00427375|Neoadjuvant radiochemotherapy|neoadjuvant radiochemotherapy
558648|NCT00427375|Randomized clinical trial|randomized clinical trial
558649|NCT00427375|Multicenter study|multicenter study
558650|NCT00427388|Cardiac Surgical Procedures|cardiac surgical procedures
558651|NCT00427388|Cardiopulmonary Bypass|cardiopulmonary bypass
558652|NCT00427388|Systemic inflammatory Response Syndrome|systemic inflammatory response syndrome
558653|NCT00427388|Steroid|steroid
558654|NCT00427388|Myocardial Infarction|myocardial infarction
558655|NCT00427388|Randomized Clinical Trial|randomized clinical trial
558656|NCT00427414|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
558657|NCT00427414|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
558658|NCT00427427|non-metastatic breast cancer|non-metastatic breast cancer
558659|NCT00427427|HER-2 positive breast cancer|her-2 positive breast cancer
558660|NCT00427427|Herceptin (trastuzumab)|herceptin (trastuzumab)
558661|NCT00427427|delayed adjuvant therapy|delayed adjuvant therapy
558662|NCT00427427|acceptability rate|acceptability rate
558663|NCT00427427|non-metastatic, HER-2 positive breast cancer|non-metastatic, her-2 positive breast cancer
558664|NCT00427440|Glioma|glioma
558665|NCT00427440|Brain Tumor|brain tumor
558666|NCT00427453|Mycobacterium tuberculosis|mycobacterium tuberculosis
558667|NCT00427453|85A antigen|85a antigen
558668|NCT00427453|Recombinant Modified Vaccinia Virus Ankara|recombinant modified vaccinia virus ankara
558669|NCT00427453|Phase I study|phase i study
558670|NCT00427453|Immunogenicity|immunogenicity
558671|NCT00427453|BCG|bcg
558672|NCT00427479|Allergy|allergy
558673|NCT00427479|Food|food
558674|NCT00427479|Hay fever|hay fever
558676|NCT00427505|Interaction|interaction
558677|NCT00427505|healthy volunteers|healthy volunteers
558678|NCT00427505|deferasirox|deferasirox
558679|NCT00427505|midazolam|midazolam
558680|NCT00427531|hot flashes|hot flashes
558681|NCT00427544|Uterine leiomyomata (Fibroids)|uterine leiomyomata (fibroids)
558682|NCT00427557|Multiple Myeloma|multiple myeloma
558683|NCT00427557|Acute Myeloid Leukemia|acute myeloid leukemia
558684|NCT00427557|Myelodysplastic Syndrome|myelodysplastic syndrome
558685|NCT00427557|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
558686|NCT00427557|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
558687|NCT00427557|Hodgkin's Lymphoma|hodgkin's lymphoma
558688|NCT00427557|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
558689|NCT00427557|Cellular Therapy|cellular therapy
558690|NCT00427557|Umbilical Cord Blood Cells|umbilical cord blood cells
558691|NCT00427557|Cord Blood Transplantation|cord blood transplantation
558692|NCT00427557|Stem Cells|stem cells
558693|NCT00427557|Stem Cell Transplantation|stem cell transplantation
558694|NCT00427557|Allogeneic|allogeneic
558695|NCT00427557|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
558696|NCT00427557|Graft vs. Host Disease|graft vs. host disease
558698|NCT00427557|Fludarabine|fludarabine
558699|NCT00427557|Fludarabine Phosphate|fludarabine phosphate
558701|NCT00427557|Melphalan|melphalan
558702|NCT00427557|Rituximab|rituximab
558703|NCT00427557|Rituxan|rituxan
558704|NCT00427557|Leukemia|leukemia
558705|NCT00427557|Lymphoma|lymphoma
558706|NCT00427570|stage II colon cancer|stage ii colon cancer
558707|NCT00427570|stage III colon cancer|stage iii colon cancer
558708|NCT00427583|Malignant,|malignant,
558709|NCT00427583|peripheral,|peripheral,
558710|NCT00427583|nerve sheath tumors,|nerve sheath tumors,
558711|NCT00427583|MPNST,|mpnst,
558712|NCT00427583|neurofibromatosis,|neurofibromatosis,
558713|NCT00427583|NF1,|nf1,
558714|NCT00427583|Imatinib mesylate|imatinib mesylate
558715|NCT00427596|GW427353 oral tablets,|gw427353 oral tablets,
558716|NCT00427596|healthy adult subjects,|healthy adult subjects,
558717|NCT00427596|food effect|food effect
558718|NCT00427609|Treatment|treatment
558719|NCT00427609|Psoriasis|psoriasis
558720|NCT00427609|efficacy|efficacy
558721|NCT00427609|Bicillin|bicillin
558722|NCT00427622|hot flashes|hot flashes
558723|NCT00427635|neonates|neonates
558724|NCT00427635|infants|infants
558725|NCT00427635|GERD|gerd
558726|NCT00427635|reflux|reflux
558727|NCT00427648|Administration, Intravesical|administration, intravesical
558728|NCT00427648|Anesthetics, Local|anesthetics, local
558729|NCT00427661|Sickle Cell Disease|sickle cell disease
558730|NCT00427661|Thalassemia|thalassemia
558731|NCT00427661|Hemoglobinopathies|hemoglobinopathies
558732|NCT00427674|Parkinson|parkinson
558733|NCT00427674|Imaging|imaging
558734|NCT00427700|Polycystic Ovary Syndrome|polycystic ovary syndrome
558735|NCT00427700|clomiphene citrate|clomiphene citrate
558736|NCT00427700|Raloxifene|raloxifene
558737|NCT00427713|adenocarcinoma of the rectum|adenocarcinoma of the rectum
558738|NCT00427713|stage III rectal cancer|stage iii rectal cancer
558739|NCT00427713|stage II rectal cancer|stage ii rectal cancer
558740|NCT00427726|Gene Transfer|gene transfer
558741|NCT00427726|Hematopoietic Stem Cells|hematopoietic stem cells
558742|NCT00427726|Follow-Up|follow-up
558743|NCT00427739|Axial Flow Ventricular Assist Device|axial flow ventricular assist device
558744|NCT00427739|Cardiac CT|cardiac ct
558745|NCT00427739|Stage IV heart failure|stage iv heart failure
558746|NCT00427752|Transgastric|transgastric
558747|NCT00427752|Endoluminal|endoluminal
558748|NCT00427752|Peritoneoscopy|peritoneoscopy
558749|NCT00427752|Diagnostic|diagnostic
558750|NCT00427752|Feasibility|feasibility
558751|NCT00427765|Multiple Myeloma|multiple myeloma
558752|NCT00427765|Hodgkin's Disease|hodgkin's disease
558753|NCT00427765|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
558754|NCT00427765|Leukemia|leukemia
558755|NCT00427765|Lymphoma|lymphoma
558756|NCT00427765|Busulfan|busulfan
558757|NCT00427765|Melphalan|melphalan
558758|NCT00427765|Autologous bone marrow|autologous bone marrow
558760|NCT00427765|Peripheral blood stem cell transplant|peripheral blood stem cell transplant
558761|NCT00427765|PBSCT|pbsct
558762|NCT00427778|incontinence ring|incontinence ring
558763|NCT00427778|pessary|pessary
558764|NCT00427778|urinary incontinence|urinary incontinence
558765|NCT00427778|urodynamic study|urodynamic study
558766|NCT00427778|quality of life|quality of life
558767|NCT00427778|crossover trial|crossover trial
558768|NCT00427778|randomised trial|randomised trial
558769|NCT00427791|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
558770|NCT00427791|Leukemia|leukemia
558771|NCT00427791|Total Body Irradiation|total body irradiation
558772|NCT00427791|Etoposide|etoposide
558773|NCT00427791|Rituximab|rituximab
558774|NCT00427791|Rituxan|rituxan
558775|NCT00427791|TBI|tbi
558776|NCT00427791|ALL|all
558777|NCT00427804|Calcium absorption|calcium absorption
558778|NCT00427804|Vitamin D|vitamin d
558779|NCT00427817|Adenoma, Prostatic|adenoma, prostatic
558780|NCT00427817|Prostate|prostate
558781|NCT00427817|Proteomics|proteomics
558782|NCT00427817|Urology|urology
558783|NCT00427830|Mycobacterium tuberculosis|mycobacterium tuberculosis
558784|NCT00427830|85A antigen|85a antigen
558785|NCT00427830|Recombinant Modified Vaccinia Ankara|recombinant modified vaccinia ankara
558786|NCT00427830|Phase I study|phase i study
558787|NCT00427830|Immunogenicity|immunogenicity
558788|NCT00427830|BCG|bcg
558789|NCT00427843|osteoarthritis|osteoarthritis
558790|NCT00427843|knee|knee
558791|NCT00427843|gait|gait
558792|NCT00427843|muscle strength|muscle strength
558793|NCT00427843|hip|hip
558794|NCT00427843|exercise|exercise
558795|NCT00427895|Vaccine|vaccine
558891|NCT00428246|Vitamin D|vitamin d
558796|NCT00427895|Pneumococcal Infections Prevention and Control|pneumococcal infections prevention and control
558797|NCT00427908|Meningococcal serogroups A, C, W-135 and/or Y diseases|meningococcal serogroups a, c, w-135 and/or y diseases
558798|NCT00427908|Conjugate vaccine|conjugate vaccine
558799|NCT00427908|Immunogenicity|immunogenicity
558800|NCT00427908|Meningococcal vaccine|meningococcal vaccine
558801|NCT00427908|Persistence|persistence
558802|NCT00427908|Non-inferiority|non-inferiority
558803|NCT00427947|phantom limb pain|phantom limb pain
558804|NCT00427947|amputation|amputation
558805|NCT00427947|anesthetics, local|anesthetics, local
558806|NCT00427947|postoperative analgesia|postoperative analgesia
558807|NCT00427947|ropivacaine|ropivacaine
558808|NCT00427947|analgesia|analgesia
558809|NCT00427960|cholesterol|cholesterol
558810|NCT00427960|statin|statin
558812|NCT00427960|LDL-cholesterol|ldl-cholesterol
558813|NCT00427986|Diabetes|diabetes
558814|NCT00427986|Macular oedema|macular oedema
558815|NCT00427986|Osmosis|osmosis
558816|NCT00427986|Galactose|galactose
558817|NCT00427986|Intravenous|intravenous
558818|NCT00427986|Retinal thickness|retinal thickness
558819|NCT00427986|Starling|starling
558820|NCT00427999|Hormone-refractory|hormone-refractory
558821|NCT00427999|prostate cancer|prostate cancer
558822|NCT00427999|multitargeted|multitargeted
558823|NCT00427999|tyrosinkinase|tyrosinkinase
558824|NCT00428012|quality of life, kidney transplantation|quality of life, kidney transplantation
558825|NCT00428025|pancreatitis|pancreatitis
558826|NCT00428038|Infant, Premature|infant, premature
558827|NCT00428038|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
558828|NCT00428038|Asthma|asthma
558829|NCT00428051|Epidemiology|epidemiology
558830|NCT00428051|Surveillance|surveillance
558831|NCT00428051|Streptococcal Pneumonia|streptococcal pneumonia
558832|NCT00428064|Renal allograft|renal allograft
558833|NCT00428064|Renal|renal
558834|NCT00428064|Kidney|kidney
558835|NCT00428064|Transplant|transplant
558836|NCT00428077|Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia|philadelphia chromosome positive (ph+) chronic myelogenous leukemia
558837|NCT00428077|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
558838|NCT00428090|apolipoprotein E|apolipoprotein e
558839|NCT00428090|monotherapy|monotherapy
558840|NCT00428090|cognition|cognition
558841|NCT00428090|mild|mild
558842|NCT00428090|rosiglitazone|rosiglitazone
558843|NCT00428090|Alzheimer's disease|alzheimer's disease
558844|NCT00428090|moderate|moderate
558845|NCT00428103|Mitral valve regurgitation|mitral valve regurgitation
558846|NCT00428116|HIV-1|hiv-1
558847|NCT00428116|Pediatric|pediatric
558848|NCT00428116|HAART|haart
558849|NCT00428116|Treatment Naive|treatment naive
558850|NCT00428129|Acute Iliofemoral Deep Vein Thrombosis|acute iliofemoral deep vein thrombosis
558851|NCT00428142|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
558852|NCT00428142|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
558853|NCT00428142|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
558854|NCT00428142|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
558855|NCT00428142|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
558856|NCT00428142|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
558857|NCT00428155|hemostasis|hemostasis
558858|NCT00428155|angioplasty|angioplasty
558859|NCT00428155|stenting|stenting
558860|NCT00428155|closure device|closure device
558861|NCT00428155|angioseal|angioseal
558862|NCT00428155|starclose|starclose
558863|NCT00428168|Betahistine|betahistine
558864|NCT00428168|Weight Gain Control|weight gain control
558865|NCT00428168|Weight Gain due to Olanzapine Treatment|weight gain due to olanzapine treatment
558866|NCT00428168|Obesity|obesity
558248|NCT00417690|Crohn's Disease|crohn's disease
558867|NCT00428168|Schizophrenic disorder|schizophrenic disorder
558868|NCT00428181|Brief alcohol intervention|brief alcohol intervention
558869|NCT00428181|Booster session|booster session
558870|NCT00428181|Personalized feedback|personalized feedback
558871|NCT00428181|Motivational interview|motivational interview
558872|NCT00428181|Injury recidivism|injury recidivism
558873|NCT00428181|Psychological Interview|psychological interview
558874|NCT00428181|Risk Reduction Behaviors|risk reduction behaviors
558875|NCT00428194|stage IIA cervical cancer|stage iia cervical cancer
558876|NCT00428194|stage IB cervical cancer|stage ib cervical cancer
558877|NCT00428194|stage IIB cervical cancer|stage iib cervical cancer
558878|NCT00428194|stage III cervical cancer|stage iii cervical cancer
558879|NCT00428194|stage IVA cervical cancer|stage iva cervical cancer
558880|NCT00428194|cervical squamous cell carcinoma|cervical squamous cell carcinoma
558881|NCT00428207|type 1 diabetes, insulin pump therapy, glycemic stability|type 1 diabetes, insulin pump therapy, glycemic stability
558882|NCT00428220|Potentially other tumor types in the future|potentially other tumor types in the future
558884|NCT00428233|vaccine|vaccine
558885|NCT00428246|Chronic Kidney Disease|chronic kidney disease
558886|NCT00428246|Endothelial dysfunction|endothelial dysfunction
558887|NCT00428246|Inflammation|inflammation
558888|NCT00428246|Hypertension|hypertension
558889|NCT00428246|paricalcitol|paricalcitol
558890|NCT00428246|Blood pressure|blood pressure
558892|NCT00428246|Glomerular filtration rate|glomerular filtration rate
558893|NCT00428272|Monoclonal Antibody Lexatumumab|monoclonal antibody lexatumumab
558894|NCT00428272|Interferon Gamma|interferon gamma
558895|NCT00428272|Solid Tumor|solid tumor
558896|NCT00428272|Phase I|phase i
558897|NCT00428272|Malignant Tumor|malignant tumor
558898|NCT00428272|Metastatic Tumor|metastatic tumor
558899|NCT00428272|Pediatric Solid Tumor|pediatric solid tumor
558900|NCT00428272|Ewing Sarcoma|ewing sarcoma
558901|NCT00428272|Osteosarcoma|osteosarcoma
558902|NCT00428272|Neuroblastoma|neuroblastoma
558903|NCT00428272|Rhabdomyosarcoma|rhabdomyosarcoma
558904|NCT00428285|Human Papilloma Virus|human papilloma virus
558905|NCT00428285|HIV infected MSM|hiv infected msm
558906|NCT00428285|Treatment Experienced|treatment experienced
558907|NCT00428285|Treatment Naive|treatment naive
558908|NCT00428285|Anal Intraepithelial Neoplasia|anal intraepithelial neoplasia
558909|NCT00428298|Bipolar|bipolar
558910|NCT00428298|Cognitive|cognitive
558911|NCT00428298|Attention|attention
558912|NCT00428298|Memory|memory
558913|NCT00428298|Manic Depression|manic depression
558914|NCT00428298|Bi-polar|bi-polar
558915|NCT00428311|Polycystic ovary syndrome|polycystic ovary syndrome
558916|NCT00428311|Hyperandrogenism|hyperandrogenism
558917|NCT00428311|Hirsutism|hirsutism
558918|NCT00428311|Cardiovascular risk|cardiovascular risk
558919|NCT00428311|Chronic inflammation|chronic inflammation
558920|NCT00428311|Metformin|metformin
558921|NCT00428311|Cyproterone acetate|cyproterone acetate
558922|NCT00428311|Oral contraceptives|oral contraceptives
558923|NCT00428337|HIV Seronegativity|hiv seronegativity
558924|NCT00428337|EP1233|ep1233
558925|NCT00428337|MVA-mBN32|mva-mbn32
558926|NCT00428337|HIV Preventive Vaccine|hiv preventive vaccine
558927|NCT00428363|posterior capsule opacification|posterior capsule opacification
558929|NCT00428363|after cataract|after cataract
558930|NCT00428363|intraocular lens|intraocular lens
558931|NCT00428363|optic edge design|optic edge design
558932|NCT00428363|sharp optic edge|sharp optic edge
558933|NCT00428389|Dementia, Alzheimer's, Rivastigmine, donepezil|dementia, alzheimer's, rivastigmine, donepezil
558934|NCT00428402|Education|education
558935|NCT00428402|4th-8th Grade Student|4th-8th grade student
558936|NCT00428402|MIDAS Project|midas project
558937|NCT00428402|Focus Group Discussion|focus group discussion
558938|NCT00428402|Bastrop|bastrop
558939|NCT00428428|kidney stone|kidney stone
558940|NCT00428428|ureteroscopy|ureteroscopy
558941|NCT00428441|D-dimer|d-dimer
558942|NCT00428441|Recurrence|recurrence
558943|NCT00428441|Venous thromboembolism|venous thromboembolism
558944|NCT00428454|drug-eluting stent|drug-eluting stent
558945|NCT00428454|chronic total occlusion|chronic total occlusion
558946|NCT00428454|sirolimus-eluting stent|sirolimus-eluting stent
558947|NCT00428454|zotarolimus-eluting stent|zotarolimus-eluting stent
558949|NCT00428467|Heart Failure|heart failure
558950|NCT00428467|LV Geometry|lv geometry
558951|NCT00428467|Heart MRT|heart mrt
558952|NCT00428493|human influenza A, H5N1, bird flu, avian influenza, China|human influenza a, h5n1, bird flu, avian influenza, china
558953|NCT00428506|ascites|ascites
558954|NCT00428506|cirrhosis|cirrhosis
558955|NCT00428506|post-paracentesis circulatory dysfunction|post-paracentesis circulatory dysfunction
558956|NCT00428506|albumin|albumin
558957|NCT00428506|portal-hypertension|portal-hypertension
558958|NCT00428519|HIV infection|hiv infection
558959|NCT00428519|Neurokinin-1 receptor antagonist|neurokinin-1 receptor antagonist
558960|NCT00428519|CCR5 expression|ccr5 expression
558961|NCT00428519|Treatment Naive|treatment naive
558962|NCT00428545|Advanced Malignancy|advanced malignancy
558963|NCT00428545|Lymphoma|lymphoma
558964|NCT00428545|Myeloma|myeloma
558965|NCT00428545|Solid Tumors|solid tumors
558966|NCT00428545|Bevacizumab|bevacizumab
558967|NCT00428545|Avastin|avastin
558968|NCT00428545|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
558969|NCT00428545|rhuMAb-VEGF|rhumab-vegf
558970|NCT00428545|Bortezomib|bortezomib
558971|NCT00428545|Velcade|velcade
558972|NCT00428545|PS-341|ps-341
558973|NCT00428545|LDP-341|ldp-341
558974|NCT00428545|MLN341|mln341
558975|NCT00428558|acute myeloid leukemia|acute myeloid leukemia
558976|NCT00428558|Core Binding Factor|core binding factor
558977|NCT00428558|t(8;21)|t(8;21)
558978|NCT00428558|inv(16)|inv(16)
558979|NCT00428558|timed-sequential induction|timed-sequential induction
559078|NCT00428987|Metabolism|metabolism
558980|NCT00428571|Type 2 Diabetes|type 2 diabetes
558981|NCT00428571|Bariatric surgery|bariatric surgery
558982|NCT00428571|Obesity|obesity
558983|NCT00428571|Laparoscopic gastric bypass|laparoscopic gastric bypass
558984|NCT00428571|Laparoscopic adjustable gastric banding|laparoscopic adjustable gastric banding
558985|NCT00428623|Patient comfort|patient comfort
558986|NCT00428623|Wound dressings|wound dressings
558987|NCT00428623|infection|infection
558988|NCT00428623|vascular surgery|vascular surgery
558989|NCT00428636|ileostomy|ileostomy
558990|NCT00428636|rectal resection|rectal resection
558991|NCT00428636|proctectomy|proctectomy
558992|NCT00428636|stoma closure|stoma closure
559292|NCT00429624|Neck Pain|neck pain
558993|NCT00428649|Selenium supplements|selenium supplements
558994|NCT00428649|Selenoprotein P|selenoprotein p
558995|NCT00428649|Optimization|optimization
558996|NCT00428662|coronary stenting|coronary stenting
558997|NCT00428662|drug eluting stents|drug eluting stents
558998|NCT00428662|paclitaxel|paclitaxel
558999|NCT00428662|nanoporous|nanoporous
559000|NCT00428675|screening|screening
559001|NCT00428675|fatigue|fatigue
559002|NCT00428688|Hodgkin's lymphoma|hodgkin's lymphoma
559003|NCT00428688|cardiovascular disease|cardiovascular disease
559004|NCT00428688|radiation therapy|radiation therapy
559005|NCT00428688|Brachial artery flow-mediated dilation (FMD)|brachial artery flow-mediated dilation (fmd)
559006|NCT00428701|stress ulcer|stress ulcer
559007|NCT00428701|critically ill|critically ill
559008|NCT00428701|gastric acid|gastric acid
559009|NCT00428701|gastric aspirates|gastric aspirates
559010|NCT00428701|esomeprazole|esomeprazole
559011|NCT00428727|Diabetic foot|diabetic foot
559012|NCT00428727|Ulcer|ulcer
559013|NCT00428727|nitric oxide|nitric oxide
559014|NCT00428727|treatment|treatment
559015|NCT00428727|donor|donor
559016|NCT00428727|controlled trial|controlled trial
559017|NCT00428753|avian influenza, China, H5N1|avian influenza, china, h5n1
559018|NCT00428779|Running during 24 hours|running during 24 hours
559019|NCT00428779|Voluntary evoked force on the muscles|voluntary evoked force on the muscles
559020|NCT00428779|Electrically evoked force on the muscles|electrically evoked force on the muscles
559021|NCT00428779|EMG activity|emg activity
559022|NCT00428779|Muscle biopsy|muscle biopsy
559023|NCT00428779|subjects will be recruited among experienced ultra-runners|subjects will be recruited among experienced ultra-runners
559024|NCT00428792|ADHD|adhd
559025|NCT00428792|methylphenidate|methylphenidate
559026|NCT00428792|children|children
559027|NCT00428792|food effect|food effect
559028|NCT00428792|Attention-Deficit Hyperactivity Disorder (ADHD) in children|attention-deficit hyperactivity disorder (adhd) in children
559029|NCT00428805|body composition|body composition
559030|NCT00428805|physical activity|physical activity
559031|NCT00428805|dietary intake|dietary intake
559032|NCT00428805|children|children
559033|NCT00428818|MRSA|mrsa
559034|NCT00428831|influenza, genomic data, nasopharyngeal aspirate|influenza, genomic data, nasopharyngeal aspirate
559035|NCT00428844|Osteomyelitis|osteomyelitis
559036|NCT00428844|Prosthetic Hip|prosthetic hip
559037|NCT00428844|Prosthetic Knee|prosthetic knee
559038|NCT00428844|MRSA|mrsa
559039|NCT00428844|Osteomyelitis Associated with an Infected Prosthetic Hip or Knee Joint|osteomyelitis associated with an infected prosthetic hip or knee joint
559040|NCT00428844|Staphylococci|staphylococci
559041|NCT00428870|Shoulder|shoulder
559042|NCT00428870|impingement|impingement
559043|NCT00428870|conservative|conservative
559044|NCT00428870|acromioplasty|acromioplasty
559045|NCT00428870|arthroscopy|arthroscopy
559046|NCT00428883|Scleroderma, Systemic|scleroderma, systemic
559047|NCT00428883|Scleroderma, Diffuse|scleroderma, diffuse
559048|NCT00428896|Breast cancer|breast cancer
559049|NCT00428896|iressa circulating tumor cells|iressa circulating tumor cells
559050|NCT00428909|Pharmacokinetic|pharmacokinetic
559051|NCT00428909|STI571|sti571
559052|NCT00428909|imatinib|imatinib
559054|NCT00428909|Chronic Myeloid Leukemia|chronic myeloid leukemia
559055|NCT00428909|Philadelphia Chromosome|philadelphia chromosome
559056|NCT00428909|acetaminophen|acetaminophen
559057|NCT00428922|Metastatic|metastatic
559058|NCT00428922|Breast Cancer|breast cancer
559059|NCT00428922|MBC|mbc
559060|NCT00428935|Duchenne|duchenne
558435|NCT00418626|nilotinib|nilotinib
559061|NCT00428935|Muscle|muscle
559062|NCT00428935|Muscular Dystrophy|muscular dystrophy
559063|NCT00428935|Gene Therapy|gene therapy
559064|NCT00428935|Dystrophin|dystrophin
559065|NCT00428935|Adeno-Associated Virus|adeno-associated virus
559066|NCT00428935|AAV|aav
559067|NCT00428948|ADPKD|adpkd
559068|NCT00428948|Polycystic|polycystic
559069|NCT00428948|kidney|kidney
559070|NCT00428948|ADPKD (Autosomal Dominant Polycystic Kidney Disease)|adpkd (autosomal dominant polycystic kidney disease)
559071|NCT00428961|diabetes mellitus|diabetes mellitus
559072|NCT00428961|insulin resistance|insulin resistance
559073|NCT00428961|atherosclerosis|atherosclerosis
559074|NCT00428974|Psoriasis|psoriasis
559075|NCT00428987|Energy Expenditure|energy expenditure
559076|NCT00428987|Neurocognitive Function|neurocognitive function
559077|NCT00428987|Obesity|obesity
559079|NCT00428987|Phenotype|phenotype
559080|NCT00428987|Body Composition|body composition
559081|NCT00428987|Morbid Obesity|morbid obesity
559082|NCT00428987|Overweight|overweight
559083|NCT00428987|Healthy Volunteer|healthy volunteer
559084|NCT00429000|Hypothermia|hypothermia
559085|NCT00429000|Infant mortality|infant mortality
559086|NCT00429000|Infant morbidity|infant morbidity
559087|NCT00429000|Intervention|intervention
559088|NCT00429000|Randomisation|randomisation
559089|NCT00429000|Longitudinal research.|longitudinal research.
559090|NCT00429000|Low-income country|low-income country
559091|NCT00429013|Pressure ulcer|pressure ulcer
559092|NCT00429013|Lingual electric stimulation|lingual electric stimulation
559093|NCT00429013|Paraplegic patient|paraplegic patient
559094|NCT00429013|Pressure Ulcer/Prevention & control|pressure ulcer/prevention & control
559095|NCT00429026|Kidney Cancer|kidney cancer
559096|NCT00429026|Renal Cell Cancer|renal cell cancer
559097|NCT00429026|Stem Cell Transplant|stem cell transplant
559098|NCT00429026|Cyclophosphamide|cyclophosphamide
559099|NCT00429026|Fludarabine|fludarabine
559100|NCT00429026|Melphalan|melphalan
559102|NCT00429052|Coronary Disease|coronary disease
559103|NCT00429052|Coronary Stenosis|coronary stenosis
559104|NCT00429052|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
559105|NCT00429052|Stents|stents
559106|NCT00429052|Sirolimus|sirolimus
559107|NCT00429065|Non-Hodgkin lymphoma|non-hodgkin lymphoma
559108|NCT00429065|rituximab|rituximab
559109|NCT00429065|immunotherapy|immunotherapy
559110|NCT00429078|Gastric Cancer|gastric cancer
559111|NCT00429078|T Cells|t cells
559112|NCT00429078|Gene Transfer|gene transfer
559113|NCT00429104|Breast Cancer|breast cancer
559114|NCT00429104|Carcinoma of the Breast|carcinoma of the breast
559115|NCT00429104|HER-2/neu Overexpression|her-2/neu overexpression
559116|NCT00429104|Herceptin|herceptin
559117|NCT00429104|Trastuzumab|trastuzumab
559118|NCT00429104|GM-CSF|gm-csf
559119|NCT00429104|Sargramostim|sargramostim
559120|NCT00429104|Leukine|leukine
559121|NCT00429117|Spirituality|spirituality
559122|NCT00429117|Work Related Stress|work related stress
559123|NCT00429117|Religious Beliefs|religious beliefs
559124|NCT00429117|Survey|survey
559125|NCT00429143|Hematologic Malignancies|hematologic malignancies
559126|NCT00429143|Two Step Approach|two step approach
559127|NCT00429143|Haploidentical Transplant|haploidentical transplant
559128|NCT00429156|Non-invasive ventilation|non-invasive ventilation
559129|NCT00429156|Non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
559130|NCT00429156|Home ventilation|home ventilation
559131|NCT00429156|Domiciliary ventilation|domiciliary ventilation
559132|NCT00429156|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
559133|NCT00429156|COPD|copd
559134|NCT00429156|Respiratory failure|respiratory failure
559135|NCT00429156|Acute hypercapnic respiratory failure|acute hypercapnic respiratory failure
559136|NCT00429156|NIV|niv
559137|NCT00429156|NIPPV|nippv
559138|NCT00429156|Type II respiratory failure|type ii respiratory failure
559139|NCT00429169|Major Depressive Disorder|major depressive disorder
559140|NCT00429169|MDD|mdd
559141|NCT00429182|Breast Cancer|breast cancer
559142|NCT00429182|breast carcinoma|breast carcinoma
559143|NCT00429182|Carboplatin|carboplatin
559144|NCT00429182|Paraplatin|paraplatin
559145|NCT00429182|Cyclophosphamide|cyclophosphamide
559146|NCT00429182|Neosar|neosar
559147|NCT00429182|Cytoxan|cytoxan
559148|NCT00429182|Thiotepa|thiotepa
559149|NCT00429182|Purged Autologous Stem Cells|purged autologous stem cells
559150|NCT00429182|Circulating Tumor Cells|circulating tumor cells
559151|NCT00429182|CTCs|ctcs
559152|NCT00429195|LIPGENE|lipgene
559153|NCT00429195|Fatty acid|fatty acid
559154|NCT00429195|Dietary intervention|dietary intervention
559155|NCT00429195|Metabolic syndrome|metabolic syndrome
559156|NCT00429195|Insulin resistance|insulin resistance
559157|NCT00429208|Nicotine Dependence|nicotine dependence
559158|NCT00429208|Smoking|smoking
559159|NCT00429208|Tobacco Use Disorder|tobacco use disorder
559160|NCT00429208|Nicotine Use Disorder|nicotine use disorder
559161|NCT00429221|ADHD|adhd
559162|NCT00429234|Advanced Cancer|advanced cancer
559163|NCT00429234|Solid Tumors|solid tumors
559164|NCT00429234|Dasatinib|dasatinib
559165|NCT00429234|BMS-354825|bms-354825
559166|NCT00429234|Sprycel|sprycel
559167|NCT00429234|Gemcitabine|gemcitabine
559168|NCT00429234|Gemcitabine Hydrochloride|gemcitabine hydrochloride
559169|NCT00429234|Gemzar|gemzar
559170|NCT00429247|Occult tumor cells|occult tumor cells
559171|NCT00429247|Micrometastatic cells|micrometastatic cells
559172|NCT00429247|Cytokeratin-19|cytokeratin-19
559173|NCT00429247|Trastuzumab|trastuzumab
559174|NCT00429247|Completion of Adjuvant Treatment|completion of adjuvant treatment
559175|NCT00429260|depression|depression
559176|NCT00429260|antidepressive agents|antidepressive agents
559177|NCT00429273|ADHD|adhd
559178|NCT00429273|Guanfacine|guanfacine
559179|NCT00429273|Methylphenidate|methylphenidate
559180|NCT00429273|Focalin XR|focalin xr
559181|NCT00429273|Pediatric|pediatric
559182|NCT00429273|Cognitive function|cognitive function
559183|NCT00429273|Combination therapy|combination therapy
559184|NCT00429286|Health Services Research|health services research
559185|NCT00429299|neo-adjuvant trastuzumab early breast cancer lapatinib|neo-adjuvant trastuzumab early breast cancer lapatinib
559186|NCT00429312|Melanoma|melanoma
559187|NCT00429312|Oncolytic virus|oncolytic virus
559188|NCT00429312|Pexa-Vec|pexa-vec
559189|NCT00429325|acute infectious diarrhea,|acute infectious diarrhea,
559190|NCT00429325|fecal calprotectin,|fecal calprotectin,
559191|NCT00429325|stool culture,|stool culture,
559192|NCT00429325|hemoccult test,|hemoccult test,
559291|NCT00429611|cardiac arrest patients|cardiac arrest patients
559193|NCT00429325|Guaiac fecal occult blood test (FOBT)|guaiac fecal occult blood test (fobt)
559194|NCT00429325|fecal lactoferrin|fecal lactoferrin
559195|NCT00429338|Genitourinary|genitourinary
559196|NCT00429338|Prostate Cancer|prostate cancer
559197|NCT00429338|Magnetic Resonance Imaging|magnetic resonance imaging
559198|NCT00429338|MRI|mri
559199|NCT00429338|Magnetic Resonance Spectroscopic Imaging|magnetic resonance spectroscopic imaging
559201|NCT00429338|Endorectal MRSI|endorectal mrsi
753081|NCT01175382|Drug Therapy|drug therapy
559202|NCT00429338|Endorectal magnetic resonance spectroscopy imaging|endorectal magnetic resonance spectroscopy imaging
559204|NCT00429338|3T Scan|3t scan
559205|NCT00429338|Endorectal coil|endorectal coil
559206|NCT00429338|Perfluorocarbon compound|perfluorocarbon compound
559207|NCT00429338|PFC|pfc
559208|NCT00429338|PFC-filled endorectal coil|pfc-filled endorectal coil
559209|NCT00429338|PFC-MRSI|pfc-mrsi
559210|NCT00429338|AIR-MRSI|air-mrsi
559211|NCT00429364|Aortic Root Dissection|aortic root dissection
559212|NCT00429364|Aortic Root Dilation|aortic root dilation
559213|NCT00429364|Pediatric Heart Network|pediatric heart network
559214|NCT00429377|tacrolimus|tacrolimus
559215|NCT00429377|FK506|fk506
559216|NCT00429377|lupus nephritis|lupus nephritis
559217|NCT00429390|Metabolic syndrome|metabolic syndrome
559218|NCT00429390|Ramadan Fasting|ramadan fasting
559219|NCT00429390|Insulin sensitivity|insulin sensitivity
559220|NCT00429390|Iran|iran
559221|NCT00429403|Breast Cancer|breast cancer
559222|NCT00429403|Chemotherapy|chemotherapy
559223|NCT00429403|Ovarian Function|ovarian function
559224|NCT00429403|Goserelin|goserelin
559225|NCT00429403|Zoladex|zoladex
559226|NCT00429403|Ovary function|ovary function
559227|NCT00429403|Fertility|fertility
559228|NCT00429403|Early Menopause|early menopause
559229|NCT00429416|Hematologic Malignancies|hematologic malignancies
559230|NCT00429416|GVHD|gvhd
559231|NCT00429416|Graft-Versus-Host-Disease|graft-versus-host-disease
559232|NCT00429416|LLME|llme
559233|NCT00429416|CD34+ stem cell infusions|cd34+ stem cell infusions
559234|NCT00429416|CD34- fraction|cd34- fraction
559235|NCT00429416|Cyclosporine|cyclosporine
559236|NCT00429416|Mycophenolate Mofetil|mycophenolate mofetil
559237|NCT00429416|HSCT|hsct
559238|NCT00429416|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
559239|NCT00429429|Peanut allergy|peanut allergy
559240|NCT00429442|Simvastatin|simvastatin
559241|NCT00429442|CNS Inflammation|cns inflammation
559242|NCT00429442|Copaxone|copaxone
559243|NCT00429455|Fertility|fertility
559244|NCT00429455|Menopause|menopause
559245|NCT00429455|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
559246|NCT00429455|Questionnaire|questionnaire
559247|NCT00429455|Survey|survey
559248|NCT00429481|Oral live attenuated human rotavirus vaccine|oral live attenuated human rotavirus vaccine
559249|NCT00429481|Gastroenteritis|gastroenteritis
559250|NCT00429481|Vomiting|vomiting
559251|NCT00429494|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
559252|NCT00429494|GnRH Analogue|gnrh analogue
559253|NCT00429494|Gonadotropin-releasing hormone analogue|gonadotropin-releasing hormone analogue
559254|NCT00429494|GnRH-a|gnrh-a
559255|NCT00429494|Ovarian Function|ovarian function
559256|NCT00429494|Fertility|fertility
559257|NCT00429494|Leuprolide Acetate|leuprolide acetate
558617|NCT00427323|alertness|alertness
559258|NCT00429494|Lupron Depot|lupron depot
559259|NCT00429494|premature ovarian failure|premature ovarian failure
559260|NCT00429494|POF|pof
559261|NCT00429494|Abnormal suppression of menstruation|abnormal suppression of menstruation
559262|NCT00429494|absence of menstruation|absence of menstruation
559263|NCT00429507|Breast Cancer|breast cancer
559264|NCT00429507|Blood Stem Cell|blood stem cell
559265|NCT00429507|Bone Metastases|bone metastases
559266|NCT00429507|Radiation Therapy|radiation therapy
559267|NCT00429507|Gamma Camera|gamma camera
559268|NCT00429507|Sm-EDTMP|sm-edtmp
559269|NCT00429507|Samarium 153-EDTMP|samarium 153-edtmp
559270|NCT00429507|Stem Cell Transplant|stem cell transplant
559271|NCT00429507|Autologous Peripheral Blood Stem Cell Transplantation|autologous peripheral blood stem cell transplantation
559272|NCT00429507|PBSCT|pbsct
559273|NCT00429507|Questionnaire|questionnaire
559274|NCT00429546|Disclosure|disclosure
559275|NCT00429546|Serostatus|serostatus
559276|NCT00429559|Cancer;|cancer;
559277|NCT00429559|Ovarian cancer;|ovarian cancer;
559460|NCT00422201|Ectopic ACTH Secretion|ectopic acth secretion
559278|NCT00429559|Recurrent ovarian cancer platinum-resistant|recurrent ovarian cancer platinum-resistant
559279|NCT00429572|Breast Cancer|breast cancer
559280|NCT00429572|PBPC Transplantation|pbpc transplantation
559281|NCT00429572|Stem Cell Infusion|stem cell infusion
559282|NCT00429572|Fludarabine|fludarabine
559283|NCT00429572|Melphalan|melphalan
559284|NCT00429585|tibia fracture|tibia fracture
559285|NCT00429585|proximal tibia|proximal tibia
559286|NCT00429611|biphasic defibrillation|biphasic defibrillation
559287|NCT00429611|inhospital|inhospital
559288|NCT00429611|post-resuscitation myocardial function|post-resuscitation myocardial function
559289|NCT00429611|defibrillation efficacy|defibrillation efficacy
559290|NCT00429611|high energy versus low energy|high energy versus low energy
559293|NCT00429624|Chiropractic manipulation|chiropractic manipulation
559294|NCT00429624|Randomized controlled trial|randomized controlled trial
559295|NCT00429637|EBC pH|ebc ph
559296|NCT00429637|Airway acidification|airway acidification
559297|NCT00429637|Condensimetry|condensimetry
559298|NCT00429637|ARDS|ards
559299|NCT00429637|RSV|rsv
559300|NCT00429637|ALI|ali
559301|NCT00429637|Airway reconstruction|airway reconstruction
559302|NCT00429650|Weight maintenance|weight maintenance
559303|NCT00429650|Weight loss|weight loss
559304|NCT00429663|distal femur|distal femur
559305|NCT00429663|femur fracture|femur fracture
559306|NCT00429676|Randomized|randomized
559307|NCT00429676|Controlled|controlled
559308|NCT00429676|Trial|trial
559309|NCT00429676|Delirium|delirium
559310|NCT00429676|Haloperidol|haloperidol
559311|NCT00429689|Male, MDD, Testosterone, DHEA-S,Cortisol|male, mdd, testosterone, dhea-s,cortisol
559312|NCT00429689|Male|male
559313|NCT00429689|18-65|18-65
559314|NCT00429689|Major Depression|major depression
559315|NCT00429702|nausea|nausea
559316|NCT00429702|vomiting|vomiting
559317|NCT00429702|emetic chemotherapy|emetic chemotherapy
559318|NCT00429702|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
559319|NCT00429715|Leishmaniasis vaccine|leishmaniasis vaccine
559320|NCT00429715|Alum-ALM|alum-alm
559321|NCT00429715|First generation vaccine|first generation vaccine
559322|NCT00429715|Healthy volunteers|healthy volunteers
559323|NCT00429715|No response to leishmanin|no response to leishmanin
559324|NCT00429715|No history of cutaneous leishmaniasis|no history of cutaneous leishmaniasis
559325|NCT00429728|Pharmacokinetics,|pharmacokinetics,
559326|NCT00429728|tolerability,|tolerability,
559327|NCT00429728|healthy,|healthy,
559328|NCT00429728|subjects,|subjects,
559329|NCT00429728|smokers,|smokers,
559330|NCT00429728|non-smokers|non-smokers
559331|NCT00429754|Nausea and vomiting after using cytostatic drugs|nausea and vomiting after using cytostatic drugs
559332|NCT00429767|Opioid|opioid
559333|NCT00429767|Cocaine|cocaine
559334|NCT00429767|Drug Self Administration|drug self administration
559335|NCT00429780|Leishmaniasis vaccine|leishmaniasis vaccine
559336|NCT00429780|Alum-ALM|alum-alm
559337|NCT00429780|First generation vaccine|first generation vaccine
559338|NCT00429780|Leishmanin positive|leishmanin positive
559339|NCT00429780|Healthy Volunteers|healthy volunteers
559340|NCT00429780|Response to Leishmanin (Leishmanin Skin Test>0)|response to leishmanin (leishmanin skin test>0)
559341|NCT00429780|No History of Cutaneous Leishmaniasis|no history of cutaneous leishmaniasis
559342|NCT00429806|Vaginal atrophy|vaginal atrophy
559343|NCT00429806|DHEA|dhea
559344|NCT00429806|Prasterone|prasterone
559345|NCT00429806|Menopause|menopause
559346|NCT00429832|Nausea, vomiting, antiemetic|nausea, vomiting, antiemetic
559347|NCT00429845|HIV|hiv
559348|NCT00429845|HAART|haart
559349|NCT00429845|Nutrition|nutrition
559350|NCT00429845|Dyslipidemia|dyslipidemia
559351|NCT00416351|anaplastic large cell lymphoma|anaplastic large cell lymphoma
559352|NCT00416351|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
559353|NCT00416351|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
721915|NCT01054586|HIV|hiv
558759|NCT00427765|BMT|bmt
559354|NCT00416351|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
559355|NCT00416351|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
559356|NCT00416351|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
559357|NCT00416351|prolymphocytic leukemia|prolymphocytic leukemia
559358|NCT00416351|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
559359|NCT00416351|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
559360|NCT00416351|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
559361|NCT00416351|small intestine lymphoma|small intestine lymphoma
559362|NCT00416364|hernia|hernia
559363|NCT00416364|inguinal|inguinal
559364|NCT00416364|quality of life|quality of life
559365|NCT00416377|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
559366|NCT00416377|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
559367|NCT00416377|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
559368|NCT00416377|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
559369|NCT00416377|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
559370|NCT00416390|benign prostatic hyperplasia|benign prostatic hyperplasia
559371|NCT00416390|stage I prostate cancer|stage i prostate cancer
559372|NCT00416390|stage IIB prostate cancer|stage iib prostate cancer
559373|NCT00416390|stage IIA prostate cancer|stage iia prostate cancer
559374|NCT00416390|stage III prostate cancer|stage iii prostate cancer
559375|NCT00416390|stage IV prostate cancer|stage iv prostate cancer
559376|NCT00416403|breast cancer in situ|breast cancer in situ
559377|NCT00416403|ductal breast carcinoma in situ|ductal breast carcinoma in situ
559378|NCT00416403|stage IA breast cancer|stage ia breast cancer
559379|NCT00416403|stage IB breast cancer|stage ib breast cancer
559380|NCT00416429|recurrent renal cell cancer|recurrent renal cell cancer
559381|NCT00416429|stage IV renal cell cancer|stage iv renal cell cancer
559860|NCT00423657|Abscess|abscess
585620|NCT00513409|Pneumococcal disease|pneumococcal disease
559382|NCT00416442|healthy subjects, safety, tolerability, dose escalation, pharmacokinetics, benzodiazepine|healthy subjects, safety, tolerability, dose escalation, pharmacokinetics, benzodiazepine
559383|NCT00416442|Healthy male and female subjects|healthy male and female subjects
559384|NCT00421798|tuberculosis, paucibacillary, mycobacteria, Mexico, Colombia|tuberculosis, paucibacillary, mycobacteria, mexico, colombia
559385|NCT00421811|cancer|cancer
559386|NCT00421811|tumors|tumors
559388|NCT00421811|anticarcinogenic agents|anticarcinogenic agents
559389|NCT00421811|antineoplastic agents|antineoplastic agents
559390|NCT00421811|cadherins|cadherins
559391|NCT00421811|solid tumors|solid tumors
559392|NCT00421837|influenza, flu, genotypic analysis, sub-study|influenza, flu, genotypic analysis, sub-study
559393|NCT00421863|hypertension|hypertension
559394|NCT00421863|systolic blood pressure|systolic blood pressure
559395|NCT00421876|cardiac rehabilitation|cardiac rehabilitation
559396|NCT00421876|lifestyle management|lifestyle management
559397|NCT00421876|risk factor management|risk factor management
559398|NCT00421876|myocardial infarction|myocardial infarction
559399|NCT00421876|randomized trials|randomized trials
559400|NCT00421889|Ovarian cancer|ovarian cancer
559401|NCT00421889|Ovarian Neoplasms|ovarian neoplasms
559402|NCT00421889|Primary peritoneal|primary peritoneal
559403|NCT00421889|Epithelial ovarian|epithelial ovarian
559404|NCT00421889|Fallopian tube|fallopian tube
559405|NCT00421889|Bladder cancer|bladder cancer
559406|NCT00421889|belinostat|belinostat
559407|NCT00421889|PXD101|pxd101
559408|NCT00421889|mixed mullerian cancer of ovarian origin|mixed mullerian cancer of ovarian origin
559409|NCT00421902|Hot flashes, prostate cancer, acupuncture|hot flashes, prostate cancer, acupuncture
559410|NCT00421902|Prostate cancer patients with hot flashes due to their hormonal treatment|prostate cancer patients with hot flashes due to their hormonal treatment
559411|NCT00421928|Chronic Pain|chronic pain
559412|NCT00421928|Osteoarthritis, Knee|osteoarthritis, knee
559413|NCT00421928|tapentadol|tapentadol
559414|NCT00421928|Pain Assessment|pain assessment
559415|NCT00421941|enteral feeding|enteral feeding
559416|NCT00421941|critical care|critical care
559417|NCT00421941|fish oil|fish oil
559418|NCT00421941|surgical|surgical
559419|NCT00421954|psychosis NOS|psychosis nos
559420|NCT00421954|MDD w/ psychotic features|mdd w/ psychotic features
559421|NCT00421954|bipolar disorder w. psychotic features|bipolar disorder w. psychotic features
559422|NCT00421967|Postoperative pain|postoperative pain
559423|NCT00421993|Acne vulgaris|acne vulgaris
559424|NCT00421993|Adapalene|adapalene
559425|NCT00421993|Benzoyl Peroxide|benzoyl peroxide
559426|NCT00422006|bariatric surgery planned|bariatric surgery planned
559427|NCT00422019|Renal Cancer|renal cancer
559428|NCT00422019|Kidney Cancer|kidney cancer
559429|NCT00422032|Myelodysplastic Syndrome|myelodysplastic syndrome
559430|NCT00422032|Leukemia|leukemia
559431|NCT00422032|Clofarabine|clofarabine
559432|NCT00422032|MDS|mds
558811|NCT00427960|Asian|asian
559433|NCT00422071|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
559434|NCT00422071|Dopamine|dopamine
559435|NCT00422071|Gambling|gambling
559436|NCT00422071|Healthy Volunteer|healthy volunteer
559437|NCT00422071|HV|hv
559438|NCT00422084|Malaria|malaria
559439|NCT00422084|ACT|act
559440|NCT00422084|P falciparum|p falciparum
559441|NCT00422110|Seletracetam|seletracetam
559442|NCT00422110|Epilepsies|epilepsies
559443|NCT00422110|Partial|partial
559444|NCT00422110|Epilepsy|epilepsy
559445|NCT00422110|Focal|focal
559446|NCT00422123|Bipolar Disorder|bipolar disorder
559447|NCT00422123|Bipolar Mania|bipolar mania
559448|NCT00422123|Manic Depression|manic depression
559449|NCT00422123|Seroquel|seroquel
559450|NCT00422123|Seroquel SR|seroquel sr
559451|NCT00422123|quetiapine fumarate|quetiapine fumarate
559452|NCT00422136|middle ear|middle ear
559453|NCT00422136|otitis|otitis
559454|NCT00422136|genetics|genetics
559455|NCT00422149|Sublingual immunotherapy|sublingual immunotherapy
559456|NCT00422149|Rhinoconjunctivitis|rhinoconjunctivitis
559457|NCT00422175|Safety, tolerability, pharmacokinetics, pharmacodynamics, oral, BAF312, healthy volunteers|safety, tolerability, pharmacokinetics, pharmacodynamics, oral, baf312, healthy volunteers
559458|NCT00422201|Cortisol|cortisol
559459|NCT00422201|Cushing's Syndrome|cushing's syndrome
559560|NCT00422630|Weight loss|weight loss
559461|NCT00422201|Cushing Syndrome|cushing syndrome
559462|NCT00422214|Bipolar Disorder|bipolar disorder
559463|NCT00422214|Bipolar Depression,|bipolar depression,
559464|NCT00422214|Manic Depression|manic depression
559465|NCT00422214|Seroquel|seroquel
559466|NCT00422214|Seroquel SR|seroquel sr
559467|NCT00422214|quetiapine fumarate|quetiapine fumarate
559468|NCT00422240|Acne vulgaris|acne vulgaris
559469|NCT00422240|Adapalene|adapalene
559470|NCT00422240|Benzoyl Peroxide|benzoyl peroxide
559471|NCT00422253|insulin resistance|insulin resistance
559472|NCT00422253|insulin secretion|insulin secretion
559473|NCT00422253|advanced glycation end-products|advanced glycation end-products
559474|NCT00422266|Dyslipidemia|dyslipidemia
585621|NCT00513409|Safety|safety
559475|NCT00422279|Bone Inductive Implant|bone inductive implant
559476|NCT00422292|Menactra vaccine|menactra vaccine
559477|NCT00422292|Meningococcal meningitis|meningococcal meningitis
559479|NCT00422292|Mumps|mumps
559480|NCT00422292|Rubella|rubella
559481|NCT00422292|Varicella vaccines|varicella vaccines
559482|NCT00422292|Haemophilus influenzae type b|haemophilus influenzae type b
559483|NCT00422292|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
559484|NCT00422305|Infant, Premature|infant, premature
559485|NCT00422305|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
559487|NCT00422318|Heart Failure|heart failure
559488|NCT00422318|Insulin|insulin
559489|NCT00422318|Metabolism|metabolism
559490|NCT00422318|Pharmacology|pharmacology
559491|NCT00422318|Uric Acid|uric acid
559492|NCT00422331|Bipolar I Disorder|bipolar i disorder
559493|NCT00422331|Bipolar Disorder|bipolar disorder
559494|NCT00422331|Lithium|lithium
559495|NCT00422344|RAD001|rad001
559496|NCT00422344|Sunitinib|sunitinib
559497|NCT00422344|renal|renal
559498|NCT00422344|kidney|kidney
559499|NCT00422357|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
559624|NCT00422838|regulation|regulation
559500|NCT00422357|Urtica Dioica (or stinging nettle)|urtica dioica (or stinging nettle)
559501|NCT00422357|Hypoglycemic agents|hypoglycemic agents
559502|NCT00422396|Hypertrigliceridemia|hypertrigliceridemia
559503|NCT00422396|Metabolic syndrome|metabolic syndrome
559504|NCT00422396|Obesity|obesity
559505|NCT00422396|Fenofibrate|fenofibrate
559506|NCT00422396|Lipoproteins|lipoproteins
559507|NCT00422396|Cytokines|cytokines
559508|NCT00422409|SEMS|sems
559509|NCT00422422|Brivaracetam|brivaracetam
559510|NCT00422422|Epilepsy|epilepsy
559511|NCT00422422|Child|child
559512|NCT00422422|Pharmacokinetics|pharmacokinetics
559513|NCT00422422|Adolescents|adolescents
559514|NCT00422435|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
559515|NCT00422435|Drug eluting stent (DES)|drug eluting stent (des)
559516|NCT00422448|Dermoscopy|dermoscopy
559517|NCT00422448|Histopathology|histopathology
559518|NCT00422448|Genetics|genetics
559519|NCT00422448|Nevi|nevi
559520|NCT00422448|Nevogenesis|nevogenesis
559521|NCT00422461|Clinical Trial, Randomized Controlled Trial, Humans, Cyclic Nucleotide Phosphodiesterases Type 5|clinical trial, randomized controlled trial, humans, cyclic nucleotide phosphodiesterases type 5
559522|NCT00422474|Ischemic stroke|ischemic stroke
559523|NCT00422474|Baroreflex sensitivity|baroreflex sensitivity
559524|NCT00422474|Prognosis|prognosis
559525|NCT00422474|Cardiovascular autonomic regulation|cardiovascular autonomic regulation
559526|NCT00422487|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
559527|NCT00422500|Lung Cancer|lung cancer
559528|NCT00422500|Advanced Lung Cancer|advanced lung cancer
559529|NCT00422500|Chemotherapy Symptoms|chemotherapy symptoms
558928|NCT00428363|PCO|pco
559530|NCT00422500|Disease-Related Symptoms|disease-related symptoms
559531|NCT00422500|Treatment-Related Symptoms|treatment-related symptoms
559532|NCT00422500|Symptom Management|symptom management
559533|NCT00422500|Questionnaire|questionnaire
559534|NCT00422500|Telephone Interactive System|telephone interactive system
559535|NCT00422500|IVR Telephone System|ivr telephone system
559536|NCT00422500|DNA Repair Capacity|dna repair capacity
559538|NCT00422500|Cognitive Symptoms|cognitive symptoms
559539|NCT00422526|Preterm delivery, short cervix, progesterone|preterm delivery, short cervix, progesterone
559540|NCT00422539|trichloroacetic acid|trichloroacetic acid
559541|NCT00422539|varicella scar|varicella scar
559542|NCT00422552|inspiratory capacity, FEV1, COPD|inspiratory capacity, fev1, copd
559543|NCT00422565|Coronary Artery Disease|coronary artery disease
559544|NCT00422565|Stent|stent
559545|NCT00422565|Myocardial Infarction|myocardial infarction
559546|NCT00422578|erectile dysfunction|erectile dysfunction
559547|NCT00422578|tadalafil|tadalafil
559548|NCT00422591|Cytarabine, Idarubicin|cytarabine, idarubicin
559549|NCT00422591|Leukemia|leukemia
559550|NCT00422591|Acute Myeloid Leukemia|acute myeloid leukemia
559552|NCT00422591|Cytarabine|cytarabine
559553|NCT00422591|Idarubicin|idarubicin
559554|NCT00422604|COPD|copd
559555|NCT00422604|plethysmography.|plethysmography.
559556|NCT00422604|muscarinic receptor antagonist|muscarinic receptor antagonist
559557|NCT00422604|anticholinergic|anticholinergic
559558|NCT00422617|psoriasis|psoriasis
559559|NCT00422617|alefacept|alefacept
559561|NCT00422630|Obesity|obesity
559562|NCT00422630|Metabolic Syndrome|metabolic syndrome
559563|NCT00422630|Diet|diet
559564|NCT00422630|Hypertension|hypertension
559565|NCT00422630|Diabetes|diabetes
559566|NCT00422630|Cholesterol|cholesterol
559567|NCT00422643|OA,HA,Intra-articular|oa,ha,intra-articular
559568|NCT00422656|relapsed Waldenstrom's Macroglobulinemia|relapsed waldenstrom's macroglobulinemia
559569|NCT00422656|refractory Waldenstrom's Macroglobulinemia|refractory waldenstrom's macroglobulinemia
559570|NCT00422656|WM|wm
559571|NCT00422656|perifosine|perifosine
559572|NCT00422669|Pacemaker|pacemaker
559573|NCT00422669|Implantable Pulse Generator (IPG)|implantable pulse generator (ipg)
559574|NCT00422669|AV Conduction Disturbance|av conduction disturbance
559575|NCT00422669|Select Site Pacing|select site pacing
559576|NCT00422682|Solid tumors|solid tumors
559577|NCT00422695|HIV|hiv
559578|NCT00422695|Quantitative Sensory Testing|quantitative sensory testing
559579|NCT00422695|Neuropathy|neuropathy
559580|NCT00422695|Treatment Experienced|treatment experienced
559581|NCT00422695|Treatment Naive|treatment naive
559478|NCT00422292|Measles|measles
559582|NCT00422721|early severe retinal dystrophy|early severe retinal dystrophy
559583|NCT00422721|amaurosis of leber|amaurosis of leber
559584|NCT00422747|asthma|asthma
559585|NCT00422747|transient wheezing|transient wheezing
559586|NCT00422747|early diagnosis|early diagnosis
559587|NCT00422747|exhaled air|exhaled air
559588|NCT00422747|nitrogen monoxide|nitrogen monoxide
559589|NCT00422747|airway resistance|airway resistance
559590|NCT00422760|esophageal perforation|esophageal perforation
559591|NCT00422760|COPD|copd
559592|NCT00422773|phase I/II|phase i/ii
559593|NCT00422773|cetuximab|cetuximab
559594|NCT00422773|oxaliplatin|oxaliplatin
559595|NCT00422773|irinotecan|irinotecan
559596|NCT00422773|5-FU|5-fu
559597|NCT00422773|chemotherapy|chemotherapy
559598|NCT00422773|dose escalation|dose escalation
559599|NCT00422773|safety|safety
559600|NCT00422786|Refractory Clear Cell Renal Cell Carcinoma|refractory clear cell renal cell carcinoma
559601|NCT00422786|Phase II|phase ii
559602|NCT00422786|Thallion|thallion
559603|NCT00422786|TLN-232|tln-232
559604|NCT00422786|CAP-232|cap-232
559605|NCT00422786|M2PK|m2pk
559606|NCT00422799|relapsed Waldenstrom's macroglobulinemia|relapsed waldenstrom's macroglobulinemia
559607|NCT00422799|refractory Waldenstrom's macroglobulinemia|refractory waldenstrom's macroglobulinemia
559608|NCT00422799|Velcade|velcade
559609|NCT00422799|WM|wm
559610|NCT00422812|Migraine, Staccato Prochlorperazine|migraine, staccato prochlorperazine
559611|NCT00422812|Migraine headache with or without aura.|migraine headache with or without aura.
559612|NCT00422825|Food effect|food effect
559613|NCT00422825|bioavailability|bioavailability
559614|NCT00422825|pharmacokinetic|pharmacokinetic
559615|NCT00422825|imatinib|imatinib
559616|NCT00422825|STI571|sti571
559617|NCT00422825|modified release formulation of STI571|modified release formulation of sti571
559618|NCT00422825|CML|cml
559619|NCT00422825|Chronic Myeloid Leukemia|chronic myeloid leukemia
559620|NCT00422825|Philadelphia Chromosome|philadelphia chromosome
559621|NCT00422838|Hepatitis C|hepatitis c
559622|NCT00422838|Liver|liver
559623|NCT00422838|immunology|immunology
559625|NCT00422838|Genotype 1,2,3|genotype 1,2,3
559626|NCT00422838|Treatment|treatment
559627|NCT00422838|Chronic|chronic
559628|NCT00422838|Pegylated interferon|pegylated interferon
559629|NCT00422838|Ribavirin|ribavirin
722317|NCT01046604|cardiac|cardiac
559630|NCT00422851|otitis|otitis
559631|NCT00422851|gas diffusion|gas diffusion
559632|NCT00422851|Eustachian tube|eustachian tube
559633|NCT00422851|tympanic membrane|tympanic membrane
559634|NCT00422877|Liver Cancer|liver cancer
559635|NCT00422890|Acute myeloid leukaemia or Myelodysplastic syndrome|acute myeloid leukaemia or myelodysplastic syndrome
559636|NCT00422903|neo-adjuvant|neo-adjuvant
559637|NCT00422903|letrozole|letrozole
559638|NCT00422903|lapatinib|lapatinib
559639|NCT00422903|primary breast cancer|primary breast cancer
559640|NCT00422929|otitis media|otitis media
559641|NCT00422929|ear|ear
559642|NCT00422929|acute otitis|acute otitis
559643|NCT00422929|middle ear|middle ear
559644|NCT00422929|Eustachian tube|eustachian tube
559645|NCT00422929|recurrent acute otitis media|recurrent acute otitis media
559646|NCT00422929|chronic otitis media with effusion|chronic otitis media with effusion
559647|NCT00422929|no significant history of otitis media|no significant history of otitis media
559648|NCT00422955|fluid retention|fluid retention
559649|NCT00422955|Autonomic Neuropathy|autonomic neuropathy
559650|NCT00422968|Coronary artery disease|coronary artery disease
559651|NCT00422968|Stent|stent
559652|NCT00422968|Bypass surgery, coronary artery|bypass surgery, coronary artery
559653|NCT00422981|Dementia|dementia
559654|NCT00422981|Memory|memory
559655|NCT00422981|Alzheimers|alzheimers
559656|NCT00422981|Cognition|cognition
559657|NCT00422981|Mind|mind
559658|NCT00422981|Aging|aging
559659|NCT00422994|end stage renal impairment|end stage renal impairment
559660|NCT00422994|tolerability|tolerability
559661|NCT00422994|ropinirole|ropinirole
559662|NCT00422994|pharmacokinetics|pharmacokinetics
559663|NCT00422994|hemodialysis|hemodialysis
559664|NCT00423020|Acute myocardial infarction|acute myocardial infarction
559665|NCT00423020|Restenosis|restenosis
559666|NCT00423020|erythropoietin|erythropoietin
559667|NCT00423020|EPOC-AMI|epoc-ami
559668|NCT00423046|Vaccines|vaccines
559669|NCT00423046|Cervical cancer|cervical cancer
559670|NCT00423046|Immunogenicity|immunogenicity
559671|NCT00423046|Humans|humans
559672|NCT00423046|Safety|safety
559673|NCT00423046|Viral infections|viral infections
559674|NCT00423046|Human papillomavirus (HPV)|human papillomavirus (hpv)
559675|NCT00423046|Comparative study|comparative study
559676|NCT00423046|Human papillomavirus vaccine|human papillomavirus vaccine
559677|NCT00423046|Adults|adults
559678|NCT00423059|intravitreal bevacizumab|intravitreal bevacizumab
559679|NCT00423059|proliferative diabetic retinopathy|proliferative diabetic retinopathy
559680|NCT00423059|VEGF|vegf
559681|NCT00423059|PEDF|pedf
559682|NCT00423072|cleft palate|cleft palate
559683|NCT00423072|palatoplasty|palatoplasty
559684|NCT00423072|otitis|otitis
559685|NCT00423072|middle ear|middle ear
559686|NCT00423072|Eustachian tube|eustachian tube
559687|NCT00423085|rivastigmine，Alzheimer's Disease, transdermal patch|rivastigmine，alzheimer's disease, transdermal patch
559688|NCT00423098|Lupus Nephritis|lupus nephritis
559689|NCT00423098|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
559690|NCT00423098|EC-MPS|ec-mps
559691|NCT00423098|Myfortic|myfortic
559692|NCT00423111|Multiple sclerosis|multiple sclerosis
559693|NCT00423111|Memory|memory
559694|NCT00423111|Cognitive deficits|cognitive deficits
559695|NCT00423111|MRI|mri
559696|NCT00423111|Hippocampus|hippocampus
559697|NCT00423111|Prefrontal cortex|prefrontal cortex
559698|NCT00423124|Hematological malignancies|hematological malignancies
559699|NCT00423124|HSV-TK|hsv-tk
559700|NCT00423124|Haploidentical HCT|haploidentical hct
559701|NCT00423124|GvHD|gvhd
559702|NCT00423124|GvL|gvl
559703|NCT00423163|Aspergillosis/blood|aspergillosis/blood
559704|NCT00423163|micafungin|micafungin
559705|NCT00423163|voriconazole|voriconazole
559706|NCT00423163|Aspergillus|aspergillus
559707|NCT00423189|LUV|luv
559708|NCT00423189|Lucentis|lucentis
559709|NCT00423189|Visudyne|visudyne
559710|NCT00423189|PDT|pdt
559711|NCT00423189|AMD|amd
559712|NCT00423189|ARMD|armd
559713|NCT00423189|Age|age
559714|NCT00423189|Related|related
559715|NCT00423189|Macular|macular
559716|NCT00423189|Degeneration|degeneration
559717|NCT00423228|Alzheimer's disease|alzheimer's disease
559718|NCT00423228|cognitive impairment|cognitive impairment
559719|NCT00423228|cholinesterase inhibitors|cholinesterase inhibitors
559720|NCT00423228|sustained-release implants|sustained-release implants
559721|NCT00423228|long acting treatment|long acting treatment
559722|NCT00423254|Cancer Vaccine|cancer vaccine
559723|NCT00423280|Endothelium|endothelium
559724|NCT00423280|Nitric Oxide|nitric oxide
559725|NCT00423280|Magnetic Resonance Imaging|magnetic resonance imaging
559726|NCT00423280|Tetrahydrobiopterin|tetrahydrobiopterin
559727|NCT00423293|stage II anal cancer|stage ii anal cancer
559728|NCT00423293|stage IIIA anal cancer|stage iiia anal cancer
559729|NCT00423293|stage IIIB anal cancer|stage iiib anal cancer
559730|NCT00423293|basaloid carcinoma of the anus|basaloid carcinoma of the anus
559101|NCT00429026|NST|nst
559731|NCT00423293|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
559732|NCT00423293|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
559733|NCT00423319|Prevention of deep vein thrombosis and|prevention of deep vein thrombosis and
559734|NCT00423319|pulmonary embolism after total hip replacement surgery|pulmonary embolism after total hip replacement surgery
559735|NCT00423332|cancer|cancer
559736|NCT00423332|tumour|tumour
559737|NCT00423332|advanced cancer|advanced cancer
559738|NCT00423332|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
559739|NCT00423332|kidney cancer|kidney cancer
559740|NCT00423332|RECENTIN|recentin
559741|NCT00423358|rheumatoid arthritis|rheumatoid arthritis
559742|NCT00423358|hypovitaminosis D|hypovitaminosis d
559743|NCT00423358|bone turnover|bone turnover
559744|NCT00423358|ergocalciferol|ergocalciferol
559745|NCT00423371|first Carpometacarpal (CMC) Joint|first carpometacarpal (cmc) joint
559746|NCT00423384|Ibandronate|ibandronate
559747|NCT00423384|Placebo|placebo
559748|NCT00423384|Doubleblind|doubleblind
559749|NCT00423384|Bone|bone
559750|NCT00423384|loss|loss
559751|NCT00423384|Kidney|kidney
559752|NCT00423384|transplant|transplant
559753|NCT00423397|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
559754|NCT00423397|recurrent skin cancer|recurrent skin cancer
559755|NCT00423410|Cancer|cancer
559756|NCT00423410|Tumor|tumor
559757|NCT00423410|Lymphoma|lymphoma
559758|NCT00423436|Non-Small Cell Lung Cancer|non-small cell lung cancer
559759|NCT00423436|Small Cell Lung Cancer|small cell lung cancer
559760|NCT00423436|Voice Response System|voice response system
559761|NCT00423436|Questionnaire|questionnaire
559762|NCT00423436|Survey|survey
559763|NCT00423436|NSCLC|nsclc
559764|NCT00423449|Advanced Stage IIIB/IV Non-Small Cell Lung Cancer|advanced stage iiib/iv non-small cell lung cancer
559765|NCT00423462|Psychotherapy|psychotherapy
559766|NCT00423462|Long-term effects|long-term effects
559767|NCT00423475|adenocarcinoma of the prostate|adenocarcinoma of the prostate
559768|NCT00423475|stage IIB prostate cancer|stage iib prostate cancer
559769|NCT00423475|stage IIA prostate cancer|stage iia prostate cancer
559770|NCT00423475|stage III prostate cancer|stage iii prostate cancer
559771|NCT00423475|recurrent prostate cancer|recurrent prostate cancer
559772|NCT00423475|stage IV prostate cancer|stage iv prostate cancer
559773|NCT00423514|graft versus host disease|graft versus host disease
559774|NCT00423514|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
559775|NCT00423514|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
559776|NCT00423514|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
559777|NCT00423514|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
559778|NCT00423514|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
559779|NCT00423514|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
753185|NCT01175798|End-stage renal disease|end-stage renal disease
559780|NCT00423514|acute undifferentiated leukemia|acute undifferentiated leukemia
559781|NCT00423514|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
559782|NCT00423514|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
559783|NCT00423514|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
559784|NCT00423514|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
559785|NCT00423514|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
559786|NCT00423514|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
559787|NCT00423514|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
559788|NCT00423514|secondary acute myeloid leukemia|secondary acute myeloid leukemia
559789|NCT00423514|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
559790|NCT00423514|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
559791|NCT00423514|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
559792|NCT00423514|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
559793|NCT00423514|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
559794|NCT00423514|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
559795|NCT00423514|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
559796|NCT00423514|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
559797|NCT00423514|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
559798|NCT00423514|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
559799|NCT00423527|multiple sclerosis|multiple sclerosis
559800|NCT00423527|central pain|central pain
559801|NCT00423527|levetiracetam|levetiracetam
559802|NCT00423540|magnesium infusion|magnesium infusion
559803|NCT00423540|magnesium sulfate|magnesium sulfate
559804|NCT00423540|rest cramps|rest cramps
559805|NCT00423540|nocturnal leg cramps|nocturnal leg cramps
559806|NCT00423540|muscle cramps|muscle cramps
722519|NCT01047683|EPA|epa
559200|NCT00429338|MRSI|mrsi
559807|NCT00423540|fractional urinary excretion|fractional urinary excretion
559808|NCT00423540|urinary excretion|urinary excretion
559809|NCT00423540|24 hour urine|24 hour urine
559810|NCT00423540|serum magnesium|serum magnesium
559811|NCT00423540|magnesium deficiency|magnesium deficiency
559812|NCT00423540|family practice|family practice
559813|NCT00423540|general practice|general practice
559814|NCT00423540|richmond|richmond
559815|NCT00423540|cramp frequency|cramp frequency
559816|NCT00423540|magnesium status|magnesium status
559817|NCT00423540|urinary magnesium|urinary magnesium
559818|NCT00423540|cramp diary|cramp diary
559819|NCT00423540|sf 36|sf 36
559820|NCT00423553|Nitrite and Cytoprotection|nitrite and cytoprotection
559821|NCT00423553|Ischemic Preconditioning|ischemic preconditioning
559822|NCT00423553|Atrial Trabeculae Contractile Function|atrial trabeculae contractile function
559823|NCT00423553|Ischemia|ischemia
559824|NCT00423566|Mycobacterium tuberculosis|mycobacterium tuberculosis
559825|NCT00423566|85A antigen|85a antigen
559826|NCT00423566|Recombinant Modified Vaccinia virus Ankara|recombinant modified vaccinia virus ankara
559827|NCT00423566|Phase I study|phase i study
559828|NCT00423566|Immunogenicity|immunogenicity
559829|NCT00423605|FMS|fms
559830|NCT00423605|Fibro|fibro
559831|NCT00423605|Pain|pain
559832|NCT00423605|Body Pain|body pain
559833|NCT00423605|Tenderness|tenderness
559834|NCT00423605|Joint pain|joint pain
559835|NCT00423605|Stiffness|stiffness
559836|NCT00423605|Muscular Pain|muscular pain
559837|NCT00423618|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
559838|NCT00423618|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
559839|NCT00423618|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
559840|NCT00423618|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
559841|NCT00423618|adult synovial sarcoma|adult synovial sarcoma
559842|NCT00423618|adult angiosarcoma|adult angiosarcoma
559843|NCT00423618|adult epithelioid sarcoma|adult epithelioid sarcoma
559844|NCT00423618|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
559845|NCT00423618|adult leiomyosarcoma|adult leiomyosarcoma
559846|NCT00423618|adult liposarcoma|adult liposarcoma
559847|NCT00423618|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
559848|NCT00423618|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
559849|NCT00423618|adult malignant mesenchymoma|adult malignant mesenchymoma
559850|NCT00423618|adult fibrosarcoma|adult fibrosarcoma
559851|NCT00423618|adult neurofibrosarcoma|adult neurofibrosarcoma
559852|NCT00423618|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
559853|NCT00423631|Pain|pain
559854|NCT00423631|Fibromyalgia|fibromyalgia
559855|NCT00423631|Internet|internet
559856|NCT00423644|Multiple Myeloma|multiple myeloma
559857|NCT00423644|arsenic|arsenic
559858|NCT00423644|cancer study|cancer study
559859|NCT00423644|failed treatment|failed treatment
559861|NCT00423657|Antibacterial|antibacterial
559862|NCT00423657|Antibiotic|antibiotic
559863|NCT00423657|Antimicrobial|antimicrobial
559864|NCT00423657|Bacterial infection, skin|bacterial infection, skin
559865|NCT00423657|Ceftaroline|ceftaroline
559866|NCT00423657|Ceftaroline acetate|ceftaroline acetate
559867|NCT00423657|Cellulitis|cellulitis
559868|NCT00423657|Cephalosporin|cephalosporin
559869|NCT00423657|Complicated skin and skin structure infection (cSSSI)|complicated skin and skin structure infection (csssi)
559870|NCT00423657|cSSSI|csssi
559871|NCT00423657|Intravenous|intravenous
559872|NCT00423657|Methicillin-resistant Staphylococcus Aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
559873|NCT00423657|PPI-0903|ppi-0903
559874|NCT00423657|Prodrug|prodrug
559875|NCT00423657|Skin disease, bacterial|skin disease, bacterial
559876|NCT00423657|Skin infection|skin infection
559877|NCT00423657|Staphylococcal skin infection|staphylococcal skin infection
559878|NCT00423657|Staphylococcus aureus|staphylococcus aureus
559879|NCT00423657|Streptococcal skin infection|streptococcal skin infection
559880|NCT00423657|Surgical site infection|surgical site infection
559881|NCT00423657|TAK-599|tak-599
559882|NCT00423683|Cancer|cancer
559883|NCT00423683|thromboembolism|thromboembolism
559884|NCT00423696|stage IV colon cancer|stage iv colon cancer
559885|NCT00423696|stage IV rectal cancer|stage iv rectal cancer
559886|NCT00423696|recurrent colon cancer|recurrent colon cancer
559887|NCT00423696|recurrent rectal cancer|recurrent rectal cancer
559888|NCT00423709|Hodgkin's Disease|hodgkin's disease
559889|NCT00423709|Allogeneic Blood Stem Cell Transplantation|allogeneic blood stem cell transplantation
559890|NCT00423709|Bone Marrow Transplantation|bone marrow transplantation
559891|NCT00423709|Fludarabine|fludarabine
559892|NCT00423709|Melphalan|melphalan
559893|NCT00423722|Advanced Cancer|advanced cancer
559894|NCT00423722|Hospice Care|hospice care
559895|NCT00423722|Caregiver|caregiver
559896|NCT00423722|Saline|saline
559897|NCT00423722|Hydration|hydration
559898|NCT00423722|Dehydration|dehydration
559899|NCT00423761|Pharmacokinetics,|pharmacokinetics,
559900|NCT00423761|tolerability,|tolerability,
559901|NCT00423761|healthy,|healthy,
559902|NCT00423761|subjects|subjects
559903|NCT00423774|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
559904|NCT00423774|Psychological Distress|psychological distress
559905|NCT00423774|Coping|coping
559906|NCT00423774|Cognitive Behavior Therapy|cognitive behavior therapy
559907|NCT00423774|Bone Marrow Transplant|bone marrow transplant
559908|NCT00423774|Coping Skills|coping skills
559909|NCT00423787|Allergy|allergy
559910|NCT00423787|Allergoid|allergoid
559911|NCT00423787|Specific Immunotherapy|specific immunotherapy
559913|NCT00423813|Fibro|fibro
559914|NCT00423813|pain|pain
559915|NCT00423813|Body pain|body pain
559916|NCT00423813|tenderness|tenderness
559917|NCT00423813|stiffness|stiffness
559918|NCT00423813|muscular pain|muscular pain
559919|NCT00423813|joint pain|joint pain
559920|NCT00423826|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
559921|NCT00423826|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
559922|NCT00423826|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
559923|NCT00423826|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
559924|NCT00423826|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
559925|NCT00423826|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
559926|NCT00423826|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
559927|NCT00423826|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
559928|NCT00423826|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
559929|NCT00423826|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
559930|NCT00423826|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
559931|NCT00423826|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
560067|NCT00424099|Methylphenidate|methylphenidate
560068|NCT00424099|Placebo|placebo
559932|NCT00423826|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
559933|NCT00423826|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
559934|NCT00423826|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
559935|NCT00423826|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
583952|NCT00514046|Molecularly-Targeted Therapy|molecularly-targeted therapy
559936|NCT00423826|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
559937|NCT00423826|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
559938|NCT00423826|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
559939|NCT00423826|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
559940|NCT00423826|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
559941|NCT00423826|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
559942|NCT00423826|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
559943|NCT00423826|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
561667|NCT00436098|children|children
559944|NCT00423826|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
559945|NCT00423826|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
559946|NCT00423826|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
559947|NCT00423826|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
559948|NCT00423826|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
559949|NCT00423826|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
559950|NCT00423826|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
559951|NCT00423826|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
559952|NCT00423826|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
559953|NCT00423826|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
559954|NCT00423826|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
559955|NCT00423826|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
559956|NCT00423826|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
559957|NCT00423826|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
559958|NCT00423826|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
559959|NCT00423826|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
559960|NCT00423826|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
559961|NCT00423826|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
559962|NCT00423826|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
559963|NCT00423826|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
559964|NCT00423826|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
559965|NCT00423826|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
559966|NCT00423826|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
559967|NCT00423826|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
559968|NCT00423826|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
559969|NCT00423826|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
559970|NCT00423826|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
559971|NCT00423826|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
559972|NCT00423826|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
559973|NCT00423826|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
559974|NCT00423826|secondary acute myeloid leukemia|secondary acute myeloid leukemia
559975|NCT00423826|stage I multiple myeloma|stage i multiple myeloma
559976|NCT00423826|stage II multiple myeloma|stage ii multiple myeloma
559977|NCT00423826|stage III multiple myeloma|stage iii multiple myeloma
559978|NCT00423826|extramedullary plasmacytoma|extramedullary plasmacytoma
559979|NCT00423826|isolated plasmacytoma of bone|isolated plasmacytoma of bone
559980|NCT00423826|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
559981|NCT00423826|primary systemic amyloidosis|primary systemic amyloidosis
559982|NCT00423826|refractory multiple myeloma|refractory multiple myeloma
559983|NCT00423826|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
559984|NCT00423826|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
559985|NCT00423826|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
559986|NCT00423826|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
559987|NCT00423826|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
559988|NCT00423826|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
559989|NCT00423826|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
559990|NCT00423826|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
559991|NCT00423826|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
559992|NCT00423826|Burkitt lymphoma|burkitt lymphoma
559993|NCT00423826|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
559994|NCT00423826|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
559995|NCT00423826|splenic marginal zone lymphoma|splenic marginal zone lymphoma
583953|NCT00514046|Pediatric|pediatric
559996|NCT00423826|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
559997|NCT00423826|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
559998|NCT00423826|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
559999|NCT00423826|secondary myelofibrosis|secondary myelofibrosis
560000|NCT00423839|Mycobacterium tuberculosis|mycobacterium tuberculosis
560001|NCT00423839|Antigen 85A|antigen 85a
560002|NCT00423839|Modified Vaccinia Virus Ankara (MVA).|modified vaccinia virus ankara (mva).
560003|NCT00423852|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
560004|NCT00423852|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
560005|NCT00423852|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
560006|NCT00423852|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
560007|NCT00423852|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
560008|NCT00423852|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
753186|NCT01175798|Immunity|immunity
560009|NCT00423852|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
560010|NCT00423852|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
560011|NCT00423852|recurrent extragonadal seminoma|recurrent extragonadal seminoma
560012|NCT00423852|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
560013|NCT00423852|stage III extragonadal seminoma|stage iii extragonadal seminoma
560014|NCT00423852|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
560015|NCT00423852|stage IV extragonadal seminoma|stage iv extragonadal seminoma
560016|NCT00423852|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
560017|NCT00423852|adult teratoma|adult teratoma
560018|NCT00423852|testicular immature teratoma|testicular immature teratoma
560019|NCT00423852|testicular mature teratoma|testicular mature teratoma
560020|NCT00423865|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
560021|NCT00423865|CISPLATIN|cisplatin
560022|NCT00423865|RAD001 (EVEROLIMUS)|rad001 (everolimus)
560024|NCT00423904|Early intervention|early intervention
560025|NCT00423904|Brief intervention|brief intervention
560026|NCT00423904|alcohol|alcohol
560027|NCT00423904|general hospital|general hospital
560028|NCT00423917|stage IV breast cancer|stage iv breast cancer
560029|NCT00423917|male breast cancer|male breast cancer
560030|NCT00423917|recurrent breast cancer|recurrent breast cancer
559551|NCT00422591|AML|aml
560031|NCT00423930|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
560032|NCT00423930|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
560033|NCT00423930|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
560034|NCT00423930|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
560035|NCT00423930|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
560036|NCT00423930|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
560037|NCT00423930|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
560038|NCT00423930|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
560039|NCT00423930|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
560040|NCT00423930|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
560041|NCT00423930|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
560042|NCT00423930|tongue cancer|tongue cancer
560043|NCT00423943|cognition|cognition
560044|NCT00423943|memory|memory
560045|NCT00423956|Teeth root resorption, ultrasound, therapy|teeth root resorption, ultrasound, therapy
560046|NCT00423969|Depression|depression
560047|NCT00423969|Cognitive Impairment|cognitive impairment
560048|NCT00424008|Glucocorticosteroids|glucocorticosteroids
560049|NCT00424008|Dry Powder Inhaler|dry powder inhaler
560050|NCT00424008|Bronchodilator|bronchodilator
560051|NCT00424008|Metered-Dose Inhaler|metered-dose inhaler
560052|NCT00424034|safety|safety
560053|NCT00424034|Pharmacokinetics|pharmacokinetics
560054|NCT00424034|effect of food on pharmacokinetics|effect of food on pharmacokinetics
560055|NCT00424047|Multiple Myeloma|multiple myeloma
560056|NCT00424047|Celgene|celgene
560057|NCT00424047|Revlimid|revlimid
560058|NCT00424047|CC-5013|cc-5013
560059|NCT00424060|adult glioblastoma|adult glioblastoma
560060|NCT00424060|recurrent adult brain tumor|recurrent adult brain tumor
560061|NCT00424060|adult giant cell glioblastoma|adult giant cell glioblastoma
560062|NCT00424060|adult gliosarcoma|adult gliosarcoma
560063|NCT00424099|Advanced Cancer|advanced cancer
560064|NCT00424099|Fatigue|fatigue
560065|NCT00424099|Nursing Telephone Intervention|nursing telephone intervention
560066|NCT00424099|NTI|nti
560069|NCT00424099|Ritalin|ritalin
560070|NCT00424112|motivation to change|motivation to change
560071|NCT00424112|treatment motivation|treatment motivation
560072|NCT00424112|alcohol use disorders|alcohol use disorders
560074|NCT00424125|Compliance|compliance
560075|NCT00424125|Randomized clinical trial|randomized clinical trial
560076|NCT00424138|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
560077|NCT00424138|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
560078|NCT00424138|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
560079|NCT00424138|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
560080|NCT00424151|Graves' Disease|graves' disease
560081|NCT00424151|Dysthyroid Ophthalmopathy|dysthyroid ophthalmopathy
560082|NCT00424151|Thyroid related orbitopathy|thyroid related orbitopathy
560083|NCT00424164|male breast cancer|male breast cancer
560084|NCT00424164|stage IIIB breast cancer|stage iiib breast cancer
560085|NCT00424164|stage IIIC breast cancer|stage iiic breast cancer
560086|NCT00424164|stage IV breast cancer|stage iv breast cancer
560087|NCT00424164|recurrent breast cancer|recurrent breast cancer
560088|NCT00424177|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
560090|NCT00424177|thrombocytopenia|thrombocytopenia
560091|NCT00424177|platelets|platelets
560093|NCT00424190|Antibacterial|antibacterial
560094|NCT00424190|Antibiotic|antibiotic
560095|NCT00424190|Antimicrobial|antimicrobial
560096|NCT00424190|Bacterial infection, skin|bacterial infection, skin
560097|NCT00424190|Ceftaroline|ceftaroline
560098|NCT00424190|Ceftaroline acetate|ceftaroline acetate
560099|NCT00424190|Cellulitis|cellulitis
560100|NCT00424190|Cephalosporin|cephalosporin
560101|NCT00424190|Complicated skin and skin structure infection|complicated skin and skin structure infection
560102|NCT00424190|cSSSI|csssi
560103|NCT00424190|Intravenous|intravenous
560104|NCT00424190|Methicillin-resistant Staphylococcus Aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
560105|NCT00424190|PPI-0903|ppi-0903
560106|NCT00424190|Prodrug|prodrug
560107|NCT00424190|Skin disease, bacterial|skin disease, bacterial
560108|NCT00424190|Skin infection|skin infection
560109|NCT00424190|Staphylococcal skin infection|staphylococcal skin infection
560110|NCT00424190|Staphylococcus aureus|staphylococcus aureus
560111|NCT00424190|Streptococcal skin infection|streptococcal skin infection
560112|NCT00424190|Surgical site infection|surgical site infection
560113|NCT00424190|TAK-599|tak-599
560114|NCT00429858|recurrent pancreatic cancer|recurrent pancreatic cancer
560115|NCT00429858|stage III pancreatic cancer|stage iii pancreatic cancer
560116|NCT00429858|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
560117|NCT00429858|stage IV pancreatic cancer|stage iv pancreatic cancer
560118|NCT00429871|Metastatic breast cancer;|metastatic breast cancer;
560119|NCT00429871|First line chemotherapy;|first line chemotherapy;
560120|NCT00429871|Docetaxel;|docetaxel;
560121|NCT00429871|Epirubicin;|epirubicin;
560122|NCT00429871|Capecitabine|capecitabine
560123|NCT00429884|Atrial fibrillation|atrial fibrillation
560124|NCT00429897|Hypertension|hypertension
560125|NCT00429897|Low Renin|low renin
560126|NCT00429910|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
560127|NCT00429910|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
560128|NCT00429910|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
560129|NCT00429910|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
560130|NCT00429936|Dry Age Related Macular Degeneration|dry age related macular degeneration
560131|NCT00429936|Geographic Atrophy|geographic atrophy
560132|NCT00429949|Dasatinib|dasatinib
560133|NCT00429949|Plateau phase|plateau phase
560134|NCT00429962|subfoveal choroidal neovascularization (CNV)|subfoveal choroidal neovascularization (cnv)
560135|NCT00429962|age-related macular degeneration|age-related macular degeneration
560136|NCT00429962|ranibizumab monotherapy|ranibizumab monotherapy
560137|NCT00429962|combined verteporfin-therapy|combined verteporfin-therapy
560138|NCT00429962|Lucentis® (ranibizumab)|lucentis® (ranibizumab)
560139|NCT00429962|Visudyne®|visudyne®
560140|NCT00429962|photodynamic therapy|photodynamic therapy
560141|NCT00429975|fluorquinolones,|fluorquinolones,
560142|NCT00429975|b-lactams,|b-lactams,
560143|NCT00429975|immunomodulation.|immunomodulation.
560144|NCT00429988|breast cancer|breast cancer
560145|NCT00430001|Metastatic breast neoplasm|metastatic breast neoplasm
560146|NCT00430014|Advanced Cancer|advanced cancer
560147|NCT00430014|Relapsed|relapsed
560148|NCT00430014|Atiprimod|atiprimod
560149|NCT00430014|Guanylyl cyclase receptor antagonist|guanylyl cyclase receptor antagonist
560150|NCT00430027|Esophageal|esophageal
560151|NCT00430027|Esophagus|esophagus
560152|NCT00430040|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
560153|NCT00430040|Hypertension|hypertension
560154|NCT00430040|Carvedilol CR|carvedilol cr
560155|NCT00430040|Beta-blocker|beta-blocker
560156|NCT00430040|Oxidative stress|oxidative stress
560157|NCT00430040|Inflammation|inflammation
560158|NCT00430040|Vascular benefits|vascular benefits
560159|NCT00430053|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
560251|NCT00431639|Oncology|oncology
560252|NCT00431639|Cancer Pain|cancer pain
560160|NCT00430053|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
560161|NCT00430053|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
560162|NCT00430053|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
560163|NCT00430053|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
560164|NCT00430053|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
560165|NCT00430053|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
560166|NCT00430053|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
560168|NCT00430105|ANCA|anca
560169|NCT00430105|Wegener's granulomatosis|wegener's granulomatosis
560170|NCT00430105|Renal vasculitis|renal vasculitis
560171|NCT00430105|Cyclophosphamide|cyclophosphamide
560172|NCT00430118|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
560173|NCT00430118|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
560270|NCT00431756|DNA methylation|dna methylation
560174|NCT00430118|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
560175|NCT00430118|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
560089|NCT00424177|ITP|itp
560176|NCT00430157|Vienna Challenge Chamber|vienna challenge chamber
560177|NCT00430157|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
560178|NCT00430157|Inflammation|inflammation
560179|NCT00430170|ischemia-reperfusion injury|ischemia-reperfusion injury
560180|NCT00430170|adenosine|adenosine
560181|NCT00430170|dipyridamole|dipyridamole
560182|NCT00430170|caffeine|caffeine
560183|NCT00430183|stage I prostate cancer|stage i prostate cancer
560184|NCT00430183|stage IIB prostate cancer|stage iib prostate cancer
560185|NCT00430183|stage IIA prostate cancer|stage iia prostate cancer
560186|NCT00430183|stage III prostate cancer|stage iii prostate cancer
560187|NCT00430183|adenocarcinoma of the prostate|adenocarcinoma of the prostate
560188|NCT00431470|Classroom violence, character, bullying, self esteem|classroom violence, character, bullying, self esteem
560189|NCT00431483|antibacterial agents|antibacterial agents
560190|NCT00431483|surgery|surgery
560191|NCT00431483|pharmacist|pharmacist
560192|NCT00431483|economics, pharmaceutical|economics, pharmaceutical
560193|NCT00431496|Anemia|anemia
560194|NCT00431496|Intact Parathyroid Hormone (iPTH)|intact parathyroid hormone (ipth)
560195|NCT00431496|Secondary Hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
560196|NCT00431509|Osteoarthritis|osteoarthritis
560197|NCT00431509|Arthroplasty|arthroplasty
560198|NCT00431509|Replacement|replacement
560199|NCT00431509|Knee|knee
560200|NCT00431509|Instrumentation|instrumentation
560201|NCT00431535|Fluid|fluid
560202|NCT00431535|SvO2|svo2
560203|NCT00431535|Mobilisation|mobilisation
560204|NCT00431535|Orthostatic function|orthostatic function
560205|NCT00431561|Glioblastoma|glioblastoma
560206|NCT00431561|Anaplastic astrocytoma|anaplastic astrocytoma
560207|NCT00431561|Antisense|antisense
560208|NCT00431561|Cancer|cancer
560209|NCT00431561|Transforming growth factor beta2 (TGF-beta2)|transforming growth factor beta2 (tgf-beta2)
560210|NCT00431561|Targeted therapy|targeted therapy
560211|NCT00431561|Immunotherapy|immunotherapy
560212|NCT00431561|Brain tumor|brain tumor
560213|NCT00431561|Central nervous system (CNS)|central nervous system (cns)
560214|NCT00431561|Convection-enhanced delivery (CED) / microperfusion|convection-enhanced delivery (ced) / microperfusion
560215|NCT00431561|Locoregional application|locoregional application
560216|NCT00431574|schizophrenia|schizophrenia
560217|NCT00431574|schizoaffective|schizoaffective
560218|NCT00431574|antipsychotic|antipsychotic
560219|NCT00431574|randomized control trial|randomized control trial
560220|NCT00431587|morbid obesity|morbid obesity
560221|NCT00431587|metabolic syndrome|metabolic syndrome
560222|NCT00431587|visceral fat|visceral fat
560223|NCT00431587|peripheral fat|peripheral fat
560224|NCT00431600|Regional Blood Flow|regional blood flow
560225|NCT00431600|Color Doppler Optical Coherence Tomography|color doppler optical coherence tomography
560226|NCT00431600|CDOCT|cdoct
560227|NCT00431600|Retinal Blood Flow|retinal blood flow
560228|NCT00431600|Hyperoxia|hyperoxia
560229|NCT00431600|Vasoconstriction|vasoconstriction
560230|NCT00431600|Laser Doppler Velocimetry|laser doppler velocimetry
560231|NCT00431600|Retinal Vessel Analyzer|retinal vessel analyzer
560232|NCT00431613|NSCLC|nsclc
560233|NCT00431613|Induction chemotherapy|induction chemotherapy
560234|NCT00431613|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
560235|NCT00431613|Consolidation therapy|consolidation therapy
560236|NCT00431613|Docetaxel|docetaxel
560237|NCT00431613|Gemcitabine|gemcitabine
560238|NCT00431613|Carboplatin|carboplatin
560239|NCT00431626|Benign|benign
560240|NCT00431626|Prostatic|prostatic
560241|NCT00431626|Hyperplasia|hyperplasia
560242|NCT00431626|Lower|lower
560243|NCT00431626|Urinary|urinary
560244|NCT00431626|Track|track
560245|NCT00431626|Symptoms|symptoms
560246|NCT00431626|Laser|laser
560247|NCT00431626|Transurethral|transurethral
560248|NCT00431626|Prostate|prostate
560249|NCT00431639|Animal-Assisted Therapy|animal-assisted therapy
560253|NCT00431665|Renal Plasma Flow|renal plasma flow
560254|NCT00431665|Glomerular Filtration Rate|glomerular filtration rate
560255|NCT00431665|Free fatty acids|free fatty acids
560256|NCT00431678|Community-acquired Pneumonia|community-acquired pneumonia
560257|NCT00431704|advanced|advanced
560258|NCT00431704|her-2 positive|her-2 positive
560259|NCT00431717|Coronary Atherosclerosis|coronary atherosclerosis
560260|NCT00431717|Diabetes Mellitus|diabetes mellitus
560261|NCT00431743|Fluid Therapy|fluid therapy
560262|NCT00431743|Crystalloid|crystalloid
560263|NCT00431743|Colloid|colloid
560264|NCT00431743|Perioperative|perioperative
560265|NCT00431743|Optimization|optimization
560266|NCT00431743|Goal-directed Therapy|goal-directed therapy
560267|NCT00431756|Barrett's esophagus|barrett's esophagus
560268|NCT00431756|gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
560269|NCT00431756|esophageal cancer|esophageal cancer
562034|NCT00437320|Photoaging|photoaging
560271|NCT00431769|Multiple myeloma|multiple myeloma
560272|NCT00431769|Bortezomib|bortezomib
560273|NCT00431769|Dexamethasone|dexamethasone
560275|NCT00431782|Atrial fibrillation|atrial fibrillation
560277|NCT00431795|Advanced breast cancer|advanced breast cancer
560278|NCT00431795|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
560279|NCT00431795|Epirubicin|epirubicin
560280|NCT00431808|Malaria|malaria
560281|NCT00431808|vaccine|vaccine
560282|NCT00431808|Apical Membrane Antigene|apical membrane antigene
560283|NCT00431808|Mali|mali
560284|NCT00431808|Adults|adults
560285|NCT00431821|Exercise|exercise
560286|NCT00431821|Rehabilitation|rehabilitation
560287|NCT00431821|Stroke|stroke
560288|NCT00431834|Permanent Atrial Fibrillation Surgical RF Ablation|permanent atrial fibrillation surgical rf ablation
560289|NCT00431834|Permanent Atrial Fibrillation|permanent atrial fibrillation
560290|NCT00431847|Anesthesia, Regional|anesthesia, regional
560291|NCT00431847|Causalgia|causalgia
560292|NCT00431847|Trauma|trauma
560293|NCT00431847|Complex Regional Pain Syndrome Type II|complex regional pain syndrome type ii
560294|NCT00431847|Neuropathic Pain|neuropathic pain
560295|NCT00431847|PTSD|ptsd
560296|NCT00431847|Combat Stress Disorders|combat stress disorders
560297|NCT00431847|Afghan War, 2001-|afghan war, 2001-
723279|NCT01049386|health|health
560298|NCT00431847|Iraq War, 2003-|iraq war, 2003-
560299|NCT00431860|Coronary atherosclerosis, Spiral Computed Tomography|coronary atherosclerosis, spiral computed tomography
560300|NCT00431873|Lymphocytic Leukemia, Chronic (Refractory)|lymphocytic leukemia, chronic (refractory)
560301|NCT00431873|Phase II|phase ii
560302|NCT00431886|Chest pains|chest pains
560303|NCT00431886|Computed tomography|computed tomography
560304|NCT00431886|Emergency|emergency
560305|NCT00431899|nutrition|nutrition
560306|NCT00431899|omega 3 fatty acids|omega 3 fatty acids
560307|NCT00431899|insulin resistance|insulin resistance
560308|NCT00431912|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
560309|NCT00431912|mycosis fungoides|mycosis fungoides
560310|NCT00431912|Sézary syndrome|sézary syndrome
560311|NCT00431912|APO866|apo866
560312|NCT00431912|phase II study|phase ii study
560313|NCT00431925|head and neck cancer|head and neck cancer
560314|NCT00431925|radiation therapy|radiation therapy
560315|NCT00431925|chemotherapy|chemotherapy
560316|NCT00431925|mucositis|mucositis
560317|NCT00431925|cytokines|cytokines
560318|NCT00431925|gastrostomy|gastrostomy
560319|NCT00431925|radiotherapy|radiotherapy
560320|NCT00431951|Healthy Volunteers|healthy volunteers
560321|NCT00431964|azithromycin, Zithromax|azithromycin, zithromax
560322|NCT00431977|Coronary Atherosclerosis|coronary atherosclerosis
560323|NCT00431977|Diabetes Mellitus|diabetes mellitus
560324|NCT00432003|Treatment Experienced|treatment experienced
560325|NCT00432003|HIV|hiv
560326|NCT00432003|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
560327|NCT00432016|HIV|hiv
560328|NCT00432016|pharmacokinetics|pharmacokinetics
560329|NCT00432016|zidovudine|zidovudine
560330|NCT00432016|amdoxovir|amdoxovir
560331|NCT00432016|DAPD|dapd
560332|NCT00432016|AMDX|amdx
560333|NCT00432016|Treatment Naive|treatment naive
560334|NCT00432029|Flicker induced vasodilatation|flicker induced vasodilatation
560335|NCT00432029|Flow mediated vasodilatation|flow mediated vasodilatation
560336|NCT00432029|Forearm blood flow|forearm blood flow
560337|NCT00432029|Retinal vessel diameter|retinal vessel diameter
560338|NCT00432029|Endothelial dysfunction|endothelial dysfunction
560339|NCT00432042|Mumps and Rubella|mumps and rubella
560340|NCT00432042|Haemophilus influenzae type b (Infanrix® hexa)|haemophilus influenzae type b (infanrix® hexa)
560341|NCT00432055|Adult|adult
560342|NCT00432055|Cerebral Palsy|cerebral palsy
560343|NCT00432055|Spastic contractures|spastic contractures
560344|NCT00432055|Botulinum toxin type A|botulinum toxin type a
560345|NCT00432068|Healthy volunteers|healthy volunteers
560346|NCT00432068|octreotide pamoate|octreotide pamoate
560347|NCT00432068|pharmacokinetics|pharmacokinetics
560348|NCT00432081|Dementia|dementia
560349|NCT00432081|Inflammation|inflammation
560350|NCT00432081|Anti-Inflammatory Agents|anti-inflammatory agents
560431|NCT00432302|Epothilone|epothilone
560351|NCT00432081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
560352|NCT00432081|Drug Therapy|drug therapy
560353|NCT00432094|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
560354|NCT00432094|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
560355|NCT00432094|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
560356|NCT00432094|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
560357|NCT00432094|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
560358|NCT00432094|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
560359|NCT00432094|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
560360|NCT00432094|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
560361|NCT00432094|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
560362|NCT00432094|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
560363|NCT00432094|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
560274|NCT00431769|VELCADE|velcade
560364|NCT00432094|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
560365|NCT00432094|testicular choriocarcinoma|testicular choriocarcinoma
560366|NCT00432094|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
560367|NCT00432094|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
560368|NCT00432094|testicular embryonal carcinoma|testicular embryonal carcinoma
560369|NCT00432094|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
560370|NCT00432094|testicular yolk sac tumor|testicular yolk sac tumor
560371|NCT00432094|testicular seminoma|testicular seminoma
560372|NCT00432094|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
560373|NCT00432094|stage IV extragonadal seminoma|stage iv extragonadal seminoma
560374|NCT00432094|stage I extragonadal non-seminomatous germ cell tumor|stage i extragonadal non-seminomatous germ cell tumor
560375|NCT00432094|stage I extragonadal seminoma|stage i extragonadal seminoma
560376|NCT00432094|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
559912|NCT00423813|FMS|fms
560377|NCT00432094|stage II extragonadal seminoma|stage ii extragonadal seminoma
560378|NCT00432094|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
560379|NCT00432094|stage III extragonadal seminoma|stage iii extragonadal seminoma
560380|NCT00432094|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
560381|NCT00432094|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
560382|NCT00432094|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
560383|NCT00432094|adult teratoma|adult teratoma
560384|NCT00432094|childhood teratoma|childhood teratoma
560385|NCT00432094|testicular immature teratoma|testicular immature teratoma
560386|NCT00432094|testicular mature teratoma|testicular mature teratoma
560387|NCT00432094|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
560388|NCT00432094|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
560389|NCT00432107|Advanced cutaneous melanoma|advanced cutaneous melanoma
560390|NCT00432107|Phase II study|phase ii study
560391|NCT00432133|Physical Activity|physical activity
560392|NCT00432133|Behavior Change|behavior change
560393|NCT00432133|Mechanism|mechanism
560394|NCT00432133|Environmental|environmental
560395|NCT00432133|Ecological Model of Physical Activity|ecological model of physical activity
560396|NCT00432146|Graves' disease, Lugol's solution|graves' disease, lugol's solution
560397|NCT00432159|cervical|cervical
560398|NCT00432159|spinal|spinal
560399|NCT00432159|arthroplasty|arthroplasty
560400|NCT00432159|disc|disc
560401|NCT00432159|surgical|surgical
560402|NCT00432159|ACDF|acdf
560404|NCT00432172|Her2neu negative breast cancer.|her2neu negative breast cancer.
560405|NCT00432172|Neoadjuvant treatment.|neoadjuvant treatment.
560406|NCT00432185|sBCC|sbcc
560407|NCT00432185|Topical|topical
560408|NCT00432185|Dermatology|dermatology
560409|NCT00432198|Insomnia|insomnia
560410|NCT00432198|Zolpidem|zolpidem
560411|NCT00432198|Adolescent|adolescent
560412|NCT00432250|Preterm labor|preterm labor
560413|NCT00432250|Cervical ultrasonography|cervical ultrasonography
560414|NCT00432250|Hospital stay|hospital stay
560415|NCT00432276|Glucose Metabolism Disorder|glucose metabolism disorder
560416|NCT00432276|Dysmetabolic Syndrome|dysmetabolic syndrome
560417|NCT00432276|Type II Diabetes|type ii diabetes
560418|NCT00432276|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
560419|NCT00432276|Dyslipidemia|dyslipidemia
560420|NCT00432276|Hyperglycemia|hyperglycemia
560421|NCT00432276|Drug Therapy|drug therapy
560422|NCT00432289|neurological function|neurological function
560423|NCT00432302|Cancer|cancer
560424|NCT00432302|Tumor|tumor
560425|NCT00432302|Malignancy|malignancy
560426|NCT00432302|Mass Balance|mass balance
560427|NCT00432302|Chemotherapy|chemotherapy
560428|NCT00432302|Drug|drug
560429|NCT00432302|Cancer Treatment|cancer treatment
560430|NCT00432302|Intravenous Infusion|intravenous infusion
560432|NCT00432302|Solid Tumor|solid tumor
560433|NCT00432354|statin|statin
560434|NCT00432354|systemic lupus erythematosus|systemic lupus erythematosus
560435|NCT00432354|microcirculation|microcirculation
560436|NCT00432367|Malaria in pregnancy|malaria in pregnancy
560437|NCT00432367|Case management|case management
560438|NCT00432367|Screening|screening
560439|NCT00432367|RDT|rdt
560440|NCT00432367|IPTp|iptp
560441|NCT00432367|Amodiaquine|amodiaquine
560442|NCT00432367|Artesunate|artesunate
560443|NCT00432380|Placebo|placebo
560444|NCT00432380|Double blind|double blind
560445|NCT00432380|Gastroenteritis|gastroenteritis
560446|NCT00432380|Randomized|randomized
560447|NCT00432380|Oral live attenuated human rotavirus liquid vaccine|oral live attenuated human rotavirus liquid vaccine
560448|NCT00432406|Psoriatic Arthritis|psoriatic arthritis
560449|NCT00432406|TNF-α|tnf-α
560450|NCT00432406|Cardiovascular risk|cardiovascular risk
560451|NCT00432406|Immunomodulatory activities|immunomodulatory activities
560453|NCT00432419|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
560454|NCT00432419|Peripheral blood stem cells transplantation|peripheral blood stem cells transplantation
560455|NCT00432432|Ankylosing Spondylitis|ankylosing spondylitis
560457|NCT00432432|Infliximab|infliximab
560458|NCT00432445|Children with retinoblastoma|children with retinoblastoma
560459|NCT00432445|Retinoblastoma|retinoblastoma
560460|NCT00432445|Pediatrics|pediatrics
560461|NCT00432445|Proton Beam Radiation Therapy|proton beam radiation therapy
560462|NCT00432445|Radiation Therapy|radiation therapy
560463|NCT00432445|Tumor of the Eye|tumor of the eye
560464|NCT00432445|Ophthalmic EUA|ophthalmic eua
560465|NCT00432445|Examination under anesthesia|examination under anesthesia
560466|NCT00432445|Bilateral retinoblastoma|bilateral retinoblastoma
560467|NCT00432445|Unilateral retinoblastoma|unilateral retinoblastoma
560468|NCT00432445|Extraocular disease|extraocular disease
560469|NCT00432445|Intraocular procedure|intraocular procedure
560470|NCT00432458|stage I multiple myeloma|stage i multiple myeloma
560471|NCT00432471|Skin Cancer|skin cancer
560472|NCT00432471|Non-Melanoma Skin Cancer|non-melanoma skin cancer
560473|NCT00432471|Optical Imaging|optical imaging
560474|NCT00432471|Multispectral Digital Microscope System|multispectral digital microscope system
560475|NCT00432471|MDM|mdm
560476|NCT00432484|Lingzhi|lingzhi
560477|NCT00432484|Sen Miao San|sen miao san
560478|NCT00432484|Rheumatoid Arthritis|rheumatoid arthritis
560479|NCT00432510|Hereditary angioedema|hereditary angioedema
560480|NCT00432510|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
560481|NCT00432523|Prevention of : Measles, Mumps, Rubella and Varicella diseases|prevention of : measles, mumps, rubella and varicella diseases
560482|NCT00432536|Neuro-monitoring|neuro-monitoring
560483|NCT00432536|Quality Improvement|quality improvement
560484|NCT00432536|Cerebral emboli|cerebral emboli
560485|NCT00432536|Cerebral desaturation|cerebral desaturation
560486|NCT00432536|Hypotension|hypotension
560487|NCT00432549|Medication overuse|medication overuse
560488|NCT00432575|tobacco use cessation|tobacco use cessation
560489|NCT00432575|cigarette smokers|cigarette smokers
560490|NCT00432588|IUFD|iufd
560491|NCT00432588|POSTTERM|postterm
560492|NCT00432588|ROM|rom
560493|NCT00432601|decision aid|decision aid
560494|NCT00432601|prostate cancer|prostate cancer
560495|NCT00432601|patient-physician communication|patient-physician communication
560496|NCT00432601|decision making|decision making
560497|NCT00432601|literacy|literacy
560498|NCT00432614|Mental Disorder|mental disorder
560499|NCT00432614|Mood Disorder|mood disorder
560500|NCT00432614|Depressive Disorder|depressive disorder
560501|NCT00432627|Hepatic impairment|hepatic impairment
560502|NCT00432627|adults|adults
560503|NCT00432627|deferasirox|deferasirox
560504|NCT00432640|(suspected) Non Small Cell Lung Cancer|(suspected) non small cell lung cancer
560505|NCT00432653|ankylosing spondylitis|ankylosing spondylitis
560506|NCT00432653|rituximab|rituximab
560507|NCT00432653|therapy|therapy
560508|NCT00432653|magnetic resonance imaging|magnetic resonance imaging
560509|NCT00432679|rosiglitazone|rosiglitazone
560510|NCT00432679|Avandia|avandia
560511|NCT00432679|type 2 diabetes mellitus|type 2 diabetes mellitus
560512|NCT00432679|diabetes|diabetes
560513|NCT00432692|osteoporosis|osteoporosis
560514|NCT00432692|falls|falls
560515|NCT00432692|prevention|prevention
560516|NCT00432692|elderly|elderly
560517|NCT00432692|exercise|exercise
560518|NCT00432692|incidence|incidence
560519|NCT00432692|obstacle avoidance|obstacle avoidance
560520|NCT00432705|ankle|ankle
560521|NCT00432705|sensorimotor|sensorimotor
560522|NCT00432705|reflex|reflex
560523|NCT00432705|training|training
560524|NCT00432718|Pneumonia|pneumonia
560525|NCT00432718|Ventilator Associated Pneumonia|ventilator associated pneumonia
560526|NCT00432718|Prevention|prevention
560527|NCT00432731|Prevention of : Varicella|prevention of : varicella
560528|NCT00432731|Measles|measles
560529|NCT00432731|Mumps|mumps
560530|NCT00432731|Rubella|rubella
560531|NCT00432744|mitochondrial diseases|mitochondrial diseases
560532|NCT00432744|respiratory chain complex I deficiencies|respiratory chain complex i deficiencies
560634|NCT00433095|Navelbine|navelbine
560533|NCT00432744|respiratory chain complex II deficiencies|respiratory chain complex ii deficiencies
560534|NCT00432744|respiratory chain complex III deficiencies|respiratory chain complex iii deficiencies
560535|NCT00432744|respiratory chain complex IV deficiencies|respiratory chain complex iv deficiencies
560536|NCT00432744|mutations of a gene coding for a respiratory chain component|mutations of a gene coding for a respiratory chain component
560537|NCT00432757|allergic conjunctivitis, ophthalmology, multicenter, controlled|allergic conjunctivitis, ophthalmology, multicenter, controlled
560538|NCT00432783|HIV, antiretroviral therapy, adherence, ritonavir|hiv, antiretroviral therapy, adherence, ritonavir
560539|NCT00432796|Anticoagulation|anticoagulation
560540|NCT00432796|Prosthetic heart valves|prosthetic heart valves
560541|NCT00432796|Atrial fibrillation|atrial fibrillation
560542|NCT00432796|Bridging Therapy|bridging therapy
560543|NCT00432796|Thromboembolism|thromboembolism
560544|NCT00432796|Warfarin|warfarin
560545|NCT00432796|Low Molecular Weight Heparin|low molecular weight heparin
560546|NCT00432809|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
560547|NCT00432809|Obesity|obesity
560548|NCT00432822|phenylketonuria|phenylketonuria
560549|NCT00432822|phenylalanine hydroxylase deficiency|phenylalanine hydroxylase deficiency
560551|NCT00432822|responsive|responsive
560552|NCT00432822|tetrahydrobiopterin|tetrahydrobiopterin
560553|NCT00432822|newborns|newborns
560554|NCT00432822|infants|infants
560555|NCT00432822|children|children
560556|NCT00432822|adolescents|adolescents
560557|NCT00432835|Nausea|nausea
560558|NCT00432835|Vomiting|vomiting
560559|NCT00432835|Delayed gastric emptying|delayed gastric emptying
560560|NCT00432835|Diabetes Mellitus|diabetes mellitus
560561|NCT00432835|Post-Surgical|post-surgical
560562|NCT00432835|Idiopathic|idiopathic
560563|NCT00432861|cystic fibrosis|cystic fibrosis
560564|NCT00432861|pancreatic insufficiency|pancreatic insufficiency
560565|NCT00432861|PANCRECARB® MS-16 (pancrelipase)|pancrecarb® ms-16 (pancrelipase)
560566|NCT00432861|steatorrhea|steatorrhea
560567|NCT00432887|caffeine|caffeine
560023|NCT00423865|06-129|06-129
560568|NCT00432887|coffee|coffee
560569|NCT00432887|glucose|glucose
560570|NCT00432887|insulin|insulin
560571|NCT00432900|Inflammation|inflammation
560572|NCT00432900|Neuroimmunology|neuroimmunology
560573|NCT00432900|Multiple Sclerosis|multiple sclerosis
560574|NCT00432900|MS|ms
560575|NCT00432900|Healthy Volunteer|healthy volunteer
560576|NCT00432900|HV|hv
560577|NCT00432913|Eicosapentaenoic acid|eicosapentaenoic acid
560578|NCT00432913|EPA|epa
560579|NCT00432913|EPA 99%|epa 99%
560580|NCT00432913|Fatty acid|fatty acid
560581|NCT00432913|omega-3|omega-3
560582|NCT00432913|apoptosis|apoptosis
560583|NCT00432913|cell proliferation|cell proliferation
560584|NCT00432913|colonic mucosa|colonic mucosa
560585|NCT00432913|polyps|polyps
560586|NCT00432913|adenomatous polyps|adenomatous polyps
560587|NCT00432913|endoscopy|endoscopy
560588|NCT00432913|PUFA|pufa
560589|NCT00432926|HIV|hiv
560590|NCT00432926|STDs|stds
560591|NCT00432926|Methamphetamine abuse|methamphetamine abuse
560592|NCT00432926|MSM|msm
560593|NCT00432926|HIV Seronegativity|hiv seronegativity
560594|NCT00432939|Primary Hyperparathyroidism|primary hyperparathyroidism
560595|NCT00432952|Cardiovascular Heart Disease|cardiovascular heart disease
560596|NCT00432965|Wound closure|wound closure
560597|NCT00432965|Accelerated healing|accelerated healing
560598|NCT00432978|hypoxia|hypoxia
560599|NCT00432978|endothelin|endothelin
560600|NCT00432978|exercise|exercise
560601|NCT00432991|Nausea|nausea
560602|NCT00432991|Vomiting|vomiting
560603|NCT00432991|Cesarean Section|cesarean section
560604|NCT00433004|Teen|teen
560605|NCT00433004|Plan B|plan b
560606|NCT00433004|Post Partum|post partum
560607|NCT00433004|Emergency Contraception|emergency contraception
560608|NCT00433017|Age-related macular degeneration|age-related macular degeneration
560609|NCT00433017|AMD|amd
560610|NCT00433017|Choroidal neovascularization|choroidal neovascularization
560611|NCT00433017|Verteporfin|verteporfin
560612|NCT00433017|Ranibizumab|ranibizumab
560613|NCT00433030|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
560614|NCT00433030|HIV Viral load|hiv viral load
560615|NCT00433030|HIV drug Resistance|hiv drug resistance
560616|NCT00433030|Thailand|thailand
560617|NCT00433043|Heart Failure|heart failure
560618|NCT00433043|Beta blockers|beta blockers
560619|NCT00433043|Resynchronization|resynchronization
560620|NCT00433043|Congestive Heart Failure, NYHA III-IV|congestive heart failure, nyha iii-iv
560621|NCT00433043|Candidate for BIVPM|candidate for bivpm
560622|NCT00433043|Not on Target Dose (Coreg 25 Bid or Toprol XL 200 qd)|not on target dose (coreg 25 bid or toprol xl 200 qd)
560624|NCT00433056|HIV|hiv
560625|NCT00433056|CD4|cd4
560626|NCT00433056|HIV-RNA|hiv-rna
560627|NCT00433056|HAART|haart
560628|NCT00433069|Chronic hepatitis C|chronic hepatitis c
560629|NCT00433069|Insulin resistance|insulin resistance
560630|NCT00433069|Pioglitazone|pioglitazone
560631|NCT00433069|Non-responders|non-responders
560632|NCT00433082|Metabolic syndrome,Ramadan,Fasting,Inflammatory markers,|metabolic syndrome,ramadan,fasting,inflammatory markers,
560633|NCT00433082|Iran|iran
560635|NCT00433095|Herceptin|herceptin
560636|NCT00433095|oral|oral
560637|NCT00433095|breast cancer|breast cancer
560638|NCT00433108|Hepatitis C|hepatitis c
560639|NCT00433108|antioxidant|antioxidant
560640|NCT00433108|liver enzymes|liver enzymes
560641|NCT00433108|ALT|alt
560642|NCT00433121|Antidepressive Agents|antidepressive agents
560643|NCT00433121|Neuroleptica|neuroleptica
560644|NCT00433121|Dementia|dementia
560645|NCT00433121|Discontinuation study|discontinuation study
560646|NCT00433121|Behavioural- and Psychological Symptoms in Dementia|behavioural- and psychological symptoms in dementia
560647|NCT00433134|renal transplant recipient|renal transplant recipient
560648|NCT00433134|adherence|adherence
560649|NCT00433134|compliance|compliance
560650|NCT00433134|immunosuppression|immunosuppression
560651|NCT00433173|testosterone|testosterone
560652|NCT00433173|insulin sensitivity|insulin sensitivity
560653|NCT00433173|insulin resistance|insulin resistance
560654|NCT00433173|metabolic disorders|metabolic disorders
560656|NCT00433199|Hypogonadism|hypogonadism
560657|NCT00433199|Testosterone Deficiency|testosterone deficiency
560658|NCT00433212|prematurity|prematurity
560659|NCT00433212|respiratory insufficiency|respiratory insufficiency
560660|NCT00433212|non-invasive ventilation|non-invasive ventilation
560661|NCT00433212|bronchopulmonary dysplasia|bronchopulmonary dysplasia
560662|NCT00433212|hyaline membrane disease|hyaline membrane disease
560663|NCT00433238|elderly|elderly
560664|NCT00433238|Chinese|chinese
560665|NCT00433238|community living|community living
560666|NCT00433238|measurement|measurement
560667|NCT00433238|depression|depression
560668|NCT00433238|dementia|dementia
560669|NCT00433238|Geriatric Depression Scale|geriatric depression scale
560670|NCT00433238|MiniCog|minicog
560671|NCT00433264|peritoneal dialysis|peritoneal dialysis
560672|NCT00433264|endothelium|endothelium
560073|NCT00424125|Asthma|asthma
560673|NCT00433264|endothelial dysfunction|endothelial dysfunction
560674|NCT00433316|ropivacaine|ropivacaine
560675|NCT00433316|laparoscopy|laparoscopy
560676|NCT00433316|intraperitoneal|intraperitoneal
560677|NCT00433316|nebulization|nebulization
560678|NCT00433316|pain|pain
560679|NCT00433316|local analgesic|local analgesic
560680|NCT00433316|gynecology|gynecology
560681|NCT00433329|pulmonary arterial hypertension|pulmonary arterial hypertension
560682|NCT00433329|bosentan|bosentan
560683|NCT00433329|sildenafil|sildenafil
560684|NCT00433329|combination therapy|combination therapy
560685|NCT00433329|Compass 3|compass 3
560686|NCT00433342|Antibiotic|antibiotic
560687|NCT00433342|p-cresol|p-cresol
560688|NCT00433342|peritoneal dialysis|peritoneal dialysis
560689|NCT00433355|Chronic Fatigue Syndrome|chronic fatigue syndrome
560690|NCT00433355|Epstein-Barr Virus|epstein-barr virus
560691|NCT00433368|L-ornithine-L-aspartate,|l-ornithine-l-aspartate,
560692|NCT00433368|porto-systemic encephalopathy,|porto-systemic encephalopathy,
560693|NCT00433368|hepatic encephalopathy,|hepatic encephalopathy,
560694|NCT00433368|liver cirrhosis,|liver cirrhosis,
560695|NCT00433368|mental state|mental state
560696|NCT00433394|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
560697|NCT00433407|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
560698|NCT00433407|stage I breast cancer|stage i breast cancer
560699|NCT00433407|stage II breast cancer|stage ii breast cancer
560700|NCT00433407|stage IIIA breast cancer|stage iiia breast cancer
560701|NCT00433407|stage IIIB breast cancer|stage iiib breast cancer
560702|NCT00433407|stage IIIC breast cancer|stage iiic breast cancer
560703|NCT00433407|stage IV breast cancer|stage iv breast cancer
560704|NCT00433407|male breast cancer|male breast cancer
560705|NCT00433407|recurrent breast cancer|recurrent breast cancer
560706|NCT00433407|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
560707|NCT00433407|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
560708|NCT00433407|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
560709|NCT00433407|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
560710|NCT00433407|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
560711|NCT00433407|stage I non-small cell lung cancer|stage i non-small cell lung cancer
560712|NCT00433407|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
560713|NCT00433407|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
560714|NCT00433407|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
560715|NCT00433407|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
560716|NCT00433407|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
560717|NCT00433407|extensive stage small cell lung cancer|extensive stage small cell lung cancer
560718|NCT00433407|limited stage small cell lung cancer|limited stage small cell lung cancer
560719|NCT00433407|recurrent small cell lung cancer|recurrent small cell lung cancer
560720|NCT00433407|stage I prostate cancer|stage i prostate cancer
560721|NCT00433407|stage IIB prostate cancer|stage iib prostate cancer
560722|NCT00433407|stage IIA prostate cancer|stage iia prostate cancer
560723|NCT00433407|stage III prostate cancer|stage iii prostate cancer
560724|NCT00433407|stage IV prostate cancer|stage iv prostate cancer
560725|NCT00433407|recurrent prostate cancer|recurrent prostate cancer
560726|NCT00433407|stage I uterine sarcoma|stage i uterine sarcoma
560727|NCT00433407|stage II uterine sarcoma|stage ii uterine sarcoma
560728|NCT00433407|stage III uterine sarcoma|stage iii uterine sarcoma
560729|NCT00433407|stage IV uterine sarcoma|stage iv uterine sarcoma
560730|NCT00433407|recurrent uterine sarcoma|recurrent uterine sarcoma
560731|NCT00433420|stage II breast cancer|stage ii breast cancer
560732|NCT00433420|stage IIIA breast cancer|stage iiia breast cancer
560733|NCT00433420|stage IIIB breast cancer|stage iiib breast cancer
560734|NCT00433420|stage IIIC breast cancer|stage iiic breast cancer
560735|NCT00433433|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
560736|NCT00433433|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
560737|NCT00433433|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
560738|NCT00433433|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
560739|NCT00433433|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
560740|NCT00433446|adenocarcinoma of the prostate|adenocarcinoma of the prostate
560741|NCT00433446|stage IV prostate cancer|stage iv prostate cancer
560742|NCT00433446|recurrent prostate cancer|recurrent prostate cancer
560743|NCT00433459|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
560744|NCT00433459|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
560745|NCT00433459|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
560746|NCT00433459|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
560747|NCT00433459|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
560748|NCT00433459|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
560749|NCT00433459|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
560167|NCT00430105|Vasculitis|vasculitis
560750|NCT00433472|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
560751|NCT00433472|adult giant cell glioblastoma|adult giant cell glioblastoma
560752|NCT00433472|adult anaplastic astrocytoma|adult anaplastic astrocytoma
560753|NCT00433472|recurrent adult brain tumor|recurrent adult brain tumor
560754|NCT00433472|adult glioblastoma|adult glioblastoma
560755|NCT00433472|adult gliosarcoma|adult gliosarcoma
560756|NCT00433485|basal cell carcinoma of the skin|basal cell carcinoma of the skin
560757|NCT00433485|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
560758|NCT00433498|extensive stage small cell lung cancer|extensive stage small cell lung cancer
560759|NCT00433498|limited stage small cell lung cancer|limited stage small cell lung cancer
560760|NCT00433524|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
560761|NCT00433563|limited stage small cell lung cancer|limited stage small cell lung cancer
560762|NCT00433589|invasive ductal breast carcinoma|invasive ductal breast carcinoma
560763|NCT00433589|invasive lobular breast carcinoma|invasive lobular breast carcinoma
560764|NCT00433589|stage IA breast cancer|stage ia breast cancer
560765|NCT00433589|stage IB breast cancer|stage ib breast cancer
560766|NCT00433589|stage II breast cancer|stage ii breast cancer
560767|NCT00433589|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
560768|NCT00433589|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
560769|NCT00433602|thromboembolism|thromboembolism
560770|NCT00433602|recurrent breast cancer|recurrent breast cancer
560771|NCT00433602|stage IV breast cancer|stage iv breast cancer
560772|NCT00433602|recurrent colon cancer|recurrent colon cancer
560773|NCT00433602|stage I colon cancer|stage i colon cancer
560774|NCT00433602|stage II colon cancer|stage ii colon cancer
560775|NCT00433602|stage III colon cancer|stage iii colon cancer
560776|NCT00433602|stage IV colon cancer|stage iv colon cancer
560777|NCT00433602|recurrent rectal cancer|recurrent rectal cancer
560778|NCT00433602|stage I rectal cancer|stage i rectal cancer
560779|NCT00433602|stage II rectal cancer|stage ii rectal cancer
560780|NCT00433602|stage III rectal cancer|stage iii rectal cancer
560781|NCT00433602|stage IV rectal cancer|stage iv rectal cancer
560782|NCT00433602|recurrent gastric cancer|recurrent gastric cancer
560783|NCT00433602|stage I gastric cancer|stage i gastric cancer
560784|NCT00433602|stage II gastric cancer|stage ii gastric cancer
560785|NCT00433602|stage III gastric cancer|stage iii gastric cancer
560786|NCT00433602|stage IV gastric cancer|stage iv gastric cancer
560787|NCT00433602|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
560788|NCT00433602|stage I non-small cell lung cancer|stage i non-small cell lung cancer
560789|NCT00433602|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
560790|NCT00433602|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
560791|NCT00433602|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
560792|NCT00433602|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
560793|NCT00433602|recurrent small cell lung cancer|recurrent small cell lung cancer
560794|NCT00433602|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
560795|NCT00433602|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
560796|NCT00433602|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
560797|NCT00433602|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
560798|NCT00433602|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
560799|NCT00433602|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
560991|NCT00415740|carbidopa|carbidopa
560800|NCT00433602|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
560801|NCT00433602|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
560802|NCT00433602|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
560803|NCT00433602|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
560804|NCT00433602|ovarian sarcoma|ovarian sarcoma
560805|NCT00433602|ovarian stromal cancer|ovarian stromal cancer
560806|NCT00433602|recurrent pancreatic cancer|recurrent pancreatic cancer
560807|NCT00433602|stage I pancreatic cancer|stage i pancreatic cancer
560808|NCT00433602|stage II pancreatic cancer|stage ii pancreatic cancer
560809|NCT00433602|stage III pancreatic cancer|stage iii pancreatic cancer
560810|NCT00433602|stage IV pancreatic cancer|stage iv pancreatic cancer
560811|NCT00433602|recurrent prostate cancer|recurrent prostate cancer
560812|NCT00433602|stage III prostate cancer|stage iii prostate cancer
562035|NCT00437320|Galderma|galderma
560813|NCT00433602|stage IV prostate cancer|stage iv prostate cancer
560814|NCT00433602|extensive stage small cell lung cancer|extensive stage small cell lung cancer
560815|NCT00433602|limited stage small cell lung cancer|limited stage small cell lung cancer
560816|NCT00433602|stage IIB prostate cancer|stage iib prostate cancer
560817|NCT00433602|stage IIA prostate cancer|stage iia prostate cancer
560818|NCT00433602|male breast cancer|male breast cancer
560819|NCT00433628|Hemoglobin A1C|hemoglobin a1c
560820|NCT00433628|HIV|hiv
560821|NCT00433628|Diabetes|diabetes
560822|NCT00433628|Diabetes Type 2|diabetes type 2
560823|NCT00433628|Hyperglycemia|hyperglycemia
560824|NCT00433641|obesity|obesity
560250|NCT00431639|Pain|pain
560825|NCT00433641|pharmacogenetics|pharmacogenetics
560826|NCT00433641|sibutramine|sibutramine
560827|NCT00433641|adrenergic|adrenergic
560828|NCT00433641|serotonergic|serotonergic
560829|NCT00433641|body composition|body composition
560830|NCT00433641|gastric emptying|gastric emptying
560831|NCT00433654|Bradycardia|bradycardia
560832|NCT00433654|Slow heart beat|slow heart beat
560833|NCT00433654|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
560834|NCT00433667|RWJ-333369|rwj-333369
560835|NCT00433667|anticonvulsants|anticonvulsants
560836|NCT00433667|antiepileptic drugs|antiepileptic drugs
560837|NCT00433680|adolescent|adolescent
560838|NCT00433680|female|female
560839|NCT00433680|obesity|obesity
560840|NCT00433680|body dissatisfaction|body dissatisfaction
560841|NCT00433706|Prostate adenocarcinoma treated by radiotherapy|prostate adenocarcinoma treated by radiotherapy
560842|NCT00433719|Human immunodeficiency virus|human immunodeficiency virus
560843|NCT00433719|Tuberculous meningitis|tuberculous meningitis
560844|NCT00433719|Treatment Naive|treatment naive
560845|NCT00433732|TREXIMA|trexima
560846|NCT00433732|MIGRAINE HEADACHES|migraine headaches
560847|NCT00433732|Subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches|subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches
560848|NCT00433745|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
560849|NCT00433745|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
560850|NCT00433745|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
560851|NCT00433745|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
560852|NCT00433745|Wilm's Tumor-1 Peptide|wilm's tumor-1 peptide
560853|NCT00433745|Leukemia|leukemia
560854|NCT00433745|Myelodysplastic Syndrome|myelodysplastic syndrome
560855|NCT00433745|MDS|mds
560856|NCT00433745|Acute Myelogenous Leukemia|acute myelogenous leukemia
560857|NCT00433745|AML|aml
560858|NCT00433745|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
560859|NCT00433745|CML|cml
560860|NCT00433745|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
560861|NCT00433745|ALL|all
560862|NCT00433758|Diabetes|diabetes
560863|NCT00433758|Blood glucose monitoring|blood glucose monitoring
560864|NCT00433758|Non invasive Blood glucose monitoring|non invasive blood glucose monitoring
560865|NCT00433771|Malignant|malignant
560866|NCT00433771|Cholestasis, Extrahepatic|cholestasis, extrahepatic
560867|NCT00433771|Biliary obstruction|biliary obstruction
560868|NCT00433784|clopidogrel|clopidogrel
560869|NCT00433784|platelet aggregation|platelet aggregation
560870|NCT00433784|CYP3A|cyp3a
560871|NCT00433784|H2 haplotype|h2 haplotype
560872|NCT00433784|polymorphisms|polymorphisms
560873|NCT00433797|Prostate cancer|prostate cancer
560874|NCT00433797|PSA|psa
560875|NCT00433797|antioxidant|antioxidant
560876|NCT00433797|phytochemical|phytochemical
560877|NCT00433797|tomatoes|tomatoes
560878|NCT00433797|PUFA|pufa
560879|NCT00433797|selenium|selenium
560880|NCT00433797|soy|soy
560881|NCT00433797|pomegranate|pomegranate
560882|NCT00433797|grapes|grapes
560883|NCT00433810|obesity|obesity
560884|NCT00433810|bariatric surgery|bariatric surgery
560885|NCT00433810|30-day mortality|30-day mortality
560886|NCT00433823|Very low level of LDL|very low level of ldl
560887|NCT00433823|Steroid hormones|steroid hormones
560888|NCT00433823|Atorvastatin|atorvastatin
560889|NCT00433823|Ezetimibe|ezetimibe
560890|NCT00433823|Lipoprotein-a|lipoprotein-a
560891|NCT00433836|Children|children
560892|NCT00433836|pediatrics|pediatrics
560893|NCT00433836|High Blood Pressure|high blood pressure
560894|NCT00433836|Hypertension|hypertension
560895|NCT00433836|Valsartan|valsartan
560896|NCT00433836|enalapril|enalapril
560897|NCT00433862|Polycythemia Vera|polycythemia vera
560898|NCT00433862|Essential Thrombocytosis|essential thrombocytosis
560899|NCT00433862|Idiopathic Myelofibrosis|idiopathic myelofibrosis
560900|NCT00433862|Janus Kinase 2|janus kinase 2
560901|NCT00433862|CD177|cd177
560902|NCT00433862|Chronic Myeloproliferative Disorders|chronic myeloproliferative disorders
560903|NCT00433862|PV|pv
560904|NCT00433862|Essential Thrombocythemia|essential thrombocythemia
560905|NCT00433862|ET|et
560906|NCT00433862|IM|im
560907|NCT00433901|obesity in children|obesity in children
560908|NCT00433901|childhood disorders|childhood disorders
560909|NCT00433901|overweight children|overweight children
560910|NCT00433901|physical activity|physical activity
562593|NCT00439166|rifampicin|rifampicin
560911|NCT00433901|home environment|home environment
560912|NCT00433914|Meningococcal disease, prevention, vaccination|meningococcal disease, prevention, vaccination
560913|NCT00433927|metastatic|metastatic
560914|NCT00433940|Hemangioma|hemangioma
560915|NCT00433940|Corticosteroid|corticosteroid
560916|NCT00433940|Prednisone|prednisone
560917|NCT00433953|Pediatric Kidney Transplant|pediatric kidney transplant
560918|NCT00433953|Kidney Transplant|kidney transplant
560919|NCT00433953|CellCept|cellcept
560403|NCT00432159|DDD|ddd
560920|NCT00433953|Mycophenolate Mofetil|mycophenolate mofetil
560921|NCT00433953|Mycophenolic Acid|mycophenolic acid
560922|NCT00433966|Myocardial Infarction|myocardial infarction
560923|NCT00433966|Angioplasty|angioplasty
560924|NCT00433966|Myocardial Ischemia|myocardial ischemia
560925|NCT00433966|Myocardial Reperfusion|myocardial reperfusion
560926|NCT00433966|Stents|stents
560927|NCT00433966|Heart Disease|heart disease
560928|NCT00433979|Anti-HIV agents|anti-hiv agents
560929|NCT00433979|Physiological Effects of Drugs|physiological effects of drugs
560930|NCT00433979|ARV-associated Adverse Events|arv-associated adverse events
560931|NCT00433979|HAART|haart
560932|NCT00433979|Pharmacokinetics|pharmacokinetics
560933|NCT00433979|Protease Inhibitors|protease inhibitors
560934|NCT00433979|Non-nucleoside Reverse Transcriptase Inhibitors|non-nucleoside reverse transcriptase inhibitors
560935|NCT00433979|Women|women
560936|NCT00433992|Mitochondria|mitochondria
560937|NCT00433992|Fat apoptosis|fat apoptosis
560938|NCT00433992|Lipoatrophy|lipoatrophy
560939|NCT00433992|Lipodystrophy|lipodystrophy
560940|NCT00433992|Thymidine|thymidine
560941|NCT00433992|Treatment experienced|treatment experienced
560942|NCT00415558|Atrial Fibrillation|atrial fibrillation
560943|NCT00415571|Hypogonadism|hypogonadism
560944|NCT00415571|Erectile Dysfunction|erectile dysfunction
560945|NCT00415584|hypercalcemia|hypercalcemia
560946|NCT00415584|transplant|transplant
560947|NCT00415597|chronic pain|chronic pain
560948|NCT00415597|joint pain|joint pain
560949|NCT00415597|back pain|back pain
560950|NCT00415597|diabetic peripheral neuropathy|diabetic peripheral neuropathy
560951|NCT00415597|post herpetic neuralgia|post herpetic neuralgia
560952|NCT00415597|ALO-01|alo-01
560953|NCT00415597|Embeda|embeda
560954|NCT00415597|Chronic Non-Malignant Pain|chronic non-malignant pain
560955|NCT00415610|cerebral hemorrhage|cerebral hemorrhage
560956|NCT00415610|intracerebral hemorrhage|intracerebral hemorrhage
560957|NCT00415610|stroke|stroke
560958|NCT00415610|hypertension|hypertension
560959|NCT00415610|blood pressure|blood pressure
560960|NCT00415610|nicardipine|nicardipine
560961|NCT00415610|antihypertensive agent|antihypertensive agent
560962|NCT00415610|hematoma expansion|hematoma expansion
560963|NCT00415649|HIV Preventive Vaccine|hiv preventive vaccine
560964|NCT00415649|HIV Seronegativity|hiv seronegativity
560965|NCT00415675|Lung Cancer|lung cancer
560966|NCT00415675|Abdominal Cancer|abdominal cancer
560967|NCT00415675|Tissue Motion|tissue motion
560968|NCT00415675|Breathing|breathing
560969|NCT00415675|Motion CT Scans|motion ct scans
560970|NCT00415688|lifestyle modification|lifestyle modification
560971|NCT00415688|weight loss|weight loss
560972|NCT00415688|hyperglycemia|hyperglycemia
560973|NCT00415688|hypoglycemic agents|hypoglycemic agents
560974|NCT00415701|Etomidate|etomidate
560975|NCT00415701|Propofol|propofol
560976|NCT00415701|Adrenocortical Insufficiency|adrenocortical insufficiency
560977|NCT00415701|Hemodynamic Process|hemodynamic process
560978|NCT00415701|Vasoactive Agonists|vasoactive agonists
560979|NCT00415701|Coronary Artery Bypass|coronary artery bypass
560980|NCT00415701|Ischemic Coronary Heart Disease|ischemic coronary heart disease
560981|NCT00415701|Mitral valve reconstruction/replacement|mitral valve reconstruction/replacement
560982|NCT00415701|Mitral valve regurgitation|mitral valve regurgitation
560983|NCT00415701|Heart Valve Prosthesis|heart valve prosthesis
560984|NCT00415701|Cardiopulmonary Bypass|cardiopulmonary bypass
560985|NCT00415714|Primary Insomnia|primary insomnia
560986|NCT00415714|Chronic Insomnia|chronic insomnia
560987|NCT00415714|Biofeedback|biofeedback
560988|NCT00415714|Sleeplessness|sleeplessness
560989|NCT00415740|Bioequivalence|bioequivalence
560990|NCT00415740|bioavailability|bioavailability
560992|NCT00415740|levodopa|levodopa
560993|NCT00415740|entacapone|entacapone
560994|NCT00415740|fasting|fasting
560995|NCT00415740|Healthy volunteers study|healthy volunteers study
560996|NCT00415766|recombinant hCG|recombinant hcg
560997|NCT00415766|urinary hCG|urinary hcg
560998|NCT00415779|hormone refractory|hormone refractory
560999|NCT00415779|bone metastasis|bone metastasis
561000|NCT00415779|chemotherapy|chemotherapy
561001|NCT00415779|biphosphonates|biphosphonates
561002|NCT00415792|Ovulation induction|ovulation induction
561003|NCT00415792|hCG|hcg
561004|NCT00415792|GnRH agonist|gnrh agonist
561005|NCT00415792|hyper-responders|hyper-responders
561006|NCT00415818|Lung Cancer|lung cancer
561007|NCT00415818|NSCLC|nsclc
561008|NCT00415818|Cancer Vaccine|cancer vaccine
561009|NCT00415818|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
561186|NCT00416312|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
561010|NCT00415818|Stage IIIb Non-Small Cell Lung Cancer with effusion|stage iiib non-small cell lung cancer with effusion
561011|NCT00415831|Bioequivalence|bioequivalence
561012|NCT00415831|bioavailability|bioavailability
561013|NCT00415831|carbidopa|carbidopa
561014|NCT00415831|levodopa|levodopa
561015|NCT00415831|entacapone|entacapone
561016|NCT00415831|fed condition|fed condition
561017|NCT00415831|Healthy volunteers study|healthy volunteers study
561018|NCT00415844|Bioequivalence|bioequivalence
561019|NCT00415844|bioavailability|bioavailability
561020|NCT00415844|carbidopa|carbidopa
561021|NCT00415844|levodopa|levodopa
561022|NCT00415844|entacapone|entacapone
561023|NCT00415844|fasting condition|fasting condition
561024|NCT00415844|Healthy volunteers study|healthy volunteers study
561025|NCT00415857|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
561026|NCT00415857|Leukemia|leukemia
561027|NCT00415857|Peptide Vaccine|peptide vaccine
561028|NCT00415857|PR1 Peptide|pr1 peptide
561029|NCT00415857|Imatinib|imatinib
561030|NCT00415857|Gleevec|gleevec
561031|NCT00415857|GM-CSF|gm-csf
561032|NCT00415857|Sargramostim|sargramostim
561033|NCT00415857|Leukine|leukine
561034|NCT00415857|Peginterferon alfa-2b|peginterferon alfa-2b
561035|NCT00415857|Peg-Intron|peg-intron
561036|NCT00415870|Overweight|overweight
561037|NCT00415870|Cell Phone|cell phone
561038|NCT00415870|Technology|technology
561039|NCT00415883|Relative bioavailability, formulation, Japanese, valsartan, healthy subjects|relative bioavailability, formulation, japanese, valsartan, healthy subjects
561040|NCT00415896|weaning|weaning
561041|NCT00415896|work of breathing|work of breathing
561042|NCT00415896|spontaneous breathing trial|spontaneous breathing trial
561043|NCT00415896|rapid shallow breathing|rapid shallow breathing
561044|NCT00415909|Leukemia|leukemia
561045|NCT00415909|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
561046|NCT00415909|CML|cml
561047|NCT00415909|Imatinib|imatinib
561048|NCT00415909|Gleevec|gleevec
561049|NCT00415909|TALL-104|tall-104
561050|NCT00415922|Bioequivalence|bioequivalence
561051|NCT00415922|bioavailability|bioavailability
561052|NCT00415922|carbidopa|carbidopa
561053|NCT00415922|levodopa|levodopa
561054|NCT00415922|entacapone|entacapone
561055|NCT00415922|fasting condition|fasting condition
561056|NCT00415922|Healthy volunteers study|healthy volunteers study
561057|NCT00415948|Heart|heart
561058|NCT00415948|Cardiac|cardiac
561059|NCT00415948|Acute Coronary Syndrome|acute coronary syndrome
561060|NCT00415948|Sample Procurement|sample procurement
561061|NCT00415961|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
561062|NCT00415961|Drug-eluting stent (DES)|drug-eluting stent (des)
561063|NCT00415974|Weight Loss|weight loss
561064|NCT00415974|Obesity|obesity
561065|NCT00415974|Overweight|overweight
561066|NCT00415974|Physical Activity|physical activity
561067|NCT00415974|Nutrition|nutrition
561068|NCT00415974|Primary Care Physicians|primary care physicians
561069|NCT00415974|Primary Care|primary care
561070|NCT00415974|Counseling|counseling
561072|NCT00415987|Multiple Myeloma|multiple myeloma
561073|NCT00416000|Open/Elective EVAR patients|open/elective evar patients
561074|NCT00416013|Beta Natriuretic Peptide|beta natriuretic peptide
561075|NCT00416013|Troponin|troponin
561076|NCT00416013|Hemodialysis|hemodialysis
561077|NCT00416026|Quality improvement|quality improvement
561078|NCT00416026|Patient-centered care|patient-centered care
561079|NCT00416026|Acute coronary syndrome|acute coronary syndrome
561080|NCT00416026|Telephone counseling|telephone counseling
561081|NCT00416039|midazolam|midazolam
561082|NCT00416039|sublingual|sublingual
561083|NCT00416039|oral morphine|oral morphine
561084|NCT00416039|children|children
561085|NCT00416039|bone fracture|bone fracture
561086|NCT00416039|bone fracture with a deformed member|bone fracture with a deformed member
561087|NCT00416052|calcium|calcium
561088|NCT00416052|calciuria|calciuria
561089|NCT00416052|PTH|pth
561090|NCT00416052|1,25-vitamin D|1,25-vitamin d
561091|NCT00416052|Calcitriol|calcitriol
561092|NCT00416052|bone mineral density|bone mineral density
561093|NCT00416052|osteodensitometry|osteodensitometry
561337|NCT00434109|Kinase|kinase
561094|NCT00416078|technology development and assessment|technology development and assessment
561095|NCT00416078|internet|internet
561096|NCT00416078|randomized control trial|randomized control trial
561097|NCT00416091|Tourette disorder, ADHD, comorbidity, neuropsychological|tourette disorder, adhd, comorbidity, neuropsychological
561098|NCT00416104|analgesia|analgesia
561099|NCT00416117|Neck pain|neck pain
561100|NCT00416117|Cervical pain|cervical pain
561101|NCT00416117|Radicular pain|radicular pain
561102|NCT00416117|Manual therapy|manual therapy
561103|NCT00416117|Mobilization|mobilization
561104|NCT00416117|Manipulation|manipulation
561105|NCT00416130|Phase I/II Clinical Trial|phase i/ii clinical trial
561106|NCT00416130|Vorinostat|vorinostat
561107|NCT00416130|SAHA|saha
561108|NCT00416130|Recurrent Breast Cancer|recurrent breast cancer
561109|NCT00416130|Metastatic Breast Cancer|metastatic breast cancer
561354|NCT00434174|Lung cancer|lung cancer
561110|NCT00416143|Bed rest for idiopathic sudden sensorineural hearing loss|bed rest for idiopathic sudden sensorineural hearing loss
561111|NCT00416156|Obesity|obesity
561112|NCT00416156|Inflammation|inflammation
561114|NCT00416169|Pick Complex|pick complex
561115|NCT00416169|galantamine hydrobromide|galantamine hydrobromide
561116|NCT00416182|Cystic fibrosis|cystic fibrosis
561117|NCT00416182|chronic sinusitis|chronic sinusitis
561118|NCT00416182|mucolytic|mucolytic
561119|NCT00416208|Multiple Myeloma|multiple myeloma
561120|NCT00416208|Clinical trial|clinical trial
561121|NCT00416208|Bortezomib|bortezomib
561122|NCT00416208|PS341|ps341
561123|NCT00416208|Proteasome inhibitor|proteasome inhibitor
561124|NCT00416208|Consolidation therapy|consolidation therapy
561125|NCT00416221|Depression|depression
561126|NCT00416221|Lexapro|lexapro
561127|NCT00416247|Hypnosis|hypnosis
561128|NCT00416247|TMS|tms
561129|NCT00416247|Cortical excitability|cortical excitability
561130|NCT00416260|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
561131|NCT00416260|High-Frequency Ventilation|high-frequency ventilation
561132|NCT00416260|Respiration, Artificial|respiration, artificial
561133|NCT00416273|Multiple Myeloma|multiple myeloma
561134|NCT00416273|Bortezomib|bortezomib
561135|NCT00416273|PS341|ps341
561136|NCT00416273|Proteasome inhibitor|proteasome inhibitor
561137|NCT00416273|Consolidation therapy|consolidation therapy
561138|NCT00416286|Cetylpyridinium chlorid|cetylpyridinium chlorid
561139|NCT00416286|Sustained release|sustained release
561140|NCT00416286|orthodontic patients|orthodontic patients
561141|NCT00416286|streptococcus mutans|streptococcus mutans
561142|NCT00416286|Lactobacillus|lactobacillus
561143|NCT00416286|Rate of bacterial load in saliva of orthodontic patients|rate of bacterial load in saliva of orthodontic patients
561144|NCT00416299|Cardiac biomarker|cardiac biomarker
561145|NCT00416299|cardiac surgery|cardiac surgery
561146|NCT00416299|elderly|elderly
561147|NCT00416299|postoperative complications|postoperative complications
561148|NCT00416299|Patients aged 75 years or older undergoing cardiac surgery|patients aged 75 years or older undergoing cardiac surgery
561149|NCT00416312|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
561150|NCT00416312|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
561151|NCT00416312|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
561152|NCT00416312|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
561153|NCT00416312|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
561154|NCT00416312|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
561155|NCT00416312|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
561156|NCT00416312|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
561157|NCT00416312|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
561158|NCT00416312|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
561159|NCT00416312|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
561160|NCT00416312|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
561161|NCT00416312|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
561162|NCT00416312|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
561163|NCT00416312|splenic marginal zone lymphoma|splenic marginal zone lymphoma
561164|NCT00416312|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
561165|NCT00416312|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
561166|NCT00416312|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
561167|NCT00416312|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
561168|NCT00416312|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
561169|NCT00416312|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
561170|NCT00416312|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
561171|NCT00416312|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
561172|NCT00416312|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
561173|NCT00416312|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
561174|NCT00416312|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
561175|NCT00416312|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
561176|NCT00416312|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
561177|NCT00416312|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
561178|NCT00416312|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
561179|NCT00416312|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
561180|NCT00416312|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
561181|NCT00416312|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
561182|NCT00416312|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
561183|NCT00416312|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
561184|NCT00416312|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
561185|NCT00416312|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
561187|NCT00416312|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
561188|NCT00416312|Waldenström macroglobulinemia|waldenström macroglobulinemia
561189|NCT00416312|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
560623|NCT00433056|STI|sti
561190|NCT00416312|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
561191|NCT00416312|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
561192|NCT00416312|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
561193|NCT00416312|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
561194|NCT00416312|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
561195|NCT00416312|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
561196|NCT00416312|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
561197|NCT00416312|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
561198|NCT00416312|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
561199|NCT00416312|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
561200|NCT00416312|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
561201|NCT00416312|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
561202|NCT00416312|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
561203|NCT00416312|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
561204|NCT00416312|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
561205|NCT00416312|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
561206|NCT00416312|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
561207|NCT00416312|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
561208|NCT00416312|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
561209|NCT00416312|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
561210|NCT00416312|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
561211|NCT00416312|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
561212|NCT00416312|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
561213|NCT00416312|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
561214|NCT00416312|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
561215|NCT00416312|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
561216|NCT00416312|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
561217|NCT00416312|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
561218|NCT00416312|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
561219|NCT00416312|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
561220|NCT00416312|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
561221|NCT00416312|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
561222|NCT00416312|stage I mantle cell lymphoma|stage i mantle cell lymphoma
561223|NCT00416312|stage I marginal zone lymphoma|stage i marginal zone lymphoma
561224|NCT00416312|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
561225|NCT00416312|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
561226|NCT00416312|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
561227|NCT00416312|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
561228|NCT00416312|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
561229|NCT00416325|prostate cancer|prostate cancer
561230|NCT00416338|renal failure|renal failure
561231|NCT00416338|infection|infection
561232|NCT00416338|peritonitis|peritonitis
561233|NCT00427115|Patients undergoing allogeneic stem cell transplantations|patients undergoing allogeneic stem cell transplantations
561234|NCT00427128|Major Depression|major depression
561235|NCT00427128|"true drug response"|"true drug response"
561236|NCT00427128|"placebo response pattern"|"placebo response pattern"
561237|NCT00427128|continuation treatment outcomes|continuation treatment outcomes
561238|NCT00427141|tolerability,|tolerability,
561239|NCT00427141|pharmacokinetics,|pharmacokinetics,
561240|NCT00427141|first time in human,|first time in human,
561241|NCT00427141|food effect|food effect
561242|NCT00427141|safety,|safety,
561243|NCT00427167|Blood Stage|blood stage
561244|NCT00427167|Investigational|investigational
561245|NCT00427167|Vaccine|vaccine
561246|NCT00427167|Malaria|malaria
561247|NCT00427167|Healthy Volunteer|healthy volunteer
561249|NCT00427180|Visual Perception|visual perception
561250|NCT00427180|Retina|retina
561251|NCT00427180|Light|light
561252|NCT00427180|Retinitis Pigmentosa|retinitis pigmentosa
561253|NCT00427180|Visual acuity|visual acuity
561254|NCT00427180|Retinal Implant|retinal implant
561255|NCT00427180|Electrical stimulation|electrical stimulation
561256|NCT00427193|dietary restriction|dietary restriction
561569|NCT00435617|stroke|stroke
561257|NCT00427193|disease /disorder prevention /control|disease /disorder prevention /control
561258|NCT00427193|nutrition of aging|nutrition of aging
561259|NCT00427193|bioenergetics|bioenergetics
561260|NCT00427193|cardiovascular function|cardiovascular function
561261|NCT00427193|disease /disorder proneness /risk|disease /disorder proneness /risk
561262|NCT00427193|insulin sensitivity / resistance|insulin sensitivity / resistance
561263|NCT00427206|acetaminophen|acetaminophen
561264|NCT00427206|alcohol|alcohol
561265|NCT00427206|liver injury|liver injury
561266|NCT00427219|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
561267|NCT00427219|Prostatic Adenoma, Benign|prostatic adenoma, benign
561268|NCT00427219|Prostatic Hypertrophy, Benign|prostatic hypertrophy, benign
561269|NCT00427219|Enlarged Prostate|enlarged prostate
561270|NCT00427219|Prostatism|prostatism
561271|NCT00427219|Adenoma, Prostatic|adenoma, prostatic
561272|NCT00427232|coronary heart disease|coronary heart disease
561273|NCT00427232|endothelins|endothelins
561274|NCT00427232|coronary angiography|coronary angiography
561275|NCT00427232|blood flow velocity|blood flow velocity
561276|NCT00427232|fractional flow reserve, myocardial|fractional flow reserve, myocardial
561277|NCT00427245|menopausal symptoms|menopausal symptoms
561278|NCT00427245|infertility|infertility
561279|NCT00427245|stage IA breast cancer|stage ia breast cancer
561280|NCT00427245|stage IB breast cancer|stage ib breast cancer
561281|NCT00427245|stage II breast cancer|stage ii breast cancer
561282|NCT00427245|stage IIIA breast cancer|stage iiia breast cancer
561283|NCT00427245|stage IIIB breast cancer|stage iiib breast cancer
561284|NCT00427245|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
561285|NCT00427245|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
561286|NCT00427245|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
561287|NCT00427258|healthy subjects|healthy subjects
561288|NCT00427271|aspirin|aspirin
561289|NCT00427271|enalapril|enalapril
561290|NCT00427271|microalbuminuria|microalbuminuria
561291|NCT00427271|glomerular filtration rate|glomerular filtration rate
561292|NCT00427284|Eplerenone auf die Endothelfunktion bei Patienten mit stabiler koronarer Herzkrankheit|eplerenone auf die endothelfunktion bei patienten mit stabiler koronarer herzkrankheit
561293|NCT00434005|Air pollution|air pollution
561294|NCT00434005|diesel|diesel
561295|NCT00434005|antioxidant|antioxidant
561296|NCT00434005|oxidative stress|oxidative stress
561297|NCT00434005|endothelial|endothelial
561298|NCT00434005|HRV|hrv
561299|NCT00434005|BAR|bar
561300|NCT00434018|Wheelchairs|wheelchairs
561301|NCT00434018|Safety|safety
561302|NCT00434031|locally advanced|locally advanced
561303|NCT00434031|stage II|stage ii
561304|NCT00434031|stage IIIa|stage iiia
561305|NCT00434031|stage IIIb|stage iiib
561306|NCT00434031|HER-2 positive|her-2 positive
561307|NCT00434031|primary|primary
561308|NCT00434057|Pigmented Skin Lesions|pigmented skin lesions
561309|NCT00434057|Dermatology|dermatology
561310|NCT00434057|Skin Cancer|skin cancer
561311|NCT00434057|Melanoma|melanoma
561312|NCT00434057|MelaFind|melafind
561313|NCT00434070|HIV|hiv
561314|NCT00434070|Antiretrovial Therapy|antiretrovial therapy
561315|NCT00434070|Resistance|resistance
561316|NCT00434070|Monitoring|monitoring
561317|NCT00434070|TAMS|tams
561318|NCT00434070|Treatment Experienced|treatment experienced
561319|NCT00434083|TREXIMA|trexima
561320|NCT00434083|MIGRAINE HEADACHES|migraine headaches
561321|NCT00434083|Subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches|subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches
561322|NCT00434096|Obesity disease|obesity disease
561323|NCT00434096|cannabinoid-1 receptor|cannabinoid-1 receptor
561324|NCT00434109|Carcinoid|carcinoid
561325|NCT00434109|Pancreatic|pancreatic
561326|NCT00434109|Metastatic|metastatic
561327|NCT00434109|Neuroendocrine|neuroendocrine
561328|NCT00434109|Tumors|tumors
561329|NCT00434109|Hepatic|hepatic
561330|NCT00434109|Artery|artery
561331|NCT00434109|Embolization|embolization
561332|NCT00434109|Angiogenesis|angiogenesis
561333|NCT00434109|Sunitinib|sunitinib
561334|NCT00434109|Malate|malate
561335|NCT00434109|Sutent|sutent
561336|NCT00434109|Tyrosine|tyrosine
561338|NCT00434109|Inhibitor|inhibitor
561339|NCT00434122|Assisted Reproductive Technology (ART)|assisted reproductive technology (art)
561340|NCT00434122|oocyte donors undergoing controlled ovarian hyperstimulation for assisted reproductive technologies|oocyte donors undergoing controlled ovarian hyperstimulation for assisted reproductive technologies
561341|NCT00434135|gemcitabine|gemcitabine
561342|NCT00434135|pemetrexed|pemetrexed
561343|NCT00434135|non-small cell lung cancer|non-small cell lung cancer
561344|NCT00434148|Cushing's Disease|cushing's disease
561345|NCT00434148|pasireotide|pasireotide
561346|NCT00434148|SOM230|som230
561347|NCT00434161|Palifermin|palifermin
561348|NCT00434161|KGF|kgf
561349|NCT00434161|Clinical Trial|clinical trial
561350|NCT00434161|Oncology|oncology
561351|NCT00434161|Oral Mucositis|oral mucositis
561352|NCT00434161|Multiple Myeloma|multiple myeloma
561353|NCT00434161|Cataract|cataract
561355|NCT00434174|Non small cell lung cancer|non small cell lung cancer
561356|NCT00434174|NSCLC|nsclc
561357|NCT00434174|RAD001|rad001
561358|NCT00434174|Everolimus|everolimus
561359|NCT00434174|Afinitor|afinitor
561360|NCT00434174|Pemetrexed|pemetrexed
561361|NCT00434187|healthy|healthy
561362|NCT00434200|rheumatoid arthritis|rheumatoid arthritis
561363|NCT00434200|exercise|exercise
561364|NCT00434200|damage|damage
561365|NCT00434226|SABER-L|saber-l
561366|NCT00434226|NSCLC|nsclc
561367|NCT00434226|Avastin|avastin
561368|NCT00434226|Sutent|sutent
561369|NCT00434239|Myelodysplasia|myelodysplasia
561370|NCT00434239|Lenalidomide|lenalidomide
561371|NCT00434239|Ancestim|ancestim
561372|NCT00434239|Pilot trial|pilot trial
561373|NCT00434239|Biomarkers|biomarkers
561374|NCT00434252|Avastin|avastin
561375|NCT00434252|BEAM|beam
561376|NCT00434252|Metastatic melanoma|metastatic melanoma
561377|NCT00434265|Obesity|obesity
561378|NCT00434265|Exercise|exercise
561379|NCT00434265|Fat oxidation|fat oxidation
561380|NCT00434265|Overweigh (IMC>25 and IMC<30)|overweigh (imc>25 and imc<30)
561381|NCT00434278|Lung disease|lung disease
561383|NCT00434278|Pulmozyme|pulmozyme
561384|NCT00434291|Community-acquired Pneumonia|community-acquired pneumonia
561385|NCT00434291|fluoroquinolone|fluoroquinolone
561386|NCT00434291|TG-873870|tg-873870
561387|NCT00434291|Nemonoxacin|nemonoxacin
561388|NCT00434304|Parkinson's Disease|parkinson's disease
561389|NCT00434304|PD|pd
561390|NCT00434317|Metastasis|metastasis
561391|NCT00434317|Neoplasm|neoplasm
561392|NCT00434317|pain|pain
561393|NCT00434317|breast cancer|breast cancer
561394|NCT00434317|prostate cancer|prostate cancer
561395|NCT00434317|bone metastasis|bone metastasis
561396|NCT00434330|anemia|anemia
561397|NCT00434330|chronic kidney disease|chronic kidney disease
561398|NCT00434330|CKD|ckd
561399|NCT00434330|chronic renal failure|chronic renal failure
561400|NCT00434330|CRF|crf
561401|NCT00434330|dialysis|dialysis
561402|NCT00434330|erythropoietin|erythropoietin
561403|NCT00434330|EPO|epo
561404|NCT00434330|erythropoiesis stimulating agent|erythropoiesis stimulating agent
561405|NCT00434330|ESA|esa
561406|NCT00434330|Hematide™|hematide™
561407|NCT00434330|hemodialysis|hemodialysis
561408|NCT00434330|hemoglobin|hemoglobin
561409|NCT00434330|Hb|hb
561410|NCT00434330|Hgb|hgb
561411|NCT00434330|Omontys|omontys
561412|NCT00434330|peginesatide|peginesatide
561413|NCT00434330|red blood cell|red blood cell
561414|NCT00434330|red blood cell production|red blood cell production
561415|NCT00434980|Cognitive adaption|cognitive adaption
561416|NCT00434980|Schizophrenia|schizophrenia
561417|NCT00434980|Cognitive rehabilitation|cognitive rehabilitation
561418|NCT00434980|Family treatment|family treatment
561419|NCT00434980|Cognitive deficits|cognitive deficits
561420|NCT00434980|Serious mental illness|serious mental illness
561421|NCT00434993|Acute Lung Injury|acute lung injury
561422|NCT00434993|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
561423|NCT00434993|Albuterol|albuterol
561424|NCT00434993|Aerosolized|aerosolized
561425|NCT00434993|Critical Care|critical care
561426|NCT00434993|Ventilator|ventilator
561427|NCT00435032|ruptured appendicitis|ruptured appendicitis
561428|NCT00435032|children|children
561429|NCT00435032|surgery|surgery
561430|NCT00435032|randomized trial|randomized trial
561431|NCT00435045|Lovaza|lovaza
561432|NCT00435045|Hyperlipidemias|hyperlipidemias
561433|NCT00435045|Triglycerides|triglycerides
561434|NCT00435045|Lipids|lipids
561435|NCT00435045|omega-3 fatty acids|omega-3 fatty acids
561436|NCT00435045|Hypercholesterolemia|hypercholesterolemia
561437|NCT00435045|Hypertriglyceridemia|hypertriglyceridemia
561438|NCT00435045|omega-3-acid ethyl esters|omega-3-acid ethyl esters
561439|NCT00435045|Omacor|omacor
561440|NCT00435045|Dyslipidemias|dyslipidemias
561441|NCT00435058|intraocular pressure|intraocular pressure
561442|NCT00435058|contrast sensitivity|contrast sensitivity
561443|NCT00435058|visual function|visual function
561444|NCT00435084|Refractory B-CLL|refractory b-cll
561445|NCT00435084|phase I/II|phase i/ii
561446|NCT00435084|CD38|cd38
561447|NCT00435097|colon cancer|colon cancer
561448|NCT00435097|metastatic colorectal cancer|metastatic colorectal cancer
561449|NCT00435097|MRI|mri
561450|NCT00435097|Magnetic resonance imaging|magnetic resonance imaging
561451|NCT00435097|Early cancer detection|early cancer detection
561452|NCT00435097|medical image processing|medical image processing
561453|NCT00435097|machine learning|machine learning
561454|NCT00435097|disease modeling|disease modeling
561455|NCT00435097|Colon Cancer Stage III|colon cancer stage iii
561456|NCT00435110|ARDS|ards
561457|NCT00435110|ALI|ali
561458|NCT00435110|Mechanical Ventilation|mechanical ventilation
561459|NCT00435110|Outcome|outcome
561460|NCT00435123|Malnutrition|malnutrition
561461|NCT00435123|ESRD|esrd
724882|NCT01062165|Obesity|obesity
561462|NCT00435123|Hemodialysis|hemodialysis
561463|NCT00435162|Children|children
561464|NCT00435162|pediatrics|pediatrics
561465|NCT00435162|High Blood Pressure|high blood pressure
561466|NCT00435162|Hypertension|hypertension
561467|NCT00435162|Valsartan|valsartan
561468|NCT00435175|Estradiol|estradiol
561469|NCT00435175|Lipolysis|lipolysis
561470|NCT00435175|Estrogen receptor|estrogen receptor
561471|NCT00435175|Adrenergic receptors|adrenergic receptors
561472|NCT00435175|UCP2|ucp2
561473|NCT00435175|Postmenopausal women|postmenopausal women
561474|NCT00435188|Aging|aging
561475|NCT00435188|Cost analysis|cost analysis
561476|NCT00435188|Counseling|counseling
561477|NCT00435188|Disabled Persons|disabled persons
561478|NCT00435188|Health Promotion|health promotion
561479|NCT00435188|Mobility Limitation|mobility limitation
561480|NCT00435188|Physical Activity|physical activity
561481|NCT00435188|Primary Care|primary care
561482|NCT00435188|Randomized Clinical Trial|randomized clinical trial
561483|NCT00435188|Veterans|veterans
561484|NCT00435214|Cytology|cytology
561485|NCT00435214|papilloma virus|papilloma virus
561486|NCT00435214|CIN|cin
561487|NCT00435214|Screening|screening
561488|NCT00435214|Cervix|cervix
561489|NCT00435214|Cervical Cancer|cervical cancer
561490|NCT00435227|Respiratory Syncytial Viruses|respiratory syncytial viruses
561491|NCT00435253|emphysema|emphysema
561492|NCT00435253|COPD|copd
561493|NCT00435253|lung volume reduction|lung volume reduction
561494|NCT00435253|NETT|nett
561495|NCT00435253|BLVR|blvr
561496|NCT00435253|biologic lung volume reduction|biologic lung volume reduction
561497|NCT00435253|bronchoscopic lung volume reduction|bronchoscopic lung volume reduction
561498|NCT00435266|myocardial infarction|myocardial infarction
561499|NCT00435266|remote|remote
561500|NCT00435266|preconditioning|preconditioning
561501|NCT00435266|perconditioning|perconditioning
561502|NCT00435266|cardioprotection|cardioprotection
561503|NCT00435279|Insomnia|insomnia
561504|NCT00435279|Depression|depression
561505|NCT00435279|Major Depressive Disorder|major depressive disorder
561506|NCT00435305|continuous infusion|continuous infusion
561507|NCT00435305|epithelial lining fluid|epithelial lining fluid
561508|NCT00435305|antibiotics|antibiotics
561509|NCT00435305|pneumonia|pneumonia
561510|NCT00435305|critical illness|critical illness
561511|NCT00435331|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
561513|NCT00435344|Pediatric practice|pediatric practice
561514|NCT00435344|Smoking cessation|smoking cessation
561515|NCT00435344|Smoking prevention|smoking prevention
561516|NCT00435344|Adolescents|adolescents
561517|NCT00435357|Mobile-bearing|mobile-bearing
561518|NCT00435357|arthroplasty|arthroplasty
561519|NCT00435357|fixed-bearing|fixed-bearing
561520|NCT00435357|knee|knee
561521|NCT00435357|patella|patella
561522|NCT00435357|posterior stabilized TKA|posterior stabilized tka
561523|NCT00435383|Caudal Block|caudal block
561524|NCT00435383|Oxygen Saturation|oxygen saturation
561525|NCT00435383|Uni or Bilateral Orchidopexy|uni or bilateral orchidopexy
561526|NCT00435435|Alcoholism|alcoholism
561527|NCT00435435|Dependence|dependence
561528|NCT00435435|Randomization|randomization
561529|NCT00435435|Effect|effect
561530|NCT00435435|Disulfiram|disulfiram
561531|NCT00435435|Naltrexone|naltrexone
561532|NCT00435435|Acamprosate|acamprosate
561533|NCT00435448|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
561534|NCT00435448|BPH|bph
561535|NCT00435448|Enlarged Prostate|enlarged prostate
561536|NCT00435461|once daily|once daily
561537|NCT00435461|mountain cedar|mountain cedar
561538|NCT00435461|fexofenadine|fexofenadine
561539|NCT00435461|allergic rhinitis|allergic rhinitis
561540|NCT00435461|fluticasone furoate|fluticasone furoate
561541|NCT00435474|Cancer|cancer
561542|NCT00435474|Malignant wounds|malignant wounds
561543|NCT00435474|Quality of life|quality of life
561544|NCT00435474|Body-Image|body-image
561545|NCT00435474|Cancer patients|cancer patients
561546|NCT00435487|Non-ST Elevation Acute Coronary Syndromes coronary interventions|non-st elevation acute coronary syndromes coronary interventions
561547|NCT00435500|Dental caries, topical fluorides|dental caries, topical fluorides
561548|NCT00435526|traveler's diarrhea|traveler's diarrhea
561549|NCT00435526|ETEC diarrhea|etec diarrhea
562039|NCT00437333|PCOS|pcos
561550|NCT00435526|passive immunization|passive immunization
561551|NCT00435526|bovine milk prophylaxis|bovine milk prophylaxis
561552|NCT00435539|Vitreomacular Traction|vitreomacular traction
561553|NCT00435539|Maculopathy|maculopathy
561554|NCT00435539|VMT|vmt
561555|NCT00435539|PVD|pvd
561556|NCT00435578|Recurrent Sensitive Small-Cell Lung Cancer|recurrent sensitive small-cell lung cancer
561557|NCT00435591|Hyponatremia|hyponatremia
561558|NCT00435591|Euvolemia|euvolemia
561559|NCT00435591|Hypervolemia|hypervolemia
561560|NCT00435591|Conivaptan|conivaptan
561561|NCT00435591|Vaprisol®|vaprisol®
561562|NCT00435591|YM087|ym087
561563|NCT00435604|hyaluronidase|hyaluronidase
561564|NCT00435604|subcutaneous drug delivery|subcutaneous drug delivery
561565|NCT00435604|Volunteer Subjects|volunteer subjects
561566|NCT00435617|stroke rehabilitation|stroke rehabilitation
561567|NCT00435617|stroke therapy|stroke therapy
561568|NCT00435617|hand therapy|hand therapy
561575|NCT00435630|Learning Curve|learning curve
561576|NCT00435643|Sleep apnea,|sleep apnea,
561577|NCT00435643|adiponectin ,|adiponectin ,
561578|NCT00435643|HPA axis|hpa axis
561583|NCT00435695|healthy males|healthy males
561586|NCT00435708|Vegetables|vegetables
561587|NCT00435708|Oxidative stress|oxidative stress
561588|NCT00435708|Inflammation|inflammation
561589|NCT00435721|schizophrenia|schizophrenia
561590|NCT00435721|family psychoeducation|family psychoeducation
561591|NCT00435760|COPD|copd
561592|NCT00435773|Osteoarthritis|osteoarthritis
561593|NCT00435773|Leeching|leeching
561594|NCT00435773|Randomized Controlled Trial|randomized controlled trial
561595|NCT00435773|Arthralgia|arthralgia
561596|NCT00435799|keratoconus|keratoconus
561597|NCT00435799|corneal cross-linking|corneal cross-linking
561598|NCT00435799|riboflavine|riboflavine
561599|NCT00435799|ultraviolet type A rays (UVA)|ultraviolet type a rays (uva)
561606|NCT00435838|HLa-B*5701 Abacavir|hla-b*5701 abacavir
561607|NCT00435864|recipient of a HSC graft in Acute Myeloblastic Leukemia therapy|recipient of a hsc graft in acute myeloblastic leukemia therapy
561608|NCT00435864|recipient of a HSC graft in others pathologies treated in hematology of Nantes university hospital or Angers university hospital|recipient of a hsc graft in others pathologies treated in hematology of nantes university hospital or angers university hospital
561609|NCT00435864|donors are healthy subjects|donors are healthy subjects
561610|NCT00435877|Connective Tissue|connective tissue
561611|NCT00435877|Stromal Cells|stromal cells
561612|NCT00435877|Surgical Waste|surgical waste
561613|NCT00435877|In Vivo Studies|in vivo studies
561614|NCT00435877|Tissue Analysis|tissue analysis
561615|NCT00435890|ED Overcrowding|ed overcrowding
561616|NCT00435890|Length of stay|length of stay
561617|NCT00435890|Emergency triage|emergency triage
561618|NCT00435890|triage|triage
561619|NCT00435903|smoking|smoking
561620|NCT00435903|self-monitoring|self-monitoring
561621|NCT00435903|major mental illness|major mental illness
561622|NCT00435903|palm pilots|palm pilots
561623|NCT00435903|subjects with DSM-IV Axis I diagnosis|subjects with dsm-iv axis i diagnosis
561624|NCT00435916|Antigens, CD40|antigens, cd40
561625|NCT00435916|Antibody, Monoclonal|antibody, monoclonal
561626|NCT00435916|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
561627|NCT00435916|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
561628|NCT00435916|Hematologic Diseases|hematologic diseases
561629|NCT00435916|Immunoproliferative Disorders|immunoproliferative disorders
561630|NCT00435916|Lymphatic Diseases|lymphatic diseases
561631|NCT00435916|Lymphoproliferative Disorders|lymphoproliferative disorders
561632|NCT00435916|Lymphoma|lymphoma
561633|NCT00435929|Treatment Naive|treatment naive
561634|NCT00435955|Follicular lymphoma|follicular lymphoma
561635|NCT00435955|age adjusted IPI >1|age adjusted ipi >1
561636|NCT00435955|IIL score > 2|iil score > 2
561637|NCT00435955|Molecular remission|molecular remission
561638|NCT00435955|High dose chemotherapy and autologous transplantation|high dose chemotherapy and autologous transplantation
561639|NCT00435955|Rituximab|rituximab
561640|NCT00435968|NK Cells|nk cells
561641|NCT00435968|Cytokines|cytokines
561642|NCT00435968|Lymphocytes|lymphocytes
561643|NCT00435968|Immunoglobulins|immunoglobulins
561644|NCT00435968|Th1 response|th1 response
561645|NCT00435981|Type 1 diabetes|type 1 diabetes
561646|NCT00435981|GAD65|gad65
561647|NCT00435981|Autoimmunity|autoimmunity
561648|NCT00435981|C-peptide|c-peptide
561649|NCT00435981|Children|children
561650|NCT00435994|Infant|infant
561651|NCT00435994|Respiratory Syncytial Virus|respiratory syncytial virus
561652|NCT00435994|Bronchiolitis|bronchiolitis
561653|NCT00436007|Africa|africa
561654|NCT00436007|Plasmodium falciparum|plasmodium falciparum
561655|NCT00436007|Malaria|malaria
561656|NCT00436020|clinical trial|clinical trial
561657|NCT00436020|TMS|tms
561658|NCT00436020|depression|depression
561659|NCT00436020|bipolar disorder|bipolar disorder
561660|NCT00436046|interferon, vaccine, influenza|interferon, vaccine, influenza
561661|NCT00436072|ZD6474|zd6474
561662|NCT00436072|cetuximab|cetuximab
561663|NCT00436072|irinotecan|irinotecan
561664|NCT00436098|congenital heart disease|congenital heart disease
561665|NCT00436098|exercise training|exercise training
561666|NCT00436098|motorpedagogical exercise|motorpedagogical exercise
561668|NCT00436098|CHD: hemodynamically not significant defects|chd: hemodynamically not significant defects
561669|NCT00436098|CHD: acyanotic defects after repair|chd: acyanotic defects after repair
561670|NCT00436098|CHD: cyanotic defects after repair|chd: cyanotic defects after repair
561671|NCT00436111|hyperprolactinemia|hyperprolactinemia
561672|NCT00436111|autoantibody|autoantibody
561673|NCT00436137|Colorectal cancer|colorectal cancer
561674|NCT00436137|Fecal occult blood test|fecal occult blood test
561675|NCT00436137|Abnormal test result|abnormal test result
561676|NCT00436137|Missed diagnosis|missed diagnosis
561071|NCT00415974|Adolescent|adolescent
561677|NCT00436137|Delayed diagnosis|delayed diagnosis
561678|NCT00436150|Adolescents|adolescents
561679|NCT00436150|Depression, postpartum|depression, postpartum
561680|NCT00436176|Diabetes mellitus|diabetes mellitus
561681|NCT00436176|Quality of Health Care|quality of health care
561682|NCT00436176|Cultural Competency|cultural competency
561683|NCT00436176|Performance Feedback|performance feedback
561684|NCT00436176|Health navigator|health navigator
561685|NCT00436176|Health disparities|health disparities
561686|NCT00436176|Racial disparities|racial disparities
561687|NCT00436189|Ovarian|ovarian
561688|NCT00436189|Cancer|cancer
561689|NCT00436189|Pelvic|pelvic
561690|NCT00436189|Mass|mass
561691|NCT00436189|Tumor|tumor
561692|NCT00436189|Adnexal|adnexal
561693|NCT00436189|Proteomics|proteomics
561694|NCT00436202|Anemia|anemia
561695|NCT00436202|Iron|iron
561696|NCT00436202|Supplement|supplement
561697|NCT00436215|Sorafenib|sorafenib
561698|NCT00436215|Ovarian Cancer|ovarian cancer
561699|NCT00436215|Fallopian Cancer|fallopian cancer
561700|NCT00436215|Bevacizumab|bevacizumab
561701|NCT00436215|Peritoneal Cancer|peritoneal cancer
561702|NCT00436215|Fallopian Tube Cancer|fallopian tube cancer
561703|NCT00436228|healthy volunteer,|healthy volunteer,
561704|NCT00436228|Bioavailability,|bioavailability,
561705|NCT00436228|safety|safety
561706|NCT00436228|Phase I,|phase i,
561707|NCT00436267|recurrent pancreatic cancer|recurrent pancreatic cancer
561708|NCT00436267|stage IV pancreatic cancer|stage iv pancreatic cancer
561709|NCT00436267|liver metastases|liver metastases
561710|NCT00436306|prevention|prevention
561711|NCT00436306|behavior|behavior
561712|NCT00436306|risk reduction behavior|risk reduction behavior
561713|NCT00436319|Infertility, downregulation, stimulation, agonists, long|infertility, downregulation, stimulation, agonists, long
561714|NCT00436332|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
561715|NCT00436332|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
561716|NCT00436332|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
561717|NCT00436332|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
561718|NCT00436332|adenocarcinoma of the lung|adenocarcinoma of the lung
561719|NCT00436345|analgesia|analgesia
561720|NCT00436345|Mechanical ventilation|mechanical ventilation
561721|NCT00436345|pharmaco-economic|pharmaco-economic
561723|NCT00436358|Mexico|mexico
561724|NCT00436358|Intussusception|intussusception
561725|NCT00436358|Epidemiology|epidemiology
561726|NCT00436384|liver transplant|liver transplant
561727|NCT00436384|lung transplant|lung transplant
561728|NCT00436384|kidney transplant|kidney transplant
561729|NCT00436384|heart transplant|heart transplant
561730|NCT00436384|CMV CMI|cmv cmi
561731|NCT00436397|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
561732|NCT00436410|stage IV colon cancer|stage iv colon cancer
561733|NCT00436410|stage IV rectal cancer|stage iv rectal cancer
561734|NCT00436410|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
561735|NCT00436410|stage IV pancreatic cancer|stage iv pancreatic cancer
561736|NCT00436410|male breast cancer|male breast cancer
561737|NCT00436410|stage IV breast cancer|stage iv breast cancer
561738|NCT00436410|stage IV melanoma|stage iv melanoma
561739|NCT00436410|stage I breast cancer|stage i breast cancer
561740|NCT00436410|stage II breast cancer|stage ii breast cancer
561741|NCT00436410|stage IIIA breast cancer|stage iiia breast cancer
561742|NCT00436410|stage IIIB breast cancer|stage iiib breast cancer
561743|NCT00436410|stage IIIC breast cancer|stage iiic breast cancer
561744|NCT00436410|recurrent breast cancer|recurrent breast cancer
561745|NCT00436410|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
561746|NCT00436410|stage I adrenocortical carcinoma|stage i adrenocortical carcinoma
561747|NCT00436410|stage II adrenocortical carcinoma|stage ii adrenocortical carcinoma
561748|NCT00436410|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
561749|NCT00436410|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
561750|NCT00436410|recurrent colon cancer|recurrent colon cancer
561751|NCT00436410|stage I colon cancer|stage i colon cancer
561752|NCT00436410|stage II colon cancer|stage ii colon cancer
561753|NCT00436410|stage III colon cancer|stage iii colon cancer
561754|NCT00436410|recurrent rectal cancer|recurrent rectal cancer
561755|NCT00436410|stage I rectal cancer|stage i rectal cancer
561756|NCT00436410|stage II rectal cancer|stage ii rectal cancer
561757|NCT00436410|stage III rectal cancer|stage iii rectal cancer
562040|NCT00437333|Treatment|treatment
561758|NCT00436410|advanced adult primary liver cancer|advanced adult primary liver cancer
562906|NCT00440180|Obesity|obesity
561759|NCT00436410|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
561760|NCT00436410|recurrent adult primary liver cancer|recurrent adult primary liver cancer
561761|NCT00436410|recurrent pancreatic cancer|recurrent pancreatic cancer
561762|NCT00436410|stage I pancreatic cancer|stage i pancreatic cancer
561763|NCT00436410|stage II pancreatic cancer|stage ii pancreatic cancer
561764|NCT00436410|stage III pancreatic cancer|stage iii pancreatic cancer
561765|NCT00436410|recurrent melanoma|recurrent melanoma
561766|NCT00436410|stage I melanoma|stage i melanoma
561767|NCT00436410|stage II melanoma|stage ii melanoma
561768|NCT00436410|stage III melanoma|stage iii melanoma
561769|NCT00436410|stage I renal cell cancer|stage i renal cell cancer
561770|NCT00436410|stage II renal cell cancer|stage ii renal cell cancer
561771|NCT00436410|stage III renal cell cancer|stage iii renal cell cancer
561772|NCT00436410|stage IV renal cell cancer|stage iv renal cell cancer
561773|NCT00436410|recurrent renal cell cancer|recurrent renal cell cancer
561774|NCT00436410|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
561775|NCT00436410|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
561776|NCT00436410|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
561777|NCT00436410|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
561778|NCT00436410|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
561779|NCT00436410|gastrointestinal cancer|gastrointestinal cancer
561780|NCT00436410|adult fibrosarcoma|adult fibrosarcoma
561781|NCT00436410|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
561782|NCT00436410|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
561783|NCT00436410|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
561784|NCT00436410|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
561785|NCT00436410|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
561786|NCT00436423|pancreatic neoplasm|pancreatic neoplasm
561787|NCT00436423|drug therapy|drug therapy
561788|NCT00436423|gemcitabine|gemcitabine
561790|NCT00436436|adult giant cell glioblastoma|adult giant cell glioblastoma
561791|NCT00436436|adult gliosarcoma|adult gliosarcoma
561792|NCT00436436|recurrent adult brain tumor|recurrent adult brain tumor
561793|NCT00436436|adult glioblastoma|adult glioblastoma
561794|NCT00436462|Steroid receptors|steroid receptors
561795|NCT00436462|Endometrium|endometrium
561797|NCT00436462|Follicular phase|follicular phase
561798|NCT00436475|Glucose intolerance|glucose intolerance
561799|NCT00436475|Type 2 diabetes mellitus|type 2 diabetes mellitus
561800|NCT00436475|Metabolic syndrome|metabolic syndrome
561801|NCT00436488|ICAM-1|icam-1
561802|NCT00436488|Obesity|obesity
561803|NCT00436488|Gene variants|gene variants
561804|NCT00436501|primary peritoneal cavity cancer|primary peritoneal cavity cancer
561805|NCT00436501|Ovarian Epithelial Cancer|ovarian epithelial cancer
561806|NCT00436501|Peritoneal Cancer|peritoneal cancer
561807|NCT00436501|Fallopian Tube Cancer|fallopian tube cancer
561808|NCT00436501|VEGF Trap|vegf trap
561809|NCT00436501|aflibercept|aflibercept
561810|NCT00436501|vascular endothelial growth factor trap|vascular endothelial growth factor trap
561811|NCT00436501|Zaltrap|zaltrap
561812|NCT00436501|docetaxel|docetaxel
561813|NCT00436501|RP 56976|rp 56976
561814|NCT00436501|Taxotere|taxotere
561815|NCT00436501|TXT|txt
561816|NCT00436514|patients|patients
561817|NCT00436514|medium risk|medium risk
561818|NCT00436514|asymptomatic|asymptomatic
561819|NCT00436514|between 50 and 74 years old|between 50 and 74 years old
561820|NCT00436514|high risk|high risk
561821|NCT00436514|case|case
561822|NCT00436514|history of neoplastic colic|history of neoplastic colic
561823|NCT00436514|cancers|cancers
561824|NCT00436514|polyps|polyps
561825|NCT00436553|Age-related macular degeneration; AMD|age-related macular degeneration; amd
561826|NCT00436553|choroidal neovascularization|choroidal neovascularization
561827|NCT00436553|verteporfin|verteporfin
561828|NCT00436553|ranibizumab|ranibizumab
561829|NCT00436566|cardiac toxicity|cardiac toxicity
561830|NCT00436566|male breast cancer|male breast cancer
561831|NCT00436566|stage I breast cancer|stage i breast cancer
561832|NCT00436566|stage II breast cancer|stage ii breast cancer
561833|NCT00436566|stage IIIA breast cancer|stage iiia breast cancer
561834|NCT00436592|acute|acute
561835|NCT00436592|ischemic|ischemic
561836|NCT00436592|stroke|stroke
561837|NCT00436592|device|device
561838|NCT00436592|treatment|treatment
561839|NCT00436618|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
561840|NCT00436618|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
561841|NCT00436618|anaplastic large cell lymphoma|anaplastic large cell lymphoma
561842|NCT00436618|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
561843|NCT00436618|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
561844|NCT00436618|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
561845|NCT00436618|splenic marginal zone lymphoma|splenic marginal zone lymphoma
561846|NCT00436618|small intestine lymphoma|small intestine lymphoma
562037|NCT00437333|Insulin-sensitizing drug|insulin-sensitizing drug
561847|NCT00436618|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
563317|NCT00434538|Neuropathic|neuropathic
561848|NCT00436618|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
561849|NCT00436618|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
561850|NCT00436618|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
561851|NCT00436618|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
561248|NCT00427167|HV|hv
561852|NCT00436618|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
561853|NCT00436618|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
561854|NCT00436618|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
561855|NCT00436618|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
561856|NCT00436618|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
561857|NCT00436618|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
561858|NCT00436618|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
561859|NCT00436618|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
561860|NCT00436618|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
561861|NCT00436618|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
561862|NCT00436618|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
561863|NCT00436618|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
561864|NCT00436618|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
561865|NCT00436631|epilepsy|epilepsy
561866|NCT00436631|seizures|seizures
561867|NCT00436631|intractable|intractable
561869|NCT00436631|ketogenic|ketogenic
561870|NCT00436631|diet|diet
561871|NCT00436644|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
561872|NCT00436644|peritoneal cavity cancer|peritoneal cavity cancer
561873|NCT00436657|Children|children
561874|NCT00436657|Pediatric|pediatric
561875|NCT00436657|Peritoneal Tumor|peritoneal tumor
561876|NCT00436657|Retroperitoneal Tumor|retroperitoneal tumor
561877|NCT00436657|Gastrointestinal Adenocarcinoma|gastrointestinal adenocarcinoma
561878|NCT00436657|Desmoplastic Round Cell Tumor|desmoplastic round cell tumor
561879|NCT00436657|Neuroblastoma|neuroblastoma
561880|NCT00436657|Ovarian Germ Cell|ovarian germ cell
561881|NCT00436657|Sarcoma|sarcoma
561882|NCT00436657|Adrenocorticocarcinoma|adrenocorticocarcinoma
561883|NCT00436657|Wilms' Tumor|wilms' tumor
561884|NCT00436657|Rhabdomyosarcoma|rhabdomyosarcoma
561885|NCT00436657|Desmoplastic Small Round Cell Tumor|desmoplastic small round cell tumor
561886|NCT00436657|Recurrent Tumors|recurrent tumors
561887|NCT00436657|Cisplatin|cisplatin
561888|NCT00436657|Platinol®-AQ|platinol®-aq
561889|NCT00436657|Platinol®|platinol®
561890|NCT00436657|CDDP|cddp
561891|NCT00436657|Abdominal Wash|abdominal wash
561892|NCT00436657|Hyperthermic Perfusion|hyperthermic perfusion
561893|NCT00436657|Continuous Hyperthermic Peritoneal Perfusion|continuous hyperthermic peritoneal perfusion
561895|NCT00436670|Asthma|asthma
561896|NCT00436670|Allergy|allergy
561897|NCT00436670|IL-13|il-13
561898|NCT00436670|IL-4|il-4
561899|NCT00436670|IL-4R|il-4r
561900|NCT00436683|Hyperphosphataemia|hyperphosphataemia
561901|NCT00436683|Phosphate binder|phosphate binder
561902|NCT00436696|disseminated neuroblastoma|disseminated neuroblastoma
561903|NCT00436696|localized resectable neuroblastoma|localized resectable neuroblastoma
561904|NCT00436696|localized unresectable neuroblastoma|localized unresectable neuroblastoma
561905|NCT00436696|recurrent neuroblastoma|recurrent neuroblastoma
561906|NCT00436696|regional neuroblastoma|regional neuroblastoma
561907|NCT00436709|male breast cancer|male breast cancer
561908|NCT00436709|stage I breast cancer|stage i breast cancer
561909|NCT00436709|stage II breast cancer|stage ii breast cancer
561910|NCT00436709|stage IIIA breast cancer|stage iiia breast cancer
561911|NCT00436722|Liver|liver
561912|NCT00436722|Transplantation|transplantation
561913|NCT00436722|Tolerance|tolerance
561914|NCT00436722|Induction|induction
561915|NCT00436722|Tacrolimus|tacrolimus
561916|NCT00436722|Liver transplantation|liver transplantation
561917|NCT00436722|Adult|adult
561918|NCT00436748|Chronic Kidney Disease|chronic kidney disease
561919|NCT00436748|Dialysis|dialysis
561920|NCT00436748|Anemia|anemia
561921|NCT00436748|Nephrology|nephrology
561922|NCT00436748|Pediatric|pediatric
561923|NCT00436748|Hemodialysis|hemodialysis
561924|NCT00436748|Peritoneal Dialysis|peritoneal dialysis
561925|NCT00436748|Chronic Renal Insufficiency|chronic renal insufficiency
561926|NCT00436761|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
561927|NCT00436774|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
561928|NCT00436774|neurotoxicity|neurotoxicity
561929|NCT00436774|gastrointestinal complications|gastrointestinal complications
561930|NCT00436774|pulmonary complications|pulmonary complications
561931|NCT00436774|sexual dysfunction|sexual dysfunction
561932|NCT00436774|infertility|infertility
561933|NCT00436774|urinary complications|urinary complications
562038|NCT00437333|Metformin|metformin
561934|NCT00436774|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
562036|NCT00437333|Insulin sensitivity|insulin sensitivity
561935|NCT00436774|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
561936|NCT00436774|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
561937|NCT00436774|childhood teratoma|childhood teratoma
561938|NCT00436787|Anticoagulation Prophylaxis|anticoagulation prophylaxis
561939|NCT00436787|Venous Thrombosis|venous thrombosis
561940|NCT00436787|Deep Vein Thrombosis|deep vein thrombosis
561941|NCT00436787|Pulmonary Embolism|pulmonary embolism
561942|NCT00436787|Fondaparinux Sodium|fondaparinux sodium
561944|NCT00436787|Pharmakinetics|pharmakinetics
561945|NCT00436826|Multiple Sclerosis|multiple sclerosis
561946|NCT00436826|Relapsing forms|relapsing forms
561947|NCT00436826|Interferon-beta therapy|interferon-beta therapy
561948|NCT00436878|Eating Behavior|eating behavior
561949|NCT00436878|Children|children
561950|NCT00436878|Portion size|portion size
561951|NCT00436878|Experimental|experimental
561952|NCT00436891|Group A Streptococcus, scabies, pyoderma, Fiji|group a streptococcus, scabies, pyoderma, fiji
561953|NCT00436904|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
561954|NCT00436904|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
561955|NCT00436904|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
561956|NCT00436904|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
561957|NCT00436917|stage I breast cancer|stage i breast cancer
561958|NCT00436917|stage II breast cancer|stage ii breast cancer
561959|NCT00436917|stage IIIA breast cancer|stage iiia breast cancer
561960|NCT00436917|osteoporosis|osteoporosis
561961|NCT00436930|recurrent melanoma|recurrent melanoma
561962|NCT00436930|stage IV melanoma|stage iv melanoma
561963|NCT00436943|smoking cessation|smoking cessation
561964|NCT00436943|nicotine replacement therapy|nicotine replacement therapy
561965|NCT00436943|bupropion|bupropion
561966|NCT00436943|smoking|smoking
561967|NCT00436956|VEGF|vegf
561968|NCT00436956|Angiogenesis|angiogenesis
561969|NCT00436956|Hormone-Refractory|hormone-refractory
561970|NCT00436956|Bone Metastases|bone metastases
561971|NCT00436956|Docetaxel-Resistant|docetaxel-resistant
561972|NCT00436956|Prostate Cancer|prostate cancer
561973|NCT00436969|Orthovisc|orthovisc
561974|NCT00436969|Osteoarthritis|osteoarthritis
561975|NCT00436969|Shoulder|shoulder
561976|NCT00436969|Randomized|randomized
561977|NCT00436995|Dialysis|dialysis
561978|NCT00436995|Anaemia|anaemia
561979|NCT00437008|endothelial dysfunction|endothelial dysfunction
561980|NCT00437008|flow-mediated dilatation|flow-mediated dilatation
561981|NCT00437008|advanced glycation end products|advanced glycation end products
561982|NCT00437008|postprandial|postprandial
561983|NCT00437021|smallpox, vaccine, IMVAMUNE®|smallpox, vaccine, imvamune®
561984|NCT00437073|brain metastases|brain metastases
561986|NCT00437073|lapatinib|lapatinib
561987|NCT00437073|Breast Cancer|breast cancer
561988|NCT00437073|HYCAMTIN|hycamtin
561989|NCT00437073|topotecan|topotecan
561990|NCT00437073|capecitabine|capecitabine
561991|NCT00437073|metastatic breast cancer|metastatic breast cancer
561992|NCT00437073|TYKERB|tykerb
561993|NCT00437073|XELODA|xeloda
561994|NCT00437086|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
561995|NCT00437086|primary myelofibrosis|primary myelofibrosis
561996|NCT00437138|Air pollution|air pollution
561997|NCT00437138|Myocardial ischemia|myocardial ischemia
561998|NCT00437138|Endothelium|endothelium
561999|NCT00437138|Fibrinolysis|fibrinolysis
562000|NCT00437138|Pathophysiology|pathophysiology
562001|NCT00437138|Diesel exhaust|diesel exhaust
562002|NCT00437164|NaBr|nabr
562003|NCT00437164|Sodium Bromide|sodium bromide
562004|NCT00437164|DEXA Deuterium|dexa deuterium
562005|NCT00437164|Total Body Water|total body water
562006|NCT00437164|Insulin|insulin
562008|NCT00437164|GW677954|gw677954
562009|NCT00437164|Randomized Withdrawal|randomized withdrawal
562010|NCT00437164|T2DM|t2dm
562011|NCT00437177|alcoholism|alcoholism
562012|NCT00437177|apomorphine|apomorphine
562013|NCT00437177|iodobenzamide|iodobenzamide
562014|NCT00437177|imaging|imaging
562015|NCT00437177|spect|spect
562016|NCT00437177|relapse|relapse
562017|NCT00437190|Cervical Disc Replacement|cervical disc replacement
562018|NCT00437190|Spondylotic radiculopathy|spondylotic radiculopathy
562019|NCT00437190|Spondylotic myelopathy|spondylotic myelopathy
562020|NCT00437190|Myelopathy|myelopathy
562021|NCT00437190|Radiculopathy|radiculopathy
562022|NCT00437203|Advanced cancer|advanced cancer
562023|NCT00437229|GW679769,|gw679769,
562024|NCT00437229|Casopitant,|casopitant,
562025|NCT00437229|Dexamethasone,|dexamethasone,
562026|NCT00437229|Healthy Human Volunteer|healthy human volunteer
562027|NCT00437229|Ondansetron,|ondansetron,
562028|NCT00437242|interval,|interval,
562029|NCT00437242|atrial fibrillation|atrial fibrillation
562031|NCT00437242|odiparcil,|odiparcil,
562032|NCT00437281|Partial-onset seizures; epilepsy; pediatric; pregabalin; safety; tolerability; pharmacokinetics|partial-onset seizures; epilepsy; pediatric; pregabalin; safety; tolerability; pharmacokinetics
562033|NCT00437320|PDT|pdt
562041|NCT00437346|dyspepsia|dyspepsia
562042|NCT00437346|functional dyspepsia|functional dyspepsia
562043|NCT00437346|treatment|treatment
562044|NCT00437346|drug therapy|drug therapy
562045|NCT00437346|information|information
562046|NCT00437359|Breast Neoplasms|breast neoplasms
562047|NCT00437359|Drug Therapy|drug therapy
562049|NCT00437372|central nervous system|central nervous system
562050|NCT00437372|head and neck|head and neck
562051|NCT00437372|thorax|thorax
562052|NCT00437372|pelvic area|pelvic area
562053|NCT00437385|therapy resistant depression, severe depression|therapy resistant depression, severe depression
562054|NCT00437398|hypoglycemic unawareness|hypoglycemic unawareness
562055|NCT00437411|Fibromyalgia|fibromyalgia
562056|NCT00437411|Affect|affect
562057|NCT00437411|Pain|pain
562058|NCT00437411|Fatigue|fatigue
562059|NCT00437411|Sleep|sleep
562060|NCT00437411|Stress|stress
562061|NCT00437411|Quality of Life|quality of life
562062|NCT00437411|Stress, Psychological|stress, psychological
562063|NCT00437411|Psychophysiology|psychophysiology
562064|NCT00437411|Randomized Controlled Trials|randomized controlled trials
562065|NCT00437424|Hepatocellular cancer|hepatocellular cancer
562066|NCT00437424|Other advanced solid malignancies|other advanced solid malignancies
562067|NCT00437437|Advanced or metastatic solid tumors|advanced or metastatic solid tumors
562068|NCT00437450|Anemia|anemia
562069|NCT00437450|myelodysplastic syndromes|myelodysplastic syndromes
562070|NCT00437450|Low risk|low risk
562071|NCT00437450|Bone Marrow diseases|bone marrow diseases
562072|NCT00437476|HIV/HCV|hiv/hcv
562073|NCT00437476|HIV and HCV coinfected patients|hiv and hcv coinfected patients
562074|NCT00437476|Treatment Naive|treatment naive
562075|NCT00430235|prostate|prostate
562076|NCT00430235|cancer|cancer
562077|NCT00430235|BAY 43-9006|bay 43-9006
562078|NCT00430248|tophi|tophi
562079|NCT00430248|hyperuricemia|hyperuricemia
562080|NCT00430248|uric acid|uric acid
562081|NCT00430248|Drug Therapy|drug therapy
562082|NCT00430261|bronchoalveolar carcinoma|bronchoalveolar carcinoma
562083|NCT00430261|BAC|bac
562084|NCT00430261|adenocarcinoma|adenocarcinoma
562085|NCT00430261|lung cancer|lung cancer
562086|NCT00430261|oral|oral
562087|NCT00430261|Stage IIIB and IV lung cancer|stage iiib and iv lung cancer
562088|NCT00430261|Any bronchoalveolar carcinoma (BAC)|any bronchoalveolar carcinoma (bac)
562089|NCT00430261|Any adenocarcinoma in a never-smoker|any adenocarcinoma in a never-smoker
562090|NCT00430274|glaucoma|glaucoma
562091|NCT00430274|retinal gliosis-like alterations|retinal gliosis-like alterations
562092|NCT00430274|optical coherence tomography|optical coherence tomography
562093|NCT00430274|automated microperimetry|automated microperimetry
562094|NCT00430287|primary open angle glaucoma|primary open angle glaucoma
562095|NCT00430287|low tension glaucoma|low tension glaucoma
562096|NCT00430287|pigmentary glaucoma|pigmentary glaucoma
562097|NCT00430287|exfoliative glaucoma|exfoliative glaucoma
562098|NCT00430300|Dry Powder for Inhalation|dry powder for inhalation
562099|NCT00430300|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
562100|NCT00430300|Lung Function testing|lung function testing
562101|NCT00430313|Nausea|nausea
562102|NCT00430313|Vomiting|vomiting
562103|NCT00430313|Electro-Stimulation|electro-stimulation
562104|NCT00430313|ES|es
562105|NCT00430313|K1 Acupuncture Point|k1 acupuncture point
562106|NCT00430313|Yongquan Acupuncture Point|yongquan acupuncture point
562107|NCT00430313|TAI|tai
562108|NCT00430313|transarterial infusion|transarterial infusion
562109|NCT00430313|liver metastasis|liver metastasis
562110|NCT00430313|chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
562112|NCT00430313|Cisplatin|cisplatin
562113|NCT00430313|Oxaliplatin|oxaliplatin
562114|NCT00430365|Myeloma|myeloma
562115|NCT00430365|Revlimid|revlimid
562116|NCT00430365|Maintenance therapy|maintenance therapy
562117|NCT00430365|Autologous Stem Cell Transplantation|autologous stem cell transplantation
562118|NCT00430378|Xerostomia|xerostomia
562119|NCT00430378|Dry Mouth|dry mouth
562120|NCT00430378|Mouth Dryness|mouth dryness
562121|NCT00430378|Nasopharyngeal Cancer|nasopharyngeal cancer
562122|NCT00430378|Acupuncture|acupuncture
562123|NCT00430391|DVD|dvd
562124|NCT00430391|Multi-media|multi-media
562125|NCT00430391|Schizophrenia|schizophrenia
562126|NCT00430391|Normal Comparison|normal comparison
562127|NCT00430391|Consent procedures|consent procedures
562128|NCT00430417|Pregnancy|pregnancy
562129|NCT00430417|Lactation|lactation
562130|NCT00430417|Endocrine System Diseases|endocrine system diseases
562131|NCT00430417|MusculoSkeletal System Disease|musculoskeletal system disease
562132|NCT00430417|Hormone|hormone
562133|NCT00430417|Physiologic Properties|physiologic properties
562134|NCT00430443|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
562135|NCT00430443|Acute Myelogenous Leukemia|acute myelogenous leukemia
562136|NCT00430443|Annamycin|annamycin
563318|NCT00434538|Chitosan|chitosan
562137|NCT00430443|Liposomal Annamycin|liposomal annamycin
562138|NCT00430456|Aerobic exercise|aerobic exercise
562139|NCT00430456|Balance, postural|balance, postural
562140|NCT00430456|Cardiovascular deconditioning|cardiovascular deconditioning
562141|NCT00430456|Gait|gait
562142|NCT00430456|MRI, functional|mri, functional
562143|NCT00430456|Physical therapy techniques|physical therapy techniques
562144|NCT00430456|Self Efficacy|self efficacy
562145|NCT00430456|Treadmill test|treadmill test
562146|NCT00430469|Lactoferrin|lactoferrin
562148|NCT00430469|Neutropenia|neutropenia
562149|NCT00430469|Myeloablative|myeloablative
562150|NCT00430469|Treatment|treatment
562151|NCT00430469|Fungal|fungal
562152|NCT00430469|Bacterial|bacterial
562153|NCT00430469|Infections|infections
562154|NCT00430469|Bone marrow transplant|bone marrow transplant
562155|NCT00430482|Substance Dependence|substance dependence
562156|NCT00430482|Cognitive-Behavior Therapy|cognitive-behavior therapy
562157|NCT00430482|Opiate Dependence|opiate dependence
562158|NCT00430482|Treatment Moderators|treatment moderators
562159|NCT00430495|atacicept|atacicept
562160|NCT00430495|arthritis|arthritis
562161|NCT00430508|Moderate-to-Severe Hypertension|moderate-to-severe hypertension
562162|NCT00430508|Essential Hypertension|essential hypertension
562163|NCT00430508|Combination Therapy|combination therapy
562164|NCT00430508|Fixed-Combination Dose|fixed-combination dose
562165|NCT00430521|Pandemic Flu|pandemic flu
562166|NCT00430521|Pandemic influenza vaccine (GSK1119711A)|pandemic influenza vaccine (gsk1119711a)
562167|NCT00430534|Epstein Barr Virus|epstein barr virus
562168|NCT00430534|Belgium|belgium
562169|NCT00430534|Infectious mononucleosis|infectious mononucleosis
562170|NCT00430560|work therapy|work therapy
562171|NCT00430560|cognitive rehabilitation|cognitive rehabilitation
562172|NCT00430560|schizophrenia|schizophrenia
562173|NCT00430560|schizoaffective disorder|schizoaffective disorder
562174|NCT00430560|treatment outcome|treatment outcome
562175|NCT00430573|cognitive-behavior therapy|cognitive-behavior therapy
562176|NCT00430573|d-cycloserine|d-cycloserine
562177|NCT00430573|cognitive enhancer|cognitive enhancer
562178|NCT00430573|drug dependence|drug dependence
562179|NCT00430573|opiate dependence|opiate dependence
562180|NCT00430573|exposure|exposure
562181|NCT00430573|isolated doses of d-cycloserine|isolated doses of d-cycloserine
562182|NCT00430573|isolated doses of matching pill placebo|isolated doses of matching pill placebo
562183|NCT00430573|DCS|dcs
562184|NCT00430612|Myocardial Infarction|myocardial infarction
562185|NCT00430612|Heart Attack|heart attack
562186|NCT00430612|Beta Blockers|beta blockers
562187|NCT00430612|Survival|survival
562189|NCT00430625|Enzyme Replacement Therapy|enzyme replacement therapy
562190|NCT00430625|Gaucher disease|gaucher disease
562191|NCT00430625|glucocerebrosidase|glucocerebrosidase
562192|NCT00430625|beta-glucocerebrosidase|beta-glucocerebrosidase
562193|NCT00430625|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
562194|NCT00430625|glucosylceramidase|glucosylceramidase
562195|NCT00430625|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
562196|NCT00430625|gene activation|gene activation
562197|NCT00430625|human|human
562198|NCT00430638|Hypertension|hypertension
562199|NCT00430638|Angiotensin Receptor Blocker|angiotensin receptor blocker
562200|NCT00430638|Calcium Channel Blocker|calcium channel blocker
562201|NCT00430638|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
562202|NCT00430638|Hydrochlorothiazide|hydrochlorothiazide
562203|NCT00430638|Stage I and II Hypertension|stage i and ii hypertension
562204|NCT00430651|Non Small Cell Lung Cancer|non small cell lung cancer
562205|NCT00430651|2nd line chemotherapy|2nd line chemotherapy
562206|NCT00430651|Docetaxel|docetaxel
562207|NCT00430664|pleurodesis|pleurodesis
562208|NCT00430664|talc|talc
562209|NCT00430664|iodopovidone|iodopovidone
562210|NCT00430703|severe traumatic brain injury|severe traumatic brain injury
562211|NCT00430703|body weight support treadmill training|body weight support treadmill training
562212|NCT00430703|Electroencephalogram|electroencephalogram
562213|NCT00430703|Event Related Potentials|event related potentials
562214|NCT00430729|Roflumilast|roflumilast
562215|NCT00430768|Gene Transfer Techniques|gene transfer techniques
562216|NCT00430768|Gene Therapy|gene therapy
562217|NCT00430768|AAV|aav
562218|NCT00430768|AAT|aat
562219|NCT00430768|Phase I|phase i
562220|NCT00430768|Intramuscular transfer|intramuscular transfer
562221|NCT00430781|pazopanib|pazopanib
562222|NCT00430781|ErB1/ErB2|erb1/erb2
562223|NCT00430781|lapatinib|lapatinib
562224|NCT00430781|persistent|persistent
562225|NCT00430781|VEGF|vegf
562226|NCT00430781|recurrent|recurrent
562227|NCT00430781|metastatic cervical cancer|metastatic cervical cancer
562228|NCT00430781|advanced|advanced
562229|NCT00430781|FIGO Stage IVB|figo stage ivb
562230|NCT00430794|resistant hypertension|resistant hypertension
562231|NCT00430794|Spironolactone|spironolactone
562232|NCT00430794|double-blind|double-blind
562233|NCT00430794|randomised controlled trial|randomised controlled trial
562328|NCT00431158|Respiratory failure|respiratory failure
562234|NCT00430794|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
562235|NCT00430807|giant cell arteritis,|giant cell arteritis,
562236|NCT00430807|hydroxychloroquine,|hydroxychloroquine,
562237|NCT00430807|corticosteroid sparing,|corticosteroid sparing,
562238|NCT00430807|corticodependence|corticodependence
562239|NCT00430820|Biomarkers|biomarkers
562240|NCT00430820|Proteomics|proteomics
562241|NCT00430820|Mass spectrometry|mass spectrometry
562243|NCT00430820|Acute coronary syndromes|acute coronary syndromes
562244|NCT00430820|Myocardial infarction|myocardial infarction
562245|NCT00430820|Coronary artery disease|coronary artery disease
562246|NCT00430846|Antigens,CD30|antigens,cd30
562247|NCT00430846|Antibody-Drug Conjugate|antibody-drug conjugate
562248|NCT00430846|Antibodies, Monoclonal|antibodies, monoclonal
562249|NCT00430846|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
562250|NCT00430846|Disease, Hodgkin|disease, hodgkin
562251|NCT00430846|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
562252|NCT00430846|Hematologic Diseases|hematologic diseases
562253|NCT00430846|Lymphoma|lymphoma
562254|NCT00430859|Sepsis|sepsis
562255|NCT00430859|Alkaline|alkaline
562256|NCT00430859|Phosphatase|phosphatase
562257|NCT00430859|Lipopolysaccharide|lipopolysaccharide
562258|NCT00430872|Spinal Cord Tumor|spinal cord tumor
562259|NCT00430872|Intramedullary Spinal Cord Tumor|intramedullary spinal cord tumor
562260|NCT00430872|Extramedullary Spinal Cord Tumor|extramedullary spinal cord tumor
562261|NCT00430872|Symptoms|symptoms
562262|NCT00430872|Survey|survey
562263|NCT00430885|Heart failure|heart failure
562264|NCT00430885|Myocardial infarction|myocardial infarction
562265|NCT00430885|Patients with acute myocardial infarction|patients with acute myocardial infarction
562266|NCT00430898|ulcerative colitis basiliximab|ulcerative colitis basiliximab
562267|NCT00430911|malignant gliomas|malignant gliomas
562268|NCT00430924|Kidney Failure, Chronic|kidney failure, chronic
562269|NCT00430924|Proteinuria|proteinuria
562270|NCT00430924|Aldosterone|aldosterone
562271|NCT00430924|Renin-Angiotensin System|renin-angiotensin system
562272|NCT00430937|Complicated Skin and Soft Tissue Infections. Daptomycin, Vancomycin, Teicoplanin|complicated skin and soft tissue infections. daptomycin, vancomycin, teicoplanin
562273|NCT00430937|Complicated skin and soft tissue infections|complicated skin and soft tissue infections
562274|NCT00430950|Moderate-to-Severe Hypertension|moderate-to-severe hypertension
562275|NCT00430950|Essential Hypertension|essential hypertension
562276|NCT00430950|Combination Therapy|combination therapy
562277|NCT00430950|Fixed-Combination Dose|fixed-combination dose
562278|NCT00430976|psychomotor function|psychomotor function
562279|NCT00430976|neuromuscular system|neuromuscular system
562280|NCT00430976|memory|memory
562281|NCT00430976|brain electrical activity|brain electrical activity
562282|NCT00430976|Mental Processes|mental processes
562283|NCT00430989|Anaesthesia|anaesthesia
562284|NCT00430989|Major Surgery|major surgery
562285|NCT00430989|Coronary artery disease|coronary artery disease
562286|NCT00430989|Nitrous oxide|nitrous oxide
562287|NCT00430989|Effects of Nitrous Oxide following Anaesthesia|effects of nitrous oxide following anaesthesia
562288|NCT00430989|Anaesthesia and coronary artery disease|anaesthesia and coronary artery disease
562289|NCT00431002|Exercise|exercise
562290|NCT00431002|Resistance training|resistance training
562291|NCT00431015|Lung Cancer|lung cancer
562292|NCT00431015|Cancer of the lung|cancer of the lung
562293|NCT00431015|Non-small cell lung cancer|non-small cell lung cancer
562294|NCT00431028|Cataract|cataract
562295|NCT00431028|Endophthalmitis|endophthalmitis
562296|NCT00431028|Antibiotics|antibiotics
562297|NCT00431028|Anti-Inflammatory Agents|anti-inflammatory agents
562298|NCT00431028|Drug Delivery Systems|drug delivery systems
562299|NCT00431041|Solifenacin succinate|solifenacin succinate
562300|NCT00431041|Oxybutynin immediate release|oxybutynin immediate release
562301|NCT00431041|Xerostomia|xerostomia
562302|NCT00431041|Overactive bladder|overactive bladder
562303|NCT00431054|Ovarian Cancer|ovarian cancer
562304|NCT00431054|Fallopian Tube Cancer|fallopian tube cancer
562305|NCT00431054|Peritoneal Cancer|peritoneal cancer
562306|NCT00431054|Perifosine|perifosine
562307|NCT00431054|Docetaxel|docetaxel
562308|NCT00431054|Taxotere|taxotere
562309|NCT00431080|Early breast cancer|early breast cancer
562310|NCT00431080|Axillary node positive|axillary node positive
562311|NCT00431080|Adjuvant chemotherapy|adjuvant chemotherapy
562312|NCT00431080|Dose dense|dose dense
562313|NCT00431080|Docetaxel|docetaxel
562314|NCT00431080|Paclitaxel|paclitaxel
562316|NCT00431106|Breast cancer|breast cancer
562317|NCT00431106|Chemotherapy|chemotherapy
562318|NCT00431106|Vinorelbine|vinorelbine
562319|NCT00431106|Gemcitabine|gemcitabine
562320|NCT00431106|Capecitabine|capecitabine
562321|NCT00431119|bullous autoimmune disease|bullous autoimmune disease
562322|NCT00431119|bullous pemphigoid|bullous pemphigoid
562323|NCT00431119|immunosuppressants|immunosuppressants
562324|NCT00431119|corticosteroids|corticosteroids
562325|NCT00431119|mycophenolate mofetil|mycophenolate mofetil
562326|NCT00431158|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
562327|NCT00431158|ARDS|ards
564837|NCT00438828|pain|pain
562329|NCT00431158|Mechanical Ventilation|mechanical ventilation
562330|NCT00431158|Positive end expiratory pressure|positive end expiratory pressure
562331|NCT00431158|Lung recruitment maneuver|lung recruitment maneuver
562332|NCT00431171|spinal cord injuries|spinal cord injuries
562333|NCT00431171|lithium|lithium
562334|NCT00431184|bipolar disorder|bipolar disorder
562335|NCT00431184|bipolar mania|bipolar mania
562336|NCT00431184|schizoaffective disorder|schizoaffective disorder
562337|NCT00431184|schizoaffective mania|schizoaffective mania
562338|NCT00431184|mania|mania
562339|NCT00431184|kappa opiates|kappa opiates
562340|NCT00431184|opiates|opiates
562341|NCT00431210|NPC|npc
562342|NCT00431210|EPV|epv
562343|NCT00431223|fMRI|fmri
562344|NCT00431223|working memory|working memory
562345|NCT00431223|schizophrenia|schizophrenia
562346|NCT00431223|treatment refractory|treatment refractory
562347|NCT00431223|cognitive skills training|cognitive skills training
562348|NCT00431223|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
562349|NCT00431223|cognitive remediation|cognitive remediation
562350|NCT00431223|treatment refractory schizophrenia of > 5 years duration|treatment refractory schizophrenia of > 5 years duration
562351|NCT00431236|cisplatin|cisplatin
562352|NCT00431236|CINV|cinv
562353|NCT00431236|highly emetogenic|highly emetogenic
562354|NCT00431262|alcoholism|alcoholism
562355|NCT00431262|antabuse|antabuse
562356|NCT00431262|disulfiram|disulfiram
562357|NCT00431262|abstinence|abstinence
562358|NCT00431262|cognitive behavioural therapy|cognitive behavioural therapy
562359|NCT00431288|nutrition|nutrition
562360|NCT00431288|adolescent nutrition|adolescent nutrition
562361|NCT00431288|blood pressure|blood pressure
562362|NCT00431288|hypertension|hypertension
562363|NCT00431288|diet therapy|diet therapy
562364|NCT00431288|patient education|patient education
562365|NCT00431301|Progressive Supranuclear Palsy|progressive supranuclear palsy
562366|NCT00431301|Epidemiology|epidemiology
562367|NCT00431301|Case-Control|case-control
562369|NCT00431301|Environmental|environmental
562370|NCT00431301|Neurodegenerative Disease|neurodegenerative disease
562371|NCT00431301|Movement Disorders|movement disorders
562372|NCT00431301|Atypical Parkinsonism|atypical parkinsonism
562373|NCT00431301|Parkinson Plus|parkinson plus
562374|NCT00431301|Steele-Richardson-Olszewski|steele-richardson-olszewski
562375|NCT00431301|PSP|psp
562376|NCT00431314|End Stage Renal Disease|end stage renal disease
562377|NCT00431314|Hemodialysis|hemodialysis
562378|NCT00431314|Critical Limb Ischemia|critical limb ischemia
562379|NCT00431314|Autofluorescence|autofluorescence
562380|NCT00431327|patient navigator|patient navigator
562381|NCT00431327|peer support|peer support
562382|NCT00431327|colonoscopy|colonoscopy
562383|NCT00431327|adherence|adherence
562384|NCT00431327|None: have to be scheduled for screening or diagnostic colonoscopy|none: have to be scheduled for screening or diagnostic colonoscopy
562385|NCT00431340|Multiple myeloma|multiple myeloma
562386|NCT00431340|myeloma|myeloma
562387|NCT00431340|plasma cell myeloma|plasma cell myeloma
562388|NCT00431340|bone marrow cancer|bone marrow cancer
562389|NCT00431340|myelomatosis|myelomatosis
562390|NCT00431340|Kahler's disease|kahler's disease
562391|NCT00431340|PXD101|pxd101
562392|NCT00431340|belinostat|belinostat
562393|NCT00431340|bortezomib|bortezomib
562394|NCT00431366|Fatigue|fatigue
562395|NCT00431366|Repetitive TMS (rTMS)|repetitive tms (rtms)
562396|NCT00431366|Parkinson's Disease|parkinson's disease
562397|NCT00431366|Peg Board Test|peg board test
562398|NCT00431366|Levodopa|levodopa
562399|NCT00431366|Parkinson Disease|parkinson disease
562400|NCT00431366|PD|pd
562401|NCT00431392|Choroidal blood flow|choroidal blood flow
562402|NCT00431392|NO-synthase|no-synthase
562403|NCT00431392|light/dark transition|light/dark transition
562404|NCT00431405|rheumatoid arthritis|rheumatoid arthritis
562405|NCT00431405|cardiovascular disease|cardiovascular disease
562406|NCT00431405|coronary disease|coronary disease
562407|NCT00431444|Osteoporosis|osteoporosis
562408|NCT00431444|Post-menopausal|post-menopausal
562409|NCT00431444|Bone mineral density|bone mineral density
562410|NCT00437502|Immunotherapeutic vaccine|immunotherapeutic vaccine
562411|NCT00437502|Ovarian cancer|ovarian cancer
562412|NCT00437502|epithelial ovarian cancer|epithelial ovarian cancer
562413|NCT00437502|tubal cancer|tubal cancer
562414|NCT00437502|peritoneal cancer|peritoneal cancer
562415|NCT00437502|immunotherapy|immunotherapy
562416|NCT00437528|Heat flow|heat flow
562417|NCT00437528|Sensor|sensor
562418|NCT00437528|Overactive bladder|overactive bladder
562419|NCT00437528|Urinary incontinence|urinary incontinence
562420|NCT00437541|Insulation|insulation
562421|NCT00437541|Warmth|warmth
562422|NCT00437541|Humidity|humidity
562423|NCT00437541|Damp|damp
562424|NCT00437541|Cold|cold
562425|NCT00437541|Respiratory|respiratory
562426|NCT00437541|Mould|mould
562427|NCT00437567|galacto-oligosaccharides|galacto-oligosaccharides
562428|NCT00437567|prebiotics|prebiotics
562429|NCT00437567|NEC|nec
562591|NCT00439127|recombinant human TSH|recombinant human tsh
562430|NCT00437580|Vancomycin Resistant Enterococcus, probiotic|vancomycin resistant enterococcus, probiotic
562431|NCT00437593|preretinal membrane|preretinal membrane
562432|NCT00437593|vitrectomy|vitrectomy
562433|NCT00437593|uhr-oct|uhr-oct
562434|NCT00437593|hd-oct|hd-oct
562435|NCT00437632|repeat dose,|repeat dose,
562436|NCT00437632|placebo,|placebo,
562437|NCT00437632|Safety,|safety,
562438|NCT00437632|pharmacodynamics,|pharmacodynamics,
562439|NCT00437632|tolerability,|tolerability,
562440|NCT00437632|GSK598809|gsk598809
562441|NCT00437632|pharmacokinetics,|pharmacokinetics,
562442|NCT00437645|Essential hypertension|essential hypertension
562443|NCT00437645|blood pressure|blood pressure
562444|NCT00437645|edema|edema
562445|NCT00437645|valsartan|valsartan
562446|NCT00437645|amlodipine|amlodipine
562447|NCT00437645|combination treatment|combination treatment
562448|NCT00437671|trismus|trismus
562449|NCT00437671|lockjaw|lockjaw
562450|NCT00437684|HIV/HCV|hiv/hcv
562451|NCT00437684|HIV and HCV coinfected patients|hiv and hcv coinfected patients
562452|NCT00437684|Treatment Experienced|treatment experienced
562453|NCT00437697|dalteparin, critically ill, thromboprophylaxis|dalteparin, critically ill, thromboprophylaxis
562454|NCT00437710|bone marrow, cell transplantation, stem cells, PTCA|bone marrow, cell transplantation, stem cells, ptca
562455|NCT00437736|solid tumor|solid tumor
562456|NCT00437736|phase I study|phase i study
562457|NCT00437736|dose-escalation|dose-escalation
562458|NCT00437749|Non small cell lung cancer|non small cell lung cancer
562459|NCT00437749|Advanced|advanced
562460|NCT00437749|Inoperable|inoperable
562461|NCT00437749|taxanes|taxanes
562462|NCT00437749|carboplatin|carboplatin
562463|NCT00437749|multi-drug resistance|multi-drug resistance
562464|NCT00437762|Lateral epicondylitis, tennis elbow, treatment|lateral epicondylitis, tennis elbow, treatment
562465|NCT00437775|Diabetes Mellitus type 2|diabetes mellitus type 2
562466|NCT00437775|ACE Inhibitors|ace inhibitors
562467|NCT00437775|ARBs|arbs
562468|NCT00437775|Adverse drug effect|adverse drug effect
562469|NCT00437788|imaging|imaging
562470|NCT00437814|Ketamine|ketamine
562471|NCT00437814|Traumatic Brain Injury|traumatic brain injury
562472|NCT00437814|Intracranial Hypertension|intracranial hypertension
562473|NCT00437827|Depression|depression
562474|NCT00437840|healthy volunteers,|healthy volunteers,
562476|NCT00437840|pharmacokinetics,|pharmacokinetics,
562477|NCT00437840|pharmacodynamics|pharmacodynamics
562478|NCT00437840|safety,|safety,
562479|NCT00437840|smoking,|smoking,
562480|NCT00438906|pancreatic lesions|pancreatic lesions
562481|NCT00438906|pancreatic cancer|pancreatic cancer
562482|NCT00438906|peutz-jeghers syndrome|peutz-jeghers syndrome
562483|NCT00438906|BRCA 2 gene mutation|brca 2 gene mutation
562484|NCT00438906|FAMMM/p16|fammm/p16
562485|NCT00438906|Genes, BRCA2|genes, brca2
562486|NCT00438932|phosphate, phosphorus, FGF-23, PTH, 1,25D|phosphate, phosphorus, fgf-23, pth, 1,25d
562487|NCT00438958|graft versus host disease|graft versus host disease
562488|NCT00438958|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
562489|NCT00438958|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
562490|NCT00438958|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
562491|NCT00438958|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
562492|NCT00438958|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
562493|NCT00438958|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
562494|NCT00438958|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
562495|NCT00438958|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
562496|NCT00438958|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
562497|NCT00438958|refractory anemia with excess blasts|refractory anemia with excess blasts
562498|NCT00438958|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
562499|NCT00438958|refractory anemia|refractory anemia
562500|NCT00438958|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
562501|NCT00438958|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
562502|NCT00438958|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
562503|NCT00438958|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
562504|NCT00438958|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
562505|NCT00438958|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
562506|NCT00438958|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
562507|NCT00438958|primary myelofibrosis|primary myelofibrosis
562508|NCT00438958|secondary myelofibrosis|secondary myelofibrosis
562509|NCT00438958|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
562510|NCT00438958|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
562511|NCT00438958|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
562512|NCT00438958|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
561894|NCT00436657|CHPP|chpp
562513|NCT00438958|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
562514|NCT00438958|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
562515|NCT00438958|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
562516|NCT00438958|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
562517|NCT00438958|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
562518|NCT00438958|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
562519|NCT00438958|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
562520|NCT00438958|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
562521|NCT00438958|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
562522|NCT00438958|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
562523|NCT00438958|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
562524|NCT00438958|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
562525|NCT00438958|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
562526|NCT00438958|splenic marginal zone lymphoma|splenic marginal zone lymphoma
562527|NCT00438958|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
562528|NCT00438958|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
562529|NCT00438958|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
562530|NCT00438958|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
562531|NCT00438958|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
562532|NCT00438958|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
562533|NCT00438958|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
562534|NCT00438958|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
562535|NCT00438958|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
562536|NCT00438958|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
562537|NCT00438958|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
562538|NCT00438958|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
562539|NCT00438958|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
562540|NCT00438958|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
562541|NCT00438958|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
562542|NCT00438958|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
562543|NCT00438958|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
562544|NCT00438958|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
562545|NCT00438958|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
562546|NCT00438958|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
562547|NCT00438958|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
562548|NCT00438958|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
562549|NCT00438958|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
562550|NCT00438958|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
562551|NCT00438958|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
562552|NCT00438958|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
562553|NCT00438958|Waldenström macroglobulinemia|waldenström macroglobulinemia
562554|NCT00438958|secondary acute myeloid leukemia|secondary acute myeloid leukemia
562555|NCT00438958|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
562557|NCT00438971|Anxiety Disorder|anxiety disorder
562558|NCT00438971|Duloxetine|duloxetine
562559|NCT00439010|neurological|neurological
562560|NCT00439010|alzheimer|alzheimer
562561|NCT00439023|Chronic renal failure, dialysis, hemodialysis,|chronic renal failure, dialysis, hemodialysis,
562562|NCT00439036|Opiate|opiate
562563|NCT00439036|Behavior Therapy|behavior therapy
562564|NCT00439036|Methadone|methadone
562565|NCT00439036|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
562566|NCT00439049|Substance Abuse|substance abuse
562567|NCT00439049|Treatment|treatment
562568|NCT00439049|Eligibility|eligibility
562569|NCT00439062|Roxithromycin,Rheumatoid arthritis,Macrolides|roxithromycin,rheumatoid arthritis,macrolides
562570|NCT00439075|pulmonary disease|pulmonary disease
562572|NCT00439075|CPAP|cpap
562573|NCT00439075|oxygenation|oxygenation
562574|NCT00439075|out-of-hospital intervention|out-of-hospital intervention
562575|NCT00439088|Ambulation|ambulation
562576|NCT00439088|Ambulatory Monitoring|ambulatory monitoring
562577|NCT00439088|Activities of Daily Living|activities of daily living
562578|NCT00439088|Pedometer|pedometer
562579|NCT00439088|Validation Studies [PT]|validation studies [pt]
562580|NCT00439101|weight loss|weight loss
562581|NCT00439101|malignancy|malignancy
562582|NCT00439101|corticosteroids|corticosteroids
562583|NCT00439101|supplemental feeding|supplemental feeding
562584|NCT00439101|adrenal insufficiency|adrenal insufficiency
562585|NCT00439101|diabetes|diabetes
752469|NCT01173133|Reconstructive Plastic Surgery|reconstructive plastic surgery
561985|NCT00437073|ErbB2|erbb2
562586|NCT00439114|Corneal topography, corneal opacity, keratitis, trachoma|corneal topography, corneal opacity, keratitis, trachoma
562587|NCT00439127|thyroglobulin|thyroglobulin
562588|NCT00439127|thyroid carcinoma|thyroid carcinoma
562589|NCT00439127|tumour marker|tumour marker
562590|NCT00439127|radioiodine|radioiodine
562592|NCT00439166|doxycycline|doxycycline
562594|NCT00439166|cerebrospinal fluid|cerebrospinal fluid
562595|NCT00439166|biomarkers|biomarkers
562596|NCT00439166|beta amyloid|beta amyloid
562598|NCT00439179|Pancreatic Cancer|pancreatic cancer
562599|NCT00439192|OAB, proof of concept|oab, proof of concept
562600|NCT00439192|Overactive Bladder (OAB)|overactive bladder (oab)
562601|NCT00439192|with incontinence|with incontinence
562602|NCT00439205|Oral Tumors|oral tumors
562603|NCT00439205|Oral Margin Spectroscopy|oral margin spectroscopy
562604|NCT00439205|Oral Spectroscopy|oral spectroscopy
562605|NCT00439205|Optical Spectroscopy|optical spectroscopy
562606|NCT00439205|Oral neoplastic lesions|oral neoplastic lesions
562608|NCT00439205|Multispectral Digital Microscope|multispectral digital microscope
562609|NCT00439205|MDM|mdm
562610|NCT00439205|Nonstandard imaging technology|nonstandard imaging technology
562611|NCT00439218|spinal muscular atrophy type I|spinal muscular atrophy type i
562612|NCT00439218|SMA type I|sma type i
562613|NCT00439218|spinal muscular atrophy|spinal muscular atrophy
562614|NCT00439218|SMA|sma
562615|NCT00439218|sodium phenylbutyrate|sodium phenylbutyrate
562616|NCT00439218|motor neuron disease|motor neuron disease
562617|NCT00439218|neuromuscular|neuromuscular
562618|NCT00439218|survival motor neuron|survival motor neuron
562619|NCT00439218|SMN|smn
562620|NCT00439218|dose escalation|dose escalation
562621|NCT00439231|Monoclonal Antibody Therapy|monoclonal antibody therapy
562622|NCT00439231|Biologic Response Modifier Therapy|biologic response modifier therapy
562623|NCT00439231|CLL|cll
562624|NCT00439231|SLL|sll
562625|NCT00439231|chemo-care (CC) 5013- Revlimid|chemo-care (cc) 5013- revlimid
562626|NCT00439231|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
562627|NCT00439231|Small Lymphocytic Leukemia|small lymphocytic leukemia
562628|NCT00439244|Bone Mineral Density (BMD)|bone mineral density (bmd)
562629|NCT00439244|C-Telopeptides (CTx)|c-telopeptides (ctx)
562630|NCT00439244|dual x-ray absorptiometry (DXA)|dual x-ray absorptiometry (dxa)
562631|NCT00439244|pro-collagen type 1 N-propeptide (P1NP)|pro-collagen type 1 n-propeptide (p1np)
562632|NCT00439244|teriparatide|teriparatide
562633|NCT00439244|zoledronic acid|zoledronic acid
562634|NCT00439244|Osteoporosis|osteoporosis
562635|NCT00439244|postmenopausal women|postmenopausal women
562636|NCT00439270|Metastatic hormone refractory prostate cancer|metastatic hormone refractory prostate cancer
562637|NCT00439283|Ankylosing spondylitis|ankylosing spondylitis
562638|NCT00439283|infliximab|infliximab
562639|NCT00439283|Systematic regimen|systematic regimen
562640|NCT00439283|On-demand regimen|on-demand regimen
562641|NCT00439296|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
562642|NCT00439296|Pediatrics|pediatrics
562643|NCT00439296|Relapsed|relapsed
562644|NCT00439296|Recurrence|recurrence
562645|NCT00439296|ABT-751|abt-751
562646|NCT00439296|Therapeutic Advances in Childhood Leukemia|therapeutic advances in childhood leukemia
562647|NCT00439296|Investigational|investigational
562648|NCT00439296|Childhood|childhood
562649|NCT00439296|ALL|all
562650|NCT00439296|Relapsed ALL|relapsed all
562651|NCT00439296|Refractory ALL|refractory all
562652|NCT00439296|Relapsed pediatric ALL|relapsed pediatric all
562653|NCT00439296|Refractory pediatric ALL|refractory pediatric all
562654|NCT00439296|TACL|tacl
562655|NCT00439322|PTSD|ptsd
562656|NCT00439335|Influenza, vaccine, A/H5N1|influenza, vaccine, a/h5n1
562657|NCT00439348|Calcium|calcium
562658|NCT00439348|Compliance|compliance
562659|NCT00439348|Medication compliance|medication compliance
562660|NCT00439348|electronic prescription|electronic prescription
562661|NCT00439348|over-the-counter medications|over-the-counter medications
562662|NCT00439348|OTC medications|otc medications
562663|NCT00439361|Hodgkin Lymphoma|hodgkin lymphoma
562664|NCT00439361|HL|hl
562665|NCT00439361|Relapsed Classical Hodgkin Lymphoma|relapsed classical hodgkin lymphoma
562666|NCT00439361|Refractory|refractory
562667|NCT00439361|Lymphoma|lymphoma
562668|NCT00439361|Nodular sclerosis|nodular sclerosis
562669|NCT00439361|Mixed cellularity|mixed cellularity
562670|NCT00439361|Lymphocyte-rich classical HL|lymphocyte-rich classical hl
562671|NCT00439361|Bortezomib|bortezomib
562672|NCT00439361|Velcade|velcade
562673|NCT00439361|LDP-341|ldp-341
562674|NCT00439361|MLN341|mln341
562675|NCT00439361|PS-341|ps-341
562676|NCT00439361|Carboplatin|carboplatin
562677|NCT00439361|Paraplatin|paraplatin
562678|NCT00439361|Etoposide|etoposide
562679|NCT00439361|VePesid®|vepesid®
562680|NCT00439361|Ifosfamide|ifosfamide
562681|NCT00439361|Mesna|mesna
562682|NCT00439361|Mesnex|mesnex
562683|NCT00439361|ICE|ice
562684|NCT00439374|nulliparous|nulliparous
562685|NCT00439374|pregnancy|pregnancy
562686|NCT00439374|short cervix|short cervix
562687|NCT00439374|progesterone|progesterone
562688|NCT00439387|Serotonin|serotonin
562689|NCT00439387|Epilepsy|epilepsy
562690|NCT00439387|Healthy Volunteer|healthy volunteer
562691|NCT00439387|HV|hv
562692|NCT00439478|Radioiodine, Thyroid Cancer, Sialadenitis, Xerostomia|radioiodine, thyroid cancer, sialadenitis, xerostomia
562693|NCT00439491|Obesity|obesity
565576|NCT00449462|CLA|cla
562694|NCT00439491|Insulin resistance|insulin resistance
562695|NCT00439491|Hypocaloric diet|hypocaloric diet
562696|NCT00439491|Adipose tissue|adipose tissue
562697|NCT00439491|adipocytokine|adipocytokine
562698|NCT00439517|Cancer|cancer
562699|NCT00439517|Colorectal|colorectal
562700|NCT00439517|Metastatic|metastatic
562701|NCT00439517|Untreated|untreated
562702|NCT00439530|oseltamivir|oseltamivir
562703|NCT00439530|pharmacokinetics|pharmacokinetics
562704|NCT00439530|probenecid|probenecid
562705|NCT00439530|avian influenza|avian influenza
562706|NCT00439543|Pulmonary fibrosis|pulmonary fibrosis
562707|NCT00439543|pulmonary hypertension|pulmonary hypertension
562708|NCT00439543|Iloprost|iloprost
562709|NCT00439543|Efficacy|efficacy
562710|NCT00439556|Lymphoma|lymphoma
562711|NCT00439556|Bortezomib|bortezomib
562712|NCT00439556|Velcade|velcade
562713|NCT00439556|LDP-341|ldp-341
562714|NCT00439556|MLN341|mln341
562715|NCT00439556|PS-341|ps-341
562716|NCT00439556|Carmustine|carmustine
562717|NCT00439556|Cytarabine|cytarabine
562718|NCT00439556|Etoposide|etoposide
562719|NCT00439556|Melphalan|melphalan
562720|NCT00439556|Rituximab|rituximab
562721|NCT00439556|BEAM|beam
562722|NCT00439556|BCNU|bcnu
562723|NCT00439556|BiCNU®|bicnu®
562724|NCT00439556|ARA-C|ara-c
562725|NCT00439556|Cytosar|cytosar
562726|NCT00439556|DepoCyt®|depocyt®
562727|NCT00439556|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
562728|NCT00439556|VePesid®|vepesid®
562729|NCT00439556|Rituxan|rituxan
562730|NCT00439569|spinal muscular atrophy type II/III|spinal muscular atrophy type ii/iii
562731|NCT00439569|SMA type II/III|sma type ii/iii
562732|NCT00439569|spinal muscular atrophy|spinal muscular atrophy
562733|NCT00439569|SMA|sma
562734|NCT00439569|sodium phenylbutyrate|sodium phenylbutyrate
562735|NCT00439569|motor neuron disease|motor neuron disease
562736|NCT00439569|neuromuscular|neuromuscular
562737|NCT00439569|survival motor neuron|survival motor neuron
562739|NCT00439569|dose escalation|dose escalation
562740|NCT00439582|Lipoproteins|lipoproteins
562741|NCT00439582|Milk fat|milk fat
562742|NCT00439582|Public health nutrition|public health nutrition
562743|NCT00439582|trans fatty acid|trans fatty acid
562744|NCT00439595|Anaemia|anaemia
562745|NCT00439595|Diagnosis|diagnosis
562746|NCT00439595|Primary|primary
562747|NCT00439595|Care|care
562748|NCT00439595|Treatment|treatment
562749|NCT00439608|esophageal cancer|esophageal cancer
562750|NCT00439608|gastroesophageal cancer|gastroesophageal cancer
562751|NCT00439608|gastric cancer|gastric cancer
562752|NCT00439621|immunotherapy|immunotherapy
562753|NCT00439621|allergy|allergy
562754|NCT00439634|psychometrics|psychometrics
562755|NCT00439634|schizophrenia|schizophrenia
562756|NCT00439647|Osteoporosis|osteoporosis
562757|NCT00439647|males|males
562758|NCT00439647|vertebral fractures|vertebral fractures
562759|NCT00439647|clinical fractures|clinical fractures
562760|NCT00439647|bone mineral density|bone mineral density
562761|NCT00439647|bone biomarkers|bone biomarkers
562762|NCT00439647|zoledronic acid|zoledronic acid
562763|NCT00439660|Rotavirus, diarrhea, vaccine|rotavirus, diarrhea, vaccine
562764|NCT00439673|MDS|mds
562765|NCT00439673|5-Azacytidine|5-azacytidine
562766|NCT00439673|valproic acid|valproic acid
562767|NCT00439673|atra|atra
562768|NCT00439673|intermediate or high risk|intermediate or high risk
562769|NCT00439673|Age ≥18 yearsAge|age ≥18 yearsage
562770|NCT00439699|Essential Tremor|essential tremor
562771|NCT00439699|Memantine|memantine
562772|NCT00439699|Clinical Trial|clinical trial
562773|NCT00439738|Obesity, hypertension, valsartan/hydrochlorothiazide|obesity, hypertension, valsartan/hydrochlorothiazide
562774|NCT00439751|Prostate Cancer|prostate cancer
562775|NCT00439751|Androgen Deprivation Therapy|androgen deprivation therapy
562776|NCT00439751|Recurrence|recurrence
562777|NCT00439751|Biochemical Failure|biochemical failure
562778|NCT00439751|Goserelin|goserelin
562779|NCT00439764|Low back pain, health education, physical therapy|low back pain, health education, physical therapy
562780|NCT00439790|implantable cardioverter defibrillator|implantable cardioverter defibrillator
562781|NCT00439790|Heart failure|heart failure
562782|NCT00439790|Sudden Cardiac Arrest|sudden cardiac arrest
562783|NCT00439790|appropriate shock|appropriate shock
562784|NCT00439790|Defibrillators, Implantable|defibrillators, implantable
562785|NCT00439803|CMV|cmv
562786|NCT00439803|cytomegalovirus|cytomegalovirus
562787|NCT00439803|Alphavirus|alphavirus
562788|NCT00439816|Hypertension Outcomes|hypertension outcomes
562789|NCT00439816|Health Outcomes|health outcomes
562790|NCT00439816|Outpatient|outpatient
752470|NCT01173133|Monitoring|monitoring
562188|NCT00430625|VPRIV®|vpriv®
562791|NCT00439816|Racial Preference|racial preference
562792|NCT00439816|Blood Pressure Control|blood pressure control
562793|NCT00439816|Clinical Trial|clinical trial
562794|NCT00439816|Intervention|intervention
562795|NCT00439816|Lifestyle modifications|lifestyle modifications
562796|NCT00439816|Ethnic Differences|ethnic differences
562797|NCT00439816|Randomized|randomized
562798|NCT00439829|follicle|follicle
562799|NCT00439829|ovary|ovary
562800|NCT00439829|poor responder|poor responder
562801|NCT00439829|stimulation|stimulation
562802|NCT00439829|follicle wave emergence|follicle wave emergence
562803|NCT00439855|Enoxaparin, heparin, hemorrhages|enoxaparin, heparin, hemorrhages
562913|NCT00440219|Prednisone|prednisone
562804|NCT00439868|WELLBUTRIN XL, intraocular pressure, healthy volunteers|wellbutrin xl, intraocular pressure, healthy volunteers
562805|NCT00439881|inflammation,|inflammation,
562806|NCT00439881|intravenous,|intravenous,
562807|NCT00439881|Chronic Obstructive Pulmonary Disease,|chronic obstructive pulmonary disease,
562808|NCT00439881|P38 inhibitor|p38 inhibitor
562809|NCT00439881|SB-681323,|sb-681323,
562810|NCT00439881|rheumatoid arthritis,|rheumatoid arthritis,
562811|NCT00439894|Rheumatoid Arthritis|rheumatoid arthritis
562812|NCT00439894|etanercept|etanercept
562814|NCT00439894|Amgen|amgen
562815|NCT00439907|Anal sphincter Delivery|anal sphincter delivery
562816|NCT00439907|Primary repair|primary repair
562817|NCT00439907|End-to-end repair|end-to-end repair
562818|NCT00439907|Over-lap repair|over-lap repair
562819|NCT00439907|Anal manometry|anal manometry
562820|NCT00439907|Anal sonography|anal sonography
562821|NCT00439907|Weksner Score|weksner score
562822|NCT00439907|Rupture of the external anal sphincter during delivery|rupture of the external anal sphincter during delivery
562823|NCT00439907|Anal sphincter|anal sphincter
562824|NCT00439907|Anal sphincter rupture|anal sphincter rupture
562825|NCT00439920|ALL|all
562826|NCT00439933|Obesity|obesity
562827|NCT00439933|Children|children
562828|NCT00439933|Weight loss|weight loss
562829|NCT00439933|Endothelial dysfunction|endothelial dysfunction
562830|NCT00439933|Intervention|intervention
562831|NCT00439946|pulmonary hypertension|pulmonary hypertension
562832|NCT00439946|PAH|pah
562833|NCT00439946|Remodulin|remodulin
562834|NCT00439946|treprostinil|treprostinil
562835|NCT00439946|Quality of Life|quality of life
562836|NCT00439946|rapid switch|rapid switch
562837|NCT00439959|GSK625433,|gsk625433,
562838|NCT00439959|Hepatitis C,|hepatitis c,
562839|NCT00439959|metabolic probe,|metabolic probe,
562840|NCT00439959|food-effect,|food-effect,
562841|NCT00439959|HCV,|hcv,
562842|NCT00439959|FTIH|ftih
562843|NCT00439959|polymerase,|polymerase,
562844|NCT00439972|Lipoproteins|lipoproteins
562845|NCT00439972|Apolipoproteins|apolipoproteins
562846|NCT00439972|Insulin sensitivity|insulin sensitivity
562847|NCT00439972|Inflammation|inflammation
562848|NCT00439972|Clotting|clotting
562849|NCT00439972|Antioxidant status|antioxidant status
562850|NCT00439972|Vascular reactivity|vascular reactivity
562851|NCT00439972|Metabolism|metabolism
562852|NCT00439985|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
562853|NCT00439985|Metabolic Control|metabolic control
562854|NCT00439985|Adherence|adherence
562855|NCT00439985|Optimism|optimism
562856|NCT00439985|Parent-Child Collaboration|parent-child collaboration
562857|NCT00439985|Prevention|prevention
562858|NCT00439998|Ultrasound|ultrasound
562859|NCT00439998|Obesity|obesity
562860|NCT00439998|Needle Depth|needle depth
562861|NCT00440024|Sun-Damaged Skin|sun-damaged skin
562862|NCT00440024|Retinoid Intolerance|retinoid intolerance
562863|NCT00440024|Tazarotene Cream|tazarotene cream
562864|NCT00440024|Dove facial cleanser|dove facial cleanser
562865|NCT00440024|Dove moisturizer|dove moisturizer
562866|NCT00440037|AMG 531|amg 531
562867|NCT00440037|ITP|itp
562868|NCT00440037|Long term treatment|long term treatment
562869|NCT00440037|Japanese|japanese
562870|NCT00440037|Romiplostim|romiplostim
562871|NCT00440050|fish oil|fish oil
562872|NCT00440050|omega-3 fatty acids|omega-3 fatty acids
562873|NCT00440050|EPA|epa
562874|NCT00440076|MDS|mds
562875|NCT00440076|Velcade|velcade
562876|NCT00440089|Cancer|cancer
562877|NCT00440089|Fatigue|fatigue
562878|NCT00440089|Breast Cancer|breast cancer
562879|NCT00440089|Healing|healing
562880|NCT00440089|Energy Healing|energy healing
562881|NCT00440089|Complementary|complementary
562882|NCT00440089|Alternative|alternative
562883|NCT00440089|Immune|immune
562884|NCT00440089|Cytokine|cytokine
562885|NCT00440089|Hormone|hormone
562886|NCT00440089|Cortisol|cortisol
562887|NCT00440089|Placebo|placebo
562888|NCT00440089|Mock Healing|mock healing
562889|NCT00440102|ETOMIDATE|etomidate
562890|NCT00440102|KETAMINE|ketamine
562891|NCT00440102|RAPID SEQUENCE INTUBATION|rapid sequence intubation
562892|NCT00440102|PREHOSPITAL|prehospital
562893|NCT00440102|During rapid sequence intubation|during rapid sequence intubation
562894|NCT00440128|Casopitant,|casopitant,
562895|NCT00440128|Neurokinin-1 Receptor Antagonist,|neurokinin-1 receptor antagonist,
562896|NCT00440128|Drug-Interaction,|drug-interaction,
562897|NCT00440128|CYP3A|cyp3a
562898|NCT00440128|NK-1 Receptor Antagonist,|nk-1 receptor antagonist,
562899|NCT00440128|GW679769,|gw679769,
562900|NCT00440128|Docetaxel,|docetaxel,
562901|NCT00440167|capecitabine|capecitabine
562902|NCT00440167|gemcitabine|gemcitabine
562903|NCT00440167|Erlotinib|erlotinib
562904|NCT00440167|pancreatic cancer|pancreatic cancer
562905|NCT00440167|advanced|advanced
562907|NCT00440180|Low sperm count|low sperm count
562908|NCT00440180|Male infertility|male infertility
562910|NCT00440206|Immune Markers|immune markers
562911|NCT00440219|Nasal polyps|nasal polyps
562912|NCT00440219|Steroids|steroids
562914|NCT00440219|Nasal polypectomy|nasal polypectomy
562915|NCT00440219|Blood loss, surgical|blood loss, surgical
562916|NCT00440258|Ovarian hyperstimulation syndrome, dopamine agonists, cabergoline, hemoconcentration, ascites, ovarian perfusion, dopamine receptor 2|ovarian hyperstimulation syndrome, dopamine agonists, cabergoline, hemoconcentration, ascites, ovarian perfusion, dopamine receptor 2
562917|NCT00440284|conventional insulin therapy|conventional insulin therapy
562918|NCT00440284|intensive insulin therapy|intensive insulin therapy
562920|NCT00440284|patient education|patient education
562921|NCT00440284|RCT|rct
562922|NCT00440284|glycosylated hemoglobin|glycosylated hemoglobin
562923|NCT00440284|hypoglycemia|hypoglycemia
562924|NCT00440284|patient preference|patient preference
562925|NCT00440297|hepatitis B virus|hepatitis b virus
562926|NCT00440310|Liver neoplasms|liver neoplasms
562927|NCT00440310|Liver metastases|liver metastases
562928|NCT00440310|MCRC|mcrc
562929|NCT00440310|Litx™|litx™
562930|NCT00440310|LS11|ls11
562931|NCT00440310|Colorectal cancer with recurrent liver metastases|colorectal cancer with recurrent liver metastases
562932|NCT00440323|Noise induced Situational insomnia,|noise induced situational insomnia,
562933|NCT00440323|healthy volunteers|healthy volunteers
562934|NCT00440323|SB-649868,|sb-649868,
562935|NCT00440323|Zolpidem,|zolpidem,
562936|NCT00440336|IOP|iop
562937|NCT00440336|SLT|slt
562938|NCT00440336|Laser|laser
562939|NCT00440336|Cosopt|cosopt
562940|NCT00440349|Retroperitoneal fibrosis|retroperitoneal fibrosis
562941|NCT00440349|Tamoxifen|tamoxifen
562942|NCT00440349|Corticosteroids|corticosteroids
562943|NCT00440349|Obstructive uropathy|obstructive uropathy
562944|NCT00440349|Periaortic fibrosis|periaortic fibrosis
562945|NCT00440349|Chronic periaortitis|chronic periaortitis
562946|NCT00440362|Influenza|influenza
562947|NCT00440362|Flu|flu
562948|NCT00440362|A/Wyoming/03/2003|a/wyoming/03/2003
562949|NCT00440362|Alphavirus|alphavirus
562950|NCT00440388|cancer|cancer
562951|NCT00440388|lymphoma|lymphoma
562952|NCT00440388|Non-Hodgkin's|non-hodgkin's
562953|NCT00440388|Non-Hodgkins|non-hodgkins
562954|NCT00440388|AT-101|at-101
562955|NCT00440388|AT101|at101
562956|NCT00440388|Rituxan|rituxan
562957|NCT00440388|Rituximab|rituximab
562958|NCT00440401|Surgical treatment of haemorrhage|surgical treatment of haemorrhage
562959|NCT00440414|Cancer|cancer
562960|NCT00440414|Non-small-cell lung cancer|non-small-cell lung cancer
562961|NCT00440414|Chemotherapy|chemotherapy
562962|NCT00440414|Pemetrexed|pemetrexed
562963|NCT00440414|Erlotinib|erlotinib
562964|NCT00440427|Major Depressive Disorder|major depressive disorder
562965|NCT00440427|MDD|mdd
562966|NCT00440440|hypogonadism|hypogonadism
562967|NCT00440440|diabetes|diabetes
562968|NCT00440440|visceral fat|visceral fat
562969|NCT00440440|hepatic fat|hepatic fat
562970|NCT00440440|lean mass|lean mass
562971|NCT00440453|Internal medicine patients|internal medicine patients
562972|NCT00440466|Anemia|anemia
562973|NCT00440466|Reduction in the number of erythrocytes|reduction in the number of erythrocytes
562974|NCT00440466|Hemoglobin low level|hemoglobin low level
562975|NCT00440466|Red blood cell deficiency|red blood cell deficiency
562976|NCT00440466|Procrit|procrit
562977|NCT00440466|Epoetin alfa|epoetin alfa
562978|NCT00440466|Chronic kidney disease|chronic kidney disease
562979|NCT00440479|Multiple Myeloma|multiple myeloma
562980|NCT00440479|hematological neoplasms|hematological neoplasms
562981|NCT00440479|chemotherapy|chemotherapy
562982|NCT00440479|efficacy|efficacy
562983|NCT00440479|safety|safety
562984|NCT00440479|bortezomib|bortezomib
562985|NCT00440479|proteasome inhibitor|proteasome inhibitor
562986|NCT00440505|chronic pain|chronic pain
562987|NCT00440505|pelvic pain|pelvic pain
562988|NCT00440505|nicotine patch|nicotine patch
562989|NCT00440518|Lacosamide|lacosamide
562990|NCT00440518|migraine prophylaxis|migraine prophylaxis
562991|NCT00440518|Vimpat|vimpat
562992|NCT00440544|Tuberculosis|tuberculosis
562993|NCT00440544|vaccine|vaccine
562994|NCT00440544|nasal immunization|nasal immunization
562995|NCT00440557|Anemia|anemia
562996|NCT00440557|Chronic Kidney disease|chronic kidney disease
562997|NCT00440557|Kidney disease|kidney disease
562998|NCT00440557|Epoetin alfa|epoetin alfa
562999|NCT00440557|Procrit|procrit
563000|NCT00440570|cancer|cancer
563001|NCT00440570|electromagnetic fields|electromagnetic fields
563002|NCT00440570|treatment|treatment
563003|NCT00440583|CHOP-Z|chop-z
563004|NCT00440622|Cancer|cancer
563005|NCT00440622|Metastatic Breast cancer|metastatic breast cancer
563006|NCT00440622|Her-2 expression|her-2 expression
563007|NCT00440622|Gemcitabine|gemcitabine
563008|NCT00440622|Capecitabine|capecitabine
563009|NCT00440622|Herceptin|herceptin
563010|NCT00440635|Multiple myeloma|multiple myeloma
563011|NCT00440635|bortezomib, Hematology|bortezomib, hematology
563012|NCT00440661|Osteoarthritis, IL-1|osteoarthritis, il-1
563013|NCT00440674|Direct Stenting|direct stenting
563014|NCT00440674|Angioplasty|angioplasty
563015|NCT00440674|Pre-dilatation|pre-dilatation
563016|NCT00440674|Drug-eluting stent|drug-eluting stent
562909|NCT00440206|HIV|hiv
563017|NCT00440687|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
563018|NCT00440687|primary care|primary care
563019|NCT00440687|randomised trials|randomised trials
563020|NCT00440687|therapeutic interventions|therapeutic interventions
563022|NCT00440700|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
563024|NCT00440713|Posttraumatic Stress Disorder|posttraumatic stress disorder
563025|NCT00440713|Depression|depression
563026|NCT00440713|Anxiety|anxiety
563027|NCT00440713|Efficacy|efficacy
563028|NCT00440726|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
563029|NCT00440726|Pediatrics|pediatrics
563030|NCT00440726|Relapsed|relapsed
563031|NCT00440726|Recurrence|recurrence
563032|NCT00440726|Bortezomib|bortezomib
563033|NCT00440726|Velcade|velcade
563034|NCT00440726|Therapeutic Advances in Childhood Leukemia|therapeutic advances in childhood leukemia
563035|NCT00440726|Investigational|investigational
563036|NCT00440726|Childhood|childhood
563037|NCT00440726|ALL|all
563038|NCT00440726|Relapsed ALL|relapsed all
563039|NCT00440726|Refractory ALL|refractory all
563040|NCT00440726|Relapsed pediatric ALL|relapsed pediatric all
563041|NCT00440726|Refractory pediatric ALL|refractory pediatric all
563042|NCT00440726|TACL|tacl
563043|NCT00440726|Recurrent Pediatric ALL|recurrent pediatric all
563044|NCT00440739|postoperative pain, etoticoxib, etoricoxib|postoperative pain, etoticoxib, etoricoxib
563045|NCT00440739|Pain relief after transurethral resection of prostate.|pain relief after transurethral resection of prostate.
563047|NCT00440752|Plasmodium falciparum|plasmodium falciparum
563048|NCT00440752|drug resistance genes|drug resistance genes
563049|NCT00440765|Multiple Myeloma|multiple myeloma
563050|NCT00440765|hematological Neoplasms|hematological neoplasms
563051|NCT00440765|chemotherapy|chemotherapy
563052|NCT00440765|efficacy|efficacy
563053|NCT00440765|safety|safety
563054|NCT00440765|bortezomib|bortezomib
563055|NCT00440765|proteasome inhibitor|proteasome inhibitor
563056|NCT00440778|Coronary artery stenting|coronary artery stenting
563057|NCT00440778|Trans-radial|trans-radial
563058|NCT00440778|Intracoronary|intracoronary
563059|NCT00440791|Colon|colon
563060|NCT00440791|colonic disease|colonic disease
563061|NCT00440791|capsule endoscopy|capsule endoscopy
563062|NCT00440791|Suspected or known colonic disease|suspected or known colonic disease
563063|NCT00440804|patent ductus arterious|patent ductus arterious
563064|NCT00440817|Lymphoma|lymphoma
563065|NCT00440817|Rheumatoid arthritis|rheumatoid arthritis
563066|NCT00440817|Crohn's disease|crohn's disease
563067|NCT00440817|Remicade|remicade
563068|NCT00440817|Infliximab|infliximab
563069|NCT00440830|acute pain|acute pain
563070|NCT00440830|nicotine|nicotine
563071|NCT00440830|nausea|nausea
563072|NCT00440830|sedation|sedation
563073|NCT00440843|schizophrenia|schizophrenia
563074|NCT00440843|attention|attention
563075|NCT00440843|task engagement|task engagement
563076|NCT00440843|antipsychotics|antipsychotics
563077|NCT00440843|cognition|cognition
563078|NCT00440843|cognitive rehabilitation|cognitive rehabilitation
563079|NCT00440856|Intervertebral disc|intervertebral disc
563080|NCT00440856|Lumbar discectomy|lumbar discectomy
563081|NCT00440856|Outcome|outcome
563082|NCT00440856|Radiculopathy due to prolapsed intervertebral disc.|radiculopathy due to prolapsed intervertebral disc.
563083|NCT00440869|N-acetylcysteine|n-acetylcysteine
563084|NCT00440869|oxidative stress|oxidative stress
563085|NCT00440869|muscle fatigue|muscle fatigue
563086|NCT00440869|end-stage renal disease|end-stage renal disease
563087|NCT00440869|hemodialysis|hemodialysis
563088|NCT00440895|Coronary artery stenting|coronary artery stenting
563089|NCT00440895|Trans-radial|trans-radial
563090|NCT00440895|Intracoronary|intracoronary
563091|NCT00440895|Rescue-PCI|rescue-pci
563092|NCT00440908|Dialyzer reuse|dialyzer reuse
563093|NCT00440908|Inflammatory markers|inflammatory markers
563094|NCT00440908|Nutritional status|nutritional status
563095|NCT00440921|fibrin sealnat|fibrin sealnat
563096|NCT00440921|knee replacement|knee replacement
563097|NCT00440921|hip replacement|hip replacement
563098|NCT00440921|woud healing|woud healing
563099|NCT00440921|blood loss|blood loss
562475|NCT00437840|tolerability,|tolerability,
563100|NCT00440921|clinical trial|clinical trial
563101|NCT00440921|randomized|randomized
563102|NCT00440934|carcinoma, hepatocellular|carcinoma, hepatocellular
563103|NCT00440934|electromagnetic fields|electromagnetic fields
563104|NCT00440947|NORVIR|norvir
563105|NCT00440947|ARIES|aries
563106|NCT00440947|EPZICOM|epzicom
563107|NCT00440947|REYATAZ|reyataz
563108|NCT00440947|HIV|hiv
563109|NCT00440947|simplification|simplification
563110|NCT00440947|Antiretroviral-naive|antiretroviral-naive
563111|NCT00440960|alfentanil|alfentanil
563112|NCT00440960|anesthesia|anesthesia
563113|NCT00440960|bronchoscopy|bronchoscopy
563114|NCT00440960|lidocaine|lidocaine
563115|NCT00440960|midazolam|midazolam
563116|NCT00440960|propofol.|propofol.
563117|NCT00440973|kidney cancer|kidney cancer
563118|NCT00440973|M3thodist|m3thodist
563023|NCT00440700|Anxiety|anxiety
563327|NCT00434577|Vaccine|vaccine
563119|NCT00440986|Clinical Management|clinical management
563121|NCT00440986|Eritrocytoapheresis|eritrocytoapheresis
563122|NCT00440999|P vivax|p vivax
563123|NCT00440999|malaria|malaria
563125|NCT00441012|Haemophilus Influenza, type b and Hepatitis B|haemophilus influenza, type b and hepatitis b
563126|NCT00441025|MabCampath + CHOP in PTCL|mabcampath + chop in ptcl
563127|NCT00441038|Low back pain|low back pain
563128|NCT00441038|disability|disability
563129|NCT00441038|health education|health education
563130|NCT00441051|Sunburn, diclofenac, topical NSAID|sunburn, diclofenac, topical nsaid
563131|NCT00441064|High blood pressure, hypertension, aliskiren, low sodium diet|high blood pressure, hypertension, aliskiren, low sodium diet
563132|NCT00441077|Genetics|genetics
563133|NCT00441077|Family History|family history
563134|NCT00441077|Latino|latino
563135|NCT00441077|Information Seeking|information seeking
563136|NCT00441077|Lay Health Advisors|lay health advisors
563137|NCT00441077|Cancer|cancer
563138|NCT00441077|Heart Disease|heart disease
563139|NCT00441077|Diabetes|diabetes
563140|NCT00441077|Information|information
563141|NCT00441090|Chronic Idiopathic Thrombocytopenic Purpura|chronic idiopathic thrombocytopenic purpura
563142|NCT00441090|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
563143|NCT00441090|ITP|itp
563144|NCT00441103|Subjects with relapsing remitting multiple sclerosis|subjects with relapsing remitting multiple sclerosis
563145|NCT00441116|dutasteride|dutasteride
563146|NCT00441116|Androgenic alopecia|androgenic alopecia
563147|NCT00441116|phase 3|phase 3
563148|NCT00441129|Improvement of the blood glucose control|improvement of the blood glucose control
563149|NCT00441142|Newly diagnosed malignant brain tumors.|newly diagnosed malignant brain tumors.
563150|NCT00441155|Oncology|oncology
563151|NCT00441155|Cancer|cancer
563152|NCT00441155|Imatinib-Resistant Gastrointestinal Stromal Tumors|imatinib-resistant gastrointestinal stromal tumors
563153|NCT00441155|GIST|gist
563154|NCT00441155|Nilotinib|nilotinib
563155|NCT00441155|Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST)|imatinib-resistant gastrointestinal stromal tumors (gist)
563156|NCT00441168|Multiple Myeloma|multiple myeloma
563157|NCT00441168|bortezomib|bortezomib
563158|NCT00441168|Cancer|cancer
563159|NCT00441168|Hematology|hematology
563160|NCT00441168|bone marrow|bone marrow
563161|NCT00441168|immunoglobulin|immunoglobulin
563162|NCT00441168|relapse|relapse
563163|NCT00441168|refractory|refractory
563164|NCT00441168|plasma cell|plasma cell
563165|NCT00441168|Velcade|velcade
563166|NCT00441168|adriamycin|adriamycin
563167|NCT00441168|dexamethasone|dexamethasone
563168|NCT00441168|vincristine|vincristine
563169|NCT00441181|Neovascular glaucoma|neovascular glaucoma
563170|NCT00441181|Travoprost|travoprost
563171|NCT00441194|Perimetry|perimetry
563172|NCT00441194|Visual Field|visual field
563173|NCT00441194|Octopus|octopus
563174|NCT00441207|IV Ascorbic Acid|iv ascorbic acid
563175|NCT00441207|IV Vitamin C|iv vitamin c
563176|NCT00441207|Cancer|cancer
563177|NCT00441207|Advanced Solid Tumors|advanced solid tumors
563178|NCT00441220|Genetic polymorphisms|genetic polymorphisms
563179|NCT00441220|Cyclophosphamide|cyclophosphamide
563180|NCT00441220|Cytochrome p450 CYP2C19 (Human)|cytochrome p450 cyp2c19 (human)
563181|NCT00441220|Systemic Lupus Erythematosus|systemic lupus erythematosus
563182|NCT00441246|Acute Respiratory Infection|acute respiratory infection
563183|NCT00441246|Bronchitis|bronchitis
563184|NCT00441246|Rhinosinusitis|rhinosinusitis
563185|NCT00441259|Japanese Encephalitis|japanese encephalitis
563186|NCT00441272|Pioglitazone|pioglitazone
563187|NCT00441272|Hepatic Steatosis|hepatic steatosis
563188|NCT00441272|Liver Toxicity|liver toxicity
563189|NCT00441272|Liver Biopsy|liver biopsy
563190|NCT00441272|HIV|hiv
563191|NCT00441272|Treatment Experienced|treatment experienced
563192|NCT00441272|Treatment Naive|treatment naive
563193|NCT00441285|neurocysticercosis|neurocysticercosis
563194|NCT00441285|NCC|ncc
563195|NCT00441285|praziquantel|praziquantel
563196|NCT00441285|PZQ|pzq
563197|NCT00441285|albendazole|albendazole
563198|NCT00441285|ABZ|abz
563199|NCT00441285|parasite|parasite
562556|NCT00438971|Panic Disorder|panic disorder
563200|NCT00441285|pig tapeworm|pig tapeworm
563201|NCT00441285|Taenia solium|taenia solium
563202|NCT00441285|epilepsy|epilepsy
563203|NCT00441285|late-onset epilepsy|late-onset epilepsy
563204|NCT00441285|acquired epilepsy|acquired epilepsy
563205|NCT00441298|microbicides|microbicides
563206|NCT00441298|safety|safety
563207|NCT00441298|effectiveness|effectiveness
563208|NCT00441298|Tenofovir gel|tenofovir gel
563209|NCT00441298|HIV|hiv
563210|NCT00441298|young women|young women
563211|NCT00441298|HIV Seronegativity|hiv seronegativity
563212|NCT00441311|colorectal cancer screening|colorectal cancer screening
563213|NCT00441311|primary care physicians|primary care physicians
563214|NCT00441311|health disparities|health disparities
563215|NCT00441311|stratified randomized clinical trial|stratified randomized clinical trial
563216|NCT00441324|Ovarian follicle|ovarian follicle
563217|NCT00441324|Thecal cells|thecal cells
563218|NCT00441324|Androgens|androgens
563124|NCT00440999|ACT|act
563528|NCT00444470|safety|safety
563219|NCT00441324|FSH sensitivity|fsh sensitivity
563220|NCT00441337|malignancies|malignancies
563221|NCT00441337|cancer|cancer
563222|NCT00441337|non small cell lung cancer|non small cell lung cancer
563223|NCT00441337|lung cancer|lung cancer
563224|NCT00441337|colorectal cancer|colorectal cancer
563225|NCT00441337|adenocarcinoma|adenocarcinoma
563226|NCT00441337|melanoma|melanoma
563227|NCT00441337|malignant melanoma|malignant melanoma
563228|NCT00441337|renal cancer|renal cancer
563229|NCT00441337|renal carcinoma|renal carcinoma
563230|NCT00441337|carcinoma|carcinoma
563231|NCT00441337|prostate cancer|prostate cancer
563232|NCT00441337|prostate adenocarcinoma|prostate adenocarcinoma
563233|NCT00441337|Recurrent or treatment refractory malignancies|recurrent or treatment refractory malignancies
563234|NCT00441363|diabetes|diabetes
563235|NCT00441363|diabetes mellitus|diabetes mellitus
563236|NCT00441376|Radiofrequency ablation|radiofrequency ablation
563237|NCT00441376|RFA|rfa
563238|NCT00441376|Doxorubicin|doxorubicin
563239|NCT00441376|Liposome|liposome
563240|NCT00441376|HCC|hcc
563241|NCT00441376|MLC|mlc
563242|NCT00441376|hepatocellular carcinoma|hepatocellular carcinoma
563243|NCT00441376|liver tumor|liver tumor
563244|NCT00441376|tumor|tumor
563245|NCT00441376|ablation|ablation
563246|NCT00441376|heat therapy|heat therapy
563247|NCT00441376|anti-tumor|anti-tumor
563248|NCT00441376|liver cancer|liver cancer
563249|NCT00441376|metastatic liver cancer (MLC)|metastatic liver cancer (mlc)
563250|NCT00434343|Interstitial Cystitis|interstitial cystitis
563251|NCT00434343|Painful Bladder Syndrome|painful bladder syndrome
563252|NCT00434343|Chronic Prostatitis|chronic prostatitis
563253|NCT00434343|Chronic Pelvic Pain Syndrome|chronic pelvic pain syndrome
563254|NCT00434356|Avastin|avastin
563255|NCT00434356|MBC|mbc
563256|NCT00434356|Breast Cancer|breast cancer
563257|NCT00434356|Sutent|sutent
563258|NCT00434382|auditory evoked potentials|auditory evoked potentials
563259|NCT00434382|sensory processing|sensory processing
563260|NCT00434382|monitoring|monitoring
563261|NCT00434382|general anesthesia|general anesthesia
563262|NCT00434408|omphalitis|omphalitis
563263|NCT00434408|neonates|neonates
563264|NCT00434408|umbilical cord|umbilical cord
563265|NCT00434408|infection|infection
563266|NCT00434408|infant mortality|infant mortality
563267|NCT00434408|neonate morbidity|neonate morbidity
563268|NCT00434408|chlorhexidine|chlorhexidine
563269|NCT00434421|Perennial Allergic Rhinitis|perennial allergic rhinitis
563270|NCT00434421|Asthma|asthma
563271|NCT00434421|Sublingual Immunotherapy (SLIT)|sublingual immunotherapy (slit)
563272|NCT00434434|AQUA|aqua
563273|NCT00434434|anti-CD11|anti-cd11
563274|NCT00434434|CD11a|cd11a
563275|NCT00434434|Asthma|asthma
563276|NCT00434434|Allergy|allergy
563277|NCT00434447|Prostate Cancer|prostate cancer
563278|NCT00434447|Breast Cancer|breast cancer
563279|NCT00434447|Multiple Myeloma|multiple myeloma
563280|NCT00434447|Zoledronic acid|zoledronic acid
563281|NCT00434447|Bone metastases|bone metastases
563282|NCT00434447|Skeletal Related Events (SREs)|skeletal related events (sres)
563283|NCT00434447|Renal Impairment|renal impairment
563284|NCT00434447|Osteonecrosis of the Jaw (ONJ)|osteonecrosis of the jaw (onj)
563285|NCT00434447|Bone involvement|bone involvement
563286|NCT00434447|Multiple Myeloma (MM)|multiple myeloma (mm)
563287|NCT00434460|Ventilator Associated Pneumonia|ventilator associated pneumonia
563288|NCT00434460|Knowledge Translation|knowledge translation
563289|NCT00434460|Clinical Practice Guidelines|clinical practice guidelines
563290|NCT00434460|Education|education
563291|NCT00434460|Behaviour Change|behaviour change
563292|NCT00434499|Green Tea|green tea
563293|NCT00434499|Insulin Resistance|insulin resistance
563294|NCT00434499|Endothelial Dysfunction|endothelial dysfunction
563295|NCT00434499|Nitric Oxide|nitric oxide
563296|NCT00434499|Inflammation|inflammation
563297|NCT00434499|Obesity|obesity
563298|NCT00434499|Overweight|overweight
563299|NCT00434499|Diabetes Type 2|diabetes type 2
563300|NCT00434499|High Blood Pressure|high blood pressure
563301|NCT00434499|Healthy Volunteer|healthy volunteer
563302|NCT00434499|HV|hv
563303|NCT00434512|Gag|gag
563304|NCT00434512|vaccine|vaccine
563305|NCT00434512|adjuvant|adjuvant
563306|NCT00434512|HIV|hiv
563307|NCT00434512|Pol|pol
563308|NCT00434512|Nef|nef
563309|NCT00434525|Morbid obesity|morbid obesity
563310|NCT00434525|Bariatric Surgery|bariatric surgery
563311|NCT00434525|Obesity Surgery|obesity surgery
563312|NCT00434525|Omentectomy|omentectomy
563313|NCT00434525|Sleeve gastrectomy|sleeve gastrectomy
563314|NCT00434538|Diabetic|diabetic
563315|NCT00434538|Foot|foot
563316|NCT00434538|Ulcer|ulcer
563319|NCT00434551|small bowel Crohn's disease|small bowel crohn's disease
563320|NCT00434551|capsule endoscopy|capsule endoscopy
563321|NCT00434551|PillCam SB|pillcam sb
563322|NCT00434551|Patients with suspected small bowel Crohn's disease|patients with suspected small bowel crohn's disease
563323|NCT00434564|Stress nuclear scan|stress nuclear scan
563324|NCT00434564|Acute chest pain|acute chest pain
563325|NCT00434577|GSK Biologicals|gsk biologicals
563328|NCT00434577|Varicella Zoster Virus (VZV)|varicella zoster virus (vzv)
563329|NCT00434577|Shingles|shingles
563330|NCT00434590|Kidney Transplantation|kidney transplantation
563331|NCT00434590|Mycophenolic Acid|mycophenolic acid
563332|NCT00434590|Immunosuppression|immunosuppression
563333|NCT00434590|Cyclosporine|cyclosporine
563334|NCT00434616|angiogenesis|angiogenesis
563335|NCT00434616|Arterial Occlusive Diseases|arterial occlusive diseases
563336|NCT00434616|Leg Ulcer|leg ulcer
563337|NCT00434616|Gangrene|gangrene
563338|NCT00434616|Ischemia|ischemia
563339|NCT00434616|PAOD|paod
563340|NCT00434616|Amputation|amputation
563341|NCT00434616|bone marrow|bone marrow
563342|NCT00434629|lymphoma|lymphoma
563343|NCT00434629|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
563344|NCT00434629|B-cell lymphoma|b-cell lymphoma
563345|NCT00434629|Radioimmunotherapy|radioimmunotherapy
563346|NCT00434629|Bexxar|bexxar
563347|NCT00434629|tositumomab|tositumomab
563348|NCT00434629|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
563349|NCT00434642|Avastin|avastin
563350|NCT00434642|Ovarian carcinoma|ovarian carcinoma
563351|NCT00434642|Peritoneal carcinoma|peritoneal carcinoma
563352|NCT00434642|Peritoneal cancer|peritoneal cancer
563353|NCT00434642|Fallopian tube cancer|fallopian tube cancer
563354|NCT00434642|Fallopian tube carcinoma|fallopian tube carcinoma
563355|NCT00434642|OCEANS|oceans
563356|NCT00434655|Morbid obesity|morbid obesity
563357|NCT00434655|Bariatric surgery|bariatric surgery
563358|NCT00434655|Obesity surgery|obesity surgery
563359|NCT00434655|Gastric banding|gastric banding
563360|NCT00434655|Sleeve gastrectomy|sleeve gastrectomy
563361|NCT00434668|Non-Small Cell Lung Cancer|non-small cell lung cancer
563362|NCT00434668|NSCLC|nsclc
563363|NCT00434668|Adjuvant chemotherapy for completely resected NSCLC|adjuvant chemotherapy for completely resected nsclc
563364|NCT00434694|Atrial Fibrillation|atrial fibrillation
563365|NCT00434694|Catheter ablation|catheter ablation
563366|NCT00434694|Pulmonary Vein|pulmonary vein
563367|NCT00434707|glaucoma|glaucoma
563368|NCT00434707|catarat|catarat
563369|NCT00434707|small pupils|small pupils
563370|NCT00434720|GlideScope|glidescope
563371|NCT00434720|Stylet|stylet
563372|NCT00434733|Influenza H5N1, pandemic|influenza h5n1, pandemic
563373|NCT00434759|randomized controlled trial|randomized controlled trial
563374|NCT00434759|stepped-care program|stepped-care program
563375|NCT00434759|cognitive therapy of social phobia according to D.M. Clark|cognitive therapy of social phobia according to d.m. clark
563376|NCT00434772|hypoglycemia|hypoglycemia
563377|NCT00434772|glucagon|glucagon
563378|NCT00434772|neonatal|neonatal
563379|NCT00434772|gestational diabetes|gestational diabetes
563380|NCT00434772|insulin|insulin
563381|NCT00434772|glyburide|glyburide
563382|NCT00434798|Campylobacter infections|campylobacter infections
563383|NCT00434811|Insulin dependence|insulin dependence
563384|NCT00434811|Hypoglycemia|hypoglycemia
563385|NCT00434811|Hypoglycemia unawareness|hypoglycemia unawareness
563386|NCT00434837|Knee|knee
563387|NCT00434837|Ligament|ligament
563389|NCT00434837|Reconstruction|reconstruction
563390|NCT00434837|Cartilage|cartilage
563391|NCT00434837|Osteoarthritis|osteoarthritis
563392|NCT00434850|Insulin dependence|insulin dependence
563393|NCT00434850|Hypoglycemia|hypoglycemia
563394|NCT00434850|Hyperglycemia unawareness|hyperglycemia unawareness
563395|NCT00434863|botulinum toxin type A|botulinum toxin type a
563396|NCT00434863|Dysport®|dysport®
563397|NCT00434863|Botox®|botox®
563398|NCT00434863|hyperfunctional forehead lines|hyperfunctional forehead lines
563399|NCT00434863|randomized controlled trial|randomized controlled trial
563400|NCT00434863|double-blinded trial|double-blinded trial
563401|NCT00434863|electromyogram (EMG)|electromyogram (emg)
563402|NCT00434876|Alcoholism|alcoholism
563403|NCT00434876|Insomnia|insomnia
562738|NCT00439569|SMN|smn
563404|NCT00434876|Quetiapine|quetiapine
563405|NCT00434876|Seroquel|seroquel
563406|NCT00434889|dementia|dementia
563407|NCT00434889|falls|falls
563408|NCT00434889|risk factors|risk factors
563409|NCT00434902|Doppler Echocardiography|doppler echocardiography
563410|NCT00434902|Pulmonary hypertension|pulmonary hypertension
563411|NCT00434902|Sickle cell disease|sickle cell disease
563412|NCT00434928|observational|observational
563413|NCT00434928|dietary intake|dietary intake
563414|NCT00434928|nutrient status|nutrient status
563415|NCT00434928|serum assessors|serum assessors
563416|NCT00434928|Attention-Deficit/Hyperactivity Disorder (ADHD)|attention-deficit/hyperactivity disorder (adhd)
563518|NCT00444418|Bisexual men|bisexual men
563417|NCT00434941|Administration of capecitabine concomitant to radiotherapy|administration of capecitabine concomitant to radiotherapy
563418|NCT00434941|Her2: negative|her2: negative
563419|NCT00434954|diabetes|diabetes
563420|NCT00434954|exenatide|exenatide
563421|NCT00434954|Byetta|byetta
563422|NCT00434954|Amylin|amylin
563423|NCT00434954|Lilly|lilly
563424|NCT00434967|Blood pressure reduction|blood pressure reduction
563425|NCT00434967|combination therapy|combination therapy
563426|NCT00434967|candesartan cilexetil|candesartan cilexetil
563427|NCT00434967|hydrochlorothiazide|hydrochlorothiazide
563428|NCT00441389|Bacteria|bacteria
563430|NCT00441389|COPD|copd
563431|NCT00441389|infectious etiology for acute exacerbation of COPD|infectious etiology for acute exacerbation of copd
563432|NCT00441441|asthma|asthma
563433|NCT00441441|fluticasone propionate|fluticasone propionate
563434|NCT00441441|children|children
563435|NCT00441441|fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
563436|NCT00441454|stress urinary incontinence|stress urinary incontinence
563437|NCT00441454|surgery|surgery
563438|NCT00441454|tension-free vaginal tape|tension-free vaginal tape
563439|NCT00441454|retropubic|retropubic
563440|NCT00441454|transobturator|transobturator
563441|NCT00441454|quality-of-life|quality-of-life
563442|NCT00441480|Hypercholesterolemia|hypercholesterolemia
563443|NCT00441480|Hypertriglyceridemia|hypertriglyceridemia
563444|NCT00441480|Plant sterol|plant sterol
563445|NCT00441480|Cholesterol|cholesterol
563446|NCT00441480|Fish oil|fish oil
563447|NCT00441493|Hepatitis C|hepatitis c
563448|NCT00441493|fluvastatin|fluvastatin
563449|NCT00441506|interruption|interruption
563450|NCT00441506|critically ill|critically ill
563451|NCT00441506|sedation|sedation
563452|NCT00441506|pediatrics|pediatrics
563453|NCT00441506|critically ill, ventilated children|critically ill, ventilated children
563454|NCT00441519|Gastroprotective effects|gastroprotective effects
563455|NCT00441519|Aspirin|aspirin
563456|NCT00441532|prostate|prostate
563457|NCT00441571|prostate cancer|prostate cancer
563458|NCT00441571|radiolabeled antibody|radiolabeled antibody
563459|NCT00441597|ischemia reperfusion injury|ischemia reperfusion injury
563460|NCT00441597|atorvastatine|atorvastatine
563461|NCT00441597|preconditioning|preconditioning
563462|NCT00441597|cardiovascular disease|cardiovascular disease
563463|NCT00441610|Gimatecan|gimatecan
563464|NCT00441610|topoisomerase I inhibitor|topoisomerase i inhibitor
563465|NCT00441610|advanced solid tumors|advanced solid tumors
563466|NCT00441623|chronic kidney disease|chronic kidney disease
563467|NCT00441623|cardiovascular disease|cardiovascular disease
563468|NCT00441623|risk stratification|risk stratification
563469|NCT00441636|depression|depression
563470|NCT00441636|CPAP|cpap
563471|NCT00441636|obstructive sleep apnea|obstructive sleep apnea
563472|NCT00441649|ADHD|adhd
563473|NCT00441662|Melanoma|melanoma
563474|NCT00441662|Uvea|uvea
563475|NCT00441662|Macula|macula
563476|NCT00441662|Edema|edema
563477|NCT00441662|Plaque radiotherapy|plaque radiotherapy
563478|NCT00441662|Brachytherapy|brachytherapy
563479|NCT00441662|Triamcinolone|triamcinolone
563480|NCT00441675|Adolescents|adolescents
563481|NCT00441675|Asthma|asthma
563482|NCT00441675|long-term follow-up|long-term follow-up
563483|NCT00441675|symptoms|symptoms
563484|NCT00441675|bronchial hyperresponsiveness|bronchial hyperresponsiveness
563485|NCT00441688|Human Immunodeficiency virus|human immunodeficiency virus
563486|NCT00441688|HLAgenetics polymorphism|hlagenetics polymorphism
563487|NCT00441714|cardiovascular disease|cardiovascular disease
563488|NCT00441714|ischemia-reperfusion injury|ischemia-reperfusion injury
563489|NCT00441714|postconditioning|postconditioning
563490|NCT00441714|annexin targeting|annexin targeting
563491|NCT00444301|Heart failure|heart failure
563492|NCT00444301|Pain|pain
563493|NCT00444301|Symptoms|symptoms
563494|NCT00444301|Advanced heart failure|advanced heart failure
563495|NCT00444301|Pain frequency, severity, location, treatments|pain frequency, severity, location, treatments
563496|NCT00444301|Shortness of breath, anxiety, depression, cognitive function|shortness of breath, anxiety, depression, cognitive function
563497|NCT00444301|Social support, other conditions and illnesses|social support, other conditions and illnesses
563498|NCT00444327|single nucleotide polymorphism|single nucleotide polymorphism
563499|NCT00444379|Kaposi's sarcoma|kaposi's sarcoma
563500|NCT00444379|KSHV|kshv
563501|NCT00444379|AIDS|aids
563502|NCT00444379|HHV-8|hhv-8
563503|NCT00444379|treatment naive|treatment naive
563504|NCT00444392|Obese|obese
563505|NCT00444392|type 2 Diabetes Mellitus|type 2 diabetes mellitus
563506|NCT00444392|Gastric Bypass Surgery|gastric bypass surgery
563507|NCT00444392|Risk of CVD|risk of cvd
563508|NCT00444405|lumbar|lumbar
563509|NCT00444405|disc|disc
563510|NCT00444405|herniation|herniation
563511|NCT00444405|discectomy|discectomy
563512|NCT00444405|fusion|fusion
563513|NCT00444405|spine|spine
563514|NCT00444418|Drinking|drinking
563515|NCT00444418|Alcohol problems|alcohol problems
563516|NCT00444418|Alcoholism|alcoholism
563517|NCT00444418|Gay men|gay men
563519|NCT00444418|Moderation-oriented treatment|moderation-oriented treatment
563520|NCT00444418|Controlled drinking|controlled drinking
563521|NCT00444418|Non-abstinence based treatment|non-abstinence based treatment
563522|NCT00444444|Autoimmune pancreatitis, HLA, relapse, Sequence-based typing|autoimmune pancreatitis, hla, relapse, sequence-based typing
563523|NCT00444457|Vaccine|vaccine
563524|NCT00444457|Infants|infants
563525|NCT00444457|Pneumococcal Conjugate Vaccines|pneumococcal conjugate vaccines
563526|NCT00444457|Vaccines, Pneumococcal|vaccines, pneumococcal
563527|NCT00444470|tranexamic acid|tranexamic acid
563529|NCT00444470|efficacy|efficacy
563530|NCT00444470|spine surgery|spine surgery
563531|NCT00444470|spinal fusion and decompression|spinal fusion and decompression
563532|NCT00444470|adult|adult
563533|NCT00444470|perioperative|perioperative
563534|NCT00444470|blood loss|blood loss
563535|NCT00444470|bleeding|bleeding
563536|NCT00444470|blood transfusion|blood transfusion
563537|NCT00444509|Asthmatic Patients|asthmatic patients
563538|NCT00444522|Panic attacks, Staccato® Alprazolam|panic attacks, staccato® alprazolam
563539|NCT00444535|VEGF|vegf
563540|NCT00444535|Tyrosine kinase|tyrosine kinase
563541|NCT00444535|ErbB2|erbb2
563542|NCT00444535|Her2-neu|her2-neu
563543|NCT00444535|metastatic breast cancer|metastatic breast cancer
563544|NCT00444535|EGFR|egfr
563545|NCT00444535|ErbB1|erbb1
563546|NCT00444535|bevacizumab|bevacizumab
563547|NCT00444535|lapatinib|lapatinib
563548|NCT00444548|Equipment|equipment
563549|NCT00444548|Supplies|supplies
563550|NCT00444561|pramlintide|pramlintide
563551|NCT00444561|Symlin|symlin
563552|NCT00444561|Amylin|amylin
563553|NCT00444574|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
563554|NCT00444600|Diabetic Retinopathy|diabetic retinopathy
563555|NCT00444600|Diabetic Macular Edema|diabetic macular edema
563556|NCT00444600|Lucentis|lucentis
563557|NCT00444600|Ranibizumab|ranibizumab
563558|NCT00444600|Triamcinolone|triamcinolone
563559|NCT00444600|Laser photocoagulation|laser photocoagulation
563560|NCT00444600|Combination Therapy|combination therapy
563561|NCT00444613|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
563562|NCT00444613|motor neurons|motor neurons
563563|NCT00444613|muscular atrophy|muscular atrophy
563564|NCT00444613|Lou Gehrig's Disease|lou gehrig's disease
563565|NCT00444626|nasolabial folds|nasolabial folds
563566|NCT00444626|facial wrinkles|facial wrinkles
563567|NCT00444652|Thromboprophylaxis|thromboprophylaxis
563568|NCT00444652|Bariatric surgery|bariatric surgery
563569|NCT00444652|prevention of venous thromboembolism in bariatric surgery|prevention of venous thromboembolism in bariatric surgery
563570|NCT00444665|Glaucoma|glaucoma
563571|NCT00444678|Previously untreated metastatic colorectal cancer|previously untreated metastatic colorectal cancer
563572|NCT00444678|Metastatic Colorectal Cancer|metastatic colorectal cancer
563573|NCT00444678|combined therapy|combined therapy
563574|NCT00444678|biologics therapy|biologics therapy
563575|NCT00444678|antibody|antibody
563576|NCT00444678|chemotherapy|chemotherapy
563577|NCT00444678|EGFR|egfr
563578|NCT00444691|synovitis score|synovitis score
563579|NCT00444691|sensitivity to change|sensitivity to change
563580|NCT00444691|clinical examination|clinical examination
563581|NCT00444691|ultra-sonography|ultra-sonography
563582|NCT00444717|statin|statin
563583|NCT00444717|metabolic syndrome|metabolic syndrome
563584|NCT00444717|oxidative stress|oxidative stress
563585|NCT00444717|inflammation|inflammation
563586|NCT00444730|Prostate Cancer|prostate cancer
563587|NCT00444730|Prostatectomy|prostatectomy
563588|NCT00444730|Pelvic pain|pelvic pain
563589|NCT00444730|urgency|urgency
563590|NCT00444730|incontinence|incontinence
563591|NCT00444730|frequency|frequency
563592|NCT00444756|local anesthesia|local anesthesia
563593|NCT00444756|analgesia|analgesia
563594|NCT00444756|peripheral IV|peripheral iv
563595|NCT00444756|Local anesthesia prior to peripheral IV insertion|local anesthesia prior to peripheral iv insertion
563596|NCT00444769|analgesia|analgesia
563597|NCT00444769|post-operative pain|post-operative pain
563598|NCT00444769|GW842166|gw842166
563599|NCT00444769|non-cannabinoid agonist|non-cannabinoid agonist
563600|NCT00444769|third molar tooth extraction|third molar tooth extraction
563601|NCT00444782|Advanced Carcinoma, Hepatocellular|advanced carcinoma, hepatocellular
563602|NCT00444795|SUTENE|sutene
563603|NCT00444795|post-marketing surveillance|post-marketing surveillance
563604|NCT00444795|GIST|gist
563605|NCT00444795|RCC|rcc
563606|NCT00444795|Korea|korea
563607|NCT00444808|Rib fracture|rib fracture
563608|NCT00444808|Pain|pain
563609|NCT00444808|intranasal calcitonin|intranasal calcitonin
563610|NCT00444821|AAA|aaa
563611|NCT00444821|Aneurysm|aneurysm
563612|NCT00444821|AneuRx|aneurx
563613|NCT00444821|Talent|talent
563614|NCT00444847|AIDS|aids
563615|NCT00444847|HIV|hiv
563616|NCT00444847|Hyperbaric Chamber|hyperbaric chamber
563617|NCT00444847|treatment experienced|treatment experienced
563717|NCT00445276|Painful osteoarthritis|painful osteoarthritis
563618|NCT00444873|Inappropriate Growth Hormone Secretion Syndrome (Acromegaly)|inappropriate growth hormone secretion syndrome (acromegaly)
563619|NCT00444886|Thoracic Outlet Syndrome (TOS)|thoracic outlet syndrome (tos)
563620|NCT00444886|Botulinum Toxin|botulinum toxin
563621|NCT00444886|Botox|botox
563622|NCT00444886|Pain|pain
563623|NCT00444899|Intensive treatment|intensive treatment
563624|NCT00444899|dietician|dietician
563626|NCT00444912|stem cell mobilization|stem cell mobilization
563627|NCT00444912|autologous transplant|autologous transplant
563628|NCT00444912|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
564746|NCT00438490|Women|women
563629|NCT00444912|Hodgkin Disease|hodgkin disease
563630|NCT00444951|N meningitidis|n meningitidis
563631|NCT00444977|HIV positive persons|hiv positive persons
563632|NCT00444977|Not received oral health care in the preceding 12 months.|not received oral health care in the preceding 12 months.
563633|NCT00444977|treatment naive|treatment naive
563634|NCT00444977|treatment experienced|treatment experienced
563635|NCT00444990|Lumbar pain|lumbar pain
563636|NCT00444990|magnets|magnets
563637|NCT00444990|Reduce low back pain|reduce low back pain
563638|NCT00445003|Diabetic Retinopathy|diabetic retinopathy
563639|NCT00445003|Diabetic Macular Edema|diabetic macular edema
563640|NCT00445003|Lucentis|lucentis
563641|NCT00445003|Ranibizumab|ranibizumab
563642|NCT00445003|Triamcinolone|triamcinolone
563643|NCT00445003|Panretinal Photocoagulation|panretinal photocoagulation
563644|NCT00445003|Combination Therapy|combination therapy
563645|NCT00445003|pdr|pdr
563646|NCT00445016|peripheral regional anesthesia|peripheral regional anesthesia
563647|NCT00445016|nerve damage|nerve damage
563648|NCT00445016|adverse effects|adverse effects
563649|NCT00445016|neurologic complication|neurologic complication
563651|NCT00445029|Allergic contact dermatitis|allergic contact dermatitis
563652|NCT00445029|para-phenylenediamine|para-phenylenediamine
563653|NCT00445029|effector cells|effector cells
563654|NCT00445029|regulatory cells|regulatory cells
563655|NCT00445029|pathophysiology|pathophysiology
563656|NCT00445042|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
563657|NCT00445042|Metastatic RCC|metastatic rcc
563658|NCT00445042|Kidney Cancer|kidney cancer
563659|NCT00445042|M3thodist|m3thodist
563660|NCT00445055|Thyroidectomy|thyroidectomy
563661|NCT00445055|Nausea|nausea
563662|NCT00445055|Vomiting|vomiting
563663|NCT00445055|Droperidol|droperidol
563664|NCT00445068|Multiple myeloma|multiple myeloma
563665|NCT00445068|adults|adults
563666|NCT00445068|LBH589|lbh589
563667|NCT00445068|refractory|refractory
563668|NCT00445081|atopic dermatitis|atopic dermatitis
563669|NCT00445081|prednisolone|prednisolone
563670|NCT00445081|ciclosporine|ciclosporine
563671|NCT00445081|SCORAD|scorad
563672|NCT00445081|DLQI|dlqi
563673|NCT00445081|QALY|qaly
563674|NCT00445081|WLQ|wlq
563675|NCT00445120|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
563676|NCT00445120|probiotic|probiotic
563677|NCT00445120|Lactobacillus Rhamnosus GG|lactobacillus rhamnosus gg
563678|NCT00445120|Children|children
563679|NCT00445120|Clinical trial|clinical trial
563680|NCT00445133|Neck Pain/Lumbar pain/Magnets/sleep deficiency/ insomnia/|neck pain/lumbar pain/magnets/sleep deficiency/ insomnia/
563681|NCT00445146|Phase 2|phase 2
563682|NCT00445146|Open-label|open-label
563683|NCT00445146|Rollover|rollover
563684|NCT00445146|Integrase Inhibitor|integrase inhibitor
563685|NCT00445146|Antiretroviral Agents|antiretroviral agents
563686|NCT00445146|Highly Active Antiretroviral Activity|highly active antiretroviral activity
563687|NCT00445146|HAART|haart
563688|NCT00445146|HIV, HIV-1, AIDS virus, Human Immunodeficiency Virus|hiv, hiv-1, aids virus, human immunodeficiency virus
563689|NCT00445146|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
563690|NCT00445146|treatment experienced|treatment experienced
563691|NCT00445159|UT-15C SR, Peripheral Vascular Disease, treprostinil|ut-15c sr, peripheral vascular disease, treprostinil
563692|NCT00445172|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
563693|NCT00445172|Motor Neurons|motor neurons
563694|NCT00445172|Muscular Atrophy|muscular atrophy
563695|NCT00445185|Dialysis|dialysis
563696|NCT00445185|Pre-dialysis|pre-dialysis
563697|NCT00445185|Hepatitis B vaccine|hepatitis b vaccine
563698|NCT00445185|vaccine|vaccine
727776|NCT01073423|HIV|hiv
563046|NCT00440752|Artemether-lumefantrine|artemether-lumefantrine
563699|NCT00445198|SCLC|sclc
563700|NCT00445211|Intraaortic balloon pumping|intraaortic balloon pumping
563701|NCT00445211|Heparin|heparin
563702|NCT00445211|Limb ischemia|limb ischemia
563703|NCT00445211|Bleeding|bleeding
563704|NCT00445224|Knee pain|knee pain
563705|NCT00445224|Rehabilitation|rehabilitation
563706|NCT00445237|major depression|major depression
563707|NCT00445237|TMS|tms
563708|NCT00445250|Calcipotriol|calcipotriol
563709|NCT00445250|Breast|breast
563710|NCT00445250|Cancer|cancer
563711|NCT00445250|Radiotherapy|radiotherapy
563712|NCT00445250|Radiodermatitis in Breast Cancer|radiodermatitis in breast cancer
563713|NCT00445263|CORONARY DISEASE|coronary disease
563714|NCT00445276|Osteoarthritis|osteoarthritis
563715|NCT00445276|Knee|knee
563716|NCT00445276|Diacerein|diacerein
563718|NCT00445276|Clinical trial|clinical trial
563719|NCT00445289|mechanical ventilation|mechanical ventilation
563720|NCT00445289|ventilator weaning|ventilator weaning
563721|NCT00445289|closed-loop|closed-loop
563722|NCT00445289|ventilation time|ventilation time
563723|NCT00445302|AMD3100|amd3100
16536|NCT03185247|POTS (Postural Orthostatic Tachycardia Syndrome)|pots (postural orthostatic tachycardia syndrome)
16538|NCT03185234|tDCS|tdcs
563806|NCT00445497|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
564089|NCT00445952|stage IV breast cancer|stage iv breast cancer
563724|NCT00445328|hospitalised acutely medically ill patients; Venous Thromboembolism, Infection, Inflammatory Bowel Diseases, Heart Failure, Congestive, Sciatica|hospitalised acutely medically ill patients; venous thromboembolism, infection, inflammatory bowel diseases, heart failure, congestive, sciatica
563726|NCT00445341|Proteomics|proteomics
563727|NCT00445341|Hybrid Schedule|hybrid schedule
563728|NCT00445341|Tumor Lysis Syndrome|tumor lysis syndrome
563729|NCT00445341|Cyclin D1|cyclin d1
563730|NCT00445341|Lymphoma|lymphoma
563731|NCT00445341|Mantle Cell Lymphoma|mantle cell lymphoma
563732|NCT00445341|MCL|mcl
563733|NCT00445341|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
563734|NCT00445341|DLBCL|dlbcl
563735|NCT00445354|cinnamon|cinnamon
563736|NCT00445354|diabetes|diabetes
563737|NCT00445354|hemoglobin a1c|hemoglobin a1c
563738|NCT00445367|Multiple Sclerosis|multiple sclerosis
563739|NCT00445367|Clinically Isolated Syndrome|clinically isolated syndrome
563740|NCT00445367|Transverse Myelitis|transverse myelitis
563741|NCT00445367|Neuromyelitis Optica|neuromyelitis optica
563742|NCT00445367|Acute Disseminated Encephalomyelitis|acute disseminated encephalomyelitis
563743|NCT00445367|Optic Neuritis|optic neuritis
563745|NCT00445367|Biobank|biobank
563746|NCT00445393|Observation|observation
563747|NCT00445393|Mental health|mental health
563748|NCT00445393|Scoliosis|scoliosis
563749|NCT00445393|Screening|screening
563750|NCT00445393|Adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
563751|NCT00445406|recurrent breast cancer|recurrent breast cancer
563752|NCT00445406|stage IV breast cancer|stage iv breast cancer
563753|NCT00445419|Hepatitis C|hepatitis c
563754|NCT00445419|Liver disease|liver disease
563755|NCT00445419|Viral infection|viral infection
563756|NCT00445419|Virosome|virosome
563757|NCT00445419|Vaccine|vaccine
563758|NCT00445419|therapeutic vaccine|therapeutic vaccine
563759|NCT00445419|Chronic hepatitis C virus infection|chronic hepatitis c virus infection
563760|NCT00445445|stage I breast cancer|stage i breast cancer
563761|NCT00445445|stage II breast cancer|stage ii breast cancer
563762|NCT00445445|stage IIIA breast cancer|stage iiia breast cancer
563763|NCT00445445|stage IIIB breast cancer|stage iiib breast cancer
563764|NCT00445445|stage IIIC breast cancer|stage iiic breast cancer
563765|NCT00445445|stage IV breast cancer|stage iv breast cancer
563766|NCT00445445|recurrent breast cancer|recurrent breast cancer
563767|NCT00445445|breast cancer in situ|breast cancer in situ
563768|NCT00445458|cancer|cancer
563769|NCT00445458|HKI-272|hki-272
563770|NCT00445458|neratinib|neratinib
563771|NCT00445458|paclitaxel|paclitaxel
563772|NCT00445458|Taxol|taxol
563773|NCT00445458|breast cancer|breast cancer
563774|NCT00445471|Autism Spectrum Disorder|autism spectrum disorder
563775|NCT00445471|Autistic Disorder|autistic disorder
563776|NCT00445471|Pervasive Developmental Disorder|pervasive developmental disorder
563777|NCT00445484|stage II multiple myeloma|stage ii multiple myeloma
563778|NCT00445484|stage III multiple myeloma|stage iii multiple myeloma
563779|NCT00445484|refractory multiple myeloma|refractory multiple myeloma
563780|NCT00445497|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
563781|NCT00445497|anaplastic large cell lymphoma|anaplastic large cell lymphoma
563782|NCT00445497|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
563783|NCT00445497|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
563784|NCT00445497|intraocular lymphoma|intraocular lymphoma
563785|NCT00445497|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
563786|NCT00445497|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
563787|NCT00445497|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
563788|NCT00445497|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
563789|NCT00445497|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
563790|NCT00445497|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
563791|NCT00445497|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
563792|NCT00445497|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
563793|NCT00445497|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
563794|NCT00445497|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
563795|NCT00445497|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
563796|NCT00445497|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
563797|NCT00445497|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
563798|NCT00445497|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
563799|NCT00445497|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
563800|NCT00445497|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
564083|NCT00445952|breast cancer in situ|breast cancer in situ
563801|NCT00445497|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
563802|NCT00445497|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
563803|NCT00445497|small intestine lymphoma|small intestine lymphoma
563804|NCT00445497|splenic marginal zone lymphoma|splenic marginal zone lymphoma
563805|NCT00445497|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
563807|NCT00445497|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
563808|NCT00445497|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
563809|NCT00445497|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
563810|NCT00445497|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
563811|NCT00445497|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
563812|NCT00445497|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
563813|NCT00445497|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
563814|NCT00445497|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
563815|NCT00445497|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
563816|NCT00445497|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
563817|NCT00445497|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
563818|NCT00445497|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
563819|NCT00445497|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
563820|NCT00445497|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
563821|NCT00445497|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
563822|NCT00445497|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
563823|NCT00445497|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
563824|NCT00445497|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
563825|NCT00445497|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
563826|NCT00445497|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
563827|NCT00445497|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
563828|NCT00445497|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
563829|NCT00445497|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
563830|NCT00445497|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
563831|NCT00445497|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
563832|NCT00445497|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
563833|NCT00445497|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
563834|NCT00445497|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
564441|NCT00446251|Glomerulonephropathy|glomerulonephropathy
563835|NCT00445497|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
563836|NCT00445497|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
563837|NCT00445497|Waldenström macroglobulinemia|waldenström macroglobulinemia
563838|NCT00445497|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
563839|NCT00445497|neutropenia|neutropenia
563840|NCT00445497|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
563841|NCT00445497|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
563842|NCT00445497|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
563843|NCT00445497|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
563844|NCT00445497|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
563845|NCT00445497|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
563846|NCT00445497|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
563847|NCT00445497|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
563848|NCT00445497|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
563849|NCT00445497|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
563850|NCT00445497|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
563851|NCT00445497|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
563852|NCT00445497|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
563853|NCT00445497|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
563854|NCT00445497|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
563855|NCT00445497|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
563856|NCT00445497|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
563857|NCT00445497|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
563858|NCT00445497|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
563859|NCT00445497|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
563860|NCT00445497|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
563861|NCT00445497|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
563862|NCT00445497|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
565577|NCT00449462|liver|liver
563863|NCT00445497|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
563864|NCT00445497|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
563865|NCT00445497|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
563866|NCT00445497|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
563945|NCT00445731|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
563867|NCT00445497|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
563868|NCT00445497|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
563869|NCT00445497|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
563870|NCT00445497|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
563871|NCT00445497|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
563872|NCT00445497|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
563873|NCT00445497|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
583954|NCT00514046|Pharmacokinetics|pharmacokinetics
563874|NCT00445497|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
563875|NCT00445497|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
563876|NCT00445497|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
563877|NCT00445497|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
563878|NCT00445497|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
563879|NCT00445497|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
563880|NCT00445497|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
563881|NCT00445497|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
563882|NCT00445510|GSK256066,|gsk256066,
563883|NCT00445510|allergen,|allergen,
563884|NCT00445510|challenge,|challenge,
563885|NCT00445510|repeat dose,|repeat dose,
563886|NCT00445510|AMP,|amp,
563887|NCT00445510|mild asthmatics|mild asthmatics
563888|NCT00445523|Advanced renal cancer|advanced renal cancer
563889|NCT00445523|metastatic renal cancer|metastatic renal cancer
563890|NCT00445523|RCC|rcc
563891|NCT00445523|kidney cancer|kidney cancer
563892|NCT00445523|M3thodist|m3thodist
563893|NCT00445549|Ovarian|ovarian
563894|NCT00445549|VEGFR2|vegfr2
563895|NCT00445549|EGFR|egfr
563896|NCT00445549|Angiogenesis|angiogenesis
563897|NCT00445549|Tyrosine Kinase|tyrosine kinase
563898|NCT00445549|Protein Phosphorylation|protein phosphorylation
563899|NCT00445549|Vandetanib|vandetanib
563900|NCT00445549|Ovarian Cancer|ovarian cancer
563901|NCT00445549|Fallopian Tube Cancer|fallopian tube cancer
563902|NCT00445549|Peritoneal Cancer|peritoneal cancer
563903|NCT00445562|male breast cancer|male breast cancer
563904|NCT00445562|recurrent breast cancer|recurrent breast cancer
563905|NCT00445562|stage IA breast cancer|stage ia breast cancer
563906|NCT00445562|stage IB breast cancer|stage ib breast cancer
563907|NCT00445562|stage II breast cancer|stage ii breast cancer
563908|NCT00445562|stage IIIA breast cancer|stage iiia breast cancer
563909|NCT00445562|stage IIIB breast cancer|stage iiib breast cancer
563910|NCT00445562|stage IIIC breast cancer|stage iiic breast cancer
563911|NCT00445562|stage IV breast cancer|stage iv breast cancer
563912|NCT00445575|fibrous dysplasia of bone|fibrous dysplasia of bone
563913|NCT00445575|Mac Cune Albright syndrome|mac cune albright syndrome
563914|NCT00445575|bisphosphonates|bisphosphonates
563915|NCT00445575|risedronate|risedronate
563916|NCT00445601|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
563917|NCT00445601|stage 0 bladder cancer|stage 0 bladder cancer
563918|NCT00445601|stage I bladder cancer|stage i bladder cancer
563919|NCT00445601|recurrent bladder cancer|recurrent bladder cancer
563920|NCT00445614|nutrition|nutrition
563921|NCT00445614|cardiovascular risk|cardiovascular risk
563922|NCT00445614|inflammation|inflammation
563923|NCT00445614|vascular function|vascular function
563924|NCT00445627|Type 2 Diabetes|type 2 diabetes
563925|NCT00445627|Obesity|obesity
563926|NCT00445627|Overweight|overweight
563927|NCT00445653|Barrett esophagus|barrett esophagus
563928|NCT00445679|major depressive disorder|major depressive disorder
563929|NCT00445679|MDD|mdd
563930|NCT00445679|depression|depression
563931|NCT00445731|poor performance status|poor performance status
563932|NCT00445731|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
563933|NCT00445731|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
563934|NCT00445731|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
563935|NCT00445731|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
563936|NCT00445731|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
563937|NCT00445731|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
563938|NCT00445731|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
563939|NCT00445731|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
563940|NCT00445731|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
563941|NCT00445731|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
563942|NCT00445731|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
563943|NCT00445731|chronic eosinophilic leukemia|chronic eosinophilic leukemia
563944|NCT00445731|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
564841|NCT00438854|dasatinib|dasatinib
563946|NCT00445731|chronic neutrophilic leukemia|chronic neutrophilic leukemia
563947|NCT00445731|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
563948|NCT00445731|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
563949|NCT00445731|disseminated neuroblastoma|disseminated neuroblastoma
563950|NCT00445731|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
563951|NCT00445731|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
563952|NCT00445731|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
563953|NCT00445731|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
563954|NCT00445731|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
563955|NCT00445731|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
563956|NCT00445731|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
563957|NCT00445731|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
563958|NCT00445731|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
563959|NCT00445731|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
563960|NCT00445731|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
563961|NCT00445731|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
563962|NCT00445731|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
563963|NCT00445731|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
563964|NCT00445731|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
563965|NCT00445731|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
563966|NCT00445731|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
563967|NCT00445731|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
563968|NCT00445731|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
563969|NCT00445731|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
563970|NCT00445731|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
563971|NCT00445731|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
563972|NCT00445731|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
563973|NCT00445731|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
563974|NCT00445731|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
563975|NCT00445731|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
563976|NCT00445731|recurrent breast cancer|recurrent breast cancer
563977|NCT00445731|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
563978|NCT00445731|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
563979|NCT00445731|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
563980|NCT00445731|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
563981|NCT00445731|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
563982|NCT00445731|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
563983|NCT00445731|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
563984|NCT00445731|recurrent neuroblastoma|recurrent neuroblastoma
563985|NCT00445731|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
563986|NCT00445731|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
563987|NCT00445731|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
563988|NCT00445731|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
563989|NCT00445731|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
563990|NCT00445731|refractory hairy cell leukemia|refractory hairy cell leukemia
563991|NCT00445731|refractory multiple myeloma|refractory multiple myeloma
563992|NCT00445731|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
563993|NCT00445731|secondary acute myeloid leukemia|secondary acute myeloid leukemia
563994|NCT00445731|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
563995|NCT00445731|splenic marginal zone lymphoma|splenic marginal zone lymphoma
563996|NCT00445731|stage I multiple myeloma|stage i multiple myeloma
563997|NCT00445731|stage II multiple myeloma|stage ii multiple myeloma
563998|NCT00445731|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
563999|NCT00445731|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
564000|NCT00445731|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
564001|NCT00445731|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
564002|NCT00445731|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
564003|NCT00445731|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
564004|NCT00445731|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
564005|NCT00445731|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
753187|NCT01175811|Metabolic Diseases|metabolic diseases
564006|NCT00445731|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
564007|NCT00445731|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
564008|NCT00445731|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
564009|NCT00445731|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
564010|NCT00445731|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
564011|NCT00445731|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
564012|NCT00445731|stage III multiple myeloma|stage iii multiple myeloma
564013|NCT00445731|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
564014|NCT00445731|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
564015|NCT00445731|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
564016|NCT00445731|stage IIIA breast cancer|stage iiia breast cancer
564017|NCT00445731|stage IIIB breast cancer|stage iiib breast cancer
564018|NCT00445731|stage IIIC breast cancer|stage iiic breast cancer
564019|NCT00445731|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
564020|NCT00445731|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
564021|NCT00445731|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
564022|NCT00445731|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
564023|NCT00445731|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
564024|NCT00445731|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
564025|NCT00445731|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
564026|NCT00445731|stage IV breast cancer|stage iv breast cancer
564027|NCT00445731|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
564028|NCT00445731|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
564442|NCT00446251|Immunosuppression|immunosuppression
564029|NCT00445731|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
564030|NCT00445731|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
564031|NCT00445731|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
564032|NCT00445731|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
564033|NCT00445731|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
564034|NCT00445731|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
564035|NCT00445757|stage I renal cell cancer|stage i renal cell cancer
564036|NCT00445757|stage II renal cell cancer|stage ii renal cell cancer
564037|NCT00445770|Rheumatoid Arthritis|rheumatoid arthritis
564038|NCT00445770|Arthritis|arthritis
564039|NCT00445783|lentigo maligna malignant melanoma|lentigo maligna malignant melanoma
564040|NCT00445783|stage IV melanoma|stage iv melanoma
564041|NCT00445783|acral lentiginous malignant melanoma|acral lentiginous malignant melanoma
564042|NCT00445783|nodular malignant melanoma|nodular malignant melanoma
564043|NCT00445783|stage IA melanoma|stage ia melanoma
564044|NCT00445783|stage IB melanoma|stage ib melanoma
564045|NCT00445783|stage IIA melanoma|stage iia melanoma
564046|NCT00445783|stage IIB melanoma|stage iib melanoma
564047|NCT00445783|stage IIC melanoma|stage iic melanoma
564048|NCT00445783|stage IIIA melanoma|stage iiia melanoma
564049|NCT00445783|stage IIIB melanoma|stage iiib melanoma
564050|NCT00445783|stage IIIC melanoma|stage iiic melanoma
564051|NCT00445809|Kidney|kidney
564052|NCT00445809|Renal|renal
564053|NCT00445809|Cardiac Surgery with bypass|cardiac surgery with bypass
564054|NCT00445809|Cardiovascular surgery with cardiopulmonary bypass|cardiovascular surgery with cardiopulmonary bypass
564055|NCT00445822|CML|cml
564056|NCT00445822|Children|children
564057|NCT00445822|Imatinib|imatinib
564058|NCT00445822|bcr-abl|bcr-abl
564059|NCT00445822|Response|response
564060|NCT00445822|Imatinib mesylate|imatinib mesylate
564061|NCT00445835|coronary artery disease|coronary artery disease
564062|NCT00445835|myocardial infarction|myocardial infarction
564063|NCT00445835|atherothrombosis|atherothrombosis
564064|NCT00445835|atherosclerosis|atherosclerosis
564065|NCT00445848|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
564066|NCT00445848|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
564067|NCT00445848|adenocarcinoma of the lung|adenocarcinoma of the lung
564068|NCT00445861|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
564069|NCT00445861|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
564070|NCT00445861|stage II esophageal cancer|stage ii esophageal cancer
564071|NCT00445861|stage III esophageal cancer|stage iii esophageal cancer
564072|NCT00445874|allergic conjunctivitis, ophthalmology, multicenter, controlled|allergic conjunctivitis, ophthalmology, multicenter, controlled
564073|NCT00445887|ovarian epithelial cancer|ovarian epithelial cancer
564074|NCT00445900|primary myelofibrosis|primary myelofibrosis
564075|NCT00445900|essential thrombocythemia|essential thrombocythemia
564076|NCT00445900|polycythemia vera|polycythemia vera
564077|NCT00445900|secondary myelofibrosis|secondary myelofibrosis
564078|NCT00445913|type 1 diabetes|type 1 diabetes
564079|NCT00445913|dendritic cells|dendritic cells
564080|NCT00445913|cell vaccine|cell vaccine
564081|NCT00445913|safety|safety
564082|NCT00445913|reversal|reversal
564084|NCT00445952|stage I breast cancer|stage i breast cancer
564085|NCT00445952|stage II breast cancer|stage ii breast cancer
564086|NCT00445952|stage IIIA breast cancer|stage iiia breast cancer
564087|NCT00445952|stage IIIB breast cancer|stage iiib breast cancer
564088|NCT00445952|stage IIIC breast cancer|stage iiic breast cancer
564842|NCT00438854|BMS-354825|bms-354825
564090|NCT00445952|recurrent breast cancer|recurrent breast cancer
564091|NCT00445952|male breast cancer|male breast cancer
564092|NCT00445952|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
564093|NCT00445952|stage I non-small cell lung cancer|stage i non-small cell lung cancer
564094|NCT00445952|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
564095|NCT00445952|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
564096|NCT00445952|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
564097|NCT00445952|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
564098|NCT00445952|extensive stage small cell lung cancer|extensive stage small cell lung cancer
564099|NCT00445952|recurrent colon cancer|recurrent colon cancer
564100|NCT00445952|stage I colon cancer|stage i colon cancer
564101|NCT00445952|stage II colon cancer|stage ii colon cancer
564102|NCT00445952|stage III colon cancer|stage iii colon cancer
564103|NCT00445952|stage IV colon cancer|stage iv colon cancer
564104|NCT00445952|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
564105|NCT00445952|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
564106|NCT00445952|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
564107|NCT00445952|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
564108|NCT00445952|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
564109|NCT00445952|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
564110|NCT00445952|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
564111|NCT00445952|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
564112|NCT00445952|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
564113|NCT00445952|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
564114|NCT00445952|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
564115|NCT00445952|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
564116|NCT00445952|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
564117|NCT00445952|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
564118|NCT00445952|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
564119|NCT00445952|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
564120|NCT00445952|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
564121|NCT00445952|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
563650|NCT00445016|neuropathy|neuropathy
564122|NCT00445952|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
564123|NCT00445952|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
564124|NCT00445952|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
564125|NCT00445952|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
564126|NCT00445952|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
564127|NCT00445952|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
564128|NCT00445952|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
564129|NCT00445952|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
564130|NCT00445952|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
564131|NCT00445952|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
564132|NCT00445952|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
564133|NCT00445952|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
564134|NCT00445952|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
564135|NCT00445952|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
564136|NCT00445952|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
564137|NCT00445952|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
564138|NCT00445952|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
564139|NCT00445952|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
564140|NCT00445952|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
564141|NCT00445952|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
564142|NCT00445952|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
564143|NCT00445952|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
564144|NCT00445952|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
564145|NCT00445952|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
564146|NCT00445952|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
564147|NCT00445952|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
564148|NCT00445952|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
564149|NCT00445952|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
564150|NCT00445952|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
564151|NCT00445952|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
564550|NCT00446745|Insulin resistance|insulin resistance
564152|NCT00445952|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
564153|NCT00445952|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
564154|NCT00445952|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
564155|NCT00445952|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
564156|NCT00445952|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
564157|NCT00445952|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
564158|NCT00445952|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
564159|NCT00445952|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
564160|NCT00445952|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
564161|NCT00445952|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
564162|NCT00445952|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
564163|NCT00445952|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
564164|NCT00445952|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
564165|NCT00445952|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
564166|NCT00445952|stage I multiple myeloma|stage i multiple myeloma
564167|NCT00445952|stage II multiple myeloma|stage ii multiple myeloma
564168|NCT00445952|stage III multiple myeloma|stage iii multiple myeloma
564169|NCT00445952|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
564170|NCT00445952|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
564171|NCT00445952|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
564172|NCT00445952|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
564173|NCT00445952|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
564174|NCT00445952|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
564175|NCT00445952|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
564176|NCT00445952|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
564177|NCT00445952|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
564178|NCT00445952|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
564179|NCT00445952|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
564180|NCT00445952|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
564181|NCT00445952|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
563744|NCT00445367|Repository|repository
564182|NCT00445952|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
564183|NCT00445952|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
564184|NCT00445952|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
564185|NCT00445952|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
564186|NCT00445952|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
564187|NCT00445952|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
564188|NCT00445952|stage I marginal zone lymphoma|stage i marginal zone lymphoma
564189|NCT00445952|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
564190|NCT00445952|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
564191|NCT00445952|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
564192|NCT00445952|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
564193|NCT00445952|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
564194|NCT00445952|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
564195|NCT00445952|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
564196|NCT00445952|stage I mantle cell lymphoma|stage i mantle cell lymphoma
564197|NCT00445952|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
564198|NCT00445952|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
564199|NCT00445952|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
564200|NCT00445952|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
564201|NCT00445952|refractory multiple myeloma|refractory multiple myeloma
564202|NCT00445952|anaplastic large cell lymphoma|anaplastic large cell lymphoma
564203|NCT00445952|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
564204|NCT00445952|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
564205|NCT00445952|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
564206|NCT00445952|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
564207|NCT00445952|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
564208|NCT00445952|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
564209|NCT00445952|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
564210|NCT00445952|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
564450|NCT00446264|hypoglycemia|hypoglycemia
564211|NCT00445952|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
564212|NCT00445952|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
585622|NCT00513409|Booster vaccination|booster vaccination
564843|NCT00438854|CLL|cll
564213|NCT00445952|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
564214|NCT00445952|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
564215|NCT00445952|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
564216|NCT00445952|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
564217|NCT00445952|chronic eosinophilic leukemia|chronic eosinophilic leukemia
564218|NCT00445952|primary myelofibrosis|primary myelofibrosis
564219|NCT00445952|chronic neutrophilic leukemia|chronic neutrophilic leukemia
564220|NCT00445952|essential thrombocythemia|essential thrombocythemia
564221|NCT00445952|polycythemia vera|polycythemia vera
564222|NCT00445952|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
564223|NCT00445952|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
564224|NCT00445952|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
564225|NCT00445952|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
564226|NCT00445952|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
564227|NCT00445952|secondary acute myeloid leukemia|secondary acute myeloid leukemia
564228|NCT00445952|acute undifferentiated leukemia|acute undifferentiated leukemia
564229|NCT00445952|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
564230|NCT00445952|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
564231|NCT00445952|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
564232|NCT00445952|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
564233|NCT00445952|refractory hairy cell leukemia|refractory hairy cell leukemia
564234|NCT00445952|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
564235|NCT00445952|prolymphocytic leukemia|prolymphocytic leukemia
564236|NCT00445952|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
564237|NCT00445952|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
564238|NCT00445952|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
564239|NCT00445952|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
564240|NCT00445952|splenic marginal zone lymphoma|splenic marginal zone lymphoma
564241|NCT00445952|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
564242|NCT00445952|extramedullary plasmacytoma|extramedullary plasmacytoma
564243|NCT00445952|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
564244|NCT00445952|primary systemic amyloidosis|primary systemic amyloidosis
564245|NCT00445952|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
564246|NCT00445952|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
564247|NCT00445952|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
564248|NCT00445952|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
564249|NCT00445952|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
564250|NCT00445952|intraocular lymphoma|intraocular lymphoma
564251|NCT00445952|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
564252|NCT00445952|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
564253|NCT00445952|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
564254|NCT00445952|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
564256|NCT00445952|limited stage small cell lung cancer|limited stage small cell lung cancer
564257|NCT00445952|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
564258|NCT00445965|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
564259|NCT00445965|untreated childhood medulloblastoma|untreated childhood medulloblastoma
564260|NCT00445965|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
564261|NCT00445965|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
564262|NCT00445965|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
564263|NCT00445965|adult anaplastic astrocytoma|adult anaplastic astrocytoma
564264|NCT00445965|adult diffuse astrocytoma|adult diffuse astrocytoma
564265|NCT00445965|adult pilocytic astrocytoma|adult pilocytic astrocytoma
564266|NCT00445965|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
564267|NCT00445965|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
564268|NCT00445965|untreated childhood subependymal giant cell astrocytoma|untreated childhood subependymal giant cell astrocytoma
564269|NCT00445965|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
564270|NCT00445965|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
564271|NCT00445965|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
564272|NCT00445965|adult brain stem glioma|adult brain stem glioma
564273|NCT00445965|adult mixed glioma|adult mixed glioma
564274|NCT00445965|childhood mixed glioma|childhood mixed glioma
564275|NCT00445965|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
564548|NCT00446719|anxiety|anxiety
16539|NCT03185221|Stents Coronary Artery Disease|stents coronary artery disease
564276|NCT00445965|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
564844|NCT00438854|SLL|sll
564277|NCT00445965|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
564278|NCT00445965|untreated childhood brain stem glioma|untreated childhood brain stem glioma
564279|NCT00445965|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
564280|NCT00445965|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
564281|NCT00445965|regional neuroblastoma|regional neuroblastoma
564282|NCT00445965|disseminated neuroblastoma|disseminated neuroblastoma
564283|NCT00445965|recurrent neuroblastoma|recurrent neuroblastoma
564284|NCT00445965|extraocular retinoblastoma|extraocular retinoblastoma
564285|NCT00445965|recurrent retinoblastoma|recurrent retinoblastoma
564286|NCT00445965|adult anaplastic ependymoma|adult anaplastic ependymoma
564287|NCT00445965|adult ependymoblastoma|adult ependymoblastoma
564288|NCT00445965|adult ependymoma|adult ependymoma
564289|NCT00445965|adult myxopapillary ependymoma|adult myxopapillary ependymoma
564290|NCT00445965|adult subependymoma|adult subependymoma
564291|NCT00445965|childhood infratentorial ependymoma|childhood infratentorial ependymoma
564292|NCT00445965|childhood supratentorial ependymoma|childhood supratentorial ependymoma
564293|NCT00445965|recurrent childhood ependymoma|recurrent childhood ependymoma
564294|NCT00445965|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
564295|NCT00445965|recurrent melanoma|recurrent melanoma
564296|NCT00445965|stage IV melanoma|stage iv melanoma
564297|NCT00445965|adult medulloblastoma|adult medulloblastoma
564299|NCT00445965|metastatic osteosarcoma|metastatic osteosarcoma
564300|NCT00445965|recurrent osteosarcoma|recurrent osteosarcoma
564301|NCT00445965|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
564302|NCT00445965|ovarian sarcoma|ovarian sarcoma
564303|NCT00445965|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
564304|NCT00445965|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
564305|NCT00445965|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
564306|NCT00445965|stage III uterine sarcoma|stage iii uterine sarcoma
564307|NCT00445965|stage IV uterine sarcoma|stage iv uterine sarcoma
564308|NCT00445965|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
728876|NCT01086514|MRI|mri
564309|NCT00445965|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
564310|NCT00445965|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
564311|NCT00445965|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
564312|NCT00445965|adult oligodendroglioma|adult oligodendroglioma
564313|NCT00445965|adult giant cell glioblastoma|adult giant cell glioblastoma
564314|NCT00445965|adult gliosarcoma|adult gliosarcoma
564315|NCT00445965|tumors metastatic to brain|tumors metastatic to brain
564316|NCT00445965|adult rhabdomyosarcoma|adult rhabdomyosarcoma
564317|NCT00445965|childhood oligodendroglioma|childhood oligodendroglioma
564318|NCT00445965|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
564319|NCT00445965|extensive stage small cell lung cancer|extensive stage small cell lung cancer
564320|NCT00445965|intraocular retinoblastoma|intraocular retinoblastoma
564321|NCT00445965|recurrent adult brain tumor|recurrent adult brain tumor
564322|NCT00445965|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
564323|NCT00445965|recurrent uterine sarcoma|recurrent uterine sarcoma
564443|NCT00446251|Graft|graft
564324|NCT00445965|small intestine leiomyosarcoma|small intestine leiomyosarcoma
564325|NCT00445965|recurrent small intestine cancer|recurrent small intestine cancer
564326|NCT00445965|recurrent small cell lung cancer|recurrent small cell lung cancer
564327|NCT00445965|extraocular extension melanoma|extraocular extension melanoma
564328|NCT00445965|recurrent intraocular melanoma|recurrent intraocular melanoma
564329|NCT00445965|metastatic intraocular melanoma|metastatic intraocular melanoma
564330|NCT00445965|iris melanoma|iris melanoma
564331|NCT00445965|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
564332|NCT00445965|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
564333|NCT00445965|adult glioblastoma|adult glioblastoma
564334|NCT00445965|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
564335|NCT00445965|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
564336|NCT00445965|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
564337|NCT00445965|untreated childhood pineoblastoma|untreated childhood pineoblastoma
564338|NCT00445965|adult pineal gland astrocytoma|adult pineal gland astrocytoma
564339|NCT00445965|stage IIIA melanoma|stage iiia melanoma
564340|NCT00445965|stage IIIB melanoma|stage iiib melanoma
564341|NCT00445965|stage IIIC melanoma|stage iiic melanoma
564342|NCT00445965|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
564343|NCT00445965|untreated childhood anaplastic astrocytoma|untreated childhood anaplastic astrocytoma
564344|NCT00445965|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
564345|NCT00445965|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
564346|NCT00445965|untreated childhood anaplastic oligoastrocytoma|untreated childhood anaplastic oligoastrocytoma
564347|NCT00445965|untreated childhood anaplastic oligodendroglioma|untreated childhood anaplastic oligodendroglioma
16540|NCT03185208|Lithium|lithium
564348|NCT00445965|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
564349|NCT00445965|recurrent childhood glioblastoma|recurrent childhood glioblastoma
564350|NCT00445965|untreated childhood giant cell glioblastoma|untreated childhood giant cell glioblastoma
564351|NCT00445965|untreated childhood glioblastoma|untreated childhood glioblastoma
564352|NCT00445965|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
564353|NCT00445965|untreated childhood gliosarcoma|untreated childhood gliosarcoma
564354|NCT00445965|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
564355|NCT00445965|untreated childhood gliomatosis cerebri|untreated childhood gliomatosis cerebri
564356|NCT00445965|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
564357|NCT00445965|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
564358|NCT00445978|Sickle Cell Disease|sickle cell disease
564359|NCT00445978|SCD|scd
564360|NCT00445978|6R-BH4|6r-bh4
564361|NCT00445978|BH4|bh4
564362|NCT00445978|sapropterin dihydrochloride|sapropterin dihydrochloride
564363|NCT00445978|endothelial dysfunction|endothelial dysfunction
564364|NCT00445978|Nitric Oxide|nitric oxide
564365|NCT00445978|NO|no
564366|NCT00446004|Pharmacokinetics|pharmacokinetics
564367|NCT00446004|Healthy volunteers|healthy volunteers
564368|NCT00446004|No condition|no condition
564369|NCT00446004|Pharmacokinetics study|pharmacokinetics study
564370|NCT00446017|coronary artery bypass grafting|coronary artery bypass grafting
564371|NCT00446017|inotropes|inotropes
564372|NCT00446017|metabolism|metabolism
564373|NCT00446017|renal failure|renal failure
564374|NCT00446043|Acne Vulgaris|acne vulgaris
564375|NCT00446043|Adapalene|adapalene
564376|NCT00446043|Benzoyl Peroxide|benzoyl peroxide
564377|NCT00446082|Refractory/ resistant carcinoid disease|refractory/ resistant carcinoid disease
564378|NCT00446082|acromegaly|acromegaly
564379|NCT00446082|adults|adults
564380|NCT00446082|pasireotide LAR|pasireotide lar
564381|NCT00446082|somatostatin analogue|somatostatin analogue
564382|NCT00446082|SOM230|som230
564383|NCT00446082|pharmacokinetics|pharmacokinetics
564384|NCT00446082|Refractory or resistant carcinoid disease and acromegaly|refractory or resistant carcinoid disease and acromegaly
564385|NCT00446095|DLCL|dlcl
564386|NCT00446095|Nodular lymphoma|nodular lymphoma
564387|NCT00446095|Mantle cell lymphoma|mantle cell lymphoma
564388|NCT00446095|Syk kinase|syk kinase
564389|NCT00446108|Pulmonary Stenosis|pulmonary stenosis
564390|NCT00446108|Right Ventricular Dilation|right ventricular dilation
564391|NCT00446108|Right Heart Failure|right heart failure
564392|NCT00446108|Imaging|imaging
564393|NCT00446108|Tetralogy of Fallot|tetralogy of fallot
564394|NCT00446121|COPD|copd
564395|NCT00446134|Phase 2b Dose-Ranging Study|phase 2b dose-ranging study
564396|NCT00446147|hand-foot syndrome|hand-foot syndrome
564397|NCT00446147|capecitabine|capecitabine
564398|NCT00446147|pyridoxine|pyridoxine
564399|NCT00446147|prevention|prevention
564400|NCT00446160|Congenital Heart Disease|congenital heart disease
564401|NCT00446160|Surgery|surgery
564402|NCT00446160|Adult|adult
564403|NCT00446173|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
564404|NCT00446173|Leukemia|leukemia
564405|NCT00446173|Philadelphia (Ph) chromosome positive CML|philadelphia (ph) chromosome positive cml
564406|NCT00446173|Busulfan|busulfan
564407|NCT00446173|Busulfex|busulfex
564408|NCT00446173|Myleran|myleran
564409|NCT00446173|Cyclophosphamide|cyclophosphamide
564410|NCT00446173|Cytoxan|cytoxan
564411|NCT00446173|Neosar|neosar
564412|NCT00446173|G-CSF|g-csf
564413|NCT00446173|Filgrastim|filgrastim
564414|NCT00446173|Neupogen|neupogen
564415|NCT00446173|GM-CSF|gm-csf
564416|NCT00446173|Sargramostim|sargramostim
564417|NCT00446173|Leukine|leukine
564418|NCT00446199|Vasomotor symptom relief|vasomotor symptom relief
564419|NCT00446199|Postmenopausal women|postmenopausal women
564420|NCT00446199|Severe to Moderate Vasomotor symptoms|severe to moderate vasomotor symptoms
564421|NCT00446212|anaesthesia|anaesthesia
564422|NCT00446212|propofol|propofol
564423|NCT00446212|desflurane|desflurane
564424|NCT00446212|dreaming|dreaming
564425|NCT00446212|electroencephalography|electroencephalography
564426|NCT00446225|Lung|lung
564427|NCT00446225|cancer|cancer
564428|NCT00446225|EGFR|egfr
564429|NCT00446225|Epidermal Growth Factor Receptor|epidermal growth factor receptor
564430|NCT00446225|tyrosine kinase|tyrosine kinase
564431|NCT00446225|Tarceva®|tarceva®
564432|NCT00446225|Erlotinib|erlotinib
564433|NCT00446238|Depression|depression
564434|NCT00446238|Physical Illness|physical illness
564435|NCT00446238|Inflammatory Bowel Disease|inflammatory bowel disease
564436|NCT00446238|Cognitive Behavioral Therapy|cognitive behavioral therapy
564437|NCT00446251|Dialysis|dialysis
564438|NCT00446251|Kidney|kidney
564439|NCT00446251|Renal|renal
564440|NCT00446251|Nephropathy|nephropathy
564444|NCT00446251|Compatibility|compatibility
564445|NCT00446251|Transplant|transplant
564446|NCT00446251|Diabetes|diabetes
564447|NCT00446251|Hypertension|hypertension
564448|NCT00446251|Transplantation, Kidney|transplantation, kidney
564449|NCT00446264|diabetes|diabetes
564549|NCT00446745|Nutritional and Metabolic Diseases|nutritional and metabolic diseases
564451|NCT00446277|cataract surgery, endothelial cell, cell loss, diabetes|cataract surgery, endothelial cell, cell loss, diabetes
564452|NCT00446277|mellitus type II|mellitus type ii
564453|NCT00446290|To determine maximal tolerated dose of DXO regimen|to determine maximal tolerated dose of dxo regimen
564455|NCT00446303|Myelodysplastic Syndromes|myelodysplastic syndromes
564457|NCT00446303|Intensive chemotherapy|intensive chemotherapy
564458|NCT00446303|azacitidine|azacitidine
564459|NCT00446316|Pharmacokinetics|pharmacokinetics
564460|NCT00446316|Healthy volunteers|healthy volunteers
564461|NCT00446316|No condition|no condition
564462|NCT00446316|Pharmacokinetics study|pharmacokinetics study
564463|NCT00446342|leukemia|leukemia
564464|NCT00446342|lymphoma|lymphoma
564465|NCT00446342|myeloma|myeloma
564466|NCT00446342|non-Hodgkin's|non-hodgkin's
564467|NCT00446342|CLL|cll
564468|NCT00446342|MCL|mcl
564469|NCT00446342|MM|mm
564470|NCT00446342|Phase 1|phase 1
564471|NCT00446342|hematological malignancy|hematological malignancy
564472|NCT00446355|C diff|c diff
564473|NCT00446355|antibiotics|antibiotics
564474|NCT00446368|metastatic kidney cancer|metastatic kidney cancer
564475|NCT00446368|metastatic renal cell cancer|metastatic renal cell cancer
564476|NCT00446381|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
564477|NCT00446381|Clinically Significant Diabetic Macular Edema|clinically significant diabetic macular edema
564478|NCT00446381|VEGF|vegf
564479|NCT00446381|Macugen (pegaptanib)|macugen (pegaptanib)
564480|NCT00446394|cognition disorder|cognition disorder
564481|NCT00446394|functional ability|functional ability
564482|NCT00446394|psychomotor function|psychomotor function
564483|NCT00446394|psychopathology|psychopathology
564484|NCT00446394|quality of life|quality of life
564485|NCT00446407|Depression|depression
564486|NCT00446407|Primary Care|primary care
564487|NCT00446407|Developing Countries|developing countries
729124|NCT01087281|HV|hv
564488|NCT00446407|Common mental disorders (depressive and anxiety disorders)|common mental disorders (depressive and anxiety disorders)
564489|NCT00446459|CellCept|cellcept
564490|NCT00446459|Dialysis|dialysis
564491|NCT00446459|Kidney|kidney
564492|NCT00446459|Renal|renal
564493|NCT00446459|Nephropathy|nephropathy
564494|NCT00446459|Glomerulonephropathy|glomerulonephropathy
564495|NCT00446459|Immunosuppression|immunosuppression
564496|NCT00446459|Allograft|allograft
564497|NCT00446459|Compatibility|compatibility
564498|NCT00446459|HLA|hla
564499|NCT00446459|PRA|pra
564500|NCT00446459|Transplant|transplant
564501|NCT00446459|Sensitization|sensitization
564502|NCT00446459|Antibodies|antibodies
564503|NCT00446459|Diabetes|diabetes
564504|NCT00446459|Hypertension|hypertension
564505|NCT00446459|Transplantation, Kidney|transplantation, kidney
564506|NCT00446472|diabetes mellitus|diabetes mellitus
564507|NCT00446472|diabetic neuropathies|diabetic neuropathies
564508|NCT00446472|peripheral vascular diseases|peripheral vascular diseases
564509|NCT00446485|ginkgo biloba|ginkgo biloba
564510|NCT00446485|cerebrovascular insufficiency|cerebrovascular insufficiency
564511|NCT00446485|mild cognitive impairment|mild cognitive impairment
564512|NCT00446485|concentration impairment|concentration impairment
564513|NCT00446511|children|children
564514|NCT00446511|pediatrics|pediatrics
564515|NCT00446511|high blood pressure|high blood pressure
564516|NCT00446511|hypertension|hypertension
564517|NCT00446511|valsartan|valsartan
564518|NCT00446511|enalapril|enalapril
564519|NCT00446524|Hypertension, Valsartan, Amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
564520|NCT00446537|Skill Acquisition and the Evolution of Long Term Procedural Memory in participants with ADHD: The Effect of Methylphenidate|skill acquisition and the evolution of long term procedural memory in participants with adhd: the effect of methylphenidate
564521|NCT00446563|Left ventricular hypertrophy, hypertension, valsartan, amlodipine|left ventricular hypertrophy, hypertension, valsartan, amlodipine
564522|NCT00446576|Anemia|anemia
564523|NCT00446576|early renal insufficiency|early renal insufficiency
564524|NCT00446602|PROCRIT|procrit
564525|NCT00446602|Epoetin alfa|epoetin alfa
564526|NCT00446602|Myelodysplastic Syndromes|myelodysplastic syndromes
564527|NCT00446602|MDS|mds
564528|NCT00446615|computer decision support|computer decision support
564529|NCT00446615|primary care|primary care
564530|NCT00446615|kidney disease, chronic|kidney disease, chronic
564531|NCT00446615|prescribing|prescribing
564532|NCT00446628|Non-pharmaceutical|non-pharmaceutical
564533|NCT00446628|influenza|influenza
564534|NCT00446628|pandemic|pandemic
564535|NCT00446641|Infarction, Cerebral|infarction, cerebral
564536|NCT00446641|Cilostazol|cilostazol
564537|NCT00446641|Aspirin Resistance|aspirin resistance
564538|NCT00446680|Mannitol|mannitol
564539|NCT00446680|Cystic Fibrosis|cystic fibrosis
564540|NCT00446680|Mucolytic|mucolytic
564541|NCT00446680|Exacerbation|exacerbation
564542|NCT00446680|FEV1|fev1
564543|NCT00446680|Quality of Life|quality of life
564544|NCT00446706|Intrinsic PEEP|intrinsic peep
564545|NCT00446719|major depression|major depression
564546|NCT00446719|antidepressant|antidepressant
564547|NCT00446719|quality of life|quality of life
564845|NCT00438854|LYN kinase|lyn kinase
564551|NCT00446745|Energy Metabolisms|energy metabolisms
564552|NCT00446745|Skeletal muscle|skeletal muscle
564553|NCT00446745|Visceral Adipose Tissue|visceral adipose tissue
564554|NCT00446758|Zinc|zinc
564555|NCT00446758|HIV|hiv
564556|NCT00446758|Infants|infants
564557|NCT00446758|Children|children
564558|NCT00446758|Morbidity|morbidity
564559|NCT00446758|Child health outcomes|child health outcomes
564560|NCT00446758|treatment naive|treatment naive
564561|NCT00446758|treatment experienced|treatment experienced
564562|NCT00446797|Ankle sprain, acute pain, NSAID, celecoxib,|ankle sprain, acute pain, nsaid, celecoxib,
564563|NCT00446810|diabetes|diabetes
564564|NCT00446810|endothelial dysfunction|endothelial dysfunction
564565|NCT00446810|benfotiamine|benfotiamine
564566|NCT00446810|postprandial|postprandial
564567|NCT00446810|autonomic neuropathy|autonomic neuropathy
564568|NCT00446810|advanced glycation end products|advanced glycation end products
564569|NCT00446823|Wound healing|wound healing
564570|NCT00446823|Venous stasis ulcer|venous stasis ulcer
564571|NCT00446823|Cellulose dressing|cellulose dressing
564572|NCT00446823|Gauze dressing|gauze dressing
564573|NCT00446823|Chronic wound|chronic wound
564574|NCT00446836|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
564575|NCT00446836|Recurrent prostate cancer|recurrent prostate cancer
564576|NCT00446836|Hormone refractory prostate cancer|hormone refractory prostate cancer
564577|NCT00437879|Breast Cancer|breast cancer
564578|NCT00437879|Ultrasound|ultrasound
564579|NCT00437892|Statins|statins
564580|NCT00437892|secondary prevention|secondary prevention
564581|NCT00437892|venous thromboembolism|venous thromboembolism
564582|NCT00437892|d-dimer|d-dimer
564583|NCT00437905|peripheral vascular disease|peripheral vascular disease
564584|NCT00437905|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
564585|NCT00437905|cutting balloon|cutting balloon
564586|NCT00437905|balloon angioplasty|balloon angioplasty
564587|NCT00437905|randomized controlled trial|randomized controlled trial
564588|NCT00437905|restenosis|restenosis
564589|NCT00437905|inflammation|inflammation
564590|NCT00437931|hypothyroidism|hypothyroidism
564591|NCT00437931|hyperthyroidism|hyperthyroidism
564592|NCT00437931|thyroid dysfunction|thyroid dysfunction
564593|NCT00437931|ultrasound|ultrasound
564594|NCT00437931|doppler|doppler
564595|NCT00437957|histone deacetylase|histone deacetylase
564596|NCT00437957|unresectable brain metastases|unresectable brain metastases
564597|NCT00437996|Labor analgesia - clonidine - epidural|labor analgesia - clonidine - epidural
564598|NCT00438009|coxsackievirus type a21|coxsackievirus type a21
564599|NCT00438009|oncolytic virus|oncolytic virus
564600|NCT00438009|melanoma|melanoma
564601|NCT00438022|Atopic Dermatitis|atopic dermatitis
564602|NCT00438022|Eczema Herpeticum|eczema herpeticum
564603|NCT00438035|Postoperative pain|postoperative pain
564604|NCT00438035|Heart rate variability, sympathetic, parasympathetic|heart rate variability, sympathetic, parasympathetic
564605|NCT00438035|Visual analog pain scale|visual analog pain scale
564606|NCT00438035|Spectral analysis of ECG|spectral analysis of ecg
564607|NCT00438048|Pilocarpine|pilocarpine
564608|NCT00438048|Artificial saliva|artificial saliva
564609|NCT00438048|Xerostomia|xerostomia
564610|NCT00438048|Xerostomy|xerostomy
564611|NCT00438048|Primary Sjogren|primary sjogren
564612|NCT00438048|Secondary Sjogren|secondary sjogren
564613|NCT00438061|Lipoprotein metabolism|lipoprotein metabolism
564614|NCT00438061|Cardiovascular disease|cardiovascular disease
564615|NCT00438061|Obesity|obesity
564616|NCT00438074|Breast Cancer|breast cancer
564617|NCT00438074|Diffuse Optical Spectroscopy|diffuse optical spectroscopy
564618|NCT00438087|Facial palsy|facial palsy
564619|NCT00438087|Vestibular schwannoma|vestibular schwannoma
564620|NCT00438087|Anti-inflammatory drugs|anti-inflammatory drugs
564621|NCT00438087|Post surgery of vestibular schwannoma|post surgery of vestibular schwannoma
564622|NCT00438087|or of cranial base tumors|or of cranial base tumors
564623|NCT00438100|Breast Neoplasms|breast neoplasms
564624|NCT00438100|Drug Therapy|drug therapy
564625|NCT00438113|blood pressure|blood pressure
564626|NCT00438113|atrial fibrillation|atrial fibrillation
564627|NCT00438113|catheter ablation|catheter ablation
564628|NCT00438126|diabetes|diabetes
564629|NCT00438126|Prevention|prevention
564630|NCT00438126|American Indian|american indian
564631|NCT00438139|marijuana dependence|marijuana dependence
564632|NCT00438152|Lopinavir|lopinavir
564633|NCT00438152|Saquinavir|saquinavir
564634|NCT00438152|Lipids|lipids
564635|NCT00438152|HIV-1|hiv-1
564636|NCT00438152|Treatment Experienced|treatment experienced
564637|NCT00438165|nurse|nurse
564638|NCT00438165|home visits|home visits
564639|NCT00438165|pregnancy|pregnancy
564640|NCT00438165|welfare|welfare
564641|NCT00438165|child development|child development
564642|NCT00438191|DeQuervain's tenosynovitis|dequervain's tenosynovitis
564643|NCT00438191|splinting|splinting
564644|NCT00438191|grip strength|grip strength
564645|NCT00438191|satisfaction|satisfaction
564646|NCT00438191|DASH questionnaire|dash questionnaire
564647|NCT00438204|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
564745|NCT00438490|Control Groups|control groups
564648|NCT00438204|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
564649|NCT00438204|adenocarcinoma of the lung|adenocarcinoma of the lung
564650|NCT00438204|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
564651|NCT00438204|large cell lung cancer|large cell lung cancer
564652|NCT00438204|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
564653|NCT00438217|precocious puberty, genetics, environmental factors|precocious puberty, genetics, environmental factors
564654|NCT00438230|Residual vein thrombosis|residual vein thrombosis
564655|NCT00438230|Optimal duration|optimal duration
564656|NCT00438230|Oral anticoagulants|oral anticoagulants
564657|NCT00438243|Pseudophakic macular edema|pseudophakic macular edema
564658|NCT00438256|accelerated short course|accelerated short course
564659|NCT00438256|proton beam radiation|proton beam radiation
564660|NCT00438269|Infection|infection
564661|NCT00438269|Empiric|empiric
564662|NCT00438269|Antibiotics|antibiotics
564663|NCT00438269|Nosocomial|nosocomial
564664|NCT00438269|Pyrexia|pyrexia
564665|NCT00438269|Leukocytosis|leukocytosis
564666|NCT00438269|Resistance|resistance
564667|NCT00438282|nurse|nurse
564668|NCT00438282|home visits|home visits
564669|NCT00438282|pregnancy|pregnancy
564670|NCT00438282|welfare|welfare
564671|NCT00438282|child development|child development
564672|NCT00438295|glucose in dialysis water, dialysis treatment, temperature|glucose in dialysis water, dialysis treatment, temperature
564673|NCT00438308|distal radius fracture|distal radius fracture
564674|NCT00438308|rehabilitation|rehabilitation
564675|NCT00438308|volar plate fixation|volar plate fixation
564676|NCT00438308|DASH questionnaire|dash questionnaire
564677|NCT00438321|Overweight|overweight
564678|NCT00438321|obesity|obesity
564679|NCT00438321|testosterone|testosterone
564680|NCT00438321|diabetes|diabetes
564681|NCT00438321|metabolic syndrome|metabolic syndrome
564682|NCT00438321|aging|aging
564683|NCT00438334|Benefit|benefit
564684|NCT00438334|Directional microphones|directional microphones
564685|NCT00438334|Hearing|hearing
564686|NCT00438334|Hearing aids|hearing aids
564687|NCT00438334|Hearing loss|hearing loss
564688|NCT00438334|Noise|noise
564689|NCT00438334|Objective benefit|objective benefit
564690|NCT00438334|Signal-to-noise ratio|signal-to-noise ratio
564691|NCT00438334|Speech understanding|speech understanding
564692|NCT00438334|Subjective benefit|subjective benefit
564693|NCT00438347|Mild Cognitive Impairment|mild cognitive impairment
564694|NCT00438347|cognition disorders|cognition disorders
564695|NCT00438347|brain health|brain health
564696|NCT00438347|psychological aspect of aging|psychological aspect of aging
564697|NCT00438347|exercise|exercise
564698|NCT00438347|physical fitness|physical fitness
564699|NCT00438360|Cyclosporine, chronic plaque psoriasis, intermittent therapy|cyclosporine, chronic plaque psoriasis, intermittent therapy
564700|NCT00438373|Subfertility, Luteinizing hormone, receptor|subfertility, luteinizing hormone, receptor
564701|NCT00438386|Generalized Anxiety Disorder|generalized anxiety disorder
564702|NCT00438386|Panic Disorder|panic disorder
564703|NCT00438386|Anxiety Disorder|anxiety disorder
564704|NCT00438386|Aripiprazole|aripiprazole
564705|NCT00438399|1 Galderma,|1 galderma,
564706|NCT00438399|2 Scalp Psoriasis|2 scalp psoriasis
564707|NCT00438399|3 Subject preference|3 subject preference
564708|NCT00438399|4 Clobetasol propionate|4 clobetasol propionate
564709|NCT00438399|5 Shampoo|5 shampoo
564710|NCT00438412|Noradrenalin|noradrenalin
564711|NCT00438412|Endothelin-1|endothelin-1
564712|NCT00438412|Angiotensin II|angiotensin ii
564713|NCT00438412|Arginine vasopressin|arginine vasopressin
564714|NCT00438412|Aldosterone|aldosterone
564715|NCT00438412|Renin|renin
564716|NCT00438412|Atrial natriuretic peptide|atrial natriuretic peptide
564717|NCT00438412|Brain natriuretic peptide|brain natriuretic peptide
564718|NCT00438412|Blood pressure|blood pressure
564719|NCT00438412|Apnea|apnea
564720|NCT00438425|Hyperlipidemia|hyperlipidemia
564721|NCT00438425|Hypercholesterolemia|hypercholesterolemia
564722|NCT00438425|Dietary modification|dietary modification
564723|NCT00438425|Portfolio|portfolio
564724|NCT00438438|forced desynchrony|forced desynchrony
564725|NCT00438438|circadian rhythms|circadian rhythms
564726|NCT00438438|sleep restriction|sleep restriction
564727|NCT00438438|sleep homeostasis|sleep homeostasis
564728|NCT00438438|neurobehavioral performance|neurobehavioral performance
564729|NCT00438451|elderly|elderly
564730|NCT00438451|focal epilepsy|focal epilepsy
564731|NCT00438451|anticonvulsive|anticonvulsive
564732|NCT00438451|treatment|treatment
564733|NCT00438451|levetiracetam|levetiracetam
564734|NCT00438451|lamotrigine|lamotrigine
564735|NCT00438451|carbamazepine|carbamazepine
564736|NCT00438477|recurrent breast cancer|recurrent breast cancer
564737|NCT00438477|stage IIIA breast cancer|stage iiia breast cancer
564738|NCT00438477|stage IIIB breast cancer|stage iiib breast cancer
564739|NCT00438477|stage IIIC breast cancer|stage iiic breast cancer
564740|NCT00438477|stage II breast cancer|stage ii breast cancer
564741|NCT00438490|galactorrhea|galactorrhea
564742|NCT00438490|prolactin|prolactin
564743|NCT00438490|bone turnover|bone turnover
564744|NCT00438490|menstrual cycle|menstrual cycle
564747|NCT00438503|Hemodialysis, diabetes mellitus,|hemodialysis, diabetes mellitus,
564748|NCT00438503|Chronic renal failure, dialysis ,|chronic renal failure, dialysis ,
564749|NCT00438516|home visits|home visits
564750|NCT00438516|pregnancy|pregnancy
564751|NCT00438516|welfare|welfare
564752|NCT00438516|child development|child development
564753|NCT00438516|mortality|mortality
564754|NCT00438542|Adiponectin, cord blood, pre-eclampsia|adiponectin, cord blood, pre-eclampsia
564755|NCT00438555|obesity,prevention,pediatric|obesity,prevention,pediatric
564756|NCT00438568|amyloid protein|amyloid protein
564757|NCT00438568|brain metabolism|brain metabolism
564758|NCT00438568|glucose metabolism|glucose metabolism
564759|NCT00438568|insulin sensitivity /resistance|insulin sensitivity /resistance
564760|NCT00438568|cognition disorders|cognition disorders
564761|NCT00438581|Zevalin|zevalin
564762|NCT00438581|Autologous one Marrow Transplant|autologous one marrow transplant
564763|NCT00438581|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
564764|NCT00438594|nurse|nurse
564765|NCT00438594|paraprofessional|paraprofessional
564766|NCT00438594|home visits|home visits
564767|NCT00438594|pregnancy|pregnancy
564768|NCT00438594|welfare|welfare
564769|NCT00438594|child development|child development
564770|NCT00438607|Moderate to late stage Parkinson's Disease|moderate to late stage parkinson's disease
564771|NCT00438633|proximal humerus fracture|proximal humerus fracture
564772|NCT00438633|rehabilitation|rehabilitation
564255|NCT00445952|infection|infection
564773|NCT00438633|non-operative treatment|non-operative treatment
564774|NCT00438633|DASH and Constant instruments|dash and constant instruments
564775|NCT00438646|Allergy|allergy
564776|NCT00438646|Asthma|asthma
564777|NCT00438646|Eczema|eczema
564778|NCT00438646|Hay Fever|hay fever
564779|NCT00438646|Epidemiology|epidemiology
564780|NCT00438659|dermatologic complications|dermatologic complications
564781|NCT00438659|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
564782|NCT00438659|radiation toxicity|radiation toxicity
564783|NCT00438659|breast cancer in situ|breast cancer in situ
564784|NCT00438659|recurrent breast cancer|recurrent breast cancer
564785|NCT00438659|stage I breast cancer|stage i breast cancer
564786|NCT00438659|stage II breast cancer|stage ii breast cancer
564787|NCT00438659|stage IIIA breast cancer|stage iiia breast cancer
564788|NCT00438659|stage IIIB breast cancer|stage iiib breast cancer
564789|NCT00438659|stage IIIC breast cancer|stage iiic breast cancer
564790|NCT00438659|male breast cancer|male breast cancer
564791|NCT00438659|ductal breast carcinoma in situ|ductal breast carcinoma in situ
564792|NCT00438659|stage IV breast cancer|stage iv breast cancer
564793|NCT00438672|lateral elbow pain|lateral elbow pain
564794|NCT00438672|tennis elbow|tennis elbow
564795|NCT00438672|pain|pain
564796|NCT00438672|psychology|psychology
564797|NCT00438685|Substance-Related Disorders|substance-related disorders
564798|NCT00438685|Depressive Disorder|depressive disorder
564799|NCT00438685|Anxiety Disorder|anxiety disorder
564800|NCT00438685|Adolescent|adolescent
564801|NCT00438685|Behavior Therapy|behavior therapy
564802|NCT00438685|Cognitive Therapy|cognitive therapy
564803|NCT00438685|Outpatients|outpatients
564804|NCT00438685|Family Relations|family relations
564805|NCT00438685|Systems Theory|systems theory
564806|NCT00438698|Nutrition|nutrition
564807|NCT00438698|Type 2 Diabetes|type 2 diabetes
564808|NCT00438724|Caregivers|caregivers
564809|NCT00438724|Caregiving|caregiving
564810|NCT00438724|Spousal relationships|spousal relationships
564811|NCT00438724|cognition disorders|cognition disorders
564812|NCT00438724|therapy|therapy
564813|NCT00438724|mental health|mental health
564814|NCT00438724|psychosocial|psychosocial
564815|NCT00438737|liver metastases|liver metastases
564816|NCT00438737|stage IV colon cancer|stage iv colon cancer
564817|NCT00438737|stage IV rectal cancer|stage iv rectal cancer
564818|NCT00438737|recurrent colon cancer|recurrent colon cancer
564819|NCT00438737|recurrent rectal cancer|recurrent rectal cancer
564820|NCT00438750|distal radius fracture|distal radius fracture
564821|NCT00438750|rehabilitation|rehabilitation
564822|NCT00438750|volar plate fixation|volar plate fixation
564823|NCT00438750|DASH questionnaire|dash questionnaire
564824|NCT00438763|CMC arthritis|cmc arthritis
564825|NCT00438763|splint treatment|splint treatment
564826|NCT00438763|patient satisfaction|patient satisfaction
564827|NCT00438763|DASH questionnaire|dash questionnaire
564828|NCT00438802|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
564829|NCT00438802|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
564830|NCT00438802|anaplastic large cell lymphoma|anaplastic large cell lymphoma
564831|NCT00438802|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
564832|NCT00438802|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
564833|NCT00438815|Hereditary angioedema|hereditary angioedema
564834|NCT00438815|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
564836|NCT00438828|palliative|palliative
564838|NCT00438841|stage I multiple myeloma|stage i multiple myeloma
564839|NCT00438841|stage II multiple myeloma|stage ii multiple myeloma
564840|NCT00438841|stage III multiple myeloma|stage iii multiple myeloma
564846|NCT00438867|angina|angina
564847|NCT00438867|FGF-4|fgf-4
564848|NCT00438867|angiogenesis|angiogenesis
564849|NCT00438867|growth factor|growth factor
564850|NCT00438867|myocardia ischemia|myocardia ischemia
564851|NCT00438867|revascularization|revascularization
564852|NCT00438893|Viscous dietary fiber|viscous dietary fiber
564853|NCT00438893|Soy protein|soy protein
564854|NCT00438893|Nuts|nuts
564855|NCT00438893|Plant sterols|plant sterols
564856|NCT00438893|Dietary Portfolio|dietary portfolio
564857|NCT00438893|Compliance|compliance
564858|NCT00438893|Blood lipids|blood lipids
564859|NCT00438893|Blood pressure|blood pressure
564860|NCT00446849|ulcerative colitis|ulcerative colitis
564861|NCT00446849|compliance|compliance
564862|NCT00446849|mesalamine|mesalamine
564863|NCT00446849|clinical study|clinical study
564864|NCT00446849|clinical trial|clinical trial
564865|NCT00446849|clinical research|clinical research
564866|NCT00446849|maintenance|maintenance
564867|NCT00446849|long term|long term
564868|NCT00446849|uc study|uc study
564869|NCT00446849|uc trial|uc trial
564298|NCT00445965|chondrosarcoma|chondrosarcoma
564870|NCT00446849|uc research|uc research
564871|NCT00446849|open label|open label
564872|NCT00446849|once a day|once a day
564873|NCT00446849|once|once
564874|NCT00446849|daily|daily
564875|NCT00446849|daily dosing|daily dosing
564876|NCT00446849|simple|simple
564877|NCT00446849|oral|oral
564878|NCT00446862|Definition: Fabry disease|definition: fabry disease
564879|NCT00446862|Definition: Progression|definition: progression
564880|NCT00446862|Definition: MDRD GFR|definition: mdrd gfr
564881|NCT00446862|Definition: Chronic Kidney Disease|definition: chronic kidney disease
564882|NCT00446862|Definition: Proteinuria|definition: proteinuria
564883|NCT00446862|Definition: Enzyme Replacement Therapy|definition: enzyme replacement therapy
564884|NCT00446862|Definition: Anti-proteinuric therapy|definition: anti-proteinuric therapy
564885|NCT00446875|Pain|pain
564886|NCT00446875|Procedural pain|procedural pain
564887|NCT00446875|Sucrose|sucrose
564888|NCT00446875|Infant|infant
564889|NCT00446888|cancer|cancer
564890|NCT00446888|metastasis|metastasis
564891|NCT00446901|Prostate Cancer|prostate cancer
564892|NCT00446901|Selenium|selenium
564893|NCT00446901|Chemoprevention|chemoprevention
564894|NCT00446901|Gene expression|gene expression
564895|NCT00446914|Hypertension|hypertension
564896|NCT00446914|Blood Pressure|blood pressure
564897|NCT00446927|Pediatrics|pediatrics
564898|NCT00446927|Cardiology|cardiology
564899|NCT00446927|Cardiopulmonary Bypass|cardiopulmonary bypass
564900|NCT00446927|Heart Surgery|heart surgery
564901|NCT00446927|Cardiac Catheterization|cardiac catheterization
564902|NCT00446927|Echocardiography|echocardiography
564903|NCT00446927|Imaging|imaging
564904|NCT00446927|ICG green dye|icg green dye
564905|NCT00446953|Caesarean section|caesarean section
564906|NCT00446953|Corticosteroids|corticosteroids
564907|NCT00446953|Betamethasone|betamethasone
564908|NCT00446953|Neonatal distress|neonatal distress
564909|NCT00446966|atrial fibrillation|atrial fibrillation
564910|NCT00446966|coronary artery disease bypass graft surgery|coronary artery disease bypass graft surgery
564911|NCT00446979|Microbicides|microbicides
564912|NCT00446979|HIV seronegativity|hiv seronegativity
564913|NCT00446992|Schizophrenia|schizophrenia
564914|NCT00446992|Schizoaffective|schizoaffective
564915|NCT00446992|psychosis|psychosis
564916|NCT00446992|olanzapine|olanzapine
564917|NCT00447005|Safety|safety
564918|NCT00447005|PK|pk
564919|NCT00447005|Biomarker|biomarker
564920|NCT00447018|intracranial pressure|intracranial pressure
564921|NCT00447018|mannitol|mannitol
564922|NCT00447018|hypertonic saline solution|hypertonic saline solution
564923|NCT00447018|brain injury|brain injury
564924|NCT00447018|traumatic brain injury|traumatic brain injury
564925|NCT00447018|Adult patients|adult patients
564926|NCT00447018|With elevation of intracranial pressure (ICP > 20 mmHg)|with elevation of intracranial pressure (icp > 20 mmhg)
564927|NCT00447031|age related macular degeneration|age related macular degeneration
564928|NCT00447031|intravitreal bevacizumab|intravitreal bevacizumab
564929|NCT00447031|intravitreal triamcinolone acetonide|intravitreal triamcinolone acetonide
564930|NCT00447031|neovascular age related macular degeneration|neovascular age related macular degeneration
564931|NCT00447044|Muscle loss and Maintenance of Muscle function|muscle loss and maintenance of muscle function
564932|NCT00447057|nonsquamous|nonsquamous
564933|NCT00447070|HIV-infection|hiv-infection
564934|NCT00447070|Dyslipidemia|dyslipidemia
564935|NCT00447070|Endothelial Dysfunction|endothelial dysfunction
564936|NCT00447070|Atherosclerosis|atherosclerosis
564937|NCT00447070|Protease inhibitor|protease inhibitor
564938|NCT00447070|treatment experienced|treatment experienced
564939|NCT00447083|Tanning|tanning
564940|NCT00447083|Musculoskeletal|musculoskeletal
564941|NCT00447083|Fibromyalgia Syndrome|fibromyalgia syndrome
564942|NCT00447096|Bipolar Type II|bipolar type ii
564943|NCT00447096|Depression|depression
564944|NCT00447096|rTMS|rtms
564945|NCT00447122|Pancreatic Cancer|pancreatic cancer
564946|NCT00447135|Elderly|elderly
564947|NCT00447135|Trauma|trauma
564948|NCT00447135|Polymorphonuclear Leukocyte|polymorphonuclear leukocyte
564949|NCT00447135|Immunity|immunity
564950|NCT00447174|Grief|grief
564951|NCT00447174|parental bereavement|parental bereavement
564952|NCT00447564|opioid dependence|opioid dependence
564953|NCT00447564|opioid addiction|opioid addiction
564954|NCT00447564|buprenorphine|buprenorphine
564955|NCT00447564|methadone|methadone
564956|NCT00447564|heroin|heroin
564957|NCT00447564|implant|implant
564958|NCT00447564|opioid withdrawal|opioid withdrawal
564959|NCT00447564|opioid pain medication|opioid pain medication
564960|NCT00447564|suboxone|suboxone
564961|NCT00447616|Prostate Cancer|prostate cancer
564962|NCT00447616|Prostatectomy|prostatectomy
564963|NCT00447642|immunology|immunology
564964|NCT00447642|cornea|cornea
564965|NCT00447642|allograft|allograft
564966|NCT00447642|corneal allograft rejection|corneal allograft rejection
564967|NCT00447642|graft failure|graft failure
564968|NCT00447655|Amputation|amputation
564969|NCT00447655|Self-management|self-management
564970|NCT00447655|Rehabilitation|rehabilitation
564971|NCT00447655|Peer support|peer support
564972|NCT00447668|Chronic Low Back Pain|chronic low back pain
564973|NCT00447668|Yoga|yoga
564974|NCT00447694|Iron Chelation|iron chelation
564975|NCT00447694|Deferasirox|deferasirox
564976|NCT00447694|Chelator|chelator
564977|NCT00447694|Desferal|desferal
564978|NCT00447694|beta-thalassemia|beta-thalassemia
564979|NCT00447694|Iron overload|iron overload
564980|NCT00447707|Substance use|substance use
564981|NCT00447707|Unprotected sex|unprotected sex
564982|NCT00447707|Behavioral intervention|behavioral intervention
564983|NCT00447707|HIV care|hiv care
564984|NCT00447707|Prevention with Positives|prevention with positives
564985|NCT00447707|HIV seronegativity|hiv seronegativity
564986|NCT00447720|HIV prevention skills|hiv prevention skills
564987|NCT00447720|Seriously Mentally Ill (SMI)|seriously mentally ill (smi)
564988|NCT00447720|Substance abuse|substance abuse
564989|NCT00447720|Philadelphia|philadelphia
564990|NCT00447720|HIV seronegativity|hiv seronegativity
564991|NCT00447733|mental health|mental health
564992|NCT00447733|substance use|substance use
564993|NCT00447733|treatment|treatment
564994|NCT00447746|Comparison between D1 and D2 lymphadenectomy for gastric cancer|comparison between d1 and d2 lymphadenectomy for gastric cancer
564995|NCT00447759|Celecoxib|celecoxib
564996|NCT00447759|Celebrex|celebrex
564997|NCT00447759|Ibuprofen|ibuprofen
564998|NCT00447759|Diclofenac|diclofenac
564999|NCT00447759|NSAID|nsaid
565000|NCT00447759|Osteoarthritis|osteoarthritis
565001|NCT00447759|Rheumatoid Arthritis|rheumatoid arthritis
565002|NCT00447759|Arthritis|arthritis
565003|NCT00447759|Safety study|safety study
565004|NCT00447759|Cardiovascular safety|cardiovascular safety
565005|NCT00447759|Clinical trial|clinical trial
565006|NCT00447759|PROBE design|probe design
565007|NCT00447759|University of Dundee|university of dundee
565008|NCT00447759|Medicines Monitoring Unit|medicines monitoring unit
565009|NCT00447759|MEMO|memo
565010|NCT00447759|Professor Tom MacDonald|professor tom macdonald
565011|NCT00447772|Dysport, Cervical Dystonia|dysport, cervical dystonia
565012|NCT00447785|alcoholism|alcoholism
565013|NCT00447785|nutrition|nutrition
565014|NCT00447785|craving|craving
565015|NCT00447785|energy supplies|energy supplies
565016|NCT00447785|water supplies|water supplies
565017|NCT00447798|HIV positive|hiv positive
565018|NCT00447798|crack cocaine user|crack cocaine user
565019|NCT00447798|inpatient hospital setting|inpatient hospital setting
565020|NCT00447798|HIV knowledge|hiv knowledge
565021|NCT00447798|motivation|motivation
565022|NCT00447798|perceived self-efficacy|perceived self-efficacy
565023|NCT00447798|risky sexual behavior|risky sexual behavior
565024|NCT00447798|HIV seronegativity|hiv seronegativity
565025|NCT00447811|Methadone|methadone
565026|NCT00447824|Pain|pain
565027|NCT00447824|Neonates|neonates
565028|NCT00447824|NIDCAP|nidcap
565030|NCT00447824|Capillary|capillary
565031|NCT00447837|Chronic Sinusitis|chronic sinusitis
565032|NCT00447902|treatment experienced|treatment experienced
565033|NCT00447928|tendonitis|tendonitis
565034|NCT00447928|nitroglycerin|nitroglycerin
565035|NCT00447928|nitric oxide|nitric oxide
565036|NCT00447928|lateral epicondylitis|lateral epicondylitis
565037|NCT00447954|eye disease|eye disease
565038|NCT00447954|retinal disorder|retinal disorder
565039|NCT00447954|CNTF|cntf
565040|NCT00447967|Metastatic Gastric Cancer|metastatic gastric cancer
565041|NCT00447967|Oxaliplatin|oxaliplatin
565042|NCT00447967|Irinotecan|irinotecan
565043|NCT00447980|Retinitis Pigmentosa|retinitis pigmentosa
565044|NCT00447980|eye disease|eye disease
565045|NCT00447980|retinal disorder|retinal disorder
565046|NCT00447980|CNTF|cntf
565047|NCT00447993|Retinitis Pigmentosa|retinitis pigmentosa
565048|NCT00447993|eye disease|eye disease
565049|NCT00447993|retinal disorder|retinal disorder
565050|NCT00447993|CNTF|cntf
565051|NCT00448006|common|common
565052|NCT00448006|bile|bile
565053|NCT00448006|duct|duct
565054|NCT00448006|biliary|biliary
565055|NCT00448006|malignant|malignant
565056|NCT00448006|obstruction|obstruction
565057|NCT00448006|stent|stent
565058|NCT00448019|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
565059|NCT00448019|Fludarabine|fludarabine
565060|NCT00448019|Cyclophosphamide|cyclophosphamide
565061|NCT00448019|Rituximab|rituximab
565062|NCT00448019|Bevacizumab|bevacizumab
565063|NCT00448019|CLL|cll
565064|NCT00448045|Spinal cord injuries|spinal cord injuries
565065|NCT00448045|Cough|cough
565066|NCT00448045|Peak cough flow|peak cough flow
565067|NCT00448045|Respiratory therapy|respiratory therapy
565068|NCT00448045|Rehabilitation|rehabilitation
565069|NCT00448058|Flexible-dose|flexible-dose
565070|NCT00448058|GSK372475|gsk372475
565071|NCT00448058|MDD|mdd
565072|NCT00448058|Venlafaxine XR|venlafaxine xr
565073|NCT00448058|Major Depressive Disorder|major depressive disorder
564454|NCT00446303|MDS|mds
565074|NCT00448071|Hypotension|hypotension
565075|NCT00448071|End Stage Renal Disease|end stage renal disease
565076|NCT00448071|Intra Dialytic Hypotension|intra dialytic hypotension
565077|NCT00448071|ESRD|esrd
565078|NCT00448071|Blood Pressure|blood pressure
565079|NCT00448071|Dialysis|dialysis
565080|NCT00448084|Psychogenic Movement Disorders|psychogenic movement disorders
565081|NCT00448084|Volition|volition
565082|NCT00448084|fMRI|fmri
565083|NCT00448084|Functional MRI|functional mri
565084|NCT00448084|Functional Movement Disorder|functional movement disorder
565085|NCT00448084|Healthy Volunteer|healthy volunteer
565086|NCT00448084|HV|hv
565087|NCT00448097|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
565088|NCT00448097|Prostate cancer|prostate cancer
565089|NCT00448097|Pre-Prostatectomy|pre-prostatectomy
565090|NCT00448097|Neoadjuvant|neoadjuvant
565091|NCT00448123|Kidney Stones|kidney stones
565092|NCT00448123|Ureteral Stones|ureteral stones
565093|NCT00448123|Flomax|flomax
565094|NCT00448123|Emergency Medicine|emergency medicine
565095|NCT00448123|Urology|urology
565096|NCT00448149|Kidney cancer|kidney cancer
565097|NCT00448149|Renal cell carcinoma|renal cell carcinoma
565098|NCT00448149|Metastatic RCC|metastatic rcc
565099|NCT00448162|hypertension, ENaC, Liddle's syndrome, variation|hypertension, enac, liddle's syndrome, variation
565100|NCT00448175|OAB symptoms of urgency, frequency, and urge incontinence|oab symptoms of urgency, frequency, and urge incontinence
565101|NCT00448188|central venous catheter|central venous catheter
565102|NCT00448188|international normalized ratio|international normalized ratio
565103|NCT00448188|thrombocytes|thrombocytes
565104|NCT00448188|bleeding risk|bleeding risk
565105|NCT00448188|all patients in need of central venous line|all patients in need of central venous line
565106|NCT00448188|comparison of patients with normal hemostasis to such with disorders in hemostasis|comparison of patients with normal hemostasis to such with disorders in hemostasis
565107|NCT00448201|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
565108|NCT00448201|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
565109|NCT00448201|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
565110|NCT00448201|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
565111|NCT00448201|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
565112|NCT00448201|prolymphocytic leukemia|prolymphocytic leukemia
565113|NCT00448201|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
565114|NCT00448201|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
565115|NCT00448201|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
565116|NCT00448201|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
565117|NCT00448201|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
565118|NCT00448201|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
565119|NCT00448201|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
565120|NCT00448201|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
565121|NCT00448201|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
565122|NCT00448201|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
565123|NCT00448201|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
565124|NCT00448201|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
565125|NCT00448201|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
565126|NCT00448201|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
565127|NCT00448201|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
565679|NCT00449917|lutein|lutein
16541|NCT03185208|Mild Cognitive Impairment|mild cognitive impairment
16542|NCT03185208|MCI|mci
565128|NCT00448201|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
565129|NCT00448201|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
565785|NCT00442091|hand eczema|hand eczema
565130|NCT00448201|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
565131|NCT00448201|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
565132|NCT00448201|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
565133|NCT00448201|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
565134|NCT00448201|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
565135|NCT00448201|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
565136|NCT00448201|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
565137|NCT00448201|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
565138|NCT00448201|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
565139|NCT00448201|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
565140|NCT00448201|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
565141|NCT00448201|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
565142|NCT00448201|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
565143|NCT00448201|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
565144|NCT00448201|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
565145|NCT00448201|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
565146|NCT00448201|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
565147|NCT00448201|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
565148|NCT00448201|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
565149|NCT00448201|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
565150|NCT00448201|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
565151|NCT00448201|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
565152|NCT00448201|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
565153|NCT00448201|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
565154|NCT00448201|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
565155|NCT00448201|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
565156|NCT00448201|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
565157|NCT00448201|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
565158|NCT00448201|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
565159|NCT00448201|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
565160|NCT00448201|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
565161|NCT00448201|refractory multiple myeloma|refractory multiple myeloma
565162|NCT00448201|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
565163|NCT00448201|secondary acute myeloid leukemia|secondary acute myeloid leukemia
565164|NCT00448201|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
565165|NCT00448201|splenic marginal zone lymphoma|splenic marginal zone lymphoma
565166|NCT00448201|stage I multiple myeloma|stage i multiple myeloma
565167|NCT00448201|stage II multiple myeloma|stage ii multiple myeloma
565168|NCT00448201|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
565169|NCT00448201|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
565170|NCT00448201|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
565171|NCT00448201|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
565172|NCT00448201|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
565173|NCT00448201|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
565174|NCT00448201|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
565175|NCT00448201|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
565176|NCT00448201|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
565177|NCT00448201|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
565178|NCT00448201|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
565179|NCT00448201|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
565180|NCT00448201|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
565181|NCT00448201|stage III multiple myeloma|stage iii multiple myeloma
565182|NCT00448201|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
565183|NCT00448201|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
565184|NCT00448201|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
565185|NCT00448201|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
565186|NCT00448201|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
565187|NCT00448201|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
565188|NCT00448201|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
565189|NCT00448201|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
565190|NCT00448201|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
566353|NCT00450099|Bupivacaine|bupivacaine
565191|NCT00448201|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
565192|NCT00448201|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
565786|NCT00442091|Compositae|compositae
565193|NCT00448201|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
565194|NCT00448201|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
565195|NCT00448201|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
565196|NCT00448201|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
565197|NCT00448201|primary myelofibrosis|primary myelofibrosis
565198|NCT00448201|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
565199|NCT00448201|adult nasal type extranodal natural killer (NK)/T-cell lymphoma|adult nasal type extranodal natural killer (nk)/t-cell lymphoma
565200|NCT00448201|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
565201|NCT00448201|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
565202|NCT00448214|Factor Xa inhibitor|factor xa inhibitor
565203|NCT00448214|Atrial fibrillation|atrial fibrillation
565205|NCT00448214|Ischemic attack|ischemic attack
565206|NCT00448214|thromboembolism|thromboembolism
565207|NCT00448214|Prevention and control|prevention and control
565208|NCT00448227|Infants, Herpes simplex infection|infants, herpes simplex infection
565209|NCT00448253|Inhalational Anthrax|inhalational anthrax
565210|NCT00448253|Human Immune globulin|human immune globulin
565211|NCT00448266|Breast cancer|breast cancer
565212|NCT00448266|high-dose chemotherapy|high-dose chemotherapy
565213|NCT00448266|Homologous Recombination Deficiency|homologous recombination deficiency
565214|NCT00448266|Alkylator therapy|alkylator therapy
565215|NCT00448266|Peripheral Blood Progenitor Cell Support|peripheral blood progenitor cell support
565216|NCT00448292|Depression|depression
565217|NCT00448292|Major Depressive Disorder|major depressive disorder
565218|NCT00448292|Major Depression|major depression
565220|NCT00448305|breast cancer|breast cancer
565221|NCT00448305|metastatic|metastatic
565222|NCT00448305|relapsed|relapsed
565223|NCT00448305|triple-receptor negative|triple-receptor negative
565224|NCT00448305|EndoTAG-1|endotag-1
565225|NCT00448305|metastatic or relapsed breast neoplasm|metastatic or relapsed breast neoplasm
565226|NCT00448318|Controlled clinical trial|controlled clinical trial
565227|NCT00448331|Mental Disorders|mental disorders
565228|NCT00448331|Mentally Ill Persons|mentally ill persons
565229|NCT00448331|Emergency Medicine|emergency medicine
565230|NCT00448331|Emergency Department|emergency department
565231|NCT00448331|Screening|screening
565232|NCT00448344|veterans|veterans
565233|NCT00448344|smoking cessation|smoking cessation
565234|NCT00448357|refractory multiple myeloma|refractory multiple myeloma
565235|NCT00448357|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
565236|NCT00448357|secondary acute myeloid leukemia|secondary acute myeloid leukemia
565237|NCT00448357|stage II multiple myeloma|stage ii multiple myeloma
565238|NCT00448357|stage III multiple myeloma|stage iii multiple myeloma
565239|NCT00448357|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
565240|NCT00448357|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
565241|NCT00448357|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
565242|NCT00448357|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
565243|NCT00448357|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
565244|NCT00448357|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
565245|NCT00448357|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
565246|NCT00448357|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
565247|NCT00448357|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
565248|NCT00448357|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
565249|NCT00448357|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
565250|NCT00448357|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
565251|NCT00448357|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
565252|NCT00448357|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
565253|NCT00448357|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
565254|NCT00448357|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
565255|NCT00448357|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
565256|NCT00448357|chronic eosinophilic leukemia|chronic eosinophilic leukemia
565257|NCT00448357|chronic neutrophilic leukemia|chronic neutrophilic leukemia
565258|NCT00448357|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
565259|NCT00448357|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
565260|NCT00448357|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
565261|NCT00448357|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
565262|NCT00448357|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
565263|NCT00448357|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
565264|NCT00448357|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
565265|NCT00448357|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
566441|NCT00452127|Follicular|follicular
565266|NCT00448357|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
565267|NCT00448357|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
565268|NCT00448357|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
565269|NCT00448357|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
565270|NCT00448357|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
565719|NCT00450060|backache|backache
565271|NCT00448357|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
565272|NCT00448357|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
565273|NCT00448357|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
565274|NCT00448357|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
565275|NCT00448357|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
565276|NCT00448357|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
565277|NCT00448357|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
565278|NCT00448357|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
565279|NCT00448357|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
565280|NCT00448357|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
565281|NCT00448357|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
565282|NCT00448357|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
565283|NCT00448357|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
565284|NCT00448357|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
565285|NCT00448357|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
565286|NCT00448357|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
565287|NCT00448357|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
565288|NCT00448357|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
565289|NCT00448357|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
565290|NCT00448357|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
565291|NCT00448357|primary myelofibrosis|primary myelofibrosis
565292|NCT00448357|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
565293|NCT00448357|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
565294|NCT00448357|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
565295|NCT00448357|prolymphocytic leukemia|prolymphocytic leukemia
565296|NCT00448357|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
565297|NCT00448357|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
565298|NCT00448357|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
565299|NCT00448357|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
565300|NCT00448357|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
565301|NCT00448357|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
565302|NCT00448357|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
565303|NCT00448357|polycythemia vera|polycythemia vera
565304|NCT00448357|essential thrombocythemia|essential thrombocythemia
565305|NCT00448357|splenic marginal zone lymphoma|splenic marginal zone lymphoma
565306|NCT00448357|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
565307|NCT00448357|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
565308|NCT00448357|stage I multiple myeloma|stage i multiple myeloma
565309|NCT00448357|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
565310|NCT00448357|adult nasal type extranodal natural killer (NK)/T-cell lymphoma|adult nasal type extranodal natural killer (nk)/t-cell lymphoma
565311|NCT00448370|Anemia, sickle cell|anemia, sickle cell
565314|NCT00448396|Patupilone|patupilone
565315|NCT00448396|Solid tumors|solid tumors
565316|NCT00448396|Advanced malignancies|advanced malignancies
565317|NCT00448409|Prostate cancer|prostate cancer
565318|NCT00448409|hormone refractory prostate cancer|hormone refractory prostate cancer
565319|NCT00448409|androgen resistant prostate cancer|androgen resistant prostate cancer
565321|NCT00448422|Diarrhea|diarrhea
565322|NCT00448435|Salmeterol|salmeterol
565323|NCT00448435|Fluticasone propionate|fluticasone propionate
565324|NCT00448435|Salmeterol/Fluticasone propionate combination|salmeterol/fluticasone propionate combination
565325|NCT00448435|Pediatric bronchial asthma|pediatric bronchial asthma
565326|NCT00448448|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
565327|NCT00448448|orthotics|orthotics
565329|NCT00448448|partially randomized preference design|partially randomized preference design
565330|NCT00448461|coronary artery disease|coronary artery disease
565331|NCT00448461|percutaneous coronary interventions|percutaneous coronary interventions
565332|NCT00448474|Disease self-management|disease self-management
565333|NCT00448474|Community program|community program
565334|NCT00448487|Diabetes|diabetes
565335|NCT00448487|Cardiovascular Disease|cardiovascular disease
565336|NCT00448487|Haptoglobin|haptoglobin
565337|NCT00448500|COPD|copd
565338|NCT00448500|exhaled breath condenate|exhaled breath condenate
16642|NCT03184597|SJS/TEN|sjs/ten
565313|NCT00448396|EPO|epo
565339|NCT00448500|Exhaled breath condenate, acute exacerbation of COPD|exhaled breath condenate, acute exacerbation of copd
565340|NCT00448513|catechin|catechin
565341|NCT00448513|oxidative stress|oxidative stress
565342|NCT00448513|chromosome damage|chromosome damage
565343|NCT00448513|aged|aged
565344|NCT00448526|Low protein diet, type 2 Diabetic nephropathy|low protein diet, type 2 diabetic nephropathy
565345|NCT00448526|Comparing the effect of Low protein Diet on diabetic nephropathy to that of normal protein diet|comparing the effect of low protein diet on diabetic nephropathy to that of normal protein diet
565346|NCT00448539|Refractory Partial Onset Seizures, epilepsy|refractory partial onset seizures, epilepsy
730305|NCT01080287|biopsy|biopsy
564835|NCT00438828|radiation therapy|radiation therapy
565347|NCT00448552|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
565348|NCT00448552|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
565349|NCT00448552|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
565350|NCT00448552|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
565351|NCT00448552|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
565352|NCT00448552|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
565353|NCT00448552|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
565354|NCT00448552|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
565355|NCT00448552|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
565356|NCT00448552|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
565357|NCT00448552|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
565358|NCT00448552|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
565359|NCT00448552|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
565360|NCT00448552|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
565361|NCT00448552|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
565362|NCT00448552|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
565363|NCT00448552|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
565364|NCT00448552|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
565365|NCT00448552|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
565366|NCT00448552|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
565367|NCT00448552|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
565368|NCT00448552|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
565369|NCT00448552|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
565370|NCT00448552|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
565371|NCT00448552|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
565372|NCT00448552|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
565373|NCT00448552|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
565374|NCT00448552|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
565375|NCT00448552|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
565376|NCT00448552|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
565377|NCT00448552|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
565378|NCT00448552|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
565379|NCT00448552|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
565380|NCT00448552|recurrent salivary gland cancer|recurrent salivary gland cancer
565381|NCT00448552|stage IV salivary gland cancer|stage iv salivary gland cancer
565382|NCT00448552|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
565383|NCT00448552|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
565384|NCT00448565|extubation|extubation
565385|NCT00448565|prediction|prediction
565386|NCT00448578|Acute Mania|acute mania
565387|NCT00448604|procalcitonin|procalcitonin
565388|NCT00448604|acute exacerbation|acute exacerbation
565389|NCT00448604|RT-PCR|rt-pcr
565390|NCT00448604|Biological Markers|biological markers
565391|NCT00448617|live attenuated influenza virus|live attenuated influenza virus
565392|NCT00448617|inflammation|inflammation
565393|NCT00448617|flu vaccine|flu vaccine
565394|NCT00448617|FluMist|flumist
565395|NCT00448617|smokers|smokers
565396|NCT00448630|Atypical antipsychotics, Metabolic syndrome, Safety|atypical antipsychotics, metabolic syndrome, safety
565397|NCT00448643|endometrial adenocarcinoma|endometrial adenocarcinoma
565398|NCT00448643|endometrial clear cell carcinoma|endometrial clear cell carcinoma
565399|NCT00448643|endometrial papillary carcinoma|endometrial papillary carcinoma
565400|NCT00448643|stage III endometrial carcinoma|stage iii endometrial carcinoma
565401|NCT00448643|stage IV endometrial carcinoma|stage iv endometrial carcinoma
565403|NCT00448656|epicardial ablation pulmonary veins|epicardial ablation pulmonary veins
565404|NCT00448656|video assisted thoracic surgery|video assisted thoracic surgery
565405|NCT00448669|HIV incidence|hiv incidence
565406|NCT00448669|HIV prevention|hiv prevention
565407|NCT00448669|Tenofovir|tenofovir
565408|NCT00448669|Emtricitabine|emtricitabine
565409|NCT00448669|Botswana|botswana
565410|NCT00448669|HIV seronegativity|hiv seronegativity
565411|NCT00448682|recurrent gastric cancer|recurrent gastric cancer
565412|NCT00448682|stage IV gastric cancer|stage iv gastric cancer
565413|NCT00448682|adenocarcinoma of the stomach|adenocarcinoma of the stomach
565414|NCT00448695|MRI|mri
565415|NCT00448695|Laser Thermal Therapy|laser thermal therapy
565416|NCT00448695|Focal Ablation|focal ablation
565417|NCT00448695|Prostate Cancer|prostate cancer
565418|NCT00448708|Hemodialysis Access|hemodialysis access
565419|NCT00448721|renal cell carcinoma|renal cell carcinoma
565420|NCT00448721|tyrosine kinase inhibitor failure|tyrosine kinase inhibitor failure
565421|NCT00448734|metastatic|metastatic
565422|NCT00448734|hormone-refractory|hormone-refractory
565423|NCT00448734|prostate cancer|prostate cancer
565424|NCT00448734|picoplatin|picoplatin
565425|NCT00448734|platinum drug|platinum drug
565426|NCT00448734|chemotherapy|chemotherapy
565427|NCT00448734|docetaxel|docetaxel
565428|NCT00448747|Ghrelin mimetic, growth hormone secretagogue|ghrelin mimetic, growth hormone secretagogue
565429|NCT00448760|stage II esophageal cancer|stage ii esophageal cancer
565430|NCT00448760|stage III esophageal cancer|stage iii esophageal cancer
565431|NCT00448760|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
565432|NCT00448786|gallbladder|gallbladder
565433|NCT00448786|AMG 706|amg 706
565434|NCT00448786|solid tumors|solid tumors
565435|NCT00448786|Phase 1b|phase 1b
565436|NCT00448786|Amgen|amgen
565437|NCT00448799|neurological|neurological
565438|NCT00448799|alzheimers|alzheimers
565439|NCT00448825|alcohol dependence|alcohol dependence
565440|NCT00448825|alcoholism|alcoholism
565441|NCT00448825|cocaine addiction|cocaine addiction
565442|NCT00448825|cocaine dependence|cocaine dependence
565443|NCT00448838|recurrent pancreatic cancer|recurrent pancreatic cancer
565444|NCT00448838|stage III pancreatic cancer|stage iii pancreatic cancer
565445|NCT00448838|stage IV pancreatic cancer|stage iv pancreatic cancer
565446|NCT00448838|stage II pancreatic cancer|stage ii pancreatic cancer
565447|NCT00448851|asthma|asthma
565448|NCT00448851|allergy|allergy
565449|NCT00448877|No specific disease is being studied, few procedures are excluded.|no specific disease is being studied, few procedures are excluded.
565450|NCT00448877|The focus of the study is to rule out the efficacy of the device, so the aim is to include as wide a variety of procedures as possible.|the focus of the study is to rule out the efficacy of the device, so the aim is to include as wide a variety of procedures as possible.
565451|NCT00448890|AMPA positive modulator, healthy volunteers|ampa positive modulator, healthy volunteers
565452|NCT00448903|diabetic|diabetic
565453|NCT00448903|foot|foot
565454|NCT00448903|ulcer|ulcer
565455|NCT00448903|bemiparin|bemiparin
565456|NCT00448903|neuropathy|neuropathy
565457|NCT00448903|neuroishemic|neuroishemic
565458|NCT00448903|diabetes|diabetes
565459|NCT00448916|Partial-onset seizures; epilepsy; pediatric; pregabalin; 1 year extension study; safety; tolerability|partial-onset seizures; epilepsy; pediatric; pregabalin; 1 year extension study; safety; tolerability
565460|NCT00448929|Glaucoma|glaucoma
565461|NCT00448929|Collagen matrix|collagen matrix
565463|NCT00448929|OculusGen|oculusgen
565464|NCT00448929|Trabeculectomy|trabeculectomy
565465|NCT00448942|Staphylococcus aureus [B03.510.400.790.750.100]|staphylococcus aureus [b03.510.400.790.750.100]
565466|NCT00448942|Enterococcus faecalis [B03.510.400.800.280.280]|enterococcus faecalis [b03.510.400.800.280.280]
565467|NCT00448942|Enterococcus faecium [B03.510.400.800.280.300]|enterococcus faecium [b03.510.400.800.280.300]
565468|NCT00448942|Bacteremia [C01.252.100]|bacteremia [c01.252.100]
565469|NCT00448942|Fungemia [C01.703.360]|fungemia [c01.703.360]
565470|NCT00448942|Infection Control [G03.850.780.200.450]|infection control [g03.850.780.200.450]
565471|NCT00448942|Antisepsis [G03.850.780.200.450.150]|antisepsis [g03.850.780.200.450.150]
565472|NCT00448968|Sepsis|sepsis
565473|NCT00448968|Ischemia Modified Albumin|ischemia modified albumin
565474|NCT00448968|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
565849|NCT00442403|Chemotherapy|chemotherapy
565475|NCT00448981|Preventing upper respiratory tract infections|preventing upper respiratory tract infections
565476|NCT00448981|Preventing influenza|preventing influenza
565477|NCT00448981|Preventing the common cold|preventing the common cold
565478|NCT00448981|Hand hygiene and upper respiratory infections|hand hygiene and upper respiratory infections
565479|NCT00448981|Mask use in preventing upper respiratory infections|mask use in preventing upper respiratory infections
565480|NCT00448994|adenovirus, fungal, diagnostics, children|adenovirus, fungal, diagnostics, children
565481|NCT00449007|Major depressive disorder|major depressive disorder
565482|NCT00449007|Alcohol abuse|alcohol abuse
565483|NCT00449007|Alcohol dependence|alcohol dependence
565484|NCT00449007|Suicide|suicide
565485|NCT00449020|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
565486|NCT00449020|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
565487|NCT00449033|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
565488|NCT00449033|Cancer|cancer
565029|NCT00447824|Venous|venous
565489|NCT00449046|salmeterol/fluticasone propionate combination|salmeterol/fluticasone propionate combination
565490|NCT00449046|pediatric bronchial asthma|pediatric bronchial asthma
565491|NCT00449059|heart transplantation|heart transplantation
565492|NCT00449059|cyclosporine|cyclosporine
565493|NCT00449059|hypertension|hypertension
565494|NCT00449059|nitroglycerin|nitroglycerin
565495|NCT00449098|Glaucoma|glaucoma
565496|NCT00449098|Collagen matrix|collagen matrix
565497|NCT00449098|ologen|ologen
565498|NCT00449098|OculusGen|oculusgen
565499|NCT00449098|Trabeculectomy|trabeculectomy
565500|NCT00449098|anti scarring|anti scarring
565501|NCT00449098|tissue engineering|tissue engineering
565502|NCT00449098|high risk patient for trabeculectomy|high risk patient for trabeculectomy
565503|NCT00449098|Aeon Astron|aeon astron
565504|NCT00449124|hepatitis C, vaccine, TG4040|hepatitis c, vaccine, tg4040
565505|NCT00449137|recurrent colon cancer|recurrent colon cancer
565506|NCT00449137|stage IV colon cancer|stage iv colon cancer
565507|NCT00449137|recurrent rectal cancer|recurrent rectal cancer
565508|NCT00449137|stage IV rectal cancer|stage iv rectal cancer
565509|NCT00449150|Cetrorelix|cetrorelix
565510|NCT00449163|stage IV colon cancer|stage iv colon cancer
565511|NCT00449163|stage IV rectal cancer|stage iv rectal cancer
565512|NCT00449163|adenocarcinoma of the colon|adenocarcinoma of the colon
565513|NCT00449163|adenocarcinoma of the rectum|adenocarcinoma of the rectum
565514|NCT00449176|Low Back Pain|low back pain
565515|NCT00449176|Chronic Pain|chronic pain
565516|NCT00449176|Pain Assessment|pain assessment
565517|NCT00449176|Tapentadol|tapentadol
565518|NCT00449215|Peak Bone Mass; Male; Genetic Polymorphisms|peak bone mass; male; genetic polymorphisms
565519|NCT00449228|Osteoarthritis,|osteoarthritis,
565520|NCT00449228|hip replacement,|hip replacement,
565521|NCT00449228|education,|education,
565522|NCT00449228|randomized controlled trial,|randomized controlled trial,
565523|NCT00449228|mini-invasive surgery|mini-invasive surgery
565524|NCT00449241|Acupuncture, Endoscopy|acupuncture, endoscopy
565525|NCT00449267|Lenses, Intraocular|lenses, intraocular
565526|NCT00449267|Prospective Studies|prospective studies
565527|NCT00449267|Visual acuity|visual acuity
565528|NCT00449267|Clinical Trial|clinical trial
565529|NCT00449280|metastatic|metastatic
565530|NCT00449280|advanced disease|advanced disease
565531|NCT00449280|phase I|phase i
565532|NCT00449293|Smoking cessation|smoking cessation
565533|NCT00449293|Tobacco dependence|tobacco dependence
565534|NCT00449293|Mindfulness|mindfulness
565535|NCT00449293|fMRI|fmri
565536|NCT00449293|Craving|craving
565537|NCT00449306|Atherosclerosis|atherosclerosis
565538|NCT00449306|Carotid plaque|carotid plaque
565539|NCT00449306|Abdominal aortic aneurysm|abdominal aortic aneurysm
565540|NCT00449306|Vulnerable plaque|vulnerable plaque
565541|NCT00449306|Angiogenesis|angiogenesis
565542|NCT00449306|Intraplaque hemorrhage|intraplaque hemorrhage
565543|NCT00449306|Carotid artery atherosclerosis|carotid artery atherosclerosis
565544|NCT00449319|AML|aml
565545|NCT00449319|adult|adult
565546|NCT00449319|Hydroxyurea|hydroxyurea
565547|NCT00449319|Transplant|transplant
565548|NCT00449319|Toevaluate biological characteristics at diagnosis.|toevaluate biological characteristics at diagnosis.
565549|NCT00449319|To identify genetic alterations with prognostic relevance.|to identify genetic alterations with prognostic relevance.
565550|NCT00449319|To follow up cases monitoring minimal disease during remission.|to follow up cases monitoring minimal disease during remission.
565551|NCT00449319|To evaluate pretreatment therapy in terms of response rate and toxicity.|to evaluate pretreatment therapy in terms of response rate and toxicity.
565552|NCT00449319|Disease free survival.|disease free survival.
565553|NCT00449319|Overal survival.|overal survival.
565554|NCT00449332|Chronic rejection, lung transplant, cytokines, bos|chronic rejection, lung transplant, cytokines, bos
565555|NCT00449345|Latent tuberculosis infection|latent tuberculosis infection
565556|NCT00449345|Health care workers|health care workers
565557|NCT00449345|Tuberculin skin test|tuberculin skin test
565558|NCT00449345|Mantoux skin test|mantoux skin test
565559|NCT00449345|Interferon gamma|interferon gamma
565560|NCT00449345|Quantiferon|quantiferon
565561|NCT00449345|Cost effectiveness|cost effectiveness
565562|NCT00449358|bcc|bcc
565563|NCT00449384|Severe Impairment Battery|severe impairment battery
565564|NCT00449384|Clinical Dementia Rating|clinical dementia rating
565565|NCT00449397|First Episode Psychosis|first episode psychosis
565566|NCT00449410|Atrial Fibrillation|atrial fibrillation
565567|NCT00449410|elderly|elderly
565568|NCT00449410|cholesterol lowering|cholesterol lowering
565569|NCT00449410|neurocognitive function|neurocognitive function
565570|NCT00449410|cerebrovascular lesion|cerebrovascular lesion
565571|NCT00449423|Acute heart failure|acute heart failure
565572|NCT00449423|Metabolic modulation|metabolic modulation
565573|NCT00449436|HIV|hiv
565574|NCT00449436|treatment experienced|treatment experienced
565575|NCT00449449|Pertubation, tubal flushing, intrauterine insemination.|pertubation, tubal flushing, intrauterine insemination.
565579|NCT00449488|erythropoietin|erythropoietin
565580|NCT00449488|myocardial infarction|myocardial infarction
565581|NCT00449488|PCI|pci
565582|NCT00449488|left ventricular function|left ventricular function
565583|NCT00449501|Mild Asthma|mild asthma
565584|NCT00449501|Moderate Asthma|moderate asthma
565585|NCT00449514|infertility|infertility
565586|NCT00449514|ovulation dysfunction|ovulation dysfunction
565587|NCT00449514|endometrium|endometrium
565588|NCT00449514|tamoxifen|tamoxifen
565589|NCT00449514|clomiphene citrate|clomiphene citrate
565590|NCT00449527|Mild asthma|mild asthma
565591|NCT00449527|Moderate asthma|moderate asthma
565592|NCT00449540|Migraine with aura|migraine with aura
565593|NCT00449540|aura|aura
565594|NCT00449540|TMS|tms
565595|NCT00449553|Glucose Metabolism Disorder|glucose metabolism disorder
565596|NCT00449553|Dysmetabolic Syndrome|dysmetabolic syndrome
565597|NCT00449553|Type II Diabetes|type ii diabetes
565598|NCT00449553|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
565599|NCT00449553|Dyslipidemia|dyslipidemia
565600|NCT00449553|Drug Therapy|drug therapy
565601|NCT00449566|Magnetic Resonance Imaging|magnetic resonance imaging
565602|NCT00449566|Diffusion Tensor Imaging|diffusion tensor imaging
565603|NCT00449579|Ischemia|ischemia
565604|NCT00449579|Myocardial|myocardial
565605|NCT00449579|HF-ECG|hf-ecg
565606|NCT00449592|Stem cell transplantation|stem cell transplantation
565607|NCT00449592|Mucositis|mucositis
565608|NCT00449592|Zinc|zinc
565609|NCT00449605|Diabetes|diabetes
565610|NCT00449605|Metformin|metformin
565611|NCT00449618|Aspirin|aspirin
565612|NCT00449618|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
565613|NCT00449618|Chronotherapy|chronotherapy
565614|NCT00449618|Circadian|circadian
565615|NCT00449631|Glaucoma|glaucoma
565616|NCT00449631|Drug Resistance, Multiple|drug resistance, multiple
565617|NCT00449631|Trabeculectomy|trabeculectomy
565618|NCT00449644|Tuberculosis|tuberculosis
565619|NCT00449644|MDR TB|mdr tb
565620|NCT00449670|Influenza|influenza
565621|NCT00449670|Influenza Vaccine|influenza vaccine
565622|NCT00449683|Depressive Disorders|depressive disorders
565623|NCT00449683|Excessive Sweating|excessive sweating
565624|NCT00449683|Sweating caused by antidepressants for those a depressive disorder|sweating caused by antidepressants for those a depressive disorder
565625|NCT00449709|Pre-term labor,|pre-term labor,
565626|NCT00449709|modified release formulation|modified release formulation
565627|NCT00449709|pharmacokinetics,|pharmacokinetics,
565628|NCT00449735|positive isolates|positive isolates
565629|NCT00449735|ecoli|ecoli
565630|NCT00449735|blood cultures|blood cultures
565631|NCT00449735|positive cultures for ecoli|positive cultures for ecoli
565632|NCT00449735|blood stream infections|blood stream infections
565633|NCT00449748|Systemic Mastocytosis|systemic mastocytosis
565634|NCT00449748|RAD001|rad001
565635|NCT00449761|Refractory|refractory
565636|NCT00449761|Chronic Myeloid|chronic myeloid
565637|NCT00449761|Leukemia|leukemia
565638|NCT00449761|accelerated phase|accelerated phase
565639|NCT00449761|blast phase (blast crisis)|blast phase (blast crisis)
565640|NCT00449761|adults|adults
565641|NCT00449761|oral LBH589|oral lbh589
565642|NCT00449774|Food effect|food effect
565643|NCT00449774|Safety|safety
565644|NCT00449774|Tolerability|tolerability
565645|NCT00449774|Water effect|water effect
565646|NCT00449774|Bioequivalence|bioequivalence
565647|NCT00449787|Emergency department|emergency department
565648|NCT00449787|headache|headache
565649|NCT00449787|migraine|migraine
565650|NCT00449800|Sepsis|sepsis
565651|NCT00449800|Ceftriaxone|ceftriaxone
565652|NCT00449800|Pharmacokinetic|pharmacokinetic
565653|NCT00449800|Intensive care unit|intensive care unit
565654|NCT00449813|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
565655|NCT00449813|Non erosive reflux disease (NERD)|non erosive reflux disease (nerd)
565656|NCT00449826|ACS|acs
565657|NCT00449826|Unstable Angina|unstable angina
565658|NCT00449826|NSTEMI|nstemi
565659|NCT00449839|Insulin pump treatment CSII|insulin pump treatment csii
565660|NCT00449839|Absorption|absorption
565661|NCT00449839|Insulin Aspart|insulin aspart
565662|NCT00449852|Randomized Control Trial|randomized control trial
565663|NCT00449852|Smoking Cessation|smoking cessation
565664|NCT00449852|Secondary Prevention|secondary prevention
565665|NCT00449852|Rehabilitation|rehabilitation
565666|NCT00449852|Counseling|counseling
565667|NCT00449865|Parkinson's disease|parkinson's disease
565668|NCT00449865|creatine|creatine
565669|NCT00449865|NET-PD|net-pd
565670|NCT00449865|neuroprotection|neuroprotection
565671|NCT00449865|PD|pd
565672|NCT00449878|cystic fibrosis-related pancreatic insufficiency|cystic fibrosis-related pancreatic insufficiency
565673|NCT00449891|Type 1 diabetes mellitus|type 1 diabetes mellitus
565674|NCT00449904|Cystic fibrosis-related exocrine pancreatic insufficiency|cystic fibrosis-related exocrine pancreatic insufficiency
565675|NCT00449917|visual caracteristics|visual caracteristics
565676|NCT00449917|macular pigment optical density|macular pigment optical density
565677|NCT00449917|visual acuity|visual acuity
565678|NCT00449917|contrast sensibility|contrast sensibility
565219|NCT00448292|MDD|mdd
565680|NCT00449917|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
565681|NCT00449943|Cardiac Invasive Catheterization Angiography|cardiac invasive catheterization angiography
565787|NCT00442104|infantile spasms|infantile spasms
565682|NCT00449943|Single Photon Emission Computed Tomography|single photon emission computed tomography
565683|NCT00449943|Computed Tomography Angiography|computed tomography angiography
565684|NCT00449969|AED (automated external defibrillation)|aed (automated external defibrillation)
565685|NCT00449969|feedback|feedback
565686|NCT00449969|out of hospital resuscitation|out of hospital resuscitation
565687|NCT00449982|Genital warts|genital warts
565688|NCT00449982|Condylomata acuminata|condylomata acuminata
565689|NCT00449982|Human Papillomavirus|human papillomavirus
565690|NCT00449982|Polyphenon E|polyphenon e
565691|NCT00449982|Green tea extract|green tea extract
565692|NCT00449982|Vulva|vulva
565693|NCT00449982|Penis|penis
565694|NCT00449982|Anus|anus
565695|NCT00450008|Prostate Cancer|prostate cancer
565696|NCT00450008|Hormone-Naïve Prostate Cancer|hormone-naïve prostate cancer
565697|NCT00450008|adenocarcinoma of the prostate|adenocarcinoma of the prostate
565698|NCT00450021|PET|pet
565699|NCT00450021|CB1 Receptor|cb1 receptor
565700|NCT00450021|Cannabinoid|cannabinoid
565701|NCT00450021|[11C] MePPEP|[11c] meppep
565702|NCT00450021|Brain Imaging|brain imaging
565703|NCT00450021|Healthy Volunteer|healthy volunteer
565704|NCT00450021|HV|hv
565705|NCT00450034|Frail Elderly|frail elderly
565706|NCT00450034|Patient Education|patient education
565707|NCT00450034|Drug optimization|drug optimization
565708|NCT00450034|Underuse|underuse
565709|NCT00450034|Vulnerable|vulnerable
565710|NCT00450034|Drug related hospitalization|drug related hospitalization
565711|NCT00450034|Medical intervention|medical intervention
565712|NCT00450047|cognitive impairment, ergometer, speed-feedback therapy|cognitive impairment, ergometer, speed-feedback therapy
565713|NCT00450060|postlumbar puncture headache|postlumbar puncture headache
565714|NCT00450060|atraumatic needle|atraumatic needle
565715|NCT00450060|Sprotte|sprotte
565716|NCT00450060|Quincke|quincke
565717|NCT00450060|lumbar puncture|lumbar puncture
565718|NCT00450060|headache|headache
565720|NCT00441831|Helicobacter pylori infection|helicobacter pylori infection
565721|NCT00441831|peptic ulcer disease|peptic ulcer disease
565722|NCT00441831|distal partial gastrectomy|distal partial gastrectomy
565723|NCT00441831|bile reflux|bile reflux
565724|NCT00441831|gastritis|gastritis
565725|NCT00441831|gastrectomy|gastrectomy
565726|NCT00441844|diabetes, statin, monocyte, crp, inflammation|diabetes, statin, monocyte, crp, inflammation
565727|NCT00441857|plant sterols|plant sterols
565728|NCT00441857|plant stanols|plant stanols
565729|NCT00441857|cholesterol absorption|cholesterol absorption
565730|NCT00441870|Cancer|cancer
565731|NCT00441870|Phase 1|phase 1
565732|NCT00441870|EC0225|ec0225
565733|NCT00441870|EC20|ec20
565734|NCT00441870|Refractory|refractory
565735|NCT00441870|Metastatic|metastatic
565736|NCT00441870|Experimental|experimental
565737|NCT00441896|infantile spasms|infantile spasms
565738|NCT00441896|anticonvulsant|anticonvulsant
565739|NCT00441896|pediatric epilepsy|pediatric epilepsy
565740|NCT00441896|West Syndrome|west syndrome
565741|NCT00441896|epileptic spasms|epileptic spasms
565742|NCT00441909|Anti-Infective Agents, Local|anti-infective agents, local
565743|NCT00441909|Healthy Women|healthy women
565744|NCT00441909|Microbicides|microbicides
565745|NCT00441909|UC-781|uc-781
565746|NCT00441909|Vaginal Gel|vaginal gel
565747|NCT00441909|HIV Seronegativity|hiv seronegativity
565748|NCT00441922|Cancer|cancer
565749|NCT00441922|Elderly|elderly
565750|NCT00441922|Chemotherapy|chemotherapy
565751|NCT00441922|Docetaxel|docetaxel
565752|NCT00441922|Vinorelbine|vinorelbine
565753|NCT00441935|Urinary Retention|urinary retention
565754|NCT00441935|Urinary Incontinence|urinary incontinence
565755|NCT00441935|Pelvic Pain|pelvic pain
565756|NCT00441948|Hirsutism|hirsutism
565757|NCT00441948|Hypertrichosis|hypertrichosis
565758|NCT00441961|Eosinophilic fasciitis, Shulman's syndrome, methotrexate|eosinophilic fasciitis, shulman's syndrome, methotrexate
565759|NCT00441974|adefovir dipivoxil|adefovir dipivoxil
565760|NCT00441974|compensated|compensated
565761|NCT00441974|chronic hepatitis B|chronic hepatitis b
565762|NCT00441974|Chinese|chinese
565763|NCT00441987|Japanese|japanese
565764|NCT00441987|Healthy|healthy
565765|NCT00441987|Alzheimers Disease|alzheimers disease
565766|NCT00442000|Prostate Cancer|prostate cancer
565767|NCT00442000|Prostatectomy|prostatectomy
565768|NCT00442026|Cancer|cancer
565769|NCT00442026|NSCLC|nsclc
565770|NCT00442026|Elderly|elderly
565771|NCT00442026|Chemotherapy|chemotherapy
565772|NCT00442026|Docetaxel|docetaxel
565773|NCT00442026|Gemcitabine|gemcitabine
565774|NCT00442039|Mania, Lithium, Bipolar, BPCA, pediatrics|mania, lithium, bipolar, bpca, pediatrics
565775|NCT00442052|Gastroprotective effects|gastroprotective effects
565776|NCT00442052|Aspirin|aspirin
565777|NCT00442065|Abdominal aortic aneurysm study|abdominal aortic aneurysm study
565778|NCT00442078|Incontinence|incontinence
565779|NCT00442078|Urinary|urinary
565780|NCT00442078|Male|male
565781|NCT00442078|Tape|tape
565782|NCT00442078|Transobturator|transobturator
565783|NCT00442091|Dandelion|dandelion
565784|NCT00442091|herbal remedy|herbal remedy
565788|NCT00442104|anticonvulsant|anticonvulsant
565789|NCT00442104|pediatric epilepsy|pediatric epilepsy
565790|NCT00442104|West Syndrome|west syndrome
565791|NCT00442104|epileptic spasms|epileptic spasms
565792|NCT00442130|GM-CSF|gm-csf
565793|NCT00442130|GM-K562|gm-k562
565794|NCT00442130|vaccine|vaccine
565796|NCT00442143|PAOD|paod
565797|NCT00442143|Severe lower limb ischemia|severe lower limb ischemia
565798|NCT00442156|Laser photocoagulation|laser photocoagulation
565799|NCT00442169|West Nile Disease|west nile disease
565800|NCT00442169|Antibody response|antibody response
565801|NCT00442169|Viremia|viremia
565802|NCT00442169|Safety|safety
565803|NCT00442169|Tolerability|tolerability
565804|NCT00442169|Prevention|prevention
565805|NCT00442182|autoinflammatory syndromes|autoinflammatory syndromes
565806|NCT00442195|Tissue Procurement|tissue procurement
565807|NCT00442195|Sample Collection|sample collection
565808|NCT00442195|Biologic Samples|biologic samples
565809|NCT00442195|Laboratory Research|laboratory research
565810|NCT00442195|Healthy Volunteer|healthy volunteer
565811|NCT00442195|HV|hv
565812|NCT00442208|Healthy adults|healthy adults
565813|NCT00442208|Phase I|phase i
565814|NCT00442221|Migrane headaches|migrane headaches
565815|NCT00442234|Acute|acute
565816|NCT00442234|pulmonary|pulmonary
565817|NCT00442234|embolism|embolism
565818|NCT00442234|accompanying|accompanying
565819|NCT00442234|hemodynamic|hemodynamic
565820|NCT00442234|instability|instability
565821|NCT00442247|anterior vaginal wall prolapse, Pelvicol, biomesh|anterior vaginal wall prolapse, pelvicol, biomesh
565822|NCT00442247|Anterior vaginal wall prolapse|anterior vaginal wall prolapse
565823|NCT00442260|breast cancer|breast cancer
565824|NCT00442260|advanced breast cancer|advanced breast cancer
565825|NCT00442286|Hypertension|hypertension
565826|NCT00442286|High Blood Pressure|high blood pressure
565827|NCT00442286|Blood Pressure|blood pressure
565828|NCT00442286|Cardiovascular Disease|cardiovascular disease
565829|NCT00442286|Resistant Hypertension|resistant hypertension
565830|NCT00442286|Stage 2 Hypertension|stage 2 hypertension
565831|NCT00442286|Hypertension that is resistant to treatment|hypertension that is resistant to treatment
565832|NCT00442299|hemodialysis, urmeic retention solute, biocompatibility|hemodialysis, urmeic retention solute, biocompatibility
565833|NCT00442312|Combigan|combigan
565834|NCT00442364|PFO|pfo
565835|NCT00442364|Patent Foramen Ovale|patent foramen ovale
565836|NCT00442364|Right-to-Left Shunt|right-to-left shunt
565837|NCT00442364|Sclerotherapy|sclerotherapy
565838|NCT00442377|Falciparum|falciparum
565839|NCT00442377|Plasmodium|plasmodium
565840|NCT00442377|Malaria|malaria
565841|NCT00442390|Cortisol|cortisol
565842|NCT00442390|adrenal insufficiency|adrenal insufficiency
565843|NCT00442390|glucose metabolism|glucose metabolism
565844|NCT00442390|protein metabolism|protein metabolism
565845|NCT00442390|lipid metabolism|lipid metabolism
565846|NCT00442390|insulin sensitivity.|insulin sensitivity.
565848|NCT00442403|Plasmodium falciparum|plasmodium falciparum
565850|NCT00442403|Chloroquine|chloroquine
565851|NCT00442403|Dehydroepiandrosterone sulphate|dehydroepiandrosterone sulphate
565852|NCT00442429|depression; dialysis; kidney failure, chronic|depression; dialysis; kidney failure, chronic
565853|NCT00442442|Malaria|malaria
565854|NCT00442442|mosquito control|mosquito control
565855|NCT00442442|mosquito coils|mosquito coils
565856|NCT00442442|LLIN|llin
565857|NCT00442455|Head Neck Carcinoma Erlotinib|head neck carcinoma erlotinib
565858|NCT00442468|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
565859|NCT00442468|Chronic Bronchitis|chronic bronchitis
565860|NCT00442468|Spirometry|spirometry
565861|NCT00442481|MDD|mdd
565862|NCT00442481|Escitalopram|escitalopram
565863|NCT00442481|Cipralex|cipralex
565864|NCT00442481|Sleep|sleep
565865|NCT00442481|REM|rem
565866|NCT00442481|SWS|sws
565867|NCT00442481|Polysomnography|polysomnography
565868|NCT00442494|Atrial fibrillation after cardiac surgery|atrial fibrillation after cardiac surgery
565869|NCT00442507|Esophagus|esophagus
565870|NCT00442507|Esophagogastric Junction|esophagogastric junction
565871|NCT00442507|Avastin|avastin
565872|NCT00442507|Bevacizumab|bevacizumab
565873|NCT00442507|Erlotinib|erlotinib
565874|NCT00442533|Carcinoid|carcinoid
565875|NCT00442533|Islet Cell Cancer|islet cell cancer
565876|NCT00442533|Paraganglioma|paraganglioma
565877|NCT00442533|Pheochromocytoma|pheochromocytoma
565878|NCT00442546|opioid|opioid
565879|NCT00442598|Ovarian|ovarian
565880|NCT00442598|Cancer|cancer
565881|NCT00442598|CA-125|ca-125
565882|NCT00442598|Third-line|third-line
565320|NCT00448422|Traveler's|traveler's
565883|NCT00442598|Glufosfamide|glufosfamide
565884|NCT00442624|insomnia|insomnia
565885|NCT00442624|glucose metabolism|glucose metabolism
567103|NCT00453973|Hematide™|hematide™
565886|NCT00442624|insulin resistance|insulin resistance
565888|NCT00442637|DCCG|dccg
565889|NCT00442637|colorectal cancer|colorectal cancer
565890|NCT00442637|induction|induction
565891|NCT00442637|metronomic chemotherapy|metronomic chemotherapy
565892|NCT00442637|observation|observation
565893|NCT00442637|capecitabine|capecitabine
565894|NCT00442637|bevacizumab|bevacizumab
565895|NCT00442637|oxaliplatin|oxaliplatin
565896|NCT00442663|Labor Induction|labor induction
565897|NCT00442663|Cervical Ripening|cervical ripening
565898|NCT00442663|Foley Catheter|foley catheter
565899|NCT00442689|Polycystic Ovary Syndrome|polycystic ovary syndrome
565900|NCT00442689|Metabolic Syndrome|metabolic syndrome
565901|NCT00442689|PCOS|pcos
565902|NCT00442689|overweight|overweight
565903|NCT00442689|infertility|infertility
565904|NCT00442689|Insulin Resistance|insulin resistance
565905|NCT00442689|menstrual cycle|menstrual cycle
565906|NCT00442715|Exercise-induced asthma,|exercise-induced asthma,
565907|NCT00442715|early childhood;|early childhood;
565908|NCT00442715|spirometry,|spirometry,
565909|NCT00442715|exercise challenge|exercise challenge
565910|NCT00442715|Data from preschool children who were referred to the Pediatric|data from preschool children who were referred to the pediatric
565911|NCT00442715|Pulmonary Clinic over a 1-year period were recruited|pulmonary clinic over a 1-year period were recruited
565912|NCT00442728|Functional electrical stimulation|functional electrical stimulation
565913|NCT00442728|muscular atrophy|muscular atrophy
565914|NCT00442728|intensive care|intensive care
565915|NCT00442741|Cancer|cancer
565916|NCT00442741|EPO906|epo906
565917|NCT00442741|Patupilone|patupilone
565918|NCT00442754|dendritic cell|dendritic cell
565919|NCT00442754|tumor vaccine|tumor vaccine
565920|NCT00442754|NSCLC|nsclc
565921|NCT00442767|pediatric|pediatric
565922|NCT00442767|juvenile|juvenile
565923|NCT00442767|diabetes mellitus|diabetes mellitus
565924|NCT00442767|Pediatric type 1 diabetes mellitus|pediatric type 1 diabetes mellitus
565925|NCT00442780|early Parkinson's Disease|early parkinson's disease
565926|NCT00442780|MOBILE|mobile
565927|NCT00442780|BIIB014|biib014
565928|NCT00442806|ADRC|adrc
565929|NCT00442806|Stem Cells|stem cells
565930|NCT00442806|Myocardial Infarction|myocardial infarction
565931|NCT00442806|STEMI|stemi
565932|NCT00442806|Heart Disease|heart disease
565933|NCT00442806|Coronary Artery Disease|coronary artery disease
565934|NCT00442806|Coronary Disease|coronary disease
565935|NCT00442806|ST-Elevation|st-elevation
565936|NCT00442806|AMI|ami
565937|NCT00442806|Interventional Cardiology|interventional cardiology
565938|NCT00442806|Heart Attack|heart attack
565939|NCT00442819|Uremic Pruritus|uremic pruritus
565940|NCT00442819|Cytokines|cytokines
565941|NCT00442819|Polymethylmethacrylate Artificial Kidney|polymethylmethacrylate artificial kidney
565942|NCT00442819|Hemodialysis|hemodialysis
565943|NCT00442832|cSSSI|csssi
565944|NCT00442832|Staph|staph
565945|NCT00442832|MRSA|mrsa
565946|NCT00442858|cardiac disease|cardiac disease
565947|NCT00442858|cerebrovascular disease|cerebrovascular disease
565948|NCT00442858|GH deficiency|gh deficiency
565949|NCT00442858|diabetes mellitus|diabetes mellitus
565950|NCT00442858|hypertension|hypertension
565951|NCT00442858|GH therapy|gh therapy
565952|NCT00442858|GH deficiency and hypopituitarims|gh deficiency and hypopituitarims
565953|NCT00442871|Renal Impairment,|renal impairment,
565954|NCT00442871|chronic immune thrombocytopenia purpura,|chronic immune thrombocytopenia purpura,
565955|NCT00442871|thrombocytopenia,|thrombocytopenia,
565956|NCT00442871|chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
565957|NCT00442884|glucose control in acute stress|glucose control in acute stress
565958|NCT00442897|Hypercholesterolaemia|hypercholesterolaemia
565959|NCT00442910|Safety and Acceptability|safety and acceptability
565960|NCT00442923|Methamphetamine|methamphetamine
565961|NCT00442923|Coreg|coreg
565962|NCT00442923|Withdrawal|withdrawal
565963|NCT00442923|anxiety|anxiety
565964|NCT00442923|Substance Addiction|substance addiction
565965|NCT00442949|Acute coronary syndrome|acute coronary syndrome
565966|NCT00442949|Angioplasty|angioplasty
565967|NCT00442949|Abciximab|abciximab
565968|NCT00442949|Troponin release|troponin release
565969|NCT00442975|Influenza Vaccine|influenza vaccine
565971|NCT00442988|NODAT|nodat
565972|NCT00442988|OGTT|ogtt
565973|NCT00442988|FPG|fpg
565974|NCT00442988|Renal Transplanation|renal transplanation
565975|NCT00442988|Risk Factors|risk factors
565976|NCT00442988|Predictive value|predictive value
565977|NCT00443001|Non-Invasive Blood Pressure|non-invasive blood pressure
565978|NCT00443001|Sinus Rhythm|sinus rhythm
565979|NCT00443001|Oscillometric|oscillometric
565980|NCT00443001|Invasive Blood Pressure|invasive blood pressure
565981|NCT00443001|AAMI/ANSI SP10 Standard|aami/ansi sp10 standard
565982|NCT00443001|Compliance with ANSI/AAMI SP10 2002 standard|compliance with ansi/aami sp10 2002 standard
565983|NCT00443014|Stimulation therapy|stimulation therapy
565984|NCT00443014|Acetylcholinesterase inhibitors|acetylcholinesterase inhibitors
565985|NCT00443014|Synergetic|synergetic
565986|NCT00443053|superficial vein thrombosis|superficial vein thrombosis
565987|NCT00443053|superficial thrombophlebitis|superficial thrombophlebitis
565988|NCT00443053|fondaparinux|fondaparinux
565989|NCT00443053|deep vein thrombosis|deep vein thrombosis
565990|NCT00443053|venous thromboembolism treatment|venous thromboembolism treatment
565991|NCT00443053|thrombosis|thrombosis
565992|NCT00443066|pediatric|pediatric
565993|NCT00443066|neuromuscular disease|neuromuscular disease
565994|NCT00443079|Clinical Trials|clinical trials
565995|NCT00443079|Pilot Projects|pilot projects
565996|NCT00443079|Milk Thistle|milk thistle
565997|NCT00443079|Liver Function Tests|liver function tests
565998|NCT00443092|osteoarthritis|osteoarthritis
566000|NCT00443092|pain|pain
566001|NCT00443092|uric acid|uric acid
566002|NCT00443092|tart cherry|tart cherry
566003|NCT00443092|alternative medicine|alternative medicine
566004|NCT00443092|knees|knees
566005|NCT00443118|Bag and mask|bag and mask
566006|NCT00443118|Neopuff|neopuff
566007|NCT00443118|Resuscitation|resuscitation
566008|NCT00443118|Newborn|newborn
566009|NCT00443118|Intubation|intubation
566010|NCT00443118|devices|devices
566011|NCT00443118|PEEP|peep
566012|NCT00443131|Adjuvant|adjuvant
566013|NCT00443131|Malaria|malaria
566014|NCT00443131|Safety|safety
566015|NCT00443131|Immunogenicity|immunogenicity
566016|NCT00443144|growth hormone receptor polymorphism|growth hormone receptor polymorphism
566017|NCT00443144|pharmacogenomics|pharmacogenomics
566018|NCT00443144|growth promoting therapy|growth promoting therapy
566019|NCT00443157|meningococcal B vaccine|meningococcal b vaccine
566020|NCT00443170|repeat dose,|repeat dose,
566021|NCT00443170|GSK626616AC,|gsk626616ac,
566022|NCT00443170|pharmacokinetic,|pharmacokinetic,
566023|NCT00443170|single dose,|single dose,
566024|NCT00443170|cytochrome P450,|cytochrome p450,
566025|NCT00443170|First time in human,|first time in human,
566026|NCT00443170|healthy volunteers|healthy volunteers
566027|NCT00443196|Chemosensitivity|chemosensitivity
566028|NCT00443196|Ovarian Cancer|ovarian cancer
566029|NCT00443196|Chemotherapy|chemotherapy
566030|NCT00443196|Fallopian Adenocarcinoma|fallopian adenocarcinoma
566031|NCT00443196|Peritoneal Adenocarcinoma|peritoneal adenocarcinoma
566032|NCT00443196|Patients with pathological diagnoses of ovarian, fallopian and primary peritoneal adenocarcinomas.|patients with pathological diagnoses of ovarian, fallopian and primary peritoneal adenocarcinomas.
566033|NCT00443196|Patients with de novo malignancies and no previous chemotherapy|patients with de novo malignancies and no previous chemotherapy
566034|NCT00443196|Patients with advanced refractory malignancies who received no more than 2 standard chemotherapy treatment protocols.|patients with advanced refractory malignancies who received no more than 2 standard chemotherapy treatment protocols.
566035|NCT00443222|infliximab|infliximab
566036|NCT00443222|polymyositis|polymyositis
566037|NCT00443222|dermatomyositis|dermatomyositis
566038|NCT00443222|inclusion body myositis|inclusion body myositis
566039|NCT00443235|Older patients|older patients
566040|NCT00443235|untreated patients|untreated patients
566041|NCT00443261|Head and Neck Cancer|head and neck cancer
566042|NCT00443287|Peripheral|peripheral
566043|NCT00443287|Artery|artery
566044|NCT00443287|Disease|disease
566046|NCT00443300|MDS|mds
566047|NCT00443300|Protected Environment|protected environment
566048|NCT00443313|Cervical neoplasia|cervical neoplasia
566049|NCT00443313|Screening|screening
566050|NCT00443313|HPV|hpv
566051|NCT00443313|Cervical Cancer Screening|cervical cancer screening
566052|NCT00443326|Psoriasis|psoriasis
566053|NCT00443326|PASI|pasi
566054|NCT00443326|Skin Biopsy|skin biopsy
566055|NCT00443326|Human Monoclonal Antibody|human monoclonal antibody
566056|NCT00443339|Myelodysplastic syndromes with IPSS Low or Int-1|myelodysplastic syndromes with ipss low or int-1
566057|NCT00443339|Anemia|anemia
566058|NCT00443378|computer counseling|computer counseling
566059|NCT00443378|HIV|hiv
566060|NCT00443378|antiretroviral adherence|antiretroviral adherence
566061|NCT00443378|sexual behavior|sexual behavior
566062|NCT00443378|prevention with positives|prevention with positives
566063|NCT00443378|HIV seronegativity|hiv seronegativity
566064|NCT00443391|ADHD|adhd
566065|NCT00443404|phantom|phantom
566066|NCT00443404|amputation|amputation
566067|NCT00443404|analgesia|analgesia
566068|NCT00443404|pain|pain
566069|NCT00443404|preemptive|preemptive
566070|NCT00443404|perioperative|perioperative
566071|NCT00443404|lower limb amputation|lower limb amputation
566072|NCT00443404|intensity of phantom limb pain|intensity of phantom limb pain
566073|NCT00443404|preemptive analgesia reduces phantom pain|preemptive analgesia reduces phantom pain
566074|NCT00443404|perioperative analgesia reduces phantom pain|perioperative analgesia reduces phantom pain
566075|NCT00443404|Severe Phantom Limb Pain (VAS>70 mm)|severe phantom limb pain (vas>70 mm)
565462|NCT00448929|ologen|ologen
566076|NCT00443404|resistant to medical treatment one week before amputation|resistant to medical treatment one week before amputation
566077|NCT00443430|Childhood Arthritis|childhood arthritis
566078|NCT00443430|Juvenile Arthritis|juvenile arthritis
566079|NCT00443430|Juvenile Arthritis Treatment|juvenile arthritis treatment
565999|NCT00443092|gout|gout
566080|NCT00443430|Childhood Arthritis Drug Treatment|childhood arthritis drug treatment
566081|NCT00443430|Juvenile Arthritis Remission|juvenile arthritis remission
566082|NCT00443430|Inactive Disease in Juvenile Arthritis|inactive disease in juvenile arthritis
566083|NCT00443430|Childhood Polyarthritis|childhood polyarthritis
566084|NCT00443430|Extended Oligoarthritis|extended oligoarthritis
566085|NCT00443443|Rituximab|rituximab
566086|NCT00443443|RA|ra
566087|NCT00443443|Sunstone|sunstone
566088|NCT00443443|anti-TNF|anti-tnf
566089|NCT00443443|Rituxan|rituxan
566090|NCT00443469|magnetic stimulation|magnetic stimulation
566091|NCT00443469|neuropathic pain|neuropathic pain
566092|NCT00443469|spinal|spinal
566093|NCT00443469|lower limb|lower limb
566094|NCT00443469|clinical trial|clinical trial
566095|NCT00443482|Asthma|asthma
566096|NCT00443482|adults|adults
566097|NCT00443482|B2 agonist|b2 agonist
566098|NCT00443482|formoterol|formoterol
566099|NCT00443508|everolimus|everolimus
566100|NCT00443508|renal transplant|renal transplant
566101|NCT00443508|tacrolimus|tacrolimus
566102|NCT00443508|Certican|certican
566103|NCT00443508|CHRONIC ALLOGRAFT NEPHROPATHY|chronic allograft nephropathy
566104|NCT00443508|Renal transplant patients|renal transplant patients
566105|NCT00443521|Diabetes Mellitus/ complications|diabetes mellitus/ complications
566106|NCT00443521|Diabetic Retinopathy|diabetic retinopathy
566107|NCT00443521|Triamcinolone|triamcinolone
566108|NCT00443521|Laser coagulation|laser coagulation
566109|NCT00443521|Tomography, optical coherence|tomography, optical coherence
566110|NCT00443547|Prospective|prospective
566111|NCT00443547|Degenerative Disc Disease|degenerative disc disease
566112|NCT00443547|Cervical|cervical
566113|NCT00443547|Translational Plate|translational plate
566114|NCT00443560|Labor|labor
566115|NCT00443560|Epidural Analgesia|epidural analgesia
566116|NCT00443560|delivery|delivery
566117|NCT00443560|vacuum extraction|vacuum extraction
566118|NCT00443560|obstetrical Forceps|obstetrical forceps
566119|NCT00443573|metastatic colorectal carcinoma (mCRC)|metastatic colorectal carcinoma (mcrc)
566120|NCT00443573|colorectal carcinoma (CRC)|colorectal carcinoma (crc)
566121|NCT00443573|tissue factor|tissue factor
566122|NCT00443573|factor VIIa|factor viia
566123|NCT00443573|rNAPc2|rnapc2
566124|NCT00443573|adenocarcinoma|adenocarcinoma
566125|NCT00443573|targeted therapy|targeted therapy
566126|NCT00443573|coagulation-dependent|coagulation-dependent
566127|NCT00443573|RECIST|recist
566128|NCT00443573|5-FU-based chemotherapy|5-fu-based chemotherapy
566129|NCT00443573|FOLFOX|folfox
566130|NCT00443573|FOLFIRI|folfiri
566131|NCT00443573|leucovorin|leucovorin
566132|NCT00443573|XELOX|xelox
566133|NCT00443586|Nurse|nurse
566134|NCT00443586|Home Visitation|home visitation
566135|NCT00443586|Welfare|welfare
566136|NCT00443586|Social Behavior|social behavior
566137|NCT00443599|Congenital Heart Defects|congenital heart defects
566138|NCT00443599|Insulin|insulin
566139|NCT00443599|Euglycemia|euglycemia
566140|NCT00443599|Normoglycemia|normoglycemia
566141|NCT00443625|SK3530|sk3530
566142|NCT00443625|Food effect|food effect
566143|NCT00443625|Pharmacokinetics|pharmacokinetics
566144|NCT00443651|Rituxan|rituxan
566145|NCT00443651|RA|ra
566146|NCT00443651|DMARD|dmard
566147|NCT00443651|Active Rheumatoid Arthritis|active rheumatoid arthritis
566148|NCT00443664|Primary Open Angle Glaucoma|primary open angle glaucoma
566149|NCT00443690|heart failure|heart failure
566150|NCT00443690|diuretic|diuretic
566151|NCT00443690|renal impairment|renal impairment
566152|NCT00443690|renal function|renal function
566153|NCT00443703|treatment experienced|treatment experienced
566154|NCT00443729|treatment experienced|treatment experienced
566155|NCT00443742|Depression|depression
566156|NCT00443742|Validation|validation
566157|NCT00443742|Adolescent|adolescent
566158|NCT00443742|Validation of three key questions and questionnaire|validation of three key questions and questionnaire
566159|NCT00443755|Inflammatory cytokine|inflammatory cytokine
566160|NCT00443755|Cardiovascular Disease|cardiovascular disease
566161|NCT00443755|Thrombotic factors|thrombotic factors
566162|NCT00443755|Dyslipidemia|dyslipidemia
566163|NCT00443768|Medication|medication
566164|NCT00443768|Diagnosis|diagnosis
566165|NCT00443768|Community|community
566166|NCT00443781|low back pain, degenerative disc disease|low back pain, degenerative disc disease
566167|NCT00443794|POLYCAP, Primary Prevention,CVD|polycap, primary prevention,cvd
566168|NCT00443820|Toenail fungus|toenail fungus
566169|NCT00443820|Onychomycosis|onychomycosis
566170|NCT00443820|Nail fungus|nail fungus
566171|NCT00443820|Toenail fungal infection|toenail fungal infection
566172|NCT00443820|Tinea unguium|tinea unguium
566173|NCT00443820|Dermatophytes|dermatophytes
566174|NCT00443820|Foot dermatoses|foot dermatoses
566175|NCT00443833|Thyrotoxicosis|thyrotoxicosis
566176|NCT00443833|genetic association study|genetic association study
566177|NCT00443833|periodic paralysis|periodic paralysis
566178|NCT00443833|whole genome scan|whole genome scan
566248|NCT00443976|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
566249|NCT00443976|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
566179|NCT00443846|Prevention of Gastroenteritis due to rotavirus infection. And prevention of Invasive disease caused by Neisseria meningitidis serogroup C.|prevention of gastroenteritis due to rotavirus infection. and prevention of invasive disease caused by neisseria meningitidis serogroup c.
566180|NCT00443859|Persistent Pulmonary Hypertension|persistent pulmonary hypertension
566181|NCT00443859|N-terminal pro brain natriuretic peptide|n-terminal pro brain natriuretic peptide
566182|NCT00443872|Parkinson's disease|parkinson's disease
566183|NCT00443872|Dopamine agonist adverse effects|dopamine agonist adverse effects
566184|NCT00443872|MAO-B inhibitor|mao-b inhibitor
566185|NCT00443872|orally disintegrating selegiline|orally disintegrating selegiline
566186|NCT00443872|Zelapar|zelapar
566187|NCT00443885|meropenem|meropenem
566188|NCT00443885|imipenem|imipenem
566189|NCT00443885|gram negative organism|gram negative organism
566190|NCT00443898|Toenail fungus|toenail fungus
566191|NCT00443898|Onychomycosis|onychomycosis
566192|NCT00443898|Nail fungus|nail fungus
566193|NCT00443898|Toenail fungal infection|toenail fungal infection
566194|NCT00443898|Tinea unguium|tinea unguium
566195|NCT00443898|Dermatophytes|dermatophytes
566196|NCT00443898|Foot dermatoses|foot dermatoses
566197|NCT00443911|age-related macular degeneration, rheopheresis, lutein|age-related macular degeneration, rheopheresis, lutein
566198|NCT00443924|Bilateral ocular hypertension or early primary open angle glaucoma|bilateral ocular hypertension or early primary open angle glaucoma
566199|NCT00443937|Kidney Transplantation|kidney transplantation
566200|NCT00443937|Renal Transplantation|renal transplantation
566201|NCT00443937|Mycophenolate|mycophenolate
566202|NCT00443937|Cyclosporine|cyclosporine
566203|NCT00443937|Everolimus|everolimus
566204|NCT00443950|Arthritis|arthritis
566205|NCT00443950|Chinese|chinese
566206|NCT00443963|Dyspepsia in patients taking NSAIDs|dyspepsia in patients taking nsaids
566207|NCT00443976|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
566208|NCT00443976|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
566209|NCT00443976|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
566210|NCT00443976|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
566211|NCT00443976|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
566212|NCT00443976|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
566213|NCT00443976|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
566214|NCT00443976|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
566215|NCT00443976|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
566216|NCT00443976|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
566217|NCT00443976|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
566218|NCT00443976|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
566219|NCT00443976|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
566220|NCT00443976|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
566221|NCT00443976|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
585623|NCT00513409|Pneumococcal vaccine|pneumococcal vaccine
566222|NCT00443976|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
566223|NCT00443976|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
566224|NCT00443976|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
566225|NCT00443976|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
566226|NCT00443976|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
566227|NCT00443976|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
566228|NCT00443976|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
566229|NCT00443976|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
566230|NCT00443976|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
566231|NCT00443976|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
566232|NCT00443976|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
566233|NCT00443976|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
566234|NCT00443976|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
566235|NCT00443976|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
566236|NCT00443976|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
566237|NCT00443976|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
566238|NCT00443976|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
566239|NCT00443976|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
566240|NCT00443976|splenic marginal zone lymphoma|splenic marginal zone lymphoma
566241|NCT00443976|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
566242|NCT00443976|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
566243|NCT00443976|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
566244|NCT00443976|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
566245|NCT00443976|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
566246|NCT00443976|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
566247|NCT00443976|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
566352|NCT00450099|Labor Analgesia|labor analgesia
566250|NCT00443989|Perioperative Myocardial Infarction|perioperative myocardial infarction
566251|NCT00443989|Stroke|stroke
566252|NCT00443989|Cardiac Death|cardiac death
566253|NCT00443989|Cardiac Arrest|cardiac arrest
566254|NCT00443989|Troponin-T|troponin-t
566255|NCT00443989|Non-Cardiac surgery|non-cardiac surgery
566256|NCT00443989|Death|death
566257|NCT00444002|Hepatitis C|hepatitis c
566258|NCT00444002|Steatosis|steatosis
566259|NCT00444002|Oxidative Stress|oxidative stress
566260|NCT00444002|Antioxidants|antioxidants
566261|NCT00444002|Inflammation|inflammation
566262|NCT00444002|Fatty acids|fatty acids
566263|NCT00444015|Erlotinib|erlotinib
566264|NCT00444015|Dasatinib|dasatinib
566265|NCT00444015|Epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
566266|NCT00444015|Tyrosine kinase|tyrosine kinase
566267|NCT00444015|NSCLC|nsclc
566268|NCT00444015|Pharmacokinetics (PK)|pharmacokinetics (pk)
566269|NCT00444015|Lung|lung
566270|NCT00444028|Schizophrenia, Staccato Loxapine|schizophrenia, staccato loxapine
566271|NCT00444041|metastatic colorectal cancer|metastatic colorectal cancer
566272|NCT00444041|surgery|surgery
566273|NCT00444041|chemotherapy|chemotherapy
566274|NCT00444054|Diet|diet
566275|NCT00444054|Cancer|cancer
566276|NCT00444054|Alternative|alternative
566277|NCT00444054|Breast|breast
566278|NCT00444054|Colon|colon
566279|NCT00444054|Cervix|cervix
566280|NCT00444054|Uterus|uterus
566281|NCT00444054|Ovary|ovary
566282|NCT00444054|Metastatic|metastatic
566283|NCT00444054|Nutrition|nutrition
566284|NCT00444054|Carbohydrate|carbohydrate
566285|NCT00444067|Prevention of CSF leak|prevention of csf leak
566286|NCT00444080|Ex-PRESS|ex-press
566287|NCT00444080|TRABECULECTOMY|trabeculectomy
566288|NCT00444093|radiation therapy|radiation therapy
566289|NCT00444093|diarrhea|diarrhea
566290|NCT00444093|enteritis|enteritis
566291|NCT00444093|supportive therapy|supportive therapy
566292|NCT00444093|therapy associated diarrhea|therapy associated diarrhea
566293|NCT00444093|therapy associated enteritis|therapy associated enteritis
566294|NCT00444093|radiation therapy of the small pelvis|radiation therapy of the small pelvis
566295|NCT00444106|Malaria|malaria
566296|NCT00444106|hearing|hearing
566297|NCT00444106|co-artemether|co-artemether
566298|NCT00444106|auditory|auditory
566299|NCT00444106|Plasmodium falciparum|plasmodium falciparum
566300|NCT00444106|marsh fever|marsh fever
566301|NCT00444106|Plasmodium infections|plasmodium infections
566302|NCT00444106|remittent fever|remittent fever
566303|NCT00444106|paludism|paludism
566304|NCT00444106|artemether|artemether
566305|NCT00444106|artemisinins|artemisinins
566306|NCT00444106|benflumetol|benflumetol
566307|NCT00444106|lumefantrine|lumefantrine
566308|NCT00444119|adrenal insufficiency|adrenal insufficiency
566309|NCT00444119|subjective health status|subjective health status
566310|NCT00444119|quality of life|quality of life
566311|NCT00444119|adrenal crisis|adrenal crisis
566312|NCT00444119|hormone replacement|hormone replacement
566313|NCT00444119|DHEA|dhea
566314|NCT00444132|clopidogrel|clopidogrel
566315|NCT00444132|platelets|platelets
566316|NCT00444132|acute coronary syndrome|acute coronary syndrome
566317|NCT00444132|percutaneous coronary intervention|percutaneous coronary intervention
566318|NCT00444158|opioids|opioids
566319|NCT00444158|chronic pain|chronic pain
566320|NCT00444171|critically ill|critically ill
566321|NCT00444171|insulin resistance|insulin resistance
566322|NCT00444171|intensive insulin therapy|intensive insulin therapy
566323|NCT00444171|computer algorithm|computer algorithm
566324|NCT00444184|travoprost/timolol fixed combination|travoprost/timolol fixed combination
566325|NCT00444223|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
566326|NCT00444223|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
566327|NCT00444223|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
566328|NCT00444236|asthma|asthma
566329|NCT00444236|GERD|gerd
566330|NCT00444236|reflux|reflux
566331|NCT00444236|exercise|exercise
566332|NCT00444249|age-related macular degeneration|age-related macular degeneration
566333|NCT00444249|melatonin|melatonin
566334|NCT00444249|blue-light filter|blue-light filter
566335|NCT00444262|Hemodynamic optimisation|hemodynamic optimisation
566336|NCT00444262|Esophageal Doppler|esophageal doppler
566337|NCT00444262|Hydroxy ethyl starch|hydroxy ethyl starch
731639|NCT01077674|Entropy|entropy
566338|NCT00444262|Hip fracture|hip fracture
566339|NCT00444262|Outcome|outcome
566340|NCT00444262|Elderly subjects (≥ 70 year old)|elderly subjects (≥ 70 year old)
566341|NCT00444262|General anesthesia|general anesthesia
566342|NCT00444275|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
566343|NCT00444275|Acid Reflux|acid reflux
566344|NCT00444288|Cystic Ovaries|cystic ovaries
566345|NCT00444288|Hyperandrogenism|hyperandrogenism
566346|NCT00444288|Anovulation|anovulation
566347|NCT00444288|Concordance Rates|concordance rates
566348|NCT00444288|Baseline Heritability|baseline heritability
566349|NCT00444288|Polycystic Ovary Syndrome|polycystic ovary syndrome
566350|NCT00444288|POS|pos
566351|NCT00450099|Epidural|epidural
566354|NCT00450099|Dose-response|dose-response
566355|NCT00450099|Minimum effective volume|minimum effective volume
566356|NCT00450125|Lung Cancer|lung cancer
566357|NCT00450125|Lung Resection|lung resection
566358|NCT00450125|Exercise Stress Test|exercise stress test
566359|NCT00450125|Six-Minute Walk Test|six-minute walk test
566360|NCT00450138|Squamous Cell Carcinoma|squamous cell carcinoma
566361|NCT00450151|Pediatric|pediatric
566362|NCT00450151|Cardiopulmonary bypass Surgery|cardiopulmonary bypass surgery
566363|NCT00450151|Cardiac Surgery|cardiac surgery
566364|NCT00450151|Platelet|platelet
566365|NCT00450151|Platelet Activation Markers|platelet activation markers
566366|NCT00450151|Platelet Factor4|platelet factor4
566367|NCT00450151|Transforming Growth Factor Beta|transforming growth factor beta
566368|NCT00450164|Variceal bleeding|variceal bleeding
566369|NCT00450164|Secondary profilaxis|secondary profilaxis
566370|NCT00450164|Hemodynamic|hemodynamic
566371|NCT00450164|Portal hypertension|portal hypertension
566372|NCT00450177|iron|iron
566373|NCT00450177|critical illness|critical illness
566374|NCT00450177|anemia|anemia
566375|NCT00450177|infection|infection
566376|NCT00450190|Growth disorders/drug therapy|growth disorders/drug therapy
566377|NCT00450203|adenocarcinoma of the stomach|adenocarcinoma of the stomach
566378|NCT00450203|adenocarcinoma of the gastro oesophageal junction|adenocarcinoma of the gastro oesophageal junction
566379|NCT00450203|adenocarcinoma of the lower oesophagus|adenocarcinoma of the lower oesophagus
566380|NCT00450216|ibuprofen|ibuprofen
566381|NCT00450216|famotidine|famotidine
566382|NCT00450216|ulcers|ulcers
566383|NCT00450216|NSAIDS|nsaids
566384|NCT00450216|pain|pain
566385|NCT00450216|arthritis|arthritis
566386|NCT00450216|chronic regional pain syndrome|chronic regional pain syndrome
566387|NCT00450216|chronic soft tissue pain|chronic soft tissue pain
566388|NCT00450216|osteoarthritis|osteoarthritis
566389|NCT00450216|rheumatoid arthritis|rheumatoid arthritis
566390|NCT00450216|chronic low back pain|chronic low back pain
566391|NCT00450242|vulvar vestibulitis|vulvar vestibulitis
566392|NCT00450242|vestibulitis|vestibulitis
566393|NCT00450268|Graft versus host disease|graft versus host disease
566394|NCT00450268|Allogeneic hematpoietic stem cell transplantation|allogeneic hematpoietic stem cell transplantation
566395|NCT00450281|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
566396|NCT00450281|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
566397|NCT00450281|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
566398|NCT00450281|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
566399|NCT00450281|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
566400|NCT00450281|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
566401|NCT00450307|recurrent neuroblastoma|recurrent neuroblastoma
566402|NCT00450307|stage 4S neuroblastoma|stage 4s neuroblastoma
566403|NCT00450307|disseminated neuroblastoma|disseminated neuroblastoma
566404|NCT00450307|localized unresectable neuroblastoma|localized unresectable neuroblastoma
566405|NCT00450307|regional neuroblastoma|regional neuroblastoma
566406|NCT00450320|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
566407|NCT00450320|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
566408|NCT00450333|Chronic|chronic
566409|NCT00450359|breast cancer|breast cancer
566410|NCT00450372|recurrent melanoma|recurrent melanoma
566411|NCT00450372|stage IV melanoma|stage iv melanoma
566412|NCT00450385|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
566413|NCT00450385|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
566414|NCT00450385|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
566415|NCT00450385|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
566416|NCT00450385|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
566417|NCT00450385|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
566418|NCT00450398|Delayed graft function|delayed graft function
566419|NCT00450411|adenocarcinoma of the prostate|adenocarcinoma of the prostate
566420|NCT00450411|recurrent prostate cancer|recurrent prostate cancer
566421|NCT00450411|stage I prostate cancer|stage i prostate cancer
566422|NCT00450411|stage IIB prostate cancer|stage iib prostate cancer
566423|NCT00450411|stage IIA prostate cancer|stage iia prostate cancer
565847|NCT00442403|Malaria|malaria
566424|NCT00452062|cuff-leak test|cuff-leak test
566425|NCT00452062|intubation|intubation
566426|NCT00452062|corticosteroids|corticosteroids
566427|NCT00452062|dexamethasone to reduce the occurrence of post-extubation airway obstruction|dexamethasone to reduce the occurrence of post-extubation airway obstruction
566428|NCT00452075|EGFR expression|egfr expression
566429|NCT00452075|erlotinib|erlotinib
566430|NCT00452088|Malaria vaccine|malaria vaccine
566431|NCT00452088|Safety of MSP 3 LSP|safety of msp 3 lsp
566432|NCT00452088|Immunogenicity of MSP 3 LSP|immunogenicity of msp 3 lsp
566433|NCT00452088|Burkina Faso children|burkina faso children
566434|NCT00452101|Osteoarthritis|osteoarthritis
566435|NCT00452101|Clinical trial|clinical trial
566436|NCT00452101|Aquamin F|aquamin f
566437|NCT00452101|Glucosamine|glucosamine
566438|NCT00452114|Bronchiectasis|bronchiectasis
566439|NCT00452127|NHL|nhl
566440|NCT00452127|Indolent|indolent
566442|NCT00452140|Breast Cancer|breast cancer
566443|NCT00452140|investigational drug|investigational drug
566444|NCT00452140|drug therapy|drug therapy
566445|NCT00452140|Antineoplastic Protocols|antineoplastic protocols
566446|NCT00452140|Immunotherapy|immunotherapy
566447|NCT00452140|Metastatic breast cancer|metastatic breast cancer
566448|NCT00452140|Advanced breast cancer|advanced breast cancer
566449|NCT00452140|Stage III to IV breast cancer|stage iii to iv breast cancer
566450|NCT00452140|Hormonal therapy refractory|hormonal therapy refractory
566451|NCT00452140|Failure of hormonal therapy|failure of hormonal therapy
566452|NCT00452140|Her-2/neu expressing breast cancer|her-2/neu expressing breast cancer
566453|NCT00452140|Her-2/neu|her-2/neu
566454|NCT00452153|legionellosis|legionellosis
566455|NCT00452153|diagnosis of legionellosis|diagnosis of legionellosis
566456|NCT00452153|PCR|pcr
566457|NCT00452179|Sleep maintenance|sleep maintenance
566458|NCT00452179|Insomnia|insomnia
566459|NCT00452179|Sleep Consolidation|sleep consolidation
566460|NCT00452179|Sleep|sleep
566461|NCT00452179|Insomnia, primarily sleep maintenance|insomnia, primarily sleep maintenance
566462|NCT00452192|Metabolic syndrome|metabolic syndrome
566463|NCT00452205|bone marrow-derived stem cell|bone marrow-derived stem cell
566464|NCT00452205|bone marrow transplantation|bone marrow transplantation
566465|NCT00452205|graft versus host disease|graft versus host disease
566466|NCT00452205|gastrointestinal cancer|gastrointestinal cancer
566467|NCT00452205|after receiving bone marrow transplantation|after receiving bone marrow transplantation
566468|NCT00452218|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
566469|NCT00452218|PAH|pah
566470|NCT00452231|Post-traumatic Stress Disorder|post-traumatic stress disorder
566471|NCT00452231|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
566472|NCT00452244|Gefitinib|gefitinib
566473|NCT00452244|Simvastatin|simvastatin
566474|NCT00452244|NSCLC|nsclc
566475|NCT00452244|Advanced NSCLC|advanced nsclc
566476|NCT00452270|Common cold, xylometazoline|common cold, xylometazoline
566477|NCT00452296|inpatients with COPD|inpatients with copd
566478|NCT00452296|glucose control|glucose control
566479|NCT00452309|peripheral arterial disease|peripheral arterial disease
566480|NCT00452309|pad|pad
566481|NCT00452309|ankle brachial index|ankle brachial index
566482|NCT00452309|abi|abi
566483|NCT00452322|Testosterone|testosterone
566484|NCT00452322|Hypogonadism|hypogonadism
566485|NCT00452322|Safety|safety
566486|NCT00452348|FLOVENT|flovent
566487|NCT00452348|fluticasone|fluticasone
566488|NCT00452348|12 month|12 month
566489|NCT00452348|salmeterol|salmeterol
566490|NCT00452348|asthma|asthma
566492|NCT00452374|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
566493|NCT00452374|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
566494|NCT00452374|CLL|cll
566495|NCT00452374|Prolymphocytic Leukemia|prolymphocytic leukemia
566496|NCT00452374|PLL|pll
566497|NCT00452374|Richter's Transformation|richter's transformation
566498|NCT00452374|High-grade non-Hodgkin's lymphoma|high-grade non-hodgkin's lymphoma
566499|NCT00452374|Hodgkin's disease|hodgkin's disease
566500|NCT00452374|Acute leukemia|acute leukemia
566501|NCT00452374|Small lymphocytic lymphoma|small lymphocytic lymphoma
566502|NCT00452374|Oxaliplatin|oxaliplatin
566503|NCT00452374|Eloxatin|eloxatin
566504|NCT00452374|Fludarabine|fludarabine
566505|NCT00452374|Cytarabine|cytarabine
566506|NCT00452374|Ara-C|ara-c
566507|NCT00452374|Cytosar|cytosar
566508|NCT00452374|DepoCyt|depocyt
566509|NCT00452374|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
566510|NCT00452374|Rituximab|rituximab
566511|NCT00452374|Rituxan|rituxan
566512|NCT00452387|Prostate Cancer|prostate cancer
566513|NCT00452426|Propofol|propofol
566514|NCT00452426|Diprivan|diprivan
566515|NCT00452426|Colonoscopy|colonoscopy
566516|NCT00452426|Endoscopy, Digestive System|endoscopy, digestive system
566517|NCT00452426|Conscious Sedation|conscious sedation
566518|NCT00452439|Leukemia|leukemia
566519|NCT00452439|Lymphoma|lymphoma
566520|NCT00452439|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
566521|NCT00452439|Lymphoblastic Lymphoma|lymphoblastic lymphoma
565970|NCT00442975|CMV|cmv
566522|NCT00452439|Actonel|actonel
566523|NCT00452439|Risedronate|risedronate
566524|NCT00452439|Bone Loss|bone loss
566525|NCT00452439|Osteoporosis|osteoporosis
566526|NCT00452452|Pneumococcal Vaccines|pneumococcal vaccines
566527|NCT00452465|Elderly|elderly
566528|NCT00452465|Nursing care plan|nursing care plan
566529|NCT00452465|Quality of Life|quality of life
566530|NCT00452478|Hyperphosphataemia|hyperphosphataemia
566531|NCT00452517|bare metal stents|bare metal stents
566532|NCT00452517|sirolimus-eluting stents|sirolimus-eluting stents
566533|NCT00452517|coronary polytetrafluoroethylene stent graft|coronary polytetrafluoroethylene stent graft
566534|NCT00452517|acute coronary syndrome|acute coronary syndrome
566535|NCT00452517|quantitative coronary angiography analysis|quantitative coronary angiography analysis
566536|NCT00452517|major adverse cardiac events|major adverse cardiac events
566537|NCT00452517|in-stent restenosis|in-stent restenosis
566538|NCT00452517|target lesion revascularisation|target lesion revascularisation
567374|NCT00447486|pain,|pain,
566539|NCT00452530|Prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery|prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery
566540|NCT00452543|Major depressive disorder|major depressive disorder
566541|NCT00452543|Alcoholism|alcoholism
566542|NCT00452543|Alcohol abuse|alcohol abuse
566543|NCT00452543|Alcohol dependence|alcohol dependence
566544|NCT00452556|Prostatic Neoplasms|prostatic neoplasms
566545|NCT00452556|Radiotherapy|radiotherapy
566546|NCT00452556|Docetaxel|docetaxel
566547|NCT00452556|Leuprolide Acetate|leuprolide acetate
566548|NCT00452569|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
566549|NCT00452582|ischemic stroke|ischemic stroke
566550|NCT00452582|recovery|recovery
566551|NCT00452582|sildenafil|sildenafil
566552|NCT00452621|blood draw five years after booster-immunization with TBE vaccine to investigate immunogenicity in children|blood draw five years after booster-immunization with tbe vaccine to investigate immunogenicity in children
566554|NCT00452634|Irinotecan|irinotecan
566555|NCT00452634|cisplatin|cisplatin
566556|NCT00452634|Simvastatin|simvastatin
566557|NCT00452634|Extensive disease|extensive disease
566558|NCT00452634|SCLC|sclc
566559|NCT00452647|Condition: No specific disease is being studied, few procedures are excluded.|condition: no specific disease is being studied, few procedures are excluded.
566560|NCT00452647|Focus: To obtain blood pressure data and detect any trends to a statistically significant degree.|focus: to obtain blood pressure data and detect any trends to a statistically significant degree.
566561|NCT00452660|IRON|iron
566562|NCT00452660|oxidative stress|oxidative stress
566563|NCT00452660|MDS|mds
566564|NCT00452686|Chinese DT vaccin|chinese dt vaccin
566565|NCT00452699|fluticasone propionate|fluticasone propionate
566566|NCT00452699|long-term study|long-term study
566567|NCT00452699|Salmeterol|salmeterol
566568|NCT00452699|FLOVENT 250|flovent 250
566569|NCT00452699|Asthma|asthma
566570|NCT00452699|ADVAIR 250|advair 250
566571|NCT00452712|orthostatism|orthostatism
566572|NCT00452712|fever|fever
566573|NCT00452738|animal-assisted intervention|animal-assisted intervention
566574|NCT00452738|pre surgery anxiety|pre surgery anxiety
566575|NCT00452738|post surgery pain medication consumption|post surgery pain medication consumption
566576|NCT00452751|gastric cancer|gastric cancer
566577|NCT00452751|laparoscopic surgery|laparoscopic surgery
566578|NCT00452751|survival|survival
566579|NCT00452751|preoperative staging|preoperative staging
566580|NCT00452751|morbidity|morbidity
566581|NCT00452751|quality of life|quality of life
566582|NCT00452751|acute inflammatory reaction|acute inflammatory reaction
566583|NCT00452751|cost|cost
566584|NCT00452764|COPD|copd
566585|NCT00452764|Healthy|healthy
566586|NCT00452764|Regulatory T cell|regulatory t cell
566587|NCT00452764|Heme oxygenase-1|heme oxygenase-1
566588|NCT00452764|peripheral blood|peripheral blood
566589|NCT00452777|Diabetic neuropathy, painful|diabetic neuropathy, painful
566590|NCT00452777|Adenosine A2A receptor|adenosine a2a receptor
566591|NCT00452790|Vaccines, Pneumococcal|vaccines, pneumococcal
566592|NCT00452803|Non small cell lung cancer|non small cell lung cancer
566593|NCT00452816|Chronic Disease|chronic disease
566594|NCT00452816|Employer Health Costs|employer health costs
566595|NCT00452816|Health Promotion|health promotion
566596|NCT00452816|Insurance Benefits|insurance benefits
566597|NCT00452816|Marketing of Health Services|marketing of health services
566598|NCT00452816|Mass Screening|mass screening
566599|NCT00452816|Prevention & Control|prevention & control
566600|NCT00452816|Tobacco Use Cessation|tobacco use cessation
566601|NCT00452816|Workplace|workplace
566602|NCT00452855|Nausea|nausea
566603|NCT00452855|Vomiting|vomiting
566604|NCT00452855|Post operative|post operative
566605|NCT00452855|Propofol remifentanil anaesthesia|propofol remifentanil anaesthesia
566606|NCT00452855|Sevoflurane remifentanil anaesthesia|sevoflurane remifentanil anaesthesia
566607|NCT00452868|cognitive/functional effects|cognitive/functional effects
566608|NCT00452868|neurotoxicity|neurotoxicity
566609|NCT00452868|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
566610|NCT00452868|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
566611|NCT00452868|radiation toxicity|radiation toxicity
566612|NCT00452868|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
566613|NCT00452868|childhood choroid plexus tumor|childhood choroid plexus tumor
566614|NCT00452868|childhood craniopharyngioma|childhood craniopharyngioma
566615|NCT00452868|childhood grade I meningioma|childhood grade i meningioma
566616|NCT00452868|childhood grade II meningioma|childhood grade ii meningioma
566617|NCT00452868|childhood grade III meningioma|childhood grade iii meningioma
566618|NCT00452868|childhood spinal cord neoplasm|childhood spinal cord neoplasm
566619|NCT00452868|childhood brain stem glioma|childhood brain stem glioma
566620|NCT00452868|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
566621|NCT00452868|childhood medulloblastoma|childhood medulloblastoma
566622|NCT00452868|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
566623|NCT00452868|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
567375|NCT00447486|efficacy,|efficacy,
566624|NCT00452868|childhood subependymal giant cell astrocytoma|childhood subependymal giant cell astrocytoma
566625|NCT00452868|childhood ependymoma|childhood ependymoma
566626|NCT00452868|childhood cerebral astrocytoma/malignant glioma|childhood cerebral astrocytoma/malignant glioma
566627|NCT00452881|Non-small cell lung cancer|non-small cell lung cancer
566628|NCT00452881|adjuvant chemotherapy|adjuvant chemotherapy
566629|NCT00452920|cervical squamous cell carcinoma|cervical squamous cell carcinoma
566630|NCT00452920|stage IIB cervical cancer|stage iib cervical cancer
566631|NCT00452920|stage III cervical cancer|stage iii cervical cancer
566632|NCT00452920|stage IVA cervical cancer|stage iva cervical cancer
566633|NCT00452972|Cesarean delivery|cesarean delivery
566634|NCT00452972|Spinal anesthesia|spinal anesthesia
566635|NCT00452972|Nausea|nausea
566636|NCT00452972|Vomiting|vomiting
566637|NCT00452972|Pain|pain
566638|NCT00452998|Sequential Laser Iridotomy|sequential laser iridotomy
566639|NCT00452998|Q-Switched 532 nm Laser|q-switched 532 nm laser
566640|NCT00452998|Frequency Doubled Neodymium Yag Laser|frequency doubled neodymium yag laser
566641|NCT00453011|vitreous loss|vitreous loss
566642|NCT00453011|intraocular lenses|intraocular lenses
566643|NCT00453011|Patients undergoing extracapsular cataract surgery|patients undergoing extracapsular cataract surgery
566644|NCT00453011|Vitreous loss with sufficient capsular support for an unsutured posterior chamber lens|vitreous loss with sufficient capsular support for an unsutured posterior chamber lens
566645|NCT00453011|5% random sample of patients with no vitreous loss|5% random sample of patients with no vitreous loss
566646|NCT00453024|Advanced glaucoma|advanced glaucoma
566647|NCT00453024|Ahmed glaucoma implant|ahmed glaucoma implant
566648|NCT00453024|Anterior segment optical coherence tomography|anterior segment optical coherence tomography
566649|NCT00453024|Pericardial patch graft|pericardial patch graft
566650|NCT00453024|Tissue glue|tissue glue
566651|NCT00453024|Scleral flap|scleral flap
566652|NCT00453024|Sutures|sutures
566653|NCT00453037|hypertension|hypertension
566654|NCT00453037|self measurement of blood pressure|self measurement of blood pressure
566655|NCT00453037|education program|education program
566656|NCT00453037|life style|life style
566657|NCT00453050|stage III melanoma|stage iii melanoma
566658|NCT00453050|stage IV melanoma|stage iv melanoma
566659|NCT00453050|skin metastases|skin metastases
566660|NCT00453076|Biliary Obstruction|biliary obstruction
566661|NCT00453089|Chinese Herbs|chinese herbs
566662|NCT00453089|Postmenopausal|postmenopausal
566663|NCT00453089|Vaginal Atrophy|vaginal atrophy
566664|NCT00453089|Vulvar Atrophy|vulvar atrophy
566666|NCT00453089|Bionovo|bionovo
566667|NCT00453089|VG101|vg101
566668|NCT00453102|Marginal Zone Lymphoma|marginal zone lymphoma
566669|NCT00453102|Non-gastric extranodal Marginal Zone Lymphoma|non-gastric extranodal marginal zone lymphoma
566670|NCT00453102|Splenic Marginal Zone Lymphoma|splenic marginal zone lymphoma
566671|NCT00453102|Nodal Marginal Zone Lymphoma|nodal marginal zone lymphoma
566672|NCT00453102|Gastric Marginal Zone Lymphoma|gastric marginal zone lymphoma
566674|NCT00453102|Non-gastric extranodal MZL|non-gastric extranodal mzl
566675|NCT00453102|Splenic MZL|splenic mzl
566676|NCT00453102|Nodal MZL|nodal mzl
566677|NCT00453102|Gastric MZL|gastric mzl
566678|NCT00453115|Non small cell lung cancer|non small cell lung cancer
566679|NCT00453115|advanced stage IIIB|advanced stage iiib
566680|NCT00453115|Stage IV|stage iv
566681|NCT00453128|Calcium Pyrophosphate|calcium pyrophosphate
566682|NCT00453128|associated conditions|associated conditions
566683|NCT00453141|Betamethasone for preterm labor|betamethasone for preterm labor
566684|NCT00453141|Preterm delivery|preterm delivery
566685|NCT00453141|Infant Respiratory Distress Syndrome|infant respiratory distress syndrome
566686|NCT00453167|Small cell lung cancer|small cell lung cancer
566687|NCT00453167|second-line therapy|second-line therapy
566688|NCT00453180|Autistic Disorder|autistic disorder
566689|NCT00453180|Asperger's|asperger's
566690|NCT00453180|PDD NOS|pdd nos
566691|NCT00453180|Pervasive Developmental Disorder|pervasive developmental disorder
566692|NCT00453180|Autism|autism
566693|NCT00453180|N-acetylcysteine|n-acetylcysteine
566694|NCT00453180|acetylcysteine|acetylcysteine
566695|NCT00453180|NAC|nac
566696|NCT00453180|antioxidant|antioxidant
566697|NCT00453180|treatment|treatment
566698|NCT00453180|core symptoms|core symptoms
566699|NCT00453180|Autism Spectrum Disorders|autism spectrum disorders
566700|NCT00453180|Asperger's Disorder|asperger's disorder
566701|NCT00453180|Pervasive Developmental Disorder Not Otherwise Specified|pervasive developmental disorder not otherwise specified
566702|NCT00453180|Pervasive Developmental Disorders|pervasive developmental disorders
566703|NCT00453193|T-Cell Neoplasms|t-cell neoplasms
566704|NCT00453193|Alemtuzumab|alemtuzumab
566705|NCT00453193|Pentostatin|pentostatin
566706|NCT00453193|Campath-1H|campath-1h
566707|NCT00453193|Deoxycoformycin|deoxycoformycin
566708|NCT00453193|Lymphoma|lymphoma
566709|NCT00453193|Leukemia|leukemia
566710|NCT00453206|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
566711|NCT00453206|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
566712|NCT00453206|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
566713|NCT00453206|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
566714|NCT00453206|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
566715|NCT00453206|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
566716|NCT00453206|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
566717|NCT00453206|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
566718|NCT00453206|primary myelofibrosis|primary myelofibrosis
566719|NCT00453206|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
566720|NCT00453206|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
566721|NCT00453206|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
566722|NCT00453206|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
566723|NCT00453206|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
566724|NCT00453206|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
566725|NCT00453206|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
566726|NCT00453206|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
566727|NCT00453206|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
566728|NCT00453206|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
566729|NCT00453206|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
566730|NCT00453206|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
566731|NCT00453206|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
566732|NCT00453206|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
566733|NCT00453206|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
566734|NCT00453206|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
566735|NCT00453206|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
566736|NCT00453206|prolymphocytic leukemia|prolymphocytic leukemia
566737|NCT00453206|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
566738|NCT00453206|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
566739|NCT00453206|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
566740|NCT00453206|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
566741|NCT00453206|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
566742|NCT00453206|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
566743|NCT00453206|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
566744|NCT00453206|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
566745|NCT00453206|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
566746|NCT00453206|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
566747|NCT00453206|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
566748|NCT00453206|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
566749|NCT00453206|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
566750|NCT00453206|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
566751|NCT00453206|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
566752|NCT00453206|refractory multiple myeloma|refractory multiple myeloma
566753|NCT00453206|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
566754|NCT00453206|secondary acute myeloid leukemia|secondary acute myeloid leukemia
566755|NCT00453206|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
566756|NCT00453206|splenic marginal zone lymphoma|splenic marginal zone lymphoma
566757|NCT00453206|stage I multiple myeloma|stage i multiple myeloma
566758|NCT00453206|stage II multiple myeloma|stage ii multiple myeloma
566759|NCT00453206|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
566760|NCT00453206|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
566761|NCT00453206|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
566762|NCT00453206|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
566763|NCT00453206|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
566764|NCT00453206|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
566765|NCT00453206|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
566766|NCT00453206|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
566767|NCT00453206|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
566768|NCT00453206|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
566769|NCT00453206|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
566770|NCT00453206|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
566771|NCT00453206|stage III multiple myeloma|stage iii multiple myeloma
566772|NCT00453206|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
566773|NCT00453206|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
566774|NCT00453206|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
566775|NCT00453206|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
566776|NCT00453206|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
566777|NCT00453206|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
566778|NCT00453206|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
566779|NCT00453206|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
566780|NCT00453206|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
566781|NCT00453206|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
566782|NCT00453206|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
566783|NCT00453206|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
566784|NCT00453206|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
566785|NCT00453206|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
566786|NCT00453206|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
566787|NCT00453206|polycythemia vera|polycythemia vera
566788|NCT00453206|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
566789|NCT00453206|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
566790|NCT00453206|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
566791|NCT00453206|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
566792|NCT00453206|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
566793|NCT00453206|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
566794|NCT00453206|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
566795|NCT00453206|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
566796|NCT00453206|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
566797|NCT00453206|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
566798|NCT00453206|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
566799|NCT00453206|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
566800|NCT00453206|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
566801|NCT00453206|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
566802|NCT00453206|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
566803|NCT00453206|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
566804|NCT00453206|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
566805|NCT00453206|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
566806|NCT00453206|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
566807|NCT00453206|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
566808|NCT00453206|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
566809|NCT00453206|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
566810|NCT00453206|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
566811|NCT00453206|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
566812|NCT00453206|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
566813|NCT00453206|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
566814|NCT00453206|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
566815|NCT00453206|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
566816|NCT00453232|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
566817|NCT00453232|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
566818|NCT00453232|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
566819|NCT00453232|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
566820|NCT00453232|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
566821|NCT00453232|testicular choriocarcinoma|testicular choriocarcinoma
566822|NCT00453232|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
566823|NCT00453232|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
566824|NCT00453232|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
566825|NCT00453232|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
566826|NCT00453232|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
566827|NCT00453232|testicular embryonal carcinoma|testicular embryonal carcinoma
566828|NCT00453232|testicular seminoma|testicular seminoma
566829|NCT00453232|testicular yolk sac tumor|testicular yolk sac tumor
566830|NCT00453232|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
566831|NCT00453232|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
566832|NCT00453232|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
566833|NCT00453232|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
566834|NCT00453232|recurrent extragonadal seminoma|recurrent extragonadal seminoma
566835|NCT00453232|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
566836|NCT00453232|stage IV extragonadal seminoma|stage iv extragonadal seminoma
566837|NCT00453232|adult teratoma|adult teratoma
566838|NCT00453232|testicular immature teratoma|testicular immature teratoma
566839|NCT00453232|testicular mature teratoma|testicular mature teratoma
566840|NCT00453232|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
566841|NCT00453258|ocular proteomics|ocular proteomics
566842|NCT00453258|eye disease|eye disease
566843|NCT00453258|proteomics|proteomics
566844|NCT00453271|chronic persistent infection of the nail bed or plate|chronic persistent infection of the nail bed or plate
566845|NCT00453297|Bionovo|bionovo
566846|NCT00453297|MF101|mf101
566847|NCT00453297|Herbs|herbs
566848|NCT00453297|The primary goal of this study is to identify the highest safe oral dose of MF101 that is well tolerated in humans.|the primary goal of this study is to identify the highest safe oral dose of mf101 that is well tolerated in humans.
566849|NCT00453310|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
566850|NCT00453310|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
566851|NCT00453310|ovarian choriocarcinoma|ovarian choriocarcinoma
566852|NCT00453310|ovarian immature teratoma|ovarian immature teratoma
566853|NCT00453310|ovarian mature teratoma|ovarian mature teratoma
566854|NCT00453310|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
566855|NCT00453310|testicular choriocarcinoma|testicular choriocarcinoma
566856|NCT00453310|testicular seminoma|testicular seminoma
566857|NCT00453310|testicular yolk sac tumor|testicular yolk sac tumor
566858|NCT00453310|ovarian dysgerminoma|ovarian dysgerminoma
566859|NCT00453310|ovarian embryonal carcinoma|ovarian embryonal carcinoma
566860|NCT00453310|ovarian yolk sac tumor|ovarian yolk sac tumor
566861|NCT00453310|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
566862|NCT00453310|ovarian polyembryoma|ovarian polyembryoma
566863|NCT00453310|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
566864|NCT00453310|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
566865|NCT00453310|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
566866|NCT00453310|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
585624|NCT00513422|Osteoarthritis, knee|osteoarthritis, knee
566867|NCT00453310|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
566868|NCT00453310|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
566869|NCT00453310|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
566870|NCT00453310|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
566871|NCT00453310|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
566872|NCT00453310|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
566873|NCT00453310|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
566874|NCT00453310|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
566875|NCT00453310|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
566876|NCT00453310|testicular embryonal carcinoma|testicular embryonal carcinoma
566877|NCT00453310|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
566878|NCT00453310|recurrent extragonadal seminoma|recurrent extragonadal seminoma
566879|NCT00453310|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
566880|NCT00453310|stage IV extragonadal seminoma|stage iv extragonadal seminoma
566881|NCT00453310|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
732485|NCT01095588|ED|ed
566882|NCT00453310|testicular immature teratoma|testicular immature teratoma
566883|NCT00453310|testicular mature teratoma|testicular mature teratoma
566884|NCT00453310|adult teratoma|adult teratoma
566885|NCT00453323|Esophageal Cancer|esophageal cancer
566886|NCT00453323|Phase II|phase ii
566887|NCT00453323|Metastatic esophageal cancer|metastatic esophageal cancer
566888|NCT00453323|Recurrent esophageal cancer|recurrent esophageal cancer
566889|NCT00453336|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
566890|NCT00453336|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
566891|NCT00453336|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
566892|NCT00453336|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
566893|NCT00453336|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
566894|NCT00453336|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
566895|NCT00453336|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
566896|NCT00453336|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
566897|NCT00453336|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
566898|NCT00453336|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
566899|NCT00453336|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
566900|NCT00453336|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
566901|NCT00453336|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
566902|NCT00453336|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
753188|NCT01175811|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
566903|NCT00453336|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
566904|NCT00453336|oral leukoplakia|oral leukoplakia
566905|NCT00453349|Uncomplicated pelvic inflammatory disease|uncomplicated pelvic inflammatory disease
566906|NCT00453362|NSCLC|nsclc
566907|NCT00453362|Tarceva|tarceva
566908|NCT00453362|Positron emission technology|positron emission technology
566909|NCT00453362|PET|pet
566910|NCT00453362|Computerized tomography|computerized tomography
566911|NCT00453362|CT|ct
566912|NCT00453375|Diabetic|diabetic
566913|NCT00453375|Diabetes|diabetes
566914|NCT00453375|Type 1 Diabetes|type 1 diabetes
566915|NCT00453375|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
566916|NCT00453375|autoimmune disease|autoimmune disease
566917|NCT00453401|cold sore|cold sore
566918|NCT00453414|PAH|pah
566919|NCT00453414|Pediatric|pediatric
566920|NCT00453414|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
566921|NCT00453427|PTL NOS|ptl nos
566922|NCT00453427|AILD|aild
566923|NCT00453427|NHL|nhl
566924|NCT00453427|CHOP|chop
566925|NCT00453440|HIV|hiv
566926|NCT00453440|HLA-B*5701|hla-b*5701
566927|NCT00453440|Abacavir hypersensitivity reaction|abacavir hypersensitivity reaction
566928|NCT00453453|Congestive heart failure|congestive heart failure
566929|NCT00453453|observation unit|observation unit
566930|NCT00453453|nesiritide|nesiritide
566931|NCT00453466|women experiencing domestic violence|women experiencing domestic violence
566932|NCT00453479|Chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
566933|NCT00453479|muscarinic receptor,|muscarinic receptor,
566934|NCT00453479|bronchodilators|bronchodilators
566935|NCT00453505|Transcranial Direct Current Stimulation (TDCS)|transcranial direct current stimulation (tdcs)
566936|NCT00453505|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
566937|NCT00453505|Peripheral Nerve Stimulation|peripheral nerve stimulation
566938|NCT00453505|Primary Motor Cortex|primary motor cortex
566939|NCT00453505|Corticomotor Excitability|corticomotor excitability
566940|NCT00453505|Healthy Volunteer|healthy volunteer
566941|NCT00453505|HV|hv
566942|NCT00453518|SVG|svg
566943|NCT00453518|Saphenous Vein Graft|saphenous vein graft
566944|NCT00453518|Embolic Protection|embolic protection
566945|NCT00453518|Distal Protection|distal protection
566946|NCT00453518|EPD|epd
566947|NCT00453518|FiberNet|fibernet
566948|NCT00453518|Saphenous Vein Graft intervention|saphenous vein graft intervention
566949|NCT00453531|Forearm Ischemia|forearm ischemia
566950|NCT00453531|Endothelial Function|endothelial function
566951|NCT00453531|Acetyicholine Vasodilation|acetyicholine vasodilation
566952|NCT00453531|Venous Plethysmography|venous plethysmography
566953|NCT00453531|Healthy Volunteer|healthy volunteer
566954|NCT00453531|HV|hv
566955|NCT00453544|computer assisted instruction|computer assisted instruction
566956|NCT00453544|decision making|decision making
566957|NCT00453544|educational resource design /development|educational resource design /development
566958|NCT00453544|executive function|executive function
566959|NCT00453557|growth hormone, obesity, visceral adiposity|growth hormone, obesity, visceral adiposity
566960|NCT00453570|Diphteria|diphteria
566491|NCT00452348|ADVAIR|advair
566961|NCT00453570|Tetanus|tetanus
566962|NCT00453570|Haemophilus influenzae type b|haemophilus influenzae type b
566963|NCT00453570|Poliomyelitis|poliomyelitis
566964|NCT00453570|Pertussis|pertussis
566965|NCT00453583|Pediatric|pediatric
566966|NCT00453583|Allergies|allergies
566967|NCT00453583|Antihistamines|antihistamines
566968|NCT00453583|Non-interventional|non-interventional
566969|NCT00453596|infertile women|infertile women
566970|NCT00453596|thin endometrial thickness|thin endometrial thickness
566971|NCT00453596|implantation failure|implantation failure
566972|NCT00453609|Bipolar Disorders|bipolar disorders
566973|NCT00453609|Schizophrenia|schizophrenia
566974|NCT00453609|Schizoaffective Disorders|schizoaffective disorders
566975|NCT00453609|Alcohol Dependence|alcohol dependence
566976|NCT00453609|Long-lasting injectable naltrexone|long-lasting injectable naltrexone
566977|NCT00453622|Heart Failure|heart failure
566978|NCT00453622|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
566979|NCT00453622|Risk stratification|risk stratification
566980|NCT00453622|Prediction|prediction
566981|NCT00453622|Proteomics|proteomics
566982|NCT00453622|Chemokine|chemokine
566983|NCT00453622|cardiac enzymes|cardiac enzymes
566984|NCT00453622|Brain Natriuretic Peptide|brain natriuretic peptide
566985|NCT00453635|Cancer|cancer
566986|NCT00453635|Breast cancer|breast cancer
566987|NCT00453635|First line treatment|first line treatment
566988|NCT00453635|Docetaxel|docetaxel
566989|NCT00453635|Carboplatin|carboplatin
566990|NCT00453635|Herceptin|herceptin
566991|NCT00453635|Vinorelbine|vinorelbine
566992|NCT00453648|stable isotopes|stable isotopes
566993|NCT00453648|vitamin A|vitamin a
566994|NCT00453648|beta-carotene|beta-carotene
566995|NCT00453648|orange-fleshed sweet potatoes|orange-fleshed sweet potatoes
566996|NCT00453648|iron|iron
566997|NCT00453648|zinc|zinc
566998|NCT00453648|absorption|absorption
566999|NCT00453648|bioavailability|bioavailability
567000|NCT00453648|vitamin A equivalency|vitamin a equivalency
567001|NCT00453648|Bangladesh|bangladesh
567002|NCT00453648|women|women
567003|NCT00453661|Breast Cancer|breast cancer
567004|NCT00453661|Cervical Cancer|cervical cancer
567005|NCT00453661|Prostate Cancer|prostate cancer
567006|NCT00453661|Colorectal Cancer|colorectal cancer
567007|NCT00453661|Lung Cancer|lung cancer
567008|NCT00453661|Cancer Prevention|cancer prevention
567009|NCT00453661|Treatment Demonstration for Ethnic and Racial Minorities|treatment demonstration for ethnic and racial minorities
567010|NCT00453661|Centers for Medicare and Medicaid Services|centers for medicare and medicaid services
567011|NCT00453661|CMS|cms
567012|NCT00453661|Hispanic American|hispanic american
567013|NCT00453661|Cancer Screening Assessment|cancer screening assessment
567014|NCT00453661|Annual Questionnaire|annual questionnaire
567015|NCT00453661|Patient Navigator|patient navigator
567016|NCT00453661|Educational Materials|educational materials
567017|NCT00453674|Adrenal cancer|adrenal cancer
567018|NCT00453674|Treatment|treatment
567019|NCT00453674|Surgery|surgery
567020|NCT00453674|Mitotane|mitotane
567021|NCT00453687|COPD|copd
567022|NCT00453687|GSK233705,|gsk233705,
567023|NCT00453687|Magnesium Stearate,|magnesium stearate,
567024|NCT00453700|chagas|chagas
567025|NCT00453700|trypanosoma cruzi|trypanosoma cruzi
567026|NCT00453713|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
567027|NCT00453713|Interstitial lung disease|interstitial lung disease
567028|NCT00453713|Diffuse parenchymal lung disease|diffuse parenchymal lung disease
567029|NCT00453713|Health disparities|health disparities
567030|NCT00453726|Natriuretic peptide brain|natriuretic peptide brain
567031|NCT00453726|Continuous positive airway pressure|continuous positive airway pressure
567032|NCT00453726|Intermittent positive pressure breathing|intermittent positive pressure breathing
567033|NCT00453726|Respiratory insufficiency|respiratory insufficiency
567034|NCT00453752|systemic sclerosis|systemic sclerosis
567035|NCT00453752|pulmonary hypertension|pulmonary hypertension
567036|NCT00453752|echocardiography|echocardiography
567037|NCT00453752|N-Terminal proBNP|n-terminal probnp
567038|NCT00453765|cough|cough
567039|NCT00453765|hyperreactivity|hyperreactivity
567040|NCT00453765|montelukast|montelukast
567041|NCT00453778|mild asthma|mild asthma
567042|NCT00453778|FLIXOTIDE|flixotide
567043|NCT00453778|methacholine|methacholine
567044|NCT00453778|bronchial challenge|bronchial challenge
567045|NCT00453778|leukotriene D4|leukotriene d4
567046|NCT00453791|GW805858|gw805858
567047|NCT00453791|MDI|mdi
567048|NCT00453791|asthma|asthma
567049|NCT00453791|surfactant|surfactant
567050|NCT00453804|Alcohol dependence|alcohol dependence
567051|NCT00453804|Major Mental Illness|major mental illness
567052|NCT00453804|Injectable naltrexone|injectable naltrexone
567053|NCT00453817|islet transplantation|islet transplantation
567054|NCT00453817|imaging|imaging
567055|NCT00453817|graft monitoring|graft monitoring
567056|NCT00453817|magnetic resonance imaging|magnetic resonance imaging
567057|NCT00453830|Diverticulitis; laparoscopy; short term outcome|diverticulitis; laparoscopy; short term outcome
567058|NCT00453843|Stroke|stroke
567059|NCT00453843|movement therapy|movement therapy
567060|NCT00453843|robotics|robotics
567061|NCT00453843|rehabilitation robotics|rehabilitation robotics
567062|NCT00453843|shoulder, elbow, wrist|shoulder, elbow, wrist
567063|NCT00453856|Malaria|malaria
567064|NCT00453856|Sulfadoxine|sulfadoxine
567065|NCT00453856|Pyrimethamine|pyrimethamine
567066|NCT00453856|Resistance|resistance
567067|NCT00453856|Gabon|gabon
567068|NCT00453869|Liver fibrosis|liver fibrosis
567069|NCT00453869|Hepatitis B virus and C virus|hepatitis b virus and c virus
567070|NCT00453869|FibroMeter|fibrometer
567071|NCT00453869|FibroScan®|fibroscan®
567072|NCT00453895|Adrenal cancer refractory to cytotoxic therapy|adrenal cancer refractory to cytotoxic therapy
567073|NCT00453895|Sunitinib|sunitinib
567074|NCT00453895|Multitargeted tyrosine-kinase inhibitor|multitargeted tyrosine-kinase inhibitor
567075|NCT00453921|TBI|tbi
567076|NCT00453921|Memory|memory
567077|NCT00453921|Methylphenidate|methylphenidate
567078|NCT00453921|Ritalin|ritalin
567079|NCT00453921|Memory and Attention Training|memory and attention training
567080|NCT00453934|Diabetes|diabetes
567081|NCT00453934|Type 1 Diabetes|type 1 diabetes
567082|NCT00453934|Type 2 Diabetes|type 2 diabetes
567083|NCT00453934|Physiologic Insulin|physiologic insulin
567084|NCT00453934|Basal Insulin|basal insulin
567085|NCT00453934|Bolus Insulin|bolus insulin
567086|NCT00453934|Mealtime insulin|mealtime insulin
567087|NCT00453934|Insulin patch|insulin patch
567088|NCT00453934|Multiple daily injections|multiple daily injections
567089|NCT00453960|Endometrial hyperplasia|endometrial hyperplasia
567090|NCT00453960|Genistein|genistein
567091|NCT00453960|Isoflavones|isoflavones
567092|NCT00453960|dysfunctional uterine bleeding|dysfunctional uterine bleeding
567093|NCT00453973|anemia|anemia
567094|NCT00453973|chronic kidney disease|chronic kidney disease
567095|NCT00453973|CKD|ckd
567096|NCT00453973|chronic renal failure|chronic renal failure
567097|NCT00453973|CRF|crf
567098|NCT00453973|dialysis|dialysis
567099|NCT00453973|erythropoietin|erythropoietin
567100|NCT00453973|EPO|epo
567101|NCT00453973|erythropoiesis stimulating agent|erythropoiesis stimulating agent
567102|NCT00453973|ESA|esa
567104|NCT00453973|hemodialysis|hemodialysis
567105|NCT00453973|hemoglobin|hemoglobin
567106|NCT00453973|Hb|hb
567107|NCT00453973|Hgb|hgb
567108|NCT00453973|Omontys|omontys
567109|NCT00453973|peginesatide|peginesatide
567110|NCT00453973|red blood cell|red blood cell
567111|NCT00453973|red blood cell production|red blood cell production
567112|NCT00453986|immunogenicity|immunogenicity
567113|NCT00453986|Meningococcal serogroups A, C, W-135 and/or Y disease|meningococcal serogroups a, c, w-135 and/or y disease
567114|NCT00453986|co-administration|co-administration
567115|NCT00453986|meningococcal vaccine|meningococcal vaccine
567116|NCT00453986|lot-to-lot consistency|lot-to-lot consistency
567117|NCT00453986|conjugate vaccine|conjugate vaccine
567118|NCT00453999|influenza|influenza
567119|NCT00453999|flu|flu
567120|NCT00454012|non reassuring fetal heart rate tracing|non reassuring fetal heart rate tracing
567121|NCT00454012|biophysical profile|biophysical profile
567122|NCT00454012|assessing fetal wellbeing|assessing fetal wellbeing
567123|NCT00454025|glaucoma|glaucoma
567124|NCT00454025|intraocular pressure|intraocular pressure
567125|NCT00454025|postural changes|postural changes
567126|NCT00454038|cystectomy|cystectomy
567127|NCT00454038|augmentation|augmentation
567128|NCT00454038|sinus|sinus
567129|NCT00454038|amputation|amputation
567130|NCT00454038|implant|implant
567131|NCT00454051|Asthma, anti-immunoglobulin E, omalizumab, IgE receptors|asthma, anti-immunoglobulin e, omalizumab, ige receptors
567132|NCT00454064|cognitive-behavioral therapy|cognitive-behavioral therapy
567133|NCT00454064|back pain|back pain
567134|NCT00454064|low back pain|low back pain
567135|NCT00454064|biofeedback|biofeedback
567136|NCT00454064|randomized controlled study|randomized controlled study
567137|NCT00454064|EMG biofeedback|emg biofeedback
567138|NCT00454077|thyroid cancer; rhTSH; thyroid ablation|thyroid cancer; rhtsh; thyroid ablation
567139|NCT00454090|Advanced Malignancies|advanced malignancies
567140|NCT00454103|adrenocortical carcinoma (ACC)|adrenocortical carcinoma (acc)
567141|NCT00454103|adrenal tumor|adrenal tumor
567142|NCT00454103|metastastic adrenocortical carcinoma|metastastic adrenocortical carcinoma
567143|NCT00454116|Colon Cancer|colon cancer
567144|NCT00454116|Rectal Cancer|rectal cancer
567145|NCT00454129|Feasibilty of cholangiography via double-balloon enteroscopy|feasibilty of cholangiography via double-balloon enteroscopy
567146|NCT00454155|HSCT|hsct
567147|NCT00454155|AGVHD|agvhd
567148|NCT00454155|Myeloablative|myeloablative
567149|NCT00454155|Allogeneic|allogeneic
567150|NCT00454155|Hematopoietic|hematopoietic
567151|NCT00454155|Stem|stem
567152|NCT00454155|Cell|cell
567153|NCT00454155|Transplantation|transplantation
567154|NCT00454168|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
566665|NCT00453089|Symptoms|symptoms
567155|NCT00454168|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
567156|NCT00454168|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
567157|NCT00454168|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
567158|NCT00454168|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
567159|NCT00454168|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
567160|NCT00454168|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
567161|NCT00454168|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
567162|NCT00454168|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
567163|NCT00454168|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
567164|NCT00454168|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
567165|NCT00454168|secondary acute myeloid leukemia|secondary acute myeloid leukemia
567166|NCT00454168|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
567167|NCT00454168|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
567168|NCT00454168|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
567169|NCT00454168|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
567170|NCT00454168|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
567171|NCT00454181|human immunodeficiency virus|human immunodeficiency virus
567172|NCT00454181|human papilloma virus|human papilloma virus
567173|NCT00454181|warts, oral|warts, oral
567174|NCT00454181|papillomatosis|papillomatosis
567175|NCT00454181|treatment experienced|treatment experienced
567176|NCT00454194|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
567177|NCT00454194|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
567178|NCT00454194|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
567179|NCT00454194|adenosquamous cell lung cancer|adenosquamous cell lung cancer
567180|NCT00454194|adenocarcinoma of the lung|adenocarcinoma of the lung
567181|NCT00454207|Pulmonary Arterial Hypertension, PAH|pulmonary arterial hypertension, pah
567182|NCT00454233|Diabetes Mellitus Type 2|diabetes mellitus type 2
567183|NCT00454233|YM543|ym543
567184|NCT00454233|Treatment|treatment
567185|NCT00454233|Safety|safety
567186|NCT00454233|efficacy|efficacy
567187|NCT00454259|Postoperative Hyperalgesia|postoperative hyperalgesia
567188|NCT00454259|Human volunteer|human volunteer
567189|NCT00454259|Fentanyl|fentanyl
567190|NCT00454259|Randomized Controlled Trial|randomized controlled trial
567191|NCT00454259|Pain chronicisation|pain chronicisation
567192|NCT00454259|Predictive test|predictive test
567193|NCT00454272|febrile|febrile
567194|NCT00454272|neutropenia|neutropenia
567195|NCT00454272|cancer|cancer
567196|NCT00454272|Gram positive infection|gram positive infection
567197|NCT00454285|bacteremia,cultures, infective endocarditis, prophylaxis|bacteremia,cultures, infective endocarditis, prophylaxis
567198|NCT00454298|Severe Osteoarthritis|severe osteoarthritis
567199|NCT00454298|Arthritis|arthritis
567200|NCT00454311|Pregnancy and implantation rates|pregnancy and implantation rates
567201|NCT00454311|Efficiency and accuracy of the genetic testing|efficiency and accuracy of the genetic testing
567202|NCT00454324|Lung cancer|lung cancer
567203|NCT00454324|Small cell lung cancer|small cell lung cancer
567204|NCT00454324|Abraxane|abraxane
567205|NCT00454324|Paclitaxel|paclitaxel
567206|NCT00454324|Carboplatin|carboplatin
567207|NCT00454324|Phase II|phase ii
567208|NCT00454324|Randomized|randomized
567209|NCT00454324|Lineberger|lineberger
567210|NCT00454324|LCCC|lccc
567211|NCT00454337|HIV-1 infection|hiv-1 infection
567212|NCT00454337|enfuvirtide|enfuvirtide
567213|NCT00454337|raltegravir|raltegravir
567214|NCT00454337|treatment experienced|treatment experienced
567215|NCT00454350|Hectorol (doxercalciferol injection)|hectorol (doxercalciferol injection)
567216|NCT00454350|Zemplar (paricalcitol injection)|zemplar (paricalcitol injection)
585625|NCT00513422|Glucosamine|glucosamine
567217|NCT00454376|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
567218|NCT00454376|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
567219|NCT00454376|pulmonary carcinoid tumor|pulmonary carcinoid tumor
567220|NCT00454376|gastrinoma|gastrinoma
567221|NCT00454376|insulinoma|insulinoma
567222|NCT00454376|WDHA syndrome|wdha syndrome
567223|NCT00454376|pancreatic polypeptide tumor|pancreatic polypeptide tumor
567224|NCT00454376|somatostatinoma|somatostatinoma
567225|NCT00454376|glucagonoma|glucagonoma
567226|NCT00454376|liver metastases|liver metastases
567227|NCT00454389|Macular|macular
567228|NCT00454389|Degeneration|degeneration
567229|NCT00454389|AMD|amd
567230|NCT00454389|Wet Age-Related macular degeneration|wet age-related macular degeneration
567231|NCT00454415|Diet|diet
567232|NCT00454415|Body Mass Index|body mass index
567233|NCT00454415|BMI|bmi
567234|NCT00454428|Bypass Surgery|bypass surgery
567235|NCT00454428|Coronary Artery|coronary artery
567236|NCT00454441|Sleep Quality|sleep quality
567237|NCT00454441|Menopausal Symptoms|menopausal symptoms
567238|NCT00454441|Actigraph|actigraph
567239|NCT00454441|Bionovo|bionovo
567240|NCT00454441|MF101|mf101
567241|NCT00454454|memory|memory
567242|NCT00454454|display enhanced testing|display enhanced testing
567243|NCT00454480|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
567244|NCT00454480|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
567245|NCT00454480|secondary acute myeloid leukemia|secondary acute myeloid leukemia
567246|NCT00454480|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
567247|NCT00454480|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
567248|NCT00454480|refractory anemia with excess blasts|refractory anemia with excess blasts
567249|NCT00454480|adult acute basophilic leukemia|adult acute basophilic leukemia
567250|NCT00454480|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
567251|NCT00454480|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
567252|NCT00454480|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
567253|NCT00454480|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
567254|NCT00454480|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
567255|NCT00454480|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
567256|NCT00454480|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
567257|NCT00454480|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
567258|NCT00454480|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
567259|NCT00454480|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
567260|NCT00454480|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
567261|NCT00454480|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
567262|NCT00454480|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
567263|NCT00454480|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
567264|NCT00454480|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
567265|NCT00454493|omacor|omacor
567266|NCT00454493|fish oil|fish oil
567267|NCT00454493|omega 3|omega 3
567268|NCT00454493|fatty acids|fatty acids
567269|NCT00454493|coronary artery disease|coronary artery disease
567270|NCT00454493|endothelial function|endothelial function
753189|NCT01175811|Glargine|glargine
567271|NCT00454493|heart rate variability|heart rate variability
567272|NCT00454493|carotid intimal media thickness|carotid intimal media thickness
567273|NCT00454493|QT dispersion|qt dispersion
567274|NCT00454519|peritoneal carcinomatosis|peritoneal carcinomatosis
567275|NCT00454519|cisplatin|cisplatin
567276|NCT00454519|mitomycin|mitomycin
567277|NCT00454519|gastric cancer|gastric cancer
567278|NCT00454519|colorectal cancer|colorectal cancer
567279|NCT00454532|Breast Cancer|breast cancer
567280|NCT00454532|Bionovo|bionovo
567281|NCT00454532|BZL101|bzl101
567282|NCT00454532|Chinese Herbs|chinese herbs
567283|NCT00454558|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
567284|NCT00454558|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
567285|NCT00441727|Peptic ulcer|peptic ulcer
567286|NCT00441727|low-dose ASA|low-dose asa
567287|NCT00441740|NSCLC|nsclc
567288|NCT00441740|1st line treatment|1st line treatment
567289|NCT00441740|Gemcitabine|gemcitabine
567290|NCT00441740|Vinorelbine|vinorelbine
567291|NCT00441740|Docetaxel|docetaxel
567292|NCT00441779|Microchimerism|microchimerism
567293|NCT00441779|Injuries|injuries
567294|NCT00441779|Burns|burns
567295|NCT00441779|Orthopedic Surgery|orthopedic surgery
567296|NCT00441779|Leukocytes|leukocytes
567297|NCT00441792|Sepsis|sepsis
567298|NCT00441792|Etomidate|etomidate
567299|NCT00441792|midazolam|midazolam
567300|NCT00441792|ketamine|ketamine
567301|NCT00441805|Acne|acne
567302|NCT00441805|RadioFrequency|radiofrequency
567303|NCT00447187|corneal graft failure|corneal graft failure
567304|NCT00447187|corneal graft rejection|corneal graft rejection
567305|NCT00447187|corneal transplant rejection|corneal transplant rejection
567306|NCT00447200|Stroke volume|stroke volume
567307|NCT00447200|SV variation|sv variation
567308|NCT00447200|Esophagus Doppler|esophagus doppler
567309|NCT00447200|Goal Directed Therapy|goal directed therapy
567310|NCT00447226|Ovarian Cancer|ovarian cancer
567311|NCT00447226|Bladder Cancer|bladder cancer
567312|NCT00447226|ErbB2 positive|erbb2 positive
567313|NCT00447226|Lapatinib|lapatinib
567314|NCT00447226|Gastric/Esophageal Cancer|gastric/esophageal cancer
567315|NCT00447226|Uterine Serous Papillary Cancer|uterine serous papillary cancer
567316|NCT00447239|mechanical ventilated|mechanical ventilated
567317|NCT00447239|surgical patients|surgical patients
567318|NCT00447239|pneumonia|pneumonia
567319|NCT00447239|blood glucose|blood glucose
567320|NCT00447239|insulin infusion|insulin infusion
567321|NCT00447239|hospital stay|hospital stay
567322|NCT00447252|bereavement|bereavement
567323|NCT00447252|grief|grief
567324|NCT00447291|Overweight|overweight
567325|NCT00447291|Obesity|obesity
567326|NCT00447291|Fish Oil|fish oil
567327|NCT00447304|acute cholecystitis|acute cholecystitis
567328|NCT00447304|cholecystectomy|cholecystectomy
567329|NCT00447304|antibiotic treatment|antibiotic treatment
567330|NCT00447304|moxifloxacin|moxifloxacin
567331|NCT00447304|intraabdominal infection|intraabdominal infection
567332|NCT00447304|morbidity and mortality of patients with acute cholecystitis, early surgery versus conservative therapy|morbidity and mortality of patients with acute cholecystitis, early surgery versus conservative therapy
567333|NCT00447317|peritoneal dialysis|peritoneal dialysis
567334|NCT00447317|diet|diet
567335|NCT00447317|sodium|sodium
567336|NCT00447330|metastatic esophagogastric adenocarcinomas|metastatic esophagogastric adenocarcinomas
567337|NCT00447330|ESOPHAGEAL CANCER|esophageal cancer
567338|NCT00447330|GASTRIC CANCER|gastric cancer
567339|NCT00447330|ADENOCARCINOMA|adenocarcinoma
567340|NCT00447330|TARGTED THERAPY|targted therapy
567341|NCT00447330|BEVACIZUMAB|bevacizumab
567342|NCT00447330|CAPECITBAINE|capecitbaine
567343|NCT00447330|OXALIPLATIN|oxaliplatin
567344|NCT00447330|METASTATIC|metastatic
567345|NCT00447343|Functional MRI|functional mri
567346|NCT00447343|Cervical myelopathy|cervical myelopathy
567347|NCT00447343|Cervical radiculopathy|cervical radiculopathy
567348|NCT00447343|Brain plasticity and regeneration|brain plasticity and regeneration
567349|NCT00447369|pregabalin|pregabalin
567350|NCT00447369|Valproic acid|valproic acid
567351|NCT00447369|migraine|migraine
567352|NCT00447369|prophylaxis|prophylaxis
567353|NCT00447369|prevention|prevention
567354|NCT00447369|treatment|treatment
567355|NCT00447408|hemodialysis|hemodialysis
567356|NCT00447408|dietary adherence|dietary adherence
567357|NCT00447408|sodium|sodium
567358|NCT00447434|Nattokinase|nattokinase
567359|NCT00447434|fibrinolytic factors|fibrinolytic factors
567360|NCT00447434|blood lipids|blood lipids
567361|NCT00447434|nutrimental supplement|nutrimental supplement
567362|NCT00447460|Graft-vs-host disease (GVHD)|graft-vs-host disease (gvhd)
567363|NCT00447460|Mesenchymal stem cell (MSC)|mesenchymal stem cell (msc)
567364|NCT00447460|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
567365|NCT00447460|Allotransplant|allotransplant
567366|NCT00447460|Allogenic|allogenic
567367|NCT00447460|Refractory|refractory
567368|NCT00447460|CSM/EICH2005|csm/eich2005
567369|NCT00447473|Prostate Cancer|prostate cancer
753190|NCT01175811|Diabetes Mellitus|diabetes mellitus
567370|NCT00447473|progressive hormone refractory prostate cancer|progressive hormone refractory prostate cancer
567371|NCT00447486|Osteoarthritis,|osteoarthritis,
567372|NCT00447486|knee,|knee,
567373|NCT00447486|GW842166,|gw842166,
567376|NCT00447486|safety|safety
567377|NCT00447499|Acromegaly|acromegaly
567378|NCT00447499|Somatostatin Analogs|somatostatin analogs
567379|NCT00447499|Somatuline® Autogel®|somatuline® autogel®
567380|NCT00447499|lanreotide|lanreotide
567381|NCT00447499|growth hormone|growth hormone
567382|NCT00447499|IGF-1|igf-1
567383|NCT00447499|Inappropriate Growth Hormone Secretion Syndrome|inappropriate growth hormone secretion syndrome
567384|NCT00447499|Somatotropin Hypersecretion Syndrome|somatotropin hypersecretion syndrome
567385|NCT00447499|Inappropriate GH Secretion Syndrome|inappropriate gh secretion syndrome
567386|NCT00447525|Prevention of : Diphtheria, Tetanus and Poliomyelitis|prevention of : diphtheria, tetanus and poliomyelitis
567387|NCT00447551|Aesthetic facial volume enhancement|aesthetic facial volume enhancement
567388|NCT00454584|Psoriasis|psoriasis
567389|NCT00454584|CNTO 1275|cnto 1275
567390|NCT00454584|Etanercept|etanercept
567391|NCT00454584|Immune diorder|immune diorder
567392|NCT00454584|Skin disorder|skin disorder
567393|NCT00454610|Pediatric|pediatric
567394|NCT00454610|Overweight|overweight
567395|NCT00454610|Obesity|obesity
567396|NCT00454610|Intervention|intervention
567397|NCT00454610|Prevention|prevention
567398|NCT00454610|Mexican American|mexican american
567399|NCT00454623|Adiponectin|adiponectin
567400|NCT00454623|diabetes|diabetes
567401|NCT00454623|metabolism|metabolism
585626|NCT00513422|Chondroitin|chondroitin
567402|NCT00454623|Adiponectin levels|adiponectin levels
567403|NCT00454649|axitinib|axitinib
567404|NCT00454649|chemotherapy|chemotherapy
567405|NCT00454649|anti-angiogenesis|anti-angiogenesis
567406|NCT00454649|VEGF inhibition|vegf inhibition
567407|NCT00454662|Elderly|elderly
567408|NCT00454662|Hypertension|hypertension
567409|NCT00454662|Cardiovascular Diseases|cardiovascular diseases
567410|NCT00454662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
567411|NCT00454662|Calcium Channel Blockers|calcium channel blockers
567412|NCT00454662|Diuretics|diuretics
567413|NCT00454662|Combination Drug Therapy|combination drug therapy
567414|NCT00454662|Diabetes|diabetes
567415|NCT00454675|Smokers|smokers
567416|NCT00454675|Chronic Bronchitis|chronic bronchitis
567417|NCT00454675|Pulmonary Function Test Abnormalities|pulmonary function test abnormalities
567418|NCT00454675|COPD|copd
567419|NCT00454688|Irritable Bowel Syndrome|irritable bowel syndrome
567420|NCT00454688|Asimadoline|asimadoline
733197|NCT01098708|DMD|dmd
567421|NCT00454701|Psoriasis|psoriasis
567422|NCT00454701|Alefacept|alefacept
567423|NCT00454701|Amevive®|amevive®
567424|NCT00454701|Drug exposure|drug exposure
567425|NCT00454740|Urinary Bladder, Overactive|urinary bladder, overactive
567426|NCT00454740|Urgency|urgency
567427|NCT00454740|VESIcare®|vesicare®
567428|NCT00454740|Solifenacin succinate|solifenacin succinate
567429|NCT00454753|Myeloid, Chronic|myeloid, chronic
567430|NCT00454753|Lymphocytic, Acute|lymphocytic, acute
567431|NCT00454766|Patient Education|patient education
567432|NCT00454766|Cervical Dysplasia|cervical dysplasia
567433|NCT00454766|Questionnaire|questionnaire
567434|NCT00454779|SCCHNC|scchnc
567435|NCT00454779|Metastatic|metastatic
567436|NCT00454779|Recurrent|recurrent
567437|NCT00454792|Low back pain|low back pain
567438|NCT00454792|Modic changes|modic changes
567439|NCT00454805|Advanced Breast Cancer|advanced breast cancer
567440|NCT00454831|Hypercholesterolemia|hypercholesterolemia
567441|NCT00454831|LDL-cholesterol|ldl-cholesterol
567442|NCT00454831|chitosan|chitosan
567443|NCT00454831|HEP-40|hep-40
567444|NCT00454857|Thrombocytopenia|thrombocytopenia
567445|NCT00454857|Chart Review|chart review
567446|NCT00454857|Platelet|platelet
567447|NCT00454857|Retrospective|retrospective
567448|NCT00454857|Prospective|prospective
567449|NCT00454857|Non-interventional|non-interventional
567450|NCT00454857|Health Resource Utilization (HRU)|health resource utilization (hru)
567451|NCT00454857|Quality of Life (QOL)|quality of life (qol)
567452|NCT00454857|Immune Thrombocytopenic Purpura (ITP)|immune thrombocytopenic purpura (itp)
567453|NCT00454857|Idiopathic Thrombocytopenic Purpura (ITP)|idiopathic thrombocytopenic purpura (itp)
567454|NCT00454857|Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|immune (idiopathic) thrombocytopenic purpura (itp)
567455|NCT00454857|Observational|observational
567456|NCT00454870|Alzheimer's Disease|alzheimer's disease
567457|NCT00454870|Cognition|cognition
567458|NCT00454870|Cognitive impairment|cognitive impairment
567459|NCT00454883|Safety of ziprasidone, efficacy of ziprasidone, manic episodes in bipolar disorder, mixed episodes in bipolar disorder, schizoaffective disorder.|safety of ziprasidone, efficacy of ziprasidone, manic episodes in bipolar disorder, mixed episodes in bipolar disorder, schizoaffective disorder.
567460|NCT00454896|Urinary Bladder, Overactive|urinary bladder, overactive
567461|NCT00454896|Urgency|urgency
567462|NCT00454896|VESIcare®|vesicare®
567463|NCT00454896|Solifenacin succinate|solifenacin succinate
567464|NCT00454909|Meningococcal Serogroups A, C, W-135 and/or Y Disease|meningococcal serogroups a, c, w-135 and/or y disease
567465|NCT00454922|glaucoma|glaucoma
567466|NCT00454922|patient educator|patient educator
567467|NCT00454935|epilepsy|epilepsy
567468|NCT00454935|glioma|glioma
567469|NCT00455104|Fabry Disease|fabry disease
567470|NCT00455104|National Registry|national registry
567471|NCT00455117|analgesia|analgesia
567472|NCT00455117|pain|pain
567473|NCT00455117|neurosurgery|neurosurgery
567474|NCT00455117|NSAIDS|nsaids
567475|NCT00455117|parecoxib|parecoxib
567476|NCT00455117|morphine consumption|morphine consumption
567477|NCT00455130|mannitol|mannitol
567478|NCT00455130|cystic fibrosis|cystic fibrosis
567479|NCT00455130|mucolytic|mucolytic
567480|NCT00455130|mucoactive|mucoactive
567481|NCT00455143|Postoperative delirium|postoperative delirium
567482|NCT00455143|PD|pd
567483|NCT00455143|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
567484|NCT00455143|POCD|pocd
567485|NCT00455156|Contraception|contraception
567486|NCT00455156|Vaginal Ring|vaginal ring
567487|NCT00455169|Influenza|influenza
567488|NCT00455169|Infant, Premature|infant, premature
567489|NCT00455169|Immunization|immunization
567490|NCT00455169|Vaccination|vaccination
567491|NCT00455182|Acupuncture|acupuncture
567492|NCT00455182|Hip Arthroplasty|hip arthroplasty
567493|NCT00455182|Knee Arthroplasty|knee arthroplasty
567494|NCT00455182|Pain Management|pain management
567495|NCT00455221|CML|cml
567496|NCT00455221|Imatinib|imatinib
567497|NCT00455221|vaccine|vaccine
567498|NCT00455221|peptide|peptide
567499|NCT00455221|gene|gene
567500|NCT00455221|MRD|mrd
567501|NCT00455221|DNA|dna
567502|NCT00455234|Aggression|aggression
567503|NCT00455234|Violent behaviour in people with psychotic illness|violent behaviour in people with psychotic illness
567504|NCT00455273|Breast Cancer|breast cancer
567505|NCT00455273|DCE MRI|dce mri
567506|NCT00455286|CNS Lymphoma|cns lymphoma
567507|NCT00455299|Laparoscopy, ventral, hernia, repair, surgery|laparoscopy, ventral, hernia, repair, surgery
567508|NCT00455312|Dyskeratosis Congenita|dyskeratosis congenita
567509|NCT00455312|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
567510|NCT00455312|Severe Aplastic Anemia|severe aplastic anemia
567511|NCT00455325|Insulin Resistance|insulin resistance
567512|NCT00455325|Atherosclerosis|atherosclerosis
567513|NCT00455325|Metabolic Syndrome|metabolic syndrome
567514|NCT00455338|meal|meal
567515|NCT00455338|composition|composition
567516|NCT00455338|postprandial|postprandial
567517|NCT00455338|PCOS|pcos
567518|NCT00455338|androgen|androgen
567519|NCT00455351|Palliative treatment|palliative treatment
567520|NCT00455351|Max. tolerable dose|max. tolerable dose
567521|NCT00455364|Fungal infection prophylaxis|fungal infection prophylaxis
567522|NCT00455364|Lung transplant|lung transplant
567523|NCT00455364|Fungal infection post lung transplant|fungal infection post lung transplant
567524|NCT00455377|Cement dust exposure|cement dust exposure
567525|NCT00455377|Induced sputum|induced sputum
567526|NCT00455377|Airway inflammation|airway inflammation
567527|NCT00455377|Peripheral blood inflammation markers|peripheral blood inflammation markers
567528|NCT00455390|Post immediate Psychotherapeutic Intervention|post immediate psychotherapeutic intervention
567529|NCT00455390|Psychotraumatic disorders|psychotraumatic disorders
567530|NCT00455390|PTSD post traumatic syndrome disorder|ptsd post traumatic syndrome disorder
567531|NCT00455390|CUMP Cellules d’Urgence Médico Psychologique|cump cellules d’urgence médico psychologique
567532|NCT00455403|Metabolic Syndrome|metabolic syndrome
567533|NCT00455403|Atherosclerosis|atherosclerosis
567534|NCT00455416|Low grade lymphoma|low grade lymphoma
567535|NCT00455416|Diet|diet
567536|NCT00455416|Antioxidants|antioxidants
567537|NCT00455416|Non Hodgkin Lymphoma - Follicular Lymphoma grade 1&2 stage III/IV|non hodgkin lymphoma - follicular lymphoma grade 1&2 stage iii/iv
567538|NCT00455429|Atopic Dermatitis|atopic dermatitis
567539|NCT00455429|JNJ-26113100|jnj-26113100
567540|NCT00455468|Severe pneumonia|severe pneumonia
567541|NCT00455468|children|children
567542|NCT00455468|day care management|day care management
567543|NCT00455468|hospitalized management|hospitalized management
567544|NCT00455468|Randomized controlled trial|randomized controlled trial
567545|NCT00455468|Under five children|under five children
567546|NCT00455494|Drug-resistant malaria|drug-resistant malaria
567547|NCT00455494|Bioavailability|bioavailability
567548|NCT00455494|Food-effect study|food-effect study
567549|NCT00455507|Parkinson's disease|parkinson's disease
567550|NCT00455507|levodopa|levodopa
567551|NCT00455507|end of dose wearing off|end of dose wearing off
567552|NCT00455507|OFF time|off time
567553|NCT00455520|Diabetic neuropathy|diabetic neuropathy
567554|NCT00455520|Painful Diabetic Polyneuropathy|painful diabetic polyneuropathy
567555|NCT00455520|Polyneuropathy|polyneuropathy
567556|NCT00455520|Peripheral neuropathy|peripheral neuropathy
567557|NCT00455533|Early Breast Cancer|early breast cancer
567558|NCT00455546|Coronary|coronary
567559|NCT00455546|Artery|artery
567560|NCT00455546|Atherosclerosis|atherosclerosis
567561|NCT00455546|Phospholipase|phospholipase
567562|NCT00455546|CAD|cad
567563|NCT00455559|Resistant Gastrointestinal Stromal Tumor|resistant gastrointestinal stromal tumor
567564|NCT00455559|GIST|gist
567565|NCT00455559|Perifosine|perifosine
567566|NCT00455559|Gleevec|gleevec
567567|NCT00455572|Immunotherapeutic|immunotherapeutic
567568|NCT00455572|Adjuvant cancer therapy|adjuvant cancer therapy
567886|NCT00456833|erlotinib|erlotinib
567569|NCT00455572|Non-small-cell lung cancer|non-small-cell lung cancer
567570|NCT00455572|ASCI|asci
567571|NCT00455585|Pharmacokinetics|pharmacokinetics
567572|NCT00455585|Antiretrovirals|antiretrovirals
567573|NCT00455585|Uganda|uganda
567574|NCT00455585|HIV|hiv
567575|NCT00455585|Treatment Experienced|treatment experienced
567576|NCT00455598|Diabetes|diabetes
567577|NCT00455611|Heart Failure, Congestive|heart failure, congestive
567578|NCT00455611|Continuous Positive Airway Pressure|continuous positive airway pressure
567579|NCT00455611|Baroreflex|baroreflex
567580|NCT00455611|Echocardiography|echocardiography
567581|NCT00455624|androgen deprivation therapy|androgen deprivation therapy
567582|NCT00455624|insulin resistance|insulin resistance
567583|NCT00455650|schizophrenia|schizophrenia
567584|NCT00455650|cognition|cognition
567585|NCT00455650|nicotinic receptors|nicotinic receptors
567586|NCT00455650|mecamylamine|mecamylamine
567587|NCT00455650|varenicline|varenicline
567588|NCT00455663|Schizoaffective Disorder|schizoaffective disorder
567589|NCT00455663|Medication Adherence|medication adherence
567590|NCT00455676|Scarf Osteotomy|scarf osteotomy
567591|NCT00455676|Chevron Osteotomy|chevron osteotomy
567592|NCT00455676|Comparison|comparison
567593|NCT00455689|Lupron|lupron
567594|NCT00455689|Premenopausal|premenopausal
567595|NCT00455689|Hot flashes|hot flashes
567597|NCT00455689|MRI|mri
567598|NCT00455702|schizophrenia|schizophrenia
567599|NCT00455702|cognition|cognition
567600|NCT00455702|d-cycloserine|d-cycloserine
567601|NCT00455702|memory|memory
567602|NCT00455715|Schizophrenia|schizophrenia
567603|NCT00455715|Cognition|cognition
567604|NCT00455715|Sildenafil|sildenafil
567605|NCT00455715|PDE5 Inhibitor|pde5 inhibitor
567606|NCT00455741|menopause|menopause
567607|NCT00455741|estrogen|estrogen
567608|NCT00455741|progesterone|progesterone
567609|NCT00455741|hormone replacement|hormone replacement
567610|NCT00455741|aging|aging
567611|NCT00455741|PET|pet
567612|NCT00455767|persistent ARDS|persistent ards
567613|NCT00455767|alveolar inflammation|alveolar inflammation
567614|NCT00455767|early pulmonary fibrosis|early pulmonary fibrosis
567615|NCT00455767|mechanichal ventilation|mechanichal ventilation
567616|NCT00455767|P/V curve|p/v curve
567617|NCT00455767|Static compliance|static compliance
567618|NCT00455767|elastase activity|elastase activity
567619|NCT00455767|inhibitor of Human Neutrophil Elastase|inhibitor of human neutrophil elastase
567620|NCT00455780|Eating|eating
567621|NCT00455780|Dieting|dieting
567622|NCT00455780|Meal replacements|meal replacements
567623|NCT00455780|Energy Density|energy density
567624|NCT00455780|Weight Loss Maintenance|weight loss maintenance
567625|NCT00455793|HIV|hiv
567626|NCT00455793|atherosclerosis|atherosclerosis
567627|NCT00455806|Helicobacter pylori|helicobacter pylori
567628|NCT00455806|rescue therapy|rescue therapy
567629|NCT00455806|eradication therapy|eradication therapy
567630|NCT00455806|esomeprazole|esomeprazole
567631|NCT00455806|moxifloxacin|moxifloxacin
567632|NCT00455806|resistance|resistance
567633|NCT00455819|pulmonary embolism|pulmonary embolism
567634|NCT00455819|pro-BNP|pro-bnp
567635|NCT00455819|home treatment|home treatment
567636|NCT00455832|sperm chromatin structure integrity|sperm chromatin structure integrity
567637|NCT00455832|sperm concentration|sperm concentration
567638|NCT00455832|sperm motility|sperm motility
567639|NCT00455832|sperm morphology|sperm morphology
567640|NCT00455832|peginterferon|peginterferon
567641|NCT00455832|ribavirin|ribavirin
567642|NCT00455832|hepatitis C|hepatitis c
567643|NCT00455845|Endometriosis|endometriosis
567644|NCT00455845|Lng IUD|lng iud
567645|NCT00455871|macular degeneration|macular degeneration
567646|NCT00455897|GM-CSF|gm-csf
567647|NCT00455897|CHOP-R|chop-r
567648|NCT00455897|Leukine|leukine
567649|NCT00455897|Sargramostim|sargramostim
567650|NCT00455897|DLBLCL|dlblcl
567651|NCT00455897|NHL|nhl
567652|NCT00455897|DLBCL|dlbcl
567653|NCT00455910|Low risk myelodysplastic syndromes|low risk myelodysplastic syndromes
567654|NCT00455910|MDS|mds
567655|NCT00455910|Bone marrow diseases|bone marrow diseases
567656|NCT00455910|Thalidomide|thalidomide
567657|NCT00455910|Cytopenias|cytopenias
567658|NCT00455910|Anemia|anemia
567659|NCT00455923|asthma|asthma
567660|NCT00455923|exacerbation|exacerbation
567661|NCT00455923|persistent|persistent
567662|NCT00455923|bronchial hyperresponsiveness|bronchial hyperresponsiveness
567663|NCT00455923|mild|mild
567664|NCT00455923|GINAII|ginaii
567665|NCT00455936|Adenocarcinoma|adenocarcinoma
567666|NCT00455936|NSCLC|nsclc
567667|NCT00455936|gemcitabine|gemcitabine
567668|NCT00455936|Cisplatin|cisplatin
567669|NCT00455936|Gefitinib|gefitinib
567670|NCT00455936|Never smoker|never smoker
567671|NCT00455962|estrogen|estrogen
567672|NCT00455962|progesterone|progesterone
567673|NCT00455962|African-American|african-american
567674|NCT00455962|Caucasian|caucasian
567675|NCT00455962|infusion|infusion
567676|NCT00455962|gonadotropins|gonadotropins
567677|NCT00455962|healthy|healthy
567678|NCT00455975|Kidney Cancer|kidney cancer
567679|NCT00455975|Renal Cancer|renal cancer
567680|NCT00455975|Clear Cell Carcinoma|clear cell carcinoma
567681|NCT00455988|questionnaire developement|questionnaire developement
567682|NCT00455988|regularity|regularity
567683|NCT00455988|lifestyle|lifestyle
567684|NCT00455988|type 2 diabetes|type 2 diabetes
567685|NCT00456001|heparin|heparin
567686|NCT00456001|low molecular weight heparin|low molecular weight heparin
567687|NCT00456001|enoxaparin|enoxaparin
567688|NCT00456001|anticoagulation|anticoagulation
567689|NCT00456001|thrombosis|thrombosis
567690|NCT00456001|venous thrombosis|venous thrombosis
567691|NCT00456001|thromboembolism|thromboembolism
567692|NCT00456001|pulmonary embolism|pulmonary embolism
567693|NCT00456001|medication|medication
567694|NCT00456014|Major Depression|major depression
567695|NCT00456014|Antidepressants|antidepressants
567696|NCT00456027|Type 2 Diabetes|type 2 diabetes
567697|NCT00456027|LADA|lada
567698|NCT00456027|Latent Autoimmune Diabetes in Adult|latent autoimmune diabetes in adult
567699|NCT00456027|Autoimmunity|autoimmunity
567700|NCT00456027|HbA1c|hba1c
567701|NCT00456027|C-peptide|c-peptide
567702|NCT00456040|amyloidosis|amyloidosis
567703|NCT00456040|heart failure|heart failure
567704|NCT00456040|heart transplant|heart transplant
567705|NCT00456040|stem cell transplant|stem cell transplant
567706|NCT00456053|Renal Anemia|renal anemia
567707|NCT00456053|Renal Failure|renal failure
567708|NCT00456053|Kidney Disease|kidney disease
567709|NCT00456053|Human EPO|human epo
567710|NCT00456066|Acute myocardial infarction|acute myocardial infarction
567711|NCT00456066|Thromboaspiration|thromboaspiration
567712|NCT00456066|Infarct size|infarct size
567713|NCT00456066|Left ventricular remodelling|left ventricular remodelling
567714|NCT00456092|psoriatic arthritis|psoriatic arthritis
567715|NCT00456092|ACR|acr
567716|NCT00456092|PASI|pasi
567717|NCT00456092|DAS|das
567718|NCT00456092|pharmacokinetic|pharmacokinetic
567719|NCT00456092|biopsy|biopsy
567720|NCT00456105|Type 2 diabetes|type 2 diabetes
567721|NCT00456105|Post-op dysglycemia|post-op dysglycemia
567722|NCT00456105|Peripheral vascular disease|peripheral vascular disease
567723|NCT00456105|Infrainguinal bypass surgery|infrainguinal bypass surgery
567724|NCT00456118|recurrent pregnancy losses|recurrent pregnancy losses
567725|NCT00456118|preeclampsia|preeclampsia
567726|NCT00456118|intervillositis|intervillositis
567727|NCT00456118|maternofetal alloimmunization|maternofetal alloimmunization
567728|NCT00456144|GnRH|gnrh
567729|NCT00456144|Insulin sensitivity|insulin sensitivity
567730|NCT00456157|Osteoarthritis|osteoarthritis
567731|NCT00456157|Osteophytes|osteophytes
567732|NCT00456157|Knee|knee
567733|NCT00456157|Intra-articular|intra-articular
567734|NCT00456157|OP-1|op-1
567735|NCT00456170|Vaginal|vaginal
567736|NCT00456170|Hysterectomy|hysterectomy
567737|NCT00456170|Harmonic|harmonic
567738|NCT00456170|Ligasure|ligasure
567739|NCT00456170|Sutures|sutures
567740|NCT00456170|Modern|modern
567741|NCT00456170|Patients undergoing vaginal hysterectomy for various reasons|patients undergoing vaginal hysterectomy for various reasons
567742|NCT00456183|Tuberculosis|tuberculosis
567743|NCT00456183|Latent|latent
567744|NCT00456183|TB|tb
567745|NCT00456183|Vaccine|vaccine
567746|NCT00456183|MVA 85A|mva 85a
567747|NCT00456196|COPD|copd
567748|NCT00456196|Thrombosis|thrombosis
567749|NCT00456196|Cancer|cancer
567750|NCT00456196|Renal|renal
567751|NCT00456196|Elderly|elderly
567752|NCT00456196|Surgery|surgery
567753|NCT00456196|Orthopedic Surgery|orthopedic surgery
567754|NCT00456196|Medically Ill|medically ill
567755|NCT00456196|Deep Vein Thrombosis|deep vein thrombosis
567756|NCT00456196|Pulmonary Embolism|pulmonary embolism
567757|NCT00456196|Anticoagulation|anticoagulation
567758|NCT00456209|Lived Experiences|lived experiences
567759|NCT00456209|Adolescents|adolescents
567760|NCT00456209|Cancer Treatment|cancer treatment
567761|NCT00456209|Occupations|occupations
567762|NCT00456222|Sleep|sleep
567763|NCT00456222|Circadian rhythms|circadian rhythms
567764|NCT00456222|Menstrual cycle|menstrual cycle
567765|NCT00456248|Chronic Hepatitis C|chronic hepatitis c
567766|NCT00456248|Liver|liver
567767|NCT00456248|Pegylated|pegylated
567768|NCT00456248|Interferon|interferon
567769|NCT00456248|Ribavirin|ribavirin
567770|NCT00456248|Combination|combination
567771|NCT00456248|Nonresponder|nonresponder
567772|NCT00456248|Relapser|relapser
567773|NCT00456248|HCV|hcv
567774|NCT00456248|Infergen|infergen
567775|NCT00456248|SVR|svr
567776|NCT00456261|Non Small Cell Lung Cancer|non small cell lung cancer
567777|NCT00456274|Hypothalamic Amenorrhea|hypothalamic amenorrhea
567778|NCT00456274|Idiopathic hypogonadotropic hypogonadism|idiopathic hypogonadotropic hypogonadism
567779|NCT00456274|Acquired hypogonadotropic hypogonadism|acquired hypogonadotropic hypogonadism
567781|NCT00456274|Amenorrhea|amenorrhea
567782|NCT00456274|Gonadotropin Releasing Hormone|gonadotropin releasing hormone
567783|NCT00456287|Sleep Apnea|sleep apnea
567784|NCT00456287|Clotting- fibrinolysis patterns|clotting- fibrinolysis patterns
567785|NCT00456287|Platelet function markers|platelet function markers
567786|NCT00456287|Endothelial dysfunction|endothelial dysfunction
567787|NCT00456300|Type 1 Diabetes|type 1 diabetes
567788|NCT00456300|Hyperglycemia|hyperglycemia
567789|NCT00456300|Hypoglycemia|hypoglycemia
567790|NCT00456313|asthma|asthma
567791|NCT00456313|fluticasone propionate|fluticasone propionate
567792|NCT00456313|salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
567793|NCT00456313|combination product|combination product
567794|NCT00456313|innate immune response|innate immune response
567795|NCT00456313|neutrophil priming|neutrophil priming
567796|NCT00456326|Heparin|heparin
567797|NCT00456326|Unfractionated Heparin|unfractionated heparin
567798|NCT00456326|Low Molecular Weight Heparin|low molecular weight heparin
567799|NCT00456326|Anticoagulation|anticoagulation
567800|NCT00456326|Thrombocytopenia|thrombocytopenia
567801|NCT00456326|Thrombosis|thrombosis
567802|NCT00456326|Venous Thrombosis|venous thrombosis
567803|NCT00456326|Pulmonary Embolism|pulmonary embolism
567804|NCT00456339|Obstructive sleep apnea syndrome (OSAS) in children|obstructive sleep apnea syndrome (osas) in children
567805|NCT00456365|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
567806|NCT00456365|Cystic kidney disease|cystic kidney disease
567807|NCT00456365|High blood pressure|high blood pressure
567808|NCT00456365|Statin|statin
567809|NCT00456391|Brain CT scan|brain ct scan
567810|NCT00456391|Pediatric emergency room|pediatric emergency room
567811|NCT00456404|peppermint water|peppermint water
567812|NCT00456404|nipple crack|nipple crack
567813|NCT00456404|lactating women|lactating women
567814|NCT00456417|Neurological|neurological
567815|NCT00456417|Alzheimers|alzheimers
567816|NCT00456443|Thalassemia|thalassemia
567817|NCT00456443|Sickle cell anemia|sickle cell anemia
567818|NCT00456443|Splenectomy|splenectomy
567819|NCT00456443|Infections|infections
567820|NCT00456443|Streptococcal Pneumonia|streptococcal pneumonia
567822|NCT00456469|latent|latent
567823|NCT00456469|infection|infection
567824|NCT00456469|Ethiopia|ethiopia
567825|NCT00456521|Obesity|obesity
567826|NCT00456521|Behavior Modification|behavior modification
567827|NCT00456534|Smoking|smoking
567828|NCT00456547|Cesarean hysterectomy|cesarean hysterectomy
567829|NCT00456547|Postpartum hemorrhage|postpartum hemorrhage
567830|NCT00456547|Coagulation|coagulation
567831|NCT00456573|Pediatric Obstructive sleep apnea syndrome|pediatric obstructive sleep apnea syndrome
567832|NCT00456586|Parkinson's disease|parkinson's disease
567833|NCT00456586|Levodopa therapy|levodopa therapy
567834|NCT00456586|End of dose wearing off|end of dose wearing off
567835|NCT00456586|Off time|off time
567836|NCT00456625|Hepatitis B vaccine|hepatitis b vaccine
567837|NCT00456625|Challenge dose|challenge dose
567838|NCT00456638|OP-CABG|op-cabg
567839|NCT00456638|Depodur traditional drug|depodur traditional drug
567840|NCT00456651|Sleep Apnea|sleep apnea
567841|NCT00456651|Obesity|obesity
567842|NCT00456651|Neuropeptides|neuropeptides
567843|NCT00456651|Hormones|hormones
567844|NCT00456664|CMV|cmv
567845|NCT00456664|IRIS|iris
567846|NCT00456677|minocycline|minocycline
567847|NCT00456677|asthma|asthma
567848|NCT00456677|oral corticosteroids|oral corticosteroids
567849|NCT00456690|Thalassemia|thalassemia
567850|NCT00456690|Nutrition|nutrition
567851|NCT00456690|Endocrine|endocrine
567852|NCT00456690|BMI|bmi
567853|NCT00456703|fluids,|fluids,
567854|NCT00456703|restriction,|restriction,
567855|NCT00456703|infection,|infection,
567856|NCT00456703|bowel surgery,|bowel surgery,
567857|NCT00456703|open abdominal|open abdominal
567858|NCT00456716|BAC lung cancer|bac lung cancer
567859|NCT00456716|adenocarcinoma of the lung|adenocarcinoma of the lung
567860|NCT00456729|Iron deficiency|iron deficiency
567861|NCT00456729|Malabsorption|malabsorption
567862|NCT00456729|Giardiasis|giardiasis
567863|NCT00456742|Generalized Anxiety Disorder|generalized anxiety disorder
567864|NCT00456742|Anxiety|anxiety
567865|NCT00456742|Treatment efficacy|treatment efficacy
567866|NCT00456755|Perennial Allergic rhinitis|perennial allergic rhinitis
567867|NCT00456755|Traditional Chinese Medicine|traditional chinese medicine
567868|NCT00456768|Panic Disorder|panic disorder
567869|NCT00456768|Anxiety|anxiety
567870|NCT00456768|Treatment efficacy|treatment efficacy
567871|NCT00456781|rotator cuff|rotator cuff
567872|NCT00456781|randomized clinical trial|randomized clinical trial
567873|NCT00456794|Parkinson's disease|parkinson's disease
567874|NCT00456794|Levodopa|levodopa
567875|NCT00456794|End of dose wearing off|end of dose wearing off
567876|NCT00456794|OFF time|off time
567877|NCT00456807|Human Papillomavirus|human papillomavirus
567878|NCT00456820|Mood Regulating Circuit|mood regulating circuit
567879|NCT00456820|SSRI|ssri
567880|NCT00456820|fMRI|fmri
567821|NCT00456469|TB|tb
567881|NCT00456833|Non Small Cell Lung Cancer|non small cell lung cancer
567883|NCT00456833|Advanced lung cancer|advanced lung cancer
567884|NCT00456833|RAD|rad
567885|NCT00456833|RAD001|rad001
567887|NCT00456846|Metastatic Breast Cancer, ABI-007, Abraxane|metastatic breast cancer, abi-007, abraxane
567888|NCT00456859|chronic kidney disease|chronic kidney disease
567889|NCT00456859|oral carbonaceous adsorbent|oral carbonaceous adsorbent
567890|NCT00456859|randomized clinical trial|randomized clinical trial
567891|NCT00456859|composite endpoint|composite endpoint
567892|NCT00456872|Pain during injection of the pre-procedure anesthetic|pain during injection of the pre-procedure anesthetic
567893|NCT00456885|obesity|obesity
567894|NCT00456885|double blind|double blind
567895|NCT00456885|placebo controlled|placebo controlled
567896|NCT00456885|weight loss|weight loss
567897|NCT00456885|appetite|appetite
567898|NCT00456885|energy expenditure|energy expenditure
567899|NCT00456911|obesity|obesity
567900|NCT00456911|prevention|prevention
567901|NCT00456911|children|children
567902|NCT00456911|adults|adults
567903|NCT00456911|family|family
567904|NCT00456911|dietary|dietary
567905|NCT00456911|coaching|coaching
567906|NCT00456911|body mass index|body mass index
567907|NCT00456911|fat mass|fat mass
567908|NCT00456924|progesterone receptor modulator|progesterone receptor modulator
567909|NCT00456950|coronary atherosclerosis|coronary atherosclerosis
567910|NCT00456950|magnetic resonance imaging|magnetic resonance imaging
567911|NCT00456950|vulnerable plaque|vulnerable plaque
567912|NCT00456963|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
567913|NCT00456963|angiotensin receptor blockers|angiotensin receptor blockers
567914|NCT00456963|diabetes|diabetes
567915|NCT00456963|hypertension|hypertension
567916|NCT00456963|therapeutic strategies|therapeutic strategies
567917|NCT00456976|Seligiline|seligiline
567918|NCT00456976|Negative symptoms|negative symptoms
567919|NCT00456976|Schizopherenia|schizopherenia
567920|NCT00456989|Androgen Independent|androgen independent
567921|NCT00456989|Prostate Cancer|prostate cancer
567922|NCT00456989|Taxotere|taxotere
567923|NCT00456989|Doxil|doxil
567924|NCT00456989|AIPC|aipc
567925|NCT00456989|Advanced Androgen-Independent Prostate Cancer|advanced androgen-independent prostate cancer
567926|NCT00457002|Prevention of deep vein thrombosis and pulmonary embolism with acutely ill hospitalized patients|prevention of deep vein thrombosis and pulmonary embolism with acutely ill hospitalized patients
567927|NCT00457028|Obsessive Compulsive Disorder|obsessive compulsive disorder
567928|NCT00457028|Anxiety|anxiety
567929|NCT00457028|Treatment efficacy|treatment efficacy
567930|NCT00457041|Trust|trust
567931|NCT00457041|Decision Making|decision making
567932|NCT00457041|Vulnerability|vulnerability
567933|NCT00457041|Survey|survey
567934|NCT00457054|Mood Regulating Circuit|mood regulating circuit
567935|NCT00457054|Lithium|lithium
567936|NCT00457054|fMRI|fmri
567937|NCT00457067|Hyperfluorescence on Fluorescein|hyperfluorescence on fluorescein
567938|NCT00457067|Idiopathic Juxtafoveal Telangiectasia|idiopathic juxtafoveal telangiectasia
567939|NCT00457067|Retinal Edema/Thinning|retinal edema/thinning
567940|NCT00457067|Vascular Endothelial Growth Factor|vascular endothelial growth factor
567941|NCT00457067|Macular Telangiectasia|macular telangiectasia
567942|NCT00457080|capnography|capnography
567943|NCT00457080|safety|safety
567944|NCT00457080|opioids|opioids
567945|NCT00457080|respiratory depression|respiratory depression
567946|NCT00457080|postoperative|postoperative
567947|NCT00457080|orthopedic|orthopedic
567949|NCT00457080|apnea|apnea
567950|NCT00457093|Type 2 Diabetes|type 2 diabetes
567951|NCT00457093|continuous glucose monitoring|continuous glucose monitoring
567952|NCT00457093|basal insulin|basal insulin
567953|NCT00457106|panic|panic
567954|NCT00457119|Non Small Cell Lung Cancer|non small cell lung cancer
567955|NCT00457119|NSCLC|nsclc
567956|NCT00457119|Advanced Lung Cancer|advanced lung cancer
567957|NCT00457119|RAD|rad
567958|NCT00457119|RAD001|rad001
567959|NCT00457119|chemotherapy|chemotherapy
567960|NCT00457119|carboplatin|carboplatin
567961|NCT00457119|paclitaxel|paclitaxel
567962|NCT00457119|bevacizumab|bevacizumab
567963|NCT00457132|Knee|knee
567964|NCT00457132|Osteoarthritis|osteoarthritis
567965|NCT00457132|WOMAC|womac
567966|NCT00457132|ALF|alf
567967|NCT00457132|Wedging|wedging
567968|NCT00457145|Hyperfluorescence on Fluorescein|hyperfluorescence on fluorescein
567969|NCT00457145|Idiopathic Juxtafoveal Telangiectasia|idiopathic juxtafoveal telangiectasia
567970|NCT00457145|Retinal Edema/Thinning|retinal edema/thinning
567971|NCT00457145|Vascular Endothelial Growth Factor|vascular endothelial growth factor
567972|NCT00457145|Macular Telangiectasia|macular telangiectasia
567973|NCT00457158|pulmonary embolism|pulmonary embolism
567974|NCT00457158|inferior vena cava filters|inferior vena cava filters
567975|NCT00457158|venous thrombosis|venous thrombosis
567976|NCT00457158|randomized controlled trial|randomized controlled trial
567977|NCT00457171|GI-270384 colitis patients ECAM oral|gi-270384 colitis patients ecam oral
567978|NCT00457184|Migraine|migraine
567979|NCT00457184|Thrombosis|thrombosis
567980|NCT00457184|Thrombophilia|thrombophilia
567981|NCT00457197|bipolar disorder|bipolar disorder
567982|NCT00457197|alcohol dependence|alcohol dependence
567983|NCT00457197|mania|mania
567984|NCT00457197|manic disorder|manic disorder
567985|NCT00457197|depression|depression
567986|NCT00457210|Psychology|psychology
567987|NCT00457223|pterygium|pterygium
567988|NCT00457223|pterygia|pterygia
567989|NCT00457223|excision|excision
567990|NCT00457223|amniotic membrane transplantation|amniotic membrane transplantation
567991|NCT00457223|fibrin glue|fibrin glue
567992|NCT00457223|suture|suture
567993|NCT00457236|Clopidogrel|clopidogrel
567994|NCT00457236|Coronary Artery Disease|coronary artery disease
567995|NCT00457236|Dose-Response Relationship, Drug|dose-response relationship, drug
567996|NCT00457236|Drug Resistance|drug resistance
567997|NCT00457236|PCI|pci
567998|NCT00457249|Pertussis|pertussis
567999|NCT00457249|Tetanus|tetanus
568000|NCT00457249|Diphtheria|diphtheria
568001|NCT00457249|Tdap|tdap
568002|NCT00457262|paraoxonase1 activity|paraoxonase1 activity
568003|NCT00457262|LDL|ldl
568004|NCT00457262|HDL|hdl
568005|NCT00457262|postmenopausal women|postmenopausal women
568006|NCT00457262|postmenopausal women and hyperlipidemia|postmenopausal women and hyperlipidemia
568008|NCT00457288|Topical treatment|topical treatment
568009|NCT00457301|Lung transplantation, health-related quality of life.|lung transplantation, health-related quality of life.
568010|NCT00457314|single-large scale deletions|single-large scale deletions
568011|NCT00457314|point mutations in mtDNA|point mutations in mtdna
568012|NCT00457327|protective ileostomy|protective ileostomy
568013|NCT00457327|rectal cancer|rectal cancer
568014|NCT00457327|low anterior resection|low anterior resection
568015|NCT00457340|Tachycardia, Ventricular|tachycardia, ventricular
568016|NCT00457340|Ventricular Fibrillation|ventricular fibrillation
568017|NCT00457379|Coronary artery disease|coronary artery disease
568018|NCT00457379|HDL-Cholesterol|hdl-cholesterol
568019|NCT00457379|Endothelial Function|endothelial function
568020|NCT00457379|Endothelial Progenitor Cells|endothelial progenitor cells
568021|NCT00457379|normal blood HDL-Cholesterol level|normal blood hdl-cholesterol level
568022|NCT00457392|Non-small cell lung cancer|non-small cell lung cancer
568023|NCT00457392|sunitinib|sunitinib
568024|NCT00457392|erlotinib|erlotinib
568025|NCT00457392|Phase 3|phase 3
568026|NCT00457405|ischemia-reperfusion injury|ischemia-reperfusion injury
568027|NCT00457405|atherosclerosis|atherosclerosis
568028|NCT00457405|dipyridamole|dipyridamole
568029|NCT00457405|annexin A5 targeting|annexin a5 targeting
568030|NCT00457431|in-hospital cardiac arrest|in-hospital cardiac arrest
568031|NCT00457431|resuscitation|resuscitation
568032|NCT00457431|mild therapeutic hypothermia|mild therapeutic hypothermia
568033|NCT00457457|With or without erectile dysfunction|with or without erectile dysfunction
568034|NCT00457483|hypertension|hypertension
568035|NCT00457483|diuretic|diuretic
568036|NCT00457483|angiotensin receptor blockers|angiotensin receptor blockers
568037|NCT00457483|prediction|prediction
568038|NCT00457496|Behavior Therapy|behavior therapy
568039|NCT00457496|Relaxation Techniques|relaxation techniques
568040|NCT00457496|Cognitive Therapy|cognitive therapy
568041|NCT00457496|Exercise Movement Techniques|exercise movement techniques
568042|NCT00457509|Pandemic influenza|pandemic influenza
568043|NCT00457509|Avian influenza|avian influenza
568044|NCT00457509|Orthomyxoviridae Infections|orthomyxoviridae infections
568045|NCT00457509|A/H5N1|a/h5n1
568046|NCT00457522|intimate partner violence|intimate partner violence
568047|NCT00457522|depression|depression
568048|NCT00457522|PTSD|ptsd
568049|NCT00457522|fatigue|fatigue
568050|NCT00457535|recombinant human erythropoietin|recombinant human erythropoietin
568051|NCT00457535|adiponectin|adiponectin
568052|NCT00457535|mortality|mortality
568053|NCT00457548|Alcohol use|alcohol use
568054|NCT00457548|Brief Interventions|brief interventions
568055|NCT00457548|Injuries|injuries
568056|NCT00457548|Emergency Department Patients|emergency department patients
568057|NCT00457548|Harmful and hazardous alcohol use among ED injured patients|harmful and hazardous alcohol use among ed injured patients
568058|NCT00457561|The relationship between all-cause mortality in patients introduced hemodialysis and recombinant human erythropoietin dose and serum adiponectin level|the relationship between all-cause mortality in patients introduced hemodialysis and recombinant human erythropoietin dose and serum adiponectin level
568059|NCT00450424|colon cancer|colon cancer
568060|NCT00450424|rectal cancer|rectal cancer
568061|NCT00450424|hereditary non-polyposis colon cancer|hereditary non-polyposis colon cancer
568062|NCT00450424|recurrent colon cancer|recurrent colon cancer
568063|NCT00450424|stage I colon cancer|stage i colon cancer
568064|NCT00450424|stage IIA colon cancer|stage iia colon cancer
568065|NCT00450424|stage IIB colon cancer|stage iib colon cancer
568066|NCT00450424|stage IIIA colon cancer|stage iiia colon cancer
568067|NCT00450424|stage IIIB colon cancer|stage iiib colon cancer
568068|NCT00450424|stage IIIC colon cancer|stage iiic colon cancer
568069|NCT00450424|stage IVA colon cancer|stage iva colon cancer
568070|NCT00450424|stage IVB colon cancer|stage ivb colon cancer
568071|NCT00450424|recurrent rectal cancer|recurrent rectal cancer
568072|NCT00450424|stage I rectal cancer|stage i rectal cancer
568073|NCT00450424|stage IIA rectal cancer|stage iia rectal cancer
568074|NCT00450424|stage IIB rectal cancer|stage iib rectal cancer
568075|NCT00450424|stage IIC rectal cancer|stage iic rectal cancer
568076|NCT00450424|stage IIIA rectal cancer|stage iiia rectal cancer
568077|NCT00450424|stage IIIB rectal cancer|stage iiib rectal cancer
568078|NCT00450424|stage IIIC rectal cancer|stage iiic rectal cancer
568079|NCT00450424|stage IVA rectal cancer|stage iva rectal cancer
568080|NCT00450424|stage IVB rectal cancer|stage ivb rectal cancer
568081|NCT00450437|Meningococcal|meningococcal
568082|NCT00450437|meningitis|meningitis
568083|NCT00450437|vaccine|vaccine
568084|NCT00450437|adolescents|adolescents
568085|NCT00450437|adults|adults
568086|NCT00450463|Immunotherapy|immunotherapy
568087|NCT00450463|Hormonal Therapy|hormonal therapy
568088|NCT00450463|Combination Therapy|combination therapy
568089|NCT00450463|Prostate Specific Antigen|prostate specific antigen
568090|NCT00450463|Immunoassay|immunoassay
568091|NCT00450463|Prostate Cancer|prostate cancer
568092|NCT00450476|ventilator associated pneumonia|ventilator associated pneumonia
568093|NCT00450476|prevention|prevention
568094|NCT00450476|endotracheal intubation|endotracheal intubation
568095|NCT00450476|mechanical ventilation|mechanical ventilation
568096|NCT00450489|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
568097|NCT00450489|Quality of Life|quality of life
568098|NCT00450489|Satisfaction of medical care delivery|satisfaction of medical care delivery
568099|NCT00450502|Cytotoxic|cytotoxic
568100|NCT00450502|Pharmacokinetics|pharmacokinetics
568101|NCT00450502|Toxicity|toxicity
568102|NCT00450502|Neoplasms|neoplasms
568103|NCT00450502|Pharmacogenomics|pharmacogenomics
568104|NCT00450502|Solid Tumor|solid tumor
568105|NCT00450502|Lymphoma|lymphoma
568106|NCT00450515|recurrent breast cancer|recurrent breast cancer
568107|NCT00450515|stage IV breast cancer|stage iv breast cancer
568108|NCT00450515|male breast cancer|male breast cancer
568109|NCT00450528|D-dimers|d-dimers
568110|NCT00450528|surgery|surgery
568111|NCT00450528|kinetics|kinetics
568112|NCT00450541|Advanced Cancer|advanced cancer
568113|NCT00450541|Fatigue|fatigue
568114|NCT00450541|Interview|interview
568115|NCT00450541|Questionnaire|questionnaire
568116|NCT00450541|Survey|survey
568117|NCT00450554|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
568118|NCT00450554|Serum bactericidal activity|serum bactericidal activity
568119|NCT00450554|Menbvac|menbvac
568120|NCT00450567|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
568121|NCT00450567|stage I non-small cell lung cancer|stage i non-small cell lung cancer
568122|NCT00450567|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
568123|NCT00450567|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
568124|NCT00450567|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
568125|NCT00450567|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
568126|NCT00450580|protease inhibitor,|protease inhibitor,
568127|NCT00450580|HIV-1,|hiv-1,
568128|NCT00450580|Fosamprenavir,|fosamprenavir,
568129|NCT00450580|non-HDL cholesterol|non-hdl cholesterol
568130|NCT00450580|ritonavir,|ritonavir,
568131|NCT00450580|naive,|naive,
568132|NCT00450593|melanoma|melanoma
568133|NCT00450593|hereditary multiple melanoma|hereditary multiple melanoma
568134|NCT00450593|recurrent melanoma|recurrent melanoma
568135|NCT00450593|stage 0 melanoma|stage 0 melanoma
568136|NCT00450593|stage IV melanoma|stage iv melanoma
568137|NCT00450593|stage IA melanoma|stage ia melanoma
568138|NCT00450593|stage IB melanoma|stage ib melanoma
568139|NCT00450593|stage IIA melanoma|stage iia melanoma
568140|NCT00450593|stage IIB melanoma|stage iib melanoma
568141|NCT00450593|stage IIC melanoma|stage iic melanoma
568142|NCT00450593|stage IIIA melanoma|stage iiia melanoma
568143|NCT00450593|stage IIIB melanoma|stage iiib melanoma
568144|NCT00450593|stage IIIC melanoma|stage iiic melanoma
568145|NCT00450619|Radionuclide|radionuclide
568146|NCT00450619|Immunotherapy|immunotherapy
568147|NCT00450619|Radiation|radiation
568148|NCT00450619|PSA|psa
568149|NCT00450619|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
568150|NCT00450619|Prostate Cancer|prostate cancer
568151|NCT00450632|meningococcal infections|meningococcal infections
568152|NCT00450632|biotheque|biotheque
568153|NCT00450632|genetic markers|genetic markers
568154|NCT00450645|Cancer|cancer
568155|NCT00450645|Residual vein thrombosis|residual vein thrombosis
568156|NCT00450645|Low Molecular Weight Heparin|low molecular weight heparin
568157|NCT00450645|Optimal duration|optimal duration
568158|NCT00450658|ibuprofen|ibuprofen
568159|NCT00450658|famotidine|famotidine
568160|NCT00450658|ulcers|ulcers
568161|NCT00450658|NSAIDS|nsaids
568162|NCT00450658|pain|pain
568163|NCT00450658|arthritis|arthritis
568164|NCT00450658|chronic regional pain syndrome|chronic regional pain syndrome
568165|NCT00450658|chronic soft tissue pain|chronic soft tissue pain
568166|NCT00450658|osteoarthritis|osteoarthritis
568167|NCT00450658|rheumatoid arthritis|rheumatoid arthritis
568168|NCT00450658|chronic low back pain|chronic low back pain
568169|NCT00450671|Fistula-in-ano|fistula-in-ano
568170|NCT00450671|Anal fistula|anal fistula
568171|NCT00450671|Perirectal fistula|perirectal fistula
568172|NCT00450671|Collagen plug|collagen plug
568173|NCT00450671|Surgisis|surgisis
568174|NCT00450671|Seton|seton
568443|NCT00451841|Gastroesophageal reflux|gastroesophageal reflux
568175|NCT00450697|Feeding intolerance in premature infants|feeding intolerance in premature infants
568176|NCT00450697|Bolus feeding every 4 hours versus every 3 hours|bolus feeding every 4 hours versus every 3 hours
568177|NCT00450697|Feeding method in premature infants|feeding method in premature infants
568178|NCT00450723|stage I breast cancer|stage i breast cancer
568179|NCT00450723|stage II breast cancer|stage ii breast cancer
568180|NCT00450723|male breast cancer|male breast cancer
568181|NCT00450736|chondrosarcoma|chondrosarcoma
568182|NCT00450736|adult angiosarcoma|adult angiosarcoma
568183|NCT00450736|adult fibrosarcoma|adult fibrosarcoma
568184|NCT00450736|adult leiomyosarcoma|adult leiomyosarcoma
568185|NCT00450736|adult liposarcoma|adult liposarcoma
568186|NCT00450736|adult neurofibrosarcoma|adult neurofibrosarcoma
568187|NCT00450736|adult synovial sarcoma|adult synovial sarcoma
568188|NCT00450736|childhood angiosarcoma|childhood angiosarcoma
568189|NCT00450736|childhood fibrosarcoma|childhood fibrosarcoma
568190|NCT00450736|childhood leiomyosarcoma|childhood leiomyosarcoma
568191|NCT00450736|childhood liposarcoma|childhood liposarcoma
568192|NCT00450736|childhood neurofibrosarcoma|childhood neurofibrosarcoma
568193|NCT00450736|childhood synovial sarcoma|childhood synovial sarcoma
568194|NCT00450736|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
568195|NCT00450736|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
568196|NCT00450736|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
568197|NCT00450736|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
568198|NCT00450736|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
568199|NCT00450736|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
568200|NCT00450736|localized childhood malignant fibrous histiocytoma of bone|localized childhood malignant fibrous histiocytoma of bone
568201|NCT00450762|pretreated|pretreated
568202|NCT00450762|metastatic|metastatic
568203|NCT00450788|Etiology|etiology
568204|NCT00450788|Carcinogens|carcinogens
567596|NCT00455689|PET|pet
568205|NCT00450788|Esophageal Cancer|esophageal cancer
568206|NCT00450801|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
568207|NCT00450801|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
568208|NCT00450801|stage I mantle cell lymphoma|stage i mantle cell lymphoma
568209|NCT00450801|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
568210|NCT00450801|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
568211|NCT00450827|recurrent neuroblastoma|recurrent neuroblastoma
568212|NCT00450840|septic shock|septic shock
568213|NCT00450840|simvastatin|simvastatin
568214|NCT00450853|emesis|emesis
568215|NCT00450853|granisetron|granisetron
568216|NCT00450853|pharmacokinetics|pharmacokinetics
568217|NCT00450853|subcutaneous.|subcutaneous.
568218|NCT00450866|recurrent breast cancer|recurrent breast cancer
568219|NCT00450866|stage IV breast cancer|stage iv breast cancer
568220|NCT00450866|tumors metastatic to brain|tumors metastatic to brain
568221|NCT00450866|leptomeningeal metastases|leptomeningeal metastases
568222|NCT00450866|male breast cancer|male breast cancer
568223|NCT00450892|inflammatory breast cancer|inflammatory breast cancer
568224|NCT00450892|stage II breast cancer|stage ii breast cancer
568225|NCT00450892|stage IIIA breast cancer|stage iiia breast cancer
568226|NCT00450892|stage IIIB breast cancer|stage iiib breast cancer
568227|NCT00450892|stage IIIC breast cancer|stage iiic breast cancer
568228|NCT00450905|Chronic musculoskeletal pain secondary to Fibromyalgia|chronic musculoskeletal pain secondary to fibromyalgia
568229|NCT00450918|Kartagener Syndrome|kartagener syndrome
568230|NCT00450931|health status unknown|health status unknown
568231|NCT00450944|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
568232|NCT00450944|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
568233|NCT00450970|Hormone Refractory Prostate Cancer (HRPC)|hormone refractory prostate cancer (hrpc)
568234|NCT00450970|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
568235|NCT00450970|Unlimited Prior Cytotoxic Chemotherapy Regimens|unlimited prior cytotoxic chemotherapy regimens
568236|NCT00450983|graft versus host disease|graft versus host disease
568237|NCT00450983|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
568238|NCT00450983|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
568239|NCT00450983|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
568240|NCT00450983|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
568241|NCT00450983|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
568242|NCT00450983|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
568243|NCT00450983|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
568244|NCT00450983|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
568245|NCT00450983|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
568246|NCT00450983|secondary acute myeloid leukemia|secondary acute myeloid leukemia
568247|NCT00450983|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
753191|NCT01175811|Insulin LISPRO|insulin lispro
568248|NCT00450983|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
568249|NCT00450983|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
568250|NCT00450983|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
568251|NCT00450983|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
568252|NCT00450983|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
568253|NCT00450983|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
568254|NCT00450983|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
568255|NCT00450983|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
568256|NCT00450983|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
585627|NCT00513422|Disease progression|disease progression
568257|NCT00450983|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
568258|NCT00450983|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
568259|NCT00451009|IVF|ivf
568260|NCT00451009|Male factor infertility|male factor infertility
568261|NCT00451009|Cryopreservation|cryopreservation
568262|NCT00451009|Cryoprotective agents|cryoprotective agents
568263|NCT00451009|Egg Freezing|egg freezing
568264|NCT00451022|Fowlpox|fowlpox
568265|NCT00451022|Vaccinia|vaccinia
568266|NCT00451022|PSA|psa
568267|NCT00451022|CEA|cea
568268|NCT00451022|MUC-1|muc-1
568269|NCT00451022|Gene Therapy|gene therapy
568270|NCT00451022|Long Term Survivor|long term survivor
568271|NCT00451022|Research Specimen|research specimen
568272|NCT00451035|Refractory Chronic Myeloid Leukemia in Chronic Phase|refractory chronic myeloid leukemia in chronic phase
568273|NCT00451035|adults|adults
568274|NCT00451035|oral LBH589|oral lbh589
568275|NCT00451061|distal ureterolithiasis|distal ureterolithiasis
568276|NCT00451061|α adrenoreceptors antagonist|α adrenoreceptors antagonist
734410|NCT01101750|HPV|hpv
568277|NCT00451074|Stop codon mutations|stop codon mutations
568278|NCT00451087|mechanical properties|mechanical properties
568279|NCT00451087|electromechanical delay|electromechanical delay
568280|NCT00451087|viscoelasticity|viscoelasticity
568281|NCT00451087|VMO|vmo
568282|NCT00451087|patellofemoral pain syndrome|patellofemoral pain syndrome
568283|NCT00451113|Type 2 diabetes|type 2 diabetes
568284|NCT00451113|Older adults|older adults
568285|NCT00451113|Incretins|incretins
568286|NCT00451113|Hyperglycemia|hyperglycemia
568287|NCT00451113|Insulin resistance|insulin resistance
568288|NCT00451126|emotion|emotion
568289|NCT00451126|personality|personality
568290|NCT00451126|social stress|social stress
568291|NCT00451126|appraisal|appraisal
568292|NCT00451152|glaucoma|glaucoma
568293|NCT00451165|Laparoscopic|laparoscopic
568294|NCT00451165|Colon|colon
568295|NCT00451165|Rectal|rectal
568296|NCT00451165|Surgery|surgery
568297|NCT00451165|Urinary function|urinary function
568298|NCT00451165|Sexual function|sexual function
568299|NCT00451165|Bowel function|bowel function
568300|NCT00451165|Male|male
568301|NCT00451191|benign prostatic hyperplasia|benign prostatic hyperplasia
568302|NCT00451191|BPH|bph
568303|NCT00451191|botulinum toxin|botulinum toxin
568304|NCT00451191|BoNT/A|bont/a
568305|NCT00451204|Multiple sclerosis|multiple sclerosis
568306|NCT00451204|estrogen|estrogen
568307|NCT00451204|estriol|estriol
568308|NCT00451204|progesterone|progesterone
568309|NCT00451230|craving, insulin, leptin|craving, insulin, leptin
568310|NCT00451243|psoriatic arthritis|psoriatic arthritis
568311|NCT00451256|coronary artery bypass|coronary artery bypass
568312|NCT00451256|cardiovascular disease|cardiovascular disease
568313|NCT00451269|Malaria|malaria
568314|NCT00451269|Diagnosis|diagnosis
568315|NCT00451269|RDT|rdt
568316|NCT00451269|pLDH|pldh
568317|NCT00451269|HRP2|hrp2
568318|NCT00451269|Patients with fever and history of travel in a malaria|patients with fever and history of travel in a malaria
568319|NCT00451269|country|country
568320|NCT00451295|Chronic Kidney Disease|chronic kidney disease
568321|NCT00451295|Dialysis|dialysis
568322|NCT00451295|Hyperphosphatemia|hyperphosphatemia
568323|NCT00451308|Induction of labor|induction of labor
568324|NCT00451308|vaginal delivery|vaginal delivery
568325|NCT00451308|cesarean section|cesarean section
568326|NCT00451308|foley balloon cathether|foley balloon cathether
568327|NCT00451308|method of labor induction|method of labor induction
568328|NCT00451308|perinatal outcomes|perinatal outcomes
568329|NCT00451321|type 1 diabetes mellitus|type 1 diabetes mellitus
568330|NCT00451321|diabetes mellitus type 1|diabetes mellitus type 1
568331|NCT00451321|type 1 diabetes|type 1 diabetes
568332|NCT00451321|diabetes mellitus|diabetes mellitus
568333|NCT00451321|diabetes|diabetes
568334|NCT00451360|Diacerein|diacerein
568335|NCT00451360|Hip osteoarthritis|hip osteoarthritis
568336|NCT00451360|Structure-modifying effect / Chondromodulating effect|structure-modifying effect / chondromodulating effect
568337|NCT00451360|Double blind study|double blind study
568338|NCT00451373|ARF, dialysis, cytokine, free radical, major operations|arf, dialysis, cytokine, free radical, major operations
568339|NCT00451399|Weight gain|weight gain
568340|NCT00451399|antipsychotic|antipsychotic
568341|NCT00451399|lifestyle interventions|lifestyle interventions
568342|NCT00451399|metformin|metformin
568543|NCT00457756|guar gum|guar gum
568343|NCT00451399|antipsychotic-induced weight gain.|antipsychotic-induced weight gain.
568344|NCT00451412|Venous thromboembolism|venous thromboembolism
568345|NCT00451412|Medical patients|medical patients
568346|NCT00451412|Heparin|heparin
568347|NCT00451412|Low molecular weight heparin|low molecular weight heparin
568348|NCT00451412|Deep vein thrombosis|deep vein thrombosis
568349|NCT00451412|Certoparin|certoparin
568350|NCT00451412|Embolism and Thrombosis|embolism and thrombosis
568351|NCT00451425|pregnancy|pregnancy
568352|NCT00451425|weight gain|weight gain
568353|NCT00451425|obesity|obesity
568354|NCT00451425|macrosomia|macrosomia
568355|NCT00451438|patellofemoral pain syndrome|patellofemoral pain syndrome
568356|NCT00451438|electromyography|electromyography
568357|NCT00451438|gluteus medius|gluteus medius
568358|NCT00451438|tensor fascia lata|tensor fascia lata
568359|NCT00451451|relapsing|relapsing
568360|NCT00451451|multiple sclerosis|multiple sclerosis
568361|NCT00451451|oral|oral
568362|NCT00451451|remitting|remitting
568363|NCT00451464|Apolipoprotein, Gene polymorphism, Hyperlipidemia|apolipoprotein, gene polymorphism, hyperlipidemia
568364|NCT00451490|agomelatin|agomelatin
568365|NCT00451490|prozac|prozac
568366|NCT00451490|heart rate variability|heart rate variability
568367|NCT00451490|major depression|major depression
568368|NCT00451490|sleep|sleep
568369|NCT00451490|depressive symptoms|depressive symptoms
568370|NCT00451503|Hearing|hearing
568371|NCT00451503|Auditory rehabilitation|auditory rehabilitation
568372|NCT00451503|Middle ear implant|middle ear implant
568373|NCT00451503|Surgery|surgery
568374|NCT00451516|Plant, medicine|plant, medicine
568375|NCT00451516|Psychiatry|psychiatry
568376|NCT00451516|Major depressive disorder|major depressive disorder
568377|NCT00451516|Anxiety|anxiety
568378|NCT00451516|Major Depressive Disorder with comorbid anxiety|major depressive disorder with comorbid anxiety
568379|NCT00451542|Bipolar Disorder|bipolar disorder
568380|NCT00451542|Relapse|relapse
568381|NCT00451542|Retrospective|retrospective
568382|NCT00451568|Polycystic ovary syndrome|polycystic ovary syndrome
568383|NCT00451581|Endoscopic papillary balloon dilatation|endoscopic papillary balloon dilatation
568384|NCT00451581|Endoscopic sphincterotomy|endoscopic sphincterotomy
568385|NCT00451581|Choledocholithiasis|choledocholithiasis
568386|NCT00451581|Efficacy|efficacy
568387|NCT00451581|Complication|complication
568389|NCT00451607|premature|premature
568390|NCT00451607|newborn|newborn
568391|NCT00451607|heart rate variability|heart rate variability
568392|NCT00451607|individualized sensorimotor care|individualized sensorimotor care
568393|NCT00451607|noise|noise
568394|NCT00451620|Type 2 diabetes|type 2 diabetes
568395|NCT00451620|Hypoglycemia|hypoglycemia
568396|NCT00451620|Oral hypoglycemic agents|oral hypoglycemic agents
568397|NCT00451620|Insulin levels|insulin levels
568398|NCT00451659|PTSD|ptsd
568399|NCT00451659|Veterans|veterans
568400|NCT00451659|Deployed|deployed
568401|NCT00451672|aldosteronism, bromocriptin, hypertension|aldosteronism, bromocriptin, hypertension
568402|NCT00451698|Erythropoietin|erythropoietin
568403|NCT00451698|Congenital heart surgery|congenital heart surgery
568404|NCT00451711|Prophylaxis|prophylaxis
568405|NCT00451711|Liposomal Amphotericin B|liposomal amphotericin b
568406|NCT00451711|Acute myeloid leukaemia|acute myeloid leukaemia
568407|NCT00451711|Invasive Fungal Infections|invasive fungal infections
568408|NCT00451724|Prospective|prospective
568409|NCT00451724|Randomized|randomized
568410|NCT00451724|Double blinded|double blinded
568411|NCT00451724|Sedation|sedation
568412|NCT00451724|Ketamine|ketamine
568413|NCT00451724|Intranasal|intranasal
568414|NCT00451737|Six-minute walk test|six-minute walk test
568415|NCT00451737|Neuromuscular system|neuromuscular system
568416|NCT00451737|Influence factors|influence factors
568417|NCT00451750|phobia|phobia
568418|NCT00451750|cortisol|cortisol
568419|NCT00451750|memory|memory
568420|NCT00451750|treatment|treatment
568421|NCT00451763|Fovea centralis/pathology|fovea centralis/pathology
568422|NCT00451763|Fundus oculi|fundus oculi
568423|NCT00451763|Retinal neovascularization|retinal neovascularization
568424|NCT00451763|Telangiectasis/diagnosis|telangiectasis/diagnosis
568425|NCT00451763|Tomography, optical coherence|tomography, optical coherence
568426|NCT00451763|Vitreous Body/drug effects|vitreous body/drug effects
568427|NCT00451776|cardiac surgery|cardiac surgery
568428|NCT00451776|adrenal insufficiency|adrenal insufficiency
568429|NCT00451776|etomidate|etomidate
568430|NCT00451776|propofol|propofol
568431|NCT00451789|Minor head injury|minor head injury
568432|NCT00451789|iintracranial bleeding|iintracranial bleeding
568433|NCT00451789|traumatic brain injury|traumatic brain injury
568434|NCT00451789|Cranial computed tomography|cranial computed tomography
568435|NCT00451789|anticoagulatory drugs|anticoagulatory drugs
568436|NCT00451802|Biotechnology|biotechnology
568437|NCT00451802|Specimen|specimen
568438|NCT00451802|Health Management Center|health management center
568439|NCT00451828|Statins|statins
568440|NCT00451828|Cholesterol|cholesterol
568441|NCT00451828|Pharmacogenetics|pharmacogenetics
568442|NCT00451841|Cough|cough
568444|NCT00451841|Exhaled breath condensate|exhaled breath condensate
568445|NCT00451854|Drug testing|drug testing
568446|NCT00451854|Adolescence|adolescence
568447|NCT00451854|Student athlete|student athlete
568448|NCT00451854|Substance abuse|substance abuse
568449|NCT00451854|Alcohol use|alcohol use
568450|NCT00451854|Drug use|drug use
568451|NCT00451867|interstitial cystitis research|interstitial cystitis research
568452|NCT00451867|painful bladder syndrome research|painful bladder syndrome research
568453|NCT00451867|pelvic pain research|pelvic pain research
568454|NCT00451867|interstitial cystitis and autoimmune|interstitial cystitis and autoimmune
568455|NCT00451867|interstitial cystitis and cellcept|interstitial cystitis and cellcept
568456|NCT00451867|interstitial cystitis and mycophenolate mofetil|interstitial cystitis and mycophenolate mofetil
568457|NCT00451867|interstitial cystitis and MMF|interstitial cystitis and mmf
568458|NCT00451867|interstitial cystitis and inflammation|interstitial cystitis and inflammation
568459|NCT00451867|inflammatory diseases and immunosupression|inflammatory diseases and immunosupression
568460|NCT00451880|Cancer|cancer
568461|NCT00451880|Solid Tumors|solid tumors
568462|NCT00451880|NSCLC|nsclc
568463|NCT00451893|Inguinal hernia|inguinal hernia
568464|NCT00451893|polypropylene mesh|polypropylene mesh
568465|NCT00451893|heavy-weight mesh|heavy-weight mesh
568466|NCT00451893|light-weight mesh|light-weight mesh
568467|NCT00451919|MRI|mri
568468|NCT00451919|Neuropsychology|neuropsychology
568469|NCT00451932|Malononitrilamide|malononitrilamide
568470|NCT00451932|Immunosuppression|immunosuppression
567948|NCT00457080|OSA|osa
568471|NCT00451932|treatment efficacy|treatment efficacy
568472|NCT00451932|treatment effectiveness|treatment effectiveness
568473|NCT00451958|Degarelix|degarelix
568474|NCT00451958|prostate cancer|prostate cancer
568475|NCT00451984|interleukin-2|interleukin-2
568476|NCT00451984|vaccination|vaccination
568477|NCT00451984|treatment experienced|treatment experienced
568478|NCT00451997|AML|aml
568479|NCT00451997|MDS|mds
568480|NCT00451997|Gleevec|gleevec
568481|NCT00451997|Ara-C|ara-c
568482|NCT00451997|C-Kit Positive Acute Myeloid Leukemia|c-kit positive acute myeloid leukemia
568483|NCT00451997|High-Risk Myelodysplastic Syndromes|high-risk myelodysplastic syndromes
568484|NCT00452010|TENS|tens
568485|NCT00452010|chronic low back pain|chronic low back pain
568486|NCT00452010|chronic lumbo-radiculalgia|chronic lumbo-radiculalgia
568487|NCT00452010|placebo|placebo
568488|NCT00452010|Roland scale|roland scale
568489|NCT00452023|Myeloproliferative Disorders|myeloproliferative disorders
568490|NCT00452023|Essential Thrombocythemia|essential thrombocythemia
568491|NCT00452023|Polycythemia Vera|polycythemia vera
568492|NCT00452023|Pegasys|pegasys
568493|NCT00452023|IFN-alpha2a|ifn-alpha2a
568494|NCT00452023|Pegylated-Interferon Alpha-2A|pegylated-interferon alpha-2a
568495|NCT00452023|PEG-IFNa-2a|peg-ifna-2a
568496|NCT00452036|risk factors|risk factors
568497|NCT00452036|plain x ray|plain x ray
568498|NCT00452036|cranial computed tomography|cranial computed tomography
568499|NCT00452036|minor head injury|minor head injury
568500|NCT00452049|parathyroidectomy|parathyroidectomy
568501|NCT00452049|arterial stiffness|arterial stiffness
568502|NCT00452049|renal function|renal function
568503|NCT00457600|information technology|information technology
568504|NCT00457600|emergency department|emergency department
568505|NCT00457600|medication error|medication error
568506|NCT00457600|quality of care|quality of care
568507|NCT00457600|patient-centered care|patient-centered care
568508|NCT00457613|alkaline phosphatase|alkaline phosphatase
568509|NCT00457613|sepsis|sepsis
568510|NCT00457613|kidney function|kidney function
568511|NCT00457626|Children|children
568512|NCT00457626|pediatrics|pediatrics
568513|NCT00457626|High Blood Pressure|high blood pressure
568514|NCT00457626|Hypertension|hypertension
568515|NCT00457626|Valsartan|valsartan
568516|NCT00457639|lipodystrophy|lipodystrophy
568517|NCT00457652|Rosuvastatin|rosuvastatin
568518|NCT00457652|Caffeine|caffeine
568519|NCT00457652|Ischemia|ischemia
568520|NCT00457652|Reperfusion|reperfusion
568521|NCT00457665|HIV|hiv
568522|NCT00457665|Lipodystrophy|lipodystrophy
568523|NCT00457665|Treatment Experienced|treatment experienced
568524|NCT00457678|Vision loss|vision loss
568525|NCT00457678|Retina|retina
568526|NCT00457678|VEG-F|veg-f
568527|NCT00457678|Fovea|fovea
568528|NCT00457678|AMD|amd
568529|NCT00457691|colorectal neoplasms|colorectal neoplasms
568530|NCT00457704|MRSA|mrsa
568531|NCT00457704|Home Care|home care
568532|NCT00457704|Risk factors|risk factors
568533|NCT00457704|transmissions|transmissions
568534|NCT00457704|observational study|observational study
568535|NCT00457717|myopia, auricular acupoint, atropine, RCT|myopia, auricular acupoint, atropine, rct
568536|NCT00457730|Multiple Sclerosis|multiple sclerosis
568537|NCT00457730|Duloxetine|duloxetine
568538|NCT00457730|Pain|pain
568539|NCT00457743|Evaluate of RTD for Japanese GIST patients|evaluate of rtd for japanese gist patients
568540|NCT00457756|LDL cholesterol|ldl cholesterol
568541|NCT00457756|HDL cholesterol|hdl cholesterol
568542|NCT00457756|natural supplement|natural supplement
568544|NCT00457756|phytosterols|phytosterols
568545|NCT00457756|policosanol|policosanol
568546|NCT00457756|chrysanthemum|chrysanthemum
568547|NCT00457769|Aricept|aricept
568548|NCT00457769|Donepezil|donepezil
568549|NCT00457769|Memory|memory
568550|NCT00457769|vascular dementia|vascular dementia
568551|NCT00457769|stroke|stroke
568552|NCT00457769|functional tasks|functional tasks
568553|NCT00457769|self-generation|self-generation
568554|NCT00457782|Cancer|cancer
568555|NCT00457782|Blood disorders|blood disorders
568556|NCT00457782|Leukaemia, Adult Chronic|leukaemia, adult chronic
568557|NCT00457782|Lymphoma|lymphoma
568558|NCT00457782|Multiple Myeloma|multiple myeloma
568559|NCT00457808|TSC and LAM|tsc and lam
568560|NCT00457808|Tuberous Sclerosis Complex and sporadic LAM|tuberous sclerosis complex and sporadic lam
568561|NCT00457821|G551D mutation|g551d mutation
568562|NCT00457821|Fibrosis|fibrosis
568563|NCT00457821|Pancreatic Diseases|pancreatic diseases
568564|NCT00457821|Digestive System Diseases|digestive system diseases
568565|NCT00457821|Lung Diseases|lung diseases
568566|NCT00457821|Respiratory Tract Diseases|respiratory tract diseases
568567|NCT00457821|Genetic Diseases, Inborn|genetic diseases, inborn
568568|NCT00457821|Infant, Newborn, Diseases|infant, newborn, diseases
568569|NCT00457821|Pathologic Processes|pathologic processes
568570|NCT00457834|Heart failure|heart failure
568571|NCT00457834|Dyssynchrony|dyssynchrony
568007|NCT00457288|Cutaneous Mastocytosis|cutaneous mastocytosis
568572|NCT00457834|Cardiac resynchronization therapy|cardiac resynchronization therapy
568573|NCT00457834|Atrial fibrillation|atrial fibrillation
568574|NCT00457834|RVOT|rvot
568575|NCT00457834|RVapex|rvapex
568576|NCT00457847|PGD|pgd
568577|NCT00457860|CLL|cll
568578|NCT00457860|PLL|pll
568579|NCT00457860|SLL|sll
568580|NCT00457860|Relapse|relapse
568581|NCT00457860|Refractory|refractory
568582|NCT00457860|immunotoxin|immunotoxin
568583|NCT00457860|HA22|ha22
568584|NCT00457860|CAT-8015|cat-8015
568585|NCT00457860|immunotherapy|immunotherapy
568586|NCT00457873|surgery|surgery
568587|NCT00457899|schizophrenia|schizophrenia
568588|NCT00457899|schizoaffective disorder|schizoaffective disorder
568589|NCT00457899|quetiapine|quetiapine
568590|NCT00457899|seroquel|seroquel
568591|NCT00457899|titration|titration
568592|NCT00457925|absorption,|absorption,
568593|NCT00457925|metabolism,|metabolism,
568594|NCT00457925|excretion|excretion
568595|NCT00457925|distribution,|distribution,
568596|NCT00458588|breast cancer|breast cancer
568597|NCT00458601|EGFRvIII vaccinetemozolomidecancer vaccineimmunotherapy|egfrviii vaccinetemozolomidecancer vaccineimmunotherapy
568598|NCT00458614|Cystic Fibrosis|cystic fibrosis
568599|NCT00458627|Plethysmograpy|plethysmograpy
568600|NCT00458627|preschool|preschool
568601|NCT00458627|methacholine challenge|methacholine challenge
568602|NCT00458627|spirometry|spirometry
568603|NCT00458627|asthma|asthma
568604|NCT00458653|DC/tumor cell fusions|dc/tumor cell fusions
568605|NCT00458653|GM-CSF|gm-csf
568606|NCT00458653|high dose chemotherapy|high dose chemotherapy
568607|NCT00458666|Amniotic fluid|amniotic fluid
568608|NCT00458666|D-dimer|d-dimer
568609|NCT00458666|coagulation|coagulation
568610|NCT00458666|factor X activation|factor x activation
568611|NCT00458679|CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL)|chronic lymphocytic leukemia (b-cll)
568612|NCT00458679|CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS|cd40 ligand and il-2-expressing tumor cells
568613|NCT00458705|stage I multiple myeloma|stage i multiple myeloma
568614|NCT00458705|stage II multiple myeloma|stage ii multiple myeloma
568615|NCT00458705|stage III multiple myeloma|stage iii multiple myeloma
568616|NCT00458705|refractory multiple myeloma|refractory multiple myeloma
568617|NCT00458718|abstinence|abstinence
568618|NCT00458718|nicotine patch|nicotine patch
568619|NCT00458744|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
568620|NCT00458744|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
568621|NCT00458744|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
568622|NCT00458744|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
568623|NCT00458744|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
568624|NCT00458744|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
568625|NCT00458744|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
568626|NCT00458744|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
568627|NCT00458744|childhood choroid plexus tumor|childhood choroid plexus tumor
568628|NCT00458744|childhood craniopharyngioma|childhood craniopharyngioma
568629|NCT00458744|childhood infratentorial ependymoma|childhood infratentorial ependymoma
568630|NCT00458744|childhood grade I meningioma|childhood grade i meningioma
568631|NCT00458744|childhood grade II meningioma|childhood grade ii meningioma
568632|NCT00458744|childhood grade III meningioma|childhood grade iii meningioma
568633|NCT00458744|childhood supratentorial ependymoma|childhood supratentorial ependymoma
568634|NCT00458744|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
753192|NCT01175811|Insulin|insulin
568635|NCT00458744|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
568636|NCT00458744|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
568637|NCT00458744|recurrent childhood ependymoma|recurrent childhood ependymoma
568638|NCT00458744|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
569013|NCT00460148|PD|pd
568639|NCT00458744|recurrent childhood supratentorial primitive neuroectodermal tumors|recurrent childhood supratentorial primitive neuroectodermal tumors
568640|NCT00458744|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
568641|NCT00458744|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
568642|NCT00458744|high-grade childhood cerebral astrocytoma|high-grade childhood cerebral astrocytoma
568643|NCT00458744|low-grade childhood cerebral astrocytoma|low-grade childhood cerebral astrocytoma
568644|NCT00458744|recurrent childhood brain tumor|recurrent childhood brain tumor
568645|NCT00458744|childhood spinal cord tumor|childhood spinal cord tumor
568646|NCT00458744|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
568647|NCT00458744|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
568648|NCT00458744|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
568649|NCT00458744|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
568650|NCT00458744|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
568651|NCT00458744|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
568652|NCT00458744|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
568653|NCT00458744|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
568654|NCT00458744|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
568655|NCT00458744|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
568656|NCT00458744|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
568657|NCT00458744|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
568658|NCT00458757|Amputees|amputees
568659|NCT00458757|Affordance|affordance
568660|NCT00458757|Peripersonal space|peripersonal space
568661|NCT00458757|Pseudo neglect|pseudo neglect
568662|NCT00458757|Reaching|reaching
568663|NCT00458757|Spatial|spatial
568664|NCT00458757|visual|visual
568665|NCT00458770|Comparison of a spontaneous acute cluster headache attack and rest (no pain) in ten patients with cluster headache defined with IHS criteria|comparison of a spontaneous acute cluster headache attack and rest (no pain) in ten patients with cluster headache defined with ihs criteria
568666|NCT00458783|Transfusion|transfusion
568667|NCT00458783|Cardiac|cardiac
568668|NCT00458783|Blood storage duration|blood storage duration
568669|NCT00458796|hypercalcemia of malignancy|hypercalcemia of malignancy
568670|NCT00458796|musculoskeletal complications|musculoskeletal complications
568671|NCT00458796|pain|pain
568672|NCT00458796|stage IV breast cancer|stage iv breast cancer
568673|NCT00458796|male breast cancer|male breast cancer
568674|NCT00458796|recurrent breast cancer|recurrent breast cancer
568675|NCT00458796|bone metastases|bone metastases
568676|NCT00458809|recurrent colon cancer|recurrent colon cancer
568677|NCT00458809|stage IV colon cancer|stage iv colon cancer
568678|NCT00458809|carcinoma of the appendix|carcinoma of the appendix
568679|NCT00458809|recurrent rectal cancer|recurrent rectal cancer
568680|NCT00458809|stage IV rectal cancer|stage iv rectal cancer
568681|NCT00458809|primary peritoneal cavity cancer|primary peritoneal cavity cancer
568682|NCT00458822|primary systemic amyloidosis|primary systemic amyloidosis
568683|NCT00458835|Allergic rhinitis|allergic rhinitis
568684|NCT00458848|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
568685|NCT00458848|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
568686|NCT00458848|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
568687|NCT00458848|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
568688|NCT00458848|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
568689|NCT00458848|TdT positive adult acute lymphoblastic leukemia|tdt positive adult acute lymphoblastic leukemia
568690|NCT00458861|Active Rheumatoid Arthritis (RA)|active rheumatoid arthritis (ra)
568691|NCT00458874|CV risk factors|cv risk factors
568692|NCT00458874|subclinical atherosclerosis|subclinical atherosclerosis
568693|NCT00458874|lifestyle intervention|lifestyle intervention
568694|NCT00458874|motivation|motivation
568695|NCT00458887|ototoxicity|ototoxicity
568696|NCT00458887|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
568697|NCT00458913|localized malignant mesothelioma|localized malignant mesothelioma
568698|NCT00458913|recurrent malignant mesothelioma|recurrent malignant mesothelioma
568699|NCT00458913|advanced malignant mesothelioma|advanced malignant mesothelioma
568700|NCT00458926|ventilation, mechanical|ventilation, mechanical
568701|NCT00458926|intubation, endotracheal|intubation, endotracheal
568702|NCT00458926|respiratory insufficiency|respiratory insufficiency
568703|NCT00458952|MIBG|mibg
568704|NCT00458952|iobenguane|iobenguane
568705|NCT00458952|iodine|iodine
568706|NCT00458952|I 131|i 131
568707|NCT00458952|radiotherapy|radiotherapy
568708|NCT00458952|radiopharmaceutical|radiopharmaceutical
568709|NCT00458952|dosimetry|dosimetry
568710|NCT00458952|neuroendocrine tumor|neuroendocrine tumor
568711|NCT00458952|Ultratrace|ultratrace
568712|NCT00458952|no carrier added|no carrier added
568713|NCT00458952|metaiodobenzyl-guanidine|metaiodobenzyl-guanidine
568714|NCT00458991|Recombinant Human Growth Hormone|recombinant human growth hormone
568715|NCT00458991|growth hormone deficiency|growth hormone deficiency
568716|NCT00458991|short stature|short stature
568717|NCT00458991|phenotyping|phenotyping
568718|NCT00459004|weight loss|weight loss
568719|NCT00459017|24 hour ambulatory blood pressure measurement|24 hour ambulatory blood pressure measurement
568720|NCT00459017|Mean blood pressure|mean blood pressure
568721|NCT00459017|Wrist manometer|wrist manometer
568722|NCT00459017|Frequent measurement|frequent measurement
568723|NCT00459030|colon cancer|colon cancer
568724|NCT00459030|rectal cancer|rectal cancer
568725|NCT00459043|SCCHN|scchn
568726|NCT00459069|tumor vaccine|tumor vaccine
568727|NCT00459069|GM-CSF|gm-csf
568728|NCT00459082|Dexmedetomine|dexmedetomine
568729|NCT00459082|Post-operative cardiac surgery|post-operative cardiac surgery
568730|NCT00459121|stage I non-small cell lung cancer|stage i non-small cell lung cancer
568731|NCT00459121|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
568732|NCT00459121|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
568733|NCT00459134|sexual dysfunction|sexual dysfunction
568734|NCT00459134|sexuality and reproductive issues|sexuality and reproductive issues
568735|NCT00459134|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
568736|NCT00459160|Hypotensive Resuscitation|hypotensive resuscitation
568737|NCT00459160|Hypotensive Anesthesia|hypotensive anesthesia
568738|NCT00459160|Hemorrhagic Shock|hemorrhagic shock
568739|NCT00459160|Penetrating Trauma|penetrating trauma
568740|NCT00459173|abstinence|abstinence
568741|NCT00459173|maintenance|maintenance
568742|NCT00459186|prostate cancer|prostate cancer
568743|NCT00459186|RAD001|rad001
568744|NCT00459186|mTOR inhibition|mtor inhibition
568745|NCT00459186|docetaxel|docetaxel
568746|NCT00459225|Pediatrics|pediatrics
568747|NCT00459225|Cardiac Defect|cardiac defect
568748|NCT00459225|Cardiac Surgery|cardiac surgery
568749|NCT00459225|Single Ventricle|single ventricle
568750|NCT00459225|Anemia|anemia
568751|NCT00459225|blood transfusions|blood transfusions
568752|NCT00459225|red cell volume|red cell volume
568753|NCT00459225|red cell distribution|red cell distribution
568754|NCT00459225|oral iron|oral iron
568755|NCT00459225|ferrous sulfate|ferrous sulfate
568756|NCT00459225|Congenital Cardiac Defects|congenital cardiac defects
568757|NCT00459225|Hemoglobin|hemoglobin
568758|NCT00459225|Iron Deficiency|iron deficiency
568759|NCT00459238|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
568760|NCT00459251|N-acetyltransferase|n-acetyltransferase
568761|NCT00459251|Pharmacogenetics|pharmacogenetics
568762|NCT00459264|Folic Acid|folic acid
568763|NCT00459264|Prevention|prevention
568764|NCT00459264|Depression|depression
568765|NCT00459264|Bipolar Disorder|bipolar disorder
568766|NCT00459264|Teenagers|teenagers
568767|NCT00459277|Pain|pain
568768|NCT00459277|Cancer|cancer
568769|NCT00459290|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
568770|NCT00459290|primary peritoneal cavity cancer|primary peritoneal cavity cancer
568771|NCT00459290|fallopian tube cancer|fallopian tube cancer
568772|NCT00459303|cataract|cataract
568773|NCT00459303|aspherical intraocular lenses|aspherical intraocular lenses
568774|NCT00459303|functional vision|functional vision
568775|NCT00459329|Depression|depression
568776|NCT00459329|Epilepsy|epilepsy
568777|NCT00459329|Problem-Solving Therapy|problem-solving therapy
568778|NCT00459329|Mental Health|mental health
568779|NCT00459329|Neurology|neurology
568780|NCT00459329|Home-based health care|home-based health care
568781|NCT00459329|Community-based program|community-based program
568782|NCT00459329|Collaborative care|collaborative care
568783|NCT00459355|Alzheimer's disease|alzheimer's disease
568784|NCT00459355|Dementia|dementia
568785|NCT00459355|Safety|safety
568786|NCT00459355|Home Care Services|home care services
568787|NCT00459368|asthma|asthma
568788|NCT00459368|patient compliance|patient compliance
568789|NCT00459368|metered dose inhalers|metered dose inhalers
568790|NCT00459368|corticosteroids|corticosteroids
568791|NCT00459368|health behaviour|health behaviour
568792|NCT00459368|prevention & control|prevention & control
568793|NCT00459420|Parkinson's disease|parkinson's disease
568794|NCT00459420|Excessive Daytime Somnolence|excessive daytime somnolence
568795|NCT00459420|Caffeine|caffeine
568796|NCT00459420|Disease-Modifying|disease-modifying
568797|NCT00459433|Low back pain|low back pain
568798|NCT00459433|Return to work|return to work
568799|NCT00459433|Biopsychosocial|biopsychosocial
568800|NCT00459433|Screening|screening
568801|NCT00459433|SMS|sms
568802|NCT00459433|Non specific low back pain|non specific low back pain
568803|NCT00459446|Magnetic Resonance Imaging|magnetic resonance imaging
568804|NCT00459446|Gadolinium Contrast|gadolinium contrast
568805|NCT00459446|Gadofosveset|gadofosveset
568806|NCT00459446|Atherosclerosis|atherosclerosis
568807|NCT00459446|Chronic Total Arterial Occlusions|chronic total arterial occlusions
568808|NCT00459446|Cardiovascular Disease|cardiovascular disease
568809|NCT00459446|Blocked Arteries|blocked arteries
568810|NCT00459446|Peripheral Artery Disease|peripheral artery disease
568811|NCT00459446|PAD|pad
568812|NCT00459446|Intermittent Claudication|intermittent claudication
569014|NCT00460161|acupuncture|acupuncture
568813|NCT00459446|Chronic Total Arterial Occlusion|chronic total arterial occlusion
568814|NCT00459472|resident training|resident training
568815|NCT00459472|laparoscopy|laparoscopy
568816|NCT00459472|virtual reality|virtual reality
568817|NCT00459472|surgical education|surgical education
568818|NCT00459485|Plasm zinc concentration|plasm zinc concentration
568819|NCT00459485|Zinc supplementation|zinc supplementation
568820|NCT00459485|Assessment of zinc status|assessment of zinc status
568821|NCT00459485|Plasma zinc concentration|plasma zinc concentration
568823|NCT00459498|thyroid adenoma|thyroid adenoma
568824|NCT00459498|thyroid cancer|thyroid cancer
568825|NCT00459498|Iodine uptake|iodine uptake
568826|NCT00459498|expression|expression
568827|NCT00459511|Adrenomedullin|adrenomedullin
568828|NCT00459511|Glucose|glucose
568829|NCT00459511|Insulin|insulin
568830|NCT00459511|Systemic Inflammatory response Syndrome|systemic inflammatory response syndrome
568831|NCT00459511|Pediatric|pediatric
568832|NCT00459511|Cortisol|cortisol
568833|NCT00459511|ACTH|acth
568834|NCT00459524|Acute Myelogenous Leukemia|acute myelogenous leukemia
568835|NCT00459524|Myelodysplastic Syndrome|myelodysplastic syndrome
568836|NCT00459524|Leukemia|leukemia
568837|NCT00459524|Quality of Life|quality of life
568838|NCT00459524|Questionnaire|questionnaire
568839|NCT00459524|Survey|survey
568840|NCT00459524|Neurocognitive Function|neurocognitive function
568841|NCT00459524|AML|aml
568842|NCT00459524|MDS|mds
568843|NCT00459524|QOL|qol
568844|NCT00459537|Toenail fungus|toenail fungus
568845|NCT00459537|Onychomycosis|onychomycosis
568846|NCT00459537|Nail fungus|nail fungus
568847|NCT00459537|Toenail fungal infection|toenail fungal infection
568848|NCT00459537|Tinea unguium|tinea unguium
568849|NCT00459537|Dermatophytes|dermatophytes
568850|NCT00459537|Foot dermatoses|foot dermatoses
568851|NCT00459550|Alzheimer's Disease|alzheimer's disease
568852|NCT00459550|First Time in Human (FTIH) Study|first time in human (ftih) study
568853|NCT00459563|vitamin D|vitamin d
568854|NCT00459563|blood pressure|blood pressure
568855|NCT00459563|hypertension|hypertension
568856|NCT00459563|Vitamin D insufficient|vitamin d insufficient
568857|NCT00459563|Systolic blood pressure between 130 and 150 mmHg|systolic blood pressure between 130 and 150 mmhg
568858|NCT00459576|Asthma|asthma
568859|NCT00459576|Eczema|eczema
568860|NCT00459576|Dermatitis, Atopic|dermatitis, atopic
568861|NCT00459576|Infant|infant
568862|NCT00459589|Cancer|cancer
568863|NCT00459589|elderly|elderly
568864|NCT00459589|malnutrition|malnutrition
568865|NCT00459589|chemotherapy|chemotherapy
568866|NCT00459589|survival|survival
568867|NCT00459589|comprehensive geriatric assessment|comprehensive geriatric assessment
568868|NCT00459589|morbidity|morbidity
568869|NCT00459602|laparoscopic surgery|laparoscopic surgery
568870|NCT00459628|early breast cancer|early breast cancer
568871|NCT00459628|post-operative radiation treatment|post-operative radiation treatment
568872|NCT00459641|Osteogenic Gel|osteogenic gel
568873|NCT00459641|Solitary Bone Cysts|solitary bone cysts
568874|NCT00459654|HRPC|hrpc
568875|NCT00459654|Recurrent Prostate Cancer|recurrent prostate cancer
568876|NCT00459654|Metastatic Cancer|metastatic cancer
568877|NCT00459667|Relapsing multiple sclerosis|relapsing multiple sclerosis
568878|NCT00459667|interferon beta 1b|interferon beta 1b
568879|NCT00459667|Betaferon|betaferon
568880|NCT00459667|Betaseron|betaseron
568881|NCT00459680|hypertension|hypertension
568882|NCT00459680|acupuncture|acupuncture
568883|NCT00459680|laser|laser
568884|NCT00459693|HIV-Dementia|hiv-dementia
568885|NCT00459693|Brain|brain
568886|NCT00459693|PET|pet
568887|NCT00459693|PBR28|pbr28
568888|NCT00459693|MCMD|mcmd
568889|NCT00459693|HIV Positive|hiv positive
568890|NCT00459693|HIV Dementia|hiv dementia
568891|NCT00459693|AIDS Related Dementia|aids related dementia
568892|NCT00459693|Minor Cognitive Motor Disorder|minor cognitive motor disorder
568893|NCT00459693|Healthy Volunteer|healthy volunteer
568894|NCT00459693|HV|hv
568895|NCT00459706|Rheumatoid Arthritis|rheumatoid arthritis
568896|NCT00459719|Liver Transplantation|liver transplantation
568897|NCT00459719|Tacrolimus|tacrolimus
568898|NCT00459719|Methylprednisolone|methylprednisolone
568899|NCT00459719|Prednisolone|prednisolone
568900|NCT00459732|zinc, thalassemia, bone mineral density|zinc, thalassemia, bone mineral density
568901|NCT00459745|Cardiovascular Disease|cardiovascular disease
568902|NCT00459745|Fenofibrate|fenofibrate
568903|NCT00459745|LDL cholesterol|ldl cholesterol
568904|NCT00459745|HDL cholesterol|hdl cholesterol
568905|NCT00459745|Hyperlipidemia|hyperlipidemia
568906|NCT00459745|Pravastatin|pravastatin
568907|NCT00459745|Triglycerides|triglycerides
568908|NCT00459758|hypertension|hypertension
568909|NCT00459758|Hans|hans
568910|NCT00459758|Electrical stimulation|electrical stimulation
569112|NCT00460460|cancer|cancer
568911|NCT00459771|angiotensin II-receptor (AT1) blocker|angiotensin ii-receptor (at1) blocker
568912|NCT00459771|prevention|prevention
568913|NCT00459771|trastuzumab|trastuzumab
568914|NCT00459771|cardiotoxicity|cardiotoxicity
568915|NCT00459784|Improvement|improvement
568916|NCT00459784|Dementia early diagnosis|dementia early diagnosis
568917|NCT00459784|Dementia management|dementia management
568918|NCT00459784|Primary care|primary care
568919|NCT00459797|GlideScope|glidescope
568920|NCT00459797|cobalt|cobalt
568921|NCT00459797|single-use|single-use
568922|NCT00459797|intubation|intubation
568923|NCT00459797|airway|airway
568924|NCT00459797|Elective surgical patients requiring orotracheal intubation|elective surgical patients requiring orotracheal intubation
568925|NCT00459810|adenocarcinoma of the prostate|adenocarcinoma of the prostate
568926|NCT00459810|recurrent prostate cancer|recurrent prostate cancer
568927|NCT00459810|stage IV prostate cancer|stage iv prostate cancer
568928|NCT00459823|Cancer|cancer
568929|NCT00459823|solid tumors|solid tumors
568388|NCT00451594|ITP|itp
568930|NCT00459836|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
568931|NCT00459849|Melanoma|melanoma
568932|NCT00459849|Brachytherapy|brachytherapy
568933|NCT00459849|Ultrasonography|ultrasonography
568934|NCT00459875|recurrent renal cell cancer|recurrent renal cell cancer
568935|NCT00459875|stage IV renal cell cancer|stage iv renal cell cancer
568937|NCT00459888|Critical Limb Ischemia|critical limb ischemia
568938|NCT00459888|Infrapopliteal|infrapopliteal
568939|NCT00459888|Cryoplasty|cryoplasty
568940|NCT00459901|Metastatic Colorectal Cancer|metastatic colorectal cancer
568941|NCT00459914|sleep apnea|sleep apnea
568942|NCT00459914|refractory hypertension|refractory hypertension
568943|NCT00459914|continuous positive airway pressure|continuous positive airway pressure
568944|NCT00459927|Adenotonsillectomy|adenotonsillectomy
568945|NCT00459927|Coblation tonsillectomy|coblation tonsillectomy
568946|NCT00459927|Floseal|floseal
568947|NCT00459940|Growth hormone|growth hormone
568948|NCT00459940|Lipolysis|lipolysis
568949|NCT00459940|Insulin resistance|insulin resistance
568950|NCT00459940|Pioglitazone|pioglitazone
569203|NCT00460811|linaclotide acetate|linaclotide acetate
568951|NCT00459940|Growth hormone replaced growth hormone deficient adults|growth hormone replaced growth hormone deficient adults
568952|NCT00459979|clear cell renal cell carcinoma|clear cell renal cell carcinoma
568953|NCT00459979|stage III renal cell cancer|stage iii renal cell cancer
568954|NCT00459979|stage IV renal cell cancer|stage iv renal cell cancer
568955|NCT00459979|papillary renal cell carcinoma|papillary renal cell carcinoma
568956|NCT00459992|Obesity|obesity
568957|NCT00459992|Weight Gain|weight gain
568958|NCT00459992|Adult|adult
568959|NCT00459992|Histamine|histamine
568960|NCT00459992|Metabolism|metabolism
568961|NCT00459992|Overweight|overweight
568962|NCT00460005|Migraine|migraine
568963|NCT00460005|headache|headache
568964|NCT00460005|observational|observational
568965|NCT00460018|Gestational Diabetes Mellitus|gestational diabetes mellitus
568966|NCT00460018|Weight Loss|weight loss
568967|NCT00460018|Physical Activity|physical activity
568968|NCT00460018|Breastfeeding|breastfeeding
568969|NCT00460018|Pregnancy|pregnancy
568970|NCT00460018|Postpartum|postpartum
568971|NCT00460018|Intervention|intervention
568972|NCT00460018|Prevention|prevention
568973|NCT00460031|adenocarcinoma of the prostate|adenocarcinoma of the prostate
568974|NCT00460031|stage III prostate cancer|stage iii prostate cancer
568975|NCT00460031|stage IV prostate cancer|stage iv prostate cancer
568976|NCT00460031|recurrent prostate cancer|recurrent prostate cancer
568977|NCT00460044|ADMA|adma
568978|NCT00460044|Preterms|preterms
568979|NCT00460044|infants|infants
568980|NCT00460044|mechanical ventilation|mechanical ventilation
568981|NCT00460044|Preterm infants|preterm infants
568982|NCT00460057|osteoporosis|osteoporosis
568983|NCT00460057|alendronate|alendronate
568984|NCT00460057|bone marker|bone marker
568985|NCT00460083|Atopic Dermatitis|atopic dermatitis
568986|NCT00460083|eczema|eczema
568987|NCT00460083|dermatitis|dermatitis
568988|NCT00460083|skin barrier|skin barrier
568989|NCT00460083|barrier repair|barrier repair
568990|NCT00460083|ceramide|ceramide
568991|NCT00460083|physiologic lipid|physiologic lipid
568992|NCT00460083|pruritus|pruritus
568993|NCT00460083|Elidel|elidel
568994|NCT00460083|Epiceram|epiceram
568995|NCT00460083|topical steroid|topical steroid
568996|NCT00460096|Pulmonary Emphysema|pulmonary emphysema
568997|NCT00460109|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
568998|NCT00460109|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
568999|NCT00460109|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
569000|NCT00460109|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
569001|NCT00460122|Human Leukocyte Antigens (HLA)|human leukocyte antigens (hla)
569002|NCT00460122|Transfusion Reactions|transfusion reactions
569003|NCT00460122|Platelet Donors|platelet donors
569004|NCT00460135|Resistance|resistance
569005|NCT00460135|Training|training
569006|NCT00460135|Obesity|obesity
569007|NCT00460135|Children|children
569008|NCT00460148|ropinirole PR/CR,|ropinirole pr/cr,
569009|NCT00460148|pharmacokinetic,|pharmacokinetic,
569010|NCT00460148|formulation,|formulation,
569011|NCT00460148|food effect,|food effect,
569012|NCT00460148|SK&F101468,|sk&f101468,
569015|NCT00460161|amputation|amputation
569016|NCT00460161|phantom limb pain|phantom limb pain
569017|NCT00460174|stage I pancreatic cancer|stage i pancreatic cancer
569018|NCT00460174|stage II pancreatic cancer|stage ii pancreatic cancer
569019|NCT00460174|stage III pancreatic cancer|stage iii pancreatic cancer
569020|NCT00460187|carotid artery, distal protection device, carotid stenting|carotid artery, distal protection device, carotid stenting
569021|NCT00460200|depression|depression
569022|NCT00460200|fatigue|fatigue
569023|NCT00460200|sleep disorders|sleep disorders
569024|NCT00460200|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
569025|NCT00460200|ovarian epithelial cancer|ovarian epithelial cancer
569026|NCT00460213|home blood pressure|home blood pressure
569027|NCT00460226|Korean|korean
569028|NCT00460226|Bipolar I disorder|bipolar i disorder
569029|NCT00460226|Non-serious rash|non-serious rash
569030|NCT00460226|Lamotrigine|lamotrigine
569031|NCT00460239|Opioid addiction|opioid addiction
569032|NCT00460239|Opioid dependence|opioid dependence
569033|NCT00460239|Buprenorphine|buprenorphine
569034|NCT00460252|algorithm|algorithm
569035|NCT00460252|insulin|insulin
569036|NCT00460252|hyperglycemia|hyperglycemia
569037|NCT00460252|tight glycemic control|tight glycemic control
569038|NCT00460252|intensive care|intensive care
569039|NCT00460252|adults|adults
569040|NCT00460265|Squamous Cell Carcinoma|squamous cell carcinoma
569041|NCT00460265|Epidermal Growth Factor|epidermal growth factor
569042|NCT00460265|Epidermal Growth Factor Receptor|epidermal growth factor receptor
569043|NCT00460265|SCCHN|scchn
569044|NCT00460265|Metastatic Head and Neck Cancer|metastatic head and neck cancer
569045|NCT00460265|EGFr|egfr
569046|NCT00460265|Head and Neck Cancer|head and neck cancer
569047|NCT00460265|Recurrent Head and Neck Cancer|recurrent head and neck cancer
569048|NCT00460278|Cancer|cancer
569049|NCT00460278|Solid Tumors|solid tumors
569050|NCT00460291|PAD|pad
569051|NCT00460291|vein bypass|vein bypass
569052|NCT00460291|supported varicose veins|supported varicose veins
569053|NCT00460304|Type I diabetes|type i diabetes
569054|NCT00460304|Insulin pump|insulin pump
569055|NCT00460304|Continuous glucose monitoring|continuous glucose monitoring
569056|NCT00460304|Insulin to carbohydrate ratio|insulin to carbohydrate ratio
569057|NCT00460304|Correction factor|correction factor
569058|NCT00460304|Pramlintide|pramlintide
569059|NCT00460317|lung|lung
569060|NCT00460317|cancer|cancer
569061|NCT00460317|chemotherapy|chemotherapy
569062|NCT00460317|paclitaxel|paclitaxel
569063|NCT00460317|carboplatin|carboplatin
569064|NCT00460317|placebo|placebo
569065|NCT00460317|angiogenesis|angiogenesis
569066|NCT00460317|VEGF|vegf
569067|NCT00460317|multi kinase inhibitor|multi kinase inhibitor
569068|NCT00460330|diagnosis|diagnosis
569069|NCT00460330|galactomannan|galactomannan
569070|NCT00460330|glucan|glucan
569071|NCT00460330|real-time PCR|real-time pcr
569072|NCT00460330|invasive fungal infection|invasive fungal infection
569073|NCT00460330|aspergillosis|aspergillosis
569074|NCT00460330|Chinese patients|chinese patients
569075|NCT00460343|patient non-adherence|patient non-adherence
569076|NCT00460343|antihypertensive agents|antihypertensive agents
569077|NCT00460343|community pharmacy services|community pharmacy services
569078|NCT00460343|professional roles|professional roles
569079|NCT00460369|uncomplicated malaria|uncomplicated malaria
569080|NCT00460369|children|children
569081|NCT00460369|treatment|treatment
569082|NCT00460369|effectiveness|effectiveness
569083|NCT00460382|HIV infections|hiv infections
569084|NCT00460382|HIV integrase inhibitor|hiv integrase inhibitor
569085|NCT00460382|etravirine|etravirine
569086|NCT00460382|darunavir|darunavir
569087|NCT00460382|MK 0518|mk 0518
569088|NCT00460382|raltegravir|raltegravir
569089|NCT00460382|Treatment Experienced|treatment experienced
569090|NCT00460382|Antiviral drug resistance|antiviral drug resistance
569091|NCT00460395|Brain Metastasis|brain metastasis
569092|NCT00460395|Cerebral Metastases|cerebral metastases
569093|NCT00460395|Brain Cancer|brain cancer
569094|NCT00460395|Stereotactic Radiosurgery|stereotactic radiosurgery
569095|NCT00460395|Craniotomy|craniotomy
569096|NCT00460408|Macular degeneration|macular degeneration
569097|NCT00460408|Safety|safety
569098|NCT00460408|Non-interventional|non-interventional
569099|NCT00460408|Non-randomized|non-randomized
569100|NCT00460421|Oral Mucositis|oral mucositis
569101|NCT00460421|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
569102|NCT00460421|Acute Myeloid Leukemia|acute myeloid leukemia
569103|NCT00460421|Palifermin|palifermin
569104|NCT00460421|Kepivance|kepivance
569105|NCT00460434|Prolapse|prolapse
569106|NCT00460434|Urinary incontinence|urinary incontinence
569107|NCT00460434|TVT|tvt
569108|NCT00460447|anti-CD33|anti-cd33
569109|NCT00460447|Immunotoxin|immunotoxin
569110|NCT00460447|Acute myeloid leukemia|acute myeloid leukemia
569113|NCT00460460|lymphoma|lymphoma
569114|NCT00460460|leukemia|leukemia
569115|NCT00460460|myeloma|myeloma
569116|NCT00460460|AML|aml
569117|NCT00460460|ALL|all
569118|NCT00460460|NHL|nhl
569119|NCT00460460|MM|mm
569120|NCT00460473|Mental Health|mental health
569121|NCT00460473|Neurological Disease|neurological disease
569122|NCT00460473|Hip Injuries and Disorders|hip injuries and disorders
569123|NCT00460499|Diabetes|diabetes
569124|NCT00460512|Schizophrenia|schizophrenia
569125|NCT00460512|Flexible dosing|flexible dosing
569126|NCT00460512|Non-acute patients|non-acute patients
569127|NCT00460512|Antipsychotic|antipsychotic
569128|NCT00460512|Atypical|atypical
569129|NCT00460512|INVEGA|invega
569130|NCT00460525|malaria, Mali, children, Plasmodium falciparum, vaccine|malaria, mali, children, plasmodium falciparum, vaccine
569131|NCT00460538|Seasonal allergic rhinitis|seasonal allergic rhinitis
569132|NCT00460538|lectranal|lectranal
569133|NCT00460538|allergy|allergy
569134|NCT00460564|Spasticity|spasticity
569135|NCT00460564|Post-Stroke|post-stroke
569136|NCT00460564|botulinum toxin type A|botulinum toxin type a
569137|NCT00460564|Upper Limb|upper limb
569138|NCT00460577|Asthma, Formoterol, Bronchial Obstruction, Children|asthma, formoterol, bronchial obstruction, children
569139|NCT00460590|Tuberculosis|tuberculosis
569140|NCT00460590|TB|tb
569141|NCT00460590|MVA 85A|mva 85a
569142|NCT00460603|GI neoplasms (phase 1)|gi neoplasms (phase 1)
569143|NCT00460616|Prolactin|prolactin
569144|NCT00460616|Prolactinomas|prolactinomas
569145|NCT00460616|Dopamine-Agonists|dopamine-agonists
569146|NCT00460616|Cabergoline|cabergoline
569147|NCT00460616|Cardiac valve disease|cardiac valve disease
569148|NCT00460629|Adoptive immunotherapy|adoptive immunotherapy
569149|NCT00460629|BCR-ABL reactive T cells|bcr-abl reactive t cells
569150|NCT00460629|Allogeneic Transplantation|allogeneic transplantation
569151|NCT00460642|Frozen embryo transfers (FET).|frozen embryo transfers (fet).
569152|NCT00460642|Egg donation (ED).|egg donation (ed).
569153|NCT00460642|IVF.|ivf.
569154|NCT00460642|ART.|art.
569155|NCT00460642|Implantation.|implantation.
569156|NCT00460642|GnRH antagonist.|gnrh antagonist.
569157|NCT00460642|Cetrotide.|cetrotide.
569158|NCT00460642|Endometrial response.|endometrial response.
569159|NCT00460642|Infertility treatments:|infertility treatments:
569160|NCT00460642|Transfer of embryos from egg donation (ED) to recipients.|transfer of embryos from egg donation (ed) to recipients.
569161|NCT00460655|Post-Stroke|post-stroke
569162|NCT00460655|Lower Limb|lower limb
569163|NCT00460655|botulinum toxin type A|botulinum toxin type a
569164|NCT00460655|Spasticity|spasticity
569165|NCT00460668|elective thoracotomy|elective thoracotomy
569166|NCT00460668|pulmonary rehabilitation|pulmonary rehabilitation
569167|NCT00460668|quality of life|quality of life
569168|NCT00460681|Hepatocellular Carcinoma|hepatocellular carcinoma
569169|NCT00460681|Thymopentin|thymopentin
569170|NCT00460681|Recurrence|recurrence
569171|NCT00460681|Resection|resection
569172|NCT00460694|allogeneic transplant|allogeneic transplant
569173|NCT00460694|haematological malignancies|haematological malignancies
569174|NCT00460694|allogeneic CIK cells|allogeneic cik cells
569175|NCT00460707|GW679769|gw679769
569176|NCT00460707|healthy adult subjects|healthy adult subjects
569177|NCT00460707|casopitant|casopitant
569178|NCT00460707|ketoconazole|ketoconazole
569179|NCT00460720|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
569180|NCT00460720|ADHD|adhd
569181|NCT00460720|Methylphenidate|methylphenidate
569182|NCT00460720|MPH|mph
569183|NCT00460720|Extended-Release Methylphenidate|extended-release methylphenidate
569184|NCT00460746|HIV|hiv
569185|NCT00460746|AIDS|aids
569186|NCT00460746|Immunodeficiency Virus, Human|immunodeficiency virus, human
569187|NCT00460746|PREZISTA|prezista
569188|NCT00460746|darunavir|darunavir
569189|NCT00460746|TMC114|tmc114
569190|NCT00460746|TMC125|tmc125
569191|NCT00460746|Protease Inhibitor|protease inhibitor
569192|NCT00460746|Non-Nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
569193|NCT00460746|enfuvirtide|enfuvirtide
569194|NCT00460746|Treatment Experienced|treatment experienced
569195|NCT00460759|Mycobacterium tuberculosis, rifapentine, moxifloxacin|mycobacterium tuberculosis, rifapentine, moxifloxacin
569196|NCT00460798|Sunitinib|sunitinib
569197|NCT00460798|kidney diseases|kidney diseases
569198|NCT00460798|urogenital neoplasms|urogenital neoplasms
569199|NCT00460798|kidney cancer|kidney cancer
569200|NCT00460811|Irritable Bowel Syndrome with Constipation|irritable bowel syndrome with constipation
569201|NCT00460811|IBS|ibs
569202|NCT00460811|Irritable Bowel Syndrome|irritable bowel syndrome
569204|NCT00460811|linaclotide|linaclotide
569205|NCT00460811|MD-1100|md-1100
569206|NCT00460824|transplant|transplant
569207|NCT00460824|HLA antibodies matching|hla antibodies matching
569208|NCT00460824|immunologic mismatching|immunologic mismatching
569209|NCT00460837|colorectal cancer|colorectal cancer
569210|NCT00460837|bowel preparation regimen|bowel preparation regimen
569211|NCT00460837|patients with symptoms attributable to colorectal cancer|patients with symptoms attributable to colorectal cancer
569212|NCT00460863|sleep|sleep
569213|NCT00460863|hemodialysis|hemodialysis
569214|NCT00460863|daytime sleepiness|daytime sleepiness
569215|NCT00460863|temperature|temperature
569216|NCT00460876|topotecan|topotecan
569217|NCT00460876|periocular|periocular
569218|NCT00460876|chemotherapy|chemotherapy
569219|NCT00460889|hand assist|hand assist
569220|NCT00460889|laparoscopy|laparoscopy
569221|NCT00460889|renal donor|renal donor
569222|NCT00460889|outcomes|outcomes
569223|NCT00460902|TMS|tms
569224|NCT00460902|drug resistant depression|drug resistant depression
569225|NCT00460915|Lacidipine|lacidipine
569226|NCT00460915|Amlodipine|amlodipine
569227|NCT00460928|congenital heart block|congenital heart block
569228|NCT00460928|neonatal lupus|neonatal lupus
735543|NCT01105000|HPV|hpv
569229|NCT00460928|systemic lupus erythematosus|systemic lupus erythematosus
569230|NCT00460928|Sjogren syndrome|sjogren syndrome
569231|NCT00460928|autoantibodies|autoantibodies
569232|NCT00460928|SSA/Ro|ssa/ro
569233|NCT00460928|SSB/La|ssb/la
569234|NCT00460928|autoimmunity|autoimmunity
569235|NCT00460928|pregnancy|pregnancy
569236|NCT00460928|intravenous immune globulin|intravenous immune globulin
569237|NCT00460928|IVIG|ivig
569238|NCT00460928|immunoglobulin|immunoglobulin
569239|NCT00460967|non-Exudative (Dry) Age-Related Macular Degeneration|non-exudative (dry) age-related macular degeneration
569240|NCT00460980|resident training|resident training
569241|NCT00460980|laparoscopic skills|laparoscopic skills
569242|NCT00460980|surgical skills assessment|surgical skills assessment
569243|NCT00460993|Aging|aging
569244|NCT00460993|Sleep|sleep
569245|NCT00460993|Nursing Home|nursing home
569246|NCT00460993|Sleep in nursing homes|sleep in nursing homes
569247|NCT00461045|multiple myeloma|multiple myeloma
569248|NCT00461045|proteasome inhibitor|proteasome inhibitor
569249|NCT00461045|relapsed|relapsed
569250|NCT00461045|refractory|refractory
569251|NCT00461071|Bulimia nervosa|bulimia nervosa
569252|NCT00461071|Guided Self-help|guided self-help
569253|NCT00461071|Psycho-education|psycho-education
569254|NCT00461084|Lymphoma|lymphoma
569255|NCT00461084|Advanced Stage|advanced stage
569256|NCT00461084|Untreated|untreated
569257|NCT00461084|Advanced Stage Lymphoma|advanced stage lymphoma
569258|NCT00461084|Untreated Lymphoma|untreated lymphoma
569259|NCT00461084|07-038|07-038
569260|NCT00461097|Egg Allergy|egg allergy
569261|NCT00461097|Egg Oral Immunotherapy (OIT)|egg oral immunotherapy (oit)
569262|NCT00461097|Food Allergy|food allergy
569263|NCT00461136|Time course|time course
569264|NCT00461136|antiproteinuric|antiproteinuric
569265|NCT00461136|blood pressure|blood pressure
569266|NCT00461136|lowering effect|lowering effect
569267|NCT00461136|initiation of renin inhibition|initiation of renin inhibition
569268|NCT00461136|Aliskiren in Type 2 diabetes|aliskiren in type 2 diabetes
569269|NCT00461136|incipient and/or established nephropathy|incipient and/or established nephropathy
569270|NCT00461149|Acromegaly|acromegaly
569271|NCT00461149|GH|gh
569272|NCT00461149|IGF-I|igf-i
569273|NCT00461149|Pituitary tumors|pituitary tumors
569274|NCT00461149|Octreotide|octreotide
569275|NCT00454948|Obesity prevention|obesity prevention
569276|NCT00454948|Dietary intake|dietary intake
569277|NCT00454948|Physical activity|physical activity
569278|NCT00454948|Mexican American|mexican american
569279|NCT00454948|Family Characteristics|family characteristics
569280|NCT00454961|Malaria|malaria
569281|NCT00454961|Plasmodium falciparum|plasmodium falciparum
569282|NCT00454961|artemether-lumefantrine|artemether-lumefantrine
569283|NCT00454961|effectiveness|effectiveness
569284|NCT00454974|end stage renal failure|end stage renal failure
569285|NCT00454974|dialysis|dialysis
569286|NCT00454974|wearable artificial kidney|wearable artificial kidney
569287|NCT00454987|antibody persistence|antibody persistence
569288|NCT00454987|Meningococcal serogroup C vaccine|meningococcal serogroup c vaccine
569289|NCT00454987|conjugate vaccine|conjugate vaccine
569290|NCT00454987|Haemophilus influenzae type b vaccine|haemophilus influenzae type b vaccine
569291|NCT00455013|Kidney transplant|kidney transplant
569292|NCT00455039|neoadjuvant, HER2, Breast,GSK,lapatinib|neoadjuvant, her2, breast,gsk,lapatinib
569293|NCT00455052|XMT-1001|xmt-1001
569294|NCT00455052|cancer|cancer
569295|NCT00455052|tumor|tumor
569296|NCT00455052|camptothecin|camptothecin
569297|NCT00455052|Fleximer|fleximer
569298|NCT00455052|polymer|polymer
569299|NCT00455052|Phase 1|phase 1
569300|NCT00455052|safety|safety
569301|NCT00455052|pharmacokinetics|pharmacokinetics
569302|NCT00455052|maximum tolerated dose|maximum tolerated dose
569303|NCT00455052|NSCLC|nsclc
569304|NCT00455052|non-small cell lung cancer|non-small cell lung cancer
569305|NCT00455052|SCLC|sclc
569306|NCT00455052|small cell lung cancer|small cell lung cancer
569307|NCT00455065|whole grain|whole grain
569308|NCT00455065|metabolic syndrome|metabolic syndrome
569309|NCT00455065|weight loss|weight loss
569310|NCT00455078|Gastric reflux|gastric reflux
569311|NCT00455078|Lung transplant|lung transplant
569312|NCT00455078|chronic rejection|chronic rejection
569412|NCT00461825|Kidney transplantation|kidney transplantation
569313|NCT00455078|Gastric reflux in lung transplant as it relates to chronic rejection|gastric reflux in lung transplant as it relates to chronic rejection
569314|NCT00455091|Post-operative Hepatocellular Carcinoma.|post-operative hepatocellular carcinoma.
569315|NCT00461175|Uterine Perforation|uterine perforation
569316|NCT00461188|acromegaly|acromegaly
569317|NCT00461188|gigantism|gigantism
569318|NCT00461188|familial pituitary adenoma|familial pituitary adenoma
569319|NCT00461188|Familial acromegaly|familial acromegaly
569320|NCT00461188|Familial Isolated Pituitary Adenoma|familial isolated pituitary adenoma
569321|NCT00461188|FIPA|fipa
569322|NCT00461188|Pituitary adenoma predisposition|pituitary adenoma predisposition
569323|NCT00461188|PAP|pap
569324|NCT00461201|Health Services Research|health services research
569325|NCT00461201|Nurse Practitioners|nurse practitioners
569326|NCT00461201|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
569327|NCT00461201|Patient Acceptance of Health Care|patient acceptance of health care
569328|NCT00461201|Patient Satisfaction|patient satisfaction
569329|NCT00461201|Primary Health Care|primary health care
569330|NCT00461201|Professional Autonomy|professional autonomy
569331|NCT00461214|laparoscopy|laparoscopy
569332|NCT00461214|surgery|surgery
569333|NCT00461214|technical skills|technical skills
569334|NCT00461214|outcomes|outcomes
569335|NCT00461214|resident training|resident training
569336|NCT00461227|Puerto Rican|puerto rican
569337|NCT00461227|Allergies|allergies
569338|NCT00461240|heart|heart
569339|NCT00461240|MRS|mrs
569340|NCT00461240|acromegaly|acromegaly
569341|NCT00461240|growth hormone|growth hormone
569342|NCT00461253|breast cancer|breast cancer
569343|NCT00461266|Treatment Experienced|treatment experienced
569344|NCT00461279|attachment|attachment
569345|NCT00461279|depression|depression
569346|NCT00461279|IPT|ipt
569347|NCT00461279|CBT|cbt
569348|NCT00461279|pharmacotherapy|pharmacotherapy
569349|NCT00461305|Dysmenorrhea|dysmenorrhea
569350|NCT00461305|Intracyclic bleeding|intracyclic bleeding
569351|NCT00461305|Drospirenone (DRSP)|drospirenone (drsp)
569352|NCT00461305|Ethinylestradiol|ethinylestradiol
569353|NCT00461318|vocational rehabilitation|vocational rehabilitation
569354|NCT00461318|psychosis|psychosis
569355|NCT00461318|cross country comparison|cross country comparison
569356|NCT00461331|Type 1 diabetes mellitus|type 1 diabetes mellitus
569357|NCT00461331|Glycemic control|glycemic control
569358|NCT00461331|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
569359|NCT00461331|Continuous glucose monitoring system|continuous glucose monitoring system
569360|NCT00461344|Breast|breast
569361|NCT00461357|Old for Old|old for old
569362|NCT00461357|Eurotransplant Senior Program|eurotransplant senior program
569363|NCT00461357|Glomerular Filtration Rate|glomerular filtration rate
569364|NCT00461370|safety|safety
569365|NCT00461370|Phase 1|phase 1
569366|NCT00461370|pharmacokinetics|pharmacokinetics
569367|NCT00461370|SRX251|srx251
569368|NCT00461370|Azevan|azevan
569369|NCT00461370|safety in healthy volunteers|safety in healthy volunteers
569370|NCT00461396|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
569371|NCT00461396|First demyelinating event|first demyelinating event
569372|NCT00461396|MRI features consistent with MS|mri features consistent with ms
569373|NCT00461409|Neonatal Seizures|neonatal seizures
569374|NCT00461409|Treatment|treatment
569375|NCT00461409|Anticonvulsant|anticonvulsant
569376|NCT00461409|Levetiracetam|levetiracetam
569377|NCT00461422|IVF|ivf
569378|NCT00461422|GnRH antagonist|gnrh antagonist
569379|NCT00461448|Potassium supplement|potassium supplement
569380|NCT00461448|Rheumatoid Arthritis|rheumatoid arthritis
569381|NCT00461448|Pain|pain
569382|NCT00461448|Disease Activity|disease activity
569383|NCT00461474|Shoulder pain|shoulder pain
569384|NCT00461474|Chronic Spinal Cord Injury|chronic spinal cord injury
569385|NCT00461474|Exercise|exercise
569386|NCT00461474|Physical therapy techniques|physical therapy techniques
569387|NCT00461474|Motor performance|motor performance
569388|NCT00461487|Adolescent Behavior|adolescent behavior
569389|NCT00461487|Communication|communication
569390|NCT00461487|Health Behavior|health behavior
569391|NCT00461487|Risk-Taking|risk-taking
569392|NCT00461487|Sexual Behavior|sexual behavior
569393|NCT00461500|persistent|persistent
569394|NCT00461500|moderate|moderate
569395|NCT00461500|asthma|asthma
569396|NCT00461500|adults|adults
569397|NCT00461500|Initial|initial
569398|NCT00461500|Maintenance|maintenance
569399|NCT00461500|Therapy|therapy
569400|NCT00461513|Heart Failure, Congestive|heart failure, congestive
569401|NCT00461513|Disease Management|disease management
569402|NCT00461513|Health Status|health status
569403|NCT00461513|Quality of Life|quality of life
569404|NCT00461513|Telemedicine|telemedicine
569405|NCT00461513|Depression|depression
569406|NCT00461799|Crigler-Najjar disease.|crigler-najjar disease.
569407|NCT00461799|Bilirubin.|bilirubin.
569408|NCT00461799|Phototherapy.|phototherapy.
569409|NCT00461799|Orlistat.|orlistat.
569410|NCT00461799|Unconjugated hyperbilirubinemia.|unconjugated hyperbilirubinemia.
569411|NCT00461825|Immunosuppression|immunosuppression
569413|NCT00461825|multicenter study|multicenter study
569414|NCT00461838|colorectal endometriosis|colorectal endometriosis
569415|NCT00461838|deep infiltrating endometriosis|deep infiltrating endometriosis
569416|NCT00461838|dysmenorroe|dysmenorroe
569417|NCT00461838|dyspareunia|dyspareunia
569418|NCT00461838|quality of life|quality of life
569419|NCT00461851|Advanced/Metastatic Bladder Carcinoma|advanced/metastatic bladder carcinoma
569420|NCT00461864|fracture|fracture
569421|NCT00461864|occult|occult
569422|NCT00461864|hip|hip
569423|NCT00461890|Alcohol|alcohol
569424|NCT00461890|Veterans|veterans
735792|NCT01105962|TBI|tbi
568822|NCT00459498|NIS|nis
569425|NCT00461890|Primary Care|primary care
569426|NCT00461890|Naltrexone|naltrexone
569427|NCT00461903|essential hypertension|essential hypertension
569428|NCT00461903|symptomatic paroxysmal or persistent atrial fibrillation|symptomatic paroxysmal or persistent atrial fibrillation
569429|NCT00461916|half-dose depot triptorelin|half-dose depot triptorelin
569430|NCT00461916|reduced-dose daily buserelin|reduced-dose daily buserelin
569431|NCT00461916|controlled ovarian stimulation|controlled ovarian stimulation
569432|NCT00461916|long protocol|long protocol
569433|NCT00461916|ICSI|icsi
569434|NCT00461929|chronic myeloid leukemia|chronic myeloid leukemia
569435|NCT00461929|gastrointestinal stromal cell tumors|gastrointestinal stromal cell tumors
569436|NCT00461929|chromosome abnormality|chromosome abnormality
569437|NCT00461929|imatinib|imatinib
569438|NCT00461929|bone marrow aspiration|bone marrow aspiration
569439|NCT00461942|Health Food;|health food;
569440|NCT00461942|Green Tea;|green tea;
569441|NCT00461942|Neuroprotection|neuroprotection
569442|NCT00461955|Symptomatic Multiple Myeloma|symptomatic multiple myeloma
569443|NCT00461955|first line treatment|first line treatment
569444|NCT00461955|first autologous Stem Cell Transplantation|first autologous stem cell transplantation
569445|NCT00461955|ex vivo amplified autologous peripheral blood stem cells|ex vivo amplified autologous peripheral blood stem cells
569446|NCT00461968|Cholesterol|cholesterol
569447|NCT00461968|LDL|ldl
569448|NCT00461968|Ezetimibe|ezetimibe
569449|NCT00461968|Statin|statin
569450|NCT00461968|Zetia|zetia
569451|NCT00461968|Zocor|zocor
569452|NCT00461968|Simvastin|simvastin
569699|NCT00462774|Bypass surgery|bypass surgery
569453|NCT00461981|Live, attenuated influenza virus vaccine (LAIV)|live, attenuated influenza virus vaccine (laiv)
569454|NCT00461981|Trivalent inactivated influenza virus vaccine (TIV)|trivalent inactivated influenza virus vaccine (tiv)
569455|NCT00461981|FluMist|flumist
569456|NCT00461994|OBESITY|obesity
569457|NCT00461994|CHILDREN|children
569458|NCT00461994|METABOLIC PARAMETERS|metabolic parameters
569459|NCT00461994|DIET|diet
569460|NCT00461994|EXERCISE|exercise
569461|NCT00462020|appendicitis, perforation, abscess, treatment|appendicitis, perforation, abscess, treatment
569462|NCT00462046|Berberine|berberine
569463|NCT00462046|Type 2 diabetes|type 2 diabetes
569464|NCT00462046|Dyslipidemia|dyslipidemia
569465|NCT00462059|Transition of care|transition of care
569466|NCT00462059|Continuity of care|continuity of care
569467|NCT00462085|cerebral palsy|cerebral palsy
569468|NCT00462085|ankle foot orthosis|ankle foot orthosis
569469|NCT00462085|emg|emg
569470|NCT00462085|surface electromyography|surface electromyography
569471|NCT00462085|gait analysis|gait analysis
569472|NCT00462098|Osteonecrosis of the jaw|osteonecrosis of the jaw
569473|NCT00462098|hyperbaric oxygen|hyperbaric oxygen
569474|NCT00462098|bisphosphonates|bisphosphonates
569475|NCT00462111|indometacin|indometacin
569476|NCT00462111|reaction time|reaction time
569477|NCT00462111|postural balance|postural balance
569478|NCT00462111|obstacle avoidance|obstacle avoidance
569479|NCT00462111|accidental falls|accidental falls
569480|NCT00462124|Prostate|prostate
569481|NCT00462124|cancer|cancer
569482|NCT00462124|radiation|radiation
569483|NCT00462124|biodegradable implantable balloon|biodegradable implantable balloon
569484|NCT00462124|intrarectal balloon|intrarectal balloon
569485|NCT00462137|GERD|gerd
569486|NCT00462137|Gastroesphageal Reflux Disease (GERD)|gastroesphageal reflux disease (gerd)
569487|NCT00462150|arthritis, rheumatoid|arthritis, rheumatoid
569488|NCT00462150|expressed emotion|expressed emotion
569489|NCT00462150|randomized controlled trial|randomized controlled trial
569490|NCT00462150|affect|affect
569491|NCT00462150|blood sedimentation|blood sedimentation
569492|NCT00462150|psychophysiology|psychophysiology
569493|NCT00462150|feasibility studies|feasibility studies
569494|NCT00462150|intervention studies|intervention studies
569495|NCT00462150|time management|time management
569496|NCT00462176|colorectal endometriosis|colorectal endometriosis
569497|NCT00462176|deep infiltrating endometriosis|deep infiltrating endometriosis
569498|NCT00462176|dysmenorroe|dysmenorroe
569499|NCT00462176|dyspareunia|dyspareunia
569500|NCT00462176|quality of life|quality of life
569501|NCT00462189|CAT-8015|cat-8015
569502|NCT00462189|HA22|ha22
569503|NCT00462189|HCL|hcl
569504|NCT00462189|Relapse|relapse
569505|NCT00462189|Refractory|refractory
569506|NCT00462189|immunotherapy|immunotherapy
569507|NCT00462189|immunotoxin|immunotoxin
569508|NCT00462202|Diabetes|diabetes
569509|NCT00462202|Microalbuminuria|microalbuminuria
569510|NCT00462202|Proteinuria|proteinuria
569511|NCT00462202|Albuminuria|albuminuria
569512|NCT00462202|KRX-101|krx-101
569513|NCT00462202|Sulodexide|sulodexide
569514|NCT00462202|Nephropathy|nephropathy
569515|NCT00462202|Keryx|keryx
569516|NCT00462202|Collaborative Study Group|collaborative study group
569517|NCT00462202|Diabetic nephropathy with persistent microalbuminuria|diabetic nephropathy with persistent microalbuminuria
568936|NCT00459888|CLI|cli
569518|NCT00462228|traumatic brain injury|traumatic brain injury
569519|NCT00462228|memory|memory
569520|NCT00462228|attention|attention
569521|NCT00462241|Chest pain|chest pain
569522|NCT00462241|Chest wall|chest wall
569523|NCT00462241|Atypical chest pain|atypical chest pain
569524|NCT00462241|Non-cardiac chest pain|non-cardiac chest pain
569525|NCT00462241|Undiagnosed chest pain|undiagnosed chest pain
569526|NCT00462241|Physical examination|physical examination
569527|NCT00462241|Randomized controlled trial|randomized controlled trial
569528|NCT00462241|Treatment study|treatment study
569529|NCT00462241|Chiropractor|chiropractor
569530|NCT00462254|Ramelteon|ramelteon
569531|NCT00462254|Parkinson's disease|parkinson's disease
569532|NCT00462254|Sleep disturbances|sleep disturbances
569533|NCT00462267|Nutrition|nutrition
569534|NCT00462267|Exercise|exercise
569535|NCT00462267|Body mass index|body mass index
569536|NCT00462267|Lifestyle change|lifestyle change
569537|NCT00462267|Obesity|obesity
569538|NCT00462267|Overweight|overweight
569539|NCT00462267|Adolescents|adolescents
569540|NCT00462267|Teens|teens
569541|NCT00462306|Obstructive Sleep Apnea|obstructive sleep apnea
569542|NCT00462306|Pregnancy|pregnancy
569543|NCT00462306|Berlin Questionnaire|berlin questionnaire
569544|NCT00462332|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
569545|NCT00462332|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
569546|NCT00462371|quality of life|quality of life
569547|NCT00462371|child diabetes mellitus type 1|child diabetes mellitus type 1
569548|NCT00462371|Continuous subcutaneous insulin infusion(CSII)|continuous subcutaneous insulin infusion(csii)
569549|NCT00462371|metabolic control|metabolic control
569550|NCT00462397|cervical adenocarcinoma|cervical adenocarcinoma
569551|NCT00462397|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
569552|NCT00462397|cervical squamous cell carcinoma|cervical squamous cell carcinoma
569553|NCT00462397|stage IB cervical cancer|stage ib cervical cancer
569554|NCT00462397|stage IIA cervical cancer|stage iia cervical cancer
569555|NCT00462397|stage IIB cervical cancer|stage iib cervical cancer
569556|NCT00462397|stage III cervical cancer|stage iii cervical cancer
569557|NCT00462397|stage IVA cervical cancer|stage iva cervical cancer
569558|NCT00462397|recurrent cervical cancer|recurrent cervical cancer
569559|NCT00462410|recurrent breast cancer|recurrent breast cancer
569560|NCT00462410|stage I breast cancer|stage i breast cancer
569561|NCT00462410|stage II breast cancer|stage ii breast cancer
569562|NCT00462410|stage IIIA breast cancer|stage iiia breast cancer
569563|NCT00462410|stage IIIB breast cancer|stage iiib breast cancer
569564|NCT00462410|stage IIIC breast cancer|stage iiic breast cancer
569565|NCT00462410|stage IV breast cancer|stage iv breast cancer
569566|NCT00462423|Metastatic malignant melanoma|metastatic malignant melanoma
569567|NCT00462423|First-line therapy|first-line therapy
569568|NCT00462436|functional foods|functional foods
569569|NCT00462436|soy|soy
569570|NCT00462436|nuts|nuts
569571|NCT00462436|LDL cholesterol|ldl cholesterol
569572|NCT00462436|fibre|fibre
569573|NCT00462436|secondary prevention|secondary prevention
569574|NCT00462436|risk reduction|risk reduction
569575|NCT00462436|endothelial function|endothelial function
569576|NCT00462436|endothelial progenitor cells|endothelial progenitor cells
569577|NCT00462436|inflammation|inflammation
569578|NCT00462436|glycemic control|glycemic control
569579|NCT00462436|HOMA|homa
569580|NCT00462449|Botulinum Toxin|botulinum toxin
569581|NCT00462449|Ness H200|ness h200
569582|NCT00462449|Functional Electrical Stimulation|functional electrical stimulation
569583|NCT00462449|Repetitive Task Practice|repetitive task practice
569584|NCT00462475|GH|gh
569585|NCT00462475|IGF-I|igf-i
569586|NCT00462475|GH deficiency|gh deficiency
569587|NCT00462475|Atherosclerosis|atherosclerosis
569588|NCT00462475|Insulin resistance syndrome|insulin resistance syndrome
569589|NCT00462501|stage II rectal cancer|stage ii rectal cancer
569590|NCT00462501|stage III rectal cancer|stage iii rectal cancer
569591|NCT00462501|adenocarcinoma of the rectum|adenocarcinoma of the rectum
569592|NCT00462527|Cystatin C|cystatin c
569593|NCT00462527|Acute renal failure|acute renal failure
569594|NCT00462527|Gastroenteritis|gastroenteritis
569595|NCT00462527|Dehydration|dehydration
569596|NCT00462540|COPD|copd
569597|NCT00462540|Formoterol|formoterol
569598|NCT00462540|Ipratropium|ipratropium
569599|NCT00462540|Crossover|crossover
585628|NCT00513422|NSAIDs|nsaids
569600|NCT00462566|Motor cortex stimulation|motor cortex stimulation
569601|NCT00462566|neuropathic|neuropathic
569602|NCT00462566|pain|pain
569603|NCT00462566|complex regional pain syndrome|complex regional pain syndrome
569604|NCT00462566|deafferentation facial pain|deafferentation facial pain
569605|NCT00462579|carbapenem-resistant acinetobacter baumannii|carbapenem-resistant acinetobacter baumannii
569606|NCT00462579|positive culture|positive culture
569607|NCT00462579|positive culture for carbapenem-resistant acinetobacter|positive culture for carbapenem-resistant acinetobacter
569794|NCT00463112|weight loss|weight loss
569608|NCT00462592|exercise-induced bronchoconstriction (EIB)|exercise-induced bronchoconstriction (eib)
569609|NCT00462592|airway inflammation|airway inflammation
569610|NCT00462618|Insomnia|insomnia
569611|NCT00462618|Elderly|elderly
569612|NCT00462618|Affective disorders|affective disorders
569613|NCT00462631|coronary artery|coronary artery
569614|NCT00462631|Diabetes|diabetes
569615|NCT00462644|adrenal insufficiency|adrenal insufficiency
569616|NCT00462644|etomidate|etomidate
569617|NCT00462644|rapid sequence induction|rapid sequence induction
569618|NCT00462657|infection|infection
569619|NCT00462657|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
569620|NCT00462657|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
569621|NCT00462657|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
569622|NCT00462657|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
569623|NCT00462657|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
569624|NCT00462657|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
569625|NCT00462657|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
569626|NCT00462657|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
569627|NCT00462657|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
569628|NCT00462657|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
569629|NCT00462657|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
569630|NCT00462657|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
569631|NCT00462657|secondary acute myeloid leukemia|secondary acute myeloid leukemia
569632|NCT00462657|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
569633|NCT00462657|graft versus host disease|graft versus host disease
569634|NCT00462670|Cardiac edema|cardiac edema
569635|NCT00462670|OPC-41061|opc-41061
569636|NCT00462670|Vasopressin antagonist|vasopressin antagonist
569637|NCT00462683|Stroke|stroke
569638|NCT00462683|Anoxia|anoxia
569639|NCT00462683|Brain Injury|brain injury
569640|NCT00462683|Rehabilitation|rehabilitation
569641|NCT00462683|Osteoporosis|osteoporosis
569642|NCT00462683|Osteopenia|osteopenia
569643|NCT00462696|stage II breast cancer|stage ii breast cancer
569644|NCT00462696|stage IIIA breast cancer|stage iiia breast cancer
569645|NCT00462696|stage IIIB breast cancer|stage iiib breast cancer
569646|NCT00462696|stage IIIC breast cancer|stage iiic breast cancer
569647|NCT00462709|Hereditary angioedema|hereditary angioedema
569648|NCT00462709|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
569649|NCT00462722|body composition|body composition
569650|NCT00462722|bone density|bone density
569651|NCT00462722|cyclooxygenase inhibitor|cyclooxygenase inhibitor
569652|NCT00462722|bone metabolism|bone metabolism
569653|NCT00462722|muscle function|muscle function
569654|NCT00462722|muscle strength|muscle strength
569655|NCT00462735|Cancer of the Nasal Cavity|cancer of the nasal cavity
569657|NCT00462761|kinase|kinase
569658|NCT00462761|inhibitor|inhibitor
569659|NCT00462761|tyrosine|tyrosine
569660|NCT00462761|acute|acute
569661|NCT00462761|FLT3|flt3
569662|NCT00462761|AC220|ac220
569663|NCT00462761|pharmacokinetic|pharmacokinetic
569664|NCT00462761|pharmacokinetics|pharmacokinetics
569665|NCT00462761|PK|pk
569666|NCT00462761|pharmacodynamic|pharmacodynamic
569667|NCT00462761|pharmacodynamics|pharmacodynamics
569668|NCT00462761|mutations|mutations
569669|NCT00462761|PD|pd
569670|NCT00462761|receptor|receptor
569671|NCT00462761|class III|class iii
569672|NCT00462761|relapsed|relapsed
569673|NCT00462761|refractory|refractory
569674|NCT00462761|t(8;21)|t(8;21)
569675|NCT00462761|q22;q22|q22;q22
569676|NCT00462761|AML1/ETO|aml1/eto
569677|NCT00462761|t(16;16|t(16;16
569678|NCT00462761|p13;q22|p13;q22
569679|NCT00462761|CBFbeta/MYH11|cbfbeta/myh11
569680|NCT00462761|inv(16)|inv(16)
569681|NCT00462761|p13q22|p13q22
569682|NCT00462761|11q23|11q23
569683|NCT00462761|dysplasia|dysplasia
569684|NCT00462761|myeloid|myeloid
569685|NCT00462761|myelomonocytic|myelomonocytic
569686|NCT00462761|monoblastic|monoblastic
569687|NCT00462761|monocytic|monocytic
569688|NCT00462761|erythroid|erythroid
569689|NCT00462761|erythroleukemia|erythroleukemia
569690|NCT00462761|megakaryoblastic|megakaryoblastic
569691|NCT00462761|basophilic|basophilic
569692|NCT00462761|panmyelosis|panmyelosis
569693|NCT00462761|myelofibrosis|myelofibrosis
569694|NCT00462774|Myocardial infarction|myocardial infarction
569695|NCT00462774|Heart failure|heart failure
569696|NCT00462774|Cell therapy|cell therapy
569697|NCT00462774|Bone marrow|bone marrow
569698|NCT00462774|CD133|cd133
569700|NCT00462774|Stem cells|stem cells
569701|NCT00462787|acute undifferentiated leukemia|acute undifferentiated leukemia
569702|NCT00462787|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
569703|NCT00462787|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
569704|NCT00462787|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
569705|NCT00462787|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
569706|NCT00462813|cervical cancer|cervical cancer
569707|NCT00462813|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
569708|NCT00462813|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
569709|NCT00462813|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
569710|NCT00462839|Estimated Blood Loss|estimated blood loss
569711|NCT00462839|Obstetrics|obstetrics
569712|NCT00462839|postpartum hemorrhage|postpartum hemorrhage
569713|NCT00462852|thromboembolism|thromboembolism
569714|NCT00462852|stage III pancreatic cancer|stage iii pancreatic cancer
569715|NCT00462852|stage IV pancreatic cancer|stage iv pancreatic cancer
569716|NCT00462852|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
569717|NCT00462852|recurrent pancreatic cancer|recurrent pancreatic cancer
569718|NCT00462852|stage II pancreatic cancer|stage ii pancreatic cancer
569719|NCT00462865|breast cancer|breast cancer
569720|NCT00462865|neoadjuvant chemotherapy|neoadjuvant chemotherapy
569721|NCT00462865|adjuvant treatment|adjuvant treatment
569722|NCT00462865|consolidation therapy|consolidation therapy
569723|NCT00462865|anti-angiogenesis therapy|anti-angiogenesis therapy
569724|NCT00462878|Febrile neutropenia|febrile neutropenia
569725|NCT00462891|breast cancer|breast cancer
569726|NCT00462917|disease /disorder proneness /risk|disease /disorder proneness /risk
569727|NCT00462917|family genetics|family genetics
569728|NCT00462917|genetic counseling|genetic counseling
569729|NCT00462917|genetic marker|genetic marker
569730|NCT00462917|genetic polymorphism|genetic polymorphism
569731|NCT00462917|genetic screening|genetic screening
569732|NCT00462917|genetic susceptibility|genetic susceptibility
569735|NCT00462943|Homoharringtonine|homoharringtonine
569736|NCT00462943|Omacetaxine|omacetaxine
569737|NCT00462956|lapatinib|lapatinib
569738|NCT00462956|metastatic breast cancer|metastatic breast cancer
569739|NCT00462956|trastuzumab (Herceptin)|trastuzumab (herceptin)
569740|NCT00462956|Stage IV breast cancer|stage iv breast cancer
569741|NCT00462956|ErbB2|erbb2
569742|NCT00462956|ErbB1|erbb1
569743|NCT00462969|Endometrial cancer|endometrial cancer
569744|NCT00462969|Sonohysterography|sonohysterography
569745|NCT00462982|stage IV melanoma|stage iv melanoma
569746|NCT00462982|tumors metastatic to brain|tumors metastatic to brain
569747|NCT00462982|stage IV renal cell cancer|stage iv renal cell cancer
569748|NCT00462982|recurrent melanoma|recurrent melanoma
569749|NCT00462982|recurrent renal cell cancer|recurrent renal cell cancer
569750|NCT00462995|Non Small Cell Lung Cancer|non small cell lung cancer
569751|NCT00462995|Lung Cancer|lung cancer
569752|NCT00462995|Erlotinib|erlotinib
569753|NCT00462995|Neoadjuvant Treatment|neoadjuvant treatment
569754|NCT00463008|adult anaplastic astrocytoma|adult anaplastic astrocytoma
569755|NCT00463008|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
569756|NCT00463008|adult glioblastoma|adult glioblastoma
569757|NCT00463008|recurrent adult brain tumor|recurrent adult brain tumor
569758|NCT00463008|adult gliosarcoma|adult gliosarcoma
569759|NCT00463008|adult giant cell glioblastoma|adult giant cell glioblastoma
569760|NCT00463021|Hectorol (doxercalciferol capsules)|hectorol (doxercalciferol capsules)
569761|NCT00463021|Zemplar (paricalcitol injection)|zemplar (paricalcitol injection)
569762|NCT00463034|stage IV breast cancer|stage iv breast cancer
569763|NCT00463034|stage I breast cancer|stage i breast cancer
569764|NCT00463034|stage II breast cancer|stage ii breast cancer
569765|NCT00463034|stage IIIA breast cancer|stage iiia breast cancer
569766|NCT00463034|stage IIIB breast cancer|stage iiib breast cancer
569767|NCT00463034|stage IIIC breast cancer|stage iiic breast cancer
569768|NCT00463047|Breakthrough pain|breakthrough pain
569769|NCT00463047|Opioid-tolerant|opioid-tolerant
569770|NCT00463047|Chronic pain|chronic pain
569771|NCT00463073|Progressive primary Glioblastoma multiforme|progressive primary glioblastoma multiforme
569772|NCT00463086|Tuberculosis|tuberculosis
569773|NCT00463086|TB|tb
569774|NCT00463086|Mycobacteria|mycobacteria
569775|NCT00463086|HIV|hiv
569776|NCT00463086|Human immunodeficiency virus|human immunodeficiency virus
569777|NCT00463086|Latent tuberculosis infection|latent tuberculosis infection
569778|NCT00463086|HAART|haart
569779|NCT00463086|Highly active anti-retroviral therapy|highly active anti-retroviral therapy
569780|NCT00463086|Isoniazid preventive therapy|isoniazid preventive therapy
569781|NCT00463086|INH|inh
569782|NCT00463086|Opportunistic infections|opportunistic infections
569783|NCT00463086|HIV-1|hiv-1
569784|NCT00463086|Treatment Experienced|treatment experienced
569785|NCT00463086|AIDS|aids
569786|NCT00463086|Mycobacterium Tuberculosis|mycobacterium tuberculosis
569787|NCT00463099|Anterior Cruciate Ligament/injuries|anterior cruciate ligament/injuries
569788|NCT00463099|Anterior Cruciate Ligament/surgery|anterior cruciate ligament/surgery
569789|NCT00463099|Knee injuries/surgery|knee injuries/surgery
569790|NCT00463099|Outcomes research|outcomes research
569791|NCT00463099|Prospective Studies|prospective studies
569792|NCT00463112|Obesity|obesity
569793|NCT00463112|Polycystic Ovary Syndrome|polycystic ovary syndrome
569795|NCT00463112|Hyperadrogonemia|hyperadrogonemia
569796|NCT00463112|Sibutramine|sibutramine
569797|NCT00463125|Scleroderma, systemic|scleroderma, systemic
569798|NCT00463125|therapeutic|therapeutic
569799|NCT00463125|platelet gel|platelet gel
569800|NCT00463138|perceived increase or decrease in symptoms post treatment|perceived increase or decrease in symptoms post treatment
569801|NCT00463138|Satisfaction with the treatment|satisfaction with the treatment
569802|NCT00463151|Rebamipide|rebamipide
569803|NCT00463151|Enema|enema
569804|NCT00463151|Ulcerative Colitis|ulcerative colitis
569805|NCT00463164|functional MRI|functional mri
569806|NCT00463177|Pain|pain
569807|NCT00463177|Chronic pain|chronic pain
569808|NCT00463177|Pain disorder|pain disorder
569809|NCT00463177|Functional MRI|functional mri
569810|NCT00463177|Sensitization|sensitization
569811|NCT00463190|Probiotics|probiotics
569812|NCT00463190|Diarrhea|diarrhea
569813|NCT00463190|Enterocolitis|enterocolitis
569814|NCT00463203|primary malignant brain tumor|primary malignant brain tumor
569815|NCT00463203|grade II glioma|grade ii glioma
569816|NCT00463203|meningeoma|meningeoma
569817|NCT00463203|ependymoma|ependymoma
569818|NCT00463203|Recurrence or progression after standard treatment|recurrence or progression after standard treatment
569819|NCT00463216|back, neck, pain, sick leave|back, neck, pain, sick leave
569820|NCT00463229|stroke|stroke
569821|NCT00463229|rehabilitation|rehabilitation
569822|NCT00463229|home care services|home care services
569823|NCT00463229|effectiveness|effectiveness
569824|NCT00463229|quantitative research|quantitative research
569825|NCT00463229|interdisciplinary|interdisciplinary
569826|NCT00463229|cost|cost
569827|NCT00463229|health services research, integrated|health services research, integrated
569828|NCT00463242|agomelatine, Major Depressive Disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
569829|NCT00463255|Diet|diet
569830|NCT00463255|elderly|elderly
569831|NCT00463255|age-related diseases|age-related diseases
569832|NCT00463255|prevention|prevention
569833|NCT00463255|cognitive decline|cognitive decline
569834|NCT00463255|Clinical study|clinical study
569835|NCT00463268|osteopenia|osteopenia
569836|NCT00463268|osteoporosis prevention|osteoporosis prevention
569837|NCT00463268|alendronate|alendronate
569838|NCT00463281|stroke, ischemic|stroke, ischemic
569839|NCT00463281|computed tomography|computed tomography
569840|NCT00463281|thrombolysis|thrombolysis
569841|NCT00463294|CABG|cabg
569842|NCT00463294|On-pump|on-pump
569843|NCT00463294|Off-pump|off-pump
569844|NCT00463307|schistosomiasis|schistosomiasis
569845|NCT00463307|Schistosoma mansoni|schistosoma mansoni
569846|NCT00463307|Circulating cathodic antigen urine dipstick|circulating cathodic antigen urine dipstick
569847|NCT00463320|Age-related macular degeneration (AMD),|age-related macular degeneration (amd),
569848|NCT00463320|vascular endothelial growth factor (VEGF)receptor (VEGFR)|vascular endothelial growth factor (vegf)receptor (vegfr)
569849|NCT00463320|choroidal neovascularization,|choroidal neovascularization,
569850|NCT00463333|postoperative delirium|postoperative delirium
569851|NCT00463333|psychometric testing|psychometric testing
569853|NCT00463333|serum markers|serum markers
569854|NCT00463346|Treatment|treatment
569855|NCT00463346|Alcohol Dependence|alcohol dependence
569856|NCT00463346|Schizophrenia|schizophrenia
569857|NCT00463359|basal cell carcinoma|basal cell carcinoma
569858|NCT00463359|curettage|curettage
569859|NCT00463359|Imiquimod|imiquimod
569860|NCT00463359|treatment|treatment
569861|NCT00463385|Celgene|celgene
569862|NCT00463385|CC-4047|cc-4047
569863|NCT00463385|Myelofibrosis|myelofibrosis
569864|NCT00463385|myelofibrosis with myeloid metaplasia|myelofibrosis with myeloid metaplasia
569865|NCT00463385|myeloid metaplasia|myeloid metaplasia
569866|NCT00463385|JAK2|jak2
569867|NCT00463385|CC-4047-MMM-001|cc-4047-mmm-001
569868|NCT00463385|Prednisone|prednisone
569869|NCT00463385|Phase II|phase ii
569870|NCT00463385|pomalidomide|pomalidomide
569871|NCT00463385|bone marrow histology|bone marrow histology
569872|NCT00463385|imids|imids
569873|NCT00463385|MMM|mmm
569874|NCT00463385|Ashkenazi Jewish Population|ashkenazi jewish population
569875|NCT00463385|exposure to Thorotrast|exposure to thorotrast
569876|NCT00463385|exposure to solvents (benzene and toluene)|exposure to solvents (benzene and toluene)
737823|NCT01114386|Dyspnea|dyspnea
569877|NCT00463385|acute megakaryocytic leukemia|acute megakaryocytic leukemia
569878|NCT00463385|history of polycythemia vera|history of polycythemia vera
569879|NCT00463398|Endometriosis|endometriosis
569880|NCT00463398|Fertility Surgery|fertility surgery
569881|NCT00463398|Quality of Life|quality of life
569882|NCT00463398|Pain|pain
569883|NCT00463398|Sexual Function|sexual function
569884|NCT00463398|Health economics|health economics
569886|NCT00463398|Pregnancy|pregnancy
569887|NCT00463411|osteoporosis|osteoporosis
569888|NCT00463411|male|male
569889|NCT00463411|fracture risk|fracture risk
569890|NCT00463411|genetical epidemiology|genetical epidemiology
569891|NCT00463424|Metacarpophalangeal Joint|metacarpophalangeal joint
569892|NCT00463424|Arthroplasty, Replacement|arthroplasty, replacement
569990|NCT00463827|COPD|copd
569893|NCT00463424|Range of Motion, Articular|range of motion, articular
569894|NCT00463424|Randomized Controlled Trials|randomized controlled trials
569895|NCT00463424|Swanson|swanson
569896|NCT00463424|NeuFlex|neuflex
569897|NCT00463437|Fever.|fever.
569898|NCT00463437|Meningococcal disease.|meningococcal disease.
569899|NCT00463437|Pneumococcal disease.|pneumococcal disease.
569900|NCT00463437|Meningococcal vaccine.|meningococcal vaccine.
569901|NCT00463437|Pneumococcal vaccine.|pneumococcal vaccine.
569902|NCT00463437|Immunogenicity.|immunogenicity.
569903|NCT00463437|Booster vaccination.|booster vaccination.
569904|NCT00463437|Safety.|safety.
569905|NCT00463450|Hormone Replacement Therapy|hormone replacement therapy
569906|NCT00463450|Impaired well-being, mood and sexuality|impaired well-being, mood and sexuality
569907|NCT00463489|lifestyle intervention|lifestyle intervention
569908|NCT00463489|breast|breast
569909|NCT00463489|cancer|cancer
569910|NCT00463489|adjuvant|adjuvant
569911|NCT00463489|letrozole|letrozole
569912|NCT00463489|weight loss|weight loss
569913|NCT00463489|BMI|bmi
569914|NCT00463489|post-menopausal|post-menopausal
569915|NCT00463489|estrogen receptor positive|estrogen receptor positive
569916|NCT00463489|progesterone receptor positive|progesterone receptor positive
569917|NCT00463502|The purpose of study was investigated the effect of|the purpose of study was investigated the effect of
569918|NCT00463502|metformin on thyroid hormone metabolism in euthyroid patients|metformin on thyroid hormone metabolism in euthyroid patients
569919|NCT00463502|with type 2 DM. The results revealed significant decreases|with type 2 dm. the results revealed significant decreases
569920|NCT00463502|in TSH and fT4|in tsh and ft4
569921|NCT00463515|Non-Small Cell Lung Cancer|non-small cell lung cancer
569922|NCT00463515|NSCLC|nsclc
569923|NCT00463515|Chemoradiation|chemoradiation
569924|NCT00463515|lung cancer|lung cancer
569925|NCT00463515|induction chemotherapy|induction chemotherapy
569926|NCT00463515|chemo-radiotherapy|chemo-radiotherapy
569927|NCT00463528|schistosomiasis|schistosomiasis
569928|NCT00463528|gender perspectives|gender perspectives
569929|NCT00463541|Urinary Bladder, Overactive|urinary bladder, overactive
569930|NCT00463541|Urgency|urgency
569931|NCT00463541|VESIcare®|vesicare®
569932|NCT00463541|Solifenacin succinate|solifenacin succinate
569933|NCT00463554|Incontinence|incontinence
569934|NCT00463554|Stress Urinary|stress urinary
569935|NCT00463567|indacaterol|indacaterol
569936|NCT00463567|long acting beta-2 agonist|long acting beta-2 agonist
569937|NCT00463580|depression|depression
569938|NCT00463580|TNF-alpha antagonist|tnf-alpha antagonist
569939|NCT00463580|infliximab|infliximab
569940|NCT00463580|treatment resistant depression|treatment resistant depression
569941|NCT00463580|major depressive disorder (MDD)|major depressive disorder (mdd)
569942|NCT00463580|bipolar I disorder|bipolar i disorder
569943|NCT00463580|bipolar II disorder|bipolar ii disorder
569944|NCT00463593|schistosomiasis|schistosomiasis
569945|NCT00463593|helminthes|helminthes
569946|NCT00463593|anaemia|anaemia
569947|NCT00463632|schistosomiasis|schistosomiasis
569948|NCT00463632|anaemia|anaemia
569949|NCT00463632|pregnancy|pregnancy
569950|NCT00463658|Falls|falls
569951|NCT00463658|Home Care|home care
569952|NCT00463658|Aging Population|aging population
569953|NCT00463658|Clinical Effectiveness|clinical effectiveness
569954|NCT00463658|Health Economics|health economics
569955|NCT00463697|GW642444,|gw642444,
569956|NCT00463697|magnesium stearate,|magnesium stearate,
569957|NCT00463697|asthmatic patients|asthmatic patients
569958|NCT00463710|MTI, DWI, Avonex, MRI|mti, dwi, avonex, mri
569959|NCT00463723|penetrating keratoplasty|penetrating keratoplasty
569960|NCT00463723|graft rejection|graft rejection
569961|NCT00463723|immunosuppression|immunosuppression
569962|NCT00463736|short term tocolysis|short term tocolysis
569963|NCT00463736|preterm premature rupture of membranes|preterm premature rupture of membranes
569964|NCT00463749|primary PCI|primary pci
569965|NCT00463749|nephropathy|nephropathy
569966|NCT00463749|infarct size|infarct size
569967|NCT00463749|infarction|infarction
569968|NCT00463749|ST-elevation myocardial infarction|st-elevation myocardial infarction
569969|NCT00463775|Treatment|treatment
569970|NCT00463775|Topiramate|topiramate
569971|NCT00463775|Alcohol Dependence|alcohol dependence
569972|NCT00463775|Borderline Personality Disorder|borderline personality disorder
569973|NCT00463788|cancer|cancer
569974|NCT00463788|breast|breast
569975|NCT00463788|metastatic|metastatic
569976|NCT00463788|triple negative|triple negative
569977|NCT00463801|Complicated Skin and Skin-Structure Infections, Daptomycin, MRSA, Diabetic Foot, Abscess, Cellulitis|complicated skin and skin-structure infections, daptomycin, mrsa, diabetic foot, abscess, cellulitis
569978|NCT00463801|Complicated skin and skin-structure infections|complicated skin and skin-structure infections
569979|NCT00463814|Advanced Malignancy|advanced malignancy
569980|NCT00463814|Cancer Eligibility|cancer eligibility
569981|NCT00463814|Malignancy|malignancy
569982|NCT00463827|asthma|asthma
569983|NCT00463827|smokers|smokers
569984|NCT00463827|statin|statin
569985|NCT00463827|atorvastatin|atorvastatin
569986|NCT00463827|randomised|randomised
569987|NCT00463827|placebo|placebo
569988|NCT00463827|cigarette|cigarette
569989|NCT00463827|blind|blind
569991|NCT00463840|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
569992|NCT00463840|oxaliplatin|oxaliplatin
569993|NCT00463840|chemoradiation|chemoradiation
569995|NCT00463853|Bone Marrow Cells|bone marrow cells
569996|NCT00463853|Cardiovascular Surgery|cardiovascular surgery
569997|NCT00463853|Coronary Artery Bypass Graft|coronary artery bypass graft
569998|NCT00463853|Phase I Study|phase i study
569999|NCT00463853|Stem Cells|stem cells
570000|NCT00463866|Asthma|asthma
570001|NCT00463879|Schizophrenia|schizophrenia
570002|NCT00463879|Cognition|cognition
570003|NCT00463879|Smoking|smoking
570004|NCT00463879|Galantamine|galantamine
570005|NCT00463879|Nicotine|nicotine
570006|NCT00463879|Cognitive Deficits|cognitive deficits
570007|NCT00463892|melanoma|melanoma
570008|NCT00463892|lymph nodes|lymph nodes
570009|NCT00463892|magnetic resonance imaging|magnetic resonance imaging
570010|NCT00463892|screening|screening
570011|NCT00463892|detection|detection
570012|NCT00463905|osteoporosis|osteoporosis
570013|NCT00463905|vertebral fractures|vertebral fractures
570014|NCT00463905|randomised controlled trial|randomised controlled trial
570015|NCT00463905|screening|screening
570016|NCT00463931|Schistosomiasis|schistosomiasis
570017|NCT00463931|Soiltransmitted helminthiasis|soiltransmitted helminthiasis
570018|NCT00463931|Community-based volunteer|community-based volunteer
570019|NCT00463931|School based treatment approach|school based treatment approach
570020|NCT00463944|Electronic voting system|electronic voting system
570021|NCT00463957|sildenafil|sildenafil
570022|NCT00463957|tadalafil|tadalafil
570023|NCT00463957|phosphodiesterase|phosphodiesterase
570024|NCT00463957|visual persistence|visual persistence
570025|NCT00463957|reaction time|reaction time
570026|NCT00463970|Chronic low back pain|chronic low back pain
570027|NCT00463970|Brief cognitive intervention|brief cognitive intervention
570028|NCT00463970|Cognitive behavior therapy|cognitive behavior therapy
570029|NCT00463970|Seal oil|seal oil
570030|NCT00463996|Ovarian cancer|ovarian cancer
570031|NCT00463996|MRI|mri
570032|NCT00463996|Contrast agent|contrast agent
570033|NCT00464009|Early childhood caries - ECC|early childhood caries - ecc
570034|NCT00464009|Prevention|prevention
570035|NCT00464009|Continuing medical education|continuing medical education
570036|NCT00464009|Randomized controlled trial|randomized controlled trial
570037|NCT00464022|pain, endoscopy|pain, endoscopy
570038|NCT00464022|Pain, endoscopy, randomised trial|pain, endoscopy, randomised trial
570039|NCT00464035|Obesity|obesity
570040|NCT00464035|Calcium|calcium
570041|NCT00464035|Fat absorption|fat absorption
570042|NCT00464035|Postprandial lipid profile|postprandial lipid profile
570043|NCT00464035|appetite|appetite
570044|NCT00464061|Sleep problems|sleep problems
570045|NCT00464061|Insomnia|insomnia
570046|NCT00464061|Sleeplessness|sleeplessness
570047|NCT00464061|Primary insomnia|primary insomnia
570048|NCT00464061|Insomnia disorder|insomnia disorder
570049|NCT00464074|fatigue|fatigue
570050|NCT00464074|Tysabri|tysabri
570051|NCT00464074|cognition|cognition
570052|NCT00464100|Neurodevelopmental outcomes|neurodevelopmental outcomes
570053|NCT00464100|congenital heart disease|congenital heart disease
570054|NCT00464100|NIRS monitoring|nirs monitoring
570055|NCT00464100|hypoxia|hypoxia
570056|NCT00464113|Myeloid Leukemia|myeloid leukemia
570057|NCT00464113|Lymphocytic Leukemia|lymphocytic leukemia
570058|NCT00464113|Ph+ ALL|ph+ all
570059|NCT00464126|crystalloid|crystalloid
570060|NCT00464126|colloid|colloid
570061|NCT00464126|pediatric|pediatric
570062|NCT00464126|cardiac|cardiac
570063|NCT00464126|resuscitation|resuscitation
570064|NCT00464126|Postoperative|postoperative
570065|NCT00464139|endometriosis|endometriosis
570066|NCT00464139|prevalence|prevalence
570067|NCT00464139|fertility|fertility
570068|NCT00464139|pain|pain
570069|NCT00464139|ultrasound|ultrasound
570070|NCT00464165|abstinence|abstinence
570071|NCT00464178|multiple myeloma|multiple myeloma
570072|NCT00464178|myeloma|myeloma
570073|NCT00464178|relapsed myeloma|relapsed myeloma
570074|NCT00464178|refractory myeloma|refractory myeloma
570075|NCT00464178|relapsed, refractory myeloma|relapsed, refractory myeloma
570076|NCT00464178|relapsed, refractory multiple myeloma|relapsed, refractory multiple myeloma
570077|NCT00464178|refractory multiple myeloma|refractory multiple myeloma
570078|NCT00464178|relapsed multiple myeloma|relapsed multiple myeloma
570079|NCT00464178|B lymphoid malignancies|b lymphoid malignancies
570080|NCT00464178|Myeloma, Plasma-Cell|myeloma, plasma-cell
570081|NCT00464178|Myeloma Proteins|myeloma proteins
570082|NCT00464178|hnRNP A1|hnrnp a1
753193|NCT01175824|Metabolic Diseases|metabolic diseases
570083|NCT00464178|myeloma helix-destabilizing protein, mouse|myeloma helix-destabilizing protein, mouse
570084|NCT00464178|IgC3kappa Jir protein, human|igc3kappa jir protein, human
570470|NCT00464698|Duloxetine|duloxetine
570085|NCT00464178|gamma 3 myeloma protein Jir, human|gamma 3 myeloma protein jir, human
570086|NCT00464178|M-proteins (Myeloma)|m-proteins (myeloma)
570087|NCT00464178|M315 myeloma protein, mouse|m315 myeloma protein, mouse
570088|NCT00464178|myeloma protein M 315, mouse|myeloma protein m 315, mouse
570477|NCT00468858|Vaccine|vaccine
570090|NCT00464178|myeloma protein McPC603 antibody|myeloma protein mcpc603 antibody
570091|NCT00464178|multiple myeloma M-proteins|multiple myeloma m-proteins
570092|NCT00464178|M protein, multiple myeloma|m protein, multiple myeloma
570093|NCT00464178|myeloma cell activator|myeloma cell activator
570094|NCT00464178|myeloma immunoglobulins|myeloma immunoglobulins
570095|NCT00464178|myeloma immunoglobulin M603|myeloma immunoglobulin m603
570096|NCT00464178|myeloma immunoglobulin S15|myeloma immunoglobulin s15
570097|NCT00464178|myeloma protein A48, mouse|myeloma protein a48, mouse
570098|NCT00464178|A48 myeloma protein, mouse|a48 myeloma protein, mouse
570099|NCT00464178|ABPC48 myeloma protein, mouse|abpc48 myeloma protein, mouse
570100|NCT00464178|myeloma protein A 48, mouse|myeloma protein a 48, mouse
570101|NCT00464178|myeloma protein Dob|myeloma protein dob
570102|NCT00464178|myeloma protein M 467|myeloma protein m 467
570103|NCT00464178|myeloma protein M467|myeloma protein m467
570104|NCT00464178|myeloma protein MOPC 141, mouse|myeloma protein mopc 141, mouse
570105|NCT00464178|MOPC141 myeloma protein, mouse|mopc141 myeloma protein, mouse
570106|NCT00464178|myeloma protein MOPC 173|myeloma protein mopc 173
570107|NCT00464178|myeloma protein Rou|myeloma protein rou
570108|NCT00464178|IgA2 myeloma protein Rou|iga2 myeloma protein rou
570109|NCT00464178|myeloma protein TEPC15|myeloma protein tepc15
570110|NCT00464178|myeloma protein T15|myeloma protein t15
570111|NCT00464178|myeloma protein TEPC 15|myeloma protein tepc 15
570112|NCT00464178|myeloma protein W3129|myeloma protein w3129
570113|NCT00464178|myeloma protein WIE|myeloma protein wie
570114|NCT00464178|myeloma-associated membrane antigen KMA|myeloma-associated membrane antigen kma
570115|NCT00464178|myeloma antigen KMA|myeloma antigen kma
570116|NCT00464178|MYEOV protein, human|myeov protein, human
570117|NCT00464178|protein 460|protein 460
570118|NCT00464178|myeloma protein MOPC 460|myeloma protein mopc 460
570119|NCT00464178|TRAPPC1 protein, human|trappc1 protein, human
570120|NCT00464178|multiple myeloma protein 2, human|multiple myeloma protein 2, human
570121|NCT00464178|Wis heavy-chain disease protein, human|wis heavy-chain disease protein, human
570122|NCT00464178|myeloma protein Wis, human|myeloma protein wis, human
570123|NCT00464191|bipolar depression|bipolar depression
570124|NCT00464191|SSRI|ssri
570125|NCT00464191|escitalopram|escitalopram
570126|NCT00464191|bipolar disorder|bipolar disorder
570127|NCT00464191|antidepressant|antidepressant
570128|NCT00464191|treatment trial|treatment trial
570130|NCT00464217|Acute Myeloblastic Leukaemia|acute myeloblastic leukaemia
570131|NCT00464230|Displaced Femoral Neck Fractures|displaced femoral neck fractures
570132|NCT00464230|Treatment|treatment
570133|NCT00464230|Function|function
570134|NCT00464230|Pain|pain
570135|NCT00464230|Quality of life|quality of life
570136|NCT00464230|Complications|complications
570137|NCT00464230|Reoperations|reoperations
570138|NCT00464230|Internal Fixation|internal fixation
570139|NCT00464230|Hemiarthroplasty|hemiarthroplasty
570140|NCT00464230|Activities of Daily Living|activities of daily living
570141|NCT00464243|Sleep problems|sleep problems
570142|NCT00464243|Insomnia|insomnia
570143|NCT00464243|Sleeplessness|sleeplessness
570144|NCT00464243|Polysomnographic|polysomnographic
570145|NCT00464256|abstinence|abstinence
570146|NCT00464269|Epilepsy|epilepsy
570147|NCT00464269|Brivaracetam|brivaracetam
570148|NCT00464269|Partial Onset Seizures, Adolescents & Adults|partial onset seizures, adolescents & adults
570149|NCT00464282|Fluorine–18-α–methyltyrosine,|fluorine–18-α–methyltyrosine,
570150|NCT00464282|Positron emission tomography,|positron emission tomography,
570151|NCT00464282|Fluorodeoxyglucose|fluorodeoxyglucose
570152|NCT00464282|Lung cancer,|lung cancer,
570153|NCT00464282|Amino acid transportor 1,|amino acid transportor 1,
570154|NCT00464282|Ki-67|ki-67
570155|NCT00464282|Proven or suspected non-small cell lung cancer were enrolled in the study|proven or suspected non-small cell lung cancer were enrolled in the study
570156|NCT00464295|Hepatocellular Carcinoma|hepatocellular carcinoma
570157|NCT00464295|Phase 2 Trial|phase 2 trial
570158|NCT00464295|Capecitabine|capecitabine
570159|NCT00464295|Treatment Efficacy|treatment efficacy
570160|NCT00464308|Gastroesophageal Reflux|gastroesophageal reflux
570161|NCT00464308|Heartburn|heartburn
570162|NCT00464308|Proton pump inhibitor|proton pump inhibitor
570163|NCT00464308|GORD|gord
570165|NCT00464347|wet AMD|wet amd
570166|NCT00464347|verteporfin PDT|verteporfin pdt
570167|NCT00464347|Avastin|avastin
570168|NCT00464347|TAC-PF|tac-pf
570169|NCT00457938|lipodystrophy|lipodystrophy
570170|NCT00457951|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
570171|NCT00457951|COPD|copd
570172|NCT00457951|Heparin|heparin
570173|NCT00457951|ODSH|odsh
570174|NCT00457951|Exacerbations of COPD|exacerbations of copd
570175|NCT00457964|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
570176|NCT00457964|Lymyphangioleiomyomatosis|lymyphangioleiomyomatosis
569656|NCT00462761|RTK|rtk
570177|NCT00457964|Mammalian Target of Rapamycin (mTOR)|mammalian target of rapamycin (mtor)
570178|NCT00457964|RAD001|rad001
570179|NCT00457964|Angiomyolipmas|angiomyolipmas
570180|NCT00457977|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
570181|NCT00457977|COPD|copd
570182|NCT00457977|Pneumococcal|pneumococcal
570183|NCT00457977|Vaccine|vaccine
570184|NCT00457977|Opsonization|opsonization
570185|NCT00457977|Antibodies|antibodies
570186|NCT00457990|Neurocognitive outcome|neurocognitive outcome
570187|NCT00457990|preterm infant|preterm infant
570188|NCT00457990|very low birth weight|very low birth weight
570189|NCT00457990|iron deficiency|iron deficiency
570190|NCT00457990|iron supplementation|iron supplementation
570191|NCT00458003|Preeclampsia|preeclampsia
570192|NCT00458003|Spinal Anesthesia|spinal anesthesia
570193|NCT00458003|Hypotension|hypotension
570194|NCT00458003|Cesarean Delivery|cesarean delivery
570195|NCT00458003|Phenylephrine|phenylephrine
570196|NCT00458003|Ephedrine|ephedrine
570197|NCT00458029|type 2 diabetes risk factors|type 2 diabetes risk factors
570198|NCT00458029|obesity|obesity
570199|NCT00458029|prevention|prevention
570200|NCT00458029|adolescence|adolescence
570201|NCT00458029|school based|school based
570202|NCT00458042|Ventavis|ventavis
570203|NCT00458042|iloporst|iloporst
570204|NCT00458042|Remodulin|remodulin
570205|NCT00458042|treprostinil|treprostinil
570206|NCT00458042|PAH|pah
570207|NCT00458042|prostacyclin|prostacyclin
570208|NCT00458055|Lipid lowering agents|lipid lowering agents
570209|NCT00458055|Drug treatment|drug treatment
570210|NCT00458055|Statin|statin
570211|NCT00458055|Fibrate|fibrate
570212|NCT00458055|Niacin|niacin
570213|NCT00458055|Cellular cholesterol efflux|cellular cholesterol efflux
570214|NCT00458068|preterm infant|preterm infant
570215|NCT00458068|iron supplementation|iron supplementation
570216|NCT00458068|iron deficiency|iron deficiency
570217|NCT00458068|blood transfusion|blood transfusion
570218|NCT00458094|Exercise|exercise
570219|NCT00458094|Mental Illness|mental illness
570220|NCT00458094|Community Psychiatry|community psychiatry
570221|NCT00458094|Peer Support|peer support
570222|NCT00458094|Mental Disorders|mental disorders
570223|NCT00458107|Pharmacokinetics|pharmacokinetics
570224|NCT00458107|Pharmacodynamics|pharmacodynamics
570225|NCT00458120|Dengue Fever|dengue fever
570226|NCT00458120|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
570227|NCT00458120|Dengue Vaccination|dengue vaccination
570228|NCT00458133|aerobic exercise|aerobic exercise
570229|NCT00458133|resistance exercise|resistance exercise
570230|NCT00458133|type 2 diabetes|type 2 diabetes
570231|NCT00458133|hemoglobin A1C|hemoglobin a1c
570232|NCT00458133|exercise|exercise
570233|NCT00458159|CC-11006|cc-11006
570234|NCT00458159|RA|ra
570235|NCT00458159|MDS|mds
570236|NCT00458159|Celgene|celgene
570237|NCT00458159|RCMD-RS|rcmd-rs
570238|NCT00458159|RARS|rars
570239|NCT00458159|RAEB-1|raeb-1
570240|NCT00458159|Low-or Intermediate-1-Risk Myelodysplastic Syndrome (MDS)|low-or intermediate-1-risk myelodysplastic syndrome (mds)
570241|NCT00458172|lay theories|lay theories
570242|NCT00458172|health concepts|health concepts
570243|NCT00458172|survey|survey
570244|NCT00458172|internet research|internet research
570245|NCT00458172|Ideas about health|ideas about health
570246|NCT00458198|Selective Mutism|selective mutism
570247|NCT00458211|Schizophrenia|schizophrenia
570248|NCT00458211|Ziprasidone|ziprasidone
570249|NCT00458224|overweight|overweight
570250|NCT00458224|obesity|obesity
570251|NCT00458224|child|child
570252|NCT00458237|HER2 positive|her2 positive
570253|NCT00458237|metastatic breast cancer|metastatic breast cancer
570254|NCT00458237|RAD001|rad001
570255|NCT00458237|Herceptin|herceptin
570256|NCT00458250|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
570257|NCT00458250|Haploidentical|haploidentical
570258|NCT00458250|Hematologic Neoplasms|hematologic neoplasms
570259|NCT00458250|human, Bone Marrow|human, bone marrow
570260|NCT00458250|Granulocyte Colony-stimulating Factor|granulocyte colony-stimulating factor
570261|NCT00458250|CAMPATH|campath
570262|NCT00458250|Alemtuzumab|alemtuzumab
570263|NCT00458250|AML|aml
570264|NCT00458250|ALL|all
570265|NCT00458250|10. Eligibility|10. eligibility
570266|NCT00458263|Growth Hormone treatment|growth hormone treatment
570267|NCT00458263|ISS|iss
570268|NCT00458263|Biochemical markers|biochemical markers
570269|NCT00458263|Growth response|growth response
570270|NCT00458276|Left sided heart disease|left sided heart disease
570271|NCT00458276|Elevated pulmonary arterial pressure|elevated pulmonary arterial pressure
570272|NCT00458276|Right ventricular failure|right ventricular failure
570273|NCT00458276|Cardiac surgery|cardiac surgery
570274|NCT00458276|heart-lung machine|heart-lung machine
570275|NCT00458276|cardiopulmonary bypass|cardiopulmonary bypass
570276|NCT00458276|tezosentan|tezosentan
570277|NCT00458276|Actelion|actelion
570278|NCT00458302|HIV|hiv
569733|NCT00462943|CML|cml
570279|NCT00458302|Monotherapy|monotherapy
570280|NCT00458302|Darunavir|darunavir
570281|NCT00458302|Protease inhibitor|protease inhibitor
570282|NCT00458302|Early pre-treated|early pre-treated
570283|NCT00458302|Undetectable|undetectable
570284|NCT00458302|Treatment Experienced|treatment experienced
570285|NCT00458341|Cystic fibrosis|cystic fibrosis
570286|NCT00458341|Nonsense mutation|nonsense mutation
570287|NCT00458341|Premature stop codon|premature stop codon
570288|NCT00458354|Spinal Sealant|spinal sealant
570289|NCT00458354|Spinal Sealant System|spinal sealant system
570290|NCT00458354|Dural Repair|dural repair
570291|NCT00458354|Spinal Surgery|spinal surgery
570292|NCT00458367|PASS|pass
570293|NCT00458367|Safety Assessment|safety assessment
570294|NCT00458367|Efficacy Assessment|efficacy assessment
570295|NCT00458367|long-acting injectable risperidone|long-acting injectable risperidone
570296|NCT00458380|Doppler ultrasonography|doppler ultrasonography
570297|NCT00458380|Embryos|embryos
570298|NCT00458380|Infertility|infertility
570299|NCT00458380|IVF|ivf
570300|NCT00458380|Oocytes|oocytes
570301|NCT00458380|Tubal factor|tubal factor
570302|NCT00458380|unexplained infertility|unexplained infertility
570303|NCT00458393|HIV|hiv
570304|NCT00458393|Chemoprophylaxis|chemoprophylaxis
570305|NCT00458393|Hepatitis|hepatitis
570306|NCT00458393|Viral human hepatitis|viral human hepatitis
570307|NCT00458393|HIV Seronegativity|hiv seronegativity
570308|NCT00458406|obstructive sleep apnea|obstructive sleep apnea
570309|NCT00458406|child|child
570310|NCT00458406|CPAP|cpap
570311|NCT00458419|dyspnea; leg discomfort; exercise duration|dyspnea; leg discomfort; exercise duration
570312|NCT00458432|fMRI|fmri
570313|NCT00458432|Pavlovian Conditioning|pavlovian conditioning
570314|NCT00458432|Functional Activity|functional activity
570315|NCT00458432|Brain|brain
570316|NCT00458432|Fear|fear
570317|NCT00458432|Healthy Volunteer|healthy volunteer
570318|NCT00458432|HV|hv
570319|NCT00458445|Attention-Deficit Hyperactivity Disorder (ADHD)|attention-deficit hyperactivity disorder (adhd)
570320|NCT00458458|Endometriosis|endometriosis
570321|NCT00458458|Dysmenorrhea|dysmenorrhea
570322|NCT00458458|Pelvic Pain|pelvic pain
570323|NCT00458458|Period Pain|period pain
570324|NCT00458458|Menstrual Cramps|menstrual cramps
570325|NCT00458458|Dyspareunia|dyspareunia
570326|NCT00458458|Norethindrone Acetate|norethindrone acetate
570327|NCT00458458|Lupron Depot|lupron depot
570328|NCT00458458|Bone Density|bone density
570329|NCT00458458|Lipid Profile|lipid profile
570330|NCT00458471|Urinary Catheter|urinary catheter
570331|NCT00458471|Spinal Cord Injury|spinal cord injury
570332|NCT00458471|Escherichia Coli|escherichia coli
570333|NCT00458471|Urinary Tract Infection|urinary tract infection
570334|NCT00458484|stage I renal cell cancer|stage i renal cell cancer
570335|NCT00458484|stage II renal cell cancer|stage ii renal cell cancer
570336|NCT00458484|stage III renal cell cancer|stage iii renal cell cancer
570337|NCT00458484|stage IV renal cell cancer|stage iv renal cell cancer
570338|NCT00458497|Holofiber|holofiber
570339|NCT00458497|chronic foot pain|chronic foot pain
570340|NCT00458497|sleep quality|sleep quality
570341|NCT00458510|Pain|pain
570342|NCT00458510|Cancer|cancer
570343|NCT00458510|Breakthrough|breakthrough
570344|NCT00458523|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
570345|NCT00458523|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
570346|NCT00458523|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
570347|NCT00458523|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
570348|NCT00458523|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
570349|NCT00458523|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
570350|NCT00458536|GM-CSF|gm-csf
570351|NCT00458536|vaccine|vaccine
570352|NCT00458536|debulking nephrectomy|debulking nephrectomy
570353|NCT00458536|dendritic cells|dendritic cells
570354|NCT00458549|stage I prostate cancer|stage i prostate cancer
570355|NCT00458549|stage II prostate cancer|stage ii prostate cancer
570356|NCT00458549|stage III prostate cancer|stage iii prostate cancer
570357|NCT00458549|stage IV prostate cancer|stage iv prostate cancer
570358|NCT00458562|cervical cancer|cervical cancer
570359|NCT00458562|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
570360|NCT00458562|stage 0 cervical cancer|stage 0 cervical cancer
570361|NCT00458562|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
570362|NCT00458562|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
570363|NCT00458562|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
570364|NCT00458575|Retinitis Pigmentosa|retinitis pigmentosa
570365|NCT00458575|Advanced retinitis pigmentosa (RP)|advanced retinitis pigmentosa (rp)
570366|NCT00458575|CNTO 2476|cnto 2476
570367|NCT00458575|Subretinal|subretinal
570368|NCT00458575|Human umbilical tissue-derived cells (hUTC)|human umbilical tissue-derived cells (hutc)
570369|NCT00458575|Light perception (LP)|light perception (lp)
570370|NCT00458575|Hand motion (HM)|hand motion (hm)
570371|NCT00464373|Prostatitis|prostatitis
570372|NCT00464373|Chronic Prostatitis with Chronic Pelvic Pain Syndrome|chronic prostatitis with chronic pelvic pain syndrome
570373|NCT00464373|Botulinum Toxin Type A|botulinum toxin type a
570374|NCT00464373|Drug therapy|drug therapy
570375|NCT00464373|Injections, intramuscular|injections, intramuscular
570376|NCT00464386|Severe burns|severe burns
570377|NCT00464386|Severe Trauma|severe trauma
570378|NCT00464386|Closed loop insulin|closed loop insulin
570379|NCT00464386|continuous glucose monitoring|continuous glucose monitoring
570380|NCT00464399|De novo renal transplantation|de novo renal transplantation
570381|NCT00464399|CNI-free protocol|cni-free protocol
570382|NCT00464399|adults|adults
570383|NCT00464399|everolimus|everolimus
570384|NCT00464399|rejections|rejections
570385|NCT00464412|Osteoporosis|osteoporosis
570386|NCT00464412|Knowledge|knowledge
570387|NCT00464412|Beliefs|beliefs
570388|NCT00464412|Education|education
570389|NCT00464412|Women|women
570390|NCT00464425|Electroacupuncture|electroacupuncture
570391|NCT00464425|Postoperative ileus|postoperative ileus
570392|NCT00464425|Colorectal surgery|colorectal surgery
570393|NCT00464425|Laparoscopic surgery|laparoscopic surgery
570394|NCT00464425|Randomised trial|randomised trial
570395|NCT00464464|Parkinson's disease|parkinson's disease
570396|NCT00464464|PD|pd
570397|NCT00464464|depression|depression
570398|NCT00464464|cognitive-behavioral therapy|cognitive-behavioral therapy
570399|NCT00464464|social support|social support
570400|NCT00464477|Autism|autism
570401|NCT00464477|Autistic disorder|autistic disorder
570402|NCT00464477|Pervasive developmental disorder|pervasive developmental disorder
570403|NCT00464477|Asperger syndrome|asperger syndrome
570404|NCT00464477|Childhood disintegrative disorder|childhood disintegrative disorder
570405|NCT00464477|Rett syndrome|rett syndrome
570406|NCT00464490|Weaning|weaning
570407|NCT00464490|Extuvation|extuvation
570408|NCT00464490|Dexmedetomidine|dexmedetomidine
570409|NCT00464503|statins|statins
570410|NCT00464503|proteinuria|proteinuria
570411|NCT00464503|proteomic analysis|proteomic analysis
570412|NCT00464503|healthy volunteers|healthy volunteers
570413|NCT00464516|Breast cancer (Estrogen Receptor positive)|breast cancer (estrogen receptor positive)
570414|NCT00464529|blood glucose|blood glucose
570415|NCT00464529|hyperglycemia|hyperglycemia
570416|NCT00464529|hypoglycemia|hypoglycemia
570417|NCT00464529|Perioperative care|perioperative care
570418|NCT00464529|inpatient|inpatient
570419|NCT00464542|herpes simplex virus|herpes simplex virus
570420|NCT00464555|Allogeneic Islets|allogeneic islets
570421|NCT00464555|Allogeneic Islet Transplantation|allogeneic islet transplantation
570422|NCT00464555|Type 1 diabetes mellitus|type 1 diabetes mellitus
570423|NCT00464555|Type 1 diabetes|type 1 diabetes
570424|NCT00464555|T1D|t1d
570425|NCT00464555|T1DM|t1dm
570426|NCT00464555|Insulin dependence|insulin dependence
570427|NCT00464555|Hypoglycemia unawareness in T1D|hypoglycemia unawareness in t1d
570428|NCT00464555|Islet transplant|islet transplant
570429|NCT00464555|Islet transplantation|islet transplantation
570430|NCT00464555|Islet graft|islet graft
570431|NCT00464568|Seasonal allergic rhinitis,|seasonal allergic rhinitis,
570432|NCT00464568|hayfever|hayfever
570433|NCT00464581|non-ischemic retinopathy|non-ischemic retinopathy
570434|NCT00464594|Japan Early Diabetes Intervention Study|japan early diabetes intervention study
570435|NCT00464620|Dasatinib|dasatinib
570436|NCT00464620|Rhabdomyosarcoma|rhabdomyosarcoma
570437|NCT00464620|Malignant peripheral nerve sheath tumor|malignant peripheral nerve sheath tumor
570438|NCT00464620|Chondrosarcoma|chondrosarcoma
570439|NCT00464620|Ewing's|ewing's
570440|NCT00464620|Alveolar soft part sarcoma (ASPS)|alveolar soft part sarcoma (asps)
570441|NCT00464620|Chordoma|chordoma
570442|NCT00464620|Epithelioid sarcoma|epithelioid sarcoma
570443|NCT00464620|Giant cell tumor of bone|giant cell tumor of bone
570444|NCT00464620|Hemangiopericytoma/solitary fibrous tumor|hemangiopericytoma/solitary fibrous tumor
570445|NCT00464620|Gastrointestinal Stromal Tumor (GIST)|gastrointestinal stromal tumor (gist)
570447|NCT00464633|PLL|pll
570448|NCT00464633|flavopiridol|flavopiridol
570449|NCT00464646|NSABP|nsabp
570450|NCT00464646|Epirubicin|epirubicin
570451|NCT00464646|Cyclophosphamide|cyclophosphamide
570452|NCT00464646|Docetaxel|docetaxel
570453|NCT00464646|Trastuzumab|trastuzumab
570454|NCT00464646|Bevacizumab|bevacizumab
570455|NCT00464646|Neoadjuvant Therapy|neoadjuvant therapy
570456|NCT00464646|HER2|her2
570457|NCT00464646|Locally Advanced Breast Cancer|locally advanced breast cancer
570458|NCT00464646|Adjuvant Therapy|adjuvant therapy
570459|NCT00464646|Pathologic Stage III Breast Cancer|pathologic stage iii breast cancer
570460|NCT00464646|Inflammatory Breast Cancer|inflammatory breast cancer
570461|NCT00464659|Sleep apnea obstructive syndrome (SAOS)|sleep apnea obstructive syndrome (saos)
570462|NCT00464659|memory deficit|memory deficit
570463|NCT00464659|Continuous Positive Airway Pression (CPAP)|continuous positive airway pression (cpap)
570464|NCT00464659|Sham CPAP|sham cpap
570465|NCT00464672|Influenza, Egg-Derived, Healthy Children, Healthy Adolescents, Healthy Adults, Safety, Immunogenicity, Trivalent, Inactivated, Vaccination|influenza, egg-derived, healthy children, healthy adolescents, healthy adults, safety, immunogenicity, trivalent, inactivated, vaccination
570467|NCT00464698|Obsessive Compulsive Disorder|obsessive compulsive disorder
570468|NCT00464698|Obsessions|obsessions
570469|NCT00464698|Compulsions|compulsions
570471|NCT00464698|Cymbalta|cymbalta
570472|NCT00468845|pain after hysterectomy|pain after hysterectomy
570473|NCT00468845|amount of opioids used|amount of opioids used
570474|NCT00468858|Dengue|dengue
570475|NCT00468858|Virus|virus
570476|NCT00468858|Live-attenuated|live-attenuated
570478|NCT00468858|Dengue viral infection|dengue viral infection
570479|NCT00468858|Dengue Vaccine|dengue vaccine
570480|NCT00468884|Kinetics of GLP-1 and PYY3-36; increasing oral doses|kinetics of glp-1 and pyy3-36; increasing oral doses
570481|NCT00468897|Alzheimers Disease|alzheimers disease
570482|NCT00468897|healthy volunteers|healthy volunteers
570483|NCT00468897|bioequivalence|bioequivalence
570484|NCT00468923|Primary prevention|primary prevention
570485|NCT00468923|Cholesterol lowering|cholesterol lowering
570486|NCT00468923|Blood pressure lowering|blood pressure lowering
570487|NCT00468923|Cardiovascular disease prevention|cardiovascular disease prevention
570488|NCT00468936|anti-rejection|anti-rejection
570489|NCT00468936|GI side effects|gi side effects
570490|NCT00468936|heart transplant patients|heart transplant patients
570491|NCT00468949|Health-Related Quality of Life|health-related quality of life
570492|NCT00468949|Dupuytren's Disease|dupuytren's disease
570493|NCT00468949|Health Utilities Index|health utilities index
570494|NCT00468949|Short Form-36;|short form-36;
570495|NCT00468949|Michigan Hand Outcomes Questionnaire|michigan hand outcomes questionnaire
570496|NCT00469001|Hospitalization and death from exacerbation CHF.|hospitalization and death from exacerbation chf.
570497|NCT00469014|Acute Myeloid Leukemia|acute myeloid leukemia
570499|NCT00469014|Myelodysplastic Syndrome|myelodysplastic syndrome
570500|NCT00469014|MDS|mds
570501|NCT00469014|Chronic Myeloid Leukemia|chronic myeloid leukemia
570502|NCT00469014|CML|cml
570503|NCT00469014|Busulfan|busulfan
570504|NCT00469014|Busulfex|busulfex
570505|NCT00469014|Myleran|myleran
570506|NCT00469014|Fludarabine|fludarabine
570507|NCT00469014|Fludara|fludara
570508|NCT00469014|Fludarabine Phosphate|fludarabine phosphate
570509|NCT00469014|Clofarabine|clofarabine
570510|NCT00469014|Clofarex|clofarex
570511|NCT00469014|Clolar|clolar
570512|NCT00469014|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
570513|NCT00469014|ASCT|asct
570514|NCT00469014|Stem Cell|stem cell
570515|NCT00469014|Gleevec|gleevec
570516|NCT00469014|Imatinib Mesylate|imatinib mesylate
570517|NCT00469027|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
570518|NCT00469040|GW642444,|gw642444,
570519|NCT00469040|healthy subjects|healthy subjects
570520|NCT00469040|magnesium stearate,|magnesium stearate,
570521|NCT00469053|Transdermal patch|transdermal patch
570522|NCT00469053|multidose|multidose
570523|NCT00469053|Centrally acting analgesic|centrally acting analgesic
570524|NCT00469053|Plasma level|plasma level
570525|NCT00469053|Healthy volunteers|healthy volunteers
570526|NCT00469066|small cell lung cancer|small cell lung cancer
570527|NCT00469066|bladder cancer|bladder cancer
570528|NCT00469066|conformal radiotherapy|conformal radiotherapy
570529|NCT00469079|Biomarkers|biomarkers
570530|NCT00469079|Smoking|smoking
570531|NCT00469079|Tobacco|tobacco
570532|NCT00469079|Cessation|cessation
570533|NCT00469105|Type 2 Diabetes|type 2 diabetes
570534|NCT00469105|Diabetes Education|diabetes education
570535|NCT00469105|Health Literacy|health literacy
570536|NCT00469131|liver transplantation,|liver transplantation,
570537|NCT00469131|HCV recurrence,|hcv recurrence,
570538|NCT00469131|immunosuppression|immunosuppression
570539|NCT00469144|Stem Cell Transplantation|stem cell transplantation
570540|NCT00469144|Leukemia|leukemia
570541|NCT00469144|Busulfan|busulfan
570542|NCT00469144|Fludarabine|fludarabine
570543|NCT00469144|MDS|mds
570544|NCT00469144|AML|aml
570545|NCT00469157|compatibility of Optive after PRK or LASIK|compatibility of optive after prk or lasik
570546|NCT00469170|HIV-1|hiv-1
570547|NCT00469170|HIV seronegativity|hiv seronegativity
570548|NCT00469196|mesothelioma|mesothelioma
570549|NCT00469196|tomotherapy|tomotherapy
570550|NCT00469209|Multiple Myeloma|multiple myeloma
570551|NCT00469209|Melphalan|melphalan
570552|NCT00469209|Trisenox|trisenox
570553|NCT00469209|Arsenic Trioxide|arsenic trioxide
570554|NCT00469209|Ascorbic Acid|ascorbic acid
570555|NCT00469209|Vitamin C|vitamin c
570556|NCT00469209|Velcade|velcade
570557|NCT00469209|Bortezomib|bortezomib
570558|NCT00469222|small cell lung cancer|small cell lung cancer
570559|NCT00469222|radiotherapy dose escalation|radiotherapy dose escalation
570560|NCT00469248|Myocardial infarction|myocardial infarction
570561|NCT00469248|Cardiogenic shock|cardiogenic shock
570562|NCT00469248|Systemic inflammatory response syndrome|systemic inflammatory response syndrome
737221|NCT01112215|SLE|sle
569994|NCT00463840|5FU|5fu
570563|NCT00469248|Percutaneous coronary intervention|percutaneous coronary intervention
570564|NCT00469248|aortic balloon counterpulsation|aortic balloon counterpulsation
570565|NCT00469261|Myocardial infarction|myocardial infarction
570498|NCT00469014|AML|aml
570566|NCT00469261|Ventricular remodeling|ventricular remodeling
570567|NCT00469261|Matrix metalloproteinases|matrix metalloproteinases
570568|NCT00469261|Doxycycline|doxycycline
570569|NCT00469274|Pertussis|pertussis
570570|NCT00469274|Healthcare worker|healthcare worker
570571|NCT00469274|Post-exposure prophylaxis|post-exposure prophylaxis
570572|NCT00469274|Vaccination|vaccination
570573|NCT00469274|Pertussis in healthcare workers following occupational|pertussis in healthcare workers following occupational
570574|NCT00469274|exposure to pertussis|exposure to pertussis
570575|NCT00469287|diabetes mellitus|diabetes mellitus
570576|NCT00469287|blood sugar|blood sugar
570577|NCT00469287|overweight|overweight
570578|NCT00469287|obesity|obesity
570579|NCT00469287|Traditional Chinese medicine|traditional chinese medicine
570580|NCT00469300|herpes labialis|herpes labialis
570581|NCT00469300|cold sore|cold sore
570582|NCT00469300|acyclovir|acyclovir
570583|NCT00469300|iontophoresis|iontophoresis
570584|NCT00469300|topical|topical
570585|NCT00469313|copd|copd
570586|NCT00469313|inspiratory muscle training|inspiratory muscle training
570587|NCT00469313|IF|if
570588|NCT00469326|coronary artery disease|coronary artery disease
570589|NCT00469326|percutaneous coronary intervention|percutaneous coronary intervention
570590|NCT00469326|atorvastatin|atorvastatin
570591|NCT00469339|Diabetes|diabetes
570592|NCT00469339|Colon Cancer|colon cancer
570593|NCT00469339|Cardiovascular Disease|cardiovascular disease
570594|NCT00469352|Pharmacogenetics|pharmacogenetics
570595|NCT00469352|Genetics|genetics
570596|NCT00469352|Treatment response|treatment response
570597|NCT00469352|AMD|amd
570598|NCT00469352|Wet AMD|wet amd
570599|NCT00469352|Age-related macular degeneration|age-related macular degeneration
570600|NCT00469365|clinical trial, medication adherence, pharmacy intervention|clinical trial, medication adherence, pharmacy intervention
570601|NCT00469365|Patients with specific chronic diseases|patients with specific chronic diseases
570602|NCT00469378|firategrast|firategrast
570603|NCT00469378|lymphocytes|lymphocytes
570604|NCT00469378|leukocytes|leukocytes
570605|NCT00469378|SB-683699|sb-683699
570606|NCT00469378|cerebrospinal fluid|cerebrospinal fluid
570607|NCT00469378|relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
570608|NCT00469391|Weight Reduction|weight reduction
570609|NCT00469404|Transdermal patch|transdermal patch
570610|NCT00469404|Centrally acting analgesic|centrally acting analgesic
570611|NCT00469404|Plasma level|plasma level
570612|NCT00469404|Healthy volunteers|healthy volunteers
570613|NCT00469417|Methyl aminolevulinate|methyl aminolevulinate
570614|NCT00469417|Photodynamic therapy|photodynamic therapy
570615|NCT00469417|Primary Superficial Basal Cell Carcinoma|primary superficial basal cell carcinoma
570616|NCT00469430|appendicitis|appendicitis
570617|NCT00469430|treatment|treatment
570618|NCT00469430|antibiotics|antibiotics
570619|NCT00469443|Metastatic colorectal cancer|metastatic colorectal cancer
570620|NCT00469443|Irinotecan|irinotecan
570621|NCT00469443|Capecitabine|capecitabine
570622|NCT00469443|Bevacizumab|bevacizumab
570623|NCT00469456|memantine|memantine
570624|NCT00469456|Alzheimer's Disease|alzheimer's disease
570625|NCT00469456|communication|communication
570626|NCT00469469|Adrenal Cortex|adrenal cortex
570627|NCT00469469|ACC|acc
570628|NCT00469482|Delirium|delirium
570629|NCT00469482|Cognitive Impairment|cognitive impairment
570630|NCT00469482|Sleep|sleep
570631|NCT00469482|Polysomnography|polysomnography
570632|NCT00469482|Sedation|sedation
570633|NCT00469482|Mechanical Ventilation|mechanical ventilation
570634|NCT00469482|Critical Illness|critical illness
570635|NCT00469508|Methamphetamine|methamphetamine
570636|NCT00469508|Modafinil|modafinil
570637|NCT00469508|Medication|medication
570638|NCT00469508|Contingency Management|contingency management
570639|NCT00469508|Crystal meth|crystal meth
570640|NCT00469508|Los Angeles|los angeles
570641|NCT00469508|Addiction|addiction
570642|NCT00469508|Meth|meth
570643|NCT00469534|minimized time to beam|minimized time to beam
737824|NCT01114386|Cough|cough
570644|NCT00469534|hypofractionated 3D CRT plus IMRT|hypofractionated 3d crt plus imrt
570645|NCT00469534|PET-scan|pet-scan
570646|NCT00469547|ethanol, microbicide, sexually transmitted, Kenya, males|ethanol, microbicide, sexually transmitted, kenya, males
570647|NCT00469547|HIV Seronegativity|hiv seronegativity
570648|NCT00469560|MDS|mds
570649|NCT00469560|Chronic transfusional hemosiderosis|chronic transfusional hemosiderosis
570650|NCT00469560|Deferasirox|deferasirox
570651|NCT00469599|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
570652|NCT00469599|Kidney Failure, Chronic|kidney failure, chronic
570653|NCT00469599|Renal Insufficiency, Chronic|renal insufficiency, chronic
570129|NCT00464191|RCT|rct
570654|NCT00469599|Vitamin D Deficiency|vitamin d deficiency
570655|NCT00469599|Renal Osteodystrophy|renal osteodystrophy
570656|NCT00469599|Hemodialysis|hemodialysis
570657|NCT00469612|Myopia|myopia
570658|NCT00469612|NeuroVision|neurovision
570659|NCT00469612|Visual acuity|visual acuity
570660|NCT00469612|Contrast sensitivity|contrast sensitivity
570661|NCT00469638|atrial fibrillation|atrial fibrillation
570662|NCT00469638|paroxysmal|paroxysmal
570663|NCT00469638|persistent|persistent
570664|NCT00469638|symptomatic|symptomatic
570665|NCT00469638|ablation|ablation
570666|NCT00469638|catheter|catheter
570667|NCT00469638|introducer|introducer
570668|NCT00469638|Agilis NxT|agilis nxt
570669|NCT00469638|sinus rhythm|sinus rhythm
570670|NCT00469638|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
570671|NCT00469638|persistent atrial fibrillation|persistent atrial fibrillation
570672|NCT00469638|symptomatic atrial fibrillation|symptomatic atrial fibrillation
570673|NCT00469651|Malaria|malaria
570674|NCT00469651|vaccine|vaccine
570675|NCT00469651|MSP3LSP|msp3lsp
570676|NCT00469651|Safety|safety
570677|NCT00469651|children|children
570678|NCT00469651|Tanzania|tanzania
570679|NCT00469664|Schizophrenia|schizophrenia
570680|NCT00469664|Schizoaffective|schizoaffective
570681|NCT00469664|Cognitive Impairment|cognitive impairment
570682|NCT00469664|Cognition|cognition
570683|NCT00469664|Memory|memory
570684|NCT00469664|Attention|attention
570685|NCT00469664|Concentration|concentration
570686|NCT00469703|Pancreatitis|pancreatitis
570687|NCT00469716|Fluid balance|fluid balance
570688|NCT00469716|respiratory function|respiratory function
570689|NCT00469716|cardiac function|cardiac function
570690|NCT00469716|inflammation|inflammation
570691|NCT00469716|Cardiopulmonary bypass|cardiopulmonary bypass
570692|NCT00469729|Tetraethylenepentamine|tetraethylenepentamine
570693|NCT00469729|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
570694|NCT00469729|Hematological Malignancies|hematological malignancies
570695|NCT00469729|Acute Lymphoid Leukemia|acute lymphoid leukemia
570696|NCT00469729|Subjects with high-risk hematologic malignancies who are candidates for allogeneic stem cell transplantation|subjects with high-risk hematologic malignancies who are candidates for allogeneic stem cell transplantation
570697|NCT00469742|Cardiology|cardiology
570698|NCT00469742|Pediatrics|pediatrics
570699|NCT00469742|Cardiac Defects|cardiac defects
570700|NCT00469742|Cardiopulmonary Bypass Surgery|cardiopulmonary bypass surgery
570701|NCT00469742|Aprotinin|aprotinin
570702|NCT00469742|thrombosis|thrombosis
570703|NCT00469742|renal dysfunction|renal dysfunction
570704|NCT00469768|HIV-1 infection|hiv-1 infection
570705|NCT00469768|HIV Seronegativity|hiv seronegativity
570706|NCT00469794|arrhythmias|arrhythmias
570707|NCT00469794|Athletes|athletes
570708|NCT00469794|exercise|exercise
570709|NCT00469807|Ghrelin|ghrelin
570710|NCT00469807|Pregnancy outcome|pregnancy outcome
570711|NCT00469820|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
570712|NCT00469820|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
570713|NCT00469820|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
570714|NCT00469820|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
570715|NCT00469820|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
570716|NCT00469820|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
570717|NCT00469820|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
570718|NCT00469820|secondary acute myeloid leukemia|secondary acute myeloid leukemia
570719|NCT00469820|stage III multiple myeloma|stage iii multiple myeloma
570720|NCT00469820|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
570721|NCT00469820|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
570722|NCT00469820|stage I multiple myeloma|stage i multiple myeloma
570723|NCT00469820|stage II multiple myeloma|stage ii multiple myeloma
570724|NCT00469820|refractory multiple myeloma|refractory multiple myeloma
570725|NCT00469833|Diabetes|diabetes
570726|NCT00469833|Glucose Tolerance|glucose tolerance
570727|NCT00469833|Incretin|incretin
570728|NCT00469833|Insulin|insulin
570729|NCT00469846|Pre-Eclampsia|pre-eclampsia
570730|NCT00469846|Hypertension,pregnancy-induced|hypertension,pregnancy-induced
570731|NCT00469846|Preterm labor|preterm labor
737825|NCT01114386|Exercise|exercise
570732|NCT00469859|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
570733|NCT00469859|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
570734|NCT00469859|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
570735|NCT00469859|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
570736|NCT00469859|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
570164|NCT00464347|AMD|amd
570737|NCT00469859|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
570738|NCT00469859|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
570739|NCT00469859|secondary acute myeloid leukemia|secondary acute myeloid leukemia
570740|NCT00469885|Smoking cessation|smoking cessation
570741|NCT00469885|cardiovascular disease|cardiovascular disease
570742|NCT00469885|smoking reduction|smoking reduction
570743|NCT00469885|nicotine replacement|nicotine replacement
570744|NCT00469898|extensive stage small cell lung cancer|extensive stage small cell lung cancer
570746|NCT00469911|Transplant|transplant
570747|NCT00469911|MRS|mrs
570748|NCT00469911|MRI|mri
570749|NCT00469911|Spectroscopy|spectroscopy
570751|NCT00469924|Clinical Laboratory Information Systems|clinical laboratory information systems
571085|NCT00470795|acupuncture|acupuncture
570752|NCT00469924|Hospital Communication Systems|hospital communication systems
570753|NCT00469924|Laboratory Techniques and Procedures|laboratory techniques and procedures
570754|NCT00469924|Point-of-Care Systems|point-of-care systems
570755|NCT00469924|Therapy, Computer-Assisted|therapy, computer-assisted
570756|NCT00469937|radiation toxicity|radiation toxicity
570757|NCT00469937|neurotoxicity|neurotoxicity
570758|NCT00469937|cognitive/functional effects|cognitive/functional effects
570759|NCT00469937|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
570760|NCT00469937|adult tumors metastatic to brain|adult tumors metastatic to brain
570761|NCT00469950|PCI|pci
570762|NCT00469950|stent|stent
570763|NCT00469950|training|training
570764|NCT00469950|endothelial function|endothelial function
570765|NCT00469950|restenosis|restenosis
570766|NCT00469950|late luminal loss|late luminal loss
570767|NCT00469950|heart rate variability|heart rate variability
570768|NCT00469950|oxygen uptake capacity|oxygen uptake capacity
570769|NCT00469950|inflammatory markers|inflammatory markers
570770|NCT00469963|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
570771|NCT00469963|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
570772|NCT00469963|recurrent adult primary liver cancer|recurrent adult primary liver cancer
570773|NCT00469963|advanced adult primary liver cancer|advanced adult primary liver cancer
570774|NCT00469976|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
570775|NCT00469976|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
570776|NCT00469976|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
570777|NCT00469989|immune system|immune system
570778|NCT00469989|allergy|allergy
570779|NCT00469989|hookworm infection|hookworm infection
570780|NCT00469989|parasite infection|parasite infection
570781|NCT00469989|asthma|asthma
570782|NCT00470002|growth hormone|growth hormone
570783|NCT00470002|nitric oxide|nitric oxide
570784|NCT00470002|nitrate|nitrate
570785|NCT00470002|cyclic guanosine monophosphate|cyclic guanosine monophosphate
570786|NCT00470002|insulin-like growth factor-1|insulin-like growth factor-1
570787|NCT00470002|asymmetric dimethylarginine|asymmetric dimethylarginine
570788|NCT00470002|blood pressure|blood pressure
570789|NCT00470002|endothelial progenitor cells|endothelial progenitor cells
570790|NCT00470015|stage II melanoma|stage ii melanoma
570791|NCT00470015|stage III melanoma|stage iii melanoma
570792|NCT00470015|stage IV melanoma|stage iv melanoma
570793|NCT00470015|recurrent melanoma|recurrent melanoma
570794|NCT00470028|TMS|tms
570795|NCT00470028|Treatment|treatment
570796|NCT00470028|Adolescents|adolescents
570797|NCT00470028|Safety|safety
570798|NCT00470028|Efficacy|efficacy
570799|NCT00470041|Healthy volunteers|healthy volunteers
570800|NCT00470067|recurrent endometrial carcinoma|recurrent endometrial carcinoma
570801|NCT00470067|stage III endometrial carcinoma|stage iii endometrial carcinoma
570802|NCT00470067|stage IV endometrial carcinoma|stage iv endometrial carcinoma
570803|NCT00470080|Venepuncture|venepuncture
570804|NCT00470080|Pain|pain
570805|NCT00470080|Emla cream|emla cream
570806|NCT00470080|Oral sucrose solution|oral sucrose solution
570807|NCT00470080|Premature infant|premature infant
570808|NCT00470080|Premature infant admitted to the care baby unit were|premature infant admitted to the care baby unit were
570809|NCT00470080|included in the study.|included in the study.
570810|NCT00470080|Programed venepuncture is performed with analgesia.|programed venepuncture is performed with analgesia.
570811|NCT00470093|refractory multiple myeloma|refractory multiple myeloma
570812|NCT00470093|stage I multiple myeloma|stage i multiple myeloma
570813|NCT00470093|stage II multiple myeloma|stage ii multiple myeloma
570814|NCT00470093|stage III multiple myeloma|stage iii multiple myeloma
570815|NCT00470106|Cognition|cognition
570816|NCT00470106|Remediation|remediation
570817|NCT00470106|Schizophrenia|schizophrenia
570818|NCT00470106|Social Cognition|social cognition
570819|NCT00470119|breast cancer|breast cancer
570820|NCT00470119|obesity|obesity
570821|NCT00470119|weight changes|weight changes
570822|NCT00470132|ventricular shunt|ventricular shunt
570823|NCT00470145|unmilled formulation,|unmilled formulation,
570824|NCT00470145|micronised formulation|micronised formulation
570825|NCT00470145|relative bioavailability,|relative bioavailability,
570826|NCT00470158|zinc|zinc
570827|NCT00470158|iron|iron
570828|NCT00470158|interaction|interaction
570829|NCT00470158|diarrhea|diarrhea
570830|NCT00470158|delivery|delivery
570831|NCT00470184|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
570832|NCT00470184|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
570833|NCT00470184|stage II esophageal cancer|stage ii esophageal cancer
570834|NCT00470184|stage III esophageal cancer|stage iii esophageal cancer
570835|NCT00470184|stage IV esophageal cancer|stage iv esophageal cancer
570836|NCT00470210|Ribavirin|ribavirin
570837|NCT00470210|non-responders|non-responders
570838|NCT00470210|HCV co-infected patients|hcv co-infected patients
570839|NCT00470210|sustained virological response|sustained virological response
570840|NCT00470210|Treatment Experienced|treatment experienced
570841|NCT00470223|localized osteosarcoma|localized osteosarcoma
570842|NCT00470223|metastatic osteosarcoma|metastatic osteosarcoma
570843|NCT00470236|Ductal carcinoma in-situ|ductal carcinoma in-situ
570844|NCT00470236|Breast conserving therapy|breast conserving therapy
570845|NCT00470236|Whole breast radiation therapy|whole breast radiation therapy
570846|NCT00470236|Tumour bed boost|tumour bed boost
570847|NCT00470236|Fractionation schedules|fractionation schedules
570848|NCT00470236|Completely excised non-low risk DCIS|completely excised non-low risk dcis
570849|NCT00470249|stage IIIB breast cancer|stage iiib breast cancer
570850|NCT00470249|stage IIIC breast cancer|stage iiic breast cancer
570851|NCT00470249|stage IV breast cancer|stage iv breast cancer
570852|NCT00470249|recurrent breast cancer|recurrent breast cancer
570853|NCT00470249|male breast cancer|male breast cancer
570854|NCT00470249|stage IIIA breast cancer|stage iiia breast cancer
570855|NCT00470262|fatty acid oxidation complex|fatty acid oxidation complex
570856|NCT00470262|fenofibrate|fenofibrate
570857|NCT00470262|Inflammation|inflammation
570858|NCT00470262|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
570859|NCT00470262|pioglitazone|pioglitazone
570860|NCT00470262|Prediabetic State|prediabetic state
570861|NCT00470262|insulin resistance|insulin resistance
570862|NCT00470275|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
570863|NCT00470288|cesarean delivery|cesarean delivery
570864|NCT00470288|bladder flaps|bladder flaps
570865|NCT00470314|Acute liver failure|acute liver failure
570866|NCT00470314|Ornithine Aspartate|ornithine aspartate
570867|NCT00470314|Ammonia|ammonia
570868|NCT00470314|Encephalopathy|encephalopathy
570869|NCT00470327|Interstitial lung diseases|interstitial lung diseases
570870|NCT00470327|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
570871|NCT00470327|Sarcoidosis|sarcoidosis
570872|NCT00470327|mRNA and cytokine expression|mrna and cytokine expression
570873|NCT00470340|Recurrence|recurrence
570874|NCT00470340|Neoplasm Recurrence, Local|neoplasm recurrence, local
570875|NCT00470340|Liver|liver
570876|NCT00470340|Liver Neoplasms|liver neoplasms
570877|NCT00470340|Liver Cirrhosis|liver cirrhosis
570878|NCT00470340|Carcinoma, Hepatocellular|carcinoma, hepatocellular
570879|NCT00470340|Iodized Oil|iodized oil
570880|NCT00470340|gemcitabine [Substance Name]|gemcitabine [substance name]
570881|NCT00470340|oxaliplatin [Substance Name]|oxaliplatin [substance name]
570882|NCT00470340|gemcitabine-oxaliplatin regimen [Substance Name]|gemcitabine-oxaliplatin regimen [substance name]
570883|NCT00470340|Randomized Controlled Trials|randomized controlled trials
570884|NCT00470340|Multicenter Studies|multicenter studies
570885|NCT00470340|Cisplatin|cisplatin
570886|NCT00470340|Injections, Intra-Arterial|injections, intra-arterial
570887|NCT00470340|Injections, Intravenous|injections, intravenous
570888|NCT00470340|Chemotherapy, Adjuvant|chemotherapy, adjuvant
570889|NCT00470353|recurrent colon cancer|recurrent colon cancer
570890|NCT00470353|stage I colon cancer|stage i colon cancer
570891|NCT00470353|stage II colon cancer|stage ii colon cancer
570892|NCT00470353|stage III colon cancer|stage iii colon cancer
570893|NCT00470366|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
570894|NCT00470366|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
570895|NCT00470366|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
570896|NCT00470366|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
570897|NCT00470366|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
570898|NCT00470366|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
570899|NCT00470366|testicular choriocarcinoma|testicular choriocarcinoma
570900|NCT00470366|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
583956|NCT00514046|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
570901|NCT00470366|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
570902|NCT00470366|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
570903|NCT00470366|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
570904|NCT00470366|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
570905|NCT00470366|testicular embryonal carcinoma|testicular embryonal carcinoma
570906|NCT00470366|testicular seminoma|testicular seminoma
570907|NCT00470366|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
570908|NCT00470366|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
570909|NCT00470366|testicular yolk sac tumor|testicular yolk sac tumor
570910|NCT00470366|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
570911|NCT00470366|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
570912|NCT00470366|ovarian choriocarcinoma|ovarian choriocarcinoma
570913|NCT00470366|ovarian dysgerminoma|ovarian dysgerminoma
570914|NCT00470366|ovarian embryonal carcinoma|ovarian embryonal carcinoma
570915|NCT00470366|ovarian yolk sac tumor|ovarian yolk sac tumor
570916|NCT00470366|ovarian immature teratoma|ovarian immature teratoma
570917|NCT00470366|ovarian mature teratoma|ovarian mature teratoma
570918|NCT00470366|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
571086|NCT00470795|symptoms|symptoms
570919|NCT00470366|ovarian polyembryoma|ovarian polyembryoma
570920|NCT00470366|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
570921|NCT00470366|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
570922|NCT00470366|stage IV extragonadal seminoma|stage iv extragonadal seminoma
570923|NCT00470366|stage I extragonadal non-seminomatous germ cell tumor|stage i extragonadal non-seminomatous germ cell tumor
570924|NCT00470366|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
570996|NCT00470418|clinical trial|clinical trial
570997|NCT00470418|dementia|dementia
570925|NCT00470366|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
570926|NCT00470366|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
570927|NCT00470366|adult teratoma|adult teratoma
570928|NCT00470366|testicular immature teratoma|testicular immature teratoma
570929|NCT00470366|testicular mature teratoma|testicular mature teratoma
570930|NCT00470366|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
570931|NCT00470366|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
570932|NCT00470366|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
570933|NCT00470366|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
570934|NCT00470366|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
570935|NCT00470366|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
570936|NCT00470366|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
570937|NCT00470366|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
570938|NCT00470366|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
570939|NCT00470379|stage II melanoma|stage ii melanoma
570940|NCT00470379|stage III melanoma|stage iii melanoma
570941|NCT00470379|stage IV melanoma|stage iv melanoma
570942|NCT00470392|Erythema|erythema
570943|NCT00470392|optimization|optimization
570944|NCT00470392|Papule|papule
570945|NCT00470392|Plaque|plaque
570946|NCT00470392|pretreatment|pretreatment
570947|NCT00470392|T cells|t cells
570948|NCT00470392|UVB laser light|uvb laser light
570949|NCT00470392|psoriasis|psoriasis
570950|NCT00470392|topical administration|topical administration
570951|NCT00470405|adult solid tumor|adult solid tumor
570952|NCT00470405|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
570953|NCT00470405|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
570954|NCT00470405|anaplastic large cell lymphoma|anaplastic large cell lymphoma
570955|NCT00470405|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
570956|NCT00470405|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
570957|NCT00470405|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
570958|NCT00470405|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
570959|NCT00470405|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
570960|NCT00470405|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
570961|NCT00470405|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
570962|NCT00470405|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
570963|NCT00470405|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
570964|NCT00470405|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
570965|NCT00470405|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
570966|NCT00470405|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
570967|NCT00470405|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
570968|NCT00470405|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
570969|NCT00470405|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
570970|NCT00470405|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
570971|NCT00470405|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
570972|NCT00470405|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
737877|NCT01114737|PKU|pku
570973|NCT00470405|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
570974|NCT00470405|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
570975|NCT00470405|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
570976|NCT00470405|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
570977|NCT00470405|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
570978|NCT00470405|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
570979|NCT00470405|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
570980|NCT00470405|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
570981|NCT00470405|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
570982|NCT00470405|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
570983|NCT00470405|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
570984|NCT00470405|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
570985|NCT00470405|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
570986|NCT00470405|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
571084|NCT00470795|gastroparesis|gastroparesis
570987|NCT00470405|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
570988|NCT00470405|splenic marginal zone lymphoma|splenic marginal zone lymphoma
570989|NCT00470405|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
570990|NCT00470405|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
570991|NCT00470405|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
570992|NCT00470405|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
570993|NCT00470418|Alzheimer Disease|alzheimer disease
570994|NCT00470418|Alzheimer Type Senile Dementia|alzheimer type senile dementia
570995|NCT00470418|Alzheimer's Disease|alzheimer's disease
570998|NCT00470418|diabetes|diabetes
570999|NCT00470418|dietary supplements|dietary supplements
571000|NCT00470418|Senile Dementia, Alzheimer Type|senile dementia, alzheimer type
571001|NCT00470418|Therapeutics|therapeutics
571002|NCT00470444|Cardiac Surgery|cardiac surgery
571003|NCT00470444|Transfusion Medicine|transfusion medicine
571004|NCT00470444|Cardiac Anesthesia Risk Evaluation (CARE) Score of 3 or 4|cardiac anesthesia risk evaluation (care) score of 3 or 4
571005|NCT00470444|(Dupuis J-Y et al, Anesthesiology 2001;94: 194-204)|(dupuis j-y et al, anesthesiology 2001;94: 194-204)
571007|NCT00470483|Social Anxiety Disorder|social anxiety disorder
571008|NCT00470483|fRMI|frmi
571009|NCT00470522|methotrexate|methotrexate
571010|NCT00470522|folic acid|folic acid
571011|NCT00470522|systemic lupus erythematosus|systemic lupus erythematosus
571012|NCT00470522|steroid|steroid
571013|NCT00470535|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
571014|NCT00470535|recurrent pancreatic cancer|recurrent pancreatic cancer
571015|NCT00470535|stage III pancreatic cancer|stage iii pancreatic cancer
571016|NCT00470535|stage IV pancreatic cancer|stage iv pancreatic cancer
571017|NCT00470548|male breast cancer|male breast cancer
571018|NCT00470548|recurrent breast cancer|recurrent breast cancer
571019|NCT00470548|stage IIIA breast cancer|stage iiia breast cancer
571020|NCT00470548|stage IIIB breast cancer|stage iiib breast cancer
571021|NCT00470548|stage IIIC breast cancer|stage iiic breast cancer
571022|NCT00470548|stage IV breast cancer|stage iv breast cancer
571023|NCT00470548|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
571024|NCT00470548|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
571025|NCT00470548|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
571026|NCT00470548|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
571027|NCT00470548|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
571028|NCT00470561|mammographic breast density aspirin|mammographic breast density aspirin
571029|NCT00470574|recurrent breast cancer|recurrent breast cancer
571030|NCT00470574|stage IV breast cancer|stage iv breast cancer
571031|NCT00470574|male breast cancer|male breast cancer
571032|NCT00470587|chest pain|chest pain
571033|NCT00470587|myocardial infarction|myocardial infarction
571034|NCT00470587|unstable angina|unstable angina
571035|NCT00470613|Neoplasm|neoplasm
571036|NCT00470626|Pulmonary Embolism|pulmonary embolism
571037|NCT00470626|Venous Thromboembolism|venous thromboembolism
571038|NCT00470626|Inferior Vena Cava Filter|inferior vena cava filter
571039|NCT00470626|IVC|ivc
571040|NCT00470626|PE|pe
571041|NCT00470639|TMS|tms
571042|NCT00470639|Treatment|treatment
571043|NCT00470639|Bipolar|bipolar
571044|NCT00470639|Efficacy|efficacy
571045|NCT00470652|pain|pain
571046|NCT00470652|Pain Measurement|pain measurement
571047|NCT00470652|Decision Making, Computer-Assisted|decision making, computer-assisted
571048|NCT00470652|Informatics|informatics
571049|NCT00470678|Age-related|age-related
571050|NCT00470678|macular|macular
571051|NCT00470678|degeneration|degeneration
571052|NCT00470678|AMD|amd
571053|NCT00470678|Ranibizumab|ranibizumab
571054|NCT00470678|Anti-VEGF|anti-vegf
571055|NCT00470678|choroidal|choroidal
571056|NCT00470678|neovascularization|neovascularization
571057|NCT00470678|CNV|cnv
571058|NCT00470678|Asian patients|asian patients
571059|NCT00470678|Korea|korea
571060|NCT00470678|Taiwan|taiwan
571061|NCT00470678|associated|associated
571062|NCT00470704|HER2-positive breast cancer|her2-positive breast cancer
571063|NCT00470704|Herceptin|herceptin
571064|NCT00470704|trastuzumab|trastuzumab
571065|NCT00470717|late preterm infant|late preterm infant
571066|NCT00470717|breastfeeding|breastfeeding
571067|NCT00470717|formula feeding|formula feeding
571068|NCT00470717|rehospitalization|rehospitalization
571069|NCT00470717|telephone|telephone
571070|NCT00470743|Ibuprofen|ibuprofen
571071|NCT00470743|Indomethacin|indomethacin
571072|NCT00470743|Infant, very low birth weight|infant, very low birth weight
571073|NCT00470743|Prematurity|prematurity
571074|NCT00470743|Ductus Arteriosus, patent|ductus arteriosus, patent
571075|NCT00470769|Color-Doppler Ultrasonography|color-doppler ultrasonography
571076|NCT00470769|Renal scintigraphy|renal scintigraphy
571077|NCT00470769|Kidney failure|kidney failure
571078|NCT00470769|GFR|gfr
571079|NCT00470782|colonic neoplasms|colonic neoplasms
571080|NCT00470782|exercise|exercise
571081|NCT00470782|body composition|body composition
571082|NCT00470782|anthropometry|anthropometry
571083|NCT00470795|diabetes|diabetes
571087|NCT00470795|gastric emptying|gastric emptying
571088|NCT00470808|Minors|minors
571089|NCT00470808|Enrollment in another study|enrollment in another study
571090|NCT00470808|Males|males
571091|NCT00470808|HBA1C greater than 7|hba1c greater than 7
571092|NCT00470808|Drug therapy for DM|drug therapy for dm
571093|NCT00470821|melatonin|melatonin
571094|NCT00470821|actigraphy|actigraphy
571095|NCT00470821|sedation|sedation
571480|NCT00473590|AMBER|amber
571096|NCT00470821|critical patients|critical patients
571097|NCT00470821|ICU|icu
571098|NCT00470834|prostate cancer|prostate cancer
571099|NCT00470834|androgen deprivation therapy|androgen deprivation therapy
571100|NCT00470847|Herceptin|herceptin
571101|NCT00470847|breast cancer|breast cancer
571102|NCT00470847|radiation therapy|radiation therapy
571103|NCT00470847|stereotactic radiosurgery|stereotactic radiosurgery
571104|NCT00470847|SRS|srs
571105|NCT00470847|whole brain radiation|whole brain radiation
571106|NCT00470847|WBRT|wbrt
571107|NCT00470899|Feto-maternal transfusion|feto-maternal transfusion
571108|NCT00470899|Kleihauer-Betke|kleihauer-betke
571109|NCT00470912|cutaneous lupus erythemaosus|cutaneous lupus erythemaosus
571110|NCT00470912|photoprotection|photoprotection
571111|NCT00470912|photoprovocation|photoprovocation
571112|NCT00470912|Sunscreen RV 2547C|sunscreen rv 2547c
571113|NCT00470925|Neurological|neurological
571114|NCT00470925|Dopamine|dopamine
571115|NCT00470951|rectal cancer|rectal cancer
571116|NCT00470951|laparoscopic assisted resection|laparoscopic assisted resection
571117|NCT00470951|open resection|open resection
571118|NCT00470951|preoperative chemoradiation|preoperative chemoradiation
571119|NCT00470951|randomized trial|randomized trial
571120|NCT00470964|laser trabeculoplasty, glaucoma, argon, titanium-sapphire|laser trabeculoplasty, glaucoma, argon, titanium-sapphire
571121|NCT00470964|IOP lowering effect|iop lowering effect
571122|NCT00470964|Adverse effects|adverse effects
571123|NCT00470964|IOP spikes|iop spikes
571124|NCT00470990|IHH|ihh
571125|NCT00470990|Kallmann syndrome|kallmann syndrome
571126|NCT00470990|hypogonadism|hypogonadism
571127|NCT00471003|Hypertension|hypertension
571128|NCT00471029|pH study, peptic ulcer, proton pump inhibitor|ph study, peptic ulcer, proton pump inhibitor
571129|NCT00471042|Heroin Dependence|heroin dependence
571130|NCT00471042|Opioid Dependence|opioid dependence
571131|NCT00471042|Primary Care|primary care
571132|NCT00471042|Buprenorphine|buprenorphine
571133|NCT00471055|osteoarthritis|osteoarthritis
571134|NCT00471055|knee|knee
571135|NCT00471055|capsaicin gel|capsaicin gel
571136|NCT00471055|capsicum|capsicum
571137|NCT00471081|Neisseria meningitidis;|neisseria meningitidis;
571138|NCT00471081|Humans;|humans;
571139|NCT00471081|Meningococcal vaccines;|meningococcal vaccines;
571140|NCT00471081|Safety|safety
571141|NCT00471081|Vaccines, conjugate;|vaccines, conjugate;
571142|NCT00471081|Toddlers;|toddlers;
571143|NCT00471081|Immunogenicity;|immunogenicity;
571144|NCT00471094|heartburn|heartburn
571145|NCT00471094|erosive esophagitis|erosive esophagitis
571146|NCT00471094|healing|healing
571147|NCT00471094|population pharmacokinetics|population pharmacokinetics
571148|NCT00471094|Quality of Life (QoL)|quality of life (qol)
571149|NCT00471107|Frontal Lobe|frontal lobe
571150|NCT00471107|Language|language
571151|NCT00471107|Dementia|dementia
571152|NCT00471107|Healthy Volunteer|healthy volunteer
571153|NCT00471107|HV|hv
571154|NCT00471133|melanoma|melanoma
571155|NCT00471133|DNA vaccine|dna vaccine
571156|NCT00471133|tyrosinase|tyrosinase
571157|NCT00471133|electroporation|electroporation
571158|NCT00471146|Randomized Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine Plus Placebo For Advanced Pancreatic Cancer.|randomized study of gemcitabine plus ag-013736 versus gemcitabine plus placebo for advanced pancreatic cancer.
571159|NCT00471185|Male Contraception|male contraception
571160|NCT00471185|Acyline|acyline
571161|NCT00471237|bone mineral density,|bone mineral density,
571162|NCT00471237|Ronacaleret|ronacaleret
571163|NCT00471237|teriparatide|teriparatide
571164|NCT00471237|alendronate,|alendronate,
571165|NCT00471237|Post-menopausal women,|post-menopausal women,
571166|NCT00471237|osteoporosis,|osteoporosis,
571167|NCT00471237|SB-751689|sb-751689
571168|NCT00471250|Bronchoscopy|bronchoscopy
571169|NCT00471250|Bronchoalveolar Lavage|bronchoalveolar lavage
571170|NCT00471250|Nasal Mucosal Biopsy|nasal mucosal biopsy
571171|NCT00471250|Research Procedures|research procedures
571172|NCT00471250|Infection Susceptibility|infection susceptibility
571173|NCT00471250|Lung Infection Susceptibility|lung infection susceptibility
571174|NCT00471250|Healthy Volunteer|healthy volunteer
571175|NCT00471250|HV|hv
571176|NCT00471276|Metastatic Breast Cancer|metastatic breast cancer
571177|NCT00471289|Critical Limb Ischemia|critical limb ischemia
571178|NCT00471289|Stents|stents
571179|NCT00471289|Drug Eluting Stents|drug eluting stents
571180|NCT00471289|Peripheral arterial disease|peripheral arterial disease
571182|NCT00471289|Paclitaxel|paclitaxel
571183|NCT00471289|TAXUS|taxus
571184|NCT00471289|Infrapopliteal|infrapopliteal
571185|NCT00471289|Infragenicular|infragenicular
571186|NCT00471289|Interventional Radiology|interventional radiology
571187|NCT00471289|CLI|cli
571188|NCT00471289|DES|des
571189|NCT00471302|Healthy Volunteers|healthy volunteers
571190|NCT00471302|Immunological Parameters|immunological parameters
571191|NCT00471302|Mali|mali
571192|NCT00471302|B Lymphocyte|b lymphocyte
571193|NCT00471302|Malaria|malaria
571194|NCT00471302|Healthy Volunteer|healthy volunteer
571195|NCT00471315|SOD|sod
571481|NCT00473590|Myeloma|myeloma
571196|NCT00471315|Common Bile Duct Diseases|common bile duct diseases
571197|NCT00471315|Sphincterotomy|sphincterotomy
571198|NCT00471315|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
571199|NCT00471328|GIST|gist
571200|NCT00471328|adults|adults
571201|NCT00471328|imatinib resistant|imatinib resistant
571202|NCT00471328|sunitinib resistant|sunitinib resistant
571203|NCT00471328|AMN107|amn107
571204|NCT00471328|nilotinib|nilotinib
571205|NCT00471328|treatment|treatment
571206|NCT00471328|Gastrointestinal stromal tumor (GIST)|gastrointestinal stromal tumor (gist)
571207|NCT00471341|arteriosclerosis|arteriosclerosis
571208|NCT00471341|coronary disease|coronary disease
571209|NCT00471341|inflammation|inflammation
571210|NCT00471341|COX-2 inhibition|cox-2 inhibition
571211|NCT00471341|hypertension|hypertension
571212|NCT00461526|IBS|ibs
571213|NCT00461526|d-IBS|d-ibs
571214|NCT00461526|Irritable Bowel Syndrome|irritable bowel syndrome
571215|NCT00461539|Tobacco Use|tobacco use
571216|NCT00461539|Alcohol and Drug Use|alcohol and drug use
571217|NCT00461539|Obesity|obesity
571218|NCT00461539|Risky Sexual Behavior|risky sexual behavior
571219|NCT00461552|Lipodystrophy|lipodystrophy
571220|NCT00461552|HIV|hiv
571221|NCT00461552|HAART|haart
571222|NCT00461552|HIV Lipodystrophy Syndrome|hiv lipodystrophy syndrome
571223|NCT00461552|Lipodystrophy syndrome|lipodystrophy syndrome
571224|NCT00461552|HIV-Associated Lipodystrophy|hiv-associated lipodystrophy
571225|NCT00461552|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
571226|NCT00461552|Treatment Experienced|treatment experienced
571227|NCT00461565|Retina|retina
571228|NCT00461565|PDE-5|pde-5
571229|NCT00461565|Levitra|levitra
571230|NCT00461565|Viagra|viagra
571231|NCT00461565|Normal healthy volunteers for evaluation of retinal function|normal healthy volunteers for evaluation of retinal function
571232|NCT00461578|P.falciparum|p.falciparum
571233|NCT00461578|malaria|malaria
571234|NCT00461578|lapdap+artesunate|lapdap+artesunate
571235|NCT00461578|safety|safety
571236|NCT00461578|efficay|efficay
571237|NCT00461591|Noninvasive Bladder Cancer|noninvasive bladder cancer
571238|NCT00461604|gastroesophageal reflux disease|gastroesophageal reflux disease
571239|NCT00461604|baclofen|baclofen
571240|NCT00461604|impedance|impedance
571241|NCT00461617|diabetes|diabetes
571242|NCT00461617|rapid and short acting insulin secretagogue|rapid and short acting insulin secretagogue
571243|NCT00461617|α-glucosidase inhibitor|α-glucosidase inhibitor
571244|NCT00461617|HbA1C|hba1c
571245|NCT00461617|insulin|insulin
571246|NCT00461630|coronary heart disease|coronary heart disease
571247|NCT00461630|cardiovascular disease|cardiovascular disease
571248|NCT00461630|stroke|stroke
571249|NCT00461630|peripheral arterial disease|peripheral arterial disease
571250|NCT00461630|diabetes mellitus|diabetes mellitus
571251|NCT00461630|cholesterol|cholesterol
571252|NCT00461630|HDL cholesterol|hdl cholesterol
571253|NCT00461630|simvastatin|simvastatin
571254|NCT00461630|ezetimibe|ezetimibe
571255|NCT00461630|ER niacin|er niacin
571256|NCT00461630|laropiprant|laropiprant
570745|NCT00469911|Heart|heart
571257|NCT00461643|Anovulation|anovulation
571258|NCT00461643|Clomiphene citrate|clomiphene citrate
571259|NCT00461643|Infertility|infertility
571260|NCT00461643|Metformin|metformin
571261|NCT00461643|PCOS|pcos
571262|NCT00461643|RCT|rct
571263|NCT00461643|Treatment|treatment
571264|NCT00461656|Antiseptic|antiseptic
571265|NCT00461656|Povidone-Iodine|povidone-iodine
571266|NCT00461669|hip|hip
571267|NCT00461669|fracture|fracture
571268|NCT00461669|ultrasound|ultrasound
571269|NCT00461682|TRPV1 antagonist|trpv1 antagonist
571270|NCT00461682|Fecal Urgency|fecal urgency
571271|NCT00461682|rectal pain|rectal pain
571272|NCT00461682|IBS|ibs
571273|NCT00461695|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
571274|NCT00461695|Tick-borne encephalitis virus (TBEV)|tick-borne encephalitis virus (tbev)
571275|NCT00461695|Ageing|ageing
571276|NCT00461695|Vaccine|vaccine
571277|NCT00461695|Immunity|immunity
571278|NCT00461734|Right Ventricular High Septal Pacing|right ventricular high septal pacing
571279|NCT00461734|Right Ventricular Apical Pacing|right ventricular apical pacing
571280|NCT00461734|Left Ventricular Dysfunction|left ventricular dysfunction
571281|NCT00461734|Heart Block|heart block
571282|NCT00461734|Pacemaker|pacemaker
571283|NCT00461734|Atrial Fibrillation|atrial fibrillation
571284|NCT00461734|Ejection Fraction|ejection fraction
571285|NCT00461747|Untreated|untreated
571286|NCT00461747|Transplant|transplant
571287|NCT00461747|Younger|younger
571288|NCT00461760|HPV Screening/Testing for cervical cancer screening|hpv screening/testing for cervical cancer screening
571289|NCT00461773|Neoadjuvant treatment|neoadjuvant treatment
571290|NCT00471367|Phase I|phase i
571291|NCT00471367|AZD4877|azd4877
571292|NCT00471367|Lymphoma|lymphoma
571293|NCT00471367|B-cell non-Hodgkin lymphoma|b-cell non-hodgkin lymphoma
571295|NCT00471393|Osteoarthritis|osteoarthritis
571296|NCT00471393|Degenerative Joint disease|degenerative joint disease
571297|NCT00471432|recurrent prostate cancer|recurrent prostate cancer
571482|NCT00473590|Velcade|velcade
571298|NCT00471432|stage IV prostate cancer|stage iv prostate cancer
571299|NCT00471432|recurrent renal cell cancer|recurrent renal cell cancer
571300|NCT00471432|stage IV renal cell cancer|stage iv renal cell cancer
571301|NCT00471432|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
571302|NCT00471432|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
571303|NCT00471432|recurrent bladder cancer|recurrent bladder cancer
571304|NCT00471432|stage IV bladder cancer|stage iv bladder cancer
571305|NCT00471432|recurrent breast cancer|recurrent breast cancer
571306|NCT00471432|stage IV breast cancer|stage iv breast cancer
571307|NCT00471432|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
571308|NCT00471432|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
571309|NCT00471432|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
571310|NCT00471432|male breast cancer|male breast cancer
571311|NCT00471445|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
571312|NCT00471445|pain|pain
571313|NCT00471445|neurotoxicity|neurotoxicity
571314|NCT00471445|peripheral neuropathy|peripheral neuropathy
571315|NCT00471458|Radioiodine|radioiodine
571316|NCT00471458|Hyperthyroidism|hyperthyroidism
571317|NCT00471458|Morbidity|morbidity
571318|NCT00471458|Cardiovascular diseases|cardiovascular diseases
571319|NCT00471471|recurrent melanoma|recurrent melanoma
571320|NCT00471471|stage IV melanoma|stage iv melanoma
571321|NCT00471471|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
571322|NCT00471471|extraocular extension melanoma|extraocular extension melanoma
571323|NCT00471471|iris melanoma|iris melanoma
571324|NCT00471471|recurrent intraocular melanoma|recurrent intraocular melanoma
571325|NCT00471471|metastatic intraocular melanoma|metastatic intraocular melanoma
571326|NCT00471471|conjunctival melanoma|conjunctival melanoma
571327|NCT00471471|stage IIIA melanoma|stage iiia melanoma
571328|NCT00471471|stage IIIB melanoma|stage iiib melanoma
571329|NCT00471471|stage IIIC melanoma|stage iiic melanoma
571330|NCT00471484|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
571331|NCT00471484|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
571332|NCT00471484|advanced adult primary liver cancer|advanced adult primary liver cancer
571333|NCT00471484|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
571334|NCT00471484|stage III childhood liver cancer|stage iii childhood liver cancer
571335|NCT00471484|stage IV childhood liver cancer|stage iv childhood liver cancer
571336|NCT00471497|leukemia|leukemia
571337|NCT00471497|bone marrow|bone marrow
571338|NCT00471497|leukemia symptoms|leukemia symptoms
571339|NCT00471497|lukemia|lukemia
571340|NCT00471497|cml|cml
571341|NCT00471497|complete blood count|complete blood count
571342|NCT00471497|lymphocyte|lymphocyte
571343|NCT00471497|blood cancer|blood cancer
571344|NCT00471497|leukocytes|leukocytes
571345|NCT00471497|chronic leukemia|chronic leukemia
571346|NCT00471497|bone marrow biopsy|bone marrow biopsy
571347|NCT00471497|leukemia research|leukemia research
571348|NCT00471497|leukemia cells|leukemia cells
571349|NCT00471497|bone marrow disease|bone marrow disease
571350|NCT00471497|chronic myeloid leukemia|chronic myeloid leukemia
571351|NCT00471497|blood cancer symptoms|blood cancer symptoms
571352|NCT00471497|white blood cell diseases|white blood cell diseases
571353|NCT00471497|chronic myelogenous leukemia|chronic myelogenous leukemia
571354|NCT00471497|leukemia treatment|leukemia treatment
571355|NCT00471497|leukemia facts|leukemia facts
571356|NCT00471497|leucemia|leucemia
571357|NCT00471497|facts about leukemia|facts about leukemia
571358|NCT00471497|myelogenous leukemia|myelogenous leukemia
571359|NCT00471497|newly diagnosed CML|newly diagnosed cml
571360|NCT00471497|newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia in chronic phase (CML-CP)|newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukemia in chronic phase (cml-cp)
571361|NCT00471510|androgenetic alopecia|androgenetic alopecia
571362|NCT00471510|male pattern hair loss|male pattern hair loss
571363|NCT00471510|male pattern baldness|male pattern baldness
571364|NCT00471510|androgenetic alopecia or male pattern hair loss|androgenetic alopecia or male pattern hair loss
571365|NCT00471523|Anovulation|anovulation
571366|NCT00471523|Clomiphene citrate|clomiphene citrate
571367|NCT00471523|Infertility|infertility
571368|NCT00471523|Metformin|metformin
571369|NCT00471523|PCOS|pcos
571371|NCT00471549|Diabetes|diabetes
571372|NCT00471549|Dyslipidaemia|dyslipidaemia
571373|NCT00471549|Atherosclerosis|atherosclerosis
571374|NCT00471549|Osteoprotegerin|osteoprotegerin
571375|NCT00471549|Adhesion molecules|adhesion molecules
571376|NCT00471549|Simvastatin|simvastatin
571377|NCT00471562|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
571378|NCT00471575|fatty liver|fatty liver
571379|NCT00471575|pregnancy|pregnancy
571380|NCT00471575|ultra sound|ultra sound
571381|NCT00471575|Pregnant women at the end of pregnancy or immediately after birth.|pregnant women at the end of pregnancy or immediately after birth.
571382|NCT00471575|controls-women with normal liver|controls-women with normal liver
571483|NCT00473603|androgens|androgens
571484|NCT00473603|fatty acids|fatty acids
571383|NCT00471575|correlation between ultrasonography and nutritional, obsthetric and laboratory data.|correlation between ultrasonography and nutritional, obsthetric and laboratory data.
571384|NCT00471588|Dopamine|dopamine
571386|NCT00471588|MRI|mri
571387|NCT00471588|stimulant users|stimulant users
571388|NCT00471601|recurrent breast cancer|recurrent breast cancer
571389|NCT00471601|stage IA breast cancer|stage ia breast cancer
571390|NCT00471601|stage IB breast cancer|stage ib breast cancer
571391|NCT00471601|stage II breast cancer|stage ii breast cancer
571392|NCT00471601|stage IIIA breast cancer|stage iiia breast cancer
571393|NCT00471601|stage IIIB breast cancer|stage iiib breast cancer
571394|NCT00471601|stage IIIC breast cancer|stage iiic breast cancer
571395|NCT00471601|stage IV breast cancer|stage iv breast cancer
571396|NCT00471614|HIV|hiv
571397|NCT00471614|AIDS|aids
571398|NCT00471614|uridine|uridine
571399|NCT00471614|mitochondria|mitochondria
571400|NCT00471614|insulin resistance|insulin resistance
571401|NCT00471614|Treatment Experienced|treatment experienced
571402|NCT00471640|pneumonia|pneumonia
571403|NCT00471640|dexamethasone|dexamethasone
571404|NCT00471640|community-acquired pneumonia|community-acquired pneumonia
571405|NCT00471653|thrombocytopenia|thrombocytopenia
571406|NCT00471653|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
571407|NCT00471653|adult brain stem glioma|adult brain stem glioma
571408|NCT00471653|adult mixed glioma|adult mixed glioma
571409|NCT00471653|adult giant cell glioblastoma|adult giant cell glioblastoma
571410|NCT00471653|adult gliosarcoma|adult gliosarcoma
571411|NCT00471653|adult glioblastoma|adult glioblastoma
571412|NCT00471653|adult anaplastic astrocytoma|adult anaplastic astrocytoma
571413|NCT00471653|adult anaplastic ependymoma|adult anaplastic ependymoma
571414|NCT00471653|adult pineal gland astrocytoma|adult pineal gland astrocytoma
571415|NCT00471666|Malaria|malaria
571416|NCT00471666|Filariasis|filariasis
571417|NCT00471666|Coinfection|coinfection
571418|NCT00471666|Co-Infection|co-infection
571419|NCT00471679|disseminated neuroblastoma|disseminated neuroblastoma
571420|NCT00471679|localized unresectable neuroblastoma|localized unresectable neuroblastoma
571421|NCT00471679|recurrent neuroblastoma|recurrent neuroblastoma
571422|NCT00471679|regional neuroblastoma|regional neuroblastoma
571423|NCT00471679|stage 4S neuroblastoma|stage 4s neuroblastoma
571424|NCT00473447|Rehabilitation|rehabilitation
571425|NCT00473447|Children|children
571426|NCT00473447|Cerebral Palsy|cerebral palsy
571427|NCT00473447|Arm|arm
571428|NCT00473447|Paresis|paresis
571429|NCT00473460|Chronic bronchitis|chronic bronchitis
571430|NCT00473460|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
571431|NCT00473460|Acute exacerbation of chronic bronchitis|acute exacerbation of chronic bronchitis
571432|NCT00473460|Prevention therapy|prevention therapy
571433|NCT00473460|Antibiotics|antibiotics
571434|NCT00473460|Fluoroquinolone|fluoroquinolone
571435|NCT00473460|Moxifloxacin|moxifloxacin
571436|NCT00473460|AECB|aecb
571437|NCT00473473|homeopathy|homeopathy
571438|NCT00473473|Traumeel|traumeel
571439|NCT00473473|mechanical ventilation|mechanical ventilation
571440|NCT00473473|secretions|secretions
571441|NCT00473499|drug eluting balloon|drug eluting balloon
571442|NCT00473499|drug eluting stent|drug eluting stent
571443|NCT00473499|stem cells|stem cells
571444|NCT00473512|Abiraterone acetate|abiraterone acetate
571445|NCT00473512|CB7630|cb7630
571446|NCT00473512|Prostatic neoplasms|prostatic neoplasms
571447|NCT00473512|Hormone refractory prostate cancer|hormone refractory prostate cancer
571448|NCT00473512|Castration resistant prostate cancer|castration resistant prostate cancer
571449|NCT00473512|Castration refractory prostate cancer|castration refractory prostate cancer
571450|NCT00473538|Structured exercise training program|structured exercise training program
571451|NCT00473538|Infertility|infertility
571452|NCT00473538|Menstrual cycle|menstrual cycle
571453|NCT00473538|PCOS|pcos
571454|NCT00473538|Treatment|treatment
571455|NCT00473551|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
571456|NCT00473551|Lymphoma|lymphoma
571457|NCT00473551|Myeloma|myeloma
571458|NCT00473551|Leukemia|leukemia
571459|NCT00473551|Anti-Third Party Cytolytic Lymphocytes|anti-third party cytolytic lymphocytes
571460|NCT00473551|Indolent Lymphoid Malignancies|indolent lymphoid malignancies
571461|NCT00473551|Fludarabine|fludarabine
571462|NCT00473551|Fludara|fludara
571463|NCT00473551|Rituximab|rituximab
571464|NCT00473551|Rituxan|rituxan
571465|NCT00473551|Cyclophosphamide|cyclophosphamide
571466|NCT00473551|Cytoxan®|cytoxan®
571467|NCT00473551|Neosar®|neosar®
571468|NCT00473551|Stem Cell Transplantation|stem cell transplantation
571469|NCT00473551|T-lymphocytes|t-lymphocytes
571470|NCT00473551|Miltenyi CliniMACS System|miltenyi clinimacs system
571681|NCT00474409|Vertigo|vertigo
571471|NCT00473551|Graft vs. Host Disease|graft vs. host disease
571472|NCT00473551|GVHD|gvhd
571473|NCT00473551|Allogenic Transplant|allogenic transplant
571474|NCT00473551|Sirolimus|sirolimus
571475|NCT00473551|Rapamycin|rapamycin
571476|NCT00473564|Lesions|lesions
571477|NCT00473564|Biopsy|biopsy
571478|NCT00473564|Surgery|surgery
571479|NCT00473590|Avastin|avastin
571485|NCT00473616|Phase I|phase i
571486|NCT00473616|solid tumors|solid tumors
571487|NCT00473616|solid malignancies|solid malignancies
571488|NCT00473616|cancer Eligibility|cancer eligibility
571489|NCT00473642|Ranibizumab|ranibizumab
571490|NCT00473642|Lucentis|lucentis
571491|NCT00473642|Verteporfin|verteporfin
571492|NCT00473642|Visudyne|visudyne
571493|NCT00473642|Photodynamic therapy|photodynamic therapy
571494|NCT00473655|Triglycerides|triglycerides
571495|NCT00473655|hypertriglyceridemia|hypertriglyceridemia
571496|NCT00473655|statins|statins
571497|NCT00473655|rosuvastatin|rosuvastatin
571498|NCT00473655|hyperlipoproteinemia|hyperlipoproteinemia
571499|NCT00473655|Fredrickson Type IIb or IV|fredrickson type iib or iv
571500|NCT00473668|Hepatitis B|hepatitis b
571501|NCT00473668|Tetanus|tetanus
571502|NCT00473668|Diphtheria|diphtheria
571503|NCT00473668|Pertussis|pertussis
571504|NCT00473668|Haemophilus influenzae type b Vaccines|haemophilus influenzae type b vaccines
571505|NCT00473707|Third stage of labor|third stage of labor
571506|NCT00473733|PATIENTS WITH DIABETES MELLITUS TYPE 2|patients with diabetes mellitus type 2
571507|NCT00473733|UNDERGO UPPER ENDOSCOPY|undergo upper endoscopy
571508|NCT00473733|BIOPSIES FOR GLP RECEPTORS EXPRESSION|biopsies for glp receptors expression
571509|NCT00473733|PCR ANALYSIS|pcr analysis
571510|NCT00473746|Prostate neoplasms|prostate neoplasms
571511|NCT00473746|Hormone refractory prostate cancer|hormone refractory prostate cancer
571512|NCT00473746|Abiraterone acetate|abiraterone acetate
571513|NCT00473746|CB7630|cb7630
571514|NCT00473772|cobalt chromium stent|cobalt chromium stent
571515|NCT00473772|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
571516|NCT00473772|DEBlue|deblue
571517|NCT00473772|drug eluting balloon|drug eluting balloon
571518|NCT00473785|Cardiovascular disease|cardiovascular disease
571519|NCT00473785|Prevention|prevention
571520|NCT00473785|Lifestyle|lifestyle
571521|NCT00473798|Patient Satisfaction|patient satisfaction
571522|NCT00473798|Quality of Life|quality of life
571523|NCT00473798|Psychological Distress|psychological distress
571524|NCT00473798|Cervical Cancer|cervical cancer
571525|NCT00473798|Cervical Cancer Screening|cervical cancer screening
571526|NCT00473798|Questionnaire|questionnaire
571527|NCT00473811|Glycemic index|glycemic index
571528|NCT00473811|carbohydrates|carbohydrates
571529|NCT00473811|diabetes mellitus, type 2|diabetes mellitus, type 2
571530|NCT00473811|randomized clinical trial|randomized clinical trial
571531|NCT00473824|hepatitis C|hepatitis c
571532|NCT00473824|liver transplantation|liver transplantation
571533|NCT00473824|immune globulin|immune globulin
571534|NCT00473837|malaria|malaria
571535|NCT00473837|anaemia|anaemia
571536|NCT00473837|chloroquine|chloroquine
571537|NCT00473837|iron delocalisation|iron delocalisation
571538|NCT00473837|macrophages|macrophages
571539|NCT00473850|DNA sequencing|dna sequencing
571540|NCT00473850|EXT genes|ext genes
571541|NCT00473850|Hereditary Multiple Exostoses,|hereditary multiple exostoses,
571542|NCT00473850|also known as Multiple Hereditary Exostoses,|also known as multiple hereditary exostoses,
571543|NCT00473850|also known as Hereditary Multiple Osteochondromas|also known as hereditary multiple osteochondromas
571544|NCT00473863|Acute coronary syndrome|acute coronary syndrome
571545|NCT00473863|Acute myocardial infarction|acute myocardial infarction
571546|NCT00473863|Unstable angina|unstable angina
571547|NCT00473863|Coronary computed tomographic angiography|coronary computed tomographic angiography
571548|NCT00473863|Coronary Angiography|coronary angiography
571549|NCT00473863|Tomography, X-Ray Computed|tomography, x-ray computed
571550|NCT00473863|Tomography, Spiral Computed|tomography, spiral computed
571551|NCT00473876|Chronic Heart Failure|chronic heart failure
571552|NCT00473876|Insulin Resistance|insulin resistance
571553|NCT00473876|Metformin|metformin
571554|NCT00473876|Peak VO2|peak vo2
571555|NCT00473928|Macular|macular
571556|NCT00473928|degeration|degeration
571557|NCT00473928|Complement|complement
571558|NCT00473941|colorectal cancer|colorectal cancer
571559|NCT00473941|colon cancer|colon cancer
571560|NCT00473941|rectal cancer|rectal cancer
571561|NCT00473967|Vaccine|vaccine
571562|NCT00473967|Hookworm|hookworm
571563|NCT00473967|Phase 1|phase 1
571564|NCT00473967|Na-ASP-2|na-asp-2
571566|NCT00473980|CTLs|ctls
571567|NCT00473980|Colon carcinoma|colon carcinoma
571568|NCT00473980|NSAID|nsaid
571569|NCT00473980|Survival|survival
571570|NCT00473993|Hepatitis C|hepatitis c
571571|NCT00473993|Opioid Maintenance Treatment|opioid maintenance treatment
571572|NCT00473993|Methadone|methadone
571573|NCT00473993|Buprenorphine|buprenorphine
571574|NCT00473993|Heroin|heroin
571575|NCT00473993|Interferon, pegylated|interferon, pegylated
571576|NCT00474019|pediatrics|pediatrics
571577|NCT00474019|neonates|neonates
571578|NCT00474032|Idiopathic clubfoot|idiopathic clubfoot
571579|NCT00474032|Botox injection|botox injection
571580|NCT00474032|Idiopathic Talipes Equinovarus, also known as Idiopathic clubfoot|idiopathic talipes equinovarus, also known as idiopathic clubfoot
571581|NCT00474058|rotigotine|rotigotine
571582|NCT00474058|Neupro®|neupro®
571583|NCT00474058|Parkinson's Disease|parkinson's disease
571584|NCT00474071|Remifentanil|remifentanil
571585|NCT00474071|endotracheal intubation|endotracheal intubation
571586|NCT00474071|pediatrics|pediatrics
571587|NCT00474084|Stent|stent
571588|NCT00474084|Hydroxyapatite|hydroxyapatite
571589|NCT00474084|Coronary Artery Stenosis|coronary artery stenosis
571590|NCT00474084|Angioplasty|angioplasty
571591|NCT00474097|Colorectal Neoplasms|colorectal neoplasms
571592|NCT00474097|Colitis, Ulcerative|colitis, ulcerative
571593|NCT00474097|Diverticulitis|diverticulitis
571594|NCT00474097|Colonic Polyps|colonic polyps
571595|NCT00474097|Crohn Disease|crohn disease
571596|NCT00474110|Ketamine|ketamine
571597|NCT00474110|hydromorphone|hydromorphone
571598|NCT00474110|pediatric mucositis|pediatric mucositis
571599|NCT00474123|angina|angina
571600|NCT00474123|atherosclerosis|atherosclerosis
571601|NCT00474123|simvastatin|simvastatin
571602|NCT00474123|ezetimibe|ezetimibe
571603|NCT00474123|inflammation|inflammation
571604|NCT00474162|Cesarean section|cesarean section
571605|NCT00474162|coagulation changes|coagulation changes
571606|NCT00474188|Celgene|celgene
571607|NCT00474188|Revlimid|revlimid
571608|NCT00474188|Lenalidomide|lenalidomide
571609|NCT00474188|Diffuse Large B-cell lymphoma|diffuse large b-cell lymphoma
571610|NCT00474188|Non-Hodgkins lymphoma|non-hodgkins lymphoma
571611|NCT00474188|CC-5013|cc-5013
571612|NCT00474188|Response Rate|response rate
571613|NCT00474188|Tumor Control Rate|tumor control rate
571614|NCT00474188|Duration of Response|duration of response
571615|NCT00474188|Time to Progression|time to progression
571616|NCT00474188|Progression-free survival and safety|progression-free survival and safety
571617|NCT00474201|Pharmacokinetic|pharmacokinetic
571619|NCT00474201|Drug-Drug Interaction|drug-drug interaction
571620|NCT00474201|Lopinavir/Ritonavir|lopinavir/ritonavir
571621|NCT00474201|Gemfibrozil|gemfibrozil
571622|NCT00474201|Healthy Volunteer|healthy volunteer
571623|NCT00474201|HV|hv
571624|NCT00474214|STEMI|stemi
571625|NCT00474214|Primary PCI|primary pci
571626|NCT00474214|Length of Stay|length of stay
571627|NCT00474214|Early Discharge|early discharge
571628|NCT00474227|obesity|obesity
571629|NCT00474227|weight gain|weight gain
571630|NCT00474227|schizophrenia|schizophrenia
571631|NCT00474227|schizoaffective disorder|schizoaffective disorder
571632|NCT00474227|antipsychotic induced weight gain|antipsychotic induced weight gain
571633|NCT00474240|cholesterol|cholesterol
571634|NCT00474266|MMRV vaccine|mmrv vaccine
571635|NCT00474266|co-administration|co-administration
571636|NCT00474266|immunogenicity|immunogenicity
571637|NCT00474266|meningococcal vaccine|meningococcal vaccine
571638|NCT00474266|conjugate vaccine|conjugate vaccine
571639|NCT00474279|Growth hormone secretagogue|growth hormone secretagogue
571640|NCT00474279|Body composition|body composition
571641|NCT00474279|Functional ability|functional ability
571642|NCT00474279|Aging|aging
571643|NCT00474279|Sarcopenia|sarcopenia
571644|NCT00474292|Stroke|stroke
571645|NCT00474292|Rehabilitation|rehabilitation
571646|NCT00474292|Plasticity|plasticity
571647|NCT00474292|fMRI|fmri
571648|NCT00474292|Reorganization|reorganization
571649|NCT00474305|PTSD|ptsd
571650|NCT00474305|Prolonged Exposure|prolonged exposure
571651|NCT00474305|Virtual Reality|virtual reality
571652|NCT00474318|Adolescents|adolescents
571653|NCT00474318|Obesity|obesity
571654|NCT00474318|Bariatrics|bariatrics
571655|NCT00474318|Surgery for Weight Loss|surgery for weight loss
571656|NCT00474318|Teen-LABS|teen-labs
571657|NCT00474331|DNA sequencing|dna sequencing
571658|NCT00474331|EXT genes|ext genes
571659|NCT00474331|Hereditary Multiple Exostoses,|hereditary multiple exostoses,
571660|NCT00474331|also known as Multiple Hereditary Exostoses,|also known as multiple hereditary exostoses,
571661|NCT00474331|also known as Hereditary Multiple Osteochondromas|also known as hereditary multiple osteochondromas
571662|NCT00474344|Genetics|genetics
571663|NCT00474344|Clubfoot|clubfoot
571664|NCT00474344|DNA|dna
571665|NCT00474344|Idiopathic Talipes Equinovarus also known as Clubfoot|idiopathic talipes equinovarus also known as clubfoot
571666|NCT00474357|Bipolar affective disorder|bipolar affective disorder
571667|NCT00474357|myths|myths
571668|NCT00474357|preconceived notions|preconceived notions
571669|NCT00474357|stigma|stigma
571670|NCT00474357|hope|hope
571671|NCT00474370|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
571672|NCT00474383|Prostate neoplasms|prostate neoplasms
571673|NCT00474383|CB7630|cb7630
571674|NCT00474383|Abiraterone acetate|abiraterone acetate
571675|NCT00474383|Glucocorticoid|glucocorticoid
571676|NCT00474383|Prednisone|prednisone
571677|NCT00474383|Prednisolone|prednisolone
571678|NCT00474396|Uric acid|uric acid
571679|NCT00474396|Dairy|dairy
571680|NCT00474396|Diet|diet
571682|NCT00474409|Posterior circulation infarction|posterior circulation infarction
571683|NCT00474422|breastfeeding|breastfeeding
571684|NCT00474422|support|support
571685|NCT00474435|Tuberculosis|tuberculosis
571686|NCT00474435|HIV|hiv
571687|NCT00474435|Coinfection|coinfection
571688|NCT00474435|Pharmacokinetics|pharmacokinetics
571689|NCT00474435|Emtricitabine|emtricitabine
571690|NCT00474435|Tenofovir|tenofovir
571691|NCT00474435|Rifampin|rifampin
571692|NCT00474435|Efavirenz|efavirenz
571693|NCT00474435|Treatment Naive|treatment naive
571694|NCT00474448|Hereditary Multiple Exostoses|hereditary multiple exostoses
571695|NCT00474448|Survey|survey
571696|NCT00474448|Quality of Life|quality of life
571697|NCT00474448|Hereditary Multiple Exostoses,|hereditary multiple exostoses,
571698|NCT00474448|also known as Multiple Hereditary Exostoses,|also known as multiple hereditary exostoses,
571699|NCT00474448|also known as Hereditary Multiple Osteochondromas|also known as hereditary multiple osteochondromas
571700|NCT00474461|coronary artery disease|coronary artery disease
571701|NCT00474461|Heart Attack|heart attack
571702|NCT00474461|Heart failure|heart failure
571703|NCT00474461|Cardiac Stem Cells|cardiac stem cells
571704|NCT00474461|Coronary Artery Bypass|coronary artery bypass
571705|NCT00474474|virtual patient|virtual patient
571706|NCT00474474|therapeutic decision making|therapeutic decision making
571707|NCT00474487|Meningococcal|meningococcal
571708|NCT00474487|meningitis|meningitis
571709|NCT00474487|vaccine|vaccine
571710|NCT00474487|adolescents|adolescents
571711|NCT00474487|adults|adults
571712|NCT00474500|Iron absorption|iron absorption
571713|NCT00474500|Coca-Cola|coca-cola
571714|NCT00474513|AD, H3, Brain, Cognitive Impairment|ad, h3, brain, cognitive impairment
571715|NCT00474526|Meningococcal|meningococcal
571716|NCT00474526|meningitis|meningitis
571717|NCT00474526|vaccine|vaccine
571718|NCT00474526|infants|infants
571719|NCT00474526|Meningococcal meningitis|meningococcal meningitis
571720|NCT00474526|Meningococcal disease|meningococcal disease
571721|NCT00474539|Vaccine|vaccine
571722|NCT00474565|Catheter,|catheter,
571723|NCT00474565|Aortic root injection,|aortic root injection,
571724|NCT00474565|low dose contrast injection,|low dose contrast injection,
571725|NCT00474565|coronary artery angiogarm and|coronary artery angiogarm and
571726|NCT00474565|coronary artery bypass graft imaging.|coronary artery bypass graft imaging.
571727|NCT00474591|Coronary artery bypass surgery, fondaparinux, graft patency, graft occlusion, graft failure, anticoagulation|coronary artery bypass surgery, fondaparinux, graft patency, graft occlusion, graft failure, anticoagulation
571728|NCT00474604|breast cancer|breast cancer
571729|NCT00474630|Obesity|obesity
571730|NCT00474630|Overweight|overweight
571731|NCT00474630|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
571732|NCT00474656|high frequency oscillation|high frequency oscillation
571733|NCT00474656|lung-protective ventilation|lung-protective ventilation
571734|NCT00474656|ARDS|ards
571735|NCT00474656|ventilator-induced lung injury|ventilator-induced lung injury
571736|NCT00474669|Ovarian Carcinoma|ovarian carcinoma
571737|NCT00474682|ferric pyrophosphate, iron bioavailability, fortification,|ferric pyrophosphate, iron bioavailability, fortification,
571738|NCT00474695|Exudative age-related macular degeneration|exudative age-related macular degeneration
571739|NCT00474721|child|child
571740|NCT00474721|pain|pain
571741|NCT00474721|analgesics|analgesics
571742|NCT00474734|hepatocellular carcinoma|hepatocellular carcinoma
571743|NCT00474734|liver transplantation|liver transplantation
571744|NCT00474734|staging|staging
571745|NCT00474734|intravascular ultrasound|intravascular ultrasound
571746|NCT00474747|Severe Aplastic Anemia|severe aplastic anemia
571747|NCT00474747|Total Body Irradiation|total body irradiation
571748|NCT00474747|Antithymocyte Globulin|antithymocyte globulin
571749|NCT00474747|Cyclophosphamide|cyclophosphamide
571750|NCT00474747|Cytoxan|cytoxan
571751|NCT00474747|Neosar|neosar
571752|NCT00474747|Fludarabine|fludarabine
571753|NCT00474747|Fludara|fludara
571754|NCT00474747|Fludarabine Phosphate|fludarabine phosphate
571755|NCT00474747|Thymoglobulin|thymoglobulin
571756|NCT00474747|ATG|atg
571757|NCT00474747|TBI|tbi
571758|NCT00474747|Cyclosporine|cyclosporine
571759|NCT00474747|Tacrolimus|tacrolimus
571760|NCT00474786|Metastatic or Advanced Renal Cell Carcinoma|metastatic or advanced renal cell carcinoma
571761|NCT00474838|type 2 diabetes mellitus|type 2 diabetes mellitus
571762|NCT00474838|intensive insulin therapy|intensive insulin therapy
571763|NCT00474851|Endometriosis|endometriosis
571764|NCT00474851|Adolescents|adolescents
571765|NCT00474851|Bone density|bone density
571766|NCT00474851|GnRH Agonist|gnrh agonist
571767|NCT00474851|Add-back therapy|add-back therapy
571768|NCT00474864|Endothelial Function,|endothelial function,
571769|NCT00474864|vascular compliance,|vascular compliance,
571771|NCT00474877|Clinical|clinical
571772|NCT00474877|Splints|splints
571773|NCT00474877|Rheumatoid|rheumatoid
571774|NCT00474890|Seasonal allergic rhinitis|seasonal allergic rhinitis
571775|NCT00474916|Neuropathic pain|neuropathic pain
571776|NCT00474916|Cancer|cancer
571777|NCT00474929|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
571852|NCT00475007|COPD|copd
571778|NCT00474929|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
571779|NCT00474929|stage III multiple myeloma|stage iii multiple myeloma
571780|NCT00474929|refractory multiple myeloma|refractory multiple myeloma
571781|NCT00474929|Waldenström macroglobulinemia|waldenström macroglobulinemia
571782|NCT00474929|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
571783|NCT00474929|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
571784|NCT00474929|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
571785|NCT00474929|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
571786|NCT00474929|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
571787|NCT00474929|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
571788|NCT00474929|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
571789|NCT00474929|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
571790|NCT00474929|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
571791|NCT00474929|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
571792|NCT00474929|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
571793|NCT00474929|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
571794|NCT00474929|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
571795|NCT00474929|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
571796|NCT00474929|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
571797|NCT00474929|splenic marginal zone lymphoma|splenic marginal zone lymphoma
571798|NCT00474929|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
571799|NCT00474929|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
571800|NCT00474942|Hypertension|hypertension
571801|NCT00474942|Metabolic Alkalosis|metabolic alkalosis
571802|NCT00474942|Hypokalemia|hypokalemia
571803|NCT00474981|neonatal mortality|neonatal mortality
571804|NCT00474981|infant mortality|infant mortality
571805|NCT00474981|newborn caring practices|newborn caring practices
571806|NCT00474994|chondrosarcoma|chondrosarcoma
571807|NCT00474994|recurrent osteosarcoma|recurrent osteosarcoma
571808|NCT00474994|localized adult malignant fibrous histiocytoma of bone|localized adult malignant fibrous histiocytoma of bone
571809|NCT00474994|metastatic adult malignant fibrous histiocytoma of bone|metastatic adult malignant fibrous histiocytoma of bone
571810|NCT00474994|recurrent adult malignant fibrous histiocytoma of bone|recurrent adult malignant fibrous histiocytoma of bone
571811|NCT00474994|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
571812|NCT00474994|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
571813|NCT00474994|recurrent uterine sarcoma|recurrent uterine sarcoma
571814|NCT00474994|adult leiomyosarcoma|adult leiomyosarcoma
571815|NCT00474994|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
571816|NCT00474994|adult rhabdomyosarcoma|adult rhabdomyosarcoma
571817|NCT00474994|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
571818|NCT00474994|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
571819|NCT00474994|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
571820|NCT00474994|ovarian sarcoma|ovarian sarcoma
571821|NCT00474994|uterine leiomyosarcoma|uterine leiomyosarcoma
571822|NCT00474994|stage III uterine sarcoma|stage iii uterine sarcoma
571823|NCT00474994|stage IV uterine sarcoma|stage iv uterine sarcoma
571824|NCT00474994|desmoid tumor|desmoid tumor
571825|NCT00474994|adult angiosarcoma|adult angiosarcoma
571826|NCT00474994|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
571827|NCT00474994|uterine carcinosarcoma|uterine carcinosarcoma
571828|NCT00474994|endometrial stromal sarcoma|endometrial stromal sarcoma
571829|NCT00474994|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
571830|NCT00474994|chondrosarcomatous osteosarcoma|chondrosarcomatous osteosarcoma
571831|NCT00474994|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
571832|NCT00474994|adult epithelioid sarcoma|adult epithelioid sarcoma
571833|NCT00474994|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
571834|NCT00474994|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
571835|NCT00474994|adult fibrosarcoma|adult fibrosarcoma
571836|NCT00474994|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
571837|NCT00474994|adult malignant mesenchymoma|adult malignant mesenchymoma
571838|NCT00474994|adult neurofibrosarcoma|adult neurofibrosarcoma
571839|NCT00474994|adult synovial sarcoma|adult synovial sarcoma
571840|NCT00474994|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
571841|NCT00474994|adult liposarcoma|adult liposarcoma
571842|NCT00474994|anaplastic osteosarcoma|anaplastic osteosarcoma
571843|NCT00474994|mixed osteosarcoma|mixed osteosarcoma
571844|NCT00474994|small intestine leiomyosarcoma|small intestine leiomyosarcoma
571845|NCT00474994|osteoblastic osteosarcoma|osteoblastic osteosarcoma
571846|NCT00474994|telangiectatic osteosarcoma|telangiectatic osteosarcoma
571847|NCT00474994|classic Kaposi sarcoma|classic kaposi sarcoma
571848|NCT00474994|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
571849|NCT00474994|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
571850|NCT00475007|Emphysema|emphysema
571851|NCT00475007|IBV® Valve|ibv® valve
571853|NCT00475007|Shortness of Breath|shortness of breath
571854|NCT00475007|Spiration|spiration
571855|NCT00475020|Idiopathic Myelofibrosis|idiopathic myelofibrosis
571856|NCT00475020|Myelofibrosis|myelofibrosis
572053|NCT00475631|Clubfoot|clubfoot
571857|NCT00475020|Essential Thrombocythemia|essential thrombocythemia
571858|NCT00475020|Polycythemia Vera|polycythemia vera
571859|NCT00475020|Busulfan|busulfan
571860|NCT00475020|Antithymocyte Globulin|antithymocyte globulin
571862|NCT00475020|Fludarabine|fludarabine
571863|NCT00475020|Thymoglobulin|thymoglobulin
571864|NCT00475046|smoking|smoking
571865|NCT00475046|post partum|post partum
571866|NCT00475046|relapse prevention|relapse prevention
571867|NCT00475046|motivational interviewing|motivational interviewing
571868|NCT00475046|TTM|ttm
571869|NCT00475046|implement motivational enhancement interventions in pediatric practices|implement motivational enhancement interventions in pediatric practices
571870|NCT00475046|examine the effectiveness of the intervention|examine the effectiveness of the intervention
571871|NCT00475046|develop measurements appropriate to tailor interventions|develop measurements appropriate to tailor interventions
571872|NCT00475046|analyze further unfavorable and favorable factors outlined by previous research|analyze further unfavorable and favorable factors outlined by previous research
571873|NCT00475059|kidney transplantation|kidney transplantation
571874|NCT00475059|Glomerular filtration rate|glomerular filtration rate
571875|NCT00475059|inulin clearance|inulin clearance
571876|NCT00475059|MDRD equation|mdrd equation
571877|NCT00475059|cystatin C|cystatin c
571878|NCT00475059|cimetidine|cimetidine
571879|NCT00475085|nausea and vomiting|nausea and vomiting
571880|NCT00475085|recurrent breast cancer|recurrent breast cancer
571881|NCT00475085|stage I breast cancer|stage i breast cancer
571882|NCT00475085|stage II breast cancer|stage ii breast cancer
571883|NCT00475085|stage IIIA breast cancer|stage iiia breast cancer
571884|NCT00475085|stage IIIB breast cancer|stage iiib breast cancer
571885|NCT00475085|stage IIIC breast cancer|stage iiic breast cancer
571886|NCT00475085|stage IV breast cancer|stage iv breast cancer
571887|NCT00475085|inflammatory breast cancer|inflammatory breast cancer
571888|NCT00475085|male breast cancer|male breast cancer
571889|NCT00475098|Low molecular weight heparin|low molecular weight heparin
571890|NCT00475098|Lung cancer|lung cancer
571891|NCT00475098|Non small cell lung cancer|non small cell lung cancer
571892|NCT00475098|Adjuvant therapy|adjuvant therapy
571893|NCT00475098|Anticoagulants|anticoagulants
571899|NCT00475111|Coping Efficacy|coping efficacy
571900|NCT00475111|Markers of Disease Activity|markers of disease activity
571901|NCT00475124|Pacemaker follow-up|pacemaker follow-up
571902|NCT00475124|Telecardiology|telecardiology
571903|NCT00475124|Home Monitoring|home monitoring
571904|NCT00475137|Bipolar II Disorder|bipolar ii disorder
571906|NCT00475137|Lamotrigine|lamotrigine
571907|NCT00475137|Add On antidepressant|add on antidepressant
571908|NCT00475137|randomized|randomized
571909|NCT00475137|single blind|single blind
739055|NCT01118767|WWW|www
571910|NCT00475137|parallel group|parallel group
571911|NCT00475163|Obesity|obesity
571912|NCT00475163|Mentoring|mentoring
571913|NCT00475163|Fitness|fitness
571914|NCT00475163|Self-esteem|self-esteem
571915|NCT00475176|Hepatitis C Virus Genotype 1|hepatitis c virus genotype 1
571916|NCT00475176|Non-Responders|non-responders
571917|NCT00475176|SAMe|same
571918|NCT00475176|Natural Killer Cells|natural killer cells
571919|NCT00475176|Interferon Signaling|interferon signaling
571920|NCT00475176|Ribavirin|ribavirin
571921|NCT00475176|Peginterferon|peginterferon
571922|NCT00475176|Hemolysis|hemolysis
571923|NCT00475176|STAT|stat
571924|NCT00475176|Hepatitis C|hepatitis c
571925|NCT00475189|birth control|birth control
571927|NCT00475189|headaches|headaches
571928|NCT00475189|mood swings|mood swings
571929|NCT00475189|pelvic pain|pelvic pain
571930|NCT00475228|levonorgestrel IUD|levonorgestrel iud
571931|NCT00475228|IUD|iud
571932|NCT00475228|dilation and evacuation|dilation and evacuation
571933|NCT00475228|contraception|contraception
571934|NCT00475241|Combat Disorders|combat disorders
571935|NCT00475241|Cortisol|cortisol
571936|NCT00475241|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
571937|NCT00475241|Psychophysiology|psychophysiology
571938|NCT00475241|Therapy|therapy
571939|NCT00475241|Treatment|treatment
571940|NCT00475241|Veterans|veterans
571941|NCT00475254|Retinitis Pigmentosa|retinitis pigmentosa
571942|NCT00475254|stress|stress
571943|NCT00475254|sleepiness|sleepiness
571944|NCT00475254|low vision|low vision
571945|NCT00475254|mind-body|mind-body
571946|NCT00475267|aortic valve|aortic valve
571947|NCT00475267|heart valve|heart valve
571948|NCT00475267|tissue valve|tissue valve
571949|NCT00475267|bioprosthesis|bioprosthesis
571950|NCT00475267|valve disorder|valve disorder
571951|NCT00475267|valve disease|valve disease
571952|NCT00475267|cardiac surgery|cardiac surgery
571953|NCT00475267|aortic valve stenosis|aortic valve stenosis
571954|NCT00475267|aortic valve regurgitation|aortic valve regurgitation
574018|NCT00472056|Etoposide|etoposide
571960|NCT00475293|metastatic colorectal cancer|metastatic colorectal cancer
571961|NCT00475293|2nd-line Therapy|2nd-line therapy
571962|NCT00475293|panitumumab|panitumumab
571963|NCT00475293|irinotecan|irinotecan
571964|NCT00475306|Metoclopramide|metoclopramide
571966|NCT00475306|Akathisia|akathisia
571967|NCT00475306|Emergency department|emergency department
571968|NCT00475319|Dry Eye Syndromes|dry eye syndromes
571969|NCT00475319|OPC-12759|opc-12759
571970|NCT00475345|Nocturnal hypoglycemia|nocturnal hypoglycemia
571971|NCT00475345|Bedtime snacks|bedtime snacks
571972|NCT00475345|Continuous glucose monitoring|continuous glucose monitoring
571973|NCT00475345|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
571974|NCT00475345|CSII|csii
571975|NCT00475345|Intensive therapy|intensive therapy
571976|NCT00475371|Healthy|healthy
571977|NCT00475371|Diabetes Mellitus: Type II|diabetes mellitus: type ii
571978|NCT00475384|Acute Myelogenous Leukemia|acute myelogenous leukemia
571979|NCT00475384|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
571980|NCT00475384|Myelodysplastic Syndrome|myelodysplastic syndrome
571981|NCT00475384|Stem Cell Transplant|stem cell transplant
571982|NCT00475384|Haploidentical Donor|haploidentical donor
571983|NCT00475384|Leukemia|leukemia
571984|NCT00475384|Fludarabine|fludarabine
571985|NCT00475384|Total Body Irradiation|total body irradiation
571986|NCT00475384|Thiotepa|thiotepa
571987|NCT00475410|Autologous adipose-derived stem cells|autologous adipose-derived stem cells
571988|NCT00475410|Complex perianal fistula|complex perianal fistula
571989|NCT00475410|Inflammatory Bowel Disease|inflammatory bowel disease
571990|NCT00475410|Advanced cell therapy|advanced cell therapy
571991|NCT00475410|Fibrin glue|fibrin glue
571992|NCT00475436|muscarinic receptor antagonist|muscarinic receptor antagonist
571993|NCT00475436|GSK573719,|gsk573719,
571994|NCT00475436|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
571995|NCT00475449|percutaneous coronary intervention|percutaneous coronary intervention
571996|NCT00475449|Stent|stent
571997|NCT00475449|coronary artery bypass grafting|coronary artery bypass grafting
571998|NCT00475462|Metoprolol and Syncope|metoprolol and syncope
571999|NCT00475475|Overweight|overweight
572000|NCT00475475|Obesity|obesity
572001|NCT00475475|Appetite|appetite
572002|NCT00475475|Dietary sugars|dietary sugars
572003|NCT00475475|Fructose|fructose
572004|NCT00475475|Glucose|glucose
572005|NCT00475475|Leptin|leptin
572006|NCT00475475|Insulin|insulin
572007|NCT00475475|Ghrelin|ghrelin
572008|NCT00475488|radial artery|radial artery
572009|NCT00475488|right internal thoracic artery|right internal thoracic artery
572010|NCT00475488|saphenous vein|saphenous vein
572011|NCT00475488|grafts|grafts
572012|NCT00475488|coronary bypass surgery|coronary bypass surgery
572013|NCT00475501|anabolic effects|anabolic effects
572014|NCT00475501|finasteride|finasteride
572015|NCT00475501|male hypogonadism|male hypogonadism
572016|NCT00475501|sarcopenia|sarcopenia
572017|NCT00475501|testosterone|testosterone
572018|NCT00475514|Menstrually-related Migraine Headache|menstrually-related migraine headache
572019|NCT00475514|'Difficult to Treat' as specified in protocol|'difficult to treat' as specified in protocol
572020|NCT00475540|prolapse|prolapse
572021|NCT00475540|uterus|uterus
572022|NCT00475540|pelvic organ|pelvic organ
572023|NCT00475540|vaginal prolpase|vaginal prolpase
572024|NCT00475553|spotting|spotting
572025|NCT00475553|PMS|pms
572026|NCT00475553|nuvaring|nuvaring
572027|NCT00475553|birth control|birth control
572028|NCT00475553|pelvic pain|pelvic pain
572029|NCT00475553|headache|headache
572030|NCT00475553|mood swings|mood swings
572031|NCT00475553|continuous use|continuous use
572032|NCT00475579|ventilator-associated pneumonia|ventilator-associated pneumonia
572033|NCT00475579|endotracheal tube|endotracheal tube
572034|NCT00475579|polyurethane cuff|polyurethane cuff
572035|NCT00475579|polyvinyl cuff|polyvinyl cuff
572036|NCT00475579|subglottic secretion drainage|subglottic secretion drainage
572037|NCT00475592|Esophageal Varices|esophageal varices
572038|NCT00475592|Gastric Varices|gastric varices
572039|NCT00475592|Capsule Endoscopy|capsule endoscopy
572040|NCT00475592|Portal Hypertension|portal hypertension
572041|NCT00475592|Cirrhosis|cirrhosis
572042|NCT00475592|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
572043|NCT00475605|atopic dermatitis|atopic dermatitis
572044|NCT00475605|child|child
572045|NCT00475605|tacrolimus ointment|tacrolimus ointment
572046|NCT00475605|Protopic Ointment|protopic ointment
572047|NCT00475618|Early chilhood caries|early chilhood caries
572048|NCT00475618|Prevention|prevention
572049|NCT00475618|Fluoride varnish|fluoride varnish
572050|NCT00475618|fluoride toothpaste|fluoride toothpaste
572051|NCT00475618|non fluoride tooth paste|non fluoride tooth paste
572052|NCT00475618|Professional cleaning|professional cleaning
572054|NCT00475631|Chart review|chart review
572055|NCT00475683|Doxorubicin|doxorubicin
572056|NCT00475683|Mucositis|mucositis
572057|NCT00475683|Prevention|prevention
572058|NCT00475683|Curcumin|curcumin
572059|NCT00475709|aortic valve|aortic valve
572060|NCT00475709|heart valve|heart valve
572061|NCT00475709|tissue valve|tissue valve
572062|NCT00475709|bioprosthesis|bioprosthesis
572063|NCT00475709|valve disorder|valve disorder
572064|NCT00475709|valve disease|valve disease
572065|NCT00475709|cardiac surgery|cardiac surgery
572066|NCT00475709|aortic valve stenosis|aortic valve stenosis
572067|NCT00475709|aortic valve regurgitation|aortic valve regurgitation
572068|NCT00475722|cancer|cancer
572069|NCT00475722|colon|colon
572070|NCT00475722|prevention|prevention
572071|NCT00475722|healthy eating|healthy eating
572072|NCT00475722|Mediterranean diet|mediterranean diet
572073|NCT00475722|PGE2|pge2
572074|NCT00475722|cyclooxygenase|cyclooxygenase
572075|NCT00475722|lipoxygenase|lipoxygenase
572076|NCT00475722|Healthy People 2010 diet|healthy people 2010 diet
572077|NCT00475722|dietary prevention of colon cancer|dietary prevention of colon cancer
572078|NCT00475748|cervical spine|cervical spine
572079|NCT00475748|spinal cord|spinal cord
572080|NCT00475748|trauma|trauma
572081|NCT00475748|spinal cord injury|spinal cord injury
572082|NCT00475748|central cord syndrome|central cord syndrome
572083|NCT00475761|Breast biopsy|breast biopsy
572084|NCT00475761|Breast imaging|breast imaging
572085|NCT00475761|Breast Cancer|breast cancer
572086|NCT00475761|Mammographic Density|mammographic density
572087|NCT00475761|Breast|breast
572088|NCT00475787|Older Adults|older adults
572089|NCT00475787|Patient Education|patient education
572090|NCT00475787|Randomized Controlled Trial|randomized controlled trial
572091|NCT00475787|Sham procedure|sham procedure
572092|NCT00475787|Spinal Manipulation|spinal manipulation
572093|NCT00475787|Veterans|veterans
572094|NCT00475800|Osteoarthritis|osteoarthritis
572095|NCT00475800|lumiracoxib|lumiracoxib
572096|NCT00475800|celecoxib|celecoxib
572097|NCT00475800|Cox-2|cox-2
572098|NCT00475800|knee|knee
572099|NCT00475813|Paediatric subjects with asthma|paediatric subjects with asthma
572100|NCT00475826|Heterozigous Familial Hypercholesterolemia|heterozigous familial hypercholesterolemia
572101|NCT00475826|Sub-clinical atherosclerosis|sub-clinical atherosclerosis
572102|NCT00475826|Chylomicrons metabolism|chylomicrons metabolism
572103|NCT00475826|Statin plus ezetimibe|statin plus ezetimibe
572104|NCT00475826|Coronary artery calcification|coronary artery calcification
572105|NCT00475839|stress urinary incontinence|stress urinary incontinence
572106|NCT00475839|sling procedures|sling procedures
572107|NCT00475839|tension-free vaginal tape|tension-free vaginal tape
572108|NCT00475839|transobturator|transobturator
572109|NCT00475852|Heart Decompensation|heart decompensation
572110|NCT00475852|Dyspnea|dyspnea
572111|NCT00475852|Heart failure|heart failure
572112|NCT00475852|Nesiritide|nesiritide
572113|NCT00475852|Decompensated|decompensated
572114|NCT00475852|ADHF|adhf
572116|NCT00475865|glatiramer acetate|glatiramer acetate
571565|NCT00473980|MHC|mhc
572117|NCT00475865|adjunctive therapy|adjunctive therapy
572118|NCT00475865|relapses|relapses
572119|NCT00475878|opiate use|opiate use
572120|NCT00475878|depression|depression
572121|NCT00475878|buprenorphine|buprenorphine
572122|NCT00475878|escitalopram|escitalopram
572123|NCT00475891|isolate|isolate
572124|NCT00475891|infection|infection
572125|NCT00475891|linezolid|linezolid
572126|NCT00475904|Post Herpetic Neuralgia|post herpetic neuralgia
572127|NCT00475904|PHN|phn
572128|NCT00475904|Neuropathy|neuropathy
572129|NCT00475904|Nerve Pain|nerve pain
572130|NCT00475904|Topical|topical
572131|NCT00475917|Advanced malignancies|advanced malignancies
572132|NCT00475917|Solid tumor|solid tumor
572133|NCT00475930|MRSA|mrsa
572134|NCT00475930|Staphylococcus aureus|staphylococcus aureus
572135|NCT00475943|Swallowing Disorders|swallowing disorders
572136|NCT00475943|Swallowing|swallowing
572137|NCT00475943|Videofluoroscopy|videofluoroscopy
572138|NCT00475943|Dysphagia|dysphagia
572139|NCT00475943|Epiglottis|epiglottis
572140|NCT00475943|Healthy Volunteer|healthy volunteer
572141|NCT00475943|HV|hv
572142|NCT00475956|Cancer|cancer
572143|NCT00475956|Tumour|tumour
572144|NCT00475956|Advanced Solid Tumour|advanced solid tumour
572145|NCT00475956|Lung Cancer|lung cancer
572146|NCT00475956|Breast Cancer|breast cancer
572147|NCT00475956|Cholangiocarcinoma|cholangiocarcinoma
572148|NCT00475956|Colon Cancer|colon cancer
572149|NCT00475956|Gastric Cancer|gastric cancer
572150|NCT00475956|Choriocarcinoma|choriocarcinoma
572151|NCT00475956|Liver Cancer|liver cancer
572152|NCT00475956|Myeloma|myeloma
572153|NCT00475956|Ovarian Cancer|ovarian cancer
572154|NCT00475956|Pancreatic Cancer|pancreatic cancer
572155|NCT00475956|Peritoneal Cancer|peritoneal cancer
572157|NCT00464711|biology|biology
572158|NCT00464724|Prostate Cancer|prostate cancer
572249|NCT00465101|enlarged prostate|enlarged prostate
572159|NCT00464724|Magnetic Resonance Spectroscopic Imaging|magnetic resonance spectroscopic imaging
572160|NCT00464724|Perfluorocarbon Compound|perfluorocarbon compound
572161|NCT00464724|AIR-MRSI|air-mrsi
572162|NCT00464724|PFC-MRSI|pfc-mrsi
572164|NCT00464724|MRSI|mrsi
572165|NCT00464724|PFC|pfc
572166|NCT00464737|Fibromyalgia Syndrome|fibromyalgia syndrome
572167|NCT00464737|Rotigotine|rotigotine
572168|NCT00464737|Neupro|neupro
572169|NCT00464750|Cardiac output|cardiac output
572170|NCT00464750|Thermodilution|thermodilution
572171|NCT00464763|Mental Health|mental health
572172|NCT00464763|Neurological Disease|neurological disease
572173|NCT00464763|Heart Valve Repair Surgery|heart valve repair surgery
572174|NCT00464776|Randomized|randomized
572175|NCT00464776|double-blind|double-blind
572176|NCT00464776|cross-over|cross-over
572177|NCT00464776|4-period|4-period
572178|NCT00464776|4 treatment|4 treatment
572179|NCT00464776|within-subject placebo-controlled study|within-subject placebo-controlled study
572180|NCT00464776|assess optimal renoprotective dose of Aliskiren|assess optimal renoprotective dose of aliskiren
572181|NCT00464776|hypertensive type 2 diabetes patients|hypertensive type 2 diabetes patients
572182|NCT00464776|incipient or overt nephropathy|incipient or overt nephropathy
572183|NCT00464789|Postmenopausal|postmenopausal
572184|NCT00464802|healthy|healthy
572185|NCT00464802|safety|safety
572186|NCT00464815|immunogenicity|immunogenicity
572187|NCT00464815|safety|safety
572188|NCT00464815|meningococcal vaccine|meningococcal vaccine
572189|NCT00464828|Central venous cannulation|central venous cannulation
572190|NCT00464828|Internal jugular vein|internal jugular vein
572191|NCT00464828|Ultrasound|ultrasound
572192|NCT00464828|Obstetrics|obstetrics
572193|NCT00464841|Tsui Test|tsui test
572194|NCT00464841|Combined Spinal Epidural|combined spinal epidural
572195|NCT00464841|Labour|labour
572196|NCT00464854|Glucose control|glucose control
572197|NCT00464854|Subcutaneous insulin treatment|subcutaneous insulin treatment
572198|NCT00464854|Multiple daily injections|multiple daily injections
572199|NCT00464867|Bifidobacterium breve|bifidobacterium breve
572200|NCT00464867|oral whole cell cholera vaccine|oral whole cell cholera vaccine
572201|NCT00464867|immunogenicity|immunogenicity
572202|NCT00464867|Supplementation with probiotic improves vibriocidal antibody response in 2-5 year old childern given the killed oral cholera vaccine|supplementation with probiotic improves vibriocidal antibody response in 2-5 year old childern given the killed oral cholera vaccine
572203|NCT00464867|Supplementation with probiotics results in improving the ASC responses to CT and LPS of V. cholerae O1|supplementation with probiotics results in improving the asc responses to ct and lps of v. cholerae o1
572204|NCT00464880|Placebo-controlled study|placebo-controlled study
572205|NCT00464880|assess the renoprotective effect of renin inhibition|assess the renoprotective effect of renin inhibition
572206|NCT00464880|Aliskiren as an alternative to irbesartan|aliskiren as an alternative to irbesartan
572207|NCT00464880|Type 2 diabetes patients|type 2 diabetes patients
572208|NCT00464880|incipient/overt diabetic nephropathy|incipient/overt diabetic nephropathy
572209|NCT00464893|gastric cancer|gastric cancer
572210|NCT00464893|catumaxomab|catumaxomab
572211|NCT00464893|neoadjuvant chemotherapy|neoadjuvant chemotherapy
572212|NCT00464893|phase II|phase ii
572213|NCT00464893|interoperative|interoperative
572214|NCT00464893|trifunctional antibody|trifunctional antibody
572215|NCT00464919|Advance, hepatocellular carcinoma|advance, hepatocellular carcinoma
572216|NCT00464932|COPD|copd
572217|NCT00464932|Vasoactive Intestinal Peptide|vasoactive intestinal peptide
572218|NCT00464932|Lung Function|lung function
572219|NCT00464958|Fatigue|fatigue
572220|NCT00464958|Spasticity|spasticity
572221|NCT00464958|Sublingual Tizanidine|sublingual tizanidine
572222|NCT00464958|Epworth Sleepiness Scale|epworth sleepiness scale
572223|NCT00464958|Fatigue Severity Scale|fatigue severity scale
572224|NCT00464984|Weight loss|weight loss
572225|NCT00464984|Physical fitness|physical fitness
572226|NCT00464984|Quality of life|quality of life
572227|NCT00464997|methotrexate aspirin pharmacokinetics|methotrexate aspirin pharmacokinetics
572228|NCT00465010|Adolescence|adolescence
572229|NCT00465010|Sexual health|sexual health
572230|NCT00465010|Communication|communication
572231|NCT00465010|Parenting|parenting
572232|NCT00465023|proton beam irradiation|proton beam irradiation
572233|NCT00465023|liver cancer|liver cancer
572234|NCT00465036|fat absorption|fat absorption
572235|NCT00465036|fibres|fibres
572236|NCT00465049|abscess, primary closure, secondary closure|abscess, primary closure, secondary closure
572237|NCT00465062|Lysosomal Disease|lysosomal disease
572238|NCT00465062|Lipids|lipids
572239|NCT00465062|B Lymphocytes|b lymphocytes
572240|NCT00465062|Brain Damage|brain damage
572241|NCT00465062|Gaucher Disease|gaucher disease
572242|NCT00465062|GD|gd
572243|NCT00465101|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
572244|NCT00465101|Transurethral resection of the prostate|transurethral resection of the prostate
572245|NCT00465101|Lower urinary tract symptoms|lower urinary tract symptoms
572247|NCT00465101|Laserscope|laserscope
572248|NCT00465101|Photoselective vaporization of the prostate|photoselective vaporization of the prostate
572250|NCT00465114|Preeclampsia|preeclampsia
572251|NCT00465114|Hemodynamic monitoring|hemodynamic monitoring
572252|NCT00465153|Inflammation|inflammation
572253|NCT00465153|cytokines|cytokines
572254|NCT00465153|sarcopenia|sarcopenia
572255|NCT00465153|strength|strength
572256|NCT00465153|muscle|muscle
572257|NCT00465153|aging|aging
572258|NCT00465153|exercise|exercise
572259|NCT00465166|Accidental dural puncture|accidental dural puncture
572260|NCT00465166|Labour epidural|labour epidural
572261|NCT00465166|Ultrasound|ultrasound
572262|NCT00465166|Ligamentum flavum|ligamentum flavum
572263|NCT00465179|Non-Clear Cell Renal Carcinoma|non-clear cell renal carcinoma
572264|NCT00465179|Non-clear cell renal cell cancer|non-clear cell renal cell cancer
572265|NCT00465179|Renal Cell Cancer|renal cell cancer
572266|NCT00465179|Kidney Cancer|kidney cancer
572267|NCT00465179|Papillary|papillary
572268|NCT00465179|Chromophobe|chromophobe
572269|NCT00465179|Collecting duct carcinoma|collecting duct carcinoma
572270|NCT00465179|CDC|cdc
572271|NCT00465179|Renal medullary carcinoma|renal medullary carcinoma
572272|NCT00465179|RMC|rmc
572273|NCT00465179|Sunitinib Malate|sunitinib malate
572274|NCT00465179|Sutent|sutent
572275|NCT00465179|SU011248|su011248
572276|NCT00465205|HIV infection|hiv infection
572277|NCT00465205|HIV Shedding|hiv shedding
572278|NCT00465205|HSV suppression|hsv suppression
572279|NCT00465205|Co-infected|co-infected
572280|NCT00465205|Women|women
572281|NCT00465205|Reactivation|reactivation
572282|NCT00465205|Valacyclovir|valacyclovir
572283|NCT00465205|Treatment Naive|treatment naive
572284|NCT00465218|Bioprosthesis|bioprosthesis
572285|NCT00465218|Thrombosis|thrombosis
572286|NCT00465218|Cerebral emboli|cerebral emboli
572287|NCT00465218|Transcranial Doppler|transcranial doppler
572288|NCT00465218|Platelet function tests|platelet function tests
572289|NCT00465231|Induction of labour|induction of labour
572290|NCT00465231|Bupivacaine consumption|bupivacaine consumption
572291|NCT00465231|Prevention|prevention
572292|NCT00465244|Prehospital and ED seizures|prehospital and ed seizures
572293|NCT00465270|Cryptogenic|cryptogenic
572294|NCT00465270|Stroke|stroke
572296|NCT00466336|Chronic hepatitis C|chronic hepatitis c
572297|NCT00466336|Non-invasive diagnosis|non-invasive diagnosis
572298|NCT00466336|Duplex Doppler ultrasonography|duplex doppler ultrasonography
572299|NCT00466336|Biochemical indices|biochemical indices
572300|NCT00466336|Hepatic fibrosis|hepatic fibrosis
572301|NCT00466336|Cirrhosis|cirrhosis
572302|NCT00466349|SMA Type I|sma type i
572303|NCT00466349|SMA Type II|sma type ii
572304|NCT00466349|SMA Type III|sma type iii
572305|NCT00466349|SMN|smn
572306|NCT00466349|Werdnig-Hoffman Disease|werdnig-hoffman disease
572307|NCT00466349|Spinal Muscular Atrophy|spinal muscular atrophy
572308|NCT00466349|Registry|registry
572309|NCT00466349|SMA Type IV|sma type iv
572310|NCT00466362|Obesity|obesity
572311|NCT00466362|Diabetes|diabetes
572312|NCT00466362|Weight|weight
572313|NCT00466362|Lifestyle|lifestyle
572314|NCT00466362|Follow up|follow up
572315|NCT00466375|hemangioma|hemangioma
572316|NCT00466375|vascular anomaly|vascular anomaly
572317|NCT00466375|infantile hemangioma|infantile hemangioma
572318|NCT00466388|dry mouth|dry mouth
572319|NCT00466466|Small-Cell Lung Cancer|small-cell lung cancer
572320|NCT00466466|SCLC|sclc
572321|NCT00466466|Advanced Lung Cancer|advanced lung cancer
572322|NCT00466466|RAD|rad
572323|NCT00466466|RAD001|rad001
572324|NCT00466466|Chemotherapy|chemotherapy
572325|NCT00466466|Cisplatin|cisplatin
572326|NCT00466466|Etoposide|etoposide
572327|NCT00466479|neuroprotection|neuroprotection
572328|NCT00466479|alpha one agonists|alpha one agonists
572329|NCT00466479|glaucoma|glaucoma
572330|NCT00466479|visual field|visual field
572331|NCT00466492|Drug Administration Schedule|drug administration schedule
572332|NCT00466492|Intensive Care Units|intensive care units
572333|NCT00466492|Length of Stay|length of stay
572334|NCT00466492|Respiration, Artificial|respiration, artificial
572335|NCT00466492|Stress Disorders, Post-Traumatic/etiology/*psychology|stress disorders, post-traumatic/etiology/*psychology
572336|NCT00466492|Critical Illness/*psychology|critical illness/*psychology
572337|NCT00466492|Pneumonia/prevention & control|pneumonia/prevention & control
572338|NCT00466492|Hypnotics and Sedatives/*administration & dosage|hypnotics and sedatives/*administration & dosage
572339|NCT00466505|recurrent colon cancer|recurrent colon cancer
572340|NCT00466505|stage IV colon cancer|stage iv colon cancer
572341|NCT00466505|recurrent rectal cancer|recurrent rectal cancer
572342|NCT00466505|stage IV rectal cancer|stage iv rectal cancer
572343|NCT00466518|Kidney transplant|kidney transplant
572344|NCT00466518|type 2 diabetes|type 2 diabetes
572345|NCT00466518|sitagliptin|sitagliptin
572346|NCT00466531|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
572347|NCT00466531|06-138|06-138
572348|NCT00466544|Chronic tonsillitis|chronic tonsillitis
572349|NCT00466544|Recurrent tonsillitis|recurrent tonsillitis
572350|NCT00466557|Malaria, Plasmodium falciparum, mosquito, Africa, Anopheles|malaria, plasmodium falciparum, mosquito, africa, anopheles
572352|NCT00466596|allergic rhinitis|allergic rhinitis
572353|NCT00466596|mild asthma|mild asthma
572354|NCT00466596|dust mite allergy|dust mite allergy
572355|NCT00466596|gamma tocopherol|gamma tocopherol
572356|NCT00466609|clomipramine|clomipramine
572357|NCT00466609|quetiapine|quetiapine
572358|NCT00466609|fluoxetine|fluoxetine
572360|NCT00466609|augmentation|augmentation
572361|NCT00466609|obsessive compulsive disorder|obsessive compulsive disorder
572362|NCT00466622|PCOS|pcos
572363|NCT00466622|pregnancy|pregnancy
572364|NCT00466622|metformin|metformin
572365|NCT00466622|blood flow|blood flow
572366|NCT00466622|Pulsatility index|pulsatility index
572367|NCT00466635|Clostridium difficile Disease|clostridium difficile disease
572368|NCT00466635|Infectious diarrhea|infectious diarrhea
572369|NCT00466635|C. difficile|c. difficile
572370|NCT00466635|CDAD|cdad
572371|NCT00466635|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
572372|NCT00466635|Clostridium difficile diarrhea|clostridium difficile diarrhea
572373|NCT00466635|Antibiotic-Associated Colitis|antibiotic-associated colitis
572374|NCT00466635|Clostridium Enterocolitis|clostridium enterocolitis
572375|NCT00466635|Antibiotic-Associated Diarrhea|antibiotic-associated diarrhea
572376|NCT00466635|Pseudomembranous Colitis|pseudomembranous colitis
572377|NCT00466635|Clostridium difficile|clostridium difficile
572378|NCT00466648|laparoscopy, port site, closure, Dermabond|laparoscopy, port site, closure, dermabond
572379|NCT00466661|Acamprosate|acamprosate
572380|NCT00466661|Alcoholism|alcoholism
572381|NCT00466661|Bipolar disorder|bipolar disorder
572382|NCT00466661|Comorbidity|comorbidity
572383|NCT00466661|Craving|craving
572384|NCT00466661|Depression|depression
572385|NCT00466661|GABA|gaba
572386|NCT00466661|Glutamate|glutamate
572387|NCT00466661|Mania|mania
572388|NCT00466661|Pharmacotherapy|pharmacotherapy
572389|NCT00466661|Withdrawal|withdrawal
572390|NCT00466674|Myeloma|myeloma
572391|NCT00466674|RICT|rict
572392|NCT00466674|conditioning|conditioning
572393|NCT00466674|allograft|allograft
572394|NCT00466687|stage IV melanoma|stage iv melanoma
572395|NCT00466687|recurrent melanoma|recurrent melanoma
572396|NCT00466700|Helicobacter pylori, Gambia, endoscopy, Africa|helicobacter pylori, gambia, endoscopy, africa
572397|NCT00466713|Nonischemic dilated cardiomyopathy|nonischemic dilated cardiomyopathy
572398|NCT00466726|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
572399|NCT00466726|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
572400|NCT00466726|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
572401|NCT00466726|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
572402|NCT00466726|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
572403|NCT00466765|Fat Grafting|fat grafting
572404|NCT00466765|Breast Augmentation|breast augmentation
572405|NCT00466765|Liposuctioned Fat Transfer|liposuctioned fat transfer
572406|NCT00466765|Lumpectomy|lumpectomy
572407|NCT00466765|Mastectomy|mastectomy
572408|NCT00466765|Micromastia|micromastia
571861|NCT00475020|ATG|atg
572409|NCT00466765|Asymmetry|asymmetry
572410|NCT00466765|Post Lumpectomy Filling Defects|post lumpectomy filling defects
572411|NCT00466765|Post implant removal filling defect|post implant removal filling defect
572412|NCT00466765|Post Mastectomy|post mastectomy
572413|NCT00466765|Autologous Fat Transfer|autologous fat transfer
572414|NCT00466765|Tubular breasts|tubular breasts
572415|NCT00466765|Tuberous breasts|tuberous breasts
572416|NCT00466765|Constricted breasts|constricted breasts
572417|NCT00466804|heart transplant recipients|heart transplant recipients
572418|NCT00466804|organ transplantation|organ transplantation
572419|NCT00466804|immune biomarkers|immune biomarkers
572420|NCT00466804|transplant rejection|transplant rejection
572421|NCT00466817|Cytomegalovirus, congenital, infants|cytomegalovirus, congenital, infants
572422|NCT00466830|pain|pain
572423|NCT00466830|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
572424|NCT00466830|stage IIIA breast cancer|stage iiia breast cancer
572425|NCT00466830|stage IIIB breast cancer|stage iiib breast cancer
572426|NCT00466830|stage I breast cancer|stage i breast cancer
572427|NCT00466830|stage II breast cancer|stage ii breast cancer
572428|NCT00466830|stage IIIC breast cancer|stage iiic breast cancer
572429|NCT00466843|Abnormal hematopoiesis|abnormal hematopoiesis
572430|NCT00466843|Leukemia|leukemia
572431|NCT00466843|Autoimmune Disease|autoimmune disease
572432|NCT00466856|neoplastic syndrome|neoplastic syndrome
572433|NCT00466856|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
572434|NCT00466856|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
572435|NCT00466856|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
572436|NCT00466856|metastatic pheochromocytoma|metastatic pheochromocytoma
572437|NCT00466856|recurrent islet cell carcinoma|recurrent islet cell carcinoma
572438|NCT00466856|liver metastases|liver metastases
572439|NCT00466856|recurrent pheochromocytoma|recurrent pheochromocytoma
572440|NCT00466856|gastrinoma|gastrinoma
572441|NCT00466856|insulinoma|insulinoma
572442|NCT00466856|WDHA syndrome|wdha syndrome
572443|NCT00466856|glucagonoma|glucagonoma
572444|NCT00466856|pancreatic polypeptide tumor|pancreatic polypeptide tumor
572445|NCT00466856|somatostatinoma|somatostatinoma
572446|NCT00466882|obese|obese
572447|NCT00466882|renal failure|renal failure
572448|NCT00466882|renal transplant candidate|renal transplant candidate
572449|NCT00466882|Hemodialysis BMI between 36 and 42|hemodialysis bmi between 36 and 42
572450|NCT00466895|Leukemia|leukemia
572451|NCT00466895|Lenalidomide|lenalidomide
572452|NCT00466921|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
572636|NCT00467766|Counseling|counseling
572453|NCT00466921|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
572454|NCT00466921|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
572455|NCT00466921|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
572456|NCT00466921|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
572457|NCT00466934|Cerebral Blood Flow|cerebral blood flow
572458|NCT00466934|Cerebral Cortex|cerebral cortex
572459|NCT00466934|Cognition|cognition
572460|NCT00466934|Optical Imaging|optical imaging
572461|NCT00466934|Healthy Volunteer|healthy volunteer
572462|NCT00466934|HV|hv
572463|NCT00466947|Otitis media|otitis media
572464|NCT00466947|Pneumonia|pneumonia
572465|NCT00466947|Community acquired pneumonia (CAP)|community acquired pneumonia (cap)
572466|NCT00466947|Pneumococcal disease|pneumococcal disease
572467|NCT00466947|Booster vaccination|booster vaccination
572468|NCT00466947|Immunogenicity|immunogenicity
572469|NCT00466947|Pneumococcal vaccine|pneumococcal vaccine
572470|NCT00466947|Safety|safety
572471|NCT00466947|Efficacy|efficacy
572472|NCT00466947|Carriage|carriage
572473|NCT00466973|Atrial fibrillation|atrial fibrillation
572474|NCT00466973|ablation device comparison|ablation device comparison
572475|NCT00466973|ablation in right atria|ablation in right atria
572476|NCT00466986|recurrent|recurrent
572477|NCT00466986|ovarian|ovarian
572478|NCT00466986|cancer|cancer
572479|NCT00466986|platinum sensitive|platinum sensitive
572480|NCT00466999|misoprostol|misoprostol
572481|NCT00466999|incomplete abortion|incomplete abortion
572482|NCT00466999|PAC|pac
572483|NCT00467012|Inoperable metastatic breast cancer|inoperable metastatic breast cancer
572484|NCT00467025|Metastatic clear cell carcinoma of the kidney|metastatic clear cell carcinoma of the kidney
572485|NCT00467025|RCC|rcc
572486|NCT00467038|affect|affect
572487|NCT00467038|aggression|aggression
572488|NCT00467038|anger|anger
572489|NCT00467038|behavior therapy|behavior therapy
572490|NCT00467038|borderline personality disorder|borderline personality disorder
572491|NCT00467038|MRI, functional|mri, functional
572492|NCT00467064|Disease self-management|disease self-management
572493|NCT00467064|Community programs|community programs
572494|NCT00467077|recurrent renal cell cancer|recurrent renal cell cancer
572495|NCT00467077|stage IV renal cell cancer|stage iv renal cell cancer
572496|NCT00467077|stage III renal cell cancer|stage iii renal cell cancer
571894|NCT00475098|Heparin|heparin
571895|NCT00475111|Cognitive Behavioral Intervention|cognitive behavioral intervention
571896|NCT00475111|Emotion Regulation|emotion regulation
571897|NCT00475111|Pain Management|pain management
571898|NCT00475111|Psychological Adaptation|psychological adaptation
571905|NCT00475137|depression|depression
572497|NCT00467090|Parkinson's Disease|parkinson's disease
572498|NCT00467090|Gene|gene
572499|NCT00467090|Genetic|genetic
572500|NCT00467090|Family Studies|family studies
572501|NCT00467090|LRRK-2|lrrk-2
572502|NCT00467090|Parkinson Disease|parkinson disease
572503|NCT00467090|PD|pd
572504|NCT00467103|Adult Aphasia|adult aphasia
572505|NCT00467103|Diffusion Tensor Imaging|diffusion tensor imaging
572506|NCT00467103|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
572507|NCT00467103|Language Recovery|language recovery
572508|NCT00467103|Left Middle Cerebral Artery Stroke|left middle cerebral artery stroke
572509|NCT00467103|Nonfluent Aphasia|nonfluent aphasia
572510|NCT00467116|stage III pancreatic cancer|stage iii pancreatic cancer
572511|NCT00467116|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
572512|NCT00467116|stage II pancreatic cancer|stage ii pancreatic cancer
572513|NCT00467116|recurrent pancreatic cancer|recurrent pancreatic cancer
572514|NCT00467129|stage IV colon cancer|stage iv colon cancer
572515|NCT00467129|stage IV rectal cancer|stage iv rectal cancer
572516|NCT00467142|stage IV colon cancer|stage iv colon cancer
572517|NCT00467142|stage IV rectal cancer|stage iv rectal cancer
572518|NCT00467142|adenocarcinoma of the colon|adenocarcinoma of the colon
572519|NCT00467142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
572520|NCT00467142|recurrent colon cancer|recurrent colon cancer
572521|NCT00467142|recurrent rectal cancer|recurrent rectal cancer
572522|NCT00467155|Helicobacter pylori, children, infants, Gambia|helicobacter pylori, children, infants, gambia
572523|NCT00467168|dietary fatty acid composition|dietary fatty acid composition
572524|NCT00467168|postprandial|postprandial
572525|NCT00467168|triglyceride-rich lipoprotein|triglyceride-rich lipoprotein
572526|NCT00467168|type 2 diabetes|type 2 diabetes
572527|NCT00467181|cardiac surgery|cardiac surgery
572528|NCT00467181|renal dysfunction|renal dysfunction
572529|NCT00467194|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
572530|NCT00467194|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
572531|NCT00467194|recurrent adult primary liver cancer|recurrent adult primary liver cancer
572532|NCT00467194|advanced adult primary liver cancer|advanced adult primary liver cancer
572533|NCT00467220|Calorie restriction|calorie restriction
572534|NCT00467220|alternate day fasting|alternate day fasting
572535|NCT00467220|calorie intake|calorie intake
572536|NCT00467246|Diabetes emergencies|diabetes emergencies
572537|NCT00467259|Natural Menopause|natural menopause
573039|NCT00476905|Skin Cancer|skin cancer
572538|NCT00467272|Catheter-Related Bloodstream Infections|catheter-related bloodstream infections
572539|NCT00467272|Bloodstream Infection|bloodstream infection
572540|NCT00467272|Daptomycin|daptomycin
572541|NCT00467272|Cubicin|cubicin
572542|NCT00467272|CRBSI|crbsi
572543|NCT00467285|Bone Density|bone density
572544|NCT00467285|C-telopeptide|c-telopeptide
572545|NCT00467285|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
572546|NCT00467285|N-telopeptide|n-telopeptide
572547|NCT00467285|Osteocalcin|osteocalcin
572548|NCT00467285|Osteoporosis|osteoporosis
572549|NCT00467285|Thiazolidinediones|thiazolidinediones
572550|NCT00467285|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
572551|NCT00467298|Exercise|exercise
572552|NCT00467298|heart failure|heart failure
572553|NCT00467298|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
572554|NCT00467298|patient education|patient education
572555|NCT00467298|costs|costs
572556|NCT00467298|quality of life|quality of life
572557|NCT00467311|Contrast-induced nephropathy|contrast-induced nephropathy
572558|NCT00467311|Cystatin C|cystatin c
572559|NCT00467311|Contrast media|contrast media
572560|NCT00467311|Creatinine|creatinine
572561|NCT00467311|Cardiac Catheterization|cardiac catheterization
572562|NCT00467324|obstructive sleep apnea|obstructive sleep apnea
572563|NCT00467324|surgery|surgery
572564|NCT00467324|tongue|tongue
572565|NCT00467337|insole|insole
572566|NCT00467337|osteoarthritis|osteoarthritis
572567|NCT00467337|pain|pain
572568|NCT00467337|valgus knee|valgus knee
572569|NCT00467350|constipation|constipation
572570|NCT00467350|treatment|treatment
572571|NCT00467350|fecal impaction|fecal impaction
572572|NCT00467350|pediatric|pediatric
572573|NCT00467389|Acetylcholine|acetylcholine
572574|NCT00467389|Acetylcholinesterase|acetylcholinesterase
572575|NCT00467389|Butyrylcholinesterase|butyrylcholinesterase
572576|NCT00467389|Cholinesterase Inhibitor|cholinesterase inhibitor
572577|NCT00467402|agomelatine, Major Depressive Disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
572578|NCT00467415|Walking|walking
572579|NCT00467415|Treadmill|treadmill
572580|NCT00467415|Partial Weightbearing|partial weightbearing
572581|NCT00467428|ADHD|adhd
572582|NCT00467454|Pyromania|pyromania
572583|NCT00467454|Fire Setting|fire setting
572584|NCT00467454|Compulsive Fire Setting|compulsive fire setting
572585|NCT00467506|Recurrence of medullary thyroid carcinoma: abnormal calcitonin level and biomarkers doubling time lower than 5 years after initial surgery|recurrence of medullary thyroid carcinoma: abnormal calcitonin level and biomarkers doubling time lower than 5 years after initial surgery
572586|NCT00467519|Tetanus; Diphtheria; Pertussis; ADACEL; DAPTACEL|tetanus; diphtheria; pertussis; adacel; daptacel
572587|NCT00467545|HBeAg-positive|hbeag-positive
572588|NCT00467545|chronic hepatitis B|chronic hepatitis b
572589|NCT00467545|telbivudine|telbivudine
572590|NCT00467558|Impulse Control Disorder|impulse control disorder
572591|NCT00467558|Compulsive Sexual Behavior|compulsive sexual behavior
572592|NCT00467571|chronic idiopathic thrombocytopenic purpura|chronic idiopathic thrombocytopenic purpura
572593|NCT00467571|Helicobacter pylori infection|helicobacter pylori infection
572594|NCT00467571|platelet|platelet
572595|NCT00467597|Dyskinesia|dyskinesia
572596|NCT00467597|Levodopa|levodopa
572597|NCT00467597|Movement Disorders|movement disorders
572598|NCT00467597|Parkinson Disease|parkinson disease
572599|NCT00467610|myelodysplastic|myelodysplastic
572601|NCT00467610|Panhematin|panhematin
572602|NCT00467610|Hemin|hemin
572603|NCT00467623|Pregnancy|pregnancy
572604|NCT00467623|holotranscobalamin|holotranscobalamin
572605|NCT00467623|cobalamin|cobalamin
572606|NCT00467623|vitamin B12 analogues|vitamin b12 analogues
572607|NCT00467623|reference interval|reference interval
572608|NCT00467636|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
572609|NCT00467636|Corticosteroid induced hyperglycaemia|corticosteroid induced hyperglycaemia
572610|NCT00467636|Insulin|insulin
572611|NCT00467649|Symlin|symlin
572612|NCT00467649|Amylin|amylin
572613|NCT00467649|insulin|insulin
572614|NCT00467649|Humalog|humalog
572615|NCT00467649|Novolog|novolog
572616|NCT00467649|Apidra|apidra
572617|NCT00467675|NonDiabetes|nondiabetes
572618|NCT00467675|CGM|cgm
572619|NCT00467688|type 1 diabetes|type 1 diabetes
572620|NCT00467688|glucose excursion|glucose excursion
572621|NCT00467688|hypoglycemia awareness|hypoglycemia awareness
572622|NCT00467688|continuous glucose monitoring|continuous glucose monitoring
572623|NCT00467701|pneumonia|pneumonia
572624|NCT00467701|Legionnaires disease|legionnaires disease
572625|NCT00467701|risk factors|risk factors
572626|NCT00467714|RHINOPLASTY ,ESTHETIC SURGERY|rhinoplasty ,esthetic surgery
572627|NCT00467727|Diagnostic Mammography|diagnostic mammography
572628|NCT00467727|Breast Imaging|breast imaging
572629|NCT00467727|Phase Contrast Mammography|phase contrast mammography
572630|NCT00467727|X-Ray Mammography|x-ray mammography
572631|NCT00467753|Irritability|irritability
572632|NCT00467753|Functional Ability|functional ability
572633|NCT00467753|Aggression|aggression
572634|NCT00467753|Mood Instability|mood instability
572635|NCT00467766|dementia|dementia
572637|NCT00467792|urticaria pigmentosa|urticaria pigmentosa
572638|NCT00467792|mastocytosis|mastocytosis
572639|NCT00467792|mastocytomas|mastocytomas
572640|NCT00467805|Light exposure|light exposure
572641|NCT00467805|light spectrum|light spectrum
572642|NCT00467805|reproductive hormones|reproductive hormones
572643|NCT00467805|women|women
572644|NCT00467818|Aggression|aggression
572645|NCT00467818|Irritability|irritability
572646|NCT00467818|Global severity|global severity
572647|NCT00467831|Restrictive Lung Disease|restrictive lung disease
572648|NCT00467831|Pulmonary Fibrosis|pulmonary fibrosis
572649|NCT00467831|Albinism|albinism
572650|NCT00467831|Platelet Storage Pool Deficiency|platelet storage pool deficiency
572651|NCT00467831|Metabolic Disease|metabolic disease
572652|NCT00467831|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
572653|NCT00467831|HPS|hps
572654|NCT00467831|Lung Disease|lung disease
572655|NCT00467844|Cachexia|cachexia
572656|NCT00467844|Muscle Wasting|muscle wasting
572657|NCT00467844|Non-Small Cell Lung Cancer|non-small cell lung cancer
572658|NCT00467844|Colorectal Cancer|colorectal cancer
572659|NCT00467844|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
572660|NCT00467844|Stage 3 or 4 Breast Cancer|stage 3 or 4 breast cancer
583957|NCT00514046|MEN|men
572661|NCT00467844|Chronis Lymphocytic Leukemia|chronis lymphocytic leukemia
572662|NCT00467857|cyanoacrylates|cyanoacrylates
572663|NCT00467857|microbial sealants|microbial sealants
572664|NCT00467857|skin flora contamination|skin flora contamination
572665|NCT00467857|surgery|surgery
572666|NCT00467870|investigational|investigational
572667|NCT00467870|testosterone|testosterone
572668|NCT00467870|testosterone undecanoate|testosterone undecanoate
572669|NCT00467870|TU|tu
572670|NCT00467870|Hypogonadism|hypogonadism
572671|NCT00467870|primary hypogonadism|primary hypogonadism
572115|NCT00475865|MS|ms
572672|NCT00467870|secondary hypogonadism|secondary hypogonadism
572673|NCT00467883|Zygomycosis|zygomycosis
572674|NCT00467883|High dose liposomal amphotericin B|high dose liposomal amphotericin b
572675|NCT00467896|PAH|pah
572676|NCT00467896|iloprost|iloprost
572677|NCT00467896|Ventavis|ventavis
572678|NCT00467896|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
572679|NCT00467896|Actelion Pharmaceuticals|actelion pharmaceuticals
572680|NCT00467896|Cotherix|cotherix
572681|NCT00467909|micronutrients|micronutrients
572682|NCT00467909|cognition|cognition
572683|NCT00467909|DHA|dha
572684|NCT00467909|healthy children|healthy children
572685|NCT00467922|Hand-assisted colorectal surgery|hand-assisted colorectal surgery
572686|NCT00467922|colorectal disease|colorectal disease
572687|NCT00467922|Crohn's|crohn's
572688|NCT00467922|diverticulitis|diverticulitis
572689|NCT00467922|Colorectal resections|colorectal resections
572690|NCT00467935|amd|amd
572691|NCT00467935|disciform|disciform
572692|NCT00467935|fibrosis|fibrosis
572693|NCT00467935|Lucentis|lucentis
572694|NCT00467935|scotoma|scotoma
572695|NCT00467948|clean contaminated, laryngectomy, wound infection|clean contaminated, laryngectomy, wound infection
572696|NCT00467961|CML (Chronic Myelogenous Leukemia)|cml (chronic myelogenous leukemia)
572697|NCT00467961|CLL (Chronic Lymphocytic Leukemia)|cll (chronic lymphocytic leukemia)
572698|NCT00467961|AML (Acute Myelogenous Leukemia)|aml (acute myelogenous leukemia)
572699|NCT00467961|Leukemia|leukemia
572700|NCT00467961|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
572701|NCT00467961|CLL|cll
572702|NCT00467961|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
572703|NCT00467961|CML|cml
572704|NCT00467961|Acute Myelogenous Leukemia|acute myelogenous leukemia
572705|NCT00467961|AML|aml
572706|NCT00467961|Acute B-Lymphoblastic Leukemia|acute b-lymphoblastic leukemia
572707|NCT00467961|ALL|all
572708|NCT00467961|Myelodysplastic Syndrome|myelodysplastic syndrome
572709|NCT00467961|MDS|mds
572710|NCT00468000|Peripheral Arterial Disease|peripheral arterial disease
572711|NCT00468000|Critical Limb Ischemia|critical limb ischemia
572712|NCT00468000|Ischemia|ischemia
572713|NCT00468000|Peripheral Vascular Disease|peripheral vascular disease
572714|NCT00468000|ixmyelocel-T|ixmyelocel-t
572715|NCT00468013|Fibromyalgia|fibromyalgia
572716|NCT00468013|Irritable Bowel|irritable bowel
572717|NCT00468013|Chronic Fatigue|chronic fatigue
572718|NCT00468013|Medically Unexplained Symptoms|medically unexplained symptoms
572719|NCT00468013|Resilience Building Exercises|resilience building exercises
572720|NCT00468013|Depression|depression
572721|NCT00468013|Well-Being|well-being
572722|NCT00468026|BPH|bph
572723|NCT00468026|Prostate|prostate
572724|NCT00468026|Stent|stent
572725|NCT00468026|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
572726|NCT00468039|metformin|metformin
572727|NCT00468039|vildagliptin|vildagliptin
572728|NCT00468039|initial combination|initial combination
572729|NCT00468052|obstructive sleep apnea|obstructive sleep apnea
572730|NCT00468052|tonsillectomy|tonsillectomy
572731|NCT00468052|adenoidectomy|adenoidectomy
572732|NCT00468065|intravenous|intravenous
572733|NCT00468065|catheter|catheter
572734|NCT00468065|IV|iv
572735|NCT00468078|Parkinson's disease|parkinson's disease
572736|NCT00468078|Essential tremor|essential tremor
572737|NCT00468078|F-18 FPCIT|f-18 fpcit
572738|NCT00468078|PET|pet
572739|NCT00468091|GLP-1|glp-1
572740|NCT00468091|exendin(9-39)|exendin(9-39)
572741|NCT00468091|atropine|atropine
572742|NCT00468091|human|human
572743|NCT00468091|motility|motility
572744|NCT00468104|parapneumonic pleural effusion|parapneumonic pleural effusion
572745|NCT00468104|empyema|empyema
572746|NCT00468104|TPA (Activase, Alteplase)|tpa (activase, alteplase)
572747|NCT00468117|Hypoglycemia|hypoglycemia
572748|NCT00468117|Kidney Transplant|kidney transplant
572749|NCT00468117|Insulin independence|insulin independence
572750|NCT00468117|Islet Transplantation|islet transplantation
572751|NCT00468117|Intensive Insulin Therapy|intensive insulin therapy
572752|NCT00468130|Aggression|aggression
572753|NCT00468130|Irritability|irritability
572754|NCT00468130|Global autism severity|global autism severity
572755|NCT00468156|fruit|fruit
572756|NCT00468156|vegetables|vegetables
572757|NCT00468156|prevention|prevention
572758|NCT00468156|cancer|cancer
572759|NCT00468156|counseling|counseling
572760|NCT00468156|cancer risk|cancer risk
572761|NCT00468169|Cetuximab|cetuximab
572762|NCT00468169|Erbitux|erbitux
572763|NCT00468169|locally|locally
572764|NCT00468169|advanced|advanced
572765|NCT00468169|head|head
572766|NCT00468169|neck|neck
572767|NCT00468169|cancer|cancer
572768|NCT00468169|neoplasms|neoplasms
572769|NCT00468169|squamous|squamous
572770|NCT00468169|carcinoma|carcinoma
572771|NCT00468169|lymphoepithelioma|lymphoepithelioma
572772|NCT00468182|Multiple sclerosis|multiple sclerosis
572773|NCT00468182|Interferon beta|interferon beta
740197|NCT01123889|PRP|prp
572774|NCT00468182|plasmacytoid dendritic cells|plasmacytoid dendritic cells
572775|NCT00468195|tomography|tomography
572776|NCT00468195|coronary artery disease|coronary artery disease
572777|NCT00468195|obesity|obesity
572778|NCT00468208|Vasculitis|vasculitis
572779|NCT00468208|Relapse|relapse
572780|NCT00468208|Wegener's|wegener's
572781|NCT00468208|Treatment|treatment
572782|NCT00468221|Ozone|ozone
572783|NCT00468221|Healthy Adults|healthy adults
572784|NCT00468234|smoking cessation|smoking cessation
572785|NCT00468234|harm reduction|harm reduction
572786|NCT00468234|biomarker|biomarker
572787|NCT00468234|exhaled breath condensate|exhaled breath condensate
572788|NCT00468247|mean systemic pressure|mean systemic pressure
572789|NCT00468247|fluid therapy|fluid therapy
572790|NCT00468247|closed loop control|closed loop control
572791|NCT00468247|circulation modelling|circulation modelling
572792|NCT00468260|Cancer|cancer
572793|NCT00468260|EPO906|epo906
572794|NCT00468260|Patupilone|patupilone
572795|NCT00468273|Deficiency Syndromes, Antibody|deficiency syndromes, antibody
572796|NCT00468273|Antibody Deficiency Syndrome|antibody deficiency syndrome
572797|NCT00468273|Bruton's agammaglobulinemia|bruton's agammaglobulinemia
572798|NCT00468273|Common Variable Immune Deficiency|common variable immune deficiency
572799|NCT00468273|Hyper IgM syndromes|hyper igm syndromes
572800|NCT00468286|Prostate Cancer|prostate cancer
572801|NCT00468299|early|early
572802|NCT00468299|pregnancy|pregnancy
572803|NCT00468299|failure|failure
572804|NCT00468299|mifepristone|mifepristone
572805|NCT00468299|misoprostol|misoprostol
572806|NCT00468299|buccal|buccal
572807|NCT00468299|miscarriage|miscarriage
572808|NCT00468299|fetal|fetal
572809|NCT00468299|demise|demise
572810|NCT00468299|anembryonic|anembryonic
572811|NCT00468299|progesterone|progesterone
572812|NCT00468325|coronary artery disease|coronary artery disease
572813|NCT00468325|chest pain|chest pain
572814|NCT00468325|emergency room|emergency room
572815|NCT00468338|general anesthesia|general anesthesia
572816|NCT00468338|dental rehabilitation|dental rehabilitation
572817|NCT00468338|mental retardation|mental retardation
572818|NCT00468351|bevacizumab|bevacizumab
572819|NCT00468351|diabetes|diabetes
572820|NCT00468351|intravitreal|intravitreal
572821|NCT00468351|macular edema|macular edema
572822|NCT00468351|triamcinolone|triamcinolone
572823|NCT00468351|VEGF|vegf
572824|NCT00468364|Hypoglycemia, bedtime insulin, long-acting insulin|hypoglycemia, bedtime insulin, long-acting insulin
572825|NCT00468403|Insulin dependence|insulin dependence
572826|NCT00468403|Hypoglycemia|hypoglycemia
572827|NCT00468403|Hypoglycemia unawareness|hypoglycemia unawareness
572828|NCT00468429|Glaucoma|glaucoma
572829|NCT00468429|Bevacizumab|bevacizumab
572830|NCT00468429|Glaucoma Filtration Surgery|glaucoma filtration surgery
572831|NCT00468429|Mitomycin C|mitomycin c
572832|NCT00468429|Intraocular Pressure|intraocular pressure
572833|NCT00468442|Insulin dependence|insulin dependence
572834|NCT00468442|Hypoglycemia|hypoglycemia
572835|NCT00468442|Hypoglycemia unawareness|hypoglycemia unawareness
572836|NCT00468455|Colorectal Surgery|colorectal surgery
572837|NCT00468455|Abdominal Surgery|abdominal surgery
572838|NCT00468455|Diverticulitis|diverticulitis
572839|NCT00468455|Colon Cancer|colon cancer
572840|NCT00468455|Rectal Cancer|rectal cancer
572841|NCT00468455|Colon Polyp|colon polyp
572842|NCT00468455|Rectal Polyp|rectal polyp
572843|NCT00468455|Crohn's Disease|crohn's disease
572844|NCT00468468|breast cancer|breast cancer
572845|NCT00468468|Internet|internet
572846|NCT00468468|computer|computer
572847|NCT00468468|support|support
572848|NCT00468468|information|information
572849|NCT00468468|education|education
572850|NCT00468481|Healthy women requesting contraception|healthy women requesting contraception
572851|NCT00468481|Folic Acid|folic acid
572852|NCT00468494|non diabetic|non diabetic
572853|NCT00468494|catabolic energy state|catabolic energy state
572854|NCT00468507|CCK release|cck release
572855|NCT00468520|induction of labor|induction of labor
572856|NCT00468520|cervical ripening|cervical ripening
572857|NCT00468520|Foley catheter|foley catheter
572858|NCT00468520|oxytocin|oxytocin
572859|NCT00468533|Arupiprazole, prolacin, PANSS, CGI, AIMS|arupiprazole, prolacin, panss, cgi, aims
572860|NCT00468559|pediatrics|pediatrics
572861|NCT00468559|neonates|neonates
572862|NCT00468572|Emotion|emotion
572863|NCT00468572|Oxytocin|oxytocin
572864|NCT00468572|Cortisol|cortisol
572865|NCT00468585|Breast cancer|breast cancer
572866|NCT00468585|Metastatic breast cancer|metastatic breast cancer
572867|NCT00468585|Breast|breast
572868|NCT00468585|Metastatic|metastatic
572869|NCT00468598|troponin|troponin
572870|NCT00468598|long-term outcome|long-term outcome
572871|NCT00468598|on-pump cardiac surgery|on-pump cardiac surgery
572872|NCT00468611|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
572873|NCT00468611|Multiple Sclerosis|multiple sclerosis
572874|NCT00468624|Growth hormone|growth hormone
740299|NCT01117805|Asthma|asthma
572295|NCT00465270|PFO|pfo
572875|NCT00468624|insulin-like growth factor 1|insulin-like growth factor 1
572876|NCT00468624|pegvisomant|pegvisomant
572877|NCT00468637|heart failure|heart failure
572878|NCT00468637|cardiovascular high risk|cardiovascular high risk
572879|NCT00468637|erectile dysfunction|erectile dysfunction
572880|NCT00468637|cardiovascular disease|cardiovascular disease
572881|NCT00468663|preeclampsia|preeclampsia
572882|NCT00468663|preterm delivery|preterm delivery
572883|NCT00468663|lipid peroxidation|lipid peroxidation
572884|NCT00468663|inflammation|inflammation
572885|NCT00468676|major Depressive Disorder|major depressive disorder
572886|NCT00468676|Diabetes|diabetes
572887|NCT00468676|Heart Disease|heart disease
572888|NCT00468689|SB-751689,|sb-751689,
572889|NCT00468689|Calcium-sensing receptor antagonist (CaR),|calcium-sensing receptor antagonist (car),
572890|NCT00468689|Osteoporosis,|osteoporosis,
572891|NCT00468689|Parathyroid hormone (PTH),|parathyroid hormone (pth),
572892|NCT00468689|Oral dose|oral dose
572893|NCT00468715|stage IV breast cancer|stage iv breast cancer
572894|NCT00468715|recurrent breast cancer|recurrent breast cancer
572895|NCT00468715|male breast cancer|male breast cancer
572896|NCT00468728|CDAD, Clostridium difficile, diarrhea|cdad, clostridium difficile, diarrhea
572897|NCT00468728|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
572898|NCT00468741|Breast Cancer|breast cancer
572899|NCT00468741|Internet|internet
572900|NCT00468741|Computer|computer
572901|NCT00468741|Support|support
572902|NCT00468741|Information|information
572903|NCT00468741|Education|education
572904|NCT00468741|Control Group: Usual care and Internet access|control group: usual care and internet access
572905|NCT00468741|CHESS Information Services only|chess information services only
572906|NCT00468741|CHESS Social Support & Information Services|chess social support & information services
572907|NCT00468741|CHESS Information, Social Support & Skills Services|chess information, social support & skills services
572908|NCT00468767|Atrial fibrillation|atrial fibrillation
572909|NCT00468767|RSD1235|rsd1235
572910|NCT00468767|Atrial fibrillation of 3 hours to 7 days duration.|atrial fibrillation of 3 hours to 7 days duration.
572911|NCT00468767|Atrial fibrillation of 3 hours to 45 days duration.|atrial fibrillation of 3 hours to 45 days duration.
572912|NCT00468780|Canadian Triage Acuity Scale|canadian triage acuity scale
572913|NCT00468780|paramedics|paramedics
572914|NCT00468780|triage nurse|triage nurse
572915|NCT00468780|triage levels|triage levels
572916|NCT00468780|inter-rater reliability|inter-rater reliability
572917|NCT00468780|health services outcomes|health services outcomes
572918|NCT00468793|central venous saturation|central venous saturation
572919|NCT00468793|bowel surgery|bowel surgery
572920|NCT00468793|morbidity|morbidity
572921|NCT00468793|intravenous infusions|intravenous infusions
572922|NCT00468806|PET scan|pet scan
572923|NCT00468806|Health Males|health males
572924|NCT00468819|Contrast-enhanced MRI|contrast-enhanced mri
572925|NCT00468819|MR angiography (MRA) Children 2-17 years|mr angiography (mra) children 2-17 years
572926|NCT00475982|Diet|diet
572927|NCT00475982|Insulin-like Growth Factor|insulin-like growth factor
572928|NCT00475982|Weight Loss|weight loss
572929|NCT00476008|Alzheimer's Disease|alzheimer's disease
572930|NCT00476008|Mild Alzheimer's Disease|mild alzheimer's disease
572931|NCT00476008|Driving|driving
572932|NCT00476008|Driving Impairment|driving impairment
572933|NCT00476021|postpartum|postpartum
572934|NCT00476021|contraception|contraception
572935|NCT00476021|postplacental IUD|postplacental iud
572936|NCT00476021|intrauterine devices|intrauterine devices
572937|NCT00476034|Osteoarthritis|osteoarthritis
572938|NCT00476034|lumiracoxib|lumiracoxib
572939|NCT00476034|celecoxib|celecoxib
572940|NCT00476034|Cox-2|cox-2
572941|NCT00476034|knee|knee
572942|NCT00476060|Cirrhosis|cirrhosis
572943|NCT00476060|Bone marrow|bone marrow
572944|NCT00476060|Mesenchymal stem cell|mesenchymal stem cell
572945|NCT00476060|MELD score|meld score
572946|NCT00476060|Quality of life|quality of life
572947|NCT00476086|oxaliplatin|oxaliplatin
572948|NCT00476086|gemcitabine|gemcitabine
572949|NCT00476086|MMMT|mmmt
572950|NCT00476112|Atrial flutter|atrial flutter
572951|NCT00476112|RSD1235|rsd1235
572952|NCT00476138|Epigallocatechin-Gallate|epigallocatechin-gallate
572953|NCT00476138|Glaucoma|glaucoma
572954|NCT00476138|Optic Nerve|optic nerve
572955|NCT00476138|Pattern Electroretinogram|pattern electroretinogram
572956|NCT00476138|Retinal Ganglion Cells|retinal ganglion cells
572957|NCT00476151|DPN|dpn
572958|NCT00476151|Diabetic|diabetic
572959|NCT00476151|Nerve Pain|nerve pain
572960|NCT00476164|chronic allograft nephropathy|chronic allograft nephropathy
572961|NCT00476164|C4d|c4d
572962|NCT00476164|Anti-CD20|anti-cd20
572963|NCT00476164|B cells|b cells
572964|NCT00476164|Antibody|antibody
572966|NCT00476177|DLI|dli
572967|NCT00476177|graft vs. host disease|graft vs. host disease
572968|NCT00476177|GVHD|gvhd
572969|NCT00476190|ALL|all
572970|NCT00476203|Breast Cancer|breast cancer
572971|NCT00476203|Yoga|yoga
572972|NCT00476203|Quality of Life|quality of life
572973|NCT00476203|Obesity|obesity
572974|NCT00476203|Fatigue|fatigue
572975|NCT00476203|Weight|weight
572976|NCT00476216|Non-Small Cell Lung Cancer|non-small cell lung cancer
572977|NCT00476216|Venous Thromboembolism|venous thromboembolism
572978|NCT00476216|VTE|vte
572979|NCT00476216|Arixtra|arixtra
572980|NCT00476229|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
572981|NCT00476229|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
572982|NCT00476229|Hodgkin's Lymphoma|hodgkin's lymphoma
572983|NCT00476229|Lymphoma|lymphoma
572984|NCT00476229|Leukemia|leukemia
572985|NCT00476229|Mycophenolate Mofetil|mycophenolate mofetil
572986|NCT00476229|Tacrolimus|tacrolimus
572987|NCT00476229|Thymoglobulin|thymoglobulin
572988|NCT00476229|Total Lymphoid Irradiation|total lymphoid irradiation
572989|NCT00476242|heroin abuse|heroin abuse
572990|NCT00476242|opiate abuse|opiate abuse
572991|NCT00476242|opioid dependence|opioid dependence
572992|NCT00476242|naltrexone|naltrexone
572993|NCT00476242|memantine|memantine
572994|NCT00476255|child safety restraint|child safety restraint
572995|NCT00476255|injury prevention|injury prevention
572996|NCT00476255|automotive|automotive
572997|NCT00476294|Multiple Myeloma|multiple myeloma
572998|NCT00476294|Disease-Free Survival|disease-free survival
572999|NCT00476294|AMD3100|amd3100
573000|NCT00476294|G-CSF|g-csf
573001|NCT00476294|Autologous Transplantation|autologous transplantation
573002|NCT00476307|Flu vaccine|flu vaccine
573003|NCT00476814|cystic fibrosis,|cystic fibrosis,
573004|NCT00476814|nasal potential difference,|nasal potential difference,
573005|NCT00476814|primary sclerosing cholangitis|primary sclerosing cholangitis
573006|NCT00476827|Breast Cancer|breast cancer
573007|NCT00476827|Metastatic|metastatic
573008|NCT00476827|Brain|brain
573009|NCT00476827|Anti-angiogenesis|anti-angiogenesis
573010|NCT00476853|HIV-TB|hiv-tb
573011|NCT00476853|nevirapine based HAART with rifampin treated TB|nevirapine based haart with rifampin treated tb
573012|NCT00476853|Compare PK profile, efficacy, safety and tolerability of HAART containing nevirapine 400mg/day versus 600 mg/day in HIV/TB co-infected patients|compare pk profile, efficacy, safety and tolerability of haart containing nevirapine 400mg/day versus 600 mg/day in hiv/tb co-infected patients
573013|NCT00476853|Treatment Naive|treatment naive
573014|NCT00476866|Paraplegia|paraplegia
573015|NCT00476866|tetraplegia|tetraplegia
573016|NCT00476866|lung compliance|lung compliance
573017|NCT00476866|work of breathing|work of breathing
573018|NCT00476866|hyperinflation|hyperinflation
573019|NCT00476866|rehabilitation|rehabilitation
573020|NCT00476879|Growth hormone|growth hormone
573021|NCT00476879|Fasting|fasting
573022|NCT00476879|Signaltransduction|signaltransduction
573023|NCT00476879|fatty liver|fatty liver
573024|NCT00476879|insulin sensitivity|insulin sensitivity
573025|NCT00476879|forearm model|forearm model
573026|NCT00476879|protein metabolism|protein metabolism
573027|NCT00476879|respiratory quotient|respiratory quotient
573028|NCT00476892|Pelvic organ prolapse|pelvic organ prolapse
573029|NCT00476892|Pelvic floor muscle training|pelvic floor muscle training
573030|NCT00476892|Prolapse symptoms|prolapse symptoms
573031|NCT00476892|Urinary symptoms|urinary symptoms
573032|NCT00476892|Sexual function|sexual function
573033|NCT00476892|randomised controlled trial|randomised controlled trial
573034|NCT00476905|Basal Cell Carcinoma|basal cell carcinoma
573035|NCT00476905|Squamous Cell Carcinoma|squamous cell carcinoma
573036|NCT00476905|Pre-Cancer Lesions|pre-cancer lesions
573037|NCT00476905|Pigmented Lesions|pigmented lesions
573038|NCT00476905|Benign Lesions|benign lesions
573040|NCT00476905|Spectral Diagnosis|spectral diagnosis
573041|NCT00476905|Optical Spectroscopy|optical spectroscopy
573042|NCT00476918|diabetic macular edema|diabetic macular edema
573043|NCT00476918|triamcinolone acetonide|triamcinolone acetonide
573044|NCT00476918|intravitreal|intravitreal
573045|NCT00476918|steroid|steroid
573046|NCT00476931|Diabetic neuropathy|diabetic neuropathy
573047|NCT00476931|Diabetes Type 1 or 2|diabetes type 1 or 2
573048|NCT00476931|Moderate to severe sensorimotor diabetic polyneuropathy|moderate to severe sensorimotor diabetic polyneuropathy
573049|NCT00476931|Unmeasurable nerve conduction velocity|unmeasurable nerve conduction velocity
573050|NCT00476944|CAD|cad
573051|NCT00476944|Coronary Artery Disease|coronary artery disease
573052|NCT00476944|Angiomax|angiomax
573053|NCT00476944|Bivalirudin|bivalirudin
573054|NCT00476944|PCI|pci
573055|NCT00476944|MAVE|mave
573056|NCT00476944|Heparin|heparin
573057|NCT00476957|Drug Eluting Stents|drug eluting stents
573058|NCT00476957|Interventional Cardiology|interventional cardiology
573059|NCT00476970|Colorectal Cancer|colorectal cancer
573060|NCT00476970|Cancer Screening|cancer screening
573061|NCT00476970|Patient Navigation|patient navigation
573062|NCT00476970|Low English Proficiency|low english proficiency
573063|NCT00476983|saquinavir/ritonavir 1500/100 mg once daily|saquinavir/ritonavir 1500/100 mg once daily
573064|NCT00476996|RA|ra
573065|NCT00476996|SCRIPT|script
573066|NCT00476996|anti-CD20|anti-cd20
573067|NCT00476996|CD20|cd20
573068|NCT00477009|Sleep apnea syndromes|sleep apnea syndromes
573069|NCT00477009|Snoring|snoring
573070|NCT00477009|Mandibular advancement|mandibular advancement
573071|NCT00477009|Activator appliances|activator appliances
573072|NCT00477009|Disorders of excessive somnolence|disorders of excessive somnolence
573073|NCT00477009|Blood pressure|blood pressure
573074|NCT00477009|Inflammation|inflammation
573075|NCT00477009|Oxidative stress|oxidative stress
573076|NCT00477009|Hormones|hormones
573077|NCT00477009|Markers of Metabolic Syndrome X|markers of metabolic syndrome x
573078|NCT00477022|Diabetic Foot Ulcer|diabetic foot ulcer
573079|NCT00477022|Vacuum compression therapy|vacuum compression therapy
573080|NCT00477022|Stereology|stereology
573081|NCT00477022|Ulcer Area|ulcer area
573082|NCT00477022|Vasotrain|vasotrain
573083|NCT00477022|Random Controlled Trial.|random controlled trial.
573084|NCT00477048|IDV nephrotoxicity|idv nephrotoxicity
573085|NCT00477061|MORPHINE|morphine
573086|NCT00477061|ANALGESIA|analgesia
573087|NCT00477061|ACUTE APPENDICITS|acute appendicits
573088|NCT00477074|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
573089|NCT00477074|emphysema|emphysema
573090|NCT00477074|inflammation|inflammation
573091|NCT00477074|repair|repair
573092|NCT00477100|Inflammatory Breast Cancer|inflammatory breast cancer
573093|NCT00477100|Cancer Registry|cancer registry
573094|NCT00477100|Core Biopsy|core biopsy
573095|NCT00477100|Skin Biopsy|skin biopsy
573096|NCT00477100|IBC|ibc
573097|NCT00477113|natalizumab|natalizumab
573098|NCT00477113|MS|ms
573099|NCT00477113|Tysabri|tysabri
573100|NCT00477113|Multiple Sclerosis|multiple sclerosis
573101|NCT00477113|TYGRIS|tygris
573102|NCT00477126|ritonavir generic capsule|ritonavir generic capsule
573103|NCT00477126|Norvir®|norvir®
573104|NCT00477126|Thailand|thailand
573105|NCT00477126|Determine bioequivalence between Norvir and GPO ritonavir|determine bioequivalence between norvir and gpo ritonavir
573106|NCT00477152|dehydration|dehydration
573107|NCT00477152|fluid therapy|fluid therapy
573108|NCT00477152|pediatrics|pediatrics
573109|NCT00477152|emergency medicine|emergency medicine
573110|NCT00477152|hyaluronoglucosaminidase|hyaluronoglucosaminidase
573111|NCT00477152|hyaluronidase|hyaluronidase
573112|NCT00477152|hypodermoclysis|hypodermoclysis
573113|NCT00477152|clysis|clysis
573114|NCT00477152|subcutaneous hydration|subcutaneous hydration
573115|NCT00477152|subcutaneous rehydration|subcutaneous rehydration
573116|NCT00477152|hyaluronan|hyaluronan
573117|NCT00477152|rHuPH20|rhuph20
573118|NCT00477165|Irritable bowel syndrome|irritable bowel syndrome
573119|NCT00477165|Antidepressant|antidepressant
573121|NCT00477165|Serotonin-reuptake inhibitor|serotonin-reuptake inhibitor
573122|NCT00477165|SSRI|ssri
573123|NCT00477165|Visceral sensitivity|visceral sensitivity
573124|NCT00477165|Barostat|barostat
573125|NCT00477165|Quality of life|quality of life
573126|NCT00477165|Depression|depression
573127|NCT00477178|possible problems using codeine when driving|possible problems using codeine when driving
573128|NCT00477191|psoriasis|psoriasis
573129|NCT00477191|metabolic syndrome|metabolic syndrome
573130|NCT00477191|Syndrome X|syndrome x
573131|NCT00477191|diabetes|diabetes
573132|NCT00477191|insulin resistance|insulin resistance
573133|NCT00477191|obesity|obesity
573134|NCT00477191|hypertension|hypertension
573135|NCT00477191|hyperlipidemia|hyperlipidemia
573420|NCT00478101|Pain|pain
573136|NCT00477191|hypercholesterolemia|hypercholesterolemia
573137|NCT00477204|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
573138|NCT00477204|dyslipidemia|dyslipidemia
573139|NCT00477204|adolescents|adolescents
573140|NCT00477217|Osteonecrosis|osteonecrosis
573141|NCT00477217|zoledronic acid|zoledronic acid
573142|NCT00477217|knee|knee
573143|NCT00477230|AF|af
573144|NCT00477230|PAF|paf
573145|NCT00477230|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
573146|NCT00477230|ablation|ablation
573147|NCT00477230|failed drugs|failed drugs
573148|NCT00477243|Advanced Cancer|advanced cancer
573149|NCT00477243|Palliative Care Patients|palliative care patients
573150|NCT00477243|Spirituality|spirituality
573151|NCT00477243|Locus of Control|locus of control
573152|NCT00477243|Questionnaire|questionnaire
573153|NCT00477256|Pediatric Cancer|pediatric cancer
573154|NCT00477256|Child Adjustment|child adjustment
573155|NCT00477256|School Reintegration|school reintegration
573156|NCT00477256|Caregiver|caregiver
573157|NCT00477256|Questionnaire|questionnaire
573158|NCT00477256|Quality of Life|quality of life
573159|NCT00477256|Survey|survey
573160|NCT00477269|Pulmonary Arterial Hypertension, tyrosine kinase inhibitor, STI571|pulmonary arterial hypertension, tyrosine kinase inhibitor, sti571
573161|NCT00477282|Ovarian|ovarian
573162|NCT00477282|Cancer|cancer
573163|NCT00477282|Advanced Ovarian Cancer|advanced ovarian cancer
573164|NCT00477295|Epilepsy|epilepsy
573165|NCT00477308|HIV children|hiv children
573166|NCT00477308|genotypic resistance|genotypic resistance
573167|NCT00477308|dual NRTIs|dual nrtis
573168|NCT00477308|Salvage therapy|salvage therapy
572600|NCT00467610|MDS|mds
573169|NCT00477308|treatment outcome|treatment outcome
573170|NCT00477308|Salvage therapy based on genotyping results|salvage therapy based on genotyping results
573171|NCT00477308|Treatment Failure|treatment failure
573172|NCT00477321|Interleukin 7|interleukin 7
573173|NCT00477321|Immune Reconstitution|immune reconstitution
573174|NCT00477321|T Cell Turnover|t cell turnover
573175|NCT00477321|CD4 Lymphenia|cd4 lymphenia
573176|NCT00477321|Immune-Based Therapies|immune-based therapies
573177|NCT00477321|HIV Infection|hiv infection
573178|NCT00477334|Recurrent genital herpes|recurrent genital herpes
573179|NCT00477334|Black population|black population
573180|NCT00477347|Liver Transplantation|liver transplantation
573181|NCT00477347|Anesthesia, general|anesthesia, general
573182|NCT00477347|Closed-loop|closed-loop
573183|NCT00477386|recurrent ovarian cancer|recurrent ovarian cancer
573184|NCT00477386|platinum resistant|platinum resistant
573185|NCT00477386|decitabine|decitabine
573186|NCT00477399|Obesity|obesity
573187|NCT00477399|Weight loss maintenance|weight loss maintenance
573188|NCT00477399|QOL|qol
573189|NCT00477399|Life Style|life style
573190|NCT00477399|Follow Up|follow up
573191|NCT00477412|Mantle Cell Lymphoma|mantle cell lymphoma
573192|NCT00477412|Lymphoma|lymphoma
573193|NCT00477412|Bortezomib|bortezomib
573194|NCT00477412|LDP-341|ldp-341
573195|NCT00477412|MLN341|mln341
573196|NCT00477412|Velcade|velcade
573197|NCT00477412|Cyclophosphamide|cyclophosphamide
573198|NCT00477412|Neosar|neosar
573199|NCT00477412|Cytoxan|cytoxan
573200|NCT00477412|Doxorubicin|doxorubicin
573201|NCT00477412|Adriamycin|adriamycin
573202|NCT00477412|Rubex|rubex
573203|NCT00477412|Rituximab|rituximab
573204|NCT00477412|Vincristine|vincristine
573205|NCT00477412|Methotrexate|methotrexate
573206|NCT00477412|Cytarabine|cytarabine
573207|NCT00477412|Cytosar|cytosar
573208|NCT00477412|DepoCyt|depocyt
573209|NCT00477412|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
573210|NCT00477412|Mesna|mesna
573211|NCT00477412|Dexamethasone|dexamethasone
573212|NCT00477425|Avastin|avastin
573213|NCT00477451|Staccato™ Alprazolam, Panic Attack, Inhaled alprazolam|staccato™ alprazolam, panic attack, inhaled alprazolam
573214|NCT00477464|dual kinase inhibitor,|dual kinase inhibitor,
573215|NCT00477464|EGFR/ErbB1,|egfr/erbb1,
573216|NCT00477464|ErbB2-overexpressing,|erbb2-overexpressing,
573217|NCT00477464|GW572016,|gw572016,
573218|NCT00477464|advanced/metastatic breast cancer, Lapatinib,|advanced/metastatic breast cancer, lapatinib,
573219|NCT00477464|HER-2/new,|her-2/new,
573220|NCT00477464|pharmacokinetics|pharmacokinetics
573221|NCT00477477|overweight|overweight
573222|NCT00477477|metabolic syndrome|metabolic syndrome
573223|NCT00477477|adolescent|adolescent
573224|NCT00477477|cardiovascular|cardiovascular
573225|NCT00477477|risk factors|risk factors
573226|NCT00477477|hypertension|hypertension
573227|NCT00477477|dyslipidemia|dyslipidemia
573228|NCT00477477|inflammation|inflammation
573229|NCT00477477|coagulopathy|coagulopathy
573230|NCT00477503|Central Nervous System Tumors|central nervous system tumors
573231|NCT00477503|Brain Tumors|brain tumors
573232|NCT00477503|Leptomeningeal Metastasis|leptomeningeal metastasis
573233|NCT00477503|Cerebral Spinal Fluid|cerebral spinal fluid
573234|NCT00477503|Human CSF Flow|human csf flow
573235|NCT00477503|Nuclear Imaging|nuclear imaging
573236|NCT00477503|Gallium-67 Citrate|gallium-67 citrate
573237|NCT00477503|In-111 DTPA|in-111 dtpa
573238|NCT00477542|Clofarabine|clofarabine
573239|NCT00477542|allogeneic HSCT|allogeneic hsct
573240|NCT00477542|refractory malignancies|refractory malignancies
573241|NCT00477555|aortic valve|aortic valve
573242|NCT00477555|concomitant procedures|concomitant procedures
573243|NCT00477555|porcine bioprosthesis|porcine bioprosthesis
573244|NCT00477555|stented valve|stented valve
573245|NCT00477568|Wheelchair users|wheelchair users
573246|NCT00477568|Back pain|back pain
573247|NCT00477568|Prevalence|prevalence
573248|NCT00477568|Risk factors|risk factors
573249|NCT00477581|diabetes|diabetes
573250|NCT00477581|exenatide|exenatide
573251|NCT00477581|sitagliptin|sitagliptin
573253|NCT00477581|Lilly|lilly
573254|NCT00477594|Familial Hypercholesterolemia|familial hypercholesterolemia
573255|NCT00477594|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
573256|NCT00477594|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
573257|NCT00477594|ISIS 301012|isis 301012
573258|NCT00477594|mipomersen|mipomersen
573259|NCT00477594|Open Label Extension|open label extension
573260|NCT00477620|Myopia|myopia
573261|NCT00477620|Prevention|prevention
573262|NCT00477633|Contraception|contraception
573263|NCT00477646|colon cancer|colon cancer
573264|NCT00477646|rectal cancer|rectal cancer
573265|NCT00477646|breast cancer|breast cancer
573266|NCT00477646|cervical cancer|cervical cancer
573267|NCT00477659|fMRI study; open-label donepezil|fmri study; open-label donepezil
573268|NCT00477672|Parkinson's disease, psychotic disorders|parkinson's disease, psychotic disorders
573269|NCT00477685|Glaucoma|glaucoma
573270|NCT00477685|Collagen matrix|collagen matrix
573271|NCT00477685|OculusGen|oculusgen
573272|NCT00477685|Phacotrabeculectomy|phacotrabeculectomy
573273|NCT00477685|anti scarring|anti scarring
573274|NCT00477685|tissue engineering|tissue engineering
573275|NCT00477685|ologen|ologen
573276|NCT00477685|Aeon Astron|aeon astron
573277|NCT00477711|Cetuximab|cetuximab
573278|NCT00477711|cisplatin|cisplatin
573279|NCT00477711|capecitabine|capecitabine
573280|NCT00477711|first line treatment|first line treatment
573281|NCT00477724|latent|latent
573282|NCT00477737|cardioprotection|cardioprotection
573283|NCT00477737|sevoflurane|sevoflurane
573284|NCT00477737|esophageal Doppler|esophageal doppler
573285|NCT00477737|thermodilution|thermodilution
573286|NCT00477737|coronary artery bypass|coronary artery bypass
573287|NCT00477750|stage I multiple myeloma|stage i multiple myeloma
573288|NCT00477750|stage II multiple myeloma|stage ii multiple myeloma
573289|NCT00477750|stage III multiple myeloma|stage iii multiple myeloma
573290|NCT00477776|Beginning of breastfeeding|beginning of breastfeeding
573291|NCT00477789|chronic heart failure|chronic heart failure
573292|NCT00477789|diastolic dysfunction|diastolic dysfunction
573293|NCT00477789|uric acid|uric acid
573294|NCT00477802|Parkinson's disease|parkinson's disease
573295|NCT00477802|levodopa-induced cervical dyskinesias|levodopa-induced cervical dyskinesias
573296|NCT00477815|stage I multiple myeloma|stage i multiple myeloma
573297|NCT00477815|refractory multiple myeloma|refractory multiple myeloma
573298|NCT00477815|stage II multiple myeloma|stage ii multiple myeloma
573299|NCT00477815|stage III multiple myeloma|stage iii multiple myeloma
573300|NCT00477828|sleep apnea|sleep apnea
573301|NCT00477828|dementia|dementia
573302|NCT00477828|excessive sleepiness|excessive sleepiness
573303|NCT00477828|cognition|cognition
573304|NCT00477841|esophageal Cancer|esophageal cancer
573305|NCT00477841|Dysphagia|dysphagia
573306|NCT00477841|Stent|stent
573307|NCT00477841|interstitial brachytherapy|interstitial brachytherapy
573308|NCT00477867|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
573309|NCT00477880|gastric cancer|gastric cancer
573310|NCT00477880|giant hypertrophic gastritis|giant hypertrophic gastritis
573311|NCT00477906|melanoma|melanoma
573312|NCT00477906|vaccine|vaccine
573313|NCT00477906|metastatic|metastatic
573314|NCT00477906|autologous|autologous
573315|NCT00477919|stage IV melanoma|stage iv melanoma
573316|NCT00477919|stage IV renal cell cancer|stage iv renal cell cancer
573317|NCT00477919|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
573318|NCT00477919|advanced malignant mesothelioma|advanced malignant mesothelioma
573319|NCT00477919|stage IV prostate cancer|stage iv prostate cancer
573320|NCT00477919|adult giant cell glioblastoma|adult giant cell glioblastoma
573321|NCT00477919|adult gliosarcoma|adult gliosarcoma
573322|NCT00477919|extensive stage small cell lung cancer|extensive stage small cell lung cancer
573323|NCT00477919|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
573324|NCT00477919|stage IV colon cancer|stage iv colon cancer
573325|NCT00477919|stage IV gastric cancer|stage iv gastric cancer
573326|NCT00477919|stage IV esophageal cancer|stage iv esophageal cancer
573327|NCT00477919|stage IV bladder cancer|stage iv bladder cancer
573328|NCT00477919|male breast cancer|male breast cancer
573329|NCT00477919|stage IV breast cancer|stage iv breast cancer
573330|NCT00477919|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
573331|NCT00477919|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
573332|NCT00477919|ovarian sarcoma|ovarian sarcoma
573524|NCT00478595|diabetes|diabetes
573333|NCT00477919|ovarian stromal cancer|ovarian stromal cancer
573335|NCT00477919|anorexia|anorexia
573336|NCT00477919|cachexia|cachexia
573337|NCT00477919|pain|pain
573338|NCT00477919|weight changes|weight changes
573339|NCT00477919|depression|depression
573340|NCT00477919|poor performance status|poor performance status
573341|NCT00477919|recurrent adult brain tumor|recurrent adult brain tumor
573342|NCT00477919|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
573343|NCT00477919|advanced adult primary liver cancer|advanced adult primary liver cancer
573344|NCT00477919|recurrent adult primary liver cancer|recurrent adult primary liver cancer
573345|NCT00477919|recurrent small cell lung cancer|recurrent small cell lung cancer
573346|NCT00477919|recurrent bladder cancer|recurrent bladder cancer
573347|NCT00477919|recurrent breast cancer|recurrent breast cancer
573348|NCT00477919|recurrent colon cancer|recurrent colon cancer
573349|NCT00477919|recurrent esophageal cancer|recurrent esophageal cancer
573350|NCT00477919|recurrent gastric cancer|recurrent gastric cancer
573351|NCT00477919|recurrent melanoma|recurrent melanoma
573352|NCT00477919|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
573353|NCT00477919|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
573354|NCT00477919|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
573355|NCT00477919|stage IV pancreatic cancer|stage iv pancreatic cancer
573356|NCT00477919|recurrent prostate cancer|recurrent prostate cancer
573357|NCT00477919|recurrent renal cell cancer|recurrent renal cell cancer
573358|NCT00477919|recurrent pancreatic cancer|recurrent pancreatic cancer
573359|NCT00477919|stage IV rectal cancer|stage iv rectal cancer
573360|NCT00477919|recurrent rectal cancer|recurrent rectal cancer
573361|NCT00477919|recurrent malignant mesothelioma|recurrent malignant mesothelioma
573362|NCT00477919|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
573363|NCT00477919|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
573364|NCT00477919|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
573365|NCT00477919|stage IV uterine sarcoma|stage iv uterine sarcoma
573366|NCT00477919|recurrent uterine sarcoma|recurrent uterine sarcoma
573367|NCT00477919|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
573368|NCT00477919|unresectable gallbladder cancer|unresectable gallbladder cancer
573369|NCT00477919|recurrent gallbladder cancer|recurrent gallbladder cancer
573370|NCT00477919|adult glioblastoma|adult glioblastoma
573371|NCT00477932|Pentalogy of Cantrell|pentalogy of cantrell
573372|NCT00477932|mutations|mutations
573374|NCT00477932|RNA|rna
573375|NCT00477945|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
573376|NCT00477945|High Risk or Refractory Non Hodgkin's Lymphoma|high risk or refractory non hodgkin's lymphoma
573377|NCT00477945|APBSCT|apbsct
573378|NCT00477945|clofarabine|clofarabine
573379|NCT00477958|cognitive/functional effects|cognitive/functional effects
573380|NCT00477958|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
573381|NCT00477958|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
573382|NCT00477971|primary systemic amyloidosis|primary systemic amyloidosis
573383|NCT00477984|Alcohol|alcohol
573384|NCT00477984|Driving|driving
573385|NCT00477984|Multitasking|multitasking
573386|NCT00477984|ERP|erp
573387|NCT00477984|social drinkers|social drinkers
573388|NCT00477997|Growth Hormone|growth hormone
573389|NCT00477997|Insulin Signaling|insulin signaling
573390|NCT00477997|GH signaling|gh signaling
573391|NCT00478010|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
573392|NCT00478010|stage III colon cancer|stage iii colon cancer
573393|NCT00478010|stage IV colon cancer|stage iv colon cancer
573394|NCT00478010|stage III rectal cancer|stage iii rectal cancer
573395|NCT00478010|stage IV rectal cancer|stage iv rectal cancer
573396|NCT00478010|stage II pancreatic cancer|stage ii pancreatic cancer
573397|NCT00478010|stage III pancreatic cancer|stage iii pancreatic cancer
573398|NCT00478010|stage IV pancreatic cancer|stage iv pancreatic cancer
573399|NCT00478023|Opioid|opioid
573400|NCT00478023|Central acting analgesic|central acting analgesic
573401|NCT00478023|Pain postoperative|pain postoperative
573402|NCT00478023|Abdomen acute|abdomen acute
573403|NCT00478023|CG5503 IR|cg5503 ir
573404|NCT00478023|Morphine|morphine
573405|NCT00478023|Placebo|placebo
573406|NCT00478036|glaucoma|glaucoma
573407|NCT00478036|selective laser trabeculoplasty|selective laser trabeculoplasty
573408|NCT00478036|anterior chamber flare|anterior chamber flare
573409|NCT00478049|Non-Small Cell Lung Cancer|non-small cell lung cancer
573410|NCT00478062|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
573411|NCT00478062|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
573412|NCT00478062|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
573413|NCT00478062|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
573414|NCT00478075|stage I multiple myeloma|stage i multiple myeloma
573415|NCT00478075|stage II multiple myeloma|stage ii multiple myeloma
573416|NCT00478075|stage III multiple myeloma|stage iii multiple myeloma
573417|NCT00478075|refractory multiple myeloma|refractory multiple myeloma
573418|NCT00478088|Single Level|single level
573419|NCT00478088|Cervical Disc Disease|cervical disc disease
573421|NCT00478114|Renal Cell Carcinoma|renal cell carcinoma
573422|NCT00478114|Sorafenib|sorafenib
573423|NCT00478179|herpes zoster|herpes zoster
573424|NCT00478179|shingles|shingles
573425|NCT00478179|PHN|phn
573426|NCT00478179|post herpetic neuralgia|post herpetic neuralgia
573427|NCT00478179|neuropathic pain|neuropathic pain
573428|NCT00478192|hyponatremia|hyponatremia
573429|NCT00478192|hypervolemic|hypervolemic
573430|NCT00478192|euvolemic|euvolemic
573431|NCT00478192|edematous|edematous
573432|NCT00478192|conivaptan|conivaptan
573433|NCT00478205|Moderate to Severe Alzheimer's Disease|moderate to severe alzheimer's disease
573434|NCT00478218|stage I multiple myeloma|stage i multiple myeloma
573435|NCT00478218|stage II multiple myeloma|stage ii multiple myeloma
573436|NCT00478218|stage III multiple myeloma|stage iii multiple myeloma
573437|NCT00478231|Multicenter|multicenter
573438|NCT00478231|Open Label|open label
573439|NCT00478231|Non-Comparative Safety Study Of Maraviroc|non-comparative safety study of maraviroc
573440|NCT00478231|Treatment Experienced|treatment experienced
573441|NCT00478244|epidermolysis bullosa|epidermolysis bullosa
573442|NCT00478244|dystrophic epidermolysis bullosa|dystrophic epidermolysis bullosa
573443|NCT00478257|fatigue|fatigue
573444|NCT00478257|sleep|sleep
573445|NCT00478257|quality of life|quality of life
573446|NCT00478257|light|light
573447|NCT00478257|cancer|cancer
573448|NCT00478283|breast cancer|breast cancer
573449|NCT00478296|Pulmonary hypertension|pulmonary hypertension
573450|NCT00478296|Sildenafil|sildenafil
573451|NCT00478296|Bosentan|bosentan
573452|NCT00478296|Trisomy 21|trisomy 21
573453|NCT00478296|Atrial septal defect|atrial septal defect
573454|NCT00478309|colon cancer|colon cancer
573455|NCT00478309|rectal cancer|rectal cancer
573456|NCT00478309|healthy, no evidence of disease|healthy, no evidence of disease
573457|NCT00478322|Diabetes;|diabetes;
573458|NCT00478322|Type II diabetes;|type ii diabetes;
573459|NCT00478322|Non-insulin dependent diabetes;|non-insulin dependent diabetes;
573460|NCT00478322|Obesity|obesity
573461|NCT00478335|congenital nephrogenic diabetes insipidus|congenital nephrogenic diabetes insipidus
573462|NCT00478335|polyuria|polyuria
573463|NCT00478335|urine osmolality|urine osmolality
573464|NCT00478335|aquaporin-2|aquaporin-2
573465|NCT00478335|vasopressin V2 receptor|vasopressin v2 receptor
573466|NCT00478348|Postoperative Complications|postoperative complications
573467|NCT00478348|Drainage|drainage
573468|NCT00478348|Infection|infection
573469|NCT00478348|Seroma|seroma
573470|NCT00478348|Hematoma|hematoma
573471|NCT00478348|Recurrence|recurrence
573472|NCT00478348|Abdominal Wall|abdominal wall
573473|NCT00478348|Hernia|hernia
573474|NCT00478348|Surgical Mesh|surgical mesh
573475|NCT00478387|Advanced Ovarian and Primary Peritoneal Cancer in Remission|advanced ovarian and primary peritoneal cancer in remission
573476|NCT00478400|Recovery|recovery
573477|NCT00478400|Magnetic resonance imaging|magnetic resonance imaging
573478|NCT00478400|Awareness|awareness
573479|NCT00478400|Neurologic deficits|neurologic deficits
573480|NCT00478439|aging|aging
573481|NCT00478439|age-related macular degeneration|age-related macular degeneration
573482|NCT00478439|macular pigment|macular pigment
573483|NCT00478439|dark adaptation|dark adaptation
573484|NCT00478465|chronic fatigue syndrome|chronic fatigue syndrome
573485|NCT00478465|fatigue|fatigue
573486|NCT00478465|valganciclovir|valganciclovir
573487|NCT00478465|valcyte|valcyte
573488|NCT00478465|Epstein-Barr virus|epstein-barr virus
573489|NCT00478465|EBV|ebv
573490|NCT00478465|Human herpes virus 6|human herpes virus 6
573491|NCT00478465|HHV 6|hhv 6
573492|NCT00478465|herpes viruses|herpes viruses
573493|NCT00478465|herpes|herpes
573494|NCT00478478|Stroke|stroke
573495|NCT00478478|Ischemic|ischemic
573496|NCT00478478|Thrombus|thrombus
573497|NCT00478478|Embolectomy|embolectomy
573498|NCT00478478|Thrombectomy|thrombectomy
573499|NCT00478478|Merci|merci
573500|NCT00478478|Concentric|concentric
573501|NCT00478478|Embolus|embolus
573502|NCT00478478|Embolism|embolism
573503|NCT00478478|Mechanical|mechanical
573504|NCT00478504|anovulation|anovulation
573505|NCT00478504|ovulation induction,|ovulation induction,
573506|NCT00478504|polycystic ovarian syndrome|polycystic ovarian syndrome
573507|NCT00478504|clomifene citrate|clomifene citrate
573508|NCT00478504|letrozole|letrozole
573509|NCT00478517|Spinal trauma|spinal trauma
573510|NCT00478517|erythropoietin|erythropoietin
573511|NCT00478517|dose escalation study|dose escalation study
573512|NCT00478543|Loop diuretics|loop diuretics
573513|NCT00478543|Chronic Kidney Disease|chronic kidney disease
573514|NCT00478543|Hypertension|hypertension
573515|NCT00478543|Blood pressure control|blood pressure control
573516|NCT00478543|Left ventricular mass|left ventricular mass
573517|NCT00478556|CT scan|ct scan
573518|NCT00478556|oral contrast|oral contrast
573519|NCT00478582|Anemia|anemia
573520|NCT00478582|Visual scale|visual scale
573521|NCT00478582|nephrological patients|nephrological patients
573522|NCT00478582|Anemia in nephrological patients|anemia in nephrological patients
573525|NCT00478595|cannabinoid-1 receptor|cannabinoid-1 receptor
573527|NCT00478634|Colorectal Cancer|colorectal cancer
573528|NCT00478634|Colorectal Carcinoma|colorectal carcinoma
573529|NCT00478634|Colorectal Tumors|colorectal tumors
573530|NCT00478634|Neoplasms, Colorectal|neoplasms, colorectal
573631|NCT00478959|Hodgkin's|hodgkin's
573531|NCT00478647|Enzyme Replacement Therapy|enzyme replacement therapy
573532|NCT00478647|Gaucher disease|gaucher disease
573533|NCT00478647|glucocerebrosidase|glucocerebrosidase
573534|NCT00478647|beta-glucocerebrosidase|beta-glucocerebrosidase
573535|NCT00478647|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
573536|NCT00478647|glucosylceramidase|glucosylceramidase
573537|NCT00478647|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
573538|NCT00478647|gene activation|gene activation
573539|NCT00478647|human|human
573540|NCT00478673|NexStent|nexstent
573541|NCT00478673|FilterWire EZ|filterwire ez
573542|NCT00478673|Boston Scientific|boston scientific
573543|NCT00478673|Carotid Artery|carotid artery
573544|NCT00478673|Carotid Endarterectomy|carotid endarterectomy
573545|NCT00478673|Carotid Revascularization|carotid revascularization
573546|NCT00478686|Breast Cancer|breast cancer
573547|NCT00478686|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
573549|NCT00478686|DPYD Variants|dpyd variants
573550|NCT00478686|Toxicity|toxicity
573551|NCT00478686|Capecitabine|capecitabine
573552|NCT00478686|Xeloda|xeloda
572965|NCT00476177|DC|dc
573553|NCT00478699|SCAT|scat
573554|NCT00478699|BRCA1|brca1
573555|NCT00478699|BRCA1 mRNA Levels|brca1 mrna levels
573556|NCT00478699|ADJUVANT|adjuvant
573557|NCT00478699|LUNG|lung
573558|NCT00478699|GECP-SCAT|gecp-scat
573559|NCT00478712|Hirschsprung|hirschsprung
573560|NCT00478725|Metastatic Cancer|metastatic cancer
573561|NCT00478725|Advanced Cancer|advanced cancer
573562|NCT00478738|b-agonist,|b-agonist,
573563|NCT00478738|COPD.|copd.
573564|NCT00478738|pharmacodynamic,|pharmacodynamic,
573565|NCT00478738|pharmacokinetic,|pharmacokinetic,
573566|NCT00478738|anti muscarinic,|anti muscarinic,
573567|NCT00478751|Visible light, Long UVA,Pigmentation|visible light, long uva,pigmentation
573568|NCT00478751|Normal healthy volunteers with dark skin type.|normal healthy volunteers with dark skin type.
573569|NCT00478764|intraocular|intraocular
573570|NCT00478764|triamcinolone|triamcinolone
573571|NCT00478764|gatifloxicin|gatifloxicin
573572|NCT00478764|inflammation|inflammation
573573|NCT00478764|visual acuity|visual acuity
573574|NCT00478777|CC-5013|cc-5013
573575|NCT00478777|Revlimid|revlimid
573576|NCT00478777|Lenalidomide|lenalidomide
573577|NCT00478777|Celgene|celgene
573578|NCT00478777|Multiple Myeloma|multiple myeloma
573579|NCT00478790|Glaucoma|glaucoma
573580|NCT00478790|Pterygium|pterygium
573581|NCT00478790|collagen matrix|collagen matrix
573582|NCT00478790|OculusGen|oculusgen
573583|NCT00478790|trabeculectomy|trabeculectomy
573584|NCT00478790|Anti scarring|anti scarring
573585|NCT00478790|pterygium recurrence|pterygium recurrence
573586|NCT00478790|tissue engineering|tissue engineering
573587|NCT00478790|ologen|ologen
573588|NCT00478790|Aeon Astron|aeon astron
573589|NCT00478803|Standardized surgical procedure|standardized surgical procedure
573590|NCT00478803|Aortic root aneurysm|aortic root aneurysm
573591|NCT00478803|Dystrophic aortic insufficiency|dystrophic aortic insufficiency
573592|NCT00478803|Conservative aortic valve surgery|conservative aortic valve surgery
573593|NCT00478803|Aortic annuloplasty|aortic annuloplasty
573594|NCT00478803|Mechanical aortic valve replacement|mechanical aortic valve replacement
573595|NCT00478803|Sinus of Valsalva|sinus of valsalva
573596|NCT00478803|Cardiac Surgical Procedures|cardiac surgical procedures
573597|NCT00478816|Bird flu|bird flu
573598|NCT00478816|influenza vaccine|influenza vaccine
573599|NCT00478816|prepandemic vaccine|prepandemic vaccine
573600|NCT00478842|Gilles de la Tourette syndrome|gilles de la tourette syndrome
573601|NCT00478842|Deep brain stimulation|deep brain stimulation
573602|NCT00478842|Globus PALLIDUS|globus pallidus
573603|NCT00478868|MODIC changes|modic changes
573604|NCT00478868|chronic low back pain|chronic low back pain
573605|NCT00478868|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
573606|NCT00478868|vertebrae|vertebrae
573607|NCT00478868|intervertebral disc|intervertebral disc
573608|NCT00478894|Anterior cruciate ligament / injuries|anterior cruciate ligament / injuries
573609|NCT00478894|Anterior cruciate ligament / surgery|anterior cruciate ligament / surgery
573610|NCT00478894|knee injuries / surgery|knee injuries / surgery
573611|NCT00478894|outcomes research|outcomes research
573612|NCT00478894|prospective studies|prospective studies
573613|NCT00478894|osteoarthritis|osteoarthritis
573614|NCT00478907|oculocardiac reflex; strabismus surgery;|oculocardiac reflex; strabismus surgery;
573615|NCT00478933|Arrhythmia|arrhythmia
573616|NCT00478933|Ventricular|ventricular
573617|NCT00478933|Atrial|atrial
573618|NCT00478933|Tachycardia|tachycardia
573619|NCT00478933|Fibrillation|fibrillation
573620|NCT00478933|Flutter|flutter
573621|NCT00478933|GNB3|gnb3
573622|NCT00478933|GNAS|gnas
573623|NCT00478933|GNAQ|gnaq
573624|NCT00478946|colorectal cancer|colorectal cancer
573625|NCT00478946|picoplatin|picoplatin
573626|NCT00478946|FOLFOX|folfox
573627|NCT00478946|FOLPI|folpi
573628|NCT00478946|chemotherapy|chemotherapy
573629|NCT00478959|Lenalidomide|lenalidomide
573630|NCT00478959|Revlimid|revlimid
573632|NCT00478959|Hodgkin|hodgkin
573633|NCT00478959|Hodgkin's Lymphoma|hodgkin's lymphoma
573634|NCT00478959|Hodgkin's Disease|hodgkin's disease
573635|NCT00478959|Lymphoma|lymphoma
573636|NCT00478972|obese|obese
573637|NCT00478972|diabetes|diabetes
573638|NCT00478972|cannabinoid-1 receptor|cannabinoid-1 receptor
573639|NCT00478985|Leukemia|leukemia
573640|NCT00478985|Adult Chronic|adult chronic
573641|NCT00478985|Myeloid|myeloid
573642|NCT00478998|expulsion therapy|expulsion therapy
573643|NCT00478998|tamsulosin|tamsulosin
573644|NCT00478998|ureterolithiasis|ureterolithiasis
573645|NCT00478998|stents|stents
573646|NCT00479011|fluid management|fluid management
573647|NCT00479011|arterial pulse pressure variation|arterial pulse pressure variation
573648|NCT00479011|high-risk surgery|high-risk surgery
573649|NCT00479037|postmenopausal women with primary osteoporosis|postmenopausal women with primary osteoporosis
573650|NCT00479050|Hepatocellular carcinoma,treatment|hepatocellular carcinoma,treatment
741245|NCT01129713|GERD|gerd
573651|NCT00479063|MODIC changes|modic changes
573652|NCT00479063|chronic low back pain|chronic low back pain
573653|NCT00479063|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
573654|NCT00479063|vertebrae|vertebrae
573655|NCT00479063|intervertebral disc|intervertebral disc
573656|NCT00479076|antineoplastic agents|antineoplastic agents
573657|NCT00479076|VEGF Trap|vegf trap
573658|NCT00479089|Transitional Cell Carcinoma|transitional cell carcinoma
573659|NCT00479089|Urothelium|urothelium
573660|NCT00479089|Urothelial Cancer|urothelial cancer
573661|NCT00479089|Bladder Cancer|bladder cancer
573662|NCT00479089|Docetaxel|docetaxel
573663|NCT00479089|Taxotere|taxotere
573664|NCT00479089|ZD1839|zd1839
573665|NCT00479089|Gefitinib|gefitinib
573666|NCT00479089|Iressa|iressa
573667|NCT00479089|Consolidation Therapy|consolidation therapy
573668|NCT00479102|Iron supplementation|iron supplementation
573669|NCT00479102|Babies|babies
573670|NCT00479102|Prevention|prevention
573671|NCT00479128|Solid Tumor|solid tumor
573672|NCT00479128|Bladder Cancer|bladder cancer
573673|NCT00479128|Ureteral Cancer|ureteral cancer
573674|NCT00479128|Urothelial Cancer|urothelial cancer
573675|NCT00479128|Urethral Cancer|urethral cancer
573676|NCT00479128|Renal Pelvis Tumor|renal pelvis tumor
573677|NCT00479128|Bortezomib|bortezomib
573678|NCT00479128|Gemcitabine|gemcitabine
573679|NCT00479128|Doxorubicin|doxorubicin
573680|NCT00479128|Gemzar|gemzar
573681|NCT00479128|Adriamycin|adriamycin
573682|NCT00479128|Velcade|velcade
573683|NCT00479128|LDP-341|ldp-341
573684|NCT00479128|MLN341|mln341
573685|NCT00479128|PS-341|ps-341
573686|NCT00479128|Gemcitabine Hydrochloride|gemcitabine hydrochloride
573687|NCT00479128|AD|ad
573688|NCT00479128|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
573689|NCT00479141|Treatment Naive|treatment naive
573690|NCT00479141|Treatment Experienced|treatment experienced
573691|NCT00479141|Complementary Therapies|complementary therapies
573692|NCT00479154|Restless Leg Syndrome|restless leg syndrome
573693|NCT00479154|Botulinum Toxin|botulinum toxin
573694|NCT00479154|RLS|rls
573695|NCT00479167|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
573696|NCT00479167|Follicular Non-Hodgkin's Lymphoma|follicular non-hodgkin's lymphoma
573697|NCT00479167|Lymphoma|lymphoma
573698|NCT00479180|Hemodialysis access|hemodialysis access
573699|NCT00479180|Arteriovenous graft|arteriovenous graft
573700|NCT00479180|Arteriovenous fistula|arteriovenous fistula
573701|NCT00479180|End stage renal disease|end stage renal disease
573702|NCT00479193|Burns|burns
573703|NCT00479193|Dressing change|dressing change
573704|NCT00479206|artesuante|artesuante
573705|NCT00479206|falciparum malaria|falciparum malaria
573706|NCT00479206|Cambodia|cambodia
573707|NCT00479206|Artemisinin resistance|artemisinin resistance
573708|NCT00479232|Leukemia|leukemia
573709|NCT00479232|Myelocytic|myelocytic
573710|NCT00479232|Acute Myelodysplastic Syndromes|acute myelodysplastic syndromes
573711|NCT00479245|nonspecific low back pain|nonspecific low back pain
573712|NCT00479245|disability|disability
573713|NCT00479245|fear avoidance beliefs|fear avoidance beliefs
573714|NCT00479245|quality of life|quality of life
573715|NCT00479271|RCT|rct
573716|NCT00479271|Dementia|dementia
573717|NCT00479271|community trial|community trial
573718|NCT00479271|Homebased care|homebased care
573719|NCT00479271|caregiver burden|caregiver burden
573720|NCT00479271|Behavioural problems|behavioural problems
573721|NCT00479271|Dementia in subjects|dementia in subjects
573722|NCT00479271|behavioral problems in subjects|behavioral problems in subjects
573723|NCT00479271|Mental health of carers|mental health of carers
573724|NCT00479284|Non-invasive ventilation|non-invasive ventilation
573726|NCT00479284|Average volume assured pressure support|average volume assured pressure support
573727|NCT00479323|pneumococcal vaccine, Pneumovax, reference sera, serum 89SF|pneumococcal vaccine, pneumovax, reference sera, serum 89sf
573728|NCT00479336|OPC-41061|opc-41061
573729|NCT00479336|Tolvaptan|tolvaptan
573730|NCT00479336|ascites|ascites
573731|NCT00479336|Cirrhosis|cirrhosis
573732|NCT00465569|Food Allergy|food allergy
573733|NCT00465569|Oral Immunotherapy|oral immunotherapy
573734|NCT00465569|Immunoglobulin E|immunoglobulin e
573735|NCT00465582|carriage|carriage
573736|NCT00465582|Neisseria meningitidis|neisseria meningitidis
573737|NCT00465582|risk factors|risk factors
573738|NCT00465608|adults|adults
573739|NCT00465608|PTSD|ptsd
573740|NCT00465608|trauma|trauma
573741|NCT00465608|AZF|azf
573742|NCT00465608|propranolol|propranolol
573743|NCT00465608|reconsolidation|reconsolidation
573744|NCT00465608|Post traumatic stress disorder|post traumatic stress disorder
573745|NCT00465608|chronic form|chronic form
573746|NCT00465608|PTSD (Post-Traumatic Stress Disorder)|ptsd (post-traumatic stress disorder)
573747|NCT00465621|Open-angle glaucoma|open-angle glaucoma
573748|NCT00465621|ocular hypertension|ocular hypertension
573749|NCT00465634|Screening|screening
573750|NCT00465634|uterine artery Doppler|uterine artery doppler
573751|NCT00465634|HELLP syndrome|hellp syndrome
573752|NCT00465634|abruption|abruption
573753|NCT00465647|Postoperative pain|postoperative pain
573754|NCT00465647|Hydromorphone oral solution|hydromorphone oral solution
573755|NCT00465647|opioid|opioid
573756|NCT00465647|pharmacokinetics|pharmacokinetics
573757|NCT00465647|pharmacodynamics|pharmacodynamics
573758|NCT00465660|Osteoarthritis|osteoarthritis
573759|NCT00465660|Cartilage|cartilage
573760|NCT00465660|Exercise|exercise
573761|NCT00465660|Progressive Resistance Training|progressive resistance training
573762|NCT00465673|breast cancer|breast cancer
573763|NCT00465673|brain metastatsis|brain metastatsis
573764|NCT00465673|Lipo-Dox|lipo-dox
573765|NCT00465686|handwriting|handwriting
573766|NCT00465686|child|child
573767|NCT00465686|primary school|primary school
573768|NCT00465686|posture|posture
573769|NCT00465686|assistive device|assistive device
573770|NCT00465699|Eczema|eczema
573771|NCT00465699|Pediatric|pediatric
573772|NCT00465699|Vitamin B12|vitamin b12
573773|NCT00465712|transabdominal amnioinfusion|transabdominal amnioinfusion
573774|NCT00465712|external cephalic version|external cephalic version
573775|NCT00465712|breech presentation|breech presentation
573776|NCT00465725|Picoplatin|picoplatin
573777|NCT00465725|tumor|tumor
573778|NCT00465725|cancer|cancer
573779|NCT00465725|sarcoma|sarcoma
573780|NCT00465725|neoplasm|neoplasm
573781|NCT00465725|advanced|advanced
573782|NCT00465725|platinum|platinum
573783|NCT00465725|chemotherapy|chemotherapy
573784|NCT00465725|Solid Tumor|solid tumor
573785|NCT00465764|healthy infants|healthy infants
573786|NCT00465777|malaria|malaria
573787|NCT00465777|mortality|mortality
573788|NCT00465777|hospital|hospital
573789|NCT00465777|incentive|incentive
573790|NCT00465777|personnel|personnel
573791|NCT00465777|paediatric|paediatric
573792|NCT00465790|biomarkers|biomarkers
573793|NCT00465790|neuroimaging|neuroimaging
573794|NCT00465790|genetics|genetics
573795|NCT00465790|PET|pet
573796|NCT00465790|Genetic and Idiopathic Parkinson|genetic and idiopathic parkinson
573797|NCT00465790|Multiple Systemic Atrophy|multiple systemic atrophy
573798|NCT00465790|Huntington|huntington
573799|NCT00465790|Dopa Responsive Dystonia|dopa responsive dystonia
573800|NCT00465803|Open-angle glaucoma or ocular hypertension|open-angle glaucoma or ocular hypertension
573801|NCT00465816|non-inferiority|non-inferiority
573802|NCT00465816|adolescents|adolescents
573803|NCT00465816|meningococcal vaccine|meningococcal vaccine
573804|NCT00465829|Obesity|obesity
573805|NCT00465842|Hepatitis|hepatitis
573806|NCT00465842|Liver Cirrhosis|liver cirrhosis
573807|NCT00465842|HCC|hcc
573808|NCT00465855|Carbon monoxide poisoning|carbon monoxide poisoning
573809|NCT00465855|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
573810|NCT00465855|Randomized controlled trial|randomized controlled trial
573811|NCT00465855|Clinical investigation|clinical investigation
573812|NCT00465868|Acute Myocardial Infarction|acute myocardial infarction
573813|NCT00465868|Coronary Revascularization|coronary revascularization
573814|NCT00465868|Microvascular Obstruction|microvascular obstruction
573815|NCT00465868|Cardiac MR|cardiac mr
573816|NCT00465868|Collagen Turnover|collagen turnover
573817|NCT00465868|Heart failure, post-mi|heart failure, post-mi
573818|NCT00465881|Diabetes|diabetes
573819|NCT00465881|CGM|cgm
573820|NCT00465894|overactive bladder|overactive bladder
573821|NCT00465894|urge leakage|urge leakage
573822|NCT00465894|nightime urination|nightime urination
573823|NCT00465894|incontinence|incontinence
573824|NCT00465894|urinary frequency|urinary frequency
573825|NCT00465907|lung cancer with malignant pleural effusion|lung cancer with malignant pleural effusion
573826|NCT00465920|schizophrenia|schizophrenia
573827|NCT00465920|cognitive behavioural therapy|cognitive behavioural therapy
573828|NCT00465920|early onset psychosis|early onset psychosis
573829|NCT00465920|Psychotic disorders (schizophrenia, schizoaffective disorder, delusional disorder, schizophreniform disorder according to DSM IV) in adolescents|psychotic disorders (schizophrenia, schizoaffective disorder, delusional disorder, schizophreniform disorder according to dsm iv) in adolescents
573830|NCT00465933|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
573831|NCT00465933|AIDA|aida
573832|NCT00465946|Salt supplementation|salt supplementation
573833|NCT00465946|Vasovagal syncope|vasovagal syncope
573834|NCT00465946|Orthostatic tolerance|orthostatic tolerance
573835|NCT00465946|Healthy volunteers|healthy volunteers
573836|NCT00465959|COPD|copd
573838|NCT00465972|Insomnia|insomnia
573839|NCT00465972|Cytokines|cytokines
573840|NCT00465972|Adherence|adherence
573841|NCT00465985|Muckle-Wells Syndrome|muckle-wells syndrome
573842|NCT00465985|children|children
573843|NCT00465985|systemic autoinflammatory disease|systemic autoinflammatory disease
573844|NCT00465985|CIAS-1 gene|cias-1 gene
573845|NCT00465985|NALP-3|nalp-3
573846|NCT00465985|ACZ885|acz885
573847|NCT00465985|human monoclonal anti-human interleukin-1beta (IL-1beta)|human monoclonal anti-human interleukin-1beta (il-1beta)
573848|NCT00465985|antibody|antibody
573849|NCT00465985|autosomal dominant|autosomal dominant
741496|NCT01131585|DME|dme
573850|NCT00465985|familial autoinflammatory syndrome|familial autoinflammatory syndrome
573851|NCT00465998|Ultrasound|ultrasound
573852|NCT00465998|Induced labor|induced labor
573853|NCT00465998|Cervical length|cervical length
573854|NCT00465998|Engagement of fetal head|engagement of fetal head
573855|NCT00465998|Occiput posterior|occiput posterior
573856|NCT00465998|Outcome of labor|outcome of labor
573857|NCT00466024|Asthma|asthma
573858|NCT00466024|persistent|persistent
573859|NCT00466024|children|children
573860|NCT00466024|particulates|particulates
573861|NCT00466024|ETS|ets
573862|NCT00466037|Rheumatoid|rheumatoid
573863|NCT00466037|rituximab|rituximab
573864|NCT00466037|influenza|influenza
573865|NCT00466050|plaque rupture,|plaque rupture,
573866|NCT00466050|acute coronary thrombose,|acute coronary thrombose,
573867|NCT00466050|coronary angiography,|coronary angiography,
573868|NCT00466050|IVUS|ivus
573869|NCT00466063|Iron overload|iron overload
573870|NCT00466063|children|children
573871|NCT00466063|deferasirox|deferasirox
573872|NCT00466063|Transfusion-dependent anemia|transfusion-dependent anemia
573873|NCT00466076|Drusen|drusen
573874|NCT00466076|AMD|amd
573875|NCT00466076|Dry form of Age related Macular Degeneration|dry form of age related macular degeneration
573876|NCT00466089|NSCLC, lung cancer|nsclc, lung cancer
573877|NCT00466089|Patients with localized-unresectable (IA-IIIB) non-small cell lung cancer non susceptible for chemotherapy treatment.|patients with localized-unresectable (ia-iiib) non-small cell lung cancer non susceptible for chemotherapy treatment.
573878|NCT00466102|Breast Cancer|breast cancer
573879|NCT00466102|Bone metastases as only metastatic site|bone metastases as only metastatic site
573880|NCT00466102|Breast cancer, HER2 negative|breast cancer, her2 negative
573881|NCT00466102|Bone metastasis as only metastatic site|bone metastasis as only metastatic site
573882|NCT00466102|Pretreated with endocrine therapy|pretreated with endocrine therapy
573883|NCT00466102|Up to one previous chemotherapy|up to one previous chemotherapy
573884|NCT00466102|Previous treatment with bisphosphonates allowed|previous treatment with bisphosphonates allowed
573885|NCT00466115|MDS|mds
573886|NCT00466115|AML|aml
573887|NCT00466128|fetal membranes, preterm rupture|fetal membranes, preterm rupture
573888|NCT00466128|preterm rupture|preterm rupture
573889|NCT00466128|PPROM|pprom
573890|NCT00466154|Aspirin resistance|aspirin resistance
573891|NCT00466154|Platelet activation|platelet activation
573892|NCT00466154|Hypercholesterolemia|hypercholesterolemia
573893|NCT00466180|Once-a-day|once-a-day
573894|NCT00466180|Adherence|adherence
573895|NCT00466180|Nevirapine|nevirapine
573896|NCT00466180|Patient noncompliance|patient noncompliance
573897|NCT00466180|Administration and dosage|administration and dosage
573898|NCT00466180|Treatment Experienced|treatment experienced
573899|NCT00466193|Insomnia|insomnia
573900|NCT00466206|pectus excavatum|pectus excavatum
573901|NCT00466206|magnetic alteration|magnetic alteration
573902|NCT00466206|chest wall deformity|chest wall deformity
573903|NCT00466219|Presence of HCV RNA in serum|presence of hcv rna in serum
573904|NCT00466219|Absence of graft rejection|absence of graft rejection
573905|NCT00466219|Recurrent hepatitis C after liver transplantation|recurrent hepatitis c after liver transplantation
573906|NCT00466232|Small Cell|small cell
573907|NCT00466232|Lung Cancer|lung cancer
573908|NCT00466232|Treatment|treatment
573909|NCT00466245|MVA Vaccine|mva vaccine
573910|NCT00466258|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
573911|NCT00466258|HIV|hiv
573912|NCT00466258|R-CHOP|r-chop
573913|NCT00466258|Highly active antiretroviral therapy|highly active antiretroviral therapy
573914|NCT00466258|Treatment Experienced|treatment experienced
573915|NCT00466271|Chronic hepatitis C|chronic hepatitis c
573916|NCT00466271|Persistently normal alanine aminotransferase levels|persistently normal alanine aminotransferase levels
573917|NCT00466271|Hepatic fibrosis|hepatic fibrosis
573918|NCT00466271|Non-invasive diagnosis|non-invasive diagnosis
574017|NCT00472056|BiCNU|bicnu
573919|NCT00466271|Splenic arterial pulsatility index|splenic arterial pulsatility index
573920|NCT00466297|Interprofessional|interprofessional
573921|NCT00466297|Collaboration|collaboration
573922|NCT00466297|Teamwork|teamwork
573923|NCT00466297|General internal medicine|general internal medicine
573924|NCT00466297|Cluster randomized|cluster randomized
573925|NCT00466310|Schizophrenia|schizophrenia
573926|NCT00466310|Metabolomics|metabolomics
573927|NCT00466323|Mental Illness|mental illness
573928|NCT00466323|Schizophrenia|schizophrenia
573929|NCT00466323|Education|education
573930|NCT00466323|Family member treatment|family member treatment
573935|NCT00471705|Thermotherapy|thermotherapy
573936|NCT00471705|Colombia|colombia
573937|NCT00471718|adenocarcinoma of the prostate|adenocarcinoma of the prostate
573938|NCT00471718|stage IV prostate cancer|stage iv prostate cancer
573939|NCT00471718|recurrent prostate cancer|recurrent prostate cancer
573940|NCT00471731|Ocular Surface Disease|ocular surface disease
573941|NCT00471731|Imprinting|imprinting
573942|NCT00471731|Eye Abnormalities|eye abnormalities
573943|NCT00471731|Ovarian Insufficiency|ovarian insufficiency
573373|NCT00477932|DNA|dna
573944|NCT00471731|Women's Eye Health and Disease|women's eye health and disease
573945|NCT00471731|Turner Syndrome|turner syndrome
573946|NCT00471731|TS|ts
573947|NCT00471731|Premature Ovarian Failure|premature ovarian failure
573948|NCT00471731|POF|pof
573949|NCT00471731|Healthy Volunteer|healthy volunteer
573950|NCT00471731|HV|hv
573951|NCT00471744|benign epilepsy|benign epilepsy
573952|NCT00471744|pediatrics|pediatrics
573953|NCT00471744|children|children
573954|NCT00471744|rolandic epilepsy|rolandic epilepsy
573955|NCT00471744|levetiracetam|levetiracetam
573956|NCT00471744|sulthiame|sulthiame
573957|NCT00471757|pnuemonia|pnuemonia
573958|NCT00471757|influenca|influenca
573959|NCT00471783|gingivitis|gingivitis
573960|NCT00471783|chlorhexidine|chlorhexidine
573961|NCT00471783|dental floss|dental floss
573962|NCT00471783|RCT|rct
573963|NCT00471783|bleeding on probing|bleeding on probing
573964|NCT00471783|gingival and plaque indices|gingival and plaque indices
573965|NCT00471796|Patients with functional chest pain and functional heartburns|patients with functional chest pain and functional heartburns
573966|NCT00471822|Streptococcus pneumoniae nasopharyngeal carriage|streptococcus pneumoniae nasopharyngeal carriage
573967|NCT00471835|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
573968|NCT00471835|stage I non-small cell lung cancer|stage i non-small cell lung cancer
573969|NCT00471835|adenocarcinoma of the lung|adenocarcinoma of the lung
573970|NCT00471835|adenosquamous cell lung cancer|adenosquamous cell lung cancer
573971|NCT00471835|large cell lung cancer|large cell lung cancer
573972|NCT00471835|squamous cell lung cancer|squamous cell lung cancer
573973|NCT00471848|Thymoglobuline|thymoglobuline
573974|NCT00471848|Rabbit ATG|rabbit atg
573975|NCT00471848|Ciclosporin|ciclosporin
573976|NCT00471848|Aplastic Anemia|aplastic anemia
573977|NCT00471861|Inflammatory Markers|inflammatory markers
573978|NCT00471861|Migraine|migraine
573979|NCT00471887|stage III melanoma|stage iii melanoma
573980|NCT00471887|stage IV melanoma|stage iv melanoma
573981|NCT00471887|recurrent melanoma|recurrent melanoma
573982|NCT00471913|Femur|femur
573983|NCT00471913|Fracture|fracture
573984|NCT00471913|Antegrade|antegrade
573985|NCT00471913|Nailing|nailing
573986|NCT00471913|Shaft|shaft
573987|NCT00471913|Abductor|abductor
573988|NCT00471926|Diabetes Care|diabetes care
573989|NCT00471939|Burn, Meshed skin graft, PDGF|burn, meshed skin graft, pdgf
573990|NCT00471939|deep partial thickness or full thickness burns|deep partial thickness or full thickness burns
573991|NCT00471952|Migraine|migraine
573995|NCT00471991|Oral contraceptive|oral contraceptive
573996|NCT00471991|ovulation inhibitory effect|ovulation inhibitory effect
573997|NCT00472017|untreated childhood brain stem glioma|untreated childhood brain stem glioma
573998|NCT00472030|bullous pemphigoid|bullous pemphigoid
573999|NCT00472030|omalizumab|omalizumab
574000|NCT00472030|xolair|xolair
574001|NCT00472030|IgE|ige
574002|NCT00472030|autoimmunity|autoimmunity
574003|NCT00472030|skin disease|skin disease
574004|NCT00472043|Nodular Basal Cell Carcinoma|nodular basal cell carcinoma
574005|NCT00472043|Basal Cell Carcinoma|basal cell carcinoma
574006|NCT00472043|Photodynamic therapy (PDT)|photodynamic therapy (pdt)
574007|NCT00472043|Metvix|metvix
574008|NCT00472043|Histological verification|histological verification
574009|NCT00472043|PDT with Metvix cream|pdt with metvix cream
574010|NCT00472043|PDT with Placebo cream|pdt with placebo cream
574011|NCT00472056|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
574012|NCT00472056|Lymphoid Malignancies|lymphoid malignancies
574013|NCT00472056|Lymphoma|lymphoma
574014|NCT00472056|BEAM Chemotherapy|beam chemotherapy
574015|NCT00472056|Carmustine|carmustine
574019|NCT00472056|VePesid|vepesid
574020|NCT00472056|Cytarabine|cytarabine
574021|NCT00472056|Cytosar|cytosar
574022|NCT00472056|DepoCyt|depocyt
574023|NCT00472056|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
574025|NCT00472056|Melphalan|melphalan
574026|NCT00472056|Rituximab|rituximab
574027|NCT00472056|Rituxan|rituxan
574028|NCT00472069|Stress Urinary Incontinence|stress urinary incontinence
738434|NCT01116544|AMES device|ames device
574029|NCT00472069|striated urethral sphincter insufficiency|striated urethral sphincter insufficiency
574030|NCT00472069|myofibers|myofibers
574031|NCT00472069|satellite cells|satellite cells
574032|NCT00472069|myotubes|myotubes
574033|NCT00472069|urethral|urethral
574034|NCT00472069|Muscle fibres|muscle fibres
574035|NCT00472082|Immunosuppression|immunosuppression
574036|NCT00472082|Renal Transplantation|renal transplantation
574037|NCT00472095|diabetes|diabetes
574038|NCT00472095|fotonovela|fotonovela
574039|NCT00472095|Latino|latino
574040|NCT00472108|Nodular Basal Cell Carcinoma|nodular basal cell carcinoma
574041|NCT00472108|Basal Cell Carcinoma|basal cell carcinoma
574042|NCT00472108|PDT with Metvix 160 mg/g cream|pdt with metvix 160 mg/g cream
574043|NCT00472108|PDT with placebo cream|pdt with placebo cream
574044|NCT00472108|Histological verification|histological verification
574045|NCT00472134|Hernia|hernia
574046|NCT00472134|Ventral|ventral
574047|NCT00472134|Laparoscopic Hernia Repair|laparoscopic hernia repair
574048|NCT00472160|Preoxygenation|preoxygenation
574049|NCT00472160|Non Invasive Ventilation|non invasive ventilation
574050|NCT00472160|Continuous Positive Airway Pressure,|continuous positive airway pressure,
574051|NCT00472160|Intubation,|intubation,
574052|NCT00472160|Organ failure|organ failure
574053|NCT00472173|Apexification|apexification
574054|NCT00472173|Pulp necrosis|pulp necrosis
574055|NCT00472173|Calcium hydroxide|calcium hydroxide
574057|NCT00472173|pulp necrosis of an anterior immature tooth|pulp necrosis of an anterior immature tooth
574058|NCT00472186|Tonsillectomy|tonsillectomy
574059|NCT00472186|Pain|pain
574060|NCT00472225|Chronic graft-versus-host disease|chronic graft-versus-host disease
574061|NCT00472225|rituximab|rituximab
574062|NCT00472251|dutasteride|dutasteride
574063|NCT00472251|body mass index|body mass index
574064|NCT00472251|testosterone|testosterone
574065|NCT00472264|methodology study, PET Imaging, COPD patients|methodology study, pet imaging, copd patients
574066|NCT00472290|Hematology|hematology
574068|NCT00472290|Myelodysplastic Syndromes|myelodysplastic syndromes
574069|NCT00472290|Thrombocytopenia|thrombocytopenia
574070|NCT00472303|Opioid|opioid
574071|NCT00472303|Central acting analgesic|central acting analgesic
574072|NCT00472303|CG5503 PR|cg5503 pr
574073|NCT00472303|Tumor related pain|tumor related pain
574074|NCT00472303|Cancer related pain|cancer related pain
574075|NCT00472303|Morphine|morphine
574076|NCT00472303|Pain assessment|pain assessment
574077|NCT00472303|Placebo|placebo
574078|NCT00472342|impaired glucose tolerance|impaired glucose tolerance
574079|NCT00472342|impaired fasting glucose|impaired fasting glucose
574080|NCT00472342|diabetes|diabetes
574081|NCT00472342|adipokine|adipokine
574082|NCT00472342|adiponectin|adiponectin
574083|NCT00472342|RBP-4|rbp-4
574084|NCT00472342|adrenomedullin|adrenomedullin
574085|NCT00472355|Parkinson's disease|parkinson's disease
574086|NCT00472355|PD|pd
574087|NCT00472355|apomorphine|apomorphine
574088|NCT00472368|Advanced cancer|advanced cancer
574089|NCT00472368|lymphoma|lymphoma
574090|NCT00472368|chronic hematological malignancies|chronic hematological malignancies
574091|NCT00472368|adult|adult
574092|NCT00472381|Acute Ischemic Stroke|acute ischemic stroke
574093|NCT00472381|Post-Stroke Hyperglycaemia|post-stroke hyperglycaemia
574094|NCT00472381|Insulin treatment|insulin treatment
574095|NCT00472381|Insulin|insulin
574096|NCT00472381|DWI|dwi
574097|NCT00472381|MRI|mri
574098|NCT00472394|Medical abortion|medical abortion
574099|NCT00472394|Preferences|preferences
574100|NCT00472394|Willingness to Pay|willingness to pay
574101|NCT00472407|Normal|normal
574102|NCT00472433|Alemtuzumab in autoimmune cytopenias|alemtuzumab in autoimmune cytopenias
574103|NCT00472446|Surgery|surgery
574104|NCT00472446|Thyroid gland|thyroid gland
574105|NCT00472446|cervical block|cervical block
574106|NCT00472446|Pain, Postoperative|pain, postoperative
574107|NCT00472459|Non-melanoma skin cancer|non-melanoma skin cancer
574108|NCT00472459|Organ transplant recipients|organ transplant recipients
574109|NCT00472459|Photodynamic therapy|photodynamic therapy
574110|NCT00472459|Actinic keratosis|actinic keratosis
574111|NCT00472472|restenosis|restenosis
574112|NCT00472472|peripheral arterial disease|peripheral arterial disease
574113|NCT00472472|paccocath|paccocath
574114|NCT00472472|drug-coated balloon|drug-coated balloon
574115|NCT00472498|Cardiac Arrest|cardiac arrest
574116|NCT00472498|Biphasic Defibrillator|biphasic defibrillator
574117|NCT00472537|Ventral hernia|ventral hernia
574118|NCT00472537|Incisional hernia|incisional hernia
574119|NCT00472550|esomeprazole, gastric emptying, reflux|esomeprazole, gastric emptying, reflux
574120|NCT00472563|bicarbonate|bicarbonate
574121|NCT00472563|nephropathy|nephropathy
574122|NCT00472563|contrast|contrast
574123|NCT00472576|NMDA Receptor|nmda receptor
574124|NCT00472576|Depression Treatment|depression treatment
574125|NCT00472576|Unipolar Depression|unipolar depression
574126|NCT00472576|Treatment Resistant|treatment resistant
574127|NCT00472576|Glutamatergic|glutamatergic
574128|NCT00472576|Depression|depression
574129|NCT00472576|Major Depression|major depression
574130|NCT00472602|Opisthorchis viverrini, liver fluke, Thailand, cancer|opisthorchis viverrini, liver fluke, thailand, cancer
574131|NCT00472615|Bipolar Disorder|bipolar disorder
574132|NCT00472615|Menstrual Cycle|menstrual cycle
574133|NCT00472615|Depression|depression
574134|NCT00472615|Mania or Hypomania|mania or hypomania
574135|NCT00472615|Predictor|predictor
574136|NCT00472654|bone mass|bone mass
574137|NCT00472654|calcium absorption|calcium absorption
574138|NCT00472654|bone quality|bone quality
574139|NCT00472654|fracture risk|fracture risk
574140|NCT00472667|Bacterial infections|bacterial infections
574141|NCT00472667|Procalcitonin|procalcitonin
574142|NCT00472667|Intensive care unit|intensive care unit
574143|NCT00472667|Antibiotic therapy|antibiotic therapy
574144|NCT00472667|Suspicion of bacterial infection or proven|suspicion of bacterial infection or proven
574145|NCT00472680|bone mass|bone mass
574146|NCT00472680|calcium absorption|calcium absorption
574147|NCT00472680|bone quality|bone quality
573548|NCT00478686|DPYD|dpyd
574148|NCT00472680|fracture risk|fracture risk
574149|NCT00472693|Breast cancer|breast cancer
574150|NCT00472693|Metastatic breast cancer|metastatic breast cancer
574151|NCT00472693|Second-Line Therapy|second-line therapy
574152|NCT00472693|Triple Negative|triple negative
574153|NCT00472693|Her-2 negative|her-2 negative
574154|NCT00472693|Hormone receptor negative|hormone receptor negative
574155|NCT00472693|Abraxane|abraxane
574156|NCT00472693|Bevacizumab|bevacizumab
574157|NCT00472706|Treatment|treatment
574158|NCT00472706|Excision|excision
574159|NCT00472706|Photodynamic therapy|photodynamic therapy
574160|NCT00472706|Recurrence rate|recurrence rate
574161|NCT00472706|Cosmetic outcome|cosmetic outcome
574162|NCT00472719|HIV Seronegativity|hiv seronegativity
574163|NCT00472719|HIV Preventive Vaccine|hiv preventive vaccine
574164|NCT00472719|Adenovirus|adenovirus
574165|NCT00472732|UCD|ucd
574166|NCT00472732|OTCD|otcd
574167|NCT00472732|Ammonia|ammonia
574168|NCT00472732|Urea Metabolism|urea metabolism
574169|NCT00472732|Inborn Errors|inborn errors
574170|NCT00472745|bone mass|bone mass
574171|NCT00472745|calcium absorption|calcium absorption
574172|NCT00472745|bone quality|bone quality
574173|NCT00472745|fracture risk|fracture risk
574174|NCT00472745|arthritis|arthritis
574175|NCT00472745|osteoporosis|osteoporosis
574176|NCT00472771|Recurrent extensive small cell lung cancer|recurrent extensive small cell lung cancer
574177|NCT00472810|Glaucoma|glaucoma
574178|NCT00472810|Collagen matrix|collagen matrix
574179|NCT00472810|ologen|ologen
574180|NCT00472810|OculusGen|oculusgen
574181|NCT00472810|Antifibrotic|antifibrotic
574182|NCT00472810|Trabeculectomy|trabeculectomy
574183|NCT00472810|anti scarring|anti scarring
574184|NCT00472810|tissue engineering|tissue engineering
574185|NCT00472810|high risk patient for trabeculectomy|high risk patient for trabeculectomy
574186|NCT00472810|Aeon Astron|aeon astron
574187|NCT00472823|cholecalciferol|cholecalciferol
574188|NCT00472823|vitamin D deficiency|vitamin d deficiency
574189|NCT00472823|bone density|bone density
574190|NCT00472823|dietary calcium|dietary calcium
574191|NCT00472823|hypercalcemia|hypercalcemia
574192|NCT00472823|hypercalciuria|hypercalciuria
574193|NCT00472849|OFAR 2|ofar 2
574194|NCT00472849|Oxaliplatin|oxaliplatin
574195|NCT00472849|Fludarabine|fludarabine
574196|NCT00472849|Cytarabine|cytarabine
574197|NCT00472849|Ara-C|ara-c
574198|NCT00472849|Rituximab|rituximab
574199|NCT00472849|Richter's Transformation|richter's transformation
574200|NCT00472849|Prolymphocytic Leukemia|prolymphocytic leukemia
574201|NCT00472849|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
574202|NCT00472849|Leukemia|leukemia
574203|NCT00472849|CLL|cll
574204|NCT00472875|hypoglycaemia|hypoglycaemia
574205|NCT00472875|type 1 diabetes mellitus|type 1 diabetes mellitus
574206|NCT00472888|Alpha-adrenergic blockers|alpha-adrenergic blockers
574207|NCT00472888|cataract surgery|cataract surgery
574208|NCT00472888|pseudoexfoliation syndrome|pseudoexfoliation syndrome
574209|NCT00472888|diabetes mellitus|diabetes mellitus
574210|NCT00472888|hypertension|hypertension
574211|NCT00472888|pupil|pupil
574212|NCT00472901|Polymorphic Light Eruption (PLE)|polymorphic light eruption (ple)
574213|NCT00472901|Afamelanotide|afamelanotide
574214|NCT00472901|CUV1647|cuv1647
574215|NCT00472901|photoprotection|photoprotection
574216|NCT00472901|sun poisoning|sun poisoning
574217|NCT00472914|Hypertonia|hypertonia
574218|NCT00472914|Childhood|childhood
574219|NCT00472940|Cancer|cancer
574220|NCT00472940|Hypogonadism|hypogonadism
574221|NCT00472940|testosterone|testosterone
574222|NCT00472940|cachexia|cachexia
574223|NCT00472992|Pregnancy|pregnancy
574224|NCT00472992|TYSABRI|tysabri
574225|NCT00473018|postexposure prophylaxis|postexposure prophylaxis
574226|NCT00473018|HIV Seronegativity|hiv seronegativity
574227|NCT00473031|bone mass|bone mass
574228|NCT00473031|calcium absorption|calcium absorption
574229|NCT00473031|bone quality|bone quality
574230|NCT00473031|fracture risk|fracture risk
574231|NCT00473057|acute stroke|acute stroke
574232|NCT00473057|middle cerebral artery|middle cerebral artery
574233|NCT00473057|autologous transplantation|autologous transplantation
574234|NCT00473057|bone marrow cells|bone marrow cells
574235|NCT00473057|stem cells|stem cells
574236|NCT00473057|cell therapy|cell therapy
574237|NCT00473083|Rash|rash
574238|NCT00473083|Erlotinib|erlotinib
574239|NCT00473083|Lung Cancer|lung cancer
574240|NCT00473096|Decision making|decision making
574241|NCT00473096|Patient Education|patient education
574242|NCT00473096|Indigency|indigency
574243|NCT00473096|Minority group|minority group
574244|NCT00473109|Hemodialysis|hemodialysis
574245|NCT00473109|Heparin|heparin
574246|NCT00473109|Clotting|clotting
574247|NCT00473122|Breast Cancer|breast cancer
574248|NCT00473122|Breast Reconstruction|breast reconstruction
574249|NCT00473122|Delayed-Immediate Reconstruction|delayed-immediate reconstruction
574250|NCT00473122|Postmastectomy Radiation Therapy|postmastectomy radiation therapy
574251|NCT00473122|Mastectomy|mastectomy
574252|NCT00473122|XRT|xrt
574253|NCT00473135|Dengue Fever|dengue fever
574254|NCT00473135|Dengue Vaccine|dengue vaccine
574255|NCT00473135|Dengue Virus|dengue virus
574256|NCT00473135|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
574257|NCT00473135|Dengue Shock Syndrome|dengue shock syndrome
574258|NCT00473148|Duration of weaning from invasive ventilation|duration of weaning from invasive ventilation
574259|NCT00473148|Mechanical ventilation|mechanical ventilation
574260|NCT00473148|Weaning|weaning
574261|NCT00473148|B-type natriuretic peptide|b-type natriuretic peptide
574262|NCT00473148|Fluid balance|fluid balance
574263|NCT00473148|Diuretics|diuretics
574264|NCT00473148|Intubated patient receiving mechanical ventilation|intubated patient receiving mechanical ventilation
574265|NCT00473148|for at least 24 hours|for at least 24 hours
574266|NCT00473148|Respiratory insufficiency|respiratory insufficiency
574267|NCT00473161|movement disorders|movement disorders
574268|NCT00473161|childhood|childhood
574269|NCT00473174|Ramipril|ramipril
574270|NCT00473174|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
574271|NCT00473174|Chronotherapy|chronotherapy
574272|NCT00473174|Circadian|circadian
574273|NCT00473174|Non-dipper|non-dipper
574274|NCT00473187|X-linked dominant hypophosphatemic rickets|x-linked dominant hypophosphatemic rickets
574275|NCT00473187|growth disorders|growth disorders
574276|NCT00473187|anthropometry|anthropometry
574277|NCT00473187|human growth hormone|human growth hormone
574278|NCT00473200|hyperhomocysteinemia|hyperhomocysteinemia
574279|NCT00473200|homocysteine|homocysteine
574280|NCT00473200|S-adenosylmethionine|s-adenosylmethionine
574281|NCT00473200|SAMe|same
574282|NCT00473200|Asymmetric dimethylagrinine (ADMA)|asymmetric dimethylagrinine (adma)
574283|NCT00473213|Multiple Sclerosis|multiple sclerosis
574284|NCT00473213|Interferon|interferon
574285|NCT00473213|Magnetic Resonance|magnetic resonance
574286|NCT00473239|vitamin D|vitamin d
574287|NCT00473239|cholecalciferol|cholecalciferol
574288|NCT00473239|25-hydroxyvitamin D|25-hydroxyvitamin d
574289|NCT00473252|aspergillus infections|aspergillus infections
574290|NCT00473252|immunosuppression|immunosuppression
574291|NCT00473252|kidney transplantation|kidney transplantation
574292|NCT00473252|hemodialysis|hemodialysis
574293|NCT00473252|galactomannan test|galactomannan test
574294|NCT00473252|fine dust|fine dust
574295|NCT00473252|construction activity|construction activity
574296|NCT00473252|airborne aspergillus spores|airborne aspergillus spores
574297|NCT00473278|tear protein|tear protein
574298|NCT00473291|pleural effusion|pleural effusion
574299|NCT00473291|lung sounds|lung sounds
574300|NCT00473291|acoustic monitoring|acoustic monitoring
574301|NCT00473304|Safety|safety
574302|NCT00473304|Efficacy|efficacy
574303|NCT00473304|Adaptation|adaptation
574304|NCT00473304|myopia and contact lens wear in children|myopia and contact lens wear in children
574305|NCT00473317|sunlight|sunlight
574306|NCT00473317|UVB|uvb
574307|NCT00473317|Vitamin D|vitamin d
574308|NCT00473330|Lucentis|lucentis
574309|NCT00473330|DME|dme
574310|NCT00473330|Diabetes|diabetes
574311|NCT00473330|Vision loss|vision loss
574312|NCT00473343|Photodynamic therapy (PDT)|photodynamic therapy (pdt)
574313|NCT00473343|PDT with Metvix cream|pdt with metvix cream
574314|NCT00473343|"High risk BCC"|"high risk bcc"
574315|NCT00473343|Basal Cell carcinoma|basal cell carcinoma
574316|NCT00473343|Histologically confirmed complete response|histologically confirmed complete response
574317|NCT00473356|Morbid obesity|morbid obesity
574318|NCT00473356|Lean body mass|lean body mass
574319|NCT00473356|amino acid supplement|amino acid supplement
574320|NCT00473356|laparoscopic gastric bypass|laparoscopic gastric bypass
574321|NCT00473369|atypical adenoma|atypical adenoma
574322|NCT00473369|Ki-67|ki-67
574323|NCT00473369|p53|p53
574324|NCT00473369|pituitary|pituitary
574325|NCT00473369|prognosis|prognosis
574326|NCT00473382|Lucentis|lucentis
574327|NCT00473382|DME|dme
574328|NCT00473382|Diabetes|diabetes
574329|NCT00473382|Vision loss|vision loss
574331|NCT00473408|DCE-MRI|dce-mri
574332|NCT00473408|Angiogenesis|angiogenesis
574333|NCT00473408|Cancer stem cells|cancer stem cells
574334|NCT00473408|Tumor vasculature|tumor vasculature
574335|NCT00473434|Schizophrenia|schizophrenia
574336|NCT00473434|Drug Therapy|drug therapy
574337|NCT00473434|Treatment Outcome|treatment outcome
574338|NCT00479362|Pacemaker|pacemaker
574339|NCT00479362|Cardioverter-defibrillator|cardioverter-defibrillator
574340|NCT00479362|Hemorrhage|hemorrhage
574341|NCT00479362|Hematoma|hematoma
574342|NCT00479362|Thrombosis|thrombosis
574343|NCT00479362|Embolism|embolism
574344|NCT00479375|screening|screening
574345|NCT00479375|human papillomavirus|human papillomavirus
574346|NCT00479427|osteoarthritis pain assessments|osteoarthritis pain assessments
574347|NCT00479479|cobalamin|cobalamin
574348|NCT00479479|methylmalonic acid|methylmalonic acid
574349|NCT00479479|homocysteine|homocysteine
742054|NCT01124786|cancer|cancer
574350|NCT00479479|folate|folate
574351|NCT00479479|newborns|newborns
574352|NCT00479479|infants|infants
574353|NCT00479479|Deficiency Disease|deficiency disease
574354|NCT00479479|Breastfeeding|breastfeeding
574355|NCT00479479|Infant|infant
574356|NCT00479492|Obesity, weight loss|obesity, weight loss
574357|NCT00479518|stroke|stroke
574358|NCT00479518|transient ischemic attack|transient ischemic attack
574359|NCT00479518|albuminuria|albuminuria
574360|NCT00479518|BNP|bnp
574361|NCT00479518|Cystatin C|cystatin c
574362|NCT00479531|Restless Legs Syndrome|restless legs syndrome
574363|NCT00479531|Sequential Compression Device|sequential compression device
574364|NCT00479531|Sleep Quality|sleep quality
574365|NCT00479531|Quality of Life|quality of life
574366|NCT00479557|Alzheimer's Disease|alzheimer's disease
574367|NCT00479557|active immunization|active immunization
574368|NCT00479583|Cancer (solid tumors)|cancer (solid tumors)
574369|NCT00479596|Overactive Bladder|overactive bladder
574370|NCT00479596|OAB|oab
574371|NCT00479596|Refractory OAB|refractory oab
574372|NCT00479596|Botox|botox
574373|NCT00479596|Bladder|bladder
574374|NCT00479609|Insulin resistance|insulin resistance
574375|NCT00479609|Glucose tolerance|glucose tolerance
574376|NCT00479609|Type 2 diabetes|type 2 diabetes
574377|NCT00479609|Androgen sensitivity|androgen sensitivity
574378|NCT00479622|Membranous Nephropathy|membranous nephropathy
574379|NCT00479622|Systemic Lupus Erythematosus|systemic lupus erythematosus
574380|NCT00479635|HRPC|hrpc
574381|NCT00479635|TPI 287|tpi 287
574382|NCT00479635|Taxane|taxane
574383|NCT00479635|MDR|mdr
574384|NCT00479635|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
574385|NCT00479661|initial sedation|initial sedation
574386|NCT00479661|mechanical ventilation|mechanical ventilation
574387|NCT00479674|Metastatic Breast Cancer|metastatic breast cancer
574388|NCT00479674|Advanced Breast Cancer|advanced breast cancer
574389|NCT00479674|Hormone Receptor AND Her2/neu Negative|hormone receptor and her2/neu negative
574390|NCT00479674|Triple Negative|triple negative
574391|NCT00479674|Triple Negative Breast Cancer|triple negative breast cancer
574392|NCT00479674|Stage IV or Inoperable Stage III Breast Cancer|stage iv or inoperable stage iii breast cancer
574393|NCT00479687|Osteoarthritis|osteoarthritis
574394|NCT00479687|Shoulder|shoulder
574395|NCT00479687|HA|ha
574396|NCT00479713|High Cholesterol|high cholesterol
574397|NCT00483626|hemodynamic|hemodynamic
574398|NCT00483626|pulmonary hypertension|pulmonary hypertension
574399|NCT00483626|sildenafil|sildenafil
574400|NCT00483639|anxiety disorder|anxiety disorder
574401|NCT00483639|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
574402|NCT00483639|head and neck cancer|head and neck cancer
574403|NCT00483639|non-small cell lung cancer|non-small cell lung cancer
574404|NCT00483639|small cell lung cancer|small cell lung cancer
574405|NCT00483652|multiple sclerosis|multiple sclerosis
574406|NCT00483652|MS|ms
574407|NCT00483652|walking|walking
574408|NCT00483652|leg strength|leg strength
574409|NCT00483652|demyelination|demyelination
574410|NCT00483665|endoleak|endoleak
574411|NCT00483678|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
574412|NCT00483678|sexual dysfunction|sexual dysfunction
574413|NCT00483678|sexuality and reproductive issues|sexuality and reproductive issues
574414|NCT00483678|recurrent prostate cancer|recurrent prostate cancer
574415|NCT00483678|stage III prostate cancer|stage iii prostate cancer
574416|NCT00483678|stage IV prostate cancer|stage iv prostate cancer
574417|NCT00483691|Intervention|intervention
574418|NCT00483691|Home Visit|home visit
574419|NCT00483691|Growth|growth
574420|NCT00483691|Child Development|child development
574421|NCT00483704|multiple attacks of moderate to severe migraine headaches|multiple attacks of moderate to severe migraine headaches
574422|NCT00483717|Migraine|migraine
574423|NCT00483717|Ketorolac|ketorolac
574424|NCT00483756|Immunosuppression|immunosuppression
574425|NCT00483756|JAK3 inhibitor|jak3 inhibitor
574426|NCT00483756|kidney transplantation.|kidney transplantation.
574427|NCT00483769|Cystis Fibrosis|cystis fibrosis
574428|NCT00483769|Glucose intolerance|glucose intolerance
574431|NCT00483782|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
574432|NCT00483782|Brenner tumor|brenner tumor
574433|NCT00483782|ovarian carcinosarcoma|ovarian carcinosarcoma
574434|NCT00483782|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
574435|NCT00483782|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
574436|NCT00483782|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
574598|NCT00484250|Metronidazole|metronidazole
574437|NCT00483782|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
574438|NCT00483782|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
574439|NCT00483782|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
574440|NCT00483782|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
574441|NCT00483782|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
574442|NCT00483782|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
574443|NCT00483782|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
574444|NCT00483782|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
574445|NCT00483782|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
574446|NCT00483782|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
574447|NCT00483782|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
574448|NCT00483782|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
574449|NCT00483782|stage IA fallopian tube cancer|stage ia fallopian tube cancer
574450|NCT00483782|stage IB fallopian tube cancer|stage ib fallopian tube cancer
574451|NCT00483782|stage IC fallopian tube cancer|stage ic fallopian tube cancer
574452|NCT00483782|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
574453|NCT00483782|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
574454|NCT00483782|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
574455|NCT00483782|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
574456|NCT00483782|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
574457|NCT00483782|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
574458|NCT00483782|stage IV fallopian tube cancer|stage iv fallopian tube cancer
574459|NCT00483782|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
574460|NCT00483782|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
574461|NCT00483782|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
574462|NCT00483782|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
574463|NCT00483782|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
574464|NCT00483782|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
574465|NCT00483782|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
574466|NCT00483782|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
574467|NCT00483782|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
574468|NCT00483782|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
574469|NCT00483821|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
574470|NCT00483821|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
574471|NCT00483821|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
574472|NCT00483821|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
574473|NCT00483821|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
574474|NCT00483821|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
574475|NCT00483821|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
574476|NCT00483821|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
574477|NCT00483821|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
574478|NCT00483821|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
574479|NCT00483821|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
574480|NCT00483821|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
574481|NCT00483821|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
574482|NCT00483821|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
574483|NCT00483821|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
574484|NCT00483821|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
574485|NCT00483821|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
574486|NCT00483821|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
574487|NCT00483821|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
574488|NCT00483821|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
574587|NCT00484146|Receptors|receptors
574489|NCT00483821|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
584145|NCT00514800|Home monitoring|home monitoring
574490|NCT00483821|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
574491|NCT00483821|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
574492|NCT00483821|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
574495|NCT00483834|CPT-11|cpt-11
574496|NCT00483834|Irinotecan|irinotecan
574497|NCT00483834|Camptothecin-11|camptothecin-11
574498|NCT00483834|Capecitabine|capecitabine
574499|NCT00483834|Xeloda|xeloda
574500|NCT00483834|Metastatic|metastatic
574501|NCT00483834|Colorectal|colorectal
574502|NCT00483834|Colon|colon
574503|NCT00483834|Rectal|rectal
574599|NCT00484250|Doxycycline|doxycycline
574504|NCT00483847|TYGRIS - Rest of World (ROW)|tygris - rest of world (row)
574505|NCT00483847|TYSABRI|tysabri
574506|NCT00483847|natalizumab|natalizumab
574507|NCT00483847|Multiple Sclerosis|multiple sclerosis
574508|NCT00483860|Cancer|cancer
742383|NCT01126203|SLT|slt
573931|NCT00466323|Active psychoses|active psychoses
573932|NCT00471705|Miltefosine|miltefosine
573933|NCT00471705|Leishmaniasis|leishmaniasis
573934|NCT00471705|Glucantime|glucantime
574509|NCT00483860|Solid tumor,|solid tumor,
574510|NCT00483860|normal renal function|normal renal function
574511|NCT00483860|renal impairment,|renal impairment,
574512|NCT00483860|prior platinum-based chemotherapy,|prior platinum-based chemotherapy,
574513|NCT00483873|Cardiac Arrest, Neurological Recovery, EEG, Quantitative EEG|cardiac arrest, neurological recovery, eeg, quantitative eeg
574514|NCT00483886|constipation|constipation
574515|NCT00483886|prucalopride|prucalopride
574516|NCT00483886|QOL|qol
574517|NCT00483886|SCBM|scbm
574518|NCT00483886|PAC-SYM|pac-sym
574519|NCT00483899|GW870086X Asthma Crossover repeat dose inhaled|gw870086x asthma crossover repeat dose inhaled
574520|NCT00483912|pancreatitis, MARS|pancreatitis, mars
574521|NCT00483912|severe acute pancreatitis with early multiple organ failure|severe acute pancreatitis with early multiple organ failure
574522|NCT00483925|Langerhans cell histiocytosis|langerhans cell histiocytosis
574523|NCT00483925|flow mediated dilatation|flow mediated dilatation
574524|NCT00483925|intima media thickness|intima media thickness
574525|NCT00483925|insulin resistance|insulin resistance
574526|NCT00483925|hypopituitarism|hypopituitarism
574527|NCT00483925|glucose and lipid metabolism,|glucose and lipid metabolism,
574528|NCT00483925|structural arterial and functional endothelial properties in patients with multisystem LCH|structural arterial and functional endothelial properties in patients with multisystem lch
574529|NCT00483951|Myocardial Infarction|myocardial infarction
574530|NCT00483951|Myocardial Ischemia|myocardial ischemia
574531|NCT00483951|Atherosclerosis|atherosclerosis
574532|NCT00483951|Congenital Heart Disease|congenital heart disease
574533|NCT00483951|Valvular Heart Disease|valvular heart disease
574534|NCT00483951|Heart Disease|heart disease
574535|NCT00483951|Cardiovascular Disease|cardiovascular disease
574536|NCT00483951|Heart Valve Disease|heart valve disease
574537|NCT00483964|Schizophrenia|schizophrenia
574538|NCT00483964|Herbal extracts|herbal extracts
574539|NCT00483964|Randomized|randomized
574540|NCT00483964|Controlled|controlled
574541|NCT00483964|Clinical Trial|clinical trial
574542|NCT00483990|Phase I Study in healthy subjects|phase i study in healthy subjects
574543|NCT00484003|Atopic eczema|atopic eczema
574544|NCT00484003|Pimecrolimus|pimecrolimus
574545|NCT00484003|Children|children
574546|NCT00484003|Quality of life|quality of life
574547|NCT00484003|Safety|safety
574548|NCT00484003|Atopic dermatitis|atopic dermatitis
574549|NCT00484016|adjuvant|adjuvant
574550|NCT00484016|chemotherapy|chemotherapy
574551|NCT00484016|observation|observation
574552|NCT00484016|resected|resected
574553|NCT00484016|cancers|cancers
574554|NCT00484029|Temporomandibular Disorders|temporomandibular disorders
574555|NCT00484029|TMD|tmd
574556|NCT00484029|TMJ/TMD|tmj/tmd
574557|NCT00484029|Pain Management|pain management
574558|NCT00484029|Pain|pain
574559|NCT00484029|Headaches|headaches
574560|NCT00484042|pancreatitis|pancreatitis
574561|NCT00484042|polyamine|polyamine
574562|NCT00484042|cytokine|cytokine
574563|NCT00484055|Antibiotic Prophylaxis|antibiotic prophylaxis
574564|NCT00484068|type 2 diabetes|type 2 diabetes
574565|NCT00484068|microalbuminuria|microalbuminuria
574566|NCT00484068|chicken-based diet|chicken-based diet
574567|NCT00484068|ACE inhibitor|ace inhibitor
574568|NCT00484081|TESE|tese
574569|NCT00484081|NON-OBSTRUCTIVE|non-obstructive
574570|NCT00484081|MICRODISSECTION|microdissection
574571|NCT00484081|AZOOSPERMIA|azoospermia
574572|NCT00484081|ICSI|icsi
574573|NCT00484094|Rapamune|rapamune
574574|NCT00484094|Safety|safety
574575|NCT00484094|Efficacy|efficacy
574576|NCT00484094|Kidney Transplantation|kidney transplantation
574577|NCT00484120|Osteoarthritis|osteoarthritis
574578|NCT00484120|Diclofenac|diclofenac
574579|NCT00484120|Nano-emulsion|nano-emulsion
574580|NCT00484133|sepsis|sepsis
574581|NCT00484133|severe sepsis|severe sepsis
574582|NCT00484133|microcirculation|microcirculation
574583|NCT00484133|Orthogonal polarisation spectral|orthogonal polarisation spectral
574584|NCT00484146|Sepsis|sepsis
574585|NCT00484146|Early Stage|early stage
574586|NCT00484146|Immune System|immune system
574588|NCT00484146|Cytokines|cytokines
741164|NCT01121146|Osteolysis|osteolysis
574589|NCT00484159|Low back pain of suspected lumbar zygapophysial etiology|low back pain of suspected lumbar zygapophysial etiology
574590|NCT00484172|Obesity|obesity
574591|NCT00484185|Hemophilia B|hemophilia b
574592|NCT00484185|BeneFIX|benefix
574593|NCT00484185|Safety|safety
574594|NCT00484185|Efficacy|efficacy
574595|NCT00484211|NGR-hTNF, Hepatocellular Carcinoma (HCC)|ngr-htnf, hepatocellular carcinoma (hcc)
574596|NCT00484237|Rheumatoid Arthritis|rheumatoid arthritis
574067|NCT00472290|MDS|mds
574597|NCT00484250|Oral Lichen Planus|oral lichen planus
574600|NCT00484276|NGR-hTNF|ngr-htnf
574601|NCT00484276|malignant pleural mesothelioma|malignant pleural mesothelioma
574602|NCT00484302|Marijuana Abuse|marijuana abuse
574603|NCT00484302|Psychotic Disorders|psychotic disorders
574604|NCT00484302|Schizophrenia|schizophrenia
574605|NCT00484315|drug-eluting stent|drug-eluting stent
574606|NCT00484315|paclitaxel-eluting stent|paclitaxel-eluting stent
574608|NCT00484328|hepatitis C|hepatitis c
574609|NCT00484328|Ribavirin|ribavirin
574610|NCT00484328|Dosage|dosage
574611|NCT00484328|Pharmacokinetics|pharmacokinetics
574612|NCT00484341|NGR-hTNF|ngr-htnf
574613|NCT00484341|Doxorubicin|doxorubicin
574614|NCT00484341|Soft Tissue Sarcoma|soft tissue sarcoma
574615|NCT00484354|Acute Renal Failure|acute renal failure
574616|NCT00484354|Cardiac Surgery|cardiac surgery
574617|NCT00484354|Sodium Bicarbonate|sodium bicarbonate
574618|NCT00484354|Length of Stay|length of stay
574619|NCT00484354|Mortality|mortality
574620|NCT00484367|Alcohol abuse|alcohol abuse
574621|NCT00484367|Substance abuse|substance abuse
574622|NCT00484367|Cannabis abuse|cannabis abuse
574623|NCT00484367|Adolescents|adolescents
574624|NCT00484367|Group therapy|group therapy
574625|NCT00484367|Family therapy|family therapy
574626|NCT00484380|Valvular surgery|valvular surgery
574627|NCT00484380|Diagnostic accuracy of coronary angiography|diagnostic accuracy of coronary angiography
574628|NCT00484380|Coronary stenosis|coronary stenosis
574629|NCT00484380|Coronary revascularisation|coronary revascularisation
574630|NCT00484406|Matrix Metalloproteinases|matrix metalloproteinases
574631|NCT00484406|Atherosclerosis|atherosclerosis
574632|NCT00484406|Genetic polymorphism|genetic polymorphism
574633|NCT00484406|Acute coronary syndromes|acute coronary syndromes
574634|NCT00484419|Colesevelam HCl,|colesevelam hcl,
574635|NCT00484419|rosiglitazone|rosiglitazone
574636|NCT00484419|sitagliptin|sitagliptin
574637|NCT00484419|Type 2 diabetes|type 2 diabetes
574638|NCT00484419|metformin|metformin
574639|NCT00484432|NGR-hTNF|ngr-htnf
574640|NCT00484432|Ovarian cancer|ovarian cancer
574641|NCT00484432|Doxorubicin|doxorubicin
574642|NCT00484445|Chronic critical illness|chronic critical illness
574643|NCT00484445|Functional status|functional status
574644|NCT00484445|Outcomes|outcomes
574645|NCT00484445|Post-ICU|post-icu
574646|NCT00484458|Degenerative Disc Disease|degenerative disc disease
574647|NCT00484458|Total Disc Replacement|total disc replacement
574648|NCT00484484|Cancer|cancer
574649|NCT00484484|Refractory pain|refractory pain
574650|NCT00484484|Uncontrolled pain|uncontrolled pain
574651|NCT00484484|Ketamine|ketamine
574652|NCT00484484|Uncontrolled cancer pain|uncontrolled cancer pain
574653|NCT00484497|Sleep quality|sleep quality
574654|NCT00484497|food supplement|food supplement
574655|NCT00484497|randomized controlled trial|randomized controlled trial
574656|NCT00484497|actigraphy|actigraphy
574657|NCT00484497|Leeds|leeds
574658|NCT00484497|Volunteers presenting moderate primary insomnia|volunteers presenting moderate primary insomnia
574659|NCT00484510|Ascorbic Acid|ascorbic acid
574660|NCT00484510|Vitamin C|vitamin c
574661|NCT00484510|Charcot Marie Tooth|charcot marie tooth
574663|NCT00484510|CMT1a|cmt1a
574664|NCT00484523|To constitute a standardized database of multimode neural imaging.|to constitute a standardized database of multimode neural imaging.
574665|NCT00484536|CDP323|cdp323
574666|NCT00484536|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
574667|NCT00484536|Magnetic Resonance Imaging|magnetic resonance imaging
574668|NCT00484536|Oral Compound|oral compound
574669|NCT00484536|MS|ms
574670|NCT00484549|Fabry disease, Screening, Ischemic stroke|fabry disease, screening, ischemic stroke
574671|NCT00484562|oxygen|oxygen
574672|NCT00484562|COPD|copd
574673|NCT00484562|exercise|exercise
574674|NCT00484575|Sevoflurane|sevoflurane
574675|NCT00484575|CABG|cabg
574676|NCT00484575|cardioprotection|cardioprotection
574677|NCT00484575|AnaConDa|anaconda
574678|NCT00484588|VAP|vap
574679|NCT00484614|Breast Cancer, breast conserving surgery|breast cancer, breast conserving surgery
574680|NCT00484627|Exercise|exercise
574681|NCT00484627|HIV|hiv
574682|NCT00484627|Creatine|creatine
574683|NCT00484627|Muscle|muscle
574684|NCT00484653|To achieve a quality and quantitative molecular biology assay for vaginal flora abnormalities|to achieve a quality and quantitative molecular biology assay for vaginal flora abnormalities
574685|NCT00484666|recurrent|recurrent
574686|NCT00484666|platinum|platinum
574687|NCT00484666|resistant|resistant
574688|NCT00484666|ovarian|ovarian
574689|NCT00484666|primary|primary
574690|NCT00484666|peritoneal|peritoneal
574691|NCT00484666|cancer|cancer
574692|NCT00484692|randomized controlled trial|randomized controlled trial
574693|NCT00484692|smoking cessation|smoking cessation
574694|NCT00484692|nicotine dependence|nicotine dependence
574695|NCT00484692|sustained-release bupropion|sustained-release bupropion
574696|NCT00484692|psychotherapy|psychotherapy
574697|NCT00484692|psychodynamic model training|psychodynamic model training
574698|NCT00484705|Androgens|androgens
574699|NCT00484705|Menstrual pattern|menstrual pattern
574700|NCT00484705|Insulin resistance|insulin resistance
574701|NCT00484705|Adipocytes|adipocytes
574702|NCT00484705|Obesity|obesity
574703|NCT00484705|Stress|stress
574704|NCT00484705|Muscle sympathetic nerve activity|muscle sympathetic nerve activity
574705|NCT00484705|Psychological distress and quality of life|psychological distress and quality of life
574706|NCT00484744|pain|pain
574707|NCT00484744|orthodontic|orthodontic
574708|NCT00484744|acetaminophen|acetaminophen
574709|NCT00484744|ibuprofen|ibuprofen
574710|NCT00484744|separator|separator
574711|NCT00484757|Narcolepsy|narcolepsy
574712|NCT00484757|Orexines|orexines
574713|NCT00484757|sleep|sleep
574714|NCT00484757|cognition|cognition
574715|NCT00484757|cytokines|cytokines
574716|NCT00484770|heart failure, brain natriuretic peptide|heart failure, brain natriuretic peptide
574717|NCT00484783|Laparoscopic Surgical Procedures|laparoscopic surgical procedures
574718|NCT00484783|Endoscopic Surgical Procedures|endoscopic surgical procedures
574719|NCT00484783|Laparoscopic & endoscopic procedures with a gastrotomy|laparoscopic & endoscopic procedures with a gastrotomy
574720|NCT00484783|or opening in bladder or urethra|or opening in bladder or urethra
574721|NCT00484796|Carotid Surgery|carotid surgery
574722|NCT00484796|Cerebral Ischemia|cerebral ischemia
574723|NCT00484796|Cognitive Deficits|cognitive deficits
574724|NCT00484796|Somatosensory-evoked Potentials|somatosensory-evoked potentials
574725|NCT00484796|Neuromonitoring|neuromonitoring
574726|NCT00484809|rheumatoid arthritis|rheumatoid arthritis
574727|NCT00484809|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
574728|NCT00484835|Abdominal|abdominal
574729|NCT00484835|Hysterectomy|hysterectomy
574730|NCT00484835|Electrocoagulation forceps|electrocoagulation forceps
574731|NCT00484835|Electrosurgery|electrosurgery
574732|NCT00484835|Gyrus plasma open seal forceps|gyrus plasma open seal forceps
574733|NCT00484835|Patients undergoing abdominal hysterectomy for various reasons|patients undergoing abdominal hysterectomy for various reasons
574734|NCT00484848|oncology, medical|oncology, medical
574735|NCT00484848|implantable catheter|implantable catheter
574736|NCT00484848|vascular access ports|vascular access ports
574737|NCT00484848|persistent withdrawal occlusion|persistent withdrawal occlusion
574738|NCT00484848|Vortex®|vortex®
574739|NCT00484848|Celsite®|celsite®
574740|NCT00484848|Vacutainer®|vacutainer®
574741|NCT00484848|venous cut-down|venous cut-down
574742|NCT00484861|Women|women
574743|NCT00484861|Healthy Volunteers|healthy volunteers
574744|NCT00484861|Triglyceride|triglyceride
574745|NCT00484861|Healthy Volunteer|healthy volunteer
574746|NCT00484861|HV|hv
574747|NCT00484874|Hodgkin's lymphoma|hodgkin's lymphoma
574748|NCT00484874|Radioimmunotherapy|radioimmunotherapy
574749|NCT00484874|Bexxar|bexxar
574750|NCT00484874|I-131 Tositumomab|i-131 tositumomab
574751|NCT00484874|Safety|safety
574752|NCT00484874|Efficacy|efficacy
574753|NCT00484874|Nuclear Medicine|nuclear medicine
574754|NCT00484874|Monoclonal antibody|monoclonal antibody
574755|NCT00484874|Radiolabeled|radiolabeled
574756|NCT00484887|Hernia mesh|hernia mesh
574757|NCT00484887|Implanted mesh material|implanted mesh material
574758|NCT00484887|Explanted mesh material|explanted mesh material
574759|NCT00484900|Open randomized multi-centre clinical trial in Africa|open randomized multi-centre clinical trial in africa
574760|NCT00484900|Uncomplicated P. falciparum malaria|uncomplicated p. falciparum malaria
574761|NCT00484900|Artemisinin-based Combination Therapy|artemisinin-based combination therapy
574762|NCT00484900|Artesunate + sulfalene + pyrimethamine|artesunate + sulfalene + pyrimethamine
574763|NCT00484900|24 hour treatment|24 hour treatment
574764|NCT00484900|Artemether + lumefantrine|artemether + lumefantrine
574765|NCT00484913|healthy subjects|healthy subjects
574766|NCT00484926|coronary disease|coronary disease
574767|NCT00484926|stents|stents
574768|NCT00484926|antiplatelet drugs|antiplatelet drugs
574769|NCT00484926|drug-eluting stents|drug-eluting stents
574770|NCT00484952|rotavirus|rotavirus
574771|NCT00484952|diarrheal diseases|diarrheal diseases
574772|NCT00484952|hospitalizations|hospitalizations
574773|NCT00484952|multicenter|multicenter
574774|NCT00484952|children|children
574775|NCT00484952|under five year old|under five year old
574776|NCT00484952|Hospitalization due to diarhheal diseases|hospitalization due to diarhheal diseases
574777|NCT00484952|Hospitalization due to rotavirus gastroenteritis|hospitalization due to rotavirus gastroenteritis
574778|NCT00484952|Nosocomial rotavirus infections|nosocomial rotavirus infections
574779|NCT00484965|Coronary stent|coronary stent
741362|NCT01131117|healthy|healthy
574780|NCT00484965|Inflammation|inflammation
574781|NCT00484965|Atherosclerosis|atherosclerosis
574782|NCT00484965|Immunosuppressive|immunosuppressive
574783|NCT00484978|Stereotactic Radiosurgery|stereotactic radiosurgery
574785|NCT00484978|Metastatic tumor to brain|metastatic tumor to brain
574786|NCT00484978|radiation|radiation
574787|NCT00484978|Brain Metastases of all pathologies|brain metastases of all pathologies
574788|NCT00484991|Phenylketonuria|phenylketonuria
574789|NCT00484991|PKU|pku
574790|NCT00484991|Phenylketonurias|phenylketonurias
574791|NCT00484991|Hyperphenylalaninaemia|hyperphenylalaninaemia
574792|NCT00484991|Hydroxylase Deficiency|hydroxylase deficiency
574793|NCT00485004|Coronary artery disease|coronary artery disease
574794|NCT00485004|Stent|stent
574795|NCT00485004|Angioplasty|angioplasty
574796|NCT00485017|Obesity|obesity
574797|NCT00485017|Weight Loss|weight loss
574798|NCT00485030|coronary artery disease|coronary artery disease
574799|NCT00485030|stent|stent
574800|NCT00485030|angioplasty|angioplasty
574801|NCT00485043|T'ai Chi|t'ai chi
574802|NCT00485043|Osteoarthritis|osteoarthritis
574803|NCT00485043|Exercise|exercise
574804|NCT00485043|Older adults|older adults
574805|NCT00485056|Diabetes|diabetes
574806|NCT00485056|Tissue doppler imaging|tissue doppler imaging
574807|NCT00485056|Wave intensity analysis.|wave intensity analysis.
574808|NCT00485069|Ropinirole hydrochloride|ropinirole hydrochloride
574809|NCT00485069|L-dopa|l-dopa
574810|NCT00485069|Parkinson's Disease|parkinson's disease
574811|NCT00485069|Dopamine agonist|dopamine agonist
574812|NCT00485082|Cystic Fibrosis|cystic fibrosis
574813|NCT00485082|Disclosure|disclosure
574814|NCT00485082|Dating Partner|dating partner
574815|NCT00485082|Phone Interview|phone interview
574816|NCT00485108|primary open angle glaucoma|primary open angle glaucoma
574817|NCT00485108|pseudoexfoliation glaucoma|pseudoexfoliation glaucoma
574818|NCT00485108|selective laser trabeculoplasty|selective laser trabeculoplasty
574819|NCT00485108|intra ocular pressure|intra ocular pressure
574820|NCT00485108|anti-inflammatory therapy|anti-inflammatory therapy
574821|NCT00485108|prednisolone acetate 1%|prednisolone acetate 1%
574822|NCT00485108|ketorolac tromethamine 0.5%|ketorolac tromethamine 0.5%
574823|NCT00485121|Ezetimibe|ezetimibe
574824|NCT00485121|Statin|statin
574825|NCT00485121|Low- density lipoprotein cholesterol|low- density lipoprotein cholesterol
574826|NCT00485121|Adipokine|adipokine
574827|NCT00485121|Adiponectin|adiponectin
574828|NCT00485121|C-reactive protein|c-reactive protein
574829|NCT00485121|Coronary artery disease|coronary artery disease
574830|NCT00485121|Metabolic Syndrome|metabolic syndrome
574831|NCT00485121|Obesity|obesity
574832|NCT00485147|Claudication|claudication
574833|NCT00485147|peripheral arterial disease|peripheral arterial disease
574834|NCT00485147|Diagnosis|diagnosis
574835|NCT00485147|Exercise|exercise
574836|NCT00485147|Walking impairment|walking impairment
574837|NCT00485147|Disability|disability
574838|NCT00485160|Patent Ductus Arteriosus|patent ductus arteriosus
574839|NCT00485160|Indomethacin|indomethacin
574840|NCT00485160|Ibuprofen|ibuprofen
574841|NCT00485160|Renal effects|renal effects
574842|NCT00485199|Pneumatic Retinopexy|pneumatic retinopexy
574843|NCT00485199|vitrectomy|vitrectomy
574844|NCT00485199|retinal detachment|retinal detachment
574845|NCT00485199|macular hole|macular hole
574846|NCT00485199|treatment|treatment
574847|NCT00485199|multi-center|multi-center
574848|NCT00485199|Retinal Detachment due to Myopic Macular hole|retinal detachment due to myopic macular hole
574849|NCT00485212|postoperative pain|postoperative pain
574850|NCT00485238|glaucoma|glaucoma
574851|NCT00485251|operation time in minutes|operation time in minutes
574852|NCT00485251|pain score from 1-10|pain score from 1-10
574853|NCT00485251|recurrence|recurrence
574854|NCT00485251|survival|survival
574855|NCT00485277|Breast cancer|breast cancer
574857|NCT00485277|Metastatic|metastatic
574858|NCT00485277|HER-2-positive|her-2-positive
574859|NCT00485277|Phase I|phase i
574860|NCT00485277|HER-2 Positive Metastatic Breast Cancer|her-2 positive metastatic breast cancer
574861|NCT00485290|cirrhosis, Portal Hypertension, Esophageal Varices, Meal|cirrhosis, portal hypertension, esophageal varices, meal
574862|NCT00485303|Prostatic Neoplasms|prostatic neoplasms
574863|NCT00485303|Prostate cancer|prostate cancer
574864|NCT00485303|Abiraterone acetate|abiraterone acetate
574865|NCT00485303|CB7630|cb7630
574866|NCT00485303|Prednisone|prednisone
574867|NCT00485316|Colorectal carcinoma|colorectal carcinoma
574868|NCT00485316|Rectal carcinoma|rectal carcinoma
574869|NCT00485316|Laparoscopy|laparoscopy
574870|NCT00485316|Laparoscopic surgery|laparoscopic surgery
574871|NCT00485316|Open surgery|open surgery
574872|NCT00485316|Randomized trial|randomized trial
574873|NCT00485329|Chronic Wounds, Venous Ulcers, Papain, Debridement, Continuous streaming|chronic wounds, venous ulcers, papain, debridement, continuous streaming
574874|NCT00485329|DermaStream-EnzyStream|dermastream-enzystream
574875|NCT00485342|Chronic hepatitis C,Genotype1,Naïf,bitherapy,Ribavirin adaptation,ribavirin AUC|chronic hepatitis c,genotype1,naïf,bitherapy,ribavirin adaptation,ribavirin auc
574876|NCT00485355|hysterectomy|hysterectomy
574877|NCT00485355|Laparoscopy|laparoscopy
574878|NCT00485355|robotics|robotics
574879|NCT00485368|marfan syndrome|marfan syndrome
574880|NCT00485368|aortic root diameter|aortic root diameter
574881|NCT00485394|AMD|amd
753194|NCT01175824|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
574882|NCT00485394|age-related macular degeneration|age-related macular degeneration
574883|NCT00485394|geographic atrophy|geographic atrophy
574885|NCT00485420|Internet based disease management program|internet based disease management program
574886|NCT00485433|hernia|hernia
574887|NCT00485433|unilateral|unilateral
574888|NCT00485433|postoperative|postoperative
574889|NCT00485433|analgesia|analgesia
574890|NCT00485472|Osteoarthritis|osteoarthritis
574891|NCT00485472|lacosamide|lacosamide
574892|NCT00485472|VIMPAT|vimpat
574893|NCT00485485|Head and Neck Cancer|head and neck cancer
574894|NCT00485485|Squamous Cell Cancer|squamous cell cancer
574895|NCT00485485|Imatinib Mesylate|imatinib mesylate
574896|NCT00485485|Gleevec|gleevec
574897|NCT00485485|Imatinib|imatinib
574898|NCT00485485|STI571|sti571
574899|NCT00485485|Docetaxel|docetaxel
574900|NCT00485485|Taxotere|taxotere
574901|NCT00485524|Near Infrared Spectroscopy|near infrared spectroscopy
574902|NCT00485524|Serum Lactate Levels|serum lactate levels
574903|NCT00485524|post operative outcomes|post operative outcomes
574904|NCT00485537|GnRH antagonist|gnrh antagonist
574905|NCT00485537|GnRH agonist|gnrh agonist
574906|NCT00485537|ICSI|icsi
574907|NCT00485537|miscarriage rate|miscarriage rate
574908|NCT00485537|pregnancy outcome|pregnancy outcome
574909|NCT00485563|Cancer|cancer
574910|NCT00485563|Vaccine|vaccine
574911|NCT00485563|Phase 2|phase 2
574912|NCT00485563|folate-hapten conjugate|folate-hapten conjugate
574913|NCT00485563|Progressive|progressive
574914|NCT00485563|Metastatic|metastatic
574915|NCT00485563|Experimental|experimental
574916|NCT00485589|FILM|film
574917|NCT00485589|RA|ra
574918|NCT00485589|anti-CD20|anti-cd20
574919|NCT00485589|CD20|cd20
574920|NCT00485602|malocclusion|malocclusion
574921|NCT00485602|aligner|aligner
574922|NCT00485602|crowding|crowding
574923|NCT00485602|expansion|expansion
574924|NCT00485602|orthodontic treatment|orthodontic treatment
574925|NCT00485615|eicosapentaenoic acid|eicosapentaenoic acid
574926|NCT00485615|fish oil|fish oil
574927|NCT00485615|Omega 3|omega 3
574928|NCT00485615|Social Anxiety Disorder|social anxiety disorder
574929|NCT00485641|Stroke|stroke
574930|NCT00485641|SaeboFlex|saeboflex
574931|NCT00485641|Hand function|hand function
574932|NCT00485654|Heterotaxy Syndrome|heterotaxy syndrome
574933|NCT00485654|Intestinal Malrotation|intestinal malrotation
574934|NCT00485654|Functional Asplenia|functional asplenia
574935|NCT00485654|Complex Cyanotic heart disease|complex cyanotic heart disease
574936|NCT00485667|pain|pain
574937|NCT00485667|postoperative|postoperative
574938|NCT00485693|pain|pain
574939|NCT00485693|postoperative|postoperative
574940|NCT00485693|total knee arthroplasty|total knee arthroplasty
574941|NCT00485693|analgesia|analgesia
574942|NCT00485706|dialysis|dialysis
574943|NCT00485706|vascular calcification|vascular calcification
574944|NCT00485706|bone mineralism|bone mineralism
574945|NCT00485706|arterial stiffness|arterial stiffness
574946|NCT00485706|bone metabolism|bone metabolism
574947|NCT00485706|chronic kidney disease|chronic kidney disease
574948|NCT00485719|Cancer|cancer
574949|NCT00485719|Solid Tumors|solid tumors
574950|NCT00485732|Cervical neoplasia|cervical neoplasia
574951|NCT00485732|AS04|as04
574952|NCT00485732|Randomized|randomized
574953|NCT00485732|Cervical cancer|cervical cancer
574954|NCT00485732|HPV-16/18 L1 VLP AS04|hpv-16/18 l1 vlp as04
574955|NCT00485732|Phase IIIb|phase iiib
574956|NCT00485732|Korea|korea
574957|NCT00485732|HPV|hpv
574958|NCT00485732|Double-blind|double-blind
574959|NCT00485732|Controlled|controlled
574960|NCT00485745|surgery|surgery
574961|NCT00485745|repeat sternotomy|repeat sternotomy
574962|NCT00485745|pediatrics|pediatrics
575085|NCT00465543|Mint tea|mint tea
575086|NCT00465543|Double-blind|double-blind
574963|NCT00485784|Identify in a population of patients with a PE, an IUGR and a FD a modification of circulating endothelial biomarkers compared with normal pregnancy.|identify in a population of patients with a pe, an iugr and a fd a modification of circulating endothelial biomarkers compared with normal pregnancy.
574964|NCT00485797|attention deficit hyperactivity disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
574965|NCT00485797|Dual tasking|dual tasking
574966|NCT00485797|Postural Control|postural control
574967|NCT00485797|Methylphenidate (Ritalin)|methylphenidate (ritalin)
574968|NCT00485797|The focus of the study is To explore the effects of Ritalin on postural control in ADHD Children, during single and dual task conditions.|the focus of the study is to explore the effects of ritalin on postural control in adhd children, during single and dual task conditions.
574969|NCT00485836|CRVO|crvo
574970|NCT00485836|RVO|rvo
574971|NCT00485836|Lucentis|lucentis
574972|NCT00485836|Edema|edema
574973|NCT00485914|employment|employment
574974|NCT00485914|work|work
574975|NCT00485927|Trauma|trauma
574976|NCT00485927|Stress|stress
574977|NCT00485927|Simulation|simulation
574978|NCT00485940|constipation|constipation
574979|NCT00485940|prucalopride|prucalopride
574980|NCT00485940|QOL|qol
574981|NCT00485940|SCBM|scbm
574983|NCT00485953|Osteoporosis|osteoporosis
574984|NCT00485953|breast cancer|breast cancer
574985|NCT00485953|aromatase inhibitors|aromatase inhibitors
574986|NCT00485953|bone loss|bone loss
574987|NCT00485953|bone mineral density|bone mineral density
574988|NCT00485966|Adult Leukemia|adult leukemia
574990|NCT00485966|B-CLL|b-cll
574991|NCT00485966|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
574992|NCT00485966|B-cell CLL|b-cell cll
574993|NCT00485979|Breast Cancer|breast cancer
574994|NCT00485979|Neoadjuvant therapy|neoadjuvant therapy
574995|NCT00485992|blood stream infection|blood stream infection
574996|NCT00485992|CICU|cicu
574997|NCT00485992|pediatric|pediatric
574998|NCT00485992|chlorhexidine swabs|chlorhexidine swabs
574999|NCT00486018|Lucentis|lucentis
575000|NCT00486018|RVO|rvo
575001|NCT00486018|BRVO|brvo
575002|NCT00486018|Edema|edema
575003|NCT00486031|IBD|ibd
575004|NCT00486031|UC|uc
575005|NCT00486031|Ulcerative Colitis|ulcerative colitis
575006|NCT00486031|Inflammatory Bowel Disease|inflammatory bowel disease
575007|NCT00486044|amyloid protein|amyloid protein
575008|NCT00486044|apolipoprotein|apolipoprotein
575009|NCT00486044|cerebrospinal fluid|cerebrospinal fluid
575010|NCT00486044|cerebrovascular circulation|cerebrovascular circulation
575011|NCT00486044|inflammation|inflammation
575012|NCT00486044|magnetic resonance imaging|magnetic resonance imaging
575013|NCT00486044|prevention & control|prevention & control
575014|NCT00486057|Daclizumab|daclizumab
575015|NCT00486057|Immuno-suppression protocol|immuno-suppression protocol
575016|NCT00486057|Heart Transplant|heart transplant
575017|NCT00486057|Rejection|rejection
575018|NCT00486070|cardiac anomaly|cardiac anomaly
575019|NCT00486070|pulmonary veins|pulmonary veins
575020|NCT00486070|cyanosis|cyanosis
575021|NCT00486070|flow reversal|flow reversal
575022|NCT00486070|TAPAVC|tapavc
575023|NCT00486096|cannulation|cannulation
575024|NCT00486096|infant|infant
575025|NCT00486096|femoral arterial|femoral arterial
575026|NCT00465283|Donepezil, ECT, Memory Disfunction|donepezil, ect, memory disfunction
575027|NCT00465309|Respiratory Insufficiency|respiratory insufficiency
575028|NCT00465309|CO2 removal|co2 removal
575029|NCT00465309|protective ventilation|protective ventilation
575030|NCT00465309|ARDS|ards
575031|NCT00465335|computed tomography|computed tomography
575032|NCT00465335|stress test|stress test
575033|NCT00465335|equivocal|equivocal
575034|NCT00465335|catheterization|catheterization
575035|NCT00465348|normal tension glaucoma|normal tension glaucoma
575036|NCT00465348|vascular dysregulation|vascular dysregulation
575037|NCT00465361|Growth and Development|growth and development
575038|NCT00465361|Child Development|child development
575039|NCT00465361|Developmental Surveillance|developmental surveillance
575040|NCT00465361|Medical Education|medical education
575041|NCT00465361|Internship and Residency|internship and residency
575042|NCT00465374|ARDS|ards
575043|NCT00465374|Pressure/time curve|pressure/time curve
575044|NCT00465374|Stress Index|stress index
575045|NCT00465400|exudative age-related macular degeneration (AMD)|exudative age-related macular degeneration (amd)
575046|NCT00465400|non-exudative age-related macular degeneration (AMD)|non-exudative age-related macular degeneration (amd)
575047|NCT00465400|oxidative stress|oxidative stress
575048|NCT00465400|photodynamic therapy|photodynamic therapy
575049|NCT00465413|metered-dose inhalers (MDI)|metered-dose inhalers (mdi)
575050|NCT00465413|forced expiratory volume in 1 second (FEV1)|forced expiratory volume in 1 second (fev1)
575051|NCT00465413|forced expiratory flow rate (FEF25-75%)|forced expiratory flow rate (fef25-75%)
575052|NCT00465426|HIV Infection|hiv infection
575053|NCT00465426|Cardiovascular Disease|cardiovascular disease
575054|NCT00465426|Antiretroviral Therapy|antiretroviral therapy
575055|NCT00465426|Inflammatory Markers|inflammatory markers
575056|NCT00465426|Treatment Experienced|treatment experienced
575057|NCT00465439|femoral artery sheath|femoral artery sheath
575058|NCT00465439|vasovagal reaction|vasovagal reaction
575059|NCT00465439|pain|pain
575060|NCT00465439|perception|perception
575061|NCT00465465|Tuberculosis|tuberculosis
575062|NCT00465465|TB|tb
575063|NCT00465465|MVA 85A|mva 85a
575064|NCT00465465|BCG|bcg
575065|NCT00465478|Diabetes Mellitus|diabetes mellitus
575066|NCT00465478|Bone Marros Mononuclear Cells|bone marros mononuclear cells
575067|NCT00465478|Transplantation|transplantation
575068|NCT00465491|refractory|refractory
575069|NCT00465491|chemotherapy|chemotherapy
575070|NCT00465491|progressed|progressed
575071|NCT00465491|second-line treatment|second-line treatment
575072|NCT00465491|small cell lung cancer|small cell lung cancer
575073|NCT00465491|best supportive care|best supportive care
575074|NCT00465491|picoplatin|picoplatin
575075|NCT00465504|local analgesia|local analgesia
741363|NCT01131117|women|women
575076|NCT00465504|intra-articular corticosteroid injection|intra-articular corticosteroid injection
575077|NCT00465504|iontophoresis|iontophoresis
575078|NCT00465504|Local analgesia for intra-articular corticosteroid injection|local analgesia for intra-articular corticosteroid injection
575079|NCT00465517|Partial onset seizures|partial onset seizures
575080|NCT00465517|Complex-partial seizures|complex-partial seizures
575081|NCT00465517|Anticonvulsant|anticonvulsant
575082|NCT00465517|Partial seizures|partial seizures
575083|NCT00465517|Catamenial epilepsy|catamenial epilepsy
575084|NCT00465543|Nasal polyposis|nasal polyposis
575087|NCT00465543|Placebo-controlled|placebo-controlled
575088|NCT00465543|Crossover|crossover
575089|NCT00476320|echocardiography|echocardiography
575090|NCT00476320|myocardial infarction|myocardial infarction
575091|NCT00476320|magnetic resonance imaging|magnetic resonance imaging
575092|NCT00476320|revascularization|revascularization
575093|NCT00476320|viability|viability
575095|NCT00476333|Kinetics|kinetics
575096|NCT00476333|Kinematics|kinematics
575097|NCT00476333|Perturbation|perturbation
575098|NCT00476333|Footwear|footwear
575099|NCT00476346|physical training|physical training
575100|NCT00476346|military training|military training
575101|NCT00476346|bone|bone
575102|NCT00476346|fracture prevention|fracture prevention
575103|NCT00476346|young adult|young adult
575104|NCT00476359|Lopinavir/r|lopinavir/r
575105|NCT00476359|Saquinavir|saquinavir
575106|NCT00476359|Dual boosted PIs|dual boosted pis
575107|NCT00476359|Pharmacokinetics|pharmacokinetics
575108|NCT00476359|HIV children|hiv children
575109|NCT00476359|C min|c min
575110|NCT00476359|Second line HAART|second line haart
575112|NCT00476359|VL failure|vl failure
575113|NCT00476359|Dosage|dosage
575114|NCT00476359|To evaluate treatment response|to evaluate treatment response
575115|NCT00476359|Treatment Experienced|treatment experienced
575116|NCT00476372|neuropsychology|neuropsychology
575117|NCT00476372|cognitive impairment|cognitive impairment
575118|NCT00476372|motor disorder|motor disorder
575119|NCT00476372|parkinson's disease|parkinson's disease
575120|NCT00476398|Capsule endoscopy|capsule endoscopy
575121|NCT00476398|Wireless imaging|wireless imaging
575122|NCT00476398|esophagus|esophagus
575123|NCT00476398|stomach|stomach
575124|NCT00476411|isolated HBc|isolated hbc
575125|NCT00476411|HBV vaccine response|hbv vaccine response
575126|NCT00476411|occult HBV in isolated antiHBC compared HIV to non HIV|occult hbv in isolated antihbc compared hiv to non hiv
575127|NCT00476424|once daily Efavirenz 400 mg|once daily efavirenz 400 mg
575128|NCT00476424|PK once daily Efavirenz 400 mg versus 600 mg|pk once daily efavirenz 400 mg versus 600 mg
575129|NCT00476424|Treatment Experienced|treatment experienced
575130|NCT00476450|Oral Microbial Flora|oral microbial flora
575131|NCT00476450|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
575132|NCT00476450|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
575133|NCT00476463|TDF+FTC|tdf+ftc
575134|NCT00476463|FTC|ftc
575135|NCT00476463|HIV/HBV|hiv/hbv
575136|NCT00476463|TDF compared to TDF+FTC in HIV/HBV|tdf compared to tdf+ftc in hiv/hbv
575137|NCT00476463|Treatment Naive|treatment naive
575138|NCT00476476|Tarceva|tarceva
575139|NCT00476476|erlotinib|erlotinib
575140|NCT00476476|squamous cell carcinoma of the vulvar|squamous cell carcinoma of the vulvar
575141|NCT00476489|secondary adrenal insuffiency|secondary adrenal insuffiency
575142|NCT00476489|hypothalamus-pituitary-adrenal axis impairement|hypothalamus-pituitary-adrenal axis impairement
575143|NCT00476489|topical steroids|topical steroids
575144|NCT00476502|genetic polymorphism|genetic polymorphism
575145|NCT00476502|CYP 3A|cyp 3a
575146|NCT00476502|MDR-1|mdr-1
575147|NCT00476502|Thai|thai
575148|NCT00476502|HIV|hiv
575149|NCT00476502|Treatment Experienced|treatment experienced
575150|NCT00476515|Kidney transplantation|kidney transplantation
575151|NCT00476515|Donor specific antibodies|donor specific antibodies
575152|NCT00476515|Positive cross match|positive cross match
575153|NCT00476528|Posttraumatic amnesia|posttraumatic amnesia
575154|NCT00476528|Early intervention|early intervention
575155|NCT00476528|A systematic nursing programme in the ICU|a systematic nursing programme in the icu
575156|NCT00476528|Early identification of patients with posttraumatic amnesia|early identification of patients with posttraumatic amnesia
575157|NCT00476541|AML|aml
575158|NCT00476541|Children|children
575159|NCT00476541|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
575160|NCT00476541|Stem cell transplantation|stem cell transplantation
575161|NCT00476554|CTCL|ctcl
575162|NCT00476567|exercise|exercise
575163|NCT00476567|pregnancy|pregnancy
575164|NCT00476567|prevention|prevention
575165|NCT00476567|pregnancy-related diseases|pregnancy-related diseases
575166|NCT00476567|labor|labor
575167|NCT00476567|complications|complications
575168|NCT00476567|physiotherapy|physiotherapy
575169|NCT00476580|Sri Lankan Sinhalese|sri lankan sinhalese
575170|NCT00476580|Epidemiology|epidemiology
575171|NCT00476580|Cancer Risk|cancer risk
575172|NCT00476580|US Migrant|us migrant
575173|NCT00476580|Questionnaire|questionnaire
575174|NCT00476580|Survey|survey
575175|NCT00476580|Acculturation|acculturation
575176|NCT00476580|Health and Cancer Risks|health and cancer risks
575177|NCT00476580|Health Habits|health habits
575178|NCT00476593|Uveitis|uveitis
575179|NCT00476593|Iritis|iritis
575180|NCT00476593|Macular Thickness|macular thickness
575094|NCT00476333|EMG|emg
575181|NCT00476593|HLA-B27 related|hla-b27 related
575182|NCT00476593|Macular edema|macular edema
575183|NCT00476593|Macular thickening|macular thickening
575184|NCT00476593|OCT|oct
575185|NCT00476593|mfERG|mferg
575186|NCT00476593|Eye drops|eye drops
575187|NCT00476593|Dexamethosone|dexamethosone
575188|NCT00476593|Diclofenac|diclofenac
575189|NCT00476593|Retinal aging|retinal aging
575190|NCT00476606|HIV children|hiv children
575191|NCT00476606|HAART|haart
575192|NCT00476606|ARV|arv
575193|NCT00476606|Second line HAART|second line haart
575194|NCT00476606|Viral Load|viral load
575195|NCT00476606|Combination drug|combination drug
575196|NCT00476606|Treatment Experienced|treatment experienced
575197|NCT00476606|Treatment Naive|treatment naive
575198|NCT00476619|Contrast|contrast
575199|NCT00476619|Nephropathy|nephropathy
575200|NCT00476619|acute renal failure|acute renal failure
575201|NCT00476619|Erythropoietin|erythropoietin
575202|NCT00476619|CT scan|ct scan
575203|NCT00476632|Epidemiology|epidemiology
575204|NCT00476632|Questionnaire|questionnaire
575205|NCT00476632|Controls|controls
575206|NCT00476658|Obesity|obesity
575207|NCT00476658|macrophage infiltration|macrophage infiltration
575208|NCT00476658|insulinoresistance|insulinoresistance
575209|NCT00476658|inflammation|inflammation
575210|NCT00476671|neuropsychiatric|neuropsychiatric
575211|NCT00476671|neurocognitive|neurocognitive
575212|NCT00476671|psychiatric|psychiatric
575213|NCT00476671|HIV related dementia|hiv related dementia
575214|NCT00476671|MCMD|mcmd
575215|NCT00476671|HIV-1|hiv-1
575216|NCT00476671|Prevalence, risk factors of neurocognitive impairment and psychiatric comorbidities in HIV-1 infected patients with undetectable viral load in the HAART era.|prevalence, risk factors of neurocognitive impairment and psychiatric comorbidities in hiv-1 infected patients with undetectable viral load in the haart era.
575217|NCT00476671|Treatment Experienced|treatment experienced
575218|NCT00476684|radiofrequency|radiofrequency
575219|NCT00476697|UVA1|uva1
575220|NCT00476697|scleroderma|scleroderma
575221|NCT00476697|keloids|keloids
575222|NCT00476697|morphea|morphea
575223|NCT00476697|light therapy|light therapy
575224|NCT00476710|Type 2 diabetes mellitus|type 2 diabetes mellitus
575225|NCT00476710|Bile acid|bile acid
575226|NCT00476710|Stable isotope|stable isotope
575227|NCT00476710|Colesevelam HCl|colesevelam hcl
575228|NCT00476710|Impaired Glucose Tolerance|impaired glucose tolerance
575229|NCT00476723|HIV infection|hiv infection
575230|NCT00476723|Hepatitis coinfection|hepatitis coinfection
575231|NCT00476736|COPD|copd
575232|NCT00476736|Pulmonary function|pulmonary function
575233|NCT00476736|Air trapping|air trapping
575234|NCT00476736|Acetyl cystein|acetyl cystein
575235|NCT00476775|obesity|obesity
575236|NCT00476775|prevention|prevention
575237|NCT00476775|girls|girls
575238|NCT00476775|Latina/Hispanic|latina/hispanic
575239|NCT00476775|Dance|dance
575240|NCT00476775|television|television
575241|NCT00476775|screen time|screen time
575242|NCT00476788|pediatrics|pediatrics
575243|NCT00476788|CSII|csii
575244|NCT00476788|diabetes|diabetes
575245|NCT00476788|C-peptide|c-peptide
575246|NCT00476788|adverse events|adverse events
575247|NCT00476801|UVA1|uva1
575248|NCT00476801|scleroderma|scleroderma
575249|NCT00476801|keloids|keloids
575250|NCT00476801|light therapy|light therapy
575251|NCT00476801|morphea|morphea
575252|NCT00486109|Diabetes|diabetes
575253|NCT00486135|Cancer|cancer
575254|NCT00486135|Solid tumors|solid tumors
575255|NCT00486135|Lymphoma|lymphoma
575256|NCT00486148|Formula|formula
575257|NCT00486148|Feeding|feeding
575258|NCT00486148|Healthy|healthy
575259|NCT00486148|Full|full
575260|NCT00486148|Term|term
575261|NCT00486148|Infants|infants
575262|NCT00486161|Obesity|obesity
575263|NCT00486161|Ghrelin|ghrelin
575264|NCT00486161|Non-esterified fatty acids|non-esterified fatty acids
575265|NCT00486161|Growth hormone|growth hormone
575266|NCT00486161|Insulin|insulin
575267|NCT00486161|Cycloergometer exercise|cycloergometer exercise
575268|NCT00486174|Sepsis|sepsis
575269|NCT00486174|Methylene Blue|methylene blue
575270|NCT00486174|Norepinephrine|norepinephrine
575271|NCT00486187|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
575272|NCT00486187|Thiazolidinediones|thiazolidinediones
575273|NCT00486187|Rosiglitazone|rosiglitazone
575274|NCT00486187|Adipokine|adipokine
575275|NCT00486187|Inflammation|inflammation
575276|NCT00486187|Cardiometabolic risk|cardiometabolic risk
575277|NCT00486187|Angiotensin receptor blocker|angiotensin receptor blocker
575278|NCT00486200|Herpes Genitalis|herpes genitalis
575279|NCT00486200|Herpes Simplex Virus Genital Infection|herpes simplex virus genital infection
575280|NCT00486200|Genital Herpes|genital herpes
575281|NCT00486200|ASP2151|asp2151
575282|NCT00486200|Treatment Outcome|treatment outcome
575283|NCT00486200|Sexually Transmitted Disease|sexually transmitted disease
575284|NCT00486213|dermatologic complications|dermatologic complications
575285|NCT00486213|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
575379|NCT00487266|Acupuncture|acupuncture
575286|NCT00486213|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
575287|NCT00486213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
575288|NCT00486239|Epilepsy|epilepsy
575289|NCT00486239|memory|memory
575290|NCT00486239|emotion|emotion
575291|NCT00486265|Phase I|phase i
575292|NCT00486265|Phase II|phase ii
575293|NCT00486265|acute myelogenous leukemia|acute myelogenous leukemia
575294|NCT00486265|AML|aml
575295|NCT00486265|cancer|cancer
575296|NCT00486291|Diabetes, Obese diabetics|diabetes, obese diabetics
575297|NCT00486304|cachexia|cachexia
575298|NCT00486304|weight changes|weight changes
575299|NCT00486304|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
575300|NCT00486304|stage I oropharyngeal cancer|stage i oropharyngeal cancer
575301|NCT00486304|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
575302|NCT00486304|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
575303|NCT00486304|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
575304|NCT00486317|Osteoarthritis, oral salmon calcitonin, tolerability, biomarkers|osteoarthritis, oral salmon calcitonin, tolerability, biomarkers
575305|NCT00486330|HIV|hiv
575306|NCT00486330|Pharmacokinetics|pharmacokinetics
575307|NCT00486330|Buprenorphine|buprenorphine
575308|NCT00486330|Tipranavir|tipranavir
575309|NCT00486330|HIV Seronegativity|hiv seronegativity
575310|NCT00486343|Asthma|asthma
575311|NCT00486343|ICS|ics
575312|NCT00486343|5-LO Inhibition|5-lo inhibition
575313|NCT00486343|Leukotrienes|leukotrienes
575314|NCT00486343|Asthma control|asthma control
575315|NCT00486343|Asthma exacerbations|asthma exacerbations
575316|NCT00486356|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
575317|NCT00486356|recurrent gastric cancer|recurrent gastric cancer
575318|NCT00486356|stage IV gastric cancer|stage iv gastric cancer
575319|NCT00486356|advanced adult primary liver cancer|advanced adult primary liver cancer
575320|NCT00486356|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
575321|NCT00486356|recurrent adult primary liver cancer|recurrent adult primary liver cancer
575322|NCT00486356|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
575323|NCT00486356|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
575324|NCT00486356|recurrent gallbladder cancer|recurrent gallbladder cancer
575325|NCT00486356|unresectable gallbladder cancer|unresectable gallbladder cancer
575326|NCT00486369|Osteoarthritis, oral salmon calcitonin, tolerability, biomarkers|osteoarthritis, oral salmon calcitonin, tolerability, biomarkers
575327|NCT00486382|visceral leishmaniasis|visceral leishmaniasis
575328|NCT00486382|vaccine|vaccine
575329|NCT00486395|prematurity|prematurity
575330|NCT00486395|randomized trial|randomized trial
575331|NCT00486395|RDS|rds
575332|NCT00486395|surfactant|surfactant
575333|NCT00486395|CPAP|cpap
575334|NCT00486395|ventilation|ventilation
575335|NCT00486408|HIV Seronegativity|hiv seronegativity
575336|NCT00486408|HIV Preventive Vaccine|hiv preventive vaccine
575337|NCT00486408|Adenovirus|adenovirus
575338|NCT00486421|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
575339|NCT00486434|Osteoarthritis, oral salmon calcitonin, treatment, efficacy, tolerability|osteoarthritis, oral salmon calcitonin, treatment, efficacy, tolerability
575340|NCT00487084|analgesia|analgesia
575341|NCT00487084|tubal ligation|tubal ligation
575342|NCT00487084|chloroprocaine|chloroprocaine
575343|NCT00487097|intensive care|intensive care
575344|NCT00487097|critically ill|critically ill
575345|NCT00487097|fish oil|fish oil
575346|NCT00487097|pressure sores|pressure sores
575347|NCT00487110|Pain|pain
575348|NCT00487110|serotonin|serotonin
575349|NCT00487110|interaction|interaction
575350|NCT00487110|Patients with postsurgical pain, after ear surgery|patients with postsurgical pain, after ear surgery
575351|NCT00487123|Hypertension, compliance, Valsartan, hydrochlorothiazide (HCTZ)|hypertension, compliance, valsartan, hydrochlorothiazide (hctz)
575352|NCT00487136|Drug Interaction|drug interaction
575353|NCT00487136|Pharmacokinetics|pharmacokinetics
575354|NCT00487136|Pharmacodynamics|pharmacodynamics
575355|NCT00487149|Repeatability|repeatability
575356|NCT00487149|Respiratory Muscle Strength|respiratory muscle strength
575357|NCT00487162|glycemic control, diabetes, obesity, comorbidities|glycemic control, diabetes, obesity, comorbidities
575358|NCT00487175|Pain|pain
575359|NCT00487175|sensitization|sensitization
575360|NCT00487175|analgesia|analgesia
575361|NCT00487175|Healthy volunteers and pain|healthy volunteers and pain
575362|NCT00487201|liver transplantation|liver transplantation
575363|NCT00487201|biliary strictures|biliary strictures
575364|NCT00487201|ERCP|ercp
575365|NCT00487227|caffeine|caffeine
575366|NCT00487227|coffee|coffee
575367|NCT00487227|decaffeinated|decaffeinated
575368|NCT00487227|cognition|cognition
575369|NCT00487227|mood|mood
575370|NCT00487227|autonomic|autonomic
575371|NCT00487240|diabetes|diabetes
575372|NCT00487240|type 1|type 1
575373|NCT00487253|Cutaneous Leishmaniasis|cutaneous leishmaniasis
575374|NCT00487253|Leishmania Viannia|leishmania viannia
575375|NCT00487253|Pediatric|pediatric
575376|NCT00487253|Miltefosine|miltefosine
574784|NCT00484978|Surgery|surgery
575377|NCT00487253|Randomized|randomized
575378|NCT00487253|Colombia|colombia
575380|NCT00487266|Torque|torque
575381|NCT00487266|Force Decay|force decay
575382|NCT00487279|Coronary|coronary
575383|NCT00487279|Artery|artery
575384|NCT00487279|Disease|disease
575385|NCT00487279|Sudden|sudden
575386|NCT00487279|Cardiac|cardiac
575387|NCT00487279|Death|death
575389|NCT00487292|accidents|accidents
575390|NCT00487292|shift work|shift work
575391|NCT00487292|sleepiness|sleepiness
575392|NCT00487292|naps|naps
575393|NCT00487292|bright light pulses|bright light pulses
575394|NCT00487292|sleep|sleep
575395|NCT00487305|GM-CSF|gm-csf
575396|NCT00487305|vaccine|vaccine
575397|NCT00487305|K562|k562
575398|NCT00487318|fluvastatin|fluvastatin
575399|NCT00487318|hepatitis C|hepatitis c
575400|NCT00487318|chronic hepatitis C|chronic hepatitis c
575401|NCT00487318|not previously treated with pegylated interferon and ribavirin|not previously treated with pegylated interferon and ribavirin
575402|NCT00487331|Solid Tumors|solid tumors
575403|NCT00487331|Acupuncture|acupuncture
575404|NCT00487331|Uncontrolled Pain|uncontrolled pain
575405|NCT00487331|Pain|pain
575406|NCT00487344|medicaid|medicaid
575407|NCT00487344|insurance|insurance
575408|NCT00487344|education|education
575409|NCT00487344|clinical|clinical
575410|NCT00487344|trial|trial
575411|NCT00487344|healthcare|healthcare
575412|NCT00487344|reimburse|reimburse
575413|NCT00487344|pay|pay
575414|NCT00487344|free|free
575415|NCT00487344|assist|assist
575416|NCT00487344|study|study
575417|NCT00487344|oklahoma|oklahoma
575418|NCT00487344|edmond|edmond
575419|NCT00487344|Oklahoma City|oklahoma city
575420|NCT00487344|diet|diet
575421|NCT00487344|nutrition|nutrition
575422|NCT00487344|weight loss|weight loss
575423|NCT00487344|body|body
575424|NCT00487344|fat|fat
575425|NCT00487344|obese|obese
575426|NCT00487344|overweight|overweight
575427|NCT00487344|health|health
575428|NCT00487344|medical|medical
575429|NCT00487344|therapy|therapy
575430|NCT00487344|meal plan|meal plan
575431|NCT00487344|jenny craig|jenny craig
575432|NCT00487344|weight watcher|weight watcher
575433|NCT00487344|LA Weightloss|la weightloss
575434|NCT00487344|Bryan Attebery|bryan attebery
575435|NCT00487344|Results|results
575436|NCT00487344|YMCA|ymca
575437|NCT00487344|UCO|uco
575438|NCT00487344|OSU|osu
575439|NCT00487344|OU|ou
575440|NCT00487344|clinics|clinics
575441|NCT00487344|physicians|physicians
575442|NCT00487344|surgery|surgery
575443|NCT00487344|pills|pills
575444|NCT00487344|financial|financial
575445|NCT00487344|money|money
575446|NCT00487357|Epidemiology|epidemiology
575447|NCT00487357|Cancer Prevention|cancer prevention
575448|NCT00487357|Questionnaire|questionnaire
575449|NCT00487357|MATCh|match
575450|NCT00487357|Survey|survey
575451|NCT00487370|Acupuncture|acupuncture
575452|NCT00487370|Gold implantation|gold implantation
575453|NCT00487370|Osteoarthritis|osteoarthritis
575454|NCT00487370|Knee osteoarthritis|knee osteoarthritis
575455|NCT00487370|Double-blind, randomized controlled trial|double-blind, randomized controlled trial
575456|NCT00487370|Intervention|intervention
575457|NCT00487370|Family practice|family practice
575458|NCT00487383|Cerebellum|cerebellum
575459|NCT00487383|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
575460|NCT00487383|Blepharospasm|blepharospasm
575461|NCT00487383|DYT-1 Generalized Dystonia|dyt-1 generalized dystonia
575462|NCT00487383|Focal Dystonia|focal dystonia
575463|NCT00487383|Dystonia|dystonia
575464|NCT00487383|Healthy Volunteer|healthy volunteer
575465|NCT00487383|HV|hv
575466|NCT00487396|capsule endoscopy|capsule endoscopy
575467|NCT00487396|Crohn's disease|crohn's disease
575468|NCT00487396|small bowel disease|small bowel disease
575469|NCT00487396|inflammatory bowel disease|inflammatory bowel disease
575470|NCT00487396|Patients with suspected small bowel Crohn's disease|patients with suspected small bowel crohn's disease
575471|NCT00487409|Ulcerative colitis|ulcerative colitis
575472|NCT00487409|Crohn's disease|crohn's disease
575473|NCT00487409|Colorectal polyps|colorectal polyps
575474|NCT00487409|Colorectal malignancy|colorectal malignancy
575475|NCT00487409|Endometriosis|endometriosis
575476|NCT00487409|Diverticulitis|diverticulitis
575477|NCT00487409|Colonic inertia|colonic inertia
575478|NCT00487422|constipation|constipation
575479|NCT00487422|prucalopride|prucalopride
575480|NCT00487422|QOL|qol
575481|NCT00487422|SCBM|scbm
575482|NCT00487422|PAC-SYM|pac-sym
575483|NCT00487435|CG5503|cg5503
575484|NCT00487435|Tapentadol|tapentadol
575485|NCT00487435|chronic non-malignant pain|chronic non-malignant pain
575486|NCT00487435|osteoarthritis|osteoarthritis
575487|NCT00487435|lower back pain|lower back pain
575488|NCT00487435|analgesic|analgesic
575489|NCT00487435|opioid|opioid
575490|NCT00487448|Myelodysplastic Syndrome|myelodysplastic syndrome
575491|NCT00487448|Chemotherapy|chemotherapy
575492|NCT00487448|Peripheral blood stem cells transplantation|peripheral blood stem cells transplantation
753195|NCT01175824|Glargine|glargine
575493|NCT00487448|Bone marrow transplantation|bone marrow transplantation
575494|NCT00487448|Secondary Acute Myeloblastic Leukemia|secondary acute myeloblastic leukemia
575496|NCT00487461|Vasospasm|vasospasm
575497|NCT00487487|Candidates for this study are survivors of paralytic poliomyelitis|candidates for this study are survivors of paralytic poliomyelitis
575498|NCT00487500|Major Depressive Disorder|major depressive disorder
575499|NCT00487500|Electroconvulsive Therapy|electroconvulsive therapy
575500|NCT00487513|Follicular B Cell lymphoma|follicular b cell lymphoma
575501|NCT00487513|vaccination|vaccination
575502|NCT00487526|Bypass|bypass
575503|NCT00487526|Duodenal jejunal|duodenal jejunal
575504|NCT00487526|type 2 diabetes|type 2 diabetes
575505|NCT00487526|non-obese adults|non-obese adults
575506|NCT00487539|Colitis, Ulcerative|colitis, ulcerative
575507|NCT00487539|Golimumab|golimumab
575508|NCT00487539|CNTO 148|cnto 148
575509|NCT00487552|endoscopy|endoscopy
575510|NCT00487552|esophagogastroduodenoscopy|esophagogastroduodenoscopy
575511|NCT00487552|gastric outlet obstruction|gastric outlet obstruction
575512|NCT00487552|gastro-jejunostomy|gastro-jejunostomy
575513|NCT00487552|gastric malignancy|gastric malignancy
575514|NCT00487552|duodenal stent|duodenal stent
575515|NCT00487552|Malignant Gastric Outlet Obstruction|malignant gastric outlet obstruction
575516|NCT00487565|Total knee replacement|total knee replacement
575517|NCT00487565|Total knee arthroplasty|total knee arthroplasty
575518|NCT00487565|Osteoarthritis|osteoarthritis
575519|NCT00487565|Rheumatoid or other inflammatory arthritis|rheumatoid or other inflammatory arthritis
575520|NCT00487565|Post-traumatic or juvenile arthritis|post-traumatic or juvenile arthritis
575521|NCT00487578|Post traumatic headache|post traumatic headache
575522|NCT00487578|Head trauma|head trauma
575523|NCT00487578|Head injury|head injury
575524|NCT00487578|Headache|headache
575525|NCT00487578|Naratriptan|naratriptan
575526|NCT00487591|cholesterol|cholesterol
575527|NCT00487591|dyslipidemia|dyslipidemia
575528|NCT00487591|omega 3|omega 3
575529|NCT00487604|Coronary Artery Disease|coronary artery disease
575530|NCT00487604|Drug Eluting Stent|drug eluting stent
575531|NCT00487604|Bare Metal Stent|bare metal stent
575532|NCT00487604|Subacute thrombosis|subacute thrombosis
575533|NCT00487604|Bleeding|bleeding
575534|NCT00487604|Economic|economic
575535|NCT00487617|Arteriopathy|arteriopathy
575536|NCT00487617|endothelial function|endothelial function
575537|NCT00487617|fruit juice|fruit juice
575538|NCT00487630|Heterozygous females|heterozygous females
575539|NCT00487630|Cardiomyopathy|cardiomyopathy
575540|NCT00487643|Lacritin|lacritin
575541|NCT00487669|paclitaxel poliglumex|paclitaxel poliglumex
575542|NCT00487669|xyotax|xyotax
575543|NCT00487669|alimta|alimta
575544|NCT00487669|advanced non-small cell lung cancer|advanced non-small cell lung cancer
575545|NCT00487682|herpes zoster|herpes zoster
575546|NCT00487682|ASP2151|asp2151
575547|NCT00487682|Valacyclovir hydrochloride|valacyclovir hydrochloride
575548|NCT00487695|Barrett's esophagus|barrett's esophagus
575549|NCT00487695|Esophageal adenocarcinoma|esophageal adenocarcinoma
575550|NCT00487695|Endoscopy|endoscopy
575551|NCT00487695|Confocal laser endomicroscopy|confocal laser endomicroscopy
575552|NCT00487708|ACZ885|acz885
575553|NCT00487708|NALP3 mutations|nalp3 mutations
575554|NCT00487708|Interleukin-1beta|interleukin-1beta
575555|NCT00487708|Muckle-Wells Syndrome|muckle-wells syndrome
575556|NCT00487721|Prostate cancer|prostate cancer
575557|NCT00487734|Metabolic Syndrome|metabolic syndrome
575558|NCT00487734|Hypogonadism|hypogonadism
575559|NCT00487734|Insulin Resistance|insulin resistance
575560|NCT00487760|Lung Cancer|lung cancer
575561|NCT00487760|African-American Families|african-american families
575562|NCT00487760|Genetic Risk Communication|genetic risk communication
575563|NCT00487760|Interest in Genetic Testing and Genetics Research|interest in genetic testing and genetics research
575564|NCT00487760|Health Disparities|health disparities
575565|NCT00487760|Smoking Cessation|smoking cessation
575566|NCT00487773|asthma|asthma
575567|NCT00487773|children|children
575568|NCT00487773|inhaled glucocorticosteroids|inhaled glucocorticosteroids
575569|NCT00487773|bone metabolism|bone metabolism
575570|NCT00487786|Antisense|antisense
575571|NCT00487786|Heat Shock Protein|heat shock protein
575572|NCT00487799|Acute Decompensated Heart Failure|acute decompensated heart failure
575573|NCT00487799|ADHF|adhf
575574|NCT00487799|Heart Failure|heart failure
575575|NCT00487812|Acute myocardial infarction|acute myocardial infarction
575576|NCT00487812|left ventricular remodelling|left ventricular remodelling
575577|NCT00487812|SPECT imaging|spect imaging
583556|NCT00512161|Any patient undergoing elective cardiac surgery|any patient undergoing elective cardiac surgery
583557|NCT00512174|Portable Ultrasound Scanner|portable ultrasound scanner
575578|NCT00487825|ACR20, ACR50, ACZ885 (anti-interleukin-1beta monoclonal antibody), rheumatoid arthritis, methotrexate|acr20, acr50, acz885 (anti-interleukin-1beta monoclonal antibody), rheumatoid arthritis, methotrexate
575579|NCT00487838|Autofluorescence Imaging|autofluorescence imaging
743680|NCT01137760|flu|flu
575580|NCT00487838|Early Age-Related Maculopathy|early age-related maculopathy
575581|NCT00487838|Photochemical Changes|photochemical changes
575582|NCT00487838|Colored Sunglasses|colored sunglasses
575583|NCT00487838|Pseudophakes|pseudophakes
575584|NCT00487838|Fundus Camera|fundus camera
575585|NCT00487838|Confocal Scanning Laser Ophthalmoscope|confocal scanning laser ophthalmoscope
575586|NCT00487838|Molecular Imaging within Retina|molecular imaging within retina
575587|NCT00487838|Spectral Balance among Photochemical Processes|spectral balance among photochemical processes
575588|NCT00487838|Noninvasive Autofluorescence Imaging|noninvasive autofluorescence imaging
575589|NCT00487838|Age-Related Maculopathy (AMD)|age-related maculopathy (amd)
575590|NCT00487838|Age-Related Macular Degeneration|age-related macular degeneration
575592|NCT00487838|Age-Related Macular Changes|age-related macular changes
575593|NCT00487838|Early Age-Related Macular Changes|early age-related macular changes
575594|NCT00487851|Pancreatic|pancreatic
575595|NCT00487851|cancer|cancer
575596|NCT00487851|Periampullay|periampullay
575597|NCT00487851|Neoplasms|neoplasms
575598|NCT00487851|Biliary|biliary
575599|NCT00487851|Duodenal|duodenal
575600|NCT00487851|Jaundice|jaundice
575601|NCT00487851|obstruction|obstruction
575602|NCT00487851|pancreas cancer|pancreas cancer
575603|NCT00487851|Pancreatic cancer|pancreatic cancer
575604|NCT00487877|metabolism, temperature changing, skin, heart rate|metabolism, temperature changing, skin, heart rate
575605|NCT00487890|Geriatric|geriatric
575606|NCT00487890|Abdominal|abdominal
575607|NCT00487890|Surgery|surgery
575608|NCT00487890|gastrointestinal surgery|gastrointestinal surgery
575609|NCT00487890|intrabdominal surgery|intrabdominal surgery
575610|NCT00487903|Coronary Artery Disease|coronary artery disease
575611|NCT00487903|Echocardiogram|echocardiogram
575612|NCT00487903|Contrast|contrast
575613|NCT00487903|Perfusion|perfusion
575614|NCT00487903|Ultrasound|ultrasound
575615|NCT00487903|Normal volunteers|normal volunteers
575616|NCT00487916|Blood Stage|blood stage
575617|NCT00487916|Investigational|investigational
575618|NCT00487916|Vaccine|vaccine
575619|NCT00487916|Malaria|malaria
575620|NCT00487916|Healthy Volunteer|healthy volunteer
575621|NCT00487916|HV|hv
575622|NCT00487929|sleep apnea|sleep apnea
575623|NCT00487929|morbidity|morbidity
575624|NCT00487929|cardiovascular|cardiovascular
575625|NCT00487929|cpap|cpap
575626|NCT00487929|oxidative stress|oxidative stress
575627|NCT00487955|gastritis|gastritis
575628|NCT00487955|helicobacter pylori|helicobacter pylori
575629|NCT00487955|REE|ree
575630|NCT00487955|patients with gastritis that refers to helicobacter pylori treatment|patients with gastritis that refers to helicobacter pylori treatment
575631|NCT00487968|healthy adult volunteers|healthy adult volunteers
575632|NCT00487968|eltrombopag|eltrombopag
575633|NCT00487981|Pain|pain
575634|NCT00487981|Implantable stimulation device|implantable stimulation device
575635|NCT00487981|Neuropathy|neuropathy
575636|NCT00487994|Hypercholesterolemia|hypercholesterolemia
575637|NCT00487994|Hyperlipidemia|hyperlipidemia
575638|NCT00487994|Drug Therapy|drug therapy
575639|NCT00488007|Alzheimer disease|alzheimer disease
575640|NCT00488007|Cognitive impairment|cognitive impairment
575641|NCT00488007|Sensorineural hearing loss|sensorineural hearing loss
575642|NCT00488007|Hearing aids|hearing aids
575643|NCT00488020|rest pain|rest pain
575644|NCT00488020|ischemic ulcers|ischemic ulcers
575645|NCT00488033|Coronary Artery Disease|coronary artery disease
575646|NCT00488033|Diabetes|diabetes
575647|NCT00488033|CT Angiography|ct angiography
575648|NCT00488046|Bird Flu|bird flu
575649|NCT00488059|Treatment Experienced|treatment experienced
575650|NCT00488072|Advanced Cancer|advanced cancer
575651|NCT00488072|Anorexia|anorexia
575652|NCT00488072|Weight Loss|weight loss
575653|NCT00488072|Insomnia|insomnia
575654|NCT00488072|Appetite|appetite
575655|NCT00488072|Mirtazapine|mirtazapine
575656|NCT00488072|Placebo|placebo
575657|NCT00488085|Crohn’s disease, obesity, REE, body composition, fat absorption|crohn’s disease, obesity, ree, body composition, fat absorption
575658|NCT00488098|Healthy Bioequivalence|healthy bioequivalence
575659|NCT00488111|Regional anesthesia|regional anesthesia
575660|NCT00488111|Fluid Therapy|fluid therapy
575661|NCT00488111|Hemostasis, Surgical|hemostasis, surgical
575662|NCT00488124|short stature|short stature
575663|NCT00488137|constipation|constipation
575664|NCT00488137|prucalopride|prucalopride
575665|NCT00488137|QOL|qol
575666|NCT00488137|SCBM|scbm
575667|NCT00488137|PAC-SYM|pac-sym
575668|NCT00488163|schizophrenia|schizophrenia
575669|NCT00488163|cognition|cognition
575670|NCT00488163|atomoxetine|atomoxetine
575671|NCT00488163|norepinephrine|norepinephrine
575672|NCT00488163|dopamine|dopamine
575673|NCT00488176|seasonal allergic rhinitis|seasonal allergic rhinitis
575674|NCT00488176|children|children
575675|NCT00488176|montelukast|montelukast
575676|NCT00488176|cetirizine|cetirizine
575677|NCT00488202|Advanced Ovarian Cancer|advanced ovarian cancer
575678|NCT00488202|Sexual Function|sexual function
575679|NCT00488215|constipation|constipation
575680|NCT00488215|prucalopride|prucalopride
575681|NCT00488215|MTD|mtd
575682|NCT00488215|cardiovascular safety|cardiovascular safety
575683|NCT00488241|Eczema|eczema
575684|NCT00488241|Medical device|medical device
575685|NCT00488254|Long QT Syndrome|long qt syndrome
575686|NCT00488254|Romano Ward|romano ward
575687|NCT00488254|Jervell-Lange Nielson Syndrome|jervell-lange nielson syndrome
575688|NCT00488267|Osteoarthritis|osteoarthritis
575689|NCT00488267|Pain|pain
575690|NCT00488280|walking|walking
575691|NCT00488280|walking recovery|walking recovery
575692|NCT00488280|physical therapy|physical therapy
575693|NCT00488280|locomotor training|locomotor training
575694|NCT00488280|body weight support|body weight support
575695|NCT00488280|neuroplasticity|neuroplasticity
575696|NCT00488280|step|step
575697|NCT00488280|treadmill|treadmill
575698|NCT00488280|treadmill training|treadmill training
575699|NCT00488280|locomotion|locomotion
575700|NCT00488293|Telemedicine|telemedicine
575701|NCT00488293|Skin diseases|skin diseases
575702|NCT00488293|Dermatology|dermatology
575703|NCT00488293|Quality of life|quality of life
575704|NCT00488293|Economics|economics
575705|NCT00488306|Tigecycline|tigecycline
575706|NCT00488306|Complicated intra-abdominal infections|complicated intra-abdominal infections
575707|NCT00488306|cIAI|ciai
575708|NCT00488319|Schizophrenia|schizophrenia
575709|NCT00488319|Adolescent|adolescent
575710|NCT00488319|Paliperidone|paliperidone
575711|NCT00488319|Antipsychotic agents|antipsychotic agents
575712|NCT00488319|Antipsychotic drugs|antipsychotic drugs
575713|NCT00488319|Psychosis.|psychosis.
575714|NCT00488332|Head and Neck Cancer|head and neck cancer
575715|NCT00488332|Oral Mucositis|oral mucositis
575716|NCT00488332|Optical Coherence Tomography|optical coherence tomography
575717|NCT00488332|Fluorescence Spectroscopy|fluorescence spectroscopy
575718|NCT00488332|Optical Assessment|optical assessment
575719|NCT00488345|cIAI|ciai
575720|NCT00488345|cSSSI|csssi
575721|NCT00488345|CAP|cap
575722|NCT00488345|Child|child
575723|NCT00488358|abdominal|abdominal
575724|NCT00488358|aortic|aortic
575725|NCT00488358|aneurysm|aneurysm
575726|NCT00488358|Zenith|zenith
575727|NCT00488358|blood pressure|blood pressure
575728|NCT00488371|Streptococcus pneumoniae nasopharyngeal carriage|streptococcus pneumoniae nasopharyngeal carriage
575729|NCT00488384|Squamous cell carcinoma of the skin under hemodialysis|squamous cell carcinoma of the skin under hemodialysis
575730|NCT00488397|Tygacil|tygacil
575731|NCT00488397|microdilution method|microdilution method
575732|NCT00488397|Tigecycline|tigecycline
575733|NCT00488397|In-Vitro|in-vitro
575734|NCT00488410|Chronic heart failure|chronic heart failure
575735|NCT00488410|real time three-dimensional echocardiography|real time three-dimensional echocardiography
575736|NCT00488410|cardiac resynchronization therapy|cardiac resynchronization therapy
575737|NCT00488410|ventricular asynchrony|ventricular asynchrony
575738|NCT00488410|systolic dysynchrony index|systolic dysynchrony index
575739|NCT00488423|diabetes|diabetes
575740|NCT00488423|MIDAS|midas
575741|NCT00488423|gut hormones|gut hormones
575742|NCT00488423|gastric bypass|gastric bypass
575743|NCT00488423|lap band|lap band
575744|NCT00488436|Myelodysplastic Syndrome|myelodysplastic syndrome
575745|NCT00488436|Antithymocyte Globulin|antithymocyte globulin
575746|NCT00488436|Cyclosporine|cyclosporine
575747|NCT00488449|Dose Escalation|dose escalation
575748|NCT00488449|GSK256073A,|gsk256073a,
575749|NCT00488462|obstetric hemorrhage|obstetric hemorrhage
575750|NCT00488462|hypovolemic shock|hypovolemic shock
575751|NCT00488462|non-pneumatic anti-shock garment|non-pneumatic anti-shock garment
575752|NCT00488462|safe motherhood|safe motherhood
575753|NCT00488462|maternal mortality|maternal mortality
575754|NCT00488462|maternal morbidity|maternal morbidity
575755|NCT00488501|intrathoracic impedance|intrathoracic impedance
575756|NCT00488501|cardiac resynchronization therapy|cardiac resynchronization therapy
575757|NCT00488501|heart failure|heart failure
575758|NCT00488514|Long-term Safety|long-term safety
575759|NCT00488514|Migraine|migraine
575760|NCT00488514|Adolescent Migraine Headache|adolescent migraine headache
575761|NCT00488514|sumatriptan succinate|sumatriptan succinate
575762|NCT00488514|naproxen sodium|naproxen sodium
575763|NCT00488540|newborn|newborn
575764|NCT00488540|infant|infant
575765|NCT00488540|pain|pain
575766|NCT00488540|acetaminophen|acetaminophen
575767|NCT00488540|paracetamol|paracetamol
575768|NCT00488540|mode of delivery|mode of delivery
575769|NCT00488540|vacuum extraction|vacuum extraction
575770|NCT00488540|forceps extraction|forceps extraction
575771|NCT00488540|cesarean section|cesarean section
575772|NCT00488540|EDIN scale|edin scale
575773|NCT00488540|Bernese Pain Scale for Neonates|bernese pain scale for neonates
741364|NCT01131117|pregnancy|pregnancy
575774|NCT00488540|pain after different modes of delivery in newborn infants|pain after different modes of delivery in newborn infants
575775|NCT00488540|efficacy of acetaminophen as analgesia for newborn infants|efficacy of acetaminophen as analgesia for newborn infants
575776|NCT00488553|Lymphoma|lymphoma
575777|NCT00488553|Epidemiology|epidemiology
575778|NCT00488553|Lifestyle Factors|lifestyle factors
575779|NCT00488553|Questionnaire|questionnaire
575780|NCT00488553|Survey|survey
575781|NCT00488566|bipolar disorder,|bipolar disorder,
575782|NCT00488566|single doses,|single doses,
575783|NCT00488566|resting motor threshold|resting motor threshold
575785|NCT00488579|iron prophylaxis|iron prophylaxis
575786|NCT00488579|pregnancy|pregnancy
575787|NCT00488579|birth weight|birth weight
575788|NCT00488579|prematurity|prematurity
575789|NCT00488579|perinatal mortality|perinatal mortality
575790|NCT00488592|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
575791|NCT00488592|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
575792|NCT00488592|Chronic Myeloid Leukemia (CML)|chronic myeloid leukemia (cml)
575793|NCT00488592|Wilm's Tumor-1|wilm's tumor-1
575794|NCT00488592|Proteinase-3|proteinase-3
575795|NCT00488592|Myelodysplastic Syndrome|myelodysplastic syndrome
575796|NCT00488592|MDS|mds
575797|NCT00488592|Acute Myeloid Leukemia|acute myeloid leukemia
575798|NCT00488592|AML|aml
575799|NCT00488592|Chronic Myeloid Leukemia|chronic myeloid leukemia
575800|NCT00488592|CML|cml
575801|NCT00488618|Mania|mania
575802|NCT00488618|Bipolar I Disorder|bipolar i disorder
575803|NCT00488618|Acute Mania Associated with Bipolar I Disorder|acute mania associated with bipolar i disorder
575804|NCT00488631|Colitis, Ulcerative|colitis, ulcerative
575805|NCT00488631|Golimumab|golimumab
575806|NCT00488631|CNTO 148|cnto 148
575807|NCT00488644|Hypothyroidism|hypothyroidism
575808|NCT00488644|Brain Tumor|brain tumor
575809|NCT00488644|Levothyroxine|levothyroxine
575810|NCT00488644|Liothyronine|liothyronine
575811|NCT00488644|Synthroid|synthroid
575812|NCT00488644|Cytomel|cytomel
575813|NCT00488657|speech|speech
575814|NCT00488657|Parkinson's disease|parkinson's disease
575815|NCT00488657|treatment|treatment
575816|NCT00488657|speech intelligibility|speech intelligibility
575817|NCT00488657|speaking rate|speaking rate
575818|NCT00488670|Alzheimer's disease|alzheimer's disease
575819|NCT00488670|elderly|elderly
575820|NCT00488670|open-label|open-label
575821|NCT00488670|escitalopram|escitalopram
575822|NCT00488683|Meningococcal disease|meningococcal disease
575823|NCT00488683|Prevention|prevention
575824|NCT00488683|Vaccination|vaccination
575825|NCT00488696|Aneurysm|aneurysm
575826|NCT00488696|Aortic Arch|aortic arch
575827|NCT00488696|Endovascular|endovascular
575828|NCT00488696|Stent-Graft|stent-graft
575829|NCT00488709|Acute Myeloid Leukemia|acute myeloid leukemia
575830|NCT00488709|Multi Drug Resistance|multi drug resistance
575831|NCT00488722|To observe the biological changes under concurrent Zoladex and CEF as neoadjuvant regimen with respect to the ER,PR,cerbB-2 status before and after therapy|to observe the biological changes under concurrent zoladex and cef as neoadjuvant regimen with respect to the er,pr,cerbb-2 status before and after therapy
575832|NCT00488735|Randomized controlled trial|randomized controlled trial
575833|NCT00488735|Back pain|back pain
575834|NCT00488735|Neck pain|neck pain
575835|NCT00488735|Rehabilitation|rehabilitation
575836|NCT00488735|Cognitive-behavioral|cognitive-behavioral
575837|NCT00488735|Primary care|primary care
575838|NCT00488735|Sick-listing|sick-listing
575839|NCT00488735|Health-care utilization.|health-care utilization.
575840|NCT00488748|MST|mst
575841|NCT00488748|Magnetic Seizure Therapy|magnetic seizure therapy
575842|NCT00488748|ECT|ect
575843|NCT00488748|Electroconvulsive Therapy|electroconvulsive therapy
575844|NCT00488748|Depression|depression
575845|NCT00488748|Magnetic|magnetic
575846|NCT00488761|Tigecycline|tigecycline
575847|NCT00488761|cSSSI|csssi
575848|NCT00488761|complicated skin and skin structure infections|complicated skin and skin structure infections
575849|NCT00488774|Colitis, ulcerative|colitis, ulcerative
575850|NCT00488774|Golimumab|golimumab
575851|NCT00488774|CNTO 148|cnto 148
575852|NCT00488787|dental|dental
575853|NCT00488787|surgery|surgery
575854|NCT00488787|analgesia|analgesia
575855|NCT00488787|2-4 impacted third molars|2-4 impacted third molars
575856|NCT00488800|Pneumococcal Infections/PC (Prevention & Control)|pneumococcal infections/pc (prevention & control)
575857|NCT00488813|Tzh-Chi ESBL study|tzh-chi esbl study
575858|NCT00488826|Vaccines, Pneumococcal Conjugate Vaccine|vaccines, pneumococcal conjugate vaccine
575859|NCT00488839|Spasticity|spasticity
575860|NCT00488839|Multiple Sclerosis|multiple sclerosis
575861|NCT00488865|increased risk for PE require caval interruption|increased risk for pe require caval interruption
575862|NCT00488878|Ovarian Cancer|ovarian cancer
575863|NCT00488878|Ovarian Carcinoma|ovarian carcinoma
575864|NCT00488878|Low-Grade Serous Carcinoma|low-grade serous carcinoma
575865|NCT00488878|Low Malignant Potential|low malignant potential
575866|NCT00488878|Peritoneum Tumors|peritoneum tumors
575867|NCT00488878|Psammocarcinoma|psammocarcinoma
575868|NCT00488878|Data Collection|data collection
575869|NCT00488878|Research Database|research database
575870|NCT00488891|Schizophrenia|schizophrenia
575871|NCT00488891|Paliperdone ER|paliperdone er
575872|NCT00488891|Invega|invega
575873|NCT00488891|Observational|observational
575874|NCT00488891|Antipsychotic agents|antipsychotic agents
575875|NCT00488904|infection|infection
575876|NCT00488904|colorectalcancer|colorectalcancer
575877|NCT00488904|omega-3 fedtsyre|omega-3 fedtsyre
575878|NCT00488904|complications|complications
575879|NCT00488917|Liver cirrhosis|liver cirrhosis
575880|NCT00488917|acute liver failure|acute liver failure
575881|NCT00488917|liver transplantation|liver transplantation
575882|NCT00488917|sepsis, infection|sepsis, infection
575884|NCT00488917|lipids|lipids
575885|NCT00488917|diagnosis|diagnosis
575886|NCT00488917|prognosis|prognosis
575887|NCT00488930|Obesity|obesity
575888|NCT00488930|Hyperglycemia|hyperglycemia
575889|NCT00488930|Diabetes Mellitus Type I|diabetes mellitus type i
575890|NCT00488930|Diabetes Mellitus Type II|diabetes mellitus type ii
575891|NCT00488943|Stent-Graft|stent-graft
575893|NCT00488943|Abdominal Aortic Anuerysm|abdominal aortic anuerysm
575894|NCT00488943|Zenith|zenith
575895|NCT00488943|Endovascular|endovascular
575995|NCT00489411|neurotoxicity|neurotoxicity
575996|NCT00489411|pain|pain
575896|NCT00488943|Treatment with Zenith Aortic Stent-Graft for repair Abdominal Aortic Aneurysm|treatment with zenith aortic stent-graft for repair abdominal aortic aneurysm
575897|NCT00488956|foot|foot
575898|NCT00488956|ankle|ankle
575899|NCT00488956|edema|edema
575900|NCT00488969|Morphine|morphine
575901|NCT00488969|Chronic Pain|chronic pain
575902|NCT00488969|Spinal Cord Injury|spinal cord injury
575903|NCT00488969|Neuropathic Pain|neuropathic pain
575904|NCT00488982|Metastatic Hormone Refractory Prostate Cancer|metastatic hormone refractory prostate cancer
575905|NCT00488995|HIV Therapeutic Vaccine|hiv therapeutic vaccine
575906|NCT00489008|Lung Cancer|lung cancer
575907|NCT00489008|Non-Small Cell|non-small cell
575908|NCT00489008|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
575909|NCT00489008|SBRT|sbrt
575910|NCT00489008|NSCLC|nsclc
575911|NCT00489021|Subacute care|subacute care
575912|NCT00489021|Activities of Daily Living|activities of daily living
575913|NCT00489021|Cognition assessment|cognition assessment
575914|NCT00489021|Mood assessment|mood assessment
575915|NCT00489021|Incontinence control|incontinence control
575916|NCT00489034|HIV|hiv
575917|NCT00489034|adolescent females|adolescent females
575918|NCT00489034|adherence|adherence
575919|NCT00489034|clinical care|clinical care
575920|NCT00489034|risk behaviors|risk behaviors
575921|NCT00489060|Cryoablation|cryoablation
575922|NCT00489060|Radiation|radiation
575923|NCT00489060|Prostate Cancer|prostate cancer
575924|NCT00489086|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
575925|NCT00489086|basal cell carcinoma of the skin|basal cell carcinoma of the skin
575926|NCT00489125|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
575927|NCT00489125|recurrent breast cancer|recurrent breast cancer
575928|NCT00489125|stage I breast cancer|stage i breast cancer
575929|NCT00489125|stage II breast cancer|stage ii breast cancer
575930|NCT00489125|stage IIIA breast cancer|stage iiia breast cancer
575931|NCT00489125|stage IIIB breast cancer|stage iiib breast cancer
575932|NCT00489125|stage IIIC breast cancer|stage iiic breast cancer
575933|NCT00489125|stage IV breast cancer|stage iv breast cancer
575934|NCT00489151|HBV|hbv
575935|NCT00489164|DIABETIC PATIENTS WITH NATIVE CORONARY ARTERY LESIONS|diabetic patients with native coronary artery lesions
575936|NCT00489177|cardiac resynchronization therapy|cardiac resynchronization therapy
575937|NCT00489177|response|response
575938|NCT00489177|Defibrillators|defibrillators
575939|NCT00489216|Graft Versus Host Disease|graft versus host disease
575940|NCT00489216|GVHD|gvhd
575941|NCT00489216|Efalizumab|efalizumab
575942|NCT00489216|Raptiva|raptiva
575943|NCT00489216|Steroid|steroid
575944|NCT00489216|Refractory|refractory
575945|NCT00489216|Skin|skin
575946|NCT00489216|Liver|liver
575947|NCT00489216|Lineberger|lineberger
575948|NCT00489216|University of North Carolina|university of north carolina
575949|NCT00489229|Rosiglitazone|rosiglitazone
575950|NCT00489229|Ramipril|ramipril
575951|NCT00489229|Impaired glucose tolerance|impaired glucose tolerance
575952|NCT00489229|Arterial stiffness|arterial stiffness
575953|NCT00489229|Diabetic vasculopathy|diabetic vasculopathy
575954|NCT00489255|Parkinson's disease|parkinson's disease
575955|NCT00489255|Anti-emetic|anti-emetic
575956|NCT00489255|Nausea|nausea
575957|NCT00489255|Vomiting|vomiting
575958|NCT00489268|Barrett's Esophagus|barrett's esophagus
575959|NCT00489268|Intestinal Metaplasia|intestinal metaplasia
575960|NCT00489268|Radiofrequency Ablation|radiofrequency ablation
575961|NCT00489281|sickle cell disease|sickle cell disease
575962|NCT00489294|Human growth hormone|human growth hormone
575963|NCT00489294|idiopathic short stature|idiopathic short stature
575964|NCT00489294|short stature|short stature
575965|NCT00489307|Advanced Cancer|advanced cancer
575966|NCT00489307|Solid Tumors|solid tumors
575967|NCT00489307|Fatigue|fatigue
575968|NCT00489307|Pain|pain
575969|NCT00489307|Nausea|nausea
575970|NCT00489307|Anorexia|anorexia
575971|NCT00489307|Dexamethasone|dexamethasone
575972|NCT00489307|Decadron|decadron
575973|NCT00489307|Placebo|placebo
575388|NCT00487279|ICD|icd
575974|NCT00489320|Coronary disease|coronary disease
575975|NCT00489320|Arteries|arteries
575976|NCT00489320|Atherosclerosis|atherosclerosis
575977|NCT00489320|Arteriosclerosis|arteriosclerosis
575978|NCT00489333|ProAlgaZyme|proalgazyme
575892|NCT00488943|AAA|aaa
575979|NCT00489333|Metabolic syndrome|metabolic syndrome
575980|NCT00489333|Inflammation|inflammation
575981|NCT00489333|Cardiovascular|cardiovascular
575982|NCT00489333|hsCRP|hscrp
575983|NCT00489333|Lipids|lipids
575984|NCT00489333|Algae|algae
575985|NCT00489385|Fibrosis|fibrosis
575986|NCT00489385|Viral Kinetics|viral kinetics
575987|NCT00489385|Hepatotoxicity|hepatotoxicity
575988|NCT00489385|Immunity|immunity
575989|NCT00489385|HIV Infection|hiv infection
575990|NCT00489385|Hepatitis C|hepatitis c
575992|NCT00489385|Treatment Experienced|treatment experienced
575993|NCT00489385|Treatment Naive|treatment naive
575994|NCT00489411|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
575997|NCT00489411|peripheral neuropathy|peripheral neuropathy
575998|NCT00489424|zoledronic acid|zoledronic acid
575999|NCT00489424|post dose symptoms|post dose symptoms
576000|NCT00489424|transient|transient
576001|NCT00489424|acetaminophen|acetaminophen
576002|NCT00489424|fluvastatin|fluvastatin
576003|NCT00489437|diagnosis|diagnosis
576004|NCT00489450|SK3530|sk3530
576005|NCT00489450|alcohol|alcohol
576006|NCT00489450|pharmacokinetics|pharmacokinetics
576007|NCT00489450|safety|safety
576008|NCT00489463|LNG-IUS|lng-ius
576009|NCT00489463|TCu 380A|tcu 380a
576010|NCT00489463|Ultrasonography|ultrasonography
576011|NCT00489463|Doppler color|doppler color
576012|NCT00489463|power Doppler|power doppler
576013|NCT00489463|female|female
576014|NCT00489463|Volunteers|volunteers
576015|NCT00489476|Staccato® Loxapine, Migraine|staccato® loxapine, migraine
576017|NCT00489489|interferon-beta|interferon-beta
576018|NCT00489489|adjunctive therapy|adjunctive therapy
576019|NCT00489489|relapses|relapses
576020|NCT00489515|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
576021|NCT00489515|stage I pancreatic cancer|stage i pancreatic cancer
576022|NCT00489515|stage II pancreatic cancer|stage ii pancreatic cancer
576023|NCT00489515|stage III pancreatic cancer|stage iii pancreatic cancer
576024|NCT00489515|stage IV pancreatic cancer|stage iv pancreatic cancer
576025|NCT00489515|stage I colon cancer|stage i colon cancer
576026|NCT00489515|stage II colon cancer|stage ii colon cancer
576027|NCT00489515|stage III colon cancer|stage iii colon cancer
576028|NCT00489515|stage IV colon cancer|stage iv colon cancer
576029|NCT00489515|stage I gastric cancer|stage i gastric cancer
576030|NCT00489515|stage II gastric cancer|stage ii gastric cancer
576031|NCT00489515|stage III gastric cancer|stage iii gastric cancer
576032|NCT00489515|stage IV gastric cancer|stage iv gastric cancer
576033|NCT00489515|localized gallbladder cancer|localized gallbladder cancer
576034|NCT00489515|small intestine adenocarcinoma|small intestine adenocarcinoma
576035|NCT00489515|adenocarcinoma of the colon|adenocarcinoma of the colon
576036|NCT00489515|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
576037|NCT00489515|adenocarcinoma of the stomach|adenocarcinoma of the stomach
576038|NCT00489528|serostim|serostim
576039|NCT00489528|Dose-Response Relationship, Drug|dose-response relationship, drug
576040|NCT00489528|Body Composition|body composition
576041|NCT00489541|paclitaxel-eluting stent|paclitaxel-eluting stent
576042|NCT00489541|PES|pes
576043|NCT00489554|Primary vaccination|primary vaccination
576044|NCT00489554|Safety|safety
576045|NCT00489554|Pneumococcal vaccine.|pneumococcal vaccine.
576046|NCT00489554|Pneumococcal disease|pneumococcal disease
576047|NCT00489554|Immunogenicity|immunogenicity
576048|NCT00489567|Rotavirus gastroenteritis|rotavirus gastroenteritis
576049|NCT00489580|stroke|stroke
576050|NCT00489580|weakness|weakness
576051|NCT00489580|motor recovery|motor recovery
576052|NCT00479739|formoterol/budesonide|formoterol/budesonide
576053|NCT00479739|exacerbations|exacerbations
576054|NCT00479739|Salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
576055|NCT00479739|adjustable maintenance dosing|adjustable maintenance dosing
576056|NCT00479739|asthma control|asthma control
576057|NCT00479765|glioblastoma multiforme|glioblastoma multiforme
576058|NCT00479765|recurrent|recurrent
576059|NCT00479765|Phase 1|phase 1
576060|NCT00479765|Phase 2|phase 2
576061|NCT00479765|Phase I|phase i
576062|NCT00479765|Phase II|phase ii
576063|NCT00479765|brain|brain
576064|NCT00479765|cancer|cancer
576065|NCT00479765|paclitaxel|paclitaxel
576066|NCT00479765|intracranial|intracranial
576067|NCT00479765|tumor|tumor
576068|NCT00479765|local|local
576069|NCT00479765|chemotherapy|chemotherapy
576070|NCT00479765|brain tumor|brain tumor
576071|NCT00479765|brain cancer|brain cancer
576072|NCT00479765|glioma|glioma
576073|NCT00479765|OncoGel|oncogel
576074|NCT00479778|Postmenopause|postmenopause
576075|NCT00479791|Type 2 diabetes mellitus|type 2 diabetes mellitus
576076|NCT00479791|Fatty acids|fatty acids
576077|NCT00479791|Postprandial response|postprandial response
576078|NCT00479791|Insulin|insulin
576079|NCT00479791|Glucose|glucose
576080|NCT00479791|Triglycerides|triglycerides
576081|NCT00479804|indication for CMR|indication for cmr
576082|NCT00479817|Advanced Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|advanced recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer
576084|NCT00479830|Health Risks|health risks
576085|NCT00479830|Questionnaire|questionnaire
576086|NCT00479830|Interview|interview
576087|NCT00479830|South Asian|south asian
576088|NCT00479830|Asian Indian|asian indian
576089|NCT00479830|Bangladeshi|bangladeshi
576090|NCT00479830|Pakistani|pakistani
576091|NCT00479830|Sri Lankan|sri lankan
576092|NCT00479843|Alzheimer Disease|alzheimer disease
576093|NCT00479843|Dementia|dementia
576094|NCT00479843|Elderly|elderly
576095|NCT00479843|Nutrition|nutrition
576096|NCT00479843|Malnutrition|malnutrition
576097|NCT00479843|Weight Loss|weight loss
576098|NCT00479856|ErbB1|erbb1
576099|NCT00479856|ErbB2|erbb2
576100|NCT00479856|GW572016|gw572016
576101|NCT00479856|lapatinib|lapatinib
576102|NCT00479856|Relapsed breast cancer|relapsed breast cancer
576103|NCT00479856|dual tyrosine kinase inhibitor|dual tyrosine kinase inhibitor
576104|NCT00479856|MBC|mbc
576105|NCT00479856|EGFR|egfr
576106|NCT00479856|Her-2/neu|her-2/neu
576107|NCT00479856|FISH amplification|fish amplification
576108|NCT00479895|Percutaneous Coronary Intervention|percutaneous coronary intervention
576109|NCT00479895|Myocardial Ischemia|myocardial ischemia
576110|NCT00479895|Balloon Occlusion|balloon occlusion
576111|NCT00479895|Catheter Lab|catheter lab
576112|NCT00479908|Blood pressure|blood pressure
576113|NCT00479908|Angina|angina
576114|NCT00479908|Sildenafil|sildenafil
576115|NCT00479908|Phosphodiesterase type 5|phosphodiesterase type 5
576116|NCT00479908|Organic nitrate|organic nitrate
576117|NCT00479908|Glyceryl trinitrate|glyceryl trinitrate
576118|NCT00479908|Drug interaction|drug interaction
576119|NCT00479921|Influenza|influenza
576120|NCT00479921|Vaccine|vaccine
576121|NCT00479921|CHMP criteria|chmp criteria
576122|NCT00479934|scleroderma|scleroderma
576123|NCT00479934|imatinib|imatinib
576124|NCT00479934|PDGFR|pdgfr
576125|NCT00479934|Rodnan|rodnan
576126|NCT00479947|Yeast vaginitis|yeast vaginitis
576127|NCT00479947|Probiotics|probiotics
576128|NCT00479947|Lactobacilli|lactobacilli
576129|NCT00479947|Fluconazole|fluconazole
576130|NCT00479960|Asthenozoospermia|asthenozoospermia
576131|NCT00479960|Azoospermia|azoospermia
576132|NCT00479960|Oligospermia|oligospermia
576133|NCT00479960|Omega-3|omega-3
576134|NCT00479960|Fatty Acids|fatty acids
576135|NCT00479973|diabetes|diabetes
576136|NCT00479973|non-insulin dependant diabetes|non-insulin dependant diabetes
576137|NCT00479973|type 2 diabetes|type 2 diabetes
576138|NCT00479973|cinnamon|cinnamon
576139|NCT00479973|natural health product|natural health product
576140|NCT00479973|hypercholesterolemia|hypercholesterolemia
576141|NCT00479973|dyslipidemia|dyslipidemia
576142|NCT00479973|elevated cholesterol|elevated cholesterol
576143|NCT00479986|diabetes mellitus|diabetes mellitus
576144|NCT00479986|monocyte activation|monocyte activation
576145|NCT00479986|cardiovascular risk|cardiovascular risk
576146|NCT00479999|HIV-Negative|hiv-negative
576147|NCT00479999|Healthy|healthy
576148|NCT00479999|Immunity|immunity
576149|NCT00479999|Preventive|preventive
576150|NCT00479999|Virus|virus
576151|NCT00479999|Healthy Volunteer|healthy volunteer
576152|NCT00479999|HV|hv
576153|NCT00479999|HIV Preventive Vaccine|hiv preventive vaccine
576154|NCT00480012|healthy subjects|healthy subjects
576155|NCT00480025|ASCI|asci
576156|NCT00480025|Immunotherapeutic|immunotherapeutic
576157|NCT00480025|MAGRIT|magrit
576158|NCT00480025|Tumor antigen|tumor antigen
576159|NCT00480025|Non-small-cell lung cancer|non-small-cell lung cancer
576160|NCT00480025|Adjuvant cancer therapy|adjuvant cancer therapy
576161|NCT00480038|symptomatic|symptomatic
576162|NCT00480038|lumbar disc herniation|lumbar disc herniation
576163|NCT00480038|disability|disability
576164|NCT00480038|fear avoidance beliefs|fear avoidance beliefs
576165|NCT00480038|quality of life|quality of life
576166|NCT00480051|Cardiac Failure|cardiac failure
576167|NCT00480051|Pacemaker|pacemaker
576168|NCT00480051|Dyssynchrony|dyssynchrony
576169|NCT00480051|Cardiac Magnetic Resonance|cardiac magnetic resonance
576170|NCT00480051|Narrow QRS|narrow qrs
576171|NCT00480064|AML|aml
576172|NCT00480064|older patients|older patients
576173|NCT00480064|lomustine|lomustine
741551|NCT01131871|overweight|overweight
576174|NCT00480077|Heart Failure, randomized, OptiVol® Fluid status monitoring|heart failure, randomized, optivol® fluid status monitoring
576175|NCT00480090|Prostate|prostate
576176|NCT00480090|Androgen independent|androgen independent
576177|NCT00480090|Phase II|phase ii
576178|NCT00480090|Second line|second line
575591|NCT00487838|AMD|amd
576179|NCT00480090|Androgen-independent prostate cancer|androgen-independent prostate cancer
576180|NCT00480103|Embryo morphological and chromosomal features|embryo morphological and chromosomal features
576181|NCT00480103|Implantation and pregnancy rate|implantation and pregnancy rate
576182|NCT00480116|Consistency|consistency
576183|NCT00480116|Immunogenicity|immunogenicity
576184|NCT00480129|grass allergies,|grass allergies,
576185|NCT00480129|ragweed allergies,|ragweed allergies,
576186|NCT00480129|probiotics, lactobacillus,|probiotics, lactobacillus,
576187|NCT00480129|bifidobacterium,|bifidobacterium,
576188|NCT00480129|functional foods,|functional foods,
576189|NCT00480129|yogurt,|yogurt,
576190|NCT00480129|inflammatory cytokines|inflammatory cytokines
576191|NCT00480168|child|child
576192|NCT00480168|adolescent|adolescent
576193|NCT00480168|weight gain|weight gain
576194|NCT00480168|endocrine disruptors|endocrine disruptors
576195|NCT00480181|Neuropathic pain|neuropathic pain
576196|NCT00480181|Multiple Sclerosis|multiple sclerosis
576197|NCT00480181|Nabilone|nabilone
576198|NCT00480181|Gabapentin|gabapentin
576199|NCT00480220|specific care|specific care
576200|NCT00480220|assistance plan|assistance plan
576201|NCT00480220|Alzheimer's disease|alzheimer's disease
576202|NCT00480233|depression|depression
576203|NCT00480233|screening|screening
576204|NCT00480233|primary care|primary care
576205|NCT00480233|validity|validity
576206|NCT00480233|Hebrew|hebrew
576207|NCT00480233|Primary care and general medical patients|primary care and general medical patients
576208|NCT00480246|receptor oocupancy|receptor oocupancy
576209|NCT00480259|blood urea nitrogen|blood urea nitrogen
576210|NCT00480259|nitrogen balance|nitrogen balance
576211|NCT00480259|nutrition|nutrition
576212|NCT00480259|intensive care|intensive care
576213|NCT00480272|rheumatoid arthritis|rheumatoid arthritis
576214|NCT00480272|clinical remission|clinical remission
576215|NCT00480285|Gastroesophageal reflux disease|gastroesophageal reflux disease
576216|NCT00480285|Laparoscopic Nissen Fundoplication|laparoscopic nissen fundoplication
576217|NCT00480285|Laparoscopic anterior partial fundoplication|laparoscopic anterior partial fundoplication
576218|NCT00480311|symptomatic|symptomatic
576219|NCT00480311|lumbar spinal stenosis|lumbar spinal stenosis
576220|NCT00480311|disability|disability
576221|NCT00480311|fear avoidance beliefs|fear avoidance beliefs
576222|NCT00480311|quality of life|quality of life
576223|NCT00480337|PCOS|pcos
576224|NCT00480337|Fertility Preservation|fertility preservation
576225|NCT00480337|Repeated IVF Failure|repeated ivf failure
576226|NCT00480337|S/P Hyperstimulation|s/p hyperstimulation
576227|NCT00480350|HIV|hiv
576228|NCT00480350|virological response|virological response
576229|NCT00480350|CD4|cd4
576230|NCT00480350|food supplement|food supplement
576231|NCT00480350|Human Immunodeficiency Virus|human immunodeficiency virus
576232|NCT00480350|Complementary Therapies|complementary therapies
576233|NCT00480363|Smoldering Multiple Myeloma|smoldering multiple myeloma
576234|NCT00480363|PETHEMA|pethema
576235|NCT00480363|Smoldering|smoldering
576236|NCT00480376|transrectal biopsy|transrectal biopsy
576237|NCT00480376|prostate|prostate
576238|NCT00480376|prophylaxis antibiotic|prophylaxis antibiotic
576239|NCT00480389|Clear cell Renal cell carcinoma|clear cell renal cell carcinoma
576240|NCT00480389|Metastatic|metastatic
576241|NCT00480389|Sorafenib tosylate|sorafenib tosylate
576242|NCT00480389|Preoperative treatment|preoperative treatment
576243|NCT00480402|preterm birth|preterm birth
576244|NCT00480402|progesterone|progesterone
576245|NCT00480402|twins|twins
576246|NCT00480402|Preterm birth in twin gestations|preterm birth in twin gestations
576247|NCT00480428|Radioactive Fallout|radioactive fallout
576248|NCT00480428|Childhood Exposures|childhood exposures
576249|NCT00480428|External Radiation Dose|external radiation dose
576250|NCT00480428|Internal Radiation Dose to Thyroid Gland|internal radiation dose to thyroid gland
576251|NCT00480428|Pasture-Dairy Animal- Milk- Thyroid Pathway|pasture-dairy animal- milk- thyroid pathway
576252|NCT00480441|Marijuana|marijuana
576253|NCT00480441|Addiction|addiction
576254|NCT00480441|Substance Withdrawal Syndrome|substance withdrawal syndrome
576255|NCT00480441|Clinical Trial|clinical trial
576256|NCT00480441|Dronabinol|dronabinol
576257|NCT00480441|Behavioral Therapy|behavioral therapy
576258|NCT00480441|Adults|adults
576259|NCT00480441|Neuroimaging|neuroimaging
576260|NCT00480441|Neuropsychological Testing|neuropsychological testing
576261|NCT00480441|Neurocognitive Testing|neurocognitive testing
576262|NCT00480441|Behavioral Probes|behavioral probes
576263|NCT00480454|TB|tb
576264|NCT00480454|Tuberculosis|tuberculosis
576265|NCT00480454|Infants|infants
576266|NCT00480454|EPI|epi
576267|NCT00480480|Trauma|trauma
576268|NCT00480480|Grief|grief
576269|NCT00480480|Depression|depression
576270|NCT00480480|Adolescent|adolescent
576271|NCT00480480|War|war
576272|NCT00480480|Group|group
576273|NCT00480480|Therapy|therapy
576274|NCT00480480|Treatment|treatment
576275|NCT00480480|Intervention|intervention
576276|NCT00480480|School|school
576277|NCT00480480|Development|development
576278|NCT00480506|chimerism|chimerism
576279|NCT00480506|allogenic hematopoietic transplantation|allogenic hematopoietic transplantation
576280|NCT00480506|assay|assay
576281|NCT00480519|meatotomy|meatotomy
576282|NCT00480519|meatal stenosis|meatal stenosis
576283|NCT00480519|local anaesthesia|local anaesthesia
576284|NCT00480519|feasibility|feasibility
576285|NCT00480519|pain control|pain control
576286|NCT00480532|birth control|birth control
576287|NCT00480532|continuous contraception|continuous contraception
576288|NCT00480532|break-through bleeding|break-through bleeding
576289|NCT00480545|Women with bleeding disorders|women with bleeding disorders
576290|NCT00480545|Menstrual cycle|menstrual cycle
576291|NCT00480545|Women|women
576292|NCT00480545|Healthy volunteers|healthy volunteers
576293|NCT00480558|HIV|hiv
576294|NCT00480558|MVA85A|mva85a
576295|NCT00480558|TB|tb
576296|NCT00480558|Tuberculosis|tuberculosis
576297|NCT00480558|Human Immunodeficiency Virus|human immunodeficiency virus
576298|NCT00480558|Safety|safety
576299|NCT00480558|Immunogenicity|immunogenicity
576300|NCT00480558|Efficacy|efficacy
576301|NCT00480558|Treatment Naive|treatment naive
576302|NCT00480571|chronic schizophrenia or schizo-affective disorder|chronic schizophrenia or schizo-affective disorder
576303|NCT00480584|pancreatic|pancreatic
576304|NCT00480584|gemcitabine|gemcitabine
576305|NCT00480584|erlotinib (HER1/epidermal growth factor receptor [EGFR] tyrosine kinase inhibitor)|erlotinib (her1/epidermal growth factor receptor [egfr] tyrosine kinase inhibitor)
576306|NCT00480584|capecitabine|capecitabine
576307|NCT00480597|gemcitabine|gemcitabine
576308|NCT00480597|vinorelbine|vinorelbine
576309|NCT00480597|cisplatin|cisplatin
576310|NCT00480597|capecitabine|capecitabine
576311|NCT00480597|pretreated metastatic breast cancer|pretreated metastatic breast cancer
576312|NCT00480610|Dermatitis, atopic|dermatitis, atopic
576313|NCT00480610|Tacrolimus|tacrolimus
576314|NCT00480610|Adult|adult
576315|NCT00480610|treatment outcomes|treatment outcomes
576316|NCT00480623|Prostate Cancer|prostate cancer
576317|NCT00480623|Biochemical Failure|biochemical failure
576318|NCT00480623|Radical Prostatectomy|radical prostatectomy
576319|NCT00480649|SERETIDE|seretide
576320|NCT00480649|asthma|asthma
576321|NCT00480649|Korean|korean
576322|NCT00480649|ACT|act
576323|NCT00480662|Paget's bone disease|paget's bone disease
576324|NCT00480675|bursitis|bursitis
576325|NCT00480675|injection|injection
576326|NCT00480675|fluoroscopy|fluoroscopy
576327|NCT00480688|TB|tb
576328|NCT00480688|BCG|bcg
576329|NCT00480701|Alzheimer|alzheimer
576330|NCT00480701|Parkinson|parkinson
576331|NCT00480701|dementia|dementia
576332|NCT00480701|neurologic|neurologic
576333|NCT00480714|TB|tb
576334|NCT00480714|Vaccine|vaccine
576335|NCT00480714|BCG|bcg
576336|NCT00480727|Halo Thoracic Orthosis|halo thoracic orthosis
576337|NCT00480727|Re-tension|re-tension
576338|NCT00480727|Pin loosening|pin loosening
576339|NCT00480740|Dexmedetomidine|dexmedetomidine
576340|NCT00480740|Congenital heart disease|congenital heart disease
576341|NCT00480740|pharmacokinetics|pharmacokinetics
576342|NCT00480740|pharmacodynamics|pharmacodynamics
576343|NCT00480740|pediatric|pediatric
576344|NCT00480740|Bidirectional cavopulmonary anastomosis|bidirectional cavopulmonary anastomosis
576345|NCT00480740|Fontan physiology|fontan physiology
576346|NCT00480740|Cardiac transplant|cardiac transplant
576347|NCT00480753|Raynaud's phenomenon|raynaud's phenomenon
576348|NCT00480753|Raynaud's Disease|raynaud's disease
576349|NCT00480753|Raynaud's disease secondary to scleroderma|raynaud's disease secondary to scleroderma
576350|NCT00480753|Raynaud's phenomenon secondary to autoimmune disease|raynaud's phenomenon secondary to autoimmune disease
576351|NCT00480766|Glucocorticoid|glucocorticoid
576352|NCT00480779|Prediabetes|prediabetes
576353|NCT00480779|Metabolic syndrome|metabolic syndrome
576354|NCT00480779|Prevention|prevention
576355|NCT00480779|Lifestyle intervention|lifestyle intervention
576356|NCT00480792|Hepatitis B vaccination|hepatitis b vaccination
576357|NCT00480792|GenHevac-B Pasteur|genhevac-b pasteur
576358|NCT00480792|HIV Infections|hiv infections
576359|NCT00480831|NSCLC|nsclc
576360|NCT00480831|Cancer|cancer
576361|NCT00480831|Avastin|avastin
576362|NCT00480831|APM4074g|apm4074g
576363|NCT00480844|schizophrenia|schizophrenia
576364|NCT00480844|Sertindole|sertindole
576365|NCT00480844|Risperidone|risperidone
576366|NCT00480844|cognitive impairment|cognitive impairment
576367|NCT00480857|Prostate|prostate
576368|NCT00480857|Radiation|radiation
576369|NCT00480870|Alzheimer|alzheimer
576370|NCT00480870|polysomnography|polysomnography
576371|NCT00480870|REM sleep|rem sleep
576372|NCT00480870|donepezil|donepezil
576373|NCT00480870|sleep apnea|sleep apnea
576374|NCT00480870|oxygen saturation|oxygen saturation
576375|NCT00480883|cutaneous leishmaniasis of the old world|cutaneous leishmaniasis of the old world
576376|NCT00480896|Dermatitis, atopic|dermatitis, atopic
576377|NCT00480896|Tacrolimus|tacrolimus
576378|NCT00480896|Child|child
576379|NCT00480896|treatment outcomes|treatment outcomes
576380|NCT00480922|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
576381|NCT00480922|steatohepatitis|steatohepatitis
576382|NCT00480922|overweight|overweight
576383|NCT00480922|insulin resistance|insulin resistance
576384|NCT00480935|Localized|localized
576385|NCT00480935|Renal Cell Carcinoma|renal cell carcinoma
576386|NCT00480935|Neoadjuvant|neoadjuvant
576387|NCT00480935|Sunitinib Malate (Sutent)|sunitinib malate (sutent)
576388|NCT00480948|infant|infant
576389|NCT00480948|infant formula|infant formula
576390|NCT00480948|fatty acids|fatty acids
576391|NCT00480948|palmitic acid|palmitic acid
576392|NCT00480948|stool|stool
576393|NCT00480948|calcium|calcium
576394|NCT00480974|Sickle cell anemia|sickle cell anemia
576395|NCT00480974|Sickle cell thalassemia|sickle cell thalassemia
576396|NCT00480974|Hydroxyurea|hydroxyurea
576397|NCT00480987|High-Risk Myelodysplastic Syndromes|high-risk myelodysplastic syndromes
576398|NCT00480987|Acute Myeloid Leukemia|acute myeloid leukemia
576399|NCT00480987|Leukemia|leukemia
576400|NCT00480987|Oxaliplatin|oxaliplatin
576401|NCT00480987|Fludarabine|fludarabine
576402|NCT00480987|Cytarabine|cytarabine
576404|NCT00480987|MDS|mds
576405|NCT00481000|Dialectical Cognitive Therapy|dialectical cognitive therapy
576406|NCT00481000|Clinical Psychology|clinical psychology
576407|NCT00481013|Spinal Muscular Atrophy|spinal muscular atrophy
576408|NCT00481013|Adult|adult
576409|NCT00481039|Sickle cell disease|sickle cell disease
576410|NCT00481039|Sickle cell thalassemia|sickle cell thalassemia
576411|NCT00481039|Population screening|population screening
576412|NCT00481052|Adult|adult
576413|NCT00481052|CML|cml
576414|NCT00481052|Philadelphia positive|philadelphia positive
576415|NCT00481052|Nilotinib|nilotinib
576416|NCT00481052|early chronic phase|early chronic phase
576417|NCT00481052|untreated or treated only with Hydroxyurea or Anagrelide|untreated or treated only with hydroxyurea or anagrelide
576418|NCT00481052|Chronic Myeloid Leukemia|chronic myeloid leukemia
576419|NCT00481104|Obesity|obesity
576420|NCT00481130|Alport Syndrome|alport syndrome
576421|NCT00481130|x linked|x linked
576422|NCT00481130|autosomal dominant Alport syndrome|autosomal dominant alport syndrome
576423|NCT00481130|glomerular basement membrane|glomerular basement membrane
576424|NCT00481130|hereditary nephritis|hereditary nephritis
576425|NCT00481130|familial benign haematuria|familial benign haematuria
576426|NCT00481130|type IV collagen|type iv collagen
576427|NCT00481130|hereditary nephritis with neurosensory deafness|hereditary nephritis with neurosensory deafness
576428|NCT00481130|vison loss|vison loss
576429|NCT00481143|Myelodysplastic Syndrome|myelodysplastic syndrome
576430|NCT00481143|MDS|mds
576431|NCT00481143|iron overload|iron overload
576432|NCT00481143|chelation|chelation
576433|NCT00481143|chelators|chelators
576434|NCT00481143|ICL670|icl670
576435|NCT00481143|Deferasirox|deferasirox
576436|NCT00481143|serum ferritin|serum ferritin
576437|NCT00481143|LIC|lic
576438|NCT00481143|transfusional hemosiderosis|transfusional hemosiderosis
576439|NCT00481143|Refractory Anemia|refractory anemia
576440|NCT00481143|RA|ra
576441|NCT00481143|Refractory Anemia with Ringed Sideroblasts|refractory anemia with ringed sideroblasts
576442|NCT00481143|RARS|rars
576443|NCT00481143|blood transfusions|blood transfusions
576444|NCT00481143|Mydelodysplastic Syndrome(s)|mydelodysplastic syndrome(s)
576445|NCT00481169|Postmenopausal Osteoporosis|postmenopausal osteoporosis
576446|NCT00481182|PK|pk
576447|NCT00481182|PD|pd
576448|NCT00481182|FPV|fpv
576449|NCT00481182|RTV|rtv
576450|NCT00481182|APV|apv
576451|NCT00481182|ritonavir|ritonavir
576452|NCT00481182|fosamprenavir|fosamprenavir
576453|NCT00481182|amprenavir|amprenavir
576454|NCT00481182|methadone|methadone
576455|NCT00481182|pharmacokinetics|pharmacokinetics
576456|NCT00481182|pharmacodynamics|pharmacodynamics
576457|NCT00481208|open-angle glaucoma|open-angle glaucoma
576458|NCT00481208|diurnal fluctuation|diurnal fluctuation
576459|NCT00481208|intraocular pressure|intraocular pressure
576460|NCT00481208|peripapillary retinal blood flow|peripapillary retinal blood flow
576461|NCT00481208|latent asymmetric intraocular pressure|latent asymmetric intraocular pressure
576462|NCT00481221|Thalassemia|thalassemia
576463|NCT00481221|Iron Deficiency|iron deficiency
576464|NCT00481221|Carrier screening|carrier screening
576465|NCT00481234|Anesthesia, General|anesthesia, general
576466|NCT00481234|Abnormalities, Cardiovascular|abnormalities, cardiovascular
576467|NCT00481234|Heart Rate|heart rate
576468|NCT00481234|Forecasting|forecasting
576469|NCT00481247|Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia|chronic phase philadelphia chromosome positive chronic myeloid leukemia
576470|NCT00481260|Hgb C|hgb c
576471|NCT00481260|Screening|screening
576472|NCT00481273|MDS|mds
576473|NCT00481286|Group clinics|group clinics
576474|NCT00481286|Goal setting|goal setting
576475|NCT00481286|Diabetes|diabetes
576476|NCT00481286|Hypertension|hypertension
576477|NCT00481286|Age 50+|age 50+
576478|NCT00481299|Insulin|insulin
576479|NCT00481299|glucose|glucose
576480|NCT00481299|lipids|lipids
576481|NCT00481299|prolactinoma|prolactinoma
576482|NCT00481299|hyperprolactinemia|hyperprolactinemia
576483|NCT00481312|Initial Sedation|initial sedation
576484|NCT00481312|Mechanical ventilation|mechanical ventilation
576485|NCT00481338|Cohort|cohort
576486|NCT00481338|Quality of life|quality of life
576487|NCT00481338|Health resource use|health resource use
576488|NCT00481338|Disability|disability
576489|NCT00481338|Prognosis|prognosis
576490|NCT00481351|artificial chilomicrons kinetics|artificial chilomicrons kinetics
576491|NCT00481351|ezetimibe plus statin|ezetimibe plus statin
576492|NCT00481351|lipid lowering therapy|lipid lowering therapy
576493|NCT00481364|hemodialysis|hemodialysis
576494|NCT00481364|endothelial function|endothelial function
576495|NCT00481364|coronary artery calcification|coronary artery calcification
576496|NCT00481364|atherosclerosis|atherosclerosis
576497|NCT00481364|statin|statin
576498|NCT00481377|Ablation|ablation
576499|NCT00481377|Ventricular tachycardia|ventricular tachycardia
576500|NCT00481377|coronary artery disease|coronary artery disease
576501|NCT00481377|Implantable cardioverter defibrillator interventions|implantable cardioverter defibrillator interventions
576503|NCT00481390|HLA-B*5701|hla-b*5701
576504|NCT00481390|prevalence|prevalence
576505|NCT00481390|Treatment Experienced|treatment experienced
576506|NCT00481390|Treatment Naive|treatment naive
576507|NCT00481403|Sperm, male fertility, microarrays|sperm, male fertility, microarrays
576508|NCT00481416|Esophageal Varices|esophageal varices
576509|NCT00481416|PillCam Eso|pillcam eso
576510|NCT00481416|Capsule Endoscopy|capsule endoscopy
576511|NCT00481416|Given Imaging|given imaging
576512|NCT00481416|Inscope|inscope
576513|NCT00481429|Biomarker|biomarker
576514|NCT00481429|Glitazone|glitazone
576515|NCT00481429|Diabetes|diabetes
576516|NCT00481442|Septic shock|septic shock
576517|NCT00481442|Sepsis|sepsis
576518|NCT00481442|Norepinephrine|norepinephrine
576519|NCT00481442|Phenylephrine|phenylephrine
576520|NCT00481455|Glioblastoma Multiforme|glioblastoma multiforme
576521|NCT00481455|temozolomide|temozolomide
576522|NCT00481468|Coronary artery disease|coronary artery disease
576523|NCT00481468|chest pain|chest pain
576524|NCT00481481|Tacrolimus, Kidney Transplantation|tacrolimus, kidney transplantation
576525|NCT00481494|Glaucoma|glaucoma
576526|NCT00481494|Drug compliance|drug compliance
576527|NCT00481494|Personality|personality
576528|NCT00481507|Probiotic|probiotic
576529|NCT00481507|Cultured dairy drink|cultured dairy drink
576530|NCT00481507|Health|health
576531|NCT00481507|10 day antibiotic|10 day antibiotic
576532|NCT00481507|Otherwise healthy|otherwise healthy
576533|NCT00481533|Cesarean Delivery|cesarean delivery
576534|NCT00481533|Uterine Contractility|uterine contractility
576535|NCT00481546|Leber congenital amaurosis|leber congenital amaurosis
576536|NCT00481546|LCA|lca
576537|NCT00481546|RPE65|rpe65
576538|NCT00481546|Retinal disease due to RPE65 mutations|retinal disease due to rpe65 mutations
576539|NCT00481546|RPE65-associated Leber congenital amaurosis|rpe65-associated leber congenital amaurosis
576540|NCT00481559|Voraxaze|voraxaze
576541|NCT00481559|glucarpidase|glucarpidase
576542|NCT00481559|carboxypeptidase|carboxypeptidase
576543|NCT00481559|cancer|cancer
576544|NCT00481559|lymphoma|lymphoma
576545|NCT00481559|leukemia|leukemia
576546|NCT00481559|osteosarcoma|osteosarcoma
576547|NCT00481559|methotrexate|methotrexate
576548|NCT00481559|delayed elimination|delayed elimination
576549|NCT00481559|renal insufficiency|renal insufficiency
576550|NCT00481559|toxicity|toxicity
576551|NCT00481572|Sepsis|sepsis
576552|NCT00481572|Septic Shock|septic shock
576553|NCT00481572|vasopressin|vasopressin
576554|NCT00481572|terlipressin|terlipressin
576555|NCT00481585|claudin|claudin
576556|NCT00481585|electrophysiology|electrophysiology
576557|NCT00481585|breast|breast
576558|NCT00481585|screening|screening
576559|NCT00481611|Industry Hygiene|industry hygiene
576560|NCT00481611|Molecular Epidemiology|molecular epidemiology
576561|NCT00481611|Cancer Susceptibility|cancer susceptibility
576562|NCT00481611|Genotoxicity|genotoxicity
576563|NCT00481611|Immune Function|immune function
576564|NCT00481611|Cancer Susceptability|cancer susceptability
576565|NCT00481624|advanced lung cancer|advanced lung cancer
576566|NCT00481624|Procrit|procrit
576567|NCT00481624|Epoetin Alfa|epoetin alfa
576568|NCT00481624|Ferric Gluconate|ferric gluconate
576569|NCT00481624|iron supplementation|iron supplementation
576570|NCT00481637|paraneoplastic; autoimmunity;|paraneoplastic; autoimmunity;
576571|NCT00481676|Chronic urticaria, omalizumab, thyroperoxidase, IgE|chronic urticaria, omalizumab, thyroperoxidase, ige
576572|NCT00481689|Cipro|cipro
576573|NCT00481689|Complicated UTI|complicated uti
576574|NCT00481689|Pseudomonas aeruginosa|pseudomonas aeruginosa
741876|NCT01132755|laparoscopy|laparoscopy
576575|NCT00481715|Web-Based Weight Loss Program|web-based weight loss program
576576|NCT00481715|Cash Incentive Weight Loss Program|cash incentive weight loss program
576577|NCT00481715|North Carolina|north carolina
576578|NCT00481741|Angioplasty, Percutaneous TransluminalCoronary|angioplasty, percutaneous transluminalcoronary
576579|NCT00481754|Endometrium|endometrium
576580|NCT00481754|PTEN|pten
576581|NCT00481754|Hormones|hormones
576582|NCT00481754|Carcinogenesis|carcinogenesis
576583|NCT00481754|Etiology|etiology
576584|NCT00481754|Tissue Evaluation|tissue evaluation
576585|NCT00481754|Questionnaire|questionnaire
576586|NCT00481767|Cervical cancer;|cervical cancer;
576587|NCT00481767|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
576588|NCT00481767|HPV;|hpv;
576589|NCT00481767|Papillomavirus;|papillomavirus;
576590|NCT00481793|Plutonium|plutonium
576591|NCT00481793|Ionizing Radiation|ionizing radiation
576593|NCT00481793|Biological Marker|biological marker
576594|NCT00481793|Russia|russia
576595|NCT00481806|Virchow's Triad|virchow's triad
576596|NCT00481806|Thrombin|thrombin
576597|NCT00481806|Graft Failure|graft failure
576598|NCT00481819|Kidney Transplantation|kidney transplantation
576599|NCT00481819|Tacrolimus|tacrolimus
576600|NCT00481819|Methylprednisolone|methylprednisolone
576601|NCT00481819|Prednisolone|prednisolone
576602|NCT00481819|Mycophenolate Mofetil|mycophenolate mofetil
576603|NCT00481858|chronic lymphocytic leukemia|chronic lymphocytic leukemia
576604|NCT00481858|biomarker|biomarker
576605|NCT00481858|prognosis|prognosis
576606|NCT00481858|apoptosis|apoptosis
576607|NCT00481858|neoplasm/cancer diagnosis|neoplasm/cancer diagnosis
576608|NCT00481858|stable isotope|stable isotope
576609|NCT00481858|diagnosis evaluation|diagnosis evaluation
576610|NCT00481858|outcomes|outcomes
576611|NCT00481858|CD19|cd19
576612|NCT00481858|CD5|cd5
576613|NCT00481871|Lymphoproliferative malignancies|lymphoproliferative malignancies
576614|NCT00481871|Lymphoma|lymphoma
576615|NCT00481871|Hodgkin's lymphoma (HL)|hodgkin's lymphoma (hl)
576616|NCT00481871|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
576617|NCT00481871|PTCL|ptcl
576618|NCT00481871|T/NK-cell leukemia/lymphoma|t/nk-cell leukemia/lymphoma
576619|NCT00481871|T-cell lymphoma/leukemia (HTLV 1+)|t-cell lymphoma/leukemia (htlv 1+)
576620|NCT00481871|Angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
576621|NCT00481871|Blastic NK lymphoma|blastic nk lymphoma
576622|NCT00481871|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
576623|NCT00481871|T/NK-cell lymphoma|t/nk-cell lymphoma
576624|NCT00481871|Enteropathy-type intestinal lymphoma|enteropathy-type intestinal lymphoma
576625|NCT00481871|Hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
576626|NCT00481871|Extranodal peripheral T/NK-cell lymphoma|extranodal peripheral t/nk-cell lymphoma
576627|NCT00481871|Subcutaneous panniculitis T-cell lymphoma|subcutaneous panniculitis t-cell lymphoma
576628|NCT00481871|Transformed mycosis fungoides|transformed mycosis fungoides
576629|NCT00481871|PDX|pdx
576630|NCT00481871|Pralatrexate|pralatrexate
576631|NCT00481871|Gemcitabine|gemcitabine
576632|NCT00481871|Gemzar|gemzar
576633|NCT00481871|Vitamin B12|vitamin b12
576634|NCT00481871|Folic acid|folic acid
576635|NCT00481884|Breast Cancer|breast cancer
576636|NCT00481884|Radiation Dermatitis|radiation dermatitis
576637|NCT00481884|RadiaPlexRx Gel|radiaplexrx gel
576638|NCT00481884|Aquaphor|aquaphor
576639|NCT00481897|overweight|overweight
576640|NCT00481897|obesity|obesity
576641|NCT00481897|type 2 diabetes|type 2 diabetes
576642|NCT00481897|diabetes|diabetes
576643|NCT00481897|worksite cost|worksite cost
576644|NCT00481897|nutrition|nutrition
576645|NCT00481923|hypocaloric diet|hypocaloric diet
576646|NCT00481923|energy intake|energy intake
576647|NCT00481936|Neoplasms|neoplasms
576648|NCT00481936|Neoplasm, Epithelial|neoplasm, epithelial
576649|NCT00481936|Neoplasm, Glandular|neoplasm, glandular
576650|NCT00481949|Gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
576651|NCT00481949|pH measurement|ph measurement
576652|NCT00481949|symptom association|symptom association
576653|NCT00481949|wireless pH monitoring system|wireless ph monitoring system
576654|NCT00481949|Functional Heartburn|functional heartburn
576655|NCT00481949|Gastro-esophageal reflux disease|gastro-esophageal reflux disease
576656|NCT00481975|binge eating|binge eating
576657|NCT00481975|eating disorders|eating disorders
576658|NCT00481975|obesity|obesity
576659|NCT00481988|depression|depression
576660|NCT00481988|transcranial direct current stimulation|transcranial direct current stimulation
576661|NCT00481988|direct current stimulation|direct current stimulation
576662|NCT00481988|tdcs|tdcs
576663|NCT00482001|Donepezil|donepezil
576664|NCT00482001|Driving|driving
576665|NCT00482001|Cholinesterase Inhibitors|cholinesterase inhibitors
576666|NCT00482001|Geriatric Psychiatry|geriatric psychiatry
576667|NCT00482001|Psychopharmacology|psychopharmacology
576668|NCT00482001|Aricept|aricept
576669|NCT00482027|HIV vaccine|hiv vaccine
576670|NCT00482027|Adeno-associated virus vactored vaccine|adeno-associated virus vactored vaccine
576671|NCT00482027|HIV-1 subtype C|hiv-1 subtype c
576672|NCT00482027|Safety|safety
576673|NCT00482027|Immunogenicity|immunogenicity
576674|NCT00482027|Biodistribution|biodistribution
576675|NCT00482027|HIV prevention|hiv prevention
576676|NCT00482040|CPAP|cpap
576677|NCT00482040|Preterm|preterm
576678|NCT00482040|Prematurity|prematurity
576679|NCT00482040|Apnea of prematurity|apnea of prematurity
576680|NCT00482066|Wegener's granulomatosis|wegener's granulomatosis
576681|NCT00482066|Microscopic polyangiitis|microscopic polyangiitis
576682|NCT00482066|Churg Strauss Syndrome|churg strauss syndrome
576683|NCT00482066|ANCA|anca
576684|NCT00482092|Crohn's disease|crohn's disease
576685|NCT00482092|adult stem cell therapy|adult stem cell therapy
576686|NCT00482105|melanoma|melanoma
576687|NCT00482118|Air Pollution|air pollution
576688|NCT00482118|Tumor Markers|tumor markers
576689|NCT00482118|Genetic Polymorphisms|genetic polymorphisms
576690|NCT00482118|Molecular Epidemiology|molecular epidemiology
576691|NCT00482118|Environmental Epidemiology|environmental epidemiology
576692|NCT00482118|Lung Cancer|lung cancer
576693|NCT00482144|Pulsed-Dye Laser|pulsed-dye laser
576694|NCT00482183|Bare metal stent|bare metal stent
576695|NCT00482183|Major adverse cardiac events|major adverse cardiac events
576696|NCT00482183|Pioglitazone|pioglitazone
576697|NCT00482183|Restenosis|restenosis
576698|NCT00482183|Sirolimus eluting stent|sirolimus eluting stent
576699|NCT00482209|mifepristone, misoprostol, medical abortion|mifepristone, misoprostol, medical abortion
576700|NCT00482222|adenocarcinoma of the colon|adenocarcinoma of the colon
576701|NCT00482222|stage IV colon cancer|stage iv colon cancer
576702|NCT00482222|adenocarcinoma of the rectum|adenocarcinoma of the rectum
576703|NCT00482222|stage IV rectal cancer|stage iv rectal cancer
576704|NCT00482222|liver metastases|liver metastases
576705|NCT00482222|recurrent colon cancer|recurrent colon cancer
576706|NCT00482222|recurrent rectal cancer|recurrent rectal cancer
576707|NCT00482248|Asthma|asthma
576708|NCT00482248|anti-immunoglobulin E|anti-immunoglobulin e
576709|NCT00482248|omalizumab|omalizumab
576710|NCT00482248|allergic asthma|allergic asthma
576711|NCT00482261|myeloma|myeloma
576712|NCT00482261|relapse|relapse
576713|NCT00482261|refractory|refractory
576714|NCT00482261|elderly|elderly
576715|NCT00482261|lenalidomide|lenalidomide
576716|NCT00482274|adenocarcinoma of the prostate|adenocarcinoma of the prostate
576717|NCT00482274|recurrent prostate cancer|recurrent prostate cancer
576718|NCT00482274|stage I prostate cancer|stage i prostate cancer
576719|NCT00482274|stage II prostate cancer|stage ii prostate cancer
576720|NCT00482274|stage III prostate cancer|stage iii prostate cancer
576721|NCT00482274|stage IV prostate cancer|stage iv prostate cancer
576722|NCT00482300|Histologically proved endometrial carcinoma preoperatively supposed stage I-II|histologically proved endometrial carcinoma preoperatively supposed stage i-ii
576723|NCT00482313|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
576724|NCT00482313|ADHD|adhd
576725|NCT00482313|Prison|prison
576726|NCT00482313|Treatment|treatment
576727|NCT00482313|Randomized|randomized
576728|NCT00482313|Double-Blind|double-blind
576729|NCT00482313|Placebo Control|placebo control
576730|NCT00482313|Parallel Assignment|parallel assignment
576731|NCT00482313|Efficacy Study|efficacy study
576732|NCT00482339|bacterial contamination|bacterial contamination
576733|NCT00482339|platelet concentrates|platelet concentrates
576734|NCT00482339|blood donation|blood donation
576735|NCT00482339|looxster|looxster
576736|NCT00482339|pureprove|pureprove
576737|NCT00482339|bacterial genomic DNA|bacterial genomic dna
576738|NCT00482339|bacterial contamination of platelet concentrates|bacterial contamination of platelet concentrates
576739|NCT00482339|"Preparation of bacterial DNA in blood"|"preparation of bacterial dna in blood"
576740|NCT00482339|comparison of blood culture versus NAT|comparison of blood culture versus nat
576741|NCT00482365|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
576742|NCT00482365|advanced adult primary liver cancer|advanced adult primary liver cancer
576743|NCT00482365|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
576744|NCT00482365|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
576745|NCT00482365|recurrent adult primary liver cancer|recurrent adult primary liver cancer
576746|NCT00482378|stage I multiple myeloma|stage i multiple myeloma
576747|NCT00482378|stage II multiple myeloma|stage ii multiple myeloma
576748|NCT00482378|stage III multiple myeloma|stage iii multiple myeloma
576749|NCT00482378|refractory multiple myeloma|refractory multiple myeloma
576750|NCT00482378|pain|pain
576751|NCT00482391|recurrent breast cancer|recurrent breast cancer
576752|NCT00482391|stage I breast cancer|stage i breast cancer
576753|NCT00482391|stage II breast cancer|stage ii breast cancer
576754|NCT00482391|stage IIIA breast cancer|stage iiia breast cancer
576755|NCT00482391|stage IIIB breast cancer|stage iiib breast cancer
576756|NCT00482391|stage IIIC breast cancer|stage iiic breast cancer
576757|NCT00482391|male breast cancer|male breast cancer
741974|NCT01133210|Maraviroc|maraviroc
576758|NCT00482430|Undifferentiated schizophrenia|undifferentiated schizophrenia
576759|NCT00482430|Residual schizophrenia|residual schizophrenia
576760|NCT00482456|Nitrous oxide|nitrous oxide
576761|NCT00482456|Homocysteine|homocysteine
576762|NCT00482456|folate|folate
576763|NCT00482456|vitamin B12|vitamin b12
576764|NCT00482469|ischemia-reperfusion|ischemia-reperfusion
576765|NCT00482469|ischemia|ischemia
576766|NCT00482469|reperfusion|reperfusion
576767|NCT00482469|DIEP-flap|diep-flap
576768|NCT00482469|flap|flap
576769|NCT00482482|Yoga|yoga
576770|NCT00482482|Bipolar disorder|bipolar disorder
576771|NCT00482482|Major depression|major depression
576772|NCT00482482|Dysthymia|dysthymia
576773|NCT00482482|Randomized|randomized
576774|NCT00482495|refractory multiple myeloma|refractory multiple myeloma
576775|NCT00482495|stage I multiple myeloma|stage i multiple myeloma
576776|NCT00482495|stage II multiple myeloma|stage ii multiple myeloma
576777|NCT00482495|stage III multiple myeloma|stage iii multiple myeloma
576778|NCT00482508|Asthma|asthma
576779|NCT00482508|anti immunoglobulin E|anti immunoglobulin e
576780|NCT00482508|omalizumab|omalizumab
576781|NCT00482521|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
576782|NCT00482547|urinary tract infection|urinary tract infection
576783|NCT00482547|urinary catheter|urinary catheter
576785|NCT00482560|Breastfeeding|breastfeeding
576786|NCT00482560|Heel lance|heel lance
577117|NCT00489658|combination|combination
576787|NCT00482573|Electrocardiography, ambulatory/methods|electrocardiography, ambulatory/methods
576788|NCT00482573|Blood Pressure monitoring, ambulatory/methods|blood pressure monitoring, ambulatory/methods
576789|NCT00482573|Cardiotocography/methods|cardiotocography/methods
576790|NCT00482573|Dental restoration, permanent|dental restoration, permanent
576791|NCT00482573|Anesthesia, local /methods|anesthesia, local /methods
576792|NCT00482573|Lidocaine|lidocaine
576793|NCT00482573|Vasoconstrictor Agents|vasoconstrictor agents
576794|NCT00482573|Epinephrine|epinephrine
576795|NCT00482573|Pregnancy|pregnancy
576796|NCT00482573|Rheumatic Heart Disease|rheumatic heart disease
576797|NCT00482586|adult primary liver cancer|adult primary liver cancer
576798|NCT00482586|liver metastases|liver metastases
576799|NCT00482677|adult glioblastoma|adult glioblastoma
576800|NCT00482677|adult giant cell glioblastoma|adult giant cell glioblastoma
576801|NCT00482677|adult gliosarcoma|adult gliosarcoma
576802|NCT00482690|Smoking cessation|smoking cessation
576803|NCT00482690|Biomarkers|biomarkers
576804|NCT00482690|Aldehydes|aldehydes
576805|NCT00482690|Exhaled breath|exhaled breath
576806|NCT00482690|Harm Reduction|harm reduction
576807|NCT00482690|Cigarette smoking|cigarette smoking
576808|NCT00482690|cessation|cessation
576809|NCT00482690|reduction|reduction
576810|NCT00482703|Imatinib resistant or intolerant chronic phase CML|imatinib resistant or intolerant chronic phase cml
576811|NCT00482716|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
576812|NCT00482716|refractory multiple myeloma|refractory multiple myeloma
576813|NCT00482716|stage I multiple myeloma|stage i multiple myeloma
576814|NCT00482716|stage II multiple myeloma|stage ii multiple myeloma
576815|NCT00482716|stage III multiple myeloma|stage iii multiple myeloma
576816|NCT00482716|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
576817|NCT00482716|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
576818|NCT00482716|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
576819|NCT00482716|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
576820|NCT00482716|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
576821|NCT00482716|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
576822|NCT00482716|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
576823|NCT00482716|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
576824|NCT00482716|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
576825|NCT00482716|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
576826|NCT00482716|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
576827|NCT00482716|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
576828|NCT00482716|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
576829|NCT00482716|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
576830|NCT00482716|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
576831|NCT00482716|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
576832|NCT00482716|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
576833|NCT00482716|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
576834|NCT00482716|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
576835|NCT00482716|stage I marginal zone lymphoma|stage i marginal zone lymphoma
584146|NCT00514800|Primary care|primary care
576836|NCT00482716|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
576837|NCT00482716|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
576838|NCT00482716|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
576839|NCT00482716|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
576840|NCT00482716|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
576841|NCT00482716|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
576842|NCT00482716|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
576843|NCT00482716|splenic marginal zone lymphoma|splenic marginal zone lymphoma
576844|NCT00482716|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
576845|NCT00482716|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
576846|NCT00482716|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
576847|NCT00482716|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
576848|NCT00482716|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
576849|NCT00482716|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
576850|NCT00482716|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
576851|NCT00482716|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
576852|NCT00482716|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
576853|NCT00482716|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
576854|NCT00482716|anemia|anemia
576855|NCT00482742|Chronic Total Occlusion|chronic total occlusion
576856|NCT00482755|male breast cancer|male breast cancer
576857|NCT00482755|stage II breast cancer|stage ii breast cancer
576858|NCT00482755|stage IIIA breast cancer|stage iiia breast cancer
576859|NCT00482768|Diabetes, type II; Primary Health Care; Outpatient Care|diabetes, type ii; primary health care; outpatient care
576860|NCT00482781|Apnea|apnea
576861|NCT00482781|Bradycardia|bradycardia
576862|NCT00482781|Preterm Infant|preterm infant
576863|NCT00482781|Immunization|immunization
576864|NCT00482781|DTaP|dtap
576865|NCT00482794|Antiphospholipid Antibody Syndrome|antiphospholipid antibody syndrome
576866|NCT00482807|stage I prostate cancer|stage i prostate cancer
576867|NCT00482807|stage II prostate cancer|stage ii prostate cancer
577331|NCT00491192|ICU|icu
576868|NCT00482807|stage III prostate cancer|stage iii prostate cancer
576869|NCT00482807|stage IV prostate cancer|stage iv prostate cancer
576870|NCT00482807|adenocarcinoma of the prostate|adenocarcinoma of the prostate
576871|NCT00482807|recurrent prostate cancer|recurrent prostate cancer
576872|NCT00482820|anxiety|anxiety
576873|NCT00482820|attention-biases|attention-biases
576874|NCT00482820|children|children
576875|NCT00482833|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
576876|NCT00482833|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
576877|NCT00482833|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
576878|NCT00482846|mucositis|mucositis
576879|NCT00482846|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
576880|NCT00482846|stage II multiple myeloma|stage ii multiple myeloma
576881|NCT00482846|stage III multiple myeloma|stage iii multiple myeloma
576882|NCT00482846|refractory multiple myeloma|refractory multiple myeloma
576883|NCT00482859|Fibromyalgia Syndrome|fibromyalgia syndrome
576884|NCT00482872|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
576885|NCT00482872|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
576886|NCT00482872|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
576887|NCT00482872|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
576888|NCT00482872|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
576889|NCT00482872|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
576890|NCT00482872|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
576891|NCT00482872|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
576892|NCT00482872|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
576893|NCT00482872|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
576894|NCT00482872|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
576895|NCT00482872|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
576896|NCT00482872|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
576897|NCT00482872|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
576898|NCT00482872|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
576899|NCT00482872|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
576900|NCT00482872|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
576901|NCT00482872|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
576902|NCT00482872|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
576903|NCT00482872|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
576904|NCT00482872|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
576403|NCT00480987|AML|aml
576905|NCT00482872|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
576906|NCT00482872|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
576907|NCT00482872|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
576908|NCT00482872|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
576909|NCT00482872|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
576910|NCT00482872|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
576911|NCT00482872|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
576912|NCT00482872|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
576913|NCT00482872|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
576914|NCT00482872|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
576915|NCT00482872|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
576916|NCT00482872|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
576917|NCT00482872|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
576918|NCT00482872|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
576919|NCT00482872|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
577314|NCT00491140|BRAF|braf
576920|NCT00482872|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
576921|NCT00482872|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
576922|NCT00482872|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
576923|NCT00482872|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
576924|NCT00482872|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
577332|NCT00491192|Outcome|outcome
576925|NCT00482872|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
576926|NCT00482872|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
576927|NCT00482872|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
576928|NCT00482885|Esophagus|esophagus
576929|NCT00482885|Peristalsis|peristalsis
576930|NCT00482885|Contractile Pressure|contractile pressure
576931|NCT00482885|Coordination of contraction|coordination of contraction
576932|NCT00482885|Bolus transport|bolus transport
576933|NCT00482885|Esophageal function|esophageal function
576934|NCT00482911|recurrent intraocular melanoma|recurrent intraocular melanoma
576935|NCT00482911|metastatic intraocular melanoma|metastatic intraocular melanoma
576936|NCT00482911|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
576937|NCT00482911|extraocular extension melanoma|extraocular extension melanoma
576938|NCT00482911|iris melanoma|iris melanoma
576939|NCT00482911|conjunctival melanoma|conjunctival melanoma
576940|NCT00482924|obesity|obesity
576941|NCT00482924|cardiovascular risk profiles|cardiovascular risk profiles
576942|NCT00482924|adipokines|adipokines
576943|NCT00482924|preatherosclerosis|preatherosclerosis
576944|NCT00482924|low grade inflammation|low grade inflammation
576945|NCT00482924|dyslipidemia|dyslipidemia
576946|NCT00482924|insulin resistance|insulin resistance
576947|NCT00482924|brown adipose tissue|brown adipose tissue
576948|NCT00482924|white adipose tissue|white adipose tissue
576949|NCT00482937|Safety|safety
576950|NCT00482937|Heart Failure|heart failure
576952|NCT00482963|Contraception|contraception
576953|NCT00482963|Antiretroviral agents|antiretroviral agents
576954|NCT00482963|Pharmacokinetics|pharmacokinetics
576955|NCT00483002|A prospective and observational program to monitor use in real practice including efficacy of Varenicline in Korea.|a prospective and observational program to monitor use in real practice including efficacy of varenicline in korea.
576956|NCT00483015|presentation|presentation
576957|NCT00483015|outcome|outcome
576958|NCT00483015|response|response
576959|NCT00483015|never- smokers|never- smokers
576960|NCT00483054|HIV|hiv
576961|NCT00483054|tuberculosis|tuberculosis
576962|NCT00483054|efavirenz|efavirenz
576963|NCT00483054|nevirapine|nevirapine
576964|NCT00483054|rifampicin|rifampicin
576965|NCT00483054|co-infected HIV and tuberculosis patients|co-infected hiv and tuberculosis patients
576966|NCT00483067|Idiopathic Hypereosinophilic Syndrome|idiopathic hypereosinophilic syndrome
576967|NCT00483067|Leukemia|leukemia
576968|NCT00483067|2-Chlorodeoxyadenosine|2-chlorodeoxyadenosine
576969|NCT00483067|Cladribine|cladribine
576970|NCT00483067|Cytarabine|cytarabine
576971|NCT00483067|Ara-C|ara-c
576972|NCT00483067|2-CdA|2-cda
576978|NCT00483093|cisplatin|cisplatin
576979|NCT00483093|solid tumors|solid tumors
576983|NCT00483119|pemphigus vulgaris|pemphigus vulgaris
576984|NCT00483119|IVIg|ivig
576985|NCT00483119|cyclophosphamide|cyclophosphamide
576986|NCT00483119|treatment|treatment
576987|NCT00483119|pemphigus antibodies|pemphigus antibodies
576988|NCT00483158|Helicobacter pylori|helicobacter pylori
576989|NCT00483158|Fluoroquinolones|fluoroquinolones
576990|NCT00483158|First in Man|first in man
576991|NCT00483197|VentrAssistTM|ventrassisttm
576992|NCT00483197|LVAD|lvad
576993|NCT00483197|End-stage heart failure|end-stage heart failure
576994|NCT00483197|Cardiomyopathy|cardiomyopathy
576995|NCT00483223|ER negative|er negative
576996|NCT00483223|PgR negative|pgr negative
576997|NCT00483223|HER2 negative|her2 negative
576998|NCT00483223|cisplatin|cisplatin
576999|NCT00483223|carboplatinum|carboplatinum
577000|NCT00483223|platinum|platinum
577001|NCT00483223|p63|p63
577002|NCT00483223|p73|p73
577003|NCT00483236|Non-Ischaemic Cardiomyopathy|non-ischaemic cardiomyopathy
577004|NCT00483249|Thoracoabdominal|thoracoabdominal
577005|NCT00483249|Paravisceral|paravisceral
577006|NCT00483249|Aneurysm|aneurysm
577007|NCT00483249|Endovascular|endovascular
577008|NCT00483249|Stent-Graft|stent-graft
577009|NCT00483249|Aorta|aorta
577010|NCT00483262|Temsirolimus|temsirolimus
577011|NCT00483262|Bortezomib|bortezomib
577012|NCT00483275|Accidental Falls|accidental falls
577013|NCT00483275|Accident Prevention|accident prevention
577014|NCT00483275|Patient Education|patient education
577015|NCT00483275|Exercise Training|exercise training
577016|NCT00483275|Alfacalcidol|alfacalcidol
577017|NCT00483288|cervical cancer|cervical cancer
577018|NCT00483301|Melanoma|melanoma
577019|NCT00483301|Abraxane|abraxane
577020|NCT00483301|Sorafenib|sorafenib
577021|NCT00483301|BAY 43-9006|bay 43-9006
577022|NCT00483301|Abraxis|abraxis
577023|NCT00483327|Well|well
577024|NCT00483327|Moderately|moderately
577025|NCT00483327|Differentiated|differentiated
577026|NCT00483366|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
577027|NCT00483392|insulin|insulin
577028|NCT00483392|rosiglitazone|rosiglitazone
577029|NCT00483392|metformin|metformin
577030|NCT00483392|hiv|hiv
577031|NCT00483392|protease inhibitors|protease inhibitors
578225|NCT00495170|Paclitaxel|paclitaxel
577032|NCT00483405|advanced adult primary liver cancer|advanced adult primary liver cancer
577033|NCT00483405|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
577034|NCT00483405|recurrent adult primary liver cancer|recurrent adult primary liver cancer
577035|NCT00483405|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
577036|NCT00483418|male|male
577037|NCT00483418|cancer|cancer
577038|NCT00483431|vitamin K2|vitamin k2
577039|NCT00483431|dosis-response|dosis-response
577040|NCT00483431|osteocalcin|osteocalcin
577041|NCT00483431|matrix-gla protein|matrix-gla protein
577042|NCT00483444|Rehabilitation|rehabilitation
577043|NCT00483444|Brain injuries|brain injuries
577044|NCT00483444|Directive counseling|directive counseling
577045|NCT00483457|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
577046|NCT00483470|Hepatitis A|hepatitis a
577047|NCT00483483|HIV|hiv
577048|NCT00483483|Unsafe sex|unsafe sex
577049|NCT00483483|High-risk sex|high-risk sex
577050|NCT00483483|Needle sharing|needle sharing
577051|NCT00483483|STDs|stds
577052|NCT00483509|NGR-hTNF|ngr-htnf
577053|NCT00483509|SCLC|sclc
577054|NCT00483522|Rehabilitation|rehabilitation
577055|NCT00483522|Directive counseling|directive counseling
577056|NCT00483522|Brain injuries|brain injuries
577057|NCT00483535|Gw273225, Oral Contraceptive Interaction|gw273225, oral contraceptive interaction
577058|NCT00483561|adenocarcinoma of the prostate|adenocarcinoma of the prostate
577059|NCT00483561|recurrent prostate cancer|recurrent prostate cancer
577060|NCT00483561|stage III prostate cancer|stage iii prostate cancer
577061|NCT00483561|stage IV prostate cancer|stage iv prostate cancer
577062|NCT00483574|Menactra® vaccine|menactra® vaccine
577063|NCT00483574|Meningococcal meningitis|meningococcal meningitis
577064|NCT00483574|Measles|measles
577065|NCT00483574|Mumps|mumps
577066|NCT00483574|Rubella|rubella
577067|NCT00483574|Varicella virus|varicella virus
577068|NCT00483574|Haemophilus influenzae type b|haemophilus influenzae type b
577069|NCT00483574|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
577070|NCT00483587|NSTEMI|nstemi
577071|NCT00483587|Acute coronary syndrome|acute coronary syndrome
577072|NCT00483587|Heme arginate|heme arginate
577073|NCT00483587|HO-1|ho-1
741975|NCT01124487|fat|fat
577074|NCT00483587|Heme oxygenase-1|heme oxygenase-1
577075|NCT00483600|Fondaparinux|fondaparinux
577076|NCT00483600|Pharmacokinetic|pharmacokinetic
577077|NCT00483613|Daily stress|daily stress
577078|NCT00483613|Cognitive-behavioral therapy|cognitive-behavioral therapy
577079|NCT00483613|Quality of life|quality of life
577080|NCT00483613|SLEDAI|sledai
577081|NCT00489593|Advanced Cancer|advanced cancer
577082|NCT00489593|Weight Loss|weight loss
577083|NCT00489593|Cachexia|cachexia
577084|NCT00489593|Olanzapine|olanzapine
577085|NCT00489593|Zyprexa|zyprexa
577086|NCT00489593|Fluoxetine|fluoxetine
577087|NCT00489593|Symbyax|symbyax
577088|NCT00489606|SK3530|sk3530
745512|NCT01144806|SAM|sam
577089|NCT00489606|tamsulosin|tamsulosin
577090|NCT00489606|hemodynamic interaction|hemodynamic interaction
577091|NCT00489606|safety|safety
577092|NCT00489619|Infectious diseases|infectious diseases
577093|NCT00489619|Democratic Republic of Congo|democratic republic of congo
577094|NCT00489619|Malaria|malaria
577095|NCT00489619|International|international
577096|NCT00489619|Maternal and child health|maternal and child health
577097|NCT00489619|Women's Health|women's health
577098|NCT00489619|Global Network|global network
577099|NCT00489619|Sexually transmitted infections (STIs)|sexually transmitted infections (stis)
577100|NCT00489632|Leukemia|leukemia
577101|NCT00489632|Pediatrics|pediatrics
577102|NCT00489632|Cancer|cancer
577103|NCT00489632|Coping|coping
577104|NCT00489632|Caregiver|caregiver
577105|NCT00489632|Questionnaire|questionnaire
577106|NCT00489632|Children|children
577107|NCT00489632|Resiliency|resiliency
577108|NCT00489632|Adjustment|adjustment
577109|NCT00489632|Illness-related factors|illness-related factors
577110|NCT00489645|pramlintide|pramlintide
577111|NCT00489645|gastric emptying|gastric emptying
577112|NCT00489645|T1DM|t1dm
577113|NCT00489645|postprandial|postprandial
577114|NCT00489658|Human African trypanosomiasis|human african trypanosomiasis
577115|NCT00489658|sleeping sickness|sleeping sickness
577116|NCT00489658|Trypanosoma brucei gambiense|trypanosoma brucei gambiense
577118|NCT00489658|eflornithine|eflornithine
577119|NCT00489658|nifurtimox|nifurtimox
577120|NCT00489658|Human African trypanosomiasis (sleeping sickness) due to Trypanosoma brucei gambiense in the late stage (stage 2 or meningo-encephalitic)|human african trypanosomiasis (sleeping sickness) due to trypanosoma brucei gambiense in the late stage (stage 2 or meningo-encephalitic)
577121|NCT00489671|pancreatic cancer|pancreatic cancer
577122|NCT00489671|precancerous condition|precancerous condition
577123|NCT00489697|colorectal cancer|colorectal cancer
577124|NCT00489697|hepatic metastases|hepatic metastases
577125|NCT00489697|bevacizumab|bevacizumab
577126|NCT00489697|anti-angiogenic agent|anti-angiogenic agent
577127|NCT00489697|chemotherapy regimens|chemotherapy regimens
577128|NCT00489697|tumor vascularity|tumor vascularity
577129|NCT00489697|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
577130|NCT00489710|stage IV renal cell cancer|stage iv renal cell cancer
577131|NCT00489710|recurrent renal cell cancer|recurrent renal cell cancer
577132|NCT00489723|size of stone 1-2 cm|size of stone 1-2 cm
577133|NCT00489723|Pt. with no use of alfa bloker prior ESWL|pt. with no use of alfa bloker prior eswl
577134|NCT00489723|Pt. without internal stent|pt. without internal stent
577135|NCT00489736|Atrial Fibrillation|atrial fibrillation
577136|NCT00489736|sinus rhythm|sinus rhythm
577137|NCT00489736|amiodarone|amiodarone
577138|NCT00489749|Achilles tendon rupture|achilles tendon rupture
577139|NCT00489749|Open surgical repair|open surgical repair
577140|NCT00489749|Early functional mobilization|early functional mobilization
577141|NCT00489749|Weightbearing|weightbearing
577142|NCT00489749|Rehabilitation|rehabilitation
577143|NCT00489762|Childhood|childhood
577144|NCT00489762|Asthma|asthma
577145|NCT00489762|Heating|heating
577146|NCT00489762|Insulation|insulation
577147|NCT00489762|Respiratory symptoms|respiratory symptoms
577148|NCT00489788|MRI|mri
577149|NCT00489788|Ventricular Strain|ventricular strain
577150|NCT00489788|Pulmonary Valve Replacement|pulmonary valve replacement
577151|NCT00489788|Post Tetralogy of Fallot|post tetralogy of fallot
577152|NCT00489801|Cardiac Rehabilitation|cardiac rehabilitation
577153|NCT00489801|Exercise|exercise
577154|NCT00489801|Heart failure|heart failure
577155|NCT00489801|Coronary heart disease|coronary heart disease
577156|NCT00489814|Prostate Cancer|prostate cancer
577157|NCT00489814|Prostate Proton Therapy|prostate proton therapy
577158|NCT00489814|Proton Radiation Therapy|proton radiation therapy
577159|NCT00489814|Proton Radiotherapy|proton radiotherapy
577160|NCT00489814|Quality of Life|quality of life
577161|NCT00489814|QOL|qol
577162|NCT00489814|Questionnaire|questionnaire
577163|NCT00489827|Coronary Artery Bypass|coronary artery bypass
577164|NCT00489827|Myocardial Protection|myocardial protection
577165|NCT00489827|Angina, Unstable|angina, unstable
577166|NCT00489827|Myocardial Ischemia|myocardial ischemia
577167|NCT00489827|Myocardial Infarction|myocardial infarction
577168|NCT00489827|Unstable Coronary Artery Disease|unstable coronary artery disease
577169|NCT00489827|Glutamate|glutamate
584147|NCT00514800|Hypertension|hypertension
577170|NCT00489840|Chronic Central Serous Chorioretinopathy|chronic central serous chorioretinopathy
577172|NCT00489866|PTSD|ptsd
577173|NCT00489866|Antidepressant|antidepressant
577174|NCT00489866|Aripiprazole|aripiprazole
577175|NCT00489866|OEF|oef
577176|NCT00489866|OIF|oif
577177|NCT00489879|Mobile Health Units|mobile health units
577178|NCT00489879|Chronic Disease|chronic disease
577179|NCT00489892|traumatic brain injury|traumatic brain injury
577180|NCT00489892|TBI|tbi
577181|NCT00489892|working memory|working memory
577182|NCT00489892|modafinil|modafinil
577183|NCT00489892|fMRI|fmri
577184|NCT00489892|MRI|mri
577185|NCT00489905|prostate cancer|prostate cancer
577186|NCT00489905|bone mineral density|bone mineral density
577187|NCT00490568|cognition|cognition
577188|NCT00490568|Alzheimer's disease|alzheimer's disease
577189|NCT00490568|Rosiglitazone extended-release (XR)|rosiglitazone extended-release (xr)
577190|NCT00490568|safety|safety
577191|NCT00490568|adjunctive therapy|adjunctive therapy
577192|NCT00490568|BRL-049653|brl-049653
577193|NCT00490568|tolerability|tolerability
577194|NCT00490568|open-label extension|open-label extension
577195|NCT00490581|Early housing after hospitalization|early housing after hospitalization
577196|NCT00490594|ACL|acl
577197|NCT00490594|ligament|ligament
577198|NCT00490594|ACL injury|acl injury
577199|NCT00490607|Hemagiomas of infancy|hemagiomas of infancy
577200|NCT00490620|primary biliary cirrhosis C06.552.630.400|primary biliary cirrhosis c06.552.630.400
577201|NCT00490620|retroviral infection C02.782.815|retroviral infection c02.782.815
577202|NCT00490633|Influenza|influenza
577203|NCT00490633|Non Pharmaceutical Intervention|non pharmaceutical intervention
577204|NCT00490633|Face Mask|face mask
577205|NCT00490633|Hand Hygiene|hand hygiene
577206|NCT00490646|Locally advanced and/or metastatic breast cancer|locally advanced and/or metastatic breast cancer
577207|NCT00490672|Hypertension|hypertension
577208|NCT00490672|Diabetes Mellitus|diabetes mellitus
577209|NCT00490672|Hyperlipidaemia|hyperlipidaemia
577210|NCT00490672|Primary Care|primary care
577211|NCT00490672|Community Care|community care
577315|NCT00491140|MET|met
577316|NCT00491140|IGFR1|igfr1
577212|NCT00490672|Multiple Risk Factors Interventional Strategies|multiple risk factors interventional strategies
577213|NCT00490698|Kidney Cancer|kidney cancer
577214|NCT00490698|Renal Cell Carcinoma|renal cell carcinoma
577215|NCT00490698|Bone-Targeted Therapy|bone-targeted therapy
577216|NCT00490698|Zoledronate|zoledronate
577217|NCT00490698|Zometa|zometa
577218|NCT00490698|Atorvastatin|atorvastatin
577219|NCT00490698|Lipitor|lipitor
577220|NCT00490698|RCC|rcc
577221|NCT00490724|Heart failure, congestive|heart failure, congestive
577222|NCT00490724|Nesiritide and|nesiritide and
577223|NCT00490724|JNS004|jns004
577224|NCT00490737|ESRD|esrd
577225|NCT00490737|dialysis|dialysis
577226|NCT00490737|hemodialysis|hemodialysis
577227|NCT00490737|continuous ambulatory peritoneal dialysis|continuous ambulatory peritoneal dialysis
577228|NCT00490750|Heller Dor|heller dor
577229|NCT00490750|Heller Toupet|heller toupet
577230|NCT00490750|Myotomy|myotomy
577231|NCT00490763|Prostate Cancer|prostate cancer
577232|NCT00490763|Active Surveillance|active surveillance
577233|NCT00490763|Prostate Specific Antigen|prostate specific antigen
577234|NCT00490763|Questionnaire|questionnaire
577235|NCT00490763|Survey|survey
577236|NCT00490776|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
577237|NCT00490776|adults|adults
577238|NCT00490776|Mycosis Fungoides|mycosis fungoides
577239|NCT00490776|Sézary Syndrome|sézary syndrome
577240|NCT00490776|CTCL|ctcl
577241|NCT00490789|tuberous sclerosis|tuberous sclerosis
577242|NCT00490789|lymphangioleiomyomatosis|lymphangioleiomyomatosis
577243|NCT00490789|sirolimus|sirolimus
577244|NCT00490789|angiomyolioma|angiomyolioma
577245|NCT00490789|rapamycin|rapamycin
577246|NCT00490789|mTOR|mtor
577247|NCT00490802|Autism|autism
577248|NCT00490802|Treatment|treatment
577249|NCT00490802|Oxytocin|oxytocin
577250|NCT00490802|Adults|adults
577251|NCT00490802|Autism Spectrum Disorder|autism spectrum disorder
577252|NCT00490828|Cardiac surgery|cardiac surgery
577253|NCT00490828|systemic inflammatory response syndrome|systemic inflammatory response syndrome
577254|NCT00490828|health-related quality of life|health-related quality of life
577255|NCT00490893|counterregulation|counterregulation
577256|NCT00490893|hypoglycemia unawareness|hypoglycemia unawareness
577257|NCT00490893|insulin therapy|insulin therapy
577258|NCT00490906|MS (Multiple Sclerosis)|ms (multiple sclerosis)
577259|NCT00490919|Chronic pain|chronic pain
577260|NCT00490919|opioid|opioid
577261|NCT00490919|transdermal|transdermal
577262|NCT00490919|Moderate to severe chronic low back pain|moderate to severe chronic low back pain
577263|NCT00490932|Watery diarrhea|watery diarrhea
577264|NCT00490932|Bloody diarrhea|bloody diarrhea
577265|NCT00490958|heart Failure|heart failure
577266|NCT00490958|haemodialysis|haemodialysis
577267|NCT00490958|telmisartan|telmisartan
584148|NCT00514800|TIA|tia
577268|NCT00490958|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
577269|NCT00490971|Bipolar Disorder|bipolar disorder
577270|NCT00490971|Mania|mania
577271|NCT00490971|Depression|depression
577272|NCT00490971|Manic-Depressive Disorder|manic-depressive disorder
577273|NCT00490984|obstructive sleep apena|obstructive sleep apena
577274|NCT00490984|tongue|tongue
577275|NCT00490984|surgery|surgery
577276|NCT00490997|ketamine|ketamine
577277|NCT00490997|propofol|propofol
577278|NCT00490997|sedation|sedation
577279|NCT00490997|pediatric|pediatric
577280|NCT00490997|emergency department|emergency department
577281|NCT00490997|fracture|fracture
577282|NCT00491010|atrial flutter|atrial flutter
577283|NCT00491010|ablation|ablation
577284|NCT00491010|voltage targeted|voltage targeted
577285|NCT00491036|Acute myocardial infarction|acute myocardial infarction
577286|NCT00491036|cardiogenic shock|cardiogenic shock
577287|NCT00491036|percutaneous coronary intervention|percutaneous coronary intervention
577288|NCT00491036|intraaortic balloon counterpulsation|intraaortic balloon counterpulsation
577289|NCT00491036|Acute myocardial infarction - cardiogenic shock|acute myocardial infarction - cardiogenic shock
577290|NCT00491049|prophylaxis|prophylaxis
577291|NCT00491049|intraocular surgery|intraocular surgery
577292|NCT00491049|endophthalmitis|endophthalmitis
577293|NCT00491049|antibiotic|antibiotic
577294|NCT00491062|Parkinson's disease|parkinson's disease
577295|NCT00491062|enteric nervous system|enteric nervous system
577296|NCT00491075|Renal Cell Carcinoma|renal cell carcinoma
577297|NCT00491075|Non-Clear Cell|non-clear cell
577298|NCT00491075|Pemetrexed|pemetrexed
577299|NCT00491075|Gemcitabine|gemcitabine
577300|NCT00491075|LY231514|ly231514
577301|NCT00491075|Alimta|alimta
577302|NCT00491075|MTA|mta
577303|NCT00491075|Multitargeted Antifolate|multitargeted antifolate
577304|NCT00491075|NSC-698037|nsc-698037
577305|NCT00491075|Gemcitabine Hydrochloride|gemcitabine hydrochloride
577306|NCT00491075|Gemzar|gemzar
577307|NCT00491075|RCC|rcc
577308|NCT00491101|Asthma Control|asthma control
577309|NCT00491101|Quality of Life|quality of life
577310|NCT00491101|Children|children
577311|NCT00491101|Polish Version of PAQLQ(S) by Juniper|polish version of paqlq(s) by juniper
577312|NCT00491140|EGFR|egfr
577313|NCT00491140|KRAS|kras
577317|NCT00491153|asthma|asthma
577318|NCT00491153|airway hyperresponsiveness|airway hyperresponsiveness
577319|NCT00491153|dry powder mannitol inhalation|dry powder mannitol inhalation
577320|NCT00491153|methacholine|methacholine
577321|NCT00491166|diabetic macular edema|diabetic macular edema
577322|NCT00491166|bromfenac ophthalmic solution|bromfenac ophthalmic solution
577323|NCT00491179|Chronic hepatitis C|chronic hepatitis c
577324|NCT00491179|hemodialysis|hemodialysis
577325|NCT00491179|interferon|interferon
577326|NCT00491179|ribavirin|ribavirin
577327|NCT00491192|Fever|fever
577328|NCT00491192|Acute cerebral damage|acute cerebral damage
577329|NCT00491192|Normothermia|normothermia
577330|NCT00491192|Diclofenac|diclofenac
577333|NCT00491192|Intracranial pressure|intracranial pressure
577334|NCT00491192|Cerebral perfusion pressure|cerebral perfusion pressure
577335|NCT00491192|Traumatic brain injury|traumatic brain injury
577336|NCT00491192|Subarachnoid hemorrhage|subarachnoid hemorrhage
577337|NCT00491218|impact of cardiac computed tomography on outpatient angina evaluation|impact of cardiac computed tomography on outpatient angina evaluation
577338|NCT00491218|downstream resource utilization|downstream resource utilization
577339|NCT00491231|orthostatic hypotension|orthostatic hypotension
577340|NCT00491231|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
577341|NCT00491244|Chronic hepatitis C|chronic hepatitis c
577342|NCT00491244|Hemodialysis|hemodialysis
577343|NCT00491244|Interferon|interferon
577344|NCT00491244|Ribavirin|ribavirin
577345|NCT00491257|Influenza|influenza
577346|NCT00491257|Orthomyxoviridae Infections|orthomyxoviridae infections
577347|NCT00491257|Orthomyxoviruses|orthomyxoviruses
577348|NCT00491257|Split-virion influenza vaccine|split-virion influenza vaccine
577349|NCT00491270|Vaginosis, Bacterial|vaginosis, bacterial
577350|NCT00491270|Abortion, Spontaneous|abortion, spontaneous
577351|NCT00491270|Premature Birth|premature birth
577352|NCT00491296|S/P Transuretral resection of bladder tumor|s/p transuretral resection of bladder tumor
577353|NCT00491296|Recurrent tumor after BCG Treatment|recurrent tumor after bcg treatment
577354|NCT00491322|Vitamin D|vitamin d
577355|NCT00491322|Vitamin D deficiency|vitamin d deficiency
577356|NCT00491322|Insulin resistance|insulin resistance
577357|NCT00491322|Diabetes|diabetes
577358|NCT00491322|Diabetes mellitus|diabetes mellitus
577359|NCT00491322|FGF-23|fgf-23
577360|NCT00491322|FGF23|fgf23
577361|NCT00491322|Phosphate|phosphate
577362|NCT00491335|AIDS|aids
577363|NCT00491335|Lung Cancer|lung cancer
577364|NCT00491335|Emphysema|emphysema
577365|NCT00491335|Nicotine|nicotine
577366|NCT00491335|HIV Infection|hiv infection
577367|NCT00491335|Smoking|smoking
577368|NCT00491348|Generalized anxiety disorder|generalized anxiety disorder
577369|NCT00491348|fMRI|fmri
577370|NCT00491348|Worry|worry
577371|NCT00491361|ADHD, SNAP-IV, SDQ, ASRS, reliability, validity|adhd, snap-iv, sdq, asrs, reliability, validity
577372|NCT00491387|hypertension|hypertension
577373|NCT00491387|sympathetic nervous system|sympathetic nervous system
577374|NCT00491400|endothelium|endothelium
577375|NCT00491400|obesity|obesity
577376|NCT00491400|diabetes mellitus|diabetes mellitus
577377|NCT00491400|dyslipidemia|dyslipidemia
577378|NCT00491413|neurodevelopmental outcomes|neurodevelopmental outcomes
577379|NCT00491426|Infection|infection
577380|NCT00491426|Anti-Infective Agents|anti-infective agents
577381|NCT00491426|Antifungal Agents|antifungal agents
577382|NCT00491426|Proteomics|proteomics
577383|NCT00491439|in vivo confocal microscopy|in vivo confocal microscopy
577384|NCT00491439|vitrectomy|vitrectomy
577385|NCT00491439|corneal transplantation|corneal transplantation
577386|NCT00491439|Epi-LASIK|epi-lasik
577387|NCT00491439|wound healing|wound healing
577388|NCT00491452|Ischemic MR|ischemic mr
577389|NCT00491452|Annuloplasty|annuloplasty
577390|NCT00491465|Type 1 Diabetes, physical activity, pediatric, metabolic control|type 1 diabetes, physical activity, pediatric, metabolic control
577391|NCT00491478|Repetitive behavior disorder|repetitive behavior disorder
577392|NCT00491478|Stereotypy|stereotypy
577393|NCT00491478|Sertraline|sertraline
577394|NCT00491491|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
577395|NCT00491491|autologous stem cell transplantation|autologous stem cell transplantation
577396|NCT00491491|radioimmunotherapy|radioimmunotherapy
577397|NCT00491491|zevalin|zevalin
577398|NCT00491556|Atazanavir/Ritonavir (ATV/r)|atazanavir/ritonavir (atv/r)
577399|NCT00491556|highly-active antiretroviral therapy (HAART)|highly-active antiretroviral therapy (haart)
577400|NCT00491556|Treatment Naive|treatment naive
577401|NCT00491569|Schizophrenia|schizophrenia
577402|NCT00491569|sarcosine|sarcosine
577403|NCT00491569|D-serine|d-serine
577404|NCT00491569|NMDA|nmda
577405|NCT00491595|Soy isoflavones|soy isoflavones
577406|NCT00491595|Genotoxicity|genotoxicity
577407|NCT00491595|Apoptosis|apoptosis
577408|NCT00491595|Estrogenic effects|estrogenic effects
577409|NCT00491608|Phase 3b|phase 3b
577410|NCT00491608|rThrombin|rthrombin
577411|NCT00491608|spine surgery|spine surgery
577412|NCT00491608|vascular surgery|vascular surgery
577413|NCT00491608|hemostasis|hemostasis
577414|NCT00491608|immunogenicity|immunogenicity
577415|NCT00491608|safety|safety
577416|NCT00491621|kidney|kidney
577417|NCT00491621|tumor|tumor
577418|NCT00491621|Molecular Markers|molecular markers
577419|NCT00491621|Cytology|cytology
577420|NCT00491621|Histology|histology
577421|NCT00491621|Cystic kidney tumor|cystic kidney tumor
577422|NCT00491634|acute myeloid leukemia|acute myeloid leukemia
577423|NCT00491634|myelodysplastic syndrome|myelodysplastic syndrome
577424|NCT00491634|allogeneic stem cell transplantation|allogeneic stem cell transplantation
577425|NCT00491634|reduced-intensity conditioning|reduced-intensity conditioning
577426|NCT00491634|treosulfan|treosulfan
577427|NCT00491647|ADHD, time perception, treatments|adhd, time perception, treatments
577428|NCT00491660|Gravity|gravity
577429|NCT00491660|Mechanical ventilation|mechanical ventilation
577430|NCT00491660|Infants|infants
577431|NCT00491660|Ventilator-associated pneumonia|ventilator-associated pneumonia
577432|NCT00491660|Types of bacterial colonies in subjects at 2-5 days of mechanical ventilation|types of bacterial colonies in subjects at 2-5 days of mechanical ventilation
577433|NCT00491660|Colony count of an organism was cultured|colony count of an organism was cultured
577434|NCT00491673|Fracture|fracture
577435|NCT00491673|Femoral neck|femoral neck
577436|NCT00491673|Arthroplasty|arthroplasty
577437|NCT00491686|Long-term depression|long-term depression
577438|NCT00491699|NSCLC|nsclc
577439|NCT00491712|Glaucoma|glaucoma
577440|NCT00491712|Neovascular Glaucoma|neovascular glaucoma
577441|NCT00491712|Drainage implant devices|drainage implant devices
577442|NCT00491712|Silicone Ahmed Tube|silicone ahmed tube
577443|NCT00491712|Triamcinolone|triamcinolone
577445|NCT00491738|Renal cell cancer|renal cell cancer
577446|NCT00491738|Avastin|avastin
577447|NCT00491738|Sutent|sutent
577448|NCT00491751|endothelium|endothelium
577449|NCT00491751|nitric oxide|nitric oxide
577450|NCT00491751|statins|statins
577451|NCT00491751|ascorbic acid|ascorbic acid
577452|NCT00491777|Noninvasive|noninvasive
577453|NCT00491777|Hemodynamic|hemodynamic
577454|NCT00491777|Monitoring|monitoring
577455|NCT00491777|Critical Care|critical care
577456|NCT00491777|Swan-Ganz|swan-ganz
577457|NCT00491790|montelukast|montelukast
577458|NCT00491790|Albuterol|albuterol
577459|NCT00491790|Status Asthmaticus|status asthmaticus
577460|NCT00491790|Asthma|asthma
577461|NCT00491803|COPD|copd
577462|NCT00491816|breast|breast
577463|NCT00491816|cancer|cancer
577464|NCT00491816|breast cancer|breast cancer
577465|NCT00491842|Huntington's Disease|huntington's disease
577466|NCT00491842|Disclosure|disclosure
577467|NCT00491842|Adaptation|adaptation
584350|NCT00515489|Schizoaffective Disorder|schizoaffective disorder
577468|NCT00491842|Communication About Huntington's Disease|communication about huntington's disease
577469|NCT00491842|Huntington Disease|huntington disease
577470|NCT00491842|HD|hd
577471|NCT00491842|Phone Interview|phone interview
577472|NCT00491855|Advanced Peritoneal Carcinomatosis|advanced peritoneal carcinomatosis
577473|NCT00491855|Peritoneal Cancer|peritoneal cancer
577474|NCT00491855|Bevacizumab|bevacizumab
577475|NCT00491855|Avastin|avastin
577476|NCT00491855|vascular endothelial growth factor|vascular endothelial growth factor
577477|NCT00491855|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
577478|NCT00491855|rhuMAb-VEGF|rhumab-vegf
577479|NCT00491855|Oxaliplatin|oxaliplatin
577480|NCT00491855|Eloxatin|eloxatin
577481|NCT00491855|Paclitaxel|paclitaxel
577482|NCT00491855|Taxol|taxol
577483|NCT00491881|blood pressure|blood pressure
577484|NCT00491881|No added salt diet|no added salt diet
577485|NCT00491881|urinary sodium|urinary sodium
577486|NCT00491894|Mental Retardation|mental retardation
577487|NCT00491894|Neurological Impairment|neurological impairment
577488|NCT00491894|Cerebral Palsy|cerebral palsy
577489|NCT00491894|Drooling|drooling
577490|NCT00491894|Neurological Conditions|neurological conditions
577491|NCT00491907|folic acid|folic acid
577492|NCT00491907|endothelial function|endothelial function
577493|NCT00491907|baroreceptor function|baroreceptor function
577494|NCT00491907|heart failure|heart failure
577495|NCT00491920|osteoporosis|osteoporosis
577496|NCT00491920|bone mineral density|bone mineral density
577497|NCT00491920|vitamin D|vitamin d
577498|NCT00491946|Cancer|cancer
577499|NCT00491946|Actinomycin|actinomycin
577500|NCT00491946|Vincristine|vincristine
577501|NCT00491959|oral mucosa|oral mucosa
577502|NCT00491959|limbal insufficiency|limbal insufficiency
577503|NCT00491959|transplantation|transplantation
577504|NCT00491959|cornea|cornea
577505|NCT00491959|ocular surface|ocular surface
577506|NCT00491985|Influenza A/H5N1 Virus|influenza a/h5n1 virus
577507|NCT00491985|Influenza Pandemic|influenza pandemic
577508|NCT00491985|Orthomyxoviridae Infections|orthomyxoviridae infections
577509|NCT00492011|Circadian Rhythm Disorders|circadian rhythm disorders
577444|NCT00491738|RCC|rcc
577510|NCT00492011|Biological Clock Disturbances|biological clock disturbances
577511|NCT00492011|Jet Lag Syndrome|jet lag syndrome
577512|NCT00492011|Time Zone Change Syndrome|time zone change syndrome
577513|NCT00492011|Drug Therapy|drug therapy
577514|NCT00492024|Respiratory Tract Infection|respiratory tract infection
577515|NCT00492024|Bacterial Sinusitis|bacterial sinusitis
577516|NCT00492037|hyponatremia|hyponatremia
577517|NCT00492037|hypervolemic|hypervolemic
577518|NCT00492037|euvolemic|euvolemic
577519|NCT00492037|conivaptan|conivaptan
577520|NCT00492050|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
577521|NCT00492050|Macroglobulinemic Lymphoma|macroglobulinemic lymphoma
577522|NCT00492050|Stem Cell Collection|stem cell collection
577523|NCT00492050|Bortezomib|bortezomib
577524|NCT00492050|LDP-341|ldp-341
577525|NCT00492050|MLN341|mln341
577526|NCT00492050|PS-341|ps-341
577527|NCT00492050|Velcade|velcade
577528|NCT00492050|Rituximab|rituximab
577529|NCT00492050|Rituxan|rituxan
577530|NCT00492063|safety|safety
577531|NCT00492063|immunogenicity|immunogenicity
577532|NCT00492063|non-inferiority|non-inferiority
577533|NCT00492063|MDCK|mdck
577534|NCT00492063|cell culture-derived|cell culture-derived
577535|NCT00492063|subunit influenza vaccine|subunit influenza vaccine
577536|NCT00492063|influenza prevention|influenza prevention
577537|NCT00492076|Specific immunotherapy|specific immunotherapy
577538|NCT00492076|Mite|mite
577539|NCT00492076|Asthma|asthma
577540|NCT00492102|pharmacokinetics|pharmacokinetics
577541|NCT00492102|Montelukast|montelukast
577542|NCT00492102|bronchopulmonary dysplasia|bronchopulmonary dysplasia
577543|NCT00492102|Pharmacokinetics of Montelukast|pharmacokinetics of montelukast
577544|NCT00492115|sleep|sleep
577545|NCT00492115|dementia|dementia
577546|NCT00492115|apnea|apnea
577547|NCT00492115|memory|memory
577548|NCT00492115|Parkinson's disease|parkinson's disease
577549|NCT00492128|hypertension|hypertension
577550|NCT00492128|angiotensin receptor blocker|angiotensin receptor blocker
577551|NCT00492128|diuretic|diuretic
577552|NCT00492128|combination therapy|combination therapy
577553|NCT00492141|Ewing's Sarcoma|ewing's sarcoma
577554|NCT00492141|Lung Involvement|lung involvement
577555|NCT00492141|Temozolomide|temozolomide
577556|NCT00492141|Temodar|temodar
577557|NCT00492141|Aerosol Liposomal 9-Nitro-20(S)-Camptothecin|aerosol liposomal 9-nitro-20(s)-camptothecin
577558|NCT00492141|Aerosol L9-NC|aerosol l9-nc
577559|NCT00492141|L9-NC|l9-nc
577560|NCT00492154|FRACTURE OF DISTAL RADIUS|fracture of distal radius
577561|NCT00492167|recurrent neuroblastoma|recurrent neuroblastoma
577562|NCT00492167|regional neuroblastoma|regional neuroblastoma
577563|NCT00492167|stage 4S neuroblastoma|stage 4s neuroblastoma
577688|NCT00492674|Arthroplasty|arthroplasty
577564|NCT00492167|disseminated neuroblastoma|disseminated neuroblastoma
577565|NCT00492193|Hand assist laparoscopic partial large bowel resection|hand assist laparoscopic partial large bowel resection
577566|NCT00492193|Laparoscopic partial large bowel resection|laparoscopic partial large bowel resection
577567|NCT00492206|Non Small Cell Lung Cancer|non small cell lung cancer
577568|NCT00492206|NSCLC|nsclc
577569|NCT00492206|EGFR Inhibitor|egfr inhibitor
577570|NCT00492206|Radiation Therapy|radiation therapy
577571|NCT00492219|arthroplasty|arthroplasty
577572|NCT00492219|replacement|replacement
577573|NCT00492219|knee|knee
577574|NCT00492219|prosthesis|prosthesis
577575|NCT00492232|Chronic Insomnia|chronic insomnia
577576|NCT00492232|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
576973|NCT00483067|G-CSF|g-csf
576974|NCT00483067|HES|hes
576975|NCT00483080|NGR-hTNF|ngr-htnf
576976|NCT00483080|CRC|crc
576977|NCT00483093|NGR-hTNF|ngr-htnf
577577|NCT00492232|Drug Therapy|drug therapy
577579|NCT00492245|corneal opacity|corneal opacity
577580|NCT00492245|mitomycin|mitomycin
577581|NCT00492258|stage II renal cell cancer|stage ii renal cell cancer
577582|NCT00492258|stage III renal cell cancer|stage iii renal cell cancer
577583|NCT00492258|stage IV renal cell cancer|stage iv renal cell cancer
577584|NCT00492258|stage I renal cell cancer|stage i renal cell cancer
577585|NCT00492258|clear cell renal cell carcinoma|clear cell renal cell carcinoma
577586|NCT00492258|papillary renal cell carcinoma|papillary renal cell carcinoma
577587|NCT00492271|Friulimicin B|friulimicin b
577588|NCT00492271|Lipopeptide Antibiotic|lipopeptide antibiotic
577589|NCT00492271|First in Man|first in man
577590|NCT00492284|Macular Degeneration|macular degeneration
577591|NCT00492284|AMD|amd
577592|NCT00492284|CNV|cnv
577593|NCT00492284|Choroidal neovascularization|choroidal neovascularization
577594|NCT00492284|Photodynamic therapy|photodynamic therapy
577595|NCT00492284|CNV Secondary to Age Related Macular Degeneration|cnv secondary to age related macular degeneration
577596|NCT00492310|Smoking|smoking
577597|NCT00492310|tobacco|tobacco
577598|NCT00492310|women|women
577599|NCT00492310|yoga|yoga
577600|NCT00492323|pain following the healing of rashes and blisters|pain following the healing of rashes and blisters
577601|NCT00492323|herpes virus|herpes virus
577602|NCT00492323|rash|rash
577603|NCT00492323|varicella-zoster virus|varicella-zoster virus
577604|NCT00492323|shingles.|shingles.
577605|NCT00492336|Cognitive impairments|cognitive impairments
577606|NCT00492336|Negative symptoms|negative symptoms
577607|NCT00492349|Varenicline|varenicline
577608|NCT00492349|Neurobiology|neurobiology
577609|NCT00492349|clinical trial|clinical trial
577610|NCT00492349|cognitive deficits|cognitive deficits
577611|NCT00492349|Schizophreniform Disorder|schizophreniform disorder
577612|NCT00492362|hemodialysis|hemodialysis
577613|NCT00492362|exercise|exercise
577614|NCT00492362|physical fitness|physical fitness
577615|NCT00492362|dialysis adequacy|dialysis adequacy
577616|NCT00492388|breakthrough|breakthrough
577617|NCT00492388|pain|pain
577618|NCT00492388|cancer|cancer
577619|NCT00492414|Panic disorder (PD)|panic disorder (pd)
577620|NCT00492440|recurrent renal cell cancer|recurrent renal cell cancer
577621|NCT00492440|stage IV renal cell cancer|stage iv renal cell cancer
577622|NCT00492440|stage III renal cell cancer|stage iii renal cell cancer
577623|NCT00492440|recurrent melanoma|recurrent melanoma
577624|NCT00492440|stage IV melanoma|stage iv melanoma
577625|NCT00492466|Multiple Sclerosis|multiple sclerosis
577626|NCT00492466|antibody|antibody
577627|NCT00492466|Neutralizing antibody|neutralizing antibody
577628|NCT00492466|Binding antibody|binding antibody
577629|NCT00492466|MxA protein|mxa protein
577630|NCT00492492|radius,|radius,
577631|NCT00492492|pinning,|pinning,
577632|NCT00492492|fixed-angle plate,|fixed-angle plate,
577633|NCT00492492|quick-DASH,|quick-dash,
577634|NCT00492492|HERZBERG-score.|herzberg-score.
577635|NCT00492505|stage IIIA melanoma|stage iiia melanoma
577636|NCT00492505|stage IIIB melanoma|stage iiib melanoma
577637|NCT00492505|stage IIIC melanoma|stage iiic melanoma
577638|NCT00492518|Contrast Induced Nephropathy|contrast induced nephropathy
577639|NCT00492518|Prophylaxis|prophylaxis
577640|NCT00492518|Theophylline|theophylline
577641|NCT00492518|Acetylcysteine|acetylcysteine
577642|NCT00492518|Coronary angiography|coronary angiography
577643|NCT00492531|Interventional Study|interventional study
577644|NCT00492531|6-Minute Walk|6-minute walk
577645|NCT00492531|Sickle Cell Anemia|sickle cell anemia
577646|NCT00492531|Sildenafil/Viagra|sildenafil/viagra
577647|NCT00492531|Tricuspid Regurgitant Velocity|tricuspid regurgitant velocity
577648|NCT00492531|Sickle Cell Disease|sickle cell disease
577649|NCT00492531|Pulmonary Hypertension|pulmonary hypertension
577650|NCT00492544|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
577651|NCT00492544|safety|safety
577652|NCT00492544|cervical cancer|cervical cancer
577653|NCT00492544|immunogenicity|immunogenicity
577654|NCT00492544|vaccine|vaccine
577655|NCT00492544|viral infections|viral infections
577656|NCT00492544|pre-adolescent and adolescent females|pre-adolescent and adolescent females
577657|NCT00492557|Pneumococcal Disease|pneumococcal disease
577658|NCT00492557|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
577659|NCT00492570|Multiple Sclerosis|multiple sclerosis
577660|NCT00492570|Cognitive Dysfunction in Multiple sclerosis|cognitive dysfunction in multiple sclerosis
577661|NCT00492570|early treatment|early treatment
577662|NCT00492570|Avonex|avonex
577663|NCT00492570|interferon beta 1a|interferon beta 1a
577664|NCT00492570|Cognitive Dysfunction|cognitive dysfunction
577665|NCT00492583|probiotic|probiotic
577666|NCT00492583|health|health
577667|NCT00492583|bifidobacterium lactis|bifidobacterium lactis
577668|NCT00492583|BB-12|bb-12
577669|NCT00492609|Surgery|surgery
577670|NCT00492609|Navigation|navigation
577671|NCT00492609|ACL|acl
577672|NCT00492609|IKDC|ikdc
577673|NCT00492609|comparative study|comparative study
577674|NCT00492622|Gastroparesis|gastroparesis
577675|NCT00492622|Gastroesophageal reflux disease|gastroesophageal reflux disease
577676|NCT00492622|heartburn|heartburn
577677|NCT00492648|GSK Biologicals|gsk biologicals
577678|NCT00492648|Varicella Zoster Virus (VZV)|varicella zoster virus (vzv)
577679|NCT00492648|Intracellular cytokine staining (ICS)|intracellular cytokine staining (ics)
577680|NCT00492648|Vaccine|vaccine
577681|NCT00492648|Cell mediated immunity (CMI)|cell mediated immunity (cmi)
577682|NCT00492648|Herpes Zoster (HZ)|herpes zoster (hz)
577683|NCT00492648|Shingles|shingles
577684|NCT00492661|Tacrolimus|tacrolimus
577685|NCT00492661|Prograf|prograf
577686|NCT00492661|PRIDE|pride
577687|NCT00492674|TKA|tka
577689|NCT00492674|Knee|knee
577690|NCT00492674|Osteoarthritis|osteoarthritis
577691|NCT00492674|Rehabilitation|rehabilitation
577692|NCT00492687|adult anaplastic astrocytoma|adult anaplastic astrocytoma
577693|NCT00492687|adult giant cell glioblastoma|adult giant cell glioblastoma
577694|NCT00492687|adult gliosarcoma|adult gliosarcoma
577695|NCT00492687|adult glioblastoma|adult glioblastoma
577696|NCT00492700|steatosis,|steatosis,
577697|NCT00492700|fibrosis,|fibrosis,
577698|NCT00492700|diabetes,|diabetes,
577699|NCT00492700|obesity|obesity
577700|NCT00492713|Bioavailability|bioavailability
577701|NCT00492713|Dark Chocolate|dark chocolate
577702|NCT00492713|Milk Chocolate|milk chocolate
577703|NCT00492713|Polyphenols|polyphenols
577704|NCT00492726|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
577705|NCT00492739|Orthotopic liver transplantation|orthotopic liver transplantation
577706|NCT00492739|Pediatric|pediatric
577707|NCT00492739|Immunosuppression|immunosuppression
577708|NCT00492739|Varicella vaccine|varicella vaccine
577710|NCT00492739|T cell response|t cell response
577711|NCT00492739|Antibodies|antibodies
577712|NCT00492739|Varicella|varicella
577713|NCT00492739|Chickenpox|chickenpox
577714|NCT00492739|transplantation|transplantation
577715|NCT00492765|Combination therapy|combination therapy
577716|NCT00492765|Simvastatin|simvastatin
577717|NCT00492765|Multiple Sclerosis|multiple sclerosis
577718|NCT00492765|Interferon-beta-1a|interferon-beta-1a
577719|NCT00492791|crohn's disease|crohn's disease
577720|NCT00492791|capsule endoscopes|capsule endoscopes
577721|NCT00492804|inguinal hernia|inguinal hernia
577722|NCT00492804|chronic pain|chronic pain
577723|NCT00492804|neurectomy|neurectomy
577724|NCT00492804|hypesthesia|hypesthesia
577725|NCT00492817|Spinal Neoplasms|spinal neoplasms
577726|NCT00492817|Paraspinal Metastases|paraspinal metastases
577727|NCT00492817|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
577728|NCT00492817|CT-on-Rails|ct-on-rails
577729|NCT00492817|Spinal Cord|spinal cord
577730|NCT00492817|SBRT|sbrt
577731|NCT00492830|Phase 1|phase 1
577732|NCT00492830|TRC093|trc093
577733|NCT00492830|denatured collagen|denatured collagen
577734|NCT00492830|solid tumor|solid tumor
577735|NCT00492830|antibody|antibody
577736|NCT00492830|TRACON|tracon
577737|NCT00492830|Locally advanced solid tumors|locally advanced solid tumors
577738|NCT00492830|Metastatic solid tumors|metastatic solid tumors
577739|NCT00492843|Ibandronate, Lung cancer, bone metastasis|ibandronate, lung cancer, bone metastasis
577740|NCT00492856|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
577741|NCT00492856|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
577742|NCT00492856|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
577743|NCT00492869|kidney transplantation|kidney transplantation
577744|NCT00492869|rejection|rejection
577745|NCT00492869|AEB071|aeb071
577746|NCT00492869|tacrolimus|tacrolimus
577747|NCT00492869|mycophenolic|mycophenolic
577748|NCT00492869|basiliximab|basiliximab
577749|NCT00492869|immunosuppression|immunosuppression
577750|NCT00492882|Polycystic Ovary Syndrome|polycystic ovary syndrome
577751|NCT00492882|Follicular Arrest|follicular arrest
577752|NCT00492882|Anti-Mullerian Hormone|anti-mullerian hormone
577754|NCT00492908|Coronary Revascularization|coronary revascularization
577755|NCT00492908|Titanium-Nitride-Oxide Coated Stent|titanium-nitride-oxide coated stent
577756|NCT00492908|Zotarolimus-Eluting Stent|zotarolimus-eluting stent
577757|NCT00492921|graft versus host disease|graft versus host disease
577758|NCT00492934|subfertility|subfertility
577759|NCT00492934|endometrium thickness|endometrium thickness
577760|NCT00492934|implantation rate|implantation rate
742172|NCT01125241|epilepsy|epilepsy
577761|NCT00492934|embryo cryopreservation|embryo cryopreservation
577762|NCT00492934|embryo transfer|embryo transfer
577763|NCT00492947|Phase I|phase i
577764|NCT00492947|dendritic cell|dendritic cell
577765|NCT00492947|vaccine|vaccine
577766|NCT00492947|intra tumoral|intra tumoral
577171|NCT00489853|COPD|copd
577767|NCT00492947|squamous cell carcinoma|squamous cell carcinoma
577768|NCT00492960|Celiac Disease|celiac disease
577769|NCT00492973|arthroplasty|arthroplasty
577770|NCT00492973|replacement|replacement
577771|NCT00492973|knee|knee
577772|NCT00492986|Renal Cell Cancer (RCC)|renal cell cancer (rcc)
577773|NCT00492986|Cancer|cancer
577774|NCT00492999|recurrent colon cancer|recurrent colon cancer
577775|NCT00492999|stage IV colon cancer|stage iv colon cancer
577776|NCT00492999|recurrent rectal cancer|recurrent rectal cancer
577777|NCT00492999|stage IV rectal cancer|stage iv rectal cancer
577778|NCT00492999|adenocarcinoma of the colon|adenocarcinoma of the colon
577779|NCT00492999|adenocarcinoma of the rectum|adenocarcinoma of the rectum
577780|NCT00492999|liver metastases|liver metastases
577781|NCT00493012|body weight|body weight
577782|NCT00493012|body compostion|body compostion
577783|NCT00493012|vitamin D|vitamin d
577784|NCT00493012|blood pressure|blood pressure
577785|NCT00493025|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
577786|NCT00493025|stage II esophageal cancer|stage ii esophageal cancer
577787|NCT00493025|stage III esophageal cancer|stage iii esophageal cancer
577788|NCT00493025|stage IV esophageal cancer|stage iv esophageal cancer
577789|NCT00493038|Treatment of acute bacterial rhinosinusitis|treatment of acute bacterial rhinosinusitis
577790|NCT00493051|diabetes|diabetes
577791|NCT00493051|nonhealing|nonhealing
577792|NCT00493051|ulcers|ulcers
577793|NCT00493051|neuropathic|neuropathic
577794|NCT00493077|Multiple Sclerosis|multiple sclerosis
577795|NCT00493077|Neutralizing antibodies|neutralizing antibodies
577796|NCT00493077|Safety|safety
577797|NCT00493077|Low immunogenicity|low immunogenicity
577798|NCT00493077|interferon|interferon
577799|NCT00493077|interferon-beta-1a|interferon-beta-1a
577800|NCT00481065|Bird flu|bird flu
577801|NCT00481065|influenza vaccine|influenza vaccine
577802|NCT00481065|Seasonal influenza vaccine|seasonal influenza vaccine
577803|NCT00481065|Prepandemic vaccine|prepandemic vaccine
577804|NCT00486460|Locally advanced or metastatic adenocarcinoma of the|locally advanced or metastatic adenocarcinoma of the
577805|NCT00486460|pancreas|pancreas
577806|NCT00486460|confirmed by histology or cytology|confirmed by histology or cytology
577807|NCT00486460|Inoperatable|inoperatable
577808|NCT00486486|24-hour IOP control|24-hour iop control
577809|NCT00486499|radiation|radiation
577810|NCT00486499|brachytherapy|brachytherapy
577811|NCT00486499|prostate|prostate
577812|NCT00486499|cancer|cancer
577813|NCT00486512|colorectal, adenomas, prevention|colorectal, adenomas, prevention
577814|NCT00486525|fatigue|fatigue
577815|NCT00486525|depression|depression
577816|NCT00486525|pain|pain
577817|NCT00486525|cancer survivor|cancer survivor
577818|NCT00486525|stage IA breast cancer|stage ia breast cancer
577819|NCT00486525|stage IB breast cancer|stage ib breast cancer
577820|NCT00486525|stage II breast cancer|stage ii breast cancer
577821|NCT00486525|stage IIIA breast cancer|stage iiia breast cancer
577822|NCT00486525|breast cancer in situ|breast cancer in situ
577823|NCT00486551|Anger control training|anger control training
577824|NCT00486551|Cognitive behavioral therapy|cognitive behavioral therapy
577825|NCT00486551|Behavior therapy|behavior therapy
577826|NCT00486551|Tourette Syndrome|tourette syndrome
577827|NCT00486551|Randomized trial|randomized trial
577828|NCT00486551|Anger|anger
577829|NCT00486551|Aggression|aggression
577830|NCT00486564|Treatment|treatment
577831|NCT00486564|Refractory or Relapsed|refractory or relapsed
577832|NCT00486577|Hearing Disorders, Hearing Loss, Hyperacusis, Tinnitus, chronic cortical stimulation, functional magnetic resonance imaging|hearing disorders, hearing loss, hyperacusis, tinnitus, chronic cortical stimulation, functional magnetic resonance imaging
577833|NCT00486590|Human milk fortification|human milk fortification
577834|NCT00486590|Premature neonate|premature neonate
577835|NCT00486590|Very low birth weight|very low birth weight
577836|NCT00486603|adult glioblastoma|adult glioblastoma
577837|NCT00486603|adult gliosarcoma|adult gliosarcoma
577838|NCT00486603|adult giant cell glioblastoma|adult giant cell glioblastoma
577839|NCT00486629|Exercise|exercise
577840|NCT00486629|Diet|diet
577841|NCT00486629|Pregnancy|pregnancy
577842|NCT00486629|Obesity|obesity
577843|NCT00486629|Macrosomia|macrosomia
577844|NCT00486655|Cholecystectomy|cholecystectomy
577845|NCT00486655|NOTES|notes
577846|NCT00486655|Transgastric|transgastric
577847|NCT00486668|HER2 positive breast cancer|her2 positive breast cancer
577848|NCT00486668|invasive breast cancer|invasive breast cancer
577849|NCT00486668|lapatinib|lapatinib
577850|NCT00486668|neoadjuvant|neoadjuvant
577851|NCT00486668|NSABP|nsabp
577852|NCT00486668|paclitaxel|paclitaxel
577853|NCT00486668|trastuzumab|trastuzumab
577854|NCT00486668|doxorubicin|doxorubicin
577855|NCT00486668|cyclophosphamide|cyclophosphamide
577856|NCT00486681|Glucose monitoring|glucose monitoring
577857|NCT00486681|Diabetes management|diabetes management
577858|NCT00486681|Information system|information system
577859|NCT00486681|In-patient glycemic control|in-patient glycemic control
577860|NCT00486694|Malaria, vivax|malaria, vivax
577861|NCT00486694|Afghanistan|afghanistan
577862|NCT00486694|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
577863|NCT00486694|drug resistance|drug resistance
577864|NCT00486707|Ovarian Cancer|ovarian cancer
577865|NCT00486707|Questionnaire|questionnaire
577866|NCT00486707|Genetic Testing|genetic testing
577867|NCT00486707|Survey|survey
577868|NCT00486733|extracorporeal shock wave therapy|extracorporeal shock wave therapy
577869|NCT00486733|soft tissue wounds|soft tissue wounds
577870|NCT00486746|sleep apnea|sleep apnea
577871|NCT00486746|lifestyle intervention|lifestyle intervention
577872|NCT00486746|cardiovascular|cardiovascular
577873|NCT00486772|This study was designed to investigate whether the suggested beneficial effects of sevelamer on VC were related to fetuin-A levels in patients with CKD.|this study was designed to investigate whether the suggested beneficial effects of sevelamer on vc were related to fetuin-a levels in patients with ckd.
577874|NCT00486798|acute schizophrenia|acute schizophrenia
577875|NCT00486798|schizoaffective disorder|schizoaffective disorder
577876|NCT00486798|psychosis Not Otherwise Specified (NOS)|psychosis not otherwise specified (nos)
577877|NCT00486798|bipolar mania with psychotic symptoms|bipolar mania with psychotic symptoms
577878|NCT00486811|Osteoarthritis|osteoarthritis
577879|NCT00486811|Knee|knee
577880|NCT00486811|Pain Assessment|pain assessment
577881|NCT00486811|CG5503 PR|cg5503 pr
577882|NCT00486811|Centrally acting analgesic|centrally acting analgesic
577883|NCT00486811|Placebo|placebo
577884|NCT00486811|Oxycodone|oxycodone
577885|NCT00486811|Chronic Pain due to knee Osteoarthritis|chronic pain due to knee osteoarthritis
577886|NCT00486811|Tapentadol|tapentadol
577887|NCT00486850|RDS|rds
577888|NCT00486850|Preterm|preterm
577889|NCT00486850|SIMV|simv
577890|NCT00486850|NIPPV|nippv
577891|NCT00486863|Philippines, Schistosoma japonicum, Schistosomiasis, pregnant women, fetuses, 08-0049|philippines, schistosoma japonicum, schistosomiasis, pregnant women, fetuses, 08-0049
577892|NCT00486876|Irritable bowel syndrome|irritable bowel syndrome
577893|NCT00486876|Diarrhea predominant Irritable Bowel Syndrome|diarrhea predominant irritable bowel syndrome
577894|NCT00486876|Alternating Irritable Bowel Syndrome|alternating irritable bowel syndrome
577895|NCT00486889|Glycogenesis 2|glycogenesis 2
577896|NCT00486902|Ketamine|ketamine
577897|NCT00486902|Spinal Anesthesia|spinal anesthesia
577898|NCT00486902|C-section|c-section
577899|NCT00486915|Atrial Fibrillation|atrial fibrillation
577900|NCT00486915|Left Atrial Appendage|left atrial appendage
577901|NCT00486915|Surgical Ligation|surgical ligation
577902|NCT00486915|Thromboembolism|thromboembolism
577903|NCT00486915|Cerebrovascular Accident|cerebrovascular accident
577904|NCT00486928|Valves, heart disease, prosthesis.|valves, heart disease, prosthesis.
577905|NCT00486941|Primary Prevention|primary prevention
577906|NCT00486941|Health Promotion|health promotion
577907|NCT00486941|Diet|diet
577908|NCT00486941|Exercise|exercise
577909|NCT00486941|Risk Factors|risk factors
577910|NCT00486941|Randomized Controlled Trial|randomized controlled trial
577911|NCT00486954|lapatinib|lapatinib
577912|NCT00486954|paclitaxel|paclitaxel
577913|NCT00486954|ErbB2|erbb2
577914|NCT00486954|Gastric cancer|gastric cancer
578226|NCT00495170|Taxol|taxol
577915|NCT00486954|Advanced gastric cancer|advanced gastric cancer
577916|NCT00486967|Insulin resistance, heart failure, congestive heart failure,|insulin resistance, heart failure, congestive heart failure,
577917|NCT00486967|Peak VO2, Endothelial Function, Leptin, TNF.|peak vo2, endothelial function, leptin, tnf.
577918|NCT00486980|influenza|influenza
577919|NCT00486993|Diet|diet
577920|NCT00486993|Exercise|exercise
577921|NCT00486993|Smoking|smoking
577922|NCT00486993|Stress|stress
577923|NCT00486993|Polyphenols|polyphenols
577924|NCT00487019|ampicillin|ampicillin
577925|NCT00487019|penicillin G|penicillin g
577926|NCT00487019|gentamicin|gentamicin
577927|NCT00487019|neonatal sepsis|neonatal sepsis
577928|NCT00487019|empiric therapy|empiric therapy
577929|NCT00487032|allergic rhinitis|allergic rhinitis
577930|NCT00487032|rhinitis medicamentosa|rhinitis medicamentosa
577931|NCT00487032|imidazolines|imidazolines
577932|NCT00487032|corticosteroid|corticosteroid
577933|NCT00487045|Hemorrhoids|hemorrhoids
577934|NCT00487045|Thrombosed External Hemorrhoids (TEH)|thrombosed external hemorrhoids (teh)
577935|NCT00487045|Reduction|reduction
577936|NCT00487045|Prevention|prevention
577937|NCT00487045|Stabilizer Device|stabilizer device
577938|NCT00487045|Pregnant|pregnant
577939|NCT00487045|Vaginal Birth|vaginal birth
577940|NCT00487045|Single Birth|single birth
577941|NCT00487045|Asymptomatic Hemorrhoids|asymptomatic hemorrhoids
577942|NCT00487058|Gimatecan|gimatecan
577943|NCT00487058|topoisomerase I inhibitor|topoisomerase i inhibitor
577944|NCT00487058|advanced solid tumors|advanced solid tumors
577945|NCT00487071|Anal fistula|anal fistula
577946|NCT00487071|High-type|high-type
577947|NCT00487071|Anal fistula plug|anal fistula plug
577948|NCT00487071|Efficacy|efficacy
577949|NCT00487071|Recurrence|recurrence
577950|NCT00493090|Professional|professional
577951|NCT00493090|patient partnership|patient partnership
577952|NCT00493090|patient satisfaction|patient satisfaction
577953|NCT00493090|professional training|professional training
577954|NCT00493103|thyroglobulin gene|thyroglobulin gene
577955|NCT00493103|congenital hypothyroidism|congenital hypothyroidism
577956|NCT00493103|gene mutations|gene mutations
577957|NCT00493103|fetal goiter|fetal goiter
577958|NCT00493103|iodine nutrition|iodine nutrition
577959|NCT00493116|recovery of efficacy|recovery of efficacy
577960|NCT00493116|MxA protein|mxa protein
577961|NCT00493116|neutralizing antibodies|neutralizing antibodies
577962|NCT00493116|Multiple sclerosis|multiple sclerosis
577963|NCT00493129|Systemic Mastocytosis|systemic mastocytosis
577964|NCT00493129|SM|sm
577965|NCT00493129|Mast Cell Leukemia|mast cell leukemia
577966|NCT00493129|Leukemia|leukemia
577967|NCT00493129|Denileukin Diftitox|denileukin diftitox
577968|NCT00493129|Ontak|ontak
577969|NCT00493181|oprelvekin|oprelvekin
577970|NCT00493181|tyrosine kinase inhibitor|tyrosine kinase inhibitor
577971|NCT00493181|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
577972|NCT00493181|Leukemia|leukemia
577973|NCT00493181|CML|cml
577974|NCT00493181|Thrombocytopenia|thrombocytopenia
577975|NCT00493181|Imatinib|imatinib
577976|NCT00493181|IL-11|il-11
577977|NCT00493181|Interleukin 11|interleukin 11
577978|NCT00493181|Neumega|neumega
577979|NCT00493194|Cyclosporine toxicity|cyclosporine toxicity
577980|NCT00493194|Interstitial Fibrosis|interstitial fibrosis
577981|NCT00493194|Chronic allograft nephropathy|chronic allograft nephropathy
577982|NCT00493194|Sirolimus|sirolimus
577983|NCT00493220|ceftriaxone|ceftriaxone
577984|NCT00493220|cephalosporins|cephalosporins
577985|NCT00493220|pharmacokinetics|pharmacokinetics
577986|NCT00493220|subcutaneous|subcutaneous
577987|NCT00493220|hyaluronoglucosaminidase|hyaluronoglucosaminidase
577988|NCT00493220|hyaluronidase|hyaluronidase
577989|NCT00493220|hyaluronan|hyaluronan
577990|NCT00493220|rHuPH20|rhuph20
577991|NCT00493233|schizophrenia|schizophrenia
577992|NCT00493233|antipsychotics|antipsychotics
577993|NCT00493233|polypharmacy|polypharmacy
577994|NCT00493233|double-blind|double-blind
577995|NCT00493233|randomized|randomized
577996|NCT00493259|Health-Related Quality of Life|health-related quality of life
577997|NCT00493272|Blood coagulation disorder, acquired|blood coagulation disorder, acquired
577998|NCT00493272|Hemodilution|hemodilution
578000|NCT00493272|Hemostasis|hemostasis
578001|NCT00493272|HES|hes
578002|NCT00493285|Lower Respiratory Tract Illness|lower respiratory tract illness
578003|NCT00493285|RSV and PIV3 infection|rsv and piv3 infection
578004|NCT00493298|disease progression|disease progression
578005|NCT00493298|Multiple Sclerosis|multiple sclerosis
578006|NCT00493298|disease activity|disease activity
578007|NCT00493298|Tysabri|tysabri
578008|NCT00493298|natalizumab|natalizumab
578009|NCT00493298|long-term safety|long-term safety
578010|NCT00493324|psoriasis|psoriasis
578011|NCT00493324|alefacept|alefacept
578012|NCT00493324|polyvalent pneumococcal vaccine|polyvalent pneumococcal vaccine
578013|NCT00493324|Immunization|immunization
578014|NCT00493337|Adherence|adherence
578015|NCT00493337|Compliance|compliance
578016|NCT00493337|Statins|statins
578017|NCT00493337|Intervention|intervention
578018|NCT00493337|Hypercholesterolemia|hypercholesterolemia
578019|NCT00493350|Breast Cancer|breast cancer
578020|NCT00493350|Circulating Tumor Cells|circulating tumor cells
578021|NCT00493350|Gene Profiling|gene profiling
578022|NCT00493350|International Stage Stratification Study|international stage stratification study
578023|NCT00493350|Blood Sample|blood sample
578024|NCT00493350|ISSS|isss
578025|NCT00493363|falciparum malaria|falciparum malaria
578026|NCT00493363|artemisinins|artemisinins
578027|NCT00493363|artesunate|artesunate
578028|NCT00493363|resistance|resistance
578029|NCT00493376|tirapazamine|tirapazamine
578030|NCT00493376|DNA damage|dna damage
578031|NCT00493376|comet assay|comet assay
578032|NCT00493389|ACTH stimulation test|acth stimulation test
578033|NCT00493389|cortisol|cortisol
578034|NCT00493389|stress|stress
578035|NCT00493402|Antineoplastic Agents|antineoplastic agents
578036|NCT00493402|administration & dosage|administration & dosage
578037|NCT00493402|Carcinoma, Hepatocellular|carcinoma, hepatocellular
578038|NCT00493402|Chemoembolization, Therapeutic|chemoembolization, therapeutic
578039|NCT00493402|Humans|humans
578040|NCT00493402|Liver Neoplasms|liver neoplasms
578041|NCT00493402|therapy|therapy
578042|NCT00493415|microcirculation|microcirculation
578043|NCT00493415|sepsis|sepsis
578044|NCT00493415|nitroglycerine|nitroglycerine
578045|NCT00493415|SDF imaging|sdf imaging
578046|NCT00493428|Hepatocellular Carcinoma|hepatocellular carcinoma
578047|NCT00493428|GABAergic Activity|gabaergic activity
578048|NCT00493428|Baclofen|baclofen
578049|NCT00494533|pulmonary arterial hypertension|pulmonary arterial hypertension
578050|NCT00494533|prostacyclin analogue|prostacyclin analogue
578051|NCT00494533|intravenous|intravenous
578052|NCT00494546|prostate|prostate
578053|NCT00494546|brachytherapy|brachytherapy
578054|NCT00494559|Type 2 Diabetes|type 2 diabetes
578055|NCT00494559|Pioglitazone|pioglitazone
578056|NCT00494559|restenosis|restenosis
578057|NCT00494572|Montelukast|montelukast
578058|NCT00494572|Albuterol|albuterol
578059|NCT00494572|Status Asthmaticus|status asthmaticus
578060|NCT00494572|Asthma|asthma
578061|NCT00494585|CEP-701|cep-701
578062|NCT00494585|Leukemia|leukemia
578063|NCT00494585|Myelofibrosis|myelofibrosis
578065|NCT00494585|JAK2|jak2
578066|NCT00494585|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
578067|NCT00494585|Lestaurtinib|lestaurtinib
578068|NCT00494585|Chronic Idiopathic Myelofibrosis|chronic idiopathic myelofibrosis
578069|NCT00494585|CIMF|cimf
578070|NCT00494598|opioids, cerebral perfusion, arterial pharmacokinetics|opioids, cerebral perfusion, arterial pharmacokinetics
578071|NCT00494624|Wheezing|wheezing
578072|NCT00494624|virus|virus
578073|NCT00494624|child|child
578074|NCT00494650|PTSD|ptsd
578075|NCT00494650|Schizophrenia|schizophrenia
578076|NCT00494650|Schizoaffective Disorder|schizoaffective disorder
578077|NCT00494650|Bipolar Disorder|bipolar disorder
578078|NCT00494650|Major Depression|major depression
578079|NCT00494663|diabetes|diabetes
578080|NCT00494663|type 2 diabetes|type 2 diabetes
578081|NCT00494663|cholesterol|cholesterol
578082|NCT00494676|Hemianopia|hemianopia
578083|NCT00494676|Mobility|mobility
578084|NCT00494676|Rehabilitation|rehabilitation
578085|NCT00494676|Low vision|low vision
578086|NCT00494689|transcranial sonolysis or monitoring|transcranial sonolysis or monitoring
578087|NCT00494689|rapid magnetic stimulation|rapid magnetic stimulation
578088|NCT00494689|cerebral ischemia|cerebral ischemia
578089|NCT00494689|hydrocephalus|hydrocephalus
578090|NCT00494689|Barthel's index|barthel's index
578091|NCT00494702|Asphyxia|asphyxia
578092|NCT00494702|Resuscitation|resuscitation
578093|NCT00494702|Oxidative stress|oxidative stress
578094|NCT00494702|Prematurity|prematurity
578095|NCT00494702|Follow up|follow up
578096|NCT00494728|Smoking|smoking
578097|NCT00494728|Depression|depression
578098|NCT00494728|Major Depressive Disorder|major depressive disorder
578099|NCT00494728|Cognitive Behavioral Analysis System of Psychotherapy|cognitive behavioral analysis system of psychotherapy
578100|NCT00494728|Smoking Cessation Treatment|smoking cessation treatment
578101|NCT00494728|Nicotine Replacement Therapy|nicotine replacement therapy
578102|NCT00494728|Nicotine Patch|nicotine patch
578103|NCT00494728|CBASP|cbasp
578104|NCT00494728|MDD|mdd
578105|NCT00494754|autism spectrum disorder|autism spectrum disorder
578106|NCT00494754|family genetic study|family genetic study
578107|NCT00494754|gene|gene
578108|NCT00494754|phenotype|phenotype
578109|NCT00494754|endophenotype|endophenotype
578110|NCT00494767|body composition|body composition
578111|NCT00494767|obesity|obesity
578112|NCT00494767|4C model|4c model
578113|NCT00494767|hunger|hunger
578114|NCT00494767|weight loss|weight loss
578115|NCT00494780|CHOP (cyclophosphamide,doxorubicin,vincristine,prednisolone)|chop (cyclophosphamide,doxorubicin,vincristine,prednisolone)
578116|NCT00494780|ofatumumab|ofatumumab
578117|NCT00494793|Open abdomen|open abdomen
578118|NCT00494793|Fascial closure|fascial closure
578119|NCT00494793|Vacuum assisted wound closure|vacuum assisted wound closure
578120|NCT00494793|Mesh|mesh
578121|NCT00494793|Abdominal compartment syndrome|abdominal compartment syndrome
578122|NCT00494793|Intraabdominal pressure|intraabdominal pressure
578123|NCT00494793|Incisional hernia|incisional hernia
578124|NCT00494806|Postoperative Ileus (POI)|postoperative ileus (poi)
578125|NCT00494806|Rocking Chair|rocking chair
578126|NCT00494806|Abdominal Cancer|abdominal cancer
578127|NCT00494819|ADHD, subtype, methylphenidate, neuropsychological measures|adhd, subtype, methylphenidate, neuropsychological measures
578128|NCT00494832|Dexmedetomidine|dexmedetomidine
578129|NCT00494832|Evoked potentials|evoked potentials
578130|NCT00494832|Spine surgery|spine surgery
578131|NCT00494845|Mindfulness|mindfulness
578132|NCT00494845|Elderly|elderly
578133|NCT00494845|Chronic Illness|chronic illness
578134|NCT00494845|Back Pain|back pain
578135|NCT00494845|Chronic Low Back Pain|chronic low back pain
578136|NCT00494845|Older adults over the age of sixty-five|older adults over the age of sixty-five
578137|NCT00494845|MMSE score of over 23|mmse score of over 23
578138|NCT00494845|Speaks English|speaks english
578139|NCT00494858|Bulimia nervosa|bulimia nervosa
578140|NCT00494858|Cognitive Behavioral Therapy|cognitive behavioral therapy
578141|NCT00494858|Personality Disorders|personality disorders
578142|NCT00494871|BAY59-7939|bay59-7939
578143|NCT00494871|Rivaroxaban|rivaroxaban
578144|NCT00494871|Non-Valvular Atrial Fibrillation|non-valvular atrial fibrillation
578145|NCT00494871|Japanese Patients|japanese patients
578146|NCT00494871|Phase III|phase iii
578147|NCT00494871|12620|12620
578148|NCT00494884|Type 2 diabetes|type 2 diabetes
578149|NCT00494884|vildagliptin|vildagliptin
578150|NCT00494884|metformin combination|metformin combination
578151|NCT00494910|Palliative Care|palliative care
578152|NCT00494910|Terminally Ill|terminally ill
578153|NCT00494910|Group Therapy|group therapy
578154|NCT00494910|07-094|07-094
578155|NCT00494936|HIV|hiv
578156|NCT00494936|HCV|hcv
578157|NCT00494936|Treatment Naive|treatment naive
578158|NCT00494936|Treatment Experienced|treatment experienced
578159|NCT00494936|HIV and HCV Coinfection|hiv and hcv coinfection
578160|NCT00494949|Anesthesia, spinal|anesthesia, spinal
578161|NCT00494949|Blood substitutes|blood substitutes
578162|NCT00494949|Oxygen therapeutics|oxygen therapeutics
578163|NCT00494949|Orthopedic surgery|orthopedic surgery
578164|NCT00494949|Plasma expanders|plasma expanders
578165|NCT00494949|Vasoconstriction|vasoconstriction
578166|NCT00494949|Hemospan|hemospan
578167|NCT00495014|GSK376501,|gsk376501,
578168|NCT00495014|Single Dose,|single dose,
578169|NCT00495014|Dose Escalation,|dose escalation,
578170|NCT00495014|Healthy Overweight/Obese Volunteer|healthy overweight/obese volunteer
578171|NCT00495027|PTSD|ptsd
578172|NCT00495027|prevention|prevention
578173|NCT00495027|World Wide Web|world wide web
578174|NCT00495027|Behavior Therapy|behavior therapy
578175|NCT00495040|Non-Small Cell Lung Cancer|non-small cell lung cancer
578176|NCT00495040|Lung Cancer|lung cancer
578177|NCT00495040|Proton Radiotherapy|proton radiotherapy
578178|NCT00495040|Proton Beam|proton beam
578179|NCT00495040|NSCLC|nsclc
578180|NCT00495053|overactive bladder, urinary urgency|overactive bladder, urinary urgency
578181|NCT00495079|acute|acute
578182|NCT00495079|lymphoblastic|lymphoblastic
578183|NCT00495079|lymphocytic|lymphocytic
578184|NCT00495079|leukemia|leukemia
578185|NCT00495079|leukaemia|leukaemia
578186|NCT00495079|lukemia|lukemia
578187|NCT00495079|leukimia|leukimia
578188|NCT00495079|ALL|all
578189|NCT00495079|Marqibo|marqibo
578190|NCT00495079|Hana Biosciences|hana biosciences
578191|NCT00495079|vincristine|vincristine
578192|NCT00495079|liposomal|liposomal
578193|NCT00495079|liposome|liposome
578194|NCT00495079|optisome|optisome
578195|NCT00495079|hematology|hematology
578196|NCT00495079|malignancy|malignancy
578197|NCT00495079|hematological|hematological
578198|NCT00495079|relapsed|relapsed
578199|NCT00495079|anti-leukemia|anti-leukemia
578200|NCT00495079|adult|adult
578201|NCT00495079|chemotherapy|chemotherapy
578202|NCT00495092|cocaine dependence|cocaine dependence
578203|NCT00495092|cocaine use|cocaine use
578204|NCT00495092|cocaine craving|cocaine craving
578205|NCT00495118|schizophrenia|schizophrenia
578206|NCT00495118|schizoaffective disorder|schizoaffective disorder
578207|NCT00495118|risperidone|risperidone
578208|NCT00495118|intramuscular injection|intramuscular injection
578209|NCT00495118|long-acting injectable|long-acting injectable
578210|NCT00495131|Chronic hepatitis C|chronic hepatitis c
578211|NCT00495131|Genotype 1|genotype 1
578212|NCT00495131|Interferon|interferon
578213|NCT00495131|Ribavirin|ribavirin
578214|NCT00495144|Phase I|phase i
578215|NCT00495144|Advanced Solid Tumors|advanced solid tumors
578216|NCT00495144|Hypoxia|hypoxia
578217|NCT00495144|Prodrug|prodrug
578218|NCT00495144|Multi-Center|multi-center
578219|NCT00495144|Open-Label|open-label
578220|NCT00495144|Dose-Escalation|dose-escalation
578221|NCT00495170|Non-Small Cell Lung Cancer|non-small cell lung cancer
578222|NCT00495170|Lung Cancer|lung cancer
578223|NCT00495170|Proton Radiotherapy|proton radiotherapy
578224|NCT00495170|Proton Beam|proton beam
578227|NCT00495170|Carboplatin|carboplatin
578228|NCT00495170|Paraplatin|paraplatin
578229|NCT00495170|NSCLC|nsclc
578230|NCT00495183|cocaine dependence|cocaine dependence
578231|NCT00495183|cocaine use|cocaine use
578232|NCT00495183|CNS stimulants|cns stimulants
578233|NCT00495183|caffeine|caffeine
578234|NCT00495183|biperiden|biperiden
578235|NCT00495183|placebo|placebo
578236|NCT00495209|Complementary and Alternative Medicine|complementary and alternative medicine
578237|NCT00495209|Breast Cancer|breast cancer
578238|NCT00495209|Qigong|qigong
578239|NCT00495209|Medical Qigong|medical qigong
578240|NCT00495209|External Qi Therapy|external qi therapy
578241|NCT00495209|EQT|eqt
578242|NCT00495222|gastrojejunostomy|gastrojejunostomy
578243|NCT00495222|stoma|stoma
578244|NCT00495235|Endometrial Cancer|endometrial cancer
578245|NCT00495235|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
578246|NCT00495235|Insulin Resistance|insulin resistance
578247|NCT00495235|Pre-diabetes|pre-diabetes
578248|NCT00495235|Harris County|harris county
578249|NCT00495235|PCOS|pcos
578250|NCT00495235|Uterus|uterus
578251|NCT00495235|Questionnaire|questionnaire
578252|NCT00495235|Body mass index|body mass index
578253|NCT00495235|BMI|bmi
578254|NCT00495248|group intervention|group intervention
578255|NCT00495248|stroke|stroke
578256|NCT00495248|senior centres|senior centres
578257|NCT00495248|health promotion|health promotion
578258|NCT00495261|Gambling|gambling
578259|NCT00495261|Mindfulness|mindfulness
578260|NCT00495261|Cognitive Behavioural Therapy|cognitive behavioural therapy
578261|NCT00495274|Bioequivalent|bioequivalent
578262|NCT00495274|pharmacodynamic|pharmacodynamic
747012|NCT01151696|anxiety|anxiety
578263|NCT00495274|Reference formulation|reference formulation
578264|NCT00495274|5 new formulation|5 new formulation
578265|NCT00495274|Food effect|food effect
578266|NCT00495274|Pharmacokinetics|pharmacokinetics
578267|NCT00495287|Acute myelogenous leukemia|acute myelogenous leukemia
578268|NCT00495287|Adult patients|adult patients
578269|NCT00495287|Cytogenetic risk class|cytogenetic risk class
578270|NCT00495287|Clinico-cytogenetic risk model|clinico-cytogenetic risk model
578271|NCT00495287|Risk-oriented therapy|risk-oriented therapy
578272|NCT00495300|HSC/MUD Transplant|hsc/mud transplant
578273|NCT00495300|NMDP|nmdp
578274|NCT00495300|NMDP Data Collection|nmdp data collection
578275|NCT00495300|NMDP Samples|nmdp samples
578276|NCT00495300|BMT|bmt
578277|NCT00495300|Samples|samples
578278|NCT00495313|Rosacea|rosacea
578279|NCT00495326|drug interactions|drug interactions
578280|NCT00495326|Treatment Naive|treatment naive
578281|NCT00495352|Schizophrenia|schizophrenia
578282|NCT00495352|NRT|nrt
578283|NCT00495352|Bupropion|bupropion
578284|NCT00495352|Stages of change|stages of change
578285|NCT00495365|Anemia|anemia
578286|NCT00495365|low blood count|low blood count
578287|NCT00495365|chronic kidney disease|chronic kidney disease
578288|NCT00495365|chronic kidney failure|chronic kidney failure
578289|NCT00495365|darbepoetin alfa|darbepoetin alfa
578290|NCT00495365|epoetin alfa|epoetin alfa
578291|NCT00495365|recombinant human erythropoietin|recombinant human erythropoietin
578292|NCT00495378|PROCRIT|procrit
578293|NCT00495378|Epoetin alfa|epoetin alfa
578294|NCT00495378|chemotherapy related anemia|chemotherapy related anemia
578295|NCT00495391|Hepatitis C, Chronic|hepatitis c, chronic
578296|NCT00495404|chronic non-malignant pain|chronic non-malignant pain
578297|NCT00495404|opiates|opiates
578298|NCT00495404|prescriptions|prescriptions
578299|NCT00495404|addiction|addiction
578300|NCT00495417|Alzheimer|alzheimer
578301|NCT00495417|Morbus Alzheimer|morbus alzheimer
578302|NCT00495417|Alzheimer Vaccine|alzheimer vaccine
578303|NCT00495417|Vaccine|vaccine
578304|NCT00495417|AD|ad
578305|NCT00495417|Aβ immunotherapy|aβ immunotherapy
578306|NCT00495430|Healthy|healthy
578307|NCT00495430|Lung sounds|lung sounds
578308|NCT00495430|Breath sounds|breath sounds
578309|NCT00495456|cardiovascular|cardiovascular
578310|NCT00495456|risk|risk
578311|NCT00495456|longitudinal|longitudinal
578312|NCT00495456|prospective|prospective
578313|NCT00495469|Diabetes mellitus HbA1c|diabetes mellitus hba1c
578314|NCT00495482|Euthanasia|euthanasia
578315|NCT00495482|Assisted Suicide|assisted suicide
578316|NCT00495482|Assisted Dying|assisted dying
578317|NCT00495482|Palliative Care Medicine|palliative care medicine
578318|NCT00495508|Quinine|quinine
578319|NCT00495508|Artemether|artemether
578320|NCT00495508|Lumefantrine|lumefantrine
578321|NCT00495508|malaria|malaria
578322|NCT00495508|Uganda|uganda
578323|NCT00495508|Artemisinin- based combination therapy|artemisinin- based combination therapy
578324|NCT00495508|pregnancy|pregnancy
578325|NCT00495508|Malaria In Pregnancy|malaria in pregnancy
578326|NCT00495521|Crohn's|crohn's
578327|NCT00495521|Crohn's Disease|crohn's disease
578328|NCT00495521|Acute Flare|acute flare
578329|NCT00495521|Mild to Moderate Crohn's Disease|mild to moderate crohn's disease
578330|NCT00495521|Children|children
578331|NCT00495521|Pediatrics|pediatrics
578332|NCT00495521|Ileo-cecal|ileo-cecal
578333|NCT00495521|Pediatric Crohn's Disease|pediatric crohn's disease
578334|NCT00495521|New Onset Crohn's Disease|new onset crohn's disease
578335|NCT00495521|Recently diagnosed Crohn's Disease|recently diagnosed crohn's disease
578336|NCT00495547|Myelodysplastic Syndrome|myelodysplastic syndrome
578337|NCT00495547|Red Cell transfusion dependent|red cell transfusion dependent
578338|NCT00495560|induction|induction
578339|NCT00495560|abortion|abortion
578340|NCT00495560|injection, intra-amniotic|injection, intra-amniotic
578341|NCT00495560|misoprostol|misoprostol
578342|NCT00495586|COPD|copd
578343|NCT00495586|Antibiotics|antibiotics
578344|NCT00495599|Obese|obese
578345|NCT00495599|Adipose Tissue|adipose tissue
578346|NCT00495599|Visfatin|visfatin
578347|NCT00495599|Gastric Bypass Surgery|gastric bypass surgery
578348|NCT00495612|Xolair|xolair
578349|NCT00495612|Allergic asthma|allergic asthma
578350|NCT00495612|Cat allergy|cat allergy
578351|NCT00495625|Hepatocellular cancer (HCC)|hepatocellular cancer (hcc)
578352|NCT00495625|Sunitinib malate|sunitinib malate
578353|NCT00495625|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
578354|NCT00495625|Platelet-derived growth factor (PDGF)|platelet-derived growth factor (pdgf)
578355|NCT00495625|Tyrosine kinases|tyrosine kinases
578356|NCT00495625|Liver|liver
578357|NCT00495638|6-Minute Walk|6-minute walk
578358|NCT00495638|Chuvash Polycythemia|chuvash polycythemia
578359|NCT00495638|Echocardiogram|echocardiogram
578360|NCT00495638|Sickle Cell Anemia|sickle cell anemia
578361|NCT00495638|Pulmonary Function Tests|pulmonary function tests
578362|NCT00495638|Sickle Cell Disease|sickle cell disease
578364|NCT00495638|Pulmonary Hypertension|pulmonary hypertension
578365|NCT00495651|HIV|hiv
578366|NCT00495651|HAART|haart
578367|NCT00495651|Early Intervention|early intervention
578368|NCT00495651|Naive patients|naive patients
578369|NCT00495664|titanium|titanium
578370|NCT00495664|paclitaxel|paclitaxel
578371|NCT00495664|stent|stent
578372|NCT00495664|myocardial infarction|myocardial infarction
578373|NCT00495664|angioplasty|angioplasty
578374|NCT00495664|PCI|pci
578375|NCT00495677|Treatment Experienced|treatment experienced
578376|NCT00495677|Treatment Naive|treatment naive
578377|NCT00495690|Zinc recipients|zinc recipients
578378|NCT00495690|Placebo recipients|placebo recipients
578379|NCT00495703|Cancer survivors|cancer survivors
578380|NCT00495703|Chemotherapy|chemotherapy
578381|NCT00495703|Cognitive function|cognitive function
578382|NCT00495703|Exercise|exercise
578383|NCT00495703|Physical Activity|physical activity
578384|NCT00495729|SB-649868,|sb-649868,
578385|NCT00495729|Simvastatin|simvastatin
578386|NCT00495729|Repeated dose,|repeated dose,
578387|NCT00495755|Chronic Graft-vs-Host Disease|chronic graft-vs-host disease
578388|NCT00495768|Hepatitis C|hepatitis c
578389|NCT00495768|HCV|hcv
578390|NCT00495768|Depression|depression
578391|NCT00495768|Interferons|interferons
578392|NCT00495768|Ribavirin|ribavirin
578393|NCT00495781|functional iron deficiency|functional iron deficiency
578394|NCT00495781|renal anemia|renal anemia
578395|NCT00495781|dialysis|dialysis
578396|NCT00495781|erythropoietin|erythropoietin
578397|NCT00495781|darbepoetin|darbepoetin
578398|NCT00495794|diabetes|diabetes
578399|NCT00495794|hypertension|hypertension
578400|NCT00495794|adherence|adherence
578401|NCT00495794|implementation|implementation
578402|NCT00495794|medications|medications
578403|NCT00495794|organization of care|organization of care
578404|NCT00495807|Psychological Tests|psychological tests
578405|NCT00495807|Pain, Postoperative|pain, postoperative
578406|NCT00495807|Nurses|nurses
578407|NCT00495820|Alzheimer's Disease|alzheimer's disease
578408|NCT00495820|Apathy|apathy
578409|NCT00495820|Dementia|dementia
578410|NCT00495820|Methylphenidate|methylphenidate
578411|NCT00495833|Hypertension|hypertension
578412|NCT00495846|Hepatocellular carcinoma|hepatocellular carcinoma
578413|NCT00495846|Somatostatin analogues|somatostatin analogues
578414|NCT00495846|Somatostatin receptors|somatostatin receptors
578415|NCT00495846|Octreotide|octreotide
578416|NCT00495846|Lanreotide|lanreotide
578417|NCT00495846|IGF-I|igf-i
578418|NCT00495846|IGF-II|igf-ii
578419|NCT00495859|Immunonutrition|immunonutrition
578420|NCT00495859|immune enhancing diets|immune enhancing diets
578421|NCT00495859|arginine|arginine
578422|NCT00495859|ω-3 fatty acids|ω-3 fatty acids
578423|NCT00495859|nucleotides|nucleotides
578424|NCT00495859|liver transplantation|liver transplantation
578425|NCT00495859|clinical trial|clinical trial
578426|NCT00495872|Solid Tumors|solid tumors
578624|NCT00496652|Antibody|antibody
578427|NCT00495872|Advanced Cancer|advanced cancer
578428|NCT00495872|Dasatinib|dasatinib
578429|NCT00495872|Erlotinib|erlotinib
578430|NCT00495872|Lapatinib|lapatinib
578431|NCT00495872|Lenalidomide|lenalidomide
578432|NCT00495872|Sorafenib|sorafenib
578433|NCT00495872|Erlotinib Hydrochloride|erlotinib hydrochloride
578434|NCT00495872|Sunitinib Malate|sunitinib malate
578435|NCT00495872|Sunitinib|sunitinib
578436|NCT00495872|Valproic Acid|valproic acid
578437|NCT00495872|SU011248|su011248
578438|NCT00495885|Sleep problems|sleep problems
578439|NCT00495885|insomnia|insomnia
578440|NCT00495885|sleeplessness|sleeplessness
578441|NCT00495885|primary insomnia|primary insomnia
578442|NCT00495885|insomnia disorder|insomnia disorder
578443|NCT00495950|Melanoma|melanoma
578444|NCT00495950|Lymphedema|lymphedema
578445|NCT00495950|Limb Swelling|limb swelling
578446|NCT00495950|Questionnaire|questionnaire
578447|NCT00495950|Quality of Life|quality of life
578448|NCT00495950|Physical Function|physical function
578449|NCT00495950|Survey|survey
578450|NCT00495963|Mechanical ventilation, Ventilator- associated pneumonia, Bronchoalveolar lavage, Pediatric intensive care unit, Flexible bronchoscopy, Critical care|mechanical ventilation, ventilator- associated pneumonia, bronchoalveolar lavage, pediatric intensive care unit, flexible bronchoscopy, critical care
578451|NCT00495976|common cold|common cold
578453|NCT00495976|influenza|influenza
578454|NCT00495989|Handicapped individuals|handicapped individuals
578455|NCT00496002|Hepatitis B virus|hepatitis b virus
578456|NCT00496002|Nucleoside Treatment-Naïve Patients with HBeAg Positive|nucleoside treatment-naïve patients with hbeag positive
578457|NCT00496015|Streptococcus Pneumoniae Vaccines|streptococcus pneumoniae vaccines
578458|NCT00496015|Meningococcal disease|meningococcal disease
578459|NCT00496015|Carriage|carriage
578460|NCT00496015|Prophylactic antipyretic|prophylactic antipyretic
578461|NCT00496015|Safety|safety
578462|NCT00496015|Pneumococcal vaccine|pneumococcal vaccine
578464|NCT00496015|Pneumococcal disease|pneumococcal disease
578465|NCT00496015|Immunogenicity|immunogenicity
578466|NCT00496015|Meningococcal vaccine|meningococcal vaccine
578467|NCT00496015|Booster vaccination|booster vaccination
578468|NCT00496028|Solid tumors|solid tumors
578469|NCT00496028|locally advanced or Metastatic Cancer suitable for treatment with carboplatin and/or paclitaxel|locally advanced or metastatic cancer suitable for treatment with carboplatin and/or paclitaxel
578470|NCT00496041|Stenosis (> 75%) or occlusion of the superficial femoral artery|stenosis (> 75%) or occlusion of the superficial femoral artery
578471|NCT00496067|Fibroids|fibroids
578472|NCT00496067|Menorrhagia|menorrhagia
578473|NCT00496067|Menorrhagia associated with uterine fibroids|menorrhagia associated with uterine fibroids
578474|NCT00496080|Menorrhagia associated with Uterine Fibroids|menorrhagia associated with uterine fibroids
578475|NCT00496119|Proton Beam Therapy|proton beam therapy
578476|NCT00496119|Skull Base Chordoma|skull base chordoma
578477|NCT00496119|Chordoma of the Skull Base|chordoma of the skull base
578478|NCT00496119|Chordoma|chordoma
578479|NCT00496132|CLL|cll
578480|NCT00496132|Leukemia|leukemia
578481|NCT00496132|Lymph|lymph
578482|NCT00496145|diabetes|diabetes
578483|NCT00496145|self management|self management
578484|NCT00496145|patient education|patient education
578485|NCT00496145|telephone reinforcement|telephone reinforcement
578486|NCT00496145|Spanish Diabetes|spanish diabetes
578487|NCT00496145|Tomando Control de su Diabetes|tomando control de su diabetes
578488|NCT00496158|Nucleoside Treatment-Naïve Patients with HBeAg Negative Chronic Hepatitis due to Hepatitis B Virus|nucleoside treatment-naïve patients with hbeag negative chronic hepatitis due to hepatitis b virus
578489|NCT00496158|hepatitis b virus|hepatitis b virus
578490|NCT00496184|Nifedipine treatment|nifedipine treatment
578491|NCT00496184|Vestibulitis|vestibulitis
578492|NCT00496184|Placebo|placebo
578493|NCT00496197|candidemia|candidemia
578494|NCT00496197|invasive candidiasis|invasive candidiasis
578495|NCT00496197|fungal bloodstream infection|fungal bloodstream infection
578496|NCT00496210|Adaptation|adaptation
578497|NCT00496210|Pervasive Developmental Disorder|pervasive developmental disorder
578498|NCT00496210|Autism Spectrum Disorders|autism spectrum disorders
578499|NCT00496210|Pervasive Developmental Disorders|pervasive developmental disorders
578500|NCT00496210|Caregiver Adaptation|caregiver adaptation
578501|NCT00496223|Sunitinib|sunitinib
578502|NCT00496223|Dacarbazine|dacarbazine
578503|NCT00496223|Melanoma|melanoma
578504|NCT00496236|head|head
578505|NCT00496236|neck|neck
578506|NCT00496236|cancer|cancer
578507|NCT00496236|neoplasm|neoplasm
578508|NCT00496249|Prostate|prostate
578509|NCT00496249|cancer|cancer
578510|NCT00496249|brachytherapy|brachytherapy
578511|NCT00496249|radiation|radiation
578512|NCT00496249|semen|semen
578513|NCT00496249|fertility|fertility
578514|NCT00496262|Congenital fibrinogen deficiency|congenital fibrinogen deficiency
578515|NCT00496262|Fibrinogen concentrate|fibrinogen concentrate
578516|NCT00496262|Pharmacokinetics|pharmacokinetics
578517|NCT00496262|Thrombelastography|thrombelastography
578518|NCT00496275|NSCLC|nsclc
578519|NCT00496275|ZACTIMA|zactima
578520|NCT00496288|BRCA mutation|brca mutation
578521|NCT00496288|Breast cancer|breast cancer
578522|NCT00496288|Prophylactic breast irradiation|prophylactic breast irradiation
578523|NCT00496288|Prevention of contralateral breast cancer|prevention of contralateral breast cancer
578524|NCT00496301|renal|renal
578525|NCT00496301|sorafenib|sorafenib
578526|NCT00496301|Unresectable and/or metastatic renal cell cancer|unresectable and/or metastatic renal cell cancer
578527|NCT00496340|Pentostatin|pentostatin
578528|NCT00496340|Busulfan|busulfan
578529|NCT00496340|Rituxan|rituxan
578530|NCT00496340|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
578531|NCT00496353|Neoplasm Malignant|neoplasm malignant
578532|NCT00496379|metastatic breast cancer|metastatic breast cancer
578533|NCT00496379|invasive breast cancer|invasive breast cancer
578534|NCT00496379|brain metastases|brain metastases
578535|NCT00496379|ZK-EPO|zk-epo
578536|NCT00496392|breakthrough pain in patients with cancer|breakthrough pain in patients with cancer
578537|NCT00496405|Vascular endothelial growth factor.|vascular endothelial growth factor.
578538|NCT00496405|Retinal Thickness|retinal thickness
578539|NCT00496405|Diabetic Macular Edema|diabetic macular edema
578540|NCT00496405|Optical Coherent Tomography|optical coherent tomography
578541|NCT00496418|colostomy|colostomy
578542|NCT00496418|parastomal|parastomal
578543|NCT00496418|peristomal|peristomal
578544|NCT00496418|hernia|hernia
578545|NCT00496418|mesh|mesh
578546|NCT00496418|surgery|surgery
578547|NCT00496418|Indication for permanent end colostomy|indication for permanent end colostomy
578548|NCT00496444|Advanced Cancers|advanced cancers
578549|NCT00496444|Azacytidine|azacytidine
578550|NCT00496444|5-Azacitidine|5-azacitidine
578551|NCT00496444|5-aza|5-aza
578552|NCT00496444|Vidaza|vidaza
578553|NCT00496444|5-AZC|5-azc
578554|NCT00496444|AZA-CR|aza-cr
578555|NCT00496444|Ladakamycin|ladakamycin
578556|NCT00496444|NSC-102816|nsc-102816
578557|NCT00496444|Valproic Acid|valproic acid
578558|NCT00496444|Depakene|depakene
578559|NCT00496457|Diabetic Neuropathy|diabetic neuropathy
578560|NCT00496457|Painful Peripheral Diabetic Neuropathy|painful peripheral diabetic neuropathy
578561|NCT00496457|TRO19622|tro19622
578562|NCT00496457|Trophos|trophos
578563|NCT00496470|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
578564|NCT00496483|Tacrolimus|tacrolimus
578565|NCT00496483|Pharmacokinetics|pharmacokinetics
578566|NCT00496483|Kidney Transplantation|kidney transplantation
578567|NCT00496509|ZD6474|zd6474
578568|NCT00496509|Colorectal Cancer|colorectal cancer
578569|NCT00496509|Liver Metastases|liver metastases
578570|NCT00496509|Biomarkers|biomarkers
578571|NCT00496522|Skull Base Chondrosarcoma|skull base chondrosarcoma
578572|NCT00496522|Proton Beam Therapy|proton beam therapy
578573|NCT00496522|Chondrosarcoma|chondrosarcoma
578575|NCT00496535|head|head
578576|NCT00496535|neck|neck
578577|NCT00496535|cancer|cancer
578578|NCT00496535|neoplasm|neoplasm
578579|NCT00496548|Crohn's Disease|crohn's disease
578580|NCT00496561|asthma|asthma
578581|NCT00496561|immunotherapy|immunotherapy
578582|NCT00496561|children|children
578583|NCT00496561|regulatory T cells|regulatory t cells
578584|NCT00496561|ECP|ecp
578585|NCT00496561|PC20M|pc20m
578586|NCT00496561|Quality of Life|quality of life
578587|NCT00496561|Symptoms score|symptoms score
578588|NCT00496561|Spirometry|spirometry
578589|NCT00496574|asthma|asthma
578590|NCT00496574|immunotherapy|immunotherapy
578591|NCT00496574|efficacy|efficacy
578592|NCT00496574|children|children
578593|NCT00496574|symptoms score|symptoms score
578594|NCT00496574|quality of life|quality of life
578595|NCT00496574|spirometry|spirometry
578596|NCT00496574|PC20M|pc20m
578597|NCT00496587|Genitourinary|genitourinary
578598|NCT00496587|Kidney Cancer|kidney cancer
578599|NCT00496587|Sarcomatoid Renal Cell Carcinoma|sarcomatoid renal cell carcinoma
578600|NCT00496587|Renal Cell Carcinoma|renal cell carcinoma
578601|NCT00496587|RCC|rcc
578602|NCT00496587|Sarcomatoid Carcinoma of the Kidney|sarcomatoid carcinoma of the kidney
578603|NCT00496587|Unresectable renal cell carcinoma|unresectable renal cell carcinoma
578604|NCT00496587|Capecitabine|capecitabine
578605|NCT00496587|Xeloda|xeloda
578606|NCT00496587|Gemcitabine|gemcitabine
578607|NCT00496587|Gemzar|gemzar
578608|NCT00496587|Bevacizumab|bevacizumab
578609|NCT00496587|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
578610|NCT00496587|rhuMAb-VEGF|rhumab-vegf
578611|NCT00496587|Avastin|avastin
578612|NCT00496587|Vascular Endothelial Growth Factor|vascular endothelial growth factor
578613|NCT00496587|VEGF|vegf
578614|NCT00496613|Breast cancer|breast cancer
578615|NCT00496613|survivor|survivor
578616|NCT00496626|HPV infections|hpv infections
578617|NCT00496639|hemodialysis|hemodialysis
578618|NCT00496639|arterio-venous grafts|arterio-venous grafts
578619|NCT00496639|angioplasty|angioplasty
578620|NCT00496639|stents|stents
578621|NCT00496639|mechanical thrombectomy|mechanical thrombectomy
578622|NCT00496652|Squamous Cell Carcinomas of the Head and Neck|squamous cell carcinomas of the head and neck
578623|NCT00496652|Epidermal Growth Factor receptor|epidermal growth factor receptor
578625|NCT00496652|Radiotherapy|radiotherapy
578626|NCT00496665|Stage IV breast cancer|stage iv breast cancer
578627|NCT00496665|metronomic chemotherapy|metronomic chemotherapy
578628|NCT00496678|PNRP|pnrp
578629|NCT00496678|navigation|navigation
578630|NCT00496678|navigator|navigator
578631|NCT00496678|activation|activation
578632|NCT00496678|disparities|disparities
578633|NCT00496678|randomized control trial|randomized control trial
578634|NCT00496678|primary care|primary care
578635|NCT00496678|racial and ethnic minorities|racial and ethnic minorities
578636|NCT00496691|HIV prevention|hiv prevention
578637|NCT00496691|HIV Seronegativity|hiv seronegativity
578638|NCT00496704|adenocarcinoma of the colon|adenocarcinoma of the colon
578639|NCT00496704|recurrent colon cancer|recurrent colon cancer
578640|NCT00496704|stage III colon cancer|stage iii colon cancer
578641|NCT00496704|stage IV colon cancer|stage iv colon cancer
578642|NCT00496704|adenocarcinoma of the rectum|adenocarcinoma of the rectum
578643|NCT00496704|recurrent rectal cancer|recurrent rectal cancer
578644|NCT00496704|stage III rectal cancer|stage iii rectal cancer
578645|NCT00496704|stage IV rectal cancer|stage iv rectal cancer
578646|NCT00496717|Calcium scoring/aorta/ cardiovascular risk factor/scann|calcium scoring/aorta/ cardiovascular risk factor/scann
578647|NCT00496717|Patients with at least one cardiovascular risk factor|patients with at least one cardiovascular risk factor
578648|NCT00496730|Metabolic Disorder|metabolic disorder
578649|NCT00496756|clear cell renal cell carcinoma|clear cell renal cell carcinoma
578650|NCT00496756|stage III renal cell cancer|stage iii renal cell cancer
578651|NCT00496756|stage IV renal cell cancer|stage iv renal cell cancer
578652|NCT00496756|recurrent renal cell cancer|recurrent renal cell cancer
578653|NCT00496782|Treatment Experienced|treatment experienced
583558|NCT00512174|Non Invasive Bladder Volume Measurement|non invasive bladder volume measurement
578654|NCT00496795|Breast cancer, chemoresistance, predictive markers.|breast cancer, chemoresistance, predictive markers.
578064|NCT00494585|MF|mf
578655|NCT00496808|Ductal Carcinoma In Situ|ductal carcinoma in situ
578656|NCT00496808|Breast Cancer|breast cancer
578657|NCT00496808|Herceptin|herceptin
578658|NCT00496808|Trastuzumab|trastuzumab
578659|NCT00496808|DCIS|dcis
578660|NCT00496821|Respiratory Syncytial Virus|respiratory syncytial virus
578661|NCT00496847|rhPDGF,|rhpdgf,
578662|NCT00496847|periodontal disease|periodontal disease
578663|NCT00496860|cancer|cancer
578664|NCT00496860|p53|p53
578665|NCT00496860|immunotherapy|immunotherapy
578666|NCT00496860|targeted|targeted
578667|NCT00496860|metastatic|metastatic
578668|NCT00496860|malignancy|malignancy
578669|NCT00496860|malignancies|malignancies
578670|NCT00496860|interleukin-2|interleukin-2
578671|NCT00496860|IL-2|il-2
578672|NCT00496860|fusion protein|fusion protein
578673|NCT00496860|antitumor|antitumor
578674|NCT00496860|melanoma|melanoma
578675|NCT00496860|renal cancer|renal cancer
578676|NCT00496860|lung cancer|lung cancer
578677|NCT00496860|kidney cancer|kidney cancer
578678|NCT00496860|breast cancer|breast cancer
578679|NCT00496860|colorectal cancer|colorectal cancer
578680|NCT00496860|colon cancer|colon cancer
578681|NCT00496860|renal cell carcinoma|renal cell carcinoma
578682|NCT00496860|advanced cancer|advanced cancer
578683|NCT00496860|head and neck cancer|head and neck cancer
578684|NCT00496860|breast tumors|breast tumors
578685|NCT00496860|cancer of head and neck|cancer of head and neck
578686|NCT00496860|esophagus cancer|esophagus cancer
578687|NCT00496860|lymphoma|lymphoma
578688|NCT00496860|ovarian cancer|ovarian cancer
578689|NCT00496860|ovary cancer|ovary cancer
578690|NCT00496860|bladder cancer|bladder cancer
578691|NCT00496860|stomach cancer|stomach cancer
578692|NCT00496860|TCR|tcr
578693|NCT00496860|T-cell receptor|t-cell receptor
578694|NCT00496860|P53 gene|p53 gene
578695|NCT00496860|p53 tumor suppressor protein|p53 tumor suppressor protein
578696|NCT00496873|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
578697|NCT00496873|NHL|nhl
578698|NCT00496873|Lymphoma|lymphoma
578699|NCT00496873|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
578700|NCT00496873|SLL|sll
578701|NCT00496873|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
578702|NCT00496873|Lymphoplasmacytic lymphoma/immunocytoma|lymphoplasmacytic lymphoma/immunocytoma
578703|NCT00496873|Follicular lymphoma|follicular lymphoma
578704|NCT00496873|Extranodal marginal zone B-cell lymphoma of MALT type|extranodal marginal zone b-cell lymphoma of malt type
578705|NCT00496873|Nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
578706|NCT00496873|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
578707|NCT00496873|CLL|cll
578708|NCT00496873|Bulky Lymphoma|bulky lymphoma
578709|NCT00496873|Nipent|nipent
578710|NCT00496873|Cytoxan|cytoxan
578711|NCT00496873|Rituxan|rituxan
578712|NCT00496873|Cyclophosphamide|cyclophosphamide
578714|NCT00496873|Pentostatin|pentostatin
578715|NCT00496886|Pain|pain
578716|NCT00496886|Nociception|nociception
578717|NCT00496899|Labor|labor
578718|NCT00496899|Obstetric|obstetric
578719|NCT00496899|cervical dilatation|cervical dilatation
578720|NCT00496938|Stents|stents
578721|NCT00496938|Angioplasty|angioplasty
578722|NCT00496938|Total coronary occlusions|total coronary occlusions
578723|NCT00496938|Coronary restenosis|coronary restenosis
578724|NCT00496938|Stent thrombosis|stent thrombosis
578725|NCT00496938|Everolimus|everolimus
578726|NCT00496951|Neonatal abstinence syndrome|neonatal abstinence syndrome
578727|NCT00496951|Methadone|methadone
578728|NCT00496951|Vagal tone|vagal tone
578729|NCT00496964|Botulinum toxin type A|botulinum toxin type a
578730|NCT00496964|Patellofemoral pain syndrome|patellofemoral pain syndrome
578832|NCT00490204|Cetirizine|cetirizine
578731|NCT00496964|Knee Injuries|knee injuries
578732|NCT00496964|Exercise Therapy|exercise therapy
578733|NCT00496977|lung cancer|lung cancer
578734|NCT00496977|CT scan|ct scan
578735|NCT00496977|screening|screening
578736|NCT00496990|male|male
578737|NCT00496990|female|female
578738|NCT00496990|couple|couple
578739|NCT00496990|cocaine|cocaine
578740|NCT00496990|opiate|opiate
578741|NCT00496990|methadone|methadone
578742|NCT00496990|detoxification|detoxification
578743|NCT00496990|pregnancy|pregnancy
578744|NCT00497003|Endothelial function|endothelial function
578745|NCT00497003|Beta blocker|beta blocker
578746|NCT00497003|Type 2 diabetes|type 2 diabetes
578747|NCT00497003|Chronic heart failure|chronic heart failure
578748|NCT00497016|hypertension|hypertension
578749|NCT00497016|statin|statin
578750|NCT00497016|sympathetic|sympathetic
578751|NCT00497029|dental caries|dental caries
578752|NCT00497029|early childhood caries|early childhood caries
578753|NCT00497029|caries prevention|caries prevention
578754|NCT00497029|infants|infants
578755|NCT00497055|Methamphetamine|methamphetamine
578756|NCT00497055|HIV|hiv
578757|NCT00497055|MSM|msm
578758|NCT00497055|HIV Seronegativity|hiv seronegativity
578759|NCT00497068|smoking|smoking
578760|NCT00497068|pregnancy|pregnancy
578761|NCT00497068|neonatal abstinence syndrome|neonatal abstinence syndrome
578762|NCT00497081|Methamphetamine|methamphetamine
578764|NCT00497081|MSM|msm
578765|NCT00497081|HIV Seronegativity|hiv seronegativity
578766|NCT00489931|Avian Influenza|avian influenza
578767|NCT00489931|Healthy|healthy
578768|NCT00489931|Immunity|immunity
578769|NCT00489931|Preventive|preventive
578770|NCT00489931|Bird Flu|bird flu
578771|NCT00489931|Healthy Volunteer|healthy volunteer
578772|NCT00489931|HV|hv
578773|NCT00489944|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
578774|NCT00489944|extraocular extension melanoma|extraocular extension melanoma
578775|NCT00489944|iris melanoma|iris melanoma
578776|NCT00489944|epithelioid cell intraocular melanoma|epithelioid cell intraocular melanoma
578777|NCT00489944|stage IIB intraocular melanoma|stage iib intraocular melanoma
578778|NCT00489944|stage IIIA intraocular melanoma|stage iiia intraocular melanoma
578779|NCT00489944|stage IIIB intraocular melanoma|stage iiib intraocular melanoma
578780|NCT00489944|stage IIIC intraocular melanoma|stage iiic intraocular melanoma
578781|NCT00489944|stage IV intraocular melanoma|stage iv intraocular melanoma
578782|NCT00489957|congenital cardiac disorders|congenital cardiac disorders
578783|NCT00489957|echocardiography|echocardiography
578784|NCT00489970|Persistence|persistence
578785|NCT00489970|immunogenicity|immunogenicity
578786|NCT00490022|Dihydrotestosterone|dihydrotestosterone
578787|NCT00490022|Androgen|androgen
578788|NCT00490022|Prostate|prostate
578789|NCT00490035|Epilepsy|epilepsy
578790|NCT00490035|Brivaracetam|brivaracetam
578791|NCT00490035|Partial Onset Seizures|partial onset seizures
578792|NCT00490048|Ulcerative colits|ulcerative colits
578793|NCT00490048|lung|lung
578794|NCT00490048|Induced sputum|induced sputum
578795|NCT00490048|Our aim to evaluate lung involvement in Ulcerative colitis patients by induced sputum|our aim to evaluate lung involvement in ulcerative colitis patients by induced sputum
578796|NCT00490074|AIDS Vaccines|aids vaccines
578797|NCT00490074|Vaccines, DNA|vaccines, dna
578798|NCT00490074|HIV Preventive Vaccine|hiv preventive vaccine
578799|NCT00490074|HIV Seronegativity|hiv seronegativity
578800|NCT00490087|Atypical endometrial polyps|atypical endometrial polyps
578801|NCT00490087|Atypical Endometrial Hyperplasia|atypical endometrial hyperplasia
578802|NCT00490087|Hysteroscopic resection|hysteroscopic resection
578803|NCT00490087|Conservative treatment|conservative treatment
578804|NCT00490087|Fertile women|fertile women
578805|NCT00490100|X-Linked Severe Combined Immune Deficiency (XSCID)|x-linked severe combined immune deficiency (xscid)
578806|NCT00490100|Growth Hormone|growth hormone
578807|NCT00490100|Insulin-Like Growth Factor 1 (IGF)-1|insulin-like growth factor 1 (igf)-1
578808|NCT00490100|Bone Age|bone age
578809|NCT00490100|Growth Failure|growth failure
578810|NCT00490100|XSCID|xscid
578811|NCT00490100|X-Linked Severe Combined Immunodeficiency|x-linked severe combined immunodeficiency
578812|NCT00490126|Laparoscopic Surgery|laparoscopic surgery
578814|NCT00490126|Gynecology|gynecology
578815|NCT00490126|Demographics|demographics
578816|NCT00490126|Perioperative Care|perioperative care
578817|NCT00490139|Adjuvant|adjuvant
578818|NCT00490139|ErbB2-overexpressing|erbb2-overexpressing
578819|NCT00490139|Early stage breast cancer|early stage breast cancer
578820|NCT00490139|HER2/neu gene amplified|her2/neu gene amplified
578821|NCT00490152|HIV|hiv
578822|NCT00490152|Microbicide Gel|microbicide gel
578823|NCT00490152|HIV Seronegativity|hiv seronegativity
578824|NCT00490178|Type II diabetes|type ii diabetes
578825|NCT00490178|dyslipidemia|dyslipidemia
578826|NCT00490178|metformin|metformin
578827|NCT00490178|fenofibrate|fenofibrate
578828|NCT00490178|synordia|synordia
578829|NCT00490204|Perennial Allergic Rhinitis|perennial allergic rhinitis
578830|NCT00490204|Placebo control|placebo control
578831|NCT00490204|anti-histamine|anti-histamine
578833|NCT00490217|Spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
578834|NCT00490217|incidence|incidence
578836|NCT00490217|etiology|etiology
578837|NCT00490217|liver cirrhosis|liver cirrhosis
578838|NCT00490230|Paromomycin|paromomycin
578839|NCT00490230|Gentamicin|gentamicin
578840|NCT00490243|Asthma|asthma
578841|NCT00490243|Children|children
578842|NCT00490243|Exercise|exercise
578843|NCT00490243|Pulmonary Function|pulmonary function
578844|NCT00490243|Budesonide|budesonide
578845|NCT00490243|Montelukast|montelukast
578846|NCT00490243|Formoterol|formoterol
578847|NCT00490256|Selective Cerebral Perfusion|selective cerebral perfusion
578848|NCT00490256|Renal Complications|renal complications
578849|NCT00490256|Gastrointestinal Complications|gastrointestinal complications
578850|NCT00490256|Aortic Arch Reconstruction|aortic arch reconstruction
578851|NCT00490256|Modified Perfusion|modified perfusion
578852|NCT00490256|Cardiopulmonary Bypass|cardiopulmonary bypass
578853|NCT00490256|Pediatrics|pediatrics
578854|NCT00490256|Cardiac Defects|cardiac defects
578855|NCT00490256|intestinal ischemia|intestinal ischemia
578856|NCT00490256|necrotizing entercolitis|necrotizing entercolitis
578857|NCT00490256|Near Infra-red spectroscopy|near infra-red spectroscopy
578858|NCT00490256|Creatinine|creatinine
578859|NCT00490256|C-reactive protein levels|c-reactive protein levels
578860|NCT00490269|Marijuana dependence|marijuana dependence
578861|NCT00490282|Head and Neck Cancer|head and neck cancer
578862|NCT00490282|Oropharyngeal Cancer|oropharyngeal cancer
578863|NCT00490282|Adaptive Radiotherapy|adaptive radiotherapy
578864|NCT00490282|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
578865|NCT00490282|IMRT|imrt
578866|NCT00490282|ART|art
578867|NCT00490295|biomarkers|biomarkers
578868|NCT00490295|brain ischemia|brain ischemia
578869|NCT00490295|neonates|neonates
578870|NCT00490295|cardiac surgery|cardiac surgery
578871|NCT00490295|congenital heart disease|congenital heart disease
578872|NCT00490308|luteal|luteal
578873|NCT00490308|phase|phase
578874|NCT00490308|estradiol|estradiol
578875|NCT00490308|pregnancy|pregnancy
578876|NCT00490308|rate|rate
578877|NCT00490321|VentrAssistTM|ventrassisttm
578878|NCT00490321|LVAD|lvad
578879|NCT00490321|End-stage heart failure|end-stage heart failure
578880|NCT00490321|Cardiomyopathy|cardiomyopathy
578881|NCT00490334|Carcinomas|carcinomas
578882|NCT00490334|Squamous Cel|squamous cel
578883|NCT00490334|Adenocarcinoma|adenocarcinoma
578884|NCT00490334|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
578885|NCT00490347|VentrAssistTM|ventrassisttm
578886|NCT00490347|LVAD|lvad
578887|NCT00490347|End-stage heart failure|end-stage heart failure
578888|NCT00490347|Cardiomyopathy|cardiomyopathy
578889|NCT00490386|Retrospective|retrospective
578890|NCT00490386|Length of Stay|length of stay
578891|NCT00490386|Helicobacter pylori|helicobacter pylori
578892|NCT00490412|Vitamin D|vitamin d
578893|NCT00490412|Treatment Experienced|treatment experienced
578894|NCT00490425|probiotics|probiotics
578895|NCT00490425|LGG|lgg
578896|NCT00490425|praevention|praevention
578897|NCT00490425|allergic asthma|allergic asthma
578898|NCT00490425|children|children
578899|NCT00490438|perineometry|perineometry
578900|NCT00490438|Modified Oxford Score|modified oxford score
578901|NCT00490438|pelvic muscles evaluation|pelvic muscles evaluation
578902|NCT00490438|urinary incontinence|urinary incontinence
578903|NCT00490438|vaginal palpation|vaginal palpation
578904|NCT00490464|Patients with SAH or ICH|patients with sah or ich
578905|NCT00490477|acute renal failure|acute renal failure
578906|NCT00490477|lipopolysaccharide|lipopolysaccharide
578907|NCT00490477|tubular apoptosis|tubular apoptosis
578908|NCT00490477|Polymyxin-B fiber|polymyxin-b fiber
578909|NCT00490477|Severe sepsis from gram negative infection|severe sepsis from gram negative infection
578910|NCT00490503|Breast Cancer|breast cancer
578911|NCT00490503|Magnetic Resonance Imaging|magnetic resonance imaging
578912|NCT00490503|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
578913|NCT00490503|DCE-MRI|dce-mri
578915|NCT00490503|MRS|mrs
578916|NCT00490503|MRI|mri
578917|NCT00490516|Schizophrenia, psychotic disorders|schizophrenia, psychotic disorders
578918|NCT00490542|Bipolar Disorder|bipolar disorder
578919|NCT00490542|Major Depression|major depression
578920|NCT00490542|Clinical pharmacology|clinical pharmacology
578921|NCT00490542|Clinical Trial|clinical trial
578922|NCT00490555|Male Contraception|male contraception
578923|NCT00490555|Testosterone|testosterone
578924|NCT00490555|Testis|testis
578925|NCT00490555|Contraception|contraception
578926|NCT00490555|Prostate|prostate
578927|NCT00497094|carotid artery stenting|carotid artery stenting
578928|NCT00497094|atherosclerosis|atherosclerosis
578929|NCT00497094|cerebrovascular|cerebrovascular
578930|NCT00497094|stroke|stroke
578931|NCT00497107|UFT/LV|uft/lv
578932|NCT00497107|PSK|psk
578933|NCT00497107|Colorectal cancer|colorectal cancer
578934|NCT00497107|Adjuvant therapy|adjuvant therapy
578935|NCT00497120|sleep apnea|sleep apnea
578936|NCT00497120|snoring|snoring
578937|NCT00497120|acetazolamide|acetazolamide
578938|NCT00497120|uvulopalatopharyngoplasty|uvulopalatopharyngoplasty
578939|NCT00497120|daytime sleepiness|daytime sleepiness
578940|NCT00497120|upper airway|upper airway
578941|NCT00497133|glucoseintolerance|glucoseintolerance
578942|NCT00497146|paricalcitol|paricalcitol
578943|NCT00497146|Zemplar|zemplar
578944|NCT00497146|PRIMO|primo
578945|NCT00497146|Chronic Kidney Disease Stage 3B/4|chronic kidney disease stage 3b/4
578946|NCT00497159|Trial of Dimebon to treat patients with mild-to-moderate Huntington's disease.|trial of dimebon to treat patients with mild-to-moderate huntington's disease.
578947|NCT00497185|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
578948|NCT00497185|Somatization Disorder|somatization disorder
578949|NCT00497185|Medically Unexplained Symptoms|medically unexplained symptoms
578950|NCT00497185|Functional Somatic Symptoms|functional somatic symptoms
578951|NCT00497185|SF-36|sf-36
578952|NCT00497198|Type 2 Diabetes|type 2 diabetes
578953|NCT00497198|anion-exchange resin|anion-exchange resin
578954|NCT00497211|First large acute myocardial infarction|first large acute myocardial infarction
578955|NCT00497224|Pancreatic Cancer|pancreatic cancer
578956|NCT00497224|Pancreatic Carcinoma|pancreatic carcinoma
578957|NCT00497224|Pancreas|pancreas
578958|NCT00497224|Adenocarcinoma|adenocarcinoma
578959|NCT00497224|Erlotinib|erlotinib
578961|NCT00497224|OSI-774|osi-774
578962|NCT00497224|Phase II|phase ii
578963|NCT00497237|Asthma|asthma
578964|NCT00497237|Stepdown|stepdown
578965|NCT00497237|Beclomethasone|beclomethasone
578966|NCT00497237|Formoterol|formoterol
578967|NCT00497237|Corticosteroids|corticosteroids
578968|NCT00497250|Phase 1 Clinical Trials|phase 1 clinical trials
578969|NCT00497250|Iressa|iressa
578970|NCT00497250|radiation therapy|radiation therapy
578971|NCT00497250|Chinese|chinese
578972|NCT00497250|NSCLC|nsclc
578973|NCT00497250|chemotherapy|chemotherapy
578974|NCT00497276|Adults|adults
578975|NCT00497276|Anesthesia recovery period|anesthesia recovery period
578976|NCT00497276|Comparative study|comparative study
578977|NCT00497276|Electric stimulation|electric stimulation
578978|NCT00497276|Humans|humans
578979|NCT00497276|Nerve blocks/methods/indications|nerve blocks/methods/indications
578980|NCT00497276|Patient satisfaction|patient satisfaction
578981|NCT00497276|Peripheral nerves|peripheral nerves
578982|NCT00497276|Sciatic nerve/ultrasonography|sciatic nerve/ultrasonography
578983|NCT00497276|Ultrasonography|ultrasonography
578984|NCT00497276|Treatment outcome|treatment outcome
578985|NCT00497276|Nerve blocks/economics|nerve blocks/economics
578986|NCT00497289|n-3 PUFA|n-3 pufa
578987|NCT00497289|parenteral nutrition|parenteral nutrition
578988|NCT00497289|preterm infant|preterm infant
578989|NCT00497302|cocaine|cocaine
578990|NCT00497302|opiate|opiate
578991|NCT00497302|pregnancy|pregnancy
578992|NCT00497302|post-partum|post-partum
578993|NCT00497302|neonatal abstinence syndrome|neonatal abstinence syndrome
578994|NCT00497302|contingency management|contingency management
578995|NCT00497302|Reinforcement Based Treatment|reinforcement based treatment
578996|NCT00497302|women|women
578997|NCT00497315|Non-Small Cell Lung Cancer|non-small cell lung cancer
578998|NCT00497315|NSCLC|nsclc
578999|NCT00497315|Chemoradiation|chemoradiation
579000|NCT00497315|locally advanced NSCLC|locally advanced nsclc
579001|NCT00497315|pemetrexed|pemetrexed
579002|NCT00497315|lung cancer|lung cancer
579003|NCT00497328|contrast induced nephropathy|contrast induced nephropathy
579004|NCT00497341|infection after total knee arthroplasty|infection after total knee arthroplasty
579005|NCT00497354|Ultrasound, Complications, Regional Anesthesia|ultrasound, complications, regional anesthesia
579006|NCT00497367|safety|safety
579007|NCT00497367|feasibility|feasibility
579008|NCT00497367|bifurcation|bifurcation
579009|NCT00497367|lesion|lesion
579010|NCT00497367|de novo|de novo
579011|NCT00497367|intervention|intervention
579012|NCT00497393|Emergency department, administration, overcrowding|emergency department, administration, overcrowding
579013|NCT00497406|submandibular salivary gland transfer|submandibular salivary gland transfer
579014|NCT00497406|intensity-modulated radiation therapy|intensity-modulated radiation therapy
579015|NCT00497406|helical tomotherapy|helical tomotherapy
579016|NCT00497406|reduction of xerostomia|reduction of xerostomia
579017|NCT00497419|STEMI|stemi
579018|NCT00497419|ST elevation myocardial infarction|st elevation myocardial infarction
579019|NCT00499798|infertility|infertility
579020|NCT00499798|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
579021|NCT00499798|adult anaplastic astrocytoma|adult anaplastic astrocytoma
579121|NCT00500058|oncology|oncology
579022|NCT00499798|adult diffuse astrocytoma|adult diffuse astrocytoma
579023|NCT00499798|adult giant cell glioblastoma|adult giant cell glioblastoma
579024|NCT00499798|adult gliosarcoma|adult gliosarcoma
579025|NCT00499798|adult pilocytic astrocytoma|adult pilocytic astrocytoma
579026|NCT00499798|adult brain stem glioma|adult brain stem glioma
579027|NCT00499798|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
579028|NCT00499798|adult choroid plexus tumor|adult choroid plexus tumor
579029|NCT00499798|adult craniopharyngioma|adult craniopharyngioma
579030|NCT00499798|adult ependymoblastoma|adult ependymoblastoma
579031|NCT00499798|adult medulloblastoma|adult medulloblastoma
579032|NCT00499798|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
579033|NCT00499798|adult anaplastic ependymoma|adult anaplastic ependymoma
579034|NCT00499798|adult ependymoma|adult ependymoma
579035|NCT00499798|adult myxopapillary ependymoma|adult myxopapillary ependymoma
579036|NCT00499798|adult subependymoma|adult subependymoma
579037|NCT00499798|adult anaplastic meningioma|adult anaplastic meningioma
579038|NCT00499798|meningeal melanocytoma|meningeal melanocytoma
579039|NCT00499798|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
579040|NCT00499798|adult papillary meningioma|adult papillary meningioma
579041|NCT00499798|adult grade I meningioma|adult grade i meningioma
579042|NCT00499798|adult grade II meningioma|adult grade ii meningioma
579043|NCT00499798|adult grade III meningioma|adult grade iii meningioma
579044|NCT00499798|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
579045|NCT00499798|adult oligodendroglioma|adult oligodendroglioma
579046|NCT00499798|adult pineoblastoma|adult pineoblastoma
578463|NCT00496015|Fever|fever
579047|NCT00499798|adult pineocytoma|adult pineocytoma
579048|NCT00499798|adult mixed glioma|adult mixed glioma
579049|NCT00499798|recurrent adult brain tumor|recurrent adult brain tumor
579050|NCT00499798|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
579051|NCT00499824|Diabetes|diabetes
579052|NCT00499824|Management guidelines|management guidelines
579053|NCT00499824|Efficacy|efficacy
579054|NCT00499850|ZD6474|zd6474
579055|NCT00499850|FOLFOX|folfox
579056|NCT00499850|colorectal|colorectal
579057|NCT00499850|adenocarcinoma|adenocarcinoma
579058|NCT00499876|Human immune deficiency virus|human immune deficiency virus
579059|NCT00499876|Acquired immune deficiency syndrome|acquired immune deficiency syndrome
579060|NCT00499876|malaria|malaria
579061|NCT00499876|mefloquine|mefloquine
579062|NCT00499876|prophylaxis|prophylaxis
579063|NCT00499876|HIV/AIDS|hiv/aids
579064|NCT00499876|Treatment Naive|treatment naive
579065|NCT00499889|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
579066|NCT00499889|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
579067|NCT00499889|Leukemia|leukemia
579068|NCT00499889|Imatinib Mesylate|imatinib mesylate
579069|NCT00499889|Gleevec|gleevec
579070|NCT00499889|Busulfan|busulfan
579071|NCT00499889|Busulfex|busulfex
579072|NCT00499889|Myleran|myleran
579073|NCT00499889|Fludarabine|fludarabine
579074|NCT00499889|ATG|atg
579075|NCT00499889|STI571|sti571
579076|NCT00499889|Antithymocyte Globulin|antithymocyte globulin
579077|NCT00499889|Thymoglobulin|thymoglobulin
579078|NCT00499902|AIS|ais
579079|NCT00499902|acute ischemic stroke|acute ischemic stroke
579080|NCT00499902|stroke|stroke
579081|NCT00499902|alfimeprase|alfimeprase
579082|NCT00499902|blood clot|blood clot
579083|NCT00499902|brain|brain
579084|NCT00499902|thrombus|thrombus
579085|NCT00499902|thrombolytic|thrombolytic
579086|NCT00499902|thrombosis|thrombosis
579087|NCT00499902|plasminogen activator|plasminogen activator
579088|NCT00499902|arterial flow|arterial flow
579089|NCT00499902|neurology|neurology
579090|NCT00499902|intra-arterial|intra-arterial
579091|NCT00499902|intra-thrombus|intra-thrombus
579092|NCT00499902|catheter-directed|catheter-directed
579093|NCT00499902|symptomatic ICH|symptomatic ich
579094|NCT00499902|ICH|ich
579095|NCT00499902|AOL|aol
579096|NCT00499902|arterial occlusive lesion|arterial occlusive lesion
579097|NCT00499902|recanalization|recanalization
579098|NCT00499928|SB-751689|sb-751689
579099|NCT00499928|osteoporosis|osteoporosis
579100|NCT00499928|metabolism|metabolism
579101|NCT00499928|excretion|excretion
579102|NCT00499941|Alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
579103|NCT00499954|microdialysis|microdialysis
579104|NCT00499954|subcutaneous adipose tissue|subcutaneous adipose tissue
579105|NCT00499954|glucose sensor|glucose sensor
579106|NCT00499954|glucose monitoring|glucose monitoring
579107|NCT00499954|type 1 diabetes|type 1 diabetes
579108|NCT00499954|Guardian RT|guardian rt
579109|NCT00499954|Glucoday S|glucoday s
579110|NCT00499967|genital warts|genital warts
579111|NCT00499967|venereal warts|venereal warts
579112|NCT00499967|human papilloma virus|human papilloma virus
579113|NCT00499980|Breast cancer|breast cancer
579114|NCT00499980|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
579115|NCT00499980|Oximetry|oximetry
579116|NCT00500032|Adult|adult
579117|NCT00500045|CRVO|crvo
579118|NCT00500045|HRVO|hrvo
579119|NCT00500045|BRVO|brvo
579120|NCT00500058|Rituximab,|rituximab,
579122|NCT00500058|IL-18,|il-18,
579123|NCT00500058|combination study,|combination study,
579124|NCT00500058|cytokine,|cytokine,
579125|NCT00500084|Chronic Pancreatitis|chronic pancreatitis
579126|NCT00500084|Pancreatectomy|pancreatectomy
579127|NCT00500110|Prostate Cancer|prostate cancer
579128|NCT00500110|Hormonal Ablation|hormonal ablation
579129|NCT00500110|Docetaxel|docetaxel
579130|NCT00500110|Imatinib Mesylate|imatinib mesylate
579131|NCT00500110|STI571|sti571
579132|NCT00500110|Gleevec|gleevec
579133|NCT00500110|Taxotere|taxotere
579541|NCT00501527|Depigmented|depigmented
579134|NCT00500110|Goserelin Acetate|goserelin acetate
579135|NCT00500110|Zoladex|zoladex
579136|NCT00500110|Leuprolide|leuprolide
579137|NCT00500110|Lupron|lupron
579138|NCT00500123|alpha-1|alpha-1
579139|NCT00500123|antitrypsin|antitrypsin
579140|NCT00500123|AAT|aat
579141|NCT00500123|genetic testing|genetic testing
579142|NCT00500123|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
579143|NCT00500123|AATD|aatd
579144|NCT00500136|bias|bias
579145|NCT00500175|diabetes|diabetes
579146|NCT00500175|ulceration|ulceration
579147|NCT00500175|amputation|amputation
579148|NCT00500175|pressure sores|pressure sores
579149|NCT00500175|shear friction|shear friction
579150|NCT00500188|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
579151|NCT00500188|GIST|gist
579152|NCT00500188|Kit expression|kit expression
579153|NCT00500188|Resectable|resectable
579154|NCT00500188|Imatinib Mesylate|imatinib mesylate
579155|NCT00500188|Gleevec|gleevec
579156|NCT00500188|STI-571|sti-571
579157|NCT00500188|Imatinib|imatinib
579158|NCT00500188|NSC-716051|nsc-716051
579159|NCT00500201|Healthy Volunteer|healthy volunteer
579160|NCT00500214|inguinal hernia|inguinal hernia
579161|NCT00500214|herniorrhaphy|herniorrhaphy
579162|NCT00500214|mesh repair|mesh repair
579163|NCT00500214|ilioinguinal neurectomy|ilioinguinal neurectomy
579164|NCT00500214|postoperative pain in cases and controls during one year.|postoperative pain in cases and controls during one year.
579165|NCT00500214|postoperative hyposthesia in cases and controls during one year.|postoperative hyposthesia in cases and controls during one year.
579166|NCT00500240|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
579167|NCT00500240|Leukemia|leukemia
579168|NCT00500240|Lymphoma|lymphoma
579169|NCT00500240|Burkitts Lymphoma|burkitts lymphoma
579170|NCT00500240|Lymphoblastic Leukemia|lymphoblastic leukemia
579171|NCT00500240|Blood Sugar|blood sugar
579172|NCT00500240|Hyperglycemia|hyperglycemia
579173|NCT00500240|Insulin Aspart|insulin aspart
579174|NCT00500240|Insulin Glargine|insulin glargine
579175|NCT00500240|Hyper-CVAD|hyper-cvad
579176|NCT00500253|exhaled nitric oxide|exhaled nitric oxide
579177|NCT00500253|asthma|asthma
579178|NCT00500253|children|children
579179|NCT00500253|inhaled glucocorticosteroids|inhaled glucocorticosteroids
579180|NCT00500266|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
579181|NCT00500266|vaccine|vaccine
579182|NCT00500279|Drug-eluting stent|drug-eluting stent
579183|NCT00500279|Restenosis|restenosis
579184|NCT00500279|Celecoxib|celecoxib
579185|NCT00500292|colorectal|colorectal
579186|NCT00500292|cancer|cancer
579187|NCT00500292|zactima|zactima
579188|NCT00500305|indomethacin therapy|indomethacin therapy
579189|NCT00500305|patent ductus arteriosus|patent ductus arteriosus
579190|NCT00500318|Bronchitis, Chronic; Emphysema|bronchitis, chronic; emphysema
579191|NCT00500331|Pioglitazone|pioglitazone
579192|NCT00500331|HbA1c|hba1c
579193|NCT00500331|Diabetes mellitus|diabetes mellitus
579194|NCT00500344|Age-related Macular Degeneration|age-related macular degeneration
579195|NCT00500344|Choroidal Neovascularization|choroidal neovascularization
579196|NCT00500344|Electroretinography|electroretinography
579197|NCT00500344|Retinal Function|retinal function
579198|NCT00500370|exenatide|exenatide
579199|NCT00500370|obesity|obesity
579200|NCT00500370|diabetes|diabetes
579201|NCT00500370|Amylin|amylin
579202|NCT00500370|Lilly|lilly
579203|NCT00500383|Breast Cancer Risk|breast cancer risk
579204|NCT00500383|BRCA1|brca1
579205|NCT00500383|BRCA2|brca2
579206|NCT00500383|Breast Cancer Susceptibility gene|breast cancer susceptibility gene
579207|NCT00500383|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
579208|NCT00500383|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
579209|NCT00500396|Retinopathy of Prematurity.|retinopathy of prematurity.
579210|NCT00500396|ROP.|rop.
579211|NCT00500396|Vascular Endothelial Growth Factor.|vascular endothelial growth factor.
579212|NCT00500396|VEGF.|vegf.
579213|NCT00500396|Vitreous.|vitreous.
579214|NCT00500396|Subretinal Fluid.|subretinal fluid.
579216|NCT00500409|rhPTH(1-34)|rhpth(1-34)
579217|NCT00500409|Osteoporosis|osteoporosis
579218|NCT00500422|Solid Tumors|solid tumors
579219|NCT00500422|Doxil|doxil
579220|NCT00500422|Adriamycin|adriamycin
579221|NCT00500422|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
579222|NCT00500422|Liposomal Doxorubicin|liposomal doxorubicin
579223|NCT00500422|Doxorubicin Hydrochloride|doxorubicin hydrochloride
579224|NCT00500422|Gemcitabine|gemcitabine
579226|NCT00500422|Bortezomib|bortezomib
579227|NCT00500422|Velcade|velcade
579228|NCT00500422|PS341|ps341
579229|NCT00500422|PS-341|ps-341
579230|NCT00500422|LDP-341|ldp-341
579231|NCT00500422|MLN341|mln341
579232|NCT00500435|Cervical Cancer|cervical cancer
579233|NCT00500435|Laparoscopy|laparoscopy
579234|NCT00500435|Lymph Node Dissection|lymph node dissection
579235|NCT00500435|Extraperitoneal Laparoscopic Lymphadenectomy|extraperitoneal laparoscopic lymphadenectomy
579236|NCT00500448|Arthritis, Knee, Quadriceps, Electrical Stimulation, Women|arthritis, knee, quadriceps, electrical stimulation, women
579542|NCT00501527|Polymerized|polymerized
579237|NCT00500461|Muscarinic Receptor Antagonist,|muscarinic receptor antagonist,
579238|NCT00500461|intravenous infusion,|intravenous infusion,
579239|NCT00500461|pharmacokinetics|pharmacokinetics
579240|NCT00500461|healthy subjects,|healthy subjects,
579241|NCT00500461|safety,|safety,
579242|NCT00500461|tolerability,|tolerability,
579243|NCT00500461|Anticholinergic,|anticholinergic,
579244|NCT00500461|oral dosing,|oral dosing,
579245|NCT00500474|Meniere's disease|meniere's disease
579246|NCT00500474|inner ear|inner ear
579247|NCT00500474|endolymphatic sac drainage|endolymphatic sac drainage
579248|NCT00500474|steroids|steroids
579249|NCT00500474|declined surgery|declined surgery
579250|NCT00500474|natural course|natural course
742173|NCT01125241|depression|depression
579251|NCT00500474|Efficacy of steroids via endolymphatic sac|efficacy of steroids via endolymphatic sac
579252|NCT00500474|for intractable Meniere's disease|for intractable meniere's disease
579253|NCT00500487|HIV prevention|hiv prevention
579254|NCT00500487|HIV seronegativity|hiv seronegativity
579255|NCT00500513|Lung Cancer|lung cancer
579256|NCT00500513|Respiratory-Induced Tumor Motion|respiratory-induced tumor motion
579257|NCT00500513|Tumor Motion|tumor motion
579258|NCT00500513|Pulmonary Function|pulmonary function
579259|NCT00500513|Fiducial Marker|fiducial marker
579260|NCT00500526|COPD|copd
579261|NCT00500526|Pulmonary function|pulmonary function
579262|NCT00500526|Respiratory muscle|respiratory muscle
579263|NCT00500526|Dyspnea|dyspnea
579264|NCT00500526|Quality of life|quality of life
579265|NCT00500539|Asthma|asthma
579266|NCT00500539|omalizumab|omalizumab
579267|NCT00500539|safety|safety
579268|NCT00500539|allergic asthma|allergic asthma
579269|NCT00500539|adolescents|adolescents
579270|NCT00500552|Perhexiline|perhexiline
579271|NCT00500552|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
579272|NCT00500565|Breast Cancer|breast cancer
579273|NCT00500565|On-Q Pain Relief System|on-q pain relief system
579274|NCT00500565|Transverse Rectus Abdominous Myocutaneous|transverse rectus abdominous myocutaneous
579275|NCT00500565|Breast Reconstruction|breast reconstruction
579276|NCT00500565|TRAM flap|tram flap
579277|NCT00500565|Bupivicaine|bupivicaine
579278|NCT00500565|Pain Management|pain management
579279|NCT00500578|Hematological Malignancies|hematological malignancies
579280|NCT00500578|Respiratory Infection|respiratory infection
579281|NCT00500578|Respiratory Syncytial Virus|respiratory syncytial virus
579282|NCT00500578|RSV|rsv
579283|NCT00500578|Ribavirin|ribavirin
579284|NCT00500578|Virazole|virazole
579285|NCT00500591|Endometrial Abnormalities|endometrial abnormalities
579286|NCT00500591|Endometrial Cancer|endometrial cancer
579287|NCT00500591|Obesity|obesity
579288|NCT00500591|Survey|survey
579289|NCT00500591|Questionnaire|questionnaire
579290|NCT00500617|Atherosclerosis|atherosclerosis
579291|NCT00500617|Biological Markers|biological markers
579292|NCT00500617|Molecular Genetics|molecular genetics
579293|NCT00500669|Varicose veins|varicose veins
579294|NCT00500669|wound infection|wound infection
579295|NCT00500669|recurrence|recurrence
579296|NCT00500682|Kidney Diseases|kidney diseases
579297|NCT00500708|Heart failure|heart failure
579298|NCT00500708|Implanted Cardioverter Defibrillator|implanted cardioverter defibrillator
579299|NCT00500708|Biological Markers|biological markers
579300|NCT00500708|Molecular Genetics|molecular genetics
579301|NCT00500721|healthy subjects|healthy subjects
579302|NCT00500734|Cardiomyopathy|cardiomyopathy
579303|NCT00500734|Tissue Bank|tissue bank
579304|NCT00500734|Heart Disease|heart disease
579305|NCT00500734|Heart Failure|heart failure
579306|NCT00500734|Congestive Heart Failure|congestive heart failure
579307|NCT00500747|hepatitis C, HCV, vaccine, recombinant vaccine, adjuvant|hepatitis c, hcv, vaccine, recombinant vaccine, adjuvant
579308|NCT00500760|Head and Neck Cancer|head and neck cancer
579309|NCT00500760|panitumumab|panitumumab
579310|NCT00500773|cardiovascular risc factors|cardiovascular risc factors
579311|NCT00500773|inflammation|inflammation
579225|NCT00500422|Gemzar|gemzar
579312|NCT00500773|aerobic and exertional exercise|aerobic and exertional exercise
579313|NCT00500799|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
579314|NCT00500799|Blink Reflex|blink reflex
579315|NCT00500799|Blepharospasm|blepharospasm
579316|NCT00500799|Healthy Volunteer|healthy volunteer
579317|NCT00500799|HV|hv
579318|NCT00500812|biologic drug|biologic drug
579319|NCT00500812|transport sequence|transport sequence
579320|NCT00500812|rho|rho
579321|NCT00500812|spinal cord injury|spinal cord injury
579322|NCT00500812|paralysis|paralysis
579323|NCT00500812|paraplegia|paraplegia
579324|NCT00500812|tetraplegia|tetraplegia
579325|NCT00500812|quadraplegia|quadraplegia
579326|NCT00500812|trauma|trauma
579327|NCT00500812|nervous system|nervous system
579328|NCT00500812|fibrin sealant|fibrin sealant
579329|NCT00500812|neurosurgery|neurosurgery
579330|NCT00500825|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
579331|NCT00500825|Therapeutic hypothermia|therapeutic hypothermia
579332|NCT00500825|resting energy expenditure|resting energy expenditure
579333|NCT00500838|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
579334|NCT00500838|Transthoracic Impedance|transthoracic impedance
579335|NCT00500851|critical illness|critical illness
579336|NCT00500851|enteral nutrition|enteral nutrition
579337|NCT00500851|gastrointestinal intubation|gastrointestinal intubation
579339|NCT00500864|Magnesium|magnesium
579340|NCT00500864|Pulmonary function|pulmonary function
579341|NCT00500864|Exercise Physiology|exercise physiology
579342|NCT00500877|Smoking cessation|smoking cessation
579343|NCT00500877|Phone Counseling|phone counseling
579344|NCT00500890|Choroid Plexus Tumors|choroid plexus tumors
579345|NCT00500890|Carboplatin|carboplatin
579346|NCT00500890|Cyclophosphamide|cyclophosphamide
579347|NCT00500890|Etoposide|etoposide
579348|NCT00500890|Vincristine|vincristine
579349|NCT00500890|Paraplatin|paraplatin
579351|NCT00500890|Neosar|neosar
579352|NCT00500903|Advanced malignancies|advanced malignancies
578763|NCT00497081|HIV|hiv
579353|NCT00500929|OHSP|ohsp
579354|NCT00500929|High risk|high risk
579355|NCT00500929|Geriatrics|geriatrics
579356|NCT00500942|Interventional Radiology|interventional radiology
579357|NCT00500942|Pain Quantification|pain quantification
579358|NCT00500942|Pain Management|pain management
579359|NCT00500942|Patient Satisfaction|patient satisfaction
579360|NCT00500942|Questionnaire|questionnaire
579361|NCT00500942|Survey|survey
579362|NCT00500955|microalbuminuria,|microalbuminuria,
579363|NCT00500955|Type 2 Diabetes|type 2 diabetes
579364|NCT00500955|rosiglitazone,|rosiglitazone,
579365|NCT00500968|Pancreas|pancreas
579366|NCT00500968|Leakage|leakage
579367|NCT00500968|Fistula|fistula
579368|NCT00500968|tail|tail
579369|NCT00500981|Fluid responsiveness|fluid responsiveness
579370|NCT00500994|Conversion Disorder|conversion disorder
579371|NCT00500994|Psychogenic Movement Disorders|psychogenic movement disorders
579372|NCT00500994|Non-Epileptic Seizure|non-epileptic seizure
579373|NCT00500994|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
579374|NCT00500994|Genetic Polymorphisms|genetic polymorphisms
579375|NCT00500994|Psychogenic Movement Disorder|psychogenic movement disorder
579376|NCT00500994|PMD|pmd
579377|NCT00500994|NES|nes
579378|NCT00500994|Healthy Volunteer|healthy volunteer
579379|NCT00500994|HV|hv
579380|NCT00501020|Type 2 Diabetes|type 2 diabetes
579381|NCT00501020|metformin|metformin
579382|NCT00501020|rosiglitazone|rosiglitazone
579383|NCT00501033|Induction of labor|induction of labor
579384|NCT00501033|Cesarean|cesarean
579385|NCT00501033|Endometritis|endometritis
579386|NCT00501033|Foley|foley
579387|NCT00501033|Infections|infections
579388|NCT00501046|Kidney Diseases|kidney diseases
579389|NCT00501059|Primary prevention of coronary heart disease|primary prevention of coronary heart disease
579390|NCT00501059|Stroke and cardiovascular death|stroke and cardiovascular death
579391|NCT00501059|Aspirin|aspirin
579392|NCT00501072|hyperglycemia|hyperglycemia
579393|NCT00501072|hypoglycemia|hypoglycemia
579394|NCT00501072|glucose variability|glucose variability
579395|NCT00501072|insulin infusion system; implantable insulin pump|insulin infusion system; implantable insulin pump
579396|NCT00501072|continuous glucose monitoring|continuous glucose monitoring
579397|NCT00501098|Leukemia|leukemia
579398|NCT00501098|Prophylaxis|prophylaxis
579399|NCT00501098|Fungal Infections|fungal infections
579400|NCT00501098|Caspofungin|caspofungin
579401|NCT00501111|Dementia|dementia
579402|NCT00501111|Alzheimer Type|alzheimer type
579403|NCT00501111|Alzheimer Disease|alzheimer disease
579404|NCT00501137|HPV|hpv
579405|NCT00501137|HPV vaccine|hpv vaccine
579406|NCT00501137|Gardasil|gardasil
579407|NCT00501137|Human Papillomavirus|human papillomavirus
579408|NCT00501137|vaccine|vaccine
579409|NCT00501137|2 dose versus 3|2 dose versus 3
579410|NCT00501150|linezolid|linezolid
579411|NCT00501150|vancomycin|vancomycin
579412|NCT00501150|glycopeptides|glycopeptides
579413|NCT00501150|methicillin resistant staphylococcus aureus|methicillin resistant staphylococcus aureus
579414|NCT00501150|resistant gram positive infections|resistant gram positive infections
579416|NCT00501163|Cardiovascular|cardiovascular
579417|NCT00501163|Risk|risk
579418|NCT00501176|Pancreas|pancreas
579419|NCT00501176|cancer|cancer
579420|NCT00501176|SEMS|sems
579421|NCT00501176|Plastic|plastic
579422|NCT00501176|stent|stent
579423|NCT00501176|Whipple|whipple
579424|NCT00501176|Jaundicie|jaundicie
579425|NCT00501189|Gardasil|gardasil
579426|NCT00501189|Human Papilloma Virus|human papilloma virus
579427|NCT00501189|Papanicolaou Smear|papanicolaou smear
579429|NCT00501189|LGSIL|lgsil
579430|NCT00501189|Human Papilloma Virus Vaccine|human papilloma virus vaccine
579431|NCT00501189|Human Papillomavirus Infection|human papillomavirus infection
579432|NCT00501202|diabetes mellitus|diabetes mellitus
579433|NCT00501202|diabetic microvascular injury|diabetic microvascular injury
579434|NCT00501202|painful polyneuropathy.|painful polyneuropathy.
579435|NCT00501215|Primary Hyperparathyroidism|primary hyperparathyroidism
579436|NCT00501215|PHPT|phpt
579437|NCT00501215|Parathyroidectomy|parathyroidectomy
579438|NCT00501215|Polysomnogram|polysomnogram
579439|NCT00501215|PSG|psg
579440|NCT00501215|Sleep Quality|sleep quality
579441|NCT00501215|Interview|interview
579442|NCT00501228|Graft-Versus-Host Disease|graft-versus-host disease
579443|NCT00501228|Stem Cell Transplantation|stem cell transplantation
579444|NCT00501228|Tissue Repair|tissue repair
579445|NCT00501228|Organ-Specific Tissue Damage|organ-specific tissue damage
579446|NCT00501228|Filgrastim|filgrastim
579447|NCT00501228|RhG-CSF|rhg-csf
579448|NCT00501254|Slow release ASA|slow release asa
579449|NCT00501254|Platelet functionalism|platelet functionalism
579450|NCT00501254|Secondary cardiovascular prevention|secondary cardiovascular prevention
579451|NCT00501267|solabegron,|solabegron,
579452|NCT00501267|oxybutynin,|oxybutynin,
579453|NCT00501267|healthy adults,|healthy adults,
579454|NCT00501267|drug interaction|drug interaction
579455|NCT00501280|Epidemiology|epidemiology
579456|NCT00501280|Genetic Susceptibility|genetic susceptibility
579457|NCT00501280|Migrant Farmworker Children|migrant farmworker children
579458|NCT00501280|Migrant Education Program|migrant education program
579459|NCT00501280|Interview|interview
579460|NCT00501280|Questionnaire|questionnaire
579461|NCT00501306|Condyloma Accuminata|condyloma accuminata
579462|NCT00501306|Low Grade Squamous Intraepithelial Lesion|low grade squamous intraepithelial lesion
579463|NCT00501306|High Grade Squamous Intraepithelial Lesion|high grade squamous intraepithelial lesion
579464|NCT00501306|Anal Cancer Screening|anal cancer screening
579465|NCT00501319|Interactive Voice Response Telephone System|interactive voice response telephone system
579466|NCT00501319|Non-Small Cell Lung Cancer|non-small cell lung cancer
579467|NCT00501319|Lung Cancer|lung cancer
579468|NCT00501319|Questionnaire|questionnaire
579469|NCT00501319|Survey|survey
579470|NCT00501319|NSCLC|nsclc
579471|NCT00501319|IVR|ivr
579472|NCT00501332|neutropenia|neutropenia
579473|NCT00501332|breast|breast
579474|NCT00501332|cancer|cancer
579475|NCT00501332|chemotherapy|chemotherapy
579476|NCT00501345|Thrombocytopenia|thrombocytopenia
579477|NCT00501345|Platelet Function|platelet function
579478|NCT00501345|Acute Coronary Syndrome|acute coronary syndrome
579479|NCT00501345|Myocardial Infarction|myocardial infarction
579480|NCT00501345|Heart Attack|heart attack
579481|NCT00501345|Aspirin|aspirin
579482|NCT00501358|SLEEP APNEA|sleep apnea
579483|NCT00501358|venous thromboembolism|venous thromboembolism
579484|NCT00501358|COAGULABILITY|coagulability
579485|NCT00501358|COAGULATION FACTORS|coagulation factors
579486|NCT00501358|HYPOXIA|hypoxia
579487|NCT00501371|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
579488|NCT00501371|MCS|mcs
579489|NCT00501371|Lower Urinary Tract Symptoms|lower urinary tract symptoms
579490|NCT00501371|International prostate symptom score|international prostate symptom score
579491|NCT00501371|Voiding|voiding
579492|NCT00501371|Alpha-blockers|alpha-blockers
579493|NCT00501384|cirrhotic ascites|cirrhotic ascites
579494|NCT00501397|ketoconazole,|ketoconazole,
579495|NCT00501397|drug interaction,|drug interaction,
579496|NCT00501397|pharmacokinetics|pharmacokinetics
579497|NCT00501397|T2DM,|t2dm,
579498|NCT00501410|Colorectal Cancer|colorectal cancer
579499|NCT00501410|Dual Inhibition of EGFR|dual inhibition of egfr
579500|NCT00501410|FOLFOX Chemotherapy|folfox chemotherapy
579501|NCT00501410|5-FU|5-fu
579502|NCT00501410|Cetuximab|cetuximab
579503|NCT00501410|Dasatinib|dasatinib
579504|NCT00501410|Leucovorin|leucovorin
579505|NCT00501410|Oxaliplatin|oxaliplatin
579506|NCT00501410|5-Fluorouracil|5-fluorouracil
579507|NCT00501410|BMS-354825|bms-354825
579508|NCT00501410|Eloxatin|eloxatin
579509|NCT00501410|Sprycel|sprycel
579510|NCT00501410|C225|c225
579511|NCT00501410|Erbitux|erbitux
579512|NCT00501410|IMC-C225|imc-c225
579513|NCT00501410|Adrucil|adrucil
579514|NCT00501410|Efudex|efudex
579515|NCT00501410|Folinic Acid|folinic acid
579516|NCT00501423|antiplatelet drug|antiplatelet drug
579517|NCT00501423|resistance|resistance
579428|NCT00501189|ASCUS|ascus
579518|NCT00501423|atherothrombosis|atherothrombosis
579519|NCT00501449|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
579520|NCT00501449|Questionnaire|questionnaire
579521|NCT00501449|Psychosocial|psychosocial
579522|NCT00501449|Surveillance Behaviors|surveillance behaviors
579523|NCT00501449|MEN Syndromes|men syndromes
579524|NCT00501462|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
579525|NCT00501462|renal insufficiency|renal insufficiency
579526|NCT00501475|N-acetylcysteine|n-acetylcysteine
579527|NCT00501475|nephropathy|nephropathy
579528|NCT00501475|bicarbonate|bicarbonate
579529|NCT00501488|pharmacodynamics|pharmacodynamics
579530|NCT00501488|insulin resistance|insulin resistance
579531|NCT00501488|therapy|therapy
579532|NCT00501488|volunteer|volunteer
579533|NCT00501501|Rehospitalization|rehospitalization
579534|NCT00501501|Cesarean|cesarean
579535|NCT00501501|Vaginal delivery|vaginal delivery
579536|NCT00501514|chronic heart failure|chronic heart failure
579537|NCT00501514|cardiopulmonary exercise|cardiopulmonary exercise
579538|NCT00501514|oxygen consumption|oxygen consumption
579539|NCT00501514|growth hormone|growth hormone
579540|NCT00501527|Allergoid|allergoid
579543|NCT00501527|Allergen-extract|allergen-extract
579544|NCT00501527|Rhinoconjunctivitis|rhinoconjunctivitis
579545|NCT00501527|Asthma|asthma
579546|NCT00501540|low-grade neuroendocrine tumors|low-grade neuroendocrine tumors
579547|NCT00501540|lithium|lithium
579548|NCT00501553|Heart Failure,|heart failure,
579549|NCT00501553|Vitamin D status,|vitamin d status,
579550|NCT00501553|NT-proBNP|nt-probnp
579551|NCT00501566|cirrhotic ascites|cirrhotic ascites
579552|NCT00501592|Farnesoid X receptor agonist|farnesoid x receptor agonist
579553|NCT00501592|Metabolic Disorder|metabolic disorder
579554|NCT00501592|Diabetes|diabetes
579555|NCT00501592|NAFLD|nafld
578960|NCT00497224|Tarceva|tarceva
579556|NCT00501605|Phase I|phase i
579557|NCT00501605|AZD2171|azd2171
579558|NCT00501605|advanced solid tumors|advanced solid tumors
579559|NCT00501618|Schizophrenia|schizophrenia
579560|NCT00501618|Schizoaffective Disorder|schizoaffective disorder
579561|NCT00501618|Orally dissolving clozapine|orally dissolving clozapine
579562|NCT00501618|orally disintegrating clozapine|orally disintegrating clozapine
579563|NCT00501618|bio-equivalence|bio-equivalence
579564|NCT00501618|desmethylclozapine|desmethylclozapine
579565|NCT00501618|clozapine plasma level|clozapine plasma level
579566|NCT00501618|equivalence|equivalence
579567|NCT00501618|fazaclo|fazaclo
579568|NCT00501618|generic clozapine|generic clozapine
579569|NCT00501631|Addiction|addiction
579570|NCT00501631|Alcoholism|alcoholism
579571|NCT00501631|Inpatient detoxification|inpatient detoxification
579572|NCT00501644|Müllerian Carcinomas|müllerian carcinomas
579573|NCT00501644|Ovarian Cancer|ovarian cancer
579574|NCT00501644|Fallopian Tube Cancer|fallopian tube cancer
579575|NCT00501644|Peritoneal Cancer|peritoneal cancer
579576|NCT00501644|Epithelial Ovarian|epithelial ovarian
579577|NCT00501644|Peritoneal|peritoneal
579578|NCT00501644|Fallopian Tube|fallopian tube
579579|NCT00501644|Chemoimmunotherapy|chemoimmunotherapy
579580|NCT00501644|Platinum Sensitive Müllerian|platinum sensitive müllerian
579581|NCT00501644|Carboplatin|carboplatin
579582|NCT00501644|Paraplatin|paraplatin
579583|NCT00501644|GM-CSF|gm-csf
579584|NCT00501644|Sargramostim|sargramostim
579585|NCT00501644|Interferon Gamma|interferon gamma
579586|NCT00501644|Quality of Life|quality of life
579588|NCT00501657|gastric emptying|gastric emptying
579589|NCT00501657|glycemia|glycemia
579590|NCT00501657|appetite|appetite
579591|NCT00501657|incretin hormones|incretin hormones
579592|NCT00501670|Herpes zoster|herpes zoster
579593|NCT00501670|PCR|pcr
579594|NCT00501670|Varicella zoster Virus (VZV)|varicella zoster virus (vzv)
579595|NCT00501670|Shingles|shingles
579596|NCT00501670|GSK Biologicals|gsk biologicals
579597|NCT00501683|metabolite profiling|metabolite profiling
579598|NCT00501683|excretion,|excretion,
579599|NCT00501683|radioactivity,|radioactivity,
579600|NCT00501683|pharmacokinetic,|pharmacokinetic,
579601|NCT00501683|mass balance,|mass balance,
579602|NCT00501722|cirrhotic ascites|cirrhotic ascites
579603|NCT00501722|hyponatraemia|hyponatraemia
579604|NCT00501735|T-Cell|t-cell
579605|NCT00501735|Lymphoma|lymphoma
579606|NCT00501735|Forodesine|forodesine
579607|NCT00501735|Mycosis Fungoides|mycosis fungoides
579608|NCT00501748|Neuromyelitis Optica|neuromyelitis optica
579609|NCT00501748|acute transverse myelitis|acute transverse myelitis
579610|NCT00501761|Endometrial Cancer|endometrial cancer
579611|NCT00501761|Healthy Controls|healthy controls
579612|NCT00501761|Social Cognitive Theory|social cognitive theory
579613|NCT00501761|Behavioral Intervention|behavioral intervention
579614|NCT00501761|Physical Activity|physical activity
579615|NCT00501761|Exercise Program|exercise program
579616|NCT00501761|Questionnaire|questionnaire
579617|NCT00501774|Localized vulvodynia|localized vulvodynia
579618|NCT00501774|Helicobacter pylori|helicobacter pylori
579619|NCT00501774|peptic disease|peptic disease
579620|NCT00501774|omeprazole|omeprazole
579622|NCT00501787|metformin|metformin
579623|NCT00501787|PCOS|pcos
579624|NCT00501787|treatment|treatment
579625|NCT00501800|Reproductive Health|reproductive health
579626|NCT00501800|Fertility|fertility
579627|NCT00501800|Infertility|infertility
579628|NCT00501800|Genetics|genetics
579629|NCT00501800|Continental Population Groups|continental population groups
579630|NCT00501800|Epidemiology|epidemiology
579631|NCT00501800|Aging|aging
579632|NCT00501800|Health|health
580141|NCT00502554|FEV1|fev1
579633|NCT00501813|Hepatocellular carcinoma|hepatocellular carcinoma
579634|NCT00501813|Intrahepatic vessels invasion|intrahepatic vessels invasion
579635|NCT00501813|Hepatectomy|hepatectomy
579636|NCT00501813|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
579637|NCT00501813|Local regional treatment|local regional treatment
579638|NCT00501826|Leukemia|leukemia
579639|NCT00501826|ALL|all
579640|NCT00501826|T-cell ALL|t-cell all
579641|NCT00501826|Lymphoblastic Lymphoma|lymphoblastic lymphoma
579642|NCT00501826|Hyper-CVAD|hyper-cvad
579643|NCT00501826|Doxorubicin|doxorubicin
579644|NCT00501826|Cyclophosphamide|cyclophosphamide
579645|NCT00501826|Cytarabine|cytarabine
579646|NCT00501826|Dexamethasone|dexamethasone
579647|NCT00501826|Methotrexate|methotrexate
579648|NCT00501826|Vincristine|vincristine
579649|NCT00501826|Nelarabine|nelarabine
579650|NCT00501839|Anovulation|anovulation
579651|NCT00501839|Clomiphene citrate|clomiphene citrate
579652|NCT00501839|Infertility|infertility
579653|NCT00501839|PCOS|pcos
579654|NCT00501839|Treatment|treatment
579655|NCT00501852|COPD, Age≥40 yrs, Glycopyrronium Bromide|copd, age≥40 yrs, glycopyrronium bromide
579656|NCT00501865|healthy volunteers|healthy volunteers
579657|NCT00501865|food effect,|food effect,
579658|NCT00501865|quantitative pharmacokinetic analysis,|quantitative pharmacokinetic analysis,
579659|NCT00501865|GW273225,|gw273225,
579660|NCT00501878|phenylephrine|phenylephrine
579661|NCT00501878|mydriasis|mydriasis
579662|NCT00501878|diabetes mellitus|diabetes mellitus
579663|NCT00501891|Glioblastoma Multiforme|glioblastoma multiforme
579664|NCT00501891|Brain and Central Nervous System Tumors|brain and central nervous system tumors
579665|NCT00501891|Recurrent Malignant Glioma|recurrent malignant glioma
579666|NCT00501891|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
579667|NCT00501891|Avastin|avastin
579668|NCT00501891|Bevacizumab|bevacizumab
579669|NCT00501891|Temodar|temodar
579670|NCT00501891|Temozolomide|temozolomide
579671|NCT00501904|Anovulation|anovulation
579672|NCT00501904|Infertility|infertility
579673|NCT00501904|Metformin|metformin
579674|NCT00501904|PCOS|pcos
579675|NCT00501904|Treatment|treatment
579676|NCT00501917|acute myocardial infarction|acute myocardial infarction
579677|NCT00501930|Dose Escalation;|dose escalation;
579678|NCT00501930|Supratherapeutic;|supratherapeutic;
579679|NCT00501930|GSK189075;|gsk189075;
579680|NCT00501930|Diabetes|diabetes
579681|NCT00501956|chronic renal replacement therapy|chronic renal replacement therapy
579682|NCT00501956|malnutrition anorexia|malnutrition anorexia
579683|NCT00501956|parenteral nutrition|parenteral nutrition
579684|NCT00501969|Rotigotine|rotigotine
579685|NCT00501969|Neupro®|neupro®
579686|NCT00501982|surfactant|surfactant
579687|NCT00501982|RDS|rds
579688|NCT00501982|nCPAP|ncpap
579689|NCT00501982|Mechanical Ventilation|mechanical ventilation
579690|NCT00501982|Premature Infants|premature infants
579691|NCT00501982|Neonatal Respiratory Distress Syndrome (nRDS)|neonatal respiratory distress syndrome (nrds)
579692|NCT00501995|High Dose Cyclophosphamide|high dose cyclophosphamide
579693|NCT00501995|Systemic Sclerosis|systemic sclerosis
579694|NCT00501995|Scleroderma|scleroderma
579695|NCT00501995|immunoablation|immunoablation
579696|NCT00502008|Diabetes|diabetes
579697|NCT00502008|India|india
579698|NCT00502008|Coccinia Cordifolia|coccinia cordifolia
579699|NCT00502008|Coccinia indica|coccinia indica
579700|NCT00502008|Blood glucose levels|blood glucose levels
579701|NCT00502021|obesity|obesity
579702|NCT00502021|alpha linolenic acid|alpha linolenic acid
579703|NCT00502021|flaxseed|flaxseed
579704|NCT00502021|C-reactive protein|c-reactive protein
579705|NCT00502021|inflammation|inflammation
579706|NCT00502034|Carcinoma, Renal Cell|carcinoma, renal cell
579707|NCT00502034|Low-dose Interleukin|low-dose interleukin
579708|NCT00502034|Adjuvant Immunotherapy|adjuvant immunotherapy
579709|NCT00502047|plantago ovata husk|plantago ovata husk
579710|NCT00502047|soluble fibre|soluble fibre
579711|NCT00502047|hypercholesterolemia|hypercholesterolemia
579712|NCT00502047|cardiovascular risk factor|cardiovascular risk factor
579713|NCT00502060|Phase I|phase i
579714|NCT00502060|AZD2171|azd2171
579715|NCT00502060|ZD1839|zd1839
579716|NCT00502060|solid tumor|solid tumor
579717|NCT00502086|Chronic hepatitis C|chronic hepatitis c
579718|NCT00502086|Cirrhosis of the liver|cirrhosis of the liver
579719|NCT00502086|Mortality|mortality
579720|NCT00502086|Complications|complications
579721|NCT00502086|Health-related quality of live|health-related quality of live
579722|NCT00502086|Hepatocellular carcinoma|hepatocellular carcinoma
579723|NCT00502086|Nutritional supplement|nutritional supplement
579724|NCT00502099|Chronic hepatitis C|chronic hepatitis c
579725|NCT00502099|pegylated interferon alfa-2a|pegylated interferon alfa-2a
579726|NCT00502099|ribavirin, rapid virologic response|ribavirin, rapid virologic response
579727|NCT00502099|early virologic response|early virologic response
579728|NCT00502099|sustained virologic response|sustained virologic response
579729|NCT00502112|Lintuzumab|lintuzumab
579730|NCT00502112|Antigens, CD33|antigens, cd33
579731|NCT00502112|Antibodies, Monoclonal|antibodies, monoclonal
579732|NCT00502112|Combined Modality Therapy|combined modality therapy
579733|NCT00502112|Myelodysplastic Syndromes|myelodysplastic syndromes
579734|NCT00502112|Hematologic Diseases|hematologic diseases
579735|NCT00502112|Preleukemia|preleukemia
579736|NCT00502125|Reflectance Confocal Imaging|reflectance confocal imaging
579737|NCT00502125|Oral Mucosal Lesions|oral mucosal lesions
579738|NCT00502125|Oral Mucosa Disease|oral mucosa disease
579739|NCT00502125|Neoplasia Detection|neoplasia detection
579740|NCT00502138|diabetes|diabetes
579741|NCT00502138|insulin|insulin
579742|NCT00502138|pramlintide|pramlintide
579743|NCT00502138|IDDM|iddm
579744|NCT00502164|Advanced Prostate Cancer|advanced prostate cancer
579745|NCT00502177|Continuous Hyperthermic Peritoneal Perfusion|continuous hyperthermic peritoneal perfusion
579746|NCT00502177|Peritoneal Neoplasms|peritoneal neoplasms
579747|NCT00502177|Quality of Life|quality of life
579748|NCT00502177|Questionnaire|questionnaire
579749|NCT00502177|Survey|survey
579750|NCT00502177|CHPP|chpp
579751|NCT00502190|pessary|pessary
579752|NCT00502190|extending pregnancy|extending pregnancy
579753|NCT00502203|Uterine Neoplasms|uterine neoplasms
579754|NCT00502203|Endometrial Cancer|endometrial cancer
579755|NCT00502203|Paclitaxel|paclitaxel
579756|NCT00502203|Taxol|taxol
579757|NCT00502203|Carboplatin|carboplatin
579758|NCT00502203|Paraplatin|paraplatin
579759|NCT00502203|Malignant Mixed Mullerian Tumors|malignant mixed mullerian tumors
579760|NCT00502203|MMMT|mmmt
579761|NCT00502203|Immunohistochemical markers|immunohistochemical markers
579762|NCT00502216|Tobacco|tobacco
579763|NCT00502216|Smoking|smoking
579764|NCT00502216|Weight|weight
579765|NCT00502216|Naltrexone|naltrexone
579766|NCT00502216|Varenicline|varenicline
579767|NCT00502229|Clomiphene citrate|clomiphene citrate
579768|NCT00502229|Controlled overian stimulation|controlled overian stimulation
579769|NCT00502229|Infertility|infertility
579770|NCT00502229|Metformin|metformin
579771|NCT00502229|Polycystic ovary syndrome|polycystic ovary syndrome
579772|NCT00502229|Treatment|treatment
579773|NCT00502255|Telemonitoring|telemonitoring
579774|NCT00502255|Cost-effectiveness|cost-effectiveness
579775|NCT00502255|Heart failure|heart failure
579776|NCT00502255|Case management|case management
579777|NCT00502268|Coronary Calcification|coronary calcification
579778|NCT00502268|Endstage Renal Disease|endstage renal disease
579779|NCT00502268|Parathyroid hormone|parathyroid hormone
579780|NCT00502281|Gonadotropins|gonadotropins
579781|NCT00502281|Infertility|infertility
579782|NCT00502281|Intrauterine insemination|intrauterine insemination
579783|NCT00502281|PCOS|pcos
579784|NCT00502281|Timed intercourse|timed intercourse
579785|NCT00502281|Treatment|treatment
579786|NCT00502294|Ulcerative Colitis, UC, Intravenous Steroid-Refractory Ulcerative Colitis, IVSR-UC|ulcerative colitis, uc, intravenous steroid-refractory ulcerative colitis, ivsr-uc
579787|NCT00493454|Indolent Lymphoma|indolent lymphoma
579788|NCT00493454|Extranodal Marginal|extranodal marginal
579789|NCT00493454|Nodal Marginal Zone|nodal marginal zone
579790|NCT00493454|Splenic Marginal|splenic marginal
579791|NCT00493454|MALT Type|malt type
579792|NCT00493454|Zevalin|zevalin
579793|NCT00493454|Ibritumomab Tiuxetan|ibritumomab tiuxetan
579794|NCT00493454|Rituximab|rituximab
579795|NCT00493467|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
579796|NCT00493467|Lymphoma|lymphoma
579797|NCT00493467|Indolent Lymphomas|indolent lymphomas
579798|NCT00493467|Ibritumomab Tiuxetan|ibritumomab tiuxetan
579799|NCT00493467|Zevalin|zevalin
579800|NCT00493493|Cymetra|cymetra
579801|NCT00493506|ProAlgaZyme|proalgazyme
579803|NCT00493506|HAART|haart
579804|NCT00493506|hsCRP|hscrp
579805|NCT00493506|Oxidative stress|oxidative stress
579806|NCT00493506|CD4+ lymphocytes|cd4+ lymphocytes
579807|NCT00493506|Algae|algae
579808|NCT00493506|HAART adverse effects|haart adverse effects
579809|NCT00493506|HBV|hbv
579810|NCT00493519|Cephalic phase|cephalic phase
579811|NCT00493519|Anorexia nervosa|anorexia nervosa
579812|NCT00493519|Bulimia nervosa|bulimia nervosa
579813|NCT00493519|obese binge eaters|obese binge eaters
579814|NCT00493519|VAS|vas
579815|NCT00493519|EDI|edi
579816|NCT00493519|shame-feed procedure|shame-feed procedure
579817|NCT00493545|Multicenter|multicenter
579818|NCT00493545|Open-Label|open-label
579819|NCT00493545|Nonrandomized|nonrandomized
579820|NCT00493545|Safety|safety
579821|NCT00493558|Roentgen Stereophotogrammetric Analysis|roentgen stereophotogrammetric analysis
579822|NCT00493558|Trabecular Metal Posterior Lumbar Interbody Cage|trabecular metal posterior lumbar interbody cage
579823|NCT00493558|Posterior Lumbar Interbody Fusion Cage|posterior lumbar interbody fusion cage
579824|NCT00493558|Posterior Lumbar spine fusion surgery|posterior lumbar spine fusion surgery
579825|NCT00493571|Myelodysplastic Syndromes|myelodysplastic syndromes
579826|NCT00493571|MDS|mds
579827|NCT00493571|Gimatecan|gimatecan
579828|NCT00493571|Leukemia|leukemia
579829|NCT00493584|Myocardial Infarction|myocardial infarction
579830|NCT00493584|Myocardial Ischemia|myocardial ischemia
579831|NCT00493584|Myocardial Revascularization|myocardial revascularization
579832|NCT00493584|Telemedicine|telemedicine
580562|NCT00504400|ranibizumab|ranibizumab
579833|NCT00493584|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
579834|NCT00493597|Atherosclerosis|atherosclerosis
579835|NCT00493597|Restenosis|restenosis
579836|NCT00493597|EPC|epc
579837|NCT00493597|DC|dc
579838|NCT00493610|Oxidant stress|oxidant stress
579839|NCT00493610|N-acetylcysteine|n-acetylcysteine
579840|NCT00493610|Hepatitis C|hepatitis c
579841|NCT00493610|Liver disease|liver disease
579842|NCT00493610|Mucomyst|mucomyst
579843|NCT00493610|Isoprostane|isoprostane
579844|NCT00493636|Breast Cancer|breast cancer
579845|NCT00493675|Cystic duct leakage|cystic duct leakage
579846|NCT00493688|Abdominal Cancer|abdominal cancer
579847|NCT00493688|Pelvic Cancer|pelvic cancer
579848|NCT00493688|Perioperative Energy Dynamics|perioperative energy dynamics
579849|NCT00493688|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
579850|NCT00493688|CPET|cpet
579851|NCT00493714|Advanced Cancer|advanced cancer
579856|NCT00493714|Questionnaire|questionnaire
579857|NCT00493727|Oxidative stress|oxidative stress
579858|NCT00493727|N-acetylcysteine|n-acetylcysteine
579859|NCT00493727|NAC|nac
579860|NCT00493727|Isoprostane|isoprostane
579861|NCT00493727|Proteinuria|proteinuria
579862|NCT00493727|Diabetes|diabetes
579863|NCT00493727|Mucomyst|mucomyst
579864|NCT00493727|albuminuria|albuminuria
579865|NCT00493740|Cephalic phase, oncology patients|cephalic phase, oncology patients
579866|NCT00493766|LBH589|lbh589
579867|NCT00493766|Prostate Cancer|prostate cancer
579868|NCT00493766|HRPC|hrpc
579869|NCT00493766|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
579870|NCT00493805|homeostasis model assessment of insulin resistance|homeostasis model assessment of insulin resistance
579871|NCT00493818|GSK690693,|gsk690693,
579872|NCT00493818|Solid Tumors,|solid tumors,
579873|NCT00493818|Lymphoma,|lymphoma,
579874|NCT00493818|AKT|akt
579875|NCT00493831|smoking reduction|smoking reduction
579876|NCT00493831|inflammation|inflammation
579877|NCT00493831|harm reduction|harm reduction
579878|NCT00493831|lipid biomarkers|lipid biomarkers
579879|NCT00493844|Chest pain|chest pain
579880|NCT00493844|Unstable angina|unstable angina
579881|NCT00493844|NT-proBNP|nt-probnp
579882|NCT00493844|Exercise test.|exercise test.
579883|NCT00493857|Colorectal cancer|colorectal cancer
579884|NCT00493857|Monoclonal antibody|monoclonal antibody
579885|NCT00493857|Anti-EGFR|anti-egfr
579886|NCT00493883|Therasphere|therasphere
579887|NCT00493883|Yttrium|yttrium
579888|NCT00493883|liver|liver
579889|NCT00493883|cancer|cancer
579890|NCT00493883|radiation|radiation
579891|NCT00493896|Venous Thromboembolism Prophylaxis|venous thromboembolism prophylaxis
579892|NCT00493896|VTE prophylaxis|vte prophylaxis
579893|NCT00493909|thoracotomy|thoracotomy
579894|NCT00493909|pain therapy|pain therapy
579895|NCT00493909|thoracic paravertebral blockade|thoracic paravertebral blockade
579896|NCT00493909|intrathecal opioids|intrathecal opioids
579897|NCT00493909|thoracic epidural analgesia|thoracic epidural analgesia
579898|NCT00493909|Analgesia after thoracotomy|analgesia after thoracotomy
579899|NCT00493922|Malaria|malaria
579900|NCT00493922|Diagnosis|diagnosis
579901|NCT00493922|Rapid diagnostic tests|rapid diagnostic tests
579902|NCT00493922|Microscopy|microscopy
579903|NCT00493922|Clinical diagnosis|clinical diagnosis
579904|NCT00493922|Africa|africa
579905|NCT00493935|bedtime snack|bedtime snack
579906|NCT00493935|hypoglycemia|hypoglycemia
579907|NCT00493935|Diabetes Mellitus, Type I|diabetes mellitus, type i
579908|NCT00493935|glucose monitoring|glucose monitoring
579912|NCT00493974|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
579913|NCT00493974|COPD|copd
579914|NCT00493974|Exacerbation|exacerbation
579915|NCT00493974|Anti-leukotriene|anti-leukotriene
579916|NCT00493974|Length of Stay|length of stay
579917|NCT00493974|LOS|los
579918|NCT00493987|Testosterone|testosterone
579919|NCT00493987|Androgens|androgens
579920|NCT00493987|Dihydrotestosterone|dihydrotestosterone
579921|NCT00493987|5-alpha reductase|5-alpha reductase
579922|NCT00493987|Body Composition|body composition
579923|NCT00493987|Muscle|muscle
579924|NCT00493987|Sexual function|sexual function
579925|NCT00493987|Men|men
579926|NCT00493987|Healthy Men|healthy men
579927|NCT00494013|diabetes|diabetes
579928|NCT00494013|type 2|type 2
579929|NCT00494039|prostate|prostate
579930|NCT00494039|cancer|cancer
579931|NCT00494039|radiation|radiation
579932|NCT00494039|brachytherapy|brachytherapy
579933|NCT00494052|Coronary Heart Disease|coronary heart disease
579935|NCT00494052|Risk Factors|risk factors
579936|NCT00494052|Risk Assessment|risk assessment
579937|NCT00494052|Primary Prevention|primary prevention
579938|NCT00494052|Decision Making|decision making
579939|NCT00494052|Decision Aids|decision aids
579940|NCT00494052|Patient Compliance|patient compliance
579941|NCT00494078|critical illness|critical illness
579942|NCT00494078|hyperglycemia|hyperglycemia
579943|NCT00494078|intensive insulin therapy|intensive insulin therapy
579944|NCT00494078|glucose monitoring|glucose monitoring
579945|NCT00494104|vitamin D deficiency|vitamin d deficiency
579946|NCT00494104|breastfed infant|breastfed infant
579947|NCT00494104|northern latitude|northern latitude
579948|NCT00494104|infant|infant
579949|NCT00494104|breastfed|breastfed
579950|NCT00494104|winter|winter
579951|NCT00494104|vitamin D status|vitamin d status
579952|NCT00494143|Amputee|amputee
579953|NCT00494143|Economy|economy
579954|NCT00494143|Efficiency|efficiency
579955|NCT00494143|Foot|foot
579956|NCT00494143|Gait|gait
579972|NCT00494182|Paclitaxel|paclitaxel
579973|NCT00494182|SCCHN|scchn
579974|NCT00494195|limb girdle muscular dystrophy type 2D|limb girdle muscular dystrophy type 2d
580073|NCT00494520|Anomia|anomia
579975|NCT00494195|alpha-sarcoglycanopathy|alpha-sarcoglycanopathy
579976|NCT00494195|LGMD|lgmd
579977|NCT00494195|LGMD2D|lgmd2d
579978|NCT00494195|gene therapy|gene therapy
579979|NCT00494195|gene transfer|gene transfer
579980|NCT00494195|muscular dystrophy|muscular dystrophy
579981|NCT00494195|SGCA|sgca
579982|NCT00494195|sarcoglycan|sarcoglycan
579983|NCT00494195|limb girdle|limb girdle
749100|NCT01159132|HIV|hiv
579350|NCT00500890|Cytoxan|cytoxan
579984|NCT00494195|adeno-associated virus|adeno-associated virus
579986|NCT00494195|AAV1|aav1
579987|NCT00494208|androgens|androgens
579988|NCT00494208|testosterone|testosterone
579989|NCT00494208|testosterone deficiency|testosterone deficiency
579990|NCT00494208|women|women
579991|NCT00494208|menopause|menopause
579992|NCT00494208|surgical Menopause|surgical menopause
579993|NCT00494208|hysterectomy|hysterectomy
579994|NCT00494208|oophorectomy|oophorectomy
579995|NCT00494208|ovariectomy|ovariectomy
579996|NCT00494208|sexual dysfunction|sexual dysfunction
579997|NCT00494208|sexual function|sexual function
579998|NCT00494208|muscle function|muscle function
579999|NCT00494208|insulin sensitivity|insulin sensitivity
580000|NCT00494208|body composition|body composition
580001|NCT00494221|Colorectal cancer|colorectal cancer
580002|NCT00494221|Recentin|recentin
580003|NCT00494221|Metastatic Cancer|metastatic cancer
580004|NCT00494221|FOLFOX|folfox
580005|NCT00494234|Advanced breast cancer|advanced breast cancer
580006|NCT00494234|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
580007|NCT00494234|AZD2281,KU-0059436 (olaparib)|azd2281,ku-0059436 (olaparib)
580008|NCT00494234|BRCA1 protein|brca1 protein
580009|NCT00494234|BRCA2 protein|brca2 protein
580010|NCT00494247|acute coronary syndromes|acute coronary syndromes
580011|NCT00494247|endothelial progenitor cells|endothelial progenitor cells
580012|NCT00494247|coronary stent|coronary stent
580013|NCT00494260|recurrent abdominal pain|recurrent abdominal pain
580014|NCT00494260|illness behavior|illness behavior
580015|NCT00494260|social learning|social learning
580016|NCT00494260|cognitive behavioral therapy|cognitive behavioral therapy
580017|NCT00494273|Haitian American Adolescents|haitian american adolescents
580018|NCT00494273|HIV Prevention|hiv prevention
580019|NCT00494273|Cognitive Behavioral Intervention|cognitive behavioral intervention
580020|NCT00494286|Abuse Focused Cognitive Behavioral Therapy|abuse focused cognitive behavioral therapy
580021|NCT00494286|Treatment Effectiveness Research|treatment effectiveness research
580022|NCT00494286|Treatment Dissemination|treatment dissemination
580023|NCT00494299|HCC|hcc
580024|NCT00494299|Cancer|cancer
580025|NCT00494299|Liver Cancer|liver cancer
580026|NCT00494299|TACE|tace
580027|NCT00494312|Glucose Metabolism Disorder|glucose metabolism disorder
580028|NCT00494312|Dysmetabolic Syndrome|dysmetabolic syndrome
580029|NCT00494312|Type II Diabetes|type ii diabetes
580030|NCT00494312|Diabetes Mellitus|diabetes mellitus
580031|NCT00494312|Lipoatrophic|lipoatrophic
580032|NCT00494312|Dyslipidemia|dyslipidemia
580033|NCT00494312|Liver|liver
580034|NCT00494312|Drug Therapy|drug therapy
580035|NCT00494325|age related maculopathy, macular pigment|age related maculopathy, macular pigment
580036|NCT00494338|Metastatic Androgen Independent Prostate Cancer (MAIPC)|metastatic androgen independent prostate cancer (maipc)
580037|NCT00494351|Hidradenitis Suppurativa|hidradenitis suppurativa
580563|NCT00504400|lucentis|lucentis
580038|NCT00494351|Nd:YAG laser|nd:yag laser
580039|NCT00494364|ear disease|ear disease
580040|NCT00494364|otitis|otitis
580041|NCT00494364|Eustachian tube|eustachian tube
580042|NCT00494364|mastoid air cells|mastoid air cells
580043|NCT00494364|Normal healthy volunteers|normal healthy volunteers
580044|NCT00494390|Biometry|biometry
580045|NCT00494390|corneal opacity|corneal opacity
580046|NCT00494390|astigmatism|astigmatism
580047|NCT00494390|refraction|refraction
580048|NCT00494403|sprain proprioception|sprain proprioception
580049|NCT00494429|Preterm Neonates|preterm neonates
580050|NCT00494429|Morphine|morphine
580051|NCT00494429|Critically ill|critically ill
580052|NCT00494442|Advanced ovarian cancer|advanced ovarian cancer
580053|NCT00494442|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
580054|NCT00494442|KU-0059436|ku-0059436
580055|NCT00494442|AZD2281|azd2281
580056|NCT00494442|BRCA1 protein|brca1 protein
580057|NCT00494442|BRCA2 protein|brca2 protein
580058|NCT00494455|critical illness|critical illness
580059|NCT00494455|hyperglycemia|hyperglycemia
580060|NCT00494455|intensive insulin therapy|intensive insulin therapy
580061|NCT00494455|glucose monitoring|glucose monitoring
580062|NCT00494455|shock|shock
580063|NCT00494468|Insomnia|insomnia
580064|NCT00494468|Sleep Disorder|sleep disorder
580065|NCT00494468|Sleep Deprivation|sleep deprivation
580066|NCT00494481|Zactima|zactima
580067|NCT00494494|cystoid macular edema|cystoid macular edema
580068|NCT00494494|cataract|cataract
580069|NCT00494494|nonsteroidal antiinflammatory drugs|nonsteroidal antiinflammatory drugs
580070|NCT00494494|optical coherence tomography|optical coherence tomography
580071|NCT00494507|periodic paralysis|periodic paralysis
580072|NCT00494507|dichlorphenamide|dichlorphenamide
580074|NCT00494520|Aphasia|aphasia
580075|NCT00494520|Traumatic Brain Injury|traumatic brain injury
580076|NCT00494520|Cerebrovascular Accident|cerebrovascular accident
580077|NCT00502307|Renal Cell Carcinoma|renal cell carcinoma
580078|NCT00502307|AV-951|av-951
580079|NCT00502307|tivozanib|tivozanib
580080|NCT00502320|Seasonal Affective Disorder|seasonal affective disorder
580081|NCT00502320|Ramelteon|ramelteon
580082|NCT00502320|Psychiatry|psychiatry
580083|NCT00502320|Randomized Controlled Trial|randomized controlled trial
580084|NCT00502320|Hamilton Depression Rating Scale- SAD Version|hamilton depression rating scale- sad version
580085|NCT00502320|Circadian Rhythm|circadian rhythm
580086|NCT00502333|back pain|back pain
580087|NCT00502333|neck pain|neck pain
580088|NCT00502333|prognosis|prognosis
580089|NCT00502333|catastrophizing|catastrophizing
580090|NCT00502333|coping strategies|coping strategies
580091|NCT00502333|disability|disability
580092|NCT00502333|Prognosis for back and neck pain|prognosis for back and neck pain
580093|NCT00502346|Pharmacodynamics|pharmacodynamics
580094|NCT00502359|Gestational diabetes, screening, glucose monitoring|gestational diabetes, screening, glucose monitoring
580095|NCT00502385|Phase I|phase i
580097|NCT00502385|de novo or secondary AML|de novo or secondary aml
580098|NCT00502385|AZD2171|azd2171
580099|NCT00502411|Soft Tissue Sarcoma|soft tissue sarcoma
580100|NCT00502411|External Beam Radiotherapy|external beam radiotherapy
580101|NCT00502411|Radiation Therapy|radiation therapy
580102|NCT00502411|Extremity and Trunk|extremity and trunk
580103|NCT00502411|EBRT|ebrt
580104|NCT00502411|Sarcoma|sarcoma
580105|NCT00502411|Doxorubicin|doxorubicin
580106|NCT00502411|AD|ad
580107|NCT00502411|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
580108|NCT00502411|XRT|xrt
580109|NCT00502411|RT|rt
580110|NCT00502411|Radiotherapy|radiotherapy
580111|NCT00502424|Rheumatoid Arthritis|rheumatoid arthritis
580112|NCT00502424|Hand|hand
580113|NCT00502424|Splint|splint
580114|NCT00502424|Occupational Therapy|occupational therapy
580115|NCT00502450|Acute mastoiditis|acute mastoiditis
580116|NCT00502450|Hearing loss|hearing loss
580117|NCT00502450|Mastoidectomy|mastoidectomy
580118|NCT00502450|Audiogram|audiogram
580119|NCT00502463|head and neck cancer, stage III/IV|head and neck cancer, stage iii/iv
580120|NCT00502463|no prior radiotherapy of head and neck region|no prior radiotherapy of head and neck region
580121|NCT00502476|MRSA|mrsa
580122|NCT00502476|VRE|vre
580123|NCT00502476|BSI|bsi
580124|NCT00502489|prolonged mechanical ventilation; weaning;rehabilitation|prolonged mechanical ventilation; weaning;rehabilitation
580125|NCT00502502|Anal Cancer|anal cancer
580126|NCT00502502|Colorectal Cancer|colorectal cancer
580127|NCT00502502|Esophageal Cancer|esophageal cancer
580128|NCT00502502|Gastric Cancer|gastric cancer
580129|NCT00502502|Lung Cancer|lung cancer
580130|NCT00502502|Questionnaire|questionnaire
580131|NCT00502502|Survey|survey
580132|NCT00502502|Chemoradiation Therapy|chemoradiation therapy
580133|NCT00502502|Symptoms|symptoms
580134|NCT00502502|Cytokines|cytokines
580135|NCT00502515|Diabetes|diabetes
580136|NCT00502515|Neuropathy|neuropathy
580137|NCT00502528|Infarction|infarction
580138|NCT00502528|Endothelin|endothelin
580139|NCT00502528|Perfusion|perfusion
580140|NCT00502554|lung function|lung function
580142|NCT00502567|advanced solid tumors|advanced solid tumors
580143|NCT00502567|AZD2171|azd2171
580144|NCT00502567|Phase I|phase i
580145|NCT00502580|Oral Cancer|oral cancer
580146|NCT00502580|Multispectral Digital Microscope|multispectral digital microscope
580147|NCT00502580|Multispectral Digital Imaging|multispectral digital imaging
580148|NCT00502580|Interview|interview
580149|NCT00502580|MDM|mdm
580150|NCT00502593|Influenza|influenza
753196|NCT01175824|Diabetes Mellitus|diabetes mellitus
580151|NCT00502593|Pandemic Influenza Vaccine (GSK1562902A)|pandemic influenza vaccine (gsk1562902a)
580152|NCT00502606|provisional restoration|provisional restoration
580153|NCT00502606|antibacterial nanoparticles|antibacterial nanoparticles
580154|NCT00502606|cement|cement
580155|NCT00502606|biofilm|biofilm
580156|NCT00502606|bacteria|bacteria
580157|NCT00502606|flora|flora
580158|NCT00502606|plaque|plaque
580159|NCT00502606|dental|dental
580160|NCT00502606|prosthesis|prosthesis
580161|NCT00502619|Low back pain|low back pain
580162|NCT00502619|acupuncture|acupuncture
580163|NCT00502619|treadmill exercise|treadmill exercise
580164|NCT00502632|Pleural empyema|pleural empyema
580165|NCT00502632|Pleural effusion|pleural effusion
580166|NCT00502632|Dornase alfa|dornase alfa
580167|NCT00502632|Urokinase|urokinase
580168|NCT00502632|Children|children
580169|NCT00503399|Glucocorticoid Induced|glucocorticoid induced
580170|NCT00503412|phase I|phase i
580171|NCT00503412|AZD2171|azd2171
580172|NCT00503412|solid tumor|solid tumor
580173|NCT00503412|metastatic tumor|metastatic tumor
580174|NCT00503438|Arthritis|arthritis
580175|NCT00503438|Osteoarthritis|osteoarthritis
580176|NCT00503438|Arthroplasty|arthroplasty
580177|NCT00503451|Advanced cancer|advanced cancer
580178|NCT00503451|solid tumors|solid tumors
580179|NCT00503451|lymphoma|lymphoma
580180|NCT00503451|HDAC|hdac
580181|NCT00503451|LBH589|lbh589
580182|NCT00503451|adults|adults
580183|NCT00503451|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
580184|NCT00503464|guideline|guideline
580185|NCT00503464|adherence|adherence
580186|NCT00503477|Japan|japan
580187|NCT00503477|Phase I|phase i
580188|NCT00503477|solid tumor|solid tumor
580189|NCT00503477|AZD2171|azd2171
580190|NCT00503516|weight loss, appetite, dementia, megestrol acetate|weight loss, appetite, dementia, megestrol acetate
580191|NCT00503542|Vaginitis|vaginitis
580192|NCT00503542|Bacterial Vaginosis|bacterial vaginosis
580193|NCT00503542|Vaginal trichomoniasis|vaginal trichomoniasis
580194|NCT00503542|Vulvovaginal candidiasis|vulvovaginal candidiasis
580195|NCT00503555|Primary Health Care|primary health care
580196|NCT00503555|Hispanic Americans|hispanic americans
580197|NCT00503568|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
580198|NCT00503568|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
580199|NCT00503568|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
580200|NCT00503594|Primary central nervous system lymphoma|primary central nervous system lymphoma
580201|NCT00503594|Brain lymphoma|brain lymphoma
580202|NCT00503594|Elderly|elderly
580203|NCT00503594|Chemotherapy|chemotherapy
580204|NCT00503594|Methotrexate|methotrexate
580205|NCT00503594|Temozolomide|temozolomide
580206|NCT00503594|Procarbazine|procarbazine
580207|NCT00503594|Vincristine|vincristine
580208|NCT00503594|Cytarabine|cytarabine
580209|NCT00503607|colonoscopy|colonoscopy
580210|NCT00503607|bowel preparation|bowel preparation
580211|NCT00503607|prep|prep
580212|NCT00503620|Cerebral Palsy|cerebral palsy
580213|NCT00503620|Botulinum Toxin|botulinum toxin
580214|NCT00503620|Neuromuscular Function|neuromuscular function
580215|NCT00503633|sleep disorders|sleep disorders
580216|NCT00503633|genetics|genetics
580217|NCT00503646|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
580218|NCT00503646|sexual dysfunction and infertility|sexual dysfunction and infertility
580219|NCT00503646|sexuality and reproductive issues|sexuality and reproductive issues
580220|NCT00503646|stage IIB prostate cancer|stage iib prostate cancer
580221|NCT00503646|stage IIA prostate cancer|stage iia prostate cancer
580222|NCT00503646|stage I prostate cancer|stage i prostate cancer
580223|NCT00503659|PC20 FEV1|pc20 fev1
580224|NCT00503659|PD20FEV1|pd20fev1
580225|NCT00503659|bronchial hyperreactivity|bronchial hyperreactivity
580226|NCT00503659|bronchial asthma|bronchial asthma
580227|NCT00503672|Motor Activity|motor activity
580228|NCT00503672|Pregnancy|pregnancy
580229|NCT00503672|Accelerometer|accelerometer
580230|NCT00503685|Metastatic Colorectal Cancer with Disease Progression|metastatic colorectal cancer with disease progression
580231|NCT00503685|Failed prior to Anti-EGFr Therapy|failed prior to anti-egfr therapy
580232|NCT00503711|ZD6474 PK|zd6474 pk
580233|NCT00503724|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
580234|NCT00503724|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
580235|NCT00503724|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
580236|NCT00503724|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
580237|NCT00503724|childhood choroid plexus tumor|childhood choroid plexus tumor
580238|NCT00503724|childhood craniopharyngioma|childhood craniopharyngioma
580239|NCT00503724|childhood infratentorial ependymoma|childhood infratentorial ependymoma
580240|NCT00503724|childhood supratentorial ependymoma|childhood supratentorial ependymoma
580241|NCT00503724|recurrent childhood ependymoma|recurrent childhood ependymoma
580242|NCT00503724|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
580243|NCT00503724|childhood oligodendroglioma|childhood oligodendroglioma
751887|NCT01171079|postoperative adhesion after thyroidectomy|postoperative adhesion after thyroidectomy
580244|NCT00503724|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
580245|NCT00503724|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
580246|NCT00503724|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
580247|NCT00503724|childhood grade I meningioma|childhood grade i meningioma
580248|NCT00503724|childhood grade II meningioma|childhood grade ii meningioma
580249|NCT00503724|childhood grade III meningioma|childhood grade iii meningioma
580250|NCT00503724|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
580251|NCT00503724|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
580252|NCT00503724|recurrent childhood brain tumor|recurrent childhood brain tumor
580253|NCT00503724|disseminated neuroblastoma|disseminated neuroblastoma
580254|NCT00503724|recurrent neuroblastoma|recurrent neuroblastoma
580255|NCT00503737|colorectal cancer screening|colorectal cancer screening
580256|NCT00503737|National Colorectal Cancer Roundtable Toolbox|national colorectal cancer roundtable toolbox
580257|NCT00503750|Breast Cancer|breast cancer
580258|NCT00503763|Smoldering multiple myeloma|smoldering multiple myeloma
580259|NCT00503763|Simvastatin|simvastatin
580260|NCT00503763|Paraprotein|paraprotein
580261|NCT00503776|xerostomia|xerostomia
580262|NCT00503776|mucositis|mucositis
580263|NCT00503776|dysphagia|dysphagia
580264|NCT00503776|radiation toxicity|radiation toxicity
580265|NCT00503776|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
580266|NCT00503776|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
580267|NCT00503776|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
580268|NCT00503776|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
580269|NCT00503776|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
580270|NCT00503776|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
580271|NCT00503776|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
580272|NCT00503776|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
580273|NCT00503776|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
580274|NCT00503776|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
580275|NCT00503776|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
580276|NCT00503776|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
580277|NCT00503776|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
580278|NCT00503776|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
580279|NCT00503776|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
580280|NCT00503776|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
580281|NCT00503776|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
580282|NCT00503776|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
580283|NCT00503776|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
580284|NCT00503776|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
580285|NCT00503776|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
580286|NCT00503776|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
580287|NCT00503776|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
580288|NCT00503776|stage III salivary gland cancer|stage iii salivary gland cancer
580289|NCT00503776|stage IV salivary gland cancer|stage iv salivary gland cancer
580290|NCT00503776|recurrent salivary gland cancer|recurrent salivary gland cancer
580291|NCT00503789|Healthy infants|healthy infants
580292|NCT00503802|Sleep Apnea|sleep apnea
580293|NCT00503802|Sleep disordered breathing|sleep disordered breathing
580294|NCT00503802|Nasal Obstruction|nasal obstruction
580295|NCT00503802|Turbinate|turbinate
580296|NCT00503802|Radiofrequency|radiofrequency
580297|NCT00503802|Continuous positive airway pressure|continuous positive airway pressure
580298|NCT00503802|CPAP|cpap
580299|NCT00503802|Sleep surgery|sleep surgery
580300|NCT00503815|colonoscopy|colonoscopy
580301|NCT00503815|bowel preparation|bowel preparation
580302|NCT00503815|prep|prep
580303|NCT00503828|Derris Scandens Benth extract|derris scandens benth extract
580304|NCT00503828|Osteoarthritis|osteoarthritis
580305|NCT00503828|WOMAC|womac
580306|NCT00503828|6-minute walk|6-minute walk
580307|NCT00503841|stage I breast cancer|stage i breast cancer
580308|NCT00503841|recurrent breast cancer|recurrent breast cancer
580309|NCT00503841|stage II breast cancer|stage ii breast cancer
580310|NCT00503841|stage IIIA breast cancer|stage iiia breast cancer
581938|NCT00506129|Lymphoma|lymphoma
580311|NCT00503841|stage IIIB breast cancer|stage iiib breast cancer
580312|NCT00503841|stage IIIC breast cancer|stage iiic breast cancer
580313|NCT00503854|Solid Tumors|solid tumors
580314|NCT00503854|Febrile Neutropenia|febrile neutropenia
580315|NCT00503854|Fatigue|fatigue
580316|NCT00503854|Symptom Burden|symptom burden
580317|NCT00503854|Questionnaire|questionnaire
580318|NCT00503854|Survey|survey
580319|NCT00503867|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
580320|NCT00503867|HCC|hcc
580321|NCT00503867|SIR-Spheres|sir-spheres
580322|NCT00503867|Y-90 Microspheres|y-90 microspheres
580323|NCT00503867|brachytherapy|brachytherapy
580324|NCT00503867|SIRT|sirt
580325|NCT00503867|liver cancer|liver cancer
580326|NCT00503880|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
580327|NCT00503880|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
580328|NCT00503880|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
580329|NCT00503893|Wilms' Tumor|wilms' tumor
580330|NCT00503893|Genitourinary Anomalies|genitourinary anomalies
580331|NCT00503893|Beckwith-Wiedemann Hemihypertrophy|beckwith-wiedemann hemihypertrophy
580332|NCT00503893|Aniridia|aniridia
580333|NCT00503893|Questionnaire|questionnaire
580334|NCT00503906|stage IV breast cancer|stage iv breast cancer
580335|NCT00503906|recurrent breast cancer|recurrent breast cancer
580336|NCT00503919|Cervix|cervix
580337|NCT00503919|Cervical dysplasia|cervical dysplasia
580338|NCT00503919|Cervical neoplasia|cervical neoplasia
580339|NCT00503919|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
580340|NCT00503919|Multi-spectral Digital Colposcopy|multi-spectral digital colposcopy
580341|NCT00503919|MDC|mdc
749579|NCT01161381|DFA|dfa
580342|NCT00503919|Acetic acid|acetic acid
580343|NCT00503919|Colposcopy|colposcopy
580344|NCT00503919|Spectroscopy|spectroscopy
580345|NCT00503919|Fluorescence Spectroscopy|fluorescence spectroscopy
580346|NCT00503919|Abnormal Pap Smear|abnormal pap smear
580347|NCT00503932|Rectal Cancer|rectal cancer
580348|NCT00503932|Capecitabine|capecitabine
580349|NCT00503932|Proton Therapy|proton therapy
580350|NCT00503932|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
580351|NCT00503932|Gastrointestinal|gastrointestinal
580352|NCT00503932|Proton Radiotherapy|proton radiotherapy
580353|NCT00503945|sleep apnea|sleep apnea
580354|NCT00503945|continuous positive airway pressure|continuous positive airway pressure
580355|NCT00503945|echocardiography|echocardiography
580356|NCT00503945|Natriuretic peptide|natriuretic peptide
580357|NCT00503958|non-small cell lung cancer|non-small cell lung cancer
580358|NCT00503958|small cell lung cancer|small cell lung cancer
580359|NCT00503958|health status unknown|health status unknown
580360|NCT00503971|Vorinostat|vorinostat
580361|NCT00503971|NSCLC|nsclc
580362|NCT00503971|EGFR|egfr
580363|NCT00503971|Erlotinib|erlotinib
580364|NCT00503984|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
580365|NCT00503984|Recurrent prostate cancer|recurrent prostate cancer
580366|NCT00503984|Stage IV prostate cancer|stage iv prostate cancer
580367|NCT00503984|Pain|pain
580368|NCT00503997|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
580369|NCT00503997|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
580370|NCT00503997|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
580371|NCT00503997|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
580372|NCT00503997|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
580373|NCT00503997|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
580374|NCT00503997|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
580375|NCT00503997|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
580376|NCT00503997|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
580377|NCT00503997|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
580378|NCT00503997|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
580379|NCT00504010|arnica|arnica
580380|NCT00504010|muscle soreness|muscle soreness
580381|NCT00504010|exercise|exercise
580382|NCT00504010|eccentric|eccentric
580383|NCT00504023|Paget disease of the vulva|paget disease of the vulva
580384|NCT00504023|recurrent vulvar cancer|recurrent vulvar cancer
580385|NCT00504023|stage 0 vulvar cancer|stage 0 vulvar cancer
580386|NCT00504023|stage I vulvar cancer|stage i vulvar cancer
580387|NCT00504023|stage II vulvar cancer|stage ii vulvar cancer
580388|NCT00504023|stage III vulvar cancer|stage iii vulvar cancer
580389|NCT00504023|imiquimod|imiquimod
580390|NCT00504023|07-029|07-029
580391|NCT00504036|Obesity|obesity
580392|NCT00504036|Morbid obesity|morbid obesity
580393|NCT00504036|Gastric balloon|gastric balloon
580394|NCT00504036|Gastric by-pass|gastric by-pass
580395|NCT00504036|Morbid obesity with BMI > 45 kg/m²|morbid obesity with bmi > 45 kg/m²
580396|NCT00504049|Cerebral Palsy|cerebral palsy
580397|NCT00504049|Electromyography|electromyography
580398|NCT00504049|Wavelet Analysis|wavelet analysis
580399|NCT00504062|asthma|asthma
580400|NCT00504062|bronchial|bronchial
580401|NCT00504075|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
580402|NCT00504075|Bleeding disorders|bleeding disorders
580403|NCT00504075|Immune System and Disorders|immune system and disorders
580404|NCT00504088|CLI|cli
580405|NCT00504088|Critical Limb Ischemia|critical limb ischemia
580406|NCT00504088|PAD|pad
580407|NCT00504088|Peripheral Arterial Disease|peripheral arterial disease
580408|NCT00504088|Artherosclerosis|artherosclerosis
580409|NCT00504088|Leg Pain|leg pain
580410|NCT00504088|Cardiovascular|cardiovascular
580411|NCT00504088|Artherectomy|artherectomy
580412|NCT00504088|Bypass|bypass
580413|NCT00504088|Peripheral Bypass|peripheral bypass
580414|NCT00504088|PROOF|proof
580415|NCT00504101|stage I multiple myeloma|stage i multiple myeloma
580416|NCT00504101|stage II multiple myeloma|stage ii multiple myeloma
580417|NCT00504101|stage III multiple myeloma|stage iii multiple myeloma
580418|NCT00504114|Osteoarthritis, knee|osteoarthritis, knee
580419|NCT00504114|anterior cruciate ligament|anterior cruciate ligament
580420|NCT00504114|Magnetic Resonance Imaging|magnetic resonance imaging
580421|NCT00504127|Arthritis|arthritis
580422|NCT00504127|Degenerative|degenerative
580423|NCT00504140|Osteosarcoma|osteosarcoma
580424|NCT00504140|Interferon Alpha|interferon alpha
580425|NCT00504140|IFN-|ifn-
580426|NCT00504140|Roferon|roferon
579852|NCT00493714|Delirium|delirium
579853|NCT00493714|Restlessness|restlessness
579854|NCT00493714|Confusion|confusion
579855|NCT00493714|Caregivers|caregivers
580427|NCT00504140|Recombinant Interferon Alpha|recombinant interferon alpha
580428|NCT00504140|Etoposide|etoposide
580429|NCT00504140|VP-16|vp-16
580430|NCT00504179|coronary artery bypass graft|coronary artery bypass graft
580431|NCT00504179|osteopathic manipulative treatment|osteopathic manipulative treatment
580432|NCT00504179|cardiovascular disease|cardiovascular disease
580433|NCT00504205|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
580434|NCT00504205|anaplastic large cell lymphoma|anaplastic large cell lymphoma
580435|NCT00504205|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
580436|NCT00504205|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
580437|NCT00504205|intraocular lymphoma|intraocular lymphoma
580438|NCT00504205|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
580439|NCT00504205|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
580440|NCT00504205|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
580441|NCT00504205|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
580442|NCT00504205|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
580443|NCT00504205|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
580444|NCT00504205|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
580445|NCT00504205|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
580446|NCT00504205|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
580447|NCT00504205|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
580448|NCT00504205|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
580449|NCT00504205|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
580450|NCT00504205|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
580451|NCT00504205|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
580452|NCT00504205|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
580453|NCT00504205|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
580454|NCT00504205|splenic marginal zone lymphoma|splenic marginal zone lymphoma
580455|NCT00504205|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
580456|NCT00504205|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
580457|NCT00504205|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
580458|NCT00504205|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
580459|NCT00504205|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
580460|NCT00504205|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
580461|NCT00504205|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
580462|NCT00504205|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
580463|NCT00504205|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
580464|NCT00504205|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
580465|NCT00504205|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
580466|NCT00504205|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
580467|NCT00504205|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
580468|NCT00504205|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
580469|NCT00504205|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
580470|NCT00504205|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
580471|NCT00504205|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
580472|NCT00504205|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
580473|NCT00504205|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
582043|NCT00506857|Myleran|myleran
580474|NCT00504205|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
580475|NCT00504205|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
580476|NCT00504205|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
742270|NCT01125696|HIV|hiv
751888|NCT01171092|stem cell|stem cell
580477|NCT00504205|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
580478|NCT00504205|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
580479|NCT00504205|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
580480|NCT00504205|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
580481|NCT00504205|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
580482|NCT00504205|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
580483|NCT00504205|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
580484|NCT00504205|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
579957|NCT00494143|Kinematics|kinematics
579958|NCT00494143|Kinetics|kinetics
579959|NCT00494143|Prosthesis|prosthesis
579967|NCT00494182|Head and Neck Cancer|head and neck cancer
579968|NCT00494182|Squamous Cell Carcinoma|squamous cell carcinoma
579969|NCT00494182|Sorafenib|sorafenib
579970|NCT00494182|BAY 43-9006|bay 43-9006
579971|NCT00494182|Carboplatin|carboplatin
579985|NCT00494195|AAV|aav
580485|NCT00504205|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
580885|NCT00505492|Taxol|taxol
580486|NCT00504205|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
580487|NCT00504205|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
580488|NCT00504205|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
580489|NCT00504218|Growth Factor|growth factor
580490|NCT00504218|Hypothalamic-Pituitary Dysfunction|hypothalamic-pituitary dysfunction
580491|NCT00504218|Primary Disorders of the Thyroid|primary disorders of the thyroid
580492|NCT00504218|Decreased Bone Mineral Density|decreased bone mineral density
580493|NCT00504218|Endocrine Side Effects Related to Cancer Therapy|endocrine side effects related to cancer therapy
580494|NCT00504218|Primary Gonadal Dysfunction|primary gonadal dysfunction
580495|NCT00504218|Obesity|obesity
580496|NCT00504218|Impaired Glucose Tolerance|impaired glucose tolerance
580497|NCT00504218|Thyroid Disorder|thyroid disorder
580498|NCT00504218|Cancer Therapy Endocrine Side Effects|cancer therapy endocrine side effects
580499|NCT00504218|Pituitary Dysfunction|pituitary dysfunction
580500|NCT00504218|Childhood Cancer Survivors|childhood cancer survivors
580501|NCT00504231|influenza|influenza
580502|NCT00504231|prevention|prevention
580503|NCT00504231|intradermal|intradermal
580504|NCT00504231|vaccine|vaccine
580505|NCT00504231|delivery|delivery
580506|NCT00504231|elderly|elderly
580508|NCT00504244|SLEDAI|sledai
580509|NCT00504244|Azathioprine|azathioprine
580510|NCT00504244|Myfortic|myfortic
580511|NCT00504257|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
580512|NCT00504257|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
580513|NCT00504257|recurrent fallopian tube cancer|recurrent fallopian tube cancer
580514|NCT00504283|Renal colic, pain, protocol, emergency department|renal colic, pain, protocol, emergency department
580515|NCT00504296|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
580516|NCT00504309|triglycerides|triglycerides
580517|NCT00504309|hypertriglyceridemia|hypertriglyceridemia
580518|NCT00504309|omega-3|omega-3
580519|NCT00504309|n-3|n-3
580520|NCT00504309|eicosapentaenoic acid|eicosapentaenoic acid
580521|NCT00504309|EPA|epa
580522|NCT00504309|docosahexaenoic acid|docosahexaenoic acid
580523|NCT00504309|DHA|dha
580524|NCT00504309|flow mediated dilation|flow mediated dilation
580525|NCT00504309|fish|fish
580526|NCT00504309|Moderate hypertriglyceridemia|moderate hypertriglyceridemia
580527|NCT00504322|Esophageal Neoplasms|esophageal neoplasms
580528|NCT00504335|Acute Radiation Syndrome|acute radiation syndrome
580529|NCT00504335|Hematopoietic Syndrome|hematopoietic syndrome
580530|NCT00504335|Radiation Injury|radiation injury
580531|NCT00504335|BIO 300|bio 300
580532|NCT00504348|Interstitial pneumonitis|interstitial pneumonitis
580533|NCT00504348|Polymyositis|polymyositis
580534|NCT00504348|Dermatomyositis|dermatomyositis
580535|NCT00504348|Tacrolimus|tacrolimus
580536|NCT00504348|Corticosteroids|corticosteroids
580537|NCT00504348|Interstitial pneumonitis associated with polymyositis or dermatomyositis|interstitial pneumonitis associated with polymyositis or dermatomyositis
580538|NCT00504361|Asthma|asthma
580539|NCT00504361|COPD|copd
580540|NCT00504361|Interstitial Lung Disease|interstitial lung disease
580541|NCT00504361|Cystic Fibrosis|cystic fibrosis
580542|NCT00504361|Lung Cancer|lung cancer
580543|NCT00504361|smokers|smokers
580544|NCT00504361|non-smokers|non-smokers
580545|NCT00504374|Lung Cancer|lung cancer
580546|NCT00504374|Epidemiology|epidemiology
580547|NCT00504374|Symptoms|symptoms
580548|NCT00504374|Gene Polymorphisms|gene polymorphisms
580549|NCT00504374|Questionnaire|questionnaire
580550|NCT00504374|Survey|survey
580551|NCT00504387|Burning mouth disorder|burning mouth disorder
580552|NCT00504387|Taste disorder|taste disorder
580553|NCT00504387|Quantitative sensory testing|quantitative sensory testing
580554|NCT00504387|Gustatory testing|gustatory testing
580555|NCT00504387|Neuropathic orofacial pain|neuropathic orofacial pain
580556|NCT00504387|Oral burning|oral burning
580557|NCT00504400|macular telangiectasia|macular telangiectasia
580558|NCT00504400|parafoveal telangiectasis|parafoveal telangiectasis
580559|NCT00504400|nonproliferative|nonproliferative
580560|NCT00504400|therapy|therapy
580561|NCT00504400|intravitreal injection|intravitreal injection
580096|NCT00502385|AML|aml
580564|NCT00504413|Metabolic Networks and Pathways|metabolic networks and pathways
580565|NCT00504413|Methadone|methadone
580566|NCT00504413|Polymorphism, genetic|polymorphism, genetic
580567|NCT00504413|Cytochrome P-450 Enzyme System|cytochrome p-450 enzyme system
580568|NCT00504439|COPD,|copd,
580569|NCT00504439|CD11b,|cd11b,
580570|NCT00504439|CXCR2,|cxcr2,
580571|NCT00504439|safety,|safety,
580572|NCT00504439|repeat dose,|repeat dose,
580573|NCT00504439|tolerability.|tolerability.
580574|NCT00504439|SB-656933,|sb-656933,
580575|NCT00504452|HIV|hiv
580576|NCT00504452|viral|viral
580577|NCT00504452|Viral decay acceleration|viral decay acceleration
580578|NCT00504452|ART|art
580579|NCT00504452|HAART|haart
580580|NCT00504452|Treatment Experienced|treatment experienced
580581|NCT00504465|Labor|labor
580582|NCT00504465|Labor induction|labor induction
580583|NCT00504465|Cervical ripening|cervical ripening
580584|NCT00504465|Dinoprostone|dinoprostone
580585|NCT00504465|Fetal safety|fetal safety
580586|NCT00504465|Oxytocin|oxytocin
580587|NCT00504465|Cesarean delivery|cesarean delivery
580588|NCT00504478|Inflammation|inflammation
580589|NCT00504478|carbohydrates|carbohydrates
580590|NCT00504478|omega-3|omega-3
580591|NCT00504478|overweight|overweight
580592|NCT00504478|diet|diet
580593|NCT00504491|Rituximab-CHOP|rituximab-chop
580594|NCT00504491|Alemtuzumab|alemtuzumab
580595|NCT00504491|Chronic lymphocytic leukaemia|chronic lymphocytic leukaemia
580596|NCT00504504|Hodgkin's Disease|hodgkin's disease
580597|NCT00504504|Lymphoma|lymphoma
580598|NCT00504504|Rituximab|rituximab
580599|NCT00504504|Rituxan|rituxan
580600|NCT00504504|Adriamycin|adriamycin
580601|NCT00504504|Doxorubicin|doxorubicin
580602|NCT00504504|Rubex|rubex
580603|NCT00504504|Bleomycin|bleomycin
580604|NCT00504504|Bleomycin sulfate|bleomycin sulfate
580605|NCT00504504|Blenoxane|blenoxane
580606|NCT00504504|BLM|blm
580607|NCT00504504|Dacarbazine|dacarbazine
580608|NCT00504504|DTIC|dtic
580609|NCT00504504|DTIC-Dome|dtic-dome
580610|NCT00504504|Vincristine|vincristine
580611|NCT00504504|Vinblastine|vinblastine
580612|NCT00504504|Vinblastine Sulfate|vinblastine sulfate
580613|NCT00504504|ABVD|abvd
580614|NCT00504504|ABVD Chemotherapy Treatment|abvd chemotherapy treatment
580615|NCT00504517|Outpatient continuity training|outpatient continuity training
580616|NCT00504517|Relevant, Patient-centered curriculum|relevant, patient-centered curriculum
580617|NCT00504517|Evaluation|evaluation
580618|NCT00504517|New graduation requirements|new graduation requirements
580619|NCT00504543|Kidney transplant, AEB071|kidney transplant, aeb071
580620|NCT00504556|Anti-coagulant|anti-coagulant
580621|NCT00504556|Non-valvular|non-valvular
580622|NCT00504556|Venous Thromboembolism|venous thromboembolism
580623|NCT00504556|Prevention of Blood Clots|prevention of blood clots
580624|NCT00504556|Atrial Fibrillation|atrial fibrillation
580625|NCT00504556|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
580626|NCT00504582|Axillary Node Dissection|axillary node dissection
580627|NCT00504582|Fibrin Sealant|fibrin sealant
580628|NCT00504582|Tisseel|tisseel
580629|NCT00504582|Melanoma|melanoma
580630|NCT00504582|Seroma|seroma
580631|NCT00504595|Rheumatoid Arthritis|rheumatoid arthritis
580632|NCT00504621|personality|personality
580633|NCT00504621|fatigue|fatigue
580634|NCT00504621|quality of life|quality of life
580635|NCT00504621|health care consumption|health care consumption
580636|NCT00504634|Multiple Myeloma|multiple myeloma
580637|NCT00504634|Post Allogeneic Transplantation|post allogeneic transplantation
580638|NCT00504634|Bortezomib|bortezomib
580639|NCT00504634|Velcade|velcade
580640|NCT00504634|PS-341|ps-341
580641|NCT00504647|Hypertrophic|hypertrophic
580642|NCT00504647|Cardiomyopathy|cardiomyopathy
580643|NCT00504647|Diastolic|diastolic
580644|NCT00504647|Ventricular|ventricular
580645|NCT00504647|Interaction|interaction
580646|NCT00504647|Biventricular|biventricular
580647|NCT00504647|Pacemaker|pacemaker
580648|NCT00504660|Anaplastic Glioma|anaplastic glioma
580649|NCT00504660|Glioblastoma Multiforme|glioblastoma multiforme
580650|NCT00504660|Brain Cancer|brain cancer
580651|NCT00504660|6-Thioguanine|6-thioguanine
580652|NCT00504660|Capecitabine|capecitabine
580653|NCT00504660|Celecoxib|celecoxib
580654|NCT00504660|Temozolomide|temozolomide
580655|NCT00504660|Xeloda|xeloda
580656|NCT00504660|Temodar|temodar
580657|NCT00504660|TMZ|tmz
580658|NCT00504660|CCNU|ccnu
580659|NCT00504660|6-TG|6-tg
580660|NCT00504699|breast cancer|breast cancer
580661|NCT00504699|ovarian stimulation|ovarian stimulation
580662|NCT00504699|aromatase inhibitors|aromatase inhibitors
580663|NCT00504699|letrozole|letrozole
580664|NCT00504699|fertility preservation|fertility preservation
580665|NCT00504699|recurrence|recurrence
580666|NCT00504712|Testosterone|testosterone
580667|NCT00504712|Hypogonadism|hypogonadism
580668|NCT00504712|Diabetes|diabetes
580669|NCT00504712|PVD|pvd
580670|NCT00504712|RCT|rct
580671|NCT00504725|Lobectomy|lobectomy
580672|NCT00504725|VATS|vats
580673|NCT00504738|lung disease|lung disease
742271|NCT01125696|Hepatitis B|hepatitis b
580674|NCT00504738|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
580675|NCT00504738|asthma|asthma
580676|NCT00504738|smokers|smokers
580677|NCT00504738|non-smokers|non-smokers
580678|NCT00504751|diffuse large b cell|diffuse large b cell
580679|NCT00504764|Relapsed Acute Promyelocytic Leukemia|relapsed acute promyelocytic leukemia
580680|NCT00504764|Arsenic Trioxide|arsenic trioxide
580681|NCT00504790|GSK923295,|gsk923295,
580682|NCT00504790|First Time in Human,|first time in human,
580683|NCT00504790|pharmacodynamics|pharmacodynamics
580684|NCT00504790|cancer,|cancer,
580685|NCT00504790|maximally tolerated dose, pharmacokinetics,|maximally tolerated dose, pharmacokinetics,
580686|NCT00504790|Refractory Cancer|refractory cancer
580687|NCT00504790|CENPE,|cenpe,
580688|NCT00504790|Phase I,|phase i,
581950|NCT00506155|Avastin|avastin
580689|NCT00504803|HCT, nonmyeloablative, mesenchymal stem cells, GVHD|hct, nonmyeloablative, mesenchymal stem cells, gvhd
580690|NCT00504816|healthy female,|healthy female,
580691|NCT00504816|pharmacokinetics,|pharmacokinetics,
580692|NCT00504816|pharmacodynamics|pharmacodynamics
580693|NCT00504816|drug interaction,|drug interaction,
580694|NCT00504829|LCP-AtorFen|lcp-atorfen
580695|NCT00504829|Non-HDL cholesterol|non-hdl cholesterol
580696|NCT00504829|Triglycerides|triglycerides
580697|NCT00504829|HDL cholesterol|hdl cholesterol
580698|NCT00504829|LDL cholesterol|ldl cholesterol
580699|NCT00504829|Atorvastatin|atorvastatin
580700|NCT00504829|Fenofibrate|fenofibrate
580701|NCT00504842|Acute Ischemic Stroke|acute ischemic stroke
580702|NCT00504842|Microbubbles|microbubbles
580703|NCT00504842|Transcranial Doppler ultrasound|transcranial doppler ultrasound
580704|NCT00504842|TIBI|tibi
580705|NCT00504842|Symptomatic Intracranial Hemorrhage|symptomatic intracranial hemorrhage
580706|NCT00504842|modified Rankin Scale|modified rankin scale
580707|NCT00504842|Recanalization|recanalization
580708|NCT00504842|Perflutren|perflutren
580709|NCT00504855|Pressure ulcer|pressure ulcer
580710|NCT00504855|Waterproof|waterproof
580711|NCT00504855|Gortex|gortex
580712|NCT00504855|Cast padding|cast padding
580713|NCT00504855|Pediatric|pediatric
580714|NCT00504855|Heel|heel
580715|NCT00504881|Epilepsy|epilepsy
580716|NCT00504881|Brivaracetam|brivaracetam
580717|NCT00504881|Partial Onset Seizures|partial onset seizures
580718|NCT00504894|N/A healthy volunteers|n/a healthy volunteers
580720|NCT00504920|Leukemia|leukemia
580721|NCT00504920|Myelodysplastic Syndrome|myelodysplastic syndrome
580722|NCT00504920|Acute Myeloblastic Leukemia|acute myeloblastic leukemia
580723|NCT00504920|Symptom-Related Cytokines|symptom-related cytokines
580724|NCT00504920|Blood or Marrow Transplantation|blood or marrow transplantation
580725|NCT00504920|Questionnaire|questionnaire
580726|NCT00504933|Rhinitis|rhinitis
580727|NCT00504933|Allergic|allergic
580728|NCT00504933|Seasonal|seasonal
580729|NCT00504933|Hay Fever|hay fever
580730|NCT00504933|Pollen Allergy|pollen allergy
580731|NCT00504933|Pollinosis|pollinosis
580732|NCT00504933|Rhinoconjunctivitis|rhinoconjunctivitis
580733|NCT00504946|allergen immunotherapy premedication|allergen immunotherapy premedication
580734|NCT00504959|Age-related macular degeneration (AMD),|age-related macular degeneration (amd),
580735|NCT00504959|choroidal neovascularization (CNV),|choroidal neovascularization (cnv),
580736|NCT00504959|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
580737|NCT00504985|Advanced Cancer|advanced cancer
580738|NCT00504985|Hematologic Malignancy|hematologic malignancy
580739|NCT00504985|Fatigue|fatigue
580740|NCT00504985|Emergency Center|emergency center
580741|NCT00504985|Survey|survey
580742|NCT00504998|Pancreatic cancer|pancreatic cancer
580743|NCT00504998|Rexin-G|rexin-g
580744|NCT00504998|Treatment|treatment
580745|NCT00505011|susceptibility|susceptibility
580746|NCT00505011|genes|genes
580747|NCT00505011|environment|environment
580748|NCT00505011|ophthalmopathy|ophthalmopathy
580749|NCT00505011|outcome|outcome
580750|NCT00505024|Non-Small Cell Lung Cancer|non-small cell lung cancer
580751|NCT00505024|Esophageal Cancer|esophageal cancer
580752|NCT00505024|Lung Cancer|lung cancer
580753|NCT00505024|Interactive Voice Response System|interactive voice response system
580754|NCT00505024|IVRS|ivrs
580755|NCT00505037|ASP1585|asp1585
580756|NCT00505037|Renal Dialysis|renal dialysis
580757|NCT00505037|Chronic Kidney Disease|chronic kidney disease
580758|NCT00505037|Hyperphosphatemia|hyperphosphatemia
580759|NCT00505050|heart failure, disease program management, treatment, education|heart failure, disease program management, treatment, education
580760|NCT00505063|vaccine|vaccine
580761|NCT00505063|childhood|childhood
580762|NCT00505063|cancer|cancer
580763|NCT00505076|Cognition|cognition
580764|NCT00505076|Schizophrenia|schizophrenia
580765|NCT00505089|pharmacokinetic, pharmacodynamic, subcutaneous, intravenous, ACZ885, patients, rheumatoid, arthritis.|pharmacokinetic, pharmacodynamic, subcutaneous, intravenous, acz885, patients, rheumatoid, arthritis.
580766|NCT00505102|Kidney Diseases|kidney diseases
580767|NCT00505102|Heart Transplantation|heart transplantation
580768|NCT00505102|Everolimus|everolimus
580769|NCT00505102|Cyclosporine Toxicity|cyclosporine toxicity
580770|NCT00505128|Biliary pancreatitis|biliary pancreatitis
580771|NCT00505128|Bile duct stones|bile duct stones
580772|NCT00505128|EUS Endoscopic UltraSonography|eus endoscopic ultrasonography
580773|NCT00505128|Endoscopic sphincterotomy|endoscopic sphincterotomy
580774|NCT00505128|ERCP|ercp
580775|NCT00505141|Childhood Brain Cancer|childhood brain cancer
580776|NCT00505141|Childhood Acute Lymphoblastic Leukemia|childhood acute lymphoblastic leukemia
580777|NCT00505154|Heart failure|heart failure
580778|NCT00505154|inflammation|inflammation
580779|NCT00505154|cytokines|cytokines
580780|NCT00505167|Alzheimer's disease|alzheimer's disease
580781|NCT00505167|Memantine|memantine
580782|NCT00505167|Donepezil|donepezil
580783|NCT00505167|Magnetic resonance Spectroscopy|magnetic resonance spectroscopy
580784|NCT00505167|randomized trial|randomized trial
580785|NCT00505180|Hemodialysis|hemodialysis
580786|NCT00505180|Mortality|mortality
580787|NCT00505219|Osteonecrosis|osteonecrosis
580788|NCT00505232|Y-90 Ibritumomab tiuxetan|y-90 ibritumomab tiuxetan
580789|NCT00505232|Rituximab|rituximab
580790|NCT00505232|Hyper-CVAD|hyper-cvad
580791|NCT00505232|Mantle Cell Lymphoma Patients|mantle cell lymphoma patients
580792|NCT00505232|Zevalin(R)|zevalin(r)
580793|NCT00505245|Advanced Cancer|advanced cancer
580794|NCT00505245|Symptom Distress|symptom distress
580795|NCT00505245|MDASI|mdasi
580796|NCT00505245|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
580797|NCT00505245|Quality of Life|quality of life
580798|NCT00505245|Questionnaire|questionnaire
580799|NCT00505245|Interactive voice response telephone system|interactive voice response telephone system
580800|NCT00505245|IVR|ivr
580801|NCT00505258|Bacteremia|bacteremia
580802|NCT00505258|Bloodstream infection|bloodstream infection
580803|NCT00505258|Staphylococcus aureus|staphylococcus aureus
580804|NCT00505258|Staphylococcal Infections|staphylococcal infections
580805|NCT00505258|MRSA|mrsa
580806|NCT00505258|MSSA|mssa
580807|NCT00505271|Breast Cancer|breast cancer
580808|NCT00505271|Rexin-G|rexin-g
580809|NCT00505271|Gene Therapy|gene therapy
580810|NCT00505284|Diabetic neuropathy|diabetic neuropathy
580811|NCT00505297|Osteoarthritis (OA)|osteoarthritis (oa)
580812|NCT00505297|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
580813|NCT00505297|delayed Gadolinium Enhanced MRI of cartilage (dGEMRIC)|delayed gadolinium enhanced mri of cartilage (dgemric)
580814|NCT00505297|disease modifying osteoarthritis drug (DMOAD)|disease modifying osteoarthritis drug (dmoad)
580815|NCT00505297|Potentially rapidly progressing osteoarthritis|potentially rapidly progressing osteoarthritis
580816|NCT00505297|MRI measurement of cartilage|mri measurement of cartilage
580817|NCT00505310|Kidney Cancer|kidney cancer
580818|NCT00505310|Renal Cell Carcinoma|renal cell carcinoma
580819|NCT00505310|Emotional Expression|emotional expression
580820|NCT00505310|Writing|writing
580821|NCT00505310|Questionnaire|questionnaire
580822|NCT00505310|Survey|survey
580823|NCT00505323|Cortex stimulation|cortex stimulation
580824|NCT00505323|Focal secondary Dystonia|focal secondary dystonia
580825|NCT00505323|Effectiveness|effectiveness
580826|NCT00505323|Quality of life improvement|quality of life improvement
580827|NCT00505323|Focal dystonias secondary to central grey nuclei lesions|focal dystonias secondary to central grey nuclei lesions
580828|NCT00505336|Diastolic heart failure|diastolic heart failure
580829|NCT00505336|Markers of collagen turnover|markers of collagen turnover
580830|NCT00505336|Statins|statins
580831|NCT00505336|Aldosterone receptor blockers|aldosterone receptor blockers
580832|NCT00505349|neurotrophic factors|neurotrophic factors
580833|NCT00505349|cognitive status|cognitive status
580834|NCT00505349|young adults|young adults
580835|NCT00505349|mature adults|mature adults
580836|NCT00505349|cognitive training|cognitive training
580837|NCT00505375|CTLA4-Ig|ctla4-ig
580838|NCT00505375|Abatacept|abatacept
580839|NCT00505375|Beta-cell function|beta-cell function
580840|NCT00505375|T-cells|t-cells
580841|NCT00505375|DPT-1|dpt-1
580842|NCT00505375|treatment|treatment
580843|NCT00505375|treatment of type 1 diabetes|treatment of type 1 diabetes
580844|NCT00505375|new onset type 1 diabetes|new onset type 1 diabetes
580845|NCT00505375|juvenile diabetes|juvenile diabetes
580846|NCT00505375|T1D|t1d
580847|NCT00505375|diabetes mellitus|diabetes mellitus
580848|NCT00505375|Type 1 diabetes TrialNet|type 1 diabetes trialnet
580849|NCT00505375|TrialNet|trialnet
580850|NCT00505388|asthma|asthma
580851|NCT00505388|bronchial|bronchial
580852|NCT00505388|Symbicort|symbicort
580853|NCT00505401|HIV|hiv
580854|NCT00505401|Tat protein|tat protein
580855|NCT00505401|HIV Therapeutic Vaccine|hiv therapeutic vaccine
580856|NCT00505414|Chronic Tumor Related Pain|chronic tumor related pain
580857|NCT00505414|Analgesic|analgesic
580858|NCT00505414|Tapentadol Extended Release|tapentadol extended release
580859|NCT00505414|Morphine Sulfate Controlled Release|morphine sulfate controlled release
580860|NCT00505414|Pain assessment|pain assessment
580861|NCT00505414|Placebo|placebo
580862|NCT00505427|PCOS|pcos
580863|NCT00505427|polycystic ovary syndrome|polycystic ovary syndrome
580864|NCT00505427|polycystic ovarian syndrome|polycystic ovarian syndrome
580865|NCT00505427|alpha lipoic acid|alpha lipoic acid
580866|NCT00505427|insulin resistance|insulin resistance
580867|NCT00505427|oxidative stress|oxidative stress
580868|NCT00505453|Influenza|influenza
580869|NCT00505466|Human Genetics|human genetics
580870|NCT00505466|Genetic Counseling|genetic counseling
580871|NCT00505466|Genetic Testing|genetic testing
580872|NCT00505466|p53 Mutation|p53 mutation
580873|NCT00505466|Genetics|genetics
580874|NCT00505479|Congenital Hypothyroidism|congenital hypothyroidism
580875|NCT00505479|pregnancy|pregnancy
580876|NCT00505479|iodine|iodine
580877|NCT00505479|deficiency|deficiency
580878|NCT00505492|Malignant Mixed Mesodermal Tumor|malignant mixed mesodermal tumor
580879|NCT00505492|MMMT|mmmt
580880|NCT00505492|Uterine Neoplasms|uterine neoplasms
580881|NCT00505492|Radiation Therapy|radiation therapy
580882|NCT00505492|Paclitaxel|paclitaxel
580883|NCT00505492|Carboplatin|carboplatin
580884|NCT00505492|Cisplatin|cisplatin
580886|NCT00505505|Neurointensive care|neurointensive care
580887|NCT00505505|Intensive insulin infusion|intensive insulin infusion
580888|NCT00505505|Hypoglycemia|hypoglycemia
580889|NCT00505505|Postoperative Mortality|postoperative mortality
580890|NCT00505505|Postoperative Morbidity|postoperative morbidity
580891|NCT00505505|Neurologic outcome|neurologic outcome
580892|NCT00505518|Major Depressive Disorder|major depressive disorder
580893|NCT00505518|Telepsychiatry|telepsychiatry
580894|NCT00505518|Chinese American|chinese american
580895|NCT00505518|Nursing Home|nursing home
580896|NCT00505531|Pain|pain
580897|NCT00505544|Advanced Cancer|advanced cancer
580898|NCT00505544|Questionnaire|questionnaire
580899|NCT00505544|Survey|survey
580900|NCT00505544|Sleep Disturbance|sleep disturbance
580901|NCT00505544|Sleep Quality|sleep quality
580902|NCT00505557|augmentation mammoplasty|augmentation mammoplasty
580903|NCT00505557|Dual plane|dual plane
580904|NCT00505557|Endoscope|endoscope
580905|NCT00505557|Transaxillary incision|transaxillary incision
580906|NCT00505570|Migraine|migraine
580907|NCT00505570|Migraine with aura|migraine with aura
580908|NCT00505570|Patent foramen ovale|patent foramen ovale
580909|NCT00505570|PFO|pfo
580910|NCT00505596|Prenatal testing|prenatal testing
580911|NCT00505596|Decisionmaking|decisionmaking
580912|NCT00505596|Decision aid|decision aid
580913|NCT00505596|Informed choice|informed choice
580914|NCT00505609|fertility awareness-based method|fertility awareness-based method
580915|NCT00505609|family planning|family planning
580916|NCT00505609|Standard Days Method|standard days method
580917|NCT00505609|Institute for Reproductive Health|institute for reproductive health
580918|NCT00505609|Efficacy|efficacy
580919|NCT00505609|CycleBeads|cyclebeads
580920|NCT00505635|advanced stage IV melanoma|advanced stage iv melanoma
580921|NCT00505635|unresectable stage III melanoma|unresectable stage iii melanoma
580922|NCT00505635|Melanoma|melanoma
580923|NCT00505635|Temozolomide|temozolomide
580924|NCT00505635|Velban|velban
580925|NCT00505635|Vinblastine|vinblastine
580926|NCT00505635|Cisplatin|cisplatin
580927|NCT00505635|Interleukin-2|interleukin-2
580928|NCT00505635|Intron-A|intron-a
580929|NCT00505635|Interferon Alpha-2b|interferon alpha-2b
580930|NCT00505635|Thalidomide|thalidomide
580931|NCT00505635|Thalomid|thalomid
580932|NCT00505635|Temodar|temodar
580933|NCT00505635|Proleukin|proleukin
580934|NCT00505648|Hypersensitivity|hypersensitivity
580935|NCT00505648|Syndrome|syndrome
580936|NCT00505648|Tegeline|tegeline
580937|NCT00505661|Ovarian Cancer|ovarian cancer
580938|NCT00505661|Fallopian Tube Cancer|fallopian tube cancer
580939|NCT00505661|Peritoneal Cancer|peritoneal cancer
580940|NCT00505661|Letrozole|letrozole
580941|NCT00505661|Femara|femara
580942|NCT00505687|Rotigotine|rotigotine
580943|NCT00505687|Neupro®|neupro®
580944|NCT00505700|acute myeloid leukemia|acute myeloid leukemia
580945|NCT00505713|Sarcoma|sarcoma
580946|NCT00505713|Rexin-G|rexin-g
580947|NCT00505713|Gene Therapy|gene therapy
580948|NCT00505726|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
580949|NCT00505726|Cervical Cancer|cervical cancer
580950|NCT00505726|Reflectance Confocal Imaging|reflectance confocal imaging
580951|NCT00505726|Colposcopy|colposcopy
580952|NCT00505739|Endometrial Cancer|endometrial cancer
580953|NCT00505739|Low Grade Endometrial Stromal Sarcoma|low grade endometrial stromal sarcoma
580954|NCT00505739|RU-486|ru-486
580955|NCT00505739|Mifepristone|mifepristone
580956|NCT00505739|LGESS|lgess
580957|NCT00505752|Assisted reproductive technology, follicle stimulating hormone|assisted reproductive technology, follicle stimulating hormone
580958|NCT00505765|Cognition|cognition
580959|NCT00505765|Schizophrenia|schizophrenia
580960|NCT00505791|Acute decompensated heart failure|acute decompensated heart failure
580961|NCT00505791|Normal left ventricular ejection fraction|normal left ventricular ejection fraction
580962|NCT00505791|Vasodilator therapy|vasodilator therapy
580963|NCT00505804|dexmedetomidine|dexmedetomidine
580964|NCT00505804|haloperidol|haloperidol
580965|NCT00505830|Asperger Syndrom|asperger syndrom
580966|NCT00505830|Autism Quotient|autism quotient
580967|NCT00505830|French version|french version
580968|NCT00505830|screening|screening
580969|NCT00505830|diagnostic test|diagnostic test
580970|NCT00505830|accuracy|accuracy
580971|NCT00505869|Pregnant Smokers|pregnant smokers
580972|NCT00505869|Mood Management Intervention|mood management intervention
580973|NCT00505869|Health & Wellness Intervention|health & wellness intervention
580975|NCT00505869|Questionnaire|questionnaire
580976|NCT00505869|Survey|survey
580977|NCT00505882|Type 1 diabetes|type 1 diabetes
580978|NCT00505882|Pramlintide|pramlintide
580979|NCT00505882|Weight gain|weight gain
580980|NCT00505882|Intensive insulin therapy|intensive insulin therapy
580981|NCT00505882|Beta cell|beta cell
580982|NCT00505895|Multiple Myeloma|multiple myeloma
580983|NCT00505895|Fludarabine|fludarabine
580984|NCT00505895|Fludara|fludara
580985|NCT00505895|Fludarabine Phosphate|fludarabine phosphate
580986|NCT00505895|Melphalan|melphalan
580987|NCT00505895|Alkeran|alkeran
581951|NCT00506155|Bevacizumab|bevacizumab
580988|NCT00505895|Stem Cell Infusion|stem cell infusion
580989|NCT00505895|Stem Cell Transfusion|stem cell transfusion
580991|NCT00505895|Allogeneic Peripheral Blood Stem Cell Transfusion|allogeneic peripheral blood stem cell transfusion
580992|NCT00505895|APBSCT|apbsct
580993|NCT00505895|Bone Marrow Transplantation|bone marrow transplantation
580994|NCT00505895|BMT|bmt
580995|NCT00505895|Rituxan|rituxan
580996|NCT00505895|Rituximab|rituximab
580997|NCT00505895|FM140|fm140
580998|NCT00505895|FM100|fm100
580999|NCT00505921|T-Cell Lymphoma|t-cell lymphoma
581000|NCT00505921|Lymphoma|lymphoma
581001|NCT00505921|Campath-1H|campath-1h
581002|NCT00505921|Allogenic Transplantation|allogenic transplantation
581003|NCT00505921|Stem Cell Transplant|stem cell transplant
581004|NCT00505921|Alemtuzumab|alemtuzumab
581005|NCT00497432|Hyperbaric Oxygen|hyperbaric oxygen
581006|NCT00497445|Peripheral arterial disease|peripheral arterial disease
581007|NCT00497445|Exercise therapy|exercise therapy
581008|NCT00497445|Angioplasty|angioplasty
581009|NCT00497445|Bypass surgery|bypass surgery
581010|NCT00497458|breast|breast
581011|NCT00497458|neoplasms|neoplasms
581012|NCT00497458|anastrazole|anastrazole
581013|NCT00497458|testosterone|testosterone
581014|NCT00497471|Plasmodium Falciparum|plasmodium falciparum
581015|NCT00497471|Antimlarial chemoprophylaxis|antimlarial chemoprophylaxis
581016|NCT00497471|Iron supplementation|iron supplementation
581017|NCT00497471|Tanzania|tanzania
581018|NCT00497497|CRC|crc
581019|NCT00497497|Colon cancer|colon cancer
581020|NCT00497497|Avastin|avastin
581021|NCT00497497|APM4187g|apm4187g
581022|NCT00497510|Balance|balance
581023|NCT00497510|Chiropractic|chiropractic
581024|NCT00497510|Older Adults|older adults
581025|NCT00497523|Asthma|asthma
581026|NCT00497523|Young Children|young children
581027|NCT00497523|Corticosteroids|corticosteroids
581028|NCT00497523|Beclomethasone|beclomethasone
581029|NCT00497523|Salbutamol|salbutamol
581030|NCT00497523|Beclomethasone/Salbutamol fixed combination|beclomethasone/salbutamol fixed combination
581031|NCT00497523|Suspension for nebulisation|suspension for nebulisation
581032|NCT00497536|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
581033|NCT00497536|Continuous Subcutaneous Insulin Infusion (CSII)|continuous subcutaneous insulin infusion (csii)
581034|NCT00497549|Esophagectomy|esophagectomy
581035|NCT00497549|hand sewn anastomosis|hand sewn anastomosis
581036|NCT00497549|side-to-side stapled|side-to-side stapled
581037|NCT00497562|Fibromyalgia|fibromyalgia
581038|NCT00497562|growth hormone|growth hormone
581039|NCT00497562|IGF-1|igf-1
581040|NCT00497562|FIQ|fiq
581041|NCT00497575|Congenital Hypothyroidism|congenital hypothyroidism
581042|NCT00497575|diagnosis|diagnosis
581043|NCT00497575|L-thyroxine|l-thyroxine
581044|NCT00497575|newborn screening|newborn screening
581045|NCT00497588|laryngeal cancer|laryngeal cancer
581046|NCT00497588|RADIOTHERAPY|radiotherapy
581047|NCT00497588|Voice Quality|voice quality
581048|NCT00497601|Visceral Leishmaniasis|visceral leishmaniasis
581049|NCT00497601|Amphotericin B|amphotericin b
581050|NCT00497601|Fat emulsion|fat emulsion
581051|NCT00497614|Rheumatoid arthritis|rheumatoid arthritis
581052|NCT00497614|Positron emission tomodensitometry|positron emission tomodensitometry
581053|NCT00497614|Tumor necrosis factor alpha inhibitor|tumor necrosis factor alpha inhibitor
581054|NCT00497640|sleep apnea, titration, CPAP, neural network|sleep apnea, titration, cpap, neural network
581055|NCT00497666|Diabetes|diabetes
581056|NCT00497666|Diabetic nephropathy|diabetic nephropathy
581057|NCT00497666|renal protection|renal protection
581058|NCT00497679|advanced solid tumours|advanced solid tumours
581059|NCT00497705|Ebsteins Anomaly|ebsteins anomaly
581060|NCT00497705|Heart Septal Defects, Ventricle|heart septal defects, ventricle
581061|NCT00497705|Heart Defects, Congenital|heart defects, congenital
742760|NCT01134770|Cocaine|cocaine
750543|NCT01166334|Web|web
581062|NCT00497705|Double Outlet Right Ventricle|double outlet right ventricle
581063|NCT00497705|Truncus Arteriosus Persistant|truncus arteriosus persistant
581064|NCT00497705|Ebstein's Anomaly|ebstein's anomaly
581065|NCT00497705|Congenital Heart Disease|congenital heart disease
581066|NCT00497705|Heart Defects|heart defects
581067|NCT00497731|Advanced solid tumors|advanced solid tumors
581068|NCT00497744|CAPD peritonitis|capd peritonitis
581069|NCT00497744|Peritoneal Dialysis, Continuous Ambulatory|peritoneal dialysis, continuous ambulatory
580990|NCT00505895|SCT|sct
581070|NCT00497757|Marrow/hematopoietic stem cell transplant|marrow/hematopoietic stem cell transplant
581071|NCT00497796|cytomegalovirus|cytomegalovirus
581073|NCT00497796|prophylaxis|prophylaxis
581075|NCT00497796|liver transplant|liver transplant
581076|NCT00497809|Breast Cancer|breast cancer
581077|NCT00497809|Neutropenia|neutropenia
581078|NCT00497809|Chemotherapy|chemotherapy
581079|NCT00497809|High risk|high risk
581080|NCT00497822|Dementia|dementia
581081|NCT00497835|motor seizures|motor seizures
581082|NCT00497835|accelerometer|accelerometer
581083|NCT00497835|algorithm|algorithm
581084|NCT00497835|detection|detection
581085|NCT00497835|alert|alert
581086|NCT00497861|Low back pain|low back pain
581087|NCT00497861|Chiropractic|chiropractic
581088|NCT00497861|Spinal manipulation|spinal manipulation
581089|NCT00497861|Activator Methods Chiropractic Technique|activator methods chiropractic technique
581090|NCT00497874|depression|depression
581091|NCT00497874|stage of change|stage of change
581092|NCT00497874|intervention|intervention
581093|NCT00497874|randomized clinical trial|randomized clinical trial
581094|NCT00497874|population-based|population-based
581095|NCT00497874|expert system|expert system
581096|NCT00497913|Tennis Elbow|tennis elbow
581097|NCT00497913|Botulinum Toxin|botulinum toxin
581098|NCT00497926|Kidney transplant|kidney transplant
581099|NCT00497926|Tolerance|tolerance
581100|NCT00497926|Marrow/Enriched Hematopoetic Stem Cell Transplant|marrow/enriched hematopoetic stem cell transplant
581101|NCT00497939|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
581102|NCT00497939|Currently on alpha blocker|currently on alpha blocker
581103|NCT00497952|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
581104|NCT00497952|Marrow/Stem cell transplant|marrow/stem cell transplant
581105|NCT00497965|Balance|balance
581106|NCT00497965|Chiropractic|chiropractic
581107|NCT00497965|Older Adults|older adults
581108|NCT00497991|AML|aml
581109|NCT00497991|phase I/II|phase i/ii
581110|NCT00497991|AZD1152|azd1152
581111|NCT00497991|Acute Myeloid Leukaemia|acute myeloid leukaemia
581112|NCT00498004|Quality of Life|quality of life
581113|NCT00498004|Schizophrenia|schizophrenia
581114|NCT00498004|Quetiapine|quetiapine
581115|NCT00498004|Risperidone|risperidone
581116|NCT00498017|Infections|infections
581117|NCT00498030|Insulin Resistance|insulin resistance
581118|NCT00498030|Stress, Psychological|stress, psychological
581119|NCT00498043|Lymphoma|lymphoma
581120|NCT00498043|PET|pet
581121|NCT00498043|Chemotherapy|chemotherapy
581122|NCT00498043|Rituximab|rituximab
581123|NCT00498056|HIV Seronegativity|hiv seronegativity
581124|NCT00498056|HIV Preventive Vaccine|hiv preventive vaccine
581125|NCT00498069|Critical limb ischemia due to peripheral arterial occlusive disease|critical limb ischemia due to peripheral arterial occlusive disease
581126|NCT00498069|Autologous bone marrow concentrate|autologous bone marrow concentrate
581127|NCT00498095|Delayed renal graft function|delayed renal graft function
581128|NCT00498095|Acute renal allograft dysfunction|acute renal allograft dysfunction
581129|NCT00498108|Rotigotine|rotigotine
581130|NCT00498108|Restless Legs Syndrome|restless legs syndrome
581131|NCT00498121|Ventilator associated pneumonia.|ventilator associated pneumonia.
581132|NCT00498121|Procalcitonin.|procalcitonin.
581133|NCT00498134|Gastric cancer|gastric cancer
581134|NCT00498147|amputation|amputation
581135|NCT00498147|angina|angina
581136|NCT00498147|angiography|angiography
581137|NCT00498147|angioplasty|angioplasty
581138|NCT00498147|arterial disease|arterial disease
581139|NCT00498147|artery disease|artery disease
581140|NCT00498147|bypass|bypass
581141|NCT00498147|CABG|cabg
581142|NCT00498147|cad|cad
581143|NCT00498147|carotid|carotid
581144|NCT00498147|cerebral accident|cerebral accident
581145|NCT00498147|CHF|chf
581146|NCT00498147|CRF|crf
581147|NCT00498147|CVA|cva
581148|NCT00498147|endarterectomy|endarterectomy
581149|NCT00498147|heart attack|heart attack
581150|NCT00498147|heart failure|heart failure
581151|NCT00498147|infarct|infarct
581152|NCT00498147|kidney disease|kidney disease
581153|NCT00498147|kidney failure|kidney failure
581154|NCT00498147|laser|laser
581155|NCT00498147|nephropathy|nephropathy
581156|NCT00498147|neuropathy|neuropathy
581157|NCT00498147|pad|pad
581158|NCT00498147|PCI|pci
581159|NCT00498147|percutaneous coronary|percutaneous coronary
581160|NCT00498147|percutaneous transluminal|percutaneous transluminal
581161|NCT00498147|pvd|pvd
581162|NCT00498147|renal failure|renal failure
581163|NCT00498147|retinopathy|retinopathy
581164|NCT00498147|revascularization|revascularization
581165|NCT00498147|schemia|schemia
581166|NCT00498147|stenosis|stenosis
581167|NCT00498147|stent|stent
581168|NCT00498147|stroke|stroke
581169|NCT00498147|transient|transient
581170|NCT00498147|ulcer|ulcer
581171|NCT00498147|vascular disease|vascular disease
581172|NCT00498160|Kidney transplant|kidney transplant
581173|NCT00498160|Tolerance|tolerance
581174|NCT00498160|Marrow/stem cell transplant|marrow/stem cell transplant
581175|NCT00498173|Autistic Disorder|autistic disorder
581176|NCT00498173|Autism Spectrum Disorder|autism spectrum disorder
581177|NCT00498186|Rotigotine|rotigotine
581178|NCT00498186|Neupro®|neupro®
581179|NCT00498199|Multiples sclerosis|multiples sclerosis
581180|NCT00498199|oscillopsia|oscillopsia
581181|NCT00498199|eye movements|eye movements
581182|NCT00498199|motion detection|motion detection
581183|NCT00498199|retinal slip|retinal slip
581184|NCT00498199|nystagmus|nystagmus
581185|NCT00498212|Heplisav|heplisav
581186|NCT00498212|Hepatitis B|hepatitis b
581187|NCT00498212|Hepatitis|hepatitis
581188|NCT00498212|HBV|hbv
581189|NCT00498212|Hepatitis B vaccine|hepatitis b vaccine
581190|NCT00498212|kidney disease|kidney disease
581191|NCT00498212|renal disease|renal disease
581192|NCT00498212|kidney failure|kidney failure
581193|NCT00498212|renal failure|renal failure
581194|NCT00498225|Pancreatic Cancer|pancreatic cancer
581195|NCT00498238|Arterial stiffness, Augmentation index, Subclinical Hypothyroidism|arterial stiffness, augmentation index, subclinical hypothyroidism
581196|NCT00498251|lung injury, acute|lung injury, acute
581197|NCT00498251|thoracic surgical procedures|thoracic surgical procedures
581198|NCT00498251|lung cancer|lung cancer
581199|NCT00498251|salbutamol|salbutamol
581200|NCT00498264|Exercise|exercise
581201|NCT00498264|Rehabilitation|rehabilitation
581202|NCT00498264|Strength exercise|strength exercise
581203|NCT00498264|Aerobic exercise|aerobic exercise
581204|NCT00498264|Pain|pain
581205|NCT00498277|Osteoporosis|osteoporosis
581206|NCT00498277|Magnetic Resonance Imaging|magnetic resonance imaging
581207|NCT00498277|Vertebral Fractures|vertebral fractures
581208|NCT00498277|Quantitative Diffusion|quantitative diffusion
581209|NCT00498277|Fat Imaging|fat imaging
581210|NCT00498277|Spine|spine
581211|NCT00498290|Enhanced Recovery After Surgery Protocol(ERAS)|enhanced recovery after surgery protocol(eras)
581212|NCT00498290|Colorectal Surgery|colorectal surgery
581213|NCT00498303|influenza vaccine|influenza vaccine
581214|NCT00498316|Myelodysplastic Syndrome|myelodysplastic syndrome
581215|NCT00498316|Leukemia|leukemia
581216|NCT00498316|Cord Blood Expansion|cord blood expansion
581217|NCT00498316|Umbilical Cord Blood|umbilical cord blood
581218|NCT00498316|Mesenchymal Stem Cells|mesenchymal stem cells
581219|NCT00498316|Acute Myelogenous Leukemia|acute myelogenous leukemia
581220|NCT00498316|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
581221|NCT00498316|ALL|all
581222|NCT00498316|AML|aml
581223|NCT00498316|MDS|mds
581224|NCT00498329|fMRI|fmri
581225|NCT00498329|Electroencephalogram (EEG)|electroencephalogram (eeg)
581226|NCT00498329|Attention|attention
581227|NCT00498329|Sensorimotor Integration|sensorimotor integration
581228|NCT00498329|Human Brain|human brain
581229|NCT00498329|Healthy Volunteer|healthy volunteer
581230|NCT00498329|HV|hv
581231|NCT00498355|uveitis|uveitis
581232|NCT00498355|cytoid macular edema|cytoid macular edema
581233|NCT00498355|steroid|steroid
581234|NCT00498355|Lucentis|lucentis
581235|NCT00498368|Estimated glomerular filtration rate (GFR)|estimated glomerular filtration rate (gfr)
581236|NCT00498368|Proteinuria|proteinuria
581237|NCT00498368|Renal Fibrosis|renal fibrosis
581238|NCT00498394|Obesity|obesity
581239|NCT00498394|Weight loss|weight loss
581240|NCT00498394|Diet fads|diet fads
581241|NCT00498407|CP-4055|cp-4055
581242|NCT00498407|ELACYT(TM)|elacyt(tm)
581243|NCT00498407|Cancer|cancer
581244|NCT00498407|Colorectal cancer|colorectal cancer
581245|NCT00498407|CRC|crc
581246|NCT00498407|Second line therapy|second line therapy
581247|NCT00498420|HUE-MAN|hue-man
581248|NCT00498420|Rare disorder|rare disorder
581249|NCT00498420|Hepatosplenomegaly|hepatosplenomegaly
581250|NCT00498420|Dysostosis|dysostosis
581251|NCT00498433|Aliskiren|aliskiren
581252|NCT00498433|Renin-Angiotensin System (RAS)|renin-angiotensin system (ras)
581253|NCT00498433|Hypertension|hypertension
581254|NCT00498433|Abdominal obesity|abdominal obesity
581255|NCT00498459|Physical activity|physical activity
581256|NCT00498459|Randomised trial|randomised trial
581257|NCT00498459|Prevention|prevention
581258|NCT00498459|Adolescents|adolescents
581259|NCT00498459|Obesity|obesity
581260|NCT00498459|Cardiovascular risk factors|cardiovascular risk factors
581261|NCT00498472|BNP|bnp
581262|NCT00498472|heart failure|heart failure
581263|NCT00498485|chronic|chronic
581264|NCT00498485|fatigue|fatigue
581265|NCT00498485|pain|pain
581266|NCT00498485|sleep|sleep
750840|NCT01161199|HIV|hiv
581267|NCT00498485|xyrem|xyrem
581268|NCT00498485|must have chronic fatigue syndrome|must have chronic fatigue syndrome
581269|NCT00498485|no hypertension|no hypertension
581270|NCT00498485|no sleep apnea|no sleep apnea
581271|NCT00498498|severe head injury|severe head injury
581272|NCT00498498|Endothelin|endothelin
581273|NCT00498498|CSF|csf
581274|NCT00498498|Plasma|plasma
581275|NCT00498498|Cellular Apoptosis|cellular apoptosis
581276|NCT00498511|Anemia, Iron-Deficiency|anemia, iron-deficiency
581277|NCT00498511|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
581278|NCT00498511|Male, aged 18 to 40|male, aged 18 to 40
581279|NCT00498524|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
581280|NCT00498524|ischemic cardiomyopathy|ischemic cardiomyopathy
581281|NCT00498524|ventricular arrhythmias|ventricular arrhythmias
581282|NCT00498524|sibling concordance|sibling concordance
581283|NCT00498537|spironolactone|spironolactone
581284|NCT00498537|aldosterone|aldosterone
581285|NCT00498537|diabetic nephropathy|diabetic nephropathy
581286|NCT00498537|proteinuria|proteinuria
581287|NCT00498537|hyperkalemia|hyperkalemia
581288|NCT00498537|albuminuria|albuminuria
581289|NCT00498537|renal failure|renal failure
581290|NCT00498550|Clozapine|clozapine
581291|NCT00498550|Schizophrenia|schizophrenia
581292|NCT00498550|Dual Diagnosis|dual diagnosis
581293|NCT00498550|Substance Abuse|substance abuse
581294|NCT00498550|Cannabis Abuse|cannabis abuse
581295|NCT00498563|high altitude|high altitude
581296|NCT00498563|sleep|sleep
581297|NCT00498563|altitude illness|altitude illness
581298|NCT00498563|neurobehavioral manifestations|neurobehavioral manifestations
581299|NCT00498563|psychomotor performance|psychomotor performance
581300|NCT00498563|mood states|mood states
581301|NCT00498576|hypertension|hypertension
581302|NCT00498576|kidney transplant|kidney transplant
581303|NCT00498576|melatonin|melatonin
581304|NCT00498576|adiponectin|adiponectin
581305|NCT00498615|scleroderma|scleroderma
581306|NCT00498615|Raynaud's phenomenon|raynaud's phenomenon
581307|NCT00498615|Rho-kinase inhibitor|rho-kinase inhibitor
581308|NCT00498628|Alcoholism|alcoholism
581309|NCT00498628|Alcohol dependence|alcohol dependence
581310|NCT00498628|Quetiapine|quetiapine
581311|NCT00498641|perceptual learning|perceptual learning
581312|NCT00498641|occlusion therapy|occlusion therapy
581313|NCT00498654|Prevention of Typhoid Fever in Adult Travelers|prevention of typhoid fever in adult travelers
581315|NCT00498667|Aggressive non-Hodgkin Lymphoma|aggressive non-hodgkin lymphoma
581316|NCT00498680|Erectile Dysfunction|erectile dysfunction
581317|NCT00498680|Treatment|treatment
581318|NCT00498680|PDE5i|pde5i
581319|NCT00498706|Depressive Disorder, Major|depressive disorder, major
581320|NCT00498706|Cognitive Behavioral Therapy|cognitive behavioral therapy
581321|NCT00498706|Psychotherapy|psychotherapy
581322|NCT00498706|Telemedicine|telemedicine
581323|NCT00498706|Primary Care|primary care
581324|NCT00498719|Leukemia|leukemia
581325|NCT00498719|Lymphoma|lymphoma
581326|NCT00498719|Brain Tumor|brain tumor
581327|NCT00498719|Attention Deficit|attention deficit
581328|NCT00498719|Cognitive Training Program|cognitive training program
581329|NCT00498719|Central Nervous System|central nervous system
581330|NCT00498719|CNS|cns
581331|NCT00498719|CTP|ctp
581332|NCT00498732|Obstructive sleep apnea syndrome; CPAP, microarray|obstructive sleep apnea syndrome; cpap, microarray
581333|NCT00498758|Parkinson's disease|parkinson's disease
581334|NCT00498758|Gait Disturbances|gait disturbances
581335|NCT00498758|Mobility|mobility
581336|NCT00498758|Quality of life|quality of life
581337|NCT00498771|Lymphedema|lymphedema
581338|NCT00498771|Aquatic Exercise|aquatic exercise
581339|NCT00498771|Breast Cancer|breast cancer
581340|NCT00498784|Intra-uterine contraception|intra-uterine contraception
581341|NCT00498784|Intrauterine Devices|intrauterine devices
581342|NCT00498797|prostate cancer|prostate cancer
581343|NCT00498797|zactima|zactima
581344|NCT00498797|vandetanib|vandetanib
581345|NCT00498797|metastatic|metastatic
581346|NCT00498836|CP-4055|cp-4055
581347|NCT00498836|Elacyt|elacyt
581348|NCT00498836|Cancer|cancer
581349|NCT00498836|Metastatic|metastatic
581350|NCT00498836|Malignant melanoma|malignant melanoma
581351|NCT00498836|Combination treatment|combination treatment
581352|NCT00498836|Sorafenib|sorafenib
581353|NCT00498836|Nexavar|nexavar
581354|NCT00498849|Sleep apnea|sleep apnea
581355|NCT00498849|Continuous positive airway pressure|continuous positive airway pressure
581356|NCT00498849|Microarray|microarray
581357|NCT00498849|Polysomnography|polysomnography
581358|NCT00498875|Oropharyngeal Cancer|oropharyngeal cancer
581359|NCT00498875|Head and Neck Cancer|head and neck cancer
581360|NCT00498875|Depression|depression
581361|NCT00498875|Questionnaire|questionnaire
581362|NCT00498875|Survey|survey
581363|NCT00498875|Interview|interview
581364|NCT00498888|urge urinary incontinence|urge urinary incontinence
581365|NCT00498888|rehabilitation|rehabilitation
581366|NCT00498888|anticholinergic|anticholinergic
581367|NCT00498901|stage IV breast cancer|stage iv breast cancer
581368|NCT00498901|recurrent breast cancer|recurrent breast cancer
581369|NCT00498914|Lymphoma, Large-Cell, Diffuse|lymphoma, large-cell, diffuse
581370|NCT00498914|Lymphoma, B-Cell|lymphoma, b-cell
581371|NCT00498914|YM155|ym155
581372|NCT00498914|Treatment outcomes|treatment outcomes
581373|NCT00498914|Refractory|refractory
581374|NCT00498927|recurrent adult brain tumor|recurrent adult brain tumor
581375|NCT00498927|adult giant cell glioblastoma|adult giant cell glioblastoma
581376|NCT00498927|adult glioblastoma|adult glioblastoma
581377|NCT00498927|adult gliosarcoma|adult gliosarcoma
582867|NCT00503126|pediatrics|pediatrics
581378|NCT00498927|adult anaplastic astrocytoma|adult anaplastic astrocytoma
581379|NCT00498927|adult diffuse astrocytoma|adult diffuse astrocytoma
581380|NCT00498927|adult pilocytic astrocytoma|adult pilocytic astrocytoma
581381|NCT00498927|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
581382|NCT00498927|adult anaplastic ependymoma|adult anaplastic ependymoma
581383|NCT00498927|adult ependymoma|adult ependymoma
581384|NCT00498927|adult myxopapillary ependymoma|adult myxopapillary ependymoma
581385|NCT00498927|adult subependymoma|adult subependymoma
581386|NCT00498927|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
581387|NCT00498927|adult oligodendroglioma|adult oligodendroglioma
581388|NCT00498927|adult brain stem glioma|adult brain stem glioma
581389|NCT00498927|adult mixed glioma|adult mixed glioma
581390|NCT00498927|adult pineal gland astrocytoma|adult pineal gland astrocytoma
581391|NCT00498940|LV function, Compliance, wall motion, echocardiography|lv function, compliance, wall motion, echocardiography
581392|NCT00498953|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
581393|NCT00498953|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
581394|NCT00498953|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
581395|NCT00498953|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
581396|NCT00498953|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
581397|NCT00498966|Kidney|kidney
581398|NCT00498966|perifosine|perifosine
581399|NCT00498966|Progression on treatment with sunitinib or sorafenib|progression on treatment with sunitinib or sorafenib
581400|NCT00498979|stage IV melanoma|stage iv melanoma
581401|NCT00498979|adult anaplastic astrocytoma|adult anaplastic astrocytoma
581402|NCT00498979|adult diffuse astrocytoma|adult diffuse astrocytoma
581403|NCT00498979|adult glioblastoma|adult glioblastoma
581404|NCT00498979|adult giant cell glioblastoma|adult giant cell glioblastoma
581405|NCT00498979|adult pilocytic astrocytoma|adult pilocytic astrocytoma
581406|NCT00498979|adult brain stem glioma|adult brain stem glioma
581407|NCT00498979|adult anaplastic ependymoma|adult anaplastic ependymoma
581408|NCT00498979|adult ependymoma|adult ependymoma
581409|NCT00498979|adult myxopapillary ependymoma|adult myxopapillary ependymoma
581410|NCT00498979|adult subependymoma|adult subependymoma
581411|NCT00498979|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
581412|NCT00498979|adult oligodendroglioma|adult oligodendroglioma
581413|NCT00498979|mixed gliomas|mixed gliomas
581414|NCT00498979|recurrent adult brain tumor|recurrent adult brain tumor
581415|NCT00498979|recurrent melanoma|recurrent melanoma
581416|NCT00498979|adult gliosarcoma|adult gliosarcoma
581417|NCT00498979|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
581418|NCT00498979|adult pineal gland astrocytoma|adult pineal gland astrocytoma
581419|NCT00498992|dermatologic complications|dermatologic complications
581420|NCT00498992|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
581421|NCT00499018|Large B-Cell Lymphoma|large b-cell lymphoma
581422|NCT00499018|Rituximab|rituximab
581423|NCT00499018|Autologous Stem Cell Transplantation|autologous stem cell transplantation
581424|NCT00499044|cognition|cognition
581425|NCT00499044|attention|attention
581426|NCT00499044|memory|memory
581427|NCT00499044|concentration|concentration
581428|NCT00499044|schizophrenia|schizophrenia
581429|NCT00499057|early stage breast cancer|early stage breast cancer
581430|NCT00499070|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
581431|NCT00499070|aplastic anemia|aplastic anemia
581432|NCT00499070|Fanconi anemia|fanconi anemia
581433|NCT00499070|dyskeratosis congenita|dyskeratosis congenita
581434|NCT00499070|Shwachman-Diamond syndrome|shwachman-diamond syndrome
581435|NCT00499070|Pearson marrow-pancreas syndrome|pearson marrow-pancreas syndrome
581436|NCT00499083|stage II breast cancer|stage ii breast cancer
581437|NCT00499083|stage IIIA breast cancer|stage iiia breast cancer
581438|NCT00499083|stage IIIB breast cancer|stage iiib breast cancer
581439|NCT00499083|stage IIIC breast cancer|stage iiic breast cancer
581440|NCT00499096|Chronic Illness|chronic illness
581441|NCT00499096|Disease management|disease management
581442|NCT00499096|Health Behaviors|health behaviors
581443|NCT00499096|Mood Disorders-Bipolar|mood disorders-bipolar
581444|NCT00499109|RRM1|rrm1
581445|NCT00499109|ERCC1|ercc1
581446|NCT00499109|Customized Chemotherapy|customized chemotherapy
581447|NCT00499122|stage II breast cancer|stage ii breast cancer
581448|NCT00499122|stage IIIC breast cancer|stage iiic breast cancer
581449|NCT00499122|inflammatory breast cancer|inflammatory breast cancer
581450|NCT00499161|Individualized care|individualized care
581451|NCT00499161|Relationship based care|relationship based care
581452|NCT00499161|Negotiated care|negotiated care
581453|NCT00499161|Patient focused care|patient focused care
581454|NCT00499174|stage II prostate cancer|stage ii prostate cancer
581455|NCT00499174|adenocarcinoma of the prostate|adenocarcinoma of the prostate
581456|NCT00499187|Fanconi|fanconi
581457|NCT00499187|Kidney|kidney
581458|NCT00499187|Renal|renal
581459|NCT00499187|HIV|hiv
581460|NCT00499187|HIV-1|hiv-1
581461|NCT00499187|Treatment Experienced|treatment experienced
582868|NCT00503126|bivalirudin|bivalirudin
581462|NCT00499239|Hematologic Malignancies|hematologic malignancies
581463|NCT00499239|CLL|cll
581464|NCT00499239|NHL|nhl
581465|NCT00499239|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
581466|NCT00499239|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
581467|NCT00499239|CLL and NHL|cll and nhl
581468|NCT00499239|Multiple Myeloma|multiple myeloma
581469|NCT00499239|MM|mm
581470|NCT00499265|recurrent pancreatic cancer|recurrent pancreatic cancer
581471|NCT00499265|stage III pancreatic cancer|stage iii pancreatic cancer
581472|NCT00499265|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
581473|NCT00499278|Osteoarthritis|osteoarthritis
581474|NCT00499278|joint|joint
581475|NCT00499278|knee|knee
581476|NCT00499278|hip|hip
581477|NCT00499278|surgery|surgery
581478|NCT00499291|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
581479|NCT00499291|recurrent breast cancer|recurrent breast cancer
581480|NCT00499291|stage IIIA breast cancer|stage iiia breast cancer
581481|NCT00499291|stage IIIB breast cancer|stage iiib breast cancer
581482|NCT00499291|stage IIIC breast cancer|stage iiic breast cancer
581483|NCT00499291|recurrent prostate cancer|recurrent prostate cancer
581484|NCT00499291|stage III prostate cancer|stage iii prostate cancer
581485|NCT00499291|stage IV prostate cancer|stage iv prostate cancer
581486|NCT00499291|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
581487|NCT00499291|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
581488|NCT00499291|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
581489|NCT00499291|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
581490|NCT00499291|extensive stage small cell lung cancer|extensive stage small cell lung cancer
581491|NCT00499291|recurrent small cell lung cancer|recurrent small cell lung cancer
581492|NCT00499291|recurrent bladder cancer|recurrent bladder cancer
581493|NCT00499291|stage III bladder cancer|stage iii bladder cancer
581494|NCT00499291|stage IV bladder cancer|stage iv bladder cancer
581495|NCT00499291|recurrent renal cell cancer|recurrent renal cell cancer
581496|NCT00499291|stage III renal cell cancer|stage iii renal cell cancer
581497|NCT00499291|stage IV renal cell cancer|stage iv renal cell cancer
581498|NCT00499291|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
581499|NCT00499291|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
581500|NCT00499291|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
581501|NCT00499291|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
581502|NCT00499291|recurrent cervical cancer|recurrent cervical cancer
581503|NCT00499291|stage III cervical cancer|stage iii cervical cancer
581504|NCT00499291|stage IVA cervical cancer|stage iva cervical cancer
581505|NCT00499291|stage IVB cervical cancer|stage ivb cervical cancer
581506|NCT00499291|recurrent endometrial carcinoma|recurrent endometrial carcinoma
581507|NCT00499291|stage III endometrial carcinoma|stage iii endometrial carcinoma
581508|NCT00499291|stage IV endometrial carcinoma|stage iv endometrial carcinoma
581509|NCT00499291|fallopian tube cancer|fallopian tube cancer
581510|NCT00499291|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
581511|NCT00499291|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
581512|NCT00499291|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
581513|NCT00499291|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
581514|NCT00499291|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
581515|NCT00499291|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
581516|NCT00499291|ovarian sarcoma|ovarian sarcoma
581517|NCT00499291|ovarian stromal cancer|ovarian stromal cancer
581518|NCT00499291|recurrent uterine sarcoma|recurrent uterine sarcoma
581519|NCT00499291|stage III uterine sarcoma|stage iii uterine sarcoma
581520|NCT00499291|stage IV uterine sarcoma|stage iv uterine sarcoma
581521|NCT00499291|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
581522|NCT00499291|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
581523|NCT00499291|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
581524|NCT00499291|recurrent laryngeal cancer|recurrent laryngeal cancer
581525|NCT00499291|stage III laryngeal cancer|stage iii laryngeal cancer
581526|NCT00499291|stage IV laryngeal cancer|stage iv laryngeal cancer
581527|NCT00499291|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
581528|NCT00499291|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
751186|NCT01168921|CLL|cll
581529|NCT00499291|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
581530|NCT00499291|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
581531|NCT00499291|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
581532|NCT00499291|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
581533|NCT00499291|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
581534|NCT00499291|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
581535|NCT00499291|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
581536|NCT00499291|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
581537|NCT00499291|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
581538|NCT00499291|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
581539|NCT00499291|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
581540|NCT00499291|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
581541|NCT00499291|recurrent salivary gland cancer|recurrent salivary gland cancer
751889|NCT01171092|transplant|transplant
581542|NCT00499291|stage III salivary gland cancer|stage iii salivary gland cancer
581543|NCT00499291|stage IV salivary gland cancer|stage iv salivary gland cancer
581544|NCT00499291|recurrent esophageal cancer|recurrent esophageal cancer
581545|NCT00499291|stage III esophageal cancer|stage iii esophageal cancer
581546|NCT00499291|stage IV esophageal cancer|stage iv esophageal cancer
581547|NCT00499291|recurrent gastric cancer|recurrent gastric cancer
581548|NCT00499291|stage III gastric cancer|stage iii gastric cancer
581549|NCT00499291|stage IV gastric cancer|stage iv gastric cancer
581550|NCT00499291|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
581551|NCT00499291|adult teratoma|adult teratoma
581552|NCT00499291|ovarian teratoma|ovarian teratoma
581553|NCT00499291|testicular teratoma|testicular teratoma
581554|NCT00499291|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
581555|NCT00499291|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
581556|NCT00499291|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
581557|NCT00499291|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
581558|NCT00499304|Forced oscillation Technique (FOT)|forced oscillation technique (fot)
581559|NCT00499304|Expiratory flow limitation (EFL)|expiratory flow limitation (efl)
581560|NCT00499304|Breathing artifacts|breathing artifacts
581561|NCT00499304|COPD|copd
581562|NCT00499317|Urgency|urgency
581563|NCT00499317|Frequency|frequency
581564|NCT00499317|Pelvic pain|pelvic pain
581565|NCT00499317|Sexual dysfunction|sexual dysfunction
581566|NCT00499317|Erectile dysfunction|erectile dysfunction
581567|NCT00499317|Painful intercourse|painful intercourse
581568|NCT00499330|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
581569|NCT00499330|adenocarcinoma of the lung|adenocarcinoma of the lung
581570|NCT00499330|squamous cell lung cancer|squamous cell lung cancer
581571|NCT00499330|large cell lung cancer|large cell lung cancer
581572|NCT00499330|adenosquamous cell lung cancer|adenosquamous cell lung cancer
581573|NCT00499330|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
581574|NCT00499343|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
581575|NCT00499343|Lymphoma|lymphoma
581576|NCT00499343|Etoposide|etoposide
581577|NCT00499343|G-CSF|g-csf
581578|NCT00499343|GM-CSF|gm-csf
581579|NCT00499343|Isophosphamide|isophosphamide
581580|NCT00499343|Rituximab|rituximab
581581|NCT00499343|Ifosfamide|ifosfamide
581582|NCT00499343|Sargramostim|sargramostim
581583|NCT00499343|Leukine|leukine
581584|NCT00499343|Filgrastim|filgrastim
581585|NCT00499343|Neupogen|neupogen
581586|NCT00499343|Apheresis|apheresis
581587|NCT00499343|Stem Cell Collection|stem cell collection
581588|NCT00499356|friction|friction
581589|NCT00499356|pressure|pressure
581590|NCT00499356|insole|insole
581591|NCT00499356|ulcer|ulcer
581592|NCT00499356|prevention|prevention
581593|NCT00499382|Advanced Cancers|advanced cancers
581594|NCT00499382|Cardiac Function|cardiac function
581595|NCT00499382|Nuclear Medicine Cardiac Scan|nuclear medicine cardiac scan
581596|NCT00499382|Positron Emission Tomography|positron emission tomography
581597|NCT00499382|Radionuclide Ventriculography|radionuclide ventriculography
581598|NCT00499382|Ventricular Ejection Fraction|ventricular ejection fraction
581599|NCT00499382|PET/CT|pet/ct
581601|NCT00499395|stage IV colon cancer|stage iv colon cancer
581602|NCT00499395|stage IV rectal cancer|stage iv rectal cancer
581603|NCT00499395|recurrent colon cancer|recurrent colon cancer
581604|NCT00499395|recurrent rectal cancer|recurrent rectal cancer
581605|NCT00499395|liver metastases|liver metastases
581606|NCT00499408|adenocarcinoma of the prostate|adenocarcinoma of the prostate
581607|NCT00499408|stage I prostate cancer|stage i prostate cancer
581608|NCT00499408|stage II prostate cancer|stage ii prostate cancer
581609|NCT00499408|stage III prostate cancer|stage iii prostate cancer
581610|NCT00499421|Prostate Cancer|prostate cancer
581611|NCT00499421|External Beam Radiation Therapy|external beam radiation therapy
751288|NCT01169194|IBD|ibd
581074|NCT00497796|liver|liver
581612|NCT00499421|Fiducial Markers|fiducial markers
581613|NCT00499421|Acculoc System|acculoc system
581614|NCT00499421|Center Of Mass|center of mass
581615|NCT00499421|EBRT|ebrt
581616|NCT00499434|aids|aids
581617|NCT00499447|stage I non-small cell lung cancer|stage i non-small cell lung cancer
581618|NCT00499447|adenocarcinoma of the lung|adenocarcinoma of the lung
581619|NCT00499447|adenosquamous cell lung cancer|adenosquamous cell lung cancer
581620|NCT00499447|large cell lung cancer|large cell lung cancer
581621|NCT00499447|squamous cell lung cancer|squamous cell lung cancer
581622|NCT00499460|Healthy, No Evidence of Disease|healthy, no evidence of disease
581623|NCT00499486|recurrent pancreatic cancer|recurrent pancreatic cancer
581624|NCT00499486|stage III pancreatic cancer|stage iii pancreatic cancer
581625|NCT00499486|stage IV pancreatic cancer|stage iv pancreatic cancer
581626|NCT00499486|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
581627|NCT00499499|Cancer|cancer
581628|NCT00499499|solid tumors|solid tumors
581629|NCT00499512|Ovarian Cancer|ovarian cancer
581630|NCT00499512|Peritoneal Cancer|peritoneal cancer
581631|NCT00499512|Fallopian Tube Cancer|fallopian tube cancer
581632|NCT00499512|Spirituality|spirituality
581633|NCT00499512|Religion|religion
581634|NCT00499512|Quality of Life|quality of life
581635|NCT00499512|Questionnaire|questionnaire
581636|NCT00499512|Survey|survey
581637|NCT00499525|male breast cancer|male breast cancer
581638|NCT00499525|recurrent breast cancer|recurrent breast cancer
581639|NCT00499525|stage IIIB breast cancer|stage iiib breast cancer
581640|NCT00499525|stage IIIC breast cancer|stage iiic breast cancer
581641|NCT00499525|stage IV breast cancer|stage iv breast cancer
581642|NCT00499525|stage IIIA breast cancer|stage iiia breast cancer
581643|NCT00499538|healthy subjects|healthy subjects
581644|NCT00499551|Anterior Uveitis|anterior uveitis
581645|NCT00499551|Posterior Uveitis|posterior uveitis
581952|NCT00506155|Cisplatin|cisplatin
581646|NCT00499551|Intermediate Uveitis|intermediate uveitis
581647|NCT00499551|Panuveitis|panuveitis
581648|NCT00499551|Iontophoresis|iontophoresis
581649|NCT00499551|Dexamethasone|dexamethasone
581650|NCT00499577|stage I multiple myeloma|stage i multiple myeloma
581651|NCT00499577|stage II multiple myeloma|stage ii multiple myeloma
581652|NCT00499577|stage III multiple myeloma|stage iii multiple myeloma
581653|NCT00499577|refractory multiple myeloma|refractory multiple myeloma
581654|NCT00499590|AMD|amd
581655|NCT00499590|Macular Degeneration|macular degeneration
581656|NCT00499590|bevasiranib|bevasiranib
581657|NCT00499590|COBALT study|cobalt study
581658|NCT00499590|age related macular degeneration|age related macular degeneration
581659|NCT00499590|wet AMD|wet amd
581660|NCT00499590|wet age related macular degeneration|wet age related macular degeneration
581661|NCT00499603|Breast Cancer|breast cancer
581662|NCT00499603|ER negative|er negative
581663|NCT00499603|PR negative|pr negative
581664|NCT00499603|HER2neu negative|her2neu negative
581665|NCT00499603|Tumor Triple Negative Receptors|tumor triple negative receptors
581666|NCT00499603|Paclitaxel|paclitaxel
581667|NCT00499603|Taxol|taxol
581668|NCT00499603|RAD001|rad001
581669|NCT00499603|FEC|fec
581670|NCT00499603|5-Fluorouracil|5-fluorouracil
581671|NCT00499603|5-FU|5-fu
581672|NCT00499603|Adrucil|adrucil
581673|NCT00499603|Efudex|efudex
581674|NCT00499603|Epirubicin|epirubicin
581675|NCT00499603|Cyclophosphamide|cyclophosphamide
581676|NCT00499616|regional neuroblastoma|regional neuroblastoma
581677|NCT00499616|disseminated neuroblastoma|disseminated neuroblastoma
581678|NCT00499616|stage 4S neuroblastoma|stage 4s neuroblastoma
581679|NCT00499616|localized unresectable neuroblastoma|localized unresectable neuroblastoma
581680|NCT00499616|localized resectable neuroblastoma|localized resectable neuroblastoma
581681|NCT00499629|healthy subjects|healthy subjects
581682|NCT00499642|Healthy Subjects|healthy subjects
581683|NCT00499668|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
581684|NCT00499668|nausea and vomiting|nausea and vomiting
581685|NCT00499668|chronic myelogenous leukemia|chronic myelogenous leukemia
581686|NCT00499668|chronic eosinophilic leukemia|chronic eosinophilic leukemia
581687|NCT00499668|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
581688|NCT00499668|chronic neutrophilic leukemia|chronic neutrophilic leukemia
581689|NCT00499668|essential thrombocythemia|essential thrombocythemia
581690|NCT00499668|polycythemia vera|polycythemia vera
581691|NCT00499668|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
581692|NCT00499668|adult acute myeloid leukemia|adult acute myeloid leukemia
581693|NCT00499668|acute undifferentiated leukemia|acute undifferentiated leukemia
581694|NCT00499668|mast cell leukemia|mast cell leukemia
581695|NCT00499668|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
581696|NCT00499668|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
581697|NCT00499668|chronic lymphocytic leukemia|chronic lymphocytic leukemia
581698|NCT00499668|hairy cell leukemia|hairy cell leukemia
581699|NCT00499668|prolymphocytic leukemia|prolymphocytic leukemia
581700|NCT00499668|AIDS-related lymphoma|aids-related lymphoma
581701|NCT00499668|adult Hodgkin lymphoma|adult hodgkin lymphoma
581702|NCT00499668|anaplastic large cell lymphoma|anaplastic large cell lymphoma
745494|NCT01144702|malaria|malaria
581703|NCT00499668|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
581704|NCT00499668|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
581705|NCT00499668|cutaneous T-cell non-Hodgkin lymphoma|cutaneous t-cell non-hodgkin lymphoma
581706|NCT00499668|mycosis fungoides/Sezary syndrome|mycosis fungoides/sezary syndrome
581707|NCT00499668|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
581708|NCT00499668|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
581709|NCT00499668|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
581710|NCT00499668|adult Burkitt lymphoma|adult burkitt lymphoma
581711|NCT00499668|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
581712|NCT00499668|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
581713|NCT00499668|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
581714|NCT00499668|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
581715|NCT00499668|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
581716|NCT00499668|grade 1 follicular lymphoma|grade 1 follicular lymphoma
581717|NCT00499668|grade 2 follicular lymphoma|grade 2 follicular lymphoma
581718|NCT00499668|grade 3 follicular lymphoma|grade 3 follicular lymphoma
581719|NCT00499668|mantle cell lymphoma|mantle cell lymphoma
581720|NCT00499668|marginal zone lymphoma|marginal zone lymphoma
581721|NCT00499668|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
581722|NCT00499668|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
581723|NCT00499668|splenic marginal zone lymphoma|splenic marginal zone lymphoma
581724|NCT00499668|small lymphocytic lymphoma|small lymphocytic lymphoma
581725|NCT00499668|intraocular lymphoma|intraocular lymphoma
581726|NCT00499668|primary central nervous system lymphoma|primary central nervous system lymphoma
581727|NCT00499668|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
581728|NCT00499668|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
581729|NCT00499668|myelodysplastic syndromes|myelodysplastic syndromes
581730|NCT00499668|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
581731|NCT00499668|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
581732|NCT00499668|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
581733|NCT00499668|chronic myeloproliferative disorders|chronic myeloproliferative disorders
581734|NCT00499668|myelodysplastic/myeloproliferative diseases|myelodysplastic/myeloproliferative diseases
581735|NCT00499681|stage I breast cancer|stage i breast cancer
581736|NCT00499681|stage II breast cancer|stage ii breast cancer
581737|NCT00499681|stage IIIA breast cancer|stage iiia breast cancer
581738|NCT00499681|stage IIIB breast cancer|stage iiib breast cancer
581739|NCT00499694|stage IV prostate cancer|stage iv prostate cancer
581740|NCT00499694|recurrent prostate cancer|recurrent prostate cancer
581741|NCT00499694|adenocarcinoma of the prostate|adenocarcinoma of the prostate
581742|NCT00499707|HbA1c|hba1c
581743|NCT00499707|Drug-naive|drug-naive
581744|NCT00499707|type 2 diabetes|type 2 diabetes
581745|NCT00499720|Cystic Fibrosis|cystic fibrosis
581746|NCT00499720|Pseudomonas aeruginosa|pseudomonas aeruginosa
581747|NCT00499720|airway infection|airway infection
581748|NCT00499720|Aztreonam Lysine for Inhalation|aztreonam lysine for inhalation
581749|NCT00499733|carcinoma of unknown primary|carcinoma of unknown primary
581750|NCT00499733|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
581751|NCT00499733|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
581752|NCT00499733|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
581753|NCT00499733|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
581754|NCT00499733|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
581755|NCT00499733|extensive stage small cell lung cancer|extensive stage small cell lung cancer
581756|NCT00499733|recurrent small cell lung cancer|recurrent small cell lung cancer
581757|NCT00499733|stage III renal cell cancer|stage iii renal cell cancer
581758|NCT00499733|stage IV renal cell cancer|stage iv renal cell cancer
581759|NCT00499733|recurrent renal cell cancer|recurrent renal cell cancer
581760|NCT00499733|stage III prostate cancer|stage iii prostate cancer
581761|NCT00499733|stage IV prostate cancer|stage iv prostate cancer
581762|NCT00499733|recurrent prostate cancer|recurrent prostate cancer
581763|NCT00499733|male breast cancer|male breast cancer
581764|NCT00499733|recurrent breast cancer|recurrent breast cancer
581765|NCT00499733|stage IIIA breast cancer|stage iiia breast cancer
581766|NCT00499733|stage IIIB breast cancer|stage iiib breast cancer
581767|NCT00499733|stage IIIC breast cancer|stage iiic breast cancer
581768|NCT00499733|stage IV breast cancer|stage iv breast cancer
581769|NCT00499733|chondrosarcoma|chondrosarcoma
581770|NCT00499733|metastatic osteosarcoma|metastatic osteosarcoma
581771|NCT00499733|recurrent osteosarcoma|recurrent osteosarcoma
581772|NCT00499733|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
581773|NCT00499733|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
581774|NCT00499733|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
581775|NCT00499733|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
745787|NCT01145963|appetite|appetite
581776|NCT00499733|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
581777|NCT00499733|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
581778|NCT00499733|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
581779|NCT00499733|ovarian sarcoma|ovarian sarcoma
581780|NCT00499733|stage III uterine sarcoma|stage iii uterine sarcoma
581781|NCT00499733|stage IV uterine sarcoma|stage iv uterine sarcoma
581782|NCT00499733|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
581783|NCT00499733|classic Kaposi sarcoma|classic kaposi sarcoma
581784|NCT00499733|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
581785|NCT00499733|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
581786|NCT00499733|stage III colon cancer|stage iii colon cancer
581787|NCT00499733|stage IV colon cancer|stage iv colon cancer
581788|NCT00499733|recurrent colon cancer|recurrent colon cancer
581789|NCT00499733|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
581790|NCT00499733|recurrent adult primary liver cancer|recurrent adult primary liver cancer
581791|NCT00499733|recurrent childhood liver cancer|recurrent childhood liver cancer
582243|NCT00507598|colorectal cancer|colorectal cancer
581792|NCT00499733|stage III childhood liver cancer|stage iii childhood liver cancer
581793|NCT00499733|stage IV childhood liver cancer|stage iv childhood liver cancer
581794|NCT00499733|stage III pancreatic cancer|stage iii pancreatic cancer
581795|NCT00499733|localized osteosarcoma|localized osteosarcoma
581796|NCT00499733|malignant giant cell tumor of bone|malignant giant cell tumor of bone
581797|NCT00499733|stage IV melanoma|stage iv melanoma
581798|NCT00499733|recurrent melanoma|recurrent melanoma
581799|NCT00499733|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
581800|NCT00499733|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
581858|NCT00499746|opioid pharmacology|opioid pharmacology
581801|NCT00499733|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
581802|NCT00499733|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
581803|NCT00499733|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
581804|NCT00499733|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
581805|NCT00499733|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
581806|NCT00499733|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
581807|NCT00499733|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
581808|NCT00499733|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
581809|NCT00499733|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
581810|NCT00499733|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
581811|NCT00499733|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
581812|NCT00499733|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
581813|NCT00499733|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
581814|NCT00499733|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
581815|NCT00499733|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
581816|NCT00499733|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
581817|NCT00499733|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
581818|NCT00499733|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
581819|NCT00499733|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
581820|NCT00499733|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
581821|NCT00499733|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
581822|NCT00499733|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
581823|NCT00499733|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
581824|NCT00499733|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
581825|NCT00499733|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
581826|NCT00499733|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
581827|NCT00499733|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
581828|NCT00499733|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
581829|NCT00499733|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
581830|NCT00499733|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
583559|NCT00512174|Radical Cystectomy|radical cystectomy
745788|NCT01145963|hunger|hunger
581831|NCT00499733|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
581832|NCT00499733|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
581833|NCT00499733|salivary gland adenocarcinoma|salivary gland adenocarcinoma
581834|NCT00499733|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
581835|NCT00499733|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
581836|NCT00499733|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
581837|NCT00499733|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
581838|NCT00499733|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
581839|NCT00499733|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
581840|NCT00499733|salivary gland acinic cell tumor|salivary gland acinic cell tumor
581841|NCT00499733|stage III salivary gland cancer|stage iii salivary gland cancer
581842|NCT00499733|stage IV salivary gland cancer|stage iv salivary gland cancer
581843|NCT00499733|recurrent salivary gland cancer|recurrent salivary gland cancer
581844|NCT00499733|intraocular lymphoma|intraocular lymphoma
581845|NCT00499733|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
581846|NCT00499733|recurrent pancreatic cancer|recurrent pancreatic cancer
581847|NCT00499733|recurrent uterine sarcoma|recurrent uterine sarcoma
581848|NCT00499733|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
751890|NCT01171092|myeloma|myeloma
581849|NCT00499733|advanced adult primary liver cancer|advanced adult primary liver cancer
581850|NCT00499733|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
581851|NCT00499733|conjunctival melanoma|conjunctival melanoma
581852|NCT00499733|stage IV pancreatic cancer|stage iv pancreatic cancer
581853|NCT00499733|stage IIIA melanoma|stage iiia melanoma
581854|NCT00499733|stage IIIB melanoma|stage iiib melanoma
581855|NCT00499733|stage IIIC melanoma|stage iiic melanoma
581856|NCT00499733|tongue cancer|tongue cancer
581857|NCT00499746|drug discrimination|drug discrimination
581859|NCT00499746|behavioral pharmacology|behavioral pharmacology
581860|NCT00499746|human research|human research
581861|NCT00499759|fatigue|fatigue
581862|NCT00499759|depression|depression
581863|NCT00499759|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
581864|NCT00499759|musculoskeletal complications|musculoskeletal complications
581865|NCT00499759|acute undifferentiated leukemia|acute undifferentiated leukemia
581866|NCT00499759|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
581867|NCT00499759|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
581868|NCT00499759|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
581869|NCT00499759|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
581870|NCT00499759|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
581871|NCT00499759|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
581872|NCT00499759|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
581873|NCT00499759|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
581874|NCT00499759|secondary acute myeloid leukemia|secondary acute myeloid leukemia
581875|NCT00499759|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
581876|NCT00499785|depression|depression
581877|NCT00499785|cognitive/functional effects|cognitive/functional effects
581878|NCT00499785|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
581879|NCT00499785|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
581880|NCT00499785|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
581881|NCT00499785|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
581882|NCT00499785|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
581883|NCT00499785|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
581884|NCT00505934|Epilepsy|epilepsy
581885|NCT00505934|Child|child
581886|NCT00505934|Levetiracetam|levetiracetam
581887|NCT00505934|Keppra®|keppra®
581888|NCT00505934|Infusion|infusion
581889|NCT00505934|Intravenous|intravenous
581890|NCT00505947|macular edema|macular edema
581891|NCT00505947|diabetes mellitus|diabetes mellitus
581892|NCT00505947|visual loss|visual loss
581893|NCT00505947|diabetic retinopathy|diabetic retinopathy
581894|NCT00505947|macula|macula
581895|NCT00505947|maculopathy|maculopathy
581896|NCT00505947|infliximab|infliximab
581897|NCT00505999|Multiple Myeloma|multiple myeloma
581898|NCT00505999|Etiology|etiology
751756|NCT01170338|smoking|smoking
581899|NCT00505999|Risk Factors|risk factors
581900|NCT00505999|Healthy Controls|healthy controls
581901|NCT00505999|Questionnaire|questionnaire
581902|NCT00505999|Survey|survey
581903|NCT00506012|Myoclonus Dystonia|myoclonus dystonia
581904|NCT00506012|Essential Myoclonus|essential myoclonus
581905|NCT00506012|Inherited Myoclonus|inherited myoclonus
581906|NCT00506012|Dyskinesia|dyskinesia
581907|NCT00506012|Movement Disorder|movement disorder
581908|NCT00506025|Pregnancy|pregnancy
581909|NCT00506025|Cranberry|cranberry
581910|NCT00506025|Asymptomatic Bacteruria|asymptomatic bacteruria
581911|NCT00506038|Calcific Tendinitis|calcific tendinitis
581912|NCT00506051|Non-small cell lung cancer|non-small cell lung cancer
581913|NCT00506051|lung cancer|lung cancer
581914|NCT00506051|alimta|alimta
581915|NCT00506051|vandetanib|vandetanib
581916|NCT00506051|phase 1|phase 1
581917|NCT00506064|Breast Cancer|breast cancer
581918|NCT00506064|Sleep|sleep
581919|NCT00506064|Melatonin|melatonin
581920|NCT00506064|Placebo|placebo
581921|NCT00506064|Survey|survey
581922|NCT00506064|Postoperative Srejic Sleep SAT Survey|postoperative srejic sleep sat survey
581923|NCT00506077|Undifferentiated schizophrenia|undifferentiated schizophrenia
581924|NCT00506077|residual schizophrenia|residual schizophrenia
581925|NCT00506090|scar|scar
581926|NCT00506090|surgery|surgery
581927|NCT00506090|lasers|lasers
581928|NCT00506103|Thyroidectomy|thyroidectomy
581929|NCT00506103|Central neck dissection|central neck dissection
581930|NCT00506103|Harmonic scalpel|harmonic scalpel
581931|NCT00506103|Perioperative complications|perioperative complications
581932|NCT00506116|Pelvic floor muscle training|pelvic floor muscle training
581933|NCT00506116|Self-directed pushing|self-directed pushing
581934|NCT00506116|Antenatal perineal massage|antenatal perineal massage
581935|NCT00506129|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
581936|NCT00506129|CTCL|ctcl
581937|NCT00506129|Allogeneic Transplantation|allogeneic transplantation
581939|NCT00506129|Allogeneic peripheral blood progenitor cell|allogeneic peripheral blood progenitor cell
581941|NCT00506129|Bone Marrow transplantation|bone marrow transplantation
581942|NCT00506129|Stem Cell Transplant|stem cell transplant
581944|NCT00506129|Fludarabine|fludarabine
581945|NCT00506129|Fludarabine Phosphate|fludarabine phosphate
581946|NCT00506129|Fludara|fludara
581947|NCT00506129|Melphalan|melphalan
581948|NCT00506155|Bladder Cancer|bladder cancer
581949|NCT00506155|Urothelial Cancer|urothelial cancer
581953|NCT00506155|Doxorubicin|doxorubicin
581954|NCT00506155|Methotrexate|methotrexate
581955|NCT00506155|Vinblastine|vinblastine
581956|NCT00506155|M-VAC|m-vac
581957|NCT00506168|Colorectal neoplasms|colorectal neoplasms
581958|NCT00506168|Secondary|secondary
581959|NCT00506168|Drug therapy, combination|drug therapy, combination
581960|NCT00506168|Irinotecan|irinotecan
581961|NCT00506168|Capecitabine|capecitabine
581962|NCT00506194|type 2 diabetes|type 2 diabetes
581963|NCT00506194|oral glucose tolerance test|oral glucose tolerance test
581964|NCT00506194|insulin|insulin
581965|NCT00506194|oral anti-diabetic drug|oral anti-diabetic drug
581966|NCT00506194|ß-cell function|ß-cell function
581967|NCT00506207|Gastrointestinal neoplasms|gastrointestinal neoplasms
581968|NCT00506207|Combination chemotherapy|combination chemotherapy
581969|NCT00506207|S-1|s-1
581970|NCT00506207|Irinotecan|irinotecan
581971|NCT00506207|Oxaliplatin|oxaliplatin
581972|NCT00506233|Graft-Versus-Host Disease|graft-versus-host disease
581973|NCT00506233|GVHD|gvhd
581974|NCT00506233|Questionnaire|questionnaire
581975|NCT00506246|anaesthesia|anaesthesia
581976|NCT00506259|Deletion 17p11.2|deletion 17p11.2
581977|NCT00506259|Melatonin|melatonin
581978|NCT00506259|Phototherapy|phototherapy
581979|NCT00506259|Behavioral Phenotype|behavioral phenotype
581980|NCT00506259|Developmental Delay/MR|developmental delay/mr
581981|NCT00506259|Smith-Magenis Syndrome|smith-magenis syndrome
581982|NCT00506259|Sleep Disturbance|sleep disturbance
581983|NCT00506259|SMS|sms
581984|NCT00506259|Sleep Disorder|sleep disorder
581985|NCT00506610|Pain|pain
581986|NCT00506610|Postherpetic Neuralgia|postherpetic neuralgia
581987|NCT00506610|Neuralgia, Postherpetic|neuralgia, postherpetic
581988|NCT00506610|Shingles|shingles
581989|NCT00506610|Herpes Zoster|herpes zoster
581990|NCT00506610|Neuropathic Pain|neuropathic pain
581991|NCT00506623|Rectal neoplasm|rectal neoplasm
581992|NCT00506623|Neoadjuvant therapy|neoadjuvant therapy
581993|NCT00506623|Radiotherapy|radiotherapy
581994|NCT00506623|Combination chemotherapy|combination chemotherapy
581995|NCT00506623|Irinotecan|irinotecan
581996|NCT00506623|Capecitabine|capecitabine
581997|NCT00506649|protocol|protocol
581998|NCT00506649|analgesia|analgesia
581999|NCT00506649|sedation|sedation
582000|NCT00506649|delirium|delirium
582001|NCT00506649|coma|coma
582002|NCT00506675|Amblyopia|amblyopia
582003|NCT00506675|Atropine|atropine
582004|NCT00506675|Patching|patching
582005|NCT00506714|Osteoarthritis|osteoarthritis
582006|NCT00506714|Walking Sticks|walking sticks
582007|NCT00506714|Canes|canes
582008|NCT00506753|substance abuse|substance abuse
582009|NCT00506766|Urinary Incontinence|urinary incontinence
582010|NCT00506766|Self efficacy|self efficacy
582011|NCT00506766|Pelvic floor muscle training|pelvic floor muscle training
582012|NCT00506766|Bladder training|bladder training
582013|NCT00506779|Uterine Papillary Serous Carcinoma|uterine papillary serous carcinoma
582014|NCT00506779|Uterine Cancer|uterine cancer
582015|NCT00506779|UPSC|upsc
582016|NCT00506779|Taxol|taxol
582017|NCT00506779|Paclitaxel|paclitaxel
582018|NCT00506779|Gleevec|gleevec
582019|NCT00506779|Imatinib Mesylate|imatinib mesylate
582020|NCT00506779|STI571|sti571
582021|NCT00506792|Cystic fibrosis, QAU145, nasal potential difference|cystic fibrosis, qau145, nasal potential difference
582022|NCT00506805|solid tumor malignancy; Hsp90|solid tumor malignancy; hsp90
582023|NCT00506818|emotional symptoms|emotional symptoms
582024|NCT00506818|vascular risk-factors|vascular risk-factors
582025|NCT00506844|Rectal neoplasms|rectal neoplasms
582026|NCT00506844|Neoadjuvant treatment|neoadjuvant treatment
582027|NCT00506844|Cetuximab|cetuximab
582028|NCT00506844|Irinotecan|irinotecan
582029|NCT00506844|Capecitabine|capecitabine
582030|NCT00506844|Radiotherapy|radiotherapy
582031|NCT00506844|Combination chemotherapy|combination chemotherapy
582032|NCT00506857|Hematologic Malignancies|hematologic malignancies
582033|NCT00506857|Blood And Marrow Transplantation|blood and marrow transplantation
582034|NCT00506857|Leukemia|leukemia
582035|NCT00506857|MDS|mds
582036|NCT00506857|Lymphoma|lymphoma
582037|NCT00506857|Myeloma|myeloma
582038|NCT00506857|Fludarabine|fludarabine
582039|NCT00506857|Fludara|fludara
582040|NCT00506857|Fludarabine Phosphate|fludarabine phosphate
582041|NCT00506857|Busulfan|busulfan
582042|NCT00506857|Busulfex|busulfex
582044|NCT00506857|Progenitor Cell Transplantation|progenitor cell transplantation
582045|NCT00506857|Granulocyte colony stimulating factor|granulocyte colony stimulating factor
582046|NCT00506857|G-CSF|g-csf
582047|NCT00506857|Apheresis|apheresis
582048|NCT00506857|Blood cell infusion|blood cell infusion
582049|NCT00506870|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
582050|NCT00506870|INR self monitoring|inr self monitoring
582051|NCT00506870|cost benefit evaluation|cost benefit evaluation
582052|NCT00506896|Rheumatoid Arthritis|rheumatoid arthritis
582053|NCT00506896|glucocorticoid|glucocorticoid
582054|NCT00506896|intraarticular injection|intraarticular injection
582055|NCT00506896|arthritis|arthritis
582056|NCT00506909|oxytocin|oxytocin
582057|NCT00506922|Graft-Versus-Host Disease|graft-versus-host disease
582058|NCT00506922|GVHD Prevention|gvhd prevention
582059|NCT00506922|Hodgkin's Disease|hodgkin's disease
582060|NCT00506922|Leukemia|leukemia
582061|NCT00506922|Lymphoma|lymphoma
582062|NCT00506922|Methotrexate|methotrexate
582063|NCT00506922|Tacrolimus|tacrolimus
582064|NCT00506922|Pentostatin|pentostatin
582065|NCT00506935|methamphetamine|methamphetamine
582066|NCT00506935|GVG|gvg
582067|NCT00506935|vigabatrin|vigabatrin
582068|NCT00506935|stimulant|stimulant
582069|NCT00506948|Hematological Malignancies|hematological malignancies
582070|NCT00506948|Myelodysplastic Syndrome|myelodysplastic syndrome
582071|NCT00506948|Graft Versus Host Disease|graft versus host disease
582072|NCT00506948|GVHD|gvhd
582073|NCT00506948|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
582074|NCT00506948|AHSCT|ahsct
582075|NCT00506948|Leukemia|leukemia
582076|NCT00506948|Lymphoma|lymphoma
582077|NCT00506948|T-Cells|t-cells
582078|NCT00506948|Thymoglobulin|thymoglobulin
582079|NCT00506948|ATG|atg
582080|NCT00506948|rATG|ratg
582081|NCT00506948|Rabbit Antithymocyte Globulin|rabbit antithymocyte globulin
582082|NCT00506948|Rapamune|rapamune
582083|NCT00506948|Sirolimus|sirolimus
582084|NCT00506948|Mycophenolate Mofetil|mycophenolate mofetil
582085|NCT00506948|Cellcept|cellcept
582086|NCT00506948|MMF|mmf
582087|NCT00506974|sleep|sleep
582088|NCT00506974|normal sleepers|normal sleepers
582089|NCT00507013|vascular closure device|vascular closure device
582090|NCT00507039|PD20 FEV1|pd20 fev1
582091|NCT00507039|grass pollen|grass pollen
582092|NCT00507039|one-step|one-step
582093|NCT00507052|Hemodialysis|hemodialysis
582094|NCT00507052|Residual Renal Function|residual renal function
582095|NCT00507078|Obstructive Sleep Apnea|obstructive sleep apnea
582096|NCT00507078|Leptin|leptin
582097|NCT00507078|Homocysteine|homocysteine
582098|NCT00507078|C-reactive Protein|c-reactive protein
582099|NCT00507091|ZD6474|zd6474
582100|NCT00507091|Irinotecan|irinotecan
582101|NCT00507091|5-Fluorouracil|5-fluorouracil
582102|NCT00507091|Leucovorin|leucovorin
582103|NCT00507091|colorectal|colorectal
582104|NCT00507104|traumatic brain injury|traumatic brain injury
582105|NCT00507104|Subarachnoid Hemorrhage|subarachnoid hemorrhage
752002|NCT01171456|GDM|gdm
582106|NCT00507104|Hypopituitarism|hypopituitarism
582107|NCT00507117|Obstructive Sleep Apnea|obstructive sleep apnea
582108|NCT00507117|Polysomnography|polysomnography
582109|NCT00507117|Non-benzodiazepine hypnotics|non-benzodiazepine hypnotics
582110|NCT00507143|Colorectal neoplasms|colorectal neoplasms
582111|NCT00507143|Secondary|secondary
582112|NCT00507143|irinotecan|irinotecan
582113|NCT00507143|Pharmacokinetics|pharmacokinetics
582114|NCT00507143|Pharmacodynamics|pharmacodynamics
582115|NCT00507143|SLCO1B1|slco1b1
582116|NCT00507143|PXR|pxr
582117|NCT00507182|Oral Mucosa Lesions|oral mucosa lesions
582118|NCT00507182|Oral Cancer|oral cancer
582119|NCT00507182|Neoplasia and Dysplasia in oral cavity mucosa|neoplasia and dysplasia in oral cavity mucosa
582120|NCT00507182|Fluorescence Spectroscopy|fluorescence spectroscopy
582121|NCT00507182|Reflectance Spectroscopy|reflectance spectroscopy
582122|NCT00507182|Pre-cancerous lesions|pre-cancerous lesions
582123|NCT00507182|Cancerous lesions|cancerous lesions
582124|NCT00507182|Mouth|mouth
582125|NCT00507195|Postanethesia cognitive recovery|postanethesia cognitive recovery
582126|NCT00507195|Postoperative delirium|postoperative delirium
582127|NCT00507195|hypnotics|hypnotics
582128|NCT00507195|propofol|propofol
582129|NCT00507195|sevoflurane|sevoflurane
582130|NCT00507195|desflurane|desflurane
582131|NCT00507195|postoperative cognitive recovery|postoperative cognitive recovery
582132|NCT00507208|trismus|trismus
582133|NCT00507208|head and neck cancer|head and neck cancer
582134|NCT00507221|HIV|hiv
582135|NCT00507221|Helminthiasis|helminthiasis
582136|NCT00507221|Co-infection|co-infection
582137|NCT00507221|Treatment Naive|treatment naive
582138|NCT00507234|COPD|copd
582139|NCT00507247|Catheter-Related Infection|catheter-related infection
582140|NCT00507247|Bloodstream Infections|bloodstream infections
582141|NCT00507247|Staphylococcus Aureus|staphylococcus aureus
582142|NCT00507247|Daptomycin|daptomycin
582143|NCT00507260|Leukemia|leukemia
582144|NCT00507260|Lymphoma|lymphoma
751891|NCT01171092|lymphoma|lymphoma
582244|NCT00507598|metabolomics|metabolomics
582245|NCT00507611|breast|breast
582145|NCT00507260|Post-Allogeneic Blood and Marrow Transplantation|post-allogeneic blood and marrow transplantation
582146|NCT00507260|Blood and Marrow Transplantation|blood and marrow transplantation
582148|NCT00507260|Cancer-Related Fatigue|cancer-related fatigue
582149|NCT00507260|Fatigue|fatigue
582150|NCT00507260|Nutritional Assessment|nutritional assessment
582151|NCT00507260|Nutritional Intervention|nutritional intervention
582152|NCT00507260|Malnutrition|malnutrition
582153|NCT00507273|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
582154|NCT00507273|Gastrointestinal Cancer|gastrointestinal cancer
582155|NCT00507273|GISTs|gists
582156|NCT00507273|GIST Registry|gist registry
582157|NCT00507273|Registry|registry
582158|NCT00507299|Child maltreatment|child maltreatment
582159|NCT00507299|Physician education|physician education
582160|NCT00507299|Prevention|prevention
582161|NCT00507312|To assess two new diagnostic devices for detecting early Heart Failure.|to assess two new diagnostic devices for detecting early heart failure.
582162|NCT00507325|Malignant Melanoma|malignant melanoma
582163|NCT00507325|Blood Sample|blood sample
582164|NCT00507325|Tumor Sample|tumor sample
582165|NCT00507325|Long-term storage|long-term storage
582166|NCT00507325|Sample Collection|sample collection
582167|NCT00507338|percutaneous coronary intervention|percutaneous coronary intervention
582168|NCT00507351|Breast Cancer|breast cancer
582169|NCT00507351|Colorectal Cancer|colorectal cancer
582170|NCT00507351|Lung Cancer|lung cancer
582171|NCT00507351|Prostate Cancer|prostate cancer
582172|NCT00507351|Pain Management|pain management
582173|NCT00507351|Questionnaire|questionnaire
582174|NCT00507351|Survey|survey
582175|NCT00507377|Esophageal Benign Disease|esophageal benign disease
582176|NCT00507377|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
582177|NCT00507377|Hiatal Hernia|hiatal hernia
582178|NCT00507377|Antireflux Surgery|antireflux surgery
582179|NCT00507377|Short Esophagus|short esophagus
582180|NCT00507390|fish oils|fish oils
582181|NCT00507429|thyroid neoplasms|thyroid neoplasms
582182|NCT00507429|thyroid cancer|thyroid cancer
582183|NCT00507429|thyroid carcinoma|thyroid carcinoma
582184|NCT00507442|Treatment for patients with multiple myeloma|treatment for patients with multiple myeloma
582185|NCT00507442|who have received no prior treatment|who have received no prior treatment
582186|NCT00507455|Lower Urinary Tract Symptoms|lower urinary tract symptoms
582187|NCT00507455|Bladder Outlet Obstruction|bladder outlet obstruction
582188|NCT00507455|Treatment|treatment
582189|NCT00507455|Solifenacin Succinate|solifenacin succinate
582190|NCT00507455|Tamsulosin hydrochloride|tamsulosin hydrochloride
582191|NCT00507468|bone marrow|bone marrow
582192|NCT00507468|autologous|autologous
582193|NCT00507468|ejection fraction|ejection fraction
582194|NCT00507468|left ventricle|left ventricle
582195|NCT00507468|heart attack|heart attack
582196|NCT00507468|myocardial infarction|myocardial infarction
582197|NCT00507468|left ventricular dysfunction post myocardial infarction|left ventricular dysfunction post myocardial infarction
582198|NCT00507481|Sleep|sleep
582199|NCT00507481|ICU|icu
582200|NCT00507481|Delirium|delirium
582201|NCT00507481|Post surgical ventilated patients|post surgical ventilated patients
582202|NCT00507481|ICU patients|icu patients
582203|NCT00507494|posttransplant diabetes mellitus|posttransplant diabetes mellitus
745789|NCT01145963|satiation|satiation
582204|NCT00507494|kidney transplantation|kidney transplantation
582205|NCT00507494|filtration fraction|filtration fraction
582206|NCT00507494|proteinuria|proteinuria
582207|NCT00507507|tenofovir|tenofovir
582208|NCT00507507|monotherapy|monotherapy
582209|NCT00507507|emtricitabine|emtricitabine
582210|NCT00507507|combination|combination
582211|NCT00507507|hepatitis B|hepatitis b
582213|NCT00507520|Almonds|almonds
582214|NCT00507520|Hyperlipidemia|hyperlipidemia
582215|NCT00507520|Blood Lipids|blood lipids
582216|NCT00507533|CPAP|cpap
582217|NCT00507533|Hematologic|hematologic
582218|NCT00507533|Neutropenic|neutropenic
582219|NCT00507533|ARF|arf
582220|NCT00507546|sleep|sleep
582221|NCT00507546|melatonin|melatonin
582222|NCT00507546|spinal cord injury|spinal cord injury
582223|NCT00507546|insomnia|insomnia
582224|NCT00507546|tetraplegia|tetraplegia
582225|NCT00507572|Solid Tumors|solid tumors
582226|NCT00507572|Pregnancy|pregnancy
582227|NCT00507572|Data Collection|data collection
582228|NCT00507585|Liver Cancer|liver cancer
582229|NCT00507585|Liver metastases|liver metastases
582230|NCT00507585|Metastatic advanced solid tumors|metastatic advanced solid tumors
582231|NCT00507585|Advanced solid tumors metastatic to the liver|advanced solid tumors metastatic to the liver
582232|NCT00507585|Hepatic Arterial Infusion|hepatic arterial infusion
582233|NCT00507585|Intra-arterial hepatic oxaliplatin|intra-arterial hepatic oxaliplatin
582234|NCT00507585|Fluorouracil|fluorouracil
582235|NCT00507585|5-FU|5-fu
582236|NCT00507585|Adrucil|adrucil
582237|NCT00507585|Efudex|efudex
582238|NCT00507585|5-fluorouracil|5-fluorouracil
582239|NCT00507585|Avastin|avastin
582240|NCT00507585|Leucovorin|leucovorin
582241|NCT00507585|Oxaliplatin|oxaliplatin
582242|NCT00507585|Bevacizumab|bevacizumab
582450|NCT00508274|lapatinib|lapatinib
582246|NCT00507611|sentinel lymph node|sentinel lymph node
582247|NCT00507611|node mapping|node mapping
582248|NCT00507650|Pressure ulcers|pressure ulcers
582249|NCT00507650|Geriatrics|geriatrics
582250|NCT00507650|Nursing home|nursing home
582251|NCT00507650|Fluid balance|fluid balance
582252|NCT00507650|Collagen deposition|collagen deposition
582253|NCT00507663|beta blocker|beta blocker
582254|NCT00507663|functional recovery|functional recovery
582255|NCT00507676|Asthma|asthma
582256|NCT00507676|Wheezing|wheezing
582257|NCT00507676|Infant|infant
582258|NCT00507689|Truvada|truvada
582259|NCT00507689|HBIg|hbig
582260|NCT00507689|Chronic Hepatitis B Recurrence|chronic hepatitis b recurrence
582261|NCT00507689|Post Orthotopic Liver Transplant|post orthotopic liver transplant
582262|NCT00507715|Parkinson's Disease, Idiopathic|parkinson's disease, idiopathic
582263|NCT00507715|l-dopa levels|l-dopa levels
582264|NCT00507715|plantago ovata husk|plantago ovata husk
582265|NCT00507728|Pharmacogenetics|pharmacogenetics
582266|NCT00507728|Emotional Reactivity|emotional reactivity
582267|NCT00507728|Smoking Cessation Counseling|smoking cessation counseling
582268|NCT00507728|Smoking|smoking
582269|NCT00507728|Bupropion|bupropion
582270|NCT00507728|Wellbutrin|wellbutrin
582271|NCT00507728|Wellbutrin SR|wellbutrin sr
582272|NCT00507728|Zyban|zyban
582273|NCT00507728|Varenicline|varenicline
582274|NCT00507728|Chantix|chantix
582275|NCT00507728|Placebo|placebo
582276|NCT00507741|Cancer|cancer
582277|NCT00507741|Ovarian|ovarian
582278|NCT00507741|Endometrial|endometrial
582279|NCT00507741|Phase II|phase ii
582280|NCT00507741|EC145|ec145
582281|NCT00507741|EC20|ec20
582282|NCT00507754|Advanced Cancer|advanced cancer
582283|NCT00507754|Solid Tumors|solid tumors
582284|NCT00507754|Latent Mycobacterium Tuberculosis|latent mycobacterium tuberculosis
582285|NCT00507754|Tuberculin Skin Test|tuberculin skin test
582286|NCT00507754|Tuberculosis|tuberculosis
582287|NCT00507754|T-SPOT TB test|t-spot tb test
582289|NCT00507780|GnRH Antagonist|gnrh antagonist
582290|NCT00507780|Premature Ovarian Failure|premature ovarian failure
582291|NCT00507780|Fertility|fertility
582292|NCT00507780|Chemotherapy|chemotherapy
582293|NCT00507780|POF|pof
582294|NCT00507806|Acute Ischemic Stroke|acute ischemic stroke
582295|NCT00507806|Microbubbles|microbubbles
582296|NCT00507806|Transcranial Doppler ultrasound|transcranial doppler ultrasound
582297|NCT00507806|TIBI|tibi
582298|NCT00507806|Symptomatic Intracranial Hemorrhage|symptomatic intracranial hemorrhage
582299|NCT00507806|modified Rankin Scale|modified rankin scale
582300|NCT00507806|Recanalization|recanalization
582301|NCT00507806|Perflutren|perflutren
582302|NCT00507819|Other Single Ventricle Anatomy|other single ventricle anatomy
582303|NCT00507819|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
582304|NCT00507819|Tricuspid Atresia|tricuspid atresia
582305|NCT00507832|Prurigo nodularis|prurigo nodularis
582306|NCT00507858|Head and Neck Cancer|head and neck cancer
582307|NCT00507858|Squamous Cell Cancer|squamous cell cancer
582308|NCT00507858|Alimta|alimta
582309|NCT00507858|Pemetrexed|pemetrexed
582310|NCT00507858|Dexamethasone|dexamethasone
582311|NCT00507858|HNSCC|hnscc
582312|NCT00507858|Decadron|decadron
582313|NCT00507871|cryptosporidiosis, Cryptosporidium, Uganda, diarrhea|cryptosporidiosis, cryptosporidium, uganda, diarrhea
582314|NCT00507884|Kidney Neoplasms|kidney neoplasms
582315|NCT00507884|Renal Tumors|renal tumors
582316|NCT00507884|Magnetic Resonance Imaging|magnetic resonance imaging
582317|NCT00507884|3 Tesla MRI|3 tesla mri
582318|NCT00507884|MRI|mri
582319|NCT00507897|thyroid nodules, blood pressure, thyroid hormones|thyroid nodules, blood pressure, thyroid hormones
582320|NCT00507910|ankle fracture|ankle fracture
582321|NCT00507910|pes planus|pes planus
582322|NCT00507923|Breast Cancer|breast cancer
582323|NCT00507923|Tibetan Yoga|tibetan yoga
582324|NCT00507923|Stretching|stretching
582325|NCT00507923|Yoga|yoga
582326|NCT00507923|Fatigue|fatigue
582327|NCT00507923|Sleep|sleep
582328|NCT00507923|Questionnaire|questionnaire
582329|NCT00507923|Survey|survey
582330|NCT00507936|Diabetic Neuropathy|diabetic neuropathy
582331|NCT00507936|Painful|painful
582332|NCT00507936|Diabetic Polyneuropathy|diabetic polyneuropathy
582333|NCT00507936|Neuralgia|neuralgia
582334|NCT00507936|Diabetic|diabetic
582335|NCT00507936|Diabetic Neuropathies|diabetic neuropathies
582336|NCT00507936|Diabetic Neuralgia|diabetic neuralgia
582337|NCT00507949|COPD|copd
582338|NCT00507949|body weight|body weight
582339|NCT00507949|megestrol acetate|megestrol acetate
582340|NCT00507949|cytokines|cytokines
582341|NCT00507962|Advanced Cancer|advanced cancer
582342|NCT00507962|Dominant Liver Involvement|dominant liver involvement
582343|NCT00507962|Hepatic Intraarterial Cisplatin|hepatic intraarterial cisplatin
582344|NCT00507962|Cisplatin|cisplatin
582345|NCT00507962|Liposomal Doxorubicin|liposomal doxorubicin
582346|NCT00507962|Platinol-AQ|platinol-aq
582347|NCT00507962|Platinol|platinol
582348|NCT00507962|CDDP|cddp
582349|NCT00507962|Doxil|doxil
582350|NCT00507962|Liposomal|liposomal
582351|NCT00507962|Doxorubicin Hydrochloride|doxorubicin hydrochloride
582352|NCT00507975|Smoking|smoking
582353|NCT00507975|pregnancy|pregnancy
582354|NCT00507975|newborn|newborn
582355|NCT00507975|birth weight|birth weight
582356|NCT00507975|nicotine patch|nicotine patch
582357|NCT00507975|birth|birth
582358|NCT00507988|Cognitive Training|cognitive training
582359|NCT00507988|Complex Problem Solving|complex problem solving
582360|NCT00507988|Goal Management|goal management
582361|NCT00507988|Planning|planning
582362|NCT00508001|Hepatocellular carcinoma|hepatocellular carcinoma
582568|NCT00508586|VEGF|vegf
582363|NCT00508001|Advanced solid, malignant tumour|advanced solid, malignant tumour
582364|NCT00508014|Cardiovascular disease|cardiovascular disease
582365|NCT00508014|Diabetes|diabetes
582366|NCT00508014|Quality improvement|quality improvement
582367|NCT00508014|Peer review|peer review
582368|NCT00508027|sickle cell disease|sickle cell disease
582369|NCT00508027|simvastatin|simvastatin
582370|NCT00508027|statin drugs|statin drugs
582371|NCT00508027|nitric oxide donors|nitric oxide donors
582372|NCT00508027|vascular injury|vascular injury
582373|NCT00508040|Birdshot Retine choroidopathy|birdshot retine choroidopathy
582374|NCT00508040|Macular edema|macular edema
582375|NCT00508040|Prednisone|prednisone
582376|NCT00508040|Interferon alpha 2a|interferon alpha 2a
582377|NCT00508040|Associated with Cystoid macular edema|associated with cystoid macular edema
582378|NCT00508040|With Visual acuity loss|with visual acuity loss
582379|NCT00508053|wound infection|wound infection
582380|NCT00508053|incisional hernia|incisional hernia
582381|NCT00508053|wound dehiscence|wound dehiscence
582382|NCT00508053|wound healing|wound healing
582383|NCT00508053|postoperative complications|postoperative complications
582384|NCT00508053|surgical techniques|surgical techniques
582385|NCT00508066|Congenital Scoliosis|congenital scoliosis
582386|NCT00508066|Idiopathic Scoliosis|idiopathic scoliosis
582387|NCT00508066|Spinal Fusion|spinal fusion
582388|NCT00508066|Post-Operative Pain Management|post-operative pain management
582389|NCT00508066|Infusion Catheter|infusion catheter
582390|NCT00508079|Venous Disease|venous disease
582391|NCT00508079|Varicose Veins|varicose veins
582392|NCT00508079|Chronic Venous Insufficiency|chronic venous insufficiency
582393|NCT00508079|PAD|pad
582394|NCT00508092|appendicectomy|appendicectomy
582395|NCT00508092|pain|pain
582396|NCT00508092|local anaesthetic|local anaesthetic
582397|NCT00508092|nerve block|nerve block
582398|NCT00508092|Post operative pain following appendicectomy|post operative pain following appendicectomy
582399|NCT00508105|Osteoarthritis|osteoarthritis
582400|NCT00508105|Shoulder|shoulder
582401|NCT00508105|tenotomy|tenotomy
582402|NCT00508105|ostotomy|ostotomy
582403|NCT00508118|Aortic Arch Reconstruction Surgery|aortic arch reconstruction surgery
752367|NCT01172652|GAD|gad
582404|NCT00508131|Milk fortification|milk fortification
582405|NCT00508131|Effectivness evaluation|effectivness evaluation
582406|NCT00508131|Iron deficiency anemia|iron deficiency anemia
582407|NCT00508131|Stunting|stunting
582408|NCT00508131|Zinc deficiency|zinc deficiency
582409|NCT00508144|Non-Small Cell Lung Cancer|non-small cell lung cancer
582410|NCT00508144|Lung Cancer|lung cancer
582411|NCT00508144|NSCLC|nsclc
582412|NCT00508144|Malignant pleural effusion|malignant pleural effusion
582413|NCT00508144|Pericardial effusion|pericardial effusion
582414|NCT00508144|Pemetrexed|pemetrexed
582415|NCT00508144|Alimta|alimta
582416|NCT00508144|LY231514|ly231514
582417|NCT00508144|Poor Performance Status|poor performance status
582418|NCT00508144|Asymptomatic Brain Metastases|asymptomatic brain metastases
582419|NCT00508170|Head and Neck Cancer|head and neck cancer
582420|NCT00508170|Human Papillomavirus Infection|human papillomavirus infection
582421|NCT00508170|Oropharyngeal Patients|oropharyngeal patients
582422|NCT00508170|Sexual Behavior|sexual behavior
582423|NCT00508170|Questionnaire|questionnaire
582424|NCT00508183|full thickness rotator cuff tear|full thickness rotator cuff tear
582425|NCT00508196|right ventricular pacing|right ventricular pacing
582426|NCT00508196|endothelial function|endothelial function
582427|NCT00508196|cardiac output|cardiac output
582428|NCT00508209|high-dose melphalan|high-dose melphalan
582429|NCT00508209|bortezomib|bortezomib
582430|NCT00508209|response|response
582431|NCT00508209|toxicity|toxicity
582432|NCT00508209|relapse|relapse
582433|NCT00508222|HIV|hiv
582434|NCT00508222|HCV|hcv
582435|NCT00508222|HIV/HCV Co-infection|hiv/hcv co-infection
582436|NCT00508222|Kaletra Monotherapy|kaletra monotherapy
582437|NCT00508222|Treatment Experienced|treatment experienced
582438|NCT00508235|Neurofibromatosis|neurofibromatosis
582439|NCT00508235|Quality of Friendships|quality of friendships
582440|NCT00508235|Disease Severity|disease severity
582441|NCT00508235|Questionnaire|questionnaire
582442|NCT00508235|NF-1|nf-1
582443|NCT00508248|omega 3fatty acids|omega 3fatty acids
582444|NCT00508261|Meningococcal vaccine|meningococcal vaccine
582445|NCT00508261|Immunogenicity|immunogenicity
582446|NCT00508261|Routine infancy vaccination|routine infancy vaccination
582447|NCT00508261|Safety|safety
582448|NCT00508274|Advanced Metastatic Breast Cancer|advanced metastatic breast cancer
582449|NCT00508274|breast cancer|breast cancer
582451|NCT00508274|HER2+ positive|her2+ positive
582452|NCT00508274|TYVERB|tyverb
582453|NCT00508274|TYKERB|tykerb
582454|NCT00508300|laparoscopic|laparoscopic
582455|NCT00508300|colectomy|colectomy
582456|NCT00508300|Fast Track|fast track
582457|NCT00508300|epidural|epidural
582458|NCT00508313|Lung Cancer|lung cancer
582459|NCT00508313|Healthy Control|healthy control
582460|NCT00508313|Thermal Imaging|thermal imaging
582461|NCT00508313|Thermal Signatures|thermal signatures
582462|NCT00508313|Radiation Therapy|radiation therapy
582463|NCT00508313|Chemoradiation Therapy|chemoradiation therapy
582464|NCT00508326|Advanced Cancer|advanced cancer
582465|NCT00508326|Solid Tumor|solid tumor
582466|NCT00508326|Liver Metastasis|liver metastasis
582467|NCT00508326|Hepatic Artery Infusion|hepatic artery infusion
582468|NCT00508326|Liver|liver
582469|NCT00508326|Paclitaxel|paclitaxel
582470|NCT00508326|Taxol|taxol
582471|NCT00508339|Soft Tissue Sarcoma|soft tissue sarcoma
582472|NCT00508339|Limb Sparing Surgery|limb sparing surgery
582473|NCT00508339|Toronto Extremity Salvage Score|toronto extremity salvage score
582474|NCT00508339|Radiotherapy|radiotherapy
582475|NCT00508339|Quality of Life|quality of life
582476|NCT00508339|Questionnaire|questionnaire
582477|NCT00508339|Survey|survey
582478|NCT00508339|TESS|tess
582479|NCT00508352|breast|breast
582480|NCT00508352|cancer|cancer
582481|NCT00508352|locoregional|locoregional
582482|NCT00508352|IMRT|imrt
582483|NCT00508352|tomotherapy|tomotherapy
582484|NCT00508365|lisinopril|lisinopril
582485|NCT00508365|carvedilol|carvedilol
582486|NCT00508365|hypertension|hypertension
582487|NCT00508378|Ovarian Cancer|ovarian cancer
582488|NCT00508378|Quality of Life|quality of life
582489|NCT00508378|Chemotherapy Side-Effects|chemotherapy side-effects
582490|NCT00508378|Interview|interview
582491|NCT00508378|Questionnaire|questionnaire
582492|NCT00508378|Caregivers|caregivers
582493|NCT00508417|Malaria Incidence|malaria incidence
582494|NCT00508417|Anemia|anemia
582495|NCT00508417|Clinical Malaria|clinical malaria
582496|NCT00508430|ASP8825|asp8825
582497|NCT00508430|Diabetic Neuropathies|diabetic neuropathies
582498|NCT00508430|Pain|pain
582499|NCT00508443|Stereotactic Spine Radiotherapy System|stereotactic spine radiotherapy system
582500|NCT00508443|SSRS|ssrs
582501|NCT00508443|CT-on-Rails|ct-on-rails
582502|NCT00508443|Metastatic Spine Disease|metastatic spine disease
582503|NCT00508443|Spinal Neoplasms|spinal neoplasms
582504|NCT00508443|Radiation Therapy|radiation therapy
582505|NCT00508443|Trilogy|trilogy
582506|NCT00508443|Cancer|cancer
582507|NCT00508443|Breast Cancer|breast cancer
582508|NCT00508443|Gastrointestinal Cancer|gastrointestinal cancer
582509|NCT00508443|Genitourinary Disease|genitourinary disease
582510|NCT00508443|Lung Cancer|lung cancer
582511|NCT00508443|Lymphoma|lymphoma
582512|NCT00508443|Melanoma|melanoma
582513|NCT00508443|Sarcoma|sarcoma
582514|NCT00508443|Spinal Cancer|spinal cancer
582515|NCT00508456|Glioblastoma Multiforme|glioblastoma multiforme
582516|NCT00508456|Methionine Restriction|methionine restriction
582517|NCT00508456|Hominex-2|hominex-2
582518|NCT00508456|Methionine Restriction Diet|methionine restriction diet
582519|NCT00508456|Hominex-2 Amino Acid-Modified Medical Food|hominex-2 amino acid-modified medical food
582520|NCT00508456|Temozolomide|temozolomide
582522|NCT00508469|Intraocular pressure|intraocular pressure
582523|NCT00508469|Open-angle glaucoma|open-angle glaucoma
582524|NCT00508469|Ocular hypertension|ocular hypertension
582525|NCT00508469|Adherence|adherence
582526|NCT00508469|Compliance|compliance
582527|NCT00508482|Acupuncture|acupuncture
582528|NCT00508482|Functional constipation|functional constipation
582529|NCT00508495|pain, postoperative|pain, postoperative
582530|NCT00508495|replacement, total hip|replacement, total hip
582531|NCT00508495|total hip replacement|total hip replacement
582532|NCT00508495|arthroplasty, replacement, hip|arthroplasty, replacement, hip
582533|NCT00508508|Heart Failure|heart failure
582534|NCT00508508|Peer Support|peer support
582535|NCT00508508|Self Management|self management
582536|NCT00508521|cerebrovascular accident|cerebrovascular accident
582537|NCT00508521|electrical stimulation|electrical stimulation
582538|NCT00508521|motor learning|motor learning
582539|NCT00508521|upper extremity rehabilitation|upper extremity rehabilitation
582540|NCT00508534|pharmacokinetic study,|pharmacokinetic study,
582541|NCT00508534|gastric pH|gastric ph
582542|NCT00508547|Methotrexate|methotrexate
582543|NCT00508547|Acitretin|acitretin
582544|NCT00508547|Cyclosporine|cyclosporine
582545|NCT00508547|Systemic PUVA|systemic puva
582546|NCT00508547|Infliximab|infliximab
582547|NCT00508547|Adalimumab|adalimumab
582548|NCT00508547|Alefacept|alefacept
582549|NCT00508547|Efalizumab|efalizumab
582550|NCT00508547|Etanercept|etanercept
582551|NCT00508547|Psoriasis|psoriasis
582552|NCT00508547|Psoriatic arthritis|psoriatic arthritis
582553|NCT00508547|Skin disease|skin disease
582554|NCT00508547|Cosentyx|cosentyx
582555|NCT00508560|Contingency management|contingency management
582556|NCT00508560|Smoking cessation|smoking cessation
582557|NCT00508560|Psychotic disorders|psychotic disorders
582558|NCT00508560|Veterans|veterans
582559|NCT00508573|Hereditary Nonpolyposis Colorectal Cancer|hereditary nonpolyposis colorectal cancer
582560|NCT00508573|Lynch Syndrome|lynch syndrome
582561|NCT00508573|HNPCC|hnpcc
582562|NCT00508573|Syndrome Registry|syndrome registry
582563|NCT00508573|Questionnaire|questionnaire
582564|NCT00508573|Endometrial cancer|endometrial cancer
582565|NCT00508573|Ovarian cancer|ovarian cancer
582566|NCT00508586|Breast cancer|breast cancer
582567|NCT00508586|PTC299|ptc299
582569|NCT00508586|Angiogenesis|angiogenesis
582570|NCT00508586|Post-transcriptional control|post-transcriptional control
582571|NCT00508586|Aromatase inhibitors|aromatase inhibitors
582572|NCT00508599|type 2 diabetes|type 2 diabetes
582573|NCT00508599|bed rest|bed rest
582574|NCT00508599|insulin resistance|insulin resistance
582575|NCT00508599|insulin|insulin
582576|NCT00508599|glucose|glucose
582577|NCT00508599|orthostatic response|orthostatic response
582578|NCT00508612|Blood Pressure|blood pressure
582579|NCT00508612|Systolic Blood Pressure|systolic blood pressure
582580|NCT00508612|Diastolic Blood Pressure|diastolic blood pressure
582581|NCT00508612|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
582582|NCT00508612|Relaxation|relaxation
582583|NCT00508612|Meditation|meditation
582584|NCT00508612|Coping Skills|coping skills
582585|NCT00508612|Adolescents|adolescents
582586|NCT00508638|Heart Failure|heart failure
582587|NCT00508651|parainfluenza virus, children, vaccine|parainfluenza virus, children, vaccine
582588|NCT00508664|by laryngectomy operable carcinoma of the larynx and the hypopharynx|by laryngectomy operable carcinoma of the larynx and the hypopharynx
582589|NCT00508677|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
582590|NCT00508677|Mazindol|mazindol
582591|NCT00508690|Antibiotic Prophylaxis|antibiotic prophylaxis
582592|NCT00508690|Colorectal Surgery|colorectal surgery
582593|NCT00508690|Laparoscopy|laparoscopy
582594|NCT00508703|Uterine Cancer|uterine cancer
582595|NCT00508703|Cervical Cancer|cervical cancer
582596|NCT00508703|Endometrial Cancer|endometrial cancer
582597|NCT00508703|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
582598|NCT00508703|IMRT|imrt
582599|NCT00508703|Computed Tomography|computed tomography
582600|NCT00508703|CT|ct
582601|NCT00508703|CT Scan|ct scan
582602|NCT00508716|Congestive Heart Failure|congestive heart failure
582603|NCT00508716|Health Literacy|health literacy
582604|NCT00508716|Health Education|health education
582605|NCT00508716|Congestive Heart Failure (inpatients)|congestive heart failure (inpatients)
582606|NCT00508742|Nasopharyngeal Colonization|nasopharyngeal colonization
582607|NCT00508742|Streptococcus pneumoniae|streptococcus pneumoniae
582608|NCT00508742|Healthy Infants|healthy infants
582609|NCT00508742|Vaccines|vaccines
582610|NCT00508742|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
582611|NCT00508755|cerebrovascular accident|cerebrovascular accident
582612|NCT00508755|electrical stimulation|electrical stimulation
582613|NCT00508755|gait training|gait training
582614|NCT00508755|motor learning|motor learning
582615|NCT00508768|Rheumatoid Arthritis|rheumatoid arthritis
582616|NCT00508768|Methotrexate|methotrexate
582617|NCT00508794|Breast Cancer|breast cancer
582618|NCT00508794|Tibetan Yoga|tibetan yoga
582619|NCT00508794|Stretching Program|stretching program
582620|NCT00508794|Yoga|yoga
582621|NCT00508794|Quality of Life|quality of life
582622|NCT00508794|Questionnaire|questionnaire
582623|NCT00508794|Survey|survey
582624|NCT00508807|Lymphoid Malignancies|lymphoid malignancies
582625|NCT00508807|Solid Tumors|solid tumors
582626|NCT00508807|RTA 402|rta 402
582627|NCT00508820|Platelet|platelet
582628|NCT00508820|AMG 531|amg 531
582629|NCT00508820|Thrombopoietin|thrombopoietin
582630|NCT00508820|blood disorder|blood disorder
582631|NCT00508820|bleeding disorder|bleeding disorder
582632|NCT00508820|immune thrombocytopenic purpura|immune thrombocytopenic purpura
582633|NCT00508820|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
582634|NCT00508820|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
582636|NCT00508820|thrombopoietic protein|thrombopoietic protein
582637|NCT00508833|Adjuvants|adjuvants
582638|NCT00508833|HBsAg|hbsag
582639|NCT00508846|Hereditary Non-Polyposis Colon Cancer|hereditary non-polyposis colon cancer
582640|NCT00508846|Gynecologic Cancers|gynecologic cancers
582641|NCT00508846|Genetic Counseling|genetic counseling
582642|NCT00508846|Questionnaire|questionnaire
582643|NCT00508846|Survey|survey
582644|NCT00508846|HNPCC|hnpcc
582645|NCT00508859|depression|depression
582646|NCT00508859|adolescents|adolescents
582647|NCT00508859|maintenance treatment|maintenance treatment
582648|NCT00508859|antidepressant|antidepressant
582649|NCT00508872|Colorectal Liver Metastases|colorectal liver metastases
582650|NCT00508872|Oxaliplatin|oxaliplatin
582651|NCT00508872|Eloxatin|eloxatin
582652|NCT00508872|Fluorouracil|fluorouracil
582654|NCT00508872|Bevacizumab|bevacizumab
582655|NCT00508872|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
582656|NCT00508872|rhuMAb-VEGF|rhumab-vegf
582657|NCT00508872|Folfox-B|folfox-b
582659|NCT00508872|Avastin|avastin
582660|NCT00508885|hyperphosphatemia|hyperphosphatemia
582661|NCT00508885|niacinamide|niacinamide
582662|NCT00508885|ESRD|esrd
582663|NCT00508885|peritoneal dialysis|peritoneal dialysis
582664|NCT00508885|renal osteodystrophy|renal osteodystrophy
582665|NCT00508898|lupus nephritis|lupus nephritis
582666|NCT00508898|proteinuria|proteinuria
582667|NCT00508898|chronic kidney diseases|chronic kidney diseases
582668|NCT00508898|SLE|sle
582669|NCT00508911|open-label,|open-label,
582670|NCT00508911|oral contraceptive,|oral contraceptive,
582671|NCT00508911|Combine Oral Contraceptives,|combine oral contraceptives,
582672|NCT00508911|single-sequence,|single-sequence,
582673|NCT00508911|volunteers|volunteers
582674|NCT00508911|GW876008,|gw876008,
582675|NCT00508911|repeat-dose,|repeat-dose,
582676|NCT00508911|female,|female,
582677|NCT00508911|pharmacokinetics,|pharmacokinetics,
582678|NCT00508924|Argatroban|argatroban
582679|NCT00508924|Direct thrombin inhibitor|direct thrombin inhibitor
582680|NCT00508924|Percutaneous coronary intervention|percutaneous coronary intervention
582681|NCT00508924|Activated clotting time|activated clotting time
582682|NCT00508924|PCI|pci
582683|NCT00508924|ACT|act
582684|NCT00508937|Diet|diet
582685|NCT00508937|Protein|protein
582686|NCT00508937|Glucose|glucose
582687|NCT00508937|Insulin|insulin
582688|NCT00508937|Cholesterol|cholesterol
582689|NCT00508937|Triglycerides|triglycerides
582690|NCT00508937|LDL subclasses|ldl subclasses
582691|NCT00508950|Vaccines|vaccines
582692|NCT00508950|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
582693|NCT00508950|Adult|adult
582694|NCT00508963|New World Cutaneous or Mucocutaneous Leishmaniasis|new world cutaneous or mucocutaneous leishmaniasis
582695|NCT00508976|bupivacaine|bupivacaine
582696|NCT00508976|marcaine|marcaine
582697|NCT00508976|lidocaine|lidocaine
582698|NCT00508976|normal saline|normal saline
582699|NCT00508976|narcotics|narcotics
582700|NCT00508976|analog pain scale|analog pain scale
582701|NCT00508976|postoperative pain|postoperative pain
582702|NCT00508976|preemptive|preemptive
582703|NCT00508976|aerosolization|aerosolization
582704|NCT00508976|streamed|streamed
582705|NCT00508989|Acetylcholine|acetylcholine
582706|NCT00508989|Forearm Blood Flow|forearm blood flow
582707|NCT00508989|HDL|hdl
582708|NCT00508989|L-NMMA|l-nmma
582709|NCT00508989|Sickle Cell Anemia|sickle cell anemia
582710|NCT00508989|Sickle Cell Disease|sickle cell disease
582711|NCT00509002|Salivary Gland Cancer|salivary gland cancer
582712|NCT00509002|Iressa|iressa
582713|NCT00509002|ZD1839|zd1839
582714|NCT00509015|antimalarials|antimalarials
582715|NCT00509015|malaria transmission|malaria transmission
582716|NCT00509015|mass drug administration|mass drug administration
582717|NCT00509015|artemisinin-based combination therapy|artemisinin-based combination therapy
582718|NCT00509015|primaquine|primaquine
582719|NCT00509015|gametocytes|gametocytes
582720|NCT00509015|QT-NASBA|qt-nasba
582721|NCT00509028|Asthma|asthma
582722|NCT00509028|Bronchial|bronchial
582723|NCT00509041|advanced malignant mesothelioma|advanced malignant mesothelioma
582724|NCT00509041|epithelial mesothelioma|epithelial mesothelioma
582725|NCT00509041|recurrent malignant mesothelioma|recurrent malignant mesothelioma
582726|NCT00509041|sarcomatous mesothelioma|sarcomatous mesothelioma
582727|NCT00509054|Parastomal hernia, wound infection, stoma care.|parastomal hernia, wound infection, stoma care.
582728|NCT00509067|Schizoaffective Disorder|schizoaffective disorder
582729|NCT00509067|Acetylcholine|acetylcholine
582730|NCT00509067|Nicotinic Receptors|nicotinic receptors
582731|NCT00509067|Nicotine|nicotine
582732|NCT00509067|Galantamine|galantamine
582733|NCT00509067|negative symptoms|negative symptoms
582734|NCT00509080|mitral regurgitation|mitral regurgitation
582735|NCT00509080|BNP|bnp
582736|NCT00509080|NT-proBNP|nt-probnp
582737|NCT00509080|natriuretic peptides|natriuretic peptides
582738|NCT00509080|valvular heart disease|valvular heart disease
582739|NCT00502645|algorithm|algorithm
582740|NCT00502645|cs-1 decision support system|cs-1 decision support system
582741|NCT00502645|insulin|insulin
582742|NCT00502645|hyperglycemia|hyperglycemia
582743|NCT00502645|tight glycemic control|tight glycemic control
582744|NCT00502645|intensive care|intensive care
582745|NCT00502645|adults|adults
582746|NCT00502658|Overweight|overweight
582747|NCT00502658|Obese|obese
582748|NCT00502658|Dietary Supplements|dietary supplements
582749|NCT00502658|Shakes|shakes
582750|NCT00502658|Nutrition|nutrition
582751|NCT00502658|Overweight and Obese Adults (BMI 25-35)|overweight and obese adults (bmi 25-35)
582752|NCT00502684|breast cancer|breast cancer
582753|NCT00502684|surgery|surgery
582754|NCT00502684|immune suppression|immune suppression
582755|NCT00502684|beta blockers|beta blockers
582756|NCT00502684|COX2 inhibitors|cox2 inhibitors
582757|NCT00502697|preterm|preterm
582758|NCT00502697|prematurity|prematurity
582759|NCT00502697|home visitation|home visitation
582760|NCT00502697|system of care|system of care
582761|NCT00502723|Retropubic Prostatectomy|retropubic prostatectomy
582762|NCT00502723|Surgical Procedures|surgical procedures
582763|NCT00502723|Laparoscopic|laparoscopic
582764|NCT00502749|Leukemia|leukemia
582765|NCT00502749|Lymphoma|lymphoma
582766|NCT00502749|Exercise|exercise
582767|NCT00502749|Quality of Life|quality of life
582768|NCT00502749|Questionnaire|questionnaire
582769|NCT00502749|Survey|survey
582770|NCT00502762|small-cell lung cancer|small-cell lung cancer
582771|NCT00502762|refractory|refractory
582772|NCT00502762|topotecan|topotecan
582773|NCT00502775|ragweed|ragweed
582774|NCT00502775|once daily|once daily
582884|NCT00503230|Latino|latino
582775|NCT00502775|fexofenadine|fexofenadine
582776|NCT00502775|fluticasone furoate|fluticasone furoate
582777|NCT00502775|allergic rhinitis|allergic rhinitis
582778|NCT00502801|Pneumonia|pneumonia
582779|NCT00502801|Lung Infection|lung infection
582780|NCT00502801|Bacterial Infection|bacterial infection
582781|NCT00502801|Hospital-Acquired Infection|hospital-acquired infection
582782|NCT00502801|Ventilator Infection|ventilator infection
582783|NCT00502801|Antibiotic Therapy|antibiotic therapy
582784|NCT00502814|Breast Cancer|breast cancer
582785|NCT00502814|3-D Optical Surface Scan|3-d optical surface scan
582786|NCT00502814|Soft Tissue Biomechanics|soft tissue biomechanics
582787|NCT00502814|Mechanical Testing|mechanical testing
582788|NCT00502814|Skin Ultrasound|skin ultrasound
582789|NCT00502814|Magnetic Resonance Imaging|magnetic resonance imaging
582790|NCT00502814|CT Scan|ct scan
582791|NCT00502827|Human Immunodeficiency Virus|human immunodeficiency virus
582792|NCT00502827|HIV positive|hiv positive
582793|NCT00502827|HIV Positive Smokers|hiv positive smokers
582794|NCT00502827|AIDS|aids
582795|NCT00502827|Cell Phone Intervention|cell phone intervention
582796|NCT00502827|CPI|cpi
582797|NCT00502827|Smoking Cessation|smoking cessation
582798|NCT00502827|Interview|interview
582799|NCT00502866|breastfeeding|breastfeeding
582800|NCT00502866|vitamin D supplementation|vitamin d supplementation
582801|NCT00502866|rickets|rickets
582802|NCT00502892|Solid Tumors|solid tumors
582803|NCT00502892|Topotecan|topotecan
582804|NCT00502892|Hycamtin|hycamtin
582805|NCT00502892|Ifosfamide|ifosfamide
582806|NCT00502892|Ifex|ifex
582807|NCT00502892|Carboplatin|carboplatin
582808|NCT00502892|Paraplatin|paraplatin
582809|NCT00502892|Pediatric|pediatric
582810|NCT00502892|Children|children
582811|NCT00502892|Young Adults|young adults
752857|NCT01174498|hurt|hurt
582212|NCT00507520|RCT|rct
582812|NCT00502905|Acute Myeloid Leukemia|acute myeloid leukemia
582813|NCT00502905|Myelodysplastic Syndromes|myelodysplastic syndromes
582814|NCT00502905|Busulfan|busulfan
582815|NCT00502905|Busulfex|busulfex
582816|NCT00502905|Myleran|myleran
582817|NCT00502905|Fludarabine|fludarabine
582818|NCT00502905|Fludarabine Phosphate|fludarabine phosphate
582819|NCT00502905|Fludara|fludara
582820|NCT00502944|HIV|hiv
582821|NCT00502944|Testing|testing
582822|NCT00502944|HIV Seronegativity|hiv seronegativity
582823|NCT00502957|biofeedback|biofeedback
582824|NCT00502957|constipation|constipation
582825|NCT00502970|Chronic HCV|chronic hcv
582826|NCT00502970|Treatment|treatment
582827|NCT00502983|Acute Myelogenous Leukemia|acute myelogenous leukemia
582828|NCT00502983|Epidemiology|epidemiology
582829|NCT00502983|Leukemia|leukemia
582830|NCT00502983|Healthy Control|healthy control
582831|NCT00502983|Lifestyle Factors|lifestyle factors
582832|NCT00502983|Genetic Susceptibility|genetic susceptibility
582833|NCT00502983|Interview|interview
582834|NCT00502983|AML|aml
582835|NCT00503009|Rhinovirus|rhinovirus
582836|NCT00503009|Asthma|asthma
582837|NCT00503022|Wet age-related macular degeneration|wet age-related macular degeneration
582838|NCT00503022|ACZ885|acz885
582839|NCT00503035|Familial Adenomatous Polyposis|familial adenomatous polyposis
582840|NCT00503035|Colorectal Tumors|colorectal tumors
582841|NCT00503035|Molecular Targeting|molecular targeting
582842|NCT00503035|Celecoxib|celecoxib
582843|NCT00503035|Celebrex|celebrex
582844|NCT00503035|SC-58635|sc-58635
582845|NCT00503035|Apoptosis Induction|apoptosis induction
582846|NCT00503035|Colon|colon
582847|NCT00503035|Rectum|rectum
582848|NCT00503035|colonoscopy|colonoscopy
582849|NCT00503035|Biopsy|biopsy
582850|NCT00503048|atopy|atopy
582851|NCT00503048|atopic diseases|atopic diseases
582852|NCT00503048|children|children
582853|NCT00503048|orphanages|orphanages
582854|NCT00503061|pharmaceopidemiological|pharmaceopidemiological
582855|NCT00503061|Symbicort SMART|symbicort smart
582856|NCT00503061|GPRD|gprd
582857|NCT00503074|Diet, reducing|diet, reducing
582858|NCT00503074|Television|television
582859|NCT00503074|Child Behavior|child behavior
582860|NCT00503087|Injections|injections
582861|NCT00503087|Vacuum|vacuum
582862|NCT00503087|Pain|pain
582863|NCT00503087|Pneumatic Skin Flattening|pneumatic skin flattening
582864|NCT00503087|PSF|psf
582865|NCT00503100|Pain|pain
582866|NCT00503100|Preterm-Born Adolescents|preterm-born adolescents
582869|NCT00503165|Menitorix|menitorix
582870|NCT00503165|vaccine|vaccine
582871|NCT00503191|Autism|autism
582872|NCT00503191|Neurodevelopmental disorder|neurodevelopmental disorder
582873|NCT00503204|cancer|cancer
582874|NCT00503204|tumor|tumor
582875|NCT00503204|advance solid tumour|advance solid tumour
582876|NCT00503204|glioblastoma|glioblastoma
582877|NCT00503204|malignant brain tumour|malignant brain tumour
582878|NCT00503217|intrauterine insemination|intrauterine insemination
582879|NCT00503217|GnRH agonist|gnrh agonist
582880|NCT00503217|implantation|implantation
582881|NCT00503230|tobacco|tobacco
582882|NCT00503230|smoking|smoking
582883|NCT00503230|HIV|hiv
582885|NCT00503256|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
582886|NCT00503256|Leukemia|leukemia
582887|NCT00503256|Lymphoma|lymphoma
582888|NCT00503256|Questionnaire|questionnaire
582889|NCT00503256|Survey|survey
582890|NCT00503256|CLL|cll
582891|NCT00503269|Haemorrhoidectomy|haemorrhoidectomy
582892|NCT00503269|Local anaesthesia|local anaesthesia
582893|NCT00503295|reovirus|reovirus
582894|NCT00503295|oncolytic virus|oncolytic virus
582895|NCT00503295|sarcoma|sarcoma
582896|NCT00503295|REOLYSIN|reolysin
582897|NCT00503295|Oncolytics Biotech|oncolytics biotech
582898|NCT00503308|HIV Seronegativity|hiv seronegativity
582899|NCT00503321|gastric cancer, TS-1, PSK|gastric cancer, ts-1, psk
582900|NCT00503347|coinfection with chronic hepatitis C virus and HIV|coinfection with chronic hepatitis c virus and hiv
582901|NCT00503347|Treatment Naive|treatment naive
582902|NCT00503360|Ocular Hypertension|ocular hypertension
582903|NCT00503360|SAD448|sad448
582904|NCT00503386|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
582905|NCT00503386|acute|acute
582906|NCT00503386|delayed|delayed
582907|NCT00503386|emesis|emesis
582908|NCT00503386|antiemetics|antiemetics
582909|NCT00503386|5-HT3 receptor antagonist|5-ht3 receptor antagonist
582910|NCT00503386|granisetron|granisetron
582911|NCT00503386|palonosetron|palonosetron
582912|NCT00509093|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
582913|NCT00509093|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
582914|NCT00509093|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
582915|NCT00509093|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
582916|NCT00509093|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
582917|NCT00509093|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
583560|NCT00512174|Bladder Reconstruction|bladder reconstruction
582918|NCT00509093|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
582919|NCT00509093|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
582920|NCT00509093|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
582921|NCT00509093|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
582922|NCT00509093|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
582923|NCT00509093|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
582924|NCT00509093|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
582925|NCT00509093|adult acute basophilic leukemia|adult acute basophilic leukemia
582926|NCT00509093|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
582927|NCT00509093|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
582928|NCT00509106|ceftaroline|ceftaroline
582929|NCT00509106|Community-acquired pneumonia|community-acquired pneumonia
582930|NCT00509106|CAP|cap
582931|NCT00509106|Streptococcus pneumoniae|streptococcus pneumoniae
582932|NCT00509106|Haemophilus influenzae|haemophilus influenzae
582933|NCT00509106|Mycoplasma pneumoniae|mycoplasma pneumoniae
582934|NCT00509106|Chlamydophila spp|chlamydophila spp
582935|NCT00509106|Legionella ssp|legionella ssp
582936|NCT00509106|multi-drug resistant Streptococcus pneumoniae (MDRSP)|multi-drug resistant streptococcus pneumoniae (mdrsp)
582937|NCT00509106|antimicrobial resistance|antimicrobial resistance
582938|NCT00509106|pneumococci|pneumococci
582939|NCT00509106|beta-lactam|beta-lactam
582940|NCT00509106|ceftaroline fosamil|ceftaroline fosamil
582941|NCT00509106|ceftriaxone|ceftriaxone
582942|NCT00509106|antibiotic|antibiotic
582943|NCT00509119|apoplexia|apoplexia
582944|NCT00509119|Intracranial and intraarterial pressure curves in acute apoplectic patients|intracranial and intraarterial pressure curves in acute apoplectic patients
582945|NCT00509145|Relapsing|relapsing
582946|NCT00509145|Remitting|remitting
582947|NCT00509158|safety|safety
582948|NCT00509158|immunogenicity|immunogenicity
582949|NCT00509158|efficacy|efficacy
582950|NCT00509171|embolism|embolism
582951|NCT00509171|femur fracture|femur fracture
582952|NCT00509171|lavage|lavage
582953|NCT00509171|TEE|tee
582954|NCT00509171|reamer|reamer
582955|NCT00509171|IM nail|im nail
582956|NCT00509184|untreated|untreated
582957|NCT00509197|Asthma|asthma
582958|NCT00509197|Non-eosinophilic Asthma|non-eosinophilic asthma
582959|NCT00509197|sputum eosinophils|sputum eosinophils
582960|NCT00509197|Inhaled Corticosteroids|inhaled corticosteroids
582961|NCT00509210|Liver Disease|liver disease
582962|NCT00509223|Type 2 diabetes|type 2 diabetes
582963|NCT00509223|Obstructive sleep apnea|obstructive sleep apnea
582964|NCT00509223|Glycemic control|glycemic control
582965|NCT00509223|Insulin resistance|insulin resistance
582966|NCT00509223|Sleep disordered breathing|sleep disordered breathing
582967|NCT00509288|Refractory|refractory
582968|NCT00509288|Gene Therapy|gene therapy
582969|NCT00509288|HLA-A2 Positive|hla-a2 positive
582970|NCT00509288|Stage IV Melanoma|stage iv melanoma
582971|NCT00509288|Melanoma|melanoma
582972|NCT00509288|Skin Cancer|skin cancer
582973|NCT00509288|Malignant Melanoma|malignant melanoma
3492|NCT03268733|PCOS|pcos
582974|NCT00509301|brain cancer|brain cancer
582975|NCT00509301|Cotara|cotara
582976|NCT00509301|radioactive isotope|radioactive isotope
582977|NCT00509301|monoclonal antibody|monoclonal antibody
582978|NCT00509301|radiation distribution|radiation distribution
582979|NCT00509327|postoperative ileus|postoperative ileus
582980|NCT00509327|colorectal surgery|colorectal surgery
582981|NCT00509327|bisacodyl|bisacodyl
582982|NCT00509327|laxatives|laxatives
582983|NCT00509340|antiretroviral|antiretroviral
582984|NCT00509340|adherence|adherence
582985|NCT00509340|poor antiretroviral adherence|poor antiretroviral adherence
582986|NCT00509353|recurrent neuroblastoma|recurrent neuroblastoma
582987|NCT00509366|genomics|genomics
582988|NCT00509366|genomics predictor|genomics predictor
582989|NCT00509366|genomics analysis|genomics analysis
582990|NCT00509366|squamous|squamous
582991|NCT00509366|non-squamous|non-squamous
582992|NCT00509379|Relapsed/refractory indolent lymphoma|relapsed/refractory indolent lymphoma
582993|NCT00509379|Non-follicular Lymphoma|non-follicular lymphoma
582994|NCT00509379|Mantle cell non-Hodgkin Lymphoma|mantle cell non-hodgkin lymphoma
582995|NCT00509379|Patients naïve or sensitive to rituximab|patients naïve or sensitive to rituximab
582996|NCT00509379|Patients not eligible for high dose chemotherapy with ASCT|patients not eligible for high dose chemotherapy with asct
582997|NCT00509392|Varicose veins, venous reflux, GSV disease|varicose veins, venous reflux, gsv disease
582998|NCT00509405|Endogenous acid production|endogenous acid production
582999|NCT00509405|metabolic acidosis|metabolic acidosis
583000|NCT00509405|potassium citrate|potassium citrate
583001|NCT00509405|osteoporosis|osteoporosis
583002|NCT00509405|sarcopenia|sarcopenia
583003|NCT00509405|hypertension|hypertension
583004|NCT00509405|Effect of potassium citrate on bone mineral density and bone mass|effect of potassium citrate on bone mineral density and bone mass
583005|NCT00509418|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
583006|NCT00509418|Nonalcoholic Fatty Liver|nonalcoholic fatty liver
583007|NCT00509418|Nutritional supplement|nutritional supplement
583008|NCT00509418|Diet|diet
583009|NCT00509418|Exercise|exercise
583010|NCT00510159|Schistosoma haematobium|schistosoma haematobium
583011|NCT00510159|Praziquantel|praziquantel
583012|NCT00510159|Artesunate + Sulfamethoxypyrazine/pyrimethamine|artesunate + sulfamethoxypyrazine/pyrimethamine
583013|NCT00510159|Randomized double blind placebo controlled clinical trial|randomized double blind placebo controlled clinical trial
583014|NCT00510172|Headache|headache
583015|NCT00510172|Migraine|migraine
583016|NCT00510172|Vasodilatation|vasodilatation
583017|NCT00510185|coronary artery disease|coronary artery disease
583018|NCT00510185|coronary angioplasty|coronary angioplasty
583019|NCT00510185|coronary artery bypass surgery|coronary artery bypass surgery
583020|NCT00510185|elderly|elderly
583021|NCT00510198|Heart Disease|heart disease
583022|NCT00510198|Congestive Heart Failure|congestive heart failure
583023|NCT00510198|Thoracic Fluid Monitoring|thoracic fluid monitoring
583025|NCT00510237|Adolescents newly diagnosed with HIV|adolescents newly diagnosed with hiv
583026|NCT00510250|Cervix Cancer|cervix cancer
583027|NCT00510250|Cervical Cancer|cervical cancer
583028|NCT00510250|Sorafenib|sorafenib
583029|NCT00510250|Cisplatin|cisplatin
583030|NCT00510250|Radiation|radiation
583031|NCT00510250|Radiotherapy|radiotherapy
583032|NCT00510250|Phase I|phase i
583033|NCT00510250|Phase II|phase ii
583034|NCT00510250|Carcinoma|carcinoma
583035|NCT00510250|Cancer|cancer
583036|NCT00510250|Cervix|cervix
583037|NCT00510263|Prednisolone|prednisolone
583038|NCT00510263|Valacyclovir|valacyclovir
583039|NCT00510289|Sorafenib|sorafenib
583040|NCT00510289|Myelodysplastic Syndromes|myelodysplastic syndromes
583041|NCT00510289|MDS|mds
583042|NCT00510302|Ultraviolet Radiation|ultraviolet radiation
583043|NCT00510302|Melanoma|melanoma
583044|NCT00510302|Questionnaire|questionnaire
583045|NCT00510302|Survey|survey
583046|NCT00510302|First Degree Relative|first degree relative
583047|NCT00510302|Interview|interview
583048|NCT00510315|leukemia|leukemia
583049|NCT00510315|survivors|survivors
583050|NCT00510315|women|women
583051|NCT00510315|leukemia survivors|leukemia survivors
583052|NCT00510315|cancer or a related illness|cancer or a related illness
583053|NCT00510315|Hodgkin's Lymphoma|hodgkin's lymphoma
583054|NCT00510315|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
583024|NCT00510237|HIV|hiv
583055|NCT00510315|myelodysplastic syndrome|myelodysplastic syndrome
583057|NCT00510315|treated with total body irradiation|treated with total body irradiation
583058|NCT00510315|followed by an allogeneic or autologous stem cell transplant|followed by an allogeneic or autologous stem cell transplant
583059|NCT00510328|whole body vibration|whole body vibration
583060|NCT00510328|muscle physiology|muscle physiology
583061|NCT00510341|Behavior Change Counseling|behavior change counseling
583062|NCT00510341|Motivational Interviewing|motivational interviewing
583063|NCT00510341|Chronic Care Model|chronic care model
583065|NCT00510341|Residency Training|residency training
583066|NCT00510341|Skill Assessment|skill assessment
583067|NCT00510354|Progressive GIST|progressive gist
583068|NCT00510354|Resistance to Imatinib mesylate|resistance to imatinib mesylate
583069|NCT00510367|Breast Cancer|breast cancer
583070|NCT00510367|FAC|fac
583071|NCT00510367|Doxorubicin|doxorubicin
583072|NCT00510367|Adriamycin|adriamycin
583073|NCT00510367|Rubex|rubex
583074|NCT00510367|5-Fluorouracil|5-fluorouracil
583075|NCT00510367|5-FU|5-fu
583076|NCT00510367|Adrucil|adrucil
583077|NCT00510367|Efudex|efudex
583078|NCT00510367|Cyclophosphamide|cyclophosphamide
583079|NCT00510367|Cytoxan|cytoxan
583080|NCT00510367|Neosar|neosar
583081|NCT00510367|Pregnancy|pregnancy
583082|NCT00510393|Critical Limb Ischemia|critical limb ischemia
583083|NCT00510393|CLI|cli
583084|NCT00510393|Drug Eluting Stent|drug eluting stent
583085|NCT00510393|DES|des
583086|NCT00510393|Bare Metal Stent|bare metal stent
583087|NCT00510393|BMS|bms
583088|NCT00510406|Lower Urinary Tract Symptoms|lower urinary tract symptoms
583089|NCT00510406|Treatment|treatment
583090|NCT00510406|Solifenacin succinate|solifenacin succinate
583091|NCT00510406|Tamsulosin hydrochloride|tamsulosin hydrochloride
583092|NCT00510406|Prostatic Hyperplasia|prostatic hyperplasia
583093|NCT00510419|Migraine|migraine
583094|NCT00510432|heparin|heparin
583095|NCT00510432|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
583096|NCT00510432|HIT|hit
583097|NCT00510432|allergy|allergy
583098|NCT00510432|skin|skin
583099|NCT00510432|dermatology|dermatology
583100|NCT00510432|DTH|dth
583101|NCT00510432|delayed-type hypersensitivity|delayed-type hypersensitivity
583102|NCT00510432|histology|histology
753233|NCT01176032|LVMI|lvmi
582521|NCT00508456|Temodar|temodar
583103|NCT00510432|Patients receiving sc heparin therapy|patients receiving sc heparin therapy
583104|NCT00510432|Age over 18 years|age over 18 years
583105|NCT00510432|Recruitment will stop when 20 patients with skin lesions are included|recruitment will stop when 20 patients with skin lesions are included
583106|NCT00510445|Non Small Cell Lung Cancer|non small cell lung cancer
583107|NCT00510445|Advanced Non Small Cell Lung Cancer|advanced non small cell lung cancer
583108|NCT00510445|Metastatic Non Small Cell Lung Cancer|metastatic non small cell lung cancer
583109|NCT00510484|Pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
583110|NCT00510484|Cystic Fibrosis|cystic fibrosis
583111|NCT00510497|dendritic cell|dendritic cell
583112|NCT00510497|therapeutic vaccine|therapeutic vaccine
583113|NCT00510497|HIV-1|hiv-1
583114|NCT00510497|apoptotic cells|apoptotic cells
583115|NCT00510497|Phase I/II|phase i/ii
583116|NCT00510510|COPD|copd
583117|NCT00510510|glycopyrronium bromide|glycopyrronium bromide
583118|NCT00510510|antimuscarinic|antimuscarinic
583119|NCT00510523|MS|ms
583120|NCT00510523|Balance|balance
583121|NCT00510523|Multiple Sclerosis|multiple sclerosis
583122|NCT00510536|Psoriasis, arthritis, arthralgia|psoriasis, arthritis, arthralgia
583123|NCT00510562|Cranial manipulation|cranial manipulation
583124|NCT00510562|Visual function|visual function
583125|NCT00510575|Juvenile Scoliosis|juvenile scoliosis
583126|NCT00510575|Adolescent Scoliosis|adolescent scoliosis
583127|NCT00510575|Scoliosis Management|scoliosis management
583128|NCT00510575|Spinal Fusion|spinal fusion
583129|NCT00510575|Scoliosis instrumentation|scoliosis instrumentation
583130|NCT00510575|Juvenile or Adolescent Idiopathic Scoliosis|juvenile or adolescent idiopathic scoliosis
583131|NCT00510588|adiposity|adiposity
583132|NCT00510614|Bacterial Vaginosis|bacterial vaginosis
583133|NCT00510614|Recurrent Bacterial Vaginosis|recurrent bacterial vaginosis
583134|NCT00510627|Metastatic Liver Cancer|metastatic liver cancer
583135|NCT00510627|Colorectal Cancer|colorectal cancer
583136|NCT00510627|Radiofrequency Ablation|radiofrequency ablation
583137|NCT00510627|Chemotherapy|chemotherapy
583138|NCT00510640|thyroid carcinoma|thyroid carcinoma
583139|NCT00510640|Sunitinib|sunitinib
583140|NCT00510640|RECIST guidelines|recist guidelines
583141|NCT00510653|Ovarian Cancer|ovarian cancer
583142|NCT00510653|Primary Peritoneal Cancer|primary peritoneal cancer
583143|NCT00510653|Fallopian Tube Cancer|fallopian tube cancer
583144|NCT00510653|Recurrent Platinum-Resistant|recurrent platinum-resistant
583145|NCT00510653|Taxane-Resistant|taxane-resistant
583146|NCT00510653|Epithelial Ovarian Cancer|epithelial ovarian cancer
583147|NCT00510653|Imatinib Mesylate|imatinib mesylate
583148|NCT00510653|Gleevec|gleevec
583149|NCT00510653|STI571|sti571
583150|NCT00510653|Protein tyrosine kinase inhibitor|protein tyrosine kinase inhibitor
751892|NCT01171092|BMT|bmt
583152|NCT00510666|Analgesics, Opioid|analgesics, opioid
583153|NCT00510666|Analgesia, Patient-Controlled|analgesia, patient-controlled
583154|NCT00510666|Pain Measurement|pain measurement
583156|NCT00510679|child health|child health
583157|NCT00510679|developing country|developing country
583158|NCT00510679|health services research|health services research
583159|NCT00510679|health worker performance|health worker performance
583160|NCT00510679|Integrated Management of Childhood Illness|integrated management of childhood illness
583161|NCT00510692|Eicosapentaenoic Acid|eicosapentaenoic acid
583162|NCT00510692|EPA|epa
583163|NCT00510692|EPA 99%|epa 99%
583164|NCT00510692|Fatty acid|fatty acid
583165|NCT00510692|omega-3|omega-3
583166|NCT00510692|apoptosis|apoptosis
583167|NCT00510692|cell proliferation|cell proliferation
583168|NCT00510692|colonic mucosa|colonic mucosa
583169|NCT00510692|polyp|polyp
583170|NCT00510692|Familial Adenomatous Polyposis Coli|familial adenomatous polyposis coli
583171|NCT00510692|FAP|fap
583172|NCT00510692|resolvin|resolvin
583173|NCT00510692|Ileo-rectal anastomosis|ileo-rectal anastomosis
583174|NCT00510692|IRA|ira
583175|NCT00510692|PUFA|pufa
583176|NCT00510692|Endoscopy|endoscopy
583177|NCT00510705|adiposity|adiposity
583178|NCT00510718|Prostate|prostate
583179|NCT00510718|Cancer|cancer
583180|NCT00510718|Hormone|hormone
583181|NCT00510718|Refractory|refractory
583182|NCT00510718|Castration|castration
583183|NCT00510731|Ventricular Tachycardia|ventricular tachycardia
583184|NCT00510731|Cardiac Sudden Death|cardiac sudden death
583185|NCT00510731|Ventricular Fibrillation|ventricular fibrillation
583186|NCT00510731|Heart Rate Variability|heart rate variability
583187|NCT00510744|obesity, bariatric surgery, pancreatic secretion|obesity, bariatric surgery, pancreatic secretion
583188|NCT00510770|CPAP|cpap
583189|NCT00510770|Post-opreative|post-opreative
583190|NCT00510770|ARF|arf
583191|NCT00510770|liver transplant|liver transplant
583192|NCT00510770|Post-operative hypoxemia in liver transplant|post-operative hypoxemia in liver transplant
583193|NCT00510783|tonic-clonic seizure|tonic-clonic seizure
583194|NCT00510783|emergency department|emergency department
583195|NCT00510783|IV levetiracetam|iv levetiracetam
583196|NCT00510783|Keppra|keppra
583197|NCT00510783|seizures|seizures
583198|NCT00510783|phenytoin|phenytoin
583199|NCT00510783|Dilantin|dilantin
583200|NCT00510783|Grand Mal seizure|grand mal seizure
583201|NCT00510796|Hereditary Non-Polyposis Colon Cancer|hereditary non-polyposis colon cancer
583202|NCT00510796|Colon Cancer|colon cancer
583203|NCT00510796|Endometrial Cancer|endometrial cancer
583204|NCT00510796|Cancer Screening|cancer screening
583206|NCT00510796|HNPCC|hnpcc
583207|NCT00510822|Cimicoxib|cimicoxib
583208|NCT00510822|Cox-2 inhibitor|cox-2 inhibitor
583209|NCT00510822|Sertraline|sertraline
583210|NCT00510835|septic shock|septic shock
583211|NCT00510835|resuscitation|resuscitation
583212|NCT00510835|sepsis|sepsis
583213|NCT00510835|cost-effectiveness|cost-effectiveness
583214|NCT00510835|sepsis-induced organ dysfunction|sepsis-induced organ dysfunction
583215|NCT00510835|early goal directed therapy|early goal directed therapy
583216|NCT00510835|emergency medicine|emergency medicine
583217|NCT00510835|critical care medicine|critical care medicine
583218|NCT00510861|male age, assisted reproduction, sperm, pregnancy outcome|male age, assisted reproduction, sperm, pregnancy outcome
583219|NCT00510874|Influenza|influenza
583220|NCT00510874|GSK 1557484A vaccine|gsk 1557484a vaccine
583221|NCT00510887|follicular lymphoma|follicular lymphoma
583222|NCT00510887|Velcade|velcade
583223|NCT00510887|VR-FND|vr-fnd
583224|NCT00510913|Treatment efficacy|treatment efficacy
583225|NCT00510913|Transplantation rejection|transplantation rejection
583226|NCT00510913|Kidney transplantation|kidney transplantation
583227|NCT00510913|Cyclosporine|cyclosporine
583228|NCT00510913|tacrolimus|tacrolimus
583229|NCT00510939|Acute myeloid leukemia|acute myeloid leukemia
583230|NCT00510939|NFkB activity and leukemia|nfkb activity and leukemia
583231|NCT00510939|expression of NFkB|expression of nfkb
583232|NCT00510952|diabetes|diabetes
583233|NCT00510952|type 2|type 2
583234|NCT00510965|choroidal neovascularization|choroidal neovascularization
583235|NCT00510965|angioid streaks|angioid streaks
583236|NCT00510965|pseudoxanthoma elasticum|pseudoxanthoma elasticum
583237|NCT00510965|Groenblad-Strandberg-Syndrome|groenblad-strandberg-syndrome
583238|NCT00510965|therapy|therapy
583239|NCT00510965|ranibizumab|ranibizumab
583240|NCT00510965|lucentis|lucentis
583241|NCT00510965|Choroidal neovascularization in patients with PXE|choroidal neovascularization in patients with pxe
583242|NCT00510978|Inflammatory Bowel Disease IBD|inflammatory bowel disease ibd
583243|NCT00510978|Ulcerative Colitis|ulcerative colitis
583244|NCT00510978|Crohn's disease|crohn's disease
583245|NCT00510978|Probiotics|probiotics
583246|NCT00510978|Gastrointestinal|gastrointestinal
583247|NCT00510991|ASTHMA|asthma
583248|NCT00511004|Brugia Malayi|brugia malayi
583249|NCT00511004|Lymphatic Filariasis|lymphatic filariasis
583250|NCT00511004|Albendazole|albendazole
759714|NCT00572481|Prevention of lymphedema|prevention of lymphedema
759715|NCT00572481|Prevention of neuroma|prevention of neuroma
759716|NCT00572481|Prevention of seroma|prevention of seroma
759727|NCT00483106|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
759728|NCT00483106|Genetics|genetics
759729|NCT00483106|Pharmacogenetics|pharmacogenetics
3452|NCT03268993|prevention|prevention
3453|NCT03268993|dietary supplement|dietary supplement
3454|NCT03268993|broccoli|broccoli
3469|NCT03268915|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
3470|NCT03268915|3 minutes sit-to-stand test|3 minutes sit-to-stand test
3471|NCT03268915|Interindividual reproductibility|interindividual reproductibility
759816|NCT00001160|Thyroid Fine Needle Biopsy|thyroid fine needle biopsy
759817|NCT00001160|Radioiodine|radioiodine
759818|NCT00001160|Dosimetry|dosimetry
3491|NCT03268733|Folic acid|folic acid
3493|NCT03268733|Insulin resistance|insulin resistance
3494|NCT03268733|Infertility|infertility
3499|NCT03268707|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
3500|NCT03268707|Pulmonary Vein Isolation|pulmonary vein isolation
3501|NCT03268707|Telemetry Monitoring|telemetry monitoring
3502|NCT03268707|Cryoballoon ablation|cryoballoon ablation
3527|NCT03268434|Depression|depression
3528|NCT03268434|Metacognition|metacognition
3530|NCT03268434|D-MCT|d-mct
3531|NCT03268434|cognitive bias|cognitive bias
3554|NCT03268278|analgesia|analgesia
3555|NCT03268278|endodontic|endodontic
3556|NCT03268278|postoperative|postoperative
3569|NCT03268135|miRNA|mirna
3570|NCT03268135|lncRNAs|lncrnas
3571|NCT03268135|transcriptome|transcriptome
3572|NCT03268135|heart failure|heart failure
3573|NCT03268135|aortic stenosis|aortic stenosis
3574|NCT03268135|biomarkers|biomarkers
3575|NCT03268122|Patient Isolation|patient isolation
3576|NCT03268122|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
3577|NCT03268122|Vancomycin-Resistant Enterococci|vancomycin-resistant enterococci
3589|NCT03268057|VX15/2503|vx15/2503
3590|NCT03268057|Semaphorin 4D|semaphorin 4d
3592|NCT03268057|safety tolerability|safety tolerability
3593|NCT03268057|pharmacokinetics|pharmacokinetics
3594|NCT03268057|monoclonal antibody|monoclonal antibody
3597|NCT03268018|calcium|calcium
3598|NCT03268018|peripheral arterial disease|peripheral arterial disease
3614|NCT03267940|Extrahepatic Cholangiocarcinoma|extrahepatic cholangiocarcinoma
3615|NCT03267940|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
3616|NCT03267940|Gallbladder Adenocarcinoma|gallbladder adenocarcinoma
3617|NCT03267940|PEGylated Recombinant Human Hyaluronidase|pegylated recombinant human hyaluronidase
3618|NCT03267940|PEGylated Recombinant Human Hyaluronidase with atezolizumab|pegylated recombinant human hyaluronidase with atezolizumab
3619|NCT03267927|OSA|osa
3620|NCT03267927|Polysomnography|polysomnography
3621|NCT03267927|Rapid palatal expansion|rapid palatal expansion
3622|NCT03267927|Mandibular advancement|mandibular advancement
3623|NCT03267927|Sleep position|sleep position
3650|NCT03267641|Intra-tumour heterogeneity|intra-tumour heterogeneity
3651|NCT03267641|Cancer immunotherapy|cancer immunotherapy
3652|NCT03267641|Tumour microenvironment|tumour microenvironment
3653|NCT03267641|Driver mutations|driver mutations
3654|NCT03267641|Precision Medicine|precision medicine
3655|NCT03267628|intrathecal morphine|intrathecal morphine
3656|NCT03267628|quadratus lumborum type 2 block|quadratus lumborum type 2 block
3657|NCT03267628|cesarean section|cesarean section
3658|NCT03267628|pain|pain
3659|NCT03267615|Liver Cirrhosis|liver cirrhosis
3660|NCT03267615|Portal Hypertension|portal hypertension
3670|NCT03267368|Comprehensive Care Program|comprehensive care program
3671|NCT03267368|Stereotactic Radiotherapy|stereotactic radiotherapy
3690|NCT03267303|Narcolepsy|narcolepsy
3696|NCT03267251|Vaccine Decision Making|vaccine decision making
3697|NCT03267251|Public Health|public health
3698|NCT03267251|Health Communication|health communication
3699|NCT03267251|Digital Interventions|digital interventions
3700|NCT03267225|drug interaction|drug interaction
3701|NCT03267225|genetic polymorphism|genetic polymorphism
3702|NCT03267212|Functional Electrical Stimulation (FES)-Rowing|functional electrical stimulation (fes)-rowing
3703|NCT03267212|Ventilatory support|ventilatory support
3704|NCT03267173|Pancreatic Cancer|pancreatic cancer
3705|NCT03267173|CAR-T|car-t
3706|NCT03267173|Mesothelin|mesothelin
3707|NCT03267173|CEA|cea
3708|NCT03267173|HER2|her2
3709|NCT03267147|Anti-CCP|anti-ccp
3710|NCT03267147|rheumatoid arthritis|rheumatoid arthritis
3711|NCT03266055|Blueberry|blueberry
3712|NCT03266055|Diet|diet
3713|NCT03266003|Tuberculosis|tuberculosis
3714|NCT03266003|Directly observed therapy|directly observed therapy
3715|NCT03266003|Adherence|adherence
3716|NCT03266003|Video assisted directly observed therapy|video assisted directly observed therapy
3717|NCT03266003|Electronic directly observed therapy|electronic directly observed therapy
3718|NCT03266003|Mobile health|mobile health
3719|NCT03265964|Suicidal Ideation|suicidal ideation
3785|NCT03266718|prostate cancer|prostate cancer
3787|NCT03266692|BCMA|bcma
3788|NCT03266692|SEA-BCMA|sea-bcma
3789|NCT03266692|B Cell Maturation Antigen|b cell maturation antigen
3790|NCT03266692|ACTR|actr
3791|NCT03266692|ACTR087|actr087
3792|NCT03266692|T cell|t cell
3793|NCT03266692|T cell product|t cell product
3794|NCT03266692|relapsed|relapsed
3795|NCT03266692|refractory|refractory
3796|NCT03266692|multiple myeloma|multiple myeloma
3797|NCT03266692|adoptive T cells|adoptive t cells
3798|NCT03266692|autologous|autologous
3799|NCT03266692|gene therapy|gene therapy
3800|NCT03266692|cell therapy|cell therapy
3801|NCT03266679|bipolar disorder|bipolar disorder
3802|NCT03266679|metacognition|metacognition
3803|NCT03266679|reflective functioning|reflective functioning
3804|NCT03266679|metacognition-based intervention|metacognition-based intervention
3889|NCT03266172|minitablet|minitablet
3890|NCT03266159|Dose escalation|dose escalation
3891|NCT03266159|Small cell lung cancer|small cell lung cancer
3892|NCT03266159|Trametinib|trametinib
3893|NCT03266159|GSK525762|gsk525762
3894|NCT03266159|Ras-mutations|ras-mutations
3895|NCT03266159|BET inhibitor|bet inhibitor
3896|NCT03266146|Drug-induced Liver Injury|drug-induced liver injury
3897|NCT03266146|Recurrence|recurrence
3898|NCT03266146|Methylprednisolone|methylprednisolone
3899|NCT03266146|Short-term|short-term
3900|NCT03266133|Gestational Diabetes Mellitus|gestational diabetes mellitus
3901|NCT03266133|Sleep education|sleep education
3902|NCT03266120|Gardening|gardening
3903|NCT03266120|Therapeutic Arts|therapeutic arts
3904|NCT03266120|Therapeutic Horticulture|therapeutic horticulture
3905|NCT03266120|Anxiety|anxiety
3906|NCT03266120|Depression|depression
3907|NCT03266120|Mood States|mood states
3908|NCT03266120|Quality of Life|quality of life
3909|NCT03266120|Social Interactions|social interactions
3910|NCT03266120|Stress|stress
3911|NCT03266120|Wellness|wellness
3912|NCT03265847|intimate partner violence|intimate partner violence
3913|NCT03265847|safety planning|safety planning
3914|NCT03265847|immigrant, refugee|immigrant, refugee
3915|NCT03265847|Native American|native american
3916|NCT03265847|risk for future violence|risk for future violence
3989|NCT03265197|Intra-tympanic|intra-tympanic
3990|NCT03265197|Lidocaine|lidocaine
3991|NCT03265197|Dexamethasone|dexamethasone
3992|NCT03265132|Interleukin 1 receptor antagonist|interleukin 1 receptor antagonist
3993|NCT03265132|IL-1 receptor antagonist|il-1 receptor antagonist
3994|NCT03265132|Kineret|kineret
3995|NCT03265132|anakinra|anakinra
3996|NCT03265132|Adult-Onset Still's Disease|adult-onset still's disease
4027|NCT03264937|TTR|ttr
4090|NCT03264508|endothelial function|endothelial function
4091|NCT03264508|arterial stiffness|arterial stiffness
4092|NCT03264508|heat|heat
4093|NCT03264508|hot water immersion|hot water immersion
4094|NCT03264443|physical activity|physical activity
4095|NCT03264443|exercise|exercise
4096|NCT03264443|aging|aging
4097|NCT03264443|older|older
4100|NCT03264404|Pancreas|pancreas
4101|NCT03264404|pembrolizumab|pembrolizumab
4102|NCT03264404|azacitidine|azacitidine
4194|NCT03263897|abortive effect|abortive effect
4195|NCT03263897|mobile interface|mobile interface
4196|NCT03263884|nerve growth factor|nerve growth factor
4197|NCT03263884|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4198|NCT03263884|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
4199|NCT03263871|nutrition|nutrition
4200|NCT03263832|Antibiogramme|antibiogramme
4201|NCT03263832|Antibiofilmogramme|antibiofilmogramme
4202|NCT03263819|Postural Orthostatic Tachycardia Syndrome, gastrointestinal hormones|postural orthostatic tachycardia syndrome, gastrointestinal hormones
4209|NCT03263793|singing|singing
4215|NCT03263767|Peripheral haemopoietic stem cell transplant|peripheral haemopoietic stem cell transplant
4216|NCT03263767|High dose cyclophosphamide|high dose cyclophosphamide
4217|NCT03263767|acute GVHD|acute gvhd
4220|NCT03263741|Paclitaxel|paclitaxel
4284|NCT03263559|Haploidentical|haploidentical
4286|NCT03263559|Transplant|transplant
4287|NCT03263559|Sickle Cell Disease|sickle cell disease
4288|NCT03263533|schizophrenia|schizophrenia
4289|NCT03263533|clozapine|clozapine
4290|NCT03263533|vorinostat|vorinostat
4291|NCT03263533|HDAC|hdac
4292|NCT03263533|histone deacetylase inhibitor|histone deacetylase inhibitor
4293|NCT03263507|IONIS PKK-LRx|ionis pkk-lrx
4294|NCT03263455|neglect,|neglect,
4295|NCT03263455|stroke,|stroke,
4296|NCT03263455|rehabilitation,|rehabilitation,
4386|NCT03262714|Dance, walking, cardiovascular risk, functional capacity.|dance, walking, cardiovascular risk, functional capacity.
4393|NCT03262675|Heart Failure|heart failure
4394|NCT03262675|Acute Heart Failure|acute heart failure
4398|NCT03262675|Registry|registry
4689|NCT03260712|gallbladder cancer|gallbladder cancer
4690|NCT03260673|cataract|cataract
4691|NCT03260673|phacoemulsification|phacoemulsification
4692|NCT03260673|type 2 diabetes mellitus|type 2 diabetes mellitus
4693|NCT03260673|corneal endothelial cells|corneal endothelial cells
4694|NCT03260634|voriconazole|voriconazole
4695|NCT03260634|therapeutic drug monitoring|therapeutic drug monitoring
4696|NCT03260608|dementia, deficits, burden, caregivers, telemedicine.|dementia, deficits, burden, caregivers, telemedicine.
4698|NCT03260582|eHealth|ehealth
4977|NCT03259139|adolescent|adolescent
4978|NCT03259139|gun|gun
4979|NCT03259139|violence|violence
4980|NCT03259139|media|media
5084|NCT03258541|TraceIT®|traceit®
5085|NCT03258541|Hydrogel spacer|hydrogel spacer
5086|NCT03258541|Rectal cancer|rectal cancer
5087|NCT03258515|Mesenchymal epithelial transition (MET) receptor|mesenchymal epithelial transition (met) receptor
5088|NCT03258515|Small molecule kinase inhibitors|small molecule kinase inhibitors
5089|NCT03258515|Moxifloxacin (Avelox)|moxifloxacin (avelox)
5090|NCT03258515|QT prolongation|qt prolongation
5091|NCT03258437|sperm motility, Clinical Trial , DA-9401|sperm motility, clinical trial , da-9401
5093|NCT03258359|MDS|mds
5097|NCT03258320|Cabazitaxel|cabazitaxel
5165|NCT03257917|Metastatic Breast Cancer|metastatic breast cancer
5166|NCT03257904|intracranial pressure|intracranial pressure
5167|NCT03257891|Adrenocortical Carcinoma|adrenocortical carcinoma
5168|NCT03257891|Cabazitaxel|cabazitaxel
5169|NCT03257865|Brexpiprazole|brexpiprazole
5170|NCT03257865|Bipolar|bipolar
5171|NCT03257865|Manic episode|manic episode
5172|NCT03257852|Methotrexate|methotrexate
5173|NCT03257852|Arthritis, Rheumatoid|arthritis, rheumatoid
5174|NCT03257852|ASP5094|asp5094
5175|NCT03257839|SoftVue|softvue
5176|NCT03257839|Dense Breast Tissue|dense breast tissue
5177|NCT03257839|Breast Screening|breast screening
5192|NCT03257839|ABUS|abus
5273|NCT03257475|PIBS|pibs
5558|NCT03255603|Resistant Starch|resistant starch
5559|NCT03255603|Dietary Fiber|dietary fiber
5560|NCT03255603|Gastrointestinal Microbiome|gastrointestinal microbiome
5663|NCT03255005|obesity|obesity
5664|NCT03255005|endoscopy|endoscopy
5665|NCT03255005|endoscopic sleeve gastroplasty|endoscopic sleeve gastroplasty
5666|NCT03254953|digital health|digital health
5667|NCT03254953|eHealth|ehealth
17239|NCT03181126|Relapsed of Refractory Acute Lymphoblastic Leukemia|relapsed of refractory acute lymphoblastic leukemia
17240|NCT03181126|Navitoclax|navitoclax
17241|NCT03181126|Cancer|cancer
17242|NCT03181126|Venetoclax|venetoclax
17243|NCT03181113|peginterferon alpha|peginterferon alpha
17342|NCT03180450|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
17343|NCT03180437|Immunotherapy|immunotherapy
17344|NCT03180437|γδ T Cell|γδ t cell
17440|NCT03179683|aluminum step-wedge|aluminum step-wedge
17441|NCT03179683|demineralized bone matrix|demineralized bone matrix
17442|NCT03179683|dental implant|dental implant
17668|NCT03178084|HIV|hiv
17955|NCT03176277|MER|mer
18153|NCT03174886|tau|tau
18226|NCT03174444|Asian American|asian american
18227|NCT03174444|Colorectal cancer screening|colorectal cancer screening
18228|NCT03174444|Print materials|print materials
18229|NCT03174418|Optical coherence tomography|optical coherence tomography
18230|NCT03174418|Percutaneous coronary interventions|percutaneous coronary interventions
18231|NCT03174418|Coronary atherosclerosis in bifurcations|coronary atherosclerosis in bifurcations
18232|NCT03174392|Exercise|exercise
18233|NCT03174392|Multimodal|multimodal
18755|NCT03170531|MRI|mri
19040|NCT03168711|ALS|als
19122|NCT03168113|epidermal transcriptome|epidermal transcriptome
19123|NCT03168113|epidermal lipid composition|epidermal lipid composition
19124|NCT03168061|advanced solid tumor|advanced solid tumor
19125|NCT03168061|unresectable soft tissue sarcoma|unresectable soft tissue sarcoma
19126|NCT03168048|mobile application|mobile application
19221|NCT03167307|omega-3 fatty acids|omega-3 fatty acids
19222|NCT03167307|eicosapentaenoic acid|eicosapentaenoic acid
19415|NCT03165812|Diabetes Mellitus|diabetes mellitus
19416|NCT03165786|fear of hypoglycemia|fear of hypoglycemia
19417|NCT03165786|self-management|self-management
19418|NCT03165786|glycemic control|glycemic control
19419|NCT03165786|glycemic variability|glycemic variability
19724|NCT03163667|RCC|rcc
19905|NCT03162627|Ovarian Tumors with PARP Resistance|ovarian tumors with parp resistance
19907|NCT03162627|AZD6244|azd6244
19908|NCT03162627|Olaparib|olaparib
20054|NCT03161834|DNA|dna
20106|NCT03161457|Moderate RA|moderate ra
20203|NCT03160664|magnetic seizure therapy|magnetic seizure therapy
20205|NCT03160664|bipolar mania|bipolar mania
20398|NCT03159364|Virus-CTL|virus-ctl
20656|NCT03157830|MS|ms
20703|NCT03156491|immune regulation|immune regulation
20704|NCT03156478|Prevention|prevention
20705|NCT03156478|Digital solutions|digital solutions
20706|NCT03156478|Type 2 diabetes|type 2 diabetes
20707|NCT03156478|Life style modification|life style modification
20708|NCT03156478|Physical activity|physical activity
20709|NCT03156478|Healthy diet|healthy diet
21506|NCT03152994|neutrophil-lymphocyte ratio|neutrophil-lymphocyte ratio
21507|NCT03152994|platelet-lymphocyte ratio|platelet-lymphocyte ratio
21509|NCT03152968|FMS|fms
21708|NCT03151785|Schools|schools
21729|NCT03151564|CT|ct
21816|NCT03151005|Obesity|obesity
22694|NCT03145220|Safety|safety
23096|NCT03142477|Spiritual Therapies|spiritual therapies
23097|NCT03142464|saline solution|saline solution
23098|NCT03142464|laparoscopy|laparoscopy
23099|NCT03142464|cholecystectomy|cholecystectomy
23202|NCT03141736|Bag|bag
23590|NCT03138928|XEN45 gel stent|xen45 gel stent
23591|NCT03138915|clinically significant portal hypertension|clinically significant portal hypertension
23592|NCT03138915|hepatic venous pressure gradient|hepatic venous pressure gradient
23593|NCT03138915|radiomics|radiomics
23594|NCT03138889|NKTR-214|nktr-214
23989|NCT03136146|ALL|all
24204|NCT03134794|risk|risk
24293|NCT03134170|Preventative Care|preventative care
24294|NCT03134170|Quality of Life|quality of life
24494|NCT03132922|Urothelial Cancer|urothelial cancer
24495|NCT03132922|Previously Treated|previously treated
24595|NCT03132233|Migraine|migraine
24596|NCT03132233|Prevention|prevention
24597|NCT03132233|Prophylaxis|prophylaxis
24598|NCT03132233|Ketone bodies|ketone bodies
24694|NCT03131596|intrauterine balloon|intrauterine balloon
25291|NCT03127358|Patient Navigation|patient navigation
25292|NCT03127358|Multi-Site|multi-site
25293|NCT03127358|Liver Disease|liver disease
25294|NCT03127358|Intervention|intervention
25295|NCT03127332|Treatment care planning|treatment care planning
25296|NCT03127306|Pain|pain
25297|NCT03127306|Behavioural Pain Scale|behavioural pain scale
25298|NCT03127306|BPS|bps
25299|NCT03127306|NRS|nrs
25300|NCT03127306|Delirium|delirium
25301|NCT03127306|CAM-ICU|cam-icu
25302|NCT03127280|urinary tract infections|urinary tract infections
25303|NCT03127280|postoperative voiding dysfunction|postoperative voiding dysfunction
25304|NCT03127280|foley removal|foley removal
25305|NCT03127280|patient satisfaction|patient satisfaction
25306|NCT03127254|Video Narrative|video narrative
25307|NCT03127241|Assistive devices|assistive devices
25884|NCT03123289|68Gallium Citrate|68gallium citrate
25885|NCT03123289|Orthopedic Hardware infection|orthopedic hardware infection
25890|NCT03123224|Caregiver|caregiver
25891|NCT03123224|Caregiving|caregiving
26497|NCT03119246|HD|hd
26779|NCT03117426|Extended depth of focus IOLs|extended depth of focus iols
26780|NCT03117413|Cochlear implantation|cochlear implantation
26781|NCT03117413|Deafness|deafness
26880|NCT03116815|blood pressure|blood pressure
26881|NCT03116815|monitoring|monitoring
26882|NCT03116815|hypertension|hypertension
27141|NCT03114917|CBT|cbt
27497|NCT03112785|Hip|hip
27580|NCT03112317|Bleeding|bleeding
27581|NCT03112304|children|children
27582|NCT03112304|youth|youth
27583|NCT03112304|adolescents|adolescents
27584|NCT03112304|anxiety|anxiety
27585|NCT03112304|depression|depression
27586|NCT03112304|trauma|trauma
27587|NCT03112304|behavior problems|behavior problems
27602|NCT03112265|anxiety|anxiety
27683|NCT03111927|Nutrition, Brain Development, Cognition, Heathy Infants|nutrition, brain development, cognition, heathy infants
27684|NCT03111901|pembrolizumab|pembrolizumab
27876|NCT03111004|integrated care|integrated care
27877|NCT03111004|MAST framework|mast framework
27878|NCT03111004|organizational change|organizational change
27879|NCT03111004|social care|social care
27880|NCT03111004|elderly patients|elderly patients
27881|NCT03110991|Depression|depression
27882|NCT03110991|Depressive symptoms|depressive symptoms
27979|NCT03110302|Posttraumatic Stress Disorder|posttraumatic stress disorder
27980|NCT03110302|Telehealth|telehealth
27981|NCT03110302|Video teleconferencing|video teleconferencing
27982|NCT03110302|In home therapy|in home therapy
28075|NCT03109522|lymphedema|lymphedema
28076|NCT03109522|breast cancer|breast cancer
28077|NCT03109522|surgery|surgery
28078|NCT03109496|OME|ome
28176|NCT03108976|Autism|autism
28380|NCT03107676|trunk extensors; endurance, peak torque, power, work|trunk extensors; endurance, peak torque, power, work
28381|NCT03107663|PET/CT|pet/ct
28382|NCT03107663|Imaging|imaging
28383|NCT03107663|89Zr-Df-IAB22M2C|89zr-df-iab22m2c
28384|NCT03107663|CD8 + T Cells|cd8 + t cells
28385|NCT03107663|Standard of Care|standard of care
28388|NCT03107637|cardiac source of embolism|cardiac source of embolism
28676|NCT03105752|Informed consent|informed consent
28775|NCT03105206|lowl pole renal calculus|lowl pole renal calculus
28776|NCT03105206|anatomical parameters|anatomical parameters
28777|NCT03105206|flexible ureteroscopy|flexible ureteroscopy
28778|NCT03105193|Colon surgery|colon surgery
28983|NCT03104101|Trospium chloride|trospium chloride
28984|NCT03104075|Genomics|genomics
29682|NCT03099408|Lactobacillus Vaginal Suppositories|lactobacillus vaginal suppositories
29683|NCT03099395|myocardial infarction|myocardial infarction
29684|NCT03099369|Peripheral Artery Disease|peripheral artery disease
29686|NCT03099369|Exercise|exercise
29884|NCT03098342|Onychomycosis|onychomycosis
29885|NCT03098342|photodynamic therapy|photodynamic therapy
30085|NCT03097003|CC-10004|cc-10004
30086|NCT03097003|Apremilast|apremilast
30087|NCT03097003|Belgium|belgium
30088|NCT03097003|OTELO|otelo
30090|NCT03096990|Observational|observational
30194|NCT03096782|Melphalan|melphalan
30195|NCT03096782|Alkeran|alkeran
30196|NCT03096782|Cyclophosphamide|cyclophosphamide
30197|NCT03096782|Cytoxan|cytoxan
30198|NCT03096782|Neosar|neosar
30199|NCT03096782|Mesna|mesna
30612|NCT03094455|ICT|ict
30884|NCT03092713|Mild and moderate TBI|mild and moderate tbi
30885|NCT03092713|Return to work|return to work
30886|NCT03092713|Randomized Controlled Trial|randomized controlled trial
30890|NCT03092661|Oxygen saturation|oxygen saturation
30891|NCT03092661|Pulse oximetry|pulse oximetry
30892|NCT03092661|Neonate|neonate
30893|NCT03092661|Infant|infant
30894|NCT03092622|Exercise Therapy|exercise therapy
30895|NCT03092609|Attentional Bias to Threat|attentional bias to threat
30905|NCT03092570|stroke|stroke
30999|NCT03091790|mesh|mesh
31076|NCT03091257|Multiple Myeloma|multiple myeloma
31077|NCT03091244|Drug-Induced Liver Injury|drug-induced liver injury
31177|NCT03090633|Fetal surgery|fetal surgery
31178|NCT03090633|Fetal spina bifida|fetal spina bifida
31179|NCT03090594|Cryoprobe|cryoprobe
31180|NCT03090594|Bronchoscopy|bronchoscopy
31183|NCT03090581|Lung Transplantation|lung transplantation
31757|NCT03087071|EGFR S492R or other ectodomain mutations in circulating free tumor DNA|egfr s492r or other ectodomain mutations in circulating free tumor dna
31759|NCT03087071|No detectable mutations in circulating free tumor DNA|no detectable mutations in circulating free tumor dna
32052|NCT03085199|gastric cancer|gastric cancer
32053|NCT03085199|laparoscopic gastrectomy|laparoscopic gastrectomy
32058|NCT03085147|Tongue|tongue
32226|NCT03083873|TIL|til
33054|NCT03079180|Triceps Surae|triceps surae
33055|NCT03079180|Quadriceps|quadriceps
33056|NCT03079115|Atorvastatin|atorvastatin
33057|NCT03079089|Allogenic cell stem transplant|allogenic cell stem transplant
33058|NCT03079089|Sequential chemotherapy|sequential chemotherapy
33059|NCT03079089|Haploidentical transplant|haploidentical transplant
33060|NCT03079076|Postoperative Analgesia|postoperative analgesia
33061|NCT03079076|Ultrasound guided thoracolumbar interfascial plane block|ultrasound guided thoracolumbar interfascial plane block
33062|NCT03079011|ESR1 mutation detection, ctDNA|esr1 mutation detection, ctdna
33256|NCT03077945|relapse|relapse
33257|NCT03077945|cigarette|cigarette
33258|NCT03077945|craving|craving
33259|NCT03077945|self regulation|self regulation
33260|NCT03077945|emotion regulation|emotion regulation
33261|NCT03077945|stress response|stress response
33457|NCT03076762|pain|pain
33458|NCT03076762|intravesical injection|intravesical injection
33459|NCT03076762|therapy|therapy
33460|NCT03076762|bladder|bladder
33461|NCT03076749|Betalactam|betalactam
34351|NCT03071406|Merkel cell carcinoma (MCC)|merkel cell carcinoma (mcc)
34352|NCT03071406|Metastatic|metastatic
34353|NCT03071406|Metastasis|metastasis
34354|NCT03071406|Stereotactic body radiation therapy (SBRT)|stereotactic body radiation therapy (sbrt)
34355|NCT03071406|Immunology|immunology
34356|NCT03071406|Antibody|antibody
34357|NCT03071406|Nivolumab|nivolumab
34358|NCT03071406|Ipilimumab|ipilimumab
34359|NCT03071406|Metastatic skin cancer|metastatic skin cancer
34360|NCT03071406|Cutaneous|cutaneous
34362|NCT03071393|walking|walking
34754|NCT03069079|neutrophil defect|neutrophil defect
34755|NCT03069079|periodontitis|periodontitis
34756|NCT03069066|In-stent restenosis|in-stent restenosis
34858|NCT03068377|eye|eye
35059|NCT03067207|eHealth|ehealth
35060|NCT03067207|randomized trial|randomized trial
35061|NCT03067194|Osteoarthritis Hand|osteoarthritis hand
35062|NCT03067155|allogeneic stem cell transplantation|allogeneic stem cell transplantation
35063|NCT03067155|CMV reactivation|cmv reactivation
35064|NCT03067129|Compensated (Child-Pugh A) cirrhosis|compensated (child-pugh a) cirrhosis
35065|NCT03067129|Treatment naïve|treatment naïve
35066|NCT03067129|pegylated interferon (pegIFN)|pegylated interferon (pegifn)
35067|NCT03067129|Ribavirin (RBV)|ribavirin (rbv)
35068|NCT03067129|Chronic Hepatitis C Virus|chronic hepatitis c virus
35069|NCT03067129|Treatment experienced|treatment experienced
35070|NCT03067129|Interferon (IFN)|interferon (ifn)
35071|NCT03067129|Pharmacokinetic|pharmacokinetic
35072|NCT03067129|Non-cirrhotic cirrhosis|non-cirrhotic cirrhosis
35073|NCT03067129|Glecaprevir|glecaprevir
35074|NCT03067129|sofosbuvir|sofosbuvir
35075|NCT03067129|Pibrentasvir|pibrentasvir
35076|NCT03067116|balance, postural|balance, postural
35158|NCT03066726|Doppler|doppler
35253|NCT03066297|Sublobar resection|sublobar resection
35254|NCT03066297|Limited resection|limited resection
35255|NCT03066284|Children|children
35355|NCT03065712|FES|fes
35461|NCT03065192|Gene Therapy|gene therapy
35463|NCT03065192|Parkinson's Disease|parkinson's disease
35464|NCT03065192|Aromatic L- Amino Acid Decarboxylase|aromatic l- amino acid decarboxylase
35465|NCT03065192|AADC|aadc
35466|NCT03065192|AAV2-AADC|aav2-aadc
35467|NCT03065192|AAV2|aav2
35468|NCT03065192|Viral Vector|viral vector
35469|NCT03065192|Gene Transfer|gene transfer
35470|NCT03065192|MRI|mri
35471|NCT03065192|PET|pet
35472|NCT03065192|VY-AADC01|vy-aadc01
35710|NCT03063554|EUS|eus
36367|NCT03059030|Y90|y90
36671|NCT03056898|EPA|epa
37153|NCT03053739|Systemic sclerosis, Associated Pulmonary Arterial Hypertension|systemic sclerosis, associated pulmonary arterial hypertension
37154|NCT03053726|Variable Frequency Stimulation|variable frequency stimulation
37155|NCT03053713|Mediterranean diet pattern|mediterranean diet pattern
37156|NCT03053713|nutrition|nutrition
37157|NCT03053713|diet intervention|diet intervention
37158|NCT03053713|disease activity|disease activity
37159|NCT03053713|intestinal microbiome|intestinal microbiome
37160|NCT03053713|inflammatory bowel disease|inflammatory bowel disease
37161|NCT03053700|Rosacea, Bromonidine, intensed pulse light|rosacea, bromonidine, intensed pulse light
37164|NCT03053661|cancer immunology|cancer immunology
37260|NCT03053271|Endogenous Cushing's Syndrome|endogenous cushing's syndrome
37261|NCT03053271|ATR-101|atr-101
37262|NCT03053271|CS|cs
37263|NCT03053245|Collaborative Care Model|collaborative care model
37264|NCT03053245|Intensive Care Unit|intensive care unit
37265|NCT03053193|breast cancer|breast cancer
37266|NCT03053193|stage I|stage i
37267|NCT03053193|stage II|stage ii
37268|NCT03053193|stage III|stage iii
37269|NCT03053180|Ombitasvir|ombitasvir
37270|NCT03053180|Dasabuvir|dasabuvir
37271|NCT03053180|Hepatitis|hepatitis
37272|NCT03053180|Chronic Hepatitis C genotype 1b (GT1b)|chronic hepatitis c genotype 1b (gt1b)
37273|NCT03053180|Paritaprevir|paritaprevir
37274|NCT03053180|Cirrhosis|cirrhosis
37275|NCT03053180|Compensated liver cirrhosis|compensated liver cirrhosis
37444|NCT03051763|pulmonary hypertension|pulmonary hypertension
37445|NCT03051763|commercial air travel|commercial air travel
37448|NCT03051750|Pressotherapy|pressotherapy
38136|NCT03047577|Alcohol use disorder|alcohol use disorder
38139|NCT03047577|Audit|audit
38431|NCT03045393|IMGN853|imgn853
38432|NCT03045367|Metamorphopsia|metamorphopsia
38434|NCT03045367|Vitrectomy|vitrectomy
39421|NCT03039205|Platelet aggregation|platelet aggregation
583205|NCT00510796|Interview|interview
39718|NCT03037333|Electrocardiogram: Electrical Alternans|electrocardiogram: electrical alternans
39719|NCT03037333|fluoroscopy|fluoroscopy
39729|NCT03037164|RBC|rbc
40247|NCT03034291|BMI|bmi
40820|NCT03030391|Camp|camp
41014|NCT03029026|Cardiac amyloidosis|cardiac amyloidosis
41015|NCT03029026|Aortic stenosis|aortic stenosis
41016|NCT03029026|DPD scintigraphy|dpd scintigraphy
41017|NCT03028987|Quadrivalent, inactivated influenza vaccine|quadrivalent, inactivated influenza vaccine
41116|NCT03028389|non-cardiac surgery|non-cardiac surgery
41117|NCT03028389|ischemic preconditioning|ischemic preconditioning
41118|NCT03028389|delirium|delirium
41119|NCT03028376|biomarker|biomarker
41120|NCT03028376|point-of-care analysis|point-of-care analysis
41122|NCT03028337|Solid tumor malignancy|solid tumor malignancy
41126|NCT03028337|Radiotherapy|radiotherapy
41216|NCT03027830|iFR|ifr
41817|NCT03024125|protein|protein
42208|NCT03021642|healthy volunteer|healthy volunteer
42209|NCT03021642|Tepotinib|tepotinib
42211|NCT03021642|Translocated promoter region|translocated promoter region
42506|NCT03019705|Cyberchondria|cyberchondria
42509|NCT03019705|ambulatory assessment|ambulatory assessment
42708|NCT03018366|menopause|menopause
42709|NCT03018366|amenorrhea|amenorrhea
43110|NCT03015740|RCC|rcc
43904|NCT03010969|Pulmonary function|pulmonary function
43905|NCT03010969|Blood glucose level|blood glucose level
44098|NCT03009708|Adaptive immunity|adaptive immunity
44099|NCT03009708|Innate immunity|innate immunity
44100|NCT03009708|Post graft follow up|post graft follow up
44101|NCT03009695|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
44102|NCT03009695|Obesity|obesity
44290|NCT03008499|High-activity natural killer|high-activity natural killer
44324|NCT03008187|AML|aml
44489|NCT03007030|Mesothelioma|mesothelioma
44491|NCT03007030|MPM|mpm
44492|NCT03007030|CD30+|cd30+
44684|NCT03005704|Platelet transfusion|platelet transfusion
44685|NCT03005704|Reversal|reversal
44686|NCT03005691|metabolite|metabolite
44736|NCT03005379|FMT|fmt
45085|NCT03003338|neuropsychiatric manifestations|neuropsychiatric manifestations
45086|NCT03003325|low risk of thrombosis|low risk of thrombosis
45087|NCT03003325|Interferon|interferon
45088|NCT03003312|Urolithiasis|urolithiasis
46099|NCT02997462|Congestive Heart Failure|congestive heart failure
46100|NCT02997449|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
46107|NCT02997410|Ozone|ozone
46396|NCT02995447|propofol|propofol
46397|NCT02995447|electroencephalogram|electroencephalogram
46405|NCT02995408|parenting|parenting
46500|NCT02994511|ctDNA|ctdna
46795|NCT02992223|Aggressive B-cell non-Hodgkin Lymphoma|aggressive b-cell non-hodgkin lymphoma
46796|NCT02992223|Relapsed|relapsed
46797|NCT02992223|Refractory|refractory
46798|NCT02992223|Zevalin|zevalin
46799|NCT02992223|Y90 Ibritumomab Tiuxetan|y90 ibritumomab tiuxetan
46898|NCT02991690|Trauma|trauma
47096|NCT02990663|Stroke|stroke
47413|NCT02988440|HCC|hcc
48284|NCT02983071|HR+|hr+
48470|NCT02982083|Rheumatoid arthritis|rheumatoid arthritis
48471|NCT02982083|Raloxifene|raloxifene
48472|NCT02982083|Disease activity|disease activity
48473|NCT02982070|psychological well-being, academic success|psychological well-being, academic success
48474|NCT02982044|blood flow|blood flow
48475|NCT02982044|endothelial function|endothelial function
48476|NCT02982044|shear stress|shear stress
48480|NCT02982031|USG LPB|usg lpb
49259|NCT02977429|Tumor|tumor
49360|NCT02976974|force|force
49996|NCT02973542|IBS|ibs
50355|NCT02971072|motor|motor
50356|NCT02971072|motor control|motor control
50357|NCT02971072|muscle|muscle
50358|NCT02971072|neuroadaptation|neuroadaptation
50359|NCT02971072|neurophysiology|neurophysiology
50360|NCT02971072|novel|novel
50361|NCT02971072|outcome|outcome
50362|NCT02971072|outcome measure|outcome measure
50363|NCT02971072|pain inhibition|pain inhibition
50442|NCT02970669|HF|hf
50843|NCT02967861|Red complex microorganisms|red complex microorganisms
50845|NCT02967848|Mebrofenin|mebrofenin
50846|NCT02967848|Liver|liver
51040|NCT02966340|Startle Potentiation|startle potentiation
51041|NCT02966340|Norepinephrine|norepinephrine
51042|NCT02966340|Anxiety|anxiety
51043|NCT02966340|Fear|fear
51044|NCT02966340|Stress|stress
51045|NCT02966314|Angioedema|angioedema
51046|NCT02966314|Idiopathic Angioedema|idiopathic angioedema
51047|NCT02966314|IAE|iae
51241|NCT02965040|Roxadustat|roxadustat
51242|NCT02965040|Metabolites|metabolites
51243|NCT02965040|Pharmacokinetics|pharmacokinetics
51244|NCT02965040|Impaired renal function|impaired renal function
51341|NCT02964455|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
51342|NCT02964455|Chemoradiotherapy|chemoradiotherapy
51343|NCT02964455|Docetaxel|docetaxel
51344|NCT02964455|Nedaplatin|nedaplatin
51345|NCT02964455|Twice weekly|twice weekly
51346|NCT02964416|supratentorial craniotomy|supratentorial craniotomy
200967|NCT02112773|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
200968|NCT02112760|specific stabilization exercise|specific stabilization exercise
200969|NCT02112760|ultrasound|ultrasound
200970|NCT02112760|low back pain|low back pain
200971|NCT02112747|Colorectal Cancer Prevention|colorectal cancer prevention
51347|NCT02964416|extubation response|extubation response
51348|NCT02964416|emergence|emergence
51349|NCT02964416|tramadol|tramadol
51350|NCT02964403|COX-2|cox-2
51351|NCT02964403|ERCP|ercp
51352|NCT02964403|Pancreatitis|pancreatitis
51354|NCT02964390|balloon pulmonary angioplasty|balloon pulmonary angioplasty
51362|NCT02964351|PET-MR|pet-mr
51846|NCT02961218|pediatric|pediatric
51847|NCT02961166|IVIG|ivig
51946|NCT02960646|Myelodysplastic syndrome (MDS|myelodysplastic syndrome (mds
51947|NCT02960646|MDS|mds
51948|NCT02960646|Aplastic anemia|aplastic anemia
51949|NCT02960646|Modified (CD45RA depleted) peripheral blood (PB) stem cell infusion|modified (cd45ra depleted) peripheral blood (pb) stem cell infusion
51950|NCT02960646|T cells|t cells
51951|NCT02960646|Haploidentical transplantation|haploidentical transplantation
51952|NCT02960646|Rituximab|rituximab
51953|NCT02960646|Rituxan|rituxan
51954|NCT02960646|Melphalan|melphalan
51955|NCT02960646|Alkeran|alkeran
51956|NCT02960646|Fludarabine|fludarabine
51957|NCT02960646|Fludarabine Phosphate|fludarabine phosphate
51958|NCT02960646|Fludara|fludara
51959|NCT02960646|Cyclophosphamide|cyclophosphamide
51960|NCT02960646|Cytoxan|cytoxan
51961|NCT02960646|Neosar|neosar
51962|NCT02960646|G-CSF|g-csf
51963|NCT02960646|Filgrastim|filgrastim
51964|NCT02960646|Neupogen|neupogen
51966|NCT02960620|Liver Disease|liver disease
52342|NCT02958397|Myeloid Malignancies|myeloid malignancies
52343|NCT02958397|CAR-T|car-t
52344|NCT02958397|CD33|cd33
52345|NCT02958384|Myeloid Malignancies|myeloid malignancies
53149|NCT02953756|Fatigue|fatigue
53268|NCT02953301|4SC|4sc
54042|NCT02948322|myocardial fibrosis|myocardial fibrosis
54043|NCT02948322|left ventricular hypertrophy|left ventricular hypertrophy
54044|NCT02948322|left ventricular dysfunction|left ventricular dysfunction
54045|NCT02948309|Primary diagnosis|primary diagnosis
54139|NCT02947490|self BP monitoring|self bp monitoring
54140|NCT02947490|self BP management|self bp management
54141|NCT02947438|Renal anemia|renal anemia
54142|NCT02947438|Haemodialysis|haemodialysis
54143|NCT02947438|Maintenance phase|maintenance phase
54344|NCT02946021|Lymphedema|lymphedema
54345|NCT02946021|Cancer|cancer
54346|NCT02946021|Head Cancer|head cancer
55151|NCT02940808|Theta/beta ratio|theta/beta ratio
55152|NCT02940808|Eye-blink rates|eye-blink rates
55153|NCT02940808|Cognitive control|cognitive control
55250|NCT02940171|burns|burns
55251|NCT02940171|critically ill|critically ill
55252|NCT02940171|surgery outcome|surgery outcome
55253|NCT02940171|mortality|mortality
55254|NCT02940158|lentils|lentils
55255|NCT02940158|diabetes|diabetes
55545|NCT02938221|Acute Vestibular Syndrome|acute vestibular syndrome
56067|NCT02934620|HIV|hiv
56752|NCT02930707|total abdominal hysterectomy|total abdominal hysterectomy
56753|NCT02930655|Fabry disease|fabry disease
56754|NCT02930655|lucerastat|lucerastat
56755|NCT02930642|Mindfulness|mindfulness
56756|NCT02930642|Obesity|obesity
56757|NCT02930642|Food insecurity|food insecurity
57248|NCT02927574|systematic review|systematic review
57249|NCT02927574|meta-analysis|meta-analysis
57250|NCT02927574|Paclitaxel|paclitaxel
57251|NCT02927522|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
57252|NCT02927522|Donepezil|donepezil
57448|NCT02926300|UCB-MSC|ucb-msc
57837|NCT02923869|Cleft Palate|cleft palate
57838|NCT02923856|Helicobacter pylori|helicobacter pylori
57839|NCT02923856|Antibiotic resistance|antibiotic resistance
57840|NCT02923856|Sequencing|sequencing
58045|NCT02922790|tobacco|tobacco
58236|NCT02921828|peripheral neuropathy|peripheral neuropathy
58531|NCT02920112|Binge eating|binge eating
58532|NCT02920099|Nutrition literacy|nutrition literacy
58533|NCT02920073|Microbiota|microbiota
58536|NCT02920073|inpatients|inpatients
58819|NCT02918305|resistant hypertension|resistant hypertension
58825|NCT02918266|Drug Therapy|drug therapy
58826|NCT02918253|High dose-rate brachytherapy|high dose-rate brachytherapy
58827|NCT02918227|Ejaculation|ejaculation
58828|NCT02918227|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
58829|NCT02918227|Prostate|prostate
58830|NCT02918214|Septic Shock|septic shock
58831|NCT02918214|echocardiography|echocardiography
58832|NCT02918214|diastolic dysfunction|diastolic dysfunction
756959|NCT03269149|Alzheimer's disease|alzheimer's disease
756960|NCT03269149|African-American Women|african-american women
756961|NCT03269149|Caregivers|caregivers
756962|NCT03269149|Tango|tango
756963|NCT03269149|Dance-based intervention|dance-based intervention
756964|NCT03270202|Exercise|exercise
756965|NCT03270202|Cardiorespiratory fitness|cardiorespiratory fitness
756966|NCT03270202|Risk factors|risk factors
756967|NCT03270202|Monitoring, physiologic|monitoring, physiologic
756968|NCT03270202|Monitoring, ambulatory|monitoring, ambulatory
756969|NCT03270202|Prognosis|prognosis
756970|NCT03270202|Norway|norway
756971|NCT03268889|Chidamide, CHOP regimen|chidamide, chop regimen
756972|NCT03268941|Drug therapy|drug therapy
756973|NCT03268954|Drug therapy|drug therapy
756974|NCT03269019|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
756975|NCT03269019|Thrombosis|thrombosis
756976|NCT03269019|thrombin-antithrombin|thrombin-antithrombin
756977|NCT03269019|d-dimer|d-dimer
756978|NCT03269019|Thrombelastograghy|thrombelastograghy
756979|NCT03269032|Mediterranean diet|mediterranean diet
756980|NCT03269032|gut microbiome|gut microbiome
756981|NCT03269032|gastrointestinal|gastrointestinal
756986|NCT03269747|glucocorticoids|glucocorticoids
756995|NCT03269656|Vitamin D|vitamin d
756996|NCT03269656|Cancer|cancer
756997|NCT03269656|Survival|survival
757011|NCT03269981|Adjuvant radiotherapy|adjuvant radiotherapy
757012|NCT03269981|Lymphatic irradiation|lymphatic irradiation
757013|NCT03269981|Taxane|taxane
757014|NCT03269981|Anthracycline|anthracycline
757015|NCT03269981|Prospective study|prospective study
757016|NCT03269994|pancreatoduodenectomy|pancreatoduodenectomy
757017|NCT03269994|17-418|17-418
757018|NCT03269994|cefoxitin|cefoxitin
757019|NCT03269994|piperacillin-tazobactam|piperacillin-tazobactam
757022|NCT03269734|Vascular Diseases|vascular diseases
757023|NCT03269734|Cerebrovascular Diseases|cerebrovascular diseases
757024|NCT03269734|Cardiovascular Diseases|cardiovascular diseases
757025|NCT03269734|Aortic aneurysm|aortic aneurysm
757026|NCT03269734|Arteriovenous malformations|arteriovenous malformations
757027|NCT03269734|Catheterization|catheterization
757028|NCT03270111|breast cancer survivor|breast cancer survivor
757029|NCT03270111|weight loss program|weight loss program
757035|NCT03270098|Schizophrenia|schizophrenia
757036|NCT03270098|Aerobic Exercise|aerobic exercise
757037|NCT03270098|Cognition|cognition
757038|NCT03270098|Daily Functioning|daily functioning
757039|NCT03270098|Biomarkers|biomarkers
757040|NCT03270098|Brain Derived Neurotrophic Factor|brain derived neurotrophic factor
757041|NCT03268486|Fetal monitoring|fetal monitoring
757042|NCT03268486|cardiotocography|cardiotocography
757043|NCT03268187|Cognitive Fatigue|cognitive fatigue
757044|NCT03268187|Multiple Sclerosis|multiple sclerosis
757045|NCT03268187|Biofeedback|biofeedback
757046|NCT03268187|Self-Alert Training|self-alert training
757047|NCT03268187|Vigilance|vigilance
757048|NCT03268187|Autonomic potentials|autonomic potentials
3586|NCT03268057|Non-Small-Cell Lung|non-small-cell lung
3587|NCT03268057|Carcinoma|carcinoma
3588|NCT03268057|Advanced|advanced
757054|NCT03270124|Aortic Valve Stenosis|aortic valve stenosis
757055|NCT03270124|KAM|kam
757056|NCT03270124|iPAD|ipad
757057|NCT03270124|Physical Exercises|physical exercises
757058|NCT03270124|Quality of Life|quality of life
757065|NCT03268031|artificial intelligence|artificial intelligence
757066|NCT03268031|glaucoma|glaucoma
757067|NCT03269422|17-407|17-407
757068|NCT03269422|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
757069|NCT03269422|DIL|dil
757070|NCT03269422|Dominant Intra-Prostatic Lesion|dominant intra-prostatic lesion
757071|NCT03270033|Shoulder Joint|shoulder joint
757072|NCT03270033|Arthroscopy|arthroscopy
757073|NCT03270033|Ambulatory surgical procedures|ambulatory surgical procedures
757074|NCT03270033|Pain, Postoperative|pain, postoperative
757075|NCT03270033|Brachial Plexus Block|brachial plexus block
757076|NCT03270033|Corticosteroid|corticosteroid
757077|NCT03270033|Dexamethasone|dexamethasone
757078|NCT03270033|Dexmedetomidine|dexmedetomidine
757079|NCT03270033|Bupivacaine|bupivacaine
757080|NCT03270033|Alpha 2 agonist|alpha 2 agonist
757081|NCT03270033|Postoperative analgesia|postoperative analgesia
757082|NCT03270345|Decubitus|decubitus
757083|NCT03270345|Pressure|pressure
757084|NCT03270345|Ulcer|ulcer
757085|NCT03270345|Injurie|injurie
757086|NCT03270345|Soares|soares
757128|NCT03266302|cardiac surgery|cardiac surgery
757129|NCT03266302|cytokines|cytokines
757131|NCT03268512|leucocyte- and platelet rich fibrin|leucocyte- and platelet rich fibrin
757132|NCT03268512|ridge preservation|ridge preservation
757133|NCT03268512|growth factors|growth factors
757134|NCT03268512|platelet concentrates|platelet concentrates
757138|NCT03270891|Pharmacogenomics|pharmacogenomics
757139|NCT03270891|Primary care physicians|primary care physicians
757140|NCT03269448|partial pressure of carbon dioxide|partial pressure of carbon dioxide
757141|NCT03269448|carbon dioxide|carbon dioxide
757142|NCT03269448|peripheral venous blood|peripheral venous blood
757143|NCT03269448|central venous blood|central venous blood
757144|NCT03269448|venous blood gas|venous blood gas
757145|NCT03269448|blood gas analysis|blood gas analysis
757151|NCT03268629|Insomnia|insomnia
757152|NCT03268629|Mindfulness-based Intervention|mindfulness-based intervention
757153|NCT03268629|Mindfulness Meditation|mindfulness meditation
757219|NCT03268408|community intervention|community intervention
757220|NCT03268408|newsletter|newsletter
757235|NCT03265652|Intense Pulsed Light|intense pulsed light
757236|NCT03265652|Meibomian Gland Dysfunction|meibomian gland dysfunction
757237|NCT03265652|Dry Eye Disease|dry eye disease
757238|NCT03268473|OSAS|osas
757239|NCT03269331|nursing practice|nursing practice
757240|NCT03269331|evidence-based practice models|evidence-based practice models
757241|NCT03269331|military nursing|military nursing
757242|NCT03269331|clinical inquiry|clinical inquiry
757243|NCT03266224|congenital muscular torticollis|congenital muscular torticollis
757244|NCT03266224|wryneck|wryneck
757245|NCT03266224|sternocleidomastoid|sternocleidomastoid
757246|NCT03266224|ultrasonography|ultrasonography
757247|NCT03266224|digital analysis|digital analysis
757259|NCT03268850|LDKT|ldkt
757260|NCT03268850|Live donor transplantation|live donor transplantation
757261|NCT03268850|Kidney transplantation|kidney transplantation
757267|NCT03269474|epidermolysis bullosa simplex|epidermolysis bullosa simplex
757268|NCT03269474|genetic expression|genetic expression
757269|NCT03269474|drug repurposing|drug repurposing
757270|NCT03269474|computational approaches|computational approaches
757271|NCT03269474|drug discovery|drug discovery
58833|NCT02918214|Transthoracic|transthoracic
58834|NCT02918214|Transesophageal|transesophageal
58835|NCT02918214|hyperkinesia|hyperkinesia
757280|NCT03257631|Pediatric|pediatric
757281|NCT03257631|Brain Tumor|brain tumor
757282|NCT03257631|Central Nervous System Neoplasms|central nervous system neoplasms
757283|NCT03257631|Glioma|glioma
757284|NCT03257631|High-grade glioma|high-grade glioma
757285|NCT03257631|HGG|hgg
757286|NCT03257631|Ependymoma|ependymoma
757287|NCT03257631|Medulloblastoma|medulloblastoma
757288|NCT03257631|DIPG|dipg
757289|NCT03257631|Diffuse intrinsic pontine gliomaProgressive|diffuse intrinsic pontine gliomaprogressive
757290|NCT03257631|RecurrentPomalidomide|recurrentpomalidomide
757291|NCT03257631|PomalystImnovid|pomalystimnovid
757292|NCT03257631|CC-4047|cc-4047
757293|NCT03257631|Children|children
757299|NCT03260426|Tolerability diet after surgery|tolerability diet after surgery
757318|NCT03266848|Magnetic Resonance Imaging|magnetic resonance imaging
757319|NCT03266848|Ferumoxytol|ferumoxytol
757323|NCT03252457|Purpura|purpura
757324|NCT03252457|Thrombocytopenia|thrombocytopenia
757325|NCT03252457|immune throbocytopenia|immune throbocytopenia
757326|NCT03255317|Substance use, youth, mobile health, data collection adherence, user engagement|substance use, youth, mobile health, data collection adherence, user engagement
757334|NCT03269526|Pancreatic Cancer|pancreatic cancer
757335|NCT03269526|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
757336|NCT03269526|Adoptive cell therapy|adoptive cell therapy
757337|NCT03269526|Armed activated T-cells|armed activated t-cells
757338|NCT03269526|Bispecific antibody|bispecific antibody
757339|NCT03269526|Immunotherapy|immunotherapy
757342|NCT03250052|Fimasartan|fimasartan
757343|NCT03263195|HIV|hiv
757344|NCT03263195|Zika Virus|zika virus
757345|NCT03263195|Pregnancy|pregnancy
757346|NCT03263195|MTCT|mtct
757347|NCT03269175|Clinically Isolated Syndrome suggestive of Multiple Sclerosis or Multiple Sclerosis|clinically isolated syndrome suggestive of multiple sclerosis or multiple sclerosis
757348|NCT03249116|human-animal interaction|human-animal interaction
757349|NCT03249116|animal-assisted intervention|animal-assisted intervention
757352|NCT03249493|Decentralised Area|decentralised area
757353|NCT03269396|severe laryngotracheal dysfunction|severe laryngotracheal dysfunction
58836|NCT02918214|prognosis|prognosis
58837|NCT02918201|Administration, topical|administration, topical
58838|NCT02918201|Tranexamic Acid|tranexamic acid
58839|NCT02918201|Postoperative Care|postoperative care
59021|NCT02917291|ATMP|atmp
60312|NCT02908919|SPMC (solution picosulfate + magnesium citrate)|spmc (solution picosulfate + magnesium citrate)
60313|NCT02908919|PEGA (Polyethylene glycol + ascorbic acid)|pega (polyethylene glycol + ascorbic acid)
60314|NCT02908880|MANTA, arterial closure device, large bore closure device|manta, arterial closure device, large bore closure device
60609|NCT02906995|nicotine absorption|nicotine absorption
60808|NCT02905695|Post-partum Perineal pain|post-partum perineal pain
60809|NCT02905695|Episiotomy|episiotomy
60810|NCT02905695|First-degree tear|first-degree tear
60811|NCT02905669|distensibility|distensibility
60812|NCT02905669|impedance planimetry|impedance planimetry
61316|NCT02902549|Laser Speckle Contrast Imaging|laser speckle contrast imaging
757363|NCT03269617|dysbiosis|dysbiosis
757364|NCT03269617|gut microbiota|gut microbiota
757365|NCT03269617|bacteriophage|bacteriophage
757366|NCT03269617|irritable bowel syndrome|irritable bowel syndrome
757367|NCT03269617|gastrointestinal distress|gastrointestinal distress
757368|NCT03269617|prebiotic|prebiotic
757383|NCT03230448|Acute alcoholism|acute alcoholism
757384|NCT03244527|BCAA|bcaa
757385|NCT03244527|stroke|stroke
757386|NCT03244527|mobility|mobility
754589|NCT03269110|ASD|asd
757418|NCT03234608|Healthcare services|healthcare services
757419|NCT03234608|Adults|adults
757442|NCT03210194|Inservice Training|inservice training
757443|NCT03210194|Neonatal Resuscitation|neonatal resuscitation
757444|NCT03210194|Randomized Cluster Trial|randomized cluster trial
757447|NCT03205488|Northwestern|northwestern
757448|NCT03205488|Nilotinib|nilotinib
757449|NCT03205488|USA|usa
757450|NCT03205488|NILO-PD|nilo-pd
61317|NCT02902536|Myasthenia Gravis|myasthenia gravis
61319|NCT02902510|function|function
61725|NCT02899650|Eccentric exercise|eccentric exercise
61726|NCT02899650|Masters athlete|masters athlete
61727|NCT02899637|Incomplete Spinal Cord Injury|incomplete spinal cord injury
61927|NCT02897947|Surgery|surgery
62409|NCT02894593|alcohol|alcohol
62510|NCT02894073|peripheral venous catheter|peripheral venous catheter
62511|NCT02894060|Cardiovascular events|cardiovascular events
62512|NCT02894047|calcium-sensitive receptor|calcium-sensitive receptor
62513|NCT02894034|optic nerve sheath|optic nerve sheath
62514|NCT02894034|meningeal hemorrhage|meningeal hemorrhage
62515|NCT02894034|early phase|early phase
62520|NCT02893995|PAH|pah
62653|NCT02893176|BOS|bos
62706|NCT02892916|Delirium|delirium
62707|NCT02892916|Ketamine|ketamine
62708|NCT02892916|Elective orthopaedic surgery|elective orthopaedic surgery
62722|NCT02892851|STN-DBS|stn-dbs
62900|NCT02891811|Study Group of Medical Tumour Therapy (AGMT)|study group of medical tumour therapy (agmt)
62901|NCT02891798|analgesia,|analgesia,
62902|NCT02891798|buprenorphine|buprenorphine
63404|NCT02888756|Sexually transmitted disease|sexually transmitted disease
63506|NCT02887963|China|china
64111|NCT02883686|pregnancy|pregnancy
64112|NCT02883686|behavioral activation|behavioral activation
64113|NCT02883686|peer delivery|peer delivery
64187|NCT02883114|GSM|gsm
64605|NCT02880800|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
65399|NCT02875613|Nasopharyngeal|nasopharyngeal
65400|NCT02875613|PD-L1|pd-l1
65401|NCT02875613|monoclonal antibody|monoclonal antibody
65405|NCT02875587|OHSS|ohss
65603|NCT02874183|HF|hf
65791|NCT02872922|Vascular endothelium|vascular endothelium
65793|NCT02872922|Ultrasound|ultrasound
66584|NCT02867735|Neovascular age-related Macular Degeneration(AMD)|neovascular age-related macular degeneration(amd)
66585|NCT02867735|Retinal Vein Occlusions(RVO)|retinal vein occlusions(rvo)
66888|NCT02865564|Colic|colic
67090|NCT02864719|Fatigue|fatigue
67185|NCT02864186|wound healing|wound healing
67186|NCT02864173|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
67190|NCT02864173|Neuropsychology|neuropsychology
67285|NCT02863510|Carbon dioxide angiography|carbon dioxide angiography
67286|NCT02863510|Renal sympathetic denervation|renal sympathetic denervation
67287|NCT02863510|Uncontrolled hypertension|uncontrolled hypertension
67289|NCT02863471|Pancreas|pancreas
67832|NCT02859987|US|us
67875|NCT02859480|Atherosclerosis|atherosclerosis
67876|NCT02859480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
67877|NCT02859480|Anticholesteremic Agents|anticholesteremic agents
67878|NCT02859480|Hypolipidemic Agents|hypolipidemic agents
67974|NCT02859025|Regenerative medicine|regenerative medicine
68077|NCT02858388|Otitis Media with Effusion|otitis media with effusion
68078|NCT02858388|Exudative otitis media|exudative otitis media
68079|NCT02858375|quality of life|quality of life
68080|NCT02858375|botulinum toxin|botulinum toxin
68280|NCT02856789|TEG 6S|teg 6s
68600|NCT02854891|Effects|effects
757451|NCT03205488|Parkinson Disease|parkinson disease
757454|NCT03202667|SGLT2-inhibitor|sglt2-inhibitor
757455|NCT03202667|Treatment|treatment
757456|NCT03263585|Osteoporosis|osteoporosis
757457|NCT03263585|Vertebral Fracture|vertebral fracture
757458|NCT03263585|Back Pain|back pain
757459|NCT03263585|Spinal orthosis|spinal orthosis
757460|NCT03263585|Elderly women|elderly women
757469|NCT03196609|Intestinal microbiota, microbial genes, oncology|intestinal microbiota, microbial genes, oncology
757470|NCT03269383|stellate ganglion block|stellate ganglion block
757471|NCT03269383|cardiac surgery|cardiac surgery
757472|NCT03269383|atrial fibrillation|atrial fibrillation
757477|NCT03264924|physical activity|physical activity
757478|NCT03264924|motivation|motivation
757479|NCT03264924|behaviour change|behaviour change
757505|NCT03191734|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
757539|NCT03165201|Liver transplantation and Biopsy|liver transplantation and biopsy
757540|NCT03165201|Liver transplantation and LiverMultiScan|liver transplantation and livermultiscan
757541|NCT03158857|Myanmar|myanmar
757543|NCT03163446|Staphylococcus aureus|staphylococcus aureus
757544|NCT03163446|bacteremia|bacteremia
757545|NCT03163446|staphylococcal endocarditis|staphylococcal endocarditis
757551|NCT03151304|MDS|mds
757555|NCT03161158|Cardio-Renal Syndrome type 1|cardio-renal syndrome type 1
757556|NCT03161158|Acutely decompensated chronic heart failure|acutely decompensated chronic heart failure
757557|NCT03161158|Ultrafiltration|ultrafiltration
757622|NCT03109886|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
757623|NCT03109886|Metastatic Hepatocellular Carcinoma|metastatic hepatocellular carcinoma
757624|NCT03109886|Child-Pugh Class A|child-pugh class a
757640|NCT03269006|Visceral leishmaniasis|visceral leishmaniasis
757641|NCT03269006|Vector control|vector control
757642|NCT03269006|Sand fly,|sand fly,
757643|NCT03269006|Bangladesh|bangladesh
757649|NCT03103243|Lupus|lupus
757650|NCT03103243|SLE|sle
757651|NCT03103243|Erythematosus|erythematosus
757659|NCT03089190|Appetite|appetite
757660|NCT03089190|Satiety|satiety
757661|NCT03089190|Energy intake|energy intake
757662|NCT03089190|Hunger|hunger
757663|NCT03089190|Peptide|peptide
757664|NCT03089190|Encapsulation|encapsulation
757665|NCT03085173|CAR T Cells Targeting CD19|car t cells targeting cd19
757666|NCT03085173|EGFRt/19-28z/4-1BBL|egfrt/19-28z/4-1bbl
757667|NCT03085173|16-1570|16-1570
757674|NCT03094052|neratinib|neratinib
757675|NCT03094052|trastuzumab|trastuzumab
757676|NCT03094052|crofelemer|crofelemer
757683|NCT03081325|URSA|ursa
757686|NCT03077698|Endometrial cancer|endometrial cancer
757687|NCT03077698|Recurrent or persistent endometrial carcinoma|recurrent or persistent endometrial carcinoma
757688|NCT03077698|Progesterone Receptor Negative|progesterone receptor negative
757689|NCT03077698|Sodium Cridanimod|sodium cridanimod
757690|NCT03078751|Hormone receptor-positive|hormone receptor-positive
757691|NCT03078751|Estrogen and/or progesterone receptor-positive|estrogen and/or progesterone receptor-positive
757692|NCT03078751|HER2-negative|her2-negative
757693|NCT03078751|High risk early breast cancer|high risk early breast cancer
757694|NCT03078751|Adjuvant|adjuvant
757695|NCT03078751|Ribociclib|ribociclib
757696|NCT03078751|LEE011|lee011
757697|NCT03078751|CDK4/6 inhibitor|cdk4/6 inhibitor
757698|NCT03078751|Endocrine therapy|endocrine therapy
757699|NCT03078751|Phase III|phase iii
757700|NCT03078751|Breast carcinoma|breast carcinoma
757701|NCT03078751|Breast cancer|breast cancer
757702|NCT03068689|Partial nephrectomy, RIPC, Reperfusion Injury|partial nephrectomy, ripc, reperfusion injury
757703|NCT03063515|Insulin secretion|insulin secretion
68672|NCT02854449|Radiotherapy|radiotherapy
68673|NCT02854449|Dose Hypofractionation|dose hypofractionation
68674|NCT02854436|Prostate cancer|prostate cancer
68675|NCT02854436|CRPC|crpc
68676|NCT02854436|Metastatic castrate-resistant prostate cancer|metastatic castrate-resistant prostate cancer
68677|NCT02854436|Prostate neoplasm|prostate neoplasm
68678|NCT02854436|Galahad|galahad
68679|NCT02854436|Niraparib|niraparib
68681|NCT02854436|DNA defect|dna defect
68892|NCT02853214|MGUS|mgus
69085|NCT02851966|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
69086|NCT02851953|cervix, cervical dilation, balloon catheter|cervix, cervical dilation, balloon catheter
69087|NCT02851940|Pain|pain
69088|NCT02851940|Bleeding|bleeding
757719|NCT03051607|Motor Fluctuations|motor fluctuations
757720|NCT03051607|Off time|off time
757721|NCT03051607|On time|on time
757722|NCT03051607|Dyskinesia|dyskinesia
757723|NCT03053297|EGFR|egfr
757724|NCT03053297|EGFR mutation|egfr mutation
757725|NCT03053297|EGFRm|egfrm
757726|NCT03053297|EGFR-TKI|egfr-tki
757727|NCT03053297|Health care resource utilization|health care resource utilization
757728|NCT03053297|Health-Related Quality of Life|health-related quality of life
757729|NCT03053297|Locally advanced or metastatic lung cancer|locally advanced or metastatic lung cancer
757730|NCT03053297|NSCLC|nsclc
757731|NCT03053297|Non-Small Cell Lung Cancer|non-small cell lung cancer
757732|NCT03053297|Observational study|observational study
757733|NCT03053297|Osimertinib|osimertinib
757734|NCT03053297|Personalized medicine|personalized medicine
757735|NCT03053297|PRO|pro
757736|NCT03053297|Patient Reported Outcome|patient reported outcome
757737|NCT03053297|Resistance|resistance
757738|NCT03053297|T790M|t790m
757739|NCT03053297|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
757740|NCT03053297|Carcinoma, Bronchogenic|carcinoma, bronchogenic
757741|NCT03053297|Bronchial Neoplasms|bronchial neoplasms
757742|NCT03053297|Lung Neoplasms|lung neoplasms
757743|NCT03053297|Respiratory Tract Neoplasms|respiratory tract neoplasms
757744|NCT03053297|Thoracic neoplasms, Neoplasms by site|thoracic neoplasms, neoplasms by site
757745|NCT03053297|Lung diseases|lung diseases
757746|NCT03053297|Respiratory Tract diseases|respiratory tract diseases
757747|NCT03053297|Cancer Chemotherapy|cancer chemotherapy
757748|NCT03053297|Combination Chemotherapy|combination chemotherapy
757749|NCT03053297|Immunotherapy|immunotherapy
757750|NCT03053297|Radiation|radiation
757761|NCT03066050|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
757762|NCT03066050|Mitral Valve Disease|mitral valve disease
757763|NCT03066050|Moderate Mitral Regurgitation|moderate mitral regurgitation
757764|NCT03066050|Severe Mitral Regurgitation|severe mitral regurgitation
758333|NCT02677740|MRI|mri
757787|NCT03053466|Advanced Solid Tumor|advanced solid tumor
757788|NCT03053466|Relapsed Solid Tumor|relapsed solid tumor
757789|NCT03053466|Recurrent Solid Tumor|recurrent solid tumor
757810|NCT03037385|medullary thyroid cancer|medullary thyroid cancer
757811|NCT03037385|non-small cell lung cancer|non-small cell lung cancer
757812|NCT03037385|papillary thyroid cancer|papillary thyroid cancer
757813|NCT03029286|Breast Cancer|breast cancer
757814|NCT03029286|Breast Density|breast density
757815|NCT03032380|Hospital-acquired pneumonia (HAP)|hospital-acquired pneumonia (hap)
757816|NCT03032380|S-649266|s-649266
757817|NCT03032380|linezolid|linezolid
757818|NCT03032380|meropenem|meropenem
757819|NCT03032380|Healthcare-associated pneumonia (HCAP)|healthcare-associated pneumonia (hcap)
757820|NCT03032380|nosocomial pneumonia|nosocomial pneumonia
757821|NCT03032380|Ventilator-associated pneumonia (VAP)|ventilator-associated pneumonia (vap)
757822|NCT03032380|Gram-negative pathogens|gram-negative pathogens
757823|NCT03032380|pneumonia|pneumonia
757824|NCT03032380|cefiderocol|cefiderocol
757830|NCT03038646|Pharmacokinetics|pharmacokinetics
757831|NCT03038646|Food Effect|food effect
757841|NCT03017872|HIV, second-line|hiv, second-line
757842|NCT03006315|multiple myeloma|multiple myeloma
757843|NCT03006315|garmin vivofit|garmin vivofit
757851|NCT02997423|Glioblastoma Multiforme|glioblastoma multiforme
757852|NCT02997423|Biomarker|biomarker
757853|NCT02997423|Cytochrome C Oxidase|cytochrome c oxidase
757854|NCT02997423|Newly diagnosed|newly diagnosed
757866|NCT03028129|Tuberculosis|tuberculosis
757867|NCT03028129|Primary prevention|primary prevention
757868|NCT03028129|Prisoners|prisoners
757869|NCT03028129|Controlled Clinical Trial|controlled clinical trial
757870|NCT03028129|Isoniazid|isoniazid
757885|NCT02967263|Acute Kidney Injury|acute kidney injury
757886|NCT02967263|Proteinosis|proteinosis
757887|NCT02967263|Epidemiology|epidemiology
757888|NCT02967263|Risk factors|risk factors
757904|NCT02964013|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
757905|NCT02964013|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
757906|NCT02964013|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
757907|NCT02964013|PD-1|pd-1
757908|NCT02964013|PDL1|pdl1
757909|NCT02964013|PD-L1|pd-l1
757910|NCT02964013|PD-L2|pd-l2
757929|NCT02957968|Breast Cancer|breast cancer
757930|NCT02957968|Invasive adenocarcinoma|invasive adenocarcinoma
757931|NCT02957968|HER2-negative|her2-negative
757932|NCT02960334|Screening|screening
757933|NCT02960334|Silent Atrial Fibrillation|silent atrial fibrillation
757934|NCT02960334|Undertreated Atrial Fibrillation|undertreated atrial fibrillation
757935|NCT02960334|Actionable Atrial Fibrillation|actionable atrial fibrillation
757936|NCT02960334|MyDiagnostick|mydiagnostick
757937|NCT02960334|Opportunistic Screening|opportunistic screening
757938|NCT02960334|Preoperative Consultation|preoperative consultation
758024|NCT02901886|Rheumatoid Arthritis|rheumatoid arthritis
758025|NCT02901886|Smoking Cessation|smoking cessation
758026|NCT02901886|Disease Activity|disease activity
758027|NCT02901886|Clinical Prevention|clinical prevention
758028|NCT02899195|Unresectable Mesothelioma|unresectable mesothelioma
758029|NCT02899195|Durvalumab|durvalumab
758030|NCT02899195|Anti-Programmed Death-Ligand 1 Antibody|anti-programmed death-ligand 1 antibody
758031|NCT02908451|Cancer|cancer
758032|NCT02908451|Antibody Drug Conjugate|antibody drug conjugate
758033|NCT02908451|AbGn-107|abgn-107
758034|NCT02908451|Adenocarcinoma|adenocarcinoma
758035|NCT02908451|Gastric|gastric
758036|NCT02908451|Colorectal|colorectal
758037|NCT02908451|Pancreatic|pancreatic
758042|NCT02883374|cephalic and cervical adenocystic Carcinoma|cephalic and cervical adenocystic carcinoma
758043|NCT02883374|Chidamide|chidamide
758048|NCT02875223|Safety|safety
758049|NCT02875223|CC-90011|cc-90011
758050|NCT02875223|Relapsed and/or Refractory Solid Tumors|relapsed and/or refractory solid tumors
758051|NCT02875223|Non-Hodgkin's Lymphomas|non-hodgkin's lymphomas
758052|NCT02926898|seizure|seizure
758053|NCT02926898|tonic clonic|tonic clonic
758054|NCT02926898|epilepsy|epilepsy
758055|NCT02926898|myoclonic|myoclonic
758056|NCT02926898|encephalopathy|encephalopathy
758064|NCT02867683|vibrotactile feedback|vibrotactile feedback
758065|NCT02867683|vestibular rehabilitation|vestibular rehabilitation
758066|NCT02867683|balance|balance
758067|NCT02858713|psoriasis|psoriasis
758071|NCT02851407|stem cell transplant|stem cell transplant
758072|NCT02851407|hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
758073|NCT02851407|veno-occlusive disease (VOD)|veno-occlusive disease (vod)
758074|NCT02851407|sinosoidial obstruction syndrome (SOS)|sinosoidial obstruction syndrome (sos)
758077|NCT02848248|Acute Myeloid Leukemia|acute myeloid leukemia
758078|NCT02848248|Antibody-Drug Conjugate|antibody-drug conjugate
758079|NCT02848248|CD123 Antigen|cd123 antigen
758080|NCT02848248|Drug Therapy|drug therapy
758081|NCT02848248|AML|aml
758082|NCT02848248|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
758091|NCT02835989|Community Paramedicine|community paramedicine
758092|NCT02835989|Paramedic|paramedic
758093|NCT02835989|Emergency Medical Services|emergency medical services
758094|NCT02835989|High Frequency Callers|high frequency callers
758095|NCT02835989|Lift Assists|lift assists
758107|NCT02832232|Physiotherapy|physiotherapy
758108|NCT02832232|Manual Therapy|manual therapy
758109|NCT02832232|Neck Pain|neck pain
758122|NCT03270787|Acute Mountain sickness|acute mountain sickness
758123|NCT03270787|Compound Danshen Dripping Pills|compound danshen dripping pills
758124|NCT02970877|Fecal microbiota transplant|fecal microbiota transplant
758125|NCT02970877|Intestinal microbiome|intestinal microbiome
758126|NCT02970877|Oral microbiome|oral microbiome
758127|NCT02970877|Mucosa associated microbiome|mucosa associated microbiome
758128|NCT02970877|Appetite|appetite
758129|NCT02970877|Metabolome|metabolome
758130|NCT02970877|Depression|depression
758131|NCT02970877|Anxiety|anxiety
758135|NCT02833844|Hyperlipidemia|hyperlipidemia
758136|NCT02833844|Dyslipidemia|dyslipidemia
758137|NCT02833844|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
758138|NCT02833844|Inhibition|inhibition
758139|NCT02833844|HIV infection|hiv infection
758140|NCT02833844|Cluster of differentiation|cluster of differentiation
758141|NCT02833844|Viral load|viral load
758148|NCT02807961|Translational read through|translational read through
758150|NCT02795507|cross education|cross education
758151|NCT02795507|visual feedback|visual feedback
758152|NCT02805283|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
758153|NCT02796339|Inflammatory Bowel Diseases|inflammatory bowel diseases
758154|NCT02796339|natural Mastiha|natural mastiha
758155|NCT02796339|supplement|supplement
758157|NCT02788279|Locally advanced or Metastatic colorectal adenocarcinoma|locally advanced or metastatic colorectal adenocarcinoma
758161|NCT02882958|Radiology|radiology
758162|NCT02787642|Advanced soft-tissue sarcoma|advanced soft-tissue sarcoma
758163|NCT02787642|Unresectable Soft-tissue Sarcoma|unresectable soft-tissue sarcoma
758164|NCT02761486|aspirin|aspirin
758165|NCT02761486|gut microbiome|gut microbiome
758166|NCT02761486|inflammation|inflammation
758167|NCT02761486|placebo|placebo
758168|NCT02761486|circulating biomarker|circulating biomarker
758169|NCT02769312|Quality of Life|quality of life
758170|NCT02769312|Post-Traumatic Stress Disorder|post-traumatic stress disorder
758171|NCT02769312|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
758172|NCT02769312|Feasibility studies|feasibility studies
758177|NCT02770131|hypercholesterolaemia|hypercholesterolaemia
758178|NCT02770131|lipid-lowering therapies|lipid-lowering therapies
758208|NCT02740179|Eplerenone|eplerenone
758209|NCT02740179|Cardiovascular Disease|cardiovascular disease
758210|NCT02740179|Mineralocorticoid Receptor Antagonist|mineralocorticoid receptor antagonist
758211|NCT02740179|Coronary Vasculature|coronary vasculature
758212|NCT02740179|Myocardial Inflammation|myocardial inflammation
758213|NCT02740179|Myocardial Fibrosis|myocardial fibrosis
758214|NCT02740179|Atherosclerosis|atherosclerosis
758215|NCT02740179|Aldosterone|aldosterone
758217|NCT03264274|Colorectal|colorectal
758218|NCT03264274|Metastatic|metastatic
758219|NCT03264274|Chemorefractory|chemorefractory
758220|NCT03264274|Ultrasound|ultrasound
758221|NCT03264274|Aflibercept|aflibercept
758226|NCT02728102|Multiple Myeloma|multiple myeloma
758227|NCT02728102|Lenalidomide|lenalidomide
758228|NCT02728102|Maintenance Therapy|maintenance therapy
758229|NCT02728102|Hematologic Disorders|hematologic disorders
758230|NCT02728102|Vaccine|vaccine
758231|NCT02728102|GM-CSF|gm-csf
758232|NCT02728102|Transplant|transplant
758233|NCT02728102|Anti-Myeloma Agents|anti-myeloma agents
758234|NCT02732457|HIV|hiv
758235|NCT02732457|Persistence|persistence
758236|NCT02732457|Reservoirs|reservoirs
758237|NCT02732457|Stem Cell Transplant|stem cell transplant
758238|NCT02732457|Functional Cure|functional cure
758255|NCT02728752|DM|dm
758256|NCT02708186|Dementia with Lewy bodies|dementia with lewy bodies
758257|NCT02708186|Lewy bodies|lewy bodies
758258|NCT02708186|REM sleep behavior disorder|rem sleep behavior disorder
758259|NCT02708186|Parkinson's disease dementia|parkinson's disease dementia
758263|NCT02713529|Solid Tumor|solid tumor
758264|NCT02713529|Pancreatic Cancer|pancreatic cancer
758265|NCT02713529|Colorectal Cancer|colorectal cancer
758266|NCT02713529|Non-Small Cell Lung Cancer|non-small cell lung cancer
758267|NCT02754076|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
758271|NCT02693665|pediatric advance care planning|pediatric advance care planning
758272|NCT02693665|adolescent|adolescent
758273|NCT02693665|family|family
758274|NCT02693665|palliative care|palliative care
758275|NCT02693665|end of life|end of life
758276|NCT02693665|communication|communication
758277|NCT02693665|decision making|decision making
758278|NCT02693665|surrogate decision maker|surrogate decision maker
758279|NCT02693665|health care proxy|health care proxy
758280|NCT02693665|intervention|intervention
758281|NCT02693665|randomized clinical trial|randomized clinical trial
758282|NCT02693665|cancer|cancer
758283|NCT02693665|quality of life|quality of life
758327|NCT02682927|seizure|seizure
758328|NCT02682927|tonic-atonic|tonic-atonic
758329|NCT02682927|clonic|clonic
758330|NCT02682927|epilepsy|epilepsy
758331|NCT02682927|myoclonic|myoclonic
758332|NCT02682927|encephalopathy|encephalopathy
758334|NCT02677740|MRS|mrs
758335|NCT02677740|rTMS|rtms
758338|NCT02673502|Carbohydrate drink|carbohydrate drink
758339|NCT02673502|Post operative complication|post operative complication
758340|NCT02673502|insulin resistance|insulin resistance
758341|NCT02673502|Fasting blood glucose|fasting blood glucose
758411|NCT02813564|Autism|autism
758412|NCT02813564|Cognitive Training|cognitive training
758413|NCT02813564|Brain|brain
758414|NCT02813564|fMRI|fmri
758415|NCT02643043|Next Generation Sequencing|next generation sequencing
758416|NCT02643043|Genomic Analysis|genomic analysis
758417|NCT02638337|Vulvo-vaginal Atrophy|vulvo-vaginal atrophy
758418|NCT02638337|menopause|menopause
758419|NCT02633046|FSGS|fsgs
758420|NCT02633046|primary FSGS|primary fsgs
758421|NCT02633046|idiopathic FSGS|idiopathic fsgs
758424|NCT02628067|PD1|pd1
758425|NCT02628067|PDL1|pdl1
758426|NCT02628067|PD-1|pd-1
758427|NCT02628067|PD-L1|pd-l1
758428|NCT02628067|MSI|msi
758501|NCT02593123|Donor Type (Matched Related Donor or Matched Unrelated Donor)|donor type (matched related donor or matched unrelated donor)
758517|NCT02575339|MLN0128|mln0128
758518|NCT02575339|Sapanisertib|sapanisertib
758519|NCT02575339|TORC1/2 inhibitor|torc1/2 inhibitor
758520|NCT02575339|INK128|ink128
758521|NCT02575339|Nexavar|nexavar
758522|NCT02575339|Sorafenib|sorafenib
758523|NCT02579005|Radiation|radiation
758524|NCT02579005|Immune response|immune response
758525|NCT02579005|Anti-tumor|anti-tumor
758526|NCT02579005|Lung Cancer|lung cancer
758527|NCT02568267|Entrectinib|entrectinib
758528|NCT02568267|RXDX-101|rxdx-101
758529|NCT02568267|TrkA|trka
758530|NCT02568267|TrkB|trkb
758531|NCT02568267|TrkC|trkc
758532|NCT02568267|NTRK1|ntrk1
758533|NCT02568267|NTRK2|ntrk2
758534|NCT02568267|NTRK3|ntrk3
758535|NCT02568267|ROS1|ros1
758536|NCT02568267|ALK|alk
758537|NCT02568267|Trk Fusions|trk fusions
758538|NCT02568267|NTRK Gene Rearrangements|ntrk gene rearrangements
758539|NCT02568267|ROS1 Fusions|ros1 fusions
758540|NCT02568267|ROS1 Gene Rearrangements|ros1 gene rearrangements
758541|NCT02568267|ALK Fusions|alk fusions
758542|NCT02568267|ALK Gene Rearrangements|alk gene rearrangements
758543|NCT02568267|Basket study|basket study
758544|NCT02568267|Non-small cell lung cancer|non-small cell lung cancer
758545|NCT02568267|Colorectal cancer|colorectal cancer
758546|NCT02568267|Salivary gland cancers|salivary gland cancers
758547|NCT02568267|Primary brain tumors|primary brain tumors
758548|NCT02568267|Melanoma|melanoma
758549|NCT02568267|Sarcomas|sarcomas
758550|NCT02568267|Papillary thyroid cancer|papillary thyroid cancer
758551|NCT02568267|Renal cell cancer|renal cell cancer
758552|NCT02568267|Pancreatic cancer|pancreatic cancer
758553|NCT02568267|Breast cancer|breast cancer
758554|NCT02568267|Cholangiocarcinoma|cholangiocarcinoma
758555|NCT02568267|Head & Neck cancers|head & neck cancers
758556|NCT02568267|Ovarian cancer|ovarian cancer
758557|NCT02568267|Neuroendocrine tumors|neuroendocrine tumors
758558|NCT02568267|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
758559|NCT02572869|Mandible Reconstruction|mandible reconstruction
758595|NCT02583672|Gaucher Disease|gaucher disease
758596|NCT02681666|FODMAP Diet|fodmap diet
758597|NCT02681666|Bowel Habit|bowel habit
758598|NCT02681666|Rome IV Criteria|rome iv criteria
758599|NCT02681666|Mindfulness|mindfulness
758600|NCT02681666|Abdominal pain|abdominal pain
758601|NCT02681666|Irritable Bowel Syndrome|irritable bowel syndrome
758602|NCT02530918|DS-7080a Monoclonal Antibody|ds-7080a monoclonal antibody
758603|NCT02504372|NSCLC|nsclc
758604|NCT02504372|PDL1|pdl1
758605|NCT02504372|PD-L1|pd-l1
758606|NCT02504372|PDL|pdl
758610|NCT02498600|Phase II Randomized Trial of Nivolumab with or without Ipilimumab in Patients with Persistent or Recurrent Epithelial Ovarian|phase ii randomized trial of nivolumab with or without ipilimumab in patients with persistent or recurrent epithelial ovarian
758611|NCT02498600|Primary Peritoneal or Fallopian|primary peritoneal or fallopian
758612|NCT02498600|Tube Cancer|tube cancer
758616|NCT02494583|Gastric carcinoma|gastric carcinoma
758617|NCT02494583|Gastric cancer|gastric cancer
758618|NCT02494583|Gastroesophageal junction cancer|gastroesophageal junction cancer
758619|NCT02494583|Gastroesophageal junction carcinoma|gastroesophageal junction carcinoma
758620|NCT02494583|PD1|pd1
758621|NCT02494583|PD-1|pd-1
758622|NCT02494583|PDL1|pdl1
758623|NCT02494583|PD-L1|pd-l1
758626|NCT02503436|Ovarian Cancer, Fallopian Tube Cancer, primary peritoneal cancer, BRCA1 Gene, BRCA2 Gene|ovarian cancer, fallopian tube cancer, primary peritoneal cancer, brca1 gene, brca2 gene
758632|NCT02500589|smoking|smoking
758633|NCT02500589|tobacco|tobacco
758634|NCT02834455|Thoracoscopy|thoracoscopy
758635|NCT02476240|Exercise|exercise
758636|NCT02476240|Attention|attention
758662|NCT02435420|Total Hip Arthroplasty|total hip arthroplasty
758663|NCT02435420|EMPERION Modular Stem|emperion modular stem
758664|NCT02435420|Survivorship|survivorship
758665|NCT02431247|Immunodeficiency Virus Type 1, Human|immunodeficiency virus type 1, human
758666|NCT02431247|Darunavir|darunavir
758667|NCT02431247|Cobicistat|cobicistat
758668|NCT02431247|Tenofovir Alafenamide|tenofovir alafenamide
758669|NCT02431247|Emtricitabine|emtricitabine
758670|NCT02431247|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
758673|NCT02446561|Healthy Volunteer|healthy volunteer
758674|NCT02446561|Pharmacokinetics|pharmacokinetics
758689|NCT02427659|VRD|vrd
758690|NCT02427659|Virtual Reality as Distraction during Procedure|virtual reality as distraction during procedure
69089|NCT02851940|Hemorrhoids|hemorrhoids
69304|NCT02850146|tau|tau
69572|NCT02848612|interventional neuroradiology|interventional neuroradiology
69573|NCT02848612|coil embolization|coil embolization
69574|NCT02848599|postoperative analgesia|postoperative analgesia
69575|NCT02848599|postoperative cognitive disfunction|postoperative cognitive disfunction
758691|NCT02427659|Burn Wound Care|burn wound care
758702|NCT02416297|malocclusion|malocclusion
758703|NCT02416297|accelerated tooth movement|accelerated tooth movement
758704|NCT02416297|Tomography|tomography
758705|NCT02416297|Extraction|extraction
758712|NCT02389075|intraepithelial lymphocytes (IEL)|intraepithelial lymphocytes (iel)
758713|NCT02389075|microbiome|microbiome
758714|NCT02389075|colon mucosa|colon mucosa
758723|NCT02389140|Blood flow|blood flow
758724|NCT02389140|Glucose|glucose
758725|NCT02389140|lactic acid|lactic acid
758726|NCT02380092|Knee|knee
758727|NCT02380092|Post-Market Surveillance|post-market surveillance
758728|NCT02380092|Legion|legion
758729|NCT02380092|Verilast|verilast
758730|NCT02380092|Degenerative Joint Disease|degenerative joint disease
758739|NCT02371369|Pigmented Villonodular Synovitis|pigmented villonodular synovitis
758740|NCT02371369|Giant Cell Tumors of the Tendon Sheath|giant cell tumors of the tendon sheath
758741|NCT02371369|Tenosynovial Giant Cell Tumour|tenosynovial giant cell tumour
758742|NCT02371369|PLX3397|plx3397
758743|NCT02371369|Colony Stimulating Factor 1 Receptor (CSF1R) inhibitor|colony stimulating factor 1 receptor (csf1r) inhibitor
758751|NCT02364648|Endothelium, vascular|endothelium, vascular
758752|NCT02364648|MitoQ|mitoq
758753|NCT02364648|Mitochondria|mitochondria
758754|NCT02364648|Oxidative Stress|oxidative stress
758755|NCT02364648|Chronic Renal Insufficiency|chronic renal insufficiency
758756|NCT02364648|Cardiovascular Disease|cardiovascular disease
758757|NCT02362646|Heart Failure|heart failure
758758|NCT02362646|Left Ventricular Assist Device|left ventricular assist device
758759|NCT02362646|Heart Transplantation|heart transplantation
758760|NCT02362646|Cardiomyopathy, Destination Therapy|cardiomyopathy, destination therapy
758761|NCT02362646|Cell Therapy|cell therapy
758762|NCT02362646|Bridge to Transplant|bridge to transplant
758763|NCT02369523|Primary Total Knee Arthroplasty|primary total knee arthroplasty
758765|NCT02358564|IBS|ibs
758766|NCT02358564|Irritable Bowel Syndrome|irritable bowel syndrome
758767|NCT02358564|Visceral Hypersensitivity|visceral hypersensitivity
758768|NCT02358564|Permeability|permeability
758769|NCT02358564|Small Bowel|small bowel
758770|NCT02358564|Lactulose|lactulose
758771|NCT02358564|Mannitol|mannitol
758772|NCT02386605|recovery|recovery
758773|NCT02386605|rehabilitation|rehabilitation
758779|NCT02369653|Anticoagulation|anticoagulation
69576|NCT02848586|HIV|hiv
69577|NCT02848586|ECIGS|ecigs
69578|NCT02848586|e-cigarettes|e-cigarettes
69579|NCT02848586|lung inflammation|lung inflammation
69580|NCT02848560|Cystic Fibrosis|cystic fibrosis
69982|NCT02846584|HSCT|hsct
69992|NCT02846558|calorie restriction|calorie restriction
758797|NCT02334241|Sorbact|sorbact
758798|NCT02334241|Best local Cares|best local cares
758799|NCT02334241|DFU|dfu
758800|NCT02313428|Diabetic Foot Ulcer|diabetic foot ulcer
758801|NCT02313428|Topical Oxygen Therapy|topical oxygen therapy
758802|NCT02313428|Medicaid Recipients|medicaid recipients
758803|NCT02313428|Standard of Care|standard of care
758804|NCT02313428|Diabetic Wounds|diabetic wounds
758808|NCT02324439|ovarian cancer|ovarian cancer
758809|NCT02324439|flaxseed|flaxseed
758810|NCT02324439|dietary supplement|dietary supplement
758811|NCT02324439|organic dietary supplement|organic dietary supplement
758812|NCT02324439|recurrence|recurrence
758820|NCT02293837|interleukin-6 (IL-6) receptor inhibitor|interleukin-6 (il-6) receptor inhibitor
758849|NCT02260570|concussion|concussion
758850|NCT02260570|traumatic brain injury|traumatic brain injury
758851|NCT02260570|MRI|mri
758852|NCT02260570|memory|memory
758853|NCT02260570|tolcapone|tolcapone
758866|NCT02240472|sentinel node biopsy, lymph node metastasis, survival|sentinel node biopsy, lymph node metastasis, survival
758867|NCT02236195|Urothelial|urothelial
758868|NCT02236195|Bladder|bladder
758869|NCT02236195|HDAC|hdac
758870|NCT02236195|MGCD0103|mgcd0103
758871|NCT02236195|Mocetinostat|mocetinostat
758872|NCT02236195|CREBBP|crebbp
758873|NCT02236195|EP300|ep300
758874|NCT02236195|Mirati|mirati
758875|NCT02236195|MethylGene|methylgene
758885|NCT02220374|Osteoarthritis|osteoarthritis
69993|NCT02846558|weight loss|weight loss
69994|NCT02846532|Thromboembolism|thromboembolism
69995|NCT02846532|Fontan Procedure|fontan procedure
69996|NCT02846532|Children|children
69997|NCT02846493|Ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
69998|NCT02846493|Dexamethasone|dexamethasone
69999|NCT02846467|Informed consent|informed consent
70000|NCT02846467|Patient Education|patient education
70291|NCT02844699|TLR5|tlr5
70492|NCT02843620|Native Collagen|native collagen
71587|NCT02836080|Integrated Collaborative Care|integrated collaborative care
71588|NCT02836080|Addiction|addiction
71589|NCT02836080|Youth|youth
71590|NCT02836054|biomarkers|biomarkers
71592|NCT02836054|MRI|mri
71789|NCT02834754|post-operative|post-operative
71805|NCT02834637|HPV|hpv
71948|NCT02833805|ATG|atg
71982|NCT02833493|Magnetic Resonance Imaging|magnetic resonance imaging
71983|NCT02833493|Iron overload|iron overload
71984|NCT02833493|Iron chelation therapy|iron chelation therapy
71985|NCT02833493|Follow-up|follow-up
72180|NCT02832401|schizophrenia|schizophrenia
72181|NCT02832336|Caffeine|caffeine
72182|NCT02832336|Caffeine citrate|caffeine citrate
72283|NCT02831764|two-drug regimen|two-drug regimen
72284|NCT02831764|safety|safety
72285|NCT02831764|non inferiority|non inferiority
72286|NCT02831751|Influenza|influenza
73100|NCT02826798|VLP|vlp
73611|NCT02823821|Sodium|sodium
73893|NCT02821637|teens|teens
73989|NCT02820961|Cancer of the Breast|cancer of the breast
73990|NCT02820961|Metastatic Breast Cancer|metastatic breast cancer
73991|NCT02820961|Hormone Receptor Positive Breast Cancer|hormone receptor positive breast cancer
73992|NCT02820961|Estrogen Receptor|estrogen receptor
74910|NCT02815579|HIV|hiv
75185|NCT02813915|cardiac monitoring, Cheetah Medical, passive leg raises|cardiac monitoring, cheetah medical, passive leg raises
75187|NCT02813889|baby|baby
75596|NCT02811809|intermittent hormone therapy|intermittent hormone therapy
75599|NCT02811796|prognosis|prognosis
75901|NCT02808806|intravenous thrombolysis|intravenous thrombolysis
758886|NCT02220374|Finger|finger
758887|NCT02220374|Supportive|supportive
758888|NCT02220374|Tape|tape
758889|NCT02220374|Pain|pain
758890|NCT02220374|Function|function
758891|NCT02220374|Trial|trial
758907|NCT02217527|crossover|crossover
758930|NCT02184221|Deep-brain magnetic stimulation|deep-brain magnetic stimulation
758931|NCT02184221|Brain derived neurotropic factor|brain derived neurotropic factor
758932|NCT02184221|Effectiveness|effectiveness
758933|NCT02184221|Safety|safety
758934|NCT02162823|The MeSH name is Carcinoma, Pancreatic Ductal|the mesh name is carcinoma, pancreatic ductal
758935|NCT02154425|Cimzia®|cimzia®
758937|NCT02154425|Breastfeeding|breastfeeding
758938|NCT02154425|Nursing|nursing
758939|NCT02154425|Autoimmune diseases and pregnancy|autoimmune diseases and pregnancy
758940|NCT02152891|Emergency Medical Services|emergency medical services
758941|NCT02152891|Elderly|elderly
758978|NCT02130973|teriparatide|teriparatide
76003|NCT02809261|Perineural injection|perineural injection
76102|NCT02808598|Refusal to Participate|refusal to participate
76295|NCT02807493|Occlusal Support Device|occlusal support device
76296|NCT02807467|reduction|reduction
76297|NCT02807467|delirium|delirium
76298|NCT02807467|duration|duration
76299|NCT02807467|severity|severity
76300|NCT02807454|Phase 2|phase 2
76301|NCT02807454|Open-Label|open-label
76500|NCT02806219|Bioequivalence|bioequivalence
76501|NCT02806219|Certolizumab pegol|certolizumab pegol
76502|NCT02806219|Human Volunteers|human volunteers
76503|NCT02806193|cardiovascular|cardiovascular
76504|NCT02806193|cardiac|cardiac
76505|NCT02806193|MRI|mri
76506|NCT02806193|CMR|cmr
76507|NCT02806193|CT|ct
76508|NCT02806193|ECG|ecg
76509|NCT02806193|magnetic resonance|magnetic resonance
76510|NCT02806193|imaging|imaging
76511|NCT02806154|Cancer|cancer
76512|NCT02806154|Chemotherapy toxicity|chemotherapy toxicity
76513|NCT02806154|Elderly patients|elderly patients
76514|NCT02806154|DEXA|dexa
76515|NCT02806154|muscle mass|muscle mass
76518|NCT02806128|cerebral infarction|cerebral infarction
76604|NCT02805517|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
77126|NCT02802137|FC|fc
77405|NCT02800642|Bayer|bayer
77557|NCT02799680|AML|aml
77605|NCT02799420|confocal laser endomicroscopy|confocal laser endomicroscopy
77606|NCT02799420|undifferentiated gastric cancer|undifferentiated gastric cancer
77607|NCT02799420|target biopsy|target biopsy
77608|NCT02799381|efficacy|efficacy
77609|NCT02799381|carbidopa|carbidopa
77610|NCT02799381|levodopa|levodopa
77611|NCT02799381|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
77795|NCT02798458|Fabry's Disease|fabry's disease
77796|NCT02798458|Fabry|fabry
77797|NCT02798445|venous ulcer|venous ulcer
77798|NCT02798445|vein|vein
77799|NCT02798445|juxta cures|juxta cures
77800|NCT02798445|foam|foam
77801|NCT02798445|laser|laser
77802|NCT02798432|Total Knee Arthroplasty|total knee arthroplasty
77803|NCT02798432|Hybrid|hybrid
77892|NCT02797990|[C25.775.650]|[c25.775.650]
77893|NCT02797990|[C25.775.793]|[c25.775.793]
77894|NCT02797990|[C25.775.635]|[c25.775.635]
77895|NCT02797990|[C25.775.675]|[c25.775.675]
77896|NCT02797990|[C25.775.300]|[c25.775.300]
77897|NCT02797990|[C25.775.467]|[c25.775.467]
77898|NCT02797990|[C25.775.225]|[c25.775.225]
77899|NCT02797990|[C25.775.100]|[c25.775.100]
77900|NCT02797990|[C25.775]|[c25.775]
77901|NCT02797977|Advanced solid tumors|advanced solid tumors
77902|NCT02797977|Bladder cancer|bladder cancer
77903|NCT02797977|Pancreatic cancer|pancreatic cancer
77904|NCT02797977|Phase 1|phase 1
77905|NCT02797977|Dose escalation|dose escalation
77906|NCT02797977|Chk1 inhibitor|chk1 inhibitor
77907|NCT02797977|Checkpoint Kinase 1|checkpoint kinase 1
77908|NCT02797977|Synthetic lethality|synthetic lethality
77990|NCT02797587|Russia|russia
78184|NCT02796586|Family Planning|family planning
758979|NCT02130973|Forteo|forteo
758980|NCT02130973|Denosumab|denosumab
758981|NCT02130973|Prolia|prolia
758982|NCT02130973|bone density|bone density
758983|NCT02130973|treatment|treatment
758998|NCT02194010|Outcome Measure|outcome measure
758999|NCT02194010|Patient Reported Questionnaires|patient reported questionnaires
759010|NCT02096263|Infants|infants
759011|NCT02096263|Safety|safety
759012|NCT02096263|Healthy|healthy
759013|NCT02096263|Infanrix Hexa|infanrix hexa
759014|NCT02096263|Immunogenicity|immunogenicity
759015|NCT02153710|Aphasia|aphasia
759016|NCT02153710|Anomia|anomia
759017|NCT02100163|Ortho trauma|ortho trauma
759032|NCT02075502|claudication|claudication
759033|NCT02075502|community walking exercise|community walking exercise
759034|NCT02075502|community-based participatory research|community-based participatory research
759035|NCT02075502|exercise adherence|exercise adherence
759036|NCT02075502|endovascular therapy|endovascular therapy
759037|NCT02049632|Breast cancer|breast cancer
759038|NCT02049632|Sentinel Node Biopsy|sentinel node biopsy
759039|NCT02049632|Micrometastasis|micrometastasis
759040|NCT02049632|Axillary lymph node dissection|axillary lymph node dissection
759041|NCT02044276|Neutropenia|neutropenia
759042|NCT02044276|NHL|nhl
759043|NCT02044276|Non-Hodgkin lymphomas|non-hodgkin lymphomas
759044|NCT02044276|R-CHOP-21|r-chop-21
759058|NCT02045017|Multiple Myeloma|multiple myeloma
759059|NCT02045017|Relapsed Multiple Myeloma|relapsed multiple myeloma
759060|NCT02045017|Refactory Multiple Myeloma|refactory multiple myeloma
759061|NCT02045017|Renal Insufficiency|renal insufficiency
759062|NCT02045017|Pomalidomide|pomalidomide
759063|NCT02045017|Dexamethasone|dexamethasone
759067|NCT02018926|Mocetinostat|mocetinostat
759068|NCT02018926|Azacitidine|azacitidine
759070|NCT02018926|Myelodysplastic syndrome|myelodysplastic syndrome
759071|NCT02018926|HDAC|hdac
759072|NCT02018926|HMA|hma
759073|NCT02018926|MDS|mds
759074|NCT02009826|Schizophrenia|schizophrenia
759075|NCT02009826|Psychosis|psychosis
759076|NCT02009826|Neuroinflammation|neuroinflammation
759077|NCT02009826|Microglial activation|microglial activation
78185|NCT02796586|Contraception|contraception
78186|NCT02796586|Group Counseling|group counseling
78187|NCT02796586|Group contraceptive counseling|group contraceptive counseling
78188|NCT02796573|blended care|blended care
78189|NCT02796573|CBT|cbt
78831|NCT02792803|IOP|iop
79487|NCT02788955|Colorectal cancer|colorectal cancer
79488|NCT02788942|Port|port
79489|NCT02788942|Infection|infection
79490|NCT02788942|cholecystectomy|cholecystectomy
79492|NCT02788929|Cardiac Rehabilitation|cardiac rehabilitation
79596|NCT02788214|Biobank|biobank
79684|NCT02787668|insulin resistance|insulin resistance
79685|NCT02787668|carbohydrate-restriction|carbohydrate-restriction
79686|NCT02787655|Aging|aging
759084|NCT02012608|breast|breast
759085|NCT01988493|Carcinoma, Hepatocellular|carcinoma, hepatocellular
759086|NCT01988493|MSC2156119J|msc2156119j
759087|NCT01988493|Sorafenib|sorafenib
759088|NCT01988493|Recommended Phase 2 dose|recommended phase 2 dose
759093|NCT01974609|pain relief|pain relief
759094|NCT01974609|narcotic pain relief|narcotic pain relief
759095|NCT01974609|non-narcotic pain relief|non-narcotic pain relief
759096|NCT01974609|post-operative pain relief|post-operative pain relief
759097|NCT01974609|carpal tunnel|carpal tunnel
759110|NCT01953016|ADA-SCID/SCID all forms|ada-scid/scid all forms
759111|NCT01953016|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
759112|NCT01953016|GATA2|gata2
759113|NCT01953016|Primary Immunodeficiencies|primary immunodeficiencies
759120|NCT02091544|overweight|overweight
759167|NCT01889537|Virtual Reality Ketamine|virtual reality ketamine
759168|NCT01838226|Chronic Disease|chronic disease
759169|NCT01838226|Prevention|prevention
759170|NCT01838226|cardiovascular disease|cardiovascular disease
759171|NCT01824433|venlafaxine|venlafaxine
759172|NCT01824433|fluoxetine|fluoxetine
759173|NCT01824433|postmenopause|postmenopause
759174|NCT01824433|major depressive disorder|major depressive disorder
759193|NCT01792115|Fatty Liver|fatty liver
759194|NCT01792115|Alpha-Tocopherol|alpha-tocopherol
759195|NCT01792115|Vitamin E|vitamin e
759196|NCT01792115|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
759205|NCT01836484|Surgically staged endometrial carcinoma|surgically staged endometrial carcinoma
759206|NCT01836484|Surgically staged cervical carcinoma|surgically staged cervical carcinoma
759225|NCT01776905|Melanoma|melanoma
759226|NCT01776905|Cancer|cancer
759235|NCT01775436|palliative care|palliative care
759236|NCT01775436|HIV/AIDS|hiv/aids
759237|NCT01775436|quality of life|quality of life
759238|NCT01775436|adherence|adherence
759239|NCT01775436|spiritual|spiritual
759240|NCT01775436|threat appraisal|threat appraisal
759241|NCT01775436|treatment congruence|treatment congruence
759242|NCT01775436|treatment preferences|treatment preferences
759243|NCT01775436|dialysis|dialysis
759244|NCT01775436|hospitalization|hospitalization
759245|NCT01775436|communication|communication
759246|NCT01775436|family intervention|family intervention
759247|NCT01775436|Family Centered Advance Care Planning|family centered advance care planning
759248|NCT01775436|decision making|decision making
759249|NCT01775436|advance care planning|advance care planning
759250|NCT01775436|end of life|end of life
759265|NCT01736293|Retinal Degeneration|retinal degeneration
759282|NCT01688856|hand|hand
759283|NCT01688856|arm|arm
759284|NCT01688856|stroke|stroke
759285|NCT01688856|hemiplegia|hemiplegia
759286|NCT01688856|electrical stimulation|electrical stimulation
759287|NCT01688856|recovery|recovery
759288|NCT01688856|rehabilitation|rehabilitation
759296|NCT01657942|MRgFUS|mrgfus
759297|NCT01657942|Prostate|prostate
759298|NCT01657942|Intermediate Risk Prostate Lesions|intermediate risk prostate lesions
759299|NCT01657942|Focal Prostate treatment|focal prostate treatment
759300|NCT01657942|InSightec|insightec
759301|NCT01657942|ExAblate|exablate
759302|NCT01657942|Non-invasive|non-invasive
759303|NCT01657942|Prostate cancer|prostate cancer
759304|NCT01657942|Gleason 7|gleason 7
759305|NCT01652157|prospective|prospective
759306|NCT01652157|pancreatic insufficiency|pancreatic insufficiency
759307|NCT01652157|fibrosing colonopathy|fibrosing colonopathy
759308|NCT01652157|observational|observational
759309|NCT01652157|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
759315|NCT01622933|melanoma|melanoma
759316|NCT01622933|recurrent|recurrent
759317|NCT01622933|metastatic|metastatic
759320|NCT01617096|HIV Infections|hiv infections
759321|NCT01617096|Anti-HIV agents|anti-hiv agents
759322|NCT01617096|HIV-1|hiv-1
759347|NCT01572480|Proteasome Inhibitor|proteasome inhibitor
759348|NCT01572480|Anti-Myeloma Inhibitor|anti-myeloma inhibitor
759349|NCT01572480|Immunomodulatory Agents|immunomodulatory agents
759350|NCT01572480|Combination Therapy|combination therapy
759351|NCT01572480|Smoldering Multiple Myeloma|smoldering multiple myeloma
759352|NCT01572480|SMM|smm
759353|NCT01571505|Oral vaccines|oral vaccines
759354|NCT01571505|Vaccine Responsiveness|vaccine responsiveness
759355|NCT01571505|Tropical Enteropathy|tropical enteropathy
759368|NCT01524822|Military|military
759369|NCT01524822|Traumatic Brain Injury|traumatic brain injury
80998|NCT02780739|Executive Function|executive function
80999|NCT02780739|Learning|learning
81000|NCT02780739|Problem Solving|problem solving
81001|NCT02780739|Transfer (Psychology)|transfer (psychology)
81244|NCT02779478|NTM|ntm
81525|NCT02777489|obesity|obesity
81900|NCT02775578|Coronary Artery Bypass Grafting, CABG|coronary artery bypass grafting, cabg
81901|NCT02775552|Child Nutrition|child nutrition
81906|NCT02775552|Ethiopia|ethiopia
82415|NCT02772406|Dysplasia|dysplasia
82416|NCT02772406|Diagnosis|diagnosis
82821|NCT02769923|fractional dose IPV|fractional dose ipv
82822|NCT02769923|fIPV|fipv
82823|NCT02769923|polio|polio
82824|NCT02769923|Polio Endgame|polio endgame
82825|NCT02769923|IPV|ipv
82827|NCT02769832|Abraxane|abraxane
83022|NCT02768545|Enterohepatic Circulation|enterohepatic circulation
83023|NCT02768545|Bile|bile
83024|NCT02768545|Feces|feces
83025|NCT02768532|Crohn's disease|crohn's disease
83026|NCT02768532|Vedolizumab|vedolizumab
83027|NCT02768532|TNF (Tumor Necrosis Factor)|tnf (tumor necrosis factor)
83192|NCT02767232|PTS|pts
83215|NCT02767102|nutraceuticals|nutraceuticals
83216|NCT02767102|nutrition|nutrition
759370|NCT01524822|Cognitive Testing|cognitive testing
759371|NCT01524822|Neuroimaging|neuroimaging
759372|NCT01524822|Brain Function|brain function
759373|NCT01506219|Randomized controlled trial|randomized controlled trial
759374|NCT01506219|Comprehensive geriatric care|comprehensive geriatric care
759375|NCT01506219|Activity of daily living|activity of daily living
759376|NCT01506219|Quality of life|quality of life
759377|NCT01506219|Hospital admissions|hospital admissions
759378|NCT01506219|Healthcare utilization|healthcare utilization
759379|NCT01506219|Community rehabilitation unit|community rehabilitation unit
759380|NCT01494805|Age-related Macular Degeneration|age-related macular degeneration
759381|NCT01494805|AAV|aav
759382|NCT01494805|AMD|amd
759383|NCT01494805|Wet AMD|wet amd
759384|NCT01494805|Neovascular AMD|neovascular amd
759385|NCT01494805|Gene Therapy|gene therapy
759386|NCT01494805|Ocular|ocular
759387|NCT01494805|Ocular Gene Therapy|ocular gene therapy
759388|NCT01494805|Eye diseases|eye diseases
759389|NCT01494805|Macular Degeneration|macular degeneration
759390|NCT01494805|Retinal Degeneration|retinal degeneration
759391|NCT01494805|Retinal Neovascularization|retinal neovascularization
759392|NCT01494805|Wet Macular Degeneration|wet macular degeneration
759393|NCT01494805|Retinal Diseases|retinal diseases
759407|NCT01459302|FALS|fals
759408|NCT01459302|ALS|als
759409|NCT01459302|SALS|sals
759410|NCT01459302|MND|mnd
759411|NCT01459302|SOD1|sod1
759412|NCT01459302|ALS GENES|als genes
759413|NCT01459302|PLS|pls
759414|NCT01459302|PMA|pma
759415|NCT01459302|ALS/FTD|als/ftd
759416|NCT01459302|FAMILIAL ALS|familial als
759417|NCT01459302|SPORADIC ALS|sporadic als
759418|NCT01459302|GENETICS|genetics
759419|NCT01459302|FTD|ftd
759420|NCT01459302|Miyoshi myopathy|miyoshi myopathy
756571|NCT01400607|cartilage|cartilage
759450|NCT01445483|Cancer|cancer
759451|NCT01445483|Radiation|radiation
759452|NCT01445483|Brain|brain
759453|NCT01445483|Neuropsychological Outcome|neuropsychological outcome
759454|NCT01445483|Metastasis|metastasis
759455|NCT01445483|Brain Metastasis|brain metastasis
759466|NCT01419327|Fosrenol|fosrenol
759467|NCT01419327|Hyperphosphatemia|hyperphosphatemia
759468|NCT01419327|Hemodialysis|hemodialysis
759469|NCT01458626|mirtazapine|mirtazapine
759470|NCT01458626|paroxetine|paroxetine
83217|NCT02767102|oxidative stress|oxidative stress
83218|NCT02767089|Glucocorticoids, Biomarkers, Dissociated Agonist of the Glucocorticoid Receptor|glucocorticoids, biomarkers, dissociated agonist of the glucocorticoid receptor
83319|NCT02766296|PTSD|ptsd
83627|NCT02763540|ILD|ild
759471|NCT01458626|major depression|major depression
759472|NCT01458626|early improvement|early improvement
759475|NCT01870375|Mucopolysaccharidosis|mucopolysaccharidosis
759476|NCT01870375|Longitudinal|longitudinal
759477|NCT01870375|Brain|brain
759478|NCT01870375|Cognition|cognition
759479|NCT01870375|Quality-of-Life|quality-of-life
759480|NCT01870375|Hurler syndrome|hurler syndrome
759481|NCT01870375|Hunter syndrome|hunter syndrome
759482|NCT01870375|Hurler-Scheie syndrome|hurler-scheie syndrome
759483|NCT01870375|Scheie syndrome|scheie syndrome
759484|NCT01870375|Maroteaux-Lamy syndrome|maroteaux-lamy syndrome
759485|NCT01870375|MPS I|mps i
759486|NCT01870375|MPS II|mps ii
759487|NCT01870375|MPS VI|mps vi
759488|NCT01870375|Mucopolysaccharidosis type I|mucopolysaccharidosis type i
759489|NCT01870375|Mucopolysaccharidosis type II|mucopolysaccharidosis type ii
759490|NCT01870375|Mucopolysaccharidosis type VI|mucopolysaccharidosis type vi
759491|NCT01870375|MPS IV|mps iv
759492|NCT01870375|MPS VII|mps vii
759493|NCT01870375|Mucopolysaccharidosis type IV|mucopolysaccharidosis type iv
759494|NCT01870375|Mucopolysaccharidosis type VII|mucopolysaccharidosis type vii
759495|NCT01870375|Morquio syndrome|morquio syndrome
759496|NCT01870375|Sly syndrome|sly syndrome
759497|NCT01403142|heart transplant|heart transplant
759498|NCT01403142|vasculopathy|vasculopathy
759521|NCT01350518|Intra-Abdominal Fat|intra-abdominal fat
759522|NCT01350518|Metabolic Syndrome|metabolic syndrome
759523|NCT01350518|Hepatic steatosis|hepatic steatosis
759524|NCT01335399|Newly Diagnosed|newly diagnosed
759525|NCT01335399|Previously Untreated|previously untreated
83824|NCT02763566|CDK4|cdk4
84026|NCT02762149|Labour|labour
84121|NCT02761590|inflammation|inflammation
84122|NCT02761590|computed tomography scan|computed tomography scan
84123|NCT02761577|Acetylcysteine|acetylcysteine
84124|NCT02761577|Sodium Bicarbonate|sodium bicarbonate
84125|NCT02761577|Lipocalins|lipocalins
84126|NCT02761577|Creatinine|creatinine
84127|NCT02761577|Blood Urea Nitrogen|blood urea nitrogen
84128|NCT02761564|Cardiac surgery|cardiac surgery
85319|NCT02754635|Abnormal first or second trimester biochemical markers|abnormal first or second trimester biochemical markers
85343|NCT02754544|TMS|tms
85418|NCT02754024|Stemless shoulder prosthesis|stemless shoulder prosthesis
86049|NCT02749916|SWI|swi
86312|NCT02748291|Walking|walking
86606|NCT02746081|Solid tumors|solid tumors
86607|NCT02746081|IDH1|idh1
86608|NCT02746081|Cancer|cancer
86906|NCT02743572|anemia|anemia
87510|NCT02740686|Biomarkers|biomarkers
87511|NCT02740660|Albuterol|albuterol
87512|NCT02740660|Caffeine|caffeine
87513|NCT02740660|Lean Body Mass|lean body mass
87514|NCT02740660|Fat Mass|fat mass
87515|NCT02740634|PCA|pca
87516|NCT02740634|LPA|lpa
87517|NCT02740595|nicotine|nicotine
87518|NCT02740595|endothelial function|endothelial function
88431|NCT02734602|PET|pet
88617|NCT02733484|Obesity,Probiotics,Treatment|obesity,probiotics,treatment
88618|NCT02733471|Lidocaine|lidocaine
88619|NCT02733471|Endoscopy|endoscopy
88620|NCT02733471|Tolerance|tolerance
88621|NCT02733393|Thoracotomy|thoracotomy
88622|NCT02733393|Postoperative|postoperative
88623|NCT02733393|Lidocaine|lidocaine
88624|NCT02733393|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
759569|NCT01261728|Gemcitabine|gemcitabine
759570|NCT01261728|Cisplatin|cisplatin
759571|NCT01261728|Bladder|bladder
759572|NCT01261728|radical nephroureterectomy|radical nephroureterectomy
759581|NCT01255826|Resuscitation|resuscitation
759582|NCT01255826|Ventilation|ventilation
759583|NCT01255826|Neopuff|neopuff
759584|NCT01255826|CPAP|cpap
759585|NCT01284283|Arthrosis|arthrosis
759586|NCT01284283|Rheumatoid Arthrosis|rheumatoid arthrosis
759587|NCT01284283|Arthritic joint|arthritic joint
759588|NCT01284283|Rheumatoid Arthritis|rheumatoid arthritis
759589|NCT01284283|Osteoarthritis|osteoarthritis
759590|NCT01230996|cervical adenocarcinoma|cervical adenocarcinoma
759591|NCT01230996|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
759592|NCT01230996|cervical squamous cell carcinoma|cervical squamous cell carcinoma
759593|NCT01230996|stage IB cervical cancer|stage ib cervical cancer
759594|NCT01230996|stage IIA cervical cancer|stage iia cervical cancer
759595|NCT01230996|stage IIB cervical cancer|stage iib cervical cancer
759596|NCT01230996|stage III cervical cancer|stage iii cervical cancer
759597|NCT01230996|stage IVA cervical cancer|stage iva cervical cancer
759599|NCT01222741|AIRE- Autoimmune Regulator Gene|aire- autoimmune regulator gene
759600|NCT01222741|APECED- Autoimmune Polyendocrinopathy-Candidiasis Ectodermal Dystrophy|apeced- autoimmune polyendocrinopathy-candidiasis ectodermal dystrophy
759601|NCT01222741|CGD (Chronic Granulomatous Disease)|cgd (chronic granulomatous disease)
759602|NCT01222741|CMC- Chronic Mucocutaneous Candidiasis|cmc- chronic mucocutaneous candidiasis
759611|NCT01153035|Breast Conservation Therapy|breast conservation therapy
759612|NCT01153035|Lumpectomy|lumpectomy
759613|NCT01153035|Radiofrequency Ablation|radiofrequency ablation
759614|NCT01153035|Radiation|radiation
759627|NCT01077232|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
759628|NCT01077232|Safety|safety
759629|NCT01077232|Efficacy|efficacy
759630|NCT01077232|Humira|humira
759631|NCT01077232|Work Productivity|work productivity
759644|NCT01010256|To evaluate the phosphate and tension homolog deleted on chromosome ten (PTEN) protein level in leukemia cells from patients with CMML.|to evaluate the phosphate and tension homolog deleted on chromosome ten (pten) protein level in leukemia cells from patients with cmml.
759645|NCT01010256|To identify the PTEN genetic defect in patients with deficient PTEN protein levels.|to identify the pten genetic defect in patients with deficient pten protein levels.
759646|NCT01010256|To evaluate the role of PTEN deregulation in CMML pathogenesis.|to evaluate the role of pten deregulation in cmml pathogenesis.
88625|NCT02733380|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
88626|NCT02733380|Relapsed and refractory|relapsed and refractory
88627|NCT02733380|Histone deacetylase inhibitor|histone deacetylase inhibitor
88628|NCT02733380|Chidamide|chidamide
88629|NCT02733341|Adenosine Diphosphate|adenosine diphosphate
759660|NCT00993889|Virtual Reality Peds|virtual reality peds
759661|NCT00953992|acute kidney disease|acute kidney disease
759662|NCT00953992|prognosis|prognosis
759663|NCT00953992|oxidative stress|oxidative stress
759664|NCT00953992|inflammation|inflammation
755252|NCT02939963|pressure support ventilation|pressure support ventilation
755253|NCT02937688|Parkinson's disease|parkinson's disease
755254|NCT02937688|Deep Brain Stimulation|deep brain stimulation
755255|NCT02940626|Pneumonia|pneumonia
755256|NCT02940626|S. aureus|s. aureus
755257|NCT02940626|Mechanically ventilated|mechanically ventilated
755266|NCT02923570|16-1416|16-1416
755503|NCT02797964|Phase 1|phase 1
755947|NCT02444611|vaccines|vaccines
755948|NCT02444611|immunity|immunity
755951|NCT02408510|Volunteers|volunteers
756196|NCT02094118|Transfusion|transfusion
756708|NCT00900419|hypopharyngeal cancer|hypopharyngeal cancer
756709|NCT00900419|laryngeal cancer|laryngeal cancer
756712|NCT00900419|nasopharyngeal cancer|nasopharyngeal cancer
3757|NCT03266965|Fatigue|fatigue
4076|NCT03264638|Diane-35|diane-35
4077|NCT03264625|Cholecalciferol|cholecalciferol
4467|NCT03262116|type 1 diabetes|type 1 diabetes
4794|NCT03259971|Rett syndrome|rett syndrome
4795|NCT03259971|Tourette syndrome|tourette syndrome
4796|NCT03259971|Probiotic|probiotic
4797|NCT03259919|Metformin|metformin
4798|NCT03259919|Pregnancy outcome|pregnancy outcome
4883|NCT03259503|Rituximab|rituximab
4884|NCT03259503|Rituxan|rituxan
4885|NCT03259503|Caphosol|caphosol
5100|NCT03258320|Satraplatin|satraplatin
5101|NCT03258320|Surgery|surgery
5231|NCT03257670|CO2|co2
5333|NCT03257137|appetite|appetite
5432|NCT03256461|sepsis|sepsis
5586|NCT03255395|MRI|mri
5614|NCT03255239|Retromuscular|retromuscular
5615|NCT03255187|Biomarker|biomarker
5616|NCT03255187|Fish oil|fish oil
5883|NCT03253757|HIV|hiv
5957|NCT03253302|transanal surgery|transanal surgery
5958|NCT03253302|total mesorectal excision|total mesorectal excision
5959|NCT03253302|rectal cancer|rectal cancer
5960|NCT03253289|Hepatocellular carcinoma, HCC, Liver cancer|hepatocellular carcinoma, hcc, liver cancer
5961|NCT03253276|Bile Acid Transporter|bile acid transporter
5962|NCT03253237|Glycemic variability|glycemic variability
6065|NCT03252301|pain|pain
6150|NCT03251755|Dao-in|dao-in
6256|NCT03250897|Alveolar macrophages|alveolar macrophages
6257|NCT03250897|Blood monocyte-derived macrophages|blood monocyte-derived macrophages
6258|NCT03250897|FACS analysis|facs analysis
6259|NCT03250897|Broncho-alveolar lavage fluids|broncho-alveolar lavage fluids
6260|NCT03250897|Non-infectious lung diseases|non-infectious lung diseases
6263|NCT03250845|Multigam|multigam
6450|NCT03249857|Sensorimotor|sensorimotor
6747|NCT03247946|ear|ear
6770|NCT03247712|radiation|radiation
6771|NCT03247712|surgery|surgery
6772|NCT03247712|phase 1|phase 1
6916|NCT03246659|MTC|mtc
6970|NCT03246321|Fluorouracil|fluorouracil
7164|NCT03244995|HGG|hgg
7263|NCT03244228|First in human|first in human
7264|NCT03244228|Multiple ascending dose|multiple ascending dose
7265|NCT03244228|Single ascending dose|single ascending dose
7266|NCT03244215|Recurrence of stroke|recurrence of stroke
7360|NCT03243695|immediate implants, implant failure, angled abutments|immediate implants, implant failure, angled abutments
7361|NCT03243682|Shock wave lithotripsy|shock wave lithotripsy
7362|NCT03243682|Bidirectional|bidirectional
7363|NCT03243682|Stones|stones
7364|NCT03243669|Colonoscopy|colonoscopy
7365|NCT03243669|High-definition endoscopy|high-definition endoscopy
7366|NCT03243669|Virtual chromoendoscopy|virtual chromoendoscopy
7367|NCT03243669|Adenoma detection rate (ADR)|adenoma detection rate (adr)
7368|NCT03243604|Cardiotoxicity|cardiotoxicity
7369|NCT03243604|abiraterone acetate|abiraterone acetate
7373|NCT03243565|children|children
7455|NCT03242980|HIV|hiv
7543|NCT03242369|colonoscopy|colonoscopy
7544|NCT03242369|quality of bowel cleansing|quality of bowel cleansing
7545|NCT03242369|bowel preparation|bowel preparation
7546|NCT03242330|Implant survival|implant survival
7547|NCT03242330|Patient satisfaction|patient satisfaction
7548|NCT03242278|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
7549|NCT03242278|Prevention|prevention
7550|NCT03242278|Stroke|stroke
7551|NCT03242239|HER2 Positive Breast Cancer|her2 positive breast cancer
7552|NCT03242239|Trastuzumab|trastuzumab
7553|NCT03242239|Biosimilar|biosimilar
7554|NCT03242226|+3.00ADD|+3.00add
7555|NCT03242226|single vision spectacle|single vision spectacle
7556|NCT03242200|survivors of childhood cancer|survivors of childhood cancer
7634|NCT03241550|ASP9766|asp9766
7827|NCT03240393|lung cancer|lung cancer
8246|NCT03237949|Text message|text message
8438|NCT03236506|Illicit drug|illicit drug
8836|NCT03234257|stiffness|stiffness
8837|NCT03234257|ultrafast ultrasound imaging|ultrafast ultrasound imaging
8838|NCT03234257|Plaque stability|plaque stability
8839|NCT03234218|vitamin D, liver transplantation|vitamin d, liver transplantation
8840|NCT03234192|extensor carpi radialis brevis|extensor carpi radialis brevis
9034|NCT03233412|Immunomodulatory treatment|immunomodulatory treatment
9035|NCT03233399|Electroencephalography|electroencephalography
9039|NCT03233373|Devices|devices
9252|NCT03231436|hyperbaric bupivacaine|hyperbaric bupivacaine
9352|NCT03230890|autonomic|autonomic
9353|NCT03230890|hyperarousal|hyperarousal
9354|NCT03230864|Treatment-resistant schizophrenia|treatment-resistant schizophrenia
9355|NCT03230864|Lu AF35700|lu af35700
9356|NCT03230851|Light Transmittance Aggregometry|light transmittance aggregometry
9386|NCT03230721|BPH|bph
9544|NCT03229642|neuropsychological tests|neuropsychological tests
9645|NCT03228849|Bony mallet injury|bony mallet injury
9646|NCT03228849|Anchor suture|anchor suture
9647|NCT03228849|Conservative treatment|conservative treatment
9648|NCT03228849|DIP joint|dip joint
9649|NCT03228823|Premature Ventricular contractions|premature ventricular contractions
9650|NCT03228823|Cardiomyopathy|cardiomyopathy
9651|NCT03228797|pain|pain
9652|NCT03228771|PRGF|prgf
9653|NCT03228771|Statins|statins
9654|NCT03228771|socket augmentation|socket augmentation
9655|NCT03228758|POEM|poem
9841|NCT03227614|abortion|abortion
9939|NCT03226990|polyether elastomeric impression|polyether elastomeric impression
10042|NCT03226483|Neurosurgery|neurosurgery
10134|NCT03225885|multi-media|multi-media
10135|NCT03225885|mobile application|mobile application
10136|NCT03225885|anxiety|anxiety
10137|NCT03225885|clinical trial|clinical trial
10138|NCT03225885|random allocation|random allocation
10139|NCT03225872|Osteosarcoma|osteosarcoma
10140|NCT03225872|Bone cancer|bone cancer
10141|NCT03225872|Family-based study|family-based study
10142|NCT03225859|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
10143|NCT03225859|Self-Management|self-management
10144|NCT03225820|pharmacogenomic information|pharmacogenomic information
10145|NCT03225807|Intubated|intubated
10146|NCT03225807|Intubation|intubation
10147|NCT03225807|Ventilator|ventilator
10148|NCT03225807|Ventilator-free days|ventilator-free days
10149|NCT03225807|Ventilator free days|ventilator free days
10357|NCT03224676|Adult patients|adult patients
10358|NCT03224663|Effectiveness|effectiveness
10359|NCT03224663|Module based learning|module based learning
10362|NCT03224663|Knowledge|knowledge
10458|NCT03224000|HPV+|hpv+
10579|NCT03223298|Temporalis Muscle|temporalis muscle
10580|NCT03223298|Botulinum Toxin|botulinum toxin
10863|NCT03221621|Cost-effectiveness|cost-effectiveness
10864|NCT03221608|Colorectal Cancer|colorectal cancer
11081|NCT03219879|Recurrent depressive disorder|recurrent depressive disorder
11082|NCT03219879|Telephone-based intervention|telephone-based intervention
11473|NCT03217695|Heart rate variability|heart rate variability
11474|NCT03217695|Self-efficacy|self-efficacy
11475|NCT03217695|Pediatrics|pediatrics
16374|NCT03186339|QoL|qol
11476|NCT03217695|Mindfulness-based yoga|mindfulness-based yoga
11477|NCT03217695|Symptoms|symptoms
11478|NCT03217682|Hospice|hospice
11563|NCT03216772|morcellation|morcellation
11564|NCT03216759|Comprehensive intestinal protection strategy|comprehensive intestinal protection strategy
11565|NCT03216759|Intestinal complications|intestinal complications
11767|NCT03215511|Advanced CNS tumor|advanced cns tumor
11768|NCT03215511|Metastatic CNS tumor|metastatic cns tumor
11769|NCT03215511|NTRK1 fusion|ntrk1 fusion
11775|NCT03215511|Cancer of Unknown Primary Site|cancer of unknown primary site
12075|NCT03213756|arteriovenous fistula maturation|arteriovenous fistula maturation
12076|NCT03213717|Obesity|obesity
12174|NCT03213080|TLD|tld
12379|NCT03211793|scleroderma|scleroderma
12380|NCT03211793|digital ulcer|digital ulcer
12381|NCT03211793|vasculopathy|vasculopathy
12454|NCT03211221|OCD|ocd
12478|NCT03211039|Genomic|genomic
12582|NCT03210389|Recurrent Nasopharyngeal Carcinoma|recurrent nasopharyngeal carcinoma
12583|NCT03210389|lobaptin|lobaptin
12584|NCT03210376|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
12831|NCT03208686|Men|men
12589|NCT03210376|NMB|nmb
12777|NCT03209024|health apps|health apps
12778|NCT03209024|informatics|informatics
12779|NCT03209024|data collection|data collection
12780|NCT03209024|personal health records|personal health records
12781|NCT03209024|smartphone|smartphone
12782|NCT03209024|self care|self care
12783|NCT03209024|blood pressure monitors|blood pressure monitors
12784|NCT03209011|chronic hepatitis B|chronic hepatitis b
12785|NCT03209011|hepatitis B virus|hepatitis b virus
12873|NCT03208244|HCV|hcv
12874|NCT03208244|Hepatitis C|hepatitis c
12876|NCT03208218|Healthy volunteers|healthy volunteers
12969|NCT03207633|OCD, rTMS, right orbitofrontal cortex|ocd, rtms, right orbitofrontal cortex
12970|NCT03207607|Adults|adults
12971|NCT03207607|Snacks|snacks
12972|NCT03207607|Appetite|appetite
13080|NCT03206944|standardized tomato extract|standardized tomato extract
13081|NCT03206944|anti-aggregation|anti-aggregation
13082|NCT03206944|high cardiovascular risk|high cardiovascular risk
13083|NCT03206944|diet supplement|diet supplement
13084|NCT03206164|Health Services Research|health services research
13300|NCT03205358|Meningococcal Meningitis|meningococcal meningitis
13301|NCT03205358|MenACYW conjugate vaccine|menacyw conjugate vaccine
13302|NCT03205358|NIMENRIX®|nimenrix®
13303|NCT03205345|Cirrhosis|cirrhosis
13304|NCT03205345|NASH Cirrhosis|nash cirrhosis
13390|NCT03204825|Physical activity|physical activity
13391|NCT03204825|Feasibility|feasibility
13392|NCT03204812|prostate cancer|prostate cancer
13393|NCT03204812|metastatic disease|metastatic disease
13394|NCT03204812|Immune responses|immune responses
13688|NCT03203304|nivolumab|nivolumab
13689|NCT03203304|ipilimumab|ipilimumab
13690|NCT03203304|stereotactic body radiotherapy|stereotactic body radiotherapy
13691|NCT03203304|SBRT|sbrt
13692|NCT03203291|stroke|stroke
13693|NCT03203291|robotic training|robotic training
13694|NCT03203291|gait|gait
13695|NCT03203278|South Asian|south asian
13779|NCT03202576|nasogastric tube|nasogastric tube
13885|NCT03201822|cocoa flavanols|cocoa flavanols
14203|NCT03199807|HCC|hcc
14301|NCT03199209|Latino adults|latino adults
14410|NCT03198546|CAR-T cell therapy|car-t cell therapy
14411|NCT03198546|GPC3 targeting|gpc3 targeting
14412|NCT03198546|Phase I clinical study|phase i clinical study
14413|NCT03198546|squamous cell lung cancer|squamous cell lung cancer
14414|NCT03198546|interventional radiology|interventional radiology
14510|NCT03197818|COPD|copd
14511|NCT03197818|Anticholinergics|anticholinergics
14512|NCT03197818|Triple Combination|triple combination
14513|NCT03197805|Equivocal Her 2|equivocal her 2
14603|NCT03197311|Medication adherence|medication adherence
14604|NCT03197298|Acute Coronary Syndrome|acute coronary syndrome
14606|NCT03197298|Drug-Eluting Stents|drug-eluting stents
14709|NCT03196713|Autism|autism
14847|NCT03195712|BMI|bmi
15205|NCT03193671|HE4|he4
15208|NCT03193671|ROMA|roma
15314|NCT03192930|Hyperbaric|hyperbaric
15414|NCT03192215|Apixaban|apixaban
15415|NCT03192215|Aspirin|aspirin
15416|NCT03192124|primary total knee|primary total knee
15417|NCT03192124|infection|infection
15418|NCT03192111|Healthy Volunteers|healthy volunteers
15419|NCT03192111|Mild Renal Impairment|mild renal impairment
15420|NCT03192111|Moderate Renal Impairment|moderate renal impairment
15421|NCT03192111|Severe Renal Impairment|severe renal impairment
15422|NCT03192111|Entinostat|entinostat
15424|NCT03192111|HDAC|hdac
15515|NCT03191630|step count|step count
15625|NCT03191084|THC|thc
15840|NCT03189706|Hu3F8|hu3f8
15948|NCT03188900|apheresis|apheresis
16267|NCT03187067|ultrasound|ultrasound
16368|NCT03186352|photodynamic therapy|photodynamic therapy
16369|NCT03186352|photoactivated disinfection|photoactivated disinfection
16370|NCT03186352|primary root caries lesion|primary root caries lesion
16371|NCT03186352|cavity disinfection|cavity disinfection
16372|NCT03186352|lasers|lasers
16373|NCT03186352|root caries|root caries
16460|NCT03185832|Implanted device|implanted device
16461|NCT03185832|ICD|icd
16462|NCT03185832|CRT|crt
16611|NCT03184779|Ski|ski
16687|NCT03184337|Weight loss|weight loss
16688|NCT03184337|Women|women
16689|NCT03184337|Sleep|sleep
16690|NCT03184337|Intervention|intervention
16691|NCT03184337|Diet|diet
16692|NCT03184337|Physical activity|physical activity
16693|NCT03184337|Fitbit|fitbit
16781|NCT03183752|insulin|insulin
16882|NCT03182972|pharmacists|pharmacists
16978|NCT03182491|Anaphylatoxins|anaphylatoxins
17178|NCT03181438|Acute pain|acute pain
17179|NCT03181438|Regional Anesthesia|regional anesthesia
17180|NCT03181438|TAP Block|tap block
17181|NCT03181425|Knee cartilage|knee cartilage
17282|NCT03181009|Omalizumab|omalizumab
17388|NCT03180086|Breast cancer risk|breast cancer risk
17495|NCT03179345|Volunteer|volunteer
17496|NCT03179345|Pharmacodynamics|pharmacodynamics
17498|NCT03179319|PrEP|prep
17696|NCT03177850|sleep related breathing disturbances|sleep related breathing disturbances
17896|NCT03176589|carbon dioxide|carbon dioxide
17994|NCT03176147|Pregnancy|pregnancy
17995|NCT03176147|Hepcidine|hepcidine
17996|NCT03176147|Iron|iron
17997|NCT03176121|Oxycodone|oxycodone
17998|NCT03176121|Cancer Pain|cancer pain
17999|NCT03176121|Long-term use|long-term use
18000|NCT03176082|colorectal cancer screening|colorectal cancer screening
18001|NCT03176082|colorectal cancer|colorectal cancer
18260|NCT03174197|TMZ|tmz
18290|NCT03173989|exercise|exercise
18401|NCT03173144|Life Style|life style
18495|NCT03172520|Parotidectomy|parotidectomy
18695|NCT03171038|eHealth|ehealth
18795|NCT03170271|Hypersensitivity, Immediate|hypersensitivity, immediate
18796|NCT03170271|Hypersensitivity|hypersensitivity
18797|NCT03170271|Immune System Diseases|immune system diseases
18891|NCT03169569|adverse event|adverse event
18985|NCT03169049|high frequency stimulation|high frequency stimulation
19064|NCT03168607|ORR|orr
19089|NCT03168438|NY-ESO-1|ny-eso-1
19400|NCT03165890|prevention|prevention
19578|NCT03164616|PFS|pfs
19605|NCT03164473|damage|damage
19834|NCT03163095|sepsis|sepsis
19912|NCT03162614|malaria vaccine|malaria vaccine
20019|NCT03162068|Bone Strength|bone strength
20173|NCT03160898|ALS|als
20221|NCT03160586|Anxiety|anxiety
20313|NCT03159975|Electroporation|electroporation
20411|NCT03159299|Diabetes Self-Management Education|diabetes self-management education
20412|NCT03159273|Dietary nitrate supplementation|dietary nitrate supplementation
20413|NCT03159273|Cold symptoms|cold symptoms
20509|NCT03158766|spine|spine
20941|NCT03156894|Primary Graft Dysfunction|primary graft dysfunction
20942|NCT03156894|heart transplant|heart transplant
20943|NCT03156894|heart failure|heart failure
20944|NCT03156894|Hemodynamic parameters|hemodynamic parameters
20945|NCT03156894|Incidence of PDG|incidence of pdg
21231|NCT03154736|CVD|cvd
21331|NCT03153956|Osteoarthritis|osteoarthritis
21532|NCT03152825|stress CMR|stress cmr
21634|NCT03152240|Gender|gender
21635|NCT03152214|Transition out of military|transition out of military
21849|NCT03150862|astrocytoma|astrocytoma
21850|NCT03150862|neuroepithelial|neuroepithelial
21942|NCT03150342|CZT scanner|czt scanner
21943|NCT03150342|myocardial perfusion imaging|myocardial perfusion imaging
21944|NCT03150342|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
21950|NCT03150264|obesity|obesity
22032|NCT03149653|olive oil|olive oil
22033|NCT03149653|fish oil|fish oil
22322|NCT03147612|ALL|all
22623|NCT03145714|Elderly|elderly
22624|NCT03145688|Behavioural|behavioural
22625|NCT03145688|Family physical activity habit|family physical activity habit
22626|NCT03145675|Anticoagulation|anticoagulation
22627|NCT03145675|Enoxaparin|enoxaparin
22628|NCT03145675|Dose|dose
22629|NCT03145649|Breast milk|breast milk
22630|NCT03145649|Hormone|hormone
22631|NCT03145649|Infant growth|infant growth
22632|NCT03145649|Gestational diabetes mellitus|gestational diabetes mellitus
22633|NCT03145636|Obesity|obesity
22634|NCT03145636|Bariatric surgery|bariatric surgery
22635|NCT03145636|Vagal blocking|vagal blocking
22636|NCT03145636|vBloc therapy|vbloc therapy
22637|NCT03145636|Vagus Nerve|vagus nerve
22638|NCT03145636|Percent excess weight loss|percent excess weight loss
22639|NCT03145636|Percent total body weight loss|percent total body weight loss
23247|NCT03141437|Decision Aid Website|decision aid website
23248|NCT03141437|DA|da
23249|NCT03141437|Fertility preservation support|fertility preservation support
23250|NCT03141437|Questionnaires|questionnaires
23451|NCT03140020|aneurysm|aneurysm
23637|NCT03138564|Nursing|nursing
23950|NCT03136341|Tremor|tremor
24050|NCT03135886|HIV|hiv
24146|NCT03135145|Gait Training|gait training
24147|NCT03135145|Functional Walking|functional walking
24149|NCT03135132|High visceral fat|high visceral fat
24241|NCT03134560|vein display instrument|vein display instrument
24242|NCT03134560|pediatric|pediatric
24243|NCT03134560|vein access|vein access
24457|NCT03133130|Scar|scar
24790|NCT03130829|QoL|qol
24852|NCT03130439|Breast Cancer|breast cancer
24955|NCT03129685|Hepatocellular carcinoma|hepatocellular carcinoma
24956|NCT03129685|Devascularization|devascularization
24957|NCT03129672|allograft|allograft
24958|NCT03129672|distal tibia sarcoma|distal tibia sarcoma
24959|NCT03129659|Coronary CT Angiography|coronary ct angiography
24960|NCT03129659|High-sensitivity Troponin|high-sensitivity troponin
24961|NCT03129659|Diagnosis|diagnosis
25043|NCT03128879|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
25044|NCT03128879|CLL|cll
25045|NCT03128879|Small lymphocytic lymphoma|small lymphocytic lymphoma
25140|NCT03128281|CIS|cis
25245|NCT03127748|ventricular septal defect,transcatheter closure|ventricular septal defect,transcatheter closure
25246|NCT03127735|Phase 1|phase 1
25247|NCT03127735|mIDH1|midh1
25248|NCT03127735|IDH1 mutation|idh1 mutation
25249|NCT03127735|mIDH1 inhibitor|midh1 inhibitor
25250|NCT03127709|17-199|17-199
25251|NCT03127709|histiocytosis|histiocytosis
25319|NCT03127098|CEA|cea
25373|NCT03126838|cardiac surgery|cardiac surgery
25375|NCT03126812|Primary stage 4|primary stage 4
25376|NCT03126812|Neo adjuvant|neo adjuvant
25377|NCT03126786|Diabetes Mellitus|diabetes mellitus
25379|NCT03126786|Microneedle|microneedle
25472|NCT03126136|Pregnancy|pregnancy
25473|NCT03126136|Epidural analgesia|epidural analgesia
25474|NCT03126136|Pulse pressure|pulse pressure
25569|NCT03125577|CD19|cd19
25764|NCT03123965|Compassionate Use|compassionate use
25765|NCT03123965|Special Access Program|special access program
25766|NCT03123965|Named Patient Basis|named patient basis
25767|NCT03123952|Expanded Access|expanded access
25768|NCT03123952|Pre-approval Access|pre-approval access
25769|NCT03123952|Compassionate Use|compassionate use
25770|NCT03123952|Special Access Program|special access program
25773|NCT03123939|ALL|all
26068|NCT03122093|dietary treatment|dietary treatment
26069|NCT03122093|celiac disease|celiac disease
26164|NCT03121105|Neuromyelitis Optica|neuromyelitis optica
26165|NCT03121105|MRI|mri
26166|NCT03121105|pahtological|pahtological
26167|NCT03121079|Interferon-alpha|interferon-alpha
26168|NCT03121079|Relapse|relapse
26357|NCT03120130|Phase I,|phase i,
26358|NCT03120117|Midurethral Slings|midurethral slings
26365|NCT03120000|DLBCL|dlbcl
26454|NCT03119545|family centered|family centered
26455|NCT03119545|parental death|parental death
26553|NCT03118804|Weaning|weaning
26658|NCT03118219|rct|rct
26763|NCT03117530|cognition|cognition
27030|NCT03115736|HIV|hiv
27082|NCT03115398|Chemoradiotherapy|chemoradiotherapy
27090|NCT03115307|Insemination|insemination
27091|NCT03115307|Luteal phase support|luteal phase support
27092|NCT03115307|Gonadotropin-releasing hormone agonist|gonadotropin-releasing hormone agonist
27292|NCT03114020|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
27293|NCT03114007|Mental health problems|mental health problems
27412|NCT03113253|Burn|burn
27488|NCT03112876|atopic dermatitis|atopic dermatitis
27489|NCT03112876|acne|acne
27490|NCT03112876|smoker|smoker
27491|NCT03112850|Crossover design|crossover design
27494|NCT03112798|tracheal intubation|tracheal intubation
27577|NCT03112317|Hypothermia|hypothermia
27578|NCT03112317|Prevention|prevention
27579|NCT03112317|Surgical Site Infection|surgical site infection
27588|NCT03112304|evidence-based treatments|evidence-based treatments
27589|NCT03112304|manualized|manualized
27805|NCT03111264|Children|children
27910|NCT03110809|fat|fat
28032|NCT03109925|non-surgical|non-surgical
28348|NCT03107897|Transcatheter Valve Replacement|transcatheter valve replacement
28349|NCT03107871|valganciclovir|valganciclovir
28350|NCT03107845|CBT|cbt
28351|NCT03107845|Psychometric Feedback|psychometric feedback
28352|NCT03107845|Clinical Support Tools|clinical support tools
28353|NCT03107845|Personalized Mental Health|personalized mental health
28354|NCT03107819|Plasma metabolomics|plasma metabolomics
28355|NCT03107819|Urinary metabolomics|urinary metabolomics
28356|NCT03107819|Metabonomics|metabonomics
28445|NCT03107208|DKA|dka
28547|NCT03106610|Cancer of urothelium|cancer of urothelium
28549|NCT03106610|Carcinoma in situ|carcinoma in situ
28646|NCT03105921|Irreversible electroporation|irreversible electroporation
28647|NCT03105921|Interventional radiology|interventional radiology
28648|NCT03105895|Incisional hernia|incisional hernia
28649|NCT03105895|Mesh prevention|mesh prevention
28783|NCT03105167|CBT|cbt
28855|NCT03104582|ERCP|ercp
29089|NCT03103230|aphasia|aphasia
29282|NCT03101748|Taxol|taxol
29283|NCT03101748|Doxorubicin|doxorubicin
29284|NCT03101748|Doxorubicin Hydrochloride|doxorubicin hydrochloride
29285|NCT03101748|Adriamycin PFS|adriamycin pfs
29286|NCT03101748|Adriamycin RDF|adriamycin rdf
29380|NCT03101189|safety|safety
29479|NCT03100656|epoxide hydrolases|epoxide hydrolases
29578|NCT03100032|Demineralized Bone Matrix|demineralized bone matrix
29579|NCT03100032|Polyetheretherketone (PEEK) cage|polyetheretherketone (peek) cage
29580|NCT03100019|Resveratrol|resveratrol
30113|NCT03096912|LEE011|lee011
30224|NCT03096665|venous blood|venous blood
30327|NCT03096119|Asia|asia
30616|NCT03094377|Multisensory stimulation; motor recovery|multisensory stimulation; motor recovery
30617|NCT03094364|Constraint-induced movement therapy|constraint-induced movement therapy
30618|NCT03094364|gaming|gaming
30619|NCT03094364|virtual reality|virtual reality
30620|NCT03094364|upper extremity|upper extremity
30621|NCT03094364|CI therapy|ci therapy
30622|NCT03094364|rehabilitation|rehabilitation
30623|NCT03094364|hemiparesis|hemiparesis
30624|NCT03094364|MS|ms
30625|NCT03094364|therapy|therapy
30626|NCT03094351|robot assisted esophagectomy|robot assisted esophagectomy
30628|NCT03094351|esophageal cancer|esophageal cancer
30804|NCT03093337|Postural management|postural management
30805|NCT03093337|Motor coordination|motor coordination
30806|NCT03093337|Parenthood|parenthood
30807|NCT03093324|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
30808|NCT03093324|RRMS|rrms
31016|NCT03091712|Mobile Insulin Dosing System|mobile insulin dosing system
31017|NCT03091712|Glooko|glooko
31018|NCT03091712|Tresiba|tresiba
31019|NCT03091712|Tresiba® U-200 FlexTouch®|tresiba® u-200 flextouch®
31336|NCT03089879|GMMA|gmma
31427|NCT03089463|Diabetes|diabetes
31520|NCT03088618|Septoplasty|septoplasty
31912|NCT03086031|Traumatic brain injury, Vocational rehabilitation, Caregiver intervention,|traumatic brain injury, vocational rehabilitation, caregiver intervention,
31913|NCT03086005|Metformin|metformin
31914|NCT03085992|rectal cancer|rectal cancer
31915|NCT03085992|FOLFOXIRI|folfoxiri
31916|NCT03085992|bevacizumab|bevacizumab
31917|NCT03085992|trust|trust
31918|NCT03085966|central memory T cell|central memory t cell
31919|NCT03085966|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
31920|NCT03085953|Psychological health|psychological health
32220|NCT03083873|LN-145|ln-145
32317|NCT03083392|maxillary|maxillary
32318|NCT03083379|Incentive spirometry|incentive spirometry
32319|NCT03083379|EzPAP|ezpap
32445|NCT03082482|HIV|hiv
32616|NCT03081585|hormonal satiety signalling|hormonal satiety signalling
32617|NCT03081585|fasting|fasting
32618|NCT03081559|transgender|transgender
32619|NCT03081559|women|women
32620|NCT03081533|Circular dance|circular dance
32621|NCT03081533|Older caregiver|older caregiver
32622|NCT03081533|Dance Therapy|dance therapy
32623|NCT03081507|Muslim Americans|muslim americans
32624|NCT03081507|Patient Navigation|patient navigation
32625|NCT03081507|Breast Cancer|breast cancer
32626|NCT03081507|Cervical Cancer|cervical cancer
32627|NCT03081494|PDR001|pdr001
32628|NCT03081494|immunotherapy|immunotherapy
32629|NCT03081494|regorafenib|regorafenib
32630|NCT03081494|CRC|crc
32631|NCT03081494|MMS|mms
32632|NCT03081494|CMS4|cms4
32633|NCT03081494|ElevatION:CRC-102|elevation:crc-102
32634|NCT03081481|Intraprostatic|intraprostatic
32635|NCT03081481|MRI lesion|mri lesion
32636|NCT03081481|Prostate biopsies|prostate biopsies
32637|NCT03081468|Optical coherence tomography|optical coherence tomography
32698|NCT03081026|surgery|surgery
32795|NCT03080402|Perturbation training|perturbation training
32796|NCT03080402|Risk factors|risk factors
32797|NCT03080389|overactive bladder|overactive bladder
32818|NCT03080259|ADHD|adhd
32892|NCT03079947|Circulating DNA|circulating dna
32992|NCT03079453|Post-tonsillectomy|post-tonsillectomy
32993|NCT03079440|Neuroendocrine tumors|neuroendocrine tumors
32994|NCT03079440|Neuroendocrine Carcinoma|neuroendocrine carcinoma
32995|NCT03079440|Capecitabine|capecitabine
32996|NCT03079440|Temozolomide|temozolomide
32997|NCT03079427|Cholangiocarcinoma|cholangiocarcinoma
32998|NCT03079427|Adjuvant chemotherapy|adjuvant chemotherapy
32999|NCT03079414|Sudden Cardiac Death|sudden cardiac death
33000|NCT03079414|Cardiac Arrhythmia|cardiac arrhythmia
33002|NCT03079414|Genetics|genetics
33109|NCT03078738|SAD|sad
33234|NCT03078023|EoE|eoe
33417|NCT03077048|CKD|ckd
33635|NCT03075761|Fitbit|fitbit
33917|NCT03074084|electronic nose|electronic nose
34217|NCT03072095|Neoplasms|neoplasms
34314|NCT03071614|Animal studies|animal studies
34449|NCT03070899|HMB|hmb
34771|NCT03068988|bone marrow stem cells|bone marrow stem cells
34772|NCT03068988|rotator cuff lesion|rotator cuff lesion
34773|NCT03068936|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
34774|NCT03068936|Intensity modulated radiotherapy|intensity modulated radiotherapy
34776|NCT03068923|Blood clot|blood clot
34777|NCT03068923|Deep Vein Thrombosis|deep vein thrombosis
34778|NCT03068923|Pulmonary Embolism|pulmonary embolism
34779|NCT03068923|Lower Extremity|lower extremity
34780|NCT03068923|Upper Extremity|upper extremity
34781|NCT03068923|Cerebral sinus|cerebral sinus
34782|NCT03068923|Renal vein|renal vein
34783|NCT03068923|Portal vein|portal vein
34784|NCT03068923|thrombin|thrombin
34861|NCT03068364|Left ventricular hypertrophy|left ventricular hypertrophy
34862|NCT03068364|NT-proBNP|nt-probnp
34863|NCT03068364|ECG|ecg
34864|NCT03068364|Transthoracic echocardiography|transthoracic echocardiography
34865|NCT03068299|Prevention|prevention
34866|NCT03068299|Cognition|cognition
34867|NCT03068299|Aged care|aged care
34868|NCT03068299|Caregivers|caregivers
34869|NCT03068299|Frail elderly|frail elderly
34870|NCT03068299|Dancing therapy|dancing therapy
34871|NCT03068299|Rural population|rural population
34872|NCT03068273|Hospitalization|hospitalization
34873|NCT03068260|caesarean section|caesarean section
34874|NCT03068260|postoperative pain|postoperative pain
34875|NCT03068260|transmuscular quadratus lumborum block|transmuscular quadratus lumborum block
35049|NCT03067259|cognitive impairment|cognitive impairment
35050|NCT03067246|Supraglottic device|supraglottic device
35051|NCT03067246|Fibre optic scope|fibre optic scope
35196|NCT03066466|BMT|bmt
35303|NCT03066102|fatigue|fatigue
35444|NCT03065322|OSA|osa
35538|NCT03064724|smoking|smoking
35635|NCT03064139|biomechanics|biomechanics
35840|NCT03062852|Safety Management|safety management
35842|NCT03062826|OCT|oct
35843|NCT03062826|STEMI|stemi
35942|NCT03062202|Anxiety|anxiety
36079|NCT03061071|OSA|osa
36135|NCT03060642|Microbiome|microbiome
36136|NCT03060642|Screening|screening
36137|NCT03060642|Barrett Esophagus|barrett esophagus
36243|NCT03059862|immunity|immunity
36756|NCT03056417|telomere|telomere
37141|NCT03053791|DBS|dbs
37142|NCT03053791|Spinal cord injury|spinal cord injury
37143|NCT03053791|SCI|sci
37409|NCT03052075|BMD|bmd
37507|NCT03051308|Parathyroid allotransplantation|parathyroid allotransplantation
37508|NCT03051308|Vitamin D Receptor|vitamin d receptor
37512|NCT03051295|Risk|risk
37707|NCT03050346|Apnea|apnea
37876|NCT03049176|ART|art
38310|NCT03046264|measurement|measurement
38413|NCT03045445|CT|ct
38612|NCT03044223|sepsis|sepsis
38814|NCT03043248|multidrug resistance 1|multidrug resistance 1
38815|NCT03043222|prostate artery embolization|prostate artery embolization
38816|NCT03043222|Prostatic Urethral Lift, Urolift|prostatic urethral lift, urolift
38823|NCT03043170|Adults|adults
38906|NCT03042715|Supportive Care|supportive care
38907|NCT03042689|AML|aml
38908|NCT03042676|anti-T lymphocytic globulin (ATG)|anti-t lymphocytic globulin (atg)
38909|NCT03042676|allogeneic stem cell transplant|allogeneic stem cell transplant
38910|NCT03042676|prophylaxis of GVHD|prophylaxis of gvhd
38911|NCT03042663|stellate ganglion block|stellate ganglion block
38913|NCT03042663|ischemia|ischemia
39094|NCT03041701|YES|yes
39096|NCT03041675|Lacer Acupuncture|lacer acupuncture
39299|NCT03040336|surgery|surgery
39400|NCT03039348|Mastectomy|mastectomy
39513|NCT03038568|CT scan|ct scan
39636|NCT03037853|MRI|mri
39920|NCT03035760|Helminths|helminths
40018|NCT03035279|Unresectable colorectal cancer|unresectable colorectal cancer
40019|NCT03035279|Maximum tolerated dose|maximum tolerated dose
40021|NCT03035279|Cancer|cancer
40157|NCT03034772|neovascular|neovascular
40345|NCT03033290|immune-modulation|immune-modulation
40346|NCT03033290|gut microbiota|gut microbiota
40347|NCT03033251|COPD exacerbation|copd exacerbation
40464|NCT03032601|PET Scan|pet scan
40567|NCT03031951|Behavior modification|behavior modification
40572|NCT03031821|ADT|adt
40664|NCT03031132|Breakfast|breakfast
40855|NCT03030131|neodjuvant|neodjuvant
40962|NCT03029312|Muscle function|muscle function
41066|NCT03028636|bowel control|bowel control
41382|NCT03026920|pelvic|pelvic
41788|NCT03024359|Hypothalamic inflammation|hypothalamic inflammation
41789|NCT03024333|Dysphagia|dysphagia
41794|NCT03024307|Direct Costs|direct costs
41984|NCT03022994|rectal biopsies|rectal biopsies
41985|NCT03022825|BCG|bcg
41986|NCT03022825|bladder cancer|bladder cancer
41987|NCT03022825|immunotherapy|immunotherapy
41988|NCT03022825|interleukin-15|interleukin-15
41989|NCT03022825|intravesical|intravesical
42175|NCT03021824|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
42177|NCT03021824|Vasodilator Agents|vasodilator agents
42371|NCT03020615|Infants|infants
42372|NCT03020589|Renal Transplant|renal transplant
42373|NCT03020589|Tacrolimus|tacrolimus
42471|NCT03019939|IFI|ifi
42580|NCT03019354|pulmonary atelectasis|pulmonary atelectasis
42581|NCT03019354|intravenous general anesthesia|intravenous general anesthesia
42582|NCT03019341|Nausea|nausea
42589|NCT03019328|eczema|eczema
42687|NCT03018470|NIV|niv
42970|NCT03016676|Spinal Manipulation|spinal manipulation
42971|NCT03016676|Postural Instability|postural instability
42972|NCT03016676|Quality of Life|quality of life
42973|NCT03016650|Acetaminophen|acetaminophen
43169|NCT03015480|Albuminuria|albuminuria
43267|NCT03014999|Humans|humans
43474|NCT03013699|diet|diet
43881|NCT03011151|epithelial barrier|epithelial barrier
43986|NCT03010449|Intra-bronchial valve (IBV)|intra-bronchial valve (ibv)
43987|NCT03010449|Endobronchial valve|endobronchial valve
43989|NCT03010423|Nicorandil|nicorandil
44193|NCT03009214|CD44v6|cd44v6
44282|NCT03008512|Antineoplastic Agents|antineoplastic agents
44283|NCT03008512|Carcinoma, Hepatocellular|carcinoma, hepatocellular
44284|NCT03008512|Genexol-PM|genexol-pm
44405|NCT03007602|dyspnea|dyspnea
44677|NCT03005743|MR based Brachytherapy|mr based brachytherapy
44678|NCT03005717|submental|submental
44679|NCT03005717|Salmeterol Xinafoate|salmeterol xinafoate
44680|NCT03005717|LIPO-202|lipo-202
44681|NCT03005717|bulge|bulge
44783|NCT03004105|AZD6244|azd6244
44778|NCT03004157|chest compressions|chest compressions
44875|NCT03004599|TAVR|tavr
44980|NCT03003858|gingivitis|gingivitis
45192|NCT03002805|Phase I|phase i
45291|NCT03002311|mHealth|mhealth
45413|NCT03001349|NET|net
45602|NCT03000387|Double blind|double blind
45814|NCT02999217|haemoglobin|haemoglobin
46020|NCT02997982|HSV|hsv
46244|NCT02996630|LVOTO|lvoto
46329|NCT02995941|symptom|symptom
46423|NCT02995317|Physical Activity|physical activity
46424|NCT02995265|Exoskeleton|exoskeleton
46425|NCT02995265|Stroke|stroke
46426|NCT02995265|Walking|walking
46427|NCT02995265|Rehabilitation|rehabilitation
46428|NCT02995187|Apatinib|apatinib
46429|NCT02995187|Third-line and Later Therapy|third-line and later therapy
46430|NCT02995187|Small Cell Lung Cancer|small cell lung cancer
46431|NCT02995174|amblyopia|amblyopia
46936|NCT02991482|MPM|mpm
47076|NCT02990793|TBI|tbi
47240|NCT02989298|Peritoneum function|peritoneum function
47336|NCT02988869|Tiotropium|tiotropium
47429|NCT02988414|Culture|culture
47531|NCT02987842|EEG|eeg
47927|NCT02985320|safety|safety
48314|NCT02982941|Neuroblastoma|neuroblastoma
48315|NCT02982941|Rhabdomyosarcoma|rhabdomyosarcoma
48316|NCT02982941|Osteosarcoma|osteosarcoma
48317|NCT02982941|Ewing Sarcoma|ewing sarcoma
48318|NCT02982941|Wilms Tumor|wilms tumor
48319|NCT02982941|Desmoplastic Small Round Cell Tumor|desmoplastic small round cell tumor
48320|NCT02982941|pediatric|pediatric
48321|NCT02982928|Obesity|obesity
48322|NCT02982928|Bariatrics|bariatrics
48408|NCT02982486|sarcoma|sarcoma
48519|NCT02981602|Hepatitis|hepatitis
48736|NCT02980367|ACL|acl
48806|NCT02979951|Prospective|prospective
48807|NCT02979951|Monitored|monitored
48808|NCT02979951|Multicentric|multicentric
48809|NCT02979951|International|international
49003|NCT02978742|Cognitive Behavioral Therapy|cognitive behavioral therapy
49004|NCT02978729|Telemedicine|telemedicine
49005|NCT02978729|Counseling, Genetic|counseling, genetic
49006|NCT02978716|Breast Cancer|breast cancer
49007|NCT02978716|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
49008|NCT02978716|Triple Negative Breast Cancer|triple negative breast cancer
49202|NCT02977845|Qigong|qigong
49203|NCT02977845|Lung cancer|lung cancer
49204|NCT02977832|LUTS|luts
49205|NCT02977832|Iresine celosia|iresine celosia
49206|NCT02977832|Odyliresin|odyliresin
49296|NCT02977247|Malignant Breast Tumor|malignant breast tumor
49297|NCT02977247|Mammary Neoplasm|mammary neoplasm
49298|NCT02977247|Mammary Cancer|mammary cancer
49299|NCT02977247|ABUS|abus
49300|NCT02977247|AWBUS|awbus
49301|NCT02977247|Breast Tomography|breast tomography
49302|NCT02977247|ATUS|atus
49303|NCT02977247|ABTUS|abtus
49304|NCT02977247|Mammogram|mammogram
49305|NCT02977247|3D Mammogram|3d mammogram
49306|NCT02977247|3D ABUS|3d abus
49307|NCT02977247|3D Breast Ultrasound|3d breast ultrasound
49308|NCT02977247|DBT|dbt
49309|NCT02977247|FFDM|ffdm
49310|NCT02977247|Digital Mammography|digital mammography
49311|NCT02977247|Breast Ultrasound|breast ultrasound
49383|NCT02976766|Neuroprotection|neuroprotection
49690|NCT02975193|Cognition|cognition
49786|NCT02974725|Non small cell lung cancer|non small cell lung cancer
49791|NCT02974712|MAP|map
49892|NCT02973958|Ketorolac|ketorolac
49893|NCT02973958|Circumcision|circumcision
49894|NCT02973945|Pulmonary Rehabilitation|pulmonary rehabilitation
49895|NCT02973945|High Flow Nasal Cannula|high flow nasal cannula
49896|NCT02973945|The Venturi Mask|the venturi mask
49897|NCT02973945|Exercise capacity|exercise capacity
49898|NCT02973945|Aerobic capacity|aerobic capacity
49899|NCT02973945|HFNC|hfnc
49900|NCT02973932|cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
49901|NCT02973932|obsessive-compulsive disorder|obsessive-compulsive disorder
49902|NCT02973932|internet-based|internet-based
49903|NCT02973893|Chronic Venous Leg Ulcer|chronic venous leg ulcer
49904|NCT02973880|Steroid/antibiotic associated treatment|steroid/antibiotic associated treatment
49905|NCT02973880|Phaco-emulsification|phaco-emulsification
49906|NCT02973880|Cataract extraction|cataract extraction
49907|NCT02973867|Bone mineral density|bone mineral density
49908|NCT02973867|Myokines|myokines
49909|NCT02973867|Adipokines|adipokines
50015|NCT02973399|CLL|cll
50264|NCT02971475|chronic pancreatitis|chronic pancreatitis
50265|NCT02971475|pain relief|pain relief
50266|NCT02971462|stroke|stroke
50267|NCT02971462|Vertebrobasilar atherosclerosis|vertebrobasilar atherosclerosis
50374|NCT02971072|staging|staging
51085|NCT02966145|Oculomotor|oculomotor
51210|NCT02965404|safety|safety
51770|NCT02961803|MD1003|md1003
52110|NCT02959892|Drug therapy|drug therapy
52111|NCT02959879|FOLFOX|folfox
52112|NCT02959879|FOLFIRINOX|folfirinox
52113|NCT02959853|Hypogonadism|hypogonadism
52114|NCT02959853|Severe obesity|severe obesity
52203|NCT02959463|PBT|pbt
52204|NCT02959463|3D conformal therapy|3d conformal therapy
52205|NCT02959450|Nutritional Intervention in Oropharyngeal Dysphagia|nutritional intervention in oropharyngeal dysphagia
52206|NCT02959437|Solid tumors|solid tumors
52207|NCT02959437|NSCLC|nsclc
52418|NCT02958059|infection|infection
52419|NCT02958059|cholangitis|cholangitis
52421|NCT02957981|BRCA1|brca1
52725|NCT02956291|glioma|glioma
53130|NCT02953899|Rural|rural
53224|NCT02953496|peripheral artery disease|peripheral artery disease
53225|NCT02953496|PAD|pad
53226|NCT02953496|vonapanitase|vonapanitase
53229|NCT02953496|SFA|sfa
53320|NCT02952937|Diabetic Neuropathies|diabetic neuropathies
53321|NCT02952937|Diabetic Neuralgia|diabetic neuralgia
53322|NCT02952937|Diabetic Polyneuropathy|diabetic polyneuropathy
53323|NCT02952937|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
53522|NCT02951234|aspirin|aspirin
53611|NCT02950727|bicortical screws|bicortical screws
53612|NCT02950727|monocortical plates|monocortical plates
53917|NCT02948881|bone|bone
54077|NCT02948101|PK|pk
54128|NCT02947516|biopsy|biopsy
54449|NCT02945449|Diabetes|diabetes
54550|NCT02944682|Pregnancy Outcomes|pregnancy outcomes
54675|NCT02944058|Philos|philos
54853|NCT02942888|Mild Cognitive Impairment|mild cognitive impairment
54854|NCT02942888|MCI|mci
54855|NCT02942888|NAD|nad
54856|NCT02942888|nicotinamide riboside|nicotinamide riboside
54857|NCT02942888|aging|aging
54858|NCT02942875|upper limb|upper limb
55054|NCT02941497|Obesity|obesity
55150|NCT02940808|EEG|eeg
55363|NCT02939612|App|app
55364|NCT02939599|Pulmonary hypertension (PH),|pulmonary hypertension (ph),
55365|NCT02939599|Increase blood pressure in the pulmonary artery|increase blood pressure in the pulmonary artery
55368|NCT02939599|Shortness of breath|shortness of breath
55552|NCT02938143|Jumping Athletes|jumping athletes
55962|NCT02935270|Neglect|neglect
55963|NCT02935270|Rehabilitation|rehabilitation
55964|NCT02935244|Epidemiology|epidemiology
55965|NCT02935231|minimal cessation advice|minimal cessation advice
56034|NCT02934776|DTI|dti
56165|NCT02934139|N91115|n91115
56367|NCT02932722|Sevoflurane|sevoflurane
56368|NCT02932722|Preconditioning|preconditioning
56468|NCT02932163|disability|disability
56664|NCT02931175|Non-Infectious Uveitis|non-infectious uveitis
56665|NCT02931175|ACTHAR|acthar
56666|NCT02931175|Posterior Uveitis|posterior uveitis
56702|NCT02930941|TXA|txa
56879|NCT02929927|PDT|pdt
56970|NCT02929004|Local vibration training|local vibration training
56971|NCT02929004|Ligamentoplasty|ligamentoplasty
56972|NCT02929004|Anterior cruciate ligament|anterior cruciate ligament
56973|NCT02929004|Corticospinal excitability|corticospinal excitability
56974|NCT02929004|Elastography|elastography
56975|NCT02929004|Knee extensor muscles|knee extensor muscles
56976|NCT02929004|Readaptation|readaptation
56977|NCT02928991|Acquired aplastic anemia|acquired aplastic anemia
56978|NCT02928991|Inherited bone marrow failure|inherited bone marrow failure
56979|NCT02928978|Premalignant Breast Disease|premalignant breast disease
56980|NCT02928978|ALH|alh
56981|NCT02928978|ADH|adh
56982|NCT02928978|DCIS|dcis
56983|NCT02928978|LCIS|lcis
56984|NCT02928978|Breast Cancer Prevention|breast cancer prevention
56985|NCT02928978|Ruxolitinib|ruxolitinib
57122|NCT02928237|VAS|vas
57156|NCT02928146|syntethic mesh|syntethic mesh
57266|NCT02927431|Danirixin|danirixin
57704|NCT02924428|Acne|acne
57915|NCT02923362|LPR|lpr
58005|NCT02922972|Keloid scar|keloid scar
58200|NCT02921997|A/H5N1|a/h5n1
58424|NCT02920749|costs|costs
58496|NCT02920307|hernia repair|hernia repair
58497|NCT02920307|herniorraphy|herniorraphy
58498|NCT02920307|laparoscopic surgery|laparoscopic surgery
58499|NCT02920294|probiotics, microbiota, ileostoma|probiotics, microbiota, ileostoma
58500|NCT02920268|dance-intervention|dance-intervention
58600|NCT02919475|Efficacy|efficacy
58692|NCT02919150|Assessment|assessment
58787|NCT02918708|immunisation|immunisation
58913|NCT02917915|COPD|copd
59012|NCT02917356|Joint stiffness|joint stiffness
59013|NCT02917356|Functional status|functional status
59014|NCT02917356|Mental health|mental health
59015|NCT02917356|Osteoarthritis|osteoarthritis
59016|NCT02917304|Quadrivalent Influenza Vaccines|quadrivalent influenza vaccines
59111|NCT02916810|MRI|mri
625697|NCT00682799|RIC|ric
59388|NCT02915172|E7080|e7080
59496|NCT02914626|Ranibizumab|ranibizumab
59497|NCT02914626|Intraocular pressure|intraocular pressure
59498|NCT02914626|anti-VEGF|anti-vegf
59499|NCT02914626|intravitreal injection|intravitreal injection
59691|NCT02913222|rehabilitation|rehabilitation
59894|NCT02911285|Alcohol|alcohol
59895|NCT02911285|PTSD|ptsd
59896|NCT02911285|Trauma|trauma
59897|NCT02911285|Veteran|veteran
59898|NCT02911272|Partograph|partograph
60091|NCT02910206|propofol|propofol
60605|NCT02907099|Phone call|phone call
60704|NCT02906436|Lung transplantation|lung transplantation
60705|NCT02906436|ExVivo reconditionning|exvivo reconditionning
60706|NCT02906423|Quality of Life|quality of life
60707|NCT02906423|Patient-Centered Care|patient-centered care
60708|NCT02906423|Patient Outcome Assessment|patient outcome assessment
60709|NCT02906384|hippocampus avoidance|hippocampus avoidance
60710|NCT02906384|volumetric modulated arc therapy|volumetric modulated arc therapy
60798|NCT02905760|Diuretic|diuretic
60911|NCT02905188|hepatocellular carcinoma|hepatocellular carcinoma
60912|NCT02905188|GPC3-CAR T cells|gpc3-car t cells
60914|NCT02905175|rheumatoid arthritis|rheumatoid arthritis
61011|NCT02904434|grapefruit juice|grapefruit juice
61116|NCT02903797|FNDC5 (fibronectin type III domain containing )|fndc5 (fibronectin type iii domain containing )
61117|NCT02903771|Cantrixil|cantrixil
61118|NCT02903771|Intraperitoneal|intraperitoneal
61119|NCT02903719|Phrenic|phrenic
61131|NCT02903628|myopia|myopia
61517|NCT02901093|Inner ear|inner ear
61622|NCT02900352|Alcohol Use Disorder|alcohol use disorder
61623|NCT02900352|Alcoholism|alcoholism
61731|NCT02899611|Epilepsy|epilepsy
61831|NCT02898662|loss of control|loss of control
62314|NCT02895217|aquacycling|aquacycling
62315|NCT02895204|Fermented Maillard reacted whey protein|fermented maillard reacted whey protein
62316|NCT02895204|Natural killer cell activity|natural killer cell activity
62827|NCT02892123|bispecific antibody|bispecific antibody
62828|NCT02892123|biparatopic antibody|biparatopic antibody
62829|NCT02892123|breast cancer|breast cancer
63030|NCT02890901|Severity|severity
63337|NCT02889237|HR-pQCT|hr-pqct
63541|NCT02887586|Auricular Needling|auricular needling
63638|NCT02886884|Endothelial dysfunction|endothelial dysfunction
63639|NCT02886884|Stem cells|stem cells
63640|NCT02886858|Depression|depression
63641|NCT02886858|Moods disorders|moods disorders
63735|NCT02886130|Alpha-GPC|alpha-gpc
63834|NCT02885532|alcohol|alcohol
64037|NCT02884180|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
64038|NCT02884180|Revision|revision
64140|NCT02883517|digital PCR|digital pcr
64340|NCT02882373|Phone call|phone call
64446|NCT02881853|healthy|healthy
64564|NCT02880956|Tau|tau
64638|NCT02880644|OCT-A|oct-a
64736|NCT02879929|measurement|measurement
64828|NCT02879370|Double stapling technique|double stapling technique
64829|NCT02879357|Care management|care management
64830|NCT02879357|end of life|end of life
64878|NCT02878928|PGx|pgx
64929|NCT02878499|Longitudinal|longitudinal
65145|NCT02877303|DepoCyt|depocyt
65338|NCT02876107|IBC|ibc
65442|NCT02875327|Cancer|cancer
65443|NCT02875327|Health Services Research|health services research
65444|NCT02875327|Epidemiology|epidemiology
65547|NCT02874612|Psychosocial Functioning|psychosocial functioning
65548|NCT02874573|Inflammation|inflammation
65549|NCT02874573|Schizophrenia|schizophrenia
65550|NCT02874560|CNS|cns
65551|NCT02874560|Antipsychotic|antipsychotic
65643|NCT02873975|PALB2 mutation|palb2 mutation
66045|NCT02871297|children|children
66143|NCT02870751|tourist diarrhea|tourist diarrhea
66144|NCT02870751|diarrhea|diarrhea
66145|NCT02870751|enterotoxigenic|enterotoxigenic
66146|NCT02870725|chronic headaches, migraines, depression|chronic headaches, migraines, depression
66147|NCT02870712|perineal tear of first degree|perineal tear of first degree
66237|NCT02870062|Chlorhexidine baths|chlorhexidine baths
66245|NCT02869971|IPSS|ipss
66331|NCT02869126|thallium-201|thallium-201
66332|NCT02869126|semiconductor camera|semiconductor camera
66333|NCT02869100|magnetic resonance imaging|magnetic resonance imaging
66339|NCT02869074|diagnosis|diagnosis
66428|NCT02868723|patient management|patient management
66527|NCT02867982|crestal bone remodeling|crestal bone remodeling
66638|NCT02867189|visual|visual
66726|NCT02866591|screening|screening
66827|NCT02865863|Mood|mood
66925|NCT02865460|Nervous System Diseases|nervous system diseases
66926|NCT02865460|Hormones, Hormone Substitutes, and Hormone Antagon|hormones, hormone substitutes, and hormone antagon
66927|NCT02865460|Anti-Inflammatory Agents|anti-inflammatory agents
66928|NCT02865460|Pharmacologic Actions|pharmacologic actions
66935|NCT02865447|DXA|dxa
66936|NCT02865447|total hip arthroplasty|total hip arthroplasty
66937|NCT02865447|PROFEMUR|profemur
66938|NCT02865447|PRESERVE|preserve
66940|NCT02865447|BMD|bmd
67133|NCT02864537|Training|training
67242|NCT02863822|Functional Dyspepsia|functional dyspepsia
67345|NCT02863185|erythrocyte membrane fatty acid|erythrocyte membrane fatty acid
67346|NCT02863172|Hereditary colorectal cancer syndrome|hereditary colorectal cancer syndrome
67347|NCT02863172|Questionnaires|questionnaires
67348|NCT02863172|Surveys|surveys
67349|NCT02863172|Blood sample|blood sample
67542|NCT02861820|fMRI|fmri
67840|NCT02859935|drug abuse|drug abuse
67841|NCT02859935|MSM|msm
67842|NCT02859935|Risk behavior|risk behavior
67843|NCT02859935|Sexually transmitted diseases|sexually transmitted diseases
67844|NCT02859935|Sexually transmitted infections|sexually transmitted infections
67845|NCT02859922|Laryngeal Tube Supreme Spontaneous Ventilation|laryngeal tube supreme spontaneous ventilation
76009|NCT02809235|dietary supplement|dietary supplement
67846|NCT02859857|Glioblastoma Multiforme, Solid Tumors|glioblastoma multiforme, solid tumors
67850|NCT02859662|ruptured aneurysm|ruptured aneurysm
67934|NCT02859298|Diagnostic tool|diagnostic tool
68042|NCT02858635|Impulsivity|impulsivity
68246|NCT02857036|rhythm|rhythm
68247|NCT02857036|depression|depression
68248|NCT02857036|antidepressant treatment|antidepressant treatment
68249|NCT02857023|Neurocognitive|neurocognitive
68250|NCT02857023|Working memory|working memory
68251|NCT02857023|Cogmed|cogmed
68252|NCT02857023|Cognitive training|cognitive training
68253|NCT02856984|Pregnancy|pregnancy
68254|NCT02856984|Infant|infant
68255|NCT02856971|Hinge Knee Prosthesis|hinge knee prosthesis
68256|NCT02856971|TKA infection|tka infection
68338|NCT02856165|infant|infant
68536|NCT02855320|Biologics safety|biologics safety
68757|NCT02854007|Bioresorbable coronary device|bioresorbable coronary device
69067|NCT02852122|staging|staging
69172|NCT02851108|sub saharan|sub saharan
69372|NCT02849782|Fatigue|fatigue
69784|NCT02847676|MSC|msc
69886|NCT02847026|RotaTeq|rotateq
69887|NCT02847026|fIPV|fipv
69888|NCT02847026|IPV|ipv
69891|NCT02847000|Decitabine|decitabine
69892|NCT02847000|Tetrahydrouridine|tetrahydrouridine
69893|NCT02847000|Epigenetic Therapy|epigenetic therapy
70110|NCT02845830|trajectory|trajectory
70111|NCT02845830|change|change
70212|NCT02845141|bone graft|bone graft
70313|NCT02844569|Dental Implants|dental implants
70314|NCT02844569|Bone Grafting|bone grafting
70315|NCT02844556|SMILE surgery|smile surgery
70316|NCT02844556|FS-LASIK surgery|fs-lasik surgery
70317|NCT02844556|multicenter|multicenter
70526|NCT02843438|Chorioretinitis|chorioretinitis
70527|NCT02843438|Infection|infection
70528|NCT02843425|Cancer Prevention|cancer prevention
70625|NCT02842866|Menomune® - A/C/Y/W-135|menomune® - a/c/y/w-135
70626|NCT02842853|Meningitis|meningitis
70627|NCT02842853|Meningococcal Meningitis|meningococcal meningitis
70719|NCT02842190|BIPAP|bipap
70919|NCT02840643|brain|brain
71124|NCT02839395|melatonin|melatonin
71428|NCT02837068|stroke|stroke
71528|NCT02836340|neuroprotection|neuroprotection
71746|NCT02835066|Stage I|stage i
71840|NCT02834390|malignancy|malignancy
71952|NCT02833766|doxorubicin|doxorubicin
72264|NCT02831907|Delirium|delirium
72389|NCT02831088|free radical|free radical
72390|NCT02831075|Adipose-derived Stem Cells|adipose-derived stem cells
72391|NCT02831062|nutrition|nutrition
72392|NCT02831062|progression|progression
72393|NCT02831049|Reconsolidation|reconsolidation
72394|NCT02831010|prematurity|prematurity
72483|NCT02830425|STOPP|stopp
72689|NCT02829632|self-monitoring|self-monitoring
73043|NCT02827006|RCT|rct
73298|NCT02825602|War Injury|war injury
73219|NCT02826018|HBV|hbv
73307|NCT02825550|microsphere|microsphere
73604|NCT02823834|protrusio acetabuli|protrusio acetabuli
73605|NCT02823834|painful hip dysplasia|painful hip dysplasia
73606|NCT02823834|rheumatoid arthritis|rheumatoid arthritis
73701|NCT02823145|epilepsy|epilepsy
73896|NCT02821637|wellbeing|wellbeing
73999|NCT02820922|Emergency orthopedic surgery|emergency orthopedic surgery
74000|NCT02820922|anesthesia|anesthesia
74301|NCT02819089|anterior cervical spine surgery|anterior cervical spine surgery
74399|NCT02818738|Levamisole|levamisole
74400|NCT02818738|Prednisone|prednisone
74500|NCT02817997|Castleman's Disease|castleman's disease
74595|NCT02817555|Cost|cost
74689|NCT02816840|prostate cancer|prostate cancer
74690|NCT02816840|radiotherapy|radiotherapy
74691|NCT02816840|PET-CT/MRI|pet-ct/mri
74692|NCT02816814|Menopause|menopause
74693|NCT02816814|Diet|diet
74694|NCT02816814|Lipidomic profile|lipidomic profile
74695|NCT02816814|Vasomotor symptoms|vasomotor symptoms
74887|NCT02815787|drug-drug interaction|drug-drug interaction
74888|NCT02815774|SP2086|sp2086
74889|NCT02815774|Renal Insufficiency|renal insufficiency
74890|NCT02815774|Pharmacokinetic|pharmacokinetic
74891|NCT02815748|SP2086|sp2086
74892|NCT02815748|Metabolite identification|metabolite identification
74893|NCT02815748|Material balance|material balance
74894|NCT02815722|SP2086|sp2086
74895|NCT02815722|Simvastatin|simvastatin
74896|NCT02815722|drug-drug interaction|drug-drug interaction
74897|NCT02815696|MRI T2 weighted|mri t2 weighted
74898|NCT02815696|intervertebral disc|intervertebral disc
74899|NCT02815696|glycosaminoglycans|glycosaminoglycans
74900|NCT02815683|Bronchoscopy|bronchoscopy
74901|NCT02815683|Emphysema|emphysema
74973|NCT02815046|stress urinary incontinence|stress urinary incontinence
74975|NCT02815046|Bulkamid|bulkamid
75277|NCT02813473|FFR|ffr
75417|NCT02812589|MRI|mri
75480|NCT02812277|letrozole|letrozole
75793|NCT02810405|Sample|sample
75897|NCT02808806|cerebral infarction|cerebral infarction
76001|NCT02809274|polycythemia vera|polycythemia vera
76002|NCT02809261|Carpal Tunnel Syndrome|carpal tunnel syndrome
76005|NCT02809248|LTX Study|ltx study
76006|NCT02809235|asthma|asthma
76007|NCT02809235|smooth muscle|smooth muscle
76008|NCT02809235|lauric acid|lauric acid
76010|NCT02809222|Myelodysplastic syndrome|myelodysplastic syndrome
76189|NCT02807896|pancreatic cancer|pancreatic cancer
76190|NCT02807896|bile duct cancer|bile duct cancer
76191|NCT02807896|miRNA|mirna
76192|NCT02807883|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
76194|NCT02807883|B-lineage Acute Lymphoblastic Leukemia|b-lineage acute lymphoblastic leukemia
76196|NCT02807883|Blinatumomab|blinatumomab
76203|NCT02807857|CHF,|chf,
76284|NCT02807506|low income population|low income population
76285|NCT02807506|activities of daily living|activities of daily living
76286|NCT02807506|instrumental activities of daily living|instrumental activities of daily living
76287|NCT02807506|social robotics|social robotics
76288|NCT02807506|stroke|stroke
76289|NCT02807506|aged|aged
76290|NCT02807506|Retirement|retirement
76291|NCT02807506|Housing for elderly|housing for elderly
76292|NCT02807506|Homes for the aged|homes for the aged
76293|NCT02807493|Pregnancy|pregnancy
76294|NCT02807493|Labor and Delivery|labor and delivery
76499|NCT02806232|Biltricide|biltricide
76302|NCT02807454|Durvalumab|durvalumab
76303|NCT02807454|Daratumumab|daratumumab
76304|NCT02807454|Multiple Myeloma|multiple myeloma
76305|NCT02807454|Relapsed and Refractory (RRMM)|relapsed and refractory (rrmm)
76374|NCT02806999|Clinical trials as topic|clinical trials as topic
76618|NCT02805374|Pharmacokinetics|pharmacokinetics
76619|NCT02805374|ASP1517|asp1517
76620|NCT02805374|Food effect|food effect
76621|NCT02805348|Kiklin|kiklin
76622|NCT02805348|Bixalomer|bixalomer
76623|NCT02805348|Chronic Kidney Disease|chronic kidney disease
76719|NCT02804724|HIV|hiv
77221|NCT02801760|HIV|hiv
77727|NCT02798796|MRI|mri
77853|NCT02798250|Insulin|insulin
77962|NCT02797834|Exosomes|exosomes
77963|NCT02797834|Microvesicles|microvesicles
77964|NCT02797834|Apoptotic bodies|apoptotic bodies
77966|NCT02797821|asfotase alfa|asfotase alfa
77967|NCT02797808|OCD|ocd
78058|NCT02797119|Tranexamic acid|tranexamic acid
78154|NCT02796677|Safety|safety
78155|NCT02796677|Efficacy|efficacy
78156|NCT02796677|Aclidinium bromide|aclidinium bromide
78266|NCT02796248|stigma|stigma
78473|NCT02794922|Vitamin B|vitamin b
78573|NCT02794207|AML|aml
78775|NCT02793128|T0|t0
79429|NCT02789254|AML|aml
79480|NCT02788968|Adolescent and young adult healthy volunteers|adolescent and young adult healthy volunteers
79481|NCT02788968|Anatomical and functionally Magnetic Resonance Imaging (MRI)|anatomical and functionally magnetic resonance imaging (mri)
79516|NCT02788734|CTS|cts
79597|NCT02788201|COXEN|coxen
79701|NCT02787538|Biologics|biologics
79989|NCT02786186|Cosentyx|cosentyx
80201|NCT02784860|colonoscopy|colonoscopy
80393|NCT02783781|Cardiac surgery (extracorporeal circulation; beating heart)|cardiac surgery (extracorporeal circulation; beating heart)
80394|NCT02783781|Biological data|biological data
80399|NCT02783768|COPD|copd
80492|NCT02783326|Rehabilitation|rehabilitation
80598|NCT02782663|ABT-494|abt-494
80904|NCT02781077|walking competency|walking competency
81254|NCT02779400|INR|inr
81312|NCT02779036|Usual Physiotherapy care|usual physiotherapy care
81313|NCT02778997|Shunt|shunt
81314|NCT02778997|CSF|csf
81315|NCT02778997|Dysfunction|dysfunction
81316|NCT02778997|Complication|complication
81317|NCT02778984|Anesthesia|anesthesia
81406|NCT02778347|Palliative care|palliative care
81507|NCT02777658|Epidermal Growth Factor Receptor (EGFR), non-small cell lung cancer (NSCLC), EGFR T790M, EGFR Mutation-Positive Locally Advanced or Advanced NSCLC|epidermal growth factor receptor (egfr), non-small cell lung cancer (nsclc), egfr t790m, egfr mutation-positive locally advanced or advanced nsclc
81508|NCT02777619|Pharmacodynamic|pharmacodynamic
81536|NCT02777437|T4|t4
81604|NCT02777112|early prevention|early prevention
81705|NCT02776644|renal cell carcinoma|renal cell carcinoma
81706|NCT02776644|sunitinib, pazopanib|sunitinib, pazopanib
81707|NCT02776644|temsirolimus|temsirolimus
81708|NCT02776644|sorafenib|sorafenib
81709|NCT02776644|everolimus|everolimus
81799|NCT02776059|survival|survival
82001|NCT02775084|CD4|cd4
82097|NCT02774382|Recurrence|recurrence
82305|NCT02772900|Vascular Function|vascular function
82408|NCT02772445|Empowerment|empowerment
82518|NCT02771769|liquid biopsy|liquid biopsy
82616|NCT02771171|Pediatric Airway, Three-dimensional Imaging, CT Scan|pediatric airway, three-dimensional imaging, ct scan
82617|NCT02771158|critical care|critical care
82618|NCT02771158|shock, septic|shock, septic
82619|NCT02771158|sepsis|sepsis
82620|NCT02771158|hypotension|hypotension
82621|NCT02771158|midodrine|midodrine
82622|NCT02771093|Type 2, Diabetes, Diabetes Mellitus|type 2, diabetes, diabetes mellitus
82809|NCT02769962|Camptothecins|camptothecins
83129|NCT02767674|R-Gemox|r-gemox
83438|NCT02765659|HIV|hiv
83752|NCT02763995|HIV|hiv
83832|NCT02763423|diabetic ketoacidosis|diabetic ketoacidosis
627917|NCT00691626|nightmares|nightmares
83835|NCT02763358|obesity|obesity
83933|NCT02762721|Cholangiocarcinoma|cholangiocarcinoma
84294|NCT02760758|NNI|nni
84539|NCT02759432|physical fitness|physical fitness
84843|NCT02757482|Warfarin|warfarin
84956|NCT02757040|ibrutinib|ibrutinib
85062|NCT02756286|Attention|attention
85172|NCT02755519|confirmatory test|confirmatory test
85173|NCT02755519|hypertension|hypertension
85273|NCT02754856|Tremelimumab|tremelimumab
85435|NCT02753842|HIV|hiv
85477|NCT02753595|High-Hyaluronan|high-hyaluronan
85917|NCT02750891|HGG|hgg
86096|NCT02749682|constipation severity scale|constipation severity scale
86097|NCT02749682|groin hernia|groin hernia
86098|NCT02749669|Inappropriate hospitalization|inappropriate hospitalization
86099|NCT02749669|elderly|elderly
86100|NCT02749669|mild or moderate cognitive impairment|mild or moderate cognitive impairment
86101|NCT02749669|qualitative research|qualitative research
86102|NCT02749669|economic evaluation|economic evaluation
86396|NCT02747771|hair pulling|hair pulling
86847|NCT02744833|DVT|dvt
86896|NCT02743611|AML|aml
86990|NCT02744287|BPX-601|bpx-601
87197|NCT02743117|Trivalent|trivalent
87198|NCT02743117|Influenza|influenza
87199|NCT02743117|FluMist Quadrivalent|flumist quadrivalent
87200|NCT02743117|Vaccine|vaccine
87201|NCT02743117|Prevention|prevention
87202|NCT02743117|Healthy|healthy
87203|NCT02743117|Monovalent|monovalent
87204|NCT02743091|heart failure|heart failure
87205|NCT02743091|survival|survival
87206|NCT02743091|end-stage kidney disease|end-stage kidney disease
87207|NCT02743078|Glioblastoma|glioblastoma
87208|NCT02743078|Glioma|glioma
87209|NCT02743078|Gliosarcoma|gliosarcoma
87211|NCT02743078|TTFields|ttfields
87212|NCT02743065|HepaSphere|hepasphere
87213|NCT02743039|Low income|low income
87214|NCT02743039|Education|education
87215|NCT02743039|Poverty|poverty
87216|NCT02743039|Children|children
87217|NCT02743039|Parents|parents
87218|NCT02743039|Head Start|head start
87219|NCT02743000|fMRI|fmri
87220|NCT02743000|emotion conflict task|emotion conflict task
87221|NCT02743000|monetary incentive delay|monetary incentive delay
87222|NCT02742974|Trauma|trauma
87223|NCT02742974|Minimally Invasive Hemodynamic Monitoring|minimally invasive hemodynamic monitoring
87224|NCT02742974|Perioperative|perioperative
87225|NCT02742974|Complications|complications
87277|NCT02742662|Obesity|obesity
87278|NCT02742662|Overweight|overweight
87279|NCT02742662|Prediabetes|prediabetes
87280|NCT02742662|Smartphone application|smartphone application
87281|NCT02742662|Technology|technology
87375|NCT02741778|Cardia|cardia
87792|NCT02738814|pediatric|pediatric
87889|NCT02738138|HCV Genotype 3|hcv genotype 3
87986|NCT02737566|Vulnerable Populations|vulnerable populations
87987|NCT02737566|Medically Uninsured|medically uninsured
87988|NCT02737566|Medicaid|medicaid
87989|NCT02737527|ultrasound|ultrasound
87990|NCT02737527|lumbar sympathetic block|lumbar sympathetic block
87991|NCT02737514|adenoma detection rate|adenoma detection rate
87992|NCT02737514|colonoscopy|colonoscopy
87993|NCT02737514|water exchange|water exchange
88081|NCT02737020|ADHD|adhd
88184|NCT02736344|lesions|lesions
88288|NCT02735564|gut microbiota|gut microbiota
88289|NCT02735551|LARC|larc
88291|NCT02735551|Contraceptive Implant|contraceptive implant
88292|NCT02735551|Contraception|contraception
88293|NCT02735551|Community college|community college
88295|NCT02735525|smartphone|smartphone
88385|NCT02734901|raspberry|raspberry
88581|NCT02733757|IOP|iop
89137|NCT02730494|mycosis|mycosis
89266|NCT02729597|MRI|mri
89361|NCT02729051|Placebo|placebo
89652|NCT02727231|HbA1C<7.5%|hba1c<7.5%
89861|NCT02725970|HEALTH|health
89862|NCT02725970|barriers|barriers
89863|NCT02725970|facilitators|facilitators
90162|NCT02724319|clopidogrel|clopidogrel
90463|NCT02722785|Quality of life|quality of life
90568|NCT02722031|prevalence|prevalence
90662|NCT02721485|Normal Saline|normal saline
91160|NCT02718287|language development|language development
91476|NCT02716402|cerebral thrombosis|cerebral thrombosis
91477|NCT02716376|Head and neck neoplasms|head and neck neoplasms
91478|NCT02716376|Radiotherapy|radiotherapy
91479|NCT02716376|Otitis media|otitis media
91675|NCT02715245|home rehabilitation|home rehabilitation
91896|NCT02714036|ALS|als
92071|NCT02713139|women|women
92391|NCT02710903|SNP|snp
92757|NCT02708719|COPD|copd
92859|NCT02707965|Bioequivalence|bioequivalence
93273|NCT02705261|child|child
93767|NCT02702375|Fructose|fructose
93857|NCT02701764|dry eye symptoms|dry eye symptoms
93858|NCT02701764|LASIK|lasik
93859|NCT02701764|prevention|prevention
93860|NCT02701712|magnetic resonance|magnetic resonance
93861|NCT02701712|external beam radiotherapy|external beam radiotherapy
93862|NCT02701712|brachytherapy|brachytherapy
93863|NCT02701712|radiotherapy|radiotherapy
93864|NCT02701699|Lung Cancer|lung cancer
93865|NCT02701699|FAZA PET Imaging|faza pet imaging
93866|NCT02701699|Lung Radiotherapy|lung radiotherapy
93867|NCT02701686|smoking cessation|smoking cessation
93868|NCT02701673|Refractory or Relapsed Lymphoma|refractory or relapsed lymphoma
93869|NCT02701673|Busulfan|busulfan
93870|NCT02701673|Busulfex|busulfex
93871|NCT02701673|Myleran|myleran
93872|NCT02701673|Caphosol|caphosol
93873|NCT02701673|Glutamine|glutamine
93874|NCT02701673|Enterex|enterex
93895|NCT02701673|SCT|sct
94034|NCT02700698|women|women
94139|NCT02699814|Anxiety|anxiety
94235|NCT02699073|metastatic|metastatic
94536|NCT02697383|15-294|15-294
94833|NCT02695992|Metoprolol|metoprolol
94834|NCT02695992|Adrenergic Agents|adrenergic agents
94835|NCT02695992|Adrenergic Antagonists|adrenergic antagonists
94853|NCT02695953|PTSD|ptsd
95123|NCT02694068|Peritoneal Dialysis|peritoneal dialysis
95281|NCT02693379|HPV|hpv
95466|NCT02692404|Midwife|midwife
95677|NCT02690987|reward|reward
95678|NCT02690987|addiction|addiction
95679|NCT02690987|hormone|hormone
95680|NCT02690987|cigarette|cigarette
95681|NCT02690987|fMRI|fmri
95682|NCT02690974|HFrEF,|hfref,
95683|NCT02690974|ACEi,|acei,
95776|NCT02690506|spinal anesthesia|spinal anesthesia
95777|NCT02690480|fulvestrant|fulvestrant
95778|NCT02690480|palbociclib|palbociclib
95887|NCT02689908|Thorax CT|thorax ct
95888|NCT02689908|Low Dose|low dose
95889|NCT02689908|Body Mass Index|body mass index
95890|NCT02689908|Neck Circumference|neck circumference
95891|NCT02689895|adolescents|adolescents
95893|NCT02689895|adherence|adherence
95978|NCT02689440|Dasatinib|dasatinib
96389|NCT02686723|Return to sport|return to sport
96390|NCT02686723|Motion analysis|motion analysis
96588|NCT02685423|Amblyopia|amblyopia
96589|NCT02685423|Lazy Eye|lazy eye
96590|NCT02685423|Anisometropia|anisometropia
96591|NCT02685384|healthcare access|healthcare access
96724|NCT02684734|UC|uc
96791|NCT02684253|15-253|15-253
97007|NCT02682862|tiotropium|tiotropium
97008|NCT02682862|olodaterol|olodaterol
97009|NCT02682862|smoker|smoker
97106|NCT02682381|Teduglutide|teduglutide
97107|NCT02682381|pediatric|pediatric
97108|NCT02682381|GLP-2|glp-2
97109|NCT02682381|parenteral support|parenteral support
97110|NCT02682381|Short Bowel Syndrome|short bowel syndrome
97111|NCT02682381|short gut syndrome|short gut syndrome
639341|NCT00735904|NSCLC|nsclc
97652|NCT02678637|MRI|mri
97864|NCT02677181|ATG|atg
98262|NCT02674789|Blood|blood
98578|NCT02672696|Navigation|navigation
98679|NCT02671864|GLP1|glp1
98770|NCT02671214|konjac mannan|konjac mannan
98869|NCT02670564|high risk acute lymphoblastic leukemia|high risk acute lymphoblastic leukemia
98870|NCT02670564|NCT01949129 add-on|nct01949129 add-on
98871|NCT02670564|ALL SCTped FORUM|all sctped forum
98872|NCT02670525|Recurrent, Refractory, or High Risk Leukemias|recurrent, refractory, or high risk leukemias
98873|NCT02670525|Matched targeted therapy|matched targeted therapy
98958|NCT02669901|Opioid Misuse|opioid misuse
98959|NCT02669901|Naloxone Coprescribing|naloxone coprescribing
98965|NCT02669823|Diagnosis|diagnosis
99061|NCT02669173|MDSC|mdsc
99388|NCT02667015|Treatment|treatment
99488|NCT02666365|anesthesia|anesthesia
99586|NCT02665754|Cats|cats
99682|NCT02665117|Isoprostanes|isoprostanes
99885|NCT02664077|NSABP|nsabp
99997|NCT02663466|recurrence|recurrence
100101|NCT02662816|Healthy human|healthy human
100227|NCT02662166|MRI|mri
100319|NCT02661464|Safety|safety
100413|NCT02661139|jaw reconstruction|jaw reconstruction
100414|NCT02661139|prosthetic rehabilitation|prosthetic rehabilitation
100418|NCT02661113|CNS|cns
100523|NCT02660567|PPH|pph
101031|NCT02658058|Elderly|elderly
101339|NCT02656342|OCD|ocd
101428|NCT02655822|Triple Negative Breast Neoplasms|triple negative breast neoplasms
101430|NCT02655822|CRC|crc
102227|NCT02650830|GLP-1|glp-1
102327|NCT02650349|voxel-based magnetic resonance morphometry|voxel-based magnetic resonance morphometry
102329|NCT02650297|Breast cancer|breast cancer
102427|NCT02649673|lung carcinoma|lung carcinoma
102644|NCT02648490|metastatic or recurrent epithelial cancer|metastatic or recurrent epithelial cancer
102645|NCT02648464|Hydroxychloroquine|hydroxychloroquine
102646|NCT02648464|anti-inflammatory|anti-inflammatory
102767|NCT02647723|docosahexaenoic|docosahexaenoic
102866|NCT02647164|Non-small-cell lung carcinoma|non-small-cell lung carcinoma
102867|NCT02647164|Circulating tumor cells|circulating tumor cells
103058|NCT02645786|heart|heart
103152|NCT02645123|manual therapy|manual therapy
103245|NCT02644564|Rotator cuff tear|rotator cuff tear
103345|NCT02643940|Cardiac MRI|cardiac mri
103444|NCT02643303|Durvalumab|durvalumab
103975|NCT02640157|HCV|hcv
103976|NCT02640157|Hepatitis C Virus|hepatitis c virus
103978|NCT02640157|Hep C|hep c
104232|NCT02638493|HIV|hiv
104392|NCT02637687|Fibrosarcoma|fibrosarcoma
104485|NCT02637180|fracture|fracture
104824|NCT02635321|MRI|mri
105086|NCT02634190|Aptima HPV Assay|aptima hpv assay
105087|NCT02634177|Genotyping|genotyping
105088|NCT02634177|Genecept Assay™|genecept assay™
105089|NCT02634164|leucine|leucine
105090|NCT02634164|isoleucine|isoleucine
105091|NCT02634151|LDL‐C|ldl‐c
105092|NCT02634151|Lipid Regulator|lipid regulator
105093|NCT02634138|Peripheral Vascular Disease|peripheral vascular disease
105094|NCT02634138|Critical Limb Ischaemia|critical limb ischaemia
105095|NCT02633072|Multifocal Intraocular Lens|multifocal intraocular lens
105096|NCT02633072|Binocular Trifocality|binocular trifocality
105097|NCT02633072|Cataract Surgery|cataract surgery
105098|NCT02633072|Spectacle Independence|spectacle independence
105099|NCT02633072|Intermediate Vision|intermediate vision
105100|NCT02633072|Photopic Vision|photopic vision
105101|NCT02633072|Mesopic Vision|mesopic vision
105102|NCT02633072|Scotopic Vision|scotopic vision
105103|NCT02633072|Binocular Vision|binocular vision
105107|NCT02632006|PIK-PD-1 Cells|pik-pd-1 cells
105108|NCT02632006|dendritic cell-precision multiple antigen T cells|dendritic cell-precision multiple antigen t cells
105109|NCT02632006|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
105110|NCT02631993|Psoralen|psoralen
105111|NCT02631993|UVA|uva
105112|NCT02631993|Time-to-treatment|time-to-treatment
105113|NCT02631993|GVL|gvl
105114|NCT02631980|Hepcidin|hepcidin
105115|NCT02631967|Crohn disease|crohn disease
105116|NCT02631967|ileocecal resection|ileocecal resection
105117|NCT02631967|anastomosis|anastomosis
105118|NCT02631967|Kono|kono
105119|NCT02631928|biphasic human insulin|biphasic human insulin
105208|NCT02633657|RLS|rls
105552|NCT02631616|PET/CT|pet/ct
105749|NCT02630537|ELISpot|elispot
106074|NCT02628912|HPV|hpv
106051|NCT02629042|Dental Emergency|dental emergency
106052|NCT02629042|Irreversible Pulpitis|irreversible pulpitis
106053|NCT02629042|Mandibulae|mandibulae
106054|NCT02629042|Pain Management|pain management
106057|NCT02629003|Serotonin|serotonin
106415|NCT02627300|PID|pid
106617|NCT02626104|antibiotic associated diarrhoea|antibiotic associated diarrhoea
106618|NCT02626104|children|children
106619|NCT02626104|antibiotic therapy|antibiotic therapy
106620|NCT02626104|diarrhoea|diarrhoea
106709|NCT02625649|obesity|obesity
107012|NCT02623959|Fentanyl by vein|fentanyl by vein
107013|NCT02623959|Sublimaze|sublimaze
107014|NCT02623959|Doxycycline|doxycycline
107015|NCT02623959|Vibramycin|vibramycin
107016|NCT02623959|Periostat|periostat
107017|NCT02623959|Doryx|doryx
107018|NCT02623959|:Phone calls|:phone calls
107019|NCT02623946|motor evoked potentials|motor evoked potentials
107225|NCT02622607|ZOL|zol
107525|NCT02620800|Gemzar|gemzar
107831|NCT02618993|mandibular nerve block|mandibular nerve block
107832|NCT02618993|mandibular osteotomy|mandibular osteotomy
107833|NCT02618980|acute coronary syndrome|acute coronary syndrome
107836|NCT02618967|Lupus|lupus
108030|NCT02617732|traditional Chinese medicine|traditional chinese medicine
108036|NCT02617680|age|age
108132|NCT02616926|hepatocellular carcinoma|hepatocellular carcinoma
108133|NCT02616926|hepatectomy|hepatectomy
108134|NCT02616926|transarterial chemoembolization|transarterial chemoembolization
108136|NCT02616874|HIV infection|hiv infection
108235|NCT02616237|nutrition|nutrition
108340|NCT02614391|Child|child
108485|NCT02614820|DMD|dmd
108537|NCT02614573|Aged, 80 and over|aged, 80 and over
108538|NCT02614573|Aged|aged
108539|NCT02614560|acute myeloid leukemia|acute myeloid leukemia
108540|NCT02614560|AML|aml
108541|NCT02614560|antibody-drug conjugate|antibody-drug conjugate
108544|NCT02614482|Children|children
108634|NCT02613715|Obesity|obesity
109018|NCT02611037|MPM|mpm
109164|NCT02610062|AML|aml
109559|NCT02607748|Coronary CTA|coronary cta
109560|NCT02607735|Chronic Hepatitis C Infection|chronic hepatitis c infection
109561|NCT02607644|Intubation|intubation
109562|NCT02607644|Ventilation|ventilation
109563|NCT02607644|Cardiac arrest|cardiac arrest
109564|NCT02607644|prehospital|prehospital
109959|NCT02605083|Lung|lung
109960|NCT02605083|Pancreatic|pancreatic
109961|NCT02605083|Hepatic|hepatic
109977|NCT02604953|VEP|vep
110055|NCT02604381|Knee|knee
110248|NCT02603419|Immunophenotypic biomarkers|immunophenotypic biomarkers
110249|NCT02603393|COPD, QVA149|copd, qva149
110250|NCT02603380|Delirium|delirium
110251|NCT02603380|Feasibility study|feasibility study
110252|NCT02603380|software application|software application
110347|NCT02602756|Choroid Melanoma|choroid melanoma
110771|NCT02600429|NK|nk
110896|NCT02599649|MDS|mds
110971|NCT02599181|Catheter infection|catheter infection
110972|NCT02599168|dexmedetomidine|dexmedetomidine
110973|NCT02599168|propofol|propofol
110974|NCT02599168|BIS|bis
110975|NCT02599168|CLADS|clads
110976|NCT02599155|crystalloid|crystalloid
110977|NCT02599155|colloid|colloid
110978|NCT02599155|children|children
111265|NCT02597478|Questionnaires|questionnaires
111480|NCT02596126|Adherence|adherence
111762|NCT02594332|treatment|treatment
111763|NCT02594306|drug addiction|drug addiction
111764|NCT02594306|Heroin|heroin
111765|NCT02594306|craving|craving
111766|NCT02594306|event related potential|event related potential
111767|NCT02594306|crystal methamphetamine|crystal methamphetamine
111977|NCT02593175|FNA|fna
111983|NCT02593084|Walking|walking
112292|NCT02591303|Stress|stress
112489|NCT02590237|Video Laryngoscopy|video laryngoscopy
112676|NCT02589093|ANI|ani
112724|NCT02588820|HIV|hiv
112989|NCT02587117|Lycopene|lycopene
113303|NCT02584855|Spondyloarthritis|spondyloarthritis
113304|NCT02584855|Spondylarthropathy|spondylarthropathy
113305|NCT02584816|BRV-PV|brv-pv
113398|NCT02584140|PrEP|prep
113502|NCT02583490|Electroconvulsive Therapy|electroconvulsive therapy
113598|NCT02582866|Vimpat|vimpat
113705|NCT02582385|Cytokines|cytokines
113907|NCT02580994|phase II|phase ii
113908|NCT02580994|randomized|randomized
113909|NCT02580994|pembrolizumab|pembrolizumab
113910|NCT02580981|Cancer|cancer
113911|NCT02580981|Oncology|oncology
113912|NCT02580981|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
114007|NCT02580370|REALISE 1|realise 1
114101|NCT02579902|vitamin D3|vitamin d3
114330|NCT02578680|PD-1|pd-1
114433|NCT02578004|Difficult|difficult
114434|NCT02578004|environmental, microbial, immunological and genetic factors|environmental, microbial, immunological and genetic factors
114435|NCT02578004|significantly different|significantly different
114622|NCT02577042|comorbidities|comorbidities
114971|NCT02575222|RCC|rcc
115149|NCT02574247|Learning|learning
115949|NCT02569879|maternal vaccination|maternal vaccination
115950|NCT02569879|Pertussis|pertussis
115951|NCT02569879|Mortality|mortality
115952|NCT02569879|Morbidity|morbidity
116061|NCT02569216|uterus|uterus
116307|NCT02568072|cardiac remodelling|cardiac remodelling
116308|NCT02568072|left ventricular non-compaction cardiomyopathy|left ventricular non-compaction cardiomyopathy
116405|NCT02567383|radiotherapy|radiotherapy
116618|NCT02566135|C-LMA|c-lma
116709|NCT02565550|IBS|ibs
116904|NCT02564302|PVI|pvi
116997|NCT02563743|Occupational stress|occupational stress
117096|NCT02563288|esmolol|esmolol
117514|NCT02560779|HCC|hcc
117690|NCT02559713|Crohn's|crohn's
117794|NCT02558972|Fainting|fainting
117795|NCT02558972|Orthostatic Intolerance|orthostatic intolerance
117796|NCT02558972|Droxidopa|droxidopa
117981|NCT02557750|Pediatric Oncology|pediatric oncology
117982|NCT02557737|stroke|stroke
117983|NCT02557737|upper extremity|upper extremity
117984|NCT02557737|spasticity|spasticity
117985|NCT02557737|botulinum toxin|botulinum toxin
117986|NCT02557737|ultrasonography|ultrasonography
117987|NCT02557737|electric stimulation|electric stimulation
117988|NCT02557711|spasticity|spasticity
117989|NCT02557711|stroke|stroke
117990|NCT02557711|ultrasound elastography|ultrasound elastography
117992|NCT02557659|Low Profile|low profile
118126|NCT02556814|ITP|itp
118174|NCT02556606|ketamine|ketamine
118271|NCT02556125|Respiratory impairment|respiratory impairment
118479|NCT02554604|HDL|hdl
118791|NCT02552797|CAMHS|camhs
118907|NCT02552121|ovary cancer|ovary cancer
118908|NCT02552121|cervix cancer|cervix cancer
118921|NCT02552017|Endocuff|endocuff
119196|NCT02550210|Breast Imaging|breast imaging
119294|NCT02549651|DLBCL|dlbcl
119586|NCT02548026|satiety|satiety
119883|NCT02546154|Fatigue|fatigue
120580|NCT02541773|Growth Degradation Factor-15|growth degradation factor-15
120581|NCT02541773|Body Composition|body composition
120582|NCT02541734|SPECT|spect
120611|NCT02541474|Matched|matched
120685|NCT02541006|FVC|fvc
120973|NCT02539238|feedback|feedback
121263|NCT02537288|TQT|tqt
121359|NCT02536638|urine protein|urine protein
121379|NCT02536560|infant|infant
121462|NCT02535988|ZADAXIN|zadaxin
121558|NCT02534974|Critical care|critical care
121674|NCT02534155|MR|mr
121767|NCT02533726|Bed Sores|bed sores
121862|NCT02533128|Triple low|triple low
122057|NCT02532166|Chromoendoscopy|chromoendoscopy
122383|NCT02530437|Taxol|taxol
123060|NCT02526355|CBT|cbt
123278|NCT02524938|Dietary polyphenols|dietary polyphenols
123279|NCT02524938|Protein glycation|protein glycation
123280|NCT02524925|fast track surgery|fast track surgery
123281|NCT02524925|eras program|eras program
123282|NCT02524925|hepatectomy|hepatectomy
123284|NCT02524925|NPY|npy
123369|NCT02524262|acetaldehyde|acetaldehyde
123765|NCT02521792|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
123766|NCT02521792|Clementia|clementia
124175|NCT02519257|CAD|cad
124275|NCT02518685|TransPyloric Shuttle|transpyloric shuttle
124276|NCT02518685|TPS|tps
124277|NCT02518659|hypomagnesemia|hypomagnesemia
124278|NCT02518659|hypocalcemia|hypocalcemia
124373|NCT02518165|Cognitive Domain: Reaction Time|cognitive domain: reaction time
124568|NCT02516631|Misoprostol|misoprostol
124569|NCT02516631|Pharmacokinetics|pharmacokinetics
124570|NCT02516631|Cardiotocography|cardiotocography
124571|NCT02516631|Safety|safety
124573|NCT02516605|Primary Biliary Cholangitis|primary biliary cholangitis
124669|NCT02515903|Key-hole approach|key-hole approach
124899|NCT02514356|SMS|sms
124975|NCT02513927|CCB|ccb
125093|NCT02513303|ESRD|esrd
125183|NCT02512848|postmenopause|postmenopause
125383|NCT02511808|Alcoholism|alcoholism
125597|NCT02510261|FAP|fap
125788|NCT02509286|surgery|surgery
125789|NCT02509286|radiotherapy|radiotherapy
125790|NCT02509286|chemotherapy|chemotherapy
125891|NCT02508753|QT/QTc Intervals|qt/qtc intervals
125893|NCT02508701|Message Design|message design
125894|NCT02508701|Adolescent Males|adolescent males
125895|NCT02508688|hepatic hydrothorax|hepatic hydrothorax
126289|NCT02506140|clopidogrel|clopidogrel
126296|NCT02506062|(RP)|(rp)
126387|NCT02505568|Infliximab|infliximab
126489|NCT02505165|Parental uncertainty management intervention|parental uncertainty management intervention
126685|NCT02504008|non-opioid|non-opioid
126792|NCT02503540|diabetic macular edema|diabetic macular edema
126793|NCT02503527|Enteral nutrition|enteral nutrition
126794|NCT02503527|Tube feeding|tube feeding
126795|NCT02503527|Diet, carbohydrate-restricted|diet, carbohydrate-restricted
126796|NCT02503527|Diabetes|diabetes
126892|NCT02503098|Mobile Phone|mobile phone
127185|NCT02501317|perineum|perineum
127395|NCT02500342|Fatigue|fatigue
127597|NCT02499055|behaviour therapy|behaviour therapy
127598|NCT02499055|computer assisted therapy|computer assisted therapy
127599|NCT02499055|psychotherapy|psychotherapy
127600|NCT02499042|post-resuscitation|post-resuscitation
127601|NCT02499042|oxygen therapy|oxygen therapy
127602|NCT02499042|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
127603|NCT02499016|Appendicitis|appendicitis
127604|NCT02499016|Appendectomy|appendectomy
127702|NCT02498379|safety|safety
127898|NCT02497196|healthy subjects|healthy subjects
127899|NCT02497196|pelvic pain|pelvic pain
127900|NCT02497196|neuromodulation|neuromodulation
127901|NCT02497196|non-invasive brain stimulation|non-invasive brain stimulation
128300|NCT02495311|uterine myoma|uterine myoma
128509|NCT02494427|Inlays|inlays
128510|NCT02494427|Onlays|onlays
128511|NCT02494414|Cardiac arrest|cardiac arrest
128512|NCT02494414|outcome|outcome
128513|NCT02494414|neurological status|neurological status
128919|NCT02491684|safety|safety
128920|NCT02491684|prevention|prevention
128921|NCT02491671|Prevention PAL Prolonged Air Leak (PAL)|prevention pal prolonged air leak (pal)
129012|NCT02491034|Depression|depression
129116|NCT02490085|Insulin|insulin
129211|NCT02489370|telemonitoring|telemonitoring
129337|NCT02488707|ISR|isr
129636|NCT02487030|HCV|hcv
129798|NCT02486042|ROP|rop
129934|NCT02485223|MS|ms
130032|NCT02484729|First-in-human|first-in-human
130132|NCT02484209|sulphonylurea|sulphonylurea
130229|NCT02483702|Irradiated Blood|irradiated blood
130230|NCT02483702|Non-Irradiated Blood|non-irradiated blood
130323|NCT02483156|HCV|hcv
130537|NCT02481869|Closed|closed
130643|NCT02481284|Breast reconstruction|breast reconstruction
130645|NCT02481284|Skin perfusion|skin perfusion
130945|NCT02479451|Malnutrition|malnutrition
130946|NCT02479425|pressure ulcer|pressure ulcer
130947|NCT02479425|Positioning|positioning
131051|NCT02478736|postoperative delirium|postoperative delirium
131052|NCT02478736|on-pump cardiac surgery|on-pump cardiac surgery
131053|NCT02478736|cerebral oximetry|cerebral oximetry
131055|NCT02478723|requiring therapy|requiring therapy
131241|NCT02477644|olaparib|olaparib
131242|NCT02477644|placebo|placebo
131243|NCT02477631|Myelodysplastic syndrome|myelodysplastic syndrome
131344|NCT02477007|morphine|morphine
131443|NCT02476669|plasma EBV DNA|plasma ebv dna
131849|NCT02474199|Liver Transplant|liver transplant
131952|NCT02473510|Prevention|prevention
131953|NCT02473510|Healthy|healthy
131954|NCT02473497|chromosomal rearrangement|chromosomal rearrangement
132057|NCT02473042|NMBM|nmbm
132164|NCT02472561|Cardiology|cardiology
132268|NCT02472041|chest drain|chest drain
132457|NCT02470949|Social Status|social status
132758|NCT02469259|PTSD|ptsd
132759|NCT02469259|Alcohol Use Disorder|alcohol use disorder
132760|NCT02469259|social cognition|social cognition
132761|NCT02469259|craving|craving
132762|NCT02469259|fear-potentiated startle|fear-potentiated startle
132860|NCT02468674|function, lean body mass, gait speed|function, lean body mass, gait speed
132861|NCT02468661|Non-Small Cell Lung Cancer|non-small cell lung cancer
132865|NCT02468635|Pulmonary rehabilitation|pulmonary rehabilitation
132866|NCT02468635|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
132960|NCT02468193|osilodrostat|osilodrostat
133062|NCT02467595|tracheal intubation|tracheal intubation
133063|NCT02467595|operating room time|operating room time
133065|NCT02467582|Aspirin|aspirin
133168|NCT02467166|AF|af
133373|NCT02465957|MCC|mcc
133894|NCT02463136|Neuroimaging|neuroimaging
133997|NCT02462460|15-120|15-120
134295|NCT02460718|diabetes mellitus|diabetes mellitus
134296|NCT02460718|peer support|peer support
134297|NCT02460718|pragmatic clinical trial|pragmatic clinical trial
134496|NCT02459561|Control|control
134600|NCT02458976|Pulsed-dye laser|pulsed-dye laser
134709|NCT02457390|robot assisted CRC resection|robot assisted crc resection
134710|NCT02457377|recurrent abortion|recurrent abortion
134711|NCT02457377|cerclage|cerclage
134726|NCT02458300|Chest|chest
134805|NCT02457832|Neurology|neurology
135111|NCT02455687|Inhaled budesonide|inhaled budesonide
135212|NCT02455024|ponatinib|ponatinib
135515|NCT02453295|Lymphedema|lymphedema
135618|NCT02452528|HBV|hbv
135710|NCT02451839|Arthritis, Rheumatoid|arthritis, rheumatoid
135729|NCT02451735|BRCA 1|brca 1
135817|NCT02451189|Obesity|obesity
136007|NCT02449954|tramadol|tramadol
136109|NCT02449460|coronary artery disease|coronary artery disease
136110|NCT02449460|arterial stiffness|arterial stiffness
136111|NCT02449460|carotid ultrasound|carotid ultrasound
136112|NCT02449447|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
136113|NCT02449447|Blended treatment|blended treatment
136117|NCT02449421|trauma|trauma
136202|NCT02448927|TAVI|tavi
136606|NCT02446210|TMS|tms
136712|NCT02445612|SMD|smd
136806|NCT02445131|CLL|cll
137316|NCT02442115|Autistic|autistic
137419|NCT02441803|Rabbit ATG|rabbit atg
137622|NCT02440841|PK|pk
137720|NCT02440230|safety|safety
137721|NCT02440230|Exemestane|exemestane
137722|NCT02440230|ovarian function suppression|ovarian function suppression
654804|NCT00789854|MDD|mdd
138128|NCT02437669|Intranasal|intranasal
138324|NCT02436577|bioequivalence|bioequivalence
138426|NCT02435979|wrist|wrist
138522|NCT02435472|Personalized exercise|personalized exercise
138523|NCT02435472|Exercise trainer|exercise trainer
138524|NCT02435433|liver cancer|liver cancer
138528|NCT02435355|Sleep apnea|sleep apnea
138529|NCT02435355|education|education
138530|NCT02435355|compliance|compliance
138531|NCT02435355|CPAP|cpap
138616|NCT02434692|POAG|poag
138723|NCT02434172|Screening|screening
138810|NCT02433535|allergic airway inflammation|allergic airway inflammation
138811|NCT02433522|ANCA-associated vasculitides|anca-associated vasculitides
138812|NCT02433522|Maintenance treatment|maintenance treatment
138813|NCT02433522|Rituximab|rituximab
138814|NCT02433522|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
138905|NCT02433041|Nu-DESC|nu-desc
139126|NCT02431858|Nerve block|nerve block
654807|NCT00789867|Pilot|pilot
139223|NCT02431390|RAPAELⓇ Smart Glove digital treatment system|rapaelⓡ smart glove digital treatment system
139224|NCT02431390|Rehabilitation|rehabilitation
139225|NCT02431390|Stroke|stroke
139226|NCT02431390|Upper limbs|upper limbs
139227|NCT02431377|infant formula|infant formula
139430|NCT02430285|EUS|eus
139525|NCT02429817|SPECT-CT analysis|spect-ct analysis
139832|NCT02428257|hip fracture|hip fracture
139936|NCT02427711|Reduction of blood loss for revisions of knee arthroplasty|reduction of blood loss for revisions of knee arthroplasty
139944|NCT02427672|associated risk factors|associated risk factors
139948|NCT02427646|Kinematics|kinematics
139949|NCT02427646|Botulinum toxin type A|botulinum toxin type a
139950|NCT02427633|recovery position|recovery position
140150|NCT02426645|CEUS|ceus
140244|NCT02425982|Tennis Elbow|tennis elbow
140592|NCT02423915|CB|cb
140791|NCT02422992|MRI|mri
140870|NCT02422628|EGFR|egfr
140968|NCT02422290|Glutamate|glutamate
141171|NCT02421081|stem cells|stem cells
141487|NCT02420119|Iron Therapy|iron therapy
141586|NCT02419560|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
141587|NCT02419560|BCL-2 inhibitor|bcl-2 inhibitor
141588|NCT02419547|Ventricular tachycardia|ventricular tachycardia
141591|NCT02419547|programed stimulation|programed stimulation
141690|NCT02419430|stress|stress
141791|NCT02418728|lipolysis|lipolysis
141893|NCT02418260|Humerus|humerus
141992|NCT02417662|NSCLC|nsclc
142199|NCT02416752|remifentanil|remifentanil
142200|NCT02416752|head and neck surgery|head and neck surgery
142201|NCT02416752|recovery pofile|recovery pofile
142202|NCT02416752|Opioid induced hyperalgesia|opioid induced hyperalgesia
142203|NCT02416752|post operative pain|post operative pain
142204|NCT02416739|EGFR mutated lung cancer|egfr mutated lung cancer
142205|NCT02416726|Gene testing|gene testing
142206|NCT02416726|Next-generation sequecing|next-generation sequecing
142207|NCT02416726|Primary tumor|primary tumor
142208|NCT02416726|Metastatic lymph node|metastatic lymph node
142209|NCT02416726|Peripheral blood|peripheral blood
142210|NCT02416713|Driving|driving
142211|NCT02416713|Teens|teens
142212|NCT02416713|Texting|texting
142213|NCT02416713|Cellphone|cellphone
142214|NCT02416713|DriveID|driveid
142215|NCT02416713|Motor vehicle accident|motor vehicle accident
142216|NCT02416700|Dental prosthesis|dental prosthesis
142217|NCT02416700|Patients|patients
142218|NCT02416700|Osseointegrated implants|osseointegrated implants
142219|NCT02416674|abdominal wall|abdominal wall
142220|NCT02416674|vascularized composite allotransplantation|vascularized composite allotransplantation
142221|NCT02416661|Gaucher Disease type 1|gaucher disease type 1
142222|NCT02416661|Lymphatic Diseases|lymphatic diseases
142223|NCT02416661|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
142280|NCT02416466|CAR-T|car-t
142395|NCT02415933|Child Labor|child labor
143046|NCT02411968|Cryosurgery|cryosurgery
142934|NCT02412709|ECG|ecg
143136|NCT02411422|manikins|manikins
143528|NCT02409303|Risk|risk
143875|NCT02407262|asthma|asthma
143760|NCT02407860|sucking|sucking
143860|NCT02407353|Phase 1|phase 1
143969|NCT02406638|TVT|tvt
144058|NCT02405962|Training parents|training parents
144059|NCT02405910|advanced|advanced
144156|NCT02405325|physical activity|physical activity
144157|NCT02405325|multilevel|multilevel
144158|NCT02405325|cost-effectiveness|cost-effectiveness
144162|NCT02405312|death|death
144260|NCT02404779|Deep sedation|deep sedation
144261|NCT02404779|Mechanical ventilation|mechanical ventilation
144262|NCT02404779|Traumatic brain injury|traumatic brain injury
144263|NCT02404779|Intracranial hypertension|intracranial hypertension
144264|NCT02404779|Cisatracurium|cisatracurium
144265|NCT02404779|Neuromuscular Blocking Agent|neuromuscular blocking agent
144266|NCT02404779|Randomization versus placebo|randomization versus placebo
144267|NCT02404766|manual therapy|manual therapy
144268|NCT02404766|cervical|cervical
144449|NCT02403817|Video Games|video games
144549|NCT02403284|glucose metabolism|glucose metabolism
145878|NCT02395328|Home visiting intervention|home visiting intervention
145879|NCT02395328|South Africa|south africa
145880|NCT02395328|Program evaluation|program evaluation
146167|NCT02393365|screening|screening
146475|NCT02391662|Elderly|elderly
146381|NCT02392221|Pediatric|pediatric
146594|NCT02391051|PSA|psa
146796|NCT02389764|HER2-negative|her2-negative
146797|NCT02389764|Breast carcinoma|breast carcinoma
147045|NCT02387242|WBA|wba
147321|NCT02387021|analgesia|analgesia
147418|NCT02386319|Surgery|surgery
147426|NCT02386254|ICU|icu
147529|NCT02385643|relapse prevention|relapse prevention
147530|NCT02385643|mobile support system|mobile support system
147531|NCT02385630|Longitudinal Studies|longitudinal studies
147621|NCT02385383|IV Iron|iv iron
147929|NCT02383693|efficiency|efficiency
147930|NCT02383693|TMS|tms
147931|NCT02383693|refractory|refractory
147932|NCT02383680|Methotrexate therapy|methotrexate therapy
147933|NCT02383654|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
148028|NCT02383030|postmenopausal|postmenopausal
148029|NCT02383030|maintenance therapy|maintenance therapy
148030|NCT02383030|fulvestrant|fulvestrant
148032|NCT02383004|myringotomy tubes|myringotomy tubes
148033|NCT02383004|acupuncture|acupuncture
148286|NCT02381457|22q|22q
148504|NCT02380521|IMT|imt
148551|NCT02380313|Afuresertib|afuresertib
148661|NCT02379728|sleep pregnancy|sleep pregnancy
148966|NCT02377960|SMS|sms
148967|NCT02377960|text message|text message
148968|NCT02377960|mHealth|mhealth
148969|NCT02377960|IMB|imb
148970|NCT02377947|Lactulose Retention Enema|lactulose retention enema
149099|NCT02377193|kidney transplant|kidney transplant
148971|NCT02377947|Hepatic Encephalopathy, Grade 3 or 4 West Haven Criteria|hepatic encephalopathy, grade 3 or 4 west haven criteria
149162|NCT02376907|stent|stent
149261|NCT02376426|Monovalent vaccine|monovalent vaccine
149352|NCT02375945|lymphedema|lymphedema
149452|NCT02375178|anti-infective agents|anti-infective agents
149767|NCT02373241|Hypertension|hypertension
149768|NCT02373241|Proteinuria|proteinuria
149769|NCT02373241|Losartan|losartan
150069|NCT02371486|ivf|ivf
150274|NCT02370212|interval training|interval training
150586|NCT02368418|China|china
150682|NCT02367859|BRAF|braf
150683|NCT02367859|odontogenic cancer|odontogenic cancer
150684|NCT02367859|adamantinoma|adamantinoma
150685|NCT02367846|Calcium Tracer|calcium tracer
150686|NCT02367846|Oral Contraceptives|oral contraceptives
150687|NCT02367846|Contraceptive Vaginal Ring|contraceptive vaginal ring
150901|NCT02366741|PCI|pci
150994|NCT02366195|T-VEC|t-vec
150995|NCT02366195|CD8+ cell density|cd8+ cell density
150996|NCT02366195|objective response rate|objective response rate
150997|NCT02366195|unresected|unresected
150998|NCT02366195|Melanoma|melanoma
150999|NCT02366130|Breast cancer|breast cancer
151000|NCT02366130|Hormone-positive bone-dominant metastatic breast cancer|hormone-positive bone-dominant metastatic breast cancer
151001|NCT02366130|Ra-223 dichloride|ra-223 dichloride
151191|NCT02365077|GWAS|gwas
151392|NCT02363738|Bipolar|bipolar
151492|NCT02363075|dexamfetamine sulphate|dexamfetamine sulphate
151493|NCT02363075|severe asthenia|severe asthenia
151495|NCT02363075|MFI-20|mfi-20
151496|NCT02363075|double-blind|double-blind
151706|NCT02361892|ulipristal acetate|ulipristal acetate
151707|NCT02361879|fibroids|fibroids
151708|NCT02361879|gnrh analogue|gnrh analogue
151709|NCT02361879|ulipristal acetate|ulipristal acetate
151710|NCT02361879|hysteroscopy|hysteroscopy
151711|NCT02361840|Troponin I|troponin i
151712|NCT02361840|Pediatric shock|pediatric shock
151791|NCT02361346|NHL|nhl
151804|NCT02361346|CLL|cll
152000|NCT02360111|14-273|14-273
152323|NCT02358473|NSCLC|nsclc
152521|NCT02357329|food preference|food preference
152619|NCT02356744|Fetal outcome|fetal outcome
152721|NCT02356029|Medical Futility|medical futility
153020|NCT02354261|BCCNS|bccns
153224|NCT02353130|cortical metrics|cortical metrics
153613|NCT02350582|fatigue|fatigue
153711|NCT02350205|Burns|burns
154025|NCT02348359|AMD|amd
154119|NCT02347748|Relaxation|relaxation
154219|NCT02346968|Kidney Transplantation|kidney transplantation
154220|NCT02346968|Delayed Graft Function|delayed graft function
154414|NCT02346123|Biomarkers|biomarkers
154821|NCT02343822|Tennis Elbow|tennis elbow
155226|NCT02341664|Statin|statin
155327|NCT02341209|CTCL|ctcl
155428|NCT02340676|chronic graft-versus-host-disease|chronic graft-versus-host-disease
155449|NCT02340481|Placebo|placebo
155737|NCT02338739|Kenya|kenya
155824|NCT02338063|Intervention|intervention
155923|NCT02337595|Immunocompromized Host|immunocompromized host
155924|NCT02337491|Recurrent|recurrent
155929|NCT02337452|Surveys|surveys
156032|NCT02336815|KPT-330|kpt-330
156130|NCT02336165|T Cell|t cell
156233|NCT02335372|Wide-field fluorescence imaging|wide-field fluorescence imaging
156742|NCT02332265|HIV|hiv
156837|NCT02331667|Fatty fish|fatty fish
156932|NCT02331004|Motor Skills|motor skills
157033|NCT02330562|BEV|bev
157131|NCT02329912|SmartPill|smartpill
157431|NCT02328040|Januvia|januvia
157531|NCT02327546|Oral anemia treatment|oral anemia treatment
157631|NCT02327026|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
157632|NCT02327026|Bag-valve-mask ventilation|bag-valve-mask ventilation
157633|NCT02327026|Tracheal intubation|tracheal intubation
157634|NCT02326961|osteoarthritis|osteoarthritis
157646|NCT02326935|MS|ms
157818|NCT02325960|exenatide|exenatide
157920|NCT02325427|TMS|tms
158113|NCT02324582|pembrolizumab|pembrolizumab
158215|NCT02323919|exercise|exercise
158309|NCT02323412|Low back pain|low back pain
158834|NCT02320981|EGD|egd
159018|NCT02319850|geriatrics|geriatrics
159166|NCT02319005|FAC|fac
159221|NCT02318745|Minority|minority
159345|NCT02318030|EBV|ebv
159445|NCT02317523|CBT|cbt
159729|NCT02315885|alcohol|alcohol
159933|NCT02314936|Fiber|fiber
160134|NCT02313857|Viralym-C|viralym-c
160328|NCT02312687|FGF23|fgf23
160639|NCT02310802|IVF|ivf
160825|NCT02309879|Pain|pain
161233|NCT02307513|Safety|safety
161925|NCT02303353|Lung cancer|lung cancer
161926|NCT02303353|Colon cancer|colon cancer
161927|NCT02303353|Gastric cancer|gastric cancer
161928|NCT02303353|Pancreatic cancer|pancreatic cancer
161929|NCT02303353|Rectum cancer|rectum cancer
161930|NCT02303353|Plasmacytoma|plasmacytoma
161931|NCT02303340|Cone Beam Computed Tomography|cone beam computed tomography
162016|NCT02302846|Leukemia|leukemia
162018|NCT02302846|AML|aml
162564|NCT02299843|RFA|rfa
162823|NCT02298465|ESWL|eswl
162916|NCT02298166|Refractory|refractory
162917|NCT02298140|SMS reminders|sms reminders
162918|NCT02298140|Provider's compliance|provider's compliance
162919|NCT02298140|malaria|malaria
162920|NCT02298127|smoking cessation|smoking cessation
163006|NCT02297542|Influenza Vaccine|influenza vaccine
163194|NCT02296086|Hip fractures [MeSH]|hip fractures [mesh]
163398|NCT02294786|Randomised|randomised
163518|NCT02294409|CBT|cbt
163606|NCT02293889|Older adults|older adults
163708|NCT02293395|Xarelto|xarelto
163810|NCT02292823|stent|stent
164010|NCT02291913|everolimus|everolimus
164699|NCT02288091|Inosine|inosine
164700|NCT02288091|Uric acid|uric acid
164701|NCT02288091|Urate|urate
164798|NCT02287467|IVIG|ivig
401979|NCT01232465|Toluidine blue assay (TBA)|toluidine blue assay (tba)
164799|NCT02287467|Hemagglutination inhibition (HAI)|hemagglutination inhibition (hai)
164800|NCT02287467|Antibody|antibody
164801|NCT02287454|Multiple Sclerosis, cognitive rehabilitation, REHACOP|multiple sclerosis, cognitive rehabilitation, rehacop
164802|NCT02287376|Migraine with and without aura|migraine with and without aura
164803|NCT02287350|pain|pain
164994|NCT02286245|Hotline|hotline
164804|NCT02287350|moderate pain|moderate pain
164805|NCT02287350|mild pain|mild pain
164806|NCT02287350|acute pain|acute pain
164807|NCT02287350|mild acute pain|mild acute pain
164878|NCT02286882|healthy subjects|healthy subjects
164879|NCT02286869|mechanical ventilation|mechanical ventilation
164880|NCT02286869|autonomic nervous system|autonomic nervous system
164971|NCT02286388|dental composite resin|dental composite resin
164972|NCT02286388|pulp vitality preservation|pulp vitality preservation
165071|NCT02285855|Genotypes|genotypes
165174|NCT02285114|HIV|hiv
165481|NCT02283060|HIV|hiv
165607|NCT02282293|Malaria|malaria
165801|NCT02281214|patients|patients
165802|NCT02281214|mutations|mutations
662227|NCT00824447|Allergy|allergy
166036|NCT02280070|SOX|sox
166128|NCT02279628|continuous wound infiltration|continuous wound infiltration
166439|NCT02278120|CDK6|cdk6
166562|NCT02277353|NICOM|nicom
166736|NCT02276222|COPD|copd
166929|NCT02274974|infiltration|infiltration
167031|NCT02274324|duodopa|duodopa
167325|NCT02272634|COPD|copd
167627|NCT02270983|Opioid-Induced Constipation|opioid-induced constipation
167730|NCT02270203|si joint|si joint
167826|NCT02269917|Emerald|emerald
168030|NCT02268864|Daclatasvir|daclatasvir
168123|NCT02268292|Metabolic syndrome|metabolic syndrome
168402|NCT02266758|Gestational Diabetes|gestational diabetes
168403|NCT02266758|Obesity|obesity
168787|NCT02264314|Rehabilitation|rehabilitation
168790|NCT02264275|Aerobic Exercise|aerobic exercise
168791|NCT02264275|Exercise|exercise
168890|NCT02263391|childbearing age|childbearing age
168891|NCT02263391|HIV testing|hiv testing
168892|NCT02263391|testing strategy|testing strategy
168893|NCT02263378|HPV, L-SIL|hpv, l-sil
168987|NCT02262728|Hepatitis C, Chronic|hepatitis c, chronic
169178|NCT02261701|shoulder surgery|shoulder surgery
169285|NCT02260791|Rheumatoid|rheumatoid
169387|NCT02260219|Neovascular Glaucoma|neovascular glaucoma
169592|NCT02259036|worries|worries
169881|NCT02257554|expectations|expectations
170085|NCT02256228|Saline|saline
665111|NCT00829114|IND|ind
170568|NCT02253446|Piroxicam|piroxicam
170662|NCT02253108|Stent|stent
170777|NCT02252471|HIV|hiv
170968|NCT02251470|exer-gaming|exer-gaming
171066|NCT02250937|AML|aml
171166|NCT02250534|Biomarkers of exposure|biomarkers of exposure
171266|NCT02250040|Stroke|stroke
171369|NCT02249520|MRI|mri
171745|NCT02247609|B cell lymphoma|b cell lymphoma
171848|NCT02247128|Aortic Stenosis|aortic stenosis
171941|NCT02246946|chest tube|chest tube
172040|NCT02246543|Protein|protein
172143|NCT02246101|renal disease|renal disease
172235|NCT02245672|Diskus|diskus
172279|NCT02245347|TB|tb
172459|NCT02244554|tattoo|tattoo
172641|NCT02243657|Age|age
172653|NCT02243514|Heart failure|heart failure
172654|NCT02243514|Sympathetic hyperactivity|sympathetic hyperactivity
172655|NCT02243514|Renal nerve|renal nerve
172656|NCT02243514|Remodeling|remodeling
172659|NCT02243488|MHM|mhm
172856|NCT02242656|DTO|dto
172857|NCT02242656|codeine|codeine
172858|NCT02242656|morphine|morphine
173049|NCT02241499|Endoscopic response|endoscopic response
173256|NCT02240537|AML|aml
173356|NCT02239991|thromboelastometry|thromboelastometry
173547|NCT02239133|Pelvic Organ Prolapse|pelvic organ prolapse
173548|NCT02239133|POP|pop
173549|NCT02239107|polycystic ovary syndrome|polycystic ovary syndrome
174474|NCT02234895|knee|knee
174578|NCT02234453|cancer|cancer
174703|NCT02233803|tolerability|tolerability
174704|NCT02233803|NEUMOTEROL|neumoterol
174707|NCT02233803|safety|safety
174914|NCT02232906|ND-CKD|nd-ckd
175111|NCT02231840|Phenotypes|phenotypes
175212|NCT02231541|Fibromylgia|fibromylgia
175338|NCT02229981|HIV|hiv
175717|NCT02229396|Exenatide|exenatide
176120|NCT02227667|14-109|14-109
176754|NCT02225028|SCI|sci
176810|NCT02224872|GVHD|gvhd
176915|NCT02224391|EEG|eeg
177208|NCT02223052|Neoplasms|neoplasms
177511|NCT02221713|diverticulitis|diverticulitis
177512|NCT02221713|diverticulosis|diverticulosis
177513|NCT02221713|diverticular disease|diverticular disease
177514|NCT02221700|Gastrointestinal cancer|gastrointestinal cancer
177516|NCT02221700|CIPN|cipn
177545|NCT02221596|MRS|mrs
177605|NCT02221245|Notch|notch
177844|NCT02220322|age|age
178027|NCT02219490|Naive|naive
178118|NCT02219035|presentation with|presentation with
178216|NCT02218723|UD-DPI|ud-dpi
178414|NCT02217878|VASP assay|vasp assay
178525|NCT02217215|HPV|hpv
179015|NCT02214784|Continence|continence
179213|NCT02214004|ER|er
179406|NCT02213302|anxiety visual analog scale|anxiety visual analog scale
179607|NCT02212366|Cognition|cognition
179608|NCT02212366|EEG|eeg
179609|NCT02212340|propofol|propofol
179610|NCT02212340|desflurane|desflurane
179611|NCT02212340|quality of recovery|quality of recovery
179612|NCT02212340|vitrectomy|vitrectomy
179702|NCT02211703|perioperative hypothermia|perioperative hypothermia
179805|NCT02211235|Diabetes|diabetes
180110|NCT02209870|Teamwork|teamwork
180414|NCT02208466|fluoxetine|fluoxetine
180699|NCT02207101|Basic Research|basic research
180900|NCT02206087|PER977|per977
181002|NCT02205645|tear|tear
181042|NCT02205437|RNA|rna
181209|NCT02204891|Abdominal pain|abdominal pain
181434|NCT02203773|AML|aml
181705|NCT02202551|LID|lid
667644|NCT00841165|CPAP|cpap
182117|NCT02200744|adults|adults
182521|NCT02198859|PSA|psa
183222|NCT02194816|PD|pd
183589|NCT02193932|intractable|intractable
184697|NCT02189356|exercise program|exercise program
184799|NCT02188992|Sepsis|sepsis
184896|NCT02188732|Community Mental Health|community mental health
184897|NCT02188732|Serious Mental Illness|serious mental illness
184898|NCT02188732|Medical Comorbidity|medical comorbidity
184899|NCT02188732|Self-Management|self-management
184900|NCT02188732|Automated Telehealth|automated telehealth
184901|NCT02188732|Early Mortality|early mortality
184989|NCT02188355|DES|des
185085|NCT02187978|NEC|nec
185304|NCT02187107|HIV|hiv
185473|NCT02186262|DWI|dwi
185510|NCT02186132|heart rate|heart rate
185613|NCT02185794|Antiviral Agents|antiviral agents
185715|NCT02185365|Developmental dysplasia of the hip|developmental dysplasia of the hip
185716|NCT02185352|Bevacizumab|bevacizumab
185717|NCT02185352|Brain Metastases|brain metastases
185924|NCT02184481|Working memory|working memory
668543|NCT00851006|Adolescents|adolescents
186333|NCT02181088|Malaria|malaria
186454|NCT02180841|soy|soy
186534|NCT02180425|lipid|lipid
186644|NCT02179905|MRI|mri
186742|NCT02179437|TIVA|tiva
186833|NCT02178982|outcome|outcome
186945|NCT02178345|MRI|mri
187630|NCT02174471|T1 Mapping|t1 mapping
187631|NCT02174471|Extracellular Volume Fraction|extracellular volume fraction
187632|NCT02174471|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
187633|NCT02174471|Diffuse Myocardial Fibrosis|diffuse myocardial fibrosis
187719|NCT02173977|GnRH Antagonist|gnrh antagonist
187720|NCT02173977|OHSS|ohss
187721|NCT02173964|fluorodeoxyglucose|fluorodeoxyglucose
187808|NCT02173405|Oculinum|oculinum
188010|NCT02171962|Chinese patient|chinese patient
188109|NCT02171117|donor|donor
188300|NCT02170051|functioning|functioning
188696|NCT02168205|Pomalyst|pomalyst
189080|NCT02166333|falls|falls
189273|NCT02165384|otitis media|otitis media
189584|NCT02163837|physical activity|physical activity
189651|NCT02163616|PPH|pph
189699|NCT02163434|pregnancy|pregnancy
189803|NCT02162940|statin|statin
190008|NCT02162173|Non-ampullary polyp|non-ampullary polyp
191024|NCT02157376|SUP|sup
190902|NCT02158026|IVF|ivf
191178|NCT02156622|HIV|hiv
191314|NCT02155972|SDS|sds
191368|NCT02155777|Oral Contraceptives|oral contraceptives
191369|NCT02155764|tooth|tooth
191370|NCT02155764|extraction|extraction
191371|NCT02155764|alveolar socket|alveolar socket
191374|NCT02155764|bone graft|bone graft
191474|NCT02155270|Imaging|imaging
191475|NCT02155270|Astigmatism|astigmatism
191580|NCT02154776|breast cancer,|breast cancer,
191693|NCT02154165|Blue light|blue light
191694|NCT02154165|Turquoise light|turquoise light
191896|NCT02153255|Morquio|morquio
192690|NCT02149498|EEG|eeg
192781|NCT02148965|motor activity|motor activity
192983|NCT02148094|Truvada|truvada
193090|NCT02147769|preterm|preterm
193203|NCT02147184|DXA|dxa
193432|NCT02146040|TIA|tia
193485|NCT02145845|amputation|amputation
193572|NCT02145455|Knee Prosthesis|knee prosthesis
193689|NCT02145039|MDS|mds
193769|NCT02144545|Bougie Size|bougie size
193867|NCT02144168|Fibre|fibre
194176|NCT02142894|TB|tb
194578|NCT02140970|ureteral spasm|ureteral spasm
194693|NCT02140502|Biopsy|biopsy
194783|NCT02139982|skin temperature|skin temperature
195561|NCT02136238|amputation|amputation
195675|NCT02135666|Twinrix|twinrix
195780|NCT02135094|Sam|sam
195884|NCT02134600|EPA|epa
195967|NCT02134288|Dialysis|dialysis
196069|NCT02133989|Stenting|stenting
196165|NCT02133573|brain development|brain development
196366|NCT02132507|ICA|ica
196466|NCT02132052|Essential Tremor|essential tremor
196467|NCT02132052|Multiple System Atrophy|multiple system atrophy
196468|NCT02132052|Corticobasal Degeneration|corticobasal degeneration
196469|NCT02132052|Supranuclear Palsy, Progressive|supranuclear palsy, progressive
196471|NCT02132052|PD|pd
196556|NCT02131714|conservative treatment|conservative treatment
196557|NCT02131714|facial pain|facial pain
196706|NCT02130960|RMR|rmr
196971|NCT02129933|EAC|eac
197365|NCT02128425|5-FU|5-fu
197465|NCT02127905|BMT|bmt
197563|NCT02127463|AMD|amd
197828|NCT02126202|PCI|pci
675914|NCT00878527|VAD|vad
198054|NCT02125045|GSH|gsh
198166|NCT02124590|Acylcarnitine|acylcarnitine
198390|NCT02123433|HIV|hiv
198645|NCT02122328|Sequential laser photocoagulation of communicating vessels|sequential laser photocoagulation of communicating vessels
198851|NCT02121457|selenium|selenium
198955|NCT02121015|Individual Internet Interventions (IIIs)|individual internet interventions (iiis)
198956|NCT02121015|Internet Support Groups (ISGs)|internet support groups (isgs)
198957|NCT02121002|Knee|knee
198958|NCT02120989|insomnia|insomnia
198959|NCT02120989|cognitive behavioral therapy for insomnia (CBT-I)|cognitive behavioral therapy for insomnia (cbt-i)
198970|NCT02120950|PCV|pcv
199267|NCT02119754|Wound|wound
199455|NCT02119026|Patients with metastatic colorectal cancer who did not receive|patients with metastatic colorectal cancer who did not receive
199456|NCT02119026|systemic treatment for their metastatic disease|systemic treatment for their metastatic disease
199457|NCT02118987|Drug Desensitization|drug desensitization
199458|NCT02118987|Hypersensitivity reactions to chemotherapeutic agents|hypersensitivity reactions to chemotherapeutic agents
199459|NCT02118974|Hysterectomy|hysterectomy
199551|NCT02118532|Proximal Popliteal Artery|proximal popliteal artery
199552|NCT02118519|Bone marrow derived Mesenchymal Stem Cells|bone marrow derived mesenchymal stem cells
199553|NCT02118519|Knee articular cartilage injury|knee articular cartilage injury
199767|NCT02117596|Transplant|transplant
199768|NCT02117583|pharmacokinetics|pharmacokinetics
199769|NCT02117583|relative bioavailability|relative bioavailability
199770|NCT02117583|food effects|food effects
199815|NCT02117375|MRI|mri
199860|NCT02117154|HbA1c|hba1c
199969|NCT02116673|Cognitive rest|cognitive rest
200603|NCT02114138|CKD|ckd
200364|NCT02115191|Closure.|closure.
200850|NCT02113215|aging|aging
201034|NCT02112526|ABC DLBCL|abc dlbcl
201227|NCT02111720|Family|family
201425|NCT02110849|Cancer|cancer
201647|NCT02109796|EMG|emg
201824|NCT02108990|rejection|rejection
202539|NCT02106182|Thrupas|thrupas
202732|NCT02105506|Esophagus|esophagus
202829|NCT02105155|acute rejection,|acute rejection,
202830|NCT02105155|GFR|gfr
202831|NCT02105142|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
202932|NCT02104544|Breast milk.|breast milk.
203466|NCT02102048|HIV|hiv
203734|NCT02100774|bioavailability|bioavailability
203946|NCT02099773|AAC|aac
204059|NCT02099383|Stroke|stroke
204157|NCT02098902|Nutrition Disorders|nutrition disorders
204158|NCT02098889|Cervix, active phase of labor, Hyoscine-N-Butylbromide (HBB)|cervix, active phase of labor, hyoscine-n-butylbromide (hbb)
204159|NCT02098876|neointimal tissue area|neointimal tissue area
204166|NCT02098863|Survival|survival
204594|NCT02096952|ASD|asd
204970|NCT02095184|Postmenopausal|postmenopausal
205169|NCT02094313|Seminal fluid|seminal fluid
205170|NCT02094313|Accessory Glands|accessory glands
205171|NCT02094313|Cholesterol|cholesterol
205172|NCT02094313|Gonadotropins,|gonadotropins,
205173|NCT02094313|Testosterone|testosterone
205174|NCT02094300|Aorta|aorta
205175|NCT02094300|Thoracic|thoracic
205265|NCT02093923|HAE|hae
205276|NCT02093871|HEATT|heatt
205470|NCT02092987|Burden|burden
205662|NCT02092038|radiotherapy|radiotherapy
205663|NCT02092038|surgery|surgery
205664|NCT02092038|pre-operative|pre-operative
205665|NCT02092038|neoadjuvant|neoadjuvant
205960|NCT02090647|dental implant, aesthetic, implant abutment|dental implant, aesthetic, implant abutment
205961|NCT02090634|HIV|hiv
205964|NCT02090621|Liver|liver
206265|NCT02089217|cognition|cognition
206456|NCT02088151|retinal vein occlusion|retinal vein occlusion
206560|NCT02087592|prevention|prevention
206654|NCT02086955|Diabetes|diabetes
206841|NCT02086110|probiotic|probiotic
207098|NCT02084940|COH|coh
207137|NCT02084654|prediabetes|prediabetes
207397|NCT02083588|PFC|pfc
207439|NCT02083380|PQP|pqp
207571|NCT02082860|AAV|aav
207732|NCT02082249|levodopa|levodopa
207733|NCT02082249|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
207734|NCT02082249|Efficacy|efficacy
207735|NCT02082249|Advanced Parkinson's Disease|advanced parkinson's disease
207937|NCT02081287|IP6|ip6
208033|NCT02080910|Caregiver|caregiver
208143|NCT02080364|RAGE|rage
208444|NCT02078934|Surgical Endoscopy|surgical endoscopy
208549|NCT02078479|VAS|vas
208877|NCT02076919|AMD|amd
209031|NCT02076360|Preoperative counseling|preoperative counseling
209032|NCT02076360|Patient satisfaction|patient satisfaction
209033|NCT02076360|Prolapse|prolapse
209132|NCT02075983|DNA|dna
209133|NCT02075983|Adverse events|adverse events
209134|NCT02075983|Electroporation|electroporation
209135|NCT02075983|Transcutaneous|transcutaneous
209136|NCT02075983|GTU MultiHIV B Clade|gtu multihiv b clade
209137|NCT02075983|Antibody|antibody
209138|NCT02075983|Intramuscular|intramuscular
209139|NCT02075983|Immunogenicity|immunogenicity
209140|NCT02075970|Neonatal|neonatal
209141|NCT02075970|Anemia|anemia
209232|NCT02075515|Zoster|zoster
209433|NCT02074800|Safety|safety
209728|NCT02073383|Ultrasound|ultrasound
209822|NCT02072824|Safety|safety
209918|NCT02072369|stroke|stroke
210221|NCT02070900|PMTCT|pmtct
210326|NCT02070380|confirmed brain disease|confirmed brain disease
210417|NCT02069886|transfusion dependent thalassemia|transfusion dependent thalassemia
210418|NCT02069873|Post Traumatic Stress Disorder|post traumatic stress disorder
210419|NCT02069873|Group|group
210820|NCT02068105|ALKS 5461|alks 5461
211132|NCT02066532|HER2 positive|her2 positive
211248|NCT02065986|HIV|hiv
211327|NCT02065622|Ulcerative Colitis|ulcerative colitis
211840|NCT02063425|Motor recovery|motor recovery
212039|NCT02062411|adult|adult
212439|NCT02060721|Chronic thromboembolic pulmonary hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
212440|NCT02060695|Parkinson disease|parkinson disease
212441|NCT02060682|Fractional Flow Reserve|fractional flow reserve
212442|NCT02060682|Rapid Exchange|rapid exchange
212504|NCT02060448|CBT|cbt
213117|NCT02057458|pulse wave velocity|pulse wave velocity
213725|NCT02055092|Frontotemporal dementia|frontotemporal dementia
213968|NCT02053883|SCI|sci
214310|NCT02052349|healthy volunteers|healthy volunteers
214608|NCT02051062|Pediatric|pediatric
214703|NCT02050568|Genital prolapse|genital prolapse
214806|NCT02050204|sleep duration|sleep duration
214807|NCT02050204|insomnia symptoms|insomnia symptoms
214808|NCT02050178|Pancreatic Cancer|pancreatic cancer
214906|NCT02049697|TPI 1062|tpi 1062
214907|NCT02049697|Tianeptine|tianeptine
214908|NCT02049697|Absorption|absorption
214909|NCT02049697|Metabolism|metabolism
214910|NCT02049697|Excretion|excretion
215017|NCT02049229|myocardial infarction|myocardial infarction
215504|NCT02047201|PET/CT|pet/ct
215607|NCT02046733|SCLC|sclc
215920|NCT02045472|Monoclonal antibody|monoclonal antibody
216023|NCT02045030|cancer|cancer
216130|NCT02044588|HBsAg(+) donor|hbsag(+) donor
216131|NCT02044588|HBsAg(-) donor|hbsag(-) donor
216132|NCT02044588|Anti-hepatitis B antibody|anti-hepatitis b antibody
216133|NCT02044588|Kidney allograft|kidney allograft
216325|NCT02043639|ROM|rom
216524|NCT02043015|male|male
216928|NCT02041299|sickle cell disease|sickle cell disease
216936|NCT02041273|AUC|auc
217035|NCT02040727|Puberty|puberty
217237|NCT02039739|Orsiro|orsiro
217441|NCT02038829|COPD|copd
217748|NCT02037412|Ticagrelor|ticagrelor
217945|NCT02036541|POAG|poag
218138|NCT02035527|head and neck|head and neck
218334|NCT02034487|Boys|boys
218642|NCT02033304|Pain|pain
218824|NCT02032316|Renal Stone|renal stone
218925|NCT02031874|HIV|hiv
219027|NCT02031198|vaccine|vaccine
219121|NCT02030717|Klonidin|klonidin
219327|NCT02029872|MRSA|mrsa
219328|NCT02029872|colonization|colonization
219329|NCT02029872|decolonization|decolonization
219520|NCT02028897|IVF|ivf
219812|NCT02027675|exercise|exercise
220015|NCT02026674|luts|luts
220121|NCT02026232|Overweight|overweight
221531|NCT02019732|Influenza|influenza
221640|NCT02019134|comparative effectiveness research|comparative effectiveness research
221641|NCT02019108|osteoarthritis|osteoarthritis
221979|NCT02017522|PET|pet
222142|NCT02016833|WT-1|wt-1
222143|NCT02016833|Survivin|survivin
222145|NCT02016820|Clostridium Difficile Infection|clostridium difficile infection
222146|NCT02016820|Proton Pump Inhibitors|proton pump inhibitors
222147|NCT02016820|Histamine-2 Receptor Antagonists|histamine-2 receptor antagonists
222303|NCT02016131|AAA|aaa
222352|NCT02015975|star-plate|star-plate
222861|NCT02014038|Ultrarunners|ultrarunners
222985|NCT02013427|MRI|mri
223048|NCT02012920|CYP17|cyp17
223147|NCT02012452|posttraumatic stress disorder|posttraumatic stress disorder
223252|NCT02012010|hysteroscopy, water intoxication, hyponatremia|hysteroscopy, water intoxication, hyponatremia
223253|NCT02011971|epilepsy|epilepsy
223254|NCT02011971|cognition|cognition
223255|NCT02011971|memory|memory
223256|NCT02011958|Visceral Leishmaniasis|visceral leishmaniasis
223257|NCT02011958|HIV positive patients|hiv positive patients
223258|NCT02011958|Phase III trial|phase iii trial
223843|NCT02009345|High LDL-cholesterol|high ldl-cholesterol
223844|NCT02009345|Registry|registry
223845|NCT02009345|Coronary artery disease|coronary artery disease
223853|NCT02009306|Hospice|hospice
224134|NCT02008097|Ultrasonography|ultrasonography
224638|NCT02005965|Cancer|cancer
683941|NCT00904826|NMO|nmo
225353|NCT02002455|FACBC|facbc
225544|NCT02001649|SNP|snp
225636|NCT02001194|Team Studies|team studies
685015|NCT00909285|TMS|tms
225928|NCT02000011|digestive or|digestive or
226036|NCT01999530|healthy|healthy
226037|NCT01999530|Positron Emission Tomography|positron emission tomography
226038|NCT01999530|PHNO|phno
226039|NCT01999530|scan|scan
226056|NCT01999413|AML|aml
685808|NCT00914537|HIV|hiv
226341|NCT01998048|Bankart|bankart
226556|NCT01997294|acute myocardial infarction|acute myocardial infarction
226557|NCT01997281|dietary fiber|dietary fiber
226558|NCT01997281|diabetes mellitus|diabetes mellitus
226559|NCT01997281|gut hormone|gut hormone
226560|NCT01997268|Dyslipidemia|dyslipidemia
226561|NCT01997268|Hyperlipidemia|hyperlipidemia
226562|NCT01997268|Omega-3 Fatty Acids|omega-3 fatty acids
226563|NCT01997268|Metabolic Diseases|metabolic diseases
226564|NCT01997268|TG ≥500 mg/dL and ≤ 2,000 mg/dL|tg ≥500 mg/dl and ≤ 2,000 mg/dl
226565|NCT01997255|Everolimus|everolimus
226566|NCT01997255|Epilepsy|epilepsy
226567|NCT01997255|Sturge Weber Syndrome|sturge weber syndrome
226568|NCT01997255|Port wine stain|port wine stain
226569|NCT01997255|Glaucoma|glaucoma
226570|NCT01997242|CORONARY STENT|coronary stent
226571|NCT01997242|CARDIAC SURGERY|cardiac surgery
226574|NCT01997229|Eculizumab|eculizumab
226640|NCT01996904|ASES|ases
226738|NCT01996410|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
226839|NCT01996137|Treadmill|treadmill
226741|NCT01996410|Taxotere (75mg/m2), Cytoxan (600 mg/m2)|taxotere (75mg/m2), cytoxan (600 mg/m2)
226888|NCT01995942|CRM|crm
227038|NCT01995214|Geriatric|geriatric
227243|NCT01994291|Diabetes|diabetes
227669|NCT01992029|ALS|als
227735|NCT01991704|incubation|incubation
227827|NCT01991171|kinesio taping|kinesio taping
227927|NCT01990716|Adult|adult
228119|NCT01989806|robotic|robotic
228225|NCT01989182|COPD|copd
228425|NCT01988363|greater occipital nerve|greater occipital nerve
228831|NCT01986465|treatment|treatment
228426|NCT01988363|occipital neuralgia|occipital neuralgia
228431|NCT01988350|smoking|smoking
228632|NCT01987427|Obese|obese
229235|NCT01984437|Robotic|robotic
229268|NCT01984294|PI|pi
229444|NCT01983735|CKD-828|ckd-828
229577|NCT01983293|QLV|qlv
229747|NCT01982383|CSC|csc
229972|NCT01981499|wheal|wheal
230051|NCT01981213|Suicide|suicide
230145|NCT01980654|Rituxan|rituxan
230265|NCT01980069|Surgery|surgery
230576|NCT01978314|AKI|aki
230737|NCT01977807|Presbyopia|presbyopia
231142|NCT01976325|mefloquine|mefloquine
231459|NCT01974557|gender differences|gender differences
231460|NCT01974557|diastole|diastole
231461|NCT01974557|fluid challenge|fluid challenge
231462|NCT01974544|diabetes complications|diabetes complications
231463|NCT01974544|metabolic surgery|metabolic surgery
231464|NCT01974544|Intensive medicines|intensive medicines
231667|NCT01973543|PD|pd
231953|NCT01972347|Pyrexia|pyrexia
232355|NCT01970553|lurbinectedin|lurbinectedin
232474|NCT01970046|SP2086|sp2086
232555|NCT01969695|ABT-199|abt-199
232703|NCT01969097|Stroke|stroke
232747|NCT01968902|toxin|toxin
233018|NCT01967563|Fat|fat
233151|NCT01967030|obesity|obesity
233250|NCT01966809|DNET|dnet
233523|NCT01965665|Honey|honey
233701|NCT01964807|SHS|shs
233955|NCT01963741|Leukotriene D4|leukotriene d4
234058|NCT01963364|microbiota|microbiota
234246|NCT01962532|Neoplasms|neoplasms
234341|NCT01962311|Spinal Cerebrospinal Fluid|spinal cerebrospinal fluid
234448|NCT01961882|Antigen specific cancer immunotherapeutic|antigen specific cancer immunotherapeutic
234449|NCT01961869|black raspberry|black raspberry
234450|NCT01961869|chemoprevention|chemoprevention
234451|NCT01961869|oral delivery|oral delivery
234452|NCT01961856|platelet reactivity|platelet reactivity
234453|NCT01961856|ticagrelor loading dose|ticagrelor loading dose
234454|NCT01961856|clopidogrel loading dose|clopidogrel loading dose
234455|NCT01961843|Castration Resistant|castration resistant
234636|NCT01960907|COPD|copd
234735|NCT01960348|TTR|ttr
234839|NCT01959828|pulmonary hypertension|pulmonary hypertension
234840|NCT01959828|cardiac surgery|cardiac surgery
234841|NCT01959828|Glenn surgery|glenn surgery
234842|NCT01959828|fontan surgery|fontan surgery
234843|NCT01959828|left ventricular assist device|left ventricular assist device
234948|NCT01959217|HIV|hiv
235317|NCT01957332|HER2-PET|her2-pet
235819|NCT01954810|Duration|duration
236019|NCT01953926|Gastroesophageal|gastroesophageal
236321|NCT01952470|Isotonic Solutions|isotonic solutions
236322|NCT01952470|Sodium Chloride|sodium chloride
236323|NCT01952470|Postoperative complications|postoperative complications
236324|NCT01952470|Postoperative care|postoperative care
236325|NCT01952470|dornase alpha|dornase alpha
236361|NCT01952236|web|web
236648|NCT01950884|•Non-alcoholic Steatohepatitis (NASH)|•non-alcoholic steatohepatitis (nash)
236649|NCT01950871|HistoScanning|histoscanning
236650|NCT01950871|TRUS|trus
236651|NCT01950871|Prostate cancer|prostate cancer
236652|NCT01950871|Biopsy guidance|biopsy guidance
236653|NCT01950845|anesthesiology, Closed-Loop system, automated fluid management, cardiac output optimization, high risk surgical patient, major abdominal surgery|anesthesiology, closed-loop system, automated fluid management, cardiac output optimization, high risk surgical patient, major abdominal surgery
236654|NCT01950832|Structure of Retina|structure of retina
236658|NCT01950832|PCOS|pcos
236838|NCT01950130|IABP|iabp
236947|NCT01949662|Placebo|placebo
237042|NCT01949181|Metals|metals
237436|NCT01947166|Whipple|whipple
237529|NCT01946802|Heart arrest|heart arrest
237633|NCT01946308|arousals|arousals
237634|NCT01946308|premature infant|premature infant
237635|NCT01946308|conformational positioning|conformational positioning
237731|NCT01945931|Ethiopia|ethiopia
237732|NCT01945918|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
237733|NCT01945918|Diabetes Mellitus|diabetes mellitus
237828|NCT01945385|video intervention|video intervention
238323|NCT01943279|misoprostol|misoprostol
238324|NCT01943253|Early gastric cancer,|early gastric cancer,
238424|NCT01942655|HIV|hiv
238516|NCT01942213|Macular|macular
238609|NCT01941849|RET|ret
238911|NCT01940341|Viread|viread
239005|NCT01940055|Balance|balance
239110|NCT01939574|PFS|pfs
239210|NCT01939119|drinking habits|drinking habits
239211|NCT01939119|body hydration|body hydration
239212|NCT01939119|body-fluid balance|body-fluid balance
239213|NCT01939106|Stoma|stoma
239214|NCT01939106|Ileostomy|ileostomy
239508|NCT01937754|Prehypertension|prehypertension
239638|NCT01937091|HIV|hiv
239743|NCT01936467|EUS|eus
239812|NCT01936142|Kidney|kidney
240018|NCT01935115|MDD|mdd
240127|NCT01934595|ICU|icu
240211|NCT01934153|topical|topical
240397|NCT01933477|HIV infection|hiv infection
240499|NCT01933022|Eligard|eligard
240780|NCT01931670|Elagolix|elagolix
240970|NCT01930747|pneumoperitoneum|pneumoperitoneum
241395|NCT01928550|OCT|oct
241473|NCT01928225|HSIL|hsil
241571|NCT01927744|SCCHN|scchn
241668|NCT01927380|prostatectomy|prostatectomy
242489|NCT01923818|TIA|tia
242675|NCT01923038|Prevent|prevent
242775|NCT01922466|NSAIDs|nsaids
243176|NCT01920503|tumor response|tumor response
243177|NCT01920477|Pemphigus|pemphigus
243178|NCT01920477|(MAB)|(mab)
243179|NCT01920477|autoimmune disorder|autoimmune disorder
243180|NCT01920477|human CD20 antigen|human cd20 antigen
243181|NCT01920477|subcutaneous|subcutaneous
243182|NCT01920477|Pemphigus vulgaris|pemphigus vulgaris
243543|NCT01919229|CDK|cdk
243767|NCT01918072|Women's Health|women's health
244055|NCT01916967|Hypersensitivity|hypersensitivity
244306|NCT01915641|OSA|osa
244345|NCT01915511|Registry|registry
244538|NCT01914770|pooled analyses|pooled analyses
244539|NCT01914770|quality of life|quality of life
244540|NCT01914770|SELENA SLEDAI|selena sledai
244743|NCT01913704|venous leg ulcer|venous leg ulcer
244877|NCT01912937|PAD|pad
245157|NCT01911429|Latuda|latuda
245355|NCT01910493|PMTCT|pmtct
245565|NCT01909492|MS|ms
245800|NCT01908426|MET|met
246347|NCT01905436|STH Soil Transmitted Helminth infections|sth soil transmitted helminth infections
246348|NCT01905436|MDA Mass Drug Administration|mda mass drug administration
246349|NCT01905423|Filariasis|filariasis
246350|NCT01905423|Albendazole|albendazole
246351|NCT01905423|Diethylcarbamazine|diethylcarbamazine
246436|NCT01904994|linkage|linkage
246643|NCT01904136|MMF|mmf
246735|NCT01903889|EGPAF Elizabeth Glaser Pediatric AIDS Foundation|egpaf elizabeth glaser pediatric aids foundation
246736|NCT01903889|FP Family planning|fp family planning
246737|NCT01903889|HIV Human immunodeficiency virus|hiv human immunodeficiency virus
246738|NCT01903889|HTC HIV testing and counseling|htc hiv testing and counseling
246750|NCT01903863|FFP|ffp
246819|NCT01903447|MRI|mri
246913|NCT01902966|Beta blocker|beta blocker
247128|NCT01902004|Executive Cognitive Impairment|executive cognitive impairment
247129|NCT01902004|Quality of Life|quality of life
247130|NCT01902004|Disability|disability
247131|NCT01902004|Comorbidity|comorbidity
247133|NCT01902004|Safety|safety
247521|NCT01900132|Electrophysiology|electrophysiology
248265|NCT01896219|CT|ct
248321|NCT01895920|HIV|hiv
248602|NCT01894828|Nutritional support|nutritional support
248701|NCT01894360|Phase 1|phase 1
248895|NCT01893671|LASIK|lasik
249001|NCT01893190|safety|safety
249404|NCT01891630|Asthma|asthma
249589|NCT01890980|MPM|mpm
249782|NCT01890044|DVT|dvt
249786|NCT01890044|Trauma|trauma
249885|NCT01889667|Safety|safety
249990|NCT01889238|triple negative|triple negative
249991|NCT01889238|androgen receptor positive|androgen receptor positive
249992|NCT01889199|polycystic ovary syndrome|polycystic ovary syndrome
250088|NCT01888783|CRPS Type I|crps type i
250604|NCT01886274|EEG|eeg
251386|NCT01882816|IMRT|imrt
251571|NCT01881971|HIV|hiv
251664|NCT01881529|limited scleroderma|limited scleroderma
251795|NCT01881191|MRI|mri
251973|NCT01880463|Dry eye disease|dry eye disease
252076|NCT01880086|OPIAD|opiad
252177|NCT01879592|Asthma|asthma
252278|NCT01879085|advanced|advanced
252380|NCT01878695|Integrative Medicine|integrative medicine
252476|NCT01878305|hepatic encephalopathy|hepatic encephalopathy
252477|NCT01878305|brain waves|brain waves
252481|NCT01878305|intensive care|intensive care
252573|NCT01878019|Pain|pain
253165|NCT01875250|PSA|psa
253374|NCT01874288|NHL|nhl
253588|NCT01873287|PCS|pcs
253681|NCT01872923|Breast Cancer|breast cancer
253682|NCT01872923|HNSCC|hnscc
253683|NCT01872923|SCCHN|scchn
253684|NCT01872923|Advanced or metastatic cancer|advanced or metastatic cancer
253685|NCT01872923|Dose finding|dose finding
253686|NCT01872910|Wisdom tooth extraction|wisdom tooth extraction
253687|NCT01872897|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
253773|NCT01872520|Safety|safety
253967|NCT01871623|Stability|stability
254061|NCT01871012|Nerve Block|nerve block
254304|NCT01869842|Resolute zotarolumus-eluting stent|resolute zotarolumus-eluting stent
254305|NCT01869842|optical coherence tomography|optical coherence tomography
254306|NCT01869829|Candida|candida
254307|NCT01869829|Pediatric|pediatric
254308|NCT01869829|Antifungal|antifungal
254309|NCT01869738|heart attack|heart attack
254310|NCT01869725|Neuroendocrine Tumor|neuroendocrine tumor
254311|NCT01869725|Ga-DOTATOC PET|ga-dotatoc pet
254312|NCT01869725|Imaging|imaging
254313|NCT01869712|cupping therapy|cupping therapy
254314|NCT01869712|acupuncture|acupuncture
254315|NCT01869712|partially randomized|partially randomized
254316|NCT01869712|patient preference|patient preference
254317|NCT01869712|fibromyalgia|fibromyalgia
254318|NCT01869712|criteria formulated by American College Rheumatology 2002|criteria formulated by american college rheumatology 2002
254319|NCT01869699|Fever|fever
254320|NCT01869699|Acetaminophen|acetaminophen
254321|NCT01869699|Critical Care|critical care
254322|NCT01869699|ICU|icu
254323|NCT01869699|Febrile|febrile
254324|NCT01869673|Difficult mask ventilation|difficult mask ventilation
254385|NCT01869361|tocolysis|tocolysis
254580|NCT01868477|MDS|mds
254672|NCT01868126|Ocular hypertension|ocular hypertension
255168|NCT01865721|Entonox|entonox
255481|NCT01864395|albumin|albumin
255659|NCT01863680|COL-1620|col-1620
255660|NCT01863680|progesterone gel|progesterone gel
693605|NCT00941876|FDA|fda
255961|NCT01862315|Gemcitabine|gemcitabine
256062|NCT01861938|vaccine|vaccine
256156|NCT01861418|EMG median frequency|emg median frequency
256383|NCT01860404|BCAA|bcaa
256564|NCT01859715|pain|pain
257288|NCT01856686|Dietary|dietary
257386|NCT01856257|Transplantation|transplantation
257387|NCT01856257|NULOJIX|nulojix
257388|NCT01856257|belatacept|belatacept
257389|NCT01856257|chronic immunosuppression|chronic immunosuppression
257390|NCT01856244|Parkinson's Disease|parkinson's disease
257906|NCT01854294|protein|protein
258293|NCT01852721|Men|men
258503|NCT01852019|CAD|cad
258790|NCT01849575|Ultrasonography|ultrasonography
258890|NCT01850381|Safety|safety
258991|NCT01849952|glioblastoma|glioblastoma
259190|NCT01848847|Pain|pain
259311|NCT01848301|OCT|oct
259494|NCT01847495|Cyberknife|cyberknife
259704|NCT01846572|Antiplatelet therapy|antiplatelet therapy
259705|NCT01846572|Platelet function tests|platelet function tests
259706|NCT01846559|Immune system processes|immune system processes
259710|NCT01846546|Prognosis|prognosis
260468|NCT01842789|RFA|rfa
260791|NCT01841164|LTE4|lte4
260891|NCT01840761|medicine,|medicine,
260986|NCT01840280|Irinotecan|irinotecan
261498|NCT01838018|PKAN|pkan
261587|NCT01837615|Efficacy|efficacy
261588|NCT01837602|refractory to at least one standard therapy|refractory to at least one standard therapy
261589|NCT01837602|newly diagnosed|newly diagnosed
261783|NCT01836861|Absorption|absorption
261985|NCT01835717|Asymptomatic phase of Alzheimer's disease|asymptomatic phase of alzheimer's disease
261986|NCT01835717|Cognitive normal|cognitive normal
261994|NCT01835691|Vitamin D|vitamin d
262078|NCT01835262|morphine|morphine
262358|NCT01833845|HCV|hcv
262474|NCT01833390|HXe|hxe
262577|NCT01832935|NPH|nph
262678|NCT01832532|Sleep Apnea|sleep apnea
263091|NCT01830803|quality of care|quality of care
263324|NCT01829646|DWI|dwi
263806|NCT01827579|Adult|adult
264101|NCT01826227|18F-FDG|18f-fdg
264198|NCT01825681|Alzheimer's|alzheimer's
264301|NCT01825278|obstructive sleep apnea|obstructive sleep apnea
264605|NCT01823926|pulmonary scintigraphy|pulmonary scintigraphy
264606|NCT01823926|radioaerosol|radioaerosol
264607|NCT01823926|nebulization.|nebulization.
264608|NCT01823913|Pharmacokinetics|pharmacokinetics
264709|NCT01823198|MDS|mds
264803|NCT01822899|GSK573719|gsk573719
265008|NCT01821963|HCC|hcc
265101|NCT01821586|Benefiber;|benefiber;
265607|NCT01819090|Speech|speech
265713|NCT01818518|Premature birth|premature birth
266600|NCT01814579|vaginal|vaginal
266899|NCT01813071|Gastroenteritis|gastroenteritis
267104|NCT01812239|twins|twins
267283|NCT01811381|physical exercise|physical exercise
267702|NCT01809353|Caucasian|caucasian
267703|NCT01809353|Male|male
267704|NCT01809353|Pharmacokinetic|pharmacokinetic
267718|NCT01809288|Women|women
267990|NCT01808118|Adalimumab|adalimumab
268684|NCT01804777|Proteinuria|proteinuria
269099|NCT01803412|safety|safety
269184|NCT01803126|atherosclerosis|atherosclerosis
269387|NCT01802203|Barrett esophagus|barrett esophagus
269490|NCT01801696|Massage|massage
269684|NCT01800747|Pediatrics|pediatrics
269889|NCT01799733|Women|women
269989|NCT01799447|Video guidances|video guidances
270488|NCT01797055|anemia|anemia
270591|NCT01796652|Home therapy|home therapy
271229|NCT01793844|DFS|dfs
271306|NCT01793506|immunodeficiency|immunodeficiency
271307|NCT01793493|Mild Cognitive Impairment|mild cognitive impairment
271308|NCT01793493|Cognitive Stimulation|cognitive stimulation
271309|NCT01793493|Aging|aging
271310|NCT01793493|Elderly|elderly
271315|NCT01793389|fibrin|fibrin
271712|NCT01791556|Antiretroviral therapy|antiretroviral therapy
271713|NCT01791556|randomized clinical trial|randomized clinical trial
271714|NCT01791556|ART monitoring|art monitoring
271715|NCT01791556|treatment failure|treatment failure
271811|NCT01790997|DLBS1033|dlbs1033
272014|NCT01789736|Glaucoma|glaucoma
272313|NCT01788527|Diabetes|diabetes
272417|NCT01788189|Lymphoma|lymphoma
272920|NCT01786109|cannabinoid|cannabinoid
273382|NCT01783951|S-1|s-1
697053|NCT00954954|Knee|knee
273810|NCT01782001|Zinc|zinc
274095|NCT01780506|HIV|hiv
274102|NCT01780493|Ureter|ureter
274282|NCT01779622|GIP|gip
274406|NCT01779232|danazol|danazol
274699|NCT01777815|MR|mr
274798|NCT01777386|perforator vessel|perforator vessel
275144|NCT01776034|Exercise|exercise
275145|NCT01776034|Weight management|weight management
275373|NCT01774929|Durogesic|durogesic
275475|NCT01774487|Conjugated bilirubin|conjugated bilirubin
275476|NCT01774487|Liver transplantation|liver transplantation
275477|NCT01774487|Fibrosis|fibrosis
275478|NCT01774474|Prevention|prevention
275479|NCT01774448|Dementia|dementia
275480|NCT01774448|Spouse Caregiver|spouse caregiver
275481|NCT01774448|Depression|depression
275482|NCT01774448|Mind Body Therapy|mind body therapy
275483|NCT01774448|Cognitive Therapy|cognitive therapy
275484|NCT01774448|Quality of Life|quality of life
275485|NCT01774448|Attention|attention
275486|NCT01774448|Memory|memory
275487|NCT01774435|Schizophrenia|schizophrenia
275488|NCT01774435|Schizophrenic|schizophrenic
275489|NCT01774435|Stable Schizophrenic|stable schizophrenic
275490|NCT01774422|Hypercapnia|hypercapnia
275755|NCT01773213|Bladder|bladder
276347|NCT01770678|Cerebral Palsy|cerebral palsy
276348|NCT01770678|Randomised|randomised
276350|NCT01770652|Renal Impairment|renal impairment
276549|NCT01769794|Fever|fever
276653|NCT01769248|FNA|fna
276743|NCT01768910|diffusion tensor imaging|diffusion tensor imaging
276839|NCT01768481|Obesity|obesity
277145|NCT01767311|Alzheimer's Disease|alzheimer's disease
277851|NCT01763944|diet|diet
277930|NCT01763619|DDD|ddd
278118|NCT01762826|GDM|gdm
278264|NCT01762059|CGM|cgm
278437|NCT01761305|Brace|brace
278438|NCT01761305|Scoliosis specific exercise|scoliosis specific exercise
278439|NCT01761305|Physical activity|physical activity
278440|NCT01761279|Colonic polyps|colonic polyps
278724|NCT01759940|carotid|carotid
278825|NCT01759420|QTc|qtc
279022|NCT01758445|Breast|breast
279429|NCT01756482|RSV|rsv
279644|NCT01755546|OA|oa
279724|NCT01755130|Mass palpable or nonpalpable|mass palpable or nonpalpable
280349|NCT01752166|Candida|candida
280765|NCT01750008|RFA|rfa
281053|NCT01748565|BPD|bpd
281142|NCT01748188|VAS|vas
281242|NCT01747811|Sleep problems|sleep problems
281354|NCT01747317|FFR|ffr
281638|NCT01746043|Dynacin|dynacin
281743|NCT01745419|Exacerbation|exacerbation
281847|NCT01744990|specific IgE's|specific ige's
281949|NCT01744535|obesity|obesity
282143|NCT01743664|Depression|depression
282244|NCT01743248|balance|balance
282348|NCT01742780|IO Access|io access
282535|NCT01742013|CFS|cfs
282733|NCT01741077|pregnancy|pregnancy
283038|NCT01739985|Postoperative|postoperative
283138|NCT01739660|Hemodialysis|hemodialysis
283337|NCT01738646|brain tumor|brain tumor
283450|NCT01738256|Psychological Stress|psychological stress
283843|NCT01736748|for age and sex|for age and sex
284139|NCT01735526|hematopoietic stem-cell transplantation|hematopoietic stem-cell transplantation
285136|NCT01730534|T2DM|t2dm
285334|NCT01729546|System Accuracy|system accuracy
285452|NCT01729104|MCL|mcl
285571|NCT01728727|HBV|hbv
285957|NCT01726933|psoriasis, systemic treatment|psoriasis, systemic treatment
285958|NCT01726920|Migraine|migraine
285959|NCT01726920|Naratriptan|naratriptan
285960|NCT01726920|Naproxen|naproxen
286017|NCT01726673|CVA|cva
286383|NCT01725165|SRS|srs
286551|NCT01724398|plasma exchange|plasma exchange
286975|NCT01722214|MRI|mri
287591|NCT01719510|PCR|pcr
288069|NCT01717547|Yoga|yoga
288161|NCT01717118|Immunogenicity|immunogenicity
288260|NCT01716663|Ablation|ablation
288463|NCT01715675|IgE|ige
288763|NCT01714362|HRV|hrv
288901|NCT01713855|ITP|itp
289155|NCT01712672|Biofilm|biofilm
289570|NCT01710774|Foot Ulcer|foot ulcer
289670|NCT01710202|Stress|stress
289975|NCT01708876|plasmodium|plasmodium
290162|NCT01708226|OCD|ocd
290374|NCT01707342|Hepatitis C virus|hepatitis c virus
290578|NCT01706445|exercise|exercise
290787|NCT01705522|NAFLD|nafld
290981|NCT01704664|immunonutrition,|immunonutrition,
291083|NCT01704287|PD-1|pd-1
291278|NCT01703585|tumor|tumor
291566|NCT01702285|EGFR|egfr
291780|NCT01701414|Femur|femur
292281|NCT01699269|Glioma|glioma
292398|NCT01698827|tube|tube
292494|NCT01698450|FUS|fus
292784|NCT01696734|Compassionate use|compassionate use
293095|NCT01695304|infants|infants
293179|NCT01694940|DAD|dad
293476|NCT01693588|Pain|pain
293783|NCT01692483|Taxane|taxane
293978|NCT01691573|cardiac|cardiac
294793|NCT01688089|study|study
294894|NCT01687582|psoriasis|psoriasis
295092|NCT01686620|Prandial insulin|prandial insulin
295296|NCT01685619|AML|aml
295600|NCT01684332|jam|jam
295706|NCT01682928|Pregnancy|pregnancy
296092|NCT01682304|blood pressure|blood pressure
296322|NCT01681225|ALI|ali
296412|NCT01680900|menopause|menopause
296413|NCT01680900|hot flashes|hot flashes
296414|NCT01680900|vilazodone|vilazodone
296415|NCT01680887|Cocaine dependence|cocaine dependence
296416|NCT01680874|Clostridium difficile|clostridium difficile
296417|NCT01680874|Diarrhea|diarrhea
296418|NCT01680874|Infection|infection
296419|NCT01680874|Lactobacilli|lactobacilli
296420|NCT01680874|Bifidobacteria|bifidobacteria
296601|NCT01680159|TA-650|ta-650
296602|NCT01680159|psoriasis|psoriasis
296603|NCT01680107|d-cycloserine, cognitive-behaviour therapy, panic disorder|d-cycloserine, cognitive-behaviour therapy, panic disorder
296604|NCT01680094|HIV Infection|hiv infection
296624|NCT01679964|Raltegravir|raltegravir
296789|NCT01679171|Outcome|outcome
297208|NCT01677286|Primary Amyloidosis|primary amyloidosis
297807|NCT01674582|Glioma|glioma
297908|NCT01674179|Fibromyalgia|fibromyalgia
298005|NCT01673685|mobility|mobility
298513|NCT01671592|vaccine|vaccine
298626|NCT01671137|Acute|acute
298832|NCT01670149|Diarrhoea|diarrhoea
299139|NCT01668771|Self-Affirmation|self-affirmation
299336|NCT01667978|antiviral|antiviral
300142|NCT01664091|tissue expander|tissue expander
300327|NCT01663311|rTMS|rtms
300838|NCT01661010|XXY|xxy
300916|NCT01659788|Coenzyme Q10|coenzyme q10
301526|NCT01657422|Adolescents|adolescents
301630|NCT01656954|pulse pressure variance|pulse pressure variance
301631|NCT01656954|stroke volume variance|stroke volume variance
301632|NCT01656954|passive leg raise|passive leg raise
301633|NCT01656954|fluid challenge|fluid challenge
301634|NCT01656954|central venous pressure|central venous pressure
301635|NCT01656941|neonate|neonate
301636|NCT01656941|congenital heart disease|congenital heart disease
301641|NCT01656915|inflammation|inflammation
302027|NCT01655329|Image Processing|image processing
302028|NCT01655329|tubes|tubes
302029|NCT01655329|lines|lines
302030|NCT01655329|catheters|catheters
302031|NCT01655329|wires|wires
302032|NCT01655329|Bedside|bedside
302624|NCT01652404|ICU|icu
303135|NCT01650116|ScvO2|scvo2
303332|NCT01649115|Z score|z score
303533|NCT01648127|Obesity|obesity
303633|NCT01647659|pharmacokinetics|pharmacokinetics
303743|NCT01646814|Healthy volunteer|healthy volunteer
303843|NCT01646411|Giardia|giardia
303947|NCT01646073|Psoriasis|psoriasis
304291|NCT01644253|CLL|cll
304354|NCT01643889|Healthy|healthy
304519|NCT01643577|nausea|nausea
304592|NCT01643148|BMI|bmi
304959|NCT01641471|Pain|pain
305163|NCT01640496|IBD|ibd
305450|NCT01639261|steroid-refractory|steroid-refractory
306249|NCT01635491|Transit time|transit time
306437|NCT01634516|Diet|diet
306628|NCT01633372|PMF|pmf
306849|NCT01632397|MSM|msm
306926|NCT01631955|Antibiotics|antibiotics
307029|NCT01631539|DC Bead™|dc bead™
307116|NCT01631149|muscle relaxation|muscle relaxation
307416|NCT01629693|myopia|myopia
307512|NCT01629381|prevention|prevention
307608|NCT01628913|Pancreatic|pancreatic
308107|NCT01626573|Active|active
308407|NCT01625299|diet|diet
308504|NCT01625000|Risperidone|risperidone
308606|NCT01624636|Wet AMD|wet amd
308709|NCT01624168|anxiety|anxiety
309031|NCT01622595|CONS|cons
309232|NCT01621659|physiotherapy|physiotherapy
309233|NCT01621659|imaging|imaging
309238|NCT01621633|hepatic impairment|hepatic impairment
309338|NCT01621204|Thrombocytopenia|thrombocytopenia
309435|NCT01620801|FIX|fix
309532|NCT01620164|Parkinson|parkinson
309634|NCT01619774|GSK2118436|gsk2118436
309718|NCT01619605|tryptases|tryptases
309889|NCT01618994|EBL|ebl
310135|NCT01618110|TMS|tms
310318|NCT01617174|prostate|prostate
310630|NCT01615783|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
310631|NCT01615783|Costs|costs
310633|NCT01615783|Medicaid|medicaid
310811|NCT01615055|FDG|fdg
311118|NCT01613716|Vitrectomy|vitrectomy
311225|NCT01613092|Cluster|cluster
311328|NCT01612520|RCT|rct
312132|NCT01609634|Healthy|healthy
312357|NCT01608542|FosD|fosd
312450|NCT01608217|Vascular dementia|vascular dementia
313157|NCT01605019|heart pumps|heart pumps
313475|NCT01603706|CRT|crt
313561|NCT01603303|Surveys|surveys
314001|NCT01601262|ED|ed
314204|NCT01600508|costs|costs
314587|NCT01599078|Restenosis|restenosis
314776|NCT01598285|Genome-Wide|genome-wide
314928|NCT01597622|PGA|pga
315084|NCT01596998|transversus abdominis plane block|transversus abdominis plane block
315085|NCT01596998|Vasoconstrictor Agents|vasoconstrictor agents
315086|NCT01596998|Ultrasonography|ultrasonography
315185|NCT01596699|cell|cell
315186|NCT01596699|transplantation|transplantation
315372|NCT01595945|Gastric bypass|gastric bypass
315763|NCT01594307|BP|bp
316079|NCT01593020|Breast cancer|breast cancer
316385|NCT01591746|Mastectomy|mastectomy
316487|NCT01591252|fracture|fracture
316587|NCT01590732|Lymphoma|lymphoma
316692|NCT01590303|severe sepsis|severe sepsis
316797|NCT01589965|STIs|stis
316904|NCT01589419|DLT|dlt
316983|NCT01588912|roadmap|roadmap
317196|NCT01587820|RADPLAT|radplat
317479|NCT01586533|5-aminosalicylic acid|5-aminosalicylic acid
317777|NCT01585298|MS|ms
317976|NCT01584427|Body composition|body composition
318367|NCT01583205|ALS|als
318478|NCT01582620|rural|rural
318696|NCT01581593|PID|pid
319113|NCT01579942|EEG|eeg
319181|NCT01579565|cataract|cataract
319389|NCT01578629|TIA|tia
319571|NCT01577797|Craving|craving
319676|NCT01577472|IVF|ivf
320147|NCT01575691|Vesanoid|vesanoid
321135|NCT01571518|TAC|tac
321139|NCT01571492|Postoperative Pain|postoperative pain
321140|NCT01571492|Nerve block|nerve block
321141|NCT01571492|Total Hip Arthroplasty|total hip arthroplasty
321142|NCT01571492|Postoperative analgesia|postoperative analgesia
321146|NCT01571479|mini-instrument|mini-instrument
321433|NCT01570322|Dementia - Alzheimer - Quality of life|dementia - alzheimer - quality of life
321434|NCT01570309|vitamin D,|vitamin d,
321435|NCT01570309|vitamin D deficiency|vitamin d deficiency
321937|NCT01568177|MCD|mcd
322029|NCT01567813|Skin diseases|skin diseases
322121|NCT01567306|Allergy|allergy
322508|NCT01565629|Children|children
322892|NCT01564160|EPA|epa
323134|NCT01562730|iECG|iecg
323523|NCT01561066|Fistulas|fistulas
323627|NCT01560650|CRRT|crrt
324220|NCT01558466|INO|ino
324424|NCT01555398|HIP0901|hip0901
324526|NCT01557231|OA|oa
324730|NCT01556295|Low back pain|low back pain
325031|NCT01554683|Seizures|seizures
325339|NCT01553461|Graft Rejection|graft rejection
325533|NCT01552629|QGE031|qge031
325941|NCT01550809|CGM|cgm
326071|NCT01550341|HIV|hiv
326241|NCT01549691|Anxiety|anxiety
326429|NCT01548833|Myopia|myopia
326519|NCT01548534|DHA|dha
326621|NCT01548040|NMES|nmes
327270|NCT01545492|famine|famine
327380|NCT01545141|HIPEC|hipec
327484|NCT01544959|pain|pain
327680|NCT01543841|ANG2|ang2
327681|NCT01543828|COPD|copd
327682|NCT01543828|Indacatarol|indacatarol
327683|NCT01543828|placebo|placebo
327684|NCT01543828|crossover|crossover
327898|NCT01542866|AMD|amd
328020|NCT01542385|PCI|pci
328173|NCT01541683|PEG-electrolyte solution|peg-electrolyte solution
328373|NCT01540786|OAB|oab
328650|NCT01539343|CLABSI|clabsi
328763|NCT01539057|Liver|liver
328856|NCT01538654|Tube feeding|tube feeding
328958|NCT01538407|Strength training|strength training
329448|NCT01535950|wet AMD|wet amd
329855|NCT01534364|diet|diet
330151|NCT01532895|Pain|pain
330351|NCT01531998|LDP-341|ldp-341
330764|NCT01530269|high|high
331163|NCT01528813|Er:YAG|er:yag
331570|NCT01526863|Egg|egg
331655|NCT01526486|urology|urology
331762|NCT01526109|quality of life|quality of life
331865|NCT01525550|sunitinib|sunitinib
332066|NCT01524575|ERCC1|ercc1
332194|NCT01524068|IPF|ipf
332265|NCT01523678|Endometrial Carcinoma|endometrial carcinoma
332266|NCT01523678|Uterine Cervical Cancer|uterine cervical cancer
332267|NCT01523678|Paclitaxel|paclitaxel
332268|NCT01523678|Carboplatin|carboplatin
332269|NCT01523678|Neupogen|neupogen
332463|NCT01522859|COPD|copd
333051|NCT01520311|CABG|cabg
333457|NCT01518790|gatorade|gatorade
333644|NCT01518023|diabetes mellitus|diabetes mellitus
333737|NCT01517685|DHA|dha
333878|NCT01517087|HV|hv
333937|NCT01516931|Relapse|relapse
334033|NCT01516463|minor burn|minor burn
334328|NCT01515059|obesity|obesity
334733|NCT01513096|colonoscopy|colonoscopy
335323|NCT01510938|Prevention|prevention
335724|NCT01509053|Schizophrenia|schizophrenia
335823|NCT01508507|Oral|oral
336151|NCT01507155|MDD|mdd
336594|NCT01505660|HIV|hiv
336638|NCT01505374|Femoral Nerve Block|femoral nerve block
336639|NCT01505374|Saphenous Nerve Block|saphenous nerve block
336640|NCT01505361|probiotic|probiotic
336641|NCT01505361|Lactobacillus salivarius|lactobacillus salivarius
336642|NCT01505361|mastitis|mastitis
336643|NCT01505361|prevention|prevention
336644|NCT01505361|group B streptococci|group b streptococci
336379|NCT01506349|fog|fog
336774|NCT01504867|ALI|ali
337159|NCT01503255|CBT|cbt
337439|NCT01502150|PBT|pbt
337687|NCT01501149|RR|rr
338285|NCT01498523|Glycaemic index|glycaemic index
338613|NCT01497184|DLI|dli
338684|NCT01496898|Vaginal|vaginal
338781|NCT01496508|preterm infants|preterm infants
338877|NCT01495988|Metastatic melanoma|metastatic melanoma
339021|NCT01495481|SVT|svt
339261|NCT01494480|ALS|als
339404|NCT01493973|EPO|epo
339603|NCT01492751|survival|survival
340112|NCT01490879|Diabetic Foot Ulcer|diabetic foot ulcer
340334|NCT01490060|AI|ai
340819|NCT01487993|Obesity|obesity
586646|NCT00517127|Doppler effect|doppler effect
341796|NCT01483898|MSC|msc
342217|NCT01482065|OSA|osa
342297|NCT01481701|Bordet|bordet
342418|NCT01481246|MCI|mci
343097|NCT01478594|AV951|av951
343231|NCT01478152|Asthma|asthma
343404|NCT01477424|PA21|pa21
343942|NCT01475097|Patient|patient
344114|NCT01474382|Safety|safety
344213|NCT01473901|Newly diagnosed|newly diagnosed
344404|NCT01473147|CSII|csii
344828|NCT01471418|TMJ|tmj
344930|NCT01471067|Alkeran|alkeran
345053|NCT01470638|CSF|csf
345338|NCT01469286|nausea|nausea
345484|NCT01468636|HPV|hpv
345639|NCT01468116|Obesity|obesity
346046|NCT01466296|CERBRAL PALSY|cerbral palsy
346117|NCT01466218|OSA|osa
346686|NCT01463839|children|children
346994|NCT01462578|AML|aml
347330|NCT01461187|Vaginal|vaginal
347820|NCT01459185|S-1|s-1
348034|NCT01458223|spine surgery|spine surgery
348035|NCT01458223|postoperative infection|postoperative infection
348036|NCT01458223|postoperative antibiotics|postoperative antibiotics
348037|NCT01458197|Overactive Bladder|overactive bladder
348038|NCT01458197|Tarafenacin|tarafenacin
348039|NCT01458184|risk factors for complications|risk factors for complications
348040|NCT01458184|precarious medical situations|precarious medical situations
348041|NCT01458171|Immune globulin subcutaneous|immune globulin subcutaneous
348042|NCT01458171|SCIG|scig
348044|NCT01458171|PID|pid
348130|NCT01457794|Body Weight|body weight
348234|NCT01457456|Mucopolysaccharidosis IV|mucopolysaccharidosis iv
348235|NCT01457456|Carbohydrate Metabolism, Inborn Errors|carbohydrate metabolism, inborn errors
348236|NCT01457456|Metabolism, Inborn Errors|metabolism, inborn errors
348332|NCT01457027|Virus|virus
348720|NCT01455285|dysmenorrhea|dysmenorrhea
348863|NCT01454700|CGM|cgm
348922|NCT01454440|Eptifibatide|eptifibatide
349031|NCT01453803|ADSC|adsc
349139|NCT01452464|safety|safety
349621|NCT01451632|EGFR|egfr
349721|NCT01451177|Hair Loss|hair loss
349821|NCT01450839|Japanese|japanese
349932|NCT01450332|ACL|acl
350142|NCT01449357|NSCLC|nsclc
350468|NCT01447966|OCD|ocd
350846|NCT01446510|VTE|vte
350940|NCT01446133|Lymphoma|lymphoma
351234|NCT01445132|BCL|bcl
351256|NCT01445080|Solid Tumor|solid tumor
351259|NCT01445080|CML|cml
351359|NCT01444677|Safety|safety
351454|NCT01444352|Pneumococcal Vaccines|pneumococcal vaccines
351455|NCT01444339|Pneumococcal Infections|pneumococcal infections
351456|NCT01444339|Streptococcus Pneumoniae Infections|streptococcus pneumoniae infections
351457|NCT01444339|Pneumococcal Vaccine|pneumococcal vaccine
351943|NCT01442259|safety|safety
352172|NCT01441245|BNP|bnp
352246|NCT01441024|Flu|flu
352648|NCT01439581|hospital|hospital
352752|NCT01439152|mesothelin|mesothelin
352856|NCT01438736|desogestrel predicts|desogestrel predicts
353186|NCT01437475|HIV|hiv
353257|NCT01437085|Needles|needles
353383|NCT01436552|MCI|mci
353652|NCT01435447|safety|safety
354349|NCT01432756|HIV|hiv
354852|NCT01430936|Hypertension|hypertension
355118|NCT01429935|CRP|crp
355143|NCT01429818|glimepiride|glimepiride
355239|NCT01429376|Restriction|restriction
355847|NCT01427049|hypertension|hypertension
355940|NCT01426633|L-sarcomas|l-sarcomas
356448|NCT01424683|VAS|vas
356857|NCT01423006|RFA|rfa
356936|NCT01422590|type 2 diabetes mellitus|type 2 diabetes mellitus
357530|NCT01420523|HIV|hiv
357718|NCT01419769|transluminal drainage|transluminal drainage
358212|NCT01417585|Rehabilitation|rehabilitation
358908|NCT01414725|Balance|balance
359212|NCT01413451|HACA|haca
359497|NCT01412346|blood pressure|blood pressure
359600|NCT01412008|Botox|botox
359696|NCT01411644|early menopause|early menopause
359810|NCT01411189|PEG|peg
360120|NCT01410006|NF1|nf1
360307|NCT01409187|Interferon Apha-2b|interferon apha-2b
360308|NCT01409187|Interleukin-2|interleukin-2
360309|NCT01409187|IL-2|il-2
360310|NCT01409187|Aldesleukin|aldesleukin
360635|NCT01408030|HHT|hht
360890|NCT01407172|PAD|pad
361331|NCT01405391|PM01183|pm01183
361746|NCT01403610|CNS|cns
361906|NCT01403272|fabrics|fabrics
362003|NCT01402856|Adolescent|adolescent
362202|NCT01401777|Kidney Tumors, Cryoablation, Biopsy|kidney tumors, cryoablation, biopsy
362302|NCT01401231|depression|depression
362416|NCT01400737|ibuprofen|ibuprofen
362525|NCT01400321|bone remodelling|bone remodelling
362623|NCT01399918|Kidney|kidney
362720|NCT01399411|Disease Validation|disease validation
362721|NCT01399411|Autoimmune Disorders|autoimmune disorders
362722|NCT01399398|Brain Scan|brain scan
362723|NCT01399398|Kinetic Analysis|kinetic analysis
362724|NCT01399398|Healthy Subjects|healthy subjects
362725|NCT01399398|Healthy Volunteer|healthy volunteer
362726|NCT01399398|HV|hv
362727|NCT01399385|Arteriosclerosis|arteriosclerosis
362728|NCT01399385|Arteriosclerosis, Narrowing of Vessels|arteriosclerosis, narrowing of vessels
362729|NCT01399385|Endothelial Dysfunction|endothelial dysfunction
362730|NCT01399385|Hardening of the arteries|hardening of the arteries
362731|NCT01399385|Noninvasive Plaque Imaging|noninvasive plaque imaging
362732|NCT01399385|Cardiovascular Disease|cardiovascular disease
362806|NCT01399073|hemianopsia|hemianopsia
363012|NCT01398189|PET|pet
363824|NCT01394380|sugar|sugar
364052|NCT01393327|PEA|pea
364233|NCT01392534|Potassium|potassium
364338|NCT01392170|CCyR|ccyr
364540|NCT01391403|Artemisinin|artemisinin
364902|NCT01389830|EOL|eol
365235|NCT01388322|Pregnancy|pregnancy
365428|NCT01387555|viral therapy|viral therapy
365733|NCT01386424|HV|hv
365918|NCT01385475|Physical Function|physical function
366489|NCT01382771|> 6 months duration|> 6 months duration
366730|NCT01381835|HCV|hcv
366876|NCT01381250|Being atleast 18 years old|being atleast 18 years old
367491|NCT01378871|T Cell|t cell
367687|NCT01378078|schizophrenia|schizophrenia
367789|NCT01377558|training|training
367992|NCT01376895|Black MSM/W|black msm/w
368492|NCT01374711|Endotoxin|endotoxin
369490|NCT01370447|MELAS|melas
369694|NCT01369693|Cadmium|cadmium
369794|NCT01369355|UNITI|uniti
369996|NCT01368549|methylcobalamin|methylcobalamin
370265|NCT01367210|HIV|hiv
370999|NCT01364298|Pain|pain
371459|NCT01362452|ALL|all
371614|NCT01361893|SIDS|sids
371807|NCT01361347|desensitization|desensitization
372373|NCT01358734|elderly|elderly
372677|NCT01357447|Cough|cough
372775|NCT01356823|vaccine|vaccine
372874|NCT01356394|Metabolic Syndrome|metabolic syndrome
373357|NCT01354314|MRS|mrs
373492|NCT01353703|combination vaccine|combination vaccine
373591|NCT01353248|HCV|hcv
373892|NCT01352091|AI|ai
374095|NCT01351194|RFA|rfa
374217|NCT01350570|IBS|ibs
374294|NCT01350232|SS disease|ss disease
374393|NCT01349920|endoscopy|endoscopy
374497|NCT01349543|Viral infection|viral infection
374498|NCT01349543|Bronchiolitis|bronchiolitis
374499|NCT01349543|Viral challenge|viral challenge
374507|NCT01349491|Ranolazine|ranolazine
374794|NCT01348451|ALS|als
375190|NCT01346930|IPF|ipf
375283|NCT01346618|children|children
375457|NCT01345812|ART|art
375487|NCT01345708|CHD|chd
375870|NCT01344213|Pregabalin|pregabalin
376303|NCT01342224|cancer|cancer
395898|NCT01260350|HCV|hcv
395968|NCT01260103|Antineoplastons|antineoplastons
376375|NCT01341834|Nasopharyngeal carcinoma, antiangiogenesis, HDACi, mTOR, Phase Ib|nasopharyngeal carcinoma, antiangiogenesis, hdaci, mtor, phase ib
376376|NCT01341821|Leadership Style|leadership style
376477|NCT01341314|joint pain|joint pain
376478|NCT01341314|stiffness|stiffness
376479|NCT01341301|allogeneic stem cell transplant|allogeneic stem cell transplant
376480|NCT01341301|TJU 2 Step|tju 2 step
376570|NCT01341028|weight loss|weight loss
376666|NCT01340651|myelofibrosis|myelofibrosis
377153|NCT01338636|ambrisentan|ambrisentan
377354|NCT01337739|Dexmedetomidine|dexmedetomidine
377659|NCT01336595|cobalt chrome|cobalt chrome
377762|NCT01336153|Efficacy|efficacy
377960|NCT01335243|CT Scan|ct scan
378065|NCT01334827|topical microbicide|topical microbicide
378150|NCT01334450|Improvement of ADAS-COG|improvement of adas-cog
378151|NCT01334437|blood test|blood test
378243|NCT01334190|safety|safety
378357|NCT01333657|sTREM-1|strem-1
378544|NCT01332786|AML|aml
378769|NCT01331811|HIV|hiv
378953|NCT01331057|Transmissions mother|transmissions mother
379054|NCT01330641|Tendonitis|tendonitis
379301|NCT01329523|IGF|igf
379555|NCT01328457|Leishmaniasis, Visceral|leishmaniasis, visceral
379681|NCT01327898|MSM|msm
379754|NCT01327612|mFOLFOX6|mfolfox6
379854|NCT01327248|Blood|blood
380221|NCT01325779|DVT|dvt
380256|NCT01325558|cancer|cancer
380355|NCT01325077|pain|pain
380451|NCT01324765|Women|women
380567|NCT01324245|Salt|salt
380658|NCT01323712|CKD|ckd
380857|NCT01323010|asthma|asthma
380989|NCT01322555|ASD|asd
381669|NCT01319799|Aorta|aorta
382041|NCT01318044|sedation|sedation
382271|NCT01317004|TSQM-9|tsqm-9
382544|NCT01316588|SSI|ssi
382844|NCT01315405|Apathy|apathy
383026|NCT01314586|flaxseed|flaxseed
383125|NCT01314209|dexmedetomidine|dexmedetomidine
383410|NCT01312948|OSA|osa
383593|NCT01312168|Vascular function|vascular function
384090|NCT01310088|PWV|pwv
384189|NCT01309659|UAE|uae
384675|NCT01307436|DTP Vaccine|dtp vaccine
385082|NCT01306019|SCID|scid
385174|NCT01305707|Efficacy|efficacy
385599|NCT01303900|Hypertension|hypertension
385600|NCT01303900|Hypercholesterolaemia|hypercholesterolaemia
385601|NCT01303900|Diabetes|diabetes
385894|NCT01302795|Canakinumab|canakinumab
386092|NCT01302080|long-term impact|long-term impact
386579|NCT01299909|Mindfulness|mindfulness
386781|NCT01299077|Methycobal|methycobal
386967|NCT01298076|Laser|laser
387093|NCT01297569|DME|dme
387161|NCT01297309|PTH 1-84|pth 1-84
387365|NCT01296425|Saizen|saizen
387833|NCT01294683|LDL|ldl
388154|NCT01293344|Men|men
388248|NCT01292967|cocoa|cocoa
389086|NCT01289665|gel|gel
389446|NCT01288248|Airway|airway
389502|NCT01288066|Glenoid|glenoid
389598|NCT01287572|TcCO2|tcco2
389696|NCT01287156|TBI|tbi
389787|NCT01286831|Beta-2 agonist|beta-2 agonist
390084|NCT01285492|QVA149|qva149
390394|NCT01284036|safety|safety
390610|NCT01282918|ICD|icd
390690|NCT01282476|LBH-589 (Panobinostat)|lbh-589 (panobinostat)
390691|NCT01282476|HDAC inhibitor (Histone deacetylase inhibitor)|hdac inhibitor (histone deacetylase inhibitor)
402069|NCT01233271|tight glycemic control|tight glycemic control
390692|NCT01282476|DAC inhibitor (deacetylase inhibitor)|dac inhibitor (deacetylase inhibitor)
390796|NCT01281995|HV|hv
390877|NCT01281566|Enteral feeding|enteral feeding
391167|NCT01280110|cornea|cornea
391485|NCT01278771|CHD|chd
391559|NCT01278446|CMA|cma
391752|NCT01277744|DSRCT|dsrct
600685|NCT00583128|IBS|ibs
392137|NCT01276145|cardiac|cardiac
392267|NCT01275586|NF1|nf1
392420|NCT01275027|diabetes|diabetes
392626|NCT01274247|Tongue-tie|tongue-tie
392921|NCT01273155|Solid Tumor|solid tumor
393175|NCT01272271|Infection|infection
393581|NCT01270490|candidemia|candidemia
393582|NCT01270490|candida sepsis|candida sepsis
393583|NCT01270490|invasive fungal disease|invasive fungal disease
393592|NCT01270412|PRP|prp
393670|NCT01270139|stenting|stenting
394083|NCT01268397|elderly|elderly
394675|NCT01265927|Breast Cancer|breast cancer
394776|NCT01265407|Hemoglobinopathies|hemoglobinopathies
395281|NCT01263067|PTSD|ptsd
395486|NCT01262222|10-206|10-206
395694|NCT01261312|SGI-110|sgi-110
395781|NCT01260974|Fungus Diseases|fungus diseases
395782|NCT01260974|Antifungal Agents|antifungal agents
395783|NCT01260974|Invasive Mycosis|invasive mycosis
395784|NCT01260948|Bioequivalence|bioequivalence
395785|NCT01260948|Healthy Subjects|healthy subjects
395786|NCT01260935|GERD|gerd
395787|NCT01260935|laparoscopic surgery|laparoscopic surgery
395788|NCT01260935|gastroesophageal|gastroesophageal
395789|NCT01260935|reflux|reflux
395790|NCT01260922|Bioequivalence|bioequivalence
395791|NCT01260922|Healthy Subjects|healthy subjects
395792|NCT01260896|Bioequivalence|bioequivalence
395793|NCT01260896|Healthy Subjects|healthy subjects
395794|NCT01260883|ketorolac pharmacokinetics|ketorolac pharmacokinetics
395795|NCT01260883|ketorolac stereo-isomers|ketorolac stereo-isomers
395796|NCT01260883|infants|infants
395798|NCT01260883|safety|safety
395969|NCT01260103|ANP therapy|anp therapy
395970|NCT01260103|Atengenal (A10)|atengenal (a10)
395971|NCT01260103|Astugenal (AS2-1)|astugenal (as2-1)
395972|NCT01260090|Minimally conscious states|minimally conscious states
396255|NCT01259102|Opioid|opioid
396354|NCT01258582|HIV|hiv
396544|NCT01257893|migraine with aura|migraine with aura
397167|NCT01254669|Haitian girls, African American girls|haitian girls, african american girls
397168|NCT01254669|Brief Negotiated Interview|brief negotiated interview
397245|NCT01254513|castration-resistant|castration-resistant
397246|NCT01254500|patients with brain lesions|patients with brain lesions
397247|NCT01254474|Depolarization, tissue|depolarization, tissue
397248|NCT01254474|Repolarization, tissue|repolarization, tissue
397249|NCT01254474|Cardiac Arrhythmias|cardiac arrhythmias
397636|NCT01252589|Questionnaire|questionnaire
398032|NCT01250626|Inulin|inulin
398126|NCT01250223|Data Collection|data collection
398511|NCT01248416|GH|gh
398521|NCT01248377|Drug hypersensitivity|drug hypersensitivity
398617|NCT01247922|Tarceva|tarceva
398808|NCT01247181|AIDS|aids
399606|NCT01243281|HBeAg|hbeag
399771|NCT01242540|Pain|pain
399877|NCT01242111|ERT|ert
400075|NCT01241357|Iron|iron
400165|NCT01240967|healthy volunteers|healthy volunteers
400971|NCT01237743|Aorta|aorta
401571|NCT01235364|labour|labour
401756|NCT01232647|osteoporosis|osteoporosis
401953|NCT01232608|Inflammation|inflammation
402421|NCT01231503|EPI|epi
402459|NCT01231204|Breast Cancer|breast cancer
402759|NCT01229813|Untreated|untreated
402865|NCT01229436|injection|injection
402960|NCT01228851|H&Y 2.5-3|h&y 2.5-3
402961|NCT01228838|postherpetic neuralgia|postherpetic neuralgia
402962|NCT01228838|PHN|phn
503390|NCT00213382|EMG|emg
402963|NCT01228838|capsaicin|capsaicin
402964|NCT01228838|herpes zoster|herpes zoster
402965|NCT01228838|shingles|shingles
402966|NCT01228838|analgesics|analgesics
402967|NCT01228838|neuropathy|neuropathy
402968|NCT01228825|Cardiac surgery|cardiac surgery
402969|NCT01228825|Cardiopulmonary bypass|cardiopulmonary bypass
403140|NCT01227941|Doxil|doxil
503700|NCT00205725|BMI|bmi
403321|NCT01226992|Fever|fever
403414|NCT01226602|Ticagrelor|ticagrelor
403520|NCT01226147|SLE|sle
403807|NCT01224639|TDV|tdv
403901|NCT01224249|Bioavailability|bioavailability
404320|NCT01222676|stage IV bladder cancer|stage iv bladder cancer
404494|NCT01221740|QST|qst
404585|NCT01221363|Obesity|obesity
404687|NCT01220908|LVRS (Lung Volume Reduction Surgery)|lvrs (lung volume reduction surgery)
404688|NCT01220908|LVRC (Lung Volume Reduction Coil)|lvrc (lung volume reduction coil)
404689|NCT01220908|Emphysema|emphysema
404690|NCT01220908|coil|coil
404691|NCT01220908|RePneu|repneu
404692|NCT01220895|Adoptive cellular therapy|adoptive cellular therapy
404879|NCT01220128|adult|adult
405173|NCT01218867|Metastatic Cancer|metastatic cancer
405269|NCT01218308|Influenza|influenza
405370|NCT01217944|verteporfin PDT|verteporfin pdt
405877|NCT01215851|EBA|eba
406156|NCT01213641|NALP3|nalp3
406350|NCT01213875|nursing|nursing
406739|NCT01212094|MS|ms
407527|NCT01208740|IVF|ivf
407629|NCT01208311|hepatitis c cirrhosis|hepatitis c cirrhosis
407836|NCT01207388|MRD|mrd
407940|NCT01205919|CBT|cbt
408125|NCT01206270|Klinefelter|klinefelter
408416|NCT01204801|Thermotherapy|thermotherapy
408417|NCT01204801|Fever Therapy|fever therapy
408418|NCT01204801|Hot Temperature|hot temperature
408419|NCT01204801|Hyperthermia|hyperthermia
408420|NCT01204801|Hyperthermia, Therapeutic|hyperthermia, therapeutic
408889|NCT01203098|prevention|prevention
409295|NCT01201551|Alphagan|alphagan
409780|NCT01199744|SSMP|ssmp
410104|NCT01198327|RVO|rvo
410184|NCT01197950|acupuncture|acupuncture
410285|NCT01197443|parent modeling|parent modeling
410476|NCT01196689|Asthma|asthma
410622|NCT01196130|CRC|crc
410671|NCT01195857|Rebif|rebif
410803|NCT01195220|HIV|hiv
410869|NCT01194999|UUI|uui
410970|NCT01194674|Uveitis|uveitis
411169|NCT01193530|Anxiety|anxiety
411263|NCT01193192|Neevo|neevo
411363|NCT01192919|NSCLC|nsclc
411551|NCT01192230|toxicity|toxicity
411650|NCT01191918|donepezil|donepezil
411778|NCT01191424|PK|pk
412221|NCT01189526|macular edema|macular edema
412615|NCT01187719|pregnancy|pregnancy
412711|NCT01187277|stroke|stroke
413012|NCT01186185|sudden|sudden
413609|NCT01183780|FOLFIRI|folfiri
413823|NCT01182909|NPC|npc
414105|NCT01181752|Ghana|ghana
414196|NCT01181440|Dermagraft|dermagraft
414293|NCT01181102|Enoxaparin sodium|enoxaparin sodium
414497|NCT01180270|SVV|svv
415308|NCT00000633|HIV-1|hiv-1
415361|NCT00000639|Flucytosine|flucytosine
416086|NCT00000768|Colitis|colitis
416273|NCT00000801|Cytarabine|cytarabine
416452|NCT00000834|Anti-Inflammatory Agents|anti-inflammatory agents
416546|NCT00000851|Stavudine|stavudine
417132|NCT00000932|Viral Load|viral load
417304|NCT00000401|RA|ra
417417|NCT00000415|Placebo|placebo
417808|NCT00001119|Antibody Formation|antibody formation
418009|NCT00001156|Twins|twins
418204|NCT00001188|Sarcoma|sarcoma
418426|NCT00001233|Adolescence|adolescence
418427|NCT00001233|Aggressivity|aggressivity
418428|NCT00001233|Anger|anger
418732|NCT00001303|Endotoxin Tolerance|endotoxin tolerance
418733|NCT00001303|Bronchoscopy|bronchoscopy
418734|NCT00001303|Human Recombinant Interleukin-1 Receptor|human recombinant interleukin-1 receptor
418735|NCT00001303|Normal Volunteer|normal volunteer
418736|NCT00001304|Hypoparathyroidism|hypoparathyroidism
418737|NCT00001304|Parathyroid Hormone|parathyroid hormone
418738|NCT00001304|Vitamin D|vitamin d
418739|NCT00001304|Calcium Metabolism|calcium metabolism
418920|NCT00000753|Zidovudine|zidovudine
419113|NCT00001356|Cytokines|cytokines
419322|NCT00001432|Purging|purging
419626|NCT00001491|Fabry Disease|fabry disease
419731|NCT00001520|Paralysis|paralysis
419831|NCT00001538|Plasmid|plasmid
420140|NCT00001605|Normal Volunteers|normal volunteers
419883|NCT00001546|EEG|eeg
420333|NCT00000998|Folic Acid Antagonists|folic acid antagonists
420512|NCT00001022|Zidovudine|zidovudine
420693|NCT00001053|p24-VLP vaccine|p24-vlp vaccine
420984|NCT00001096|HIV-1|hiv-1
752075|NCT01171664|SAR|sar
421557|NCT00002083|HIV-1|hiv-1
421716|NCT00002120|Trimetrexate|trimetrexate
421992|NCT00002174|Cytokines|cytokines
422099|NCT00002189|Paclitaxel|paclitaxel
422293|NCT00001386|AIDS|aids
422786|NCT00002289|Semen|semen
422971|NCT00002325|Mycoses|mycoses
423233|NCT00002378|Anti-HIV Agents|anti-hiv agents
424175|NCT00001919|SPECT|spect
424176|NCT00001919|Brain Disorders|brain disorders
424177|NCT00001920|Schizophrenia|schizophrenia
424178|NCT00001920|Eyeblink|eyeblink
424179|NCT00001920|Evoked Potentials|evoked potentials
424180|NCT00001920|Learning|learning
424181|NCT00001920|Normal Volunteer|normal volunteer
424284|NCT00001944|Pgp|pgp
424375|NCT00001962|T-cells|t-cells
424760|NCT00002452|Viral Load|viral load
424832|NCT00002466|localized osteosarcoma|localized osteosarcoma
425032|NCT00002485|childhood teratoma|childhood teratoma
531234|NCT00317538|MRI|mri
425220|NCT00002503|bone metastases|bone metastases
427019|NCT00001685|IL-12|il-12
584768|NCT00509769|MBC|mbc
427020|NCT00001685|IL-2|il-2
425757|NCT00002546|uterine carcinosarcoma|uterine carcinosarcoma
427022|NCT00001685|Vaccine|vaccine
426360|NCT00002641|ovarian sarcoma|ovarian sarcoma
426885|NCT00001658|Amoxicillin|amoxicillin
533805|NCT00334074|AML|aml
426551|NCT00002658|neutropenia|neutropenia
583281|NCT00511134|insomnia|insomnia
426901|NCT00001661|Use|use
427207|NCT00001730|Ablation|ablation
427310|NCT00001750|Cell-Cycle|cell-cycle
427678|NCT00002753|adult glioblastoma|adult glioblastoma
441514|NCT00005764|Didanosine|didanosine
427755|NCT00002759|neutropenia|neutropenia
427782|NCT00002762|stage II breast cancer|stage ii breast cancer
428053|NCT00002824|adult glioblastoma|adult glioblastoma
428422|NCT00002900|cardiac toxicity|cardiac toxicity
444246|NCT00006301|PCR|pcr
428848|NCT00002442|Anti-HIV Agents|anti-hiv agents
428999|NCT00002977|Brenner tumor|brenner tumor
539060|NCT00352456|HV|hv
753428|NCT01179230|CAD|cad
430004|NCT00003483|adult meningioma|adult meningioma
430656|NCT00003569|neurotoxicity|neurotoxicity
430745|NCT00003574|adult glioblastoma|adult glioblastoma
430904|NCT00003598|cervical cancer|cervical cancer
584783|NCT00509847|Bacteraemia|bacteraemia
451835|NCT00019578|cancer|cancer
431793|NCT00003805|infection|infection
431963|NCT00003816|aplastic anemia|aplastic anemia
454266|NCT00025857|fMRI|fmri
432350|NCT00003883|infection|infection
432385|NCT00003884|bone metastases|bone metastases
584787|NCT00509860|CPT-11|cpt-11
432653|NCT00002996|pain|pain
432725|NCT00003022|retinoblastoma|retinoblastoma
432781|NCT00003027|stage IV melanoma|stage iv melanoma
454269|NCT00025857|Emotion|emotion
433189|NCT00003232|pain|pain
433380|NCT00003266|fatigue|fatigue
584793|NCT00509951|Neuroses|neuroses
433960|NCT00003336|refractory anemia|refractory anemia
583293|NCT00511186|Sepsis|sepsis
584799|NCT00509951|Phobias|phobias
583296|NCT00511186|infection|infection
436104|NCT00004234|oral complications|oral complications
436754|NCT00003057|colon cancer|colon cancer
436922|NCT00003084|Doxorubicin|doxorubicin
437121|NCT00003107|ovarian yolk sac tumor|ovarian yolk sac tumor
437685|NCT00003657|ovarian sarcoma|ovarian sarcoma
438150|NCT00004788|porphyria|porphyria
438472|NCT00004875|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
438473|NCT00004875|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
438474|NCT00004875|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
438475|NCT00004875|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
438476|NCT00004875|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
438526|NCT00004875|thromboembolism|thromboembolism
438782|NCT00004904|polycythemia vera|polycythemia vera
459735|NCT00031408|Blood|blood
439159|NCT00003926|teratoma|teratoma
439248|NCT00003938|primary myelofibrosis|primary myelofibrosis
440606|NCT00005002|HIV-1|hiv-1
439419|NCT00003939|ovarian sarcoma|ovarian sarcoma
439828|NCT00004024|adult oligodendroglioma|adult oligodendroglioma
440334|NCT00004065|ovarian sarcoma|ovarian sarcoma
440562|NCT00004997|Anemia|anemia
440916|NCT00004426|hypogonadism|hypogonadism
441370|NCT00004647|pain|pain
441526|NCT00005766|ALS|als
441718|NCT00005796|adult ependymoma|adult ependymoma
441770|NCT00005798|stage II breast cancer|stage ii breast cancer
442447|NCT00005860|regional neuroblastoma|regional neuroblastoma
562571|NCT00439075|CPO|cpo
442594|NCT00005878|esophageal cancer|esophageal cancer
442671|NCT00005892|leukemia|leukemia
442849|NCT00005925|Brain Catheter|brain catheter
442830|NCT00005920|MK 0991|mk 0991
583563|NCT00512213|complication|complication
445386|NCT00005572|Anti-HIV Agents|anti-hiv agents
444079|NCT00006253|cancer|cancer
444357|NCT00006339|Stavudine|stavudine
469708|NCT00068471|infection|infection
469709|NCT00068471|neutropenia|neutropenia
445185|NCT00005021|intraocular lymphoma|intraocular lymphoma
445529|NCT00005590|infection|infection
446350|NCT00006494|AIDS|aids
446754|NCT00007241|OA|oa
446882|NCT00007670|Carbamazepine|carbamazepine
447092|NCT00008034|stage II breast cancer|stage ii breast cancer
570446|NCT00464633|CLL|cll
470242|NCT00063674|exercise|exercise
447796|NCT00008476|Capsaicin|capsaicin
448958|NCT00006143|serostim|serostim
448077|NCT00006034|stage 0 bladder cancer|stage 0 bladder cancer
448422|NCT00006070|Pain|pain
470244|NCT00063674|dance|dance
448823|NCT00006108|stage IV breast cancer|stage iv breast cancer
448904|NCT00006126|stage IV melanoma|stage iv melanoma
449260|NCT00008554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
449261|NCT00008554|Anti-HIV Agents|anti-hiv agents
449262|NCT00008554|abacavir|abacavir
449263|NCT00008697|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
449264|NCT00008697|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
449267|NCT00008736|Feeding intolerance|feeding intolerance
449362|NCT00014300|adult glioblastoma|adult glioblastoma
449482|NCT00014391|infection|infection
449561|NCT00014456|ovarian sarcoma|ovarian sarcoma
449820|NCT00014794|PET Scan|pet scan
449914|NCT00015444|Isaacs Syndrome|isaacs syndrome
450230|NCT00016263|stage III melanoma|stage iii melanoma
450395|NCT00016666|HV|hv
450352|NCT00016549|IBC|ibc
450627|NCT00006443|T-Lymphocytes|t-lymphocytes
583585|NCT00512291|Hyperactive Delirium|hyperactive delirium
450851|NCT00017355|stage IV melanoma|stage iv melanoma
450990|NCT00017927|IGF-1|igf-1
451058|NCT00018044|NTM|ntm
451152|NCT00018616|compliance|compliance
451715|NCT00019448|adult solid tumor|adult solid tumor
451807|NCT00019539|cancer|cancer
579587|NCT00501644|QOL|qol
452788|NCT00009542|Caffeine|caffeine
452905|NCT00009854|adult glioblastoma|adult glioblastoma
453038|NCT00011856|Genetics|genetics
453199|NCT00012428|Prenatal exposure|prenatal exposure
453350|NCT00013611|HIV|hiv
453379|NCT00013663|HIV Therapeutic Vaccine|hiv therapeutic vaccine
453482|NCT00013949|Cardiac|cardiac
471792|NCT00076102|Side Effect|side effect
453839|NCT00024622|Genetic|genetic
454186|NCT00025701|Inhibition|inhibition
454264|NCT00025844|HV|hv
471895|NCT00076427|Virology|virology
454716|NCT00026884|Molecular Basis|molecular basis
454717|NCT00026884|Genome Sequencing|genome sequencing
454718|NCT00026897|Adoptive Immunotherapy|adoptive immunotherapy
454719|NCT00026897|Cellular Therapy|cellular therapy
454720|NCT00026897|Lymphocyte Migration|lymphocyte migration
454721|NCT00026897|Tumor Imaging|tumor imaging
455246|NCT00011258|stroke|stroke
455432|NCT00017771|Viral Load|viral load
455533|NCT00027261|HIV-1|hiv-1
474392|NCT00083382|Aredia|aredia
456112|NCT00028574|hot flashes|hot flashes
456229|NCT00028951|lymphedema|lymphedema
456245|NCT00029029|bone metastases|bone metastases
456362|NCT00029341|Genotype|genotype
456623|NCT00030160|Exercise|exercise
586164|NCT00523705|PMS|pms
456979|NCT00022516|stroma|stroma
457238|NCT00023088|Functional Level|functional level
458233|NCT00038142|Ewing's Sarcoma|ewing's sarcoma
458346|NCT00038558|Adriamycin|adriamycin
458449|NCT00038805|CMML|cmml
458778|NCT00039611|stage IV colon cancer|stage iv colon cancer
458957|NCT00041925|neointimal hyperplasia|neointimal hyperplasia
459063|NCT00042250|G1|g1
459170|NCT00042679|Adenocarcinoma|adenocarcinoma
459207|NCT00042848|fatigue|fatigue
459693|NCT00031317|Depression|depression
459877|NCT00031915|metastatic osteosarcoma|metastatic osteosarcoma
460098|NCT00032513|Virus|virus
460574|NCT00034398|HV|hv
460664|NCT00034749|Schizophrenia|schizophrenia
460977|NCT00036400|Rectal Cancer|rectal cancer
461163|NCT00043888|HIV|hiv
461273|NCT00046254|fracture|fracture
461385|NCT00046722|HIV|hiv
461691|NCT00047541|POAG|poag
461692|NCT00047554|open-angle|open-angle
461975|NCT00048880|Cancer|cancer
462402|NCT00040833|pain|pain
583605|NCT00512369|Monocyte Function|monocyte function
462666|NCT00049231|cervical adenocarcinoma|cervical adenocarcinoma
462836|NCT00051077|Hepatitis C|hepatitis c
463046|NCT00052026|Female|female
463283|NCT00052962|Carcinomatosis|carcinomatosis
583608|NCT00512382|ASHTMA|ashtma
463581|NCT00053443|Adherence|adherence
463750|NCT00044291|recurrent breast cancer|recurrent breast cancer
583611|NCT00512382|PH-IMPEDANCE|ph-impedance
464338|NCT00045838|Healthy|healthy
464512|NCT00054002|epithelial mesothelioma|epithelial mesothelioma
464633|NCT00055991|breast cancer|breast cancer
464806|NCT00056576|AED|aed
465038|NCT00057408|Autism|autism
465250|NCT00058279|iris melanoma|iris melanoma
466045|NCT00050908|Brachial Artery|brachial artery
465960|NCT00050635|CTID|ctid
466063|NCT00050921|Cell Division|cell division
466179|NCT00059046|Kinetic Analysis|kinetic analysis
466180|NCT00059046|Test/Retest|test/retest
466181|NCT00059046|Healthy Volunteer|healthy volunteer
466182|NCT00059046|HV|hv
466183|NCT00060268|recurrent esophageal cancer|recurrent esophageal cancer
466184|NCT00060268|stage I esophageal cancer|stage i esophageal cancer
466471|NCT00061087|Treatment|treatment
466803|NCT00062231|infection|infection
583722|NCT00506480|Endometrium|endometrium
467097|NCT00062517|GAD|gad
467128|NCT00062595|Bone turnover|bone turnover
467232|NCT00054327|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
467233|NCT00054327|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
467234|NCT00054327|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
467246|NCT00054327|refractory anemia|refractory anemia
467304|NCT00054470|male breast cancer|male breast cancer
467385|NCT00054756|HV|hv
467601|NCT00055445|Silybin|silybin
467645|NCT00055588|HV|hv
467947|NCT00064181|stage IV colon cancer|stage iv colon cancer
468237|NCT00064909|Perfusion|perfusion
468238|NCT00064909|Imaging|imaging
468239|NCT00064909|Cerebral Blood Flow|cerebral blood flow
468240|NCT00064909|Cerebral Blood Volume|cerebral blood volume
468241|NCT00064909|CO2 Inhalation|co2 inhalation
468242|NCT00064909|Contrast Agent|contrast agent
468548|NCT00065897|Prenatal diagnosis|prenatal diagnosis
468616|NCT00066183|FGF-23|fgf-23
468897|NCT00059618|MLN341|mln341
469379|NCT00066690|tamoxifen|tamoxifen
469422|NCT00067405|IVMT|ivmt
469517|NCT00067769|Web|web
469575|NCT00068068|Litx™|litx™
469673|NCT00068328|stage II breast cancer|stage ii breast cancer
470179|NCT00063284|Electrical Stimulation|electrical stimulation
470534|NCT00071734|HV|hv
470712|NCT00072488|disseminated neuroblastoma|disseminated neuroblastoma
470808|NCT00072735|HV|hv
471163|NCT00074074|refractory anemia|refractory anemia
471402|NCT00074360|Ethanol|ethanol
471710|NCT00075842|fatigue|fatigue
471823|NCT00076219|Hemodialysis|hemodialysis
471929|NCT00076505|Parkinson Disease|parkinson disease
472038|NCT00076843|HAM/TSP|ham/tsp
472223|NCT00070577|Alcohol|alcohol
472386|NCT00071214|Staphylococcus|staphylococcus
472568|NCT00078234|Genta|genta
472770|NCT00078845|stage IV breast cancer|stage iv breast cancer
473149|NCT00079807|ALA|ala
473259|NCT00080275|Statin|statin
473523|NCT00074672|Dopamine|dopamine
473597|NCT00080938|adenosquamous cell lung cancer|adenosquamous cell lung cancer
473677|NCT00081783|T Cells|t cells
473760|NCT00081926|CML|cml
473967|NCT00082550|Genetics|genetics
474527|NCT00083707|Waldenstrom|waldenstrom
474716|NCT00077896|Treatment|treatment
474819|NCT00084656|iris melanoma|iris melanoma
474992|NCT00085657|Stroke|stroke
475037|NCT00085748|geriatric|geriatric
475135|NCT00086060|fMRI|fmri
475239|NCT00086476|SAC|sac
475454|NCT00087529|Rituxan|rituxan
475495|NCT00081354|SNP's|snp's
475954|NCT00091533|HV|hv
475978|NCT00091676|tumor-derived|tumor-derived
476632|NCT00096525|recurrent renal cell cancer|recurrent renal cell cancer
476748|NCT00097045|HCV|hcv
476851|NCT00097292|T1D|t1d
477587|NCT00089596|AML|aml
477843|NCT00098072|HV|hv
477893|NCT00100698|HIV|hiv
478138|NCT00101777|Children|children
478227|NCT00101972|recurrent salivary gland cancer|recurrent salivary gland cancer
478228|NCT00101972|recurrent small intestine cancer|recurrent small intestine cancer
478229|NCT00101972|recurrent vaginal cancer|recurrent vaginal cancer
478230|NCT00101972|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
478535|NCT00102960|Perinatal|perinatal
478614|NCT00093288|MDD|mdd
478687|NCT00093561|prostate cancer|prostate cancer
479313|NCT00104403|Vomiting|vomiting
479578|NCT00105066|HDL|hdl
480038|NCT00098683|refractory anemia|refractory anemia
480466|NCT00100204|HV|hv
480565|NCT00100542|Child|child
480661|NCT00109369|Guideline Adherence|guideline adherence
481256|NCT00110448|aspirin|aspirin
481557|NCT00111514|Subunit vaccine|subunit vaccine
482085|NCT00115193|NHL|nhl
482154|NCT00115401|Joint Inmpairment|joint inmpairment
482352|NCT00116103|Antiasthmatic agents|antiasthmatic agents
482453|NCT00116467|AML|aml
482554|NCT00106795|Fatigue|fatigue
482658|NCT00107159|recurrent melanoma|recurrent melanoma
482812|NCT00107718|IL-18|il-18
482915|NCT00108069|Malignant Glioma|malignant glioma
483228|NCT00109291|anemia|anemia
483337|NCT00117039|clinical trial|clinical trial
483429|NCT00118378|AIDS|aids
483644|NCT00119093|HIV|hiv
483778|NCT00119678|SLE|sle
483931|NCT00120354|Hepatitis B Virus|hepatitis b virus
484030|NCT00112216|Vaccination|vaccination
484143|NCT00112593|Lymphoma|lymphoma
484456|NCT00113659|Asthma|asthma
484552|NCT00113997|Pharmacodynamics|pharmacodynamics
484715|NCT00120874|memantine|memantine
484984|NCT00122226|HIV|hiv
485393|NCT00123877|Breast|breast
486999|NCT00130234|hives|hives
485582|NCT00117702|GvHD|gvhd
485773|NCT00124267|malaria|malaria
485887|NCT00125060|MRI|mri
485969|NCT00125359|tarceva|tarceva
486163|NCT00126035|Device|device
486253|NCT00126321|AML, relapsed|aml, relapsed
486641|NCT00127452|DHA|dha
487201|NCT00131014|Genetics|genetics
487394|NCT00124488|conformal|conformal
487501|NCT00131950|breast cancer|breast cancer
488089|NCT00134394|psoriasis|psoriasis
488161|NCT00134667|Macugen|macugen
488047|NCT00134056|bone metastases|bone metastases
488251|NCT00127725|non-union|non-union
489223|NCT00132093|Eplerenone|eplerenone
489750|NCT00142597|PET|pet
490274|NCT00136929|AMI|ami
490364|NCT00143728|HIV|hiv
490565|NCT00145015|Fish|fish
490859|NCT00140400|GVAX|gvax
492132|NCT00147082|neutrophil|neutrophil
492539|NCT00148759|Lopinavir/ritonavir|lopinavir/ritonavir
493040|NCT00158405|HIV|hiv
493354|NCT00146679|ICD|icd
493414|NCT00152295|asoprisnil|asoprisnil
493709|NCT00160082|PPS|pps
493799|NCT00160563|Pediatry|pediatry
493913|NCT00161135|MRI|mri
494175|NCT00161226|endometrial cancer|endometrial cancer
494275|NCT00161980|Seroma|seroma
494673|NCT00164541|dating violence|dating violence
495080|NCT00168519|Blood Glucose|blood glucose
495289|NCT00169273|Obesity|obesity
495392|NCT00169741|Nephrolithiasis|nephrolithiasis
495598|NCT00162968|pain|pain
495664|NCT00170716|Rehabilitation|rehabilitation
495797|NCT00174954|MRI|mri
495986|NCT00175760|TTG|ttg
496051|NCT00176046|mistletoe|mistletoe
496213|NCT00166660|MRI|mri
496345|NCT00167232|naltrexone|naltrexone
496643|NCT00176514|mucositis|mucositis
496719|NCT00177268|Mycosis Fungoides|mycosis fungoides
496836|NCT00178022|tbi|tbi
497025|NCT00178880|MRI|mri
497223|NCT00171821|Thalassemia|thalassemia
497531|NCT00173277|colonoscopy|colonoscopy
498059|NCT00182247|DVT|dvt
498220|NCT00182845|dementia|dementia
498314|NCT00183131|Alcohol consumption|alcohol consumption
498485|NCT00171223|CML|cml
498711|NCT00188942|Mood Disorders|mood disorders
498934|NCT00189904|HIV|hiv
499210|NCT00180206|Hip|hip
499421|NCT00194961|leptin|leptin
499767|NCT00183781|HIV|hiv
499837|NCT00184288|Lipid|lipid
500400|NCT00188734|Lung Cancer|lung cancer
500592|NCT00199329|ondansetron|ondansetron
501096|NCT00192738|patients' satisfaction|patients' satisfaction
501288|NCT00194025|Valproate|valproate
501496|NCT00202735|anterior|anterior
501904|NCT00186030|PTSD|ptsd
502011|NCT00197561|HIV|hiv
502393|NCT00209599|Colonoscopy|colonoscopy
502794|NCT00211133|Survival|survival
503000|NCT00201955|dry eye|dry eye
503232|NCT00212888|HIV|hiv
503301|NCT00213083|prevention|prevention
503495|NCT00213889|twist|twist
503989|NCT00207753|trichuris|trichuris
504194|NCT00208702|Mental Health|mental health
504498|NCT00216515|galantamine|galantamine
504499|NCT00216515|attention|attention
504500|NCT00216515|executive function|executive function
504501|NCT00216528|Schizophrenia|schizophrenia
505081|NCT00221702|Safety|safety
505174|NCT00222053|Maintenance therapy|maintenance therapy
505271|NCT00222469|bevacizumab|bevacizumab
505368|NCT00222872|Hormone|hormone
506070|NCT00227032|adult gliosarcoma|adult gliosarcoma
506442|NCT00219349|Escitalopram|escitalopram
506536|NCT00219869|Headache|headache
507033|NCT00229593|Nestorone|nestorone
507233|NCT00230568|Hispanic|hispanic
507557|NCT00218894|Effect|effect
507718|NCT00225004|BMD|bmd
507951|NCT00231868|UPSC|upsc
508337|NCT00234793|cope|cope
508383|NCT00234975|HIV|hiv
509043|NCT00237471|Hyperglycaemia|hyperglycaemia
509369|NCT00238355|infection|infection
509627|NCT00238810|BNP|bnp
509929|NCT00241917|testing|testing
509930|NCT00241917|vaccination|vaccination
509931|NCT00241930|Heroin|heroin
509932|NCT00241930|HIV|hiv
509933|NCT00241930|buprenorphine|buprenorphine
509934|NCT00241930|integration|integration
509935|NCT00241930|drug treatment|drug treatment
510026|NCT00242463|rehabilitation|rehabilitation
510406|NCT00244569|Liver Function|liver function
510500|NCT00244894|hot flashes|hot flashes
510779|NCT00245453|bronchitis|bronchitis
510877|NCT00245986|HV|hv
511970|NCT00250055|NIH|nih
512051|NCT00243529|Immunotherapy|immunotherapy
512155|NCT00250224|marker|marker
512331|NCT00251160|MDI|mdi
512349|NCT00251251|Defibrillator|defibrillator
513256|NCT00254423|CML|cml
558700|NCT00427557|Fludara|fludara
512846|NCT00247130|Endoscopic treatment|endoscopic treatment
513050|NCT00253214|controlled-release|controlled-release
513808|NCT00255788|male breast cancer|male breast cancer
513874|NCT00250510|Health care costs|health care costs
514052|NCT00257907|PPD|ppd
514811|NCT00259805|encephalitis|encephalitis
515000|NCT00263237|CVID|cvid
515098|NCT00263640|Allergy|allergy
515196|NCT00264342|Smoking|smoking
515288|NCT00264641|PET|pet
515389|NCT00265174|SERUM DNA|serum dna
516072|NCT00268853|NHL|nhl
516256|NCT00260299|MKD|mkd
516631|NCT00261677|Anemia|anemia
517148|NCT00273338|DN-101|dn-101
517232|NCT00273728|Hydroxyethyl Starch|hydroxyethyl starch
517340|NCT00274469|cancer|cancer
753951|NCT01178385|Autism|autism
517700|NCT00266058|PK|pk
517790|NCT00266448|MRSA|mrsa
518060|NCT00275158|Pre-Eclampsia|pre-eclampsia
518153|NCT00276198|Infants|infants
518339|NCT00277043|Taxane|taxane
519106|NCT00270933|LLECG|llecg
519210|NCT00271388|Stroke|stroke
519335|NCT00271804|MDS|mds
519505|NCT00282802|NAS/NRC|nas/nrc
519603|NCT00283296|travel wheelchair|travel wheelchair
519723|NCT00283686|pkd|pkd
520114|NCT00275509|therapy|therapy
520413|NCT00286637|OCT|oct
520511|NCT00287092|Clostridium tetani;|clostridium tetani;
520921|NCT00279305|T1D|t1d
521082|NCT00280358|Fluticasone|fluticasone
521279|NCT00281372|female|female
521280|NCT00281372|dental care|dental care
521281|NCT00281372|need of control|need of control
521282|NCT00281385|adherence|adherence
521283|NCT00281385|lifestyle|lifestyle
521869|NCT00282633|Surgery|surgery
521966|NCT00291109|Ki-67|ki-67
522716|NCT00280072|Anuria|anuria
522910|NCT00294424|The15D|the15d
523462|NCT00295997|polycythemia vera|polycythemia vera
523501|NCT00296010|stage II breast cancer|stage ii breast cancer
523578|NCT00296049|infection|infection
523764|NCT00288704|CIAS1|cias1
523954|NCT00289627|Stage IV|stage iv
524065|NCT00290108|BIS|bis
524497|NCT00290771|GBM|gbm
524701|NCT00300820|Bipolar|bipolar
525169|NCT00302302|GIP|gip
525372|NCT00294190|Lung Cancer|lung cancer
525671|NCT00305305|MRI|mri
525674|NCT00305305|Aicardi Syndrome.|aicardi syndrome.
525675|NCT00305331|Parkinson's disease|parkinson's disease
525676|NCT00305331|Domperidone|domperidone
525678|NCT00305331|Pramipexole|pramipexole
525772|NCT00305643|Celebrex|celebrex
525773|NCT00305643|Capecitabine|capecitabine
525774|NCT00305643|Xeloda|xeloda
525941|NCT00305903|Dementia,|dementia,
526417|NCT00297375|Pain|pain
526508|NCT00298233|Bird Flu|bird flu
526803|NCT00299377|no-reflow|no-reflow
527215|NCT00307502|HIV|hiv
527315|NCT00308451|OGTT|ogtt
527417|NCT00308984|Pediatrics|pediatrics
527782|NCT00310323|drug metabolism|drug metabolism
528644|NCT00319748|852A|852a
528743|NCT00320203|open-angle|open-angle
529349|NCT00327769|fulvestrant|fulvestrant
529452|NCT00328159|FAO disorders|fao disorders
529745|NCT00329264|GAD|gad
529854|NCT00329758|rosuvastatin|rosuvastatin
529957|NCT00311194|Death|death
530343|NCT00313872|irinotecan|irinotecan
530551|NCT00314756|imiquimod cream|imiquimod cream
530955|NCT00316394|Reminders|reminders
531055|NCT00316875|male breast cancer|male breast cancer
531240|NCT00317564|Birth Defects|birth defects
531501|NCT00318240|Men|men
531605|NCT00318747|AIC|aic
531726|NCT00312598|BMI|bmi
532130|NCT00330811|Pediatrics|pediatrics
532131|NCT00330811|Non-cardiac Illness|non-cardiac illness
532132|NCT00330811|B-type Natriuretic Peptide (BNP)|b-type natriuretic peptide (bnp)
532133|NCT00330824|prevention of post inflammation in LASIK surgery|prevention of post inflammation in lasik surgery
532134|NCT00330850|Migraine|migraine
532135|NCT00330850|Photophobia|photophobia
532136|NCT00330850|Phonophobia|phonophobia
532529|NCT00332735|articaine|articaine
532818|NCT00322400|Locally Recurrent|locally recurrent
533115|NCT00324857|race|race
533313|NCT00325819|Vaccination|vaccination
533415|NCT00326170|AML|aml
533806|NCT00334074|MDS|mds
533911|NCT00334321|IMRT|imrt
534851|NCT00330304|Child|child
535264|NCT00342433|Serum|serum
535382|NCT00342836|Akt|akt
535476|NCT00343213|CIN 1|cin 1
536631|NCT00348010|opioid|opioid
537334|NCT00340080|HLA-B*5701|hla-b*5701
537335|NCT00340093|Adherence|adherence
537336|NCT00340093|Behavioral Intervention|behavioral intervention
537337|NCT00340093|Adolescence|adolescence
537338|NCT00340093|Self-Regulation|self-regulation
537339|NCT00340093|Behavioral Medicine|behavioral medicine
537340|NCT00340093|Diabetes|diabetes
537452|NCT00340444|Fine Mapping|fine mapping
537562|NCT00340743|Heterocyclic Aminos|heterocyclic aminos
537563|NCT00340743|Cruciferous Vegetables|cruciferous vegetables
537564|NCT00340743|Yogurt|yogurt
537565|NCT00340743|Chlorophyllin|chlorophyllin
537908|NCT00348478|water|water
538078|NCT00350012|stroke|stroke
538274|NCT00350896|pain|pain
538275|NCT00350896|orthoses|orthoses
558948|NCT00428454|QCA|qca
559203|NCT00429338|3 Tesla|3 tesla
538276|NCT00350896|Osteoarthritis in the BTOA concerns the trapezometacarpal joint|osteoarthritis in the btoa concerns the trapezometacarpal joint
538481|NCT00338377|Fludarabine Phosphate|fludarabine phosphate
538593|NCT00338819|IPC|ipc
538871|NCT00351650|T1DM|t1dm
539156|NCT00352768|OCD|ocd
539366|NCT00353535|renal transplant|renal transplant
539876|NCT00349050|TMS|tms
539919|NCT00354887|Xeloda|xeloda
540027|NCT00357409|MRS|mrs
540878|NCT00362128|Obesity|obesity
540988|NCT00362596|HIV|hiv
541554|NCT00355680|Retinal Diseases|retinal diseases
542122|NCT00365638|lipids|lipids
542009|NCT00357097|RLS|rls
542110|NCT00365612|AIDS|aids
542205|NCT00365937|IMP321|imp321
542398|NCT00366847|MRI|mri
542597|NCT00367796|Craniosynostosis|craniosynostosis
542598|NCT00367796|Philadelphia Type|philadelphia type
542599|NCT00367809|Meditation|meditation
542600|NCT00367809|Mindfulness|mindfulness
542601|NCT00367809|Organ Transplant|organ transplant
542602|NCT00367809|Transplantation|transplantation
542603|NCT00367809|Minnesota|minnesota
542604|NCT00367809|Immune suppressive therapy|immune suppressive therapy
542605|NCT00367822|Restless Legs Syndrome|restless legs syndrome
542639|NCT00367952|HIV|hiv
16242|NCT03187275|Cancer|cancer
543649|NCT00370669|MPC|mpc
543247|NCT00361699|pravastatin|pravastatin
543248|NCT00361699|c-reactive Protein|c-reactive protein
543249|NCT00361712|Epidural|epidural
543250|NCT00361712|analgesia|analgesia
543251|NCT00361712|labor|labor
543252|NCT00361712|cytokines|cytokines
543253|NCT00361725|severe sepsis|severe sepsis
543254|NCT00361725|organ failure|organ failure
543255|NCT00361725|activated protein C|activated protein c
543256|NCT00361725|thrombomodulin|thrombomodulin
543271|NCT00361803|recurrent|recurrent
543272|NCT00361803|refractory|refractory
543273|NCT00361803|research|research
543274|NCT00361803|cancer|cancer
543275|NCT00361803|pharmacokinetics|pharmacokinetics
543317|NCT00368264|TNF|tnf
543359|NCT00368420|recurrence|recurrence
543553|NCT00370305|rosiglitazone|rosiglitazone
543749|NCT00371020|5-FU|5-fu
543946|NCT00371878|Conjugate vaccine|conjugate vaccine
544139|NCT00365222|Neurological|neurological
544281|NCT00365300|GERD|gerd
544375|NCT00372203|NSCLC|nsclc
544465|NCT00372489|Hematide™|hematide™
544546|NCT00372684|Malaria|malaria
544968|NCT00374205|ACT|act
545034|NCT00374439|schools|schools
545256|NCT00368797|PAOD|paod
545698|NCT00375973|CFS|cfs
546710|NCT00378781|mast cell leukemia|mast cell leukemia
546815|NCT00378820|Whey|whey
547254|NCT00380887|bioequivalence|bioequivalence
547356|NCT00381134|nephropathy|nephropathy
547561|NCT00382525|Heart Failure|heart failure
547664|NCT00382824|CoQ10|coq10
547954|NCT00384137|Kidney Transplantation|kidney transplantation
548054|NCT00384592|proton pump inhibitor|proton pump inhibitor
548154|NCT00384969|Metastatic|metastatic
548461|NCT00386698|Influenza,|influenza,
548661|NCT00387348|depression|depression
548907|NCT00381472|Dyskinesia|dyskinesia
549041|NCT00381927|Anxiety|anxiety
549136|NCT00388128|QoL|qol
549418|NCT00389194|kidney function|kidney function
549530|NCT00389636|Foot|foot
549795|NCT00390637|Family|family
550092|NCT00391287|Registries|registries
550218|NCT00392132|HIV|hiv
550279|NCT00392509|PAD|pad
550954|NCT00397657|niacin|niacin
551137|NCT00398398|cetuximab|cetuximab
551424|NCT00399685|HIV|hiv
551526|NCT00391495|ADHD|adhd
551623|NCT00400244|wheelchairs|wheelchairs
552009|NCT00403052|neoplasm|neoplasm
552246|NCT00404001|LDL|ldl
552471|NCT00395330|Environmental Exposure|environmental exposure
552768|NCT00396500|India|india
552869|NCT00396812|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
552965|NCT00397215|H5N1|h5n1
553166|NCT00405600|BMP-2|bmp-2
553273|NCT00406003|safety|safety
553367|NCT00406536|LXS|lxs
553565|NCT00407576|AD|ad
553678|NCT00394836|NHL|nhl
553758|NCT00400569|Phase II|phase ii
554050|NCT00401726|Anxiety|anxiety
554399|NCT00409721|ALS|als
554960|NCT00405080|Rifampin GW679769|rifampin gw679769
555070|NCT00411463|Depression|depression
555167|NCT00412893|Aspergillus species|aspergillus species
555313|NCT00413283|CIT|cit
555467|NCT00413556|inmunotherapy|inmunotherapy
555674|NCT00414453|Lidocaine|lidocaine
556092|NCT00415402|Vitamin D3|vitamin d3
556396|NCT00420030|PCI|pci
556597|NCT00420966|palivizumab|palivizumab
556791|NCT00412022|postmenopause|postmenopause
556891|NCT00412373|placebo|placebo
557089|NCT00424242|mast cell leukemia|mast cell leukemia
557156|NCT00424255|Adjuvant|adjuvant
557240|NCT00424814|Kaletra|kaletra
557413|NCT00425646|adenocarcinoma of the lung|adenocarcinoma of the lung
557605|NCT00426322|bone graft|bone graft
585619|NCT00513409|Immunogenicity|immunogenicity
558045|NCT00416975|breast cancer|breast cancer
558129|NCT00417287|Pancreas|pancreas
558323|NCT00418028|schedule|schedule
558425|NCT00418561|rhASA|rhasa
558523|NCT00426829|RT|rt
558604|NCT00427297|Pediatric|pediatric
559387|NCT00421811|melanoma|melanoma
559486|NCT00422305|asthma|asthma
560092|NCT00424190|Abscess|abscess
560276|NCT00431782|Anticoagulation|anticoagulation
560456|NCT00432432|MTX|mtx
560550|NCT00432822|BH4|bh4
560655|NCT00433186|Scleroderma|scleroderma
561113|NCT00416169|Frontotemporal Dementia|frontotemporal dementia
561579|NCT00435656|Human immunodeficiency virus|human immunodeficiency virus
561580|NCT00435669|Advanced or metastatic solid tumors|advanced or metastatic solid tumors
561581|NCT00435682|The trial is performed on healthy normal males.|the trial is performed on healthy normal males.
561582|NCT00435695|PET scan|pet scan
561585|NCT00435708|Fruit|fruit
561722|NCT00436345|ICU|icu
561789|NCT00436423|TS-1|ts-1
561868|NCT00436631|ketosis|ketosis
562030|NCT00437242|QT,|qt,
562048|NCT00437372|solid tumor|solid tumor
562147|NCT00430469|hLF|hlf
562242|NCT00430820|Atherosclerosis|atherosclerosis
562597|NCT00439166|tau|tau
562607|NCT00439205|FastEEM4 System|fasteem4 system
562813|NCT00439894|Enbrel|enbrel
562919|NCT00440284|self-management|self-management
563021|NCT00440700|Ventilator|ventilator
563120|NCT00440986|Phlebotomy|phlebotomy
563326|NCT00434577|Herpes Zoster (HZ)|herpes zoster (hz)
563429|NCT00441389|Viruses|viruses
563625|NCT00444912|AMD3100|amd3100
563725|NCT00445341|Microarray|microarray
583955|NCT00514046|MTC|mtc
565578|NCT00449462|kidney|kidney
564456|NCT00446303|AML|aml
565204|NCT00448214|Stroke|stroke
565328|NCT00448448|bracing|bracing
565402|NCT00448656|atrial fibrillation|atrial fibrillation
565795|NCT00442143|CLI|cli
565887|NCT00442637|CAIRO3|cairo3
566045|NCT00443300|AML|aml
566553|NCT00452621|TBE|tbe
567780|NCT00456274|Kallmann's Syndrome|kallmann's syndrome
567882|NCT00456833|NSCLC|nsclc
569111|NCT00460460|Phase I|phase i
569734|NCT00462943|HHT|hht
569885|NCT00463398|Recurrence|recurrence
570089|NCT00464178|McPC603 antibody|mcpc603 antibody
570466|NCT00464698|OCD|ocd
570750|NCT00469924|Informatics|informatics
571006|NCT00470483|PET|pet
571181|NCT00471289|PAD|pad
571294|NCT00471393|TMJ|tmj
571370|NCT00471523|Treatment|treatment
571618|NCT00474201|HIV|hiv
571770|NCT00474864|atherosclerosis|atherosclerosis
571965|NCT00475306|Nausea|nausea
572156|NCT00464711|depression|depression
572246|NCT00465101|GreenLight|greenlight
572351|NCT00466583|Carcinoma, Lymphoma|carcinoma, lymphoma
573252|NCT00477581|Amylin|amylin
573334|NCT00477919|fatigue|fatigue
573523|NCT00478595|obese|obese
573725|NCT00479284|Polysomnography|polysomnography
574016|NCT00472056|BCNU|bcnu
574024|NCT00472056|Ara-C|ara-c
574330|NCT00473408|Glioma|glioma
574429|NCT00483769|Glargine|glargine
574493|NCT00483834|Bevacizumab|bevacizumab
574662|NCT00484510|CMT|cmt
574884|NCT00485394|GA|ga
574989|NCT00485966|CLL|cll
575111|NCT00476359|ARV|arv
575495|NCT00487461|SAH|sah
575784|NCT00488566|TMS,|tms,
575883|NCT00488917|endothelium|endothelium
576016|NCT00489489|MS|ms
576083|NCT00479830|Epidemiology|epidemiology
576592|NCT00481793|Polymorphism|polymorphism
576784|NCT00482560|Sucrose|sucrose
576951|NCT00482963|HIV|hiv
577709|NCT00492739|B cell response|b cell response
577999|NCT00493272|Fibrinogen|fibrinogen
578713|NCT00496873|Rituximab|rituximab
578813|NCT00490126|Laparoscopy|laparoscopy
578914|NCT00490503|DW-MRI|dw-mri
579215|NCT00500396|ELISA.|elisa.
579415|NCT00501163|Schizophrenia|schizophrenia
579621|NCT00501787|Anovulation|anovulation
579934|NCT00494052|Choice Behavior|choice behavior
580507|NCT00504244|SLE|sle
580974|NCT00505869|Smoking Cessation|smoking cessation
581600|NCT00499382|RNV|rnv
581940|NCT00506129|PBPC|pbpc
582147|NCT00507260|BMT|bmt
582288|NCT00507754|TB|tb
582653|NCT00508872|Leucovorin|leucovorin
583056|NCT00510315|aplastic anemia|aplastic anemia
583151|NCT00510666|Pain, Postoperative|pain, postoperative
583251|NCT00511004|Diethylcarbamazine|diethylcarbamazine
583252|NCT00511017|Solid Tumors|solid tumors
583253|NCT00511017|Doxercalciferol|doxercalciferol
583254|NCT00511017|Pediatric Cancer|pediatric cancer
583255|NCT00511017|Recurrent Pediatric Solid Tumors|recurrent pediatric solid tumors
583256|NCT00511017|Calcium|calcium
583257|NCT00511017|Vitamin D|vitamin d
583258|NCT00511030|Diabetes|diabetes
583259|NCT00511043|PTK787|ptk787
583260|NCT00511043|DLCL|dlcl
583261|NCT00511043|Diffuse large cell lymphoma|diffuse large cell lymphoma
583262|NCT00511056|HIV|hiv
583263|NCT00511056|Adherence|adherence
583264|NCT00511056|Compliance|compliance
583265|NCT00511056|Highly Active Antiretroviral Therapy (HAART)|highly active antiretroviral therapy (haart)
583266|NCT00511056|ARV|arv
583267|NCT00511056|ART|art
583268|NCT00511056|Sexual Risk Behavior|sexual risk behavior
583269|NCT00511056|Unsafe|unsafe
583270|NCT00511056|Transmission|transmission
583271|NCT00511069|Bortezomib|bortezomib
583272|NCT00511069|CML033|cml033
583273|NCT00511095|Hepatitis B vaccine|hepatitis b vaccine
583274|NCT00511095|HBV vaccine|hbv vaccine
583275|NCT00511095|Hepatitis B|hepatitis b
583276|NCT00511095|Hepatitis|hepatitis
759683|NCT00766779|hematopoietic cell transplantation|hematopoietic cell transplantation
759684|NCT00766779|Acute Myeloid Leukemia|acute myeloid leukemia
759685|NCT00766779|first Complete Remission|first complete remission
759687|NCT00705926|Acute Infection|acute infection
759688|NCT00705926|HIV|hiv
759689|NCT00705926|HAART|haart
759690|NCT00705926|Treatment Naive|treatment naive
759691|NCT00675233|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
759692|NCT00675233|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
759693|NCT00675233|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
759694|NCT00675233|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
759695|NCT00675233|stage 0 laryngeal cancer|stage 0 laryngeal cancer
759696|NCT00671814|antibiotic|antibiotic
759697|NCT00641641|Viral compartments|viral compartments
759698|NCT00641641|integrase inhibitor therapy|integrase inhibitor therapy
759699|NCT00641641|viral species|viral species
759712|NCT00572481|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
759713|NCT00572481|Axillary Node Dissection|axillary node dissection
759753|NCT00340288|Fibroids|fibroids
759754|NCT00340288|Life Style/Endrocrinology|life style/endrocrinology
759755|NCT00340288|Magnetic Resonance Imaging|magnetic resonance imaging
759756|NCT00340288|Molecular Characterization|molecular characterization
759757|NCT00340288|Symptoms/Clinical Outcome|symptoms/clinical outcome
759758|NCT00340288|Uterine Fibroids|uterine fibroids
759762|NCT00305825|recurrent breast cancer|recurrent breast cancer
759763|NCT00305825|stage IIIA breast cancer|stage iiia breast cancer
759764|NCT00305825|stage IIIB breast cancer|stage iiib breast cancer
759765|NCT00305825|stage IIIC breast cancer|stage iiic breast cancer
759766|NCT00305825|stage IV breast cancer|stage iv breast cancer
759770|NCT00127660|Behavior|behavior
759774|NCT00064883|Radiation Therapy|radiation therapy
759775|NCT00064883|Children|children
759776|NCT00064883|Cancer|cancer
759777|NCT00064883|Late Effects|late effects
759778|NCT00064883|Natural History|natural history
759779|NCT00064883|Radiation|radiation
759792|NCT00026754|Screening|screening
759793|NCT00026754|Cancer|cancer
759794|NCT00026754|HIV Infection|hiv infection
759795|NCT00026754|Scans|scans
759796|NCT00026754|Laboratory Tests|laboratory tests
759797|NCT00026754|HIV|hiv
759798|NCT00026754|Skin Disorders|skin disorders
759799|NCT00006177|Emotion|emotion
759800|NCT00006177|Children and Adolescents|children and adolescents
759801|NCT00006177|Affective Neuroscience|affective neuroscience
759802|NCT00006177|Bipolar Disorder|bipolar disorder
759803|NCT00006177|Child|child
759804|NCT00006177|Child Bipolar|child bipolar
759805|NCT00006177|BPD|bpd
759806|NCT00006177|Adolescent Bipolar|adolescent bipolar
26587|NCT03118557|Stress|stress
33064|NCT03078998|Cerebral Palsy|cerebral palsy
51353|NCT02964390|CTEPH|cteph
61226|NCT02903069|MRZ|mrz
71591|NCT02836054|CSF|csf
89715|NCT02726867|levetiracetam|levetiracetam
108885|NCT02611960|PD1|pd1
165794|NCT02281292|OCT|oct
196364|NCT02132507|fMRI|fmri
236494|NCT01951677|vaccine|vaccine
259532|NCT01847365|Okustim|okustim
461266|NCT00044200|PET|pet
532182|NCT00331097|adjuvant therapy|adjuvant therapy
583500|NCT00511992|Avastin|avastin
586000|NCT00523055|Pain|pain
583917|NCT00513890|Infant|infant
584144|NCT00514787|NIS|nis
586398|NCT00524472|Outcome|outcome
584416|NCT00515736|outcome|outcome
584754|NCT00509704|Sutent|sutent
584954|NCT00517803|Healthy|healthy
587509|NCT00520546|PET|pet
585265|NCT00519181|HTLV|htlv
585373|NCT00519597|Revascularization|revascularization
587849|NCT00521703|child|child
586012|NCT00523107|PG2|pg2
587025|NCT00530270|ACS|acs
587116|NCT00530712|SFA|sfa
589317|NCT00527904|NSAIDS|nsaids
587249|NCT00531310|CML|cml
587331|NCT00531765|contrast|contrast
587427|NCT00532168|late presenters|late presenters
587717|NCT00521339|Apremilast,|apremilast,
588077|NCT00532571|CoQ10|coq10
588273|NCT00536679|Randomised|randomised
588365|NCT00536965|NIS|nis
590618|NCT00540384|Anemia|anemia
588641|NCT00538200|COPD|copd
588784|NCT00525486|PTL|ptl
588849|NCT00525746|MDS|mds
588947|NCT00525993|etoricoxib|etoricoxib
589033|NCT00526188|Primovist|primovist
589224|NCT00527579|HV|hv
589318|NCT00527917|IC/PBS|ic/pbs
589423|NCT00528320|ICD|icd
589602|NCT00528957|HIV|hiv
589702|NCT00529360|Clofarabine|clofarabine
589881|NCT00538824|myeloma|myeloma
591893|NCT00543712|Sarcoma|sarcoma
590624|NCT00540423|eltrombopag,|eltrombopag,
592687|NCT00539201|HIV|hiv
590986|NCT00527072|plaque psoriasis|plaque psoriasis
591080|NCT00533806|Active Control|active control
591241|NCT00534183|Obesity|obesity
591311|NCT00534443|sTREM-1|strem-1
591493|NCT00535184|breast|breast
593732|NCT00549679|COPD|copd
591912|NCT00543777|MRE|mre
592075|NCT00544232|pCR rates|pcr rates
594282|NCT00553709|nausea|nausea
592405|NCT00544960|bcl|bcl
594778|NCT00555698|DBS|dbs
595052|NCT00559780|Aging|aging
593228|NCT00548197|Pars plana vitrectomy|pars plana vitrectomy
593322|NCT00542256|Apoplexy|apoplexy
593460|NCT00542789|GI|gi
593719|NCT00549601|switch|switch
594191|NCT00551720|HIV|hiv
596628|NCT00557245|TDF|tdf
594367|NCT00554177|sexual|sexual
594561|NCT00554996|biofilm|biofilm
596921|NCT00558363|PSA|psa
594727|NCT00555503|registry|registry
595733|NCT00552682|HIV|hiv
595913|NCT00553488|subcutaneous|subcutaneous
598315|NCT00569322|BG|bg
596085|NCT00563030|Neutrophils|neutrophils
598326|NCT00569439|Labor|labor
596176|NCT00563459|levetiracetam|levetiracetam
598439|NCT00569881|PRK|prk
598720|NCT00571220|obesity|obesity
596665|NCT00557440|QMF|qmf
598909|NCT00571688|Mania|mania
596757|NCT00557921|ACS|acs
597468|NCT00566787|AF|af
599980|NCT00580515|Cancer|cancer
600076|NCT00580905|VEGF|vegf
598003|NCT00562692|OAD|oad
97894|NCT02677038|Stage IV pancreatic ductal adenocarcinoma (PDAC) with BRCAness|stage iv pancreatic ductal adenocarcinoma (pdac) with brcaness
98092|NCT02675816|OSA|osa
98293|NCT02674568|Refractory|refractory
98294|NCT02674555|Phase 1|phase 1
98306|NCT02674529|MDD|mdd
98398|NCT02673892|discharge|discharge
98399|NCT02673892|transitions|transitions
98400|NCT02673892|patient experience|patient experience
98401|NCT02673866|Diabetic Peripheral Neuropathic Pain (DPNP)|diabetic peripheral neuropathic pain (dpnp)
98402|NCT02673866|Diabetes|diabetes
98403|NCT02673866|Pregabalin|pregabalin
100080|NCT02662907|Dysphagia therapy|dysphagia therapy
100081|NCT02662907|Modified barium swallow|modified barium swallow
601759|NCT00585312|FAP|fap
600021|NCT00580723|acne|acne
600518|NCT00581789|sunitinib|sunitinib
600824|NCT00583791|VSD|vsd
601031|NCT00584805|EEE|eee
601128|NCT00576836|DiGeorge Syndrome|digeorge syndrome
601291|NCT00577525|ADENOVIRUS|adenovirus
603751|NCT00597142|renal|renal
603877|NCT00597584|CKD|ckd
604037|NCT00598273|CKD|ckd
601848|NCT00587197|esophageal varices|esophageal varices
604202|NCT00598897|MAC|mac
602159|NCT00588627|Chronic cough|chronic cough
605206|NCT00601978|ERP|erp
603012|NCT00594191|Statins|statins
100082|NCT02662907|Neurocognitive exams|neurocognitive exams
603218|NCT00595114|COPD|copd
603321|NCT00595569|insulin|insulin
605681|NCT00590096|MIBG|mibg
605991|NCT00596921|Shock|shock
100083|NCT02662907|Questionnaires|questionnaires
606200|NCT00604630|EPO|epo
100084|NCT02662907|Surveys|surveys
604225|NCT00599053|Ureaplasma|ureaplasma
100085|NCT02662907|Digital Manometer|digital manometer
100092|NCT02662829|TB|tb
606963|NCT00611325|GBM|gbm
100184|NCT02662465|Laser|laser
605007|NCT00601341|arthralgia|arthralgia
605429|NCT00603122|hypoxia|hypoxia
607786|NCT00613886|NPH|nph
605844|NCT00596284|Alzheimer's Disease|alzheimer's disease
606289|NCT00605098|HIV|hiv
606366|NCT00605514|HV|hv
606630|NCT00600067|Diabetes|diabetes
607065|NCT00611377|delirium|delirium
100185|NCT02662439|Heart Failure|heart failure
607646|NCT00613379|HIV|hiv
607740|NCT00604175|HIV|hiv
100189|NCT02662426|Lingdancao|lingdancao
610606|NCT00616343|ET|et
608599|NCT00607516|wear|wear
609094|NCT00610571|Temodar|temodar
609193|NCT00611078|04-088|04-088
100900|NCT02658812|IBC|ibc
101200|NCT02657200|KAP|kap
101398|NCT02655926|OCD|ocd
101601|NCT02654600|cardiac surgery|cardiac surgery
611694|NCT00625963|ILD;|ild;
609658|NCT00621062|vein|vein
611953|NCT00630383|foxp3|foxp3
612065|NCT00630734|HIV|hiv
609947|NCT00607815|OEF/OIF|oef/oif
612458|NCT00622752|Craving|craving
610312|NCT00614926|ALS|als
610475|NCT00615758|Erlotinib|erlotinib
610655|NCT00622440|AIN|ain
610674|NCT00622505|skeletal complications|skeletal complications
613222|NCT00634439|TIA|tia
613309|NCT00634894|Femara|femara
611351|NCT00607984|thiotepa|thiotepa
611546|NCT00619541|5FU|5fu
611820|NCT00629824|ribavirin|ribavirin
614165|NCT00635128|DTP|dtp
612015|NCT00630578|PTSD|ptsd
612304|NCT00631527|Zoladex|zoladex
612763|NCT00632697|infertility|infertility
615071|NCT00640653|HIV|hiv
612962|NCT00633503|observation|observation
101602|NCT02654600|thoracopulmonary compliance|thoracopulmonary compliance
101604|NCT02654587|NSCLC|nsclc
102491|NCT02649439|PSA|psa
102591|NCT02648737|social phobia|social phobia
613327|NCT00626197|SLE|sle
613544|NCT00627263|Anger|anger
613825|NCT00628407|CPR|cpr
614003|NCT00629083|SUI|sui
616207|NCT00646906|smoking|smoking
102596|NCT02648698|CD138|cd138
614283|NCT00635960|ALS|als
615252|NCT00641342|Onlay mesh|onlay mesh
614740|NCT00637663|Lamivudine|lamivudine
615008|NCT00638456|Eosinophils|eosinophils
615125|NCT00640900|obesity|obesity
615194|NCT00641173|PTSD|ptsd
615523|NCT00642213|TIA|tia
617806|NCT00644995|Smoking|smoking
618114|NCT00654732|BLM|blm
616034|NCT00646152|HV|hv
616285|NCT00647244|HIV|hiv
103476|NCT02643108|Lateral episiotomy|lateral episiotomy
103477|NCT02643108|Obstetrical anal sphincter injury|obstetrical anal sphincter injury
103571|NCT02642471|surgery|surgery
103784|NCT02641457|aflibercept|aflibercept
103785|NCT02641431|radiofrequency ablation|radiofrequency ablation
103786|NCT02641431|mapping|mapping
103787|NCT02641431|sudden death|sudden death
103897|NCT02640820|HPV|hpv
616572|NCT00639301|Eye|eye
618894|NCT00657072|lunate|lunate
616852|NCT00648232|VCT|vct
617008|NCT00651313|Periods|periods
619386|NCT00659594|SAR|sar
619674|NCT00653783|MSA|msa
617433|NCT00652704|Fed|fed
103984|NCT02640144|pain reduction|pain reduction
103985|NCT02640144|swelling|swelling
620320|NCT00662090|MDS|mds
618132|NCT00654784|DMD|dmd
618336|NCT00655590|Sildenafil|sildenafil
618831|NCT00650130|oral fluid|oral fluid
618933|NCT00657878|chemotherapy|chemotherapy
619075|NCT00658411|AML|aml
619136|NCT00658749|IL-13|il-13
619448|NCT00659958|zonisamide|zonisamide
103986|NCT02640144|osteoarthritis|osteoarthritis
619597|NCT00653536|device|device
104685|NCT02636231|NPC|npc
105074|NCT02634229|monogenic diabetes|monogenic diabetes
105075|NCT02634229|MODY|mody
105076|NCT02634229|beta-cell|beta-cell
105541|NCT02631785|CBT|cbt
622825|NCT00671151|histone|histone
622900|NCT00671372|CRC|crc
106177|NCT02628353|phenolic compounds|phenolic compounds
620911|NCT00664924|ICU|icu
623094|NCT00672035|LT|lt
106178|NCT02628353|hypertension|hypertension
106179|NCT02628327|glaucoma care|glaucoma care
106180|NCT02628327|quality of life|quality of life
106181|NCT02628327|patient satisfaction|patient satisfaction
106182|NCT02628301|Obesity|obesity
106183|NCT02628301|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
106184|NCT02628301|Hypercaloric diet|hypercaloric diet
106185|NCT02628301|Microcirculation|microcirculation
106186|NCT02628301|Microvascular dysfunction|microvascular dysfunction
623720|NCT00675831|DLI|dli
106187|NCT02628301|Insulin Resistance|insulin resistance
106188|NCT02628301|Insulin Sensitivity|insulin sensitivity
622048|NCT00668759|AF|af
622137|NCT00669292|TTK|ttk
622231|NCT00669643|Leprosy|leprosy
622428|NCT00664196|Prostate Cancer|prostate cancer
106189|NCT02628301|Insulin signaling|insulin signaling
625984|NCT00683839|NRT|nrt
106190|NCT02628262|Macular hole|macular hole
106191|NCT02628236|Actinic keratosis|actinic keratosis
623919|NCT00676624|uveitis|uveitis
106192|NCT02628223|glaucoma|glaucoma
106193|NCT02628223|Elevated IOP|elevated iop
626609|NCT00686413|PET|pet
624739|NCT00680173|Peginterferon|peginterferon
625061|NCT00673816|Sutent|sutent
625927|NCT00683709|Clozapine|clozapine
106194|NCT02628223|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
106196|NCT02628223|open angle glaucoma|open angle glaucoma
106197|NCT02628223|ocular hypertension|ocular hypertension
106198|NCT02628223|Glaucoma, Open Angle, Pseudo-exfoliative|glaucoma, open angle, pseudo-exfoliative
106199|NCT02628223|pigment dispersion syndrome|pigment dispersion syndrome
106200|NCT02628223|Pseudoexfoliation|pseudoexfoliation
626410|NCT00684749|Breast implant choice|breast implant choice
629076|NCT00689299|Cat|cat
626898|NCT00687778|GIST|gist
627289|NCT00689572|crack|crack
627491|NCT00690248|Bipolar disorder|bipolar disorder
106201|NCT02628223|IOP ≥ 21 mmHg|iop ≥ 21 mmhg
628961|NCT00688974|BMI > 35.|bmi > 35.
106202|NCT02628158|Epiretinal membrane|epiretinal membrane
627958|NCT00691717|IOP|iop
629089|NCT00689338|ICU|icu
631425|NCT00693940|PAD|pad
106203|NCT02628145|Sarcopenia|sarcopenia
631646|NCT00708656|IBD|ibd
106204|NCT02628145|aging|aging
629719|NCT00701753|RNA|rna
632110|NCT00710411|ISS|iss
632311|NCT00710840|OA|oa
630279|NCT00695851|PCK3145|pck3145
630380|NCT00696332|ALS|als
632973|NCT00714103|CLL|cll
106205|NCT02628145|resistance training|resistance training
106206|NCT02628145|physical functioning|physical functioning
106880|NCT02624635|Pain|pain
107176|NCT02622867|Maltodextrin|maltodextrin
107177|NCT02622867|Probiotics|probiotics
107178|NCT02622867|Randomized Controlled Trial|randomized controlled trial
631150|NCT00692861|HV|hv
107185|NCT02622841|Safety|safety
631372|NCT00693758|MRI|mri
633974|NCT00716365|duplex|duplex
634071|NCT00716807|BMS|bms
632135|NCT00710450|IL4|il4
634744|NCT00718536|HIV|hiv
632528|NCT00712426|UHDRS|uhdrs
632610|NCT00712569|Patient|patient
632902|NCT00713791|ZD4054|zd4054
633011|NCT00714285|safety|safety
633116|NCT00706095|Cancer|cancer
635484|NCT00720733|HIV|hiv
635695|NCT00715091|SpA|spa
633599|NCT00708201|ileus|ileus
636055|NCT00723411|Diamyd|diamyd
633894|NCT00715988|analgesia|analgesia
633994|NCT00716456|Lung|lung
636239|NCT00724282|sleep|sleep
634255|NCT00717236|Cimzia|cimzia
634366|NCT00717730|Folate|folate
634549|NCT00711646|Multiple Sclerosis|multiple sclerosis
752992|NCT01175057|compliance|compliance
635284|NCT00719849|polycythemia vera|polycythemia vera
635356|NCT00720122|rhIGF-1|rhigf-1
638244|NCT00733902|OA|oa
635973|NCT00722995|Efficacity|efficacity
636165|NCT00723970|Insomnia|insomnia
636262|NCT00724360|HER2|her2
636833|NCT00728182|Stroke|stroke
636982|NCT00728676|PKU,|pku,
637009|NCT00728754|non-lateralized|non-lateralized
637214|NCT00729417|women|women
637318|NCT00721318|Estonia|estonia
637437|NCT00721812|IBD|ibd
637716|NCT00731848|PSA|psa
637917|NCT00732693|HRT|hrt
638398|NCT00725829|cholesterol|cholesterol
640848|NCT00742989|OLT|olt
638615|NCT00726713|Metanx|metanx
640960|NCT00734695|EYE|eye
638815|NCT00727142|NPH|nph
638919|NCT00734357|contrast|contrast
641470|NCT00746941|HIV|hiv
639672|NCT00737139|Hip|hip
639959|NCT00731133|disulfiram|disulfiram
642448|NCT00747955|HV|hv
640057|NCT00731510|Expedition,|expedition,
640162|NCT00737581|changes|changes
640374|NCT00741468|DDI|ddi
640474|NCT00741767|COPD|copd
643013|NCT00750048|pain,|pain,
640775|NCT00742716|Vitamin D|vitamin d
643165|NCT00750724|MRI|mri
643340|NCT00737828|CPX|cpx
641070|NCT00745368|HIV|hiv
641742|NCT00738387|VDA|vda
644171|NCT00752037|HIV|hiv
642060|NCT00739453|Pancreatic cancer|pancreatic cancer
642356|NCT00740480|Evaluation|evaluation
644671|NCT00753766|A1c|a1c
642435|NCT00747916|Neoplasms|neoplasms
644776|NCT00754247|HSE|hse
642734|NCT00749736|measures|measures
645071|NCT00757783|HIV|hiv
643096|NCT00750425|Phase I|phase i
643516|NCT00743730|pain assessment|pain assessment
645911|NCT00763126|labor|labor
646628|NCT00756405|Adults|adults
646739|NCT00756912|ANC|anc
646845|NCT00757315|AKN|akn
644932|NCT00748761|CBT|cbt
645574|NCT00760253|BIS|bis
647996|NCT00769665|Dry Eye|dry eye
646189|NCT00764231|AML|aml
107686|NCT02619942|Right colon cancer, Survival, Laparoscopic surgery|right colon cancer, survival, laparoscopic surgery
107687|NCT02619929|Oral Vinorelbine|oral vinorelbine
649083|NCT00766402|Diclofenac|diclofenac
649274|NCT00772759|PK|pk
649428|NCT00773604|DBS|dbs
647306|NCT00768846|PCI|pci
107689|NCT02619929|Metastatic Breast Cancer|metastatic breast cancer
647570|NCT00760695|chronic|chronic
647754|NCT00761449|MDS|mds
650036|NCT00775632|Campath|campath
650495|NCT00777998|DLI|dli
648313|NCT00771069|JNC7|jnc7
648513|NCT00771927|LCM|lcm
650890|NCT00781261|hip|hip
648627|NCT00772330|GDD|gdd
648934|NCT00765752|MRS|mrs
651323|NCT00775853|PD|pd
651528|NCT00783848|CHF|chf
651710|NCT00784693|pain|pain
649444|NCT00773682|hands|hands
651806|NCT00784979|PRA|pra
651925|NCT00785343|arm|arm
649616|NCT00774319|TPF|tpf
651982|NCT00785616|HIV|hiv
652082|NCT00779181|Htn|htn
650123|NCT00776373|ALL|all
652473|NCT00793910|PRK|prk
652594|NCT00794391|IDU|idu
650272|NCT00777101|HKI-272|hki-272
652878|NCT00795717|HIV|hiv
650673|NCT00778895|Flu|flu
651043|NCT00781950|PAD|pad
653548|NCT00798720|HDAC|hdac
653844|NCT00786734|PCI|pci
651953|NCT00785499|obesity|obesity
654467|NCT00788632|BMD|bmd
652156|NCT00779506|PANSS|panss
652253|NCT00779909|vitamin D|vitamin d
652453|NCT00793780|obesity|obesity
652939|NCT00795964|surgery|surgery
653237|NCT00797472|R-mabHD|r-mabhd
653527|NCT00798655|panitumumab|panitumumab
655907|NCT00800995|ARMD|armd
656007|NCT00801398|Pain|pain
654018|NCT00787462|Pain|pain
654210|NCT00787774|HIV|hiv
654273|NCT00788099|Aplidin|aplidin
654527|NCT00788788|Heliox|heliox
108083|NCT02617329|Extracorporeal shock wave therapy (ESWT), Neck Pain|extracorporeal shock wave therapy (eswt), neck pain
108084|NCT02617316|running speeds, strike patterns|running speeds, strike patterns
655075|NCT00791206|MRI|mri
655114|NCT00791336|NFV|nfv
108085|NCT02617303|elderly|elderly
108086|NCT02617303|accidental falls|accidental falls
655393|NCT00792584|etravirine|etravirine
655493|NCT00793052|trismus|trismus
655636|NCT00787865|DTI|dti
108087|NCT02617303|osteoporosis|osteoporosis
656081|NCT00801658|IOP|iop
656287|NCT00802555|HCC|hcc
658892|NCT00813969|MSC|msc
659100|NCT00806754|PAR|par
108088|NCT02617303|fractures|fractures
108884|NCT02611960|PD-1|pd-1
108886|NCT02611960|PD-L1|pd-l1
108887|NCT02611960|PDL1|pdl1
108895|NCT02611908|CLL|cll
658909|NCT00814073|Skin|skin
661207|NCT00820456|MRI|mri
658982|NCT00806247|Acute pain|acute pain
659080|NCT00806676|kidney transplant|kidney transplant
659198|NCT00806845|HIV|hiv
659222|NCT00807053|Ciclesonide|ciclesonide
659828|NCT00816426|Lesions|lesions
659939|NCT00816764|ovarian|ovarian
662373|NCT00817973|GIP|gip
662517|NCT00824993|Boniva|boniva
663094|NCT00827424|obesity|obesity
663181|NCT00827762|Kuvan|kuvan
663282|NCT00821509|hygiene|hygiene
661007|NCT00819832|VCF|vcf
661321|NCT00820976|AML|aml
661885|NCT00823472|IVF|ivf
662027|NCT00823654|BRCA1|brca1
662023|NCT00823641|HTLV-I|htlv-i
662091|NCT00823901|clindamycin|clindamycin
664749|NCT00834548|MRI|mri
662587|NCT00825604|physical training|physical training
662682|NCT00825916|POSAS|posas
665252|NCT00836043|CLL|cll
662904|NCT00826748|COPD|copd
663066|NCT00827281|DCS|dcs
663253|NCT00821340|LCA|lca
665809|NCT00838266|fluor|fluor
663536|NCT00828256|arthroscopic repair|arthroscopic repair
666175|NCT00843232|Aging|aging
664023|NCT00831064|colonoscopy|colonoscopy
666444|NCT00844454|PEI|pei
664228|NCT00825487|leukemia|leukemia
665108|NCT00829114|GCP|gcp
667607|NCT00841022|RCT|rct
665367|NCT00836446|school-aged|school-aged
668011|NCT00842634|HIV|hiv
668097|NCT00848523|GBM|gbm
665757|NCT00838071|Recurrence|recurrence
665868|NCT00832221|PET|pet
665947|NCT00832520|Advanced cancer|advanced cancer
666233|NCT00843479|Aging|aging
666319|NCT00843765|Rehabilitation|rehabilitation
666418|NCT00844402|Cholestasis|cholestasis
109084|NCT02610595|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
669242|NCT00845845|MRI|mri
667188|NCT00847379|DMD|dmd
667289|NCT00847743|aging|aging
667779|NCT00841711|Buprenorphine|buprenorphine
667974|NCT00842504|Prophylaxis|prophylaxis
668270|NCT00849940|Oximetry|oximetry
670924|NCT00852579|Asthma|asthma
668663|NCT00851279|arrhythmia|arrhythmia
668832|NCT00838695|phenylephrine|phenylephrine
109185|NCT02609919|study of contrast reaction in children under 2 years of age|study of contrast reaction in children under 2 years of age
109186|NCT02609919|safety|safety
109187|NCT02609906|proximal humerus|proximal humerus
669213|NCT00840320|Safety|safety
672327|NCT00866593|SDS|sds
670006|NCT00848848|Flu|flu
670105|NCT00849173|Infertility|infertility
670325|NCT00856570|DDI|ddi
672818|NCT00870025|hCG|hcg
670382|NCT00856856|angioplasty|angioplasty
670489|NCT00857259|AMD|amd
672986|NCT00870636|Safety|safety
670589|NCT00857610|Retinol|retinol
670881|NCT00852423|Safety|safety
671304|NCT00860106|VTE|vte
671409|NCT00860639|AML|aml
671459|NCT00860821|LPS|lps
671631|NCT00861471|PSA|psa
671652|NCT00861523|promethazine|promethazine
672458|NCT00866983|PAH|pah
674946|NCT00868868|Cancer|cancer
672566|NCT00859339|TCC|tcc
672740|NCT00869713|Neurologic diseases|neurologic diseases
672835|NCT00870077|obesity|obesity
672987|NCT00870636|ROP|rop
673148|NCT00871286|CRS|crs
673248|NCT00871598|BTT1023|btt1023
109596|NCT02607371|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
109597|NCT02607371|NOAC|noac
109598|NCT02607371|VKA|vka
109599|NCT02607358|Clopidogrel|clopidogrel
109600|NCT02607358|acetacylic acid|acetacylic acid
109602|NCT02607358|HOTPR|hotpr
110590|NCT02601534|sedentary behaviour|sedentary behaviour
110591|NCT02601534|physical activity|physical activity
673740|NCT00863811|IOP|iop
675383|NCT00876473|CPAP|cpap
110592|NCT02601508|deep NM block|deep nm block
676733|NCT00882908|RBV|rbv
674623|NCT00874562|ALL|all
674703|NCT00867763|Polycystic ovaries,|polycystic ovaries,
676111|NCT00879255|Remote|remote
676552|NCT00875199|Obesity|obesity
678971|NCT00890461|ECG|ecg
676781|NCT00882999|MS|ms
677246|NCT00884949|ERT|ert
677419|NCT00885638|GLP-1|glp-1
677683|NCT00886574|Type 2 DM|type 2 dm
677770|NCT00886899|CTO|cto
680294|NCT00896389|HCTZ|hctz
678149|NCT00881660|FETO|feto
110593|NCT02601508|Surgeon's satisfaction|surgeon's satisfaction
110594|NCT02601508|bridion|bridion
110595|NCT02601482|Glycemic control|glycemic control
111001|NCT02599064|Retinal scarring|retinal scarring
678998|NCT00890669|treadmill training|treadmill training
679208|NCT00891137|refractory anemia|refractory anemia
679288|NCT00891306|AMT-011|amt-011
679410|NCT00892190|AML|aml
679443|NCT00892307|CT|ct
679641|NCT00893048|oral|oral
679747|NCT00893581|mania|mania
679829|NCT00893893|Obesity|obesity
679960|NCT00894387|BNP|bnp
680059|NCT00895479|ESRD|esrd
680125|NCT00895700|Anxiety|anxiety
680244|NCT00896272|XXY|xxy
680657|NCT00897273|infection|infection
681202|NCT00891631|tobacco|tobacco
681205|NCT00891631|drug use|drug use
111002|NCT02599064|Subretinal scarring|subretinal scarring
111102|NCT02598479|Cancer|cancer
111292|NCT02597335|IDH1/IDH2 mutation|idh1/idh2 mutation
111293|NCT02597335|Spectroscopy MRI|spectroscopy mri
111294|NCT02597335|D-2-hydroxyglutarate|d-2-hydroxyglutarate
111295|NCT02597335|Free circulating DNA|free circulating dna
111296|NCT02597322|Axitinib|axitinib
111406|NCT02596594|IUGR|iugr
111990|NCT02593058|Savoring|savoring
111991|NCT02593032|hemoglobin A1c protein, human > 7.5|hemoglobin a1c protein, human > 7.5
111992|NCT02593006|Joint Diseases|joint diseases
111993|NCT02593006|Juvenile Arthritis|juvenile arthritis
111994|NCT02593006|treatment|treatment
111995|NCT02593006|biologic therapy|biologic therapy
112778|NCT02588469|obstructive sleep apnea|obstructive sleep apnea
112779|NCT02588469|physical exercise|physical exercise
112780|NCT02588469|compression socks|compression socks
681206|NCT00891631|seat-belt|seat-belt
683274|NCT00901771|OSA|osa
681498|NCT00898976|stage I breast cancer|stage i breast cancer
112781|NCT02588469|rostral fluid shift|rostral fluid shift
112784|NCT02588339|Hematologic disorder|hematologic disorder
112968|NCT02587234|chronic|chronic
114051|NCT02580071|ALL|all
682654|NCT00900367|breast cancer|breast cancer
682723|NCT00900497|granulocytes|granulocytes
682889|NCT00901082|information|information
683277|NCT00901797|ABD|abd
683395|NCT00902876|root coverage|root coverage
683699|NCT00904098|migraine|migraine
685465|NCT00910364|Thrombosis|thrombosis
683944|NCT00904826|NMO-IgG|nmo-igg
114282|NCT02578914|allergic conjunctivitis|allergic conjunctivitis
684700|NCT00907972|PD|pd
114283|NCT02578914|seasonal allergies|seasonal allergies
685097|NCT00909649|seroma|seroma
687596|NCT00911612|IBS|ibs
685305|NCT00902226|SAD|sad
687867|NCT00912782|ESRD|esrd
685628|NCT00913744|AMD|amd
685684|NCT00914043|fatigue|fatigue
685973|NCT00915213|E. Coli|e. coli
114284|NCT02578914|ragweed allergy|ragweed allergy
686264|NCT00906516|Neuradiab|neuradiab
686454|NCT00907218|ADHD|adhd
114476|NCT02577705|violence exposure|violence exposure
114682|NCT02576691|outcome|outcome
687487|NCT00911196|Markers|markers
690228|NCT00921544|ROP|rop
687681|NCT00911924|OAG|oag
687791|NCT00912522|reward|reward
687875|NCT00912808|falling|falling
688190|NCT00923442|MDS|mds
688343|NCT00923910|AML|aml
690935|NCT00930488|MXF|mxf
691032|NCT00930852|Obesity|obesity
688895|NCT00916058|MM|mm
691797|NCT00937274|ORS|ors
689471|NCT00925847|Lithium|lithium
691972|NCT00937846|PET|pet
689565|NCT00926432|Balance|balance
690059|NCT00928499|Interstim|interstim
692555|NCT00940342|GM-CSF|gm-csf
690158|NCT00921297|cataract|cataract
692639|NCT00940654|Fever|fever
690265|NCT00921700|Pain|pain
690406|NCT00922259|Flu|flu
690677|NCT00929422|PET|pet
114888|NCT02575482|serotonin 4 (5-HT4) receptor|serotonin 4 (5-ht4) receptor
693425|NCT00935480|HIV|hiv
691235|NCT00931801|Tenofovir|tenofovir
693723|NCT00942084|Neonate|neonate
691798|NCT00937287|HPV|hpv
691819|NCT00937365|Attachment|attachment
691986|NCT00937924|EUS|eus
694603|NCT00944554|Relapse|relapse
694692|NCT00948753|GVHD|gvhd
695032|NCT00949377|opioid|opioid
692945|NCT00933894|HCV|hcv
114889|NCT02575482|first in human|first in human
114890|NCT02575482|safety|safety
114891|NCT02575482|pharmacokinetics|pharmacokinetics
114892|NCT02575482|tolerability|tolerability
115004|NCT02575001|Stress|stress
115105|NCT02574468|MTA|mta
115298|NCT02573623|Zambia|zambia
115387|NCT02573129|Mediterranean diet|mediterranean diet
115388|NCT02573129|red meat|red meat
693734|NCT00942136|HIV|hiv
696275|NCT00945594|bladder|bladder
694127|NCT00943644|MBI|mbi
694415|NCT00932997|stage I breast cancer|stage i breast cancer
694513|NCT00938756|adult meningioma|adult meningioma
694962|NCT00949156|Obesity|obesity
695274|NCT00950352|MRI|mri
695757|NCT00953498|HDL|hdl
698222|NCT00951743|HIV|hiv
696417|NCT00946270|CC-4047|cc-4047
115389|NCT02573116|obstructive sleep apnea|obstructive sleep apnea
696853|NCT00947700|ERP|erp
699064|NCT00964457|MRI|mri
115390|NCT02573116|endothelial dysfunction|endothelial dysfunction
699418|NCT00955617|MRA|mra
697464|NCT00956735|Nutrition|nutrition
116875|NCT02564484|Pharmacogenomics|pharmacogenomics
699150|NCT00964795|AMD|amd
701607|NCT00959166|HIV|hiv
699255|NCT00964873|AML|aml
699405|NCT00955552|knee|knee
699587|NCT00965497|ALS|als
702539|NCT00976638|VRE|vre
700284|NCT00960349|S-1|s-1
700854|NCT00962702|Exclusion|exclusion
700967|NCT00971165|Amiloride|amiloride
116876|NCT02564484|Drug Response|drug response
701312|NCT00972816|Flu|flu
703886|NCT00981279|HIV|hiv
116877|NCT02564484|Genetic Variants|genetic variants
704137|NCT00974402|Anger|anger
702150|NCT00975104|Frailty|frailty
704542|NCT00983541|HCC|hcc
702072|NCT00973986|CYP3A|cyp3a
702244|NCT00975468|one lung|one lung
702431|NCT00976183|vorinostat|vorinostat
705169|NCT00977951|Scar|scar
702726|NCT00968747|fat|fat
702983|NCT00969722|3F8|3f8
117168|NCT02562755|Thymidine Kinase-Deactivated Vaccinia Virus|thymidine kinase-deactivated vaccinia virus
703597|NCT00980174|BMD|bmd
703653|NCT00980330|RBV|rbv
703864|NCT00981136|SILS|sils
704624|NCT00983879|GLD|gld
704912|NCT00984516|M6P|m6p
705303|NCT00978432|NHL|nhl
117169|NCT02562755|Oncology|oncology
707874|NCT00999154|HV|hv
705853|NCT00986973|BH4|bh4
705969|NCT00987389|GPA|gpa
117856|NCT02558673|Healthy|healthy
118640|NCT02553590|allergen|allergen
118641|NCT02553590|tree|tree
118642|NCT02553590|birch|birch
118643|NCT02553590|alder|alder
118850|NCT02552381|Cancer|cancer
709263|NCT00993811|HIV|hiv
707108|NCT00996229|Diet|diet
707251|NCT00996528|HIV|hiv
707358|NCT00986063|treatment naive|treatment naive
118851|NCT02552381|Thromboembolic event|thromboembolic event
709885|NCT01003626|IFP|ifp
710259|NCT00997139|nasal|nasal
710463|NCT01004861|PVNS|pvns
118852|NCT02552381|Fibrin Structure|fibrin structure
118853|NCT02552381|LMWH|lmwh
118854|NCT02552368|Stroke Rehabilitation|stroke rehabilitation
118855|NCT02552368|BCI|bci
118856|NCT02552368|Stroke|stroke
118857|NCT02552368|Upper Extremity Rehabilitation|upper extremity rehabilitation
118858|NCT02552368|paresis|paresis
708149|NCT00989261|AML|aml
708435|NCT00990379|HIV|hiv
708525|NCT00990665|CRT|crt
708798|NCT00992446|NHL|nhl
708827|NCT00992589|GERD|gerd
118859|NCT02552368|hemiparesis|hemiparesis
118861|NCT02552329|Tai Chi|tai chi
119040|NCT02551315|DXA|dxa
119644|NCT02547740|macula|macula
713041|NCT01011413|HIV|hiv
710891|NCT01006655|asthma|asthma
713487|NCT01019915|CRT|crt
711209|NCT01000948|ZD4054|zd4054
711426|NCT01007266|Buddy|buddy
714014|NCT01023308|DACi|daci
714123|NCT01023620|HIV|hiv
711896|NCT01015092|HIV|hiv
712062|NCT01015625|TGF|tgf
712121|NCT01004666|CZT|czt
119725|NCT02547025|Helicobacter pylori|helicobacter pylori
119726|NCT02547025|third-line therapy|third-line therapy
120035|NCT02545192|PTSD|ptsd
121400|NCT02536417|Delirium prevention|delirium prevention
121401|NCT02536417|End-of-life|end-of-life
121402|NCT02536352|Fluoride Supplementation|fluoride supplementation
122113|NCT02531880|MRI|mri
122204|NCT02531282|Patient education as topic|patient education as topic
122521|NCT02529761|HCC|hcc
122922|NCT02527005|IPT|ipt
713042|NCT01011413|ART|art
715663|NCT01008748|EMA|ema
716093|NCT01021020|fed|fed
124104|NCT02519582|Colorectal Cancer|colorectal cancer
124105|NCT02519582|S100A4|s100a4
124106|NCT02519556|Probiotics|probiotics
714507|NCT01009866|astrocytomas|astrocytomas
717015|NCT01030640|IENF|ienf
124107|NCT02519556|Inflammation|inflammation
714919|NCT01016899|cancer|cancer
715200|NCT01025180|PCT|pct
717986|NCT01037049|CRM|crm
124108|NCT02519556|Awareness|awareness
124109|NCT02519556|Immune tolerance|immune tolerance
124609|NCT02516280|CO2 cryotherapy|co2 cryotherapy
124611|NCT02516267|platelet aggregability|platelet aggregability
716527|NCT01029002|CKD|ckd
125117|NCT02513264|Registry|registry
717228|NCT01032525|IBD|ibd
125119|NCT02513212|Sensitivity|sensitivity
717506|NCT01033695|Cancer|cancer
718005|NCT01037088|mood|mood
720518|NCT01045733|Toric|toric
125120|NCT02513199|Hepatocellular Carcinoma|hepatocellular carcinoma
718402|NCT01038635|MDS|mds
125230|NCT02512575|AZD9567|azd9567
125419|NCT02511600|Progel|progel
718880|NCT01039311|Lung|lung
718978|NCT01039636|Iron chelation|iron chelation
721611|NCT01053325|HIV|hiv
719450|NCT01041365|females|females
722025|NCT01055158|HIV|hiv
125420|NCT02511600|Talcum powder|talcum powder
723005|NCT01048476|AMD|amd
125421|NCT02511600|Pain questionnaires|pain questionnaires
125422|NCT02511600|Surveys|surveys
721497|NCT01052584|malaria|malaria
724166|NCT01047501|EPA|epa
722083|NCT01055379|Cognition|cognition
722086|NCT01055392|Lithium|lithium
722399|NCT01046942|TEG|teg
725066|NCT01067833|AF|af
125423|NCT02511600|Intraoperative air leaks|intraoperative air leaks
126617|NCT02504502|Laboratory Report|laboratory report
126618|NCT02504502|Patient Centered|patient centered
126684|NCT02504008|RSD|rsd
126717|NCT02503852|Female Pattern Baldness|female pattern baldness
723792|NCT01057251|Nebivolol|nebivolol
723940|NCT01057784|bariatric|bariatric
724236|NCT01052922|Colonoscopy|colonoscopy
726909|NCT01064323|IPC|ipc
727006|NCT01064700|Anxiety|anxiety
724625|NCT01061086|Greece|greece
724829|NCT01061970|COPD|copd
724946|NCT01062490|MDS|mds
725040|NCT01062724|Methionine|methionine
728480|NCT01065285|H1N1|h1n1
727484|NCT01066728|apnea|apnea
126718|NCT02503852|Male Pattern Baldness|male pattern baldness
126719|NCT02503852|Genetic Alopecia|genetic alopecia
127312|NCT02500654|Regenerative therapy|regenerative therapy
127619|NCT02498912|Intraperitoneal Infusion|intraperitoneal infusion
728737|NCT01085851|Sunburn|sunburn
726516|NCT01072942|Phase I|phase i
729606|NCT01089465|Cimex|cimex
729900|NCT01090700|HCV|hcv
727670|NCT01067469|CNS|cns
727777|NCT01073423|sleep|sleep
730401|NCT01080833|EMS|ems
728847|NCT01086358|triptan|triptan
728268|NCT01075581|Hemostasis|hemostasis
730765|NCT01082718|Brazil|brazil
731627|NCT01077635|HIV|hiv
729436|NCT01088776|CKD|ckd
729594|NCT01089400|CD4|cd4
729823|NCT01090336|ACS|acs
732450|NCT01095497|HAE|hae
127621|NCT02498899|Advanced Cancers|advanced cancers
730412|NCT01080859|oct|oct
730716|NCT01081847|Malaria|malaria
730840|NCT01082939|CLL|cll
127622|NCT02498899|Video|video
733215|NCT01098773|BNP|bnp
733474|NCT01099644|09-090|09-090
731383|NCT01077154|Breast Tumors|breast tumors
733978|NCT01092338|HIV|hiv
734245|NCT01093443|IVF|ivf
732009|NCT01093703|hypertension|hypertension
734444|NCT01101867|glucose|glucose
732203|NCT01094496|muscle invasive|muscle invasive
732381|NCT01095237|ABI|abi
732687|NCT01082081|paracetamol|paracetamol
732786|NCT01082497|Stress|stress
733000|NCT01096095|SCA|sca
127623|NCT02498899|Questionnaires|questionnaires
127624|NCT02498899|Surveys|surveys
128425|NCT02494765|3D magnetic resonance imaging|3d magnetic resonance imaging
733052|NCT01096303|COPD|copd
128426|NCT02494752|Contour deformities of face|contour deformities of face
733210|NCT01098734|eczema|eczema
128427|NCT02494752|autologous fat grafting|autologous fat grafting
735898|NCT01106534|Stents|stents
733605|NCT01100307|Macugen|macugen
736292|NCT01107145|Vivax|vivax
733985|NCT01092416|CAD|cad
128428|NCT02494752|Post traumatic facial contour defects|post traumatic facial contour defects
128429|NCT02494739|antioxidant|antioxidant
734273|NCT01093495|RDS|rds
128430|NCT02494739|oxidative stress|oxidative stress
734462|NCT01101971|Gynecology|gynecology
734606|NCT01102673|PK|pk
734763|NCT01103388|Rituxan|rituxan
128431|NCT02494739|inflammation|inflammation
128731|NCT02492737|myelodysplastic syndrome|myelodysplastic syndrome
737167|NCT01111968|adjuvant|adjuvant
735213|NCT01097577|PRK|prk
737644|NCT01113918|HA,|ha,
735533|NCT01104974|HIV|hiv
735815|NCT01106014|PAH|pah
735912|NCT01106573|fibulin-1|fibulin-1
128733|NCT02492737|dual mutation|dual mutation
128734|NCT02492737|MPN|mpn
736309|NCT01107197|Healing|healing
736503|NCT01108328|viscous|viscous
128746|NCT02492724|NDI|ndi
129332|NCT02488707|low rectal cancer|low rectal cancer
736788|NCT01109498|LPLD|lpld
736885|NCT01109953|Lung|lung
129333|NCT02488707|minimally invasive colorectal surgery|minimally invasive colorectal surgery
737087|NCT01111630|Anaemia|anaemia
739565|NCT01120821|PV|pv
739656|NCT01121588|ALK|alk
737277|NCT01112553|Imaging|imaging
739762|NCT01122043|DSAEK|dsaek
739894|NCT01122615|RCC|rcc
740018|NCT01123161|tPA|tpa
740439|NCT01118117|SFA|sfa
740611|NCT01127204|HIV|hiv
738371|NCT01116310|Soy isoflavones|soy isoflavones
738477|NCT01116700|Seizure|seizure
741108|NCT01129232|insulin|insulin
738873|NCT01117233|PK|pk
738963|NCT01118533|Intubation|intubation
739069|NCT01118767|web|web
129334|NCT02488707|trans-anal endoscopic microsurgery|trans-anal endoscopic microsurgery
129335|NCT02488707|TEM|tem
129728|NCT02486497|Adjuvant chemotherapy|adjuvant chemotherapy
129729|NCT02486497|hENT1|hent1
739177|NCT01119144|eye|eye
739267|NCT01119508|TMZ|tmz
129743|NCT02486458|Topical|topical
741897|NCT01132859|HV|hv
130038|NCT02484716|Timolol|timolol
130749|NCT02480725|CJD|cjd
130848|NCT02479906|PTSD|ptsd
130943|NCT02479451|Dialysis|dialysis
740264|NCT01117662|kidney|kidney
740432|NCT01118091|Randomized|randomized
131049|NCT02478762|Foetal glycated hemoglobin|foetal glycated hemoglobin
743053|NCT01136200|Adults|adults
740894|NCT01128400|obesity|obesity
741352|NCT01131065|HBV|hbv
742080|NCT01124812|NSCLC|nsclc
741670|NCT01132547|cachexia|cachexia
744153|NCT01138878|HIV|hiv
742002|NCT01124604|Pain|pain
744436|NCT01133574|SLV354|slv354
742287|NCT01125722|Urgency|urgency
742390|NCT01126216|5-FU|5-fu
742670|NCT01134419|Handoff|handoff
743096|NCT01136395|CMV|cmv
131050|NCT02478762|Glycemic objectives treatment|glycemic objectives treatment
131437|NCT02476708|schizoaffective disorder|schizoaffective disorder
131438|NCT02476708|cognition|cognition
131736|NCT02474797|Diaphragm|diaphragm
743445|NCT01136746|Hospital|hospital
131737|NCT02474797|Lung ultrasound|lung ultrasound
131738|NCT02474797|Sepsis|sepsis
744263|NCT01139346|sarcoma|sarcoma
744610|NCT01140633|HIV/AIDS|hiv/aids
131836|NCT02474290|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
131837|NCT02474238|Iridotomy|iridotomy
131838|NCT02474225|intraocular pressure|intraocular pressure
747384|NCT01153217|BMD|bmd
745079|NCT01142466|Rebif|rebif
745175|NCT01142908|Diabetes|diabetes
745283|NCT01137487|vomiting|vomiting
747859|NCT01155375|CKD|ckd
745461|NCT01144559|UCSD|ucsd
745713|NCT01145638|CIA|cia
745907|NCT01146548|MSA|msa
745948|NCT01140360|Neurofibromas|neurofibromas
746146|NCT01147614|Child|child
746251|NCT01147874|non-therapeutic|non-therapeutic
746842|NCT01143818|Male hypogonadism|male hypogonadism
746946|NCT01149707|Mild|mild
131839|NCT02474225|intravitreal|intravitreal
747346|NCT01153048|peer educators|peer educators
748300|NCT01157078|MDD|mdd
748597|NCT01150929|DXA|dxa
751075|NCT01168440|VHL|vhl
132040|NCT02473081|Type 2 diabetes|type 2 diabetes
751445|NCT01169649|10-067|10-067
751581|NCT01170325|EEG|eeg
749224|NCT01159691|Rotigotine|rotigotine
749324|NCT01160159|IMT|imt
749625|NCT01161589|CRT D|crt d
749781|NCT01162330|CMV|cmv
752398|NCT01172873|OCD|ocd
752490|NCT01167426|CIS|cis
750112|NCT01163838|LDL|ldl
750284|NCT01164878|Preterm|preterm
750391|NCT01165450|cornea|cornea
750686|NCT01166867|assessment|assessment
751305|NCT01169207|IBD|ibd
751362|NCT01169402|ECMO|ecmo
751462|NCT01169753|CML|cml
132041|NCT02473081|Minimal psychological intervention|minimal psychological intervention
132242|NCT02472145|CLS362|cls362
132659|NCT02469766|SWL|swl
132739|NCT02469389|Schizophrenia|schizophrenia
132740|NCT02469389|Negative Symptoms|negative symptoms
132763|NCT02469246|HIV|hiv
132851|NCT02468713|DHA|dha
133547|NCT02464774|Mastectomy|mastectomy
133548|NCT02464774|Recurrence|recurrence
133549|NCT02464735|Sleep disruption|sleep disruption
133550|NCT02464735|Spontaneous breathing trial|spontaneous breathing trial
133654|NCT02464397|Vascular healing of coronary stents in patients with acute coronary syndrome|vascular healing of coronary stents in patients with acute coronary syndrome
133655|NCT02464384|ultrasound and cartilage biodegradation markers|ultrasound and cartilage biodegradation markers
133656|NCT02464371|muscle weakness|muscle weakness
133751|NCT02463903|Anxiety|anxiety
133846|NCT02463435|sarcopenia|sarcopenia
133847|NCT02463435|inflammation|inflammation
133848|NCT02463435|food intake|food intake
135059|NCT02456155|ultrasound|ultrasound
135060|NCT02456155|severe acute pancreatitis|severe acute pancreatitis
135061|NCT02456155|endoscope|endoscope
135356|NCT02454114|Pneumonia|pneumonia
135462|NCT02453724|Lung|lung
135463|NCT02453724|Hemorrhage|hemorrhage
135464|NCT02453724|Point of care ultrasound|point of care ultrasound
135561|NCT02452983|Anemia|anemia
135916|NCT02450552|ALS|als
136254|NCT02448589|MTD|mtd
136439|NCT02447159|Hospitals, Maternity/Utilization|hospitals, maternity/utilization
136847|NCT02444897|PCA|pca
136848|NCT02444897|laparoscopy|laparoscopy
136849|NCT02444871|IgM-enriched immunoglobulins|igm-enriched immunoglobulins
136850|NCT02444871|endotoxin activity assay|endotoxin activity assay
136851|NCT02444871|thrombelastometry|thrombelastometry
136852|NCT02444871|aggregometry|aggregometry
136964|NCT02444221|Stroke|stroke
138367|NCT02436252|MDS|mds
138448|NCT02435940|rod dystrophy|rod dystrophy
138449|NCT02435940|rod monochromacy|rod monochromacy
138450|NCT02435940|Sorsby pseudoinflammatory dystrophy|sorsby pseudoinflammatory dystrophy
139250|NCT02431312|DNA vaccine|dna vaccine
139251|NCT02431312|electroporation|electroporation
139252|NCT02431286|nausea and vomiting, postoperative|nausea and vomiting, postoperative
139253|NCT02431286|emesis, postoperative|emesis, postoperative
139254|NCT02431273|TDF|tdf
139255|NCT02431273|FTC|ftc
139445|NCT02430168|Stone|stone
139539|NCT02429752|low back pain|low back pain
139540|NCT02429752|respiration|respiration
139541|NCT02429752|breathing|breathing
139542|NCT02429739|Working Memory Training, computerized|working memory training, computerized
139543|NCT02429739|Dyslexia|dyslexia
139544|NCT02429739|Reading fluency|reading fluency
139676|NCT02429037|p53|p53
139902|NCT02427919|AML|aml
139939|NCT02427711|Bipolar sealer|bipolar sealer
139940|NCT02427672|antisocial behavior|antisocial behavior
139941|NCT02427672|aggression|aggression
139942|NCT02427672|transcranial direct current stimulation|transcranial direct current stimulation
139943|NCT02427672|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
140552|NCT02424279|pain|pain
140650|NCT02423733|computerized therapy|computerized therapy
140651|NCT02423668|cataract surgery|cataract surgery
140652|NCT02423668|biometry|biometry
140653|NCT02423668|second eye refinement|second eye refinement
140654|NCT02423668|effective lens position|effective lens position
141014|NCT02421965|SMI|smi
142286|NCT02416453|Monovalent vaccine|monovalent vaccine
142287|NCT02416453|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
142825|NCT02413242|ICU|icu
142875|NCT02412904|Gonadotrophin releasing hormone (GnRH) antagonists|gonadotrophin releasing hormone (gnrh) antagonists
142876|NCT02412904|GnRH agonist|gnrh agonist
142877|NCT02412904|in vitro fertilization|in vitro fertilization
142878|NCT02412904|controled ovarian stimulation|controled ovarian stimulation
142879|NCT02412904|number of mature oocytes|number of mature oocytes
142880|NCT02412891|introduction of urinary catheter|introduction of urinary catheter
142881|NCT02412865|mhealth|mhealth
142882|NCT02412852|neuropathy|neuropathy
142883|NCT02412826|pancreatitis|pancreatitis
142884|NCT02412826|acoustic|acoustic
142885|NCT02412826|sensor|sensor
142886|NCT02412813|hypersensitivity|hypersensitivity
142887|NCT02412813|metal sensitivity|metal sensitivity
142888|NCT02412813|arthroplasty|arthroplasty
142889|NCT02412813|implant-related hypersensitivity|implant-related hypersensitivity
142890|NCT02412813|metal-on-metal implants|metal-on-metal implants
142891|NCT02412813|knee revision|knee revision
142892|NCT02412800|Extravascular lung water|extravascular lung water
142893|NCT02412800|Pulmonary vascualr permeability index|pulmonary vascualr permeability index
142894|NCT02412800|Liver transplantation|liver transplantation
142895|NCT02412774|diet beverages|diet beverages
142896|NCT02412774|water|water
142897|NCT02412774|diabetes|diabetes
142904|NCT02412748|Fathers|fathers
143092|NCT02411721|MRI|mri
143574|NCT02409043|Ischemic stroke|ischemic stroke
144380|NCT02404194|at risk|at risk
144499|NCT02403505|SNP|snp
144581|NCT02403193|Immunotherapy|immunotherapy
144679|NCT02402764|Erythroblastosis virus oncogene B (erbB)|erythroblastosis virus oncogene b (erbb)
144682|NCT02402699|HBV|hbv
144772|NCT02402140|intrasubject variability|intrasubject variability
144773|NCT02402127|Contact lenses|contact lenses
144774|NCT02402127|Lubricity|lubricity
144886|NCT02401529|Dexamethasone|dexamethasone
144887|NCT02401529|Prednisolone|prednisolone
144888|NCT02401529|Tonsillectomy Nausea|tonsillectomy nausea
144889|NCT02401529|Pain, Postoperative|pain, postoperative
144890|NCT02401529|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
144891|NCT02401529|Randomized controlled trial|randomized controlled trial
144892|NCT02401529|Post-tonsillectomy pain|post-tonsillectomy pain
144893|NCT02401529|delayed feeding|delayed feeding
144895|NCT02401516|Blood Pressure|blood pressure
145170|NCT02399657|implant|implant
145171|NCT02399644|pain|pain
146476|NCT02391662|Nab-paclitaxel|nab-paclitaxel
146478|NCT02391649|schizophrenia|schizophrenia
146480|NCT02391649|problem-solving|problem-solving
147015|NCT02388490|EBV|ebv
147383|NCT02386631|bunions|bunions
147384|NCT02386618|colorectal cancer|colorectal cancer
147631|NCT02385279|CAD|cad
147894|NCT02383953|twins|twins
148000|NCT02383147|Adult|adult
148092|NCT02382744|Ankle Surgery|ankle surgery
148093|NCT02382718|fish allergy|fish allergy
148094|NCT02382718|parvalbumin|parvalbumin
148198|NCT02381990|PSA|psa
148505|NCT02380521|Atherogenic lipoproteins|atherogenic lipoproteins
148506|NCT02380508|BCG study|bcg study
148507|NCT02380495|Adolescents|adolescents
148508|NCT02380495|Respiratory Pathology|respiratory pathology
148514|NCT02380469|Cancer|cancer
148605|NCT02380001|Dexketoprofen trometamol|dexketoprofen trometamol
148606|NCT02380001|third molar surgery|third molar surgery
148607|NCT02379962|biobanking|biobanking
148608|NCT02379962|research participation|research participation
148609|NCT02379962|China|china
148826|NCT02378701|MDS|mds
149230|NCT02376686|Music|music
149504|NCT02374827|standard tubal ligation|standard tubal ligation
149505|NCT02374827|cesarean delivery|cesarean delivery
149506|NCT02374827|feasibility|feasibility
149507|NCT02374827|safety|safety
149508|NCT02374827|partial salpingectomy|partial salpingectomy
149509|NCT02374801|CRT-D device|crt-d device
149512|NCT02374801|Sinus rhythm|sinus rhythm
149718|NCT02373449|fMRI|fmri
150301|NCT02370030|toxemia|toxemia
150302|NCT02370030|endothelial determination of progression|endothelial determination of progression
150817|NCT02367235|robotic|robotic
151111|NCT02364388|OA|oa
151208|NCT02364908|lupus Quality Of Life|lupus quality of life
151209|NCT02364908|internal medicine|internal medicine
151210|NCT02364895|Mailed invitation|mailed invitation
151211|NCT02364895|Fecal Occult Blood Test|fecal occult blood test
151212|NCT02364895|Screening|screening
151219|NCT02364856|Pain|pain
151505|NCT02363049|TNM Staging Primary Tumor (T)|tnm staging primary tumor (t)
151506|NCT02363049|Unresectable|unresectable
151507|NCT02363023|Ventilator associated pneumonia|ventilator associated pneumonia
151508|NCT02363023|Bronchoalveolar lavage|bronchoalveolar lavage
151509|NCT02363010|Obesity|obesity
151510|NCT02363010|Weight loss|weight loss
151511|NCT02363010|Overweight|overweight
151512|NCT02362997|Classical Hodgkin Lymphoma (cHL)|classical hodgkin lymphoma (chl)
151911|NCT02360631|smoking|smoking
152007|NCT02360072|child|child
152008|NCT02360072|allergic rhinitis|allergic rhinitis
152009|NCT02360072|asthma|asthma
152017|NCT02360059|Placebo|placebo
152211|NCT02358993|Pelvic Reconstructive Surgery|pelvic reconstructive surgery
152212|NCT02358993|Urogynecology|urogynecology
152213|NCT02358993|Urinary catheterization|urinary catheterization
152214|NCT02358993|Post-operative Infections|post-operative infections
152215|NCT02358993|Methenamine hippurate|methenamine hippurate
152216|NCT02358980|Multiple Myeloma|multiple myeloma
152817|NCT02355457|acs|acs
153217|NCT02353143|AML|aml
153726|NCT02350140|HIV|hiv
154701|NCT02344602|Physiological Effects of Drugs|physiological effects of drugs
154702|NCT02344602|Angiotensin II Infusion|angiotensin ii infusion
155299|NCT02341326|smoking|smoking
155826|NCT02338050|ALL|all
155895|NCT02337673|Electrical Impedance Tomography|electrical impedance tomography
156400|NCT02334280|Community mental health|community mental health
156401|NCT02334280|Health coach|health coach
156497|NCT02333799|TB|tb
156535|NCT02333552|Fit|fit
156704|NCT02332512|apatinib|apatinib
157298|NCT02328794|NRT|nrt
157417|NCT02328118|PDR|pdr
157594|NCT02327325|Aged|aged
158076|NCT02324764|radial artery occlusion|radial artery occlusion
158077|NCT02324764|coronary heart disease|coronary heart disease
158078|NCT02324764|Glidesheath Slender|glidesheath slender
158079|NCT02324738|Mefloquine/Dihydroartemisinin-piperaquine|mefloquine/dihydroartemisinin-piperaquine
158273|NCT02323555|Cancer|cancer
158373|NCT02323022|AML|aml
158571|NCT02322164|Skin|skin
158704|NCT02321527|SLN|sln
159726|NCT02315911|OSA|osa
159780|NCT02315638|HCV|hcv
160371|NCT02312401|MRI|mri
160570|NCT02311192|B scan|b scan
161273|NCT02307240|NMC|nmc
162361|NCT02301130|Tremelimumab|tremelimumab
162362|NCT02301130|POTELIGEO®|poteligeo®
162363|NCT02301130|KW-0761|kw-0761
162364|NCT02301117|Renal|renal
162365|NCT02301117|Kidney Diseases|kidney diseases
162366|NCT02301117|Urologic Diseases|urologic diseases
162367|NCT02301117|Renal Insufficiency|renal insufficiency
162385|NCT02301104|LFT|lft
162466|NCT02300597|ADHD|adhd
162471|NCT02300558|LQT3|lqt3
163330|NCT02295293|Herbal medicine|herbal medicine
163331|NCT02295280|headache|headache
163332|NCT02295267|Food allergy|food allergy
163334|NCT02295267|Components|components
163335|NCT02295267|Allergens|allergens
163629|NCT02293733|EGFR|egfr
163844|NCT02292680|dentin|dentin
164028|NCT02291809|Vaccine|vaccine
165094|NCT02285699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
165095|NCT02285686|troponin|troponin
165201|NCT02285049|Chronic urticaria|chronic urticaria
165202|NCT02285049|Urticaria Control Test|urticaria control test
165203|NCT02285023|Chronic urticaria|chronic urticaria
165204|NCT02285023|CU-Q2oL|cu-q2ol
165205|NCT02285010|pregabalin|pregabalin
165206|NCT02285010|postoperative pain|postoperative pain
165207|NCT02285010|abdominal hysterectomy|abdominal hysterectomy
165208|NCT02284984|Antibodies, Monoclonal|antibodies, monoclonal
165209|NCT02284984|mabthera|mabthera
165210|NCT02284984|benlysta|benlysta
165211|NCT02284984|Antinuclear Antibodies|antinuclear antibodies
165212|NCT02284958|walking|walking
165213|NCT02284958|pedometer|pedometer
165293|NCT02284191|Emergency Medicine|emergency medicine
165294|NCT02284191|Cardiology|cardiology
165295|NCT02284178|mechanical ventilation|mechanical ventilation
165394|NCT02283502|non-invasive therapy|non-invasive therapy
165397|NCT02283489|clinical trial|clinical trial
166012|NCT02280174|TRL|trl
166189|NCT02279264|placement|placement
166190|NCT02279264|Nasogastric Tube|nasogastric tube
166437|NCT02278120|CDK|cdk
166930|NCT02274974|cs|cs
168204|NCT02267798|Stroke|stroke
168465|NCT02266381|PCNL|pcnl
168473|NCT02266368|UTI|uti
168745|NCT02264509|Ankle-brachial index|ankle-brachial index
168746|NCT02264509|HAART|haart
169143|NCT02261857|Obstructive Sleep Apnea|obstructive sleep apnea
169144|NCT02261857|Craniofacial Abnormalities|craniofacial abnormalities
169243|NCT02261389|follow-up|follow-up
169244|NCT02261389|tumor markers|tumor markers
169245|NCT02261376|pharmacokinetics|pharmacokinetics
169369|NCT02260388|CSPN|cspn
169544|NCT02259257|CEUS|ceus
170930|NCT02251652|Actinic|actinic
171510|NCT02248662|DCIS|dcis
172115|NCT02246218|UCD|ucd
172500|NCT02244385|obesity|obesity
172605|NCT02243774|Letters|letters
172995|NCT02241733|dynamic hyperinflation|dynamic hyperinflation
172996|NCT02241707|Varicose vein|varicose vein
172997|NCT02241707|Endovenous ablation|endovenous ablation
172998|NCT02241707|Compression|compression
173190|NCT02240927|Anticoagulation|anticoagulation
173191|NCT02240927|Prosthetic Heart Valves|prosthetic heart valves
173690|NCT02238548|milk|milk
173883|NCT02237456|Myocardial infarction|myocardial infarction
173884|NCT02237456|Atherosclerosis|atherosclerosis
173885|NCT02237456|PCI|pci
173886|NCT02237456|OCT|oct
175214|NCT02231541|Pain|pain
175398|NCT02230930|Massage|massage
175604|NCT02230111|Women|women
177818|NCT02220439|rotavirus vaccine|rotavirus vaccine
177819|NCT02220439|gut microbiome|gut microbiome
177820|NCT02220439|microbiome|microbiome
177821|NCT02220426|Brown adipose tissue|brown adipose tissue
177822|NCT02220426|Hyperpolarized xenon gas MRI|hyperpolarized xenon gas mri
178410|NCT02217878|morphine|morphine
178893|NCT02215525|HCV|hcv
179710|NCT02211625|Healthy|healthy
179897|NCT02210806|Mild-to-moderate persistent asthma|mild-to-moderate persistent asthma
179898|NCT02210806|Mild asthma|mild asthma
179899|NCT02210806|Moderate asthma|moderate asthma
179900|NCT02210806|Persistent asthma|persistent asthma
179962|NCT02210481|OCT|oct
179996|NCT02210286|memory|memory
180989|NCT02205684|Smoking|smoking
181243|NCT02204683|AMD|amd
181292|NCT02204488|Thumb|thumb
183857|NCT02192814|LCM|lcm
184967|NCT02188420|PAS|pas
185168|NCT02187653|Intraoperative Neuromonitoring|intraoperative neuromonitoring
185169|NCT02187653|Spine|spine
185170|NCT02187653|Lumbar|lumbar
185171|NCT02187653|Cervical|cervical
185172|NCT02187640|Acupressure|acupressure
185173|NCT02187640|Self-administration|self-administration
185175|NCT02187640|Constipation|constipation
185714|NCT02185365|DDH|ddh
185810|NCT02184949|PCI|pci
185971|NCT02184208|ALI|ali
185972|NCT02184208|mechanical ventilation|mechanical ventilation
185974|NCT02184169|hemodynamics|hemodynamics
187852|NCT02173093|Osteosarcoma|osteosarcoma
187853|NCT02173093|Solid tumor|solid tumor
187854|NCT02173093|Immunotherapy targeting GD2|immunotherapy targeting gd2
187855|NCT02173093|Bispecific antibodies|bispecific antibodies
187856|NCT02173093|Activated T cells|activated t cells
187947|NCT02172638|ERAS|eras
187948|NCT02172638|Fast-Track|fast-track
187949|NCT02172638|Ovarian cancer|ovarian cancer
188044|NCT02171338|Procalcitonin|procalcitonin
188539|NCT02168972|global|global
188966|NCT02166879|OSA|osa
189514|NCT02164188|Stress|stress
189831|NCT02162849|NRT|nrt
189959|NCT02162329|Surveys|surveys
190036|NCT02162017|Death|death
191101|NCT02157038|MRI|mri
191596|NCT02154750|AV block|av block
191597|NCT02154750|Echocardiography|echocardiography
191598|NCT02154750|Arrhythmia|arrhythmia
191599|NCT02154750|AV optimization|av optimization
191600|NCT02154737|Pancreatic|pancreatic
191701|NCT02154139|Pharmacological therapy|pharmacological therapy
191804|NCT02153658|HIV|hiv
191901|NCT02153242|Haemodynamics|haemodynamics
191902|NCT02153242|Pilot|pilot
192976|NCT02148094|HIV|hiv
193292|NCT02146742|ASP1707|asp1707
193600|NCT02145390|TCC|tcc
193979|NCT02143791|SCS|scs
194086|NCT02143349|obesity|obesity
194789|NCT02139930|smoking|smoking
194898|NCT02139358|HER2+|her2+
195883|NCT02134600|DHA|dha
196158|NCT02133586|Ozone|ozone
196566|NCT02131649|PET|pet
196662|NCT02131129|first episode|first episode
196663|NCT02131129|psychosis|psychosis
196664|NCT02131129|cognition|cognition
196665|NCT02131116|schizophrenia|schizophrenia
196666|NCT02131116|schizophreniform disorder|schizophreniform disorder
196670|NCT02131116|insight|insight
196763|NCT02130804|Hispanics|hispanics
196765|NCT02130765|Ischemic|ischemic
196874|NCT02130349|IBD|ibd
197262|NCT02128867|GOR|gor
197645|NCT02127099|OSA|osa
198817|NCT02121626|Vomiting|vomiting
198818|NCT02121626|Weight loss|weight loss
199127|NCT02120313|total knee arthroplasty|total knee arthroplasty
199128|NCT02120287|Border Zone Stereotactic Radiosurgery|border zone stereotactic radiosurgery
199129|NCT02120287|Bevacizumab|bevacizumab
199130|NCT02120287|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
199131|NCT02120287|Progressive Glioblastoma Multiforme|progressive glioblastoma multiforme
199615|NCT02118259|Adverse drug events geriatric risk score|adverse drug events geriatric risk score
199616|NCT02118259|Residence for dependent elderly|residence for dependent elderly
199617|NCT02118246|Knee pain,Dry Needling, kinesioTape,Trigger point|knee pain,dry needling, kinesiotape,trigger point
199618|NCT02118233|carotid|carotid
199619|NCT02118233|stenosis|stenosis
199620|NCT02118233|surgery|surgery
199621|NCT02118233|cognitive|cognitive
199715|NCT02117830|To determine|to determine
199716|NCT02117830|effects|effects
199717|NCT02117830|once|once
199718|NCT02117830|daily|daily
199719|NCT02117830|oral doses|oral doses
199919|NCT02116920|VIA|via
199920|NCT02116920|Cervix Cancer|cervix cancer
199921|NCT02116907|Healthy|healthy
199922|NCT02116907|Male Subjects|male subjects
199923|NCT02116894|Colorectal cancer|colorectal cancer
201116|NCT02112175|MPV|mpv
201301|NCT02111447|MRI|mri
201754|NCT02109367|HE4|he4
202813|NCT02105233|brain|brain
202901|NCT02104700|HIV|hiv
202902|NCT02104687|GTD, goal-directed haemodynamic therapy|gtd, goal-directed haemodynamic therapy
202903|NCT02104687|CI, cardiac index|ci, cardiac index
203804|NCT02100449|Doppler|doppler
204136|NCT02098954|TKI|tki
204207|NCT02098668|endometriosis|endometriosis
204208|NCT02098668|infertility|infertility
204209|NCT02098655|Stabilometric Platform|stabilometric platform
204210|NCT02098655|Postural instability|postural instability
204211|NCT02098642|Gait Disturbances|gait disturbances
204784|NCT02096055|AML|aml
205205|NCT02094144|Postmenopausal women|postmenopausal women
205206|NCT02094144|Body composition|body composition
205208|NCT02094144|Muscle strength|muscle strength
205209|NCT02094144|Depression, bone density|depression, bone density
205210|NCT02094144|Nutrition|nutrition
205224|NCT02094105|screening|screening
205503|NCT02092883|PET|pet
205698|NCT02091921|Critical Limb Ischemia, ticagrelor, Brilinta|critical limb ischemia, ticagrelor, brilinta
205700|NCT02091908|H5N1|h5n1
205978|NCT02090504|alcohol withdrawal syndrome|alcohol withdrawal syndrome
205980|NCT02090504|sodium oxybate|sodium oxybate
206665|NCT02086916|Failure|failure
207097|NCT02084940|IVF|ivf
207555|NCT02082886|CRS|crs
207752|NCT02082106|alpine skiing|alpine skiing
207753|NCT02082106|cross country skiing|cross country skiing
207754|NCT02082106|indoor cycling|indoor cycling
207755|NCT02082106|physical fitness|physical fitness
207756|NCT02082106|training status|training status
207977|NCT02081092|PAP|pap
208157|NCT02080286|tDCS|tdcs
208460|NCT02078843|NET|net
208853|NCT02077010|inhaled|inhaled
209045|NCT02076282|Optimization|optimization
209046|NCT02076282|MRI|mri
209047|NCT02076282|Radiotherapy|radiotherapy
209048|NCT02076269|HRCT|hrct
209146|NCT02075970|Survival|survival
209147|NCT02075970|Pharmacodynamics|pharmacodynamics
209148|NCT02075970|Model|model
209149|NCT02075957|Non-small cell lung cancer, adjuvant chemo-therapy, DNA chip|non-small cell lung cancer, adjuvant chemo-therapy, dna chip
209150|NCT02075944|Aerobic exercise|aerobic exercise
209151|NCT02075944|Cognitive function|cognitive function
209152|NCT02075944|Executive function|executive function
209204|NCT02075606|NET|net
209927|NCT02072356|HUD|hud
210427|NCT02069860|nephrology|nephrology
210428|NCT02069860|retroauricular anchored devices|retroauricular anchored devices
210433|NCT02069847|Budesonide|budesonide
210841|NCT02067962|JIA|jia
212424|NCT02060786|Antiplatelet; clopidogrel; acute coronary syndrome|antiplatelet; clopidogrel; acute coronary syndrome
212425|NCT02060773|Septic shock|septic shock
212426|NCT02060773|Early goal directed therapy|early goal directed therapy
212427|NCT02060773|Fluid resuscitation|fluid resuscitation
212484|NCT02060513|KPC|kpc
213210|NCT02057146|PSC|psc
213719|NCT02055118|MPS2|mps2
214709|NCT02050542|PSA|psa
214796|NCT02050230|pulmonary hypertension|pulmonary hypertension
214797|NCT02050230|intensive care medicine|intensive care medicine
214893|NCT02049827|Renal transplant, BK virus|renal transplant, bk virus
214894|NCT02049814|Drug therapy|drug therapy
214895|NCT02049762|novel P2Y12 inhibitors|novel p2y12 inhibitors
214896|NCT02049762|aspirin|aspirin
215001|NCT02049294|Allergy|allergy
215912|NCT02045537|HIV|hiv
216103|NCT02044692|Mucopolysaccharidosis II|mucopolysaccharidosis ii
216104|NCT02044692|Hunterase|hunterase
216105|NCT02044666|Critical Limb Ischemia|critical limb ischemia
216106|NCT02044666|Amputation|amputation
216500|NCT02043080|UNC|unc
216899|NCT02041494|Herniorrhaphy|herniorrhaphy
217925|NCT02036671|CKD|ckd
218828|NCT02032316|UURS|uurs
219281|NCT02030028|Rheumatoid Arthritis|rheumatoid arthritis
219289|NCT02030015|Sandhoff disease|sandhoff disease
221484|NCT02019927|NAION|naion
221584|NCT02019550|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
222074|NCT02017171|Glomerular filtration rate|glomerular filtration rate
222075|NCT02017171|Coronary artery disease|coronary artery disease
222076|NCT02017158|Obesity|obesity
222077|NCT02017158|Nutrition|nutrition
222078|NCT02017158|Children|children
222101|NCT02017067|RFD|rfd
222278|NCT02016235|Dents|dents
223086|NCT02012751|Melanoma|melanoma
223181|NCT02012322|Coenzyme Q10|coenzyme q10
223182|NCT02012322|Q10|q10
223183|NCT02012322|Quality of Life|quality of life
223184|NCT02012322|Oxidative Stress|oxidative stress
223185|NCT02012322|Mitochondrial Function|mitochondrial function
223186|NCT02012322|Cell Energetics|cell energetics
223187|NCT02012322|Fatigue|fatigue
223188|NCT02012322|Ubiquinone|ubiquinone
223771|NCT02009813|Insulin resistance|insulin resistance
223772|NCT02009813|Inflammation|inflammation
223773|NCT02009813|Hypoxia|hypoxia
223775|NCT02009774|Colonoscopy|colonoscopy
224064|NCT02008396|MDMA|mdma
225272|NCT02002819|AD|ad
225562|NCT02001597|surgery|surgery
225859|NCT02000297|Knee|knee
225953|NCT01999959|Unexplained Infertility, Pertubation, Gonadotrophin, Ovulation Induction, Intrauterine Insemination|unexplained infertility, pertubation, gonadotrophin, ovulation induction, intrauterine insemination
226453|NCT01997762|beta cell function|beta cell function
226454|NCT01997762|history|history
226455|NCT01997749|stroke, ketogenic diet, ketosis, ischemia, brain, ketones, hyperglycemia, neuroprotection|stroke, ketogenic diet, ketosis, ischemia, brain, ketones, hyperglycemia, neuroprotection
226456|NCT01997736|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
226457|NCT01997736|Catheter Ablation|catheter ablation
226458|NCT01997736|Ablation Techniques|ablation techniques
226459|NCT01997723|OSA, portable monitoring, home diagnosis|osa, portable monitoring, home diagnosis
226460|NCT01997684|Colorectal Cancer|colorectal cancer
226461|NCT01997684|Colonic Obstruction|colonic obstruction
226462|NCT01997671|Primary Care|primary care
226463|NCT01997671|Lipid-lowering therapy|lipid-lowering therapy
226464|NCT01997671|Prescription|prescription
226465|NCT01997671|Adequacy|adequacy
226504|NCT01997489|Eye|eye
226647|NCT01996852|Erectile dysfunction|erectile dysfunction
226648|NCT01996852|ED|ed
226649|NCT01996852|Prostate|prostate
226650|NCT01996852|Prostatectomy|prostatectomy
226764|NCT01996384|TCM|tcm
227166|NCT01994668|healthy|healthy
228167|NCT01989468|PsA|psa
228274|NCT01989052|CTO|cto
228325|NCT01988857|Children|children
228326|NCT01988857|Reactogenicity|reactogenicity
228327|NCT01988857|BoostrixTM|boostrixtm
228328|NCT01988857|Safety|safety
229141|NCT01984892|Efficacy|efficacy
229655|NCT01982968|GER|ger
229968|NCT01981499|safety|safety
231058|NCT01976598|leg|leg
231356|NCT01975051|Pathogenesis|pathogenesis
231357|NCT01975051|Bangladesh|bangladesh
231358|NCT01975038|Melanin Index|melanin index
231359|NCT01975038|Fitzpatrick Skin Phototype|fitzpatrick skin phototype
231360|NCT01975038|Spectrophotometry|spectrophotometry
231363|NCT01974999|Kidney|kidney
232472|NCT01970072|Health|health
233546|NCT01965535|HCV|hcv
233881|NCT01964105|3D|3d
234045|NCT01963429|RFA|rfa
234328|NCT01962376|Oxaliplatin|oxaliplatin
234329|NCT01962376|Bevacizumab|bevacizumab
234330|NCT01962376|Potentially Resectable Gastric Cancer Liver Metastasis|potentially resectable gastric cancer liver metastasis
234331|NCT01962363|Friedreich's ataxia point mutation|friedreich's ataxia point mutation
254142|NCT01870635|Low-middle income country|low-middle income country
234332|NCT01962350|Deep Brain Transcranial Magnetic Stimulation;|deep brain transcranial magnetic stimulation;
234333|NCT01962350|H1-Coil deep brain rTMS;|h1-coil deep brain rtms;
234334|NCT01962350|H1-Coil;|h1-coil;
234542|NCT01961297|tremor|tremor
234626|NCT01960933|STEMI|stemi
234721|NCT01960400|Complex regional pain syndrome type 1 (CRPS)|complex regional pain syndrome type 1 (crps)
234722|NCT01960400|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
234723|NCT01960400|Graded motor imagery (GMI)|graded motor imagery (gmi)
235236|NCT01957800|website|website
235702|NCT01955278|Mesh|mesh
235886|NCT01954498|Sperm|sperm
236180|NCT01953237|antipsychotic medication adherence|antipsychotic medication adherence
236181|NCT01953237|mobile phones|mobile phones
236182|NCT01953224|Physical activity|physical activity
236183|NCT01953224|Video game|video game
236184|NCT01953224|Mobile|mobile
236185|NCT01953224|Technology|technology
236489|NCT01951690|FAK inhibitor|fak inhibitor
236490|NCT01951690|Cancer Stem Cells|cancer stem cells
236491|NCT01951690|CSC|csc
236492|NCT01951690|KRAS mutation|kras mutation
236493|NCT01951677|hepatitis B virus|hepatitis b virus
236495|NCT01951677|adjuvant|adjuvant
236496|NCT01951677|prophylaxis|prophylaxis
236497|NCT01951651|Diabetes|diabetes
236498|NCT01951638|Worsening Heart Failure|worsening heart failure
236499|NCT01951638|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
236690|NCT01948622|Anxiety|anxiety
236908|NCT01949844|MRI|mri
237407|NCT01947270|Elderly|elderly
237482|NCT01947036|autoimmune disease|autoimmune disease
237483|NCT01947036|immune-mediated disease|immune-mediated disease
237485|NCT01947036|IL23 signaling|il23 signaling
237582|NCT01946542|physical endurance|physical endurance
237583|NCT01946542|functional food|functional food
237584|NCT01946516|viral screening|viral screening
238168|NCT01943825|IXIARO JE vaccine|ixiaro je vaccine
238169|NCT01943825|Flavivirus|flavivirus
238921|NCT01940289|VAS|vas
239049|NCT01939834|Continuous Glucose Monitor|continuous glucose monitor
239050|NCT01939821|Fecal incontinence|fecal incontinence
239051|NCT01939821|attitudes|attitudes
239052|NCT01939821|knowledge|knowledge
239357|NCT01938456|Japanese|japanese
240077|NCT01934855|cancer|cancer
240261|NCT01933906|CML|cml
243026|NCT01921127|COPD, Comparative effectiveness, Symbicort|copd, comparative effectiveness, symbicort
243027|NCT01921101|nutrition|nutrition
243028|NCT01921101|enteral feeding|enteral feeding
243029|NCT01921101|parenteral feeding|parenteral feeding
243030|NCT01921101|hospital malnutrition|hospital malnutrition
243031|NCT01921088|fMRI|fmri
243065|NCT01920867|MSC|msc
244411|NCT01915290|physical activity|physical activity
244412|NCT01915290|maximal oxygen uptake|maximal oxygen uptake
244610|NCT01914419|Bolus|bolus
246199|NCT01906281|adipocytokines|adipocytokines
246200|NCT01906281|osteoarthritis|osteoarthritis
246201|NCT01906281|cardiovascular risk|cardiovascular risk
246202|NCT01906268|Generalized Anxiety Disorder|generalized anxiety disorder
246203|NCT01906268|Social Anxiety Disorder|social anxiety disorder
246540|NCT01904552|i-Root|i-root
246594|NCT01904318|PDF inhibitor|pdf inhibitor
246595|NCT01904305|Pneumonia|pneumonia
246596|NCT01904253|Second line Small Cell Lung Cancer, (SCLC), Refractory or Sensitive to First line Platinum based chemotherapy|second line small cell lung cancer, (sclc), refractory or sensitive to first line platinum based chemotherapy
246624|NCT01904136|AML|aml
246777|NCT01903733|CML|cml
246972|NCT01902771|Tumor Lysate|tumor lysate
246973|NCT01902771|Glioblastoma Multiforme|glioblastoma multiforme
246974|NCT01902771|GBM|gbm
246975|NCT01902771|Pheresis|pheresis
246976|NCT01902771|Leukapheresis|leukapheresis
248482|NCT01895361|SelG1|selg1
249272|NCT01892111|SET|set
249490|NCT01891344|CO-338|co-338
249653|NCT01890746|acute myeloid leukemia|acute myeloid leukemia
249848|NCT01889823|Innate immunity|innate immunity
249849|NCT01889810|Vitamin D, Pre-diabetes, Insulin Resistance|vitamin d, pre-diabetes, insulin resistance
251840|NCT01881022|Couples|couples
251943|NCT01880593|lithium|lithium
252262|NCT01879202|fatigue|fatigue
252346|NCT01878799|Direct Acting Antiviral|direct acting antiviral
252347|NCT01878799|Treatment Naive|treatment naive
252628|NCT01877746|ICM|icm
253542|NCT01873521|Patient/ventilator Asynchrony|patient/ventilator asynchrony
253543|NCT01873521|Pediatric patient|pediatric patient
253544|NCT01873521|Infant|infant
253545|NCT01873469|glioblastoma multiforme|glioblastoma multiforme
253546|NCT01873469|radiotherapy|radiotherapy
253547|NCT01873430|Melatonin|melatonin
253548|NCT01873430|Sunburn|sunburn
253549|NCT01873430|Erythema|erythema
254131|NCT01870687|prospective|prospective
254132|NCT01870674|safety|safety
254133|NCT01870674|tolerability|tolerability
254134|NCT01870674|pharmacokinetics|pharmacokinetics
254135|NCT01870674|pharmacodynamics|pharmacodynamics
254136|NCT01870661|Intravenous placement|intravenous placement
254137|NCT01870661|Ultrasound|ultrasound
254138|NCT01870648|Low-middle income country|low-middle income country
254139|NCT01870648|Dehydration|dehydration
254140|NCT01870648|Intravenous Rehydration|intravenous rehydration
254141|NCT01870648|Pakistan|pakistan
254143|NCT01870635|Dehydration|dehydration
254144|NCT01870635|Intravenous Rehydration|intravenous rehydration
254145|NCT01870635|Pakistan|pakistan
254146|NCT01870622|Newborn,|newborn,
254147|NCT01870622|Infant,|infant,
254148|NCT01870622|Endotracheal Intubation,|endotracheal intubation,
254149|NCT01870622|Carbon dioxide detector,|carbon dioxide detector,
254150|NCT01870622|Flow waves|flow waves
254153|NCT01870583|Pregnancy|pregnancy
255521|NCT01864291|Hearing loss|hearing loss
255522|NCT01864291|Non-tumor|non-tumor
255523|NCT01864291|Non-NF2|non-nf2
255871|NCT01862744|MRI|mri
256019|NCT01862055|Stress|stress
256421|NCT01860261|HIV|hiv
257221|NCT01857011|Anemia, Iron-Deficiency|anemia, iron-deficiency
257222|NCT01857011|bariatric surgery|bariatric surgery
257223|NCT01857011|abdominoplasty|abdominoplasty
257224|NCT01857011|surgery, plastic|surgery, plastic
257225|NCT01857011|iron|iron
258642|NCT01851304|Bitter|bitter
585131|NCT00518609|Sepsis|sepsis
259531|NCT01847365|Transcorneal electrical stimulation|transcorneal electrical stimulation
259533|NCT01847352|Hypoxia|hypoxia
259534|NCT01847352|Pulmonary hypertension|pulmonary hypertension
261119|NCT01839656|SMA|sma
261424|NCT01838395|Acute Myeloid Leukemia|acute myeloid leukemia
261425|NCT01838395|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
261441|NCT01838291|DFP|dfp
261823|NCT01836679|Chidamide,lung cancer|chidamide,lung cancer
261824|NCT01836653|Bevacizumab|bevacizumab
261825|NCT01836653|Cetuximab|cetuximab
261838|NCT01836575|PS2|ps2
262529|NCT01833169|BKM120|bkm120
264148|NCT01825954|Pain|pain
264447|NCT01823562|Prostate Cancer|prostate cancer
264448|NCT01823562|Surgery|surgery
264449|NCT01824784|Normal Eyes|normal eyes
264450|NCT01824771|Continuous veno-venoous haemofiltration|continuous veno-venoous haemofiltration
265553|NCT01819415|DHA|dha
267533|NCT01810159|substance use disorders|substance use disorders
267534|NCT01810159|implementation science|implementation science
267539|NCT01810133|Comorbidity|comorbidity
268534|NCT01805518|CNSVS|cnsvs
269848|NCT01799889|CLL|cll
271130|NCT01794364|Diabetes Mellitus Type 2|diabetes mellitus type 2
271131|NCT01794325|Occupational radiation exposure|occupational radiation exposure
271132|NCT01794325|Transradial approach|transradial approach
271133|NCT01794325|Transfemoral approach|transfemoral approach
271524|NCT01792531|children|children
271525|NCT01792531|obesity|obesity
271526|NCT01792531|treatment|treatment
271527|NCT01792531|family|family
271528|NCT01792492|Thyroid Neoplasms|thyroid neoplasms
273323|NCT01784263|Autism|autism
274628|NCT01778257|Obesity|obesity
274907|NCT01777100|Abdominal surgery|abdominal surgery
274908|NCT01777100|Safety|safety
275211|NCT01775696|Blood markers|blood markers
275212|NCT01775696|MRI|mri
275213|NCT01775683|homelessness|homelessness
275214|NCT01775670|Arthrosis|arthrosis
275215|NCT01775657|pulmonary air leak|pulmonary air leak
275216|NCT01775657|Thopaz|thopaz
275217|NCT01775657|digital|digital
275218|NCT01775657|analog|analog
275219|NCT01775657|randomized|randomized
275220|NCT01775618|Hemophilia A|hemophilia a
275221|NCT01775618|Factor VIII|factor viii
275222|NCT01775618|Prophylaxis|prophylaxis
275223|NCT01775618|Pediatric|pediatric
275224|NCT01775605|Subject|subject
275225|NCT01775592|P.f resistance|p.f resistance
275226|NCT01775553|Relapsed Multiple Myeloma|relapsed multiple myeloma
275227|NCT01775553|Refractory Multiple Myeloma|refractory multiple myeloma
276109|NCT01771874|MDMA|mdma
276110|NCT01771874|pharmacokinetics|pharmacokinetics
276112|NCT01771874|emotions|emotions
276516|NCT01769937|Lupus|lupus
276652|NCT01769248|EUS|eus
276905|NCT01768273|CL-006|cl-006
278189|NCT01762475|Magnetic resonance imaging|magnetic resonance imaging
278190|NCT01762475|Blood oxygen level dependent signal|blood oxygen level dependent signal
278191|NCT01762475|Hypercapnia|hypercapnia
278788|NCT01759602|NMO|nmo
279469|NCT01756326|Bone|bone
280476|NCT01751464|youth|youth
281490|NCT01746680|RA|ra
282781|NCT01740869|autism|autism
282901|NCT01740557|TIL|til
283190|NCT01739387|Asthma|asthma
283880|NCT01736631|cognitive behavioural therapy|cognitive behavioural therapy
285274|NCT01729793|IL6|il6
285670|NCT01728285|electronic compliance device|electronic compliance device
285671|NCT01728272|metoprolol, atrial fibrillation|metoprolol, atrial fibrillation
285672|NCT01728246|Osteoarthritis|osteoarthritis
287906|NCT01718015|CD-163|cd-163
288595|NCT01715246|HMO|hmo
289714|NCT01710111|Fomites|fomites
290123|NCT01708317|ACASI|acasi
290823|NCT01705405|cancer|cancer
291515|NCT01702506|fed|fed
292126|NCT01700010|Cancer|cancer
292544|NCT01698177|Cancer|cancer
293519|NCT01693471|asthma|asthma
294531|NCT01689246|AD|ad
294625|NCT01687673|TORISEL|torisel
295335|NCT01685489|PSK|psk
295835|NCT01683331|Insulin|insulin
296134|NCT01682109|paediatric|paediatric
296135|NCT01682096|Chest pain|chest pain
296136|NCT01682096|Emergency room|emergency room
296137|NCT01682096|Acute coronary syndrome|acute coronary syndrome
446721|NCT00007163|IL-12|il-12
296138|NCT01682096|Computed tomography coronary angiography|computed tomography coronary angiography
296139|NCT01682096|Stress echocardiography|stress echocardiography
296148|NCT01682070|Sublingual immunotherapy|sublingual immunotherapy
296203|NCT01681719|VO2|vo2
296326|NCT01681199|Coronary heart disease|coronary heart disease
296328|NCT01681199|OPG|opg
296329|NCT01681173|Nutritional support|nutritional support
296330|NCT01681173|Diet therapy|diet therapy
296332|NCT01681173|Insoluble fiber|insoluble fiber
296922|NCT01678612|Copper|copper
298220|NCT01672853|MRE|mre
298532|NCT01671501|HIV|hiv
299059|NCT01669161|VNS|vns
301333|NCT01658280|transbronchial needle aspiration|transbronchial needle aspiration
301334|NCT01658280|ultrasound guided transbronchial needle aspiration|ultrasound guided transbronchial needle aspiration
301335|NCT01658280|sensitivity|sensitivity
301336|NCT01658280|hilar/mediastinal adenopathy|hilar/mediastinal adenopathy
301337|NCT01658254|Clinical trials|clinical trials
585237|NCT00519090|cml|cml
301338|NCT01658254|Basic results|basic results
301339|NCT01658254|Registry|registry
301748|NCT01656564|Longitudinal|longitudinal
301749|NCT01656564|Outcomes|outcomes
301750|NCT01656551|elderly|elderly
301751|NCT01656551|chemotherapy|chemotherapy
301753|NCT01656512|zoledronic acid|zoledronic acid
302542|NCT01652898|PK|pk
303038|NCT01650558|HIV|hiv
303262|NCT01649427|GFR|gfr
303345|NCT01649115|growth|growth
303451|NCT01647529|uveitis|uveitis
304993|NCT01641328|MCI|mci
305951|NCT01636622|PLX4032|plx4032
306846|NCT01632397|PrEP|prep
308135|NCT01626391|AD|ad
308238|NCT01626053|HbA1C|hba1c
308940|NCT01623063|uterus|uterus
308941|NCT01623063|histeroscopy|histeroscopy
308971|NCT01622855|Rape|rape
309252|NCT01621568|VEGF|vegf
309354|NCT01621152|AKI|aki
310337|NCT01617109|Parathyroid hormone|parathyroid hormone
310338|NCT01617109|Bone|bone
310339|NCT01617109|Bone formation|bone formation
310867|NCT01614730|EMS|ems
312184|NCT01609374|ACDF|acdf
312901|NCT01606254|JNS010|jns010
314292|NCT01600183|MTA|mta
314786|NCT01598272|Grape Seed|grape seed
314787|NCT01598272|Broccoli Seed|broccoli seed
314788|NCT01598246|Extubation failures|extubation failures
314789|NCT01598246|Sedation|sedation
314888|NCT01597765|Thalassemia|thalassemia
314905|NCT01597674|YF476|yf476
315095|NCT01596959|contact|contact
315781|NCT01594255|ECG|ecg
316083|NCT01593020|Taxol|taxol
316216|NCT01592643|PRK|prk
316814|NCT01589900|IHC|ihc
317665|NCT01585740|Hyperchloraemic metabolic acidosis|hyperchloraemic metabolic acidosis
318164|NCT01582763|Outcome|outcome
320829|NCT01572727|paclitaxel|paclitaxel
320830|NCT01572727|breast cancer|breast cancer
320831|NCT01572727|metastatic|metastatic
320832|NCT01572727|locally advanced|locally advanced
320833|NCT01572727|PI3K|pi3k
320834|NCT01572727|PIK3CA|pik3ca
320835|NCT01572727|PTEN|pten
321129|NCT01571570|Oral solution|oral solution
321130|NCT01571570|TMC435HPC1002|tmc435hpc1002
321131|NCT01571570|TMC435|tmc435
321132|NCT01571570|HPC|hpc
322232|NCT01566864|Omron|omron
323231|NCT01562275|Akt|akt
323341|NCT01561729|pH|ph
324154|NCT01555567|ACL|acl
324265|NCT01558206|PTE|pte
324430|NCT01557608|cancer|cancer
325044|NCT01554631|ODT|odt
325261|NCT01553708|Safety|safety
326253|NCT01549665|GVHD|gvhd
327407|NCT01544062|Cardiac surgery|cardiac surgery
327408|NCT01544062|Acute Pain|acute pain
327409|NCT01544062|Wound Hyperalgesia|wound hyperalgesia
327410|NCT01544062|Intravenous Acetaminophen|intravenous acetaminophen
327906|NCT01542840|surgery|surgery
331988|NCT01524874|nutritional supplements|nutritional supplements
331989|NCT01524874|hypovitaminosis d|hypovitaminosis d
331991|NCT01524874|toll like receptor 4|toll like receptor 4
331992|NCT01524861|Tako-Tsubo|tako-tsubo
334122|NCT01516021|CBF|cbf
335502|NCT01510132|OAG|oag
335562|NCT01509859|pfna|pfna
336380|NCT01506349|attention|attention
336381|NCT01506336|GIST|gist
336382|NCT01506336|resistant|resistant
336383|NCT01506336|imatinib|imatinib
336384|NCT01506336|gastro intestinal stromal tumor resistant to imatinib|gastro intestinal stromal tumor resistant to imatinib
336385|NCT01506323|Complementary Therapy|complementary therapy
338053|NCT01499719|Disease|disease
338440|NCT01497899|HIV|hiv
338553|NCT01497405|HIV|hiv
338643|NCT01497093|Myeloma|myeloma
339329|NCT01494285|Topical|topical
339835|NCT01491958|AML|aml
340657|NCT01488643|Obesity|obesity
342819|NCT01479582|CML|cml
344655|NCT01472198|GSI|gsi
345363|NCT01469247|XRT|xrt
347708|NCT01459653|observational study|observational study
347709|NCT01459653|noninterventional study|noninterventional study
347710|NCT01459640|Osteoarthritis|osteoarthritis
347711|NCT01459640|Bone marrow|bone marrow
347712|NCT01459640|Mesenchymal stem cells|mesenchymal stem cells
347713|NCT01459640|Autologous|autologous
347714|NCT01459640|Mild osteoarthritis|mild osteoarthritis
347715|NCT01459640|Moderate osteoarthritis|moderate osteoarthritis
449043|NCT00006157|IBS|ibs
347716|NCT01459627|DAPT- Dual Antiplatelet Therapy|dapt- dual antiplatelet therapy
347717|NCT01459627|STEMI|stemi
347916|NCT01458782|Cartilage repair|cartilage repair
347917|NCT01458782|Chondrocytes|chondrocytes
347918|NCT01458782|Stemcells|stemcells
347921|NCT01458743|pharmacokinetics|pharmacokinetics
348019|NCT01458327|MDMA|mdma
348427|NCT01456702|SVV|svv
348782|NCT01455012|RLS|rls
349318|NCT01453114|relapse|relapse
349822|NCT01450839|elderly|elderly
350231|NCT01449058|AML|aml
350662|NCT01447251|DM2|dm2
351106|NCT01445535|CD2 Positive|cd2 positive
351107|NCT01445535|Toxicity|toxicity
351108|NCT01445535|EBV Lymphoma|ebv lymphoma
351109|NCT01445535|Chemotherapy Naive|chemotherapy naive
351111|NCT01445535|Lymphoma|lymphoma
355573|NCT01428154|CKD|ckd
356500|NCT01424423|Safety|safety
357905|NCT01419119|D3|d3
359179|NCT01413542|BNP|bnp
359286|NCT01413178|QOL|qol
359389|NCT01412801|GBS|gbs
359980|NCT01410474|ACWY|acwy
359981|NCT01410474|bacterial meningitis|bacterial meningitis
359982|NCT01410474|conjugate vaccine|conjugate vaccine
360028|NCT01410331|CLI|cli
360976|NCT01406834|PTSD|ptsd
361380|NCT01405170|fed|fed
361880|NCT01403298|Family|family
361881|NCT01403298|Prevention|prevention
362219|NCT01401699|OCT|oct
362384|NCT01400932|inflammatory lesion|inflammatory lesion
362385|NCT01400932|Benzoyl peroxide (BPO)|benzoyl peroxide (bpo)
362386|NCT01400932|once daily|once daily
362387|NCT01400932|acne vulgaris|acne vulgaris
362388|NCT01400932|vehicle gel|vehicle gel
362389|NCT01400932|clindamycin (CLDM) 1%-BPO 3% gel|clindamycin (cldm) 1%-bpo 3% gel
362390|NCT01400932|non-inflammatory lesion|non-inflammatory lesion
362391|NCT01400919|Peripheral arterial disease|peripheral arterial disease
362392|NCT01400919|claudication|claudication
362393|NCT01400919|stent|stent
362394|NCT01400919|EverFlex|everflex
362395|NCT01400919|GPS|gps
362396|NCT01400919|Iliac Artery|iliac artery
362397|NCT01400893|Acute Renal Failure|acute renal failure
362484|NCT01400529|knee|knee
363509|NCT01395745|SLE|sle
365588|NCT01386957|Child|child
366542|NCT01382537|Neck|neck
367138|NCT01380249|Phase I|phase i
367342|NCT01379495|burns|burns
368161|NCT01376076|QTc|qtc
369705|NCT01369641|STS|sts
371470|NCT01362452|Alkeran|alkeran
372078|NCT01360112|Feeding|feeding
373861|NCT01352312|NHL|nhl
373970|NCT01351740|HIV|hiv
374154|NCT01350895|Polycystic ovarian syndrome (PCOS)|polycystic ovarian syndrome (pcos)
374155|NCT01350882|kidney transplantation|kidney transplantation
374156|NCT01350882|acute humoral rejection|acute humoral rejection
375972|NCT01343693|DDD|ddd
376032|NCT01343420|Allergy Extract|allergy extract
376033|NCT01343394|Autologous|autologous
376034|NCT01343394|Stem Cells|stem cells
376037|NCT01343381|Heparin|heparin
376139|NCT01343017|Anaesthesia|anaesthesia
376140|NCT01343017|Pulmonary gas exchange|pulmonary gas exchange
376141|NCT01343017|Functional residual capacity|functional residual capacity
376157|NCT01342978|HPV|hpv
377048|NCT01338987|FLT|flt
377363|NCT01337700|ASD|asd
377833|NCT01335906|Early Diagnosis of Cancer|early diagnosis of cancer
377834|NCT01335906|Mammography|mammography
378719|NCT01332019|MS|ms
379230|NCT01329809|JX-594|jx-594
379438|NCT01328899|COPD|copd
379940|NCT01326871|TCR|tcr
380083|NCT01326403|hip|hip
380528|NCT01324362|FP|fp
381734|NCT01319552|storage|storage
383357|NCT01313247|opioids|opioids
384386|NCT01308697|Chest|chest
384690|NCT01307384|THA|tha
384902|NCT01306643|NHL|nhl
385275|NCT01305239|prospective|prospective
385276|NCT01305239|multicenter|multicenter
385277|NCT01305239|survey|survey
385278|NCT01305239|France.|france.
385586|NCT01303926|QoL|qol
385789|NCT01303198|CPAP|cpap
386340|NCT01300806|HIV|hiv
386473|NCT01300221|Z-score|z-score
386713|NCT01299324|CHF|chf
387057|NCT01297699|CAS|cas
389354|NCT01288677|HCV|hcv
389445|NCT01288274|DMPA|dmpa
390239|NCT01284881|MRA|mra
390328|NCT01284374|Decision Making|decision making
390329|NCT01284374|Qualitative Research|qualitative research
390330|NCT01284361|intermittent catheter|intermittent catheter
390331|NCT01284361|preference|preference
390332|NCT01284348|Chemotherapy induced anemia|chemotherapy induced anemia
390561|NCT01283152|HE|he
390776|NCT01282047|HIV|hiv
390819|NCT01281930|wick|wick
391232|NCT01279863|VRI|vri
392870|NCT01273311|Aging|aging
393228|NCT01272011|Spinal cord injuries|spinal cord injuries
393229|NCT01272011|Walking recovery|walking recovery
393233|NCT01271985|Cardiovascular Diseases|cardiovascular diseases
393341|NCT01271582|UGT1A1|ugt1a1
393770|NCT01269697|AMD|amd
394473|NCT01266642|Tis|tis
395412|NCT01262586|Continuous glucose monitoring|continuous glucose monitoring
395426|NCT01262534|Psoriasis|psoriasis
395427|NCT01262534|comorbidities, associated treatment, quality of life|comorbidities, associated treatment, quality of life
395428|NCT01262521|Dietary nitrate|dietary nitrate
395429|NCT01262508|autonomic nervous system|autonomic nervous system
395430|NCT01262482|adenocarcinoma|adenocarcinoma
395431|NCT01262482|gastric|gastric
395432|NCT01262482|gastroesophageal junction|gastroesophageal junction
395433|NCT01262482|Relapsed|relapsed
395434|NCT01262482|sorafenib|sorafenib
395435|NCT01262482|oxaliplatin|oxaliplatin
395436|NCT01262443|Atrial flutter|atrial flutter
395437|NCT01262430|Osteoarthritis|osteoarthritis
395438|NCT01262417|colorectal cancer|colorectal cancer
395439|NCT01262417|two stage surgery for the resection of hepatic metastases|two stage surgery for the resection of hepatic metastases
395518|NCT01262118|550|550
395608|NCT01261754|Metastatic Prostate Adenocarcinoma|metastatic prostate adenocarcinoma
395615|NCT01261702|Magnesium sulphate|magnesium sulphate
395616|NCT01261702|Post Pulmonary Resection|post pulmonary resection
395633|NCT01261598|SUV|suv
396203|NCT01256944|PCOS|pcos
396782|NCT01256294|pharmacokinetics|pharmacokinetics
396783|NCT01256294|tacrolimus|tacrolimus
396784|NCT01256281|Sickle Cell Disease|sickle cell disease
396888|NCT01255865|Oral Temperature|oral temperature
396889|NCT01255852|atorvastatin|atorvastatin
396890|NCT01255852|intracranial artery stenting|intracranial artery stenting
396891|NCT01255852|restenosis|restenosis
396892|NCT01255839|double-balloon|double-balloon
396893|NCT01255839|balloon catheter|balloon catheter
397269|NCT01254357|Burns|burns
397708|NCT01252251|eye|eye
397782|NCT01251913|Glioma|glioma
398187|NCT01249937|Kenalog|kenalog
398500|NCT01248455|SMM|smm
399466|NCT01243879|fasting|fasting
399712|NCT01242865|Stress|stress
399871|NCT01242111|LSD|lsd
401220|NCT01236781|Hologic|hologic
401430|NCT01235949|Safety|safety
402299|NCT01231971|tau|tau
402393|NCT01231555|HAART|haart
402492|NCT01231061|spine metastasis|spine metastasis
402493|NCT01231061|SBRT|sbrt
402494|NCT01231061|Radiosurgery|radiosurgery
402495|NCT01231035|acute cardiac syndrome|acute cardiac syndrome
402496|NCT01231035|stent thrombosis|stent thrombosis
402497|NCT01231035|platelet function|platelet function
402498|NCT01231035|antiplatelet therapy|antiplatelet therapy
402499|NCT01231022|breast neoplasm|breast neoplasm
402501|NCT01231022|Stem Cells|stem cells
402700|NCT01230151|DBS|dbs
402774|NCT01229761|HIV|hiv
403739|NCT01224925|MTA|mta
404066|NCT01222338|HIV|hiv
404208|NCT01223170|Cardiac rehabilitation|cardiac rehabilitation
404209|NCT01223170|Internet based intervention|internet based intervention
404210|NCT01223170|Exercise|exercise
404211|NCT01223170|Cardiovascular Disease rehabilitation|cardiovascular disease rehabilitation
404212|NCT01223157|obesity|obesity
404220|NCT01223118|IVF|ivf
404698|NCT01220843|FGF23|fgf23
404903|NCT01219998|NGAL|ngal
405417|NCT01217762|AMD|amd
405882|NCT01215851|PA-824|pa-824
406012|NCT01215383|HDL|hdl
407170|NCT01210378|HX4|hx4
407465|NCT01209000|FSGS|fsgs
407957|NCT01205867|pharmacodynamics|pharmacodynamics
407958|NCT01205867|BChE deficient subjects and matched control subject|bche deficient subjects and matched control subject
407959|NCT01205854|rheumatoid arthritis|rheumatoid arthritis
407960|NCT01205854|ultrasonography|ultrasonography
409814|NCT01199614|HPTH|hpth
410133|NCT01198197|HV|hv
411201|NCT01193478|NS5A|ns5a
412202|NCT01189669|PCOS|pcos
413860|NCT01182779|protons|protons
416054|NCT00000746|HIV-1|hiv-1
416150|NCT00000778|Sputum|sputum
416808|NCT00000886|Mannose|mannose
417390|NCT00000411|MRI|mri
417791|NCT00001117|HIV-1|hiv-1
417976|NCT00001148|Mutation|mutation
417977|NCT00001148|Anaplastic Astrocytoma|anaplastic astrocytoma
417980|NCT00001149|Epilepsy|epilepsy
418275|NCT00001203|Cardiac Disease|cardiac disease
418276|NCT00001203|Acquired Anemia|acquired anemia
418277|NCT00001204|Dyslipoprotein|dyslipoprotein
418278|NCT00001204|Hypercholesterolemia|hypercholesterolemia
418279|NCT00001204|Atherosclerosis|atherosclerosis
418280|NCT00001205|Taenia Solium|taenia solium
418281|NCT00001205|Cysticercosis|cysticercosis
418282|NCT00001205|Praziquantel|praziquantel
418285|NCT00001206|Cerebrospinal Fluid|cerebrospinal fluid
418688|NCT00001292|Keratin|keratin
419287|NCT00001421|Muscle|muscle
419727|NCT00001519|VO2|vo2
422610|NCT00002250|IgG|igg
423732|NCT00001839|Immunosuppressive|immunosuppressive
423734|NCT00001839|Pre-Leukemia|pre-leukemia
423735|NCT00001839|Therapy|therapy
423736|NCT00001839|Myelodysplastic Syndrome|myelodysplastic syndrome
423737|NCT00001840|Infarct|infarct
423738|NCT00001840|Ischemia|ischemia
424364|NCT00001960|HCM|hcm
427230|NCT00001734|Uveitis|uveitis
433215|NCT00003239|HHT|hht
435753|NCT00004215|anemia|anemia
437924|NCT00004727|ASA|asa
438266|NCT00004831|erythropoietic protoporphyria|erythropoietic protoporphyria
438267|NCT00004831|inborn errors of metabolism|inborn errors of metabolism
438269|NCT00004831|rare disease|rare disease
438270|NCT00004832|Lambert-Eaton myasthenic syndrome|lambert-eaton myasthenic syndrome
438271|NCT00004832|neurologic and psychiatric disorders|neurologic and psychiatric disorders
438272|NCT00004832|rare disease|rare disease
444260|NCT00006318|MRI|mri
446266|NCT00006439|HIV|hiv
449093|NCT00006167|strength training|strength training
449094|NCT00006167|progressive resistance training|progressive resistance training
449095|NCT00006167|exercise|exercise
449096|NCT00006167|dietary intervention|dietary intervention
449097|NCT00006168|primary biliary cirrhosis|primary biliary cirrhosis
449098|NCT00006168|Ursodeoxycholic acid|ursodeoxycholic acid
449099|NCT00006168|UDCA|udca
450628|NCT00006443|HIV-1|hiv-1
451049|NCT00018031|HIV|hiv
453268|NCT00013494|elderly|elderly
453481|NCT00013949|ECG|ecg
454602|NCT00026624|Virus Replication|virus replication
454603|NCT00026624|Injections, Subcutaneous|injections, subcutaneous
454604|NCT00026624|HIV-1|hiv-1
454605|NCT00026624|AIDS Vaccines|aids vaccines
454606|NCT00026624|Dendritic Cells|dendritic cells
454610|NCT00026637|depression|depression
456626|NCT00030186|AML|aml
458271|NCT00038272|MMF|mmf
458785|NCT00039624|MRI|mri
458907|NCT00041730|KLH|klh
460513|NCT00034229|BPD|bpd
463716|NCT00044239|OCD|ocd
465679|NCT00049725|ITP|itp
466034|NCT00050882|GM-611|gm-611
466129|NCT00058890|liver disease|liver disease
466130|NCT00058890|hepatitis|hepatitis
466131|NCT00058890|cirrhosis|cirrhosis
466132|NCT00058903|Cholestatic|cholestatic
466133|NCT00058903|Pruritus|pruritus
466134|NCT00058903|Sertraline|sertraline
466135|NCT00058903|primary biliary cirrhosis|primary biliary cirrhosis
467093|NCT00062465|RA|ra
467192|NCT00062855|GENE MODIFIED AUTOLOGOUS NEUROBLASTOMA CELLS|gene modified autologous neuroblastoma cells
467193|NCT00062855|Gene Therapy|gene therapy
467201|NCT00062881|Cancer|cancer
467202|NCT00062881|Leukemia|leukemia
467203|NCT00062881|Lymphoma|lymphoma
467204|NCT00062881|Solid Tumor|solid tumor
468187|NCT00064792|Malformation Syndrome|malformation syndrome
468188|NCT00064792|Mental Retardation|mental retardation
468189|NCT00064792|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
468190|NCT00064805|Cognitive therapy|cognitive therapy
468191|NCT00064805|Aphasia therapy|aphasia therapy
468505|NCT00065741|Healthy|healthy
469433|NCT00067444|MDD|mdd
470182|NCT00063284|PD|pd
470747|NCT00072592|ANCA|anca
471203|NCT00066911|HV|hv
471801|NCT00076102|NF1|nf1
472542|NCT00078195|Ragweed|ragweed
473134|NCT00079768|IBM|ibm
473763|NCT00081926|US177|us177
473948|NCT00082459|Renal|renal
475038|NCT00085748|elderly|elderly
475488|NCT00087867|myeloma|myeloma
475987|NCT00091715|PAH|pah
476626|NCT00096473|Aricept|aricept
477586|NCT00089596|ALL|all
477841|NCT00098072|PPH|pph
477892|NCT00100685|RCC|rcc
478218|NCT00101972|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
478219|NCT00101972|recurrent gallbladder cancer|recurrent gallbladder cancer
478220|NCT00101972|recurrent gastric cancer|recurrent gastric cancer
478221|NCT00101972|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
481570|NCT00111540|Amylin|amylin
482073|NCT00115154|AK|ak
482157|NCT00115414|TAC|tac
483428|NCT00118378|HIV|hiv
483957|NCT00120458|Anxiety|anxiety
484749|NCT00120952|RSA|rsa
485495|NCT00117403|CoQ|coq
485596|NCT00117741|DBT|dbt
485813|NCT00124748|CML|cml
487505|NCT00132327|Skin|skin
488056|NCT00134134|Raptiva|raptiva
490867|NCT00140426|Leptin|leptin
492545|NCT00148772|Tarceva|tarceva
493318|NCT00146562|G-CSF|g-csf
495968|NCT00175682|SCI|sci
497540|NCT00173316|VEGF-CR|vegf-cr
498049|NCT00182208|PTS|pts
498751|NCT00189059|erp|erp
500593|NCT00199329|PCA|pca
502823|NCT00211224|MSA|msa
503589|NCT00214708|BCG|bcg
503988|NCT00207753|ascaris|ascaris
504425|NCT00216034|PSK|psk
504493|NCT00216502|placebo|placebo
504494|NCT00216502|Caregiver|caregiver
504495|NCT00216502|Brain disease|brain disease
506253|NCT00227929|MDD|mdd
506506|NCT00219726|CML|cml
507034|NCT00229619|rituxan|rituxan
507234|NCT00230568|Latino|latino
507941|NCT00231842|MMT|mmt
508336|NCT00234793|anxiety|anxiety
509916|NCT00241618|Efficacy Safety Study|efficacy safety study
509917|NCT00241644|Rotavirus gastroenteritis|rotavirus gastroenteritis
509926|NCT00241917|hepatitis C|hepatitis c
509927|NCT00241917|heroin|heroin
584516|NCT00516204|NIS|nis
509928|NCT00241917|populations at risk|populations at risk
510051|NCT00242580|AMD|amd
512490|NCT00251810|CSM|csm
512852|NCT00247156|Autism|autism
513098|NCT00253851|DVT|dvt
514043|NCT00257855|MRI|mri
515206|NCT00264381|STP|stp
515395|NCT00265200|Zometa|zometa
516567|NCT00261456|PSA|psa
516696|NCT00261911|BMI|bmi
517265|NCT00273884|AML|aml
517729|NCT00266149|UGT|ugt
517913|NCT00266955|cardiac|cardiac
519633|NCT00283439|NHL|nhl
520547|NCT00287235|MARS|mars
521303|NCT00281463|spinal cord injury|spinal cord injury
521304|NCT00281463|rehabilitation|rehabilitation
521305|NCT00281476|multiple myeloma|multiple myeloma
521307|NCT00281476|bone|bone
524006|NCT00289939|HIV|hiv
524193|NCT00290498|AD|ad
524494|NCT00290771|glioma|glioma
525422|NCT00303199|Arsenic|arsenic
525726|NCT00305513|right hemispheric CVA|right hemispheric cva
525727|NCT00305513|neglect|neglect
525728|NCT00305513|phasic alert treatment|phasic alert treatment
525732|NCT00305539|Placebo|placebo
525812|NCT00305838|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
525827|NCT00305851|fatigue|fatigue
526556|NCT00298402|MMP|mmp
526882|NCT00299611|OCD|ocd
527472|NCT00309374|LPS|lps
527765|NCT00310245|HAART|haart
529913|NCT00311025|stroke|stroke
530404|NCT00314119|NF1|nf1
531141|NCT00317226|CKD|ckd
531295|NCT00317707|obesity|obesity
531402|NCT00317889|THA|tha
532177|NCT00331071|Oral contraception|oral contraception
532178|NCT00331071|Ethinyl estradiol, Progestin, Contraception|ethinyl estradiol, progestin, contraception
532179|NCT00331071|Transdermal|transdermal
532180|NCT00331084|prevention of post inflammation in cataract surgery|prevention of post inflammation in cataract surgery
532181|NCT00331097|elderly|elderly
532861|NCT00322595|GAD|gad
533354|NCT00325936|CCB|ccb
533942|NCT00334490|Viagra|viagra
534044|NCT00334906|MRI|mri
535303|NCT00342563|smoking|smoking
537374|NCT00340210|Breast Cancer|breast cancer
537375|NCT00340210|Etiology|etiology
537376|NCT00340210|Hormones|hormones
537377|NCT00340210|Prospective Study|prospective study
537378|NCT00340223|Immunity|immunity
537379|NCT00340223|Mutations|mutations
537380|NCT00340223|Viral Selection|viral selection
537481|NCT00340522|Sarcoma|sarcoma
537589|NCT00340808|Questionnaire|questionnaire
537590|NCT00340808|Etiology|etiology
537591|NCT00340808|Biomarkers|biomarkers
537592|NCT00340821|HTLV-I|htlv-i
538294|NCT00351013|Plasmodium falciparum|plasmodium falciparum
538295|NCT00351013|Tropica Nosode|tropica nosode
538296|NCT00351013|Homeopathy|homeopathy
538297|NCT00351026|opioid dependence|opioid dependence
538511|NCT00338468|Anemia|anemia
538901|NCT00351741|Burns|burns
540993|NCT00362661|PTSD|ptsd
542611|NCT00367861|Glivec®|glivec®
542612|NCT00367861|randomized|randomized
542613|NCT00367861|phase III|phase iii
542614|NCT00367874|Opiate dependence|opiate dependence
542615|NCT00367874|Benzodiazepine dependence|benzodiazepine dependence
542616|NCT00367874|Polydrug Abuse|polydrug abuse
542617|NCT00367874|Detoxification|detoxification
542618|NCT00367874|Withdrawal Treatment|withdrawal treatment
542619|NCT00367887|Hepatitis C|hepatitis c
542620|NCT00367900|Diet|diet
543258|NCT00361738|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
543259|NCT00361751|Glucose metabolism|glucose metabolism
543260|NCT00361751|Fat Metabolism|fat metabolism
543261|NCT00361751|Insulin Resistance|insulin resistance
543262|NCT00361751|Protein Metabolism|protein metabolism
543263|NCT00361751|Tracer Methodology|tracer methodology
543264|NCT00361777|Obesity|obesity
543265|NCT00361777|Pseudo-Cushing State|pseudo-cushing state
543266|NCT00361777|Hypercortisolism|hypercortisolism
543267|NCT00361777|Cushing's Syndrome|cushing's syndrome
543268|NCT00361777|Cushing Syndrome|cushing syndrome
543269|NCT00361790|Healthy Subjects|healthy subjects
543270|NCT00361803|chemotherapy|chemotherapy
543944|NCT00371878|HIV|hiv
544464|NCT00372489|ESA|esa
545047|NCT00374491|ACL|acl
547258|NCT00380887|MPA|mpa
547420|NCT00381303|HIV|hiv
547960|NCT00384150|NHL|nhl
548053|NCT00384592|reflux|reflux
549488|NCT00389467|MRI|mri
551183|NCT00398580|DHT|dht
552000|NCT00403026|PDR|pdr
552238|NCT00403962|SAD|sad
552461|NCT00395278|HIV|hiv
553152|NCT00405535|OCD|ocd
553250|NCT00405899|Allergy|allergy
555161|NCT00412841|SLE|sle
556097|NCT00415402|TH1|th1
557406|NCT00425633|Kalium|kalium
558072|NCT00417079|Cancer|cancer
558697|NCT00427557|GVD|gvd
560452|NCT00432419|HIV|hiv
561570|NCT00435617|cerebrovascular stroke|cerebrovascular stroke
561571|NCT00435617|cerebral stroke|cerebral stroke
561572|NCT00435630|Education|education
561573|NCT00435630|Virtual Reality|virtual reality
561574|NCT00435630|Laparoscopic Surgery|laparoscopic surgery
561584|NCT00435708|COPD|copd
561943|NCT00436787|Arixtra|arixtra
563388|NCT00434837|ACL|acl
571385|NCT00471588|OCD|ocd
572163|NCT00464724|3 Tesla|3 tesla
572359|NCT00466609|placebo|placebo
573526|NCT00478621|HPV|hpv
573837|NCT00465972|HIV|hiv
574056|NCT00472173|MTA|mta
574430|NCT00483769|FEV1%|fev1%
574494|NCT00483834|Avastin|avastin
574982|NCT00485940|PAC-SYM|pac-sym
575991|NCT00489385|HCV|hcv
578835|NCT00490217|Finland|finland
581072|NCT00497796|CMV|cmv
581943|NCT00506129|SCT|sct
582658|NCT00508872|5-FU|5-fu
583064|NCT00510341|Communication|communication
583155|NCT00510679|Benin|benin
583764|NCT00512629|PN|pn
583864|NCT00513734|eye|eye
584231|NCT00515151|Alcohol|alcohol
584476|NCT00516009|VAS|vas
584938|NCT00517764|MDD|mdd
585682|NCT00513487|IgE|ige
583339|NCT00511420|cocoa|cocoa
583340|NCT00511420|cardiovascular disease|cardiovascular disease
583341|NCT00511420|blood pressure|blood pressure
583342|NCT00511446|Stomach neoplasms|stomach neoplasms
583343|NCT00511446|docetaxel|docetaxel
583344|NCT00511446|oxaliplatin|oxaliplatin
583345|NCT00511446|capecitabine|capecitabine
583346|NCT00511459|Randomized|randomized
583347|NCT00511459|4-Arm|4-arm
583348|NCT00511459|Placebo controlled|placebo controlled
583349|NCT00511459|Phase 2 Trial|phase 2 trial
583350|NCT00511459|AMG 386|amg 386
583351|NCT00511459|Paclitaxel|paclitaxel
583352|NCT00511459|Bevacizumab|bevacizumab
583353|NCT00511459|First-line Therapy|first-line therapy
583354|NCT00511459|Her-2 Negative|her-2 negative
583452|NCT00511810|Trouble thinking|trouble thinking
583355|NCT00511459|Metastatic or Locally Recurrent Breast Cancer|metastatic or locally recurrent breast cancer
583356|NCT00511485|Cancer|cancer
583357|NCT00511485|Adenocarcinoma|adenocarcinoma
583358|NCT00511485|Phase II|phase ii
583359|NCT00511485|Lung|lung
583360|NCT00511485|Non-small cell lung cancer|non-small cell lung cancer
583361|NCT00511485|NSCLC|nsclc
583362|NCT00511485|EC145|ec145
583363|NCT00511485|EC20|ec20
583364|NCT00511498|Laparoscopic Radical Prostatectomy|laparoscopic radical prostatectomy
583365|NCT00511498|Nightly sildenafil|nightly sildenafil
583366|NCT00511511|hypertension|hypertension
583367|NCT00511511|angiogenesis inhibitors|angiogenesis inhibitors
583368|NCT00511511|tyrosine kinase inhibitor|tyrosine kinase inhibitor
583369|NCT00511511|Sunitinib|sunitinib
583370|NCT00511524|brain,|brain,
583371|NCT00511524|inflammation,|inflammation,
583372|NCT00511524|CB2,|cb2,
583374|NCT00511524|analgesia,|analgesia,
583375|NCT00511537|AML|aml
583376|NCT00511537|ALL|all
583377|NCT00511537|CML|cml
583378|NCT00511537|Lymphoma|lymphoma
583379|NCT00511537|Myelodysplasia|myelodysplasia
583380|NCT00511537|Unrelated stem cell transplantation|unrelated stem cell transplantation
583381|NCT00511537|Hematopoietic disorders|hematopoietic disorders
583382|NCT00511550|peripheral blood stem cells|peripheral blood stem cells
583383|NCT00511550|filgrastim-mobilized|filgrastim-mobilized
583384|NCT00511550|allogeneic transplantation|allogeneic transplantation
583385|NCT00511550|Unrelated Donors for allogeneic transplantation|unrelated donors for allogeneic transplantation
583386|NCT00511563|Cortisol,|cortisol,
583387|NCT00511563|stress,|stress,
583388|NCT00511563|response,|response,
583389|NCT00511563|Irritable Bowel Syndrome,|irritable bowel syndrome,
583390|NCT00511563|cytokine.|cytokine.
583391|NCT00511576|Advanced or Metastatic Breast Cancer|advanced or metastatic breast cancer
583392|NCT00511576|Breast Cancer|breast cancer
583393|NCT00511576|Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)|advanced or metastatic non-small-cell lung cancer (nsclc)
583394|NCT00511576|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
583395|NCT00511576|Prostate Cancer|prostate cancer
583826|NCT00512824|children|children
583435|NCT00511771|Tegaserod, treatment IND, irritable bowel syndrome with constipation, IBS-C, chronic idiopathic constipation, CIC, chronic constipation, CC|tegaserod, treatment ind, irritable bowel syndrome with constipation, ibs-c, chronic idiopathic constipation, cic, chronic constipation, cc
583436|NCT00511784|Contraception|contraception
583437|NCT00511784|Hormonal contraception|hormonal contraception
583438|NCT00511784|Oral contraception|oral contraception
583439|NCT00511784|Ethinyl estradiol, Levonorgestrel, Contraception|ethinyl estradiol, levonorgestrel, contraception
583440|NCT00511784|Transdermal|transdermal
583441|NCT00511784|Venous thromboembolism|venous thromboembolism
583442|NCT00511784|Norelgestromin|norelgestromin
583443|NCT00511797|Dysmenorrhea|dysmenorrhea
583444|NCT00511797|Dysmenorrheal score|dysmenorrheal score
583445|NCT00511797|Drospirenone|drospirenone
583446|NCT00511797|DRSP|drsp
583447|NCT00511797|Ethinylestradiol|ethinylestradiol
583448|NCT00511810|Sadness|sadness
583449|NCT00511810|Insomnia|insomnia
583450|NCT00511810|Loss of appetite|loss of appetite
583451|NCT00511810|Fatigue|fatigue
583453|NCT00511823|drug-drug interaction,|drug-drug interaction,
583454|NCT00511823|rosiglitazone,|rosiglitazone,
583455|NCT00511823|safety|safety
583456|NCT00511823|CYP2C8,|cyp2c8,
583457|NCT00511823|pharmacokinetics,|pharmacokinetics,
583458|NCT00511823|CYP3A4,|cyp3a4,
583459|NCT00511823|granisetron,|granisetron,
583460|NCT00511823|dolasetron,|dolasetron,
583461|NCT00511823|CYP2D6,|cyp2d6,
583462|NCT00511823|casopitant,|casopitant,
583463|NCT00511836|alcoholism|alcoholism
583464|NCT00511836|addiction|addiction
583465|NCT00511836|alcohol detoxification|alcohol detoxification
583466|NCT00511862|TheraSphere|therasphere
583467|NCT00511862|radioactive microspheres|radioactive microspheres
583468|NCT00511862|Yttrium-90|yttrium-90
583469|NCT00511862|Yttrium glass microspheres|yttrium glass microspheres
583470|NCT00511875|diabetic retinopathy|diabetic retinopathy
583471|NCT00511875|diabetes|diabetes
583472|NCT00511875|diabetic eye studies|diabetic eye studies
583473|NCT00511875|neovascularization|neovascularization
583474|NCT00511888|chronic heart failure|chronic heart failure
583475|NCT00511888|hypertension|hypertension
583476|NCT00511888|beta blockers|beta blockers
583477|NCT00511901|anemia|anemia
583478|NCT00511901|function|function
583479|NCT00511901|rehabilitation|rehabilitation
583480|NCT00511914|Influenza vaccine|influenza vaccine
583481|NCT00511927|heart|heart
583482|NCT00511927|failure|failure
583483|NCT00511927|growth|growth
583484|NCT00511927|hormone|hormone
583485|NCT00511927|igf|igf
583486|NCT00511927|dilative|dilative
583487|NCT00511927|cardiomyopathy|cardiomyopathy
583488|NCT00511953|Hot flashes|hot flashes
583489|NCT00511953|Hot flushes|hot flushes
583490|NCT00511953|Postmenopausal symptoms|postmenopausal symptoms
583491|NCT00511966|Gastroesophageal Reflux|gastroesophageal reflux
583492|NCT00511966|Rabeprazole|rabeprazole
583493|NCT00511979|Healthy Patients|healthy patients
583494|NCT00511992|Ovarian Cancer|ovarian cancer
583495|NCT00511992|Gynecologic Cancer|gynecologic cancer
583496|NCT00511992|Ovarian Carcinoma|ovarian carcinoma
583497|NCT00511992|Peritoneal Carcinoma|peritoneal carcinoma
583498|NCT00511992|IP chemotherapy|ip chemotherapy
583499|NCT00511992|Intraperitoneal|intraperitoneal
583501|NCT00511992|Bevacizumab|bevacizumab
583502|NCT00512005|Functional Mitral Regurgitation (FMR)|functional mitral regurgitation (fmr)
583503|NCT00512005|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
583504|NCT00512005|Less invasive repair|less invasive repair
583505|NCT00512005|Percutaneous MV repair|percutaneous mv repair
583506|NCT00512005|Mitral Valve Repair|mitral valve repair
583507|NCT00512005|Heart Failure|heart failure
583508|NCT00512005|Left Ventricular Dysfunction|left ventricular dysfunction
583509|NCT00512018|Electric Stimulation|electric stimulation
583510|NCT00512018|Quadriceps Muscle|quadriceps muscle
583511|NCT00512018|Muscle Strength|muscle strength
583512|NCT00512018|Neuromuscular Properties|neuromuscular properties
583513|NCT00512018|Tension-Length Relationship|tension-length relationship
583514|NCT00512018|Healthy young adults|healthy young adults
583515|NCT00512031|atherosclerosis|atherosclerosis
583516|NCT00512031|metabolic pathways|metabolic pathways
583517|NCT00512031|monocyte adhesion,|monocyte adhesion,
583518|NCT00512044|anesthesia, Longo, mucosectomy, hemorrhoids|anesthesia, longo, mucosectomy, hemorrhoids
583519|NCT00512057|cardiac syndrome X|cardiac syndrome x
583520|NCT00512057|endothelial function|endothelial function
583521|NCT00512070|schizophrenia|schizophrenia
583522|NCT00512070|schizoaffective disorder|schizoaffective disorder
583523|NCT00512070|bipolar disorder|bipolar disorder
583524|NCT00512070|olanzapine|olanzapine
583525|NCT00512070|melatonin|melatonin
583526|NCT00512070|obesity|obesity
583527|NCT00512070|metabolic syndrome|metabolic syndrome
583528|NCT00512083|Leukemia, Myeloid + Acute Disease|leukemia, myeloid + acute disease
583529|NCT00512096|Genitourinary|genitourinary
583530|NCT00512096|Penile Cancer|penile cancer
583531|NCT00512096|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
583532|NCT00512096|Extirpative Surgery|extirpative surgery
583718|NCT00506467|Lung Cancer|lung cancer
583617|NCT00512408|To assess the effect of a 12 week testosterone administration on maximal exercise capacity, muscle strength and insulin resistance in elderly CHF patients|to assess the effect of a 12 week testosterone administration on maximal exercise capacity, muscle strength and insulin resistance in elderly chf patients
583619|NCT00512434|shaft|shaft
583620|NCT00512434|fracture|fracture
583621|NCT00512434|open|open
583622|NCT00512434|bone-marrow|bone-marrow
583623|NCT00512434|graft|graft
583624|NCT00512434|injection|injection
583625|NCT00512434|mesenchymal stem cell|mesenchymal stem cell
583626|NCT00512447|Aging|aging
583627|NCT00512460|Neoplastic Meningitis|neoplastic meningitis
583628|NCT00512460|Leptomeningeal Disease|leptomeningeal disease
583629|NCT00512460|Solid Tumor|solid tumor
583630|NCT00512460|Lymphoma|lymphoma
583631|NCT00512460|Leukemia|leukemia
583632|NCT00512460|Brain Tumor|brain tumor
583633|NCT00512460|RTA 744|rta 744
583634|NCT00512473|GH, GH receptor blockade, GH signaling, insulin resistance|gh, gh receptor blockade, gh signaling, insulin resistance
583635|NCT00512499|Osteoporosis|osteoporosis
583636|NCT00512499|Fragility fractures|fragility fractures
583637|NCT00512499|Fracture clinics|fracture clinics
583638|NCT00512499|Orthopedic surgeons|orthopedic surgeons
583639|NCT00512512|transoral|transoral
583640|NCT00512512|transluminal|transluminal
583641|NCT00512512|endoscopic|endoscopic
583642|NCT00512512|laparoscopic|laparoscopic
583643|NCT00512512|liver|liver
583644|NCT00512512|biopsy|biopsy
583645|NCT00512538|Diabetic foot|diabetic foot
583646|NCT00512551|Cervical Cancer|cervical cancer
583647|NCT00512551|DNA Array Analysis|dna array analysis
583648|NCT00512551|Gene Expression|gene expression
583650|NCT00512564|Sickle Cell Anemia|sickle cell anemia
583651|NCT00512564|Sickle Cell Thalassemia|sickle cell thalassemia
583652|NCT00512564|Iron overload|iron overload
583653|NCT00512564|Non transferrin binding iron|non transferrin binding iron
583655|NCT00512577|sickle cell disease|sickle cell disease
583656|NCT00512577|pre-operative transfusion|pre-operative transfusion
583657|NCT00512577|blood transfusion|blood transfusion
583658|NCT00512590|fibromyalgia|fibromyalgia
583659|NCT00512590|relaxation|relaxation
583660|NCT00512590|imagery|imagery
583661|NCT00512590|pain|pain
583662|NCT00512590|functional status|functional status
583663|NCT00512590|self efficacy|self efficacy
583664|NCT00512590|minority health|minority health
583665|NCT00506272|diabetes mellitus|diabetes mellitus
583666|NCT00506272|hyperglycemia|hyperglycemia
583667|NCT00506272|hypoglycemia|hypoglycemia
583668|NCT00506272|self care|self care
583669|NCT00506285|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
583670|NCT00506285|ADHD|adhd
583671|NCT00506285|Adult|adult
583672|NCT00506285|Methylphenidate Transdermal System|methylphenidate transdermal system
583673|NCT00506285|Daytrana|daytrana
583674|NCT00506298|Diabetes|diabetes
583675|NCT00506298|CRx-401|crx-401
583676|NCT00506298|Bezafibrate|bezafibrate
583677|NCT00506298|Diflunisal|diflunisal
583678|NCT00506298|Metformin|metformin
583679|NCT00506298|plasma glucose|plasma glucose
583680|NCT00506311|Superficial Groin Dissection|superficial groin dissection
583681|NCT00506311|Melanoma|melanoma
583682|NCT00506311|Fibrin Tissue Adhesive|fibrin tissue adhesive
583683|NCT00506311|Fibrin Sealant|fibrin sealant
583684|NCT00506311|Tisseel|tisseel
583685|NCT00506311|Seroma|seroma
583686|NCT00506324|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
583687|NCT00506324|Chemotherapy|chemotherapy
583688|NCT00506324|Head and Neck Neoplasms|head and neck neoplasms
583689|NCT00506324|Dysphagia|dysphagia
583690|NCT00506363|scar|scar
583691|NCT00506363|surgery|surgery
583692|NCT00506363|lasers|lasers
583693|NCT00506376|Cervical Cancer|cervical cancer
583694|NCT00506376|Hysterectomy|hysterectomy
583695|NCT00506376|Interview|interview
583696|NCT00506389|Sleep Initiation and Maintenance Disorders, Sleep Disorders, Intrinsic Dyssomnias, Sleep Disorders, Nervous System Diseases, Mental Disorders|sleep initiation and maintenance disorders, sleep disorders, intrinsic dyssomnias, sleep disorders, nervous system diseases, mental disorders
583697|NCT00506402|Adult patients with refractory leukemias, MDS or AMM|adult patients with refractory leukemias, mds or amm
583698|NCT00506415|Alzheimer's|alzheimer's
583699|NCT00506415|Patch|patch
583700|NCT00506415|Cognitive|cognitive
583701|NCT00506415|Decline|decline
583702|NCT00506428|aging|aging
583703|NCT00506428|sleep|sleep
583704|NCT00506428|sleep deprivation|sleep deprivation
583705|NCT00506428|performance|performance
583706|NCT00506428|memory|memory
583707|NCT00506428|metabolism|metabolism
583708|NCT00506441|Chronic Kidney Disease|chronic kidney disease
583709|NCT00506441|Dialysis|dialysis
583710|NCT00506441|Hyperphosphatemia|hyperphosphatemia
583711|NCT00506441|Phosphate binder|phosphate binder
583712|NCT00506454|Fatigue|fatigue
583713|NCT00506454|Hemodialysis|hemodialysis
583714|NCT00506454|Endotoxemia|endotoxemia
583715|NCT00506454|Phospholipid|phospholipid
583716|NCT00506454|Emulsion|emulsion
583717|NCT00506467|Intrathoracic Malignancy|intrathoracic malignancy
583727|NCT00506493|Persistent Atrial Fibrillation Surgical RF Ablation|persistent atrial fibrillation surgical rf ablation
583728|NCT00506493|Perisistent Atrial Fibrillation|perisistent atrial fibrillation
583729|NCT00506493|Surgical Ablation|surgical ablation
583730|NCT00506506|N-acetylcysteine|n-acetylcysteine
583731|NCT00506506|Chronic kidney disease|chronic kidney disease
583732|NCT00506506|eGFR|egfr
583733|NCT00506506|Cystatin C|cystatin c
583734|NCT00506506|proteinuria|proteinuria
583735|NCT00506506|Stage 3 chronic kidney disease|stage 3 chronic kidney disease
583736|NCT00506519|DIC associated with severe sepsis|dic associated with severe sepsis
583737|NCT00506532|Pulmonary Surfactants|pulmonary surfactants
583738|NCT00506532|Lung transplantation|lung transplantation
583739|NCT00506532|Primary Graft Dysfunction|primary graft dysfunction
583740|NCT00506558|cervical spondylotic myelopathy|cervical spondylotic myelopathy
583741|NCT00506558|degenerative cervical spondylosis|degenerative cervical spondylosis
583742|NCT00506558|spinal fusion|spinal fusion
583743|NCT00506571|colorectal neoplasms|colorectal neoplasms
583744|NCT00506571|secondary|secondary
583745|NCT00506571|Combination chemotherapy|combination chemotherapy
583746|NCT00506571|S-1|s-1
583747|NCT00506571|irinotecan|irinotecan
583748|NCT00506571|oxaliplatin|oxaliplatin
583749|NCT00506584|Human milk nutritional intervention|human milk nutritional intervention
583750|NCT00506584|Pre-term, very low birth weight|pre-term, very low birth weight
583751|NCT00506584|Fortification of human breast milk|fortification of human breast milk
584229|NCT00515151|Bacteremia|bacteremia
583752|NCT00506597|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
583753|NCT00506597|Leukemia|leukemia
583754|NCT00506597|Erwinia L-Asparaginase|erwinia l-asparaginase
583755|NCT00506597|Erwinase|erwinase
583756|NCT00512603|cerebro vascular event|cerebro vascular event
583757|NCT00512616|Ceftriaxone|ceftriaxone
583758|NCT00512616|Acute Antidepressant Effects|acute antidepressant effects
583759|NCT00512616|Glutamatergic System|glutamatergic system
583760|NCT00512616|Double-Blind|double-blind
583761|NCT00512616|Mood Disorders|mood disorders
583762|NCT00512616|Bipolar Disorder|bipolar disorder
583763|NCT00512616|Depression|depression
583765|NCT00512629|cholestasis|cholestasis
583766|NCT00512629|gastrointestinal disease in infants|gastrointestinal disease in infants
583767|NCT00512629|short bowel syndrome|short bowel syndrome
583768|NCT00512642|Non-Small Cell Lung Cancer|non-small cell lung cancer
583769|NCT00512642|p53|p53
583770|NCT00512642|Smoking|smoking
583771|NCT00512642|Carcinogenesis|carcinogenesis
583772|NCT00512642|Loss of Heterozygosity|loss of heterozygosity
583773|NCT00512655|Fear of falling|fear of falling
583774|NCT00512655|Intraindividual variability|intraindividual variability
583775|NCT00512655|Cognition|cognition
583776|NCT00512655|Fall prevention|fall prevention
583777|NCT00512655|Fear|fear
583778|NCT00512655|Frail elderly|frail elderly
583779|NCT00512655|Intervention|intervention
583780|NCT00512681|Stomach Neoplasms|stomach neoplasms
583781|NCT00512681|Secondary|secondary
583782|NCT00512681|Combination chemotherapy|combination chemotherapy
583783|NCT00512681|S-1|s-1
583784|NCT00512681|irinotecan|irinotecan
583785|NCT00512681|oxaliplatin|oxaliplatin
583786|NCT00512694|Lupus|lupus
583787|NCT00512694|Systemic Lupus Erythematosus|systemic lupus erythematosus
583788|NCT00512694|Cutaneous Lupus|cutaneous lupus
583789|NCT00512707|testosterone|testosterone
583790|NCT00512707|erectile dysfunction|erectile dysfunction
583791|NCT00512707|sildenafil|sildenafil
583792|NCT00512720|PAD|pad
583793|NCT00512720|Peripheral Artery Disease|peripheral artery disease
583794|NCT00512720|PVD|pvd
583795|NCT00512720|Peripheral Vascular Disease|peripheral vascular disease
583796|NCT00512720|Leg Blockage|leg blockage
583797|NCT00512720|Angioplasty|angioplasty
583798|NCT00512720|Stent|stent
583799|NCT00512720|Claudication|claudication
583800|NCT00512733|Healthy volunteers|healthy volunteers
583801|NCT00512746|small cell lung cancer|small cell lung cancer
583802|NCT00512746|non-small cell lung cancer|non-small cell lung cancer
583803|NCT00512746|precancerous condition|precancerous condition
583804|NCT00512772|Time series|time series
583805|NCT00512772|Implementation|implementation
583806|NCT00512785|Imidafenacin|imidafenacin
583807|NCT00512785|KRP-197/ONO-8025|krp-197/ono-8025
583808|NCT00512785|overactive bladder|overactive bladder
583809|NCT00512785|antimuscarinic|antimuscarinic
583810|NCT00512798|stage III melanoma|stage iii melanoma
583811|NCT00512798|stage IV melanoma|stage iv melanoma
583812|NCT00512798|recurrent melanoma|recurrent melanoma
583813|NCT00512798|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
583814|NCT00512798|recurrent adult brain tumor|recurrent adult brain tumor
583815|NCT00512798|melanoma (skin)|melanoma (skin)
583816|NCT00512811|furosemide|furosemide
583817|NCT00512811|inhalation|inhalation
583818|NCT00512811|dyspnea|dyspnea
583819|NCT00512811|spirometry|spirometry
583820|NCT00512811|mustard gas|mustard gas
583821|NCT00512811|bronchiolitis|bronchiolitis
583822|NCT00512811|sulfur mustard|sulfur mustard
583823|NCT00512824|calcium|calcium
583824|NCT00512824|probiotics|probiotics
583825|NCT00512824|diarrhea|diarrhea
583855|NCT00512928|carboxylation level of osteocalcin and matrix-gla protein|carboxylation level of osteocalcin and matrix-gla protein
583856|NCT00513721|prostate|prostate
583857|NCT00513721|prostate cancer|prostate cancer
583858|NCT00513721|surgical margins|surgical margins
583859|NCT00513721|gleason score|gleason score
583860|NCT00513721|positive lateral biopsies|positive lateral biopsies
583861|NCT00513734|keratopathy|keratopathy
583862|NCT00513734|exposure|exposure
583863|NCT00513734|intensive care|intensive care
583865|NCT00513734|ulcer|ulcer
583866|NCT00513734|Corneal|corneal
583867|NCT00513747|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
583868|NCT00513747|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
583869|NCT00513747|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
583870|NCT00513760|Pharmacogenetics|pharmacogenetics
583871|NCT00513760|Singulair|singulair
583872|NCT00513760|montelukast|montelukast
583873|NCT00513760|Leukotriene Antagonists|leukotriene antagonists
583874|NCT00513760|Anti-Asthmatic Agents|anti-asthmatic agents
583875|NCT00513760|Intestinal Absorption|intestinal absorption
583876|NCT00513760|pharmacokinetics|pharmacokinetics
583877|NCT00513760|absorption|absorption
583878|NCT00513760|biochemical transport|biochemical transport
583879|NCT00513760|Membrane Transport Proteins|membrane transport proteins
583880|NCT00513760|Drug Interactions|drug interactions
583881|NCT00513773|Abdominal Aortic Aneurysm,|abdominal aortic aneurysm,
583882|NCT00513773|Inflammation and Risk Prediction|inflammation and risk prediction
583883|NCT00513773|Diagnostic Tool Efficacy|diagnostic tool efficacy
583884|NCT00513786|Endometrial Cancer|endometrial cancer
583885|NCT00513786|Advanced Stage Endometrial Cancer|advanced stage endometrial cancer
583886|NCT00513786|Stage 3 or 4 endometrial cancer|stage 3 or 4 endometrial cancer
583887|NCT00513786|Cancer treatment|cancer treatment
583888|NCT00513786|gyn cancer|gyn cancer
583889|NCT00513825|Contrast Nephropathy|contrast nephropathy
583890|NCT00513825|Sodium Bicarbonate|sodium bicarbonate
583891|NCT00513825|Prevention|prevention
583892|NCT00513851|Advanced Cancer|advanced cancer
583893|NCT00513851|Non-small cell lung cancer|non-small cell lung cancer
583894|NCT00513851|Small cell lung cancer|small cell lung cancer
583895|NCT00513851|Uterine cancer|uterine cancer
583896|NCT00513851|Ovarian cancer|ovarian cancer
583897|NCT00513851|Renal cancer|renal cancer
583898|NCT00513851|Head and neck cancer|head and neck cancer
583899|NCT00513851|Cervical cancer|cervical cancer
583900|NCT00513851|Metastatic cancer|metastatic cancer
583901|NCT00513851|Colorectal cancer|colorectal cancer
583902|NCT00513851|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
583903|NCT00513864|Opioid Analgesics|opioid analgesics
583904|NCT00513864|Morphine|morphine
583905|NCT00513864|Codeine|codeine
583906|NCT00513864|Sickle Cell Disease|sickle cell disease
583907|NCT00513877|recurrent malignant mesothelioma|recurrent malignant mesothelioma
583908|NCT00513877|stage IA malignant mesothelioma|stage ia malignant mesothelioma
583909|NCT00513877|stage IB malignant mesothelioma|stage ib malignant mesothelioma
583910|NCT00513877|stage II malignant mesothelioma|stage ii malignant mesothelioma
583911|NCT00513877|stage III malignant mesothelioma|stage iii malignant mesothelioma
583912|NCT00513877|stage IV malignant mesothelioma|stage iv malignant mesothelioma
583913|NCT00513890|Bronchiolitis|bronchiolitis
583914|NCT00513890|Esophageal pressure mesurement|esophageal pressure mesurement
583915|NCT00513890|Clinical score|clinical score
583916|NCT00513890|Citical care|citical care
583918|NCT00513903|Pulmonary Diseases|pulmonary diseases
583919|NCT00513903|Continuity of Pharmacy Care|continuity of pharmacy care
583920|NCT00513916|breast cancer|breast cancer
583921|NCT00513916|healthy, no evidence of disease|healthy, no evidence of disease
583922|NCT00513929|Severe Pneumonia|severe pneumonia
583923|NCT00513929|Zinc|zinc
583924|NCT00513929|Associated pathogens|associated pathogens
583925|NCT00513929|Severe Pneumonia by type of associated pathogens|severe pneumonia by type of associated pathogens
583926|NCT00513929|Severe Pneumonia by basal plasma zinc status|severe pneumonia by basal plasma zinc status
583927|NCT00513942|Fetal Movement|fetal movement
583928|NCT00513942|Maternal-Fetal-Attachment|maternal-fetal-attachment
583929|NCT00513942|Fetus|fetus
583930|NCT00513955|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
583931|NCT00513981|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
583932|NCT00513981|recurrent osteosarcoma|recurrent osteosarcoma
583933|NCT00513981|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
583934|NCT00513981|recurrent childhood ependymoma|recurrent childhood ependymoma
583935|NCT00513981|untreated childhood brain stem glioma|untreated childhood brain stem glioma
583936|NCT00513981|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
583937|NCT00513994|Pharmacokinetics|pharmacokinetics
583938|NCT00513994|Nitroglycerin|nitroglycerin
583939|NCT00513994|pharmacokinetics study of nitroglycerin containing treatments|pharmacokinetics study of nitroglycerin containing treatments
583940|NCT00514007|Non-small cell lung cancer|non-small cell lung cancer
583941|NCT00514007|Ovarian cancer|ovarian cancer
583942|NCT00514007|Renal cancer|renal cancer
583943|NCT00514007|Advanced Cancer|advanced cancer
583958|NCT00514059|Diphteria-tetanus-pertussis-polio vaccine|diphteria-tetanus-pertussis-polio vaccine
583959|NCT00514059|Booster immunization|booster immunization
583960|NCT00514059|Vaccine effect (Diphtheria-tetanus-acellular pertussis-polio)|vaccine effect (diphtheria-tetanus-acellular pertussis-polio)
583961|NCT00514059|Immunity|immunity
583962|NCT00514059|Safety|safety
583963|NCT00514072|stage IV prostate cancer|stage iv prostate cancer
583964|NCT00514072|recurrent prostate cancer|recurrent prostate cancer
583965|NCT00514085|recurrent melanoma|recurrent melanoma
583966|NCT00514085|stage IV melanoma|stage iv melanoma
583967|NCT00514098|Microbicide|microbicide
583968|NCT00514098|Seroconversion|seroconversion
583969|NCT00514098|Treatment Experienced|treatment experienced
583970|NCT00514098|Treatment Naive|treatment naive
583971|NCT00514150|angiography|angiography
583972|NCT00514150|complications|complications
583973|NCT00514150|contrast media|contrast media
583974|NCT00514150|kidney|kidney
583975|NCT00514150|prevention|prevention
583976|NCT00514163|pancreatic carcinoma|pancreatic carcinoma
583977|NCT00514163|gemcitabine|gemcitabine
583978|NCT00514163|S-1|s-1
583979|NCT00514163|phaseⅡstudy|phaseⅱstudy
583980|NCT00514189|Acute Myelogenous Leukemia|acute myelogenous leukemia
583981|NCT00514189|Leukemia|leukemia
583982|NCT00514189|Autologous Dendritic Cells|autologous dendritic cells
583983|NCT00514189|Vaccine|vaccine
583984|NCT00514189|AML|aml
583985|NCT00514189|mRNA|mrna
583986|NCT00514202|cocaine|cocaine
583987|NCT00514202|ADHD|adhd
583988|NCT00514202|attention|attention
583989|NCT00514202|hyperactivity|hyperactivity
583990|NCT00514202|drug|drug
583991|NCT00514202|dependence|dependence
583992|NCT00514215|lung metastases|lung metastases
583993|NCT00514215|stage I non-small cell lung cancer|stage i non-small cell lung cancer
583994|NCT00514215|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
583995|NCT00514215|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
583996|NCT00514215|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
583997|NCT00514215|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
583998|NCT00514215|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
583999|NCT00514215|recurrent renal cell cancer|recurrent renal cell cancer
584000|NCT00514215|stage IV renal cell cancer|stage iv renal cell cancer
584001|NCT00514215|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
584002|NCT00514228|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
584003|NCT00514228|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
584004|NCT00514228|advanced adult primary liver cancer|advanced adult primary liver cancer
584005|NCT00514228|recurrent adult primary liver cancer|recurrent adult primary liver cancer
584006|NCT00514254|endometrial cancer|endometrial cancer
584007|NCT00514254|risk factors|risk factors
584008|NCT00514254|questionnaire|questionnaire
584009|NCT00514254|07-093|07-093
584010|NCT00514267|Prostate Cancer|prostate cancer
584011|NCT00514267|HRPC|hrpc
584012|NCT00514267|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
584013|NCT00514267|YM155|ym155
584014|NCT00514267|Treatment Outcome|treatment outcome
584015|NCT00514267|Solid Tumors|solid tumors
584016|NCT00514280|Lead and Smoke Study in D.C.|lead and smoke study in d.c.
584017|NCT00514280|Birth Weight|birth weight
584018|NCT00514280|Gestational Age|gestational age
584019|NCT00514280|Lead|lead
584020|NCT00514280|Tobacco Smoke|tobacco smoke
584021|NCT00514293|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
584022|NCT00514293|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
584023|NCT00514293|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
584024|NCT00514306|Advanced Cancer|advanced cancer
584025|NCT00514306|Breast cancer|breast cancer
584026|NCT00514306|Renal cancer|renal cancer
584027|NCT00514306|Ovarian Cancer|ovarian cancer
584028|NCT00514306|Metastatic Cancer|metastatic cancer
584029|NCT00514306|Non-small cell lung cancer|non-small cell lung cancer
584030|NCT00514306|Colorectal cancer|colorectal cancer
584031|NCT00514332|colorectal stents|colorectal stents
584032|NCT00514332|colonic obstruction|colonic obstruction
584033|NCT00514332|colonic adenocarcinoma|colonic adenocarcinoma
584034|NCT00514332|colorectal surgery|colorectal surgery
584838|NCT00516308|NightHawk|nighthawk
584035|NCT00514345|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
584036|NCT00514345|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
584037|NCT00514345|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
584038|NCT00514345|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
584039|NCT00514345|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
584040|NCT00514345|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
584041|NCT00514345|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
584042|NCT00514345|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
584143|NCT00514787|Asthma|asthma
584043|NCT00514345|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
584044|NCT00514345|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
584045|NCT00514358|Fungal|fungal
584046|NCT00514358|Infection|infection
584047|NCT00514358|sepsis|sepsis
584048|NCT00514358|pharmacokinetics|pharmacokinetics
584049|NCT00514371|Multiple Myeloma|multiple myeloma
584050|NCT00514371|Heat Shock Protein 90|heat shock protein 90
584051|NCT00514371|Hsp90|hsp90
584052|NCT00514371|KOS-953|kos-953
584053|NCT00514371|17-AAG|17-aag
584054|NCT00514371|bortezomib|bortezomib
584055|NCT00514371|relapsed-refractory|relapsed-refractory
584056|NCT00514371|tanespimycin|tanespimycin
584057|NCT00514397|untreated childhood brain stem glioma|untreated childhood brain stem glioma
584058|NCT00514410|Depression|depression
584059|NCT00514410|Folate|folate
584060|NCT00514410|Folic acid|folic acid
584061|NCT00514410|Antidepressants|antidepressants
584062|NCT00514436|Asthma|asthma
584063|NCT00514436|children|children
584064|NCT00514436|low-income, underserved|low-income, underserved
584065|NCT00514436|Reduction in hospitalization|reduction in hospitalization
584066|NCT00514475|Mantle cell lymphoma|mantle cell lymphoma
584067|NCT00514475|Zevalin|zevalin
584068|NCT00514475|90Y-ibritumomab tiuxetan|90y-ibritumomab tiuxetan
584069|NCT00514475|Radioimmunotherapy|radioimmunotherapy
584070|NCT00514475|High-dose therapy|high-dose therapy
584071|NCT00514475|First line|first line
584072|NCT00514488|chronic myeloid leukemia|chronic myeloid leukemia
584073|NCT00514488|STI 571|sti 571
584074|NCT00514488|CML022|cml022
584075|NCT00514514|Everolimus|everolimus
584076|NCT00514514|mycophenolate|mycophenolate
584077|NCT00514514|CNI-free|cni-free
584078|NCT00514514|kidney transplantation|kidney transplantation
584079|NCT00514540|Prostate Cancer|prostate cancer
584080|NCT00514540|Anaplastic Prostate Cancer|anaplastic prostate cancer
584081|NCT00514540|Carboplatin|carboplatin
584082|NCT00514540|Docetaxel|docetaxel
584083|NCT00514540|Taxotere|taxotere
584084|NCT00514540|Paraplatin|paraplatin
584085|NCT00514553|Prenatal Testing|prenatal testing
584086|NCT00514553|Test Decision-Making|test decision-making
584087|NCT00514553|Decision-Making Intervention|decision-making intervention
584088|NCT00514553|Theory of Unconscious Thought|theory of unconscious thought
584089|NCT00514553|Informed Choice|informed choice
584090|NCT00514553|Decision Making|decision making
584091|NCT00514553|Counseling|counseling
584092|NCT00514566|Polyamide|polyamide
584093|NCT00514566|Polydioxanone|polydioxanone
584094|NCT00514566|Midline|midline
584095|NCT00514566|Abdominal|abdominal
584096|NCT00514566|Closure|closure
584097|NCT00514579|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
584098|NCT00514579|Hematologic Malignancies|hematologic malignancies
584099|NCT00514579|Leukemia|leukemia
584100|NCT00514579|Myelodysplastic Syndrome|myelodysplastic syndrome
584101|NCT00514592|Carotid stenosis|carotid stenosis
584102|NCT00514592|Carotid endarterectomy|carotid endarterectomy
584103|NCT00514605|HIV 1|hiv 1
584104|NCT00514605|AIDS|aids
584105|NCT00514605|Assay|assay
584106|NCT00514605|Rapid Test|rapid test
584107|NCT00514605|HIV-1|hiv-1
584108|NCT00514605|HIV Seronegativity|hiv seronegativity
584109|NCT00514618|Term Pregnancy|term pregnancy
584110|NCT00514618|Diabetes|diabetes
584111|NCT00514618|Cervical Ripening|cervical ripening
584112|NCT00514618|Induction|induction
584113|NCT00514618|misoprostol|misoprostol
584114|NCT00514618|Term Gestational Diabetics|term gestational diabetics
584115|NCT00514644|Panorama|panorama
584116|NCT00514644|Carotid stenoses|carotid stenoses
584117|NCT00514670|Prevention of gastrointestinal and respiratory illness|prevention of gastrointestinal and respiratory illness
584118|NCT00514696|Cancer|cancer
584119|NCT00514696|Leukemia|leukemia
584120|NCT00514696|GCS-100|gcs-100
584121|NCT00514696|CLL|cll
584122|NCT00514709|Diphtheria|diphtheria
584123|NCT00514709|Tetanus|tetanus
584124|NCT00514709|Pertussis|pertussis
584125|NCT00514709|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
584126|NCT00514709|Haemophilus influenzae type b|haemophilus influenzae type b
584127|NCT00514722|Hematopoietic malignancies|hematopoietic malignancies
584128|NCT00514722|Umbilical cord blood transplantation|umbilical cord blood transplantation
584228|NCT00515151|Bloodstream Infection|bloodstream infection
584129|NCT00514722|Lymphoma: diffuse large cell, mantle cell, peripheral T-cell, T-NK cell, or Hodgkin's|lymphoma: diffuse large cell, mantle cell, peripheral t-cell, t-nk cell, or hodgkin's
584130|NCT00514735|atrial fibrillation|atrial fibrillation
584131|NCT00514748|breast reconstruction|breast reconstruction
584132|NCT00514748|DIEP|diep
584133|NCT00514748|vessel pedicle|vessel pedicle
584134|NCT00514761|colorectal cancer|colorectal cancer
584135|NCT00514761|AZD6244|azd6244
584136|NCT00514774|Huntington chorea|huntington chorea
584137|NCT00514774|chorea|chorea
584138|NCT00514774|hereditary|hereditary
584139|NCT00514774|tauroursodeoxycholic acid|tauroursodeoxycholic acid
584140|NCT00514774|ursodeoxycholic acid|ursodeoxycholic acid
584141|NCT00514774|TUDCA|tudca
584142|NCT00514774|UDCA|udca
584149|NCT00514839|Prescription drug use disorder|prescription drug use disorder
584150|NCT00514839|Brief intervention|brief intervention
584151|NCT00514839|General hospital|general hospital
584152|NCT00514839|Motivational Interviewing|motivational interviewing
584153|NCT00514865|ONO-2333Ms|ono-2333ms
584154|NCT00514865|Major Depressive Disorder|major depressive disorder
584155|NCT00514878|nausea|nausea
584156|NCT00514878|postoperative nausea and vomiting|postoperative nausea and vomiting
584157|NCT00514878|postoperative pain|postoperative pain
584158|NCT00514904|safety|safety
584159|NCT00514904|meningococcal vaccine|meningococcal vaccine
584160|NCT00514904|immunogenicity|immunogenicity
584161|NCT00514930|radiofrequency ablation|radiofrequency ablation
584162|NCT00514930|liver cancer|liver cancer
584163|NCT00514930|complications|complications
584164|NCT00514930|liver tumors|liver tumors
584165|NCT00514956|Post-Traumatic Stress Syndrome (PTSD)|post-traumatic stress syndrome (ptsd)
584166|NCT00514969|accelerated and blastic phase|accelerated and blastic phase
584167|NCT00514969|STI571|sti571
584168|NCT00514982|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
584169|NCT00514982|Colitis|colitis
584170|NCT00514982|Medical Therapy|medical therapy
584171|NCT00514982|Immunopathogenesis|immunopathogenesis
584172|NCT00514982|Cytokine|cytokine
584173|NCT00514982|Hermansky-Pudlak Syndrome Associated Colitis|hermansky-pudlak syndrome associated colitis
584175|NCT00515021|Metabolic syndrome|metabolic syndrome
584176|NCT00515021|Aldosterone inhibitor|aldosterone inhibitor
584177|NCT00515021|Diurnal drug regimen|diurnal drug regimen
584178|NCT00515021|PAI-1 levels|pai-1 levels
584179|NCT00515034|Doripenem|doripenem
584180|NCT00515034|Imipenem|imipenem
584181|NCT00515034|Cilastatin|cilastatin
584182|NCT00515034|Vancomycin|vancomycin
584183|NCT00515034|DORIBAX, DORIPREX, FINIBAX, DURAPTA, PRIMAXIN, Anti Bacterial Agents|doribax, doriprex, finibax, durapta, primaxin, anti bacterial agents
584184|NCT00515034|Ileus|ileus
584185|NCT00515034|Hospitalized|hospitalized
584186|NCT00515034|Fever|fever
584187|NCT00515047|Atopic Dermatitis|atopic dermatitis
584188|NCT00515047|Eczema|eczema
584189|NCT00515047|Eczema Herpeticum|eczema herpeticum
584190|NCT00515047|Molluscum Contagiousum|molluscum contagiousum
584191|NCT00515047|Herpes Simplex|herpes simplex
584192|NCT00515047|Vaccinia|vaccinia
584193|NCT00515060|Advanced Cancer|advanced cancer
584194|NCT00515060|Therapy-Induced Pain|therapy-induced pain
584195|NCT00515060|Pain Threshold|pain threshold
584196|NCT00515060|Sensory Tests|sensory tests
584197|NCT00515060|Stimuli|stimuli
584198|NCT00515060|Pain|pain
584302|NCT00515359|Sedation|sedation
584199|NCT00515073|Endometrial Cancer|endometrial cancer
584200|NCT00515073|Papillary Serous Carcinoma|papillary serous carcinoma
584201|NCT00515073|Pelvic Radiation Therapy|pelvic radiation therapy
584202|NCT00515073|Paclitaxel|paclitaxel
584203|NCT00515073|Taxol|taxol
584204|NCT00515086|Glioblastoma Multiforme, GBM, RAD001, RAD|glioblastoma multiforme, gbm, rad001, rad
584205|NCT00515099|New-onset Type 1 Diabetes Mellitus|new-onset type 1 diabetes mellitus
584206|NCT00515099|New-onset T1DM|new-onset t1dm
584207|NCT00515099|New-onset Type 1 Diabetes|new-onset type 1 diabetes
584208|NCT00515099|New-onset T1D|new-onset t1d
584209|NCT00515099|Newly Diagnosed Type 1 Diabetes Mellitus|newly diagnosed type 1 diabetes mellitus
584210|NCT00515099|Autoimmune diabetes|autoimmune diabetes
584211|NCT00515099|Thymoglobulin|thymoglobulin
584212|NCT00515099|ATG|atg
584213|NCT00515099|Rabbit antithymocyte globulin|rabbit antithymocyte globulin
584214|NCT00515112|prostate|prostate
584215|NCT00515112|cancer|cancer
584216|NCT00515112|testosterone replacement|testosterone replacement
584217|NCT00515112|AndroGel|androgel
584218|NCT00515112|prostatic cancer|prostatic cancer
584219|NCT00515112|prostatic neoplasms|prostatic neoplasms
584220|NCT00515125|Quality of life|quality of life
584221|NCT00515125|Supplement|supplement
584222|NCT00515125|Care home|care home
584223|NCT00515125|Elderly|elderly
584224|NCT00515125|Malnutrition|malnutrition
584225|NCT00515138|B-Cell NHL|b-cell nhl
584226|NCT00515138|Autologous Stem Cell Transplant|autologous stem cell transplant
584227|NCT00515138|RICE|rice
584230|NCT00515151|Central Venous Catheter|central venous catheter
584232|NCT00515151|Disinfection|disinfection
584233|NCT00515151|Octenidine Dihydrochloride|octenidine dihydrochloride
584234|NCT00515164|lung volume reduction|lung volume reduction
584235|NCT00515164|emphysema|emphysema
584236|NCT00515164|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
584237|NCT00515177|mindfulness|mindfulness
584238|NCT00515177|meditation|meditation
584239|NCT00515177|MBSR|mbsr
584240|NCT00515177|mindfulness meditation|mindfulness meditation
584241|NCT00515177|sleep|sleep
584242|NCT00515177|insomnia|insomnia
584243|NCT00515177|chronic insomnia|chronic insomnia
584244|NCT00515177|primary insomnia|primary insomnia
584245|NCT00515177|Minnesota|minnesota
584246|NCT00515190|Stomach Neoplasms|stomach neoplasms
584247|NCT00515190|Secondary|secondary
584248|NCT00515190|Combination chemotherapy|combination chemotherapy
584249|NCT00515190|S-1|s-1
584250|NCT00515190|oxaliplatin|oxaliplatin
584251|NCT00515203|Immune (Idiopathic) Thrombocytopenic Purpura|immune (idiopathic) thrombocytopenic purpura
584252|NCT00515203|Pediatric Idiopathic Thrombocytopenic Purpura|pediatric idiopathic thrombocytopenic purpura
584253|NCT00515216|Phase II|phase ii
584254|NCT00515216|Gastric cancer|gastric cancer
584255|NCT00515216|Gastroesophageal cancer|gastroesophageal cancer
584256|NCT00515216|Metastatic|metastatic
584257|NCT00515216|FOLFOX|folfox
584258|NCT00515216|Thymidylate synthase|thymidylate synthase
584259|NCT00515216|Pharmacogenomic|pharmacogenomic
584260|NCT00515229|cystic fibrosis|cystic fibrosis
584261|NCT00515229|ceramide|ceramide
584262|NCT00515229|amitriptyline|amitriptyline
584263|NCT00515229|Pseudomonas aeruginosa|pseudomonas aeruginosa
584264|NCT00515229|lung function|lung function
584265|NCT00515242|massage therapy|massage therapy
584266|NCT00515242|relaxation treatments|relaxation treatments
584267|NCT00515255|Obsessive Compulsive Disorder|obsessive compulsive disorder
584268|NCT00515255|Neuropharm|neuropharm
584269|NCT00515255|NPL-2003|npl-2003
584270|NCT00515268|LPS challenge,|lps challenge,
584271|NCT00515268|Healthy volunteers|healthy volunteers
584272|NCT00515281|prematurity|prematurity
584273|NCT00515281|nitric oxide|nitric oxide
584274|NCT00515281|bronchopulmonary dysplasia|bronchopulmonary dysplasia
584275|NCT00515281|intraventricular hemorrhage|intraventricular hemorrhage
584276|NCT00515281|periventricular leukomalacia|periventricular leukomalacia
584277|NCT00515281|neurodevelopment|neurodevelopment
584278|NCT00515294|Caffeine|caffeine
584279|NCT00515294|Alcohol|alcohol
584280|NCT00515294|Alcohol Consumption|alcohol consumption
584281|NCT00515294|Residual Effects|residual effects
584282|NCT00515294|Family History|family history
584283|NCT00515294|Psychomotor Vigilance Test|psychomotor vigilance test
584284|NCT00515294|Driving Simulation|driving simulation
584285|NCT00515294|Reaction Time|reaction time
584286|NCT00515307|Hypercholesterolemia, Familial|hypercholesterolemia, familial
584287|NCT00515307|Bone marrow|bone marrow
584288|NCT00515307|Mesenchymal stem cell|mesenchymal stem cell
584289|NCT00515307|Hepatocyte|hepatocyte
584290|NCT00515320|Autism|autism
584291|NCT00515320|children|children
584292|NCT00515320|adolescent|adolescent
584293|NCT00515320|Fluoxetine|fluoxetine
584294|NCT00515320|Autistic Disorder|autistic disorder
584295|NCT00515320|Repetitive behavior|repetitive behavior
584296|NCT00515320|SSRI|ssri
584297|NCT00515320|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
584298|NCT00515333|Alzheimer|alzheimer
584299|NCT00515333|Dementia|dementia
584300|NCT00515346|CLI|cli
584301|NCT00515346|Critical Limb Ischemia|critical limb ischemia
584303|NCT00515359|MRI|mri
584304|NCT00515359|pediatric|pediatric
584305|NCT00515359|propofol|propofol
584306|NCT00515359|brain|brain
584307|NCT00515359|spine|spine
584308|NCT00515359|quality of MRI|quality of mri
584309|NCT00515359|Continuous propofol dosing|continuous propofol dosing
584310|NCT00515359|continuous propofol administration|continuous propofol administration
584311|NCT00515359|Intermittent propofol dosing|intermittent propofol dosing
584312|NCT00515359|intermittent propofol administration|intermittent propofol administration
584313|NCT00515359|Sedative agent|sedative agent
584314|NCT00515359|propofol continuous infusions|propofol continuous infusions
584315|NCT00515359|Recovery time|recovery time
584316|NCT00515359|Complications of sedation|complications of sedation
584317|NCT00515359|bolus dosing|bolus dosing
584318|NCT00515372|Ovarian Cancer|ovarian cancer
584319|NCT00515372|Peritoneal Cancer|peritoneal cancer
584320|NCT00515372|Fallopian Tube Cancer|fallopian tube cancer
584321|NCT00515372|Depression|depression
584322|NCT00515372|Telephone Counseling|telephone counseling
584323|NCT00515372|Quality of Life|quality of life
584324|NCT00515385|Randomized|randomized
584325|NCT00515385|Double-Blind|double-blind
584326|NCT00515385|Dose-Escalation|dose-escalation
584327|NCT00515385|Cohort Study|cohort study
584328|NCT00515411|gastroesophageal junction|gastroesophageal junction
584329|NCT00515411|gastric cancer|gastric cancer
584330|NCT00515411|adenocarcinoma|adenocarcinoma
584331|NCT00515411|unresectable gastric cancer|unresectable gastric cancer
584332|NCT00515411|metastatic gastric|metastatic gastric
584333|NCT00515424|Glaucoma|glaucoma
584334|NCT00515424|Ocular Hypertension|ocular hypertension
584335|NCT00515424|RKI983|rki983
584336|NCT00515424|Primary Open Angle Glaucoma and Ocular Hypertension|primary open angle glaucoma and ocular hypertension
584337|NCT00515437|Sialorrhea|sialorrhea
584338|NCT00515450|Myasthenia Gravis|myasthenia gravis
584339|NCT00515463|Osteopenia|osteopenia
584340|NCT00515463|Osteoporosis|osteoporosis
584341|NCT00515463|AMG 162|amg 162
584342|NCT00515463|Postmenopausal|postmenopausal
584343|NCT00515463|Pre-filled syringe|pre-filled syringe
584344|NCT00515476|metabolic syndrome|metabolic syndrome
584345|NCT00515476|HDL-Cholesterol|hdl-cholesterol
584346|NCT00515476|EPC|epc
584347|NCT00515476|endothelial function|endothelial function
584348|NCT00515476|reduced blood HDL-Cholesterol level|reduced blood hdl-cholesterol level
584349|NCT00515489|Schizophrenia|schizophrenia
585506|NCT00513084|Moderators,|moderators,
584352|NCT00515502|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
584353|NCT00515502|GSK573719,|gsk573719,
584354|NCT00515502|muscarinic receptor antagonist|muscarinic receptor antagonist
584355|NCT00515528|metastatic melanoma|metastatic melanoma
584356|NCT00515541|Platelet|platelet
584357|NCT00515541|Cardiovascular|cardiovascular
584358|NCT00515541|Lipid|lipid
584359|NCT00515541|Fish Oil|fish oil
584360|NCT00515541|Omega 3|omega 3
584361|NCT00515541|DHA|dha
584362|NCT00515541|EPA|epa
584363|NCT00515541|Bleeding|bleeding
584364|NCT00515541|Clotting|clotting
584365|NCT00515541|platelet function|platelet function
584366|NCT00515541|Lipid profile|lipid profile
584367|NCT00515541|Weight and Bleeding risk|weight and bleeding risk
584368|NCT00515554|Hodgkin lymphoma|hodgkin lymphoma
584369|NCT00515554|PET|pet
584370|NCT00515554|advances stages|advances stages
584371|NCT00515554|Rituximab|rituximab
584372|NCT00515567|explanted lungs|explanted lungs
584373|NCT00515567|pulmonary fibrosis|pulmonary fibrosis
584374|NCT00515580|obstructive sleep apnea|obstructive sleep apnea
584375|NCT00515580|upper airway resistance syndrome|upper airway resistance syndrome
584376|NCT00515580|tongue suture|tongue suture
584377|NCT00515580|retrolingual tongue collapse|retrolingual tongue collapse
584378|NCT00515580|minimally invasive|minimally invasive
584379|NCT00515593|osteoporosis|osteoporosis
584380|NCT00515593|postmenopausal women|postmenopausal women
584381|NCT00515593|Severe postmenopausal osteoporosis|severe postmenopausal osteoporosis
584382|NCT00515632|Type 2 diabetes mellitus on Stable insulin therapy|type 2 diabetes mellitus on stable insulin therapy
584383|NCT00515632|Balaglitazone|balaglitazone
584384|NCT00515632|Pioglitazone (Actos®)|pioglitazone (actos®)
584385|NCT00515632|HbA1c|hba1c
584386|NCT00515632|Weight gain|weight gain
584387|NCT00515632|Oedema|oedema
584388|NCT00515632|Fasting blood glucose|fasting blood glucose
584389|NCT00515645|Autonomic nervous system|autonomic nervous system
584390|NCT00515645|Immersion|immersion
584391|NCT00515645|Heart rate variability|heart rate variability
584392|NCT00515645|Head-down tilt|head-down tilt
584393|NCT00515645|Healthy volunteers|healthy volunteers
584394|NCT00515658|Major depression|major depression
584395|NCT00515658|Theta-burst rTMS|theta-burst rtms
584396|NCT00515658|Cortical excitability|cortical excitability
584397|NCT00515658|Hamilton depression rating scale|hamilton depression rating scale
584398|NCT00515671|self-management|self-management
584399|NCT00515671|recovery|recovery
584400|NCT00515671|severe mental illness|severe mental illness
584401|NCT00515710|Hemophilia B|hemophilia b
584402|NCT00515710|Gene Transfer|gene transfer
584403|NCT00515710|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
584404|NCT00515710|Coagulation Factor IX|coagulation factor ix
584405|NCT00515710|Long-term Follow-up|long-term follow-up
584406|NCT00515710|Delayed Adverse Events|delayed adverse events
584407|NCT00515723|control|control
584408|NCT00515723|risperidone|risperidone
584409|NCT00515723|olanzapine|olanzapine
584410|NCT00515723|quetiapine|quetiapine
584411|NCT00515723|ziprasidone|ziprasidone
584412|NCT00515736|selenium|selenium
584413|NCT00515736|oxidative stress|oxidative stress
584414|NCT00515736|glutathione peroxidase|glutathione peroxidase
584415|NCT00515736|critically ill|critically ill
584417|NCT00515736|supplementation|supplementation
584418|NCT00515762|persistent alopecia|persistent alopecia
584419|NCT00515762|docetaxel|docetaxel
584420|NCT00515762|breast cancer|breast cancer
584421|NCT00515788|Neoplastic Meningitis|neoplastic meningitis
584422|NCT00515788|Leptomeningeal Disease|leptomeningeal disease
584423|NCT00515788|Temozolomide|temozolomide
584424|NCT00515788|Temodar|temodar
584425|NCT00515788|DepoCyt|depocyt
584426|NCT00515788|Liposomal Cytarabine|liposomal cytarabine
584427|NCT00515788|Liposomal ara-C|liposomal ara-c
584428|NCT00515801|diabetes mellitus type 1|diabetes mellitus type 1
584429|NCT00515801|hypoglycemia|hypoglycemia
584430|NCT00515801|sulfonylurea|sulfonylurea
584431|NCT00515801|glucagon|glucagon
584432|NCT00515814|Legal blindness|legal blindness
584433|NCT00515814|Retinopathy pigmentosa|retinopathy pigmentosa
584434|NCT00515814|Hereditary condition|hereditary condition
584435|NCT00515814|Photo-receptor degeneration|photo-receptor degeneration
584436|NCT00515814|Retina implant|retina implant
584437|NCT00515814|Subretinal implant|subretinal implant
584438|NCT00515827|Treatment Experienced|treatment experienced
584439|NCT00515853|Rectal neoplasms|rectal neoplasms
584440|NCT00515853|Biofeedback (Psychology)|biofeedback (psychology)
584441|NCT00515853|Fecal Incontinence|fecal incontinence
584442|NCT00515853|Aged|aged
584443|NCT00515853|Anterior resection|anterior resection
584444|NCT00515866|Advanced pancreatic cancer|advanced pancreatic cancer
584445|NCT00515866|Poly (ADP ribose) polymerases|poly (adp ribose) polymerases
584446|NCT00515866|Advanced Solid Tumours|advanced solid tumours
584447|NCT00515879|Generalized subtype|generalized subtype
584448|NCT00515918|Iron deficiency|iron deficiency
584449|NCT00515918|brain|brain
584450|NCT00515918|cognition|cognition
584451|NCT00515918|behavior|behavior
584452|NCT00515931|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
584453|NCT00515931|GIST|gist
584454|NCT00515931|Sarcoma|sarcoma
584455|NCT00515931|Radiation therapy|radiation therapy
584456|NCT00515931|Radiotherapy|radiotherapy
584457|NCT00515944|No condition|no condition
584458|NCT00515944|healthy volunteers|healthy volunteers
584459|NCT00515970|Carcinoma, Basal Cell|carcinoma, basal cell
584460|NCT00515970|Curettage|curettage
584461|NCT00515970|Excision|excision
584462|NCT00515970|Recurrence|recurrence
584463|NCT00515970|Complication|complication
584464|NCT00515970|Esthetic outcome|esthetic outcome
584465|NCT00515983|melanoma|melanoma
584466|NCT00515983|dendritic cells|dendritic cells
584467|NCT00515983|apoptotic/necrotic cells|apoptotic/necrotic cells
584468|NCT00515983|therapeutic vaccine|therapeutic vaccine
584469|NCT00515996|panic disorder|panic disorder
584470|NCT00515996|paroxetine|paroxetine
584471|NCT00515996|genetic polymorphism|genetic polymorphism
584472|NCT00515996|serotonin|serotonin
584473|NCT00516009|RADICULAR PAIN|radicular pain
584474|NCT00516009|DISC HERNIATION|disc herniation
584475|NCT00516009|DEXAMETHASONE|dexamethasone
584477|NCT00516035|Bird Flu|bird flu
584478|NCT00516048|exenatide|exenatide
584479|NCT00516048|Byetta|byetta
584480|NCT00516048|antibodies|antibodies
584481|NCT00516048|Amylin|amylin
584482|NCT00516048|Lilly|lilly
584483|NCT00516074|exenatide|exenatide
584484|NCT00516074|Byetta|byetta
584485|NCT00516074|type 2 diabetes|type 2 diabetes
584486|NCT00516074|heart rate|heart rate
584487|NCT00516074|Amylin|amylin
584488|NCT00516074|Lilly|lilly
584489|NCT00516087|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
584490|NCT00516100|NSCLC|nsclc
584491|NCT00516113|paroxetine|paroxetine
584492|NCT00516113|onset of action|onset of action
584493|NCT00516113|serotonin reuptake inhibitors|serotonin reuptake inhibitors
584494|NCT00516126|hemostasis monitoring|hemostasis monitoring
584495|NCT00516126|perioperative blood loss|perioperative blood loss
584496|NCT00516139|Epilepsy elderly seizure|epilepsy elderly seizure
584497|NCT00516152|Matched Unrelated Donor|matched unrelated donor
584498|NCT00516152|Stem Cell Transplantation|stem cell transplantation
584499|NCT00516152|Busulfan|busulfan
584500|NCT00516152|fludarabine|fludarabine
584501|NCT00516152|Hematopoietic Disorder|hematopoietic disorder
584502|NCT00516165|liver cancer|liver cancer
584503|NCT00516165|RAD001|rad001
584504|NCT00516178|Fish oil supplement|fish oil supplement
584505|NCT00516178|n-3 PUFA|n-3 pufa
584506|NCT00516178|Cardiac function|cardiac function
584507|NCT00516178|Membrane incorporation|membrane incorporation
584508|NCT00516178|Inflammation|inflammation
584509|NCT00516178|Clinical outcome|clinical outcome
584510|NCT00516191|Multiple Myeloma|multiple myeloma
584511|NCT00516191|Velcade|velcade
584512|NCT00516191|Doxil|doxil
584513|NCT00516191|Melphalan|melphalan
584514|NCT00516204|Hyperlipidemia|hyperlipidemia
584515|NCT00516204|Diabetics|diabetics
584517|NCT00516204|Diabetics with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PAVK, etc.)|diabetics with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, pavk, etc.)
584518|NCT00516217|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
584519|NCT00516217|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
584520|NCT00516230|Colonic Neoplasms|colonic neoplasms
584521|NCT00516230|Lynch syndrome|lynch syndrome
584522|NCT00516256|Prostate Cancer|prostate cancer
584523|NCT00516256|Quality of Life|quality of life
584524|NCT00516256|Cancer Information Mentor|cancer information mentor
584525|NCT00516256|CHESS|chess
584526|NCT00516256|the Comprehensive Health Enhancement Support System|the comprehensive health enhancement support system
584527|NCT00516256|Social support|social support
584528|NCT00516256|Skill-building tools|skill-building tools
584529|NCT00516269|Breast Cancer|breast cancer
584530|NCT00516269|Gastrointestinal Cancer|gastrointestinal cancer
584531|NCT00516269|GI Cancer|gi cancer
584532|NCT00516269|Fatigue|fatigue
584533|NCT00516269|OROS Methylphenidate HCl|oros methylphenidate hcl
584534|NCT00516269|Methylphenidate|methylphenidate
584535|NCT00516269|Methylphenidate Hydrochloride|methylphenidate hydrochloride
584536|NCT00516269|Concerta|concerta
584537|NCT00516269|Ritalin|ritalin
584538|NCT00516269|Placebo|placebo
584539|NCT00516282|adult glioblastoma|adult glioblastoma
584540|NCT00516282|adult giant cell glioblastoma|adult giant cell glioblastoma
584541|NCT00516282|adult gliosarcoma|adult gliosarcoma
584542|NCT00516282|adult anaplastic astrocytoma|adult anaplastic astrocytoma
584543|NCT00516282|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
584544|NCT00516282|adult mixed glioma|adult mixed glioma
584545|NCT00509431|adult giant cell glioblastoma|adult giant cell glioblastoma
584546|NCT00509431|adult gliosarcoma|adult gliosarcoma
584547|NCT00509431|adult anaplastic astrocytoma|adult anaplastic astrocytoma
584548|NCT00509431|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
584549|NCT00509431|adult mixed glioma|adult mixed glioma
584550|NCT00509431|recurrent adult brain tumor|recurrent adult brain tumor
584554|NCT00509431|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
584555|NCT00509431|adult oligodendroglioma|adult oligodendroglioma
584556|NCT00509457|NSCLC, vaccination|nsclc, vaccination
584557|NCT00509457|Inoperable NSCLC stage IIIA/B in good performance status|inoperable nsclc stage iiia/b in good performance status
584558|NCT00509483|multinodular|multinodular
584559|NCT00509483|goitre|goitre
584560|NCT00509483|recombinant human TSH|recombinant human tsh
584561|NCT00509496|Refractory|refractory
584562|NCT00509496|Gene Therapy|gene therapy
584563|NCT00509496|HLA-A2 Positive|hla-a2 positive
584564|NCT00509496|Stage IV Melanoma|stage iv melanoma
584565|NCT00509496|Melanoma|melanoma
584566|NCT00509496|Skin Cancer|skin cancer
584567|NCT00509496|Malignant Melanoma|malignant melanoma
584568|NCT00509509|Hereditary Breast Cancer (BRCA1, BRCA2)|hereditary breast cancer (brca1, brca2)
584569|NCT00509535|Vitreoscilla filiformis extract|vitreoscilla filiformis extract
584570|NCT00509535|SCORAD|scorad
584571|NCT00509535|pruritus|pruritus
584572|NCT00509535|microflora|microflora
584573|NCT00509535|TEWL|tewl
584574|NCT00509561|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
584575|NCT00509561|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
584576|NCT00509561|stage IA esophageal cancer|stage ia esophageal cancer
584577|NCT00509561|stage IB esophageal cancer|stage ib esophageal cancer
584578|NCT00509561|stage IIA esophageal cancer|stage iia esophageal cancer
584579|NCT00509561|stage IIB esophageal cancer|stage iib esophageal cancer
584580|NCT00509561|stage IIIA esophageal cancer|stage iiia esophageal cancer
584581|NCT00509561|stage IIIB esophageal cancer|stage iiib esophageal cancer
584582|NCT00509561|stage IIIC esophageal cancer|stage iiic esophageal cancer
584583|NCT00509574|Single Nucleotide Polymorphism|single nucleotide polymorphism
584584|NCT00509574|statins|statins
584585|NCT00509574|hyperlipidemia|hyperlipidemia
584586|NCT00509600|Juvenile Myelomonocytic Leukemia|juvenile myelomonocytic leukemia
584587|NCT00509600|JMML|jmml
584588|NCT00509600|Leukemia|leukemia
584589|NCT00509600|Etanercept|etanercept
584590|NCT00509600|Enbrel|enbrel
584591|NCT00509626|fatigue|fatigue
584592|NCT00509626|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
584593|NCT00509626|weight changes|weight changes
584594|NCT00509626|depression|depression
584595|NCT00509626|stage I breast cancer|stage i breast cancer
584596|NCT00509626|stage II breast cancer|stage ii breast cancer
584597|NCT00509652|Hemochromatosis|hemochromatosis
584598|NCT00509652|Primary hemochromatosis|primary hemochromatosis
584599|NCT00509652|Hereditary hemochromatosis|hereditary hemochromatosis
584600|NCT00509652|Therapy|therapy
584601|NCT00509652|Erythrocyte apheresis|erythrocyte apheresis
584602|NCT00509652|Phlebotomy|phlebotomy
584603|NCT00509652|Apheresis|apheresis
584604|NCT00509652|Efficacy|efficacy
584605|NCT00509665|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
584606|NCT00509665|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
752173|NCT01172028|stage III prostate cancer|stage iii prostate cancer
584607|NCT00509665|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
584608|NCT00509665|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
584609|NCT00509665|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
584610|NCT00509665|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
584611|NCT00509665|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
584612|NCT00509665|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
584613|NCT00509665|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
584614|NCT00509665|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
584615|NCT00509665|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
584616|NCT00509665|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
584617|NCT00509665|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
584618|NCT00509665|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
584619|NCT00509665|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
584620|NCT00509665|recurrent salivary gland cancer|recurrent salivary gland cancer
584621|NCT00509665|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
584622|NCT00509665|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
584623|NCT00509678|Rituximab|rituximab
584625|NCT00509678|Psoriatic Arthritis|psoriatic arthritis
584626|NCT00509678|Arthritis|arthritis
584627|NCT00509691|infection|infection
584628|NCT00509691|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
584629|NCT00509691|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
584630|NCT00509691|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
584691|NCT00509691|recurrent neuroblastoma|recurrent neuroblastoma
584631|NCT00509691|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
584632|NCT00509691|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
584633|NCT00509691|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
584634|NCT00509691|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
584635|NCT00509691|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
584636|NCT00509691|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
584637|NCT00509691|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
584638|NCT00509691|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
584639|NCT00509691|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
584640|NCT00509691|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
584641|NCT00509691|chronic eosinophilic leukemia|chronic eosinophilic leukemia
584642|NCT00509691|primary myelofibrosis|primary myelofibrosis
584643|NCT00509691|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
584644|NCT00509691|chronic neutrophilic leukemia|chronic neutrophilic leukemia
584645|NCT00509691|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
584646|NCT00509691|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
584647|NCT00509691|disseminated neuroblastoma|disseminated neuroblastoma
584648|NCT00509691|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
584649|NCT00509691|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
584650|NCT00509691|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
584651|NCT00509691|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
584652|NCT00509691|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
584653|NCT00509691|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
584654|NCT00509691|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
584655|NCT00509691|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
584656|NCT00509691|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
584657|NCT00509691|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
584658|NCT00509691|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
584659|NCT00509691|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
584660|NCT00509691|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
585756|NCT00513669|Phase I|phase i
584661|NCT00509691|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
584662|NCT00509691|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
584663|NCT00509691|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
751754|NCT01164592|Cheyne Stokes Respiration (CSR)|cheyne stokes respiration (csr)
584664|NCT00509691|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
584665|NCT00509691|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
584666|NCT00509691|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
584667|NCT00509691|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
584668|NCT00509691|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
584669|NCT00509691|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
584670|NCT00509691|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
584671|NCT00509691|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
584672|NCT00509691|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
584673|NCT00509691|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
584674|NCT00509691|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
584675|NCT00509691|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
584676|NCT00509691|recurrent breast cancer|recurrent breast cancer
584677|NCT00509691|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
584678|NCT00509691|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
584679|NCT00509691|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
584680|NCT00509691|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
584681|NCT00509691|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
584682|NCT00509691|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
584683|NCT00509691|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
584684|NCT00509691|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
584685|NCT00509691|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
584686|NCT00509691|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
584687|NCT00509691|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
584688|NCT00509691|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
584689|NCT00509691|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
584690|NCT00509691|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
584692|NCT00509691|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
584693|NCT00509691|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
584694|NCT00509691|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
584695|NCT00509691|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
584696|NCT00509691|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
584697|NCT00509691|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
584698|NCT00509691|refractory hairy cell leukemia|refractory hairy cell leukemia
584699|NCT00509691|refractory multiple myeloma|refractory multiple myeloma
584700|NCT00509691|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
584701|NCT00509691|secondary acute myeloid leukemia|secondary acute myeloid leukemia
584702|NCT00509691|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
584703|NCT00509691|splenic marginal zone lymphoma|splenic marginal zone lymphoma
584704|NCT00509691|stage I multiple myeloma|stage i multiple myeloma
584705|NCT00509691|stage II multiple myeloma|stage ii multiple myeloma
584706|NCT00509691|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
584707|NCT00509691|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
584708|NCT00509691|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
584709|NCT00509691|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
752329|NCT01172535|Pediatric dosing|pediatric dosing
584710|NCT00509691|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
584711|NCT00509691|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
584712|NCT00509691|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
584713|NCT00509691|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
584714|NCT00509691|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
584715|NCT00509691|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
584716|NCT00509691|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
584717|NCT00509691|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
584718|NCT00509691|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
584719|NCT00509691|stage III multiple myeloma|stage iii multiple myeloma
584720|NCT00509691|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
584721|NCT00509691|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
584722|NCT00509691|stage IIIA breast cancer|stage iiia breast cancer
584723|NCT00509691|stage IIIB breast cancer|stage iiib breast cancer
584724|NCT00509691|stage IIIC breast cancer|stage iiic breast cancer
585757|NCT00513669|Safety|safety
584725|NCT00509691|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
584726|NCT00509691|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
584727|NCT00509691|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
584728|NCT00509691|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
584729|NCT00509691|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
584730|NCT00509691|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
584731|NCT00509691|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
584732|NCT00509691|stage IV breast cancer|stage iv breast cancer
584733|NCT00509691|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
584734|NCT00509691|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
584735|NCT00509691|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
584736|NCT00509691|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
584737|NCT00509691|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
584738|NCT00509691|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
584739|NCT00509691|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
584740|NCT00509691|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
584741|NCT00509691|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
584742|NCT00509691|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
584743|NCT00509691|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
584744|NCT00509691|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
584745|NCT00509691|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
584746|NCT00509691|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
584747|NCT00509691|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
584748|NCT00509691|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
584749|NCT00509691|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
584750|NCT00509691|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
584751|NCT00509691|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
584752|NCT00509691|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
584753|NCT00509691|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
584755|NCT00509704|tumor necrosis|tumor necrosis
584756|NCT00509704|DCE-MRI (Dynamic enhanced magnetic resonance imaging)|dce-mri (dynamic enhanced magnetic resonance imaging)
584757|NCT00509717|quality of health care|quality of health care
584758|NCT00509717|prescriptions, drug|prescriptions, drug
584759|NCT00509717|anticholesteremic agents|anticholesteremic agents
584760|NCT00509717|community pharmacy services|community pharmacy services
585100|NCT00518518|Asthma|asthma
584800|NCT00509990|Atopic dermatitis, pimecrolimus, children|atopic dermatitis, pimecrolimus, children
584921|NCT00516646|Alegebrium|alegebrium
584801|NCT00510003|Atopic dermatitis, children, pimecrolimus, eczema|atopic dermatitis, children, pimecrolimus, eczema
584802|NCT00510016|infants|infants
584803|NCT00510016|opioid withdrawal|opioid withdrawal
584804|NCT00510016|abstinence syndrome|abstinence syndrome
584805|NCT00510016|methadone|methadone
584806|NCT00510016|heroin|heroin
584807|NCT00510042|von Willebrand disease|von willebrand disease
584808|NCT00510042|von Willebrand factor|von willebrand factor
584809|NCT00510042|national study|national study
584810|NCT00510042|bleeding disorder|bleeding disorder
584811|NCT00510042|quality of life|quality of life
584812|NCT00510068|Phase III|phase iii
584813|NCT00510068|Advanced Neuroendocrine Tumor in adults|advanced neuroendocrine tumor in adults
584814|NCT00510068|RAD001|rad001
584815|NCT00510068|NET|net
584816|NCT00510068|everolimus|everolimus
584817|NCT00510068|mTOr|mtor
584818|NCT00510068|islet cell|islet cell
584819|NCT00510068|neuroendocrine|neuroendocrine
584820|NCT00510094|Social Skills|social skills
584821|NCT00510094|Anger Management|anger management
584822|NCT00510094|Relational Aggression|relational aggression
584823|NCT00510120|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
584824|NCT00510120|Conduct Disorder|conduct disorder
584825|NCT00510120|Behavior Problems in Youth|behavior problems in youth
584826|NCT00510120|Argumentativeness|argumentativeness
584827|NCT00510120|Children|children
584828|NCT00510120|Therapy|therapy
584829|NCT00510120|Attention Deficit Disorder|attention deficit disorder
584830|NCT00516308|CLI|cli
584831|NCT00516308|Critical Limb Ischemia|critical limb ischemia
584832|NCT00516308|PAD|pad
584833|NCT00516308|Paripheral Arterial Disease|paripheral arterial disease
584834|NCT00516308|Artherosclerosis|artherosclerosis
584835|NCT00516308|Leg pain|leg pain
584836|NCT00516308|Cardiovascular|cardiovascular
584837|NCT00516308|Atherectomy|atherectomy
584839|NCT00516321|thrombopoietin|thrombopoietin
584840|NCT00516321|hepatitis C|hepatitis c
584841|NCT00516321|ribavirin|ribavirin
584842|NCT00516321|platelets|platelets
584843|NCT00516321|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
584844|NCT00516321|peginterferon alfa-2a|peginterferon alfa-2a
584845|NCT00516334|brain|brain
584846|NCT00516334|electroencephalography|electroencephalography
584847|NCT00516334|premature infant|premature infant
584848|NCT00516334|neurodevelopment|neurodevelopment
584849|NCT00516347|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
584850|NCT00516347|esophageal cancer|esophageal cancer
584851|NCT00516347|Barrett esophagus|barrett esophagus
584852|NCT00516360|Catheter related bloodstream infections|catheter related bloodstream infections
584853|NCT00516360|Infant, Newborn|infant, newborn
584854|NCT00516360|Intensive Care Units, Neonatal|intensive care units, neonatal
584855|NCT00516360|Neonatal Central Line Infections|neonatal central line infections
584856|NCT00516373|advanced ovarian cancer|advanced ovarian cancer
584857|NCT00516373|BRCA 1 protein|brca 1 protein
584858|NCT00516373|BRCA 2 protein|brca 2 protein
584859|NCT00516373|Poly(ADP ribose)polymerases|poly(adp ribose)polymerases
584860|NCT00516386|Adolescents|adolescents
584861|NCT00516386|Anorexia nervosa (AN)|anorexia nervosa (an)
584862|NCT00516386|Bone formation markers|bone formation markers
584863|NCT00516386|Insulin like growth factor-1 (IGF-I)|insulin like growth factor-1 (igf-i)
584864|NCT00516399|Fungal keratitis|fungal keratitis
584865|NCT00516399|povidone iodine|povidone iodine
584866|NCT00516399|childhood blindness|childhood blindness
584867|NCT00516399|povidone-iodine|povidone-iodine
584868|NCT00516412|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
584869|NCT00516412|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
584870|NCT00516412|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
584871|NCT00516412|stage I mantle cell lymphoma|stage i mantle cell lymphoma
584872|NCT00516412|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
584873|NCT00516412|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
584874|NCT00516425|stage IA breast cancer|stage ia breast cancer
584875|NCT00516425|stage IB breast cancer|stage ib breast cancer
584876|NCT00516425|stage II breast cancer|stage ii breast cancer
584877|NCT00516425|stage IIIA breast cancer|stage iiia breast cancer
584878|NCT00516438|malignant solid tumours|malignant solid tumours
584879|NCT00516438|Poly(ADP ribose)|poly(adp ribose)
584880|NCT00516438|polymerases|polymerases
584881|NCT00516464|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
584882|NCT00516464|Vitrectomy|vitrectomy
584883|NCT00516464|Ranibizumab|ranibizumab
584884|NCT00516477|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
584885|NCT00516477|Leber Congenital Amaurosis|leber congenital amaurosis
584886|NCT00516477|Gene transfer|gene transfer
584887|NCT00516490|GnRH agonist|gnrh agonist
584888|NCT00516490|IVF/ICSI outcome|ivf/icsi outcome
584889|NCT00516490|luteal phase|luteal phase
584890|NCT00516516|muscle cramp|muscle cramp
584891|NCT00516516|pregnancy|pregnancy
584892|NCT00516516|carnitine|carnitine
584893|NCT00516516|randomized controlled clinical trials|randomized controlled clinical trials
584901|NCT00516581|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
584902|NCT00516581|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
584903|NCT00516581|Treatment Experienced|treatment experienced
584904|NCT00516581|Treatment Naive|treatment naive
584905|NCT00516607|recurrent adult brain tumor|recurrent adult brain tumor
584906|NCT00516607|adult mixed glioma|adult mixed glioma
584907|NCT00516607|adult anaplastic astrocytoma|adult anaplastic astrocytoma
584908|NCT00516607|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
584909|NCT00516607|adult glioblastoma|adult glioblastoma
584910|NCT00516607|adult anaplastic ependymoma|adult anaplastic ependymoma
584911|NCT00516607|adult giant cell glioblastoma|adult giant cell glioblastoma
584912|NCT00516607|adult gliosarcoma|adult gliosarcoma
584913|NCT00516607|adult pineal gland astrocytoma|adult pineal gland astrocytoma
584914|NCT00516620|Body Weight|body weight
584916|NCT00516633|Adherence|adherence
584917|NCT00516633|Burden of asthma|burden of asthma
584918|NCT00516633|Quality of life|quality of life
584919|NCT00516633|Questionnaires|questionnaires
584920|NCT00516646|Advanced Glycation End-products (AGEs)|advanced glycation end-products (ages)
584922|NCT00517712|Acute promyelocytic leukemia|acute promyelocytic leukemia
584923|NCT00517712|Arsenic trioxide|arsenic trioxide
584924|NCT00517712|Molecular remission|molecular remission
584925|NCT00517712|Toxicity profile|toxicity profile
584926|NCT00517712|Maintenance therapy|maintenance therapy
584927|NCT00517725|exercise|exercise
584928|NCT00517725|lung diffusion|lung diffusion
584929|NCT00517725|hypoxia|hypoxia
584930|NCT00517725|chemoreceptor|chemoreceptor
584931|NCT00517725|beta-blockers|beta-blockers
584932|NCT00517725|heart failure|heart failure
584933|NCT00517751|Lumbar Spinal Stenosis|lumbar spinal stenosis
584934|NCT00517751|X-STOP Spacer|x-stop spacer
584935|NCT00517751|Interspinous process decompression|interspinous process decompression
584936|NCT00517751|Neurogenic Intermittent Claudication|neurogenic intermittent claudication
584937|NCT00517764|major depressive disorder|major depressive disorder
584939|NCT00517764|escitalopram|escitalopram
584940|NCT00517764|open-label|open-label
584941|NCT00517764|major depression|major depression
584942|NCT00517764|serotonin transporter|serotonin transporter
584943|NCT00517764|brain-derived neurotrophic factor|brain-derived neurotrophic factor
584944|NCT00517777|sleep apnea syndrome|sleep apnea syndrome
584945|NCT00517777|metabolic syndrome|metabolic syndrome
584946|NCT00517777|cardiac remodelling|cardiac remodelling
585051|NCT00518245|unstable angina|unstable angina
584947|NCT00517777|continuous positive airway pressure ventilation|continuous positive airway pressure ventilation
584948|NCT00517790|Refractory|refractory
584949|NCT00517790|Metastatic|metastatic
584950|NCT00517803|micronutrients|micronutrients
584951|NCT00517803|immunodeficiency|immunodeficiency
584952|NCT00517803|probiotics|probiotics
584953|NCT00517803|yogurt|yogurt
584955|NCT00517803|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
584956|NCT00517803|Complementary Therapies|complementary therapies
584957|NCT00517829|metastatic gastric or adenocarcinoma of the GE junction|metastatic gastric or adenocarcinoma of the ge junction
584958|NCT00517842|Parkinson's disease|parkinson's disease
584959|NCT00517868|bladder|bladder
584960|NCT00517868|pain|pain
584961|NCT00517868|urgency|urgency
584962|NCT00517868|frequency|frequency
584963|NCT00517894|lymphoma|lymphoma
584964|NCT00517894|aggressive|aggressive
584965|NCT00517894|chemotherapy|chemotherapy
584966|NCT00517894|dose-dense|dose-dense
584967|NCT00517933|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
584968|NCT00517933|Pulmonary Hypertension|pulmonary hypertension
584969|NCT00517946|anti-allergy.|anti-allergy.
584970|NCT00517946|seasonal allergic rhinitis (SAR),|seasonal allergic rhinitis (sar),
584971|NCT00517946|intranasal allergen challenge,|intranasal allergen challenge,
584972|NCT00517946|MRI,|mri,
584973|NCT00517959|Stereotactic radiotherapy|stereotactic radiotherapy
584974|NCT00517959|conformal radiotherapy|conformal radiotherapy
584975|NCT00517959|late sequelae|late sequelae
584976|NCT00517959|cognition|cognition
584977|NCT00517959|endocrine dysfunction|endocrine dysfunction
584978|NCT00517972|perimenopausal depression|perimenopausal depression
584979|NCT00517972|omacor|omacor
584980|NCT00517972|major depressive disorder|major depressive disorder
584981|NCT00517972|women|women
584982|NCT00517985|perimenopausal depression|perimenopausal depression
584983|NCT00517985|duloxetine|duloxetine
584984|NCT00517985|cymbalta|cymbalta
584985|NCT00517985|major depressive disorder|major depressive disorder
584986|NCT00517985|women|women
584987|NCT00517998|Lung volume reduction|lung volume reduction
584988|NCT00517998|Bronchoscopy|bronchoscopy
584989|NCT00517998|Emphysema|emphysema
584990|NCT00517998|COPD|copd
584991|NCT00517998|NETT|nett
584992|NCT00517998|Lung disease|lung disease
584993|NCT00517998|COLD|cold
584994|NCT00517998|BLVR|blvr
584995|NCT00518024|tinnitus|tinnitus
584996|NCT00518024|transcranial magnetic stimulation|transcranial magnetic stimulation
584997|NCT00518024|treatment|treatment
584998|NCT00518024|cortex|cortex
585002|NCT00518076|Staphylococcus aureus carriers students nursing|staphylococcus aureus carriers students nursing
585003|NCT00518102|REGRANEX (becaplermin)|regranex (becaplermin)
585004|NCT00518102|Platelet-derived growth factor BB|platelet-derived growth factor bb
585005|NCT00518102|Cancer|cancer
585006|NCT00518102|Cancer incidence|cancer incidence
585007|NCT00518102|Cancer mortality|cancer mortality
585008|NCT00518115|GLP-1,|glp-1,
585009|NCT00518115|Type 2 Diabetes,|type 2 diabetes,
585010|NCT00518115|pharmacokinetics,|pharmacokinetics,
585011|NCT00518115|pharmacodynamics,|pharmacodynamics,
585012|NCT00518115|GSK716155,|gsk716155,
585013|NCT00518115|metformin,|metformin,
585014|NCT00518115|exenatide|exenatide
585015|NCT00518115|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
585016|NCT00518128|Obstructive Sleep Apnea|obstructive sleep apnea
585017|NCT00518128|Leptin|leptin
585018|NCT00518128|Homocysteine|homocysteine
585019|NCT00518128|C-reactive protein|c-reactive protein
585020|NCT00518154|AIDS|aids
585021|NCT00518154|Immunological non-responders|immunological non-responders
585022|NCT00518154|Neuroimmune modulation|neuroimmune modulation
585023|NCT00518154|Pyridostigmine|pyridostigmine
585024|NCT00518154|Treatment Experienced|treatment experienced
585025|NCT00518167|Type 2 diabetes|type 2 diabetes
585026|NCT00518167|primary prevention|primary prevention
585027|NCT00518167|diet|diet
585028|NCT00518167|physical activity|physical activity
585029|NCT00518167|intervention|intervention
585030|NCT00518167|impaired glucose tolerance|impaired glucose tolerance
585031|NCT00518167|lifestyle|lifestyle
585032|NCT00518167|randomized controlled study|randomized controlled study
585033|NCT00518180|Meningococcal|meningococcal
585034|NCT00518180|meningitis|meningitis
585035|NCT00518180|vaccine|vaccine
585036|NCT00518180|adolescents|adolescents
585037|NCT00518206|Clinical Trial|clinical trial
585038|NCT00518206|Phase 2|phase 2
585039|NCT00518206|Cancer Vaccine|cancer vaccine
585040|NCT00518206|NY-ESO-1 protein, human|ny-eso-1 protein, human
585041|NCT00518206|ISCOMATRIX, immunological adjuvant|iscomatrix, immunological adjuvant
585042|NCT00518206|Cyclophosphamide|cyclophosphamide
585043|NCT00518206|T-Cells, Regulatory|t-cells, regulatory
585044|NCT00518219|TW|tw
585045|NCT00518219|Valsartan|valsartan
585046|NCT00518219|treatment|treatment
585047|NCT00518219|membranous nephropathy|membranous nephropathy
585048|NCT00518219|proteinuria|proteinuria
585049|NCT00518232|Methylphenidate|methylphenidate
585050|NCT00518232|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
585052|NCT00518245|drug therapy|drug therapy
585053|NCT00518245|myocardial ischemia|myocardial ischemia
585054|NCT00518245|myocardial infarction|myocardial infarction
585055|NCT00518245|hemorrhage|hemorrhage
585056|NCT00518258|Parkinson's Disease|parkinson's disease
585057|NCT00518258|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
585058|NCT00518258|neuropsychological assessment|neuropsychological assessment
585059|NCT00518284|Restenosis|restenosis
585060|NCT00518284|Superficial Femoral Artery|superficial femoral artery
585061|NCT00518284|Prevention of restenosis|prevention of restenosis
585062|NCT00518284|Revascularization of the superficial Femoral Artery|revascularization of the superficial femoral artery
585063|NCT00518297|Antivirals / HIV|antivirals / hiv
585064|NCT00518310|Interstitial lung disease|interstitial lung disease
585065|NCT00518310|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
585066|NCT00518310|Usual interstitial pneumonia|usual interstitial pneumonia
585067|NCT00518310|Cryptogenic fibrosing alveolitis|cryptogenic fibrosing alveolitis
585068|NCT00518310|Therapy|therapy
585069|NCT00518310|Azathioprine|azathioprine
585070|NCT00518310|Steroids|steroids
585071|NCT00518310|Glucocorticoids|glucocorticoids
585072|NCT00518310|Corticosteroids|corticosteroids
585073|NCT00518310|Prednisone|prednisone
585074|NCT00518323|Schizophrenia|schizophrenia
585075|NCT00518323|Antipsychotic|antipsychotic
585076|NCT00518362|TW|tw
585077|NCT00518362|Valsartan|valsartan
585078|NCT00518362|treatment|treatment
585079|NCT00518362|diabetic nephropathy|diabetic nephropathy
585080|NCT00518362|Proteinuria|proteinuria
585081|NCT00518388|Epidemiology|epidemiology
585082|NCT00518388|Cervical Cancer|cervical cancer
585083|NCT00518388|Human Papillomavirus|human papillomavirus
585084|NCT00518388|Focus Group|focus group
585085|NCT00518388|Questionnaire|questionnaire
585086|NCT00518388|Survey|survey
585087|NCT00518388|HPV|hpv
585088|NCT00518401|A hypoperfusion of the blood through a leg|a hypoperfusion of the blood through a leg
585089|NCT00518401|Stem cells|stem cells
585090|NCT00518401|Stem cell transplantation|stem cell transplantation
585091|NCT00518401|Stem cell autologous transplantation|stem cell autologous transplantation
585092|NCT00518414|infant, formula, LC PUFA|infant, formula, lc pufa
585093|NCT00518440|Liver disease|liver disease
585094|NCT00518440|Liver injury|liver injury
585095|NCT00518453|Influenza vaccine|influenza vaccine
585096|NCT00518466|Obesity|obesity
585097|NCT00518479|Hypertension|hypertension
585098|NCT00518479|Left Ventricular Hypertrophy|left ventricular hypertrophy
585099|NCT00518505|GERD, laparoscopic surgery|gerd, laparoscopic surgery
585112|NCT00518544|hydroxyethyl starch, blood type, coagulation|hydroxyethyl starch, blood type, coagulation
585113|NCT00518557|liver cancer|liver cancer
585114|NCT00518557|interventional radiology|interventional radiology
585115|NCT00518557|Chemoembolization|chemoembolization
585116|NCT00518557|Safety|safety
585117|NCT00518557|Effectiveness|effectiveness
585118|NCT00518570|PMDD|pmdd
585120|NCT00518570|Levetiracetam|levetiracetam
585121|NCT00518583|Breast cancer|breast cancer
585122|NCT00518583|Over-expressing Her2-neu|over-expressing her2-neu
585123|NCT00518596|Neonatal|neonatal
585124|NCT00518596|Sepsis|sepsis
585125|NCT00518596|Global Network|global network
585126|NCT00518596|Probiotics|probiotics
585127|NCT00518596|India|india
585128|NCT00518596|International|international
585129|NCT00518596|Maternal and child health|maternal and child health
585130|NCT00518609|Neonatal|neonatal
585132|NCT00518609|Global Network|global network
585133|NCT00518609|Antibiotics|antibiotics
585134|NCT00518609|India|india
585135|NCT00518609|International|international
585136|NCT00518609|Maternal and child health|maternal and child health
585137|NCT00518635|Growth hormone|growth hormone
585138|NCT00518635|Insulin sensitivity|insulin sensitivity
585139|NCT00518635|Polycystic ovary|polycystic ovary
585140|NCT00518648|Accidental falls|accidental falls
585141|NCT00518648|Prevention|prevention
585142|NCT00518648|Treatment effectiveness|treatment effectiveness
585143|NCT00518661|quinolone resistance|quinolone resistance
585144|NCT00518661|ESBL|esbl
585145|NCT00518661|Klebsiella species|klebsiella species
585146|NCT00518661|Infection|infection
585147|NCT00518674|pain|pain
585148|NCT00518674|local infiltration analgesia|local infiltration analgesia
585149|NCT00518713|Epilepsy|epilepsy
585150|NCT00518713|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
585151|NCT00518713|Drop seizures|drop seizures
585152|NCT00518713|Clobazam|clobazam
585153|NCT00518726|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
585154|NCT00518752|Ventilator Acquired Pneumonia|ventilator acquired pneumonia
585155|NCT00518752|Oral Hygiene|oral hygiene
585156|NCT00518752|Oral Care|oral care
585157|NCT00518752|Xerostomia|xerostomia
585158|NCT00518765|aliskiren, renal hemodynamics, hormonal response, renin pathway, RAAS biomarkers|aliskiren, renal hemodynamics, hormonal response, renin pathway, raas biomarkers
585159|NCT00518778|fusariosis|fusariosis
585160|NCT00518778|solid organ transplants|solid organ transplants
585161|NCT00518791|Integrated health care system|integrated health care system
585162|NCT00518791|Treatment effectiveness|treatment effectiveness
585163|NCT00518791|Cost effectiveness|cost effectiveness
585164|NCT00518791|Program evaluation|program evaluation
585165|NCT00518817|Dystrophy|dystrophy
585166|NCT00518817|Cardiomyopathy|cardiomyopathy
585167|NCT00518830|postnatal depression|postnatal depression
585168|NCT00518830|primary care|primary care
585169|NCT00518830|depressed women|depressed women
585170|NCT00518843|binge eating|binge eating
585171|NCT00518843|purging|purging
585172|NCT00518856|birth asphyxia|birth asphyxia
585173|NCT00518856|neonatal sepsis|neonatal sepsis
585174|NCT00518856|maternal to child transmission of HIV|maternal to child transmission of hiv
585175|NCT00518869|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
585176|NCT00518869|Complementary and Alternative Medicine (CAM)|complementary and alternative medicine (cam)
585177|NCT00518869|Chemotherapy|chemotherapy
585178|NCT00518869|Myelosuppression|myelosuppression
585179|NCT00518869|Quality of Life|quality of life
585180|NCT00518869|Fatigue|fatigue
585181|NCT00518869|EORTC QLQ-C30 and LC13|eortc qlq-c30 and lc13
585182|NCT00518895|Melanoma|melanoma
585183|NCT00518895|Advanced Melanoma|advanced melanoma
585184|NCT00518895|Malignant Melanoma|malignant melanoma
585185|NCT00518895|Metastatic Melanoma|metastatic melanoma
585186|NCT00518895|Skin Cancer|skin cancer
585187|NCT00518895|Genasense|genasense
585188|NCT00518895|oblimersen|oblimersen
585189|NCT00518895|antisense|antisense
585190|NCT00518895|Bcl-2 antisense|bcl-2 antisense
585191|NCT00518895|G3139|g3139
585192|NCT00518895|dacarbazine|dacarbazine
585193|NCT00518908|Ischemia reperfusion injury|ischemia reperfusion injury
585194|NCT00518908|Organ protection|organ protection
585195|NCT00518921|adenosin agonist|adenosin agonist
585196|NCT00518921|chronic stable angina|chronic stable angina
585197|NCT00518934|Safety and efficiency of angiogenesis for patients with limb|safety and efficiency of angiogenesis for patients with limb
585198|NCT00518934|ischemia by transplantation of human cord blood mononuclear|ischemia by transplantation of human cord blood mononuclear
585199|NCT00518934|cells|cells
585200|NCT00518947|Bipolar Disorder|bipolar disorder
585201|NCT00518947|Mania|mania
585202|NCT00518947|Antimanic|antimanic
585203|NCT00518947|Verapamil|verapamil
585204|NCT00518947|Lithium|lithium
585205|NCT00518960|ProAlgaZyme|proalgazyme
585206|NCT00518960|Algae|algae
585207|NCT00518960|High density lipoprotein; HDL|high density lipoprotein; hdl
585208|NCT00518960|C-Reactive Protein; CRP|c-reactive protein; crp
585209|NCT00518960|Hyperlipidemia|hyperlipidemia
585210|NCT00518960|Metabolic Syndrome|metabolic syndrome
585211|NCT00518986|Obstructive Sleep Apnea/Hypopnea Syndrome|obstructive sleep apnea/hypopnea syndrome
585212|NCT00518986|Excessive Sleepiness|excessive sleepiness
585213|NCT00518999|cognition, attention, memory, executive functions, illness-awareness, insight.|cognition, attention, memory, executive functions, illness-awareness, insight.
585214|NCT00519012|early nonresponse|early nonresponse
585215|NCT00519025|Linezolid|linezolid
585216|NCT00519025|Staphylococcus Aureus|staphylococcus aureus
585217|NCT00519025|Infections|infections
585218|NCT00519038|Critical Pathways|critical pathways
585219|NCT00519038|Congestive Heart Failure|congestive heart failure
585220|NCT00519038|Randomized Controlled Trial|randomized controlled trial
585221|NCT00519038|Effectiveness|effectiveness
585222|NCT00519051|depression|depression
585223|NCT00519051|primary care|primary care
585224|NCT00519051|pharmacotherapy|pharmacotherapy
585225|NCT00519064|influenza|influenza
585226|NCT00519064|influenza vaccine|influenza vaccine
585227|NCT00519064|adjuvanted influenza vaccine|adjuvanted influenza vaccine
585228|NCT00519064|H5N1 influenza antigen|h5n1 influenza antigen
585229|NCT00519077|cancer|cancer
585230|NCT00519077|squamous cell|squamous cell
585231|NCT00519077|carcinoma|carcinoma
585232|NCT00519077|head|head
585233|NCT00519077|neck|neck
585234|NCT00519090|leukemia|leukemia
585235|NCT00519090|bone marrow|bone marrow
585236|NCT00519090|leukemia symptoms|leukemia symptoms
585238|NCT00519090|complete blood count|complete blood count
585239|NCT00519090|lymphocyte|lymphocyte
585240|NCT00519090|blood cancer|blood cancer
585241|NCT00519090|leukocytes|leukocytes
585242|NCT00519090|chronic leukemia|chronic leukemia
585243|NCT00519090|bone marrow biopsy|bone marrow biopsy
585244|NCT00519090|leukemia research|leukemia research
585245|NCT00519090|leukemia cells|leukemia cells
585246|NCT00519090|bone marrow disease|bone marrow disease
585247|NCT00519090|chronic myeloid leukemia|chronic myeloid leukemia
585248|NCT00519090|blood cancer symptoms|blood cancer symptoms
585249|NCT00519090|white blood cell diseases|white blood cell diseases
585250|NCT00519090|chronic myelogenous leukemia|chronic myelogenous leukemia
585251|NCT00519090|leukemia treatment|leukemia treatment
585252|NCT00519090|leukemia facts|leukemia facts
585253|NCT00519090|leucemia|leucemia
585254|NCT00519090|facts about leukemia|facts about leukemia
585255|NCT00519090|myelogenous leukemia|myelogenous leukemia
585256|NCT00519090|newly diagnosed CML|newly diagnosed cml
585257|NCT00519090|suboptimal response|suboptimal response
585258|NCT00519090|Philadelphia chromosome positive (Ph+)|philadelphia chromosome positive (ph+)
585369|NCT00519584|Ropivacaine|ropivacaine
585857|NCT00522535|Stent|stent
585259|NCT00519090|chronic myelogenous leukemia in chronic phase (CML-CP)|chronic myelogenous leukemia in chronic phase (cml-cp)
585260|NCT00519103|microarray|microarray
585261|NCT00519103|Inflammtion|inflammtion
585262|NCT00519103|fibrosis|fibrosis
585263|NCT00519129|Pain|pain
585264|NCT00519129|Patient satisfaction|patient satisfaction
585266|NCT00519181|HAM/TSP|ham/tsp
585267|NCT00519181|VALPROIC ACID|valproic acid
585268|NCT00519181|PROVIRAL LOAD|proviral load
585269|NCT00519194|Arrhythmia|arrhythmia
585270|NCT00519194|Atrial Fibrillation|atrial fibrillation
585271|NCT00519207|pediatrics|pediatrics
585272|NCT00519207|pain|pain
585273|NCT00519207|infants|infants
585274|NCT00519207|newborn screening|newborn screening
585275|NCT00519207|venipuncture|venipuncture
585276|NCT00519207|lidocaine|lidocaine
585277|NCT00519207|sucrose|sucrose
585278|NCT00519220|achalasia, Heller myotomy|achalasia, heller myotomy
585279|NCT00519233|HRPC|hrpc
585280|NCT00519233|Advanced hormone refractory prostate cancer|advanced hormone refractory prostate cancer
585281|NCT00519246|Breast Neoplasms|breast neoplasms
585282|NCT00519246|Non-Steroidal Anti-Inflammatory Agents|non-steroidal anti-inflammatory agents
585283|NCT00519246|Analgesia|analgesia
585284|NCT00519272|Cervical Cancer|cervical cancer
585285|NCT00519272|Cervix|cervix
585286|NCT00519272|Precancerous Lesions|precancerous lesions
585287|NCT00519272|Cervical carcinoma in situ|cervical carcinoma in situ
585288|NCT00519272|CIS|cis
585289|NCT00519272|Early cervical cancer detection and treatment|early cervical cancer detection and treatment
585290|NCT00519272|Barriers to Care|barriers to care
585291|NCT00519272|Harris County|harris county
585292|NCT00519272|Questionnaire|questionnaire
585293|NCT00519285|metastatic|metastatic
585294|NCT00519285|prostate|prostate
585295|NCT00519285|cancer|cancer
585296|NCT00519298|Alzheimer Disease|alzheimer disease
585297|NCT00519311|Intellectual disability|intellectual disability
585298|NCT00519311|Health promotion|health promotion
585299|NCT00519311|RCT|rct
585300|NCT00519324|Gastric Cancer|gastric cancer
585301|NCT00519324|RAD001|rad001
585302|NCT00519324|mTOR|mtor
585303|NCT00519337|Atrial Fibrillation|atrial fibrillation
585304|NCT00519337|cardiac surgery|cardiac surgery
585305|NCT00519337|ascorbic acid|ascorbic acid
585306|NCT00519337|vitamin-c|vitamin-c
585307|NCT00519337|inflammation|inflammation
585308|NCT00519350|SIRS, sepsis and related syndromes|sirs, sepsis and related syndromes
585309|NCT00519363|Lupus|lupus
585310|NCT00519363|TLR's|tlr's
585311|NCT00519363|Hyperlipidemia|hyperlipidemia
585317|NCT00519376|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
585318|NCT00519376|safety,|safety,
585319|NCT00519376|COPD patients|copd patients
585320|NCT00519376|pharmacokinetics,|pharmacokinetics,
585321|NCT00519376|tolerability,|tolerability,
585322|NCT00519376|GW642444,|gw642444,
585323|NCT00519402|partial tonsillectomy|partial tonsillectomy
585324|NCT00519402|complete tonsillectomy|complete tonsillectomy
585325|NCT00519402|tonsillectomy|tonsillectomy
585326|NCT00519402|obstruction sleep disordered breathing OSDB|obstruction sleep disordered breathing osdb
585327|NCT00519402|apnea|apnea
585328|NCT00519415|Tongue plate|tongue plate
585329|NCT00519415|Facemask|facemask
585330|NCT00519415|class III maxillary deficiency|class iii maxillary deficiency
585331|NCT00519415|orthodontic angle class three|orthodontic angle class three
585332|NCT00519428|depression|depression
585333|NCT00519428|MDD|mdd
585334|NCT00519428|Major Depressive Disorder|major depressive disorder
585335|NCT00519441|laparoscopic Heller myotomy, achalasia, reflux|laparoscopic heller myotomy, achalasia, reflux
585336|NCT00519454|Systemic Lupus Erythematosus|systemic lupus erythematosus
585337|NCT00519454|Estrogen receptors|estrogen receptors
585338|NCT00519454|T cells|t cells
585339|NCT00519454|Hormones|hormones
585340|NCT00519454|Female adult SLE|female adult sle
585341|NCT00519467|dose-ranging study|dose-ranging study
585342|NCT00519467|SB-714703|sb-714703
585343|NCT00519467|artesunate,|artesunate,
585344|NCT00519467|malaria|malaria
585345|NCT00519467|CDA,|cda,
585346|NCT00519467|chlorproguanil,|chlorproguanil,
585347|NCT00519467|dapsone,|dapsone,
585348|NCT00519480|Tolerability|tolerability
585349|NCT00519480|GSK189075,|gsk189075,
585350|NCT00519480|Metformin,|metformin,
585351|NCT00519480|Safety,|safety,
585352|NCT00519480|Diabetes,|diabetes,
585353|NCT00519493|Clozex|clozex
585354|NCT00519493|Sutures|sutures
585355|NCT00519506|Pulmonary Embolism|pulmonary embolism
585356|NCT00519506|PE|pe
585357|NCT00519519|Rebleeding after endoscopic therapy|rebleeding after endoscopic therapy
585358|NCT00519532|Neupro®|neupro®
585359|NCT00519532|Rotigotine|rotigotine
585360|NCT00519532|Parkinson's Disease|parkinson's disease
585361|NCT00519545|breast|breast
585362|NCT00519545|cancer|cancer
585363|NCT00519545|stage|stage
585364|NCT00519545|one|one
585365|NCT00519545|four|four
585366|NCT00519571|Dental Implantation, Endosseous|dental implantation, endosseous
585367|NCT00519584|Interscalene nerve block|interscalene nerve block
585368|NCT00519584|Dexamethasone|dexamethasone
585370|NCT00519597|Coronary Artery Disease|coronary artery disease
585371|NCT00519597|Sleep Apnea|sleep apnea
585372|NCT00519597|CPAP|cpap
585374|NCT00519597|Mortality|mortality
585375|NCT00519610|portal hypertension, H-graft shunt|portal hypertension, h-graft shunt
585376|NCT00519623|diabetes|diabetes
585377|NCT00519623|insulin|insulin
585378|NCT00519623|blood sugar|blood sugar
585379|NCT00519623|type 1 diabetes|type 1 diabetes
585380|NCT00519623|insulin dependent diabetes|insulin dependent diabetes
585381|NCT00519623|transdermal|transdermal
585382|NCT00519636|experience|experience
585383|NCT00519636|GW685698X|gw685698x
585384|NCT00519636|fluticasone furoate|fluticasone furoate
585385|NCT00519636|preference|preference
585386|NCT00519636|seasonal allergic rhinitis|seasonal allergic rhinitis
585387|NCT00519636|fluticasone propionate|fluticasone propionate
585388|NCT00519649|Hepatitis B vaccine|hepatitis b vaccine
585389|NCT00519649|Challenge dose|challenge dose
585390|NCT00519662|Solid|solid
585391|NCT00519662|Tumors|tumors
585392|NCT00519662|Advanced|advanced
585393|NCT00519675|Chronic hand eczema|chronic hand eczema
585394|NCT00519675|Chronic hand dermatitis|chronic hand dermatitis
585395|NCT00519675|Patients with chronic hand eczema, who are refractory to topical corticosteroids|patients with chronic hand eczema, who are refractory to topical corticosteroids
585396|NCT00519688|tegafur|tegafur
585397|NCT00519688|thalidomide|thalidomide
585398|NCT00519688|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
585399|NCT00519701|sickle cell anemia|sickle cell anemia
585400|NCT00519701|hydroxyurea|hydroxyurea
585401|NCT00519727|diabetes|diabetes
585402|NCT00519740|grass-pollen|grass-pollen
585403|NCT00519740|allergy|allergy
585404|NCT00519740|bronchial hyperreactivity|bronchial hyperreactivity
585405|NCT00519740|asthma|asthma
585406|NCT00519753|Glaucoma|glaucoma
585407|NCT00519766|Ratio of 3-Hydroxycotinine to Cotinine|ratio of 3-hydroxycotinine to cotinine
585408|NCT00519766|Nicotine Metabolism|nicotine metabolism
585409|NCT00519766|Pregnancy|pregnancy
585410|NCT00519779|affect|affect
585411|NCT00519779|inflammation|inflammation
585412|NCT00519792|Relapse|relapse
585413|NCT00519792|HCV|hcv
585414|NCT00519792|Hepatitis C|hepatitis c
585415|NCT00519792|Interferon|interferon
585416|NCT00519792|Ribavirin|ribavirin
585417|NCT00519805|thromboembolism|thromboembolism
585418|NCT00519805|extensive stage small cell lung cancer|extensive stage small cell lung cancer
585419|NCT00519805|limited stage small cell lung cancer|limited stage small cell lung cancer
585420|NCT00519805|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
585421|NCT00519805|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
585422|NCT00519805|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
585423|NCT00519805|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
585424|NCT00519805|stage I non-small cell lung cancer|stage i non-small cell lung cancer
585515|NCT00513110|Endotoxin|endotoxin
585425|NCT00519818|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
585426|NCT00519818|Hydrocortisone|hydrocortisone
585427|NCT00519818|Pharmacokinetic|pharmacokinetic
585428|NCT00519818|Pharmacodynamic|pharmacodynamic
585429|NCT00519831|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
585430|NCT00519831|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
585431|NCT00519831|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
585432|NCT00519870|Pulmonary hypertension|pulmonary hypertension
585433|NCT00519870|Angiotensin receptor blocker|angiotensin receptor blocker
585434|NCT00519870|Calcium channel blocker|calcium channel blocker
585435|NCT00519883|Anastrozole|anastrozole
585436|NCT00519883|Exercise|exercise
585437|NCT00519909|dairy products, calcium, fat excretion, energy excretion|dairy products, calcium, fat excretion, energy excretion
585438|NCT00519935|Insulin Dependent Diabetes Mellitus|insulin dependent diabetes mellitus
585439|NCT00519935|family therapy|family therapy
585440|NCT00519935|adolescents|adolescents
585441|NCT00519974|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
585442|NCT00519974|stage I breast cancer|stage i breast cancer
585443|NCT00519974|stage II breast cancer|stage ii breast cancer
585444|NCT00519974|stage IIIA breast cancer|stage iiia breast cancer
585445|NCT00519974|stage IIIB breast cancer|stage iiib breast cancer
585446|NCT00519974|stage IIIC breast cancer|stage iiic breast cancer
585447|NCT00519974|stage IV breast cancer|stage iv breast cancer
585448|NCT00519974|recurrent breast cancer|recurrent breast cancer
585449|NCT00519987|pharmacokinetics|pharmacokinetics
585450|NCT00520000|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
585451|NCT00520026|suicide|suicide
585452|NCT00520026|prevention|prevention
585453|NCT00520026|lithium|lithium
585454|NCT00520026|suicidality|suicidality
585455|NCT00520039|Otitis Media|otitis media
585456|NCT00520039|Effusion|effusion
585457|NCT00520039|OMM|omm
585458|NCT00520039|OMT|omt
585459|NCT00520039|Resolution|resolution
585460|NCT00520052|bisphosphonates, prostate cancer, bone density, osteoporosis|bisphosphonates, prostate cancer, bone density, osteoporosis
585461|NCT00520091|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
585570|NCT00513240|cardiac|cardiac
585462|NCT00520091|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
585463|NCT00520091|stage II esophageal cancer|stage ii esophageal cancer
585464|NCT00520091|stage III esophageal cancer|stage iii esophageal cancer
585465|NCT00520091|stage IV esophageal cancer|stage iv esophageal cancer
585466|NCT00520130|Unrelated Donors|unrelated donors
585467|NCT00520130|Reduced Intensity Stem Cell Transplant|reduced intensity stem cell transplant
585468|NCT00520130|Leukemia|leukemia
585469|NCT00520130|Lymphoma|lymphoma
585470|NCT00520130|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
585471|NCT00520130|Myelodysplastic Syndrome|myelodysplastic syndrome
585472|NCT00520130|Multiple Myeloma|multiple myeloma
585473|NCT00520143|GSD-II, Pompe Disease, Glycogen Storage Disease II|gsd-ii, pompe disease, glycogen storage disease ii
585474|NCT00520169|bioavailability|bioavailability
585475|NCT00512954|airway inflammation|airway inflammation
585476|NCT00512954|susceptibility to infections|susceptibility to infections
585477|NCT00512954|inflammatory response in blood and urine|inflammatory response in blood and urine
585478|NCT00512954|infective exacerbations|infective exacerbations
585479|NCT00512954|asthma|asthma
585480|NCT00512954|COPD|copd
585481|NCT00512967|oxidative stress|oxidative stress
585482|NCT00512967|antioxidants|antioxidants
585483|NCT00512967|inflammation|inflammation
585484|NCT00512967|quercetin|quercetin
585485|NCT00512980|intermediate stages|intermediate stages
585486|NCT00512993|Postoperative treatment with zoledronic acid|postoperative treatment with zoledronic acid
585487|NCT00512993|Preoperative anthracycline/taxane containing chemotherapy|preoperative anthracycline/taxane containing chemotherapy
585488|NCT00513019|Neurotic Excoriation|neurotic excoriation
585489|NCT00513019|Pathologic Skin Picking|pathologic skin picking
585490|NCT00513019|Psychogenic Excoriation|psychogenic excoriation
585491|NCT00513032|propofol|propofol
585492|NCT00513032|anaesthesia induction|anaesthesia induction
585493|NCT00513032|parathyroidectomy|parathyroidectomy
585494|NCT00513032|methylene blue|methylene blue
585495|NCT00513032|General anesthesia|general anesthesia
585496|NCT00513045|Nightmares|nightmares
585497|NCT00513045|treatment|treatment
585498|NCT00513045|self-help|self-help
585499|NCT00513058|metastatic breast cancer|metastatic breast cancer
585500|NCT00513058|advanced breast cancer|advanced breast cancer
585501|NCT00513084|Behavioral,|behavioral,
585502|NCT00513084|Self-Determination Theory,|self-determination theory,
585503|NCT00513084|Motivational Interviewing,|motivational interviewing,
585504|NCT00513084|Exercise, Physical Activity,|exercise, physical activity,
585505|NCT00513084|Motivation,|motivation,
585519|NCT00513123|Digital Colposcopy for Fluorescence|digital colposcopy for fluorescence
585520|NCT00513123|DCF|dcf
585521|NCT00513123|Fluorescence Spectroscopy|fluorescence spectroscopy
585522|NCT00513123|Digital Colposcopy|digital colposcopy
585523|NCT00513123|DC|dc
585524|NCT00513123|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
585525|NCT00513123|Cervical Cancer|cervical cancer
585526|NCT00513123|Cervix|cervix
585527|NCT00513123|Vagina|vagina
585528|NCT00513123|Lesions of the cervix|lesions of the cervix
585529|NCT00513123|Precancerous lesions|precancerous lesions
585530|NCT00513136|Fatigue|fatigue
585531|NCT00513136|Breast Cancer|breast cancer
585532|NCT00513136|Behavioral Research|behavioral research
585533|NCT00513136|Quality of Life|quality of life
585534|NCT00513149|angioplasty|angioplasty
585535|NCT00513149|clopidogrel|clopidogrel
585536|NCT00513149|coronary artery disease|coronary artery disease
585537|NCT00513149|PFA|pfa
585538|NCT00513162|Advanced Cancers|advanced cancers
585539|NCT00513162|Brain|brain
585540|NCT00513162|CNS|cns
585541|NCT00513162|Neural|neural
585542|NCT00513162|Pediatrics|pediatrics
585543|NCT00513162|Spinal|spinal
585544|NCT00513162|Neuroectodermal Tumor|neuroectodermal tumor
585545|NCT00513162|Brain Metastases|brain metastases
585546|NCT00513162|Valproate|valproate
585547|NCT00513162|Valproic Acid|valproic acid
585548|NCT00513162|Depakene|depakene
585549|NCT00513162|Etoposide|etoposide
585550|NCT00513162|VePesid|vepesid
585551|NCT00513175|Allogeneic SCT|allogeneic sct
585552|NCT00513175|Matched unrelated donors|matched unrelated donors
585553|NCT00513175|hematologic malignancies|hematologic malignancies
585554|NCT00513175|renal cell carcinoma|renal cell carcinoma
585555|NCT00513175|aplastic anemia|aplastic anemia
585556|NCT00513188|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
585557|NCT00513188|anaplastic large cell lymphoma|anaplastic large cell lymphoma
585558|NCT00513188|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
585559|NCT00513188|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
585560|NCT00513188|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
585561|NCT00513201|lyspro|lyspro
585562|NCT00513201|regular insulin|regular insulin
585563|NCT00513201|cirrhotic patients|cirrhotic patients
585564|NCT00513214|Diabetes|diabetes
585565|NCT00513214|Type 2|type 2
585566|NCT00513214|Mellitus|mellitus
585567|NCT00513240|erythropoetin|erythropoetin
585568|NCT00513240|neuroprotection|neuroprotection
585569|NCT00513240|neonate|neonate
585571|NCT00513240|magnetic resonance imaging|magnetic resonance imaging
585572|NCT00513240|brain magnetic resonance imaging|brain magnetic resonance imaging
585573|NCT00513240|electroencephalogram|electroencephalogram
585574|NCT00513253|lapatinib|lapatinib
585575|NCT00513253|Healthy Adult Volunteer|healthy adult volunteer
585576|NCT00513266|recurrent rectal cancer|recurrent rectal cancer
585577|NCT00513266|stage IV rectal cancer|stage iv rectal cancer
585578|NCT00513266|recurrent colon cancer|recurrent colon cancer
585579|NCT00513266|stage IV colon cancer|stage iv colon cancer
585580|NCT00513266|adenocarcinoma of the colon|adenocarcinoma of the colon
585581|NCT00513266|adenocarcinoma of the rectum|adenocarcinoma of the rectum
585582|NCT00513266|liver metastases|liver metastases
585583|NCT00513266|lung metastases|lung metastases
585584|NCT00513279|Safety,|safety,
585585|NCT00513279|tolerability,|tolerability,
585586|NCT00513279|pharmacokinetics,|pharmacokinetics,
585587|NCT00513279|pharmacodynamics,|pharmacodynamics,
585588|NCT00513279|repeat dose,|repeat dose,
585589|NCT00513279|placebo,|placebo,
585590|NCT00513279|GSK618334|gsk618334
585591|NCT00513305|acute myeloid leukemia, cytarabine, arsenic trioxide.|acute myeloid leukemia, cytarabine, arsenic trioxide.
585592|NCT00513318|Umbilical cord blood transplantation|umbilical cord blood transplantation
585593|NCT00513318|hematopoietic malignancies|hematopoietic malignancies
585594|NCT00513331|Barrett's Esophagus|barrett's esophagus
585595|NCT00513331|GERD|gerd
585596|NCT00513331|Carcinoma|carcinoma
585597|NCT00513344|Endothelial function|endothelial function
585598|NCT00513344|Arterial stiffness|arterial stiffness
585599|NCT00513344|Dark chocolate|dark chocolate
585600|NCT00513344|Milk chocolate|milk chocolate
585601|NCT00513344|Polyphenols|polyphenols
585602|NCT00513357|Gastrointestinal Cancer|gastrointestinal cancer
585603|NCT00513357|Lung Cancer|lung cancer
585604|NCT00513357|Cachexia|cachexia
585605|NCT00513357|Melatonin|melatonin
585606|NCT00513357|Placebo|placebo
585607|NCT00513357|Anorexia|anorexia
585608|NCT00513357|Weight Loss|weight loss
585609|NCT00513370|Psoriasis|psoriasis
585610|NCT00513370|adalimumab|adalimumab
585611|NCT00513383|basaloid squamous cell carcinoma|basaloid squamous cell carcinoma
585612|NCT00513383|undifferentiated carcinoma|undifferentiated carcinoma
585613|NCT00513383|adenosquamous cell carcinoma|adenosquamous cell carcinoma
585614|NCT00513396|Randomized control trial|randomized control trial
585615|NCT00513396|multidrug resistant tuberculosis|multidrug resistant tuberculosis
585616|NCT00513396|isoniazid|isoniazid
585806|NCT00520429|Anxiety|anxiety
585635|NCT00513474|anaplastic large cell lymphoma|anaplastic large cell lymphoma
585636|NCT00513474|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
585637|NCT00513474|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
585638|NCT00513474|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
585639|NCT00513474|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
585640|NCT00513474|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
585641|NCT00513474|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
585642|NCT00513474|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
585643|NCT00513474|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
585644|NCT00513474|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
585645|NCT00513474|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
585646|NCT00513474|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
585647|NCT00513474|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
585648|NCT00513474|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
585649|NCT00513474|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
585650|NCT00513474|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
585651|NCT00513474|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
585652|NCT00513474|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
585653|NCT00513474|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
585654|NCT00513474|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
585655|NCT00513474|splenic marginal zone lymphoma|splenic marginal zone lymphoma
585656|NCT00513474|Waldenström macroglobulinemia|waldenström macroglobulinemia
585657|NCT00513474|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
585658|NCT00513474|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
585659|NCT00513474|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
585660|NCT00513474|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
585661|NCT00513474|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
585662|NCT00513474|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
585663|NCT00513474|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
585664|NCT00513474|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
585665|NCT00513474|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
585755|NCT00513669|Trial|trial
585666|NCT00513474|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
585667|NCT00513474|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
585668|NCT00513474|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
585669|NCT00513474|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
585670|NCT00513474|primary myelofibrosis|primary myelofibrosis
585671|NCT00513474|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
585672|NCT00513474|chronic eosinophilic leukemia|chronic eosinophilic leukemia
585673|NCT00513474|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
585674|NCT00513474|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
585675|NCT00513474|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
585676|NCT00513474|refractory hairy cell leukemia|refractory hairy cell leukemia
585677|NCT00513474|refractory multiple myeloma|refractory multiple myeloma
585678|NCT00513474|secondary acute myeloid leukemia|secondary acute myeloid leukemia
585679|NCT00513474|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
585680|NCT00513487|Allergic Rhinitis|allergic rhinitis
585681|NCT00513487|dust mites|dust mites
585683|NCT00513487|IL-13|il-13
585684|NCT00513487|nasal|nasal
585685|NCT00513487|inflammation|inflammation
585686|NCT00513500|community health care|community health care
585687|NCT00513500|community health worker|community health worker
585688|NCT00513500|malaria|malaria
585689|NCT00513500|pneumonia|pneumonia
585690|NCT00513500|rapid diagnostic test|rapid diagnostic test
585691|NCT00513513|HIV|hiv
585692|NCT00513513|AIDS|aids
585693|NCT00513513|TMC114|tmc114
585694|NCT00513513|Protease inhibitor|protease inhibitor
585695|NCT00513513|Darunavir|darunavir
585696|NCT00513513|Antiretroviral agents|antiretroviral agents
585697|NCT00513513|Treatment Naive|treatment naive
585698|NCT00513526|infection|infection
585699|NCT00513526|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
585700|NCT00513526|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
585701|NCT00513539|unresectable gallbladder cancer|unresectable gallbladder cancer
585702|NCT00513539|recurrent gallbladder cancer|recurrent gallbladder cancer
585703|NCT00513539|metastatic gallbladder cancer|metastatic gallbladder cancer
585704|NCT00513539|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
585705|NCT00513539|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
585706|NCT00513539|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
585905|NCT00522730|Lipids|lipids
585707|NCT00513539|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
585708|NCT00513539|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
585709|NCT00513565|GSK561679,|gsk561679,
585710|NCT00513565|single,|single,
585711|NCT00513565|dose,|dose,
585712|NCT00513565|lorazepam,|lorazepam,
585713|NCT00513565|fMRI,|fmri,
585714|NCT00513565|BOLD,|bold,
585715|NCT00513565|healthy volunteers|healthy volunteers
585716|NCT00513578|refractory anemia with excess blasts|refractory anemia with excess blasts
585717|NCT00513578|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
585718|NCT00513578|refractory anemia|refractory anemia
585719|NCT00513578|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
585720|NCT00513578|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
585721|NCT00513578|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
585722|NCT00513591|Pregnancy|pregnancy
585723|NCT00513591|Lupus (systemic lupus erythematosus or cutaneous lupus)|lupus (systemic lupus erythematosus or cutaneous lupus)
585724|NCT00513591|Rheumatoid Arthritis|rheumatoid arthritis
585725|NCT00513591|Sjogren's Syndrome|sjogren's syndrome
585726|NCT00513591|Scleroderma|scleroderma
585727|NCT00513604|Clinical Response|clinical response
585728|NCT00513604|Immunotherapy|immunotherapy
585729|NCT00513604|Cancer|cancer
585730|NCT00513604|Cytokines|cytokines
585731|NCT00513604|Adoptive Cell Therapy|adoptive cell therapy
585732|NCT00513604|Melanoma|melanoma
585733|NCT00513604|Skin Cancer|skin cancer
585734|NCT00513604|Malignant Melanoma|malignant melanoma
585735|NCT00513617|Sickle Cell Disease|sickle cell disease
585736|NCT00513617|Anemia|anemia
585737|NCT00513617|Nitric Oxide|nitric oxide
585738|NCT00513617|Vaso Occlusive Events|vaso occlusive events
585739|NCT00513617|Arginine Supplementation|arginine supplementation
585740|NCT00513643|euglycaemic glucose clamp|euglycaemic glucose clamp
585741|NCT00513643|duration of action|duration of action
585742|NCT00513643|late metabolic activity|late metabolic activity
585743|NCT00513643|hypoglycaemia|hypoglycaemia
585744|NCT00513656|Efficacy|efficacy
585745|NCT00513656|chronic|chronic
585746|NCT00513656|cancer|cancer
585747|NCT00513656|pain|pain
585748|NCT00513656|constipation|constipation
585749|NCT00513656|oxycodone|oxycodone
585750|NCT00513656|naloxone|naloxone
585751|NCT00513656|Moderate to severe chronic cancer pain|moderate to severe chronic cancer pain
585752|NCT00513669|Malaria|malaria
585753|NCT00513669|Vaccine|vaccine
585754|NCT00513669|Falciparum|falciparum
585758|NCT00513669|Immunogenicity|immunogenicity
585759|NCT00513682|Cystic Fibrosis|cystic fibrosis
585760|NCT00513682|Pancreatic insufficiency|pancreatic insufficiency
585761|NCT00513682|Steatorrhea|steatorrhea
585762|NCT00513682|Children 7 to 11 years|children 7 to 11 years
585763|NCT00513682|Pancreatic enzyme|pancreatic enzyme
585764|NCT00513708|Detoxification|detoxification
585765|NCT00513708|Treatment|treatment
585766|NCT00520208|ATRA|atra
585767|NCT00520208|Trisenox|trisenox
585768|NCT00520208|Arsenic|arsenic
585769|NCT00520208|Arsenic Trioxide|arsenic trioxide
585770|NCT00520208|APL|apl
585771|NCT00520221|minocycline|minocycline
585772|NCT00520221|pleurodesis|pleurodesis
585773|NCT00520221|aspiration|aspiration
585774|NCT00520221|pneumothorax|pneumothorax
585775|NCT00520221|Primary spontaneous pneumothorax|primary spontaneous pneumothorax
585776|NCT00520221|First attack|first attack
585777|NCT00520221|Successful aspiration|successful aspiration
585778|NCT00520234|Candida|candida
585779|NCT00520234|Prophylaxis|prophylaxis
585780|NCT00520234|High risk adults|high risk adults
585781|NCT00520234|Intensive care unit (ICU)|intensive care unit (icu)
585782|NCT00520247|enalapril|enalapril
585783|NCT00520247|folic acid|folic acid
585784|NCT00520247|hyperglycemia|hyperglycemia
585785|NCT00520247|hypertension|hypertension
586389|NCT00524446|Stunting|stunting
585786|NCT00520247|fasting plasma glucose|fasting plasma glucose
585787|NCT00520286|Methamphetamine Dependence|methamphetamine dependence
585788|NCT00520299|metastatic melanoma|metastatic melanoma
585789|NCT00520299|ADI|adi
585790|NCT00520299|ADI PEG 20|adi peg 20
585791|NCT00520299|ADI SS PEG 20,000mw|adi ss peg 20,000mw
585792|NCT00520299|arginine|arginine
585793|NCT00520299|enzyme therapy|enzyme therapy
585794|NCT00520312|Peripheral Arterial Disease|peripheral arterial disease
585795|NCT00520312|PAD|pad
585796|NCT00520312|Functional Impairment|functional impairment
585797|NCT00520312|Magnetic Resonance Imaging|magnetic resonance imaging
585798|NCT00520325|MBL deficient oncologic hematologic pediatric fever neutropenia|mbl deficient oncologic hematologic pediatric fever neutropenia
585799|NCT00520338|celecoxib|celecoxib
585800|NCT00520338|postoperative pain|postoperative pain
585801|NCT00520338|thyroidectomy|thyroidectomy
585802|NCT00520377|Sinus Lift Surgery|sinus lift surgery
585803|NCT00520377|Sinus Floor Augmentation|sinus floor augmentation
585804|NCT00520377|Insufficient Bone Height|insufficient bone height
585805|NCT00520429|Depression|depression
585807|NCT00520429|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
585808|NCT00520429|Heart Failure, Congestive|heart failure, congestive
585809|NCT00520442|fracture|fracture
585810|NCT00520468|Myelodysplastic Syndrome|myelodysplastic syndrome
585811|NCT00520468|MDS|mds
585812|NCT00520468|Erythropoietin|erythropoietin
585813|NCT00520468|Darbepoetin alfa|darbepoetin alfa
585814|NCT00520468|Aranesp|aranesp
585815|NCT00520468|Erythropoiesis stimulating protein|erythropoiesis stimulating protein
585816|NCT00520468|G-CSF|g-csf
585817|NCT00520468|Filgrastim|filgrastim
585818|NCT00520468|Neupogen|neupogen
585819|NCT00520468|Prednisone|prednisone
585820|NCT00520468|Cyclosporin A|cyclosporin a
585821|NCT00520468|Sandimmune|sandimmune
585822|NCT00520468|CYA|cya
585823|NCT00520468|Cyclosporine|cyclosporine
585824|NCT00520494|Previously Untreated Patient (PUP)|previously untreated patient (pup)
585825|NCT00520494|Primary Immunodeficiency (PID)|primary immunodeficiency (pid)
585826|NCT00520494|CVID|cvid
585827|NCT00520494|XLA|xla
585828|NCT00520494|Subcutaneous immunoglobulin (SCIG)|subcutaneous immunoglobulin (scig)
585829|NCT00520494|IgG trough level|igg trough level
585830|NCT00520494|Quality of life|quality of life
585831|NCT00520494|Common variable immunodeficiency (CVID)|common variable immunodeficiency (cvid)
585832|NCT00520494|X-linked agammaglobulinemia (XLA)|x-linked agammaglobulinemia (xla)
585833|NCT00520507|Depression|depression
585834|NCT00520507|Bipolar Disorder|bipolar disorder
585835|NCT00520507|Major|major
585836|NCT00522457|Breast Cancer|breast cancer
585837|NCT00522457|investigational drug|investigational drug
585838|NCT00522457|drug therapy|drug therapy
585839|NCT00522457|Antineoplastic Protocols|antineoplastic protocols
585840|NCT00522457|Immunotherapy|immunotherapy
585841|NCT00522457|Metastatic breast cancer|metastatic breast cancer
585842|NCT00522457|Advanced breast cancer|advanced breast cancer
585843|NCT00522457|Stage IV breast cancer|stage iv breast cancer
585844|NCT00522457|Her-2/neu expressing breast cancer|her-2/neu expressing breast cancer
585845|NCT00522457|Her-2/neu|her-2/neu
585846|NCT00522457|Trastuzumab refractory|trastuzumab refractory
585847|NCT00522496|Craniocerebral trauma|craniocerebral trauma
585848|NCT00522496|matrix metalloproteinase|matrix metalloproteinase
585849|NCT00522496|microdialysis|microdialysis
585850|NCT00522522|Naturalistic, retrospective, utilization of care services, diagnosis, epilepsy|naturalistic, retrospective, utilization of care services, diagnosis, epilepsy
585851|NCT00522535|AAA|aaa
585852|NCT00522535|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
585853|NCT00522535|Endovascular|endovascular
585854|NCT00522535|EVAR|evar
585855|NCT00522535|Aorta|aorta
585856|NCT00522535|Stent Graft|stent graft
585858|NCT00522535|Tortuous|tortuous
585859|NCT00522535|High Angle|high angle
585860|NCT00522535|Angled Necks|angled necks
585861|NCT00522548|African American|african american
585862|NCT00522548|Kidney Transplant|kidney transplant
585863|NCT00522561|Healthy volunteers|healthy volunteers
585864|NCT00522561|running|running
585865|NCT00522561|energetic cost|energetic cost
585866|NCT00522561|limb mechanical characteristics|limb mechanical characteristics
585867|NCT00522561|contractile components|contractile components
585868|NCT00522561|elastic components|elastic components
585869|NCT00522561|healthy men doing regularly physical activities|healthy men doing regularly physical activities
585870|NCT00522574|Myeloproliferative Disorders|myeloproliferative disorders
585871|NCT00522600|eyedrops|eyedrops
585872|NCT00522600|compliance|compliance
585873|NCT00522600|glaucoma medications|glaucoma medications
585874|NCT00522600|adherence|adherence
585875|NCT00522613|recovery|recovery
585876|NCT00522613|serious mental illness|serious mental illness
585877|NCT00522613|bipolar disorder|bipolar disorder
585878|NCT00522613|schizophrenia|schizophrenia
585879|NCT00522613|schizoaffective disorder|schizoaffective disorder
585880|NCT00522626|Fetus|fetus
585881|NCT00522626|Drug abuse|drug abuse
585882|NCT00522626|Fetal development|fetal development
585883|NCT00522626|Substance abuse|substance abuse
585884|NCT00522626|Opioids|opioids
585885|NCT00522626|Methadone|methadone
585886|NCT00522639|lung cancer|lung cancer
585887|NCT00522639|FDG-PET-CT|fdg-pet-ct
585888|NCT00522639|blood proteins|blood proteins
585889|NCT00522639|prognose|prognose
585890|NCT00522652|cancer|cancer
585891|NCT00522652|advanced cancer|advanced cancer
585892|NCT00522652|lymphoma|lymphoma
585893|NCT00522678|Healthy Volunteers|healthy volunteers
585894|NCT00522691|Fecal incontinence|fecal incontinence
585895|NCT00522691|sacral nerve stimulation|sacral nerve stimulation
585896|NCT00522704|Arteriovenous fistula|arteriovenous fistula
585897|NCT00522704|Access blood flow|access blood flow
585898|NCT00522704|Extracorporeal blood flow|extracorporeal blood flow
585899|NCT00522704|Dynamic arterial line pressure|dynamic arterial line pressure
585900|NCT00522704|Hemodialysis treatment|hemodialysis treatment
585901|NCT00522730|Liver failure|liver failure
585902|NCT00522730|Liver cirrhosis|liver cirrhosis
585903|NCT00522730|Parenteral nutrition|parenteral nutrition
585904|NCT00522730|Enteral nutrition|enteral nutrition
585919|NCT00522769|cognitive behavioral therapy|cognitive behavioral therapy
585920|NCT00522795|Esophageal Cancer|esophageal cancer
585921|NCT00522808|HCV|hcv
585922|NCT00522808|antiviral|antiviral
585923|NCT00522808|PK|pk
585924|NCT00522808|Safety|safety
585925|NCT00522821|IgG subclass deficiency|igg subclass deficiency
585926|NCT00522821|Anti-polysaccharide deficiency|anti-polysaccharide deficiency
585927|NCT00522821|therapy|therapy
585928|NCT00522821|Immunoglobulins, Intravenous|immunoglobulins, intravenous
585929|NCT00522821|co-trimoxazole|co-trimoxazole
585930|NCT00522834|melanoma|melanoma
585931|NCT00522834|oncology|oncology
585932|NCT00522834|Stage IV Metastatic Melanoma|stage iv metastatic melanoma
585933|NCT00522847|Postmenopausal|postmenopausal
585934|NCT00522847|non dry eye|non dry eye
585935|NCT00522860|Trichiasis|trichiasis
585936|NCT00522860|Trachoma|trachoma
585937|NCT00522860|Surgery|surgery
585938|NCT00522860|Suture|suture
585939|NCT00522860|Ethiopia|ethiopia
585940|NCT00522873|Postmenopausal Symptoms e.g.|postmenopausal symptoms e.g.
585941|NCT00522873|Hot flushes|hot flushes
585942|NCT00522873|Sweating episodes|sweating episodes
585943|NCT00522873|Vaginal dryness|vaginal dryness
585944|NCT00522886|cetuximab|cetuximab
585945|NCT00522886|concurrent|concurrent
585946|NCT00522886|iso-toxic|iso-toxic
585947|NCT00522886|NSCLC|nsclc
585948|NCT00522899|aged|aged
585949|NCT00522899|exercise|exercise
585950|NCT00522899|cognitive therapy|cognitive therapy
585951|NCT00522899|dementia|dementia
585952|NCT00522899|prevention|prevention
585953|NCT00522912|Trachoma|trachoma
585954|NCT00522912|Trichiasis|trichiasis
585955|NCT00522912|Surgery|surgery
585956|NCT00522912|Epilation|epilation
585957|NCT00522912|Ethiopia|ethiopia
585958|NCT00522925|hypertension|hypertension
585959|NCT00522925|high blood pressure|high blood pressure
585960|NCT00522938|Lung|lung
585961|NCT00522938|Cancer|cancer
585962|NCT00522938|Non-small|non-small
585963|NCT00522938|Lung Cancer|lung cancer
585964|NCT00522938|NSCLC|nsclc
585965|NCT00522938|erlotinib|erlotinib
585966|NCT00522938|oral|oral
585967|NCT00522938|Locally Advanced Non-small Cell Lung Cancer|locally advanced non-small cell lung cancer
585968|NCT00522938|Metastatic Non-small Cell Lung Cancer|metastatic non-small cell lung cancer
585969|NCT00522951|MRI|mri
585970|NCT00522951|Brain Metastasis|brain metastasis
585971|NCT00522951|Gadolinium|gadolinium
585972|NCT00522951|Imaging|imaging
585973|NCT00522951|Diagnostic Agent|diagnostic agent
585974|NCT00522964|Chinese-American|chinese-american
585975|NCT00522964|Children|children
585976|NCT00522964|Obesity|obesity
586188|NCT00523783|quetiapine|quetiapine
585977|NCT00522964|health behaviors|health behaviors
585978|NCT00522964|Behavioral intervention|behavioral intervention
585979|NCT00522964|normal|normal
585980|NCT00522977|Myocardial strain|myocardial strain
585981|NCT00522977|Myocardial function|myocardial function
585982|NCT00522977|Pregnancy|pregnancy
585983|NCT00522977|Postpartum|postpartum
585984|NCT00522977|Echocardiography|echocardiography
585985|NCT00522977|Myocardial adaptation to pregnancy|myocardial adaptation to pregnancy
585986|NCT00522977|Systolic function|systolic function
585987|NCT00522977|Diastolic function|diastolic function
585988|NCT00523003|weight loss|weight loss
585989|NCT00523003|obesity|obesity
586390|NCT00524446|Growth|growth
585990|NCT00523003|high protein|high protein
585991|NCT00523003|meal replacement|meal replacement
585992|NCT00523016|acupuncture|acupuncture
585993|NCT00523016|electroacupuncture|electroacupuncture
585994|NCT00523016|sham acupuncture|sham acupuncture
585995|NCT00523016|spinal cord injury|spinal cord injury
585996|NCT00523016|neuropathic pain|neuropathic pain
585997|NCT00523016|burning pain|burning pain
585998|NCT00523029|Self-management programs|self-management programs
585999|NCT00523029|Chronic medical illness|chronic medical illness
586001|NCT00523055|Brachial Plexus Anesthesia|brachial plexus anesthesia
586002|NCT00523055|Plasma Lidocaine Levels|plasma lidocaine levels
586003|NCT00523055|Ultrasound|ultrasound
586004|NCT00523068|overactive bladder|overactive bladder
586005|NCT00523068|stress urinary incontinence|stress urinary incontinence
586006|NCT00523068|detrusor overactivity|detrusor overactivity
586007|NCT00523068|urodynamics|urodynamics
586008|NCT00523081|adolescent depression treatment, cognitive behavioral therapy,|adolescent depression treatment, cognitive behavioral therapy,
586009|NCT00523081|collaborative care|collaborative care
586010|NCT00523107|Fatigue|fatigue
586011|NCT00523107|Standard Palliative Care|standard palliative care
586013|NCT00523107|QLQ-C30|qlq-c30
586014|NCT00523107|Compassionate|compassionate
586015|NCT00523133|alcoholism|alcoholism
586016|NCT00523133|naltrexone|naltrexone
586017|NCT00523133|motivational enhancement therapy|motivational enhancement therapy
586018|NCT00523146|primary dysmenorrhea|primary dysmenorrhea
586019|NCT00523146|Herbal remedy|herbal remedy
586020|NCT00523159|clear cell renal cell carcinoma|clear cell renal cell carcinoma
586021|NCT00523172|Chiropractic Manipulation|chiropractic manipulation
586022|NCT00523185|alcohol withdrawal|alcohol withdrawal
586026|NCT00523211|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
586027|NCT00523211|Treatment Experienced|treatment experienced
586028|NCT00523224|Stem cells|stem cells
586029|NCT00523224|Coronary Artery Bypass grafting|coronary artery bypass grafting
586030|NCT00523224|Congestive Heart Failure|congestive heart failure
586031|NCT00523224|Coronary Artery Disease|coronary artery disease
586032|NCT00523224|Angiogenesis|angiogenesis
586033|NCT00523250|Glaucoma|glaucoma
586034|NCT00523276|Severe acute respiratory syndrome, SARS, China|severe acute respiratory syndrome, sars, china
586035|NCT00523289|Ropivacaine|ropivacaine
586036|NCT00523289|Bupivacaine|bupivacaine
586037|NCT00523289|Upper Extremity|upper extremity
586038|NCT00523289|Local anesthetic|local anesthetic
586039|NCT00523302|Major Depression|major depression
586040|NCT00523302|Fibromyalgia|fibromyalgia
586042|NCT00523315|Aromatase Inhibitor|aromatase inhibitor
586043|NCT00523315|Breast Cancer|breast cancer
586044|NCT00523315|compliance|compliance
586045|NCT00523315|Naturalistic|naturalistic
586046|NCT00523315|Observational|observational
586047|NCT00523328|Rheumatoid Arthritis|rheumatoid arthritis
586048|NCT00523328|Arthritis|arthritis
586049|NCT00523328|BG9924|bg9924
586050|NCT00523328|methotrexate|methotrexate
586051|NCT00523341|postmenopausal osteoporosis|postmenopausal osteoporosis
586052|NCT00523341|low bone density|low bone density
586053|NCT00523341|fractures|fractures
586054|NCT00523341|low bone mass|low bone mass
586055|NCT00523354|Eosinophilic Esophagitis|eosinophilic esophagitis
586056|NCT00523354|TNF-alpha|tnf-alpha
586057|NCT00523354|TNF-alpha Blockade|tnf-alpha blockade
586058|NCT00523354|Infliximab|infliximab
586059|NCT00523367|Gastro Esophageal Reflux Disease (GERD)|gastro esophageal reflux disease (gerd)
586060|NCT00523367|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
586061|NCT00523406|choroidal neovascularisation,|choroidal neovascularisation,
586062|NCT00523406|vision,|vision,
586063|NCT00523406|macula,|macula,
586064|NCT00523406|macular degeneration|macular degeneration
586065|NCT00523406|optical coherence tomography|optical coherence tomography
586066|NCT00523406|neovascular age related macular degeneration|neovascular age related macular degeneration
586067|NCT00523432|ovarian cancer|ovarian cancer
586068|NCT00523432|cervical cancer|cervical cancer
586069|NCT00523432|uterine cancer|uterine cancer
586070|NCT00523432|fallopian tube cancer|fallopian tube cancer
586071|NCT00523432|endometrial cancer|endometrial cancer
586072|NCT00523432|vaginal cancer|vaginal cancer
586073|NCT00523432|peritoneal cancer|peritoneal cancer
586074|NCT00523432|reproductive cancer|reproductive cancer
586075|NCT00523445|Schizophrenia|schizophrenia
586076|NCT00523445|Cognition|cognition
586077|NCT00523445|Varenicline|varenicline
586078|NCT00523458|Co-infection|co-infection
586079|NCT00523458|Tuberculosis|tuberculosis
586080|NCT00523458|HIV|hiv
586081|NCT00523458|Drug interactions|drug interactions
586082|NCT00523458|Non nucleoside reverse transcriptase inhibitors|non nucleoside reverse transcriptase inhibitors
586083|NCT00523458|Therapy|therapy
586084|NCT00523458|Treatment Naive|treatment naive
586085|NCT00523471|prostate cancer|prostate cancer
586086|NCT00523471|gamma H2AX|gamma h2ax
586087|NCT00523471|radiosensitivity|radiosensitivity
586088|NCT00523484|Beck Anxiety Inventory|beck anxiety inventory
586089|NCT00523484|Prostate Cancer|prostate cancer
586090|NCT00523484|Prostate Specific Antigen|prostate specific antigen
586091|NCT00523484|Naturalistic|naturalistic
586092|NCT00523484|Observational|observational
586093|NCT00523497|Severe community-acquired pneumonia|severe community-acquired pneumonia
586094|NCT00523497|Noninvasive mechanical ventilation|noninvasive mechanical ventilation
586095|NCT00523497|Acute hypoxemic respiratory failure.|acute hypoxemic respiratory failure.
586096|NCT00523510|breastmilk|breastmilk
586097|NCT00523510|perinatal HIV|perinatal hiv
586098|NCT00523510|infant feeding|infant feeding
586099|NCT00523510|flash heat|flash heat
586100|NCT00523510|pasteurization|pasteurization
586101|NCT00523510|pmtct|pmtct
586102|NCT00523510|HIV|hiv
586103|NCT00523510|HIV Seronegativity|hiv seronegativity
586104|NCT00523510|Treatment Naive|treatment naive
586105|NCT00523523|Rehabilitation|rehabilitation
586106|NCT00523523|hemiplegia|hemiplegia
586107|NCT00523523|stroke|stroke
586108|NCT00523523|upper extremity|upper extremity
586109|NCT00523523|motor skills|motor skills
586110|NCT00523523|therapy|therapy
586111|NCT00523536|High Blood Pressure|high blood pressure
586112|NCT00523536|Cardiovascular|cardiovascular
586113|NCT00523549|Hypertension|hypertension
586114|NCT00523549|systolic blood pressure|systolic blood pressure
586115|NCT00523549|diastolic dysfunction|diastolic dysfunction
586116|NCT00523549|valsartan|valsartan
586117|NCT00523549|amlodipine|amlodipine
586118|NCT00523562|fructose|fructose
586119|NCT00523562|dietary lipids|dietary lipids
586120|NCT00523562|dietary proteins|dietary proteins
586121|NCT00523562|hepatic steatosis|hepatic steatosis
586122|NCT00523562|insulin resistance|insulin resistance
586123|NCT00523562|Healthy humans|healthy humans
586124|NCT00523562|overweight humans|overweight humans
586131|NCT00523588|Cutaneous lupus erythematosus|cutaneous lupus erythematosus
586132|NCT00523588|Pulsed dye laser|pulsed dye laser
586133|NCT00523601|Bipolar depression|bipolar depression
586134|NCT00523601|quetiapine|quetiapine
586135|NCT00523601|observational|observational
586136|NCT00523601|Naturalistic|naturalistic
586137|NCT00523614|venous thromboembolism|venous thromboembolism
586138|NCT00523627|Energy Expenditure|energy expenditure
586139|NCT00523627|Adaptive Thermogenesis|adaptive thermogenesis
586140|NCT00523627|Low-protein Overfeeding|low-protein overfeeding
586141|NCT00523627|Fasting|fasting
586142|NCT00523627|Weight Gain|weight gain
586143|NCT00523640|metastatic|metastatic
586144|NCT00523640|renal cell|renal cell
586145|NCT00523640|kidney|kidney
586146|NCT00523640|neoplasm|neoplasm
586147|NCT00523666|Alzheimer's disease|alzheimer's disease
586148|NCT00523666|diffusion tensor imaging|diffusion tensor imaging
586149|NCT00523679|Asthma|asthma
586150|NCT00523679|Symbicort|symbicort
586151|NCT00523679|SMART|smart
586152|NCT00523679|inhaler|inhaler
586153|NCT00523679|compliance|compliance
586154|NCT00523679|Naturalistic|naturalistic
586155|NCT00523679|Observational|observational
586156|NCT00523692|Early arthritis|early arthritis
587200|NCT00531089|HUS|hus
586157|NCT00523692|Rheumatoid arthritis|rheumatoid arthritis
586158|NCT00523692|Rheumatoid factor|rheumatoid factor
586159|NCT00523692|Anti CCP antibody|anti ccp antibody
586160|NCT00523692|Remission|remission
586161|NCT00523692|Anti-TNF therapy|anti-tnf therapy
586162|NCT00523692|methotrexate|methotrexate
586163|NCT00523705|premenstrual syndrome|premenstrual syndrome
586165|NCT00523705|PMDD|pmdd
586166|NCT00523705|treatment|treatment
586167|NCT00523705|SSRI|ssri
586168|NCT00523718|obsessive-compulsive disorder|obsessive-compulsive disorder
586169|NCT00523718|OCD|ocd
586170|NCT00523718|glutamate|glutamate
586171|NCT00523718|riluzole|riluzole
586172|NCT00523718|augmentation|augmentation
586173|NCT00523718|treatment|treatment
586174|NCT00523731|Stem cells|stem cells
586175|NCT00523731|Rest pain|rest pain
586176|NCT00523731|claudication|claudication
586177|NCT00523731|chronic ischemic or non-healing ulcers|chronic ischemic or non-healing ulcers
586178|NCT00523731|Angiogenesis|angiogenesis
586179|NCT00523731|no-option cases|no-option cases
586180|NCT00523744|hypertension, valsartan, amlodipine|hypertension, valsartan, amlodipine
586181|NCT00523757|heart failure|heart failure
586182|NCT00523757|collagen|collagen
586183|NCT00523757|diastolic function|diastolic function
586184|NCT00523770|Invasive Pneumococcal Diseases|invasive pneumococcal diseases
586185|NCT00523770|Pneumonia|pneumonia
586186|NCT00523783|Schizophrenia|schizophrenia
586187|NCT00523783|Schizoaffective|schizoaffective
586189|NCT00523783|long-term efficacy|long-term efficacy
586190|NCT00523783|Naturalistic|naturalistic
586191|NCT00523783|Observational|observational
586192|NCT00523796|dyslipidemia|dyslipidemia
586193|NCT00523796|in practice survey|in practice survey
586194|NCT00523796|Vietnam|vietnam
586195|NCT00523809|Breast Cancer|breast cancer
586196|NCT00523809|Ovarian Cancer|ovarian cancer
586197|NCT00523809|Stem Cell Transplantation|stem cell transplantation
586198|NCT00523809|Bevacizumab|bevacizumab
586199|NCT00523809|Fludarabine|fludarabine
586200|NCT00523809|Melphalan|melphalan
586201|NCT00523809|Avastin|avastin
586202|NCT00523809|Thymoglobulin|thymoglobulin
586203|NCT00523809|ATG|atg
586204|NCT00523809|Antithymocyte Globulin|antithymocyte globulin
586205|NCT00523809|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
586206|NCT00523809|AHSCT|ahsct
586207|NCT00523822|This study seeks to determine if the correction of a sacroiliac lesion can produce a functional change in cervical spine.|this study seeks to determine if the correction of a sacroiliac lesion can produce a functional change in cervical spine.
586208|NCT00523848|stage I multiple myeloma|stage i multiple myeloma
586209|NCT00523848|stage II multiple myeloma|stage ii multiple myeloma
586210|NCT00523848|stage III multiple myeloma|stage iii multiple myeloma
586211|NCT00523861|Glucose|glucose
586212|NCT00523861|Insulin sensitivity|insulin sensitivity
586213|NCT00523861|Glucose metabolism|glucose metabolism
586214|NCT00523861|Appetite|appetite
586215|NCT00523861|Satiety|satiety
586216|NCT00523887|Radiation pain|radiation pain
586217|NCT00523887|Duragesic|duragesic
586218|NCT00523887|Fentanyl|fentanyl
586219|NCT00523887|Pain|pain
586220|NCT00523900|malnutrition|malnutrition
586221|NCT00523900|underweight|underweight
586222|NCT00523900|low body weight|low body weight
586223|NCT00523900|BMI under 19|bmi under 19
586224|NCT00523900|under nourished|under nourished
586225|NCT00523900|malnourished|malnourished
586226|NCT00523913|type 2 diabetes mellitus;|type 2 diabetes mellitus;
586227|NCT00523913|diabetes;|diabetes;
586228|NCT00523913|rosiglitazone|rosiglitazone
586229|NCT00523913|Avandia;|avandia;
586230|NCT00523926|Tuberculosis|tuberculosis
586231|NCT00523939|Lymphoma|lymphoma
586232|NCT00523939|Leukemia|leukemia
586233|NCT00523939|Leukemic Meningitis|leukemic meningitis
587091|NCT00530517|migraine|migraine
586242|NCT00524004|Passive immunization, Bovine Milk Immunoglobulin|passive immunization, bovine milk immunoglobulin
586243|NCT00524017|hypopharyngeal cancer|hypopharyngeal cancer
586244|NCT00524017|laryngeal cancer|laryngeal cancer
586245|NCT00524017|lip and oral cavity cancer|lip and oral cavity cancer
586246|NCT00524017|nasopharyngeal cancer|nasopharyngeal cancer
586247|NCT00524017|oropharyngeal cancer|oropharyngeal cancer
586248|NCT00524017|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
586249|NCT00524017|salivary gland cancer|salivary gland cancer
586250|NCT00524017|precancerous condition|precancerous condition
586251|NCT00524030|Epilepsy|epilepsy
586252|NCT00524030|partial seizures|partial seizures
586253|NCT00524030|pregabalin monotherapy|pregabalin monotherapy
586254|NCT00524030|double-blind and randomized trial|double-blind and randomized trial
586255|NCT00524043|Schizophrenia|schizophrenia
586256|NCT00524056|Essential Tremor|essential tremor
586257|NCT00524056|Tremor|tremor
586258|NCT00524056|Anti-epileptic drug (AED)|anti-epileptic drug (aed)
586259|NCT00524069|stage I pancreatic cancer|stage i pancreatic cancer
586260|NCT00524069|stage II pancreatic cancer|stage ii pancreatic cancer
586261|NCT00524069|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
586262|NCT00524095|prophylaxis|prophylaxis
586263|NCT00524095|Antibiotic|antibiotic
586264|NCT00524095|inhaled steroids|inhaled steroids
586265|NCT00524095|bronchiectasis|bronchiectasis
586266|NCT00524095|prevalence|prevalence
586267|NCT00524095|chronic bronchitis|chronic bronchitis
586268|NCT00524108|shunt|shunt
586269|NCT00524108|internal ventriculoperitoneal|internal ventriculoperitoneal
586270|NCT00524121|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
586271|NCT00524121|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
586272|NCT00524121|stage I esophageal cancer|stage i esophageal cancer
586273|NCT00524121|stage II esophageal cancer|stage ii esophageal cancer
586274|NCT00524121|stage III esophageal cancer|stage iii esophageal cancer
586275|NCT00524121|stage IV esophageal cancer|stage iv esophageal cancer
586276|NCT00524134|Epilepsy|epilepsy
586277|NCT00524134|Seizure|seizure
586278|NCT00524134|p-glycoprotein|p-glycoprotein
586279|NCT00524147|loculated pleural effusion|loculated pleural effusion
586280|NCT00524147|pigtail drainage|pigtail drainage
586281|NCT00524147|pleural effusion|pleural effusion
586282|NCT00524147|pleural thickening|pleural thickening
586283|NCT00524147|tuberculosis|tuberculosis
586284|NCT00524160|Fentanyl|fentanyl
586285|NCT00524160|opioid analgesics|opioid analgesics
586286|NCT00524160|arthritis|arthritis
586287|NCT00524160|osteoarthritis|osteoarthritis
586288|NCT00524160|rheumatoid arthritis|rheumatoid arthritis
586289|NCT00524160|transdermal administration|transdermal administration
586290|NCT00524173|Emtricitabine|emtricitabine
586291|NCT00524173|Tenofovir|tenofovir
586292|NCT00524173|Antiviral Therapy|antiviral therapy
586293|NCT00524173|Hepatitis B|hepatitis b
586294|NCT00524173|HBV|hbv
586295|NCT00524186|stage III gastric cancer|stage iii gastric cancer
586296|NCT00524186|stage IV gastric cancer|stage iv gastric cancer
586297|NCT00524186|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
586298|NCT00524186|stage IV esophageal cancer|stage iv esophageal cancer
586299|NCT00524186|recurrent gastric cancer|recurrent gastric cancer
586300|NCT00524186|recurrent esophageal cancer|recurrent esophageal cancer
586301|NCT00524186|adenocarcinoma of the stomach|adenocarcinoma of the stomach
586302|NCT00524199|homocysteine|homocysteine
586303|NCT00524199|hemodialysis|hemodialysis
586304|NCT00524199|mesna|mesna
586305|NCT00524225|IL-11|il-11
586306|NCT00524225|von Willebrand disease|von willebrand disease
586307|NCT00524225|von Willebrand factor|von willebrand factor
586308|NCT00524225|VWFmRNA|vwfmrna
586309|NCT00524225|surgery|surgery
586310|NCT00524238|hypothyroidism|hypothyroidism
586311|NCT00524238|glucose turnover|glucose turnover
586312|NCT00524238|clamp|clamp
586313|NCT00524238|insulin resistance|insulin resistance
586314|NCT00524238|lipid turnover|lipid turnover
586315|NCT00524238|amino acid turnover|amino acid turnover
586316|NCT00524251|Patients with reflux complaints|patients with reflux complaints
586317|NCT00524251|GERD|gerd
586318|NCT00524251|quality of life|quality of life
586319|NCT00524251|lifestyle adjustments|lifestyle adjustments
586320|NCT00524277|stage I breast cancer|stage i breast cancer
586321|NCT00524277|stage II breast cancer|stage ii breast cancer
586322|NCT00524277|stage IIIA breast cancer|stage iiia breast cancer
586323|NCT00524277|stage IIIB breast cancer|stage iiib breast cancer
586324|NCT00524277|stage IIIC breast cancer|stage iiic breast cancer
586325|NCT00524277|male breast cancer|male breast cancer
586326|NCT00524290|Acinetobacter|acinetobacter
586327|NCT00524290|infection|infection
586328|NCT00524290|isolate|isolate
586329|NCT00524303|ErbB2 Overexpressing|erbb2 overexpressing
586330|NCT00524303|ErbB2 Positive|erbb2 positive
586331|NCT00524303|Lapatinib|lapatinib
586332|NCT00524303|Invasive Breast Cancer|invasive breast cancer
586333|NCT00524316|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
586334|NCT00524316|advanced adult primary liver cancer|advanced adult primary liver cancer
586541|NCT00516659|patch vaccine|patch vaccine
586335|NCT00524316|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
586336|NCT00524316|recurrent adult primary liver cancer|recurrent adult primary liver cancer
586337|NCT00524329|upper GI-symptoms|upper gi-symptoms
586338|NCT00524329|heartburn|heartburn
586339|NCT00524329|NSAID|nsaid
586340|NCT00524329|risk|risk
586341|NCT00524329|PPI|ppi
586342|NCT00524329|Bloating|bloating
586343|NCT00524329|Regurgitation|regurgitation
586344|NCT00524342|IL-11|il-11
586345|NCT00524342|von Willebrand disease|von willebrand disease
586346|NCT00524342|von Willebrand factor|von willebrand factor
586347|NCT00524342|VWFmRNA|vwfmrna
586348|NCT00524342|menorrhagia|menorrhagia
586349|NCT00524355|GERD|gerd
586350|NCT00524355|GIS|gis
586351|NCT00524355|heartburn|heartburn
586352|NCT00524355|NIS|nis
586353|NCT00524355|PPI|ppi
586354|NCT00524368|Human immunodeficiency virus - type 1|human immunodeficiency virus - type 1
586355|NCT00524368|HIV-1 Infection|hiv-1 infection
586356|NCT00524368|TMC-114|tmc-114
586357|NCT00524368|Darunavir|darunavir
586358|NCT00524368|Ritonavir|ritonavir
586359|NCT00524394|VLBW|vlbw
586360|NCT00524394|sepsis|sepsis
586361|NCT00524394|diagnosis|diagnosis
586362|NCT00524394|suspected sepsis|suspected sepsis
586363|NCT00524407|Anemia|anemia
586364|NCT00524407|hemoglobin|hemoglobin
586365|NCT00524407|chemotherapy|chemotherapy
586366|NCT00524407|hematologic response|hematologic response
586367|NCT00524407|subcutaneous injection|subcutaneous injection
586368|NCT00524407|Epoetin alfa|epoetin alfa
586369|NCT00524407|FACT-An|fact-an
586370|NCT00524407|LASA|lasa
586371|NCT00524407|PROCRIT|procrit
586372|NCT00524420|Pain|pain
586373|NCT00524420|Fatigue|fatigue
586374|NCT00524420|Chronic Fatigue Syndrome|chronic fatigue syndrome
586375|NCT00524420|Chronic Fatigue-Fibromyalgia Syndrome|chronic fatigue-fibromyalgia syndrome
586376|NCT00524420|Depression|depression
586377|NCT00524420|Major Depressive Disorder|major depressive disorder
586378|NCT00524433|acute heart failure|acute heart failure
586379|NCT00524433|acute decompensation of chronic heart failure|acute decompensation of chronic heart failure
586380|NCT00524433|new onset of heart failure|new onset of heart failure
586381|NCT00524433|tezosentan|tezosentan
586382|NCT00524433|Actelion|actelion
586383|NCT00524446|Infant|infant
586384|NCT00524446|Sub-Saharan Africa|sub-saharan africa
586385|NCT00524446|Complementary feeding|complementary feeding
586386|NCT00524446|Fortified spread|fortified spread
586387|NCT00524446|Lipid-based nutrient supplement|lipid-based nutrient supplement
586388|NCT00524446|Malnutrition|malnutrition
586391|NCT00524446|Morbidity|morbidity
586392|NCT00524446|Development|development
586393|NCT00524446|Haemoglobin|haemoglobin
586699|NCT00517426|exercise|exercise
586394|NCT00524459|stage IIIA breast cancer|stage iiia breast cancer
586395|NCT00524459|stage IIIB breast cancer|stage iiib breast cancer
586396|NCT00524472|Hyperinsulinemic glucose control|hyperinsulinemic glucose control
586397|NCT00524472|cardiac surgery|cardiac surgery
586399|NCT00524485|actinic keratosis|actinic keratosis
586400|NCT00524498|OPC-18|opc-18
586401|NCT00524498|Interferon-alpha|interferon-alpha
586402|NCT00524498|Fluorouracil|fluorouracil
586403|NCT00524511|cesarean|cesarean
586404|NCT00524511|wound|wound
586405|NCT00524511|Dermabond|dermabond
586406|NCT00524511|superglue|superglue
586407|NCT00524511|staples|staples
586408|NCT00524511|wound complications|wound complications
586409|NCT00524524|solid tumors|solid tumors
586410|NCT00524524|biopsy|biopsy
586411|NCT00524537|Crohn's Disease|crohn's disease
586412|NCT00524550|Moderate alcohol consumption|moderate alcohol consumption
586413|NCT00524550|insulin secretion|insulin secretion
586414|NCT00524550|insulin sensitivity|insulin sensitivity
586415|NCT00524550|Beta-cell function|beta-cell function
586416|NCT00524550|Adiponectin|adiponectin
586417|NCT00524550|Appetite|appetite
586418|NCT00524550|Satiety|satiety
586419|NCT00524550|Alcohol-induced gene expression|alcohol-induced gene expression
586420|NCT00524550|Endocannabinoids|endocannabinoids
586421|NCT00524550|Glucose metabolism|glucose metabolism
586422|NCT00524550|Lipid metabolism|lipid metabolism
586423|NCT00524550|Ratio HMW/total adiponectin|ratio hmw/total adiponectin
586424|NCT00524550|Appetite regulation|appetite regulation
586425|NCT00524550|Alcohol-induced adiponectin increase|alcohol-induced adiponectin increase
586426|NCT00524563|Acinetobacter|acinetobacter
586427|NCT00524563|bloodstream infection|bloodstream infection
586428|NCT00524563|Isolate|isolate
586429|NCT00524576|Hepatitis B|hepatitis b
586430|NCT00524576|Persistence|persistence
586431|NCT00524576|Challenge dose|challenge dose
586432|NCT00524589|recurrent prostate cancer|recurrent prostate cancer
586433|NCT00524602|Stereotaxis|stereotaxis
586434|NCT00524602|Arrythmia|arrythmia
586435|NCT00524602|Catheter ablation|catheter ablation
586436|NCT00524602|Heart|heart
586437|NCT00524615|resistant hypertension treatment|resistant hypertension treatment
586438|NCT00524615|spironolactone|spironolactone
586439|NCT00524615|aldosterone antagonists|aldosterone antagonists
586440|NCT00524615|resistant arterial hypertension|resistant arterial hypertension
586441|NCT00524615|refractory arterial hypertension|refractory arterial hypertension
586443|NCT00524641|Symbicort|symbicort
586444|NCT00524641|NIS|nis
586445|NCT00524654|To determine the effects of cervical spine manipulation on postural control.|to determine the effects of cervical spine manipulation on postural control.
586446|NCT00524667|Active CLL|active cll
586447|NCT00524680|adenocarcinoma of the prostate|adenocarcinoma of the prostate
586448|NCT00524680|recurrent prostate cancer|recurrent prostate cancer
586449|NCT00524680|stage I prostate cancer|stage i prostate cancer
586450|NCT00524680|stage II prostate cancer|stage ii prostate cancer
586451|NCT00524680|stage III prostate cancer|stage iii prostate cancer
586452|NCT00524680|stage IV prostate cancer|stage iv prostate cancer
586453|NCT00524693|Bronchiolitis|bronchiolitis
586454|NCT00524693|controlled clinical trial|controlled clinical trial
586455|NCT00524693|pediatrics|pediatrics
586456|NCT00524693|Infants|infants
586457|NCT00524693|montelukast|montelukast
586458|NCT00524693|Respiratory syncytial virus|respiratory syncytial virus
586459|NCT00524706|S-1|s-1
586460|NCT00524706|oral fluoropyrimidine|oral fluoropyrimidine
586461|NCT00524706|tegafur|tegafur
586462|NCT00524706|Gimeracil|gimeracil
586463|NCT00524706|Oteracil Potassium|oteracil potassium
586464|NCT00524706|Leucovorin|leucovorin
586465|NCT00524706|Calcium Folinate|calcium folinate
586466|NCT00524706|Oxaliplatin|oxaliplatin
586467|NCT00524706|L-OHP|l-ohp
586468|NCT00524706|colorectal cancer|colorectal cancer
586469|NCT00524732|Pertussis|pertussis
586470|NCT00524732|Tetanus|tetanus
586471|NCT00524732|Diphtheria|diphtheria
586472|NCT00524745|Gardasil|gardasil
586473|NCT00524745|Human Papillomavirus|human papillomavirus
586474|NCT00524745|HPV vaccine|hpv vaccine
586475|NCT00524745|Cervical cancer|cervical cancer
586476|NCT00524758|ologen|ologen
586477|NCT00524758|oculusgen|oculusgen
586478|NCT00524758|collagen matrix|collagen matrix
586479|NCT00524758|trabeculectomy|trabeculectomy
586480|NCT00524758|filtering surgery|filtering surgery
586481|NCT00524758|mitomycin-C|mitomycin-c
586482|NCT00524758|MMC|mmc
586483|NCT00524758|Aeon Astron|aeon astron
586484|NCT00524771|Contraception|contraception
586485|NCT00524771|Contraceptive Vaginal Ring|contraceptive vaginal ring
586486|NCT00524784|GVHD|gvhd
586487|NCT00524784|HSCT|hsct
586488|NCT00524784|BMT|bmt
586489|NCT00524784|APOPTOTIC CELLS|apoptotic cells
586490|NCT00524797|Myelosuppression,|myelosuppression,
586491|NCT00524797|chemotherapeutic agents,|chemotherapeutic agents,
586492|NCT00524797|leucopenia,|leucopenia,
586493|NCT00524797|thrombocytopenia,|thrombocytopenia,
586494|NCT00524797|Profonycia|profonycia
586495|NCT00524823|Prostate Cancer|prostate cancer
586496|NCT00524823|Hyperplasia - BPH|hyperplasia - bph
586497|NCT00524823|FACS|facs
586498|NCT00524823|Prostate Cancer, Hyperplasia - BPH, Malignancy|prostate cancer, hyperplasia - bph, malignancy
586499|NCT00524836|levocetirizine dihydrochloride|levocetirizine dihydrochloride
586500|NCT00524836|Xyzal tablets|xyzal tablets
586501|NCT00524849|Breast cancer|breast cancer
586502|NCT00524849|Bone metastasis|bone metastasis
586503|NCT00524849|Circulating VEGF|circulating vegf
586504|NCT00524849|Zoledronic acid|zoledronic acid
586505|NCT00524849|Angiogenesis|angiogenesis
586506|NCT00524862|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
586507|NCT00524862|Ejection Fraction|ejection fraction
586508|NCT00524862|QRS duration|qrs duration
586509|NCT00524875|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
586510|NCT00524875|Bevacizumab|bevacizumab
586511|NCT00524875|Early post-vitrectomy vitreous hemorrhage|early post-vitrectomy vitreous hemorrhage
586512|NCT00524888|Hand|hand
586513|NCT00524888|Laceration|laceration
586514|NCT00524888|bioadhesive|bioadhesive
586515|NCT00524888|ER|er
586516|NCT00524888|Hand laceration distal to the volar wrist crease|hand laceration distal to the volar wrist crease
586517|NCT00524901|Apoptosis|apoptosis
586518|NCT00524901|CABG|cabg
586519|NCT00524901|Coronary Artery Disease|coronary artery disease
586520|NCT00524901|Three Vessel Disease|three vessel disease
586521|NCT00524901|Erythropoietin|erythropoietin
586522|NCT00524901|EPO-receptor signaling|epo-receptor signaling
586523|NCT00524914|Parkinson's disease|parkinson's disease
586524|NCT00524914|Pain|pain
586525|NCT00524914|Nociceptive threshold|nociceptive threshold
586526|NCT00524914|Functional imaging|functional imaging
586527|NCT00524914|Cerebral activity|cerebral activity
586528|NCT00524914|Dopamine agonist.|dopamine agonist.
586529|NCT00524927|Incident Pain|incident pain
586530|NCT00524927|Bone Marrow Biopsy|bone marrow biopsy
586531|NCT00524940|Influenza|influenza
586532|NCT00524940|Orthomyxoviruses|orthomyxoviruses
586533|NCT00524940|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
586534|NCT00524953|allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
586535|NCT00524953|non-T-cell depleted|non-t-cell depleted
586536|NCT00524953|UV-c|uv-c
586537|NCT00524953|GVHD|gvhd
586538|NCT00516659|ETEC|etec
586539|NCT00516659|Traveler's diarrhea|traveler's diarrhea
586540|NCT00516659|TCI|tci
586560|NCT00516711|Surgery with Pringle maneuver needed for liver resection|surgery with pringle maneuver needed for liver resection
586561|NCT00516724|malignant solid tumours|malignant solid tumours
586562|NCT00516724|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
586563|NCT00516750|recurrent bladder cancer|recurrent bladder cancer
586564|NCT00516750|stage II bladder cancer|stage ii bladder cancer
586565|NCT00516750|stage III bladder cancer|stage iii bladder cancer
586566|NCT00516750|stage IV bladder cancer|stage iv bladder cancer
586567|NCT00516802|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
586568|NCT00516802|dacarbazine|dacarbazine
586569|NCT00516828|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
586570|NCT00516828|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
586571|NCT00516828|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
586572|NCT00516828|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
586573|NCT00516828|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
586574|NCT00516828|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
586575|NCT00516828|secondary acute myeloid leukemia|secondary acute myeloid leukemia
586576|NCT00516828|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
586577|NCT00516828|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
586578|NCT00516841|epithelial ovarian cancer|epithelial ovarian cancer
586579|NCT00516841|peritoneal cancer|peritoneal cancer
586580|NCT00516841|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
586581|NCT00516841|Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer|platinum-resistant advanced epithelial ovarian cancer or primary peritoneal cancer
586582|NCT00516854|Non-cardiac chest pain|non-cardiac chest pain
586583|NCT00516880|chronic kidney disease|chronic kidney disease
586584|NCT00516880|cardiovascular disease|cardiovascular disease
586585|NCT00516893|natalizumab|natalizumab
586586|NCT00516893|Tysabri|tysabri
586587|NCT00516893|Multiple Sclerosis|multiple sclerosis
586588|NCT00516893|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
586589|NCT00516919|Obesity|obesity
586590|NCT00516919|Binge Eating|binge eating
586591|NCT00516919|Monolingual Hispanic Persons|monolingual hispanic persons
586592|NCT00516919|Orlistat|orlistat
586593|NCT00516919|Behavioral Weight Loss Treatment|behavioral weight loss treatment
586594|NCT00516932|Suicidal Event|suicidal event
586595|NCT00516932|Behavioral Activation|behavioral activation
586596|NCT00516945|hepatitis B during cancer chemotherapy|hepatitis b during cancer chemotherapy
586597|NCT00516958|diabetic|diabetic
586598|NCT00516958|ulcer|ulcer
586599|NCT00516958|infection|infection
586600|NCT00516958|topical|topical
586601|NCT00516958|wound|wound
586602|NCT00516971|Non-erosive reflux disease|non-erosive reflux disease
586700|NCT00517426|periodic breathing,|periodic breathing,
586603|NCT00516984|Relationship between Osteopathic Manipulative Therapy (OMT) and the autonomic nervous system|relationship between osteopathic manipulative therapy (omt) and the autonomic nervous system
586604|NCT00516984|LF/HF ratio|lf/hf ratio
586605|NCT00517010|Age-related macular degeneration|age-related macular degeneration
586606|NCT00517010|Exudative age-related macular degeneration|exudative age-related macular degeneration
586607|NCT00517010|Wet macular degeneration|wet macular degeneration
586608|NCT00517010|Intravitreal injection|intravitreal injection
586609|NCT00517010|Proton beam irradiation|proton beam irradiation
586610|NCT00517010|Lucentis|lucentis
586611|NCT00517010|Ranibizumab|ranibizumab
586612|NCT00517023|Implantable Loop Recorder|implantable loop recorder
586613|NCT00517023|Home monitoring|home monitoring
586614|NCT00517023|Syncope/ Falls Clinic|syncope/ falls clinic
586615|NCT00517036|Major Depression|major depression
586616|NCT00517036|Omega-3|omega-3
586617|NCT00517036|Major Depressive Disorder|major depressive disorder
586618|NCT00517049|NHL|nhl
586619|NCT00517049|Rituxan|rituxan
586620|NCT00517049|Lymphoma|lymphoma
586621|NCT00517049|CD20-positive|cd20-positive
586622|NCT00517049|B-Cell|b-cell
586623|NCT00517049|APM4083g|apm4083g
586624|NCT00517062|Growth hormone|growth hormone
586625|NCT00517062|insulin sensitivity|insulin sensitivity
586626|NCT00517062|cortisol|cortisol
586627|NCT00517075|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
586628|NCT00517075|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
586629|NCT00517075|Schizophrenia|schizophrenia
586630|NCT00517075|Schizoaffective Disorder|schizoaffective disorder
586631|NCT00517075|Treatment|treatment
586632|NCT00517075|Negative Symptoms|negative symptoms
586633|NCT00517075|Social Dysfunction|social dysfunction
586634|NCT00517075|TMS|tms
586635|NCT00517075|rTMS|rtms
586636|NCT00517088|Physical Activity|physical activity
586637|NCT00517088|Breast Cancer|breast cancer
586638|NCT00517101|spondyloarthropathy|spondyloarthropathy
586639|NCT00517101|inflammatory bowel disease|inflammatory bowel disease
586640|NCT00517101|antibodies|antibodies
586641|NCT00517114|Reflux laryngitis|reflux laryngitis
586642|NCT00517127|Intraoperative care|intraoperative care
586643|NCT00517127|Ringer's lactate|ringer's lactate
586644|NCT00517127|Voluven|voluven
586645|NCT00517127|Cardiovascular diagnostic technique|cardiovascular diagnostic technique
586647|NCT00517140|Pregnancy women with a scarred uterus due to previous caesarean section|pregnancy women with a scarred uterus due to previous caesarean section
586648|NCT00517153|Zavesca|zavesca
586649|NCT00517153|miglustat|miglustat
586650|NCT00517153|Niemann-Pick Type C|niemann-pick type c
586651|NCT00517153|Actelion|actelion
586652|NCT00517166|tourniquet|tourniquet
586653|NCT00517166|extremity injury|extremity injury
586654|NCT00517166|hemostatic device|hemostatic device
586655|NCT00517179|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
586656|NCT00517179|Erectile Dysfunction (ED)|erectile dysfunction (ed)
586657|NCT00517205|upper ureteric stone|upper ureteric stone
586658|NCT00517218|Evaluate the Effect of Genasense on the Efficacy/Safety of Rituximab/Fludarabine Treatment in Untreated Subjects With Chronic Lymphocyctic Leukemia|evaluate the effect of genasense on the efficacy/safety of rituximab/fludarabine treatment in untreated subjects with chronic lymphocyctic leukemia
586659|NCT00517231|Pulmonary tuberculosis|pulmonary tuberculosis
586660|NCT00517231|Mycobacterium tuberculosis|mycobacterium tuberculosis
586661|NCT00517231|Cytokines|cytokines
586662|NCT00517231|Acute Phase Response|acute phase response
586663|NCT00517231|Treatment|treatment
586664|NCT00517244|Children|children
586665|NCT00517244|Healthy Controls|healthy controls
586666|NCT00517244|Assessment|assessment
586667|NCT00517257|Retinal vein occlusion|retinal vein occlusion
586668|NCT00517257|Retinal vein thrombosis|retinal vein thrombosis
586669|NCT00517257|Central retinal vein occlusion|central retinal vein occlusion
586670|NCT00517257|Branch retinal vein occlusion|branch retinal vein occlusion
586671|NCT00517257|Visual loss|visual loss
586672|NCT00517257|Atorvastatin|atorvastatin
586673|NCT00517257|Statin|statin
586674|NCT00517257|Neovascularization|neovascularization
586675|NCT00517257|Thrombosis|thrombosis
586676|NCT00517270|Non-cardiac chest pain|non-cardiac chest pain
586677|NCT00517283|diabetes|diabetes
586678|NCT00517283|gastric emptying|gastric emptying
586679|NCT00517283|exenatide|exenatide
586680|NCT00517283|Byetta|byetta
586681|NCT00517283|Amylin|amylin
586682|NCT00517283|Lilly|lilly
586683|NCT00517322|left atrial volume|left atrial volume
586684|NCT00517322|hypertension|hypertension
586685|NCT00517322|ramipril|ramipril
586686|NCT00517322|irbesartan|irbesartan
586687|NCT00517322|diastolic function|diastolic function
586688|NCT00517335|anorexia nervosa|anorexia nervosa
586689|NCT00517335|bulimia nervosa|bulimia nervosa
586690|NCT00517348|Adult|adult
586691|NCT00517387|Depression|depression
586692|NCT00517387|SSRI|ssri
586693|NCT00517387|Atypical Antipsychotic|atypical antipsychotic
586694|NCT00517387|Cognition|cognition
586695|NCT00517387|Mood|mood
586696|NCT00517387|Quality of Life|quality of life
586697|NCT00517400|PTSD|ptsd
586698|NCT00517426|heart failure,|heart failure,
586701|NCT00517426|acetazolamide|acetazolamide
586702|NCT00517504|methylphenidate|methylphenidate
586703|NCT00517504|ritalin|ritalin
586704|NCT00517504|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
586705|NCT00517504|developmental disorder|developmental disorder
586706|NCT00517504|preschool children|preschool children
586707|NCT00517517|Pandemic influenza|pandemic influenza
586708|NCT00517543|inflammation|inflammation
586709|NCT00517556|Dysmenorrhea|dysmenorrhea
586710|NCT00517556|continuous OCP|continuous ocp
586711|NCT00517569|Gene Therapy|gene therapy
586712|NCT00517569|GX-12|gx-12
586713|NCT00517569|HIV-1|hiv-1
586714|NCT00517569|Interleukin|interleukin
586715|NCT00517569|AIDS|aids
586716|NCT00517569|HIV-1 type B infection|hiv-1 type b infection
586717|NCT00517569|Treatment Naive|treatment naive
586718|NCT00517582|ACE Inhibitor|ace inhibitor
586719|NCT00517582|Angioedema|angioedema
586720|NCT00517582|Bradykinin|bradykinin
586721|NCT00517582|Swelling|swelling
586722|NCT00517595|Non-Small Cell Lung Cancer|non-small cell lung cancer
586723|NCT00517621|Peritoneal cancer|peritoneal cancer
586724|NCT00517621|Relapse or progression|relapse or progression
586725|NCT00517634|asthma|asthma
586726|NCT00517634|allergen challenge|allergen challenge
586727|NCT00517634|IL-5|il-5
586728|NCT00517634|eosinophils|eosinophils
586729|NCT00517647|ADHD|adhd
586730|NCT00517647|atomoxetine|atomoxetine
586731|NCT00517647|preschool children|preschool children
586732|NCT00517647|efficacy|efficacy
586733|NCT00517647|safety|safety
586734|NCT00517660|Healthy subjects|healthy subjects
586735|NCT00517660|Lower Respiratory Tract Infections|lower respiratory tract infections
586736|NCT00517660|Upper Respiratory Tract Infections|upper respiratory tract infections
586737|NCT00517673|Healthy Volunteer|healthy volunteer
586738|NCT00517686|Poor risk factor control|poor risk factor control
586739|NCT00517686|Treatment intensification|treatment intensification
586740|NCT00517686|Medication adherence|medication adherence
586741|NCT00517686|Cardiovascular disease (CVD)|cardiovascular disease (cvd)
586742|NCT00524992|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
586743|NCT00524992|Collapsing Glomerulopathy|collapsing glomerulopathy
586744|NCT00524992|Anti-Retroviral Toxicity|anti-retroviral toxicity
586753|NCT00524992|HIV-Associated Focal Segmental Glomerulosclerosis|hiv-associated focal segmental glomerulosclerosis
586754|NCT00525005|Stomach Neoplasm|stomach neoplasm
586755|NCT00525005|Docetaxel|docetaxel
586756|NCT00525005|Oxaliplatin|oxaliplatin
586758|NCT00525018|Pain|pain
586759|NCT00525018|Functional neuroimaging|functional neuroimaging
586760|NCT00525018|Neuropathy|neuropathy
586761|NCT00525018|Thermal sensation|thermal sensation
586762|NCT00525031|Melanoma|melanoma
586763|NCT00525031|Temozolomide|temozolomide
586764|NCT00525031|Temodar|temodar
586765|NCT00525031|Pegylated Interferon Alpha-2b|pegylated interferon alpha-2b
586766|NCT00525031|PEG-Intron|peg-intron
586767|NCT00525031|PGI|pgi
586768|NCT00525031|Resectable metastatic melanoma|resectable metastatic melanoma
586769|NCT00525031|Surgery|surgery
586770|NCT00525057|Bone Cancer|bone cancer
586771|NCT00525057|Orthopaedic Oncology|orthopaedic oncology
586772|NCT00525057|Orthopaedics|orthopaedics
586773|NCT00525057|Myeloma|myeloma
586774|NCT00525057|Lymphoma|lymphoma
586775|NCT00525057|Deep Venous Thrombosis|deep venous thrombosis
586776|NCT00525057|DVT Prophylaxis|dvt prophylaxis
586777|NCT00525057|Thromboembolic disease|thromboembolic disease
586778|NCT00525057|Blood clots|blood clots
586779|NCT00525057|Dalteparin|dalteparin
586780|NCT00525057|Fragmin|fragmin
586781|NCT00525057|Surgery|surgery
586782|NCT00525057|Bone Tumor|bone tumor
586783|NCT00525057|Tumor of soft tissue|tumor of soft tissue
586784|NCT00525057|Lower extremity|lower extremity
586785|NCT00525057|Leg|leg
586786|NCT00525057|TED hose|ted hose
586787|NCT00525057|Mechanical compression stocking|mechanical compression stocking
586788|NCT00525083|hyperlipidemia|hyperlipidemia
586789|NCT00525083|HDL-C|hdl-c
586790|NCT00525083|low density lipoprotein|low density lipoprotein
586791|NCT00525109|Cholesterol|cholesterol
586792|NCT00525109|Hyperlipidemia|hyperlipidemia
586793|NCT00525109|Gene array|gene array
586794|NCT00525122|hyperthyroidism|hyperthyroidism
586795|NCT00525122|radioactive iodine|radioactive iodine
586796|NCT00525122|antithyroid drugs|antithyroid drugs
586797|NCT00525122|Hyperthyroidism, treatment with radioactive iodine without antithyroid drugs|hyperthyroidism, treatment with radioactive iodine without antithyroid drugs
586798|NCT00525161|breast cancer|breast cancer
586799|NCT00525161|Sorafenib|sorafenib
586800|NCT00525161|Nexavar|nexavar
586801|NCT00525161|Endocrine Therapy|endocrine therapy
586802|NCT00525174|Amblyopia|amblyopia
586803|NCT00525174|Patching|patching
586804|NCT00525174|Bangerter filters|bangerter filters
586805|NCT00525187|onychomycosis|onychomycosis
752174|NCT01172028|stage IV prostate cancer|stage iv prostate cancer
586806|NCT00525187|diabetic neuropathic patients|diabetic neuropathic patients
586807|NCT00525187|reliability of the diagnostic of onychomycosis|reliability of the diagnostic of onychomycosis
586808|NCT00525200|predictive marker|predictive marker
586809|NCT00525200|personalized therapy|personalized therapy
586810|NCT00525200|response assessment|response assessment
586811|NCT00525200|p53 genotype|p53 genotype
586812|NCT00525213|Rheumatoid Arthritis|rheumatoid arthritis
586813|NCT00525226|Psychiatry|psychiatry
586814|NCT00525226|Psychology|psychology
586815|NCT00525226|Pregnancy|pregnancy
586816|NCT00525226|Stress|stress
586817|NCT00525226|Anxiety|anxiety
586818|NCT00525239|Lipids|lipids
586819|NCT00525239|lipoproteins|lipoproteins
586820|NCT00525239|VLDL|vldl
586821|NCT00525239|triglycerides|triglycerides
586822|NCT00525239|apo B100|apo b100
586823|NCT00525239|HDL|hdl
586824|NCT00525239|apo A1|apo a1
586825|NCT00525239|endothelial dysfunction|endothelial dysfunction
586826|NCT00525239|insulin secretion|insulin secretion
586827|NCT00525239|hyperglycemic clamp|hyperglycemic clamp
586828|NCT00525239|HIV-seronegative Volunteers|hiv-seronegative volunteers
586829|NCT00525239|HIV-infected subjects starting an efavirenz-based regimen|hiv-infected subjects starting an efavirenz-based regimen
586830|NCT00525239|Treatment Experienced|treatment experienced
586831|NCT00525252|Liver cirrhosis|liver cirrhosis
586832|NCT00525252|Alcoholism|alcoholism
586833|NCT00525252|Craving|craving
586834|NCT00525265|Vasopressin antagonist|vasopressin antagonist
586835|NCT00525265|Cardiac Edema|cardiac edema
586836|NCT00525265|Diuretics|diuretics
586837|NCT00525278|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
586838|NCT00525278|Xyzal tablets|xyzal tablets
586839|NCT00525291|Exercise Therapy|exercise therapy
586840|NCT00525291|Biofeedback (Psychology)|biofeedback (psychology)
586841|NCT00525291|Adult|adult
586842|NCT00525291|Fecal Incontinence/*therapy|fecal incontinence/*therapy
586843|NCT00525291|EMG - Biofeedback|emg - biofeedback
586844|NCT00525291|EMG - Triggered Stimulation|emg - triggered stimulation
586845|NCT00525291|Augmented biofeedback|augmented biofeedback
586846|NCT00525304|medical co-morbidity|medical co-morbidity
586847|NCT00525304|diabetes|diabetes
586848|NCT00525304|heart disease|heart disease
586849|NCT00525304|respiratory illness|respiratory illness
586850|NCT00529971|Mindfulness|mindfulness
586851|NCT00529971|HIV|hiv
586852|NCT00529971|Male|male
586853|NCT00529971|Living with HIV|living with hiv
586854|NCT00529971|18-70 years of age|18-70 years of age
586855|NCT00529971|live within one hour of hospital|live within one hour of hospital
586856|NCT00529971|fluent in English|fluent in english
586857|NCT00529971|Complementary Therapies|complementary therapies
586858|NCT00529971|HIV Therapeutic Vaccine|hiv therapeutic vaccine
586859|NCT00529984|CEA|cea
586860|NCT00529984|CEA-expressing malignancies|cea-expressing malignancies
586861|NCT00529984|Metastatic malignancies|metastatic malignancies
586862|NCT00529984|VRP Vaccine|vrp vaccine
586863|NCT00529984|Alphavirus replicons|alphavirus replicons
586864|NCT00529984|Molecular therapeutics|molecular therapeutics
586865|NCT00529984|Stage III colon cancer|stage iii colon cancer
586866|NCT00529997|Lumbar Spine|lumbar spine
586867|NCT00529997|Lumbar Spinal Stenosis|lumbar spinal stenosis
586868|NCT00529997|Spondylolisthesis|spondylolisthesis
586869|NCT00529997|Dynamic Stabilization|dynamic stabilization
586870|NCT00529997|Motion Preserving|motion preserving
586871|NCT00529997|Arthroplasty|arthroplasty
586872|NCT00529997|Randomized|randomized
586873|NCT00529997|Investigational|investigational
586874|NCT00529997|Back Pain|back pain
586875|NCT00529997|Leg Pain|leg pain
586876|NCT00530010|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
587017|NCT00530244|infant formula|infant formula
586877|NCT00530010|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
586878|NCT00530010|advanced adult primary liver cancer|advanced adult primary liver cancer
586879|NCT00530036|Mortality|mortality
586880|NCT00530036|Patient readmission|patient readmission
586881|NCT00530036|Institutionalization|institutionalization
586882|NCT00530049|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
586883|NCT00530049|hypopharyngeal cancer|hypopharyngeal cancer
586884|NCT00530049|laryngeal cancer|laryngeal cancer
586885|NCT00530049|lip and oral cavity cancer|lip and oral cavity cancer
586886|NCT00530049|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
586887|NCT00530049|nasopharyngeal cancer|nasopharyngeal cancer
586888|NCT00530049|oropharyngeal cancer|oropharyngeal cancer
586889|NCT00530049|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
586890|NCT00530049|salivary gland cancer|salivary gland cancer
586891|NCT00530049|tongue cancer|tongue cancer
586892|NCT00530049|07-098|07-098
586893|NCT00530062|Asthma and Poor Coordinators of Asthma Inhalers|asthma and poor coordinators of asthma inhalers
586894|NCT00530075|Wegener Granulomatosis|wegener granulomatosis
586895|NCT00530075|Vasculitis|vasculitis
586896|NCT00530075|Gusperimus|gusperimus
586897|NCT00530075|Immunosuppression|immunosuppression
586898|NCT00530088|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
586899|NCT00530088|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
586900|NCT00530088|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
586901|NCT00530088|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
586902|NCT00530088|stage 0 laryngeal cancer|stage 0 laryngeal cancer
586903|NCT00530088|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
586904|NCT00530127|Friedreich's ataxia|friedreich's ataxia
586905|NCT00530140|Follicular Lymphoma|follicular lymphoma
586906|NCT00530140|Idiotype vaccine|idiotype vaccine
586908|NCT00530153|Food Habits|food habits
586909|NCT00530153|Adolescent|adolescent
586910|NCT00530153|Dental Research|dental research
586911|NCT00530166|Asthma|asthma
586912|NCT00530166|persistant asthma|persistant asthma
586913|NCT00530166|controller medications|controller medications
586914|NCT00530166|FEV1|fev1
586915|NCT00530179|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
586916|NCT00530179|Positron Emission Tomography|positron emission tomography
586917|NCT00530179|CHOP Chemotherapy protocol|chop chemotherapy protocol
586918|NCT00530179|Stem Cell Transplantation|stem cell transplantation
586919|NCT00530179|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
586920|NCT00530192|Refractory Cancer|refractory cancer
586921|NCT00530192|Molecular Profile|molecular profile
586922|NCT00530205|weight changes|weight changes
586923|NCT00530205|malnutrition|malnutrition
586924|NCT00530205|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
586925|NCT00530218|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
586926|NCT00530218|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
586927|NCT00530218|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
586928|NCT00530218|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
586929|NCT00530218|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
586930|NCT00530218|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
586931|NCT00530218|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
586932|NCT00530218|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
586933|NCT00530218|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
586934|NCT00530218|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
586935|NCT00530218|chronic eosinophilic leukemia|chronic eosinophilic leukemia
587198|NCT00531089|TTP|ttp
586936|NCT00530218|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
586937|NCT00530218|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
586938|NCT00530218|chronic neutrophilic leukemia|chronic neutrophilic leukemia
586939|NCT00530218|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
586940|NCT00530218|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
586941|NCT00530218|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
586942|NCT00530218|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
586943|NCT00530218|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
586944|NCT00530218|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
586945|NCT00530218|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
586946|NCT00530218|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
586947|NCT00530218|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
586948|NCT00530218|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
586949|NCT00530218|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
586950|NCT00530218|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
586951|NCT00530218|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
586952|NCT00530218|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
586953|NCT00530218|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
586954|NCT00530218|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
586955|NCT00530218|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
586956|NCT00530218|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
586957|NCT00530218|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
586958|NCT00530218|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
586959|NCT00530218|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
586960|NCT00530218|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
586961|NCT00530218|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
586962|NCT00530218|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
586963|NCT00530218|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
586964|NCT00530218|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
586965|NCT00530218|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
586966|NCT00530218|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
586967|NCT00530218|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
586968|NCT00530218|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
586969|NCT00530218|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
586970|NCT00530218|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
586971|NCT00530218|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
586972|NCT00530218|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
586973|NCT00530218|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
586974|NCT00530218|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
586975|NCT00530218|refractory hairy cell leukemia|refractory hairy cell leukemia
586976|NCT00530218|refractory multiple myeloma|refractory multiple myeloma
586977|NCT00530218|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
586978|NCT00530218|secondary acute myeloid leukemia|secondary acute myeloid leukemia
586979|NCT00530218|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
586980|NCT00530218|splenic marginal zone lymphoma|splenic marginal zone lymphoma
586981|NCT00530218|stage I multiple myeloma|stage i multiple myeloma
586982|NCT00530218|stage II multiple myeloma|stage ii multiple myeloma
586983|NCT00530218|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
586984|NCT00530218|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
586985|NCT00530218|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
586986|NCT00530218|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
586987|NCT00530218|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
586988|NCT00530218|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
586989|NCT00530218|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
586990|NCT00530218|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
586991|NCT00530218|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
586992|NCT00530218|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
586993|NCT00530218|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
586994|NCT00530218|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
586995|NCT00530218|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
586996|NCT00530218|stage III multiple myeloma|stage iii multiple myeloma
586997|NCT00530218|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
587090|NCT00530504|Embolic Protection|embolic protection
586998|NCT00530218|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
586999|NCT00530218|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
587000|NCT00530218|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
587001|NCT00530218|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
587002|NCT00530218|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
587003|NCT00530218|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
587004|NCT00530218|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
587005|NCT00530218|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
587006|NCT00530218|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
587007|NCT00530218|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
587008|NCT00530218|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
587009|NCT00530218|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
587010|NCT00530218|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
587011|NCT00530218|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
587012|NCT00530231|Capsule endoscopy|capsule endoscopy
587013|NCT00530231|Missing rate|missing rate
587014|NCT00530244|cystic fibrosis|cystic fibrosis
587015|NCT00530244|fatty acids|fatty acids
587016|NCT00530244|docosahexaenoic acid|docosahexaenoic acid
587018|NCT00530244|growth|growth
587019|NCT00530244|pancreatic function|pancreatic function
587020|NCT00530257|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
587021|NCT00530257|Methylphenidate|methylphenidate
587022|NCT00530257|Attention|attention
587023|NCT00530257|Working Memory|working memory
587024|NCT00530270|Sickle Cell Disease|sickle cell disease
587026|NCT00530270|Acute Chest Syndrome|acute chest syndrome
587027|NCT00530270|Hgb SS|hgb ss
587028|NCT00530270|Hgb Sβ0|hgb sβ0
587029|NCT00530270|Dexamethasone|dexamethasone
587030|NCT00530283|Squamous|squamous
587031|NCT00530283|Unknown Primary|unknown primary
587032|NCT00530283|Patients with Squamous cell cancer neck nodes|patients with squamous cell cancer neck nodes
587033|NCT00530296|Depression|depression
587034|NCT00530296|End stage renal disease|end stage renal disease
587035|NCT00530296|Quality of Life|quality of life
587036|NCT00530296|Cognitive Behavioral Therapy|cognitive behavioral therapy
587037|NCT00530309|GLP-1|glp-1
587038|NCT00530309|type 2 diabeted mellitus|type 2 diabeted mellitus
587039|NCT00530309|safety|safety
587040|NCT00530309|GSK716155|gsk716155
587041|NCT00530309|GLP-1 receptor agonist|glp-1 receptor agonist
587042|NCT00530309|tolerability|tolerability
587043|NCT00530309|pharmacokinetics|pharmacokinetics
587044|NCT00530309|pharmacodynamics|pharmacodynamics
587045|NCT00530322|Adhesions|adhesions
587046|NCT00530322|Laparoscopy|laparoscopy
587047|NCT00530322|Colorectal surgery|colorectal surgery
587048|NCT00530322|Colorectal disease|colorectal disease
587049|NCT00530348|Multiple Sclerosis|multiple sclerosis
587050|NCT00530361|Myocardial Ischemia|myocardial ischemia
587051|NCT00530361|Kidney failure|kidney failure
587052|NCT00530361|CABG|cabg
587053|NCT00530361|Cardiopulmonary bypass (CPB) pump|cardiopulmonary bypass (cpb) pump
587054|NCT00530361|Coronary Artery Bypass Surgery|coronary artery bypass surgery
587055|NCT00530361|Heart surgery|heart surgery
587056|NCT00530361|Nesiritide|nesiritide
587057|NCT00530361|Coronary Heart Disease|coronary heart disease
587058|NCT00530374|Pediatrics|pediatrics
587059|NCT00530374|Malnutrition|malnutrition
587060|NCT00530374|Iron Deficiency|iron deficiency
587061|NCT00530374|Sprinkles|sprinkles
587062|NCT00530374|Oral Iron Supplementation|oral iron supplementation
587063|NCT00530387|Photocontact|photocontact
587064|NCT00530387|Dermatitis|dermatitis
587065|NCT00530387|NSAID|nsaid
587066|NCT00530387|Sunscreen|sunscreen
587067|NCT00530387|Photopatch|photopatch
587068|NCT00530400|Antibiotic prophylaxis|antibiotic prophylaxis
587069|NCT00530400|Bacterial Infections / prevention & control|bacterial infections / prevention & control
587070|NCT00530400|Surgical wound infection / prevention & control|surgical wound infection / prevention & control
587071|NCT00530400|Neurosurgery|neurosurgery
587072|NCT00530400|Postoperative Complications / prevention & control|postoperative complications / prevention & control
587073|NCT00530400|Clinical trial [publication type]|clinical trial [publication type]
587074|NCT00530426|Heart Failure, Congestive|heart failure, congestive
587075|NCT00530426|Registry|registry
587076|NCT00530426|Acute Decompensated Heart Failure|acute decompensated heart failure
587077|NCT00530426|Dyspnea|dyspnea
587078|NCT00530452|COX-2|cox-2
587079|NCT00530452|carbonic anhydrase|carbonic anhydrase
587080|NCT00530452|osteoarthritis|osteoarthritis
587081|NCT00530452|anti-inflammatory|anti-inflammatory
587082|NCT00530452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
587083|NCT00530478|Donepezil|donepezil
587084|NCT00530478|Stroke|stroke
587085|NCT00530478|Cognitive function|cognitive function
587086|NCT00530478|Cognitive neural network|cognitive neural network
587087|NCT00530491|lung resection|lung resection
587088|NCT00530491|reduced pulmonary function|reduced pulmonary function
587089|NCT00530504|Carotid Artery Disease|carotid artery disease
587101|NCT00530582|progesterone, postmenopause, sleep-EEG|progesterone, postmenopause, sleep-eeg
587102|NCT00530595|hemodialysis|hemodialysis
587103|NCT00530634|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
587104|NCT00530634|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
587105|NCT00530634|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
587106|NCT00530647|Brain motor network, Plasticity, functional MRI, Stroke|brain motor network, plasticity, functional mri, stroke
587107|NCT00530660|Pandemic influenza|pandemic influenza
587108|NCT00530686|Diabetes Mellitus|diabetes mellitus
587109|NCT00530686|Hypoglycemia|hypoglycemia
587110|NCT00530686|Hyperglycemia|hyperglycemia
587111|NCT00530686|Type 1 Diabetes|type 1 diabetes
587112|NCT00530686|Islet cell transplantation|islet cell transplantation
587113|NCT00530699|Acute Myeloid Leukaemia|acute myeloid leukaemia
587114|NCT00530699|Phase 1|phase 1
587115|NCT00530699|AZD1152|azd1152
587117|NCT00530712|Popliteal|popliteal
587118|NCT00530712|Stent|stent
587119|NCT00530712|EverFlex|everflex
587120|NCT00530725|occult pneumothorax|occult pneumothorax
587121|NCT00530725|mechanical ventilation|mechanical ventilation
587122|NCT00530725|critical care|critical care
587123|NCT00530725|pneumothorax|pneumothorax
587124|NCT00530725|thoracostomy|thoracostomy
587125|NCT00530738|HPN|hpn
587126|NCT00530738|lipid emulsion|lipid emulsion
587127|NCT00530738|long term|long term
587128|NCT00530738|insufficient enteral resorption capacity|insufficient enteral resorption capacity
587129|NCT00530751|breast cancer|breast cancer
587130|NCT00530764|Pain|pain
587131|NCT00530764|Cancer|cancer
587132|NCT00530764|Palliative|palliative
587133|NCT00530777|Disease Transmission, Vertical|disease transmission, vertical
587134|NCT00530777|valacyclovir|valacyclovir
587135|NCT00530777|Randomized Controlled Trials|randomized controlled trials
587136|NCT00530777|HIV|hiv
587137|NCT00530777|herpes|herpes
587138|NCT00530777|Herpesvirus 2, Human|herpesvirus 2, human
587139|NCT00530777|HIV Seronegativity|hiv seronegativity
587140|NCT00530790|Restless Legs Syndrome|restless legs syndrome
587141|NCT00530803|pain|pain
587142|NCT00530803|venipuncture|venipuncture
587143|NCT00530803|children|children
587144|NCT00530829|diarrhea|diarrhea
587145|NCT00530829|zinc|zinc
587146|NCT00530829|oral rehydration therapy|oral rehydration therapy
587147|NCT00530855|Epilepsy|epilepsy
587148|NCT00530855|Partial-onset Seizures|partial-onset seizures
587149|NCT00530855|Lacosamide|lacosamide
587150|NCT00530855|Monotherapy|monotherapy
587151|NCT00530855|Vimpat|vimpat
587152|NCT00530868|Hormonal and antibody therapy for breast cancer|hormonal and antibody therapy for breast cancer
587153|NCT00530868|Hormonal therapy for breast cancer|hormonal therapy for breast cancer
587154|NCT00530868|Antibody therapy for breast cancer|antibody therapy for breast cancer
587155|NCT00530894|Valvular Heart Disease|valvular heart disease
587156|NCT00530894|Critical/Severe Aortic Stenosis|critical/severe aortic stenosis
587157|NCT00530894|High risk symptomatic patients|high risk symptomatic patients
587158|NCT00530907|Advanced Cancer|advanced cancer
587159|NCT00530907|Valproic Acid|valproic acid
587160|NCT00530907|Depakene|depakene
587161|NCT00530907|Bevacizumab|bevacizumab
587162|NCT00530907|Avastin|avastin
587163|NCT00530907|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
587164|NCT00530907|rhuMAb-VEGF|rhumab-vegf
587165|NCT00530972|co-infected HCV/HIV|co-infected hcv/hiv
587166|NCT00530972|relapsers|relapsers
587167|NCT00530985|disability|disability
587168|NCT00530985|substance abuse|substance abuse
587169|NCT00530985|vocational rehabilitation|vocational rehabilitation
587170|NCT00530985|case management|case management
587171|NCT00530998|appendicitis|appendicitis
587172|NCT00530998|cholelithiasis|cholelithiasis
587173|NCT00530998|Gallstones|gallstones
587174|NCT00531011|Stents|stents
587175|NCT00531011|Drug-eluting Stent|drug-eluting stent
587176|NCT00531011|Angioplasty|angioplasty
587177|NCT00531011|Coronary Artery stenosis|coronary artery stenosis
587178|NCT00531011|Coronary Artery Stent Restenosis|coronary artery stent restenosis
587179|NCT00531011|Stent Thrombosis|stent thrombosis
587180|NCT00531024|Exudative Neovascular|exudative neovascular
587181|NCT00531024|AMD|amd
587182|NCT00531024|Avastin|avastin
587183|NCT00531024|Systemic|systemic
587184|NCT00531024|Exudative Age-Related Macular Degeneration|exudative age-related macular degeneration
587185|NCT00531037|AV block, SND, BTS, AAIsafeR, SafeR, PM implanted|av block, snd, bts, aaisafer, safer, pm implanted
587186|NCT00531050|COPD|copd
587187|NCT00531050|cycle ergometry|cycle ergometry
587188|NCT00531050|exercise testing|exercise testing
587189|NCT00531050|spirometry|spirometry
587190|NCT00531050|cardiovascular|cardiovascular
587191|NCT00531050|salbutamol|salbutamol
587192|NCT00531050|indacaterol|indacaterol
587193|NCT00531050|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
587194|NCT00531063|Renal transplantation, everolimus, Immunosuppressants|renal transplantation, everolimus, immunosuppressants
587195|NCT00531076|bevacizumab|bevacizumab
587196|NCT00531076|thoracic radiotherapy|thoracic radiotherapy
587197|NCT00531076|locally-advanced non-small cell lung cancer|locally-advanced non-small cell lung cancer
587199|NCT00531089|thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
587201|NCT00531089|hemolytic uremic syndrome|hemolytic uremic syndrome
587202|NCT00531089|plasma exchange|plasma exchange
587203|NCT00531102|oxygen|oxygen
587204|NCT00531102|continuous positive airway pressure|continuous positive airway pressure
587205|NCT00531102|infant, newborn|infant, newborn
587206|NCT00531102|resuscitation|resuscitation
587207|NCT00531115|metastatic colorectal cancer|metastatic colorectal cancer
587208|NCT00531115|elderly patients|elderly patients
587209|NCT00531115|cetuximab, oxaliplatin, capecitabine|cetuximab, oxaliplatin, capecitabine
587210|NCT00531128|Sitosterol|sitosterol
587211|NCT00531128|Nutrigenomics|nutrigenomics
587212|NCT00531128|Gene Expression|gene expression
587213|NCT00531128|Insulin Resistance|insulin resistance
587214|NCT00531128|Sitosterolemia|sitosterolemia
587215|NCT00531141|age-related macular degeneration|age-related macular degeneration
587216|NCT00531141|optical coherence tomography|optical coherence tomography
587217|NCT00531141|retinal thickness|retinal thickness
587218|NCT00531141|exudative age-related macular degeneration|exudative age-related macular degeneration
587219|NCT00531167|lamivudine resistant mutations|lamivudine resistant mutations
587220|NCT00531167|rescue therapy|rescue therapy
587221|NCT00531180|Esophageal Cancer|esophageal cancer
587222|NCT00531180|Lung Cancer|lung cancer
587223|NCT00531180|Thoracic Malignancies|thoracic malignancies
587224|NCT00531180|4D CT scans|4d ct scans
587225|NCT00531180|Lung Function|lung function
587226|NCT00531193|Healthy male volunteers|healthy male volunteers
587227|NCT00531219|appendicitis|appendicitis
587228|NCT00531219|cholelithiasis|cholelithiasis
587229|NCT00531219|gallstones|gallstones
587230|NCT00531232|Previously treated Myelodysplastic Syndromes (MDS)|previously treated myelodysplastic syndromes (mds)
587231|NCT00531232|oral clofarabine|oral clofarabine
587232|NCT00531232|Intermediate-1, Intermediate-2 and High Risk Myelodysplastic Syndromes (MDS)|intermediate-1, intermediate-2 and high risk myelodysplastic syndromes (mds)
587233|NCT00531232|secondary AML (with history of MDS)|secondary aml (with history of mds)
587234|NCT00531245|TS-1 and oxaliplatin|ts-1 and oxaliplatin
587235|NCT00531245|Phase I/II study|phase i/ii study
587236|NCT00531245|Colorectal cancer|colorectal cancer
587237|NCT00531245|First line treatment|first line treatment
587238|NCT00531258|Depression|depression
587240|NCT00531258|TMS|tms
752175|NCT01172028|recurrent prostate cancer|recurrent prostate cancer
587241|NCT00531258|Major Depression resulting from a mild to moderate closed head injury|major depression resulting from a mild to moderate closed head injury
587242|NCT00531284|Non-small cell lung carcinoma|non-small cell lung carcinoma
587243|NCT00531284|Small-cell lung carcinoma|small-cell lung carcinoma
587244|NCT00531284|Ovarian Cancer|ovarian cancer
587245|NCT00531284|Renal Cancer|renal cancer
587246|NCT00531284|Other solid tumors|other solid tumors
587247|NCT00531284|multiple myeloma|multiple myeloma
587248|NCT00531284|lymphoma|lymphoma
587250|NCT00531310|allogeneic SCT|allogeneic sct
587251|NCT00531310|matched family donor|matched family donor
587252|NCT00531310|unrelated donor|unrelated donor
587253|NCT00531310|cord blood donor|cord blood donor
587254|NCT00531310|persistent disease|persistent disease
587255|NCT00531323|Pharmacokinetic|pharmacokinetic
587256|NCT00531323|TMC125|tmc125
587257|NCT00531323|Healthy volunteers|healthy volunteers
587258|NCT00531323|Efavarinz|efavarinz
587259|NCT00531336|age-related Macular degeneration|age-related macular degeneration
587260|NCT00531336|Macugen|macugen
587261|NCT00531336|Avastin|avastin
587262|NCT00531349|Endometrial Cancer|endometrial cancer
587263|NCT00531349|Anesthesia; regional|anesthesia; regional
587264|NCT00531349|cancer recurrence|cancer recurrence
587265|NCT00531349|Analgesia; opioid|analgesia; opioid
587266|NCT00531362|Atherosclerosis|atherosclerosis
587267|NCT00531362|Aspirin|aspirin
587268|NCT00531362|Resistance,|resistance,
587269|NCT00531362|Acute coronary syndromes|acute coronary syndromes
587270|NCT00531401|Non-Small-Cell Lung|non-small-cell lung
587271|NCT00531414|Asthmatic|asthmatic
587272|NCT00531414|healthy|healthy
587273|NCT00531427|Chronic pain,|chronic pain,
587274|NCT00531427|OA of the knee,|oa of the knee,
587275|NCT00531427|opioid,|opioid,
587276|NCT00531427|transdermal|transdermal
587277|NCT00531440|Renal transplantation, everolimus, Immunosuppressants|renal transplantation, everolimus, immunosuppressants
587278|NCT00531466|Spinal cord injury|spinal cord injury
587279|NCT00531492|Maternal and child health|maternal and child health
587280|NCT00531492|Developing country|developing country
587281|NCT00531492|Skin to skin care|skin to skin care
587282|NCT00531492|Newly born low birth weight infants and their mothers|newly born low birth weight infants and their mothers
587283|NCT00531492|(Delivery at University Hospital Center, Mahajanga, Madagascar)|(delivery at university hospital center, mahajanga, madagascar)
587284|NCT00531505|Obesity|obesity
587285|NCT00531518|Schizophrenia|schizophrenia
587286|NCT00531518|Bipolar disorder|bipolar disorder
587287|NCT00531518|Psychosis|psychosis
587288|NCT00531518|Prodromal psychosis|prodromal psychosis
587289|NCT00531518|Family psychoeducation|family psychoeducation
587290|NCT00531518|Supported education|supported education
587291|NCT00531518|Supported employment|supported employment
587292|NCT00531518|Ulra-high-risk for psychosis|ulra-high-risk for psychosis
587293|NCT00531518|Major depression|major depression
587294|NCT00531518|Bipolar disorder, with psychotic features|bipolar disorder, with psychotic features
587295|NCT00531518|Major depression, with psychotic features|major depression, with psychotic features
587296|NCT00531518|Attenuated, prodromal psychotic symptoms|attenuated, prodromal psychotic symptoms
587297|NCT00531531|pulmonary infection|pulmonary infection
587298|NCT00531531|transmission|transmission
587299|NCT00531531|P.Aeruginosa|p.aeruginosa
587300|NCT00531531|surfaces|surfaces
587301|NCT00531557|Darunavir|darunavir
587302|NCT00531557|Euglycaemic clamp|euglycaemic clamp
587303|NCT00531557|HIV|hiv
587304|NCT00531557|Treatment Experienced|treatment experienced
587305|NCT00531570|Women with ultrasound defined complex pelvic masses|women with ultrasound defined complex pelvic masses
587306|NCT00531583|AML in 1st & 2nd complete remission w/no HLA matched related donor|aml in 1st & 2nd complete remission w/no hla matched related donor
587307|NCT00531596|Elderly|elderly
587308|NCT00531596|Non Elderly|non elderly
587309|NCT00531596|Healthy Volunteers|healthy volunteers
587310|NCT00531622|Depression|depression
587311|NCT00531622|Major Depressive Episode|major depressive episode
587312|NCT00531622|Antidepressant|antidepressant
587313|NCT00531635|Mixed hemopoietic chimerism, Fludarabine, TBI, PBSC, immunosuppression, Mycophenolate Mofetil|mixed hemopoietic chimerism, fludarabine, tbi, pbsc, immunosuppression, mycophenolate mofetil
587314|NCT00531648|Toddlers that having feeding disorders and SPD|toddlers that having feeding disorders and spd
587315|NCT00531674|Efficacy of public health intervention (nutrition)|efficacy of public health intervention (nutrition)
587316|NCT00531687|relapse|relapse
587317|NCT00531700|influenza|influenza
587318|NCT00531700|risk behaviors|risk behaviors
587319|NCT00531700|immunization|immunization
587320|NCT00531700|knowledge attitudes behaviors|knowledge attitudes behaviors
587321|NCT00531700|personally controlled health record|personally controlled health record
587322|NCT00531700|Indivo|indivo
587323|NCT00531713|hypothyroidism, quality og life, depression|hypothyroidism, quality og life, depression
587324|NCT00531739|Surgery|surgery
587325|NCT00531739|Colectomy|colectomy
587326|NCT00531739|Proctocolectomy|proctocolectomy
587327|NCT00531739|Adhesions|adhesions
587328|NCT00531765|contrast-induced-nephropathy,|contrast-induced-nephropathy,
587329|NCT00531765|cardiac cath|cardiac cath
587330|NCT00531765|creatinine|creatinine
587332|NCT00531765|nephropathy|nephropathy
587333|NCT00531778|Women with increased risk for developing ovarian cancer|women with increased risk for developing ovarian cancer
587334|NCT00531778|early detection|early detection
587335|NCT00531778|biomarker for ovarian cancer|biomarker for ovarian cancer
587336|NCT00531791|COPD|copd
587337|NCT00531791|exacerbation|exacerbation
587338|NCT00531791|fluticasone|fluticasone
587339|NCT00531791|salmeterol|salmeterol
587340|NCT00531791|steroid|steroid
587341|NCT00531830|children with PDD|children with pdd
587545|NCT00520728|Psychosis|psychosis
587342|NCT00531843|deep vein thrombosis|deep vein thrombosis
587343|NCT00531843|venous thromboembolism|venous thromboembolism
587344|NCT00531843|pulmonary embolism|pulmonary embolism
587345|NCT00531856|Kidney Transplant, Carbon Monoxide|kidney transplant, carbon monoxide
587346|NCT00531869|safewater|safewater
587347|NCT00531869|randomized|randomized
587348|NCT00531882|healthy volunteers|healthy volunteers
587349|NCT00531882|neutrophil migration|neutrophil migration
587350|NCT00531882|anti inflammatory non-steroidal agent|anti inflammatory non-steroidal agent
587351|NCT00531882|simvastatin|simvastatin
587352|NCT00531882|pioglitazone|pioglitazone
587353|NCT00531895|major depression|major depression
587354|NCT00531895|chronic headache|chronic headache
587355|NCT00531895|antidepressant|antidepressant
587356|NCT00531895|duloxetine|duloxetine
587357|NCT00531908|Growth Hormone|growth hormone
587358|NCT00531908|Epithelial sodium channel|epithelial sodium channel
587359|NCT00531908|Hypertension|hypertension
587360|NCT00531908|A Furosemide|a furosemide
587361|NCT00531908|Nasal Mucosa|nasal mucosa
587362|NCT00531921|Heart Diseases|heart diseases
587363|NCT00531921|Kidney Diseases|kidney diseases
587364|NCT00531921|Liver Diseases|liver diseases
587365|NCT00531921|Liver Failure|liver failure
587366|NCT00531921|Lung Diseases|lung diseases
587367|NCT00531921|Transplant|transplant
587368|NCT00531921|Transplantation, Homologous|transplantation, homologous
587369|NCT00531921|Rejection|rejection
587370|NCT00531921|Kidney Failure|kidney failure
587371|NCT00531947|Mental Health|mental health
587372|NCT00531947|Adolescents|adolescents
587373|NCT00531947|Major Depressive Disorder|major depressive disorder
587374|NCT00531947|Depression|depression
587375|NCT00531947|Adolescent Depression|adolescent depression
587376|NCT00531947|Pediatric Depression|pediatric depression
587377|NCT00531973|breast cancer|breast cancer
587378|NCT00531973|echocardiography|echocardiography
587379|NCT00531973|neoplasia|neoplasia
587380|NCT00531986|Monotherapy|monotherapy
587381|NCT00531986|Neuropsychological tests|neuropsychological tests
587382|NCT00531986|HIV viral load in ZNS|hiv viral load in zns
587383|NCT00531986|HIV viral load in genital|hiv viral load in genital
587480|NCT00532389|Bortezomib|bortezomib
587384|NCT00531986|Lumbar puncture and HIV viral load in ZNS|lumbar puncture and hiv viral load in zns
587385|NCT00531986|Monotherapy and compartment failure (ZNS and genital)|monotherapy and compartment failure (zns and genital)
587386|NCT00531986|ZNS viral load under monotherapy|zns viral load under monotherapy
587387|NCT00531986|Genital viral load under monotherapy|genital viral load under monotherapy
587388|NCT00531986|Neuropsychological tests (HIV Dementia)|neuropsychological tests (hiv dementia)
587389|NCT00531986|Treatment Experienced|treatment experienced
587390|NCT00531999|Raltegravir|raltegravir
587391|NCT00531999|Euglycaemic clamp|euglycaemic clamp
587392|NCT00531999|healthy volunteer|healthy volunteer
587393|NCT00532012|Rheumatoid Arthritis|rheumatoid arthritis
587394|NCT00532012|RhuDex®|rhudex®
587395|NCT00532012|Meglumine|meglumine
587396|NCT00532012|Oral Bioavailability|oral bioavailability
587397|NCT00532025|Sorafenib|sorafenib
587398|NCT00532025|NSCLC|nsclc
587399|NCT00532025|Adjuvant Treatment|adjuvant treatment
587400|NCT00532025|resected Non-Small Cell Lung Carcinoma|resected non-small cell lung carcinoma
587401|NCT00532038|Osteoarthritis|osteoarthritis
587402|NCT00532038|Pain|pain
587403|NCT00532051|cataract, lasik, laser refractive surgery|cataract, lasik, laser refractive surgery
587404|NCT00532064|Advanced Cancers|advanced cancers
587405|NCT00532064|Cardiotoxicity Detection|cardiotoxicity detection
587406|NCT00532064|Heart Damage|heart damage
587407|NCT00532064|Troponin 1 Blood Test|troponin 1 blood test
587408|NCT00532064|B-type Natriuretic Peptide Blood Test|b-type natriuretic peptide blood test
587409|NCT00532064|Questionnaire|questionnaire
587410|NCT00532064|Survey|survey
587411|NCT00532064|BNP|bnp
587412|NCT00532077|renal,|renal,
587413|NCT00532077|pharmacology,|pharmacology,
587414|NCT00532077|Osteoporosis|osteoporosis
587415|NCT00532103|Suicidal Ideation|suicidal ideation
587416|NCT00532103|Major Depressive Disorder|major depressive disorder
587417|NCT00532103|Suicide Risk|suicide risk
587418|NCT00532103|Antidepressant Medication|antidepressant medication
587419|NCT00532116|Healthy|healthy
587420|NCT00532116|Elderly|elderly
587421|NCT00532116|Non Elderly|non elderly
587422|NCT00532116|Healthy Volunteers|healthy volunteers
587423|NCT00532155|lung cancer|lung cancer
587424|NCT00532155|angiogenesis inhibitor|angiogenesis inhibitor
587425|NCT00532155|chemotherapy|chemotherapy
587426|NCT00532168|advanced HIV-infected patients|advanced hiv-infected patients
587428|NCT00532168|antiretroviral therapy|antiretroviral therapy
587429|NCT00532168|immune reconstitution|immune reconstitution
587430|NCT00532168|Treatment Naive|treatment naive
587431|NCT00532181|Health insurance|health insurance
587432|NCT00532181|Health utilization rates|health utilization rates
587433|NCT00532181|Saving Behavior|saving behavior
587434|NCT00532181|Risk aversion|risk aversion
587435|NCT00532194|ovarian cancer|ovarian cancer
587436|NCT00532194|fallopian tube cancer|fallopian tube cancer
587437|NCT00532194|primary serous peritoneal cancer|primary serous peritoneal cancer
587438|NCT00532194|gynaecological carcinoma|gynaecological carcinoma
587439|NCT00532194|randomised controlled trial|randomised controlled trial
587440|NCT00532194|Cediranib|cediranib
587441|NCT00532194|AZD2171|azd2171
587442|NCT00532194|efficacy|efficacy
587443|NCT00532220|osteonecrosis|osteonecrosis
587444|NCT00532220|bone marrow edema|bone marrow edema
587445|NCT00532220|ibandronate|ibandronate
587446|NCT00532220|bisphosphonate|bisphosphonate
587447|NCT00532220|knee|knee
587448|NCT00532233|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
587449|NCT00532259|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
587450|NCT00532259|Transformed Follicular Lymphoma|transformed follicular lymphoma
587451|NCT00532259|Stem cell transplantation|stem cell transplantation
587452|NCT00532259|Relapsed|relapsed
587453|NCT00532259|Refractory|refractory
587454|NCT00532298|Fluarix|fluarix
587455|NCT00532298|Influenza Infection|influenza infection
587456|NCT00532298|GSK Biologicals' influenza vaccine GSK576389A|gsk biologicals' influenza vaccine gsk576389a
587457|NCT00532311|Hyperlipidemia|hyperlipidemia
587458|NCT00532311|Drug Therapy|drug therapy
587459|NCT00532324|Methicillin resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
587460|NCT00532324|Staphylococcus aureus|staphylococcus aureus
587461|NCT00532324|Healthy term and near term neonates|healthy term and near term neonates
587462|NCT00532324|Prevention|prevention
587463|NCT00532324|Nasal and Vaginal Colonization rates|nasal and vaginal colonization rates
587464|NCT00532324|Pregnant women|pregnant women
587465|NCT00532337|ONO-5334|ono-5334
587466|NCT00532337|osteoporosis|osteoporosis
587467|NCT00532337|osteopenia|osteopenia
587468|NCT00532350|COPD|copd
587469|NCT00532350|pharmacokinetics|pharmacokinetics
587470|NCT00532350|plethysmography|plethysmography
587471|NCT00532350|cycle ergometry|cycle ergometry
587472|NCT00532350|exercise testing|exercise testing
587473|NCT00532350|spirometry|spirometry
587474|NCT00532376|epilepsy|epilepsy
587475|NCT00532376|depression|depression
587476|NCT00532376|fMRI|fmri
587477|NCT00532376|emotion|emotion
587478|NCT00532389|Myeloma|myeloma
587479|NCT00532389|Multiple Myeloma|multiple myeloma
587484|NCT00532402|Breathing Gas|breathing gas
587485|NCT00532402|Propofol|propofol
587486|NCT00532415|Vitrectomy|vitrectomy
587487|NCT00532415|Visualization|visualization
587488|NCT00532467|healthy volunteers|healthy volunteers
587489|NCT00532480|Depression|depression
587490|NCT00532480|Duloxetine|duloxetine
587491|NCT00532480|fMRI|fmri
587492|NCT00532480|pictures|pictures
587493|NCT00532493|Combat Trauma|combat trauma
587494|NCT00532493|Post traumatic stress disorder|post traumatic stress disorder
587495|NCT00532493|PTSD|ptsd
587496|NCT00532493|Sleep Disturbance|sleep disturbance
587497|NCT00532493|Trauma-Related Nightmares|trauma-related nightmares
587498|NCT00520520|post resuscitation|post resuscitation
587499|NCT00520520|post ventricular fibrillation|post ventricular fibrillation
587500|NCT00520520|patients receiving mild therapeutic hypothermia|patients receiving mild therapeutic hypothermia
587501|NCT00520533|Clinical trials|clinical trials
587502|NCT00520533|cG250 mAb|cg250 mab
587503|NCT00520533|monoclonal antibody G250|monoclonal antibody g250
587504|NCT00520533|sunitinib|sunitinib
587505|NCT00520533|angiogenesis inhibitors|angiogenesis inhibitors
587506|NCT00520533|Positron-Emission Tomography|positron-emission tomography
587507|NCT00520533|Pharmacokinetics|pharmacokinetics
587508|NCT00520533|Pharmacodynamics|pharmacodynamics
587510|NCT00520546|MRI|mri
587511|NCT00520546|Choline|choline
587512|NCT00520546|FEC|fec
587513|NCT00520546|prostate cancer|prostate cancer
587514|NCT00520572|Rheumatoid Arthritis|rheumatoid arthritis
587515|NCT00520585|atorvastatin|atorvastatin
587516|NCT00520585|repolarisation|repolarisation
587517|NCT00520585|cardiomyocytes|cardiomyocytes
587518|NCT00520611|Obesity|obesity
587519|NCT00520611|Weight Loss|weight loss
587520|NCT00520611|Financial Incentives|financial incentives
587521|NCT00520611|Lottery|lottery
587522|NCT00520611|Deposit|deposit
587523|NCT00520624|EIL|eil
587524|NCT00520663|Distribution,|distribution,
587525|NCT00520663|SB-649868,|sb-649868,
587526|NCT00520663|Healthy,|healthy,
587527|NCT00520663|Excretion,|excretion,
587528|NCT00520663|Sleep disturbances|sleep disturbances
587529|NCT00520663|Volunteer,|volunteer,
587530|NCT00520663|Metabolism,|metabolism,
587531|NCT00520663|Absorption,|absorption,
587532|NCT00520702|Non-Small Cell Lung Cancer|non-small cell lung cancer
587533|NCT00520702|Lung Cancer|lung cancer
587534|NCT00520702|3-Dimensional Conformal Radiation Therapy|3-dimensional conformal radiation therapy
587535|NCT00520702|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
587536|NCT00520702|3D CRT|3d crt
587537|NCT00520702|IMRT|imrt
587538|NCT00520702|NSCLC|nsclc
587539|NCT00520702|TRP|trp
587540|NCT00520702|Treatment related pneumonitis|treatment related pneumonitis
587541|NCT00520715|fluoroquinolone resistance|fluoroquinolone resistance
587542|NCT00520715|commensal flora|commensal flora
587543|NCT00520715|carriage|carriage
587544|NCT00520728|Schizophrenia|schizophrenia
587546|NCT00520728|Occupational Disengagement|occupational disengagement
587547|NCT00520728|Occupational Imbalance|occupational imbalance
587548|NCT00520741|Epilepsy|epilepsy
587549|NCT00520741|Partial Onset Seizures|partial onset seizures
587550|NCT00520741|Lacosamide|lacosamide
587551|NCT00520741|Monotherapy|monotherapy
587552|NCT00520741|Vimpat|vimpat
587553|NCT00520754|levocetirizine dihydrochloride Xyzal tablets|levocetirizine dihydrochloride xyzal tablets
587554|NCT00520767|primary systemic amyloidosis|primary systemic amyloidosis
587555|NCT00520767|light chain deposition disease|light chain deposition disease
587556|NCT00520780|Chronic Heart Failure|chronic heart failure
587557|NCT00520780|Iron deficiency|iron deficiency
587558|NCT00520780|Iron deficiency anaemia|iron deficiency anaemia
587559|NCT00520780|Anaemia|anaemia
587560|NCT00520780|Heart disease|heart disease
587561|NCT00520806|Heart failure|heart failure
587562|NCT00520806|Renal dysfunction|renal dysfunction
587563|NCT00520806|Relaxin|relaxin
587564|NCT00520806|Vasodilator|vasodilator
587565|NCT00520819|Antioxidants|antioxidants
587566|NCT00520819|Phytochemicals|phytochemicals
587567|NCT00520819|Oxidative stress|oxidative stress
587568|NCT00520819|Inflammation|inflammation
587569|NCT00520819|Endothelial function|endothelial function
587570|NCT00520832|Primary Insomnia|primary insomnia
587571|NCT00520832|Microcurrent Therapy|microcurrent therapy
587572|NCT00520832|Sleep Surveys|sleep surveys
587573|NCT00520845|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
587574|NCT00520845|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
587575|NCT00520845|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
587576|NCT00520845|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
587577|NCT00520871|Cardiovascular disease|cardiovascular disease
587578|NCT00520871|Blueberruy|blueberruy
587579|NCT00520871|Antioxidants|antioxidants
587580|NCT00520871|Oxidative stress|oxidative stress
587581|NCT00520871|Inflammation|inflammation
587582|NCT00520884|frailty|frailty
587583|NCT00520884|ghrelin|ghrelin
587584|NCT00520884|appetite|appetite
587585|NCT00520884|weight loss|weight loss
587586|NCT00520897|chronic HIV infection|chronic hiv infection
587587|NCT00520897|Human Immunodeficiency Virus|human immunodeficiency virus
587588|NCT00520897|Treatment Experienced|treatment experienced
587589|NCT00520910|Polypodium leucotomos, Ultraviolet Rays, Heliocare, calaguala, anapsos|polypodium leucotomos, ultraviolet rays, heliocare, calaguala, anapsos
587590|NCT00520910|Skin Aging and Damage|skin aging and damage
587591|NCT00520949|H.pylori|h.pylori
587592|NCT00520949|Triple therapy failure|triple therapy failure
587593|NCT00520949|Quadruple therapy|quadruple therapy
587594|NCT00520962|cardiovascular disease|cardiovascular disease
587595|NCT00520962|glucose intolerance|glucose intolerance
587596|NCT00520962|type 2 diabetes|type 2 diabetes
587597|NCT00520962|endothelial dysfunction|endothelial dysfunction
587598|NCT00520962|inflammation|inflammation
587599|NCT00520962|Age> 30 years, male and female|age> 30 years, male and female
587600|NCT00520962|Fasting glucose below 126 mg/dl|fasting glucose below 126 mg/dl
587601|NCT00520975|Trastuzumab|trastuzumab
587602|NCT00520975|Bevacizumab|bevacizumab
587603|NCT00520975|Metastatic Breast Cancer|metastatic breast cancer
587604|NCT00520975|HER2/NEU|her2/neu
587605|NCT00520988|hypertension|hypertension
587606|NCT00520988|intervention|intervention
587607|NCT00520988|disease management|disease management
587608|NCT00520988|telephone-based|telephone-based
587609|NCT00520988|Hypertension: diagnosed but uncontrolled|hypertension: diagnosed but uncontrolled
587610|NCT00521001|stage IV melanoma|stage iv melanoma
587611|NCT00521014|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
587612|NCT00521014|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
587613|NCT00521014|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
587614|NCT00521027|Debridement|debridement
587615|NCT00521027|hydrosurgery|hydrosurgery
587616|NCT00521027|Versajet|versajet
587617|NCT00521027|leg ulcer|leg ulcer
587618|NCT00521040|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
587619|NCT00521040|Xyzal tablets|xyzal tablets
587620|NCT00521053|immune|immune
587621|NCT00521053|vaccine|vaccine
587622|NCT00521053|systemic|systemic
587623|NCT00521053|Metastatic Melanoma (AJCC Stage III or IV)|metastatic melanoma (ajcc stage iii or iv)
587624|NCT00521079|Obesity|obesity
587625|NCT00521079|Bariatric surgery|bariatric surgery
587626|NCT00521079|Excess weight loss|excess weight loss
587627|NCT00521079|Vagus nerve|vagus nerve
587628|NCT00521079|Vagal blocking|vagal blocking
587629|NCT00521079|vBloc(TM) therapy|vbloc(tm) therapy
587630|NCT00521092|Treatment Experienced|treatment experienced
587631|NCT00521105|Type 1 Diabetes|type 1 diabetes
587632|NCT00521105|Telemedicine|telemedicine
587633|NCT00521105|Children|children
587634|NCT00521131|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
587635|NCT00521131|Xyzal tablets|xyzal tablets
587636|NCT00521157|Substance abuse|substance abuse
587637|NCT00521157|Opiate dependency|opiate dependency
587638|NCT00521157|Treatment|treatment
587639|NCT00521157|Relapse prevention|relapse prevention
587640|NCT00521170|Levocetirizine|levocetirizine
587641|NCT00521170|Wheal and flare|wheal and flare
587642|NCT00521170|Allergic|allergic
587643|NCT00521183|adult tumors metastatic to brain|adult tumors metastatic to brain
587644|NCT00521196|migraine|migraine
587645|NCT00521196|headache|headache
587646|NCT00521196|chronic|chronic
587647|NCT00521196|pain|pain
587648|NCT00521196|brain|brain
587649|NCT00521196|neurology|neurology
587650|NCT00521196|stimulation|stimulation
587651|NCT00521196|noninvasive|noninvasive
587652|NCT00521196|transcranial|transcranial
587653|NCT00521196|direct|direct
587654|NCT00521196|current|current
587655|NCT00521196|tDCS|tdcs
587656|NCT00521196|tms|tms
587657|NCT00521196|rTMS|rtms
587658|NCT00521196|BIDMC|bidmc
587659|NCT00521209|Impoverished Population|impoverished population
587660|NCT00521222|asthma|asthma
587661|NCT00521222|beta agonist|beta agonist
587662|NCT00521222|bronchodilator|bronchodilator
587663|NCT00521222|pulmonary|pulmonary
587664|NCT00521222|genotype|genotype
587665|NCT00521222|pharmacogenomics|pharmacogenomics
587666|NCT00521222|corticosteroid|corticosteroid
587667|NCT00521222|allergy|allergy
587668|NCT00521222|immunology|immunology
587669|NCT00521235|risk factors|risk factors
587670|NCT00521235|metabolic syndrome|metabolic syndrome
587671|NCT00521235|dentists|dentists
587672|NCT00521235|trainers|trainers
587673|NCT00521235|Healthy subjects|healthy subjects
587674|NCT00521235|students|students
587675|NCT00521235|seniors|seniors
587676|NCT00521248|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
587677|NCT00521248|buprenorphine|buprenorphine
587678|NCT00521248|neonatal|neonatal
587679|NCT00521248|opioid withdrawal|opioid withdrawal
587680|NCT00521261|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
587681|NCT00521261|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
587682|NCT00521261|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
587683|NCT00521261|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
588130|NCT00532753|health|health
587684|NCT00521261|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
587685|NCT00521261|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
587686|NCT00521261|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
587687|NCT00521261|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
587688|NCT00521261|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
587689|NCT00521261|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
587690|NCT00521261|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
587691|NCT00521261|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
587692|NCT00521261|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
587693|NCT00521261|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
587694|NCT00521261|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
587695|NCT00521261|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
587696|NCT00521261|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
587697|NCT00521261|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
587698|NCT00521274|Progressive Hormone Refractory Prostate Cancer|progressive hormone refractory prostate cancer
587699|NCT00521274|HRPC|hrpc
587700|NCT00521274|MVA 5T4|mva 5t4
587701|NCT00521274|Trovax®|trovax®
587702|NCT00521274|Docetaxel|docetaxel
587703|NCT00521274|M3thodist|m3thodist
587704|NCT00521287|Immunologic Surveillance|immunologic surveillance
587705|NCT00521287|Vaccination|vaccination
587706|NCT00521287|Immunotherapy|immunotherapy
587707|NCT00521287|Dendritic Cells|dendritic cells
587708|NCT00521300|Acromegaly|acromegaly
587709|NCT00521326|doppler|doppler
587710|NCT00521326|coronary stenosis|coronary stenosis
587711|NCT00521326|non-invasive testing|non-invasive testing
587712|NCT00521326|A prospective study of a new diagnostic method.|a prospective study of a new diagnostic method.
587713|NCT00521326|Study consists of a transthoracic doppler of LAD.|study consists of a transthoracic doppler of lad.
587714|NCT00521326|Doppler to be performed prior to coronary angiography.|doppler to be performed prior to coronary angiography.
587715|NCT00521326|F/U doppler examination for those who undergo PCI.|f/u doppler examination for those who undergo pci.
751755|NCT01164592|Adaptive Servoventilation (ASV)|adaptive servoventilation (asv)
587716|NCT00521326|Doppler results will be compared with coronary angiography.|doppler results will be compared with coronary angiography.
587718|NCT00521339|Psoriasis,|psoriasis,
587719|NCT00521339|PASI-75,|pasi-75,
587720|NCT00521339|sPGA|spga
587721|NCT00521352|TMS|tms
587722|NCT00521352|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
587723|NCT00521365|Bipolar Disorder|bipolar disorder
587724|NCT00521365|Bipolar Affective Psychosis|bipolar affective psychosis
587725|NCT00521365|Mania|mania
587726|NCT00521365|Manic Disorder|manic disorder
587727|NCT00521365|Manic State|manic state
587728|NCT00521378|Diabetes|diabetes
587729|NCT00521378|Type 1 and Type 2 Diabetes|type 1 and type 2 diabetes
587730|NCT00521391|smoking cessation|smoking cessation
587731|NCT00521391|nicotine|nicotine
587732|NCT00521391|physical activity|physical activity
587733|NCT00521404|Pancreatic cancer|pancreatic cancer
587734|NCT00521404|chemotherapy naive|chemotherapy naive
587735|NCT00521404|unresectable or metastatic pancreatic cancer|unresectable or metastatic pancreatic cancer
587736|NCT00521404|CS1008|cs1008
587737|NCT00521404|Gemcitabine|gemcitabine
587738|NCT00521404|Gemzar|gemzar
587739|NCT00521417|RCT|rct
587740|NCT00521430|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
587741|NCT00521430|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
587742|NCT00521430|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
587743|NCT00521430|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
587744|NCT00521430|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
587745|NCT00521430|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
587746|NCT00521430|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
587747|NCT00521430|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
587748|NCT00521430|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
587749|NCT00521430|aplastic anemia|aplastic anemia
587750|NCT00521430|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
587751|NCT00521430|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
587752|NCT00521430|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
587753|NCT00521430|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
587754|NCT00521430|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
587755|NCT00521430|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
587756|NCT00521430|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
587757|NCT00521430|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
587758|NCT00521430|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
587830|NCT00521560|stem cell transplantation|stem cell transplantation
587759|NCT00521430|refractory anemia with excess blasts|refractory anemia with excess blasts
587760|NCT00521430|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
587761|NCT00521430|refractory anemia|refractory anemia
587762|NCT00521430|refractory multiple myeloma|refractory multiple myeloma
587763|NCT00521430|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
587764|NCT00521430|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
587765|NCT00521430|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
587766|NCT00521430|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
587767|NCT00521430|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
587768|NCT00521430|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
587769|NCT00521430|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
587770|NCT00521430|anaplastic large cell lymphoma|anaplastic large cell lymphoma
587771|NCT00521430|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
587772|NCT00521430|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
587773|NCT00521430|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
587774|NCT00521430|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
587775|NCT00521430|Waldenström macroglobulinemia|waldenström macroglobulinemia
587776|NCT00521430|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
587777|NCT00521430|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
587778|NCT00521430|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
587779|NCT00521430|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
587780|NCT00521430|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
587781|NCT00521430|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
587782|NCT00521430|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
587783|NCT00521430|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
587784|NCT00521430|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
587785|NCT00521430|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
587786|NCT00521430|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
587787|NCT00521430|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
587788|NCT00521430|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
587789|NCT00521430|stage I multiple myeloma|stage i multiple myeloma
587790|NCT00521430|stage II multiple myeloma|stage ii multiple myeloma
587791|NCT00521430|stage III multiple myeloma|stage iii multiple myeloma
587792|NCT00521430|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
587793|NCT00521430|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
587794|NCT00521430|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
587795|NCT00521430|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
587796|NCT00521430|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
587797|NCT00521430|splenic marginal zone lymphoma|splenic marginal zone lymphoma
587798|NCT00521430|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
587799|NCT00521430|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
587800|NCT00521430|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
587801|NCT00521430|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
587802|NCT00521430|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
587803|NCT00521430|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
587804|NCT00521430|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
587805|NCT00521469|Disequilibrium|disequilibrium
587806|NCT00521469|Spinal Manipulation|spinal manipulation
587807|NCT00521469|Postural control|postural control
587808|NCT00521482|recurrent|recurrent
587809|NCT00521482|after standard therapy|after standard therapy
587810|NCT00521495|static magnetic field|static magnetic field
587811|NCT00521495|permanent magnet|permanent magnet
587812|NCT00521495|carpal tunnel syndrome|carpal tunnel syndrome
587813|NCT00521495|median nerve|median nerve
587815|NCT00521508|kidney|kidney
587816|NCT00521508|Berger'disease|berger'disease
587817|NCT00521508|regulatory T cells|regulatory t cells
587818|NCT00521508|pathogenesis of Berger's disease|pathogenesis of berger's disease
587819|NCT00521534|Sleep related Breathing Disorder|sleep related breathing disorder
587820|NCT00521534|Congestive Heart Failure|congestive heart failure
587821|NCT00521534|Atrial Overdrive Pacing|atrial overdrive pacing
587822|NCT00521534|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
587823|NCT00521547|Acupuncture|acupuncture
587824|NCT00521547|Analgesia|analgesia
587946|NCT00522015|dementia|dementia
587825|NCT00521547|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
587826|NCT00521547|Neuronal Mechanisms|neuronal mechanisms
587827|NCT00521547|Quantitative Peripheral Sensory Testings|quantitative peripheral sensory testings
587828|NCT00521547|Normal Volunteers|normal volunteers
587829|NCT00521560|High-Dose Radio-Immuno- and Chemotherapy|high-dose radio-immuno- and chemotherapy
587831|NCT00521560|90Y-Ibritumomab-Tiuxetan|90y-ibritumomab-tiuxetan
587832|NCT00521586|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
587833|NCT00521612|sevoflurane|sevoflurane
587834|NCT00521612|isoflurane|isoflurane
587835|NCT00521612|anaesthesia|anaesthesia
587836|NCT00521651|Physical Activity|physical activity
587837|NCT00521651|Cancer Risk|cancer risk
587838|NCT00521664|proof of safety and cost effectiveness of the new therapeutic platelet transfusion strategy|proof of safety and cost effectiveness of the new therapeutic platelet transfusion strategy
587839|NCT00521677|VAP|vap
587840|NCT00521677|Oral care|oral care
587841|NCT00521677|Acquired pneumonia|acquired pneumonia
587842|NCT00521677|Mortality|mortality
587843|NCT00521677|LOS in ICU|los in icu
587844|NCT00521677|LOS in hospital|los in hospital
587845|NCT00521677|All patients on ventilator in the ICU|all patients on ventilator in the icu
587846|NCT00521703|endoscopy, gastrointestinal|endoscopy, gastrointestinal
587847|NCT00521703|lidocaine|lidocaine
587848|NCT00521703|propofol|propofol
587850|NCT00521703|adolescent|adolescent
587851|NCT00521716|Hip Prosthesis Implantation|hip prosthesis implantation
587852|NCT00521729|Thyroid|thyroid
587853|NCT00521729|Thermoregulation|thermoregulation
587854|NCT00521729|Catecholamines|catecholamines
587855|NCT00521729|Energy Expenditure|energy expenditure
587856|NCT00521729|Obesity|obesity
587857|NCT00521729|Healthy Volunteer|healthy volunteer
587858|NCT00521729|HV|hv
587859|NCT00521742|Glucose Metabolism Disorder|glucose metabolism disorder
587860|NCT00521742|Dysmetabolic Syndrome|dysmetabolic syndrome
587861|NCT00521742|Type II Diabetes|type ii diabetes
587862|NCT00521742|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
587863|NCT00521742|Dyslipidemia|dyslipidemia
587864|NCT00521742|Drug Therapy|drug therapy
587865|NCT00521755|Laser bonding soft tissue albumin|laser bonding soft tissue albumin
587866|NCT00521768|Post traumatic stress disorder|post traumatic stress disorder
587867|NCT00521768|Anxiety disorder|anxiety disorder
587868|NCT00521768|Comunity base intervention|comunity base intervention
587869|NCT00521768|Education|education
587870|NCT00521768|Behavioural treatment|behavioural treatment
587871|NCT00521781|Unresectable or Metastatic Adenocarcinoma Prostate Cancer|unresectable or metastatic adenocarcinoma prostate cancer
587872|NCT00521781|Hormonal Therapy|hormonal therapy
587873|NCT00521781|Abraxane|abraxane
587874|NCT00521781|M3thodist|m3thodist
587875|NCT00521794|Arrhythmia|arrhythmia
587876|NCT00521794|Muscle Weakness|muscle weakness
587877|NCT00521794|Periodic Paralysis|periodic paralysis
587878|NCT00521794|Channelopathy|channelopathy
587879|NCT00521807|Hypnosis,|hypnosis,
587880|NCT00521807|Chronic widespread pain,|chronic widespread pain,
587881|NCT00521807|CWP,|cwp,
587882|NCT00521807|General Practice|general practice
587883|NCT00521820|Glucose Metabolism Disorder|glucose metabolism disorder
587884|NCT00521820|Dysmetabolic Syndrome|dysmetabolic syndrome
587885|NCT00521820|Type II Diabetes|type ii diabetes
587886|NCT00521820|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
587887|NCT00521820|Dyslipidemia|dyslipidemia
587888|NCT00521820|Drug Therapy|drug therapy
587889|NCT00521833|Kataract|kataract
587890|NCT00521833|Astigmatism|astigmatism
587891|NCT00521833|phacoemulsification|phacoemulsification
587892|NCT00521859|Hematologic Malignancies|hematologic malignancies
587893|NCT00521859|Leukemia|leukemia
587894|NCT00521859|Lymphoma|lymphoma
587895|NCT00521859|Myeloma|myeloma
587896|NCT00521859|Hodgkin's Disease|hodgkin's disease
587897|NCT00521859|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
587898|NCT00521859|Cloretazine|cloretazine
587899|NCT00521859|VNP40101M|vnp40101m
587900|NCT00521859|Fludarabine|fludarabine
587901|NCT00521859|Fludarabine Phosphate|fludarabine phosphate
587902|NCT00521859|Fludara|fludara
587903|NCT00521859|ATG|atg
587904|NCT00521859|Antithymocyte|antithymocyte
587905|NCT00521859|Thymoglobulin|thymoglobulin
587906|NCT00521872|surgery (STARR operation)|surgery (starr operation)
587907|NCT00521885|Bleeding rates|bleeding rates
587908|NCT00521885|Prophylaxis for deep vein thrombosis|prophylaxis for deep vein thrombosis
587909|NCT00521898|Corneal transplantation, Descemet membrane|corneal transplantation, descemet membrane
587910|NCT00521911|Intervention Studies|intervention studies
587911|NCT00521911|Randomized Controlled Trials|randomized controlled trials
587912|NCT00521911|Cognitive Therapy|cognitive therapy
587913|NCT00521911|Hospitals, General|hospitals, general
587914|NCT00521911|Prevalence|prevalence
587915|NCT00521950|Pharmacogenetics|pharmacogenetics
587916|NCT00521950|Cost Effectiveness|cost effectiveness
587917|NCT00521950|Inflammatory Bowel Diseases|inflammatory bowel diseases
587918|NCT00521950|Crohn Disease|crohn disease
587919|NCT00521950|Ulcerative Colitis|ulcerative colitis
587920|NCT00521950|Randomized Controlled Trials|randomized controlled trials
587921|NCT00521963|Intraarticular injection|intraarticular injection
587922|NCT00521963|Infliximab|infliximab
587923|NCT00521976|Risk assessment|risk assessment
587924|NCT00521976|Chest pain|chest pain
587925|NCT00521976|Coronary Artery Disease|coronary artery disease
587926|NCT00521976|Acute coronary syndromes|acute coronary syndromes
587927|NCT00521976|Factor XIIa|factor xiia
587928|NCT00521976|B-type natriuretic peptide (BNP)|b-type natriuretic peptide (bnp)
587929|NCT00521976|high-sensitive C-reactive protein (hsCRP)|high-sensitive c-reactive protein (hscrp)
587930|NCT00521976|Omega-3|omega-3
587931|NCT00521989|Osteoarthritis|osteoarthritis
587932|NCT00521989|Knee|knee
587933|NCT00521989|CRx-102|crx-102
587934|NCT00521989|prednisolone|prednisolone
587935|NCT00521989|dipyridamole|dipyridamole
587936|NCT00521989|CombinatoRx|combinatorx
587937|NCT00521989|WOMAC|womac
587938|NCT00522002|Connective tissue diseases|connective tissue diseases
587939|NCT00522002|Blood coagulation disorders|blood coagulation disorders
587940|NCT00522002|Leg ulcers|leg ulcers
587941|NCT00522002|Rheumatoid Arthritis|rheumatoid arthritis
587942|NCT00522002|Systemic Lupus Erythematosus|systemic lupus erythematosus
587943|NCT00522002|Systemic Scleroderma|systemic scleroderma
587944|NCT00522002|Mixed Connective Tissue Disease|mixed connective tissue disease
587947|NCT00522015|neuropsychology|neuropsychology
587948|NCT00522015|treatment|treatment
587949|NCT00522028|QoL|qol
587950|NCT00522028|Osteodensitometry|osteodensitometry
587951|NCT00522028|Arterial pressure|arterial pressure
587952|NCT00522028|PTH|pth
587953|NCT00522041|Pain associated with chronic anal fissure|pain associated with chronic anal fissure
587954|NCT00522054|Exercise|exercise
587955|NCT00522054|Physical function|physical function
587956|NCT00522054|Rheumatoid arthritis|rheumatoid arthritis
587957|NCT00522054|Tai Chi|tai chi
587958|NCT00522067|influenza|influenza
587959|NCT00522067|influenza vaccine|influenza vaccine
587960|NCT00522067|adjuvanted influenza vaccine|adjuvanted influenza vaccine
587961|NCT00522067|subunit influenza vaccine|subunit influenza vaccine
587962|NCT00522067|surface antigen|surface antigen
587963|NCT00522093|constipation|constipation
587964|NCT00522106|Behavioral graded activity|behavioral graded activity
587965|NCT00522106|Hip|hip
587966|NCT00522106|Knee|knee
587967|NCT00522106|Physical therapy|physical therapy
587968|NCT00522106|Exercise therapy|exercise therapy
587969|NCT00522119|Essential Hypertension|essential hypertension
587970|NCT00522119|High Blood Pressure|high blood pressure
587971|NCT00522132|intravenous artesunate|intravenous artesunate
587972|NCT00522132|severe malaria|severe malaria
587973|NCT00522132|Plasmodium falciparum|plasmodium falciparum
587974|NCT00522132|Africa|africa
587975|NCT00522132|Severe Plasmodium falciparum Malaria|severe plasmodium falciparum malaria
587976|NCT00522145|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
587977|NCT00522171|Harmonic|harmonic
587978|NCT00522171|Massive Weight Loss|massive weight loss
587979|NCT00522171|Electro Surgery|electro surgery
587980|NCT00522171|Skin and Fat Redundancy after massive weight loss|skin and fat redundancy after massive weight loss
587981|NCT00522171|Obesity|obesity
587982|NCT00522184|intra-articular injection|intra-articular injection
587983|NCT00522184|acute synovitis|acute synovitis
587984|NCT00522184|etanercept|etanercept
587985|NCT00522197|non-small cell lung cancer|non-small cell lung cancer
588465|NCT00537355|allergic|allergic
587986|NCT00522197|small cell lung cancer|small cell lung cancer
587987|NCT00522197|squamous lung dysplasia|squamous lung dysplasia
587988|NCT00522210|type 1 diabetes|type 1 diabetes
587989|NCT00522210|children|children
587990|NCT00522210|long acting insulin analogue|long acting insulin analogue
587991|NCT00522210|hemoglobin A1c|hemoglobin a1c
587992|NCT00522223|Cervical Cancer|cervical cancer
587993|NCT00522223|Cancer Survivors|cancer survivors
587994|NCT00522223|Cervix Cancer|cervix cancer
587995|NCT00522223|Sexual Functioning|sexual functioning
587996|NCT00522223|Quality Of Life|quality of life
587997|NCT00522223|Questionnaire|questionnaire
587998|NCT00522223|Radiation Therapy|radiation therapy
587999|NCT00522223|Radical Hysterectomy|radical hysterectomy
588000|NCT00522236|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
588001|NCT00522249|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
588002|NCT00522249|RCC|rcc
588003|NCT00522249|M3thodist|m3thodist
588004|NCT00522249|Pegylated Alfa Interferon|pegylated alfa interferon
588005|NCT00522249|Sunitinib|sunitinib
588006|NCT00522249|Tarceva|tarceva
588007|NCT00522249|Peg IFN|peg ifn
588008|NCT00522262|Breast Neoplasms|breast neoplasms
588009|NCT00522262|Exercise|exercise
588010|NCT00522262|Physical activity|physical activity
588011|NCT00522262|Estrone|estrone
588012|NCT00522262|Estradiol|estradiol
588013|NCT00522262|Adiposity|adiposity
588014|NCT00522262|Breast density|breast density
588015|NCT00522262|Mammographic density|mammographic density
588016|NCT00522262|Insulin-Like Growth Factor I|insulin-like growth factor i
588017|NCT00522262|Insulin Resistance|insulin resistance
588018|NCT00522262|Women|women
588019|NCT00522262|Postmenopause|postmenopause
588020|NCT00522275|Adjunctive treatment in epilepsy|adjunctive treatment in epilepsy
588021|NCT00522275|add-on treatment for epilepsy|add-on treatment for epilepsy
588022|NCT00522275|partial seizures|partial seizures
588023|NCT00522275|AEDs|aeds
588024|NCT00522275|antiepileptic drugs|antiepileptic drugs
588025|NCT00522275|seizures|seizures
588026|NCT00522288|Myopia|myopia
588027|NCT00522288|Self-Perception|self-perception
588028|NCT00522288|Contact Lenses|contact lenses
588029|NCT00522288|Glasses|glasses
588030|NCT00522288|Randomized|randomized
588031|NCT00522288|Children|children
588032|NCT00522288|Self-esteem|self-esteem
588033|NCT00522301|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
588034|NCT00522301|fallopian tube cancer|fallopian tube cancer
588035|NCT00522301|primary peritoneal cavity cancer|primary peritoneal cavity cancer
588036|NCT00522301|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
588037|NCT00522301|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
588038|NCT00522301|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
588614|NCT00538083|Cocoa|cocoa
588039|NCT00522301|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
588040|NCT00522314|Non-invasive ventilation|non-invasive ventilation
588041|NCT00522314|Airway clearance|airway clearance
588042|NCT00522314|Bronchiectasis|bronchiectasis
588043|NCT00522327|Immigrant|immigrant
588044|NCT00522327|Interpreting|interpreting
588045|NCT00522340|Implantable Cardioverter Defibrillators|implantable cardioverter defibrillators
588046|NCT00522340|ICD|icd
588047|NCT00522340|Exercise|exercise
588048|NCT00522340|Cardiac|cardiac
588049|NCT00522340|Inflammation|inflammation
588050|NCT00522353|obesity|obesity
588051|NCT00522353|weight loss|weight loss
588052|NCT00522353|satiety hormones|satiety hormones
588053|NCT00522353|body composition|body composition
588054|NCT00522353|appetite ratings|appetite ratings
588055|NCT00522379|Parkinson's disease|parkinson's disease
588056|NCT00522379|rotigotine|rotigotine
588057|NCT00522379|patch|patch
588058|NCT00522379|transdermal|transdermal
588059|NCT00522379|dopamine agonist|dopamine agonist
588060|NCT00522379|off time|off time
588061|NCT00522379|Neupro|neupro
588062|NCT00522392|Consolidation therapy|consolidation therapy
588063|NCT00522392|First-line therapy|first-line therapy
588064|NCT00522392|Proteasome inhibitor|proteasome inhibitor
588065|NCT00522392|Thalidomide analogue|thalidomide analogue
588066|NCT00522392|Quality of life|quality of life
588067|NCT00522405|Transarterial chemoembolisation|transarterial chemoembolisation
588068|NCT00522405|Thalidomide|thalidomide
588069|NCT00522405|Capecitabine|capecitabine
588070|NCT00522405|Treatment|treatment
588071|NCT00522418|Epilepsy|epilepsy
588072|NCT00522418|VNS Therapy|vns therapy
588073|NCT00522431|Hypogonadism|hypogonadism
588074|NCT00532532|Multiple sclerosis|multiple sclerosis
588075|NCT00532558|Hyperlipidemia|hyperlipidemia
588076|NCT00532558|Drug Therapy|drug therapy
588078|NCT00532571|PSP|psp
588079|NCT00532571|CBD|cbd
588080|NCT00532584|COPD|copd
588081|NCT00532584|inhaled steroids|inhaled steroids
588082|NCT00532584|bronchodilator|bronchodilator
588083|NCT00532584|gene expression|gene expression
588084|NCT00532584|smoker's lungs|smoker's lungs
588085|NCT00532597|Vascular Endothelium-Dependent Relaxation|vascular endothelium-dependent relaxation
588086|NCT00532597|Hemodialysis|hemodialysis
588566|NCT00537797|18FDG|18fdg
588087|NCT00532597|Hemodiafiltration|hemodiafiltration
588088|NCT00532610|Diabetes,|diabetes,
588089|NCT00532610|ECG,|ecg,
588090|NCT00532610|Healthy Volunteers|healthy volunteers
588091|NCT00532610|GSK189075,|gsk189075,
588092|NCT00532636|Airway|airway
588093|NCT00532636|Airway obstruction|airway obstruction
588094|NCT00532636|Mouth-to-mask resuscitation|mouth-to-mask resuscitation
588095|NCT00532636|Respiration artificial|respiration artificial
588096|NCT00532636|Ventilation|ventilation
588097|NCT00532636|Ventilation of an unprotected airway|ventilation of an unprotected airway
588098|NCT00532636|Safety and efficiency of mask ventilation|safety and efficiency of mask ventilation
588099|NCT00532636|Avoidance of stomach inflation|avoidance of stomach inflation
588100|NCT00532662|Epidural|epidural
588101|NCT00532662|Intravenous|intravenous
588102|NCT00532662|Ketamine|ketamine
588103|NCT00532662|Analgesia|analgesia
588104|NCT00532662|Caudal|caudal
588105|NCT00532662|Pediatric|pediatric
588106|NCT00532662|Regional|regional
588107|NCT00532662|Local Anesthetics|local anesthetics
588108|NCT00532675|Myeloma|myeloma
588109|NCT00532675|Multiple Myeloma|multiple myeloma
588110|NCT00532675|Lenalidomide|lenalidomide
588111|NCT00532675|Revlimid|revlimid
588112|NCT00532675|Dexamethasone|dexamethasone
588113|NCT00532675|LBH589|lbh589
588114|NCT00532675|Combination|combination
588115|NCT00532688|acetylcysteine|acetylcysteine
588116|NCT00532688|N-acetylcysteine|n-acetylcysteine
588117|NCT00532688|heart failure|heart failure
588118|NCT00532688|renal failure|renal failure
588119|NCT00532701|Chronic hepatitis C|chronic hepatitis c
588120|NCT00532701|Genotype|genotype
588121|NCT00532701|Interferon|interferon
588122|NCT00532701|Ribavirin|ribavirin
588123|NCT00532701|Genotype 2|genotype 2
588124|NCT00532701|Peginterferon|peginterferon
588125|NCT00532727|Breast Cancer|breast cancer
588126|NCT00532727|Triple Negative|triple negative
588127|NCT00532740|liver metastases|liver metastases
588128|NCT00532740|advanced adult primary liver cancer|advanced adult primary liver cancer
588129|NCT00532753|empowerment|empowerment
588132|NCT00532766|Healthy subjects|healthy subjects
588133|NCT00532779|Obesity|obesity
588134|NCT00532779|Antiobesity agents|antiobesity agents
588135|NCT00532779|Antiobesity drugs|antiobesity drugs
588136|NCT00532779|Overweight drug therapy|overweight drug therapy
588137|NCT00532779|Obese drug therapy|obese drug therapy
588138|NCT00532779|Weight loss drug effects|weight loss drug effects
588139|NCT00532779|Bupropion administration and dosage|bupropion administration and dosage
588140|NCT00532779|Naltrexone administration and dosage|naltrexone administration and dosage
588141|NCT00532779|Double blind method|double blind method
588706|NCT00538512|Influenza|influenza
588142|NCT00532779|Combination drug therapy|combination drug therapy
588143|NCT00532779|Delayed action preparations|delayed action preparations
588144|NCT00532792|Avian|avian
588145|NCT00532792|Pandemic|pandemic
588146|NCT00532792|Influenza|influenza
588147|NCT00532792|A/H5N1|a/h5n1
588148|NCT00532805|Alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
588149|NCT00532818|Epigenetic therapy|epigenetic therapy
588150|NCT00532818|Hydralazine|hydralazine
588151|NCT00532818|Valproate|valproate
588152|NCT00532818|Cervical cancer|cervical cancer
588153|NCT00532818|Randomized|randomized
588154|NCT00532818|Phase III|phase iii
588155|NCT00532844|6R-BH4|6r-bh4
588156|NCT00532844|BH4|bh4
588157|NCT00532844|BH4 deficiency|bh4 deficiency
588158|NCT00532844|sapropterin dihydrochloride|sapropterin dihydrochloride
588159|NCT00532844|endothelial dysfunction|endothelial dysfunction
588160|NCT00532844|NO|no
588161|NCT00532844|Hypertension|hypertension
588162|NCT00532844|Nitric Oxide|nitric oxide
588163|NCT00532844|Vitamin C|vitamin c
588164|NCT00536185|ALOX5|alox5
588165|NCT00536185|5-lipoxygenase|5-lipoxygenase
588166|NCT00536185|Heart Disease|heart disease
588167|NCT00536185|Blacks|blacks
588168|NCT00536198|Premenstrual Syndrome|premenstrual syndrome
588169|NCT00536211|Exercise|exercise
588170|NCT00536211|Physical Activity|physical activity
588171|NCT00536211|Metformin|metformin
588172|NCT00536211|Hyperinsulinemic-Euglycemic Clamp|hyperinsulinemic-euglycemic clamp
588173|NCT00536211|Muscle Biopsy|muscle biopsy
588174|NCT00536211|Fatty Acid Oxidation|fatty acid oxidation
751757|NCT01170338|tobacco abuse|tobacco abuse
588175|NCT00536211|Peroxisome proliferator-activated receptor gamma|peroxisome proliferator-activated receptor gamma
588176|NCT00536211|Detraining|detraining
588177|NCT00536211|Inactivity|inactivity
588178|NCT00536211|Skeletal muscle|skeletal muscle
588179|NCT00536224|Health promotion|health promotion
588180|NCT00536224|Emergency Medical Services|emergency medical services
588181|NCT00536224|Randomized controlled trial|randomized controlled trial
588182|NCT00536224|Chest pain observation unit|chest pain observation unit
588183|NCT00536224|Cardiovascular risk factors|cardiovascular risk factors
588184|NCT00536250|Pre-Diabetes|pre-diabetes
588185|NCT00536250|Childhood Obesity|childhood obesity
588186|NCT00536250|Metabolic Syndrome|metabolic syndrome
588187|NCT00536250|insulin resistance|insulin resistance
588567|NCT00537810|Obesity|obesity
588188|NCT00536250|Impaired Glucose Tolerance|impaired glucose tolerance
588189|NCT00536250|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
588190|NCT00536250|High Molecular Weight Adiponectin|high molecular weight adiponectin
588191|NCT00536250|Hypoadiponectinemia|hypoadiponectinemia
588192|NCT00536276|vitamin D|vitamin d
588193|NCT00536289|Blunt needles|blunt needles
588194|NCT00536289|obstetric lacerations|obstetric lacerations
588195|NCT00536289|Needlestick injuries|needlestick injuries
588196|NCT00536289|Needlestick injuries to physicians|needlestick injuries to physicians
588197|NCT00536302|OA|oa
588198|NCT00536302|Knee arthritis|knee arthritis
588199|NCT00536302|Osteoarthritis|osteoarthritis
588200|NCT00536302|Nutritional supplement|nutritional supplement
588201|NCT00536302|CAM|cam
588202|NCT00536302|MRI|mri
588203|NCT00536315|COPD|copd
588204|NCT00536328|Reflux Impact Scale (RIS)|reflux impact scale (ris)
588205|NCT00536328|predictive value|predictive value
588206|NCT00536328|treatment success|treatment success
588207|NCT00536328|patient satisfaction|patient satisfaction
588208|NCT00536328|proton pump inhibitor|proton pump inhibitor
588209|NCT00536328|gastro-esophageal reflux disease|gastro-esophageal reflux disease
588210|NCT00536328|PPU|ppu
588211|NCT00536341|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
588212|NCT00536341|untreated|untreated
588213|NCT00536341|minimally treated|minimally treated
588214|NCT00536341|fludarabine|fludarabine
588215|NCT00536341|rituximab|rituximab
588216|NCT00536341|lenalidomide|lenalidomide
588217|NCT00536367|Heart Failure, Congestive|heart failure, congestive
588218|NCT00536367|Mortality Prediction Model|mortality prediction model
588219|NCT00536393|diffuse larg cells lymphoma|diffuse larg cells lymphoma
588220|NCT00536393|chemotherapy|chemotherapy
588221|NCT00536393|toxicity|toxicity
588222|NCT00536393|diffuse high grade lymphoma|diffuse high grade lymphoma
588223|NCT00536406|Geriatric|geriatric
588224|NCT00536406|Nursing Homes|nursing homes
588225|NCT00536445|NAVA|nava
588226|NCT00536445|Preterm|preterm
588227|NCT00536445|Case study|case study
588228|NCT00536458|localized low grade lymphoma|localized low grade lymphoma
588229|NCT00536458|Chemotherapy|chemotherapy
588230|NCT00536458|Radiotherapy|radiotherapy
588231|NCT00536458|Molecular analyses|molecular analyses
588233|NCT00536484|Overactive Bladder|overactive bladder
588234|NCT00536497|GW842166,|gw842166,
588235|NCT00536497|Healthy volunteers,|healthy volunteers,
588236|NCT00536497|Inflammatory Pain.|inflammatory pain.
588237|NCT00536510|High Cholesterol|high cholesterol
588238|NCT00536510|Excess lipids|excess lipids
588239|NCT00536523|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
588240|NCT00536523|ovarian epithelial cancer|ovarian epithelial cancer
588810|NCT00525616|mabthera|mabthera
588241|NCT00536523|peritoneal cavity cancer|peritoneal cavity cancer
588242|NCT00536523|fallopian tube cancer|fallopian tube cancer
588243|NCT00536536|Childhood|childhood
588244|NCT00536536|Obesity|obesity
588245|NCT00536536|Primary Care|primary care
588246|NCT00536549|Glucose monitoring system|glucose monitoring system
588247|NCT00536549|life style intervention|life style intervention
588248|NCT00536562|Comprehensive Cardiac Rehabilitation|comprehensive cardiac rehabilitation
588249|NCT00536562|Randomized Controlled Trial|randomized controlled trial
588250|NCT00536562|TIA (Transient Ischemic Attack)|tia (transient ischemic attack)
588251|NCT00536562|Mild Non-Disabling Stroke|mild non-disabling stroke
588252|NCT00536562|Vascular Protection|vascular protection
588253|NCT00536575|Multiple Myeloma|multiple myeloma
588254|NCT00536575|Relapsed|relapsed
588255|NCT00536575|Refractory|refractory
588256|NCT00536575|Sorafenib|sorafenib
588257|NCT00536575|Bortezomib|bortezomib
588258|NCT00536614|pancreatic cancer|pancreatic cancer
588259|NCT00536614|metastatic|metastatic
588260|NCT00536614|EGFR|egfr
588261|NCT00536614|locally advanced pancreatic cancer|locally advanced pancreatic cancer
588262|NCT00536627|DNA vaccine|dna vaccine
588263|NCT00536640|Non Small Cell Lung Carcinoma (NSCLC Stage III an IV)|non small cell lung carcinoma (nsclc stage iii an iv)
588264|NCT00536653|prostate cancer|prostate cancer
588265|NCT00536653|bone density|bone density
588266|NCT00536653|osteoporosis|osteoporosis
588267|NCT00536653|androgen antagonists|androgen antagonists
588268|NCT00536666|Chronic kidney disease|chronic kidney disease
588269|NCT00536666|Aneamia|aneamia
588270|NCT00536666|Iron oligosaccharide|iron oligosaccharide
588271|NCT00536666|Chronic kidney disease patients|chronic kidney disease patients
588272|NCT00536679|Relative Bioavailability|relative bioavailability
588274|NCT00536679|GSK163090|gsk163090
588275|NCT00536679|Food Effect|food effect
588276|NCT00536692|macular edema|macular edema
588277|NCT00536692|DME|dme
588278|NCT00536692|diabetic|diabetic
588279|NCT00536692|mecamylamine|mecamylamine
588280|NCT00536692|Comentis|comentis
588281|NCT00536705|asthma|asthma
588282|NCT00536705|child|child
588283|NCT00536705|transforming growth factor beta(TGF-β)|transforming growth factor beta(tgf-β)
588284|NCT00536705|Leukotriene Antagonists(Montelukast)|leukotriene antagonists(montelukast)
588460|NCT00537342|Rhinoconjunctivitis|rhinoconjunctivitis
588285|NCT00536718|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
588286|NCT00536718|invasive lobular breast carcinoma|invasive lobular breast carcinoma
588287|NCT00536718|lobular breast carcinoma in situ|lobular breast carcinoma in situ
588288|NCT00536731|Asthma|asthma
588289|NCT00536731|Symbicort|symbicort
588290|NCT00536783|Psychiatry|psychiatry
588291|NCT00536783|Antipsychotic|antipsychotic
588292|NCT00536783|Psychopharmacology|psychopharmacology
588293|NCT00536783|Clinical Trial|clinical trial
588294|NCT00536783|Open Label|open label
588295|NCT00536783|Schizophrenia|schizophrenia
588296|NCT00536783|Sensory Gating|sensory gating
588297|NCT00536783|Attention|attention
588298|NCT00536783|Memory|memory
588299|NCT00536796|Hyperlipidemia|hyperlipidemia
588300|NCT00536796|Need-to-treat|need-to-treat
588301|NCT00536796|NIS|nis
588302|NCT00536796|Secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PVD, etc.) and/or diabetes|secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, pvd, etc.) and/or diabetes
588303|NCT00536809|fluoropyrimidines cancers|fluoropyrimidines cancers
588304|NCT00536809|Metastatic Colorectal Cancer|metastatic colorectal cancer
588305|NCT00536809|Advanced Colorectal Cancer|advanced colorectal cancer
588306|NCT00536809|oxaliplatin|oxaliplatin
588307|NCT00536809|lapatinib|lapatinib
588308|NCT00536809|capecitabine|capecitabine
588309|NCT00536822|rehabilitation|rehabilitation
588310|NCT00536822|pediatrics|pediatrics
588311|NCT00536835|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
588312|NCT00536835|Cancer|cancer
588313|NCT00536835|First time in human|first time in human
588314|NCT00536835|PLK1 inhibitor|plk1 inhibitor
588315|NCT00536835|Advanced Solid Tumor|advanced solid tumor
588316|NCT00536835|GSK461364|gsk461364
588317|NCT00536848|Probiotics|probiotics
588318|NCT00536848|HIV|hiv
588319|NCT00536848|AIDS|aids
588320|NCT00536848|Diarrhea|diarrhea
588321|NCT00536848|Lactobacillus rhamnosus GR-1|lactobacillus rhamnosus gr-1
588322|NCT00536848|Lactobacillus reuteri RC-14|lactobacillus reuteri rc-14
588323|NCT00536848|Immune system|immune system
588324|NCT00536848|Infectious Diseases|infectious diseases
588325|NCT00536848|Complementary Therapies|complementary therapies
588326|NCT00536848|Treatment Naive|treatment naive
588327|NCT00536861|erlotinib|erlotinib
588328|NCT00536861|cranial radiotherapy|cranial radiotherapy
588329|NCT00536874|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
588330|NCT00536874|stage IA pancreatic cancer|stage ia pancreatic cancer
588331|NCT00536874|stage IB pancreatic cancer|stage ib pancreatic cancer
588332|NCT00536874|stage IIA pancreatic cancer|stage iia pancreatic cancer
588333|NCT00536874|stage IIB pancreatic cancer|stage iib pancreatic cancer
588334|NCT00536874|stage III pancreatic cancer|stage iii pancreatic cancer
588335|NCT00536900|Substance abuse|substance abuse
588336|NCT00536900|Behavior therapy|behavior therapy
588337|NCT00536900|representative payee|representative payee
588338|NCT00536900|cocaine abuse|cocaine abuse
588339|NCT00536900|alcohol abuse|alcohol abuse
588340|NCT00536900|case management|case management
588341|NCT00536900|dual diagnosis|dual diagnosis
588342|NCT00536913|Symbicort pMDI|symbicort pmdi
588343|NCT00536913|spacer|spacer
588344|NCT00536913|children|children
588345|NCT00536926|telemedicine|telemedicine
588346|NCT00536926|lung transplantation|lung transplantation
588347|NCT00536926|home spirometry|home spirometry
588348|NCT00536952|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
588349|NCT00536952|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
588350|NCT00536952|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
588351|NCT00536952|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
588352|NCT00536952|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
588353|NCT00536952|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
588354|NCT00536952|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
588355|NCT00536952|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
588356|NCT00536952|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
588357|NCT00536952|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
588358|NCT00536952|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
588359|NCT00536952|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
588360|NCT00536952|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
588361|NCT00536952|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
588362|NCT00536952|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
588363|NCT00536965|Hyperlipidemia|hyperlipidemia
588364|NCT00536965|Need-to-treat|need-to-treat
588461|NCT00537355|ragweed|ragweed
588462|NCT00537355|ragweed allergy|ragweed allergy
588463|NCT00537355|allergy|allergy
588464|NCT00537355|allergies|allergies
588366|NCT00536965|Secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PVD, etc.) and/or diabetes|secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, pvd, etc.) and/or diabetes
588367|NCT00536978|Lymphoma|lymphoma
588368|NCT00536978|Leukemia|leukemia
588369|NCT00536978|B-Cell Lymphoid Malignancies|b-cell lymphoid malignancies
588370|NCT00536978|CLL|cll
588371|NCT00536978|Cll/Small Lymphocytic Lymphoma|cll/small lymphocytic lymphoma
588372|NCT00536978|Follicular Lymphoma|follicular lymphoma
588373|NCT00536978|Mantle Cell Lymphoma|mantle cell lymphoma
588374|NCT00536978|Diffuse Large Cell Lymphoma|diffuse large cell lymphoma
588375|NCT00536978|Splenic Lymphoma|splenic lymphoma
588376|NCT00536978|MALT|malt
588377|NCT00536978|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
588378|NCT00536978|Burkitt's Lymphoma|burkitt's lymphoma
588379|NCT00536978|ARA-C|ara-c
588380|NCT00536978|BCNU|bcnu
588381|NCT00536978|Campath-1H|campath-1h
588382|NCT00536978|Cytoxan|cytoxan
588383|NCT00536978|Etoposide|etoposide
588384|NCT00536978|Fludarabine|fludarabine
588385|NCT00536978|Melphalan|melphalan
588386|NCT00536978|Rituximab|rituximab
588387|NCT00536978|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
588388|NCT00536978|T-Cell Cell Adback|t-cell cell adback
588389|NCT00536978|Natural Killer (NK) Cell Adback|natural killer (nk) cell adback
588390|NCT00537004|primary progressive aphasia|primary progressive aphasia
588391|NCT00537004|frontotemporal dementia|frontotemporal dementia
588392|NCT00537004|semantic dementia|semantic dementia
588393|NCT00537004|progressive nonfluent aphasia|progressive nonfluent aphasia
588394|NCT00537004|progressive aphasia|progressive aphasia
588395|NCT00537004|frontotemporal lobar degeneration|frontotemporal lobar degeneration
588396|NCT00537043|hypertension,|hypertension,
588397|NCT00537043|carvedilol,|carvedilol,
588398|NCT00537043|repeat-dosing|repeat-dosing
588399|NCT00537082|FTY720,|fty720,
588400|NCT00537082|MS|ms
588401|NCT00537095|follicular|follicular
588402|NCT00537095|papillary|papillary
588403|NCT00537108|Pregnancy in adolescence|pregnancy in adolescence
588404|NCT00537121|recurrent gastric cancer|recurrent gastric cancer
588405|NCT00537121|stage IV gastric cancer|stage iv gastric cancer
588406|NCT00537121|recurrent esophageal cancer|recurrent esophageal cancer
588407|NCT00537121|stage IV esophageal cancer|stage iv esophageal cancer
588408|NCT00537121|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
588409|NCT00537121|adenocarcinoma of the stomach|adenocarcinoma of the stomach
588410|NCT00537121|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
588411|NCT00537121|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
588412|NCT00537121|stage III gastric cancer|stage iii gastric cancer
588413|NCT00537121|stage III esophageal cancer|stage iii esophageal cancer
588414|NCT00537121|advanced adult primary liver cancer|advanced adult primary liver cancer
588415|NCT00537121|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
588416|NCT00537121|recurrent adult primary liver cancer|recurrent adult primary liver cancer
588417|NCT00537134|Aneurysm|aneurysm
588418|NCT00537134|Brain|brain
588419|NCT00537134|Unruptured|unruptured
588420|NCT00537134|observation|observation
588421|NCT00537134|treatment|treatment
588422|NCT00537134|Endovascular|endovascular
588423|NCT00537147|Chimeric West Nile Virus|chimeric west nile virus
588424|NCT00537147|West Nile Virus|west nile virus
588425|NCT00537147|Dengue Virus|dengue virus
588426|NCT00537160|Pediatrics|pediatrics
588427|NCT00537186|Congestive heart failure|congestive heart failure
588428|NCT00537186|Anaemia|anaemia
588429|NCT00537186|Iron oligosaccharide|iron oligosaccharide
588430|NCT00537199|Head And Neck|head and neck
588431|NCT00537199|Oropharynx|oropharynx
588432|NCT00537199|Oral Cancer|oral cancer
588433|NCT00537199|OraTest|oratest
588434|NCT00537199|OraTest Dye|oratest dye
588435|NCT00537199|Rinse Staining Procedure|rinse staining procedure
588436|NCT00537199|Visual Examination|visual examination
588437|NCT00537212|Psoriasis|psoriasis
588438|NCT00537212|Weight loss|weight loss
588439|NCT00537212|diet|diet
588440|NCT00537225|peripheral arterial disease|peripheral arterial disease
588441|NCT00537225|walking time|walking time
588442|NCT00537225|lifestyle modification|lifestyle modification
588443|NCT00537225|cardiovascular risk reduction|cardiovascular risk reduction
588444|NCT00537225|exercise|exercise
588445|NCT00537225|diet|diet
588446|NCT00537225|claudication|claudication
588447|NCT00537238|Epilepsies partial|epilepsies partial
588448|NCT00537238|Partial Seizure Disorder|partial seizure disorder
588449|NCT00537238|Complex Partial Seizure Disorder|complex partial seizure disorder
588450|NCT00537238|Epilepsy|epilepsy
588451|NCT00537264|health-related quality of life|health-related quality of life
588452|NCT00537264|primary care|primary care
588453|NCT00537264|computer-assisted instruction|computer-assisted instruction
588454|NCT00537290|antiphospholipid syndrome|antiphospholipid syndrome
588455|NCT00537342|Immunotherapy|immunotherapy
588456|NCT00537342|Allergoid|allergoid
588457|NCT00537342|Depigmented|depigmented
588458|NCT00537342|Polymerized|polymerized
588459|NCT00537342|Allergen-extract|allergen-extract
588466|NCT00537355|seasonal allergic rhinitis|seasonal allergic rhinitis
588467|NCT00537355|allergic rhinitis|allergic rhinitis
588468|NCT00537368|infusion|infusion
588469|NCT00537368|CNTO 888|cnto 888
588470|NCT00537368|Phase 1|phase 1
588471|NCT00537368|solid tumor|solid tumor
588472|NCT00537368|cancer|cancer
588473|NCT00537381|Prostatic neoplasms|prostatic neoplasms
588474|NCT00537381|CNTO 95|cnto 95
588475|NCT00537381|Intetumumab|intetumumab
588476|NCT00537381|Docetaxel|docetaxel
588477|NCT00537381|Prednisone|prednisone
588478|NCT00537394|Treatment Experienced|treatment experienced
588479|NCT00537407|Hepatitis|hepatitis
588480|NCT00537407|Hepatitis C|hepatitis c
588481|NCT00537420|weight loss|weight loss
588482|NCT00537420|dieting|dieting
588483|NCT00537433|Medication errors|medication errors
588484|NCT00537433|Patient nonadherence|patient nonadherence
588485|NCT00537433|Literacy|literacy
588486|NCT00537433|Communication|communication
588487|NCT00537446|noninvasive ventilation|noninvasive ventilation
588488|NCT00537459|Premature ejaculation (PE) ejaculatory latency time (ELT)|premature ejaculation (pe) ejaculatory latency time (elt)
588489|NCT00537472|Bupivacaine|bupivacaine
588490|NCT00537472|spinal anesthesia|spinal anesthesia
588491|NCT00537472|total knee arthroplasty|total knee arthroplasty
588492|NCT00537485|SPM 962|spm 962
588493|NCT00537485|rotigotine|rotigotine
588494|NCT00537485|Parkinson's disease|parkinson's disease
588495|NCT00537485|monotherapy|monotherapy
588496|NCT00537498|urokinase, diabetes, wound healing, major amputation|urokinase, diabetes, wound healing, major amputation
588497|NCT00537524|Bird flu|bird flu
588498|NCT00537524|seasonal influenza vaccine|seasonal influenza vaccine
588499|NCT00537524|influenza vaccine|influenza vaccine
588500|NCT00537524|prepandemic vaccine|prepandemic vaccine
588501|NCT00537524|virus strain with the potential to cause pandemic|virus strain with the potential to cause pandemic
588502|NCT00537524|toddlers|toddlers
588503|NCT00537524|children|children
588504|NCT00537524|adolescents|adolescents
588505|NCT00537537|Hepatitis B, Chronic, Hepatitis B e Antigen positive, Adults, Telbivudine, Adefovir|hepatitis b, chronic, hepatitis b e antigen positive, adults, telbivudine, adefovir
588506|NCT00537550|ALL|all
588507|NCT00537550|Adult|adult
588508|NCT00537589|arthrocentesis|arthrocentesis
588509|NCT00537589|ultrasound|ultrasound
588510|NCT00537589|emergency|emergency
588511|NCT00537602|cystic fibrosis|cystic fibrosis
588512|NCT00537602|miglustat|miglustat
588513|NCT00537602|Zavesca|zavesca
588514|NCT00537602|Actelion|actelion
588515|NCT00537602|nasal potential difference|nasal potential difference
588516|NCT00537602|transmembrane conductance regulator (CFTR)|transmembrane conductance regulator (cftr)
588517|NCT00537641|noninvasive ventilation|noninvasive ventilation
588518|NCT00537654|benign prostatic hyperplasia,|benign prostatic hyperplasia,
588519|NCT00537654|AVODART,|avodart,
588520|NCT00537654|FLOMAX|flomax
588521|NCT00537667|IL-1ra|il-1ra
588522|NCT00537667|PEG sTNF-RI|peg stnf-ri
588523|NCT00537667|Synovial biopsy|synovial biopsy
588524|NCT00537667|Inflammation|inflammation
588525|NCT00537667|Bone and Cartilage Destruction|bone and cartilage destruction
588526|NCT00537667|Rheumatoid Arthritis|rheumatoid arthritis
588527|NCT00537680|Friedreich's Ataxia|friedreich's ataxia
588528|NCT00537680|Idebenone|idebenone
588529|NCT00537680|ICARS|icars
588530|NCT00537693|Continuous Renal Replacement Therapy (CRRT)|continuous renal replacement therapy (crrt)
588531|NCT00537693|Sepsis|sepsis
588532|NCT00537693|Convection|convection
588533|NCT00537693|Diffusion|diffusion
588534|NCT00537706|Socioeconomic Determinants|socioeconomic determinants
588535|NCT00537706|Health Status|health status
588536|NCT00537706|Low-income|low-income
588537|NCT00537706|Priority-setting|priority-setting
588538|NCT00537706|Group Discussion|group discussion
588539|NCT00537719|healthy|healthy
588540|NCT00537719|pharmacodynamics|pharmacodynamics
588541|NCT00537719|glucagon-like peptide 1|glucagon-like peptide 1
588542|NCT00537719|pharmacokinetics|pharmacokinetics
588543|NCT00537719|scintigraphy|scintigraphy
588544|NCT00537719|radiation|radiation
588545|NCT00537719|albiglutide|albiglutide
588546|NCT00537732|gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
588547|NCT00537758|binge eating disorder|binge eating disorder
588548|NCT00537758|cognitive behavior therapy|cognitive behavior therapy
588549|NCT00537758|combination therapy|combination therapy
588550|NCT00537758|obesity|obesity
588551|NCT00537758|weight loss|weight loss
588552|NCT00537758|body weight|body weight
588553|NCT00537758|clinical trial|clinical trial
588554|NCT00537758|dietary restriction|dietary restriction
588555|NCT00537758|overeating|overeating
588556|NCT00537758|weight control|weight control
588557|NCT00537771|Early Breast cancer|early breast cancer
588558|NCT00537771|adjuvant therapy|adjuvant therapy
588559|NCT00537771|hormone receptor|hormone receptor
588560|NCT00537771|hormonal therapy|hormonal therapy
588561|NCT00537771|anastrozole|anastrozole
588562|NCT00537771|tamoxifen|tamoxifen
588563|NCT00537784|platelets tendon ligament|platelets tendon ligament
588564|NCT00537797|Thyroid Neoplasms|thyroid neoplasms
588565|NCT00537797|Positron Emission Tomography|positron emission tomography
588568|NCT00537810|Binge eating|binge eating
588569|NCT00537810|Sibutramine|sibutramine
588570|NCT00537810|Self-help|self-help
588571|NCT00537810|Primary care|primary care
588572|NCT00537823|Colorectal Cancer|colorectal cancer
588573|NCT00537823|Metastasis|metastasis
588574|NCT00537823|Neoadjuvant Therapy|neoadjuvant therapy
588575|NCT00537836|Hot flushes|hot flushes
588576|NCT00537836|Therapy of hot flushes|therapy of hot flushes
588577|NCT00537836|17ß-estradiol (E2)|17ß-estradiol (e2)
588578|NCT00537836|Hormone replacement therapy|hormone replacement therapy
588579|NCT00537862|Kidney Transplant Patients|kidney transplant patients
588580|NCT00537862|Immunosuppresion|immunosuppresion
588581|NCT00537862|Enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
588582|NCT00537901|Colon and Rectum Cancer|colon and rectum cancer
588583|NCT00537914|Small for Gestational Age, Omnitrope®/Somatropin, rhGH,SGA|small for gestational age, omnitrope®/somatropin, rhgh,sga
588584|NCT00537927|laparoscopic correction|laparoscopic correction
588585|NCT00537927|ventral and incisional hernia|ventral and incisional hernia
588586|NCT00537927|mesh fixation|mesh fixation
588587|NCT00537927|postoperative pain|postoperative pain
588588|NCT00537953|Leishmaniasis|leishmaniasis
588589|NCT00537953|Cutaneous leishmaniasis|cutaneous leishmaniasis
588590|NCT00537953|Miltefosine|miltefosine
588591|NCT00537953|Glucantime|glucantime
588592|NCT00537953|Antimony|antimony
588593|NCT00537953|Pentavalent antimonials|pentavalent antimonials
588594|NCT00537953|Combination therapy|combination therapy
588595|NCT00537966|Primary HIV Infection|primary hiv infection
588596|NCT00537979|Dialysis|dialysis
588597|NCT00537979|Hyperparathyroidism|hyperparathyroidism
588598|NCT00537979|Zemplar|zemplar
588599|NCT00537992|combined surgery,|combined surgery,
588600|NCT00537992|cataract surgery,|cataract surgery,
588601|NCT00537992|vitrectomy,|vitrectomy,
588602|NCT00537992|blue light-filter iols|blue light-filter iols
588603|NCT00538005|recurrent melanoma|recurrent melanoma
588604|NCT00538005|stage IV melanoma|stage iv melanoma
588605|NCT00538044|pulmonary hypertension|pulmonary hypertension
588606|NCT00538044|simvastatin|simvastatin
588607|NCT00538044|advanced pulmonary hypertension secondary to congenital heart disease|advanced pulmonary hypertension secondary to congenital heart disease
588608|NCT00538044|advanced pulmonary hypertension secondary to chronic pulmonary embolism|advanced pulmonary hypertension secondary to chronic pulmonary embolism
588609|NCT00538057|Healthy volunteers|healthy volunteers
588610|NCT00538070|Sarcosine|sarcosine
588611|NCT00538070|Glycine|glycine
588612|NCT00538070|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
588613|NCT00538070|Schizophrenia|schizophrenia
588615|NCT00538083|Overweight adults|overweight adults
588616|NCT00538083|Endothelial function|endothelial function
588617|NCT00538083|Blood pressure|blood pressure
588618|NCT00538083|Cardiovascular disease risk|cardiovascular disease risk
588619|NCT00538083|Dark chocolate|dark chocolate
588620|NCT00538083|Sugar|sugar
588621|NCT00538096|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
588622|NCT00538109|CML in Blast Crisis|cml in blast crisis
588623|NCT00538109|Accelerated Phase oe Chronic Phase|accelerated phase oe chronic phase
588624|NCT00538122|schizophrenia|schizophrenia
588625|NCT00538122|schizoaffective disorder|schizoaffective disorder
588626|NCT00538122|bipolar disorder|bipolar disorder
588627|NCT00538122|antipsychotic drug treatment|antipsychotic drug treatment
588628|NCT00538122|safety|safety
588629|NCT00538122|arrythmias|arrythmias
588630|NCT00538135|randomised controlled trial|randomised controlled trial
588631|NCT00538135|borderline personality disorder|borderline personality disorder
588632|NCT00538135|cognitive behavioural therapy|cognitive behavioural therapy
588633|NCT00538135|treatment as usual|treatment as usual
588634|NCT00538161|Acute lung injury|acute lung injury
588635|NCT00538161|cardiac surgery|cardiac surgery
588636|NCT00538161|The incidence of ARDS after elective cardiac surgery is 1-3%|the incidence of ards after elective cardiac surgery is 1-3%
588637|NCT00538161|The impairment of lung function and oxygenation may occur in 20-80% of patients undergoing surgery.|the impairment of lung function and oxygenation may occur in 20-80% of patients undergoing surgery.
751758|NCT01170351|autoimmune hepatitis|autoimmune hepatitis
751759|NCT01170351|corticosteroids|corticosteroids
588638|NCT00538161|The purpose of this study is to assess the efficacy of low tidal volume ventilation.|the purpose of this study is to assess the efficacy of low tidal volume ventilation.
588639|NCT00538161|Reducing interleukin and cytokine production may prevent or reduce the incidence of acute lung injury.|reducing interleukin and cytokine production may prevent or reduce the incidence of acute lung injury.
588640|NCT00538200|Nutrition|nutrition
588642|NCT00538213|Influenza vaccine GSK576389A|influenza vaccine gsk576389a
588643|NCT00538213|Fluarix|fluarix
588644|NCT00538213|Influenza infection|influenza infection
588645|NCT00538252|drug use, antisocial behavior, early intervention, prevention|drug use, antisocial behavior, early intervention, prevention
588646|NCT00538265|liver transplantation, hepatitis C virus, immunoprophylaxis|liver transplantation, hepatitis c virus, immunoprophylaxis
588647|NCT00538278|AML|aml
588648|NCT00538291|recurrent colon cancer|recurrent colon cancer
588649|NCT00538291|stage IV colon cancer|stage iv colon cancer
588650|NCT00538291|recurrent rectal cancer|recurrent rectal cancer
588651|NCT00538291|stage IV rectal cancer|stage iv rectal cancer
588652|NCT00538317|Acute myocardial infarction,|acute myocardial infarction,
588653|NCT00538317|GPIIbIIIa inhibitors,|gpiibiiia inhibitors,
588654|NCT00538317|primary angioplasty,|primary angioplasty,
588655|NCT00538317|tirofiban|tirofiban
588656|NCT00538343|brain metastases|brain metastases
588657|NCT00538343|breast cancer|breast cancer
588658|NCT00538356|Heart failure|heart failure
588659|NCT00538356|Rehospitalization:|rehospitalization:
588660|NCT00538356|Packer composite score|packer composite score
588661|NCT00538356|Home Monitoring|home monitoring
588662|NCT00538356|Cardiac resynchronization therapy|cardiac resynchronization therapy
588663|NCT00538356|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
588664|NCT00538369|Nursing|nursing
588665|NCT00538369|critical care|critical care
588666|NCT00538369|sedation assessment|sedation assessment
588667|NCT00538369|Bispectral index|bispectral index
588668|NCT00538382|Malaria|malaria
588669|NCT00538382|Pregnancy|pregnancy
588670|NCT00538382|Artesunate|artesunate
588671|NCT00538382|Pharmacokinetics|pharmacokinetics
588672|NCT00538382|Pharmacodynamics|pharmacodynamics
588673|NCT00538382|Democratic Republic of Congo|democratic republic of congo
588674|NCT00538408|Magnetic resonance|magnetic resonance
588675|NCT00538408|whole body|whole body
588676|NCT00538408|angiography|angiography
588677|NCT00538408|vasovist|vasovist
588678|NCT00538408|gadofosveset|gadofosveset
588679|NCT00538408|dotarem|dotarem
588680|NCT00538408|blood pool agent|blood pool agent
588681|NCT00538421|propofol|propofol
588682|NCT00538421|Anaesthesia|anaesthesia
588683|NCT00538421|Sevoflurane|sevoflurane
588684|NCT00538421|Abdominal|abdominal
588685|NCT00538421|Aortic|aortic
588686|NCT00538421|Aneurysm|aneurysm
588687|NCT00538434|Eosinophilic Esophagitis|eosinophilic esophagitis
588688|NCT00538434|GERD|gerd
588689|NCT00538434|EE|ee
588690|NCT00538434|Reslizumab|reslizumab
588691|NCT00538434|IL-5|il-5
588692|NCT00538434|Interleukin-5|interleukin-5
588693|NCT00538434|Cinquil|cinquil
588696|NCT00538460|coronary artery disease|coronary artery disease
588697|NCT00538460|magnetic resonance imaging|magnetic resonance imaging
588698|NCT00538473|GSK Bio's influenza vaccine GSK576389A|gsk bio's influenza vaccine gsk576389a
588699|NCT00538473|Influenza Infection|influenza infection
588700|NCT00538473|Fluarix|fluarix
588701|NCT00538486|Hypertension|hypertension
588702|NCT00538486|Abdominal obesity|abdominal obesity
588703|NCT00538486|Treatment|treatment
588704|NCT00538499|pain|pain
588705|NCT00538499|perioperative/postoperative complications|perioperative/postoperative complications
588707|NCT00538512|Live attenuated influenza vaccine|live attenuated influenza vaccine
588708|NCT00538512|Inactivated influenza vaccine|inactivated influenza vaccine
588709|NCT00538512|Vaccine Efficacy|vaccine efficacy
588710|NCT00538538|Macular Degeneration|macular degeneration
588711|NCT00538538|AMD|amd
588712|NCT00538538|Hemorrhage|hemorrhage
588713|NCT00538538|Wet AMD|wet amd
588714|NCT00538551|HD|hd
588715|NCT00538551|NHL|nhl
588716|NCT00538564|prolonged, painful erection|prolonged, painful erection
588717|NCT00538564|priapism|priapism
588718|NCT00538564|sickle cell anemia|sickle cell anemia
588719|NCT00538577|Necrotizing fasciitis|necrotizing fasciitis
588720|NCT00538590|ologen|ologen
588721|NCT00538590|collagen matrix|collagen matrix
588722|NCT00538590|glaucoma|glaucoma
588723|NCT00538590|trabeculectomy|trabeculectomy
588724|NCT00538590|Mitomycin-C|mitomycin-c
588725|NCT00538616|Brain Injury|brain injury
588726|NCT00538642|schizophrenia|schizophrenia
588727|NCT00538642|antipsychotics|antipsychotics
588728|NCT00538642|diabetes|diabetes
588729|NCT00538642|bipolar disorder|bipolar disorder
588730|NCT00538655|amphetamine|amphetamine
588731|NCT00538655|methamphetamine|methamphetamine
588732|NCT00538655|addition|addition
588733|NCT00538655|treatment study|treatment study
588734|NCT00538655|drug use|drug use
588735|NCT00538655|modafinil|modafinil
588736|NCT00538668|Prostate|prostate
588737|NCT00538668|Prostate Cancer|prostate cancer
588738|NCT00538668|Prostate Ca|prostate ca
588739|NCT00525317|Pregnancy|pregnancy
588740|NCT00525317|Magnesium|magnesium
588741|NCT00525317|Leg Pain|leg pain
588742|NCT00525343|Avonex pivotal trial|avonex pivotal trial
588743|NCT00525343|Avonex|avonex
588744|NCT00525343|Avonex long term follow-up|avonex long term follow-up
588745|NCT00525343|Avonex outcomes|avonex outcomes
588746|NCT00525356|Aorta|aorta
588747|NCT00525356|Dissection|dissection
588748|NCT00525356|Thoracic|thoracic
588749|NCT00525382|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
588750|NCT00525382|Xyzal tablets|xyzal tablets
588751|NCT00525395|Phototherapy|phototherapy
588752|NCT00525395|Vitiligo scoring system|vitiligo scoring system
588753|NCT00525408|HRPC|hrpc
588754|NCT00525408|Metastatic Hormone Refractory Prostate Cancer|metastatic hormone refractory prostate cancer
588755|NCT00525408|Docetaxel|docetaxel
588756|NCT00525408|Mycobacterium w|mycobacterium w
588757|NCT00525421|curcuminoids|curcuminoids
588758|NCT00525421|oral lichen planus|oral lichen planus
588759|NCT00525421|c reactive protein|c reactive protein
588760|NCT00525421|interleukin 6|interleukin 6
588761|NCT00525434|Laser bonding soft tissue albumin|laser bonding soft tissue albumin
588762|NCT00525447|Antigens, CD40|antigens, cd40
588763|NCT00525447|Antibodies, Monoclonal|antibodies, monoclonal
588764|NCT00525447|Combined Modality Therapy|combined modality therapy
588765|NCT00525447|Multiple Myeloma|multiple myeloma
588766|NCT00525447|Blood Coagulation Disorders|blood coagulation disorders
588767|NCT00525447|Hematologic Diseases|hematologic diseases
588768|NCT00525447|Hemorrhagic Disorders|hemorrhagic disorders
588769|NCT00525447|Hemostatic Disorders|hemostatic disorders
588770|NCT00525447|Immunoproliferative Disorders|immunoproliferative disorders
588771|NCT00525447|Lymphoproliferative Disorders|lymphoproliferative disorders
588772|NCT00525447|Paraproteinemias|paraproteinemias
588773|NCT00525447|Vascular Diseases|vascular diseases
588774|NCT00525447|Antibody-Dependent Cell Cytotoxicity|antibody-dependent cell cytotoxicity
588775|NCT00525460|fertility|fertility
588776|NCT00525460|stage I ovarian cancer|stage i ovarian cancer
588777|NCT00525460|stage II ovarian cancer|stage ii ovarian cancer
588778|NCT00525460|fertility sparing|fertility sparing
588779|NCT00525486|Nifedipine|nifedipine
588780|NCT00525486|Tocolysis|tocolysis
588781|NCT00525486|Maintenance|maintenance
588782|NCT00525486|Preterm delivery|preterm delivery
588783|NCT00525486|extended release nifedipine|extended release nifedipine
588785|NCT00525499|acne|acne
588786|NCT00525525|Glioblastoma|glioblastoma
588787|NCT00525525|Gliosarcoma|gliosarcoma
588788|NCT00525525|Bevacizumab|bevacizumab
588789|NCT00525525|Avastin|avastin
588790|NCT00525525|Erlotinib|erlotinib
588791|NCT00525525|Tarceva|tarceva
588792|NCT00525525|Temozolomide|temozolomide
588793|NCT00525525|Temodar|temodar
588794|NCT00525564|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
588795|NCT00525564|Exercise|exercise
588796|NCT00525564|Endurance shuttle walking test|endurance shuttle walking test
588797|NCT00525564|Bronchodilation|bronchodilation
588799|NCT00525577|Type 2 diabetes, glycemic control|type 2 diabetes, glycemic control
588800|NCT00525590|Gliadel|gliadel
588801|NCT00525603|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
588802|NCT00525603|CML|cml
588803|NCT00525603|Leukemia|leukemia
588804|NCT00525603|Cyclophosphamide|cyclophosphamide
588805|NCT00525603|Fludarabine|fludarabine
588806|NCT00525603|Alemtuzumab|alemtuzumab
588807|NCT00525603|Rituximab|rituximab
588808|NCT00525603|CFAR|cfar
588809|NCT00525616|bullous pemphigoid|bullous pemphigoid
588811|NCT00525642|Breast-adjuvant|breast-adjuvant
588812|NCT00525642|Breast-chemotherapy|breast-chemotherapy
588813|NCT00525642|Combination chemotherapy regimens|combination chemotherapy regimens
588814|NCT00525655|Familial Adenomatous Polyposis|familial adenomatous polyposis
588815|NCT00525655|Colorectal Cancer|colorectal cancer
588816|NCT00525655|Multimedia Intervention|multimedia intervention
588817|NCT00525655|Questionnaire|questionnaire
588818|NCT00525655|Survey|survey
588820|NCT00525668|multiple sclerosis|multiple sclerosis
588821|NCT00525668|inflammation|inflammation
588822|NCT00525668|neurodegeneration|neurodegeneration
588823|NCT00525668|neuroprotection|neuroprotection
588824|NCT00525681|Obese|obese
588825|NCT00525681|Calcineurine inhibitor|calcineurine inhibitor
588826|NCT00525681|Pharmacokinetics|pharmacokinetics
588827|NCT00525681|Interaction|interaction
588828|NCT00525707|acute heart failure|acute heart failure
588829|NCT00525707|Actelion|actelion
588830|NCT00525707|tezosentan|tezosentan
588831|NCT00525707|acute decompensation of chronic heart failure|acute decompensation of chronic heart failure
588832|NCT00525707|New onset of heart failure|new onset of heart failure
588833|NCT00525720|Prostate Cancer|prostate cancer
588834|NCT00525720|Prostatic Carcinoma|prostatic carcinoma
588835|NCT00525720|Intermediate prostate cancer|intermediate prostate cancer
588836|NCT00525720|Transperineal Interstitial Permanent Brachytherapy|transperineal interstitial permanent brachytherapy
588837|NCT00525720|Brachytherapy|brachytherapy
588838|NCT00525720|Prostate brachytherapy|prostate brachytherapy
588839|NCT00525720|Prostate implant|prostate implant
588840|NCT00525720|Prostate|prostate
588841|NCT00525720|Questionnaire|questionnaire
588842|NCT00525720|Survey|survey
588843|NCT00525733|HIV-1|hiv-1
588844|NCT00525733|Acute Infection|acute infection
588845|NCT00525733|Treatment Naive|treatment naive
588846|NCT00525746|Acute Myeloid Leukemia|acute myeloid leukemia
588847|NCT00525746|Myelodysplastic Syndrome|myelodysplastic syndrome
588848|NCT00525746|Leukemia|leukemia
588850|NCT00525746|AML|aml
588851|NCT00525746|Malignancy|malignancy
588852|NCT00525746|Molecular Epidemiology|molecular epidemiology
588853|NCT00525746|Epidemiologic markers|epidemiologic markers
588854|NCT00525746|Clinical markers|clinical markers
588855|NCT00525746|Constitutional genetic markers|constitutional genetic markers
588856|NCT00525746|Case-comparison study|case-comparison study
588857|NCT00525759|Breast cancer|breast cancer
588858|NCT00525759|Zoledronic acid|zoledronic acid
588859|NCT00525759|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
588860|NCT00525759|Synergy|synergy
588861|NCT00525759|Apoptosis|apoptosis
588862|NCT00525772|asthma|asthma
588970|NCT00526058|Device|device
588863|NCT00525772|exercise induced bronchoconstriction|exercise induced bronchoconstriction
588864|NCT00525772|sputum eosinophils|sputum eosinophils
588865|NCT00525785|Stomach Cancer|stomach cancer
588866|NCT00525785|Gastric Cancer|gastric cancer
588867|NCT00525785|Adenocarcinoma of the Stomach|adenocarcinoma of the stomach
588868|NCT00525785|Gastroesophageal Junction|gastroesophageal junction
588869|NCT00525785|Esophageal|esophageal
588870|NCT00525785|Gastric|gastric
588871|NCT00525785|5-Fluorouracil|5-fluorouracil
588872|NCT00525785|5-FU|5-fu
588873|NCT00525785|Adrucil|adrucil
588874|NCT00525785|Efudex|efudex
588875|NCT00525785|Folinic Acid|folinic acid
588876|NCT00525785|Oxaliplatin|oxaliplatin
588877|NCT00525785|Eloxatin|eloxatin
588878|NCT00525785|Chemoradiotherapy|chemoradiotherapy
588879|NCT00525785|Radiation|radiation
588880|NCT00525785|Radiotherapy|radiotherapy
588881|NCT00525785|XRT|xrt
588882|NCT00525798|Osteoporosis, oral salmon calcitonin, treatment, efficacy, tolerability|osteoporosis, oral salmon calcitonin, treatment, efficacy, tolerability
588883|NCT00525824|Hypercholesterolaemia|hypercholesterolaemia
588884|NCT00525824|Coronary Heart Disease (CHD)|coronary heart disease (chd)
588885|NCT00525824|Atherosclerosis|atherosclerosis
588886|NCT00525837|varenicline|varenicline
588887|NCT00525837|depression|depression
588888|NCT00525837|anhedonia|anhedonia
588889|NCT00525837|smoking|smoking
588890|NCT00525850|cardiovascular disease|cardiovascular disease
588891|NCT00525850|weight loss|weight loss
588892|NCT00525863|schizophrenia|schizophrenia
588893|NCT00525863|oxygen therapy|oxygen therapy
588894|NCT00525876|Mantle Cell Lymphoma|mantle cell lymphoma
588895|NCT00525876|Lymphoma|lymphoma
588896|NCT00525876|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
588897|NCT00525876|Rituximab|rituximab
588898|NCT00525876|Cyclophosphamide|cyclophosphamide
588899|NCT00525876|Neosar|neosar
588900|NCT00525876|Cytoxan|cytoxan
588901|NCT00525876|Fludarabine|fludarabine
588903|NCT00525876|Fludarabine phosphate|fludarabine phosphate
588905|NCT00525876|Alemtuzumab|alemtuzumab
588906|NCT00525876|CAMPATH-1H|campath-1h
588907|NCT00525876|Campath|campath
588908|NCT00525876|Total Body Irradiation|total body irradiation
588909|NCT00525876|TBI|tbi
588910|NCT00525889|diabetes|diabetes
588911|NCT00525889|juvenile diabetes|juvenile diabetes
588912|NCT00525889|type 1 diabetes|type 1 diabetes
588913|NCT00525889|diabetes mellitus|diabetes mellitus
588914|NCT00525889|recent onset|recent onset
588915|NCT00525889|new onset|new onset
588916|NCT00525915|Esophageal Cancer|esophageal cancer
588917|NCT00525915|Gastroesophageal Cancer|gastroesophageal cancer
588918|NCT00525915|Gastroesophageal Junction|gastroesophageal junction
588919|NCT00525915|Radiation Therapy|radiation therapy
588920|NCT00525915|5-Fluorouracil|5-fluorouracil
588921|NCT00525915|5-FU|5-fu
588922|NCT00525915|Adrucil|adrucil
588923|NCT00525915|Efudex|efudex
588924|NCT00525915|Oxaliplatin|oxaliplatin
588925|NCT00525928|craving|craving
588926|NCT00525928|smoking|smoking
588927|NCT00525928|depression|depression
588928|NCT00525954|Coronary|coronary
588929|NCT00525954|Artery|artery
588930|NCT00525954|Artheroschlerosis|artheroschlerosis
588931|NCT00525954|Phospholipase|phospholipase
588932|NCT00525954|CAD|cad
588933|NCT00525954|Coronary Artery Disease (CAD)|coronary artery disease (cad)
588934|NCT00525967|Cancer Pain|cancer pain
588935|NCT00525967|Methadone|methadone
588936|NCT00525967|Morphine|morphine
588937|NCT00525967|Acetaminophen|acetaminophen
588938|NCT00525967|Palliative Care|palliative care
588939|NCT00525980|Breast Cancer|breast cancer
588940|NCT00525980|Cancer Risk|cancer risk
588941|NCT00525980|CD-ROM|cd-rom
588942|NCT00525980|Focus Group|focus group
588943|NCT00525980|Cancer Genetics|cancer genetics
588944|NCT00525993|sports|sports
588945|NCT00525993|ankle|ankle
588946|NCT00525993|sprain|sprain
588948|NCT00525993|antiinflammatory|antiinflammatory
588949|NCT00525993|treatment outcome|treatment outcome
588950|NCT00526006|Clinical significance of the acid rebound phenomenon after withdrawal of treatment with a PPI|clinical significance of the acid rebound phenomenon after withdrawal of treatment with a ppi
588951|NCT00526019|remission of asthma|remission of asthma
588952|NCT00526032|Skin Cancer|skin cancer
588953|NCT00526032|Cancerous skin lesions|cancerous skin lesions
588954|NCT00526032|Melanoma Detection|melanoma detection
588955|NCT00526032|Spectroscopic Oblique-Incidence Reflectometry|spectroscopic oblique-incidence reflectometry
588956|NCT00526032|OIR Imaging Probe|oir imaging probe
588957|NCT00526045|AUY922|auy922
588958|NCT00526045|Solid tumors|solid tumors
588959|NCT00526045|Breast Cancer|breast cancer
588960|NCT00526045|Phase I/II|phase i/ii
588961|NCT00526045|Advanced Solid malignancies (Phase I)|advanced solid malignancies (phase i)
588962|NCT00526045|Breast Cancer ( Phase II )|breast cancer ( phase ii )
588963|NCT00526045|HER2+|her2+
588964|NCT00526045|ER+|er+
588965|NCT00526045|HSP90|hsp90
588966|NCT00526058|Heparin|heparin
588967|NCT00526058|Extracorporeal|extracorporeal
588968|NCT00526058|Low Density Lipo-Protein (LDL) Cholesterol|low density lipo-protein (ldl) cholesterol
588969|NCT00526058|Apheresis|apheresis
588971|NCT00526071|Fabry Disease|fabry disease
588972|NCT00526071|Lysosomal Storage Disorder|lysosomal storage disorder
588973|NCT00526084|ALL|all
588974|NCT00526084|Healthy subjects|healthy subjects
588975|NCT00526110|Gastrointestinal Diseases|gastrointestinal diseases
588976|NCT00526110|Adenocarcinoma of the Stomach|adenocarcinoma of the stomach
588977|NCT00526110|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
588978|NCT00526110|Cancer of the Stomach|cancer of the stomach
588979|NCT00526110|5-Fluorouracil|5-fluorouracil
588980|NCT00526110|5-FU|5-fu
588981|NCT00526110|Adrucil|adrucil
588982|NCT00526110|Efudex|efudex
588983|NCT00526110|Docetaxel|docetaxel
588984|NCT00526110|Oxaliplatin|oxaliplatin
588985|NCT00526110|Eloxatin|eloxatin
588986|NCT00526110|Taxotere|taxotere
588987|NCT00526110|Esophagus|esophagus
588988|NCT00526123|Dialysis|dialysis
588989|NCT00526123|Dialysis Catheter|dialysis catheter
588990|NCT00526123|Kidney Disease|kidney disease
588991|NCT00526123|Dialysis Clinic|dialysis clinic
588992|NCT00526123|Chronic Catheter|chronic catheter
588993|NCT00526123|Catheter|catheter
588994|NCT00526123|Kidney|kidney
588995|NCT00526136|Atrial Fibrillation|atrial fibrillation
588996|NCT00526149|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
588997|NCT00526149|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
588998|NCT00526149|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
588999|NCT00526149|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
589000|NCT00526149|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
589079|NCT00526331|Arterial Pressure Based Cardiac Output|arterial pressure based cardiac output
589001|NCT00526149|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
589002|NCT00526149|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
589003|NCT00526149|recurrent breast cancer|recurrent breast cancer
589004|NCT00526149|stage IV breast cancer|stage iv breast cancer
589005|NCT00526149|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
589006|NCT00526149|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
589007|NCT00526149|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
589091|NCT00526370|tampon test|tampon test
589008|NCT00526149|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
589009|NCT00526149|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
589010|NCT00526149|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
589011|NCT00526149|adult leiomyosarcoma|adult leiomyosarcoma
589012|NCT00526149|uterine leiomyosarcoma|uterine leiomyosarcoma
589013|NCT00526149|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
589014|NCT00526149|adult angiosarcoma|adult angiosarcoma
589015|NCT00526149|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
589016|NCT00526149|adult epithelioid sarcoma|adult epithelioid sarcoma
589017|NCT00526149|adult fibrosarcoma|adult fibrosarcoma
589018|NCT00526149|adult liposarcoma|adult liposarcoma
589019|NCT00526149|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
589020|NCT00526149|adult malignant mesenchymoma|adult malignant mesenchymoma
589021|NCT00526149|adult neurofibrosarcoma|adult neurofibrosarcoma
589022|NCT00526149|adult rhabdomyosarcoma|adult rhabdomyosarcoma
589023|NCT00526149|adult synovial sarcoma|adult synovial sarcoma
589024|NCT00526149|endometrial stromal sarcoma|endometrial stromal sarcoma
589025|NCT00526149|ovarian carcinosarcoma|ovarian carcinosarcoma
589026|NCT00526149|ovarian sarcoma|ovarian sarcoma
589027|NCT00526149|recurrent uterine sarcoma|recurrent uterine sarcoma
589028|NCT00526149|stage IV uterine sarcoma|stage iv uterine sarcoma
589029|NCT00526149|recurrent melanoma|recurrent melanoma
589030|NCT00526149|stage IV melanoma|stage iv melanoma
589031|NCT00526175|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
589032|NCT00526175|Minimal Residual Disease|minimal residual disease
589034|NCT00526188|Chinese patients|chinese patients
589035|NCT00526188|Liver MRI|liver mri
589036|NCT00526201|Arthritis|arthritis
589037|NCT00526201|Osteoarthritis|osteoarthritis
589038|NCT00526201|Rheumatoid Arthritis|rheumatoid arthritis
589039|NCT00526201|Fibromyalgia|fibromyalgia
589040|NCT00526201|Lupus|lupus
589041|NCT00526214|Spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
589042|NCT00526214|Acute Spontaneous, Supratentorial intracerebral hemorrhage|acute spontaneous, supratentorial intracerebral hemorrhage
589043|NCT00526253|Congestive Heart Failure|congestive heart failure
589044|NCT00526253|CHF|chf
589045|NCT00526253|Heart Disease|heart disease
589046|NCT00526253|Heart Attack|heart attack
589047|NCT00526253|Stem Cell|stem cell
589048|NCT00526253|Myoblast|myoblast
589049|NCT00526253|Bioheart|bioheart
589050|NCT00526279|Hypertension|hypertension
589051|NCT00526279|Atacand/Atacand plus|atacand/atacand plus
589052|NCT00526279|COMBAT|combat
589053|NCT00526279|Compliance|compliance
589054|NCT00526279|Naturalistic|naturalistic
589055|NCT00526279|Observational|observational
589247|NCT00527657|Thalomid|thalomid
589056|NCT00526292|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
589057|NCT00526292|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
589058|NCT00526292|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
589059|NCT00526292|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
589060|NCT00526292|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
589061|NCT00526292|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
589062|NCT00526292|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
589063|NCT00526292|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
589064|NCT00526292|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
589065|NCT00526292|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
589066|NCT00526292|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
589067|NCT00526292|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
589068|NCT00526292|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
589069|NCT00526292|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
589070|NCT00526305|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
589071|NCT00526305|Chromosome Philadelphia positive|chromosome philadelphia positive
589072|NCT00526318|localized resectable neuroblastoma|localized resectable neuroblastoma
589073|NCT00526318|localized unresectable neuroblastoma|localized unresectable neuroblastoma
589074|NCT00526318|regional neuroblastoma|regional neuroblastoma
589075|NCT00526318|stage 4S neuroblastoma|stage 4s neuroblastoma
589076|NCT00526318|disseminated neuroblastoma|disseminated neuroblastoma
589077|NCT00526331|Perioperative Therapy|perioperative therapy
589078|NCT00526331|Perioperative Hydration|perioperative hydration
589080|NCT00526331|Vigileo Monitor|vigileo monitor
589081|NCT00526331|FloTrac Sensor|flotrac sensor
589082|NCT00526331|Fluid Volume|fluid volume
589083|NCT00526331|APCO|apco
589084|NCT00526344|remission of asthma|remission of asthma
589085|NCT00526357|omega-3 fatty acids|omega-3 fatty acids
589086|NCT00526357|asthma|asthma
589087|NCT00526357|airway hyperresponsiveness|airway hyperresponsiveness
589088|NCT00526357|inflammation|inflammation
589089|NCT00526370|self test|self test
589090|NCT00526370|PAP smear|pap smear
589092|NCT00526370|E6/E7|e6/e7
589093|NCT00526370|mRNA|mrna
589094|NCT00526370|HPV|hpv
589095|NCT00526383|Major depressive disorder|major depressive disorder
589096|NCT00526383|Antidepressants|antidepressants
589097|NCT00526383|Weight gain|weight gain
589098|NCT00526383|Metabolic syndromes|metabolic syndromes
589099|NCT00526396|chemotherapy|chemotherapy
589100|NCT00526396|toxicity adjusted dose|toxicity adjusted dose
589101|NCT00526409|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
589102|NCT00526422|Questionnaire, dental caries, diagnosis,treatment|questionnaire, dental caries, diagnosis,treatment
589103|NCT00526435|Arthritis|arthritis
589104|NCT00526435|osteoarthritis|osteoarthritis
589105|NCT00526435|rheumatoid arthritis|rheumatoid arthritis
589106|NCT00526435|fibromyalgia|fibromyalgia
589107|NCT00526435|lupus|lupus
589108|NCT00526448|high dose of ribavirin|high dose of ribavirin
589109|NCT00526448|extend treatment duration|extend treatment duration
589110|NCT00526448|tailoring treatment|tailoring treatment
589111|NCT00526461|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
589112|NCT00526461|adenocarcinoma of the lung|adenocarcinoma of the lung
589113|NCT00526461|squamous cell lung cancer|squamous cell lung cancer
589114|NCT00526461|large cell lung cancer|large cell lung cancer
589115|NCT00526487|Thoracic Dissection|thoracic dissection
589116|NCT00526487|Dissection|dissection
589117|NCT00526487|Endovascular|endovascular
589118|NCT00526500|Severe Traumatic Brain Injury|severe traumatic brain injury
589119|NCT00526500|Subarachnoid Hemorrhage|subarachnoid hemorrhage
589120|NCT00526500|Anoxic Brain Injury|anoxic brain injury
589121|NCT00526500|Passive Gait Training|passive gait training
589122|NCT00526500|Tilt Table With Integrated Stepping System|tilt table with integrated stepping system
589123|NCT00526500|Electroencephalogram|electroencephalogram
589124|NCT00526500|Event Related Potentials|event related potentials
589125|NCT00526539|THR|thr
589126|NCT00526539|reversed hybrid|reversed hybrid
589127|NCT00526539|wear|wear
589128|NCT00526552|dyslipidemia|dyslipidemia
589129|NCT00526552|rosuvastatin|rosuvastatin
589130|NCT00526552|diabetes|diabetes
589131|NCT00526552|cholesterol|cholesterol
589132|NCT00526552|Naturalistic|naturalistic
589133|NCT00526552|Observational|observational
589134|NCT00526578|Pancreatic Cancer|pancreatic cancer
589135|NCT00526578|Pancreatic Cancer Genetic Epidemiology|pancreatic cancer genetic epidemiology
589136|NCT00526578|PACGENE|pacgene
589137|NCT00526578|Healthy Control|healthy control
589138|NCT00526578|Familial Pancreatic Cancer|familial pancreatic cancer
589139|NCT00526578|FPC|fpc
589140|NCT00526578|Questionnaire|questionnaire
589141|NCT00526591|adenocarcinoma of the prostate|adenocarcinoma of the prostate
589142|NCT00526591|stage I prostate cancer|stage i prostate cancer
589143|NCT00526591|stage II prostate cancer|stage ii prostate cancer
589144|NCT00526591|stage III prostate cancer|stage iii prostate cancer
589145|NCT00526604|return to work|return to work
589146|NCT00526604|low back pain|low back pain
589147|NCT00526604|work related rehabilitation|work related rehabilitation
589148|NCT00526617|Solid Tumor|solid tumor
589149|NCT00526617|Melanoma|melanoma
589150|NCT00526617|Breast cancer|breast cancer
589151|NCT00526617|Ovarian cancer|ovarian cancer
589152|NCT00526617|Primary peritoneal cancer|primary peritoneal cancer
589153|NCT00526617|Fallopian tube cancer|fallopian tube cancer
589154|NCT00526617|Hepatocellular carcinoma|hepatocellular carcinoma
589155|NCT00526617|HCC|hcc
589156|NCT00526617|BRCA deficient|brca deficient
589157|NCT00526617|BRCA mutation|brca mutation
589158|NCT00526617|Temozolomide|temozolomide
589159|NCT00526617|Temodar|temodar
589160|NCT00526617|TMZ|tmz
589161|NCT00526617|ABT-888|abt-888
589162|NCT00526617|PARP inhibitor|parp inhibitor
589163|NCT00526630|freezing|freezing
589164|NCT00526630|gait|gait
589165|NCT00526630|festination|festination
589166|NCT00526630|shuffling|shuffling
589167|NCT00526630|balance|balance
589168|NCT00526643|stage IIIB|stage iiib
589169|NCT00526643|Stage IV|stage iv
589170|NCT00526643|chemotherapy|chemotherapy
589171|NCT00526643|monotherapy|monotherapy
589172|NCT00526643|combination chemotherapy|combination chemotherapy
589173|NCT00526643|poor performance status|poor performance status
589174|NCT00526656|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
589175|NCT00526656|stage II bladder cancer|stage ii bladder cancer
589176|NCT00526656|stage III bladder cancer|stage iii bladder cancer
589177|NCT00526656|stage IV bladder cancer|stage iv bladder cancer
589178|NCT00526669|tumor biopsy|tumor biopsy
589179|NCT00526669|capecitabine|capecitabine
589180|NCT00526669|first line|first line
589181|NCT00526669|Gastro Esophageal (GE) Junction Cancer|gastro esophageal (ge) junction cancer
589182|NCT00526669|Gastric cancer|gastric cancer
589183|NCT00526669|newly diagnosed|newly diagnosed
589184|NCT00526669|GE junction|ge junction
589185|NCT00526669|lapatinib|lapatinib
589186|NCT00526669|metastatic or unresectable|metastatic or unresectable
589187|NCT00526682|Antiobesity|antiobesity
589188|NCT00526682|Weight loss|weight loss
589189|NCT00526695|Ischemia/Reperfusion|ischemia/reperfusion
589190|NCT00526695|Organ Protection|organ protection
589191|NCT00526695|Anesthetics|anesthetics
589192|NCT00526708|dyslipidemia|dyslipidemia
589193|NCT00526708|hypertension|hypertension
589194|NCT00526708|rosuvastatin|rosuvastatin
589195|NCT00526708|efficacy|efficacy
589196|NCT00526708|Naturalistic|naturalistic
589197|NCT00526708|Observational|observational
589198|NCT00526721|Hypercholesterolemia|hypercholesterolemia
589200|NCT00526721|LDL target goal|ldl target goal
589201|NCT00526721|high risk patients|high risk patients
589202|NCT00526721|Naturalistic|naturalistic
589203|NCT00526721|Observational|observational
589204|NCT00526734|stage I multiple myeloma|stage i multiple myeloma
589205|NCT00526734|stage II multiple myeloma|stage ii multiple myeloma
589206|NCT00526734|stage III multiple myeloma|stage iii multiple myeloma
589207|NCT00527501|Open-angle glaucoma|open-angle glaucoma
589208|NCT00527501|ocular hypertension|ocular hypertension
589209|NCT00527514|Hypertension|hypertension
589210|NCT00527514|Angiotensin Receptor Blocker|angiotensin receptor blocker
589211|NCT00527514|Calcium Channel Blocker|calcium channel blocker
589212|NCT00527514|Stage I and II Hypertension|stage i and ii hypertension
589213|NCT00527553|Macular pigment|macular pigment
589215|NCT00527553|ARM|arm
589216|NCT00527566|Churg Strauss Syndrome|churg strauss syndrome
589217|NCT00527579|Epilepsy|epilepsy
589218|NCT00527579|Taenia Solium|taenia solium
589219|NCT00527579|Microglia|microglia
589220|NCT00527579|Neuroinflammation|neuroinflammation
589221|NCT00527579|Compartment Model|compartment model
589222|NCT00527579|Neurocysticercosis|neurocysticercosis
589223|NCT00527579|Healthy Volunteer|healthy volunteer
589225|NCT00527592|Comfort|comfort
589226|NCT00527605|placebo control|placebo control
589227|NCT00527605|Chinese|chinese
589228|NCT00527605|Dutasteride|dutasteride
589229|NCT00527605|Randomized|randomized
589230|NCT00527605|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
589231|NCT00527605|Double blind|double blind
589232|NCT00527618|Herpes Simplex Virus Type 2|herpes simplex virus type 2
589233|NCT00527618|Human Immunodeficiency Virus|human immunodeficiency virus
589234|NCT00527618|Treatment Naive|treatment naive
589235|NCT00527631|advanced ovarian cancer|advanced ovarian cancer
589236|NCT00527631|whole abdominal irradiation|whole abdominal irradiation
589237|NCT00527631|intensity modulated radiotherapy|intensity modulated radiotherapy
589238|NCT00527631|ovarian cancer stage FIGO III|ovarian cancer stage figo iii
589239|NCT00527644|biliary leaks after laparoscopic cholecystectomy|biliary leaks after laparoscopic cholecystectomy
589240|NCT00527657|Brain Neoplasms|brain neoplasms
589241|NCT00527657|Melanoma|melanoma
589242|NCT00527657|Metastatic Melanoma|metastatic melanoma
589243|NCT00527657|Brain Metastasis|brain metastasis
589244|NCT00527657|Temozolomide|temozolomide
589245|NCT00527657|Temodar|temodar
589246|NCT00527657|Thalidomide|thalidomide
589248|NCT00527657|Lomustine|lomustine
589249|NCT00527657|CCNU|ccnu
589250|NCT00527657|CeeNU|ceenu
589251|NCT00527670|Genomics|genomics
589252|NCT00527683|vigabatrin|vigabatrin
589253|NCT00527683|GVG|gvg
589254|NCT00527683|addiction|addiction
589255|NCT00527683|treatment|treatment
589256|NCT00527683|cocaine dependence|cocaine dependence
589257|NCT00527722|Lung Cancer|lung cancer
589258|NCT00527722|Bio-Seal Track Plug|bio-seal track plug
589259|NCT00527722|Lung Biopsy|lung biopsy
589260|NCT00527722|Lung Plug|lung plug
589261|NCT00527722|Air Leaks|air leaks
589262|NCT00527735|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
589263|NCT00527735|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
589264|NCT00527748|Range of Motion|range of motion
589265|NCT00527748|Ankle Fractures|ankle fractures
589266|NCT00527748|Elderly patients|elderly patients
589267|NCT00527761|Metastatic Melanoma|metastatic melanoma
589268|NCT00527761|Temozolomide|temozolomide
589269|NCT00527761|Temodar|temodar
589270|NCT00527761|Taxotere|taxotere
589271|NCT00527761|Cisplatin|cisplatin
589272|NCT00527761|TTC|ttc
589273|NCT00527774|Hepatitis C|hepatitis c
589274|NCT00527774|malnutrition-inflammation complex syndrome (MICS)|malnutrition-inflammation complex syndrome (mics)
589275|NCT00527774|dialysis|dialysis
589276|NCT00527774|mortality|mortality
589277|NCT00527774|hospitalization|hospitalization
589278|NCT00527774|health-related quality of life (HRQOL)|health-related quality of life (hrqol)
589279|NCT00527774|peripheral arterial occlusive disease (PAOD)|peripheral arterial occlusive disease (paod)
589280|NCT00527787|NSAID|nsaid
589281|NCT00527787|gastric ulcers|gastric ulcers
589282|NCT00527787|Vimovo|vimovo
589284|NCT00527787|Esomeprazole|esomeprazole
589285|NCT00527800|Malaria|malaria
589286|NCT00527800|HIV|hiv
589287|NCT00527800|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
589288|NCT00527800|Artemether-lumefantrine|artemether-lumefantrine
589289|NCT00527800|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
589290|NCT00527800|Acute Infection|acute infection
589291|NCT00527813|acute respiratory distress syndrome|acute respiratory distress syndrome
589292|NCT00527813|prone position|prone position
589293|NCT00527813|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
589294|NCT00527826|Severe and very severe COPD (GOLD stage III / IV) exacerbations|severe and very severe copd (gold stage iii / iv) exacerbations
589295|NCT00527826|health care utilisation|health care utilisation
589296|NCT00527826|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
589297|NCT00527826|quality of life|quality of life
589298|NCT00527826|compliance|compliance
589299|NCT00527826|salmeterol/fluticasone combination|salmeterol/fluticasone combination
589300|NCT00527852|Flocked swab|flocked swab
589301|NCT00527852|Group A streptococcus|group a streptococcus
589302|NCT00527865|Influenza, Flu, DAS181, Fludase|influenza, flu, das181, fludase
589303|NCT00527878|Hyper-IgE Recurrent Infection Syndrome|hyper-ige recurrent infection syndrome
589304|NCT00527878|Ranitidine Therapy|ranitidine therapy
589305|NCT00527878|Job's Syndrome|job's syndrome
589306|NCT00527878|Cross-Over Study|cross-over study
589307|NCT00527878|Double-Blind Placebo Controlled|double-blind placebo controlled
589308|NCT00527878|Hyper-IgE Syndrome|hyper-ige syndrome
589309|NCT00527878|Job Syndrome|job syndrome
589310|NCT00527878|Immune Deficiency|immune deficiency
589311|NCT00527891|Liver Cancer|liver cancer
589312|NCT00527891|Magnetic Resonance Imaging|magnetic resonance imaging
589313|NCT00527891|Signa Excite 3.0T MRI Scan|signa excite 3.0t mri scan
589314|NCT00527904|osteoarthritis|osteoarthritis
589315|NCT00527904|rheumatoid arthritis|rheumatoid arthritis
589316|NCT00527904|ankylosing spondylisit|ankylosing spondylisit
589319|NCT00527917|Interstitial Cystitis/Painful Bladder Syndrome|interstitial cystitis/painful bladder syndrome
589320|NCT00527930|Breast Neoplasms|breast neoplasms
589321|NCT00527930|Oxaliplatin|oxaliplatin
589322|NCT00527930|S1|s1
589323|NCT00527956|Breastfeeding premature infants|breastfeeding premature infants
589324|NCT00527969|American ginseng extract|american ginseng extract
589325|NCT00527969|Panax quinquefolius|panax quinquefolius
589326|NCT00527969|Memory enhancement|memory enhancement
589327|NCT00527969|Cognitive function|cognitive function
589328|NCT00527969|Working memory|working memory
589329|NCT00527969|Declarative memory|declarative memory
589330|NCT00527969|Psychomotor speed|psychomotor speed
589331|NCT00527969|Executive skills|executive skills
589332|NCT00527969|Psychosocial adaptation|psychosocial adaptation
589333|NCT00527982|Head and Neck Cancer|head and neck cancer
589334|NCT00527982|Lung Cancer|lung cancer
589335|NCT00527982|Non-Small Cell Lung Cancer|non-small cell lung cancer
589336|NCT00527982|Celecoxib|celecoxib
589337|NCT00527982|Celebrex|celebrex
589338|NCT00528008|infection|infection
589339|NCT00528008|sepsis|sepsis
589340|NCT00528008|povidone-iodine|povidone-iodine
589341|NCT00528008|chlorhexidine gluconate|chlorhexidine gluconate
589342|NCT00528008|fever|fever
589343|NCT00528008|erythema|erythema
589344|NCT00528008|leukocytosis|leukocytosis
589345|NCT00528008|drainage|drainage
589346|NCT00528008|vaginal discharge|vaginal discharge
589540|NCT00528684|REOLYSIN|reolysin
589347|NCT00528008|elective cesarean section|elective cesarean section
589348|NCT00528021|Head Lice|head lice
589349|NCT00528021|Lice Infestation|lice infestation
589350|NCT00528021|Pediculosis|pediculosis
589351|NCT00528021|Pediculosis Capitis|pediculosis capitis
589352|NCT00528034|Vaginal Cancer|vaginal cancer
589353|NCT00528034|Lymphoscintigraphy|lymphoscintigraphy
589354|NCT00528034|Lymphatic Mapping|lymphatic mapping
589355|NCT00528034|Sentinel Lymph Node|sentinel lymph node
589356|NCT00528034|Isosulfan Blue|isosulfan blue
589357|NCT00528034|Lymph|lymph
589358|NCT00528047|Cancer|cancer
589359|NCT00528047|Solid Tumor|solid tumor
589360|NCT00528047|Metastatic|metastatic
589361|NCT00528047|Neoplasm, Malignant|neoplasm, malignant
589362|NCT00528060|HIV infections|hiv infections
589363|NCT00528060|atazanavir|atazanavir
589364|NCT00528060|Pharmacokinetics|pharmacokinetics
589365|NCT00528060|Treatment Naive|treatment naive
589366|NCT00528073|Rifaximin-EIR|rifaximin-eir
589367|NCT00528073|Crohn's disease|crohn's disease
589368|NCT00528073|remission|remission
589369|NCT00528086|Group visits|group visits
589370|NCT00528112|Contraception|contraception
589371|NCT00528112|Intrauterine|intrauterine
589372|NCT00528112|IUD|iud
589373|NCT00528112|IUS|ius
589374|NCT00528138|Appendicitis|appendicitis
589375|NCT00528138|Hyperbilirubinemia|hyperbilirubinemia
589376|NCT00528138|CRP|crp
589377|NCT00528138|Values of bilirubin|values of bilirubin
589378|NCT00528138|Values of liver function test|values of liver function test
589379|NCT00528138|Values of white blood cells|values of white blood cells
589380|NCT00528138|Values of CRP|values of crp
589381|NCT00528151|Curcumin, LHON, antioxidant, visual outcome|curcumin, lhon, antioxidant, visual outcome
589386|NCT00528164|intervention|intervention
589387|NCT00528164|control|control
589388|NCT00528164|randomized|randomized
589389|NCT00528164|physical activity|physical activity
589390|NCT00528164|diet|diet
589391|NCT00528164|nutrition|nutrition
589392|NCT00528164|behavior|behavior
589393|NCT00528164|body mass index|body mass index
589394|NCT00528177|kappa-opioid receptor|kappa-opioid receptor
589395|NCT00528177|my-opioid receptor|my-opioid receptor
589396|NCT00528177|oxycodone|oxycodone
589397|NCT00528177|morphine|morphine
589398|NCT00528177|postoperative pain|postoperative pain
589399|NCT00528190|Cystic Fibrosis|cystic fibrosis
589400|NCT00528190|Aspergillus Fumigatus|aspergillus fumigatus
589401|NCT00528190|randomized controlled clinical trials|randomized controlled clinical trials
589402|NCT00528203|Sickle Cell Disease|sickle cell disease
589403|NCT00528203|Sickle Cell Anemia|sickle cell anemia
589404|NCT00528203|DNA|dna
589405|NCT00528216|Analgesics|analgesics
589406|NCT00528216|Capsaicin|capsaicin
589407|NCT00528255|cervical ripening|cervical ripening
589408|NCT00528255|induction of labor|induction of labor
589409|NCT00528268|Spinal Muscular Atrophy|spinal muscular atrophy
589410|NCT00528268|SMA|sma
589411|NCT00528268|Sodium Phenylbutyrate|sodium phenylbutyrate
589412|NCT00528281|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
589413|NCT00528281|Pemetrexed,|pemetrexed,
589414|NCT00528281|Lapatinib (GW572016),|lapatinib (gw572016),
589415|NCT00528294|Recurrent head and neck tumors|recurrent head and neck tumors
589416|NCT00528307|myocardial perfusion|myocardial perfusion
589417|NCT00528307|His ablation|his ablation
589418|NCT00528307|biventricular pacing|biventricular pacing
589419|NCT00528307|His bundle ablation for atrial fibrillation|his bundle ablation for atrial fibrillation
589420|NCT00528320|Congestive Heart Failure|congestive heart failure
589421|NCT00528320|Heart Failure|heart failure
589422|NCT00528320|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
589424|NCT00528320|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
589425|NCT00528320|Defibrillator|defibrillator
589426|NCT00528333|Lintuzumab|lintuzumab
589427|NCT00528333|Antigens, CD33|antigens, cd33
589428|NCT00528333|Antibodies, Monoclonal|antibodies, monoclonal
589429|NCT00528333|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
589430|NCT00528333|Hematologic Diseases|hematologic diseases
589431|NCT00528333|Leukemia|leukemia
589432|NCT00528346|chronic pain|chronic pain
589433|NCT00528346|functional magnetic resonance imaging|functional magnetic resonance imaging
589434|NCT00528346|fMRI|fmri
589435|NCT00528346|cognitive training|cognitive training
589436|NCT00528359|antipsychotic drugs|antipsychotic drugs
589437|NCT00528359|schizophrenia|schizophrenia
589438|NCT00528359|β-cell function|β-cell function
589439|NCT00528359|insulin resistance|insulin resistance
589440|NCT00528385|Proteinuria|proteinuria
589441|NCT00528385|Renin-Angiotensin-Aldosterone System|renin-angiotensin-aldosterone system
589442|NCT00528385|Aldosterone Antagonists|aldosterone antagonists
589443|NCT00528398|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
589444|NCT00528398|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
589445|NCT00528398|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
589446|NCT00528398|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
589447|NCT00528398|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
589448|NCT00528398|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
589449|NCT00528398|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
589450|NCT00528398|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
589451|NCT00528398|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
589452|NCT00528398|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
589453|NCT00528398|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
589454|NCT00528398|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
589455|NCT00528398|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
589456|NCT00528398|secondary acute myeloid leukemia|secondary acute myeloid leukemia
589457|NCT00528398|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
589458|NCT00528411|Coronary artery disease|coronary artery disease
589459|NCT00528411|CAD|cad
589460|NCT00528411|heart attack|heart attack
589461|NCT00528411|stable angina|stable angina
589462|NCT00528411|Stable coronary artery disease|stable coronary artery disease
589463|NCT00528437|Recurrent or refractory medulloblastoma/PNET|recurrent or refractory medulloblastoma/pnet
589464|NCT00528437|CNS germ cell tumors|cns germ cell tumors
589465|NCT00528437|Ependymomas|ependymomas
589466|NCT00528437|AT/RT|at/rt
589467|NCT00528437|High grade glioma|high grade glioma
589468|NCT00528437|Other malignant brain tumors|other malignant brain tumors
589469|NCT00528450|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
589470|NCT00528450|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
589666|NCT00529204|ALT|alt
589471|NCT00528450|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
589472|NCT00528463|Pre-emptive analgesia|pre-emptive analgesia
589473|NCT00528463|Peripheral nerve block (sciatic)|peripheral nerve block (sciatic)
589474|NCT00528463|phantom lomb pain|phantom lomb pain
589475|NCT00528476|pyelonephritis|pyelonephritis
589476|NCT00528476|cystitis|cystitis
589477|NCT00528476|risk factor|risk factor
589478|NCT00528476|children|children
589479|NCT00528476|urodynamics|urodynamics
589480|NCT00528489|HIV Seronegativity|hiv seronegativity
589481|NCT00528489|DNA Plasmid Vaccine|dna plasmid vaccine
589482|NCT00528489|HIV Preventive Vaccine|hiv preventive vaccine
589483|NCT00528502|Parathyroid Disease|parathyroid disease
589484|NCT00528502|Minimal Invasive Parathyroid Surgery|minimal invasive parathyroid surgery
589485|NCT00528502|MIPS|mips
589486|NCT00528502|Laryngeal Reflexes|laryngeal reflexes
589487|NCT00528502|Lidocaine|lidocaine
589488|NCT00528502|Saline|saline
589489|NCT00528515|anesthesia intravenous|anesthesia intravenous
589490|NCT00528515|propofol|propofol
589491|NCT00528515|anesthesia inhalation|anesthesia inhalation
589492|NCT00528515|desflurane|desflurane
589493|NCT00528515|heart surgery|heart surgery
589494|NCT00528515|coronary artery by-pass off-pump|coronary artery by-pass off-pump
589495|NCT00528515|hemodynamic processes|hemodynamic processes
589496|NCT00528515|anesthesia|anesthesia
589497|NCT00528528|Chronic Hepatitis C|chronic hepatitis c
589498|NCT00528528|Genotype 1|genotype 1
589499|NCT00528528|Telaprevir|telaprevir
589500|NCT00528528|Treatment-naïve|treatment-naïve
589501|NCT00528528|VX-950-C208|vx-950-c208
589502|NCT00528528|VX-950-TiDP24-C208|vx-950-tidp24-c208
589503|NCT00528554|CINV|cinv
589504|NCT00528554|chemotherapy induced nausea and vomiting (CINV)|chemotherapy induced nausea and vomiting (cinv)
589505|NCT00528580|Sepsis|sepsis
589506|NCT00528580|Statin|statin
589507|NCT00528580|Infection|infection
589508|NCT00528580|Immunomodulatory|immunomodulatory
589509|NCT00528593|HIV|hiv
589510|NCT00528593|AIDS|aids
589511|NCT00528593|neuropathy|neuropathy
589512|NCT00528593|Procrit|procrit
589513|NCT00528593|epoetin alfa|epoetin alfa
589514|NCT00528593|erythropoetin|erythropoetin
589515|NCT00528593|Treatment Experienced|treatment experienced
589516|NCT00528619|Solid tumor malignancy|solid tumor malignancy
589517|NCT00528619|non-small cell lung cancer|non-small cell lung cancer
589518|NCT00528619|sunitinib|sunitinib
589519|NCT00528619|pemetrexed|pemetrexed
589520|NCT00528619|Phase 1|phase 1
589521|NCT00528619|Mesothelioma|mesothelioma
589522|NCT00528632|Gallstones|gallstones
589523|NCT00528632|Gallbladder|gallbladder
589524|NCT00528632|Cholesterolosis|cholesterolosis
589525|NCT00528632|Serum cholesterol|serum cholesterol
589526|NCT00528632|triglycerides|triglycerides
589527|NCT00528632|Body Mass Index|body mass index
589528|NCT00528658|Soft Tissue Injuries|soft tissue injuries
589529|NCT00528671|phenprocoumon|phenprocoumon
589530|NCT00528671|INR self-management|inr self-management
589531|NCT00528671|mechanical heart valve replacement|mechanical heart valve replacement
589532|NCT00528671|bleeding|bleeding
589533|NCT00528671|thromboembolism|thromboembolism
589534|NCT00528684|Oncolytics Biotech|oncolytics biotech
589535|NCT00528684|cancer alternative therapies|cancer alternative therapies
589536|NCT00528684|malignant glioma|malignant glioma
589537|NCT00528684|glioblastoma multiforme|glioblastoma multiforme
589538|NCT00528684|oncolytic virus|oncolytic virus
589539|NCT00528684|reovirus|reovirus
589541|NCT00528710|S-Adenosylmethionine|s-adenosylmethionine
589542|NCT00528723|beclomethasone|beclomethasone
589543|NCT00528723|as needed|as needed
589544|NCT00528723|salbutamol|salbutamol
589545|NCT00528723|wheezing|wheezing
589546|NCT00528736|preterm infants < 28 weeks|preterm infants < 28 weeks
589547|NCT00528736|B-type natriuretic peptide|b-type natriuretic peptide
589548|NCT00528736|prediction|prediction
589549|NCT00528736|ductus intervention|ductus intervention
589550|NCT00528749|Respiratory effort|respiratory effort
589551|NCT00528749|Upper Airway Resistance Syndrome|upper airway resistance syndrome
589552|NCT00528762|Epidemiology|epidemiology
589553|NCT00528762|Puberty|puberty
589554|NCT00528762|Body Weight|body weight
589555|NCT00528762|Body Image|body image
589556|NCT00528762|Focus Group|focus group
589557|NCT00528775|adenocarcinoma of the lung|adenocarcinoma of the lung
589558|NCT00528775|large cell lung cancer|large cell lung cancer
589559|NCT00528775|squamous cell lung cancer|squamous cell lung cancer
589560|NCT00528775|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
589561|NCT00528775|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
589562|NCT00528775|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
589563|NCT00528775|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
589564|NCT00528801|Sickle Cell Disease|sickle cell disease
589565|NCT00528801|Sickle Cell Anemia|sickle cell anemia
589566|NCT00528801|Hemoglobin SS|hemoglobin ss
589567|NCT00528801|Hemoglobin SB0|hemoglobin sb0
589568|NCT00528814|Hand Sanitizer|hand sanitizer
589569|NCT00528814|Respiratory Infection|respiratory infection
589570|NCT00528827|Hypertension, High Blood Pressure, Pediatric Hypertension, High blood pressure in children|hypertension, high blood pressure, pediatric hypertension, high blood pressure in children
589571|NCT00528853|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
589572|NCT00528866|adenocarcinoma of the prostate|adenocarcinoma of the prostate
592385|NCT00544817|First-line|first-line
589573|NCT00528866|stage IIB prostate cancer|stage iib prostate cancer
589574|NCT00528866|stage IIA prostate cancer|stage iia prostate cancer
589575|NCT00528866|stage III prostate cancer|stage iii prostate cancer
589576|NCT00528866|stage IV prostate cancer|stage iv prostate cancer
589577|NCT00528879|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
589578|NCT00528879|Diabetes Mellitus|diabetes mellitus
589579|NCT00528879|Endocrine System Diseases|endocrine system diseases
589580|NCT00528879|Glucose Metabolism Disorders|glucose metabolism disorders
589581|NCT00528879|Metabolic Diseases|metabolic diseases
589582|NCT00528879|Metformin|metformin
589583|NCT00528879|Hypoglycemic Agents|hypoglycemic agents
589584|NCT00528879|Pharmacologic Actions|pharmacologic actions
589585|NCT00528879|Physiological Effects of Drugs|physiological effects of drugs
589586|NCT00528892|Treatment Experienced|treatment experienced
589587|NCT00528905|Schizophrenia|schizophrenia
589588|NCT00528905|Cognitive Deficits|cognitive deficits
589589|NCT00528918|diabetes|diabetes
589590|NCT00528918|hyperglycemia|hyperglycemia
589591|NCT00528918|insulin|insulin
589592|NCT00528918|Apidra|apidra
589593|NCT00528918|Glargine|glargine
589594|NCT00528931|Assessment of AUX I and/or AUX II in human plasma|assessment of aux i and/or aux ii in human plasma
589595|NCT00528944|alveolar volume|alveolar volume
589596|NCT00528944|pulmonary function testing|pulmonary function testing
589597|NCT00528944|emphysema|emphysema
589598|NCT00528957|Phase 3|phase 3
589599|NCT00528957|Randomized, Open-Label|randomized, open-label
589600|NCT00528957|Treatment-Experienced|treatment-experienced
589601|NCT00528957|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
589603|NCT00528957|Tenofovir DF|tenofovir df
589604|NCT00528957|Pediatrics|pediatrics
589605|NCT00528970|POI|poi
589606|NCT00528970|Hernia|hernia
589607|NCT00528970|Ventral Wall Hernia Repair|ventral wall hernia repair
589608|NCT00528970|Post Operative Ileus|post operative ileus
589609|NCT00528983|Myelodysplastic Syndromes MDS|myelodysplastic syndromes mds
589610|NCT00528983|Acute Myelogenous Leukemia AML|acute myelogenous leukemia aml
589611|NCT00528983|Chronic Myelomonocytic Leukemia CMML|chronic myelomonocytic leukemia cmml
589612|NCT00529009|PK analysis|pk analysis
589613|NCT00529022|Advanced Cancer|advanced cancer
589614|NCT00529022|Solid Tumors|solid tumors
589615|NCT00529022|Ovarian Cancer|ovarian cancer
589616|NCT00529022|Fallopian Tube Cancer|fallopian tube cancer
589617|NCT00529022|Peritoneal Cancer|peritoneal cancer
589618|NCT00529022|Azacitidine|azacitidine
589619|NCT00529022|5-Azacitidine|5-azacitidine
589620|NCT00529022|5-Aza|5-aza
589621|NCT00529022|Vidaza™|vidaza™
589622|NCT00529022|5-AZC|5-azc
589623|NCT00529022|AZA-CR|aza-cr
589624|NCT00529022|Ladakamycin|ladakamycin
589625|NCT00529022|NSC-102816|nsc-102816
589626|NCT00529022|Vidaza|vidaza
589627|NCT00529022|Valproic Acid|valproic acid
589628|NCT00529022|Depakene|depakene
589629|NCT00529022|Carboplatin|carboplatin
589630|NCT00529022|Paraplatin|paraplatin
589631|NCT00529035|Chronic GVHD|chronic gvhd
589632|NCT00529035|Steroid refractory GVHD|steroid refractory gvhd
589633|NCT00529035|allogeneic stem cell transplantation|allogeneic stem cell transplantation
589634|NCT00529048|Type 2 diabetes mellitus|type 2 diabetes mellitus
589635|NCT00529048|Incretin effect|incretin effect
589636|NCT00529048|Glucagon-Like Peptide 1|glucagon-like peptide 1
589637|NCT00529048|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
589638|NCT00529061|Sickle Cell Disease|sickle cell disease
589639|NCT00529061|Sickle Cell Anemia|sickle cell anemia
589640|NCT00529074|Epidural Analgesia|epidural analgesia
589641|NCT00529087|Opioid-Induced Constipation|opioid-induced constipation
589642|NCT00529113|pancreatic cancer|pancreatic cancer
589643|NCT00529113|gemcitabine|gemcitabine
589644|NCT00529126|hemorrhoidectomy|hemorrhoidectomy
589645|NCT00529126|pain|pain
589646|NCT00529126|Postoperative|postoperative
589647|NCT00529126|analgesia|analgesia
589648|NCT00529139|Extended dialysis|extended dialysis
589649|NCT00529139|Acute kidney injury|acute kidney injury
589650|NCT00529139|Intensive care unit|intensive care unit
589651|NCT00529139|Renal replacement therapy|renal replacement therapy
589652|NCT00529139|Survival|survival
589653|NCT00529139|Dialysis|dialysis
589654|NCT00529152|Iron Overload|iron overload
589655|NCT00529165|injection to meal time|injection to meal time
589656|NCT00529165|human insulin|human insulin
589657|NCT00529191|Type I Diabetes (T1DM)|type i diabetes (t1dm)
589658|NCT00529191|Atorvastatin (Lipitor)|atorvastatin (lipitor)
589659|NCT00529191|Insulin|insulin
589660|NCT00529191|Pancreas|pancreas
589661|NCT00529191|Beta Cells|beta cells
589662|NCT00529204|Fatty Liver|fatty liver
589663|NCT00529204|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
589664|NCT00529204|NAFDL|nafdl
589665|NCT00529204|Diabetes|diabetes
589668|NCT00529217|Dissociative|dissociative
589669|NCT00529217|Dissociation|dissociation
589670|NCT00529217|Depersonalization|depersonalization
589671|NCT00529217|Depersonalization Disorder|depersonalization disorder
592387|NCT00544817|Phase II|phase ii
589672|NCT00529217|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
589673|NCT00529217|TMS|tms
589674|NCT00529217|Depersonalization Disorder (DPD)|depersonalization disorder (dpd)
589675|NCT00529217|rTMS|rtms
589676|NCT00529230|Advanced Cancer|advanced cancer
589677|NCT00529230|Chronic Opioid Therapy|chronic opioid therapy
589678|NCT00529230|Secondary Hypogonadism|secondary hypogonadism
589679|NCT00529230|Cancer-Related Pain Syndromes|cancer-related pain syndromes
589680|NCT00529230|Questionnaire|questionnaire
589681|NCT00529243|Treatment Experience|treatment experience
589682|NCT00529243|On enfuvirtide|on enfuvirtide
589683|NCT00529256|Adult smokers|adult smokers
589684|NCT00529269|Renal Transplant Patients, GI symptom, Enteric-coated mycophenolate sodium|renal transplant patients, gi symptom, enteric-coated mycophenolate sodium
589685|NCT00529282|Low numbers of neutrophils in the blood|low numbers of neutrophils in the blood
589686|NCT00529282|increased body temperature|increased body temperature
589687|NCT00529282|cancer chemotherapy|cancer chemotherapy
589688|NCT00529282|ceftobiprole|ceftobiprole
589689|NCT00529282|pseudomonas infections|pseudomonas infections
589690|NCT00529295|misoprostol|misoprostol
589691|NCT00529295|labor induction|labor induction
589692|NCT00529308|Tourette|tourette
589693|NCT00529308|Tourette's|tourette's
589694|NCT00529334|Breast Cancer|breast cancer
589695|NCT00529334|Partial breast irradiation|partial breast irradiation
589696|NCT00529334|Radiosurgery|radiosurgery
589697|NCT00529334|CyberKnife|cyberknife
589698|NCT00529334|Radiotherapy|radiotherapy
589699|NCT00529334|PBI|pbi
589700|NCT00529360|Acute Leukemia|acute leukemia
589701|NCT00529360|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
589703|NCT00529360|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
589704|NCT00529360|Acute Myelogenous Leukemia|acute myelogenous leukemia
589705|NCT00529386|prostatitis|prostatitis
589706|NCT00529386|Botox|botox
589707|NCT00529399|immune tolerance|immune tolerance
589708|NCT00529399|immunotherapy|immunotherapy
589709|NCT00529399|antigen-specific tolerance|antigen-specific tolerance
589710|NCT00529399|vaccine induced tolerance|vaccine induced tolerance
589711|NCT00529399|Beta-cell function|beta-cell function
589712|NCT00529399|T-cells|t-cells
589713|NCT00529399|DPT-1|dpt-1
589714|NCT00529399|treatment of type 1 diabetes|treatment of type 1 diabetes
589715|NCT00529399|new onset type 1 diabetes|new onset type 1 diabetes
589716|NCT00529399|juvenile diabetes|juvenile diabetes
589717|NCT00529399|T1D|t1d
589718|NCT00529399|diabetes mellitus|diabetes mellitus
589719|NCT00529399|Type 1 diabetes TrialNet|type 1 diabetes trialnet
589720|NCT00529399|TrialNet|trialnet
589721|NCT00529425|Femoral neck fracture|femoral neck fracture
589722|NCT00529425|Hip fracture|hip fracture
589723|NCT00529451|Hypertension, Aliskiren, Ramipril|hypertension, aliskiren, ramipril
589724|NCT00529464|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
589725|NCT00529464|Cervical Dysplasia|cervical dysplasia
589726|NCT00529464|Cervical Cancer|cervical cancer
589727|NCT00529464|Fluorescence Spectroscopy|fluorescence spectroscopy
589728|NCT00529464|Colposcopy|colposcopy
589729|NCT00529464|Loop Electrical Excision Procedure|loop electrical excision procedure
589730|NCT00529464|LEEP|leep
589731|NCT00529490|coronary|coronary
589732|NCT00529490|artery|artery
589733|NCT00529490|bypass|bypass
589734|NCT00529490|grafting|grafting
589735|NCT00529490|I.V.|i.v.
589736|NCT00529490|cardiac output|cardiac output
589737|NCT00529503|Lymphoproliferative Disorders|lymphoproliferative disorders
589738|NCT00529503|Lymphoma|lymphoma
589739|NCT00529503|Antigens, CD40|antigens, cd40
589740|NCT00529503|Antibody, Monoclonal|antibody, monoclonal
589741|NCT00529503|Combined Modality Therapy|combined modality therapy
589742|NCT00529503|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
589743|NCT00529503|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
589744|NCT00529503|Hematologic Diseases|hematologic diseases
589745|NCT00529503|Immunoproliferative Disorders|immunoproliferative disorders
589746|NCT00529503|Lymphatic Diseases|lymphatic diseases
589747|NCT00529516|Fluarix|fluarix
589748|NCT00529516|GSK Bio's influenza vaccine GSK576389A|gsk bio's influenza vaccine gsk576389a
589749|NCT00529516|Influenza infection|influenza infection
589750|NCT00529529|asthma|asthma
589751|NCT00529529|QAB149|qab149
589752|NCT00529529|indacaterol|indacaterol
589753|NCT00529542|Polycystic Ovary Syndrome|polycystic ovary syndrome
589754|NCT00529568|hepatitis C|hepatitis c
589755|NCT00529568|ribavirin|ribavirin
589756|NCT00529568|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
589757|NCT00529568|thrombopoietin|thrombopoietin
589758|NCT00529568|peginterferon alfa-2b|peginterferon alfa-2b
589759|NCT00529568|platelets|platelets
589760|NCT00529581|multiple sclerosis|multiple sclerosis
589761|NCT00529581|cognitive impairment|cognitive impairment
589762|NCT00529581|cognitive dysfunction|cognitive dysfunction
589763|NCT00529581|Cognitive Dysfunction associated with Multiple Sclerosis|cognitive dysfunction associated with multiple sclerosis
589764|NCT00529594|Laser Photocoagulation|laser photocoagulation
589765|NCT00529594|Pain relief|pain relief
589856|NCT00538707|platelet adhesion|platelet adhesion
589766|NCT00529607|myocardial infarction, reperfusion injury, echocardiography, magnetic resonance imaging, inflammation, nitric oxide|myocardial infarction, reperfusion injury, echocardiography, magnetic resonance imaging, inflammation, nitric oxide
589767|NCT00529620|Malaria|malaria
589768|NCT00529620|IPT|ipt
589769|NCT00529620|preventive treatment|preventive treatment
589770|NCT00529633|Inflammation|inflammation
589771|NCT00529633|albumin|albumin
589772|NCT00529646|Healthy adult volunteers|healthy adult volunteers
589773|NCT00529659|Sarcopenia (loss of muscle mass)|sarcopenia (loss of muscle mass)
589774|NCT00529672|endovenous laser therapy|endovenous laser therapy
589775|NCT00529672|sclerotherapy|sclerotherapy
589776|NCT00529672|crossectomy and stripping|crossectomy and stripping
589777|NCT00529672|surgery|surgery
589778|NCT00529672|treatment|treatment
589779|NCT00529672|varicose veins|varicose veins
589780|NCT00529698|HIV|hiv
589781|NCT00529698|Tat protein|tat protein
589782|NCT00529698|Preventative vaccine|preventative vaccine
589783|NCT00529698|Healthy volunteers|healthy volunteers
589784|NCT00529698|HIV-1/2 uninfected|hiv-1/2 uninfected
589785|NCT00529698|HIV Preventive Vaccine|hiv preventive vaccine
589786|NCT00529711|coronary|coronary
589787|NCT00529711|artery|artery
589788|NCT00529711|bypass|bypass
589789|NCT00529711|grafting|grafting
589790|NCT00529711|IV|iv
589791|NCT00529711|cardiac output|cardiac output
589792|NCT00529724|Energy metabolism, metabolic syndrome, by chronic bilateral subthalamic stimulation, Parkinson's disease|energy metabolism, metabolic syndrome, by chronic bilateral subthalamic stimulation, parkinson's disease
589793|NCT00529724|Patients with Parkinson's disease and will be treated by chronic bilateral subthalamic stimulation.|patients with parkinson's disease and will be treated by chronic bilateral subthalamic stimulation.
589794|NCT00529737|Breast Cancer|breast cancer
589795|NCT00529737|Marker Clip Migration|marker clip migration
589796|NCT00529737|Vacuum-Assisted Biopsy|vacuum-assisted biopsy
589797|NCT00529737|Postprocedure Mammogram|postprocedure mammogram
589798|NCT00529737|Breast Biopsy|breast biopsy
589799|NCT00529763|Chronic Phase, Advanced Phase chronic myeloid leukemia|chronic phase, advanced phase chronic myeloid leukemia
589800|NCT00529763|Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
589801|NCT00529776|Prevention of ventilator associated pneumonia|prevention of ventilator associated pneumonia
589802|NCT00529802|metastatic|metastatic
589803|NCT00529802|renal|renal
589804|NCT00529802|cell|cell
589805|NCT00529802|carcinoma|carcinoma
589806|NCT00529802|cancer|cancer
589807|NCT00529815|Continuous|continuous
589808|NCT00529815|blood|blood
589809|NCT00529815|glucose|glucose
589810|NCT00529815|monitoring|monitoring
589811|NCT00529815|diabetes|diabetes
589812|NCT00529815|type2|type2
589813|NCT00529828|CLA|cla
589814|NCT00529828|Industrial trans fatty acids|industrial trans fatty acids
589815|NCT00529828|Oleic acid|oleic acid
589816|NCT00529828|Controlled dietary trial|controlled dietary trial
589817|NCT00529841|Salt Wasting Congenital Adrenal Hyperplasia|salt wasting congenital adrenal hyperplasia
589818|NCT00529841|Subcutaneous Hydrocortisone|subcutaneous hydrocortisone
589819|NCT00529854|Intensive care unit|intensive care unit
589820|NCT00529854|medical documentation|medical documentation
589821|NCT00529854|medical billing|medical billing
589822|NCT00529867|Artemether/Lumefantrine suspension|artemether/lumefantrine suspension
589823|NCT00529867|P. falciparum malaria|p. falciparum malaria
589824|NCT00529867|children|children
589825|NCT00529867|uncomplicated Plasmodium falciparum malaria|uncomplicated plasmodium falciparum malaria
589826|NCT00529880|AML|aml
589827|NCT00529893|Attention-deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
589828|NCT00529893|neuropsychological functioning|neuropsychological functioning
589829|NCT00529893|Atomoxetine|atomoxetine
589830|NCT00529906|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
589831|NCT00529906|neuropsychological deficits|neuropsychological deficits
589832|NCT00529906|endophenotype|endophenotype
589833|NCT00529906|molecular genetics|molecular genetics
589834|NCT00529906|candidate gene|candidate gene
589835|NCT00529906|family-based association study|family-based association study
589836|NCT00529919|Overweight|overweight
589837|NCT00529919|Obesity|obesity
589838|NCT00529919|Weight loss|weight loss
589839|NCT00529919|Medium chain triglycerides|medium chain triglycerides
589840|NCT00529919|Cardiovascular disease risk|cardiovascular disease risk
589841|NCT00529932|Acute Myocardial Infarction|acute myocardial infarction
589842|NCT00529932|Celltherapy|celltherapy
589843|NCT00529932|Bone Marrow|bone marrow
589844|NCT00529945|PFO|pfo
589845|NCT00529945|Stroke|stroke
589846|NCT00529945|Transient Ischemic Attack|transient ischemic attack
589847|NCT00529945|Migraine|migraine
589848|NCT00529945|Decompression Illness|decompression illness
589849|NCT00529958|Anterior Cruciate Ligament (ACL) Reconstruction|anterior cruciate ligament (acl) reconstruction
589850|NCT00529958|Patellar Tendon|patellar tendon
589851|NCT00529958|Hamstring Tendon|hamstring tendon
589852|NCT00529958|Double-Bundle|double-bundle
589853|NCT00529958|Autograft|autograft
589854|NCT00538694|Moderate to severe community-acquired acute bacterial pneumonia due to S. Pneumoniae|moderate to severe community-acquired acute bacterial pneumonia due to s. pneumoniae
589855|NCT00538707|mental stress|mental stress
589857|NCT00538707|platelet function|platelet function
589858|NCT00538707|catecholamines|catecholamines
589859|NCT00538720|Primary Hyperparathyroidism|primary hyperparathyroidism
589860|NCT00538720|PHPT|phpt
589861|NCT00538720|Parathyroid glands|parathyroid glands
589862|NCT00538720|Vitamin D deficiency|vitamin d deficiency
589863|NCT00538720|Vitamin D|vitamin d
589864|NCT00538720|Ergocalciferol|ergocalciferol
589865|NCT00538733|myeloma|myeloma
589866|NCT00538733|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
589867|NCT00538759|Aortic valve stenosis|aortic valve stenosis
589868|NCT00538759|Balloon aortic valvuloplasty|balloon aortic valvuloplasty
589869|NCT00538759|Aortic valve restenosis|aortic valve restenosis
589870|NCT00538772|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
589871|NCT00538772|Biomarkers|biomarkers
589872|NCT00538772|Biomarkers in patients with Metastatic Renal Cell Carcinoma Who Have Progressed After Sunitinib Therapy|biomarkers in patients with metastatic renal cell carcinoma who have progressed after sunitinib therapy
589873|NCT00538785|Synagis, motavizumab, palivizumab, children, MEDI-524, RSV, congenital hear disease|synagis, motavizumab, palivizumab, children, medi-524, rsv, congenital hear disease
589874|NCT00538798|Pharmacokinetics|pharmacokinetics
589875|NCT00538798|Binding Potential|binding potential
589876|NCT00538798|Glutamate|glutamate
589877|NCT00538798|Positron Emission Tomography|positron emission tomography
589878|NCT00538798|Metabolic Glutamate Receptors|metabolic glutamate receptors
589879|NCT00538798|Healthy Volunteer|healthy volunteer
589880|NCT00538798|HV|hv
589882|NCT00538824|relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
589883|NCT00538850|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
589884|NCT00538850|pain|pain
589885|NCT00538850|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
589886|NCT00538850|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
589887|NCT00538850|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
589888|NCT00538850|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
589889|NCT00538850|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
589890|NCT00538850|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
589891|NCT00538850|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
589892|NCT00538850|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
589893|NCT00538850|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
589894|NCT00538850|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
589895|NCT00538850|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
589896|NCT00538850|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
589897|NCT00538850|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
589898|NCT00538850|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
589899|NCT00538850|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
589900|NCT00538850|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
589901|NCT00538850|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
589902|NCT00538850|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
589903|NCT00538850|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
589904|NCT00538850|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
589905|NCT00538850|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
589906|NCT00538850|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
589907|NCT00538850|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
589908|NCT00538850|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
589909|NCT00538850|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
589910|NCT00538850|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
589911|NCT00538850|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
589912|NCT00538850|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
589913|NCT00538850|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
589914|NCT00538850|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
589915|NCT00538850|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
589916|NCT00538850|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
589917|NCT00538850|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
589918|NCT00538850|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
589919|NCT00538850|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
589920|NCT00538850|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
589921|NCT00538850|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
589922|NCT00538850|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
589923|NCT00538850|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
589924|NCT00538850|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
589925|NCT00538850|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
589926|NCT00538850|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
589927|NCT00538850|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
589928|NCT00538850|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
589929|NCT00538850|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
589930|NCT00538850|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
589931|NCT00538850|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
589932|NCT00538850|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
589933|NCT00538850|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
589934|NCT00538850|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
589935|NCT00538850|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
589936|NCT00538850|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
589937|NCT00538850|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
589938|NCT00538850|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
589939|NCT00538850|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
589940|NCT00538850|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
589941|NCT00538850|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
589942|NCT00538850|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
589943|NCT00538850|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
589944|NCT00538850|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
589945|NCT00538850|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
589946|NCT00538850|stage I multiple myeloma|stage i multiple myeloma
589947|NCT00538850|stage II multiple myeloma|stage ii multiple myeloma
589948|NCT00538850|stage III multiple myeloma|stage iii multiple myeloma
589949|NCT00538850|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
589950|NCT00538850|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
589951|NCT00538850|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
589952|NCT00538850|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
589953|NCT00538850|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
589954|NCT00538850|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
589955|NCT00538850|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
589956|NCT00538850|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
589957|NCT00538850|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
589958|NCT00538850|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
589959|NCT00538850|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
589960|NCT00538850|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
589961|NCT00538850|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
589962|NCT00538850|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
589963|NCT00538850|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
589964|NCT00538850|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
589965|NCT00538850|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
590836|NCT00541385|Coartem|coartem
589966|NCT00538850|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
589967|NCT00538850|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
589968|NCT00538850|stage I marginal zone lymphoma|stage i marginal zone lymphoma
589969|NCT00538850|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
589970|NCT00538850|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
589971|NCT00538850|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
589972|NCT00538850|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
589973|NCT00538850|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
589974|NCT00538850|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
589975|NCT00538850|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
589976|NCT00538850|stage I mantle cell lymphoma|stage i mantle cell lymphoma
589977|NCT00538850|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
589978|NCT00538850|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
589979|NCT00538850|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
589980|NCT00538850|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
589981|NCT00538850|refractory multiple myeloma|refractory multiple myeloma
589982|NCT00538850|anaplastic large cell lymphoma|anaplastic large cell lymphoma
589983|NCT00538850|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
589984|NCT00538850|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
589985|NCT00538850|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
589986|NCT00538850|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
589987|NCT00538850|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
589988|NCT00538850|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
589989|NCT00538850|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
589990|NCT00538850|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
589991|NCT00538850|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
589992|NCT00538850|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
589993|NCT00538850|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
589994|NCT00538850|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
590877|NCT00541749|SLE|sle
589995|NCT00538850|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
589996|NCT00538850|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
589997|NCT00538850|chronic eosinophilic leukemia|chronic eosinophilic leukemia
589998|NCT00538850|primary myelofibrosis|primary myelofibrosis
589999|NCT00538850|chronic neutrophilic leukemia|chronic neutrophilic leukemia
590000|NCT00538850|essential thrombocythemia|essential thrombocythemia
590001|NCT00538850|polycythemia vera|polycythemia vera
590002|NCT00538850|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
751760|NCT01170351|cysclosporine-A|cysclosporine-a
590003|NCT00538850|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
590004|NCT00538850|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
590005|NCT00538850|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
590006|NCT00538850|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
590007|NCT00538850|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
590008|NCT00538850|secondary acute myeloid leukemia|secondary acute myeloid leukemia
590009|NCT00538850|acute undifferentiated leukemia|acute undifferentiated leukemia
590010|NCT00538850|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
590011|NCT00538850|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
590012|NCT00538850|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
590013|NCT00538850|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
590014|NCT00538850|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
590015|NCT00538850|refractory hairy cell leukemia|refractory hairy cell leukemia
590016|NCT00538850|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
590017|NCT00538850|prolymphocytic leukemia|prolymphocytic leukemia
590018|NCT00538850|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
590019|NCT00538850|Waldenström macroglobulinemia|waldenström macroglobulinemia
590020|NCT00538850|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
590021|NCT00538850|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
590022|NCT00538850|splenic marginal zone lymphoma|splenic marginal zone lymphoma
590023|NCT00538850|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
590024|NCT00538850|extramedullary plasmacytoma|extramedullary plasmacytoma
590025|NCT00538850|isolated plasmacytoma of bone|isolated plasmacytoma of bone
590026|NCT00538850|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
590027|NCT00538850|primary systemic amyloidosis|primary systemic amyloidosis
590028|NCT00538850|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
590029|NCT00538850|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
590030|NCT00538850|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
590031|NCT00538850|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
590032|NCT00538850|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
590033|NCT00538850|intraocular lymphoma|intraocular lymphoma
590034|NCT00538850|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
590035|NCT00538850|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
590036|NCT00538850|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
590037|NCT00538850|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
590038|NCT00538850|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
590039|NCT00538850|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
590040|NCT00538850|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
590041|NCT00538850|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
590042|NCT00538850|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
590043|NCT00538850|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
590044|NCT00538850|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
590045|NCT00538850|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
590046|NCT00538850|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
590047|NCT00538850|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
590161|NCT00538850|adult mixed glioma|adult mixed glioma
590048|NCT00538850|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
590049|NCT00538850|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
590050|NCT00538850|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
593232|NCT00548210|scarring|scarring
590051|NCT00538850|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
590052|NCT00538850|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
590053|NCT00538850|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
590054|NCT00538850|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
590055|NCT00538850|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
590056|NCT00538850|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
590057|NCT00538850|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
590058|NCT00538850|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
590059|NCT00538850|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
590060|NCT00538850|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
590061|NCT00538850|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
751761|NCT01170351|treatment|treatment
590062|NCT00538850|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
590063|NCT00538850|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
590064|NCT00538850|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
590065|NCT00538850|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
590066|NCT00538850|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
590067|NCT00538850|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
590068|NCT00538850|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
590069|NCT00538850|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
590070|NCT00538850|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
590071|NCT00538850|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
590072|NCT00538850|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
590073|NCT00538850|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
590074|NCT00538850|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
590075|NCT00538850|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
590076|NCT00538850|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
590077|NCT00538850|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
590078|NCT00538850|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
590079|NCT00538850|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
590080|NCT00538850|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
590081|NCT00538850|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
590082|NCT00538850|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
590083|NCT00538850|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
590136|NCT00538850|adult choroid plexus tumor|adult choroid plexus tumor
590084|NCT00538850|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
590085|NCT00538850|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
590086|NCT00538850|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
590087|NCT00538850|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
590088|NCT00538850|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
590089|NCT00538850|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
590090|NCT00538850|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
590091|NCT00538850|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
590092|NCT00538850|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
590093|NCT00538850|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
590094|NCT00538850|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
590095|NCT00538850|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
590096|NCT00538850|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
590097|NCT00538850|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
590098|NCT00538850|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
590099|NCT00538850|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
590100|NCT00538850|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
590101|NCT00538850|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
590102|NCT00538850|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
590103|NCT00538850|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
590166|NCT00538850|stage IA cervical cancer|stage ia cervical cancer
590104|NCT00538850|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
590105|NCT00538850|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
590106|NCT00538850|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
590107|NCT00538850|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
590108|NCT00538850|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
590109|NCT00538850|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
590110|NCT00538850|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
590111|NCT00538850|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
590112|NCT00538850|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
590113|NCT00538850|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
590114|NCT00538850|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
590115|NCT00538850|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
590116|NCT00538850|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
590117|NCT00538850|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
590118|NCT00538850|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
590119|NCT00538850|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
590120|NCT00538850|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
590121|NCT00538850|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
590122|NCT00538850|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
590123|NCT00538850|recurrent salivary gland cancer|recurrent salivary gland cancer
590124|NCT00538850|salivary gland acinic cell tumor|salivary gland acinic cell tumor
590125|NCT00538850|salivary gland adenocarcinoma|salivary gland adenocarcinoma
590126|NCT00538850|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
590127|NCT00538850|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
590128|NCT00538850|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
590129|NCT00538850|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
590130|NCT00538850|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
590131|NCT00538850|stage I salivary gland cancer|stage i salivary gland cancer
590132|NCT00538850|stage II salivary gland cancer|stage ii salivary gland cancer
590133|NCT00538850|stage III salivary gland cancer|stage iii salivary gland cancer
590134|NCT00538850|stage IV salivary gland cancer|stage iv salivary gland cancer
590135|NCT00538850|adult grade I meningioma|adult grade i meningioma
590137|NCT00538850|adult craniopharyngioma|adult craniopharyngioma
590138|NCT00538850|adult myxopapillary ependymoma|adult myxopapillary ependymoma
590139|NCT00538850|adult diffuse astrocytoma|adult diffuse astrocytoma
590140|NCT00538850|adult pilocytic astrocytoma|adult pilocytic astrocytoma
590141|NCT00538850|adult pineocytoma|adult pineocytoma
590142|NCT00538850|adult ependymoma|adult ependymoma
590143|NCT00538850|adult subependymoma|adult subependymoma
590144|NCT00538850|adult oligodendroglioma|adult oligodendroglioma
590145|NCT00538850|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
590146|NCT00538850|meningeal melanocytoma|meningeal melanocytoma
590147|NCT00538850|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
590148|NCT00538850|adult pineal gland astrocytoma|adult pineal gland astrocytoma
590149|NCT00538850|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
590150|NCT00538850|adult medulloblastoma|adult medulloblastoma
590151|NCT00538850|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
590152|NCT00538850|adult ependymoblastoma|adult ependymoblastoma
590153|NCT00538850|adult anaplastic astrocytoma|adult anaplastic astrocytoma
590154|NCT00538850|adult anaplastic ependymoma|adult anaplastic ependymoma
590155|NCT00538850|adult glioblastoma|adult glioblastoma
590156|NCT00538850|adult gliosarcoma|adult gliosarcoma
590157|NCT00538850|adult giant cell glioblastoma|adult giant cell glioblastoma
590158|NCT00538850|adult grade III meningioma|adult grade iii meningioma
590159|NCT00538850|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
590160|NCT00538850|adult pineoblastoma|adult pineoblastoma
590698|NCT00540904|bicarbonate|bicarbonate
590162|NCT00538850|recurrent adult brain tumor|recurrent adult brain tumor
590163|NCT00538850|adult anaplastic meningioma|adult anaplastic meningioma
590164|NCT00538850|adult papillary meningioma|adult papillary meningioma
590165|NCT00538850|adult brain stem glioma|adult brain stem glioma
591143|NCT00533975|colonoscopy|colonoscopy
590167|NCT00538850|stage IB cervical cancer|stage ib cervical cancer
590168|NCT00538850|stage IIA cervical cancer|stage iia cervical cancer
590169|NCT00538850|stage IIB cervical cancer|stage iib cervical cancer
590170|NCT00538850|stage III cervical cancer|stage iii cervical cancer
590171|NCT00538850|stage IVA cervical cancer|stage iva cervical cancer
590172|NCT00538850|stage IVB cervical cancer|stage ivb cervical cancer
590173|NCT00538850|recurrent cervical cancer|recurrent cervical cancer
590174|NCT00538850|recurrent endometrial carcinoma|recurrent endometrial carcinoma
590175|NCT00538850|stage I endometrial carcinoma|stage i endometrial carcinoma
590176|NCT00538850|stage II endometrial carcinoma|stage ii endometrial carcinoma
590177|NCT00538850|stage III endometrial carcinoma|stage iii endometrial carcinoma
590178|NCT00538850|stage IV endometrial carcinoma|stage iv endometrial carcinoma
590179|NCT00538850|fallopian tube cancer|fallopian tube cancer
590180|NCT00538850|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
751762|NCT01170351|treatment-naive|treatment-naive
590181|NCT00538850|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
590182|NCT00538850|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
590183|NCT00538850|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
590184|NCT00538850|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
590185|NCT00538850|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
590186|NCT00538850|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
590187|NCT00538850|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
590188|NCT00538850|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
590189|NCT00538850|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
590190|NCT00538850|ovarian sarcoma|ovarian sarcoma
590191|NCT00538850|ovarian stromal cancer|ovarian stromal cancer
590192|NCT00538850|recurrent uterine sarcoma|recurrent uterine sarcoma
590193|NCT00538850|stage I uterine sarcoma|stage i uterine sarcoma
590194|NCT00538850|stage II uterine sarcoma|stage ii uterine sarcoma
590195|NCT00538850|stage III uterine sarcoma|stage iii uterine sarcoma
590196|NCT00538850|stage IV uterine sarcoma|stage iv uterine sarcoma
590197|NCT00538850|recurrent colon cancer|recurrent colon cancer
590198|NCT00538850|stage I colon cancer|stage i colon cancer
590199|NCT00538850|stage II colon cancer|stage ii colon cancer
590200|NCT00538850|stage III colon cancer|stage iii colon cancer
590201|NCT00538850|stage IV colon cancer|stage iv colon cancer
590202|NCT00538850|recurrent bladder cancer|recurrent bladder cancer
590203|NCT00538850|recurrent gallbladder cancer|recurrent gallbladder cancer
590204|NCT00538850|stage I bladder cancer|stage i bladder cancer
590205|NCT00538850|stage II bladder cancer|stage ii bladder cancer
590206|NCT00538850|stage III bladder cancer|stage iii bladder cancer
590207|NCT00538850|stage IV bladder cancer|stage iv bladder cancer
590208|NCT00538850|recurrent gastric cancer|recurrent gastric cancer
590209|NCT00538850|stage I gastric cancer|stage i gastric cancer
590210|NCT00538850|stage II gastric cancer|stage ii gastric cancer
590211|NCT00538850|stage III gastric cancer|stage iii gastric cancer
590212|NCT00538850|stage IV gastric cancer|stage iv gastric cancer
590213|NCT00538850|advanced adult primary liver cancer|advanced adult primary liver cancer
590214|NCT00538850|recurrent small intestine cancer|recurrent small intestine cancer
590215|NCT00538850|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
590216|NCT00538850|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
590217|NCT00538850|recurrent renal cell cancer|recurrent renal cell cancer
590218|NCT00538850|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
590219|NCT00538850|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
590220|NCT00538850|stage I renal cell cancer|stage i renal cell cancer
590221|NCT00538850|stage II renal cell cancer|stage ii renal cell cancer
590222|NCT00538850|stage III renal cell cancer|stage iii renal cell cancer
590223|NCT00538850|stage IV renal cell cancer|stage iv renal cell cancer
590224|NCT00538850|distal urethral cancer|distal urethral cancer
590225|NCT00538850|proximal urethral cancer|proximal urethral cancer
590226|NCT00538850|recurrent urethral cancer|recurrent urethral cancer
590227|NCT00538850|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
590228|NCT00538850|stage I adrenocortical carcinoma|stage i adrenocortical carcinoma
590229|NCT00538850|stage II adrenocortical carcinoma|stage ii adrenocortical carcinoma
590230|NCT00538850|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
590231|NCT00538850|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
590232|NCT00538850|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
590233|NCT00538850|extragonadal germ cell tumor|extragonadal germ cell tumor
590234|NCT00538850|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
590235|NCT00538850|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
590236|NCT00538850|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
590237|NCT00538850|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
590238|NCT00538850|gastrinoma|gastrinoma
590239|NCT00538850|insulinoma|insulinoma
590240|NCT00538850|WDHA syndrome|wdha syndrome
590241|NCT00538850|glucagonoma|glucagonoma
590242|NCT00538850|pancreatic polypeptide tumor|pancreatic polypeptide tumor
590243|NCT00538850|somatostatinoma|somatostatinoma
590244|NCT00538850|recurrent islet cell carcinoma|recurrent islet cell carcinoma
590245|NCT00538850|carcinoma of the appendix|carcinoma of the appendix
590246|NCT00538850|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
590247|NCT00538850|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
590248|NCT00538850|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
590249|NCT00538850|localized gallbladder cancer|localized gallbladder cancer
590250|NCT00538850|unresectable gallbladder cancer|unresectable gallbladder cancer
590251|NCT00538850|gastrointestinal stromal tumor|gastrointestinal stromal tumor
590252|NCT00538850|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
590253|NCT00538850|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
590254|NCT00538850|recurrent adult primary liver cancer|recurrent adult primary liver cancer
590255|NCT00538850|stage I pancreatic cancer|stage i pancreatic cancer
590256|NCT00538850|stage II pancreatic cancer|stage ii pancreatic cancer
590257|NCT00538850|stage III pancreatic cancer|stage iii pancreatic cancer
590258|NCT00538850|stage IV pancreatic cancer|stage iv pancreatic cancer
590259|NCT00538850|recurrent pancreatic cancer|recurrent pancreatic cancer
590260|NCT00538850|small intestine adenocarcinoma|small intestine adenocarcinoma
590261|NCT00538850|small intestine leiomyosarcoma|small intestine leiomyosarcoma
590262|NCT00538850|small intestine lymphoma|small intestine lymphoma
590263|NCT00538850|stage I non-small cell lung cancer|stage i non-small cell lung cancer
590264|NCT00538850|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
590265|NCT00538850|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
590266|NCT00538850|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
590267|NCT00538850|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
590268|NCT00538850|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
590269|NCT00538850|pulmonary carcinoid tumor|pulmonary carcinoid tumor
590270|NCT00538850|extensive stage small cell lung cancer|extensive stage small cell lung cancer
590271|NCT00538850|limited stage small cell lung cancer|limited stage small cell lung cancer
590272|NCT00538850|recurrent small cell lung cancer|recurrent small cell lung cancer
590273|NCT00538850|liver metastases|liver metastases
590274|NCT00538850|lung metastases|lung metastases
590275|NCT00538850|primary peritoneal cavity cancer|primary peritoneal cavity cancer
590276|NCT00538850|lung papilloma|lung papilloma
590277|NCT00538850|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
590278|NCT00538850|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
590279|NCT00538850|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
590280|NCT00538850|congenital mesoblastic nephroma|congenital mesoblastic nephroma
590281|NCT00538850|stage II breast cancer|stage ii breast cancer
590282|NCT00538850|stage IIIA breast cancer|stage iiia breast cancer
590283|NCT00538850|stage IIIB breast cancer|stage iiib breast cancer
590284|NCT00538850|stage IIIC breast cancer|stage iiic breast cancer
590285|NCT00538850|stage IV breast cancer|stage iv breast cancer
590286|NCT00538850|recurrent breast cancer|recurrent breast cancer
590287|NCT00538850|male breast cancer|male breast cancer
590288|NCT00538850|breast cancer in situ|breast cancer in situ
590563|NCT00540111|Cytokines|cytokines
590289|NCT00538850|localized osteosarcoma|localized osteosarcoma
590290|NCT00538850|metastatic osteosarcoma|metastatic osteosarcoma
590291|NCT00538850|recurrent osteosarcoma|recurrent osteosarcoma
590292|NCT00538850|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
590293|NCT00538850|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
590294|NCT00538850|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
590295|NCT00538850|chondrosarcoma|chondrosarcoma
590296|NCT00538850|malignant giant cell tumor of bone|malignant giant cell tumor of bone
590297|NCT00538850|desmoid tumor|desmoid tumor
590298|NCT00538850|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
590299|NCT00538850|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
590300|NCT00538850|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
590301|NCT00538850|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
590302|NCT00538850|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
590303|NCT00538850|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
590304|NCT00538850|advanced malignant mesothelioma|advanced malignant mesothelioma
590305|NCT00538850|localized malignant mesothelioma|localized malignant mesothelioma
590306|NCT00538850|recurrent malignant mesothelioma|recurrent malignant mesothelioma
590307|NCT00538850|phosphaturic mesenchymal tumor|phosphaturic mesenchymal tumor
590308|NCT00538850|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
590309|NCT00538850|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
590404|NCT00539006|seasonal allergic rhinitis|seasonal allergic rhinitis
590310|NCT00538850|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
590311|NCT00538850|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
590312|NCT00538850|stage 0 penile cancer|stage 0 penile cancer
590313|NCT00538850|stage I penile cancer|stage i penile cancer
590314|NCT00538850|stage II penile cancer|stage ii penile cancer
590315|NCT00538850|stage III penile cancer|stage iii penile cancer
590316|NCT00538850|stage IV penile cancer|stage iv penile cancer
590317|NCT00538850|recurrent penile cancer|recurrent penile cancer
590318|NCT00538850|stage I prostate cancer|stage i prostate cancer
590319|NCT00538850|stage IIB prostate cancer|stage iib prostate cancer
590320|NCT00538850|stage IIA prostate cancer|stage iia prostate cancer
590321|NCT00538850|stage III prostate cancer|stage iii prostate cancer
590322|NCT00538850|stage IV prostate cancer|stage iv prostate cancer
590323|NCT00538850|recurrent prostate cancer|recurrent prostate cancer
590324|NCT00538850|stage 0 vaginal cancer|stage 0 vaginal cancer
590325|NCT00538850|stage I vaginal cancer|stage i vaginal cancer
590326|NCT00538850|stage II vaginal cancer|stage ii vaginal cancer
590327|NCT00538850|stage III vaginal cancer|stage iii vaginal cancer
590328|NCT00538850|stage IVA vaginal cancer|stage iva vaginal cancer
590329|NCT00538850|stage IVB vaginal cancer|stage ivb vaginal cancer
590330|NCT00538850|recurrent vaginal cancer|recurrent vaginal cancer
590331|NCT00538850|stage 0 vulvar cancer|stage 0 vulvar cancer
590332|NCT00538850|stage I vulvar cancer|stage i vulvar cancer
590333|NCT00538850|stage II vulvar cancer|stage ii vulvar cancer
590334|NCT00538850|stage III vulvar cancer|stage iii vulvar cancer
590335|NCT00538850|stage IVB vulvar cancer|stage ivb vulvar cancer
590336|NCT00538850|recurrent vulvar cancer|recurrent vulvar cancer
590337|NCT00538850|stage 0 anal cancer|stage 0 anal cancer
590338|NCT00538850|stage I anal cancer|stage i anal cancer
590339|NCT00538850|stage II anal cancer|stage ii anal cancer
590340|NCT00538850|stage IIIA anal cancer|stage iiia anal cancer
590341|NCT00538850|stage IIIB anal cancer|stage iiib anal cancer
590342|NCT00538850|stage IV anal cancer|stage iv anal cancer
590343|NCT00538850|recurrent anal cancer|recurrent anal cancer
590344|NCT00538850|stage 0 rectal cancer|stage 0 rectal cancer
590345|NCT00538850|stage I rectal cancer|stage i rectal cancer
590346|NCT00538850|stage II rectal cancer|stage ii rectal cancer
590347|NCT00538850|stage III rectal cancer|stage iii rectal cancer
590348|NCT00538850|stage IV rectal cancer|stage iv rectal cancer
590349|NCT00538850|recurrent rectal cancer|recurrent rectal cancer
590350|NCT00538850|stage 0 esophageal cancer|stage 0 esophageal cancer
590351|NCT00538850|stage I esophageal cancer|stage i esophageal cancer
590352|NCT00538850|stage II esophageal cancer|stage ii esophageal cancer
590353|NCT00538850|stage III esophageal cancer|stage iii esophageal cancer
590354|NCT00538850|stage IV esophageal cancer|stage iv esophageal cancer
590355|NCT00538850|recurrent esophageal cancer|recurrent esophageal cancer
590356|NCT00538850|stage I thymoma|stage i thymoma
590357|NCT00538850|stage II thymoma|stage ii thymoma
590358|NCT00538850|stage III thymoma|stage iii thymoma
590359|NCT00538850|stage IVA thymoma|stage iva thymoma
590360|NCT00538850|stage IVB thymoma|stage ivb thymoma
590361|NCT00538850|recurrent melanoma|recurrent melanoma
590362|NCT00538850|stage 0 melanoma|stage 0 melanoma
590363|NCT00538850|stage IA melanoma|stage ia melanoma
590364|NCT00538850|stage IB melanoma|stage ib melanoma
590365|NCT00538850|stage IIA melanoma|stage iia melanoma
590366|NCT00538850|stage IIB melanoma|stage iib melanoma
590367|NCT00538850|stage IIC melanoma|stage iic melanoma
590368|NCT00538850|stage IIIA melanoma|stage iiia melanoma
590369|NCT00538850|stage IIIB melanoma|stage iiib melanoma
590370|NCT00538850|stage IIIC melanoma|stage iiic melanoma
590371|NCT00538850|stage IV melanoma|stage iv melanoma
590373|NCT00538902|Humira, methotrexate|humira, methotrexate
590374|NCT00538915|immunodeficiency|immunodeficiency
590375|NCT00538915|humoral immunity|humoral immunity
590376|NCT00538915|antibody deficiency|antibody deficiency
590377|NCT00538915|PID|pid
590378|NCT00538915|PIDD|pidd
590379|NCT00538928|acute respiratory distress syndrome|acute respiratory distress syndrome
590380|NCT00538928|extracorporeal lung support|extracorporeal lung support
590381|NCT00538928|hypoxia|hypoxia
590382|NCT00538928|hypercapnia|hypercapnia
590383|NCT00538928|acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
590384|NCT00538941|chocolate,|chocolate,
590385|NCT00538941|heart failure,|heart failure,
590386|NCT00538941|endothelial function,|endothelial function,
590387|NCT00538941|platelet adhesion,|platelet adhesion,
590388|NCT00538941|oxidative stress,|oxidative stress,
590389|NCT00538941|baroreceptor function,|baroreceptor function,
590390|NCT00538954|Perioperative|perioperative
590391|NCT00538954|recovery|recovery
590392|NCT00538954|nutrition|nutrition
590393|NCT00538954|enhanced|enhanced
590394|NCT00538954|laxative|laxative
590395|NCT00538967|Collagenases|collagenases
590396|NCT00538967|MMP|mmp
590397|NCT00538967|Cathepsins|cathepsins
590398|NCT00538967|Doxycycline|doxycycline
590399|NCT00538967|Aneurysm|aneurysm
590400|NCT00538980|Polycythemia Vera|polycythemia vera
590401|NCT00538980|PV|pv
590402|NCT00538980|P Vera|p vera
590403|NCT00539006|fluticasone propionate|fluticasone propionate
590405|NCT00539006|fluticasone furoate|fluticasone furoate
590406|NCT00539006|experience|experience
590407|NCT00539006|GW685698X|gw685698x
590408|NCT00539006|preference|preference
590409|NCT00539019|nutrition assessment|nutrition assessment
590410|NCT00539019|pediatric|pediatric
590411|NCT00539409|Diabetes Mellitus|diabetes mellitus
752330|NCT01172535|World Health Organization|world health organization
590412|NCT00539409|Pulsatile Intravenous Insulin Therapy|pulsatile intravenous insulin therapy
590413|NCT00539409|Diabetic Quality of Life|diabetic quality of life
590414|NCT00539409|Orthostatic Hypotension|orthostatic hypotension
590415|NCT00539409|Brittle or Labile diabetes|brittle or labile diabetes
590416|NCT00539422|breast cancer|breast cancer
590417|NCT00539422|cytochrome 450|cytochrome 450
590418|NCT00539422|CYP2D6*4|cyp2d6*4
590419|NCT00539422|Ferritin|ferritin
590420|NCT00539422|oxidative stress|oxidative stress
590421|NCT00539422|cancer|cancer
590422|NCT00539422|cancer breast|cancer breast
590423|NCT00539435|Diabetes Mellitus|diabetes mellitus
590424|NCT00539435|Pulsatile Intravenous Insulin Therapy|pulsatile intravenous insulin therapy
590425|NCT00539435|Diabetic Cardiac Quality of Life|diabetic cardiac quality of life
590426|NCT00539435|Cardiac Disease|cardiac disease
590427|NCT00539474|ROLL trial|roll trial
590428|NCT00539474|Minimally invasive surgery|minimally invasive surgery
590429|NCT00539474|Non palpable breast cancer|non palpable breast cancer
590430|NCT00539500|Neuroblastoma|neuroblastoma
590431|NCT00539500|ClinicMACS|clinicmacs
590432|NCT00539500|CliniMACS|clinimacs
590433|NCT00539500|Stem Cell Transplantation|stem cell transplantation
590434|NCT00539500|Blood And Marrow Transplantation|blood and marrow transplantation
590435|NCT00539500|Pediatric|pediatric
590436|NCT00539500|Solid Tumors|solid tumors
590437|NCT00539500|Carboplatin|carboplatin
590438|NCT00539500|Paraplatin|paraplatin
590439|NCT00539500|Etoposide|etoposide
590440|NCT00539500|VePesid|vepesid
590441|NCT00539500|Melphalan|melphalan
590442|NCT00539500|Alkeran|alkeran
590443|NCT00539500|CD133+ Cells|cd133+ cells
590444|NCT00539513|obsessive-compulsive disorder|obsessive-compulsive disorder
590445|NCT00539513|OCD|ocd
590446|NCT00539513|glutamate|glutamate
590447|NCT00539513|N-Acetylcysteine|n-acetylcysteine
590448|NCT00539513|augmentation|augmentation
590449|NCT00539565|biliary atresia|biliary atresia
590450|NCT00539565|Kasai portoenterostomy|kasai portoenterostomy
590451|NCT00539565|corticosteroids|corticosteroids
590452|NCT00539591|Cutaneous Melanoma|cutaneous melanoma
590453|NCT00539604|Comparison study between MDCT and coronary angiography|comparison study between mdct and coronary angiography
590454|NCT00539617|metastatic esophageal cancer|metastatic esophageal cancer
590455|NCT00539617|erlotinib|erlotinib
590456|NCT00539617|folfox|folfox
590457|NCT00539617|advanced esophageal cancer|advanced esophageal cancer
590458|NCT00539617|unresectable esophageal cancer|unresectable esophageal cancer
590459|NCT00539643|Liver Cancer|liver cancer
590460|NCT00539643|Hepatoma|hepatoma
590461|NCT00539643|07-099|07-099
590462|NCT00539656|Cord blood stem cell transplantation|cord blood stem cell transplantation
590463|NCT00539656|Ex vivo expansion|ex vivo expansion
590464|NCT00539656|Alternative donor|alternative donor
590465|NCT00539695|Stem Cell transplant|stem cell transplant
590466|NCT00539695|Graft verus host disease|graft verus host disease
590467|NCT00539695|IL-2|il-2
590468|NCT00539695|acute lymphoblastic leukemia|acute lymphoblastic leukemia
590469|NCT00539695|ALL|all
590470|NCT00539695|acute myelogenous leukemia|acute myelogenous leukemia
590471|NCT00539695|AML|aml
590472|NCT00539695|chronic myelogenous leukemia|chronic myelogenous leukemia
590473|NCT00539695|myelodysplastic syndrome|myelodysplastic syndrome
590474|NCT00539695|myeloproliferative disorder|myeloproliferative disorder
590475|NCT00539695|Hodgkin lymphoma|hodgkin lymphoma
590476|NCT00539695|non-Hodgkin lymphoma|non-hodgkin lymphoma
590477|NCT00539695|non-malignant diseases requiring allogeneic HSCT|non-malignant diseases requiring allogeneic hsct
590478|NCT00539708|Non-invasive ventilation|non-invasive ventilation
590479|NCT00539708|Hypercapnic respiratory failure|hypercapnic respiratory failure
590480|NCT00539708|Mechanical ventilation|mechanical ventilation
590481|NCT00539708|Respiratory failure after extubation|respiratory failure after extubation
590482|NCT00539721|Nausea|nausea
590483|NCT00539721|Vomiting|vomiting
590484|NCT00539734|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
590485|NCT00539734|choroidal neovascularization membrane(CNVM)|choroidal neovascularization membrane(cnvm)
590486|NCT00539734|ranibizumab|ranibizumab
590487|NCT00539734|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
590488|NCT00539734|electrophysiology|electrophysiology
590489|NCT00539734|electroretinography|electroretinography
590490|NCT00539747|Presymptomatic|presymptomatic
590491|NCT00539747|Huntington Disease|huntington disease
590492|NCT00539747|Meaning Making|meaning making
590493|NCT00539747|Genetic Testing|genetic testing
590494|NCT00539747|HD|hd
590495|NCT00539760|domain antibody|domain antibody
590496|NCT00539760|Rheumatoid Arthritis,|rheumatoid arthritis,
590497|NCT00539786|Patients with extraesophageal manifestation of gastroesophageal reflux disease|patients with extraesophageal manifestation of gastroesophageal reflux disease
590697|NCT00540904|nephropathy|nephropathy
590498|NCT00539799|systemic lupus erythematosus|systemic lupus erythematosus
590499|NCT00539799|lupus nephritis|lupus nephritis
590500|NCT00539812|Intimate partner violence|intimate partner violence
590501|NCT00539812|alcohol use|alcohol use
590502|NCT00539812|substance use|substance use
591476|NCT00535106|AED|aed
590503|NCT00539825|Anticholinergic,|anticholinergic,
590504|NCT00539825|Plethysmography|plethysmography
590505|NCT00539825|Muscarinic Receptor Antagonist,|muscarinic receptor antagonist,
590506|NCT00539825|COPD,|copd,
590507|NCT00539825|FTIH,|ftih,
590508|NCT00539838|SLE|sle
590509|NCT00539851|Allogenic Stem Cell Transplantation|allogenic stem cell transplantation
590510|NCT00539851|Diabetes Mellitus|diabetes mellitus
590511|NCT00539864|Influenza|influenza
590512|NCT00539877|Gstric cancer|gstric cancer
590513|NCT00539877|Pritoneal seeding|pritoneal seeding
590514|NCT00539877|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
590515|NCT00539877|Irinotecan|irinotecan
590516|NCT00539903|Activity Level|activity level
590517|NCT00539942|Randomized Clinical Trials|randomized clinical trials
590518|NCT00539942|Randomized Controlled Trial|randomized controlled trial
590519|NCT00539942|Venous thrombosis|venous thrombosis
590520|NCT00539942|Anticoagulant Drugs|anticoagulant drugs
590521|NCT00539942|Doppler Ultrasound|doppler ultrasound
590522|NCT00539942|Postoperative complications|postoperative complications
590523|NCT00539955|intimate partner violence|intimate partner violence
590524|NCT00539955|alcohol use|alcohol use
590525|NCT00539955|substance use|substance use
590526|NCT00539981|Influenza|influenza
590527|NCT00539994|Altabax|altabax
590528|NCT00539994|SB-275833|sb-275833
590529|NCT00539994|retapamulin|retapamulin
590530|NCT00539994|nasal colonization|nasal colonization
590531|NCT00539994|PK|pk
590532|NCT00539994|tolerability|tolerability
590533|NCT00539994|safety|safety
590534|NCT00539994|efficacy|efficacy
590535|NCT00540007|Hodgkin Lymphoma|hodgkin lymphoma
590536|NCT00540007|Lenalidomide|lenalidomide
590537|NCT00540007|Anti-neoplastic agents|anti-neoplastic agents
590538|NCT00540007|Thalidomide|thalidomide
590539|NCT00540020|Brain Injuries|brain injuries
590540|NCT00540020|Cognition|cognition
590541|NCT00540020|Randomized Trials|randomized trials
590542|NCT00540020|Rehabilitation|rehabilitation
590543|NCT00540020|Treatment Outcome|treatment outcome
590544|NCT00540033|probiotics|probiotics
590545|NCT00540033|necrotizing enterocolitis|necrotizing enterocolitis
590546|NCT00540033|preterm very low birth weight infants (VLBW)|preterm very low birth weight infants (vlbw)
590547|NCT00540046|IUD|iud
590548|NCT00540046|Second trimester termination|second trimester termination
590549|NCT00540046|Contraception|contraception
590550|NCT00540059|Prostate carcinoma|prostate carcinoma
590551|NCT00540059|LHRH|lhrh
590552|NCT00540059|Zoladex|zoladex
590553|NCT00540072|Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae|moderate to severe community-acquired acute bacterial pneumonia due to s. pneumoniae
590554|NCT00540098|panic disorder|panic disorder
590555|NCT00540098|pharmacotherapy|pharmacotherapy
590556|NCT00540098|non-pharmacological treatment|non-pharmacological treatment
590557|NCT00540098|SSRI|ssri
590558|NCT00540098|paroxetine|paroxetine
590559|NCT00540098|exercise|exercise
590560|NCT00540111|Soluble fiber|soluble fiber
590561|NCT00540111|HIV/aids|hiv/aids
590562|NCT00540111|Hypertriglyceridemia|hypertriglyceridemia
590564|NCT00540111|Alternative Medicine|alternative medicine
590565|NCT00540111|Complementary Medicine|complementary medicine
590566|NCT00540137|Antiretroviral therapy|antiretroviral therapy
590567|NCT00540137|Neurocognitive function|neurocognitive function
590568|NCT00540137|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
590569|NCT00540137|HIV disease|hiv disease
590570|NCT00540137|Treatment Naive|treatment naive
590571|NCT00540150|Immunotherapy|immunotherapy
590572|NCT00540150|Mite|mite
590573|NCT00540150|Asthma|asthma
590574|NCT00540150|bronchial provocation|bronchial provocation
590575|NCT00540150|SIT|sit
590576|NCT00540150|specific immunotherapy|specific immunotherapy
590577|NCT00540176|Dichloroacetate|dichloroacetate
590578|NCT00540176|Glioblastoma Multiforme|glioblastoma multiforme
590579|NCT00540176|Glioma|glioma
590580|NCT00540189|appendicitis, perforated, children|appendicitis, perforated, children
590581|NCT00540202|Effectiveness|effectiveness
590582|NCT00540202|Oral quinine|oral quinine
590583|NCT00540202|Coartem|coartem
590584|NCT00540202|Uncomplicated malaria|uncomplicated malaria
590585|NCT00540202|Children|children
590586|NCT00540228|Influenza|influenza
590587|NCT00540228|Influenza Vaccine|influenza vaccine
590588|NCT00540254|Chronic Fatigue|chronic fatigue
590589|NCT00540254|Insomnia|insomnia
590590|NCT00540254|Cognitive Behavioral Therapy|cognitive behavioral therapy
590591|NCT00540267|Schizophrenia|schizophrenia
590592|NCT00540267|Alcohol Abuse|alcohol abuse
590593|NCT00540267|Bone Density|bone density
590594|NCT00540280|NSCLC|nsclc
590595|NCT00540306|breast tissue|breast tissue
590596|NCT00540319|Risky behaviors|risky behaviors
590597|NCT00540319|Prenatal care|prenatal care
590598|NCT00540319|Substance use|substance use
590599|NCT00540319|Domestic violence|domestic violence
590600|NCT00540332|Oncology|oncology
590601|NCT00540332|KGF|kgf
590602|NCT00540332|HNC|hnc
590603|NCT00540332|head and neck|head and neck
590604|NCT00540332|oral mucositis|oral mucositis
590605|NCT00540332|OM|om
590606|NCT00540332|proteinurea|proteinurea
590607|NCT00540332|palifermin|palifermin
590608|NCT00540332|clinical trial|clinical trial
590609|NCT00540345|chronic hepatitis C|chronic hepatitis c
590610|NCT00540345|genotype 2|genotype 2
590611|NCT00540345|rapid virological response|rapid virological response
590612|NCT00540345|sustained virological response|sustained virological response
590613|NCT00540345|peginterferon|peginterferon
590614|NCT00540345|ribavirin|ribavirin
590615|NCT00540345|treatment duration|treatment duration
590616|NCT00540358|Triple negative breast cancer|triple negative breast cancer
590617|NCT00540371|Port Wine Stain|port wine stain
590619|NCT00540384|Solid tumors|solid tumors
590620|NCT00540384|Multicycle chemotherapy|multicycle chemotherapy
590621|NCT00540384|NESP|nesp
590622|NCT00540423|thrombopoietin,|thrombopoietin,
590623|NCT00540423|immunosuppressive therapy,|immunosuppressive therapy,
590625|NCT00540423|idiopathic thrombocytopenic purpura,|idiopathic thrombocytopenic purpura,
590626|NCT00540423|blood platelet,|blood platelet,
590627|NCT00540423|splenectomy|splenectomy
590628|NCT00540436|Ambrisentan|ambrisentan
590629|NCT00540436|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
590630|NCT00540436|6MWD|6mwd
590631|NCT00540449|TMC278-C209|tmc278-c209
590632|NCT00540449|Antiretroviral|antiretroviral
590633|NCT00540449|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
590634|NCT00540449|HIV-1|hiv-1
590635|NCT00540449|AIDS|aids
590636|NCT00540449|TMC278-TiDP6-C209|tmc278-tidp6-c209
590637|NCT00540449|Treatment Naive|treatment naive
590638|NCT00540462|Type II Diabetes Mellitus|type ii diabetes mellitus
590639|NCT00540462|Gastric bypass|gastric bypass
590640|NCT00540462|Obese-related diabetes mellitus|obese-related diabetes mellitus
590641|NCT00540462|Sugar control|sugar control
590642|NCT00540462|treatment of obesity related diabetes mellitus|treatment of obesity related diabetes mellitus
590643|NCT00540475|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
590644|NCT00540475|Interstitial Lung Disease|interstitial lung disease
590645|NCT00540501|zanamivir,|zanamivir,
590646|NCT00540501|influenza virus,|influenza virus,
590647|NCT00540501|healthy volunteer,|healthy volunteer,
590648|NCT00540501|PK, drug interaction,|pk, drug interaction,
590649|NCT00540501|IV, and oseltamivir.|iv, and oseltamivir.
590650|NCT00540514|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
590651|NCT00540527|acute ischemic stroke;thrombolysis;intraarterial thrombolysis|acute ischemic stroke;thrombolysis;intraarterial thrombolysis
590652|NCT00540553|SARM,|sarm,
590653|NCT00540553|FTIH,|ftih,
590654|NCT00540553|pharmacokinetics|pharmacokinetics
590655|NCT00540579|Pancreas|pancreas
590656|NCT00540579|Untreated|untreated
590657|NCT00540579|Advanced|advanced
590658|NCT00540579|Gemcitabine|gemcitabine
590659|NCT00540579|CC-4047|cc-4047
590660|NCT00540592|Influenza vaccine GSK576389A|influenza vaccine gsk576389a
590661|NCT00540592|Influenza infection|influenza infection
590662|NCT00540592|Fluarix|fluarix
590663|NCT00540605|Microbicide|microbicide
590664|NCT00540605|Pregnancy|pregnancy
590665|NCT00540605|HIV Seronegativity|hiv seronegativity
590666|NCT00540631|House Dust Mite Allergen|house dust mite allergen
590667|NCT00540631|Aluminium hydroxide-adsorbed|aluminium hydroxide-adsorbed
590668|NCT00540644|Multiple Myeloma|multiple myeloma
590669|NCT00540644|Revlimid|revlimid
590670|NCT00540670|Coronary artery disease|coronary artery disease
590671|NCT00540696|Anemia|anemia
590672|NCT00540696|Non-Myeloid Malignancies|non-myeloid malignancies
590673|NCT00540696|darbepoetin alfa|darbepoetin alfa
590674|NCT00540696|chemotherapy|chemotherapy
590675|NCT00540748|first trimester abortion|first trimester abortion
590676|NCT00540748|oxytocin|oxytocin
590677|NCT00540761|Coronary Artery Disease|coronary artery disease
590678|NCT00540761|Atherosclerosis|atherosclerosis
590679|NCT00540774|oral cancer|oral cancer
590680|NCT00540774|oral mucositis|oral mucositis
590681|NCT00540774|oral stomatitis|oral stomatitis
590682|NCT00540774|Dry mouth|dry mouth
590683|NCT00540774|Gingivitis|gingivitis
590684|NCT00540800|anthracycline pre-treated|anthracycline pre-treated
590685|NCT00540800|chemotherapy|chemotherapy
590686|NCT00540800|first-line|first-line
590687|NCT00540800|metastatic breast cancer|metastatic breast cancer
590688|NCT00540800|locally advanced breast cancer|locally advanced breast cancer
590689|NCT00540813|bifurcation stenosis|bifurcation stenosis
590690|NCT00540813|Patients with documented ischemia due to a de-novo bifurcation stenosis|patients with documented ischemia due to a de-novo bifurcation stenosis
590691|NCT00540852|Breast cancer receiving chemotherapy|breast cancer receiving chemotherapy
590692|NCT00540865|Homebound Persons|homebound persons
590693|NCT00540865|Case Management|case management
590694|NCT00540865|Problem Solving Therapy|problem solving therapy
590695|NCT00540878|Formulation Drug Study|formulation drug study
590696|NCT00540904|contrast|contrast
590703|NCT00540943|Colorectal cancer,|colorectal cancer,
590704|NCT00540956|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
590705|NCT00540956|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
590706|NCT00540956|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
590707|NCT00540956|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
590708|NCT00540956|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
590709|NCT00540956|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
590710|NCT00540956|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
590711|NCT00540956|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
590712|NCT00540956|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
590713|NCT00540956|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
590714|NCT00540956|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
590715|NCT00540956|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
590716|NCT00540956|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
590717|NCT00540956|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
590718|NCT00540969|bone metastases|bone metastases
590719|NCT00540969|pain|pain
590720|NCT00540969|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
590721|NCT00540969|stage IV melanoma|stage iv melanoma
590722|NCT00540969|stage IV renal cell cancer|stage iv renal cell cancer
590723|NCT00540982|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
590724|NCT00540982|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
590725|NCT00540982|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
590726|NCT00540982|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
590727|NCT00540982|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
590728|NCT00541008|type 1 papillary renal cell carcinoma|type 1 papillary renal cell carcinoma
590729|NCT00541008|type 2 papillary renal cell carcinoma|type 2 papillary renal cell carcinoma
590730|NCT00541008|stage IV renal cell cancer|stage iv renal cell cancer
590731|NCT00541008|stage III renal cell cancer|stage iii renal cell cancer
590732|NCT00541021|stage III pancreatic cancer|stage iii pancreatic cancer
590733|NCT00541021|stage IV pancreatic cancer|stage iv pancreatic cancer
590734|NCT00541021|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
590735|NCT00541021|recurrent pancreatic cancer|recurrent pancreatic cancer
590736|NCT00541034|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
590737|NCT00541034|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
590738|NCT00541034|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
590739|NCT00541034|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
590740|NCT00541034|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
590741|NCT00541034|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
590742|NCT00541034|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
590743|NCT00541034|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
590744|NCT00541034|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
590745|NCT00541047|sexual dysfunction|sexual dysfunction
590746|NCT00541047|urinary complications|urinary complications
590747|NCT00541047|gastrointestinal complications|gastrointestinal complications
590835|NCT00541385|Phillipines|phillipines
590748|NCT00541047|adenocarcinoma of the prostate|adenocarcinoma of the prostate
590749|NCT00541047|stage I prostate cancer|stage i prostate cancer
590750|NCT00541047|stage IIB prostate cancer|stage iib prostate cancer
590751|NCT00541047|stage IIA prostate cancer|stage iia prostate cancer
590752|NCT00541047|stage III prostate cancer|stage iii prostate cancer
590753|NCT00541060|caries susceptibility,enamel matrix,candidate genes,mutation|caries susceptibility,enamel matrix,candidate genes,mutation
590754|NCT00541073|advanced malignant mesothelioma|advanced malignant mesothelioma
590755|NCT00541073|recurrent malignant mesothelioma|recurrent malignant mesothelioma
590756|NCT00541086|stage IA breast cancer|stage ia breast cancer
590757|NCT00541086|stage IB breast cancer|stage ib breast cancer
590758|NCT00541086|stage II breast cancer|stage ii breast cancer
590759|NCT00541086|stage IIIA breast cancer|stage iiia breast cancer
590760|NCT00541086|stage IIIB breast cancer|stage iiib breast cancer
590761|NCT00541086|stage IIIC breast cancer|stage iiic breast cancer
590762|NCT00541086|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
590763|NCT00541086|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
590764|NCT00541099|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
590765|NCT00541099|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
590766|NCT00541099|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
590767|NCT00541112|stage III rectal cancer|stage iii rectal cancer
590768|NCT00541112|stage IV rectal cancer|stage iv rectal cancer
590769|NCT00541112|adenocarcinoma of the rectum|adenocarcinoma of the rectum
590770|NCT00541125|recurrent colon cancer|recurrent colon cancer
590771|NCT00541125|stage IV colon cancer|stage iv colon cancer
590772|NCT00541125|recurrent rectal cancer|recurrent rectal cancer
590773|NCT00541125|stage IV rectal cancer|stage iv rectal cancer
590774|NCT00541125|adenocarcinoma of the colon|adenocarcinoma of the colon
590775|NCT00541125|adenocarcinoma of the rectum|adenocarcinoma of the rectum
590776|NCT00541138|tumors metastatic to brain|tumors metastatic to brain
590777|NCT00541138|recurrent adult brain tumor|recurrent adult brain tumor
590778|NCT00541138|adult anaplastic astrocytoma|adult anaplastic astrocytoma
590779|NCT00541138|adult diffuse astrocytoma|adult diffuse astrocytoma
590780|NCT00541138|adult giant cell glioblastoma|adult giant cell glioblastoma
590781|NCT00541138|adult gliosarcoma|adult gliosarcoma
590782|NCT00541138|adult pilocytic astrocytoma|adult pilocytic astrocytoma
590783|NCT00541138|adult pineal gland astrocytoma|adult pineal gland astrocytoma
590784|NCT00541138|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
590785|NCT00541138|adult brain stem glioma|adult brain stem glioma
590786|NCT00541138|adult anaplastic ependymoma|adult anaplastic ependymoma
590787|NCT00541138|adult ependymoma|adult ependymoma
590788|NCT00541138|adult myxopapillary ependymoma|adult myxopapillary ependymoma
590789|NCT00541138|adult subependymoma|adult subependymoma
590790|NCT00541138|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
590791|NCT00541138|adult oligodendroglioma|adult oligodendroglioma
590792|NCT00541138|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
590793|NCT00541138|adult mixed glioma|adult mixed glioma
590794|NCT00541151|Stress urinary incontinence in Women|stress urinary incontinence in women
590795|NCT00541164|CMT|cmt
590796|NCT00541164|Charcot-Marie Tooth|charcot-marie tooth
590797|NCT00541164|CoQ10|coq10
590798|NCT00541164|Coenzyme Q10|coenzyme q10
590799|NCT00541177|prevention myopia|prevention myopia
590800|NCT00541190|cystic fibrosis|cystic fibrosis
590801|NCT00541190|mucociliary clearance|mucociliary clearance
590802|NCT00541190|outcome measures|outcome measures
590803|NCT00541203|tomography|tomography
590804|NCT00541203|coronary artery disease|coronary artery disease
590805|NCT00541203|Stress Test|stress test
590806|NCT00541203|Coronary Angiography|coronary angiography
590807|NCT00541216|congenital myasthenia|congenital myasthenia
590808|NCT00541216|ephedrine|ephedrine
590809|NCT00541255|Bronchial Asthma|bronchial asthma
590810|NCT00541255|Food Allergy|food allergy
590811|NCT00541255|Bronchial Hyperresponsiveness|bronchial hyperresponsiveness
590812|NCT00541268|Heart Failure|heart failure
590813|NCT00541268|ICD|icd
590814|NCT00541268|Dilated cardiomyopathy|dilated cardiomyopathy
590815|NCT00541281|prostate cancer|prostate cancer
590816|NCT00541281|hormone resistant|hormone resistant
590817|NCT00541281|metastatic|metastatic
590818|NCT00541281|estramustine combine to docetaxel|estramustine combine to docetaxel
590819|NCT00541281|randomized study|randomized study
590820|NCT00541294|Tuberculosis|tuberculosis
590821|NCT00541294|HIV|hiv
590822|NCT00541294|Diagnostics|diagnostics
590823|NCT00541294|Pediatrics|pediatrics
590824|NCT00541307|Peripheral Arterial Disease|peripheral arterial disease
590825|NCT00541307|Peripheral Vascular Disease|peripheral vascular disease
590826|NCT00541320|Anti-thrombolytic direct Factor Xa inhibitor|anti-thrombolytic direct factor xa inhibitor
590827|NCT00541333|Dry Age Related Macular Degeneration|dry age related macular degeneration
590828|NCT00541333|Dry AMD|dry amd
590829|NCT00541346|Autism|autism
590830|NCT00541346|Autism Spectrum Disorders|autism spectrum disorders
590831|NCT00541346|ADHD|adhd
590832|NCT00541385|malaria|malaria
590833|NCT00541385|pediatric|pediatric
590834|NCT00541385|Africa|africa
590837|NCT00541385|Artesunate|artesunate
590838|NCT00541385|lumefantrine|lumefantrine
590839|NCT00541385|Arthemeter|arthemeter
590840|NCT00541385|pyronaridine|pyronaridine
590841|NCT00541385|Pyramax|pyramax
590842|NCT00541398|Antipsychotic polypharmacy|antipsychotic polypharmacy
590843|NCT00541398|Schizophrenia|schizophrenia
590844|NCT00541398|Implementation of clinical guidelines|implementation of clinical guidelines
590845|NCT00541424|Mantle Cell Lymphoma|mantle cell lymphoma
590846|NCT00541424|Lymphoma|lymphoma
590847|NCT00541424|CT Colonography|ct colonography
590848|NCT00541424|PET Scan|pet scan
590849|NCT00541424|PET/CT Scan|pet/ct scan
590850|NCT00541424|Gas Insufflation|gas insufflation
590851|NCT00541437|Change from baseline of HbA1c after 16 weeks of treatment|change from baseline of hba1c after 16 weeks of treatment
590852|NCT00541437|Change from baseline of FPG after 16 weeks of treatment|change from baseline of fpg after 16 weeks of treatment
590853|NCT00541437|Change from baseline of diabetes self-care scale by patient on drug administration after 16 weeks of treatment|change from baseline of diabetes self-care scale by patient on drug administration after 16 weeks of treatment
590854|NCT00541463|HIV|hiv
590855|NCT00541463|Treatment Experienced|treatment experienced
590856|NCT00541489|Osteoarthritis|osteoarthritis
590857|NCT00541489|Osteoarthritis, Hip|osteoarthritis, hip
590858|NCT00541502|evaluate the effectiveness of improving cognitive function of aripiprazole in treating adolescents and young adults with psychotic disorder in Taiwan|evaluate the effectiveness of improving cognitive function of aripiprazole in treating adolescents and young adults with psychotic disorder in taiwan
590859|NCT00541515|Type 1 diabetes|type 1 diabetes
590860|NCT00541515|Artificial pancreas|artificial pancreas
590861|NCT00541515|Insulin Pump|insulin pump
590961|NCT00526942|SAAGE|saage
590862|NCT00541567|Wheight management in T2D|wheight management in t2d
593424|NCT00542633|NIDDM|niddm
590863|NCT00541593|Pancreatic pseudocyst|pancreatic pseudocyst
590864|NCT00541593|NOTES|notes
590865|NCT00541606|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
590866|NCT00541606|Pharmaceutical Care|pharmaceutical care
590867|NCT00541606|Collaborative Practice|collaborative practice
590868|NCT00541619|hypertension|hypertension
590869|NCT00541619|sympathetic activity|sympathetic activity
590870|NCT00541619|early renal damage|early renal damage
590871|NCT00541671|Narcotics|narcotics
590872|NCT00541671|Nausea|nausea
590873|NCT00541710|menopause|menopause
590874|NCT00541710|genistein|genistein
590875|NCT00541710|pre-diabetes|pre-diabetes
590876|NCT00541736|Familial Hemiplegic Migraine|familial hemiplegic migraine
590878|NCT00541762|Neurotensin|neurotensin
590879|NCT00541762|Human|human
590880|NCT00541762|Physiology of neurotensin|physiology of neurotensin
590881|NCT00541762|fat perfusion|fat perfusion
590882|NCT00541762|healthy subjects|healthy subjects
590883|NCT00541814|Renal Transplantation|renal transplantation
590884|NCT00541814|Calcineurin Inhibitor|calcineurin inhibitor
590885|NCT00541814|Cyclosporine|cyclosporine
590886|NCT00541814|Withdrawal|withdrawal
590887|NCT00541814|Minimisation|minimisation
590888|NCT00541827|Sepsis. Shock, septic. Mitochondria.|sepsis. shock, septic. mitochondria.
590889|NCT00541840|Sarcoma|sarcoma
590890|NCT00541840|Sorafenib|sorafenib
590891|NCT00541840|GEIS|geis
590892|NCT00541853|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
590893|NCT00541853|Hypertension|hypertension
590894|NCT00541853|Angiotensin-2 Receptor Blocker|angiotensin-2 receptor blocker
590895|NCT00541853|Calcium Channel Blocker|calcium channel blocker
590896|NCT00541853|Kidney Volume|kidney volume
590897|NCT00541866|Leukemia|leukemia
590898|NCT00541866|Acute Myeloid|acute myeloid
590899|NCT00541866|Relapsed|relapsed
590900|NCT00541866|Refractory|refractory
590901|NCT00541866|Cancer|cancer
590902|NCT00541866|AML|aml
590903|NCT00541866|Cytarabine|cytarabine
590904|NCT00541866|SNS-595|sns-595
590905|NCT00541866|Phase 1|phase 1
590906|NCT00541866|Voreloxin|voreloxin
590907|NCT00541879|Childhood|childhood
590908|NCT00541879|Prevention|prevention
590909|NCT00541879|Energy balance|energy balance
590910|NCT00541879|Glucose regulation|glucose regulation
590911|NCT00541879|Healthy lifestyle|healthy lifestyle
590912|NCT00541879|Healthy eating|healthy eating
590913|NCT00541879|Active living|active living
590914|NCT00541892|Cell Culture Techniques|cell culture techniques
590915|NCT00526760|Dexmedetomidine, Sedation, Long-term, Phase 3|dexmedetomidine, sedation, long-term, phase 3
590916|NCT00526773|motivational therapy|motivational therapy
590917|NCT00526786|Low Grade Dysplasia|low grade dysplasia
590918|NCT00526786|High Grade Dysplasia|high grade dysplasia
590919|NCT00526786|Barrett's Esophagus|barrett's esophagus
590920|NCT00526786|Cryospray ablation|cryospray ablation
590921|NCT00526786|ICE|ice
590922|NCT00526786|Cryotherapy|cryotherapy
590923|NCT00526786|Cryo|cryo
590924|NCT00526786|CryoSpray|cryospray
590925|NCT00526838|Solid Tumor|solid tumor
590926|NCT00526838|Multiple Myeloma|multiple myeloma
590927|NCT00526851|lip and oral cavity cancer|lip and oral cavity cancer
590928|NCT00526851|oropharyngeal cancer|oropharyngeal cancer
590929|NCT00526864|Burden of Illness for Herpes zoster in Thailand.|burden of illness for herpes zoster in thailand.
590930|NCT00526877|Schizophrenia|schizophrenia
590931|NCT00526877|Schizoaffective disorders|schizoaffective disorders
590932|NCT00526877|Risperidone|risperidone
590933|NCT00526877|Risperdal Consta|risperdal consta
590934|NCT00526890|squamous cell lung cancer|squamous cell lung cancer
590935|NCT00526890|adenocarcinoma of the lung|adenocarcinoma of the lung
590936|NCT00526890|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
590937|NCT00526890|large cell lung cancer|large cell lung cancer
590938|NCT00526890|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
590939|NCT00526890|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
590940|NCT00526890|adenosquamous cell lung cancer|adenosquamous cell lung cancer
590941|NCT00526903|IBS|ibs
590942|NCT00526903|abdominal pain|abdominal pain
590943|NCT00526903|recurrent abdominal pain|recurrent abdominal pain
590944|NCT00526903|irritable bowel syndrome|irritable bowel syndrome
590945|NCT00526903|diarrhea|diarrhea
590946|NCT00526903|constipation|constipation
590947|NCT00526903|bloating|bloating
590948|NCT00526916|Epilepsy|epilepsy
590949|NCT00526916|Taenia Solium|taenia solium
590950|NCT00526916|Microglia|microglia
590951|NCT00526916|Neuroinflammation|neuroinflammation
590952|NCT00526916|Compartment Model|compartment model
590953|NCT00526916|Neurocysticercosis|neurocysticercosis
590954|NCT00526916|Healthy Volunteer|healthy volunteer
590955|NCT00526916|HV|hv
590956|NCT00526942|ACRD|acrd
590957|NCT00526942|Visual Memory|visual memory
590958|NCT00526942|Visual Perception|visual perception
590959|NCT00526942|Speed|speed
590960|NCT00526942|Computerized|computerized
590962|NCT00526942|Cognitive Decline|cognitive decline
593528|NCT00543075|G3139|g3139
590963|NCT00526955|Manual muscle testing|manual muscle testing
590964|NCT00526994|intimate partner violence|intimate partner violence
590965|NCT00526994|domestic violence|domestic violence
590966|NCT00526994|spouse abuse|spouse abuse
590967|NCT00526994|screening|screening
590968|NCT00527007|Vasopressor|vasopressor
590969|NCT00527007|Epinephrine|epinephrine
590970|NCT00527007|Norepinephrine|norepinephrine
590971|NCT00527007|Cooling|cooling
590972|NCT00527007|Fever|fever
590974|NCT00527020|qEEG,|qeeg,
590975|NCT00527020|GlyT-1 inhibitor,|glyt-1 inhibitor,
590976|NCT00527020|ERP|erp
590977|NCT00527020|GSK1018921,|gsk1018921,
590978|NCT00527020|FTIH,|ftih,
590979|NCT00527020|schizophrenia,|schizophrenia,
590980|NCT00527020|single-dose,|single-dose,
590981|NCT00527020|healthy volunteers,|healthy volunteers,
590982|NCT00527020|MMN,|mmn,
590983|NCT00527033|YM178|ym178
590984|NCT00527033|Urinary Bladder, Overactive|urinary bladder, overactive
590985|NCT00527059|Cardiorenal syndrome|cardiorenal syndrome
590987|NCT00527072|psoriasis|psoriasis
590988|NCT00527072|infliximab|infliximab
590989|NCT00527072|remicade|remicade
590990|NCT00527072|etanercept|etanercept
590991|NCT00527072|enbrel|enbrel
590992|NCT00527072|psunrise|psunrise
590993|NCT00527072|C0168Z04|c0168z04
590994|NCT00527098|Trauma Resuscitation|trauma resuscitation
590995|NCT00527163|Echocardiogram|echocardiogram
590996|NCT00527163|Endothelial Dysfunction|endothelial dysfunction
590997|NCT00527163|Malaria|malaria
590998|NCT00527163|Mali|mali
590999|NCT00527163|Screening|screening
591000|NCT00527176|Systemic Lupus Erythematosus|systemic lupus erythematosus
591001|NCT00527176|Corticosteroid|corticosteroid
591002|NCT00527176|Pulse therapy|pulse therapy
591003|NCT00527176|Diffusion weighted imaging|diffusion weighted imaging
591004|NCT00527176|q Space Imaging|q space imaging
591005|NCT00527189|Arthritis|arthritis
591006|NCT00527189|Exercise|exercise
591007|NCT00527189|Balance - Postural Control|balance - postural control
591008|NCT00527228|Muscular dystrophy|muscular dystrophy
591009|NCT00527228|therapy|therapy
591010|NCT00527228|steroids|steroids
591011|NCT00527228|deflazacort|deflazacort
591012|NCT00527228|dysferlinopathy|dysferlinopathy
591013|NCT00527228|LGMD|lgmd
591014|NCT00527228|MM|mm
591015|NCT00527241|partner violence, spouse abuse|partner violence, spouse abuse
591016|NCT00527280|Allotransplantation:composite tissue|allotransplantation:composite tissue
591017|NCT00527280|Face transplantation|face transplantation
591018|NCT00527293|stage I breast cancer|stage i breast cancer
591019|NCT00527293|stage II breast cancer|stage ii breast cancer
591020|NCT00527293|invasive ductal breast carcinoma|invasive ductal breast carcinoma
591021|NCT00527293|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
591022|NCT00527293|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
591023|NCT00527293|tubular ductal breast carcinoma|tubular ductal breast carcinoma
591024|NCT00527293|papillary ductal breast carcinoma|papillary ductal breast carcinoma
591025|NCT00527306|aphthous stomatitis|aphthous stomatitis
591026|NCT00527306|canker sores|canker sores
591027|NCT00527306|multivitamins|multivitamins
591028|NCT00527306|vitamin deficiency|vitamin deficiency
591029|NCT00527319|NSCLC|nsclc
591030|NCT00527319|anorexia|anorexia
591031|NCT00527319|cachexia|cachexia
591032|NCT00527319|grip strength|grip strength
591033|NCT00527319|lean body mass|lean body mass
591034|NCT00527332|Hospitalization|hospitalization
591035|NCT00527332|Postoperative care|postoperative care
591036|NCT00527332|Quality of Life|quality of life
591037|NCT00527332|Health economy|health economy
591038|NCT00527332|Anesthesia. Spinal|anesthesia. spinal
591039|NCT00527332|Anesthesia, General|anesthesia, general
591040|NCT00527345|Asthma|asthma
591041|NCT00527345|Diesel exhaust|diesel exhaust
591042|NCT00527358|violence|violence
591043|NCT00527371|Benign hyperplasia of the prostate|benign hyperplasia of the prostate
591044|NCT00527384|Stress|stress
591045|NCT00527397|Diabetes Mellitus|diabetes mellitus
591046|NCT00527423|VEGF Trap-Eye|vegf trap-eye
591047|NCT00527423|Macular Degeneration|macular degeneration
591048|NCT00527423|AMD|amd
591049|NCT00527423|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
591050|NCT00527462|Asthma GINA 1|asthma gina 1
591051|NCT00527475|Anti-VEGF therapy|anti-vegf therapy
591052|NCT00527475|photodynamic therapy|photodynamic therapy
591053|NCT00527475|neovascularization|neovascularization
591054|NCT00527488|Benign Prostate Hyperplasia|benign prostate hyperplasia
591055|NCT00527488|BPH|bph
591056|NCT00527488|PK/PD|pk/pd
591057|NCT00527488|GnRH antagonist|gnrh antagonist
591058|NCT00532857|Patients with HER2 + stage II/III breast cancer|patients with her2 + stage ii/iii breast cancer
591059|NCT00532870|laparoscopy|laparoscopy
591060|NCT00532870|ventral hernia|ventral hernia
591061|NCT00532870|mesh|mesh
591377|NCT00534677|Terlipressin|terlipressin
591062|NCT00532870|Ventral hernias are the second most common type of abdominal hernias after inguinal hernias.|ventral hernias are the second most common type of abdominal hernias after inguinal hernias.
752331|NCT01172548|Resected GIST|resected gist
752332|NCT01172548|primary GIST|primary gist
591063|NCT00532870|The majority of ventral hernias are incisional hernias that develop in 11% to 20% of patients who undergo Laparotomy .|the majority of ventral hernias are incisional hernias that develop in 11% to 20% of patients who undergo laparotomy .
591064|NCT00532870|Surgeons have struggled to reduce the morbidity from incarceration (6% to 15% of cases) and strangulation (2%) of these hernias.|surgeons have struggled to reduce the morbidity from incarceration (6% to 15% of cases) and strangulation (2%) of these hernias.
591065|NCT00532883|Sickle Cell Disease|sickle cell disease
591066|NCT00532883|Vaso-occlusive Event|vaso-occlusive event
591067|NCT00532883|Painful Crises|painful crises
591068|NCT00532883|Acute Chest Syndrome|acute chest syndrome
591069|NCT00533702|Phase II|phase ii
591070|NCT00533702|Melanoma|melanoma
591071|NCT00533702|IMC-1121B|imc-1121b
591073|NCT00533715|Inspiratory Spirometry; Preschool Children; Computer games|inspiratory spirometry; preschool children; computer games
591074|NCT00533715|Health|health
591075|NCT00533741|Severe Acute Respiratory Syndrome, Coronavirus, vaccine|severe acute respiratory syndrome, coronavirus, vaccine
591076|NCT00533754|age-related macular degeneration, genetics|age-related macular degeneration, genetics
591077|NCT00533767|Hantavirus cardiopulmonary syndrome, Andes virus, Chile|hantavirus cardiopulmonary syndrome, andes virus, chile
591078|NCT00533793|bone, tibial shaft fracture|bone, tibial shaft fracture
591079|NCT00533806|Cognitive Behavior Therapy|cognitive behavior therapy
591081|NCT00533806|Relaxation Therapy|relaxation therapy
591082|NCT00533806|Young Children|young children
591083|NCT00533819|Exercise intervention|exercise intervention
591084|NCT00533819|Maths Scores|maths scores
591085|NCT00533819|Blood pressure|blood pressure
591086|NCT00533819|Female school children|female school children
591087|NCT00533819|Body mass index|body mass index
591088|NCT00533832|depression|depression
591089|NCT00533832|vagus nerve stimulation|vagus nerve stimulation
591090|NCT00533858|Systolic hypertension|systolic hypertension
591091|NCT00533871|Natriuretic Peptide Brain|natriuretic peptide brain
591092|NCT00533884|delirium|delirium
591093|NCT00533884|cognitive/functional effects|cognitive/functional effects
591094|NCT00533884|hypopharyngeal cancer|hypopharyngeal cancer
591095|NCT00533884|laryngeal cancer|laryngeal cancer
591096|NCT00533884|lip and oral cavity cancer|lip and oral cavity cancer
591097|NCT00533884|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
591098|NCT00533884|nasopharyngeal cancer|nasopharyngeal cancer
591099|NCT00533884|oropharyngeal cancer|oropharyngeal cancer
591100|NCT00533884|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
591101|NCT00533884|salivary gland cancer|salivary gland cancer
591102|NCT00533884|esophageal cancer|esophageal cancer
591103|NCT00533884|non-small cell lung cancer|non-small cell lung cancer
591104|NCT00533884|small cell lung cancer|small cell lung cancer
591105|NCT00533897|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
591106|NCT00533910|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
591107|NCT00533923|Nonmyeloablative Allogeneic Stem Cell Transplantation|nonmyeloablative allogeneic stem cell transplantation
591108|NCT00533923|mini-transplant|mini-transplant
591109|NCT00533923|AML|aml
591110|NCT00533923|ALL|all
591111|NCT00533923|CML|cml
591112|NCT00533923|CLL|cll
591113|NCT00533923|Myelodysplastic syndrome|myelodysplastic syndrome
591114|NCT00533923|Relapsed non-Hodgkin's or Hodgkin's lymphoma|relapsed non-hodgkin's or hodgkin's lymphoma
591115|NCT00533923|Relapsed multiple myeloma|relapsed multiple myeloma
591116|NCT00533923|Aplastic anemia|aplastic anemia
591347|NCT00534534|acute|acute
591117|NCT00533923|Myeloproliferative disorder|myeloproliferative disorder
591118|NCT00533923|GM-CSF|gm-csf
591119|NCT00533923|Cyclosporin|cyclosporin
591120|NCT00533923|Fludarabine (FLUDARA)|fludarabine (fludara)
591121|NCT00533923|Cyclophosphamide|cyclophosphamide
591122|NCT00533923|CAMPATH-1H|campath-1h
591123|NCT00533923|GVHD|gvhd
591124|NCT00533923|CMV|cmv
591125|NCT00533923|AML in first remission, first relapse or subsequent remission|aml in first remission, first relapse or subsequent remission
591126|NCT00533923|ALL in first relapse, second or subsequent remission|all in first relapse, second or subsequent remission
591127|NCT00533923|ALL in first remission, in a high-risk category|all in first remission, in a high-risk category
591128|NCT00533923|Aplastic anemia characterized by ANC< 1000 and/or platelets < 30 without transfusional support|aplastic anemia characterized by anc< 1000 and/or platelets < 30 without transfusional support
591129|NCT00533923|Myeloproliferative disorder (P Vera, CMML, ET)|myeloproliferative disorder (p vera, cmml, et)
591130|NCT00533936|stage II breast cancer|stage ii breast cancer
591131|NCT00533936|stage IIIA breast cancer|stage iiia breast cancer
591132|NCT00533936|stage IIIB breast cancer|stage iiib breast cancer
591133|NCT00533936|stage IIIC breast cancer|stage iiic breast cancer
591134|NCT00533949|radiation toxicity|radiation toxicity
591135|NCT00533949|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
591136|NCT00533949|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
591137|NCT00533962|Glaucoma|glaucoma
591138|NCT00533962|Anecortave Acetate|anecortave acetate
591139|NCT00533962|Intraocular pressure|intraocular pressure
591378|NCT00534677|Octreotide|octreotide
591140|NCT00533962|Advanced glaucoma cases with uncontrolled IOP|advanced glaucoma cases with uncontrolled iop
591141|NCT00533975|Colon Cancer screening|colon cancer screening
591142|NCT00533975|immunofecal occult blood test|immunofecal occult blood test
591144|NCT00533975|diagnostic validity|diagnostic validity
591145|NCT00533988|Central venous catheters|central venous catheters
591146|NCT00533988|Antimicrobial impregnated catheters|antimicrobial impregnated catheters
591147|NCT00533988|Duration of catheter use|duration of catheter use
591148|NCT00533988|Catheter-related infection|catheter-related infection
591149|NCT00533988|Insertion site|insertion site
591150|NCT00533988|Parenteral nutrition|parenteral nutrition
591151|NCT00533988|Critically ill patients (multidisciplinary)|critically ill patients (multidisciplinary)
591152|NCT00534001|bladder cancer|bladder cancer
591153|NCT00534001|cervical cancer|cervical cancer
591154|NCT00534001|esophageal cancer|esophageal cancer
591155|NCT00534001|gastric cancer|gastric cancer
591156|NCT00534001|renal cell carcinoma|renal cell carcinoma
591157|NCT00534001|adult primary liver cancer|adult primary liver cancer
591158|NCT00534001|non-small cell lung cancer|non-small cell lung cancer
591159|NCT00534001|small cell lung cancer|small cell lung cancer
591160|NCT00534001|pancreatic cancer|pancreatic cancer
591161|NCT00534001|hypopharyngeal cancer|hypopharyngeal cancer
591162|NCT00534001|laryngeal cancer|laryngeal cancer
591163|NCT00534001|lip and oral cavity cancer|lip and oral cavity cancer
591164|NCT00534001|nasopharyngeal cancer|nasopharyngeal cancer
591165|NCT00534001|oropharyngeal cancer|oropharyngeal cancer
591166|NCT00534001|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
591167|NCT00534001|adult acute myeloid leukemia|adult acute myeloid leukemia
591168|NCT00534001|tobacco use disorder|tobacco use disorder
591169|NCT00534027|NSCLC|nsclc
591170|NCT00534027|Non-Small Cell Lung Cancer|non-small cell lung cancer
591171|NCT00534027|Paclitaxel|paclitaxel
591172|NCT00534027|Carboplatin|carboplatin
591173|NCT00534027|AMG 655|amg 655
591174|NCT00534053|colon cancer screening|colon cancer screening
591175|NCT00534053|mail reminders|mail reminders
591176|NCT00534053|fecal occult blood test|fecal occult blood test
591177|NCT00534053|compliance|compliance
591178|NCT00534066|Natriuretic Peptide, Brain|natriuretic peptide, brain
591179|NCT00534079|Cystic Fibrosis and chronic rhinosinusitis|cystic fibrosis and chronic rhinosinusitis
591180|NCT00534092|Lumbar Spinal Stenosis|lumbar spinal stenosis
591181|NCT00534092|X STOP|x stop
591182|NCT00534105|Pregnancy|pregnancy
591183|NCT00534105|Gestational diabetes|gestational diabetes
591184|NCT00534105|Hyperlipidemia|hyperlipidemia
591185|NCT00534118|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
591186|NCT00534118|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
591187|NCT00534118|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
591188|NCT00534118|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
591189|NCT00534118|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
591190|NCT00534118|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
591191|NCT00534118|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
591192|NCT00534118|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
591193|NCT00534118|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
591194|NCT00534118|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
591195|NCT00534118|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
591270|NCT00534352|Protease Inhibitor|protease inhibitor
591196|NCT00534118|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
591197|NCT00534118|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
591198|NCT00534118|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
591199|NCT00534118|stage I multiple myeloma|stage i multiple myeloma
591200|NCT00534118|stage II multiple myeloma|stage ii multiple myeloma
591201|NCT00534118|stage III multiple myeloma|stage iii multiple myeloma
591202|NCT00534118|refractory multiple myeloma|refractory multiple myeloma
591203|NCT00534118|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
591204|NCT00534118|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
591205|NCT00534118|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
591206|NCT00534118|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
591207|NCT00534118|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
591208|NCT00534118|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
591209|NCT00534118|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
591210|NCT00534118|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
591211|NCT00534118|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
591212|NCT00534118|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
591213|NCT00534118|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
591214|NCT00534118|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
591215|NCT00534118|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
591216|NCT00534118|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
591217|NCT00534118|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
591218|NCT00534118|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
591381|NCT00534690|Intubation, Intratracheal|intubation, intratracheal
591219|NCT00534118|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
591220|NCT00534118|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
591221|NCT00534118|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
591222|NCT00534118|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
591223|NCT00534118|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
591224|NCT00534118|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
591225|NCT00534118|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
591226|NCT00534118|secondary acute myeloid leukemia|secondary acute myeloid leukemia
591227|NCT00534118|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
591228|NCT00534118|splenic marginal zone lymphoma|splenic marginal zone lymphoma
591229|NCT00534118|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
591230|NCT00534118|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
591231|NCT00534118|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
591232|NCT00534118|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
591233|NCT00534118|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
591234|NCT00534157|intracranial pressure|intracranial pressure
591235|NCT00534157|intraocular pressure|intraocular pressure
591236|NCT00534157|tonometry|tonometry
591237|NCT00534170|Probiotic|probiotic
591238|NCT00534170|Prevention of diarrhoea|prevention of diarrhoea
591239|NCT00534170|Nutritional status|nutritional status
591240|NCT00534183|Metabolic syndrome|metabolic syndrome
591242|NCT00534183|Diabetes|diabetes
591243|NCT00534196|recurrent prostate cancer|recurrent prostate cancer
591244|NCT00534196|stage I prostate cancer|stage i prostate cancer
591245|NCT00534196|stage IIB prostate cancer|stage iib prostate cancer
591246|NCT00534196|stage IIA prostate cancer|stage iia prostate cancer
591247|NCT00534196|stage III prostate cancer|stage iii prostate cancer
591248|NCT00534209|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
591249|NCT00534209|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
591250|NCT00534222|Patients with a manic episode|patients with a manic episode
591251|NCT00534222|Patients diagnosed w/schizophrenia, who start a treatment with an atypical antipsychotic & who are at least scored as moderately ill on the CGI at baseline|patients diagnosed w/schizophrenia, who start a treatment with an atypical antipsychotic & who are at least scored as moderately ill on the cgi at baseline
591252|NCT00534261|Multiple Sclerosis|multiple sclerosis
591253|NCT00534261|Avonex|avonex
591254|NCT00534261|Interferon beta-1a|interferon beta-1a
591255|NCT00534274|stage II breast cancer|stage ii breast cancer
591256|NCT00534274|stage IIIA breast cancer|stage iiia breast cancer
591257|NCT00534287|sepsis|sepsis
591258|NCT00534287|antibiotics|antibiotics
591259|NCT00534287|carbapenems|carbapenems
591260|NCT00534287|fluoroquinolones|fluoroquinolones
591261|NCT00534287|Severe sepsis and septic shock|severe sepsis and septic shock
591262|NCT00534300|ICD-pacemaker|icd-pacemaker
591263|NCT00534352|HIV|hiv
591264|NCT00534352|AIDS|aids
591265|NCT00534352|Immunodeficiency Virus, Human|immunodeficiency virus, human
591266|NCT00534352|PREZISTA|prezista
591267|NCT00534352|darunavir|darunavir
591268|NCT00534352|TMC114|tmc114
591269|NCT00534352|TMC125|tmc125
591271|NCT00534352|Non-Nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
591272|NCT00534352|Truvada|truvada
591273|NCT00534352|Treatment Naive|treatment naive
591274|NCT00534365|stress urinary incontinence|stress urinary incontinence
591275|NCT00534365|sling procedures|sling procedures
591276|NCT00534365|tension-free vaginal tape|tension-free vaginal tape
591277|NCT00534378|Nerve agent|nerve agent
591278|NCT00534378|Midazolam|midazolam
591279|NCT00534378|Seizures|seizures
591280|NCT00534378|Severe recurrent convulsive seizures induced by nerve agent exposure|severe recurrent convulsive seizures induced by nerve agent exposure
591281|NCT00534391|Antibiotics|antibiotics
591282|NCT00534391|hordeolum|hordeolum
591283|NCT00534404|Internet-Assisted Tobacco Treatments|internet-assisted tobacco treatments
591284|NCT00534404|Online Smoking Cessation Programs|online smoking cessation programs
591285|NCT00534404|Nicotine Patches|nicotine patches
591286|NCT00534404|Telephone Counseling|telephone counseling
591287|NCT00534404|Smoking Abstinence|smoking abstinence
591288|NCT00534417|Hormone|hormone
591289|NCT00534417|Receptor|receptor
591290|NCT00534417|Positive|positive
591291|NCT00534417|Metastatic|metastatic
591292|NCT00534417|Breast|breast
591293|NCT00534417|Cancer|cancer
591294|NCT00534430|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
591295|NCT00534430|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
591296|NCT00534430|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
591297|NCT00534430|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
591298|NCT00534430|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
591877|NCT00543608|pneumonia|pneumonia
591299|NCT00534430|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
591300|NCT00534430|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
591301|NCT00534430|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
591302|NCT00534430|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
591303|NCT00534430|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
591304|NCT00534430|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
591305|NCT00534430|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
591306|NCT00534430|refractory anemia with excess blasts|refractory anemia with excess blasts
591307|NCT00534430|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
591308|NCT00534430|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
591309|NCT00534443|peptic ulcer|peptic ulcer
591310|NCT00534443|gastritis|gastritis
591312|NCT00534443|cytokines|cytokines
591313|NCT00534443|Changes of inflammatory status in gastric mucosa|changes of inflammatory status in gastric mucosa
591314|NCT00534443|sTREM-1 as a disease marker|strem-1 as a disease marker
591315|NCT00534456|exploratory study|exploratory study
591316|NCT00534456|anemia|anemia
591317|NCT00534456|pharmacogenetics testing|pharmacogenetics testing
591318|NCT00534456|biomarkers|biomarkers
591319|NCT00534456|echocardiography|echocardiography
591320|NCT00534469|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
591321|NCT00534469|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
591322|NCT00534469|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
591323|NCT00534469|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
591324|NCT00534469|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
591325|NCT00534469|adult acute basophilic leukemia|adult acute basophilic leukemia
591326|NCT00534469|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
591327|NCT00534469|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
591328|NCT00534469|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
591329|NCT00534469|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
591330|NCT00534469|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
591331|NCT00534469|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
591332|NCT00534469|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
591333|NCT00534469|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
591334|NCT00534469|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
591335|NCT00534469|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
591336|NCT00534482|fitness|fitness
591337|NCT00534495|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
591338|NCT00534495|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
591339|NCT00534495|Systemic Juvenile Rheumatoid Arthritis|systemic juvenile rheumatoid arthritis
591340|NCT00534508|Skin|skin
591341|NCT00534508|Pharmacokinetics|pharmacokinetics
591342|NCT00534508|Tacrolimus|tacrolimus
591343|NCT00534508|dermatitis, atopic|dermatitis, atopic
591344|NCT00534521|overactive bladder|overactive bladder
591345|NCT00534521|posterior tibial nerve stimulation|posterior tibial nerve stimulation
591346|NCT00534534|Pancreatitis|pancreatitis
591348|NCT00534534|alcoholic|alcoholic
591349|NCT00534534|recurrence|recurrence
591350|NCT00534534|alcoholism|alcoholism
591351|NCT00534534|treatment|treatment
591352|NCT00534534|Acute alcoholic pancreatitis|acute alcoholic pancreatitis
591353|NCT00534586|Pain|pain
591354|NCT00534586|SSEP|ssep
591355|NCT00534586|CHEPS|cheps
591356|NCT00534586|Propofol|propofol
591357|NCT00534586|Sevoflurane|sevoflurane
591358|NCT00534586|S-Ketamine|s-ketamine
591359|NCT00534586|Remifentanil|remifentanil
591360|NCT00534586|Healthy volunteers|healthy volunteers
591361|NCT00534599|Generalized anxiety disorders|generalized anxiety disorders
591362|NCT00534599|anxiety|anxiety
591363|NCT00534599|adjunct treatment in anxiety|adjunct treatment in anxiety
591364|NCT00534599|anxiety disorder|anxiety disorder
591365|NCT00534599|partial or non-responder in anxiety|partial or non-responder in anxiety
591366|NCT00534612|Parotid gland neoplasms|parotid gland neoplasms
591367|NCT00534625|Asthma, exacerbation, pulmonary function|asthma, exacerbation, pulmonary function
591368|NCT00534638|HPV vaccine|hpv vaccine
591369|NCT00534638|Healthy adolescents|healthy adolescents
591370|NCT00534638|Cervical cancer|cervical cancer
591371|NCT00534638|Safety|safety
591372|NCT00534638|Immunogenicity|immunogenicity
591373|NCT00534638|Cervarix|cervarix
591374|NCT00534677|Variceal bleed|variceal bleed
591375|NCT00534677|Cirrhosis|cirrhosis
591376|NCT00534677|Vasoactive agents|vasoactive agents
591379|NCT00534677|Safety & Efficacy|safety & efficacy
591380|NCT00534690|Pulmonary disease|pulmonary disease
593529|NCT00543075|Genta|genta
591382|NCT00534690|Positive-pressure ventilation|positive-pressure ventilation
591383|NCT00534716|Cannabis|cannabis
591384|NCT00534716|doping|doping
591385|NCT00534716|THC|thc
591386|NCT00534716|GC/MS|gc/ms
591387|NCT00534716|Pharmacokinetics|pharmacokinetics
591388|NCT00534716|Volunteers|volunteers
591389|NCT00534729|Organ Preservation|organ preservation
591390|NCT00534729|Carboplatin|carboplatin
591391|NCT00534729|Taxol|taxol
591392|NCT00534729|RT|rt
591393|NCT00534729|laryngeal & Hypopharyngeal CA|laryngeal & hypopharyngeal ca
591394|NCT00534729|Locally advanced laryngeal & Hypopharyngeal CA|locally advanced laryngeal & hypopharyngeal ca
591395|NCT00534742|Siblings|siblings
591396|NCT00534781|Achilles|achilles
591397|NCT00534781|Tendinosis|tendinosis
591398|NCT00534781|Tendinitis|tendinitis
591399|NCT00534781|Achilles Tendinosis|achilles tendinosis
591400|NCT00534781|Achilles Tendinitis|achilles tendinitis
591401|NCT00534781|Coblation|coblation
591402|NCT00534781|Bipolar Radiofrequency|bipolar radiofrequency
591403|NCT00534781|Surgical Debridement|surgical debridement
591404|NCT00534781|Debridement|debridement
591405|NCT00534781|Heel Pain|heel pain
591406|NCT00534781|Achilles Pain|achilles pain
591407|NCT00534820|Cytogenetic Analysis of Bone Marrow Specimen in Non-Hodgkin's Lymphoma or Hodgkin's Disease|cytogenetic analysis of bone marrow specimen in non-hodgkin's lymphoma or hodgkin's disease
591408|NCT00534833|Diphtheria|diphtheria
591409|NCT00534833|Tetanus|tetanus
591410|NCT00534833|Pertussis|pertussis
591411|NCT00534833|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
591412|NCT00534833|Haemophilus influenzae type b|haemophilus influenzae type b
591413|NCT00534846|premenstrual syndrome|premenstrual syndrome
591414|NCT00534846|mastalgia|mastalgia
591415|NCT00534846|toremifene|toremifene
591416|NCT00534846|selective estrogen receptor modulators|selective estrogen receptor modulators
591417|NCT00534872|4 Parallel cohorts|4 parallel cohorts
591418|NCT00534872|Healthy Female|healthy female
591419|NCT00534872|Healthy Elderly|healthy elderly
591420|NCT00534872|Pharmacokinetic|pharmacokinetic
591421|NCT00534872|Safety and Tolerability|safety and tolerability
591422|NCT00534885|inactivated hepatitis A vaccine|inactivated hepatitis a vaccine
591423|NCT00534885|Healive|healive
591424|NCT00534885|safety|safety
591425|NCT00534885|immunogenicity|immunogenicity
591426|NCT00534885|immune persistence|immune persistence
591427|NCT00534911|Depression|depression
591428|NCT00534911|Physical Illness|physical illness
591429|NCT00534911|Inflammatory Bowel Disease|inflammatory bowel disease
591430|NCT00534911|Cognitive Behavioral Therapy|cognitive behavioral therapy
591431|NCT00534924|IR injury|ir injury
591432|NCT00534924|MRI|mri
591433|NCT00534924|Vitamin C|vitamin c
591434|NCT00534924|Postconditioning|postconditioning
591435|NCT00534937|Venous stasis ulcer|venous stasis ulcer
591436|NCT00534937|Compression pump|compression pump
591437|NCT00534937|Randomized trial|randomized trial
591438|NCT00534937|Flexitouch compression|flexitouch compression
591439|NCT00534950|Randomized multicenter study of 5 vs 6 weekly fraction of RT in the treatment of SCC of the head and neck|randomized multicenter study of 5 vs 6 weekly fraction of rt in the treatment of scc of the head and neck
591440|NCT00534963|sonohysterography, catheter placement|sonohysterography, catheter placement
591441|NCT00534989|NHL and HD|nhl and hd
591442|NCT00535002|Cocaine Addiction|cocaine addiction
591443|NCT00535002|Cocaine Dependence|cocaine dependence
591444|NCT00535028|asthma|asthma
591445|NCT00535028|allergy|allergy
591446|NCT00535028|interleukin-4|interleukin-4
591447|NCT00535028|interleukin-13|interleukin-13
591448|NCT00535028|IL-4|il-4
591449|NCT00535028|IL-13|il-13
591450|NCT00535028|atopic|atopic
591451|NCT00535028|late asthmatic response|late asthmatic response
591452|NCT00535028|inflammation|inflammation
591453|NCT00535041|Pilot trial of pre-operative chemo/RT using Xeloda and external beam RT followed by definite surgery in patients with localized rectal CA|pilot trial of pre-operative chemo/rt using xeloda and external beam rt followed by definite surgery in patients with localized rectal ca
591454|NCT00535054|Dry Eye Syndrome|dry eye syndrome
591455|NCT00535067|Breast Cancer|breast cancer
591456|NCT00535067|Questionnaire|questionnaire
591457|NCT00535067|Survey|survey
591458|NCT00535067|Neuropathic Pain|neuropathic pain
591459|NCT00535067|Cancer Survivors|cancer survivors
591460|NCT00535067|Quality of Life|quality of life
591461|NCT00535067|QOL|qol
591462|NCT00535080|actinic|actinic
591463|NCT00535080|keratoses|keratoses
591464|NCT00535080|superficial|superficial
591465|NCT00535080|basal|basal
591466|NCT00535080|carcinomas|carcinomas
591467|NCT00535080|Bowen's|bowen's
591468|NCT00535080|large or multiple superficial Basal Carcinomas|large or multiple superficial basal carcinomas
591469|NCT00535093|Pharyngitis|pharyngitis
591470|NCT00535093|Community infections|community infections
591471|NCT00535093|Rapid Testing|rapid testing
591472|NCT00535093|Group A Streptococcus|group a streptococcus
591473|NCT00535106|Ventricular fibrillation|ventricular fibrillation
591474|NCT00535106|Cardiac arrest|cardiac arrest
591671|NCT00535990|Surgical|surgical
591475|NCT00535106|Automated external defibrillator|automated external defibrillator
591477|NCT00535106|Waveform based algorithms|waveform based algorithms
591478|NCT00535106|VF waveform analysis|vf waveform analysis
591479|NCT00535132|schizophrenia|schizophrenia
591480|NCT00535132|medication satisfaction, Invega|medication satisfaction, invega
591481|NCT00535145|antipsychotic|antipsychotic
591482|NCT00535145|paliperidone ER|paliperidone er
591483|NCT00535145|liver disease|liver disease
591484|NCT00535145|Schizophrenia|schizophrenia
591485|NCT00535145|Schizoaffective Disorder|schizoaffective disorder
591486|NCT00535145|Invega|invega
591487|NCT00535158|Chronic Kidney disease|chronic kidney disease
591488|NCT00535158|Dialysis|dialysis
591489|NCT00535158|Vitamin D|vitamin d
751763|NCT01170351|induction of remossion|induction of remossion
751764|NCT01170351|efficacy|efficacy
591490|NCT00535158|Chronic kidney disease is associated with impaired muscle strength, pain and fractures.|chronic kidney disease is associated with impaired muscle strength, pain and fractures.
591491|NCT00535184|Mammography|mammography
591492|NCT00535184|mammogram|mammogram
591494|NCT00535184|Abnormal and normal breast tissue|abnormal and normal breast tissue
591495|NCT00535210|spinal cord injury|spinal cord injury
591496|NCT00535210|exercise rehabilitation|exercise rehabilitation
591497|NCT00535210|inpatient|inpatient
591498|NCT00535210|RCT|rct
591499|NCT00535210|physical function|physical function
591500|NCT00535223|Cognitive Behavior Therapy|cognitive behavior therapy
591501|NCT00535223|Group therapy|group therapy
591502|NCT00535223|Posttraumatic Stress Disorder|posttraumatic stress disorder
591503|NCT00535223|Randomized Controlled Trial|randomized controlled trial
591504|NCT00535223|Treatment outcome|treatment outcome
591505|NCT00535223|Veterans|veterans
591506|NCT00535223|War|war
591507|NCT00535236|Prevention of herpes zoster and HZ-related complications|prevention of herpes zoster and hz-related complications
591508|NCT00535262|Bipolar|bipolar
591509|NCT00535262|depression|depression
591510|NCT00535275|NSCLC relapse after adjuvant chemotherapy|nsclc relapse after adjuvant chemotherapy
591511|NCT00535301|cystocele|cystocele
591512|NCT00535301|uterine prolapse|uterine prolapse
591513|NCT00535301|urinary incontinence|urinary incontinence
591514|NCT00535314|Melanoma|melanoma
591515|NCT00535327|Mammography|mammography
591516|NCT00535327|mammogram|mammogram
591517|NCT00535327|breast|breast
591518|NCT00535327|Abnormal and normal breast tissue|abnormal and normal breast tissue
591519|NCT00535340|Anxiety|anxiety
591520|NCT00535340|Anti-Anxiety Agents|anti-anxiety agents
591521|NCT00535353|recurrent colon cancer|recurrent colon cancer
591522|NCT00535353|stage IV colon cancer|stage iv colon cancer
591523|NCT00535353|recurrent rectal cancer|recurrent rectal cancer
591524|NCT00535353|stage IV rectal cancer|stage iv rectal cancer
591525|NCT00535353|stage III rectal cancer|stage iii rectal cancer
591526|NCT00535353|stage III colon cancer|stage iii colon cancer
591527|NCT00535379|glioblastoma multiforme|glioblastoma multiforme
591528|NCT00535379|sunitinib|sunitinib
591529|NCT00535379|recurrent|recurrent
591530|NCT00535379|progressive|progressive
591531|NCT00535392|Epilepsy|epilepsy
591532|NCT00535392|Child|child
591533|NCT00535392|Levetiracetam|levetiracetam
591534|NCT00535392|Keppra®|keppra®
591535|NCT00535392|Infusion|infusion
591536|NCT00535392|Intravenous|intravenous
591537|NCT00535405|High Cholesterol|high cholesterol
591538|NCT00535418|Breast cancer|breast cancer
591539|NCT00535418|neoadjuvant treatment|neoadjuvant treatment
591540|NCT00535418|treatment duration|treatment duration
591541|NCT00535418|Primary hormone receptor positive|primary hormone receptor positive
591542|NCT00535418|breast cancer in postmenopausal women|breast cancer in postmenopausal women
591543|NCT00535431|Asthma|asthma
591544|NCT00535431|allergy|allergy
591545|NCT00535431|interleukin-4|interleukin-4
591546|NCT00535431|interleukin-13|interleukin-13
591547|NCT00535431|IL-4|il-4
591548|NCT00535431|IL-13|il-13
591549|NCT00535444|Hypertension|hypertension
591550|NCT00535444|parish nurse|parish nurse
591551|NCT00535457|anxiety|anxiety
591552|NCT00535457|maladaptive behavior|maladaptive behavior
591553|NCT00535457|anesthesia|anesthesia
591554|NCT00535457|Anxiety before anesthesia and maladaptive behavior after anesthesia.|anxiety before anesthesia and maladaptive behavior after anesthesia.
591555|NCT00535483|blood microdialysis|blood microdialysis
591556|NCT00535483|glucose monitoring|glucose monitoring
591557|NCT00535483|glucose control|glucose control
591558|NCT00535483|automated blood sampling|automated blood sampling
591559|NCT00535483|online-sensor|online-sensor
591560|NCT00535483|algorithm|algorithm
591561|NCT00535483|type 1 diabetes|type 1 diabetes
591562|NCT00535522|Pharmacokinetics|pharmacokinetics
591563|NCT00535522|pharmacodynamics|pharmacodynamics
591564|NCT00535522|maximal tolerated dose|maximal tolerated dose
591565|NCT00535535|Elevated triglycerides|elevated triglycerides
591566|NCT00535535|Diabetes|diabetes
591567|NCT00535535|Cardiovascular disease|cardiovascular disease
591568|NCT00535548|Chronic wounds|chronic wounds
591569|NCT00535548|Pressure sores|pressure sores
591570|NCT00535548|Hematopoietic stem cells|hematopoietic stem cells
591571|NCT00535548|Wound healing|wound healing
591572|NCT00535561|iron deficiency anemia|iron deficiency anemia
591574|NCT00535561|hypothyroidism|hypothyroidism
593728|NCT00549666|lurasidone|lurasidone
591575|NCT00535561|subclinical hypothyroidism|subclinical hypothyroidism
591576|NCT00535574|retinoids|retinoids
591577|NCT00535574|bexarotene|bexarotene
591578|NCT00535574|schizophrenia|schizophrenia
591579|NCT00535574|PANSS|panss
591580|NCT00535574|Positive and negative symptoms of schizophrenia|positive and negative symptoms of schizophrenia
591581|NCT00535587|Fibromyalgia|fibromyalgia
591582|NCT00535587|Exercise|exercise
591583|NCT00535587|Mestinon|mestinon
591584|NCT00535600|Bariatric Surgery|bariatric surgery
591585|NCT00535600|Insulin Action|insulin action
591586|NCT00535600|Insulin Secretion|insulin secretion
591587|NCT00535600|Insulin Resistance|insulin resistance
591588|NCT00535600|Gut Hormones|gut hormones
591589|NCT00535600|Obesity|obesity
591590|NCT00535639|Tolerability of ALK Tree Tablet in patients with birch pollen induced allergy|tolerability of alk tree tablet in patients with birch pollen induced allergy
591591|NCT00535678|Mammography|mammography
591592|NCT00535678|mammogram|mammogram
591593|NCT00535678|breast|breast
591594|NCT00535678|Abnormal and normal breast tissue|abnormal and normal breast tissue
591595|NCT00535717|Urethral stricture|urethral stricture
591596|NCT00535717|Ayurvedic treatment|ayurvedic treatment
591597|NCT00535717|mutra marg sankoch|mutra marg sankoch
591598|NCT00535717|uttarbasti|uttarbasti
591599|NCT00535717|Sesame oil|sesame oil
591600|NCT00535717|Honey|honey
591601|NCT00535717|Rock salt|rock salt
591602|NCT00535756|Pancreatic Exocrine Insufficiency After Pancreatic Surgery|pancreatic exocrine insufficiency after pancreatic surgery
591603|NCT00535769|topical|topical
591604|NCT00535769|medication adherence|medication adherence
591605|NCT00535769|adherence|adherence
591606|NCT00535769|compliance|compliance
591607|NCT00535769|medication compliance|medication compliance
591608|NCT00535769|sunscreen|sunscreen
591609|NCT00535769|reminder|reminder
591610|NCT00535821|Emergency Department|emergency department
591611|NCT00535821|Hemodynamic Optimization|hemodynamic optimization
591612|NCT00535821|Esophageal Doppler monitoring|esophageal doppler monitoring
591613|NCT00535821|Early Goal-Directed Therapy|early goal-directed therapy
591614|NCT00535834|stage I prostate cancer|stage i prostate cancer
591615|NCT00535834|stage II prostate cancer|stage ii prostate cancer
591616|NCT00535834|stage III prostate cancer|stage iii prostate cancer
591617|NCT00535834|adenocarcinoma of the prostate|adenocarcinoma of the prostate
591618|NCT00535847|Genotype 1|genotype 1
591619|NCT00535860|Osteoporosis|osteoporosis
591620|NCT00535860|Transdermal|transdermal
591621|NCT00535860|hPTH(1-34)|hpth(1-34)
591622|NCT00535873|Leukemia|leukemia
591623|NCT00535873|CLL|cll
591624|NCT00535873|chronic lymphocytic leukemia|chronic lymphocytic leukemia
591625|NCT00535873|SLL|sll
591626|NCT00535873|small lymphocytic lymphoma|small lymphocytic lymphoma
591627|NCT00535873|Untreated CLL|untreated cll
591628|NCT00535873|Lenalidomide|lenalidomide
591629|NCT00535873|CC-5013|cc-5013
591630|NCT00535873|Revlimid|revlimid
591631|NCT00535873|Oral|oral
591632|NCT00535886|Trans Fatty Acids|trans fatty acids
591633|NCT00535886|conjugated linoleic acid|conjugated linoleic acid
591634|NCT00535886|vaccenic acid|vaccenic acid
591635|NCT00535886|High Density Lipoprotein Cholesterol|high density lipoprotein cholesterol
591636|NCT00535886|Low Density Lipoprotein Cholesterol|low density lipoprotein cholesterol
591637|NCT00535886|Beef|beef
591638|NCT00535899|Aortic stenosis|aortic stenosis
591639|NCT00535899|Speckle tracking imaging|speckle tracking imaging
591640|NCT00535899|Low ejection fraction|low ejection fraction
591641|NCT00535899|Aortic valve replacement|aortic valve replacement
591642|NCT00535899|Strain|strain
591643|NCT00535912|CLL|cll
591644|NCT00535925|type 2 diabetes|type 2 diabetes
591645|NCT00535925|nephropathy|nephropathy
591646|NCT00535925|CV events|cv events
591647|NCT00535951|Non-small cell lung cancer|non-small cell lung cancer
591648|NCT00535951|NSCLC|nsclc
591649|NCT00535951|lung cancer|lung cancer
591650|NCT00535951|pleural mesothelioma|pleural mesothelioma
591651|NCT00535951|malignant|malignant
591652|NCT00535951|advanced stage|advanced stage
591653|NCT00535951|mesothelioma|mesothelioma
591654|NCT00535951|phase I|phase i
591655|NCT00535951|LBH589|lbh589
591656|NCT00535951|dextromethorphan|dextromethorphan
591657|NCT00535951|CYP2D6|cyp2d6
591658|NCT00535951|oral|oral
591659|NCT00535964|Cigarette Smoking|cigarette smoking
591660|NCT00535964|Tobacco Use|tobacco use
591661|NCT00535964|Adolescents|adolescents
591662|NCT00535964|Anxiety Sensitivity (AS)|anxiety sensitivity (as)
591663|NCT00535977|Gene expression|gene expression
591664|NCT00535977|Prostate|prostate
591665|NCT00535977|Broccoli|broccoli
591666|NCT00535977|Cancer|cancer
591667|NCT00535977|Men diagnosed with high-grade Prostatic Intraepithelia Neoplasia|men diagnosed with high-grade prostatic intraepithelia neoplasia
591668|NCT00535990|Cholecystectomy|cholecystectomy
591669|NCT00535990|Appendectomy|appendectomy
591670|NCT00535990|Esophageal|esophageal
591676|NCT00536003|preterm delivery|preterm delivery
591677|NCT00536003|preterm labor|preterm labor
591678|NCT00536003|perinatal morbidity|perinatal morbidity
591679|NCT00536003|perinatal mortality|perinatal mortality
591680|NCT00536016|AMD|amd
591681|NCT00536016|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
591682|NCT00536029|Melanoma|melanoma
591683|NCT00536029|SIAscope|siascope
591684|NCT00536029|pigmented skin lesions|pigmented skin lesions
591685|NCT00536042|minocycline|minocycline
591686|NCT00536042|asthma|asthma
591687|NCT00536042|oral steroids|oral steroids
591688|NCT00536042|IgE|ige
591689|NCT00536055|breast cancer|breast cancer
591690|NCT00536055|prostate cancer|prostate cancer
591691|NCT00536055|dyadic coping|dyadic coping
591692|NCT00536068|platelet|platelet
591693|NCT00536068|aggregation|aggregation
591694|NCT00536068|aspirin|aspirin
591695|NCT00536081|Breast cancer|breast cancer
591696|NCT00536081|Adjuvant|adjuvant
591697|NCT00536081|Advanced|advanced
591698|NCT00536081|Chemotherapy|chemotherapy
591699|NCT00536081|G-CSF|g-csf
591700|NCT00536081|Pegfilgrastim|pegfilgrastim
591701|NCT00536081|Prevention|prevention
591702|NCT00536081|Febrile neutropenia|febrile neutropenia
591703|NCT00536094|Cognitive behavioral therapy|cognitive behavioral therapy
591704|NCT00536094|Youth|youth
591705|NCT00536094|School|school
591706|NCT00536094|African American|african american
591707|NCT00536107|Non-Small Cell Lung Cancer|non-small cell lung cancer
591708|NCT00536107|Locally Advanced or Metastatic NSCL Cancer|locally advanced or metastatic nscl cancer
591709|NCT00536120|MS|ms
591710|NCT00536120|Multiple sclerosis|multiple sclerosis
591711|NCT00536120|Relapsing forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
591712|NCT00536133|zinc|zinc
591713|NCT00536133|aute lower respiratory infections|aute lower respiratory infections
591714|NCT00536146|Glucocorticoid|glucocorticoid
591715|NCT00536146|Steroids|steroids
591716|NCT00536146|Dose-Responsive Curve|dose-responsive curve
591717|NCT00536146|EC50|ec50
591718|NCT00536146|Stress Response|stress response
591719|NCT00536146|Alcoholism|alcoholism
591720|NCT00536159|nurse-community health worker team|nurse-community health worker team
591721|NCT00536159|perinatal depression|perinatal depression
591722|NCT00536159|stress|stress
591723|NCT00536159|Medicaid enhanced prenatal programs|medicaid enhanced prenatal programs
591724|NCT00536172|Antidepressant|antidepressant
591725|NCT00536172|Major depression|major depression
591726|NCT00536172|Prevention|prevention
591727|NCT00536172|Head and neck cancer|head and neck cancer
591728|NCT00541918|sevoflurane,|sevoflurane,
591729|NCT00541918|propofol,|propofol,
591730|NCT00541918|heart surgery,|heart surgery,
591731|NCT00541918|cardiopulmonary bypass,|cardiopulmonary bypass,
591732|NCT00541918|memory disorders,|memory disorders,
591733|NCT00541944|hyponatremia|hyponatremia
591734|NCT00541944|diagnosis and treatment of hyponatremia|diagnosis and treatment of hyponatremia
591735|NCT00541944|classification of hyponatremia|classification of hyponatremia
591736|NCT00541957|Major depression|major depression
591737|NCT00541957|Primary care|primary care
591738|NCT00541970|viral infections|viral infections
591739|NCT00541970|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
591740|NCT00541970|safety|safety
591741|NCT00541970|vaccine|vaccine
591742|NCT00541970|immunogenicity|immunogenicity
591743|NCT00541970|cervical cancer|cervical cancer
591744|NCT00541983|Diabetes|diabetes
591745|NCT00541983|Type 2|type 2
591746|NCT00541983|Mellitus|mellitus
591747|NCT00542009|Phase 2A, safety and efficacy trial with CE-326,597 in patients with T2DM.|phase 2a, safety and efficacy trial with ce-326,597 in patients with t2dm.
591748|NCT00542035|Analgesia|analgesia
591749|NCT00542048|Hepatic metastases|hepatic metastases
591750|NCT00542048|Angiogenesis|angiogenesis
591751|NCT00542048|EndoTAG-1|endotag-1
591752|NCT00542048|Pharmacokinetics|pharmacokinetics
591753|NCT00542048|Pharmacodynamics|pharmacodynamics
591754|NCT00542048|Metastases of the liver|metastases of the liver
591755|NCT00542061|COPD|copd
591756|NCT00542061|Asthma|asthma
591757|NCT00542061|Lung function|lung function
591758|NCT00542061|Monitoring|monitoring
591759|NCT00542061|Primary Care|primary care
591760|NCT00542074|Bacterial vaginosis|bacterial vaginosis
591761|NCT00542074|recurrence|recurrence
591762|NCT00542074|male factor|male factor
591763|NCT00542113|Parental|parental
591764|NCT00542113|Parents|parents
591765|NCT00542113|Prevention|prevention
591766|NCT00542113|Energy balance|energy balance
591767|NCT00542113|Glucose regulation|glucose regulation
591768|NCT00542113|Healthy lifestyles|healthy lifestyles
591769|NCT00542113|Healthy families|healthy families
591770|NCT00542113|Active living|active living
591771|NCT00542126|GnRH analog, IVF, infertility, frozen-thawed embryos|gnrh analog, ivf, infertility, frozen-thawed embryos
591772|NCT00542139|Osteoarthritis|osteoarthritis
591773|NCT00542139|Knee arthroplasty|knee arthroplasty
591774|NCT00542139|Steroid injection|steroid injection
591775|NCT00542139|Rehabilitation|rehabilitation
591776|NCT00542152|IBD|ibd
593729|NCT00549666|Latuda|latuda
591777|NCT00542152|Ulcerative colitis|ulcerative colitis
591778|NCT00542152|refractory to steroids|refractory to steroids
591779|NCT00542178|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
591780|NCT00542178|Cardiovascular Diseases|cardiovascular diseases
591781|NCT00542191|Triple negative (ER/PR negative; HER2 negative)|triple negative (er/pr negative; her2 negative)
591782|NCT00542204|Diabetes|diabetes
591783|NCT00542204|Blood Glucose Self-Monitoring|blood glucose self-monitoring
591784|NCT00542204|Home Blood Glucose Monitoring|home blood glucose monitoring
591785|NCT00542204|Internet|internet
591786|NCT00542204|Personal Health Record (PHR)|personal health record (phr)
591787|NCT00542204|Health Information Technology (HIT)|health information technology (hit)
591788|NCT00542204|Care management|care management
591789|NCT00542204|Disease Management|disease management
591790|NCT00542204|Diabetes self-management|diabetes self-management
591791|NCT00542204|Consumer Health Information|consumer health information
591792|NCT00542204|Medical Records Systems, Computerized|medical records systems, computerized
591793|NCT00542204|Computerized Medical Records System|computerized medical records system
591794|NCT00542204|Automated Medical Records System|automated medical records system
591795|NCT00542204|Electronic Health Record (EHR)|electronic health record (ehr)
591796|NCT00542204|Remote patient monitoring|remote patient monitoring
591797|NCT00542217|Healthy Volunteers|healthy volunteers
591798|NCT00542230|Erythrocytes|erythrocytes
591799|NCT00542230|Drug Screen|drug screen
591800|NCT00542230|Sickle Cell Trait|sickle cell trait
591801|NCT00542230|Sickle Cell Disease|sickle cell disease
591802|NCT00542243|enlarged prostate|enlarged prostate
591803|NCT00542243|finasteride|finasteride
591804|NCT00543140|Obesity|obesity
591805|NCT00543140|Morbid Obesity|morbid obesity
591806|NCT00543153|Advanced Cancer|advanced cancer
591807|NCT00543153|Exceptional Patient|exceptional patient
591808|NCT00543153|Cancer Care|cancer care
591809|NCT00543153|Interview|interview
591810|NCT00543166|Sjögren's syndrome|sjögren's syndrome
591811|NCT00543166|fatigue|fatigue
591812|NCT00543166|salivary gland|salivary gland
591813|NCT00543166|dehydroepiandrosterone|dehydroepiandrosterone
591814|NCT00543192|Endometrial Cancer|endometrial cancer
591815|NCT00543192|Sexual Function|sexual function
591816|NCT00543231|ECOG|ecog
591817|NCT00543231|MRT|mrt
591818|NCT00543231|NCI CTC|nci ctc
591819|NCT00543231|SAE|sae
591820|NCT00543231|Short Intravenous Infusion to Patients with Solid Tumors|short intravenous infusion to patients with solid tumors
591821|NCT00543244|Chronic hepatitis C|chronic hepatitis c
591822|NCT00543244|Pegylated interferon|pegylated interferon
591823|NCT00543244|Ribavirin|ribavirin
591824|NCT00543244|Virokinetics|virokinetics
591825|NCT00543270|EVAR|evar
591826|NCT00543270|AAA|aaa
591827|NCT00543270|Aneurysm|aneurysm
591828|NCT00543270|Powerlink|powerlink
591829|NCT00543296|uveitis|uveitis
591830|NCT00543296|Cystoid Macular Edema (CME)|cystoid macular edema (cme)
591831|NCT00543296|fluocinolone acetonide|fluocinolone acetonide
591832|NCT00543296|non-infectious uveitis affecting the posterior segment|non-infectious uveitis affecting the posterior segment
591833|NCT00543309|Fontan Operation|fontan operation
591834|NCT00543309|Cardiopulmonary Bypass|cardiopulmonary bypass
591835|NCT00543309|Heart Defects, Congenital|heart defects, congenital
591836|NCT00543309|Milrinone|milrinone
591837|NCT00543309|Natriuretic peptide, brain|natriuretic peptide, brain
591838|NCT00543335|Non-Small Cell Lung Cancer|non-small cell lung cancer
591839|NCT00543335|Lung Cancer|lung cancer
591840|NCT00543335|NSCLC|nsclc
591841|NCT00543335|Radiation Therapy|radiation therapy
591842|NCT00543335|Sorafenib|sorafenib
591843|NCT00543335|BAY 43-9006|bay 43-9006
591844|NCT00543335|Thoracic Radiation|thoracic radiation
591845|NCT00543348|BALLOON ANGIOPLASTY|balloon angioplasty
591846|NCT00543348|AUTOGENOUS FISTULA|autogenous fistula
591847|NCT00543426|Fuzheng Huayu Tablets|fuzheng huayu tablets
591848|NCT00543426|Multicenter clinical study|multicenter clinical study
591849|NCT00543478|Irritable bowel syndrome|irritable bowel syndrome
591850|NCT00543478|Diarrhea|diarrhea
591851|NCT00543478|Probiotics|probiotics
591852|NCT00543504|Advanced Cancer|advanced cancer
591853|NCT00543504|Bevacizumab|bevacizumab
591854|NCT00543504|Avastin|avastin
591855|NCT00543504|Sorafenib|sorafenib
591856|NCT00543504|BAY 43-9006|bay 43-9006
591857|NCT00543504|Erlotinib|erlotinib
591858|NCT00543504|OSI-774|osi-774
591859|NCT00543504|Tarceva|tarceva
591860|NCT00543504|Trastuzumab|trastuzumab
591861|NCT00543504|Herceptin|herceptin
591862|NCT00543504|Sunitinib|sunitinib
591863|NCT00543504|SU011248|su011248
591864|NCT00543504|Sutent|sutent
591865|NCT00543504|Cetuximab|cetuximab
591866|NCT00543504|Lapatinib|lapatinib
591867|NCT00543504|Tykerb|tykerb
591868|NCT00543504|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
591869|NCT00543504|rhuMAb-VEGF|rhumab-vegf
591870|NCT00543504|Erlotinib hydrochloride|erlotinib hydrochloride
591871|NCT00543504|GW572016|gw572016
591872|NCT00543504|Sunitinib Malate|sunitinib malate
591873|NCT00543530|HIV|hiv
591874|NCT00543530|Treatment Experienced|treatment experienced
591875|NCT00543569|kidney transplant|kidney transplant
591876|NCT00543569|alefacept|alefacept
591878|NCT00543608|nosocomial pneumonia|nosocomial pneumonia
591879|NCT00543647|Fenofibrate|fenofibrate
591880|NCT00543647|Glomerular filtration rate|glomerular filtration rate
591881|NCT00543647|inulin clearance|inulin clearance
591882|NCT00543647|creatinine|creatinine
591883|NCT00543647|healthy volunteers|healthy volunteers
591884|NCT00543647|cross-over|cross-over
591885|NCT00543660|Corneal transplantation, Descemet membrane, endothelium|corneal transplantation, descemet membrane, endothelium
591886|NCT00543673|Healthy term infants|healthy term infants
591887|NCT00543686|Pre-School Asthma|pre-school asthma
591888|NCT00543686|Responder Profiles|responder profiles
591889|NCT00543686|Fluticasone|fluticasone
591890|NCT00543686|Montelukast|montelukast
591891|NCT00543686|Leukotriene|leukotriene
591892|NCT00543686|Children with Pre-School Asthma|children with pre-school asthma
591894|NCT00543712|synovial sarcoma|synovial sarcoma
591895|NCT00543712|APM4171g|apm4171g
591896|NCT00543725|Antiretroviral|antiretroviral
591897|NCT00543725|HIV-1|hiv-1
591898|NCT00543725|AIDS|aids
591899|NCT00543725|TMC278-C215|tmc278-c215
591900|NCT00543725|TMC278-TiDP6-C215|tmc278-tidp6-c215
591901|NCT00543725|Treatment Naive|treatment naive
591902|NCT00543764|Intraoperative Pathway|intraoperative pathway
591903|NCT00543764|Breast Reconstruction|breast reconstruction
591904|NCT00543764|DIEP flap|diep flap
591905|NCT00543777|Liver Cancer|liver cancer
591906|NCT00543777|Magnetic Resonance Elastography|magnetic resonance elastography
591907|NCT00543777|2-Point Dixon Magnetic Resonance Imaging|2-point dixon magnetic resonance imaging
591908|NCT00543777|Liver Disease|liver disease
591909|NCT00543777|Fatty Liver|fatty liver
591910|NCT00543777|Liver Fibrosis|liver fibrosis
591911|NCT00543777|Liver Cirrhosis|liver cirrhosis
591913|NCT00543777|2PD MRI|2pd mri
591914|NCT00543777|phase correction algorithm|phase correction algorithm
591915|NCT00543829|breast cancer|breast cancer
591916|NCT00543829|doxorubicin|doxorubicin
591917|NCT00543829|docetaxel|docetaxel
591918|NCT00543829|tamoxifen|tamoxifen
591919|NCT00543842|Rectal Cancer|rectal cancer
591920|NCT00543842|Bevacizumab|bevacizumab
591921|NCT00543842|Erlotinib|erlotinib
591922|NCT00543842|Capecitabine|capecitabine
591923|NCT00543855|Lewy Body Disease|lewy body disease
591924|NCT00543855|Dementia|dementia
591925|NCT00543855|Clinical Trial|clinical trial
591926|NCT00543855|Phase II|phase ii
591927|NCT00543855|E2020|e2020
591928|NCT00543855|donepezil hydrochloride|donepezil hydrochloride
591929|NCT00543881|telemedicine|telemedicine
591930|NCT00543881|remote patient monitoring|remote patient monitoring
591931|NCT00543881|chronic heart failure|chronic heart failure
591932|NCT00543881|mortality|mortality
591933|NCT00543881|health economics|health economics
591934|NCT00543894|Antibiotic, ICU, hospital acquired infection.|antibiotic, icu, hospital acquired infection.
591935|NCT00543907|breast reconstruction|breast reconstruction
591936|NCT00543907|DIEP flap|diep flap
591937|NCT00543985|metabolic syndrome|metabolic syndrome
591938|NCT00543985|obesity|obesity
591939|NCT00543985|exercise|exercise
591940|NCT00543998|Sinusitis|sinusitis
591941|NCT00544011|stage IV colon cancer|stage iv colon cancer
591942|NCT00544011|stage IV rectal cancer|stage iv rectal cancer
591943|NCT00544011|adenocarcinoma of the colon|adenocarcinoma of the colon
591944|NCT00544011|adenocarcinoma of the rectum|adenocarcinoma of the rectum
591945|NCT00544024|Mefloquine|mefloquine
591946|NCT00544050|Levetiracetam|levetiracetam
591947|NCT00544050|Keppra|keppra
591948|NCT00544063|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
591949|NCT00544089|azoospermia FISH IL-18 TESTICULAR BIOPSY|azoospermia fish il-18 testicular biopsy
591950|NCT00544102|Insulin Resistance|insulin resistance
591951|NCT00544102|Systemic Lupus Erythematosus|systemic lupus erythematosus
591952|NCT00544102|Atherosclerosis|atherosclerosis
591953|NCT00544102|Lupus|lupus
591954|NCT00544102|SLE|sle
591955|NCT00544115|graft versus host disease|graft versus host disease
591956|NCT00544115|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
591957|NCT00544115|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
591958|NCT00544115|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
591959|NCT00544115|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
591960|NCT00544115|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
591961|NCT00544115|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
591962|NCT00544115|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
591963|NCT00544115|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
591964|NCT00544115|refractory anemia with excess blasts|refractory anemia with excess blasts
591965|NCT00544115|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
591966|NCT00544115|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
591967|NCT00544115|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
591968|NCT00544115|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
592035|NCT00544128|Treatment Naive|treatment naive
591969|NCT00544115|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
591970|NCT00544115|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
591971|NCT00544115|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
591972|NCT00544115|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
591973|NCT00544115|secondary acute myeloid leukemia|secondary acute myeloid leukemia
591974|NCT00544115|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
591975|NCT00544115|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
591976|NCT00544115|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
591977|NCT00544115|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
591978|NCT00544115|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
591979|NCT00544115|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
591980|NCT00544115|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
591981|NCT00544115|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
591982|NCT00544115|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
591983|NCT00544115|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
591984|NCT00544115|chronic eosinophilic leukemia|chronic eosinophilic leukemia
591985|NCT00544115|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
591986|NCT00544115|chronic neutrophilic leukemia|chronic neutrophilic leukemia
591987|NCT00544115|essential thrombocythemia|essential thrombocythemia
591988|NCT00544115|polycythemia vera|polycythemia vera
591989|NCT00544115|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
591990|NCT00544115|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
591991|NCT00544115|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
591992|NCT00544115|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
591993|NCT00544115|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
591994|NCT00544115|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
591995|NCT00544115|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
591996|NCT00544115|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
591997|NCT00544115|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
591998|NCT00544115|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
591999|NCT00544115|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
592000|NCT00544115|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
592001|NCT00544115|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
592002|NCT00544115|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
592003|NCT00544115|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
592004|NCT00544115|splenic marginal zone lymphoma|splenic marginal zone lymphoma
592005|NCT00544115|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
592006|NCT00544115|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
592007|NCT00544115|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
592008|NCT00544115|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
592009|NCT00544115|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
592010|NCT00544115|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
592011|NCT00544115|Burkitt lymphoma|burkitt lymphoma
592012|NCT00544115|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
592013|NCT00544115|anaplastic large cell lymphoma|anaplastic large cell lymphoma
592551|NCT00533169|ZD6474|zd6474
592014|NCT00544115|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
592015|NCT00544115|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
592016|NCT00544115|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
592017|NCT00544115|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
592018|NCT00544115|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
592019|NCT00544115|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
592020|NCT00544115|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
592021|NCT00544115|refractory multiple myeloma|refractory multiple myeloma
592022|NCT00544115|stage III multiple myeloma|stage iii multiple myeloma
592023|NCT00544115|aplastic anemia|aplastic anemia
592024|NCT00544115|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
592025|NCT00544115|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
592427|NCT00545181|vaginal acidifying gel|vaginal acidifying gel
592026|NCT00544115|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
592027|NCT00544115|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
592028|NCT00544115|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
592029|NCT00544115|stage II multiple myeloma|stage ii multiple myeloma
592031|NCT00544128|initial therapy|initial therapy
592032|NCT00544128|once daily|once daily
592033|NCT00544128|randomized trial|randomized trial
592034|NCT00544128|non inferiority|non inferiority
592036|NCT00544141|Temperature measurement|temperature measurement
592037|NCT00544154|CDP870|cdp870
592038|NCT00544154|Certolizumab pegol|certolizumab pegol
592039|NCT00544167|Breast Cancer|breast cancer
592040|NCT00544167|Early Stage|early stage
592041|NCT00544167|High Risk|high risk
592042|NCT00544167|Node Positive|node positive
592043|NCT00544167|Doxorubicin|doxorubicin
592044|NCT00544167|Cyclophosphamide|cyclophosphamide
592045|NCT00544167|Paclitaxel|paclitaxel
592046|NCT00544167|Sorafenib|sorafenib
592047|NCT00544193|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
592048|NCT00544193|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
592049|NCT00544193|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
592050|NCT00544193|adenocarcinoma of the stomach|adenocarcinoma of the stomach
592051|NCT00544193|stage I pancreatic cancer|stage i pancreatic cancer
592052|NCT00544193|stage II pancreatic cancer|stage ii pancreatic cancer
592053|NCT00544193|stage III pancreatic cancer|stage iii pancreatic cancer
592054|NCT00544193|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
592055|NCT00544193|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
592056|NCT00544193|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
592057|NCT00544193|localized gallbladder cancer|localized gallbladder cancer
592058|NCT00544193|recurrent gallbladder cancer|recurrent gallbladder cancer
592059|NCT00544193|unresectable gallbladder cancer|unresectable gallbladder cancer
592060|NCT00544193|recurrent gastric cancer|recurrent gastric cancer
592061|NCT00544193|stage II gastric cancer|stage ii gastric cancer
592062|NCT00544193|stage III gastric cancer|stage iii gastric cancer
592063|NCT00544193|stage IV gastric cancer|stage iv gastric cancer
592064|NCT00544193|stage I gastric cancer|stage i gastric cancer
592065|NCT00544193|recurrent pancreatic cancer|recurrent pancreatic cancer
592066|NCT00544193|small intestine adenocarcinoma|small intestine adenocarcinoma
592067|NCT00544193|stage IV pancreatic cancer|stage iv pancreatic cancer
592068|NCT00544219|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
592069|NCT00544219|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
592070|NCT00544219|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
592071|NCT00544219|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
592072|NCT00544219|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
592073|NCT00544232|Breast Cancer|breast cancer
592074|NCT00544232|neoadjuvant therapy|neoadjuvant therapy
592076|NCT00544245|overweight|overweight
592077|NCT00544245|obesity|obesity
592078|NCT00544245|accelerometer|accelerometer
592079|NCT00544245|pedometer|pedometer
592080|NCT00544245|energy balance|energy balance
592081|NCT00544245|weight loss|weight loss
592082|NCT00544245|weight maintenance|weight maintenance
592083|NCT00544258|Pharmacokinetic study|pharmacokinetic study
592084|NCT00544258|Actinic Keratosis|actinic keratosis
592085|NCT00544258|Topical|topical
592086|NCT00544258|Dermatology|dermatology
592087|NCT00544271|BOOSTRIX|boostrix
592088|NCT00544271|INFANRIX|infanrix
592089|NCT00544284|adult glioblastoma|adult glioblastoma
592090|NCT00544284|adult anaplastic astrocytoma|adult anaplastic astrocytoma
592091|NCT00544284|adult giant cell glioblastoma|adult giant cell glioblastoma
592092|NCT00544284|recurrent adult brain tumor|recurrent adult brain tumor
592093|NCT00544284|adult gliosarcoma|adult gliosarcoma
592094|NCT00544284|adult mixed glioma|adult mixed glioma
592095|NCT00544284|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
592096|NCT00544284|primary central nervous system lymphoma|primary central nervous system lymphoma
592097|NCT00544284|adult diffuse astrocytoma|adult diffuse astrocytoma
592098|NCT00544284|adult brain stem glioma|adult brain stem glioma
592099|NCT00544284|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
592100|NCT00544284|adult choroid plexus tumor|adult choroid plexus tumor
592101|NCT00544284|adult craniopharyngioma|adult craniopharyngioma
592102|NCT00544284|adult ependymoblastoma|adult ependymoblastoma
592103|NCT00544284|adult medulloblastoma|adult medulloblastoma
592104|NCT00544284|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
592105|NCT00544284|adult anaplastic ependymoma|adult anaplastic ependymoma
592106|NCT00544284|adult ependymoma|adult ependymoma
592107|NCT00544284|adult myxopapillary ependymoma|adult myxopapillary ependymoma
592108|NCT00544284|adult subependymoma|adult subependymoma
592109|NCT00544284|adult anaplastic meningioma|adult anaplastic meningioma
592110|NCT00544284|adult melanocytic lesion|adult melanocytic lesion
592111|NCT00544284|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
592112|NCT00544284|adult grade I meningioma|adult grade i meningioma
592113|NCT00544284|adult grade II meningioma|adult grade ii meningioma
592114|NCT00544284|adult grade III meningioma|adult grade iii meningioma
592115|NCT00544284|adult papillary meningioma|adult papillary meningioma
592116|NCT00544284|adult oligodendroglioma|adult oligodendroglioma
592117|NCT00544284|adult pineoblastoma|adult pineoblastoma
592118|NCT00544284|adult pineocytoma|adult pineocytoma
592119|NCT00544284|tumors metastatic to brain|tumors metastatic to brain
594012|NCT00551031|Influenza|influenza
592120|NCT00544284|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
592121|NCT00544284|adult pilocytic astrocytoma|adult pilocytic astrocytoma
592122|NCT00544284|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
592123|NCT00544297|Actinic Keratosis|actinic keratosis
592124|NCT00544297|Topical|topical
592125|NCT00544297|Dermatology|dermatology
592126|NCT00544297|Hand|hand
592127|NCT00544323|alveolar bone|alveolar bone
592128|NCT00544323|radiographic alveolar bone changes around oral implants of various designs 12 m post loading|radiographic alveolar bone changes around oral implants of various designs 12 m post loading
592129|NCT00544336|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
592130|NCT00544336|recurrent breast cancer|recurrent breast cancer
592131|NCT00544336|stage I breast cancer|stage i breast cancer
592132|NCT00544336|stage II breast cancer|stage ii breast cancer
592133|NCT00544336|stage IIIA breast cancer|stage iiia breast cancer
592134|NCT00544336|stage IIIB breast cancer|stage iiib breast cancer
592135|NCT00544336|stage IIIC breast cancer|stage iiic breast cancer
592136|NCT00544336|stage IV breast cancer|stage iv breast cancer
592137|NCT00544336|recurrent prostate cancer|recurrent prostate cancer
592138|NCT00544336|stage I prostate cancer|stage i prostate cancer
592139|NCT00544336|stage II prostate cancer|stage ii prostate cancer
592140|NCT00544336|stage III prostate cancer|stage iii prostate cancer
592141|NCT00544336|stage IV prostate cancer|stage iv prostate cancer
592142|NCT00544336|extensive stage small cell lung cancer|extensive stage small cell lung cancer
592143|NCT00544336|limited stage small cell lung cancer|limited stage small cell lung cancer
592144|NCT00544336|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
592145|NCT00544336|recurrent small cell lung cancer|recurrent small cell lung cancer
592146|NCT00544336|stage I non-small cell lung cancer|stage i non-small cell lung cancer
592147|NCT00544336|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
592148|NCT00544336|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
592149|NCT00544336|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
592150|NCT00544336|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
592151|NCT00544336|recurrent colon cancer|recurrent colon cancer
592152|NCT00544336|stage I colon cancer|stage i colon cancer
592153|NCT00544336|stage II colon cancer|stage ii colon cancer
592154|NCT00544336|stage III colon cancer|stage iii colon cancer
592155|NCT00544336|stage IV colon cancer|stage iv colon cancer
592156|NCT00544336|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
592157|NCT00544336|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
592158|NCT00544336|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
592159|NCT00544336|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
592160|NCT00544336|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
592161|NCT00544336|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
592162|NCT00544336|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
592163|NCT00544336|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
592164|NCT00544336|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
592165|NCT00544336|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
592166|NCT00544336|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
592167|NCT00544336|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
592168|NCT00544336|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
592169|NCT00544336|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
592552|NCT00533169|Zactima|zactima
592170|NCT00544336|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
592171|NCT00544336|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
592172|NCT00544336|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
592173|NCT00544336|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
592174|NCT00544336|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
592175|NCT00544336|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
592176|NCT00544336|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
592177|NCT00544336|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
592178|NCT00544336|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
592179|NCT00544336|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
592180|NCT00544336|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
592181|NCT00544336|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
592182|NCT00544336|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
592183|NCT00544336|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
592184|NCT00544336|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
592386|NCT00544817|Glioblastoma Multiforme|glioblastoma multiforme
592185|NCT00544336|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
752333|NCT01172548|tumor recurrence|tumor recurrence
592186|NCT00544336|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
592187|NCT00544336|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
592188|NCT00544336|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
592189|NCT00544336|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
592190|NCT00544336|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
592191|NCT00544336|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
592192|NCT00544336|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
592193|NCT00544336|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
592194|NCT00544336|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
592195|NCT00544336|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
592196|NCT00544336|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
592197|NCT00544336|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
592198|NCT00544336|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
592199|NCT00544336|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
592200|NCT00544336|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
592201|NCT00544336|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
592202|NCT00544336|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
592203|NCT00544336|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
592204|NCT00544336|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
592205|NCT00544336|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
592206|NCT00544336|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
592207|NCT00544336|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
592208|NCT00544336|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
592209|NCT00544336|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
592210|NCT00544336|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
592211|NCT00544336|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
592212|NCT00544336|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
592213|NCT00544336|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
592214|NCT00544336|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
592215|NCT00544336|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
592216|NCT00544336|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
592217|NCT00544336|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
592218|NCT00544336|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
592219|NCT00544336|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
592220|NCT00544336|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
592221|NCT00544336|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
592355|NCT00544726|Rehabilitation|rehabilitation
592222|NCT00544336|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
592428|NCT00545181|recurrence|recurrence
592223|NCT00544336|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
592224|NCT00544336|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
592225|NCT00544336|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
592226|NCT00544336|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
592227|NCT00544336|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
592228|NCT00544336|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
592229|NCT00544336|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
592230|NCT00544336|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
592231|NCT00544336|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
592232|NCT00544336|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
592233|NCT00544336|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
592301|NCT00544466|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
592234|NCT00544336|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
592235|NCT00544336|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
751765|NCT01170351|tolerability|tolerability
751766|NCT01170364|Obesity|obesity
592236|NCT00544336|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
592237|NCT00544336|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
592238|NCT00544336|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
592239|NCT00544336|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
592240|NCT00544336|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
592241|NCT00544336|recurrent salivary gland cancer|recurrent salivary gland cancer
592242|NCT00544336|salivary gland acinic cell tumor|salivary gland acinic cell tumor
592243|NCT00544336|salivary gland adenocarcinoma|salivary gland adenocarcinoma
592244|NCT00544336|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
592245|NCT00544336|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
592246|NCT00544336|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
592247|NCT00544336|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
592248|NCT00544336|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
592249|NCT00544336|stage I salivary gland cancer|stage i salivary gland cancer
592250|NCT00544336|stage II salivary gland cancer|stage ii salivary gland cancer
592251|NCT00544336|stage III salivary gland cancer|stage iii salivary gland cancer
592252|NCT00544336|stage IV salivary gland cancer|stage iv salivary gland cancer
592253|NCT00544349|stage IV colon cancer|stage iv colon cancer
592254|NCT00544349|recurrent colon cancer|recurrent colon cancer
592255|NCT00544349|stage IV rectal cancer|stage iv rectal cancer
592256|NCT00544349|recurrent rectal cancer|recurrent rectal cancer
592257|NCT00544349|liver metastases|liver metastases
592258|NCT00544362|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
592259|NCT00544362|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
592260|NCT00544362|stage IIIA esophageal cancer|stage iiia esophageal cancer
592261|NCT00544362|stage IIIB esophageal cancer|stage iiib esophageal cancer
592262|NCT00544362|stage IIIC esophageal cancer|stage iiic esophageal cancer
592263|NCT00544362|stage IV esophageal cancer|stage iv esophageal cancer
592264|NCT00544388|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
592265|NCT00544388|Xyzal tablet|xyzal tablet
592266|NCT00544401|infertility|infertility
592267|NCT00544401|in vitro fertilization|in vitro fertilization
592268|NCT00544401|intracytoplasmic sperm implantation|intracytoplasmic sperm implantation
592269|NCT00544401|acupuncture|acupuncture
592270|NCT00544401|hypnosis|hypnosis
592271|NCT00544401|hypnopuncture|hypnopuncture
592272|NCT00544414|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
592273|NCT00544414|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
592274|NCT00544414|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
592275|NCT00544414|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
592276|NCT00544414|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
592277|NCT00544414|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
592278|NCT00544414|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
592279|NCT00544414|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
592280|NCT00544414|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
592281|NCT00544414|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
592282|NCT00544414|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
592283|NCT00544427|Upper Areo-Digestive tract|upper areo-digestive tract
592284|NCT00544440|Prostate neoplasms|prostate neoplasms
592285|NCT00544440|Prostate cancer|prostate cancer
592286|NCT00544440|Castration-resistant prostate cancer|castration-resistant prostate cancer
592287|NCT00544440|Abiraterone acetate|abiraterone acetate
592288|NCT00544440|CB7630|cb7630
592289|NCT00544440|Prednisone|prednisone
592290|NCT00544440|Testosterone|testosterone
592291|NCT00544440|Bone marrow|bone marrow
592292|NCT00544453|SPECT|spect
592293|NCT00544453|Alzheimer disease|alzheimer disease
592294|NCT00544466|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
592295|NCT00544466|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
592296|NCT00544466|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
592297|NCT00544466|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
592298|NCT00544466|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
752334|NCT01172548|KIT receptor|kit receptor
592299|NCT00544466|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
592300|NCT00544466|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
592383|NCT00544817|Temozolomide|temozolomide
592302|NCT00544466|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
592303|NCT00544466|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
592304|NCT00544466|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
592305|NCT00544466|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
592306|NCT00544466|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
592307|NCT00544466|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
592308|NCT00544466|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
592309|NCT00544466|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
592310|NCT00544466|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
592311|NCT00544466|secondary acute myeloid leukemia|secondary acute myeloid leukemia
592312|NCT00544466|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
592313|NCT00544466|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
592314|NCT00544466|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
592315|NCT00544466|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
592316|NCT00544466|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
592317|NCT00544466|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
592318|NCT00544492|arteriovenous fistula|arteriovenous fistula
592319|NCT00544492|dialysis access|dialysis access
592320|NCT00544492|pain|pain
592321|NCT00544492|anxiety|anxiety
592322|NCT00544492|fistula related complications|fistula related complications
592323|NCT00544492|aneurysm|aneurysm
592324|NCT00544518|type 2 diabetes|type 2 diabetes
592325|NCT00544518|Benfluorex|benfluorex
592326|NCT00544518|Metformin|metformin
592327|NCT00544518|insulin secretion|insulin secretion
592328|NCT00544518|glucose control|glucose control
592329|NCT00544531|MI oocytes, FISH,chromosomal aberrations|mi oocytes, fish,chromosomal aberrations
592330|NCT00544544|Bipolar|bipolar
592331|NCT00544544|depression|depression
592332|NCT00544570|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
592333|NCT00544570|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
592334|NCT00544583|Abdominal wall|abdominal wall
592335|NCT00544609|Bladder|bladder
592336|NCT00544609|Sorafenib|sorafenib
592337|NCT00544609|Radiotherapy|radiotherapy
592338|NCT00544622|Stroke treatment|stroke treatment
592339|NCT00544622|Rehabilitation|rehabilitation
592340|NCT00544622|Stroke chain|stroke chain
592341|NCT00544622|Stroke unit|stroke unit
592342|NCT00544648|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
592343|NCT00544648|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
592344|NCT00544674|extensive stage small cell lung cancer|extensive stage small cell lung cancer
592345|NCT00544674|limited stage small cell lung cancer|limited stage small cell lung cancer
592346|NCT00544674|recurrent small cell lung cancer|recurrent small cell lung cancer
592347|NCT00544687|Skin|skin
592348|NCT00544687|Atrophy|atrophy
592349|NCT00544687|CRX-191|crx-191
592350|NCT00544687|mometasone furoate|mometasone furoate
592351|NCT00544687|nortriptyline hydrochloride|nortriptyline hydrochloride
592352|NCT00544687|Skin Thickness in Normal Healthy Volunteers|skin thickness in normal healthy volunteers
592353|NCT00544700|stage IV colon cancer|stage iv colon cancer
592354|NCT00544700|stage IV rectal cancer|stage iv rectal cancer
592356|NCT00544739|Coronary Artery Disease|coronary artery disease
592357|NCT00544739|Premature|premature
592358|NCT00544739|Female|female
592359|NCT00544752|sleep apnea syndromes, ambient indoor temperature|sleep apnea syndromes, ambient indoor temperature
592360|NCT00544765|Breast cancer|breast cancer
592361|NCT00544765|neoadjuvant therapy|neoadjuvant therapy
592362|NCT00544765|pCR rates|pcr rates
592363|NCT00544778|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
592364|NCT00544778|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
592365|NCT00544778|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
592366|NCT00544778|metastatic osteosarcoma|metastatic osteosarcoma
592367|NCT00544778|recurrent osteosarcoma|recurrent osteosarcoma
592368|NCT00544778|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
592369|NCT00544778|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
592370|NCT00544778|Ewing sarcoma of bone|ewing sarcoma of bone
592371|NCT00544791|Mild Cognitive Impairment|mild cognitive impairment
592372|NCT00544791|Melatonin|melatonin
592373|NCT00544791|Antioxidant|antioxidant
592374|NCT00544791|Memory|memory
592375|NCT00544791|Alzheimer|alzheimer
592376|NCT00544804|recurrent breast cancer|recurrent breast cancer
592377|NCT00544804|stage IIIA breast cancer|stage iiia breast cancer
592378|NCT00544804|stage IIIB breast cancer|stage iiib breast cancer
592379|NCT00544804|stage IIIC breast cancer|stage iiic breast cancer
592380|NCT00544804|stage IV breast cancer|stage iv breast cancer
592381|NCT00544804|bone metastases|bone metastases
592382|NCT00544817|Concurrent Radiation Therapy|concurrent radiation therapy
592384|NCT00544817|Sorafenib|sorafenib
592388|NCT00544830|stage IV prostate cancer|stage iv prostate cancer
751767|NCT01170364|sibutramine|sibutramine
592389|NCT00544830|adenocarcinoma of the prostate|adenocarcinoma of the prostate
592390|NCT00544830|recurrent prostate cancer|recurrent prostate cancer
592391|NCT00544856|mild Alzheimer's disease|mild alzheimer's disease
592392|NCT00544856|mild cognitive impairment|mild cognitive impairment
592393|NCT00544869|Vasopressin antagonist , Cardiac Edema ,Diuretics|vasopressin antagonist , cardiac edema ,diuretics
592394|NCT00544908|stage IV pancreatic cancer|stage iv pancreatic cancer
592395|NCT00544947|Respiratory Depression|respiratory depression
592396|NCT00544947|Caesarean Section|caesarean section
592397|NCT00544947|Diamorphine|diamorphine
592398|NCT00544947|Fentanyl|fentanyl
592399|NCT00544960|AT101|at101
592400|NCT00544960|AT-101|at-101
592401|NCT00544960|cancer|cancer
592402|NCT00544960|lung|lung
592403|NCT00544960|non-small cell|non-small cell
592404|NCT00544960|docetaxel|docetaxel
592406|NCT00544986|breast cancer|breast cancer
592407|NCT00544986|post menopausal women|post menopausal women
592408|NCT00544986|Post menopausal women with hormone sensitive advanced breast cancer|post menopausal women with hormone sensitive advanced breast cancer
592409|NCT00544999|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
592410|NCT00544999|secondary acute myeloid leukemia|secondary acute myeloid leukemia
592411|NCT00544999|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
592412|NCT00544999|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
592413|NCT00544999|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
592414|NCT00544999|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
592415|NCT00544999|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
592416|NCT00544999|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
592417|NCT00544999|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
592418|NCT00544999|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
592419|NCT00544999|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
592420|NCT00544999|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
592421|NCT00545012|Levetiracetam|levetiracetam
592422|NCT00545012|Keppra|keppra
592423|NCT00545025|Influenza|influenza
592424|NCT00545025|Influenza vaccine|influenza vaccine
592425|NCT00545168|head lice|head lice
592426|NCT00545181|bacterial vaginosis|bacterial vaginosis
592429|NCT00545194|Prostaglandin E2|prostaglandin e2
592430|NCT00545194|Intravaginal gel|intravaginal gel
592431|NCT00545194|Bishop score|bishop score
592432|NCT00545194|Induction of labor|induction of labor
592433|NCT00545194|randomized trial|randomized trial
592434|NCT00545194|Vaginal insert|vaginal insert
592435|NCT00545246|VEGF Trap|vegf trap
592436|NCT00545259|Organ transplant, liver, pharmacokinetics, AEB071, immunosuppression|organ transplant, liver, pharmacokinetics, aeb071, immunosuppression
592437|NCT00545272|QMF|qmf
592438|NCT00545272|indacaterol|indacaterol
592439|NCT00545272|Twisthaler®|twisthaler®
592440|NCT00545285|clinical outcomes|clinical outcomes
592441|NCT00545285|radiographic outcomes|radiographic outcomes
592442|NCT00545285|total hip arthroplasty|total hip arthroplasty
592443|NCT00545285|survivorship|survivorship
592444|NCT00545298|Nitric Oxide|nitric oxide
592445|NCT00545298|Venous Leg Ulcers|venous leg ulcers
592446|NCT00545311|multiple inhaled, NVA237, COPD|multiple inhaled, nva237, copd
592447|NCT00545350|Prevention|prevention
592448|NCT00545350|Falls, accidental falls|falls, accidental falls
592449|NCT00545350|Fractures|fractures
592450|NCT00545350|Physical injuries|physical injuries
592451|NCT00545350|Women|women
592452|NCT00545350|Elderly|elderly
592453|NCT00545350|Physical exercise|physical exercise
592454|NCT00545350|Balance exercise|balance exercise
592455|NCT00545415|fruit|fruit
592456|NCT00545415|antioxidant|antioxidant
592457|NCT00545415|Healthy subjects|healthy subjects
592458|NCT00545428|Nasal acquired diseases|nasal acquired diseases
592459|NCT00545428|Nasal congenital diseases|nasal congenital diseases
592460|NCT00545428|Rhinoplasty|rhinoplasty
592461|NCT00545428|Grafts|grafts
592462|NCT00545441|Anal fistula|anal fistula
592463|NCT00545441|fistula in ano|fistula in ano
592464|NCT00545441|anorectal fistula|anorectal fistula
592465|NCT00545454|Inflammation|inflammation
592466|NCT00545454|anti-cytokine|anti-cytokine
592467|NCT00545454|anti-chemokine|anti-chemokine
592468|NCT00545467|Aripiprazole|aripiprazole
592469|NCT00545467|schizophrenia|schizophrenia
592470|NCT00545467|antipsychotics|antipsychotics
592471|NCT00545467|pharmacogenomics|pharmacogenomics
592472|NCT00545467|cytochrome P450 enzyme|cytochrome p450 enzyme
592473|NCT00545493|Rasmussen encephalitis|rasmussen encephalitis
592474|NCT00545493|Chronic encephalitis|chronic encephalitis
592475|NCT00545493|Cerebral hemiatrophy|cerebral hemiatrophy
592476|NCT00545493|Hemiparesis|hemiparesis
592477|NCT00545493|Epilepsy|epilepsy
592478|NCT00545506|wound infection|wound infection
592479|NCT00545506|tissue oxygen tension|tissue oxygen tension
592480|NCT00545506|local warming|local warming
592481|NCT00545519|Multiple Myeloma|multiple myeloma
592482|NCT00545519|Thymoglobulin|thymoglobulin
592483|NCT00545545|Colorectal|colorectal
592484|NCT00545545|Carcinoma|carcinoma
592485|NCT00545545|Recurrent|recurrent
592486|NCT00545545|Progressive|progressive
592487|NCT00545545|Cetuximab|cetuximab
592488|NCT00545545|Irinotecan|irinotecan
592489|NCT00545545|5-Fluorouracil|5-fluorouracil
592490|NCT00545558|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
592491|NCT00545558|Coinfection|coinfection
592492|NCT00545558|Treatment Naive|treatment naive
592493|NCT00545597|adrenoleukodystrophy|adrenoleukodystrophy
592494|NCT00545597|adrenomyeloneuropathy|adrenomyeloneuropathy
592495|NCT00545623|HIV/AIDS|hiv/aids
592496|NCT00545623|Alternative Medicine|alternative medicine
592497|NCT00545623|Complementary Medicine|complementary medicine
592498|NCT00545649|Fibromyalgia|fibromyalgia
592499|NCT00545649|chronic pain|chronic pain
592500|NCT00545649|physical|physical
592501|NCT00545649|exercise|exercise
592502|NCT00545649|activity|activity
592503|NCT00545649|education|education
592504|NCT00545662|traumatic brain injury|traumatic brain injury
592505|NCT00545662|cognition|cognition
592506|NCT00545662|behavioral outcome|behavioral outcome
592507|NCT00545662|functional outcome|functional outcome
592508|NCT00545662|treatment|treatment
592509|NCT00545662|early intervention|early intervention
592510|NCT00545662|citicoline|citicoline
592511|NCT00532974|HIV|hiv
592512|NCT00532974|Human Immunodeficiency Virus|human immunodeficiency virus
592513|NCT00532974|Vaccines|vaccines
592514|NCT00532974|HIV Vaccines|hiv vaccines
592515|NCT00532974|Peptide|peptide
592516|NCT00532974|Peptide Vaccines|peptide vaccines
592517|NCT00532974|HIV 1|hiv 1
592518|NCT00533052|Behavioral weight loss|behavioral weight loss
592519|NCT00533065|Aging|aging
592520|NCT00533078|omega3 fatty acid|omega3 fatty acid
592521|NCT00533078|parenteral nutrition|parenteral nutrition
592522|NCT00533078|chemotherapy|chemotherapy
592523|NCT00533078|infection|infection
592524|NCT00533078|neutropenia|neutropenia
592525|NCT00533104|Limb ischemia|limb ischemia
592526|NCT00533104|Cell Therapy|cell therapy
592527|NCT00533117|suicide|suicide
592528|NCT00533117|self-mutilation|self-mutilation
592529|NCT00533117|fluoxetine|fluoxetine
592530|NCT00533117|placebo|placebo
592531|NCT00533117|dialectical behavior therapy|dialectical behavior therapy
592532|NCT00533117|supportive therapy|supportive therapy
592533|NCT00533130|AO|ao
592534|NCT00533130|Pediatric|pediatric
592535|NCT00533130|Classification|classification
592536|NCT00533130|Long Bones|long bones
592537|NCT00533130|fractures|fractures
592538|NCT00533130|bones|bones
592539|NCT00533143|Solid cancer patient|solid cancer patient
592540|NCT00533143|Non-invasive ventilation|non-invasive ventilation
592541|NCT00533143|Acute Respiratory Failure|acute respiratory failure
592542|NCT00533156|Closure Device|closure device
592543|NCT00533156|Angiography|angiography
592544|NCT00533156|Angioplasty|angioplasty
592545|NCT00533156|Hemostasis|hemostasis
592546|NCT00533156|Heart Catheterization|heart catheterization
592547|NCT00533156|Vascular Closure|vascular closure
592548|NCT00533156|Peripheral Closure|peripheral closure
592549|NCT00533156|Coronary Angiography|coronary angiography
592550|NCT00533169|Neuroblastoma|neuroblastoma
592553|NCT00533169|Isotretinoin|isotretinoin
592554|NCT00533169|13-Cis Retinoic Acid|13-cis retinoic acid
592555|NCT00533169|Accutane|accutane
592556|NCT00533169|Pediatric Neuroblastoma|pediatric neuroblastoma
592557|NCT00533182|Influenza Infection|influenza infection
592558|NCT00533182|Immunocompromised Host|immunocompromised host
592559|NCT00533182|Resistance Mutations|resistance mutations
592560|NCT00533182|Prolonged Infection|prolonged infection
592561|NCT00533195|UVA1|uva1
592562|NCT00533195|PUVA|puva
592563|NCT00533195|atopic dermatitis|atopic dermatitis
592564|NCT00533221|growth hormone|growth hormone
592565|NCT00533221|strength|strength
592566|NCT00533221|Spinal muscular atrophy type II and III|spinal muscular atrophy type ii and iii
592567|NCT00533234|Elbow fracture|elbow fracture
592568|NCT00533234|Elbow dislocation|elbow dislocation
592569|NCT00533234|Radial head fracture|radial head fracture
592570|NCT00533234|Radial neck fracture|radial neck fracture
592571|NCT00533247|Cox-2 Inhibitor|cox-2 inhibitor
592572|NCT00533247|Pre-emptive Pain|pre-emptive pain
592573|NCT00533247|Preoperative Pain|preoperative pain
592574|NCT00533247|Pain Prophylaxis|pain prophylaxis
592575|NCT00533247|Celebrex|celebrex
592576|NCT00533247|Celecoxib|celecoxib
592577|NCT00533260|Patients with a manic episode or patients diagnosed with schizophrenia , patients who are being treated with quetiapine and are on a stable dosing regime|patients with a manic episode or patients diagnosed with schizophrenia , patients who are being treated with quetiapine and are on a stable dosing regime
592578|NCT00533286|physiotherapy|physiotherapy
592579|NCT00533286|Tuebingen concept|tuebingen concept
592580|NCT00533286|benzodiazepines|benzodiazepines
592581|NCT00533286|muscle relaxants|muscle relaxants
592582|NCT00533286|disc herniation|disc herniation
592583|NCT00533299|Epigenetics, hydralazine, valproate, ovarian cancer|epigenetics, hydralazine, valproate, ovarian cancer
592584|NCT00533338|Breast Cancer|breast cancer
592585|NCT00533338|Cancer Survivors|cancer survivors
592586|NCT00533338|Weight Gain Prevention|weight gain prevention
592587|NCT00533338|Diet|diet
592588|NCT00533338|Exercise|exercise
592589|NCT00533338|Questionnaire|questionnaire
592590|NCT00533338|Survey|survey
592591|NCT00533390|efavirenz|efavirenz
592592|NCT00533390|tuberculosis|tuberculosis
592593|NCT00533390|AIDS|aids
592594|NCT00533390|rifampicin|rifampicin
592595|NCT00533390|efficacy|efficacy
592596|NCT00533390|safety|safety
592597|NCT00533390|Treatment Naive|treatment naive
592598|NCT00533416|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
592599|NCT00533416|Selective Mitotic Inhibitor|selective mitotic inhibitor
592600|NCT00533416|Targeted Therapy|targeted therapy
592601|NCT00533416|Myelodysplastic Syndrome|myelodysplastic syndrome
592602|NCT00533416|MDS|mds
592603|NCT00533442|Rapamycin|rapamycin
592604|NCT00533442|Mycophenolate Mofetil (MMF)|mycophenolate mofetil (mmf)
592605|NCT00533442|Kidney-Pancreas Transplant|kidney-pancreas transplant
592606|NCT00533455|Antipsychotics, tremor|antipsychotics, tremor
592607|NCT00533468|pain|pain
592608|NCT00533468|lumbar puncture|lumbar puncture
592609|NCT00533468|neonates|neonates
592610|NCT00533468|infants|infants
592611|NCT00533468|emergency department|emergency department
592612|NCT00533468|topical anesthesia|topical anesthesia
592613|NCT00533468|LMX4|lmx4
592614|NCT00533507|Pneumococcal vaccine.|pneumococcal vaccine.
592615|NCT00533507|Pneumococcal disease|pneumococcal disease
592616|NCT00533507|Safety|safety
592617|NCT00533507|Immunogenicity|immunogenicity
592618|NCT00533507|Primary vaccination|primary vaccination
592619|NCT00533533|Docetaxel,Oxaliplatin|docetaxel,oxaliplatin
592620|NCT00533533|Phase I/II study|phase i/ii study
592621|NCT00533533|Advanced gastric cancer|advanced gastric cancer
592622|NCT00533533|First line treatment|first line treatment
592623|NCT00533533|Advanced gastric cancer with measurable disease|advanced gastric cancer with measurable disease
592624|NCT00533546|Acute Ischemic Stroke|acute ischemic stroke
592625|NCT00533559|type 2 diabetes|type 2 diabetes
592626|NCT00533559|free fatty acids|free fatty acids
592627|NCT00533559|insulin resistance|insulin resistance
592628|NCT00533559|beta cell lipotoxic effect|beta cell lipotoxic effect
592629|NCT00533585|Non-Small Cell Lung Cancer|non-small cell lung cancer
592630|NCT00533585|Lung Cancer|lung cancer
592631|NCT00533585|NSCLC|nsclc
592632|NCT00533585|malignant pleural effusions|malignant pleural effusions
592633|NCT00533585|Sorafenib|sorafenib
592634|NCT00533585|Paclitaxel|paclitaxel
592635|NCT00533585|Taxol|taxol
592636|NCT00533585|Carboplatin|carboplatin
592637|NCT00533585|Paraplatin|paraplatin
592638|NCT00533585|Bevacizumab|bevacizumab
592639|NCT00533585|Avastin|avastin
592640|NCT00533585|BAY 43-9006|bay 43-9006
592641|NCT00533585|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
592642|NCT00533585|rhuMAb-VEGF|rhumab-vegf
592643|NCT00533624|Gastrointestinal toxicity|gastrointestinal toxicity
592644|NCT00533637|Allergic rhinitis|allergic rhinitis
592645|NCT00533637|Nasal spray|nasal spray
592646|NCT00533637|Anti-histamine|anti-histamine
592647|NCT00533637|Tolerability|tolerability
592648|NCT00539032|N. meningitidis|n. meningitidis
592649|NCT00539032|Meningitis|meningitis
592650|NCT00539032|Meningococcemia|meningococcemia
592651|NCT00539045|myocardial infarction, thrombus|myocardial infarction, thrombus
592652|NCT00539071|schizophrenia|schizophrenia
592653|NCT00539071|schizoaffective disorder|schizoaffective disorder
592654|NCT00539071|long acting injectable|long acting injectable
592655|NCT00539071|treatment resistant|treatment resistant
592656|NCT00539084|microneedles|microneedles
592657|NCT00539084|microneedle|microneedle
592658|NCT00539084|intradermal|intradermal
592659|NCT00539097|pediatrics|pediatrics
592660|NCT00539123|buprenorphine|buprenorphine
592661|NCT00539123|drug counseling|drug counseling
592662|NCT00539123|HIV risk reduction counseling|hiv risk reduction counseling
592663|NCT00539136|GSK561679,|gsk561679,
592664|NCT00539136|Pharmacokinetic,|pharmacokinetic,
592665|NCT00539136|healthy volunteers,|healthy volunteers,
592666|NCT00539136|Gamma Scintigraphy,|gamma scintigraphy,
592667|NCT00539136|PillCam™,|pillcam™,
592668|NCT00539136|acoustic vest|acoustic vest
592669|NCT00539149|Acute otitis media|acute otitis media
592670|NCT00539149|Otitis media with effusion|otitis media with effusion
592671|NCT00539149|Tympanic membrane perforation|tympanic membrane perforation
592672|NCT00539162|Ovarian Cancer|ovarian cancer
592673|NCT00539162|CA 125 Algorithm|ca 125 algorithm
592674|NCT00539162|Cancer Detection|cancer detection
592675|NCT00539162|Questionnaire|questionnaire
592676|NCT00539162|Survey|survey
592677|NCT00539175|diabetes mellitus|diabetes mellitus
592678|NCT00539175|neuropathy|neuropathy
592679|NCT00539175|diabetic neuropathy|diabetic neuropathy
592680|NCT00539188|Borderline Personality Disorder(BPD)|borderline personality disorder(bpd)
594947|NCT00556348|AMD|amd
592681|NCT00539188|Dialectical Behavioral Therapy (DBT)|dialectical behavioral therapy (dbt)
592682|NCT00539188|glutamate|glutamate
592683|NCT00539188|N-Acetylcysteine|n-acetylcysteine
592684|NCT00539188|Borderline Personality Disorder with Self-Injurious Behavior|borderline personality disorder with self-injurious behavior
592685|NCT00539201|GSK706769,|gsk706769,
592686|NCT00539201|CCR5 inhibitor,|ccr5 inhibitor,
592688|NCT00539227|Breast Cancer|breast cancer
592689|NCT00539227|Nipple-Areolar Complex|nipple-areolar complex
592690|NCT00539227|Mastectomy|mastectomy
592691|NCT00539227|Prophylactic mastectomy|prophylactic mastectomy
592692|NCT00539227|Immediate reconstruction|immediate reconstruction
592693|NCT00539227|Reconstructive surgery|reconstructive surgery
592694|NCT00539227|Questionnaire|questionnaire
592695|NCT00539227|Survey|survey
592696|NCT00539227|NAC|nac
592697|NCT00539240|acid reflux|acid reflux
592698|NCT00539240|acid regurgitation|acid regurgitation
592699|NCT00539240|esophagitis|esophagitis
592700|NCT00539240|GERD|gerd
592701|NCT00539240|heartburn|heartburn
592702|NCT00539240|pain|pain
592703|NCT00539240|peptic|peptic
592704|NCT00539253|liver cancer|liver cancer
592705|NCT00539253|transarterial chemoembolization|transarterial chemoembolization
592706|NCT00539266|Claudication|claudication
592707|NCT00539266|Critical limb ischemia|critical limb ischemia
592708|NCT00539266|Cell therapy|cell therapy
592709|NCT00539266|Bone marrow|bone marrow
592710|NCT00539279|Cognitive- Behavior Therapy|cognitive- behavior therapy
592711|NCT00539279|Combat Disorders|combat disorders
592712|NCT00539279|Elderly|elderly
592713|NCT00539279|Geriatrics|geriatrics
592714|NCT00539279|Implosive therapy|implosive therapy
592715|NCT00539279|Neuropsychological Test|neuropsychological test
592716|NCT00539279|Post-traumatic Stress Disorder|post-traumatic stress disorder
592717|NCT00539279|Psychotherapy|psychotherapy
592718|NCT00539279|Randomized Controlled Trial|randomized controlled trial
592719|NCT00539279|Relaxation techniques|relaxation techniques
592720|NCT00539292|pediatrics|pediatrics
592721|NCT00539292|gastroschisis|gastroschisis
592722|NCT00539292|silastic spring-loaded silo|silastic spring-loaded silo
592723|NCT00539305|selective androgen receptor modulators (SARMs)|selective androgen receptor modulators (sarms)
592724|NCT00539305|hormone replacement therapy|hormone replacement therapy
592725|NCT00539305|age-associated cognitive decline|age-associated cognitive decline
592726|NCT00539305|testosterone supplementation|testosterone supplementation
592727|NCT00539331|Non-small Cell Lung Cancer|non-small cell lung cancer
592728|NCT00539331|NSCLC|nsclc
592729|NCT00539331|AZD2171|azd2171
592730|NCT00539331|Paclitaxel/Carboplatin|paclitaxel/carboplatin
592731|NCT00539331|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
592732|NCT00539344|Glioblastoma multiforme|glioblastoma multiforme
592733|NCT00539344|Anaplastic astrocytoma|anaplastic astrocytoma
592734|NCT00539344|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
592735|NCT00539357|Cranial Electrostimulation Therapy|cranial electrostimulation therapy
592736|NCT00539370|Scleritis|scleritis
592737|NCT00539370|Intermediate Uveitis|intermediate uveitis
592738|NCT00539370|Posterior Uveitis|posterior uveitis
592739|NCT00539370|Intraocular Inflammatory Disease|intraocular inflammatory disease
592740|NCT00539370|Data Analysis|data analysis
592741|NCT00539370|Data Collection|data collection
592742|NCT00539370|Sample Analysis|sample analysis
592743|NCT00539383|Lung cancer|lung cancer
592744|NCT00539383|Breast cancer|breast cancer
592745|NCT00539383|Melanoma|melanoma
592746|NCT00539383|Hepatocellular carcinoma|hepatocellular carcinoma
592747|NCT00539383|Brain metastases|brain metastases
592748|NCT00545701|Influenza|influenza
592749|NCT00545701|A/H5N1 strain|a/h5n1 strain
592750|NCT00545701|Orthomyxoviridae Infections|orthomyxoviridae infections
592751|NCT00545701|Influenza Pandemics|influenza pandemics
592752|NCT00545727|Diabetes|diabetes
592753|NCT00545727|Children|children
592754|NCT00545727|Adolescents|adolescents
592755|NCT00545727|Diet|diet
592756|NCT00545727|Glycemic index|glycemic index
592757|NCT00545753|Human Head lice|human head lice
592758|NCT00545766|Prostate Cancer|prostate cancer
592759|NCT00545766|Hormone Refractory|hormone refractory
592760|NCT00545766|Vinflunine|vinflunine
592761|NCT00545766|Salvage Chemotherapy|salvage chemotherapy
592762|NCT00545792|Recurrent Endometrial cancer|recurrent endometrial cancer
592763|NCT00545792|Recurrent Cervical cancer|recurrent cervical cancer
592764|NCT00545792|Recurrent Ovarian cancer|recurrent ovarian cancer
592765|NCT00545792|Recurrent Vaginal cancer|recurrent vaginal cancer
592766|NCT00545792|Recurrent Vulvar cancer|recurrent vulvar cancer
592767|NCT00545792|Vaginal recurrence|vaginal recurrence
592768|NCT00545792|Brachytherapy|brachytherapy
592769|NCT00545792|Radiation Treatment|radiation treatment
592770|NCT00545792|External Beam Radiation|external beam radiation
592771|NCT00545792|Avastin|avastin
592772|NCT00545792|Bevacizumab|bevacizumab
592773|NCT00545805|Insulin resistance|insulin resistance
592774|NCT00545805|Metabolic syndrome X|metabolic syndrome x
592775|NCT00545805|Obesity|obesity
592776|NCT00545805|Intra-Abdominal Fat|intra-abdominal fat
592777|NCT00545805|Omentum|omentum
592778|NCT00545805|Bariatric surgery|bariatric surgery
592779|NCT00545805|Glucose Clamp Technique|glucose clamp technique
592780|NCT00545805|Intravenous Glucose Tolerance Test|intravenous glucose tolerance test
592781|NCT00545805|Adiponectin|adiponectin
592782|NCT00545805|Cytokines|cytokines
592783|NCT00545831|Home Parenteral Nutrition|home parenteral nutrition
592784|NCT00545831|Sepsis Prevention|sepsis prevention
592785|NCT00545831|Central Venous Catheters|central venous catheters
592786|NCT00545831|Taurolidine|taurolidine
592787|NCT00545857|Type 1 diabetes|type 1 diabetes
592788|NCT00545857|Insulin dependent diabetes|insulin dependent diabetes
592789|NCT00545857|Juvenile onset diabetes|juvenile onset diabetes
592790|NCT00545857|pioglitazone|pioglitazone
592791|NCT00545883|GERD|gerd
592792|NCT00545883|esophagitis|esophagitis
592793|NCT00545883|PPI|ppi
592794|NCT00545922|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
592795|NCT00545922|anxiety|anxiety
592796|NCT00545922|depression|depression
592797|NCT00545922|cognitive behavioral therapy|cognitive behavioral therapy
592798|NCT00545948|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
592799|NCT00545948|NSCLC|nsclc
592800|NCT00545948|Non-Squamous|non-squamous
592801|NCT00545948|Genomics|genomics
592802|NCT00545948|Guided Therapy|guided therapy
592803|NCT00545948|Directed Therapy|directed therapy
592804|NCT00545948|Genomic Expression Profiles|genomic expression profiles
592805|NCT00545948|Chemotherapy Sensitivity|chemotherapy sensitivity
592806|NCT00545961|respiratory infection|respiratory infection
592807|NCT00545961|sinusitis|sinusitis
592808|NCT00545961|rhinosinusitis|rhinosinusitis
592809|NCT00545961|children|children
592810|NCT00545961|middle meatal specimens|middle meatal specimens
592811|NCT00545961|respiratory track bacteria|respiratory track bacteria
592812|NCT00545961|amoxicillin-clavulanate|amoxicillin-clavulanate
592813|NCT00545961|pneumococci|pneumococci
592814|NCT00545961|haemophilus|haemophilus
592815|NCT00545961|moraxella|moraxella
592816|NCT00545974|Randomized|randomized
592817|NCT00545974|Double-Blind|double-blind
592818|NCT00545974|Placebo-Controlled|placebo-controlled
592819|NCT00545974|memantine|memantine
592820|NCT00545974|Namenda|namenda
592821|NCT00545974|Frontotemporal Dementia|frontotemporal dementia
592822|NCT00545974|Semantic Dementia|semantic dementia
592823|NCT00545974|FTD|ftd
592824|NCT00545974|SD|sd
592825|NCT00545974|dementia|dementia
592826|NCT00545974|behavioral decline|behavioral decline
592827|NCT00545974|cognitive decline|cognitive decline
592828|NCT00545987|HIV vaccine|hiv vaccine
592829|NCT00545987|HIV|hiv
592830|NCT00545987|AIDS|aids
592831|NCT00545987|prevention|prevention
592832|NCT00545987|HIV/AIDS|hiv/aids
592833|NCT00545987|HIV Preventative Vaccine|hiv preventative vaccine
592834|NCT00545987|HIV Seronegativity|hiv seronegativity
592835|NCT00546013|abdominal aortic aneurysms|abdominal aortic aneurysms
592836|NCT00546013|pseudoexfoliation syndrome|pseudoexfoliation syndrome
592837|NCT00546013|glaucoma|glaucoma
592838|NCT00546065|Barrett's esophagus|barrett's esophagus
592839|NCT00546065|ablation|ablation
592840|NCT00546065|esomeprazole|esomeprazole
592841|NCT00546065|Barrett's cancer|barrett's cancer
592842|NCT00546065|Ablation of Barrett's esophagus|ablation of barrett's esophagus
592843|NCT00546065|Surveillance of Barrett's esophagus after endoscopic resection of Barrett's cancer|surveillance of barrett's esophagus after endoscopic resection of barrett's cancer
592844|NCT00546065|Recurrence of Barrett's cancer|recurrence of barrett's cancer
592845|NCT00546078|HPV vaccine|hpv vaccine
592846|NCT00546078|Cervical cancer|cervical cancer
592847|NCT00546078|Human papillomavirus infection|human papillomavirus infection
592848|NCT00546091|Imaging|imaging
592849|NCT00546091|Multi-Spectral Imaging|multi-spectral imaging
592850|NCT00546091|Thermography|thermography
592851|NCT00546091|Laser Doppler Imaging|laser doppler imaging
592852|NCT00546091|Vasculature|vasculature
592853|NCT00546091|Healthy Volunteer|healthy volunteer
592854|NCT00546091|HV|hv
592855|NCT00546104|Advanced Breast Cancer|advanced breast cancer
592856|NCT00546104|Breast cancer|breast cancer
592857|NCT00546104|Dasatinib|dasatinib
592858|NCT00546104|Inoperable Stage III Breast Cancer|inoperable stage iii breast cancer
592859|NCT00546104|Metastatic Breast Cancer|metastatic breast cancer
592860|NCT00546104|Stage IV Breast Cancer|stage iv breast cancer
592861|NCT00546117|otitis media with effusion|otitis media with effusion
592862|NCT00546117|gastroesophageal reflux|gastroesophageal reflux
592863|NCT00546117|ear infection|ear infection
592864|NCT00546117|proton pump inhibitor|proton pump inhibitor
592865|NCT00546130|ED-SCLC|ed-sclc
592866|NCT00546130|small cell lung cancer|small cell lung cancer
592867|NCT00546130|CPT-11|cpt-11
592868|NCT00546130|irinotecan hydrochloride|irinotecan hydrochloride
592869|NCT00546130|CDDP|cddp
592870|NCT00546130|cisplatin|cisplatin
592871|NCT00546130|PSK|psk
592872|NCT00546130|Krestin|krestin
592873|NCT00546143|Asthma, anti-immunoglobulin E, omalizumab|asthma, anti-immunoglobulin e, omalizumab
592874|NCT00546156|ER positive|er positive
592875|NCT00546156|PR positive|pr positive
592876|NCT00546169|Patients undergoing elective or acute cholecystectomy|patients undergoing elective or acute cholecystectomy
592877|NCT00546182|Lipophilic statins|lipophilic statins
592878|NCT00546182|Insulin resistance|insulin resistance
592879|NCT00546182|hypercholesterolemic patients|hypercholesterolemic patients
592880|NCT00546195|Cord Blood|cord blood
592881|NCT00546195|Neutrophils|neutrophils
592882|NCT00546195|Polysaccharide|polysaccharide
592883|NCT00546195|Gene Expression|gene expression
592884|NCT00546208|bladder function|bladder function
592885|NCT00546208|cutaneous ureterostomy|cutaneous ureterostomy
592886|NCT00546208|hydronephrosis|hydronephrosis
592887|NCT00546221|Depression|depression
592888|NCT00546221|Mental health|mental health
592889|NCT00546221|Exercise|exercise
592890|NCT00546221|Prescribed exercise|prescribed exercise
592891|NCT00546221|Physical health|physical health
592892|NCT00546221|Social wellbeing|social wellbeing
592893|NCT00546234|asthma|asthma
592894|NCT00546234|tiotropium|tiotropium
592895|NCT00546234|smoking|smoking
592896|NCT00546234|eNO|eno
592897|NCT00546234|metabolites|metabolites
592898|NCT00546234|Virtual Asthma Clinic|virtual asthma clinic
592899|NCT00546260|STEMI|stemi
592900|NCT00546260|ACS|acs
592901|NCT00546273|LTBI (Latent tuberculosis infection)|ltbi (latent tuberculosis infection)
592902|NCT00546273|TB(Tuberculosis)|tb(tuberculosis)
592903|NCT00546273|Vaccine|vaccine
592904|NCT00546299|Ambulatory oxygen therapy|ambulatory oxygen therapy
592905|NCT00546299|COPD|copd
592906|NCT00546299|exertional hypoxemia|exertional hypoxemia
592907|NCT00546351|Lacosamide|lacosamide
592908|NCT00546377|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
592909|NCT00546377|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
592910|NCT00546377|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
592911|NCT00546377|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
592912|NCT00546377|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
592913|NCT00546377|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
592914|NCT00546377|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
592915|NCT00546377|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
592916|NCT00546377|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
592917|NCT00546403|Excessive Daytime Sleepiness|excessive daytime sleepiness
592918|NCT00546429|Proximal femoral fracture|proximal femoral fracture
592919|NCT00546429|Trochanteric fracture|trochanteric fracture
592920|NCT00546429|Intramedullary nailing|intramedullary nailing
592921|NCT00546442|insulin resistance|insulin resistance
592922|NCT00546442|chronic hepatitis C|chronic hepatitis c
592923|NCT00546442|genotype 1|genotype 1
592924|NCT00546455|Obesity|obesity
592925|NCT00546455|insulin resistance|insulin resistance
592926|NCT00546468|stomach cancer|stomach cancer
592927|NCT00546468|laparoscopy|laparoscopy
592928|NCT00546468|gastrectomy|gastrectomy
592929|NCT00546468|QOL|qol
592930|NCT00546468|survival|survival
592931|NCT00546468|clinical study|clinical study
592932|NCT00546520|Asthma|asthma
592933|NCT00546520|Ciclesonide|ciclesonide
592934|NCT00546520|Airway hyperresponsiveness|airway hyperresponsiveness
592935|NCT00546520|Sputum|sputum
592936|NCT00546520|Nitric oxide|nitric oxide
592937|NCT00546546|Crohn|crohn
592938|NCT00546546|immunosuppressants|immunosuppressants
592939|NCT00546546|natural history|natural history
592940|NCT00546546|steroids|steroids
592941|NCT00546559|Lipophilic statins|lipophilic statins
592942|NCT00546559|Insulin resistance|insulin resistance
593032|NCT00547170|abortion|abortion
593033|NCT00547170|doxycycline|doxycycline
593106|NCT00547482|Obese|obese
592943|NCT00546559|simvastatin and pravastatin may have differential metabolic effects in hypercholesterolemic patients.|simvastatin and pravastatin may have differential metabolic effects in hypercholesterolemic patients.
592944|NCT00546585|influenza, inactivated influenza A/H7N7 vaccine, parent protocol|influenza, inactivated influenza a/h7n7 vaccine, parent protocol
592945|NCT00546598|Total hip replacement, Total hip arthroplasty|total hip replacement, total hip arthroplasty
592946|NCT00546611|PEP005|pep005
592947|NCT00546611|Common Wart(s)|common wart(s)
592948|NCT00546611|Common warts (verruca[e] vulgaris)|common warts (verruca[e] vulgaris)
592949|NCT00546650|Focus of study is to compare pharmacokinetics|focus of study is to compare pharmacokinetics
592950|NCT00546663|Cystic Fibrosis, hypertonic saline|cystic fibrosis, hypertonic saline
592951|NCT00546689|HIV|hiv
592952|NCT00546689|aids|aids
592953|NCT00546689|intestinal parasites|intestinal parasites
592954|NCT00546689|eosinophils|eosinophils
592955|NCT00546689|immunoglobulins|immunoglobulins
592956|NCT00546689|HIV/aids|hiv/aids
592957|NCT00546689|Treatment Experienced|treatment experienced
592958|NCT00546741|Diabetes,NOS|diabetes,nos
592959|NCT00546780|Multiple Myeloma|multiple myeloma
592960|NCT00546780|Heat Shock Protein 90|heat shock protein 90
592961|NCT00546780|Hsp90|hsp90
592962|NCT00546780|KOS-953|kos-953
592963|NCT00546780|17-AAG|17-aag
592964|NCT00546780|bortezomib|bortezomib
592965|NCT00546780|first relapse|first relapse
592966|NCT00546780|tanespimycin|tanespimycin
592967|NCT00546780|TIME-1|time-1
592968|NCT00546793|humanized anti-CD20 veltuzumab (IMMU-106) administered subcutaneously|humanized anti-cd20 veltuzumab (immu-106) administered subcutaneously
592969|NCT00546806|Rehabilitation,|rehabilitation,
592970|NCT00546806|Treatment outcome,|treatment outcome,
595047|NCT00559767|Genes|genes
592971|NCT00546806|Whiplash injuries,|whiplash injuries,
592972|NCT00546806|Randomized Clinical Trials|randomized clinical trials
592973|NCT00546858|Pelvic pain|pelvic pain
592974|NCT00546858|Vulvar pain|vulvar pain
592975|NCT00546884|End of Life|end of life
592976|NCT00546884|Advance Directives|advance directives
592977|NCT00546884|Randomized controlled trial|randomized controlled trial
592978|NCT00546884|End of life care|end of life care
592979|NCT00546884|End of life advance care planning|end of life advance care planning
592980|NCT00546936|Histoplasmosis|histoplasmosis
592981|NCT00546949|Decompression, Surgical|decompression, surgical
592982|NCT00546949|x-stop|x-stop
592983|NCT00546949|lumbar decompression|lumbar decompression
592984|NCT00546949|spinal stenosis|spinal stenosis
592985|NCT00546949|radiculopathy|radiculopathy
592986|NCT00546975|gastrointestinal surgery|gastrointestinal surgery
592987|NCT00546975|nutritional intervention|nutritional intervention
592988|NCT00546975|functional status|functional status
592989|NCT00546975|quality of life|quality of life
592990|NCT00546988|primary treatment|primary treatment
592991|NCT00546988|allogeneic stem-cell transplantation|allogeneic stem-cell transplantation
592992|NCT00546988|high-dose therapy|high-dose therapy
592993|NCT00546988|cytogenetics|cytogenetics
592994|NCT00547001|Menopause|menopause
592995|NCT00547001|Hot flashes|hot flashes
592996|NCT00547001|vasomotor symptoms|vasomotor symptoms
592997|NCT00547001|tapering regimen|tapering regimen
592998|NCT00547001|hormonal therapy|hormonal therapy
592999|NCT00547001|Other menopausal symptoms including mood changes|other menopausal symptoms including mood changes
593000|NCT00547014|treatment, parallel assignment, double blind, randomized, placebo control, safety study,SLE (Systemic Lupus Erythematosus)|treatment, parallel assignment, double blind, randomized, placebo control, safety study,sle (systemic lupus erythematosus)
593001|NCT00547027|diabetes|diabetes
593002|NCT00547027|physical activity|physical activity
593003|NCT00547027|print-based intervention|print-based intervention
593004|NCT00547027|tailored intervention|tailored intervention
593005|NCT00547040|calcification|calcification
593006|NCT00547040|bone lesions|bone lesions
593007|NCT00547066|ITP|itp
593008|NCT00547066|hA20|ha20
593009|NCT00547066|Treatment|treatment
593010|NCT00547105|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
593011|NCT00547105|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
593012|NCT00547105|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
593013|NCT00547105|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
593014|NCT00547118|Metabolic abnormalities|metabolic abnormalities
593015|NCT00547118|Safety|safety
593016|NCT00547118|Satiety|satiety
593017|NCT00547131|tumors metastatic to brain|tumors metastatic to brain
593018|NCT00547131|recurrent adult brain tumor|recurrent adult brain tumor
593019|NCT00547157|head and neck|head and neck
593020|NCT00547157|squamous cell carcinoma|squamous cell carcinoma
593021|NCT00547157|radiotherapy|radiotherapy
593022|NCT00547157|chemoradiotherapy|chemoradiotherapy
593023|NCT00547157|panitumumab|panitumumab
593024|NCT00547157|locally advanced head & neck cancer|locally advanced head & neck cancer
593025|NCT00547157|EGFr|egfr
593026|NCT00547157|epidermal growth factor receptor|epidermal growth factor receptor
593027|NCT00547157|SCCHN|scchn
593028|NCT00547157|locally advanced SCCHN|locally advanced scchn
593029|NCT00547157|HNC|hnc
593030|NCT00547157|epidermal growth factor|epidermal growth factor
593031|NCT00547170|pelvic infection|pelvic infection
593034|NCT00547196|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
593035|NCT00547196|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
593036|NCT00547196|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
593037|NCT00547196|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
593038|NCT00547196|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
593039|NCT00547196|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
593040|NCT00547196|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
593041|NCT00547196|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
593042|NCT00547196|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
593043|NCT00547196|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
593044|NCT00547196|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
593045|NCT00547196|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
593046|NCT00547196|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
593047|NCT00547196|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
593048|NCT00547196|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
593049|NCT00547196|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
593050|NCT00547196|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
751768|NCT01170364|eating behavior|eating behavior
593051|NCT00547196|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
593052|NCT00547196|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
594566|NCT00555022|FTIH,|ftih,
593053|NCT00547196|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
593054|NCT00547196|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
593055|NCT00547196|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
593056|NCT00547196|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
593057|NCT00547196|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
593058|NCT00547196|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
593059|NCT00547196|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
593060|NCT00547196|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
593061|NCT00547196|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
593062|NCT00547196|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
593063|NCT00547196|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
593064|NCT00547196|splenic marginal zone lymphoma|splenic marginal zone lymphoma
593065|NCT00547196|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
593066|NCT00547196|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
593067|NCT00547196|secondary acute myeloid leukemia|secondary acute myeloid leukemia
593068|NCT00547235|infection|infection
593069|NCT00547235|precancerous/nonmalignant condition|precancerous/nonmalignant condition
593070|NCT00547248|Booster vaccination.|booster vaccination.
593071|NCT00547248|Immunogenicity|immunogenicity
593072|NCT00547248|Pneumococcal vaccine|pneumococcal vaccine
593073|NCT00547248|Safety|safety
593074|NCT00547248|Pneumococcal disease|pneumococcal disease
593075|NCT00547261|solid tumor|solid tumor
593076|NCT00547261|antimitotic|antimitotic
593077|NCT00547261|tubulin binder|tubulin binder
593078|NCT00547300|Hypertension|hypertension
593079|NCT00547300|Nebivolol|nebivolol
593080|NCT00547300|Beta blocker|beta blocker
593081|NCT00547300|Tolerability|tolerability
593082|NCT00547339|adenocarcinoma of the prostate|adenocarcinoma of the prostate
593083|NCT00547339|stage I prostate cancer|stage i prostate cancer
593084|NCT00547339|stage IIB prostate cancer|stage iib prostate cancer
593085|NCT00547339|stage IIA prostate cancer|stage iia prostate cancer
593086|NCT00547365|primary systemic amyloidosis|primary systemic amyloidosis
593087|NCT00547378|overactive bladder, urinary incontinence, incontinence,Urgency-frequency|overactive bladder, urinary incontinence, incontinence,urgency-frequency
593088|NCT00547391|adults|adults
593089|NCT00547391|children|children
593090|NCT00547391|tonsillectomy|tonsillectomy
593091|NCT00547443|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
593092|NCT00547443|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
593093|NCT00547443|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
593094|NCT00547443|adenocarcinoma of the lung|adenocarcinoma of the lung
593095|NCT00547443|squamous cell lung cancer|squamous cell lung cancer
593096|NCT00547443|large cell lung cancer|large cell lung cancer
593097|NCT00547443|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
593098|NCT00547443|adenosquamous cell lung cancer|adenosquamous cell lung cancer
593099|NCT00547469|Irritable Bowel Syndrome|irritable bowel syndrome
593100|NCT00547469|IBS-c|ibs-c
593101|NCT00547469|IBS constipation|ibs constipation
593102|NCT00547469|women with IBS|women with ibs
593103|NCT00547469|women with constipation|women with constipation
593104|NCT00547482|Type 2 Diabetes|type 2 diabetes
593105|NCT00547482|Overweight|overweight
593107|NCT00547534|Bortezomib|bortezomib
593108|NCT00547534|Bendamustine|bendamustine
593109|NCT00547534|Rituximab|rituximab
593110|NCT00547534|Relapsed|relapsed
593111|NCT00547534|Refractory|refractory
593112|NCT00547534|Mantle Cell|mantle cell
593113|NCT00547534|Indolent|indolent
593114|NCT00547547|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
593115|NCT00547560|Alzheimer Disease|alzheimer disease
593116|NCT00547612|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
593117|NCT00547612|stage I pancreatic cancer|stage i pancreatic cancer
593118|NCT00547612|stage II pancreatic cancer|stage ii pancreatic cancer
593119|NCT00547612|stage III pancreatic cancer|stage iii pancreatic cancer
593120|NCT00547612|stage IV pancreatic cancer|stage iv pancreatic cancer
593121|NCT00547612|recurrent pancreatic cancer|recurrent pancreatic cancer
593122|NCT00547638|laceration/wound closure|laceration/wound closure
593123|NCT00547638|topical skin adhesive|topical skin adhesive
593124|NCT00547651|Small Cell Lung Cancer|small cell lung cancer
593125|NCT00547651|Lung Cancer|lung cancer
593126|NCT00547651|Limited Disease Sensitive Small Cell Lung Cancer|limited disease sensitive small cell lung cancer
593127|NCT00547651|Extensive Disease Sensitive Small Cell Lung Cancer|extensive disease sensitive small cell lung cancer
593128|NCT00547651|Limited Disease Refractory Small Cell Lung Cancer|limited disease refractory small cell lung cancer
593129|NCT00547651|Extensive Disease Refractory Small Cell Lung Cancer|extensive disease refractory small cell lung cancer
593130|NCT00547651|Refractory Small Cell Lung Cancer|refractory small cell lung cancer
593131|NCT00547651|Sensitive Small Cell Lung Cancer|sensitive small cell lung cancer
593132|NCT00547664|Hylenex, time tagged pain pain reduction, hospice population|hylenex, time tagged pain pain reduction, hospice population
593133|NCT00547677|liver metastases|liver metastases
593134|NCT00547677|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
593135|NCT00547703|Nonulcer dyspepsia|nonulcer dyspepsia
593136|NCT00547703|Functional dyspepsia|functional dyspepsia
593137|NCT00547703|Antidepressant use in dyspepsia|antidepressant use in dyspepsia
593138|NCT00547703|Nortriptyline|nortriptyline
593139|NCT00547703|Tricyclic antidepressants|tricyclic antidepressants
593140|NCT00547716|Hepatitis C|hepatitis c
593141|NCT00547716|Omega 3 fatty acids|omega 3 fatty acids
593142|NCT00547716|Omacor|omacor
593143|NCT00547716|Interferon|interferon
593144|NCT00547729|Heart Failure|heart failure
593145|NCT00547729|Left Atrial Pressure Monitoring|left atrial pressure monitoring
593146|NCT00547807|Pain, neonate, nursing care|pain, neonate, nursing care
593147|NCT00547820|radiation dose|radiation dose
593148|NCT00547820|VCUG|vcug
593149|NCT00547820|pediatric patients|pediatric patients
593150|NCT00547833|language disorders|language disorders
593151|NCT00547833|language learning disabilities|language learning disabilities
593152|NCT00547833|vocabulary|vocabulary
593153|NCT00547833|reading|reading
593154|NCT00547846|Cough|cough
593155|NCT00547846|Antitussive|antitussive
593156|NCT00547846|PDC-748|pdc-748
593157|NCT00547846|PhytoHealth|phytohealth
593158|NCT00547859|microcirculation|microcirculation
593159|NCT00547859|cardiac surgery|cardiac surgery
593160|NCT00547859|metabolism|metabolism
593161|NCT00547859|capnometry|capnometry
593162|NCT00547885|dihydrocodeine|dihydrocodeine
593163|NCT00547885|opioids, long acting|opioids, long acting
593164|NCT00547885|opioids, short acting|opioids, short acting
593165|NCT00547885|Chronic pain|chronic pain
593166|NCT00547885|non-malignant pain|non-malignant pain
593168|NCT00547898|AIDS|aids
593169|NCT00547898|Diarrhea|diarrhea
593170|NCT00547898|HIV Associated Diarrhea|hiv associated diarrhea
593171|NCT00547911|Entacapone|entacapone
593172|NCT00547911|Carbidopa|carbidopa
593173|NCT00547911|Locus Ceruleus/Norepinephrine-Autonomic System|locus ceruleus/norepinephrine-autonomic system
593174|NCT00547911|Norepinephrine|norepinephrine
593175|NCT00547911|Adrenergic Nervous System|adrenergic nervous system
593176|NCT00547937|Sleep Apnea|sleep apnea
593177|NCT00547937|Oxidative Stress|oxidative stress
593178|NCT00547937|Nitric oxide|nitric oxide
593179|NCT00547937|Cardiovascular disease|cardiovascular disease
593180|NCT00547963|Alcohol Drinking|alcohol drinking
593181|NCT00547963|Marijuana Smoking|marijuana smoking
593182|NCT00547963|Substance Use|substance use
593183|NCT00547963|Emergency Department (ED)|emergency department (ed)
593184|NCT00547976|Inflammation|inflammation
593185|NCT00547976|Unstable Plaque|unstable plaque
593186|NCT00547976|Macrophage|macrophage
593187|NCT00547976|Thrombosis|thrombosis
593188|NCT00547976|Autoradiography|autoradiography
593189|NCT00547976|Atherosclerosis|atherosclerosis
593190|NCT00547976|Vasculitis|vasculitis
593191|NCT00547989|ASA class I and II|asa class i and ii
593192|NCT00548002|Staphylococcus aureus|staphylococcus aureus
593193|NCT00548002|bacteremia|bacteremia
593194|NCT00548002|endocarditis|endocarditis
593195|NCT00548002|sepsis|sepsis
593196|NCT00548002|fluoroquinolone|fluoroquinolone
593197|NCT00548002|rifampin|rifampin
593198|NCT00548002|levofloxacin|levofloxacin
593199|NCT00548002|trovafloxacin|trovafloxacin
593200|NCT00548041|HIV|hiv
593201|NCT00548041|Emergency Department|emergency department
593202|NCT00548041|HIV Seronegativity|hiv seronegativity
593203|NCT00548054|cholera|cholera
593204|NCT00548054|vaccine|vaccine
593205|NCT00548054|Kolkata|kolkata
593206|NCT00548054|West Bengal|west bengal
593207|NCT00548054|India|india
593208|NCT00548054|immunogenicity|immunogenicity
593209|NCT00548054|safety|safety
593210|NCT00548054|infants|infants
593211|NCT00548054|expanded programme on immunization|expanded programme on immunization
593212|NCT00548067|High blood pressure, hypertension, drug interaction, steady state, valsartan, hydrochlorothiazide, amlodipine|high blood pressure, hypertension, drug interaction, steady state, valsartan, hydrochlorothiazide, amlodipine
593213|NCT00548093|non-small cell lung cancer|non-small cell lung cancer
593214|NCT00548093|advanced|advanced
593215|NCT00548093|previously treated|previously treated
593216|NCT00548106|infant formula, milk allergy, hydrolized whey|infant formula, milk allergy, hydrolized whey
593217|NCT00548145|Pitavastatin|pitavastatin
593218|NCT00548145|Statins|statins
593219|NCT00548145|Donepezil|donepezil
593220|NCT00548145|Alzheimer's Disease|alzheimer's disease
593221|NCT00548145|Hypercholesterolemia|hypercholesterolemia
593222|NCT00548145|ADAS-Jcog|adas-jcog
593223|NCT00548145|Alzheimer Disease (MMSE 15-23 and CDR1 or 2)|alzheimer disease (mmse 15-23 and cdr1 or 2)
593224|NCT00548158|diabetes|diabetes
593225|NCT00548184|primary breast cancers|primary breast cancers
593226|NCT00548184|Locally advanced breast cancers|locally advanced breast cancers
751769|NCT01170377|Intravenous sedation|intravenous sedation
593227|NCT00548197|Intravitreal Bevacizumab injection|intravitreal bevacizumab injection
593229|NCT00548197|tractional retinal detachment|tractional retinal detachment
593230|NCT00548197|Diabetic retinopathy|diabetic retinopathy
593231|NCT00548210|Hypertrophy|hypertrophy
593233|NCT00548210|scar treatment|scar treatment
593234|NCT00548210|silicone|silicone
593235|NCT00548223|recurrence of stroke|recurrence of stroke
593236|NCT00548223|Dengzhan Shengmai Capsule|dengzhan shengmai capsule
593237|NCT00548223|Traditional Chinese Medicine|traditional chinese medicine
593238|NCT00548236|exercise intervention|exercise intervention
593239|NCT00548236|AACT|aact
593240|NCT00548249|Subjects with ESRD receiving chronic Hemodialysis|subjects with esrd receiving chronic hemodialysis
593241|NCT00548262|Open-label|open-label
593242|NCT00548262|non-comparative study to evaluate short course of IV anidulafungin|non-comparative study to evaluate short course of iv anidulafungin
593243|NCT00548262|followed by oral voriconazole|followed by oral voriconazole
593244|NCT00548262|for tx of candidemia/invasive candidiasis.|for tx of candidemia/invasive candidiasis.
593245|NCT00548275|Buprenorphine|buprenorphine
593246|NCT00548275|Drug counseling|drug counseling
593247|NCT00548275|HIV risk reduction counseling|hiv risk reduction counseling
593248|NCT00548275|HIV Seronegativity|hiv seronegativity
593249|NCT00548275|HIV risk behaviors|hiv risk behaviors
593250|NCT00548314|Matriderm|matriderm
593251|NCT00548314|Dermal matrix|dermal matrix
593252|NCT00548314|VAC therapy|vac therapy
593253|NCT00548314|Split skin graft|split skin graft
593254|NCT00548314|Burns|burns
593255|NCT00548314|Scar quality|scar quality
593256|NCT00548327|Genes|genes
593257|NCT00548327|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
593258|NCT00548327|Dopamine|dopamine
593259|NCT00548327|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
593260|NCT00548327|Neuropsychological Testing|neuropsychological testing
593261|NCT00548327|Schizophrenia|schizophrenia
593262|NCT00548327|Atomoxetine|atomoxetine
593263|NCT00548327|Cognitive Study|cognitive study
593264|NCT00548327|Pharmacogenetics|pharmacogenetics
593265|NCT00548327|Normal Volunteers|normal volunteers
593266|NCT00548327|Catechol-O-Methyltransferase|catechol-o-methyltransferase
593267|NCT00548327|Healthy Volunteer|healthy volunteer
593268|NCT00548366|cirrhosis|cirrhosis
593269|NCT00548366|portal hypertension|portal hypertension
593270|NCT00548366|ascites|ascites
593271|NCT00548366|sodium restriction|sodium restriction
593272|NCT00548379|vitamin D|vitamin d
593273|NCT00548379|pneumonia|pneumonia
593274|NCT00548392|breast|breast
593275|NCT00548392|cancer|cancer
593276|NCT00548392|ultrasound|ultrasound
593277|NCT00548392|high risk|high risk
593278|NCT00548392|marker clip|marker clip
593279|NCT00548405|Multiple Sclerosis|multiple sclerosis
593280|NCT00548431|Leukemia, Lymphocytic, Acute [C04.557.337.428.511]|leukemia, lymphocytic, acute [c04.557.337.428.511]
593281|NCT00548431|6-mercaptopurine|6-mercaptopurine
593282|NCT00548431|methotrexate|methotrexate
593283|NCT00548431|asparaginase|asparaginase
593284|NCT00548444|Tuberculosis|tuberculosis
593285|NCT00548444|Lymphocyte kinetics|lymphocyte kinetics
593286|NCT00548444|MVA85A|mva85a
593287|NCT00548444|Deuterium|deuterium
593288|NCT00548457|the function of the endothelium of the arteries in patients suffering from ectatic coronary arteries|the function of the endothelium of the arteries in patients suffering from ectatic coronary arteries
593289|NCT00548470|schizophrenia|schizophrenia
593290|NCT00548470|varenicline|varenicline
593291|NCT00548470|cognition|cognition
593292|NCT00548470|cigarette smoking|cigarette smoking
593293|NCT00548483|Endotracheal intubation|endotracheal intubation
593294|NCT00548483|Laryngeal edema|laryngeal edema
593295|NCT00548483|Cuff-leak test|cuff-leak test
593296|NCT00548483|Corticosteroids|corticosteroids
593297|NCT00548483|This study was to ascertain whether administration of dexamethasone to critically intubated patients prevent postextubation airway obstruction.|this study was to ascertain whether administration of dexamethasone to critically intubated patients prevent postextubation airway obstruction.
593298|NCT00548483|This study was to compare high dose and low dose dexamethasone in preventing noninvasive ventilation or reintubation among critically ill intubated patients|this study was to compare high dose and low dose dexamethasone in preventing noninvasive ventilation or reintubation among critically ill intubated patients
593299|NCT00548496|fractured wrist|fractured wrist
593300|NCT00548496|Distal radial fracture,|distal radial fracture,
593301|NCT00548522|Type 1 Diabetes|type 1 diabetes
593302|NCT00548522|Pregnancy|pregnancy
593303|NCT00548522|Islet Mass|islet mass
593304|NCT00548522|C-peptide|c-peptide
593305|NCT00548548|Avastin|avastin
593306|NCT00548548|Metastatic Adenocarcinoma|metastatic adenocarcinoma
593307|NCT00548548|AVAGAST|avagast
593308|NCT00548561|extravasation|extravasation
593309|NCT00548561|anthracyclines|anthracyclines
593310|NCT00548587|Acute Coronary Syndrome|acute coronary syndrome
593311|NCT00548600|Prostate Cancer|prostate cancer
593312|NCT00548600|Iridium|iridium
593313|NCT00548600|Implant|implant
593314|NCT00548600|Radiotherapy|radiotherapy
593315|NCT00548613|Myocardial Infarction|myocardial infarction
593316|NCT00548613|Heart Attack|heart attack
593317|NCT00548613|Coronary Artery Bypass Grafting|coronary artery bypass grafting
593318|NCT00548626|Pancreatic Cancer|pancreatic cancer
593319|NCT00548626|Endoscopic Ultrasonography|endoscopic ultrasonography
593320|NCT00548626|Fine-Needle Aspiration|fine-needle aspiration
593321|NCT00548626|Cytopathology|cytopathology
595429|NCT00561535|IBS|ibs
593323|NCT00542256|Cerebral Stroke|cerebral stroke
593324|NCT00542256|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
593325|NCT00542256|Cerebrovascular Apoplexy|cerebrovascular apoplexy
593326|NCT00542256|Cerebrovascular Stroke|cerebrovascular stroke
593327|NCT00542256|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
593328|NCT00542256|Stroke|stroke
593329|NCT00542256|Stroke, Acute|stroke, acute
593330|NCT00542256|Vascular Accident, Brain|vascular accident, brain
593331|NCT00542269|Hypertension|hypertension
593332|NCT00542269|Metabolic Syndrome|metabolic syndrome
593333|NCT00542269|Dual combination therapy|dual combination therapy
593334|NCT00542269|Triple combination therapy|triple combination therapy
593335|NCT00542269|Aliskiren|aliskiren
593336|NCT00542269|Direct Renin inhibitor|direct renin inhibitor
593337|NCT00542282|lung sounds,|lung sounds,
593338|NCT00542282|airway obstruction,|airway obstruction,
593339|NCT00542282|asthma,|asthma,
593340|NCT00542282|auscultation|auscultation
593341|NCT00542321|lateral rotation|lateral rotation
593342|NCT00542321|kinetic therapy|kinetic therapy
593343|NCT00542321|mechanical ventilation|mechanical ventilation
593344|NCT00542321|pulmonary complications|pulmonary complications
593345|NCT00542334|Nocturnal Hypoglycemia|nocturnal hypoglycemia
593346|NCT00542334|Type 1 diabetes|type 1 diabetes
593347|NCT00542334|Children|children
593348|NCT00542334|Adolescents|adolescents
593349|NCT00542334|CGMS|cgms
593350|NCT00542347|gastric acid|gastric acid
593351|NCT00542347|proton pump inhibitors|proton pump inhibitors
593352|NCT00542347|omeprazole|omeprazole
593353|NCT00542347|esomeprazole|esomeprazole
593354|NCT00542360|Accidental Falls|accidental falls
593355|NCT00542360|Aged|aged
593356|NCT00542360|Social Marketing|social marketing
593357|NCT00542360|Exercise|exercise
593358|NCT00542360|Accident Prevention|accident prevention
593359|NCT00542360|Religion|religion
593360|NCT00542360|Randomized Controlled Trial|randomized controlled trial
593361|NCT00542373|Oral Cancer|oral cancer
593362|NCT00542373|Oral Cavity Mucosa|oral cavity mucosa
593363|NCT00542373|Leukoplakia|leukoplakia
593364|NCT00542373|Erythroplakia|erythroplakia
593365|NCT00542373|Fluorescence Imaging|fluorescence imaging
593366|NCT00542373|Reflectance Imaging|reflectance imaging
593367|NCT00542373|Multispectral Digital Microscope|multispectral digital microscope
593368|NCT00542373|Portable Spectroscopy System|portable spectroscopy system
593369|NCT00542373|Fast Excitation-Emission Matrix|fast excitation-emission matrix
593370|NCT00542373|PS2|ps2
593371|NCT00542373|MDM|mdm
593372|NCT00542373|Fast EEM4|fast eem4
593373|NCT00542386|Chronic Kidney Disease|chronic kidney disease
593374|NCT00542386|Dialysis|dialysis
593375|NCT00542386|Hyperphosphatemia|hyperphosphatemia
593376|NCT00542386|Dyslipidemia|dyslipidemia
593377|NCT00542386|Phosphate binder|phosphate binder
593378|NCT00542399|levemir|levemir
593379|NCT00542399|type 1 diabetes|type 1 diabetes
593380|NCT00542425|osteoporosis|osteoporosis
593381|NCT00542425|postmenopausal|postmenopausal
593382|NCT00542425|bone loss|bone loss
593383|NCT00542438|Cardiovascular Disease|cardiovascular disease
593384|NCT00542438|Cancer Prevention|cancer prevention
593385|NCT00542438|Physical Activity|physical activity
593386|NCT00542438|Body Composition|body composition
593387|NCT00542438|Environment|environment
593388|NCT00542438|Exercise|exercise
593389|NCT00542451|node-negative breast cancer|node-negative breast cancer
593390|NCT00542451|HER-2 positive|her-2 positive
593391|NCT00542464|Safety in Healthy Adult Subjects|safety in healthy adult subjects
593392|NCT00542490|Endometrial cancer|endometrial cancer
593393|NCT00542490|Gynecologic Cancer|gynecologic cancer
593394|NCT00542490|Vaginal Cuff Brachytherapy|vaginal cuff brachytherapy
593395|NCT00542490|Vaginal radiation|vaginal radiation
593396|NCT00542503|Cardiac Outcomes|cardiac outcomes
593397|NCT00542503|MRI|mri
593398|NCT00542503|Cardiac Stress Testing|cardiac stress testing
593399|NCT00542516|Hip Replacement Arthroplasty|hip replacement arthroplasty
593400|NCT00542516|Hydroxyethyl Starch|hydroxyethyl starch
593401|NCT00542516|Hemodilution|hemodilution
593402|NCT00542516|Hetastarch|hetastarch
593403|NCT00542516|Colloids|colloids
593404|NCT00542529|Healthy Subjects|healthy subjects
593405|NCT00542542|Breast Cancer|breast cancer
593406|NCT00542542|Reconstructive Surgery|reconstructive surgery
593407|NCT00542542|Paravertebral Block|paravertebral block
593408|NCT00542542|Anesthesia|anesthesia
593409|NCT00542542|Propofol|propofol
593410|NCT00542542|Fentanyl|fentanyl
593411|NCT00542542|Ropivacaine|ropivacaine
593412|NCT00542542|Midazolam|midazolam
593413|NCT00542581|Visual Outcomes|visual outcomes
593414|NCT00542581|Patient Satisfaction|patient satisfaction
593415|NCT00542581|Ophthalmology|ophthalmology
593416|NCT00542581|Cataractous Lens|cataractous lens
593417|NCT00542594|breast cancer|breast cancer
593418|NCT00542594|anastrozole|anastrozole
593419|NCT00542607|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
593420|NCT00542607|Xyzal tablets|xyzal tablets
593421|NCT00542633|Diabetes mellitus type 2|diabetes mellitus type 2
593422|NCT00542633|Diabetes|diabetes
593423|NCT00542633|Insulin|insulin
593425|NCT00542633|Rapid acting|rapid acting
593426|NCT00542659|Atrial fibrillation|atrial fibrillation
593427|NCT00542659|Maze procedure|maze procedure
593428|NCT00542672|Mexican American|mexican american
593429|NCT00542672|Dietary Intake|dietary intake
593430|NCT00542672|Child-Feeding Practices|child-feeding practices
593431|NCT00542672|Weight|weight
593432|NCT00542672|Cultural Values|cultural values
593433|NCT00542698|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
593434|NCT00542698|Glucose Monitor graphs|glucose monitor graphs
593435|NCT00542698|Physical Activity|physical activity
593436|NCT00542711|Curcumin|curcumin
593437|NCT00542711|Bioavilability|bioavilability
593438|NCT00542711|Healthy subjects|healthy subjects
593439|NCT00542724|Insulin|insulin
593440|NCT00542724|Diabetes Mellitus type I|diabetes mellitus type i
593441|NCT00542724|Juvenile diabetes|juvenile diabetes
593442|NCT00542737|Acute Lung Injury|acute lung injury
593443|NCT00542737|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
593444|NCT00542737|Acute Respiratory Failure|acute respiratory failure
593445|NCT00542737|Web-Based Intervention|web-based intervention
593446|NCT00542737|Lung Preventive Ventilation|lung preventive ventilation
593447|NCT00542750|Cannabis|cannabis
593448|NCT00542750|Marijuana|marijuana
593449|NCT00542750|Pharmacotherapy|pharmacotherapy
593450|NCT00542750|Adolescent|adolescent
593451|NCT00542763|Sjogren's syndrome|sjogren's syndrome
593452|NCT00542763|Mycophenolate sodium|mycophenolate sodium
593453|NCT00542776|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
593454|NCT00542776|immunosuppressed or non-immunosuppressed|immunosuppressed or non-immunosuppressed
593455|NCT00542776|influenza vaccine|influenza vaccine
593456|NCT00542776|antibody titers|antibody titers
593457|NCT00542776|seroprotective titers|seroprotective titers
593458|NCT00542776|vaccine-associated adverse events|vaccine-associated adverse events
593459|NCT00542789|gastrointestinal|gastrointestinal
593461|NCT00542789|NSAID|nsaid
593462|NCT00542789|Japan|japan
593463|NCT00542789|Japanese|japanese
593464|NCT00542789|Gastric ulcer|gastric ulcer
593465|NCT00542789|duodenal ulcer|duodenal ulcer
593466|NCT00542802|post stroke epileptic late onset seizures|post stroke epileptic late onset seizures
593467|NCT00542815|Chronic Kidney Disease|chronic kidney disease
593468|NCT00542815|Dialysis|dialysis
593469|NCT00542815|Hyperphosphatemia|hyperphosphatemia
593470|NCT00542841|Adrenal Hyperplasia, Congenital|adrenal hyperplasia, congenital
593471|NCT00542841|Steroid Biosynthesis Disorders|steroid biosynthesis disorders
593472|NCT00542854|arrhythmia|arrhythmia
593473|NCT00542854|pacemaker|pacemaker
593474|NCT00542854|defibrillator|defibrillator
593475|NCT00542854|electromagnetic interference|electromagnetic interference
593476|NCT00542867|Hypercholesterolemia|hypercholesterolemia
593477|NCT00542867|Third Joint European Task Force guidelines|third joint european task force guidelines
593478|NCT00542867|Survey|survey
593479|NCT00542880|COPD|copd
593480|NCT00542880|Symbicort|symbicort
593481|NCT00542880|Seretide|seretide
593482|NCT00542893|bcl-2|bcl-2
593483|NCT00542893|CFR|cfr
593484|NCT00542893|DTIC|dtic
593485|NCT00542893|ECOG|ecog
593486|NCT00542893|EMEA|emea
593487|NCT00542893|MedDRA|meddra
593488|NCT00542893|NCI CTC|nci ctc
593489|NCT00542893|SAE|sae
593490|NCT00542906|healthy volunteers|healthy volunteers
593491|NCT00542906|Somatosensory stimuli|somatosensory stimuli
593492|NCT00542906|fMRI|fmri
593493|NCT00542906|second somatosensory area|second somatosensory area
593494|NCT00542906|insular cortex|insular cortex
593495|NCT00542906|functional anatomy|functional anatomy
593496|NCT00542932|COPD|copd
593497|NCT00542932|Exercise|exercise
593498|NCT00542932|Home|home
593499|NCT00542945|Heart Failure|heart failure
593500|NCT00542945|ICD|icd
593501|NCT00542945|Dilated cardiomyopathy|dilated cardiomyopathy
593502|NCT00542958|Cancer|cancer
593503|NCT00542958|Refractory solid tumor|refractory solid tumor
593504|NCT00542971|Leukemia|leukemia
593505|NCT00542971|AML|aml
593506|NCT00542971|High-Risk MDS|high-risk mds
593507|NCT00542971|Acute Myeloid Leukemia|acute myeloid leukemia
593508|NCT00542971|High-Risk Myelodysplastic Disorder|high-risk myelodysplastic disorder
593509|NCT00542971|Idarubicin|idarubicin
593510|NCT00542971|Ara-C|ara-c
593511|NCT00542971|Cytarabine|cytarabine
593512|NCT00542971|Sorafenib|sorafenib
593513|NCT00542971|BAY43-9006|bay43-9006
593514|NCT00542997|Subcutaneous immune globulin|subcutaneous immune globulin
593515|NCT00542997|SCIG|scig
593516|NCT00543036|Cannabis|cannabis
593517|NCT00543036|Addiction|addiction
593518|NCT00543036|Craving|craving
593519|NCT00543036|TMS|tms
593520|NCT00543049|platinum refractory|platinum refractory
593521|NCT00543049|epithelial ovarian cancer|epithelial ovarian cancer
593522|NCT00543049|primary cancer of the peritoneum|primary cancer of the peritoneum
593523|NCT00543049|cancer of the fallopian tube|cancer of the fallopian tube
593524|NCT00543075|Renal Function|renal function
593525|NCT00543075|Adult|adult
593526|NCT00543075|Genasense|genasense
593527|NCT00543075|oblimersen|oblimersen
593530|NCT00543075|Pharmacokinetics|pharmacokinetics
593531|NCT00543088|Schizophrenia|schizophrenia
593532|NCT00543088|Bipolar Disorder|bipolar disorder
593533|NCT00543088|manic episode|manic episode
593534|NCT00543088|atypical antipsychotic|atypical antipsychotic
593535|NCT00543088|Schizophrenia or Bipolar Disorder (currently in a manic episode)|schizophrenia or bipolar disorder (currently in a manic episode)
593536|NCT00543101|HIV/AIDS|hiv/aids
593537|NCT00543101|darunavir|darunavir
593538|NCT00543101|Protease inhibitors|protease inhibitors
593539|NCT00543101|Dual boosted|dual boosted
593540|NCT00543101|Treatment experienced|treatment experienced
593541|NCT00543114|CLL|cll
593542|NCT00543114|SLL|sll
593543|NCT00543114|Revlimid|revlimid
593544|NCT00543114|lenalidomide|lenalidomide
593545|NCT00548652|apathy|apathy
593546|NCT00548652|obesity|obesity
593547|NCT00548652|methylphenidate|methylphenidate
593548|NCT00548652|MOVE|move
593549|NCT00548652|medical crisis counselling|medical crisis counselling
593550|NCT00548665|Atherosclerosis|atherosclerosis
593551|NCT00548665|Smoking cessation|smoking cessation
593552|NCT00548665|Diagnostic techniques, cardiovascular|diagnostic techniques, cardiovascular
593553|NCT00548665|Ultrasonography|ultrasonography
593554|NCT00548665|Health behavior|health behavior
593555|NCT00548678|diclofenac, platelet aggregation, ketorolac, aspirin|diclofenac, platelet aggregation, ketorolac, aspirin
593556|NCT00548704|Extravasation|extravasation
593557|NCT00548704|Anthracyclines|anthracyclines
593558|NCT00548717|GVHD|gvhd
593559|NCT00548717|Stem cell transplantation|stem cell transplantation
593560|NCT00548717|Sirolimus|sirolimus
593561|NCT00548730|Bronchoscopy|bronchoscopy
593562|NCT00548730|Endoscopy|endoscopy
593563|NCT00548730|Image Enhancement|image enhancement
593564|NCT00548730|Autofluorescence|autofluorescence
593565|NCT00548730|Narrow Band Image|narrow band image
593566|NCT00548743|Depression|depression
593567|NCT00548743|Postpartum|postpartum
593568|NCT00548743|Dyad satisfaction|dyad satisfaction
593569|NCT00548743|Parenting comfort|parenting comfort
593570|NCT00548743|Screening|screening
593571|NCT00548743|Management|management
593572|NCT00548743|Follow up|follow up
593573|NCT00548743|Primary care|primary care
593574|NCT00548743|Practice based research|practice based research
593575|NCT00548756|Brain Cancer|brain cancer
593576|NCT00548756|Whole Brain Radiation Therapy|whole brain radiation therapy
593577|NCT00548756|Quality of Life|quality of life
593578|NCT00548756|QOL|qol
593579|NCT00548756|Questionnaire|questionnaire
593580|NCT00548756|Survey|survey
593581|NCT00548756|WBRT|wbrt
593582|NCT00548769|PK,|pk,
593583|NCT00548769|SB-683699,|sb-683699,
593584|NCT00548769|multiple sclerosis|multiple sclerosis
593585|NCT00548769|firategrast,|firategrast,
593586|NCT00548769|surface area,|surface area,
593587|NCT00548795|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
593588|NCT00548795|ARDS|ards
593589|NCT00548795|Neutrophil|neutrophil
593590|NCT00548834|CDP870|cdp870
593591|NCT00548834|Certolizumab Pegol|certolizumab pegol
593592|NCT00548847|Leukemia|leukemia
593593|NCT00548886|QT Prolongation|qt prolongation
593594|NCT00548886|QT Interval|qt interval
593595|NCT00548886|Epinephrine|epinephrine
593596|NCT00548886|Stress test|stress test
593597|NCT00548899|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
593598|NCT00548899|Targeted therapy|targeted therapy
593599|NCT00548912|Kidney Failure, Chronic|kidney failure, chronic
593600|NCT00548912|Hemodialysis|hemodialysis
593601|NCT00548912|Spironolactone|spironolactone
593602|NCT00548938|Brain Tumor|brain tumor
593603|NCT00548938|GBM|gbm
593604|NCT00548938|Glioblastoma Multiforme|glioblastoma multiforme
593605|NCT00548938|Giladel|giladel
593606|NCT00548938|Temozolomide|temozolomide
593607|NCT00548951|Dementia|dementia
593608|NCT00548964|Ketamine|ketamine
593609|NCT00548964|glutamate|glutamate
593610|NCT00548964|N-methyl-D-aspartate|n-methyl-d-aspartate
593611|NCT00548964|treatment resistant|treatment resistant
593612|NCT00548964|major depressive disorder|major depressive disorder
593613|NCT00548964|lithium|lithium
593614|NCT00548977|spermatogenesis defect|spermatogenesis defect
593615|NCT00548977|male infertility|male infertility
593616|NCT00548977|azoospermia|azoospermia
593617|NCT00548977|oligozoospermia|oligozoospermia
593618|NCT00548977|Y chromosome markers|y chromosome markers
593619|NCT00548977|estrogen gene|estrogen gene
593620|NCT00549120|Healthy Subjects|healthy subjects
593621|NCT00549120|muscarinic receptor antagonist|muscarinic receptor antagonist
593622|NCT00549120|propranolol|propranolol
593623|NCT00549120|beta-blocker|beta-blocker
593624|NCT00549120|beta-agonist|beta-agonist
593625|NCT00549133|Microalbuminaria in hypertensive patients with type II diabetes mellitus|microalbuminaria in hypertensive patients with type ii diabetes mellitus
593626|NCT00549146|reversibility|reversibility
593627|NCT00549146|COPD|copd
593628|NCT00549146|lung function|lung function
593629|NCT00549159|menorrhagia|menorrhagia
593630|NCT00549159|dysfunctional uterine bleeding|dysfunctional uterine bleeding
593631|NCT00549159|endometrial ablation|endometrial ablation
593632|NCT00549172|Osteoarthritis, Knee|osteoarthritis, knee
593633|NCT00549172|Arthroscopic Surgery|arthroscopic surgery
593634|NCT00549172|Menisci, Medial|menisci, medial
593635|NCT00549172|Placebo Effect|placebo effect
593636|NCT00549172|Treatment Efficacy|treatment efficacy
593637|NCT00549198|tenofovir|tenofovir
593638|NCT00549198|HIV|hiv
593639|NCT00549198|efavirenz|efavirenz
593640|NCT00549198|naive|naive
593641|NCT00549198|lamivudine|lamivudine
593642|NCT00549198|abacavir|abacavir
593643|NCT00549198|emtricitabine|emtricitabine
593644|NCT00549198|renal|renal
593645|NCT00549211|Healthy Subjects,|healthy subjects,
593646|NCT00549211|Safety,|safety,
593647|NCT00549211|Tolerability,|tolerability,
593648|NCT00549211|Pharmacokinetics|pharmacokinetics
593649|NCT00549237|RYGBP|rygbp
593650|NCT00549237|Early nutrition|early nutrition
593651|NCT00549237|Lean body mass|lean body mass
593652|NCT00549237|Length of stay|length of stay
593653|NCT00549237|Body Composition|body composition
593654|NCT00549250|Human papillomavirus 6/11|human papillomavirus 6/11
593655|NCT00549250|Neonates|neonates
593656|NCT00549250|Human papillomavirus 6 or 11 infection|human papillomavirus 6 or 11 infection
593657|NCT00549263|Safety|safety
593658|NCT00549263|Pharmacokinetics|pharmacokinetics
593659|NCT00549263|Bioequivalence|bioequivalence
593660|NCT00549328|anti-angiogenesis|anti-angiogenesis
593661|NCT00549328|Non-small cell lung cancer,|non-small cell lung cancer,
593662|NCT00549328|pazopanib (GW786034)|pazopanib (gw786034)
593663|NCT00549341|Torticollis|torticollis
593664|NCT00549341|Cervical Dystonia|cervical dystonia
593665|NCT00549354|Abdominal Infrarenal Aortic|abdominal infrarenal aortic
593666|NCT00549354|Aorto-Iliac Aneurysms|aorto-iliac aneurysms
593667|NCT00549367|Nutritional status|nutritional status
593668|NCT00549367|Nutrition counselling|nutrition counselling
593669|NCT00549367|Nutrition assessment|nutrition assessment
593670|NCT00549367|HIV|hiv
593671|NCT00549367|Alternative Medicine|alternative medicine
593672|NCT00549367|Complementary Medicine|complementary medicine
593673|NCT00549380|Aneurysmal Disease in Thorax, Abdominal or Extremity|aneurysmal disease in thorax, abdominal or extremity
593674|NCT00549393|intensive care unit|intensive care unit
593675|NCT00549393|Healthcare associated infections (HAI)|healthcare associated infections (hai)
593676|NCT00549393|pediatric|pediatric
593677|NCT00549406|Vision|vision
593678|NCT00549406|Visual attention|visual attention
593679|NCT00549406|Postural balance|postural balance
593680|NCT00549406|Geriatrics|geriatrics
593681|NCT00549445|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
593682|NCT00549445|COPD|copd
593683|NCT00549445|Exacerbation|exacerbation
593684|NCT00549445|Macrolide|macrolide
593685|NCT00549458|Week pelvic floor muscle in females|week pelvic floor muscle in females
593686|NCT00549471|children with cerebral palsy ages eight to eleven.|children with cerebral palsy ages eight to eleven.
593687|NCT00549484|Thrombocytopenia|thrombocytopenia
593688|NCT00549484|Thrombopoietin|thrombopoietin
593689|NCT00549484|Platelet Transfusion|platelet transfusion
593690|NCT00549484|Platelet Factor 4|platelet factor 4
593691|NCT00549497|GW870086X, inhaled, asthma, cortisol, pharmacokinetics, osteocalcin|gw870086x, inhaled, asthma, cortisol, pharmacokinetics, osteocalcin
593692|NCT00549510|COREG CR,|coreg cr,
593693|NCT00549510|lisinopril,|lisinopril,
593694|NCT00549510|hypertension,|hypertension,
593695|NCT00549510|dose proportionality,|dose proportionality,
593696|NCT00549510|fixed dose combination (FDC)|fixed dose combination (fdc)
593697|NCT00549523|HIV|hiv
593698|NCT00549523|Alternative Medicine|alternative medicine
593699|NCT00549523|Complementary Medicine|complementary medicine
593700|NCT00549536|calcium supplementation|calcium supplementation
593701|NCT00549536|intracellular ions|intracellular ions
593702|NCT00549536|sodium/hydrogen exchange activity|sodium/hydrogen exchange activity
593703|NCT00549562|Autistic Disorder|autistic disorder
593704|NCT00549575|Severe Intra uterine growth retardation below the third centile with abnormal uterine doppler|severe intra uterine growth retardation below the third centile with abnormal uterine doppler
593705|NCT00549575|Severe growth retardation with pathologic uterine Doppler|severe growth retardation with pathologic uterine doppler
593706|NCT00549575|L-Arginine|l-arginine
593707|NCT00549575|Nitric Oxide Donor|nitric oxide donor
593708|NCT00549588|Polymorphic light eruption|polymorphic light eruption
593709|NCT00549588|UV radiation|uv radiation
593710|NCT00549588|photoprotection|photoprotection
593711|NCT00549588|sunscreen|sunscreen
593712|NCT00549588|DNA repair enzymes|dna repair enzymes
593713|NCT00549588|after-sun-lotion|after-sun-lotion
593714|NCT00549601|Alzheimer's|alzheimer's
593715|NCT00549601|rivastigmine|rivastigmine
593716|NCT00549601|transdermal|transdermal
593717|NCT00549601|safety|safety
593718|NCT00549601|randomized|randomized
593720|NCT00549601|patch|patch
593721|NCT00549614|heart failure|heart failure
593722|NCT00549640|nicotine dependence|nicotine dependence
593723|NCT00549640|tobacco dependence|tobacco dependence
593724|NCT00549653|GW856553,|gw856553,
593725|NCT00549653|drug-drug interactions,|drug-drug interactions,
593726|NCT00549653|rosuvastatin|rosuvastatin
593727|NCT00549666|OC DDI|oc ddi
593730|NCT00549666|schizophenia|schizophenia
593731|NCT00549679|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
593733|NCT00549679|Repeat Dose|repeat dose
593734|NCT00549679|GSK256066|gsk256066
593735|NCT00549705|Anticoagulation|anticoagulation
593736|NCT00549705|Thrombosis|thrombosis
593737|NCT00549705|Bleeding|bleeding
593738|NCT00549705|Clotting|clotting
593739|NCT00549705|Pulmonary Embolism|pulmonary embolism
593740|NCT00549705|Deep Vein Thrombosis|deep vein thrombosis
593741|NCT00549718|Schizophrenia|schizophrenia
593742|NCT00549718|SM-13496|sm-13496
593743|NCT00549718|Latuda|latuda
593744|NCT00549718|Lurasidone|lurasidone
593745|NCT00549731|autism|autism
593746|NCT00549731|autistic|autistic
593747|NCT00549731|language|language
593748|NCT00549731|development|development
593749|NCT00549731|developmental|developmental
593750|NCT00549731|assessment|assessment
593751|NCT00549744|ASTHMA|asthma
593752|NCT00549744|CLINICAL ENDPOINT,|clinical endpoint,
593753|NCT00549757|Type 2 diabetes mellitus|type 2 diabetes mellitus
593754|NCT00549757|renal morbidity and mortality|renal morbidity and mortality
593755|NCT00549757|cardiovascular disease|cardiovascular disease
593756|NCT00549757|micro-albuminuria|micro-albuminuria
593757|NCT00549757|macro-albuminuria|macro-albuminuria
593758|NCT00549757|RAAS|raas
593759|NCT00549757|renin inhibitor|renin inhibitor
593760|NCT00549757|Reduced estimated glomerular filtration rate|reduced estimated glomerular filtration rate
593761|NCT00549770|Hypertension, valsartan, LCZ696|hypertension, valsartan, lcz696
593762|NCT00549796|coronary artery disease|coronary artery disease
593763|NCT00549796|angioplasty|angioplasty
593764|NCT00549796|stent|stent
593765|NCT00549796|percutaneous coronary intervention|percutaneous coronary intervention
593766|NCT00549796|on-site cardiac surgery|on-site cardiac surgery
593767|NCT00549796|randomized trial|randomized trial
593768|NCT00549809|mechanical ventilation; respiratory failure|mechanical ventilation; respiratory failure
593769|NCT00549822|aromatase inhibitor|aromatase inhibitor
593770|NCT00549822|CA 15-3|ca 15-3
593771|NCT00549822|Hormone receptor positive|hormone receptor positive
593772|NCT00549835|mucositis pain|mucositis pain
593773|NCT00549835|cancer|cancer
593774|NCT00549835|pain|pain
593775|NCT00549835|acupuncture|acupuncture
593776|NCT00549835|mucositis|mucositis
593777|NCT00549835|cancer pain|cancer pain
593778|NCT00549848|Leukemia|leukemia
593779|NCT00549861|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
593780|NCT00549861|Contrast agents|contrast agents
593781|NCT00549861|Gadobutrol|gadobutrol
593782|NCT00549861|Fibrosis|fibrosis
593783|NCT00549861|Prognosis|prognosis
593784|NCT00549861|Magnetic Resonance|magnetic resonance
593785|NCT00549861|Gadolinium|gadolinium
593786|NCT00549874|insulin resistance|insulin resistance
593787|NCT00549874|type 2 diabetes|type 2 diabetes
593788|NCT00549874|myocardial perfusion|myocardial perfusion
593789|NCT00549874|nitrosative stress|nitrosative stress
593790|NCT00549874|thiazolidinediones|thiazolidinediones
593791|NCT00549900|HPV vaccine,|hpv vaccine,
593792|NCT00549900|Cervical cancer|cervical cancer
593793|NCT00549900|Human papillomavirus infection,|human papillomavirus infection,
593794|NCT00549913|adjacent vertebral levels between L1 and S1|adjacent vertebral levels between l1 and s1
593795|NCT00549939|child|child
593796|NCT00549939|bladder|bladder
593797|NCT00549939|neuropathic|neuropathic
593798|NCT00549939|alpha blockers|alpha blockers
593799|NCT00549978|Safety and Pharmacokinetics in healthy subjects|safety and pharmacokinetics in healthy subjects
593800|NCT00549991|High Blood Pressure|high blood pressure
593801|NCT00550004|Unresectable|unresectable
593802|NCT00550004|locally advanced|locally advanced
593803|NCT00550004|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
593804|NCT00550004|Stage III|stage iii
593805|NCT00550004|Stage IV|stage iv
593806|NCT00550030|Psoriasis|psoriasis
593807|NCT00550030|UVB radiation|uvb radiation
593808|NCT00550030|Biologics|biologics
593809|NCT00550030|Etanercept|etanercept
593810|NCT00550030|PASI|pasi
593811|NCT00550043|Rheumatoid arthritis|rheumatoid arthritis
593812|NCT00550056|PTSD, Posttraumatic Stress Disorder, refugees, war|ptsd, posttraumatic stress disorder, refugees, war
593813|NCT00550069|late preterm infants|late preterm infants
593814|NCT00550069|near term infants|near term infants
593815|NCT00550069|outcome|outcome
593816|NCT00550082|Anticoagulation|anticoagulation
593817|NCT00550082|High-Risk|high-risk
593818|NCT00550082|Deep Vein Thrombosis|deep vein thrombosis
593819|NCT00550082|Pulmonary Embolism|pulmonary embolism
593820|NCT00550082|Surgery|surgery
593821|NCT00550095|Microalbuminuria/proteinuria|microalbuminuria/proteinuria
593822|NCT00550095|hypertensive patients with type 2 diabetes|hypertensive patients with type 2 diabetes
593823|NCT00550095|Valsartan|valsartan
593824|NCT00550095|microalbuminuria/proteinuria in hypertensive patients with type 2 diabetes|microalbuminuria/proteinuria in hypertensive patients with type 2 diabetes
593825|NCT00550108|pancreatic cyst|pancreatic cyst
593826|NCT00550108|ethanol injection|ethanol injection
593827|NCT00550134|Breast Cancer|breast cancer
593828|NCT00550134|Quality of life|quality of life
593829|NCT00550147|ADHD-Combined TypeDisruptive behavior Disorder|adhd-combined typedisruptive behavior disorder
593830|NCT00550186|spinal anesthesia|spinal anesthesia
593831|NCT00550186|preload|preload
593832|NCT00550186|diuresis|diuresis
593833|NCT00550186|bladder retention|bladder retention
593834|NCT00550199|Solid Tumors|solid tumors
593835|NCT00550199|Phase I|phase i
593836|NCT00550199|LBH589|lbh589
593837|NCT00550199|Gemcitabine|gemcitabine
593838|NCT00550212|healthy subjects|healthy subjects
593839|NCT00550225|succinate|succinate
593840|NCT00550225|anti-muscarinic|anti-muscarinic
593841|NCT00550225|b-agonist|b-agonist
593842|NCT00550238|Parkinson's Disease Psychosis|parkinson's disease psychosis
593843|NCT00550251|Nausea|nausea
593844|NCT00550251|Vomiting|vomiting
593845|NCT00550251|Emesis|emesis
593846|NCT00550251|Palliative|palliative
593847|NCT00550251|Terminal|terminal
593848|NCT00550251|Cancer|cancer
593849|NCT00550264|Hospital Readmission|hospital readmission
593850|NCT00550264|Continuity of Care|continuity of care
593851|NCT00550264|Quality of Health Care|quality of health care
593852|NCT00550277|Renal Cell Carcinoma|renal cell carcinoma
593853|NCT00550277|Refractory|refractory
593854|NCT00550277|LBH589|lbh589
593855|NCT00550290|vulvectomy|vulvectomy
593856|NCT00550290|wound infection|wound infection
593857|NCT00550290|wound complication|wound complication
593858|NCT00550290|prophylactic antibiotic|prophylactic antibiotic
593859|NCT00550290|Post-operative wound complications following vulvectomy|post-operative wound complications following vulvectomy
593860|NCT00550342|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
593861|NCT00550342|FSGS|fsgs
593862|NCT00550342|Proteinuria|proteinuria
593863|NCT00550342|rituximab|rituximab
593864|NCT00550342|B cell|b cell
593865|NCT00550342|autoimmune|autoimmune
593866|NCT00550342|CD20|cd20
593867|NCT00550342|treatment|treatment
593868|NCT00550342|children|children
593869|NCT00550381|healthy subjects|healthy subjects
593870|NCT00550394|Adolescents|adolescents
593871|NCT00550407|Lamotrigine|lamotrigine
593872|NCT00550407|Prevention of relapse or recurrence of a mood episode|prevention of relapse or recurrence of a mood episode
593873|NCT00550407|Bipolar I disorder|bipolar i disorder
593874|NCT00550420|open-label extension|open-label extension
593875|NCT00550420|tolerability|tolerability
593876|NCT00550420|Alzheimer's disease|alzheimer's disease
593877|NCT00550420|Rosiglitazone extended-release (XR)|rosiglitazone extended-release (xr)
593878|NCT00550420|safety|safety
593879|NCT00550420|cognition|cognition
593880|NCT00550420|BRL-049653|brl-049653
593881|NCT00550446|Janus Kinase 3 Clinical Trial|janus kinase 3 clinical trial
593882|NCT00550459|Hyponatremia|hyponatremia
593883|NCT00550459|Cognitive|cognitive
593884|NCT00550459|Neurological Function|neurological function
593885|NCT00550459|Elderly|elderly
593886|NCT00550472|probiotics|probiotics
593887|NCT00550472|atopic dermatitis|atopic dermatitis
593888|NCT00550472|immune system|immune system
593889|NCT00550472|human|human
593890|NCT00550472|Lactobacillus|lactobacillus
593891|NCT00550472|Bifidobacterium|bifidobacterium
593892|NCT00550472|healthy subjects|healthy subjects
593893|NCT00550498|Retinal Vasculitis|retinal vasculitis
593894|NCT00550498|Retinal Edema|retinal edema
593895|NCT00550498|Behcet's Disease|behcet's disease
593896|NCT00550511|Abdominal pain|abdominal pain
593897|NCT00550511|ultrasound|ultrasound
593898|NCT00550511|surgery|surgery
593899|NCT00550511|emergency department|emergency department
594148|NCT00551564|T2DM,|t2dm,
593900|NCT00550511|diagnostic accuracy|diagnostic accuracy
593901|NCT00550524|Knee osteoarthritis|knee osteoarthritis
593902|NCT00550537|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
593903|NCT00550537|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
593904|NCT00550537|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
593905|NCT00550537|squamous cell lung cancer|squamous cell lung cancer
593906|NCT00550537|adenosquamous cell lung cancer|adenosquamous cell lung cancer
593907|NCT00550537|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
593908|NCT00550537|large cell lung cancer|large cell lung cancer
593909|NCT00550537|adenocarcinoma of the lung|adenocarcinoma of the lung
593910|NCT00550550|rhinoconjunctivitis|rhinoconjunctivitis
593911|NCT00550550|rhinitis|rhinitis
593912|NCT00550550|conjunctivitis|conjunctivitis
595022|NCT00559663|HDL|hdl
593913|NCT00550550|allergy|allergy
593914|NCT00550550|allergen|allergen
593915|NCT00550550|immunotherapy|immunotherapy
593916|NCT00550563|recurrent colon cancer|recurrent colon cancer
593917|NCT00550563|stage I colon cancer|stage i colon cancer
593918|NCT00550563|stage II colon cancer|stage ii colon cancer
593919|NCT00550563|stage III colon cancer|stage iii colon cancer
593920|NCT00550563|stage IV colon cancer|stage iv colon cancer
593921|NCT00550563|recurrent rectal cancer|recurrent rectal cancer
593922|NCT00550563|stage I rectal cancer|stage i rectal cancer
593923|NCT00550563|stage II rectal cancer|stage ii rectal cancer
593924|NCT00550563|stage III rectal cancer|stage iii rectal cancer
593925|NCT00550563|stage IV rectal cancer|stage iv rectal cancer
593926|NCT00550576|Digoxin Antibodies|digoxin antibodies
593927|NCT00550576|Bipolar Disorder|bipolar disorder
593928|NCT00550589|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
593929|NCT00550589|stage 0 anal cancer|stage 0 anal cancer
593930|NCT00550602|Tracheomalacia|tracheomalacia
593931|NCT00550602|Tracheobronchomalacia|tracheobronchomalacia
593932|NCT00550602|Airway Stabilization|airway stabilization
593933|NCT00550602|Bronchoscopy|bronchoscopy
593934|NCT00550602|Stent Placement|stent placement
593935|NCT00550602|Tracheobronchoplasty|tracheobronchoplasty
593936|NCT00550602|COPD|copd
593937|NCT00550615|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
593938|NCT00550615|Relapsed Non Hodgkins Lymphoma|relapsed non hodgkins lymphoma
593939|NCT00550615|Refractory Non Hodgkins Lymphoma|refractory non hodgkins lymphoma
593940|NCT00550615|Dasatinib|dasatinib
593941|NCT00550628|neoplasm of uncertain malignant potential|neoplasm of uncertain malignant potential
593942|NCT00550628|colon cancer|colon cancer
593943|NCT00550641|fibromyalgia|fibromyalgia
593944|NCT00550641|pool-based exercise|pool-based exercise
593945|NCT00550654|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
593946|NCT00550654|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
593947|NCT00550654|recurrent melanoma|recurrent melanoma
593948|NCT00550654|recurrent osteosarcoma|recurrent osteosarcoma
593949|NCT00550654|recurrent renal cell cancer|recurrent renal cell cancer
593950|NCT00550654|recurrent uterine sarcoma|recurrent uterine sarcoma
593951|NCT00550654|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
593952|NCT00550654|stage IV melanoma|stage iv melanoma
593953|NCT00550654|stage IV uterine sarcoma|stage iv uterine sarcoma
593954|NCT00550654|ovarian sarcoma|ovarian sarcoma
593955|NCT00550654|chondrosarcoma|chondrosarcoma
593956|NCT00550654|metastatic osteosarcoma|metastatic osteosarcoma
593957|NCT00550654|stage IV renal cell cancer|stage iv renal cell cancer
593958|NCT00550654|lung metastases|lung metastases
593959|NCT00550654|liver metastases|liver metastases
593960|NCT00550654|bone metastases|bone metastases
593961|NCT00550667|Attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
593962|NCT00550667|adult|adult
593963|NCT00550667|diagnostic validity|diagnostic validity
593964|NCT00550667|neuropsychological functions|neuropsychological functions
593965|NCT00550667|social functioning|social functioning
593966|NCT00550693|bloodstream infections|bloodstream infections
593967|NCT00550693|hemodialysis catheter|hemodialysis catheter
593968|NCT00550706|Prescription point prevalence|prescription point prevalence
593969|NCT00550706|Drug utilization|drug utilization
593970|NCT00550706|Define Daily Dose|define daily dose
593971|NCT00550732|Triazoles|triazoles
593972|NCT00550758|Methacholine challenge; Spirometry, Early childhood|methacholine challenge; spirometry, early childhood
593973|NCT00550784|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
593974|NCT00550784|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
593975|NCT00550784|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
593976|NCT00550784|fallopian tube cancer|fallopian tube cancer
593977|NCT00550784|peritoneal cavity cancer|peritoneal cavity cancer
593978|NCT00550797|Steroid-naive, non-smokers|steroid-naive, non-smokers
593979|NCT00550797|Mild to moderate allergic asthmatic adults|mild to moderate allergic asthmatic adults
593980|NCT00550810|Sutent|sutent
593981|NCT00550836|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
593982|NCT00550836|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
593983|NCT00550836|stage IV pancreatic cancer|stage iv pancreatic cancer
593984|NCT00550862|PBC, Primary Biliary Cirrhosis, Liver,|pbc, primary biliary cirrhosis, liver,
593985|NCT00550875|Allergic rhinoconjunctivitis,|allergic rhinoconjunctivitis,
593986|NCT00550875|Immunotherapy|immunotherapy
593987|NCT00550888|uterus|uterus
593988|NCT00550888|abdominal delivery|abdominal delivery
593989|NCT00550888|suture techniques|suture techniques
593990|NCT00550901|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
593991|NCT00550914|Papilloma, Papillomatosis, Laser, Laser Surgery|papilloma, papillomatosis, laser, laser surgery
593992|NCT00550927|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
593993|NCT00550940|epilepsy|epilepsy
593994|NCT00550940|attention|attention
593995|NCT00550940|emotion|emotion
593996|NCT00550940|behavior problems|behavior problems
593997|NCT00550940|child|child
593998|NCT00550940|adolescent|adolescent
593999|NCT00550966|Fibromyalgia|fibromyalgia
594000|NCT00550966|Quality of life|quality of life
594001|NCT00550966|Primary Care|primary care
594002|NCT00550966|Non-pharmacological treatment|non-pharmacological treatment
594003|NCT00550966|Cost / Cost-efficacy|cost / cost-efficacy
594004|NCT00550979|gestational diabetes mellitus|gestational diabetes mellitus
594005|NCT00550979|cardiovascular disease risk|cardiovascular disease risk
594006|NCT00550979|heart disease risk|heart disease risk
594007|NCT00550992|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
594008|NCT00550992|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
594009|NCT00550992|acute undifferentiated leukemia|acute undifferentiated leukemia
594010|NCT00551005|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
595430|NCT00561535|Diarrhea|diarrhea
594011|NCT00551018|Treatment Naive|treatment naive
594013|NCT00551031|Orthomyxoviruses|orthomyxoviruses
594014|NCT00551031|Myxovirus Infection|myxovirus infection
594015|NCT00551031|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
594017|NCT00551044|prostatic neoplasms|prostatic neoplasms
594018|NCT00551044|bicalutamide|bicalutamide
594019|NCT00551044|quality of life|quality of life
594020|NCT00551044|osteoporosis|osteoporosis
594021|NCT00551096|Advanced Solid Tumors|advanced solid tumors
594022|NCT00551096|Biliary or Pancreatic Malignancies|biliary or pancreatic malignancies
594023|NCT00551122|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
594024|NCT00551122|testicular seminoma|testicular seminoma
594025|NCT00551122|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
594026|NCT00551122|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
594027|NCT00551122|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
594028|NCT00551122|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
594029|NCT00551122|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
594030|NCT00551122|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
594031|NCT00551122|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
594032|NCT00551122|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
594033|NCT00551122|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
594034|NCT00551122|recurrent extragonadal seminoma|recurrent extragonadal seminoma
594035|NCT00551122|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
594036|NCT00551122|stage IV extragonadal seminoma|stage iv extragonadal seminoma
594037|NCT00551122|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
594038|NCT00551122|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
594039|NCT00551122|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
594040|NCT00551135|postoperative pain chronic pain|postoperative pain chronic pain
594041|NCT00551161|Alzheimer disease|alzheimer disease
594042|NCT00551161|memantine|memantine
594043|NCT00551161|cholinesterase inhibitors|cholinesterase inhibitors
594044|NCT00551161|magnetic resonance spectroscopy|magnetic resonance spectroscopy
594045|NCT00551161|N-acetylaspartate|n-acetylaspartate
594046|NCT00551161|inositol|inositol
594047|NCT00551161|cerebrospinal fluid|cerebrospinal fluid
594048|NCT00551161|tau proteins|tau proteins
594049|NCT00551161|amyloid beta-protein|amyloid beta-protein
594050|NCT00551200|Buphenyl|buphenyl
594051|NCT00551200|Sodium Phenylbutyrate|sodium phenylbutyrate
594052|NCT00551200|Urea Cycle Disorder|urea cycle disorder
594053|NCT00551200|UCD|ucd
594054|NCT00551213|anti-IGF-1R|anti-igf-1r
594055|NCT00551226|TB|tb
594056|NCT00551226|Patients with tuberculosis|patients with tuberculosis
594057|NCT00551239|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
594058|NCT00551239|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
594059|NCT00551239|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
594060|NCT00551239|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
594061|NCT00551239|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
594062|NCT00551239|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
594063|NCT00551239|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
594064|NCT00551239|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
594065|NCT00551239|splenic marginal zone lymphoma|splenic marginal zone lymphoma
594066|NCT00551239|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
594067|NCT00551239|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
594068|NCT00551239|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
594069|NCT00551239|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
594070|NCT00551239|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
594071|NCT00551239|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
594072|NCT00551239|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
594073|NCT00551239|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
594074|NCT00551239|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
594075|NCT00551239|stage I marginal zone lymphoma|stage i marginal zone lymphoma
594076|NCT00551239|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
594077|NCT00551239|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
594078|NCT00551239|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
594079|NCT00551239|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
594080|NCT00551239|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
594081|NCT00551239|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
594082|NCT00551239|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
594083|NCT00551239|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
594084|NCT00551239|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
594085|NCT00551239|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
594086|NCT00551239|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
594087|NCT00551239|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
594088|NCT00551239|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
594089|NCT00551278|sentinel lymph node|sentinel lymph node
594090|NCT00551278|metastasis|metastasis
594091|NCT00551278|molecular pathology|molecular pathology
594092|NCT00551317|SB480848,|sb480848,
594093|NCT00551317|Japanese healthy volunteers|japanese healthy volunteers
594094|NCT00551317|darapladib,|darapladib,
594095|NCT00551330|Treatment Experienced|treatment experienced
594096|NCT00551356|Diabetes|diabetes
594097|NCT00551356|Diabetic|diabetic
594098|NCT00551356|Insulin|insulin
594099|NCT00551356|Humalog|humalog
594100|NCT00551356|Lantus|lantus
594101|NCT00551356|Glargine|glargine
594102|NCT00551356|Lispro|lispro
594103|NCT00551369|stage I non-small cell lung cancer|stage i non-small cell lung cancer
594104|NCT00551369|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
594105|NCT00551369|adenocarcinoma of the lung|adenocarcinoma of the lung
594106|NCT00551369|large cell lung cancer|large cell lung cancer
594107|NCT00551369|squamous cell lung cancer|squamous cell lung cancer
594108|NCT00551369|adenosquamous cell lung cancer|adenosquamous cell lung cancer
594109|NCT00551382|Montelukast|montelukast
594110|NCT00551382|Upper respiratory tract infection|upper respiratory tract infection
594111|NCT00551382|leukotriene|leukotriene
594112|NCT00551382|Children|children
594113|NCT00551395|glaucoma|glaucoma
594114|NCT00551395|laser|laser
594115|NCT00551395|trabeculoplasty|trabeculoplasty
594116|NCT00551460|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
594117|NCT00551460|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
594118|NCT00551460|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
594119|NCT00551460|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
594120|NCT00551460|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
594121|NCT00551473|pharmacodynamics,|pharmacodynamics,
594122|NCT00551473|tolerance|tolerance
594123|NCT00551473|H2 antagonist,|h2 antagonist,
594124|NCT00551473|AH23844,|ah23844,
594125|NCT00551473|lavoltidine,|lavoltidine,
594126|NCT00551473|gastroesophageal reflux disease (GERD), pharmacokinetics,|gastroesophageal reflux disease (gerd), pharmacokinetics,
594127|NCT00551486|Pyrosequencing|pyrosequencing
594128|NCT00551486|BRAFV600E mutation|brafv600e mutation
594129|NCT00551486|Thyroid incidentaloma|thyroid incidentaloma
594130|NCT00551486|Ultrasound-guided fine-needle aspiration biopsy|ultrasound-guided fine-needle aspiration biopsy
594131|NCT00551499|Sleep Apnea, CRT|sleep apnea, crt
594132|NCT00551512|cancer|cancer
594133|NCT00551512|solid tumors|solid tumors
594134|NCT00551525|stage IIB prostate cancer|stage iib prostate cancer
594135|NCT00551525|stage IIA prostate cancer|stage iia prostate cancer
594136|NCT00551525|stage III prostate cancer|stage iii prostate cancer
594137|NCT00551525|stage IV prostate cancer|stage iv prostate cancer
594138|NCT00551538|Diabetes|diabetes
594139|NCT00551538|Diabetic|diabetic
594140|NCT00551538|Insulin|insulin
594141|NCT00551538|Glargine|glargine
594142|NCT00551538|Lispro|lispro
594143|NCT00551551|Pelvic floor|pelvic floor
594144|NCT00551551|Kegel exercises|kegel exercises
594145|NCT00551551|Quality of Life|quality of life
594146|NCT00551551|Pelvic Pain|pelvic pain
594147|NCT00551564|total body water|total body water
594149|NCT00551564|Healthy Obese,|healthy obese,
594150|NCT00551564|Insulin Resistance,|insulin resistance,
594151|NCT00551564|Rosiglitazone maleate,|rosiglitazone maleate,
594152|NCT00551564|Glucose Disposal,|glucose disposal,
594153|NCT00551564|hyperinsulinemic-euglycemic clamp,|hyperinsulinemic-euglycemic clamp,
594154|NCT00551577|Ovarian neoplasms,|ovarian neoplasms,
594155|NCT00551577|Neoadjuvant Therapy,|neoadjuvant therapy,
594156|NCT00551577|Docetaxel,|docetaxel,
594157|NCT00551577|Neoplasm, Residual|neoplasm, residual
594158|NCT00551590|diabetes mellitus|diabetes mellitus
594159|NCT00551590|DPP-4 inhibitor|dpp-4 inhibitor
594160|NCT00551590|sitagliptin|sitagliptin
595286|NCT00560989|CBD|cbd
594161|NCT00551590|exendin(9-39)|exendin(9-39)
594162|NCT00551590|GLP-1|glp-1
594163|NCT00551603|epoetinum beta once-weekly|epoetinum beta once-weekly
594164|NCT00551603|darbepoetinum once-fortnightly|darbepoetinum once-fortnightly
594165|NCT00551603|anemia correction|anemia correction
594166|NCT00551603|hemoglobin stability|hemoglobin stability
594167|NCT00546026|placental function|placental function
594168|NCT00546026|high-risk pregnancies|high-risk pregnancies
594169|NCT00546026|psychological distress|psychological distress
594170|NCT00546039|Prostate cancer|prostate cancer
594171|NCT00546039|Localized prostatectomy|localized prostatectomy
594172|NCT00546039|Laparoscopic prostatectomy|laparoscopic prostatectomy
594173|NCT00546039|Chemoprevention|chemoprevention
594174|NCT00546039|Genistein|genistein
594175|NCT00546039|BONISTEIN™|bonistein™
595431|NCT00561535|Rome III|rome iii
594176|NCT00551642|Preemie, Inhaled Nitric Oxide|preemie, inhaled nitric oxide
594177|NCT00551655|Human Immunodeficiency Viruses|human immunodeficiency viruses
594178|NCT00551655|Glomerular Filtration Rate|glomerular filtration rate
594179|NCT00551655|Tenofovir|tenofovir
594180|NCT00551655|Treatment Experienced|treatment experienced
594181|NCT00551681|cardiac resynchronisation therapy|cardiac resynchronisation therapy
594182|NCT00551681|epicardial lead|epicardial lead
594183|NCT00551681|coronary sinus|coronary sinus
594184|NCT00551694|GSK256073A|gsk256073a
594185|NCT00551707|CombinatoRx|combinatorx
594186|NCT00551707|CRx-102|crx-102
594187|NCT00551707|Rheumatoid Arthritis|rheumatoid arthritis
594188|NCT00551707|Prednisolone|prednisolone
594189|NCT00551707|Dipyridamole|dipyridamole
594190|NCT00551707|ACR20|acr20
594192|NCT00551720|HIV positive|hiv positive
594193|NCT00551720|AIDS|aids
594194|NCT00551720|smoking cessation|smoking cessation
594195|NCT00551720|smoking|smoking
594196|NCT00551720|smoking counseling|smoking counseling
594197|NCT00551733|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
594198|NCT00551733|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
594199|NCT00551733|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
594200|NCT00551746|purple grape juice|purple grape juice
594201|NCT00551746|antioxidants|antioxidants
594202|NCT00551746|platelet aggregation|platelet aggregation
594203|NCT00551746|anti-thrombotic|anti-thrombotic
594204|NCT00551759|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
594205|NCT00551759|chemoradiotherapy|chemoradiotherapy
594206|NCT00551759|oxaliplatin|oxaliplatin
594207|NCT00551759|cetuximab|cetuximab
594208|NCT00551759|docetaxel|docetaxel
594209|NCT00551772|Bio-availability, healthy elderly volunteers|bio-availability, healthy elderly volunteers
594210|NCT00551785|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
594211|NCT00551785|Menopause|menopause
594212|NCT00551785|Androgen|androgen
594213|NCT00551798|Hodgkin's Disease|hodgkin's disease
594214|NCT00551798|Malignant lymphomas high grade|malignant lymphomas high grade
594215|NCT00551798|Chemoresistance|chemoresistance
594216|NCT00551798|MIBI|mibi
594217|NCT00551798|PGP|pgp
594218|NCT00551798|MRP1|mrp1
594219|NCT00551798|Tumor response|tumor response
594220|NCT00551811|SB-656933-AAA,|sb-656933-aaa,
594221|NCT00551811|ozone challenge|ozone challenge
594222|NCT00551811|single dose,|single dose,
594223|NCT00551824|esophageal stricture|esophageal stricture
594224|NCT00551837|Lung Transplantation|lung transplantation
594225|NCT00551837|Kidney Transplnatation|kidney transplnatation
594226|NCT00551837|Chroinic Kidney Disease|chroinic kidney disease
594227|NCT00551837|Influenza|influenza
594228|NCT00551850|epidermal growth factor inhibitor|epidermal growth factor inhibitor
594229|NCT00551850|solid tumors|solid tumors
594230|NCT00551850|advanced cancer|advanced cancer
594231|NCT00551863|alcohol, drugs, aggression, substance use disorder treatment|alcohol, drugs, aggression, substance use disorder treatment
594232|NCT00551889|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
594233|NCT00551902|Glaucoma|glaucoma
594234|NCT00551902|trabeculectomy|trabeculectomy
594235|NCT00551902|anterior chamber maintainer|anterior chamber maintainer
594236|NCT00551902|anterior chamber infusion|anterior chamber infusion
594237|NCT00551928|Multiple Myeloma|multiple myeloma
594238|NCT00551928|Lenalidomide|lenalidomide
594239|NCT00551928|High dose Melphalan|high dose melphalan
594240|NCT00551928|Mobilization|mobilization
594241|NCT00551928|CD34|cd34
594242|NCT00553618|Interleukin 2|interleukin 2
594243|NCT00553618|Proleukin|proleukin
594244|NCT00553618|DTIC|dtic
594245|NCT00553618|Dacarbazine|dacarbazine
594246|NCT00553618|metastatic melanoma|metastatic melanoma
594247|NCT00553618|adjuvant|adjuvant
594248|NCT00553631|Enzyme Replacement Therapy|enzyme replacement therapy
594249|NCT00553631|Gaucher disease|gaucher disease
594250|NCT00553631|glucocerebrosidase|glucocerebrosidase
594251|NCT00553631|beta-glucocerebrosidase|beta-glucocerebrosidase
594252|NCT00553631|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
594253|NCT00553631|glucosylceramidase|glucosylceramidase
594254|NCT00553631|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
594255|NCT00553631|gene activation|gene activation
594256|NCT00553631|human|human
594257|NCT00553657|Experimental Medicine|experimental medicine
594258|NCT00553670|coronary artery|coronary artery
594259|NCT00553670|bifurcation|bifurcation
594260|NCT00553670|stent|stent
594261|NCT00553670|intravascular ultrasound|intravascular ultrasound
594262|NCT00553670|fractional flow reserve|fractional flow reserve
594263|NCT00553683|stage IV pancreatic cancer|stage iv pancreatic cancer
594264|NCT00553683|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
594265|NCT00553683|advanced adult primary liver cancer|advanced adult primary liver cancer
594266|NCT00553683|recurrent adult primary liver cancer|recurrent adult primary liver cancer
594267|NCT00553683|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
594268|NCT00553683|recurrent pancreatic cancer|recurrent pancreatic cancer
594269|NCT00553683|recurrent colon cancer|recurrent colon cancer
594270|NCT00553683|recurrent breast cancer|recurrent breast cancer
594271|NCT00553683|recurrent gastric cancer|recurrent gastric cancer
594272|NCT00553683|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
594273|NCT00553683|recurrent melanoma|recurrent melanoma
594274|NCT00553683|stage IV breast cancer|stage iv breast cancer
594275|NCT00553683|stage IV gastric cancer|stage iv gastric cancer
594276|NCT00553683|stage IV colon cancer|stage iv colon cancer
594277|NCT00553683|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
594278|NCT00553683|stage IV melanoma|stage iv melanoma
594279|NCT00553683|liver metastases|liver metastases
594280|NCT00553696|chemotherapy|chemotherapy
594281|NCT00553696|combination|combination
594283|NCT00553709|vomiting|vomiting
594284|NCT00553709|retching|retching
594285|NCT00553709|emesis|emesis
594286|NCT00553709|surgery|surgery
594287|NCT00553709|anesthesia|anesthesia
594288|NCT00553722|hypertension|hypertension
594289|NCT00553722|dialysis|dialysis
594290|NCT00553722|hyperaldosteronism|hyperaldosteronism
594291|NCT00553735|Dry Eye|dry eye
594292|NCT00553735|Graft versus Host Disease|graft versus host disease
594293|NCT00553735|GVHD|gvhd
594294|NCT00553761|Band atrophy|band atrophy
594295|NCT00553761|Pattern electroretinogram|pattern electroretinogram
594296|NCT00553761|Chiasmal compression|chiasmal compression
594297|NCT00553761|Neural loss|neural loss
594298|NCT00553761|Electrophysiological tests|electrophysiological tests
594299|NCT00553774|CAD Patients on Optimal Treatment|cad patients on optimal treatment
594300|NCT00553787|Obesity, Type 2 diabetes|obesity, type 2 diabetes
594301|NCT00553813|Unresectable|unresectable
594302|NCT00553813|Gemcitabine|gemcitabine
594303|NCT00553813|Taxane|taxane
594304|NCT00553813|TPI 287|tpi 287
594305|NCT00553839|anesthesia|anesthesia
594306|NCT00553839|children|children
594307|NCT00553839|ketamine|ketamine
594308|NCT00553839|pharmacokinetics|pharmacokinetics
594309|NCT00553852|Very Severe Obesity|very severe obesity
594310|NCT00553852|Body Composition|body composition
594311|NCT00553852|GH deficiency|gh deficiency
594312|NCT00553852|IGF-I|igf-i
594313|NCT00553852|LASGB|lasgb
594314|NCT00553852|GH therapy|gh therapy
594315|NCT00553917|Pregnancy|pregnancy
594316|NCT00553917|Depression|depression
594317|NCT00553917|Antidepressants|antidepressants
594318|NCT00553930|HCV/HIV-coinfected patients|hcv/hiv-coinfected patients
594319|NCT00553930|Peginterferon alfa-2a|peginterferon alfa-2a
594320|NCT00553943|lymphoma|lymphoma
594321|NCT00553943|cerebral lymphoma|cerebral lymphoma
594322|NCT00553943|central nervous system|central nervous system
594323|NCT00553943|cytarabine|cytarabine
594324|NCT00553943|rituximab|rituximab
594325|NCT00553943|Diffuse large B-cell lymphomas, with cerebral or neuromeningeal involvement|diffuse large b-cell lymphomas, with cerebral or neuromeningeal involvement
594326|NCT00553969|cardiovascular disease prevention|cardiovascular disease prevention
594327|NCT00553982|Replacement|replacement
594328|NCT00553982|Knee|knee
594329|NCT00553982|Patella|patella
594330|NCT00553982|Arthroplasty|arthroplasty
594331|NCT00554008|Appendicitis|appendicitis
594332|NCT00554008|laparoscopy|laparoscopy
594333|NCT00554008|randomized trial|randomized trial
594334|NCT00554008|children|children
594335|NCT00554008|pediatric|pediatric
594336|NCT00554021|Central venous catheter|central venous catheter
594337|NCT00554021|nosocomial infection|nosocomial infection
594338|NCT00554034|gingivitis, localized treatment|gingivitis, localized treatment
594339|NCT00554047|Dementia|dementia
594340|NCT00554047|Caregivers|caregivers
594341|NCT00554047|Costs and cost analysis|costs and cost analysis
594342|NCT00554047|Multicenter study|multicenter study
594343|NCT00554047|Randomized controlled trial|randomized controlled trial
594344|NCT00554047|Quality Adjusted Life Years|quality adjusted life years
594345|NCT00554047|Quality of life|quality of life
594346|NCT00554047|Technology assessment, biomedical; Methods|technology assessment, biomedical; methods
594347|NCT00554073|Magnetic resonance|magnetic resonance
594348|NCT00554073|whole body|whole body
594349|NCT00554073|angiography|angiography
594350|NCT00554073|vasovist|vasovist
594351|NCT00554073|gadofosveset|gadofosveset
594352|NCT00554073|blood pool agent|blood pool agent
594353|NCT00554073|3T|3t
594354|NCT00554073|1.5T|1.5t
594355|NCT00554073|Field strength|field strength
594356|NCT00554112|Exercise Training|exercise training
594357|NCT00554112|Glucose Intolerance|glucose intolerance
594358|NCT00554112|Human Aging|human aging
594359|NCT00554112|Insulin Secretion|insulin secretion
594360|NCT00554125|Sirolimus; Orthotopic liver transplantation; HCC|sirolimus; orthotopic liver transplantation; hcc
594361|NCT00554138|rosuvastatin|rosuvastatin
594362|NCT00554138|dipyridamole|dipyridamole
594363|NCT00554138|caffeine|caffeine
594364|NCT00554164|Aggressive non-Hodgkin's lymphoma|aggressive non-hodgkin's lymphoma
594365|NCT00554164|Positron emission tomography|positron emission tomography
594366|NCT00554164|Chemotherapy|chemotherapy
594368|NCT00554177|combat|combat
594369|NCT00554177|PTSD|ptsd
594370|NCT00554177|Clinical trial|clinical trial
594371|NCT00554177|Trauma|trauma
594372|NCT00554177|PTSD treatment|ptsd treatment
594373|NCT00554177|PTSD medication|ptsd medication
594374|NCT00554177|Post traumatic stress disorder|post traumatic stress disorder
594375|NCT00554190|rhinosinusitis, ethmoid|rhinosinusitis, ethmoid
594376|NCT00554216|Obesity, morbid obesity|obesity, morbid obesity
594377|NCT00554229|Hormone Resistant Prostate Cancer|hormone resistant prostate cancer
594378|NCT00554229|Endothelin A Receptor Antagonist|endothelin a receptor antagonist
594379|NCT00554229|Endothelin A|endothelin a
594380|NCT00554229|Endothelin A antagonist|endothelin a antagonist
594381|NCT00554242|endothelium|endothelium
594382|NCT00554242|antioxidants|antioxidants
594383|NCT00554242|flavonoids|flavonoids
594384|NCT00554255|Pharmacodynamics|pharmacodynamics
594385|NCT00554255|Japanese|japanese
594386|NCT00554255|safety|safety
594387|NCT00554255|Pharmacokinetics|pharmacokinetics
594388|NCT00554268|Advanced Cancers|advanced cancers
594389|NCT00554268|Solid Tumors|solid tumors
594390|NCT00554268|PBI-05204|pbi-05204
594391|NCT00554281|Type 1 diabetes|type 1 diabetes
594392|NCT00554281|Hypoglycemia|hypoglycemia
594393|NCT00554281|Glucose sensor|glucose sensor
594394|NCT00554294|children|children
594395|NCT00554294|primary prevention|primary prevention
594396|NCT00554294|environmental change|environmental change
594397|NCT00554294|behavioural change|behavioural change
594398|NCT00554294|school setting|school setting
594399|NCT00554294|changing of drinking habits|changing of drinking habits
594400|NCT00554294|promotion of drinking tap water|promotion of drinking tap water
594401|NCT00554307|patent ductus arteriosus|patent ductus arteriosus
594402|NCT00554307|indomethacin|indomethacin
594403|NCT00554307|neoprofen|neoprofen
594404|NCT00554307|blood flow|blood flow
594405|NCT00554320|vulvodynia|vulvodynia
594406|NCT00554320|painful bladder syndrome|painful bladder syndrome
594407|NCT00554320|myofascial pain syndrome|myofascial pain syndrome
594408|NCT00554320|pelvic floor tension myalgia|pelvic floor tension myalgia
594409|NCT00554346|COX-2; post-operative ; sports injury; surgical pain|cox-2; post-operative ; sports injury; surgical pain
594410|NCT00554359|Acute Kidney Injury|acute kidney injury
594411|NCT00554359|Acute Renal Failure|acute renal failure
594412|NCT00554372|Jennerex|jennerex
594413|NCT00554372|HCC|hcc
594414|NCT00554372|unresectable primary hepatocellular carcinoma|unresectable primary hepatocellular carcinoma
594415|NCT00554372|hepatocellular carcinoma|hepatocellular carcinoma
594416|NCT00554372|liver cancer|liver cancer
594417|NCT00554372|Phase 2|phase 2
594418|NCT00554372|oncolytic virus|oncolytic virus
594419|NCT00554372|Pexa-Vec|pexa-vec
594420|NCT00554398|Raltegravir|raltegravir
594421|NCT00554398|MK-0518|mk-0518
594422|NCT00554398|Treatment intensification|treatment intensification
594423|NCT00554398|HIV-1 latency|hiv-1 latency
594424|NCT00554398|HIV eradication|hiv eradication
594425|NCT00554398|treatment experienced|treatment experienced
594426|NCT00554411|Travatan Z|travatan z
594427|NCT00554411|glaucoma|glaucoma
594428|NCT00554411|tear film break up time|tear film break up time
594429|NCT00554424|oocyte retrieval|oocyte retrieval
594430|NCT00554424|pain relief|pain relief
594431|NCT00554424|Local anaesthetic|local anaesthetic
594432|NCT00554437|Accidental Falls|accidental falls
594433|NCT00554437|RCT|rct
594434|NCT00554437|Age 65 and older|age 65 and older
594435|NCT00554437|noninstitualized populations|noninstitualized populations
594436|NCT00554463|limited stage small cell lung cancer|limited stage small cell lung cancer
594437|NCT00554476|Lateral Epicondylitis|lateral epicondylitis
594438|NCT00554476|Treatment|treatment
594439|NCT00554476|Corticosteroid|corticosteroid
594440|NCT00554476|Elbow Cast|elbow cast
594441|NCT00554476|Icing|icing
594442|NCT00554476|NSAIDs|nsaids
594443|NCT00554489|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
594444|NCT00554489|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
594445|NCT00554489|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
594446|NCT00554489|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
594447|NCT00554489|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
594448|NCT00554489|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
594449|NCT00554515|Kidney|kidney
594450|NCT00554515|Renal Cell|renal cell
594451|NCT00554515|Metastatic|metastatic
594452|NCT00554515|interleukin-2|interleukin-2
594453|NCT00554515|select|select
594454|NCT00554528|Cervical|cervical
594455|NCT00554528|disc|disc
594456|NCT00554528|prosthesis|prosthesis
594457|NCT00554528|adjacent|adjacent
594458|NCT00554528|disease|disease
594459|NCT00554528|randomized|randomized
594460|NCT00554528|prospective|prospective
594461|NCT00554528|study|study
594462|NCT00554567|HIV/AIDS|hiv/aids
594463|NCT00554567|Voluntary Counseling and Testing|voluntary counseling and testing
594464|NCT00554567|Rural India|rural india
594465|NCT00554567|HIV Care|hiv care
597840|NCT00556491|prevention|prevention
594466|NCT00554567|Health Services Research|health services research
594467|NCT00554580|continuous positive airway pressure|continuous positive airway pressure
594468|NCT00554580|outcome measure|outcome measure
594469|NCT00554580|clinical trial|clinical trial
594470|NCT00554606|Rheumatoid Arthritis|rheumatoid arthritis
594471|NCT00554606|Anit-interleukin-1 beta|anit-interleukin-1 beta
594472|NCT00554606|ACZ885|acz885
594473|NCT00554619|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
594474|NCT00554619|Ambrisentan|ambrisentan
594475|NCT00554632|Contraceptive|contraceptive
594476|NCT00554632|Venous thrombosis|venous thrombosis
594477|NCT00554632|Coagulation parameter|coagulation parameter
594478|NCT00554645|obesity|obesity
594479|NCT00554645|children|children
594480|NCT00554645|psychological intervention|psychological intervention
594481|NCT00554671|Diabetes Mellitus|diabetes mellitus
594482|NCT00554671|Clinical pharmacists|clinical pharmacists
594483|NCT00554671|guideline adherence|guideline adherence
594484|NCT00554671|group medical visits|group medical visits
594485|NCT00554671|behavioral modification|behavioral modification
594486|NCT00554671|pharmacotherapy|pharmacotherapy
594487|NCT00554684|Outcome|outcome
594488|NCT00554684|Elderly|elderly
594489|NCT00554684|ICU|icu
594490|NCT00554684|Quality of Life|quality of life
594491|NCT00554697|tissue oxygenation|tissue oxygenation
594492|NCT00554697|perioperative|perioperative
594493|NCT00554697|outcome|outcome
594494|NCT00554710|Crohn's disease|crohn's disease
594495|NCT00554710|immunomodulators|immunomodulators
594496|NCT00554710|biologicals|biologicals
594497|NCT00554723|Stroke|stroke
594498|NCT00554723|Cerebral infarct|cerebral infarct
594499|NCT00554723|Recovery|recovery
594500|NCT00554723|Double blind|double blind
594501|NCT00554723|Randomized|randomized
594502|NCT00554723|Placebo|placebo
594503|NCT00554723|Traditional Chinese Medicine|traditional chinese medicine
594504|NCT00554723|Neuroaid|neuroaid
594505|NCT00554736|Pollen Allergy|pollen allergy
594506|NCT00554736|Allergy|allergy
594507|NCT00554749|Selective mutism|selective mutism
594508|NCT00554749|Children|children
594509|NCT00554749|Treatment|treatment
594510|NCT00554762|mechanical pain,|mechanical pain,
594511|NCT00554762|heat pain,|heat pain,
594512|NCT00554762|dose,|dose,
594513|NCT00554762|efficacy|efficacy
594514|NCT00554762|dose response,|dose response,
594515|NCT00554762|GW842166,|gw842166,
594516|NCT00554762|Single,|single,
594517|NCT00554762|pharmacodynamics,|pharmacodynamics,
594518|NCT00554762|repeat dose,|repeat dose,
594519|NCT00554775|tumors metastatic to brain|tumors metastatic to brain
594520|NCT00554775|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
594521|NCT00554775|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
594522|NCT00554801|Central Auditory Processing|central auditory processing
594523|NCT00554801|Traumatic Brain Injury|traumatic brain injury
594524|NCT00554801|Hearing Loss|hearing loss
594525|NCT00554814|Iron deficiency|iron deficiency
594526|NCT00554814|Ferritin|ferritin
594527|NCT00554814|Encapsulated iron|encapsulated iron
594528|NCT00554814|Infant formula|infant formula
594529|NCT00554827|Relapsed or Refractory Cutaneous T-cell Lymphoma|relapsed or refractory cutaneous t-cell lymphoma
594530|NCT00554827|Lymphoma|lymphoma
594531|NCT00554827|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
594532|NCT00554827|T-cell Lymphoma|t-cell lymphoma
594533|NCT00554827|Mycosis fungoides|mycosis fungoides
594534|NCT00554827|Sézary syndrome|sézary syndrome
594535|NCT00554827|Primary cutaneous anaplastic large cell|primary cutaneous anaplastic large cell
594536|NCT00554892|Rectal cancer|rectal cancer
594537|NCT00554892|Sphincter preservation|sphincter preservation
594611|NCT00555061|impetigo|impetigo
594538|NCT00554892|Mechanical bowel preparation|mechanical bowel preparation
594539|NCT00554892|Post operative morbidity|post operative morbidity
594540|NCT00554892|Anastomotic leakage|anastomotic leakage
594541|NCT00554905|ablation|ablation
594542|NCT00554905|catheter|catheter
594543|NCT00554905|Carcinoma, Hepatocellular|carcinoma, hepatocellular
594544|NCT00554905|therapy|therapy
594545|NCT00554905|Chemoembolization, Therapeutic|chemoembolization, therapeutic
594546|NCT00554905|Humans|humans
594547|NCT00554905|Liver Neoplasms|liver neoplasms
594548|NCT00554918|adenocarcinoma of the prostate|adenocarcinoma of the prostate
594549|NCT00554918|recurrent prostate cancer|recurrent prostate cancer
594550|NCT00554918|stage IV prostate cancer|stage iv prostate cancer
594551|NCT00554918|bone metastases|bone metastases
594552|NCT00554944|Fluid Management|fluid management
594553|NCT00554944|surgery|surgery
594554|NCT00554944|Obesity|obesity
594555|NCT00554970|Adult Asthmatics|adult asthmatics
594556|NCT00554983|Recombinant birch pollen allergy|recombinant birch pollen allergy
594557|NCT00554983|IgE-mediated allergic disease attributed to birch pollen|ige-mediated allergic disease attributed to birch pollen
594558|NCT00554996|urinary tract infection|urinary tract infection
594559|NCT00554996|urinary catheter|urinary catheter
594560|NCT00554996|Escherichia coli|escherichia coli
594562|NCT00555009|traumatic brain Injury, cognitive function|traumatic brain injury, cognitive function
598010|NCT00562705|ISS|iss
594563|NCT00555022|Muscarinic Receptor Antagonist,|muscarinic receptor antagonist,
594564|NCT00555022|Anticholinergic,|anticholinergic,
594565|NCT00555022|COPD,|copd,
594567|NCT00555022|Plethysmography|plethysmography
594568|NCT00555035|GSK1349572,|gsk1349572,
594569|NCT00555035|healthy volunteers|healthy volunteers
594570|NCT00555048|graft versus host disease|graft versus host disease
594571|NCT00555048|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
594572|NCT00555048|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
594573|NCT00555048|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
594574|NCT00555048|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
594575|NCT00555048|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
594576|NCT00555048|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
594577|NCT00555048|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
594578|NCT00555048|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
594579|NCT00555048|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
594580|NCT00555048|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
594581|NCT00555048|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
594582|NCT00555048|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
594583|NCT00555048|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
594584|NCT00555048|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
594585|NCT00555048|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
594586|NCT00555048|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
594587|NCT00555048|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
594588|NCT00555048|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
594589|NCT00555048|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
594590|NCT00555048|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
594591|NCT00555048|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
594592|NCT00555048|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
594593|NCT00555048|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
594594|NCT00555048|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
594595|NCT00555048|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
594596|NCT00555048|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
594597|NCT00555048|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
594598|NCT00555048|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
594599|NCT00555048|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
594600|NCT00555048|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
594601|NCT00555048|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
594602|NCT00555048|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
594603|NCT00555048|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
594604|NCT00555048|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
594605|NCT00555048|secondary acute myeloid leukemia|secondary acute myeloid leukemia
594606|NCT00555048|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
594607|NCT00555048|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
594608|NCT00555048|myelodysplastic/myeloproliferative diseases|myelodysplastic/myeloproliferative diseases
594609|NCT00555048|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
594610|NCT00555061|SID|sid
594612|NCT00555061|pharmacokinetics|pharmacokinetics
594613|NCT00555061|Retapamulin ointment, 1%|retapamulin ointment, 1%
594614|NCT00555061|Skin abnormalities|skin abnormalities
594615|NCT00555061|Dermatoses|dermatoses
594616|NCT00555061|pediatric|pediatric
594617|NCT00555061|infection|infection
594618|NCT00555061|SITL|sitl
594619|NCT00555087|Erectile dysfunction|erectile dysfunction
594620|NCT00555087|Hypogonadotrophic males|hypogonadotrophic males
594621|NCT00555113|pseudoxanthoma elasticum|pseudoxanthoma elasticum
594622|NCT00555113|Visual acuity|visual acuity
594623|NCT00555113|Choroidal neovascularization|choroidal neovascularization
594624|NCT00555113|angioid streaks|angioid streaks
594625|NCT00555126|Polytrauma|polytrauma
594626|NCT00555126|Hypothermia|hypothermia
594627|NCT00555126|Wound Infection|wound infection
594628|NCT00555126|Blood Loss|blood loss
594629|NCT00555126|Combined perioperative morbidity|combined perioperative morbidity
594630|NCT00555139|anxiety,|anxiety,
594631|NCT00555139|depression,|depression,
594632|NCT00555139|fMRI|fmri
594633|NCT00555139|CRF-1 antagonists,|crf-1 antagonists,
594634|NCT00555165|Macular Degeneration|macular degeneration
594635|NCT00555165|Visual Impairment|visual impairment
594636|NCT00555165|Quality of Life|quality of life
594637|NCT00555165|Implantable Telescope|implantable telescope
594638|NCT00555178|Polymorphic light eruption|polymorphic light eruption
594639|NCT00555178|Regulatory T cells (Tregs)|regulatory t cells (tregs)
594640|NCT00555178|Seasonal fluctuation|seasonal fluctuation
594641|NCT00555178|UV radiation|uv radiation
594642|NCT00555178|Phototherapy|phototherapy
594643|NCT00555191|fructose|fructose
594644|NCT00555191|Irritable bowel syndrome|irritable bowel syndrome
594645|NCT00555191|malabsorption|malabsorption
594646|NCT00555191|Glut5 transporter gene|glut5 transporter gene
594647|NCT00555204|mild to moderate Alzheimer's disease, memory, cognition, dementia|mild to moderate alzheimer's disease, memory, cognition, dementia
594648|NCT00555217|kidney disease|kidney disease
594649|NCT00555217|nephropathy|nephropathy
594650|NCT00555217|type 2 diabetes|type 2 diabetes
594651|NCT00555217|hyperkalemia|hyperkalemia
594652|NCT00555217|acute kidney injury|acute kidney injury
594653|NCT00555230|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
594654|NCT00555230|Crestor|crestor
594655|NCT00555230|Rosuvastatin|rosuvastatin
594656|NCT00555243|Laparoscopic Surgical Simulation|laparoscopic surgical simulation
594657|NCT00555256|NSCLC|nsclc
594658|NCT00555269|Macular pucker|macular pucker
594659|NCT00555269|Macular hole|macular hole
594660|NCT00555269|Membrane Blue|membrane blue
594661|NCT00555269|Infracyanine Green|infracyanine green
594662|NCT00555269|Peripheral Visual Field|peripheral visual field
594663|NCT00555282|central venous catheter|central venous catheter
594664|NCT00555282|cvc|cvc
594665|NCT00555282|coated catheter|coated catheter
594666|NCT00555282|bacteriaemia|bacteriaemia
594667|NCT00555282|bloodstream infection|bloodstream infection
594668|NCT00555308|urolithiasis|urolithiasis
594669|NCT00555308|ultrasound|ultrasound
594670|NCT00555308|hydronephrosis|hydronephrosis
594671|NCT00555334|hepatocellular carcinoma|hepatocellular carcinoma
594672|NCT00555334|liver cancer|liver cancer
594673|NCT00555334|radiofrequency ablation|radiofrequency ablation
594674|NCT00555334|lamivudine|lamivudine
594675|NCT00555347|Sarcoidosis|sarcoidosis
594676|NCT00555347|Fatigue|fatigue
594677|NCT00555360|Health Information Technology|health information technology
594678|NCT00555360|Patient Care Management|patient care management
594679|NCT00555360|Self Care|self care
594680|NCT00555360|Quality of Life|quality of life
594681|NCT00555360|Family or non-Family Informal Caregivers|family or non-family informal caregivers
594682|NCT00555373|Pediatric|pediatric
594683|NCT00555373|Renal|renal
594684|NCT00555373|Transplant|transplant
594685|NCT00555386|Selenium|selenium
594686|NCT00555386|Soy|soy
594687|NCT00555386|Breast Cancer Risk|breast cancer risk
594688|NCT00555399|Glioblastoma Multiforme|glioblastoma multiforme
594689|NCT00555399|Anaplastic Glioma|anaplastic glioma
594690|NCT00555399|Vorinostat|vorinostat
594691|NCT00555399|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
594692|NCT00555399|SAHA|saha
594693|NCT00555399|MSK-390|msk-390
594694|NCT00555399|Zolinza|zolinza
594695|NCT00555399|Isotretinoin|isotretinoin
594696|NCT00555399|Accutane|accutane
594697|NCT00555399|13-cis-Retinoic Acid|13-cis-retinoic acid
594698|NCT00555399|Carboplatin|carboplatin
594699|NCT00555399|Paraplatin|paraplatin
594700|NCT00555399|CBT|cbt
594701|NCT00555399|Temozolomide|temozolomide
594702|NCT00555399|Temodar|temodar
594703|NCT00555412|pharmacokinetic|pharmacokinetic
594704|NCT00555412|multidose|multidose
594705|NCT00555412|Staccato Loxapine|staccato loxapine
594706|NCT00555425|Buprenorphine|buprenorphine
594707|NCT00555425|Buprenorphine/naloxone|buprenorphine/naloxone
594708|NCT00555425|Counseling|counseling
594709|NCT00555425|Primary care|primary care
594710|NCT00555438|major orthopaedic surgery|major orthopaedic surgery
594711|NCT00555438|venous thromboembolic events prevention|venous thromboembolic events prevention
594712|NCT00555438|renal impairment|renal impairment
594713|NCT00555438|Arixtra|arixtra
594714|NCT00555438|anti-Xa activity|anti-xa activity
594715|NCT00555451|phase I|phase i
594716|NCT00555451|safety|safety
594717|NCT00555451|tolerance|tolerance
594718|NCT00555451|insulin resistance|insulin resistance
594719|NCT00555451|obese|obese
594720|NCT00555451|pharmacokinetics|pharmacokinetics
594721|NCT00555464|hemangioma, steroid, prednisolone, vincristine|hemangioma, steroid, prednisolone, vincristine
594722|NCT00555477|premenopausal breast cancer with chemotherapy-induced ovarian failure|premenopausal breast cancer with chemotherapy-induced ovarian failure
594723|NCT00555490|Soy|soy
594724|NCT00555490|Diabetes|diabetes
594725|NCT00555490|Nephropathy|nephropathy
594726|NCT00555503|prospective study|prospective study
594728|NCT00555503|quality of life|quality of life
594729|NCT00555503|mastectomy|mastectomy
594730|NCT00555503|reconstructive surgical procedures|reconstructive surgical procedures
594731|NCT00555503|BrCa1|brca1
594732|NCT00555503|BrCa2|brca2
594733|NCT00555503|breast cancer prevention|breast cancer prevention
594734|NCT00555516|Breast Cancer、 Chemotherapy、 Neutropenia、WBC|breast cancer、 chemotherapy、 neutropenia、wbc
594735|NCT00555529|COPD|copd
594736|NCT00555529|exhaled breath condensate|exhaled breath condensate
594737|NCT00555529|applanation tonometry|applanation tonometry
594738|NCT00555529|induced sputum|induced sputum
594739|NCT00555529|smokers|smokers
594740|NCT00555529|healthy control|healthy control
594741|NCT00555542|B-cell|b-cell
594743|NCT00555542|Rheumatoid Arthritis|rheumatoid arthritis
594744|NCT00555555|Factor VIII deficiency|factor viii deficiency
594745|NCT00555555|Von Willebrand disease|von willebrand disease
594746|NCT00555555|FVIII/VWF concentrate|fviii/vwf concentrate
594747|NCT00555555|Bleeding disorders|bleeding disorders
594748|NCT00555555|Blood disorders|blood disorders
594749|NCT00555568|mental health|mental health
594750|NCT00555568|group processes|group processes
594751|NCT00555581|Systemic Sclerosis|systemic sclerosis
594752|NCT00555594|corneal neovascularization|corneal neovascularization
594753|NCT00555594|Bevacizumab (Avastin)|bevacizumab (avastin)
594754|NCT00555594|Immunologic rejection|immunologic rejection
594755|NCT00555594|vascular endothelial growth factor|vascular endothelial growth factor
594756|NCT00555607|asthma|asthma
594757|NCT00555607|COPD|copd
594758|NCT00555607|severe|severe
594759|NCT00555607|controlled|controlled
594760|NCT00555607|mild|mild
594761|NCT00555607|biomarker|biomarker
594762|NCT00555607|exacerbation|exacerbation
594763|NCT00555633|Photoprotection|photoprotection
594764|NCT00555633|Sunscreen|sunscreen
594765|NCT00555633|After-sun-lotion|after-sun-lotion
594766|NCT00555633|DNA repair enzymes|dna repair enzymes
594767|NCT00555633|liposomes|liposomes
594768|NCT00555633|skin cancer|skin cancer
594769|NCT00555633|Xeroderma pigmentosum|xeroderma pigmentosum
594770|NCT00555633|Basal cell nevus syndrome|basal cell nevus syndrome
594771|NCT00555659|Degeneration|degeneration
594772|NCT00555659|Spondylosis|spondylosis
594773|NCT00555659|Spondylolisthesis|spondylolisthesis
594774|NCT00555659|Stenosis|stenosis
594775|NCT00555685|Heart Failure|heart failure
594776|NCT00555685|Renal failure|renal failure
594777|NCT00555685|Hyponatremia|hyponatremia
594779|NCT00555698|Depression|depression
594780|NCT00555711|Brain tumor|brain tumor
594781|NCT00555724|Relapsed|relapsed
594782|NCT00555724|refractory|refractory
594783|NCT00555724|solid tumor|solid tumor
594784|NCT00555737|Celiac Disease|celiac disease
594785|NCT00555737|Capsule Endoscopy|capsule endoscopy
594786|NCT00555737|small Bowel Disease|small bowel disease
594787|NCT00555750|sleep|sleep
594788|NCT00555750|metabolism|metabolism
594789|NCT00555750|insulin|insulin
594790|NCT00555750|glucose|glucose
594791|NCT00555750|actigraphy|actigraphy
594792|NCT00555750|diary|diary
594793|NCT00555750|volumetry|volumetry
594794|NCT00555750|GABA|gaba
594795|NCT00555763|Intraocular pressure|intraocular pressure
594796|NCT00555763|Goldmann tonometry|goldmann tonometry
594797|NCT00555763|applanation tonometry|applanation tonometry
594798|NCT00555763|Tonometry, Ocular|tonometry, ocular
594799|NCT00555776|tinnitus|tinnitus
594800|NCT00555776|gabapentin|gabapentin
594801|NCT00555789|kidney transplantation|kidney transplantation
594802|NCT00555789|rejection|rejection
594803|NCT00555789|AEB071|aeb071
594804|NCT00555789|tacrolimus|tacrolimus
594805|NCT00555789|mycophenolic acid|mycophenolic acid
594806|NCT00555789|immunosuppression|immunosuppression
594807|NCT00555802|Low Back Pain|low back pain
594808|NCT00555802|Motor Control Exercise|motor control exercise
594809|NCT00555802|General exercise|general exercise
594810|NCT00555802|Ultrasonography, Multifidus|ultrasonography, multifidus
594811|NCT00555802|Transversus abdominis|transversus abdominis
594812|NCT00555802|Randomized Controlled trial.|randomized controlled trial.
594813|NCT00555828|Myocardial Infarction|myocardial infarction
594814|NCT00555828|Myocardial infarct|myocardial infarct
594815|NCT00555828|Infarction|infarction
594816|NCT00555841|breast cancer|breast cancer
594817|NCT00555854|Motivational interviewing,|motivational interviewing,
595220|NCT00560690|metformin|metformin
594818|NCT00555854|Multidisciplinary|multidisciplinary
594819|NCT00555854|Life style changes|life style changes
594820|NCT00555854|Prevention|prevention
594821|NCT00555854|Compliance|compliance
594822|NCT00555854|Self Care|self care
594823|NCT00555854|Behaviour|behaviour
594824|NCT00555867|hormone-receptor positive primary breast cancer|hormone-receptor positive primary breast cancer
594825|NCT00555867|compliance|compliance
594826|NCT00555867|Postmenopausal women|postmenopausal women
594827|NCT00555893|randomized|randomized
594828|NCT00555893|blinded|blinded
594829|NCT00555893|controlled|controlled
594830|NCT00555893|efficacy|efficacy
594831|NCT00555919|Metastatic breast cancer stage IV|metastatic breast cancer stage iv
594832|NCT00555919|Metastatic breast cancer|metastatic breast cancer
594833|NCT00555919|mBC|mbc
594834|NCT00555919|Stage IV breast cancer|stage iv breast cancer
594835|NCT00555919|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
594836|NCT00555932|Intracranial Thrombosis|intracranial thrombosis
594837|NCT00555932|Cerebral Sinovenous Thrombosis|cerebral sinovenous thrombosis
594838|NCT00555932|Pediatrics|pediatrics
594839|NCT00555932|Cranial Ultrasound|cranial ultrasound
594840|NCT00555945|Intertrochanteric fracture|intertrochanteric fracture
594841|NCT00555945|Gamma3 intramedullary nail|gamma3 intramedullary nail
594842|NCT00555945|Sliding hip screw|sliding hip screw
594843|NCT00555958|Obesity|obesity
594844|NCT00555958|Bariatric surgery|bariatric surgery
594845|NCT00555958|Excess weight loss|excess weight loss
594847|NCT00555958|Vagal blocking|vagal blocking
594848|NCT00555958|VBLOC(TM) therapy|vbloc(tm) therapy
594849|NCT00555984|Intracranial tumors|intracranial tumors
594850|NCT00555984|Inflammatory markers|inflammatory markers
594851|NCT00555984|Craniotomy|craniotomy
594852|NCT00555984|Postoperative complications|postoperative complications
594853|NCT00555997|Major Depressive Disorder|major depressive disorder
594854|NCT00555997|Major Depression|major depression
594855|NCT00555997|Depression|depression
594856|NCT00555997|Geodon|geodon
594857|NCT00555997|Ziprasidone|ziprasidone
594858|NCT00556023|interventional|interventional
594859|NCT00556023|dose-finding|dose-finding
594860|NCT00556036|healthy|healthy
594861|NCT00556036|overweight|overweight
594862|NCT00556036|obese|obese
594863|NCT00556036|anorexia nervosa|anorexia nervosa
594864|NCT00556036|weight|weight
594865|NCT00556036|cortisol|cortisol
594866|NCT00556036|hormone|hormone
594867|NCT00556036|bone density|bone density
594868|NCT00556036|bone|bone
594869|NCT00556036|osteopenia|osteopenia
594870|NCT00556036|osteoporosis|osteoporosis
594871|NCT00556036|amenorrhea|amenorrhea
594872|NCT00556036|menses|menses
594873|NCT00556036|irregular|irregular
594874|NCT00556036|stress|stress
594875|NCT00556036|depression|depression
594876|NCT00556036|exercise|exercise
594877|NCT00556036|diet|diet
594878|NCT00556049|mRCC|mrcc
594879|NCT00556049|sunitinib|sunitinib
594880|NCT00556049|gemcitabine|gemcitabine
594881|NCT00556075|Endometriosis|endometriosis
594882|NCT00556075|Pelvic pain|pelvic pain
594883|NCT00556075|Oral progesterone blocker|oral progesterone blocker
594884|NCT00556088|LBH589|lbh589
594885|NCT00556088|Phase I|phase i
594886|NCT00556088|Solid Tumors|solid tumors
594887|NCT00556088|Paclitaxel|paclitaxel
594888|NCT00556088|Carboplatin|carboplatin
594889|NCT00556088|Bevacizumab|bevacizumab
594890|NCT00556088|Dose escalation|dose escalation
594891|NCT00556101|Magnetic resonance|magnetic resonance
594892|NCT00556101|whole body|whole body
594893|NCT00556101|angiography|angiography
594894|NCT00556101|questionnaire|questionnaire
594895|NCT00556114|eye exam|eye exam
594896|NCT00556114|Retina|retina
594897|NCT00556127|Large B-cell Lymphoma|large b-cell lymphoma
594898|NCT00556127|Rituximab|rituximab
594899|NCT00556127|ASCT|asct
594900|NCT00549016|Aneurysm Exclusion|aneurysm exclusion
594901|NCT00549029|muscle disorder|muscle disorder
594902|NCT00549029|statins|statins
594903|NCT00549029|creatine kinase|creatine kinase
594904|NCT00549042|Back Pain|back pain
594905|NCT00549042|Chronic Low Back Pain|chronic low back pain
594906|NCT00549042|Chronic Back Pain|chronic back pain
594907|NCT00549042|Pain|pain
594908|NCT00549042|Chronic Pain|chronic pain
594909|NCT00549055|Macugen Age-related macular degeneration (AMD) Observational study|macugen age-related macular degeneration (amd) observational study
594910|NCT00549081|DHEA|dhea
594911|NCT00549081|IVF|ivf
594912|NCT00549081|low ovarian response|low ovarian response
594913|NCT00549107|low cardiac output syndrome|low cardiac output syndrome
594914|NCT00549107|open heart surgery|open heart surgery
594915|NCT00549107|infants|infants
594916|NCT00549107|Low cardiac output syndrome in infants undergoing corrective open heart surgery|low cardiac output syndrome in infants undergoing corrective open heart surgery
594917|NCT00556153|brain tumors, children|brain tumors, children
594918|NCT00556166|Enterra therapy|enterra therapy
594919|NCT00556166|Gastric Simulation System|gastric simulation system
594920|NCT00556192|SLE|sle
594921|NCT00556192|Rituximab|rituximab
594922|NCT00556192|Methylprednisolone|methylprednisolone
594923|NCT00556192|Cyclophosphamide|cyclophosphamide
594924|NCT00556205|mRCC|mrcc
594925|NCT00556205|sunitinib|sunitinib
594926|NCT00556205|bevacizumab|bevacizumab
594927|NCT00556218|Breast Cancer|breast cancer
594928|NCT00556218|Tibetan Meditation|tibetan meditation
594929|NCT00556218|Quality of Life|quality of life
594930|NCT00556218|Cognitive Function|cognitive function
594931|NCT00556218|QOL|qol
594932|NCT00556231|NIRS|nirs
594933|NCT00556231|cardiac output|cardiac output
594934|NCT00556231|anaerobic threshold|anaerobic threshold
594935|NCT00556231|exercise stress|exercise stress
594936|NCT00556231|congenital heart defect|congenital heart defect
594937|NCT00556257|Immunosuppression, JAK3 inhibitor, kidney transplantation|immunosuppression, jak3 inhibitor, kidney transplantation
594938|NCT00556270|pain|pain
594939|NCT00556270|fentanyl|fentanyl
594940|NCT00556270|transdermal patch|transdermal patch
594941|NCT00556283|outlet obstruction|outlet obstruction
594942|NCT00556283|rectocele|rectocele
594943|NCT00556335|manual aspiration|manual aspiration
594944|NCT00556335|conventional|conventional
594945|NCT00556335|length of stay|length of stay
594946|NCT00556348|bevacizumab|bevacizumab
594948|NCT00556348|Complications|complications
594949|NCT00556348|Visual acuity|visual acuity
594950|NCT00556348|OCt|oct
594951|NCT00556348|Age Macular Degeneration|age macular degeneration
594952|NCT00556374|confirmed adenocarcinoma|confirmed adenocarcinoma
594953|NCT00556374|non-metastatic breast cancer|non-metastatic breast cancer
594954|NCT00556374|estrogen receptor positive|estrogen receptor positive
594955|NCT00556374|progesterone receptor positive|progesterone receptor positive
594956|NCT00556374|non-steroidal aromatase|non-steroidal aromatase
594957|NCT00556374|aromatase inhibitor therapy|aromatase inhibitor therapy
594958|NCT00556374|postmenopausal woman|postmenopausal woman
594959|NCT00556374|adjuvant chemotherapy|adjuvant chemotherapy
594960|NCT00556374|neoadjuvant chemotherapy|neoadjuvant chemotherapy
594961|NCT00556387|traumatic brain injury|traumatic brain injury
594962|NCT00556400|Uterine Bleeding|uterine bleeding
594963|NCT00556400|Thrombocytopenia|thrombocytopenia
594964|NCT00556400|Aplastic Anemia|aplastic anemia
594965|NCT00556400|Oral Contraceptive Pills|oral contraceptive pills
594966|NCT00556400|Menorrhagia|menorrhagia
594967|NCT00556413|stage IV colon cancer|stage iv colon cancer
594968|NCT00556413|stage IV rectal cancer|stage iv rectal cancer
594969|NCT00556413|recurrent colon cancer|recurrent colon cancer
594970|NCT00556413|recurrent rectal cancer|recurrent rectal cancer
594971|NCT00556426|Venous Thromboembolic Disease|venous thromboembolic disease
594972|NCT00556426|IVC Filter|ivc filter
594973|NCT00556426|Pulmonary Embolism|pulmonary embolism
594974|NCT00556439|Vasculitis|vasculitis
594975|NCT00556439|Arteritis|arteritis
594976|NCT00556439|Takayasu's|takayasu's
594977|NCT00556439|Temporal Arteritis|temporal arteritis
594978|NCT00556439|Abatacept|abatacept
594979|NCT00556465|diabetic nephropathy|diabetic nephropathy
594980|NCT00556465|proteinuria|proteinuria
594981|NCT00556465|antioxidant|antioxidant
594982|NCT00556478|Premature Ejaculation|premature ejaculation
594983|NCT00556478|Lidocaine|lidocaine
594984|NCT00556478|Prilocaine|prilocaine
594985|NCT00556478|EMLA® cream|emla® cream
594986|NCT00556478|topical anesthetics|topical anesthetics
594987|NCT00559481|recurrent prostate cancer|recurrent prostate cancer
594988|NCT00559494|complete spinal cord injury|complete spinal cord injury
594989|NCT00559494|incomplete spinal cord injury|incomplete spinal cord injury
594990|NCT00559494|central cord spinal cord injury|central cord spinal cord injury
594991|NCT00559494|traumatic|traumatic
594992|NCT00559520|Patients|patients
594993|NCT00559520|Suffering|suffering
594994|NCT00559520|Undernutrition|undernutrition
594995|NCT00559520|Requiring|requiring
594996|NCT00559520|Vascular|vascular
594997|NCT00559520|Surgery|surgery
594998|NCT00559559|Primary and secondary prevention for ventricular tachycardia|primary and secondary prevention for ventricular tachycardia
594999|NCT00559572|Exercise|exercise
595000|NCT00559572|Group Counseling|group counseling
595001|NCT00559572|Obesity|obesity
595002|NCT00559598|pancreatic cancer|pancreatic cancer
595003|NCT00559598|extrahepatic bile duct cancer|extrahepatic bile duct cancer
595004|NCT00559611|Non-Small Lung Cancer|non-small lung cancer
595005|NCT00559611|Lung Cancer|lung cancer
595006|NCT00559611|Endobronchial Ultrasound|endobronchial ultrasound
595007|NCT00559611|Fine Needle Aspiration|fine needle aspiration
595008|NCT00559611|Mediastinoscopy|mediastinoscopy
595009|NCT00559611|EBUS-FNA|ebus-fna
595010|NCT00559611|EBUS|ebus
595011|NCT00559611|Needle Biopsy|needle biopsy
595012|NCT00559611|NSCLC|nsclc
595013|NCT00559624|safety|safety
595014|NCT00559624|tolerability|tolerability
595015|NCT00559624|dose-escalation|dose-escalation
595016|NCT00559650|Acute decompensated heart failure|acute decompensated heart failure
595017|NCT00559650|Double blind study,|double blind study,
595018|NCT00559650|BAY58-2667|bay58-2667
595019|NCT00559650|Soluble guanylate cyclase activator|soluble guanylate cyclase activator
595020|NCT00559663|Flavonoid|flavonoid
595021|NCT00559663|hsCRP|hscrp
595023|NCT00559663|LDL|ldl
595024|NCT00559663|platelet reactivity|platelet reactivity
595025|NCT00559676|recurrent colon cancer|recurrent colon cancer
595026|NCT00559676|stage IV colon cancer|stage iv colon cancer
595027|NCT00559676|recurrent rectal cancer|recurrent rectal cancer
595028|NCT00559676|stage IV rectal cancer|stage iv rectal cancer
595029|NCT00559689|asthma patients|asthma patients
595030|NCT00559689|well-controlled|well-controlled
595031|NCT00559702|natalizumab|natalizumab
595032|NCT00559702|multiple sclerosis|multiple sclerosis
595033|NCT00559702|Tysabri ®|tysabri ®
595034|NCT00559715|bevacizumab|bevacizumab
595035|NCT00559715|ranibizumab|ranibizumab
595036|NCT00559715|macular degeneration|macular degeneration
595037|NCT00559715|age-related|age-related
595038|NCT00559715|neovascular|neovascular
595039|NCT00559715|intravitreal injection|intravitreal injection
595040|NCT00559715|vision loss|vision loss
595041|NCT00559715|outpatient setting|outpatient setting
595042|NCT00559741|stage IV colon cancer|stage iv colon cancer
595043|NCT00559741|recurrent colon cancer|recurrent colon cancer
595044|NCT00559741|stage IV rectal cancer|stage iv rectal cancer
595045|NCT00559741|recurrent rectal cancer|recurrent rectal cancer
595046|NCT00559767|Kidney Function|kidney function
595048|NCT00559767|Association Analysis|association analysis
595049|NCT00559767|Polymorphisms|polymorphisms
595050|NCT00559767|Diabetes|diabetes
595051|NCT00559780|Resistance training|resistance training
595053|NCT00559780|hip-surgery|hip-surgery
595054|NCT00559806|immobilisation|immobilisation
595056|NCT00559806|resistance training|resistance training
595057|NCT00559806|atrophy|atrophy
595058|NCT00559806|The effect of immobilisation in elderly compared to young individuals|the effect of immobilisation in elderly compared to young individuals
595059|NCT00559819|Alcohol|alcohol
595060|NCT00559819|Driving|driving
595061|NCT00559819|Impairment|impairment
595062|NCT00559832|acute mountain sickness|acute mountain sickness
595063|NCT00559832|intermittent hypoxia|intermittent hypoxia
595064|NCT00559832|acclimatization|acclimatization
595065|NCT00559858|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
595066|NCT00559858|breast cancer|breast cancer
595067|NCT00559858|male breast cancer|male breast cancer
595068|NCT00559858|colon cancer|colon cancer
595069|NCT00559858|rectal cancer|rectal cancer
595070|NCT00559871|dyskinesia|dyskinesia
595071|NCT00559871|movement disorders|movement disorders
595072|NCT00559871|basal ganglia diseases|basal ganglia diseases
595073|NCT00559871|JP-1730|jp-1730
595074|NCT00559871|Parkinson|parkinson
595075|NCT00559871|end-of-dose wearing off|end-of-dose wearing off
595076|NCT00559871|fluctuations|fluctuations
595077|NCT00559884|pharmacokinetics,|pharmacokinetics,
595078|NCT00559884|healthy male and females,|healthy male and females,
595079|NCT00559884|pharmacodynamics|pharmacodynamics
595080|NCT00559897|bone metastases|bone metastases
595081|NCT00559897|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
595082|NCT00559897|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
595083|NCT00559897|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
595084|NCT00559962|LDL|ldl
595085|NCT00559962|hepatic fat|hepatic fat
595086|NCT00559975|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
595087|NCT00559988|Implanted Cardioverter Defibrillator|implanted cardioverter defibrillator
595088|NCT00559988|Cardiac Resynchronization Therapy Defibrillator|cardiac resynchronization therapy defibrillator
595089|NCT00559988|Home Monitoring|home monitoring
595090|NCT00559988|Oral Anticoagulation|oral anticoagulation
595091|NCT00560001|frail elderly|frail elderly
595092|NCT00560001|medication errors|medication errors
595093|NCT00560001|patient compliance & attitudes|patient compliance & attitudes
595094|NCT00560001|guideline adherence|guideline adherence
595095|NCT00560027|postpartum depression|postpartum depression
595096|NCT00560027|intimate partner violence|intimate partner violence
595097|NCT00560040|Troponin|troponin
595098|NCT00560040|Natriuretic Peptide, Brain|natriuretic peptide, brain
595099|NCT00560040|Exercise|exercise
595100|NCT00560040|Echocardiography|echocardiography
595101|NCT00560053|Multiple Myeloma|multiple myeloma
595102|NCT00560053|Alternating chemotherapy|alternating chemotherapy
595103|NCT00560053|Transplantation|transplantation
595104|NCT00560066|influenza|influenza
595105|NCT00560066|vaccine|vaccine
595106|NCT00560092|Magnesium|magnesium
595107|NCT00560092|Pain|pain
595108|NCT00560092|Morphine|morphine
595109|NCT00560092|Intrathecal|intrathecal
595110|NCT00560092|NMDA|nmda
595231|NCT00560794|immunotherapeutic treatment|immunotherapeutic treatment
595111|NCT00560092|Elective total hip replacement under intrathecal anesthesia|elective total hip replacement under intrathecal anesthesia
595112|NCT00560105|COPD|copd
595113|NCT00560118|recurrent melanoma|recurrent melanoma
595114|NCT00560118|stage IV melanoma|stage iv melanoma
595115|NCT00560157|ICU patients|icu patients
595116|NCT00560170|HMG-CoA Reductase Inhibitors|hmg-coa reductase inhibitors
595117|NCT00560170|endothelial function|endothelial function
595118|NCT00560170|HMG-CoA Reductase Inhibitors on vascular protection|hmg-coa reductase inhibitors on vascular protection
595119|NCT00560183|Acute|acute
595120|NCT00560183|Bunionectomy|bunionectomy
595121|NCT00560196|Neuropathic pain|neuropathic pain
595122|NCT00560196|Chronic pain|chronic pain
595123|NCT00560196|Depression|depression
595124|NCT00560196|Anxiety|anxiety
595125|NCT00560209|ONO-1101|ono-1101
595126|NCT00560209|Coronary Artery Disease|coronary artery disease
595127|NCT00560209|Multi-slice CT|multi-slice ct
595128|NCT00560222|randomized controlled trial|randomized controlled trial
595129|NCT00560222|lactoferrin|lactoferrin
595130|NCT00560222|children|children
595131|NCT00560222|diarrhea|diarrhea
595132|NCT00560222|malnutrition|malnutrition
595133|NCT00560222|growth|growth
595134|NCT00560248|Chest Pain|chest pain
595135|NCT00560248|STEMI|stemi
595136|NCT00560248|UA/NSTEMI|ua/nstemi
595137|NCT00560248|ACS|acs
595138|NCT00560248|Emergency Department|emergency department
595139|NCT00560261|Sickle cell disease;|sickle cell disease;
595140|NCT00560261|Lung capillary blood volume;|lung capillary blood volume;
595141|NCT00560261|Children|children
595142|NCT00560287|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
595143|NCT00560287|Non-invasive ventilation|non-invasive ventilation
595144|NCT00560287|Chronic Respiratory Failure|chronic respiratory failure
595145|NCT00560313|Meningococcal disease|meningococcal disease
595146|NCT00560313|prevention|prevention
595147|NCT00560313|vaccination|vaccination
595148|NCT00560326|Paediatric patients|paediatric patients
595149|NCT00560326|Tacrolimus|tacrolimus
595150|NCT00560326|Dermatitis, Atopic|dermatitis, atopic
595439|NCT00561587|quetiapine|quetiapine
595151|NCT00560339|Congestive Heart Failure|congestive heart failure
595152|NCT00560339|Implantable Defibrillators|implantable defibrillators
595153|NCT00560339|Intrathoracic Impedance|intrathoracic impedance
595154|NCT00560365|stage I colon cancer|stage i colon cancer
595155|NCT00560365|stage II colon cancer|stage ii colon cancer
595156|NCT00560365|stage III colon cancer|stage iii colon cancer
595157|NCT00560365|stage I rectal cancer|stage i rectal cancer
595158|NCT00560365|stage II rectal cancer|stage ii rectal cancer
595159|NCT00560365|stage III rectal cancer|stage iii rectal cancer
595160|NCT00560378|Tacrolimus|tacrolimus
595161|NCT00560378|Administration, topical|administration, topical
595162|NCT00560378|Drug safety|drug safety
595163|NCT00560378|Adults|adults
595164|NCT00560378|Children|children
595165|NCT00560443|bone fracture|bone fracture
595166|NCT00560443|ketorolac|ketorolac
595167|NCT00560443|tramadol|tramadol
595168|NCT00560456|Age, Snoring, Driving simulator, Sleep deprivation, chronic sleep restriction, objective and subjective sleepiness|age, snoring, driving simulator, sleep deprivation, chronic sleep restriction, objective and subjective sleepiness
595169|NCT00560469|Adipokines|adipokines
595170|NCT00560469|Inflammation|inflammation
595171|NCT00560469|Metabolic syndrome|metabolic syndrome
595172|NCT00560482|prostate|prostate
595173|NCT00560482|cancer|cancer
595174|NCT00560482|prostatic cancer|prostatic cancer
595175|NCT00560482|castrate-resistant prostate cancer (CRPC)|castrate-resistant prostate cancer (crpc)
595176|NCT00560495|stage I non-small cell lung cancer|stage i non-small cell lung cancer
595177|NCT00560495|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
595178|NCT00560495|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
595179|NCT00560495|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
595180|NCT00560495|adenocarcinoma of the lung|adenocarcinoma of the lung
595181|NCT00560495|adenosquamous cell lung cancer|adenosquamous cell lung cancer
595182|NCT00560495|large cell lung cancer|large cell lung cancer
595183|NCT00560495|squamous cell lung cancer|squamous cell lung cancer
595184|NCT00560521|CPAP|cpap
595185|NCT00560521|Tuberculosis|tuberculosis
595186|NCT00560521|Pleural effusion|pleural effusion
595187|NCT00560521|Physiotherapy|physiotherapy
595188|NCT00560534|Magnetic resonance|magnetic resonance
595189|NCT00560534|whole body|whole body
595190|NCT00560534|angiography|angiography
595191|NCT00560534|venous compression|venous compression
595192|NCT00560534|MRI|mri
595193|NCT00560560|Refractory Colorectal|refractory colorectal
595194|NCT00560560|Single arm|single arm
595195|NCT00560560|Phase 2|phase 2
595196|NCT00560586|sleep fragmentation|sleep fragmentation
595197|NCT00560586|apnea|apnea
595198|NCT00560586|hypoxia|hypoxia
595199|NCT00560599|MRSA|mrsa
595200|NCT00560599|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
595201|NCT00560599|Staphylococcus aureus|staphylococcus aureus
595202|NCT00560599|Skin Infections|skin infections
595203|NCT00560599|Body Decolonization|body decolonization
595204|NCT00560599|Environmental Decolonization|environmental decolonization
595205|NCT00560612|PTSD|ptsd
595206|NCT00560612|Paroxetine|paroxetine
595207|NCT00560612|Subthreshold|subthreshold
595208|NCT00560651|keratoconus|keratoconus
595209|NCT00560651|cornea|cornea
595210|NCT00560651|cross linking|cross linking
595211|NCT00560651|UV-light|uv-light
595212|NCT00560651|riboflavin|riboflavin
595213|NCT00560664|knee|knee
595214|NCT00560664|chondral defect|chondral defect
595215|NCT00560664|osteochondral defect|osteochondral defect
595216|NCT00560677|Schizophrenia|schizophrenia
595217|NCT00560677|PTSD|ptsd
595218|NCT00560677|Cognition|cognition
595219|NCT00560690|Hepatitis C|hepatitis c
595221|NCT00560690|Insulin Resistance|insulin resistance
595222|NCT00560729|elderly people|elderly people
595223|NCT00560755|Prevention of: measles, mumps, rubella and varicella|prevention of: measles, mumps, rubella and varicella
595224|NCT00560768|Risk stratification method, negative predictive value, fast ventricular arrhythmias, ICD|risk stratification method, negative predictive value, fast ventricular arrhythmias, icd
595225|NCT00560768|The negative predictive value of the T amplitude variance as a method for risk stratification for patients with an increased risk for SCD.|the negative predictive value of the t amplitude variance as a method for risk stratification for patients with an increased risk for scd.
595226|NCT00560781|PTSD|ptsd
595227|NCT00560781|Pregnenolone|pregnenolone
595228|NCT00560781|Cognition|cognition
595229|NCT00560794|Minimal Residual Disease|minimal residual disease
595230|NCT00560794|adult ALL|adult all
595478|NCT00561743|Multiple myeloma|multiple myeloma
595232|NCT00560794|anti-CD19 bispecific antibody derivative|anti-cd19 bispecific antibody derivative
595233|NCT00560794|Blinatumomab|blinatumomab
595234|NCT00560794|MT103|mt103
595235|NCT00560807|WAD II|wad ii
595236|NCT00560807|WAD III|wad iii
595237|NCT00560807|mobilization|mobilization
595238|NCT00560807|dosage|dosage
595239|NCT00560807|acute whiplash associated disorders (WAD) II and III (113) with a symptom duration of less than 30 days|acute whiplash associated disorders (wad) ii and iii (113) with a symptom duration of less than 30 days
595240|NCT00560807|neck pain|neck pain
595241|NCT00560820|β-thalassemia|β-thalassemia
595242|NCT00560820|transfusional iron overload|transfusional iron overload
595243|NCT00560820|renal function|renal function
595244|NCT00560820|renal biomarkers|renal biomarkers
595245|NCT00560820|deferasirox|deferasirox
595246|NCT00560846|Gastric cancer|gastric cancer
595247|NCT00560846|Esophageal cancer|esophageal cancer
595248|NCT00560846|Surgical complications|surgical complications
595249|NCT00560846|Immunonutrition|immunonutrition
595250|NCT00560859|Sleep disordered breathing|sleep disordered breathing
595251|NCT00560859|Sleep apnea|sleep apnea
595252|NCT00560859|Tonsillectomy|tonsillectomy
595253|NCT00560859|Adenoidectomy|adenoidectomy
595254|NCT00560859|Snoring|snoring
595255|NCT00560859|Neurobehavioral Manifestations|neurobehavioral manifestations
595256|NCT00560859|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
595257|NCT00560872|atrial flutter|atrial flutter
595258|NCT00560872|ablation|ablation
595259|NCT00560872|navigation|navigation
595260|NCT00560885|atrial fibrillation|atrial fibrillation
595262|NCT00560885|ablation|ablation
595263|NCT00560885|arrhythmia|arrhythmia
595264|NCT00560885|racing heart|racing heart
595265|NCT00560885|afib|afib
595266|NCT00560885|surgical ablation|surgical ablation
595267|NCT00560898|staining|staining
595268|NCT00560898|epithelial barrier function|epithelial barrier function
595269|NCT00560911|oral anticoagulation|oral anticoagulation
595270|NCT00560911|self-management|self-management
595271|NCT00560911|elderly patients|elderly patients
595272|NCT00560911|randomised controlled trial|randomised controlled trial
595273|NCT00560937|Schizophrenia|schizophrenia
595274|NCT00560937|Pregnenolone|pregnenolone
595275|NCT00560937|Cognition|cognition
595276|NCT00560937|Negative Symptoms|negative symptoms
595277|NCT00560963|Advanced or metastatic pancreas carcinoma|advanced or metastatic pancreas carcinoma
595278|NCT00560963|gemcitabine|gemcitabine
595279|NCT00560963|everolimus|everolimus
595280|NCT00560976|neutrophil gelatinase associated lipocalin|neutrophil gelatinase associated lipocalin
595281|NCT00560976|hemodialysis|hemodialysis
595282|NCT00560976|iron|iron
595283|NCT00560976|inflammation|inflammation
595284|NCT00560976|Oxidative Stress|oxidative stress
595285|NCT00560989|Chronic Beryllium Disease|chronic beryllium disease
595287|NCT00560989|Beryllium|beryllium
595288|NCT00560989|Genetic|genetic
595289|NCT00560989|Environmental|environmental
595290|NCT00561002|Influenza Vaccine|influenza vaccine
595291|NCT00561002|Influenza Virus|influenza virus
595292|NCT00561002|Orthomyxoviridae Infections|orthomyxoviridae infections
595293|NCT00561002|Fluzone®|fluzone®
595294|NCT00561015|Hepatitis C, Chronic|hepatitis c, chronic
595295|NCT00561015|Genotype 2|genotype 2
595296|NCT00561015|Genotype 3|genotype 3
595297|NCT00561015|Telaprevir|telaprevir
595298|NCT00561028|Atherosclerosis|atherosclerosis
595299|NCT00561028|Coronary artery disease|coronary artery disease
595300|NCT00561028|Chlamydia pneumoniae|chlamydia pneumoniae
595301|NCT00561028|Mycoplasma pneumoniae|mycoplasma pneumoniae
595302|NCT00561041|alcohol|alcohol
595303|NCT00561041|alcohol use disorder|alcohol use disorder
595304|NCT00561041|cognitive-behavioral therapy|cognitive-behavioral therapy
595305|NCT00561041|brief phone aftercare intervention|brief phone aftercare intervention
595306|NCT00561041|individual aftercare therapy|individual aftercare therapy
595307|NCT00561054|Coimbra|coimbra
595308|NCT00561054|NSCLC|nsclc
595309|NCT00561054|CETUXIMAB|cetuximab
595310|NCT00561067|Spinal cord injury|spinal cord injury
595311|NCT00561067|spinal shock|spinal shock
595312|NCT00561067|erythropoietin|erythropoietin
595313|NCT00561093|Hypoalbuminemia|hypoalbuminemia
595314|NCT00561093|Protein-energy malnutrition|protein-energy malnutrition
595315|NCT00561093|Inflammation|inflammation
595316|NCT00561093|Oxidative stress|oxidative stress
595317|NCT00561093|Chronic Kidney disease (CKD) stage 5|chronic kidney disease (ckd) stage 5
595318|NCT00561093|maintenance hemodialysis|maintenance hemodialysis
595319|NCT00561106|Bell´s palsy|bell´s palsy
595320|NCT00561106|prednisone|prednisone
595321|NCT00561106|valacyclovir|valacyclovir
595322|NCT00561119|maintenance chemotherapy|maintenance chemotherapy
595323|NCT00561119|metastatic or recurrent breast cancer|metastatic or recurrent breast cancer
595324|NCT00561119|gemcitabine|gemcitabine
595325|NCT00561119|paclitaxel(GP)|paclitaxel(gp)
595326|NCT00561132|vanadium|vanadium
595327|NCT00561132|insulin sensitivity|insulin sensitivity
595328|NCT00561132|impaired glucose tolerance|impaired glucose tolerance
595329|NCT00561132|triglycerides|triglycerides
595330|NCT00561145|Anorexia of ageing|anorexia of ageing
595331|NCT00561145|Anorexia of aging|anorexia of aging
595332|NCT00561145|Energy balance|energy balance
595333|NCT00561145|Elderly|elderly
595334|NCT00561184|H5N1 Pandemic|h5n1 pandemic
595335|NCT00561210|infections|infections
595336|NCT00561223|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
595337|NCT00561223|pulmonary hypertension|pulmonary hypertension
595338|NCT00561262|adenocarcinoma of the prostate|adenocarcinoma of the prostate
595339|NCT00561262|stage I prostate cancer|stage i prostate cancer
595340|NCT00561262|stage IIB prostate cancer|stage iib prostate cancer
595341|NCT00561262|stage IIA prostate cancer|stage iia prostate cancer
595342|NCT00561262|stage III prostate cancer|stage iii prostate cancer
595343|NCT00561288|Acetaminophen|acetaminophen
595344|NCT00561288|Social Psychology|social psychology
595345|NCT00561288|Affect|affect
595346|NCT00561288|Interpersonal Rejection|interpersonal rejection
595347|NCT00561314|sexual dysfunction|sexual dysfunction
595348|NCT00561314|urinary incontinence|urinary incontinence
595349|NCT00561314|adenocarcinoma of the prostate|adenocarcinoma of the prostate
595350|NCT00561314|stage I prostate cancer|stage i prostate cancer
595351|NCT00561314|stage IIB prostate cancer|stage iib prostate cancer
595352|NCT00561314|stage IIA prostate cancer|stage iia prostate cancer
595353|NCT00561327|hypertension|hypertension
595354|NCT00561327|angiotensin receptor blockers|angiotensin receptor blockers
595355|NCT00561327|peroxisome proliferator activated receptor gamma|peroxisome proliferator activated receptor gamma
595356|NCT00561340|ADHD|adhd
595357|NCT00561340|Growth|growth
595358|NCT00561340|Atomoxetine|atomoxetine
595359|NCT00561340|Pediasure|pediasure
595360|NCT00561353|Hepatitis C, Chronic|hepatitis c, chronic
595361|NCT00561353|Tibotec|tibotec
595362|NCT00561353|TMC435350-TiDP16-C201|tmc435350-tidp16-c201
595363|NCT00561353|TMC435350-C201|tmc435350-c201
595364|NCT00561353|TMC435|tmc435
595365|NCT00561353|PEGASYS (peginterferon alpha-2a, PegIFNα-2a)|pegasys (peginterferon alpha-2a, pegifnα-2a)
595366|NCT00561353|COPEGUS (ribavirin)|copegus (ribavirin)
595368|NCT00561366|Lou Gehrig's disease|lou gehrig's disease
595369|NCT00561379|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
595370|NCT00561379|not previously treated|not previously treated
595371|NCT00561392|Alzheimer's Disease|alzheimer's disease
595372|NCT00561392|Rivastigmine|rivastigmine
595373|NCT00561392|Patch|patch
595374|NCT00561405|Stroke|stroke
595375|NCT00561405|Walking|walking
595376|NCT00561405|Motor learning|motor learning
595377|NCT00561405|Skill acquisition|skill acquisition
595378|NCT00561418|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
595379|NCT00561418|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
595380|NCT00561418|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
595381|NCT00561418|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
595382|NCT00561418|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
595383|NCT00561418|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
595384|NCT00561418|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
595385|NCT00561418|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
595386|NCT00561418|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
595387|NCT00561418|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
595388|NCT00561418|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
595389|NCT00561418|small intestine lymphoma|small intestine lymphoma
595390|NCT00561418|anaplastic large cell lymphoma|anaplastic large cell lymphoma
595391|NCT00561431|CVVHDF Dose Study|cvvhdf dose study
595392|NCT00561444|Prostate Cancer|prostate cancer
595393|NCT00561444|Radical retropubic prostatectomy|radical retropubic prostatectomy
595394|NCT00561444|Robotic prostatectomy|robotic prostatectomy
595395|NCT00561444|Photon external beam radiation|photon external beam radiation
595396|NCT00561444|Photon external beam radiation with hormone therapy|photon external beam radiation with hormone therapy
595397|NCT00561444|Proton radiation|proton radiation
595398|NCT00561444|Radioisotopic implant|radioisotopic implant
595399|NCT00561444|Cryotherapy|cryotherapy
595400|NCT00561444|Quality of Life|quality of life
595401|NCT00561444|Questionnaire|questionnaire
595402|NCT00561444|Survey|survey
595403|NCT00561444|QOL|qol
595404|NCT00561457|Iliac|iliac
595405|NCT00561457|Artery|artery
595406|NCT00561457|Occlusive|occlusive
595407|NCT00561457|Stenosis|stenosis
595408|NCT00561470|colorectal cancer|colorectal cancer
595409|NCT00561470|metastatic|metastatic
595410|NCT00561470|anti-angiogenic|anti-angiogenic
595411|NCT00561470|irinotecan|irinotecan
595412|NCT00561470|5-FU|5-fu
595413|NCT00561470|FOLFIRI|folfiri
595414|NCT00561483|Acute heart failure|acute heart failure
595415|NCT00561483|cystatin C|cystatin c
595416|NCT00561483|renal failure|renal failure
595417|NCT00561483|biomarker|biomarker
595418|NCT00561496|HIV prevention|hiv prevention
595419|NCT00561496|Microbicides|microbicides
595420|NCT00561496|Pharmacokinetics|pharmacokinetics
595421|NCT00561496|vaginal biopsies|vaginal biopsies
595422|NCT00561522|Recurrence|recurrence
595423|NCT00561522|Metastasis|metastasis
595424|NCT00561522|Hepatocellular Carcinoma|hepatocellular carcinoma
595425|NCT00561522|Radical Hepatic Resection|radical hepatic resection
595426|NCT00561522|Drug Prevention|drug prevention
595427|NCT00561522|Capecitabine|capecitabine
595428|NCT00561522|Surgery|surgery
595432|NCT00561561|Schizophrenia|schizophrenia
595433|NCT00561561|Prepulse Inhibition|prepulse inhibition
595434|NCT00561561|Acoustic Startle|acoustic startle
595435|NCT00561574|elderly|elderly
595436|NCT00561574|randomized|randomized
595437|NCT00561574|double blind|double blind
595438|NCT00561587|novel antipsychotic|novel antipsychotic
595441|NCT00561587|psychopathology|psychopathology
595442|NCT00561600|Hip arthroplasty|hip arthroplasty
595443|NCT00561600|Acetabular cup replacement|acetabular cup replacement
595444|NCT00561600|Acetabulum arthroplasty|acetabulum arthroplasty
595445|NCT00561613|Diaphragm|diaphragm
595446|NCT00561613|postcoital test|postcoital test
595447|NCT00561613|SILCS|silcs
595448|NCT00561613|nonoxynol-9|nonoxynol-9
595449|NCT00561639|sepsis|sepsis
595450|NCT00561639|immunosuppressed|immunosuppressed
595451|NCT00561639|multiplex PCR|multiplex pcr
595452|NCT00561639|diagnosis|diagnosis
595453|NCT00561639|therapeutic|therapeutic
595454|NCT00561652|Low back pain|low back pain
595455|NCT00561652|Chiropractic|chiropractic
595456|NCT00561652|Exercise|exercise
595457|NCT00561652|Veterans|veterans
595458|NCT00561678|Postoperative Confusion|postoperative confusion
595459|NCT00561678|Postoperative Delirium|postoperative delirium
595460|NCT00561678|PD|pd
595461|NCT00561678|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
595462|NCT00561678|POCD|pocd
595463|NCT00561691|diffuse instrinsic ponitine glioma, brainstem|diffuse instrinsic ponitine glioma, brainstem
595464|NCT00561704|obese female|obese female
595465|NCT00561704|Type 2 Diabetes|type 2 diabetes
595466|NCT00561704|Diabetic Nephropathy|diabetic nephropathy
595467|NCT00561704|Glucose Metabolism|glucose metabolism
595468|NCT00561704|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
595469|NCT00561704|Adiponectin|adiponectin
595470|NCT00561717|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
595471|NCT00561717|Ragweed|ragweed
595472|NCT00561717|Pollen|pollen
595473|NCT00561717|Allergy|allergy
595474|NCT00561730|PPI (Proton Pump Inhibitor) therapy|ppi (proton pump inhibitor) therapy
595475|NCT00561730|Pantoprazole|pantoprazole
595476|NCT00561730|eGERD (Erosive Gastroesophageal Reflux Disease)|egerd (erosive gastroesophageal reflux disease)
595477|NCT00561730|NERD (Non-Erosive Reflux Disease)|nerd (non-erosive reflux disease)
595479|NCT00561743|response rate|response rate
595480|NCT00561743|peripheral stem cell transplant|peripheral stem cell transplant
595481|NCT00561743|safety|safety
595482|NCT00561743|tolerability|tolerability
595483|NCT00561756|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
595484|NCT00561756|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
595485|NCT00561756|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
595486|NCT00561756|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
595487|NCT00561756|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
595488|NCT00561756|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
595489|NCT00561756|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
595490|NCT00561756|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
595491|NCT00561756|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
595492|NCT00561769|poor responder|poor responder
595493|NCT00561769|growth hormone|growth hormone
595494|NCT00561769|luteal|luteal
595495|NCT00561782|Spinal Cord Injury Pain|spinal cord injury pain
595496|NCT00561782|Chronic Neuropathic Pain|chronic neuropathic pain
595497|NCT00561782|SCI Pain|sci pain
595498|NCT00561782|Pain, Chronic Neuropathic|pain, chronic neuropathic
595499|NCT00561782|Spectroscopy, Magnetic Resonance|spectroscopy, magnetic resonance
595500|NCT00561782|MRS|mrs
595501|NCT00561782|Traumatic Brain Injury Pain|traumatic brain injury pain
595502|NCT00561795|AGO|ago
595503|NCT00561795|Advanced,|advanced,
595504|NCT00561795|Gynaecologic cancer(s),|gynaecologic cancer(s),
595505|NCT00561795|Genetics|genetics
595506|NCT00561795|GW786034,|gw786034,
595507|NCT00561795|Pazopanib,|pazopanib,
595508|NCT00561808|PCO/PCOD|pco/pcod
595509|NCT00561808|IVM|ivm
595510|NCT00561808|Immature Oocytes|immature oocytes
595511|NCT00561821|elderly|elderly
595512|NCT00561821|randomized|randomized
595513|NCT00561821|placebo controlled|placebo controlled
595514|NCT00561834|non-arteritic ischemic optic neuropathy|non-arteritic ischemic optic neuropathy
595515|NCT00561834|ranibizumab|ranibizumab
595516|NCT00561834|naion|naion
595517|NCT00561860|Obstructive sleep apnea-hypopnea|obstructive sleep apnea-hypopnea
595518|NCT00561860|Telemedicine|telemedicine
752335|NCT01172548|KIT positive|kit positive
595519|NCT00561873|astrocytoma, glioblastoma, intrinsic pontine glioma|astrocytoma, glioblastoma, intrinsic pontine glioma
595520|NCT00561886|COPD|copd
595521|NCT00561886|lung function|lung function
595522|NCT00561886|dysnpea|dysnpea
595523|NCT00561899|safety|safety
595524|NCT00561899|tolerability|tolerability
595525|NCT00561899|efficacy|efficacy
595526|NCT00561899|intermittent prevetive treatment|intermittent prevetive treatment
595527|NCT00561899|children|children
598011|NCT00562705|SGA|sga
595528|NCT00561912|Renal Cell Carcinoma|renal cell carcinoma
595529|NCT00561912|Renal Cell Cancer|renal cell cancer
595530|NCT00561912|Clear Cell|clear cell
595531|NCT00561912|Kidney|kidney
595532|NCT00561912|Decitabine|decitabine
595533|NCT00561912|Dacogen|dacogen
595534|NCT00561912|5-Aza-Deoxycytidine|5-aza-deoxycytidine
595535|NCT00561912|Interferon Alfa-2b|interferon alfa-2b
595536|NCT00561912|Intron A®|intron a®
595538|NCT00561938|Confocal laser endomicroscopy|confocal laser endomicroscopy
595539|NCT00561938|cancerous and non-cancerous conditions|cancerous and non-cancerous conditions
595540|NCT00561938|tolerance|tolerance
595541|NCT00561938|intravenous fluorescein|intravenous fluorescein
595542|NCT00561938|Digestive symptoms or disease requiring an endoscopy procedure (upper GI endoscopy or colonoscopy) performed under general anaesthesia|digestive symptoms or disease requiring an endoscopy procedure (upper gi endoscopy or colonoscopy) performed under general anaesthesia
595543|NCT00551967|clinical outcomes|clinical outcomes
595544|NCT00551967|radiographic outcomes|radiographic outcomes
595545|NCT00551967|total hip arthroplasty|total hip arthroplasty
595546|NCT00551967|survivorship|survivorship
595547|NCT00551980|Headache|headache
595548|NCT00551980|Cervical Pain|cervical pain
595549|NCT00551980|Cognitive treatment|cognitive treatment
595550|NCT00551980|Relaxation|relaxation
595551|NCT00551980|Exercise|exercise
595552|NCT00551993|laparoscopy|laparoscopy
595553|NCT00551993|robot|robot
595554|NCT00551993|vaginal prolapse|vaginal prolapse
595555|NCT00551993|sacrocolpopexy|sacrocolpopexy
595556|NCT00551993|sacral colpopexy|sacral colpopexy
595557|NCT00552006|PTSD|ptsd
595558|NCT00552006|Treatment|treatment
595559|NCT00552006|Randomized Controlled Clinical Trial|randomized controlled clinical trial
595560|NCT00552006|Combat|combat
595561|NCT00552006|Child Soldiers|child soldiers
595562|NCT00552006|Dissemination|dissemination
595563|NCT00552006|Narrative Exposure Therapy|narrative exposure therapy
595564|NCT00552006|Africa|africa
595565|NCT00552045|epilepsy|epilepsy
595566|NCT00552045|localization-related epilepsy|localization-related epilepsy
595567|NCT00552045|idiopathic generalized epilepsy|idiopathic generalized epilepsy
595568|NCT00552045|infantile spasms|infantile spasms
595569|NCT00552045|Lennox-Gastaut syndrome|lennox-gastaut syndrome
595570|NCT00552045|polymicrogyria|polymicrogyria
595571|NCT00552045|periventricular heterotopias|periventricular heterotopias
595572|NCT00552045|malformations of cortical development|malformations of cortical development
595573|NCT00552045|phenome|phenome
595574|NCT00552045|genome|genome
595575|NCT00552045|genotype|genotype
595576|NCT00552045|phenotype|phenotype
595577|NCT00552058|CDP 870|cdp 870
595578|NCT00552058|Certolizumab Pegol|certolizumab pegol
595579|NCT00552058|CIMZIA ®|cimzia ®
595580|NCT00552058|Crohn's disease|crohn's disease
595581|NCT00552058|Induction|induction
595582|NCT00552058|Clinical remission|clinical remission
595583|NCT00552058|Clinical response|clinical response
595584|NCT00552071|Acromegaly|acromegaly
595585|NCT00552071|Octreotide LAR|octreotide lar
595586|NCT00552071|Ultrasound guidance|ultrasound guidance
595587|NCT00552084|Fish Oil|fish oil
595588|NCT00552188|Atherosclerosis|atherosclerosis
595589|NCT00552201|kidney transplantation|kidney transplantation
595590|NCT00552201|Tacrolimus|tacrolimus
595591|NCT00552201|P450 3A5 cytochrome|p450 3a5 cytochrome
595592|NCT00552201|genotype|genotype
595593|NCT00552214|Nucleic acid test|nucleic acid test
595594|NCT00552214|HIV-1|hiv-1
595595|NCT00552214|hepatitis|hepatitis
595596|NCT00552214|HBV|hbv
595597|NCT00552214|HCV|hcv
595598|NCT00552214|TMA|tma
595599|NCT00552214|HIV Seronegativity|hiv seronegativity
595600|NCT00552266|Methylphenidate|methylphenidate
595601|NCT00552266|Trichotillomania|trichotillomania
595602|NCT00552266|Attention deficit|attention deficit
595603|NCT00552279|HPV|hpv
595604|NCT00552279|cervical cancer|cervical cancer
595605|NCT00552279|papillomavirus|papillomavirus
595606|NCT00552279|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
595607|NCT00552292|metabolic syndrome|metabolic syndrome
595608|NCT00552292|hypertension|hypertension
595609|NCT00552292|obesity|obesity
595610|NCT00552292|dyslipidemia|dyslipidemia
595611|NCT00552292|hyperglycemia|hyperglycemia
595612|NCT00552292|cardiovascular complications|cardiovascular complications
595613|NCT00552344|CDP 870|cdp 870
595614|NCT00552344|Certolizumab Pegol|certolizumab pegol
595615|NCT00552344|CIMZIA|cimzia
595616|NCT00552344|Crohn's Disease|crohn's disease
595617|NCT00552344|Crohn Disease|crohn disease
595618|NCT00552344|CD Induction|cd induction
595619|NCT00552344|Induction|induction
595620|NCT00552344|Clinical response|clinical response
595621|NCT00552344|Clinical remission|clinical remission
595622|NCT00552383|Preterm Infant|preterm infant
595623|NCT00552383|Behaviour|behaviour
595624|NCT00552383|Developmental Care|developmental care
595625|NCT00552383|NIDCAP|nidcap
595626|NCT00552383|Family Centred Care|family centred care
595627|NCT00552383|Neurodevelopmental Outcome, preterm infant|neurodevelopmental outcome, preterm infant
595628|NCT00552396|multiple myeloma|multiple myeloma
595629|NCT00552396|Anti-KIR (1-7F9)|anti-kir (1-7f9)
595630|NCT00552409|Diabetes mellitus|diabetes mellitus
595631|NCT00552409|Type 2 diabetes|type 2 diabetes
595632|NCT00552409|Chronic kidney disease|chronic kidney disease
595633|NCT00552409|Diabetic kidney disease|diabetic kidney disease
595634|NCT00552409|Microalbuminuria|microalbuminuria
595635|NCT00552409|Albuminuria|albuminuria
595636|NCT00552409|Vitamin D|vitamin d
595637|NCT00552409|Cholecalciferol|cholecalciferol
595640|NCT00552409|Cardiovascular|cardiovascular
595641|NCT00552409|Clinical trial|clinical trial
595642|NCT00552409|Placebo|placebo
595643|NCT00552422|gastroparesis|gastroparesis
595644|NCT00552422|gastroesophageal reflux|gastroesophageal reflux
595645|NCT00552448|Pediatric, asthma, pediatric ICU|pediatric, asthma, pediatric icu
595646|NCT00552461|Pulmonary alveolar proteinosis|pulmonary alveolar proteinosis
595647|NCT00552461|Primary Pulmonary alveolar proteinosis|primary pulmonary alveolar proteinosis
595648|NCT00552461|Rituximab|rituximab
595649|NCT00552461|Idiopathic|idiopathic
595650|NCT00552461|Symptomatic|symptomatic
595651|NCT00552461|GM-CSF Antibody|gm-csf antibody
595652|NCT00552474|Parkinson disease|parkinson disease
595653|NCT00552474|Movement disorders|movement disorders
595654|NCT00552474|Deep Brain Stimulation|deep brain stimulation
595655|NCT00552474|Libra|libra
595656|NCT00552474|l-dopa|l-dopa
595657|NCT00552474|levodopa|levodopa
595658|NCT00552474|neuromodulation|neuromodulation
595659|NCT00552474|neurostimulation|neurostimulation
595660|NCT00552474|Electrical stimulation of the brain|electrical stimulation of the brain
595661|NCT00552474|STN|stn
595662|NCT00552474|Subthalamic nucleus|subthalamic nucleus
595663|NCT00552487|isolated ACTH deficiency|isolated acth deficiency
595664|NCT00552487|Hashimoto disease|hashimoto disease
595665|NCT00552487|Hashimoto thyroiditis|hashimoto thyroiditis
595666|NCT00552487|autoimmune thyroiditis|autoimmune thyroiditis
595667|NCT00552513|timing|timing
595668|NCT00552513|intervention|intervention
595669|NCT00552513|early|early
595670|NCT00552513|delayed|delayed
595671|NCT00552513|acute coronary syndromes|acute coronary syndromes
595672|NCT00552513|PCI|pci
595673|NCT00552513|angiography|angiography
595674|NCT00552513|Non ST-segment elevation myocardial infarction|non st-segment elevation myocardial infarction
595675|NCT00552513|unstable angina|unstable angina
595676|NCT00552526|Epilepsy|epilepsy
595677|NCT00552526|Children|children
595678|NCT00552526|Mental retardation|mental retardation
595679|NCT00552526|Ketogenic diet|ketogenic diet
595680|NCT00552526|Diet|diet
595681|NCT00552539|syphilis|syphilis
595682|NCT00552539|educational video|educational video
595683|NCT00552539|knowledge|knowledge
595684|NCT00552539|black|black
595685|NCT00552539|Hispanic|hispanic
595686|NCT00552552|cancer-related fatigue|cancer-related fatigue
595687|NCT00552552|self-management|self-management
595688|NCT00552552|patient education|patient education
595689|NCT00552552|cancer survivors|cancer survivors
595690|NCT00552552|chronic disease|chronic disease
595691|NCT00552565|IBS, IBS-D, R-verapamil, Arverpamil, Rezular|ibs, ibs-d, r-verapamil, arverpamil, rezular
595692|NCT00552578|drug dependence|drug dependence
595693|NCT00552578|substance abuse|substance abuse
595694|NCT00552578|substance use disorders|substance use disorders
595695|NCT00552578|myofascial pain syndrome|myofascial pain syndrome
595696|NCT00552578|neuralgia|neuralgia
595697|NCT00552578|back pain|back pain
595698|NCT00552591|family risk|family risk
595699|NCT00552591|behavior modification|behavior modification
595700|NCT00552591|lifestyle change|lifestyle change
595701|NCT00552591|prevention of CHD|prevention of chd
595702|NCT00552591|health care costs|health care costs
595703|NCT00552604|multiple sclerosis|multiple sclerosis
595704|NCT00552604|muscle stiffness|muscle stiffness
595705|NCT00552604|spasticity|spasticity
595706|NCT00552604|pain|pain
595707|NCT00552604|treatment|treatment
595708|NCT00552604|cannabinoids|cannabinoids
595709|NCT00552630|lead poisoning|lead poisoning
595710|NCT00552630|chelation|chelation
595711|NCT00552643|Recalcitrant ulcers|recalcitrant ulcers
595712|NCT00552643|Chronic wounds|chronic wounds
595713|NCT00552643|Venous insufficiency wounds|venous insufficiency wounds
595714|NCT00552643|Ulcers|ulcers
595715|NCT00552643|Exposed bones|exposed bones
595716|NCT00552643|Exposed Tendons|exposed tendons
595717|NCT00552643|Granulation tissue|granulation tissue
595718|NCT00552643|Polyheal 1|polyheal 1
595719|NCT00552643|Wound care|wound care
595720|NCT00552643|Wound healing|wound healing
595721|NCT00552643|Diabetic wounds healing|diabetic wounds healing
595722|NCT00552643|Post trauma|post trauma
595723|NCT00552643|Post surgery complication|post surgery complication
751770|NCT01170377|Dental treatment|dental treatment
751771|NCT01170377|Mental retardation|mental retardation
595724|NCT00552643|Recalcitrant wounds including venous, post-operative and post-traumatic chronic wounds with different etiologies including wounds with exposed bone and tendon.|recalcitrant wounds including venous, post-operative and post-traumatic chronic wounds with different etiologies including wounds with exposed bone and tendon.
595725|NCT00552656|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
595726|NCT00552656|Drug-eluting stents|drug-eluting stents
595727|NCT00552656|Treatment Outcome|treatment outcome
595728|NCT00552669|Drug Eluting Stents|drug eluting stents
595729|NCT00552669|Stents Bare Metal|stents bare metal
595730|NCT00552669|Stent Thrombosis|stent thrombosis
595731|NCT00552669|Coronary revascularization|coronary revascularization
595732|NCT00552669|Survival|survival
595734|NCT00552682|fibromialgy|fibromialgy
595735|NCT00552682|chronic fatigue syndrome|chronic fatigue syndrome
595736|NCT00552682|duloxetine|duloxetine
595737|NCT00552682|pain|pain
595738|NCT00552682|treatment experienced|treatment experienced
595739|NCT00552682|Fibromialgy in patients with HIV-1 infection|fibromialgy in patients with hiv-1 infection
595740|NCT00552695|intravenous catheter|intravenous catheter
595741|NCT00552695|emergency department|emergency department
595742|NCT00552695|pain|pain
595743|NCT00552708|COREG CR|coreg cr
595744|NCT00552721|Motor control|motor control
595745|NCT00552721|Spasticity|spasticity
595746|NCT00552734|Type 1 diabetes|type 1 diabetes
595747|NCT00552734|Improved glycemic control|improved glycemic control
595748|NCT00552734|Glucose excursions|glucose excursions
595749|NCT00552734|Target range glucose levels|target range glucose levels
595750|NCT00552734|Insulin guidance software|insulin guidance software
595751|NCT00552734|Advisor|advisor
595752|NCT00552747|fenofibrate|fenofibrate
595753|NCT00552747|coronary heart disease|coronary heart disease
595754|NCT00552747|mixed hyperlipidemia|mixed hyperlipidemia
595755|NCT00552773|SINUSITIS|sinusitis
595756|NCT00552773|CYCLAMEN|cyclamen
595757|NCT00552786|noise|noise
595758|NCT00552786|hearing loss|hearing loss
595759|NCT00552786|temporary threshold shift|temporary threshold shift
595760|NCT00552799|cellulitis|cellulitis
595761|NCT00552799|lymphoedema|lymphoedema
595762|NCT00552799|penicillin|penicillin
595763|NCT00552799|clinical trial|clinical trial
595764|NCT00552812|Aortic Coarctation|aortic coarctation
595765|NCT00552812|Heart Defects, Congenital|heart defects, congenital
595766|NCT00552812|Stents|stents
595767|NCT00552812|Heart Catheterization|heart catheterization
595768|NCT00552825|acute lymphoblastic leukemia|acute lymphoblastic leukemia
595769|NCT00552825|long-term lung function|long-term lung function
595770|NCT00552838|Antimicrobial prescribing|antimicrobial prescribing
595771|NCT00552838|Antimicrobial utilization|antimicrobial utilization
595772|NCT00552851|acromegaly|acromegaly
595773|NCT00552851|heart failure|heart failure
595774|NCT00552851|hypertrophy|hypertrophy
595775|NCT00552851|cardiomegaly|cardiomegaly
595776|NCT00552877|PCI|pci
595777|NCT00552877|Drug-eluting stent|drug-eluting stent
595778|NCT00552890|obesity|obesity
595779|NCT00552890|atkins|atkins
595780|NCT00552890|weight reduction|weight reduction
595781|NCT00552890|kidney function|kidney function
595782|NCT00552942|obesity|obesity
595783|NCT00552942|diabetes|diabetes
595784|NCT00552942|cytokines|cytokines
595785|NCT00552955|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
595786|NCT00552955|Abdominal Lymphangioleiomyomas|abdominal lymphangioleiomyomas
595787|NCT00552955|Chyle|chyle
595788|NCT00552955|Ascites|ascites
595789|NCT00552955|Tuberous Sclerosis Complex|tuberous sclerosis complex
595790|NCT00552955|LAM|lam
595791|NCT00552968|trauma|trauma
595792|NCT00552968|pain|pain
595793|NCT00552981|common cold|common cold
595794|NCT00552981|Finnish sauna|finnish sauna
595795|NCT00552981|rct|rct
595796|NCT00552994|Drug eluting stent|drug eluting stent
595797|NCT00552994|Diabetics|diabetics
595798|NCT00552994|Intravascular ultrasound|intravascular ultrasound
595799|NCT00552994|Pathophysiologic (neointimal hyperplasia and peri-stent remodeling)|pathophysiologic (neointimal hyperplasia and peri-stent remodeling)
595800|NCT00553007|Periodontal disease|periodontal disease
595801|NCT00553007|Metabolic Syndrome|metabolic syndrome
595802|NCT00553033|Patients must be candidable to liver resection|patients must be candidable to liver resection
595803|NCT00553046|ethics|ethics
595804|NCT00553046|COPD|copd
595805|NCT00553046|end of life|end of life
595806|NCT00553046|mechanical ventilation|mechanical ventilation
595807|NCT00553046|CRF home ventilated patients|crf home ventilated patients
595808|NCT00553059|nausea and vomiting|nausea and vomiting
595809|NCT00553059|unspecified adult solid tumor|unspecified adult solid tumor
595810|NCT00553059|Palonosetron|palonosetron
595811|NCT00553059|Dexamethasone|dexamethasone
595812|NCT00553072|Asphyxia|asphyxia
595813|NCT00553072|perinatal|perinatal
595814|NCT00553072|magnesium sulphate|magnesium sulphate
595815|NCT00553085|anxiety disorders|anxiety disorders
595816|NCT00553085|children|children
595817|NCT00553085|neurodevelopmental disorder|neurodevelopmental disorder
595818|NCT00553085|neurodevelopmental delay|neurodevelopmental delay
595819|NCT00553085|temperament|temperament
595820|NCT00553111|syphilis|syphilis
595821|NCT00553111|video education|video education
595822|NCT00553111|knowledge|knowledge
595823|NCT00553111|black|black
595824|NCT00553111|hispanic|hispanic
595825|NCT00553124|stage 0 bladder cancer|stage 0 bladder cancer
595826|NCT00553124|stage I bladder cancer|stage i bladder cancer
595827|NCT00553124|stage II bladder cancer|stage ii bladder cancer
595828|NCT00553124|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
595829|NCT00553137|oropharyngeal candidiasis|oropharyngeal candidiasis
595830|NCT00553150|adult gliosarcoma|adult gliosarcoma
595831|NCT00553150|adult giant cell glioblastoma|adult giant cell glioblastoma
595832|NCT00553150|adult glioblastoma|adult glioblastoma
595833|NCT00553150|adult anaplastic astrocytoma|adult anaplastic astrocytoma
595834|NCT00553150|adult diffuse astrocytoma|adult diffuse astrocytoma
595835|NCT00553150|adult pilocytic astrocytoma|adult pilocytic astrocytoma
596293|NCT00563927|T1-4N2-3M0|t1-4n2-3m0
595836|NCT00553150|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
595837|NCT00553163|Hypnotherapy|hypnotherapy
595838|NCT00553163|Prevention of relapse|prevention of relapse
595839|NCT00553163|ulcerative colitis|ulcerative colitis
595840|NCT00553176|Infliximab|infliximab
595841|NCT00553176|Immune disorder|immune disorder
595842|NCT00553176|Remicade|remicade
595843|NCT00553176|Registry|registry
595844|NCT00553176|Crohn's Disease|crohn's disease
595845|NCT00553189|PARP Inhibitor|parp inhibitor
595846|NCT00553189|Advanced Cancer|advanced cancer
595847|NCT00553189|Combination Therapy|combination therapy
595848|NCT00553189|Early Trial|early trial
595849|NCT00553189|DNA Damage Repair|dna damage repair
595850|NCT00553189|Topotecan|topotecan
595851|NCT00553189|Cancer|cancer
595852|NCT00553189|Solid Tumor|solid tumor
595853|NCT00553189|Lymphoma|lymphoma
595854|NCT00553202|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
595855|NCT00553202|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
595856|NCT00553215|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
595857|NCT00553215|stage 0 bladder cancer|stage 0 bladder cancer
595858|NCT00553215|stage I bladder cancer|stage i bladder cancer
595859|NCT00553215|stage II bladder cancer|stage ii bladder cancer
595860|NCT00553228|maternal immunization|maternal immunization
595861|NCT00553228|whooping cough|whooping cough
595862|NCT00553228|pertussis|pertussis
595863|NCT00553241|TIA|tia
595864|NCT00553241|prognosis|prognosis
595865|NCT00553241|evaluation|evaluation
595866|NCT00553241|management|management
595867|NCT00553293|infertility|infertility
595868|NCT00553293|in vitro fertilization|in vitro fertilization
595869|NCT00553293|LH supplementation|lh supplementation
595870|NCT00553293|Benefits|benefits
595871|NCT00553319|ADHD|adhd
595872|NCT00553319|Cocaine|cocaine
595873|NCT00553319|Treatment|treatment
595874|NCT00553345|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
595875|NCT00553345|stage 0 bladder cancer|stage 0 bladder cancer
595876|NCT00553345|stage I bladder cancer|stage i bladder cancer
595877|NCT00553358|Lapatinib|lapatinib
595878|NCT00553358|ErbB2+|erbb2+
595879|NCT00553358|Early Breast Cancer|early breast cancer
595880|NCT00553358|Neoadjuvant|neoadjuvant
595881|NCT00553371|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
595882|NCT00553371|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
595883|NCT00553384|smell|smell
595884|NCT00553384|olfaction|olfaction
595885|NCT00553384|androstadienone|androstadienone
595886|NCT00553384|women|women
595887|NCT00553384|pheromones|pheromones
595888|NCT00553384|Healthy Volunteers|healthy volunteers
595889|NCT00553384|Physiological Effects of Androstadienone Exposure|physiological effects of androstadienone exposure
595890|NCT00553397|Living donor lung transplant|living donor lung transplant
595891|NCT00553397|End stage lung disease|end stage lung disease
595892|NCT00553410|stage IA breast cancer|stage ia breast cancer
595893|NCT00553410|stage IB breast cancer|stage ib breast cancer
595894|NCT00553410|stage II breast cancer|stage ii breast cancer
595895|NCT00553410|stage IIIA breast cancer|stage iiia breast cancer
595896|NCT00553436|colon|colon
595897|NCT00553436|rectum|rectum
595898|NCT00553436|polyp|polyp
595899|NCT00553436|EMR|emr
595900|NCT00553436|Established indication for a procedure greater than colonoscopy and colonic polypectomy|established indication for a procedure greater than colonoscopy and colonic polypectomy
595901|NCT00553449|nocturnal heartburn|nocturnal heartburn
595902|NCT00553449|day-time heartburn|day-time heartburn
595903|NCT00553449|rabeprazole|rabeprazole
595904|NCT00553449|GERD|gerd
595905|NCT00553462|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
595906|NCT00553462|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
595907|NCT00553462|adenocarcinoma of the lung|adenocarcinoma of the lung
595908|NCT00553462|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
595909|NCT00553462|large cell lung cancer|large cell lung cancer
595910|NCT00553462|squamous cell lung cancer|squamous cell lung cancer
595911|NCT00553488|diabetes|diabetes
595912|NCT00553488|insulin|insulin
595914|NCT00553488|intra-dermal|intra-dermal
595915|NCT00553488|blood glucose|blood glucose
595916|NCT00553501|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
595917|NCT00553501|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
595918|NCT00553501|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
595919|NCT00553501|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
595920|NCT00553501|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
595921|NCT00553501|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
595922|NCT00553501|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
595923|NCT00553501|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
595924|NCT00553501|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
595925|NCT00553514|Infertility|infertility
595926|NCT00553514|Oligo-anovulation|oligo-anovulation
595927|NCT00553514|GONAL-f®|gonal-f®
595928|NCT00553514|AS900672-Enriched|as900672-enriched
595929|NCT00553514|hyperglycosylated recombinant human follicle stimulating hormone (r-hFSH)|hyperglycosylated recombinant human follicle stimulating hormone (r-hfsh)
595930|NCT00553540|backache|backache
595931|NCT00553540|low backpain|low backpain
595932|NCT00553540|sciatica|sciatica
595933|NCT00553553|Intrathecal morphine ITM intravenous morphine remifentanil hepatic resection|intrathecal morphine itm intravenous morphine remifentanil hepatic resection
595934|NCT00553553|Adult|adult
595935|NCT00553553|ASA I-III (stable)|asa i-iii (stable)
595936|NCT00553553|Liver dysfunction requiring primary parenchymal resection|liver dysfunction requiring primary parenchymal resection
595937|NCT00553566|stage 0 bladder cancer|stage 0 bladder cancer
595938|NCT00553566|stage I bladder cancer|stage i bladder cancer
595939|NCT00553566|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
595940|NCT00553579|contrast sensitivity, retention time|contrast sensitivity, retention time
595941|NCT00553605|Renal Colic Pain Urinary Tract Colic|renal colic pain urinary tract colic
595942|NCT00561977|Nutrition|nutrition
595943|NCT00561977|Dietary Quality|dietary quality
595944|NCT00561977|Weight loss|weight loss
595945|NCT00561990|pancreatic cancer|pancreatic cancer
595946|NCT00562003|Ovarian cancer study|ovarian cancer study
595947|NCT00562016|Patient undergoing scheduled PCI|patient undergoing scheduled pci
595948|NCT00562029|Diabetes Mellitus|diabetes mellitus
595949|NCT00562029|Surgery|surgery
595950|NCT00562029|Duodenal Bypass|duodenal bypass
595951|NCT00562029|Resolution|resolution
595952|NCT00562029|Surgical Procedures|surgical procedures
595953|NCT00562042|pulmonary embolism|pulmonary embolism
595954|NCT00562042|risk stratification|risk stratification
595955|NCT00562042|prognosis|prognosis
595956|NCT00562042|troponin|troponin
595957|NCT00562042|Brain natriuretic peptide|brain natriuretic peptide
595958|NCT00562042|echocardiogram|echocardiogram
595959|NCT00562068|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
595960|NCT00562068|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
595961|NCT00562068|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
595962|NCT00562068|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
595963|NCT00562068|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
595964|NCT00562068|anaplastic large cell lymphoma|anaplastic large cell lymphoma
595965|NCT00562068|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
595966|NCT00562068|small intestine lymphoma|small intestine lymphoma
595967|NCT00562068|peripheral T-cell lymphoma|peripheral t-cell lymphoma
595968|NCT00562081|asthma|asthma
595969|NCT00562081|Virtual Asthma Clinic|virtual asthma clinic
595970|NCT00562081|metabolites|metabolites
595971|NCT00562081|asthma education|asthma education
595972|NCT00562094|Pantoprazole|pantoprazole
595973|NCT00562094|eGERD (Erosive Gastroesophageal Reflux Disease)|egerd (erosive gastroesophageal reflux disease)
595974|NCT00562094|NERD (Non-Erosive Reflux Disease)|nerd (non-erosive reflux disease)
595975|NCT00562094|sleep disorders|sleep disorders
595976|NCT00562107|Minimized ventricular pacing, clinical outcome, SafeR, AAIsafeR, dual chamber pacemaker therapy, % of ventricular pacing, hospitalizations, symptomatic AF|minimized ventricular pacing, clinical outcome, safer, aaisafer, dual chamber pacemaker therapy, % of ventricular pacing, hospitalizations, symptomatic af
595977|NCT00562146|nutrition|nutrition
595978|NCT00562146|enteral access|enteral access
595979|NCT00562159|rhinoconjunctivitis|rhinoconjunctivitis
595980|NCT00562159|rhinitis|rhinitis
595981|NCT00562159|conjunctivitis|conjunctivitis
595982|NCT00562159|allergy|allergy
595983|NCT00562159|allergen|allergen
595984|NCT00562159|immunotherapy|immunotherapy
595985|NCT00562185|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
595986|NCT00562185|ovarian sarcoma|ovarian sarcoma
595987|NCT00562185|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
595988|NCT00562185|ovarian stromal cancer|ovarian stromal cancer
595989|NCT00562211|children|children
595990|NCT00562224|PCI-24781|pci-24781
595991|NCT00562224|Neoplasms by site|neoplasms by site
595992|NCT00562224|Lymphoma, non-hodgkin|lymphoma, non-hodgkin
595993|NCT00562224|Hodgkin disease|hodgkin disease
595994|NCT00562224|Multiple myeloma|multiple myeloma
595995|NCT00562224|Leukemia, lymphocytic, chronic|leukemia, lymphocytic, chronic
595996|NCT00562237|immunogenicity|immunogenicity
595997|NCT00562237|safety|safety
595998|NCT00562237|adjuvanted pandemic vaccine|adjuvanted pandemic vaccine
595999|NCT00562263|overweight|overweight
596000|NCT00562263|obesity|obesity
596001|NCT00562263|adolescent|adolescent
596002|NCT00562263|insulin resistance|insulin resistance
596003|NCT00562263|treatment|treatment
596004|NCT00562276|IUD|iud
598012|NCT00562705|IGHD|ighd
596005|NCT00562276|insertion timing|insertion timing
596006|NCT00562289|Stroke|stroke
596007|NCT00562289|Patent Foramen Ovale|patent foramen ovale
596008|NCT00562289|Atrial septal aneurysm|atrial septal aneurysm
596009|NCT00562289|Antiplatelet therapy|antiplatelet therapy
596010|NCT00562289|Oral anticoagulants|oral anticoagulants
596011|NCT00562289|Transcatheter closure|transcatheter closure
596012|NCT00562289|Migraine|migraine
596013|NCT00562302|lung biopsy|lung biopsy
596014|NCT00562848|gastric emptying|gastric emptying
596015|NCT00562848|pharmacokinetic|pharmacokinetic
596016|NCT00562848|tolerability|tolerability
596017|NCT00562848|safety|safety
596018|NCT00562848|GSK962040|gsk962040
596019|NCT00562848|gut motility|gut motility
596020|NCT00562848|First Time in Human|first time in human
596021|NCT00562861|Bipolar Disorder|bipolar disorder
596022|NCT00562861|Bipolar Depression|bipolar depression
596023|NCT00562861|Clinical Trials, Phase II|clinical trials, phase ii
596024|NCT00562861|Clinical Pharmacology|clinical pharmacology
596025|NCT00562874|HIV|hiv
596026|NCT00562874|AIDS|aids
596027|NCT00562874|WOMEN|women
596028|NCT00562874|KENYA|kenya
596029|NCT00562874|NUTRITION|nutrition
596030|NCT00562874|HIV/AIDS|hiv/aids
596031|NCT00562874|treatment naive|treatment naive
596032|NCT00562887|Crohn's Disease|crohn's disease
596033|NCT00562913|Cancer|cancer
596034|NCT00562913|Sorafenib|sorafenib
596035|NCT00562913|Cyclophosphamide|cyclophosphamide
596036|NCT00562913|Doxorubicin|doxorubicin
596037|NCT00562926|Schizophrenia|schizophrenia
596038|NCT00562926|Schizophrenia spectrum disorder|schizophrenia spectrum disorder
596039|NCT00562939|Antibody Formation|antibody formation
596040|NCT00562939|Antibody Affinity|antibody affinity
596041|NCT00562939|Immunity|immunity
596042|NCT00562939|Pneumococcal Vaccines|pneumococcal vaccines
596043|NCT00562939|Oligodeoxyribonucleotides|oligodeoxyribonucleotides
596044|NCT00562952|Natriuretic peptide|natriuretic peptide
596045|NCT00562952|Prognosis|prognosis
596046|NCT00562952|Diabetes|diabetes
596047|NCT00562952|Heart failure|heart failure
596048|NCT00562952|Heart disease|heart disease
596049|NCT00562978|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
596050|NCT00562978|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
596051|NCT00562978|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
596052|NCT00562978|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
596053|NCT00562978|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
596054|NCT00562978|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
596055|NCT00562978|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
596056|NCT00562978|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
596057|NCT00562978|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
596058|NCT00562978|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
596059|NCT00562978|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
596060|NCT00562978|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
596061|NCT00562978|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
596062|NCT00562978|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
596063|NCT00562978|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
596064|NCT00562978|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
596065|NCT00562978|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
596066|NCT00562978|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
596067|NCT00562978|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
596068|NCT00562978|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
596069|NCT00562978|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
596070|NCT00562978|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
596071|NCT00562978|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
596072|NCT00562978|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
596073|NCT00562991|exhaled NO|exhaled no
596074|NCT00562991|asthma|asthma
596075|NCT00562991|child|child
596076|NCT00563004|Diabetes mellitus|diabetes mellitus
596077|NCT00563004|Herbal treatment|herbal treatment
596078|NCT00563004|Food supplement|food supplement
596079|NCT00563017|Catatonic Schizophrenia|catatonic schizophrenia
596080|NCT00563017|Disorganized Schizophrenia|disorganized schizophrenia
596081|NCT00563017|Paranoid Schizophrenia|paranoid schizophrenia
596082|NCT00563017|Undifferentiated Schizophrenia|undifferentiated schizophrenia
596083|NCT00563017|Schizo-affective disorders|schizo-affective disorders
596084|NCT00563030|Cardiopulmonary bypass|cardiopulmonary bypass
596086|NCT00563030|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
596087|NCT00563043|Pattern Scan Laser.|pattern scan laser.
596088|NCT00563043|Photocoagulation.|photocoagulation.
596089|NCT00563043|Diabetic retinopathy treatment.|diabetic retinopathy treatment.
596090|NCT00563043|Laser treatment.|laser treatment.
598013|NCT00562705|MPHD|mphd
596091|NCT00563043|Electroretinogram.|electroretinogram.
596092|NCT00563043|a wave.|a wave.
596093|NCT00563043|b wave.|b wave.
596094|NCT00563043|Implicit time.|implicit time.
596095|NCT00563056|Formoterol|formoterol
596096|NCT00563056|Fluticasone|fluticasone
596097|NCT00563056|Asthma|asthma
596098|NCT00563069|diagnostic and therapeutic rigid cystoscopy|diagnostic and therapeutic rigid cystoscopy
596099|NCT00563082|SLE|sle
596100|NCT00563082|Genetics|genetics
596101|NCT00563095|Hepatocellular carcinoma|hepatocellular carcinoma
596102|NCT00563108|Acute graft-versus-host disease post allogeneic stem cell transplantation|acute graft-versus-host disease post allogeneic stem cell transplantation
596103|NCT00563121|Retinopathy of Prematurity|retinopathy of prematurity
596104|NCT00563121|ROP|rop
596105|NCT00563121|Vascular Endothelial Growth Factor|vascular endothelial growth factor
596106|NCT00563121|VEGF|vegf
596107|NCT00563121|Vitreous|vitreous
596108|NCT00563121|Subretinal Fluid|subretinal fluid
596109|NCT00563121|ELISA|elisa
596110|NCT00563121|VEGF levels in Aqueous, Vitreous and subretinal Fluid|vegf levels in aqueous, vitreous and subretinal fluid
596111|NCT00563134|Suspected or confirmed severe Gram-negative sepsis|suspected or confirmed severe gram-negative sepsis
596112|NCT00563147|tivozanib|tivozanib
596113|NCT00563147|AV-951|av-951
596114|NCT00563160|lung cancer|lung cancer
596115|NCT00563186|infection control|infection control
596116|NCT00563186|nosocomial infection|nosocomial infection
596117|NCT00563186|hospital design|hospital design
596118|NCT00563186|physical plant design|physical plant design
596119|NCT00563186|antibiotic resistant organisms|antibiotic resistant organisms
596120|NCT00563199|smoking cessation|smoking cessation
596121|NCT00563199|smoking behaviors|smoking behaviors
596122|NCT00563212|Lung Diseases, Interstitial|lung diseases, interstitial
596123|NCT00563212|Fibrosis|fibrosis
596124|NCT00563212|Interferons|interferons
596125|NCT00563212|Pulmonary Fibrosis|pulmonary fibrosis
596126|NCT00563212|Pathologic Processes|pathologic processes
596127|NCT00563212|Lung Diseases|lung diseases
596128|NCT00563212|Fibrosing alveolitis|fibrosing alveolitis
596129|NCT00563212|Interferon-gamma, Recombinant|interferon-gamma, recombinant
596130|NCT00563212|Aerosols|aerosols
596131|NCT00563238|Extubation|extubation
596132|NCT00563251|Bronchiolitis obliterans in bone marrow transplant recipients|bronchiolitis obliterans in bone marrow transplant recipients
596133|NCT00563264|obesity|obesity
596134|NCT00563264|parenting|parenting
596135|NCT00563264|postpartum period|postpartum period
596136|NCT00563264|family research|family research
596137|NCT00563277|Pterygium|pterygium
596138|NCT00563277|Cataract|cataract
596139|NCT00563277|Intraocular lens power calculation accuracy|intraocular lens power calculation accuracy
596140|NCT00563316|colorectal cancer|colorectal cancer
596141|NCT00563316|chemotherapy|chemotherapy
596142|NCT00563316|cancer|cancer
596143|NCT00563316|metastatic|metastatic
596144|NCT00563316|irinotecan|irinotecan
596145|NCT00563316|EGFr|egfr
596146|NCT00563316|epidermal growth factor|epidermal growth factor
596147|NCT00563329|Smokers who are not willing to quit in the near future but intend to reduce smoking|smokers who are not willing to quit in the near future but intend to reduce smoking
596148|NCT00563342|Ethanol, lock solution, infection|ethanol, lock solution, infection
596149|NCT00563355|chronic kidney disease|chronic kidney disease
596150|NCT00563355|cardiovascular disease|cardiovascular disease
596151|NCT00563394|diabetic|diabetic
596152|NCT00563394|diabetes mellitus|diabetes mellitus
596153|NCT00563394|foot|foot
596154|NCT00563394|ulcers|ulcers
596155|NCT00563394|Floxin|floxin
596156|NCT00563394|oral antibiotic|oral antibiotic
596157|NCT00563394|topical cream|topical cream
596158|NCT00563407|skin toxicity prediction|skin toxicity prediction
596159|NCT00563407|cardiac toxicity prediction|cardiac toxicity prediction
596160|NCT00563420|Lung cancer|lung cancer
596161|NCT00563433|diabetic|diabetic
596162|NCT00563433|diabetes mellitus|diabetes mellitus
596163|NCT00563433|foot|foot
596164|NCT00563433|ulcers|ulcers
596165|NCT00563433|Floxin|floxin
596166|NCT00563433|oral antibiotic|oral antibiotic
596167|NCT00563433|topical cream|topical cream
596168|NCT00563446|Anemia|anemia
596169|NCT00563446|End-stage renal failure|end-stage renal failure
596170|NCT00563446|Continuous ambulatory peritoneal dialysis|continuous ambulatory peritoneal dialysis
596171|NCT00563459|Epilepsy, seizures|epilepsy, seizures
596172|NCT00563459|partial onset seizures|partial onset seizures
596173|NCT00563459|anti-epileptic drugs (AED)|anti-epileptic drugs (aed)
596174|NCT00563459|carisbamate|carisbamate
596175|NCT00563459|topiramate|topiramate
752336|NCT01172548|advanced GIST|advanced gist
596177|NCT00563472|Healthy female volunteers will participate in this study|healthy female volunteers will participate in this study
596178|NCT00563485|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
596179|NCT00563485|Acute Retention of Urine (AUR)|acute retention of urine (aur)
596180|NCT00563498|Veno-occlusive disease|veno-occlusive disease
596181|NCT00563498|Mucositis|mucositis
596182|NCT00563511|smoking cessation|smoking cessation
596183|NCT00563537|neurology|neurology
596184|NCT00563537|sclerosis|sclerosis
596185|NCT00563537|imaging|imaging
596186|NCT00563537|tomography|tomography
596187|NCT00563563|Nicotine-dependence in overweight and obese subjects|nicotine-dependence in overweight and obese subjects
596188|NCT00563576|Depo-Provera|depo-provera
596189|NCT00563576|Medroxyprogesterone Acetate|medroxyprogesterone acetate
596190|NCT00563576|Metrorrhagia|metrorrhagia
596191|NCT00563576|Irregular Bleeding|irregular bleeding
596192|NCT00563589|Acute graft-versus-host disease post high risk allogeneic stem cell transplantation|acute graft-versus-host disease post high risk allogeneic stem cell transplantation
596193|NCT00563602|Portal hypertension|portal hypertension
596194|NCT00563602|Prevention of rebleeding|prevention of rebleeding
596195|NCT00563602|Complications of cirrhosis|complications of cirrhosis
596196|NCT00563602|Portal hemodynamic|portal hemodynamic
596197|NCT00563602|Prazosine|prazosine
596198|NCT00563602|Nadolol|nadolol
596199|NCT00563602|isosorbide mononitrate|isosorbide mononitrate
596200|NCT00563615|Constipation (idiopathic)|constipation (idiopathic)
596201|NCT00563628|Pattern Scan Laser.|pattern scan laser.
596202|NCT00563628|Photocoagulation.|photocoagulation.
596203|NCT00563628|Diabetic retinopathy treatment.|diabetic retinopathy treatment.
596204|NCT00563628|Laser treatment|laser treatment
596205|NCT00563641|NCPAP|ncpap
596206|NCT00563641|Very early surfactant|very early surfactant
596207|NCT00563654|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
596208|NCT00563654|Acute Retention of Urine (AUR)|acute retention of urine (aur)
596209|NCT00563667|Pterygium|pterygium
596210|NCT00563667|Cataract|cataract
596211|NCT00563667|Astigmatism|astigmatism
596212|NCT00563680|AMG 479|amg 479
596213|NCT00563680|IGF-1R|igf-1r
596214|NCT00563680|Insulin-like growth factor|insulin-like growth factor
596215|NCT00563680|Insulin-like growth factor receptor|insulin-like growth factor receptor
596216|NCT00563680|Ewing's|ewing's
596217|NCT00563680|Sarcoma|sarcoma
596218|NCT00563693|heart failure|heart failure
596219|NCT00563693|cheyne stokes respiration|cheyne stokes respiration
596220|NCT00563693|adaptive servo ventilator|adaptive servo ventilator
596221|NCT00563745|COPD|copd
596222|NCT00563745|ALS|als
596223|NCT00563745|Telemedicine|telemedicine
596224|NCT00563745|mechanical ventilation|mechanical ventilation
596225|NCT00563745|Integrated care|integrated care
596226|NCT00563745|strict follow up|strict follow up
596227|NCT00563745|impact and costs on health care resources|impact and costs on health care resources
596228|NCT00563745|telemedicine programme|telemedicine programme
596229|NCT00563745|home mechanical ventilation (HMV)|home mechanical ventilation (hmv)
596230|NCT00563745|frail patients|frail patients
596231|NCT00563745|chronic respiratory failure (CRF)|chronic respiratory failure (crf)
596232|NCT00563758|Chronic constipation|chronic constipation
596233|NCT00563784|Non-Small Cell Lung Cancer|non-small cell lung cancer
596234|NCT00563784|Lung Cancer|lung cancer
596235|NCT00563784|Squamous Cell Carcinoma|squamous cell carcinoma
596236|NCT00563784|Adenocarcinoma|adenocarcinoma
596237|NCT00563784|Bronchoalveolar Cell Carcinoma|bronchoalveolar cell carcinoma
596238|NCT00563784|Large Cell Anaplastic Carcinoma|large cell anaplastic carcinoma
596239|NCT00563784|Giant Cell Carcinoma|giant cell carcinoma
596240|NCT00563784|Clear Cell Carcinoma|clear cell carcinoma
596241|NCT00563784|Erlotinib|erlotinib
596242|NCT00563784|Erlotinib Hydrocholoride|erlotinib hydrocholoride
596243|NCT00563784|OSI-774|osi-774
596244|NCT00563784|Tarceva|tarceva
596245|NCT00563784|Carboplatin|carboplatin
596246|NCT00563784|Paraplatin|paraplatin
596247|NCT00563784|Paclitaxel|paclitaxel
596248|NCT00563784|Taxol|taxol
596249|NCT00563784|NSCLC|nsclc
596250|NCT00563797|treatment|treatment
596251|NCT00563797|alcohol dependence|alcohol dependence
596252|NCT00563797|depression|depression
596253|NCT00563797|mecamylamine|mecamylamine
596254|NCT00563810|Adult|adult
596255|NCT00563810|Aged|aged
596256|NCT00563823|stage IV melanoma|stage iv melanoma
596257|NCT00563823|recurrent melanoma|recurrent melanoma
596258|NCT00563836|ovarian cancer|ovarian cancer
596259|NCT00563836|catumaxomab|catumaxomab
596260|NCT00563836|phase II|phase ii
596261|NCT00563836|intraoperative|intraoperative
596262|NCT00563836|adjuvant|adjuvant
596263|NCT00563836|trifunctional antibody|trifunctional antibody
596264|NCT00563862|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
596265|NCT00563862|T3-4N0-1M0|t3-4n0-1m0
596266|NCT00563875|Platelets|platelets
596267|NCT00563875|Platelet aggregation|platelet aggregation
596268|NCT00563875|Drug resistance|drug resistance
596269|NCT00563875|Aspirin|aspirin
596270|NCT00563875|Diabetes mellitus|diabetes mellitus
596271|NCT00563888|PTSD|ptsd
596272|NCT00563888|torture survivors|torture survivors
596273|NCT00563888|Narrative Exposure Therapy|narrative exposure therapy
596274|NCT00563888|trauma-related memory processes|trauma-related memory processes
596275|NCT00563888|steady state visual evoked fields|steady state visual evoked fields
596276|NCT00563901|CHD|chd
596277|NCT00563901|Combined CHD|combined chd
596278|NCT00563901|Stroke|stroke
596279|NCT00563901|Combined Cardiovascular Disease (CVD)|combined cardiovascular disease (cvd)
596280|NCT00563901|Pharmacogenetics|pharmacogenetics
596281|NCT00563901|End-Stage Renal Disease|end-stage renal disease
596282|NCT00563901|Heart Failure|heart failure
598324|NCT00569413|dopamine|dopamine
596283|NCT00563901|Hospitalized/Fatal Heart Failure|hospitalized/fatal heart failure
596284|NCT00563901|Angina|angina
596285|NCT00563901|Coronary Revascularizations|coronary revascularizations
596286|NCT00563901|CHD Mortality|chd mortality
596287|NCT00563901|Lisinopril|lisinopril
596288|NCT00563901|Chlorthalidone|chlorthalidone
596289|NCT00563901|Amlodipine|amlodipine
596290|NCT00563901|Doxazosin|doxazosin
596291|NCT00563914|Malaria|malaria
596292|NCT00563927|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
596294|NCT00563940|diabetic macular edema|diabetic macular edema
596295|NCT00563940|OCT|oct
596296|NCT00563953|Breast|breast
596297|NCT00563953|Cancer|cancer
596298|NCT00563953|Anthracyclines|anthracyclines
596299|NCT00563953|Cardiopathy|cardiopathy
596300|NCT00563966|smoking pregnancy behaviour polymorphisms|smoking pregnancy behaviour polymorphisms
596301|NCT00563979|age related macular degeneration|age related macular degeneration
596302|NCT00563979|supplementation|supplementation
596303|NCT00563979|macular pigment|macular pigment
596304|NCT00564005|stroke rehabilitation|stroke rehabilitation
596305|NCT00564005|cortical reorganization|cortical reorganization
596306|NCT00564005|kinematic analysis|kinematic analysis
596307|NCT00564018|type 1 diabetes, basal-bolus, honeymoon, C-peptide|type 1 diabetes, basal-bolus, honeymoon, c-peptide
596308|NCT00564031|hormone replacement therapy; endothelial function;|hormone replacement therapy; endothelial function;
596309|NCT00564044|biofilm-infection-related immune hyperreactivity|biofilm-infection-related immune hyperreactivity
596310|NCT00564044|mesh extrusion|mesh extrusion
596311|NCT00564044|mid-urethral sling|mid-urethral sling
596312|NCT00564044|determine the immune reactivity of biofilms in mesh erosion|determine the immune reactivity of biofilms in mesh erosion
596313|NCT00564057|HIV|hiv
596314|NCT00564057|blood pressure|blood pressure
596315|NCT00564057|left ventricle|left ventricle
596316|NCT00564057|metabolic profile|metabolic profile
596317|NCT00564057|treatment experienced|treatment experienced
596318|NCT00564070|Depression|depression
596319|NCT00564070|Diabetes|diabetes
596320|NCT00564070|Adherence|adherence
596321|NCT00564083|Compare the relative differences between the organic and sythentic materials for sacryl colpopexy.|compare the relative differences between the organic and sythentic materials for sacryl colpopexy.
596322|NCT00564122|Murmur|murmur
596323|NCT00564122|Artificial-Intelligence|artificial-intelligence
596324|NCT00564122|Stethoscope|stethoscope
596325|NCT00564122|Congenital Heart Disease|congenital heart disease
596326|NCT00564122|Structural Heart Disease|structural heart disease
596327|NCT00564135|hysterectomy|hysterectomy
596328|NCT00564135|laparoscopy|laparoscopy
596329|NCT00564135|urinary retention|urinary retention
596330|NCT00564135|urinary tract infection|urinary tract infection
596331|NCT00564135|catheterization|catheterization
596332|NCT00564148|antiVEGF therapy|antivegf therapy
596333|NCT00564174|recurrent pregnancy loss|recurrent pregnancy loss
596334|NCT00564174|lupus anticoagulant|lupus anticoagulant
596335|NCT00564174|anti cardiolipin antibodies|anti cardiolipin antibodies
596336|NCT00564174|thrombophilia|thrombophilia
596337|NCT00564174|low molecular weight heparin|low molecular weight heparin
596338|NCT00564174|aspirin|aspirin
596339|NCT00564174|randomized clinical trial|randomized clinical trial
596340|NCT00564200|Multiple Myeloma, transplant|multiple myeloma, transplant
596341|NCT00564213|Myopia|myopia
596342|NCT00564213|Mitomycin|mitomycin
596343|NCT00564226|urge urinary incontinence|urge urinary incontinence
596344|NCT00564265|GIST|gist
596345|NCT00564278|Hispanic Americans|hispanic americans
596346|NCT00564278|Major Depressive Disorder|major depressive disorder
596347|NCT00564278|Antidepressant Therapy|antidepressant therapy
596348|NCT00564278|Motivational Interviewing|motivational interviewing
596349|NCT00564278|Treatment Retention|treatment retention
596350|NCT00564278|Treatment Adherence|treatment adherence
596351|NCT00564291|OCT|oct
596352|NCT00564304|Nasal Potential Difference|nasal potential difference
596353|NCT00564317|PTSD|ptsd
596354|NCT00564317|Depression|depression
596355|NCT00564317|Suicidality|suicidality
596356|NCT00564317|trauma-focussed treatment|trauma-focussed treatment
596357|NCT00564317|KIDNET|kidnet
596358|NCT00564317|Narrative Exposure Therapy for Children|narrative exposure therapy for children
596359|NCT00564317|Meditation|meditation
596360|NCT00564317|Relaxation|relaxation
596361|NCT00564317|War|war
596362|NCT00564330|dental erosion|dental erosion
596363|NCT00564330|OCT|oct
596364|NCT00564330|proton pump inhibitor|proton pump inhibitor
596365|NCT00564343|Balance|balance
596366|NCT00564343|Water based training|water based training
596367|NCT00564343|Physical functioning|physical functioning
596368|NCT00564343|stepping behavior|stepping behavior
596369|NCT00564356|cataract, phacoemulsification, coumadin, antiaggregants|cataract, phacoemulsification, coumadin, antiaggregants
596370|NCT00564369|HIV testing|hiv testing
596371|NCT00564369|HIV Seronegativity|hiv seronegativity
596372|NCT00564382|Acute coronary syndrome|acute coronary syndrome
596373|NCT00564382|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
596374|NCT00564382|Contrast agents|contrast agents
596375|NCT00564382|Gadolinium|gadolinium
596376|NCT00564434|delirium|delirium
598616|NCT00570791|Tonopen|tonopen
596377|NCT00564434|pathophysiology|pathophysiology
596378|NCT00564434|risk factors|risk factors
596379|NCT00564434|pain|pain
596380|NCT00564434|dementia|dementia
596381|NCT00564473|internal medicine|internal medicine
596382|NCT00564473|herbal medicine|herbal medicine
596383|NCT00564473|prevalence|prevalence
596384|NCT00564473|attitudes|attitudes
596385|NCT00564473|herb-drug interaction|herb-drug interaction
596386|NCT00564486|Abdominal Laparoscopic Surgery|abdominal laparoscopic surgery
596387|NCT00564499|COPD|copd
596389|NCT00564499|General Practitioners|general practitioners
596390|NCT00564512|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
596391|NCT00564512|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
596392|NCT00564512|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
596393|NCT00564512|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
596394|NCT00564512|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
596395|NCT00564525|children|children
596396|NCT00564525|abdominal pain|abdominal pain
596397|NCT00564525|amitriptyline|amitriptyline
596398|NCT00564538|liver transplant|liver transplant
596399|NCT00564551|Prediabetes|prediabetes
596400|NCT00564551|Type 2 diabetes|type 2 diabetes
596401|NCT00564551|Metabolic syndrome|metabolic syndrome
596402|NCT00564551|Insulin resistance syndrome|insulin resistance syndrome
596403|NCT00564551|Weight loss|weight loss
596404|NCT00564551|Milk products|milk products
596405|NCT00564551|Calcium|calcium
596406|NCT00564564|obsessive compulsive disorder|obsessive compulsive disorder
596407|NCT00564564|pharmacological treatment|pharmacological treatment
596408|NCT00564564|quetiapine|quetiapine
596409|NCT00564564|clomipramine|clomipramine
596410|NCT00564564|SSRI|ssri
596411|NCT00564577|Diarrhea ETEC|diarrhea etec
596412|NCT00564603|Glucocorticoid|glucocorticoid
596413|NCT00564603|Opioids|opioids
596414|NCT00564603|Balanced analgesia|balanced analgesia
596415|NCT00564616|cardiac arrest|cardiac arrest
596416|NCT00564616|video cell phone|video cell phone
596417|NCT00564616|dispatcher-assisted CPR|dispatcher-assisted cpr
596418|NCT00564655|pediatrics|pediatrics
596419|NCT00564655|Gastric Tube Insertion|gastric tube insertion
596420|NCT00564655|Anesthesia|anesthesia
596421|NCT00564655|Regional Anesthetic|regional anesthetic
596422|NCT00564655|Transversus Abdominal Plane|transversus abdominal plane
596423|NCT00564694|adenocarcinoma of the colon|adenocarcinoma of the colon
596424|NCT00564694|recurrent colon cancer|recurrent colon cancer
596425|NCT00564694|stage I colon cancer|stage i colon cancer
596426|NCT00564694|stage II colon cancer|stage ii colon cancer
596427|NCT00564694|stage III colon cancer|stage iii colon cancer
596428|NCT00564694|stage IV colon cancer|stage iv colon cancer
596429|NCT00564694|adenocarcinoma of the rectum|adenocarcinoma of the rectum
596430|NCT00564694|recurrent rectal cancer|recurrent rectal cancer
596431|NCT00564694|stage I rectal cancer|stage i rectal cancer
596432|NCT00564694|stage II rectal cancer|stage ii rectal cancer
596433|NCT00564694|stage III rectal cancer|stage iii rectal cancer
596434|NCT00564694|stage IV rectal cancer|stage iv rectal cancer
596435|NCT00564746|SB-681323,|sb-681323,
596436|NCT00564746|ADME,|adme,
596437|NCT00564746|radiolabel|radiolabel
596438|NCT00564759|CGD|cgd
596439|NCT00564772|raltegravir|raltegravir
596440|NCT00564772|lopinavir|lopinavir
596441|NCT00564772|ritonavir|ritonavir
596442|NCT00564772|pharmacokinetics|pharmacokinetics
596443|NCT00564798|protocoladolescents|protocoladolescents
596444|NCT00564798|children|children
596445|NCT00564798|health behaviours/attitudes|health behaviours/attitudes
596446|NCT00564798|weight loss/management|weight loss/management
596447|NCT00564798|program evaluation|program evaluation
596448|NCT00564811|Agaricus blazei (Murrill) ss. Heinemann,|agaricus blazei (murrill) ss. heinemann,
596449|NCT00564811|Hepatitis C|hepatitis c
596450|NCT00564811|Nutritional status|nutritional status
596451|NCT00564811|Liver Function Tests|liver function tests
596452|NCT00564811|Antiviral Agents|antiviral agents
596453|NCT00564824|coronary disease|coronary disease
596454|NCT00564824|atherosclerosis|atherosclerosis
596455|NCT00564824|endothelial function|endothelial function
596456|NCT00564824|caffeine|caffeine
596457|NCT00564824|cerebrovascular disease|cerebrovascular disease
596458|NCT00564824|prevention|prevention
596459|NCT00564837|Anterior cruciate ligament|anterior cruciate ligament
596460|NCT00564837|Reconstruction|reconstruction
596461|NCT00564837|Rehabilitation|rehabilitation
596462|NCT00564837|Home-based|home-based
596463|NCT00564863|Diarrhea|diarrhea
596464|NCT00564863|ETEC|etec
596465|NCT00564876|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
596466|NCT00564876|carcinoma|carcinoma
596467|NCT00564876|dasatinib|dasatinib
596468|NCT00564876|neoadjuvant|neoadjuvant
596469|NCT00564876|adjuvant|adjuvant
596470|NCT00564876|resection|resection
596471|NCT00564876|genomic signature|genomic signature
596472|NCT00564876|predictor|predictor
596473|NCT00564876|microarray|microarray
596474|NCT00564889|primary systemic amyloidosis|primary systemic amyloidosis
598617|NCT00570791|Shiotz|shiotz
596475|NCT00564902|Macular Pigment Optical Density|macular pigment optical density
596476|NCT00564902|Skin Carotenoids|skin carotenoids
596477|NCT00564902|Lipofuscin|lipofuscin
596478|NCT00564902|Photostress (Glare Recovery)|photostress (glare recovery)
596479|NCT00564902|Visual Field Progression|visual field progression
596480|NCT00564902|Contrast Sensitivity|contrast sensitivity
596481|NCT00564902|Color Vision|color vision
596482|NCT00564902|Cognitive Function|cognitive function
596483|NCT00564915|Epilepsy|epilepsy
596484|NCT00564928|Hormone resistant prostate cancer|hormone resistant prostate cancer
596485|NCT00564928|castrate resistant prostate cancer|castrate resistant prostate cancer
596486|NCT00564928|HRPC|hrpc
596487|NCT00564928|CRPC|crpc
596488|NCT00564941|Myelodysplastic Syndromes|myelodysplastic syndromes
596489|NCT00564941|beta-Thalassemia|beta-thalassemia
596490|NCT00564941|Iron Overload|iron overload
596491|NCT00564941|Iron Chelating Agents|iron chelating agents
596492|NCT00564941|deferasirox|deferasirox
596493|NCT00564954|ADHD|adhd
596494|NCT00564954|children|children
596495|NCT00564954|laboratory classroom|laboratory classroom
596496|NCT00564954|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
596497|NCT00564980|Randomized|randomized
596498|NCT00564980|Prospective|prospective
596499|NCT00564980|Procedure / Surgery|procedure / surgery
596500|NCT00565032|postpartum depression|postpartum depression
596501|NCT00565032|thyroxine|thyroxine
596502|NCT00565032|thyroid antibodies|thyroid antibodies
596503|NCT00565032|thyroid stimulating hormone|thyroid stimulating hormone
596504|NCT00565032|Edinburgh Postnatal Depression Scale (EPDS)|edinburgh postnatal depression scale (epds)
596505|NCT00565045|hand|hand
596506|NCT00565045|stroke|stroke
596507|NCT00565045|hemiplegia|hemiplegia
596508|NCT00565045|electrical stimulation|electrical stimulation
596509|NCT00565045|recovery|recovery
596510|NCT00565071|Cost-effectiveness|cost-effectiveness
596511|NCT00565071|Diagnosis|diagnosis
596512|NCT00565071|Treatment|treatment
596513|NCT00565071|Malaria|malaria
596514|NCT00565097|Polycystic Liver Disease|polycystic liver disease
596515|NCT00565097|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
596516|NCT00565097|Liver cyst|liver cyst
596517|NCT00565097|Lanreotide|lanreotide
596518|NCT00565123|bacterial conjunctivitis levofloxacin fluoroquinolone|bacterial conjunctivitis levofloxacin fluoroquinolone
596519|NCT00565136|Device study|device study
596520|NCT00565136|Pelvic floor weakness|pelvic floor weakness
596521|NCT00565136|Fecal incontinence|fecal incontinence
596522|NCT00565175|Treatment resistant|treatment resistant
596523|NCT00565175|Chronic|chronic
596524|NCT00565201|Stroke, Cerebrovascular accident, Spasticity, Arm, Hand|stroke, cerebrovascular accident, spasticity, arm, hand
596525|NCT00565214|vitamin supplements|vitamin supplements
596526|NCT00565214|healthy smokers|healthy smokers
596527|NCT00565214|epithelial lung tissue|epithelial lung tissue
596528|NCT00565214|bronchoscopy|bronchoscopy
596529|NCT00565214|antioxidant levels|antioxidant levels
596530|NCT00565240|ovarian synchronization|ovarian synchronization
596531|NCT00565240|folliculogenesis|folliculogenesis
596532|NCT00565253|pulmonary embolism|pulmonary embolism
596533|NCT00565253|inhaled nitric oxide|inhaled nitric oxide
596534|NCT00565279|Seborrhoeic dermatitis|seborrhoeic dermatitis
596535|NCT00565305|Healing Touch|healing touch
596536|NCT00565305|NK cytotoxicity|nk cytotoxicity
596537|NCT00565305|cytokines|cytokines
596538|NCT00565305|fatigue|fatigue
596539|NCT00565318|Benfotiamine|benfotiamine
596540|NCT00565318|Diabetes|diabetes
596541|NCT00565318|Nephropathy|nephropathy
596542|NCT00556816|COPD|copd
596543|NCT00556816|outpatient on demand clinic|outpatient on demand clinic
596544|NCT00556842|Hemi-Arthroplasty|hemi-arthroplasty
596545|NCT00556842|Total Hip Arthroplasty|total hip arthroplasty
596546|NCT00556855|chronic hand dermatitis|chronic hand dermatitis
596547|NCT00556855|research study|research study
596548|NCT00556855|E-do|e-do
596549|NCT00556855|HK-03|hk-03
596550|NCT00556868|High school students|high school students
596551|NCT00556868|Boarding school|boarding school
596552|NCT00556868|Breakfast|breakfast
596553|NCT00556868|Fasting|fasting
596554|NCT00556868|Memory|memory
596555|NCT00556868|Attention|attention
596556|NCT00556868|Mood|mood
596557|NCT00556907|DCIS|dcis
751772|NCT01170377|Antiepileptic drug|antiepileptic drug
596558|NCT00556907|To evaluate Preoperative mammagraphy and MRI to select candiates with DCIS for IORT|to evaluate preoperative mammagraphy and mri to select candiates with dcis for iort
596559|NCT00556920|Coreg CR|coreg cr
596560|NCT00556933|Induction|induction
596561|NCT00556933|rATG|ratg
596562|NCT00556933|Calcineurin-inhibitor withdrawal|calcineurin-inhibitor withdrawal
596563|NCT00556946|Vascular Malformation|vascular malformation
596564|NCT00556959|ADHD|adhd
596565|NCT00556959|Clonidine|clonidine
596566|NCT00556959|Attention Deficit|attention deficit
596567|NCT00556959|Hyperactivity|hyperactivity
596568|NCT00556959|CLONICEL|clonicel
596569|NCT00556959|Addrenex|addrenex
596570|NCT00556998|pharmacokinetics and safety data of voriconazole in immunocompromised adolescents|pharmacokinetics and safety data of voriconazole in immunocompromised adolescents
598904|NCT00571675|Prednisone|prednisone
596571|NCT00557024|hepatocellular carcinoma|hepatocellular carcinoma
596572|NCT00557024|liver cancer|liver cancer
596573|NCT00557024|radiofrequency ablation|radiofrequency ablation
596574|NCT00557024|radiotherapy|radiotherapy
596575|NCT00557024|adjuvant therapy|adjuvant therapy
596576|NCT00557037|Castrate and Non-Castrate Prostate Cancer|castrate and non-castrate prostate cancer
596577|NCT00557050|Hamstring|hamstring
596578|NCT00557050|Muscle|muscle
596579|NCT00557050|Injury|injury
596580|NCT00557050|Prevention|prevention
596581|NCT00557050|Muscles|muscles
596582|NCT00557076|Randomized Clinical Trial|randomized clinical trial
596583|NCT00557076|Auditory Stimulation|auditory stimulation
596584|NCT00557089|Pediatrics|pediatrics
596585|NCT00557089|Cystic Fibrosis|cystic fibrosis
596586|NCT00557089|Lung Clearance Index|lung clearance index
596587|NCT00557089|rhDNAse|rhdnase
596588|NCT00557102|liver metastases|liver metastases
596589|NCT00557102|lung metastases|lung metastases
596590|NCT00557102|recurrent rectal cancer|recurrent rectal cancer
596591|NCT00557102|stage IV rectal cancer|stage iv rectal cancer
596592|NCT00557102|adenocarcinoma of the rectum|adenocarcinoma of the rectum
596593|NCT00557102|adenocarcinoma of the colon|adenocarcinoma of the colon
596594|NCT00557102|recurrent colon cancer|recurrent colon cancer
596595|NCT00557102|stage IV colon cancer|stage iv colon cancer
596596|NCT00557115|Quality of life|quality of life
596597|NCT00557115|Quadriceps|quadriceps
596598|NCT00557115|Muscle|muscle
596599|NCT00557115|Exacerbation|exacerbation
596600|NCT00557128|COREG CR,|coreg cr,
596601|NCT00557128|lisinopril,|lisinopril,
596602|NCT00557128|hypertension,|hypertension,
596603|NCT00557128|dose proportionality,|dose proportionality,
596604|NCT00557128|fixed dose combination (FDC)|fixed dose combination (fdc)
596605|NCT00557141|Single arm observational retrospective and prospective study|single arm observational retrospective and prospective study
596606|NCT00557154|Pediatrics|pediatrics
596607|NCT00557154|Venous access|venous access
596608|NCT00557154|Emergency|emergency
596609|NCT00557180|Steroid Resistance|steroid resistance
596610|NCT00557180|Inflammation|inflammation
596611|NCT00557206|Recurrent Disease|recurrent disease
596612|NCT00557206|Metastatic Disease|metastatic disease
596613|NCT00557206|Squamous Cell Carcinoma|squamous cell carcinoma
596614|NCT00557206|Multicenter|multicenter
596615|NCT00557206|Phase II|phase ii
596616|NCT00557219|cardiac surgery|cardiac surgery
596617|NCT00557219|fenoldopam|fenoldopam
596618|NCT00557219|ketanserin|ketanserin
596619|NCT00557219|renal replacement therapy|renal replacement therapy
596620|NCT00557232|bevacizumab|bevacizumab
596621|NCT00557232|rubeosis iridis|rubeosis iridis
596622|NCT00557232|glaucoma|glaucoma
596623|NCT00557245|HIV infection|hiv infection
596624|NCT00557245|HIV uninfected partners|hiv uninfected partners
596625|NCT00557245|Double Blind|double blind
596626|NCT00557245|Placebo|placebo
596627|NCT00557245|Seroconversion|seroconversion
596629|NCT00557245|FTC TDF|ftc tdf
596630|NCT00557245|Safety|safety
596631|NCT00557245|HIV Seronegativity|hiv seronegativity
596632|NCT00557284|Atopic Dermatitis (Eczema) associated with food allergies|atopic dermatitis (eczema) associated with food allergies
596633|NCT00557297|asthma|asthma
596634|NCT00557297|SMART|smart
596635|NCT00557297|inhaled|inhaled
596636|NCT00557297|glucocorticosteroid|glucocorticosteroid
596637|NCT00557297|reliever|reliever
596638|NCT00557297|maintenance|maintenance
596639|NCT00557297|single inhaler|single inhaler
596640|NCT00557310|osteoporosis, teriparatide, postmenopausal, MRI, finite element analysis|osteoporosis, teriparatide, postmenopausal, mri, finite element analysis
596641|NCT00557349|gastric bypass surgery|gastric bypass surgery
596642|NCT00557349|anastomosis, Roux-en-Y|anastomosis, roux-en-y
596643|NCT00557349|Complication, Postoperative|complication, postoperative
596644|NCT00557362|Keratitis|keratitis
596645|NCT00557362|Eye Infection, Fungal|eye infection, fungal
596646|NCT00557362|Fungal Eye Infection|fungal eye infection
596647|NCT00557362|Ocular Infection, Fungal|ocular infection, fungal
596648|NCT00557362|Fungal Keratitis|fungal keratitis
596649|NCT00557362|Mycotic Infections, Ocular|mycotic infections, ocular
596650|NCT00557362|Voriconazole|voriconazole
596651|NCT00557362|Natamycin|natamycin
596652|NCT00557375|Brain Tumors|brain tumors
596653|NCT00557375|Survey|survey
596654|NCT00557388|muscle loss|muscle loss
596655|NCT00557388|aging|aging
596656|NCT00557388|protein|protein
596657|NCT00557388|amino acids|amino acids
596658|NCT00557388|exercise|exercise
596659|NCT00557388|protein synthesis|protein synthesis
596660|NCT00557414|acute respiratory distress syndrome|acute respiratory distress syndrome
596661|NCT00557414|soluble triggering receptor expressed on myeloid cells-1|soluble triggering receptor expressed on myeloid cells-1
596662|NCT00557414|prognosis|prognosis
596663|NCT00557427|mild to moderate depression according to the DSM-IV scale|mild to moderate depression according to the dsm-iv scale
596664|NCT00557440|Asthma|asthma
596666|NCT00557440|Indacaterol|indacaterol
596667|NCT00557440|Mometasone|mometasone
596668|NCT00557466|QMF|qmf
596669|NCT00557466|indacaterol|indacaterol
596670|NCT00557466|TWISTHALER® device|twisthaler® device
596671|NCT00557492|pancreas|pancreas
596672|NCT00557492|pancreatic|pancreatic
596673|NCT00557492|cancer|cancer
596674|NCT00557492|resectable|resectable
596675|NCT00557544|migraine|migraine
596676|NCT00557544|metoclopramide|metoclopramide
596677|NCT00557544|ketoprofen|ketoprofen
596678|NCT00557544|child|child
596679|NCT00557557|Colorectal|colorectal
596680|NCT00557557|liver|liver
596681|NCT00557557|cancer|cancer
596682|NCT00557557|metastases|metastases
596683|NCT00557570|Antiretroviral|antiretroviral
596684|NCT00557570|Opportunistic Infection|opportunistic infection
596685|NCT00557570|treatment experienced|treatment experienced
596686|NCT00557570|treatment naive|treatment naive
596687|NCT00557583|VBY-376 Hepatitis C pharmacokinetics safety|vby-376 hepatitis c pharmacokinetics safety
596688|NCT00557596|Pancreatic|pancreatic
596689|NCT00557596|antisense|antisense
596690|NCT00557596|oligonucleotide|oligonucleotide
596691|NCT00557596|gemcitabine|gemcitabine
596692|NCT00557609|Microphthalmia transcription (MiT) factor associated tumors|microphthalmia transcription (mit) factor associated tumors
596693|NCT00557609|Alveolar soft part sarcoma (ASPS)|alveolar soft part sarcoma (asps)
596694|NCT00557609|Clear cell sarcoma (CCS)|clear cell sarcoma (ccs)
596695|NCT00557609|Renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
596696|NCT00557622|PTSD (Posttraumatic Stress Disorder)|ptsd (posttraumatic stress disorder)
596697|NCT00557622|CAPS|caps
596698|NCT00557622|fMRI|fmri
596699|NCT00557622|Paroxetine|paroxetine
596700|NCT00557635|pseudo-arthrosis, osseous matrix, cell therapy|pseudo-arthrosis, osseous matrix, cell therapy
596702|NCT00557648|Children|children
596703|NCT00557648|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
596704|NCT00557648|School-Based Interventions|school-based interventions
596705|NCT00557661|Heart failure|heart failure
596706|NCT00557661|CD-NP|cd-np
596707|NCT00557687|IVF|ivf
596708|NCT00557687|ovarian reserve|ovarian reserve
596709|NCT00557687|poor response|poor response
596710|NCT00557700|Mild to moderate asthma|mild to moderate asthma
596711|NCT00557726|Inflammation|inflammation
596712|NCT00557726|Infection|infection
596713|NCT00557726|Fever|fever
596714|NCT00557739|CRx-191|crx-191
596715|NCT00557739|Plaque|plaque
596716|NCT00557739|Psoriasis|psoriasis
596717|NCT00557739|nortriptyline hydrochloride|nortriptyline hydrochloride
596718|NCT00557739|mometasone furoate|mometasone furoate
596719|NCT00557739|psoriatic infiltrate|psoriatic infiltrate
596720|NCT00557765|Tuberculosis|tuberculosis
596721|NCT00557765|Latent tuberculosis infection|latent tuberculosis infection
596722|NCT00557765|Interferon gamma release assay|interferon gamma release assay
596723|NCT00557765|Contact tracing|contact tracing
596724|NCT00557778|prevention|prevention
596725|NCT00557778|dyslipidemia|dyslipidemia
596726|NCT00557791|AMD|amd
596727|NCT00557791|ARMD|armd
596728|NCT00557791|Exudative Macular Degeneration|exudative macular degeneration
596729|NCT00557791|Bevasiranib|bevasiranib
596730|NCT00557791|siRNA|sirna
596731|NCT00557804|Congestive Heart Failure|congestive heart failure
596732|NCT00557817|HCT|hct
596733|NCT00557817|autologous|autologous
596734|NCT00557817|erythropoiesis|erythropoiesis
596735|NCT00557817|iron saccharate|iron saccharate
596736|NCT00557817|erythropoietin|erythropoietin
596737|NCT00557817|darbepoetin alpha|darbepoetin alpha
596738|NCT00557830|Renal Cell Carcinoma|renal cell carcinoma
596739|NCT00557830|Kidney Cancer|kidney cancer
596740|NCT00557843|Bupivacaine|bupivacaine
596741|NCT00557843|Colon|colon
596742|NCT00557843|Surgery|surgery
596743|NCT00557843|Oxygenation|oxygenation
596744|NCT00557856|Solid Tumors Transforming Growth Factor Beta Activin Receptor-like Kinase 1|solid tumors transforming growth factor beta activin receptor-like kinase 1
596745|NCT00557882|prolapse|prolapse
596746|NCT00557882|uterus|uterus
596747|NCT00557882|mesh|mesh
596748|NCT00557882|bladder|bladder
596749|NCT00557895|Asthma|asthma
596750|NCT00557895|Hypersensitivity|hypersensitivity
596751|NCT00557895|Peanut Allergy|peanut allergy
596752|NCT00557895|Eosinophilic Esophagitis|eosinophilic esophagitis
596753|NCT00557895|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
596754|NCT00557908|Von Willebrand Disease|von willebrand disease
596755|NCT00557908|VWD|vwd
596756|NCT00557908|prophylaxis|prophylaxis
596758|NCT00557921|CAD|cad
596759|NCT00557921|MI|mi
596760|NCT00557921|PCI|pci
596761|NCT00557921|PTCA|ptca
596762|NCT00557921|NSTEMI|nstemi
596763|NCT00557921|STEMI|stemi
596764|NCT00557921|acute coronary syndrome|acute coronary syndrome
596765|NCT00557921|cerebrovascular disorders|cerebrovascular disorders
596766|NCT00557921|coronary artery stent placement|coronary artery stent placement
596767|NCT00557921|coronary thrombosis|coronary thrombosis
596768|NCT00557921|myocardial infarction|myocardial infarction
596769|NCT00557921|myocardial ischemia|myocardial ischemia
596770|NCT00557921|percutaneous coronary intervention|percutaneous coronary intervention
596771|NCT00557921|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
596772|NCT00557921|peripheral vascular diseases|peripheral vascular diseases
596773|NCT00557921|duodenal obstruction|duodenal obstruction
596774|NCT00557921|duodenal ulcer|duodenal ulcer
596775|NCT00557921|dyspepsia|dyspepsia
596776|NCT00557921|esophagitis, peptic|esophagitis, peptic
596777|NCT00557921|gastric outlet obstruction|gastric outlet obstruction
596778|NCT00557921|gastroduodenal ulcer|gastroduodenal ulcer
596779|NCT00557921|gastroesophageal reflux disease|gastroesophageal reflux disease
596780|NCT00557921|gastrointestinal hemorrhage|gastrointestinal hemorrhage
596781|NCT00557921|peptic ulcer|peptic ulcer
596782|NCT00557921|peptic ulcer perforation|peptic ulcer perforation
597544|NCT00567034|naltrexone|naltrexone
596783|NCT00557934|tetralogy of Fallot|tetralogy of fallot
596784|NCT00557934|right ventricular dysfunction|right ventricular dysfunction
596785|NCT00557934|pulmonary insufficiency|pulmonary insufficiency
596786|NCT00557934|pulmonary valve replacement|pulmonary valve replacement
596787|NCT00557934|pressure-volume loops|pressure-volume loops
596788|NCT00557934|long-term follow-up in tetralogy of Fallot|long-term follow-up in tetralogy of fallot
596789|NCT00557947|Abdominoplasty|abdominoplasty
596790|NCT00557947|Body Lift|body lift
596791|NCT00557947|Plastic Surgery|plastic surgery
596792|NCT00557947|Skin Closure|skin closure
596793|NCT00557947|Wound Healing|wound healing
596794|NCT00557947|Dermabond|dermabond
596795|NCT00557986|1-Metastatic breast cancer|1-metastatic breast cancer
596796|NCT00557986|2-Surgery|2-surgery
596797|NCT00557986|3-Survival|3-survival
596798|NCT00557999|Cardiology|cardiology
596799|NCT00557999|Mechanical ventilation|mechanical ventilation
596800|NCT00557999|Intensive care|intensive care
596801|NCT00558012|Osteoporosis|osteoporosis
596802|NCT00558012|Bone loss|bone loss
596803|NCT00558012|Frail Geriatric Women|frail geriatric women
596804|NCT00558012|Nursing Home Patients|nursing home patients
596805|NCT00558012|Fragility Fractures|fragility fractures
596806|NCT00558038|Hepatic|hepatic
596807|NCT00558038|Encephalopathy|encephalopathy
596808|NCT00558038|Liver|liver
596809|NCT00558038|Liver Disease|liver disease
596810|NCT00558038|Liver Failure|liver failure
596811|NCT00558038|Lactulose|lactulose
596812|NCT00558038|AST-120|ast-120
596813|NCT00558051|Colorectal Cancer|colorectal cancer
596814|NCT00558051|Colorectal Carcinoma|colorectal carcinoma
596815|NCT00558051|Colorectal Tumors|colorectal tumors
596816|NCT00558051|Neoplasms, Colorectal|neoplasms, colorectal
596817|NCT00558077|Anovulation|anovulation
596818|NCT00558077|Clomiphene citrate|clomiphene citrate
596819|NCT00558077|Fertility|fertility
596820|NCT00558077|Metformin|metformin
596821|NCT00558077|Ovulation induction|ovulation induction
596822|NCT00558077|PCOS|pcos
596823|NCT00558077|Sterility|sterility
596824|NCT00558077|Treatment|treatment
596825|NCT00558077|Clomiphene citrate-resistance|clomiphene citrate-resistance
596826|NCT00558090|pain|pain
596827|NCT00558090|Intensive Care Unit|intensive care unit
596828|NCT00558090|morphine|morphine
596829|NCT00558090|pKpD|pkpd
596830|NCT00558090|numerical rating scale|numerical rating scale
596831|NCT00558090|critically ill patients|critically ill patients
596832|NCT00558103|GW572016|gw572016
596833|NCT00558103|Breast Cancer|breast cancer
596834|NCT00558103|RECIST|recist
596835|NCT00558103|Inflammatory Breast Cancer|inflammatory breast cancer
596836|NCT00558103|Pazopanib|pazopanib
596837|NCT00558103|ErbB2|erbb2
596838|NCT00558103|Cutaneous Disease|cutaneous disease
596839|NCT00558103|Tykerb|tykerb
596840|NCT00558103|Inflammatory|inflammatory
596841|NCT00558103|Skin|skin
596842|NCT00558103|Her2|her2
596843|NCT00558103|Lapatinib|lapatinib
596844|NCT00558103|GW786034|gw786034
596845|NCT00558116|Carpal Tunnel Syndrome|carpal tunnel syndrome
596846|NCT00558116|Dynamic Splinting|dynamic splinting
596847|NCT00558116|Nerve Conduction Studies|nerve conduction studies
596848|NCT00558116|Splinting|splinting
596849|NCT00558116|Levine Katz Survey|levine katz survey
596850|NCT00558129|Lumbar Spinal Stenosis|lumbar spinal stenosis
596851|NCT00558129|X-STOP® IPD|x-stop® ipd
596852|NCT00558129|Interspinous process decompression|interspinous process decompression
596853|NCT00558129|Neurogenic Intermittent Claudication|neurogenic intermittent claudication
596854|NCT00558142|contrast nephropathy|contrast nephropathy
596855|NCT00558142|radiocontrast-induced nephropathy|radiocontrast-induced nephropathy
596856|NCT00558142|chronic kidney disease|chronic kidney disease
596857|NCT00558142|acetylcysteine|acetylcysteine
596858|NCT00558142|clinical study|clinical study
596859|NCT00558155|immunonutrition|immunonutrition
596860|NCT00558155|enteral nutrition|enteral nutrition
596861|NCT00558155|parenteral nutrition|parenteral nutrition
596862|NCT00558155|surgery|surgery
596863|NCT00558168|Anastrazole|anastrazole
596864|NCT00558168|safety|safety
596865|NCT00558168|early breast cancer|early breast cancer
596866|NCT00558181|B CLL|b cll
596867|NCT00558181|Chronic B Lymphocytic Leukemia|chronic b lymphocytic leukemia
596868|NCT00558181|Methylprednisolone|methylprednisolone
596869|NCT00558181|Rituximab|rituximab
596870|NCT00558194|Weight loss|weight loss
596871|NCT00558207|Pancreatic cancer|pancreatic cancer
596872|NCT00558207|pancreas cancer|pancreas cancer
596971|NCT00558675|Chronic Myeloid Leukemia|chronic myeloid leukemia
596873|NCT00558207|Locally advanced or metastatic pancreatic adenocarcioma|locally advanced or metastatic pancreatic adenocarcioma
596874|NCT00558220|Lymphoma, B-cell|lymphoma, b-cell
596875|NCT00558220|Immunotherapy, passive|immunotherapy, passive
596876|NCT00558220|Remission induction|remission induction
596877|NCT00558220|Autologous transplantation|autologous transplantation
596878|NCT00558233|Colorectal cancer|colorectal cancer
596879|NCT00558233|Screening|screening
596880|NCT00558233|Health literacy|health literacy
596881|NCT00558233|Patient education|patient education
598022|NCT00562757|Noninvasive|noninvasive
596882|NCT00558233|Computer assisted instruction|computer assisted instruction
596883|NCT00558246|Breast Lift|breast lift
596884|NCT00558246|Breast Reduction|breast reduction
596885|NCT00558246|Breast Reconstruction|breast reconstruction
596886|NCT00558246|Plastic Surgery|plastic surgery
596887|NCT00558246|Skin Closure|skin closure
596888|NCT00558246|Wound Healing|wound healing
596889|NCT00558246|Dermabond|dermabond
596890|NCT00558272|breast cancer|breast cancer
596891|NCT00558272|prostate cancer|prostate cancer
596892|NCT00558272|metastatic bone disease|metastatic bone disease
596893|NCT00558272|Subjects with breast cancer or prostate cancer with metastatic bone disease|subjects with breast cancer or prostate cancer with metastatic bone disease
596894|NCT00558285|COPD|copd
596895|NCT00558285|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
596896|NCT00558285|Indacaterol|indacaterol
596897|NCT00558285|QVA149|qva149
596898|NCT00558298|schizophrenia|schizophrenia
596899|NCT00558298|schizoaffective disorder|schizoaffective disorder
596900|NCT00558298|risperidone|risperidone
596901|NCT00558298|intramuscular injection|intramuscular injection
596902|NCT00558298|long-acting injectable|long-acting injectable
596903|NCT00558311|Aneurysmal|aneurysmal
596904|NCT00558311|Subarachnoid|subarachnoid
596905|NCT00558311|Hemorrhage|hemorrhage
596906|NCT00558311|vasospasm|vasospasm
596907|NCT00558311|clazosentan|clazosentan
596908|NCT00558311|PIVLAZ|pivlaz
596909|NCT00558311|Actelion|actelion
596910|NCT00558311|surgical clipping|surgical clipping
596911|NCT00558324|LASIK|lasik
596912|NCT00558324|Confocal microscopy|confocal microscopy
596913|NCT00558324|Flap|flap
596914|NCT00558337|Treatment of Parkinson's Disease|treatment of parkinson's disease
596915|NCT00558350|lobectomy|lobectomy
596916|NCT00558350|inflammatory reaction|inflammatory reaction
596917|NCT00558350|intrapulmonary|intrapulmonary
596918|NCT00558350|intrapleural|intrapleural
596919|NCT00558363|Prostate Cancer|prostate cancer
596920|NCT00558363|AVODART|avodart
596922|NCT00558363|dutasteride|dutasteride
596923|NCT00558363|PSADT|psadt
596924|NCT00558363|Prostate specific antigen|prostate specific antigen
596925|NCT00558363|radical therapy|radical therapy
596926|NCT00558363|doubling time|doubling time
596927|NCT00558376|Colonoscopy|colonoscopy
596928|NCT00558454|Iron supplements|iron supplements
596929|NCT00558454|Infant|infant
596930|NCT00558454|Low birth weight|low birth weight
596931|NCT00558454|Prevention of iron deficiency and its physiological consequences|prevention of iron deficiency and its physiological consequences
596932|NCT00558454|Safety|safety
596933|NCT00558506|Ankylosing spondylitis|ankylosing spondylitis
596934|NCT00558506|activity|activity
596935|NCT00558506|treatment|treatment
596936|NCT00558506|clinical trial|clinical trial
596937|NCT00558519|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
596938|NCT00558519|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
596939|NCT00558519|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
596940|NCT00558532|Morbid obesity|morbid obesity
596941|NCT00558532|Omega-3 fatty acid levels|omega-3 fatty acid levels
596942|NCT00558545|Breast|breast
596943|NCT00558545|paclitaxel|paclitaxel
596944|NCT00558545|antisense|antisense
596945|NCT00558545|oligonucleotide|oligonucleotide
596946|NCT00558558|Solid Tumors|solid tumors
596947|NCT00558558|Cancer-Associated Anorexia|cancer-associated anorexia
596948|NCT00558558|Weight Loss|weight loss
596949|NCT00558558|Haelan|haelan
596950|NCT00558558|Fermented Soy Product|fermented soy product
596951|NCT00558558|Nutrition|nutrition
596952|NCT00558558|Cachexia|cachexia
596953|NCT00558584|dilated cardiomyopathy|dilated cardiomyopathy
596954|NCT00558584|immunoadsorption|immunoadsorption
596955|NCT00558584|immunoglobulin G|immunoglobulin g
596956|NCT00558597|Proteomics|proteomics
596957|NCT00558597|Lung Transplantation|lung transplantation
596958|NCT00558623|lead, blood|lead, blood
596959|NCT00558623|pregnancy|pregnancy
596960|NCT00558623|calcium|calcium
596961|NCT00558623|randomized trial|randomized trial
596962|NCT00558623|dietary supplementation|dietary supplementation
596963|NCT00558623|bone resorption|bone resorption
596964|NCT00558636|NSCLC|nsclc
596965|NCT00558662|compression therapy|compression therapy
596966|NCT00558662|venous leg ulcer|venous leg ulcer
596967|NCT00558662|sub bandage pressure|sub bandage pressure
596968|NCT00558675|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
596969|NCT00558675|Hodgkins Lymphoma|hodgkins lymphoma
596970|NCT00558675|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
596972|NCT00558675|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
596973|NCT00558675|Multiple Myeloma|multiple myeloma
596974|NCT00558675|Immunotherapy|immunotherapy
596975|NCT00558675|Allogeneic Cell Therapy|allogeneic cell therapy
596976|NCT00558701|burns|burns
596977|NCT00558701|donor site|donor site
596978|NCT00558701|healing|healing
596979|NCT00558701|microcurrent|microcurrent
596980|NCT00558727|Advanced Solid Tumors|advanced solid tumors
596981|NCT00558727|Solid Tumors|solid tumors
596982|NCT00558727|Tumor|tumor
598820|NCT00565747|infertility|infertility
596983|NCT00558727|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
596984|NCT00558727|Chemotherapy|chemotherapy
596985|NCT00558727|Benzoquinone|benzoquinone
596986|NCT00558740|Dietary protein|dietary protein
596987|NCT00558740|Fructose|fructose
596988|NCT00558740|VLDL-triglycerides|vldl-triglycerides
596989|NCT00558740|Hepatic de novo lipogenesis|hepatic de novo lipogenesis
596990|NCT00558740|Lipid oxidation|lipid oxidation
596991|NCT00558766|Disruptive Behavior Disorders|disruptive behavior disorders
596992|NCT00558766|Behavior|behavior
596993|NCT00558766|Gambling|gambling
596994|NCT00558766|Dopaminergic Mechanisms|dopaminergic mechanisms
596995|NCT00558766|Dopamine|dopamine
596996|NCT00558766|Parkinson Disease|parkinson disease
596997|NCT00558766|PD|pd
596998|NCT00558779|Coronary artery bypass|coronary artery bypass
596999|NCT00558779|off pump coronary artery bypass grafting (OPCAB)|off pump coronary artery bypass grafting (opcab)
597000|NCT00558831|Acne|acne
597001|NCT00558844|Cystic Fibrosis|cystic fibrosis
597002|NCT00558844|Respiratory Infections|respiratory infections
597003|NCT00558844|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
597004|NCT00558844|CFTR|cftr
597005|NCT00558870|Solid Tumors|solid tumors
597006|NCT00558870|Morphine|morphine
597007|NCT00558870|Methadone|methadone
597008|NCT00558870|Co-Opioid Analgesic|co-opioid analgesic
597009|NCT00558870|Pain|pain
597010|NCT00558896|stage II multiple myeloma|stage ii multiple myeloma
597011|NCT00558896|stage III multiple myeloma|stage iii multiple myeloma
597012|NCT00558896|refractory multiple myeloma|refractory multiple myeloma
597013|NCT00558922|Lung|lung
597014|NCT00558922|Non small cell|non small cell
597015|NCT00558922|antisense|antisense
597016|NCT00558922|oligonucleotide|oligonucleotide
597017|NCT00558922|paclitaxel|paclitaxel
597018|NCT00558922|carboplatin|carboplatin
597019|NCT00558948|Bone Marrow Transplant|bone marrow transplant
597020|NCT00558948|Bone Mineral Density|bone mineral density
597021|NCT00558948|Survivors|survivors
597022|NCT00558948|Muscle Strength|muscle strength
597023|NCT00558961|CLL|cll
597024|NCT00558961|chronic lymphocytic leukemia|chronic lymphocytic leukemia
597025|NCT00558961|leukemia|leukemia
597026|NCT00558961|gleevec|gleevec
597027|NCT00558961|chlorambucil|chlorambucil
597028|NCT00558987|Discipline|discipline
597029|NCT00558987|Parenting|parenting
597030|NCT00558987|Primary Care|primary care
597031|NCT00558987|Videos|videos
597032|NCT00559000|PTSD|ptsd
597033|NCT00559000|Children|children
597034|NCT00559000|trauma-focused Treatment|trauma-focused treatment
597035|NCT00559000|KIDNET|kidnet
597036|NCT00559000|Narrative Exposure Therapy for Children|narrative exposure therapy for children
597037|NCT00559013|Staple line reinforcement|staple line reinforcement
597038|NCT00559013|Staple line buttress|staple line buttress
597039|NCT00559013|Anastomotic reinforcement|anastomotic reinforcement
597040|NCT00559039|breast cancer|breast cancer
597041|NCT00559039|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
597042|NCT00559052|Enzymes|enzymes
597043|NCT00559052|VIOKASE|viokase
597044|NCT00559052|Bioavailability|bioavailability
597045|NCT00559065|Case-Cohort Study|case-cohort study
597046|NCT00559065|Leukemia|leukemia
597047|NCT00559065|Lymphoma|lymphoma
597048|NCT00559065|Benzene|benzene
597049|NCT00559065|Blood Disorders|blood disorders
597050|NCT00559065|Solvent Exposure|solvent exposure
597051|NCT00559065|Cancer Risk|cancer risk
597052|NCT00559078|Adrenal Hyperplasia, Congenital|adrenal hyperplasia, congenital
597053|NCT00559078|Psychosexual Development|psychosexual development
597054|NCT00559078|Sexual Development|sexual development
597055|NCT00559078|Intersex|intersex
597056|NCT00559078|Qualitative|qualitative
597057|NCT00559078|CAH|cah
597058|NCT00559078|Interview|interview
597059|NCT00559078|Disorder of Sex Development|disorder of sex development
597060|NCT00559078|Telephone|telephone
597061|NCT00559078|Quality of Life|quality of life
597062|NCT00559078|Mental Health|mental health
597063|NCT00559078|Counseling|counseling
597064|NCT00559091|AML|aml
597065|NCT00559091|Acute myelocytic leukemia|acute myelocytic leukemia
597066|NCT00559091|leukemia|leukemia
597067|NCT00559091|relapsed|relapsed
597068|NCT00559091|refractory|refractory
597069|NCT00559091|M4|m4
597070|NCT00559091|M5|m5
597071|NCT00559104|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
597072|NCT00559104|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
597073|NCT00559104|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
597074|NCT00559104|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
597075|NCT00559104|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
597076|NCT00559104|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
597077|NCT00559104|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
597078|NCT00559104|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
597079|NCT00559104|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
597080|NCT00559104|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
597081|NCT00559130|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
597082|NCT00559130|Acute Lung Injury|acute lung injury
597083|NCT00559130|Sepsis|sepsis
597084|NCT00559130|Hemoperfusion|hemoperfusion
597085|NCT00559143|AV conduction disturbances|av conduction disturbances
597086|NCT00559143|LV function|lv function
597087|NCT00559143|Biventricular Pacing|biventricular pacing
597088|NCT00559143|Conductance Catheters|conductance catheters
597089|NCT00559156|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
597090|NCT00559156|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
597091|NCT00559156|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
597092|NCT00559156|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
597093|NCT00559156|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
597094|NCT00559156|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
597095|NCT00559156|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
597096|NCT00559156|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
597097|NCT00559156|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
597098|NCT00559156|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
597099|NCT00559156|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
597100|NCT00559156|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
597101|NCT00559156|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
597102|NCT00559156|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
597103|NCT00559156|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
597104|NCT00559156|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
597105|NCT00559156|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
597106|NCT00559156|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
597107|NCT00559156|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
597108|NCT00559156|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
597109|NCT00559156|recurrent salivary gland cancer|recurrent salivary gland cancer
597110|NCT00559156|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
597111|NCT00559156|stage III salivary gland cancer|stage iii salivary gland cancer
597112|NCT00559156|stage IV salivary gland cancer|stage iv salivary gland cancer
597113|NCT00559169|epilepsy|epilepsy
597114|NCT00559169|seizures|seizures
597115|NCT00559169|menstrual cycle|menstrual cycle
597116|NCT00559195|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
597117|NCT00559195|anemia|anemia
597118|NCT00559195|fatigue|fatigue
597119|NCT00559208|Children and Youth|children and youth
597120|NCT00559208|Families|families
597121|NCT00559208|Differential Response|differential response
597122|NCT00559221|AML|aml
597123|NCT00559234|Optic Nerve|optic nerve
597124|NCT00559234|Retina|retina
597125|NCT00559234|Cornea|cornea
597126|NCT00559234|Lens|lens
597127|NCT00559234|Ocular Genetic Diseases|ocular genetic diseases
597128|NCT00559234|Inherited Eye Disease|inherited eye disease
597129|NCT00559234|Genetic Eye Disease|genetic eye disease
597130|NCT00559286|perfusion|perfusion
597131|NCT00559286|microcirculation|microcirculation
597132|NCT00559286|RBC function|rbc function
597133|NCT00559286|NO metabolism|no metabolism
597134|NCT00559286|AT receptor blocker|at receptor blocker
597135|NCT00559299|163090|163090
597136|NCT00559299|placebo-controlled|placebo-controlled
597137|NCT00559299|MDD|mdd
597138|NCT00559299|Depression|depression
597139|NCT00559299|Tolerability|tolerability
597140|NCT00559299|MDE|mde
597141|NCT00559312|mild COPD|mild copd
597142|NCT00559312|dyspnea|dyspnea
597143|NCT00559312|exercise|exercise
597144|NCT00559312|combination therapy|combination therapy
597145|NCT00559338|CHF|chf
597146|NCT00559338|Heart Failure|heart failure
597147|NCT00559338|Dyspnea|dyspnea
597148|NCT00559338|Cardiomyopathy|cardiomyopathy
597149|NCT00559351|esophagectomy|esophagectomy
597150|NCT00559351|chemotherapy|chemotherapy
597151|NCT00559351|chemoradiotherapy|chemoradiotherapy
597535|NCT00567008|cocaine|cocaine
597152|NCT00559351|combined modality therapy|combined modality therapy
597153|NCT00559390|Polycystic Ovary Syndrome|polycystic ovary syndrome
597154|NCT00559390|Metabolic Syndrome|metabolic syndrome
597155|NCT00559390|PCOS|pcos
597156|NCT00559390|children|children
597157|NCT00559390|girls|girls
597158|NCT00559390|daughters|daughters
597159|NCT00559390|sisters|sisters
597160|NCT00559390|irregular periods|irregular periods
597161|NCT00559403|Human immunodeficiency virus|human immunodeficiency virus
597162|NCT00559403|South Africa|south africa
597163|NCT00559403|Intervention Studies|intervention studies
597164|NCT00559403|Sexual Behavior|sexual behavior
597165|NCT00559403|Adolescents|adolescents
597166|NCT00559403|STD|std
597167|NCT00559403|HIV Seronegativity|hiv seronegativity
597168|NCT00559416|HIV/AIDS|hiv/aids
597169|NCT00559416|HLA-B*57|hla-b*57
597170|NCT00559416|Cell Transfer|cell transfer
597171|NCT00559416|HIV|hiv
597172|NCT00559416|treatment experienced|treatment experienced
597173|NCT00559429|Prostate Cancer|prostate cancer
597174|NCT00559442|high altitude pulmonary edema|high altitude pulmonary edema
597175|NCT00559442|hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
597176|NCT00559442|right ventricular function|right ventricular function
597177|NCT00559442|hypoxia|hypoxia
597178|NCT00565344|Medicaid|medicaid
597179|NCT00565344|Disenrollment|disenrollment
597180|NCT00565357|Postnatal Growth|postnatal growth
597181|NCT00565357|Postnatal Development|postnatal development
597182|NCT00565357|Noise|noise
597183|NCT00565357|Neonatal Intensive Care Unit|neonatal intensive care unit
597184|NCT00565370|Gastric cancer|gastric cancer
597185|NCT00565370|capecitabine|capecitabine
597186|NCT00565370|cisplatin|cisplatin
597187|NCT00565370|sorafenib|sorafenib
597188|NCT00565370|phase I|phase i
597189|NCT00565370|phase II|phase ii
597190|NCT00565383|Pregnancy|pregnancy
597191|NCT00565383|37 Weeks Gestation|37 weeks gestation
597192|NCT00565383|Breech Presentation|breech presentation
597193|NCT00565383|Version Procedure|version procedure
597194|NCT00565383|Pain Control|pain control
597195|NCT00565383|Neuraxial analgesia|neuraxial analgesia
597196|NCT00565409|Active Rheumatoid Arthritis|active rheumatoid arthritis
597197|NCT00565422|Internet addiction|internet addiction
597198|NCT00565422|Problematic internet use|problematic internet use
597199|NCT00565422|Escitalopram|escitalopram
597200|NCT00565422|Lexapro|lexapro
597201|NCT00565435|Chiari I Malformation|chiari i malformation
597202|NCT00565448|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
597203|NCT00565474|Renal transplantation|renal transplantation
597204|NCT00565474|fluvastatin|fluvastatin
597205|NCT00565487|Radiotherapy|radiotherapy
597206|NCT00565487|Non-operable pancreatic cancer|non-operable pancreatic cancer
597207|NCT00565487|locally advanced pancreatic cancer|locally advanced pancreatic cancer
597208|NCT00565526|Autonomic Nervous System|autonomic nervous system
597209|NCT00565526|Sjogren's Syndrome|sjogren's syndrome
597210|NCT00565526|Pathogenesis|pathogenesis
597211|NCT00565526|Cholinergic|cholinergic
597212|NCT00565526|Parasympathetic|parasympathetic
597213|NCT00565526|Sjogren Syndrome|sjogren syndrome
597214|NCT00565539|PEGylated recombinant interleukin 29|pegylated recombinant interleukin 29
597215|NCT00565539|interferon lambda|interferon lambda
597216|NCT00565539|interleukin 29|interleukin 29
597217|NCT00565539|hepatitis C|hepatitis c
597218|NCT00565539|virus|virus
597219|NCT00565539|infection|infection
597220|NCT00565539|liver|liver
597221|NCT00565552|silicone gel|silicone gel
597222|NCT00565552|cicatrix|cicatrix
597223|NCT00565552|wound healing|wound healing
597224|NCT00565552|scar|scar
597225|NCT00565552|keloid|keloid
597226|NCT00565565|Biventriular chronic heart failure, Pulmonary hypertension|biventriular chronic heart failure, pulmonary hypertension
597227|NCT00565591|asthma|asthma
597228|NCT00565591|inhaler device|inhaler device
597229|NCT00565591|albuterol sulfate|albuterol sulfate
597230|NCT00565604|Perforator Veins|perforator veins
597231|NCT00565604|Incompetent Veins|incompetent veins
597232|NCT00565604|Varicose Veins|varicose veins
597233|NCT00565617|depression|depression
597234|NCT00565617|epidural|epidural
597235|NCT00565617|cortical stimulation|cortical stimulation
597236|NCT00565617|brain stimulation|brain stimulation
597237|NCT00565617|treatment-resistant|treatment-resistant
597238|NCT00565617|deep brain stimulation|deep brain stimulation
597239|NCT00565617|TMS|tms
597240|NCT00565617|DBS|dbs
597241|NCT00565617|ECS|ecs
597242|NCT00565643|Adhesion|adhesion
597243|NCT00565643|Seprafilm|seprafilm
597244|NCT00565643|Cesarean section|cesarean section
597245|NCT00565656|Myelodysplastic syndromes (int-1, int-2 and high risk according to IPSS) with excess of marrow blasts including CMML with leucocytes<10 000/mm3|myelodysplastic syndromes (int-1, int-2 and high risk according to ipss) with excess of marrow blasts including cmml with leucocytes<10 000/mm3
597246|NCT00565669|Treatment|treatment
597247|NCT00565669|Dry Eye|dry eye
597248|NCT00565994|hemodialysis|hemodialysis
597249|NCT00565994|Vascular access|vascular access
597250|NCT00565994|arteriovenous fistula|arteriovenous fistula
597634|NCT00567424|seizure|seizure
597251|NCT00565994|indwelling percutaneous catheters|indwelling percutaneous catheters
597252|NCT00565994|arteriovenous grafts|arteriovenous grafts
597253|NCT00566007|disc herniation|disc herniation
597254|NCT00566007|lumbar|lumbar
597255|NCT00566007|ozone therapy|ozone therapy
597256|NCT00566020|Open-label extension|open-label extension
597257|NCT00566020|Tolerability|tolerability
597258|NCT00566020|Lamotrigine|lamotrigine
597259|NCT00566020|Safety|safety
597260|NCT00566020|Bipolar I disorder|bipolar i disorder
597261|NCT00566033|AUDIT|audit
597262|NCT00566033|Chronic kidney disease|chronic kidney disease
597263|NCT00566033|Clinical trial|clinical trial
597264|NCT00566033|Creatinine|creatinine
597265|NCT00566033|Multiple intervents|multiple intervents
597266|NCT00566033|Nephrology guidelines.|nephrology guidelines.
597267|NCT00566059|therapeutic advice|therapeutic advice
597268|NCT00566072|the effect of information on compliance of medication|the effect of information on compliance of medication
597269|NCT00566085|MBI|mbi
597270|NCT00566085|Breast Cancer|breast cancer
597271|NCT00566085|Neoadjuvant Therapy|neoadjuvant therapy
597272|NCT00566085|Molecular Breast Imaging|molecular breast imaging
597273|NCT00566098|stage II multiple myeloma|stage ii multiple myeloma
597274|NCT00566098|stage III multiple myeloma|stage iii multiple myeloma
597275|NCT00566111|Ceftriaxone|ceftriaxone
597276|NCT00566111|Acute Antidepressant Effects|acute antidepressant effects
597277|NCT00566111|Glutamatergic System|glutamatergic system
597278|NCT00566111|Double-Blind|double-blind
597279|NCT00566111|Mood Disorders|mood disorders
597280|NCT00566111|Bipolar Disorder|bipolar disorder
597281|NCT00566111|Depression|depression
597282|NCT00566111|Affective Disorders|affective disorders
597283|NCT00566124|Levemir, Lantus, Insulatard, Pharmacodynamics, Healthy humans|levemir, lantus, insulatard, pharmacodynamics, healthy humans
597284|NCT00566137|Scleroderma|scleroderma
597285|NCT00566137|Pulmonary Hypertension|pulmonary hypertension
597286|NCT00566150|Keppra|keppra
597287|NCT00566150|Levetiracetam|levetiracetam
597288|NCT00566150|Anticonvulsant|anticonvulsant
597289|NCT00566150|Depression|depression
597290|NCT00566150|Bipolar Disorder|bipolar disorder
597291|NCT00566150|Affective Disorders|affective disorders
597292|NCT00566150|Mood Disorders|mood disorders
597293|NCT00566150|Double Blind|double blind
597294|NCT00566150|Acute Antidepressant Effects|acute antidepressant effects
597295|NCT00566176|Atrial Fibrillation|atrial fibrillation
597296|NCT00566176|AF|af
597297|NCT00566176|AFIB|afib
597298|NCT00566176|racing heart|racing heart
597299|NCT00566176|pulmonary vein isolation|pulmonary vein isolation
597300|NCT00566176|pvi|pvi
597301|NCT00566176|mini maze|mini maze
597302|NCT00566176|maze|maze
597303|NCT00566189|diabetes mellitus, type 2|diabetes mellitus, type 2
597304|NCT00566189|Insulin resistance|insulin resistance
597305|NCT00566189|Intra-Abdominal Fat|intra-abdominal fat
597306|NCT00566189|Omentum|omentum
597307|NCT00566189|duodenal exclusion|duodenal exclusion
597308|NCT00566189|bariatric surgery|bariatric surgery
597309|NCT00566189|Glucagon-Like Peptide 1|glucagon-like peptide 1
597310|NCT00566189|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
597311|NCT00566189|insulin|insulin
597312|NCT00566189|glucagon|glucagon
597313|NCT00566189|ghrelin|ghrelin
597314|NCT00566189|adiponectin|adiponectin
597315|NCT00566189|Cytokines|cytokines
597316|NCT00566202|Major Depressive Disorder|major depressive disorder
597317|NCT00566202|Depression|depression
597318|NCT00566202|JNJ-18038683|jnj-18038683
597319|NCT00566202|Escitalopram|escitalopram
597320|NCT00566215|diabetes mellitus, type 2|diabetes mellitus, type 2
597321|NCT00566215|Insulin resistance|insulin resistance
597322|NCT00566215|Intra-Abdominal Fat|intra-abdominal fat
597323|NCT00566215|Omentum|omentum
597324|NCT00566215|duodenal exclusion|duodenal exclusion
597325|NCT00566215|bariatric surgery|bariatric surgery
597326|NCT00566215|Glucagon-Like Peptide 1|glucagon-like peptide 1
597327|NCT00566215|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
597328|NCT00566215|insulin|insulin
597329|NCT00566215|glucagon|glucagon
597330|NCT00566215|ghrelin|ghrelin
597331|NCT00566215|adiponectin|adiponectin
597332|NCT00566215|Cytokines|cytokines
597333|NCT00566228|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
597334|NCT00566228|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
597335|NCT00566228|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
597336|NCT00566228|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
597337|NCT00566241|Body weight|body weight
597338|NCT00566241|Body composition|body composition
597339|NCT00566241|Pulmonary function|pulmonary function
597340|NCT00566241|Carbohydrate tolerance|carbohydrate tolerance
597341|NCT00566254|Epilepsy|epilepsy
597342|NCT00566254|paediatric|paediatric
597343|NCT00566254|partial onset seizures|partial onset seizures
597344|NCT00566280|MBI|mbi
597345|NCT00566280|Mammogram|mammogram
597346|NCT00566280|Breast Cancer|breast cancer
597347|NCT00566280|Breast Ultrasound|breast ultrasound
597348|NCT00566280|Bloody Nipple Discharge|bloody nipple discharge
597349|NCT00566280|Molecular Breast Imaging|molecular breast imaging
597350|NCT00566306|Clostridium difficile|clostridium difficile
597351|NCT00566306|disinfectant|disinfectant
597352|NCT00566319|Exercise|exercise
597353|NCT00566332|Waldenström Macroglobulinemia|waldenström macroglobulinemia
597354|NCT00566332|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
597355|NCT00566332|Splenic Marginal Zone Lymphoma|splenic marginal zone lymphoma
597356|NCT00566332|Fludarabine|fludarabine
597357|NCT00566332|Chlorambucil|chlorambucil
597358|NCT00566358|diabetes mellitus, type 2|diabetes mellitus, type 2
597359|NCT00566358|duodenal exclusion|duodenal exclusion
597360|NCT00566358|bariatric surgery|bariatric surgery
597361|NCT00566358|Glucagon-Like Peptide 1|glucagon-like peptide 1
597362|NCT00566358|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
597363|NCT00566358|insulin|insulin
597364|NCT00566358|glucagon|glucagon
597365|NCT00566358|ghrelin|ghrelin
597366|NCT00566371|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
597367|NCT00566371|insomnia|insomnia
597368|NCT00566371|atomoxetine|atomoxetine
597369|NCT00566384|Loss of libido|loss of libido
597370|NCT00566384|Acquired, oral contraceptive -associated female sexual dysfunction|acquired, oral contraceptive -associated female sexual dysfunction
597371|NCT00566397|RI RI Study Rage Inhibitors|ri ri study rage inhibitors
597372|NCT00566410|DCA|dca
597373|NCT00566410|Phase I|phase i
597374|NCT00566410|Dose Escalation|dose escalation
597375|NCT00566410|Solid Tumours|solid tumours
597376|NCT00566410|Dichloroacetate|dichloroacetate
597377|NCT00566410|Pharmacokinetic|pharmacokinetic
597378|NCT00566423|PAH|pah
597379|NCT00566423|Biomarkers|biomarkers
597380|NCT00566423|MIF|mif
597381|NCT00566423|BNP|bnp
597382|NCT00566423|6 Minute Walk (6MW)|6 minute walk (6mw)
597383|NCT00566436|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
597384|NCT00566436|Superficial Femoral Artery|superficial femoral artery
597385|NCT00566436|Remote Endarterectomy|remote endarterectomy
597386|NCT00566436|Suprageniculate Bypass Surgery|suprageniculate bypass surgery
597387|NCT00566436|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
597388|NCT00566436|Vascular Patency|vascular patency
597389|NCT00566449|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
597390|NCT00566449|ADHD|adhd
597391|NCT00566449|JNJ-31001074|jnj-31001074
597392|NCT00566488|Thymus Transplantation|thymus transplantation
597393|NCT00566488|Parathyroid Transplantation|parathyroid transplantation
597394|NCT00566488|DiGeorge Syndrome|digeorge syndrome
597395|NCT00566488|Hypoparathyroidism|hypoparathyroidism
597396|NCT00566488|Athymia|athymia
597397|NCT00566501|Moderate-to-severe|moderate-to-severe
597398|NCT00566501|Alzheimer's|alzheimer's
597399|NCT00566501|Disease|disease
597400|NCT00566514|fibromyalgia|fibromyalgia
597401|NCT00566514|ribose|ribose
597402|NCT00566514|d-ribose|d-ribose
597403|NCT00566514|dextrose|dextrose
597404|NCT00566540|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
597405|NCT00566540|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
597406|NCT00566540|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
597407|NCT00566540|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
597408|NCT00566540|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
597409|NCT00566540|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
597410|NCT00566540|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
597411|NCT00566553|Grape Seed Extract|grape seed extract
597412|NCT00566553|Breast Cancer|breast cancer
597413|NCT00566553|Estrogen Levels|estrogen levels
597414|NCT00566553|Aromatase Inhibitor|aromatase inhibitor
597415|NCT00566566|adipocytokines|adipocytokines
597416|NCT00566566|inflammatory markers|inflammatory markers
597417|NCT00566566|cardiovascular disease|cardiovascular disease
597418|NCT00566566|diabetes mellitus|diabetes mellitus
597419|NCT00566566|Leptin|leptin
597420|NCT00566579|Human papillomavirus|human papillomavirus
597421|NCT00566579|Clearance|clearance
597422|NCT00566579|Cryotherapy|cryotherapy
597423|NCT00566618|Breast Cancer|breast cancer
597424|NCT00566618|Bone Metastases|bone metastases
597425|NCT00566618|Breast Cancer with Bone Metastases|breast cancer with bone metastases
597426|NCT00566618|Breast Cancer with Metastases to Bone|breast cancer with metastases to bone
597427|NCT00566618|Dasatinib|dasatinib
597428|NCT00566618|Zometa|zometa
597429|NCT00566618|Zoledronic Acid|zoledronic acid
597430|NCT00566618|Zoledronate|zoledronate
597431|NCT00566618|BMS-345825|bms-345825
597432|NCT00566618|Sprycel®|sprycel®
597433|NCT00566631|Schizophrenia|schizophrenia
597434|NCT00566631|Paliperidone Extended Release (ER)|paliperidone extended release (er)
597435|NCT00566631|Invega|invega
597436|NCT00566644|endometrial cancer|endometrial cancer
597437|NCT00566644|hereditary non-polyposis colon cancer (hMSH2, hMLH1, hPMS1, hPMS2)|hereditary non-polyposis colon cancer (hmsh2, hmlh1, hpms1, hpms2)
597438|NCT00566657|Critical Limb Ischemia|critical limb ischemia
597439|NCT00566657|Peripheral Artery Disease|peripheral artery disease
597440|NCT00566657|Plasmid based gene therapy|plasmid based gene therapy
597441|NCT00566670|Hemodialysis|hemodialysis
597442|NCT00566683|Propofol|propofol
597443|NCT00566683|colonoscopy|colonoscopy
597444|NCT00566683|sedation|sedation
597445|NCT00566683|pain|pain
597446|NCT00566683|compare NAPS versus diazemuls in outpatient colonoscopy|compare naps versus diazemuls in outpatient colonoscopy
597447|NCT00566696|Haploidentical stem cell transplant|haploidentical stem cell transplant
597448|NCT00566696|Allogeneic stem cell transplant|allogeneic stem cell transplant
598821|NCT00565760|Acute|acute
597449|NCT00566696|Mismatched family member stem cell donor transplant|mismatched family member stem cell donor transplant
597450|NCT00566696|Bone marrow transplant|bone marrow transplant
597451|NCT00566696|High risk hematologic malignancies|high risk hematologic malignancies
597452|NCT00566696|T cell depletion methodology|t cell depletion methodology
597453|NCT00566696|Miltenyi Biotec CliniMACS stem cell selection device|miltenyi biotec clinimacs stem cell selection device
597454|NCT00566696|Campath-1H intravenous|campath-1h intravenous
597455|NCT00566709|transfusion|transfusion
597456|NCT00566709|NIRS|nirs
597457|NCT00566709|cerebral oxygenation|cerebral oxygenation
597458|NCT00566709|red blood cell|red blood cell
597459|NCT00566709|near infrared spectroscopy|near infrared spectroscopy
597460|NCT00566761|Macular edema|macular edema
597461|NCT00566761|central retinal vein occlusion|central retinal vein occlusion
597462|NCT00566761|bevacizumab|bevacizumab
597463|NCT00566761|triamcinolone|triamcinolone
597464|NCT00566774|myocardial infarction|myocardial infarction
597465|NCT00566774|secondary prevention|secondary prevention
597466|NCT00566774|health insurance|health insurance
597467|NCT00566774|cost-sharing|cost-sharing
597469|NCT00566787|Atrial Fibrillation|atrial fibrillation
597470|NCT00566787|afib|afib
597471|NCT00566787|racing heart|racing heart
597472|NCT00566787|cabg|cabg
597473|NCT00566787|valve|valve
597474|NCT00566787|ablation|ablation
597475|NCT00566787|bipolar|bipolar
597476|NCT00566787|radiofrequency|radiofrequency
597477|NCT00566787|rf|rf
597478|NCT00566800|esophageal cancer|esophageal cancer
597479|NCT00566800|Barrett esophagus|barrett esophagus
597480|NCT00566813|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
597481|NCT00566813|Islets of Langerhans Transplantation|islets of langerhans transplantation
597482|NCT00566813|Exenatide|exenatide
597483|NCT00566813|Soluble tumor necrosis factor receptor|soluble tumor necrosis factor receptor
597484|NCT00566826|Physical Function|physical function
597485|NCT00566826|Total Knee Replacement|total knee replacement
597486|NCT00566826|Physical Activity|physical activity
597487|NCT00566826|Behavioral Support|behavioral support
597488|NCT00566826|Arthroplasty|arthroplasty
597489|NCT00566826|Function|function
597490|NCT00566826|Self-Care|self-care
597491|NCT00566839|COPD|copd
597492|NCT00566839|LVRS|lvrs
597493|NCT00566839|Awake surgery|awake surgery
597494|NCT00566839|Thoracic epidural anesthesia|thoracic epidural anesthesia
597495|NCT00566839|One-lung ventilation|one-lung ventilation
597496|NCT00566839|Emphysema|emphysema
597497|NCT00566839|VATS|vats
597498|NCT00566839|Lung surgery|lung surgery
597499|NCT00566852|cognitive/functional effects|cognitive/functional effects
597500|NCT00566852|neurotoxicity|neurotoxicity
597501|NCT00566852|tumors metastatic to brain|tumors metastatic to brain
597502|NCT00566852|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
597503|NCT00566878|Glycogen Storage Disease|glycogen storage disease
597504|NCT00566878|GSD-II|gsd-ii
597505|NCT00566878|Pompe Disease|pompe disease
597506|NCT00566878|Pompe Disease (Late-Onset)|pompe disease (late-onset)
597507|NCT00566878|Acid Maltase Deficiency Disease|acid maltase deficiency disease
597508|NCT00566878|Glycogenosis II|glycogenosis ii
597509|NCT00566891|percutaneous coronary angioplasty|percutaneous coronary angioplasty
597510|NCT00566891|pci|pci
597511|NCT00566891|tirofiban|tirofiban
597512|NCT00566891|side effects|side effects
597513|NCT00566904|Post-herpetic Neuralgia|post-herpetic neuralgia
597514|NCT00566904|Pain after Shingles|pain after shingles
597515|NCT00566904|Shingles|shingles
597516|NCT00566904|PHN|phn
597517|NCT00566917|Vagina|vagina
597518|NCT00566917|Prolapse|prolapse
597519|NCT00566917|Anterior vaginal wall prolapse|anterior vaginal wall prolapse
597520|NCT00566943|Staple Line Reinforcement, Buttress|staple line reinforcement, buttress
597521|NCT00566956|Hydrosalpinx/IVF/Reproductive outcome.|hydrosalpinx/ivf/reproductive outcome.
597522|NCT00566956|Hydrosalpinx|hydrosalpinx
597523|NCT00566969|cocaine, opiate, methadone, carvedilol|cocaine, opiate, methadone, carvedilol
597524|NCT00566982|Urogenital atrophy|urogenital atrophy
597525|NCT00566982|Menopausal symptoms|menopausal symptoms
597526|NCT00566982|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
597527|NCT00566982|Vaginal atrophy|vaginal atrophy
597528|NCT00566995|Kidney Tumors|kidney tumors
597529|NCT00566995|Clear Cell Renal Cancer|clear cell renal cancer
597530|NCT00566995|VEGFR Inhibitor|vegfr inhibitor
597531|NCT00566995|EGFR Inhibitor|egfr inhibitor
597532|NCT00566995|VHL|vhl
597533|NCT00566995|Von Hippel Lindau|von hippel lindau
597534|NCT00566995|Kidney Tumor|kidney tumor
597536|NCT00567008|crack cocaine|crack cocaine
597537|NCT00567008|cocaine-related disorders|cocaine-related disorders
597538|NCT00567008|substance-related disorders|substance-related disorders
597539|NCT00567008|alpha4beta2 nicotinic acetylcholine receptor|alpha4beta2 nicotinic acetylcholine receptor
597540|NCT00567021|reflux|reflux
597541|NCT00567021|NSAR treatment|nsar treatment
597542|NCT00567021|Patients with reflux symptoms or gastrointestinal symptoms after NSAR Treatment|patients with reflux symptoms or gastrointestinal symptoms after nsar treatment
597543|NCT00567034|Zyprexa|zyprexa
597545|NCT00567034|schizophrenia|schizophrenia
597546|NCT00567034|Metabolic Syndrome|metabolic syndrome
597547|NCT00567034|pain|pain
597548|NCT00567060|Piracetam|piracetam
597549|NCT00567060|Nootropil|nootropil
597550|NCT00567073|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
597551|NCT00567073|GSD-II|gsd-ii
597552|NCT00567073|Pompe Disease|pompe disease
597553|NCT00567073|Pompe Disease (Late-Onset)|pompe disease (late-onset)
597554|NCT00567073|Acid Maltase Deficiency Disease|acid maltase deficiency disease
597555|NCT00567073|Glycogenosis II|glycogenosis ii
597556|NCT00567086|Migraine|migraine
597557|NCT00567099|Psychiatry|psychiatry
597558|NCT00567099|Antipsychotic|antipsychotic
597559|NCT00567099|Psychopharmacology|psychopharmacology
597560|NCT00567099|Clinical Trial|clinical trial
597561|NCT00567099|Open Label|open label
597562|NCT00567099|Schizophrenia|schizophrenia
597563|NCT00567099|Sensory Gating|sensory gating
597564|NCT00567099|Attention|attention
597566|NCT00567125|low-pressure pneumoperitoneum|low-pressure pneumoperitoneum
597567|NCT00567125|laparoscopy|laparoscopy
597568|NCT00567125|cytokines|cytokines
597569|NCT00567125|VEGF-A|vegf-a
597570|NCT00567125|endostatin|endostatin
597571|NCT00567164|Oral Contraception|oral contraception
597572|NCT00567164|Birth Control pill|birth control pill
597573|NCT00567164|Healthy women requesting oral contraception|healthy women requesting oral contraception
597574|NCT00567164|Contraceptive efficacy|contraceptive efficacy
597575|NCT00567190|Herceptin|herceptin
597576|NCT00567190|Breast cancer|breast cancer
597577|NCT00567190|MBC|mbc
597578|NCT00567190|Taxotere|taxotere
597579|NCT00567190|HER2|her2
597580|NCT00567190|HER2 positive breast cancer|her2 positive breast cancer
597581|NCT00567190|HER2 + breast cancer|her2 + breast cancer
597582|NCT00567190|HER2-positive|her2-positive
597583|NCT00567190|HER2-positive metastatic breast cancer|her2-positive metastatic breast cancer
597584|NCT00567229|refractory multiple myeloma|refractory multiple myeloma
597585|NCT00567242|aphasia|aphasia
597586|NCT00567242|therapies, investigational|therapies, investigational
597587|NCT00567242|rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
597588|NCT00567242|magnetic resonance imaging, functional|magnetic resonance imaging, functional
597589|NCT00567242|language|language
597590|NCT00567255|Obesity|obesity
597591|NCT00567268|Post-Marketing surveillance|post-marketing surveillance
597592|NCT00567281|Schizoaffective disorder|schizoaffective disorder
597593|NCT00567281|Auditory Hallucinations|auditory hallucinations
597594|NCT00567281|Voices|voices
597595|NCT00567281|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
597596|NCT00567281|rTMS|rtms
597597|NCT00567281|Wernicke's Area|wernicke's area
597598|NCT00567281|Middle Temporal Cortex|middle temporal cortex
597599|NCT00567281|Persistent Auditory Hallucinations|persistent auditory hallucinations
597600|NCT00567281|"Previously Participated in Parent rTMS Protocol"|"previously participated in parent rtms protocol"
597601|NCT00567294|Osteoporosis|osteoporosis
597602|NCT00567294|Medication adherence|medication adherence
597603|NCT00567294|Telephonic education|telephonic education
597604|NCT00567294|Motivational interviewing|motivational interviewing
597605|NCT00567320|varenicline|varenicline
597606|NCT00567346|randomised|randomised
597607|NCT00567346|double-blind|double-blind
597608|NCT00567346|placebo-controlled|placebo-controlled
597609|NCT00567346|efficacy and safety|efficacy and safety
597610|NCT00567346|Oralgen® Grass Pollen|oralgen® grass pollen
597611|NCT00567346|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
597612|NCT00567346|Allergy|allergy
597613|NCT00567346|Rhinoconjunctivitis|rhinoconjunctivitis
597614|NCT00567346|Immunotherapy|immunotherapy
597615|NCT00567346|Grass pollen extract|grass pollen extract
597616|NCT00567359|NSCLC|nsclc
597617|NCT00567359|erlotinib|erlotinib
597618|NCT00567359|epidermal growth factor receptor|epidermal growth factor receptor
597619|NCT00567359|EGFR|egfr
597620|NCT00567372|Diffuse diabetic macular edema|diffuse diabetic macular edema
597621|NCT00567372|sub-tenon|sub-tenon
597622|NCT00567372|Bevacizumab|bevacizumab
597623|NCT00567398|ESRD|esrd
597624|NCT00567398|Diabetes|diabetes
597625|NCT00567398|CAPD|capd
597626|NCT00567398|APD|apd
597627|NCT00567411|Glaucoma|glaucoma
597628|NCT00567411|Laser|laser
597629|NCT00567411|laser trabeculoplasty|laser trabeculoplasty
597630|NCT00567411|selective laser trabeculoplasty|selective laser trabeculoplasty
597631|NCT00567411|intraocular pressure|intraocular pressure
597632|NCT00567424|epilepsy|epilepsy
597633|NCT00567424|refractory|refractory
597635|NCT00567424|drug interactions|drug interactions
597636|NCT00567424|pharmacokinetics|pharmacokinetics
597637|NCT00567437|aortic stenosis|aortic stenosis
597638|NCT00567437|prognosis|prognosis
597639|NCT00567437|brain natriuretic peptide|brain natriuretic peptide
597640|NCT00567450|sciatic block|sciatic block
597641|NCT00567450|ropivacaine|ropivacaine
597642|NCT00567450|mepivacaine|mepivacaine
597643|NCT00567450|locoregional anesthesia|locoregional anesthesia
597644|NCT00567463|Asthma|asthma
597645|NCT00567463|Bronchial hyperresponsiveness|bronchial hyperresponsiveness
597646|NCT00567463|Methacholine|methacholine
597647|NCT00567463|Induced sputum|induced sputum
597648|NCT00567463|bronchial biopsies|bronchial biopsies
597649|NCT00567476|Asthma, anti-immunoglobulin E, omalizumab|asthma, anti-immunoglobulin e, omalizumab
597650|NCT00567489|ESRD|esrd
597651|NCT00567489|Diabetes|diabetes
597652|NCT00567489|CAPD|capd
597653|NCT00567489|APD|apd
597654|NCT00567528|Soft tissue injuries|soft tissue injuries
597655|NCT00567528|Topical ibuprofen|topical ibuprofen
597656|NCT00567528|Adolescent athletes|adolescent athletes
597657|NCT00567541|shoulder|shoulder
597658|NCT00567541|pain|pain
597659|NCT00567541|stroke|stroke
597660|NCT00567541|subluxation|subluxation
597661|NCT00567554|breast cancer|breast cancer
597662|NCT00567554|primary systemic therapy|primary systemic therapy
597663|NCT00567554|pCR Rates|pcr rates
597664|NCT00567554|Bevacizumab|bevacizumab
597665|NCT00567554|Trastuzumab|trastuzumab
597666|NCT00567554|Lapatinib|lapatinib
597667|NCT00567554|Everolimus|everolimus
597668|NCT00567580|stage IIB prostate cancer|stage iib prostate cancer
597669|NCT00567580|stage IIA prostate cancer|stage iia prostate cancer
597670|NCT00567580|stage III prostate cancer|stage iii prostate cancer
597671|NCT00567580|adenocarcinoma of the prostate|adenocarcinoma of the prostate
597672|NCT00567619|GERD|gerd
597673|NCT00567619|NIS|nis
597674|NCT00567632|Pneumococci|pneumococci
597675|NCT00567632|Antibody|antibody
597676|NCT00567632|Standard laboratory values|standard laboratory values
597677|NCT00567671|keratoconus|keratoconus
597678|NCT00567671|ectasia|ectasia
597679|NCT00567671|cross-linking|cross-linking
597680|NCT00567671|riboflavin|riboflavin
597681|NCT00567671|UVA light|uva light
597682|NCT00567671|cornea|cornea
597683|NCT00567684|Transitional Cell Carcinoma|transitional cell carcinoma
597684|NCT00567684|Urothelial Cancer|urothelial cancer
597685|NCT00567684|Bladder Cancer|bladder cancer
597686|NCT00567684|Computed Tomography Urography|computed tomography urography
597687|NCT00567684|CTU|ctu
597688|NCT00567684|Intravenous Urography|intravenous urography
597689|NCT00567684|IVU|ivu
597690|NCT00567684|TCC|tcc
597691|NCT00567684|transitional cell carcinomas|transitional cell carcinomas
597692|NCT00567697|ranibizumab|ranibizumab
597693|NCT00567697|CRVO|crvo
597694|NCT00567697|macular edema|macular edema
597695|NCT00567697|sham|sham
597696|NCT00567736|low back pain|low back pain
597697|NCT00567736|complementary therapies|complementary therapies
597698|NCT00567749|HIV-1 Infections|hiv-1 infections
597699|NCT00567762|Keratoconjunctivitis|keratoconjunctivitis
597700|NCT00567762|vernal keratoconjunctivitis|vernal keratoconjunctivitis
597701|NCT00567762|FK506|fk506
597702|NCT00567762|Tacrolimus|tacrolimus
597703|NCT00567788|Glaucoma, angle-closure|glaucoma, angle-closure
597704|NCT00567801|Lower Extremity|lower extremity
597705|NCT00567801|Ischemia|ischemia
597706|NCT00567814|Cocaine|cocaine
597707|NCT00567814|Dependence|dependence
597708|NCT00567814|Addiction|addiction
597709|NCT00567814|Cortisol|cortisol
597710|NCT00567814|GABA|gaba
597711|NCT00567827|Pneumonia|pneumonia
597712|NCT00567840|Early Bactericidal Activity|early bactericidal activity
597713|NCT00567840|EBA|eba
597714|NCT00567840|pulmonary tuberculosis|pulmonary tuberculosis
597715|NCT00567840|PA-824|pa-824
597716|NCT00567840|Pretomanid|pretomanid
597717|NCT00567840|CL-007|cl-007
597718|NCT00567853|mitral valve regurgitation|mitral valve regurgitation
597719|NCT00567853|mitral valve disease|mitral valve disease
597720|NCT00567853|mitral valve repair|mitral valve repair
598090|NCT00568815|Toxicity|toxicity
597721|NCT00567853|mitral valve dysfunction|mitral valve dysfunction
597722|NCT00567853|heart valve|heart valve
597723|NCT00567853|valve disease|valve disease
597724|NCT00567853|cardiac surgery|cardiac surgery
597725|NCT00567879|Breast Cancer|breast cancer
597726|NCT00567879|HER2 positive|her2 positive
597727|NCT00567879|adult-female|adult-female
597728|NCT00567879|LBH589|lbh589
597729|NCT00567879|HDAC inhibitor|hdac inhibitor
597730|NCT00567879|panobinostat|panobinostat
597731|NCT00567892|tinnitus|tinnitus
597732|NCT00567892|subjective tinnitus|subjective tinnitus
597733|NCT00567892|therapy|therapy
597734|NCT00567892|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
597735|NCT00567892|clinical trial|clinical trial
597736|NCT00567905|Type 2 Diabetes|type 2 diabetes
597737|NCT00567905|Green tea extract|green tea extract
597738|NCT00567905|overweight|overweight
597739|NCT00567918|Keratoconjunctivitis|keratoconjunctivitis
597839|NCT00556491|minocycline|minocycline
597740|NCT00567918|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
597741|NCT00567918|FK506|fk506
597742|NCT00567918|Tacrolimus|tacrolimus
597743|NCT00567944|Physical Therapy Modalities|physical therapy modalities
597744|NCT00567944|Electric Stimulation|electric stimulation
597745|NCT00567944|Postural Balance|postural balance
597746|NCT00567957|pre-eclampsia|pre-eclampsia
597747|NCT00567957|remifentanil|remifentanil
597748|NCT00567957|anesthesia, general|anesthesia, general
597749|NCT00567957|analgesics, opioid|analgesics, opioid
598822|NCT00565760|Pain|pain
597750|NCT00567957|anesthetics, intravenous|anesthetics, intravenous
597751|NCT00567957|Cesarean section|cesarean section
597752|NCT00567957|newborn|newborn
597753|NCT00567957|maternal haemodynamic|maternal haemodynamic
597754|NCT00567970|liver metastases|liver metastases
597755|NCT00567996|Chronic obstructive pulmonary disease, indacaterol, salmeterol, placebo controlled|chronic obstructive pulmonary disease, indacaterol, salmeterol, placebo controlled
597756|NCT00568009|Congestive Heart Failure|congestive heart failure
597757|NCT00568009|Impaired Renal Function|impaired renal function
597758|NCT00568035|diabetic|diabetic
597759|NCT00568035|peripheral|peripheral
597760|NCT00568035|neuropathy|neuropathy
597761|NCT00568048|stage IV melanoma|stage iv melanoma
597762|NCT00568048|recurrent melanoma|recurrent melanoma
597763|NCT00568061|INOT44|inot44
597764|NCT00568061|NOMI|nomi
597765|NCT00568087|N-acetylcysteine|n-acetylcysteine
597766|NCT00568087|Alcoholism|alcoholism
597767|NCT00568087|Treatment|treatment
597768|NCT00568100|gas exchange|gas exchange
597769|NCT00568100|pressure support ventilation|pressure support ventilation
597770|NCT00568100|respiratory mechanics|respiratory mechanics
597771|NCT00568100|COPD|copd
597772|NCT00568100|NAVA|nava
597773|NCT00568113|preterm labour|preterm labour
597774|NCT00568113|n acetyl cysteine|n acetyl cysteine
597775|NCT00568113|bacterial vaginosis|bacterial vaginosis
597776|NCT00568126|Antidepressant Induced Sexual Dysfunction|antidepressant induced sexual dysfunction
597777|NCT00568126|Depression|depression
597778|NCT00568126|Sexual Dysfunction|sexual dysfunction
597779|NCT00568139|adrenal cancer|adrenal cancer
597780|NCT00568139|mitotane (Lysodren)|mitotane (lysodren)
597781|NCT00568139|adverse events|adverse events
597782|NCT00568152|Apples|apples
597783|NCT00568152|Dietary intervention|dietary intervention
597784|NCT00568152|Procyanidins|procyanidins
597785|NCT00568165|Heart failure, congestive|heart failure, congestive
597786|NCT00568165|Echocardiography|echocardiography
597787|NCT00568165|Patient care team|patient care team
597788|NCT00568191|Age-related macular degeneration|age-related macular degeneration
597789|NCT00568191|choroidal neovascularization|choroidal neovascularization
597790|NCT00568191|Stratus OCT|stratus oct
597791|NCT00568191|Cirrus OCT|cirrus oct
597792|NCT00568204|pruritus, itching, mexyn-a, clearitch, magicool-plus|pruritus, itching, mexyn-a, clearitch, magicool-plus
597793|NCT00568230|heart failure|heart failure
597794|NCT00568230|mitral regurgitation|mitral regurgitation
597795|NCT00568243|Visuomotor Integration|visuomotor integration
597796|NCT00568243|Visual Attention|visual attention
597797|NCT00568243|Healthy Volunteer|healthy volunteer
597798|NCT00568243|HV|hv
597799|NCT00568256|Ulcerative Colitis|ulcerative colitis
597800|NCT00568256|IBD Flare-Up|ibd flare-up
597801|NCT00568256|Stress|stress
597802|NCT00568269|Recurrence rate after inguinal hernia repair on primary inguinal herina.|recurrence rate after inguinal hernia repair on primary inguinal herina.
597803|NCT00568308|Hepatocellular Carcinoma|hepatocellular carcinoma
597804|NCT00568308|PI-88|pi-88
597805|NCT00568308|Phase III|phase iii
597806|NCT00568308|Adjuvant Therapy|adjuvant therapy
597807|NCT00568308|Hepatoma|hepatoma
597808|NCT00568308|Liver Cancer|liver cancer
597809|NCT00568321|monoclonal antibody|monoclonal antibody
597810|NCT00568334|chickenpox|chickenpox
597811|NCT00568334|varicella|varicella
597812|NCT00568334|two-dose schedule|two-dose schedule
597813|NCT00568334|second year of life|second year of life
597814|NCT00568347|chronic airflow obstruction|chronic airflow obstruction
597815|NCT00568373|Gastroparesis|gastroparesis
598494|NCT00570167|Artroplasty|artroplasty
597816|NCT00568373|Gastric electrical stimulator|gastric electrical stimulator
597817|NCT00568386|Dry eye|dry eye
597818|NCT00568399|Coronary|coronary
597819|NCT00568399|Calcification|calcification
597820|NCT00568399|Dialysis|dialysis
597821|NCT00568399|Thiosulfate|thiosulfate
597822|NCT00568399|Cardiovascular|cardiovascular
597823|NCT00568412|atopic dermatitis|atopic dermatitis
597824|NCT00568451|stage IV melanoma|stage iv melanoma
597825|NCT00568451|recurrent melanoma|recurrent melanoma
597826|NCT00568464|ESFT (Ewing's sarcoma family of tumors)|esft (ewing's sarcoma family of tumors)
597827|NCT00568464|Response rate|response rate
597828|NCT00568464|TTP|ttp
597829|NCT00568464|OS|os
597830|NCT00568464|Toxicity|toxicity
597831|NCT00568477|Rituximab, Heemannn|rituximab, heemannn
597832|NCT00568503|COPD/TIOTROPIUM/QAX028|copd/tiotropium/qax028
597833|NCT00556491|renal|renal
597834|NCT00556491|kidney|kidney
597835|NCT00556491|injury|injury
597836|NCT00556491|acute|acute
597837|NCT00556491|bypass|bypass
597838|NCT00556491|cardiac|cardiac
597841|NCT00556491|Acute Kidney Failure|acute kidney failure
597842|NCT00556504|add-on treatment|add-on treatment
597843|NCT00556504|botanical drug|botanical drug
597844|NCT00556504|HCV genotype 1|hcv genotype 1
597845|NCT00556504|TCM-700C|tcm-700c
597846|NCT00556504|genotype I|genotype i
597847|NCT00556517|Hamstring|hamstring
597848|NCT00556517|Strain|strain
597849|NCT00556517|Rehabilitation|rehabilitation
597850|NCT00556517|muscles|muscles
597851|NCT00556530|Congenital Heart Defects|congenital heart defects
597852|NCT00556530|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
597853|NCT00556530|Copy Number Variations|copy number variations
597854|NCT00556530|Whole Genome Association Study|whole genome association study
597855|NCT00556543|Rib Fracture|rib fracture
597856|NCT00556543|Rib Fracture Repair|rib fracture repair
597857|NCT00556543|Rib Fracture ORIF|rib fracture orif
597858|NCT00556543|Flail Chest|flail chest
597859|NCT00556543|Implant|implant
597860|NCT00556543|Prosthesis|prosthesis
597861|NCT00556543|Rib fracture non-union|rib fracture non-union
597862|NCT00556543|Chest wall deformity|chest wall deformity
597863|NCT00556569|Physical activity|physical activity
597864|NCT00556569|Obesity|obesity
597865|NCT00556595|atrial fibrillation|atrial fibrillation
597866|NCT00556595|paroxysmal|paroxysmal
597867|NCT00556595|symptomatic|symptomatic
597868|NCT00556595|drug-refractory|drug-refractory
597869|NCT00556621|stage II bladder cancer|stage ii bladder cancer
597870|NCT00556621|stage III bladder cancer|stage iii bladder cancer
597871|NCT00556621|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
597873|NCT00556634|efavirenz|efavirenz
597874|NCT00556634|central nervous system|central nervous system
597875|NCT00556634|adverse effects|adverse effects
597876|NCT00556647|fast-track diagnosis|fast-track diagnosis
597877|NCT00556647|PET-CT|pet-ct
597878|NCT00556647|endoscopic techniques|endoscopic techniques
597879|NCT00556647|lung cancer|lung cancer
597880|NCT00556660|Alzheimer|alzheimer
597881|NCT00556660|SPECT|spect
597882|NCT00556673|Asthma, QMF149, fixed combination of indacaterol and mometasone furoate|asthma, qmf149, fixed combination of indacaterol and mometasone furoate
597883|NCT00556699|NHL|nhl
597884|NCT00556699|Rituxan|rituxan
597885|NCT00556699|anti-CD40|anti-cd40
597886|NCT00556738|HFPV|hfpv
597887|NCT00556738|neonatal respiratory distress|neonatal respiratory distress
597888|NCT00556751|Electrocardiogram|electrocardiogram
597889|NCT00556751|Electrocardiography|electrocardiography
597890|NCT00556751|Cardiovascular Risk Factors|cardiovascular risk factors
597891|NCT00556751|Cholesterol|cholesterol
597892|NCT00556751|Blood Pressure|blood pressure
597893|NCT00556751|Diabetes|diabetes
597894|NCT00556764|ANAM|anam
597895|NCT00556764|Parkinson's|parkinson's
597896|NCT00556777|stage I breast cancer|stage i breast cancer
597897|NCT00556803|hepatocellular carcinoma|hepatocellular carcinoma
597898|NCT00556803|liver cancer|liver cancer
597899|NCT00556803|radiofrequency ablation|radiofrequency ablation
597900|NCT00556803|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
597901|NCT00556803|adjuvant therapy|adjuvant therapy
597902|NCT00562328|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
597903|NCT00562328|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
597904|NCT00562328|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
597905|NCT00562341|obesity|obesity
597906|NCT00562341|psa|psa
597907|NCT00562341|prostate cancer|prostate cancer
597908|NCT00562354|Vaccines, Pneumococcal Conjugate Vaccine|vaccines, pneumococcal conjugate vaccine
597909|NCT00562380|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
597910|NCT00562380|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
597911|NCT00562380|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
751773|NCT01170377|Valproate|valproate
597912|NCT00562380|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
597913|NCT00562380|anaplastic large cell lymphoma|anaplastic large cell lymphoma
597989|NCT00562640|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
597914|NCT00562380|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
597915|NCT00562380|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
597916|NCT00562380|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
752337|NCT01172548|minimal toxicity|minimal toxicity
597917|NCT00562380|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
597918|NCT00562380|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
597919|NCT00562380|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
597920|NCT00562380|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
597921|NCT00562380|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
597922|NCT00562380|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
597923|NCT00562380|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
597924|NCT00562380|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
597925|NCT00562380|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
597926|NCT00562380|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
599001|NCT00573300|Kynurenate|kynurenate
597927|NCT00562380|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
597928|NCT00562380|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
597929|NCT00562380|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
597930|NCT00562380|small intestine lymphoma|small intestine lymphoma
597931|NCT00562380|splenic marginal zone lymphoma|splenic marginal zone lymphoma
597932|NCT00562380|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
598023|NCT00562757|Ischemic heart disease|ischemic heart disease
597933|NCT00562380|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
597934|NCT00562380|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
597935|NCT00562380|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
597936|NCT00562380|recurrent prostate cancer|recurrent prostate cancer
597937|NCT00562406|Macular edema secondary to branch retinal vein occlusion|macular edema secondary to branch retinal vein occlusion
597938|NCT00562432|atrial fibrillation|atrial fibrillation
597939|NCT00562432|CABG|cabg
597940|NCT00562432|ganglionated plexi|ganglionated plexi
597941|NCT00562445|Adrenal insufficiency|adrenal insufficiency
597942|NCT00562445|GI bleeding|gi bleeding
597943|NCT00562445|Portal hypertension|portal hypertension
597944|NCT00562445|Acute pancreatitis|acute pancreatitis
597945|NCT00562445|Critical emergencies in digestive diseases|critical emergencies in digestive diseases
597946|NCT00562445|Severe acute pancreatitis|severe acute pancreatitis
597947|NCT00562458|Advanced breast cancer|advanced breast cancer
597948|NCT00562458|Advanced breast cancer in postmenopausal women|advanced breast cancer in postmenopausal women
597949|NCT00562471|adhesions|adhesions
597950|NCT00562471|gynecologic surgery|gynecologic surgery
597951|NCT00562471|laparoscopy|laparoscopy
597952|NCT00562471|laparotomy|laparotomy
597953|NCT00562471|polyethylene glycol|polyethylene glycol
597954|NCT00562471|hydrogel|hydrogel
597955|NCT00562471|Adhesions following gynecologic surgery to remove myomas|adhesions following gynecologic surgery to remove myomas
597956|NCT00562497|Acute GVHD|acute gvhd
597957|NCT00562497|Acute Graft Versus Host Disease|acute graft versus host disease
597958|NCT00562510|HIV-1 infection|hiv-1 infection
597959|NCT00562510|raltegravir|raltegravir
597960|NCT00562510|immune discordance|immune discordance
597961|NCT00562510|treatment experienced|treatment experienced
597962|NCT00562523|Cancer|cancer
597963|NCT00562523|Docetaxel|docetaxel
597964|NCT00562523|Sorafenib|sorafenib
597965|NCT00562536|Umbilical cord clamping|umbilical cord clamping
597966|NCT00562536|Preterm infants|preterm infants
597967|NCT00562536|Randomized controlled trial|randomized controlled trial
597968|NCT00562536|For women giving birth to singleton infants 32 weeks gestational age or less|for women giving birth to singleton infants 32 weeks gestational age or less
597969|NCT00562601|Leukapheresis|leukapheresis
597970|NCT00562601|Plasmapheresis|plasmapheresis
597971|NCT00562601|Lymphocytes|lymphocytes
597972|NCT00562601|Neutrophils|neutrophils
597973|NCT00562627|osteoarthritis|osteoarthritis
597974|NCT00562627|knee arthroplasty|knee arthroplasty
597975|NCT00562627|local infiltration analgesia|local infiltration analgesia
597976|NCT00562627|TKA|tka
597977|NCT00562627|epidural analgesia|epidural analgesia
597978|NCT00562627|operation|operation
597979|NCT00562627|surgery|surgery
597980|NCT00562640|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
597981|NCT00562640|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
597982|NCT00562640|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
597983|NCT00562640|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
597984|NCT00562640|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
597985|NCT00562640|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
597986|NCT00562640|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
597987|NCT00562640|recurrent fallopian tube cancer|recurrent fallopian tube cancer
597988|NCT00562640|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
597990|NCT00562640|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
597991|NCT00562640|stage IV fallopian tube cancer|stage iv fallopian tube cancer
597992|NCT00562640|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
597993|NCT00562640|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
597994|NCT00562640|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
597995|NCT00562640|06-155|06-155
597996|NCT00562653|profile autoantibodies|profile autoantibodies
597997|NCT00562653|clinical symptoms|clinical symptoms
597998|NCT00562666|cell therapy|cell therapy
597999|NCT00562666|T lymphocytes|t lymphocytes
598000|NCT00562666|hepatic intra-arterial injection|hepatic intra-arterial injection
598001|NCT00562679|Patients with coronary artery disease|patients with coronary artery disease
598002|NCT00562692|Heart failure|heart failure
598004|NCT00562692|BNP|bnp
598005|NCT00562692|Heart Failure patients who present to the emergency department|heart failure patients who present to the emergency department
598006|NCT00562705|growth hormone|growth hormone
598007|NCT00562705|eating regulation|eating regulation
598008|NCT00562705|nutritional intervention|nutritional intervention
598009|NCT00562705|short stature|short stature
598014|NCT00562718|stage II breast cancer|stage ii breast cancer
598015|NCT00562718|stage IIIA breast cancer|stage iiia breast cancer
598016|NCT00562718|stage IIIB breast cancer|stage iiib breast cancer
598017|NCT00562718|male breast cancer|male breast cancer
598018|NCT00562718|recurrent breast cancer|recurrent breast cancer
598019|NCT00562757|Wedensky modulation|wedensky modulation
598020|NCT00562757|Risk stratification|risk stratification
598021|NCT00562757|Electrophysiology|electrophysiology
598024|NCT00562757|ICD guidelines|icd guidelines
598025|NCT00562757|Myocardial infarction|myocardial infarction
598026|NCT00562770|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
598027|NCT00562770|CLL|cll
598028|NCT00562770|Leukemia|leukemia
598029|NCT00562783|HBV|hbv
598030|NCT00562783|HCV|hcv
598031|NCT00562783|Liver cirrhosis|liver cirrhosis
598032|NCT00562796|Growth Hormone Deficiency|growth hormone deficiency
598033|NCT00562796|Cardiovascular Disease|cardiovascular disease
598034|NCT00562796|Intra-abdominal Fat|intra-abdominal fat
598035|NCT00562796|Insulin Resistance|insulin resistance
598036|NCT00562835|ARDS|ards
598037|NCT00562835|Adult|adult
598038|NCT00562835|Methylprednisolone|methylprednisolone
598039|NCT00568516|ASP3550|asp3550
598040|NCT00568516|Degarelix|degarelix
598041|NCT00568516|Prostate cancer|prostate cancer
598042|NCT00568516|Prostatic neoplasms|prostatic neoplasms
598043|NCT00568529|Advanced gastric cancer|advanced gastric cancer
598044|NCT00568529|Response rate|response rate
598045|NCT00568529|Side effects|side effects
598046|NCT00568529|time to progression|time to progression
598047|NCT00568529|overall survival|overall survival
598048|NCT00568542|cardiomyopathy|cardiomyopathy
598049|NCT00568542|ischemia|ischemia
598050|NCT00568542|percutaneous coronary intervention|percutaneous coronary intervention
598051|NCT00568542|remodeling|remodeling
598052|NCT00568568|Growth Hormone|growth hormone
598053|NCT00568568|GH signaling|gh signaling
598054|NCT00568568|Insulin resistance|insulin resistance
598055|NCT00568568|Insulin Signaling|insulin signaling
598056|NCT00568594|Apolipoprotein A-I,|apolipoprotein a-i,
598057|NCT00568594|Atherosclerosis,|atherosclerosis,
598058|NCT00568594|HDL,|hdl,
598059|NCT00568594|Inflammation,|inflammation,
598060|NCT00568607|NK/T cell lymphoma|nk/t cell lymphoma
598061|NCT00568607|Response Rate|response rate
598062|NCT00568607|TTP|ttp
598063|NCT00568607|OS|os
598064|NCT00568607|Toxicities|toxicities
598065|NCT00568659|Gas exchange|gas exchange
598066|NCT00568659|Respiratory mechanics|respiratory mechanics
598067|NCT00568659|Ventilator Induced Lung Injury|ventilator induced lung injury
598068|NCT00568672|Major Depression|major depression
598069|NCT00568672|Olanzapine|olanzapine
598070|NCT00568672|add-on therapy|add-on therapy
598071|NCT00568672|antidepressant|antidepressant
598072|NCT00568672|atypical antipsychotic|atypical antipsychotic
598073|NCT00568711|Doxycycline,|doxycycline,
598074|NCT00568711|Rifampin|rifampin
598075|NCT00568711|Scrub typhus.|scrub typhus.
598076|NCT00568724|Hydronephrosis|hydronephrosis
598077|NCT00568724|Ureteral obstruction|ureteral obstruction
598078|NCT00568737|Severe Sepsis|severe sepsis
598079|NCT00568750|gastrointestinal stromal tumor|gastrointestinal stromal tumor
598080|NCT00568763|stage IV melanoma|stage iv melanoma
598081|NCT00568763|recurrent melanoma|recurrent melanoma
598082|NCT00568789|Insomnia|insomnia
598083|NCT00568789|Aged|aged
598084|NCT00568789|Postural Balance|postural balance
598085|NCT00568789|Drug Therapy|drug therapy
598086|NCT00568815|DLBCL|dlbcl
598087|NCT00568815|Rituximab|rituximab
598088|NCT00568815|ESHAP|eshap
600260|NCT00572182|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
600261|NCT00572182|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
600262|NCT00572182|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
600276|NCT00572195|Epilepsy|epilepsy
598089|NCT00568815|Efficacy|efficacy
598091|NCT00568828|Macular Teleangiectasia|macular teleangiectasia
598092|NCT00568828|Macular Pigment|macular pigment
599137|NCT00573846|IBD|ibd
598093|NCT00568841|advanced Non-Small-Cell Lung Cancer|advanced non-small-cell lung cancer
598094|NCT00568841|erlotinib|erlotinib
598095|NCT00568841|FDG-PET|fdg-pet
598096|NCT00568841|FLT-PET|flt-pet
598097|NCT00568958|heavy episodic drinking|heavy episodic drinking
598098|NCT00568958|young adults|young adults
598099|NCT00568958|naltrexone|naltrexone
598100|NCT00568958|BASICS counseling|basics counseling
598101|NCT00568958|alcohol-related consequences|alcohol-related consequences
598102|NCT00568958|double-blind trial|double-blind trial
598103|NCT00568958|randomized clinical trial|randomized clinical trial
598104|NCT00568971|DCF|dcf
598105|NCT00568971|Advanced gastric cancer|advanced gastric cancer
598106|NCT00568971|Phase II study|phase ii study
598107|NCT00568971|Efficacy|efficacy
598108|NCT00568971|Toxicity|toxicity
598109|NCT00568997|Atopic dermatitis, eczema, children, pediatric patients, pimecrolimus, malignancy, registry|atopic dermatitis, eczema, children, pediatric patients, pimecrolimus, malignancy, registry
598110|NCT00569010|Acute Myelogenous Leukemia|acute myelogenous leukemia
598111|NCT00569010|AML|aml
598112|NCT00569010|Myelodysplastic Syndrome|myelodysplastic syndrome
598113|NCT00569010|MDS|mds
598114|NCT00569010|Leukemia|leukemia
598115|NCT00569023|Beta Carotene|beta carotene
598116|NCT00569023|visual functions|visual functions
598117|NCT00569023|Fundus albipunctatus|fundus albipunctatus
598118|NCT00569023|Night Blindness|night blindness
598119|NCT00569036|Advanced or Metastatic Solid Tumors or Neoplasms|advanced or metastatic solid tumors or neoplasms
598120|NCT00569062|Psychomotor retardation|psychomotor retardation
598121|NCT00569062|cytokines|cytokines
598122|NCT00569062|GW856553|gw856553
598123|NCT00569062|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
598124|NCT00569075|Apoptic biomarkers|apoptic biomarkers
598823|NCT00565799|DM|dm
598125|NCT00569075|Early detection periodontitis|early detection periodontitis
598126|NCT00569075|Gingival crevicular fluid|gingival crevicular fluid
598127|NCT00569075|Healthy subjects|healthy subjects
598128|NCT00569088|hemorrhagic stroke|hemorrhagic stroke
598129|NCT00569088|Chinese Medicine|chinese medicine
598130|NCT00569088|pathogenesis|pathogenesis
598131|NCT00569088|YURE|yure
598132|NCT00569153|Androgen-independent prostate cancer, metastatic|androgen-independent prostate cancer, metastatic
598133|NCT00569166|fatigue|fatigue
598134|NCT00569166|sleep disorders|sleep disorders
598135|NCT00569166|ductal breast carcinoma in situ|ductal breast carcinoma in situ
598136|NCT00569166|lobular breast carcinoma in situ|lobular breast carcinoma in situ
598137|NCT00569166|breast cancer|breast cancer
598138|NCT00569166|hot flashes|hot flashes
598139|NCT00569179|Myeloid Malignancies|myeloid malignancies
598140|NCT00569179|Bone Marrow Transplant|bone marrow transplant
598141|NCT00569179|AML|aml
598142|NCT00569179|ALL|all
598143|NCT00569179|MDS|mds
598144|NCT00569179|CML|cml
598145|NCT00569192|asthmatic children|asthmatic children
598146|NCT00569231|Warts|warts
598147|NCT00569231|Candida|candida
598148|NCT00569231|HPV|hpv
598149|NCT00569231|Injections, Intralesional|injections, intralesional
598150|NCT00569231|Immune System|immune system
598151|NCT00569244|Primary Dysmenorrhea|primary dysmenorrhea
598152|NCT00569244|Menstrual Pain|menstrual pain
598153|NCT00569244|Oral Contraception|oral contraception
598154|NCT00569257|LHRH receptor|lhrh receptor
598155|NCT00569257|receptor positive tumors|receptor positive tumors
598156|NCT00569257|platinum resistant ovarian cancer|platinum resistant ovarian cancer
598157|NCT00569283|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
598158|NCT00569283|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
598159|NCT00569283|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
598160|NCT00569283|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
598161|NCT00569283|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
598162|NCT00569283|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
598163|NCT00569283|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
598164|NCT00569283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
598165|NCT00569283|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
598166|NCT00569283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
600353|NCT00572533|Chronic Hemodialysis|chronic hemodialysis
598167|NCT00569283|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
598168|NCT00569283|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
598169|NCT00569283|chronic eosinophilic leukemia|chronic eosinophilic leukemia
598170|NCT00569283|primary myelofibrosis|primary myelofibrosis
598171|NCT00569283|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
598172|NCT00569283|chronic neutrophilic leukemia|chronic neutrophilic leukemia
598173|NCT00569283|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
598174|NCT00569283|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
598175|NCT00569283|disseminated neuroblastoma|disseminated neuroblastoma
752338|NCT01172548|GIST|gist
598176|NCT00569283|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
598177|NCT00569283|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
598178|NCT00569283|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
598179|NCT00569283|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
598180|NCT00569283|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
598181|NCT00569283|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
598182|NCT00569283|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
598183|NCT00569283|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
598184|NCT00569283|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
598185|NCT00569283|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
598186|NCT00569283|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
598187|NCT00569283|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
598188|NCT00569283|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
598189|NCT00569283|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
599187|NCT00574093|Lucentis|lucentis
598190|NCT00569283|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
598191|NCT00569283|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
598192|NCT00569283|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
598193|NCT00569283|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
598194|NCT00569283|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
598260|NCT00569283|stage IIIB breast cancer|stage iiib breast cancer
598195|NCT00569283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
598196|NCT00569283|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
598197|NCT00569283|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
598198|NCT00569283|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
598199|NCT00569283|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
598200|NCT00569283|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
598201|NCT00569283|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
598202|NCT00569283|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
598203|NCT00569283|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
598204|NCT00569283|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
598205|NCT00569283|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
598206|NCT00569283|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
598207|NCT00569283|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
598208|NCT00569283|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
598209|NCT00569283|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
598210|NCT00569283|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
598211|NCT00569283|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
598212|NCT00569283|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
598213|NCT00569283|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
598214|NCT00569283|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
598215|NCT00569283|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
598216|NCT00569283|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
598217|NCT00569283|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
598218|NCT00569283|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
598219|NCT00569283|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
598220|NCT00569283|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
598221|NCT00569283|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
598222|NCT00569283|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
598223|NCT00569283|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
598224|NCT00569283|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
598225|NCT00569283|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
598226|NCT00569283|splenic marginal zone lymphoma|splenic marginal zone lymphoma
598227|NCT00569283|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
598228|NCT00569283|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
598229|NCT00569283|recurrent neuroblastoma|recurrent neuroblastoma
598230|NCT00569283|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
598231|NCT00569283|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
598232|NCT00569283|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
598233|NCT00569283|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
598398|NCT00569647|preoperative anxiety|preoperative anxiety
598234|NCT00569283|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
598235|NCT00569283|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
598236|NCT00569283|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
598237|NCT00569283|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
598238|NCT00569283|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
598239|NCT00569283|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
598240|NCT00569283|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
598241|NCT00569283|refractory hairy cell leukemia|refractory hairy cell leukemia
598242|NCT00569283|refractory multiple myeloma|refractory multiple myeloma
598243|NCT00569283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
598244|NCT00569283|secondary acute myeloid leukemia|secondary acute myeloid leukemia
598245|NCT00569283|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
598246|NCT00569283|stage I multiple myeloma|stage i multiple myeloma
598247|NCT00569283|stage II multiple myeloma|stage ii multiple myeloma
598248|NCT00569283|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
598249|NCT00569283|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
598250|NCT00569283|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
598251|NCT00569283|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
598252|NCT00569283|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
598253|NCT00569283|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
599188|NCT00574093|Visudyne|visudyne
598254|NCT00569283|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
598255|NCT00569283|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
598256|NCT00569283|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
598257|NCT00569283|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
598258|NCT00569283|stage III multiple myeloma|stage iii multiple myeloma
598259|NCT00569283|stage IIIA breast cancer|stage iiia breast cancer
598261|NCT00569283|stage IIIC breast cancer|stage iiic breast cancer
598262|NCT00569283|stage IV breast cancer|stage iv breast cancer
598263|NCT00569283|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
598264|NCT00569283|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
598265|NCT00569283|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
598266|NCT00569283|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
598267|NCT00569283|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
598268|NCT00569283|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
598269|NCT00569283|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
598270|NCT00569283|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
598271|NCT00569283|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
598272|NCT00569296|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
598273|NCT00569296|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
598274|NCT00569309|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
598275|NCT00569309|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
598276|NCT00569309|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
598277|NCT00569309|stage I mantle cell lymphoma|stage i mantle cell lymphoma
598278|NCT00569309|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
598279|NCT00569309|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
598280|NCT00569309|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
598281|NCT00569309|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
598282|NCT00569309|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
598283|NCT00569309|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
598284|NCT00569309|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
598285|NCT00569309|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
598286|NCT00569309|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
598287|NCT00569309|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
598288|NCT00569309|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
598289|NCT00569309|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
598290|NCT00569309|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
598291|NCT00569309|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
598292|NCT00569309|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
598293|NCT00569309|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
598294|NCT00569309|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
598295|NCT00569309|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
598296|NCT00569309|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
598297|NCT00569309|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
598298|NCT00569309|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
598299|NCT00569309|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
598300|NCT00569309|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
598301|NCT00569309|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
598302|NCT00569309|stage I multiple myeloma|stage i multiple myeloma
598303|NCT00569309|stage II multiple myeloma|stage ii multiple myeloma
598304|NCT00569309|stage III multiple myeloma|stage iii multiple myeloma
598305|NCT00569309|refractory multiple myeloma|refractory multiple myeloma
598306|NCT00569309|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
598307|NCT00569309|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
598308|NCT00569309|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
598309|NCT00569309|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
598310|NCT00569309|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
598311|NCT00569309|anaplastic large cell lymphoma|anaplastic large cell lymphoma
598312|NCT00569309|small intestine lymphoma|small intestine lymphoma
598314|NCT00569322|Admission|admission
598316|NCT00569335|S-1, Bevacizumab, Irinotecan|s-1, bevacizumab, irinotecan
598317|NCT00569361|allergic rhinitis to dust mite|allergic rhinitis to dust mite
598318|NCT00569361|allergic rhinitis associated with bronchial hyperreactivity|allergic rhinitis associated with bronchial hyperreactivity
598319|NCT00569361|allergic rhinitis associated with asthma|allergic rhinitis associated with asthma
598320|NCT00569387|pancreatic cancer|pancreatic cancer
598321|NCT00569387|vaccine|vaccine
598322|NCT00569413|Sex|sex
598323|NCT00569413|brain imaging|brain imaging
598325|NCT00569413|sexual disorder|sexual disorder
598327|NCT00569439|Carbohydrate|carbohydrate
598328|NCT00569439|Dystocia|dystocia
598329|NCT00569465|nitric oxide|nitric oxide
598330|NCT00569465|oxidative stress|oxidative stress
598331|NCT00569465|diabetes|diabetes
598332|NCT00569465|hypertension|hypertension
598333|NCT00569465|endothelial dysfunction|endothelial dysfunction
598334|NCT00569478|ICD|icd
598335|NCT00569478|Rehabilitation|rehabilitation
598336|NCT00569504|schizophrenia|schizophrenia
598337|NCT00569504|antipsychotics|antipsychotics
598338|NCT00569504|metabolic syndrome|metabolic syndrome
598339|NCT00569504|prevalence|prevalence
598340|NCT00569517|obesity|obesity
598341|NCT00569517|CBT|cbt
598342|NCT00569517|Atypical antipsychotics|atypical antipsychotics
598343|NCT00569517|metabolic syndrome|metabolic syndrome
598344|NCT00569530|nitric oxide|nitric oxide
598345|NCT00569530|surfactant|surfactant
598346|NCT00569530|bronchopulmonary dysplasia|bronchopulmonary dysplasia
598347|NCT00569530|prematurity|prematurity
598348|NCT00569530|neonates|neonates
598349|NCT00569530|iNO|ino
598350|NCT00569530|Infasurf|infasurf
598351|NCT00569530|lung function|lung function
598352|NCT00569530|ventilated infants|ventilated infants
598353|NCT00569543|breast cancer in situ|breast cancer in situ
598354|NCT00569543|ductal breast carcinoma in situ|ductal breast carcinoma in situ
598355|NCT00569543|stage I breast cancer|stage i breast cancer
598356|NCT00569543|stage II breast cancer|stage ii breast cancer
598357|NCT00569543|stage IIIA breast cancer|stage iiia breast cancer
598358|NCT00569543|stage IIIB breast cancer|stage iiib breast cancer
598359|NCT00569543|stage IIIC breast cancer|stage iiic breast cancer
598360|NCT00569543|stage IV breast cancer|stage iv breast cancer
598361|NCT00569556|Diabetes Mellitus|diabetes mellitus
598362|NCT00569556|Chronic Care Model|chronic care model
598363|NCT00569556|Case Management|case management
598364|NCT00569582|Cushing's Disease|cushing's disease
598365|NCT00569582|Cushing's Syndrome|cushing's syndrome
598366|NCT00569582|Cushings|cushings
598367|NCT00569582|Pituitary|pituitary
598368|NCT00569582|ACTH|acth
598369|NCT00569582|Adrenocorticotropic hormone|adrenocorticotropic hormone
598370|NCT00569582|Ectopic|ectopic
598371|NCT00569582|Adrenal adenoma|adrenal adenoma
598372|NCT00569582|Adrenal carcinoma|adrenal carcinoma
598373|NCT00569582|Adrenal autonomy|adrenal autonomy
598374|NCT00569582|Cortisol|cortisol
598375|NCT00569582|Hypercortisolemia|hypercortisolemia
598376|NCT00569582|Cushingoid|cushingoid
598377|NCT00569582|Moon facies|moon facies
598378|NCT00569582|Dorsocervical fat|dorsocervical fat
598379|NCT00569582|Plethora|plethora
598380|NCT00569582|Hirsutism|hirsutism
598381|NCT00569582|Violaceous striae|violaceous striae
598382|NCT00569582|Hormone|hormone
751774|NCT01170377|Propofol|propofol
598383|NCT00569582|Contraceptive|contraceptive
598384|NCT00569582|Endocrine|endocrine
598385|NCT00569582|Cushing Syndrome|cushing syndrome
598386|NCT00569582|Ectopic ACTH Secretion|ectopic acth secretion
598387|NCT00569595|Prevention of Diabetes and other chronic diseases|prevention of diabetes and other chronic diseases
598388|NCT00569608|Parental stress|parental stress
598389|NCT00569608|Early discharge|early discharge
598390|NCT00569608|Anxiety|anxiety
598391|NCT00569608|Depression|depression
598392|NCT00569608|Neonatal Intensive Care Unit|neonatal intensive care unit
598393|NCT00569634|Venous blood gas|venous blood gas
598394|NCT00569634|Arterial blood gas|arterial blood gas
598395|NCT00569634|pH|ph
598396|NCT00569634|pCO2|pco2
598397|NCT00569634|Bicarbonate|bicarbonate
598399|NCT00569647|burn reconstruction|burn reconstruction
598400|NCT00569660|Myelofibrosis|myelofibrosis
598401|NCT00569660|MF|mf
598402|NCT00569660|Leukemia|leukemia
598403|NCT00569660|Azacitidine|azacitidine
598404|NCT00569660|Vidaza|vidaza
598405|NCT00569673|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
598406|NCT00569673|fallopian tube cancer|fallopian tube cancer
598407|NCT00569673|primary peritoneal cavity cancer|primary peritoneal cavity cancer
598408|NCT00569686|PAD|pad
598409|NCT00569686|peripheral artery disease|peripheral artery disease
598410|NCT00569699|S-1|s-1
598411|NCT00569699|Bevacizumab|bevacizumab
598412|NCT00569712|non-small cell lung cancer|non-small cell lung cancer
598413|NCT00569712|precancerous condition|precancerous condition
598414|NCT00569738|neuroendocrine tumor|neuroendocrine tumor
598415|NCT00569738|somatostatin analog|somatostatin analog
598416|NCT00569738|Gallium 68|gallium 68
598417|NCT00569738|PET|pet
598418|NCT00569751|de novo|de novo
598419|NCT00569751|coronary|coronary
598420|NCT00569751|coronary artery disease|coronary artery disease
598421|NCT00569751|coronary disease|coronary disease
598422|NCT00569764|schizophrenia|schizophrenia
598423|NCT00569764|metabolic syndrome|metabolic syndrome
598424|NCT00569764|aripiprazole|aripiprazole
598425|NCT00569790|S-1|s-1
598426|NCT00569790|Irinotecan|irinotecan
598427|NCT00569790|Bevacizumab|bevacizumab
598428|NCT00569816|myocardial protection|myocardial protection
598429|NCT00569816|pharmacological preconditioning|pharmacological preconditioning
598430|NCT00569816|volatile anesthetics|volatile anesthetics
598431|NCT00569816|myocardial injury following CABG surgery|myocardial injury following cabg surgery
598432|NCT00569829|cognitive behavioral therapy|cognitive behavioral therapy
598433|NCT00569829|anxiety disorders|anxiety disorders
598434|NCT00569829|school-based intervention|school-based intervention
598435|NCT00569829|randomized, controlled trial|randomized, controlled trial
598436|NCT00569868|PLASMACYTOMA|plasmacytoma
598437|NCT00569881|Epithelium|epithelium
598438|NCT00569881|Wound Healing|wound healing
598719|NCT00571220|diabetes|diabetes
598440|NCT00569907|type 2 diabetes|type 2 diabetes
598441|NCT00569907|continuous glucose monitoring|continuous glucose monitoring
598442|NCT00569907|exenatide|exenatide
598443|NCT00569907|exenatide use|exenatide use
598444|NCT00569933|Hip Surgery|hip surgery
598445|NCT00569933|Perioperative|perioperative
598446|NCT00569933|suggestions/imagery|suggestions/imagery
598447|NCT00569946|AG-013736|ag-013736
598448|NCT00569946|RCC|rcc
598449|NCT00569946|Phase 2|phase 2
598450|NCT00569959|fasting lipid measures|fasting lipid measures
598451|NCT00569959|non-fasting lipid measures|non-fasting lipid measures
598452|NCT00569959|clinical decision-making|clinical decision-making
598453|NCT00569959|LDL-Cholesterol|ldl-cholesterol
598454|NCT00569985|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
598455|NCT00569985|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
598456|NCT00569985|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
598457|NCT00569985|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
598458|NCT00569985|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
598459|NCT00569985|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
598460|NCT00569985|Treatment Experienced|treatment experienced
598461|NCT00570024|Acupuncture|acupuncture
598462|NCT00570024|Coronary Artery Disease|coronary artery disease
598463|NCT00570037|Influenza|influenza
598464|NCT00570037|Vaccine|vaccine
598465|NCT00570037|Children|children
598466|NCT00570050|Major Depressive Disorder, Memory, Executive function|major depressive disorder, memory, executive function
598467|NCT00570063|Schizophrenia, acute exacerbation, and PF-02545920|schizophrenia, acute exacerbation, and pf-02545920
598468|NCT00570089|Ranolazine|ranolazine
598469|NCT00570089|Myocardial ischemia|myocardial ischemia
598470|NCT00570089|Double blinded|double blinded
598471|NCT00570089|Placebo controlled|placebo controlled
598472|NCT00570102|dietary manipulation|dietary manipulation
598473|NCT00570102|infants|infants
598474|NCT00570102|feasibility|feasibility
598475|NCT00570102|Type 1 Diabetes Mellitus, Beta-cell Autoimmunity|type 1 diabetes mellitus, beta-cell autoimmunity
598476|NCT00570115|Sleep Apnea Syndromes diastolic disfunction left atrium|sleep apnea syndromes diastolic disfunction left atrium
598477|NCT00570128|Down Syndrome|down syndrome
598478|NCT00570128|trisomy 21|trisomy 21
598479|NCT00570154|Mitochondrial Function in Monocytes|mitochondrial function in monocytes
598480|NCT00570154|Macrophages and Diabetes or Insulin Resistance|macrophages and diabetes or insulin resistance
598481|NCT00570154|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
598482|NCT00570154|Diabetes|diabetes
598483|NCT00570154|Monocyte|monocyte
598484|NCT00570154|Macrophages|macrophages
598485|NCT00570154|Proteome|proteome
598486|NCT00570154|Type 2 Diabetes|type 2 diabetes
598487|NCT00570154|Insulin Resistance|insulin resistance
598488|NCT00570154|Insulin Sensitivity|insulin sensitivity
598489|NCT00570154|Pre-Diabetes|pre-diabetes
598490|NCT00570154|Healthy Volunteer|healthy volunteer
598492|NCT00570167|Osteoarthritis|osteoarthritis
598493|NCT00570167|Hip|hip
598495|NCT00570167|Resurfacing|resurfacing
598496|NCT00570180|newly diagnosed|newly diagnosed
598497|NCT00570206|Probation|probation
598498|NCT00570206|Motivational|motivational
598499|NCT00570232|Resectable, recurrent head and neck cancer|resectable, recurrent head and neck cancer
598500|NCT00570245|Lung transplantation|lung transplantation
598501|NCT00570271|placebo effect|placebo effect
598502|NCT00570271|blood pressure|blood pressure
598503|NCT00570271|autonomic nervous system|autonomic nervous system
598504|NCT00570271|prestige|prestige
598505|NCT00570271|basic research on physiological placebo effects|basic research on physiological placebo effects
598506|NCT00570284|Cancer|cancer
598507|NCT00570284|solid tumor|solid tumor
598508|NCT00570284|food effect|food effect
598509|NCT00570284|HDAC inhibitor|hdac inhibitor
598510|NCT00570284|oral|oral
598511|NCT00570284|LBH589|lbh589
598512|NCT00570297|Pediatric|pediatric
598513|NCT00570297|Polymorphism, Genetic|polymorphism, genetic
598514|NCT00570297|Adrenergic beta-Agonists|adrenergic beta-agonists
598515|NCT00570323|Breast Cancer|breast cancer
598516|NCT00570323|HORMONE RECEPTOR POSITIVE BREAST CANCER|hormone receptor positive breast cancer
598517|NCT00570336|HCV|hcv
598518|NCT00570336|HCV treatment failure|hcv treatment failure
598519|NCT00570336|Elevated aminotransferases|elevated aminotransferases
598520|NCT00570349|Inhaled Nitric oxide|inhaled nitric oxide
598521|NCT00570349|Cystic Fibrosis|cystic fibrosis
598522|NCT00570362|Normal tension glaucoma|normal tension glaucoma
598523|NCT00570362|Glutathione|glutathione
598524|NCT00570362|Antioxidant|antioxidant
598525|NCT00570375|Blood disease, bone marrow|blood disease, bone marrow
598526|NCT00570388|Neurocognitive|neurocognitive
598527|NCT00570388|Alcohol Dependence|alcohol dependence
598528|NCT00570388|Prometa|prometa
598529|NCT00570388|Prometa Protocol|prometa protocol
598530|NCT00570388|Starosta|starosta
598531|NCT00570401|adenocarcinoma of the lung|adenocarcinoma of the lung
598532|NCT00570401|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
598533|NCT00570401|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
598534|NCT00570401|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
598535|NCT00570401|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
598536|NCT00570427|psychotherapy|psychotherapy
598537|NCT00570427|behavior therapy|behavior therapy
598538|NCT00570427|counseling|counseling
598539|NCT00570427|aging|aging
598540|NCT00570427|medically underserved population|medically underserved population
598541|NCT00570440|AE adverse event|ae adverse event
598542|NCT00570440|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
598543|NCT00570440|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
598544|NCT00570440|ART antiretroviral therapy|art antiretroviral therapy
598545|NCT00570440|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
598546|NCT00570440|DCF data collection forms|dcf data collection forms
598547|NCT00570440|DMC Data Monitoring Committee|dmc data monitoring committee
598548|NCT00570440|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
598549|NCT00570440|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
598550|NCT00570440|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
598551|NCT00570440|ICH International Conference of Harmonisation|ich international conference of harmonisation
598552|NCT00570440|IND Investigational New Drug Application|ind investigational new drug application
598553|NCT00570440|IRB Institutional Review Board|irb institutional review board
598554|NCT00570440|IU international units|iu international units
598555|NCT00570440|mg milligram(s)|mg milligram(s)
598556|NCT00570440|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
598557|NCT00570440|PCR polymerase chain reaction|pcr polymerase chain reaction
598558|NCT00570440|SAE serious adverse event|sae serious adverse event
598559|NCT00570440|µg microgram|µg microgram
598560|NCT00570440|ULN upper limit of the normal range|uln upper limit of the normal range
598561|NCT00570440|WB Western Blot|wb western blot
598562|NCT00570466|Type 2 Diabetes|type 2 diabetes
598563|NCT00570466|Prevention|prevention
598564|NCT00570466|Children|children
598565|NCT00570466|Diet|diet
598566|NCT00570466|Physical Activity|physical activity
598567|NCT00570479|Retisert|retisert
598568|NCT00570479|Uveitis|uveitis
598569|NCT00570479|glaucoma|glaucoma
600859|NCT00583921|AF|af
598570|NCT00570492|allergic rhinitis|allergic rhinitis
598571|NCT00570492|fluticasone furoate nasal spray|fluticasone furoate nasal spray
598572|NCT00570492|growth|growth
598573|NCT00570518|driving under the influence|driving under the influence
598574|NCT00570518|psychoactive substances|psychoactive substances
598575|NCT00570518|roadside surveys|roadside surveys
598576|NCT00570518|hospital surveys|hospital surveys
598577|NCT00570518|accident involvement risk estimation|accident involvement risk estimation
598578|NCT00570544|copd|copd
598579|NCT00570544|emphysema|emphysema
598580|NCT00570544|tiotropium|tiotropium
598581|NCT00570544|lung function|lung function
598582|NCT00570544|dynamic hyperinflation|dynamic hyperinflation
598583|NCT00570557|Skill Maintenance|skill maintenance
598584|NCT00570557|Skill Decay|skill decay
598585|NCT00570557|Screening|screening
598586|NCT00570570|stroke|stroke
598587|NCT00570570|hemiplegia|hemiplegia
598588|NCT00570570|gait|gait
598589|NCT00570570|Strengthening|strengthening
598590|NCT00570570|Physiotherapy|physiotherapy
598591|NCT00570583|Depression|depression
598592|NCT00570583|Cognitive impairment|cognitive impairment
598593|NCT00570583|Dementia|dementia
598594|NCT00570583|Neuroimaging|neuroimaging
598595|NCT00570583|Genetics|genetics
598596|NCT00570609|CPR|cpr
598597|NCT00570622|Cirrhosis|cirrhosis
598598|NCT00570622|oxidative stress|oxidative stress
598599|NCT00570622|pioglitazone|pioglitazone
598600|NCT00570635|GIST|gist
598601|NCT00570635|Gastrointestinal Cancer|gastrointestinal cancer
598602|NCT00570648|Corneal transplantation|corneal transplantation
598603|NCT00570674|SSCHN|sschn
598604|NCT00570674|Abraxane|abraxane
598605|NCT00570674|IMRT|imrt
598606|NCT00570687|Inhaled Insulin|inhaled insulin
598607|NCT00570700|prostate|prostate
598608|NCT00570739|Colesevelam|colesevelam
598609|NCT00570739|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
598610|NCT00570739|Pre-diabetes|pre-diabetes
598611|NCT00570739|Metformin|metformin
598612|NCT00570778|QVA, Indacaterol, Glycopyrrolate, Concept1, COPD, cross over study, safety and efficacy, trough FEV1|qva, indacaterol, glycopyrrolate, concept1, copd, cross over study, safety and efficacy, trough fev1
598613|NCT00570791|Cornea|cornea
598614|NCT00570791|Tonometers|tonometers
598615|NCT00570791|Goldmann applanation|goldmann applanation
598618|NCT00570791|Pneumatonometer|pneumatonometer
598619|NCT00570804|Smoking Cessation|smoking cessation
598620|NCT00570804|Puerto Rico Quitline|puerto rico quitline
598621|NCT00570804|Motivational Relapse Prevention|motivational relapse prevention
598622|NCT00570804|Oral Cancer|oral cancer
598623|NCT00570804|Risk Reduction|risk reduction
598624|NCT00570804|Tobacco Use|tobacco use
598625|NCT00570804|Alcohol Use|alcohol use
598626|NCT00570804|MAPS|maps
598627|NCT00570804|Motivation and Problem-Solving|motivation and problem-solving
598628|NCT00570804|Telephone Interview|telephone interview
598629|NCT00570804|Counseling|counseling
598630|NCT00570817|Methotrexate|methotrexate
598631|NCT00570817|Nephrotoxicity|nephrotoxicity
598632|NCT00570817|Hydration|hydration
598633|NCT00570817|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
598634|NCT00570817|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
598635|NCT00570817|Medulloblastoma|medulloblastoma
598636|NCT00570817|Ependymoma|ependymoma
598637|NCT00570817|Prolonged elimination time of methotrexate|prolonged elimination time of methotrexate
598638|NCT00570856|Folic Acid|folic acid
598639|NCT00570856|Homocysteine|homocysteine
598640|NCT00570856|intima-media thickness|intima-media thickness
598641|NCT00570869|Infant CPR|infant cpr
598642|NCT00570882|Renal cell carcinoma|renal cell carcinoma
598643|NCT00570882|Sunitinib|sunitinib
598644|NCT00570882|phase II study|phase ii study
598645|NCT00570882|Randomized study|randomized study
598646|NCT00570895|Iron|iron
598647|NCT00570895|Absorption|absorption
598648|NCT00570895|Ascorbic Acid|ascorbic acid
598649|NCT00570895|Ferrous Fumarate|ferrous fumarate
598650|NCT00570908|brain metastasis|brain metastasis
598651|NCT00570908|breast cancer|breast cancer
598652|NCT00570908|metastatic breast cancer|metastatic breast cancer
598653|NCT00570921|Breast cancer|breast cancer
598654|NCT00570921|Fulvestrant|fulvestrant
598655|NCT00570921|Everolimus|everolimus
598656|NCT00570947|CPR Anytime|cpr anytime
598657|NCT00570960|Peritonitis|peritonitis
598658|NCT00570973|Variceal Bleeding|variceal bleeding
598659|NCT00570973|Cirrhosis|cirrhosis
598660|NCT00570973|Encephalopathy|encephalopathy
598661|NCT00570973|Endoscopic band ligation|endoscopic band ligation
598662|NCT00570973|TIPS|tips
598663|NCT00570986|Plaque Psoriasis|plaque psoriasis
598664|NCT00570999|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
598665|NCT00570999|Palifermin|palifermin
598666|NCT00570999|Kepivance|kepivance
598667|NCT00570999|Prevenar|prevenar
598668|NCT00570999|Placebo|placebo
598669|NCT00571012|glaucoma|glaucoma
598670|NCT00571012|outflow facility|outflow facility
598671|NCT00571012|Healthy eye function|healthy eye function
598672|NCT00571025|Mild Cognitive Impairment|mild cognitive impairment
598673|NCT00571025|disease/disorder proneness/risk|disease/disorder proneness/risk
598674|NCT00571025|family genetics|family genetics
598675|NCT00571025|genetic counseling|genetic counseling
598676|NCT00571025|genetic marker|genetic marker
598677|NCT00571025|genetic polymorphism|genetic polymorphism
598678|NCT00571025|genetic susceptibility|genetic susceptibility
598679|NCT00571038|Hypertension|hypertension
598680|NCT00571038|Self-help groups|self-help groups
598681|NCT00571038|Community health networks|community health networks
598682|NCT00571038|Health knowledge, attitudes, practice|health knowledge, attitudes, practice
598683|NCT00571038|Patient participation|patient participation
598684|NCT00571038|Randomized clinical trial|randomized clinical trial
598685|NCT00571051|MEG, mindfulness, tactile perception|meg, mindfulness, tactile perception
598686|NCT00571077|Thyroid neoplasms|thyroid neoplasms
598687|NCT00571077|thyroid nodules|thyroid nodules
598777|NCT00571389|Advanced Stage III|advanced stage iii
598688|NCT00571077|electrical impedance scanning|electrical impedance scanning
598689|NCT00571090|Thyroid nodule|thyroid nodule
598690|NCT00571090|Biopsy, Fine-Needle|biopsy, fine-needle
598691|NCT00571103|acamprosate, impulse-control disorders|acamprosate, impulse-control disorders
598692|NCT00571116|Metastatic Melanoma|metastatic melanoma
598693|NCT00571116|Disulfiram|disulfiram
598694|NCT00571116|Arsenic Trioxide|arsenic trioxide
598695|NCT00571116|Metastatic Melanoma and at Least One Prior Systemic Therapy|metastatic melanoma and at least one prior systemic therapy
598696|NCT00571129|Primary,silicone tube,revision,mitomycin C,endoscopic DCR|primary,silicone tube,revision,mitomycin c,endoscopic dcr
598697|NCT00571142|edema|edema
598698|NCT00571142|retinal thickness|retinal thickness
598699|NCT00571142|diabetic retinopathy|diabetic retinopathy
598700|NCT00571168|chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
598701|NCT00571168|autologous peripheral blood stemcell transplantation|autologous peripheral blood stemcell transplantation
598702|NCT00571168|high dose chemotherapy|high dose chemotherapy
598703|NCT00571181|Algorithms|algorithms
598704|NCT00571181|Anesthesia, General/*methods|anesthesia, general/*methods
598705|NCT00571181|Anesthetics, Intravenous/*administration & dosage|anesthetics, intravenous/*administration & dosage
598706|NCT00571181|Drug Delivery Systems/*methods/statistics & numerical data|drug delivery systems/*methods/statistics & numerical data
598707|NCT00571181|Electroencephalography/drug effects/*methods/|electroencephalography/drug effects/*methods/
598708|NCT00571181|Feasibility Studies|feasibility studies
598805|NCT00571506|Thiazolidinediones|thiazolidinediones
598709|NCT00571181|Propofol/*administration & dosage|propofol/*administration & dosage
598710|NCT00571181|Remifentanil/*administration & dosage|remifentanil/*administration & dosage
598711|NCT00571181|Bronchoscopy/*methods|bronchoscopy/*methods
598712|NCT00571181|Prospective Studies|prospective studies
598713|NCT00571181|Software|software
598714|NCT00571194|pravastatin, peritoneal dialysis, pediatric patients|pravastatin, peritoneal dialysis, pediatric patients
598715|NCT00571207|driving under the influence of drugs|driving under the influence of drugs
598716|NCT00571207|on-site oral fluid screening devices|on-site oral fluid screening devices
598717|NCT00571207|checklist|checklist
598718|NCT00571220|gastric bypass|gastric bypass
598721|NCT00571220|diet-induced weight loss|diet-induced weight loss
598722|NCT00571220|incretin levels (GLP-1,GIP)|incretin levels (glp-1,gip)
598723|NCT00571220|incretin effect|incretin effect
598724|NCT00571233|Single Ventricle|single ventricle
598725|NCT00571233|Congenital Heart Disease|congenital heart disease
598726|NCT00571233|Children|children
598727|NCT00571233|Fontan|fontan
598728|NCT00571233|Tricuspid Atresia|tricuspid atresia
598729|NCT00571233|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
598730|NCT00571233|Heart Failure|heart failure
598731|NCT00571233|Biomarkers|biomarkers
598732|NCT00571233|Single ventricle physiology such as:|single ventricle physiology such as:
598733|NCT00571233|unbalanced AV canal|unbalanced av canal
598734|NCT00571233|Interested in patients both before and after Fontan Surgery|interested in patients both before and after fontan surgery
598735|NCT00571246|treatment|treatment
598736|NCT00571246|Lamotrigine|lamotrigine
598737|NCT00571246|Topiramate|topiramate
598738|NCT00571246|alcohol dependence|alcohol dependence
598739|NCT00571246|post traumatic stress disorder|post traumatic stress disorder
598740|NCT00571259|Sodium citrate|sodium citrate
598741|NCT00571259|Gentamicin|gentamicin
598742|NCT00571259|Prophylaxis|prophylaxis
598743|NCT00571259|Hemodialysis|hemodialysis
598744|NCT00571259|Central venous catheter|central venous catheter
598745|NCT00571272|Cholestatic Liver Disease|cholestatic liver disease
598746|NCT00571272|Cholestasis|cholestasis
598747|NCT00571272|Childhood Diseases|childhood diseases
598748|NCT00571272|Genetic Diseases|genetic diseases
598749|NCT00571272|Bile Acid Synthesis and Metabolism Defects|bile acid synthesis and metabolism defects
598750|NCT00571272|Progressive Familial Intrahepatic Cholestasis|progressive familial intrahepatic cholestasis
598751|NCT00571285|Parkinson's disease|parkinson's disease
598752|NCT00571285|Nutrition|nutrition
598753|NCT00571285|Vitamin supplement|vitamin supplement
598754|NCT00571285|Motor function|motor function
598755|NCT00571285|Non-motor function|non-motor function
598756|NCT00571298|Extrapleural pneumonectomy|extrapleural pneumonectomy
598757|NCT00571298|Pleurectomy Decortication|pleurectomy decortication
598758|NCT00571298|Mesothelioma|mesothelioma
598759|NCT00571298|cisplatin|cisplatin
598760|NCT00571298|gemcitabine|gemcitabine
598761|NCT00571298|amifostine|amifostine
598762|NCT00571298|sodium thiosulfate|sodium thiosulfate
598763|NCT00571311|Assent|assent
598764|NCT00571311|Adolescent|adolescent
598765|NCT00571311|Informed Consent|informed consent
598766|NCT00571324|hyperinsulinism|hyperinsulinism
598767|NCT00571324|hypoglycemia|hypoglycemia
598768|NCT00571324|KATP channel|katp channel
598769|NCT00571324|Kir6.2|kir6.2
598770|NCT00571337|Stop infliximab.|stop infliximab.
598771|NCT00571350|Cystocele|cystocele
598772|NCT00571350|tension free vaginal tapes|tension free vaginal tapes
598773|NCT00571350|urinary incontinence|urinary incontinence
598774|NCT00571376|Quality of health care|quality of health care
598775|NCT00571376|Health care costs|health care costs
598776|NCT00571389|Stage IV|stage iv
598778|NCT00571402|Family Treatment|family treatment
598779|NCT00571402|Pharmacotherapy|pharmacotherapy
598780|NCT00571415|Image guided adaptive radiotherapy|image guided adaptive radiotherapy
598781|NCT00571428|COPD|copd
598782|NCT00571428|Chronic Bronchitis|chronic bronchitis
598783|NCT00571428|Emphysema|emphysema
598784|NCT00571441|stroke|stroke
598785|NCT00571441|Brain injury|brain injury
598786|NCT00571441|nursing|nursing
598787|NCT00571441|Critical care|critical care
598788|NCT00571454|depression|depression
598789|NCT00571454|primary care|primary care
598790|NCT00571454|Latino|latino
598791|NCT00571454|telephone|telephone
598792|NCT00571454|care management|care management
598793|NCT00571467|Autoimmune Diseases|autoimmune diseases
598794|NCT00571467|Bleeding Disorders|bleeding disorders
598795|NCT00571467|Blood and Blood Disorders|blood and blood disorders
598796|NCT00571480|auricular acupuncture|auricular acupuncture
598797|NCT00571480|pregnancy related low back pain|pregnancy related low back pain
598798|NCT00571480|acupuncture|acupuncture
598799|NCT00571493|non-hodgkin's lymphoma|non-hodgkin's lymphoma
598800|NCT00571493|mantle cell lymphoma|mantle cell lymphoma
598801|NCT00571493|BEAM|beam
598802|NCT00571493|Velcade|velcade
598803|NCT00571506|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
598804|NCT00571506|Vascular Diseases|vascular diseases
598806|NCT00571506|Platelet Aggregation|platelet aggregation
598807|NCT00565695|Visual Outcomes|visual outcomes
598808|NCT00565695|Patient Satisfaction|patient satisfaction
598809|NCT00565695|Cataract Extraction|cataract extraction
598810|NCT00565708|stage II colon cancer|stage ii colon cancer
598811|NCT00565708|stage III colon cancer|stage iii colon cancer
598812|NCT00565708|stage II rectal cancer|stage ii rectal cancer
598813|NCT00565708|stage III rectal cancer|stage iii rectal cancer
598814|NCT00565721|Static PET imaging|static pet imaging
598815|NCT00565721|Dynamic PET imaging|dynamic pet imaging
598816|NCT00565721|Angiogenesis|angiogenesis
598817|NCT00565721|αvβ3 integrins|αvβ3 integrins
598818|NCT00565721|oncology imaging|oncology imaging
598819|NCT00565747|GM-CSF|gm-csf
598824|NCT00565812|knee Osteoarthritis Disease Modifying Osteoarthritis Drug|knee osteoarthritis disease modifying osteoarthritis drug
598825|NCT00565838|Randomized study|randomized study
598826|NCT00565838|surgical treatment|surgical treatment
598827|NCT00565838|autologous fascial sling|autologous fascial sling
598828|NCT00565838|TVT|tvt
598829|NCT00565838|stress urinary incontinence.|stress urinary incontinence.
598830|NCT00565864|Hypothyroidism|hypothyroidism
598831|NCT00565864|Cognition|cognition
598832|NCT00565864|Metabolism|metabolism
598833|NCT00565877|Catheter|catheter
598834|NCT00565877|Peripherally inserted central catheter|peripherally inserted central catheter
598835|NCT00565877|ultrasound|ultrasound
598836|NCT00565877|malposition|malposition
598837|NCT00565890|very low birth weight infant|very low birth weight infant
598838|NCT00565890|hypothyroxinemia|hypothyroxinemia
598839|NCT00565890|outcomes|outcomes
598840|NCT00565903|pleuropulmonary blastoma|pleuropulmonary blastoma
598841|NCT00565903|PPB|ppb
598842|NCT00565903|cystic nephroma|cystic nephroma
598843|NCT00565903|DICER1|dicer1
598844|NCT00565903|miRNA|mirna
598845|NCT00565916|Post-Menopausal|post-menopausal
598846|NCT00565916|PET|pet
598847|NCT00565916|Estrogen|estrogen
598848|NCT00565916|Progesterone|progesterone
598849|NCT00565916|Heart Metabolism|heart metabolism
598850|NCT00565916|Cardiovascular Disease|cardiovascular disease
598851|NCT00565929|Variola major, smallpox, vaccine, hematopoietic stem cell transplant|variola major, smallpox, vaccine, hematopoietic stem cell transplant
598852|NCT00565942|Integrative medicine|integrative medicine
598853|NCT00565942|Primary care|primary care
598854|NCT00565942|Swedish massage therapy|swedish massage therapy
598855|NCT00565942|Manual therapy|manual therapy
598856|NCT00565942|Naprapathy|naprapathy
598857|NCT00565942|Shiatsu|shiatsu
598858|NCT00565942|Acupuncture/TCM|acupuncture/tcm
598859|NCT00565942|Qigong|qigong
598860|NCT00565942|Pragmatic RCT|pragmatic rct
598861|NCT00565942|Health services research|health services research
598862|NCT00565955|Montelukast|montelukast
598863|NCT00565955|Acute Asthma|acute asthma
601172|NCT00577044|NAFLD|nafld
598864|NCT00565968|stage IIIB melanoma|stage iiib melanoma
598865|NCT00565968|stage IIIC melanoma|stage iiic melanoma
598866|NCT00565968|recurrent melanoma|recurrent melanoma
598867|NCT00565981|B-CLL|b-cll
598868|NCT00565981|refractory|refractory
598869|NCT00565981|molecular profiling|molecular profiling
598870|NCT00565981|alemtuzumab|alemtuzumab
598871|NCT00565981|fludarabinephosphate|fludarabinephosphate
598872|NCT00571545|Traumatic brain injury|traumatic brain injury
598873|NCT00571545|Depression|depression
598874|NCT00571545|Exercise|exercise
599992|NCT00580593|ALS|als
598875|NCT00571571|Identity difussion|identity difussion
598876|NCT00571571|Adolescent psychotherapy|adolescent psychotherapy
598877|NCT00571571|Transference Focused Psychotherapy for Adolescents|transference focused psychotherapy for adolescents
598878|NCT00571571|Identity|identity
598879|NCT00571571|Identity crisis|identity crisis
598880|NCT00571571|Identity pathology|identity pathology
598881|NCT00571597|surgery|surgery
598882|NCT00571597|ablation|ablation
598883|NCT00571597|radiofrequency|radiofrequency
598884|NCT00571597|minimaze|minimaze
598885|NCT00571597|transtelephonic monitoring|transtelephonic monitoring
598886|NCT00571610|Heart Failure|heart failure
598887|NCT00571610|Mitral Regurgitation|mitral regurgitation
598888|NCT00571623|Brain Injury|brain injury
598889|NCT00571623|Intracranial hypertension|intracranial hypertension
598890|NCT00571623|Human subjects|human subjects
598891|NCT00571623|Nursing care|nursing care
598892|NCT00571636|Opioids infusion|opioids infusion
598893|NCT00571636|mechanical ventilation|mechanical ventilation
598894|NCT00571649|Acute medical illnesses with increased risk for VTE.|acute medical illnesses with increased risk for vte.
598895|NCT00571649|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
598896|NCT00571649|Pulmonary embolism (PE),|pulmonary embolism (pe),
598897|NCT00571649|Venous Thromboembolic disease (VTE),|venous thromboembolic disease (vte),
598898|NCT00571649|Medical illness|medical illness
598899|NCT00571675|Prostate Cancer|prostate cancer
598900|NCT00571675|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
598901|NCT00571675|HRPC|hrpc
598902|NCT00571675|Docetaxel|docetaxel
598903|NCT00571675|Taxotere|taxotere
598905|NCT00571675|Metastatic (Stage IV) Disease|metastatic (stage iv) disease
598906|NCT00571675|Chemotherapy-naïve metastatic Hormone Refractory Prostate Cancer (HRPC)|chemotherapy-naïve metastatic hormone refractory prostate cancer (hrpc)
598907|NCT00571688|Bipolar Disorder|bipolar disorder
598908|NCT00571688|Depression, Bipolar|depression, bipolar
598910|NCT00571701|HPV|hpv
598911|NCT00571701|RRP|rrp
598912|NCT00571714|Chronic hepatitis C|chronic hepatitis c
598913|NCT00571714|Pilot Comparison|pilot comparison
598914|NCT00571714|Peginterferon alph-2a|peginterferon alph-2a
598915|NCT00571714|Ribavirin|ribavirin
598916|NCT00571714|Betaine|betaine
598917|NCT00571714|Genotype 1|genotype 1
598918|NCT00571714|Treatment naive|treatment naive
598919|NCT00571727|growth|growth
598920|NCT00571727|insulin like growth factor|insulin like growth factor
598921|NCT00571727|Larons syndrome|larons syndrome
598922|NCT00571740|stage IV colon cancer|stage iv colon cancer
598923|NCT00571740|stage IV rectal cancer|stage iv rectal cancer
598924|NCT00571740|recurrent colon cancer|recurrent colon cancer
598925|NCT00571740|recurrent rectal cancer|recurrent rectal cancer
598926|NCT00571753|pulmonary tuberculosis|pulmonary tuberculosis
598927|NCT00571753|NAT2 genotyping|nat2 genotyping
598928|NCT00571753|hepatotoxicity of isoniazid|hepatotoxicity of isoniazid
598929|NCT00571766|chronic hypertension in pregnancy|chronic hypertension in pregnancy
598930|NCT00571766|chronic Hypertension|chronic hypertension
598931|NCT00571792|COPD|copd
598932|NCT00571792|The cohort will be comprised of normal non-smoking individuals, those individuals|the cohort will be comprised of normal non-smoking individuals, those individuals
598933|NCT00571792|who smoke who do not exhibit symptoms of COPD and individuals who smoke who do demonstrate|who smoke who do not exhibit symptoms of copd and individuals who smoke who do demonstrate
598934|NCT00571792|symptoms of COPD|symptoms of copd
598935|NCT00571805|cigarette|cigarette
598936|NCT00571805|craving|craving
598937|NCT00571805|reward|reward
598938|NCT00571818|euglycemic|euglycemic
598939|NCT00571818|transplant|transplant
598940|NCT00571818|pancreas|pancreas
598941|NCT00571818|hyperglycemic|hyperglycemic
598942|NCT00571818|kidney|kidney
598943|NCT00571831|macula edema|macula edema
598944|NCT00571831|intraocular lens|intraocular lens
598945|NCT00571831|prospective randomized parallel clinical design|prospective randomized parallel clinical design
598946|NCT00571844|High Blood Pressure|high blood pressure
598947|NCT00571844|Exercise|exercise
598948|NCT00571844|Diet|diet
598949|NCT00571844|Biomarkers|biomarkers
598950|NCT00573131|Esophageal cancer|esophageal cancer
598951|NCT00573131|Localized esophageal cancer|localized esophageal cancer
598952|NCT00573131|Operable esophageal cancer|operable esophageal cancer
598953|NCT00573131|Loco-regional esophageal cancer|loco-regional esophageal cancer
598954|NCT00573131|Esophagectomy|esophagectomy
598955|NCT00573131|Phase 2|phase 2
598956|NCT00573131|Paclitaxel|paclitaxel
598957|NCT00573131|Tumor|tumor
598958|NCT00573131|Local|local
598959|NCT00573131|Chemotherapy|chemotherapy
598960|NCT00573131|radiation therapy|radiation therapy
598961|NCT00573131|surgery|surgery
598962|NCT00573131|OncoGel|oncogel
598963|NCT00573131|Squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
598964|NCT00573157|nephritis|nephritis
598965|NCT00573157|atacicept|atacicept
598966|NCT00573170|Migraine, acute|migraine, acute
598967|NCT00573170|Migraine|migraine
598968|NCT00573170|Butalbital-containing Combination Medication (BCM)|butalbital-containing combination medication (bcm)
598969|NCT00573170|Naproxen sodium|naproxen sodium
598970|NCT00573170|Sumatriptan succinate|sumatriptan succinate
598971|NCT00573170|TREXIMET®|treximet®
598972|NCT00573183|Cocaine, methamphetamine, amphetamine, other stimulant drugs|cocaine, methamphetamine, amphetamine, other stimulant drugs
598973|NCT00573196|Affective Psychosis, Bipolar|affective psychosis, bipolar
598974|NCT00573196|Depression, Bipolar|depression, bipolar
598975|NCT00573196|Mania|mania
598976|NCT00573196|Manic Disorder|manic disorder
598977|NCT00573196|Manic State|manic state
598978|NCT00573196|Manic-Depressive Psychosis|manic-depressive psychosis
598979|NCT00573196|Psychoses, Manic-Depressive|psychoses, manic-depressive
598980|NCT00573196|Psychosis, Manic-Depressive|psychosis, manic-depressive
598981|NCT00573209|Impotence|impotence
598982|NCT00573209|Male Impotence|male impotence
598983|NCT00573209|Male Sexual Impotence|male sexual impotence
598984|NCT00573222|Asthma|asthma
598985|NCT00573235|isolates|isolates
598986|NCT00573235|infection|infection
598987|NCT00573235|E coli isolates|e coli isolates
598988|NCT00573248|Nicotine|nicotine
598989|NCT00573248|ADHD|adhd
598990|NCT00573248|Gender|gender
598991|NCT00573261|Diabetic neuropathy|diabetic neuropathy
598992|NCT00573261|Pregabalin|pregabalin
598993|NCT00573261|Lyrica|lyrica
598994|NCT00573274|Cesarean section|cesarean section
598995|NCT00573274|Cardiac Output|cardiac output
598996|NCT00573274|Physioflow|physioflow
598997|NCT00573274|Cardiography, Impedance|cardiography, impedance
598998|NCT00573287|Clozapine, risperidone, first episode,|clozapine, risperidone, first episode,
598999|NCT00573300|Schizophrenia|schizophrenia
599000|NCT00573300|Immune System|immune system
599002|NCT00573300|tryptophan metabolism|tryptophan metabolism
599003|NCT00573300|NMDA receptor|nmda receptor
599004|NCT00573300|indolamine 2,3-deoxygenase (IDO)|indolamine 2,3-deoxygenase (ido)
599005|NCT00573313|Alcoholic Liver Disease (ALD)|alcoholic liver disease (ald)
599006|NCT00573313|S-adenosylmethionine|s-adenosylmethionine
599007|NCT00573313|SAMe|same
599008|NCT00573339|Cardiac|cardiac
599010|NCT00573339|normal controls|normal controls
599011|NCT00573352|Arthritis, Degenerative|arthritis, degenerative
599012|NCT00573352|Osteoarthrosis|osteoarthrosis
599013|NCT00573352|Osteoarthrosis Deformans|osteoarthrosis deformans
599014|NCT00573365|dermatitis|dermatitis
599015|NCT00573365|skin|skin
599016|NCT00573365|radiation|radiation
599017|NCT00573365|light|light
599018|NCT00573365|LED photomodulation|led photomodulation
599019|NCT00573365|Gentlewaves|gentlewaves
599020|NCT00573378|CML|cml
599021|NCT00573404|gastrointestinal stromal tumor|gastrointestinal stromal tumor
599022|NCT00573417|Schizophrenia|schizophrenia
599023|NCT00573417|Clozapine|clozapine
599024|NCT00573417|Cognition|cognition
599025|NCT00573417|Metabolic Syndrome|metabolic syndrome
599026|NCT00573417|Negative Symptoms|negative symptoms
599027|NCT00573417|Wakefulness|wakefulness
599028|NCT00573417|Fatigue|fatigue
599029|NCT00573430|Candesartan Cilexetil|candesartan cilexetil
599030|NCT00573430|Non-diabetic Nephropathy|non-diabetic nephropathy
599031|NCT00573430|hypertension|hypertension
599032|NCT00573430|urine protein creatinine ratio|urine protein creatinine ratio
599033|NCT00573443|Amyotrophic Lateral Sclerosis (Lou Gehrig's disease, ALS)|amyotrophic lateral sclerosis (lou gehrig's disease, als)
599034|NCT00573443|Multiple Sclerosis (MS)|multiple sclerosis (ms)
599035|NCT00573456|Thye 1 Diabetes|thye 1 diabetes
599036|NCT00573456|Type 2 Diabetes|type 2 diabetes
599037|NCT00573469|gastrointestinal|gastrointestinal
599038|NCT00573469|GI|gi
599039|NCT00573469|Crohn's disease|crohn's disease
599040|NCT00573469|Japan|japan
599041|NCT00573469|Japanese|japanese
599042|NCT00573482|weight gain prevention|weight gain prevention
599043|NCT00573482|obesity|obesity
599044|NCT00573482|overweight|overweight
599045|NCT00573482|food environment|food environment
599046|NCT00573482|The intervention group received the education in REDE techniques|the intervention group received the education in rede techniques
599047|NCT00573482|The control group received no intervention at all.|the control group received no intervention at all.
599048|NCT00573482|Both groups were exposed to the food labels and the new lower ED foods.|both groups were exposed to the food labels and the new lower ed foods.
599049|NCT00573482|Only the intervention group received the education sessions and only they were eligible for the price reductions.|only the intervention group received the education sessions and only they were eligible for the price reductions.
599050|NCT00573495|Advanced breast cancer|advanced breast cancer
599051|NCT00573508|Overactive Bladder|overactive bladder
599052|NCT00573521|ESBL positive cultures|esbl positive cultures
599053|NCT00573534|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
599054|NCT00573534|ADHD|adhd
599055|NCT00573534|ADD|add
599056|NCT00573534|Prevention|prevention
599057|NCT00573534|Substance use|substance use
599058|NCT00573534|Adolescent|adolescent
599059|NCT00573547|depression|depression
599060|NCT00573547|chronic renal failures|chronic renal failures
599061|NCT00573547|end stage renal disease|end stage renal disease
599062|NCT00573560|Heart failure|heart failure
599063|NCT00573560|percutaneous|percutaneous
599064|NCT00573560|interventional cardiology|interventional cardiology
599065|NCT00573560|apical remodeling|apical remodeling
599066|NCT00573560|LV dilatation|lv dilatation
599067|NCT00573560|akinesis|akinesis
599068|NCT00573560|dyskinesis|dyskinesis
599069|NCT00573573|PRIMARY HYPERPARATHYROIDISM|primary hyperparathyroidism
599070|NCT00573573|PARATHYROID NEOPLASMS|parathyroid neoplasms
599071|NCT00573573|SECONDARY HYPERPARATHYROIDISM|secondary hyperparathyroidism
599072|NCT00573573|HYPOCALCEMIA|hypocalcemia
599073|NCT00573599|Migraine|migraine
599074|NCT00573599|Emergency|emergency
599075|NCT00573599|imitrex|imitrex
599076|NCT00573599|prochlorperazine|prochlorperazine
599077|NCT00573599|Acute Migraine Headache in the Emergency Department|acute migraine headache in the emergency department
599078|NCT00573612|Fibromyalgia|fibromyalgia
599079|NCT00573612|Fibromyalgia patients|fibromyalgia patients
599080|NCT00573638|glaucoma|glaucoma
599081|NCT00573638|compliance|compliance
599082|NCT00573638|eye drops|eye drops
599083|NCT00573638|deliver aid|deliver aid
599084|NCT00573638|Patients could range anywhere from 40 to 80 years old|patients could range anywhere from 40 to 80 years old
599085|NCT00573638|Patients must have diagnosis requiring treatment with Xalatan.|patients must have diagnosis requiring treatment with xalatan.
599086|NCT00573638|Patients will be male or female and from any racial/ethnic background.|patients will be male or female and from any racial/ethnic background.
599087|NCT00573651|JIA|jia
599088|NCT00573651|SEA syndrome|sea syndrome
599089|NCT00573651|AS|as
599090|NCT00573651|psoriatic arthritis|psoriatic arthritis
599091|NCT00573651|HPV vaccine|hpv vaccine
599092|NCT00573664|Cesarean section|cesarean section
599093|NCT00573664|Gabapentin|gabapentin
599094|NCT00573690|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
599095|NCT00573703|Laparoscopic Burch colposuspension|laparoscopic burch colposuspension
599096|NCT00573703|Stress incontinence|stress incontinence
599097|NCT00573703|Surgery|surgery
599098|NCT00573703|TOT|tot
599099|NCT00573703|Treatment|treatment
599100|NCT00573703|Predominant or genuine stress urinary incontinence|predominant or genuine stress urinary incontinence
599101|NCT00573716|bone mineral content|bone mineral content
599102|NCT00573716|aripiprazole monotherapy|aripiprazole monotherapy
599103|NCT00573716|risperidone monotherapy|risperidone monotherapy
599104|NCT00573729|vascular malformation|vascular malformation
599105|NCT00573742|hypertension|hypertension
599106|NCT00573755|stage IV breast cancer|stage iv breast cancer
599107|NCT00573755|recurrent breast cancer|recurrent breast cancer
599108|NCT00573768|Ankle, sprain, diclofenac diethylamine|ankle, sprain, diclofenac diethylamine
599109|NCT00573781|Systems biology|systems biology
599110|NCT00573781|Nutrigenomics|nutrigenomics
599111|NCT00573781|Metabolomics|metabolomics
599112|NCT00573781|Gene expression|gene expression
599113|NCT00573781|Fat tissue|fat tissue
599114|NCT00573781|Peripheral mononuclear cells|peripheral mononuclear cells
599115|NCT00573781|Gene clusters|gene clusters
599116|NCT00573781|Gene expression profiles|gene expression profiles
599117|NCT00573781|Personal diets|personal diets
599118|NCT00573781|Metabolic syndrome|metabolic syndrome
599119|NCT00573781|Type 2 Diabetes|type 2 diabetes
599120|NCT00573781|Atherosclerosis|atherosclerosis
599121|NCT00573794|Ulcerative Colitis|ulcerative colitis
599122|NCT00573807|Neuralgia, Sciatic|neuralgia, sciatic
599123|NCT00573807|Sciatic Neuralgia|sciatic neuralgia
599124|NCT00573807|Sciatica, Bilateral|sciatica, bilateral
599125|NCT00573807|Lower back pain|lower back pain
599126|NCT00573820|Tumors or cancer of the prostate|tumors or cancer of the prostate
599127|NCT00573820|Cancer of Prostate|cancer of prostate
599128|NCT00573820|Cancer of the Prostate|cancer of the prostate
599129|NCT00573820|Neoplasms, Prostate|neoplasms, prostate
599130|NCT00573820|Neoplasms, Prostatic|neoplasms, prostatic
599131|NCT00573820|Prostate Cancer|prostate cancer
599132|NCT00573820|Prostate Neoplasms|prostate neoplasms
599133|NCT00573820|Prostatic Cancer|prostatic cancer
599134|NCT00573833|adenocarcinoma of the prostate|adenocarcinoma of the prostate
599135|NCT00573833|stage IIB prostate cancer|stage iib prostate cancer
599136|NCT00573833|stage IIA prostate cancer|stage iia prostate cancer
599138|NCT00573859|Smoking|smoking
599139|NCT00573859|ADHD|adhd
599140|NCT00573859|Stimulant medication|stimulant medication
599141|NCT00573872|Radiosurgery|radiosurgery
599142|NCT00573872|Phase II|phase ii
599143|NCT00573872|Cancer|cancer
599144|NCT00573872|Spinal|spinal
599145|NCT00573872|AVM|avm
599146|NCT00573885|non-small cell lung cancer|non-small cell lung cancer
599147|NCT00573885|small cell lung cancer|small cell lung cancer
599148|NCT00573885|tobacco use disorder|tobacco use disorder
599149|NCT00573898|daptomycin|daptomycin
599150|NCT00573911|Barrett's esophagus|barrett's esophagus
599151|NCT00573911|GERD|gerd
599152|NCT00573937|Neoplasms|neoplasms
599153|NCT00573937|Pain|pain
599154|NCT00573937|Methadone|methadone
599155|NCT00573937|Morphine|morphine
599156|NCT00573950|cilostazol|cilostazol
599157|NCT00573950|Type 2 Diabetes mellitus|type 2 diabetes mellitus
599158|NCT00573950|Metabolic Syndrome|metabolic syndrome
599159|NCT00573950|adipocytokines|adipocytokines
599160|NCT00573950|arterial stiffness|arterial stiffness
599161|NCT00573950|Pulse wave velocity|pulse wave velocity
599162|NCT00573963|Cesarean section|cesarean section
599163|NCT00573976|SCIM|scim
599164|NCT00573976|SCIM III|scim iii
599165|NCT00573976|Multi-Center|multi-center
599166|NCT00573976|United States|united states
599167|NCT00573989|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
599168|NCT00573989|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
599169|NCT00573989|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
599170|NCT00573989|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
599171|NCT00573989|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
599172|NCT00573989|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
599173|NCT00573989|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
599174|NCT00573989|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
599175|NCT00574015|toothache|toothache
599176|NCT00574015|regional anesthesia|regional anesthesia
599177|NCT00574015|emergency department|emergency department
599178|NCT00574028|IBD Study|ibd study
599179|NCT00574041|Multiple Sclerosis|multiple sclerosis
599180|NCT00574041|Avonex|avonex
599181|NCT00574041|side effects|side effects
599182|NCT00574041|flu like symptoms|flu like symptoms
599183|NCT00574054|Familial Dementia|familial dementia
599184|NCT00574054|Semantic Dementia|semantic dementia
599185|NCT00574054|Senile Paranoid Dementia|senile paranoid dementia
599186|NCT00574093|combination therapy|combination therapy
599189|NCT00574106|Cancer|cancer
599190|NCT00574106|Tumors|tumors
599191|NCT00574119|heart failure|heart failure
599192|NCT00574119|positron emission tomography|positron emission tomography
599193|NCT00574119|magnetic resonance imaging|magnetic resonance imaging
599194|NCT00574119|myocardial energetics|myocardial energetics
599195|NCT00574119|myocardial perfusion|myocardial perfusion
599196|NCT00574145|fatigue|fatigue
599197|NCT00574145|depression|depression
599198|NCT00574145|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
599199|NCT00574145|stage I breast cancer|stage i breast cancer
599200|NCT00574145|stage II breast cancer|stage ii breast cancer
599201|NCT00574145|stage IIIA breast cancer|stage iiia breast cancer
599202|NCT00574145|stage IIIB breast cancer|stage iiib breast cancer
599203|NCT00574145|stage IIIC breast cancer|stage iiic breast cancer
599204|NCT00574145|recurrent breast cancer|recurrent breast cancer
599205|NCT00574158|ozone|ozone
599206|NCT00574158|inflammatory airway disease|inflammatory airway disease
599207|NCT00574158|polymorphisms|polymorphisms
599208|NCT00574184|ED|ed
599209|NCT00574184|Erectile Dysfunction|erectile dysfunction
599210|NCT00574197|Heart Transplant|heart transplant
599211|NCT00574197|gastrointestinal|gastrointestinal
599212|NCT00574197|Cellcept|cellcept
599213|NCT00574197|Myfortic|myfortic
599214|NCT00574197|GI|gi
599215|NCT00574197|GI symptoms with Mycophenolate Mofetil after heart transplant|gi symptoms with mycophenolate mofetil after heart transplant
599216|NCT00574210|Seasonal Allergic Rhinitis (SAR)|seasonal allergic rhinitis (sar)
599217|NCT00574210|Environmental Exposure Chamber (EEC)|environmental exposure chamber (eec)
599218|NCT00574210|Therapeutic Uses|therapeutic uses
599219|NCT00574210|Antihistamine Drug|antihistamine drug
599220|NCT00574210|Ragweed Pollen|ragweed pollen
599221|NCT00574249|Psoriasis|psoriasis
599222|NCT00574249|Moderate Psoriasis|moderate psoriasis
599223|NCT00574249|Severe Psoriasis|severe psoriasis
599224|NCT00574249|Chronic Plaque Psoriasis|chronic plaque psoriasis
599225|NCT00574249|Severe Chronic Plaque Psoriasis|severe chronic plaque psoriasis
599226|NCT00574262|acute ischemic stroke|acute ischemic stroke
599227|NCT00574262|clinical pathway|clinical pathway
599228|NCT00574262|quality of care|quality of care
599229|NCT00574262|secondary prevention|secondary prevention
599230|NCT00574275|metastatic pancreatic cancer|metastatic pancreatic cancer
599231|NCT00574275|angiogenesis inhibitor|angiogenesis inhibitor
599232|NCT00574275|gemcitabine|gemcitabine
599233|NCT00574288|Multiple Myeloma|multiple myeloma
599234|NCT00574288|Daratumumab|daratumumab
599235|NCT00574288|Safety|safety
599236|NCT00574288|HuMax-CD38|humax-cd38
599237|NCT00574288|Dose-escalation|dose-escalation
599238|NCT00574301|Image Guided Vacuum Assisted Biopsy|image guided vacuum assisted biopsy
599239|NCT00574301|Radiofrequency Ablation|radiofrequency ablation
599240|NCT00574301|Breast Conservation Therapy|breast conservation therapy
599241|NCT00574301|Mastectomy|mastectomy
599242|NCT00574301|MRI|mri
599243|NCT00574314|women|women
599244|NCT00574314|Registry|registry
599245|NCT00574327|Role|role
599246|NCT00574327|Registry|registry
599247|NCT00574327|Barrett's Esophagus|barrett's esophagus
599248|NCT00574340|Type 2 Diabetes|type 2 diabetes
599249|NCT00574340|Endothelial Function|endothelial function
599250|NCT00574340|Fibrinolytic Balance|fibrinolytic balance
599251|NCT00574340|Hypoglycemia|hypoglycemia
599252|NCT00574353|colorectal cancer|colorectal cancer
599253|NCT00574353|07-151|07-151
600431|NCT00572897|ATG|atg
599254|NCT00574366|recurrent breast cancer|recurrent breast cancer
599255|NCT00574366|stage IV breast cancer|stage iv breast cancer
599256|NCT00574366|male breast cancer|male breast cancer
599257|NCT00574379|Allergic Rhinitis|allergic rhinitis
599258|NCT00574379|Mountain Cedar Pollen|mountain cedar pollen
599259|NCT00574379|Pollen Allergy|pollen allergy
599260|NCT00574379|Rhinoconjunctivitis|rhinoconjunctivitis
599261|NCT00574392|skin disorders|skin disorders
599262|NCT00574405|Insulin pump|insulin pump
599263|NCT00574405|Beta cell|beta cell
599264|NCT00574418|Fibroid Tumor|fibroid tumor
599265|NCT00574418|Fibroid Uterus|fibroid uterus
599266|NCT00574418|Fibroids, Uterine|fibroids, uterine
599267|NCT00574418|Fibromyoma|fibromyoma
599268|NCT00574418|Uterine Neoplasms|uterine neoplasms
599269|NCT00574431|Critical care|critical care
599270|NCT00574431|Intensive care unit|intensive care unit
599271|NCT00574431|Early enteral nutrition|early enteral nutrition
599272|NCT00574431|Nutritional management protocol|nutritional management protocol
599273|NCT00574444|transvaginal peritoneoscopy|transvaginal peritoneoscopy
599274|NCT00574457|Atherosclerosis|atherosclerosis
599275|NCT00574457|Cardiovascular Risk Prevention|cardiovascular risk prevention
599276|NCT00574457|Carotid Ultrasound|carotid ultrasound
599277|NCT00574457|Handheld ultrasound|handheld ultrasound
599278|NCT00574457|Office Practice|office practice
599279|NCT00574457|Carotid Intima Media Thickness|carotid intima media thickness
599280|NCT00574457|Carotid Plaque|carotid plaque
599281|NCT00574483|Renal cell carcinoma|renal cell carcinoma
599282|NCT00574496|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
599283|NCT00574496|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
599284|NCT00574496|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
599285|NCT00574496|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
599286|NCT00574496|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
599287|NCT00574496|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
599288|NCT00574496|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
599289|NCT00574496|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
599290|NCT00574496|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
599291|NCT00574496|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
599292|NCT00574496|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
599293|NCT00574496|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
599294|NCT00574509|NHL|nhl
599295|NCT00574509|Non Hodgkins Lymphoma|non hodgkins lymphoma
599483|NCT00575432|renal function|renal function
599296|NCT00574509|131Iodine-Anti-B1 Radioimmunotherapy|131iodine-anti-b1 radioimmunotherapy
599297|NCT00574509|Autologous Hematopoietic Stem Cell Transplant|autologous hematopoietic stem cell transplant
599298|NCT00574509|AHSCT|ahsct
599299|NCT00574522|HIV|hiv
599300|NCT00574522|AIDS|aids
599301|NCT00574522|Radiation|radiation
599302|NCT00574522|Far infrared|far infrared
599303|NCT00574522|Treatment|treatment
599304|NCT00574522|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
599305|NCT00574522|Complimentary therapies|complimentary therapies
599306|NCT00574535|Reproductive Hormones|reproductive hormones
599307|NCT00574548|Vaccines, Pneumococcal Conjugate Vaccine|vaccines, pneumococcal conjugate vaccine
599308|NCT00574561|CT angiography (CTA)|ct angiography (cta)
599309|NCT00574561|Magnetocardiography (MCG)|magnetocardiography (mcg)
599310|NCT00574561|heart disease|heart disease
599311|NCT00574574|cardiovascular disease|cardiovascular disease
599312|NCT00574574|CVD|cvd
599313|NCT00574574|skin health|skin health
599314|NCT00574574|postmenopausal women|postmenopausal women
599315|NCT00574574|anthocyanin|anthocyanin
599316|NCT00574574|inflammation|inflammation
599317|NCT00574587|Vorinostat|vorinostat
599318|NCT00574587|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
599319|NCT00574600|HIV Seronegativity|hiv seronegativity
599320|NCT00574600|HIV Preventive Vaccine|hiv preventive vaccine
599321|NCT00574613|Skin fibrosis|skin fibrosis
599322|NCT00574613|systemic scleroderma|systemic scleroderma
599323|NCT00574613|systemic sclerosis|systemic sclerosis
599324|NCT00574613|P144|p144
599325|NCT00574613|orphan drug|orphan drug
599326|NCT00574613|soluble collagen|soluble collagen
599327|NCT00574613|durometer|durometer
599328|NCT00574613|skin fibrosis in systemic sclerosis|skin fibrosis in systemic sclerosis
599329|NCT00574626|NHL|nhl
599330|NCT00574626|Non Hodgkins Lymphoma|non hodgkins lymphoma
599331|NCT00574626|BMT|bmt
599332|NCT00574626|Bone Marrow Transplant|bone marrow transplant
599333|NCT00574626|PBSCT|pbsct
599334|NCT00574626|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
601568|NCT00578383|affective disorders|affective disorders
601569|NCT00578396|Grapes and colon cancer prevention|grapes and colon cancer prevention
601570|NCT00578409|castration resistant prostate cancer|castration resistant prostate cancer
601572|NCT00578422|PAD|pad
601574|NCT00578422|IVUS|ivus
599335|NCT00574626|PSCT|psct
599336|NCT00574639|Type 1 Diabetes|type 1 diabetes
599337|NCT00574639|Alprazolam|alprazolam
599338|NCT00574639|Exercise|exercise
599339|NCT00574652|HCV+|hcv+
599340|NCT00574652|cryoglobulinemia|cryoglobulinemia
599341|NCT00574652|Vasculitis|vasculitis
599342|NCT00574652|IL-2 treatment|il-2 treatment
599343|NCT00574652|safety and efficacy|safety and efficacy
599344|NCT00574665|Type 2 Diabetes|type 2 diabetes
599345|NCT00574665|Endothelial Function|endothelial function
599346|NCT00574665|Fibrinolytic Balance|fibrinolytic balance
599347|NCT00574678|Screening tool for cancer|screening tool for cancer
599348|NCT00574691|Closure Device|closure device
599349|NCT00574691|Angiography|angiography
599350|NCT00574691|Angioplasty|angioplasty
599351|NCT00574691|Hemostasis|hemostasis
599352|NCT00574691|Heart Catheterization|heart catheterization
599353|NCT00574691|Coronary Angiography|coronary angiography
599354|NCT00574717|hyperopia|hyperopia
599355|NCT00574717|ocular refraction|ocular refraction
599356|NCT00574717|infant|infant
599357|NCT00574717|vision|vision
599358|NCT00574743|ERL080A, Heart Transplantation, Mycophenolate, EC-MPS|erl080a, heart transplantation, mycophenolate, ec-mps
599359|NCT00574769|RAD001|rad001
599360|NCT00574769|mTOR inhibition|mtor inhibition
599361|NCT00574769|docetaxel|docetaxel
599362|NCT00574769|bevacizumab|bevacizumab
599363|NCT00574769|adenocarcinoma of the prostate|adenocarcinoma of the prostate
599364|NCT00574769|recurrent prostate cancer|recurrent prostate cancer
599365|NCT00574769|stage IV prostate cancer|stage iv prostate cancer
599366|NCT00574769|prostate cancer|prostate cancer
599367|NCT00574769|Metastatic, androgen independent prostate cancer|metastatic, androgen independent prostate cancer
599368|NCT00574782|cholesterol, coronary heart disease|cholesterol, coronary heart disease
599369|NCT00574782|rosuvastatin|rosuvastatin
599370|NCT00574782|LDL-C goal|ldl-c goal
599371|NCT00574782|hypercholesterolemia|hypercholesterolemia
599372|NCT00574808|Primary care|primary care
599373|NCT00574808|Prevention of Cardiovascular Disease|prevention of cardiovascular disease
599374|NCT00574808|Chronic Disease Management|chronic disease management
599375|NCT00574808|Chronic Disease Prevention|chronic disease prevention
599376|NCT00574808|Chronic Care Model|chronic care model
599377|NCT00574808|Outreach Facilitation|outreach facilitation
599378|NCT00574821|Hypertrophic Cardiomyopathy(HCM)|hypertrophic cardiomyopathy(hcm)
599379|NCT00574821|Magnetocardiography (MCG)|magnetocardiography (mcg)
599380|NCT00574847|ischemic heart disease|ischemic heart disease
599381|NCT00574847|mental stress-induced myocardial ischemia|mental stress-induced myocardial ischemia
599382|NCT00574847|escitalopram|escitalopram
599383|NCT00574860|Oral Mucositis|oral mucositis
599384|NCT00574860|Chemoradiation therapy|chemoradiation therapy
599385|NCT00574860|Head and neck cancer|head and neck cancer
599386|NCT00574873|Bosutinib|bosutinib
599387|NCT00574873|imatinib|imatinib
599388|NCT00574873|CML|cml
599389|NCT00574899|Prostate|prostate
599390|NCT00574912|Type 2 diabetes|type 2 diabetes
599391|NCT00574912|Insulin Glargine|insulin glargine
599988|NCT00580567|Risk-taking|risk-taking
599392|NCT00574912|Endogenous Glucose Production|endogenous glucose production
599393|NCT00574925|H. pylori|h. pylori
599394|NCT00574951|fallopian tube cancer|fallopian tube cancer
599395|NCT00574951|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
599396|NCT00574951|primary peritoneal cavity cancer|primary peritoneal cavity cancer
599397|NCT00574977|vaccinia|vaccinia
599398|NCT00574977|virus|virus
599399|NCT00574977|tumor|tumor
599400|NCT00574977|melanoma|melanoma
599401|NCT00574977|breast cancer|breast cancer
599402|NCT00574977|squamous cell cancer|squamous cell cancer
599403|NCT00574977|colorectal|colorectal
599404|NCT00574977|liver|liver
599405|NCT00574977|pancreatic|pancreatic
599406|NCT00574977|adenocarcinoma|adenocarcinoma
599407|NCT00574990|Interdisciplinary Communication|interdisciplinary communication
599408|NCT00574990|Safety Management|safety management
599409|NCT00574990|Management, Medication Therapy|management, medication therapy
599410|NCT00574990|Cooperative Behavior|cooperative behavior
599411|NCT00574990|Drug Therapy Management|drug therapy management
599412|NCT00574990|Physician Nurse Relationships|physician nurse relationships
599413|NCT00574990|Side Effects|side effects
599414|NCT00574990|Hospital Information Systems|hospital information systems
599415|NCT00574990|Documentation|documentation
599416|NCT00574990|Quality Assurance, Health Care|quality assurance, health care
599417|NCT00575029|megestrol acetate|megestrol acetate
599418|NCT00575029|adrenal insufficiency|adrenal insufficiency
599419|NCT00575029|adrenal suppression|adrenal suppression
599421|NCT00575042|Primary Biliary Cirrhosis|primary biliary cirrhosis
599422|NCT00575042|Fenofibrate|fenofibrate
599423|NCT00575042|Triglide|triglide
599424|NCT00575081|Physiological Brain Atlas, Brain registry, Brain database|physiological brain atlas, brain registry, brain database
599425|NCT00575120|Endothelial Function, MRI, Vascular Biology|endothelial function, mri, vascular biology
599426|NCT00575146|glioblastoma|glioblastoma
599427|NCT00575146|ketogenic diet|ketogenic diet
599428|NCT00575159|Adult male and females,|adult male and females,
599429|NCT00575159|type 1 Diabetes mellitus, pharmacokinetics,|type 1 diabetes mellitus, pharmacokinetics,
599430|NCT00575159|pharmacodynamics|pharmacodynamics
599431|NCT00575172|type2 diabetes mellitus|type2 diabetes mellitus
599432|NCT00575172|cardiovascular disease|cardiovascular disease
599433|NCT00575172|macrovascular event|macrovascular event
599434|NCT00575185|Mono|mono
599435|NCT00575185|Mononucleosis|mononucleosis
599436|NCT00575185|Epstein-Barr virus|epstein-barr virus
599437|NCT00575198|Chest tubes|chest tubes
599438|NCT00575198|Trauma|trauma
599439|NCT00575211|New onset cardiomyopathy|new onset cardiomyopathy
599440|NCT00575211|Onset of symptoms less than 6 months|onset of symptoms less than 6 months
599441|NCT00575211|LVEF < 40%|lvef < 40%
599442|NCT00575224|Hepatitis C|hepatitis c
599443|NCT00575224|Genotype 6|genotype 6
599444|NCT00575224|Novel genoytpe|novel genoytpe
599445|NCT00575224|HCV|hcv
599446|NCT00575224|Treatment|treatment
599447|NCT00575237|Laparoscopic Surgery|laparoscopic surgery
599448|NCT00575237|Shoulder pain|shoulder pain
599449|NCT00575237|PDNV|pdnv
599450|NCT00575237|Anesthesia|anesthesia
599451|NCT00575237|Residual CO2|residual co2
599452|NCT00575237|Postoperative Pain|postoperative pain
599453|NCT00575237|Female ASA 1 and 2 outpatients who were scheduled for elective gynecologic laparoscopic surgery|female asa 1 and 2 outpatients who were scheduled for elective gynecologic laparoscopic surgery
599454|NCT00575250|Osteoporosis/prevention & control|osteoporosis/prevention & control
599455|NCT00575250|Osteoporosis Prevention and Self-Management Course|osteoporosis prevention and self-management course
599578|NCT00575835|bone markers|bone markers
599456|NCT00575250|Patient Education/*trends//Questionnaires|patient education/*trends//questionnaires
599457|NCT00575250|Adult//Aged//Middle Aged|adult//aged//middle aged
599458|NCT00575250|Life Style//|life style//
599459|NCT00575263|Pain, Sodium Channel, Dental pulp|pain, sodium channel, dental pulp
599460|NCT00575276|Pain, Cholecystectomy, Cytokines, Sex Differences|pain, cholecystectomy, cytokines, sex differences
599461|NCT00575302|IVF|ivf
599462|NCT00575302|poor responder|poor responder
599463|NCT00575302|recFSH|recfsh
599464|NCT00575302|Fertilization in Vitro|fertilization in vitro
599465|NCT00575302|Poor responders|poor responders
599466|NCT00575315|HIV-HCV Coinfection|hiv-hcv coinfection
599467|NCT00575315|HIV|hiv
599468|NCT00575315|Histology|histology
599469|NCT00575328|Sexual Dysfunction|sexual dysfunction
599470|NCT00575328|Bipolar Disorder|bipolar disorder
599471|NCT00575341|Central Adrenal Insufficiency|central adrenal insufficiency
599472|NCT00575341|DHEA|dhea
599473|NCT00575341|Pubes|pubes
599474|NCT00575354|Sevoflurane|sevoflurane
599475|NCT00575354|Isoflurane|isoflurane
599476|NCT00575354|Breast tumor|breast tumor
599477|NCT00575354|Anesthesia|anesthesia
599478|NCT00575393|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
599479|NCT00575393|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
599480|NCT00575393|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
599481|NCT00575419|Contrast Induced Nephropathy|contrast induced nephropathy
599482|NCT00575432|magnetic resonance imaging|magnetic resonance imaging
599484|NCT00575432|renal transplant|renal transplant
599485|NCT00575432|urinary calculi|urinary calculi
599486|NCT00575432|healthy controls|healthy controls
599487|NCT00575432|kidney|kidney
599488|NCT00575471|rivoglitazone HCl|rivoglitazone hcl
599489|NCT00575471|thiazolidinedione|thiazolidinedione
599490|NCT00575471|peroxisome proliferator-activated receptor gamma (PPARgamma)|peroxisome proliferator-activated receptor gamma (ppargamma)
599491|NCT00575471|diabetes mellitus, type 2|diabetes mellitus, type 2
599492|NCT00575484|Congestive Heart Failure|congestive heart failure
599493|NCT00575484|Renal Insufficiency|renal insufficiency
599494|NCT00575484|Hypertonic Saline Solution|hypertonic saline solution
599495|NCT00575484|Diuretic Resistance|diuretic resistance
599496|NCT00575484|Cardiorenal Syndrome|cardiorenal syndrome
599497|NCT00575497|Hemodialysis|hemodialysis
599498|NCT00575497|Adequacy|adequacy
599499|NCT00575497|Frequency|frequency
599500|NCT00575510|unified theory of behavior|unified theory of behavior
599501|NCT00575510|Pap test|pap test
599502|NCT00575510|cervical dysplasia|cervical dysplasia
599503|NCT00575510|women's health|women's health
599504|NCT00575523|atropine|atropine
599505|NCT00575523|percutaneous ethanol instillation|percutaneous ethanol instillation
599506|NCT00575523|hepatoma|hepatoma
599507|NCT00575523|bradycardia|bradycardia
599508|NCT00575523|arrhythmia|arrhythmia
599509|NCT00575536|spasticity|spasticity
599510|NCT00575536|rhizotomy|rhizotomy
599511|NCT00575536|surgery|surgery
599512|NCT00575575|Suicidal ideation|suicidal ideation
599513|NCT00575575|cognitive behavior therapy|cognitive behavior therapy
599514|NCT00575588|DPP-4 Inhibitors|dpp-4 inhibitors
599515|NCT00575588|HbA1c|hba1c
599516|NCT00575588|incretins|incretins
599517|NCT00575601|pco|pco
599518|NCT00575601|simvastatin|simvastatin
599519|NCT00575601|ivf|ivf
599520|NCT00575601|embryo transfer|embryo transfer
599521|NCT00575614|Constipation|constipation
599522|NCT00575614|Prucalopride|prucalopride
599523|NCT00575614|Ano-rectal physiology|ano-rectal physiology
599524|NCT00575614|Oro-caecal transit time|oro-caecal transit time
599525|NCT00575614|QOL|qol
599526|NCT00575627|Hepatitis C|hepatitis c
599527|NCT00575627|persistently normal ALT|persistently normal alt
599528|NCT00575627|pNNALT|pnnalt
599529|NCT00575627|Theraphy for Hepatitis C|theraphy for hepatitis c
599530|NCT00575627|Pegylated Interferon|pegylated interferon
599531|NCT00575627|Combined therapy|combined therapy
599532|NCT00568880|stage I multiple myeloma|stage i multiple myeloma
599533|NCT00568880|stage II multiple myeloma|stage ii multiple myeloma
599534|NCT00568880|stage III multiple myeloma|stage iii multiple myeloma
599535|NCT00568880|refractory multiple myeloma|refractory multiple myeloma
599536|NCT00568945|Atrial Fibrillation|atrial fibrillation
599537|NCT00568945|Capadenoson|capadenoson
599538|NCT00575653|Guillain-Barre Syndrome|guillain-barre syndrome
599539|NCT00575653|Meningococcal vaccines|meningococcal vaccines
599540|NCT00575653|Tetravalent Meningococcal Vaccine|tetravalent meningococcal vaccine
599541|NCT00575653|Vaccination|vaccination
599542|NCT00575653|Vaccines|vaccines
599543|NCT00575653|Vaccines, Conjugate|vaccines, conjugate
599544|NCT00575666|cognition, psychopathology|cognition, psychopathology
599545|NCT00575679|Automobile driving|automobile driving
599546|NCT00575679|Driving under the influence|driving under the influence
599547|NCT00575679|Interview, psychological|interview, psychological
599548|NCT00575679|Brief intervention|brief intervention
599549|NCT00575679|Brief motivational interview|brief motivational interview
599550|NCT00575705|cystic kidney disease|cystic kidney disease
599551|NCT00575705|polycystic kidney disease|polycystic kidney disease
599552|NCT00575705|congenital hepatic fibrosis|congenital hepatic fibrosis
599553|NCT00575705|genetic disease|genetic disease
599554|NCT00575718|Quitting tobacco|quitting tobacco
599555|NCT00575718|tobacco use|tobacco use
599556|NCT00575744|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
599557|NCT00575744|Axillary Node Dissection|axillary node dissection
599558|NCT00575744|Intraoperative Injection|intraoperative injection
599559|NCT00575744|Lumpectomy|lumpectomy
599560|NCT00575744|Mastectomy|mastectomy
599561|NCT00575757|Steatosis|steatosis
599562|NCT00575757|NASH|nash
599563|NCT00575783|type 1 diabetes|type 1 diabetes
599564|NCT00575783|hypoglycemia|hypoglycemia
599565|NCT00575783|magnetic resonance imaging|magnetic resonance imaging
599566|NCT00575796|pediatrics|pediatrics
599567|NCT00575796|Low Grade Glioma|low grade glioma
599568|NCT00575796|Vinblastine|vinblastine
599569|NCT00575809|Mucositis, hematopoietic stem cell transplantation, chemotherapy|mucositis, hematopoietic stem cell transplantation, chemotherapy
599570|NCT00575822|GERD|gerd
599571|NCT00575822|Sham|sham
599572|NCT00575822|Randomized Controlled Study|randomized controlled study
599573|NCT00575822|Endoscopic Full-thickness Plication|endoscopic full-thickness plication
599574|NCT00575822|Plicator|plicator
599575|NCT00575835|vitamin D|vitamin d
599576|NCT00575835|seasonal variation|seasonal variation
599577|NCT00575835|PTH|pth
599579|NCT00575848|Schizophrenia|schizophrenia
599580|NCT00575848|Glycine|glycine
599581|NCT00575848|Magnetic Resonance Spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
599582|NCT00575861|asthma|asthma
599583|NCT00575861|nitric oxide gas exchange|nitric oxide gas exchange
599584|NCT00575861|lung function|lung function
599585|NCT00575874|rivoglitazone HCl|rivoglitazone hcl
599586|NCT00575874|pioglitazone HCl|pioglitazone hcl
599587|NCT00575874|thiazolidinedione|thiazolidinedione
599588|NCT00575874|peroxisome proliferator-activated receptor gamma (PPAR gamma)|peroxisome proliferator-activated receptor gamma (ppar gamma)
599589|NCT00575874|type 2 diabetes mellitus|type 2 diabetes mellitus
599590|NCT00575887|Temozolomide|temozolomide
599591|NCT00575887|Brain Tumor, Recurrent|brain tumor, recurrent
599592|NCT00575887|Chemotherapy|chemotherapy
599593|NCT00575900|Adolescent obesity,|adolescent obesity,
599594|NCT00575900|low carbohydrate diets|low carbohydrate diets
599595|NCT00575900|metabolic risk factors|metabolic risk factors
599596|NCT00575900|BMI|bmi
599597|NCT00575926|Randomized controlled trial|randomized controlled trial
599598|NCT00575926|Lingzhi|lingzhi
599599|NCT00575926|Immune functions|immune functions
599600|NCT00575926|Quality of life|quality of life
599601|NCT00575926|Survival|survival
599602|NCT00575939|HIV|hiv
599603|NCT00575939|IMT|imt
599604|NCT00575939|coronary|coronary
599605|NCT00575939|Treatment Naive|treatment naive
599606|NCT00575965|simvastatin|simvastatin
599607|NCT00575978|breast cancer|breast cancer
599608|NCT00575991|conjugated linoleic acid, body fat, children, overweight|conjugated linoleic acid, body fat, children, overweight
599609|NCT00579033|somatosensory|somatosensory
599610|NCT00579033|cortex|cortex
599611|NCT00579033|neuroimaging|neuroimaging
599612|NCT00579033|tactile|tactile
599613|NCT00579033|cortical plasticity|cortical plasticity
599614|NCT00579033|dystonia|dystonia
599615|NCT00579046|Anemia|anemia
599616|NCT00579046|Chronic obstructive Pulmonary Disease|chronic obstructive pulmonary disease
599617|NCT00579046|Erythropoietin|erythropoietin
599618|NCT00579046|6-minute walk test|6-minute walk test
599619|NCT00579072|Prostate|prostate
599620|NCT00579072|cognitive effects|cognitive effects
599621|NCT00579072|06-084|06-084
599622|NCT00579098|Atrial Fibrillation|atrial fibrillation
599623|NCT00579098|Arrhythmia|arrhythmia
600800|NCT00583726|diet|diet
599624|NCT00579098|Pulmonary Vein Isolation|pulmonary vein isolation
599625|NCT00579098|Left atrial catheter ablation|left atrial catheter ablation
599626|NCT00579098|Inflammation|inflammation
599627|NCT00579098|Endothelial dysfunction|endothelial dysfunction
599628|NCT00579111|Myelodysplastic and Myeloproliferative Disorders|myelodysplastic and myeloproliferative disorders
599629|NCT00579111|Acute Myelogenous Leukemia|acute myelogenous leukemia
599630|NCT00579111|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
599631|NCT00579111|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
599632|NCT00579111|Multiple Myeloma|multiple myeloma
599732|NCT00579527|Athymia|athymia
599633|NCT00579111|Plasma Cell dyscrasia|plasma cell dyscrasia
599634|NCT00579111|Lymphoproliferative disorders|lymphoproliferative disorders
599635|NCT00579111|Hematologic Diseases|hematologic diseases
599636|NCT00579111|Fludarabine|fludarabine
599637|NCT00579111|Busulfan|busulfan
599638|NCT00579111|Campath|campath
599639|NCT00579111|Alemtuzumab|alemtuzumab
599640|NCT00579111|allogeneic stem cell transplant|allogeneic stem cell transplant
599641|NCT00579124|Blood and Marrow Transplant|blood and marrow transplant
599642|NCT00579124|T cell Depletion|t cell depletion
599643|NCT00579124|Unrelated|unrelated
599644|NCT00579124|Related|related
599645|NCT00579124|Donor|donor
599646|NCT00579137|Severe Combined Immunodeficiency Disease|severe combined immunodeficiency disease
599647|NCT00579137|Severe Primary Immunodeficiency Disorder|severe primary immunodeficiency disorder
599648|NCT00579137|Undefined T cell Deficiency Disorder|undefined t cell deficiency disorder
599649|NCT00579137|Wiskott-Aldrick Syndrome|wiskott-aldrick syndrome
599650|NCT00579137|Allogeneic stem cell transplant|allogeneic stem cell transplant
599651|NCT00579137|Fludarabine|fludarabine
599652|NCT00579137|monoclonal antibodies|monoclonal antibodies
599653|NCT00579150|Birth Defects|birth defects
599654|NCT00579150|High Risk Pregnancy|high risk pregnancy
599655|NCT00579150|Type 2 Diabetes|type 2 diabetes
599656|NCT00579163|Blood|blood
599657|NCT00579163|Salvia|salvia
599658|NCT00579163|Tissue|tissue
599659|NCT00579189|ear tubes|ear tubes
599660|NCT00579189|ear drainage|ear drainage
599661|NCT00579189|ear infection|ear infection
599662|NCT00579189|ear drops|ear drops
599663|NCT00579202|Dialyzer|dialyzer
599664|NCT00579215|Cancer|cancer
599665|NCT00579215|Enhanced Care|enhanced care
599666|NCT00579215|Decision-Making|decision-making
599667|NCT00579215|Advance Lung Cancer|advance lung cancer
599668|NCT00579215|Questionaires|questionaires
599669|NCT00579215|Stage III Lung Cancer|stage iii lung cancer
599670|NCT00579215|Stage IV Lung Cancer|stage iv lung cancer
599671|NCT00579228|Diabetes|diabetes
599672|NCT00579228|Vascular risk|vascular risk
599673|NCT00579228|Inflammation|inflammation
599674|NCT00579254|Efficacy,safety & tolerability of Caduet In Patients With Cardiovascular Risk Factors|efficacy,safety & tolerability of caduet in patients with cardiovascular risk factors
599675|NCT00579267|MINI-KID|mini-kid
599676|NCT00579267|structured diagnostic interview|structured diagnostic interview
599677|NCT00579267|reliability and validity|reliability and validity
599678|NCT00579267|K-SADS|k-sads
599679|NCT00579267|Sheehan Disability Scale|sheehan disability scale
599680|NCT00579280|Randomized|randomized
599681|NCT00579280|Double-Blind|double-blind
599682|NCT00579280|Placebo-Controlled|placebo-controlled
599683|NCT00579280|Quetiapine|quetiapine
599684|NCT00579280|DivalproexSodiumER|divalproexsodiumer
599685|NCT00579280|Bipolar|bipolar
599686|NCT00579280|Anxiety|anxiety
599687|NCT00579280|Panic|panic
599688|NCT00579280|GAD|gad
599689|NCT00579293|adult survivor of childhood cancer|adult survivor of childhood cancer
599690|NCT00579293|computer assisted screening of survivors (CASS)|computer assisted screening of survivors (cass)
599691|NCT00579306|hypertension|hypertension
599692|NCT00579306|stroke|stroke
599693|NCT00579306|cerebrovascular accident|cerebrovascular accident
599694|NCT00579319|breast cancer|breast cancer
599695|NCT00579332|PSA|psa
599696|NCT00579332|biochemical failure|biochemical failure
599697|NCT00579358|Congenital heart defects|congenital heart defects
599698|NCT00579371|islet transplantation|islet transplantation
599699|NCT00579371|type 1 diabetes mellitus|type 1 diabetes mellitus
599700|NCT00579371|steroid-free immunosuppression|steroid-free immunosuppression
599701|NCT00579371|rabbit anti-thymocyte globulin|rabbit anti-thymocyte globulin
599702|NCT00579384|Photosensitive epilepsy|photosensitive epilepsy
599703|NCT00579384|Reflex epilepsy|reflex epilepsy
599704|NCT00579384|Epilepsy|epilepsy
599705|NCT00579384|JNJ-26489112|jnj-26489112
599706|NCT00579397|Markers of Inflammation|markers of inflammation
599707|NCT00579397|acute graft versus host disease|acute graft versus host disease
599708|NCT00579397|predicting aGVHD|predicting agvhd
599709|NCT00579410|gastric acid|gastric acid
599710|NCT00579410|esophageal reflux|esophageal reflux
599711|NCT00579410|peptic ulcer|peptic ulcer
599712|NCT00579410|heartburn|heartburn
599713|NCT00579423|prostate|prostate
599714|NCT00579423|cancer|cancer
599715|NCT00579423|vaccine|vaccine
599716|NCT00579436|inflammation|inflammation
599717|NCT00579436|obesity|obesity
599718|NCT00579436|diabetes|diabetes
599719|NCT00579449|child abuse|child abuse
599720|NCT00579449|child neglect|child neglect
599721|NCT00579462|Stage III or IV Lung Cancer|stage iii or iv lung cancer
599722|NCT00579475|mifepristone|mifepristone
599723|NCT00579475|leiomyomas|leiomyomas
599724|NCT00579475|breast epithelial cell proliferation|breast epithelial cell proliferation
599725|NCT00579501|Myxoid|myxoid
599726|NCT00579501|Liposarcoma|liposarcoma
599727|NCT00579501|Trabectedin|trabectedin
599728|NCT00579501|Dexamethasone|dexamethasone
599729|NCT00579527|DiGeorge Anomaly|digeorge anomaly
599730|NCT00579527|Thymus Transplantation|thymus transplantation
599731|NCT00579527|DiGeorge Syndrome|digeorge syndrome
599733|NCT00579527|Parathyroid Transplantation|parathyroid transplantation
599734|NCT00579527|Hypocalcemia|hypocalcemia
599735|NCT00579527|Hypoparathyroidism|hypoparathyroidism
599736|NCT00579527|Low T cell numbers|low t cell numbers
599737|NCT00579527|Immunoreconstitution|immunoreconstitution
599738|NCT00579527|Immunodeficiency|immunodeficiency
599739|NCT00579527|Complete DiGeorge Anomaly|complete digeorge anomaly
599740|NCT00579527|Complete Atypical DiGeorge Anomaly|complete atypical digeorge anomaly
599741|NCT00579527|Complete DiGeorge Syndrome|complete digeorge syndrome
599742|NCT00579527|Complete Atypical DiGeorge Syndrome|complete atypical digeorge syndrome
599743|NCT00579553|Pre Term|pre term
599744|NCT00579553|Pre Term Birth|pre term birth
599745|NCT00579553|Premature Birth|premature birth
599746|NCT00579553|Premature baby|premature baby
599747|NCT00579553|High risk pregnancy|high risk pregnancy
599748|NCT00579553|Progesterone|progesterone
599749|NCT00579553|IM Progesterone|im progesterone
599750|NCT00579553|Vaginal Progesterone|vaginal progesterone
599751|NCT00579566|Biochemical Determinants|biochemical determinants
599752|NCT00579566|Molecular Determinants|molecular determinants
599753|NCT00579579|Bowel function|bowel function
599754|NCT00579579|Bladder function|bladder function
599755|NCT00579579|Sexual function|sexual function
599756|NCT00579579|Quality of life|quality of life
599757|NCT00579605|Breastfeeding|breastfeeding
599758|NCT00579605|Self-efficacy|self-efficacy
599759|NCT00579605|Motivational Interviewing|motivational interviewing
599760|NCT00579618|non-cancer affected volunteers|non-cancer affected volunteers
599761|NCT00579618|aged 60 years or older|aged 60 years or older
599762|NCT00579631|survivors|survivors
599763|NCT00579631|adolescent|adolescent
599764|NCT00579631|pediatric|pediatric
599765|NCT00579657|parameters of metabolic syndrome|parameters of metabolic syndrome
599766|NCT00579670|Ziprasidone in patients with schizophrenia|ziprasidone in patients with schizophrenia
599767|NCT00579683|non-small cell lung cancer|non-small cell lung cancer
599768|NCT00579683|NSCLC|nsclc
599769|NCT00579683|metastatic disease|metastatic disease
599770|NCT00579683|resistent disease|resistent disease
599771|NCT00579683|RNA analysis|rna analysis
599772|NCT00579683|04-103|04-103
599773|NCT00579696|Multiple Diseases|multiple diseases
599774|NCT00579696|Queens|queens
599775|NCT00579709|Thymus Transplantation|thymus transplantation
599776|NCT00579709|DiGeorge Anomaly|digeorge anomaly
599989|NCT00580567|Inhibition|inhibition
599777|NCT00579709|DiGeorge Syndrome|digeorge syndrome
599779|NCT00579709|Low T cell numbers|low t cell numbers
599780|NCT00579709|Immunoreconstitution|immunoreconstitution
599781|NCT00579709|Immunodeficiency|immunodeficiency
599782|NCT00579709|Complete DiGeorge|complete digeorge
599783|NCT00579709|Typical DiGeorge|typical digeorge
599784|NCT00579709|Atypical DiGeorge|atypical digeorge
599785|NCT00579709|Complete DiGeorge Anomaly|complete digeorge anomaly
599786|NCT00579735|Breast cancer|breast cancer
599787|NCT00579748|OCT imaging|oct imaging
599788|NCT00579748|Barrett's esophagus|barrett's esophagus
599789|NCT00579761|Endocarditis|endocarditis
599790|NCT00579761|neurological deficit|neurological deficit
599791|NCT00579774|Aging|aging
599792|NCT00579774|oxidative stress|oxidative stress
599793|NCT00579774|glycoxidative stress|glycoxidative stress
599794|NCT00579774|glycation|glycation
599795|NCT00579774|inflammation|inflammation
599796|NCT00579774|nutrition|nutrition
599797|NCT00579774|low AGE intake|low age intake
599798|NCT00579774|dietary AGEs|dietary ages
599799|NCT00579787|cervical cancer|cervical cancer
599800|NCT00579787|quality of life assessment|quality of life assessment
599801|NCT00579787|behavioral|behavioral
599802|NCT00579800|Vibrant-DE|vibrant-de
599803|NCT00579800|IDEAL|ideal
599804|NCT00579800|MRI|mri
599805|NCT00579800|Breast|breast
599806|NCT00579800|07-091|07-091
599807|NCT00579813|obesity|obesity
599808|NCT00579813|inflammation|inflammation
599809|NCT00579813|diabetes|diabetes
599810|NCT00579839|PreTerm Birth|preterm birth
599811|NCT00579839|PreTerm Neonate|preterm neonate
599812|NCT00579839|High risk pregnancy|high risk pregnancy
599813|NCT00579839|Preterm Baby|preterm baby
599814|NCT00579839|Premature Baby|premature baby
599815|NCT00579839|Cord Clamping|cord clamping
599816|NCT00579839|Milking the cord|milking the cord
599817|NCT00579852|Lung|lung
599818|NCT00579865|Quality of Life|quality of life
599819|NCT00579891|colorectal cancer|colorectal cancer
599820|NCT00579891|tissue collection|tissue collection
599821|NCT00579904|PCOS|pcos
599822|NCT00579904|polycystic ovary syndrome|polycystic ovary syndrome
599823|NCT00579904|insulin resistance|insulin resistance
599824|NCT00579904|fish oil|fish oil
599825|NCT00579904|walnut-oil|walnut-oil
599826|NCT00579904|walnuts|walnuts
599827|NCT00579904|almonds|almonds
599828|NCT00579904|monounsaturated fats|monounsaturated fats
599829|NCT00579904|polyunsaturated fats|polyunsaturated fats
599830|NCT00579904|MUFA|mufa
599831|NCT00579904|PUFA|pufa
599832|NCT00579917|Survivor|survivor
599833|NCT00579917|Behavioral Intervention|behavioral intervention
599834|NCT00579917|Bone Marrow|bone marrow
599835|NCT00579917|Stem Cell Transplantation|stem cell transplantation
599836|NCT00579930|Bone|bone
599837|NCT00579930|Soft Tissue|soft tissue
599838|NCT00579943|very low birth weight infant|very low birth weight infant
599839|NCT00579943|cerebral autoregulation|cerebral autoregulation
599840|NCT00579943|intraventricular hemorrhage|intraventricular hemorrhage
599841|NCT00579943|carbon dioxide|carbon dioxide
599842|NCT00579943|cerebral blood flow velocity|cerebral blood flow velocity
599843|NCT00579943|ultrasonography, Doppler, transcranial|ultrasonography, doppler, transcranial
599844|NCT00579943|cerebrovascular circulation|cerebrovascular circulation
599845|NCT00579982|Mood disorder|mood disorder
599846|NCT00580008|tomography|tomography
599847|NCT00580008|coronary artery disease|coronary artery disease
599848|NCT00580008|coronary artery bypass grafting|coronary artery bypass grafting
599849|NCT00580008|vein graft|vein graft
599850|NCT00580021|Ashkenazi ancestry|ashkenazi ancestry
599851|NCT00580021|mutations in BRCA1 or BRCA2|mutations in brca1 or brca2
599852|NCT00580021|Breast Cancer|breast cancer
599853|NCT00580021|Pancreatic Cancer|pancreatic cancer
599854|NCT00580034|Allogeneic Stem Cell Transplantation, Campath, HLA-Matched|allogeneic stem cell transplantation, campath, hla-matched
599855|NCT00580047|bone density|bone density
599856|NCT00580047|osteopenia|osteopenia
599857|NCT00580047|transplant|transplant
599858|NCT00580047|zoledronic acid|zoledronic acid
599859|NCT00580047|alendronate|alendronate
599860|NCT00580060|AJCC|ajcc
599861|NCT00580060|stage|stage
599862|NCT00580060|IIB|iib
599863|NCT00580060|IIC|iic
599864|NCT00580060|III|iii
599865|NCT00580060|IV|iv
599866|NCT00580060|Melanoma|melanoma
599867|NCT00580060|HLA-A2+|hla-a2+
599868|NCT00580060|Vaccine|vaccine
599869|NCT00580086|Breast cancer|breast cancer
599870|NCT00580086|MR spectroscopy|mr spectroscopy
599871|NCT00580086|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
599872|NCT00580099|premature infant, body composition, total energy expenditure|premature infant, body composition, total energy expenditure
599873|NCT00580099|inflammatory growth mediators|inflammatory growth mediators
599874|NCT00580112|Breast Neoplasms|breast neoplasms
599875|NCT00580112|Trabectedin|trabectedin
599876|NCT00580112|Yondelis|yondelis
599877|NCT00580138|Deglutition Disorders|deglutition disorders
599878|NCT00580138|Evaluation|evaluation
599879|NCT00580138|Real-time internet|real-time internet
599880|NCT00580151|Pain not controled by morphine|pain not controled by morphine
599881|NCT00580151|Anxiety not controled by lorazepam|anxiety not controled by lorazepam
599882|NCT00580177|Inguinal hernia|inguinal hernia
599883|NCT00580177|Randomized controlled trial|randomized controlled trial
599885|NCT00580177|Complications|complications
599886|NCT00580177|Surgical mesh|surgical mesh
599887|NCT00580203|HEENT cancers|heent cancers
599888|NCT00580203|larynx|larynx
599889|NCT00580203|thyroid|thyroid
599890|NCT00580203|sarcoma|sarcoma
599891|NCT00580203|specimen analysis|specimen analysis
599892|NCT00580216|stroke|stroke
599893|NCT00580216|systemic thromboembolic events|systemic thromboembolic events
599894|NCT00580229|Rituxan|rituxan
599895|NCT00580229|Rituximab|rituximab
599896|NCT00580242|Myelodysplasia|myelodysplasia
599897|NCT00580255|CHF|chf
599898|NCT00580255|CRT|crt
599899|NCT00580255|Atrial Arrhythmias|atrial arrhythmias
599900|NCT00580255|Ventricular Arrhythmias|ventricular arrhythmias
599901|NCT00580255|BioZ|bioz
599902|NCT00580255|Optivol|optivol
599903|NCT00580281|Gastric cancer|gastric cancer
599904|NCT00580281|Leukemia|leukemia
599905|NCT00580281|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
599906|NCT00580281|Imatinib|imatinib
599907|NCT00580281|Gleevec|gleevec
599908|NCT00580294|Sciatica|sciatica
599909|NCT00580294|Diabetic Neuropathies|diabetic neuropathies
599910|NCT00580294|Complex Regional Pain Syndromes|complex regional pain syndromes
599911|NCT00580294|Low Back Pain|low back pain
599912|NCT00580294|Neck Pain|neck pain
599913|NCT00580294|Headache|headache
599914|NCT00580294|Back Pain|back pain
599915|NCT00580294|Arthritis|arthritis
599916|NCT00580294|Brachial Plexus Injury (stinger/burner)|brachial plexus injury (stinger/burner)
599917|NCT00580294|Chronic Pain|chronic pain
599918|NCT00580294|Contractures|contractures
599919|NCT00580294|Diabetes|diabetes
599920|NCT00580294|Fibromyalgia|fibromyalgia
599921|NCT00580294|Foot Pain|foot pain
599922|NCT00580294|Fracture|fracture
599923|NCT00580294|Hip|hip
599924|NCT00580294|Herpes Zoster (shingles)|herpes zoster (shingles)
599925|NCT00580294|Migraine|migraine
599926|NCT00580294|Neuropathic Pain|neuropathic pain
599927|NCT00580294|Osteoarthritis|osteoarthritis
599928|NCT00580294|Osteoporosis|osteoporosis
599929|NCT00580294|Rheumatoid Arthritis|rheumatoid arthritis
599930|NCT00580294|Scoliosis|scoliosis
599931|NCT00580294|Nerve pain|nerve pain
599932|NCT00580294|Opana|opana
599933|NCT00580294|Opioid|opioid
599934|NCT00580294|Opioid Rotation|opioid rotation
599935|NCT00580294|Oxymorphone|oxymorphone
599936|NCT00580294|Morphine|morphine
599937|NCT00580294|neuropathic|neuropathic
599938|NCT00580294|oxycodone|oxycodone
599939|NCT00580307|Headache|headache
599940|NCT00580307|Rhinogenic|rhinogenic
599941|NCT00580307|Nose|nose
599942|NCT00580307|Nasal septum|nasal septum
599943|NCT00580307|Deviated septum|deviated septum
599944|NCT00580307|Surgery|surgery
599945|NCT00580307|Septoplasty|septoplasty
599946|NCT00580307|Turbinoplasty|turbinoplasty
599947|NCT00580307|Contact point|contact point
599948|NCT00580307|HIT-6|hit-6
599949|NCT00580320|melanoma|melanoma
599950|NCT00580320|soft tissue sarcoma|soft tissue sarcoma
599951|NCT00580320|APUD tumor|apud tumor
599952|NCT00580320|dacarbazine|dacarbazine
599953|NCT00580320|bortezomib|bortezomib
599954|NCT00580320|velcade|velcade
599955|NCT00580333|ER negative|er negative
599956|NCT00580333|PR negative|pr negative
599957|NCT00580333|HER2 negative|her2 negative
599958|NCT00580346|Aspiration pneumonia|aspiration pneumonia
599959|NCT00580346|Implanted laryngeal stimulator|implanted laryngeal stimulator
599960|NCT00580346|Vocal cord closure|vocal cord closure
599961|NCT00580346|Modified barium swallow|modified barium swallow
599962|NCT00580359|Stomach Neoplasms|stomach neoplasms
599963|NCT00580359|Secondary|secondary
599964|NCT00580359|Combination chemotherapy|combination chemotherapy
599965|NCT00580359|S-1|s-1
599966|NCT00580359|Capecitabine|capecitabine
599967|NCT00580385|BONE|bone
599968|NCT00580463|central nervous system (CNS) tumor|central nervous system (cns) tumor
599969|NCT00580463|tissue collection|tissue collection
599970|NCT00580476|Breast Cancer|breast cancer
599971|NCT00580476|Prostate Cancer|prostate cancer
599972|NCT00580489|helicopter|helicopter
599973|NCT00580489|aeromedical|aeromedical
599974|NCT00580489|pain relief|pain relief
599975|NCT00580489|analgesia|analgesia
599976|NCT00580489|fentanyl|fentanyl
599977|NCT00580489|morphine|morphine
599978|NCT00580489|adverse events|adverse events
599979|NCT00580502|Obesity, 50 lbs overweight|obesity, 50 lbs overweight
599981|NCT00580515|Randomized Controlled Trial|randomized controlled trial
599982|NCT00580515|Family Therapy intervention|family therapy intervention
599983|NCT00580567|Impulsivity|impulsivity
599984|NCT00580567|Gambling|gambling
599985|NCT00580567|Pathological Gamblers|pathological gamblers
599986|NCT00580567|Problem Gamblers|problem gamblers
599987|NCT00580567|Non-Pathological Gamblers|non-pathological gamblers
599990|NCT00580567|Gambling Severity|gambling severity
599991|NCT00580593|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
599993|NCT00580593|nocturnal noninvasive positive pressure ventilation|nocturnal noninvasive positive pressure ventilation
599994|NCT00580593|NIPPV|nippv
599995|NCT00580593|forced vital capacity|forced vital capacity
599996|NCT00580593|FVC|fvc
599997|NCT00580606|Food Allergy|food allergy
599998|NCT00580606|Peanut Allergy|peanut allergy
599999|NCT00580606|Sublingual Immunotherapy|sublingual immunotherapy
600000|NCT00580619|Chronic fatigue syndrome|chronic fatigue syndrome
600001|NCT00580619|Postural tachycardia syndrome|postural tachycardia syndrome
600002|NCT00580619|Autonomic nervous system|autonomic nervous system
600003|NCT00580645|alcohol|alcohol
600004|NCT00580645|smoking cessation|smoking cessation
600005|NCT00580645|varenicline|varenicline
600006|NCT00580645|bupropion|bupropion
600007|NCT00580645|smoking cessation medications|smoking cessation medications
600008|NCT00580658|Dystonia|dystonia
600009|NCT00580671|Adolescent Marijuana Abuse|adolescent marijuana abuse
600010|NCT00580684|pneumococcus conjugated vaccine 7 valent|pneumococcus conjugated vaccine 7 valent
600011|NCT00580697|Lower urinary tract symptoms|lower urinary tract symptoms
600012|NCT00580697|Gynecologic malignancy|gynecologic malignancy
600013|NCT00580697|Urinary incontinence|urinary incontinence
600014|NCT00580697|Fecal incontinence|fecal incontinence
600015|NCT00580697|Frequency|frequency
600016|NCT00580697|Voiding dysfunction|voiding dysfunction
600017|NCT00580697|Sexual dysfunction|sexual dysfunction
600018|NCT00580710|type 1 diabetes|type 1 diabetes
600019|NCT00580710|hypoglycemia|hypoglycemia
600020|NCT00580710|magnetic resonance imaging|magnetic resonance imaging
600022|NCT00580723|rosacea|rosacea
600023|NCT00580723|acne rosacea|acne rosacea
600024|NCT00580723|papulopustular rosacea|papulopustular rosacea
600025|NCT00580723|erythema|erythema
600026|NCT00580723|telangiectasia|telangiectasia
600027|NCT00580723|flushing|flushing
600028|NCT00580736|sebaceous hyperplasia|sebaceous hyperplasia
600029|NCT00580749|Pancreatitis|pancreatitis
600030|NCT00580749|enteral feeding|enteral feeding
600031|NCT00580749|distal jejunal feeding|distal jejunal feeding
600032|NCT00580749|naso gastric feeding|naso gastric feeding
600033|NCT00580749|pancreatic rest|pancreatic rest
600034|NCT00580775|Menopause|menopause
600035|NCT00580775|Hormone Replacement Therapy|hormone replacement therapy
600036|NCT00580775|Sudden Cardiac Death|sudden cardiac death
600037|NCT00580788|Endocrine System Diseases|endocrine system diseases
600038|NCT00580788|MusculoSkeletal System Diseases|musculoskeletal system diseases
600039|NCT00580788|Hormones|hormones
600040|NCT00580788|Malignancy|malignancy
600041|NCT00580788|Postmenopausal Women|postmenopausal women
600042|NCT00580788|Bone metabolism|bone metabolism
600043|NCT00580801|Hepatitis C|hepatitis c
600044|NCT00580801|Telaprevir|telaprevir
600045|NCT00580801|Pegylated-interferon-alfa-2a|pegylated-interferon-alfa-2a
600046|NCT00580801|Pegasys|pegasys
600047|NCT00580801|Ribavirin|ribavirin
600048|NCT00580801|Copegus|copegus
600049|NCT00580814|Brookhaven|brookhaven
600050|NCT00580814|ADHD|adhd
600051|NCT00580814|Dopamine|dopamine
600052|NCT00580814|methylphenidate|methylphenidate
600053|NCT00580814|PET|pet
600054|NCT00580840|Rheumatoid Arthritis|rheumatoid arthritis
600055|NCT00580840|Joint Disease|joint disease
600056|NCT00580840|Arthritis|arthritis
600057|NCT00580840|Certolizumab pegol|certolizumab pegol
600058|NCT00580840|Cimzia|cimzia
600059|NCT00580853|smoking lapse behavior|smoking lapse behavior
600060|NCT00580853|smoking cessation|smoking cessation
600061|NCT00580853|varenicline|varenicline
600062|NCT00580853|bupropion|bupropion
600063|NCT00580853|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
600064|NCT00580866|Elbow|elbow
600065|NCT00580866|Upper Extremity Fractures|upper extremity fractures
600066|NCT00580866|Distal Humerus|distal humerus
600067|NCT00580866|Elbow Injuries|elbow injuries
600068|NCT00580866|Dislocations|dislocations
600069|NCT00580866|Peri-articular Elbow Injuries|peri-articular elbow injuries
600070|NCT00580879|Anorectal sphincter laceration|anorectal sphincter laceration
600071|NCT00580879|Pelvic floor dysfunction|pelvic floor dysfunction
600072|NCT00580879|Sphincter tear|sphincter tear
600073|NCT00580905|Adenosine|adenosine
600074|NCT00580905|Cytokines|cytokines
600075|NCT00580905|Inflammation|inflammation
600077|NCT00580918|Mild Traumatic Brain Injury|mild traumatic brain injury
600078|NCT00580918|fMRI|fmri
600079|NCT00580931|nutraceutical, dementia, cognition, HDAC inhibitor|nutraceutical, dementia, cognition, hdac inhibitor
600080|NCT00580944|Port wine stain|port wine stain
600081|NCT00580944|progressive malformation of human skin|progressive malformation of human skin
600082|NCT00580957|Obesity|obesity
600083|NCT00580957|Hypertension|hypertension
600084|NCT00580957|Autonomic Nervous System|autonomic nervous system
600085|NCT00580970|prostate cancer|prostate cancer
600086|NCT00580970|radiation therapy|radiation therapy
600087|NCT00580970|lovastatin|lovastatin
600088|NCT00580970|rectal injury|rectal injury
600089|NCT00580983|Head and Neck cancer|head and neck cancer
600090|NCT00580996|water|water
600091|NCT00580996|orthostatic hypotension|orthostatic hypotension
600092|NCT00580996|blood pressure|blood pressure
600093|NCT00581009|Sleep deprivation|sleep deprivation
600094|NCT00581009|antidepressant|antidepressant
600095|NCT00581009|depression|depression
600096|NCT00581009|chronobiological|chronobiological
600097|NCT00581022|postural tachycardia syndrome|postural tachycardia syndrome
600098|NCT00581022|sleep|sleep
600099|NCT00581022|insomnia|insomnia
600100|NCT00581035|Meningococcal disease|meningococcal disease
600101|NCT00581035|pneumococcal disease|pneumococcal disease
600102|NCT00581035|meningitis|meningitis
600103|NCT00581048|Asthma|asthma
600104|NCT00581048|Allergy|allergy
600105|NCT00581048|Atopy|atopy
600106|NCT00581048|Vitamin E|vitamin e
600107|NCT00581048|GSTP1|gstp1
600108|NCT00581048|Oxidative stress|oxidative stress
600109|NCT00581061|Incontinence|incontinence
600110|NCT00581061|Robotic Prostatectomy|robotic prostatectomy
600111|NCT00581074|obesity|obesity
600112|NCT00581074|diet|diet
600113|NCT00581074|weight loss|weight loss
600114|NCT00581074|metabolic syndrome|metabolic syndrome
600115|NCT00581087|Hypertension, pulmonary|hypertension, pulmonary
600116|NCT00581087|DHEA|dhea
600117|NCT00581087|six-minute walk test|six-minute walk test
600118|NCT00581087|pulmonary arterial pressure|pulmonary arterial pressure
600119|NCT00581100|Nail Psoriasis|nail psoriasis
600120|NCT00581100|Plaque Psoriasis|plaque psoriasis
600121|NCT00581113|whole brain radiotherapy|whole brain radiotherapy
600122|NCT00581113|neural stem cell|neural stem cell
600123|NCT00581113|brain metastases|brain metastases
600124|NCT00581113|radiosurgery|radiosurgery
600125|NCT00581126|BENEFIX|benefix
600126|NCT00581126|Hemophilia B|hemophilia b
600127|NCT00581152|TBX3|tbx3
600128|NCT00581178|Ureteral Stent|ureteral stent
600129|NCT00581178|Kidney Stones|kidney stones
600130|NCT00581191|SAD|sad
600131|NCT00581191|Healthy|healthy
600132|NCT00581204|trauma situations|trauma situations
600133|NCT00581204|Lower Body Negative Pressure (LBNP)|lower body negative pressure (lbnp)
600134|NCT00581217|Burn injury|burn injury
600135|NCT00581217|Skin graft|skin graft
600136|NCT00581217|Donor site dressing|donor site dressing
600137|NCT00581217|Outcomes|outcomes
600138|NCT00581217|Infection rate|infection rate
600139|NCT00581217|Healing time|healing time
600140|NCT00581217|Cosmetic Result|cosmetic result
600141|NCT00581217|Pain|pain
600142|NCT00581217|Burn injured patients requiring skin grafting|burn injured patients requiring skin grafting
600143|NCT00581230|Endotracheal Intubation|endotracheal intubation
600144|NCT00581230|Rapid Airway Management Positioner|rapid airway management positioner
600145|NCT00581243|Safety,Tolerability, Schizophrenia|safety,tolerability, schizophrenia
600146|NCT00581256|left sided|left sided
600147|NCT00581282|Cocaine abstinence|cocaine abstinence
600148|NCT00581282|PET scan|pet scan
600149|NCT00581295|internal bleeding|internal bleeding
600150|NCT00581295|changes in tissue perfusion|changes in tissue perfusion
600151|NCT00581308|atrial septal defect, septal occluder, HELEX|atrial septal defect, septal occluder, helex
600152|NCT00581321|water|water
600153|NCT00581321|blood pressure|blood pressure
600154|NCT00581321|vascular resistance|vascular resistance
600155|NCT00581321|cardiac transplantation|cardiac transplantation
600156|NCT00581334|Pelvic organ prolapse|pelvic organ prolapse
600157|NCT00581334|Robotic-assisted laparoscopic sacrocolpopexy|robotic-assisted laparoscopic sacrocolpopexy
600158|NCT00581334|Post hysterectomy prolapse|post hysterectomy prolapse
600159|NCT00581334|Symptomatic post hysterectomy prolapse of stage II or greater|symptomatic post hysterectomy prolapse of stage ii or greater
600160|NCT00581360|Adenoid cystic carcinoma|adenoid cystic carcinoma
600161|NCT00581360|bortezomib|bortezomib
600162|NCT00581360|doxorubicin|doxorubicin
600163|NCT00581373|water|water
600164|NCT00581373|orthostatic hypotension|orthostatic hypotension
600165|NCT00581373|blood pressure|blood pressure
600166|NCT00581386|Endotracheal Intubation|endotracheal intubation
600167|NCT00581386|Supraglottic Airway|supraglottic airway
600168|NCT00581399|Open heart surgery|open heart surgery
600169|NCT00581399|Cardiopulmonary Bypass|cardiopulmonary bypass
600170|NCT00581399|Coronary Artery Bypass Grafting|coronary artery bypass grafting
600171|NCT00581399|Chest Tube|chest tube
600172|NCT00581399|Valve Replacement|valve replacement
600173|NCT00581399|Valve Repair|valve repair
600174|NCT00581412|Pelvic organ prolapse|pelvic organ prolapse
600175|NCT00581412|Composite biologic/synthetic graft|composite biologic/synthetic graft
600176|NCT00581412|Abdominal sacrocolpopexy|abdominal sacrocolpopexy
600177|NCT00581425|BCC|bcc
600178|NCT00581425|Basal Cell Carcinoma|basal cell carcinoma
600179|NCT00581425|Intron-A|intron-a
600180|NCT00581425|Aldara|aldara
600181|NCT00581425|Basal Cell Carcinoma excluding scalp and face|basal cell carcinoma excluding scalp and face
600182|NCT00581438|Approach Haemophilia A and B|approach haemophilia a and b
600183|NCT00581464|Smoking cessation|smoking cessation
600184|NCT00581464|Tobacco dependence|tobacco dependence
600185|NCT00581464|Mindfulness|mindfulness
600186|NCT00581464|fMRI|fmri
600188|NCT00581477|autonomic nervous system diseases|autonomic nervous system diseases
600189|NCT00581477|blood pressure|blood pressure
600190|NCT00581477|congenital|congenital
600191|NCT00581477|orthostasis|orthostasis
600192|NCT00581477|catecholamines|catecholamines
600193|NCT00581490|Premature pubarche|premature pubarche
600194|NCT00581490|Adrenal hyperandrogenism|adrenal hyperandrogenism
600195|NCT00581490|Metabolic syndrome|metabolic syndrome
600196|NCT00581503|early detection of lung and pleural cancer|early detection of lung and pleural cancer
600197|NCT00581503|early detection of prostate cancer|early detection of prostate cancer
600198|NCT00581516|Prostate Cancer|prostate cancer
600199|NCT00581516|PCA3|pca3
600200|NCT00571883|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
600201|NCT00571883|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
600202|NCT00571883|tongue cancer|tongue cancer
600203|NCT00571896|constipation|constipation
600204|NCT00571896|SennaS|sennas
600205|NCT00571909|Polycystic Kidney Disease|polycystic kidney disease
600206|NCT00571909|Chronic Kidney Pain|chronic kidney pain
600207|NCT00571909|Autosomal Dominant Polycystic Kidney|autosomal dominant polycystic kidney
600208|NCT00571909|Kidney Cyst|kidney cyst
600209|NCT00571909|VSPL|vspl
600210|NCT00571909|video thoracoscopic splanchnicectomy|video thoracoscopic splanchnicectomy
600211|NCT00571922|methamphetamine, crystal, treatment|methamphetamine, crystal, treatment
751775|NCT01170390|Obesity|obesity
751776|NCT01170390|Body weight|body weight
600212|NCT00571948|infant, complementary food, iron, meat, LC-PUFA, omega-3,|infant, complementary food, iron, meat, lc-pufa, omega-3,
600213|NCT00571948|rapeseed oil, diet|rapeseed oil, diet
600214|NCT00571961|HIV|hiv
600215|NCT00571961|Pharmacokinetics|pharmacokinetics
600216|NCT00571961|Buprenorphine|buprenorphine
600217|NCT00571961|Kaletra|kaletra
600218|NCT00571961|HIV Seronegativity|hiv seronegativity
600219|NCT00571987|Breast cancer|breast cancer
600220|NCT00571987|Lumpectomy|lumpectomy
600221|NCT00571987|Radiofrequency Ablation|radiofrequency ablation
600222|NCT00571987|Negative margins|negative margins
600223|NCT00571987|Breast Conserving Surgery|breast conserving surgery
600224|NCT00572026|Attention deficit|attention deficit
600225|NCT00572026|Hyperactivity|hyperactivity
600226|NCT00572026|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
600227|NCT00572039|Age-Related Macular Degeneration|age-related macular degeneration
600228|NCT00572039|AMD|amd
600229|NCT00572039|Vision Function|vision function
600230|NCT00572039|Problem Solving Treatment|problem solving treatment
600231|NCT00572039|PST|pst
600232|NCT00572078|solid tumor|solid tumor
600233|NCT00572091|Heart Failure|heart failure
600234|NCT00572091|Mitral Regurgitation|mitral regurgitation
600235|NCT00572117|Bipolar Disorder|bipolar disorder
600236|NCT00572117|Manic Disorder|manic disorder
600237|NCT00572117|Alcoholism|alcoholism
600238|NCT00572117|Alcohol Abuse|alcohol abuse
600239|NCT00572117|Alcohol Dependence|alcohol dependence
600240|NCT00572117|Clinical Trial|clinical trial
600241|NCT00572117|Evaluation Trial|evaluation trial
600242|NCT00572117|Intervention Trial|intervention trial
600243|NCT00572117|Validation Studies|validation studies
600244|NCT00572130|Tumor-targeted gene medicine|tumor-targeted gene medicine
600245|NCT00572130|Cyclin G1 gene|cyclin g1 gene
600246|NCT00572130|Osteosarcoma|osteosarcoma
600247|NCT00572143|Colonic Neoplasms/surgery*|colonic neoplasms/surgery*
600248|NCT00572143|Continuity of Patient Care*|continuity of patient care*
600249|NCT00572143|Follow-Up Studies|follow-up studies
600250|NCT00572143|Quality of Life|quality of life
600251|NCT00572143|Patient Satisfaction|patient satisfaction
600252|NCT00572156|IGF-1 Deficiency|igf-1 deficiency
600253|NCT00572156|growth|growth
600254|NCT00572156|ISS|iss
600255|NCT00572156|Constitutional growth delay|constitutional growth delay
600256|NCT00572156|Primary IGFD|primary igfd
600257|NCT00572156|Primary IGF Deficiency|primary igf deficiency
600258|NCT00572182|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
600259|NCT00572182|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
600547|NCT00582543|Prostate|prostate
600263|NCT00572182|childhood choroid plexus tumor|childhood choroid plexus tumor
600264|NCT00572182|childhood craniopharyngioma|childhood craniopharyngioma
600265|NCT00572182|recurrent childhood ependymoma|recurrent childhood ependymoma
600266|NCT00572182|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
600267|NCT00572182|childhood oligodendroglioma|childhood oligodendroglioma
600268|NCT00572182|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
600269|NCT00572182|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
600270|NCT00572182|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
600271|NCT00572182|childhood spinal cord neoplasm|childhood spinal cord neoplasm
600272|NCT00572182|childhood infratentorial ependymoma|childhood infratentorial ependymoma
600273|NCT00572182|childhood supratentorial ependymoma|childhood supratentorial ependymoma
600274|NCT00572182|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
600275|NCT00572182|childhood grade III meningioma|childhood grade iii meningioma
600277|NCT00572195|Responsive neurostimulation|responsive neurostimulation
600280|NCT00572195|Brain stimulation|brain stimulation
600281|NCT00572195|Seizures|seizures
600282|NCT00572221|CQI|cqi
600283|NCT00572221|QA|qa
600284|NCT00572221|Best Practice|best practice
600285|NCT00572221|Quality Improvement|quality improvement
600286|NCT00572221|Nursing Facilities|nursing facilities
600287|NCT00572221|Nursing Homes|nursing homes
600288|NCT00572221|Care|care
600289|NCT00572234|Methamphetamine|methamphetamine
600290|NCT00572234|Bupropion SR|bupropion sr
600291|NCT00572260|MRSA|mrsa
600292|NCT00572260|Increased risk for infection|increased risk for infection
600293|NCT00572286|heart transplant|heart transplant
600294|NCT00572286|advanced heart failure|advanced heart failure
600295|NCT00572286|orthotropic heart transplantation|orthotropic heart transplantation
600296|NCT00572286|(MCG) magnetocardiograph|(mcg) magnetocardiograph
600297|NCT00572286|echocardiogram|echocardiogram
600298|NCT00572299|glucocorticoids, prednisone, alendronate,osteoclasts|glucocorticoids, prednisone, alendronate,osteoclasts
600299|NCT00572312|Proteinuria,|proteinuria,
600300|NCT00572312|atorvastatin|atorvastatin
600301|NCT00572325|radiotherapy|radiotherapy
600302|NCT00572325|NSCLC|nsclc
600303|NCT00572325|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
600304|NCT00572351|Wine|wine
600305|NCT00572364|Cancer|cancer
600306|NCT00572364|Advanced solid malignancies|advanced solid malignancies
600307|NCT00572377|Sexual|sexual
600308|NCT00572377|Arousal|arousal
600309|NCT00572377|Female|female
600310|NCT00572403|microalbuminuria|microalbuminuria
600311|NCT00572403|risk factors|risk factors
600312|NCT00572416|fatigue|fatigue
600313|NCT00572416|activity-rest|activity-rest
600314|NCT00572416|sleep-wake|sleep-wake
600315|NCT00572416|psychological distress|psychological distress
600316|NCT00572416|symptom management|symptom management
600317|NCT00572429|HIV/AIDS|hiv/aids
600318|NCT00572429|HAART|haart
600319|NCT00572429|high cholesterol|high cholesterol
600320|NCT00572429|exercise|exercise
600321|NCT00572429|L-carnitine|l-carnitine
600322|NCT00572429|Complimentary therapies|complimentary therapies
600323|NCT00572442|Non-invasive heart scan|non-invasive heart scan
600324|NCT00572442|MCG|mcg
600325|NCT00572442|Cardiac Risk Factors|cardiac risk factors
600326|NCT00572442|healthy volunteers|healthy volunteers
600327|NCT00572455|Open-Angle Glaucoma|open-angle glaucoma
600328|NCT00572455|Ocular Hypertension|ocular hypertension
600329|NCT00572468|cancer|cancer
600330|NCT00572468|pre-operative surgery|pre-operative surgery
600331|NCT00572468|prostate|prostate
600332|NCT00572468|prostatectomy|prostatectomy
600333|NCT00572468|radiation|radiation
600339|NCT00572494|Tibial arteries|tibial arteries
600340|NCT00572494|Absorbable implants|absorbable implants
600341|NCT00572494|Stents|stents
600342|NCT00572494|Limb salvage|limb salvage
600343|NCT00572507|Absorbable Monofilament Suture Material|absorbable monofilament suture material
600344|NCT00572507|Safety and Efficacy|safety and efficacy
600345|NCT00572507|Abdominal Wall/ Fascia|abdominal wall/ fascia
600346|NCT00572507|Laparotomy|laparotomy
600347|NCT00572520|Depressive Disorder|depressive disorder
600348|NCT00572520|Weight Loss|weight loss
600349|NCT00572520|Behavioral Treatment|behavioral treatment
600350|NCT00572520|Behavior Therapy|behavior therapy
600351|NCT00572520|Randomized Clinical Trial|randomized clinical trial
600352|NCT00572533|End-Stage Renal Disease|end-stage renal disease
600354|NCT00572585|Ulcerative colitis|ulcerative colitis
600355|NCT00572585|immunosuppressive therapy|immunosuppressive therapy
600356|NCT00572585|AEB071|aeb071
600357|NCT00572585|Modified Baron score|modified baron score
600358|NCT00572585|Partial Mayo score|partial mayo score
600359|NCT00572598|PET|pet
600360|NCT00572598|multidrug resistance|multidrug resistance
600361|NCT00572598|fluoropaclitaxel|fluoropaclitaxel
600362|NCT00572598|paclitaxel|paclitaxel
600363|NCT00572598|breast cancer|breast cancer
600364|NCT00572598|dosimetry|dosimetry
600365|NCT00572598|imaging feasibility|imaging feasibility
600366|NCT00572611|Mass Balance|mass balance
600367|NCT00572611|Metabolism|metabolism
600368|NCT00572611|Absorption|absorption
600369|NCT00572611|Excretion|excretion
600370|NCT00572611|Pharmacokinetics|pharmacokinetics
600371|NCT00572624|Heart Metabolism|heart metabolism
600372|NCT00572624|Obesity|obesity
600373|NCT00572624|Weight loss|weight loss
600374|NCT00572624|Gastric bypass surgery|gastric bypass surgery
600375|NCT00572624|Diet and exercise|diet and exercise
600376|NCT00572650|Type-2 diabetes, DPP-4 inhibitor, vildagliptin|type-2 diabetes, dpp-4 inhibitor, vildagliptin
600377|NCT00572663|Proteinuria|proteinuria
600378|NCT00572663|Antioxidant|antioxidant
600379|NCT00572663|N-acetylcysteine|n-acetylcysteine
600380|NCT00572689|Exenatide|exenatide
600381|NCT00572689|TCF7L2 polymorphism|tcf7l2 polymorphism
600382|NCT00572689|Pharmacodynamics|pharmacodynamics
600383|NCT00572689|Pharmacokinetics|pharmacokinetics
600384|NCT00572702|Biocompatible Materials|biocompatible materials
600385|NCT00572702|Female|female
600386|NCT00572702|Humans|humans
600387|NCT00572702|Pelvic Floor|pelvic floor
600388|NCT00572702|Polypropylenes|polypropylenes
600389|NCT00572702|Prostheses and Implants|prostheses and implants
600390|NCT00572702|Surgical Mesh|surgical mesh
600391|NCT00572702|Uterine Prolapse/*therapy|uterine prolapse/*therapy
600392|NCT00572715|kidney|kidney
600393|NCT00572715|neonates|neonates
600394|NCT00572741|Autism|autism
600395|NCT00572741|vitamin B 12|vitamin b 12
600396|NCT00572741|glutathione|glutathione
600397|NCT00572767|randomised-controlled trial|randomised-controlled trial
600398|NCT00572767|ischemic stroke|ischemic stroke
600399|NCT00572767|motor recovery|motor recovery
600400|NCT00572767|amphetamine|amphetamine
600401|NCT00572767|motor recovery of patients after a first-ever ischemic stroke|motor recovery of patients after a first-ever ischemic stroke
600402|NCT00572780|Crohn's Disease|crohn's disease
600403|NCT00572780|CT Enteroclysis|ct enteroclysis
600404|NCT00572819|Hysteroscopy|hysteroscopy
600405|NCT00572819|Misoprostol|misoprostol
600406|NCT00572819|Postmenopausal women|postmenopausal women
600407|NCT00572819|Cervical ripening|cervical ripening
600408|NCT00572819|Dilatation|dilatation
600409|NCT00572819|Sequential trial|sequential trial
600410|NCT00572819|Estradiol|estradiol
600411|NCT00572832|Human Papillomavirus Vaccine|human papillomavirus vaccine
600412|NCT00572845|Basal Energy Expenditure|basal energy expenditure
600413|NCT00572845|Spasticity|spasticity
600414|NCT00572845|Modified Ashworth Scale|modified ashworth scale
600415|NCT00572845|Penn Spasm Frequency Score|penn spasm frequency score
600416|NCT00572858|Hypo E|hypo e
600417|NCT00572884|permethrin|permethrin
600418|NCT00572884|pyrethroid|pyrethroid
600419|NCT00572884|pharmacokinetics|pharmacokinetics
600420|NCT00572884|metabolism|metabolism
600421|NCT00572884|accelerator mass spectrometry|accelerator mass spectrometry
600422|NCT00572884|human exposure|human exposure
600423|NCT00572897|Myelofibrosis|myelofibrosis
600424|NCT00572897|Myeloproliferative disease|myeloproliferative disease
600425|NCT00572897|Stem Cell Transplant|stem cell transplant
600426|NCT00572897|Allogeneic Transplant|allogeneic transplant
600427|NCT00572897|Conditioning Regimen|conditioning regimen
600428|NCT00572897|Reduced Intensity Regimen|reduced intensity regimen
600429|NCT00572897|Fludarabine|fludarabine
600430|NCT00572897|Melphalan|melphalan
600432|NCT00572923|radiotherapy|radiotherapy
600433|NCT00572923|LD-SCLC|ld-sclc
600434|NCT00572923|stage I-III small cell lung cancer|stage i-iii small cell lung cancer
600435|NCT00572936|Glaucoma|glaucoma
600436|NCT00572936|Ocular Hypertension|ocular hypertension
600437|NCT00572936|Timolol®, Latanoprost® and Dorzolamide®|timolol®, latanoprost® and dorzolamide®
600438|NCT00572949|heart disease|heart disease
600439|NCT00572949|chest pain|chest pain
600440|NCT00572949|coronary artery disease|coronary artery disease
600441|NCT00572949|atherosclerosis|atherosclerosis
600442|NCT00572975|New diagnostic test for Cystic Fibrosis.|new diagnostic test for cystic fibrosis.
600443|NCT00572988|symptom management|symptom management
600444|NCT00572988|function status|function status
600445|NCT00572988|physical activity|physical activity
600446|NCT00572988|health care utilization|health care utilization
600447|NCT00573001|naive|naive
600448|NCT00573001|HIV-1|hiv-1
600449|NCT00573001|simplified treatment|simplified treatment
600450|NCT00573001|Treatment Experienced|treatment experienced
600856|NCT00583921|BiV ICD|biv icd
600452|NCT00573027|microvascular dysfunction|microvascular dysfunction
600453|NCT00573027|Microvascular|microvascular
600454|NCT00573040|Radiotherapy|radiotherapy
600455|NCT00573040|NSCLC|nsclc
600456|NCT00573040|Stage III non-small cell lung cancer|stage iii non-small cell lung cancer
600457|NCT00573053|hypercapneic response|hypercapneic response
600458|NCT00573053|hyperoxic response|hyperoxic response
600459|NCT00573053|breathing pattern|breathing pattern
600460|NCT00573053|periodic breathing|periodic breathing
600461|NCT00573053|sighs|sighs
600462|NCT00573066|Postoperative from cardiac surgery|postoperative from cardiac surgery
600463|NCT00573066|Dexmedetomidine|dexmedetomidine
600464|NCT00573079|Kidney|kidney
600465|NCT00573079|Infants|infants
600466|NCT00573092|Cardiovascular Epidemiology|cardiovascular epidemiology
600467|NCT00573092|Genomics|genomics
600468|NCT00573092|Genome-Wide Association Study|genome-wide association study
600469|NCT00573118|Pregnancy complications: preeclampsia , severe IUGR , IUFD or placental abruption (n = 5).|pregnancy complications: preeclampsia , severe iugr , iufd or placental abruption (n = 5).
600470|NCT00581529|breast|breast
600471|NCT00581555|Psoriasis|psoriasis
600472|NCT00581568|Skin cooling during laser treatment|skin cooling during laser treatment
600473|NCT00581581|neonatal encephalopathy|neonatal encephalopathy
600474|NCT00581581|therapeutic hypothermia|therapeutic hypothermia
600475|NCT00581581|head cooling|head cooling
600476|NCT00581581|neonatal asphyxia|neonatal asphyxia
600477|NCT00581594|Pelvic organ prolapse|pelvic organ prolapse
600478|NCT00581594|Posterior wall defects|posterior wall defects
600479|NCT00581594|Graft-augmented repair|graft-augmented repair
600480|NCT00581594|Posterior colporrhaphy|posterior colporrhaphy
600481|NCT00581607|Sarcoidosis|sarcoidosis
600482|NCT00581620|pneumococcus conjugated vaccine|pneumococcus conjugated vaccine
600483|NCT00581633|saline|saline
600484|NCT00581633|sodium|sodium
600489|NCT00581672|Prostate Cancer|prostate cancer
600490|NCT00581672|07-125|07-125
600491|NCT00581685|Chronic pain|chronic pain
600492|NCT00581685|Preemptive analgesia|preemptive analgesia
600493|NCT00581685|Pregabalin|pregabalin
600494|NCT00581685|Celecoxib|celecoxib
600495|NCT00581685|Hip Arthroplasty|hip arthroplasty
600496|NCT00581685|Osteoarthritis|osteoarthritis
600497|NCT00581698|Melanoma|melanoma
600498|NCT00581698|Negative regional lymph nodes|negative regional lymph nodes
600499|NCT00581698|Primary melanomas Clark III and Breslow thickness > 1 mm, or Clark|primary melanomas clark iii and breslow thickness > 1 mm, or clark
600500|NCT00581698|IV-V and any Breslow thickness, and clinically negative regional nodes|iv-v and any breslow thickness, and clinically negative regional nodes
600501|NCT00581711|Electronic Health Record|electronic health record
600502|NCT00581711|Clinical Decision Support|clinical decision support
600503|NCT00581711|Otitis Media|otitis media
600504|NCT00581724|breast cancer|breast cancer
600505|NCT00581724|Colorectal cancer|colorectal cancer
600506|NCT00581724|Prostate cancer|prostate cancer
600507|NCT00581724|Head and Neck cancer|head and neck cancer
600508|NCT00581724|Lung cancer|lung cancer
600509|NCT00581724|cancer survivors|cancer survivors
600510|NCT00581724|07-068|07-068
600511|NCT00581724|quality of life|quality of life
600512|NCT00581724|Pain in cancer survivors|pain in cancer survivors
600513|NCT00581750|Biopsy|biopsy
600514|NCT00581750|Breast|breast
600515|NCT00581750|01-135|01-135
600516|NCT00581776|Untreated Mantle Cell Lymphoma|untreated mantle cell lymphoma
600517|NCT00581789|non small cell lung cancer|non small cell lung cancer
600519|NCT00581789|erlotinib|erlotinib
600520|NCT00581789|phase 1|phase 1
600521|NCT00581802|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
600522|NCT00581802|Treatment Naive|treatment naive
600523|NCT00581802|Latent HIV Infections|latent hiv infections
600524|NCT00581828|Calcium Absorption|calcium absorption
600525|NCT00581828|Intestinal Absorption of Calcium|intestinal absorption of calcium
600526|NCT00581828|Fractional Calcium Absorption|fractional calcium absorption
600527|NCT00581828|Stable Calcium Isotopes|stable calcium isotopes
600528|NCT00581828|Hypovitaminosis D|hypovitaminosis d
600529|NCT00581828|Vitamin D|vitamin d
600530|NCT00581828|Bone Mineral Density|bone mineral density
600531|NCT00581828|Physical Function|physical function
600532|NCT00581841|Healthy adult normals|healthy adult normals
600533|NCT00581854|untreated mantle cell lymphoma|untreated mantle cell lymphoma
600534|NCT00582491|Modafinil|modafinil
600535|NCT00582491|Sleep|sleep
600536|NCT00582491|Cognition|cognition
600537|NCT00582491|Cocaine Dependence|cocaine dependence
600538|NCT00582504|Encephalitis,VEE|encephalitis,vee
600539|NCT00582517|Orthopaedic Trauma|orthopaedic trauma
600540|NCT00582517|Knee Dislocation|knee dislocation
600541|NCT00582517|Compass Hinge External Fixator|compass hinge external fixator
600542|NCT00582517|External Brace|external brace
600543|NCT00582530|Prostate Cancer|prostate cancer
600544|NCT00582530|Early Prostate Cancer|early prostate cancer
600545|NCT00582530|Radical Prostatectomy|radical prostatectomy
600546|NCT00582543|Prostate Cancer|prostate cancer
600548|NCT00582556|bone mineral density|bone mineral density
600549|NCT00582569|Breast lesion|breast lesion
600550|NCT00582569|Spectroscopy|spectroscopy
600551|NCT00582569|MRI|mri
600552|NCT00582582|Metastatic|metastatic
600553|NCT00582582|Hormone Refractory|hormone refractory
600554|NCT00582582|Prostate Cancer|prostate cancer
600555|NCT00582621|Genetic Studies|genetic studies
600556|NCT00582621|00-069|00-069
600557|NCT00582621|blood|blood
600558|NCT00582621|saliva|saliva
600559|NCT00582621|buccal cell|buccal cell
600560|NCT00582634|non small cell lung cancer|non small cell lung cancer
600561|NCT00582634|adjuvant|adjuvant
600562|NCT00582634|cisplatin|cisplatin
600563|NCT00582634|docetaxel|docetaxel
600564|NCT00582673|Parkinson's, L-dopa, dyskinesia|parkinson's, l-dopa, dyskinesia
600565|NCT00582686|Calcaneus Fractures|calcaneus fractures
600566|NCT00582686|Iliac Crest Bone Grafting|iliac crest bone grafting
600567|NCT00582686|Open Reduction & Internal Fixation|open reduction & internal fixation
600568|NCT00582699|Pancreatic Cancer|pancreatic cancer
600569|NCT00582699|Pancreatic|pancreatic
600570|NCT00582712|medullary thyroid cancer|medullary thyroid cancer
600571|NCT00582712|lithium|lithium
600572|NCT00582725|DLBCL, Elderly|dlbcl, elderly
600573|NCT00582725|previously untreated DLBCL in the elderly|previously untreated dlbcl in the elderly
600574|NCT00582738|Fibrosis progression|fibrosis progression
600575|NCT00582738|recurrent hepatitis C|recurrent hepatitis c
600576|NCT00582738|viral infection|viral infection
600577|NCT00582738|liver transplant recipients|liver transplant recipients
600578|NCT00582738|everolimus|everolimus
600579|NCT00582738|Hepatitis C recurrence after orthotopic liver transplantation (OLT)|hepatitis c recurrence after orthotopic liver transplantation (olt)
600580|NCT00582751|Volumetric Analysis|volumetric analysis
600581|NCT00582751|Multiple Diseases|multiple diseases
600582|NCT00582764|Breast Lesion|breast lesion
600583|NCT00582764|Lesion|lesion
600584|NCT00582764|Breast|breast
600585|NCT00582764|Cancer|cancer
600586|NCT00582764|05-091|05-091
600587|NCT00582777|nocturnal blood pressure|nocturnal blood pressure
600588|NCT00582777|chronic renal disease|chronic renal disease
600589|NCT00582777|hypertensive renal disease|hypertensive renal disease
600590|NCT00582777|African Americans|african americans
600591|NCT00582777|ABPM|abpm
600592|NCT00582790|Renal Cell Cancer|renal cell cancer
600593|NCT00582790|Metastatic|metastatic
600594|NCT00582803|breast cancer|breast cancer
600595|NCT00582803|germline mutation|germline mutation
600596|NCT00582803|BRCA1|brca1
600597|NCT00582803|BRCA2|brca2
600598|NCT00582803|family history|family history
600599|NCT00582803|genetic testing|genetic testing
600600|NCT00582803|unaffected women over age 25 who are at elevated risk for|unaffected women over age 25 who are at elevated risk for
600601|NCT00582803|breast cancer by virtue by a hereditary predisposition|breast cancer by virtue by a hereditary predisposition
600602|NCT00582816|Recurrent or Refractory Leukemia or Solid Tumors in Pediatrics|recurrent or refractory leukemia or solid tumors in pediatrics
600603|NCT00582829|Colorectal|colorectal
600604|NCT00582829|Cancer|cancer
600605|NCT00582829|Screening|screening
600606|NCT00582829|Intervention|intervention
600607|NCT00582829|Family|family
600608|NCT00582842|Early Stage|early stage
600609|NCT00582842|Localized|localized
600610|NCT00582855|AQW051|aqw051
600611|NCT00582855|Mild Alzheimer's disease|mild alzheimer's disease
600612|NCT00582855|Amnestic Mild Cognitive Impairment|amnestic mild cognitive impairment
600613|NCT00582868|Subarachnoid hemorrhage|subarachnoid hemorrhage
600614|NCT00582868|Cerebral Vasospasm|cerebral vasospasm
600615|NCT00582868|Cleaved-tau protein|cleaved-tau protein
600616|NCT00582868|Brain oxygen tension level|brain oxygen tension level
600617|NCT00582881|Anti-RNP/Sm Autoantibody-Positive|anti-rnp/sm autoantibody-positive
600618|NCT00582881|MCTD|mctd
600619|NCT00582881|SLE|sle
600620|NCT00582894|Allogenic stem cell transplant|allogenic stem cell transplant
600621|NCT00582894|Hematologic diseases|hematologic diseases
600622|NCT00582907|FMF|fmf
600623|NCT00582907|IL1 Trap (Rilonacept)|il1 trap (rilonacept)
600624|NCT00582907|Periodic fever syndromes|periodic fever syndromes
600625|NCT00582907|Autoinflammatory syndromes|autoinflammatory syndromes
600626|NCT00582907|Familial Mediterranean Fever|familial mediterranean fever
600627|NCT00582907|colchicine|colchicine
600628|NCT00582920|osseous lesions|osseous lesions
600629|NCT00582920|breast cancer|breast cancer
600630|NCT00582920|metastatic breast cancer|metastatic breast cancer
600631|NCT00582933|Cancer|cancer
600632|NCT00582933|Donors|donors
600633|NCT00582933|Leukemia|leukemia
600634|NCT00582933|Myelodysplastic Syndrome|myelodysplastic syndrome
600635|NCT00582933|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
600636|NCT00582933|Lymphoma|lymphoma
600637|NCT00582933|AML|aml
600638|NCT00582933|ALL|all
600639|NCT00582933|CML|cml
600640|NCT00582933|Allogeneic marrow transplant|allogeneic marrow transplant
600641|NCT00582933|Bone marrow transplant|bone marrow transplant
600746|NCT00583466|submucosal cushion|submucosal cushion
600642|NCT00582946|Hearing Loss, Eardrum, Transducer, Hearing in Noise|hearing loss, eardrum, transducer, hearing in noise
600643|NCT00582959|radiology imaging|radiology imaging
600644|NCT00582959|malignancy|malignancy
600857|NCT00583921|CHF|chf
600645|NCT00582959|undergoing radiation therapy|undergoing radiation therapy
600646|NCT00582972|Calcium Absorption|calcium absorption
600647|NCT00582972|Fractional Calcium Absorption|fractional calcium absorption
600648|NCT00582972|Omeprazole|omeprazole
600649|NCT00582972|Stable Calcium Isotopes|stable calcium isotopes
600650|NCT00582972|Proton Pump Inhibitor|proton pump inhibitor
600651|NCT00582972|Intestinal Absorption of Calcium|intestinal absorption of calcium
600652|NCT00582985|Tracon|tracon
600653|NCT00582985|CD105|cd105
600654|NCT00582985|Anti CD105|anti cd105
600655|NCT00582985|TRC105|trc105
600656|NCT00582985|Phase 1|phase 1
600657|NCT00582985|Cancer|cancer
600658|NCT00582985|Monoclonal antibody|monoclonal antibody
600659|NCT00582985|Solid Tumor|solid tumor
600660|NCT00582998|Vacuum Assisted Closure (VAC)|vacuum assisted closure (vac)
600661|NCT00582998|Calcaneus Fracture|calcaneus fracture
600662|NCT00582998|Pilon Fracture|pilon fracture
600663|NCT00582998|Tibial Plateau Fracture|tibial plateau fracture
600664|NCT00582998|Open Reduction and Internal Fixation|open reduction and internal fixation
600665|NCT00583011|Amniocentesis|amniocentesis
600666|NCT00583011|Genetic amniocentesis|genetic amniocentesis
600667|NCT00583011|Fetal lung maturity|fetal lung maturity
600668|NCT00583011|Pain control|pain control
600669|NCT00583011|Pregnancy|pregnancy
600670|NCT00583011|High risk pregnancy|high risk pregnancy
600671|NCT00583024|prostate cancer|prostate cancer
600672|NCT00583024|vaccine|vaccine
600673|NCT00583024|immunotherapy|immunotherapy
600674|NCT00583037|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
600675|NCT00583037|Sleep quality|sleep quality
600676|NCT00583037|Adult|adult
600677|NCT00583037|Critical Care|critical care
600678|NCT00583076|Pouchitis|pouchitis
600679|NCT00583076|Active Pouchitis|active pouchitis
600680|NCT00583076|Safety and Efficacy of AST120|safety and efficacy of ast120
600681|NCT00583102|Acute Myeloid Leukemia|acute myeloid leukemia
600682|NCT00583102|AML|aml
600683|NCT00583102|Lovastatin|lovastatin
600686|NCT00583128|Irritable Bowel Syndrome|irritable bowel syndrome
600687|NCT00583154|constipation|constipation
600688|NCT00583154|laxative|laxative
600690|NCT00583167|AIDS|aids
600691|NCT00583167|CNS|cns
600692|NCT00583167|brain|brain
600693|NCT00583167|affects|affects
600694|NCT00583180|Primary and/or secondary hyperalgesia|primary and/or secondary hyperalgesia
600695|NCT00583180|hypoesthesia|hypoesthesia
600696|NCT00583193|Post Traumatic Stress Disorder|post traumatic stress disorder
600697|NCT00583193|Duloxetine|duloxetine
600698|NCT00583193|Antidepressants|antidepressants
600699|NCT00583206|sepsis|sepsis
600700|NCT00583206|atrophy|atrophy
600701|NCT00583206|muscle|muscle
600702|NCT00583206|weakness|weakness
600703|NCT00583232|Pediatric|pediatric
600704|NCT00583232|Crohn's disease|crohn's disease
600705|NCT00583232|protein metabolism|protein metabolism
600706|NCT00583232|energy metabolism|energy metabolism
600707|NCT00583245|Osteoarthritis|osteoarthritis
600708|NCT00583245|Gait training|gait training
600709|NCT00583245|Knee pain|knee pain
600710|NCT00583245|Rehabilitation|rehabilitation
600711|NCT00583245|Physical Therapy|physical therapy
600712|NCT00583284|delayed enhancement computed tomography|delayed enhancement computed tomography
600713|NCT00583284|ventricular tachycardia ablation|ventricular tachycardia ablation
600714|NCT00583284|ventricular tachycardia|ventricular tachycardia
600715|NCT00583297|Arrhythmia|arrhythmia
600716|NCT00583297|Heart Failure|heart failure
600717|NCT00583297|T wave Alternans (TWA)|t wave alternans (twa)
600718|NCT00583297|Implanted Cardioverter Defibrillator(ICD)|implanted cardioverter defibrillator(icd)
600719|NCT00583297|Biological Markers|biological markers
600720|NCT00583297|Molecular Genetics|molecular genetics
600721|NCT00583310|Prehypertension|prehypertension
600722|NCT00583349|Bladder Cancer|bladder cancer
600723|NCT00583349|Chemotherapy|chemotherapy
600724|NCT00583349|Bladder Neoplasms|bladder neoplasms
600725|NCT00583362|SLE|sle
600726|NCT00583362|Lupus|lupus
600727|NCT00583375|arthritis|arthritis
600728|NCT00583375|ankle pain|ankle pain
600729|NCT00583375|foot pain|foot pain
600730|NCT00583375|hindfoot fracture|hindfoot fracture
600731|NCT00583375|ankle fracture|ankle fracture
600732|NCT00583388|cardiology|cardiology
600733|NCT00583388|preventive medicine|preventive medicine
600734|NCT00583388|cardiovascular physiology|cardiovascular physiology
600735|NCT00583388|healthy subjects|healthy subjects
600736|NCT00583401|PFO|pfo
600737|NCT00583401|stroke|stroke
600738|NCT00583440|12-step|12-step
600739|NCT00583440|mutual help|mutual help
600740|NCT00583440|dual diagnosis|dual diagnosis
600741|NCT00583440|serious mental illness|serious mental illness
600742|NCT00583453|Tonsillectomy|tonsillectomy
600743|NCT00583453|Analgesia|analgesia
600744|NCT00583453|Pain measurement|pain measurement
600745|NCT00583453|Celecoxib|celecoxib
600747|NCT00583466|polypectomy|polypectomy
600748|NCT00583466|endoscopic mucosal resection|endoscopic mucosal resection
600749|NCT00583492|Prostatic Neoplasms|prostatic neoplasms
600750|NCT00583492|Prostate Cancer|prostate cancer
600751|NCT00583492|Adenocarinomas|adenocarinomas
600752|NCT00583492|Tumors of the Prostate|tumors of the prostate
600753|NCT00583492|Gene Therapy|gene therapy
600754|NCT00583492|IMRT|imrt
600755|NCT00583505|membranous|membranous
600756|NCT00583505|ventricular|ventricular
600757|NCT00583505|septal|septal
600758|NCT00583505|defects|defects
600759|NCT00583505|VSD|vsd
600760|NCT00583531|Antibiotic-refractory Pouchitis|antibiotic-refractory pouchitis
600761|NCT00583531|Pouchitis|pouchitis
600762|NCT00583531|Ulcerative Colitis|ulcerative colitis
600763|NCT00583544|Healthy|healthy
600764|NCT00583544|Healthy Volunteers|healthy volunteers
600765|NCT00583557|Rheumatoid Arthritis|rheumatoid arthritis
600766|NCT00583557|RA|ra
600767|NCT00583596|patent ductus arteriosus (PDA)|patent ductus arteriosus (pda)
600768|NCT00583622|Ovarian Cancer|ovarian cancer
600769|NCT00583622|Epithelial Ovarian Cancer|epithelial ovarian cancer
600770|NCT00583622|Bevacizumab|bevacizumab
600771|NCT00583622|Carboplatin|carboplatin
600772|NCT00583622|Gemcitabine|gemcitabine
600773|NCT00583622|Docetaxel|docetaxel
600774|NCT00583622|Melphalan|melphalan
600775|NCT00583635|Preeclampsia|preeclampsia
600776|NCT00583635|Prevention|prevention
600777|NCT00583635|Food Supplement|food supplement
600778|NCT00583648|urinary tract infections|urinary tract infections
600779|NCT00583648|urine|urine
600780|NCT00583648|urinalysis|urinalysis
600781|NCT00583648|urine protocols|urine protocols
600782|NCT00583648|urinalysis protocols|urinalysis protocols
600783|NCT00583648|nursing protocols|nursing protocols
600784|NCT00583648|Emergency Department|emergency department
600785|NCT00583661|Ventricular Assist Device|ventricular assist device
600786|NCT00583661|Pediatric Ventricular Assist Device|pediatric ventricular assist device
600787|NCT00583674|Gastric Cancer|gastric cancer
600788|NCT00583674|Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma|metastatic gastric, gastroesophageal junction, or distal esophageal adenocarcinoma
600791|NCT00583674|Capecitabine|capecitabine
600792|NCT00583687|Arterial pulse contour cardiac output|arterial pulse contour cardiac output
600793|NCT00583687|Changing vascular tone|changing vascular tone
600794|NCT00583687|Tissue Oxymetry|tissue oxymetry
600795|NCT00583687|Prediction of Fluid Responsiveness|prediction of fluid responsiveness
600796|NCT00583700|Breast Neoplasms|breast neoplasms
600797|NCT00583700|Radiotherapy|radiotherapy
600798|NCT00583726|chemotherapy|chemotherapy
600799|NCT00583726|exercise|exercise
600801|NCT00583726|fruit|fruit
600802|NCT00583726|vegetables|vegetables
600803|NCT00583726|low-fat|low-fat
600804|NCT00583739|Fatigue|fatigue
600805|NCT00583739|Yoga|yoga
600806|NCT00583739|Anxiety|anxiety
600807|NCT00583739|Quality of Life|quality of life
600808|NCT00583752|prostate cancer|prostate cancer
600809|NCT00583752|vaccine|vaccine
600810|NCT00583752|immunotherapy|immunotherapy
600811|NCT00583765|Kidney Failure, Acute|kidney failure, acute
600812|NCT00583765|Hemodialysis|hemodialysis
600813|NCT00583765|Hemofiltration|hemofiltration
600814|NCT00583765|Anticoagulation|anticoagulation
600815|NCT00583765|Citrate|citrate
600816|NCT00583778|Asthma|asthma
600817|NCT00583778|Bronchodilators|bronchodilators
600818|NCT00583778|Levalbuterol|levalbuterol
600819|NCT00583778|Ipratropium|ipratropium
600820|NCT00583791|muscular|muscular
600821|NCT00583791|ventricular|ventricular
600822|NCT00583791|septal|septal
600823|NCT00583791|defects|defects
600825|NCT00583804|Spinal Cord Injury|spinal cord injury
600826|NCT00583804|Tetraplegia|tetraplegia
600827|NCT00583804|Functional Electrical Stimulation|functional electrical stimulation
600828|NCT00583804|Neuroprosthesis|neuroprosthesis
600829|NCT00583830|Lung Cancer|lung cancer
600830|NCT00583843|Lumpectomy|lumpectomy
600831|NCT00583843|Ultrasonography|ultrasonography
600832|NCT00583843|Radiotherapy|radiotherapy
600833|NCT00583856|computer aided design|computer aided design
600834|NCT00583856|maxillofacial fracture|maxillofacial fracture
600835|NCT00583856|orbital design|orbital design
600836|NCT00583869|Post-operative Pain|post-operative pain
600837|NCT00583869|Fracture Patients|fracture patients
600838|NCT00583869|Pregabalin|pregabalin
600839|NCT00583869|LYRICA|lyrica
600840|NCT00583882|Central Venous Catheter|central venous catheter
600841|NCT00583882|Guidewire|guidewire
600842|NCT00583882|Burn|burn
600843|NCT00583895|dermatitis|dermatitis
600844|NCT00583895|atopic|atopic
600845|NCT00583895|ImCOOH|imcooh
600846|NCT00583895|safety|safety
600847|NCT00583895|tolerability|tolerability
600848|NCT00583895|efficacy|efficacy
600849|NCT00583895|pharmacokinetics|pharmacokinetics
600850|NCT00583908|astigmatism|astigmatism
600851|NCT00583908|orientation|orientation
600852|NCT00583908|visual acuity|visual acuity
600853|NCT00583908|contact lenses|contact lenses
600854|NCT00583921|Atrial Fibrillation|atrial fibrillation
600855|NCT00583921|ICD|icd
600858|NCT00583921|Congestive Heart Failure|congestive heart failure
600860|NCT00583934|esophageal cancer, head and neck cancer, dysplasia|esophageal cancer, head and neck cancer, dysplasia
600861|NCT00583947|Asthma|asthma
600862|NCT00583947|Respiratory Tract Diseases|respiratory tract diseases
600863|NCT00583960|swallowing problems|swallowing problems
600864|NCT00583960|tracheal stenosis|tracheal stenosis
600865|NCT00583986|top mounted|top mounted
600866|NCT00583986|actuation indicator|actuation indicator
600867|NCT00583986|Asthma|asthma
600868|NCT00583986|COPD|copd
600869|NCT00583986|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
600870|NCT00583999|leptin, leptin receptors, adiponectin|leptin, leptin receptors, adiponectin
600871|NCT00584012|Any cancer|any cancer
600872|NCT00584012|Breast cancer|breast cancer
600873|NCT00584012|Lovastatin|lovastatin
600874|NCT00584012|Docetaxel|docetaxel
600875|NCT00584025|Parkinson's disease|parkinson's disease
600876|NCT00584025|dyskinesia|dyskinesia
600877|NCT00584025|levetiracetam|levetiracetam
600878|NCT00584025|keppra|keppra
600879|NCT00584038|contraceptive compliance|contraceptive compliance
600880|NCT00584038|educational intervention|educational intervention
600881|NCT00584038|oral contraception|oral contraception
600882|NCT00584051|Control group|control group
600883|NCT00584064|patent|patent
600884|NCT00584064|foramen|foramen
600885|NCT00584064|ovale|ovale
600886|NCT00584064|PFO|pfo
600887|NCT00584090|urinary incontinence|urinary incontinence
600888|NCT00584090|parkinson's disease|parkinson's disease
600889|NCT00584090|vesicare|vesicare
600890|NCT00584090|solifenacin succinate|solifenacin succinate
600891|NCT00584103|transradial amputation|transradial amputation
600892|NCT00584103|prosthesis|prosthesis
600893|NCT00584103|prefabricated prosthesis|prefabricated prosthesis
600894|NCT00584103|inexpensive|inexpensive
600895|NCT00584103|custom prosthesis|custom prosthesis
600896|NCT00584103|adult transradial amputation|adult transradial amputation
600897|NCT00584116|Aortic Valve Replacement|aortic valve replacement
600898|NCT00584116|AVR|avr
600899|NCT00584129|Cancer|cancer
600902|NCT00584129|Patients with H&N cancer who will be receiving chemoradiation|patients with h&n cancer who will be receiving chemoradiation
600903|NCT00584142|breast cancer|breast cancer
600904|NCT00584142|survivors|survivors
600905|NCT00584155|Cisplatin Ototoxicity|cisplatin ototoxicity
600906|NCT00584155|Lactated Ringer's|lactated ringer's
600907|NCT00584155|Ear Cancer|ear cancer
600908|NCT00584155|Hearing loss|hearing loss
600909|NCT00584155|Hearing loss due to Cisplatin Ototoxicity|hearing loss due to cisplatin ototoxicity
600910|NCT00584168|UPPP|uppp
600911|NCT00584168|Dexamethasone|dexamethasone
600912|NCT00584168|Uvulopalatopharyngoplasty|uvulopalatopharyngoplasty
600913|NCT00584168|Pain Management|pain management
600914|NCT00584168|Increasing pain management in patients that have undergone UPPP surgery|increasing pain management in patients that have undergone uppp surgery
600915|NCT00584194|Hemorrhagic Fever, Viral Infections, Neurologic diseases, Arbovirus Infections, RVF|hemorrhagic fever, viral infections, neurologic diseases, arbovirus infections, rvf
600916|NCT00584207|uterine fibroids|uterine fibroids
600917|NCT00584220|Astigmatism|astigmatism
600918|NCT00584220|vision|vision
600919|NCT00584220|comfort|comfort
600920|NCT00584220|satisfaction|satisfaction
600921|NCT00584220|contact lenses|contact lenses
600922|NCT00584233|breast cancer|breast cancer
600923|NCT00584246|Restless legs syndrome|restless legs syndrome
600924|NCT00584246|RLS|rls
600925|NCT00584246|Pregabalin|pregabalin
600926|NCT00584246|Lyrica|lyrica
600927|NCT00584259|GERD|gerd
600928|NCT00584259|Gastro-Esophageal Disease|gastro-esophageal disease
600929|NCT00584272|cleft palate|cleft palate
600930|NCT00584272|suture materials|suture materials
600931|NCT00584298|Barostat|barostat
600932|NCT00584298|distention|distention
600933|NCT00584298|IBS|ibs
600934|NCT00584298|irritable|irritable
600935|NCT00584298|bowel|bowel
600936|NCT00584298|syndrome|syndrome
600937|NCT00584298|colorectal|colorectal
600938|NCT00584298|sensation|sensation
600939|NCT00584298|modulation|modulation
600940|NCT00584298|reproducibility|reproducibility
600941|NCT00584324|elective surgery|elective surgery
600942|NCT00584324|general anesthesia|general anesthesia
600943|NCT00584324|implicit memory|implicit memory
600944|NCT00584337|tomography|tomography
600945|NCT00584337|coronary artery disease|coronary artery disease
600946|NCT00584337|Stress Test|stress test
600947|NCT00584337|Coronary CT Angiography|coronary ct angiography
600948|NCT00584337|Diagnostic Accuracy|diagnostic accuracy
600949|NCT00584337|Non invasive testing|non invasive testing
600950|NCT00584350|coronary angiogram|coronary angiogram
600951|NCT00584350|percutaneous coronary intervention|percutaneous coronary intervention
600952|NCT00584376|Essential tremor|essential tremor
600953|NCT00584376|tremor|tremor
600954|NCT00584376|pregabalin|pregabalin
600955|NCT00584376|lyrica|lyrica
600956|NCT00584389|Obesity|obesity
600957|NCT00584389|Energy expenditure|energy expenditure
600958|NCT00584389|Fatty acid|fatty acid
600959|NCT00584389|Triglyceride|triglyceride
600960|NCT00584402|liver cancer|liver cancer
600961|NCT00584415|Catheter Ablation|catheter ablation
600962|NCT00584415|Atrial Fibrillation|atrial fibrillation
600963|NCT00584428|Breast Cancer|breast cancer
600964|NCT00584428|Cancer Treatment|cancer treatment
600965|NCT00584428|Breast Cancer Treatment|breast cancer treatment
600966|NCT00584454|Coxiella burnetti, Bacterial Infections, Rickettsia, Hepatits, Endocarditis|coxiella burnetti, bacterial infections, rickettsia, hepatits, endocarditis
600967|NCT00584467|GEM|gem
600968|NCT00584467|Arteriosclerosis|arteriosclerosis
600969|NCT00584467|biomarkers|biomarkers
600970|NCT00584467|Atherosclerosis|atherosclerosis
600971|NCT00584506|orbital fractures|orbital fractures
600972|NCT00584519|Schizophrenia, Overweight, Cardiovascular Risk, Obesity|schizophrenia, overweight, cardiovascular risk, obesity
600973|NCT00584532|Localized|localized
600974|NCT00584532|Prostate|prostate
600975|NCT00584532|Cancer|cancer
600976|NCT00584545|pharyngeal manometry|pharyngeal manometry
600977|NCT00584545|videofluoroscopy|videofluoroscopy
600978|NCT00584558|Arrhythmia|arrhythmia
600979|NCT00584558|Catheter Ablation|catheter ablation
600980|NCT00584584|Allergic rhinitis, adults, monoclonal antibody, interleukin-13.|allergic rhinitis, adults, monoclonal antibody, interleukin-13.
600981|NCT00584597|Radiation-Induced Mucositis|radiation-induced mucositis
600982|NCT00584597|Head and neck cancer|head and neck cancer
600983|NCT00584597|TRAUMEEL|traumeel
600984|NCT00584597|Mucositis|mucositis
600985|NCT00584597|Radiation|radiation
600986|NCT00584597|Oral cancer|oral cancer
600987|NCT00584597|Inflammation of the mouth|inflammation of the mouth
600988|NCT00584597|Homeopathic Medication|homeopathic medication
600989|NCT00584610|Women's health|women's health
600990|NCT00584623|dysphagia|dysphagia
600991|NCT00584623|videofluoroscopy|videofluoroscopy
600992|NCT00584623|flexible endoscopic evaluation|flexible endoscopic evaluation
600993|NCT00584636|child|child
600994|NCT00584636|emergency department|emergency department
600995|NCT00584649|Inappropriate Sinus Tachycardia|inappropriate sinus tachycardia
600996|NCT00584649|Inappropiate Tachycardia|inappropiate tachycardia
600997|NCT00584649|Sinus Tachycardia|sinus tachycardia
600998|NCT00584649|Palpitations|palpitations
600999|NCT00584649|Fast Heart rate|fast heart rate
601000|NCT00584662|Rhinitis|rhinitis
601001|NCT00584675|GERD|gerd
601002|NCT00584675|laryngopharyngeal reflux disease|laryngopharyngeal reflux disease
601003|NCT00584688|anorexia|anorexia
601004|NCT00584688|nervosa|nervosa
601005|NCT00584688|eating|eating
601006|NCT00584688|disorder|disorder
601007|NCT00584688|study|study
601008|NCT00584688|research|research
601009|NCT00584688|clinical|clinical
601010|NCT00584688|trial|trial
601011|NCT00584688|psychiatry|psychiatry
601012|NCT00584688|psychiatric|psychiatric
601013|NCT00584714|ultrasound|ultrasound
601014|NCT00584714|perfusion|perfusion
601015|NCT00584714|SPECT|spect
601016|NCT00584714|coronary artery disease|coronary artery disease
601017|NCT00584714|chest pain|chest pain
601018|NCT00584714|low probability|low probability
601019|NCT00584714|angiography|angiography
601020|NCT00584714|clinical outcomes|clinical outcomes
601021|NCT00584727|astigmatism|astigmatism
601022|NCT00584727|visual acuity|visual acuity
601023|NCT00584727|fit|fit
601024|NCT00584727|comfort|comfort
601025|NCT00584727|satisfaction|satisfaction
601026|NCT00584727|contact lens|contact lens
601027|NCT00584740|Crohn's disease, moderate, severe, active, AIN457|crohn's disease, moderate, severe, active, ain457
601028|NCT00584753|Breast cancer|breast cancer
601029|NCT00584779|Gabapentin Pharmacokinetics, renal impairment|gabapentin pharmacokinetics, renal impairment
601030|NCT00584792|Prostate Cancer|prostate cancer
601032|NCT00584818|coronary artery disease|coronary artery disease
601033|NCT00584818|chest pain|chest pain
601034|NCT00584818|healthy volunteers|healthy volunteers
601035|NCT00584818|SPECT|spect
601036|NCT00584818|angiogram|angiogram
601037|NCT00584818|ultrasound|ultrasound
601038|NCT00584818|echocardiogram|echocardiogram
601039|NCT00584818|perfusion|perfusion
601040|NCT00584831|astigmatism|astigmatism
601041|NCT00584831|visual acuity|visual acuity
601042|NCT00584831|orientation|orientation
601043|NCT00584831|contact lenses|contact lenses
601044|NCT00584844|Live Vaccine Strain (LVS), Bacterial Infections, Ulceroglandular, Oculoglandular|live vaccine strain (lvs), bacterial infections, ulceroglandular, oculoglandular
601045|NCT00584883|Patients who have newly diagnosed brain tumors|patients who have newly diagnosed brain tumors
601046|NCT00584896|heart disease|heart disease
601047|NCT00584896|coronary artery disease|coronary artery disease
601048|NCT00584896|echocardiogram|echocardiogram
601049|NCT00584896|ultrasound|ultrasound
601050|NCT00584896|angiogram|angiogram
601051|NCT00584896|SPECT|spect
601052|NCT00584896|chest pain|chest pain
601053|NCT00584896|perfusion|perfusion
601054|NCT00584922|Esophageal injury|esophageal injury
601055|NCT00584922|Catheter Ablation|catheter ablation
601056|NCT00584922|Atrial Fibrillation|atrial fibrillation
601057|NCT00584935|Pemphigoid|pemphigoid
601058|NCT00584935|Blistering Diseases|blistering diseases
601059|NCT00584935|Blindness|blindness
601060|NCT00584935|Autoimmune|autoimmune
601061|NCT00584935|Rituximab|rituximab
601156|NCT00576914|vinorelbine|vinorelbine
601062|NCT00584948|FXTAS, Fragile X Premutation|fxtas, fragile x premutation
601063|NCT00584961|Metabolic Syndrome, Bipolar Disorder and Cardiovascular Risk Factors|metabolic syndrome, bipolar disorder and cardiovascular risk factors
601064|NCT00584974|Depression|depression
601065|NCT00584974|Mental Disorders|mental disorders
601066|NCT00584974|Mood Disorders|mood disorders
601067|NCT00584974|Depressive Disorder, Major|depressive disorder, major
601068|NCT00584974|Dysthymic Disorder|dysthymic disorder
601069|NCT00576472|Brain Tumor, Acute Lymphoblastic Leukemia, Methylphenidate, Cognitive Late Effects|brain tumor, acute lymphoblastic leukemia, methylphenidate, cognitive late effects
601070|NCT00576485|Cataract|cataract
601071|NCT00576485|Intraocular lens|intraocular lens
601072|NCT00576485|Spherical aberration|spherical aberration
601073|NCT00576485|Contrast sensitivity|contrast sensitivity
601074|NCT00576498|GERD|gerd
601075|NCT00576498|NBI|nbi
601076|NCT00576498|AFI|afi
601077|NCT00576498|IM|im
601078|NCT00576498|SSBE|ssbe
601079|NCT00576498|LSBE|lsbe
601080|NCT00576498|LGD|lgd
601081|NCT00576498|HGD|hgd
601082|NCT00576511|Constipation|constipation
601083|NCT00576511|Prucalopride|prucalopride
601084|NCT00576511|Colonic Transit Time|colonic transit time
601085|NCT00576524|Hypotension during dialysis|hypotension during dialysis
601086|NCT00576524|End Stage Renal Disease|end stage renal disease
601087|NCT00576524|Decrease complications during dialysis|decrease complications during dialysis
601088|NCT00576524|Low Blood Pressure|low blood pressure
601089|NCT00576537|New/Recurrent Glioblastoma|new/recurrent glioblastoma
601090|NCT00576550|Hand eczema|hand eczema
601091|NCT00576550|Prevention|prevention
601092|NCT00576563|rectal cancer|rectal cancer
601093|NCT00576563|blood proteins|blood proteins
601094|NCT00576563|irradiation|irradiation
601095|NCT00576563|FDG-PET-CT|fdg-pet-ct
601096|NCT00576576|Atherosclerosis, vulnerable plaque, IVUS, shear stress|atherosclerosis, vulnerable plaque, ivus, shear stress
601097|NCT00576589|Safety in patients with Asymptomatic cholelithiasis/gallstones.|safety in patients with asymptomatic cholelithiasis/gallstones.
601098|NCT00576615|healthy volunteers|healthy volunteers
601099|NCT00576615|amnesic effects|amnesic effects
601101|NCT00576667|chronic liver disease|chronic liver disease
601102|NCT00576680|RAD001|rad001
601103|NCT00576680|temozolomide|temozolomide
601104|NCT00576693|ischemic stroke|ischemic stroke
601105|NCT00576693|intracranial stenting|intracranial stenting
601106|NCT00576693|vascular risk factor management|vascular risk factor management
601107|NCT00576706|Patients with rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis or any other arthritis-like disease requiring continuous NSAIDs therapy|patients with rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis or any other arthritis-like disease requiring continuous nsaids therapy
601108|NCT00576732|Irritability|irritability
601109|NCT00576732|Risperidone|risperidone
601110|NCT00576732|Antipsychotic agent|antipsychotic agent
601111|NCT00576732|Autism|autism
601112|NCT00576732|Adolescents|adolescents
601113|NCT00576732|Children|children
601114|NCT00576745|Sutures|sutures
601115|NCT00576784|type 2 diabetes|type 2 diabetes
601116|NCT00576784|insulin treatment|insulin treatment
601117|NCT00576784|ß-cell function|ß-cell function
601118|NCT00576797|vaginal|vaginal
601119|NCT00576797|bacteria|bacteria
601120|NCT00576797|microflora|microflora
601121|NCT00576797|bacterial DNA|bacterial dna
601122|NCT00576797|To determine the normal bacteria in the vagina|to determine the normal bacteria in the vagina
601123|NCT00576823|child|child
601124|NCT00576823|bladder|bladder
601125|NCT00576823|neuropathic|neuropathic
601126|NCT00576823|alpha blockers|alpha blockers
601127|NCT00576836|Thymus Transplantation|thymus transplantation
601129|NCT00576836|DiGeorge Anomaly|digeorge anomaly
601130|NCT00576836|Athymia|athymia
601131|NCT00576836|Parathyroid Transplantation|parathyroid transplantation
601132|NCT00576836|Hypocalcemia|hypocalcemia
601133|NCT00576836|Hypoparathyroidism|hypoparathyroidism
601134|NCT00576836|Low T cell numbers|low t cell numbers
601135|NCT00576836|Immunoreconstitution|immunoreconstitution
601136|NCT00576836|Immunodeficiency|immunodeficiency
601137|NCT00576836|Complete DiGeorge|complete digeorge
601138|NCT00576836|Complete DiGeorge Anomaly|complete digeorge anomaly
601139|NCT00576836|Typical DiGeorge|typical digeorge
601140|NCT00576875|Depression|depression
601141|NCT00576875|Elderly|elderly
601142|NCT00576875|Neuroimaging|neuroimaging
601143|NCT00576875|Postmortem|postmortem
601144|NCT00576875|Knockout mouse|knockout mouse
601145|NCT00576888|Multifocal lymphangioendoltheliomatosis with thrombocytopenia|multifocal lymphangioendoltheliomatosis with thrombocytopenia
601146|NCT00576888|Cutaneovisceral angiomatosis with thrombocytopenia|cutaneovisceral angiomatosis with thrombocytopenia
601147|NCT00576888|Thrombocytopenia|thrombocytopenia
601148|NCT00576888|Hemangiomas|hemangiomas
601149|NCT00576888|Hemangiomatosis|hemangiomatosis
601150|NCT00576888|Lymphatic malformation|lymphatic malformation
601151|NCT00576888|Kasabach-Merritt|kasabach-merritt
601465|NCT00577993|Bleomycin|bleomycin
601152|NCT00576888|Blue-rubber bleb nevus|blue-rubber bleb nevus
601153|NCT00576888|Angiomatosis|angiomatosis
601154|NCT00576914|adjuvant therapy|adjuvant therapy
601155|NCT00576914|non-small cell lung cancer|non-small cell lung cancer
601157|NCT00576914|cisplatin|cisplatin
601158|NCT00576914|recombinant human endostatin(endostar)|recombinant human endostatin(endostar)
601159|NCT00576927|Sleep hygiene|sleep hygiene
601160|NCT00576927|Sleep latency|sleep latency
601161|NCT00576927|Elderly sleep|elderly sleep
601162|NCT00576927|Nursing Home sleep|nursing home sleep
601163|NCT00576940|enteral nutrition, immunomodulating nutrition|enteral nutrition, immunomodulating nutrition
601164|NCT00576979|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
601165|NCT00576979|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
601166|NCT00576992|Barrett's Esophagus|barrett's esophagus
601167|NCT00576992|Demographics|demographics
601168|NCT00576992|Questionnaire|questionnaire
601169|NCT00576992|Heartburn|heartburn
601170|NCT00577005|GABAergic|gabaergic
601171|NCT00577005|levetiracetam|levetiracetam
601173|NCT00577057|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
601174|NCT00577057|Stage III - IVB|stage iii - ivb
601175|NCT00577083|miss rates|miss rates
601176|NCT00577096|multiple myeloma|multiple myeloma
601177|NCT00577096|polysomnography|polysomnography
601178|NCT00577096|quality of life|quality of life
601179|NCT00577096|exercise|exercise
601180|NCT00577122|Medroxyprogesterone progesterone acetate (MPA)|medroxyprogesterone progesterone acetate (mpa)
601181|NCT00577122|Cyclophosphamide plus Methotrexate|cyclophosphamide plus methotrexate
601182|NCT00577135|Loop Diuretics|loop diuretics
601183|NCT00577135|Furosemide|furosemide
601184|NCT00577135|Fluid Overload|fluid overload
601185|NCT00577135|Cardio Renal Failure|cardio renal failure
601186|NCT00577148|NASH|nash
601187|NCT00577148|chronic liver disease|chronic liver disease
601188|NCT00577161|pixantrone|pixantrone
601189|NCT00577161|NHL|nhl
601190|NCT00577161|rituximab|rituximab
601191|NCT00577161|fludarabine|fludarabine
601192|NCT00577174|Children|children
601193|NCT00577174|Obesity|obesity
601194|NCT00577174|Insulin resistance|insulin resistance
601196|NCT00577174|Mitochondrial Function|mitochondrial function
601197|NCT00577213|Diagnosis|diagnosis
601198|NCT00577213|Hemangiomas|hemangiomas
601199|NCT00577213|Vascular Malformations|vascular malformations
601200|NCT00577213|Venular Malformations|venular malformations
601201|NCT00577213|Venous Malformations|venous malformations
601202|NCT00577213|Lymphatic Malformations|lymphatic malformations
601203|NCT00577213|Arteriovenous Malformations|arteriovenous malformations
601204|NCT00577226|scoliosis, immature spine|scoliosis, immature spine
601205|NCT00577252|Cystic fibrosis|cystic fibrosis
601206|NCT00577252|Adolescents|adolescents
601207|NCT00577252|Coping Compliance|coping compliance
601208|NCT00577252|Adjustment|adjustment
601209|NCT00577265|Asthma Control|asthma control
601210|NCT00577278|graft versus host disease|graft versus host disease
601211|NCT00577278|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
601212|NCT00577278|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
601213|NCT00577278|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
601214|NCT00577278|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
601215|NCT00577278|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
601216|NCT00577278|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
601217|NCT00577278|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
601218|NCT00577278|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
601219|NCT00577278|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
601220|NCT00577278|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
601221|NCT00577278|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
601222|NCT00577278|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
601223|NCT00577278|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
601224|NCT00577278|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
601225|NCT00577278|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
601226|NCT00577278|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
601227|NCT00577278|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
601228|NCT00577278|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
601229|NCT00577278|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
601230|NCT00577278|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
601231|NCT00577278|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
601232|NCT00577278|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
601233|NCT00577278|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
601234|NCT00577278|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
601235|NCT00577278|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
601236|NCT00577278|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
601237|NCT00577278|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
601238|NCT00577278|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
601239|NCT00577278|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
601240|NCT00577278|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
601241|NCT00577278|stage I marginal zone lymphoma|stage i marginal zone lymphoma
601242|NCT00577278|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
601243|NCT00577278|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
601244|NCT00577278|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
601245|NCT00577278|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
601246|NCT00577278|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
601247|NCT00577278|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
601248|NCT00577278|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
601249|NCT00577278|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
601250|NCT00577278|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
601251|NCT00577278|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
601252|NCT00577278|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
601253|NCT00577278|stage I mantle cell lymphoma|stage i mantle cell lymphoma
601254|NCT00577278|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
601255|NCT00577278|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
601256|NCT00577278|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
601257|NCT00577278|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
601258|NCT00577278|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
601259|NCT00577278|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
601260|NCT00577278|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
601261|NCT00577278|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
601262|NCT00577278|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
601263|NCT00577278|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
601264|NCT00577278|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
601265|NCT00577278|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
601266|NCT00577278|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
601267|NCT00577278|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
601268|NCT00577304|Raynaud's|raynaud's
601269|NCT00577304|Nitroglycerin|nitroglycerin
601270|NCT00577304|Scleroderma|scleroderma
601271|NCT00577369|arterial line|arterial line
601272|NCT00577369|end-expiratory desflurane|end-expiratory desflurane
601273|NCT00577382|Sutent|sutent
601274|NCT00577382|malignant melanoma|malignant melanoma
601275|NCT00577408|Opiate Dependence|opiate dependence
601276|NCT00577408|Heroin Dependence|heroin dependence
601277|NCT00577408|Naltrexone|naltrexone
601278|NCT00577434|Procedural sedation|procedural sedation
601279|NCT00577434|Sedation for diagnostic imaging|sedation for diagnostic imaging
601280|NCT00577447|autism|autism
601281|NCT00577447|omega-3 fatty acids|omega-3 fatty acids
601282|NCT00577447|docosahexaenoic acid|docosahexaenoic acid
601283|NCT00577499|cystic fibrosis|cystic fibrosis
601284|NCT00577499|constipation|constipation
601285|NCT00577499|lubiprostone|lubiprostone
601286|NCT00577499|nutrition|nutrition
601287|NCT00577499|pulmonary function|pulmonary function
601288|NCT00577525|LATENT VIRAL INFECTION|latent viral infection
601289|NCT00577525|GENOME HYBRIDIZATION|genome hybridization
601290|NCT00577525|HERPES VIRUS|herpes virus
601292|NCT00577590|Type II Diabetes Mellitus|type ii diabetes mellitus
601293|NCT00577590|Diabetes|diabetes
601294|NCT00577590|PET|pet
601295|NCT00577590|Heart Metabolism|heart metabolism
601296|NCT00577590|Lovaza|lovaza
601297|NCT00577603|stoma, hernia, mesh|stoma, hernia, mesh
601298|NCT00577616|Endovascular repair|endovascular repair
601299|NCT00577616|Ruptured aorta-iliac aneurysms|ruptured aorta-iliac aneurysms
601300|NCT00577616|Mortality at 30 days|mortality at 30 days
601301|NCT00577629|high risk non-hodgkins lymphoma|high risk non-hodgkins lymphoma
601302|NCT00577629|NHL|nhl
601303|NCT00577629|Bexxar|bexxar
601304|NCT00577629|high dose chemotherapy|high dose chemotherapy
601305|NCT00577642|aminobisphosphonates|aminobisphosphonates
601306|NCT00577655|Pediatric, asthma, albuterol-HFA and Placebo|pediatric, asthma, albuterol-hfa and placebo
601307|NCT00577681|HIV|hiv
601308|NCT00577681|Lipoproteins|lipoproteins
601309|NCT00577681|Inflammatory Markers|inflammatory markers
601310|NCT00577681|Coagulation Markers|coagulation markers
601311|NCT00577681|Treatment Experienced|treatment experienced
601312|NCT00577694|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
601313|NCT00577707|Lung Cancer|lung cancer
601314|NCT00577707|Erlotinib|erlotinib
601315|NCT00577707|clinical stage IB-IIIA|clinical stage ib-iiia
601316|NCT00577733|Pulmonary function test|pulmonary function test
601317|NCT00577733|Methacholine challenge|methacholine challenge
601318|NCT00577733|Breathing variability|breathing variability
601319|NCT00577733|Polygraphy|polygraphy
601320|NCT00577746|Non Small Cell Lung|non small cell lung
601321|NCT00577759|Quality assurance, health care|quality assurance, health care
601322|NCT00577759|primary health care|primary health care
601323|NCT00577759|community health services|community health services
601324|NCT00577759|referral and consultation|referral and consultation
601325|NCT00577759|exercise|exercise
601326|NCT00577759|diet|diet
601327|NCT00577759|tobacco|tobacco
601328|NCT00577772|SmartPill Capsule|smartpill capsule
601329|NCT00577772|Digestive System Diseases|digestive system diseases
601330|NCT00577772|Small Bowel Bacterial Overgrowth|small bowel bacterial overgrowth
601331|NCT00577772|Gastrointestinal Device|gastrointestinal device
601332|NCT00577772|Oro-cecal|oro-cecal
601333|NCT00577785|cystectomy|cystectomy
601334|NCT00577798|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
601335|NCT00577798|cardiac toxicity|cardiac toxicity
601336|NCT00577798|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
601337|NCT00577798|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
601338|NCT00577798|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
601339|NCT00577798|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
601340|NCT00577798|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
601341|NCT00577798|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
601342|NCT00577798|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
601343|NCT00577798|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
601344|NCT00577798|anaplastic large cell lymphoma|anaplastic large cell lymphoma
601345|NCT00577798|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
601346|NCT00577798|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
601347|NCT00577798|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
601348|NCT00577798|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
601349|NCT00577798|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
601350|NCT00577798|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
601351|NCT00577798|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
601514|NCT00578201|Cetuximab|cetuximab
601352|NCT00577798|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
601353|NCT00577798|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
601354|NCT00577798|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
601355|NCT00577798|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
601356|NCT00577798|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
601357|NCT00577798|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
601358|NCT00577798|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
601359|NCT00577798|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
601360|NCT00577798|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
601361|NCT00577798|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
601362|NCT00577798|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
601363|NCT00577798|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
601364|NCT00577798|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
601365|NCT00577798|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
601366|NCT00577798|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
601367|NCT00577798|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
601368|NCT00577798|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
601369|NCT00577798|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
601370|NCT00577798|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
601371|NCT00577798|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
601372|NCT00577798|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
601373|NCT00577798|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
601374|NCT00577798|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
601375|NCT00577798|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
752339|NCT01172574|Osteoporosis|osteoporosis
601376|NCT00577798|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
601377|NCT00577798|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
601378|NCT00577798|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
601379|NCT00577798|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
601380|NCT00577798|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
601381|NCT00577798|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
601382|NCT00577798|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
601383|NCT00577798|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
601384|NCT00577798|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
601385|NCT00577798|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
601386|NCT00577798|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
601387|NCT00577798|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
601388|NCT00577798|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
601389|NCT00577798|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
601390|NCT00577798|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
601391|NCT00577798|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
601392|NCT00577798|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
601393|NCT00577798|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
601394|NCT00577798|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
601395|NCT00577798|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
601396|NCT00577798|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
601397|NCT00577798|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
601398|NCT00577798|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
601399|NCT00577798|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
601400|NCT00577798|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
601401|NCT00577798|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
601402|NCT00577798|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
601403|NCT00577798|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
601404|NCT00577798|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
601405|NCT00577798|stage I mantle cell lymphoma|stage i mantle cell lymphoma
601406|NCT00577798|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
601407|NCT00577798|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
601408|NCT00577798|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
601409|NCT00577798|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
601410|NCT00577798|splenic marginal zone lymphoma|splenic marginal zone lymphoma
601411|NCT00577798|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
601412|NCT00577798|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
601413|NCT00577798|stage I marginal zone lymphoma|stage i marginal zone lymphoma
601414|NCT00577798|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
601415|NCT00577798|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
601416|NCT00577798|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
601417|NCT00577798|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
601418|NCT00577798|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
601419|NCT00577798|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
601420|NCT00577798|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
601421|NCT00577811|Special Need Plans|special need plans
601422|NCT00577811|Fee for Services|fee for services
601423|NCT00577811|Access to Care|access to care
601424|NCT00577811|Medicaid|medicaid
601425|NCT00577824|diabetes|diabetes
601426|NCT00577824|exenatide|exenatide
601427|NCT00577824|LY2148568|ly2148568
601428|NCT00577824|Byetta|byetta
601429|NCT00577824|Lilly|lilly
601430|NCT00577824|Amylin|amylin
601431|NCT00577902|head and neck cancer|head and neck cancer
601432|NCT00577915|Breast cancer|breast cancer
601433|NCT00577915|MRI spectroscopy|mri spectroscopy
601434|NCT00577915|Diagnostic radiology|diagnostic radiology
601435|NCT00577954|Coma|coma
601436|NCT00577954|TBI|tbi
601437|NCT00577954|Stroke|stroke
601438|NCT00577954|SAH|sah
601439|NCT00577954|Cerebral Anoxia|cerebral anoxia
601440|NCT00577954|Multimodal MRI|multimodal mri
601441|NCT00577967|Uremic pruritis|uremic pruritis
601442|NCT00577980|Prostate Cancer|prostate cancer
601443|NCT00577980|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
601444|NCT00577980|Testosterone Replacement Therapy|testosterone replacement therapy
601445|NCT00577980|Testosterone|testosterone
601446|NCT00577980|CRPC|crpc
601447|NCT00577980|TRT|trt
601448|NCT00577993|Lymphoma|lymphoma
601449|NCT00577993|Follicular Lymphoma|follicular lymphoma
601450|NCT00577993|Indolent Lymphoma|indolent lymphoma
601451|NCT00577993|Fludarabine|fludarabine
601452|NCT00577993|Novantrone|novantrone
601453|NCT00577993|Mitoxantrone|mitoxantrone
601454|NCT00577993|Decadron|decadron
601455|NCT00577993|Dexamethasone|dexamethasone
601456|NCT00577993|Rituximab|rituximab
601457|NCT00577993|Anti-CD20|anti-cd20
601458|NCT00577993|IDEC-C2B8|idec-c2b8
601459|NCT00577993|Chimeric Anti-CD20 Antibody|chimeric anti-cd20 antibody
601460|NCT00577993|Interferon|interferon
601461|NCT00577993|Interferon Alpha-2b|interferon alpha-2b
601462|NCT00577993|IFN|ifn
601463|NCT00577993|Doxorubicin|doxorubicin
601464|NCT00577993|Vincristine|vincristine
601466|NCT00577993|Cyclophosphamide|cyclophosphamide
601467|NCT00577993|Etoposide|etoposide
601468|NCT00577993|Cisplatin|cisplatin
601469|NCT00577993|Ara-C|ara-c
601470|NCT00577993|Methyl-Prednisolone|methyl-prednisolone
601471|NCT00577993|Procarbazine|procarbazine
601472|NCT00577993|Prednisone|prednisone
601473|NCT00577993|FND|fnd
601474|NCT00578006|toxicity related symptoms|toxicity related symptoms
601475|NCT00578006|04-020|04-020
601476|NCT00578019|Comparative|comparative
601477|NCT00578019|Supracondylar Femur Fracture|supracondylar femur fracture
601478|NCT00578019|Intramedullary nailing|intramedullary nailing
601479|NCT00578019|Less Invasive Stabilization System (LISS) Plating|less invasive stabilization system (liss) plating
601480|NCT00578032|head|head
601481|NCT00578032|neck|neck
601482|NCT00578032|cancer|cancer
601483|NCT00578032|reconstruction|reconstruction
601484|NCT00578032|quality of life|quality of life
601485|NCT00578032|07-150|07-150
601486|NCT00578071|esophageal cancer|esophageal cancer
601487|NCT00578110|glaucoma VEP detection device diagnosis vision|glaucoma vep detection device diagnosis vision
601488|NCT00578123|Prostate|prostate
601489|NCT00578123|Cancer|cancer
601490|NCT00578123|Quality of Life|quality of life
601491|NCT00578123|Questionaires|questionaires
601492|NCT00578123|04-094|04-094
601493|NCT00578136|Rectus Sheath|rectus sheath
601494|NCT00578136|Local infiltration|local infiltration
601495|NCT00578136|Pain Control|pain control
601496|NCT00578149|chemoradiotherapy|chemoradiotherapy
601497|NCT00578149|Lung cancer|lung cancer
601498|NCT00578162|Cancer|cancer
601499|NCT00578162|Survivors|survivors
601500|NCT00578175|Vaccines|vaccines
601501|NCT00578175|Rubella|rubella
601502|NCT00578175|Varicella Vaccine|varicella vaccine
601503|NCT00578175|Children|children
601504|NCT00578175|Humans|humans
601505|NCT00578175|Mumps|mumps
601506|NCT00578175|Immunogenicity|immunogenicity
601507|NCT00578175|Safety|safety
601508|NCT00578175|Measles|measles
601509|NCT00578175|Combined Vaccine|combined vaccine
601510|NCT00578188|Adolescent Health|adolescent health
601511|NCT00578188|Sexually transmitted infection|sexually transmitted infection
601512|NCT00578188|Women's Health|women's health
601513|NCT00578201|Esophageal neoplasms|esophageal neoplasms
601516|NCT00578201|Fluorouracil|fluorouracil
601517|NCT00578201|radiotherapy|radiotherapy
601518|NCT00578214|mohs micrographic surgery|mohs micrographic surgery
601519|NCT00578214|skin cancer|skin cancer
601520|NCT00578214|anxiety|anxiety
601521|NCT00578214|basal cell carcinoma|basal cell carcinoma
601522|NCT00578214|squamous cell carcinoma|squamous cell carcinoma
601523|NCT00578214|midazolam|midazolam
601524|NCT00578214|versed|versed
601525|NCT00578227|Human papillomavirus infection,|human papillomavirus infection,
601526|NCT00578227|cervical cancer|cervical cancer
601527|NCT00578227|HPV vaccine,|hpv vaccine,
601528|NCT00578240|benign|benign
601529|NCT00578240|Rising PSA|rising psa
601530|NCT00578240|Clinical Metastases|clinical metastases
601531|NCT00578240|90-040|90-040
601532|NCT00578266|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
601533|NCT00578266|Transplant for Severe Aplastic Anemia (SAA)|transplant for severe aplastic anemia (saa)
601534|NCT00578292|transfusion-dependent|transfusion-dependent
601535|NCT00578292|homozygous b0/+-thalassemia|homozygous b0/+-thalassemia
601536|NCT00578292|severe variants of b0/+-thalassemia|severe variants of b0/+-thalassemia
601537|NCT00578292|chronic transfusion therapy|chronic transfusion therapy
601538|NCT00578292|iron chelating agents|iron chelating agents
601539|NCT00578292|severe|severe
601540|NCT00578292|transfusion-dependent homozygous b0/+-thalassemia or severe variants of b0/+-thalassemia|transfusion-dependent homozygous b0/+-thalassemia or severe variants of b0/+-thalassemia
601541|NCT00578331|rhinitis|rhinitis
601542|NCT00578331|perennial allergic rhinitis|perennial allergic rhinitis
601543|NCT00578331|allergic rhinitis|allergic rhinitis
601544|NCT00578344|Sickle Cell Disease|sickle cell disease
601546|NCT00578344|Hemoglobin SS|hemoglobin ss
601547|NCT00578344|Hemoglobin SC|hemoglobin sc
601548|NCT00578344|Hemoglobin Sb0/+|hemoglobin sb0/+
601549|NCT00578344|HLA genotype|hla genotype
601550|NCT00578344|Severe anemia|severe anemia
601551|NCT00578344|Transfusion therapy|transfusion therapy
601552|NCT00578357|problem gambling|problem gambling
601553|NCT00578357|personalized feedback|personalized feedback
601554|NCT00578357|gambling addiction|gambling addiction
601555|NCT00578370|Ciclosporin|ciclosporin
601556|NCT00578370|Plaque type psoriasis|plaque type psoriasis
601557|NCT00578370|Psoriasis plaque test|psoriasis plaque test
601558|NCT00578370|Sonography|sonography
601559|NCT00578370|Cyclosporin|cyclosporin
601560|NCT00578370|Psoriasis|psoriasis
601561|NCT00578383|Depression|depression
601562|NCT00578383|Major depression|major depression
601563|NCT00578383|Bipolar Disorder|bipolar disorder
601564|NCT00578383|Bipolar depression|bipolar depression
601565|NCT00578383|LFMS|lfms
601566|NCT00578383|low field magnetic stimulation|low field magnetic stimulation
601567|NCT00578383|mood disorders|mood disorders
601571|NCT00578409|progressive castrate metastatic prostate cancer|progressive castrate metastatic prostate cancer
601573|NCT00578422|Peripheral Artery Disease|peripheral artery disease
601575|NCT00578422|Plaque|plaque
601576|NCT00578435|ERYTHROPOIESIS|erythropoiesis
601577|NCT00578435|Genetic Disorders|genetic disorders
601578|NCT00578435|Sickle Cell Anemia|sickle cell anemia
601579|NCT00578435|Thalassemia|thalassemia
601580|NCT00578435|Diamond Blackfan Anemia|diamond blackfan anemia
601581|NCT00578461|Stem Cell Transplant|stem cell transplant
601582|NCT00578461|myeloproliferative disease|myeloproliferative disease
601583|NCT00578461|myelodsyplastic disease|myelodsyplastic disease
601584|NCT00578461|Leukemia|leukemia
601585|NCT00578461|Cancer|cancer
601586|NCT00578461|Lymphoma|lymphoma
601587|NCT00578461|Lymphoma, Hodgkin|lymphoma, hodgkin
601588|NCT00578461|Lymphoma, non-Hodgkin|lymphoma, non-hodgkin
601589|NCT00578474|Acute otitis media|acute otitis media
601590|NCT00578474|Tympanostomy tubes|tympanostomy tubes
601591|NCT00578500|chemotherapy, female, fertility preservation, gonadotoxicity|chemotherapy, female, fertility preservation, gonadotoxicity
601592|NCT00578500|oophorectomy, in vitro maturation, ovarian cryopreservation,|oophorectomy, in vitro maturation, ovarian cryopreservation,
601593|NCT00578500|oocyte cryopreservation, ovarian transplantation|oocyte cryopreservation, ovarian transplantation
601594|NCT00578526|urothelial cancer|urothelial cancer
601595|NCT00578526|targeted therapy|targeted therapy
601596|NCT00578526|antiangiogenesis therapy|antiangiogenesis therapy
601597|NCT00578526|SU011248|su011248
601598|NCT00578526|clinical trial|clinical trial
601599|NCT00578539|Stem Cell Transplantation|stem cell transplantation
601600|NCT00578552|tobacco|tobacco
601601|NCT00578552|smoking|smoking
601602|NCT00578552|gabapentin|gabapentin
601603|NCT00578552|abstinence|abstinence
601604|NCT00578565|Rheumatoid Arthritis|rheumatoid arthritis
601605|NCT00578565|Interstitial Pneumonia|interstitial pneumonia
601606|NCT00578565|Rheumatology|rheumatology
601607|NCT00578565|Rituximab|rituximab
601608|NCT00578578|Omega3 fatty acids|omega3 fatty acids
601609|NCT00578578|hsCRP|hscrp
601610|NCT00578578|CAD|cad
601611|NCT00578591|Graft Versus Host Disease|graft versus host disease
601612|NCT00578591|GVHD|gvhd
601613|NCT00578591|allogeneic hematopoietic transplant|allogeneic hematopoietic transplant
601614|NCT00578591|AHT|aht
601615|NCT00578591|posttransplant|posttransplant
601616|NCT00578591|Rituximab|rituximab
601617|NCT00578617|Atrial fibrillation|atrial fibrillation
601618|NCT00578617|Left Atrial Ablation|left atrial ablation
601619|NCT00578617|Pulmonary Vein Isolation|pulmonary vein isolation
601620|NCT00578617|Catheter Ablation|catheter ablation
601621|NCT00578617|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
601622|NCT00578630|pediatric tumors|pediatric tumors
601623|NCT00578630|genetic test development|genetic test development
601624|NCT00578630|All Pediatric patients with a histologically proven tumor.|all pediatric patients with a histologically proven tumor.
601630|NCT00578656|Food Allergy|food allergy
601631|NCT00578656|Milk Allergy|milk allergy
601632|NCT00578669|Smoking Cessation|smoking cessation
601633|NCT00578669|Tobacco Use Cessation|tobacco use cessation
601634|NCT00578669|Antidepressants|antidepressants
601635|NCT00578695|Hyponatremia|hyponatremia
601636|NCT00578695|Serum Sodium|serum sodium
601637|NCT00578695|Fluid Overload|fluid overload
601638|NCT00578695|Heart Failure|heart failure
601639|NCT00578695|Acute Heart Failure|acute heart failure
601640|NCT00578695|Vasopressin Antagonist|vasopressin antagonist
601641|NCT00578708|membranous|membranous
601642|NCT00578708|ventricular|ventricular
601643|NCT00578708|septal|septal
601644|NCT00578708|defect|defect
601645|NCT00578708|VSD|vsd
601646|NCT00578721|Colorectal cancer|colorectal cancer
601647|NCT00578721|aspirin|aspirin
601648|NCT00578747|Breast Cancer|breast cancer
601649|NCT00578747|Breast Neoplasms|breast neoplasms
601650|NCT00578747|Targeted Radiotherapy|targeted radiotherapy
601651|NCT00578747|Mastectomy|mastectomy
601652|NCT00578747|Seroma|seroma
601653|NCT00578760|hearing loss|hearing loss
601654|NCT00578760|ototoxicity|ototoxicity
601655|NCT00578760|cisplatin|cisplatin
601656|NCT00578773|ear tubes|ear tubes
601657|NCT00578773|ear infection|ear infection
601658|NCT00578773|ear drops|ear drops
601659|NCT00578773|ear tube surgery|ear tube surgery
601660|NCT00578773|acute otitis media|acute otitis media
601661|NCT00578799|ulcerative colitis|ulcerative colitis
601662|NCT00578825|Severe acute respiratory syndrome|severe acute respiratory syndrome
601663|NCT00578851|Hip Arthroplasty|hip arthroplasty
601664|NCT00578851|Hip Arthritis|hip arthritis
601665|NCT00578864|Neuroblastoma|neuroblastoma
601666|NCT00578864|Etoposide|etoposide
601667|NCT00578864|Cisplatin|cisplatin
601668|NCT00578864|Adriamycin|adriamycin
601669|NCT00578864|Cyclophosphamide|cyclophosphamide
601670|NCT00578864|Cytoxan|cytoxan
601671|NCT00578877|Contraception|contraception
601672|NCT00578877|SILCS Diaphragm|silcs diaphragm
601673|NCT00578877|Contraceptive Gel|contraceptive gel
601674|NCT00578890|diabetic foot|diabetic foot
601675|NCT00578890|osteomyelitis|osteomyelitis
601676|NCT00578903|Severe Aplastic Anemia|severe aplastic anemia
601677|NCT00578903|Severe|severe
601678|NCT00578929|allergic rhinitis|allergic rhinitis
601679|NCT00578929|allergies|allergies
601680|NCT00578929|seasonal allergies|seasonal allergies
601681|NCT00578942|Allogeneic Stem Cell Transplantation, Campath, HLA-Matched|allogeneic stem cell transplantation, campath, hla-matched
601682|NCT00578955|Blepharoconjunctivitis, Ophthalmology|blepharoconjunctivitis, ophthalmology
601683|NCT00578968|COPD|copd
601684|NCT00578968|Tiotropium|tiotropium
601685|NCT00578968|Spiriva|spiriva
601686|NCT00578981|Osteoporosis, age-related|osteoporosis, age-related
601687|NCT00578981|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
601688|NCT00578981|Bone Loss|bone loss
601689|NCT00578981|Low Bone Density|low bone density
601690|NCT00578994|Unicompartmental Knee|unicompartmental knee
601691|NCT00578994|Partial Knee|partial knee
601692|NCT00578994|Knee arthroplasty|knee arthroplasty
601693|NCT00579007|Prophylactic Mastectomy|prophylactic mastectomy
601694|NCT00579007|Prophylactic Oophorectomy|prophylactic oophorectomy
601695|NCT00579020|cornea|cornea
601696|NCT00579020|inflammation|inflammation
601697|NCT00579020|blepharitis|blepharitis
601698|NCT00579020|lid infection|lid infection
601699|NCT00585013|Inhaled Nitric Oxide (NO)|inhaled nitric oxide (no)
601700|NCT00585013|Anti-inflammatory|anti-inflammatory
601701|NCT00585013|Anti-reperfusion agent|anti-reperfusion agent
601702|NCT00585026|Refractive error|refractive error
601703|NCT00585026|Asthenopia|asthenopia
601704|NCT00585026|Presbyopia|presbyopia
601705|NCT00585026|Eyeglasses|eyeglasses
601706|NCT00585026|Productivity|productivity
601707|NCT00585026|Visual comfort|visual comfort
601708|NCT00585026|Ergonomics|ergonomics
601709|NCT00585039|child|child
601710|NCT00585039|emergency department|emergency department
601711|NCT00585052|Ovarian Cancer|ovarian cancer
601712|NCT00585052|Epithelial Ovarian Cancer|epithelial ovarian cancer
601713|NCT00585052|Lovastatin|lovastatin
601714|NCT00585052|Paclitaxel|paclitaxel
601715|NCT00585078|capecitabine|capecitabine
601716|NCT00585078|oxaliplatin|oxaliplatin
601717|NCT00585143|Dyslipidemia|dyslipidemia
601718|NCT00585156|Celebrex, Bone Ingrowth, Pain relief|celebrex, bone ingrowth, pain relief
601719|NCT00585169|Pathological Gambling|pathological gambling
601720|NCT00585169|Compulsive Gambling|compulsive gambling
601721|NCT00585169|Gambling Addiction|gambling addiction
601722|NCT00585169|Gambling|gambling
601725|NCT00585169|Pharmacology|pharmacology
601726|NCT00585182|Obesity|obesity
601727|NCT00585182|venous thrombosis|venous thrombosis
601728|NCT00585182|Anticoagulants|anticoagulants
601729|NCT00585195|Crizotinib|crizotinib
601730|NCT00585195|dose-finding|dose-finding
601731|NCT00585195|drug-drug interaction|drug-drug interaction
601732|NCT00585195|ALK rearrangements|alk rearrangements
601733|NCT00585195|c-Met mutations or amplifications|c-met mutations or amplifications
601734|NCT00585195|c-Met dependent tumors|c-met dependent tumors
601735|NCT00585195|ROS1 rearrangements|ros1 rearrangements
601736|NCT00585195|c-Met exon 14 deletion|c-met exon 14 deletion
601737|NCT00585195|c-Met exon 14 skipping|c-met exon 14 skipping
601738|NCT00585195|c-Met exon 14 alterations|c-met exon 14 alterations
601739|NCT00585208|insomnia|insomnia
601740|NCT00585208|sleep disturbance|sleep disturbance
601741|NCT00585208|bipolar disorder|bipolar disorder
601742|NCT00585221|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
601743|NCT00585221|Imatinib|imatinib
601744|NCT00585221|Peginterferon α-2b|peginterferon α-2b
601745|NCT00585221|Immunotherapy|immunotherapy
601746|NCT00585221|Targeted therapy|targeted therapy
601747|NCT00585247|birthmarks|birthmarks
601748|NCT00585260|asthma|asthma
601749|NCT00585260|bronchoprovocation challenge test|bronchoprovocation challenge test
601750|NCT00585260|mannitol|mannitol
601751|NCT00585260|methacholine|methacholine
601752|NCT00585286|acne vulgaris|acne vulgaris
601753|NCT00585286|scarring|scarring
601754|NCT00585286|laser|laser
601755|NCT00585299|steatosis|steatosis
601756|NCT00585299|fatty liver|fatty liver
601757|NCT00585299|insulin sensitivity|insulin sensitivity
601758|NCT00585299|fatty liver (steatosis)|fatty liver (steatosis)
601760|NCT00586885|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
601761|NCT00586885|NASH|nash
601762|NCT00586885|L-Alanine|l-alanine
601763|NCT00586898|Prostate|prostate
601764|NCT00586898|Cancer|cancer
601765|NCT00586898|Hormones|hormones
601766|NCT00586898|01-085|01-085
601767|NCT00586898|ANTIFUNGAL ANTIBIOTICS|antifungal antibiotics
601768|NCT00586898|ESTROGENS|estrogens
601769|NCT00586898|LUPRON|lupron
601770|NCT00586898|TESTOSTERONE|testosterone
601771|NCT00586898|ZOLADEX|zoladex
601772|NCT00586911|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
601773|NCT00586911|NASH|nash
601774|NCT00586911|Betaine|betaine
601775|NCT00586937|Lung Cancer Survivors|lung cancer survivors
601776|NCT00586950|Myocardial Free Fatty Acid metabolism|myocardial free fatty acid metabolism
601777|NCT00586950|High risk patients|high risk patients
601778|NCT00586950|End-stage renal failure|end-stage renal failure
601779|NCT00586950|Cardiovascular events|cardiovascular events
601780|NCT00586950|prognosis|prognosis
601781|NCT00586963|Erosive Esophagitis|erosive esophagitis
601782|NCT00586963|Reflux Esophagitis|reflux esophagitis
601783|NCT00586963|GERD|gerd
601784|NCT00586976|pain, ropivacaine, infusion, sternotomy|pain, ropivacaine, infusion, sternotomy
601785|NCT00586989|Barrett's Esophagus|barrett's esophagus
601786|NCT00586989|Esophageal Cancer|esophageal cancer
601787|NCT00586989|High Grade Dysplasia|high grade dysplasia
601788|NCT00587002|Acute Coronary Syndrome|acute coronary syndrome
601789|NCT00587002|Women|women
601790|NCT00587028|Colonography|colonography
601791|NCT00587028|Colonoscopy|colonoscopy
601792|NCT00587028|Virtual|virtual
601793|NCT00587028|Computed Tomographic Colonography|computed tomographic colonography
601794|NCT00587028|Large intestine|large intestine
601795|NCT00587028|colon|colon
601796|NCT00587041|Synbiotic|synbiotic
601797|NCT00587041|Urine Oxalate|urine oxalate
601798|NCT00587041|Probiotic|probiotic
601799|NCT00587041|Kidney Stone|kidney stone
601800|NCT00587041|Gastric Bypass|gastric bypass
601801|NCT00587041|Crohn's|crohn's
601802|NCT00587041|Stone|stone
601803|NCT00587041|Hyperoxaluria|hyperoxaluria
601804|NCT00587041|Enteric Hyperoxaluria|enteric hyperoxaluria
601805|NCT00587054|leukemia|leukemia
601806|NCT00587054|non-Hodgkins|non-hodgkins
601807|NCT00587054|lymphoblastic lymphoma|lymphoblastic lymphoma
601808|NCT00587054|myelodysplastic syndrome|myelodysplastic syndrome
601809|NCT00587054|paroxysmal nocturnal hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
601810|NCT00587054|cytoreductive regimen|cytoreductive regimen
601811|NCT00587054|allogeneic stem cell transplant|allogeneic stem cell transplant
601812|NCT00587067|FUDR|fudr
601813|NCT00587067|FLOXORUIDINE|floxoruidine
601814|NCT00587067|DEXAMETHASONE|dexamethasone
601815|NCT00587067|Hepatic|hepatic
601816|NCT00587067|Cancer|cancer
601817|NCT00587067|02-120|02-120
601818|NCT00587093|Newly diagnosed|newly diagnosed
601819|NCT00587093|CA 125|ca 125
601820|NCT00587093|CT scan|ct scan
601821|NCT00587093|01-048|01-048
601822|NCT00587119|Urso|urso
601823|NCT00587119|Budesonide|budesonide
601825|NCT00587119|overlap AIH|overlap aih
601826|NCT00587119|PBC with overlap features of autoimmune hepatitis|pbc with overlap features of autoimmune hepatitis
601827|NCT00587132|Diabetes mellitus|diabetes mellitus
601828|NCT00587132|Peutz-Jeghers syndrome|peutz-jeghers syndrome
602131|NCT00588536|6-TG|6-tg
601829|NCT00587145|Stomach Neoplasms|stomach neoplasms
601830|NCT00587145|Secondary|secondary
601831|NCT00587145|Combination chemotherapy|combination chemotherapy
601832|NCT00587145|S-1|s-1
601833|NCT00587145|Docetaxel|docetaxel
601834|NCT00587145|oxaliplatin|oxaliplatin
601835|NCT00587158|Paricalcitol|paricalcitol
601836|NCT00587158|Parathyroid Hormone|parathyroid hormone
601837|NCT00587158|Bone Alkaline Phosphatase|bone alkaline phosphatase
601838|NCT00587158|Chronic Kidney Disease|chronic kidney disease
601839|NCT00587158|Glomerular Filtration Rate|glomerular filtration rate
601840|NCT00587158|Vitamin D Receptor|vitamin d receptor
601841|NCT00587158|Interstitial Fibrosis and Tubular Atrophy|interstitial fibrosis and tubular atrophy
601842|NCT00587158|Zemplar®|zemplar®
601843|NCT00587171|Amblyopia|amblyopia
601844|NCT00587171|Vision Therapy|vision therapy
601845|NCT00587171|Patching|patching
601846|NCT00587184|Barrett's Esophagus|barrett's esophagus
601847|NCT00587184|Confocal Microscopy|confocal microscopy
601849|NCT00587197|portal hypertension|portal hypertension
601850|NCT00587197|gastric varices|gastric varices
601851|NCT00587197|cost effectiveness|cost effectiveness
601852|NCT00587210|Crohn Disease|crohn disease
601853|NCT00587210|Inflammatory Bowel Disease|inflammatory bowel disease
601854|NCT00587236|Autofluorescence|autofluorescence
601855|NCT00587236|Narrow Band|narrow band
601856|NCT00587236|High definition white light|high definition white light
601857|NCT00587249|Malaria, Plasmodium falciparium, Hepatitis B Core Antigen, Circumsporozoite Epitopes|malaria, plasmodium falciparium, hepatitis b core antigen, circumsporozoite epitopes
601858|NCT00587262|Cochlear|cochlear
601859|NCT00587262|Hearing|hearing
601860|NCT00587262|High frequency hearing loss|high frequency hearing loss
601861|NCT00587275|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
601862|NCT00587275|GERD|gerd
601863|NCT00587288|Cinquil™|cinquil™
601864|NCT00587288|Reslizumab|reslizumab
601865|NCT00587301|Child Obesity|child obesity
601866|NCT00587314|Photodynamic Therapy|photodynamic therapy
601867|NCT00587314|Barrett's Esophagus|barrett's esophagus
601868|NCT00587314|Early Esophageal Adenocarcinoma|early esophageal adenocarcinoma
752340|NCT01172574|Pain|pain
601869|NCT00587353|tobacco use cessation|tobacco use cessation
601870|NCT00587353|radiation oncology|radiation oncology
601871|NCT00587353|smoking|smoking
601872|NCT00587379|testing for Endothelial Dysfunction and coronary angiography|testing for endothelial dysfunction and coronary angiography
601873|NCT00587392|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
601874|NCT00587392|Long-term follow-up (LTFU)|long-term follow-up (ltfu)
601875|NCT00587392|Endoscopic Full-thickness Plication|endoscopic full-thickness plication
601876|NCT00587392|Plicator|plicator
601877|NCT00587405|Watermelon Stomach|watermelon stomach
601878|NCT00587405|Cryotherapy|cryotherapy
601879|NCT00587405|Argon Plasma Coagulation|argon plasma coagulation
601880|NCT00587431|Prostate|prostate
601881|NCT00587431|Cancer|cancer
601882|NCT00587431|Docetaxel|docetaxel
601883|NCT00587431|03-076|03-076
601884|NCT00587444|heparin management|heparin management
601885|NCT00587457|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
601886|NCT00587457|Prolymphocytic Leukemia|prolymphocytic leukemia
601887|NCT00587457|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
601888|NCT00587457|Moxetumomab pasudotox|moxetumomab pasudotox
601889|NCT00587470|valve, mitral, regurgitation|valve, mitral, regurgitation
601890|NCT00587483|cardiopulmonary bypass|cardiopulmonary bypass
601891|NCT00587483|reperfusion ventricular fibrillation|reperfusion ventricular fibrillation
601892|NCT00587483|ventricular fibrillation|ventricular fibrillation
601893|NCT00587483|amiodarone|amiodarone
601894|NCT00587483|lidocaine|lidocaine
601895|NCT00587483|cardiac surgery|cardiac surgery
601896|NCT00587496|HSV DNA|hsv dna
601897|NCT00587496|volunteers|volunteers
601898|NCT00587522|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
601899|NCT00587522|NDO Full-thickness Plicator|ndo full-thickness plicator
601900|NCT00587522|Plicator|plicator
601901|NCT00587522|Endoluminal GERD Therapy|endoluminal gerd therapy
601902|NCT00587535|hemochromatosis|hemochromatosis
601903|NCT00587535|liver cirrhosis|liver cirrhosis
601904|NCT00587535|liver diseases|liver diseases
601905|NCT00587548|locate the ureters during abdominal surgery|locate the ureters during abdominal surgery
601906|NCT00587561|schizophrenia|schizophrenia
601907|NCT00587561|social cognition|social cognition
601908|NCT00587561|cognition|cognition
601909|NCT00587561|treatment|treatment
601911|NCT00587574|chronic graft-versus-host disease|chronic graft-versus-host disease
601912|NCT00587600|Barrett's Esophagus|barrett's esophagus
601913|NCT00587600|High Grade Dysplasia|high grade dysplasia
601914|NCT00587600|Photodynamic Therapy|photodynamic therapy
601915|NCT00587626|neck pain|neck pain
601916|NCT00587626|shoulder pain|shoulder pain
601917|NCT00587626|cervical pain|cervical pain
601918|NCT00587626|chronic|chronic
601919|NCT00587626|recurrent|recurrent
601920|NCT00587639|Adolescent|adolescent
601921|NCT00587639|Depression|depression
601922|NCT00587639|rTMS|rtms
601923|NCT00587652|Barrett Esophagus|barrett esophagus
601924|NCT00587652|Methylene blue|methylene blue
601925|NCT00587652|Chromoendoscopy|chromoendoscopy
601926|NCT00587665|Pain|pain
601927|NCT00587678|PAD|pad
601928|NCT00587691|Tovaxin|tovaxin
601929|NCT00587691|TCV|tcv
601930|NCT00587691|Autologous|autologous
601931|NCT00587730|heart disease|heart disease
601932|NCT00587730|cardiac disease|cardiac disease
601933|NCT00587730|chest pain|chest pain
601934|NCT00587730|myocardial infarction|myocardial infarction
601935|NCT00587730|heart attack|heart attack
601936|NCT00587756|intraoperative ultrasonography|intraoperative ultrasonography
601937|NCT00587756|colorectal liver metastases|colorectal liver metastases
601938|NCT00587756|hepatectomy|hepatectomy
601939|NCT00587756|portal vein embolization|portal vein embolization
601940|NCT00587756|Liver|liver
601941|NCT00587769|Smoking|smoking
601942|NCT00587769|Smoking cessation|smoking cessation
601943|NCT00587769|Bupropion|bupropion
601944|NCT00587769|Varenicline|varenicline
601945|NCT00587769|Tobacco use disorder|tobacco use disorder
601946|NCT00587808|Heart Failure|heart failure
601947|NCT00587808|Heart Failure, Diastolic|heart failure, diastolic
601948|NCT00587808|Stroke Volume|stroke volume
601949|NCT00587821|Breast Cancer|breast cancer
601950|NCT00587821|Breast biopsy|breast biopsy
601951|NCT00587847|leukemia|leukemia
601952|NCT00587873|Relapsed|relapsed
601953|NCT00587873|Hodgkin's Disease|hodgkin's disease
601954|NCT00587873|Methotrexate|methotrexate
601955|NCT00587873|6-Thioguanine|6-thioguanine
601956|NCT00587873|94-030|94-030
601957|NCT00587886|Cancer|cancer
601958|NCT00587886|Endometrial cancer|endometrial cancer
601959|NCT00587886|Ovarian cancer|ovarian cancer
601960|NCT00587886|Corpus Uteri|corpus uteri
601961|NCT00587886|Endometrium|endometrium
601962|NCT00587899|Atrial Fibrillation|atrial fibrillation
601963|NCT00587899|AF|af
601964|NCT00587899|A fib|a fib
601965|NCT00587899|cardiac ablation|cardiac ablation
601966|NCT00587899|modified maze procedure|modified maze procedure
601967|NCT00587912|Kaposi's Sarcoma AIDS Related|kaposi's sarcoma aids related
601968|NCT00587912|Kaposi's Sarcoma Classical|kaposi's sarcoma classical
601969|NCT00587912|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
601970|NCT00587912|HEMATOPOIETIC SYSTEM|hematopoietic system
601971|NCT00587912|Cancer|cancer
601972|NCT00587912|AIDS|aids
601973|NCT00587925|osteoporosis|osteoporosis
601974|NCT00587938|congestive heart failure|congestive heart failure
601975|NCT00587938|Brain naturietic peptide|brain naturietic peptide
601976|NCT00587938|hospital utilization cost|hospital utilization cost
601977|NCT00587951|Clinical decision-making|clinical decision-making
601978|NCT00587951|Ictal SPECT|ictal spect
601979|NCT00587951|Epilepsy surgery|epilepsy surgery
601980|NCT00587964|Cancer|cancer
601981|NCT00587964|Brain Metastasis|brain metastasis
601982|NCT00587964|Radiosurgery|radiosurgery
601983|NCT00587964|Bladder cancer|bladder cancer
601984|NCT00587964|Breast cancer|breast cancer
601985|NCT00587964|Cervical cancer|cervical cancer
601986|NCT00587964|Colon cancer|colon cancer
601987|NCT00587964|HEENT cancer|heent cancer
601988|NCT00587964|Lung cancer|lung cancer
601989|NCT00587964|Melanoma|melanoma
601990|NCT00587964|Pancreatic cancer|pancreatic cancer
601991|NCT00587964|Prostate cancer|prostate cancer
601992|NCT00587964|Rectal cancer|rectal cancer
601993|NCT00587964|Sarcoma|sarcoma
601994|NCT00587964|Testicular cancer|testicular cancer
601995|NCT00587964|Radiation|radiation
601996|NCT00587977|Abdominal aortic aneurysm|abdominal aortic aneurysm
601997|NCT00587990|Chronic Ischemic Left Ventricular Dysfunction|chronic ischemic left ventricular dysfunction
601998|NCT00588003|Breast|breast
601999|NCT00588003|ANASTROZOLE|anastrozole
602000|NCT00588016|Itraconazole|itraconazole
602001|NCT00588029|Family members|family members
602002|NCT00588042|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
602003|NCT00588042|Coronary Artery Disease|coronary artery disease
602004|NCT00588042|Coronary Occlusion|coronary occlusion
602005|NCT00588068|Adrenal Gland|adrenal gland
602006|NCT00588068|No stage requirement|no stage requirement
602007|NCT00588081|Vaginal Reconstruction|vaginal reconstruction
602008|NCT00588094|Lymphoma|lymphoma
602009|NCT00588094|ASCT|asct
602010|NCT00588094|B-cell non-Hodgkin's lymphoma|b-cell non-hodgkin's lymphoma
602011|NCT00588094|Cancer|cancer
602012|NCT00588094|Second line therapy|second line therapy
602013|NCT00588094|ICE|ice
602014|NCT00588094|Stem cell transplant|stem cell transplant
602015|NCT00588107|Cancer|cancer
602016|NCT00588107|Smoker|smoker
602017|NCT00588107|Web based intervention|web based intervention
602018|NCT00588107|Partnership for Health|partnership for health
602019|NCT00588107|Cancer Survivors|cancer survivors
602020|NCT00588120|Hyperoxaluria|hyperoxaluria
602021|NCT00588120|Unknown Hyperoxaluria|unknown hyperoxaluria
602022|NCT00588120|Enteric Hyperoxaluria|enteric hyperoxaluria
602023|NCT00588120|Oxaluric|oxaluric
602024|NCT00588120|High Oxalate|high oxalate
602025|NCT00588120|Oxalate|oxalate
602026|NCT00588120|C13|c13
602027|NCT00588120|Oxalate Diet|oxalate diet
602132|NCT00588536|Methotrexate|methotrexate
602028|NCT00588133|antifibrinolytic, bleeding, heart|antifibrinolytic, bleeding, heart
602029|NCT00588146|anemia|anemia
602030|NCT00588146|HHT|hht
602031|NCT00588146|Liver disease|liver disease
602032|NCT00588146|Hypoxemia|hypoxemia
602033|NCT00588146|Iron deficiency anemia|iron deficiency anemia
602034|NCT00588146|Liver disease with high cardiac output|liver disease with high cardiac output
602035|NCT00588146|Diffuse pulmonary AVMs with hypoxemia|diffuse pulmonary avms with hypoxemia
602036|NCT00588159|Preoperative gabapentin|preoperative gabapentin
602037|NCT00588159|Acute pain|acute pain
602038|NCT00588159|Post-thoracotomy pain|post-thoracotomy pain
602039|NCT00588159|Epidural analgesia|epidural analgesia
602040|NCT00588172|Metformin|metformin
602041|NCT00588172|Type 2 diabetes|type 2 diabetes
602042|NCT00588172|Oct1|oct1
602043|NCT00588185|Progressive Prostate Cancer|progressive prostate cancer
602044|NCT00588185|[18F]-Fluoro-2-Deoxy-D-Glucose|[18f]-fluoro-2-deoxy-d-glucose
602045|NCT00588185|[18F] Dihydro-Testosterone|[18f] dihydro-testosterone
602046|NCT00588185|Pet Imaging|pet imaging
602047|NCT00588185|Pet scan|pet scan
602048|NCT00588185|00-095|00-095
602049|NCT00588198|histologically confirmed melanoma of any site|histologically confirmed melanoma of any site
602050|NCT00588211|Cancer related-Risks|cancer related-risks
602051|NCT00588211|Risk Perception|risk perception
602052|NCT00588211|Survey|survey
602053|NCT00588211|Focus Group|focus group
602054|NCT00588211|Smoking cessation|smoking cessation
602055|NCT00588211|tobacco|tobacco
602056|NCT00588224|stomach|stomach
602057|NCT00588224|accommodation|accommodation
602058|NCT00588224|volume|volume
602059|NCT00588224|SPECT|spect
602060|NCT00588224|3 dimensional ultrasonography|3 dimensional ultrasonography
602061|NCT00588224|healthy volunteers|healthy volunteers
602062|NCT00588237|ovary|ovary
602063|NCT00588237|BEVACIZUMAB|bevacizumab
602064|NCT00588237|CISPLATIN|cisplatin
602065|NCT00588237|TAXOL|taxol
602066|NCT00588263|Ashkenazi Jewish|ashkenazi jewish
602067|NCT00588263|Cancer|cancer
602068|NCT00588263|00-087|00-087
602069|NCT00588276|measurable disease|measurable disease
602070|NCT00588276|locally advanced disease|locally advanced disease
602071|NCT00588289|Pediatric Cancers|pediatric cancers
602072|NCT00588289|Oncology|oncology
602073|NCT00588302|primary biliary cirrhosis|primary biliary cirrhosis
602074|NCT00588302|ursodeoxycholic acid|ursodeoxycholic acid
602075|NCT00588341|Melanoma|melanoma
602076|NCT00588341|Skin Cancer|skin cancer
602077|NCT00588341|Cancer|cancer
602078|NCT00588341|Temozolamide|temozolamide
602079|NCT00588341|TMZ|tmz
602080|NCT00588354|herniated disk|herniated disk
602081|NCT00588354|radiculopathy|radiculopathy
602082|NCT00588354|clonidine|clonidine
602083|NCT00588354|epidural|epidural
602084|NCT00588354|steroid|steroid
602085|NCT00588354|corticosteroid|corticosteroid
602086|NCT00588354|nucleus pulposus|nucleus pulposus
602087|NCT00588354|transforaminal|transforaminal
602088|NCT00588367|Inflammation|inflammation
602089|NCT00588367|Pancreas|pancreas
602090|NCT00588367|Chronic pancreatitis|chronic pancreatitis
602091|NCT00588367|Alcoholic pancreatitis|alcoholic pancreatitis
602092|NCT00588367|Carcinoma, pancreatic ductal|carcinoma, pancreatic ductal
602093|NCT00588367|Pancreatic neoplasms|pancreatic neoplasms
602094|NCT00588380|GLP-1|glp-1
602095|NCT00588380|Insulin Secretion|insulin secretion
602096|NCT00588406|acute, emergency department|acute, emergency department
602097|NCT00588419|Breast Cancer|breast cancer
602098|NCT00588419|Cancer|cancer
602099|NCT00588419|Breast Sensation|breast sensation
602100|NCT00588419|Postmastectomy Breast Reconstruction|postmastectomy breast reconstruction
602101|NCT00588432|Stroke|stroke
602102|NCT00588432|Immobilization|immobilization
602103|NCT00588432|Myofacial Pain|myofacial pain
602104|NCT00588432|Hyperthyroid Myopathy|hyperthyroid myopathy
602105|NCT00588445|Lung Cancer|lung cancer
602106|NCT00588445|Non-small cell lung cancer|non-small cell lung cancer
602107|NCT00588445|Gefitnib|gefitnib
602108|NCT00588445|Cancer|cancer
602109|NCT00588445|NSCLC|nsclc
602110|NCT00588445|bronchioloalveolar cancer|bronchioloalveolar cancer
602111|NCT00588445|smoker|smoker
602112|NCT00588458|Primary sclerosing cholangitis|primary sclerosing cholangitis
602113|NCT00588458|Computed tomographic cholangiography|computed tomographic cholangiography
602114|NCT00588458|MELD score|meld score
602115|NCT00588458|Mayo risk score for PSC|mayo risk score for psc
602116|NCT00588484|Carotid artery|carotid artery
602117|NCT00588484|Common carotid artery|common carotid artery
602118|NCT00588484|Measurement|measurement
602119|NCT00588484|Ultrasound|ultrasound
602120|NCT00588497|female sterilization, micro-insert, hysteroscopy|female sterilization, micro-insert, hysteroscopy
602121|NCT00588510|Sarcoma|sarcoma
602122|NCT00588510|Bone|bone
602123|NCT00588523|Brain|brain
602124|NCT00588523|CNS|cns
602125|NCT00588523|TEMOZOLOMIDE|temozolomide
602126|NCT00588523|Busulfan|busulfan
602127|NCT00588523|Thiotepa|thiotepa
602128|NCT00588536|Langerhans Cell Histiocytosis|langerhans cell histiocytosis
602129|NCT00588536|LCH|lch
602130|NCT00588536|6-Thioguanine|6-thioguanine
602142|NCT00588562|PH NonI-NonII|ph noni-nonii
602143|NCT00588562|Primary Hyperoxaluria|primary hyperoxaluria
602144|NCT00588562|Primary Oxalosis|primary oxalosis
602145|NCT00588562|Hyperoxaluria|hyperoxaluria
602146|NCT00588562|Oxalate|oxalate
602147|NCT00588562|Cystinuria|cystinuria
602148|NCT00588562|Cystine|cystine
602149|NCT00588562|APRT|aprt
602150|NCT00588562|Adenine phosphoribosyl transferase deficiency|adenine phosphoribosyl transferase deficiency
602151|NCT00588562|Dent disease|dent disease
602152|NCT00588562|Dent|dent
602153|NCT00588575|Barrett's Esophagus|barrett's esophagus
602154|NCT00588588|Ventilator associated pneumonia|ventilator associated pneumonia
602155|NCT00588588|Intensive Care|intensive care
602156|NCT00588588|Antibiotics|antibiotics
602157|NCT00588588|Mortality|mortality
602158|NCT00588588|Length of stay|length of stay
602160|NCT00588627|Post nasal drip|post nasal drip
602161|NCT00588640|Pain|pain
602162|NCT00588640|HEENT cancer|heent cancer
602163|NCT00588653|Crohn's disease|crohn's disease
602164|NCT00588653|capsule endoscopy|capsule endoscopy
602165|NCT00588653|computed tomography enterography|computed tomography enterography
602166|NCT00588653|colonoscopy|colonoscopy
602167|NCT00588653|small bowel follow-through|small bowel follow-through
602168|NCT00588666|Myeloproliferative Disorder|myeloproliferative disorder
602169|NCT00588666|urinary bladder|urinary bladder
602170|NCT00588666|Cancer|cancer
602171|NCT00588666|ureter|ureter
602172|NCT00588666|renal pelvis|renal pelvis
602173|NCT00588666|chemotherapy|chemotherapy
602174|NCT00588679|Prostate Cancer|prostate cancer
602175|NCT00588679|Cancer|cancer
602177|NCT00588679|Magnetic Resonance Imaging|magnetic resonance imaging
602179|NCT00588692|Heart Failure|heart failure
602180|NCT00588692|Afterload Reduction|afterload reduction
602181|NCT00588692|Sphygmocor|sphygmocor
602182|NCT00588705|Daughters|daughters
602183|NCT00588705|Communication|communication
602184|NCT00588705|genetic risk|genetic risk
602185|NCT00588705|Genetic Counseling|genetic counseling
602186|NCT00588718|Necrotizing enterocolitis|necrotizing enterocolitis
602187|NCT00588718|Progressive necrotizing enterocolitis|progressive necrotizing enterocolitis
602188|NCT00588718|Proteomics in blood|proteomics in blood
602189|NCT00588718|Genomics in blood|genomics in blood
602190|NCT00588718|Multi-center|multi-center
602191|NCT00588757|IVC filters|ivc filters
602192|NCT00588757|Trauma|trauma
602193|NCT00588757|Dwell time|dwell time
602194|NCT00588796|fibrinogen|fibrinogen
602195|NCT00588796|burns|burns
602196|NCT00588796|trauma|trauma
602197|NCT00588796|metabolism|metabolism
602198|NCT00588822|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
602199|NCT00588835|pharmacokinetics|pharmacokinetics
602200|NCT00588835|nausea and vomiting post chemotherapy|nausea and vomiting post chemotherapy
602201|NCT00588848|Obstructive Sleep Apnea Hypopnea Syndrome|obstructive sleep apnea hypopnea syndrome
602202|NCT00588848|OSA|osa
602203|NCT00588848|Postoperative|postoperative
602204|NCT00588848|CPAP|cpap
602205|NCT00588874|male osteoporosis|male osteoporosis
602206|NCT00588874|male osteopenia|male osteopenia
602297|NCT00589329|pergnancy|pergnancy
602207|NCT00588874|calciotropic hormones|calciotropic hormones
602208|NCT00588900|stage IV colon cancer|stage iv colon cancer
602209|NCT00588900|stage IV rectal cancer|stage iv rectal cancer
602210|NCT00588900|recurrent colon cancer|recurrent colon cancer
602211|NCT00588900|recurrent rectal cancer|recurrent rectal cancer
602212|NCT00588913|recurrent renal cell cancer|recurrent renal cell cancer
602213|NCT00588913|stage IV renal cell cancer|stage iv renal cell cancer
602214|NCT00588913|clear cell renal cell carcinoma|clear cell renal cell carcinoma
602215|NCT00588913|lung metastases|lung metastases
602216|NCT00588926|Deep Brain Stimulation|deep brain stimulation
602217|NCT00588926|Movement Disorders|movement disorders
602218|NCT00588926|Remifentanil|remifentanil
602219|NCT00588926|Sedation|sedation
602220|NCT00588926|Basal Ganglia electrical activity|basal ganglia electrical activity
602221|NCT00588939|reflux|reflux
602222|NCT00588939|heartburn|heartburn
602223|NCT00588965|QT interval|qt interval
602224|NCT00588965|beta-blocker|beta-blocker
602225|NCT00588965|exercise|exercise
602226|NCT00588965|electrocardiogram|electrocardiogram
602227|NCT00588965|repolarizaton|repolarizaton
602228|NCT00588978|c-reactive protein|c-reactive protein
602229|NCT00588978|obesity|obesity
602230|NCT00588978|women's cardiovascular health|women's cardiovascular health
602231|NCT00589030|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
602232|NCT00589030|advanced adult primary liver cancer|advanced adult primary liver cancer
602233|NCT00589030|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
602234|NCT00589030|recurrent adult primary liver cancer|recurrent adult primary liver cancer
602235|NCT00589056|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
602236|NCT00589056|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
602237|NCT00589056|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
602238|NCT00589082|AML|aml
602239|NCT00589082|elderly|elderly
602241|NCT00589108|knee arthroplasty|knee arthroplasty
602242|NCT00589121|radiation fibrosis|radiation fibrosis
602243|NCT00589121|radiation toxicity|radiation toxicity
602244|NCT00589121|lymphedema|lymphedema
602245|NCT00589121|musculoskeletal complications|musculoskeletal complications
602246|NCT00589121|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
602247|NCT00589121|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
602248|NCT00589121|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
602249|NCT00589121|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
602250|NCT00589173|Preventive Care|preventive care
602251|NCT00589173|Health information technology|health information technology
602252|NCT00589173|Personal health record|personal health record
602253|NCT00589186|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
602254|NCT00589186|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
602255|NCT00589186|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
602256|NCT00589186|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
602257|NCT00589212|GliaSite|gliasite
602258|NCT00589212|Brain metastases|brain metastases
602259|NCT00589212|1-3 METS|1-3 mets
602261|NCT00589225|PH type I|ph type i
602262|NCT00589225|Primary Hyperoxaluria|primary hyperoxaluria
602263|NCT00589225|Hyperoxaluria|hyperoxaluria
602264|NCT00589225|Primary Oxalosis|primary oxalosis
602265|NCT00589225|PH type II|ph type ii
602266|NCT00589225|PH type III|ph type iii
602267|NCT00589225|Genetic testing for PH|genetic testing for ph
602268|NCT00589225|Genetic testing for Primary Hyperoxaluria|genetic testing for primary hyperoxaluria
603040|NCT00594373|Microbicide|microbicide
602269|NCT00589225|Hereditary study for PH|hereditary study for ph
602270|NCT00589225|Hereditary study for Primary Hyperoxaluria|hereditary study for primary hyperoxaluria
602271|NCT00589238|stage II breast cancer|stage ii breast cancer
602272|NCT00589238|stage IIIA breast cancer|stage iiia breast cancer
602273|NCT00589238|stage IIIB breast cancer|stage iiib breast cancer
602274|NCT00589238|stage IIIC breast cancer|stage iiic breast cancer
602275|NCT00589251|penicillin allergy, penicillin skin test|penicillin allergy, penicillin skin test
602276|NCT00589264|zinc|zinc
602277|NCT00589264|iron|iron
602278|NCT00589264|child development|child development
602279|NCT00589264|visual attention|visual attention
602280|NCT00589264|Peru|peru
602281|NCT00589277|Smoking|smoking
602282|NCT00589277|Tobacco|tobacco
602283|NCT00589277|Message Framing|message framing
602284|NCT00589290|Histone deacetylase (HDAC) Inhibitors|histone deacetylase (hdac) inhibitors
602285|NCT00589290|Mediastinal Neoplasm|mediastinal neoplasm
602286|NCT00589290|Thymic Carcinoma|thymic carcinoma
602287|NCT00589290|Thymoma|thymoma
602288|NCT00589303|Atrial Fibrillation|atrial fibrillation
602289|NCT00589303|Heart Failure|heart failure
602290|NCT00589303|AV Node ablation|av node ablation
602291|NCT00589303|Cardiac pacemaker|cardiac pacemaker
602292|NCT00589303|Antiarrhythmic drug|antiarrhythmic drug
602293|NCT00589329|Preterm birth|preterm birth
602294|NCT00589329|antibiotics|antibiotics
602295|NCT00589329|preterm labor|preterm labor
602296|NCT00589329|respiratory distress|respiratory distress
602298|NCT00589355|c-reactive protein|c-reactive protein
602299|NCT00589355|endothelial dysfunction|endothelial dysfunction
602300|NCT00589355|glucose intolerance|glucose intolerance
602301|NCT00589368|Brain Infarction|brain infarction
602302|NCT00589368|pathology|pathology
602303|NCT00589368|physiopathology|physiopathology
602304|NCT00589368|psychology|psychology
602305|NCT00589368|rehabilitation|rehabilitation
602306|NCT00589368|Fingers|fingers
602307|NCT00589368|Grasp|grasp
602308|NCT00589368|Functional Laterality|functional laterality
602309|NCT00589368|Hand|hand
602310|NCT00589368|Strength|strength
602311|NCT00589368|Neuronal Plasticity|neuronal plasticity
602312|NCT00589368|Psychomotor Performance|psychomotor performance
602313|NCT00589368|Biomechanis|biomechanis
602314|NCT00589368|Touch|touch
602315|NCT00589368|Weight-Bearing|weight-bearing
602316|NCT00589381|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
602317|NCT00589381|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
602318|NCT00589381|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
602319|NCT00589381|anaplastic large cell lymphoma|anaplastic large cell lymphoma
602320|NCT00589381|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
602321|NCT00589381|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
602322|NCT00589381|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
602323|NCT00589381|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
602324|NCT00589381|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
602325|NCT00589381|Waldenström macroglobulinemia|waldenström macroglobulinemia
602326|NCT00589381|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
602327|NCT00589381|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
602328|NCT00589381|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
602329|NCT00589381|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
602330|NCT00589381|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
602331|NCT00589381|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
602332|NCT00589381|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
602333|NCT00589381|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
602334|NCT00589381|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
602335|NCT00589381|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
602336|NCT00589381|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
751777|NCT01170390|Oral contraception|oral contraception
751778|NCT01170390|Efficacy|efficacy
602337|NCT00589381|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
602338|NCT00589381|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
602339|NCT00589381|splenic marginal zone lymphoma|splenic marginal zone lymphoma
602340|NCT00589381|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
602341|NCT00589394|pneumococcal vaccine|pneumococcal vaccine
602342|NCT00589394|normal response|normal response
602343|NCT00589394|immunodeficiency|immunodeficiency
602344|NCT00589394|Healthy patients|healthy patients
602345|NCT00589394|Healthy Volunteers|healthy volunteers
602346|NCT00589420|adenocarcinoma of the prostate|adenocarcinoma of the prostate
602347|NCT00589420|recurrent prostate cancer|recurrent prostate cancer
602348|NCT00589420|stage IV prostate cancer|stage iv prostate cancer
602349|NCT00589446|Embryoscopy|embryoscopy
602350|NCT00589446|recurrent miscarriage|recurrent miscarriage
602351|NCT00589446|missed abortion|missed abortion
602352|NCT00589446|Structural anomalies in recurrent miscarriage|structural anomalies in recurrent miscarriage
602353|NCT00589446|Embryoscopically directed biopsy for karyotyping|embryoscopically directed biopsy for karyotyping
602354|NCT00589459|undiagnosed diabetes|undiagnosed diabetes
602355|NCT00589459|undiagnosed pre-diabetes|undiagnosed pre-diabetes
602356|NCT00589459|acute coronary syndrome|acute coronary syndrome
602357|NCT00589459|undiagnosed pre-diabetes and undiagnosed diabetes|undiagnosed pre-diabetes and undiagnosed diabetes
602358|NCT00576004|Pelvic organ prolapse, Urinary incontinence, Burch colposuspension, surgery|pelvic organ prolapse, urinary incontinence, burch colposuspension, surgery
602359|NCT00576017|Cancer pain treatment|cancer pain treatment
602360|NCT00576017|Fentanyl TTS|fentanyl tts
602361|NCT00576017|Dihydrocodeine|dihydrocodeine
602362|NCT00576017|Tramadol|tramadol
602363|NCT00576017|Cancer pain|cancer pain
602364|NCT00576017|Durogesic|durogesic
602365|NCT00576017|Ultram|ultram
602366|NCT00576043|training|training
602367|NCT00576043|Patient satisfaction|patient satisfaction
602368|NCT00576043|endoscopy|endoscopy
602369|NCT00576043|simulator|simulator
602370|NCT00576043|Safety|safety
602371|NCT00576056|Hepatocellular|hepatocellular
602372|NCT00576056|Carcinoma|carcinoma
602373|NCT00576056|TACE|tace
602374|NCT00576056|Sorafenib|sorafenib
602375|NCT00576056|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
602376|NCT00576056|Nexavar|nexavar
602377|NCT00576056|Unresectable|unresectable
602378|NCT00576069|asthma|asthma
602379|NCT00576069|lung function|lung function
602380|NCT00576069|inflammation|inflammation
602381|NCT00576082|Lyme borreliosis|lyme borreliosis
602382|NCT00576082|Erythema migrans|erythema migrans
602383|NCT00576082|Borrelial lymphocytoma|borrelial lymphocytoma
602384|NCT00576082|Acrodermatitis chronica atrophicans|acrodermatitis chronica atrophicans
602385|NCT00576082|Borrelia burgdorferi|borrelia burgdorferi
602386|NCT00576082|Borrelia afzelii|borrelia afzelii
602387|NCT00576082|Borrelia garinii|borrelia garinii
602388|NCT00576134|Larynx, tracheotomy, titanium beads|larynx, tracheotomy, titanium beads
602389|NCT00576147|TBI|tbi
602390|NCT00576147|NIRS|nirs
602391|NCT00576147|Hematoma|hematoma
602392|NCT00576160|medication adherence|medication adherence
602393|NCT00576173|Cancer pain|cancer pain
602394|NCT00576173|Breakthrough pain|breakthrough pain
602395|NCT00576173|acetaminophen|acetaminophen
602396|NCT00576173|tramadol hydrochloride|tramadol hydrochloride
602397|NCT00576173|Ultracet|ultracet
602398|NCT00576212|termination fetal anomaly|termination fetal anomaly
602399|NCT00576212|psychological sequelae pregnancy termination for anomalies|psychological sequelae pregnancy termination for anomalies
602521|NCT00582205|Women's Cancer|women's cancer
602400|NCT00576212|supportive follow-up pregnancy termination anomalies|supportive follow-up pregnancy termination anomalies
602401|NCT00576225|NSCLC|nsclc
602402|NCT00576225|women|women
602403|NCT00576225|CT-2103|ct-2103
602404|NCT00576225|paclitaxel|paclitaxel
602405|NCT00576225|carboplatin|carboplatin
602406|NCT00576238|Atopic eczema|atopic eczema
602407|NCT00576238|Topical corticosteroid|topical corticosteroid
602408|NCT00576251|Ocular inflammation|ocular inflammation
602409|NCT00576251|blepharaconjunctivitis|blepharaconjunctivitis
602410|NCT00576264|open abdominal surgery|open abdominal surgery
602411|NCT00576264|abdominal laparoscopic surgery|abdominal laparoscopic surgery
602412|NCT00576264|peritoneal stem cells|peritoneal stem cells
602811|NCT00589810|in-stent restenosis|in-stent restenosis
602413|NCT00576264|patients scheduled for any type of elective intra-abdominal surgery at Cedars-Sinai Medical Center with designated surgeons|patients scheduled for any type of elective intra-abdominal surgery at cedars-sinai medical center with designated surgeons
602414|NCT00576316|Asthma|asthma
602415|NCT00576329|vitreoretinal surgery, ketorolac, Acular, mydriasis|vitreoretinal surgery, ketorolac, acular, mydriasis
602416|NCT00576355|Adolescent|adolescent
602417|NCT00576355|Psychopathology|psychopathology
602418|NCT00576355|Interpersonal Therapy|interpersonal therapy
602419|NCT00576355|Interpersonal and Social Rhythm Therapy|interpersonal and social rhythm therapy
602420|NCT00576381|Precedex|precedex
602421|NCT00576381|Open Heart Surgery|open heart surgery
602422|NCT00576381|Dexmedetomidine|dexmedetomidine
602423|NCT00576381|Sedation|sedation
602424|NCT00576394|Glucose, Insulin|glucose, insulin
602425|NCT00576407|Thymus Transplantation|thymus transplantation
602426|NCT00576407|DiGeorge Syndrome|digeorge syndrome
602427|NCT00576407|Athymia|athymia
602428|NCT00576407|Low T cell numbers|low t cell numbers
602429|NCT00576407|Immunoreconstitution|immunoreconstitution
602430|NCT00576407|Primary immunodeficiency|primary immunodeficiency
602431|NCT00576407|DiGeorge Anomaly|digeorge anomaly
602432|NCT00576407|Complete DiGeorge|complete digeorge
602433|NCT00576407|Typical DiGeorge|typical digeorge
602434|NCT00581880|end stage|end stage
602435|NCT00581880|Terminally Ill|terminally ill
602436|NCT00581893|epilepsy|epilepsy
602437|NCT00581893|cognitive impairment|cognitive impairment
602438|NCT00581893|driving simulation|driving simulation
602439|NCT00581893|cross-over study|cross-over study
602440|NCT00581906|Head and Neck Cancer|head and neck cancer
602441|NCT00581906|Head Cancer|head cancer
602442|NCT00581906|Neck Cancer|neck cancer
602443|NCT00581906|Dynamic Contrast Enhanced MRI|dynamic contrast enhanced mri
602540|NCT00582270|non-follicular|non-follicular
602444|NCT00581906|Magnetic Resonance Spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
602445|NCT00581906|Diffusion Weighted MRI (DW-MRI)|diffusion weighted mri (dw-mri)
602446|NCT00581906|06-007|06-007
602447|NCT00581919|previously treated multiple myeloma|previously treated multiple myeloma
602448|NCT00581932|clozapine, schizophrenia|clozapine, schizophrenia
602449|NCT00581958|total body irradiation|total body irradiation
602450|NCT00581958|Cancer|cancer
602451|NCT00581958|Hematopoietic System|hematopoietic system
602452|NCT00581971|Radiosensitization|radiosensitization
602453|NCT00581971|COX-2 inhibitor|cox-2 inhibitor
602454|NCT00581971|Celecoxib|celecoxib
602455|NCT00581971|Head and Neck Cancer|head and neck cancer
602456|NCT00581971|Chemoradiation|chemoradiation
602457|NCT00581984|breast cancer|breast cancer
602458|NCT00581984|breast reconstruction|breast reconstruction
602459|NCT00581984|silicone implants|silicone implants
602460|NCT00581997|Pulmonary fibrosis, systemic sclerosis|pulmonary fibrosis, systemic sclerosis
602461|NCT00582010|ischemia-reperfusion|ischemia-reperfusion
602462|NCT00582010|nitric oxide|nitric oxide
602463|NCT00582010|inflammation|inflammation
602464|NCT00582010|cell-death|cell-death
602465|NCT00582010|Liver-function post transplantation|liver-function post transplantation
602466|NCT00582023|HIV|hiv
602467|NCT00582023|coping|coping
602468|NCT00582023|emotion|emotion
602469|NCT00582023|affect|affect
602470|NCT00582023|HIV infection|hiv infection
602471|NCT00582023|Complimentary therapies|complimentary therapies
602472|NCT00582036|Hyperglycemia|hyperglycemia
602473|NCT00582036|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
602474|NCT00582036|Bone marrow transplant|bone marrow transplant
602475|NCT00582036|High blood sugar|high blood sugar
602476|NCT00582049|Retinoblastoma|retinoblastoma
602477|NCT00582049|Sporadic heritable retinoblastoma|sporadic heritable retinoblastoma
602478|NCT00582049|Paternal exposures|paternal exposures
602479|NCT00582062|Gastric Cancer|gastric cancer
602480|NCT00582062|Pancreatic cancer|pancreatic cancer
602481|NCT00582075|Cancer|cancer
602482|NCT00582075|Brain metastases|brain metastases
602483|NCT00582075|Gamma Knife Radiosurgery|gamma knife radiosurgery
602484|NCT00582075|Temodar|temodar
602485|NCT00582075|Temozolomide|temozolomide
602486|NCT00582088|Encephalitis, Viral Infections, Neurologic diseases, Alphavirus Infections, VEE|encephalitis, viral infections, neurologic diseases, alphavirus infections, vee
602487|NCT00582101|HIV|hiv
602488|NCT00582101|prevention|prevention
602489|NCT00582101|families|families
602490|NCT00582101|Latinos|latinos
602491|NCT00582101|communication|communication
602492|NCT00582101|sexuality|sexuality
602493|NCT00582101|monitoring|monitoring
602494|NCT00582101|health promotion|health promotion
602495|NCT00582101|HIV Prevention|hiv prevention
602496|NCT00582101|HIV Seronegativity|hiv seronegativity
602497|NCT00582114|Hemodialysis|hemodialysis
602498|NCT00582114|Hypertension|hypertension
602499|NCT00582114|Left ventricular hypertrophy|left ventricular hypertrophy
602500|NCT00582127|senile|senile
602501|NCT00582127|dementia|dementia
602502|NCT00582140|Prostate|prostate
602503|NCT00582140|Cancer|cancer
602504|NCT00582140|Stage D0|stage d0
602505|NCT00582140|Non-Metastatic|non-metastatic
602506|NCT00582140|Rising PSA|rising psa
602812|NCT00589810|restenosis|restenosis
602507|NCT00582166|Zevalin, High Tumor Burden Indolent Non-Hodgkin's Lymphoma|zevalin, high tumor burden indolent non-hodgkin's lymphoma
602508|NCT00582179|Draining Hematoma|draining hematoma
602509|NCT00582179|Vacuum Assisted Closure (VAC)|vacuum assisted closure (vac)
602510|NCT00582179|Negative Pressure Wound Therapy (NPWT)|negative pressure wound therapy (npwt)
602511|NCT00582179|Draining Hematoma following orthopaedic surgery|draining hematoma following orthopaedic surgery
602512|NCT00582192|Phase I trial|phase i trial
602513|NCT00582192|Oncologists' Communication Styles|oncologists' communication styles
602514|NCT00582205|Ovarian Cancer|ovarian cancer
602515|NCT00582205|Fallopian Tube Cancer|fallopian tube cancer
602516|NCT00582205|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
602517|NCT00582205|Uterine Cancer|uterine cancer
602518|NCT00582205|Intraperitoneal Chemotherapy|intraperitoneal chemotherapy
602519|NCT00582205|IP Chemotherapy|ip chemotherapy
602520|NCT00582205|Gynecologic Cancer|gynecologic cancer
602522|NCT00582205|Cisplatin|cisplatin
602523|NCT00582205|Paclitaxel|paclitaxel
602524|NCT00582205|Recurrent Platinum Sensitive Ovarian Cancer|recurrent platinum sensitive ovarian cancer
602525|NCT00582218|HIV/AIDS|hiv/aids
602526|NCT00582218|Access to care|access to care
602527|NCT00582231|Penile injection therapy|penile injection therapy
602528|NCT00582231|Erectile dysfunction|erectile dysfunction
602529|NCT00582231|Radical pelvic surgery|radical pelvic surgery
602530|NCT00582231|Penile Injection Anxiety|penile injection anxiety
602531|NCT00582244|Menopausal symptoms|menopausal symptoms
602532|NCT00582244|Quality of Life|quality of life
602533|NCT00582244|Breast cancer|breast cancer
602534|NCT00582244|Multicenter trial|multicenter trial
602535|NCT00582257|Gastric Cancer|gastric cancer
602536|NCT00582257|Stomach Cancer|stomach cancer
602537|NCT00582257|05-118|05-118
602538|NCT00582270|non-hodkin's lymphoma|non-hodkin's lymphoma
602539|NCT00582270|follicular|follicular
603243|NCT00595205|vaccine|vaccine
602541|NCT00582270|infectious disease|infectious disease
602542|NCT00582296|Lynch syndrome|lynch syndrome
602543|NCT00582296|04-144|04-144
602544|NCT00582309|Glycemic Control|glycemic control
602545|NCT00582309|Intravenous Infusion|intravenous infusion
602546|NCT00582309|Standard Insulin infusion algorithm|standard insulin infusion algorithm
602547|NCT00582309|Infusion|infusion
602548|NCT00582309|Critically Ill|critically ill
602549|NCT00582322|Breast Cancer|breast cancer
602550|NCT00582322|Ovarian Cancer|ovarian cancer
602551|NCT00582322|Family History|family history
602552|NCT00582322|Genetic Studies|genetic studies
602553|NCT00582335|Colorectal cancer|colorectal cancer
602554|NCT00582335|Genetic testing|genetic testing
602555|NCT00582335|Genetic mutations|genetic mutations
602556|NCT00582348|Lung Cancer|lung cancer
602557|NCT00582348|Survivor|survivor
602558|NCT00582348|Lung|lung
602559|NCT00582361|Open Fractures|open fractures
602560|NCT00582361|Vacuum Assisted Closure (VAC) device|vacuum assisted closure (vac) device
602561|NCT00582361|Irrigation and Debridement|irrigation and debridement
602562|NCT00582374|Periodontal Disease|periodontal disease
602563|NCT00582374|Preterm Birth|preterm birth
602564|NCT00582374|Low Birth Weight|low birth weight
602565|NCT00582374|Pregnancy|pregnancy
602566|NCT00582400|livers, hepatocellular carcinoma (HCC)|livers, hepatocellular carcinoma (hcc)
602567|NCT00582413|Head and Neck Cancer|head and neck cancer
602568|NCT00582426|Colorectal cancer|colorectal cancer
602569|NCT00582426|diarrhea|diarrhea
602570|NCT00582426|drug therapy|drug therapy
602571|NCT00582426|octreotide|octreotide
602572|NCT00582426|fluorouracil|fluorouracil
602573|NCT00582426|irinotecan|irinotecan
602574|NCT00582426|capecitabine|capecitabine
602575|NCT00582426|prevention|prevention
602576|NCT00582439|Orthopaedic Trauma Fractures|orthopaedic trauma fractures
602577|NCT00582439|Orthopaedic Trauma Non-unions|orthopaedic trauma non-unions
602578|NCT00582439|Reamer-Irrigator-Aspirator (RIA)|reamer-irrigator-aspirator (ria)
602579|NCT00582439|Bone Graft|bone graft
602580|NCT00582452|HNPCC|hnpcc
602581|NCT00582452|prophylactic colectomy|prophylactic colectomy
602582|NCT00582478|Breast cancer|breast cancer
602583|NCT00582478|Quality of Life|quality of life
602584|NCT00589511|Bilateral severe to profound sensorineural hearing loss|bilateral severe to profound sensorineural hearing loss
602585|NCT00589524|blocked arteries|blocked arteries
602586|NCT00589524|narrowing arteries|narrowing arteries
602587|NCT00589524|IVUS|ivus
602588|NCT00589524|CT|ct
602589|NCT00589537|testicular seminoma|testicular seminoma
602590|NCT00589537|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
602591|NCT00589550|clear cell renal cell carcinoma|clear cell renal cell carcinoma
602592|NCT00589550|stage III renal cell cancer|stage iii renal cell cancer
602593|NCT00589550|stage IV renal cell cancer|stage iv renal cell cancer
602594|NCT00589563|graft versus host disease|graft versus host disease
602595|NCT00589563|infection|infection
602596|NCT00589563|adult favorable prognosis Hodgkin lymphoma|adult favorable prognosis hodgkin lymphoma
602597|NCT00589563|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
602598|NCT00589563|childhood favorable prognosis Hodgkin lymphoma|childhood favorable prognosis hodgkin lymphoma
602813|NCT00589810|BMS|bms
603309|NCT00595517|Japanese|japanese
602599|NCT00589563|childhood unfavorable prognosis Hodgkin lymphoma|childhood unfavorable prognosis hodgkin lymphoma
602600|NCT00589563|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
602601|NCT00589563|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
602602|NCT00589563|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
602603|NCT00589563|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
602604|NCT00589563|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
602605|NCT00589563|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
602606|NCT00589563|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
602607|NCT00589563|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
602608|NCT00589563|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
602609|NCT00589563|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
602610|NCT00589563|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
602611|NCT00589563|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
602612|NCT00589563|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
602613|NCT00589563|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
602614|NCT00589563|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
602615|NCT00589563|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
602616|NCT00589563|anaplastic large cell lymphoma|anaplastic large cell lymphoma
602617|NCT00589563|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
602618|NCT00589563|Burkitt lymphoma|burkitt lymphoma
602619|NCT00589563|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
602620|NCT00589563|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
602621|NCT00589563|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
602622|NCT00589563|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
752343|NCT01172574|Exercise therapy|exercise therapy
602623|NCT00589563|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
602624|NCT00589563|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
602625|NCT00589563|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
602626|NCT00589563|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
602627|NCT00589563|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
602628|NCT00589563|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
602629|NCT00589563|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
602630|NCT00589563|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
602631|NCT00589563|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
602632|NCT00589563|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
602633|NCT00589563|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
602634|NCT00589563|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
602635|NCT00589563|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
602636|NCT00589563|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
602637|NCT00589563|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
602638|NCT00589563|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
602639|NCT00589563|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
602640|NCT00589563|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
602641|NCT00589563|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
602642|NCT00589563|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
602643|NCT00589563|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
602644|NCT00589563|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
602645|NCT00589563|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
602646|NCT00589563|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
602647|NCT00589563|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
602648|NCT00589563|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
602649|NCT00589563|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
602650|NCT00589563|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
602651|NCT00589563|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
602652|NCT00589563|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
602653|NCT00589563|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
602654|NCT00589563|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
602655|NCT00589563|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
602656|NCT00589563|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
602657|NCT00589563|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
602658|NCT00589563|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
602659|NCT00589563|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
602660|NCT00589563|recurrent grade I lymphomatoid granulomatosis|recurrent grade i lymphomatoid granulomatosis
602661|NCT00589563|recurrent grade II lymphomatoid granulomatosis|recurrent grade ii lymphomatoid granulomatosis
602662|NCT00589563|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
602663|NCT00589563|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
602664|NCT00589563|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
602665|NCT00589563|small intestine lymphoma|small intestine lymphoma
602666|NCT00589563|splenic marginal zone lymphoma|splenic marginal zone lymphoma
602667|NCT00589563|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
602668|NCT00589563|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
602669|NCT00589563|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
602670|NCT00589563|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
602671|NCT00589563|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
602672|NCT00589563|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
602673|NCT00589563|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
602674|NCT00589563|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
602675|NCT00589563|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
602676|NCT00589563|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
602677|NCT00589563|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
602678|NCT00589563|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
602679|NCT00589563|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
602680|NCT00589563|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
602681|NCT00589563|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
602682|NCT00589563|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
602683|NCT00589563|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
602684|NCT00589563|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
602685|NCT00589563|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
602686|NCT00589563|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
602687|NCT00589563|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
602688|NCT00589563|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
602689|NCT00589563|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
602690|NCT00589563|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
602691|NCT00589563|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
602692|NCT00589563|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
602693|NCT00589563|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
602694|NCT00589563|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
602695|NCT00589563|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
602696|NCT00589563|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
602697|NCT00589563|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
602698|NCT00589563|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
602699|NCT00589563|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
602700|NCT00589563|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
602701|NCT00589563|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
602702|NCT00589563|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
602703|NCT00589563|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
602704|NCT00589563|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
602705|NCT00589563|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
602706|NCT00589563|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
602707|NCT00589563|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
602708|NCT00589563|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
602709|NCT00589563|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
602710|NCT00589563|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
602711|NCT00589563|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
602712|NCT00589563|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
602713|NCT00589563|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
602714|NCT00589563|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
602715|NCT00589563|secondary acute myeloid leukemia|secondary acute myeloid leukemia
602716|NCT00589563|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
602717|NCT00589563|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
602718|NCT00589563|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
602719|NCT00589563|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
603207|NCT00595049|tracleer|tracleer
602720|NCT00589563|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
602721|NCT00589563|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
602722|NCT00589563|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
602723|NCT00589563|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
602724|NCT00589563|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
751779|NCT01170403|coronary heart disease|coronary heart disease
602725|NCT00589563|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
602726|NCT00589563|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
602727|NCT00589563|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
602728|NCT00589563|stage I multiple myeloma|stage i multiple myeloma
602729|NCT00589563|stage II multiple myeloma|stage ii multiple myeloma
602730|NCT00589563|stage III multiple myeloma|stage iii multiple myeloma
602731|NCT00589563|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
602732|NCT00589563|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
602733|NCT00589563|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
602734|NCT00589563|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
602735|NCT00589563|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
602736|NCT00589563|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
602737|NCT00589563|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
602738|NCT00589563|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
602739|NCT00589563|primary myelofibrosis|primary myelofibrosis
602740|NCT00589563|secondary myelofibrosis|secondary myelofibrosis
602741|NCT00589589|burns|burns
602742|NCT00589589|hypoglycemia|hypoglycemia
602743|NCT00589589|hyperglycemia|hyperglycemia
602744|NCT00589589|glucose monitoring|glucose monitoring
602745|NCT00589602|Adult leukemia|adult leukemia
602746|NCT00589602|lymphoma|lymphoma
602747|NCT00589602|myelodysplastic syndromes|myelodysplastic syndromes
603345|NCT00595673|Chest pain|chest pain
602748|NCT00589602|plasma cell disorders|plasma cell disorders
602749|NCT00589615|vitamin D|vitamin d
602750|NCT00589615|bone density|bone density
602751|NCT00589628|Childhood|childhood
602752|NCT00589628|Uveitis|uveitis
602753|NCT00589641|adolescents|adolescents
602754|NCT00589641|suicidal ideation and behavior|suicidal ideation and behavior
602755|NCT00589641|depression|depression
602756|NCT00589641|substance abuse|substance abuse
602757|NCT00589654|amenorrhea|amenorrhea
602758|NCT00589654|menstrual cycle|menstrual cycle
602759|NCT00589654|Breast cancer|breast cancer
602760|NCT00589654|questionnaire|questionnaire
602761|NCT00589654|97-127|97-127
602762|NCT00589667|Head and Neck Cancer|head and neck cancer
602763|NCT00589667|GEMCITABINE|gemcitabine
602764|NCT00589667|PEMETREXED|pemetrexed
602765|NCT00589667|ALTIMA|altima
602766|NCT00589667|epidermoid/squamous cell|epidermoid/squamous cell
602767|NCT00589667|carcinoma|carcinoma
602768|NCT00589667|pharynx|pharynx
602769|NCT00589667|larynx|larynx
602770|NCT00589667|paranasal sinus|paranasal sinus
602871|NCT00593502|influenza|influenza
602771|NCT00589667|head/neck squamous cell carcinoma|head/neck squamous cell carcinoma
602772|NCT00589680|Acidosis, Diabetic|acidosis, diabetic
602773|NCT00589680|Diabetic Acidosis|diabetic acidosis
602774|NCT00589680|Diabetic Ketosis|diabetic ketosis
602775|NCT00589680|Ketoacidosis, Diabetic|ketoacidosis, diabetic
602776|NCT00589680|Ketosis, Diabetic|ketosis, diabetic
602777|NCT00589693|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
602778|NCT00589693|Pneumonia, hospital-acquired|pneumonia, hospital-acquired
602779|NCT00589693|Doripenem|doripenem
602780|NCT00589693|Imipenem-cilastatin|imipenem-cilastatin
602781|NCT00589706|high grade gliomas of the brain|high grade gliomas of the brain
602782|NCT00589706|anti-body treatment|anti-body treatment
602783|NCT00589706|survival|survival
602784|NCT00589719|Asthma; minority; low-income; African American; Arkansas|asthma; minority; low-income; african american; arkansas
602785|NCT00589732|stents|stents
602786|NCT00589732|angiotensin-converting enzyme|angiotensin-converting enzyme
602787|NCT00589745|Diagnosis|diagnosis
602788|NCT00589758|Right Ventricle|right ventricle
602789|NCT00589758|Echocardiogram|echocardiogram
602790|NCT00589758|Evaluation of Heart Failure|evaluation of heart failure
602791|NCT00589771|IBS|ibs
602792|NCT00589771|Saccharomyces boulardii|saccharomyces boulardii
602793|NCT00589771|probiotics|probiotics
602794|NCT00589771|cytokine|cytokine
602795|NCT00589771|histology|histology
602796|NCT00589771|Efficacy|efficacy
602797|NCT00589784|Sunitinib|sunitinib
602798|NCT00589784|Brain Cancer|brain cancer
602799|NCT00589784|CNS Cancer|cns cancer
602800|NCT00589784|meningioma|meningioma
602801|NCT00589784|intracranial hemangiopericytoma|intracranial hemangiopericytoma
602802|NCT00589784|hemangioblastoma|hemangioblastoma
602803|NCT00589784|malignant meningioma|malignant meningioma
602804|NCT00589784|neurofibromatosis|neurofibromatosis
602805|NCT00589784|neurofibromatosis type 1|neurofibromatosis type 1
602806|NCT00589784|neurofibromatosis type 2|neurofibromatosis type 2
602807|NCT00589784|07-135|07-135
602808|NCT00589797|Degenerative|degenerative
602809|NCT00589797|Disc|disc
602810|NCT00589810|ISR|isr
602814|NCT00589810|bare metal stent|bare metal stent
602815|NCT00589810|revascularization|revascularization
602816|NCT00589810|genetic|genetic
602817|NCT00589810|cardiac catheterization|cardiac catheterization
602818|NCT00593242|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
602819|NCT00593242|autologous cord blood cells|autologous cord blood cells
602820|NCT00593242|newborn infants|newborn infants
602821|NCT00593281|Hyaluronidase|hyaluronidase
602822|NCT00593281|Hylenex|hylenex
602823|NCT00593281|subcutaneous|subcutaneous
602824|NCT00593281|morphine|morphine
602825|NCT00593281|absorption|absorption
602826|NCT00593281|bioavailability|bioavailability
602827|NCT00593281|PK study of morphine in patients with pain|pk study of morphine in patients with pain
602828|NCT00593294|PCOS|pcos
602829|NCT00593294|oral contraceptives|oral contraceptives
602830|NCT00593294|physical exercise|physical exercise
602831|NCT00593294|CVR|cvr
602832|NCT00593307|glycemic response|glycemic response
602833|NCT00593307|hunger|hunger
602834|NCT00593320|SRS|srs
602835|NCT00593333|Femur Fracture|femur fracture
602836|NCT00593333|Intramedullary Nailing|intramedullary nailing
602837|NCT00593333|Trochanteric Nailing|trochanteric nailing
602838|NCT00593333|Piriformis Starting Portal|piriformis starting portal
602839|NCT00593333|Trochanteric Insertion Portal|trochanteric insertion portal
602840|NCT00593359|Spinal surgery|spinal surgery
602841|NCT00593359|Prone spinal surgery|prone spinal surgery
602842|NCT00593372|Alzheimer's Disease|alzheimer's disease
602843|NCT00593372|Memory|memory
602844|NCT00593372|Treatment|treatment
602845|NCT00593385|Symptomatic claudication or rest pain and angiographic confirmation of either de novo or restenotic lesions in the common and/or external iliac artery.|symptomatic claudication or rest pain and angiographic confirmation of either de novo or restenotic lesions in the common and/or external iliac artery.
602846|NCT00593398|Malaria|malaria
602847|NCT00593398|pregnant women|pregnant women
602848|NCT00593398|infants|infants
602849|NCT00593398|Cameroon|cameroon
602850|NCT00593411|MD Analyze|md analyze
602851|NCT00593411|Central Nervous System|central nervous system
602852|NCT00593411|Spine Disease|spine disease
602853|NCT00593411|Peripheral Nerve|peripheral nerve
602854|NCT00593437|bone density diagnostic equipment discrepancies|bone density diagnostic equipment discrepancies
602855|NCT00593450|bevacizumab|bevacizumab
602856|NCT00593450|ranibizumab|ranibizumab
602857|NCT00593450|choroidal neovascularization|choroidal neovascularization
602858|NCT00593463|opioid dependence|opioid dependence
602859|NCT00593463|methadone|methadone
602860|NCT00593463|opioid|opioid
602861|NCT00593476|Type 2 Diabetes|type 2 diabetes
602862|NCT00593476|Glycemic Control|glycemic control
602863|NCT00593476|Diabetes Support and Education|diabetes support and education
602864|NCT00593476|Portion Control|portion control
602865|NCT00593476|Prepackaged meals|prepackaged meals
602866|NCT00593489|Insulin|insulin
602867|NCT00593489|Diabetes Mellitus|diabetes mellitus
602868|NCT00593489|Practice Behaviour|practice behaviour
602869|NCT00593489|Preceptor|preceptor
602870|NCT00593489|Pharmacy|pharmacy
602872|NCT00593502|children|children
602873|NCT00593502|acute otitis media|acute otitis media
602874|NCT00593502|oseltamivir|oseltamivir
602875|NCT00593528|Cirrhosis, STIC TIPS, Portal Hypertension, Transjugular Intrahepatic Portosystemic Shunt , Stents, PTFE|cirrhosis, stic tips, portal hypertension, transjugular intrahepatic portosystemic shunt , stents, ptfe
602876|NCT00593528|cirrhotic HTP|cirrhotic htp
602878|NCT00593567|Diabetic Foot Ulcer|diabetic foot ulcer
602879|NCT00593580|Ovarian cancer|ovarian cancer
602880|NCT00593580|bone mineral density|bone mineral density
602881|NCT00593580|bisphosphonates|bisphosphonates
602882|NCT00593580|chemotherapy|chemotherapy
602883|NCT00593593|benign prostate hyperplasia|benign prostate hyperplasia
602884|NCT00593593|Dutasteride|dutasteride
602885|NCT00593593|pharmacovigilance|pharmacovigilance
602886|NCT00593606|Rotigotine|rotigotine
602887|NCT00593606|NEUPRO|neupro
602888|NCT00593606|Switching trial from ropinirole to rotigotine,|switching trial from ropinirole to rotigotine,
602889|NCT00593606|safety and tolerability|safety and tolerability
602890|NCT00593606|Parkinson disease|parkinson disease
602891|NCT00593619|Intravenous Iron|intravenous iron
602892|NCT00593619|Safety|safety
602893|NCT00593619|Perioperative|perioperative
602894|NCT00593619|Iron deficiency|iron deficiency
602895|NCT00593619|Non hemodialysis population|non hemodialysis population
602896|NCT00593619|Perioperative blood conservation|perioperative blood conservation
602897|NCT00593632|low HDL|low hdl
602898|NCT00593645|Conditioning regimens|conditioning regimens
602899|NCT00593645|Stem Cell Transplantation|stem cell transplantation
602900|NCT00593645|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
602901|NCT00593645|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
602902|NCT00593645|Nonmyeloablative conditioning|nonmyeloablative conditioning
602903|NCT00593645|Clofarabine|clofarabine
602904|NCT00593645|Cytarabine|cytarabine
602905|NCT00593645|Anti-thymocyte globulin|anti-thymocyte globulin
602906|NCT00593658|hypoxemia|hypoxemia
602907|NCT00593658|liver transplantation evaluation|liver transplantation evaluation
602908|NCT00593658|cirrhosis|cirrhosis
602909|NCT00593671|aneuploidies in 7 chromosomes increased with advanced maternal age|aneuploidies in 7 chromosomes increased with advanced maternal age
602910|NCT00593684|neonate|neonate
602911|NCT00593684|central lines|central lines
602912|NCT00593684|very low birth weight|very low birth weight
602913|NCT00593684|silver alginate|silver alginate
602914|NCT00593697|breast cancer|breast cancer
602915|NCT00593697|adjuvant therapy|adjuvant therapy
602916|NCT00593697|trastuzumab|trastuzumab
602917|NCT00593697|chemotherapy|chemotherapy
602918|NCT00593710|Randomized|randomized
602919|NCT00593710|double-blind superiority trial|double-blind superiority trial
602920|NCT00593723|IMRT|imrt
602921|NCT00593736|Delayed sleep phase syndrome; drug therapy|delayed sleep phase syndrome; drug therapy
602922|NCT00593749|obesity prevention|obesity prevention
602923|NCT00593749|corner stores|corner stores
602924|NCT00593749|schools|schools
602925|NCT00593762|Peripheral arterial occlusive disease|peripheral arterial occlusive disease
602926|NCT00593762|Aspirin|aspirin
602927|NCT00593762|Clopidogrel|clopidogrel
602928|NCT00593762|Resistance|resistance
602929|NCT00593762|Catheter interventional procedure|catheter interventional procedure
602930|NCT00593762|ASA and clopidogrel resistance|asa and clopidogrel resistance
602931|NCT00593775|implantation rate|implantation rate
602932|NCT00593788|GIN test|gin test
602933|NCT00593788|gap detection|gap detection
602934|NCT00593788|temporal resolution|temporal resolution
602935|NCT00593788|auditory perception|auditory perception
602936|NCT00593788|psychoacoustics|psychoacoustics
602937|NCT00593801|extremely low birth weight infants|extremely low birth weight infants
602938|NCT00593801|transfusion need|transfusion need
602939|NCT00593801|erythropoietin|erythropoietin
602940|NCT00593801|trace elements|trace elements
602941|NCT00593801|antioxidant enzymes|antioxidant enzymes
603039|NCT00594360|Physical Activity|physical activity
602942|NCT00593801|reduction of the transfusion need by EPO treatment|reduction of the transfusion need by epo treatment
602943|NCT00593801|trace elements and antioxidant enzymes in blood|trace elements and antioxidant enzymes in blood
602944|NCT00593853|LHRH-agonist related fatigue|lhrh-agonist related fatigue
602945|NCT00593866|Patients who have confirmed cancer arising from the pancreas|patients who have confirmed cancer arising from the pancreas
602946|NCT00593879|MDD|mdd
602947|NCT00593879|Depression|depression
602948|NCT00593879|Mecamylamine|mecamylamine
602949|NCT00593879|Add-on Therapy|add-on therapy
602950|NCT00593879|Major Depressive Disorder|major depressive disorder
602951|NCT00593892|Cytokine Levels|cytokine levels
602952|NCT00593892|Traumatic Injury|traumatic injury
602953|NCT00593892|Multisystem Organ Failure|multisystem organ failure
602954|NCT00593905|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
602955|NCT00593905|Pulmonary Hypertension|pulmonary hypertension
602956|NCT00593905|Pharmacogenomics|pharmacogenomics
602957|NCT00593905|DNA Testing|dna testing
602958|NCT00593905|sitaxsentan|sitaxsentan
602959|NCT00593905|bosentan|bosentan
602960|NCT00593905|ambrisentan|ambrisentan
602961|NCT00593905|elevated pulmonary artery pressures|elevated pulmonary artery pressures
602962|NCT00593905|Letairis|letairis
602963|NCT00593905|Tracleer|tracleer
602965|NCT00593905|Primary Pulmonary Hypertension|primary pulmonary hypertension
602966|NCT00593905|Pulmonary Artery|pulmonary artery
602967|NCT00593918|RSV, asthma, innate immunity, gene, cytokines|rsv, asthma, innate immunity, gene, cytokines
602968|NCT00593931|Brain functional MRI|brain functional mri
602969|NCT00593944|CLL|cll
602970|NCT00593944|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
602971|NCT00593944|B cell|b cell
602972|NCT00593944|leukemia|leukemia
602973|NCT00593944|lymphocyte|lymphocyte
602974|NCT00593944|antibody|antibody
602975|NCT00593944|monoclonal|monoclonal
602976|NCT00593944|cancer|cancer
602977|NCT00593944|blood|blood
602978|NCT00593957|Rett Syndrome|rett syndrome
602979|NCT00593957|Dextromethorphan|dextromethorphan
602980|NCT00593970|influenza|influenza
602981|NCT00593970|vaccine|vaccine
602982|NCT00593970|pregnancy|pregnancy
602983|NCT00594022|Electric Stimulation|electric stimulation
602984|NCT00594022|Latency to Persistent Sleep (LPS)|latency to persistent sleep (lps)
602985|NCT00594022|Transient Insomnia|transient insomnia
602986|NCT00594022|Insomnia|insomnia
602987|NCT00594035|Spinal procedure|spinal procedure
602988|NCT00594035|Dura incision|dura incision
602989|NCT00594048|high blood pressure|high blood pressure
602990|NCT00594100|carotid artery stenosis|carotid artery stenosis
602991|NCT00594100|embolic protection device|embolic protection device
602992|NCT00594100|GORE Neuro Protection System|gore neuro protection system
602993|NCT00594100|GORE Flow Reversal System|gore flow reversal system
602994|NCT00594100|reverse flow|reverse flow
602995|NCT00594100|proximal occlusion device|proximal occlusion device
602996|NCT00594100|GNPS|gnps
602997|NCT00594100|Parodi|parodi
602998|NCT00594100|EMPiRE|empire
602999|NCT00594100|distal embolization|distal embolization
603000|NCT00594100|minimizing risks of CAS|minimizing risks of cas
603001|NCT00594100|PAES|paes
603002|NCT00594126|Myeloma|myeloma
603003|NCT00594126|Multiple Myeloma|multiple myeloma
603004|NCT00594126|Relapsed Multiple Myeloma|relapsed multiple myeloma
603005|NCT00594126|Refractory Multiple Myeloma|refractory multiple myeloma
603006|NCT00594126|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
603007|NCT00594139|non-neurogenic over active bladder|non-neurogenic over active bladder
603008|NCT00594139|urge predominant incontinence|urge predominant incontinence
752176|NCT01172028|stage III esophageal cancer|stage iii esophageal cancer
603009|NCT00594152|Diabetic autonomic neuropathy|diabetic autonomic neuropathy
603010|NCT00594165|Rotigotine|rotigotine
603011|NCT00594178|spinal cord injury|spinal cord injury
603013|NCT00594191|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
603014|NCT00594191|Cirrhosis|cirrhosis
603015|NCT00594191|Portal hypertension|portal hypertension
603016|NCT00594191|Variceal bleeding|variceal bleeding
603017|NCT00594217|PCOS|pcos
603018|NCT00594230|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
603019|NCT00594230|Refractory|refractory
603020|NCT00594230|LBH589|lbh589
603021|NCT00594256|Schizophrenia|schizophrenia
603022|NCT00594256|Sleep Architecture|sleep architecture
603023|NCT00594256|Sodium Oxybate|sodium oxybate
603024|NCT00594256|Insomnia|insomnia
603025|NCT00594256|Cognition|cognition
603026|NCT00594269|Antidepressants|antidepressants
603027|NCT00594269|Antipsychotics|antipsychotics
603028|NCT00594269|Dementia|dementia
603029|NCT00594269|Discontinuation study|discontinuation study
603030|NCT00594269|Behavioural- and Psychological Symptoms in Dementia|behavioural- and psychological symptoms in dementia
603031|NCT00594321|spinal fractures|spinal fractures
603032|NCT00594334|osteopenia|osteopenia
603033|NCT00594334|periodontitis|periodontitis
603034|NCT00594347|Streptococcus pneumoniae|streptococcus pneumoniae
603035|NCT00594360|Exercise Prescription|exercise prescription
603036|NCT00594360|Self-efficacy|self-efficacy
603037|NCT00594360|Decisional Balance|decisional balance
603038|NCT00594360|Readiness to Change|readiness to change
603041|NCT00594373|HIV Seronegativity|hiv seronegativity
603042|NCT00594386|Rotigotine|rotigotine
603043|NCT00594386|Neupro|neupro
603044|NCT00594399|Aging|aging
603045|NCT00594399|Exercise|exercise
603046|NCT00594399|Impaired Glucose Tolerance|impaired glucose tolerance
603047|NCT00594399|Obesity|obesity
603048|NCT00594399|Functional Status|functional status
603049|NCT00594399|Disability|disability
603050|NCT00594399|Health Services Research|health services research
603051|NCT00594399|Randomized Controlled Trial|randomized controlled trial
603052|NCT00594399|Diabetes|diabetes
603053|NCT00594399|Adaptive Randomization Design|adaptive randomization design
603054|NCT00594412|1H-Magnetic Resonance Spectroscopy|1h-magnetic resonance spectroscopy
603055|NCT00594412|Hepatic Steatosis|hepatic steatosis
603056|NCT00594412|Liver Fat|liver fat
603057|NCT00594412|Liver Biopsy|liver biopsy
603058|NCT00594412|Liver|liver
603059|NCT00594412|Hepatitis|hepatitis
603060|NCT00594412|Fatty Liver|fatty liver
603061|NCT00594438|Synthes Reamer-Irrigator-Aspirator (RIA)|synthes reamer-irrigator-aspirator (ria)
603062|NCT00594438|Zimmer Sentinal Reamer|zimmer sentinal reamer
603063|NCT00594438|Transesophageal Echocardiogram (TEE)|transesophageal echocardiogram (tee)
603266|NCT00595335|Proptosis|proptosis
603064|NCT00594451|rheumatoid arthritis|rheumatoid arthritis
603065|NCT00594451|cigarette smoking|cigarette smoking
603066|NCT00594451|gene-environmental interactions|gene-environmental interactions
603067|NCT00594451|autoimmunity|autoimmunity
603068|NCT00594451|disease severity|disease severity
603069|NCT00594464|Rotigotine|rotigotine
603070|NCT00594464|NEUPRO®|neupro®
603071|NCT00594464|Parkinson's Disease (PD)|parkinson's disease (pd)
603072|NCT00594464|perioperative use|perioperative use
603073|NCT00594464|anaesthesia,|anaesthesia,
603074|NCT00594477|IMRT|imrt
603075|NCT00594477|breast cancer with regional nodal metastasis|breast cancer with regional nodal metastasis
603076|NCT00594490|Breast, reconstruction, silicone|breast, reconstruction, silicone
603077|NCT00594503|traumatic brain injury|traumatic brain injury
603078|NCT00594516|Low Back Pain|low back pain
603079|NCT00594516|Dose Equivalence|dose equivalence
603080|NCT00594516|Tapentadol (CG5503)|tapentadol (cg5503)
603081|NCT00594516|Tapentadol-IR|tapentadol-ir
603082|NCT00594516|Tapentadol-ER|tapentadol-er
603083|NCT00594529|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
603084|NCT00594529|Metastatic liver lesions from colorectal cancers|metastatic liver lesions from colorectal cancers
603085|NCT00594542|lidocaine|lidocaine
603086|NCT00594542|local anesthesia|local anesthesia
603087|NCT00594542|Mohs micrographic surgery|mohs micrographic surgery
603088|NCT00594555|Blood disease, bone marrow|blood disease, bone marrow
603089|NCT00594555|AML|aml
603090|NCT00594555|CML,Blast Crisis|cml,blast crisis
603091|NCT00594581|cicatrix, scarring, TGF-beta3, avotermin, Juvista|cicatrix, scarring, tgf-beta3, avotermin, juvista
603092|NCT00594594|spinal cord injury|spinal cord injury
603093|NCT00594594|urinary tract infection|urinary tract infection
603094|NCT00594594|probiotics|probiotics
603095|NCT00594594|Lactobacilli|lactobacilli
603096|NCT00594607|clotting|clotting
603097|NCT00594607|hemodialysis|hemodialysis
603098|NCT00594607|anticoagulation|anticoagulation
603099|NCT00594607|bleeding risk|bleeding risk
603100|NCT00594633|Cognitive dysfunction|cognitive dysfunction
603101|NCT00594646|HIV Prevention|hiv prevention
603102|NCT00594646|Non-occupational post-exposure prophylaxis|non-occupational post-exposure prophylaxis
603103|NCT00594646|HIV seronegativity|hiv seronegativity
603104|NCT00594659|Marijuana|marijuana
603105|NCT00594659|Treatment|treatment
603106|NCT00594659|Behavioral|behavioral
605378|NCT00602758|HIV|hiv
603107|NCT00594659|Computer|computer
603108|NCT00594659|Internet|internet
603109|NCT00594672|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
603110|NCT00594672|Cataracts|cataracts
603111|NCT00594672|Age Related Macular Degeneration|age related macular degeneration
603112|NCT00594672|AMD|amd
603113|NCT00594672|Cataract|cataract
603114|NCT00594685|Heparin|heparin
603115|NCT00594685|Thromboembolism|thromboembolism
603116|NCT00594685|Thrombosis|thrombosis
603117|NCT00594698|Perfusion|perfusion
603118|NCT00594698|Echocardiography|echocardiography
603119|NCT00594698|Cardiac angiography|cardiac angiography
603120|NCT00594698|SPECT|spect
603121|NCT00594711|Psychotherapy|psychotherapy
603122|NCT00594711|depression|depression
603123|NCT00594724|Tongue|tongue
603124|NCT00594724|Carcinoma|carcinoma
603125|NCT00594724|Cancer|cancer
603126|NCT00594724|02-093|02-093
603127|NCT00594737|PET|pet
603128|NCT00594737|frontotemporal dementia|frontotemporal dementia
603129|NCT00594737|memantine|memantine
603130|NCT00594737|Pick's disease|pick's disease
604358|NCT00590837|AML|aml
603131|NCT00594763|Turner syndrome|turner syndrome
603132|NCT00594763|Thromboembolic disease|thromboembolic disease
603133|NCT00594776|Cone Beam CT|cone beam ct
603134|NCT00594776|CBCT|cbct
603135|NCT00594776|Bone Tumors|bone tumors
603136|NCT00594776|Autographs|autographs
603137|NCT00594776|Allographs|allographs
603138|NCT00594789|Osteoporosis|osteoporosis
603139|NCT00594789|Fractures|fractures
603140|NCT00594789|Bone densitometry|bone densitometry
603141|NCT00594789|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
603142|NCT00594802|ALLERGIC REACTION|allergic reaction
603143|NCT00594815|Lymphoma|lymphoma
603144|NCT00594815|Central Nervous System|central nervous system
603145|NCT00594828|Patient self-testing|patient self-testing
603146|NCT00594828|Oral anticoagulation therapy|oral anticoagulation therapy
603147|NCT00594828|Expert Systems|expert systems
603148|NCT00594828|Point-of-Care Systems|point-of-care systems
603149|NCT00594828|International Normalized Ratio|international normalized ratio
603150|NCT00594841|Acromioclavicular Joint|acromioclavicular joint
603151|NCT00594841|Shoulder dislocation|shoulder dislocation
603152|NCT00594841|AC dislocation|ac dislocation
603153|NCT00594854|NSAID|nsaid
603154|NCT00594854|Gastric Ulcer|gastric ulcer
603155|NCT00594854|High risk|high risk
603156|NCT00594854|Arthrotec|arthrotec
603157|NCT00594854|Vimovo|vimovo
603158|NCT00594867|Healthy|healthy
603159|NCT00594867|Volunteer|volunteer
603160|NCT00594880|HIV|hiv
603161|NCT00594880|HIV-1|hiv-1
603162|NCT00594880|Pegasys|pegasys
603163|NCT00594880|Peg-IFN-Alpha-2A|peg-ifn-alpha-2a
603164|NCT00594880|Viral Suppression|viral suppression
603165|NCT00594880|ART cessation|art cessation
603166|NCT00594880|Immune function|immune function
603167|NCT00594880|Innate Immunity|innate immunity
603168|NCT00594880|Toxicity|toxicity
603169|NCT00594880|Immune-based therapy|immune-based therapy
603170|NCT00594880|Treatment interruption|treatment interruption
603171|NCT00594893|Hip|hip
603172|NCT00594893|Arthroplasty|arthroplasty
603173|NCT00594893|Minimally Invasive|minimally invasive
603174|NCT00594906|Fracture Healing|fracture healing
603175|NCT00594906|Teriparatide|teriparatide
603176|NCT00594906|Forteo|forteo
603177|NCT00594906|Pelvic Fractures|pelvic fractures
603178|NCT00594919|acute kidney injury|acute kidney injury
603179|NCT00594919|ngal|ngal
603180|NCT00594919|cardiac surgery|cardiac surgery
603181|NCT00594932|lupus, arthritis, mycophenolate, biomarkers|lupus, arthritis, mycophenolate, biomarkers
603182|NCT00594971|Health Services Research|health services research
603183|NCT00594971|Family practice|family practice
603184|NCT00594997|Lyme disease|lyme disease
603185|NCT00594997|educational intervention for children|educational intervention for children
603186|NCT00594997|tick borne illness|tick borne illness
603187|NCT00594997|prophylactic therapy in children|prophylactic therapy in children
603188|NCT00594997|Self-efficacy|self-efficacy
603189|NCT00594997|tick prevention|tick prevention
603190|NCT00594997|tick avoidance|tick avoidance
603191|NCT00594997|health behavior modification|health behavior modification
603192|NCT00595010|Child Maltreatment|child maltreatment
603193|NCT00595010|Child Neglect|child neglect
603194|NCT00595010|Child Physical Abuse|child physical abuse
603195|NCT00595010|Evidence-Based Practice|evidence-based practice
603196|NCT00595023|Sentinel lymph node|sentinel lymph node
603197|NCT00595023|Metastasis|metastasis
603198|NCT00595049|pulmonary|pulmonary
603199|NCT00595049|arterial|arterial
603200|NCT00595049|artery|artery
603201|NCT00595049|hypertension|hypertension
603202|NCT00595049|systemic|systemic
603203|NCT00595049|sclerosis|sclerosis
603204|NCT00595049|scleroderma|scleroderma
603205|NCT00595049|remodelling|remodelling
603206|NCT00595049|bosentan|bosentan
603208|NCT00595049|intravascular|intravascular
603209|NCT00595062|Breast|breast
603210|NCT00595062|Cancer|cancer
603211|NCT00595075|sleep|sleep
603212|NCT00595075|performance|performance
603213|NCT00595075|night shift|night shift
603214|NCT00595075|Ramelteon|ramelteon
603215|NCT00595075|Healthy Individuals|healthy individuals
603216|NCT00595088|Bladder Cancer|bladder cancer
603217|NCT00595088|Refractory|refractory
603219|NCT00595114|Airway|airway
603220|NCT00595114|Inflammation|inflammation
603221|NCT00595114|Infection|infection
603222|NCT00595114|Lipid Mediators|lipid mediators
603223|NCT00595114|Oxidative Stress|oxidative stress
603224|NCT00595127|Fanconi|fanconi
603225|NCT00595127|Anemia|anemia
603226|NCT00595127|Stem Cell|stem cell
603227|NCT00595127|Transplant|transplant
603228|NCT00595140|Acromegaly,|acromegaly,
603229|NCT00595140|growth hormone receptor antagonist,|growth hormone receptor antagonist,
603230|NCT00595140|somatostatin analogue,|somatostatin analogue,
603231|NCT00595140|combined medical treatment,|combined medical treatment,
603232|NCT00595140|acute effect,|acute effect,
603233|NCT00595140|endogenous GH|endogenous gh
603234|NCT00595166|Women with excessive vaginal tissue that obstruct the examiner's view of the cervix during a vaginal speculum examination|women with excessive vaginal tissue that obstruct the examiner's view of the cervix during a vaginal speculum examination
603235|NCT00595179|Infrared|infrared
603236|NCT00595179|Imaging Techniques|imaging techniques
603237|NCT00595179|Kidney Reperfusion|kidney reperfusion
603238|NCT00595179|Pneumoperitoneum|pneumoperitoneum
603239|NCT00595179|Nephrectomy|nephrectomy
603240|NCT00595205|vaccination|vaccination
603241|NCT00595205|intussusception|intussusception
603242|NCT00595205|Rotavirus|rotavirus
603244|NCT00595218|Patient Preferences|patient preferences
603245|NCT00595218|Patient Satisfaction|patient satisfaction
603246|NCT00595218|Patient-Doctor Relationship|patient-doctor relationship
603247|NCT00595231|GAD|gad
603248|NCT00595244|Perfusion|perfusion
603249|NCT00595244|Echocardiograpy|echocardiograpy
603250|NCT00595244|SPECT|spect
603251|NCT00595244|angiography|angiography
603252|NCT00595244|Chest pain|chest pain
603253|NCT00595257|PAD, CLI, Critical Limb Ischemia, bone marrow, stem cell, injection, infusion|pad, cli, critical limb ischemia, bone marrow, stem cell, injection, infusion
603254|NCT00595283|Preschool Onset Major Depressive Disorder|preschool onset major depressive disorder
603255|NCT00595283|Preschool Depression|preschool depression
603256|NCT00595283|Emotion Development|emotion development
603257|NCT00595283|Parent Child Interaction|parent child interaction
603258|NCT00595296|BreastCancer|breastcancer
603259|NCT00595296|Sentinel Lymph Nodes|sentinel lymph nodes
603260|NCT00595296|Metastasis|metastasis
603261|NCT00595322|Bevacizumab|bevacizumab
603262|NCT00595322|Radiation Treatment|radiation treatment
603263|NCT00595322|Brain Cancer|brain cancer
603264|NCT00595335|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
603265|NCT00595335|Rituximab|rituximab
603267|NCT00595361|asthma|asthma
603268|NCT00595361|exercise induced asthma|exercise induced asthma
603269|NCT00595361|exercise induced bronchoconstriction|exercise induced bronchoconstriction
603270|NCT00595361|long acting beta agonist|long acting beta agonist
603271|NCT00595361|salmeterol|salmeterol
603272|NCT00595361|exercise challenge|exercise challenge
603273|NCT00595361|bronchoprotection|bronchoprotection
603274|NCT00595361|beta 2 adrenergic receptor polymorphisms|beta 2 adrenergic receptor polymorphisms
603275|NCT00595361|pharmacogenetics|pharmacogenetics
603276|NCT00595387|Cognitive Behavioral Therapy|cognitive behavioral therapy
603277|NCT00595413|Rheumatoid arthritis|rheumatoid arthritis
603278|NCT00595413|Atacicept|atacicept
603279|NCT00595413|Adalimumab|adalimumab
603280|NCT00595413|Humira®|humira®
603281|NCT00595426|Knee Arthroplasty|knee arthroplasty
603282|NCT00595426|Factor Xa|factor xa
603283|NCT00595426|VTE|vte
603284|NCT00595426|Thrombosis|thrombosis
603285|NCT00595426|Anticoagulants|anticoagulants
603286|NCT00595439|Sensory Evoked Potentials (SEPs)|sensory evoked potentials (seps)
603287|NCT00595439|Electromyogram|electromyogram
603288|NCT00595439|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
603289|NCT00595439|Complex Regional Pain Syndrome|complex regional pain syndrome
603290|NCT00595439|Focal Hand Dystonia|focal hand dystonia
603291|NCT00595439|Focal Dystonia|focal dystonia
603292|NCT00595439|Chronic Regional Pain Syndrome|chronic regional pain syndrome
603293|NCT00595439|CRPS|crps
603294|NCT00595491|Asthma|asthma
603295|NCT00595491|Inflammation|inflammation
603296|NCT00595491|Allergic|allergic
603297|NCT00595491|Airway|airway
603298|NCT00595491|Challenge|challenge
603299|NCT00595491|Chemokines|chemokines
603300|NCT00595504|schizophrenia|schizophrenia
603301|NCT00595504|metabolism|metabolism
603302|NCT00595504|antipsychotics|antipsychotics
603303|NCT00595504|diabetes|diabetes
603304|NCT00595504|rozerem|rozerem
603305|NCT00595517|gastrointestinal|gastrointestinal
603306|NCT00595517|GI|gi
603307|NCT00595517|NSAID|nsaid
603308|NCT00595517|Japan|japan
603310|NCT00595517|Gastric ulcer|gastric ulcer
603311|NCT00595517|duodenal ulcer|duodenal ulcer
603312|NCT00595530|ketamine|ketamine
603313|NCT00595530|vasoocclusive pain|vasoocclusive pain
603314|NCT00595556|Zonisamide|zonisamide
603315|NCT00595556|Pharmacotherapy|pharmacotherapy
603316|NCT00595556|Alcohol dependence|alcohol dependence
603317|NCT00595556|anticonvulsant|anticonvulsant
603318|NCT00595569|flexible insulin therapy|flexible insulin therapy
603319|NCT00595569|diabetes education|diabetes education
603320|NCT00595569|diabetes|diabetes
603322|NCT00595569|Weekly ambulatory sessions|weekly ambulatory sessions
603323|NCT00595595|Dental Pulp|dental pulp
603324|NCT00595595|Regenerative Medicine|regenerative medicine
603325|NCT00595595|Odontoblasts|odontoblasts
603326|NCT00595595|Stem Cells|stem cells
603327|NCT00595595|Growth factor differentiation of stem/progenitor cells|growth factor differentiation of stem/progenitor cells
603328|NCT00595595|Odontoblast-specific cell phenotypes|odontoblast-specific cell phenotypes
603329|NCT00595608|aftercare|aftercare
603330|NCT00595608|nasal septum|nasal septum
603331|NCT00595608|turbinates|turbinates
603332|NCT00595634|Hip|hip
603333|NCT00595634|Fracture|fracture
603334|NCT00595634|Intertrochanteric|intertrochanteric
603335|NCT00595634|intramedullary|intramedullary
603336|NCT00595660|Palpable Breast Mass|palpable breast mass
603337|NCT00595660|FNA|fna
603338|NCT00595660|Cytology|cytology
603339|NCT00595660|Fine needle aspiration|fine needle aspiration
603340|NCT00595660|Specimen Adequacy|specimen adequacy
603341|NCT00595673|Perfusion|perfusion
603342|NCT00595673|Echocardiograpy|echocardiograpy
603343|NCT00595673|SPECT|spect
603344|NCT00595673|angiography|angiography
603346|NCT00595686|Hematologic Malignancies Hsp90 Hematologic Malignancy|hematologic malignancies hsp90 hematologic malignancy
603347|NCT00595712|Genovarum|genovarum
603348|NCT00595712|Medial opening-wedge high tibial osteotomy|medial opening-wedge high tibial osteotomy
603349|NCT00595712|allograft|allograft
603350|NCT00595725|Cervix|cervix
603351|NCT00595725|Endometrium|endometrium
603352|NCT00595725|Cervical Carcinoma|cervical carcinoma
603353|NCT00595725|Lymphatic Mapping|lymphatic mapping
603354|NCT00595738|Congestive heart failure|congestive heart failure
603355|NCT00595738|Cardiac biomarkers|cardiac biomarkers
603356|NCT00595738|Hemodynamics|hemodynamics
603357|NCT00595738|Tailored therapy|tailored therapy
603358|NCT00595751|ADHD, Attention Deficit Hyperactivity Disorder|adhd, attention deficit hyperactivity disorder
603359|NCT00585338|facial telangiectasia,|facial telangiectasia,
603360|NCT00585338|leg vein telangiectasia|leg vein telangiectasia
603361|NCT00585338|Port Wine Stain birthmarks|port wine stain birthmarks
603362|NCT00585364|Allergic Bronchopulmonary Aspergillosis|allergic bronchopulmonary aspergillosis
603363|NCT00585364|Aspergillus fumigatus|aspergillus fumigatus
603364|NCT00585364|cytokine expression|cytokine expression
603365|NCT00585416|Prostate Cancer|prostate cancer
603366|NCT00585416|Hormone Refractory|hormone refractory
603367|NCT00585416|Metastatic|metastatic
603368|NCT00585455|vascular endothelium|vascular endothelium
603369|NCT00585455|nitric oxide|nitric oxide
603370|NCT00585455|depression|depression
603371|NCT00585455|heart failure|heart failure
603372|NCT00585455|vascular biology|vascular biology
603373|NCT00585481|Epidemiological Study|epidemiological study
603374|NCT00585481|Incidence of severe Respiratory Syncytial Virus|incidence of severe respiratory syncytial virus
603375|NCT00585481|Preterm Brazilian children|preterm brazilian children
603376|NCT00585507|hormone receptor positive breast cancer|hormone receptor positive breast cancer
603377|NCT00585507|Fulvestrant|fulvestrant
603378|NCT00585546|heart failure|heart failure
603379|NCT00585546|dilated cardiomyopathy|dilated cardiomyopathy
603380|NCT00585546|heart assist device|heart assist device
603381|NCT00585546|clenbuterol|clenbuterol
603382|NCT00585546|adrenergic beta agonists|adrenergic beta agonists
603383|NCT00585546|heart transplantation|heart transplantation
603384|NCT00585559|Lipid|lipid
603385|NCT00585559|Peroxidation|peroxidation
603386|NCT00585559|N-Acetylcysteine|n-acetylcysteine
603387|NCT00585559|Acetaminophen|acetaminophen
603388|NCT00585559|Vasospasm|vasospasm
603389|NCT00585572|Normal Tissues/Brains|normal tissues/brains
603390|NCT00585572|Alzheimer|alzheimer
603391|NCT00585572|Motor Neuron Disease|motor neuron disease
603392|NCT00585572|Dementia|dementia
603393|NCT00585572|Healthy Control Volunteers|healthy control volunteers
603394|NCT00585572|Populations At Risk|populations at risk
603396|NCT00585585|Depression|depression
603397|NCT00585585|Betahistine Dihydrochloride|betahistine dihydrochloride
603398|NCT00585611|Heart Failure, Congestive|heart failure, congestive
603399|NCT00585624|Esophagectomy|esophagectomy
603400|NCT00585624|Pancreaticoduodenectomy|pancreaticoduodenectomy
603401|NCT00585624|Whipple|whipple
603402|NCT00585637|Vitamin D|vitamin d
603403|NCT00585637|Blacks|blacks
603404|NCT00585637|cancer|cancer
603405|NCT00585637|hypertension|hypertension
603406|NCT00585650|palmoplantar psoriasis|palmoplantar psoriasis
603407|NCT00585650|etanercept|etanercept
603408|NCT00585650|Enbrel|enbrel
603511|NCT00586222|Pediatric Bipolar Disorder|pediatric bipolar disorder
603409|NCT00585689|Locally advanced urothelial carcinoma of the bladder|locally advanced urothelial carcinoma of the bladder
603410|NCT00585702|Bipolar Disorder|bipolar disorder
603411|NCT00585702|Pregnancy|pregnancy
603412|NCT00585702|Infant Development|infant development
603413|NCT00585715|Cellulite|cellulite
603414|NCT00585715|Nd:YAG Laser|nd:yag laser
603415|NCT00585767|Hydronephrosis|hydronephrosis
603416|NCT00585793|HIV/AIDS|hiv/aids
603417|NCT00585806|Heart Failure with preserved ejection fraction|heart failure with preserved ejection fraction
603418|NCT00585832|hypertension|hypertension
603419|NCT00585832|pre-hypertension|pre-hypertension
603420|NCT00585832|adolescents|adolescents
603421|NCT00585832|diet|diet
603422|NCT00585832|vascular function|vascular function
603423|NCT00585845|Cancer|cancer
603424|NCT00585845|Ovarian cancer|ovarian cancer
603425|NCT00585845|Pancreatic cancer|pancreatic cancer
603426|NCT00585845|Non-small cell lung cancer|non-small cell lung cancer
603427|NCT00585845|Mesothelioma|mesothelioma
603428|NCT00585845|Mesothelin|mesothelin
603429|NCT00585845|Immunotherapy|immunotherapy
603430|NCT00585871|ICD patients with 5 VTs per 3 month period|icd patients with 5 vts per 3 month period
603431|NCT00585884|Reconstruction, Silicone prostheses|reconstruction, silicone prostheses
603432|NCT00585897|Diabetes|diabetes
603433|NCT00585897|Obesity|obesity
603434|NCT00585910|ADHD|adhd
603435|NCT00585910|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
603436|NCT00585910|Strattera|strattera
603437|NCT00585910|Concerta|concerta
603438|NCT00585910|Atomoxetine|atomoxetine
603439|NCT00585910|OROS Methylphenidate|oros methylphenidate
603440|NCT00585962|proton beam radiation|proton beam radiation
603441|NCT00586001|Anxiety|anxiety
603442|NCT00586001|Emotional Disorders|emotional disorders
603443|NCT00586001|Unified|unified
603444|NCT00586001|Depression|depression
603445|NCT00586014|Multiple myeloma|multiple myeloma
603446|NCT00586014|Autologous Stem Cell Transplant|autologous stem cell transplant
603447|NCT00586027|cardiac surgery|cardiac surgery
603448|NCT00586027|low cardiac output|low cardiac output
603449|NCT00586027|natriuretic peptide B|natriuretic peptide b
603450|NCT00586027|mortality|mortality
603451|NCT00586027|morbidity|morbidity
603452|NCT00586040|skin cancer|skin cancer
603453|NCT00586040|skin excision|skin excision
603454|NCT00586040|laser|laser
603455|NCT00586040|superficial sutures|superficial sutures
603456|NCT00586040|wound healing|wound healing
603457|NCT00586053|Colonic Polyps|colonic polyps
603458|NCT00586053|Colon|colon
603459|NCT00586053|Large Intestine|large intestine
603460|NCT00586053|Cecum|cecum
603461|NCT00586053|Sigmoid|sigmoid
603462|NCT00586053|Rectum|rectum
603463|NCT00586053|Colonoscopy|colonoscopy
603464|NCT00586053|Virtual Colonoscopy|virtual colonoscopy
603465|NCT00586053|CT Colonography|ct colonography
603466|NCT00586053|Computed Tomographic Colonography|computed tomographic colonography
603467|NCT00586053|Colonography|colonography
603468|NCT00586066|Bipolar disorder|bipolar disorder
603571|NCT00586469|Influenza|influenza
603469|NCT00586066|Cognitive dysfunction|cognitive dysfunction
603470|NCT00586066|Memantine|memantine
603471|NCT00586066|NMDA antagonist|nmda antagonist
603472|NCT00586092|Phase I|phase i
603473|NCT00586092|Phase 1|phase 1
603474|NCT00586092|avastin|avastin
603475|NCT00586092|bevacizumab|bevacizumab
603476|NCT00586092|ABT-510|abt-510
603477|NCT00586092|solid tumors|solid tumors
603478|NCT00586092|angiogenesis|angiogenesis
603479|NCT00586105|Sorafenib|sorafenib
603480|NCT00586105|Nexavar|nexavar
603481|NCT00586105|Metastatic RCC|metastatic rcc
603482|NCT00586105|Renal Cell Carcinoma|renal cell carcinoma
603483|NCT00586105|Unresectable RCC|unresectable rcc
603484|NCT00586118|Sedation|sedation
603485|NCT00586118|Volatile anaesthetic|volatile anaesthetic
603486|NCT00586118|Sevoflurane|sevoflurane
603487|NCT00586118|Propofol|propofol
603488|NCT00586118|Recovery|recovery
603489|NCT00586131|end-stage renal disease|end-stage renal disease
603490|NCT00586131|automated peritoneal dialysis|automated peritoneal dialysis
603491|NCT00586131|metabolic acidosis|metabolic acidosis
603492|NCT00586131|nitrogen balances|nitrogen balances
603493|NCT00586157|ADHD|adhd
603494|NCT00586157|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
603495|NCT00586157|Daytrana|daytrana
603496|NCT00586157|MTS Patch|mts patch
603497|NCT00586157|Methylphenidate Transdermal System|methylphenidate transdermal system
603498|NCT00586170|nonunion|nonunion
603499|NCT00586170|fracture|fracture
603500|NCT00586183|Ventricular Remodeling|ventricular remodeling
603501|NCT00586196|Delirium|delirium
603502|NCT00586196|Postoperative confusion|postoperative confusion
603503|NCT00586196|Hip fracture|hip fracture
603504|NCT00586196|Long bone fracture|long bone fracture
603505|NCT00586209|sickle cell disease|sickle cell disease
603506|NCT00586209|sickle cell anemia|sickle cell anemia
603507|NCT00586209|L-glutamine|l-glutamine
603508|NCT00586209|Sickle Cell Anemia (homozygous and heterozygous)|sickle cell anemia (homozygous and heterozygous)
603509|NCT00586209|Sickle ß0-Thalassemia|sickle ß0-thalassemia
603510|NCT00586222|Omega-3 Fatty Acids|omega-3 fatty acids
603512|NCT00586222|Adolescent Bipolar Disorder|adolescent bipolar disorder
603513|NCT00586222|MRS|mrs
603514|NCT00586235|Fusion|fusion
603515|NCT00586235|Ultrasound|ultrasound
603516|NCT00586235|Computed tomography|computed tomography
603517|NCT00586248|Peripheral nerve stimulator, cardiac pacemaker|peripheral nerve stimulator, cardiac pacemaker
603518|NCT00586261|Kidney Failure, Chronic|kidney failure, chronic
603519|NCT00586261|Renal Insufficiency, Chronic|renal insufficiency, chronic
603520|NCT00586261|Proteinuria|proteinuria
603521|NCT00586261|Albuminuria|albuminuria
603522|NCT00586274|Stem Cell Transplant|stem cell transplant
603523|NCT00586274|Anemia|anemia
603524|NCT00586274|Fanconi|fanconi
603525|NCT00586287|Phenprocoumon|phenprocoumon
603526|NCT00586287|Dosing algorithm|dosing algorithm
603527|NCT00586287|loading dose|loading dose
603528|NCT00586300|Knee pain|knee pain
603529|NCT00586313|EUS Biopsy for Non-alcoholic Fatty Liver Disease|eus biopsy for non-alcoholic fatty liver disease
603530|NCT00586326|MammoSite|mammosite
603531|NCT00586326|DCIS|dcis
603532|NCT00586339|HPV|hpv
603533|NCT00586339|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
603534|NCT00586339|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
603535|NCT00586339|Cervical cancer|cervical cancer
603536|NCT00586339|Papillomavirus|papillomavirus
603537|NCT00586352|Pediatric|pediatric
603538|NCT00586352|Crohn's disease|crohn's disease
603539|NCT00586352|Ulcerative colitis|ulcerative colitis
603540|NCT00586365|complex elbow trauma|complex elbow trauma
603541|NCT00586365|prevention|prevention
603542|NCT00586365|complication|complication
603543|NCT00586365|naproxen|naproxen
603544|NCT00586365|NSAIDS|nsaids
603545|NCT00586391|B cell Lymphoma|b cell lymphoma
603546|NCT00586391|Cancer|cancer
603547|NCT00586391|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
603548|NCT00586391|CD19 CHIMERIC RECEPTOR EXPRESSING T LYMPHOCYTES|cd19 chimeric receptor expressing t lymphocytes
603549|NCT00586391|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
603550|NCT00586404|Barrett's Esophagus|barrett's esophagus
603551|NCT00586404|Esophageal neoplasms|esophageal neoplasms
603552|NCT00586404|gastroesophageal reflux|gastroesophageal reflux
603553|NCT00586404|gastrointestinal neoplasms|gastrointestinal neoplasms
603554|NCT00586417|angiogenesis|angiogenesis
603555|NCT00586417|tumor angiogenesis|tumor angiogenesis
603556|NCT00586417|biomarkers|biomarkers
603557|NCT00586417|healthy volunteers|healthy volunteers
603558|NCT00586430|apolipoprotein E e4|apolipoprotein e e4
603559|NCT00586430|Alzheimer's disease|alzheimer's disease
603560|NCT00586430|somnolence|somnolence
603561|NCT00586430|Early detection|early detection
603562|NCT00586443|solid tumors|solid tumors
603563|NCT00586443|avastin|avastin
603564|NCT00586443|Phase I|phase i
603565|NCT00586443|Phase 1|phase 1
603566|NCT00586443|combination therapy|combination therapy
603567|NCT00586443|bevacizumab|bevacizumab
603568|NCT00586443|RAD001|rad001
603569|NCT00586443|everolimus|everolimus
603570|NCT00586443|pantitumumab|pantitumumab
603572|NCT00586482|cigarettes, surgery|cigarettes, surgery
603573|NCT00586482|Smokers scheduled for elective surgery|smokers scheduled for elective surgery
603574|NCT00586495|Sorafenib|sorafenib
603575|NCT00586495|Nexavar|nexavar
603576|NCT00586495|Metastatic RCC|metastatic rcc
603577|NCT00586495|Renal Cell Carcinoma|renal cell carcinoma
603578|NCT00586495|Unresectable RCC|unresectable rcc
603579|NCT00586521|Coagulation Disorders|coagulation disorders
603580|NCT00586534|crack, cocaine, addiction treatment, virtual reality|crack, cocaine, addiction treatment, virtual reality
603581|NCT00586547|Haploidentical|haploidentical
603582|NCT00586547|Stem Cell Transplant|stem cell transplant
603583|NCT00586547|Graft-Versus-Host disease|graft-versus-host disease
603584|NCT00586560|solid tumors|solid tumors
603585|NCT00586573|ADHD|adhd
603586|NCT00586573|Namenda|namenda
603587|NCT00586599|IBD|ibd
603588|NCT00586599|CD|cd
603589|NCT00586599|UC|uc
603590|NCT00586599|Crohn's Disease|crohn's disease
603591|NCT00586599|Ulcerative Colitis|ulcerative colitis
603592|NCT00586599|Pediatric|pediatric
603593|NCT00586599|inflammatory markers|inflammatory markers
603594|NCT00586612|Conjugate vaccine|conjugate vaccine
603595|NCT00586612|Persistence|persistence
603596|NCT00586612|Hib vaccine|hib vaccine
603597|NCT00586612|Combination vaccine|combination vaccine
603598|NCT00586612|Meningococcal vaccine|meningococcal vaccine
603599|NCT00586612|Safety|safety
603600|NCT00586612|Preterm/full-term infants|preterm/full-term infants
603601|NCT00586612|Immunogenicity|immunogenicity
603602|NCT00586638|cognition|cognition
603603|NCT00586638|cognition disorders|cognition disorders
603604|NCT00586638|executive function|executive function
603605|NCT00586638|cognitive control|cognitive control
603606|NCT00586638|attentional control|attentional control
603607|NCT00586638|biomedical enhancement|biomedical enhancement
603608|NCT00586638|cognitive enhancement|cognitive enhancement
603609|NCT00586638|computerized|computerized
603610|NCT00586638|computer-based|computer-based
603611|NCT00586638|video game|video game
603612|NCT00586677|child abuse|child abuse
603712|NCT00595985|Toxicity|toxicity
603613|NCT00586677|child neglect|child neglect
603614|NCT00586677|PCIT|pcit
603615|NCT00586677|Lutzker|lutzker
603616|NCT00586677|attachment|attachment
603617|NCT00586677|parenting|parenting
603618|NCT00586690|Stem cell transplant|stem cell transplant
603619|NCT00586690|matched donor|matched donor
603620|NCT00586690|NK infusion|nk infusion
603621|NCT00586703|Stem cell transplant|stem cell transplant
603622|NCT00586703|mismatched donor|mismatched donor
603623|NCT00586703|NK infusion|nk infusion
603624|NCT00586729|Burn|burn
603625|NCT00586729|Burn wound management|burn wound management
603626|NCT00586729|Burn graft|burn graft
603627|NCT00586742|SLAP lesions|slap lesions
603628|NCT00586742|labral repair|labral repair
603629|NCT00586742|bicepstenodesis|bicepstenodesis
603630|NCT00586742|conservative treatment|conservative treatment
603631|NCT00586755|Intensive Induction|intensive induction
603632|NCT00586755|High Dose Chemotherapy|high dose chemotherapy
603633|NCT00586755|Bone Marrow Transplantation|bone marrow transplantation
603634|NCT00586755|Mantle Cell Lymphoma|mantle cell lymphoma
603635|NCT00586781|ankle replacement|ankle replacement
603636|NCT00586781|end-stage arthritis of the ankle|end-stage arthritis of the ankle
603637|NCT00586781|degenerative ankle disease|degenerative ankle disease
603638|NCT00586794|Hypertension|hypertension
603639|NCT00586794|Eisenmenger|eisenmenger
603640|NCT00586807|Ulcerative colitis|ulcerative colitis
603641|NCT00586807|pediatrics|pediatrics
603642|NCT00586807|UC|uc
603643|NCT00586807|protein metabolism|protein metabolism
603644|NCT00586807|energy expenditure|energy expenditure
603645|NCT00586820|Coronary Atherosclerosis|coronary atherosclerosis
603646|NCT00586820|Microvascular Dysfunction|microvascular dysfunction
603748|NCT00597142|stent|stent
603647|NCT00586820|Non-ST Elevation Myocardial Infarction|non-st elevation myocardial infarction
603648|NCT00586833|Heart Failure|heart failure
603649|NCT00586833|Heart Failure, Diastolic|heart failure, diastolic
603650|NCT00586833|Dyspnea, Paroxysmal|dyspnea, paroxysmal
603651|NCT00586833|Edema, Cardiac|edema, cardiac
603652|NCT00586846|Cisplatin|cisplatin
603653|NCT00586846|Doxorubicin|doxorubicin
603654|NCT00586846|Methotrexate|methotrexate
603655|NCT00586846|Osteosarcoma|osteosarcoma
603656|NCT00586846|03-074|03-074
603657|NCT00586859|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
603658|NCT00586859|NDO Full-thickness Plicator|ndo full-thickness plicator
603659|NCT00586859|Plicator|plicator
603660|NCT00586859|Endoluminal GERD Therapy|endoluminal gerd therapy
603661|NCT00586872|Barrett's Esophagus|barrett's esophagus
603662|NCT00586872|Early Esophageal Adenocarcinoma|early esophageal adenocarcinoma
603663|NCT00586872|Endoscopic Mucosal Resection|endoscopic mucosal resection
603664|NCT00595764|Buprenorphine|buprenorphine
603665|NCT00595764|Buprenorphine/naloxone|buprenorphine/naloxone
603666|NCT00595764|Counseling|counseling
603667|NCT00595764|Primary care|primary care
603668|NCT00595777|Institutional change|institutional change
603669|NCT00595777|Improved pain management|improved pain management
603670|NCT00595816|low back pain|low back pain
603671|NCT00595816|physical fitness|physical fitness
603672|NCT00595816|injury|injury
603673|NCT00595816|prevention|prevention
603674|NCT00595816|conscripts|conscripts
603675|NCT00595829|Polycythemia Vera|polycythemia vera
603676|NCT00595829|PV|pv
603677|NCT00595842|Mineral trioxide aggregate|mineral trioxide aggregate
603678|NCT00595855|glaucoma|glaucoma
603679|NCT00595855|surgery|surgery
603680|NCT00595855|non penetrating procedures|non penetrating procedures
603681|NCT00595855|cataract|cataract
603682|NCT00595868|Nicotine|nicotine
603683|NCT00595868|Smoking|smoking
603684|NCT00595868|Smoking Cessation|smoking cessation
603685|NCT00595881|Bedside emergency ultrasound|bedside emergency ultrasound
603686|NCT00595881|Abscess|abscess
603687|NCT00595881|Cellulitis|cellulitis
603688|NCT00595881|Soft tissue infection|soft tissue infection
603689|NCT00595881|Methicillin resistant staphylococcus aureus (MRSA)|methicillin resistant staphylococcus aureus (mrsa)
603690|NCT00595894|rheumatoid arthritis|rheumatoid arthritis
603691|NCT00595894|African Americans|african americans
603692|NCT00595894|osteopenia|osteopenia
603693|NCT00595894|osteoporosis|osteoporosis
603694|NCT00595894|bone mineral density|bone mineral density
603695|NCT00595907|tuberculosis|tuberculosis
603696|NCT00595907|interferon gamma release assays|interferon gamma release assays
603697|NCT00595907|treatment|treatment
603698|NCT00595920|Tovaxin|tovaxin
603699|NCT00595920|Autologous|autologous
603700|NCT00595920|T-cell vaccine (TCV)|t-cell vaccine (tcv)
603701|NCT00595933|Head and Neck cancer|head and neck cancer
603702|NCT00595933|Radiation therapy|radiation therapy
603703|NCT00595933|Dry mouth remedies|dry mouth remedies
603704|NCT00595933|Dry Mouth|dry mouth
603705|NCT00595933|Xerostomia|xerostomia
603706|NCT00595972|Time to Progression|time to progression
603707|NCT00595972|Overall survival|overall survival
603708|NCT00595972|Response rate|response rate
603709|NCT00595972|Quality of Live|quality of live
603710|NCT00595972|Toxicities|toxicities
603711|NCT00595985|Time to Progression|time to progression
603713|NCT00595985|Overall survival|overall survival
603714|NCT00595985|Response rate|response rate
603715|NCT00595985|Quality of live|quality of live
603716|NCT00595985|Toxicities|toxicities
603717|NCT00595998|AMD, HMP, PHP|amd, hmp, php
603718|NCT00596011|prostate cancer|prostate cancer
603719|NCT00596011|PIN|pin
603720|NCT00596011|polyphenon E|polyphenon e
603721|NCT00596011|EGCG|egcg
603722|NCT00596037|Growth hormone Deficiency|growth hormone deficiency
603723|NCT00596050|procedural sedation|procedural sedation
603724|NCT00596050|fracture reduction|fracture reduction
603725|NCT00596050|pediatric emergency medicine|pediatric emergency medicine
603726|NCT00596050|etomidate|etomidate
603727|NCT00596050|ketamine|ketamine
603728|NCT00596050|analgesia|analgesia
603729|NCT00596063|pharmacokinetics|pharmacokinetics
603730|NCT00596063|pharmacodynamics|pharmacodynamics
603731|NCT00596063|recombinant human insulin|recombinant human insulin
603732|NCT00596063|healthy volunteers|healthy volunteers
603733|NCT00596076|Low back pain|low back pain
603734|NCT00597090|Infections|infections
603735|NCT00597090|lymphoma|lymphoma
603736|NCT00597103|Hemodialysis|hemodialysis
603737|NCT00597103|Frequent Hemodialysis|frequent hemodialysis
603738|NCT00597103|Sleep Apnea|sleep apnea
603739|NCT00597103|Restless Leg Syndrome|restless leg syndrome
603740|NCT00597103|Cognitive Function|cognitive function
603741|NCT00597116|Mesothelioma|mesothelioma
603742|NCT00597116|inoperable|inoperable
603743|NCT00597116|relapsed|relapsed
603744|NCT00597129|pancreatic cancer|pancreatic cancer
603745|NCT00597129|cancer of the pancreas|cancer of the pancreas
603746|NCT00597129|pancreas cancer|pancreas cancer
603747|NCT00597142|renal stent|renal stent
603749|NCT00597142|atherosclerosis|atherosclerosis
603750|NCT00597142|aortorenal ostium|aortorenal ostium
603752|NCT00597142|renal artery|renal artery
603753|NCT00597142|PTRA|ptra
603754|NCT00597168|Schizophrenia|schizophrenia
603755|NCT00597168|atypical antipsychotic|atypical antipsychotic
603756|NCT00597168|quality of life|quality of life
603757|NCT00597168|ambulatory setting|ambulatory setting
603758|NCT00597181|Inflammatory response|inflammatory response
603759|NCT00597194|inguinal hernia|inguinal hernia
603760|NCT00597194|laparoscopic repair|laparoscopic repair
603761|NCT00597194|open repair|open repair
603762|NCT00597194|randomized|randomized
603763|NCT00597207|CPR|cpr
603764|NCT00597207|mechanical|mechanical
603765|NCT00597207|manual|manual
603766|NCT00597207|outcome|outcome
603767|NCT00597207|survival|survival
603768|NCT00597207|quality|quality
603769|NCT00597246|Brain|brain
603770|NCT00597246|CNS|cns
603771|NCT00597246|Central Nervous System|central nervous system
603772|NCT00597259|hepatitis B, entecavir, pegylated interferon alfa-2a|hepatitis b, entecavir, pegylated interferon alfa-2a
603773|NCT00597272|melanoma|melanoma
603774|NCT00597272|resected local|resected local
603775|NCT00597272|systemic metastasis|systemic metastasis
603776|NCT00597285|18-F-Fluoro-2-Deoxy-D-Glucose (FDG)|18-f-fluoro-2-deoxy-d-glucose (fdg)
603777|NCT00597285|Magnetic Resonance|magnetic resonance
603778|NCT00597285|Epilepsy|epilepsy
603779|NCT00597285|HHV-6B|hhv-6b
603780|NCT00597285|Healthy Volunteer|healthy volunteer
603781|NCT00597285|HV|hv
603782|NCT00597298|diaphragmatic paralysis|diaphragmatic paralysis
603783|NCT00597298|cardiac surgery|cardiac surgery
603784|NCT00597298|respiratory muscle training|respiratory muscle training
603785|NCT00597311|rectal cancer|rectal cancer
603786|NCT00597311|radiotherapy|radiotherapy
603787|NCT00597311|radiochemotherapy|radiochemotherapy
603788|NCT00597324|Allen's test|allen's test
603789|NCT00597324|lactate|lactate
603790|NCT00597324|safety|safety
603791|NCT00597324|radial intervention|radial intervention
603792|NCT00597324|Patients with coronary artery disease|patients with coronary artery disease
603793|NCT00597337|bullying|bullying
603794|NCT00597337|victimisation|victimisation
603795|NCT00597337|aggressive behavior|aggressive behavior
603796|NCT00597350|Fenugreek|fenugreek
603797|NCT00597350|Trigonella foenum-graecum|trigonella foenum-graecum
603798|NCT00597350|Diabetes mellitus|diabetes mellitus
603799|NCT00597350|Blood sugar|blood sugar
603800|NCT00597350|Insulin|insulin
603801|NCT00597350|Glucose|glucose
603802|NCT00597363|vascular access site|vascular access site
603803|NCT00597363|arterial puncture|arterial puncture
603804|NCT00597363|femoral pseudoaneurysm|femoral pseudoaneurysm
603805|NCT00597376|memory loss|memory loss
603806|NCT00597389|posttraumatic stress disorder|posttraumatic stress disorder
603807|NCT00597389|propranolol|propranolol
603808|NCT00597389|inderol|inderol
603809|NCT00597389|child|child
603810|NCT00597389|trauma|trauma
603811|NCT00597389|Posttraumatic stress disorders (PTSD)|posttraumatic stress disorders (ptsd)
603812|NCT00597402|Avastin|avastin
603813|NCT00597402|Bevacizumab|bevacizumab
603814|NCT00597402|Temozolomide|temozolomide
603815|NCT00597402|Temodar|temodar
603816|NCT00597402|Irinotecan|irinotecan
603817|NCT00597402|Camptosar|camptosar
603818|NCT00597402|GBM|gbm
603819|NCT00597402|Glioblastoma Multiforme|glioblastoma multiforme
603820|NCT00597402|Gliosarcoma|gliosarcoma
603824|NCT00597402|Newly diagnosed GBM or gliosarcoma malignant brain tumor|newly diagnosed gbm or gliosarcoma malignant brain tumor
603825|NCT00597415|Osteoarthritis|osteoarthritis
603826|NCT00597415|Knee pain|knee pain
603827|NCT00597441|unrelated|unrelated
603828|NCT00597441|umbilical cord blood transplantation|umbilical cord blood transplantation
603829|NCT00597441|thymus transplantation|thymus transplantation
603830|NCT00597454|Breast|breast
603831|NCT00597467|myopia|myopia
603832|NCT00597467|hyperopia|hyperopia
603833|NCT00597467|extended wear|extended wear
603834|NCT00597467|ametropia|ametropia
603835|NCT00597480|Growth hormone|growth hormone
603836|NCT00597480|Child|child
603837|NCT00597480|insulin resistance|insulin resistance
603838|NCT00597480|metabolic syndrome X|metabolic syndrome x
603839|NCT00597480|children born small for gestational age|children born small for gestational age
603840|NCT00597493|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
603841|NCT00597493|GBM|gbm
603842|NCT00597493|Glioblastoma|glioblastoma
603843|NCT00597493|Sorafenib|sorafenib
603844|NCT00597493|Temozolomide|temozolomide
603845|NCT00597493|Brain Tumor|brain tumor
603846|NCT00597493|Recurrent GBM|recurrent gbm
603847|NCT00597493|Temodar|temodar
603848|NCT00597493|Gliosarcoma|gliosarcoma
603849|NCT00597493|Glioma|glioma
603850|NCT00597493|Nexavar|nexavar
603851|NCT00597506|colorectal|colorectal
603852|NCT00597506|refractory|refractory
603853|NCT00597506|adenocarcinoma|adenocarcinoma
603854|NCT00597506|bevacizumab|bevacizumab
603855|NCT00597506|everolimus|everolimus
603856|NCT00597519|Cancer|cancer
603857|NCT00597519|Leukemia|leukemia
603858|NCT00597519|Myelodysplastic Syndrome|myelodysplastic syndrome
603859|NCT00597519|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
603860|NCT00597519|Total Body Irradiation|total body irradiation
603861|NCT00597519|Umbilical Cord Blood Grafts|umbilical cord blood grafts
603862|NCT00597519|06-014|06-014
603863|NCT00597532|Breast Cancer|breast cancer
603865|NCT00597532|Milk|milk
603866|NCT00597532|Supplementation|supplementation
603867|NCT00597532|02-062|02-062
603868|NCT00597545|Carotid Endarterectomy|carotid endarterectomy
603869|NCT00597545|Neuropsychological tests|neuropsychological tests
603870|NCT00597545|Stroke|stroke
603871|NCT00597545|Transient ischemia|transient ischemia
603872|NCT00597545|Hypoperfusion|hypoperfusion
603873|NCT00597545|Ischemia|ischemia
603874|NCT00597558|Egg allergy|egg allergy
603875|NCT00597584|anemia|anemia
603876|NCT00597584|chronic kidney disease|chronic kidney disease
603878|NCT00597584|chronic renal failure|chronic renal failure
603879|NCT00597584|CRF|crf
603880|NCT00597584|dialysis|dialysis
603881|NCT00597584|erythropoietin|erythropoietin
603882|NCT00597584|EPO|epo
603883|NCT00597584|erythropoiesis stimulating agent|erythropoiesis stimulating agent
603884|NCT00597584|ESA|esa
603885|NCT00597584|Hematide™|hematide™
603886|NCT00597584|hemodialysis|hemodialysis
603887|NCT00597584|hemoglobin|hemoglobin
603888|NCT00597584|Hb|hb
603889|NCT00597584|Hgb|hgb
603890|NCT00597584|Omontys|omontys
603891|NCT00597584|peginesatide|peginesatide
603892|NCT00597584|red blood cell|red blood cell
603893|NCT00597584|red blood cell production|red blood cell production
603894|NCT00597597|Metastatic breast cancer|metastatic breast cancer
603895|NCT00597597|ER and PR hormone receptor negative|er and pr hormone receptor negative
603896|NCT00597597|HER2/neu negative|her2/neu negative
603897|NCT00597597|EGFR positive|egfr positive
603898|NCT00597610|Rectum|rectum
603899|NCT00597610|Rectal|rectal
603900|NCT00597623|Osteoarthritis|osteoarthritis
603901|NCT00597623|Hand|hand
603902|NCT00597623|Tumor Necrosis Factor-alpha inhibitors|tumor necrosis factor-alpha inhibitors
603903|NCT00597623|Biological Therapy|biological therapy
603904|NCT00597636|smokers|smokers
603905|NCT00597675|Peanut allergy|peanut allergy
603906|NCT00597701|Alcohol withdrawal|alcohol withdrawal
603907|NCT00597701|Delirium tremors|delirium tremors
603908|NCT00597714|Stem Cell Transplantation, Non-myeloablative|stem cell transplantation, non-myeloablative
603909|NCT00597727|Peanut Allergy|peanut allergy
603910|NCT00597727|Sublingual immunotherapy|sublingual immunotherapy
603911|NCT00597753|anemia|anemia
603912|NCT00597753|chronic kidney disease|chronic kidney disease
603913|NCT00597753|CKD|ckd
603914|NCT00597753|chronic renal failure|chronic renal failure
603915|NCT00597753|CRF|crf
603916|NCT00597753|dialysis|dialysis
603917|NCT00597753|erythropoietin|erythropoietin
603918|NCT00597753|EPO|epo
603919|NCT00597753|erythropoiesis stimulating agent|erythropoiesis stimulating agent
603920|NCT00597753|ESA|esa
603921|NCT00597753|Hematide™|hematide™
603922|NCT00597753|hemodialysis|hemodialysis
603923|NCT00597753|hemoglobin|hemoglobin
603924|NCT00597753|Hb|hb
603925|NCT00597753|Hgb|hgb
603926|NCT00597753|Omontys|omontys
603927|NCT00597753|peginesatide|peginesatide
603928|NCT00597753|red blood cell|red blood cell
603929|NCT00597753|red blood cell production|red blood cell production
603930|NCT00597766|CVA|cva
603931|NCT00597766|Hemiplegia|hemiplegia
604229|NCT00599079|MAC|mac
603932|NCT00597766|Hemiplegic shoulder pain|hemiplegic shoulder pain
603933|NCT00597766|Subacromial steroid injection|subacromial steroid injection
603934|NCT00597779|intertrochanteric fractures|intertrochanteric fractures
603935|NCT00597792|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
603936|NCT00597792|Plicator|plicator
603937|NCT00597792|Full-thickness Plication|full-thickness plication
603938|NCT00597831|depression|depression
603939|NCT00597831|electroconvulsive therapy|electroconvulsive therapy
603940|NCT00597831|Ultrasonography Doppler Transcranial|ultrasonography doppler transcranial
603941|NCT00597831|intracranial pressure|intracranial pressure
603942|NCT00597844|type I thyroplasty|type i thyroplasty
603943|NCT00597844|unilateral vocal fold augmentation|unilateral vocal fold augmentation
603944|NCT00597870|TAA|taa
603945|NCT00597883|carotid endarterectomy|carotid endarterectomy
603946|NCT00597883|Neuropsychological tests|neuropsychological tests
603947|NCT00597883|Stroke|stroke
603948|NCT00597883|Transient ischemia|transient ischemia
603949|NCT00597909|Ammonul®|ammonul®
603950|NCT00597909|sodium phenylacetate and sodium benzoate|sodium phenylacetate and sodium benzoate
603951|NCT00597909|hepatic encephalopathy|hepatic encephalopathy
603952|NCT00597909|Grade 3 or 4 Hepatic Encephalopathy|grade 3 or 4 hepatic encephalopathy
603953|NCT00597922|Acute Myocardial Infarction|acute myocardial infarction
603954|NCT00597922|Heart Attack|heart attack
603955|NCT00597922|Gender Differences|gender differences
603956|NCT00597922|Risk Factors|risk factors
603957|NCT00597922|Quality of Care|quality of care
603958|NCT00597935|prolapse|prolapse
603959|NCT00597935|urinary incontinence|urinary incontinence
603960|NCT00597935|uterosacral vaginal vault ligament suspension|uterosacral vaginal vault ligament suspension
603961|NCT00597935|sacrospinous ligament fixation|sacrospinous ligament fixation
603962|NCT00597935|behavioral therapy|behavioral therapy
603963|NCT00597935|pelvic muscle training|pelvic muscle training
603964|NCT00597948|mental retardation|mental retardation
603965|NCT00597948|downs syndrome|downs syndrome
603966|NCT00597948|autism|autism
603967|NCT00597948|autism spectrum disorder|autism spectrum disorder
603968|NCT00597948|cerebral palsy|cerebral palsy
603969|NCT00597948|developmental disability|developmental disability
603970|NCT00597948|developmental disabilities|developmental disabilities
603971|NCT00597948|intellectual disability|intellectual disability
603972|NCT00597948|intellectual disabilities|intellectual disabilities
603973|NCT00597948|health promotion|health promotion
603974|NCT00597948|disease prevention|disease prevention
603975|NCT00597948|physical health|physical health
603976|NCT00597948|emotional health|emotional health
603977|NCT00597948|behavioral health|behavioral health
603978|NCT00597948|mental health|mental health
603979|NCT00597948|spiritual health|spiritual health
603980|NCT00597948|prevention|prevention
603981|NCT00597961|Lung|lung
603982|NCT00597961|skin|skin
603983|NCT00597961|melanoma|melanoma
603984|NCT00597974|carotid artery stenosis|carotid artery stenosis
603985|NCT00597974|Neuropsychological tests|neuropsychological tests
603986|NCT00597974|Stroke|stroke
603987|NCT00597974|Transient ischemia|transient ischemia
603988|NCT00597974|Stenting|stenting
603989|NCT00597987|BRCA1|brca1
603990|NCT00598000|Lung cancer|lung cancer
603991|NCT00598000|Quality of Life|quality of life
603992|NCT00598000|VATS|vats
603993|NCT00598000|thoracotomy|thoracotomy
603994|NCT00598000|05-006|05-006
603995|NCT00598013|Kidney Transplantation|kidney transplantation
603996|NCT00598013|Thiazolidinediones|thiazolidinediones
603997|NCT00598013|Insulin Resistance|insulin resistance
603998|NCT00598013|Atherosclerosis|atherosclerosis
603999|NCT00598026|Tele medicine|tele medicine
604000|NCT00598026|ICD follow-up|icd follow-up
604001|NCT00598026|Cost / benefit study|cost / benefit study
604002|NCT00598052|Marijuana dependence withdrawal Escitalopram|marijuana dependence withdrawal escitalopram
604003|NCT00598065|lung|lung
604004|NCT00598091|Solid Tumors|solid tumors
604005|NCT00598091|Phase I|phase i
604006|NCT00598091|Expanded Cohort|expanded cohort
604007|NCT00598091|Pancreatic Cancer|pancreatic cancer
604008|NCT00598091|Dasatinib|dasatinib
604009|NCT00598091|Gemcitabine|gemcitabine
604010|NCT00598104|Asthma, interleukin-13|asthma, interleukin-13
604011|NCT00598117|Esophageal|esophageal
604012|NCT00598117|CancerEsophagus|canceresophagus
604013|NCT00598130|Patients undergoing elective open partial nephrectomy surgery|patients undergoing elective open partial nephrectomy surgery
604014|NCT00598130|Excision of a kidney|excision of a kidney
604015|NCT00598169|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
604016|NCT00598169|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
604017|NCT00598169|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
604018|NCT00598169|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
604019|NCT00598169|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
604020|NCT00598169|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
604021|NCT00598169|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
604022|NCT00598169|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
604023|NCT00598182|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
604024|NCT00598182|OROS methylphenidate|oros methylphenidate
604025|NCT00598195|Ketamine|ketamine
604026|NCT00598195|Phamacokinetics|phamacokinetics
604027|NCT00598195|Cardiopulmonary bypass (CPB)|cardiopulmonary bypass (cpb)
604028|NCT00598195|ketamine/norketamine pharmacokinetic parameters|ketamine/norketamine pharmacokinetic parameters
604029|NCT00598208|In-vitro fertilization|in-vitro fertilization
604030|NCT00598247|Colon Cancer Rectal Colorectal Women|colon cancer rectal colorectal women
604031|NCT00598260|active management|active management
604032|NCT00598260|induction of labor|induction of labor
604033|NCT00598260|cesarean delivery|cesarean delivery
604034|NCT00598260|Cesarean|cesarean
604035|NCT00598273|anemia|anemia
604036|NCT00598273|chronic kidney disease|chronic kidney disease
604038|NCT00598273|chronic renal failure|chronic renal failure
604039|NCT00598273|CRF|crf
604040|NCT00598273|erythropoietin|erythropoietin
604041|NCT00598273|EPO|epo
604042|NCT00598273|erythropoiesis stimulating agent|erythropoiesis stimulating agent
604043|NCT00598273|ESA|esa
604044|NCT00598273|Hematide™|hematide™
604045|NCT00598273|hemoglobin|hemoglobin
604046|NCT00598273|Hb|hb
604047|NCT00598273|Hgb|hgb
604048|NCT00598273|Omontys|omontys
604049|NCT00598273|peginesatide|peginesatide
604050|NCT00598273|red blood cell|red blood cell
604051|NCT00598273|red blood cell production|red blood cell production
604052|NCT00598286|CB1 Receptor|cb1 receptor
604053|NCT00598286|PET|pet
604054|NCT00598286|Cannabinoid|cannabinoid
604055|NCT00598286|[18F]FMPEP-d2|[18f]fmpep-d2
604056|NCT00598286|Brain Imaging|brain imaging
604057|NCT00598286|Healthy Volunteer|healthy volunteer
604058|NCT00598286|HV|hv
604059|NCT00598299|corneal epithelium|corneal epithelium
604060|NCT00598325|Nicotine|nicotine
604061|NCT00598325|Vaccine|vaccine
604062|NCT00598325|Immunogenicity|immunogenicity
604063|NCT00598325|Tobacco|tobacco
604064|NCT00598325|Habits|habits
604065|NCT00598351|Meningioma|meningioma
604066|NCT00598351|Ependymoma|ependymoma
604067|NCT00598351|Schwannoma|schwannoma
604068|NCT00598351|Acoustic Neuroma|acoustic neuroma
604069|NCT00598351|Vestibular Schwannoma|vestibular schwannoma
604070|NCT00598351|Neurofibromatosis Type 2|neurofibromatosis type 2
604071|NCT00598351|NF2|nf2
604072|NCT00598364|thyroid|thyroid
604073|NCT00598364|nodule|nodule
604074|NCT00598364|genetic|genetic
604075|NCT00598364|mutation|mutation
604076|NCT00598364|malignancy|malignancy
604077|NCT00598377|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
604078|NCT00598377|Adrenal functions|adrenal functions
604079|NCT00598377|Renal volume|renal volume
604080|NCT00598377|Glomerular filtration rate|glomerular filtration rate
604081|NCT00598377|Adrenal Cortex Function Tests|adrenal cortex function tests
604082|NCT00598390|Cannabinoid|cannabinoid
604083|NCT00598390|CB1 Receptor|cb1 receptor
604084|NCT00598390|Brain Imaging|brain imaging
604085|NCT00598390|PET Imaging|pet imaging
604086|NCT00598390|[11C]MePPEP|[11c]meppep
604087|NCT00598390|Healthy Volunteer|healthy volunteer
604088|NCT00598390|HV|hv
604089|NCT00598403|Cystitis|cystitis
604090|NCT00598416|Hepatitis C|hepatitis c
604091|NCT00598416|Substance Abuse|substance abuse
604092|NCT00598416|Psychoeducation|psychoeducation
604093|NCT00598416|Psychiatric functioning|psychiatric functioning
604094|NCT00598416|Physical Functioning|physical functioning
604095|NCT00598416|Quality of Life|quality of life
604096|NCT00598416|NIAAA|niaaa
604097|NCT00598416|Alcohol|alcohol
604098|NCT00598429|NICHD Neonatal Research Network|nichd neonatal research network
604099|NCT00598429|Hypoxemic respiratory failure (HRF)|hypoxemic respiratory failure (hrf)
604100|NCT00598429|Persistent pulmonary hypertension of the newborn (PPHN)|persistent pulmonary hypertension of the newborn (pphn)
604101|NCT00598429|Prostaglandin E1 (PGE1)|prostaglandin e1 (pge1)
604102|NCT00598429|Mechanical ventilation|mechanical ventilation
604103|NCT00598429|Meconium, aspiration|meconium, aspiration
604104|NCT00598442|anemia|anemia
604105|NCT00598442|chronic kidney disease|chronic kidney disease
604106|NCT00598442|CKD|ckd
604107|NCT00598442|chronic renal failure|chronic renal failure
604108|NCT00598442|CRF|crf
604109|NCT00598442|erythropoietin|erythropoietin
604110|NCT00598442|EPO|epo
604111|NCT00598442|erythropoiesis stimulating agent|erythropoiesis stimulating agent
604112|NCT00598442|ESA|esa
604113|NCT00598442|Hematide™|hematide™
604114|NCT00598442|hemoglobin|hemoglobin
604115|NCT00598442|Hb|hb
604116|NCT00598442|Hgb|hgb
604117|NCT00598442|Omontys|omontys
604118|NCT00598442|peginesatide|peginesatide
604119|NCT00598442|red blood cell|red blood cell
604120|NCT00598442|red blood cell production|red blood cell production
604121|NCT00598455|angiomyolipomata|angiomyolipomata
604122|NCT00598455|tuberous sclerosis complex|tuberous sclerosis complex
604123|NCT00598481|SCID|scid
604124|NCT00598481|gene therapy|gene therapy
604125|NCT00598481|Adenosine deaminase|adenosine deaminase
604126|NCT00598481|retroviral vector|retroviral vector
604127|NCT00598494|effect of bedrest|effect of bedrest
604128|NCT00598494|cardiac atrophy|cardiac atrophy
604129|NCT00598507|ZK-EPO|zk-epo
604130|NCT00598507|ZK219477|zk219477
604131|NCT00598507|EpothiloneZK|epothilonezk
604132|NCT00598546|Stomach|stomach
604133|NCT00598546|Gastric|gastric
604134|NCT00598546|Stomach Tumor|stomach tumor
604135|NCT00598546|Stomach Cancer|stomach cancer
604136|NCT00598559|Acute pain|acute pain
604137|NCT00598559|Fever|fever
604138|NCT00598559|IV Acetaminophen|iv acetaminophen
604139|NCT00598559|Analgesic|analgesic
604140|NCT00598572|Deferoxamine|deferoxamine
604141|NCT00598572|Safety|safety
604142|NCT00598572|Intracerebral hemorrhage|intracerebral hemorrhage
604143|NCT00598598|Aortic valve insufficiency|aortic valve insufficiency
604144|NCT00598598|Aortic valve stenosis|aortic valve stenosis
604145|NCT00598598|3D echocardiogram|3d echocardiogram
604146|NCT00598611|urticaria|urticaria
604147|NCT00598637|drug eluting stent|drug eluting stent
604148|NCT00598637|left main disease|left main disease
604149|NCT00598650|Lewy Body Disease|lewy body disease
604150|NCT00598650|Dementia|dementia
604151|NCT00598650|Clinical Trial|clinical trial
604152|NCT00598650|Phase II|phase ii
604153|NCT00598650|E2020|e2020
604154|NCT00598650|donepezil hydrochloride|donepezil hydrochloride
604155|NCT00598663|Type 1 diabetes|type 1 diabetes
604156|NCT00598689|LASIK|lasik
604157|NCT00598689|Ocular Lubricants|ocular lubricants
604158|NCT00598689|Corneal Epithelium|corneal epithelium
604159|NCT00598689|Wound Healing|wound healing
604160|NCT00598715|In-stent restenosis|in-stent restenosis
604161|NCT00598715|In-DES-restenosis|in-des-restenosis
604162|NCT00598715|paclitaxel|paclitaxel
604163|NCT00598715|sirolimus|sirolimus
604164|NCT00598728|Survivors|survivors
604165|NCT00598728|Quality of Life|quality of life
604166|NCT00598741|Bone|bone
604167|NCT00598741|Sarcoma|sarcoma
604168|NCT00598741|04-083|04-083
604169|NCT00598754|Aortic valve stenosis|aortic valve stenosis
604170|NCT00598754|Aortic valve insufficiency|aortic valve insufficiency
604171|NCT00598754|Two dimensional echocardiography|two dimensional echocardiography
604172|NCT00598754|Three dimensional echocardiography|three dimensional echocardiography
604173|NCT00598767|Aortic valve insufficiency|aortic valve insufficiency
604174|NCT00598767|Aortic valve stenosis|aortic valve stenosis
604175|NCT00598767|3D echocardiogram|3d echocardiogram
604176|NCT00598767|3D computed tomography|3d computed tomography
604177|NCT00598780|Levocetirizine|levocetirizine
604178|NCT00598780|Xyzal|xyzal
604179|NCT00598780|Rhinitis allergic persistent|rhinitis allergic persistent
604180|NCT00598780|Rhinitis nonseasonal|rhinitis nonseasonal
604181|NCT00598806|Noninvasive Bladder Cancer|noninvasive bladder cancer
604182|NCT00598819|Cerebral Oxygenation|cerebral oxygenation
604183|NCT00598819|Oxygen Monitoring|oxygen monitoring
604184|NCT00598832|Acne Vulgaris|acne vulgaris
604185|NCT00598832|Adapalene|adapalene
604186|NCT00598845|Endometrial cancer|endometrial cancer
604187|NCT00598845|Molecular markers|molecular markers
604188|NCT00598845|Lymph node metastasis|lymph node metastasis
604189|NCT00598845|Prospective study|prospective study
604190|NCT00598845|Prognosis|prognosis
604191|NCT00598845|Cancer of Endometrium|cancer of endometrium
604192|NCT00598845|Tumor Markers, Biological|tumor markers, biological
604193|NCT00598858|prostate cancer|prostate cancer
604194|NCT00598858|Prostatectomy|prostatectomy
604195|NCT00598871|Thymosin beta 4|thymosin beta 4
604196|NCT00598871|Corneal wound healing|corneal wound healing
604197|NCT00598871|Vitrectomy|vitrectomy
604198|NCT00598871|Diabetes|diabetes
604199|NCT00598884|Clinical Protocols|clinical protocols
604200|NCT00598884|Behavioral Research|behavioral research
604201|NCT00598884|Prevention|prevention
604203|NCT00598910|HIV infection|hiv infection
604204|NCT00598923|tbi|tbi
604205|NCT00598923|traumatic brain injury|traumatic brain injury
604206|NCT00598923|epilepsy|epilepsy
604207|NCT00598936|Hypoxia|hypoxia
604208|NCT00598936|Cerebral Hypoxia|cerebral hypoxia
604209|NCT00598949|Pituitary|pituitary
604210|NCT00598949|Adenoma|adenoma
604211|NCT00598949|Tumor|tumor
604212|NCT00598949|Acromegaly|acromegaly
604213|NCT00598949|Prolactinoma|prolactinoma
604214|NCT00598949|Cushing's|cushing's
604215|NCT00598962|MAC|mac
604216|NCT00598975|Phase 2a: Multiple solid tumor types|phase 2a: multiple solid tumor types
604217|NCT00598975|Phase 2b: Second-Line Colorectal Cancer (CRC)|phase 2b: second-line colorectal cancer (crc)
604218|NCT00598988|infectious mononucleosis, mono, acupuncture|infectious mononucleosis, mono, acupuncture
604219|NCT00599001|healthy volunteer|healthy volunteer
604220|NCT00599001|research subjects|research subjects
604221|NCT00599001|Immunostimulatory sequence (ISS)|immunostimulatory sequence (iss)
604222|NCT00599001|phase 1|phase 1
604223|NCT00599014|Cardiomyopathy, heart failure, DNA,|cardiomyopathy, heart failure, dna,
604344|NCT00590785|Doxorubicin|doxorubicin
604224|NCT00599014|echocardiography, messenger RNA, natural history|echocardiography, messenger rna, natural history
604226|NCT00599053|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
604227|NCT00599053|very low birthweight|very low birthweight
604228|NCT00599066|M-Entropy|m-entropy
604230|NCT00599092|pituitary tumor|pituitary tumor
604231|NCT00599092|recurrence|recurrence
604232|NCT00599118|Atrial Fibrillation|atrial fibrillation
604233|NCT00599118|Genetics|genetics
604234|NCT00599131|Cancer of Larynx|cancer of larynx
604235|NCT00599144|Cholecystectomy|cholecystectomy
604236|NCT00599170|This is a standard phase II trial, in which patients with newly diagnosed diffuse large B cell lymphoma will receive R-CHOP with GM-CSF|this is a standard phase ii trial, in which patients with newly diagnosed diffuse large b cell lymphoma will receive r-chop with gm-csf
604237|NCT00599183|Cervical spine herniation|cervical spine herniation
604238|NCT00599183|MRI cervical spine|mri cervical spine
604239|NCT00599183|Diffusion tensor imaging cervical spine|diffusion tensor imaging cervical spine
604240|NCT00599196|Rotigotine|rotigotine
604241|NCT00599196|Neupro®|neupro®
604242|NCT00599222|AMD|amd
604243|NCT00599222|macular degeneration|macular degeneration
604244|NCT00599222|anti-VEGF|anti-vegf
604245|NCT00599222|laser treatment|laser treatment
604246|NCT00599235|Hypertension|hypertension
604247|NCT00599235|Exercise capacity|exercise capacity
604248|NCT00599235|PDE5 inhibitors|pde5 inhibitors
604249|NCT00599248|osteoarthritis, knee|osteoarthritis, knee
604250|NCT00599261|Cardiac Pacemaker, Artificial|cardiac pacemaker, artificial
604251|NCT00599274|Multiple Sclerosis|multiple sclerosis
604252|NCT00599274|Interferon beta 1a|interferon beta 1a
604253|NCT00599274|Avonex|avonex
604254|NCT00599287|ICU delirium|icu delirium
604255|NCT00599287|Hypoactive delirium|hypoactive delirium
604256|NCT00599287|Haloperidol|haloperidol
604257|NCT00599287|Methylphenidate|methylphenidate
604258|NCT00599287|Rivastigmine|rivastigmine
604259|NCT00599287|Hypoactive ICU delirium|hypoactive icu delirium
604260|NCT00599326|Exjade PCT Study|exjade pct study
604261|NCT00599326|PCT Study|pct study
604262|NCT00599326|Porphyria Cutanea Tarda|porphyria cutanea tarda
604263|NCT00599339|Rotigotine|rotigotine
604264|NCT00599339|Neupro|neupro
604265|NCT00599352|Hypovitaminosis|hypovitaminosis
604266|NCT00599352|Chronic liver disease|chronic liver disease
604267|NCT00599365|adherence|adherence
604268|NCT00599365|pharmacist intervention|pharmacist intervention
604269|NCT00599365|persistence|persistence
604270|NCT00599365|renal clinic|renal clinic
604271|NCT00599365|pill count|pill count
604272|NCT00599391|KIDNEY FAILURE, ACUTE|kidney failure, acute
604273|NCT00599391|KIDNEY FAILURE, CHRONIC|kidney failure, chronic
604274|NCT00599391|RENAL INSUFFICIENCY|renal insufficiency
604275|NCT00599404|Pharmacokinetics study|pharmacokinetics study
604276|NCT00599430|Probiotic|probiotic
604277|NCT00599430|Lactobacillus|lactobacillus
604278|NCT00599430|NCFM|ncfm
604279|NCT00599430|Bifidobacterium|bifidobacterium
604280|NCT00599430|Healthy children|healthy children
604281|NCT00599443|Cell-derived subunit influenza vaccine|cell-derived subunit influenza vaccine
604282|NCT00599443|Safety|safety
604283|NCT00599443|Reactogenicity|reactogenicity
604284|NCT00599456|Hot flashes|hot flashes
604285|NCT00599456|Menopause|menopause
604286|NCT00599456|Omega 3 fatty Acids|omega 3 fatty acids
604287|NCT00599469|Acute Confusional Senile Dementia|acute confusional senile dementia
604288|NCT00599469|Alzheimer Type Senile Dementia|alzheimer type senile dementia
604289|NCT00599469|SENILE PLAQUES|senile plaques
604290|NCT00599469|NEUROFIBRILLARY TANGLES|neurofibrillary tangles
604291|NCT00599469|NEUROPIL THREADS|neuropil threads
604292|NCT00599482|HEMOGLOBIN SC DISEASE|hemoglobin sc disease
604293|NCT00599482|HEMOGLOBIN C DISEASE|hemoglobin c disease
604294|NCT00599482|SICKLE CELL TRAIT|sickle cell trait
604295|NCT00599482|THALASSEMIA|thalassemia
604296|NCT00599495|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
604297|NCT00599495|Multiple Myeloma|multiple myeloma
604298|NCT00599508|memory|memory
604299|NCT00599508|aging|aging
604300|NCT00599521|Acne Vulgaris|acne vulgaris
604301|NCT00599521|Adapalene|adapalene
604302|NCT00599547|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
604303|NCT00599560|Meniere's disease|meniere's disease
604304|NCT00599560|stress|stress
604305|NCT00599560|vasopressin|vasopressin
604306|NCT00599560|endolymphatic sac|endolymphatic sac
604307|NCT00599560|V2 receptor|v2 receptor
604308|NCT00599560|cyclic AMP|cyclic amp
604309|NCT00599560|Plasma vasopressin level and V2R mRNA expression level in the endolymphatic sac both were significantly higher in patients with Meniere's disease.|plasma vasopressin level and v2r mrna expression level in the endolymphatic sac both were significantly higher in patients with meniere's disease.
604310|NCT00599560|In Meniere's disease, there were significant negative co-relationships between vasopressin and V2R.|in meniere's disease, there were significant negative co-relationships between vasopressin and v2r.
604311|NCT00599560|The cyclic AMP activity was basically up-regulated in the endolymphatic sac in Meniere's disease..|the cyclic amp activity was basically up-regulated in the endolymphatic sac in meniere's disease..
751780|NCT01170403|Multidetector row cardiac computed tomography|multidetector row cardiac computed tomography
604312|NCT00599560|The cyclic AMP sensitivity for vasopressin was significantly elevated in the endolymphatic sac in Meniere's disease.|the cyclic amp sensitivity for vasopressin was significantly elevated in the endolymphatic sac in meniere's disease.
604313|NCT00599573|HIV|hiv
604314|NCT00599573|cocaine dependence|cocaine dependence
604315|NCT00599573|cocaine abuse|cocaine abuse
604316|NCT00599573|cocaine addiction|cocaine addiction
604317|NCT00599573|cocaine users|cocaine users
605439|NCT00603187|Acyline|acyline
604318|NCT00599573|cocaine-related disorders|cocaine-related disorders
604319|NCT00599573|HIV Infection|hiv infection
604320|NCT00599586|migraine|migraine
604321|NCT00599586|acupuncture|acupuncture
604322|NCT00599586|efficacy|efficacy
604323|NCT00599586|safety|safety
604324|NCT00599586|meridian|meridian
604325|NCT00599586|acupoint|acupoint
604326|NCT00599599|Prolonged Exposure Therapy|prolonged exposure therapy
604327|NCT00599599|Adherence to HIV Medications|adherence to hiv medications
604328|NCT00599599|Complementary Therapies|complementary therapies
604329|NCT00599612|GW856553,|gw856553,
604330|NCT00599612|radiolabel|radiolabel
604331|NCT00599612|ADME,|adme,
604332|NCT00599625|Crohn's Disease|crohn's disease
604333|NCT00590720|Asthma|asthma
604334|NCT00590720|Bronchitis|bronchitis
604335|NCT00590772|sleep|sleep
604336|NCT00590772|somnolence|somnolence
604337|NCT00590772|allergies|allergies
604338|NCT00590772|rhinitis|rhinitis
604339|NCT00590772|fatigue|fatigue
604340|NCT00590785|High Risk|high risk
604341|NCT00590785|Breast Cancer|breast cancer
604342|NCT00590785|Positive Nodes|positive nodes
604343|NCT00590785|Cyclophosphamide|cyclophosphamide
604345|NCT00590785|96-041|96-041
604346|NCT00590798|Cardiac Catheterization|cardiac catheterization
604347|NCT00590798|Walk|walk
604348|NCT00590798|Heart Catheterization|heart catheterization
604349|NCT00590798|Coronary Disease|coronary disease
604350|NCT00590798|Heart Disease|heart disease
604351|NCT00590798|Coronary Artery Disease|coronary artery disease
604352|NCT00590811|adolescents|adolescents
604353|NCT00590811|young adults|young adults
604354|NCT00590811|dysmenorrhea|dysmenorrhea
604355|NCT00590811|pelvic pain|pelvic pain
604356|NCT00590824|Melanoma|melanoma
604357|NCT00590824|hu14.18-IL2|hu14.18-il2
604359|NCT00590837|Chemotherapy|chemotherapy
604360|NCT00590837|older|older
604361|NCT00590837|De novo AML|de novo aml
604362|NCT00590863|depression, medication, antidepressant, chronic, recurrent|depression, medication, antidepressant, chronic, recurrent
604363|NCT00590876|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
604364|NCT00590876|Hypoglycemia|hypoglycemia
604365|NCT00590876|Pancreatic Islet Cell Allotransplantation|pancreatic islet cell allotransplantation
604366|NCT00590889|artificial heart valve|artificial heart valve
604367|NCT00590889|mitral heart valve|mitral heart valve
604368|NCT00590889|aortic heart valve|aortic heart valve
604369|NCT00590889|endocarditis|endocarditis
604370|NCT00590889|Aortic valve disease requiring replacement|aortic valve disease requiring replacement
604371|NCT00590889|Mitral valve disease requiring replacement|mitral valve disease requiring replacement
604372|NCT00590902|non small cell lung cancer|non small cell lung cancer
604373|NCT00590915|ALL|all
604374|NCT00590941|Lymphoma|lymphoma
604375|NCT00590941|Rituximab|rituximab
604376|NCT00590941|CHOP|chop
604377|NCT00590954|Malignant Gliomas|malignant gliomas
604378|NCT00590954|CNS|cns
604379|NCT00590954|Brain Cancer|brain cancer
604380|NCT00590954|Cancer|cancer
604381|NCT00590954|Perifosine|perifosine
604382|NCT00590967|para-aortic lymph nodes|para-aortic lymph nodes
604383|NCT00590980|Stroke|stroke
604384|NCT00590980|TIA (transient ischemic attack)|tia (transient ischemic attack)
604385|NCT00590980|Brain|brain
604386|NCT00590980|Blood Flow|blood flow
604387|NCT00590980|Quantitative magnetic resonance angiography (QMRA)|quantitative magnetic resonance angiography (qmra)
604388|NCT00590993|MRSI|mrsi
604389|NCT00590993|MRI|mri
604390|NCT00590993|Prostate Cancer|prostate cancer
604391|NCT00591006|Phenytoin|phenytoin
604392|NCT00591006|Dilantin|dilantin
604393|NCT00591006|Corticosteroid|corticosteroid
604394|NCT00591006|Neuroprotection|neuroprotection
604395|NCT00591006|Mania|mania
604396|NCT00591006|Cognition|cognition
604397|NCT00591006|Mood|mood
604398|NCT00591006|Memory|memory
604399|NCT00591006|Hydrocortisone|hydrocortisone
604400|NCT00591006|Healthy Controls|healthy controls
604401|NCT00591006|MRI|mri
604402|NCT00591006|hippocampal activation|hippocampal activation
604403|NCT00591019|P50, Psychomotor Vigilance Test (PVT), Arousal, Reaction Time|p50, psychomotor vigilance test (pvt), arousal, reaction time
604404|NCT00591032|Critical illness|critical illness
604405|NCT00591032|Euthyroid sick syndromes|euthyroid sick syndromes
604406|NCT00591032|Intensive care|intensive care
604407|NCT00591032|Non-thyroidal illness syndrome|non-thyroidal illness syndrome
604408|NCT00591032|Low-T3 syndrome|low-t3 syndrome
604409|NCT00591045|gastric adenocarcinoma|gastric adenocarcinoma
604410|NCT00591045|neoadjuvant chemotherapy|neoadjuvant chemotherapy
604411|NCT00591045|efficacy|efficacy
604412|NCT00591045|safety|safety
604413|NCT00591045|chemotherapy|chemotherapy
606667|NCT00600301|Macula|macula
604414|NCT00591058|recurrent glioma|recurrent glioma
604415|NCT00591058|Phase I|phase i
604416|NCT00591058|Multi-Center|multi-center
604417|NCT00591058|Open label|open label
604418|NCT00591058|Brain Cancer|brain cancer
604419|NCT00591058|Brain tumor|brain tumor
604420|NCT00591058|GBM|gbm
604421|NCT00591058|Glioma|glioma
604422|NCT00591058|Glioblastoma multiforme|glioblastoma multiforme
604423|NCT00591071|hyperglycemia|hyperglycemia
604424|NCT00591071|insulin treatment|insulin treatment
604425|NCT00591071|intensive care|intensive care
604426|NCT00591071|hypoglycemia|hypoglycemia
604427|NCT00591071|mechanical ventilation|mechanical ventilation
604428|NCT00591071|critically ill patients|critically ill patients
604429|NCT00591084|randomized trial|randomized trial
604430|NCT00591084|ischemic stroke|ischemic stroke
604431|NCT00591084|Ginsenoside-Rd|ginsenoside-rd
604432|NCT00591097|urine|urine
604433|NCT00591097|pediatric|pediatric
604434|NCT00591097|Normal urine from healthy pediatric population|normal urine from healthy pediatric population
604435|NCT00591123|Unresectable|unresectable
604436|NCT00591123|Metastatic|metastatic
604437|NCT00591123|Esophagus|esophagus
604438|NCT00591123|Gastric Cardia|gastric cardia
604439|NCT00591149|cancer|cancer
604440|NCT00591149|head and neck cancer|head and neck cancer
604441|NCT00591149|squamous cell cancer|squamous cell cancer
604442|NCT00591162|Bone, Dexa, Parathyroid, Diuretic, Tetracycline|bone, dexa, parathyroid, diuretic, tetracycline
752993|NCT01175057|telemedical home monitoring|telemedical home monitoring
604443|NCT00591188|kidney cancer, capecitabine, interferon|kidney cancer, capecitabine, interferon
604444|NCT00591201|Spondylarthritis|spondylarthritis
604445|NCT00591201|TNF|tnf
604446|NCT00591201|Infliximab|infliximab
604447|NCT00591201|Ankylosing spondylitis|ankylosing spondylitis
604448|NCT00591201|Juvenile SpA|juvenile spa
604449|NCT00591201|Juvenile arthritis|juvenile arthritis
604450|NCT00591214|Chronic Hepatitis C|chronic hepatitis c
604451|NCT00591214|Protease Inhibitor|protease inhibitor
604452|NCT00591240|RNA, ribosomal, 16S|rna, ribosomal, 16s
604453|NCT00591240|Biosensing techniques|biosensing techniques
604454|NCT00591240|Microchip analytical procedures|microchip analytical procedures
604455|NCT00591253|Blood pressure|blood pressure
604456|NCT00591253|blood pressure monitoring ambulatory|blood pressure monitoring ambulatory
604457|NCT00591253|Drug Therapy|drug therapy
604458|NCT00591266|Blood pressure|blood pressure
604459|NCT00591266|blood pressure monitoring ambulatory|blood pressure monitoring ambulatory
604460|NCT00591266|Drug Therapy|drug therapy
604461|NCT00591279|large bowel cancer|large bowel cancer
604462|NCT00591279|polyps|polyps
604463|NCT00591279|colorectal cancer|colorectal cancer
604464|NCT00591292|cancer|cancer
604465|NCT00591292|tumor|tumor
604466|NCT00591292|solid tumor|solid tumor
604467|NCT00591292|advanced tumor|advanced tumor
604468|NCT00591305|papilloma|papilloma
604469|NCT00591305|PDL|pdl
604470|NCT00591305|diindolylmethane|diindolylmethane
604471|NCT00591305|recurrence|recurrence
604472|NCT00591318|Ceftriaxone|ceftriaxone
604473|NCT00591318|Psychosis|psychosis
604474|NCT00591318|Schizophrenia|schizophrenia
604475|NCT00591318|Schizoaffective Disorder|schizoaffective disorder
604476|NCT00591331|Head Lice|head lice
604477|NCT00591344|Parkinson's disease|parkinson's disease
604478|NCT00591344|exercise|exercise
604479|NCT00591357|Antibiotic associated diarrhea|antibiotic associated diarrhea
604480|NCT00591357|Clostridium difficile|clostridium difficile
604481|NCT00591357|loperamide|loperamide
604482|NCT00591370|Memorial Sloan-Kettering Cancer Center patients with measurable, unresectable stage|memorial sloan-kettering cancer center patients with measurable, unresectable stage
604483|NCT00591370|III or IV melanoma|iii or iv melanoma
604484|NCT00591383|Cancer|cancer
604485|NCT00591383|Indibulin|indibulin
604486|NCT00591383|Erlotinib|erlotinib
604487|NCT00591422|Arsenic|arsenic
604488|NCT00591422|Cancer|cancer
604489|NCT00591435|Anesthesia|anesthesia
604490|NCT00591435|Surgery|surgery
604491|NCT00591435|Education|education
604492|NCT00591435|Economics|economics
604493|NCT00591448|Thermal injury|thermal injury
604494|NCT00591461|Barrett's Esophagus|barrett's esophagus
604495|NCT00591461|Upper Endoscopy|upper endoscopy
604496|NCT00591461|Esophageal biopsies|esophageal biopsies
604497|NCT00591461|Accuracy|accuracy
604498|NCT00591461|Interobserver Agreement|interobserver agreement
604499|NCT00591474|VRE|vre
604500|NCT00591474|Probiotics|probiotics
604501|NCT00591474|colonization|colonization
604502|NCT00591474|gut health|gut health
604503|NCT00591487|suction|suction
604504|NCT00591487|assisted|assisted
604505|NCT00591487|lipectomy|lipectomy
604506|NCT00591487|liposuction|liposuction
604507|NCT00591487|contour|contour
604508|NCT00591487|cosmetic|cosmetic
604509|NCT00591487|plastic|plastic
604510|NCT00591487|surgery|surgery
604511|NCT00591487|Klein|klein
604512|NCT00591487|tumescent|tumescent
604513|NCT00591487|technique|technique
604514|NCT00591487|Healthy women wanting Suction Assisted Lipectomy|healthy women wanting suction assisted lipectomy
604515|NCT00591500|Melanoma|melanoma
604516|NCT00591500|Skin cancer|skin cancer
604517|NCT00591500|Genetic Susceptibility|genetic susceptibility
604518|NCT00591500|polymorphisms|polymorphisms
604519|NCT00591513|burns|burns
604520|NCT00591513|burn scars|burn scars
604521|NCT00591513|congenital giant nevi|congenital giant nevi
604522|NCT00591526|APL|apl
604523|NCT00591539|Carotid Artery Disease|carotid artery disease
604524|NCT00591539|Intima-Media Thickening|intima-media thickening
604525|NCT00591539|Carotid Ultrasound|carotid ultrasound
604526|NCT00591539|Pediatric Cancer Survivors|pediatric cancer survivors
604527|NCT00591539|Cancer Survivors|cancer survivors
604528|NCT00591539|Head or Neck Cancer|head or neck cancer
604529|NCT00591539|Radiation Therapy|radiation therapy
604530|NCT00591552|Lung cancer|lung cancer
604531|NCT00591552|Lymph node dissection|lymph node dissection
604532|NCT00591565|Anxiety|anxiety
604533|NCT00591565|SSRI|ssri
604534|NCT00591565|SNRI|snri
604535|NCT00591565|Acamprosate|acamprosate
604536|NCT00591578|Blood pressure|blood pressure
604537|NCT00591578|blood pressure monitoring, ambulatory|blood pressure monitoring, ambulatory
604538|NCT00591591|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
604539|NCT00591591|sleep disordered breathing|sleep disordered breathing
604540|NCT00591591|polysomnography (psg)|polysomnography (psg)
604541|NCT00591591|continuous positive airway pressure (cpap)|continuous positive airway pressure (cpap)
604542|NCT00591591|brain vascular autoregulation|brain vascular autoregulation
604543|NCT00591591|brain tissue oxygenation|brain tissue oxygenation
604544|NCT00591591|near-infrared spectroscopy|near-infrared spectroscopy
604545|NCT00591591|Obstructive Sleep Apnea|obstructive sleep apnea
604546|NCT00591604|burn|burn
604547|NCT00591604|vitamin D|vitamin d
604548|NCT00591604|nutrition|nutrition
604549|NCT00591604|burn recovery|burn recovery
604550|NCT00591617|Opioids|opioids
604551|NCT00591617|drug dependence|drug dependence
604552|NCT00591617|drug abuse|drug abuse
604553|NCT00591617|treatment|treatment
604554|NCT00591630|Diffuse Large Cell Lymphoma|diffuse large cell lymphoma
604555|NCT00591630|Lymphoma|lymphoma
604556|NCT00591630|Zevalin|zevalin
604557|NCT00591630|Ibritumomab|ibritumomab
604558|NCT00591630|IDEC-Y2B8|idec-y2b8
604559|NCT00591630|Carmustine|carmustine
604560|NCT00591630|BCNU|bcnu
604561|NCT00591630|BiCNU|bicnu
604562|NCT00591630|Etoposide|etoposide
604563|NCT00591630|VePesid|vepesid
604564|NCT00591630|Cytarabine|cytarabine
604565|NCT00591630|Ara-C|ara-c
604566|NCT00591630|Cytosar|cytosar
604567|NCT00591630|DepoCyt|depocyt
604568|NCT00591630|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
604569|NCT00591630|Melphalan|melphalan
604570|NCT00591630|Rituximab|rituximab
604571|NCT00591630|Rituxan|rituxan
604572|NCT00591630|BEAM|beam
604573|NCT00591643|Adrenal tumors|adrenal tumors
604574|NCT00591643|Adrenal malignancies|adrenal malignancies
604575|NCT00591643|abnormal hormonal secretions|abnormal hormonal secretions
604576|NCT00591643|electrolytes abnormalities|electrolytes abnormalities
604577|NCT00591643|Imaging|imaging
604578|NCT00591643|Scanning|scanning
604579|NCT00591643|tumor localization|tumor localization
604580|NCT00591669|Inflammatory bowel disease|inflammatory bowel disease
604581|NCT00591669|Crohn's disease|crohn's disease
604775|NCT00592449|Insomnia|insomnia
604582|NCT00591695|Malignant Colorectal Obstruction|malignant colorectal obstruction
604583|NCT00591695|Stent Bridge to Surgery|stent bridge to surgery
604584|NCT00591708|calcium|calcium
604585|NCT00591708|bone|bone
604586|NCT00591708|bone density|bone density
604587|NCT00591708|adolescence|adolescence
604588|NCT00591721|energy conservation education|energy conservation education
604589|NCT00591721|occupational therapy intervention|occupational therapy intervention
604590|NCT00591721|fatigue management|fatigue management
604591|NCT00591721|psychoeducation|psychoeducation
604592|NCT00591734|Metastatic Melanoma|metastatic melanoma
604593|NCT00591734|Everolimus|everolimus
604594|NCT00591734|RAD001|rad001
604595|NCT00591734|Bevacizumab|bevacizumab
604596|NCT00591747|randomized clinical trial|randomized clinical trial
604597|NCT00591747|elderly|elderly
604598|NCT00591747|cancer survivor|cancer survivor
604599|NCT00591747|bone health|bone health
604600|NCT00591747|body composition|body composition
604601|NCT00591747|signs and symptoms|signs and symptoms
604602|NCT00591760|Heart Failure|heart failure
604603|NCT00591760|Growth Hormone|growth hormone
604604|NCT00591760|Anabolism|anabolism
604605|NCT00591760|Anabolic Deficiency|anabolic deficiency
604606|NCT00591760|Hormone replacement|hormone replacement
604607|NCT00591773|Blood pressure|blood pressure
604608|NCT00591773|Blood pressure monitoring, ambulatory|blood pressure monitoring, ambulatory
604609|NCT00591838|SBRT|sbrt
604610|NCT00591851|breast cancer|breast cancer
604611|NCT00591851|adenocarcinoma of the breast|adenocarcinoma of the breast
604612|NCT00591851|cardiac safety|cardiac safety
604613|NCT00591851|Breast cancer patients seen at the Memorial Sloan-Kettering Cancer Center|breast cancer patients seen at the memorial sloan-kettering cancer center
604614|NCT00591864|Benign breast disease|benign breast disease
604615|NCT00591864|Breast|breast
604616|NCT00591864|MRI|mri
604617|NCT00591864|Mammography|mammography
604618|NCT00591864|Ultrasound|ultrasound
604619|NCT00591864|Molecular Breast Imaging|molecular breast imaging
604620|NCT00591864|Breast Cancer|breast cancer
604621|NCT00591877|GERDCAM: Complementary and alternative medicine|gerdcam: complementary and alternative medicine
604622|NCT00591877|NERD: non-erosive reflux disease|nerd: non-erosive reflux disease
604623|NCT00591877|GERD: gastroesophageal reflux disease|gerd: gastroesophageal reflux disease
604624|NCT00591877|AC: acupuncture|ac: acupuncture
605649|NCT00589979|Knee|knee
604625|NCT00591877|SAC: sham acupuncture|sac: sham acupuncture
604626|NCT00591877|LES: lower esophageal sphincter pressure|les: lower esophageal sphincter pressure
604627|NCT00591877|TLESR: transient lower esophageal sphincter relaxation|tlesr: transient lower esophageal sphincter relaxation
604628|NCT00591877|Acupuncture|acupuncture
604629|NCT00591877|Yoga|yoga
604630|NCT00591903|Diabetes and Cardiac Proteomics|diabetes and cardiac proteomics
604631|NCT00591903|Atrial Appendage and Proteomics|atrial appendage and proteomics
604632|NCT00591903|Diabetic Cardiomyopathy|diabetic cardiomyopathy
604633|NCT00591903|Tissue Sample|tissue sample
604634|NCT00591916|burn|burn
604635|NCT00591916|donor site|donor site
604636|NCT00591916|grafting|grafting
604637|NCT00591916|scar|scar
604638|NCT00591942|dental cement|dental cement
604639|NCT00591942|ceramic crowns|ceramic crowns
604640|NCT00591942|three-unit bridges|three-unit bridges
604641|NCT00591942|sensitivity|sensitivity
604642|NCT00591955|geriatric|geriatric
604643|NCT00591955|sepsis|sepsis
604644|NCT00591955|outcome assessment(healthcare)|outcome assessment(healthcare)
604645|NCT00591968|ultrasound|ultrasound
604646|NCT00591968|telediagnosis|telediagnosis
604647|NCT00591968|teleultrasound|teleultrasound
604648|NCT00591968|telesonography|telesonography
604649|NCT00591968|teleultrasonography|teleultrasonography
604650|NCT00591968|teleradiology|teleradiology
604651|NCT00591968|telemedicine|telemedicine
604652|NCT00591968|dominican republic|dominican republic
604653|NCT00591968|puntacana|puntacana
604654|NCT00591968|veron|veron
604655|NCT00591968|store-and-forward|store-and-forward
604656|NCT00591968|asynchronous|asynchronous
604657|NCT00591981|Geriatric|geriatric
604658|NCT00591981|Thoracic|thoracic
604659|NCT00591981|neoplasm|neoplasm
604660|NCT00591981|(Patients over 70 years of age) Geriatric oncology patients with thoracic neoplasms of the lung, esophagus, pleura and thymus.|(patients over 70 years of age) geriatric oncology patients with thoracic neoplasms of the lung, esophagus, pleura and thymus.
604661|NCT00591994|tinnitus|tinnitus
604662|NCT00591994|piribedil|piribedil
604663|NCT00591994|acoustic otoemissions|acoustic otoemissions
604664|NCT00591994|ECoG|ecog
604665|NCT00592007|Non Small Cell Lung Cancer|non small cell lung cancer
604666|NCT00592007|Stage IIIB|stage iiib
604667|NCT00592007|Stage IV|stage iv
604668|NCT00592007|Stable on Erlotinib|stable on erlotinib
604669|NCT00592007|Exhibit Positivity for Estrogen or Progesterone Receptor|exhibit positivity for estrogen or progesterone receptor
604670|NCT00592020|kidney|kidney
604671|NCT00592020|transplantation|transplantation
604672|NCT00592020|minimal invasive|minimal invasive
604673|NCT00592020|short transverse|short transverse
604674|NCT00592020|hockey stick|hockey stick
604675|NCT00592020|incision|incision
604676|NCT00592020|quality of life|quality of life
604677|NCT00592020|planned kidney transplantation|planned kidney transplantation
604678|NCT00592033|COPD oxygen|copd oxygen
604679|NCT00592033|COPD rehabilitation|copd rehabilitation
604680|NCT00592033|exercise|exercise
604681|NCT00592046|Phase I|phase i
604682|NCT00592046|Hematologic Cancers|hematologic cancers
604683|NCT00592046|Blood Cancers|blood cancers
604684|NCT00592046|Leukemia|leukemia
604685|NCT00592046|multiple myeloma|multiple myeloma
604686|NCT00592046|myelodysplasia (MDS)|myelodysplasia (mds)
604687|NCT00592046|Relapsed/refractory leukemia or lymphoma|relapsed/refractory leukemia or lymphoma
604688|NCT00592072|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
604689|NCT00592072|Medium Chain Fatty Acid|medium chain fatty acid
604690|NCT00592072|Hypoglycemia|hypoglycemia
604691|NCT00592085|Tobacco Use|tobacco use
604692|NCT00592085|Smoking|smoking
604693|NCT00592085|Alcohol Use|alcohol use
604694|NCT00592085|Smoking Cessation|smoking cessation
604695|NCT00592098|Lower limb amputation at least 6 months prior to inclusion|lower limb amputation at least 6 months prior to inclusion
604696|NCT00592098|Presenting with moderate-to-severe pain intensity|presenting with moderate-to-severe pain intensity
604697|NCT00592098|Outpatients, aged 18 years and above|outpatients, aged 18 years and above
604698|NCT00592111|Pediatric|pediatric
604699|NCT00592111|Hodgkin's Disease|hodgkin's disease
604700|NCT00592111|96-016|96-016
604701|NCT00592124|Microbicide|microbicide
604702|NCT00592124|HIV Seronegativity|hiv seronegativity
604703|NCT00592137|calcium carbonate|calcium carbonate
604704|NCT00592137|obesity|obesity
604705|NCT00592137|dairy|dairy
604706|NCT00592137|energy expenditure|energy expenditure
604707|NCT00592150|Essential Hypertension|essential hypertension
604708|NCT00592163|Cancer|cancer
604709|NCT00592163|Arsenic|arsenic
604710|NCT00592189|Burns|burns
604711|NCT00592189|Wound healing|wound healing
604712|NCT00592189|Amnion|amnion
604713|NCT00592202|Morbid obesity|morbid obesity
604714|NCT00592202|Adolescents|adolescents
604715|NCT00592202|Gastric restrictive procedure|gastric restrictive procedure
604716|NCT00592202|Adjustable gastric band|adjustable gastric band
604717|NCT00592202|Treatment|treatment
604718|NCT00592215|Second trimester labor induction|second trimester labor induction
604719|NCT00592228|intermediate lesion|intermediate lesion
604720|NCT00592228|drug-eluting stent|drug-eluting stent
604721|NCT00592228|fractional flow reserve|fractional flow reserve
604722|NCT00592241|Insulin Pump|insulin pump
604723|NCT00592254|ADHD|adhd
604724|NCT00592254|Adults|adults
604725|NCT00592267|pediatric|pediatric
604726|NCT00592267|bipolar disorder|bipolar disorder
604727|NCT00592280|Pancreas transplantation|pancreas transplantation
604728|NCT00592280|graft pancreatitis|graft pancreatitis
604729|NCT00592280|Two-layer method|two-layer method
604730|NCT00592280|organ preservation|organ preservation
604731|NCT00592293|proton beam radiation|proton beam radiation
604732|NCT00592306|ATG|atg
604733|NCT00592306|rabbit thymoglobulin|rabbit thymoglobulin
604734|NCT00592306|reperfusion lung injury|reperfusion lung injury
604735|NCT00592306|primary graft dysfunction|primary graft dysfunction
604736|NCT00592306|lung transplantation|lung transplantation
604737|NCT00592319|Papilloma|papilloma
604738|NCT00592319|pulsed dye laser|pulsed dye laser
604739|NCT00592319|Celebrex|celebrex
604740|NCT00592319|voice|voice
604741|NCT00592345|sarcoma of the thoracic/lumbar/spine/sacrum|sarcoma of the thoracic/lumbar/spine/sacrum
604742|NCT00592345|paraspinal soft tissues|paraspinal soft tissues
604743|NCT00592345|proton radiation therapy|proton radiation therapy
604744|NCT00592345|photon radiation therapy|photon radiation therapy
604745|NCT00592345|radiation applicator plaque|radiation applicator plaque
604746|NCT00592358|bipolar disorder|bipolar disorder
604747|NCT00592358|children|children
604748|NCT00592358|adolescents|adolescents
604749|NCT00592358|Invega|invega
604750|NCT00592384|spinal cord injuries|spinal cord injuries
604751|NCT00592384|major depressive disorder|major depressive disorder
604752|NCT00592384|dysthymia|dysthymia
604753|NCT00592384|antidepressant agents|antidepressant agents
604754|NCT00592384|pain|pain
604755|NCT00592384|quality of life|quality of life
604756|NCT00592384|muscle spasticity|muscle spasticity
604757|NCT00592384|community participation|community participation
604758|NCT00592384|anxiety|anxiety
604759|NCT00592397|Dietary Intervention|dietary intervention
604760|NCT00592397|Nutrigenomics|nutrigenomics
604761|NCT00592397|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
604762|NCT00592397|Gene Expression|gene expression
604763|NCT00592397|Gene Expression Profiling|gene expression profiling
604764|NCT00592397|Oligonucleotide Array Sequence Analysis|oligonucleotide array sequence analysis
604765|NCT00592397|Biological Markers|biological markers
604766|NCT00592397|Food|food
604767|NCT00592397|Obesity|obesity
604768|NCT00592397|Blood|blood
604769|NCT00592397|Subcutaneous Fat, Abdominal|subcutaneous fat, abdominal
604770|NCT00592423|Lateral neck rotation|lateral neck rotation
604771|NCT00592423|Continuous Positive Airway Pressure|continuous positive airway pressure
604772|NCT00592436|ADHD|adhd
604773|NCT00592436|pediatric|pediatric
604774|NCT00592436|children|children
604776|NCT00592449|Knee pain|knee pain
604777|NCT00592449|Osteoarthritis|osteoarthritis
604778|NCT00592449|Arthritis|arthritis
604779|NCT00592449|Sleep|sleep
604780|NCT00592462|Breast Cancer|breast cancer
604781|NCT00592462|Whole Body MRI|whole body mri
604782|NCT00592462|Magnetic Resonance Imaging|magnetic resonance imaging
604783|NCT00592462|Metastases|metastases
604784|NCT00592475|conivaptan|conivaptan
604785|NCT00592475|Liver Cirrhosis|liver cirrhosis
604786|NCT00592475|Hypertension, Portal|hypertension, portal
604787|NCT00592488|Septic shock|septic shock
604788|NCT00592488|Acetyl-L-carnitine|acetyl-l-carnitine
604789|NCT00592501|proton radiation|proton radiation
604790|NCT00592501|photon radiation|photon radiation
604791|NCT00592501|5-FU|5-fu
604792|NCT00592501|cisplatin|cisplatin
604793|NCT00592514|Patients undergoing head and neck surgery that involves the upper aerodigestive tract|patients undergoing head and neck surgery that involves the upper aerodigestive tract
604794|NCT00592553|Duchenne muscular dystrophy|duchenne muscular dystrophy
604795|NCT00592553|Becker muscular dystrophy|becker muscular dystrophy
604796|NCT00592553|Nonsense mutation|nonsense mutation
604797|NCT00592553|Premature stop codon|premature stop codon
604798|NCT00592553|DMD/BMD|dmd/bmd
604799|NCT00592553|PTC124|ptc124
604800|NCT00592566|Severe leptospirosis|severe leptospirosis
604801|NCT00592566|Pulmonary hemorrhage|pulmonary hemorrhage
604802|NCT00592592|pediatric rhabdomyosarcoma|pediatric rhabdomyosarcoma
604803|NCT00592592|proton radiation therapy|proton radiation therapy
604804|NCT00592618|ESRD|esrd
604805|NCT00592618|Hemodialysis|hemodialysis
604806|NCT00592618|Sleep Apnea|sleep apnea
604807|NCT00592631|asthma|asthma
604808|NCT00592631|sleep apnea|sleep apnea
604809|NCT00592644|ectasia|ectasia
604810|NCT00592644|vascular lesions|vascular lesions
604811|NCT00592644|vocal cords|vocal cords
604812|NCT00592644|voice|voice
604813|NCT00592644|pulsed dye laser|pulsed dye laser
604814|NCT00592657|retrospective chart review|retrospective chart review
604815|NCT00592657|Jimsonweed ingestion|jimsonweed ingestion
604816|NCT00592683|bipolar disorder|bipolar disorder
604817|NCT00592683|fish oil|fish oil
604818|NCT00592683|aripiprazole|aripiprazole
604819|NCT00592683|children|children
604820|NCT00592696|Adolescent depression|adolescent depression
605650|NCT00589979|Lidoderm|lidoderm
604821|NCT00592696|Adolescent smoking|adolescent smoking
604822|NCT00592748|charged particle radiation therapy|charged particle radiation therapy
604823|NCT00592761|Deglutition Disorders|deglutition disorders
604824|NCT00592761|Mendelsohn Maneuver|mendelsohn maneuver
604826|NCT00592774|Post-Herpetic Neuralgia|post-herpetic neuralgia
604827|NCT00592774|PHN)|phn)
604828|NCT00592800|statistics|statistics
604829|NCT00592800|probability|probability
604830|NCT00592813|rehabilitation|rehabilitation
604831|NCT00592813|function|function
604832|NCT00592826|PHP|php
604833|NCT00592826|HMP|hmp
604834|NCT00592826|HPHP|hphp
604835|NCT00592826|AMD|amd
604836|NCT00592826|CNV|cnv
604837|NCT00592839|Nocturnal vasomotor symptoms in postmenopausal women|nocturnal vasomotor symptoms in postmenopausal women
604838|NCT00592852|bipolar disorder|bipolar disorder
604839|NCT00592852|obsessive compulsive disorder|obsessive compulsive disorder
604840|NCT00592852|Prozac|prozac
604841|NCT00592891|brain injury|brain injury
604842|NCT00592891|brain disorders|brain disorders
604843|NCT00592904|Neuralgia|neuralgia
604844|NCT00592904|neuropathy|neuropathy
604845|NCT00592917|osteoporosis|osteoporosis
604846|NCT00592917|fractures|fractures
604847|NCT00592917|risk of fracture|risk of fracture
604848|NCT00592917|vitamin-D|vitamin-d
604849|NCT00592917|calcium|calcium
604850|NCT00592917|falls|falls
604851|NCT00592917|bone mineral density|bone mineral density
604852|NCT00592917|bone metabolism|bone metabolism
604853|NCT00592930|anorexia nervosa, treatment, adolescents, olanzapine|anorexia nervosa, treatment, adolescents, olanzapine
604854|NCT00592943|Adults|adults
604855|NCT00592943|Healthy Volunteers|healthy volunteers
604856|NCT00592943|Nuvigil|nuvigil
604857|NCT00592943|Armodafinil|armodafinil
604858|NCT00592943|DAT occupancy in healthy volunteers|dat occupancy in healthy volunteers
604859|NCT00593008|metastatic pancreatic cancer|metastatic pancreatic cancer
604860|NCT00593021|Obscure Gastrointestinal Bleeding|obscure gastrointestinal bleeding
604861|NCT00593021|Occult Gastrointestinal Bleeding|occult gastrointestinal bleeding
604862|NCT00593021|Overt Gastrointestinal Bleeding|overt gastrointestinal bleeding
604863|NCT00593021|Capsule Endoscopy|capsule endoscopy
604864|NCT00593021|CT Enterography|ct enterography
604865|NCT00593034|Alcohol abuse|alcohol abuse
604866|NCT00593034|Drug abuse|drug abuse
604867|NCT00593047|hypercholesterolemia|hypercholesterolemia
604868|NCT00593060|Temsirolimus|temsirolimus
604869|NCT00593060|cetuximab|cetuximab
604870|NCT00593060|metastatic disease|metastatic disease
604871|NCT00593086|wound care|wound care
604872|NCT00593099|Bipolar Disorder|bipolar disorder
604873|NCT00593099|Nicotine Dependence|nicotine dependence
604874|NCT00593099|Smoking Cessation|smoking cessation
604875|NCT00593099|Bupropion, sustained-release|bupropion, sustained-release
604876|NCT00593112|HMRS Scanning|hmrs scanning
604877|NCT00593112|ADHD|adhd
604878|NCT00593112|Child|child
604879|NCT00593112|Adolescent|adolescent
604880|NCT00593112|HMRS Scans|hmrs scans
604881|NCT00593125|cocaine|cocaine
604882|NCT00593125|opioids|opioids
604883|NCT00593125|heroin|heroin
604884|NCT00593125|levetiracetam|levetiracetam
604885|NCT00593138|Focalin XR|focalin xr
604886|NCT00593138|Adult|adult
604887|NCT00593138|PET scan|pet scan
604888|NCT00593151|Antimetabolites|antimetabolites
604889|NCT00593151|Virus Diseases|virus diseases
604890|NCT00593151|Anti-Infective Agents|anti-infective agents
604891|NCT00593151|RNA Virus Infections|rna virus infections
604892|NCT00593151|Digestive System Diseases|digestive system diseases
604893|NCT00593151|Flaviviridae Infections|flaviviridae infections
604894|NCT00593151|Antineoplastic Agents|antineoplastic agents
604895|NCT00593151|Therapeutic Uses|therapeutic uses
604896|NCT00593151|Antiviral Agents|antiviral agents
604897|NCT00593151|Molecular Mechanisms of Action|molecular mechanisms of action
604898|NCT00593151|Pharmacologic Actions|pharmacologic actions
604899|NCT00593164|Hypothermia, Induced|hypothermia, induced
604900|NCT00593164|Death, Sudden, Cardiac|death, sudden, cardiac
604901|NCT00593164|Resuscitation|resuscitation
604902|NCT00593164|Coma|coma
604903|NCT00593177|Plaque psoriasis|plaque psoriasis
604904|NCT00593177|Psoriasis|psoriasis
604905|NCT00593216|functional magnetic Resonance Imaging|functional magnetic resonance imaging
604906|NCT00593216|vertigo|vertigo
604907|NCT00593216|vestibular|vestibular
604908|NCT00593229|Thrombotic microangiopathy (TMA)|thrombotic microangiopathy (tma)
604909|NCT00593229|Hemolytic uremic syndrome (HUS)|hemolytic uremic syndrome (hus)
751781|NCT01170403|type 2 diabetes|type 2 diabetes
604910|NCT00593229|Thrombotic thrombocytopenic purpura (TTP)|thrombotic thrombocytopenic purpura (ttp)
604911|NCT00599651|Respiratory Distress Syndrome|respiratory distress syndrome
604912|NCT00599651|Newborn RDS|newborn rds
604913|NCT00599664|Urinary Calculi|urinary calculi
604914|NCT00599664|Urinary Stones|urinary stones
604915|NCT00599664|Urinary Tract Stones|urinary tract stones
604916|NCT00599664|Calculi|calculi
604917|NCT00599677|acupuncture|acupuncture
604918|NCT00599677|meridian|meridian
604919|NCT00599677|acupoint|acupoint
604920|NCT00599690|Epi-LASIK-LASIK microkeratome|epi-lasik-lasik microkeratome
604921|NCT00599690|Corneal thickness|corneal thickness
604922|NCT00599690|Confocal microscope|confocal microscope
604923|NCT00599716|dry eye syndrome|dry eye syndrome
604924|NCT00599716|dry eye disease|dry eye disease
604925|NCT00599716|Vismed|vismed
604926|NCT00599716|dry eye|dry eye
604927|NCT00599716|sodium hyaluronate|sodium hyaluronate
604928|NCT00599716|hyaluronic acid|hyaluronic acid
604929|NCT00599742|Balance disorder|balance disorder
604930|NCT00599742|Vestibular disorder|vestibular disorder
604931|NCT00599742|Generalized anxiety disorder|generalized anxiety disorder
604932|NCT00599742|Separation anxiety disorder|separation anxiety disorder
604933|NCT00599742|Children|children
604934|NCT00599742|Balance training|balance training
604935|NCT00599781|adenosine deaminase|adenosine deaminase
604936|NCT00599781|SCID|scid
604937|NCT00599781|gene therapy|gene therapy
604938|NCT00599781|retroviral vector|retroviral vector
604939|NCT00599794|Sepsis|sepsis
604940|NCT00599794|Intravascular volume|intravascular volume
604941|NCT00599794|Ultrasound|ultrasound
604942|NCT00599794|Noninvasive measurement|noninvasive measurement
604943|NCT00599820|Angioid Streaks|angioid streaks
604944|NCT00599820|Choroidal Neovascularization|choroidal neovascularization
604945|NCT00599820|Bevacizumab|bevacizumab
604946|NCT00599833|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
604947|NCT00599833|stage III pancreatic cancer|stage iii pancreatic cancer
604948|NCT00599846|age-related macular degeneration|age-related macular degeneration
605576|NCT00603668|CLL|cll
604949|NCT00599846|geographic atrophy|geographic atrophy
604950|NCT00599859|lactase|lactase
604951|NCT00599859|lactose|lactose
604952|NCT00599859|microflora|microflora
604953|NCT00599872|Allergy|allergy
604954|NCT00599872|Sublingual Immunotherapy|sublingual immunotherapy
604955|NCT00599872|Allergic Rhinitis|allergic rhinitis
604956|NCT00599898|Preterm labor|preterm labor
604957|NCT00599898|Atosiban|atosiban
604958|NCT00599898|Nifedipine|nifedipine
604959|NCT00599911|Drug therapy|drug therapy
604960|NCT00599911|Depressive disorder|depressive disorder
604961|NCT00599911|Antidepressive agents|antidepressive agents
604962|NCT00599911|Depressive symptoms|depressive symptoms
604963|NCT00599911|Affective disorders|affective disorders
604964|NCT00599911|Randomized controlled trial|randomized controlled trial
604965|NCT00599911|Placebo-controlled|placebo-controlled
604966|NCT00599911|Double-blind|double-blind
604967|NCT00599911|Active reference|active reference
604968|NCT00599911|Multicenter study|multicenter study
604969|NCT00599924|advanced solid tumors,|advanced solid tumors,
604970|NCT00599924|colorectal cancer,|colorectal cancer,
604971|NCT00599924|sunitinib (SUTENT),|sunitinib (sutent),
604972|NCT00599924|FOLFOX|folfox
604973|NCT00599937|APL|apl
604974|NCT00599950|Mitomycin C|mitomycin c
604975|NCT00599950|Corneal epithelium|corneal epithelium
604976|NCT00599950|Photorefractive keratectomy (PRK)|photorefractive keratectomy (prk)
604977|NCT00599950|Confocal microscope|confocal microscope
604979|NCT00601185|Confocal reflectance microscopy|confocal reflectance microscopy
604980|NCT00601185|shave-biopsy|shave-biopsy
604981|NCT00601198|Oxaliplatin-induced Neuropathy|oxaliplatin-induced neuropathy
604982|NCT00601198|Colon and rectum|colon and rectum
604983|NCT00601224|Social Cognition|social cognition
604984|NCT00601224|Group Therapy|group therapy
604985|NCT00601224|Psychosocial Intervention|psychosocial intervention
604986|NCT00601237|HIV Prevention|hiv prevention
604987|NCT00601237|Mobile Phone|mobile phone
604988|NCT00601237|Technology-Based Intervention|technology-based intervention
604989|NCT00601237|HIV|hiv
604990|NCT00601237|HIV Seronegativity|hiv seronegativity
604991|NCT00601263|Chinese Herbal Therapy|chinese herbal therapy
604992|NCT00601263|Asthma|asthma
604993|NCT00601263|Investigational new drug (IND)|investigational new drug (ind)
604994|NCT00601263|Complementary and Alternative Medicine|complementary and alternative medicine
604995|NCT00601276|pedophilia|pedophilia
604996|NCT00601276|antiandrogens|antiandrogens
604997|NCT00601276|gonadotropin releasing hormone agonists|gonadotropin releasing hormone agonists
604998|NCT00601289|pituitary chromophobe adenoma|pituitary chromophobe adenoma
604999|NCT00601289|recurrent pituitary tumor|recurrent pituitary tumor
605000|NCT00601289|ACTH-producing pituitary tumor|acth-producing pituitary tumor
605001|NCT00601289|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
605002|NCT00601289|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
605003|NCT00601289|pituitary basophilic adenoma|pituitary basophilic adenoma
605004|NCT00601289|pituitary eosinophilic adenoma|pituitary eosinophilic adenoma
605005|NCT00601289|prolactin secreting adenoma|prolactin secreting adenoma
605006|NCT00601289|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
605008|NCT00601341|joint pain|joint pain
605009|NCT00601341|knee injuries|knee injuries
605010|NCT00601341|knee joint|knee joint
605011|NCT00601341|low back pain|low back pain
605012|NCT00601354|Binge Eating|binge eating
605013|NCT00601354|Orlistat|orlistat
605014|NCT00601354|Alli|alli
605015|NCT00601354|Guided Self-Help|guided self-help
605016|NCT00601406|male breast cancer|male breast cancer
605651|NCT00589979|Lidocaine|lidocaine
605017|NCT00601406|stage IA breast cancer|stage ia breast cancer
605018|NCT00601406|stage IB breast cancer|stage ib breast cancer
605019|NCT00601406|stage II breast cancer|stage ii breast cancer
605020|NCT00601406|stage I prostate cancer|stage i prostate cancer
605021|NCT00601406|stage IIB prostate cancer|stage iib prostate cancer
605022|NCT00601406|stage IIA prostate cancer|stage iia prostate cancer
605023|NCT00601406|stage III prostate cancer|stage iii prostate cancer
605024|NCT00601406|stage IA cervical cancer|stage ia cervical cancer
605025|NCT00601406|stage IB cervical cancer|stage ib cervical cancer
605026|NCT00601406|stage IIA cervical cancer|stage iia cervical cancer
605027|NCT00601406|stage IIB cervical cancer|stage iib cervical cancer
605028|NCT00601406|stage III cervical cancer|stage iii cervical cancer
605029|NCT00601406|stage IVA cervical cancer|stage iva cervical cancer
605030|NCT00601406|stage IVB cervical cancer|stage ivb cervical cancer
605031|NCT00601406|stage I vaginal cancer|stage i vaginal cancer
605032|NCT00601406|stage II vaginal cancer|stage ii vaginal cancer
605033|NCT00601406|stage III vaginal cancer|stage iii vaginal cancer
605034|NCT00601406|stage IVA vaginal cancer|stage iva vaginal cancer
605035|NCT00601406|stage IVB vaginal cancer|stage ivb vaginal cancer
605036|NCT00601406|stage IA vulvar cancer|stage ia vulvar cancer
605037|NCT00601406|stage IB vulvar cancer|stage ib vulvar cancer
605038|NCT00601406|stage II vulvar cancer|stage ii vulvar cancer
605039|NCT00601406|stage IIIC vulvar cancer|stage iiic vulvar cancer
605040|NCT00601406|stage IIIA vulvar cancer|stage iiia vulvar cancer
605041|NCT00601406|stage IIIB vulvar cancer|stage iiib vulvar cancer
605042|NCT00601406|stage IVB vulvar cancer|stage ivb vulvar cancer
605043|NCT00601406|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
605044|NCT00601406|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
605045|NCT00601406|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
605046|NCT00601406|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
605047|NCT00601406|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
605048|NCT00601406|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
605049|NCT00601406|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
605050|NCT00601406|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
605051|NCT00601406|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
605052|NCT00601406|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
605053|NCT00601406|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
605054|NCT00601406|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
605055|NCT00601406|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
605056|NCT00601406|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
605057|NCT00601406|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
605058|NCT00601406|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
605134|NCT00601653|Nutrition|nutrition
605059|NCT00601406|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
605060|NCT00601406|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
605061|NCT00601406|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
605062|NCT00601406|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
605063|NCT00601406|stage II endometrial carcinoma|stage ii endometrial carcinoma
605064|NCT00601406|ovarian stromal cancer|ovarian stromal cancer
605065|NCT00601406|ovarian sarcoma|ovarian sarcoma
605066|NCT00601406|stage IA fallopian tube cancer|stage ia fallopian tube cancer
605067|NCT00601406|stage IB fallopian tube cancer|stage ib fallopian tube cancer
605068|NCT00601406|stage IC fallopian tube cancer|stage ic fallopian tube cancer
605069|NCT00601406|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
605070|NCT00601406|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
605071|NCT00601406|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
605072|NCT00601406|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
605073|NCT00601406|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
605074|NCT00601406|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
605075|NCT00601406|stage IV fallopian tube cancer|stage iv fallopian tube cancer
605076|NCT00601406|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
605077|NCT00601406|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
605078|NCT00601406|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
605079|NCT00601406|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
605080|NCT00601406|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
605081|NCT00601406|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
605082|NCT00601406|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
605083|NCT00601406|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
605084|NCT00601406|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
605085|NCT00601406|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
605086|NCT00601406|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
605087|NCT00601406|stage IA endometrial carcinoma|stage ia endometrial carcinoma
605088|NCT00601406|stage IB endometrial carcinoma|stage ib endometrial carcinoma
605089|NCT00601406|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
605090|NCT00601406|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
605091|NCT00601406|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
605092|NCT00601406|stage IVA endometrial carcinoma|stage iva endometrial carcinoma
605093|NCT00601406|stage IVB endometrial carcinoma|stage ivb endometrial carcinoma
605094|NCT00601406|stage IA uterine sarcoma|stage ia uterine sarcoma
605095|NCT00601406|stage IB uterine sarcoma|stage ib uterine sarcoma
605096|NCT00601406|stage IC uterine sarcoma|stage ic uterine sarcoma
605097|NCT00601406|stage IIA uterine sarcoma|stage iia uterine sarcoma
605098|NCT00601406|stage IIB uterine sarcoma|stage iib uterine sarcoma
605099|NCT00601406|stage IIIA uterine sarcoma|stage iiia uterine sarcoma
605100|NCT00601406|stage IIIB uterine sarcoma|stage iiib uterine sarcoma
605101|NCT00601406|stage IIIC uterine sarcoma|stage iiic uterine sarcoma
605102|NCT00601406|stage IVA uterine sarcoma|stage iva uterine sarcoma
605103|NCT00601406|stage IVB uterine sarcoma|stage ivb uterine sarcoma
605104|NCT00601432|open-label|open-label
605105|NCT00601432|randomized|randomized
605106|NCT00601432|crossover|crossover
605107|NCT00601432|food effect|food effect
605108|NCT00601445|Changes in sleep with aging|changes in sleep with aging
605109|NCT00601458|Primary, unilateral, first metatarsal bunionectomy with osteotomy|primary, unilateral, first metatarsal bunionectomy with osteotomy
605110|NCT00601471|ankle sprain|ankle sprain
605111|NCT00601471|ankle injuries|ankle injuries
605112|NCT00601471|sprains and strains|sprains and strains
605113|NCT00601484|Painful Bladder Syndrome, monoclonal antibody|painful bladder syndrome, monoclonal antibody
605114|NCT00601510|stage III gastric cancer|stage iii gastric cancer
605115|NCT00601510|stage IV gastric cancer|stage iv gastric cancer
605116|NCT00601549|Rectal cancer|rectal cancer
605117|NCT00601549|CCRT|ccrt
605118|NCT00601549|Laparoscopic Surgery|laparoscopic surgery
605119|NCT00601549|rectal cancer can be resected by curative and elective surgery|rectal cancer can be resected by curative and elective surgery
605120|NCT00601549|rectal adenocarcinoma below peritoneal reflection|rectal adenocarcinoma below peritoneal reflection
605121|NCT00601549|American Society of Anesthesiology（ASA） classⅠ to Ⅲ lesions|american society of anesthesiology（asa） classⅰ to ⅲ lesions
605122|NCT00601562|HIV|hiv
605123|NCT00601601|stage 0 cervical cancer|stage 0 cervical cancer
605124|NCT00601601|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
605125|NCT00601601|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
605126|NCT00601601|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
605127|NCT00601614|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
605128|NCT00601627|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
605129|NCT00601627|stage II pancreatic cancer|stage ii pancreatic cancer
605130|NCT00601627|stage III pancreatic cancer|stage iii pancreatic cancer
605131|NCT00601640|skin cancer|skin cancer
605132|NCT00601653|Binge Eating Disorder|binge eating disorder
605133|NCT00601653|BED|bed
605135|NCT00601653|Energy Density|energy density
605136|NCT00601653|Cognitive Behavioral Therapy|cognitive behavioral therapy
605137|NCT00601653|CBT|cbt
605138|NCT00601679|CHF treatment&prognosis,NT-proBNP testing.|chf treatment&prognosis,nt-probnp testing.
605139|NCT00601692|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
605140|NCT00601692|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
605141|NCT00601692|stage II esophageal cancer|stage ii esophageal cancer
605142|NCT00601692|stage III esophageal cancer|stage iii esophageal cancer
605143|NCT00601692|stage IV esophageal cancer|stage iv esophageal cancer
605144|NCT00601705|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
605145|NCT00601705|adenocarcinoma of the stomach|adenocarcinoma of the stomach
605146|NCT00601705|stage III esophageal cancer|stage iii esophageal cancer
605147|NCT00601705|stage IV esophageal cancer|stage iv esophageal cancer
605148|NCT00601705|stage III gastric cancer|stage iii gastric cancer
605149|NCT00601705|stage IV gastric cancer|stage iv gastric cancer
605150|NCT00601705|stage II esophageal cancer|stage ii esophageal cancer
605151|NCT00601705|stage II gastric cancer|stage ii gastric cancer
605152|NCT00601731|Prevention of Meningococcal disease|prevention of meningococcal disease
605153|NCT00601744|Orbital Exenteration|orbital exenteration
605154|NCT00601744|Eye Cancer|eye cancer
605155|NCT00601744|Social-Psychological Aspects|social-psychological aspects
605156|NCT00601744|Quality of Life|quality of life
605157|NCT00601744|Questionnaire|questionnaire
605158|NCT00601744|Facial Appearance|facial appearance
605159|NCT00601744|Survey|survey
605160|NCT00601744|Interview|interview
605161|NCT00601757|Preventive Intervention|preventive intervention
605162|NCT00601757|Postpartum Depression|postpartum depression
605163|NCT00601757|Women on Public Assistance|women on public assistance
605164|NCT00601796|adenocarcinoma of the lung|adenocarcinoma of the lung
605165|NCT00601796|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
605166|NCT00601809|Gastrointestinal|gastrointestinal
605167|NCT00601809|Adhesive Small Intestine Obstruction|adhesive small intestine obstruction
605168|NCT00601809|Oral water soluble contrast|oral water soluble contrast
605169|NCT00601809|Non-operative Conservative Management|non-operative conservative management
605170|NCT00601809|Operative rate|operative rate
605171|NCT00601809|Hospital stay|hospital stay
605172|NCT00601835|Diphtheria|diphtheria
605173|NCT00601835|Tetanus|tetanus
605174|NCT00601848|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
605175|NCT00601848|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
605176|NCT00601848|malignant pleural effusion|malignant pleural effusion
605177|NCT00601887|Anti-inflammatory|anti-inflammatory
605178|NCT00601913|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
605179|NCT00601913|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
605180|NCT00601913|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
605181|NCT00601913|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
605182|NCT00601913|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
753139|NCT01175629|Metabolic Diseases|metabolic diseases
605183|NCT00601913|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
605184|NCT00601913|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
605185|NCT00601913|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
605186|NCT00601913|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
605187|NCT00601913|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
605188|NCT00601913|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
605189|NCT00601926|papillary renal cell carcinoma|papillary renal cell carcinoma
605190|NCT00601926|stage III renal cell cancer|stage iii renal cell cancer
605191|NCT00601926|stage IV renal cell cancer|stage iv renal cell cancer
605192|NCT00601939|Abused|abused
605193|NCT00601939|Female|female
605194|NCT00601939|African American|african american
605195|NCT00601939|Group Empowerment Psychoeducational Intervention|group empowerment psychoeducational intervention
605196|NCT00601939|Enhanced Treatment as Usual|enhanced treatment as usual
605197|NCT00601952|post traumatic stress disorder|post traumatic stress disorder
605198|NCT00601952|cognitive bias|cognitive bias
605199|NCT00601952|attention|attention
605200|NCT00601952|combat|combat
605201|NCT00601978|Parkinson's disease|parkinson's disease
605202|NCT00601978|carbidopa/levodopa/entacapone|carbidopa/levodopa/entacapone
605203|NCT00601978|carbidopa/levodopa|carbidopa/levodopa
605204|NCT00601978|non-motor symptoms|non-motor symptoms
605205|NCT00601978|event-related potential|event-related potential
605208|NCT00601978|electroencephalogram|electroencephalogram
605209|NCT00601991|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
605210|NCT00601991|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
605211|NCT00602004|Arteriovenous fistula|arteriovenous fistula
605212|NCT00602004|hypertrophy|hypertrophy
605213|NCT00602004|losartan|losartan
605214|NCT00602030|lung cancer|lung cancer
605215|NCT00602030|NSCLC|nsclc
605216|NCT00602030|lung neoplasms|lung neoplasms
605217|NCT00602030|respiratory|respiratory
605218|NCT00602056|Immunization dropout|immunization dropout
605219|NCT00602056|Immunization card|immunization card
605220|NCT00602056|Center based education|center based education
605221|NCT00602069|PTSD|ptsd
605222|NCT00602069|Intimate Partner Violence|intimate partner violence
605223|NCT00602069|Cognitive Behavioral Therapy|cognitive behavioral therapy
605224|NCT00602069|Empowerment|empowerment
605225|NCT00602082|pancreatic alpha cell adenoma|pancreatic alpha cell adenoma
605226|NCT00602082|pancreatic alpha cell carcinoma|pancreatic alpha cell carcinoma
605227|NCT00602082|pancreatic beta islet cell adenoma|pancreatic beta islet cell adenoma
605228|NCT00602082|pancreatic beta islet cell carcinoma|pancreatic beta islet cell carcinoma
605229|NCT00602082|pancreatic delta cell adenoma|pancreatic delta cell adenoma
605230|NCT00602082|pancreatic delta cell carcinoma|pancreatic delta cell carcinoma
605231|NCT00602082|pancreatic G-cell adenoma|pancreatic g-cell adenoma
605232|NCT00602082|pancreatic G-cell carcinoma|pancreatic g-cell carcinoma
605233|NCT00602082|gastrinoma|gastrinoma
605234|NCT00602082|insulinoma|insulinoma
605235|NCT00602082|glucagonoma|glucagonoma
605236|NCT00602082|pancreatic polypeptide tumor|pancreatic polypeptide tumor
605237|NCT00602082|somatostatinoma|somatostatinoma
605238|NCT00602082|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
605239|NCT00602082|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
605240|NCT00602082|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
605241|NCT00602082|islet cell carcinoma|islet cell carcinoma
605242|NCT00602082|recurrent islet cell carcinoma|recurrent islet cell carcinoma
605243|NCT00602095|Labor induction|labor induction
605244|NCT00602095|cervical ripening|cervical ripening
605245|NCT00602095|misoprostol|misoprostol
605246|NCT00602095|dinoprostone|dinoprostone
605247|NCT00602095|balloon catheter|balloon catheter
605248|NCT00602095|prostaglandin|prostaglandin
605249|NCT00602108|stage I breast cancer|stage i breast cancer
605250|NCT00602108|stage II breast cancer|stage ii breast cancer
605251|NCT00602147|mucositis|mucositis
605252|NCT00602147|stage I multiple myeloma|stage i multiple myeloma
605253|NCT00602147|stage II multiple myeloma|stage ii multiple myeloma
605254|NCT00602147|stage III multiple myeloma|stage iii multiple myeloma
605255|NCT00602147|refractory multiple myeloma|refractory multiple myeloma
605256|NCT00602160|Food allergy|food allergy
605257|NCT00602160|Chinese Herbs|chinese herbs
605258|NCT00602160|Investigational new drug|investigational new drug
605259|NCT00602160|Herbs|herbs
605260|NCT00602160|Therapeutic medicine|therapeutic medicine
605261|NCT00602160|Traditional Chinese medicine|traditional chinese medicine
605262|NCT00602186|female voiding dysfunction|female voiding dysfunction
605263|NCT00602186|Tamsolusin|tamsolusin
605264|NCT00602186|prazosin|prazosin
605265|NCT00602199|stage IV melanoma|stage iv melanoma
605266|NCT00602212|generalized anxiety disorder (GAD)|generalized anxiety disorder (gad)
605267|NCT00602264|Anorexia nervosa|anorexia nervosa
605268|NCT00602264|Adipokines|adipokines
605269|NCT00602264|Ghrelin|ghrelin
605270|NCT00602264|Fat mass|fat mass
605271|NCT00602290|Major Depression|major depression
605272|NCT00602290|Geriatric Major Unipolar Depression|geriatric major unipolar depression
605273|NCT00602290|Executive Cognitive Dysfunction|executive cognitive dysfunction
605274|NCT00602290|Elderly|elderly
605275|NCT00602290|Geriatric|geriatric
605276|NCT00602290|Executive Cognitive Impairment|executive cognitive impairment
605277|NCT00602290|Quality of Life|quality of life
605278|NCT00602290|Disability|disability
605279|NCT00602290|Comorbidity|comorbidity
605280|NCT00602290|Medical Burden|medical burden
605281|NCT00602290|Safety|safety
605282|NCT00602290|Candidate Genes|candidate genes
605283|NCT00602316|invasive ductal breast carcinoma|invasive ductal breast carcinoma
605284|NCT00602316|stage IA breast cancer|stage ia breast cancer
605285|NCT00602316|stage IB breast cancer|stage ib breast cancer
605286|NCT00602316|stage II breast cancer|stage ii breast cancer
605287|NCT00602316|stage IIIA breast cancer|stage iiia breast cancer
605288|NCT00602329|recurrent colon cancer|recurrent colon cancer
605289|NCT00602329|recurrent rectal cancer|recurrent rectal cancer
605290|NCT00602329|stage III colon cancer|stage iii colon cancer
605291|NCT00602329|stage III rectal cancer|stage iii rectal cancer
605292|NCT00602329|stage IV colon cancer|stage iv colon cancer
605293|NCT00602329|stage IV rectal cancer|stage iv rectal cancer
605294|NCT00602329|adenocarcinoma of the colon|adenocarcinoma of the colon
605295|NCT00602329|adenocarcinoma of the rectum|adenocarcinoma of the rectum
605296|NCT00602355|Postpartum|postpartum
605297|NCT00602355|Depression|depression
605298|NCT00602355|Medication Therapy|medication therapy
605299|NCT00602355|Zoloft|zoloft
605300|NCT00602355|Sertraline|sertraline
605301|NCT00602355|Interpersonal Psychotherapy|interpersonal psychotherapy
605302|NCT00602368|cervical cancer|cervical cancer
605303|NCT00602368|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
605304|NCT00602368|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
605305|NCT00602368|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
605306|NCT00602420|pain|pain
605307|NCT00602420|musculoskeletal complications|musculoskeletal complications
605425|NCT00603083|Treatment Outcome|treatment outcome
605308|NCT00602420|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
605309|NCT00602433|advanced nonsmall cell lung cancer|advanced nonsmall cell lung cancer
605310|NCT00602446|iron overload|iron overload
605311|NCT00602485|adherence, cardiac rehabilitation|adherence, cardiac rehabilitation
605312|NCT00602511|Melfalan refractory multiple myeloma|melfalan refractory multiple myeloma
605313|NCT00602511|Multiple myeloma|multiple myeloma
605314|NCT00602511|Relapsing|relapsing
605315|NCT00602511|Refractory|refractory
605316|NCT00602511|Thalidomide|thalidomide
605317|NCT00602511|Bortezomib|bortezomib
605318|NCT00602511|Randomized clinical trial|randomized clinical trial
605319|NCT00602537|Bipolar Type II Disorder|bipolar type ii disorder
605320|NCT00602537|Hypomania|hypomania
605321|NCT00602537|Antidepressant|antidepressant
605322|NCT00602537|Mood Stabilizer|mood stabilizer
605323|NCT00602537|Venlafaxine|venlafaxine
605324|NCT00602537|Lithium Carbonate|lithium carbonate
605325|NCT00602537|Major Depressive Episode|major depressive episode
605326|NCT00602537|Hypomanic Episodes|hypomanic episodes
605327|NCT00602537|Prevention of Depression Relapse|prevention of depression relapse
605328|NCT00602550|HIV|hiv
605329|NCT00602563|Generalized Anxiety Disorder|generalized anxiety disorder
605330|NCT00602563|Information Processing|information processing
605331|NCT00602576|recurrent melanoma|recurrent melanoma
605332|NCT00602576|stage III melanoma|stage iii melanoma
605333|NCT00602576|stage IV melanoma|stage iv melanoma
605334|NCT00602589|open-label|open-label
605335|NCT00602589|randomized|randomized
605336|NCT00602589|crossover|crossover
605337|NCT00602589|bioequivalence|bioequivalence
605338|NCT00602602|stage IV pancreatic cancer|stage iv pancreatic cancer
605339|NCT00602602|recurrent pancreatic cancer|recurrent pancreatic cancer
605340|NCT00602628|ductal breast carcinoma in situ|ductal breast carcinoma in situ
605341|NCT00602628|invasive ductal breast carcinoma|invasive ductal breast carcinoma
605342|NCT00602628|breast cancer in situ|breast cancer in situ
605343|NCT00602628|stage I breast cancer|stage i breast cancer
605344|NCT00602628|stage II breast cancer|stage ii breast cancer
605345|NCT00602628|stage IIIA breast cancer|stage iiia breast cancer
605346|NCT00602667|untreated childhood medulloblastoma|untreated childhood medulloblastoma
605440|NCT00603200|Quality of Life|quality of life
605347|NCT00602667|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
605348|NCT00602667|untreated childhood pineoblastoma|untreated childhood pineoblastoma
605349|NCT00602667|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
605350|NCT00602667|childhood choroid plexus tumor|childhood choroid plexus tumor
605351|NCT00602667|childhood high grade glioma|childhood high grade glioma
605352|NCT00602667|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
605353|NCT00602680|Alzheimer|alzheimer
605354|NCT00602680|cognitive|cognitive
605355|NCT00602693|chronic myelogenous leukemia|chronic myelogenous leukemia
605356|NCT00602693|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
605357|NCT00602693|prolymphocytic leukemia|prolymphocytic leukemia
605358|NCT00602693|advanced chronic lymphocytic leukemia|advanced chronic lymphocytic leukemia
605359|NCT00602693|small lymphocytic lymphoma|small lymphocytic lymphoma
605360|NCT00602693|B-cell lymphoma|b-cell lymphoma
605361|NCT00602693|follicular lymphoma|follicular lymphoma
605362|NCT00602693|diffuse large cell lymphoma|diffuse large cell lymphoma
605363|NCT00602693|anaplastic large cell lymphoma|anaplastic large cell lymphoma
605364|NCT00602693|Hodgkin lymphoma|hodgkin lymphoma
605365|NCT00602693|multiple myeloma|multiple myeloma
605366|NCT00602706|refractory multiple myeloma|refractory multiple myeloma
605367|NCT00602706|stage I multiple myeloma|stage i multiple myeloma
605368|NCT00602706|stage II multiple myeloma|stage ii multiple myeloma
605369|NCT00602706|stage III multiple myeloma|stage iii multiple myeloma
605370|NCT00602732|Partner Abuse|partner abuse
605371|NCT00602732|Preventive Intervention|preventive intervention
605372|NCT00602732|Postpartum Depression|postpartum depression
605373|NCT00602732|Postpartum PTSD|postpartum ptsd
605374|NCT00602745|pancreatic cancer|pancreatic cancer
605375|NCT00602758|AIDS|aids
605376|NCT00602758|Adherence|adherence
605377|NCT00602758|Antiretroviral Therapy|antiretroviral therapy
605379|NCT00602836|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
605380|NCT00602836|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
605381|NCT00602836|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
605382|NCT00602836|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
605383|NCT00602836|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
605384|NCT00602836|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
605385|NCT00602836|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
605386|NCT00602836|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
605387|NCT00602836|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
605388|NCT00602836|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
605389|NCT00602862|Angiogenesis inhibitors|angiogenesis inhibitors
605390|NCT00602914|MicronJet (microneedles)|micronjet (microneedles)
605391|NCT00602914|Intradermal|intradermal
605392|NCT00602927|Varenicline, Imaging, fMRI|varenicline, imaging, fmri
605393|NCT00602940|PCOS|pcos
605394|NCT00602940|ovulation|ovulation
605395|NCT00602940|hormones|hormones
605396|NCT00602940|women|women
605397|NCT00602966|Oocyte cryopreservation|oocyte cryopreservation
605398|NCT00602966|slow freeze|slow freeze
605399|NCT00602966|vitrification|vitrification
605400|NCT00602979|endotracheal intubation|endotracheal intubation
605401|NCT00602979|intubation|intubation
605402|NCT00602979|laryngoscopy|laryngoscopy
605403|NCT00602979|laryngoscope|laryngoscope
605404|NCT00602979|surgery|surgery
605405|NCT00602992|3T MRI|3t mri
605406|NCT00602992|Gamma Knife Radiosurgery|gamma knife radiosurgery
605407|NCT00603005|Glaucoma|glaucoma
605408|NCT00603005|Adherence|adherence
605409|NCT00603018|eating disorders|eating disorders
605410|NCT00603018|anorexia nervosa|anorexia nervosa
605411|NCT00603018|anorexia|anorexia
605413|NCT00603018|brain imaging|brain imaging
605414|NCT00603018|serotonin|serotonin
605415|NCT00603018|fMRI|fmri
605416|NCT00603018|Prozac|prozac
605417|NCT00603018|fluoxetine|fluoxetine
605418|NCT00603057|Non Small Cell Lung Cancer|non small cell lung cancer
605419|NCT00603070|Medication Errors|medication errors
605420|NCT00603070|Adverse Drug Events|adverse drug events
605421|NCT00603070|Patient Safety|patient safety
605422|NCT00603070|Electronic Prescribing Systems|electronic prescribing systems
605423|NCT00603070|Medication Reconciliation|medication reconciliation
605424|NCT00603083|Hip Arthroplasty|hip arthroplasty
605426|NCT00603083|Local Anesthesia|local anesthesia
605427|NCT00603109|Body weight, fat mass, growth hormone, ghrelin|body weight, fat mass, growth hormone, ghrelin
605428|NCT00603122|altitude illness|altitude illness
605430|NCT00603148|Genetic Polymorphism|genetic polymorphism
605431|NCT00603148|Integrin alpha2beta1|integrin alpha2beta1
605432|NCT00603148|Phenotype|phenotype
605433|NCT00603174|NAVA|nava
605434|NCT00603174|mechanical ventilation|mechanical ventilation
605435|NCT00603174|infants|infants
605436|NCT00603174|pediatric intensive care|pediatric intensive care
605437|NCT00603174|infant|infant
605438|NCT00603187|Male Contraception|male contraception
605441|NCT00603213|Congestive Heart Failure|congestive heart failure
605442|NCT00603213|Impedance|impedance
605443|NCT00603213|Optivol Thoracid Fluid Status monitoring system|optivol thoracid fluid status monitoring system
605444|NCT00603226|Coronary slow flow phenomenon|coronary slow flow phenomenon
605445|NCT00603226|Coronary angiography|coronary angiography
605446|NCT00603226|Acute coronary syndrome|acute coronary syndrome
605447|NCT00603226|Chest pain|chest pain
605448|NCT00603226|Unstable angina|unstable angina
605449|NCT00603239|diabetes|diabetes
605450|NCT00603239|exenatide|exenatide
605451|NCT00603239|metformin|metformin
605452|NCT00603239|thiazolidinedione|thiazolidinedione
605453|NCT00603239|Byetta|byetta
605454|NCT00603239|Amylin|amylin
605455|NCT00603239|Lilly|lilly
605456|NCT00603252|combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
605457|NCT00603252|risk factors|risk factors
605458|NCT00603265|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
605459|NCT00603265|Neuropathic Pain|neuropathic pain
605460|NCT00603278|Adolescents|adolescents
605461|NCT00603278|Adults|adults
605462|NCT00603278|Pharmacokinetics|pharmacokinetics
605463|NCT00603278|Asthma|asthma
605464|NCT00603278|GW685698X|gw685698x
605465|NCT00603278|Pharmacogenetics|pharmacogenetics
605466|NCT00603291|obesity|obesity
605467|NCT00603291|weight loss|weight loss
605468|NCT00603291|lorcaserin|lorcaserin
605469|NCT00603291|APD356|apd356
605470|NCT00603291|BLOOM-DM|bloom-dm
605471|NCT00603291|hypertension|hypertension
605472|NCT00603291|dyslipidemia|dyslipidemia
605473|NCT00603291|sleep apnea|sleep apnea
605474|NCT00603291|glucose tolerance|glucose tolerance
605475|NCT00603291|cardiovascular disease|cardiovascular disease
605476|NCT00603291|Arena|arena
605477|NCT00603304|Serenoa repens|serenoa repens
605478|NCT00603304|Urological symptoms|urological symptoms
605479|NCT00603304|hyperplasia|hyperplasia
605480|NCT00603304|BPH|bph
605481|NCT00603317|Warfarin|warfarin
605482|NCT00603317|Drug interaction|drug interaction
605483|NCT00603317|Pharmacogenetics|pharmacogenetics
605484|NCT00603317|Amoxicillin|amoxicillin
605485|NCT00603317|Clavulanic acid|clavulanic acid
605486|NCT00603330|Mesenchymal stem cells|mesenchymal stem cells
605487|NCT00603330|Graft-versus-host disease|graft-versus-host disease
605488|NCT00603330|Poor graft function|poor graft function
605489|NCT00603330|Chimerism|chimerism
605490|NCT00603330|Hematopoietic cell transplantation recipients|hematopoietic cell transplantation recipients
605491|NCT00603330|Low donor T-cell chimerism|low donor t-cell chimerism
605492|NCT00603343|antimuscarinics|antimuscarinics
605493|NCT00603343|children|children
605494|NCT00603343|overactive bladder|overactive bladder
605495|NCT00603343|propiverine|propiverine
605496|NCT00603343|urinary incontinence|urinary incontinence
605497|NCT00603343|urotherapy|urotherapy
605498|NCT00603356|GIST|gist
605499|NCT00603356|Ovarian Cancer|ovarian cancer
605500|NCT00603356|Mesothelioma|mesothelioma
605501|NCT00603356|Renal|renal
605502|NCT00603356|Colorectal Cancer|colorectal cancer
605503|NCT00603356|Sarcoma|sarcoma
605504|NCT00603356|NSCLC|nsclc
605505|NCT00603356|Cancer|cancer
605506|NCT00603369|HIV prevention|hiv prevention
605507|NCT00603369|HIV seronegativity|hiv seronegativity
605508|NCT00603382|Adults|adults
605509|NCT00603382|Pharmacokinetics|pharmacokinetics
605510|NCT00603382|Pharmacogenetics|pharmacogenetics
605511|NCT00603382|Asthma|asthma
605512|NCT00603382|Adolescents|adolescents
605513|NCT00603382|GW685698X|gw685698x
605514|NCT00603408|Breast Cancer|breast cancer
605515|NCT00603408|Locally Advanced|locally advanced
605516|NCT00603408|Neoadjuvant|neoadjuvant
605517|NCT00603421|borderline personality disorder|borderline personality disorder
605518|NCT00603421|suicide|suicide
605519|NCT00603421|suicidality|suicidality
605520|NCT00603421|suicide attempt|suicide attempt
605521|NCT00603421|suicidal behavior|suicidal behavior
605522|NCT00603421|self-injurious behavior|self-injurious behavior
605523|NCT00603421|self-harm behavior|self-harm behavior
605524|NCT00603421|suicide prevention center|suicide prevention center
605525|NCT00603421|telephone intervention|telephone intervention
605526|NCT00603434|Methamphetamine|methamphetamine
605527|NCT00603460|Ovarian Cancer|ovarian cancer
605528|NCT00603460|Peritoneal Cancer|peritoneal cancer
605529|NCT00603486|Non-invasive Blood Pressure (NIBP)|non-invasive blood pressure (nibp)
605530|NCT00603486|GE Dinamap|ge dinamap
605531|NCT00603486|SuperSTAT|superstat
605532|NCT00603499|Diabetes|diabetes
605533|NCT00603499|Hypertension|hypertension
605534|NCT00603499|Hypomagnesemia|hypomagnesemia
605535|NCT00603512|Phase II MTX add-on study in Japan|phase ii mtx add-on study in japan
605536|NCT00603538|CP-751,871, Non-small cell lung cancer, Phase 1|cp-751,871, non-small cell lung cancer, phase 1
605537|NCT00603551|Osteoporosis|osteoporosis
605538|NCT00603551|Cancer|cancer
605539|NCT00603551|Chemotherapy|chemotherapy
605540|NCT00603551|Bone Density|bone density
605541|NCT00603551|DXA Scan|dxa scan
605542|NCT00603551|Heel Scan|heel scan
605543|NCT00603564|CPAP|cpap
605544|NCT00603564|community-acquired pneumonia|community-acquired pneumonia
605545|NCT00603564|acute respiratory failure|acute respiratory failure
605546|NCT00603564|hypoxemia|hypoxemia
605547|NCT00603564|Continuous Positive Airway Pressure|continuous positive airway pressure
605548|NCT00603590|Cardiovascular disease|cardiovascular disease
605549|NCT00603590|primary prevention|primary prevention
605550|NCT00603590|Polypill|polypill
605551|NCT00603590|efficacy|efficacy
605552|NCT00603590|safety|safety
605553|NCT00603590|ADR|adr
605554|NCT00603590|Diabetes|diabetes
605555|NCT00603590|Adherence|adherence
605556|NCT00603590|Compliance|compliance
605557|NCT00603603|C-section|c-section
605558|NCT00603603|Surg Wound Infect|surg wound infect
606743|NCT00600639|NIV|niv
605559|NCT00603616|Inflammatory Bowel Disease|inflammatory bowel disease
605560|NCT00603616|Crohn disease|crohn disease
605561|NCT00603616|Crohn's disease|crohn's disease
605562|NCT00603616|Rifaximin|rifaximin
605563|NCT00603629|Acute Asthma|acute asthma
605564|NCT00603642|AMG 531|amg 531
605565|NCT00603642|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
605566|NCT00603642|ITP|itp
605567|NCT00603642|Thrombocytopenia|thrombocytopenia
605568|NCT00603642|Japan|japan
605569|NCT00603642|Placebo controlled|placebo controlled
605570|NCT00603642|Phase 3|phase 3
605571|NCT00603655|Diet|diet
605572|NCT00603655|glycemic load|glycemic load
605573|NCT00603655|overweight|overweight
605574|NCT00603655|obesity|obesity
605575|NCT00603655|hyperlipidemia|hyperlipidemia
605577|NCT00603681|constipation|constipation
605578|NCT00603681|aged|aged
605579|NCT00603681|polyethylene glycol|polyethylene glycol
605580|NCT00603694|Hippocampus|hippocampus
605581|NCT00603694|Memory|memory
605582|NCT00603694|Radiation|radiation
605583|NCT00603707|capsule|capsule
605584|NCT00603707|constipation|constipation
605585|NCT00603707|whole gut transit|whole gut transit
605586|NCT00603707|colonic transit|colonic transit
605587|NCT00603707|gastric emptying|gastric emptying
605588|NCT00603707|small bowel transit|small bowel transit
605589|NCT00603720|PET|pet
605590|NCT00603720|Heart metabolism|heart metabolism
605591|NCT00603720|Nitric oxide|nitric oxide
605592|NCT00603720|Myocardial remodeling|myocardial remodeling
605593|NCT00603733|Ulcerative Colitis|ulcerative colitis
605594|NCT00603733|5-Aminosalicylate|5-aminosalicylate
605595|NCT00603746|Adolescents|adolescents
605596|NCT00603746|Adults|adults
605597|NCT00603746|Asthma|asthma
605598|NCT00603746|Pharmacokinetics|pharmacokinetics
605599|NCT00603746|Pharmacogenetics|pharmacogenetics
605600|NCT00603746|GW685698X|gw685698x
605601|NCT00603759|COX2 inhibitor|cox2 inhibitor
605602|NCT00603759|head and neck cancer|head and neck cancer
605603|NCT00603759|chemoradiation|chemoradiation
605604|NCT00589823|Pain|pain
605605|NCT00589823|Cancer|cancer
605606|NCT00589823|Breakthrough|breakthrough
605607|NCT00589836|HCM|hcm
605608|NCT00589836|HOCM|hocm
605609|NCT00589836|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
605610|NCT00589836|tissue doppler echocardiography|tissue doppler echocardiography
605611|NCT00589836|myocardial torsion|myocardial torsion
605612|NCT00589849|Myocardial Infarction|myocardial infarction
605613|NCT00589849|Arrhythmia|arrhythmia
605614|NCT00589849|T-wave alternans|t-wave alternans
605615|NCT00589862|Drug Eluting Stents|drug eluting stents
605616|NCT00589862|Clopidogrel Resistance|clopidogrel resistance
605617|NCT00589862|Aspirin Resistance|aspirin resistance
605618|NCT00589875|Immunotherapy|immunotherapy
605619|NCT00589875|Cytotoxicity|cytotoxicity
605620|NCT00589875|Tumor vaccine|tumor vaccine
605621|NCT00589888|hypertension|hypertension
605622|NCT00589888|metabolic syndrome|metabolic syndrome
605623|NCT00589888|vascular reactivity|vascular reactivity
605624|NCT00589888|Elevated blood pressure|elevated blood pressure
605625|NCT00589888|lipid toxicity|lipid toxicity
605626|NCT00589901|metastatic breast cancer|metastatic breast cancer
605627|NCT00589901|capecitabine|capecitabine
605628|NCT00589901|synergistic effect|synergistic effect
605629|NCT00589901|chemotherapy|chemotherapy
605630|NCT00589914|Schizophrenia|schizophrenia
605631|NCT00589914|long-acting injectable antipsychotic medication|long-acting injectable antipsychotic medication
605632|NCT00589927|stents|stents
605633|NCT00589927|cilostazol|cilostazol
605634|NCT00589953|Extreme Prematurity|extreme prematurity
605635|NCT00589953|Erythropoietin|erythropoietin
605636|NCT00589953|Perinatal Brain Injury|perinatal brain injury
605637|NCT00589953|Intraventricular Hemorrhage|intraventricular hemorrhage
605638|NCT00589953|Periventricular Leukomalacia|periventricular leukomalacia
605639|NCT00589953|Neurodevelopmental Outcomes|neurodevelopmental outcomes
605640|NCT00589953|Randomized Clinical Trial|randomized clinical trial
605641|NCT00589966|prostate cancer treatment|prostate cancer treatment
605642|NCT00589966|treatment side-effects|treatment side-effects
605643|NCT00589966|early diagnosis|early diagnosis
605644|NCT00589966|African American Men|african american men
605645|NCT00589966|coping skills training|coping skills training
605646|NCT00589966|quality of life|quality of life
605647|NCT00589966|Prostate cancer treatment side-effects|prostate cancer treatment side-effects
605648|NCT00589979|Osteoarthritis|osteoarthritis
605652|NCT00589979|Topical patch|topical patch
605653|NCT00589979|Adjunct therapy|adjunct therapy
605654|NCT00590005|severe asthma|severe asthma
605655|NCT00590005|poorly controlled asthma|poorly controlled asthma
605656|NCT00590018|Congenital heart disease.|congenital heart disease.
605657|NCT00590018|Low cardiac output syndrome.|low cardiac output syndrome.
605658|NCT00590018|Corticosteroids.|corticosteroids.
605659|NCT00590018|Hydrocortisone.|hydrocortisone.
605660|NCT00590018|Blood pressure.|blood pressure.
605661|NCT00590018|Inotropes.|inotropes.
605662|NCT00590031|Esophageal Carcinoma|esophageal carcinoma
605663|NCT00590031|Cisplatin|cisplatin
605664|NCT00590031|Irinotecan|irinotecan
605665|NCT00590031|Radiation Therapy|radiation therapy
605666|NCT00590031|02-045|02-045
605667|NCT00590044|Diabetic ketoacidosis|diabetic ketoacidosis
605668|NCT00590044|insulin therapy|insulin therapy
605670|NCT00590070|myocardial infarction|myocardial infarction
605671|NCT00590070|no reflow|no reflow
605672|NCT00590070|primary PCI|primary pci
605673|NCT00590070|Coronary no-reflow phenomenon|coronary no-reflow phenomenon
605674|NCT00590070|primary percutaneous coronary intervention (primary PCI)|primary percutaneous coronary intervention (primary pci)
605675|NCT00590083|stem cell transplantation|stem cell transplantation
605676|NCT00590083|adenovirus|adenovirus
605677|NCT00590083|Cytotoxic T-Lymphocytes|cytotoxic t-lymphocytes
605678|NCT00590083|prophylaxis|prophylaxis
605679|NCT00590096|Neuroblastoma|neuroblastoma
605680|NCT00590096|Pheochromocytoma|pheochromocytoma
605682|NCT00590109|Breast Cancer|breast cancer
605683|NCT00590109|Jewish|jewish
605684|NCT00590109|BRCA1|brca1
605685|NCT00590109|BRCA2|brca2
605686|NCT00590109|97-029|97-029
605687|NCT00590122|Parkinson's disease|parkinson's disease
605688|NCT00590122|"time to on"|"time to on"
605689|NCT00590122|delayed on|delayed on
605690|NCT00590135|calcific aortic valve stenosis|calcific aortic valve stenosis
605691|NCT00590135|echocardiography, transthoracic|echocardiography, transthoracic
605692|NCT00590161|Fatty Liver|fatty liver
605693|NCT00590161|Nonalcoholic fatty liver disease (NALFD)|nonalcoholic fatty liver disease (nalfd)
605694|NCT00590161|NAFLD|nafld
605695|NCT00590161|Nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
605696|NCT00590161|NASH|nash
605697|NCT00590161|pentoxifylline|pentoxifylline
605698|NCT00590174|stent|stent
605699|NCT00590174|antiplatelet therapy|antiplatelet therapy
605700|NCT00590200|CAD|cad
605701|NCT00590200|Cardiovascular Disease|cardiovascular disease
605702|NCT00590200|CVD|cvd
605703|NCT00590200|MI|mi
605704|NCT00590200|Myocardial Infarction|myocardial infarction
605705|NCT00590200|Heart Attack|heart attack
605706|NCT00590200|CABG|cabg
605707|NCT00590200|Revascularization|revascularization
605708|NCT00590200|genetic|genetic
605709|NCT00590213|Casodex|casodex
605710|NCT00590213|Prostate Cancer|prostate cancer
605711|NCT00590226|type 2 diabetes|type 2 diabetes
605712|NCT00590226|inpatient hyperglycemia|inpatient hyperglycemia
605713|NCT00590226|SQ insulin|sq insulin
605714|NCT00590226|Hospitalized patients with type 2 diabetes|hospitalized patients with type 2 diabetes
605715|NCT00590239|Barrett's Esophagus|barrett's esophagus
605716|NCT00590239|Neoplasia|neoplasia
605717|NCT00590239|Endoscopic mucosal resection|endoscopic mucosal resection
605718|NCT00590239|High resolution endoscopy|high resolution endoscopy
605719|NCT00590239|Chromoendoscopy|chromoendoscopy
605720|NCT00590252|Magnetic Resonance|magnetic resonance
605721|NCT00590252|Imaging|imaging
605722|NCT00590252|Spectroscopy|spectroscopy
605723|NCT00590265|bipolar type II disorder|bipolar type ii disorder
605724|NCT00590265|depression|depression
605725|NCT00590265|remission|remission
605726|NCT00590265|light-therapy|light-therapy
605727|NCT00590265|efficacy|efficacy
605728|NCT00590265|safety|safety
605729|NCT00590278|Tomudex|tomudex
605730|NCT00590278|inoperable rectal cancer|inoperable rectal cancer
605731|NCT00590278|recurrent rectal cancer|recurrent rectal cancer
605732|NCT00590291|Coronary Artery Disease|coronary artery disease
605733|NCT00590291|Arteriovenous Malformations|arteriovenous malformations
605734|NCT00590291|Myocardial Infarction|myocardial infarction
605735|NCT00590291|CAD|cad
605736|NCT00590291|MI|mi
605737|NCT00590291|Heart Attack|heart attack
605738|NCT00590291|AVM|avm
605739|NCT00590291|genetic|genetic
605740|NCT00590291|familial|familial
605741|NCT00590304|Asthma, Children, Rural Population, Morbidity, Endotoxin|asthma, children, rural population, morbidity, endotoxin
605742|NCT00590356|Device closure|device closure
605743|NCT00590395|Cholecystitis|cholecystitis
605744|NCT00590395|FDG PET/CT|fdg pet/ct
605745|NCT00590395|HIDA scan|hida scan
605746|NCT00590408|coenzyme Q10|coenzyme q10
605747|NCT00590408|statin|statin
605748|NCT00590408|myalgia|myalgia
605749|NCT00590434|CRC - Colorectal cancer|crc - colorectal cancer
605750|NCT00590434|CVA - Cerebral Vascular Accident|cva - cerebral vascular accident
605751|NCT00590434|MI - Myocardial Infarction|mi - myocardial infarction
605752|NCT00590434|CAD - Coronary Artery Disease|cad - coronary artery disease
605753|NCT00590434|DM - Diabetes Mellitus|dm - diabetes mellitus
605754|NCT00590434|PVD - Peripheral Vascular Disease|pvd - peripheral vascular disease
605755|NCT00590434|NSAIDS - Non-Steroidal Anti inflammatory Drugs|nsaids - non-steroidal anti inflammatory drugs
605756|NCT00590434|screening|screening
605757|NCT00590434|colonoscopy|colonoscopy
605758|NCT00590447|1st-line therapy|1st-line therapy
605759|NCT00590447|single agent rituximab|single agent rituximab
605761|NCT00590447|risk stratification|risk stratification
605762|NCT00590460|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
605763|NCT00590460|Fanconi Anemia|fanconi anemia
605764|NCT00590460|Severe Aplastic Anemia|severe aplastic anemia
605765|NCT00590460|fludarabine|fludarabine
605766|NCT00590460|campath|campath
605767|NCT00590460|anti-CD45|anti-cd45
605768|NCT00590473|Interstitial Cystitis|interstitial cystitis
605769|NCT00590473|IC|ic
605770|NCT00590473|Neuromodulation|neuromodulation
605771|NCT00590473|Interstim Therapy|interstim therapy
605772|NCT00590499|agitation|agitation
605773|NCT00590499|craniotomy|craniotomy
605774|NCT00590499|incidence|incidence
605775|NCT00590499|risk factor|risk factor
605776|NCT00590499|outcome|outcome
605777|NCT00590512|dietary salt|dietary salt
605778|NCT00590512|sodium|sodium
605779|NCT00590512|blood vessels|blood vessels
605780|NCT00590512|vascular function|vascular function
605781|NCT00590512|endothelial function|endothelial function
605782|NCT00590512|heart disease risk|heart disease risk
605783|NCT00590512|cardiovascular disease risk|cardiovascular disease risk
605784|NCT00590525|hsCRP|hscrp
605785|NCT00590551|Skin Breakdown|skin breakdown
605786|NCT00590551|Skin Damage|skin damage
605787|NCT00590551|Skin Integrity|skin integrity
605788|NCT00590551|Pressure|pressure
605789|NCT00590551|Slings|slings
605790|NCT00590564|Hepatitis C|hepatitis c
605791|NCT00590564|Sho-saiko-to|sho-saiko-to
605792|NCT00590564|SST|sst
605793|NCT00590564|Interferon Therapy|interferon therapy
605794|NCT00590577|Schizophrenia|schizophrenia
605795|NCT00590577|Long-acting injectable antipsychotic medication|long-acting injectable antipsychotic medication
605796|NCT00590603|Multiple myeloma|multiple myeloma
605797|NCT00590616|Aortic atheroma|aortic atheroma
605798|NCT00590629|Women with and without CAD|women with and without cad
605799|NCT00590642|obsessive compulsive disorder|obsessive compulsive disorder
605800|NCT00590642|OCD|ocd
605801|NCT00590642|treatment-resistant|treatment-resistant
605802|NCT00590642|SSRI|ssri
605803|NCT00590655|maintenance therapy|maintenance therapy
605804|NCT00590668|atrial fibrillation|atrial fibrillation
605805|NCT00590668|pulmonary vein ablation|pulmonary vein ablation
605806|NCT00590668|pulmonary vein stenosis|pulmonary vein stenosis
605807|NCT00590694|ranibizumab|ranibizumab
605808|NCT00590694|Lucentis|lucentis
605809|NCT00590694|Pigment Epithelial Detachment|pigment epithelial detachment
605810|NCT00590694|Macular Degeneration|macular degeneration
605811|NCT00590694|PrONTO|pronto
605812|NCT00590707|Hip fractures|hip fractures
605813|NCT00590707|Femoral neck fractures|femoral neck fractures
605814|NCT00590707|Trochanteric fractures|trochanteric fractures
605815|NCT00590707|Intertrochanteric fractures|intertrochanteric fractures
605816|NCT00590707|Subtrochanteric fractures|subtrochanteric fractures
605817|NCT00590707|Delirium|delirium
605818|NCT00590707|Confusion|confusion
605819|NCT00596128|Blood glucose|blood glucose
605820|NCT00596128|Clinical pathways|clinical pathways
605821|NCT00596141|oral periodontal gingival intraoral mucosal mucoperiosteal|oral periodontal gingival intraoral mucosal mucoperiosteal
605822|NCT00596141|Surgery, Oral|surgery, oral
605823|NCT00596167|Short-daily hemodialysis|short-daily hemodialysis
605824|NCT00596167|pharmacokinetics|pharmacokinetics
605825|NCT00596167|levofloxacin|levofloxacin
605826|NCT00596167|gentamicin|gentamicin
605827|NCT00596167|vancomycin|vancomycin
605828|NCT00596180|carbon monoxide poisoning|carbon monoxide poisoning
605829|NCT00596180|brain injury|brain injury
605830|NCT00596193|Hyperalgesia|hyperalgesia
605831|NCT00596193|nociceptors|nociceptors
605832|NCT00596193|Neurons|neurons
605833|NCT00596219|HEAD|head
605834|NCT00596219|NECK|neck
605835|NCT00596219|SQUAMOUS|squamous
605836|NCT00596219|CARCINOMA|carcinoma
605837|NCT00596245|non-smoking healthy volunteers aged 18 - 35|non-smoking healthy volunteers aged 18 - 35
605838|NCT00596258|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
605839|NCT00596258|High-grade Cervical Intraepithelial Neoplasia|high-grade cervical intraepithelial neoplasia
605840|NCT00596258|High-grade Squamous Intraepithelial Lesions (HSIL)|high-grade squamous intraepithelial lesions (hsil)
605841|NCT00596258|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
605842|NCT00596258|High-Grade Cervical Intraepithelial Lesions (CIN 2/3)|high-grade cervical intraepithelial lesions (cin 2/3)
605843|NCT00596284|Cognitive Behavior Therapy|cognitive behavior therapy
605845|NCT00596297|Diabetic Retinopathy|diabetic retinopathy
605846|NCT00596297|Vitreous Hemorrhage|vitreous hemorrhage
605847|NCT00596297|Bevacizumab|bevacizumab
605848|NCT00596297|pars plana vitrectomy|pars plana vitrectomy
605849|NCT00596297|preoperative|preoperative
605850|NCT00596310|Lung cancer|lung cancer
605853|NCT00596323|continuous glucose monitoring|continuous glucose monitoring
605854|NCT00596323|electromagnetic|electromagnetic
605855|NCT00596349|epithelial Ovarian Cancer|epithelial ovarian cancer
605856|NCT00596349|Quality of Life|quality of life
605857|NCT00596349|Survivorship|survivorship
605858|NCT00596362|Melanoma|melanoma
605859|NCT00596362|Eye|eye
605860|NCT00596362|Avastin|avastin
605861|NCT00596375|Lidocaine|lidocaine
605862|NCT00596375|Infant|infant
605863|NCT00596375|Urinary Catheterization|urinary catheterization
605864|NCT00596375|Emergency Medicine|emergency medicine
605865|NCT00596375|Analgesia|analgesia
605866|NCT00596388|HMP, AMD, CNV, PHP, HPHP|hmp, amd, cnv, php, hphp
605867|NCT00596414|liver|liver
605868|NCT00596414|biopsy|biopsy
605869|NCT00596427|type two diabetes|type two diabetes
605870|NCT00596427|gluconeogenesis|gluconeogenesis
605871|NCT00596427|glucose|glucose
605872|NCT00596427|lipid synthesis|lipid synthesis
605873|NCT00596427|hepatic insulin sensitivity|hepatic insulin sensitivity
605874|NCT00596427|colesevelam HCl|colesevelam hcl
605875|NCT00596440|smoking|smoking
605876|NCT00596440|teachable moment|teachable moment
605877|NCT00596440|cancer|cancer
605974|NCT00596830|871|871
605878|NCT00596453|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
605879|NCT00596453|Elevated Prostate Specific Antigen (PSA)|elevated prostate specific antigen (psa)
605880|NCT00596466|open-label|open-label
605881|NCT00596466|extension study|extension study
605882|NCT00596466|pregabalin|pregabalin
605883|NCT00596466|partial epilepsy|partial epilepsy
605884|NCT00596479|CAD|cad
605885|NCT00596479|G-CSF|g-csf
605886|NCT00596479|Collaterals|collaterals
605887|NCT00596479|CFI|cfi
605888|NCT00596479|perfusion|perfusion
605889|NCT00596505|proliferative diabetic retinopathy|proliferative diabetic retinopathy
605890|NCT00596505|bevacizumab (Avastin)|bevacizumab (avastin)
605891|NCT00596505|vitreous hemorrhage|vitreous hemorrhage
605892|NCT00596505|silicone oil|silicone oil
605893|NCT00596531|Tinnitus|tinnitus
605894|NCT00596531|acamprosate|acamprosate
605895|NCT00596531|clinical trial|clinical trial
605896|NCT00596544|sexual dysfunction|sexual dysfunction
605897|NCT00596557|Renal function, heart transplant, everolimus|renal function, heart transplant, everolimus
605898|NCT00596570|Atrial fibrillation|atrial fibrillation
605899|NCT00596570|Oral Anticoagulation|oral anticoagulation
605900|NCT00596570|Percutaneous coronary intervention|percutaneous coronary intervention
605901|NCT00596596|Constipation|constipation
605902|NCT00596596|prucalopride|prucalopride
605903|NCT00596609|Injections, intrathecal|injections, intrathecal
605904|NCT00596609|Transcranial|transcranial
605905|NCT00596609|Spinal Fusion|spinal fusion
605906|NCT00596609|Evoked Potentials, Motor|evoked potentials, motor
605907|NCT00596622|Major Depressive or Manic Episodes|major depressive or manic episodes
605908|NCT00596622|Bipolar|bipolar
605909|NCT00596622|Mania|mania
605910|NCT00596622|Depression|depression
605911|NCT00596622|Lithium|lithium
605912|NCT00596622|fMRI|fmri
605913|NCT00596622|Pictures|pictures
605914|NCT00596622|Brain Scan|brain scan
605915|NCT00596635|UTI|uti
605916|NCT00596635|elderly|elderly
605917|NCT00596635|prevention|prevention
605918|NCT00596635|cranberry|cranberry
605919|NCT00596635|E.Coli|e.coli
605920|NCT00596648|Lung Cancer|lung cancer
605921|NCT00596648|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
605922|NCT00596648|NSCLC|nsclc
605923|NCT00596661|coronary stent|coronary stent
605924|NCT00596674|Women|women
605925|NCT00596674|Fibromyalgia Syndrome|fibromyalgia syndrome
605926|NCT00596674|Health Behaviors|health behaviors
605927|NCT00596674|Quality of Life|quality of life
605928|NCT00596687|diabetes|diabetes
605929|NCT00596687|post-op complications|post-op complications
605930|NCT00596687|inpatient hyperglycemia|inpatient hyperglycemia
605931|NCT00596700|Capsule endoscopy|capsule endoscopy
605932|NCT00596700|Crohn's disease|crohn's disease
605933|NCT00596700|IBD|ibd
605934|NCT00596700|Activity score|activity score
605935|NCT00596700|Small bowel|small bowel
605936|NCT00596700|Crohn's disease of the small bowel in any stage|crohn's disease of the small bowel in any stage
605937|NCT00596700|Recruiting|recruiting
605938|NCT00596713|general population|general population
751782|NCT01170403|metabolic syndrome|metabolic syndrome
751783|NCT01170416|Ventricular Tachycardia|ventricular tachycardia
751784|NCT01170416|Body Surface Mapping|body surface mapping
605939|NCT00596726|All patients presenting for high-risk cardiac surgery and who might post-operatively meet the study inclusion criteria are potential study candidates.|all patients presenting for high-risk cardiac surgery and who might post-operatively meet the study inclusion criteria are potential study candidates.
605940|NCT00596739|Bariatric surgery, weight loss surgery, male infertility, Roux-En-Y, gastric banding|bariatric surgery, weight loss surgery, male infertility, roux-en-y, gastric banding
605941|NCT00596752|Alprostadil|alprostadil
605942|NCT00596752|Prostavasin|prostavasin
605943|NCT00596752|PAOD|paod
605944|NCT00596752|Fontaine Stage IV|fontaine stage iv
605945|NCT00596765|Brain Injury|brain injury
605946|NCT00596765|Neuropsychology|neuropsychology
605947|NCT00596765|Cognitive Behavioral Therapy|cognitive behavioral therapy
605948|NCT00596765|Neuropsychological Rehabilitation|neuropsychological rehabilitation
605949|NCT00596778|Physical therapy specialty|physical therapy specialty
606933|NCT00607061|Glutathione|glutathione
605950|NCT00596778|Postoperative period. Abdominal surgery|postoperative period. abdominal surgery
605951|NCT00596778|Anesthesia recovery period|anesthesia recovery period
605952|NCT00596778|Spirometry|spirometry
605953|NCT00596804|NHL|nhl
605954|NCT00596804|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
605955|NCT00596804|follicular lymphoma|follicular lymphoma
605956|NCT00596804|B-cell lymphoma|b-cell lymphoma
605957|NCT00596804|diffuse large cell lymphoma|diffuse large cell lymphoma
605958|NCT00596804|small lymphoctytic lymphoma|small lymphoctytic lymphoma
605959|NCT00596804|Mantle cell lymphoma|mantle cell lymphoma
605960|NCT00596804|MALT|malt
605961|NCT00596804|marginal zone lymphoma|marginal zone lymphoma
605962|NCT00596804|High-Grade|high-grade
605963|NCT00596804|Intermediate-Grade|intermediate-grade
605964|NCT00596804|Low-Grade|low-grade
605965|NCT00596804|Mixed|mixed
605966|NCT00596817|Relapse prevention|relapse prevention
605967|NCT00596817|Antidepressants|antidepressants
605968|NCT00596817|Placebo-controlled|placebo-controlled
605969|NCT00596817|Double-blind|double-blind
605970|NCT00596817|Multicentre study|multicentre study
605971|NCT00596830|IGF-1R inhibitor|igf-1r inhibitor
605972|NCT00596830|Non-small-cell lung carcinoma|non-small-cell lung carcinoma
605973|NCT00596830|CP-751|cp-751
605975|NCT00596856|Early childhood caries - ECC|early childhood caries - ecc
605976|NCT00596856|Referral behavior|referral behavior
605977|NCT00596856|Oral health risk assessment|oral health risk assessment
605978|NCT00596856|Guideline development and dissemination|guideline development and dissemination
605979|NCT00596882|smoking cessation|smoking cessation
605980|NCT00596882|nicotine dependence|nicotine dependence
605981|NCT00596882|message prime|message prime
605982|NCT00596882|recruitment|recruitment
605983|NCT00596895|Isoflavone, PSA, prostate cancer, recurrent, quality of life|isoflavone, psa, prostate cancer, recurrent, quality of life
605984|NCT00596908|Essential Tremor|essential tremor
605985|NCT00596908|Parkinsonian Tremor|parkinsonian tremor
605986|NCT00596908|Parkinson Disease|parkinson disease
605987|NCT00596908|Upper Extremity Tremor with duration of less than 2 years|upper extremity tremor with duration of less than 2 years
605988|NCT00596921|Ultrasonography|ultrasonography
605989|NCT00596921|Central Venous Pressure|central venous pressure
605990|NCT00596921|Noninvasive monitoring|noninvasive monitoring
605992|NCT00596921|Resuscitation|resuscitation
605993|NCT00596934|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
605994|NCT00596934|Insulin resistance|insulin resistance
605995|NCT00596934|Obesity|obesity
605996|NCT00596934|Leptin therapy|leptin therapy
605997|NCT00596934|NASH|nash
605998|NCT00596947|kidney transplantation|kidney transplantation
605999|NCT00596947|tacrolimus|tacrolimus
606000|NCT00596947|Prograf|prograf
606001|NCT00596947|mycophenolate mofetil|mycophenolate mofetil
606002|NCT00596947|CellCept|cellcept
606103|NCT00603941|Neoplasm|neoplasm
606003|NCT00596947|corticosteroid withdrawal|corticosteroid withdrawal
606004|NCT00596947|prednisone withdrawal|prednisone withdrawal
606005|NCT00596947|prednisone maintenance|prednisone maintenance
606006|NCT00596947|rabbit antithymocyte globulin|rabbit antithymocyte globulin
606007|NCT00596947|Thymoglobulin|thymoglobulin
606008|NCT00596960|Alcohol Abuse|alcohol abuse
606009|NCT00596960|Alcohol Dependence|alcohol dependence
606010|NCT00596960|Carbohydrate Deficient Transferrin|carbohydrate deficient transferrin
606011|NCT00596960|Drug Dependence|drug dependence
606012|NCT00596960|Hepatitis C|hepatitis c
606013|NCT00596960|Motivation|motivation
606014|NCT00596986|Depression|depression
606015|NCT00596986|Duloxetine|duloxetine
606016|NCT00596986|Psychotherapy|psychotherapy
606017|NCT00596986|Magnetic Resonance Imaging|magnetic resonance imaging
606018|NCT00596999|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
606019|NCT00596999|Acute myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
606020|NCT00596999|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
606021|NCT00596999|Sickle Cell Disease (SCD)|sickle cell disease (scd)
606022|NCT00596999|Beta Thalassemia|beta thalassemia
606023|NCT00596999|Inborn Errors of Metabolism|inborn errors of metabolism
606024|NCT00596999|Severe Combined Immunodeficiency Disease (SCID)|severe combined immunodeficiency disease (scid)
606025|NCT00597012|Meniscal Tear|meniscal tear
606026|NCT00597012|Osteoarthritis|osteoarthritis
606027|NCT00597012|Arthroscopic Partial Meniscectomy|arthroscopic partial meniscectomy
606028|NCT00597012|Physical Therapy|physical therapy
606029|NCT00597025|Malnutrition|malnutrition
606030|NCT00597025|Hypoalbuminemia|hypoalbuminemia
606031|NCT00597025|Dietary Supplements|dietary supplements
606032|NCT00597025|Hemodialysis|hemodialysis
606033|NCT00597025|Peritoneal Dialysis|peritoneal dialysis
606034|NCT00597038|Dasatinib|dasatinib
606035|NCT00597038|Dacarbazine|dacarbazine
606036|NCT00597064|asthma|asthma
606037|NCT00597064|asthma control questionnaire|asthma control questionnaire
606038|NCT00597064|oral corticosteroid|oral corticosteroid
606039|NCT00597064|air trapping|air trapping
606040|NCT00597064|AQLQ|aqlq
606041|NCT00597064|control|control
606042|NCT00597064|quality of life|quality of life
606043|NCT00603772|Tretinoin|tretinoin
606044|NCT00603772|exposure to UV light|exposure to uv light
606045|NCT00603772|phototoxicity|phototoxicity
606934|NCT00607061|Cysteine|cysteine
606046|NCT00603772|Safety when exposed to sunlight|safety when exposed to sunlight
606047|NCT00603785|Chronic sinusitis|chronic sinusitis
606048|NCT00603785|Xolair|xolair
606049|NCT00603785|Nasal Discharge|nasal discharge
606050|NCT00603785|Nasal Obstruction|nasal obstruction
606051|NCT00603785|Facial Pain|facial pain
606052|NCT00603785|Hyposmia|hyposmia
606053|NCT00603798|Actinic keratosis|actinic keratosis
606054|NCT00603798|Dermatologic disease|dermatologic disease
606055|NCT00603811|Influenza vaccines|influenza vaccines
606056|NCT00603811|M2e|m2e
606057|NCT00603824|heparin-Induced thrombocytopenia|heparin-induced thrombocytopenia
606058|NCT00603824|fondaparinux|fondaparinux
606059|NCT00603837|Hypothermia|hypothermia
606060|NCT00603837|Prevention|prevention
606061|NCT00603837|ELGANs(Extremely low gestational age neonates)|elgans(extremely low gestational age neonates)
606062|NCT00603837|Polyethylene Wrap|polyethylene wrap
606063|NCT00603837|Sodium Acetate Transport Mattress|sodium acetate transport mattress
606064|NCT00603850|HMP, PHP, AMD, CNV, HPHP|hmp, php, amd, cnv, hphp
606065|NCT00603863|pancreatic cancer|pancreatic cancer
606066|NCT00603863|hPAM4|hpam4
606067|NCT00603863|MUC1 antibody|muc1 antibody
606068|NCT00603863|cancer of the pancreas|cancer of the pancreas
606069|NCT00603889|Hookworm|hookworm
606070|NCT00603889|Allergy|allergy
606071|NCT00603889|Vaccine|vaccine
606072|NCT00603889|Skin test|skin test
606073|NCT00603902|Obesity|obesity
606074|NCT00603902|Weight loss|weight loss
606075|NCT00603902|lorcaserin|lorcaserin
606076|NCT00603902|APD356|apd356
606077|NCT00603902|BLOSSOM|blossom
606078|NCT00603902|Hypertension|hypertension
606079|NCT00603902|Dyslipidemia|dyslipidemia
606080|NCT00603902|Sleep apnea|sleep apnea
606081|NCT00603902|glucose tolerance|glucose tolerance
606082|NCT00603902|cardiovascular disease|cardiovascular disease
606083|NCT00603902|Arena|arena
606084|NCT00603915|gemcitabine|gemcitabine
606085|NCT00603915|carboplatin|carboplatin
606086|NCT00603915|cisplatin|cisplatin
606087|NCT00603915|erlotinib|erlotinib
606088|NCT00603915|tarceva|tarceva
606089|NCT00603915|nasopharyngeal|nasopharyngeal
606090|NCT00603928|attitude|attitude
606091|NCT00603928|attitude of health personnel|attitude of health personnel
606092|NCT00603928|ethics|ethics
606093|NCT00603928|bioethics|bioethics
606094|NCT00603928|biomedical ethics|biomedical ethics
606095|NCT00603928|patient care|patient care
606096|NCT00603928|physicians|physicians
606097|NCT00603928|placebo effect|placebo effect
606098|NCT00603928|placebos|placebos
606099|NCT00603928|questionnaires|questionnaires
606100|NCT00603928|therapy|therapy
606101|NCT00603928|general practice|general practice
606102|NCT00603941|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
606104|NCT00603941|Tumor|tumor
606105|NCT00603941|Anti-neoplastic Agent|anti-neoplastic agent
606106|NCT00603941|First-line treatment of advanced Anaplastic thyroid cancer|first-line treatment of advanced anaplastic thyroid cancer
606107|NCT00603954|Nonmyeloablative conditioning.|nonmyeloablative conditioning.
606108|NCT00603954|Hematological malignancies.|hematological malignancies.
606109|NCT00603954|GVHD.|gvhd.
606110|NCT00603967|Breast Cancer|breast cancer
606111|NCT00603967|Postmenopausal|postmenopausal
606112|NCT00603967|Aromatase|aromatase
606113|NCT00603993|Rheumatoid arthritis|rheumatoid arthritis
606114|NCT00604006|Prevention of heart failure in individuals at high risk|prevention of heart failure in individuals at high risk
606115|NCT00604019|sepsis|sepsis
606116|NCT00604019|septic shock|septic shock
606117|NCT00604032|Safety when exposed to sunlight|safety when exposed to sunlight
606118|NCT00604045|post traumatic stress disorder|post traumatic stress disorder
606119|NCT00604045|cognitive bias|cognitive bias
606120|NCT00604045|attention|attention
606121|NCT00604045|combat|combat
606122|NCT00604045|neuroimaging|neuroimaging
606123|NCT00604058|Poliomyelitis|poliomyelitis
606124|NCT00604058|intradermal|intradermal
606125|NCT00604071|HMP, CNV, PHP, HPHP, AMD|hmp, cnv, php, hphp, amd
606126|NCT00604084|Scabies|scabies
606127|NCT00604084|Ivermectin|ivermectin
606128|NCT00604084|Lindane|lindane
606129|NCT00604084|Mass Eradication|mass eradication
606130|NCT00604097|youth suicide|youth suicide
606131|NCT00604097|family therapy|family therapy
606132|NCT00604097|primary care|primary care
606133|NCT00604097|intervention|intervention
606134|NCT00604318|quality of life|quality of life
606135|NCT00604331|Pyruvic Acid|pyruvic acid
606136|NCT00604331|Shock, Cardiogenic|shock, cardiogenic
606137|NCT00604331|Catecholamines|catecholamines
606138|NCT00604331|Intra-Aortic Balloon Pumping|intra-aortic balloon pumping
606139|NCT00604331|Cardiac Output|cardiac output
606140|NCT00604331|Cardiac Index|cardiac index
606141|NCT00604331|Cardiac Function|cardiac function
606142|NCT00604357|CNI free|cni free
606143|NCT00604357|mTOR inhibition|mtor inhibition
606144|NCT00604357|induction|induction
606145|NCT00604357|IL2 receptor antibodies|il2 receptor antibodies
606146|NCT00604357|renal function|renal function
606147|NCT00604357|liver transplantation|liver transplantation
606148|NCT00604422|Colonic disease|colonic disease
606149|NCT00604422|Ulcerative colitis|ulcerative colitis
606150|NCT00604422|suspected or known colonic disease|suspected or known colonic disease
606151|NCT00604435|breast cancer|breast cancer
606152|NCT00604435|neoadjuvant chemotherapy|neoadjuvant chemotherapy
606153|NCT00604435|docetaxel|docetaxel
606154|NCT00604435|epirubicin|epirubicin
606155|NCT00604435|recombinant human endostatin (endostar)|recombinant human endostatin (endostar)
606156|NCT00604435|chemotherapy|chemotherapy
606157|NCT00604435|endostatin|endostatin
606158|NCT00604448|pulses|pulses
606159|NCT00604448|beans|beans
606160|NCT00604448|obesity|obesity
606161|NCT00604448|overweight|overweight
606162|NCT00604448|metabolic syndrome|metabolic syndrome
606163|NCT00604461|Carboplatin|carboplatin
606164|NCT00604461|Bevacizumab|bevacizumab
606165|NCT00604461|Avastin|avastin
606166|NCT00604461|Pemetrexed|pemetrexed
606167|NCT00604461|Alimta|alimta
606168|NCT00604474|Deafness|deafness
606169|NCT00604474|Hearing Loss|hearing loss
606170|NCT00604474|Cochlear Implants|cochlear implants
606171|NCT00604474|Advanced Bionics|advanced bionics
606172|NCT00604474|HiResolution Bionic Ear System|hiresolution bionic ear system
606173|NCT00604487|induction|induction
606174|NCT00604487|cervix|cervix
606175|NCT00604487|balloon|balloon
606176|NCT00604487|Bishop|bishop
606177|NCT00604526|recurrent|recurrent
606178|NCT00604539|Chondroitin sulphate|chondroitin sulphate
606179|NCT00604539|Synovitis|synovitis
606180|NCT00604539|Knee osteoarthritis|knee osteoarthritis
606181|NCT00604539|Magnetic Resonance Imaging|magnetic resonance imaging
606182|NCT00604552|Abdominal Aneurysm|abdominal aneurysm
606183|NCT00604552|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
606184|NCT00604552|Endovascular Stent Graft|endovascular stent graft
606185|NCT00604552|Endograft|endograft
606186|NCT00604565|Hemodialysis|hemodialysis
606187|NCT00604578|Pioglitazone|pioglitazone
606188|NCT00604578|Asthma|asthma
606189|NCT00604578|Peroxisome Proliferator-Advanced Receptor Gamma|peroxisome proliferator-advanced receptor gamma
606190|NCT00604578|Airflow Obstruction|airflow obstruction
606191|NCT00604578|Airway Inflammation|airway inflammation
606192|NCT00604591|Dementia Treatment|dementia treatment
606193|NCT00604591|Frontotemporal Dementia|frontotemporal dementia
606194|NCT00604591|Dopamine|dopamine
606195|NCT00604591|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
606196|NCT00604617|Mycobacterium tuberculosis|mycobacterium tuberculosis
606197|NCT00604617|Tuberculin Test|tuberculin test
606198|NCT00604617|South Africa|south africa
606199|NCT00604630|stroke|stroke
606201|NCT00604630|erythropoietin|erythropoietin
606202|NCT00604630|ischemia|ischemia
606203|NCT00604630|hypoxia|hypoxia
606204|NCT00604630|antiapoptosis|antiapoptosis
606205|NCT00604630|neuroprotection|neuroprotection
606206|NCT00604630|rtPA|rtpa
606207|NCT00604630|thrombolysis|thrombolysis
606208|NCT00604630|stroke, middle cerebral artery|stroke, middle cerebral artery
606209|NCT00604630|Ischemic stroke in the middle cerebral artery territory|ischemic stroke in the middle cerebral artery territory
606210|NCT00604643|Abdominal Aneurysm|abdominal aneurysm
606211|NCT00604643|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
606212|NCT00604643|Endovascular Stent Graft|endovascular stent graft
606213|NCT00604643|Endograft|endograft
606214|NCT00604669|Diabetes|diabetes
606215|NCT00604669|Nutrition/Dietics|nutrition/dietics
606216|NCT00604669|clinical outcomes|clinical outcomes
606217|NCT00604669|total parenteral nutrition|total parenteral nutrition
606218|NCT00604682|psoriasis|psoriasis
606219|NCT00604695|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
606220|NCT00604695|Acute Myocardial Infarction|acute myocardial infarction
606221|NCT00604695|No Reflow|no reflow
606222|NCT00604747|motor learning|motor learning
606223|NCT00604747|hemiplegia|hemiplegia
606224|NCT00604747|stroke|stroke
606225|NCT00604747|practice|practice
606226|NCT00604747|physiotherapy|physiotherapy
606227|NCT00604773|delirium|delirium
606228|NCT00604773|critical care|critical care
606229|NCT00604773|risk factors|risk factors
606230|NCT00604773|prediction|prediction
606231|NCT00604786|Basophils|basophils
606232|NCT00604786|Mast Cells|mast cells
606233|NCT00604786|IgE|ige
606234|NCT00604786|IgE receptors|ige receptors
606235|NCT00604786|omalizumab|omalizumab
606236|NCT00604825|vasomotor symptoms|vasomotor symptoms
606237|NCT00604825|hormone therapy|hormone therapy
606238|NCT00604825|hot flashes|hot flashes
606239|NCT00604825|menopause|menopause
606240|NCT00604838|amniotic fluid leakage|amniotic fluid leakage
606241|NCT00604838|urinary incontinence|urinary incontinence
606242|NCT00604838|pregnancy|pregnancy
606243|NCT00604838|home test|home test
606244|NCT00604838|vaginal wetness|vaginal wetness
606245|NCT00604864|deep endometriosis|deep endometriosis
606246|NCT00604864|pelvic pain|pelvic pain
606247|NCT00604864|infliximab|infliximab
606248|NCT00604864|anti TNFa|anti tnfa
606249|NCT00604877|exercise|exercise
606250|NCT00604877|glucose metabolism|glucose metabolism
606251|NCT00604877|insulin sensitivity|insulin sensitivity
606252|NCT00604877|Vascular Function|vascular function
606253|NCT00604890|Double-Blind|double-blind
606254|NCT00604890|Placebo|placebo
606255|NCT00604890|Topical|topical
606256|NCT00604890|Treatment|treatment
606257|NCT00604890|Dose-Ranging|dose-ranging
606258|NCT00604890|sBCC|sbcc
606259|NCT00604916|oral hygiene|oral hygiene
606260|NCT00604929|muscle protein synthesis|muscle protein synthesis
606261|NCT00604929|whole-body protein breakdown|whole-body protein breakdown
606262|NCT00604929|nutrition|nutrition
606263|NCT00604942|Oesophagus|oesophagus
606264|NCT00604942|Dysphagia|dysphagia
606265|NCT00604942|Impedance|impedance
606266|NCT00604942|High Resolution Manometry|high resolution manometry
606267|NCT00604942|Peristalsis|peristalsis
606268|NCT00604942|Contractile Pressure|contractile pressure
606269|NCT00604942|Coordination of contraction|coordination of contraction
606270|NCT00604942|Bolus transport|bolus transport
606271|NCT00604955|visceral leishmaniasis|visceral leishmaniasis
606272|NCT00604955|kala-azar|kala-azar
606273|NCT00604955|Bihar, India|bihar, india
606274|NCT00604994|Lymphoedema|lymphoedema
606275|NCT00604994|Gynaecology|gynaecology
606276|NCT00604994|Oncology|oncology
606277|NCT00604994|Malignant|malignant
606278|NCT00604994|Benign|benign
606279|NCT00604994|Incidence|incidence
606280|NCT00605007|COPD|copd
606281|NCT00605007|Diabetes|diabetes
606282|NCT00605007|Respiratory Disorders|respiratory disorders
606283|NCT00605046|Alzheimer|alzheimer
606284|NCT00605046|SPECT|spect
606285|NCT00605059|Alzheimer|alzheimer
606286|NCT00605059|SPECT|spect
606287|NCT00605072|cognitive disorders|cognitive disorders
606288|NCT00605072|angiotensin receptor blockers|angiotensin receptor blockers
606290|NCT00605098|Pregnancy|pregnancy
606291|NCT00605098|Vertical disease transmission|vertical disease transmission
606292|NCT00605098|Pharmacokinetics|pharmacokinetics
606293|NCT00605098|HIV seronegativity|hiv seronegativity
606294|NCT00605124|osteoarthritis|osteoarthritis
606295|NCT00605124|knee|knee
606296|NCT00605124|total knee arthroplasty|total knee arthroplasty
606297|NCT00605124|exercise|exercise
606298|NCT00605150|Unresectable HCC|unresectable hcc
606299|NCT00605163|Parkinson disease, observational, longitudinal|parkinson disease, observational, longitudinal
606300|NCT00605176|Actinic keratosis|actinic keratosis
606301|NCT00605176|Skin disease|skin disease
606302|NCT00605241|pharmacodynamics,|pharmacodynamics,
606303|NCT00605241|pharmacokinetics,|pharmacokinetics,
606304|NCT00605241|tolerability,|tolerability,
606305|NCT00605241|Safety,|safety,
606306|NCT00605241|single dose,|single dose,
606307|NCT00605241|placebo,|placebo,
606308|NCT00605241|Nicotine reward|nicotine reward
606309|NCT00605241|GSK598809|gsk598809
606310|NCT00605254|P-Glycoprotein|p-glycoprotein
606311|NCT00605254|Positron Emission Tomography|positron emission tomography
606312|NCT00605254|Blood Brain Barrier|blood brain barrier
606313|NCT00605254|Quantitative Imaging|quantitative imaging
606314|NCT00605254|Multi-Drug Transporter|multi-drug transporter
606315|NCT00605254|Healthy Volunteer|healthy volunteer
606317|NCT00605267|Breast Cancer|breast cancer
606318|NCT00605267|Breast Neoplasms|breast neoplasms
606319|NCT00605267|Tumors or cancer of the human BREAST|tumors or cancer of the human breast
606320|NCT00605267|Tumor or cancer of the human MAMMARY GLAND|tumor or cancer of the human mammary gland
606321|NCT00605280|randomized sham-controlled multicenter macular edema|randomized sham-controlled multicenter macular edema
606322|NCT00605306|Asthma|asthma
606323|NCT00605306|spirometry|spirometry
606324|NCT00605306|lung function|lung function
606325|NCT00605306|serum cortisol|serum cortisol
606326|NCT00605306|serum potassium|serum potassium
606327|NCT00605306|plasma glucose|plasma glucose
606328|NCT00605319|BPH|bph
606329|NCT00605319|BOO|boo
606330|NCT00605358|geriatric depression|geriatric depression
606331|NCT00605371|Healthy volunteers|healthy volunteers
606332|NCT00605371|Bioequivalence|bioequivalence
606333|NCT00605371|Food Effects|food effects
606334|NCT00605397|Cu-64 LABELED TRASTUZUMAB|cu-64 labeled trastuzumab
606335|NCT00605410|Methacholine bronchoprovocation|methacholine bronchoprovocation
606336|NCT00605410|Antimuscarinic|antimuscarinic
606337|NCT00605423|AMD|amd
606338|NCT00605423|Almera|almera
606339|NCT00605423|Steroid|steroid
606340|NCT00605423|Macular|macular
606341|NCT00605423|ARMD|armd
606342|NCT00605436|overweight|overweight
606343|NCT00605436|sedentary|sedentary
606344|NCT00605436|metabolic syndrome|metabolic syndrome
606345|NCT00605449|GSK376501|gsk376501
606346|NCT00605449|Simvastatin|simvastatin
606347|NCT00605449|Healthy Subjects|healthy subjects
606348|NCT00605449|Repeat Dose|repeat dose
606349|NCT00605449|Drug Interaction|drug interaction
606350|NCT00605449|Randomized|randomized
606351|NCT00605449|Pharmacokinetics|pharmacokinetics
606352|NCT00605475|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
606353|NCT00605475|Canakinumab|canakinumab
606354|NCT00605475|ACZ885|acz885
606355|NCT00605475|IL-1B antagonist|il-1b antagonist
606356|NCT00605475|metformin|metformin
606357|NCT00605475|glycemic control|glycemic control
606358|NCT00605475|insulin sensitivity|insulin sensitivity
606359|NCT00605488|Pet Scan|pet scan
606360|NCT00605514|Hemorrhagic Fever|hemorrhagic fever
606361|NCT00605514|Healthy|healthy
606362|NCT00605514|Immunity|immunity
606363|NCT00605514|T-Cells|t-cells
606364|NCT00605514|Filovirus|filovirus
606365|NCT00605514|Healthy Volunteer|healthy volunteer
606367|NCT00605527|Acute Lung Injury|acute lung injury
606368|NCT00605527|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
606369|NCT00605540|COPD|copd
606370|NCT00605540|Survival|survival
606371|NCT00605540|Exacerbation|exacerbation
606372|NCT00605540|Disease markers|disease markers
606373|NCT00605566|Neuroendocrine|neuroendocrine
606374|NCT00605566|sorafenib|sorafenib
606375|NCT00605566|cyclophosphamide|cyclophosphamide
606376|NCT00605566|pharmacodynamic|pharmacodynamic
606377|NCT00605592|Type 1 Diabetes|type 1 diabetes
606378|NCT00605592|Kidney Transplant|kidney transplant
606379|NCT00605592|Hypoglycemic Unawareness|hypoglycemic unawareness
606380|NCT00605592|Islet Transplant|islet transplant
606381|NCT00605592|Pancreatic Islet Cell Transplantation|pancreatic islet cell transplantation
606382|NCT00605592|University of Virginia|university of virginia
606383|NCT00605592|Islet Transplantation|islet transplantation
606384|NCT00605592|Kidney Transplantation|kidney transplantation
606385|NCT00605605|endothelial function|endothelial function
606386|NCT00605605|atherosclerosis|atherosclerosis
606387|NCT00605605|smoking|smoking
606388|NCT00605605|inflammation|inflammation
606389|NCT00605605|antioxidant|antioxidant
606390|NCT00605631|Pacing|pacing
606391|NCT00605657|ALPS|alps
606392|NCT00605657|Valproic Acid|valproic acid
606393|NCT00605657|Lymphadenopathy|lymphadenopathy
606394|NCT00605657|Splenomegaly|splenomegaly
606395|NCT00605657|Histone Deacytelase (HDAC) Inhibitor|histone deacytelase (hdac) inhibitor
606396|NCT00605657|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
606397|NCT00605696|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
606398|NCT00605696|Acute Lung Injury|acute lung injury
606399|NCT00605748|catheter ablation|catheter ablation
606400|NCT00605748|atrial fibrillation|atrial fibrillation
606401|NCT00605748|pulmonary vein|pulmonary vein
606402|NCT00605761|Cystic Fibrosis|cystic fibrosis
606403|NCT00605761|Lung function|lung function
606404|NCT00605761|Anti-Inflammatory|anti-inflammatory
606405|NCT00605774|catecholamines|catecholamines
606406|NCT00605774|diabetes|diabetes
606407|NCT00605774|exercise|exercise
606408|NCT00605800|Liver resection|liver resection
606409|NCT00605839|mobile technology|mobile technology
606410|NCT00605839|cell phones|cell phones
606411|NCT00605839|type 1 diabetes|type 1 diabetes
606412|NCT00605852|Allergic rhinitis|allergic rhinitis
606413|NCT00605852|first time in human|first time in human
606414|NCT00605878|Atopic Dermatitis (Eczema)|atopic dermatitis (eczema)
606415|NCT00605878|Bacteria|bacteria
606416|NCT00605878|Filaggrin|filaggrin
606417|NCT00605878|Skin|skin
606418|NCT00605878|Microbiome|microbiome
606419|NCT00605878|Atopic Dermatitis|atopic dermatitis
606420|NCT00605878|Eczema|eczema
606421|NCT00605878|Health Volunteer|health volunteer
606422|NCT00605878|HG|hg
606423|NCT00605904|Chemical Stressor|chemical stressor
606424|NCT00605904|Alcoholism|alcoholism
606425|NCT00605904|Yohimbine|yohimbine
606426|NCT00605904|Acamprosate|acamprosate
606427|NCT00605904|Craving|craving
606428|NCT00605930|Progressive Supranuclear Palsy|progressive supranuclear palsy
606429|NCT00605930|PSP|psp
606430|NCT00605930|Nutriceutical|nutriceutical
606431|NCT00605930|Pyruvate|pyruvate
606432|NCT00605930|Creatine|creatine
606433|NCT00605930|Niacinamide|niacinamide
606434|NCT00605943|Retinal Disease|retinal disease
606435|NCT00605943|Bevacizumab|bevacizumab
606436|NCT00605943|Ranibizumab|ranibizumab
606437|NCT00605943|Retinal Eye Disease|retinal eye disease
606438|NCT00605943|Macular Degeneration|macular degeneration
606439|NCT00605956|head lice|head lice
606440|NCT00605956|NatrOVA Creme Rinse - 1% is intended for the treatment of head lice|natrova creme rinse - 1% is intended for the treatment of head lice
606441|NCT00605969|femoroacetabular, impingement|femoroacetabular, impingement
606443|NCT00605995|Schizophrenia|schizophrenia
606444|NCT00605995|Randomized trial|randomized trial
606445|NCT00605995|Statin|statin
606446|NCT00605995|Placebo|placebo
606447|NCT00606008|Sutent|sutent
606448|NCT00606034|Type 2 diabetes|type 2 diabetes
606449|NCT00606034|Insulin Resistance|insulin resistance
606450|NCT00606034|Continuous Subcutaneous Insulin Infusion|continuous subcutaneous insulin infusion
606451|NCT00606034|U-500 Insulin|u-500 insulin
606452|NCT00606034|Omnipod|omnipod
606453|NCT00606047|femoroacetabular impingement|femoroacetabular impingement
606454|NCT00606060|Hemophilia,|hemophilia,
606455|NCT00606060|Continuous Infusion|continuous infusion
606456|NCT00606086|Hepatitis, HCV, Liver disease, HepC|hepatitis, hcv, liver disease, hepc
606457|NCT00606099|Adults|adults
606458|NCT00606099|compensated chronic hepatitis B|compensated chronic hepatitis b
606459|NCT00606099|telbivudin|telbivudin
606460|NCT00606099|aedevofir dipivoxil|aedevofir dipivoxil
606461|NCT00606125|Chemotherapy|chemotherapy
606462|NCT00606125|Solid Tumors|solid tumors
606463|NCT00606125|Sorafenib|sorafenib
606464|NCT00606125|Carboplatin|carboplatin
606465|NCT00606125|Paclitaxel|paclitaxel
606466|NCT00606151|drug eluding stents|drug eluding stents
606467|NCT00606151|perioperative bridging|perioperative bridging
606468|NCT00606151|Stents|stents
606469|NCT00606164|Alzheimer's Disease|alzheimer's disease
606470|NCT00606164|bryostatin 1|bryostatin 1
606471|NCT00606164|bryostatin|bryostatin
606472|NCT00606164|safety|safety
606473|NCT00606164|efficacy|efficacy
606474|NCT00606164|pharmacokinetics|pharmacokinetics
606475|NCT00606164|pharmacodynamics|pharmacodynamics
606476|NCT00606164|protein kinase C|protein kinase c
606477|NCT00606216|MRI|mri
606478|NCT00606255|blood pressure|blood pressure
606479|NCT00606255|compliance|compliance
606480|NCT00606255|treatment|treatment
606481|NCT00606268|Antifungal Prophylaxis|antifungal prophylaxis
606482|NCT00606268|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
606483|NCT00606268|HSCT|hsct
606484|NCT00606268|Micafungin|micafungin
606485|NCT00606294|Head|head
606486|NCT00606294|Neck|neck
606487|NCT00606294|04-070|04-070
606488|NCT00606333|Coronary artery disease|coronary artery disease
606489|NCT00606333|drug-eluting stents|drug-eluting stents
606490|NCT00606333|sirolimus-eluting coronary stents|sirolimus-eluting coronary stents
606491|NCT00606346|Crohn's Disease|crohn's disease
606492|NCT00606346|Ulcerative Colitis|ulcerative colitis
606493|NCT00606346|Indeterminate Colitis|indeterminate colitis
606494|NCT00606346|Inflammatory Bowel Diseases|inflammatory bowel diseases
606495|NCT00606346|Immunomodulators|immunomodulators
606496|NCT00606346|infliximab|infliximab
606497|NCT00606346|TNF-alpha|tnf-alpha
606498|NCT00606359|Influenza|influenza
606499|NCT00606359|Orthomyxoviridae Infections|orthomyxoviridae infections
606500|NCT00606359|Renal Transplant|renal transplant
606501|NCT00606372|Off-pump|off-pump
606502|NCT00606372|OPCAB|opcab
606503|NCT00606372|EuroSCORE|euroscore
606504|NCT00606372|high-risk patients|high-risk patients
606505|NCT00606372|Quality of life|quality of life
606506|NCT00606372|Validity of EuroSCORE|validity of euroscore
606507|NCT00606385|Recurrence|recurrence
606508|NCT00606385|Survival|survival
606509|NCT00606385|Immunology|immunology
606510|NCT00606385|Laparoscopy|laparoscopy
606511|NCT00606398|colorectal metastases|colorectal metastases
606512|NCT00606411|Sleep-Related Eating Disorder|sleep-related eating disorder
606513|NCT00606411|Topiramate|topiramate
606514|NCT00606411|Parasomnia|parasomnia
606515|NCT00606424|head and neck cancer|head and neck cancer
606516|NCT00606437|Umbilical Cord Blood Graft|umbilical cord blood graft
606517|NCT00606437|Stem Cell Transplantation|stem cell transplantation
606518|NCT00606450|plaque psoriasis|plaque psoriasis
606519|NCT00606502|Stage IIIB/IV non-small cell lung cancer|stage iiib/iv non-small cell lung cancer
606520|NCT00606502|Non-small cell lung cancer|non-small cell lung cancer
606521|NCT00606502|NSCLC|nsclc
606522|NCT00606502|Lung Cancer|lung cancer
606523|NCT00606502|Pralatrexate|pralatrexate
606524|NCT00606502|Erlotinib|erlotinib
606525|NCT00606502|Tarceva|tarceva
606526|NCT00606502|PDX|pdx
606527|NCT00606502|Smoking|smoking
606528|NCT00606502|Smoker|smoker
606529|NCT00606515|Pharmacokinetics|pharmacokinetics
606530|NCT00606515|Liposomal paclitaxel|liposomal paclitaxel
606531|NCT00606528|Antiviral therapy|antiviral therapy
606532|NCT00606541|Social Anxiety Disorder|social anxiety disorder
606533|NCT00606541|Quetiapine XR|quetiapine xr
606534|NCT00606541|Prevention|prevention
606535|NCT00606541|tolerability|tolerability
606536|NCT00606554|Respiratory Insufficiency|respiratory insufficiency
606537|NCT00606554|Ventilators, Mechanical|ventilators, mechanical
606538|NCT00606554|Ventilator Weaning|ventilator weaning
606539|NCT00606554|Therapy, Computer-Assisted|therapy, computer-assisted
606540|NCT00606567|Defibrillators, Implantable|defibrillators, implantable
606541|NCT00606580|cutaneous leishmaniasis, topical treatment, Tunisia|cutaneous leishmaniasis, topical treatment, tunisia
606542|NCT00606593|insomnia|insomnia
606543|NCT00606593|elderly|elderly
606544|NCT00606593|sleeplessness|sleeplessness
606545|NCT00606619|Gastrectomy|gastrectomy
606546|NCT00606619|Oral feeding|oral feeding
606547|NCT00606619|Nutrition|nutrition
606548|NCT00606619|Gastric cancer|gastric cancer
606549|NCT00606632|Renal Mass|renal mass
606550|NCT00606632|Clear Cell Renal Cell Carcinoma|clear cell renal cell carcinoma
606551|NCT00606632|Cancer of Kidney|cancer of kidney
606552|NCT00606632|Kidney Cancer|kidney cancer
606553|NCT00606632|Neoplasms|neoplasms
606554|NCT00606632|cG250|cg250
606555|NCT00606632|antibody, monoclonal|antibody, monoclonal
606556|NCT00606632|Iodine 124|iodine 124
606557|NCT00606632|Positron-Emission Tomography|positron-emission tomography
606558|NCT00606632|Kidney|kidney
606559|NCT00606632|Renal Cancer|renal cancer
606560|NCT00606632|Renal Neoplasms|renal neoplasms
606561|NCT00606658|Insomnia|insomnia
606562|NCT00606658|Ayurveda|ayurveda
606563|NCT00606658|Shirodhara|shirodhara
607277|NCT00612300|Lokomat|lokomat
606564|NCT00606658|Quality of Life|quality of life
606565|NCT00606671|polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
606566|NCT00606684|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
606567|NCT00606684|COPD|copd
606568|NCT00606684|GW642444|gw642444
606569|NCT00606697|Primary Insomnia Adults|primary insomnia adults
606570|NCT00606723|relapsed or refractory AML|relapsed or refractory aml
606571|NCT00606723|in children, adolescents and young adults|in children, adolescents and young adults
606572|NCT00606736|right ventricular outflow tract arrhythmia|right ventricular outflow tract arrhythmia
606573|NCT00606736|sex hormone level|sex hormone level
606574|NCT00606736|menstrual cycle|menstrual cycle
606575|NCT00606736|Gonadal Hormones|gonadal hormones
606576|NCT00606762|laparoscopic cholecystectomy|laparoscopic cholecystectomy
606577|NCT00606762|low pressure pneumoperitoneum|low pressure pneumoperitoneum
606578|NCT00606775|Adrenergic beta-Antagonists|adrenergic beta-antagonists
606579|NCT00606775|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
606580|NCT00606775|Cardiomyopathies|cardiomyopathies
606581|NCT00606775|Troponin I|troponin i
606582|NCT00606788|randomized clinical trials|randomized clinical trials
606583|NCT00606788|intensive care|intensive care
607302|NCT00612404|endoscopy|endoscopy
606584|NCT00606788|mechanical ventilation|mechanical ventilation
606585|NCT00606788|ventilator weaning|ventilator weaning
606586|NCT00606788|clinical protocols|clinical protocols
606587|NCT00606788|therapy, computer-assisted|therapy, computer-assisted
606588|NCT00606788|humans|humans
606589|NCT00606788|various surgical diseases requiring mechanical ventilation over 24 hours|various surgical diseases requiring mechanical ventilation over 24 hours
606590|NCT00606801|cognitive enhancers|cognitive enhancers
606591|NCT00606801|Nootropic Agents|nootropic agents
606592|NCT00606814|Solid Tumors, IPI-504, docetaxel,cancer|solid tumors, ipi-504, docetaxel,cancer
606593|NCT00599989|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
606594|NCT00599989|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
606595|NCT00599989|stage I breast cancer|stage i breast cancer
606596|NCT00599989|stage II breast cancer|stage ii breast cancer
606597|NCT00599989|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
606598|NCT00599989|invasive lobular breast carcinoma|invasive lobular breast carcinoma
606599|NCT00599989|comedo ductal breast carcinoma|comedo ductal breast carcinoma
606600|NCT00599989|ductal breast carcinoma in situ|ductal breast carcinoma in situ
606601|NCT00599989|invasive ductal breast carcinoma|invasive ductal breast carcinoma
606602|NCT00599989|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
606603|NCT00599989|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
606604|NCT00599989|papillary ductal breast carcinoma|papillary ductal breast carcinoma
606605|NCT00599989|tubular ductal breast carcinoma|tubular ductal breast carcinoma
606606|NCT00599989|Paget disease of the breast with intraductal carcinoma|paget disease of the breast with intraductal carcinoma
606607|NCT00599989|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
606608|NCT00599989|breast cancer in situ|breast cancer in situ
606609|NCT00600002|GM-CSF|gm-csf
606610|NCT00600002|Leukine|leukine
606611|NCT00600015|Non-Small Cell Lung Cancer|non-small cell lung cancer
606612|NCT00600015|Advanced|advanced
606613|NCT00600015|Sorafenib|sorafenib
606614|NCT00600015|Erlotinib|erlotinib
606615|NCT00600015|Double-blind|double-blind
606616|NCT00600015|Placebo-controlled|placebo-controlled
606617|NCT00600028|idiopathic pulmonary fibrosis cough|idiopathic pulmonary fibrosis cough
606618|NCT00600041|Proton Pump Inhibitors|proton pump inhibitors
606619|NCT00600041|pantoprazole|pantoprazole
606620|NCT00600041|Cardiac Output|cardiac output
606621|NCT00600041|Echocardiography|echocardiography
606622|NCT00600041|adverse effects|adverse effects
606623|NCT00600054|Diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
606624|NCT00600054|Common Terminology Criteria|common terminology criteria
606625|NCT00600054|Epidermal Growth factor receptor|epidermal growth factor receptor
606626|NCT00600054|Human antihuman antibody|human antihuman antibody
606627|NCT00600054|pharmacokinetics|pharmacokinetics
606628|NCT00600054|monoclonal antibody|monoclonal antibody
606629|NCT00600054|Informed Consent Form|informed consent form
606631|NCT00600067|Type 2 Diabetes|type 2 diabetes
606632|NCT00600067|Diabetes Mellitus|diabetes mellitus
606633|NCT00600067|Metabolic Diseases|metabolic diseases
606634|NCT00600067|Glucose Metabolism Disorders|glucose metabolism disorders
606635|NCT00600067|Glycemic Control|glycemic control
606636|NCT00600093|Amantadine|amantadine
606637|NCT00600119|NKTR, constipation, opioid, induced, bowel, dysfunction, Naloxol, Naloxone, Narcan, PEG naloxol, OIC, OBD, Nektar|nktr, constipation, opioid, induced, bowel, dysfunction, naloxol, naloxone, narcan, peg naloxol, oic, obd, nektar
606638|NCT00600145|Human volunteers|human volunteers
606639|NCT00600145|amphetamine dependence|amphetamine dependence
606640|NCT00600158|colectomy|colectomy
606641|NCT00600171|dose ranging|dose ranging
606642|NCT00600171|placebo|placebo
606643|NCT00600171|asthma|asthma
606644|NCT00600171|safety|safety
606645|NCT00600171|efficacy|efficacy
606646|NCT00600171|pharmacokinetics|pharmacokinetics
606647|NCT00600184|Stroke|stroke
606648|NCT00600184|Rehabilitation|rehabilitation
606649|NCT00600184|Robotics|robotics
606650|NCT00600236|Diabetes mellitus type 2 with 10 years of diagnosis and no diabetic retinopathy|diabetes mellitus type 2 with 10 years of diagnosis and no diabetic retinopathy
606651|NCT00600236|Diabetes mellitus type 2 with 10 years of diagnosis and proliferative diabetic retinopathy|diabetes mellitus type 2 with 10 years of diagnosis and proliferative diabetic retinopathy
606652|NCT00600249|Breast cancer.|breast cancer.
606653|NCT00600249|Triple negative.|triple negative.
606654|NCT00600249|Neoadjuvant chemotherapy.|neoadjuvant chemotherapy.
606655|NCT00600249|Targeted therapy.|targeted therapy.
606656|NCT00600262|severe nonproliferative|severe nonproliferative
606657|NCT00600262|proliferative diabetic retinopathy|proliferative diabetic retinopathy
606658|NCT00600262|active photocoagulated diabetic retinopathy|active photocoagulated diabetic retinopathy
606659|NCT00600262|intravitreal bevacizumab|intravitreal bevacizumab
606660|NCT00600275|BGT226|bgt226
606661|NCT00600275|Solid tumors|solid tumors
606662|NCT00600275|Breast cancer|breast cancer
606663|NCT00600275|Cowden Syndrome|cowden syndrome
606664|NCT00600275|Phosphatidylinositol 3'-kinase (PI3K) inhibitor|phosphatidylinositol 3'-kinase (pi3k) inhibitor
607572|NCT00613132|Gleevec|gleevec
606665|NCT00600275|Advanced solid tumors (including sporadic and Cowden Syndrome) (Phase I part)|advanced solid tumors (including sporadic and cowden syndrome) (phase i part)
606666|NCT00600275|Advanced breast cancer (including sporadic and Cowden Syndrome) (Phase II part)|advanced breast cancer (including sporadic and cowden syndrome) (phase ii part)
606668|NCT00600301|Edema|edema
606669|NCT00600314|Graft-Versus-Host Disease|graft-versus-host disease
606670|NCT00600314|Transplantation, Allogeneic|transplantation, allogeneic
606671|NCT00600314|Transplantation, Hematopoietic Stem Cell|transplantation, hematopoietic stem cell
606672|NCT00600314|Calorimetry, Respiration|calorimetry, respiration
606673|NCT00600327|Stroke|stroke
606674|NCT00600327|thrombosis|thrombosis
606675|NCT00600327|thromboembolic|thromboembolic
606676|NCT00600327|Transient Ischemic Attack|transient ischemic attack
606677|NCT00600327|TIA|tia
606678|NCT00600353|nausea|nausea
606679|NCT00600353|cancer|cancer
606680|NCT00600353|CINV|cinv
606681|NCT00600379|stroke chronic gait deficits virtual reality training|stroke chronic gait deficits virtual reality training
606682|NCT00600405|Nephrolithiasis|nephrolithiasis
606683|NCT00600405|Ureteral Calculi|ureteral calculi
606684|NCT00600418|PTSD|ptsd
606685|NCT00600418|DYADIC TREATMENT|dyadic treatment
606686|NCT00600418|WAR AND TERROR|war and terror
606687|NCT00600418|Posttraumatic symptoms among toddlers|posttraumatic symptoms among toddlers
606688|NCT00600431|nevus count|nevus count
606689|NCT00600431|children|children
606690|NCT00600431|chemotherapy|chemotherapy
606691|NCT00600444|permanent venous access|permanent venous access
606692|NCT00600444|chemotherapy|chemotherapy
606693|NCT00600444|parenteral nutrition|parenteral nutrition
606694|NCT00600444|Patients with a benign and/or malignant diseases which demand a safe and permanent venous access, e.g. for chemotherapy and/or parenteral nutrition|patients with a benign and/or malignant diseases which demand a safe and permanent venous access, e.g. for chemotherapy and/or parenteral nutrition
606695|NCT00600444|benign diseases|benign diseases
606696|NCT00600444|malignant diseases|malignant diseases
606697|NCT00600457|healing time|healing time
606698|NCT00600457|pain|pain
606699|NCT00600457|infection|infection
606700|NCT00600470|Behavior Problems|behavior problems
606701|NCT00600470|Behavior Disorders|behavior disorders
606702|NCT00600483|obesity|obesity
606703|NCT00600483|diabetes|diabetes
606704|NCT00600496|ARRY-142886|arry-142886
606705|NCT00600496|AZD6244|azd6244
606706|NCT00600496|Cancer|cancer
606707|NCT00600496|Colon Cancer|colon cancer
606708|NCT00600496|Breast Cancer|breast cancer
606709|NCT00600496|Lung Cancer|lung cancer
606710|NCT00600496|Melanoma|melanoma
606711|NCT00600496|Kidney Cancer|kidney cancer
606712|NCT00600509|Levetiracetam|levetiracetam
606713|NCT00600509|Keppra|keppra
606714|NCT00600522|intraoperative ultrasonography|intraoperative ultrasonography
606715|NCT00600522|hepatectomy|hepatectomy
606716|NCT00600522|colorectal liver metastases|colorectal liver metastases
606717|NCT00600522|hepatocellular carcinoma|hepatocellular carcinoma
606718|NCT00600522|contrast enhanced intraoperative ultrasonography.|contrast enhanced intraoperative ultrasonography.
606719|NCT00600535|Prostate neoplasms|prostate neoplasms
606720|NCT00600535|Abiraterone acetate|abiraterone acetate
606721|NCT00600535|CB7630|cb7630
606722|NCT00600535|Prostate cancer|prostate cancer
606723|NCT00600535|Pharmacokinetics|pharmacokinetics
606724|NCT00600548|Cutaneous leishmaniasis|cutaneous leishmaniasis
606725|NCT00600548|Miltefosine|miltefosine
606726|NCT00600548|Meglumine antimoniate|meglumine antimoniate
606727|NCT00600548|L. braziliensis, L. guyanensis|l. braziliensis, l. guyanensis
606728|NCT00600561|meditation|meditation
606729|NCT00600561|mindfulness|mindfulness
606730|NCT00600561|HIV|hiv
606731|NCT00600561|CD4|cd4
606732|NCT00600561|Complementary Therapies|complementary therapies
606733|NCT00600574|fibromyalgia|fibromyalgia
606734|NCT00600574|physical therapies|physical therapies
606735|NCT00600574|stretching|stretching
606736|NCT00600574|Ai Chi|ai chi
606737|NCT00600587|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
606738|NCT00600587|Genes, erbB-1|genes, erbb-1
606739|NCT00600587|tyrosine kinase inhibitor|tyrosine kinase inhibitor
606740|NCT00600587|Neoadjuvant Therapy|neoadjuvant therapy
606741|NCT00600613|Radiation Therapy|radiation therapy
606742|NCT00600639|old patients|old patients
606744|NCT00600639|Intubation|intubation
606745|NCT00600639|COPD|copd
606746|NCT00600652|glucocorticoid-receptor|glucocorticoid-receptor
606747|NCT00600652|flow cytometry|flow cytometry
606748|NCT00600652|glucocorticoid-resistant|glucocorticoid-resistant
606749|NCT00600652|prediction|prediction
606750|NCT00600665|Sickle Cell Anemia|sickle cell anemia
606751|NCT00600665|Sickle Cell Disease|sickle cell disease
606752|NCT00600678|food for special medical purposes|food for special medical purposes
606753|NCT00600691|Finasteride|finasteride
606754|NCT00600691|hematuria|hematuria
606755|NCT00600691|hematospermia|hematospermia
606756|NCT00600691|prostate biopsy|prostate biopsy
606757|NCT00600704|Allogenic Blood Use|allogenic blood use
606758|NCT00600704|Total Blood Loss|total blood loss
606759|NCT00600704|Reinfusion of Washed Shed Blood|reinfusion of washed shed blood
606760|NCT00600717|Magnetoencephalography(MEG)|magnetoencephalography(meg)
606761|NCT00600717|Electroencephalography (EEG)|electroencephalography (eeg)
606762|NCT00600717|Intracranial recordings (iEEG/ECoG/SEEG)|intracranial recordings (ieeg/ecog/seeg)
606763|NCT00600717|Functional Mapping|functional mapping
606764|NCT00600717|Epilepsy|epilepsy
606765|NCT00600717|Migraine|migraine
606766|NCT00600717|HFOs|hfos
606767|NCT00600717|ripples|ripples
606768|NCT00600717|fast ripples|fast ripples
606769|NCT00600717|high-gamma|high-gamma
606770|NCT00600730|fMRi|fmri
606771|NCT00600730|hypoglycemia|hypoglycemia
606772|NCT00600743|Eating|eating
606773|NCT00600743|Food Intake|food intake
606774|NCT00600743|Appetite|appetite
606775|NCT00600756|schizophrenia|schizophrenia
606776|NCT00600756|SWNK|swnk
606777|NCT00600769|MAC|mac
606778|NCT00600769|NTM|ntm
606779|NCT00600782|Tuberculosis vaccine|tuberculosis vaccine
606780|NCT00600795|NPH|nph
606781|NCT00600795|TGF-beta|tgf-beta
606782|NCT00600808|SR-hGH, Pharmacokinetics, Pharmacodynamics|sr-hgh, pharmacokinetics, pharmacodynamics
606783|NCT00600847|urticaria|urticaria
606784|NCT00600847|cold urticaria|cold urticaria
606785|NCT00600847|acquired cold urticaria|acquired cold urticaria
606786|NCT00600860|MDS (all IPSS subtypes)|mds (all ipss subtypes)
606787|NCT00600860|Newly diagnosed|newly diagnosed
606788|NCT00600873|neuroprotection|neuroprotection
606789|NCT00600873|oxidative stress|oxidative stress
606790|NCT00600886|Acromegaly,|acromegaly,
606791|NCT00600886|adult,|adult,
606792|NCT00600886|growth hormone,|growth hormone,
606793|NCT00600886|insulin-like growth factor I,|insulin-like growth factor i,
606794|NCT00600886|somatostatin analogue|somatostatin analogue
606795|NCT00600899|Postoperative pain treatment|postoperative pain treatment
606796|NCT00600912|lipid emulsion|lipid emulsion
606797|NCT00600912|fish oil|fish oil
606798|NCT00600912|parenteral nutrition|parenteral nutrition
606799|NCT00600912|leucotriene LTB5|leucotriene ltb5
606800|NCT00600912|hepatic function|hepatic function
606801|NCT00600925|Colorectal surgery|colorectal surgery
606802|NCT00600938|iron overload|iron overload
606803|NCT00600938|cardiac iron|cardiac iron
606804|NCT00600938|haemosiderosis|haemosiderosis
606805|NCT00600938|myocardial T2*|myocardial t2*
606806|NCT00600938|left ventricular ejection fraction|left ventricular ejection fraction
606807|NCT00600938|LVEF|lvef
606808|NCT00600938|cardiac dysfunction|cardiac dysfunction
606809|NCT00600938|thalassaemia|thalassaemia
606810|NCT00600938|Diamond Blackfan anemia|diamond blackfan anemia
606811|NCT00600938|DBA|dba
606812|NCT00600938|sideroblastic anemia|sideroblastic anemia
606813|NCT00600938|myelodysplastic syndromes|myelodysplastic syndromes
606814|NCT00600938|MDS (low and INT-1 risk as per the IPSS for MDS)|mds (low and int-1 risk as per the ipss for mds)
606815|NCT00600938|liver MRI|liver mri
606816|NCT00600938|deferasirox|deferasirox
606817|NCT00600938|deferoxamine|deferoxamine
606818|NCT00600938|ICL670|icl670
606819|NCT00600938|DFO|dfo
606820|NCT00600938|cardiovascular magnetic resonance imaging|cardiovascular magnetic resonance imaging
606821|NCT00600964|CLL|cll
606822|NCT00600964|obatoclax|obatoclax
606823|NCT00600977|ALL|all
606824|NCT00600977|Chemotherapy|chemotherapy
606825|NCT00600977|Pharmacokinetics of doxorubicin (pegylated or not)|pharmacokinetics of doxorubicin (pegylated or not)
606826|NCT00600977|elderly ALL|elderly all
606827|NCT00600990|post-operative nausea and vomiting|post-operative nausea and vomiting
606828|NCT00600990|PONV|ponv
606829|NCT00601016|Infantile hemangioma|infantile hemangioma
606830|NCT00601016|Hemangioma|hemangioma
606831|NCT00601016|Hemangioma of Infancy|hemangioma of infancy
606832|NCT00601016|benign tumors of infancy|benign tumors of infancy
606833|NCT00601016|Congenital hemangioma|congenital hemangioma
606834|NCT00601016|Capillary|capillary
606835|NCT00601029|Exertional Rhabdomyolysis|exertional rhabdomyolysis
606836|NCT00601042|smoking reduction|smoking reduction
606837|NCT00601042|smoking cessation|smoking cessation
606838|NCT00601042|randomized trial|randomized trial
606839|NCT00601042|Swedish snus|swedish snus
606840|NCT00601042|smokeless tobacco|smokeless tobacco
606841|NCT00601055|COPD|copd
606842|NCT00601055|Geriatric Depression|geriatric depression
606843|NCT00601055|Problem-Solving Therapy|problem-solving therapy
606844|NCT00601055|Treatment Adherence|treatment adherence
606845|NCT00601068|osteonecrosis, jaws, bisphosphonate, fosamax, alendronate|osteonecrosis, jaws, bisphosphonate, fosamax, alendronate
606846|NCT00601081|Very low birth weight infants|very low birth weight infants
606848|NCT00601081|immune system function|immune system function
606849|NCT00601094|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
606850|NCT00601094|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
606851|NCT00601094|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
606852|NCT00601107|psoriasis|psoriasis
606853|NCT00601107|psoriasis vulgaris|psoriasis vulgaris
606854|NCT00601107|plaque psoriasis|plaque psoriasis
606855|NCT00601107|chronic plaque psoriasis|chronic plaque psoriasis
606856|NCT00601120|antiangiogenic therapy|antiangiogenic therapy
606857|NCT00601120|RF ablation|rf ablation
606858|NCT00601133|Solid Tumors|solid tumors
606859|NCT00601133|Acute Inpatient Rehabilitation|acute inpatient rehabilitation
606860|NCT00601133|Postural Instability|postural instability
606861|NCT00601133|Balance|balance
606862|NCT00601133|Function|function
606863|NCT00601133|Walking|walking
606864|NCT00601133|Questionnaire|questionnaire
606865|NCT00601133|Survey|survey
606866|NCT00601146|Hodgkin's disease|hodgkin's disease
606867|NCT00601146|CT scan|ct scan
606868|NCT00601159|Metastatic Breast Cancer|metastatic breast cancer
606869|NCT00601159|triple-negative Breast Cancer|triple-negative breast cancer
606870|NCT00601159|cisplatin|cisplatin
606871|NCT00601159|chemotherapy|chemotherapy
606872|NCT00601172|vomiting|vomiting
606873|NCT00601172|colorectal cancer|colorectal cancer
606874|NCT00601172|nausea|nausea
606875|NCT00601172|oxaliplatin|oxaliplatin
606876|NCT00606827|Contrast-induced nephrophaty|contrast-induced nephrophaty
606877|NCT00606827|Contrast media|contrast media
606878|NCT00606827|Angiography|angiography
606879|NCT00606827|Coronary percutaneous intervention|coronary percutaneous intervention
606880|NCT00606840|overweight|overweight
606881|NCT00606840|prevention of weight gain|prevention of weight gain
606882|NCT00606840|young adults|young adults
606883|NCT00606840|self-regulation|self-regulation
606884|NCT00606840|daily weighing|daily weighing
606885|NCT00606840|weight gain prevention|weight gain prevention
606886|NCT00606853|Substance abuse|substance abuse
606887|NCT00606853|Contingency Management|contingency management
606888|NCT00606866|renal, metastatic, carcinoma|renal, metastatic, carcinoma
606889|NCT00606879|Solid tumor|solid tumor
606890|NCT00606879|Advanced Cancer|advanced cancer
606891|NCT00606879|MET inhibitor|met inhibitor
606892|NCT00606879|Receptor Tyrosine Kinase Inhibitor (RTKI)|receptor tyrosine kinase inhibitor (rtki)
606893|NCT00606892|therapeutic effects|therapeutic effects
606894|NCT00606905|Recurrent miscarriage|recurrent miscarriage
606895|NCT00606905|Recurrent spontaneous abortion|recurrent spontaneous abortion
606896|NCT00606905|Habitual abortion|habitual abortion
606897|NCT00606905|IVIG|ivig
606898|NCT00606905|Randomized Controlled Trial|randomized controlled trial
606899|NCT00606918|Strength testing|strength testing
606900|NCT00606918|Disease progression|disease progression
606901|NCT00606918|ALS|als
606902|NCT00606918|Healthy Adults|healthy adults
606903|NCT00606931|biopsy|biopsy
606904|NCT00606931|PET|pet
606905|NCT00606931|image-guidance|image-guidance
606906|NCT00606931|breast cancer|breast cancer
606907|NCT00606931|FDG|fdg
606908|NCT00606931|PEM|pem
606909|NCT00606944|enhanced recovery program|enhanced recovery program
606910|NCT00606957|Obesity|obesity
606911|NCT00606957|Metabolism|metabolism
606912|NCT00606970|Chemotherapy|chemotherapy
606913|NCT00606970|Breast Cancer|breast cancer
606914|NCT00606970|Colon Cancer|colon cancer
606915|NCT00606970|Lung Cancer|lung cancer
606916|NCT00606996|Drug Abuse|drug abuse
606917|NCT00606996|Drug Dependence|drug dependence
606918|NCT00606996|Alcohol Abuse|alcohol abuse
606919|NCT00606996|Alcohol Dependence|alcohol dependence
606920|NCT00606996|Major Depressive Disorder|major depressive disorder
606921|NCT00606996|Dysthymic Disorder|dysthymic disorder
606922|NCT00606996|Prisoners|prisoners
606923|NCT00606996|Women|women
606924|NCT00607022|dental implant|dental implant
606925|NCT00607022|early loading|early loading
606926|NCT00607022|traditional loading|traditional loading
606927|NCT00607022|anterior|anterior
606928|NCT00607022|implant stability|implant stability
606929|NCT00607022|Subjects presenting with one tooth missing in the anterior|subjects presenting with one tooth missing in the anterior
606930|NCT00607022|incisor/canine) or pre-molar regions of the mandible|incisor/canine) or pre-molar regions of the mandible
606931|NCT00607022|or maxilla with existing teeth that were healthy|or maxilla with existing teeth that were healthy
606932|NCT00607022|or adequately restored shall be screened.|or adequately restored shall be screened.
606935|NCT00607061|Synthesis rate|synthesis rate
606936|NCT00607061|Newborns|newborns
606937|NCT00607061|Low birth weight newborn babies|low birth weight newborn babies
606938|NCT00607100|High-Resolution Optical Coherence Tomography|high-resolution optical coherence tomography
606939|NCT00607100|Retinal Nerve Fiber Layer|retinal nerve fiber layer
606940|NCT00607100|Band Atrophy|band atrophy
606941|NCT00607113|Neuroendocrine Carcinoma|neuroendocrine carcinoma
606943|NCT00607113|Bevacizumab|bevacizumab
606944|NCT00607113|RAD001|rad001
606945|NCT00607113|Everolimus|everolimus
606946|NCT00607126|impaired ambulation|impaired ambulation
606947|NCT00611286|Drug-eluting stent|drug-eluting stent
606948|NCT00611286|clopidogrel|clopidogrel
606949|NCT00611286|bare metal stent|bare metal stent
606950|NCT00611286|landmark analysis|landmark analysis
606951|NCT00611286|Patients with coronary artery disease|patients with coronary artery disease
606952|NCT00611299|Probiotics|probiotics
606953|NCT00611299|Immune response|immune response
606954|NCT00611299|Blood lipids|blood lipids
606955|NCT00611299|Intestinal microflora|intestinal microflora
606956|NCT00611299|Tolerance|tolerance
606957|NCT00611312|Alzheimer's disease|alzheimer's disease
606958|NCT00611312|Cognitive training|cognitive training
606959|NCT00611325|Glioblastoma|glioblastoma
606960|NCT00611325|Gliosarcoma|gliosarcoma
606961|NCT00611325|Glioblastoma multiforme|glioblastoma multiforme
606962|NCT00611325|Recurrent malignant glioma|recurrent malignant glioma
606964|NCT00611325|Recurrent GBM|recurrent gbm
606965|NCT00611325|Malignant glioma|malignant glioma
606966|NCT00611325|Brain tumor|brain tumor
606967|NCT00611325|Avastin|avastin
606968|NCT00611325|Bevacizumab|bevacizumab
606969|NCT00611325|Bortezomib|bortezomib
606970|NCT00611325|Velcade|velcade
606971|NCT00611338|Complementary Therapies|complementary therapies
606972|NCT00611351|graft versus host disease|graft versus host disease
606973|NCT00611351|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
606974|NCT00611351|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
606975|NCT00611351|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
606976|NCT00611351|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
606977|NCT00611351|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
606978|NCT00611351|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
606979|NCT00611351|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
606980|NCT00611351|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
606981|NCT00611351|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
606982|NCT00611351|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
606983|NCT00611351|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
606984|NCT00611351|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
607499|NCT00612989|Temodar|temodar
606985|NCT00611351|stage III multiple myeloma|stage iii multiple myeloma
606986|NCT00611351|refractory multiple myeloma|refractory multiple myeloma
606987|NCT00611351|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
606988|NCT00611351|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
606989|NCT00611351|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
606990|NCT00611351|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
606991|NCT00611351|secondary myelofibrosis|secondary myelofibrosis
606992|NCT00611351|secondary acute myeloid leukemia|secondary acute myeloid leukemia
606993|NCT00611351|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
606994|NCT00611351|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
606995|NCT00611351|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
606996|NCT00611351|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
606997|NCT00611351|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
606998|NCT00611351|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
606999|NCT00611351|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
607000|NCT00611351|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
607001|NCT00611351|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
607002|NCT00611351|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
607003|NCT00611351|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
607004|NCT00611351|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
607005|NCT00611351|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
607006|NCT00611351|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
607007|NCT00611351|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
607008|NCT00611351|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
607009|NCT00611351|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
607010|NCT00611351|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
607011|NCT00611351|splenic marginal zone lymphoma|splenic marginal zone lymphoma
607012|NCT00611351|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
607013|NCT00611351|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
607014|NCT00611351|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
607015|NCT00611351|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
607016|NCT00611351|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
607017|NCT00611351|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
607018|NCT00611351|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
607019|NCT00611351|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
607020|NCT00611351|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
607021|NCT00611351|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
607022|NCT00611351|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
607023|NCT00611351|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
607024|NCT00611351|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
607025|NCT00611351|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
607026|NCT00611351|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
607027|NCT00611351|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
607028|NCT00611351|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
607265|NCT00612248|Splint|splint
607029|NCT00611351|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
607030|NCT00611351|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
607031|NCT00611351|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
607032|NCT00611351|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
607033|NCT00611351|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
607034|NCT00611351|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
607035|NCT00611351|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
607036|NCT00611351|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
607037|NCT00611351|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
607038|NCT00611351|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
607039|NCT00611351|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
607040|NCT00611351|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
607041|NCT00611351|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
607042|NCT00611351|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
607043|NCT00611351|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
607044|NCT00611351|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
607045|NCT00611351|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
607046|NCT00611351|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
607047|NCT00611351|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
607048|NCT00611351|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
607049|NCT00611351|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
607050|NCT00611351|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
607051|NCT00611351|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
607052|NCT00611351|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
607053|NCT00611351|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
607054|NCT00611351|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
607055|NCT00611351|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
607056|NCT00611351|refractory hairy cell leukemia|refractory hairy cell leukemia
607057|NCT00611351|stage I multiple myeloma|stage i multiple myeloma
607058|NCT00611351|stage II multiple myeloma|stage ii multiple myeloma
607059|NCT00611364|Physical therapy|physical therapy
607060|NCT00611364|hypertension|hypertension
607061|NCT00611364|aged|aged
607062|NCT00611364|exercise|exercise
607063|NCT00611364|Physical exercise|physical exercise
607064|NCT00611364|Physical activity|physical activity
607066|NCT00611377|mechanical ventilation|mechanical ventilation
607067|NCT00611377|age|age
607068|NCT00611377|severity score|severity score
607069|NCT00611390|Viral laryngitis;|viral laryngitis;
607070|NCT00611390|Viral tracheitis;|viral tracheitis;
607071|NCT00611390|Herbal medicine;|herbal medicine;
607072|NCT00611390|Traditional medicine;|traditional medicine;
607073|NCT00611390|Aromatic essential oils;|aromatic essential oils;
607074|NCT00611403|LASIK|lasik
607075|NCT00611416|catechins|catechins
607076|NCT00611416|caffeine|caffeine
607077|NCT00611416|energy expenditure|energy expenditure
607078|NCT00611416|fat oxidation|fat oxidation
607079|NCT00611416|appetite|appetite
607080|NCT00611429|Treatment|treatment
607081|NCT00611429|Adherence|adherence
607082|NCT00611429|Intervention|intervention
607083|NCT00611429|Quality of Life|quality of life
607084|NCT00611494|Drug tolerance|drug tolerance
607085|NCT00611494|Quality of Life|quality of life
607086|NCT00611520|treatment of COPD|treatment of copd
607087|NCT00611520|related to the budesonide/formoterole therapy in patients with COPD.|related to the budesonide/formoterole therapy in patients with copd.
607088|NCT00611533|Menopause|menopause
607089|NCT00611533|Cognition|cognition
607090|NCT00611546|preterm|preterm
607091|NCT00611546|parenteral nutrition|parenteral nutrition
607092|NCT00611546|TPN|tpn
607093|NCT00611546|lipid emulsions|lipid emulsions
607094|NCT00611546|photo-protection|photo-protection
607095|NCT00611546|oxidative stress|oxidative stress
607096|NCT00611559|Infanrix hexa|infanrix hexa
607097|NCT00611559|combined vaccine|combined vaccine
607098|NCT00611572|GABA|gaba
607099|NCT00611572|glutamate|glutamate
607100|NCT00611572|NMDA|nmda
607101|NCT00611572|P300|p300
607102|NCT00611572|MMN|mmn
607103|NCT00611624|MammoSite|mammosite
607104|NCT00611624|brachytherapy|brachytherapy
607105|NCT00611637|Immunotherapy|immunotherapy
607106|NCT00611650|non-small cell lung cancer|non-small cell lung cancer
607107|NCT00611650|squamous lung dysplasia|squamous lung dysplasia
607108|NCT00611650|tobacco use disorder|tobacco use disorder
607109|NCT00611663|Pneumococcal vaccine|pneumococcal vaccine
607110|NCT00611663|SLE|sle
607111|NCT00611663|Vaccination|vaccination
607112|NCT00611663|Immunosuppression|immunosuppression
607113|NCT00611663|SLE as defined by the ACR classification|sle as defined by the acr classification
607114|NCT00611663|Stable SLE|stable sle
607115|NCT00611663|SLE treated by systemic corticosteroids|sle treated by systemic corticosteroids
607116|NCT00611676|osteoarthritis pain|osteoarthritis pain
607117|NCT00611676|activity limitation|activity limitation
607118|NCT00611676|antidepressant|antidepressant
607119|NCT00611676|depression|depression
607120|NCT00611676|single-blind|single-blind
607121|NCT00611689|Refractory Malignancy|refractory malignancy
607122|NCT00611689|Solid Tumors|solid tumors
607123|NCT00611689|PTK787|ptk787
607124|NCT00611689|ZK222584|zk222584
607125|NCT00611702|ELISPOT|elispot
607126|NCT00611702|RT-PCR|rt-pcr
607127|NCT00611702|Luminex|luminex
607128|NCT00611702|Genomics|genomics
607129|NCT00611715|recurrent breast cancer|recurrent breast cancer
607130|NCT00611715|stage IV breast cancer|stage iv breast cancer
607131|NCT00611728|Glioblastoma|glioblastoma
607132|NCT00611728|CPT 11|cpt 11
607133|NCT00611728|Sutent|sutent
607134|NCT00611728|Sunitinib|sunitinib
607135|NCT00611728|Sunitinib malate|sunitinib malate
607136|NCT00611728|Malignant Glioma|malignant glioma
607137|NCT00611728|GBM|gbm
607138|NCT00611728|Irinotecan|irinotecan
607139|NCT00611728|Camptosar|camptosar
607140|NCT00611728|Anaplastic astrocytoma|anaplastic astrocytoma
607141|NCT00611728|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
607142|NCT00611728|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
607143|NCT00611728|SU011248|su011248
607144|NCT00611728|Brain tumor|brain tumor
607717|NCT00613717|infant|infant
607145|NCT00611728|Recurrent malignant glioma|recurrent malignant glioma
607146|NCT00611741|MRS, glutamate, osmolality|mrs, glutamate, osmolality
607147|NCT00611767|Thiopental|thiopental
607148|NCT00611767|Alcohol|alcohol
607149|NCT00611767|Family History|family history
607150|NCT00611767|Vulnerability|vulnerability
607151|NCT00611767|GABA|gaba
607152|NCT00611780|Coronary CT angiography|coronary ct angiography
607153|NCT00611780|Radiation dose estimates|radiation dose estimates
607154|NCT00611793|Refractory Malignancy|refractory malignancy
607155|NCT00611793|Advanced Malignancies|advanced malignancies
607156|NCT00611793|PTK787/ZK222584|ptk787/zk222584
607157|NCT00611793|Bevacizumab|bevacizumab
607158|NCT00611806|Cognition|cognition
607159|NCT00611806|Folic Acid|folic acid
607160|NCT00611806|B12|b12
607161|NCT00611819|hepatitis|hepatitis
607162|NCT00611819|co-infection|co-infection
607163|NCT00611832|behavior problems|behavior problems
607164|NCT00611832|children|children
607165|NCT00611832|prevention|prevention
607166|NCT00611832|television|television
607167|NCT00611832|media|media
607168|NCT00611832|parenting|parenting
607169|NCT00611845|CABG surgery requiring CPB and at increased risk of bleeding and blood transfusion|cabg surgery requiring cpb and at increased risk of bleeding and blood transfusion
607170|NCT00611858|5-FU|5-fu
607171|NCT00611858|cetuximab|cetuximab
607172|NCT00611858|radiation|radiation
607173|NCT00611858|adenocarcinoma of the rectum|adenocarcinoma of the rectum
607174|NCT00611858|neoadjuvant therapy|neoadjuvant therapy
607175|NCT00611897|NMDA|nmda
607176|NCT00611897|glutamate|glutamate
607177|NCT00611897|N-acetylcysteine|n-acetylcysteine
607178|NCT00611897|P3|p3
607179|NCT00611923|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
607180|NCT00611923|PMDD|pmdd
607181|NCT00611923|PMS|pms
607182|NCT00611936|Atomoxetine|atomoxetine
607183|NCT00611936|Stress|stress
607184|NCT00611936|d-amphetamine|d-amphetamine
607185|NCT00611949|Geranium oil|geranium oil
607186|NCT00611949|Neuropathy|neuropathy
607187|NCT00611949|Shingles|shingles
607188|NCT00611949|Herpes zoster|herpes zoster
607189|NCT00611975|Gonadal Steroid Hormones|gonadal steroid hormones
607190|NCT00611975|Healthy Volunteers|healthy volunteers
607191|NCT00611975|Antidepressant Side Effects|antidepressant side effects
607192|NCT00611975|Fluoxetine|fluoxetine
607193|NCT00611975|Bupropion|bupropion
607194|NCT00611975|Prolactin|prolactin
607195|NCT00611975|Testosterone|testosterone
607196|NCT00611975|Estradiol|estradiol
607197|NCT00611975|Progesterone|progesterone
607198|NCT00611975|Sexual Function|sexual function
607199|NCT00611975|Serotonin Reuptake Inhibitors|serotonin reuptake inhibitors
607200|NCT00611975|17-OH Pregnenolone|17-oh pregnenolone
607201|NCT00611988|Walking therapy|walking therapy
607202|NCT00611988|Diabetes mellitus|diabetes mellitus
607203|NCT00611988|Peripheral arterial disease|peripheral arterial disease
607204|NCT00612001|adult anaplastic astrocytoma|adult anaplastic astrocytoma
607205|NCT00612001|adult glioblastoma|adult glioblastoma
607206|NCT00612001|adult giant cell glioblastoma|adult giant cell glioblastoma
607207|NCT00612001|adult gliosarcoma|adult gliosarcoma
607208|NCT00612001|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
607573|NCT00613132|Imatinib|imatinib
607209|NCT00612001|recurrent adult brain tumor|recurrent adult brain tumor
607210|NCT00612001|adult mixed glioma|adult mixed glioma
607211|NCT00612014|delayed gastric emptying|delayed gastric emptying
607212|NCT00612014|symptomatic gastroparesis|symptomatic gastroparesis
607213|NCT00612014|diabetes mellitus|diabetes mellitus
607214|NCT00612027|gastrointestinal disorder|gastrointestinal disorder
607215|NCT00612027|acid associated gastrointestinal symptoms.|acid associated gastrointestinal symptoms.
607216|NCT00612027|esomeprazole therapy in patients with gastrointestinal disorders|esomeprazole therapy in patients with gastrointestinal disorders
607217|NCT00612027|patients with acid associated gastrointestinal symptoms|patients with acid associated gastrointestinal symptoms
607218|NCT00612053|cardiovascular disease|cardiovascular disease
607219|NCT00612053|coronary artery bypass grafting (CABG)|coronary artery bypass grafting (cabg)
607220|NCT00612053|coronary artery disease (CAD)|coronary artery disease (cad)
607221|NCT00612053|percutaneous transluminal coronary angioplasty (PCI)|percutaneous transluminal coronary angioplasty (pci)
607222|NCT00612053|unprotected left main disease|unprotected left main disease
607223|NCT00612066|ACTH-producing pituitary tumor|acth-producing pituitary tumor
607224|NCT00612079|Sertindole|sertindole
607225|NCT00612079|sensory gating|sensory gating
607226|NCT00612079|PPI|ppi
607227|NCT00612079|P50 suppression|p50 suppression
607228|NCT00612079|CANTAB|cantab
607229|NCT00612079|Effect of Sertindole on sensory gating (P50 suppression)|effect of sertindole on sensory gating (p50 suppression)
607230|NCT00612079|on sensorimotor gating (PPI)|on sensorimotor gating (ppi)
607231|NCT00612079|and cognition (CANTAB)|and cognition (cantab)
607232|NCT00612092|Coronary CT angiography|coronary ct angiography
607233|NCT00612092|Radiation dose estimates|radiation dose estimates
607234|NCT00612105|Postherpetic Neuralgia, PHN, Shingles,|postherpetic neuralgia, phn, shingles,
607235|NCT00612118|Allergic rhinitis,|allergic rhinitis,
607236|NCT00612118|Vienna Challenge Chamber|vienna challenge chamber
607237|NCT00612131|medical residents PGY 2 and 3|medical residents pgy 2 and 3
607238|NCT00612144|Type 2 DM|type 2 dm
607239|NCT00612157|Obstructive Sleep Apnea|obstructive sleep apnea
607240|NCT00612157|Continuous Positive Airway Pressure|continuous positive airway pressure
607241|NCT00612157|CPAP Compliance|cpap compliance
607242|NCT00612157|Non-benzodiazepine hypnotics|non-benzodiazepine hypnotics
607243|NCT00612170|Phase 3, safety and efficacy study, [S,S[-Reboxetine, Fibromyalgia|phase 3, safety and efficacy study, [s,s[-reboxetine, fibromyalgia
607244|NCT00612183|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
607245|NCT00612183|mantle cell lymphoma|mantle cell lymphoma
607246|NCT00612196|Safety and tolerability|safety and tolerability
607247|NCT00612209|ARQ 197, advanced solid tumors, phase 1, dose escalation, pharmacodynamics, safety|arq 197, advanced solid tumors, phase 1, dose escalation, pharmacodynamics, safety
607248|NCT00612222|Immunotherapy|immunotherapy
607249|NCT00612222|Metastatic Melanoma|metastatic melanoma
607250|NCT00612222|Vaccination|vaccination
607251|NCT00612222|Tumor Regression|tumor regression
607252|NCT00612222|Skin Cancer|skin cancer
607253|NCT00612235|epilepsy|epilepsy
607254|NCT00612235|lamotrigine|lamotrigine
607255|NCT00612235|levetiracetam|levetiracetam
607256|NCT00612235|carbamazepine|carbamazepine
607257|NCT00612235|phenytoin|phenytoin
607258|NCT00612235|lamictal|lamictal
607259|NCT00612235|keppra|keppra
607260|NCT00612235|tegretol|tegretol
607261|NCT00612235|carbatrol|carbatrol
607262|NCT00612235|dilantin|dilantin
607263|NCT00612248|Osteoarthritis|osteoarthritis
607264|NCT00612248|Thumb|thumb
607266|NCT00612248|Pain|pain
607267|NCT00612248|Function|function
607268|NCT00612248|Osteoarthritis of the trapeziometacarpal (TMC) joint|osteoarthritis of the trapeziometacarpal (tmc) joint
607269|NCT00612261|Branch retinal vein occlusion; treatment|branch retinal vein occlusion; treatment
607270|NCT00612274|allogeneic|allogeneic
607271|NCT00612287|Pain|pain
607272|NCT00612287|Chronic pain|chronic pain
607273|NCT00612287|Buprenorphine|buprenorphine
607274|NCT00612287|Drug addiction|drug addiction
607275|NCT00612300|Ambulatory stroke patients|ambulatory stroke patients
607276|NCT00612300|Gait training|gait training
607278|NCT00612300|Physical therapy|physical therapy
607279|NCT00612313|Major Depressive Disorder|major depressive disorder
607280|NCT00612313|MDD|mdd
607281|NCT00612313|Children|children
607282|NCT00612313|Adolescents|adolescents
607283|NCT00612313|Antidepressant|antidepressant
607284|NCT00612313|CBT|cbt
607285|NCT00612339|Glioma|glioma
607286|NCT00612339|Temozolomide|temozolomide
607287|NCT00612339|Temodar|temodar
607288|NCT00612339|Avastin|avastin
607289|NCT00612339|Bevacizumab|bevacizumab
607290|NCT00612339|GBM|gbm
607291|NCT00612339|Gliosarcoma|gliosarcoma
607292|NCT00612339|Multifocal GBM|multifocal gbm
607293|NCT00612339|Brain tumor|brain tumor
607294|NCT00612339|Unresectable GBM|unresectable gbm
607295|NCT00612339|Glioblastoma multiforme|glioblastoma multiforme
607296|NCT00612365|Body Composition|body composition
607297|NCT00612365|Abdomen|abdomen
607298|NCT00612365|Atherosclerosis|atherosclerosis
607299|NCT00612378|Glabellar Furrowing|glabellar furrowing
607300|NCT00612391|humerus fracture|humerus fracture
607301|NCT00612404|gastrointestinal disorder|gastrointestinal disorder
607303|NCT00612404|patient with gastrointestinal disorders for whom an endoscopy is performed and who is treated with esomeprazole afterwards.|patient with gastrointestinal disorders for whom an endoscopy is performed and who is treated with esomeprazole afterwards.
607304|NCT00612417|Interaction with recombinant FVIII|interaction with recombinant fviii
607305|NCT00612430|Glioblastoma|glioblastoma
607306|NCT00612430|Gliosarcoma|gliosarcoma
607307|NCT00612430|GBM|gbm
607308|NCT00612430|MG|mg
607309|NCT00612430|Brain tumor|brain tumor
607310|NCT00612430|Bevacizumab|bevacizumab
607311|NCT00612430|Avastin|avastin
607312|NCT00612430|Etoposide|etoposide
607313|NCT00612430|VP-16|vp-16
607314|NCT00612430|Etopophos|etopophos
607315|NCT00612430|Toposar|toposar
607316|NCT00612430|VePesid|vepesid
607317|NCT00612430|Glioblastoma multiforme|glioblastoma multiforme
607318|NCT00612430|Recurrent GBM|recurrent gbm
607319|NCT00612430|Anaplastic astrocytoma|anaplastic astrocytoma
607320|NCT00612430|Malignant glioma|malignant glioma
607321|NCT00612443|breast cancer|breast cancer
607322|NCT00612456|angiogenesis|angiogenesis
607323|NCT00612456|pazopanib,|pazopanib,
607324|NCT00612456|age-related macular degeneration (AMD),|age-related macular degeneration (amd),
607325|NCT00612456|vascular endothelial growth factor (VEGF),|vascular endothelial growth factor (vegf),
607326|NCT00612456|choroidal neovascularization (CNV),|choroidal neovascularization (cnv),
607327|NCT00612469|dental caries|dental caries
607328|NCT00612469|vancomycin|vancomycin
607329|NCT00612469|chlorhexidine|chlorhexidine
607330|NCT00612469|sodium fluoride|sodium fluoride
607331|NCT00612469|mutans streptococci|mutans streptococci
607332|NCT00612482|Substance abuse|substance abuse
607333|NCT00612508|contraception|contraception
607334|NCT00612508|NuvaRing|nuvaring
607335|NCT00612508|Desogen|desogen
607336|NCT00612508|vaginal biopsy|vaginal biopsy
607337|NCT00612521|Coronary artery disease|coronary artery disease
607718|NCT00613717|development|development
607338|NCT00612521|Coronary artery stenting|coronary artery stenting
607339|NCT00612521|peri-procedural myonecrosis|peri-procedural myonecrosis
607340|NCT00612521|Adenosine|adenosine
607341|NCT00612547|Protozoan Infections|protozoan infections
607342|NCT00612547|Communicable Diseases|communicable diseases
607343|NCT00612547|Malaria Infection|malaria infection
607344|NCT00612547|Malaria, falciparum|malaria, falciparum
607345|NCT00612547|Malaria, vivax|malaria, vivax
607346|NCT00612547|Artesunate Amodiaquine|artesunate amodiaquine
607347|NCT00612560|breast neoplasms|breast neoplasms
607348|NCT00612560|phytoestrogens|phytoestrogens
607349|NCT00612560|tumor characteristics|tumor characteristics
607350|NCT00612560|proliferation|proliferation
607351|NCT00612560|apoptosis|apoptosis
607352|NCT00612560|estrogen receptor|estrogen receptor
607353|NCT00612560|HER2|her2
607354|NCT00612638|Temodar|temodar
607355|NCT00612638|Temozolomide|temozolomide
607356|NCT00612638|O6-Benzylguanine|o6-benzylguanine
607357|NCT00612638|O6-BG|o6-bg
607358|NCT00612638|NSC 637037|nsc 637037
607359|NCT00612638|Irinotecan|irinotecan
607360|NCT00612638|CPT-11|cpt-11
751785|NCT01170429|Cough Variant Asthma|cough variant asthma
607361|NCT00612638|Recurrent cerebral anaplastic glioma|recurrent cerebral anaplastic glioma
607362|NCT00612638|Progressive cerebral anaplastic glioma|progressive cerebral anaplastic glioma
607363|NCT00612638|Malignant glioma|malignant glioma
607364|NCT00612651|GBM|gbm
607365|NCT00612651|Malignant glioma|malignant glioma
607366|NCT00612651|Brain tumor|brain tumor
607367|NCT00612651|Temodar|temodar
607368|NCT00612651|Temozolomide|temozolomide
607369|NCT00612651|SCH 66336|sch 66336
607370|NCT00612651|Farnesyl transferase inhibitor|farnesyl transferase inhibitor
607371|NCT00612651|Glioblastoma multiforme|glioblastoma multiforme
607372|NCT00612651|Gliosarcoma|gliosarcoma
607373|NCT00612651|Anaplastic astrocytoma|anaplastic astrocytoma
607374|NCT00612651|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
607375|NCT00612651|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
607376|NCT00612677|recurrent|recurrent
607377|NCT00612677|non-small cell|non-small cell
607378|NCT00612690|Children|children
607379|NCT00612690|School-Based Mental Health Services|school-based mental health services
607380|NCT00612690|Urban Poverty|urban poverty
607381|NCT00612703|Cancer, oral, erlotinib, tarceva, solid tumor, advanced tumor, phase 1|cancer, oral, erlotinib, tarceva, solid tumor, advanced tumor, phase 1
607382|NCT00612703|Tumor|tumor
607383|NCT00612716|stage I multiple myeloma|stage i multiple myeloma
607384|NCT00612716|stage II multiple myeloma|stage ii multiple myeloma
607385|NCT00612716|stage III multiple myeloma|stage iii multiple myeloma
607386|NCT00612716|refractory multiple myeloma|refractory multiple myeloma
607387|NCT00612716|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
607388|NCT00612716|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
607389|NCT00612716|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
607390|NCT00612716|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
607391|NCT00612716|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
607392|NCT00612716|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
607393|NCT00612716|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
607394|NCT00612716|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
607395|NCT00612716|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
607396|NCT00612716|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
607397|NCT00612716|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
607398|NCT00612716|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
607399|NCT00612716|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
607400|NCT00612716|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
607401|NCT00612716|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
607402|NCT00612716|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
607403|NCT00612716|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
607404|NCT00612716|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
607405|NCT00612716|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
607406|NCT00612716|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
607407|NCT00612716|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
607408|NCT00612716|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
607409|NCT00612716|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
607410|NCT00612716|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
607411|NCT00612716|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
607412|NCT00612716|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
607413|NCT00612716|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
607414|NCT00612716|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
607415|NCT00612716|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
607416|NCT00612716|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
607719|NCT00613717|behavior|behavior
607417|NCT00612716|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
607418|NCT00612716|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
607419|NCT00612716|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
607420|NCT00612716|splenic marginal zone lymphoma|splenic marginal zone lymphoma
607421|NCT00612716|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
607422|NCT00612716|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
607423|NCT00612716|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
607424|NCT00612716|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
607425|NCT00612716|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
607426|NCT00612716|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
607427|NCT00612716|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
607428|NCT00612716|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
607429|NCT00612716|Burkitt lymphoma|burkitt lymphoma
607430|NCT00612716|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
607431|NCT00612716|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
607432|NCT00612716|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
607433|NCT00612716|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
607434|NCT00612716|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
607435|NCT00612729|intraocular lens|intraocular lens
607436|NCT00612729|light filtering intraocular lens|light filtering intraocular lens
607437|NCT00612729|contrast acuity|contrast acuity
607438|NCT00612729|color vision|color vision
607439|NCT00612742|Cardiovascular event|cardiovascular event
607440|NCT00612742|Breast Cancer|breast cancer
607441|NCT00612742|Testosterone|testosterone
607442|NCT00612742|Menopause|menopause
607443|NCT00612742|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
607444|NCT00612755|chronic hepatitis C|chronic hepatitis c
607445|NCT00612755|co-infection|co-infection
607446|NCT00612755|extend treatment|extend treatment
607447|NCT00612755|co-infected HIV-HCV|co-infected hiv-hcv
607448|NCT00612768|Bioequivalence|bioequivalence
607449|NCT00612768|Thimerosal|thimerosal
607450|NCT00612768|Fragrance Mix|fragrance mix
607451|NCT00612768|PVP formulation|pvp formulation
607452|NCT00612768|Contact dermatitis|contact dermatitis
607453|NCT00612781|intraocular lens|intraocular lens
607454|NCT00612781|blue-light filtering intraocular lens|blue-light filtering intraocular lens
607455|NCT00612781|contrast acuity|contrast acuity
607456|NCT00612781|color vision|color vision
607457|NCT00612794|exenatide|exenatide
607458|NCT00612794|Byetta|byetta
607459|NCT00612794|diabetes|diabetes
607460|NCT00612794|Amylin|amylin
607461|NCT00612794|Lilly|lilly
607462|NCT00612807|Older Adults|older adults
607463|NCT00612820|Vienna Challenge Chamber|vienna challenge chamber
607464|NCT00612820|Seasonal Allergic Rhinitis,|seasonal allergic rhinitis,
607465|NCT00612833|Vasectomy|vasectomy
607466|NCT00612833|Male contraception|male contraception
607467|NCT00612833|Contraceptive effectiveness|contraceptive effectiveness
607468|NCT00612833|Semen analysis|semen analysis
607469|NCT00612833|Surgical techniques|surgical techniques
607470|NCT00612833|Fascial interposition|fascial interposition
607471|NCT00612833|Cautery|cautery
607472|NCT00612833|The relative contraceptive effectiveness of three methods of occluding the vas, in the context of a no-scalpel vasectomy procedure.|the relative contraceptive effectiveness of three methods of occluding the vas, in the context of a no-scalpel vasectomy procedure.
607473|NCT00612846|Common Bile Duct Calculi|common bile duct calculi
607474|NCT00612846|Choledocholithiasis|choledocholithiasis
607475|NCT00612846|Endoscopic sphincterotomy|endoscopic sphincterotomy
607476|NCT00612846|Cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
607477|NCT00612846|Laparoscopic bile duct exploration|laparoscopic bile duct exploration
607478|NCT00612859|Levetiracetam|levetiracetam
607479|NCT00612859|Keppra|keppra
607480|NCT00612898|HIV infection|hiv infection
607481|NCT00612898|Drug resistance|drug resistance
607482|NCT00612898|Reverse transcriptase inhibitor|reverse transcriptase inhibitor
607483|NCT00612898|Nucleoside analogue|nucleoside analogue
607484|NCT00612898|treatment experienced|treatment experienced
607485|NCT00612937|Group B Streptococci|group b streptococci
607486|NCT00612937|Respiratory Disease|respiratory disease
607487|NCT00612937|Beta Lactam|beta lactam
607488|NCT00612937|Newborn|newborn
607489|NCT00612937|Respiratory Distress|respiratory distress
607490|NCT00612963|Candidiasis, Oral|candidiasis, oral
607491|NCT00612963|Thrush|thrush
607492|NCT00612963|Candidiasis|candidiasis
607493|NCT00612976|treatment of COPD|treatment of copd
607494|NCT00612976|documentation of relevant data|documentation of relevant data
607627|NCT00613288|experimental|experimental
607495|NCT00612976|related to the budesonide/formoterole therapy in patients with COPD.|related to the budesonide/formoterole therapy in patients with copd.
607496|NCT00612989|Glioblastoma|glioblastoma
607497|NCT00612989|Gliosarcoma|gliosarcoma
607498|NCT00612989|GBM|gbm
607500|NCT00612989|Temozolomide|temozolomide
607501|NCT00612989|O6-BG|o6-bg
607502|NCT00612989|O6-Benzylguanine|o6-benzylguanine
607503|NCT00612989|Recurrent GBM|recurrent gbm
607504|NCT00612989|Progressive GBM|progressive gbm
607505|NCT00612989|Brain tumor|brain tumor
607506|NCT00612989|Malignant glioma|malignant glioma
607507|NCT00612989|Neulasta|neulasta
607508|NCT00612989|Pegfilgrastim|pegfilgrastim
607509|NCT00613002|hypoactive sexual desire disorder|hypoactive sexual desire disorder
607510|NCT00613002|testosterone|testosterone
607511|NCT00613002|menopause|menopause
607512|NCT00613015|Cocaine Addiction|cocaine addiction
607513|NCT00613015|Cocaine Dependence|cocaine dependence
607514|NCT00613028|Glioblastoma|glioblastoma
607515|NCT00613028|Gliosarcoma|gliosarcoma
607516|NCT00613028|GBM|gbm
607517|NCT00613028|Bevacizumab|bevacizumab
607518|NCT00613028|Avastin|avastin
607519|NCT00613028|Etoposide|etoposide
607520|NCT00613028|Brain tumor|brain tumor
607521|NCT00613028|Irinotecan|irinotecan
607522|NCT00613028|Glioblastoma multiforme|glioblastoma multiforme
607523|NCT00613028|Temodar|temodar
607524|NCT00613028|Temozolomide|temozolomide
609770|NCT00621504|CAP|cap
607525|NCT00613028|Etopophos|etopophos
607526|NCT00613028|Toposar|toposar
607527|NCT00613028|VePesid|vepesid
607528|NCT00613028|VP-16|vp-16
607529|NCT00613028|Camptosar|camptosar
607530|NCT00613054|GBM|gbm
607531|NCT00613054|Brain tumor|brain tumor
607532|NCT00613054|Zactima|zactima
607533|NCT00613054|Gleevec|gleevec
607534|NCT00613054|Hydroxyurea|hydroxyurea
607535|NCT00613054|Glioblastoma|glioblastoma
607536|NCT00613054|Gliosarcoma|gliosarcoma
607537|NCT00613054|Recurrent malignant glioma|recurrent malignant glioma
607538|NCT00613054|ZD6474|zd6474
607539|NCT00613054|Malignant glioma|malignant glioma
607540|NCT00613054|Imatinib|imatinib
607541|NCT00613054|Droxia|droxia
607542|NCT00613054|Hydrea|hydrea
607543|NCT00613054|Hydroxycarbamide|hydroxycarbamide
607544|NCT00613054|Vandetanib|vandetanib
607545|NCT00613067|Generalized anxiety disorder|generalized anxiety disorder
607546|NCT00613067|N100|n100
607547|NCT00613067|Central serotonergic activity|central serotonergic activity
607759|NCT00604227|hypoxia|hypoxia
607548|NCT00613080|stage III rectal cancer|stage iii rectal cancer
607549|NCT00613080|adenocarcinoma of the rectum|adenocarcinoma of the rectum
607551|NCT00613093|Temozolomide|temozolomide
607552|NCT00613093|O6-BG|o6-bg
607553|NCT00613093|O6-Benzylguanine|o6-benzylguanine
607554|NCT00613093|NSC 637037|nsc 637037
607555|NCT00613093|Temodar-Resistant Malignant Glioma|temodar-resistant malignant glioma
607556|NCT00613093|Brain tumor|brain tumor
607557|NCT00613093|CNS tumor|cns tumor
607558|NCT00613093|Cerebral glioblastoma|cerebral glioblastoma
607559|NCT00613093|Anaplastic astrocytomas|anaplastic astrocytomas
607560|NCT00613093|Glioma|glioma
607561|NCT00613119|Inflammation|inflammation
607562|NCT00613119|Frontotemporal Dementia|frontotemporal dementia
607563|NCT00613119|Dementia|dementia
607564|NCT00613119|PBR28|pbr28
607565|NCT00613119|PET Imaging|pet imaging
607566|NCT00613132|Glioblastoma|glioblastoma
607567|NCT00613132|Gliosarcoma|gliosarcoma
607568|NCT00613132|GBM|gbm
607569|NCT00613132|Brain tumor|brain tumor
607570|NCT00613132|RAD0001|rad0001
607571|NCT00613132|Hydroxyurea|hydroxyurea
607574|NCT00613132|Droxia|droxia
607575|NCT00613132|Everolimus|everolimus
607576|NCT00613132|Hydrea|hydrea
607577|NCT00613132|Hydroxycarbamide|hydroxycarbamide
607578|NCT00613132|Recurrent GBM|recurrent gbm
607579|NCT00613132|Imatinib mesylate|imatinib mesylate
607580|NCT00613132|Glioblastoma multiforme|glioblastoma multiforme
607581|NCT00613145|Refractory Malignancy|refractory malignancy
607582|NCT00613145|Phase I|phase i
607583|NCT00613145|Sorafenib|sorafenib
607584|NCT00613145|Capecitabine|capecitabine
607585|NCT00613158|Subclincal Atherosclerosis|subclincal atherosclerosis
607586|NCT00613171|Systemic sclerosis, scleroderma, fibrosis, STI571, imatinib|systemic sclerosis, scleroderma, fibrosis, sti571, imatinib
607587|NCT00613184|Respiratory Syncytial virus|respiratory syncytial virus
607588|NCT00613184|Bronchiolitis|bronchiolitis
607589|NCT00613184|Pediatric|pediatric
607590|NCT00613197|Crohn's Disease|crohn's disease
607591|NCT00613210|preterm delivery|preterm delivery
607592|NCT00613210|shory cervix|shory cervix
607593|NCT00613210|amniotic fluid sludge|amniotic fluid sludge
607594|NCT00613210|uterine artery doppler|uterine artery doppler
607595|NCT00613210|singeltone|singeltone
607596|NCT00613210|normal amniotic fluid index|normal amniotic fluid index
607597|NCT00613210|without rupter of membranes|without rupter of membranes
607598|NCT00613210|24-34 weeks of gestation|24-34 weeks of gestation
607599|NCT00613223|Malignant Gliomas|malignant gliomas
607600|NCT00613223|Etopophos|etopophos
607601|NCT00613223|Toposar|toposar
607602|NCT00613223|VePesid|vepesid
607603|NCT00613223|Etoposide|etoposide
607604|NCT00613223|Vandetanib|vandetanib
607605|NCT00613223|Zactima|zactima
607606|NCT00613223|ZD6474|zd6474
607607|NCT00613223|VP-16|vp-16
607608|NCT00613223|Brain Tumor|brain tumor
607609|NCT00613223|Recurring Malignant Brain Tumor|recurring malignant brain tumor
607610|NCT00613223|Gliosarcoma|gliosarcoma
607611|NCT00613223|Glioblastoma|glioblastoma
607612|NCT00613223|Glioma|glioma
607613|NCT00613223|Malignant Glioma|malignant glioma
607614|NCT00613223|GBM|gbm
607615|NCT00613249|HIV-1 Infection|hiv-1 infection
607616|NCT00613249|HIV Seronegativity|hiv seronegativity
607617|NCT00613262|Narrow Band Imaging|narrow band imaging
607618|NCT00613275|PNRP|pnrp
607619|NCT00613275|Navigation|navigation
607620|NCT00613275|Navigator|navigator
607621|NCT00613275|Activation|activation
607622|NCT00613275|Disparities|disparities
607623|NCT00613275|Primary Care|primary care
607624|NCT00613275|Racial and Ethnic Minorities|racial and ethnic minorities
607625|NCT00613288|acute|acute
607626|NCT00613288|testosterone|testosterone
607628|NCT00613288|hypogonadism|hypogonadism
607629|NCT00613288|lipolysis|lipolysis
607630|NCT00613288|insulin sensitivity|insulin sensitivity
607631|NCT00613288|protein|protein
607632|NCT00613288|metabolism|metabolism
607633|NCT00613288|Experimental hypogonadism|experimental hypogonadism
607634|NCT00613288|Testosterone substitution|testosterone substitution
607635|NCT00613327|Overactive bladder|overactive bladder
607636|NCT00613327|Oxybutynin chloride|oxybutynin chloride
607637|NCT00613327|OROS|oros
607638|NCT00613340|Cervical pain|cervical pain
607639|NCT00613340|Zygapophysial joint|zygapophysial joint
607640|NCT00613340|Specificity|specificity
607641|NCT00613353|Female|female
607642|NCT00613366|intrauterine device|intrauterine device
607643|NCT00613366|cervical dilation|cervical dilation
607644|NCT00613366|nulliparous women|nulliparous women
607645|NCT00613366|pain management|pain management
607647|NCT00613379|treatment naïve|treatment naïve
607648|NCT00613392|antioxidant|antioxidant
607649|NCT00613392|oxidant stress|oxidant stress
607650|NCT00613392|trauma|trauma
607651|NCT00613392|free radical|free radical
607652|NCT00613405|substance-related disorders|substance-related disorders
607653|NCT00613431|pharmacodynamics|pharmacodynamics
607654|NCT00613444|Acne|acne
607655|NCT00613444|laser|laser
607656|NCT00613470|Depression|depression
607657|NCT00613470|Antidepressants|antidepressants
607658|NCT00613496|Atrial Fibrillation|atrial fibrillation
607659|NCT00613496|irbesartan|irbesartan
607660|NCT00613496|AT-II-antagonist|at-ii-antagonist
607661|NCT00613496|Adhesion Molecules|adhesion molecules
607662|NCT00613496|oxidative stress markers|oxidative stress markers
607663|NCT00613496|hsCRP|hscrp
607664|NCT00613496|ICAM|icam
607665|NCT00613496|VCAM|vcam
607666|NCT00613496|MCP-1|mcp-1
607667|NCT00613496|vWF|vwf
607668|NCT00613496|TGFβ1|tgfβ1
607669|NCT00613496|TNF-α|tnf-α
607670|NCT00613496|Interleukin-6|interleukin-6
607671|NCT00613496|8isoProstaglandinF2α|8isoprostaglandinf2α
607672|NCT00613509|Melanoma, Cancer|melanoma, cancer
607673|NCT00613522|Sleep apnea, Berlin, Stroke|sleep apnea, berlin, stroke
607674|NCT00613535|Partial Meniscectomy|partial meniscectomy
607675|NCT00613535|Partial Thickness Knee Tear|partial thickness knee tear
607676|NCT00613535|MR Imaging|mr imaging
607677|NCT00613535|Mechanical Debridement|mechanical debridement
607678|NCT00613535|Crepitus|crepitus
607679|NCT00613535|Stability|stability
607680|NCT00613535|Coblation|coblation
607681|NCT00613535|Bipolar Radiofrequency|bipolar radiofrequency
607682|NCT00613535|Debridement|debridement
607683|NCT00613535|Recurrent Knee Pain|recurrent knee pain
607684|NCT00613535|meniscectomy|meniscectomy
607685|NCT00613535|meniscus|meniscus
607686|NCT00613535|cartilage lesion|cartilage lesion
607687|NCT00613535|articular cartilage lesion|articular cartilage lesion
607688|NCT00613535|articular cartilage|articular cartilage
607689|NCT00613535|knee|knee
607690|NCT00613548|Moderate|moderate
607691|NCT00613548|Mitral|mitral
607692|NCT00613548|Regurgitation|regurgitation
607693|NCT00613548|CABG|cabg
607694|NCT00613561|Patients with the Severe Immunodeficiency diseases|patients with the severe immunodeficiency diseases
607695|NCT00613561|Severe Immunodeficiency diseases|severe immunodeficiency diseases
607696|NCT00613587|Interleukin 13|interleukin 13
607697|NCT00613587|Interleukin 4|interleukin 4
607698|NCT00613587|Leukotrienes|leukotrienes
607699|NCT00613587|Basophil Histamine Release|basophil histamine release
607700|NCT00613600|Safety|safety
607701|NCT00613600|Efficacy|efficacy
607702|NCT00613600|Glucomannan|glucomannan
607703|NCT00613600|Dietary fiber|dietary fiber
607704|NCT00613600|Weight loss|weight loss
607705|NCT00613626|Extensive Stage|extensive stage
607706|NCT00613626|Untreated|untreated
607707|NCT00613652|solid tumors|solid tumors
607708|NCT00613652|solid malignancies|solid malignancies
607709|NCT00613678|pain|pain
607710|NCT00613678|activities of daily living|activities of daily living
607711|NCT00613678|symptoms|symptoms
607712|NCT00613678|self-management|self-management
607713|NCT00613691|Refractory|refractory
607714|NCT00613691|Progressive|progressive
607715|NCT00613717|iron deficiency anemia|iron deficiency anemia
607716|NCT00613717|iron deficiency|iron deficiency
607720|NCT00613769|Surgical site infections|surgical site infections
607721|NCT00613795|pneumonia|pneumonia
607722|NCT00613795|ventilator associated pneumonia|ventilator associated pneumonia
607723|NCT00613795|probiotics|probiotics
607724|NCT00613795|Lactobacillus GG|lactobacillus gg
607725|NCT00604110|Biventricular pacing|biventricular pacing
607726|NCT00604110|resynchronisation therapy|resynchronisation therapy
607727|NCT00604110|cardiac surgery|cardiac surgery
607728|NCT00604110|ejection fraction of less 45%|ejection fraction of less 45%
607729|NCT00604123|JNJ-17166864|jnj-17166864
607730|NCT00604123|allergic rhinitis|allergic rhinitis
607731|NCT00604123|pharmacokinetics|pharmacokinetics
607732|NCT00604123|biomarkers|biomarkers
607733|NCT00604123|rhinitis symptoms|rhinitis symptoms
607734|NCT00604123|mountain cedar pollen|mountain cedar pollen
607735|NCT00604136|melanoma|melanoma
607736|NCT00604136|tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
607737|NCT00604136|interleukin-2|interleukin-2
607738|NCT00604162|Suspected colonic disease|suspected colonic disease
607739|NCT00604162|Known colonic disease|known colonic disease
607741|NCT00604175|HPV 6|hpv 6
607742|NCT00604175|HPV 11|hpv 11
607743|NCT00604175|HPV 16|hpv 16
607744|NCT00604175|HPV 18|hpv 18
607745|NCT00604175|Vaccine|vaccine
607746|NCT00604201|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
607747|NCT00604201|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
607748|NCT00604201|Stem Cell Transplant|stem cell transplant
607749|NCT00604201|Haploidentical Stem Cells|haploidentical stem cells
607750|NCT00604201|Umbilical Cord Blood|umbilical cord blood
607751|NCT00604201|Severe Aplastic Anemia|severe aplastic anemia
607752|NCT00604201|Myelodysplastic Syndrome|myelodysplastic syndrome
607753|NCT00604201|MDS|mds
607754|NCT00604214|Sepsis|sepsis
607755|NCT00604214|Septic shock|septic shock
607756|NCT00604227|high altitude pulmonary edema|high altitude pulmonary edema
607757|NCT00604227|pulmonary interstitial fluid|pulmonary interstitial fluid
607758|NCT00604227|pulmonary function testing|pulmonary function testing
607760|NCT00604227|pulmonary endothelial function|pulmonary endothelial function
607761|NCT00604227|high altitude exposure without prior acclimatization|high altitude exposure without prior acclimatization
607762|NCT00604240|NICU|nicu
607763|NCT00604240|caregivers|caregivers
607764|NCT00604240|discharge instructions|discharge instructions
608816|NCT00609479|DASH|dash
607765|NCT00604266|Potentially resectable hilar cholangiocarcinoma as per initial imaging studies.|potentially resectable hilar cholangiocarcinoma as per initial imaging studies.
607766|NCT00604266|Able to undergo PET/CT and MRI with Gadolinium|able to undergo pet/ct and mri with gadolinium
607767|NCT00604279|Schizophrenia|schizophrenia
607768|NCT00604279|Paliperidone|paliperidone
607769|NCT00604279|Paliperidone palmitate|paliperidone palmitate
607770|NCT00604279|Risperidone|risperidone
607771|NCT00604279|Risperidone long acting injection|risperidone long acting injection
607772|NCT00604279|R092670|r092670
607773|NCT00604292|Colonic Diseases|colonic diseases
607774|NCT00613808|venous|venous
607775|NCT00613808|leg|leg
607776|NCT00613808|ulcer|ulcer
607777|NCT00613821|surgical abortion|surgical abortion
607778|NCT00613821|pain management|pain management
608091|NCT00617305|ambrisentan|ambrisentan
607779|NCT00613834|Essure sterilization|essure sterilization
607780|NCT00613834|pain management|pain management
607781|NCT00613834|intrauterine lidocaine infusion|intrauterine lidocaine infusion
607782|NCT00613847|PET Scan|pet scan
607783|NCT00613847|Invasive Solid Tumors|invasive solid tumors
607784|NCT00613860|Endoscopic lung volume reduction, heterogeneous emphysema, interventional bronchoscopy|endoscopic lung volume reduction, heterogeneous emphysema, interventional bronchoscopy
607785|NCT00613873|colonoscopy|colonoscopy
607787|NCT00613886|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
607788|NCT00613899|home care|home care
607789|NCT00613899|home rehabilitation|home rehabilitation
607790|NCT00613899|telemedicine|telemedicine
607791|NCT00613899|ALS|als
607792|NCT00613912|Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, Perfusion, brain|magnetic resonance imaging, magnetic resonance spectroscopy, perfusion, brain
607793|NCT00613925|endometrial biopsy|endometrial biopsy
607794|NCT00613925|pain management|pain management
607795|NCT00613938|Acute pain|acute pain
607796|NCT00613938|bunionectomy|bunionectomy
607797|NCT00613938|tapentadol|tapentadol
607798|NCT00613964|Natriuretic Peptides|natriuretic peptides
607799|NCT00613964|Heart Failure|heart failure
607800|NCT00613964|Renal Failure|renal failure
607801|NCT00613977|fetal lung maturity|fetal lung maturity
607802|NCT00613977|lamellar body count|lamellar body count
607803|NCT00614003|decisional conflict;|decisional conflict;
607804|NCT00614003|decision quality;|decision quality;
607805|NCT00614003|place of end of life care;|place of end of life care;
607806|NCT00614003|provider education|provider education
607807|NCT00614016|healthy volunteers|healthy volunteers
607808|NCT00614029|sumatriptan|sumatriptan
607809|NCT00614029|Injections|injections
607810|NCT00614029|Subcutaneous|subcutaneous
607811|NCT00614042|CLL|cll
607812|NCT00614042|NHL|nhl
607813|NCT00614042|TRU-016|tru-016
607814|NCT00614042|chronic lymphocytic leukemia|chronic lymphocytic leukemia
607815|NCT00614042|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
607816|NCT00614068|Treatment|treatment
607817|NCT00614068|PTSD|ptsd
607818|NCT00614081|Glomerular filtration rate measurement|glomerular filtration rate measurement
607819|NCT00614081|Contrast-enhanced dynamic MR imaging|contrast-enhanced dynamic mr imaging
607820|NCT00614081|Renal transplant recipients|renal transplant recipients
607821|NCT00614094|placenta, hypoglycemia|placenta, hypoglycemia
607822|NCT00614107|Atrial Fibrillation post open heart surgery|atrial fibrillation post open heart surgery
607823|NCT00614133|protein metabolism|protein metabolism
607824|NCT00614133|surgery|surgery
607825|NCT00614133|parenteral nutrition|parenteral nutrition
607826|NCT00614146|liver failure, albumin dialysis, liver support|liver failure, albumin dialysis, liver support
607827|NCT00616382|PDA|pda
607828|NCT00616382|indomethacin|indomethacin
607829|NCT00616382|pentoxifylline|pentoxifylline
607830|NCT00616382|Patent Ductus Arteriosus [PDA] resistant to therapy|patent ductus arteriosus [pda] resistant to therapy
607831|NCT00616395|Infant Nutrition|infant nutrition
607832|NCT00616395|Soy Phytochemicals|soy phytochemicals
607833|NCT00616395|Infant Body Composition|infant body composition
607834|NCT00616395|Brain Function|brain function
607835|NCT00616395|Cognition and Development|cognition and development
607836|NCT00616395|Healthy Infants|healthy infants
607837|NCT00616408|GH|gh
607838|NCT00616408|IGF-I|igf-i
607839|NCT00616408|GH-secreting tumors|gh-secreting tumors
607840|NCT00616408|Octreotide|octreotide
607841|NCT00616421|vaccine|vaccine
607842|NCT00616421|children|children
607843|NCT00616421|healthy|healthy
607844|NCT00616421|meningitis|meningitis
607845|NCT00616421|meningococcal|meningococcal
607846|NCT00616421|prevention of meningococcal disease serogroups ACWY|prevention of meningococcal disease serogroups acwy
607847|NCT00616421|Menveo|menveo
607848|NCT00616460|safety|safety
607849|NCT00616460|efficacy|efficacy
607850|NCT00616499|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
607851|NCT00616499|adenocarcinoma of the lung|adenocarcinoma of the lung
607852|NCT00616499|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
607853|NCT00616499|large cell lung cancer|large cell lung cancer
607854|NCT00616512|Water|water
607855|NCT00616512|oral care|oral care
607856|NCT00616512|oral hygiene|oral hygiene
607857|NCT00616512|dysphagia|dysphagia
607858|NCT00616512|thin liquid dysphagia|thin liquid dysphagia
607859|NCT00616512|thickened liquids|thickened liquids
607860|NCT00616538|Atopic|atopic
607861|NCT00616538|Dermatitis|dermatitis
607862|NCT00616538|eczema|eczema
607863|NCT00616538|skin barrier|skin barrier
607864|NCT00616538|ceramide|ceramide
607865|NCT00616538|topical|topical
607866|NCT00616538|inflamation|inflamation
607867|NCT00616538|steroid|steroid
607868|NCT00616538|SCORAD|scorad
607869|NCT00616538|glucocorticoids|glucocorticoids
607870|NCT00616538|EpiCeram|epiceram
607871|NCT00616538|Cutivate|cutivate
607872|NCT00616538|fluticasone|fluticasone
607873|NCT00616551|Acromegaly|acromegaly
607874|NCT00616564|GM-CSF|gm-csf
607875|NCT00616564|Interleukin|interleukin
607876|NCT00616564|IL-2|il-2
607877|NCT00616564|Sargrostim|sargrostim
607878|NCT00616577|Caudal Epidural Ropivacaine|caudal epidural ropivacaine
607879|NCT00616590|sleep disorders|sleep disorders
608078|NCT00617201|stimulants|stimulants
607880|NCT00616590|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
607882|NCT00616590|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
607883|NCT00616590|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
607884|NCT00616590|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
607885|NCT00616590|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
607886|NCT00616590|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
607887|NCT00616590|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
607888|NCT00616590|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
607889|NCT00616590|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
607890|NCT00616590|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
607891|NCT00616590|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
607892|NCT00616590|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
607893|NCT00616590|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
607894|NCT00616590|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
607895|NCT00616590|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
607896|NCT00616590|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
607897|NCT00616590|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
607898|NCT00616590|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
607899|NCT00616590|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
607900|NCT00616590|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
607901|NCT00616590|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
607902|NCT00616590|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
607903|NCT00616590|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
607904|NCT00616590|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
607905|NCT00616590|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
607906|NCT00616590|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
607907|NCT00616590|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
607908|NCT00616590|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
607909|NCT00616590|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
607910|NCT00616590|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
607911|NCT00616590|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
607912|NCT00616590|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
607913|NCT00616590|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
607914|NCT00616590|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
607915|NCT00616590|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
607916|NCT00616590|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
607917|NCT00616590|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
607918|NCT00616590|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
607919|NCT00616590|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
607920|NCT00616590|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
607921|NCT00616590|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
607975|NCT00616616|adrenalectomy|adrenalectomy
607976|NCT00616616|Gastric lap-band placement|gastric lap-band placement
607922|NCT00616590|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
752344|NCT01172587|Cognitive Behavioral Therapy|cognitive behavioral therapy
607923|NCT00616590|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
607924|NCT00616590|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
607925|NCT00616590|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
607926|NCT00616590|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
607927|NCT00616590|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
607928|NCT00616590|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
607929|NCT00616590|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
607930|NCT00616590|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
607931|NCT00616590|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
607932|NCT00616590|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
607933|NCT00616590|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
608092|NCT00617305|PAH|pah
607934|NCT00616590|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
607935|NCT00616590|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
607936|NCT00616590|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
607937|NCT00616590|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
607938|NCT00616590|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
607939|NCT00616590|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
607940|NCT00616590|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
607941|NCT00616590|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
607942|NCT00616590|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
607943|NCT00616590|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
607944|NCT00616590|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
607945|NCT00616590|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
607946|NCT00616590|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
607947|NCT00616590|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
607948|NCT00616590|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
607949|NCT00616590|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
607950|NCT00616590|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
608029|NCT00616954|mismatched|mismatched
607951|NCT00616590|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
607952|NCT00616590|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
607953|NCT00616590|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
607954|NCT00616590|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
607955|NCT00616590|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
607956|NCT00616590|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
607957|NCT00616590|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
607958|NCT00616590|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
607959|NCT00616590|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
607960|NCT00616590|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
607961|NCT00616590|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
607962|NCT00616590|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
607963|NCT00616590|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
607964|NCT00616590|recurrent salivary gland cancer|recurrent salivary gland cancer
607965|NCT00616590|stage I salivary gland cancer|stage i salivary gland cancer
607966|NCT00616590|stage II salivary gland cancer|stage ii salivary gland cancer
607967|NCT00616590|stage III salivary gland cancer|stage iii salivary gland cancer
607968|NCT00616590|stage IV salivary gland cancer|stage iv salivary gland cancer
607969|NCT00616603|Total Knee Arthroplasty.|total knee arthroplasty.
607970|NCT00616603|Sciatic nerve Blocks.|sciatic nerve blocks.
607971|NCT00616603|Dexamethasone.|dexamethasone.
607972|NCT00616616|appendectomy|appendectomy
607973|NCT00616616|cholecystectomy|cholecystectomy
607974|NCT00616616|gastric banding|gastric banding
607977|NCT00616642|recurrent pituitary tumor|recurrent pituitary tumor
607978|NCT00616642|ACTH-producing pituitary tumor|acth-producing pituitary tumor
607979|NCT00616642|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
607980|NCT00616655|Anxiety|anxiety
607981|NCT00616668|Transtibial amputees due to vascular diseases.|transtibial amputees due to vascular diseases.
607982|NCT00616707|Inflammation|inflammation
607983|NCT00616707|Oxidative Stress|oxidative stress
607984|NCT00616707|Microalbuminuria|microalbuminuria
607985|NCT00616720|stage I multiple myeloma|stage i multiple myeloma
607986|NCT00616720|stage II multiple myeloma|stage ii multiple myeloma
607987|NCT00616720|stage III multiple myeloma|stage iii multiple myeloma
607988|NCT00616720|refractory multiple myeloma|refractory multiple myeloma
607989|NCT00616733|Multiple sclerosis, relapsing, secondary progressive, clinically isolated syndrome, MRI|multiple sclerosis, relapsing, secondary progressive, clinically isolated syndrome, mri
607990|NCT00616746|Alcohol, nicotine|alcohol, nicotine
607991|NCT00616759|Depression|depression
607992|NCT00616759|Electroconvulsive therapy|electroconvulsive therapy
608540|NCT00607347|Atenolol|atenolol
607993|NCT00616785|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
607994|NCT00616785|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
607995|NCT00616811|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
607996|NCT00616824|Acellular dermal matrix|acellular dermal matrix
607997|NCT00616824|breast reconstruction|breast reconstruction
607998|NCT00616824|tissue expander|tissue expander
607999|NCT00616824|postoperative pain|postoperative pain
608000|NCT00616824|complication|complication
608001|NCT00616824|pain|pain
608002|NCT00616824|patient satisfaction|patient satisfaction
608003|NCT00616837|Remote consultation/*methods|remote consultation/*methods
608004|NCT00616837|Orthopaedics methods|orthopaedics methods
608005|NCT00616837|Telemedicine|telemedicine
608006|NCT00616837|Follow-up study|follow-up study
608007|NCT00616837|Ambulatory care|ambulatory care
608008|NCT00616850|Total Knee Arthroplasty|total knee arthroplasty
608009|NCT00616850|Intravenous Lidocaine Infusion|intravenous lidocaine infusion
608010|NCT00616850|Femoral Block Catheter|femoral block catheter
608011|NCT00616876|lactulose|lactulose
608012|NCT00616876|prebiotic|prebiotic
608013|NCT00616876|premature infant|premature infant
608014|NCT00616876|enteral feeding|enteral feeding
608015|NCT00616876|stools|stools
608016|NCT00616876|lactobacillus|lactobacillus
608017|NCT00616876|nutrition|nutrition
608018|NCT00616876|growth|growth
608019|NCT00616902|Zemplar, paricalcitol, PRIMO II|zemplar, paricalcitol, primo ii
608020|NCT00616915|Wellbutrin SR|wellbutrin sr
608021|NCT00616928|vaccines|vaccines
608022|NCT00616928|immunogenicity|immunogenicity
608023|NCT00616928|human|human
608024|NCT00616928|safety|safety
608025|NCT00616928|influenza|influenza
608026|NCT00616941|NY-ESO-1 OLP4|ny-eso-1 olp4
608027|NCT00616941|Ovarian Cancer|ovarian cancer
608028|NCT00616941|Cancer Vaccine|cancer vaccine
608030|NCT00616954|Stem cell transplatation|stem cell transplatation
608031|NCT00616954|Bone marrow transplantation|bone marrow transplantation
608032|NCT00616954|T cell depletion|t cell depletion
608033|NCT00616954|engraftment|engraftment
608034|NCT00616954|Patients undergoing allogeneic haplo-SCT|patients undergoing allogeneic haplo-sct
608035|NCT00616967|stage II breast cancer|stage ii breast cancer
608036|NCT00616967|stage IIIA breast cancer|stage iiia breast cancer
608037|NCT00616967|stage IIIB breast cancer|stage iiib breast cancer
608038|NCT00616967|stage IIIC breast cancer|stage iiic breast cancer
608039|NCT00616967|ductal breast carcinoma|ductal breast carcinoma
608040|NCT00616967|lobular breast carcinoma|lobular breast carcinoma
608041|NCT00616980|PAD|pad
608042|NCT00616980|PVD|pvd
608043|NCT00616980|CLI|cli
608044|NCT00616980|Stem Cells|stem cells
608045|NCT00617006|Anesthesia Workspace|anesthesia workspace
608046|NCT00617006|Hospital Acquired Infections|hospital acquired infections
608047|NCT00617006|Hand Hygiene|hand hygiene
608048|NCT00617006|Alcohol Based Cleanser|alcohol based cleanser
608049|NCT00617006|Bacterial Contamination|bacterial contamination
608050|NCT00617045|Post Partum Depression|post partum depression
608051|NCT00617058|antipsychotic|antipsychotic
608052|NCT00617058|metformin|metformin
608053|NCT00617058|children|children
608054|NCT00617058|adolescents|adolescents
608055|NCT00617071|colon cancer|colon cancer
608056|NCT00617071|rectal cancer|rectal cancer
608057|NCT00617084|Drug Eluting Stents|drug eluting stents
608058|NCT00617084|Interventional Cardiology|interventional cardiology
608059|NCT00617097|Pain associated with first trimester surgical abortion|pain associated with first trimester surgical abortion
608060|NCT00617110|diesel exhaust particles|diesel exhaust particles
608061|NCT00617110|live attenuated influenza virus vaccine|live attenuated influenza virus vaccine
608062|NCT00617110|flu vaccine|flu vaccine
608063|NCT00617136|Surgery|surgery
608064|NCT00617136|Anesthesia|anesthesia
608065|NCT00617136|Hypothermia|hypothermia
608066|NCT00617136|Temperature|temperature
608067|NCT00617136|Perioperative|perioperative
608068|NCT00617136|Temperature Management|temperature management
608069|NCT00617149|exercise,|exercise,
608070|NCT00617149|excessive weight gain during pregnancy|excessive weight gain during pregnancy
608071|NCT00617175|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
608072|NCT00617175|therapies reduction|therapies reduction
608073|NCT00617175|Shocks|shocks
608074|NCT00617175|Quality of Life|quality of life
608075|NCT00617188|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
608076|NCT00617201|cocaine|cocaine
608077|NCT00617201|dependence|dependence
608079|NCT00617214|Schizophrenia|schizophrenia
608080|NCT00617214|Integrated care program|integrated care program
608081|NCT00617214|Seroquel|seroquel
608082|NCT00617227|Enteral vancomycin therapy, serum vancomycin levels, renal failure|enteral vancomycin therapy, serum vancomycin levels, renal failure
608083|NCT00617240|antipsychotic|antipsychotic
608084|NCT00617240|metformin|metformin
608085|NCT00617240|children|children
608086|NCT00617240|adolescents|adolescents
608087|NCT00617266|tobacco, cessation, BPO, RCT, KAP|tobacco, cessation, bpo, rct, kap
608088|NCT00617292|21-hydroxylase deficiency|21-hydroxylase deficiency
608089|NCT00617292|21OHD|21ohd
608090|NCT00617292|CAH|cah
608093|NCT00617305|combination therapy|combination therapy
608094|NCT00617305|phosphodiesterase type-5 inhibitor (PDE-5i)|phosphodiesterase type-5 inhibitor (pde-5i)
608095|NCT00617305|cardiovascular|cardiovascular
608096|NCT00617305|endothelin receptor antagonist|endothelin receptor antagonist
608097|NCT00617305|ERA|era
608098|NCT00617318|Pomegranate|pomegranate
608099|NCT00617318|Influenza|influenza
608100|NCT00617318|Common Cold|common cold
608101|NCT00617318|Cough|cough
608102|NCT00617318|Severity|severity
608103|NCT00617318|Efficacy|efficacy
608104|NCT00617331|vaccine, priming, influenza, flu, A/H9N2|vaccine, priming, influenza, flu, a/h9n2
608105|NCT00617344|Dengue fever|dengue fever
608106|NCT00617344|Dengue hemorrhagic fever|dengue hemorrhagic fever
608107|NCT00617344|Dengue virus|dengue virus
608108|NCT00617357|incisional hernia|incisional hernia
608109|NCT00617357|abdominal hernia repair|abdominal hernia repair
608110|NCT00617357|Ventral incisional hernia repair|ventral incisional hernia repair
608111|NCT00617370|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
608112|NCT00617370|EPIRUBICIN|epirubicin
608113|NCT00617370|PEGFILGRASTIM|pegfilgrastim
608114|NCT00617370|TAXOL (PACLITAXEL)|taxol (paclitaxel)
608115|NCT00617383|demyelinating disease|demyelinating disease
608116|NCT00617383|multiple sclerosis|multiple sclerosis
608117|NCT00617383|female monozygotic identical twins|female monozygotic identical twins
608118|NCT00617383|MS|ms
608119|NCT00617383|non-concordant|non-concordant
608120|NCT00617383|clinically isolated syndrome - CIS|clinically isolated syndrome - cis
608121|NCT00617383|brain MRI|brain mri
608122|NCT00617383|proteomics|proteomics
608123|NCT00617396|Irritable Bowel Syndrome|irritable bowel syndrome
608124|NCT00617396|Seroquel|seroquel
608125|NCT00617396|Abdominal Pain|abdominal pain
608126|NCT00617409|SCLC|sclc
608127|NCT00617409|vaccine|vaccine
608128|NCT00617409|immunize|immunize
608392|NCT00618436|Seizures|seizures
608129|NCT00617435|Trans fatty acid|trans fatty acid
608130|NCT00617435|Insulin resistance|insulin resistance
608131|NCT00617435|Skeletal muscle|skeletal muscle
608132|NCT00617435|Adipose tissue|adipose tissue
608133|NCT00617448|diathermy hemorrhoids|diathermy hemorrhoids
608134|NCT00617448|Ligasure|ligasure
608135|NCT00617448|randomized controlled trial|randomized controlled trial
608136|NCT00617448|Postoperative pain|postoperative pain
608137|NCT00617448|Surgical Procedure, Ambulatory|surgical procedure, ambulatory
608138|NCT00617448|Local Anesthesia|local anesthesia
608139|NCT00617448|Safety procedure long term|safety procedure long term
608140|NCT00617448|Day Surgery|day surgery
608141|NCT00617461|Post-herpetic neuralgia(PHN)|post-herpetic neuralgia(phn)
608142|NCT00617461|Neuropathic pain|neuropathic pain
608143|NCT00617474|erythropoietin|erythropoietin
608144|NCT00617474|kidney allograft survival|kidney allograft survival
608145|NCT00617474|Recombinant Erythropoietin|recombinant erythropoietin
608146|NCT00617474|erythropoietin (Epo)-induced protein 29, human|erythropoietin (epo)-induced protein 29, human
608147|NCT00617500|climacteric|climacteric
608148|NCT00617500|complementary therapy|complementary therapy
608149|NCT00617500|hormonal replacement therapy|hormonal replacement therapy
608150|NCT00617526|HIV|hiv
608151|NCT00617526|treatment naïve|treatment naïve
608152|NCT00617539|recurrent breast cancer|recurrent breast cancer
608153|NCT00617539|stage IV breast cancer|stage iv breast cancer
608154|NCT00617539|male breast cancer|male breast cancer
608155|NCT00617539|tumors metastatic to brain|tumors metastatic to brain
608156|NCT00617552|postoperative ileus|postoperative ileus
608157|NCT00617552|POI|poi
608158|NCT00617552|major open abdominal surgery|major open abdominal surgery
608159|NCT00617578|Antitachy pacing|antitachy pacing
608160|NCT00617578|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
608161|NCT00617591|Lenalidomide|lenalidomide
608162|NCT00617591|Revlimid|revlimid
608163|NCT00617591|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
608164|NCT00617591|Doxil|doxil
608165|NCT00617591|Dexamethasone|dexamethasone
608166|NCT00617591|Decadron|decadron
608167|NCT00617604|kidney transplant|kidney transplant
608168|NCT00617604|alefacept|alefacept
608173|NCT00617643|Pharmacokinetics|pharmacokinetics
608174|NCT00617656|LUNG CANCER|lung cancer
608175|NCT00617669|Hormone Resistant Prostate Cancer|hormone resistant prostate cancer
608176|NCT00617669|Endothelin A Receptor Antagonist|endothelin a receptor antagonist
608177|NCT00617669|Endothelin A|endothelin a
608178|NCT00617669|Endothelin A antagonist|endothelin a antagonist
608179|NCT00617682|Maternal immunization|maternal immunization
608180|NCT00617682|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
608181|NCT00617682|Otitis media|otitis media
608182|NCT00617695|Zolmitriptan|zolmitriptan
608183|NCT00617695|ZOMIG|zomig
608184|NCT00617695|migraine|migraine
608185|NCT00617695|headache response|headache response
608186|NCT00617695|headache|headache
608187|NCT00617695|headache pain|headache pain
608188|NCT00617721|Defective gene(s) in plasma membrane remodelling.|defective gene(s) in plasma membrane remodelling.
608189|NCT00617721|Scott syndrome,|scott syndrome,
608190|NCT00617721|Reduced prothrombin consumption,|reduced prothrombin consumption,
608191|NCT00617721|Circulating biomakers of scott syndrome|circulating biomakers of scott syndrome
608192|NCT00617734|Squamous Cell Carcinoma in Head and Neck|squamous cell carcinoma in head and neck
608193|NCT00617734|Prior Platinum-based chemotherapy|prior platinum-based chemotherapy
608194|NCT00617734|Cetuximab|cetuximab
608195|NCT00617734|Erbitux|erbitux
608196|NCT00617734|IMC-A12|imc-a12
608197|NCT00617747|Zolmitriptan|zolmitriptan
608198|NCT00617747|ZOMIG|zomig
608199|NCT00617747|migraine|migraine
608200|NCT00617747|headache response|headache response
608201|NCT00617747|headache|headache
608202|NCT00617747|headache pain|headache pain
608203|NCT00617773|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
608204|NCT00617773|recurrent fallopian tube cancer|recurrent fallopian tube cancer
608205|NCT00617773|recurrent primary peritoneal cancer|recurrent primary peritoneal cancer
608206|NCT00617786|urinary urgency|urinary urgency
608207|NCT00617786|urinary frequency|urinary frequency
608208|NCT00617786|urge incontinence|urge incontinence
608209|NCT00617786|sacral neuromodulation therapy|sacral neuromodulation therapy
608210|NCT00617786|urgency|urgency
608211|NCT00617786|frequency|frequency
608212|NCT00617799|stage IV renal cell cancer|stage iv renal cell cancer
608213|NCT00617799|stage IV melanoma|stage iv melanoma
608214|NCT00617812|Vaccine|vaccine
608215|NCT00617812|Prevention|prevention
608216|NCT00617812|Diphtheria|diphtheria
608217|NCT00617812|Tetanus|tetanus
608218|NCT00617812|Pertussis|pertussis
608219|NCT00617812|Hepatitis B|hepatitis b
608220|NCT00617812|Haemophilus influenzae type b|haemophilus influenzae type b
608221|NCT00617812|Healthy infants|healthy infants
608222|NCT00617825|chronic venous disorders|chronic venous disorders
608223|NCT00617825|cryotherapy|cryotherapy
608224|NCT00617825|skin microcirculation|skin microcirculation
608225|NCT00617825|skin temperature|skin temperature
608226|NCT00617838|Celiac disease|celiac disease
608227|NCT00617838|genetic risk|genetic risk
608228|NCT00617838|gluten introduction|gluten introduction
608229|NCT00617838|predicting antibodies|predicting antibodies
608230|NCT00617851|Influenza|influenza
608231|NCT00617851|adults|adults
608232|NCT00617851|different lots|different lots
608233|NCT00617851|trivalent subunit influenza virus vaccine (IVV)|trivalent subunit influenza virus vaccine (ivv)
608234|NCT00617851|trivalent subunit influenza vaccine|trivalent subunit influenza vaccine
608235|NCT00617890|anti-IGF-1R|anti-igf-1r
608236|NCT00617903|rosacea|rosacea
608237|NCT00617903|papulopustular|papulopustular
608238|NCT00617903|azelaic acid|azelaic acid
608239|NCT00617903|foam|foam
608240|NCT00617916|hyperspectral imaging|hyperspectral imaging
608241|NCT00617916|tissue oxygenation|tissue oxygenation
608242|NCT00617916|diabetic foot ulcers|diabetic foot ulcers
608243|NCT00617916|wound healing|wound healing
608244|NCT00617916|prevention|prevention
608245|NCT00617929|chronic myelogenous leukemia|chronic myelogenous leukemia
608246|NCT00617929|acute lymphoblastic leukemia|acute lymphoblastic leukemia
608247|NCT00617929|chronic myeloid leukemia|chronic myeloid leukemia
608248|NCT00617929|lymphoblastic leukemia|lymphoblastic leukemia
608249|NCT00617929|acute myeloid leukemia|acute myeloid leukemia
608250|NCT00617929|chronic eosinophilic leukemia|chronic eosinophilic leukemia
608251|NCT00617929|primary myelofibrosis|primary myelofibrosis
608252|NCT00617929|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
608253|NCT00617929|chronic neutrophilic leukemia|chronic neutrophilic leukemia
608254|NCT00617929|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
608255|NCT00617929|disseminated neuroblastoma|disseminated neuroblastoma
608256|NCT00617929|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
608257|NCT00617929|Burkitt lymphoma|burkitt lymphoma
608258|NCT00617929|rhabdomyosarcoma|rhabdomyosarcoma
608259|NCT00617929|myelodysplastic syndromes|myelodysplastic syndromes
608260|NCT00617929|Hodgkin lymphoma|hodgkin lymphoma
608261|NCT00617929|lymphoblastic lymphoma|lymphoblastic lymphoma
608262|NCT00617929|breast cancer|breast cancer
608263|NCT00617929|follicular lymphoma|follicular lymphoma
608264|NCT00617929|mantle cell lymphoma|mantle cell lymphoma
608265|NCT00617929|marginal zone lymphoma|marginal zone lymphoma
608432|NCT00618592|outcomes|outcomes
608266|NCT00617929|recurrent neuroblastoma|recurrent neuroblastoma
608267|NCT00617929|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
608268|NCT00617929|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
608269|NCT00617929|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
608270|NCT00617929|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
608271|NCT00617929|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
608272|NCT00617929|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
608273|NCT00617929|refractory hairy cell leukemia|refractory hairy cell leukemia
608274|NCT00617929|refractory multiple myeloma|refractory multiple myeloma
608275|NCT00617929|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
608276|NCT00617929|secondary acute myeloid leukemia|secondary acute myeloid leukemia
608277|NCT00617929|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
608278|NCT00617929|splenic marginal zone lymphoma|splenic marginal zone lymphoma
608279|NCT00617929|stage I multiple myeloma|stage i multiple myeloma
608280|NCT00617929|stage II multiple myeloma|stage ii multiple myeloma
608281|NCT00617929|stage III multiple myeloma|stage iii multiple myeloma
608282|NCT00617929|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
608283|NCT00617929|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
608284|NCT00617929|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
608285|NCT00617929|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
608286|NCT00617929|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
608287|NCT00617929|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
608288|NCT00617929|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
608289|NCT00617929|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
608290|NCT00617929|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
608291|NCT00617929|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
608292|NCT00617929|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
608293|NCT00617929|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
608294|NCT00617929|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
608295|NCT00617929|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
608296|NCT00617929|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
608297|NCT00617929|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
608298|NCT00617929|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
608299|NCT00617929|stage IIIA breast cancer|stage iiia breast cancer
608300|NCT00617929|stage IIIB breast cancer|stage iiib breast cancer
608301|NCT00617929|stage IIIC breast cancer|stage iiic breast cancer
608302|NCT00617929|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
608303|NCT00617929|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
608304|NCT00617929|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
608305|NCT00617929|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
608306|NCT00617929|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
608307|NCT00617929|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
608308|NCT00617929|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
608309|NCT00617929|stage IV breast cancer|stage iv breast cancer
608310|NCT00617929|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
608311|NCT00617929|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
608312|NCT00617929|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
608313|NCT00617929|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
608314|NCT00617929|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
608315|NCT00617929|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
608316|NCT00617929|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
608317|NCT00617929|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
608318|NCT00617929|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
608319|NCT00617942|Breast Cancer|breast cancer
608320|NCT00617981|hepatocellular carcinoma|hepatocellular carcinoma
608321|NCT00617981|liver cancer|liver cancer
608322|NCT00617994|psoriasis|psoriasis
608324|NCT00618020|Chronic Total Occlusion|chronic total occlusion
608325|NCT00618020|Revascularization|revascularization
608326|NCT00618033|Hemodialysis|hemodialysis
608327|NCT00618033|ESRD|esrd
608328|NCT00618072|hyperinsulinemia|hyperinsulinemia
608329|NCT00618072|insulin resistance|insulin resistance
608330|NCT00618072|perimenopause|perimenopause
608331|NCT00618072|obesity|obesity
608332|NCT00618072|overweight|overweight
608333|NCT00618072|women|women
608334|NCT00618098|anticoagulant reversal|anticoagulant reversal
608335|NCT00618098|urgent surgery|urgent surgery
608336|NCT00618098|invasive procedures|invasive procedures
608337|NCT00618098|vitamin K|vitamin k
608338|NCT00618098|prothrombin complex concentrate|prothrombin complex concentrate
608339|NCT00618111|Prevention of nausea and vomiting associated with radiation or chemotherapy|prevention of nausea and vomiting associated with radiation or chemotherapy
608433|NCT00618605|HIV Seronegativity|hiv seronegativity
608340|NCT00618124|solid tumor malignancy, SU011248, sunitinib, capecitabine, Phase 1|solid tumor malignancy, su011248, sunitinib, capecitabine, phase 1
608341|NCT00618137|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
608342|NCT00618137|Gene expression profiling|gene expression profiling
608343|NCT00618137|Inert dusts|inert dusts
608344|NCT00618137|Natural course|natural course
608345|NCT00618137|Prospective assessment|prospective assessment
608346|NCT00618150|GERD|gerd
608347|NCT00618150|Dyspepsia|dyspepsia
608348|NCT00618150|Education|education
608349|NCT00618150|Information|information
608350|NCT00618163|Anti-inflammatory|anti-inflammatory
608351|NCT00618176|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
608352|NCT00618176|adverse effects|adverse effects
608353|NCT00618176|Treatment Outcome|treatment outcome
608354|NCT00618176|Drug Resistance, Viral|drug resistance, viral
608355|NCT00618176|treatment naïve|treatment naïve
608356|NCT00618215|cluster-randomised trial|cluster-randomised trial
608357|NCT00618215|routine oral examination|routine oral examination
608358|NCT00618215|implementation research|implementation research
608359|NCT00618215|practice based research|practice based research
608360|NCT00618215|CPG|cpg
608361|NCT00618215|recall interval assignment for routine oral examination|recall interval assignment for routine oral examination
608362|NCT00618215|prescription bitewing radiographs|prescription bitewing radiographs
608363|NCT00618215|preventive advice and feed back oral disease|preventive advice and feed back oral disease
608364|NCT00618241|interactions|interactions
608365|NCT00618241|neuropathic pain|neuropathic pain
608366|NCT00618241|pharmacokinetics|pharmacokinetics
608367|NCT00618254|Prevention of nausea and vomiting associated with radiation or chemotherapy|prevention of nausea and vomiting associated with radiation or chemotherapy
608368|NCT00618293|intraoperative bleeding|intraoperative bleeding
608369|NCT00618293|aortic-valve replacement|aortic-valve replacement
608370|NCT00618293|aortic stenosis|aortic stenosis
608371|NCT00618293|Von Willebrand|von willebrand
608372|NCT00618293|HEAMATE|heamate
608373|NCT00618345|refractory multiple myeloma|refractory multiple myeloma
608374|NCT00618371|Intensification|intensification
608375|NCT00618371|HIV viremia|hiv viremia
608376|NCT00618371|Human Immunodeficiency Virus|human immunodeficiency virus
608377|NCT00618384|TACE|tace
608378|NCT00618384|hepatocellular carcinoma|hepatocellular carcinoma
608379|NCT00618397|ketamine|ketamine
608380|NCT00618397|pharmacokinetics|pharmacokinetics
608381|NCT00618397|sedation|sedation
608382|NCT00618397|critical care|critical care
608383|NCT00618397|opioid tolerance|opioid tolerance
608384|NCT00618397|NMDA Antagonist|nmda antagonist
608385|NCT00618423|Neuropathic pain|neuropathic pain
608386|NCT00618423|Chronic pain|chronic pain
608387|NCT00618423|Acute postoperative pain|acute postoperative pain
608388|NCT00618423|Ketamine|ketamine
608389|NCT00618423|Back surgery|back surgery
608390|NCT00618423|Anesthesia|anesthesia
608391|NCT00618423|Perioperative|perioperative
608393|NCT00618436|Traumatic Brain Injury|traumatic brain injury
608394|NCT00618436|Subarachnoid Hemorrhage|subarachnoid hemorrhage
608395|NCT00618449|Trachoma|trachoma
608396|NCT00618449|Chlamydia trachomatis|chlamydia trachomatis
608397|NCT00618462|Cognitive Behavioral Therapy|cognitive behavioral therapy
608398|NCT00618462|Pathological Gambling|pathological gambling
608399|NCT00618475|Depression|depression
608400|NCT00618475|End Stage Renal Disease|end stage renal disease
608401|NCT00618475|Kidney Disease|kidney disease
608402|NCT00618475|Mental Health|mental health
608403|NCT00618488|Probiotics|probiotics
608404|NCT00618488|BB12|bb12
608405|NCT00618488|Gastrointestinal Symptoms|gastrointestinal symptoms
608406|NCT00618501|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
608407|NCT00618514|Varicose Veins|varicose veins
608408|NCT00618514|Laser Ablation|laser ablation
608409|NCT00618514|Laser Wire Fibers|laser wire fibers
608410|NCT00618527|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
608411|NCT00618527|multiple sclerosis|multiple sclerosis
608412|NCT00618540|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
608413|NCT00618553|Lung Cancer|lung cancer
608414|NCT00618553|Pulmonary Rehabilitation|pulmonary rehabilitation
608415|NCT00618553|Questionnaire|questionnaire
608416|NCT00618553|Survey|survey
608417|NCT00618553|Lung Function|lung function
608418|NCT00618553|Quality of Life|quality of life
608419|NCT00618566|Women with physical Disabilities|women with physical disabilities
608420|NCT00618566|Secondary Conditions|secondary conditions
608421|NCT00618566|Depression|depression
608422|NCT00618566|Cognitive Behavioral Therapy|cognitive behavioral therapy
608423|NCT00618566|Consumer Control|consumer control
608424|NCT00618579|Interaction with LMWH or warfarin|interaction with lmwh or warfarin
608425|NCT00618592|carbohydrate supplementation|carbohydrate supplementation
608426|NCT00618592|cardiac surgery|cardiac surgery
608427|NCT00618592|spine surgery|spine surgery
608428|NCT00618592|insulin resistance|insulin resistance
608429|NCT00618592|insulin sensitivity|insulin sensitivity
608430|NCT00618592|short insulin tolerance test|short insulin tolerance test
608431|NCT00618592|HOMA|homa
608434|NCT00618605|HIV Preventative Vaccine|hiv preventative vaccine
608435|NCT00618631|Smoking|smoking
608436|NCT00618631|Nicotine|nicotine
608437|NCT00618631|Endogenous Opioids|endogenous opioids
608438|NCT00618631|PET Study|pet study
608439|NCT00618631|Carfentanil|carfentanil
608440|NCT00618657|pre-operative|pre-operative
608441|NCT00618657|neo-adjuvant|neo-adjuvant
608442|NCT00618657|triple negative|triple negative
608443|NCT00618657|HER2 positive|her2 positive
608444|NCT00618657|hormone receptor positive|hormone receptor positive
608445|NCT00618657|breast|breast
608446|NCT00618657|Carboplatin|carboplatin
608447|NCT00618657|Nab-paclitaxel|nab-paclitaxel
608448|NCT00618657|Trastuzumab|trastuzumab
608449|NCT00618657|Bevacizumab|bevacizumab
608450|NCT00618657|Inflammatory|inflammatory
608451|NCT00618670|aging|aging
608452|NCT00618670|gait|gait
608453|NCT00618670|musculoskeletal disorder therapy|musculoskeletal disorder therapy
608454|NCT00618670|peripheral blood vessel disorder|peripheral blood vessel disorder
608455|NCT00618670|muscle function|muscle function
608456|NCT00618670|muscle strength|muscle strength
608457|NCT00618670|quality of life|quality of life
608458|NCT00618683|AVNRT|avnrt
608459|NCT00618683|Atrioventricular|atrioventricular
608460|NCT00618683|nodal reentrant circuit|nodal reentrant circuit
608461|NCT00618683|nodal reentrant tachycardia|nodal reentrant tachycardia
608462|NCT00618683|Paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
608463|NCT00618696|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
608464|NCT00618696|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
608465|NCT00618696|secondary acute myeloid leukemia|secondary acute myeloid leukemia
608466|NCT00618696|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
608467|NCT00618696|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
608468|NCT00618696|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
608469|NCT00618696|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
608470|NCT00618696|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
608471|NCT00618696|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
608472|NCT00618696|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
608473|NCT00618696|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
608474|NCT00618709|Healthy volunteers|healthy volunteers
608475|NCT00618748|Bipolar|bipolar
608476|NCT00618761|glucose clamp|glucose clamp
608477|NCT00618761|beta-cell|beta-cell
608478|NCT00618800|Falls|falls
608479|NCT00618800|Elderly|elderly
608480|NCT00618800|Injury|injury
608481|NCT00618800|Medication|medication
608482|NCT00618800|Pharmacy|pharmacy
608483|NCT00618800|Pharmacist|pharmacist
608484|NCT00618826|Breast cancer|breast cancer
608485|NCT00618839|Complex skin defects|complex skin defects
608486|NCT00618839|Burns|burns
608487|NCT00618839|Wound infection|wound infection
608488|NCT00618839|Skin trauma|skin trauma
608489|NCT00618852|Pediatrics|pediatrics
608490|NCT00618852|Erythrocyte Transfusion|erythrocyte transfusion
608491|NCT00618852|Furosemide|furosemide
608492|NCT00618852|Fluid Overload|fluid overload
608493|NCT00618865|Omega-3 Fatty Acids|omega-3 fatty acids
608494|NCT00618865|Major Depressive Disorder|major depressive disorder
608495|NCT00618865|Pregnancy|pregnancy
608496|NCT00618865|Women during pregnancy and after childbirth are more vulnerable to psychiatric disorders|women during pregnancy and after childbirth are more vulnerable to psychiatric disorders
751786|NCT01170429|Procaterol Hydrochloride|procaterol hydrochloride
608497|NCT00618865|Pharmacotherapy for depression during pregnancy is a clinical dilemma.|pharmacotherapy for depression during pregnancy is a clinical dilemma.
608498|NCT00618865|Omega-3 polyunsaturated fatty acids (PUFAs) might be a promising alternative of treatment for pregnant women with depression.|omega-3 polyunsaturated fatty acids (pufas) might be a promising alternative of treatment for pregnant women with depression.
608499|NCT00618904|Probiotics|probiotics
608500|NCT00618904|Functional Gastrointestinal Symptoms|functional gastrointestinal symptoms
608501|NCT00607178|Influenza|influenza
608502|NCT00607178|Vaccine|vaccine
608503|NCT00607191|Idiopathic talipes equinovarus (ITEV)|idiopathic talipes equinovarus (itev)
608504|NCT00607204|Basic Research|basic research
608505|NCT00607204|Individual Sleep Duration|individual sleep duration
608506|NCT00607204|Melatonin|melatonin
608507|NCT00607204|Electroencephalogram|electroencephalogram
608508|NCT00607204|Alertness|alertness
608509|NCT00607204|Mood|mood
608510|NCT00607217|Coronary artery diseases|coronary artery diseases
608511|NCT00607217|Myocardial infarction|myocardial infarction
608512|NCT00607217|Stable angina|stable angina
608513|NCT00607217|Influenza|influenza
608514|NCT00607217|Vaccine|vaccine
608515|NCT00607230|type 1 diabetes mellitus|type 1 diabetes mellitus
608516|NCT00607230|immune modulation|immune modulation
608517|NCT00607230|cure|cure
608518|NCT00607230|autoimmunity|autoimmunity
608519|NCT00607243|Smallpox vaccine efficacy|smallpox vaccine efficacy
608520|NCT00607269|Drug Abuse|drug abuse
608521|NCT00607269|Contingency management|contingency management
608522|NCT00607269|Voucher-based Reinforcement Therapy|voucher-based reinforcement therapy
608523|NCT00607269|Homosexuality|homosexuality
608524|NCT00607269|Homeless Persons|homeless persons
608525|NCT00607295|chemotherapy|chemotherapy
608526|NCT00607295|hormonal therapy|hormonal therapy
608527|NCT00607295|urogenital atrophy|urogenital atrophy
608528|NCT00607321|restenosis|restenosis
608529|NCT00607321|Coronary Disease|coronary disease
608530|NCT00607321|Coronary Arteriosclerosis|coronary arteriosclerosis
608531|NCT00607321|Arterial Occlusive Diseases|arterial occlusive diseases
608532|NCT00607334|Child Language|child language
608533|NCT00607334|Language Therapy|language therapy
608534|NCT00607334|Vocabulary|vocabulary
608535|NCT00607347|Keywords by National Institute of General Medical Sciences|keywords by national institute of general medical sciences
608536|NCT00607347|Hypertension|hypertension
608537|NCT00607347|Adverse metabolic effects|adverse metabolic effects
608538|NCT00607347|Beta blockers|beta blockers
608539|NCT00607347|Dyslipidemia|dyslipidemia
608541|NCT00607347|New onset diabetes|new onset diabetes
608542|NCT00607347|Pharmacokinetic study|pharmacokinetic study
608543|NCT00607347|Oral glucose tolerance test|oral glucose tolerance test
608544|NCT00607360|cocaine addiction, treatment, contingency management, employment intervention|cocaine addiction, treatment, contingency management, employment intervention
608545|NCT00607373|Apolipoprotein B|apolipoprotein b
608546|NCT00607373|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
608547|NCT00607373|LDL-receptor gene|ldl-receptor gene
608548|NCT00607386|Hunter syndrome|hunter syndrome
608549|NCT00607386|hunters syndrome|hunters syndrome
608550|NCT00607386|hunter's syndrome|hunter's syndrome
608551|NCT00607386|hunter disease|hunter disease
608552|NCT00607386|hunters disease|hunters disease
608553|NCT00607386|hunter's disease|hunter's disease
608554|NCT00607386|MPS II|mps ii
608555|NCT00607386|MPSII|mpsii
608556|NCT00607386|MPS2|mps2
608557|NCT00607386|MPS 2|mps 2
608558|NCT00607386|mucopolysaccharides|mucopolysaccharides
608559|NCT00607386|lysosomal storage disease|lysosomal storage disease
608560|NCT00607386|lysosomal storage disorder|lysosomal storage disorder
608561|NCT00607386|chronic ear infection|chronic ear infection
608562|NCT00607386|enlarged adenoids|enlarged adenoids
608563|NCT00607386|mps symptoms|mps symptoms
608564|NCT00607386|mps diagnosis|mps diagnosis
608565|NCT00607386|mps ii therapy|mps ii therapy
608566|NCT00607386|MPS II treatment|mps ii treatment
608567|NCT00607386|ert treatment|ert treatment
608568|NCT00607386|elaprase|elaprase
608569|NCT00607386|idursulfase|idursulfase
608570|NCT00607386|iduronate sulfatase|iduronate sulfatase
608571|NCT00607386|iduronate 2 sulfatase|iduronate 2 sulfatase
608572|NCT00607386|enzyme replacement therapy|enzyme replacement therapy
608573|NCT00607386|hunter syndrome treatment|hunter syndrome treatment
608574|NCT00607386|hunter's syndrome treatment|hunter's syndrome treatment
608575|NCT00607386|hunter syndrome therapy|hunter syndrome therapy
608576|NCT00607386|hunter's disease treatment|hunter's disease treatment
608577|NCT00607386|mps society|mps society
608578|NCT00607399|Solid tumor|solid tumor
608579|NCT00607399|Advanced Cancer|advanced cancer
608580|NCT00607399|MET Inhibitor|met inhibitor
608581|NCT00607399|Receptor Tyrosine Kinase Inhibitor (RTKI)|receptor tyrosine kinase inhibitor (rtki)
608582|NCT00607412|PTSD|ptsd
608583|NCT00607412|substance use disorders|substance use disorders
608584|NCT00607412|psychotherapy|psychotherapy
608585|NCT00607425|non-small cell lung cancer|non-small cell lung cancer
608586|NCT00607425|screening|screening
608587|NCT00607425|saliva|saliva
608588|NCT00607425|gene expression|gene expression
608589|NCT00607425|healthy control subject|healthy control subject
608590|NCT00607438|Locally Advanced or Metastatic|locally advanced or metastatic
608591|NCT00607464|Hypothermia, premature infants, Polyethylene occlusive wrap|hypothermia, premature infants, polyethylene occlusive wrap
608592|NCT00607490|Vulvodynia|vulvodynia
608593|NCT00607490|Vulvar pain|vulvar pain
608594|NCT00607490|Dyspareunia|dyspareunia
608595|NCT00607490|Sexual dysfunction|sexual dysfunction
608596|NCT00607490|Vestibulitis|vestibulitis
608597|NCT00607516|fracture|fracture
608598|NCT00607516|arthroplasty|arthroplasty
608600|NCT00607516|osteoporosis|osteoporosis
608601|NCT00607516|bone|bone
608602|NCT00607529|Multiple Diseases|multiple diseases
608603|NCT00607542|spasticity|spasticity
608604|NCT00607542|cerebral palsy|cerebral palsy
608605|NCT00607542|baclofen|baclofen
608606|NCT00607542|pharmacokinetics|pharmacokinetics
608607|NCT00607542|pharmacodynamics|pharmacodynamics
608608|NCT00607542|dosing|dosing
608609|NCT00607542|safety|safety
608610|NCT00607542|efficacy|efficacy
608611|NCT00607555|Infant, premature|infant, premature
608612|NCT00607555|Infant, very low birth weight|infant, very low birth weight
608613|NCT00607555|Apnea|apnea
608614|NCT00607555|Feeding methods|feeding methods
608615|NCT00607555|Diaphragm|diaphragm
608616|NCT00607568|physical stress|physical stress
608617|NCT00607568|psychological stress|psychological stress
608618|NCT00607581|amyloidosis|amyloidosis
608619|NCT00607581|lenalidomide|lenalidomide
608620|NCT00607581|cyclophosphamide|cyclophosphamide
608621|NCT00607581|dexamethasone|dexamethasone
608622|NCT00607607|ovarian cancer|ovarian cancer
608623|NCT00607607|endometrial cancer|endometrial cancer
608624|NCT00607620|Alcohol Abuse|alcohol abuse
608625|NCT00607620|Alcohol Dependence|alcohol dependence
608626|NCT00607620|Alcohol Use Disorder|alcohol use disorder
608627|NCT00607620|Screening|screening
608628|NCT00607620|Brief Intervention|brief intervention
608629|NCT00607620|Motivational Interviewing|motivational interviewing
608630|NCT00607633|essential hypertension|essential hypertension
608632|NCT00607633|left ventricular hypertrophy|left ventricular hypertrophy
608633|NCT00607633|candesartan|candesartan
608634|NCT00607646|hypoglycemia|hypoglycemia
608635|NCT00607646|dehydroepiandrosterone|dehydroepiandrosterone
608636|NCT00607659|Chlamydia|chlamydia
608637|NCT00607659|Chlamydia trachomatis|chlamydia trachomatis
608638|NCT00607659|Adolescent Health|adolescent health
608639|NCT00607659|Female Health|female health
608640|NCT00607659|Sexually Transmitted Infections|sexually transmitted infections
608641|NCT00607659|Infertility|infertility
608642|NCT00607659|Pelvic Inflammatory Disease|pelvic inflammatory disease
608643|NCT00607672|Angiotensin Converting Enzyme|angiotensin converting enzyme
608644|NCT00607672|Angiotensin Receptor Blockers|angiotensin receptor blockers
608645|NCT00607672|Cardiopulmonary Bypass|cardiopulmonary bypass
608646|NCT00607672|Fibrinolysis|fibrinolysis
608647|NCT00607672|Inflammation|inflammation
608648|NCT00607685|Trabeculectomy|trabeculectomy
608649|NCT00607685|Wound healing|wound healing
608650|NCT00607685|5 Fluorouracil|5 fluorouracil
608651|NCT00607685|Hyaluronic acid|hyaluronic acid
608652|NCT00607685|post-operative scarring|post-operative scarring
608653|NCT00607724|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
608654|NCT00607750|Wet AMD, Comentis, ATG003, mecamylamine|wet amd, comentis, atg003, mecamylamine
608655|NCT00607763|Antifungal|antifungal
608656|NCT00607763|Echinocandin|echinocandin
608657|NCT00607763|Candidiasis|candidiasis
608658|NCT00607763|Micafungin|micafungin
608659|NCT00607776|dry, eyes|dry, eyes
608660|NCT00607776|Amelioration of dry eye symptoms|amelioration of dry eye symptoms
608661|NCT00608725|heart rate|heart rate
608662|NCT00608725|blood pressure|blood pressure
608663|NCT00608725|blood volume|blood volume
608664|NCT00608725|sympathetic nervous system|sympathetic nervous system
608665|NCT00608725|orthostatic tachycardia|orthostatic tachycardia
608666|NCT00608725|orthostatic intolerance|orthostatic intolerance
608667|NCT00608725|POTS|pots
608668|NCT00608738|neutropenia|neutropenia
608669|NCT00608738|infection|infection
608670|NCT00608738|radiation toxicity|radiation toxicity
608671|NCT00608738|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
608672|NCT00608738|malnutrition|malnutrition
608673|NCT00608738|musculoskeletal complications|musculoskeletal complications
608674|NCT00608738|thrombocytopenia|thrombocytopenia
608675|NCT00608738|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
609073|NCT00610493|Bevacizumab|bevacizumab
608676|NCT00608751|Newly Diagnosed head and neck cancer|newly diagnosed head and neck cancer
608677|NCT00608764|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
608678|NCT00608764|COPD|copd
608679|NCT00608764|Emphysema|emphysema
608680|NCT00608764|Chronic Bronchitis|chronic bronchitis
608681|NCT00608764|Genetics|genetics
608682|NCT00608764|Association Studies|association studies
608683|NCT00608764|Computed Tomography|computed tomography
608684|NCT00608777|Localized mild breakthrough|localized mild breakthrough
751787|NCT01170455|nasal|nasal
751788|NCT01170455|intubation|intubation
608685|NCT00608790|Tuberculosis, TB, Mycobacterium tuberculosis, children, South Africa|tuberculosis, tb, mycobacterium tuberculosis, children, south africa
608686|NCT00608816|epinephrine|epinephrine
608687|NCT00608855|bone metastases|bone metastases
608688|NCT00608855|pain|pain
608689|NCT00608855|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
608690|NCT00608868|Carcinoma|carcinoma
608691|NCT00608868|Non Small Cell Lung|non small cell lung
608692|NCT00608868|EGFR mutation|egfr mutation
608693|NCT00608868|Gefitinib|gefitinib
608694|NCT00608881|Huntington's disease|huntington's disease
608695|NCT00608881|Huntington disease|huntington disease
608696|NCT00608881|HD|hd
608697|NCT00608881|coenzyme Q10|coenzyme q10
608698|NCT00608881|CoQ|coq
608699|NCT00608894|Autoimmune hepatitis|autoimmune hepatitis
608700|NCT00608894|Chronic active hepatitis|chronic active hepatitis
608701|NCT00608920|SPECT|spect
608702|NCT00608933|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
608703|NCT00608933|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
608704|NCT00608946|efficacy of treatment with copper in patients with mild Alzheimer´s disease|efficacy of treatment with copper in patients with mild alzheimer´s disease
608705|NCT00608946|cognitive status over time|cognitive status over time
752345|NCT01172587|Couples Treatment|couples treatment
608706|NCT00608946|CSF and volumetric data over time (1 year)|csf and volumetric data over time (1 year)
608707|NCT00608959|Skin colonization|skin colonization
608708|NCT00608959|Catheter colonization|catheter colonization
608709|NCT00608959|Catheter site infection|catheter site infection
608710|NCT00608972|negative for a protein called HER2/neu|negative for a protein called her2/neu
608711|NCT00608972|negative for estrogen receptors (ER) and progesterone receptors (PR).|negative for estrogen receptors (er) and progesterone receptors (pr).
608712|NCT00608972|breast cancer|breast cancer
608713|NCT00608985|sleeplessness|sleeplessness
608714|NCT00608985|orexin receptor antagonist|orexin receptor antagonist
608715|NCT00608985|almorexant|almorexant
608716|NCT00608985|insomnia|insomnia
608717|NCT00608998|Chronic renal failure|chronic renal failure
608718|NCT00608998|Vasculopathy|vasculopathy
608719|NCT00608998|Cardiovascular risk|cardiovascular risk
608720|NCT00608998|Chronic renal failure patients|chronic renal failure patients
608721|NCT00609011|Melanoma|melanoma
608722|NCT00609011|Metastatic|metastatic
608723|NCT00609037|Gastric Bypass|gastric bypass
608724|NCT00609037|Body contouring|body contouring
608725|NCT00609037|Excessive weight loss|excessive weight loss
608726|NCT00609050|cystic fibrosis|cystic fibrosis
608727|NCT00609050|exercise|exercise
608728|NCT00609050|perceived exertion|perceived exertion
608729|NCT00609050|aerobic fitness|aerobic fitness
608730|NCT00609050|lung function|lung function
608731|NCT00609050|health related quality of life|health related quality of life
608732|NCT00609050|self-regulated exercise|self-regulated exercise
608733|NCT00609063|Statins|statins
608734|NCT00609063|Myalgia|myalgia
608735|NCT00609063|Muscle Cramp|muscle cramp
608736|NCT00609089|Family|family
608737|NCT00609089|treatment|treatment
608738|NCT00609089|reinforcement|reinforcement
608739|NCT00609089|substance|substance
608740|NCT00609089|trial|trial
608741|NCT00609089|drug|drug
608742|NCT00609089|abuse|abuse
608743|NCT00609089|HIV|hiv
608744|NCT00609089|risk|risk
608745|NCT00609102|Type 2 diabetes|type 2 diabetes
608746|NCT00609115|Sub-acute care|sub-acute care
608747|NCT00609115|Robotics|robotics
608748|NCT00609128|tears|tears
608749|NCT00609128|conjunctival epithelial cells|conjunctival epithelial cells
608750|NCT00609128|olopatadine|olopatadine
608751|NCT00609128|impression cytology|impression cytology
608752|NCT00609154|Type 2 diabetes|type 2 diabetes
608753|NCT00609154|Insulin|insulin
608754|NCT00609154|biosynthesis|biosynthesis
608755|NCT00609154|Non diabetic control|non diabetic control
608756|NCT00609167|stage II multiple myeloma|stage ii multiple myeloma
608757|NCT00609167|stage III multiple myeloma|stage iii multiple myeloma
608758|NCT00609180|Acute Lung Injury|acute lung injury
608759|NCT00609180|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
608760|NCT00609180|Feeding|feeding
608761|NCT00609180|Critical Care|critical care
608762|NCT00609180|Ventilator|ventilator
608763|NCT00609180|Omega-3 Fatty Acid|omega-3 fatty acid
608764|NCT00609180|Antioxidant|antioxidant
608765|NCT00609219|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
608766|NCT00609219|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
608767|NCT00609219|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
608768|NCT00609219|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
608769|NCT00609245|epilepsy|epilepsy
608770|NCT00609245|photosensitive|photosensitive
608771|NCT00609245|valproic acid|valproic acid
608772|NCT00609284|Stage III|stage iii
608773|NCT00609284|Stage IV|stage iv
608774|NCT00609284|locally advanced|locally advanced
608775|NCT00609297|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
608776|NCT00609297|pain|pain
608777|NCT00609310|clinical trial|clinical trial
608778|NCT00609310|flavonoid treatment|flavonoid treatment
608779|NCT00609310|neoplasia recurrence|neoplasia recurrence
608780|NCT00609310|colorectal cancer|colorectal cancer
608781|NCT00609310|polypectomy|polypectomy
608782|NCT00609310|adenoma in Colon|adenoma in colon
608783|NCT00609310|Neoplasia Recurrence Rates|neoplasia recurrence rates
608784|NCT00609310|postpolypectomy patients|postpolypectomy patients
608785|NCT00609323|Pain|pain
608786|NCT00609323|postherpetic neuralgia|postherpetic neuralgia
608787|NCT00609349|risk factors for pulmonary arterial hypertension|risk factors for pulmonary arterial hypertension
608788|NCT00609362|BMD|bmd
608789|NCT00609362|Rosiglitazone|rosiglitazone
608790|NCT00609362|Bone marrow fat|bone marrow fat
608791|NCT00609375|Sepsis|sepsis
608792|NCT00609375|Bacteremia|bacteremia
608793|NCT00609375|Intravenous infusions|intravenous infusions
608794|NCT00609375|cefepime|cefepime
608795|NCT00609401|Sorafenib|sorafenib
608796|NCT00609401|RCC|rcc
608797|NCT00609401|Metastatic disease|metastatic disease
608798|NCT00609414|Burns|burns
608799|NCT00609414|Albumin|albumin
608800|NCT00609414|Fluid Resuscitation|fluid resuscitation
608801|NCT00609427|cognitive training|cognitive training
608802|NCT00609427|cognitive rehabilitation|cognitive rehabilitation
608803|NCT00609440|Morquio's disease; physiotherapy; results|morquio's disease; physiotherapy; results
608804|NCT00609453|Control participants|control participants
608805|NCT00609466|Opioid|opioid
608806|NCT00609466|Central acting analgesic|central acting analgesic
608807|NCT00609466|CG5503 IR|cg5503 ir
608808|NCT00609466|Postoperative pain|postoperative pain
608809|NCT00609466|Bunionectomy|bunionectomy
608810|NCT00609466|Morphine|morphine
608811|NCT00609466|Placebo|placebo
608812|NCT00609479|Distal radius fracture|distal radius fracture
608813|NCT00609479|Colle´s fracture|colle´s fracture
608814|NCT00609479|Internal fixation|internal fixation
608815|NCT00609479|External fixation|external fixation
608817|NCT00609479|PRWE|prwe
608818|NCT00609505|Hereditary Breast and Ovarian Cancer syndrome|hereditary breast and ovarian cancer syndrome
608819|NCT00609505|genetic counseling|genetic counseling
608820|NCT00609505|breast cancer|breast cancer
608821|NCT00609505|ovarian cancer|ovarian cancer
608822|NCT00609505|telemedicine|telemedicine
608823|NCT00609505|Cancer genetic counseling|cancer genetic counseling
608824|NCT00609531|Restricted repetitive behaviors|restricted repetitive behaviors
608825|NCT00609531|restricted interests|restricted interests
608826|NCT00609531|Aspergers|aspergers
608827|NCT00609531|Autism|autism
608828|NCT00609544|Non Dialysis-dependent chronic kidney disease and anemia|non dialysis-dependent chronic kidney disease and anemia
608829|NCT00609557|osteoarthritis pain|osteoarthritis pain
608830|NCT00609557|activity limitation|activity limitation
608831|NCT00609557|antidepressant|antidepressant
608832|NCT00609557|depression|depression
608833|NCT00609557|single-blind|single-blind
608834|NCT00609570|hypertension|hypertension
608835|NCT00609570|supplement|supplement
608836|NCT00609570|HRV|hrv
608837|NCT00609596|dutasteride|dutasteride
608838|NCT00609596|tamsulosin|tamsulosin
608839|NCT00609596|benign prostatic hyperplasia|benign prostatic hyperplasia
608840|NCT00609609|Allogeneic stem cell grafts|allogeneic stem cell grafts
608841|NCT00609609|Allogeneic bone marrow graft|allogeneic bone marrow graft
608842|NCT00609609|Blood and Marrow Transplantation|blood and marrow transplantation
608843|NCT00609609|Stem cell graft|stem cell graft
608844|NCT00609609|Graft Versus Host Disease|graft versus host disease
608845|NCT00609609|GVHD|gvhd
608846|NCT00609609|Extracorporeal Photopheresis|extracorporeal photopheresis
608847|NCT00609609|ECP|ecp
608848|NCT00609609|Photopheresis|photopheresis
608849|NCT00609609|Methylprednisolone|methylprednisolone
608850|NCT00609609|Medrol|medrol
608851|NCT00609609|Depo-Medrol|depo-medrol
608852|NCT00609609|Solu-Medrol|solu-medrol
608853|NCT00609622|metastatic colorectal cancer sunitinib (Sutent) bevacizumab (Avastin) randomized study|metastatic colorectal cancer sunitinib (sutent) bevacizumab (avastin) randomized study
608854|NCT00609635|Respiratory|respiratory
608855|NCT00609635|RSV-induced respiratory illness|rsv-induced respiratory illness
608856|NCT00609648|Dental Anxiety|dental anxiety
608857|NCT00609648|Dental Phobia|dental phobia
608858|NCT00609648|Odontophobia|odontophobia
608859|NCT00609661|Mesenchymal Stem Cells, Burn|mesenchymal stem cells, burn
608860|NCT00609674|Perennial allergic rhinitis; fluticasone furoate nasal spray|perennial allergic rhinitis; fluticasone furoate nasal spray
608861|NCT00609687|sarcoidosis|sarcoidosis
608862|NCT00609687|diagnostic vitrectomy|diagnostic vitrectomy
608863|NCT00609687|vitreous biopsy|vitreous biopsy
609074|NCT00610493|Temsirolimus|temsirolimus
608864|NCT00609687|sarcoidosis-associated ocular inflammation|sarcoidosis-associated ocular inflammation
608865|NCT00609700|burn injury|burn injury
608866|NCT00609700|volume replacement|volume replacement
608867|NCT00609700|Ringer's Lactate solution|ringer's lactate solution
608868|NCT00609700|Ringer's Acetate solution|ringer's acetate solution
608869|NCT00609700|volume replacement with crystalloids|volume replacement with crystalloids
608870|NCT00609713|Child|child
608871|NCT00609713|Obesity|obesity
608872|NCT00609726|Endoscopic Ultrasonography|endoscopic ultrasonography
608873|NCT00609726|Pancreatitis|pancreatitis
608874|NCT00609726|EUS|eus
608875|NCT00609739|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
608876|NCT00609752|Crohn Disease|crohn disease
608877|NCT00609752|Children|children
608878|NCT00609752|Bone Density|bone density
608879|NCT00609752|Prednisolone|prednisolone
608880|NCT00609752|Liquid Diet Therapy|liquid diet therapy
608881|NCT00609752|Quality of Life|quality of life
608882|NCT00609752|Metabolic Bone Disease|metabolic bone disease
608883|NCT00609765|advanced|advanced
608884|NCT00609765|unresectable|unresectable
608885|NCT00609765|metastatic|metastatic
608886|NCT00609765|endocrine|endocrine
608887|NCT00609765|tumors|tumors
608888|NCT00609778|CPR|cpr
608889|NCT00609778|Mechanical|mechanical
608890|NCT00609778|Manual|manual
608891|NCT00609778|Survival|survival
608892|NCT00609778|ROSC|rosc
608893|NCT00609791|recurrent breast cancer|recurrent breast cancer
608894|NCT00609791|stage IV breast cancer|stage iv breast cancer
608895|NCT00609791|male breast cancer|male breast cancer
608896|NCT00609804|Non-Small Cell Lung Cancer|non-small cell lung cancer
608897|NCT00609804|Advanced|advanced
608898|NCT00609804|Erlotinib|erlotinib
608899|NCT00609804|Sorafenib|sorafenib
608900|NCT00609804|Progressing on erlotinib|progressing on erlotinib
608901|NCT00609817|Relapsed Multiple Myeloma|relapsed multiple myeloma
608902|NCT00609817|Refractory Multiple Myeloma|refractory multiple myeloma
608903|NCT00609817|GCS 100|gcs 100
608904|NCT00609830|Glucocorticoids|glucocorticoids
608905|NCT00609830|Osteoporosis|osteoporosis
608906|NCT00609830|Rheumatoid Arthritis|rheumatoid arthritis
608907|NCT00609830|Prevention|prevention
608908|NCT00609830|GIOP|giop
608909|NCT00609830|Patient Education|patient education
608910|NCT00609843|Bladder cancer|bladder cancer
608911|NCT00609843|Radiotherapy|radiotherapy
608912|NCT00609843|Tumour delineation|tumour delineation
608913|NCT00609843|Markers|markers
608914|NCT00609882|Nasal CPAP|nasal cpap
608915|NCT00609882|High flow nasal cannula|high flow nasal cannula
608916|NCT00609882|Neonate|neonate
608917|NCT00609934|renal cell carcinoma|renal cell carcinoma
608918|NCT00609934|kidney cancer|kidney cancer
608919|NCT00609934|bone metastases|bone metastases
608920|NCT00609934|RCC|rcc
608921|NCT00609934|bone pain|bone pain
608922|NCT00609934|palliative radiotherapy|palliative radiotherapy
608923|NCT00609934|sorafenib|sorafenib
608924|NCT00609934|radiation|radiation
608925|NCT00609934|renal cell|renal cell
608926|NCT00609960|children anesthesia anxiety clowns|children anesthesia anxiety clowns
608927|NCT00609973|Postoperative recurrence, inflammatory bowel disease|postoperative recurrence, inflammatory bowel disease
608928|NCT00609986|Kidney|kidney
608929|NCT00609986|Transplantation|transplantation
608930|NCT00609986|Diabetes|diabetes
608931|NCT00609986|Hyperglycemia|hyperglycemia
608932|NCT00609999|Glioblastoma|glioblastoma
608933|NCT00609999|Gliosarcoma|gliosarcoma
608934|NCT00609999|GBM|gbm
608935|NCT00609999|Recurrent MG|recurrent mg
608936|NCT00609999|Erlotinib|erlotinib
608937|NCT00609999|Dasatinib|dasatinib
608938|NCT00609999|Brain tumor|brain tumor
608939|NCT00609999|Malignant glioma|malignant glioma
608940|NCT00609999|Tarceva|tarceva
608941|NCT00609999|Sprycel|sprycel
608942|NCT00610012|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
608943|NCT00610012|MRCC|mrcc
608944|NCT00610012|Therapy-reality|therapy-reality
608945|NCT00610012|Observation|observation
608946|NCT00610012|Registry|registry
608947|NCT00610012|RCC|rcc
608948|NCT00610012|ARCC|arcc
608949|NCT00610012|Germany|germany
608950|NCT00610012|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
608951|NCT00610012|Renal Cell Carcinoma|renal cell carcinoma
608952|NCT00610012|Renal Cell Cancer|renal cell cancer
608953|NCT00610012|Sorafenib|sorafenib
608954|NCT00610012|Sunitinib|sunitinib
608955|NCT00610012|Interferon|interferon
608956|NCT00610012|Interleukin|interleukin
608957|NCT00610012|Temsirolimus|temsirolimus
608958|NCT00610012|Pazopanib|pazopanib
608959|NCT00610012|Cytokines|cytokines
608960|NCT00610012|VEGF|vegf
608961|NCT00610025|NOTES|notes
608962|NCT00610025|transgastric endoscopy|transgastric endoscopy
608963|NCT00610025|obesity surgery|obesity surgery
608964|NCT00610025|Roux-en-Y surgery|roux-en-y surgery
608965|NCT00610038|neonatal|neonatal
608966|NCT00610038|diabetes mellitus|diabetes mellitus
608967|NCT00610038|mutation|mutation
608968|NCT00610038|KIR6.2|kir6.2
608969|NCT00610038|SUR1|sur1
609075|NCT00610493|Avastin|avastin
608970|NCT00610038|Neonatal diabetes mellitus with KIR6.2 or SUR1 mutations|neonatal diabetes mellitus with kir6.2 or sur1 mutations
608971|NCT00610051|severe heart failure|severe heart failure
608972|NCT00610051|transplants|transplants
608973|NCT00610064|Refractory lower urinary tract dysfunction|refractory lower urinary tract dysfunction
608974|NCT00610064|Sacral neuromodulation|sacral neuromodulation
608975|NCT00610064|Brain effects|brain effects
608976|NCT00610064|Neuroimaging|neuroimaging
608977|NCT00610064|Neuromodulation|neuromodulation
608978|NCT00610077|Letrozole|letrozole
608979|NCT00610077|Clomiphene citrate|clomiphene citrate
608980|NCT00610077|Anovulatory infertility|anovulatory infertility
608981|NCT00610077|Ovulation induction|ovulation induction
608982|NCT00610090|UNITE|unite
608983|NCT00610090|AAA|aaa
608984|NCT00610090|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
608985|NCT00610090|Stent|stent
608986|NCT00610090|Graft|graft
608987|NCT00610129|MK-0646|mk-0646
608988|NCT00610142|atopic dermatitis|atopic dermatitis
608989|NCT00610142|pimecrolimus|pimecrolimus
608990|NCT00610142|hydrocortison|hydrocortison
608991|NCT00610142|Optical Coherence Tomography|optical coherence tomography
608992|NCT00610168|dTpa vaccine|dtpa vaccine
608993|NCT00610168|pertussis|pertussis
608994|NCT00610168|Tdap|tdap
608995|NCT00610168|Boostrix|boostrix
608996|NCT00610168|booster|booster
608997|NCT00610168|tetanus|tetanus
608998|NCT00610168|diphtheria|diphtheria
608999|NCT00610181|Breast Cancer|breast cancer
609000|NCT00610181|Breast Carcinoma|breast carcinoma
609001|NCT00610181|Invasive Lobular Cancer|invasive lobular cancer
609002|NCT00610181|Mixed Invasive Ductal-lobular Carcinoma|mixed invasive ductal-lobular carcinoma
609003|NCT00610181|Magnetic Resonance Imaging|magnetic resonance imaging
609004|NCT00610181|MRI|mri
609005|NCT00610207|Anal fistula|anal fistula
609006|NCT00610207|fistula in ano|fistula in ano
609007|NCT00610207|anorectal fistula|anorectal fistula
609008|NCT00610207|Crohn's Disease|crohn's disease
609009|NCT00610220|pediatrics|pediatrics
609010|NCT00610220|wrist fractures|wrist fractures
609011|NCT00610220|casting|casting
609012|NCT00610220|wrist splint|wrist splint
609013|NCT00610233|deep brain stimulation|deep brain stimulation
609014|NCT00610233|urodynamics|urodynamics
609015|NCT00610246|Thorax|thorax
609016|NCT00610246|Abdomen|abdomen
609017|NCT00610246|Pelvis|pelvis
609021|NCT00610246|Chemotherapy|chemotherapy
609022|NCT00610246|Phase 1|phase 1
609023|NCT00610246|Advanced Cancer|advanced cancer
609024|NCT00610246|Sorafenib|sorafenib
609025|NCT00610246|Nexavar|nexavar
609026|NCT00610246|BAY43-9006|bay43-9006
609027|NCT00610259|Depressive disorder|depressive disorder
609028|NCT00610259|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
609029|NCT00610259|Behavior therapy|behavior therapy
609030|NCT00610272|single bone metastasis|single bone metastasis
609031|NCT00610272|multiple bone metastasis|multiple bone metastasis
609032|NCT00610272|pain relief|pain relief
609033|NCT00610272|radiotherapy|radiotherapy
609034|NCT00610298|disability affecting strength, balance and coordination|disability affecting strength, balance and coordination
609035|NCT00610311|Metastatic Melanoma|metastatic melanoma
609036|NCT00610311|Immunotherapy|immunotherapy
609037|NCT00610311|Vaccination|vaccination
609038|NCT00610311|Tumor Regression|tumor regression
609039|NCT00610311|Skin Cancer|skin cancer
609040|NCT00610324|oropharyngeal cleansing|oropharyngeal cleansing
609041|NCT00610324|oral decontamination|oral decontamination
609042|NCT00610324|oropharyngeal bacterial flora|oropharyngeal bacterial flora
609043|NCT00610324|oropharyngeal colonization|oropharyngeal colonization
609044|NCT00610324|critical illness|critical illness
609045|NCT00610324|mechanical ventilation|mechanical ventilation
609046|NCT00610324|tracheal intubation|tracheal intubation
609047|NCT00610324|prophylaxis|prophylaxis
609048|NCT00610350|Levosimendan|levosimendan
609049|NCT00610350|pre-conditioning|pre-conditioning
609050|NCT00610350|cardiac surgery|cardiac surgery
609051|NCT00610350|myocardial function|myocardial function
609052|NCT00610350|contractility|contractility
609053|NCT00610350|heart|heart
609054|NCT00610350|ischaemia|ischaemia
609055|NCT00610376|Handwashing|handwashing
609056|NCT00610376|Randomized controlled trial|randomized controlled trial
609057|NCT00610376|Cluster randomization|cluster randomization
609058|NCT00610376|Community intervention trial|community intervention trial
609059|NCT00610376|Disease prevention|disease prevention
609060|NCT00610376|Pediatric communicable disease|pediatric communicable disease
609061|NCT00610376|Preschool|preschool
609062|NCT00610376|Illness absenteeism|illness absenteeism
609063|NCT00610428|Migraine, Staccato Prochlorperazine|migraine, staccato prochlorperazine
609064|NCT00610428|Migraine headache with or without aura.|migraine headache with or without aura.
609065|NCT00610441|randomized|randomized
609066|NCT00610441|double blind|double blind
609067|NCT00610441|placebo controlled|placebo controlled
609068|NCT00610454|Levetiracetam|levetiracetam
609069|NCT00610454|Keppra|keppra
609070|NCT00610480|Dry Eyes|dry eyes
609071|NCT00610480|Tear Film Stability|tear film stability
609072|NCT00610493|Advanced Cancer|advanced cancer
609076|NCT00610493|Torisel|torisel
609077|NCT00610493|CCI-779|cci-779
609078|NCT00610493|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
609079|NCT00610493|rhuMAb-VEGF|rhumab-vegf
609080|NCT00610493|dynamic contrast-enhanced magnetic resonance imaging|dynamic contrast-enhanced magnetic resonance imaging
609081|NCT00610493|DCE|dce
609082|NCT00610493|magnetic resonance imaging|magnetic resonance imaging
609083|NCT00610493|MRI|mri
609084|NCT00610506|Atypical Depression|atypical depression
609085|NCT00610519|Viral pharyngo-tonsillitis;|viral pharyngo-tonsillitis;
609086|NCT00610519|Herbal medicine;|herbal medicine;
609087|NCT00610519|Traditional medicine;|traditional medicine;
609088|NCT00610519|Aromatic essential oils;|aromatic essential oils;
609089|NCT00610532|pharmacoresistance|pharmacoresistance
609090|NCT00610532|healthy volunteers|healthy volunteers
609091|NCT00610545|ATORVASTATIN|atorvastatin
609092|NCT00610545|VASCULAR SURGERY|vascular surgery
609093|NCT00610545|CARDIOVASCULAR OUTCOMES|cardiovascular outcomes
609095|NCT00610571|Temozolomide|temozolomide
609096|NCT00610571|Topotecan|topotecan
609097|NCT00610571|Hycamtin|hycamtin
609098|NCT00610571|Malignant Gliomas|malignant gliomas
609099|NCT00610571|Brain tumor|brain tumor
609100|NCT00610571|Anaplastic astrocytoma|anaplastic astrocytoma
609101|NCT00610571|AA|aa
609102|NCT00610571|GBM|gbm
609103|NCT00610571|Glioblastoma Multiform|glioblastoma multiform
609104|NCT00610571|Gliosarcoma|gliosarcoma
609105|NCT00610584|seasonal allergic rhinitis|seasonal allergic rhinitis
609106|NCT00610584|acupuncture|acupuncture
609107|NCT00610584|RCT|rct
609108|NCT00610584|CAM|cam
609109|NCT00610597|liver|liver
609110|NCT00610597|alcohol|alcohol
609111|NCT00610597|lymphocyte|lymphocyte
609112|NCT00610610|Fibromyalgia|fibromyalgia
609113|NCT00610610|Paroxetine|paroxetine
609114|NCT00610623|Pseudomonas aeruginosa|pseudomonas aeruginosa
609115|NCT00610623|Pneumonia|pneumonia
609116|NCT00610623|Ventilator-Associated|ventilator-associated
609117|NCT00610623|Quorum Sensing|quorum sensing
609118|NCT00610636|FOLFOX-4|folfox-4
609119|NCT00610636|neoadjuvant chemotherapy|neoadjuvant chemotherapy
609120|NCT00610636|colorectal cancer|colorectal cancer
609121|NCT00610636|liver metastasis|liver metastasis
609122|NCT00610636|resectability|resectability
609123|NCT00610649|randomized|randomized
609124|NCT00610649|placebo controlled|placebo controlled
609125|NCT00610649|maximum tolerated dose|maximum tolerated dose
609126|NCT00610662|cervical cancer|cervical cancer
609127|NCT00610662|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
609128|NCT00610662|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
609129|NCT00610662|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
609130|NCT00610675|Fifty two weeks|fifty two weeks
609131|NCT00610675|Open label|open label
609132|NCT00610675|extension|extension
609133|NCT00610714|Cancer|cancer
609134|NCT00610714|Tumour|tumour
609135|NCT00610714|Ovarian Neoplasms|ovarian neoplasms
609136|NCT00610714|Ovarian Cancer|ovarian cancer
609137|NCT00610727|Migraine, Prochlorperazine aerosol|migraine, prochlorperazine aerosol
609138|NCT00610740|recurrent cervical cancer|recurrent cervical cancer
609139|NCT00610740|cervical cancer|cervical cancer
609140|NCT00610740|endometrial carcinoma|endometrial carcinoma
609141|NCT00610740|ovarian epithelial cancer|ovarian epithelial cancer
609142|NCT00610740|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
609143|NCT00610740|recurrent endometrial carcinoma|recurrent endometrial carcinoma
609144|NCT00610753|Anorexia nervosa|anorexia nervosa
609145|NCT00610753|Adolescents|adolescents
609146|NCT00610753|Family therapy|family therapy
609147|NCT00610766|coronary CT angiography|coronary ct angiography
609148|NCT00610766|radiation dose estimates|radiation dose estimates
609149|NCT00610779|Rhino-sinusitis;|rhino-sinusitis;
609150|NCT00610779|Herbal medicine;|herbal medicine;
609151|NCT00610779|Traditional medicine;|traditional medicine;
609152|NCT00610779|Aromatic essential oils;|aromatic essential oils;
609153|NCT00610805|SLE|sle
609154|NCT00610805|lupus|lupus
609155|NCT00610805|cardiovascular|cardiovascular
609156|NCT00610805|IMT|imt
609157|NCT00610805|Systemic Lupus Erythematosus|systemic lupus erythematosus
609158|NCT00610844|lung cancer|lung cancer
609159|NCT00610844|lung metastasis|lung metastasis
609160|NCT00610844|radiofrequency ablation|radiofrequency ablation
609161|NCT00610870|Myocardial infarct size|myocardial infarct size
609162|NCT00610870|Atorvastatin|atorvastatin
609163|NCT00610870|SPECT|spect
609164|NCT00610870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
609165|NCT00610909|IBS|ibs
609166|NCT00610922|Performance of motor skills|performance of motor skills
609167|NCT00610935|Influenza|influenza
609168|NCT00610935|Subjects with uncomplicated acute influenza|subjects with uncomplicated acute influenza
609169|NCT00610948|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
609170|NCT00610961|BK Polyomavirus|bk polyomavirus
609171|NCT00610961|Transplantation, Kidney|transplantation, kidney
609172|NCT00610961|Transplantation, Pancreas|transplantation, pancreas
609173|NCT00610974|Spinal cord injury|spinal cord injury
609174|NCT00610974|walking|walking
609175|NCT00610974|gait training|gait training
609176|NCT00610974|body-weight supported treadmill training|body-weight supported treadmill training
609177|NCT00610974|rehabilitation|rehabilitation
609178|NCT00610987|Antibiotic Prophylaxis|antibiotic prophylaxis
609179|NCT00611000|colon cancer|colon cancer
609180|NCT00611000|rectal cancer|rectal cancer
609181|NCT00611013|Development of multi-purpose novel imaging protocols|development of multi-purpose novel imaging protocols
609182|NCT00611026|Treatment of overactive bladder|treatment of overactive bladder
609183|NCT00611039|Darunavir/ritonavir|darunavir/ritonavir
609184|NCT00611039|virtual inhibitory quotient|virtual inhibitory quotient
609185|NCT00611039|dose reduction|dose reduction
609186|NCT00611052|Depressive Disorder|depressive disorder
609187|NCT00611052|Depressive Disorder, Major|depressive disorder, major
609188|NCT00611052|Mental Health|mental health
609189|NCT00611052|Prevention|prevention
609190|NCT00611078|Soft Tissue Sarcoma|soft tissue sarcoma
609191|NCT00611078|environment|environment
609192|NCT00611078|pollutants|pollutants
609194|NCT00611104|breast cancer|breast cancer
609195|NCT00611117|adaptation to high fat diet|adaptation to high fat diet
609196|NCT00611117|activity|activity
609197|NCT00611117|exercise|exercise
609198|NCT00611130|Cocaine|cocaine
609199|NCT00611130|Addiction|addiction
609200|NCT00611130|Dependence|dependence
609201|NCT00611130|Treatment|treatment
609202|NCT00611143|Off-pump coronary artery bypass graft|off-pump coronary artery bypass graft
609203|NCT00611143|Atorvastatin|atorvastatin
609204|NCT00611143|Postoperative atrial fibrillation|postoperative atrial fibrillation
609205|NCT00611156|Thermogenesis|thermogenesis
609206|NCT00611156|Meal-induced thermogenesis|meal-induced thermogenesis
609207|NCT00611156|energy expenditure|energy expenditure
609208|NCT00611156|fat oxidation|fat oxidation
609209|NCT00611156|bioactive ingredients|bioactive ingredients
609210|NCT00611156|spices|spices
609211|NCT00611156|ginger|ginger
609212|NCT00611156|horseradish|horseradish
609213|NCT00611156|black pepper|black pepper
609214|NCT00611156|mustard|mustard
609215|NCT00611169|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
609216|NCT00611169|tirofiban|tirofiban
609217|NCT00611169|Magnetic Resonance Imaging|magnetic resonance imaging
609218|NCT00611169|Myocardial Infarction|myocardial infarction
609219|NCT00611182|dyspnea|dyspnea
609220|NCT00611182|pulmonary fibrosis|pulmonary fibrosis
609221|NCT00611182|interstitial lung disease|interstitial lung disease
609222|NCT00611182|shortness of breath|shortness of breath
609223|NCT00611195|Anesthesia|anesthesia
609224|NCT00611195|Children|children
609225|NCT00611195|Larynx|larynx
609226|NCT00611221|massage|massage
609227|NCT00611221|labour|labour
609228|NCT00611260|Meditation|meditation
609229|NCT00611260|Congestive Heart Failure|congestive heart failure
609230|NCT00611260|ICD|icd
609231|NCT00611260|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
609232|NCT00611273|Glabellar Furrowing|glabellar furrowing
609233|NCT00618917|NSCLC|nsclc
609234|NCT00618917|lung cancer|lung cancer
609235|NCT00618917|chemotherapy|chemotherapy
609236|NCT00618917|radiation therapy|radiation therapy
609237|NCT00618917|radiation toxicity|radiation toxicity
609238|NCT00618956|NSRI|nsri
609239|NCT00618956|milnacipran|milnacipran
609240|NCT00618956|fibromyalgia|fibromyalgia
609241|NCT00618956|blood pressure|blood pressure
609242|NCT00618956|hypertension|hypertension
609243|NCT00618969|Haploidentical|haploidentical
609244|NCT00618969|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
609245|NCT00618969|leukemia|leukemia
609246|NCT00618969|myeloma|myeloma
609247|NCT00618969|Hodgkin's disease|hodgkin's disease
609248|NCT00618969|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
609249|NCT00618982|Kidney cancer,|kidney cancer,
609250|NCT00618982|Sorafenib,|sorafenib,
609251|NCT00618982|Dose escalation,|dose escalation,
609252|NCT00618982|No previous treatment|no previous treatment
609253|NCT00619008|obesity|obesity
609254|NCT00619008|low carbohydrate diet|low carbohydrate diet
609255|NCT00619008|high complex carbohydrate diet|high complex carbohydrate diet
609256|NCT00619008|weight regulation hormones|weight regulation hormones
609257|NCT00619008|hunger|hunger
609258|NCT00619008|satiety|satiety
609259|NCT00619008|energy expenditure|energy expenditure
609260|NCT00619008|body composition|body composition
609261|NCT00619008|weight loss|weight loss
609262|NCT00619021|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
609263|NCT00619021|stage I non-small cell lung cancer|stage i non-small cell lung cancer
609264|NCT00619021|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
609265|NCT00619060|skin cancer|skin cancer
609266|NCT00619060|healthy, no evidence of disease|healthy, no evidence of disease
609267|NCT00619073|blood platelets|blood platelets
609268|NCT00619073|platelet aggregation inhibitors|platelet aggregation inhibitors
609269|NCT00619073|antiplatelet drugs|antiplatelet drugs
609270|NCT00619073|clopidogrel|clopidogrel
609271|NCT00619086|thyroidectomy|thyroidectomy
609272|NCT00619086|dexamethasone|dexamethasone
609273|NCT00619086|steroid|steroid
609274|NCT00619086|nausea|nausea
609275|NCT00619099|Myelodysplastic Syndrome|myelodysplastic syndrome
609276|NCT00619099|Decitabine|decitabine
609277|NCT00619099|Dacogen|dacogen
609278|NCT00619099|MGI PHARMA, Inc.|mgi pharma, inc.
609279|NCT00619112|adult glioblastoma|adult glioblastoma
609280|NCT00619112|adult gliosarcoma|adult gliosarcoma
609281|NCT00619112|adult anaplastic astrocytoma|adult anaplastic astrocytoma
609282|NCT00619112|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
611513|NCT00619437|family|family
609283|NCT00619112|adult mixed glioma|adult mixed glioma
609284|NCT00619112|recurrent adult brain tumor|recurrent adult brain tumor
609285|NCT00619138|Cognitive therapy|cognitive therapy
609286|NCT00619138|Stepped care|stepped care
609287|NCT00619138|Self-help|self-help
609288|NCT00619138|Internet|internet
609289|NCT00619138|Anxiety|anxiety
609290|NCT00619151|aortic valve|aortic valve
609291|NCT00619151|heart valve|heart valve
609292|NCT00619151|valve replacement|valve replacement
609293|NCT00619151|Valve disease|valve disease
609294|NCT00619164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
609295|NCT00619164|Coronary Stenosis|coronary stenosis
609296|NCT00619164|Coronary Thrombosis|coronary thrombosis
609297|NCT00619190|open label|open label
609298|NCT00619190|aripiprazole|aripiprazole
609299|NCT00619190|children|children
609300|NCT00619190|adolescents|adolescents
609301|NCT00619190|autism spectrum disorders|autism spectrum disorders
609302|NCT00619203|Bacterial meningitis|bacterial meningitis
609303|NCT00619203|glycerol|glycerol
609304|NCT00619203|high dose paracetamol|high dose paracetamol
609305|NCT00619203|children|children
609306|NCT00619216|Orthotopic Liver Transplant Recipients with GI disturbance|orthotopic liver transplant recipients with gi disturbance
609307|NCT00619229|Alprostadil|alprostadil
609308|NCT00619229|prostaglandin E1|prostaglandin e1
609309|NCT00619229|Prostavasin®|prostavasin®
609310|NCT00619229|macular degeneration|macular degeneration
609311|NCT00619242|Esophageal cancer|esophageal cancer
609312|NCT00619736|Healthy|healthy
609313|NCT00619762|Breast reconstruction|breast reconstruction
609314|NCT00619775|Carotid Artery Disease|carotid artery disease
609315|NCT00619775|Embolic Protection|embolic protection
609316|NCT00619801|Xyzal|xyzal
609317|NCT00619801|Levocetirizine|levocetirizine
609318|NCT00619801|Allergy|allergy
609319|NCT00619801|Children|children
609320|NCT00619801|Seasonal Allergies|seasonal allergies
609321|NCT00619814|Colon polyps|colon polyps
609322|NCT00619814|Fecal occult blood test|fecal occult blood test
609323|NCT00619814|Double contrast barium enema|double contrast barium enema
609324|NCT00619814|Colonoscopy|colonoscopy
609325|NCT00619827|Sublingual immunotherapy|sublingual immunotherapy
609326|NCT00619827|Rhinitis|rhinitis
609327|NCT00619827|Conjunctivitis|conjunctivitis
609328|NCT00619827|Allergen challenge|allergen challenge
609329|NCT00619827|Allergen exposition chamber|allergen exposition chamber
609330|NCT00619827|Grass pollen tablet|grass pollen tablet
609331|NCT00619827|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
609332|NCT00619840|ADHD|adhd
609333|NCT00619840|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
609334|NCT00619840|adult|adult
609335|NCT00619840|methylphenidate hydrochloride|methylphenidate hydrochloride
609336|NCT00619840|Medikinet retard|medikinet retard
609337|NCT00619840|long-term observation|long-term observation
609338|NCT00619840|controlled clinical trial|controlled clinical trial
609339|NCT00619840|safety|safety
609340|NCT00619840|randomized, double-blind, placebo-controlled trial|randomized, double-blind, placebo-controlled trial
609341|NCT00619840|treatment|treatment
609342|NCT00619840|central nervous system stimulants|central nervous system stimulants
609343|NCT00619840|therapeutic uses|therapeutic uses
609344|NCT00619853|Improving the assisting hand function in children with Hemiplegic Cerebral palsy|improving the assisting hand function in children with hemiplegic cerebral palsy
609345|NCT00619866|bone mineral density|bone mineral density
609346|NCT00619866|NBI-56418|nbi-56418
609347|NCT00619866|estradiol|estradiol
609348|NCT00619866|Endometriosis|endometriosis
609349|NCT00619866|Pelvic Pain|pelvic pain
609350|NCT00619879|Leukemia, Myelogenous, Chronic|leukemia, myelogenous, chronic
609351|NCT00619879|Leukemia, Lymphoblastic, Acute|leukemia, lymphoblastic, acute
609352|NCT00619879|Leukemia, Myelogenous, Acute|leukemia, myelogenous, acute
609353|NCT00619879|Myeloproliferative-Myelodysplastic Diseases|myeloproliferative-myelodysplastic diseases
609354|NCT00619879|Juvenile Myelomonocytic Leukemia|juvenile myelomonocytic leukemia
609355|NCT00619879|Dysmyelopoietic Syndromes|dysmyelopoietic syndromes
609356|NCT00619879|Lymphoma, Malignant|lymphoma, malignant
609357|NCT00619879|Stem Cell Transplantation, Hematopoietic|stem cell transplantation, hematopoietic
609358|NCT00619879|Allogeneic Transplantation|allogeneic transplantation
609359|NCT00619879|Human Leukocyte Antigens|human leukocyte antigens
609360|NCT00619879|Busulfan|busulfan
609361|NCT00619879|Total Body Irradiation|total body irradiation
609362|NCT00619879|VP-16|vp-16
609363|NCT00619879|Etoposide|etoposide
609364|NCT00619879|Cyclophosphamide|cyclophosphamide
609365|NCT00619879|Graft-Versus-Host Disease|graft-versus-host disease
609366|NCT00619892|SSRI Resistant|ssri resistant
609367|NCT00619892|Seroquel SR|seroquel sr
609368|NCT00619892|Seroquel XR|seroquel xr
609369|NCT00619892|Panic Disorder|panic disorder
609370|NCT00619892|Comorbid Panic Disorder|comorbid panic disorder
609371|NCT00619892|Quetiapine SR|quetiapine sr
609372|NCT00619892|Quetiapine XR|quetiapine xr
609373|NCT00619905|Rheumatoid Arthritis|rheumatoid arthritis
609374|NCT00619905|Anti-interleukin-1 beta|anti-interleukin-1 beta
611634|NCT00619671|Rituxan|rituxan
609375|NCT00619905|ACZ885|acz885
609376|NCT00619918|bronchiolitis|bronchiolitis
609377|NCT00619918|hypertonic saline|hypertonic saline
609378|NCT00619931|Healthy adult volunteers|healthy adult volunteers
609380|NCT00619944|lumefantrine|lumefantrine
609381|NCT00619944|lopinavir|lopinavir
609382|NCT00619944|Africa|africa
609383|NCT00619944|Antimalarials|antimalarials
609384|NCT00619944|treatment naïve|treatment naïve
609385|NCT00619983|Asymmetric Diabetic Proximal Motor Neuropathy|asymmetric diabetic proximal motor neuropathy
609386|NCT00619983|Diabetic Autonomic Neuropathy|diabetic autonomic neuropathy
609387|NCT00619983|Diabetic Neuralgia|diabetic neuralgia
609388|NCT00619983|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
609389|NCT00619983|Neuralgia, Diabetic|neuralgia, diabetic
609390|NCT00619983|Low back pain, chronic|low back pain, chronic
609391|NCT00619996|Prostate Cancer|prostate cancer
609392|NCT00619996|Sorafenib|sorafenib
609393|NCT00619996|Nexavar|nexavar
609394|NCT00619996|Docetaxel|docetaxel
609395|NCT00619996|Pisa|pisa
609396|NCT00619996|Ricci|ricci
609397|NCT00620009|Empathy|empathy
609398|NCT00620009|Feedback|feedback
609399|NCT00620009|Psychotherapy|psychotherapy
609400|NCT00620022|indacaterol|indacaterol
609401|NCT00620022|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
609402|NCT00620022|exercise endurance|exercise endurance
752346|NCT01172587|Alcohol Use|alcohol use
609403|NCT00620022|moderate to severe chronic obstructive pulmonary disease|moderate to severe chronic obstructive pulmonary disease
609404|NCT00620022|COPD|copd
609405|NCT00620048|heart|heart
609406|NCT00620048|stem Cells|stem cells
609407|NCT00620048|low EF|low ef
609408|NCT00620048|heart attack|heart attack
609409|NCT00620048|cardiomyopathy|cardiomyopathy
609410|NCT00620048|congestive heart failure|congestive heart failure
609411|NCT00620048|cardiovascular disease|cardiovascular disease
609412|NCT00620048|Heart Failure|heart failure
609413|NCT00620048|Low Ejection Fraction|low ejection fraction
609414|NCT00620074|invasive aspergillosis, opportunistic mold infection|invasive aspergillosis, opportunistic mold infection
609415|NCT00620087|Atypical lobular hyperplasia|atypical lobular hyperplasia
609416|NCT00620087|Atypical ductal hyperplasia|atypical ductal hyperplasia
609417|NCT00620087|Lobular carcinoma in situ|lobular carcinoma in situ
609418|NCT00620087|Molecular Breast Imaging|molecular breast imaging
609419|NCT00620126|Inflammatory bowel disease|inflammatory bowel disease
609420|NCT00620126|Ulcerative colitis|ulcerative colitis
609421|NCT00620126|Telemedicine|telemedicine
609422|NCT00620126|Telemanagement|telemanagement
609423|NCT00620126|Chronic disease|chronic disease
609527|NCT00620529|liver fat|liver fat
609424|NCT00620139|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
609425|NCT00620139|chemoradiotherapy|chemoradiotherapy
609426|NCT00620139|molecular effects|molecular effects
609427|NCT00620139|05-016|05-016
609428|NCT00620165|tremor|tremor
609429|NCT00620165|writing|writing
609430|NCT00620165|feeding|feeding
609431|NCT00620165|pouring|pouring
609432|NCT00620178|candesartan|candesartan
609433|NCT00620178|losartan|losartan
609434|NCT00620178|blood pressure|blood pressure
609435|NCT00620178|cardiovascular disease|cardiovascular disease
609436|NCT00620178|health care consumption|health care consumption
609437|NCT00620191|metformin|metformin
609438|NCT00620191|mild cognitive impairment|mild cognitive impairment
609439|NCT00620191|alzheimer's disease|alzheimer's disease
609440|NCT00620191|overweight|overweight
609441|NCT00620191|insulin|insulin
609442|NCT00620204|atorvastatin|atorvastatin
609443|NCT00620204|Angina Pectoris, Variant|angina pectoris, variant
609444|NCT00620204|endothelial dysfunction|endothelial dysfunction
609445|NCT00620217|heart ischemia|heart ischemia
609446|NCT00620217|coronary artery disease|coronary artery disease
609447|NCT00620217|plasmid|plasmid
609448|NCT00620217|VEGF|vegf
609450|NCT00620217|percutaneous|percutaneous
609451|NCT00620217|gene therapy|gene therapy
609452|NCT00620217|SPECT|spect
609453|NCT00620217|nuclear magnetic resonance|nuclear magnetic resonance
609454|NCT00620230|Allergic rhinitis, anti-interleukin 4|allergic rhinitis, anti-interleukin 4
609455|NCT00620243|Ovarian cancer|ovarian cancer
609456|NCT00620243|PET|pet
609457|NCT00620243|CT|ct
609458|NCT00620243|04-064|04-064
609459|NCT00620256|Glaucoma|glaucoma
609460|NCT00620256|Hypertension|hypertension
609461|NCT00620269|NSCLC|nsclc
609462|NCT00620269|EGFR mutation|egfr mutation
609463|NCT00620269|Erlotinib|erlotinib
609464|NCT00620269|IP chemotherapy|ip chemotherapy
609465|NCT00620269|CCRT|ccrt
609466|NCT00620295|recurrent pancreatic cancer|recurrent pancreatic cancer
610574|NCT00616135|Lumpectomy|lumpectomy
609467|NCT00620295|recurrent breast cancer|recurrent breast cancer
609468|NCT00620295|recurrent small cell lung cancer|recurrent small cell lung cancer
609469|NCT00620295|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
609470|NCT00620295|recurrent colon cancer|recurrent colon cancer
609471|NCT00620295|recurrent prostate cancer|recurrent prostate cancer
609472|NCT00620295|recurrent head and neck cancer|recurrent head and neck cancer
609473|NCT00620295|ovarian cancer|ovarian cancer
609474|NCT00620295|recurrent uterine cancer|recurrent uterine cancer
609475|NCT00620295|recurrent kidney cancer|recurrent kidney cancer
609476|NCT00620295|recurrent osteosarcoma|recurrent osteosarcoma
609477|NCT00620334|ASTHMA|asthma
609478|NCT00620347|SCLC (small cell lung cancer)|sclc (small cell lung cancer)
609479|NCT00620347|ED (extensive disease)|ed (extensive disease)
609480|NCT00620347|RR (response rate)|rr (response rate)
609481|NCT00620360|dietary fructose|dietary fructose
609482|NCT00620360|plasma lipids|plasma lipids
609483|NCT00620360|healthy humans|healthy humans
609484|NCT00620360|gender differences|gender differences
609485|NCT00620360|hepatic de novo lipogenesis|hepatic de novo lipogenesis
609486|NCT00620373|Dense breast tissue|dense breast tissue
609487|NCT00620373|Breast Cancer Screening|breast cancer screening
609488|NCT00620373|Molecular Breast Imaging|molecular breast imaging
609489|NCT00620373|Breast Cancer|breast cancer
609490|NCT00620373|Breast|breast
609491|NCT00620386|Intubating conditions|intubating conditions
609492|NCT00620386|Bonfils intubation fiberscope|bonfils intubation fiberscope
609493|NCT00620386|Macintosh laryngoscope|macintosh laryngoscope
609494|NCT00620386|neuromuscular blockade|neuromuscular blockade
609495|NCT00620399|lumbar fusion|lumbar fusion
609496|NCT00620412|influenza|influenza
609497|NCT00620412|vaccines|vaccines
609498|NCT00620412|probiotics|probiotics
609499|NCT00620412|LGG|lgg
609500|NCT00620425|sumatriptan|sumatriptan
609501|NCT00620425|Intraject|intraject
609502|NCT00620425|Local Site Reactions|local site reactions
609503|NCT00620438|Lumefantrine|lumefantrine
609504|NCT00620438|Efavirenz|efavirenz
609505|NCT00620438|Nevirapine|nevirapine
609506|NCT00620438|Rifampicin|rifampicin
609507|NCT00620438|HIV|hiv
609508|NCT00620451|Treatment|treatment
609509|NCT00620451|Active|active
609513|NCT00620490|Epidural analgesia|epidural analgesia
609514|NCT00620490|Contraindications|contraindications
609515|NCT00620490|Paravertebral nerve block analgesia|paravertebral nerve block analgesia
609516|NCT00620490|ropivacaine|ropivacaine
609517|NCT00620490|Visual analogical scale|visual analogical scale
609518|NCT00620490|Morphine|morphine
609519|NCT00620490|Side effects|side effects
609520|NCT00620490|Pain and thoracotomy|pain and thoracotomy
609521|NCT00620503|PK|pk
609522|NCT00620503|Pharmacokinetics|pharmacokinetics
609523|NCT00620529|polycystic ovary syndrome|polycystic ovary syndrome
609524|NCT00620529|cardiovascular risk|cardiovascular risk
609525|NCT00620529|metabolism|metabolism
609526|NCT00620529|blood pressure|blood pressure
609528|NCT00620529|heart rate variability|heart rate variability
609529|NCT00620542|Coronary artery disease|coronary artery disease
609530|NCT00620568|Safety|safety
609531|NCT00620568|Tolerability|tolerability
609532|NCT00620568|Schizophrenia|schizophrenia
609533|NCT00620594|Neoplasms|neoplasms
609534|NCT00620594|breast neoplasms|breast neoplasms
609535|NCT00620594|breast diseases|breast diseases
609536|NCT00620594|solid tumors|solid tumors
609537|NCT00620594|BEZ235|bez235
609538|NCT00620594|breast cancer|breast cancer
609539|NCT00620594|PI3K Inhibitor|pi3k inhibitor
609540|NCT00620594|Phosphatidylinositol 3|phosphatidylinositol 3
609541|NCT00620594|kinase|kinase
609542|NCT00620594|advanced|advanced
609543|NCT00620607|gastric|gastric
609544|NCT00620620|Healthy adult volunteers|healthy adult volunteers
609545|NCT00620633|Bone Marrow|bone marrow
609546|NCT00620646|clopidogrel|clopidogrel
609547|NCT00620646|platelets|platelets
609548|NCT00620646|percutaneous coronary intervention|percutaneous coronary intervention
609549|NCT00620672|n-3 supplementation during pregnancy|n-3 supplementation during pregnancy
609550|NCT00620672|DHA and pregnancy, infant development|dha and pregnancy, infant development
609551|NCT00620672|n-3 status and gestation|n-3 status and gestation
609552|NCT00620672|DHA and visual acuity and cognition during infancy|dha and visual acuity and cognition during infancy
609553|NCT00620685|Arthritis, rheumatoid|arthritis, rheumatoid
609554|NCT00620698|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
609555|NCT00620698|motor neuron disease|motor neuron disease
609556|NCT00620698|outcome measure|outcome measure
609557|NCT00620698|biomarker|biomarker
609558|NCT00620698|impedance|impedance
609559|NCT00620711|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
609560|NCT00620711|HIE|hie
609561|NCT00620711|Neonatal encephalopathy|neonatal encephalopathy
609562|NCT00620711|Cooling|cooling
609563|NCT00620711|hypothermia|hypothermia
609564|NCT00620750|Alcohol dependence|alcohol dependence
609565|NCT00620763|Meat protein|meat protein
609566|NCT00620763|acid load|acid load
609567|NCT00620763|calcium retention|calcium retention
609568|NCT00620763|postmenopausal women|postmenopausal women
609569|NCT00620776|Generalized Anxiety Disorder|generalized anxiety disorder
609570|NCT00620776|Cognitive Behavioral Therapy|cognitive behavioral therapy
609571|NCT00620776|Psychotherapy plus medication|psychotherapy plus medication
609572|NCT00620776|Combined treatment|combined treatment
609573|NCT00620789|Insomnia|insomnia
609574|NCT00620789|Depression|depression
609575|NCT00620802|Platelet function testing|platelet function testing
609576|NCT00620802|Healthy volunteers|healthy volunteers
609577|NCT00620815|avian flu|avian flu
609578|NCT00620815|seasonal influenza vaccine|seasonal influenza vaccine
609579|NCT00620815|influenza vaccine|influenza vaccine
609580|NCT00620815|prepandemic vaccine|prepandemic vaccine
609581|NCT00620815|virus strain with the potential to cause pandemic|virus strain with the potential to cause pandemic
609582|NCT00620815|tetravalent vaccine|tetravalent vaccine
609583|NCT00620815|Prophylaxis of influenza|prophylaxis of influenza
609584|NCT00620841|Tacrolimus|tacrolimus
609585|NCT00620841|Renal Transplantation|renal transplantation
609586|NCT00620841|genetic polymorphisms|genetic polymorphisms
609587|NCT00620841|Drug drug interactions|drug drug interactions
609588|NCT00620893|Dry eye signs and symptoms|dry eye signs and symptoms
609589|NCT00620893|refractive regression|refractive regression
609590|NCT00620906|manipulation|manipulation
609591|NCT00620906|manual therapy|manual therapy
609592|NCT00620906|Sacroiliac joint|sacroiliac joint
609593|NCT00620906|effects on manipulation on sacroiliac joint|effects on manipulation on sacroiliac joint
609594|NCT00620945|Congenital heart surgery|congenital heart surgery
609595|NCT00620945|Cardiopulmonary bypass|cardiopulmonary bypass
609596|NCT00620945|Phenoxybenzamine|phenoxybenzamine
609597|NCT00620958|Mediation|mediation
609598|NCT00620958|Outcome|outcome
609599|NCT00620958|CBT|cbt
609600|NCT00620958|Child Anxiety Intervention|child anxiety intervention
610732|NCT00623506|TBI|tbi
609601|NCT00620971|Non Small Cell Lung Cancer|non small cell lung cancer
609602|NCT00620971|Cisplatin|cisplatin
609603|NCT00620971|VInorelbine|vinorelbine
609604|NCT00620971|Docetaxel|docetaxel
609605|NCT00620971|Gemcitabine|gemcitabine
609606|NCT00620971|Bevacizumab|bevacizumab
609607|NCT00620984|Staphylococcus aureus|staphylococcus aureus
609608|NCT00620984|Breastfeeding|breastfeeding
609609|NCT00620984|Lactational Mastitis|lactational mastitis
609693|NCT00621192|safety|safety
609610|NCT00620984|Polymerase Chain Reaction (PCR) amplification analysis|polymerase chain reaction (pcr) amplification analysis
609611|NCT00620984|staphylococcal infections|staphylococcal infections
609612|NCT00620984|staphylococcal Carrier State|staphylococcal carrier state
609613|NCT00620997|cornea|cornea
609614|NCT00620997|analgesia|analgesia
609615|NCT00620997|topical|topical
609616|NCT00620997|anesthetic|anesthetic
609617|NCT00621023|Myelodysplastic syndrome|myelodysplastic syndrome
609618|NCT00621023|MDS|mds
609619|NCT00621036|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
609620|NCT00621036|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
609621|NCT00621036|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
609622|NCT00621036|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
609623|NCT00621036|anaplastic large cell lymphoma|anaplastic large cell lymphoma
609624|NCT00621036|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
609625|NCT00621036|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
609626|NCT00621036|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
609627|NCT00621036|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
609628|NCT00621036|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
609629|NCT00621036|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
609630|NCT00621036|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
609631|NCT00621036|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
609632|NCT00621036|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
609633|NCT00621036|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
609634|NCT00621036|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
609635|NCT00621036|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
609636|NCT00621036|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
609637|NCT00621036|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
609638|NCT00621036|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
609639|NCT00621036|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
609640|NCT00621036|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
609641|NCT00621036|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
609642|NCT00621036|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
609643|NCT00621036|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
609644|NCT00621036|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
609645|NCT00621036|intraocular lymphoma|intraocular lymphoma
609646|NCT00621036|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
609747|NCT00621413|seed brachytherapy|seed brachytherapy
609647|NCT00621036|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
609648|NCT00621036|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
609649|NCT00621036|small intestine lymphoma|small intestine lymphoma
609650|NCT00621036|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
609651|NCT00621049|Non-Small Cell Lung Cancer|non-small cell lung cancer
609652|NCT00621049|Resected|resected
609653|NCT00621049|Carboplatin|carboplatin
609654|NCT00621049|Docetaxel|docetaxel
609655|NCT00621049|Bevacizumab|bevacizumab
609656|NCT00621049|Erlotinib|erlotinib
609657|NCT00621062|varicose|varicose
609659|NCT00621062|ligation|ligation
609660|NCT00621062|laser|laser
609661|NCT00621062|foam|foam
609662|NCT00621062|sclerotherapy|sclerotherapy
609663|NCT00621062|radiofrequency|radiofrequency
609664|NCT00621062|duplex|duplex
609665|NCT00621062|sf36|sf36
609666|NCT00621062|Aberdeen|aberdeen
609667|NCT00621062|VCSS|vcss
609668|NCT00621062|quality|quality
609669|NCT00621062|recurrence|recurrence
609670|NCT00621075|PAH; V/Q SCAN;RHC;Echo;CT Scans; Angiography;PFTs|pah; v/q scan;rhc;echo;ct scans; angiography;pfts
609671|NCT00621101|pharmacokinetics|pharmacokinetics
609672|NCT00621101|drug interactions|drug interactions
609673|NCT00621101|ezetimibe|ezetimibe
609674|NCT00621101|sirolimus|sirolimus
609675|NCT00621101|human experimentation|human experimentation
609676|NCT00621114|Dialysis, Extracorporeal|dialysis, extracorporeal
609677|NCT00621114|Dialysis, Renal|dialysis, renal
609678|NCT00621114|Extracorporeal Dialysis|extracorporeal dialysis
609679|NCT00621114|Hemodialysis|hemodialysis
609680|NCT00621153|Candesartan Cilexetil|candesartan cilexetil
609681|NCT00621153|hydrochlorothiazide|hydrochlorothiazide
609682|NCT00621153|severe hypertension|severe hypertension
609683|NCT00621166|Generic lopinavir/ritonavir|generic lopinavir/ritonavir
609684|NCT00621166|Pharmacokinetics|pharmacokinetics
609685|NCT00621166|Pregnancy|pregnancy
609686|NCT00621166|Antiviral activity|antiviral activity
609687|NCT00621166|Safety|safety
609688|NCT00621179|Endometriosis,infertility,in vitro fertilization|endometriosis,infertility,in vitro fertilization
609689|NCT00621192|meropenem|meropenem
609690|NCT00621192|infants|infants
609691|NCT00621192|intra-abdominal infection|intra-abdominal infection
609692|NCT00621192|pharmacokinetics|pharmacokinetics
609694|NCT00621205|Insulin resistance, weight reduction, adipose tissue, peripheral|insulin resistance, weight reduction, adipose tissue, peripheral
609695|NCT00621205|mononuclear cells, gene expression profile, transcriptomics|mononuclear cells, gene expression profile, transcriptomics
609696|NCT00621218|tretinoin, efficacy, safety, rosacea|tretinoin, efficacy, safety, rosacea
609697|NCT00621231|Protein Function|protein function
609698|NCT00621231|normal versus high protein intake|normal versus high protein intake
609699|NCT00621244|HDAC inhibitor|hdac inhibitor
609700|NCT00621244|Oral|oral
609701|NCT00621244|LBH589|lbh589
609702|NCT00621244|Lymphoma|lymphoma
609703|NCT00621244|Leukemia|leukemia
609704|NCT00621244|Multiple myeloma|multiple myeloma
609705|NCT00621257|IBD|ibd
609706|NCT00621257|Inflammatory Bowel Disease|inflammatory bowel disease
609707|NCT00621257|Crohn's Disease|crohn's disease
609708|NCT00621257|Ulcerative Colitis|ulcerative colitis
609709|NCT00621257|Vitamin D|vitamin d
609710|NCT00621270|Major Depression Neurogenesis|major depression neurogenesis
609711|NCT00621270|Major Depressive Disorder with Concomitant Anxiety|major depressive disorder with concomitant anxiety
609712|NCT00621296|Chronic Hepatitis C|chronic hepatitis c
609713|NCT00621296|Protease Inhibitor|protease inhibitor
609714|NCT00621309|drug interactions|drug interactions
609715|NCT00621309|cytochrome P4503A4|cytochrome p4503a4
609716|NCT00621309|Pregnane X-receptor|pregnane x-receptor
609717|NCT00621309|induction|induction
609718|NCT00621309|drug metabolism|drug metabolism
609719|NCT00621322|Tuberculosis vaccine|tuberculosis vaccine
609720|NCT00621335|Open angle glaucoma|open angle glaucoma
609721|NCT00621335|Ocular hypertension|ocular hypertension
609722|NCT00621335|Parallel comparison|parallel comparison
609723|NCT00621335|Combigan|combigan
609724|NCT00621335|Cosopt|cosopt
609725|NCT00621348|maintenance fluids|maintenance fluids
609726|NCT00621348|hyponatremia|hyponatremia
609727|NCT00621348|vasopressin|vasopressin
609728|NCT00621348|children|children
609729|NCT00621361|Lung Cancer|lung cancer
609730|NCT00621361|AZD2171|azd2171
609731|NCT00621361|cediranib|cediranib
609732|NCT00621361|RECENTIN|recentin
609733|NCT00621361|etoposide|etoposide
609734|NCT00621361|cisplatin|cisplatin
609735|NCT00621374|Pain Management|pain management
609736|NCT00621374|Cognitive Behavior Therapy|cognitive behavior therapy
609737|NCT00621374|Hypnosis|hypnosis
609738|NCT00621387|reactive arthritis|reactive arthritis
609739|NCT00621387|antibiotics|antibiotics
609740|NCT00621400|newly-diagnosed light-chain (AL)-amyloidosis|newly-diagnosed light-chain (al)-amyloidosis
609741|NCT00621413|prostate|prostate
609742|NCT00621413|cancer|cancer
609743|NCT00621413|intermediate risk|intermediate risk
609744|NCT00621413|high risk|high risk
609745|NCT00621413|brachytherapy|brachytherapy
609746|NCT00621413|Cesium-131|cesium-131
609748|NCT00621413|intermediate and high risk cancer of the prostate|intermediate and high risk cancer of the prostate
609749|NCT00621426|T wave alternans (TWA)|t wave alternans (twa)
609750|NCT00621426|dialysis|dialysis
609751|NCT00621426|end stage renal disease|end stage renal disease
609752|NCT00621426|sudden cardiac death|sudden cardiac death
609753|NCT00621426|T-wave alternans|t-wave alternans
609754|NCT00621426|Cardiac electrical instability|cardiac electrical instability
609755|NCT00621426|Sympathetic and electrolyte-induced alterations|sympathetic and electrolyte-induced alterations
609756|NCT00621426|Ventricular repolarization|ventricular repolarization
609757|NCT00621439|ocular melanoma|ocular melanoma
609758|NCT00621465|Psychosis|psychosis
609759|NCT00621465|Homelessness|homelessness
609760|NCT00621465|Case Management|case management
609761|NCT00621465|Severe Mental Illness|severe mental illness
609762|NCT00621491|cardiac pacing|cardiac pacing
609763|NCT00621491|pacing complication|pacing complication
609764|NCT00621491|venous thrombosis|venous thrombosis
609765|NCT00621491|warfarin|warfarin
609766|NCT00621491|anticoagulation|anticoagulation
609767|NCT00621491|randomized trial|randomized trial
609768|NCT00621504|ceftaroline|ceftaroline
609769|NCT00621504|Community-acquired pneumonia|community-acquired pneumonia
609771|NCT00621504|IV (intravenous)|iv (intravenous)
609772|NCT00621504|Streptococcus pneumoniae|streptococcus pneumoniae
609773|NCT00621504|Haemophilus influenzae|haemophilus influenzae
609774|NCT00621504|Mycoplasma pneumoniae|mycoplasma pneumoniae
609775|NCT00621504|Chlamydophila spp|chlamydophila spp
609776|NCT00621504|Legionella spp|legionella spp
609777|NCT00621504|Multi-drug resistant Streptococcus pneumoniae (MDRSP)|multi-drug resistant streptococcus pneumoniae (mdrsp)
609778|NCT00621504|antimicrobial resistance|antimicrobial resistance
609779|NCT00621504|pneumococci|pneumococci
609780|NCT00621504|Ceftriaxone|ceftriaxone
609781|NCT00621504|bacteria|bacteria
609782|NCT00621504|ß-lactam|ß-lactam
609783|NCT00621504|beta-lactam|beta-lactam
609784|NCT00621504|antibiotic|antibiotic
609785|NCT00621517|Restless Legs Syndrome|restless legs syndrome
609786|NCT00621517|Bupropion|bupropion
609787|NCT00621530|Total hip arthroplasty|total hip arthroplasty
609788|NCT00621530|Total hip replacement|total hip replacement
609789|NCT00621530|Pain, postoperative|pain, postoperative
609790|NCT00621530|Ketorolac|ketorolac
609791|NCT00621530|Patients undergoing unilateral total hip arthroplasty|patients undergoing unilateral total hip arthroplasty
609792|NCT00621543|Intrauterine Device|intrauterine device
609793|NCT00621543|Induced Abortion|induced abortion
609794|NCT00621543|Medical Abortion|medical abortion
609795|NCT00621569|Blood Pressure|blood pressure
609796|NCT00621569|Dash Diet|dash diet
609797|NCT00621595|School Breakfast|school breakfast
609798|NCT00621595|Diet|diet
609799|NCT00621595|Nutrition|nutrition
609800|NCT00621595|Brain Function|brain function
609801|NCT00621595|Cognition|cognition
609802|NCT00621595|USDA|usda
609803|NCT00621595|Healthy Children|healthy children
609804|NCT00621608|Chronic ulcers|chronic ulcers
609805|NCT00621608|Diabetes|diabetes
609806|NCT00621608|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
609807|NCT00621621|atrioventricular nodal reentrant tachycardia|atrioventricular nodal reentrant tachycardia
609808|NCT00621621|AVNRT|avnrt
609809|NCT00621634|Tardive dyskinesia|tardive dyskinesia
609810|NCT00621634|Schizophrenia|schizophrenia
609811|NCT00621634|Essential fatty acids|essential fatty acids
609812|NCT00621647|Seroquel|seroquel
609813|NCT00621647|dementia|dementia
609814|NCT00621647|agitation symptoms|agitation symptoms
609815|NCT00621647|Alzheimer's disease|alzheimer's disease
609816|NCT00621647|vascular dementia|vascular dementia
609817|NCT00621647|quetiapine fumarate|quetiapine fumarate
609818|NCT00621660|Acupuncture therapy|acupuncture therapy
609819|NCT00621660|Cancer|cancer
609820|NCT00621660|Emesis|emesis
609821|NCT00621660|Expectations|expectations
609822|NCT00621660|Placebo|placebo
609823|NCT00621673|Hemophilia A,|hemophilia a,
609824|NCT00621673|Inhibitor formation,|inhibitor formation,
609825|NCT00621673|rFVIII|rfviii
609826|NCT00621686|adult glioblastoma|adult glioblastoma
609827|NCT00621686|adult giant cell glioblastoma|adult giant cell glioblastoma
609828|NCT00621686|adult gliosarcoma|adult gliosarcoma
609829|NCT00621686|recurrent adult brain tumor|recurrent adult brain tumor
609830|NCT00621699|pharmacokinetics|pharmacokinetics
609831|NCT00621699|drug interactions|drug interactions
609832|NCT00621699|ezetimibe|ezetimibe
609833|NCT00621699|tacrolimus|tacrolimus
609834|NCT00621699|human experimentation|human experimentation
609835|NCT00621712|Renal Dialysis|renal dialysis
609836|NCT00621712|Dialysis, Extracorporeal|dialysis, extracorporeal
609837|NCT00621712|Dialysis, Renal|dialysis, renal
609838|NCT00621712|Extracorporeal Dialysis|extracorporeal dialysis
609839|NCT00621725|Advanced cancer|advanced cancer
609840|NCT00621725|metastatic|metastatic
609841|NCT00621725|hepatic impairment|hepatic impairment
609842|NCT00621738|mental stress|mental stress
609843|NCT00621738|cardiovascular risk factor|cardiovascular risk factor
609844|NCT00621738|platelet adhesion|platelet adhesion
609845|NCT00621751|Brain Injury|brain injury
609846|NCT00621751|Irritability|irritability
609847|NCT00621751|Aggression|aggression
609848|NCT00621764|Japanese encephalitis (JE)|japanese encephalitis (je)
609849|NCT00621764|Hepatitis A|hepatitis a
609850|NCT00621764|Inactivated Mouse-Brain|inactivated mouse-brain
609851|NCT00621777|schizophrenia|schizophrenia
609852|NCT00621777|bipolar disorder|bipolar disorder
609853|NCT00621777|varenicline|varenicline
609854|NCT00621777|smoking cessation|smoking cessation
609855|NCT00621777|relapse prevention|relapse prevention
609856|NCT00621777|cognitive behavioral therapy|cognitive behavioral therapy
609857|NCT00621790|fenoldopam|fenoldopam
609858|NCT00621790|acute renal failure|acute renal failure
609859|NCT00621790|renal replacement therapy|renal replacement therapy
609860|NCT00621790|mortality|mortality
609861|NCT00621790|cardiac surgery|cardiac surgery
609862|NCT00621790|cardiac anesthesia|cardiac anesthesia
609863|NCT00621790|intensive care unit|intensive care unit
609864|NCT00621803|Probiotic|probiotic
609865|NCT00621803|Pseudomonas aeruginosa|pseudomonas aeruginosa
609866|NCT00621803|Gastric colonization|gastric colonization
609867|NCT00621803|Respiratory tract colonization|respiratory tract colonization
609868|NCT00621803|Ventilator aquired pneumoniae|ventilator aquired pneumoniae
609869|NCT00621803|determine the effect of oral administration of this probiotic on gastric and respiratory tract colonisation/infection by P. aeruginosa|determine the effect of oral administration of this probiotic on gastric and respiratory tract colonisation/infection by p. aeruginosa
609870|NCT00621816|nitroprusside|nitroprusside
609871|NCT00621816|intensive care unit|intensive care unit
609872|NCT00621816|hypertension|hypertension
609873|NCT00621816|blood pressure reduction|blood pressure reduction
609874|NCT00621842|Geriatric Psychiatry|geriatric psychiatry
609875|NCT00621842|Aged|aged
609876|NCT00621842|lamotrigine|lamotrigine
609877|NCT00621868|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
609878|NCT00621868|ASP1941|asp1941
609879|NCT00621881|hepatic impairment|hepatic impairment
609880|NCT00621894|Immune thrombocytopenic purpura|immune thrombocytopenic purpura
609881|NCT00621894|thrombopoietin mimetic|thrombopoietin mimetic
609882|NCT00621894|ITP|itp
609883|NCT00621907|randomized|randomized
609884|NCT00621907|analgesic|analgesic
609885|NCT00621907|caesarean scars|caesarean scars
609886|NCT00621907|locoregional anaesthesia|locoregional anaesthesia
610420|NCT00615524|Efficacy|efficacy
609887|NCT00621907|infiltration|infiltration
609888|NCT00621907|levobupivacaïne|levobupivacaïne
609889|NCT00621907|Chirocaïne|chirocaïne
609890|NCT00621907|caesarian|caesarian
609891|NCT00621907|unique administration|unique administration
609892|NCT00621907|post-caesarian analgesic|post-caesarian analgesic
609893|NCT00621946|Asthma|asthma
609894|NCT00621946|Depression|depression
609895|NCT00621946|Escitalopram|escitalopram
609896|NCT00621959|levocetirizine|levocetirizine
609897|NCT00621959|Xyzal|xyzal
609898|NCT00621959|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
609899|NCT00621959|total symptom score|total symptom score
609900|NCT00621959|quality of life|quality of life
609901|NCT00621972|acute renal failure|acute renal failure
609902|NCT00621972|arteriovenous fistula|arteriovenous fistula
609903|NCT00621972|KIM-1|kim-1
609904|NCT00621972|chronic kidney disease|chronic kidney disease
609905|NCT00621998|Risperidone|risperidone
609906|NCT00621998|Olanzapine|olanzapine
609907|NCT00621998|Tardive dyskinesia|tardive dyskinesia
609908|NCT00622024|Arrhythmia|arrhythmia
609909|NCT00622024|Depression|depression
609910|NCT00622024|Coronary Artery Disease|coronary artery disease
609911|NCT00622063|cancer, solid tumor|cancer, solid tumor
609912|NCT00622076|postoperative|postoperative
609913|NCT00622076|Catheterization|catheterization
609914|NCT00622076|colporrhaphy|colporrhaphy
609915|NCT00622076|cystocele|cystocele
609916|NCT00622076|cystitis|cystitis
609917|NCT00622089|diabetes|diabetes
609918|NCT00622089|type 2 diabetes|type 2 diabetes
609919|NCT00622089|cholesterol|cholesterol
609920|NCT00622102|warfarin|warfarin
609921|NCT00622102|adherence|adherence
609922|NCT00622102|Mechanical heart valves|mechanical heart valves
609923|NCT00622128|Behavioral Research|behavioral research
609924|NCT00622128|Dementia|dementia
609925|NCT00622128|Aggression|aggression
609926|NCT00622141|bioequivalence|bioequivalence
609927|NCT00622141|ritonavir boosted generic GPO saquinavir|ritonavir boosted generic gpo saquinavir
609928|NCT00622141|saftey|saftey
609929|NCT00622141|pharmacokinetics|pharmacokinetics
609930|NCT00622167|Plaque characteristics|plaque characteristics
609931|NCT00622167|DSCT|dsct
609932|NCT00622167|IVUS|ivus
609933|NCT00622180|Vitiligo|vitiligo
609934|NCT00622180|Light treatment for vitiligo|light treatment for vitiligo
609935|NCT00622180|Excilite|excilite
609936|NCT00622193|NSCLC|nsclc
609937|NCT00622206|Pharmacokinetics|pharmacokinetics
609938|NCT00622206|ritonavir|ritonavir
609939|NCT00622206|saquinavir|saquinavir
609940|NCT00622206|safety and toxicity|safety and toxicity
609941|NCT00622206|treatment experienced|treatment experienced
609942|NCT00622219|Alcohol abuse|alcohol abuse
609943|NCT00622219|Drug abuse|drug abuse
611266|NCT00625638|Caregiver|caregiver
609944|NCT00607802|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
609945|NCT00607802|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
609946|NCT00607815|PTSD|ptsd
609948|NCT00607815|Combat|combat
609949|NCT00607815|Treatment|treatment
609950|NCT00607815|CPT|cpt
609951|NCT00607815|PCT|pct
609952|NCT00607815|Cognitive|cognitive
609953|NCT00607828|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
609954|NCT00607828|advanced adult primary liver cancer|advanced adult primary liver cancer
609955|NCT00607828|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
609956|NCT00607828|recurrent adult primary liver cancer|recurrent adult primary liver cancer
609957|NCT00607854|Zevalin|zevalin
609958|NCT00607854|Reduced intensity conditioning|reduced intensity conditioning
609959|NCT00607854|Allogenic stem cell transplantation|allogenic stem cell transplantation
609960|NCT00607867|Diabetes Mellitus (type 2)|diabetes mellitus (type 2)
609961|NCT00607867|Diet|diet
609962|NCT00607867|Glycohemoglobin|glycohemoglobin
609963|NCT00607867|Lipids|lipids
609964|NCT00607867|Kidney Function|kidney function
609965|NCT00607867|Glycemic Index|glycemic index
609966|NCT00607867|Dietary Protein|dietary protein
609967|NCT00607867|Dietary Carbohydrate|dietary carbohydrate
609968|NCT00607880|vascular access device complications|vascular access device complications
609969|NCT00607880|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
609970|NCT00608348|exercise|exercise
609971|NCT00608348|hypoglycemia|hypoglycemia
609972|NCT00608348|sympathetic nerve activity|sympathetic nerve activity
609973|NCT00608374|Waldenström macroglobulinemia|waldenström macroglobulinemia
609974|NCT00608374|splenic marginal zone lymphoma|splenic marginal zone lymphoma
609975|NCT00608374|stage I marginal zone lymphoma|stage i marginal zone lymphoma
609976|NCT00608374|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
609977|NCT00608374|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
609978|NCT00608374|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
609979|NCT00608374|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
609980|NCT00608400|CLA|cla
609981|NCT00608400|PTH|pth
609982|NCT00608400|nutritional supplement|nutritional supplement
609983|NCT00608426|African Americans|african americans
609984|NCT00608426|telephone counseling|telephone counseling
609985|NCT00608426|community health planning|community health planning
609986|NCT00608426|ethnic groups|ethnic groups
609987|NCT00608439|CAST|cast
609988|NCT00608439|Centella asiatica|centella asiatica
609989|NCT00608439|Diabetes|diabetes
609990|NCT00608439|Diabetic neuropathy|diabetic neuropathy
609991|NCT00608452|Lung|lung
609992|NCT00608452|Ovarian|ovarian
609993|NCT00608452|Breast|breast
609994|NCT00608452|Hodgkin's|hodgkin's
609995|NCT00608465|Fibrolytic Dysfunction|fibrolytic dysfunction
609996|NCT00608465|Obesity|obesity
609997|NCT00608465|PAI-1|pai-1
610239|NCT00614601|vaccine therapy|vaccine therapy
609998|NCT00608491|Acute Decompensated Heart Failure|acute decompensated heart failure
609999|NCT00608491|Acute Decompensated Heart Failure With Cardiorenal Syndrome|acute decompensated heart failure with cardiorenal syndrome
610000|NCT00608491|Cardiorenal Syndrome|cardiorenal syndrome
610001|NCT00608491|Persistent Congestion|persistent congestion
610002|NCT00608491|Ultra Filtration|ultra filtration
610003|NCT00608504|Behavioral Economics|behavioral economics
610004|NCT00608504|Drug self administration|drug self administration
610005|NCT00608504|Opioid|opioid
610006|NCT00608517|graft versus host disease|graft versus host disease
610007|NCT00608517|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
610008|NCT00608517|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
610009|NCT00608517|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
610010|NCT00608517|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
610011|NCT00608517|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
610012|NCT00608517|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
610013|NCT00608517|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
610014|NCT00608517|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
610015|NCT00608517|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
610016|NCT00608517|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
610017|NCT00608517|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
610018|NCT00608517|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
610019|NCT00608517|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
610020|NCT00608517|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
610021|NCT00608517|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
610022|NCT00608517|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
610023|NCT00608517|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
610024|NCT00608517|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
610025|NCT00608517|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
610026|NCT00608517|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
610027|NCT00608517|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
610028|NCT00608517|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
610029|NCT00608517|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
610030|NCT00608517|noncontiguous stage II adult non-Hodgkin lymphoma|noncontiguous stage ii adult non-hodgkin lymphoma
610031|NCT00608517|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
610032|NCT00608517|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
610033|NCT00608517|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
610034|NCT00608517|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
610035|NCT00608517|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
610036|NCT00608517|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
610037|NCT00608517|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
610038|NCT00608517|secondary acute myeloid leukemia|secondary acute myeloid leukemia
610039|NCT00608517|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
610040|NCT00608517|splenic marginal zone lymphoma|splenic marginal zone lymphoma
610041|NCT00608517|stage I multiple myeloma|stage i multiple myeloma
610042|NCT00608517|stage II multiple myeloma|stage ii multiple myeloma
610043|NCT00608517|refractory multiple myeloma|refractory multiple myeloma
752347|NCT01172587|Effects on Youth|effects on youth
610044|NCT00608517|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
610045|NCT00608517|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
610046|NCT00608517|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
610047|NCT00608517|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
610048|NCT00608517|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
610049|NCT00608517|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
610050|NCT00608517|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
610051|NCT00608517|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
610052|NCT00608517|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
610053|NCT00608517|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
610054|NCT00608517|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
610055|NCT00608517|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
610056|NCT00608517|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
610057|NCT00608517|stage III multiple myeloma|stage iii multiple myeloma
610058|NCT00608517|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
610059|NCT00608517|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
610536|NCT00616005|Camptosar|camptosar
610060|NCT00608517|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
610061|NCT00608517|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
610062|NCT00608517|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
610063|NCT00608517|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
610064|NCT00608517|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
610065|NCT00608517|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
610066|NCT00608517|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
610067|NCT00608517|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
610068|NCT00608517|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
610069|NCT00608517|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
610070|NCT00608517|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
610071|NCT00608517|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
610072|NCT00608517|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
610073|NCT00608517|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
610074|NCT00608517|Philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia|philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia
610075|NCT00608517|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
610076|NCT00608517|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
610077|NCT00608517|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
610078|NCT00608517|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
610079|NCT00608517|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
610080|NCT00608517|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
610081|NCT00608517|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
610082|NCT00608517|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
610083|NCT00608517|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
751789|NCT01170455|direct laryngoscope|direct laryngoscope
610084|NCT00608517|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
610085|NCT00608530|pain|pain
610086|NCT00608530|chronic pain|chronic pain
610087|NCT00608530|chronic back pain|chronic back pain
610088|NCT00608530|randomized clinical trial|randomized clinical trial
610089|NCT00608543|cognitive function|cognitive function
610090|NCT00608543|psychosocial function|psychosocial function
610091|NCT00608543|augmentation|augmentation
610092|NCT00608543|treatment refractory depression|treatment refractory depression
610093|NCT00608556|Heterotaxy|heterotaxy
610094|NCT00608556|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
610095|NCT00608556|Congenital Heart Disease|congenital heart disease
610096|NCT00608556|Genetic Study|genetic study
610097|NCT00608556|Situs Inversus|situs inversus
610098|NCT00608569|Drug Therapy, Combination|drug therapy, combination
610099|NCT00608569|HIV Non-Nucleoside Reverse Transcriptase Inhibitors|hiv non-nucleoside reverse transcriptase inhibitors
610100|NCT00608569|HIV Protease Inhibitors|hiv protease inhibitors
610101|NCT00608569|Viral Load|viral load
610102|NCT00608569|Virologic Failure|virologic failure
610103|NCT00608582|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
610104|NCT00608582|TMS|tms
610105|NCT00608582|Treat Naming|treat naming
610106|NCT00608582|Aphasia|aphasia
610107|NCT00608582|Chronic Stroke|chronic stroke
610108|NCT00608582|Randomized, Controlled Trial|randomized, controlled trial
610109|NCT00608595|adenocarcinoma of the rectum|adenocarcinoma of the rectum
610110|NCT00608595|recurrent rectal cancer|recurrent rectal cancer
610111|NCT00608595|stage I rectal cancer|stage i rectal cancer
610112|NCT00608595|stage II rectal cancer|stage ii rectal cancer
610113|NCT00608595|stage III rectal cancer|stage iii rectal cancer
610114|NCT00608621|physostigmine|physostigmine
610115|NCT00608621|postoperative analgesia|postoperative analgesia
610116|NCT00608621|pain|pain
610117|NCT00608621|patient-controlled analgesia|patient-controlled analgesia
610118|NCT00608621|Opioid consumption|opioid consumption
610119|NCT00608621|Pain quality (VAS Score)|pain quality (vas score)
610120|NCT00608621|Hemodynamics|hemodynamics
610121|NCT00608621|Mobilisation|mobilisation
610122|NCT00608621|Side effects|side effects
610123|NCT00608634|actinic keratosis|actinic keratosis
610124|NCT00608660|Peripheral Facial Paralysis|peripheral facial paralysis
610125|NCT00608660|Acupuncture|acupuncture
610126|NCT00608660|RCT|rct
610127|NCT00608673|discoid lupus erythematosus|discoid lupus erythematosus
610128|NCT00608673|pimecrolimus 1% cream|pimecrolimus 1% cream
610129|NCT00608673|betamethasone valerate 0.1% cream|betamethasone valerate 0.1% cream
610130|NCT00608686|NIAAA|niaaa
610131|NCT00608686|Alcohol|alcohol
610132|NCT00608686|Neurosteroids|neurosteroids
610133|NCT00608686|Intoxication|intoxication
610134|NCT00608699|Flushing|flushing
610135|NCT00608699|GSK256073A,|gsk256073a,
610136|NCT00608699|Dose Escalation,|dose escalation,
610137|NCT00608699|Immediate Release Niacin,|immediate release niacin,
610138|NCT00608712|bariatric surgery|bariatric surgery
610139|NCT00608712|ulcer prevention|ulcer prevention
610936|NCT00624351|Lupus|lupus
610140|NCT00614159|Child age 1-10 years having a GI Endoscopy with sedation|child age 1-10 years having a gi endoscopy with sedation
610141|NCT00614172|Proton|proton
610142|NCT00614172|Radiation|radiation
610143|NCT00614172|Breast cancer|breast cancer
610144|NCT00614198|autism|autism
610145|NCT00614198|autism spectrum disorder|autism spectrum disorder
610146|NCT00614198|diet|diet
610147|NCT00614198|gluten|gluten
610148|NCT00614198|casein|casein
610149|NCT00614198|intervention|intervention
610150|NCT00614198|peptide|peptide
610151|NCT00614198|randomised|randomised
610152|NCT00614198|controlled|controlled
610153|NCT00614198|adaptive design|adaptive design
610154|NCT00614198|Autism Diagnostic Observation Schedule (ADOS)|autism diagnostic observation schedule (ados)
610155|NCT00614198|Gilliam Autism Rating Scale (GARS)|gilliam autism rating scale (gars)
610156|NCT00614198|Vineland Adaptive Behaviour Scale (VABS)|vineland adaptive behaviour scale (vabs)
610157|NCT00614198|Attention-Deficit Hyperactivity Disorder (ADHD)-IV Scale|attention-deficit hyperactivity disorder (adhd)-iv scale
610158|NCT00614211|Cervix|cervix
610159|NCT00614211|Cervical|cervical
610160|NCT00614211|Cancer|cancer
610161|NCT00614211|Carcinoma|carcinoma
610162|NCT00614211|Radical hysterectomy|radical hysterectomy
610163|NCT00614211|Hysterectomy|hysterectomy
610164|NCT00614211|Laparoscopy|laparoscopy
610165|NCT00614211|Laparoscopic|laparoscopic
610166|NCT00614211|Robotic|robotic
610167|NCT00614211|Squamous Cell|squamous cell
610168|NCT00614211|Adenosquamous|adenosquamous
610169|NCT00614211|Adenocarcinoma|adenocarcinoma
610170|NCT00614211|Lymphatic Mapping|lymphatic mapping
610171|NCT00614211|IOLM|iolm
610172|NCT00614211|SPECT|spect
610173|NCT00614211|Sentinel Node|sentinel node
610174|NCT00614211|Uterine cervix|uterine cervix
610175|NCT00614250|Obstructive sleep apnea|obstructive sleep apnea
610176|NCT00614263|Colonoscopy|colonoscopy
610177|NCT00614263|Sedation levels|sedation levels
610178|NCT00614276|Sexual Dysfunction|sexual dysfunction
610179|NCT00614276|Cancer-related Sexual Dysfunction|cancer-related sexual dysfunction
610180|NCT00614276|Female Cancer Survivors|female cancer survivors
610181|NCT00614276|Tendrils|tendrils
610182|NCT00614276|Website program|website program
610183|NCT00614276|Self-help tool|self-help tool
610184|NCT00614276|Sexual counseling|sexual counseling
610185|NCT00614276|Questionnaires|questionnaires
610186|NCT00614289|Mild to Moderate Hand Dermatitis|mild to moderate hand dermatitis
610187|NCT00614289|Hand Eczema|hand eczema
610188|NCT00614328|Alcohol|alcohol
610189|NCT00614328|Alcohol Abuse|alcohol abuse
610190|NCT00614328|Alcohol Drinking|alcohol drinking
610191|NCT00614341|diabetes mellitus|diabetes mellitus
610192|NCT00614341|neuropathy|neuropathy
610193|NCT00614341|distal symmetric polyneuropathy|distal symmetric polyneuropathy
610194|NCT00614341|pulsed electric fild|pulsed electric fild
610195|NCT00614354|99mTc-glucarate imaging to detect acute coronary syndrome|99mtc-glucarate imaging to detect acute coronary syndrome
610196|NCT00614367|chromosomal abnormalities in single cells|chromosomal abnormalities in single cells
610197|NCT00614406|Celebrex|celebrex
610198|NCT00614406|prostaglandin inhibitor|prostaglandin inhibitor
610199|NCT00614406|ovulation|ovulation
610200|NCT00614406|menstrual cycles|menstrual cycles
610201|NCT00614419|Hernioplasty|hernioplasty
610202|NCT00614419|polypropylene|polypropylene
610203|NCT00614419|extracellular matrix|extracellular matrix
610204|NCT00614419|xenograft|xenograft
610205|NCT00614432|anticoagulation|anticoagulation
610206|NCT00614432|surgical abortion|surgical abortion
610207|NCT00614445|Nausea|nausea
610208|NCT00614445|Vomiting|vomiting
610209|NCT00614445|Pregnancy|pregnancy
610210|NCT00614445|Hyperemesis gravidarum|hyperemesis gravidarum
610211|NCT00614445|Pregnancy complications|pregnancy complications
610212|NCT00614458|latent HIV|latent hiv
610213|NCT00614458|resting CD4+ T cell|resting cd4+ t cell
610214|NCT00614458|valproic acid (VPA)|valproic acid (vpa)
610215|NCT00614458|Raltegravir (MK-0518) intensification|raltegravir (mk-0518) intensification
610216|NCT00614458|HIV replication|hiv replication
610217|NCT00614458|treatment experienced|treatment experienced
610218|NCT00614484|Proton|proton
610219|NCT00614484|Radiation|radiation
610220|NCT00614523|MDS|mds
610221|NCT00614523|Low Risk MDS|low risk mds
610222|NCT00614523|Intermediate-1 Risk MDS|intermediate-1 risk mds
610223|NCT00614523|Thrombocytopenia|thrombocytopenia
610224|NCT00614536|Reflux Symptom Index|reflux symptom index
610225|NCT00614536|Reflux Finding Score|reflux finding score
610226|NCT00614536|Rabeprazole|rabeprazole
610227|NCT00614536|LaryngoPharyngeal Reflux Disease|laryngopharyngeal reflux disease
610228|NCT00614536|GastroEsophageal Reflux Disease|gastroesophageal reflux disease
610229|NCT00614549|Levetiracetam|levetiracetam
610230|NCT00614549|Keppra|keppra
610231|NCT00614549|Epilepsy|epilepsy
610232|NCT00614549|Efficacy|efficacy
610233|NCT00614549|Safety|safety
610234|NCT00614562|critical associated illness polyneuropathy or polymyopathy (CIP/M)|critical associated illness polyneuropathy or polymyopathy (cip/m)
610235|NCT00614588|temperature|temperature
610236|NCT00614588|monitor|monitor
610237|NCT00614588|surgery|surgery
610238|NCT00614601|pancreatic cancer|pancreatic cancer
610240|NCT00614614|Meningococcal disease|meningococcal disease
610241|NCT00614614|Toddlers|toddlers
610242|NCT00614614|Neisseria meningitidis|neisseria meningitidis
610243|NCT00614614|Meningococcal vaccines|meningococcal vaccines
610244|NCT00614614|Immunogenicity|immunogenicity
610245|NCT00614614|Human serum bactericidal assay|human serum bactericidal assay
610246|NCT00614614|Safety|safety
610247|NCT00614614|Vaccines, conjugate|vaccines, conjugate
610248|NCT00614614|Booster vaccination|booster vaccination
610249|NCT00614640|HAART|haart
610250|NCT00614640|Therapeutic vaccine|therapeutic vaccine
610251|NCT00614653|Pancreatic Cancer|pancreatic cancer
610252|NCT00614653|Bevacizumab|bevacizumab
610253|NCT00614653|Avastin™|avastin™
610254|NCT00614653|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
610255|NCT00614653|rhuMAb-VEGF|rhumab-vegf
610256|NCT00614653|Erlotinib|erlotinib
610257|NCT00614653|Erlotinib Hydrochloride|erlotinib hydrochloride
610258|NCT00614653|Tarceva|tarceva
610259|NCT00614653|OSI-774|osi-774
610260|NCT00614653|Capecitabine|capecitabine
610261|NCT00614653|Xeloda|xeloda
610262|NCT00614666|coccidioidomycosis|coccidioidomycosis
610263|NCT00614666|Valley Fever|valley fever
610264|NCT00614666|nikkomycin Z|nikkomycin z
610265|NCT00614679|biofilm|biofilm
610266|NCT00614679|catheter lock solution|catheter lock solution
610267|NCT00614679|catheter salvage|catheter salvage
610268|NCT00614718|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
610269|NCT00614718|lead failure|lead failure
610270|NCT00614718|pace/sense lead|pace/sense lead
610271|NCT00614718|ICD complication|icd complication
610272|NCT00614718|inappropriate therapy|inappropriate therapy
610273|NCT00614718|Defibrillators|defibrillators
610274|NCT00614731|Keyhole Limpet Hemocyanin|keyhole limpet hemocyanin
610275|NCT00614731|KLH|klh
610276|NCT00614731|atopic dermatitis|atopic dermatitis
610277|NCT00614731|IgG antibodies|igg antibodies
610278|NCT00614731|scarification|scarification
610279|NCT00614744|NICHD Neonatal Research Network|nichd neonatal research network
610280|NCT00614744|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
610281|NCT00614744|Hypothermia|hypothermia
610282|NCT00614744|Neonatal depression|neonatal depression
610283|NCT00614744|Perinatal asphyxia|perinatal asphyxia
610284|NCT00614770|colonoscopy|colonoscopy
610285|NCT00614783|Screening|screening
610286|NCT00614796|COPD|copd
610287|NCT00614796|Lifestyle|lifestyle
610288|NCT00614796|Pedometer|pedometer
610289|NCT00614809|gefitinib|gefitinib
610290|NCT00614809|brain metastasis|brain metastasis
610291|NCT00614835|Gemcitabine|gemcitabine
610292|NCT00614835|Docetaxel|docetaxel
610293|NCT00614835|uterine sarcoma|uterine sarcoma
610294|NCT00614848|restenosis|restenosis
610295|NCT00614861|Non-cancer pain|non-cancer pain
610296|NCT00614861|Pain|pain
610297|NCT00614874|Asthma|asthma
610298|NCT00614874|Avandia|avandia
610299|NCT00614887|Subarachnoid hemorrhage|subarachnoid hemorrhage
610300|NCT00614887|Pituitary gland|pituitary gland
610301|NCT00614887|Adrenal gland|adrenal gland
610302|NCT00614900|COPD|copd
610303|NCT00614900|pulmonary hypertension|pulmonary hypertension
610304|NCT00614900|NT-proBNP|nt-probnp
610305|NCT00614900|6 minutes walk test|6 minutes walk test
610306|NCT00614913|Proton|proton
610307|NCT00614913|Radiotherapy|radiotherapy
610308|NCT00614913|Hepatocellular carcinoma|hepatocellular carcinoma
610309|NCT00614913|Liver Cancer|liver cancer
610310|NCT00614926|Fatigue|fatigue
610311|NCT00614926|low energy|low energy
610313|NCT00614926|treatment|treatment
610314|NCT00614939|DPP-4 inhibitors|dpp-4 inhibitors
610315|NCT00614939|HbA1c|hba1c
610316|NCT00614939|incretins|incretins
610317|NCT00614939|Renal Impairment|renal impairment
610318|NCT00614965|Cancer|cancer
610319|NCT00614965|NSCLC|nsclc
610320|NCT00614965|second-line chemotherapy|second-line chemotherapy
610321|NCT00614965|irinotecan|irinotecan
610322|NCT00614965|pemetrexed|pemetrexed
610323|NCT00614978|HER-2 positive; brain metastases|her-2 positive; brain metastases
610324|NCT00614991|Healthy Subjects|healthy subjects
610325|NCT00614991|Pharmacokinetics study|pharmacokinetics study
610326|NCT00614991|Pharmacokinetics of medications|pharmacokinetics of medications
610327|NCT00615004|Acromegaly|acromegaly
610328|NCT00615004|GH|gh
610329|NCT00615004|IGF-I|igf-i
610620|NCT00622245|Mania|mania
610330|NCT00615004|Octreotide-LAR|octreotide-lar
610331|NCT00615004|Lanreotide|lanreotide
610332|NCT00615004|Transsphenoidal surgery|transsphenoidal surgery
610333|NCT00615017|Sepsis|sepsis
610334|NCT00615017|septic shock|septic shock
610335|NCT00615017|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
610336|NCT00615030|COPD, bronchodilator, long acting beta agonist, LABA|copd, bronchodilator, long acting beta agonist, laba
610337|NCT00615043|Transurethral resection of bladder tumor|transurethral resection of bladder tumor
610338|NCT00615043|TURBT|turbt
610339|NCT00615121|Smoking|smoking
610340|NCT00615121|Hypertension|hypertension
610341|NCT00615121|Diabetes|diabetes
610342|NCT00615121|Cardiovascular disease|cardiovascular disease
610343|NCT00615121|Renal Failure|renal failure
610344|NCT00615134|treatment experienced|treatment experienced
610345|NCT00615147|Any cancer|any cancer
610346|NCT00615147|suspected pulmonary embolism|suspected pulmonary embolism
610347|NCT00615160|Metastatic melanoma|metastatic melanoma
610348|NCT00615160|anti angiogenetic treatment|anti angiogenetic treatment
610349|NCT00615173|Tacrolimus|tacrolimus
610350|NCT00615173|lupus nephritis|lupus nephritis
610351|NCT00615186|Neuradiab|neuradiab
610352|NCT00615186|Locoregional glioblastoma multiforme disease|locoregional glioblastoma multiforme disease
610353|NCT00615186|Anti-tenascin|anti-tenascin
610354|NCT00615186|Radiolabeled antibody therapy|radiolabeled antibody therapy
610355|NCT00615186|Survival|survival
610356|NCT00615212|GSK376501,|gsk376501,
610357|NCT00615212|Cytochrome P450 isoenzymes,|cytochrome p450 isoenzymes,
610358|NCT00615212|Healthy Subjects,|healthy subjects,
610359|NCT00615212|Repeat Dose|repeat dose
610360|NCT00615225|brain death|brain death
610361|NCT00615225|inflammation|inflammation
610362|NCT00615225|endotoxin|endotoxin
610363|NCT00615225|transplantation|transplantation
610364|NCT00615225|graft|graft
610365|NCT00615225|apoptosis|apoptosis
610366|NCT00615225|Systemic inflammatory response|systemic inflammatory response
610367|NCT00615225|Apoptosis activation|apoptosis activation
610368|NCT00615225|Graft outcome|graft outcome
610369|NCT00615238|overweight, physical activity, body composition, metabolic syndrome|overweight, physical activity, body composition, metabolic syndrome
610370|NCT00615251|In vitro fertilization|in vitro fertilization
610371|NCT00615277|Young adults|young adults
610372|NCT00615277|Long-chain polyunsaturated fatty acids|long-chain polyunsaturated fatty acids
610373|NCT00615277|Cognitive function|cognitive function
610374|NCT00615277|Mood|mood
610375|NCT00615277|Supply with omega-3 fatty acids|supply with omega-3 fatty acids
610376|NCT00615303|Bowel preparation, colonoscopy, simethicone, air bubble|bowel preparation, colonoscopy, simethicone, air bubble
751790|NCT01170455|blind|blind
610573|NCT00616135|Functional breast deformity|functional breast deformity
610377|NCT00615329|Create tumor specific gene profiles to improve diagnostic accuracy|create tumor specific gene profiles to improve diagnostic accuracy
610378|NCT00615329|Perform gene set validation for diagnostic predictive power|perform gene set validation for diagnostic predictive power
610379|NCT00615329|Define deviant gene list implicated in pathogenesis|define deviant gene list implicated in pathogenesis
610380|NCT00615355|vitiligo|vitiligo
610381|NCT00615355|narrow-band UVB|narrow-band uvb
610382|NCT00615355|ReCell|recell
610383|NCT00615355|transplantation|transplantation
610384|NCT00615355|laser|laser
610385|NCT00615368|Type 1 diabetes|type 1 diabetes
610386|NCT00615368|Hypoglycaemia|hypoglycaemia
610387|NCT00615368|Cognitive function|cognitive function
610388|NCT00615368|Erythropoietin|erythropoietin
610389|NCT00615381|Intracranial Aneurysm, Unruptured|intracranial aneurysm, unruptured
610390|NCT00615381|Craniotomy|craniotomy
610391|NCT00615381|Insulin|insulin
610392|NCT00615381|Neuropsychology|neuropsychology
610393|NCT00615394|cardiomyopathy, stem cell, cardiac failure|cardiomyopathy, stem cell, cardiac failure
610394|NCT00615407|Asthma, alcohol|asthma, alcohol
610395|NCT00615420|Mucositis|mucositis
610396|NCT00615420|Radiation|radiation
610397|NCT00615420|Honey|honey
610398|NCT00615433|Schizophrenia|schizophrenia
610399|NCT00615433|Latuda|latuda
610400|NCT00615433|Lurasidone|lurasidone
610401|NCT00615446|solid tumor malignancy, SU011248, sunitinib, neoplasms|solid tumor malignancy, su011248, sunitinib, neoplasms
610402|NCT00615459|Chronic obstructive pulmonary disease, indacaterol, tiotropium, placebo controlled|chronic obstructive pulmonary disease, indacaterol, tiotropium, placebo controlled
610403|NCT00615472|Parkinson's Disease|parkinson's disease
610404|NCT00615472|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
610405|NCT00615472|Subthalamic Nucleus|subthalamic nucleus
610406|NCT00615472|Total Intravenous Anesthesia|total intravenous anesthesia
610407|NCT00615472|Inhalational Anesthesia|inhalational anesthesia
610408|NCT00615485|Examine the risk of osteoporosis in survivors of solid pediatric cancers|examine the risk of osteoporosis in survivors of solid pediatric cancers
610409|NCT00615498|Asthma, obesity, bariatric|asthma, obesity, bariatric
610410|NCT00615511|schizophrenia|schizophrenia
610411|NCT00615511|schizoaffective disorder|schizoaffective disorder
610412|NCT00615511|negative symptoms|negative symptoms
610413|NCT00615511|cognition|cognition
610414|NCT00615524|Breast cancer|breast cancer
610415|NCT00615524|Advanced|advanced
610416|NCT00615524|Metastatic|metastatic
610417|NCT00615524|Pazopanib|pazopanib
610418|NCT00615524|GW786034|gw786034
610419|NCT00615524|Exemestane|exemestane
610421|NCT00615524|Tolerability|tolerability
610422|NCT00615524|Health-Related Quality of Life|health-related quality of life
610423|NCT00615537|Thyroid Nodule|thyroid nodule
610424|NCT00615537|Thyroid Cancer|thyroid cancer
610425|NCT00615537|Laser Ablation|laser ablation
610426|NCT00615537|LITT|litt
610427|NCT00615537|Nodular Goiter|nodular goiter
610428|NCT00615537|Thyroid Mass|thyroid mass
610429|NCT00615550|Preterm|preterm
610430|NCT00615550|Cervix|cervix
610431|NCT00615576|Smoker,|smoker,
610432|NCT00615576|Male,|male,
610433|NCT00615576|Chronic Obstructive Lung Disease|chronic obstructive lung disease
610434|NCT00615576|Cystic Fibrosis,|cystic fibrosis,
610435|NCT00615576|Healthy Volunteer,|healthy volunteer,
610436|NCT00615589|Stage II/III Multiple Myeloma(within 10 months from diagnosis)|stage ii/iii multiple myeloma(within 10 months from diagnosis)
610437|NCT00615589|high risk|high risk
610438|NCT00615589|relapse|relapse
610439|NCT00615589|persistent|persistent
610440|NCT00615602|Early breast cancer|early breast cancer
610441|NCT00615602|Axillary node positive|axillary node positive
610442|NCT00615602|HER2 overexpression|her2 overexpression
610443|NCT00615602|Adjuvant chemotherapy|adjuvant chemotherapy
610444|NCT00615602|Dose dense|dose dense
610445|NCT00615602|Docetaxel|docetaxel
610446|NCT00615602|Trastuzumab|trastuzumab
610447|NCT00615602|FEC|fec
610448|NCT00615615|Levetiracetam|levetiracetam
610449|NCT00615615|Keppra|keppra
610450|NCT00615628|Inheritance of Osteosarcoma & Paget's Disease through Chromosome 18|inheritance of osteosarcoma & paget's disease through chromosome 18
610451|NCT00615641|Children|children
610452|NCT00615641|Nutrition|nutrition
610453|NCT00615641|Body Fat|body fat
610454|NCT00615641|Physical Activity|physical activity
610455|NCT00615641|Diet|diet
610456|NCT00615641|Childhood Obesity|childhood obesity
610457|NCT00615641|Healthy Children|healthy children
610458|NCT00615654|Hydrotherapy,|hydrotherapy,
610459|NCT00615654|RCT,|rct,
610460|NCT00615667|Refractory Nephrotic syndrome|refractory nephrotic syndrome
610461|NCT00615667|Tacrolimus|tacrolimus
610462|NCT00615693|Uveitis|uveitis
610463|NCT00615693|Macular Edema|macular edema
610464|NCT00615706|asthma, inhaled corticosteroids|asthma, inhaled corticosteroids
610465|NCT00615719|Chest Pain|chest pain
610466|NCT00615719|Coronary Angiography|coronary angiography
610467|NCT00615719|Acute Coronary Syndromes|acute coronary syndromes
610468|NCT00615719|Computed Tomography|computed tomography
610469|NCT00615732|qigong|qigong
610470|NCT00615732|traditional chinese medicine|traditional chinese medicine
610471|NCT00615732|exercise therapy|exercise therapy
610472|NCT00615732|neck pain|neck pain
610473|NCT00615745|Human Immunodeficiency Virus|human immunodeficiency virus
610474|NCT00615745|treatment experienced|treatment experienced
610476|NCT00615758|Biological therapy|biological therapy
610477|NCT00615758|Tyrosin Kinase Inhibitor therapy|tyrosin kinase inhibitor therapy
610478|NCT00615784|Acute Myeloid Leukemia|acute myeloid leukemia
610479|NCT00615784|AML|aml
610480|NCT00615784|Bexarotene|bexarotene
610481|NCT00615810|LDL|ldl
610482|NCT00615810|HDL|hdl
610483|NCT00615810|triglycerides|triglycerides
610484|NCT00615810|non HDL cholesterol|non hdl cholesterol
610485|NCT00615810|cholesterol|cholesterol
610486|NCT00615810|HIV 1|hiv 1
610487|NCT00615810|Metabolic parameters|metabolic parameters
610488|NCT00615810|treatment experienced|treatment experienced
610489|NCT00615823|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
610490|NCT00615849|pneumothorax, thoracoscopy, pleurodesis|pneumothorax, thoracoscopy, pleurodesis
610491|NCT00615862|Sepsis, alcoholism, cortisol, delirium, critical care|sepsis, alcoholism, cortisol, delirium, critical care
610492|NCT00615875|naproxen|naproxen
610493|NCT00615875|acute pain|acute pain
610494|NCT00615875|postoperative pain|postoperative pain
610495|NCT00615875|thoracic surgery|thoracic surgery
610496|NCT00615875|head and neck surgery|head and neck surgery
610497|NCT00615875|opiate sparing|opiate sparing
610498|NCT00615888|elective open repair|elective open repair
610499|NCT00615888|complications|complications
610500|NCT00615888|morbidity and mortality|morbidity and mortality
610501|NCT00615888|fast track patient management|fast track patient management
610502|NCT00615901|cyclophosphamide|cyclophosphamide
610503|NCT00615901|methotrexate|methotrexate
610504|NCT00615901|fluorouracil|fluorouracil
610505|NCT00615901|PEG-filgrastim|peg-filgrastim
610506|NCT00615927|Glioblastoma|glioblastoma
610507|NCT00615927|Gliosarcoma|gliosarcoma
610508|NCT00615927|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
610509|NCT00615927|GBM|gbm
610510|NCT00615927|Imatinib Mesylate|imatinib mesylate
610511|NCT00615927|Gleevec|gleevec
610512|NCT00615927|Hydroxyurea|hydroxyurea
610513|NCT00615927|Droxia|droxia
610514|NCT00615927|Hydrea|hydrea
610515|NCT00615927|Hydroxycarbamide|hydroxycarbamide
610516|NCT00615927|Imatinib|imatinib
610517|NCT00615927|Brain tumor|brain tumor
610518|NCT00615927|Malignant brain tumor|malignant brain tumor
610519|NCT00615927|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
610520|NCT00615927|Progressive glioblastoma multiforme|progressive glioblastoma multiforme
610521|NCT00615940|HER2negative|her2negative
610522|NCT00615966|kidney transplantation|kidney transplantation
610523|NCT00615966|ischemia-reperfusion injury|ischemia-reperfusion injury
610524|NCT00615966|phosphatidylserine binding|phosphatidylserine binding
610525|NCT00615979|trauma|trauma
610526|NCT00615979|portable ultrasound|portable ultrasound
610527|NCT00615979|telemedicine|telemedicine
610528|NCT00615979|Department of Defense|department of defense
610529|NCT00616005|Glioblastoma|glioblastoma
610530|NCT00616005|GBM|gbm
610531|NCT00616005|Brain tumor|brain tumor
610532|NCT00616005|Temodar|temodar
610533|NCT00616005|Temozolomide|temozolomide
610534|NCT00616005|Irinotecan|irinotecan
610535|NCT00616005|CPT-11|cpt-11
610537|NCT00616005|Malignant glioma|malignant glioma
610538|NCT00616005|Anaplastic astrocytoma|anaplastic astrocytoma
610539|NCT00616005|Glioblastoma multiforme|glioblastoma multiforme
610540|NCT00616018|acetaminophen|acetaminophen
610541|NCT00616018|protein adducts|protein adducts
610542|NCT00616018|hepatic function|hepatic function
610543|NCT00616018|drug safety|drug safety
610544|NCT00616018|non drinkers|non drinkers
610545|NCT00616031|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
610546|NCT00616031|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
610547|NCT00616044|Spinal Anesthesia|spinal anesthesia
610548|NCT00616044|Epidural Anesthesia|epidural anesthesia
610549|NCT00616044|Orthopedic procedures|orthopedic procedures
610550|NCT00616057|fructans supplementation|fructans supplementation
610551|NCT00616083|Breast Feeding|breast feeding
610552|NCT00616083|Body Composition|body composition
610553|NCT00616083|Body Fat|body fat
610554|NCT00616083|Infant|infant
610555|NCT00616083|Diet|diet
610556|NCT00616083|Healthy Infants|healthy infants
610557|NCT00616096|Serum Immunoglobulin E above 5000 kU/l|serum immunoglobulin e above 5000 ku/l
610558|NCT00616122|recurrent breast cancer|recurrent breast cancer
610559|NCT00616122|stage IV breast cancer|stage iv breast cancer
610560|NCT00616122|male breast cancer|male breast cancer
610561|NCT00616135|Breast|breast
610562|NCT00616135|Stem Cell|stem cell
610563|NCT00616135|Adipose Derived Stem Cells|adipose derived stem cells
610564|NCT00616135|Adipose Derived Regenerative Cells|adipose derived regenerative cells
610565|NCT00616135|ADRC|adrc
610566|NCT00616135|Reconstructive Breast Surgery|reconstructive breast surgery
610567|NCT00616135|Breast Reconstruction|breast reconstruction
610568|NCT00616135|Cancer|cancer
610569|NCT00616135|Carcinoma|carcinoma
610570|NCT00616135|Autologous fat transplantation|autologous fat transplantation
610571|NCT00616135|Autologous fat|autologous fat
610572|NCT00616135|Cosmetic breast deformities|cosmetic breast deformities
610575|NCT00616135|Segmental mastectomy|segmental mastectomy
610576|NCT00616135|Quadrantectomy|quadrantectomy
610577|NCT00616135|breast conservation therapy|breast conservation therapy
610578|NCT00616148|Epilepsy|epilepsy
610579|NCT00616148|Seizures|seizures
610580|NCT00616161|Acute Heart Failure|acute heart failure
610581|NCT00616161|Inotropes|inotropes
610582|NCT00616161|Lusitropic agents|lusitropic agents
610583|NCT00616161|Istaroxime|istaroxime
610584|NCT00616161|PST2744|pst2744
610585|NCT00616174|Cesarean delivery|cesarean delivery
610586|NCT00616174|Active Warming|active warming
610587|NCT00616174|Neonatal Temperature|neonatal temperature
610588|NCT00616200|D-IBS (diarrhea predominant irritable bowel syndrome)|d-ibs (diarrhea predominant irritable bowel syndrome)
610589|NCT00616213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
610590|NCT00616239|Melasma|melasma
610591|NCT00616239|Dark spots on the face|dark spots on the face
610592|NCT00616252|Antiretroviral|antiretroviral
610593|NCT00616252|Pharmacokinetics|pharmacokinetics
610594|NCT00616252|Pregnancy|pregnancy
610595|NCT00616265|Sleep apnea|sleep apnea
610596|NCT00616265|Refractory Hypertension|refractory hypertension
610597|NCT00616265|Difficult-to-treat hypertension|difficult-to-treat hypertension
610598|NCT00616265|CPAP|cpap
610599|NCT00616278|Growth Failure AND|growth failure and
610600|NCT00616278|Chronic Renal Insufficiency OR|chronic renal insufficiency or
610601|NCT00616278|End Stage Renal Disease|end stage renal disease
610602|NCT00616291|recurrent prostate cancer|recurrent prostate cancer
610603|NCT00616291|stage IV prostate cancer|stage iv prostate cancer
610604|NCT00616304|severe falciparum malaria|severe falciparum malaria
610605|NCT00616317|Antiphospholipid Syndrome|antiphospholipid syndrome
610607|NCT00616356|Yellow Fever|yellow fever
610608|NCT00616369|pulmonary hypertension|pulmonary hypertension
610609|NCT00616369|hypertension|hypertension
610610|NCT00616369|cardiomyopathy|cardiomyopathy
610611|NCT00616369|arrhythmias|arrhythmias
610612|NCT00622232|HIV-1|hiv-1
610613|NCT00622232|treatment experienced, complementary therapies|treatment experienced, complementary therapies
610614|NCT00622245|Depression|depression
610615|NCT00622245|Bipolar disorder|bipolar disorder
610616|NCT00622245|Placebo-controlled|placebo-controlled
610617|NCT00622245|Double-blind|double-blind
610618|NCT00622245|Multicenter|multicenter
610619|NCT00622245|Clinical study|clinical study
610622|NCT00622258|mTOR inhibitor|mtor inhibitor
610623|NCT00622258|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
610624|NCT00622271|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
610625|NCT00622271|Adolescents and Families|adolescents and families
610626|NCT00622271|Group Therapy Intervention|group therapy intervention
610627|NCT00622323|diabetes|diabetes
610628|NCT00622323|exenatide|exenatide
610629|NCT00622323|metformin|metformin
610630|NCT00622323|sulfonylurea|sulfonylurea
610631|NCT00622323|Byetta|byetta
610632|NCT00622323|Amylin|amylin
610633|NCT00622323|Lilly|lilly
610634|NCT00622336|Multiple Myeloma|multiple myeloma
610635|NCT00622336|Revlimid|revlimid
610636|NCT00622349|Randomised phase III|randomised phase iii
610637|NCT00622349|Chemotherapy|chemotherapy
610638|NCT00622349|Advanced non-small cell lung carcinoma|advanced non-small cell lung carcinoma
610639|NCT00622362|Immunotherapy|immunotherapy
610640|NCT00622362|Allergy|allergy
610641|NCT00622362|Allergoid|allergoid
610642|NCT00622362|Depigmented|depigmented
610643|NCT00622362|Polymerized|polymerized
610644|NCT00622362|Allergen-extract|allergen-extract
610645|NCT00622362|mites|mites
610646|NCT00622362|Asthma|asthma
610647|NCT00622375|Pharmacokinetic study|pharmacokinetic study
610648|NCT00622375|Healthy subjects|healthy subjects
610649|NCT00622401|stage IV breast cancer|stage iv breast cancer
610650|NCT00622401|dendritic cell vaccine|dendritic cell vaccine
610651|NCT00622401|tumor fusion vaccine|tumor fusion vaccine
610652|NCT00622401|IL-12|il-12
610653|NCT00622440|HSIL|hsil
610654|NCT00622440|HGAIN|hgain
610656|NCT00622440|neoplasia|neoplasia
610657|NCT00622440|dysplasia|dysplasia
610658|NCT00622440|TCM|tcm
610659|NCT00622440|Traditional Chinese Medicine|traditional chinese medicine
610660|NCT00622466|stage IV breast cancer|stage iv breast cancer
610661|NCT00622466|male breast cancer|male breast cancer
610662|NCT00622466|recurrent breast cancer|recurrent breast cancer
610663|NCT00622466|HER2-negative breast cancer|her2-negative breast cancer
610664|NCT00622479|Sorafenib|sorafenib
610665|NCT00622479|Hypophosphatemia|hypophosphatemia
610666|NCT00622479|Left ventricular ejection fraction (LVEF)|left ventricular ejection fraction (lvef)
610667|NCT00622479|Beta-type Natriuretic Peptide (BNP)|beta-type natriuretic peptide (bnp)
610668|NCT00622492|VV-ECMO|vv-ecmo
610669|NCT00622492|VA-ECMO|va-ecmo
610670|NCT00622492|PPHN|pphn
610671|NCT00622492|organ circulation|organ circulation
610672|NCT00622505|Multiple myeloma|multiple myeloma
610673|NCT00622505|zoledronic acid|zoledronic acid
610675|NCT00622505|bone|bone
610676|NCT00622518|otitis media|otitis media
610677|NCT00622518|children|children
610678|NCT00622531|heart failure|heart failure
610679|NCT00622531|BNP|bnp
610680|NCT00622531|natriuretic peptide|natriuretic peptide
610681|NCT00622544|Microalbuminuria|microalbuminuria
610682|NCT00622544|Proteinuria|proteinuria
610683|NCT00622570|Traumatic brain injury, barbiturate coma|traumatic brain injury, barbiturate coma
610684|NCT00623272|The assessment of left ventricular ejection fraction (LVEF)|the assessment of left ventricular ejection fraction (lvef)
610685|NCT00623285|Pain.|pain.
610686|NCT00623285|Postoperative.|postoperative.
610687|NCT00623285|CABG.|cabg.
610688|NCT00623298|Posttraumatic stress disorder|posttraumatic stress disorder
610689|NCT00623298|depression|depression
610690|NCT00623298|Narrative Exposure Therapy|narrative exposure therapy
610691|NCT00623298|Interpersonal Psychotherapy|interpersonal psychotherapy
610692|NCT00623337|care seeking|care seeking
610693|NCT00623337|pregnancy and childbirth|pregnancy and childbirth
610694|NCT00623337|newborn care practices|newborn care practices
610695|NCT00623337|low birth weight babies|low birth weight babies
610696|NCT00623350|Telemedicine|telemedicine
610697|NCT00623350|Stroke, Acute|stroke, acute
610698|NCT00623350|Rural|rural
610699|NCT00623350|Thrombolysis|thrombolysis
610700|NCT00623350|Consultation|consultation
610701|NCT00623363|Parkinson's Disease|parkinson's disease
610702|NCT00623363|motor complications|motor complications
610703|NCT00623363|dyskinesia|dyskinesia
610704|NCT00623363|Motor complications associated with Parkinson's|motor complications associated with parkinson's
610705|NCT00623389|Neurologic disorders|neurologic disorders
610706|NCT00623389|Rare disease|rare disease
610707|NCT00623389|Spinal cord injuries|spinal cord injuries
610708|NCT00623389|Stroke|stroke
610709|NCT00623389|Paraplegia|paraplegia
610710|NCT00623389|Tetraplegia|tetraplegia
610711|NCT00623402|Metastatic melanoma|metastatic melanoma
610712|NCT00623402|Pegylated interferon|pegylated interferon
610713|NCT00623402|Protein Kinase Inhibitors|protein kinase inhibitors
610714|NCT00623402|Sorafenib|sorafenib
610715|NCT00623402|PegIntron|pegintron
610716|NCT00623402|Therapeutic Uses|therapeutic uses
610717|NCT00623402|melanoma (skin)|melanoma (skin)
610718|NCT00623441|Coronary Artery Disease|coronary artery disease
610719|NCT00623441|Drug-eluting stent|drug-eluting stent
610720|NCT00623454|anxiety|anxiety
610721|NCT00623454|panic disorder|panic disorder
610722|NCT00623454|chest pain|chest pain
610723|NCT00623454|palpitations|palpitations
610724|NCT00623467|Central Nervous System Imaging|central nervous system imaging
610725|NCT00623467|Diagnostic Imaging|diagnostic imaging
610726|NCT00623480|Hemophilia A|hemophilia a
610727|NCT00623493|Screening|screening
610728|NCT00623493|Suicide|suicide
610729|NCT00623493|Emergency Department|emergency department
610730|NCT00623493|Children and Adolescents|children and adolescents
610731|NCT00623493|Suicide Risk|suicide risk
610733|NCT00623506|Pregnenolone|pregnenolone
610734|NCT00623506|Cognition|cognition
610735|NCT00623519|Adjuvant postmenopausal breast cancer women|adjuvant postmenopausal breast cancer women
610736|NCT00623532|Tertiary prevention of disability|tertiary prevention of disability
610737|NCT00623545|Exenatide|exenatide
610738|NCT00623545|Byetta|byetta
610739|NCT00623545|weight loss|weight loss
610740|NCT00623545|energy expenditure|energy expenditure
610741|NCT00623545|normal volunteers|normal volunteers
610742|NCT00623558|head and neck neoplasm|head and neck neoplasm
610743|NCT00623558|cetuximab|cetuximab
610744|NCT00623558|docetaxel|docetaxel
610745|NCT00623558|cisplatin|cisplatin
610746|NCT00623558|radiotherapy|radiotherapy
610747|NCT00623571|frail elderly|frail elderly
610748|NCT00623571|hospital at home|hospital at home
610749|NCT00623571|heart failure|heart failure
610750|NCT00623571|Acute exacerbation of chronic heart failure|acute exacerbation of chronic heart failure
610751|NCT00623584|penetrating keratoplasty|penetrating keratoplasty
610752|NCT00623584|corneal transplantation|corneal transplantation
610753|NCT00623584|corneal grafting|corneal grafting
610754|NCT00623584|corneal grafts|corneal grafts
610755|NCT00623584|culture media|culture media
610756|NCT00623584|corneal culturing|corneal culturing
610757|NCT00623584|in vitro culturing|in vitro culturing
610758|NCT00623610|Diabetes mellitus, type 1|diabetes mellitus, type 1
610759|NCT00623610|pancreatic beta cell|pancreatic beta cell
610760|NCT00623610|transplantation|transplantation
610761|NCT00623636|Migraine|migraine
610762|NCT00623662|Glucose infusion|glucose infusion
610763|NCT00623662|Liver function|liver function
610764|NCT00623662|Liver resection|liver resection
610765|NCT00623662|Albumin synthesis|albumin synthesis
610766|NCT00623662|Stable isotopes|stable isotopes
610767|NCT00623675|zeolites|zeolites
610768|NCT00623675|nutraceuticals|nutraceuticals
610769|NCT00623675|natural supplements|natural supplements
610770|NCT00623675|Healthy volunteers|healthy volunteers
610771|NCT00623688|Metered Dose Inhalers|metered dose inhalers
610772|NCT00623688|Nebulizers|nebulizers
610773|NCT00623688|Randomized Controlled Trial|randomized controlled trial
610774|NCT00623701|sublingual grass pollen preparation|sublingual grass pollen preparation
610775|NCT00623701|IgE-mediated Allergic Disease attributed to grass pollen|ige-mediated allergic disease attributed to grass pollen
610776|NCT00623727|Hemophilia A|hemophilia a
610777|NCT00623727|FVIII disease|fviii disease
610778|NCT00623727|rFVIII|rfviii
610779|NCT00623740|Hydrocortisone|hydrocortisone
610780|NCT00623740|Very low birth weight|very low birth weight
610781|NCT00623740|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
610782|NCT00623740|Prevention Cerebral palsy|prevention cerebral palsy
610783|NCT00623753|Vaccine|vaccine
610784|NCT00623753|Prevention|prevention
610785|NCT00623753|HIV|hiv
610786|NCT00623753|AIDS|aids
610787|NCT00623753|Human Immunodeficiency Virus|human immunodeficiency virus
610788|NCT00623753|HIV Seronegativity, HIV Preventive Vaccine|hiv seronegativity, hiv preventive vaccine
610789|NCT00623792|Morbid obesity|morbid obesity
610790|NCT00623792|Diet therapy|diet therapy
610791|NCT00623792|Bariatric Surgery|bariatric surgery
610792|NCT00623792|Gastric bypass|gastric bypass
610793|NCT00623792|Behavior therapy|behavior therapy
610794|NCT00623792|Randomized controlled trial|randomized controlled trial
610795|NCT00623792|Weight loss|weight loss
610796|NCT00623818|Mirror Therapy|mirror therapy
610797|NCT00623818|Phantom Limb Pain|phantom limb pain
610798|NCT00623818|Amputee|amputee
610799|NCT00623818|Healthy Volunteer|healthy volunteer
610800|NCT00623818|HV|hv
610801|NCT00623831|MBV|mbv
610802|NCT00623831|Mixed Bacterial Vaccine|mixed bacterial vaccine
610803|NCT00623831|NY-ESO-1|ny-eso-1
610804|NCT00623844|Prevention|prevention
610805|NCT00623844|Physical activity|physical activity
610806|NCT00623844|Obesity|obesity
610807|NCT00623844|Motor skills|motor skills
610808|NCT00623844|Kindergarten|kindergarten
610809|NCT00623857|Micronutrients|micronutrients
610810|NCT00623857|Zinc|zinc
610811|NCT00623857|Vitamins|vitamins
610812|NCT00623857|Trace elements|trace elements
610813|NCT00623857|Minerals|minerals
610814|NCT00623857|Vitamin A|vitamin a
610815|NCT00623857|Vitamin B1|vitamin b1
610816|NCT00623857|Vitamin B2|vitamin b2
610817|NCT00623857|Niacin|niacin
610818|NCT00623857|Vitamin B6|vitamin b6
610819|NCT00623857|Folic acid|folic acid
610820|NCT00623857|Vitamin B12|vitamin b12
610821|NCT00623857|Vitamin C|vitamin c
610822|NCT00623857|Vitamin D|vitamin d
610823|NCT00623857|Vitamin E|vitamin e
610824|NCT00623857|Vitamin K|vitamin k
610833|NCT00623857|Anthropometry|anthropometry
610834|NCT00623883|Human Colonic Aberrant Crypt Foci|human colonic aberrant crypt foci
610835|NCT00623896|Nehb|nehb
610836|NCT00623896|ST Elevation Myocardial Infarcton|st elevation myocardial infarcton
610837|NCT00623896|STEMI|stemi
610838|NCT00623896|ECG|ecg
610839|NCT00623909|Laser Therapy|laser therapy
610840|NCT00623909|Post Thoracotomy Pain|post thoracotomy pain
610841|NCT00623909|AvicennaTM laser|avicennatm laser
610842|NCT00623922|Patient education|patient education
610843|NCT00623922|Nurse consultation|nurse consultation
610844|NCT00623922|Arthritis|arthritis
610845|NCT00623922|Wellbeing|wellbeing
610846|NCT00623922|Coping|coping
610847|NCT00623922|Health related quality of life|health related quality of life
610848|NCT00623935|AML|aml
610849|NCT00623948|Pressure ulcers|pressure ulcers
610850|NCT00623948|Electrical Stimulation|electrical stimulation
610851|NCT00623948|Spinal Cord Injury|spinal cord injury
610852|NCT00623961|Neuropathic Pain|neuropathic pain
610853|NCT00623974|Hypocalcemia|hypocalcemia
610854|NCT00623974|Teriparatide|teriparatide
610855|NCT00623974|Forteo|forteo
610856|NCT00623974|Calcium|calcium
610857|NCT00623974|Calcitriol|calcitriol
610858|NCT00623974|Rocaltrol|rocaltrol
610859|NCT00623987|Residual vein thrombosis|residual vein thrombosis
610860|NCT00623987|Optimal duration|optimal duration
610861|NCT00623987|Oral anticoagulants|oral anticoagulants
610862|NCT00624000|Ischemic Stroke|ischemic stroke
610863|NCT00624013|Diabetes|diabetes
610864|NCT00624013|Depression|depression
610865|NCT00624013|diabetes outcomes|diabetes outcomes
610866|NCT00624013|quality of life|quality of life
610867|NCT00624039|presbyopia|presbyopia
610868|NCT00624065|target blood pressure|target blood pressure
610869|NCT00624065|hypertension|hypertension
610870|NCT00624065|COREG CR|coreg cr
610871|NCT00624065|carvedilol CR|carvedilol cr
610872|NCT00624065|Stage 1 or 2 essential hypertension|stage 1 or 2 essential hypertension
610873|NCT00624065|lisinopril|lisinopril
610874|NCT00624078|faboterapics|faboterapics
610875|NCT00624078|treatment|treatment
610876|NCT00624078|scorpion sting|scorpion sting
610877|NCT00624078|envenomation|envenomation
610878|NCT00624091|Early-surgery, infective endocarditis, in-hospital mortality|early-surgery, infective endocarditis, in-hospital mortality
610879|NCT00624104|VLDL|vldl
610880|NCT00624104|Kinetics|kinetics
610881|NCT00624104|Hyperinsulinaemia|hyperinsulinaemia
610882|NCT00624104|Obesity|obesity
610883|NCT00624117|shoulder joint|shoulder joint
610884|NCT00624117|recovery of function|recovery of function
610885|NCT00624117|effectiveness of rehabilitation|effectiveness of rehabilitation
610886|NCT00624117|rehabilitation|rehabilitation
610887|NCT00624130|Contraception,|contraception,
610888|NCT00624130|Cycle control,|cycle control,
610889|NCT00624130|Bleeding pattern|bleeding pattern
611359|NCT00607997|Blood|blood
610890|NCT00624143|Antifungal prophylaxis, acute leukemia induction,|antifungal prophylaxis, acute leukemia induction,
610891|NCT00624156|Breast Cancer|breast cancer
610892|NCT00624169|Perforated peptic ulcer|perforated peptic ulcer
610893|NCT00624169|Mortality|mortality
610894|NCT00624195|HIV Dementia|hiv dementia
610895|NCT00624195|HAART|haart
610896|NCT00624195|Cognitive Impairment|cognitive impairment
610897|NCT00624195|Antiretroviral Regimen|antiretroviral regimen
610898|NCT00624195|Viral Load|viral load
610899|NCT00624195|CNS Drug Penetration|cns drug penetration
610900|NCT00624208|Randomized|randomized
610901|NCT00624208|double-blind|double-blind
610902|NCT00624208|4-group clinical interventional study|4-group clinical interventional study
610903|NCT00624234|neurofibromatosis type 1|neurofibromatosis type 1
610904|NCT00624234|reading disabilities|reading disabilities
610905|NCT00624234|NF-1|nf-1
610906|NCT00624234|learning disabilities|learning disabilities
610907|NCT00624234|tutoring intervention|tutoring intervention
610908|NCT00624247|routine HIV testing|routine hiv testing
610909|NCT00624247|jails|jails
610910|NCT00624247|criminal justice system|criminal justice system
610911|NCT00624247|substance abuse|substance abuse
610912|NCT00624247|mental illness|mental illness
610913|NCT00624247|HIV|hiv
610914|NCT00624260|Colorectal cancer|colorectal cancer
610915|NCT00624260|Recurrence|recurrence
610916|NCT00624260|Positron Emission Tomography|positron emission tomography
610917|NCT00624260|Colorectal Cancer with high risk of recurrence stage III|colorectal cancer with high risk of recurrence stage iii
610918|NCT00624260|Colorectal Cancer with high risk of recurrence stage IV|colorectal cancer with high risk of recurrence stage iv
610919|NCT00624260|T4N0M0 operated in emergency( because of perforation)|t4n0m0 operated in emergency( because of perforation)
610920|NCT00624273|digital ulcers,|digital ulcers,
610921|NCT00624273|systemic sclerosis,|systemic sclerosis,
610922|NCT00624273|sildenafil,|sildenafil,
610923|NCT00624273|vasoactive therapies|vasoactive therapies
610924|NCT00624286|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
610925|NCT00624286|COPD|copd
610926|NCT00624286|indacaterol|indacaterol
610927|NCT00624299|botox|botox
610928|NCT00624299|limb reconstructions|limb reconstructions
610929|NCT00624299|limb reconstruction surgery|limb reconstruction surgery
610930|NCT00624312|Procrit|procrit
610931|NCT00624312|Erythropoietin|erythropoietin
610932|NCT00624312|Patients undergoing major surgical oncology operations|patients undergoing major surgical oncology operations
610933|NCT00624325|genotype 1 nonresponders|genotype 1 nonresponders
610934|NCT00624338|Atacicept 75 and 150 mg|atacicept 75 and 150 mg
610935|NCT00624338|Placebo|placebo
610937|NCT00624351|Monoclonal antibody|monoclonal antibody
610938|NCT00624351|B-Cell immunotherapy|b-cell immunotherapy
610939|NCT00624403|Anesthesia|anesthesia
610940|NCT00624403|Laryngeal mask airway|laryngeal mask airway
610941|NCT00624416|Obesity therapy|obesity therapy
610942|NCT00624416|fat|fat
610943|NCT00624416|drug mechanism|drug mechanism
610944|NCT00624416|adipose tissue|adipose tissue
610945|NCT00624416|cellular pharmacology|cellular pharmacology
610946|NCT00624429|Asthma|asthma
610947|NCT00624429|Children|children
610948|NCT00624455|Gabapentin|gabapentin
610949|NCT00624455|tonsillectomy|tonsillectomy
610950|NCT00624455|post-operative pain|post-operative pain
610951|NCT00624455|morphine requirements|morphine requirements
610952|NCT00624455|randomized double blind|randomized double blind
610953|NCT00624455|adenotonsillectomy|adenotonsillectomy
610954|NCT00624468|atacicept|atacicept
610955|NCT00624468|neuritis|neuritis
610956|NCT00624481|osteoporosis|osteoporosis
610957|NCT00624481|osteopenia|osteopenia
610958|NCT00624481|bone mineral density|bone mineral density
610959|NCT00624481|teriparatide|teriparatide
610960|NCT00624494|venous oxygen saturation|venous oxygen saturation
610961|NCT00624494|transpulmonary thermodilution|transpulmonary thermodilution
610962|NCT00624520|Stress, Psychological|stress, psychological
610963|NCT00624520|Tachycardia, Ventricular|tachycardia, ventricular
610964|NCT00624520|Defibrillators, Implantable|defibrillators, implantable
610965|NCT00624520|Death, Sudden Cardiac|death, sudden cardiac
610966|NCT00624520|Cognitive Therapy|cognitive therapy
610967|NCT00624520|Anger|anger
610968|NCT00624533|Low back Pain|low back pain
610969|NCT00624533|Physical Therapy Modalities|physical therapy modalities
610970|NCT00624533|Exercise Movement Techniques|exercise movement techniques
610971|NCT00624533|Primary Health Care|primary health care
610972|NCT00624546|GERD|gerd
610973|NCT00624546|gastroesophageal reflux|gastroesophageal reflux
610974|NCT00624546|antireflux surgery|antireflux surgery
610975|NCT00624546|Barrett's|barrett's
610976|NCT00624546|Esophagus|esophagus
610977|NCT00624546|Esophagitis|esophagitis
610978|NCT00624559|Salt sensitivity of Blood Pressure|salt sensitivity of blood pressure
610979|NCT00624572|primary teeth|primary teeth
610980|NCT00624572|chlorexidine|chlorexidine
610981|NCT00624572|root canal therapy|root canal therapy
610982|NCT00624572|Pulpectomy|pulpectomy
610983|NCT00624585|MDS|mds
610984|NCT00624585|MDS/MPD|mds/mpd
610985|NCT00624585|MDS/AML|mds/aml
610986|NCT00624585|CMML|cmml
611360|NCT00607997|Cancer|cancer
610987|NCT00624585|Excess Marrow Blasts|excess marrow blasts
610988|NCT00624611|CPB|cpb
610989|NCT00624611|red blood cell washing|red blood cell washing
610990|NCT00624624|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
610991|NCT00624624|bariatric surgery|bariatric surgery
610992|NCT00624624|serum androgen levels|serum androgen levels
610993|NCT00624624|bone density|bone density
610994|NCT00624637|aromatherapy|aromatherapy
610995|NCT00624637|massage|massage
610996|NCT00624637|comfort|comfort
610997|NCT00624637|postoperative|postoperative
610998|NCT00624637|infants|infants
610999|NCT00624637|craniofacial surgery|craniofacial surgery
611000|NCT00624650|Acute Lung Injury|acute lung injury
611001|NCT00624650|Extravascular Lung Water|extravascular lung water
611002|NCT00624650|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
611003|NCT00624663|Rivastigmine, Repeated administration, Healthy Volunteers, organophosphate poisoning, protection, pharmacokinetics, behavioral effects|rivastigmine, repeated administration, healthy volunteers, organophosphate poisoning, protection, pharmacokinetics, behavioral effects
611004|NCT00624676|Acne|acne
611005|NCT00624676|lipophilic hydroxy acid|lipophilic hydroxy acid
611006|NCT00624676|benzoyl peroxide|benzoyl peroxide
611007|NCT00624689|Body composition|body composition
611008|NCT00624689|Glucose tolerance|glucose tolerance
611009|NCT00624689|Intima-media thickness|intima-media thickness
611010|NCT00624689|Visual acuity|visual acuity
611011|NCT00624689|Neurological development|neurological development
611012|NCT00624702|Asthma, cough, spirometry, maleate, xinafoate, acetate, SDDPI (single dose dry powder inhaler)|asthma, cough, spirometry, maleate, xinafoate, acetate, sddpi (single dose dry powder inhaler)
611013|NCT00624728|Positron-Emission Tomography|positron-emission tomography
611014|NCT00624728|Alovudine [Substance Name]|alovudine [substance name]
611015|NCT00624728|18F-FLT|18f-flt
611016|NCT00624728|Magnetic Resonance Imaging|magnetic resonance imaging
611017|NCT00624728|Astrocytoma|astrocytoma
611018|NCT00624728|Glioblastoma|glioblastoma
611019|NCT00624741|Parkinson's disease|parkinson's disease
611020|NCT00624741|Antiparkinsonian|antiparkinsonian
611021|NCT00624741|Compassionate use|compassionate use
611022|NCT00624754|Obstructive airway disease|obstructive airway disease
611023|NCT00624754|bronchiolitis obliterans|bronchiolitis obliterans
611024|NCT00624754|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
611025|NCT00624754|bone marrow transplantation|bone marrow transplantation
611026|NCT00624754|inhaled treatment|inhaled treatment
611027|NCT00624754|Budesonide Formoterol|budesonide formoterol
611028|NCT00624767|insulin|insulin
611029|NCT00624767|insulin aspart|insulin aspart
611030|NCT00624767|Type 2 Diabetes|type 2 diabetes
611031|NCT00624767|diabetes mellitus|diabetes mellitus
611032|NCT00624793|Nausea|nausea
611033|NCT00624793|Vomiting|vomiting
611034|NCT00624793|Retching|retching
611035|NCT00624793|HIV/AIDS|hiv/aids
611036|NCT00624793|Symptom Management|symptom management
611037|NCT00624793|Complementary Therapies|complementary therapies
611038|NCT00624806|Pressure ulcer|pressure ulcer
611039|NCT00624806|Telemedicine|telemedicine
611040|NCT00624819|Streptococcus pneumoniae|streptococcus pneumoniae
611041|NCT00624819|Haemophilus influenzae|haemophilus influenzae
611042|NCT00624819|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
611043|NCT00624819|Antibody persistence|antibody persistence
611044|NCT00624832|Asthma|asthma
611045|NCT00624832|allergen challenge|allergen challenge
611046|NCT00624832|bronchoprovocation|bronchoprovocation
611047|NCT00624832|Methacholine challenge|methacholine challenge
611048|NCT00624832|serum Immunoglobulin E|serum immunoglobulin e
611049|NCT00624832|Nitric Oxide|nitric oxide
611050|NCT00624832|skin prick test|skin prick test
611051|NCT00624845|Meniscectomy|meniscectomy
611052|NCT00624858|Depression|depression
611053|NCT00624858|depressed|depressed
611054|NCT00624858|overweight|overweight
611055|NCT00624858|obese|obese
611056|NCT00624871|Interleukin 1-beta|interleukin 1-beta
611057|NCT00624871|Interleukin 6|interleukin 6
611058|NCT00624871|Vitamin C|vitamin c
611059|NCT00624871|HIE|hie
611060|NCT00624871|neonates|neonates
611061|NCT00624884|Aortic regurgitation,velocity vector imaging|aortic regurgitation,velocity vector imaging
611062|NCT00624910|Post Operative Pain|post operative pain
611063|NCT00624910|Hysterectomy|hysterectomy
611064|NCT00624923|Coronary Artery Disease|coronary artery disease
611065|NCT00624923|Inflammation|inflammation
611066|NCT00624923|Overweight|overweight
611067|NCT00624923|Metabolic Syndrome|metabolic syndrome
611068|NCT00624923|Salsalate|salsalate
611069|NCT00624936|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
611070|NCT00624936|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
611071|NCT00624936|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
611072|NCT00624936|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
611073|NCT00624936|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
611074|NCT00624936|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
611265|NCT00625638|Advanced Cancer|advanced cancer
611075|NCT00624936|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
611076|NCT00624936|myelodysplastic syndromes|myelodysplastic syndromes
611077|NCT00624936|secondary acute myeloid leukemia|secondary acute myeloid leukemia
611078|NCT00624949|Turner syndrome|turner syndrome
611079|NCT00624949|aortic dimensions|aortic dimensions
611080|NCT00624949|blood pressure|blood pressure
611081|NCT00624949|aortic dilatation|aortic dilatation
611082|NCT00624949|aortic rupture|aortic rupture
611083|NCT00624962|childhood soft tissue sarcoma|childhood soft tissue sarcoma
611084|NCT00624962|neuroblastoma|neuroblastoma
611085|NCT00624962|childhood hepatoblastoma|childhood hepatoblastoma
611086|NCT00624962|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
611087|NCT00624962|childhood ependymoma|childhood ependymoma
611088|NCT00624962|childhood brain stem glioma|childhood brain stem glioma
611089|NCT00624962|childhood meningioma|childhood meningioma
611090|NCT00624962|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
611091|NCT00624962|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
611092|NCT00624962|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
611093|NCT00624962|central nervous system neoplasm|central nervous system neoplasm
611094|NCT00624962|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
611095|NCT00624962|childhood brain tumor|childhood brain tumor
611096|NCT00624962|childhood medulloblastoma|childhood medulloblastoma
611097|NCT00624988|Spinal cord injury|spinal cord injury
611098|NCT00624988|vibration therapy|vibration therapy
611099|NCT00624988|bone density|bone density
611100|NCT00625001|Turner Syndrome|turner syndrome
611101|NCT00625001|bone mineral density|bone mineral density
611102|NCT00625001|estrogen replacement therapy|estrogen replacement therapy
611103|NCT00625001|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
611104|NCT00625014|Insulin resistance|insulin resistance
611105|NCT00625014|Dyslipidemia|dyslipidemia
611106|NCT00625014|Haloperidol|haloperidol
611107|NCT00625027|Emergency Department Visit|emergency department visit
611108|NCT00625027|Telehealth Ontario|telehealth ontario
611109|NCT00625027|Triage Levels|triage levels
611110|NCT00625040|Incretin effect|incretin effect
611111|NCT00625040|Gastric banding|gastric banding
611112|NCT00625040|Glucagon|glucagon
611113|NCT00625040|Glucagon-Like Peptide 1|glucagon-like peptide 1
611114|NCT00625040|Gastric Inhibitory Peptide|gastric inhibitory peptide
611115|NCT00625040|Glucose Intestinal Peptide|glucose intestinal peptide
611116|NCT00625040|Insulin|insulin
611117|NCT00625040|C-peptide|c-peptide
611118|NCT00625053|Neuroticism|neuroticism
611119|NCT00625053|Hernia, ventral|hernia, ventral
611120|NCT00625053|Laparoscopy|laparoscopy
611121|NCT00625053|Quality of life|quality of life
611122|NCT00625066|precancerous condition|precancerous condition
611123|NCT00625066|colon cancer|colon cancer
611124|NCT00625066|rectal cancer|rectal cancer
611125|NCT00625079|pulmonary hypertension|pulmonary hypertension
611126|NCT00625079|pulmonary arterial hypertension|pulmonary arterial hypertension
611127|NCT00625079|interstitial lung disease|interstitial lung disease
611128|NCT00625079|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
611129|NCT00625092|peritoneal cavity cancer|peritoneal cavity cancer
611130|NCT00625118|Hib conjugate vaccine|hib conjugate vaccine
611131|NCT00625118|reactogenicity|reactogenicity
611132|NCT00625118|local reactions|local reactions
611133|NCT00625118|systemic symptoms|systemic symptoms
611134|NCT00625131|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
611135|NCT00625131|Tobacco Use Disorder|tobacco use disorder
611136|NCT00625170|Antipsychotics|antipsychotics
611137|NCT00625170|Olanzapine|olanzapine
611138|NCT00625170|Haloperidol|haloperidol
611139|NCT00625170|Insulin resistance|insulin resistance
611140|NCT00625170|Dyslipidemia|dyslipidemia
611141|NCT00625183|adenocarcinoma of the rectum|adenocarcinoma of the rectum
611142|NCT00625183|stage II rectal cancer|stage ii rectal cancer
611143|NCT00625183|stage III rectal cancer|stage iii rectal cancer
611144|NCT00625196|Healthy Japanese volunteers|healthy japanese volunteers
611145|NCT00625209|septic shock|septic shock
611146|NCT00625209|coagulation|coagulation
611147|NCT00625209|immunomodulation|immunomodulation
611148|NCT00625209|survival|survival
611149|NCT00625222|Electroencephalography|electroencephalography
611150|NCT00625222|Seizure frequency|seizure frequency
611151|NCT00625222|Seizure severity|seizure severity
611152|NCT00625235|Obesity|obesity
611153|NCT00625235|Weight loss|weight loss
611154|NCT00625235|Weight maintenance|weight maintenance
611155|NCT00625235|VLED|vled
611156|NCT00625261|Language delay|language delay
611157|NCT00625261|Speech and language disorders|speech and language disorders
611158|NCT00625261|Early language intervention|early language intervention
613450|NCT00626704|STS|sts
611159|NCT00625261|Parent-based language intervention|parent-based language intervention
611160|NCT00625274|Nexium|nexium
611161|NCT00625274|esomeprazole|esomeprazole
611162|NCT00625274|lansoprazole|lansoprazole
611163|NCT00625274|pantoprazole|pantoprazole
611164|NCT00625274|Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)|nonsteroidal anti-inflammatory drugs (nsaids)
611165|NCT00625300|repetitive transcranial stimulation|repetitive transcranial stimulation
611166|NCT00625300|Parkinson's Disease|parkinson's disease
611167|NCT00625313|Cataract|cataract
611168|NCT00625313|aphakia|aphakia
611169|NCT00625313|intraocular lens|intraocular lens
611170|NCT00625313|IOL|iol
611171|NCT00625313|Optical correction of aphakia|optical correction of aphakia
611172|NCT00625326|psoriasis|psoriasis
611173|NCT00625339|Chronic hepatitis B|chronic hepatitis b
611174|NCT00625339|Lamivudine|lamivudine
611175|NCT00625339|Entecavir|entecavir
611176|NCT00625352|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
611177|NCT00625352|Aged|aged
611178|NCT00625352|Gemcitabine|gemcitabine
611179|NCT00625352|UFT|uft
611180|NCT00625365|DEFINITY|definity
611181|NCT00625365|Safety|safety
611182|NCT00625365|Survelliance|survelliance
611183|NCT00625378|Cancer|cancer
611184|NCT00625378|Sorafenib|sorafenib
611185|NCT00625378|Extension program|extension program
611186|NCT00625391|postmenopausal, bone, dietary supplement, mind-body exercise|postmenopausal, bone, dietary supplement, mind-body exercise
611187|NCT00625404|Aspartate Aminotransferase (AST)|aspartate aminotransferase (ast)
611188|NCT00625404|Alanine Aminotransferase (ALT)|alanine aminotransferase (alt)
611189|NCT00625404|HIV|hiv
611190|NCT00625404|HIV Prevention|hiv prevention
611191|NCT00625404|Oral PrEP|oral prep
611192|NCT00625404|Truvada|truvada
611193|NCT00625404|women|women
611194|NCT00625404|Tenofovir|tenofovir
611195|NCT00625404|TDF|tdf
611196|NCT00625404|FTC|ftc
611197|NCT00625404|emtricitabine|emtricitabine
611198|NCT00625404|hepatitis|hepatitis
611199|NCT00625404|Pre-exposure Prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
611200|NCT00625404|HIV Seronegativity|hiv seronegativity
611201|NCT00625417|male breast cancer|male breast cancer
611202|NCT00625417|stage IA breast cancer|stage ia breast cancer
611203|NCT00625417|stage IB breast cancer|stage ib breast cancer
611204|NCT00625417|stage II breast cancer|stage ii breast cancer
611205|NCT00625417|stage IIIA breast cancer|stage iiia breast cancer
611206|NCT00625417|stage IIIB breast cancer|stage iiib breast cancer
611207|NCT00625417|stage IIIC breast cancer|stage iiic breast cancer
611208|NCT00625417|stage IV breast cancer|stage iv breast cancer
611209|NCT00625430|Prostate Cancer|prostate cancer
611210|NCT00625430|Gene Therapy|gene therapy
611211|NCT00625430|Fludarabine|fludarabine
611212|NCT00625430|Adenovirus|adenovirus
611214|NCT00625443|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
611215|NCT00625443|ITP|itp
611216|NCT00625443|Chronic Idiopathic Thrombocytopenic Purpura|chronic idiopathic thrombocytopenic purpura
611217|NCT00625456|phase I|phase i
611309|NCT00625742|Juven|juven
611218|NCT00625456|advanced metastatic solid tumors|advanced metastatic solid tumors
611219|NCT00625456|oncolytic virus|oncolytic virus
611220|NCT00625456|vaccinia virus|vaccinia virus
611221|NCT00625456|melanoma|melanoma
611222|NCT00625456|lung cancer|lung cancer
611223|NCT00625456|renal cell carcinoma|renal cell carcinoma
611224|NCT00625456|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
611225|NCT00625456|Pexa-Vec|pexa-vec
611226|NCT00625469|pulmonary arterial hypertension|pulmonary arterial hypertension
611227|NCT00625469|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
611228|NCT00625469|bosentan|bosentan
611229|NCT00625482|BCG vaccine|bcg vaccine
611230|NCT00625482|Oral polio vaccine|oral polio vaccine
611231|NCT00625482|Vitamin A supplementation|vitamin a supplementation
611232|NCT00625482|Low-birth-weigth|low-birth-weigth
611233|NCT00625482|Sex-differential|sex-differential
611234|NCT00625482|Prevention|prevention
611235|NCT00625482|Immunological parameters|immunological parameters
611236|NCT00625495|Gastroesophageal reflux disease|gastroesophageal reflux disease
611237|NCT00625495|Nexium|nexium
611238|NCT00625495|Esomeprazole|esomeprazole
611239|NCT00625495|Administration methods.|administration methods.
611240|NCT00625521|Discoid lupus erythematosus|discoid lupus erythematosus
611241|NCT00625534|Hernia|hernia
611242|NCT00625534|Laparoscopy|laparoscopy
611243|NCT00625534|Pain|pain
611244|NCT00625534|Sexual|sexual
611245|NCT00625534|Quality|quality
611246|NCT00625560|Chronic hepatitis B|chronic hepatitis b
611247|NCT00625560|Lamivudine|lamivudine
611248|NCT00625560|Entecavir|entecavir
611249|NCT00625573|Colon Cancer|colon cancer
611250|NCT00625573|Abraxis Oncology|abraxis oncology
611251|NCT00625573|Abraxane|abraxane
611252|NCT00625573|Phase II|phase ii
611253|NCT00625573|Colorectal|colorectal
611254|NCT00625573|Mt. Sinai Medical Center|mt. sinai medical center
611255|NCT00625573|CCOP|ccop
611256|NCT00625586|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
611257|NCT00625586|stage IV pancreatic cancer|stage iv pancreatic cancer
611258|NCT00625586|recurrent pancreatic cancer|recurrent pancreatic cancer
611259|NCT00625625|stage I colon cancer|stage i colon cancer
611260|NCT00625625|stage II colon cancer|stage ii colon cancer
611261|NCT00625625|stage III colon cancer|stage iii colon cancer
611262|NCT00625625|stage I rectal cancer|stage i rectal cancer
611263|NCT00625625|stage II rectal cancer|stage ii rectal cancer
611264|NCT00625625|stage III rectal cancer|stage iii rectal cancer
611267|NCT00625638|Interactive Voice Response|interactive voice response
611268|NCT00625638|Symptom Control|symptom control
611269|NCT00625638|IVR System|ivr system
611270|NCT00625638|Questionnaire|questionnaire
611271|NCT00625651|Colon Cancer|colon cancer
611272|NCT00625651|Colorectal Cancer|colorectal cancer
611273|NCT00625651|Rectal Cancer|rectal cancer
611274|NCT00625651|AMG 655|amg 655
611275|NCT00625651|Bevacizumab|bevacizumab
611276|NCT00625651|Modified FOLFOX6|modified folfox6
611277|NCT00625651|mFOLFOX6|mfolfox6
611278|NCT00625651|FOLFOX|folfox
611279|NCT00625664|Cancer|cancer
611280|NCT00625664|Neoplasms|neoplasms
611281|NCT00625664|Bladder|bladder
611282|NCT00625664|Urothelial Tract|urothelial tract
611283|NCT00625677|meningococcal serogroup C vaccine|meningococcal serogroup c vaccine
611284|NCT00625677|reduced dose|reduced dose
611285|NCT00625677|meningococcal serogroup C conjugate vaccine|meningococcal serogroup c conjugate vaccine
752348|NCT01172600|radiating back pain|radiating back pain
611286|NCT00625677|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
611287|NCT00625690|lung cancer|lung cancer
611288|NCT00625703|Pharmacokinetic|pharmacokinetic
611289|NCT00625729|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
611290|NCT00625729|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
611291|NCT00625729|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
611292|NCT00625729|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
611293|NCT00625729|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
611294|NCT00625729|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
611295|NCT00625729|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
611296|NCT00625729|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
611297|NCT00625729|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
611298|NCT00625729|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
611299|NCT00625729|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
611300|NCT00625729|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
611301|NCT00625729|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
611302|NCT00625729|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
611303|NCT00625729|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
611304|NCT00625729|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
611305|NCT00625742|Advanced Cancer|advanced cancer
611306|NCT00625742|Cancer Cachexia|cancer cachexia
611307|NCT00625742|Cachexia|cachexia
611308|NCT00625742|Melatonin|melatonin
611310|NCT00625742|Exercise Training|exercise training
611311|NCT00625742|Weight Loss|weight loss
611312|NCT00625755|renal cell carcinoma|renal cell carcinoma
611313|NCT00625755|AJCC Stage IV (primary or relasped) renal cell carcinoma|ajcc stage iv (primary or relasped) renal cell carcinoma
611314|NCT00625768|Antibody|antibody
611315|NCT00625768|safety|safety
611316|NCT00625768|tolerability|tolerability
611317|NCT00625768|efficacy|efficacy
611318|NCT00625768|metastatic renal cell carcinoma|metastatic renal cell carcinoma
611319|NCT00625768|metastatic malignant melanoma|metastatic malignant melanoma
611320|NCT00625781|Gestational diabetes mellitus|gestational diabetes mellitus
611321|NCT00625781|Impaired glucose Tolerance|impaired glucose tolerance
611322|NCT00625781|Pregnancy|pregnancy
611323|NCT00625781|Fetal macrosomia|fetal macrosomia
611324|NCT00625781|Treatment|treatment
611325|NCT00625781|Perinatal morbidity|perinatal morbidity
611326|NCT00625807|Stress|stress
611327|NCT00625807|meditation|meditation
611328|NCT00625807|stress reduction|stress reduction
611329|NCT00625807|fMRI|fmri
611330|NCT00625807|behavioral|behavioral
611331|NCT00625820|Kidney Disease|kidney disease
611332|NCT00625820|Albuminuria|albuminuria
611333|NCT00625820|Glomerular filtration rate|glomerular filtration rate
611334|NCT00607893|Sleep-Disordered Breathing|sleep-disordered breathing
611335|NCT00607906|safety|safety
611336|NCT00607906|pharmacodynamics|pharmacodynamics
611337|NCT00607906|diabetes|diabetes
611338|NCT00607906|pharmacokinetics|pharmacokinetics
611339|NCT00607932|recurrent prostate cancer|recurrent prostate cancer
611340|NCT00607945|Type 2 diabetes mellitus|type 2 diabetes mellitus
611341|NCT00607945|conjugated linoleic acid|conjugated linoleic acid
611342|NCT00607945|weight loss|weight loss
611343|NCT00607945|rosiglitazone|rosiglitazone
611344|NCT00607945|glucose control|glucose control
611345|NCT00607945|insulin sensitivity|insulin sensitivity
611346|NCT00607958|Tipranavir|tipranavir
611347|NCT00607958|ritonavir|ritonavir
611348|NCT00607958|dose reduction|dose reduction
611349|NCT00607958|inhibitory quotient|inhibitory quotient
611350|NCT00607971|Constipation predominant irritable bowel syndrome|constipation predominant irritable bowel syndrome
611352|NCT00607984|melphalan|melphalan
611353|NCT00607984|brain tumor|brain tumor
611354|NCT00607984|tumors of central nervous system and other solid tumors|tumors of central nervous system and other solid tumors
611355|NCT00607997|Leukemia|leukemia
611356|NCT00607997|Myeloid|myeloid
611357|NCT00607997|Elderly|elderly
611358|NCT00607997|Hematologic|hematologic
611361|NCT00607997|Malignancy|malignancy
611362|NCT00607997|SNS-595|sns-595
611363|NCT00607997|Sunesis|sunesis
611364|NCT00607997|Hematologic Diseases|hematologic diseases
611365|NCT00607997|Myelodysplastic Syndromes|myelodysplastic syndromes
611366|NCT00607997|Older|older
611367|NCT00607997|voreloxin|voreloxin
611368|NCT00607997|reveal-1|reveal-1
611369|NCT00608010|Preservation of supernumerary embryos in an IVF program|preservation of supernumerary embryos in an ivf program
611370|NCT00608023|HIV|hiv
611371|NCT00608023|Lipodystrophy|lipodystrophy
611372|NCT00608023|Abdominal fat accumulation|abdominal fat accumulation
611373|NCT00608023|Growth hormone releasing hormone|growth hormone releasing hormone
611374|NCT00608023|HIV-associated lipodystrophy|hiv-associated lipodystrophy
611375|NCT00608023|Treatment experienced|treatment experienced
611376|NCT00608036|Adolescents|adolescents
611377|NCT00608036|Neighborhood|neighborhood
611378|NCT00608036|Walkability|walkability
611379|NCT00608036|Physical Activity|physical activity
611380|NCT00608036|Quality of Life|quality of life
611381|NCT00608036|Ecological Analysis|ecological analysis
611382|NCT00608036|Dietary Patterns|dietary patterns
611383|NCT00608036|Weight Status|weight status
611384|NCT00608036|Neighborhood Environment|neighborhood environment
611385|NCT00608036|Food Environment|food environment
611386|NCT00608036|Recreation Environment|recreation environment
611387|NCT00608049|Blood Pressure|blood pressure
611388|NCT00608049|Diabetes|diabetes
611389|NCT00608049|Nutrition|nutrition
611390|NCT00608049|Dietary Carbohydrate|dietary carbohydrate
611391|NCT00608049|Lipoproteins|lipoproteins
611392|NCT00608049|Insulin Resistance|insulin resistance
611393|NCT00608062|endothelial function|endothelial function
611394|NCT00608062|women|women
611395|NCT00608062|female|female
611396|NCT00608062|estrogen deficiency|estrogen deficiency
611397|NCT00608062|sex hormones|sex hormones
611398|NCT00608062|adiposity|adiposity
611399|NCT00608062|oxidative stress|oxidative stress
611400|NCT00608062|antioxidants|antioxidants
611401|NCT00608088|Breast feeding|breast feeding
611402|NCT00608088|breastfeeding|breastfeeding
611403|NCT00608088|randomized clinical trial|randomized clinical trial
611404|NCT00608088|poverty|poverty
611405|NCT00608101|hypoglycemia|hypoglycemia
611406|NCT00608101|exercise|exercise
611407|NCT00608101|corticosteroids|corticosteroids
611408|NCT00608140|Advanced Heart Failure|advanced heart failure
611409|NCT00608140|Non-Ischemic Heart Failure|non-ischemic heart failure
611410|NCT00608140|Mitral Regurgitation|mitral regurgitation
611411|NCT00608140|Mitral Valve Replacement|mitral valve replacement
611412|NCT00608140|Congestive Heart Failure|congestive heart failure
611413|NCT00608140|Surgical Mitral Valvuloplasty|surgical mitral valvuloplasty
611414|NCT00608140|Dilated Cardiomyopathy|dilated cardiomyopathy
611415|NCT00608140|Annular Ring|annular ring
611416|NCT00608153|essential hypertension|essential hypertension
611417|NCT00608153|ARB|arb
611418|NCT00608153|compliance|compliance
611419|NCT00608153|candesartan|candesartan
611420|NCT00608179|epinephrine|epinephrine
611421|NCT00608179|glucose clamp|glucose clamp
611422|NCT00608192|HIV|hiv
611423|NCT00608192|viral hepatitis|viral hepatitis
611424|NCT00608192|methadone maintenance|methadone maintenance
611425|NCT00608192|case management|case management
611426|NCT00608192|costs|costs
611427|NCT00608192|vaccination|vaccination
611428|NCT00608192|risk reduction education|risk reduction education
611429|NCT00608205|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
611430|NCT00608205|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
611431|NCT00608205|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
611432|NCT00608205|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
611433|NCT00608205|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
611434|NCT00608205|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
611435|NCT00608205|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
611436|NCT00608205|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
611437|NCT00608218|Asthma|asthma
611438|NCT00608218|ciclesonide|ciclesonide
611439|NCT00608218|inhaled steroids|inhaled steroids
611440|NCT00608218|Alvesco|alvesco
611441|NCT00608244|Tacrolimus|tacrolimus
611442|NCT00608244|Pharmacokinetics|pharmacokinetics
611443|NCT00608244|Liver Transplantation|liver transplantation
613675|NCT00627796|GH|gh
611444|NCT00608283|Kidney transplant|kidney transplant
611445|NCT00608283|Live donor transplant|live donor transplant
611446|NCT00608322|Sepsis|sepsis
611447|NCT00608322|Severe sepsis|severe sepsis
611448|NCT00608322|Septic shock|septic shock
611449|NCT00608335|Antifungal|antifungal
611450|NCT00608335|Echinocandin|echinocandin
611451|NCT00608335|Candidiasis|candidiasis
611452|NCT00608335|Micafungin|micafungin
611453|NCT00619255|Adolescents|adolescents
611454|NCT00619255|Quality Assurance and Improvement|quality assurance and improvement
611455|NCT00619255|Substance Abuse|substance abuse
611456|NCT00619255|Posttraumatic Stress|posttraumatic stress
611457|NCT00619255|Family Centered Care|family centered care
611458|NCT00619255|Trauma Systems|trauma systems
611459|NCT00619268|Temsirolimus|temsirolimus
611460|NCT00619268|Bevacizumab|bevacizumab
611461|NCT00619268|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
611462|NCT00619268|Non-progression|non-progression
611463|NCT00619281|Cardiac surgery|cardiac surgery
611464|NCT00619281|Low cardiac output syndrome|low cardiac output syndrome
611465|NCT00619281|Mortality|mortality
611466|NCT00619281|Morbidity|morbidity
611467|NCT00619294|Coronary Vasospasm|coronary vasospasm
611468|NCT00619294|Endothelium, Vascular|endothelium, vascular
611469|NCT00619294|Vasodilation|vasodilation
611470|NCT00619294|Hyperemia|hyperemia
611471|NCT00619320|HIV primary prevention|hiv primary prevention
611472|NCT00619320|Health promotion|health promotion
611473|NCT00619320|Health behavior|health behavior
611474|NCT00619320|Risk reduction behavior|risk reduction behavior
611475|NCT00619320|Sexual behavior|sexual behavior
611476|NCT00619320|Safe sex|safe sex
611477|NCT00619320|Women's health|women's health
611478|NCT00619320|Minority health|minority health
611479|NCT00619320|Pregnant Women|pregnant women
611480|NCT00619320|HIV seronegativity|hiv seronegativity
611481|NCT00619346|Safety|safety
611482|NCT00619346|Tolerability|tolerability
611483|NCT00619346|Assessment of potential adverse events and/or laboratory abnormalities|assessment of potential adverse events and/or laboratory abnormalities
611484|NCT00619372|OKT3|okt3
611485|NCT00619372|beta-glucosylceramide|beta-glucosylceramide
611486|NCT00619372|oral tolerance|oral tolerance
611487|NCT00619372|anti-CD3|anti-cd3
611488|NCT00619372|Safety assessment and healthy volunteers|safety assessment and healthy volunteers
611489|NCT00619385|Pharmacokinetics|pharmacokinetics
611490|NCT00619398|FK506|fk506
611491|NCT00619398|tacrolimus|tacrolimus
611492|NCT00619398|prograf|prograf
611493|NCT00619398|Liver transplantation|liver transplantation
611494|NCT00619411|Major Depression|major depression
611495|NCT00619411|Dysthymic Disorder|dysthymic disorder
611496|NCT00619411|Adjustment Disorder|adjustment disorder
611497|NCT00619411|With Depressed Mood|with depressed mood
611498|NCT00619411|Depressive|depressive
611499|NCT00619411|Disorder Not|disorder not
611500|NCT00619411|Otherwise|otherwise
611501|NCT00619411|Specified|specified
611502|NCT00619411|Adolescent|adolescent
611503|NCT00619411|Psychotherapy|psychotherapy
611504|NCT00619424|erlotinib|erlotinib
611505|NCT00619424|pharmacokinetics|pharmacokinetics
611506|NCT00619424|Solid tumors|solid tumors
611507|NCT00619424|pemetrexed|pemetrexed
611508|NCT00619424|anti-angiogenesis|anti-angiogenesis
611509|NCT00619424|pazopanib (GW786034)|pazopanib (gw786034)
611510|NCT00619424|cytokine and angiogenic factors|cytokine and angiogenic factors
611511|NCT00619437|schizophrenia|schizophrenia
611512|NCT00619437|genetics|genetics
611514|NCT00619437|multiplex|multiplex
611515|NCT00619437|haplotypes|haplotypes
611516|NCT00619450|atrial fibrillation|atrial fibrillation
611517|NCT00619450|cardiac pacing|cardiac pacing
611518|NCT00619450|CAT scanner|cat scanner
611519|NCT00619463|Traumatic Brain Injury|traumatic brain injury
611520|NCT00619463|Exercise|exercise
611521|NCT00619463|Cognition|cognition
611522|NCT00619463|Brain Derived Neurotrophic Factor (BDNF)|brain derived neurotrophic factor (bdnf)
611523|NCT00619463|peripheral vascular endothelial growth factor (VEGF)|peripheral vascular endothelial growth factor (vegf)
611524|NCT00619476|Neuropathic Pain|neuropathic pain
611525|NCT00619476|Post-herpetic neuralgia|post-herpetic neuralgia
611526|NCT00619476|PHN|phn
611527|NCT00619502|Hepatitis B|hepatitis b
611528|NCT00619502|Polio|polio
611529|NCT00619502|Diphtheria|diphtheria
611530|NCT00619502|Pertussis|pertussis
611531|NCT00619502|H.influenzae type b|h.influenzae type b
611532|NCT00619515|adenocarcinoma of the prostate|adenocarcinoma of the prostate
611533|NCT00619515|stage I prostate cancer|stage i prostate cancer
611534|NCT00619515|stage II prostate cancer|stage ii prostate cancer
611535|NCT00619528|Transplants|transplants
611536|NCT00619528|Kidney Transplantation|kidney transplantation
611537|NCT00619528|Immunosuppression|immunosuppression
611538|NCT00619528|HLA Antigens|hla antigens
611539|NCT00619528|Stem Cells|stem cells
611540|NCT00619528|Bone Marrow|bone marrow
611541|NCT00619541|HCC|hcc
611542|NCT00619541|Sorafenib|sorafenib
611543|NCT00619541|Pisa|pisa
611544|NCT00619541|Ricci|ricci
611545|NCT00619541|5-FU|5-fu
611547|NCT00619541|5 FU|5 fu
611548|NCT00619541|Advanced HCC|advanced hcc
611549|NCT00619554|Healthy volunteers|healthy volunteers
611550|NCT00619567|Cognition|cognition
611551|NCT00619567|Rehabilitation|rehabilitation
611552|NCT00619567|Cognitive Stimulation|cognitive stimulation
611553|NCT00619567|Human Immunodeficiency Virus|human immunodeficiency virus
611554|NCT00619567|AIDS|aids
611555|NCT00619580|E coli|e coli
611556|NCT00619593|Heart failure|heart failure
611557|NCT00619593|Ventricular Fibrillation|ventricular fibrillation
611558|NCT00619593|Sudden cardiac death|sudden cardiac death
611559|NCT00619593|Hospitalization due to heart failure|hospitalization due to heart failure
611560|NCT00619593|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
611561|NCT00619593|Risk of 1st heart failure hospitalization|risk of 1st heart failure hospitalization
611562|NCT00619606|prevention of hypoxia|prevention of hypoxia
611563|NCT00619606|prevention of hypercapnia|prevention of hypercapnia
611564|NCT00619619|MDD|mdd
611565|NCT00619619|Child|child
611566|NCT00619619|Adolescent|adolescent
611567|NCT00619619|Pharmacokinetic|pharmacokinetic
611568|NCT00619619|Outpatient|outpatient
611569|NCT00619619|Pediatrics|pediatrics
611570|NCT00619619|Depressive Disorder|depressive disorder
611571|NCT00619619|Major|major
611572|NCT00619645|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
611573|NCT00619645|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
753140|NCT01175629|Mental Disorders|mental disorders
611574|NCT00619645|refractory anemia with excess blasts|refractory anemia with excess blasts
611575|NCT00619645|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
611576|NCT00619645|refractory anemia|refractory anemia
611577|NCT00619645|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
611578|NCT00619645|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
611579|NCT00619645|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
611580|NCT00619645|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
611581|NCT00619645|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
611582|NCT00619645|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
611583|NCT00619645|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
611584|NCT00619645|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
611585|NCT00619645|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
611586|NCT00619645|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
611587|NCT00619645|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
611588|NCT00619645|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
611589|NCT00619645|refractory multiple myeloma|refractory multiple myeloma
612040|NCT00630617|Prevention|prevention
611596|NCT00619645|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
611597|NCT00619645|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
611598|NCT00619645|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
611599|NCT00619645|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
611600|NCT00619645|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
611601|NCT00619645|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
611602|NCT00619645|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
611603|NCT00619645|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
611604|NCT00619645|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
611605|NCT00619645|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
611606|NCT00619645|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
611607|NCT00619645|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
611608|NCT00619645|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
611609|NCT00619645|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
611610|NCT00619645|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
611611|NCT00619645|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
611612|NCT00619645|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
611613|NCT00619645|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
611614|NCT00619645|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
611615|NCT00619645|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
611616|NCT00619645|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
611617|NCT00619645|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
611618|NCT00619645|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
611619|NCT00619645|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
611620|NCT00619645|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
611621|NCT00619645|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
611622|NCT00619645|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
611623|NCT00619645|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
611624|NCT00619645|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
611625|NCT00619645|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
611626|NCT00619645|stage I multiple myeloma|stage i multiple myeloma
611627|NCT00619645|stage II multiple myeloma|stage ii multiple myeloma
611628|NCT00619645|stage III multiple myeloma|stage iii multiple myeloma
611629|NCT00619645|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
611630|NCT00619645|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
611631|NCT00619658|telephone follow-up|telephone follow-up
611632|NCT00619658|medical abortion|medical abortion
611633|NCT00619658|induced abortion|induced abortion
611635|NCT00619671|Rituximab|rituximab
611636|NCT00619671|Myasthenia Gravis|myasthenia gravis
611637|NCT00619671|MG|mg
611648|NCT00625859|pharmacodynamics|pharmacodynamics
611649|NCT00625859|Healthy adult male volunteers,|healthy adult male volunteers,
611650|NCT00625859|pharmacokinetics,|pharmacokinetics,
611651|NCT00625885|Anterior Cruciate Ligament/injuries|anterior cruciate ligament/injuries
611652|NCT00625885|Anterior Cruciate Ligament/surgery|anterior cruciate ligament/surgery
611653|NCT00625885|Knee injuries/surgery|knee injuries/surgery
611654|NCT00625885|Outcomes research|outcomes research
611655|NCT00625885|Prospective Studies|prospective studies
611656|NCT00625898|HER2 positive breast cancer|her2 positive breast cancer
611657|NCT00625898|invasive breast cancer|invasive breast cancer
611658|NCT00625898|bevacizumab|bevacizumab
611659|NCT00625898|NSABP|nsabp
611660|NCT00625898|Roche|roche
611661|NCT00625898|CIRG|cirg
611662|NCT00625898|trastuzumab|trastuzumab
611663|NCT00625898|cyclophosphamide|cyclophosphamide
611664|NCT00625898|docetaxel|docetaxel
611665|NCT00625898|carboplatin|carboplatin
611666|NCT00625898|5-fluorouracil|5-fluorouracil
611667|NCT00625898|epirubicin|epirubicin
611668|NCT00625911|thoracotomy|thoracotomy
612041|NCT00630617|Childhood|childhood
611669|NCT00625911|minimally invasive direct coronary artery bypass|minimally invasive direct coronary artery bypass
611670|NCT00625911|ketamine|ketamine
611671|NCT00625911|pain|pain
611672|NCT00625924|Plastic surgery|plastic surgery
611673|NCT00625924|reconstruction|reconstruction
611674|NCT00625937|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
611675|NCT00625937|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
611676|NCT00625937|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
611677|NCT00625937|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
611678|NCT00625937|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
611679|NCT00625937|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
611680|NCT00625937|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
611681|NCT00625937|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
611682|NCT00625937|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
611683|NCT00625937|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
611684|NCT00625937|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
611685|NCT00625937|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
611686|NCT00625937|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
611687|NCT00625937|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
611688|NCT00625937|tongue cancer|tongue cancer
611689|NCT00625950|Hyperprolactinemia|hyperprolactinemia
611690|NCT00625950|Endometriosis|endometriosis
611691|NCT00625950|laparoscopy|laparoscopy
611692|NCT00625950|angiogenesis, VEGF|angiogenesis, vegf
611693|NCT00625963|Pulmonary Hypertension;|pulmonary hypertension;
611695|NCT00625963|CT Imaging;|ct imaging;
611696|NCT00625963|Echocardiogram;|echocardiogram;
611697|NCT00625963|Hemodynamic measurements of RHC.|hemodynamic measurements of rhc.
611698|NCT00625963|Pulmonary Function Tests|pulmonary function tests
611699|NCT00625976|Complex regional pain syndrome type I|complex regional pain syndrome type i
611700|NCT00625976|Graded exposure in vivo|graded exposure in vivo
611701|NCT00625976|Physiotherapy|physiotherapy
611702|NCT00625976|Pain-related fear|pain-related fear
611703|NCT00625989|asthma|asthma
611704|NCT00625989|atopy|atopy
611705|NCT00625989|allergen challenge|allergen challenge
611706|NCT00625989|sputum myeloid and plasmacytoid dendritic cells|sputum myeloid and plasmacytoid dendritic cells
611707|NCT00626002|Open label|open label
611708|NCT00626015|adult glioblastoma|adult glioblastoma
611709|NCT00626015|adult giant cell glioblastoma|adult giant cell glioblastoma
611710|NCT00626015|adult gliosarcoma|adult gliosarcoma
611711|NCT00626015|adult high grade glioma|adult high grade glioma
611712|NCT00626028|Pulmonary Vasculature|pulmonary vasculature
611713|NCT00626028|Nitric Oxide|nitric oxide
611714|NCT00626028|INOmax®|inomax®
611715|NCT00626028|Acute Lung Injury|acute lung injury
611716|NCT00626028|Pulmonary Vasodilator Testing|pulmonary vasodilator testing
611717|NCT00626028|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
611718|NCT00626028|Congenital Heart Disease|congenital heart disease
611719|NCT00626028|reversible pulmonary hypertension|reversible pulmonary hypertension
611720|NCT00626028|vasoreactivity|vasoreactivity
611721|NCT00626041|Community pharmacies|community pharmacies
611722|NCT00626041|Primary care networks|primary care networks
611723|NCT00626041|Global risk assessment|global risk assessment
611724|NCT00626041|Blood pressure screening|blood pressure screening
611725|NCT00626054|Colonoscopy|colonoscopy
611726|NCT00626054|PEG Solution|peg solution
611727|NCT00626067|Travatan Dosing Aid|travatan dosing aid
611728|NCT00626067|compliance monitoring dispenser|compliance monitoring dispenser
611729|NCT00626080|Insulin|insulin
611730|NCT00626080|Detemir|detemir
611731|NCT00626080|Brain|brain
611732|NCT00626080|Glucose metabolism|glucose metabolism
611733|NCT00626106|postmenopausal|postmenopausal
611734|NCT00626106|hormone receptor positive|hormone receptor positive
611735|NCT00626106|locally advanced|locally advanced
611736|NCT00626106|metastatic|metastatic
611737|NCT00626119|breast cancer|breast cancer
611738|NCT00626132|Blood pressure|blood pressure
611739|NCT00626132|Herbs|herbs
611740|NCT00626132|Food|food
611741|NCT00626145|BMMNC|bmmnc
611742|NCT00626145|STEMI|stemi
611743|NCT00626145|stem cell|stem cell
611744|NCT00626145|intracoronary delivery|intracoronary delivery
611745|NCT00626158|pancreatic cancer|pancreatic cancer
611746|NCT00626158|biliary cancer|biliary cancer
611747|NCT00626158|gemcitabine|gemcitabine
611748|NCT00626158|capecitabine|capecitabine
611749|NCT00629538|congestive heart failure|congestive heart failure
611750|NCT00629538|thoracentesis|thoracentesis
611751|NCT00629538|transudative pleural effusions|transudative pleural effusions
611752|NCT00629551|Major Depressive Disorder|major depressive disorder
611753|NCT00629551|Depression|depression
611754|NCT00629551|Major Depressive Episode|major depressive episode
611755|NCT00629551|Antidepressant|antidepressant
611756|NCT00629564|Gastroesophageal Reflux Disease (GERD), esomeprazole, Nexium|gastroesophageal reflux disease (gerd), esomeprazole, nexium
611758|NCT00629577|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
611759|NCT00629577|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
611760|NCT00629577|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
611761|NCT00629603|hepatitis C virus infection|hepatitis c virus infection
611762|NCT00629603|chronic liver disease|chronic liver disease
611763|NCT00629603|fibrosis-related cytokine|fibrosis-related cytokine
611764|NCT00629616|stage II breast cancer|stage ii breast cancer
611765|NCT00629616|stage IIIA breast cancer|stage iiia breast cancer
611766|NCT00629616|stage IIIB breast cancer|stage iiib breast cancer
611767|NCT00629616|stage IIIC breast cancer|stage iiic breast cancer
611768|NCT00629629|Health Plan Implementation|health plan implementation
611769|NCT00629629|Feeding and Eating Disorders of Childhood|feeding and eating disorders of childhood
611770|NCT00629629|Breastfeeding|breastfeeding
611771|NCT00629629|Complementary feeding|complementary feeding
611773|NCT00629629|Anemia|anemia
611774|NCT00629629|Public policy|public policy
611777|NCT00629655|fMRI|fmri
611778|NCT00629655|spinal cord|spinal cord
611779|NCT00629655|human|human
611780|NCT00629655|health|health
611781|NCT00629655|cerebral infarction|cerebral infarction
611782|NCT00629655|healthy|healthy
611783|NCT00629694|adenoidectomy, myringotomy, tubes insertion, otitis media, adenoid hyperthophy|adenoidectomy, myringotomy, tubes insertion, otitis media, adenoid hyperthophy
611784|NCT00629707|diabetic ketoacidosis|diabetic ketoacidosis
611785|NCT00629707|DKA|dka
611786|NCT00629707|cerebral edema|cerebral edema
611787|NCT00629707|brain edema|brain edema
611788|NCT00629720|elevated detrusor leak point pressure|elevated detrusor leak point pressure
611789|NCT00629733|pharmacokinetics|pharmacokinetics
611790|NCT00629733|ultra low molecular weight heparin|ultra low molecular weight heparin
611791|NCT00629746|Thyroid|thyroid
611792|NCT00629746|RLN|rln
611793|NCT00629746|EMG|emg
611794|NCT00629759|Jennerex|jennerex
611795|NCT00629759|unresectable liver tumors|unresectable liver tumors
611796|NCT00629759|primary liver cancer|primary liver cancer
611797|NCT00629759|metastatic liver cancer|metastatic liver cancer
611798|NCT00629759|oncolytic virus|oncolytic virus
611799|NCT00629759|vaccinia virus|vaccinia virus
611800|NCT00629759|Pexa-Vec|pexa-vec
611801|NCT00629772|Palmoplantar psoriasis|palmoplantar psoriasis
611802|NCT00629772|Infliximab|infliximab
611803|NCT00629785|asthma|asthma
611804|NCT00629785|pulmonary function tests|pulmonary function tests
611805|NCT00629785|obesity|obesity
611806|NCT00629798|Busulfan|busulfan
611807|NCT00629798|Melphalan|melphalan
611808|NCT00629798|Fludarabine|fludarabine
611809|NCT00629798|08-008|08-008
611810|NCT00629811|Cicatrix|cicatrix
611811|NCT00629811|Scar|scar
611812|NCT00629811|TGFβ3|tgfβ3
611813|NCT00629811|Avotermin|avotermin
611814|NCT00629811|Juvista|juvista
611815|NCT00629811|RN1001|rn1001
611816|NCT00629824|chronic hepatitis C|chronic hepatitis c
611817|NCT00629824|sustained virological response|sustained virological response
611818|NCT00629824|rapid virological response|rapid virological response
611819|NCT00629824|peginterferon|peginterferon
611821|NCT00629824|old age|old age
611822|NCT00629837|FVIII|fviii
611823|NCT00629837|Long acting|long acting
611824|NCT00629837|pk|pk
611825|NCT00629850|spinal cord injury|spinal cord injury
611826|NCT00629850|respiratory muscle training|respiratory muscle training
611827|NCT00629850|sleep quality|sleep quality
611828|NCT00629863|stage I gastric cancer|stage i gastric cancer
611829|NCT00629863|stage II gastric cancer|stage ii gastric cancer
611830|NCT00629863|stage III gastric cancer|stage iii gastric cancer
612778|NCT00632736|safety|safety
611831|NCT00629863|stage I esophageal cancer|stage i esophageal cancer
611832|NCT00629863|stage II esophageal cancer|stage ii esophageal cancer
611833|NCT00629863|stage III esophageal cancer|stage iii esophageal cancer
611834|NCT00629876|Chemotherapy|chemotherapy
611835|NCT00629876|Drug Therapy|drug therapy
611836|NCT00629889|seizure|seizure
611837|NCT00629889|adult anaplastic astrocytoma|adult anaplastic astrocytoma
611838|NCT00629889|adult diffuse astrocytoma|adult diffuse astrocytoma
611839|NCT00629889|adult pineal gland astrocytoma|adult pineal gland astrocytoma
611840|NCT00629889|adult glioblastoma|adult glioblastoma
611841|NCT00629889|adult gliosarcoma|adult gliosarcoma
611842|NCT00629889|adult giant cell glioblastoma|adult giant cell glioblastoma
611843|NCT00629889|adult brain stem glioma|adult brain stem glioma
611844|NCT00629889|adult ependymoblastoma|adult ependymoblastoma
611845|NCT00629889|adult medulloblastoma|adult medulloblastoma
611846|NCT00629889|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
611847|NCT00629889|adult ependymoma|adult ependymoma
611848|NCT00629889|adult anaplastic ependymoma|adult anaplastic ependymoma
611849|NCT00629889|adult anaplastic meningioma|adult anaplastic meningioma
612042|NCT00630617|Children|children
611850|NCT00629889|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
611851|NCT00629889|adult oligodendroglioma|adult oligodendroglioma
611852|NCT00629889|adult pineoblastoma|adult pineoblastoma
611853|NCT00629889|adult pineocytoma|adult pineocytoma
611854|NCT00629889|adult mixed glioma|adult mixed glioma
611855|NCT00629889|adult papillary meningioma|adult papillary meningioma
611856|NCT00629889|recurrent adult brain tumor|recurrent adult brain tumor
611857|NCT00629889|adult grade II meningioma|adult grade ii meningioma
611858|NCT00629902|Heart valve prosthesis|heart valve prosthesis
611859|NCT00629915|Moyamoya|moyamoya
611860|NCT00629915|stroke|stroke
611861|NCT00629928|NSAID, Nexium, esomeprazole, Gastric Ulcers|nsaid, nexium, esomeprazole, gastric ulcers
611862|NCT00629954|ABUJA HEART STUDY NIGERIA|abuja heart study nigeria
611863|NCT00629954|CARDIOVASCULAR DISEASES|cardiovascular diseases
611864|NCT00629967|chronic hepatitis C|chronic hepatitis c
611865|NCT00629967|genotype 1|genotype 1
611866|NCT00629967|rapid virological response|rapid virological response
611867|NCT00629967|sustained virological response|sustained virological response
611868|NCT00629967|peginterferon|peginterferon
611869|NCT00629967|ribavirin|ribavirin
611870|NCT00629967|treatment duration|treatment duration
611871|NCT00629993|cervical cancer screening|cervical cancer screening
611872|NCT00629993|medically underserved women|medically underserved women
611873|NCT00629993|HPV vaccine|hpv vaccine
611874|NCT00630019|Aqueous humor penetration by anti-infectives|aqueous humor penetration by anti-infectives
611875|NCT00630032|stage II breast cancer|stage ii breast cancer
611876|NCT00630032|stage IIIA breast cancer|stage iiia breast cancer
611877|NCT00630032|stage IIIB breast cancer|stage iiib breast cancer
611878|NCT00630032|stage IIIC breast cancer|stage iiic breast cancer
611879|NCT00630058|Chronic Hepatitis C|chronic hepatitis c
611880|NCT00630058|Protease Inhibitor|protease inhibitor
611881|NCT00630058|Telaprevir|telaprevir
611882|NCT00630071|Diagnostic Appendicitis|diagnostic appendicitis
611883|NCT00630071|Procalcitonin|procalcitonin
611884|NCT00630084|chronic hepatitis C|chronic hepatitis c
611885|NCT00630084|sustained virological response|sustained virological response
611886|NCT00630084|peginterferon|peginterferon
611887|NCT00630084|ribavirin|ribavirin
611888|NCT00630084|neoplasms|neoplasms
611889|NCT00630097|methamphetamine addiction, meth dependence|methamphetamine addiction, meth dependence
611890|NCT00630110|Non Small Cell Lung|non small cell lung
611891|NCT00630149|Nasopharyngeal Neoplasms|nasopharyngeal neoplasms
611892|NCT00630149|Pemetrexed|pemetrexed
611893|NCT00630162|protozoa|protozoa
611894|NCT00630162|Amoeba|amoeba
611895|NCT00630175|Insomnia|insomnia
611896|NCT00630188|prostate cancer screening|prostate cancer screening
611897|NCT00630188|shared decision making|shared decision making
611898|NCT00630188|prostate-specific antigen|prostate-specific antigen
611899|NCT00630188|decision making|decision making
611900|NCT00630188|physician-patient relations|physician-patient relations
611901|NCT00630201|opioid dependence|opioid dependence
611902|NCT00630201|opioid addiction|opioid addiction
611903|NCT00630201|buprenorphine|buprenorphine
611904|NCT00630201|methadone|methadone
611905|NCT00630201|heroin|heroin
611906|NCT00630201|implant|implant
611907|NCT00630201|opioid withdrawal|opioid withdrawal
611908|NCT00630201|opioid pain medication|opioid pain medication
611909|NCT00630201|suboxone|suboxone
611910|NCT00630214|Total thyroidectomy|total thyroidectomy
611911|NCT00630214|CND|cnd
611912|NCT00630214|hypocalcemia|hypocalcemia
611913|NCT00630214|calcium|calcium
611914|NCT00630214|vitamin D|vitamin d
611915|NCT00630227|emphysema|emphysema
611916|NCT00630227|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
611917|NCT00630227|lung volume reduction|lung volume reduction
611918|NCT00630240|epirubicin|epirubicin
611919|NCT00630240|mitomycin C|mitomycin c
611920|NCT00630240|cisplatin|cisplatin
611921|NCT00630240|Hepatocellular carcinoma|hepatocellular carcinoma
611922|NCT00630253|Fanconi anemia|fanconi anemia
611923|NCT00630266|Heart failure|heart failure
611924|NCT00630266|left ventricular dilation|left ventricular dilation
611925|NCT00630266|mitral valve repair|mitral valve repair
611926|NCT00630266|mitral valve replacement|mitral valve replacement
611927|NCT00630279|pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
611928|NCT00630279|chronic pancreatitis|chronic pancreatitis
611929|NCT00630305|toric|toric
611930|NCT00630305|endothelial bleb|endothelial bleb
611931|NCT00630318|MR scanning|mr scanning
611932|NCT00630331|Influenza|influenza
611933|NCT00630331|Flu|flu
611934|NCT00630331|Cell Culture-Derived|cell culture-derived
611935|NCT00630331|Egg-Derived|egg-derived
611936|NCT00630331|Healthy Adults|healthy adults
611937|NCT00630331|Efficacy|efficacy
611938|NCT00630331|Safety|safety
611939|NCT00630331|Immunogenicity|immunogenicity
611940|NCT00630331|Trivalent|trivalent
611941|NCT00630331|Inactivated|inactivated
611942|NCT00630331|Influenza-Like Illness|influenza-like illness
611943|NCT00630331|Vaccination|vaccination
611944|NCT00630344|RAD001|rad001
611945|NCT00630344|bicalutamide|bicalutamide
611946|NCT00630344|androgen independent prostate cancer|androgen independent prostate cancer
611947|NCT00630357|Levetiracetam|levetiracetam
611948|NCT00630357|Keppra|keppra
611949|NCT00630383|Parasite|parasite
611950|NCT00630383|Necator|necator
612440|NCT00622700|CDMS|cdms
611951|NCT00630383|immune regulation|immune regulation
611952|NCT00630383|regulatory T cells|regulatory t cells
611954|NCT00630383|cytokines|cytokines
611955|NCT00630383|multiple sclerosis|multiple sclerosis
611956|NCT00630383|hygiene hypothesis|hygiene hypothesis
611957|NCT00630396|stroke|stroke
611958|NCT00630396|ischemic|ischemic
611959|NCT00630396|neuroprotection|neuroprotection
611960|NCT00630396|minocycline|minocycline
611961|NCT00630396|tissue plasminogen activator (tPA)|tissue plasminogen activator (tpa)
611962|NCT00630396|biomarkers|biomarkers
611963|NCT00630396|pharmacokinetics|pharmacokinetics
611964|NCT00630396|antiapoptotic|antiapoptotic
611965|NCT00630396|anti-inflammatory|anti-inflammatory
611966|NCT00630396|treatment|treatment
611967|NCT00630396|matrix metalloproteinase-9 (MMP-9)|matrix metalloproteinase-9 (mmp-9)
611968|NCT00630396|thrombolysis|thrombolysis
611969|NCT00630396|Minocycline to Improve Neurologic Outcome in Stroke (MINOS)|minocycline to improve neurologic outcome in stroke (minos)
611970|NCT00630396|cerebrovascular stroke|cerebrovascular stroke
611971|NCT00630396|cerebrovascular accident|cerebrovascular accident
611972|NCT00630396|cerebral stroke|cerebral stroke
611973|NCT00630396|cerebrovascular accident (CVA)|cerebrovascular accident (cva)
611974|NCT00630409|Renal cell carcinoma|renal cell carcinoma
611975|NCT00630409|Kidney Cancer|kidney cancer
611976|NCT00630409|Gemcitabine|gemcitabine
611977|NCT00630409|Doxil|doxil
611978|NCT00630409|Chemotherapy|chemotherapy
611979|NCT00630422|Rett Syndrome|rett syndrome
611980|NCT00630422|Selfcare|selfcare
611981|NCT00630422|Mobility limitation|mobility limitation
611982|NCT00630422|Interpersonal relations|interpersonal relations
611983|NCT00630422|This study avaliated patients with Rett Syndrome|this study avaliated patients with rett syndrome
611984|NCT00630435|Premarin®|premarin®
611985|NCT00630461|mild asthma, mild allergies|mild asthma, mild allergies
611986|NCT00630474|sleep apnea, rhinitis|sleep apnea, rhinitis
611987|NCT00630500|Dementia associated with Parkinson's disease|dementia associated with parkinson's disease
611988|NCT00630500|Dementia with Lewy bodies|dementia with lewy bodies
611989|NCT00630500|Memantine|memantine
611990|NCT00630500|Placebo-controlled|placebo-controlled
611991|NCT00630500|Parallel group|parallel group
611992|NCT00630513|localized community acquired intra-abdominal infection (IAI)|localized community acquired intra-abdominal infection (iai)
611993|NCT00630513|antibiotics|antibiotics
611994|NCT00630513|localized peritonitis|localized peritonitis
611995|NCT00630513|ertapenem|ertapenem
611996|NCT00630539|Menopausal symptoms|menopausal symptoms
611997|NCT00630539|Urogenital atrophy|urogenital atrophy
611998|NCT00630539|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
611999|NCT00630539|Vaginal atrophy|vaginal atrophy
612000|NCT00630552|AMG 479|amg 479
612001|NCT00630552|Gemcitabine|gemcitabine
612002|NCT00630552|TR-2|tr-2
612003|NCT00630552|IGF-1R|igf-1r
612004|NCT00630552|AMG 655|amg 655
612005|NCT00630552|Pancreatic cancer|pancreatic cancer
612006|NCT00630552|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
612007|NCT00630552|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
612008|NCT00630565|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
612009|NCT00630565|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
612010|NCT00630565|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
612011|NCT00630565|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
612012|NCT00630565|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
612013|NCT00630565|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
612014|NCT00630565|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
612016|NCT00630578|Posttraumatic Stress Disorder|posttraumatic stress disorder
612017|NCT00630578|Physical Assault|physical assault
612018|NCT00630578|Physical Abuse|physical abuse
612019|NCT00630578|Sexual Assault|sexual assault
612020|NCT00630578|Sexual Abuse|sexual abuse
612021|NCT00630578|Interpersonal Assault|interpersonal assault
612022|NCT00630578|Cognitive Processing Therapy|cognitive processing therapy
612023|NCT00630591|Daughters And MothErS Against Breast Cancer|daughters and mothers against breast cancer
612024|NCT00630591|DAMES|dames
612025|NCT00630591|Breast Cancer|breast cancer
612026|NCT00630591|Weight Loss|weight loss
612027|NCT00630591|Home-based weight loss|home-based weight loss
612028|NCT00630591|Quality of Life|quality of life
612029|NCT00630591|Diet|diet
612030|NCT00630591|Exercise|exercise
612031|NCT00630591|Daughter|daughter
612032|NCT00630591|Mother|mother
612033|NCT00630591|Cancer Prevention|cancer prevention
612034|NCT00630591|Prevention|prevention
612035|NCT00630604|ultrasonography|ultrasonography
612036|NCT00630604|knee|knee
612037|NCT00630604|early degeneration|early degeneration
612038|NCT00630604|cartilage|cartilage
612039|NCT00630617|Obesity|obesity
612043|NCT00630617|Primary care-giver|primary care-giver
612044|NCT00630630|Levetiracetam|levetiracetam
612045|NCT00630630|Keppra|keppra
612046|NCT00630656|sepsis|sepsis
612047|NCT00630656|talactoferrin|talactoferrin
612048|NCT00630656|lactoferrin|lactoferrin
612049|NCT00630656|recombinant human lactoferrin|recombinant human lactoferrin
612050|NCT00630669|Internal hemorrhoids|internal hemorrhoids
612051|NCT00630669|Rubber band ligation|rubber band ligation
612052|NCT00630669|Bipolar coagulation|bipolar coagulation
612053|NCT00630682|Methamphetamine|methamphetamine
612054|NCT00630682|Drug Abuse|drug abuse
612055|NCT00630682|Drug Treatment|drug treatment
612056|NCT00630682|Addiction|addiction
612057|NCT00630682|Meth|meth
612058|NCT00630682|Treatment for Methamphetamine Dependence|treatment for methamphetamine dependence
612059|NCT00630695|Axillary lymphocele breast cancer|axillary lymphocele breast cancer
612060|NCT00630708|Renal insufficiency|renal insufficiency
612061|NCT00630708|Benazepril|benazepril
612062|NCT00630708|Losartan|losartan
612063|NCT00630708|combination treatment|combination treatment
612064|NCT00630708|Safety|safety
612066|NCT00630734|Pravastatin|pravastatin
612067|NCT00630734|Darunavir|darunavir
612068|NCT00630734|Ritonavir|ritonavir
612069|NCT00630734|Genetic|genetic
612070|NCT00630747|Hunter syndrome|hunter syndrome
612071|NCT00630747|hunters syndrome|hunters syndrome
612072|NCT00630747|hunter's syndrome|hunter's syndrome
612073|NCT00630747|hunter disease|hunter disease
612074|NCT00630747|hunters disease|hunters disease
612075|NCT00630747|hunter's disease|hunter's disease
612076|NCT00630747|MPS II|mps ii
612077|NCT00630747|MPSII|mpsii
612078|NCT00630747|MPS2|mps2
612079|NCT00630747|MPS 2|mps 2
612080|NCT00630747|mucopolysaccharides|mucopolysaccharides
612081|NCT00630747|lysosomal storage disease|lysosomal storage disease
612082|NCT00630747|lysosomal storage disorder|lysosomal storage disorder
612083|NCT00630747|chronic ear infection|chronic ear infection
612084|NCT00630747|enlarged adenoids|enlarged adenoids
612085|NCT00630747|mps symptoms|mps symptoms
612086|NCT00630747|mps diagnosis|mps diagnosis
612087|NCT00630747|mps ii therapy|mps ii therapy
612088|NCT00630747|MPS II treatment|mps ii treatment
612089|NCT00630747|ert treatment|ert treatment
612090|NCT00630747|elaprase|elaprase
612091|NCT00630747|idursulfase|idursulfase
612092|NCT00630747|iduronate sulfatase|iduronate sulfatase
612093|NCT00630747|iduronate 2 sulfatase|iduronate 2 sulfatase
612094|NCT00630747|enzyme replacement therapy|enzyme replacement therapy
612095|NCT00630747|hunter syndrome treatment|hunter syndrome treatment
612096|NCT00630747|hunter's syndrome treatment|hunter's syndrome treatment
612097|NCT00630747|hunter syndrome therapy|hunter syndrome therapy
612098|NCT00630747|hunter's disease treatment|hunter's disease treatment
612099|NCT00630747|mps society|mps society
612100|NCT00630773|CPR|cpr
612101|NCT00630773|compression sensor|compression sensor
612102|NCT00630773|chest compression adjuncts|chest compression adjuncts
612103|NCT00630799|prostate|prostate
612104|NCT00630799|cancer|cancer
612105|NCT00630812|cystic fibrosis|cystic fibrosis
612106|NCT00630812|mannitol|mannitol
612107|NCT00630812|mucoactive|mucoactive
612108|NCT00630838|Hirschsprung disease|hirschsprung disease
612109|NCT00630838|enterocolitis|enterocolitis
612110|NCT00630838|probiotics|probiotics
612111|NCT00630864|Transthyretin, TTR, amyloidosis, TTR amyloidosis, polyneuropathy|transthyretin, ttr, amyloidosis, ttr amyloidosis, polyneuropathy
612112|NCT00630890|Hilar Cholangiocarcinoma (Klatskin Tumor)|hilar cholangiocarcinoma (klatskin tumor)
612113|NCT00630890|External Beam Radiation|external beam radiation
612114|NCT00630890|Cyberknife|cyberknife
612115|NCT00630890|Capecitabine|capecitabine
612116|NCT00630916|Aortic valve insufficiency|aortic valve insufficiency
612117|NCT00630916|Aortic valve|aortic valve
612118|NCT00630916|Aortic disease|aortic disease
612119|NCT00630916|Aortic incompetence|aortic incompetence
612120|NCT00630942|PSC|psc
612974|NCT00633542|interferon|interferon
612121|NCT00630955|Alcohol Drinking|alcohol drinking
612122|NCT00630955|Memantine|memantine
612123|NCT00630968|Levetiracetam|levetiracetam
612124|NCT00630968|Keppra|keppra
612125|NCT00630981|dissociative disorders|dissociative disorders
612126|NCT00630994|primary myelofibrosis|primary myelofibrosis
612127|NCT00630994|secondary myelofibrosis|secondary myelofibrosis
612128|NCT00630994|essential thrombocythemia|essential thrombocythemia
612129|NCT00630994|polycythemia vera|polycythemia vera
612130|NCT00631007|Type 2 diabetes|type 2 diabetes
612131|NCT00631007|diabetes|diabetes
612132|NCT00631007|diabetes mellitus|diabetes mellitus
612133|NCT00631007|diabetes mellitus, type 2|diabetes mellitus, type 2
612134|NCT00631007|non-TZD|non-tzd
612135|NCT00631007|thiazolidinedione|thiazolidinedione
752352|NCT01172600|Lumbar Epidural Steroid Block with 3 injections|lumbar epidural steroid block with 3 injections
612136|NCT00631007|selective peroxisome proliferator-activated receptor gamma modulator|selective peroxisome proliferator-activated receptor gamma modulator
612137|NCT00631007|SPPARM|spparm
612138|NCT00631007|peroxisome proliferator-activated receptor gamma|peroxisome proliferator-activated receptor gamma
612139|NCT00631007|PPAR gamma|ppar gamma
612140|NCT00631007|insulin sensitizer|insulin sensitizer
612141|NCT00631007|glucose control|glucose control
612142|NCT00631007|endocrinopathy|endocrinopathy
612143|NCT00631007|hypoglycemic agent|hypoglycemic agent
612144|NCT00631007|sulfonylurea|sulfonylurea
612145|NCT00631007|metformin|metformin
612146|NCT00631007|pioglitazone|pioglitazone
612147|NCT00631007|nutritional and metabolic diseases|nutritional and metabolic diseases
612148|NCT00631020|Youth|youth
612149|NCT00631020|Smoking|smoking
612150|NCT00631020|Tobacco|tobacco
612151|NCT00631020|Adolescent|adolescent
612152|NCT00631020|Dependence|dependence
612153|NCT00631020|Teen smoking|teen smoking
612154|NCT00631020|Smoking and youth|smoking and youth
612155|NCT00631020|Youth and tobacco|youth and tobacco
612156|NCT00631033|obesity|obesity
612157|NCT00631033|hyperinsulinism|hyperinsulinism
612158|NCT00631033|diazoxide|diazoxide
612159|NCT00631033|metformin|metformin
612160|NCT00631046|n-3 LCPUFA|n-3 lcpufa
612161|NCT00631046|Fish oil|fish oil
612162|NCT00631046|essential fatty acids|essential fatty acids
612163|NCT00631046|infant growth|infant growth
612164|NCT00631046|obesity|obesity
612165|NCT00631046|Intestinal microbiota|intestinal microbiota
612166|NCT00631059|Hitachi|hitachi
612167|NCT00631059|Leukemia|leukemia
612168|NCT00631059|Relapse|relapse
612169|NCT00631059|Chemotherapy Resistance|chemotherapy resistance
612170|NCT00631072|iNKT|inkt
612171|NCT00631072|in vitro autologous iNKT|in vitro autologous inkt
612172|NCT00631085|healthy nonsmoking nonasthmatic volunteers|healthy nonsmoking nonasthmatic volunteers
612173|NCT00631098|Resuscitation|resuscitation
612174|NCT00631098|venous cannulation|venous cannulation
612175|NCT00631098|external jugular vein|external jugular vein
612176|NCT00631098|cubital vein|cubital vein
612177|NCT00631111|dental pain|dental pain
612178|NCT00631111|analgesic|analgesic
612179|NCT00631111|NSAID|nsaid
612180|NCT00631111|ibuprofen|ibuprofen
612181|NCT00631111|aspirin|aspirin
612182|NCT00631124|Contraception|contraception
612183|NCT00631137|musculoskeletal complications|musculoskeletal complications
612184|NCT00631137|adult anaplastic astrocytoma|adult anaplastic astrocytoma
612185|NCT00631137|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
612186|NCT00631137|adult giant cell glioblastoma|adult giant cell glioblastoma
612187|NCT00631137|adult glioblastoma|adult glioblastoma
612188|NCT00631137|adult gliosarcoma|adult gliosarcoma
612189|NCT00631150|Levetiracetam|levetiracetam
612190|NCT00631150|Keppra|keppra
612191|NCT00631163|Iron Overload,|iron overload,
612192|NCT00631163|Chelation,|chelation,
612193|NCT00631163|MDS,|mds,
612194|NCT00631163|Chronic Anemia,|chronic anemia,
612195|NCT00631163|Deferasirox,|deferasirox,
612196|NCT00631163|Transfusional hemosiderosis,|transfusional hemosiderosis,
612197|NCT00631176|oral intubation|oral intubation
612198|NCT00631176|just in time|just in time
612199|NCT00631176|simulation education|simulation education
612200|NCT00631176|high fidelity training|high fidelity training
612201|NCT00631176|intubation training|intubation training
612202|NCT00631176|intubation success|intubation success
612203|NCT00631189|dyslipidemia|dyslipidemia
612204|NCT00631202|FRDA|frda
612205|NCT00631202|Erythropoietin|erythropoietin
612206|NCT00631202|Epoetin alfa|epoetin alfa
612207|NCT00631215|Hyperbaric|hyperbaric
612208|NCT00631215|Oxygen|oxygen
612209|NCT00631215|autism|autism
612210|NCT00631228|drug eluting stents|drug eluting stents
612211|NCT00631228|stents|stents
612212|NCT00631228|Angioplasty|angioplasty
612213|NCT00631228|coronary artery disease|coronary artery disease
612214|NCT00631228|total coronary occlusion|total coronary occlusion
612215|NCT00631228|coronary artery restenosis|coronary artery restenosis
612216|NCT00631228|stent thrombosis|stent thrombosis
612217|NCT00631228|vascular disease|vascular disease
612218|NCT00631228|myocardial ischemia|myocardial ischemia
612219|NCT00631228|coronary artery stenosis|coronary artery stenosis
612220|NCT00631241|Cervical Cancer|cervical cancer
612221|NCT00631241|Parametrial Lymph Nodes|parametrial lymph nodes
612222|NCT00631241|Sentinel Nodes|sentinel nodes
612223|NCT00631241|Intraoperative Lymphatic Mapping|intraoperative lymphatic mapping
612224|NCT00631241|Single Photon Emission Computed Tomography|single photon emission computed tomography
612225|NCT00631241|SPECT/CT|spect/ct
612226|NCT00631267|reduction|reduction
612227|NCT00631267|satisfaction|satisfaction
612228|NCT00631267|visual-analog scale|visual-analog scale
612229|NCT00631267|complications|complications
612230|NCT00631267|functional outcome|functional outcome
612231|NCT00631267|radiological outcome|radiological outcome
612232|NCT00631280|Decision Aid|decision aid
612233|NCT00631280|Informed Choice|informed choice
612234|NCT00631280|Adherence|adherence
612235|NCT00631293|Healthy volunteers|healthy volunteers
612236|NCT00631319|OA|oa
612237|NCT00631319|Chronic Pain|chronic pain
612238|NCT00631319|Osteoarthritis|osteoarthritis
612239|NCT00631319|OA Pain|oa pain
612240|NCT00631319|Osteoarthritis Pain|osteoarthritis pain
612241|NCT00631319|Pain|pain
612242|NCT00631319|Hip Pain|hip pain
612243|NCT00631319|Knee Pain|knee pain
612244|NCT00631319|Joint Pain|joint pain
612441|NCT00622700|relapses|relapses
612541|NCT00623051|HIV|hiv
612245|NCT00631332|women, dementia, cognition.|women, dementia, cognition.
612246|NCT00631332|non-demented women at least age 65|non-demented women at least age 65
612247|NCT00631345|prediabetes|prediabetes
612248|NCT00631345|overweight|overweight
612249|NCT00631345|obesity|obesity
612250|NCT00631345|metabolic syndrome|metabolic syndrome
612251|NCT00631345|community health worker|community health worker
612252|NCT00631358|Ocular inflammation|ocular inflammation
612253|NCT00631371|temsirolimus|temsirolimus
612254|NCT00631371|renal cell carcinoma|renal cell carcinoma
612255|NCT00631371|kidney cancer|kidney cancer
612256|NCT00631371|urogenital cancer|urogenital cancer
612257|NCT00631384|Voluntary Counseling and Testing|voluntary counseling and testing
612258|NCT00631384|HIV|hiv
612259|NCT00631384|HIV seronegativity|hiv seronegativity
612260|NCT00631397|weakening of the bones|weakening of the bones
612261|NCT00631410|Phase 1|phase 1
612262|NCT00631410|CRC|crc
612263|NCT00631410|SU011248|su011248
612264|NCT00631410|Sunitinib|sunitinib
612265|NCT00631410|FOLFOX|folfox
612266|NCT00631410|Colorectal cancer|colorectal cancer
612267|NCT00631410|metastatic carcinoma of the colon or rectum|metastatic carcinoma of the colon or rectum
612268|NCT00631436|Diffusion Tensor Imaging|diffusion tensor imaging
612269|NCT00631436|Electroencephalography|electroencephalography
612270|NCT00631436|Blast Injury|blast injury
612271|NCT00631436|Traumatic Brain Injury|traumatic brain injury
612272|NCT00631449|HIV|hiv
612273|NCT00631449|Treatment intensification|treatment intensification
612274|NCT00631449|Low level viremia|low level viremia
612275|NCT00631449|Suboptimal CD4+ T cell response|suboptimal cd4+ t cell response
612276|NCT00631449|treatment experienced|treatment experienced
612277|NCT00631462|primary myelofibrosis|primary myelofibrosis
612278|NCT00631462|post-polycythemia vera myelofibrosis|post-polycythemia vera myelofibrosis
612279|NCT00631462|post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
612280|NCT00631475|Actelion|actelion
612281|NCT00631475|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
612282|NCT00631475|bosentan|bosentan
612283|NCT00631475|Tracleer|tracleer
612284|NCT00631475|Interstitial Lung Disease|interstitial lung disease
612285|NCT00631475|BUILD 3 (NCT00391443)|build 3 (nct00391443)
612286|NCT00631501|tendinopathy|tendinopathy
612287|NCT00631501|tennis elbow|tennis elbow
612288|NCT00631501|lateral epicondylitis|lateral epicondylitis
612289|NCT00631501|lateral epicondylalgia|lateral epicondylalgia
612290|NCT00631501|MMP-inhibitor|mmp-inhibitor
612291|NCT00631514|antihypertensive drugs|antihypertensive drugs
612292|NCT00631514|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
612293|NCT00631514|interaction|interaction
612294|NCT00631514|family practice|family practice
612295|NCT00631514|arterial blood pressure|arterial blood pressure
612296|NCT00631527|Prostate Cancer|prostate cancer
612297|NCT00631527|Radiation Therapy|radiation therapy
612298|NCT00631527|RT|rt
612299|NCT00631527|Radiotherapy|radiotherapy
612300|NCT00631527|Hormone Ablation|hormone ablation
612301|NCT00631527|Sunitinib Malate|sunitinib malate
612302|NCT00631527|Leuprolide|leuprolide
612303|NCT00631527|Lupron|lupron
612305|NCT00631527|Goserelin|goserelin
612306|NCT00631527|Casodex|casodex
612307|NCT00631527|Bicalutamide|bicalutamide
612308|NCT00631527|SU011248|su011248
612309|NCT00631527|Sutent|sutent
612310|NCT00631527|Angiogenesis inhibitor|angiogenesis inhibitor
612311|NCT00631540|renal artery stenosis|renal artery stenosis
612312|NCT00631540|hypertension|hypertension
612313|NCT00631540|renovascular|renovascular
612314|NCT00631540|renal artery blockage|renal artery blockage
612315|NCT00631540|renal artery disease|renal artery disease
612316|NCT00631540|renal arteries|renal arteries
612317|NCT00631540|angioplasty renal artery|angioplasty renal artery
612318|NCT00631540|renal artery stent|renal artery stent
612319|NCT00631540|renal artery doppler|renal artery doppler
612320|NCT00631540|renovascular hypertension|renovascular hypertension
612321|NCT00631540|kidney stenosis|kidney stenosis
612322|NCT00631540|renal artery|renal artery
612323|NCT00631540|stent|stent
612324|NCT00631540|stenting|stenting
612325|NCT00631540|kidney disease|kidney disease
612326|NCT00631540|renal failure|renal failure
612327|NCT00631540|atherosclerosis|atherosclerosis
612328|NCT00631540|arterial hypertension|arterial hypertension
612329|NCT00631540|stenosis|stenosis
612330|NCT00631566|HIV|hiv
612331|NCT00631566|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
612332|NCT00631566|HIV and Staphylococcus aureus infection|hiv and staphylococcus aureus infection
612333|NCT00631592|GSK1349572,|gsk1349572,
612334|NCT00631592|healthy volunteers,|healthy volunteers,
612335|NCT00631592|repeat dose,|repeat dose,
612336|NCT00631592|relative bioavailability|relative bioavailability
612337|NCT00631592|Healthy subjects|healthy subjects
612338|NCT00631605|eating disorders|eating disorders
612339|NCT00631605|ghrelin|ghrelin
612340|NCT00631605|leptin|leptin
612341|NCT00631605|BIA|bia
612342|NCT00631631|Drug Therapy|drug therapy
612343|NCT00631644|Adolescents|adolescents
612344|NCT00631644|Eating Behavior|eating behavior
612345|NCT00631644|Eating in the Absence of Hunger|eating in the absence of hunger
612346|NCT00631644|Disordered Eating|disordered eating
612347|NCT00631644|Food Intake|food intake
612348|NCT00631644|Macronutrient Composition|macronutrient composition
612349|NCT00631644|Obesity|obesity
612350|NCT00631644|Adolescent|adolescent
612351|NCT00631644|Healthy Volunteer|healthy volunteer
612352|NCT00631644|HV|hv
612353|NCT00631657|placebo controlled|placebo controlled
612354|NCT00631657|randomized|randomized
612355|NCT00631657|double blind|double blind
612356|NCT00631696|Healthy males Human volunteers pregabalin or placebo sperm quality and quantity|healthy males human volunteers pregabalin or placebo sperm quality and quantity
612357|NCT00631722|PANSS|panss
612358|NCT00631722|Acute Episode of Schizophrenia|acute episode of schizophrenia
612359|NCT00631735|cancer|cancer
612360|NCT00631735|qualitative|qualitative
612361|NCT00631748|cocaine|cocaine
612362|NCT00631748|quetiapine fumarate|quetiapine fumarate
612363|NCT00631748|dependence|dependence
612364|NCT00631748|abuse|abuse
612365|NCT00631748|addiction|addiction
612366|NCT00631748|treatment|treatment
612367|NCT00631761|urethrocystoscopy|urethrocystoscopy
612368|NCT00631761|cystoscopy|cystoscopy
612369|NCT00631761|objective structured assessment of surgical skills (OSATS)|objective structured assessment of surgical skills (osats)
612370|NCT00631774|type 2 diabetes|type 2 diabetes
612371|NCT00631774|meal replacement|meal replacement
612372|NCT00631774|postprandial response|postprandial response
612373|NCT00631774|Glucerna SR|glucerna sr
612374|NCT00631787|Nitric Oxide|nitric oxide
612375|NCT00631787|Hemolysis|hemolysis
612376|NCT00631787|Plasma Hemoglobin|plasma hemoglobin
612377|NCT00631787|Dimethyl Sulfoxide|dimethyl sulfoxide
612378|NCT00631787|Organ Dysfuntion|organ dysfuntion
612379|NCT00631787|Healthy Volunteer|healthy volunteer
612380|NCT00631787|HV|hv
612381|NCT00631800|Staphylococcal|staphylococcal
612382|NCT00631800|Monoclonal antibodies|monoclonal antibodies
612383|NCT00631800|Very Low Birth Weight Infants|very low birth weight infants
612384|NCT00631800|Prophylaxis|prophylaxis
612385|NCT00631826|Shoulder|shoulder
612386|NCT00631826|Injuries|injuries
612387|NCT00631826|Flexiblity|flexiblity
612388|NCT00631826|Rotational resistance|rotational resistance
612389|NCT00631839|Thoracic Neoplasms|thoracic neoplasms
612390|NCT00631839|Platinum-based chemotherapy|platinum-based chemotherapy
612391|NCT00631839|3-D Conformal Radiotherapy|3-d conformal radiotherapy
612392|NCT00631839|Chemo-radiotherapy induced lung injury|chemo-radiotherapy induced lung injury
612393|NCT00631839|Chemo-radiotherapy induced esophagus injury|chemo-radiotherapy induced esophagus injury
612394|NCT00631852|Breast Cancer, Biomarkers, Ginseng Root|breast cancer, biomarkers, ginseng root
612395|NCT00631865|melanocytes|melanocytes
612396|NCT00631878|Staphylococcal|staphylococcal
612397|NCT00631878|Monoclonal antibodies|monoclonal antibodies
612398|NCT00631878|Very Low Birth Weight Infants|very low birth weight infants
612399|NCT00631878|Prophylaxis|prophylaxis
612400|NCT00631904|Pacemaker|pacemaker
612401|NCT00631917|Hypertension, aliskiren, ramipril, colonoscopy|hypertension, aliskiren, ramipril, colonoscopy
612402|NCT00631969|Erectile Dysfunction|erectile dysfunction
612403|NCT00631982|in vitro maturation oocytes|in vitro maturation oocytes
612404|NCT00631995|Neisseria meningitidis|neisseria meningitidis
612405|NCT00622583|Herniorrhaphy|herniorrhaphy
612406|NCT00622596|opiate dependence|opiate dependence
612407|NCT00622596|buprenorphine|buprenorphine
612408|NCT00622609|first time in human,|first time in human,
612409|NCT00622609|MAG|mag
612410|NCT00622609|monoclonal antibody,|monoclonal antibody,
612411|NCT00622609|healthy subjects,|healthy subjects,
612412|NCT00622609|GSK249320,|gsk249320,
612413|NCT00622635|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
612414|NCT00622635|COPD|copd
612415|NCT00622635|indacaterol|indacaterol
613079|NCT00633867|time|time
612416|NCT00622648|Medical prevention therapy|medical prevention therapy
612417|NCT00622661|Glycemic response|glycemic response
612418|NCT00622661|Glycemic index|glycemic index
612419|NCT00622661|Obesity|obesity
612420|NCT00622661|Carbohydrates|carbohydrates
612421|NCT00622661|Insulin|insulin
612422|NCT00622661|Blood glucose|blood glucose
612423|NCT00622674|recurrent breast cancer|recurrent breast cancer
612424|NCT00622674|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
612425|NCT00622674|recurrent small cell lung cancer|recurrent small cell lung cancer
612426|NCT00622674|recurrent colon cancer|recurrent colon cancer
612427|NCT00622674|recurrent pancreatic cancer|recurrent pancreatic cancer
612428|NCT00622674|recurrent head and neck cancer|recurrent head and neck cancer
612429|NCT00622674|recurrent sarcoma|recurrent sarcoma
612430|NCT00622674|recurrent kidney cancer|recurrent kidney cancer
612431|NCT00622674|recurrent renal cell cancer|recurrent renal cell cancer
612432|NCT00622687|iloprost|iloprost
612433|NCT00622687|systemic sclerosis|systemic sclerosis
612434|NCT00622687|digital ulcers|digital ulcers
612435|NCT00622687|observational study|observational study
612436|NCT00622687|randomized|randomized
612437|NCT00622700|MS|ms
612438|NCT00622700|Clinically Isolated Syndrome|clinically isolated syndrome
612439|NCT00622700|CIS|cis
612442|NCT00622713|Alzheimer's disease|alzheimer's disease
612443|NCT00622713|cholinesterase inhibitor|cholinesterase inhibitor
612444|NCT00622713|rivastigmine|rivastigmine
612674|NCT00632294|Allograft Retrieval|allograft retrieval
612445|NCT00622726|Vascular Endothelial Growth Factor|vascular endothelial growth factor
612446|NCT00622726|Angiogenesis Inhibitor|angiogenesis inhibitor
612447|NCT00622726|Premature infants|premature infants
612448|NCT00622726|Bevacizumab|bevacizumab
612449|NCT00622726|Zone I or Posterior Zone II ROP|zone i or posterior zone ii rop
612450|NCT00622726|Aggressive Posterior ROP|aggressive posterior rop
612451|NCT00622726|Stage 3 ROP|stage 3 rop
612452|NCT00622726|Neonatal Intensive Care Unit|neonatal intensive care unit
612453|NCT00622739|Bipolar Disorder|bipolar disorder
612454|NCT00622739|Children|children
612455|NCT00622739|Adolescents|adolescents
612456|NCT00622739|Treatment|treatment
612457|NCT00622752|Smoking cessation|smoking cessation
612459|NCT00622752|Smokers|smokers
612460|NCT00622765|Obesity, Overweight, Body Weight, Body Size, Nutritional and Metabolic Diseases|obesity, overweight, body weight, body size, nutritional and metabolic diseases
612461|NCT00622778|intracranial bleeding|intracranial bleeding
612462|NCT00622778|computed tomography scan|computed tomography scan
612463|NCT00622791|Cardiopulmonary bypass|cardiopulmonary bypass
612464|NCT00622791|coronary artery bypass graft|coronary artery bypass graft
612465|NCT00622791|coronary artery disease|coronary artery disease
612466|NCT00622791|propofol|propofol
612467|NCT00622791|pharmacokinetics|pharmacokinetics
612468|NCT00622791|pharmacodynamics|pharmacodynamics
612469|NCT00622804|Stomach cancer|stomach cancer
612470|NCT00622804|Gastrectomy|gastrectomy
612471|NCT00622804|Postgastrectomy syndrome|postgastrectomy syndrome
612472|NCT00622817|Epinephrine|epinephrine
612473|NCT00622817|Nasal decongestant|nasal decongestant
612474|NCT00622817|RSV|rsv
612475|NCT00622817|xylometazoline|xylometazoline
612476|NCT00622817|Bronchiolitis|bronchiolitis
612477|NCT00622830|darapladib,|darapladib,
612478|NCT00622830|SB480848,|sb480848,
612479|NCT00622830|Japanese healthy volunteers|japanese healthy volunteers
612480|NCT00622843|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
612481|NCT00622843|polysaccharide vaccine|polysaccharide vaccine
612482|NCT00622843|PPV|ppv
612483|NCT00622843|PCV|pcv
612484|NCT00622843|Streptococcus pneumoniae|streptococcus pneumoniae
612485|NCT00622843|Prevnar|prevnar
612486|NCT00622843|Pneumovax|pneumovax
612487|NCT00622843|HIV|hiv
612488|NCT00622856|diabetes|diabetes
612489|NCT00622856|adolescents|adolescents
612490|NCT00622856|psychological therapy|psychological therapy
612491|NCT00622869|Liver transplantation|liver transplantation
612492|NCT00622869|everolimus|everolimus
612493|NCT00622869|calcineurin inhibitors|calcineurin inhibitors
612494|NCT00622869|tacrolimus|tacrolimus
612495|NCT00622869|renal function|renal function
612496|NCT00622869|MDRD formula|mdrd formula
612497|NCT00622869|progression of fibrosis|progression of fibrosis
612498|NCT00622882|Staphylococcus aureus|staphylococcus aureus
612499|NCT00622882|Bacteremia|bacteremia
612500|NCT00622882|Outcome|outcome
612501|NCT00622882|Mortality|mortality
612502|NCT00622882|Recurrence|recurrence
612503|NCT00622882|Infectious Diseases specialists|infectious diseases specialists
612504|NCT00622895|scleroderma|scleroderma
612505|NCT00622895|systemic sclerosis|systemic sclerosis
612506|NCT00622921|PTSD|ptsd
612507|NCT00622921|alcohol dependence|alcohol dependence
612508|NCT00622934|multiple trauma|multiple trauma
612509|NCT00622947|Depression|depression
612510|NCT00622947|antidepressant effect|antidepressant effect
612511|NCT00622947|rTMS|rtms
612512|NCT00622947|sham|sham
612513|NCT00622947|cognition|cognition
612514|NCT00622947|saliva cortisol|saliva cortisol
612515|NCT00622947|brain derived neurotropic factor|brain derived neurotropic factor
612516|NCT00622960|obesity|obesity
612517|NCT00622960|type 2 diabetes|type 2 diabetes
612518|NCT00622960|weight loss|weight loss
612519|NCT00622960|monounsaturated fat|monounsaturated fat
612520|NCT00622960|diet|diet
612521|NCT00622973|Prostate cancer|prostate cancer
612522|NCT00622973|Bladder cancer|bladder cancer
612523|NCT00622973|Pelvic lymph node metastases|pelvic lymph node metastases
612524|NCT00622973|Diffusion-weighted MRI|diffusion-weighted mri
612525|NCT00622973|Sinerem (USPIO)-enhanced MRI|sinerem (uspio)-enhanced mri
612526|NCT00622973|Imaging influence on surgery|imaging influence on surgery
612527|NCT00622973|Noninvasive detection of pelvic lymph node metastases|noninvasive detection of pelvic lymph node metastases
612528|NCT00622973|Influence of imaging protocol on surgical outcome|influence of imaging protocol on surgical outcome
612529|NCT00622999|Malnutrition|malnutrition
612530|NCT00622999|Colon cancer|colon cancer
612531|NCT00622999|Colon surgery|colon surgery
612532|NCT00622999|Outcome|outcome
612533|NCT00622999|Complication rate|complication rate
612534|NCT00623025|HIV|hiv
612535|NCT00623025|Steatorrhea|steatorrhea
612536|NCT00623038|Apgar score|apgar score
612537|NCT00623038|neonatal assessment|neonatal assessment
612538|NCT00623038|preterm infants|preterm infants
612539|NCT00623038|resuscitation|resuscitation
612540|NCT00623051|male circumcision|male circumcision
612542|NCT00623051|sexual behavior|sexual behavior
612543|NCT00623051|HIV prevention|hiv prevention
612544|NCT00623051|HIV Seronegativity|hiv seronegativity
612545|NCT00623064|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
612546|NCT00623064|stage IV bladder cancer|stage iv bladder cancer
612547|NCT00623064|stage III bladder cancer|stage iii bladder cancer
612548|NCT00623064|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
612549|NCT00623064|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
612550|NCT00623077|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
612551|NCT00623077|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
612552|NCT00623077|childhood hepatoblastoma|childhood hepatoblastoma
612553|NCT00623077|recurrent childhood liver cancer|recurrent childhood liver cancer
612554|NCT00623077|stage IV childhood liver cancer|stage iv childhood liver cancer
612555|NCT00623077|adult primary liver cancer|adult primary liver cancer
612556|NCT00623077|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
612557|NCT00623077|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
612558|NCT00623077|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
612559|NCT00623077|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
612560|NCT00623077|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
612561|NCT00623077|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
612562|NCT00623077|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
612675|NCT00632294|Allograft Bone|allograft bone
612563|NCT00623077|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
612564|NCT00623077|stage IV Wilms tumor|stage iv wilms tumor
612565|NCT00623077|stage V Wilms tumor|stage v wilms tumor
612566|NCT00623077|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
612567|NCT00623077|stage IV renal cell cancer|stage iv renal cell cancer
612568|NCT00623077|childhood mixed glioma|childhood mixed glioma
612569|NCT00623077|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
612570|NCT00623077|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
612571|NCT00623077|recurrent childhood ependymoma|recurrent childhood ependymoma
612572|NCT00623077|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
612573|NCT00623077|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
612574|NCT00623077|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
612575|NCT00623077|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
612576|NCT00623077|untreated childhood brain stem glioma|untreated childhood brain stem glioma
612577|NCT00623077|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
612578|NCT00623077|childhood infratentorial ependymoma|childhood infratentorial ependymoma
612579|NCT00623077|childhood supratentorial ependymoma|childhood supratentorial ependymoma
612580|NCT00623077|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
612581|NCT00623077|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
612582|NCT00623077|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
612583|NCT00623077|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
612584|NCT00623077|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
612585|NCT00623077|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
612586|NCT00623077|recurrent retinoblastoma|recurrent retinoblastoma
612587|NCT00623077|extraocular retinoblastoma|extraocular retinoblastoma
612588|NCT00623077|intraocular retinoblastoma|intraocular retinoblastoma
612589|NCT00623077|childhood renal cell carcinoma|childhood renal cell carcinoma
612590|NCT00623077|clear cell renal cell carcinoma|clear cell renal cell carcinoma
612591|NCT00623077|recurrent renal cell cancer|recurrent renal cell cancer
612592|NCT00623077|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
612593|NCT00623077|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
612594|NCT00623077|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
612595|NCT00623090|prostate cancer screening education|prostate cancer screening education
612596|NCT00623090|behavioral oncology|behavioral oncology
612597|NCT00623090|randomized trial|randomized trial
612598|NCT00623103|Parkinson's disease dementia|parkinson's disease dementia
612599|NCT00623103|cholinesterase inhibitor|cholinesterase inhibitor
612600|NCT00623103|rivastigmine|rivastigmine
612601|NCT00623116|Kallmann Syndrome|kallmann syndrome
612602|NCT00623116|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
612603|NCT00623129|hypopharyngeal cancer|hypopharyngeal cancer
612604|NCT00623129|lip and oral cavity cancer|lip and oral cavity cancer
612605|NCT00623129|laryngeal cancer|laryngeal cancer
612606|NCT00623129|nasopharyngeal cancer|nasopharyngeal cancer
612607|NCT00623129|oropharyngeal cancer|oropharyngeal cancer
612608|NCT00623129|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
612609|NCT00623129|salivary gland cancer|salivary gland cancer
612610|NCT00623129|xerostomia|xerostomia
612611|NCT00623129|radiation toxicity|radiation toxicity
612612|NCT00623142|Myocardial protection|myocardial protection
612613|NCT00623142|Ischemic Reperfusion Injury|ischemic reperfusion injury
612614|NCT00623142|Hyperbaric Oxygen|hyperbaric oxygen
612615|NCT00623142|Preconditioning|preconditioning
612616|NCT00623155|malaria|malaria
612617|NCT00623155|intermittent preventive treatment|intermittent preventive treatment
612618|NCT00623155|season|season
612619|NCT00623155|children|children
612620|NCT00623168|Ribavirin|ribavirin
612621|NCT00623168|Hemorrhagic Fever with Renal Syndrome|hemorrhagic fever with renal syndrome
612622|NCT00623181|Influenza|influenza
612623|NCT00623181|Influenza virus|influenza virus
612624|NCT00623207|Chest Pain Low work Capacity Rate Incompetence|chest pain low work capacity rate incompetence
612625|NCT00623220|pain, retinopathy of prematurity, infant, premature, eye exam, nitrous oxide|pain, retinopathy of prematurity, infant, premature, eye exam, nitrous oxide
612626|NCT00623233|Breast Neoplasm|breast neoplasm
612627|NCT00623246|Obstructive Sleep Apnea|obstructive sleep apnea
612628|NCT00623246|OSA|osa
612629|NCT00623246|Adherence|adherence
612630|NCT00623246|CPAP|cpap
612631|NCT00623246|Cognition|cognition
612632|NCT00632021|Low Health Literacy|low health literacy
612633|NCT00632021|Medication Errors|medication errors
612634|NCT00632021|Cardiovascular Disease|cardiovascular disease
612635|NCT00632021|Pharmacist|pharmacist
612636|NCT00632021|Care Transition|care transition
612637|NCT00632034|fracture|fracture
612638|NCT00632034|tibia|tibia
612639|NCT00632034|stem cell|stem cell
612640|NCT00632047|breast cancer|breast cancer
612641|NCT00632047|cervical cancer|cervical cancer
612642|NCT00632060|Low Back Pain|low back pain
612643|NCT00632060|Manual / Manipulative Therapy|manual / manipulative therapy
612644|NCT00632073|HIV Infections|hiv infections
612645|NCT00632073|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
612646|NCT00632073|treatment experienced|treatment experienced
612647|NCT00632086|PK|pk
612648|NCT00632099|cocaine|cocaine
612649|NCT00632099|treatment|treatment
612650|NCT00632099|progesterone|progesterone
612651|NCT00632112|large volume nebulizer|large volume nebulizer
612652|NCT00632125|CKD subjects with or without dialysis treatment|ckd subjects with or without dialysis treatment
612653|NCT00632138|sexual dysfunction|sexual dysfunction
612654|NCT00632138|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
612655|NCT00632138|prostate cancer|prostate cancer
612656|NCT00632138|benign prostatic hyperplasia|benign prostatic hyperplasia
612657|NCT00632138|urinary incontinence|urinary incontinence
612658|NCT00632190|cervical cancer|cervical cancer
612659|NCT00632190|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
612660|NCT00632190|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
612661|NCT00632190|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
612662|NCT00632229|Obsessive-Compulsive Disorder; Adults; Medication; Treatment|obsessive-compulsive disorder; adults; medication; treatment
612663|NCT00632255|Chronic Myeloid Leukemia|chronic myeloid leukemia
612664|NCT00632255|Long term Imatinib therapy compliance|long term imatinib therapy compliance
612665|NCT00632255|Newly diagnosed|newly diagnosed
612666|NCT00632255|Late side effects|late side effects
612667|NCT00632268|mTOR inhibitor|mtor inhibitor
612668|NCT00632268|RAD001|rad001
612669|NCT00632268|everolimus|everolimus
612670|NCT00632268|chemotherapy|chemotherapy
612671|NCT00632268|cisplatin|cisplatin
612672|NCT00632268|high-dose 5-FU|high-dose 5-fu
612673|NCT00632294|Bone Cancer|bone cancer
612676|NCT00632294|Bone Mineral Density|bone mineral density
612677|NCT00632307|lung tumor|lung tumor
612678|NCT00632307|pleural tumor|pleural tumor
612679|NCT00632307|interstitial lung disease|interstitial lung disease
612680|NCT00632307|airway infection|airway infection
612681|NCT00632307|COPD|copd
612682|NCT00632307|sleep apnea|sleep apnea
613080|NCT00633880|NOH|noh
612683|NCT00632307|ion mobility spectrometry|ion mobility spectrometry
612684|NCT00632307|breath analysis|breath analysis
612685|NCT00632320|Ventilator, mechanical|ventilator, mechanical
612686|NCT00632320|Ventilator weaning|ventilator weaning
612687|NCT00632320|Rapid shallow breathing index|rapid shallow breathing index
612688|NCT00632320|Continuous positive airway pressure|continuous positive airway pressure
612689|NCT00632320|Receiver operating characteristic curve|receiver operating characteristic curve
612690|NCT00632320|COPD|copd
612691|NCT00632333|Epitope peptide|epitope peptide
612692|NCT00632333|Vaccination|vaccination
612693|NCT00632333|Chemoradiation|chemoradiation
612694|NCT00632333|Esophageal cancer|esophageal cancer
612695|NCT00632346|childhood abuse|childhood abuse
612696|NCT00632346|overweight|overweight
612697|NCT00632346|obesity|obesity
612698|NCT00632346|BMI as a young adult|bmi as a young adult
612699|NCT00632346|childhood physical abuse|childhood physical abuse
612700|NCT00632346|childhood emotional abuse|childhood emotional abuse
612701|NCT00632346|childhood sexual abuse|childhood sexual abuse
612702|NCT00632346|childhood physical neglect|childhood physical neglect
612703|NCT00632346|childhood emotional neglect|childhood emotional neglect
612895|NCT00633217|COPD|copd
612896|NCT00633217|HFA MDI|hfa mdi
612704|NCT00632346|childhood witnessing of domestic violence|childhood witnessing of domestic violence
612705|NCT00632346|parental marital discord|parental marital discord
612706|NCT00632346|household members with substance abuse|household members with substance abuse
612707|NCT00632346|household members with mental illness|household members with mental illness
612708|NCT00632346|household members with criminal behavior|household members with criminal behavior
612709|NCT00632346|cumulative adverse childhood experiences|cumulative adverse childhood experiences
612710|NCT00632359|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
612711|NCT00632359|CLL|cll
612712|NCT00632359|Lenalidomide|lenalidomide
612713|NCT00632359|Revlimid|revlimid
612714|NCT00632463|Transplant|transplant
612715|NCT00632463|Immunosuppression|immunosuppression
612716|NCT00632476|Smoking During Pregnancy|smoking during pregnancy
612717|NCT00632476|Vitamin C|vitamin c
612718|NCT00632476|Newborn Lung Function|newborn lung function
612719|NCT00632476|Ascorbic Acid|ascorbic acid
612720|NCT00632489|Refractory Malignancy|refractory malignancy
612721|NCT00632489|Breast Cancer|breast cancer
612722|NCT00632489|LBH589|lbh589
612723|NCT00632489|Capecitabine|capecitabine
612724|NCT00632489|Lapatinib|lapatinib
612725|NCT00632515|Colorectal Cancer|colorectal cancer
612726|NCT00632515|CRC|crc
612727|NCT00632515|Familial CRC|familial crc
612728|NCT00632515|Cancer Screening|cancer screening
612729|NCT00632515|Questionnaire|questionnaire
612730|NCT00632515|First Degree Relatives|first degree relatives
612731|NCT00632515|FDRs|fdrs
612732|NCT00632515|Risk Communication|risk communication
612733|NCT00632528|MEOPA|meopa
612734|NCT00632528|spasticity|spasticity
612735|NCT00632528|multilevel surgery|multilevel surgery
612736|NCT00632528|cerebral palsy|cerebral palsy
612737|NCT00632528|children|children
612738|NCT00632567|Anal incontinence|anal incontinence
612739|NCT00632567|First delivery was traumatic|first delivery was traumatic
612740|NCT00632567|No anal incontinence|no anal incontinence
612741|NCT00632580|Pain, Postoperative|pain, postoperative
612742|NCT00632593|Early Complications of both techniques|early complications of both techniques
612743|NCT00632593|Fistula rate|fistula rate
612744|NCT00632593|Dehiscence rate|dehiscence rate
612745|NCT00632593|reoperation rate and cause|reoperation rate and cause
612746|NCT00632606|pregnant women|pregnant women
612747|NCT00632619|Subthreshold Manic States in Children|subthreshold manic states in children
612748|NCT00632619|ADHD|adhd
612749|NCT00632632|World Trade Center Victims|world trade center victims
612750|NCT00632632|Iraq War Veterans|iraq war veterans
612751|NCT00632632|PTSD|ptsd
612752|NCT00632645|Huntington|huntington
612753|NCT00632645|Neuroleptic|neuroleptic
612754|NCT00632645|Unified Huntington Disease Rating Scale (UHDRS)|unified huntington disease rating scale (uhdrs)
612755|NCT00632645|Independence Scale|independence scale
612756|NCT00632645|Neuroleptic Prescription required|neuroleptic prescription required
612757|NCT00632658|cGVHD|cgvhd
612758|NCT00632671|Obesity cohort|obesity cohort
612759|NCT00632684|Family Caregiving|family caregiving
612760|NCT00632684|Dementia|dementia
612761|NCT00632697|endometriosis|endometriosis
612762|NCT00632697|immunomodulation|immunomodulation
612764|NCT00632697|laparoscopic surgery|laparoscopic surgery
612765|NCT00632697|pentoxifylline|pentoxifylline
612766|NCT00632710|rheumatoid arthritis|rheumatoid arthritis
612767|NCT00632710|hands|hands
612768|NCT00632710|randomized controlled|randomized controlled
612769|NCT00632710|low level laser|low level laser
612770|NCT00632723|oestrogen receptor|oestrogen receptor
612771|NCT00632723|ER negative tumours|er negative tumours
612772|NCT00632723|epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
612773|NCT00632736|ropinirole XL|ropinirole xl
612774|NCT00632736|REQUIP|requip
612775|NCT00632736|Parkinson's disease|parkinson's disease
612776|NCT00632736|long term safety|long term safety
612777|NCT00632736|efficacy|efficacy
612779|NCT00632736|ropinirole CR|ropinirole cr
612780|NCT00632736|ropinirole IR|ropinirole ir
612781|NCT00632736|open-label|open-label
612782|NCT00632762|Amantadine benefit|amantadine benefit
612783|NCT00632762|Dyskinesia|dyskinesia
612784|NCT00632762|Parkinson's disease|parkinson's disease
612785|NCT00632775|pediatrics|pediatrics
612786|NCT00632775|Hyponatremia|hyponatremia
612787|NCT00632775|Sodium Chloride|sodium chloride
612788|NCT00632775|maintenance fluids|maintenance fluids
612789|NCT00632788|myocardial infarction|myocardial infarction
612790|NCT00632788|catheterization|catheterization
612791|NCT00632788|angioplasty|angioplasty
612792|NCT00632788|door-to-balloon time|door-to-balloon time
612793|NCT00632801|elective laparoscopic colectomy|elective laparoscopic colectomy
612794|NCT00632801|chewing gum|chewing gum
612795|NCT00632801|ileus|ileus
612796|NCT00632801|post-operative care|post-operative care
612797|NCT00632801|colectomy|colectomy
612798|NCT00632814|Kogenate,|kogenate,
612799|NCT00632814|Children,|children,
612800|NCT00632814|Factor VIII,|factor viii,
612801|NCT00632814|Hemophilia A,|hemophilia a,
612802|NCT00632814|Prophylactic|prophylactic
612803|NCT00632853|limited stage small cell lung cancer|limited stage small cell lung cancer
612804|NCT00632866|auto-immune diseases|auto-immune diseases
612805|NCT00632866|hydroxychloroquine|hydroxychloroquine
612806|NCT00632866|primary Sjögren's syndrome|primary sjögren's syndrome
612807|NCT00632866|inflammatory arthritides|inflammatory arthritides
612808|NCT00632866|inflammatory rheumatic diseases|inflammatory rheumatic diseases
612809|NCT00632866|dryness|dryness
612810|NCT00632866|joint diseases|joint diseases
612811|NCT00632892|oxidative stress markers in urine|oxidative stress markers in urine
612812|NCT00632892|urine norepinephrine|urine norepinephrine
612813|NCT00632892|renal tubular enzyme markers|renal tubular enzyme markers
612814|NCT00632905|Prostate Cancer|prostate cancer
612815|NCT00632905|Prostatic adenoma|prostatic adenoma
612816|NCT00632905|Prostatic neoplasm|prostatic neoplasm
612817|NCT00632918|Image quality|image quality
612818|NCT00632918|Dual-source CT|dual-source ct
612819|NCT00632918|Coronary angiography|coronary angiography
612820|NCT00632918|Heart rate|heart rate
612821|NCT00632970|Raltegravir|raltegravir
612822|NCT00632970|Lopinavir|lopinavir
612823|NCT00632983|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
612824|NCT00632983|anxiety disorder|anxiety disorder
612825|NCT00632983|sexual dysfunction|sexual dysfunction
612826|NCT00632983|urinary complications|urinary complications
612827|NCT00632983|stage I prostate cancer|stage i prostate cancer
612828|NCT00632983|stage IIB prostate cancer|stage iib prostate cancer
612829|NCT00632983|stage IIA prostate cancer|stage iia prostate cancer
612830|NCT00632996|shoulder pain|shoulder pain
612831|NCT00632996|shoulder impingement syndrome|shoulder impingement syndrome
612832|NCT00632996|manual therapy|manual therapy
612833|NCT00632996|rehabilitation|rehabilitation
612834|NCT00633009|Leishmaniasis|leishmaniasis
612835|NCT00633009|Delayed-Type Hypersensitivity (DTH)|delayed-type hypersensitivity (dth)
612836|NCT00633009|Skin Test|skin test
612837|NCT00633009|Conversion|conversion
612838|NCT00633009|Prior exposure to Leishmania major|prior exposure to leishmania major
612839|NCT00633022|FDG-PET/CT, atherosclerosis|fdg-pet/ct, atherosclerosis
612840|NCT00633035|ulcer|ulcer
612841|NCT00633035|esomeprazole|esomeprazole
612842|NCT00633035|famotidine|famotidine
612843|NCT00633035|Neurosurgery|neurosurgery
612844|NCT00633048|ascending single-dose study|ascending single-dose study
612845|NCT00633048|healthy subjects|healthy subjects
612846|NCT00633061|Childhood Cancer|childhood cancer
612847|NCT00633061|Central Venous Catheter|central venous catheter
612848|NCT00633061|Deep Vein Thrombosis|deep vein thrombosis
612849|NCT00633061|Catheter-related Infection|catheter-related infection
612850|NCT00633061|Catheter-related Occlusion|catheter-related occlusion
612851|NCT00633074|Influenza|influenza
612852|NCT00633113|Total Knee Arthroplasty|total knee arthroplasty
612853|NCT00633113|Minimally Invasive Knee Replacement|minimally invasive knee replacement
612854|NCT00633113|Knee Osteoarthritis|knee osteoarthritis
612855|NCT00633113|Cost effectiveness minimally invasive knee surgery|cost effectiveness minimally invasive knee surgery
612856|NCT00633126|PK|pk
612857|NCT00633126|Pharmacokinetics|pharmacokinetics
612858|NCT00633139|Metazym|metazym
612859|NCT00633139|Late infantile|late infantile
612860|NCT00633139|Metachromatic leukodystrophy|metachromatic leukodystrophy
612861|NCT00633139|Long-term safety|long-term safety
612862|NCT00633152|complicated skin and skin structure infections|complicated skin and skin structure infections
612863|NCT00633152|linezolid|linezolid
612864|NCT00633152|ceftaroline|ceftaroline
612865|NCT00633152|clinical response|clinical response
612866|NCT00633152|microbiological response|microbiological response
612867|NCT00633152|Cellulitis|cellulitis
612868|NCT00633152|Abscess|abscess
612869|NCT00633152|Wound infection|wound infection
612870|NCT00633152|Deeper soft tissue|deeper soft tissue
612871|NCT00633152|Significant surgical intervention|significant surgical intervention
612872|NCT00633152|Gram-positive bacterial infection|gram-positive bacterial infection
612975|NCT00633542|dexamethasone|dexamethasone
612873|NCT00633152|Gram-negative bacterial infection|gram-negative bacterial infection
612874|NCT00633152|bacterial infection|bacterial infection
612875|NCT00633152|cephalosporin|cephalosporin
612876|NCT00633152|broad-spectrum activity|broad-spectrum activity
612877|NCT00633165|sarcoma|sarcoma
612878|NCT00633165|myxoid liposarcoma|myxoid liposarcoma
612879|NCT00633178|Prenatal Depression|prenatal depression
612880|NCT00633178|Postpartum Depression|postpartum depression
612881|NCT00633178|Fetal Development|fetal development
612882|NCT00633178|Interpersonal Therapy|interpersonal therapy
612883|NCT00633191|Cystic fibrosis|cystic fibrosis
612884|NCT00633191|Prevention|prevention
612885|NCT00633191|Infection|infection
612886|NCT00633191|Pseudomonas aeruginosa|pseudomonas aeruginosa
612887|NCT00633191|Gargle|gargle
612888|NCT00633204|Epitope peptide, CTL, TUR-Bt, Bladder cancer, Vaccination|epitope peptide, ctl, tur-bt, bladder cancer, vaccination
612889|NCT00633204|Bladder cancer after surgery|bladder cancer after surgery
612890|NCT00633217|DISKUS|diskus
612891|NCT00633217|Salmeterol|salmeterol
612892|NCT00633217|Fluticasone Propionate|fluticasone propionate
612893|NCT00633217|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
612894|NCT00633217|Hydroflouroalkane|hydroflouroalkane
612897|NCT00633230|hepatitis C virus|hepatitis c virus
612898|NCT00633230|complementary and alternative medicine|complementary and alternative medicine
612899|NCT00633230|peginterferon alfa and ribavirin|peginterferon alfa and ribavirin
612900|NCT00633269|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
612901|NCT00633269|Metastatic Solid Tumours|metastatic solid tumours
612902|NCT00633282|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
612903|NCT00633282|Pioglitazone|pioglitazone
612904|NCT00633282|Berberine|berberine
612905|NCT00633282|Impaired Glucose Metabolism|impaired glucose metabolism
612907|NCT00633295|TKI|tki
612908|NCT00633295|IMATINIB|imatinib
612909|NCT00633295|NILOTINIB|nilotinib
612910|NCT00633295|AMN107|amn107
612911|NCT00633308|hemodialysis|hemodialysis
612912|NCT00633321|smoking cessation|smoking cessation
612913|NCT00633321|quit smoking|quit smoking
612914|NCT00633321|smoking vaccine|smoking vaccine
612915|NCT00633321|nicotine vaccine|nicotine vaccine
612916|NCT00633321|TA-NIC|ta-nic
612917|NCT00633321|Aid for smoking cessation in smokers motivated to quit|aid for smoking cessation in smokers motivated to quit
612918|NCT00633334|Cancer|cancer
612919|NCT00633334|GI|gi
612920|NCT00633334|Tumor|tumor
612921|NCT00633334|Gastrointestinal|gastrointestinal
612922|NCT00633334|high risk|high risk
612923|NCT00633347|oocyte donation|oocyte donation
612924|NCT00633347|endometrial preparation|endometrial preparation
612925|NCT00633360|Women|women
612926|NCT00633360|PMS|pms
612927|NCT00633360|Depression|depression
612928|NCT00633373|lung|lung
612929|NCT00633373|transplant|transplant
612930|NCT00633373|transplant rejection|transplant rejection
612931|NCT00633373|Cyclosporine|cyclosporine
612932|NCT00633373|bronchiolitis obliterans|bronchiolitis obliterans
612933|NCT00633373|aerosol|aerosol
612934|NCT00633386|Knee Surgery|knee surgery
612935|NCT00633386|Arthroscopic Surgery|arthroscopic surgery
612936|NCT00633399|Major Depressive Disorder|major depressive disorder
612937|NCT00633399|Major Depression|major depression
612938|NCT00633399|Depression|depression
612939|NCT00633399|Geodon|geodon
612940|NCT00633399|Ziprasidone|ziprasidone
612941|NCT00633399|SSRI Augmentation|ssri augmentation
612942|NCT00633399|Treatment Resistant Depression|treatment resistant depression
612943|NCT00633412|NSAID|nsaid
612944|NCT00633412|Nexium|nexium
612945|NCT00633412|esomeprazole|esomeprazole
612946|NCT00633412|Gastric Ulcers|gastric ulcers
612947|NCT00633438|Knee Surgery Arthroscopic Surgery|knee surgery arthroscopic surgery
612948|NCT00633451|shoulder pain|shoulder pain
612949|NCT00633451|shoulder impingement syndrome|shoulder impingement syndrome
612950|NCT00633451|manual therapy|manual therapy
612951|NCT00633451|rehabilitation|rehabilitation
612952|NCT00633477|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
612953|NCT00633477|Septic Shock|septic shock
612954|NCT00633477|Septicemia|septicemia
612955|NCT00633477|Drug Therapy|drug therapy
612956|NCT00633490|Toxicity|toxicity
612957|NCT00633490|Efficacy|efficacy
612958|NCT00633503|free tissue transfer|free tissue transfer
612959|NCT00633503|pedicle tissue transfer|pedicle tissue transfer
612960|NCT00633503|complications|complications
612961|NCT00633503|modulated imaging spectroscopy|modulated imaging spectroscopy
612963|NCT00633503|clinical observation/diagnosis|clinical observation/diagnosis
612964|NCT00633503|tissue defects requiring free tissue transfer|tissue defects requiring free tissue transfer
612965|NCT00633503|tissue defects requiring pedicle tissue transfer|tissue defects requiring pedicle tissue transfer
612966|NCT00633516|moles|moles
612967|NCT00633516|melanoma|melanoma
612968|NCT00633529|Phase 1b|phase 1b
612969|NCT00633529|Non-Small Cell Lung Cancer|non-small cell lung cancer
612970|NCT00633529|Advanced or Metastatic Disease|advanced or metastatic disease
612971|NCT00633529|Prior chemotherapy|prior chemotherapy
612972|NCT00633542|thalidomide|thalidomide
612973|NCT00633542|maintenance|maintenance
612976|NCT00633542|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
612977|NCT00633542|relapsed refractory multiple myeloma|relapsed refractory multiple myeloma
612978|NCT00633568|Non-small cell lung carcinoma|non-small cell lung carcinoma
612979|NCT00633568|Concomitant radiochemotherapy|concomitant radiochemotherapy
612980|NCT00633568|Cisplatin|cisplatin
612981|NCT00633568|Docetaxel|docetaxel
612982|NCT00633568|Radiotherapy|radiotherapy
612983|NCT00633568|Chemotherapy|chemotherapy
612984|NCT00633568|Unresectable stage III non-small cell lung carcinoma|unresectable stage iii non-small cell lung carcinoma
612985|NCT00633581|fatigue|fatigue
612986|NCT00633581|ascorbic acid|ascorbic acid
612987|NCT00633581|oxidative stress|oxidative stress
612988|NCT00633594|Mantle Cell Lymphoma|mantle cell lymphoma
612989|NCT00633594|Rituximab|rituximab
612990|NCT00633594|Lenalidomide|lenalidomide
612991|NCT00633594|Bortezomib|bortezomib
612992|NCT00633594|Phase 1/2|phase 1/2
612993|NCT00633620|colonoscopy|colonoscopy
612994|NCT00633620|narrow band imaging|narrow band imaging
612995|NCT00633620|adenoma|adenoma
612997|NCT00633620|colonoscopic adenoma detection|colonoscopic adenoma detection
612998|NCT00633633|Heart Failure|heart failure
612999|NCT00633633|Lifestyle Intervention|lifestyle intervention
613000|NCT00633633|Exercise|exercise
613001|NCT00633633|Diet|diet
613002|NCT00633646|nitrogen balance|nitrogen balance
613003|NCT00633646|malnutrition|malnutrition
613004|NCT00633646|chronic kidney disease|chronic kidney disease
613005|NCT00633646|diet|diet
613006|NCT00633646|glomerular filtration rate|glomerular filtration rate
613007|NCT00633659|Hemospan|hemospan
613008|NCT00633659|Oxygen carriers|oxygen carriers
613009|NCT00633659|Blood substitutes|blood substitutes
613010|NCT00633659|Ischemia|ischemia
613011|NCT00633659|Tissue oxygenation|tissue oxygenation
613012|NCT00633672|NSAID|nsaid
613013|NCT00633672|Nexium|nexium
613014|NCT00633672|esomeprazole|esomeprazole
613015|NCT00633672|Gastric Ulcers|gastric ulcers
613016|NCT00633685|Posttraumatic Stress Disorder|posttraumatic stress disorder
613017|NCT00633685|Fluoxetine|fluoxetine
613018|NCT00633685|Factors predicting response|factors predicting response
613019|NCT00633685|Resilience|resilience
613020|NCT00633685|Pharmacologic augmentation strategies|pharmacologic augmentation strategies
613021|NCT00633698|lipoprotein(a)|lipoprotein(a)
613022|NCT00633698|niacin|niacin
613023|NCT00633698|placebo|placebo
613024|NCT00633698|intervention|intervention
613025|NCT00633711|OSAS|osas
613026|NCT00633711|blood pressure|blood pressure
613027|NCT00633711|sympathetic nervous system|sympathetic nervous system
613028|NCT00633711|treatment|treatment
613029|NCT00633711|CPAP|cpap
613030|NCT00633737|Psychology|psychology
613031|NCT00633737|Laparoscopy|laparoscopy
613032|NCT00633737|Cholecystectomy|cholecystectomy
613033|NCT00633737|Psychoneuroimmunology|psychoneuroimmunology
613034|NCT00633737|Wound healing|wound healing
613035|NCT00633737|Preparation for surgery|preparation for surgery
613036|NCT00633737|Stress reduction|stress reduction
613037|NCT00633737|Stress|stress
613038|NCT00633737|Relaxation|relaxation
613039|NCT00633750|stage I breast cancer|stage i breast cancer
613040|NCT00633750|stage II breast cancer|stage ii breast cancer
613041|NCT00633750|stage IIIA breast cancer|stage iiia breast cancer
613042|NCT00633750|stage IIIB breast cancer|stage iiib breast cancer
613043|NCT00633763|Diagnostic|diagnostic
613044|NCT00633763|PET/CT imaging of pancreas|pet/ct imaging of pancreas
613045|NCT00633763|Detecting pancreatic beta cell loss during diabetes|detecting pancreatic beta cell loss during diabetes
613046|NCT00633776|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
613047|NCT00633776|COPD|copd
613048|NCT00633776|Chronic bronchitis|chronic bronchitis
613049|NCT00633776|Emphysema|emphysema
613050|NCT00633776|Perforomist|perforomist
613051|NCT00633776|Foradil|foradil
613053|NCT00633776|lung function|lung function
613054|NCT00633802|Risperidone|risperidone
613055|NCT00633802|Borderlone Personality Disorder|borderlone personality disorder
613056|NCT00633815|Supine|supine
613057|NCT00633815|Upright|upright
613058|NCT00633828|Bone Density|bone density
613059|NCT00633828|Bone mass|bone mass
613060|NCT00633828|Bone mineral density|bone mineral density
613061|NCT00633828|Bone structure|bone structure
613062|NCT00633828|Cardiovascular risk factors|cardiovascular risk factors
613063|NCT00633828|Fat Mass|fat mass
613064|NCT00633828|Adiposity|adiposity
613065|NCT00633841|Alzheimer|alzheimer
613066|NCT00633841|Morbus Alzheimer|morbus alzheimer
613067|NCT00633841|Alzheimer Vaccine|alzheimer vaccine
613068|NCT00633841|Vaccine|vaccine
613069|NCT00633841|AD|ad
613070|NCT00633841|Aβ immunotherapy|aβ immunotherapy
613071|NCT00633854|annular array ultrasound|annular array ultrasound
613072|NCT00633854|ophthalmic ultrasound|ophthalmic ultrasound
613073|NCT00633854|posterior vitreous detachment (PVD)|posterior vitreous detachment (pvd)
613074|NCT00633867|Tracheal intubation|tracheal intubation
613075|NCT00633867|Laryngoscopy|laryngoscopy
613076|NCT00633867|videolaryngoscope|videolaryngoscope
613077|NCT00633867|McGrath|mcgrath
613078|NCT00633867|success|success
613081|NCT00633880|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
613082|NCT00633880|Orthostatic hypotension|orthostatic hypotension
613083|NCT00633880|PAF|paf
613084|NCT00633880|Pure Autonomic Failure|pure autonomic failure
613085|NCT00633880|MSA|msa
613086|NCT00633880|Multiple System Atrophy|multiple system atrophy
613087|NCT00633880|Neuropathy|neuropathy
613088|NCT00633880|Autonomic Failure|autonomic failure
613089|NCT00633880|Parkinson|parkinson
613090|NCT00633880|Dopamine Deficiency|dopamine deficiency
613091|NCT00633880|Dopamine|dopamine
613092|NCT00633880|Droxidopa|droxidopa
613093|NCT00633906|HIV|hiv
613094|NCT00633906|Sexually Transmitted diseases|sexually transmitted diseases
613095|NCT00633906|Adolescents|adolescents
613096|NCT00633906|Prevention|prevention
613097|NCT00633906|HIV Seronegativity|hiv seronegativity
613098|NCT00633919|House dust mites|house dust mites
613396|NCT00626522|Bronchitis|bronchitis
613099|NCT00633919|Sublingual immunotherapy|sublingual immunotherapy
613101|NCT00633919|Allergic asthma|allergic asthma
613102|NCT00633932|Reflux Esophagitis|reflux esophagitis
613103|NCT00633945|Cutaneous Lupus Erythematosus|cutaneous lupus erythematosus
613104|NCT00633945|CLE|cle
613105|NCT00633945|lenalidomide|lenalidomide
613106|NCT00633945|revlimid|revlimid
613107|NCT00633945|thalidomide derivative|thalidomide derivative
613108|NCT00633945|drug|drug
613109|NCT00633945|lupus|lupus
613110|NCT00633958|18F-FLT|18f-flt
613111|NCT00633958|FLT|flt
613112|NCT00633958|PET|pet
613113|NCT00633958|CNS tumors|cns tumors
613114|NCT00633958|Newly|newly
613115|NCT00633958|diagnosed|diagnosed
613116|NCT00633971|Post thrombotic syndrome|post thrombotic syndrome
613117|NCT00633971|Thrombosis|thrombosis
613118|NCT00633971|Deep vein thrombosis|deep vein thrombosis
613119|NCT00633971|Venous thrombosis|venous thrombosis
613120|NCT00633971|Edema|edema
613121|NCT00633971|stasis ulcers|stasis ulcers
613122|NCT00633984|Social Anxiety Disorder|social anxiety disorder
613123|NCT00633984|Cognitive Behavioral Group Therapy|cognitive behavioral group therapy
613124|NCT00633984|D-cycloserine|d-cycloserine
613125|NCT00633997|Diabetes mellitus|diabetes mellitus
613126|NCT00633997|type 2 diabetes|type 2 diabetes
613127|NCT00633997|vildagliptin|vildagliptin
613128|NCT00633997|pharmacokinetics|pharmacokinetics
613129|NCT00634010|Advanced Cancer|advanced cancer
613130|NCT00634010|Solid Tumors|solid tumors
613131|NCT00634010|Cancer Pain|cancer pain
613132|NCT00634010|Opioid Pain Killer|opioid pain killer
613133|NCT00634010|Morphine|morphine
613134|NCT00634010|Methadone|methadone
613135|NCT00634036|Asthma|asthma
613136|NCT00634036|obesity|obesity
613137|NCT00634036|exacerbation|exacerbation
613138|NCT00634036|asthmatics|asthmatics
613139|NCT00634036|fat|fat
613140|NCT00634036|overweight|overweight
613141|NCT00634036|adipose tissue|adipose tissue
613142|NCT00634036|leptin|leptin
613143|NCT00634036|adiponectin|adiponectin
613144|NCT00634036|pioglitazone|pioglitazone
613145|NCT00634036|Actos|actos
613146|NCT00634036|wheezing|wheezing
613147|NCT00634036|Pittsburgh|pittsburgh
613148|NCT00634036|Pennsylvania|pennsylvania
613149|NCT00634036|pulmonary|pulmonary
613150|NCT00634036|lung|lung
613151|NCT00634049|invasive fungal infections caused by rare molds, rare yeasts|invasive fungal infections caused by rare molds, rare yeasts
613152|NCT00634049|BAL8557|bal8557
613153|NCT00634049|Isavuconazole|isavuconazole
613154|NCT00634049|Aspergillosis|aspergillosis
613155|NCT00634049|or by dimorphic fungi|or by dimorphic fungi
613156|NCT00634049|ASP9766|asp9766
613157|NCT00634062|Affective Lability|affective lability
613158|NCT00634062|Borderline Personality Disorder|borderline personality disorder
613159|NCT00634062|Pharmacotherapy|pharmacotherapy
613160|NCT00634075|Severe sepsis|severe sepsis
613161|NCT00634075|Proinflammatory cytokines|proinflammatory cytokines
613162|NCT00634075|ICU|icu
613163|NCT00634114|Reflux Esophagitis|reflux esophagitis
613164|NCT00634140|gallbladder|gallbladder
615341|NCT00641563|Electroencephalography|electroencephalography
615342|NCT00641563|Event related potentials|event related potentials
615343|NCT00641563|BIS|bis
613165|NCT00634140|ezetimibe for 4 to 6 weeks prior to gallbladder removal|ezetimibe for 4 to 6 weeks prior to gallbladder removal
613166|NCT00634166|thermal injuries|thermal injuries
613167|NCT00634166|burns|burns
613168|NCT00634166|Burn Patients (Subjects with Thermal Injuries Requiring Meshed Autografts)|burn patients (subjects with thermal injuries requiring meshed autografts)
613169|NCT00634179|Lymphoma|lymphoma
613170|NCT00634192|Chronic infection with P. aeruginosa in Cystic Fibrosis subjects|chronic infection with p. aeruginosa in cystic fibrosis subjects
613171|NCT00634205|Mesothelioma|mesothelioma
613172|NCT00634205|Valproate|valproate
613173|NCT00634205|Doxorubicin|doxorubicin
613174|NCT00634205|Chemotherapy|chemotherapy
613175|NCT00634205|Phase II|phase ii
613176|NCT00634218|nicotine|nicotine
613177|NCT00634218|smoking|smoking
613178|NCT00634218|smoking cessation|smoking cessation
613179|NCT00634231|Malignant glioma|malignant glioma
613180|NCT00634231|Glioblastoma multiforme|glioblastoma multiforme
613181|NCT00634231|Anaplastic astrocytoma|anaplastic astrocytoma
613182|NCT00634231|Recurrent ependymoma|recurrent ependymoma
613183|NCT00634231|Gene therapy|gene therapy
613184|NCT00634231|Immunotherapy|immunotherapy
613185|NCT00634244|Acute Myelogenous Leukemia (AML), Carboplatin, Topotecan, Flavopiridol, Mitoxantrone, Cytosine Arabinoside, Sirolimus, Etoposide|acute myelogenous leukemia (aml), carboplatin, topotecan, flavopiridol, mitoxantrone, cytosine arabinoside, sirolimus, etoposide
613186|NCT00634257|Advanced Cancer|advanced cancer
613187|NCT00634257|Solid Tumors|solid tumors
613188|NCT00634257|Spirituality|spirituality
613189|NCT00634257|Religiosity|religiosity
613190|NCT00634257|Symptom Distress|symptom distress
613191|NCT00634257|Quality of Life|quality of life
613192|NCT00634257|Caregivers|caregivers
613193|NCT00634257|Questionnaire|questionnaire
613194|NCT00634257|Survey|survey
613195|NCT00634270|Plexiform, Neurofibromatosis Type 1, Sirolimus, Phase II|plexiform, neurofibromatosis type 1, sirolimus, phase ii
613196|NCT00634296|Heart failure|heart failure
613197|NCT00634296|Systolic dysfunction|systolic dysfunction
613397|NCT00626522|Chronic|chronic
613198|NCT00634296|Inspiratory muscle weakness|inspiratory muscle weakness
613401|NCT00626535|Nexium|nexium
613199|NCT00634309|Congestive Heart Failure|congestive heart failure
613200|NCT00634309|Atacand|atacand
613201|NCT00634309|Candesartan|candesartan
613202|NCT00634322|osteosarcoma|osteosarcoma
613203|NCT00634322|high dose methotrexate|high dose methotrexate
613204|NCT00634322|leucovorin|leucovorin
613205|NCT00634374|Rx medibottle|rx medibottle
613206|NCT00634374|Oral syringe|oral syringe
613207|NCT00634374|Liquid medication|liquid medication
613208|NCT00634374|Bitter-tasting|bitter-tasting
613209|NCT00634374|Infants|infants
613210|NCT00634400|Congestive Heart Failure|congestive heart failure
613211|NCT00634400|Atacand|atacand
613212|NCT00634400|Candesartan|candesartan
613213|NCT00634413|COPD|copd
613214|NCT00634426|Spine|spine
613215|NCT00634426|Neoplasm metastasis|neoplasm metastasis
613216|NCT00634426|Treatment, surgical|treatment, surgical
613217|NCT00634426|Treatment, nonoperative|treatment, nonoperative
613218|NCT00634426|Quality of life|quality of life
613219|NCT00634439|cerebrovascular accident|cerebrovascular accident
613220|NCT00634439|stroke|stroke
613221|NCT00634439|transient ischemic attack|transient ischemic attack
613223|NCT00634439|CVA|cva
613224|NCT00634439|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
613225|NCT00634439|ADHD|adhd
613226|NCT00634452|Hodgkin's|hodgkin's
613227|NCT00634452|Cancer|cancer
613228|NCT00634452|bi-measurable disease|bi-measurable disease
613229|NCT00634452|Lymphoma|lymphoma
613230|NCT00634478|essential tremor|essential tremor
613231|NCT00634478|deep brain stimulation|deep brain stimulation
613232|NCT00634504|high dose methotrexate|high dose methotrexate
613233|NCT00634504|Voraxaze|voraxaze
613234|NCT00634504|leucovorin|leucovorin
613235|NCT00634504|delayed elimination|delayed elimination
613236|NCT00634504|methotrexate toxicity|methotrexate toxicity
613237|NCT00634504|rescue|rescue
613238|NCT00634504|renal insufficiency|renal insufficiency
613239|NCT00634530|Pregnancy|pregnancy
613240|NCT00634530|Prenatal Care|prenatal care
613241|NCT00634530|Weight|weight
613242|NCT00634530|Nutritional Status|nutritional status
613243|NCT00634543|Diabetic neuropathy|diabetic neuropathy
613244|NCT00634543|Ultracet|ultracet
613245|NCT00634543|Tramadol hydrochloride|tramadol hydrochloride
613246|NCT00634543|Acetaminophen|acetaminophen
613247|NCT00634543|Gabapentin|gabapentin
613248|NCT00634556|Tourette Syndrome|tourette syndrome
613249|NCT00634556|fMRI|fmri
613250|NCT00634556|levodopa|levodopa
613251|NCT00634556|working memory|working memory
613252|NCT00634556|dopamine|dopamine
613253|NCT00634569|CVID, XLA, hyper IgM syndrome, Wiskott-Aldrich Syndrome|cvid, xla, hyper igm syndrome, wiskott-aldrich syndrome
613254|NCT00634582|adenocarcinoma of the prostate|adenocarcinoma of the prostate
613255|NCT00634582|stage IV prostate cancer|stage iv prostate cancer
613256|NCT00634582|recurrent prostate cancer|recurrent prostate cancer
613257|NCT00634582|bone metastases|bone metastases
613258|NCT00634595|clinical trial|clinical trial
613259|NCT00634595|randomized|randomized
613260|NCT00634595|Endostatin|endostatin
613261|NCT00634595|gene therapy|gene therapy
613262|NCT00634595|head and neck cancer|head and neck cancer
613263|NCT00634595|head and neck squamous carcinoma|head and neck squamous carcinoma
613264|NCT00634621|Bladder|bladder
613265|NCT00634621|Cancer|cancer
613266|NCT00634621|Cystoscopy|cystoscopy
613267|NCT00634621|Hexaminolevulinate|hexaminolevulinate
613268|NCT00634621|Hexvix|hexvix
613269|NCT00634634|breast cancer|breast cancer
613270|NCT00634634|Postmenopausal Women with Hormone Receptor-Positive Locally Advanced Breast Cancer|postmenopausal women with hormone receptor-positive locally advanced breast cancer
613271|NCT00634647|Chemotherapy|chemotherapy
613272|NCT00634647|Pharmacokinetics|pharmacokinetics
613273|NCT00634647|Gene Polymorphisms|gene polymorphisms
613274|NCT00634647|Prostate Cancer|prostate cancer
613275|NCT00634673|Serum Fatty Acids|serum fatty acids
613276|NCT00634673|FABP2 Gene|fabp2 gene
613277|NCT00634673|Polymorphism Ala54Thr|polymorphism ala54thr
613278|NCT00634686|Omega-3 fatty acids|omega-3 fatty acids
613279|NCT00634686|immune response|immune response
613280|NCT00634712|Congestive Heart Failure|congestive heart failure
613281|NCT00634712|Atacand|atacand
613282|NCT00634712|Candesartan|candesartan
613283|NCT00634725|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
613284|NCT00634725|stage III pancreatic cancer|stage iii pancreatic cancer
613285|NCT00634738|ischemic compression;carpal tunnel syndrome|ischemic compression;carpal tunnel syndrome
613286|NCT00634751|advanced pancreatic and biliary tract carcinomas|advanced pancreatic and biliary tract carcinomas
613287|NCT00634764|Maternal weight gain|maternal weight gain
613288|NCT00634764|Neonatal birth weight|neonatal birth weight
613289|NCT00634764|Weight gain attitude|weight gain attitude
613290|NCT00634764|Pregnancy|pregnancy
613291|NCT00634764|Body fat|body fat
613292|NCT00634764|Maternal Behavior|maternal behavior
613293|NCT00634764|Birth outcomes|birth outcomes
613294|NCT00634777|HNSCC biopsy-proven|hnscc biopsy-proven
613295|NCT00634777|T1-T4 oral cavity oropharynx hypopharynx larynx|t1-t4 oral cavity oropharynx hypopharynx larynx
613296|NCT00634777|N+ scheduled for an organ preservation treatment protocol based on concomitant|n+ scheduled for an organ preservation treatment protocol based on concomitant
613297|NCT00634777|chemoradiation|chemoradiation
613298|NCT00634855|Endothelial progenitor cells|endothelial progenitor cells
613299|NCT00634855|Endothelial dysfunction|endothelial dysfunction
613300|NCT00634868|ulcer wound diabetes|ulcer wound diabetes
613301|NCT00634881|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
613302|NCT00634881|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
613303|NCT00634881|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
613304|NCT00634881|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
613305|NCT00634881|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
613306|NCT00634894|Ovarian Cancer|ovarian cancer
613307|NCT00634894|Fallopian Tube Cancer|fallopian tube cancer
613308|NCT00634894|Peritoneal Cancer|peritoneal cancer
613310|NCT00634894|Letrozole|letrozole
613311|NCT00634894|Placebo|placebo
613312|NCT00634907|Genotyping|genotyping
613313|NCT00634907|Warfarin dosing|warfarin dosing
613314|NCT00634907|arthroplasty|arthroplasty
613315|NCT00634920|De novo renal transplantation|de novo renal transplantation
613316|NCT00634933|active|active
613317|NCT00634933|rheumatoid|rheumatoid
613318|NCT00634933|arthritis|arthritis
613319|NCT00634933|anti CD20|anti cd20
613320|NCT00634946|Chemonucleolysis|chemonucleolysis
613321|NCT00634946|Lumbar Vertebrae|lumbar vertebrae
613322|NCT00634946|Hernia|hernia
613323|NCT00626171|smoking|smoking
613324|NCT00626171|asthma|asthma
613325|NCT00626171|sputum|sputum
613326|NCT00626184|Celiac Disease|celiac disease
613328|NCT00626197|Lupus|lupus
613329|NCT00626197|BELONG|belong
613330|NCT00626210|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
613331|NCT00626210|Sleep|sleep
613332|NCT00626210|Fatigue|fatigue
613333|NCT00626210|Memory|memory
613334|NCT00626223|ESRD patients|esrd patients
613335|NCT00626223|C-reactive protein|c-reactive protein
613336|NCT00626223|homocysteine|homocysteine
613337|NCT00626223|5-MTHF|5-mthf
613338|NCT00626223|survival|survival
613339|NCT00626223|Hemodialysis patients|hemodialysis patients
613340|NCT00626236|ADHD and conduct problems|adhd and conduct problems
613341|NCT00626249|Nephropathy|nephropathy
613342|NCT00626249|Kidney Disease|kidney disease
613343|NCT00626249|Diabetic|diabetic
613344|NCT00626249|Renal|renal
613345|NCT00626249|Diabetics|diabetics
613346|NCT00626262|Gastroesophageal reflux disease|gastroesophageal reflux disease
613347|NCT00626262|Nexium|nexium
613348|NCT00626262|Esomeprazole|esomeprazole
613349|NCT00626262|Administration methods.|administration methods.
613350|NCT00626275|Rheumatoid arthritis|rheumatoid arthritis
613351|NCT00626275|arthritis|arthritis
613352|NCT00626288|Mesalazine in Irritable Bowel Syndrome|mesalazine in irritable bowel syndrome
613353|NCT00626301|efficacy|efficacy
613354|NCT00626301|safety|safety
613355|NCT00626301|pharmacokinetics|pharmacokinetics
613356|NCT00626301|LPV/r monotherapy|lpv/r monotherapy
613357|NCT00626301|Thai children|thai children
613358|NCT00626301|efficacy safety LPV/r monotherapy maintenance|efficacy safety lpv/r monotherapy maintenance
613359|NCT00626301|treatment experienced|treatment experienced
613360|NCT00626327|vaccine|vaccine
613361|NCT00626327|toddlers|toddlers
613362|NCT00626327|healthy|healthy
613363|NCT00626327|meningitis|meningitis
613364|NCT00626327|meningococcal|meningococcal
613365|NCT00626327|measles|measles
613366|NCT00626327|mumps|mumps
613367|NCT00626327|rubella|rubella
613368|NCT00626327|varicella|varicella
613369|NCT00626327|Prevention of Meningococcal disease types ACWY|prevention of meningococcal disease types acwy
613370|NCT00626340|menopause|menopause
613371|NCT00626340|women|women
613372|NCT00626340|major depressive disorder|major depressive disorder
613373|NCT00626340|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
613374|NCT00626353|Stroke|stroke
613375|NCT00626353|rehabilitation|rehabilitation
613376|NCT00626353|motor recovery|motor recovery
613377|NCT00626353|cognition|cognition
613378|NCT00626353|quality of life|quality of life
613379|NCT00626366|Nasal Spray|nasal spray
613380|NCT00626366|Nasal Drop|nasal drop
613381|NCT00626366|Intranasal Medication|intranasal medication
613382|NCT00626379|Coronary Heart Disease|coronary heart disease
613383|NCT00626379|Subclinical Atherosclerosis|subclinical atherosclerosis
613384|NCT00626379|CVD-Related Markers of Inflammation|cvd-related markers of inflammation
613385|NCT00626379|Mortality|mortality
613386|NCT00626405|stage IV melanoma|stage iv melanoma
613387|NCT00626431|Lupron Depot|lupron depot
613388|NCT00626431|prostate cancer|prostate cancer
613389|NCT00626431|leuprolide acetate|leuprolide acetate
613390|NCT00626470|Trochanter|trochanter
613391|NCT00626470|Femur|femur
613392|NCT00626470|Fracture|fracture
613393|NCT00626483|adult giant cell glioblastoma|adult giant cell glioblastoma
613394|NCT00626483|adult gliosarcoma|adult gliosarcoma
613395|NCT00626509|stage IV renal cell cancer|stage iv renal cell cancer
613398|NCT00626522|Emphysema|emphysema
613399|NCT00626522|Smokers or ex-Smokers|smokers or ex-smokers
613400|NCT00626535|Symptomatic Gastroesophageal Reflux Disease (sGERD)|symptomatic gastroesophageal reflux disease (sgerd)
613402|NCT00626535|Esomeprazole|esomeprazole
613403|NCT00626548|Hormone Resistant Prostate Cancer|hormone resistant prostate cancer
613404|NCT00626548|Endothelin A Receptor Antagonist|endothelin a receptor antagonist
613405|NCT00626548|Endothelin A|endothelin a
613406|NCT00626548|Endothelin A antagonist|endothelin a antagonist
613407|NCT00626561|Cervical Cancer|cervical cancer
613408|NCT00626561|Uterine Cancer|uterine cancer
613409|NCT00626561|Bevacizumab|bevacizumab
613410|NCT00626561|Avastin|avastin
613411|NCT00626561|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
613412|NCT00626561|rhuMAb-VEGF|rhumab-vegf
613413|NCT00626561|Paclitaxel|paclitaxel
613414|NCT00626561|Taxol|taxol
613415|NCT00626574|Epoetin alfa|epoetin alfa
613416|NCT00626574|aneurysm|aneurysm
613417|NCT00626574|subarachnoid hemorrhage|subarachnoid hemorrhage
613418|NCT00626587|Endobronchial ultrasonography|endobronchial ultrasonography
613419|NCT00626587|Peripheral pulmonary lesions|peripheral pulmonary lesions
613420|NCT00626587|Transbronchial needle aspiration|transbronchial needle aspiration
613421|NCT00626587|Probe location|probe location
613422|NCT00626587|Diagnostic yield|diagnostic yield
613423|NCT00626587|EBUS guided TBNA for peripheral pulmonary lesions|ebus guided tbna for peripheral pulmonary lesions
613775|NCT00628238|Frontline|frontline
613424|NCT00626600|Oxycodone Hydrochloride 50mg/mL|oxycodone hydrochloride 50mg/ml
613425|NCT00626600|Observational|observational
613426|NCT00626600|Infusion|infusion
613427|NCT00626600|Severe cancer pain|severe cancer pain
613428|NCT00626626|leukemia|leukemia
613429|NCT00626626|myelodysplastic syndrome|myelodysplastic syndrome
613430|NCT00626626|chronic myelogenous leukemia|chronic myelogenous leukemia
613431|NCT00626626|lymphoma|lymphoma
613432|NCT00626626|mantle cell lymphoma|mantle cell lymphoma
613433|NCT00626639|palifermin|palifermin
613434|NCT00626639|Clinical Trial|clinical trial
613435|NCT00626639|Oncology|oncology
613436|NCT00626639|Head & Neck|head & neck
613437|NCT00626665|Raynaud disease|raynaud disease
613438|NCT00626665|Scleroderma|scleroderma
613439|NCT00626678|Pemphigus Vulgaris|pemphigus vulgaris
613440|NCT00626678|Azathioprine|azathioprine
613441|NCT00626678|Prednisone|prednisone
613442|NCT00626691|antioxidant|antioxidant
613443|NCT00626691|walnut|walnut
613444|NCT00626691|nutritional status|nutritional status
613445|NCT00626691|Antioxidant capacity|antioxidant capacity
613446|NCT00626704|Sarcoma|sarcoma
613447|NCT00626704|Soft Tissue Sarcoma|soft tissue sarcoma
613448|NCT00626704|Locally Advanced or Metastatic, Unresectable Soft Tissue Sarcoma|locally advanced or metastatic, unresectable soft tissue sarcoma
613449|NCT00626704|AMG 655|amg 655
613451|NCT00626704|Doxorubicin|doxorubicin
613452|NCT00626704|Death receptor|death receptor
613453|NCT00626704|TRAIL receptor|trail receptor
613454|NCT00626704|Apoptosis|apoptosis
613455|NCT00626717|Keratoconus|keratoconus
613456|NCT00626717|Cross linking|cross linking
613457|NCT00626717|Riboflavin|riboflavin
613458|NCT00626730|adult grade II meningioma|adult grade ii meningioma
613459|NCT00626730|adult grade III meningioma|adult grade iii meningioma
613460|NCT00626964|Arterial stiffness|arterial stiffness
613461|NCT00626964|PulseWave velocity|pulsewave velocity
613462|NCT00626964|Body composition|body composition
613463|NCT00626964|Bioimpedance|bioimpedance
613464|NCT00626964|Morbid Obesity|morbid obesity
613465|NCT00626964|APO A|apo a
613466|NCT00626964|APO B|apo b
613467|NCT00626964|Framingham risk score|framingham risk score
613468|NCT00626964|Prevention of Coronary Heart Disease|prevention of coronary heart disease
613469|NCT00626964|Lifestyle Intervention|lifestyle intervention
613470|NCT00626964|Bariatric Surgery|bariatric surgery
613471|NCT00626964|Low Energy Diet|low energy diet
613472|NCT00626977|Analgesia|analgesia
613473|NCT00626977|Obstetrical|obstetrical
613474|NCT00626977|Anesthesia|anesthesia
613475|NCT00626977|Epidural|epidural
613476|NCT00626977|Newborn|newborn
613477|NCT00626977|Anesthetics, local|anesthetics, local
613478|NCT00626977|Clonidine|clonidine
613479|NCT00626977|Pregnant women|pregnant women
613480|NCT00626977|Infant, newborn|infant, newborn
613481|NCT00626990|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
613482|NCT00626990|adult anaplastic astrocytoma|adult anaplastic astrocytoma
613483|NCT00627016|Non-Erosive Gastroesophageal Reflux Disease|non-erosive gastroesophageal reflux disease
613484|NCT00627016|GERD|gerd
613485|NCT00627016|heartburn|heartburn
613486|NCT00627016|sleep disturbance|sleep disturbance
613487|NCT00627016|nocturnal Reflux|nocturnal reflux
613488|NCT00627029|Care coordination|care coordination
613489|NCT00627029|Disease management|disease management
613490|NCT00627029|Medicare|medicare
613491|NCT00627029|Fee-for-service|fee-for-service
613492|NCT00627029|Random assignment|random assignment
613493|NCT00627029|Elderly|elderly
613494|NCT00627042|Liver disease|liver disease
613495|NCT00627042|Neoplasms|neoplasms
613496|NCT00627042|Liver neoplasms|liver neoplasms
613497|NCT00627042|Carcinoma, Hepatocellular|carcinoma, hepatocellular
613498|NCT00627055|Second line antiretroviral therapy|second line antiretroviral therapy
613499|NCT00627055|HIV genotypic resistance|hiv genotypic resistance
614635|NCT00637546|Balance|balance
613500|NCT00627055|Kaletra monotherapy|kaletra monotherapy
613501|NCT00627055|Thailand|thailand
613502|NCT00627055|48-week efficacy and safety between 2 NRTIs plus lopinavir/ritonavir (LPV/r) and LPV/r monotherapy in patients failing a standard NNRTI-based treatment regimen|48-week efficacy and safety between 2 nrtis plus lopinavir/ritonavir (lpv/r) and lpv/r monotherapy in patients failing a standard nnrti-based treatment regimen
613503|NCT00627055|treatment experienced|treatment experienced
613504|NCT00627068|cardiovascular|cardiovascular
613505|NCT00627068|vasodilation|vasodilation
613506|NCT00627068|endothelium|endothelium
613507|NCT00627068|Subjects with high cardiovascular risk|subjects with high cardiovascular risk
613508|NCT00627107|ReWalk, Paraplegia, SCI|rewalk, paraplegia, sci
613509|NCT00627120|healthy volunteers|healthy volunteers
613510|NCT00627133|Alcohol seizure|alcohol seizure
613511|NCT00627146|Diabetes Mellitus, type 1|diabetes mellitus, type 1
613512|NCT00627146|ChAgly CD3|chagly cd3
613513|NCT00627159|community-based|community-based
613514|NCT00627159|culturally-sensitive|culturally-sensitive
613515|NCT00627159|high risk assessment|high risk assessment
613516|NCT00627159|education classes|education classes
613517|NCT00627159|cardiovascular risk profile|cardiovascular risk profile
613518|NCT00627159|Indo-Asian population|indo-asian population
613519|NCT00627172|Coronary artery disease|coronary artery disease
613520|NCT00627172|MDCT|mdct
613521|NCT00627172|Positron emission tomography|positron emission tomography
613522|NCT00627172|Ultrasound|ultrasound
613523|NCT00627185|Tobacco control|tobacco control
613524|NCT00627185|Tobacco cessation|tobacco cessation
613525|NCT00627185|Tobacco use|tobacco use
613526|NCT00627198|Metastatic; neuroendocrine tumor; clinical trial|metastatic; neuroendocrine tumor; clinical trial
613527|NCT00627211|quality assessment|quality assessment
613528|NCT00627211|pain reduction|pain reduction
613529|NCT00627211|gastroscopy|gastroscopy
613530|NCT00627211|carbondioxide insufflation|carbondioxide insufflation
613531|NCT00627211|Patient satisfaction|patient satisfaction
613532|NCT00627237|Brain Injuries|brain injuries
613533|NCT00627237|Cognitive Rehabilitation|cognitive rehabilitation
613534|NCT00627237|Executive Functioning|executive functioning
613535|NCT00627250|Irritability|irritability
613536|NCT00627250|Aggression|aggression
613537|NCT00627250|Brain Injury|brain injury
613538|NCT00627250|Amantadine|amantadine
613539|NCT00627250|Irritability and Aggression Due to Traumatic Brain Injury|irritability and aggression due to traumatic brain injury
613540|NCT00627263|ICD|icd
613541|NCT00627263|Cardiac Arrhythmia|cardiac arrhythmia
613542|NCT00627263|Arrhythmia|arrhythmia
613543|NCT00627263|Stress|stress
613545|NCT00627276|ductal breast carcinoma in situ|ductal breast carcinoma in situ
613546|NCT00627276|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
613547|NCT00627289|Chronic pain|chronic pain
613548|NCT00627289|groin hernia|groin hernia
613549|NCT00627289|neuropathic pain|neuropathic pain
613550|NCT00627289|chronic postoperative pain|chronic postoperative pain
613551|NCT00627289|Postherniotomy pain|postherniotomy pain
613552|NCT00627289|Neuroplastic changes|neuroplastic changes
613553|NCT00627302|Quality of Vision|quality of vision
613554|NCT00627315|Obesity|obesity
613555|NCT00627315|Insulin Resistance|insulin resistance
613556|NCT00627315|Bariatric Surgery|bariatric surgery
613557|NCT00627315|Gastric Banding|gastric banding
613558|NCT00627315|Gastric Bypass|gastric bypass
613559|NCT00627328|Physiologic Pacing|physiologic pacing
613560|NCT00627328|Dual Chamber Pacing|dual chamber pacing
613561|NCT00627328|Atrioventricular Block|atrioventricular block
613562|NCT00627328|Bradycardia|bradycardia
613563|NCT00627328|Sick Sinus Syndrome|sick sinus syndrome
613564|NCT00627341|Exposure Therapy|exposure therapy
613565|NCT00627341|Relapse Prevention|relapse prevention
613566|NCT00627341|Anorexia Nervosa|anorexia nervosa
613567|NCT00627354|stage IV prostate cancer|stage iv prostate cancer
613568|NCT00627354|recurrent prostate cancer|recurrent prostate cancer
613569|NCT00627354|adenocarcinoma of the prostate|adenocarcinoma of the prostate
613839|NCT00628433|tolerance|tolerance
613570|NCT00627367|Acute Pain Emergency Department ED Hydromorphone Dilaudid Protocolized Nonprotocolized Usual Care|acute pain emergency department ed hydromorphone dilaudid protocolized nonprotocolized usual care
613572|NCT00627380|AIDS|aids
613573|NCT00627380|insulin resistance|insulin resistance
613574|NCT00627380|diabetes|diabetes
613575|NCT00627380|dyslipidemia|dyslipidemia
613576|NCT00627380|visceral adiposity|visceral adiposity
613577|NCT00627380|subcutaneous adipose wasting|subcutaneous adipose wasting
613578|NCT00627380|cardiovascular disease|cardiovascular disease
613579|NCT00627380|hypertension|hypertension
613580|NCT00627380|endothelial function|endothelial function
613581|NCT00627380|quality of life|quality of life
613582|NCT00627380|Complementary Therapies|complementary therapies
613583|NCT00627393|Granulocyte Transfusions|granulocyte transfusions
613584|NCT00627406|GnRH antagonist|gnrh antagonist
613585|NCT00627406|GnRH agonist|gnrh agonist
613586|NCT00627406|hCG|hcg
613587|NCT00627406|OHSS|ohss
613588|NCT00627406|In vitro fertilization|in vitro fertilization
613589|NCT00627406|ovulation induction|ovulation induction
613590|NCT00627406|Clinical pregnancy rate|clinical pregnancy rate
613591|NCT00627432|stage III bladder cancer|stage iii bladder cancer
613592|NCT00627432|stage IV bladder cancer|stage iv bladder cancer
613593|NCT00627432|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
613594|NCT00627458|Hexavalent vaccine|hexavalent vaccine
613595|NCT00627458|Booster|booster
613596|NCT00627484|Insulin resistance|insulin resistance
613597|NCT00627484|Insulin sensitivity|insulin sensitivity
613598|NCT00627484|bariatric surgery|bariatric surgery
613599|NCT00627484|diabetes|diabetes
613600|NCT00627484|calorie restriction|calorie restriction
613601|NCT00627484|body composition|body composition
613602|NCT00627510|Therapeutic Drug Monitoring (TDM)|therapeutic drug monitoring (tdm)
613603|NCT00627510|Antidepressant|antidepressant
613604|NCT00627510|Antipsychotic|antipsychotic
613605|NCT00627510|Treatment adherence|treatment adherence
613606|NCT00627510|Compliance|compliance
613607|NCT00627510|Metabolism|metabolism
613608|NCT00627510|Do patients take their psychiatric medication as prescribed?|do patients take their psychiatric medication as prescribed?
613609|NCT00627510|Do psychiatric patients metabolize their medication faster than expected?|do psychiatric patients metabolize their medication faster than expected?
613610|NCT00627510|What are the exact odds that the patient of a physician prescribing antidepressants or antipsychotics has plasma levels that are BELOW those intended?|what are the exact odds that the patient of a physician prescribing antidepressants or antipsychotics has plasma levels that are below those intended?
613611|NCT00627536|scarring, Juvista, avotermin, transforming growth factor beta 3, TGFB3|scarring, juvista, avotermin, transforming growth factor beta 3, tgfb3
613612|NCT00627549|cystocele, anterior repair, mesh|cystocele, anterior repair, mesh
613613|NCT00627562|robotic|robotic
613614|NCT00627562|robot assisted|robot assisted
613615|NCT00627562|minimally invasive|minimally invasive
613616|NCT00627562|tumors of head and neck|tumors of head and neck
613617|NCT00627575|drug interaction|drug interaction
613618|NCT00627575|pharmacokinetics|pharmacokinetics
613619|NCT00627575|healthy volunteers|healthy volunteers
613620|NCT00627588|ProSavin|prosavin
613621|NCT00627588|Parkinson's Disease|parkinson's disease
613622|NCT00627588|Gene Therapy|gene therapy
613623|NCT00627614|stage I breast cancer|stage i breast cancer
613624|NCT00627614|stage II breast cancer|stage ii breast cancer
613625|NCT00627614|stage IIIA breast cancer|stage iiia breast cancer
613626|NCT00627614|stage IIIB breast cancer|stage iiib breast cancer
613627|NCT00627614|stage IIIC breast cancer|stage iiic breast cancer
613628|NCT00627614|stage IV breast cancer|stage iv breast cancer
613629|NCT00627653|PPAR|ppar
613630|NCT00627653|PET study|pet study
613631|NCT00627653|heart metabolism|heart metabolism
613632|NCT00627666|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
613633|NCT00627666|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
613634|NCT00627666|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
613635|NCT00627666|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
613636|NCT00627666|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
613637|NCT00627666|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
613638|NCT00627666|acute lymphocytic leukemia|acute lymphocytic leukemia
613639|NCT00627666|secondary acute myeloid leukemia|secondary acute myeloid leukemia
613640|NCT00627666|acute undifferentiated leukemia|acute undifferentiated leukemia
613641|NCT00627666|mast cell leukemia|mast cell leukemia
613642|NCT00627666|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
613643|NCT00627666|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
613644|NCT00627666|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
613645|NCT00627666|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
613646|NCT00627666|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
613647|NCT00627666|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
613648|NCT00627666|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
613649|NCT00627666|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
613650|NCT00627666|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
613651|NCT00627666|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
613652|NCT00627666|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
613653|NCT00627666|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
613654|NCT00627666|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
614825|NCT00637962|HIV|hiv
613655|NCT00627666|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
613656|NCT00627666|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
613657|NCT00627666|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
613658|NCT00627666|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
613659|NCT00627666|refractory anemia with excess blasts|refractory anemia with excess blasts
613660|NCT00627679|Pediatric asthma|pediatric asthma
613756|NCT00628186|stent|stent
613661|NCT00627692|Constipation in elderly patients|constipation in elderly patients
613662|NCT00627718|Age-related macular degeneration|age-related macular degeneration
613664|NCT00627718|Macular edema|macular edema
614636|NCT00637559|Nexium|nexium
613665|NCT00627718|Screening for disease|screening for disease
613666|NCT00627731|Asthma Patients|asthma patients
613667|NCT00627744|Type 2 diabetes, IGT, Myocardial infarction, Incretins|type 2 diabetes, igt, myocardial infarction, incretins
613668|NCT00627757|metabolic syndrome|metabolic syndrome
613669|NCT00627757|weight gain|weight gain
613670|NCT00627757|antipsychotic drugs|antipsychotic drugs
613671|NCT00627757|Metabolic syndrome and treatment with antipsychotic drugs|metabolic syndrome and treatment with antipsychotic drugs
613672|NCT00627770|Physical Therapy - Therapeutics - Edema|physical therapy - therapeutics - edema
613673|NCT00627770|Arthroplasty replacement knee|arthroplasty replacement knee
613674|NCT00627770|Treatment outcome|treatment outcome
613676|NCT00627796|IGF-I|igf-i
613677|NCT00627796|tumor|tumor
613678|NCT00627796|lanreotide|lanreotide
613679|NCT00627809|coronary microcirculation|coronary microcirculation
613680|NCT00627809|acut myocardial infarction|acut myocardial infarction
613681|NCT00627809|infarct size|infarct size
613682|NCT00627809|streptokinase|streptokinase
613683|NCT00627809|reperfusion|reperfusion
613684|NCT00627822|Medical students|medical students
613685|NCT00627822|Medical education|medical education
613686|NCT00627822|Private hospital|private hospital
613687|NCT00627822|Patient satisfaction|patient satisfaction
613688|NCT00627822|Questionnaires|questionnaires
613689|NCT00627835|squamous cell carcinoma|squamous cell carcinoma
613690|NCT00627835|head and neck|head and neck
613691|NCT00627835|Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation|neoadjuvant sorafenib and concurrent sorafenib, cisplatin and radiation
613692|NCT00627848|Alzheimer's disease|alzheimer's disease
613693|NCT00627848|fmri|fmri
613694|NCT00627848|face recognition|face recognition
613695|NCT00627848|rivastigmine|rivastigmine
613696|NCT00627887|Depressive Disorder, Major|depressive disorder, major
613697|NCT00627887|Electroconvulsive Therapy|electroconvulsive therapy
613698|NCT00627887|Lithium Carbonate|lithium carbonate
613699|NCT00627887|venlafaxine|venlafaxine
613700|NCT00627900|drug-eluting stents|drug-eluting stents
613701|NCT00627913|Floppy Iris Syndrome|floppy iris syndrome
613702|NCT00627926|Genotype 1|genotype 1
613703|NCT00627952|hypertension|hypertension
613704|NCT00627952|intraglomerular pressure|intraglomerular pressure
613705|NCT00627965|Sildenafil citrate|sildenafil citrate
613706|NCT00627965|Prevention|prevention
613707|NCT00627965|High Altitude Pulmonary Edema|high altitude pulmonary edema
613708|NCT00627965|Acute Mountain Sickness|acute mountain sickness
613709|NCT00627965|Healthy Lowland Subjects|healthy lowland subjects
613710|NCT00627965|Pulmonary Artery Systolic Pressure|pulmonary artery systolic pressure
613711|NCT00627978|breast|breast
613712|NCT00628017|polyunsaturated fatty acids|polyunsaturated fatty acids
613713|NCT00628017|Alzheimer's disease|alzheimer's disease
613714|NCT00628017|mild cognitive impairment|mild cognitive impairment
613715|NCT00628017|fish oil|fish oil
613716|NCT00628017|cognition|cognition
613717|NCT00628030|Behavioral intervention|behavioral intervention
613718|NCT00628030|Obesity prevention|obesity prevention
613719|NCT00628043|Cancer|cancer
613720|NCT00628043|patients|patients
613721|NCT00628043|with|with
613722|NCT00628043|chemotherapy|chemotherapy
613723|NCT00628043|induced|induced
613724|NCT00628043|anemia|anemia
613725|NCT00628056|Perhexiline|perhexiline
613726|NCT00628056|diabetes|diabetes
613727|NCT00628056|diabetic cardiomyopathy|diabetic cardiomyopathy
613728|NCT00628056|high energy phosphate kinetics|high energy phosphate kinetics
613729|NCT00628056|magnetic resonance spectroscopy|magnetic resonance spectroscopy
613730|NCT00628069|Orthopedics|orthopedics
613731|NCT00628069|bone fixation|bone fixation
613732|NCT00628082|Cardiac Energetics|cardiac energetics
613733|NCT00628082|Dynamic Diastolic filling Assessment|dynamic diastolic filling assessment
613734|NCT00628082|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
613735|NCT00628082|Arterial and Ventricular Stiffening|arterial and ventricular stiffening
613736|NCT00628095|rheumatoid arthritis DMARD methotrexate|rheumatoid arthritis dmard methotrexate
613737|NCT00628108|Xyzal|xyzal
613738|NCT00628108|Levocetirizine|levocetirizine
613739|NCT00628108|Allergy|allergy
613740|NCT00628108|Children|children
613741|NCT00628108|Seasonal Allergies|seasonal allergies
613742|NCT00628121|infertility, menstrual cycle, LH surge|infertility, menstrual cycle, lh surge
613743|NCT00628134|cystic fibrosis|cystic fibrosis
613744|NCT00628134|surfactant|surfactant
613745|NCT00628134|aerosol|aerosol
613746|NCT00628134|inhaled drug|inhaled drug
613747|NCT00628134|inhaled antibiotic|inhaled antibiotic
613748|NCT00628147|colonic neoplasms|colonic neoplasms
613749|NCT00628147|colonoscopy|colonoscopy
613750|NCT00628147|narrow band imaging|narrow band imaging
613751|NCT00628147|diagnostic techniques|diagnostic techniques
613752|NCT00628160|Septic shock|septic shock
613753|NCT00628160|Cirrhosis|cirrhosis
613754|NCT00628160|Survival|survival
613755|NCT00628186|pancreaticoduodenectomy|pancreaticoduodenectomy
613757|NCT00628186|pancreaticojejunostomy|pancreaticojejunostomy
613758|NCT00628186|hospital stay|hospital stay
613759|NCT00628186|complication|complication
613760|NCT00628186|pancreatic fistula|pancreatic fistula
613761|NCT00628212|insulin resistance|insulin resistance
613762|NCT00628225|Smoking cessation|smoking cessation
613763|NCT00628238|Chronic Lymphocytic Leukemia Research Consortium|chronic lymphocytic leukemia research consortium
613764|NCT00628238|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
613765|NCT00628238|CLL|cll
613766|NCT00628238|CLL Research Consortium|cll research consortium
613767|NCT00628238|CRC|crc
613768|NCT00628238|Revlimid|revlimid
613769|NCT00628238|lenalidomide|lenalidomide
613770|NCT00628238|Rituximab|rituximab
613771|NCT00628238|Rituxan|rituxan
613772|NCT00628238|First-line|first-line
613773|NCT00628238|therapy|therapy
613774|NCT00628238|untreated|untreated
613776|NCT00628251|Advanced ovarian cancer|advanced ovarian cancer
613777|NCT00628251|BRCA1 protein|brca1 protein
613778|NCT00628251|BRCA2 protein|brca2 protein
613779|NCT00628251|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
613780|NCT00628264|cardiac surgery|cardiac surgery
613781|NCT00628264|coronary artery bypass grafting|coronary artery bypass grafting
613782|NCT00628264|valve surgery|valve surgery
613783|NCT00628264|acute kidney injury|acute kidney injury
613784|NCT00628277|Obesity|obesity
613785|NCT00628277|coronary heart disease|coronary heart disease
613786|NCT00628277|coronary risk factors|coronary risk factors
613787|NCT00628277|weight loss|weight loss
613788|NCT00628277|exercise|exercise
613789|NCT00628303|Good health|good health
613790|NCT00628316|tinnitus|tinnitus
613791|NCT00628316|caffeine|caffeine
613792|NCT00628329|asthma, retinol, cis-retinoic acid|asthma, retinol, cis-retinoic acid
613793|NCT00628342|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
613794|NCT00628342|GERD|gerd
613795|NCT00628342|Esomeprazole|esomeprazole
613796|NCT00628342|Heartburn|heartburn
613797|NCT00628342|Nexium|nexium
613798|NCT00628355|lidocaine|lidocaine
613799|NCT00628355|ischemic compression|ischemic compression
613800|NCT00628355|chronic pelvic pain|chronic pelvic pain
613801|NCT00628355|myofascial pain syndrome|myofascial pain syndrome
613802|NCT00628368|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
613803|NCT00628368|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
613804|NCT00628368|adenocarcinoma of the rectum|adenocarcinoma of the rectum
613805|NCT00628368|recurrent rectal cancer|recurrent rectal cancer
613806|NCT00628368|stage I rectal cancer|stage i rectal cancer
613807|NCT00628368|stage II rectal cancer|stage ii rectal cancer
613808|NCT00628368|stage III rectal cancer|stage iii rectal cancer
613809|NCT00628368|stage IV rectal cancer|stage iv rectal cancer
613810|NCT00628368|recurrent esophageal cancer|recurrent esophageal cancer
613811|NCT00628368|stage I esophageal cancer|stage i esophageal cancer
613812|NCT00628368|stage II esophageal cancer|stage ii esophageal cancer
613813|NCT00628368|stage III esophageal cancer|stage iii esophageal cancer
613814|NCT00628368|stage IV esophageal cancer|stage iv esophageal cancer
613815|NCT00628381|sepsis|sepsis
613816|NCT00628381|microcirculation|microcirculation
613817|NCT00628381|nitric oxide|nitric oxide
613818|NCT00628381|citrulline|citrulline
613819|NCT00628394|Cognition|cognition
613820|NCT00628394|schizophrenia|schizophrenia
613821|NCT00628394|Atomoxetine|atomoxetine
613822|NCT00628394|Strattera|strattera
613823|NCT00628394|cognitive remediation|cognitive remediation
613824|NCT00628407|leaning|leaning
613826|NCT00628407|sternal pressure|sternal pressure
613827|NCT00628407|incomplete release|incomplete release
613828|NCT00628407|chest compressions|chest compressions
613829|NCT00628407|pediatric|pediatric
613830|NCT00628420|Schizophrenia|schizophrenia
613831|NCT00628420|N-desmethylclozapine|n-desmethylclozapine
613832|NCT00628420|clozapine|clozapine
613833|NCT00628420|psychosis|psychosis
613834|NCT00628420|randomized|randomized
613835|NCT00628420|placebo studies|placebo studies
613836|NCT00628433|phase I/II|phase i/ii
613837|NCT00628433|ulcerative colitis|ulcerative colitis
613838|NCT00628433|safety|safety
613840|NCT00628433|pharmacokinetics|pharmacokinetics
613841|NCT00628446|spinal cord injury|spinal cord injury
613842|NCT00628446|Coronary artery calcium|coronary artery calcium
613843|NCT00628446|Dyslipidemia|dyslipidemia
613844|NCT00628459|iron|iron
613845|NCT00628459|multiple micronutrient|multiple micronutrient
613846|NCT00628459|malaria|malaria
613847|NCT00628459|anemia|anemia
613848|NCT00628459|preschool children|preschool children
613849|NCT00628472|botulinum toxin a|botulinum toxin a
613850|NCT00628472|botox|botox
613851|NCT00628472|Decreasing botox injection pain|decreasing botox injection pain
613852|NCT00628472|injections|injections
613853|NCT00628485|swallowing function|swallowing function
613854|NCT00628485|neuromuscular stimulator|neuromuscular stimulator
613855|NCT00628498|VOD|vod
613856|NCT00628537|Neuromuscular stimulator|neuromuscular stimulator
613857|NCT00628537|Flexor deformities of wrist and fingers|flexor deformities of wrist and fingers
613858|NCT00628550|cardiac arrest|cardiac arrest
613859|NCT00628550|cardiopulmonary arrest|cardiopulmonary arrest
613860|NCT00628550|vasopressin|vasopressin
613861|NCT00628550|epinephrine|epinephrine
613862|NCT00628550|pediatrics|pediatrics
614879|NCT00626782|glaucoma|glaucoma
613863|NCT00628550|in hospital cardiopulmonary resuscitation|in hospital cardiopulmonary resuscitation
613864|NCT00628576|Deep Venous Thrombosis|deep venous thrombosis
613865|NCT00628576|lower extremities|lower extremities
613866|NCT00628576|Chronic Venous Insufficiency|chronic venous insufficiency
613867|NCT00628576|Postthrombotic Syndrome|postthrombotic syndrome
613868|NCT00628576|Heparins|heparins
613869|NCT00628576|Low-molecular- weight heparin|low-molecular- weight heparin
613870|NCT00628576|Tinzaparin|tinzaparin
613871|NCT00628589|schizophrenia, agitation, inhaled loxapine, ADASUVE|schizophrenia, agitation, inhaled loxapine, adasuve
613872|NCT00628602|Neuromuscular stimulator|neuromuscular stimulator
613873|NCT00628602|Pressure ulcer prevention|pressure ulcer prevention
613874|NCT00628615|Urodynamics|urodynamics
613875|NCT00628615|Overactive bladder syndrome|overactive bladder syndrome
613876|NCT00628615|Lower urinary tract symptoms LUTS|lower urinary tract symptoms luts
613877|NCT00628628|Tumor Lysis Syndrome|tumor lysis syndrome
613878|NCT00628628|TLS|tls
613879|NCT00628628|hyperuricemia|hyperuricemia
613880|NCT00628628|Leukemia|leukemia
613881|NCT00628628|Lymphoma|lymphoma
613882|NCT00628628|Acute myeloid leukemia|acute myeloid leukemia
613883|NCT00628628|Chronic myelocytic leukemia|chronic myelocytic leukemia
613884|NCT00628628|CML|cml
613885|NCT00628628|lactate dehydrogenase|lactate dehydrogenase
613886|NCT00628628|LDH|ldh
613887|NCT00628628|Myelodysplastic Syndrome|myelodysplastic syndrome
613888|NCT00628628|Rasburicase|rasburicase
613889|NCT00628628|Elitek™|elitek™
613890|NCT00628654|ovarian germ cell tumor|ovarian germ cell tumor
613891|NCT00628654|ovarian epithelial cancer|ovarian epithelial cancer
613892|NCT00628667|Chronic Posterior Laryngitis|chronic posterior laryngitis
613893|NCT00628667|CPL|cpl
613894|NCT00628667|Pharyngeal acid reflux|pharyngeal acid reflux
613895|NCT00628667|Esomeprazole|esomeprazole
613896|NCT00628667|Nexium|nexium
613897|NCT00628680|Renal Disease|renal disease
613898|NCT00628680|Kidney Failure|kidney failure
613899|NCT00628680|End Stage Renal Disease|end stage renal disease
613900|NCT00628693|CPR|cpr
613901|NCT00628706|tetrahydrocannabinol|tetrahydrocannabinol
613902|NCT00628706|memory|memory
613903|NCT00628706|reward|reward
613904|NCT00628706|magnetic resonance imaging|magnetic resonance imaging
613905|NCT00628706|endocannabinoids|endocannabinoids
613906|NCT00628719|Visceral leishmaniasis|visceral leishmaniasis
613907|NCT00628719|India|india
613908|NCT00628719|Liposomal Amphotericin B|liposomal amphotericin b
613909|NCT00628719|Amphotericin B deoxycholate|amphotericin b deoxycholate
613910|NCT00628732|Cyclophosphamide|cyclophosphamide
613911|NCT00628732|Topotecan|topotecan
613912|NCT00628732|Phase II|phase ii
613913|NCT00628732|Children|children
613914|NCT00628732|Relapsed solid tumors|relapsed solid tumors
613915|NCT00628745|TRANSTHYRETIN|transthyretin
613916|NCT00628745|AMYLOIDOSIS|amyloidosis
613917|NCT00628745|TRANSTHYRETIN AMYLOIDOSIS|transthyretin amyloidosis
613918|NCT00628758|Symbicort|symbicort
613919|NCT00628758|Turbuhaler|turbuhaler
613920|NCT00628758|Persistent Asthma|persistent asthma
613921|NCT00628771|HIV Prevention|hiv prevention
613922|NCT00628771|Teen Pregnancy|teen pregnancy
613923|NCT00628771|Translational Research|translational research
613924|NCT00628771|Group Care|group care
613925|NCT00628771|Prenatal Care|prenatal care
613926|NCT00628771|STD Prevention|std prevention
613927|NCT00628771|Gonorrhea|gonorrhea
613928|NCT00628771|Chlamydia|chlamydia
613929|NCT00628771|Adolescent Health|adolescent health
613930|NCT00628771|Community Health Centers|community health centers
613931|NCT00628771|CenteringPregnancy Plus|centeringpregnancy plus
613932|NCT00628771|HIV seronegativity|hiv seronegativity
613933|NCT00628784|Dysplasia|dysplasia
613934|NCT00628784|Ablation|ablation
613935|NCT00628784|Squamous dysplasia|squamous dysplasia
613936|NCT00628784|Early esophageal adenocarcinoma|early esophageal adenocarcinoma
613937|NCT00628784|Cryotherapy|cryotherapy
615044|NCT00640497|anti-CD7|anti-cd7
613938|NCT00628797|systemic sclerosis|systemic sclerosis
613939|NCT00628797|skin fibrosis|skin fibrosis
613940|NCT00628810|adenocarcinoma of the colon|adenocarcinoma of the colon
613941|NCT00628810|adenocarcinoma of the rectum|adenocarcinoma of the rectum
613942|NCT00628810|stage IV colon cancer|stage iv colon cancer
613943|NCT00628810|stage IV rectal cancer|stage iv rectal cancer
613944|NCT00628810|recurrent colon cancer|recurrent colon cancer
613945|NCT00628810|recurrent rectal cancer|recurrent rectal cancer
613946|NCT00628823|Celiac Disease|celiac disease
613947|NCT00628823|Endomysial antibodies|endomysial antibodies
613948|NCT00628823|Mild enteropathy|mild enteropathy
613949|NCT00628823|Treatment|treatment
613950|NCT00628823|Gluten-free diet|gluten-free diet
613951|NCT00628836|Neuromuscular stimulator|neuromuscular stimulator
613952|NCT00628836|Shoulder subluxation|shoulder subluxation
613953|NCT00628849|Mandible|mandible
613954|NCT00628849|fracture|fracture
613955|NCT00628849|Champy|champy
613956|NCT00628849|AO technique|ao technique
613957|NCT00628862|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
613958|NCT00628862|COPD|copd
613959|NCT00628875|mechanical ventilation|mechanical ventilation
613960|NCT00628875|thoracic impedence|thoracic impedence
613961|NCT00628875|defibrillator pads|defibrillator pads
613962|NCT00628875|ventilation detection|ventilation detection
613963|NCT00628875|pediatric ventilation|pediatric ventilation
613964|NCT00628888|Unipolar Depression|unipolar depression
613965|NCT00628888|Anxiety|anxiety
613966|NCT00628888|Adolescent|adolescent
613967|NCT00628888|Emotion|emotion
613968|NCT00628888|Cognitive Behavioral|cognitive behavioral
613969|NCT00628901|Leiomyoma|leiomyoma
613970|NCT00628901|Uterine Fibroids|uterine fibroids
613971|NCT00628901|Uterine Fibroid Embolization (UFE)|uterine fibroid embolization (ufe)
613972|NCT00628901|Uterine Artery Embolization (UAE)|uterine artery embolization (uae)
613973|NCT00628901|Uterine Neoplasms|uterine neoplasms
613974|NCT00628901|Menorrhagia|menorrhagia
613975|NCT00628914|Major Depressive Disorder|major depressive disorder
613976|NCT00628914|Insomnia|insomnia
613977|NCT00628914|Escitalopram|escitalopram
613978|NCT00628914|Lexapro|lexapro
613979|NCT00628914|Eszopiclone|eszopiclone
613980|NCT00628914|Lunesta|lunesta
613981|NCT00628914|Cordance|cordance
613982|NCT00628953|Asthma|asthma
613983|NCT00628953|Acid Reflux|acid reflux
613984|NCT00628953|Nexium|nexium
613985|NCT00628953|Esomeprazole|esomeprazole
613986|NCT00628992|COPD: chronic obstructive pulmonary disease and acute respiratory failure|copd: chronic obstructive pulmonary disease and acute respiratory failure
613987|NCT00629005|rehabilitation|rehabilitation
613988|NCT00629005|upper extremity|upper extremity
613989|NCT00629005|motor skills|motor skills
613990|NCT00629018|Stem Cells|stem cells
613991|NCT00629018|Heart Failure|heart failure
613992|NCT00629018|Dilated Cardiomyopathy|dilated cardiomyopathy
613993|NCT00629031|Visceral leishmaniasis|visceral leishmaniasis
613994|NCT00629031|Paromomycin|paromomycin
613995|NCT00629057|androgen-insensitive, non-metastatic, prostate, cancer|androgen-insensitive, non-metastatic, prostate, cancer
613996|NCT00629070|cerebral palsy|cerebral palsy
613997|NCT00629070|muscle strength|muscle strength
613998|NCT00629070|muscle architecture|muscle architecture
613999|NCT00629070|ultrasound|ultrasound
614000|NCT00629070|rehabilitation|rehabilitation
614001|NCT00629070|rectus femoris|rectus femoris
614002|NCT00629070|quadriceps muscle|quadriceps muscle
614004|NCT00629083|Bulkamid|bulkamid
614005|NCT00629083|Urinary Incontinence|urinary incontinence
614006|NCT00629096|Dilated Cardiomyopathy|dilated cardiomyopathy
614007|NCT00629096|Marrow stem cells|marrow stem cells
614008|NCT00629096|Myocardial regeneration|myocardial regeneration
614009|NCT00629096|Mesenchymal stem cells|mesenchymal stem cells
614010|NCT00629096|Marrow-derived endothelial progenitor cells|marrow-derived endothelial progenitor cells
614011|NCT00629122|Kidney Transplantation|kidney transplantation
614012|NCT00629122|Tacrolimus (Prograf)|tacrolimus (prograf)
614013|NCT00629122|Pharmacokinetics|pharmacokinetics
614014|NCT00629122|Sublingual administration|sublingual administration
614015|NCT00629122|Drug interactions (Cytochrome P450 and p-glycoprotein)|drug interactions (cytochrome p450 and p-glycoprotein)
614016|NCT00629135|abscess|abscess
614017|NCT00629135|intraabdominal abscess|intraabdominal abscess
614018|NCT00629135|Moxifloxacine|moxifloxacine
614019|NCT00629135|Moxifloxacin|moxifloxacin
614020|NCT00629135|Metronidazole|metronidazole
614021|NCT00629135|Tazobactam|tazobactam
614022|NCT00629135|Piperacilline|piperacilline
614023|NCT00629135|Piperacillin|piperacillin
614024|NCT00629135|Tazobac|tazobac
614025|NCT00629148|metastasis|metastasis
614026|NCT00629148|chemotherapy|chemotherapy
614027|NCT00629148|breast cancer|breast cancer
614028|NCT00629148|Vinorelbine|vinorelbine
614029|NCT00629148|Capecitabine|capecitabine
614030|NCT00629148|sequential chemotherapy|sequential chemotherapy
614031|NCT00629148|TTF|ttf
614032|NCT00629174|Cognitive function|cognitive function
614033|NCT00629174|Elderly|elderly
614034|NCT00629174|Exercise|exercise
614035|NCT00629174|Mental activity|mental activity
614036|NCT00629187|Lung Neoplasm|lung neoplasm
614037|NCT00629187|Breast Neoplasm|breast neoplasm
614038|NCT00629187|Melanoma|melanoma
614039|NCT00629187|Central Nervous System Neoplasms|central nervous system neoplasms
614040|NCT00629187|Neoplasm Metastasis|neoplasm metastasis
614041|NCT00629187|Neoplasm Second Primary|neoplasm second primary
614042|NCT00629187|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
614043|NCT00629200|Advanced Malignancies|advanced malignancies
614044|NCT00629200|Solid Tumors|solid tumors
614045|NCT00629200|Melanoma|melanoma
614046|NCT00629200|Renal Cell Carcinoma|renal cell carcinoma
614047|NCT00629200|Phase I Studies|phase i studies
614048|NCT00629200|Sodium Stibogluconate|sodium stibogluconate
614049|NCT00629200|Interferon Alpha-2b|interferon alpha-2b
614050|NCT00629200|Intron A|intron a
614051|NCT00629200|SSG|ssg
614052|NCT00629213|prevention,|prevention,
614053|NCT00629213|type 2 diabetes,|type 2 diabetes,
614054|NCT00629213|metabolic syndrome,|metabolic syndrome,
614055|NCT00629213|acarbose treatment|acarbose treatment
614056|NCT00629226|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
614057|NCT00629226|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
615257|NCT00641368|Child|child
614058|NCT00629226|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
614059|NCT00629226|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
614060|NCT00629226|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
614061|NCT00629226|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
614062|NCT00629226|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
614063|NCT00629226|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
614064|NCT00629226|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
614065|NCT00629226|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
614066|NCT00629226|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
614067|NCT00629239|COPD|copd
614068|NCT00629239|tolerability|tolerability
614069|NCT00629239|inhalation|inhalation
614070|NCT00629252|Schizophrenia|schizophrenia
614071|NCT00629252|PPI|ppi
614072|NCT00629252|P50|p50
614073|NCT00629252|CANTAB|cantab
614074|NCT00629252|sensory gating|sensory gating
614075|NCT00629252|Schizophrenic patients according to DSM-IV|schizophrenic patients according to dsm-iv
614076|NCT00629265|Dysphagia|dysphagia
614077|NCT00629265|Neuromuscular Electrical Stimulation (NMES)|neuromuscular electrical stimulation (nmes)
614078|NCT00629265|Head & Neck Cancer|head & neck cancer
614079|NCT00629265|Radiation and ChemoTherapy|radiation and chemotherapy
614080|NCT00629278|stage IA breast cancer|stage ia breast cancer
614081|NCT00629278|stage IB breast cancer|stage ib breast cancer
614082|NCT00629278|stage II breast cancer|stage ii breast cancer
614083|NCT00629278|stage IIIA breast cancer|stage iiia breast cancer
614084|NCT00629278|HER2-positive breast cancer|her2-positive breast cancer
614085|NCT00629291|iron overload|iron overload
614086|NCT00629291|Thalassemia|thalassemia
614087|NCT00629291|Anemia, Sickle Cell|anemia, sickle cell
614088|NCT00629291|Magnetic Resonance Imaging|magnetic resonance imaging
614089|NCT00629304|type 1 diabetes|type 1 diabetes
614090|NCT00629304|PDA phone (Personal Digital Assistant)|pda phone (personal digital assistant)
614091|NCT00629304|HbA1c|hba1c
614092|NCT00629317|Skin Aging|skin aging
614093|NCT00629317|Rejuvenation|rejuvenation
614094|NCT00629317|Photodynamic Therapy|photodynamic therapy
614095|NCT00629317|Methyl Aminolevulinate|methyl aminolevulinate
614096|NCT00629330|prostate cancer|prostate cancer
614097|NCT00629330|prostate cancer screening|prostate cancer screening
614098|NCT00629330|prostate specific antigen|prostate specific antigen
614099|NCT00629330|African American males|african american males
614100|NCT00629343|Soft Tissue Sarcoma|soft tissue sarcoma
614101|NCT00629343|Mesothelioma|mesothelioma
614102|NCT00629343|Azacitidine|azacitidine
614103|NCT00629343|Temozolomide|temozolomide
614104|NCT00629343|Temodar|temodar
614105|NCT00629382|abdominal sepsis|abdominal sepsis
614106|NCT00629382|abdominal surgery|abdominal surgery
614107|NCT00629382|septic shock|septic shock
614108|NCT00629382|polymyxin B|polymyxin b
614109|NCT00629382|hemoperfusion|hemoperfusion
614110|NCT00629382|Endotoxins|endotoxins
614111|NCT00629395|pediatric|pediatric
614112|NCT00629395|brain tumor|brain tumor
614113|NCT00629395|survivors|survivors
614114|NCT00629434|Diabetes Education|diabetes education
614115|NCT00629434|Telemedicine|telemedicine
614116|NCT00629447|Primary Brain Tumor|primary brain tumor
614117|NCT00629447|Venous Thromboembolism|venous thromboembolism
614118|NCT00629447|Heparin|heparin
614119|NCT00629460|Pulmonary Nodules|pulmonary nodules
614120|NCT00629473|multiple myeloma|multiple myeloma
614121|NCT00629473|leukemias (inc. CLL)|leukemias (inc. cll)
614122|NCT00629473|lymphomas|lymphomas
614123|NCT00629473|cutaneous lymphoma|cutaneous lymphoma
614124|NCT00629473|marginal zone lymphoma|marginal zone lymphoma
614125|NCT00629473|advanced malignancies without standard treatment options|advanced malignancies without standard treatment options
614126|NCT00629486|cytokine gene|cytokine gene
614127|NCT00629486|hepatitis B|hepatitis b
614128|NCT00629486|hepatocellular carcinoma|hepatocellular carcinoma
614129|NCT00629486|chronic liver disease|chronic liver disease
614130|NCT00629499|Early Stage Breast Cancer|early stage breast cancer
614131|NCT00629499|Her2-positive|her2-positive
614132|NCT00629499|nab paclitaxel|nab paclitaxel
614133|NCT00629499|cyclophosphamide|cyclophosphamide
614134|NCT00629499|trastuzumab|trastuzumab
614135|NCT00629512|NSAID, Nexium, esomeprazole, Gastric Ulcers|nsaid, nexium, esomeprazole, gastric ulcers
614136|NCT00634959|HIV Infections|hiv infections
614137|NCT00634959|Treatment Naïve|treatment naïve
614138|NCT00634972|Retinopathy of Prematurity|retinopathy of prematurity
614139|NCT00634972|Premature Infants|premature infants
614140|NCT00634972|ACULAR|acular
614141|NCT00634972|Refresh Tears|refresh tears
614142|NCT00634998|Vitamin C|vitamin c
614143|NCT00634998|Ascorbic Acid|ascorbic acid
614144|NCT00634998|Diabetic Neuropathies|diabetic neuropathies
614145|NCT00635011|comorbidity|comorbidity
614146|NCT00635011|Quality of Life|quality of life
615258|NCT00641368|Computer|computer
614147|NCT00635011|Body Weight Changes|body weight changes
614148|NCT00635024|refractory multiple myeloma|refractory multiple myeloma
614149|NCT00635024|stage I multiple myeloma|stage i multiple myeloma
614150|NCT00635024|stage II multiple myeloma|stage ii multiple myeloma
614151|NCT00635024|stage III multiple myeloma|stage iii multiple myeloma
614152|NCT00635037|Myofascial pain syndrome|myofascial pain syndrome
614153|NCT00635037|Acupuncture|acupuncture
614154|NCT00635037|Nonsteroidal anti-inflammatory agents|nonsteroidal anti-inflammatory agents
614155|NCT00635037|Muscle relaxants, central|muscle relaxants, central
614156|NCT00635037|Quality of life.|quality of life.
614157|NCT00635037|muscle relaxants, analgesia|muscle relaxants, analgesia
614158|NCT00635050|Breast cancer|breast cancer
614159|NCT00635063|Cancer Breakthrough Pain|cancer breakthrough pain
614160|NCT00635089|Eosinophilic Esophagitis|eosinophilic esophagitis
614161|NCT00635089|Cinquil|cinquil
614162|NCT00635102|Alcohol Dependence, Alcoholism, Glycine, D-Cycloserine|alcohol dependence, alcoholism, glycine, d-cycloserine
614163|NCT00635128|Diphtheria|diphtheria
614164|NCT00635128|vaccine|vaccine
614166|NCT00635128|Poliomyelitis|poliomyelitis
614167|NCT00635128|Pertussis|pertussis
614168|NCT00635128|Booster|booster
614169|NCT00635128|Tetanus|tetanus
614170|NCT00635141|Cystic Fibrosis|cystic fibrosis
614171|NCT00635141|Lung Clearance Index|lung clearance index
614172|NCT00635141|Hypertonic Saline|hypertonic saline
614173|NCT00635141|Pediatrics|pediatrics
614174|NCT00635154|stage I multiple myeloma|stage i multiple myeloma
614175|NCT00635154|stage II multiple myeloma|stage ii multiple myeloma
614176|NCT00635154|stage III multiple myeloma|stage iii multiple myeloma
614177|NCT00635167|Prostate cancer|prostate cancer
614178|NCT00635167|prostatic vascularity|prostatic vascularity
614179|NCT00635167|External Beam Radiation treatment|external beam radiation treatment
614180|NCT00635167|Contrast Enhanced transrectal Ultrasound|contrast enhanced transrectal ultrasound
614181|NCT00635180|Isometric exercise|isometric exercise
614182|NCT00635180|intraocular pressure|intraocular pressure
614183|NCT00635180|Physiological changes in intraocular pressure during isometric exercise|physiological changes in intraocular pressure during isometric exercise
614184|NCT00635193|Ovarian neoplasms|ovarian neoplasms
614185|NCT00635193|Angiogenesis inhibitors|angiogenesis inhibitors
614186|NCT00635193|Angiogenesis|angiogenesis
616389|NCT00638534|AOM|aom
614187|NCT00635193|Volociximab|volociximab
614188|NCT00635193|Ovarian cancer|ovarian cancer
614189|NCT00635193|Antibody|antibody
614190|NCT00635193|Monoclonals|monoclonals
614191|NCT00635206|OSA|osa
614192|NCT00635219|Major depressive disorder|major depressive disorder
614193|NCT00635219|Placebo-controlled|placebo-controlled
614194|NCT00635219|Active reference|active reference
614195|NCT00635219|Multicenter study|multicenter study
614196|NCT00635219|Randomised study|randomised study
614197|NCT00635219|Acute treatment|acute treatment
614198|NCT00635232|Hypertension|hypertension
614199|NCT00635232|High Blood Pressure|high blood pressure
614200|NCT00635245|stage IA breast cancer|stage ia breast cancer
614201|NCT00635245|stage IB breast cancer|stage ib breast cancer
614202|NCT00635245|stage II breast cancer|stage ii breast cancer
614203|NCT00635258|GnRH antagonist|gnrh antagonist
614204|NCT00635258|oocyte donation|oocyte donation
614205|NCT00635258|pregnancy|pregnancy
614206|NCT00635258|implantation|implantation
614207|NCT00635271|Asthma|asthma
614208|NCT00635271|Biomarker|biomarker
614209|NCT00635271|Exhaled Breath Condensate|exhaled breath condensate
614210|NCT00635271|Cytokine|cytokine
614211|NCT00635271|Healthy Volunteer|healthy volunteer
614212|NCT00635271|HV|hv
614213|NCT00635661|function|function
614214|NCT00635661|disability|disability
614215|NCT00635674|sleep apnea|sleep apnea
614216|NCT00635674|risk factors|risk factors
614217|NCT00635674|continuous positive airway pressure|continuous positive airway pressure
614218|NCT00635674|insulin resistance|insulin resistance
615045|NCT00640497|Ricin A|ricin a
614219|NCT00635674|metabolic syndrome|metabolic syndrome
614220|NCT00635674|compliance|compliance
614221|NCT00635687|variceal bleeding|variceal bleeding
614222|NCT00635687|transient elastography|transient elastography
614223|NCT00635700|psychosis|psychosis
614224|NCT00635700|schizophrenia|schizophrenia
614225|NCT00635700|prodrome|prodrome
614226|NCT00635700|ziprasidone|ziprasidone
614227|NCT00635700|placebo|placebo
615404|NCT00641849|BMI|bmi
614228|NCT00635713|Advanced breast cancer, FASLODEX, ARIMIDEX, Fulvestrant, Anastrozole, postmenopausal|advanced breast cancer, faslodex, arimidex, fulvestrant, anastrozole, postmenopausal
614229|NCT00635726|Bladder Cancer|bladder cancer
614230|NCT00635739|Whey protein|whey protein
614231|NCT00635739|Resistance exercise|resistance exercise
614232|NCT00635739|Physical activity|physical activity
614233|NCT00635739|Mobility disability|mobility disability
614234|NCT00635739|Physical function|physical function
614235|NCT00635739|Muscle mass|muscle mass
614236|NCT00635739|Muscle strength|muscle strength
614237|NCT00635739|Older Adults|older adults
614238|NCT00635739|Mobility-Limited|mobility-limited
614239|NCT00635752|TF-CBT|tf-cbt
614240|NCT00635752|Effectiveness study|effectiveness study
614241|NCT00635752|Trauma|trauma
614242|NCT00635752|Therapy|therapy
614243|NCT00635765|Acromegaly|acromegaly
615259|NCT00641368|Depression|depression
614244|NCT00635791|Malignant Solid Tumour|malignant solid tumour
614245|NCT00635791|Renal cell carcinoma|renal cell carcinoma
614246|NCT00635791|Non small cell lung carcinoma|non small cell lung carcinoma
614247|NCT00635817|CPP|cpp
614248|NCT00635817|central precocious puberty|central precocious puberty
614249|NCT00635817|pediatrics|pediatrics
614250|NCT00635817|suppression of luteinizing hormone|suppression of luteinizing hormone
614251|NCT00635817|Lupron|lupron
614252|NCT00635817|leuprolide acetate|leuprolide acetate
614253|NCT00635817|depot formulation|depot formulation
614254|NCT00635817|GnRHa|gnrha
614255|NCT00635817|GnRH agonist|gnrh agonist
614256|NCT00635817|GnRH analog|gnrh analog
614257|NCT00635817|luteinizing hormone|luteinizing hormone
614258|NCT00635843|Lumbar degenerative disc disease at one level from L4-S1|lumbar degenerative disc disease at one level from l4-s1
614259|NCT00635856|Iressa|iressa
614260|NCT00635856|Gefitinib|gefitinib
614261|NCT00635856|Prostate Cancer|prostate cancer
614262|NCT00635856|PSA|psa
614263|NCT00635869|evidence based practice beliefs|evidence based practice beliefs
614264|NCT00635869|evidence based practice implementation|evidence based practice implementation
614390|NCT00636467|Detection|detection
614265|NCT00635869|evidence based practice knowledge|evidence based practice knowledge
614266|NCT00635869|nurse physician collaboration|nurse physician collaboration
614267|NCT00635882|mometasone|mometasone
614268|NCT00635882|formoterol|formoterol
614269|NCT00635895|Fibromyalgia|fibromyalgia
614270|NCT00635895|Manual Lymphatic Drainage|manual lymphatic drainage
614271|NCT00635895|Connective Tissue Massage|connective tissue massage
614272|NCT00635895|Pain|pain
614273|NCT00635895|Health Related Quality of Life|health related quality of life
614274|NCT00635895|Randomized Controlled Trial|randomized controlled trial
614275|NCT00635921|Borderline Personality Disorder|borderline personality disorder
614276|NCT00635921|ziprasidone|ziprasidone
614277|NCT00635934|Lumbar Degenerative Disc Disease at One Level from L4-S1|lumbar degenerative disc disease at one level from l4-s1
614278|NCT00635947|Amniotic fluid index|amniotic fluid index
614279|NCT00635947|maternal hydration|maternal hydration
614280|NCT00635947|isotonic solution|isotonic solution
614281|NCT00635947|Amniotic Fluid|amniotic fluid
614282|NCT00635960|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
614284|NCT00635960|Growth Hormone|growth hormone
614285|NCT00635960|IGF-I|igf-i
614286|NCT00635973|Iressa|iressa
614287|NCT00635973|Gefitinib|gefitinib
614288|NCT00635973|Cancer|cancer
614289|NCT00635973|Patients diagnosed with cancer who have previously received Iressa in an Iressa clinical trial|patients diagnosed with cancer who have previously received iressa in an iressa clinical trial
614290|NCT00635986|Analgesia|analgesia
614291|NCT00635986|Fentanyl|fentanyl
614292|NCT00635986|Orthopedic|orthopedic
614293|NCT00635986|Mechanism of action|mechanism of action
614294|NCT00635986|Surgery|surgery
614295|NCT00636012|acupuncture|acupuncture
614296|NCT00636012|Acupuncture points|acupuncture points
614297|NCT00636038|beta-carotene|beta-carotene
614298|NCT00636038|yellow maize|yellow maize
614299|NCT00636038|vitamin A|vitamin a
614300|NCT00636051|evidence based practice beliefs|evidence based practice beliefs
614301|NCT00636051|evidence based practice implementation|evidence based practice implementation
614302|NCT00636051|evidence based practice dissemination|evidence based practice dissemination
614303|NCT00636077|Hemodialysis|hemodialysis
614304|NCT00636077|Dialysis, Renal|dialysis, renal
614305|NCT00636103|Traditional Chinese Medicine|traditional chinese medicine
614306|NCT00636103|Asthma|asthma
614307|NCT00636103|Paediatric|paediatric
614308|NCT00636116|snake bite|snake bite
614309|NCT00636116|antivenin treatment|antivenin treatment
614310|NCT00636129|relaxation|relaxation
614311|NCT00636129|relaxation response|relaxation response
614312|NCT00636129|meditation|meditation
614313|NCT00636129|nitric oxide|nitric oxide
614314|NCT00636129|stress management|stress management
614315|NCT00636129|stress|stress
614316|NCT00636129|Relaxation Techniques|relaxation techniques
614317|NCT00636155|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
614318|NCT00636155|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
614319|NCT00636155|EL625|el625
614320|NCT00636155|cenersen|cenersen
615462|NCT00642005|Colon|colon
614321|NCT00636220|HIV-1 Infections|hiv-1 infections
614322|NCT00636233|anencephaly|anencephaly
614323|NCT00636233|acrania|acrania
614324|NCT00636259|Prostate cancer|prostate cancer
614325|NCT00636259|Casodex|casodex
614326|NCT00636272|ICD|icd
614327|NCT00636272|CRT-D|crt-d
614328|NCT00636285|A110|a110
614329|NCT00636285|Safety|safety
614330|NCT00636298|esophageal carcinoma|esophageal carcinoma
614331|NCT00636298|cancer of the esophagus|cancer of the esophagus
614332|NCT00636298|locally advanced or metastatic esophageal cancer|locally advanced or metastatic esophageal cancer
614333|NCT00636311|Hodgkin disease|hodgkin disease
614334|NCT00636311|Salvage therapy|salvage therapy
614335|NCT00636311|Bortezomib|bortezomib
614336|NCT00636311|Transplantation|transplantation
614337|NCT00636324|Respiratory distress syndrome|respiratory distress syndrome
614338|NCT00636324|Preterm infants|preterm infants
614339|NCT00636324|Extubation failure|extubation failure
614340|NCT00636324|Pneumothorax|pneumothorax
614341|NCT00636324|Lung injury|lung injury
614342|NCT00636324|Airway pressure|airway pressure
614343|NCT00636337|Pediatric|pediatric
614344|NCT00636337|Brain Tumor|brain tumor
614345|NCT00636337|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
614346|NCT00636337|Inattention|inattention
614347|NCT00636337|Childhood cancer survivors|childhood cancer survivors
614348|NCT00636350|pepper carotenoids|pepper carotenoids
614349|NCT00636350|xanthophylls|xanthophylls
614350|NCT00636350|healthy volunteers|healthy volunteers
614351|NCT00636376|elevated intracranial pressure|elevated intracranial pressure
614352|NCT00636376|inadequate cerebral perfusion|inadequate cerebral perfusion
614353|NCT00636376|secondary brain damage|secondary brain damage
614354|NCT00636389|Hemodialysis|hemodialysis
614355|NCT00636389|Dialysis, Renal|dialysis, renal
614356|NCT00636389|Dialysis, Extracorporeal|dialysis, extracorporeal
614357|NCT00636389|Extracorporeal Dialysis|extracorporeal dialysis
614358|NCT00636402|Vessel Sealing System|vessel sealing system
614359|NCT00636402|Cold Knife|cold knife
614360|NCT00636402|Tonsillectomy|tonsillectomy
614361|NCT00636402|Pain|pain
614362|NCT00636402|Postoperative|postoperative
614363|NCT00636415|Analgesia|analgesia
614364|NCT00636415|Morphine|morphine
614365|NCT00636415|Bupivacaine|bupivacaine
614366|NCT00636415|Osteoarthritis|osteoarthritis
614367|NCT00636415|Knee|knee
614368|NCT00636428|endoscopy|endoscopy
614369|NCT00636428|Midazolam|midazolam
614370|NCT00636428|pediatric|pediatric
614371|NCT00636428|sedation|sedation
614372|NCT00636428|comfort|comfort
614373|NCT00636441|Early-Stage Breast Cancer|early-stage breast cancer
614374|NCT00636441|Preoperative systemic chemotherapy (PST)|preoperative systemic chemotherapy (pst)
614375|NCT00636441|Genomic|genomic
614376|NCT00636441|Genomic Predictor|genomic predictor
614377|NCT00636441|Genomic Expression Profiles|genomic expression profiles
614378|NCT00636441|Randomized|randomized
614379|NCT00636441|Pathologic complete response (pCR)|pathologic complete response (pcr)
614380|NCT00636441|HER2 negative|her2 negative
614381|NCT00636441|Doxorubicin and docetaxel|doxorubicin and docetaxel
614382|NCT00636441|Doxorubicin and cyclophosphamide|doxorubicin and cyclophosphamide
614383|NCT00636454|OA|oa
614384|NCT00636454|Pain|pain
614385|NCT00636454|Cognitive Therapy|cognitive therapy
614386|NCT00636454|Behavior Therapy|behavior therapy
614387|NCT00636454|Knee OA|knee oa
614388|NCT00636454|Hip OA|hip oa
614389|NCT00636467|Breast cancer (tumors> 2 cm)|breast cancer (tumors> 2 cm)
614391|NCT00636467|Axillary sentinel lymph node|axillary sentinel lymph node
614392|NCT00636480|Antimicrobial|antimicrobial
614393|NCT00636480|Antisepsis|antisepsis
614394|NCT00636493|retinal vein occlusion|retinal vein occlusion
614395|NCT00636493|sustained drug delivery implant|sustained drug delivery implant
614396|NCT00636493|steroid|steroid
614397|NCT00636493|macular edema|macular edema
614398|NCT00636506|Erectile dysfunction|erectile dysfunction
614399|NCT00636506|Impotence|impotence
614400|NCT00636519|Botulism Antitoxin,Heptavalent,Bivalent,EDB Muscle,Paralysis|botulism antitoxin,heptavalent,bivalent,edb muscle,paralysis
614401|NCT00636545|Genasense|genasense
614402|NCT00636545|oblimersen|oblimersen
614403|NCT00636545|antisense|antisense
614404|NCT00636545|Bcl-2 antisense|bcl-2 antisense
614405|NCT00636545|Solid Tumors|solid tumors
614406|NCT00636558|coxsackie virus|coxsackie virus
614407|NCT00636558|melanoma|melanoma
614408|NCT00636558|breast cancer|breast cancer
614409|NCT00636558|prostate cancer|prostate cancer
614410|NCT00636571|Exercise|exercise
614411|NCT00636571|Non-Small Cell Lung Cancer|non-small cell lung cancer
614412|NCT00636571|Cardiopulmonary Fitness|cardiopulmonary fitness
614413|NCT00636584|sodium nitroprusside|sodium nitroprusside
614414|NCT00636584|thyroid hormones|thyroid hormones
614415|NCT00636584|thoracic surgery|thoracic surgery
614416|NCT00636610|Hedgehog|hedgehog
614417|NCT00636610|CRC|crc
614418|NCT00636610|Colorectal Cancer|colorectal cancer
614419|NCT00636610|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
614420|NCT00636623|Pilates Exercises|pilates exercises
614421|NCT00636623|Connective Tissue Massage|connective tissue massage
614422|NCT00636636|Postherpetic Neuralgia (PHN), shingles|postherpetic neuralgia (phn), shingles
614423|NCT00636649|Eating disorder|eating disorder
614424|NCT00636675|Accidental falls|accidental falls
614425|NCT00636688|Obesity|obesity
614426|NCT00636688|Lifestyle changes|lifestyle changes
614427|NCT00636701|Cerebrovascular Accident|cerebrovascular accident
614428|NCT00636701|rehabilitation|rehabilitation
614429|NCT00636714|intensive insulin therapy|intensive insulin therapy
614430|NCT00636714|glucose control|glucose control
614431|NCT00636714|nurse directed|nurse directed
614432|NCT00636714|nomogram directed|nomogram directed
614433|NCT00636727|arthrocentesis|arthrocentesis
614434|NCT00636727|arthroscopy|arthroscopy
614435|NCT00636727|arthroplasty|arthroplasty
614629|NCT00637520|Insulin Resistance|insulin resistance
614436|NCT00636740|Prostate cancer, hormone resistant, bisphosphonate|prostate cancer, hormone resistant, bisphosphonate
614534|NCT00637078|hypertension|hypertension
615260|NCT00641368|Resilience|resilience
614437|NCT00636753|Metabolic and endocrine changes in schizophrenic patients by antipsychotics treatment.|metabolic and endocrine changes in schizophrenic patients by antipsychotics treatment.
614438|NCT00636766|cardiovascular events|cardiovascular events
614439|NCT00636805|Aloxi|aloxi
614440|NCT00636805|Brain Neoplasm, Primary|brain neoplasm, primary
614441|NCT00636805|Brain Neoplasms, Malignant|brain neoplasms, malignant
614442|NCT00636831|Prophylactic|prophylactic
614443|NCT00636831|Antibiotic|antibiotic
614444|NCT00636831|Infection|infection
614445|NCT00636831|Primary case|primary case
614446|NCT00636844|chemotherapy, cardiotoxicity|chemotherapy, cardiotoxicity
614447|NCT00636857|Water-Electrolyte Imbalance|water-electrolyte imbalance
614448|NCT00636883|Pancreatic cancer|pancreatic cancer
614449|NCT00636896|weight gain|weight gain
614450|NCT00636896|olanzapine|olanzapine
614451|NCT00636896|atypical antipsychotic|atypical antipsychotic
614453|NCT00636909|ALL|all
614454|NCT00636909|CML|cml
614455|NCT00636909|CLL|cll
614456|NCT00636909|MDS|mds
614457|NCT00636909|NHL|nhl
614458|NCT00636909|HODGKIN'S LYMPHOMA|hodgkin's lymphoma
614459|NCT00636909|APLASTIC ANEMIA|aplastic anemia
614460|NCT00636909|MULTIPLE MYELOMA|multiple myeloma
614461|NCT00636909|MYELOPROLIFERATIVE DISORDER|myeloproliferative disorder
614462|NCT00636909|ALLOGENEIC|allogeneic
614463|NCT00636909|STEM CELL TRANSPLANT|stem cell transplant
614464|NCT00636909|HEMATOLOGIC DISORDERS|hematologic disorders
614465|NCT00636909|CYCLOPHOSPHAMIDE|cyclophosphamide
614466|NCT00636909|FLUDARABINE|fludarabine
614467|NCT00636909|CYCLOSPORINE|cyclosporine
614468|NCT00636909|METHOTREXATE|methotrexate
614469|NCT00636909|G-CSF|g-csf
614470|NCT00636909|GVHD|gvhd
614471|NCT00636909|ENGRAFTMENT|engraftment
614472|NCT00636909|CHIMERISM|chimerism
614473|NCT00636922|Acute Myeloid Leukemia|acute myeloid leukemia
614474|NCT00636922|Elderly|elderly
614475|NCT00636922|Unfit|unfit
614476|NCT00636922|Everolimus|everolimus
614477|NCT00636922|RAD001|rad001
614478|NCT00636935|Pneumocystis jirovecii Pneumonia|pneumocystis jirovecii pneumonia
614479|NCT00636935|Corticosteroid Therapy|corticosteroid therapy
614480|NCT00636935|HIV|hiv
614481|NCT00636935|Pneumonia|pneumonia
614482|NCT00636935|Pulmonary Function Testing|pulmonary function testing
614483|NCT00636935|Antibiotics|antibiotics
614484|NCT00636935|Prednisone|prednisone
614485|NCT00636935|Human Immunodeficiency Virus|human immunodeficiency virus
614486|NCT00636935|CD4|cd4
614487|NCT00636935|CD8|cd8
614488|NCT00636935|Viral Load|viral load
614489|NCT00636935|Bactrim|bactrim
614490|NCT00636935|Pentamidine|pentamidine
614491|NCT00636935|Atovaquone|atovaquone
614492|NCT00636935|Primaquine/Clindamycin|primaquine/clindamycin
614493|NCT00636935|Trimethoprim/Dapsone|trimethoprim/dapsone
614494|NCT00636948|Rectal cancer surgery|rectal cancer surgery
614495|NCT00636948|Symptomatic anastomotic leakage|symptomatic anastomotic leakage
614496|NCT00636948|Defunctioning stoma|defunctioning stoma
614497|NCT00636948|TME surgery|tme surgery
614498|NCT00636961|COPD, Indacaterol Maleate, Exercise testing|copd, indacaterol maleate, exercise testing
614499|NCT00636974|Patients who are going to have regional anaesthesia for lower limbs surgery.|patients who are going to have regional anaesthesia for lower limbs surgery.
614500|NCT00636974|Leg Surgery.|leg surgery.
614501|NCT00636987|aortic valve|aortic valve
614502|NCT00636987|mitral valve|mitral valve
614503|NCT00636987|heart valve|heart valve
614504|NCT00636987|tissue valve|tissue valve
614505|NCT00636987|bioprosthesis|bioprosthesis
614506|NCT00636987|valve disorder|valve disorder
614507|NCT00636987|valve disease|valve disease
614508|NCT00636987|cardiac surgery|cardiac surgery
614509|NCT00636987|aortic valve regurgitation|aortic valve regurgitation
614510|NCT00636987|aortic valve stenosis|aortic valve stenosis
614511|NCT00636987|mitral valve regurgitation|mitral valve regurgitation
614512|NCT00636987|mitral valve stenosis|mitral valve stenosis
614513|NCT00637000|Opioid dependence|opioid dependence
614514|NCT00637000|Opioid withdrawal symptoms|opioid withdrawal symptoms
614515|NCT00637013|Subacromial impingement|subacromial impingement
614516|NCT00637013|Shoulder|shoulder
614517|NCT00637013|RCT|rct
614518|NCT00637013|Effectiveness|effectiveness
614519|NCT00637013|Cost-effectiveness|cost-effectiveness
614520|NCT00637026|Iressa, Gefitinib, Breast Cancer, Surgery|iressa, gefitinib, breast cancer, surgery
614521|NCT00637039|Advanced cancer|advanced cancer
614522|NCT00637039|Solid tumour|solid tumour
614523|NCT00637039|Solid malignancies|solid malignancies
614524|NCT00637039|Neoplasms|neoplasms
614525|NCT00637052|preleukemia|preleukemia
614526|NCT00637052|dysplasia of myeloid blood cells|dysplasia of myeloid blood cells
614527|NCT00637065|Pulmonary hypertension|pulmonary hypertension
614528|NCT00637065|Interstitial lung disease|interstitial lung disease
614529|NCT00637065|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
614530|NCT00637065|Nonspecific interstitial pneumonia|nonspecific interstitial pneumonia
614531|NCT00637065|Bosentan|bosentan
614532|NCT00637065|Endothelin receptor antagonists|endothelin receptor antagonists
614630|NCT00637520|Lipid Metabolism|lipid metabolism
614533|NCT00637065|Pulmonary vascular resistance|pulmonary vascular resistance
614535|NCT00637078|hypercholesterolemia|hypercholesterolemia
614536|NCT00637078|family physicians|family physicians
614537|NCT00637078|fixed dose combination therapy|fixed dose combination therapy
614538|NCT00637078|cluster randomized controlled trial|cluster randomized controlled trial
614539|NCT00637104|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
614540|NCT00637104|stents|stents
614541|NCT00637104|restenosis|restenosis
614542|NCT00637104|biocompatible materials|biocompatible materials
614543|NCT00637104|ceramics|ceramics
614544|NCT00637117|Lymphoma, Dendritic, Vaccine, Radiotherapy|lymphoma, dendritic, vaccine, radiotherapy
614545|NCT00637143|Renal transplant|renal transplant
614546|NCT00637143|Cyclosporine|cyclosporine
614547|NCT00637143|Tacrolimus|tacrolimus
614548|NCT00637143|Intervention|intervention
614549|NCT00637143|Interstitial Fibrosis Tubular Atrophy|interstitial fibrosis tubular atrophy
614550|NCT00637143|Chronic Renal Allograft Failure|chronic renal allograft failure
614551|NCT00637156|Symptomatic DDD at Two Adjacent Levels of cervical spine|symptomatic ddd at two adjacent levels of cervical spine
614552|NCT00637169|oxygen therapy|oxygen therapy
614553|NCT00637169|neurodevelopmental impairment|neurodevelopmental impairment
614554|NCT00637182|Gynecomastia|gynecomastia
614555|NCT00637182|Anastrazole|anastrazole
614556|NCT00637182|Arimidex|arimidex
614557|NCT00637182|Pubertal|pubertal
614558|NCT00637182|males|males
614559|NCT00637182|boys|boys
614560|NCT00637195|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
614561|NCT00637195|Hepatitis B|hepatitis b
614562|NCT00637195|Cervical cancer|cervical cancer
614563|NCT00637195|HPV|hpv
614564|NCT00637195|Papillomavirus|papillomavirus
614565|NCT00637208|prostate cancer|prostate cancer
614566|NCT00637208|venography|venography
614567|NCT00637208|male patients|male patients
614568|NCT00637208|Localized microscopic prostate cancer up to Gleason 6 (3+3)|localized microscopic prostate cancer up to gleason 6 (3+3)
614569|NCT00637208|PSA level <14|psa level <14
614570|NCT00637208|presence of varicocele|presence of varicocele
614571|NCT00637221|Safety|safety
614572|NCT00637221|Tolerability|tolerability
614573|NCT00637247|pancreatic cancer|pancreatic cancer
614574|NCT00637247|metastatic|metastatic
614575|NCT00637247|chemotherapy naive|chemotherapy naive
614576|NCT00637260|motorcortex stimulation|motorcortex stimulation
614577|NCT00637260|Parkinson's disease|parkinson's disease
614578|NCT00637260|neuromodulation|neuromodulation
614579|NCT00637273|diabetes|diabetes
614580|NCT00637273|exenatide once weekly|exenatide once weekly
614581|NCT00637273|Byetta|byetta
614582|NCT00637273|sitagliptin|sitagliptin
614583|NCT00637273|Januvia|januvia
614584|NCT00637273|thiazolidinedione|thiazolidinedione
614585|NCT00637273|Amylin|amylin
614586|NCT00637273|Lilly|lilly
614587|NCT00637273|Pioglitazone|pioglitazone
614588|NCT00637286|Zolmitriptan|zolmitriptan
614589|NCT00637286|ZOMIG|zomig
614590|NCT00637286|migraine|migraine
614591|NCT00637286|headache response|headache response
614592|NCT00637286|headache|headache
614593|NCT00637286|headache pain|headache pain
614594|NCT00637286|MIDAS|midas
614595|NCT00637286|HCPC|hcpc
614596|NCT00637299|COPD|copd
614597|NCT00637325|trastuzumab optimization in breast cancer|trastuzumab optimization in breast cancer
614598|NCT00637338|Long-acting GLP-1 Diabetes|long-acting glp-1 diabetes
614599|NCT00637364|pain|pain
614600|NCT00637364|pancreas|pancreas
614601|NCT00637364|pancreatic cancer|pancreatic cancer
614602|NCT00637364|pancreatic adenocarcinoma|pancreatic adenocarcinoma
614603|NCT00637364|ductal adenocarcinoma|ductal adenocarcinoma
614604|NCT00637377|Eye diseases|eye diseases
614605|NCT00637377|Vision Impairment and Blindness|vision impairment and blindness
614606|NCT00637377|Eyes and Vision|eyes and vision
614607|NCT00637377|Seniors|seniors
614692|NCT00637637|stage IV laryngeal cancer|stage iv laryngeal cancer
614608|NCT00637377|Neovascular Age-Related Macular Degeneration (AMD)|neovascular age-related macular degeneration (amd)
614609|NCT00637377|Retinal Disease|retinal disease
614610|NCT00637403|renal impairment|renal impairment
614611|NCT00637403|end stage renal disease|end stage renal disease
614612|NCT00637403|megestrol acetate|megestrol acetate
614613|NCT00637403|pharmacokinetics|pharmacokinetics
614614|NCT00637403|hemodialysis|hemodialysis
614615|NCT00637403|renal dialysis|renal dialysis
614616|NCT00637403|kidney failure, chronic|kidney failure, chronic
614617|NCT00637403|renal insufficiency|renal insufficiency
614618|NCT00637403|Megace ES|megace es
614619|NCT00637416|horseness|horseness
614620|NCT00637494|psychotic depression|psychotic depression
614621|NCT00637494|major depression with psychotic features|major depression with psychotic features
614622|NCT00637494|psychosis|psychosis
614623|NCT00637507|High-Frequency Ventilation|high-frequency ventilation
614624|NCT00637507|Tracheal Gas Insufflation|tracheal gas insufflation
614625|NCT00637507|Respiration, Artificial|respiration, artificial
614626|NCT00637507|Respiratory Distress Syndrome|respiratory distress syndrome
614627|NCT00637507|Adult|adult
614628|NCT00637520|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
614631|NCT00637546|Treatment|treatment
614632|NCT00637546|Efficacy|efficacy
614633|NCT00637546|Diabetes|diabetes
614634|NCT00637546|Gait|gait
614637|NCT00637559|Barrett's esophagus|barrett's esophagus
614638|NCT00637572|Weight loss|weight loss
614639|NCT00637572|Cachexia|cachexia
614640|NCT00637572|Anorexia|anorexia
614641|NCT00637572|Megestrol acetate oral suspension|megestrol acetate oral suspension
614642|NCT00637572|Nanocrystal dispersion|nanocrystal dispersion
614643|NCT00637572|Nanocrystal technology|nanocrystal technology
614644|NCT00637572|Body weight changes|body weight changes
614645|NCT00637572|AIDS wasting|aids wasting
614646|NCT00637572|HIV wasting|hiv wasting
614647|NCT00637572|Emaciation|emaciation
614648|NCT00637572|Megace ES|megace es
614649|NCT00637572|Megace|megace
614650|NCT00637572|Treatment Experienced|treatment experienced
614651|NCT00637598|Diagnostic Imaging|diagnostic imaging
614652|NCT00637598|Mammography|mammography
614653|NCT00637598|Breast Tomosynthesis|breast tomosynthesis
614654|NCT00637624|Acetylcysteine|acetylcysteine
614655|NCT00637624|Cisplatin|cisplatin
614656|NCT00637624|Neuropathy|neuropathy
614657|NCT00637624|Antioxidants|antioxidants
614658|NCT00637637|tumors metastatic to brain|tumors metastatic to brain
614659|NCT00637637|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
614660|NCT00637637|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
614661|NCT00637637|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
614662|NCT00637637|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
614663|NCT00637637|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
614664|NCT00637637|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
614665|NCT00637637|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
614666|NCT00637637|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
614667|NCT00637637|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
614668|NCT00637637|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
614669|NCT00637637|stage IV anal cancer|stage iv anal cancer
614670|NCT00637637|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
614671|NCT00637637|stage IV bladder cancer|stage iv bladder cancer
751791|NCT01170455|normal airway|normal airway
614672|NCT00637637|stage IV borderline ovarian surface epithelial-stromal tumor|stage iv borderline ovarian surface epithelial-stromal tumor
614673|NCT00637637|stage IV breast cancer|stage iv breast cancer
614674|NCT00637637|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
614675|NCT00637637|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
614676|NCT00637637|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
614677|NCT00637637|stage IV childhood liver cancer|stage iv childhood liver cancer
614678|NCT00637637|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
614679|NCT00637637|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
614680|NCT00637637|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
614681|NCT00637637|stage IV colon cancer|stage iv colon cancer
614682|NCT00637637|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
614683|NCT00637637|stage IV esophageal cancer|stage iv esophageal cancer
614684|NCT00637637|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
614685|NCT00637637|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
614686|NCT00637637|stage IV gastric cancer|stage iv gastric cancer
614687|NCT00637637|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
614688|NCT00637637|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
614689|NCT00637637|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
614690|NCT00637637|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
614691|NCT00637637|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
614693|NCT00637637|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
614694|NCT00637637|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
614695|NCT00637637|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
614696|NCT00637637|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
614697|NCT00637637|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
614698|NCT00637637|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
614699|NCT00637637|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
614700|NCT00637637|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
614701|NCT00637637|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
614702|NCT00637637|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
614703|NCT00637637|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
614704|NCT00637637|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
614705|NCT00637637|stage IV pancreatic cancer|stage iv pancreatic cancer
614706|NCT00637637|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
614707|NCT00637637|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
614708|NCT00637637|stage IV penile cancer|stage iv penile cancer
614709|NCT00637637|stage IV prostate cancer|stage iv prostate cancer
614710|NCT00637637|stage IV rectal cancer|stage iv rectal cancer
614711|NCT00637637|stage IV renal cell cancer|stage iv renal cell cancer
614712|NCT00637637|stage IV salivary gland cancer|stage iv salivary gland cancer
614713|NCT00637637|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
614714|NCT00637637|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
614715|NCT00637637|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
614716|NCT00637637|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
614717|NCT00637637|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
614718|NCT00637637|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
614719|NCT00637637|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
614720|NCT00637637|stage IV endometrial carcinoma|stage iv endometrial carcinoma
614721|NCT00637637|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
614722|NCT00637637|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
614723|NCT00637637|stage IVB vulvar cancer|stage ivb vulvar cancer
614724|NCT00637637|stage IV Wilms tumor|stage iv wilms tumor
614725|NCT00637637|stage IVB cervical cancer|stage ivb cervical cancer
614726|NCT00637637|stage IVB vaginal cancer|stage ivb vaginal cancer
614727|NCT00637637|metastatic adult malignant fibrous histiocytoma of bone|metastatic adult malignant fibrous histiocytoma of bone
614728|NCT00637637|metastatic childhood malignant fibrous histiocytoma of bone|metastatic childhood malignant fibrous histiocytoma of bone
614729|NCT00637637|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
614730|NCT00637637|metastatic parathyroid cancer|metastatic parathyroid cancer
614731|NCT00637637|metastatic pheochromocytoma|metastatic pheochromocytoma
614732|NCT00637637|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
614733|NCT00637637|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
614734|NCT00637637|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
614735|NCT00637637|disseminated neuroblastoma|disseminated neuroblastoma
614736|NCT00637637|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
614737|NCT00637637|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
614738|NCT00637637|tongue cancer|tongue cancer
614739|NCT00637663|Chronic hepatitis B|chronic hepatitis b
614741|NCT00637663|Entecavir|entecavir
614742|NCT00637676|malignant pleural effusion|malignant pleural effusion
614743|NCT00637676|subcutaneous tunneled drainage|subcutaneous tunneled drainage
614744|NCT00637676|talc pleurodesis|talc pleurodesis
614745|NCT00637689|Chronic graft versus host disease|chronic graft versus host disease
614746|NCT00637689|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
614747|NCT00637689|Biomarkers|biomarkers
614748|NCT00637689|Response criteria|response criteria
614749|NCT00637689|Surrogate endpoints|surrogate endpoints
614750|NCT00637689|Natural history|natural history
614751|NCT00637728|Megestrol acetate|megestrol acetate
614752|NCT00637728|Anorexia|anorexia
614753|NCT00637728|Cachexia|cachexia
614754|NCT00637728|Lung cancer|lung cancer
614755|NCT00637728|Pancreatic cancer|pancreatic cancer
614756|NCT00637728|Unintended weight loss|unintended weight loss
614757|NCT00637728|Body weight|body weight
614758|NCT00637728|Appetite|appetite
614759|NCT00637728|Megace ES|megace es
614760|NCT00637741|Peripheral Vascular Disease|peripheral vascular disease
614761|NCT00637741|Intermittent claudication|intermittent claudication
614762|NCT00637741|Critical Limb Ischemia|critical limb ischemia
614763|NCT00637741|TASC|tasc
614764|NCT00637754|ICD|icd
614765|NCT00637754|Sports|sports
614766|NCT00637767|stage I multiple myeloma|stage i multiple myeloma
614767|NCT00637767|stage II multiple myeloma|stage ii multiple myeloma
614768|NCT00637767|stage III multiple myeloma|stage iii multiple myeloma
614769|NCT00637780|Sulfasalazine delayed release tablets|sulfasalazine delayed release tablets
614770|NCT00637780|azulfidine entabs|azulfidine entabs
614771|NCT00637780|Pharmacokinetics|pharmacokinetics
614772|NCT00637780|Juvenile Idiopathic Arthritis (JIA)|juvenile idiopathic arthritis (jia)
614773|NCT00637793|Xerostomia|xerostomia
614774|NCT00637793|Sjogren's Syndrome|sjogren's syndrome
614775|NCT00637806|Megestrol acetate|megestrol acetate
614776|NCT00637806|Anorexia|anorexia
614777|NCT00637806|Cachexia|cachexia
614778|NCT00637806|Cancer|cancer
614779|NCT00637806|Unintended weight loss|unintended weight loss
614780|NCT00637806|Body weight|body weight
614781|NCT00637806|Appetite|appetite
614782|NCT00637806|Megace ES|megace es
614783|NCT00637832|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
614784|NCT00637832|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
614785|NCT00637832|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
614786|NCT00637832|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
614787|NCT00637832|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
615458|NCT00641992|failure|failure
614788|NCT00637832|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
614789|NCT00637832|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
614790|NCT00637832|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
614791|NCT00637832|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
614792|NCT00637832|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
614793|NCT00637832|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
614794|NCT00637832|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
614795|NCT00637832|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
614796|NCT00637832|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
614797|NCT00637832|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
614798|NCT00637845|Nexium|nexium
614799|NCT00637845|Esomeprazole Magnesium|esomeprazole magnesium
614800|NCT00637845|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
614801|NCT00637845|Heartburn|heartburn
614802|NCT00637871|Casodex|casodex
614803|NCT00637871|bicalutamide|bicalutamide
614804|NCT00637871|Tamoxifen|tamoxifen
614805|NCT00637871|Gynaecomastia|gynaecomastia
614806|NCT00637871|Prostate Cancer|prostate cancer
614807|NCT00637897|recurrent breast cancer|recurrent breast cancer
614808|NCT00637897|stage IV breast cancer|stage iv breast cancer
614809|NCT00637910|Advanced NSCLC|advanced nsclc
614810|NCT00637910|EGFR|egfr
614811|NCT00637910|EGFR copy number|egfr copy number
614812|NCT00637910|Kras mutations|kras mutations
614813|NCT00637910|EGRF mutations|egrf mutations
614814|NCT00637910|Docetaxel|docetaxel
614815|NCT00637910|Erlotinib|erlotinib
614816|NCT00637910|Polymorphisms|polymorphisms
614817|NCT00637923|Hepatitis C, Chronic|hepatitis c, chronic
614818|NCT00637936|perioperative oxygen|perioperative oxygen
614819|NCT00637936|respiratory complications|respiratory complications
614820|NCT00637949|Osteoarthritis|osteoarthritis
614821|NCT00637949|lumiracoxib|lumiracoxib
614822|NCT00637949|rofecoxib|rofecoxib
614823|NCT00637949|Cox-2|cox-2
614824|NCT00637949|Osteoarthritis (primary osteoarthritis hip, hand, knee or spine (cervical or lumbar)|osteoarthritis (primary osteoarthritis hip, hand, knee or spine (cervical or lumbar)
614826|NCT00637962|AIDS|aids
614827|NCT00637962|Vaccine|vaccine
614828|NCT00637962|intravaginal|intravaginal
614829|NCT00637962|mucosal|mucosal
614830|NCT00637962|HIV Seronegativity|hiv seronegativity
614831|NCT00637975|neuropathic pain|neuropathic pain
614832|NCT00637975|oxycodone|oxycodone
614833|NCT00637975|pregabalin|pregabalin
614834|NCT00637975|Patients with cancer and presenting a neuropathic pain|patients with cancer and presenting a neuropathic pain
614835|NCT00637988|Barrett's Esophagus|barrett's esophagus
614836|NCT00637988|Nexium|nexium
614837|NCT00638001|patients with haemophilia A moderate or severe|patients with haemophilia a moderate or severe
614838|NCT00638001|patients with haemophilia B moderate or severe|patients with haemophilia b moderate or severe
614839|NCT00638014|Sternal wound closure|sternal wound closure
614840|NCT00638014|cardiac surgery|cardiac surgery
614841|NCT00638014|sternal nonunion|sternal nonunion
614842|NCT00638027|multiple sclerosis|multiple sclerosis
614843|NCT00638040|hypoxia|hypoxia
614844|NCT00638040|lactate|lactate
614845|NCT00638040|pH|ph
614846|NCT00638040|tumor microenvironments|tumor microenvironments
614847|NCT00638040|survival|survival
614848|NCT00638066|vaginismus|vaginismus
614849|NCT00638066|botulinum toxin A|botulinum toxin a
614850|NCT00638066|dyspareunia|dyspareunia
614851|NCT00638066|unconsummated marriage|unconsummated marriage
614852|NCT00638079|Pharmacokinetics|pharmacokinetics
614853|NCT00638079|Food Effect|food effect
614854|NCT00638079|Bioavailability|bioavailability
614855|NCT00638079|Megace ES|megace es
614856|NCT00638092|hypothyroxinemia|hypothyroxinemia
614857|NCT00638092|preterm infants|preterm infants
614858|NCT00638092|iodine|iodine
614859|NCT00638092|neurodevelopmental outcome|neurodevelopmental outcome
614860|NCT00638092|Iodine supplementation|iodine supplementation
614861|NCT00638092|Randomised controlled trial|randomised controlled trial
614862|NCT00638144|Hepatitis C|hepatitis c
614863|NCT00638144|liver transplantation|liver transplantation
614864|NCT00638144|antibodies mediated neutralization|antibodies mediated neutralization
614865|NCT00638144|monoclonal antibodies|monoclonal antibodies
614866|NCT00638157|Gram-positive bacterial infections|gram-positive bacterial infections
614867|NCT00638157|Staph Aureus|staph aureus
614868|NCT00638157|endocarditis|endocarditis
614869|NCT00638157|bacteremia|bacteremia
614870|NCT00638157|methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
614871|NCT00626756|fluid|fluid
614872|NCT00626756|Lidco technology|lidco technology
614873|NCT00626756|guided therapy|guided therapy
614874|NCT00626756|fluid management guided by Lidco technology|fluid management guided by lidco technology
614875|NCT00626769|Genistein|genistein
615253|NCT00641342|Sublay mesh|sublay mesh
614876|NCT00626769|Bone mineral density|bone mineral density
614877|NCT00626769|digital mammography|digital mammography
614878|NCT00626769|safety|safety
614880|NCT00626782|glucoma filtering surgery|glucoma filtering surgery
614881|NCT00626782|ranibizumab|ranibizumab
614882|NCT00626782|mitomycin C|mitomycin c
614883|NCT00626782|patients requiring first time glaucoma filtering surgery|patients requiring first time glaucoma filtering surgery
614884|NCT00626821|Stoma|stoma
614885|NCT00626821|Ostomy|ostomy
614886|NCT00626834|cocaine addiction|cocaine addiction
614887|NCT00626834|vigabatrin|vigabatrin
614888|NCT00626834|ovation pharmaceuticals|ovation pharmaceuticals
614889|NCT00626834|cocaine|cocaine
614890|NCT00626834|cocaine related disorders|cocaine related disorders
614891|NCT00626834|behavior addictive|behavior addictive
614892|NCT00626834|mental disorders|mental disorders
614893|NCT00626834|therapeutic uses|therapeutic uses
614894|NCT00626834|physiologic effects of drugs|physiologic effects of drugs
614895|NCT00626834|disorder of environmental origin|disorder of environmental origin
614896|NCT00626834|central nervous system stimulants|central nervous system stimulants
614897|NCT00626834|central nervous system agents|central nervous system agents
614898|NCT00626834|pharmacological actions|pharmacological actions
614899|NCT00626834|substance related disorders|substance related disorders
614900|NCT00626847|primary open angle glaucoma|primary open angle glaucoma
614901|NCT00626847|Nuclear Genetics|nuclear genetics
614902|NCT00626847|Mitochondrial DNA|mitochondrial dna
614903|NCT00626847|POAG|poag
614904|NCT00626860|melanoma|melanoma
614905|NCT00626873|ovarian germ cell tumor|ovarian germ cell tumor
614906|NCT00626873|ovarian epithelial cancer|ovarian epithelial cancer
614907|NCT00626886|Herniorrhaphy|herniorrhaphy
614908|NCT00626886|Inguinal Hernia Repair|inguinal hernia repair
614909|NCT00626886|Postoperative pain|postoperative pain
614910|NCT00626899|Validation of Cardiac Output measurement in hypothermic patients|validation of cardiac output measurement in hypothermic patients
614911|NCT00626912|large aneurysm|large aneurysm
614912|NCT00626912|recurrence|recurrence
614913|NCT00626912|hydrocoil|hydrocoil
614914|NCT00626925|Randomized Trial|randomized trial
614915|NCT00626925|Medication for Heavy Drinking|medication for heavy drinking
614916|NCT00626925|Topiramate Treatment|topiramate treatment
614917|NCT00626938|sarcoidosis|sarcoidosis
614918|NCT00626938|protein profile|protein profile
614919|NCT00626938|CYP-450|cyp-450
614920|NCT00626938|TNF-alpha polymorphisms|tnf-alpha polymorphisms
614921|NCT00626938|HLA|hla
614922|NCT00626951|LMA Supreme|lma supreme
614923|NCT00626951|LMA ProSeal|lma proseal
614924|NCT00626951|Laryngeal mask airway|laryngeal mask airway
614925|NCT00626951|Ventilation|ventilation
614926|NCT00632398|massage|massage
614927|NCT00632398|oncology massage|oncology massage
614928|NCT00632398|palliative care|palliative care
614929|NCT00632398|supportive care|supportive care
614930|NCT00632398|integrative oncology|integrative oncology
614931|NCT00632398|informal caregiving|informal caregiving
614932|NCT00632398|spouse caregiving|spouse caregiving
614933|NCT00632398|family caregiving|family caregiving
614934|NCT00632398|caregiver education|caregiver education
614935|NCT00632398|psychosocial oncology|psychosocial oncology
614936|NCT00632398|caregiver stress|caregiver stress
614937|NCT00632398|coping with cancer|coping with cancer
614938|NCT00632398|quality of life|quality of life
614939|NCT00632398|end of life care|end of life care
614940|NCT00632437|Brain Tumor|brain tumor
614941|NCT00632437|Craniotomy Surgery|craniotomy surgery
614942|NCT00632437|Brain Function|brain function
614943|NCT00632437|Intraoperative Optical Imaging|intraoperative optical imaging
614944|NCT00632437|Speckle-Contrast Imaging|speckle-contrast imaging
614945|NCT00632437|Cortical Mapping|cortical mapping
614946|NCT00632437|Somatosensory Cortex|somatosensory cortex
614947|NCT00632437|Cerebral blood flow|cerebral blood flow
614948|NCT00632437|CBF|cbf
614949|NCT00632437|Laser Speckle Contrast Imaging|laser speckle contrast imaging
614950|NCT00632437|Multi-Spectral Imaging|multi-spectral imaging
615043|NCT00640497|anti-CD3|anti-cd3
614951|NCT00638170|Urinary Tract Infections|urinary tract infections
614952|NCT00638170|Cranberry|cranberry
614953|NCT00638170|Prevention|prevention
614954|NCT00638196|relapsing multiple sclerosis|relapsing multiple sclerosis
614955|NCT00638196|polyunsaturated fatty acids|polyunsaturated fatty acids
614956|NCT00638196|omega-6 fatty acids|omega-6 fatty acids
614957|NCT00638222|Carvedilol|carvedilol
614958|NCT00638222|Heart Disease|heart disease
614959|NCT00638222|Vascular Disease|vascular disease
614960|NCT00638222|Kidney|kidney
614961|NCT00638235|Pelvic floor repair|pelvic floor repair
614962|NCT00638235|prolapse|prolapse
614963|NCT00638235|mesh|mesh
614964|NCT00638248|Acute ischemic stroke|acute ischemic stroke
614965|NCT00638261|Psoriasis|psoriasis
614966|NCT00638261|Biologic|biologic
614967|NCT00638261|Adalimumab|adalimumab
614968|NCT00638261|Narrow-band UVB|narrow-band uvb
614969|NCT00638261|phototherapy|phototherapy
614970|NCT00638261|half-side comparison|half-side comparison
614971|NCT00638274|Quality of pain relief with 2 different methods of identifying epidural space|quality of pain relief with 2 different methods of identifying epidural space
614972|NCT00638287|Subjects with pituitary disease undergoing testing for GH|subjects with pituitary disease undergoing testing for gh
614973|NCT00638287|deficiency|deficiency
615459|NCT00641992|prognosis|prognosis
614974|NCT00638287|Subjects with suspicion for (or diagnosis of) acromegaly|subjects with suspicion for (or diagnosis of) acromegaly
614975|NCT00638287|undergoing OGTT testing|undergoing ogtt testing
614976|NCT00638287|Normal controls without evidence of pituitary dysfunction|normal controls without evidence of pituitary dysfunction
614977|NCT00638300|hemodialysis|hemodialysis
614978|NCT00638300|iron|iron
614979|NCT00638300|inflammation|inflammation
614980|NCT00638300|atomic absorption|atomic absorption
614981|NCT00638300|dialysate|dialysate
614982|NCT00638300|advanced oxidation protein products|advanced oxidation protein products
614983|NCT00638300|large pore dialysate|large pore dialysate
614984|NCT00638300|bicarbonate|bicarbonate
614985|NCT00638300|calcium|calcium
614986|NCT00638300|citrate|citrate
614987|NCT00638300|ligand|ligand
614988|NCT00638313|GLP-1|glp-1
614989|NCT00638326|Clopidogrel, thrombosis, Percutaneous Transluminal Coronary Angioplasty, stents|clopidogrel, thrombosis, percutaneous transluminal coronary angioplasty, stents
614990|NCT00638339|Respiration, artificial|respiration, artificial
614991|NCT00638339|respiratory insufficiency|respiratory insufficiency
614992|NCT00638339|noninvasive ventilation|noninvasive ventilation
614993|NCT00638339|sleep deprivation|sleep deprivation
614994|NCT00638339|intensive care units|intensive care units
614995|NCT00638352|Core Biopsy|core biopsy
614996|NCT00638352|Needle Biopsy|needle biopsy
614997|NCT00638352|Percutaneous Biopsy|percutaneous biopsy
614998|NCT00638365|Cystic Fibrosis, Pseudomonas aeruginosa, Pulmonary CF|cystic fibrosis, pseudomonas aeruginosa, pulmonary cf
614999|NCT00638378|Prostate Cancer|prostate cancer
615000|NCT00638391|Primary early MCa|primary early mca
615001|NCT00638391|Arimidex|arimidex
615002|NCT00638404|Preoperative somatic questions|preoperative somatic questions
615003|NCT00638404|Preoperative audio tone evaluations|preoperative audio tone evaluations
615004|NCT00638404|Preoperative anxiety and previous experience with postop pain|preoperative anxiety and previous experience with postop pain
615005|NCT00638430|myopia|myopia
615006|NCT00638430|Humphery Matrix 30-2 test|humphery matrix 30-2 test
615007|NCT00638443|Neurogenic claudication, lumbar spinal stenosis, treadmill testing|neurogenic claudication, lumbar spinal stenosis, treadmill testing
615009|NCT00638456|Esophagitis|esophagitis
615010|NCT00638456|Microscopy|microscopy
615011|NCT00638469|Psoriasis|psoriasis
615012|NCT00638469|Biologic|biologic
615013|NCT00638469|adalimumab|adalimumab
615014|NCT00638469|narrowband UVB|narrowband uvb
615015|NCT00638469|phototherapy|phototherapy
615016|NCT00638469|half-side comparison|half-side comparison
615017|NCT00638482|Dent's disease|dent's disease
615018|NCT00638482|Nephrolithiasis|nephrolithiasis
615019|NCT00638482|clinical trial|clinical trial
615020|NCT00638482|thiazides|thiazides
615021|NCT00640354|Automated External Defibrillator|automated external defibrillator
615022|NCT00640354|Resuscitation|resuscitation
615023|NCT00640354|Pediatric|pediatric
615024|NCT00640367|Acute ischemic stroke|acute ischemic stroke
615025|NCT00640367|thrombolysis|thrombolysis
615026|NCT00640367|intra-arterial thrombolysis|intra-arterial thrombolysis
615027|NCT00640380|cervical|cervical
615028|NCT00640380|paravertebral|paravertebral
615029|NCT00640380|block|block
615030|NCT00640393|Etanercept, UVB, Enbrel, Psoriasis.|etanercept, uvb, enbrel, psoriasis.
615031|NCT00640445|Clinical Trial|clinical trial
615032|NCT00640445|Combat Disorders|combat disorders
615033|NCT00640445|PTSD|ptsd
615034|NCT00640445|Internet-Based Intervention|internet-based intervention
615035|NCT00640445|Mental Health Services|mental health services
615036|NCT00640445|Post-deployment Reintegration|post-deployment reintegration
615037|NCT00640471|recurrent colon cancer|recurrent colon cancer
615038|NCT00640471|stage IV colon cancer|stage iv colon cancer
615039|NCT00640471|recurrent rectal cancer|recurrent rectal cancer
615040|NCT00640471|stage IV rectal cancer|stage iv rectal cancer
615041|NCT00640497|acute GVHD|acute gvhd
615042|NCT00640497|immunotoxin|immunotoxin
615046|NCT00640549|LDL-subfractions, HDL-subfractions, non insulin dependent diabetes mellitus (NIDDM), hyperlipidemia, atorvastatin|ldl-subfractions, hdl-subfractions, non insulin dependent diabetes mellitus (niddm), hyperlipidemia, atorvastatin
615047|NCT00640562|Schizophrenia|schizophrenia
615048|NCT00640562|Depression|depression
615049|NCT00640562|Quetiapine|quetiapine
615050|NCT00640588|Hepatitis B, chronic|hepatitis b, chronic
615051|NCT00640588|Viral kinetics|viral kinetics
615052|NCT00640588|Telbivudine|telbivudine
615053|NCT00640588|Adefovir|adefovir
615054|NCT00640588|Compliance|compliance
615055|NCT00640601|Seroquel|seroquel
615056|NCT00640601|schizophrenia|schizophrenia
615057|NCT00640601|Extended Release|extended release
615058|NCT00640614|Dermatitis, Contact|dermatitis, contact
615059|NCT00640640|IOP|iop
615060|NCT00640640|OPA|opa
615061|NCT00640640|AMD|amd
615062|NCT00640640|bevacizumab|bevacizumab
615063|NCT00640640|ranibizumab|ranibizumab
615064|NCT00640640|choroidal blood flow|choroidal blood flow
615065|NCT00640640|DCT|dct
615066|NCT00640640|Ocular Pulse Amplitude change following anti VEGF|ocular pulse amplitude change following anti vegf
615774|NCT00642863|development|development
615067|NCT00640640|Ocular Pulse Amplitude|ocular pulse amplitude
615068|NCT00640653|Sexual Behavior|sexual behavior
615069|NCT00640653|Abstinence|abstinence
615070|NCT00640653|Intervention Studies|intervention studies
615072|NCT00640653|Sexually Transmitted Infection|sexually transmitted infection
615073|NCT00640653|Theory of Planned Behavior|theory of planned behavior
615074|NCT00640653|HIV Seronegativity|hiv seronegativity
615075|NCT00640666|Breast cancer|breast cancer
615076|NCT00640666|Exercise|exercise
615077|NCT00640666|Biomarkers|biomarkers
615078|NCT00640679|Clopidogrel|clopidogrel
615079|NCT00640679|Drug-eluting Stent|drug-eluting stent
615080|NCT00640692|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
615081|NCT00640692|GIST|gist
615082|NCT00640692|Sunitinib|sunitinib
615083|NCT00640692|Imatinib|imatinib
615084|NCT00640718|heart and respiratory monitoring|heart and respiratory monitoring
615085|NCT00640731|DVT|dvt
615086|NCT00640731|Peripheral Vascular Disease|peripheral vascular disease
615087|NCT00640731|Venous Thrombosis|venous thrombosis
615088|NCT00640731|Deep Vein Thrombosis|deep vein thrombosis
615089|NCT00640744|Atherogenesis|atherogenesis
615090|NCT00640744|Atheroma|atheroma
615091|NCT00640744|Arteriosclerosis|arteriosclerosis
615092|NCT00640757|Methionine|methionine
615093|NCT00640757|Metabolic syndrome|metabolic syndrome
615094|NCT00640757|Glucose Metabolism|glucose metabolism
615095|NCT00640757|Amino acid|amino acid
615096|NCT00640757|Insulin clamp|insulin clamp
615097|NCT00640783|Metabolic syndrome|metabolic syndrome
615098|NCT00640783|Mediterranean diet|mediterranean diet
615099|NCT00640783|Inflammatory markers|inflammatory markers
615100|NCT00640783|Endothelial function|endothelial function
615101|NCT00640796|Hematologic malignancies, non-B lineage|hematologic malignancies, non-b lineage
615102|NCT00640796|NK cell expansion|nk cell expansion
615103|NCT00640796|CliniMACS device|clinimacs device
615104|NCT00640796|Immunotherapy|immunotherapy
615105|NCT00640809|Bowel Disease|bowel disease
615106|NCT00640835|Opioid dependence|opioid dependence
615107|NCT00640861|stage II breast cancer|stage ii breast cancer
615108|NCT00640861|stage IIIA breast cancer|stage iiia breast cancer
615109|NCT00640861|stage IIIB breast cancer|stage iiib breast cancer
615110|NCT00640861|stage IIIC breast cancer|stage iiic breast cancer
615111|NCT00640861|stage IA breast cancer|stage ia breast cancer
615112|NCT00640861|stage IB breast cancer|stage ib breast cancer
615113|NCT00640861|triple-negative breast cancer|triple-negative breast cancer
615114|NCT00640861|HER2-positive breast cancer|her2-positive breast cancer
615115|NCT00640874|Prophylaxis|prophylaxis
615116|NCT00640874|pandemic influenza|pandemic influenza
615117|NCT00640874|influenza A|influenza a
615118|NCT00640874|H5N1 virus|h5n1 virus
615120|NCT00640887|Tuberculosis|tuberculosis
615121|NCT00640887|Rifabutin|rifabutin
615122|NCT00640887|Pharmacokinetics|pharmacokinetics
615123|NCT00640887|South Africa|south africa
615124|NCT00640900|overweight|overweight
615126|NCT00640900|weight loss|weight loss
615127|NCT00640900|commercial weight loss program|commercial weight loss program
615128|NCT00640913|Defunctioning stoma|defunctioning stoma
615129|NCT00640913|Low anterior resection|low anterior resection
615130|NCT00640913|TME surgery|tme surgery
615131|NCT00640913|Early stoma reversal|early stoma reversal
615132|NCT00640939|Tendonitis|tendonitis
615133|NCT00640939|Bursitis|bursitis
615134|NCT00640952|Parkinson's disease|parkinson's disease
615135|NCT00640952|impulse control behaviors|impulse control behaviors
615136|NCT00640952|dopa-dysregulation|dopa-dysregulation
615137|NCT00640978|Pancreatic Cancer|pancreatic cancer
615138|NCT00640978|Advanced Pancreatic Cancer|advanced pancreatic cancer
615139|NCT00640978|Unresectable|unresectable
615140|NCT00640978|Metastatic|metastatic
615141|NCT00640978|RAD001|rad001
615142|NCT00640978|Everolimus|everolimus
615143|NCT00640978|Erlotinib|erlotinib
615144|NCT00640978|OSI-774|osi-774
615145|NCT00640978|Erlotinib Hydrochloride|erlotinib hydrochloride
615146|NCT00640978|Tarceva|tarceva
615147|NCT00640991|Clinical Trial|clinical trial
615148|NCT00640991|Insulin|insulin
615149|NCT00641030|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
615150|NCT00641030|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
615151|NCT00641030|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
615152|NCT00641030|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
615153|NCT00641030|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
615154|NCT00641030|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
615155|NCT00641030|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
615156|NCT00641030|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
615157|NCT00641030|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
615158|NCT00641030|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
615159|NCT00641030|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
615255|NCT00641342|Health questionnaire|health questionnaire
615160|NCT00641030|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
615161|NCT00641030|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
615162|NCT00641030|secondary acute myeloid leukemia|secondary acute myeloid leukemia
615163|NCT00641030|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
615164|NCT00641030|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
615165|NCT00641030|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
615166|NCT00641030|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
615167|NCT00641056|diabetes|diabetes
615168|NCT00641056|exenatide|exenatide
615169|NCT00641056|exenatide once weekly|exenatide once weekly
615170|NCT00641056|metformin|metformin
615171|NCT00641056|sulfonylurea|sulfonylurea
615172|NCT00641056|insulin glargine|insulin glargine
615173|NCT00641056|Amylin|amylin
615174|NCT00641056|Lilly|lilly
615175|NCT00641069|Cardiac arrest|cardiac arrest
615176|NCT00641069|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
615177|NCT00641095|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
615178|NCT00641095|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
615179|NCT00641095|stage I mantle cell lymphoma|stage i mantle cell lymphoma
615180|NCT00641095|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
615181|NCT00641095|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
615182|NCT00641108|SPECT Brain Imaging|spect brain imaging
615183|NCT00641108|Cognitive Therapy|cognitive therapy
615184|NCT00641108|Serotonin Transporter Binding|serotonin transporter binding
615185|NCT00641108|Predictive Biomarker|predictive biomarker
615186|NCT00641134|Cardiac Rehabilitation|cardiac rehabilitation
615187|NCT00641134|Old age|old age
615188|NCT00641134|Home physical training|home physical training
615189|NCT00641160|vinorelbine|vinorelbine
615190|NCT00641160|metronomic dosing|metronomic dosing
615191|NCT00641160|oral administration|oral administration
615192|NCT00641160|nonhematologic malignancies|nonhematologic malignancies
615193|NCT00641160|pharmacokinetics|pharmacokinetics
615195|NCT00641173|cortisol|cortisol
615196|NCT00641173|hippocampus|hippocampus
615197|NCT00641173|memory|memory
615198|NCT00641186|excessive daytime somnolence|excessive daytime somnolence
615199|NCT00641186|Parkinson disease|parkinson disease
615200|NCT00641186|sleep disturbance|sleep disturbance
615201|NCT00641199|Antibiotic-associated diarrhea|antibiotic-associated diarrhea
615202|NCT00641199|Probiotic|probiotic
615203|NCT00641199|Quality of life|quality of life
615204|NCT00641199|Antibiotics|antibiotics
615205|NCT00641212|Allergic rhinitis|allergic rhinitis
615206|NCT00641212|Perennial allergic rhinitis|perennial allergic rhinitis
615207|NCT00641212|Paediatric|paediatric
615208|NCT00641212|Growth|growth
615209|NCT00641212|budesonide|budesonide
615210|NCT00641212|Rhinocort AQUA|rhinocort aqua
615211|NCT00641225|Ascending Single Dose|ascending single dose
615212|NCT00641225|Safety|safety
615213|NCT00641225|Pharmacokinetics|pharmacokinetics
615214|NCT00641225|Open-label|open-label
615215|NCT00641238|NSCLC|nsclc
615216|NCT00641238|lung cancer|lung cancer
615217|NCT00641251|T2 Diabetes|t2 diabetes
615218|NCT00641251|Type 2 diabetes CVD event rates and mortality|type 2 diabetes cvd event rates and mortality
615219|NCT00641264|Laryngopharyngeal reflux (LPR)|laryngopharyngeal reflux (lpr)
615220|NCT00641264|Omeprazole|omeprazole
615221|NCT00641264|Losec|losec
615222|NCT00641264|Quality of Life|quality of life
615223|NCT00641264|Laryngitis|laryngitis
615224|NCT00641277|endosseous dental implants|endosseous dental implants
615225|NCT00641277|dental aesthetics|dental aesthetics
615226|NCT00641290|CABG|cabg
615227|NCT00641290|Valve surgery|valve surgery
615228|NCT00641303|pain|pain
615229|NCT00641303|fatigue|fatigue
615230|NCT00641303|hot flashes|hot flashes
615231|NCT00641303|sleep disorders|sleep disorders
615232|NCT00641303|depression|depression
615233|NCT00641303|anxiety disorder|anxiety disorder
615234|NCT00641303|stage I breast cancer|stage i breast cancer
615235|NCT00641303|stage II breast cancer|stage ii breast cancer
615236|NCT00641303|stage IIIA breast cancer|stage iiia breast cancer
615237|NCT00641303|stage IIIB breast cancer|stage iiib breast cancer
615238|NCT00641303|stage IIIC breast cancer|stage iiic breast cancer
615239|NCT00641316|Freeze-dried bone allograft|freeze-dried bone allograft
615240|NCT00641316|Platelet-rich plasma|platelet-rich plasma
615241|NCT00641316|Platelet-derived growth factors|platelet-derived growth factors
615242|NCT00641316|Laser-threaded dental implants|laser-threaded dental implants
615243|NCT00641316|Resorbable blast textured dental implants|resorbable blast textured dental implants
615244|NCT00641329|ADHD|adhd
615245|NCT00641329|ADD|add
615246|NCT00641329|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
615247|NCT00641329|Attention Deficit|attention deficit
615248|NCT00641329|Clonidine|clonidine
615249|NCT00641329|CLONICEL|clonicel
615250|NCT00641329|Addrenex|addrenex
615251|NCT00641342|Parastomal hernia|parastomal hernia
615254|NCT00641342|Pain|pain
615256|NCT00641368|Adolescent|adolescent
615261|NCT00641381|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
615262|NCT00641381|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
615263|NCT00641381|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
615264|NCT00641381|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
615265|NCT00641381|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
615266|NCT00641381|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
615267|NCT00641381|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
615268|NCT00641381|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
615269|NCT00641381|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
615270|NCT00641381|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
615271|NCT00641381|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
615272|NCT00641381|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
615273|NCT00641381|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
615274|NCT00641381|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
615275|NCT00641381|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
615276|NCT00641381|Burkitt lymphoma|burkitt lymphoma
615277|NCT00641381|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
615278|NCT00641381|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
615279|NCT00641381|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
615280|NCT00641381|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
615281|NCT00641381|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
615282|NCT00641381|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
615283|NCT00641381|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
615284|NCT00641381|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
615285|NCT00641381|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
615286|NCT00641381|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
615287|NCT00641381|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
615288|NCT00641381|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
615289|NCT00641381|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
615290|NCT00641381|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
615291|NCT00641381|HIV Infections|hiv infections
615292|NCT00641381|Treatment Experienced|treatment experienced
615293|NCT00641394|cortisol|cortisol
615294|NCT00641394|hydrocortisone|hydrocortisone
615295|NCT00641394|psychotherapy|psychotherapy
615296|NCT00641394|Emotional Freedom Techniques (EFT)|emotional freedom techniques (eft)
615297|NCT00641394|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
615298|NCT00641394|depression|depression
615299|NCT00641394|anxiety|anxiety
615300|NCT00641407|Bedtime insulins|bedtime insulins
615301|NCT00641407|Poorly controlled type 2 diabetes|poorly controlled type 2 diabetes
615302|NCT00641407|Glycemic control|glycemic control
615303|NCT00641407|HbA1c|hba1c
615304|NCT00641420|Acne scarring|acne scarring
615305|NCT00641420|Post inflammatory hyperpigmentation|post inflammatory hyperpigmentation
615306|NCT00641433|chemocautery|chemocautery
615307|NCT00641446|Children|children
615308|NCT00641446|Asthma|asthma
615309|NCT00641446|Varivax|varivax
615310|NCT00641446|varicella|varicella
615311|NCT00641446|Pulmicort|pulmicort
615312|NCT00641446|budesonide|budesonide
615313|NCT00641459|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
615314|NCT00641459|BPSD|bpsd
615315|NCT00641459|NPI|npi
615316|NCT00641459|CGI|cgi
615317|NCT00641459|MMSE|mmse
615318|NCT00641472|Asthma|asthma
615319|NCT00641472|Pulmicort|pulmicort
615320|NCT00641472|Children|children
615321|NCT00641472|paediatrics|paediatrics
615322|NCT00641472|budesonide|budesonide
615323|NCT00641498|suicide|suicide
615324|NCT00641498|parasuicide|parasuicide
615325|NCT00641498|prevention|prevention
615326|NCT00641498|individual supportive psychotherapy|individual supportive psychotherapy
615327|NCT00641511|PTSD|ptsd
615328|NCT00641524|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
615329|NCT00641524|liver fibrosis|liver fibrosis
615330|NCT00641524|metabolic syndrome|metabolic syndrome
615331|NCT00641524|iron overload|iron overload
615332|NCT00641524|phlebotomy|phlebotomy
615333|NCT00641550|physical exercise|physical exercise
615334|NCT00641550|maternal complications|maternal complications
615335|NCT00641550|preterm labor|preterm labor
615336|NCT00641550|birthweight|birthweight
615337|NCT00641550|Apgar scores|apgar scores
615338|NCT00641563|dexmedetomidine|dexmedetomidine
615339|NCT00641563|midazolam|midazolam
615340|NCT00641563|remifentanil|remifentanil
615344|NCT00641563|Bispectral Index|bispectral index
615345|NCT00641563|Response Entropy|response entropy
615346|NCT00641563|State Entropy|state entropy
615347|NCT00641576|Endosseous implants|endosseous implants
615348|NCT00641589|Chronic Kidney Disease|chronic kidney disease
615349|NCT00641589|anemia|anemia
615350|NCT00641589|epoetin alfa|epoetin alfa
615351|NCT00641602|Erosive Esophagitis|erosive esophagitis
615352|NCT00641602|Nexium|nexium
615353|NCT00641602|Heartburn|heartburn
615354|NCT00641628|Nipple sparing mastectomy|nipple sparing mastectomy
615355|NCT00641628|NAC conservation|nac conservation
615359|NCT00641654|Chronic hepatitis C|chronic hepatitis c
615360|NCT00641654|genotype 2 or 3|genotype 2 or 3
615361|NCT00641654|relapse|relapse
615362|NCT00641654|pegylated interferon|pegylated interferon
615363|NCT00641654|ribavirin|ribavirin
615364|NCT00641667|Pain|pain
615365|NCT00641667|Cancer|cancer
615366|NCT00641667|Fentanyl|fentanyl
615367|NCT00641667|JNS020QD|jns020qd
615368|NCT00641680|Seasonal allergic rhinitis|seasonal allergic rhinitis
615369|NCT00641680|Nasal symptoms|nasal symptoms
615370|NCT00641680|Congestion|congestion
615371|NCT00641680|Rhinorrhea|rhinorrhea
615372|NCT00641680|Sneeze|sneeze
615373|NCT00641680|budesonide|budesonide
615374|NCT00641680|Rhinocort AQUA|rhinocort aqua
615375|NCT00641680|Fluticasone propionate|fluticasone propionate
615376|NCT00641680|Flonase|flonase
615377|NCT00641693|Allergic rhinitis|allergic rhinitis
615378|NCT00641693|Paediatric|paediatric
615379|NCT00641693|Nasal symptoms|nasal symptoms
615380|NCT00641693|Congestion|congestion
615381|NCT00641693|Rhinorrhea|rhinorrhea
615382|NCT00641693|Sneeze|sneeze
615383|NCT00641693|budesonide|budesonide
615384|NCT00641693|Rhinocort AQUA|rhinocort aqua
615385|NCT00641732|venous thromboembolism|venous thromboembolism
615386|NCT00641732|oral anticoagulant|oral anticoagulant
615387|NCT00641732|direct factor Xa inhibitor|direct factor xa inhibitor
615388|NCT00641732|total knee replacement|total knee replacement
615389|NCT00641732|drug therapy|drug therapy
615390|NCT00641745|Lurasidone|lurasidone
615391|NCT00641745|Schizophrenia|schizophrenia
615392|NCT00641745|Latuda|latuda
615393|NCT00641758|Coronary Artery Disease|coronary artery disease
615394|NCT00641758|endothelial dysfunction|endothelial dysfunction
615395|NCT00641758|Nitric oxide|nitric oxide
615396|NCT00641784|Composite Early neonatal Outcome|composite early neonatal outcome
615397|NCT00641784|Late Neurological neonatal outcome|late neurological neonatal outcome
615398|NCT00641797|Canalith Repositioning Technique|canalith repositioning technique
615399|NCT00641797|Vertigo|vertigo
615400|NCT00641810|Caffeine|caffeine
615401|NCT00641810|Snoring|snoring
615402|NCT00641810|Sleep|sleep
615403|NCT00641823|Orthopedic Surgical Procedures|orthopedic surgical procedures
615405|NCT00641849|Physical Activity|physical activity
615406|NCT00641849|Food|food
615407|NCT00641849|Nutrition|nutrition
615408|NCT00641849|Dietary behaviors|dietary behaviors
615409|NCT00641849|Diet|diet
615410|NCT00641849|Adult|adult
615411|NCT00641849|Adults|adults
615412|NCT00641849|Fat|fat
615413|NCT00641849|Fats|fats
615414|NCT00641849|Self monitoring|self monitoring
615415|NCT00641849|Automated feedback|automated feedback
615416|NCT00641862|Pregnancy|pregnancy
615417|NCT00641862|Maternal Nutritional Status|maternal nutritional status
615418|NCT00641862|Vitamin B12|vitamin b12
615419|NCT00641875|arterial stiffness|arterial stiffness
615420|NCT00641875|artery|artery
615421|NCT00641875|aortic pulse wave velocity|aortic pulse wave velocity
615422|NCT00641875|pulse wave analysis|pulse wave analysis
615423|NCT00641875|augmentation index|augmentation index
615424|NCT00641875|end stage renal disease|end stage renal disease
615425|NCT00641875|nocturnal hemodialysis|nocturnal hemodialysis
615426|NCT00641875|extended hours of hemodialysis|extended hours of hemodialysis
615427|NCT00641875|cardiovascular|cardiovascular
615428|NCT00641875|hemodialysis|hemodialysis
615429|NCT00641888|Cardiovascular risk|cardiovascular risk
615430|NCT00641888|Inflammatory biomarkers|inflammatory biomarkers
615431|NCT00641888|Human immunodeficiency virus|human immunodeficiency virus
615432|NCT00641901|gingivitis|gingivitis
615433|NCT00641901|pregnancy|pregnancy
615434|NCT00641901|pre-term birth|pre-term birth
615435|NCT00641914|Asthma|asthma
615436|NCT00641914|Pulmicort|pulmicort
615437|NCT00641914|budesonide|budesonide
615438|NCT00641927|bipolar disorder|bipolar disorder
615439|NCT00641927|bipolar type II disorder|bipolar type ii disorder
615440|NCT00641927|antidepressant|antidepressant
615441|NCT00641927|mood stabilizer|mood stabilizer
615442|NCT00641927|venlafaxine|venlafaxine
615443|NCT00641927|lithium carbonate|lithium carbonate
615444|NCT00641940|Prevention|prevention
615445|NCT00641940|Girls|girls
615446|NCT00641940|Resilience|resilience
615447|NCT00641953|Foot Pain|foot pain
615448|NCT00641953|Diabetic Neuropathy Pain|diabetic neuropathy pain
615449|NCT00641953|Diabetic Peripheral Neuropathy foot pain|diabetic peripheral neuropathy foot pain
615450|NCT00641979|Allergic rhinitis|allergic rhinitis
615451|NCT00641979|Nasal symptoms|nasal symptoms
615452|NCT00641979|Congestion|congestion
615453|NCT00641979|Rhinorrhea|rhinorrhea
615454|NCT00641979|Sneeze|sneeze
615455|NCT00641979|budesonide|budesonide
615456|NCT00641979|Rhinocort AQUA|rhinocort aqua
615457|NCT00641992|amebic liver abscess|amebic liver abscess
615460|NCT00642005|Humidification|humidification
615461|NCT00642005|Laparoscopy|laparoscopy
615463|NCT00642005|Hemicolectomy|hemicolectomy
615464|NCT00642005|Warming|warming
615465|NCT00642018|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
615466|NCT00642031|Hematologic Malignancies|hematologic malignancies
615467|NCT00642031|Leukemia|leukemia
615468|NCT00642031|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
615469|NCT00642031|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
615470|NCT00642031|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
615471|NCT00642031|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
615472|NCT00642031|Agnogenic Myeloid Metaplasia|agnogenic myeloid metaplasia
615473|NCT00642031|Triciribine Phosphate Monohydrate|triciribine phosphate monohydrate
615474|NCT00642031|Triciribine|triciribine
615475|NCT00642031|TCN-PM|tcn-pm
615476|NCT00642031|VD-0002|vd-0002
615477|NCT00642044|Keratoconus|keratoconus
615478|NCT00642057|chorea|chorea
615479|NCT00642057|dyskinesia|dyskinesia
615480|NCT00642057|hyperkinetic|hyperkinetic
615481|NCT00642070|Current symptoms of urinary tract infection|current symptoms of urinary tract infection
615482|NCT00642083|outflow stenosis|outflow stenosis
615483|NCT00642083|stentgraft|stentgraft
615484|NCT00642096|High blood pressure|high blood pressure
615485|NCT00642096|hypertension|hypertension
615486|NCT00642096|(TOPROL-XL)|(toprol-xl)
615487|NCT00642096|metoprolol succinate|metoprolol succinate
615488|NCT00642096|hydrochlorothiazide|hydrochlorothiazide
615489|NCT00642122|Asthma|asthma
615490|NCT00642122|Pulmicort|pulmicort
615491|NCT00642122|budesonide|budesonide
615492|NCT00642122|respules|respules
615493|NCT00642122|turbuhaler|turbuhaler
615494|NCT00642135|premature|premature
615495|NCT00642135|neonates|neonates
615496|NCT00642135|infants|infants
615497|NCT00642135|children|children
615498|NCT00642135|Mydriasert®|mydriasert®
615499|NCT00642135|mydriasis|mydriasis
615500|NCT00642135|fundus|fundus
615501|NCT00642135|Tropicamide|tropicamide
615502|NCT00642135|Phenylephrine|phenylephrine
615503|NCT00642135|clinical trial|clinical trial
615504|NCT00642135|Infant|infant
615505|NCT00642135|premature newborns|premature newborns
615506|NCT00642135|bilateral diagnosis fundus|bilateral diagnosis fundus
615507|NCT00642148|GW856553|gw856553
615508|NCT00642148|p38 MAPK|p38 mapk
615509|NCT00642148|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
615510|NCT00642161|Asthma|asthma
615511|NCT00642161|Pulmicort|pulmicort
615512|NCT00642161|Children|children
615513|NCT00642161|Paediatrics|paediatrics
615514|NCT00642161|budesonide|budesonide
615515|NCT00642161|Flexhaler|flexhaler
615516|NCT00642187|Asthma|asthma
615517|NCT00642187|Pulmicort|pulmicort
615518|NCT00642187|Turbuhaler|turbuhaler
615519|NCT00642187|Budesonide|budesonide
615520|NCT00642187|Flexhaler|flexhaler
615521|NCT00642213|stroke|stroke
615522|NCT00642213|ischemic|ischemic
615524|NCT00642213|hemorrhage|hemorrhage
615525|NCT00642213|incidence|incidence
615526|NCT00642213|case-fatality|case-fatality
615527|NCT00642213|risk factors|risk factors
615528|NCT00642213|genetic|genetic
615529|NCT00642226|Branch Retinal Vein Occlusion|branch retinal vein occlusion
615530|NCT00642226|BRVO|brvo
615531|NCT00642226|Macular Edema|macular edema
615532|NCT00642226|Triamcinolone|triamcinolone
615533|NCT00642226|Vitrectomy|vitrectomy
615534|NCT00642239|Sodium Glycididazole, Radiochemotherapy, Esophageal Carcinoma|sodium glycididazole, radiochemotherapy, esophageal carcinoma
615535|NCT00642252|remineraliation|remineraliation
615536|NCT00642252|pre-existing white-spot (non-cavitated) enamel lesions|pre-existing white-spot (non-cavitated) enamel lesions
615537|NCT00642278|Type 2 diabetes mellitus|type 2 diabetes mellitus
615538|NCT00642278|Metformin|metformin
615539|NCT00642278|Hemoglobin A1c|hemoglobin a1c
615540|NCT00642291|Emtricitabine|emtricitabine
615541|NCT00642291|Pediatric|pediatric
615542|NCT00642291|HIV-1|hiv-1
615543|NCT00642291|Treatment of HIV-1|treatment of hiv-1
615544|NCT00642317|Healthy Control|healthy control
615545|NCT00642317|Tobacco Use|tobacco use
615546|NCT00642317|Tobacco Initiation|tobacco initiation
615547|NCT00642317|Smoking|smoking
615548|NCT00642317|Questionnaire|questionnaire
615549|NCT00642317|Survey|survey
615550|NCT00642330|patent|patent
615551|NCT00642330|ductus|ductus
615552|NCT00642330|arteriosus|arteriosus
615553|NCT00642330|ibuprofen|ibuprofen
615554|NCT00642330|premature|premature
615555|NCT00642330|infant|infant
615556|NCT00642343|Balance|balance
615557|NCT00642343|Severe, Profound deafness|severe, profound deafness
615558|NCT00642343|Children|children
615559|NCT00642343|unilateral/bilateral cochlear implants|unilateral/bilateral cochlear implants
615560|NCT00642343|unilateral cochlear implant|unilateral cochlear implant
615561|NCT00642343|bilateral cochlear implants|bilateral cochlear implants
615562|NCT00642356|Idiopathic Parkinson's disease|idiopathic parkinson's disease
615563|NCT00642356|carbidopa/levodopa/entacapone|carbidopa/levodopa/entacapone
615564|NCT00642356|non-motor symptoms|non-motor symptoms
615565|NCT00642356|motor-symptoms|motor-symptoms
615566|NCT00642369|Polysomnograph|polysomnograph
615567|NCT00642382|Osteoarthritis|osteoarthritis
615568|NCT00642382|Hyaluronic Acid|hyaluronic acid
615569|NCT00642395|Multiple Myeloma|multiple myeloma
615570|NCT00642395|Autologous Stem Cells Transplantation|autologous stem cells transplantation
615571|NCT00642395|High Dose Melphalan|high dose melphalan
615572|NCT00642395|Bortezomib|bortezomib
615573|NCT00642421|Acromegaly|acromegaly
615574|NCT00642434|diabetes blood pressure oxidative stress|diabetes blood pressure oxidative stress
615575|NCT00642447|noninvasive ventilation|noninvasive ventilation
615576|NCT00642447|helium|helium
615577|NCT00642447|oxygen|oxygen
615578|NCT00642447|sulfur mustard|sulfur mustard
615579|NCT00642447|chronic bronchitis|chronic bronchitis
615580|NCT00642447|bronchiolitis|bronchiolitis
615581|NCT00642486|treatment|treatment
615582|NCT00642486|positive airway pressure|positive airway pressure
615583|NCT00642486|compliance|compliance
615584|NCT00642486|cost effectiveness|cost effectiveness
615585|NCT00642486|clinical trial|clinical trial
615586|NCT00642499|HIV|hiv
615587|NCT00642499|AIDS|aids
615588|NCT00642499|nausea|nausea
615589|NCT00642499|vomiting|vomiting
615590|NCT00642499|HAART|haart
615591|NCT00642499|Treatment Experienced|treatment experienced
615592|NCT00642499|HIV Infections|hiv infections
615593|NCT00642512|CINV|cinv
615594|NCT00642512|chemotherapy|chemotherapy
615595|NCT00642512|nausea|nausea
615596|NCT00642512|vomiting|vomiting
615597|NCT00642512|retching|retching
615598|NCT00642525|detection of anastomotic leakage|detection of anastomotic leakage
615599|NCT00642525|esophageal resection|esophageal resection
615600|NCT00642525|diagnostic safety|diagnostic safety
615601|NCT00642538|Diabetic adult male, diabetic postmenopausal women|diabetic adult male, diabetic postmenopausal women
615602|NCT00642551|vitamin K2|vitamin k2
615603|NCT00642551|menaquinone-7|menaquinone-7
615604|NCT00642551|bone health|bone health
615605|NCT00642551|vascular health|vascular health
615606|NCT00642564|Epilepsy|epilepsy
615607|NCT00642564|Headache|headache
615608|NCT00642564|Migraine|migraine
615609|NCT00642590|Fertility|fertility
615610|NCT00642590|Pregnancy|pregnancy
615611|NCT00642590|Conception|conception
615612|NCT00642590|Infertility|infertility
615613|NCT00642590|Behavioral|behavioral
615614|NCT00642590|Lifestyle|lifestyle
615615|NCT00642590|Nutrition|nutrition
615616|NCT00642642|Acne|acne
615617|NCT00642655|IVIG|ivig
615618|NCT00642655|Rituximab|rituximab
615619|NCT00642655|Highly Sensitized|highly sensitized
615620|NCT00642655|Kidney Transplantation|kidney transplantation
615621|NCT00642694|MDD|mdd
615622|NCT00642694|Major Depressive Disorder|major depressive disorder
615623|NCT00642694|Depression|depression
615624|NCT00642694|Initial Insomnia|initial insomnia
615625|NCT00642694|sleep|sleep
615626|NCT00642694|difficulty sleeping|difficulty sleeping
615627|NCT00642694|down|down
615628|NCT00642694|sad|sad
615629|NCT00642694|Major Depressive Disorder(MDD) and initial insomnia|major depressive disorder(mdd) and initial insomnia
615630|NCT00642707|HIV|hiv
615631|NCT00642707|Treatment Naïve|treatment naïve
615632|NCT00642746|Colon|colon
615633|NCT00642746|Cancer|cancer
615634|NCT00642746|Metastatic|metastatic
615635|NCT00642746|Colorectal|colorectal
615636|NCT00642759|NSCLC|nsclc
615637|NCT00642759|Abraxane|abraxane
615638|NCT00642759|Carboplatin|carboplatin
615639|NCT00642759|Bevacizumab|bevacizumab
615640|NCT00642759|Avastin|avastin
615641|NCT00642772|Osteoarthritis|osteoarthritis
615642|NCT00642772|Veterans|veterans
615643|NCT00642772|Physical Therapy|physical therapy
615644|NCT00642772|Health Services Research|health services research
615645|NCT00642785|herpes|herpes
615646|NCT00642785|HSV|hsv
615647|NCT00642785|zoster|zoster
615648|NCT00642785|HZV|hzv
615649|NCT00642785|shingles|shingles
615650|NCT00642811|coronary artery disease (CAD)|coronary artery disease (cad)
615651|NCT00642811|heart attack|heart attack
615652|NCT00642811|stable angina|stable angina
615653|NCT00642837|Health-Related Quality of Life|health-related quality of life
615654|NCT00642837|KEQ-5D|keq-5d
615655|NCT00642837|Sleep disturbance|sleep disturbance
615656|NCT00642837|Sleep quality|sleep quality
615657|NCT00642837|SF-1|sf-1
615658|NCT00642837|Pain intensity|pain intensity
615659|NCT00642837|Pain relief|pain relief
615660|NCT00642837|Tramadol|tramadol
615661|NCT00642837|Acetaminophen|acetaminophen
615662|NCT00635297|osteoporosis|osteoporosis
615663|NCT00635297|vertebroplasty|vertebroplasty
615664|NCT00635297|prophylactic|prophylactic
615665|NCT00635297|vertebrae|vertebrae
615666|NCT00635297|fracture|fracture
615667|NCT00635310|Chronic hepatitis C|chronic hepatitis c
615668|NCT00635310|Chronic hepatitis B|chronic hepatitis b
615669|NCT00635310|Liver biopsy|liver biopsy
615670|NCT00635310|Hemodialysis|hemodialysis
615671|NCT00635310|1-Deamino-8- D-Arginine Vasopressin|1-deamino-8- d-arginine vasopressin
615672|NCT00635336|Epitope peptide|epitope peptide
615673|NCT00635336|CTL|ctl
615674|NCT00635336|Advanced bladder cancer|advanced bladder cancer
615675|NCT00635336|Vaccination|vaccination
615676|NCT00635336|advanced bladder cancer which showed resistance for standard treatments|advanced bladder cancer which showed resistance for standard treatments
615677|NCT00635349|WOMAC|womac
615678|NCT00635349|Knee osteoarthritis pain|knee osteoarthritis pain
615679|NCT00635349|Pain intensity|pain intensity
615680|NCT00635349|Tramadol|tramadol
615681|NCT00635349|Acetaminophen|acetaminophen
615682|NCT00635349|Meloxicam|meloxicam
615683|NCT00635349|Aceclofenac|aceclofenac
615684|NCT00635362|Contraception|contraception
615685|NCT00635362|Contraceptive Devices|contraceptive devices
615686|NCT00635362|Intrauterine Devices|intrauterine devices
615687|NCT00635362|Unplanned Pregnancy|unplanned pregnancy
615688|NCT00635362|Postpartum Period|postpartum period
615689|NCT00635414|Gastroesophageal Reflux Disease (GERD), esomeprazole, Nexium|gastroesophageal reflux disease (gerd), esomeprazole, nexium
615690|NCT00635427|VPRIV|vpriv
615691|NCT00635427|Enzyme Replacement Therapy|enzyme replacement therapy
615692|NCT00635427|Gaucher disease|gaucher disease
615693|NCT00635427|glucocerebrosidase|glucocerebrosidase
615694|NCT00635427|beta-glucocerebrosidase|beta-glucocerebrosidase
615695|NCT00635427|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
615696|NCT00635427|glucosylceramidase|glucosylceramidase
615697|NCT00635427|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
615698|NCT00635427|gene activation|gene activation
615699|NCT00635427|human|human
615700|NCT00635440|skeletal muscle|skeletal muscle
615701|NCT00635440|ubiquitin|ubiquitin
615702|NCT00635440|proteasome|proteasome
615703|NCT00635440|IGF-1|igf-1
615704|NCT00635440|MGF|mgf
615705|NCT00635440|protein catabolism|protein catabolism
615706|NCT00635440|neuromuscular electrical stimulation|neuromuscular electrical stimulation
617982|NCT00654433|MLD|mld
615707|NCT00635440|Investigate effect of NMES on muscle metabolism of catabolic patients|investigate effect of nmes on muscle metabolism of catabolic patients
615708|NCT00635453|Breast Feeding|breast feeding
615709|NCT00635453|Child|child
615710|NCT00635453|Infant Nutrition Physiology|infant nutrition physiology
615711|NCT00635453|Public Health|public health
615712|NCT00635453|Morbidity|morbidity
615713|NCT00635453|Health Plan Implementation|health plan implementation
615714|NCT00635466|laparoscopic surgery, rectal carcinoma, phase II trial|laparoscopic surgery, rectal carcinoma, phase ii trial
615715|NCT00635479|Fractures|fractures
615716|NCT00635479|Pelvic bones|pelvic bones
615717|NCT00635479|Acetabulum|acetabulum
615718|NCT00635479|Hip bones|hip bones
615719|NCT00635492|diabetes|diabetes
615720|NCT00635492|insulin|insulin
615721|NCT00635492|exenatide|exenatide
615722|NCT00635492|Byetta|byetta
615723|NCT00635492|Amylin|amylin
615724|NCT00635492|Lilly|lilly
615725|NCT00635505|Asthma|asthma
615726|NCT00635505|albuterol|albuterol
615727|NCT00635505|HFA|hfa
615728|NCT00635518|Health Plan Implementation|health plan implementation
615729|NCT00635518|Feeding and Eating Disorders of Childhood|feeding and eating disorders of childhood
615730|NCT00635518|Breast Feeding|breast feeding
615731|NCT00635518|Overweight|overweight
615732|NCT00635518|Child|child
615733|NCT00635518|Infant Nutrition Physiology|infant nutrition physiology
615734|NCT00635518|Public Health|public health
615735|NCT00635544|Adolescence|adolescence
615736|NCT00635544|Overweight|overweight
615737|NCT00635544|Dietary Fiber|dietary fiber
615738|NCT00635544|Glycemic Index|glycemic index
615739|NCT00635544|Healthy lifestyle|healthy lifestyle
615740|NCT00635557|Recurrent|recurrent
615741|NCT00635557|Relapsed|relapsed
615742|NCT00635557|Glioblastoma|glioblastoma
615743|NCT00635557|Multiforme|multiforme
615744|NCT00635570|Contraception, Compliance, Acceptability|contraception, compliance, acceptability
615745|NCT00635583|Bone|bone
615746|NCT00635583|Dairy Intervention|dairy intervention
615747|NCT00635583|Girls|girls
615748|NCT00635583|Boys|boys
615749|NCT00635583|Calcium|calcium
615750|NCT00635583|Bone Mineralization|bone mineralization
615751|NCT00635583|Peak Bone Mass|peak bone mass
615752|NCT00635583|Bone and Bones|bone and bones
615753|NCT00635583|Female|female
615754|NCT00635583|Male|male
615755|NCT00635583|Adolescent|adolescent
615756|NCT00635583|Healthy|healthy
615757|NCT00635596|MT110|mt110
615758|NCT00635596|solid tumors|solid tumors
615759|NCT00635596|phase I|phase i
615760|NCT00635596|BiTE|bite
615761|NCT00635596|bispecific T-cell engager|bispecific t-cell engager
615762|NCT00635622|Bacterial Vaginosis|bacterial vaginosis
615763|NCT00635622|BV|bv
615764|NCT00635622|UCSF|ucsf
615765|NCT00635622|SFGH|sfgh
615766|NCT00635635|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
615767|NCT00635635|Anxiety,|anxiety,
615768|NCT00635635|Depression,|depression,
615769|NCT00635635|Guided Imagery|guided imagery
615770|NCT00635635|Military Sexual Trauma|military sexual trauma
615771|NCT00642863|iron deficiency|iron deficiency
615772|NCT00642863|iron deficiency anemia|iron deficiency anemia
615773|NCT00642863|infant|infant
615776|NCT00642889|Parkinson's disease|parkinson's disease
615777|NCT00642902|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
615778|NCT00642902|Atacicept|atacicept
615779|NCT00642928|Excessive Daytime Sleepiness|excessive daytime sleepiness
615780|NCT00642928|Parkinson's disease|parkinson's disease
615781|NCT00642980|Pregnancy|pregnancy
615782|NCT00642980|Preterm delivery|preterm delivery
615783|NCT00642980|Bacterial vaginosis|bacterial vaginosis
615784|NCT00642980|Randomized Clinical Trial|randomized clinical trial
615785|NCT00642980|Clindamycin|clindamycin
615786|NCT00643006|Fibromyalgia|fibromyalgia
615787|NCT00643006|Physical activity|physical activity
615788|NCT00643006|Function|function
615789|NCT00643006|Pain|pain
615790|NCT00643006|Exercise|exercise
615791|NCT00643006|Inflammation|inflammation
615792|NCT00643019|Sexually Transmitted Infections|sexually transmitted infections
615793|NCT00643019|Secondary Prevention|secondary prevention
615794|NCT00643019|Cognitive Behavioral Intervention|cognitive behavioral intervention
615795|NCT00643045|Parkinson Disease|parkinson disease
615796|NCT00643058|LPS endotoxin|lps endotoxin
615797|NCT00643071|Ulcerative colitis|ulcerative colitis
615798|NCT00643071|Tacrolimus|tacrolimus
615799|NCT00643071|FK506|fk506
615800|NCT00643071|Treatment outcome|treatment outcome
615801|NCT00643084|Colorectal|colorectal
615802|NCT00643084|Bowel preparation|bowel preparation
615803|NCT00643084|Laparoscopic surgery|laparoscopic surgery
615804|NCT00643097|adult giant cell glioblastoma|adult giant cell glioblastoma
615805|NCT00643097|adult gliosarcoma|adult gliosarcoma
615806|NCT00643097|adult glioblastoma|adult glioblastoma
615807|NCT00643110|Hypoglycemia|hypoglycemia
615808|NCT00643123|Bipolar Disorder|bipolar disorder
615809|NCT00643123|Mania|mania
615810|NCT00643123|Mixed mania|mixed mania
615811|NCT00643123|Allopurinol|allopurinol
615812|NCT00643123|Treatment-Resistant mania|treatment-resistant mania
615813|NCT00643162|Depression|depression
615814|NCT00643162|Massage|massage
615815|NCT00643162|Lexapro|lexapro
615816|NCT00643162|Alternative Therapy|alternative therapy
615817|NCT00643162|Anti-depressant|anti-depressant
615818|NCT00643175|The main objective is to have an endocrinologist treat osteoporosis in patients with fragility hip fractures.|the main objective is to have an endocrinologist treat osteoporosis in patients with fragility hip fractures.
615819|NCT00645450|Stress|stress
615820|NCT00645450|Posttraumatic|posttraumatic
615821|NCT00645450|PTSD|ptsd
615822|NCT00645450|Propranolol|propranolol
615823|NCT00645450|Treatment|treatment
615824|NCT00645476|DSM-IV diagnostic criteria for any bipolar disorder (type I, type II, and NOS)|dsm-iv diagnostic criteria for any bipolar disorder (type i, type ii, and nos)
615825|NCT00645476|(diagnosed with the use of the Structured Clinical Interview for DSM-IV-TR Mood Module (SCID Mood Module)|(diagnosed with the use of the structured clinical interview for dsm-iv-tr mood module (scid mood module)
615826|NCT00645489|heart failure intervention|heart failure intervention
615827|NCT00645502|Schizophrenia|schizophrenia
615828|NCT00645502|Risperidone|risperidone
615829|NCT00645502|Orally-disintegrating tablet|orally-disintegrating tablet
615830|NCT00645502|Bioequivalence|bioequivalence
615831|NCT00645528|insulin|insulin
615832|NCT00645528|teaching|teaching
615833|NCT00645541|Breast Cancer|breast cancer
615834|NCT00645541|Carcinoma of the Breast|carcinoma of the breast
615835|NCT00645541|Lymph Nodes|lymph nodes
615836|NCT00645541|Lymphazurin|lymphazurin
615837|NCT00645541|Axillary Reverse Mapping|axillary reverse mapping
615838|NCT00645554|Galantamine oral solution|galantamine oral solution
615839|NCT00645554|Galantamine tablet|galantamine tablet
615840|NCT00645554|Bioequivalence|bioequivalence
615841|NCT00645567|Biomechanics|biomechanics
615842|NCT00645567|Ergonomics|ergonomics
615843|NCT00645567|Spinal Cord Injury|spinal cord injury
615844|NCT00645567|Pain|pain
615845|NCT00645567|Shoulder|shoulder
615846|NCT00645593|Bladder Cancer|bladder cancer
616069|NCT00646360|prenatal nutrition, DHA|prenatal nutrition, dha
615847|NCT00645606|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
615848|NCT00645606|Maintenance in first-line treatment|maintenance in first-line treatment
615849|NCT00645606|Elderly patients|elderly patients
615850|NCT00645619|Pneumonia,viral|pneumonia,viral
616107|NCT00646555|VEGF|vegf
615851|NCT00645619|Pneumonia,bacterial|pneumonia,bacterial
615852|NCT00645619|TREM-1 protein,human|trem-1 protein,human
615853|NCT00645632|localized osteosarcoma|localized osteosarcoma
615854|NCT00645645|Holoprosencephaly|holoprosencephaly
615855|NCT00645645|Agenesis of Corpus|agenesis of corpus
615856|NCT00645645|Callosum|callosum
615857|NCT00645645|Genetic Tests|genetic tests
615858|NCT00645684|Gastrointestinal Anastomosis|gastrointestinal anastomosis
615859|NCT00645684|Multicentre|multicentre
615860|NCT00645684|Randomized controlled single-blind study|randomized controlled single-blind study
615861|NCT00645684|synthetic, absorbable, braided and coated suture material|synthetic, absorbable, braided and coated suture material
615862|NCT00645684|Laparotomy|laparotomy
615863|NCT00645697|tuberculosis|tuberculosis
615864|NCT00645697|Multifocal serpiginous choroiditis|multifocal serpiginous choroiditis
615865|NCT00645697|histoplasmosis|histoplasmosis
615866|NCT00645697|Harada toxoplasmosis|harada toxoplasmosis
615867|NCT00645723|Acinetobacter baumanii|acinetobacter baumanii
615868|NCT00645723|Ventilator-associated pneumonia|ventilator-associated pneumonia
615869|NCT00645736|Chronic Hepatitis B|chronic hepatitis b
615870|NCT00645762|Chronic rhinosinusitis|chronic rhinosinusitis
615871|NCT00645762|Chronic sinusitis|chronic sinusitis
615872|NCT00645762|Maxillary sinus|maxillary sinus
615873|NCT00645762|Anterior ethmoid sinus|anterior ethmoid sinus
615874|NCT00645762|Ethmoid infundibulum|ethmoid infundibulum
615875|NCT00645762|Balloon dilation|balloon dilation
615876|NCT00645762|Endoscopic visualization|endoscopic visualization
615877|NCT00645762|Local anesthesia|local anesthesia
615878|NCT00645762|Canine fossa|canine fossa
615879|NCT00645762|Less invasive|less invasive
615880|NCT00645775|Weight loss|weight loss
615881|NCT00645775|Antiobesity|antiobesity
615882|NCT00645775|Metabolic syndrome|metabolic syndrome
615884|NCT00645788|Ciprofloxacin|ciprofloxacin
615885|NCT00645788|cystic fibrosis|cystic fibrosis
615886|NCT00645788|sweat test|sweat test
615887|NCT00645788|pulmonary function test|pulmonary function test
615888|NCT00645801|Routine screening colonoscopy|routine screening colonoscopy
615889|NCT00645801|Colonoscopy Preparation|colonoscopy preparation
615890|NCT00645801|Amitiza|amitiza
615891|NCT00645801|GoLYTELY|golytely
615892|NCT00645801|Pegylated Electrolytes|pegylated electrolytes
615893|NCT00645801|Preparation Solution|preparation solution
615894|NCT00645801|Colonoscopy Solution|colonoscopy solution
615895|NCT00645827|Insulin|insulin
615896|NCT00645827|Blood Glucose|blood glucose
615897|NCT00645840|Type 1 diabetes mellitus|type 1 diabetes mellitus
615898|NCT00645840|IL1 beta|il1 beta
615899|NCT00645840|Anakinra|anakinra
615900|NCT00645866|stage IIIA breast cancer|stage iiia breast cancer
615901|NCT00645866|stage IIIB breast cancer|stage iiib breast cancer
615902|NCT00645866|stage IIIC breast cancer|stage iiic breast cancer
615903|NCT00645879|Propionic Acidemia|propionic acidemia
615904|NCT00645879|hyperammonemia|hyperammonemia
615905|NCT00645879|hypotonia|hypotonia
615906|NCT00645879|glutamine|glutamine
615907|NCT00645879|ornithine alpha ketoglutarate|ornithine alpha ketoglutarate
615908|NCT00645879|citrate|citrate
615909|NCT00645918|Platelets|platelets
615910|NCT00645918|Platelet Function Tests|platelet function tests
615911|NCT00645918|Clopidogrel|clopidogrel
615912|NCT00645918|Drug Eluting Stents|drug eluting stents
615913|NCT00645918|Acute Coronary Syndrome|acute coronary syndrome
615914|NCT00645918|Myocardial Ischemia|myocardial ischemia
615915|NCT00645918|Stent Thrombosis|stent thrombosis
615916|NCT00645918|Heart Diseases|heart diseases
615917|NCT00645918|Coronary Disease|coronary disease
615918|NCT00645918|Arterial Occlusive Disease|arterial occlusive disease
615919|NCT00645931|Bone Marrow|bone marrow
615920|NCT00645931|Bone Marrow Transplant|bone marrow transplant
615921|NCT00645931|Pediatric|pediatric
615922|NCT00645931|Psychological Impact|psychological impact
615923|NCT00645931|Psychology|psychology
615924|NCT00645957|drainage|drainage
615925|NCT00645957|irrigation|irrigation
615926|NCT00645970|chronic pain|chronic pain
615927|NCT00645970|combat injuries|combat injuries
615928|NCT00645970|pain assessment|pain assessment
615929|NCT00645970|multiple traumas|multiple traumas
615930|NCT00645970|rehabilitation|rehabilitation
615931|NCT00645983|Chamomile|chamomile
615932|NCT00645983|Anxiety|anxiety
615933|NCT00645983|Complementary and Alternative Medicine|complementary and alternative medicine
615934|NCT00645996|Probiotics|probiotics
615935|NCT00645996|vaccines|vaccines
615936|NCT00645996|Measles|measles
615937|NCT00645996|Mumps|mumps
615938|NCT00645996|Rubella|rubella
615939|NCT00646009|asthma|asthma
615940|NCT00646009|adults|adults
615941|NCT00646009|Symbicort|symbicort
615942|NCT00646009|budesonide/formoterol|budesonide/formoterol
615943|NCT00646009|Advair Diskus|advair diskus
615944|NCT00646009|Ventolin|ventolin
615945|NCT00646022|Neuroendocrine|neuroendocrine
615946|NCT00646022|PET|pet
615947|NCT00646022|Gastrointestinal|gastrointestinal
615948|NCT00646022|Serotonin|serotonin
615949|NCT00646022|Carcinoid Tumor|carcinoid tumor
752353|NCT01172613|allergic rhinitis|allergic rhinitis
616108|NCT00646555|Microvessel Density|microvessel density
615950|NCT00646022|Gastrointestinal Carcinoid Tumor|gastrointestinal carcinoid tumor
615951|NCT00646022|Familial Cancer Tumor|familial cancer tumor
615952|NCT00646048|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
615953|NCT00646048|AAA|aaa
615954|NCT00646048|TriVascular Stent-Graft System|trivascular stent-graft system
615955|NCT00646048|Stent-Graft|stent-graft
615956|NCT00646061|renal colic|renal colic
615957|NCT00646074|Caregiver|caregiver
615958|NCT00646074|Alzheimer's disease|alzheimer's disease
615959|NCT00646074|Caregiving as experienced by older adults caring for a spouse with Alzheimer's disease or dementia|caregiving as experienced by older adults caring for a spouse with alzheimer's disease or dementia
615960|NCT00646100|hepatocellular carcinoma|hepatocellular carcinoma
615961|NCT00646100|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
615962|NCT00646100|prospective control study|prospective control study
615963|NCT00646100|best support care|best support care
615964|NCT00646100|survival|survival
615965|NCT00646139|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
615966|NCT00646139|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
615967|NCT00646139|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
616070|NCT00646373|Cardiac surgery|cardiac surgery
615968|NCT00646139|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
615969|NCT00646139|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
615970|NCT00646139|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
615971|NCT00646139|anaplastic large cell lymphoma|anaplastic large cell lymphoma
615972|NCT00646139|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
615973|NCT00646139|splenic marginal zone lymphoma|splenic marginal zone lymphoma
615974|NCT00646139|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
615975|NCT00646139|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
615976|NCT00646139|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
615977|NCT00646139|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
615978|NCT00646139|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
615979|NCT00646139|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
615980|NCT00646139|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
615981|NCT00646139|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
615982|NCT00646139|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
615983|NCT00646139|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
615984|NCT00646139|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
615985|NCT00646139|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
751792|NCT01170468|Prediabetics|prediabetics
615986|NCT00646139|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
615987|NCT00646139|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
615988|NCT00646139|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
615989|NCT00646139|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
615990|NCT00646139|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
615991|NCT00646139|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
615992|NCT00646139|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
615993|NCT00646139|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
615994|NCT00646139|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
615995|NCT00646139|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
615996|NCT00646139|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
615997|NCT00646139|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
615998|NCT00646139|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
615999|NCT00646139|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
616000|NCT00646139|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
616001|NCT00646139|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
616002|NCT00646139|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
616003|NCT00646139|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
616004|NCT00646139|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
616005|NCT00646139|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
616006|NCT00646139|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
616007|NCT00646139|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
616008|NCT00646139|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
616009|NCT00646139|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
616010|NCT00646139|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
616011|NCT00646139|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
616012|NCT00646139|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
616013|NCT00646139|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
617197|NCT00651755|AD|ad
616014|NCT00646139|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
616015|NCT00646139|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
616016|NCT00646139|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
616017|NCT00646139|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
616018|NCT00646139|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
616019|NCT00646139|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
616869|NCT00650507|SHAM|sham
616020|NCT00646139|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
616021|NCT00646139|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
616022|NCT00646139|intraocular lymphoma|intraocular lymphoma
616023|NCT00646139|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
616024|NCT00646139|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
616025|NCT00646139|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
616026|NCT00646139|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
616027|NCT00646139|small intestine lymphoma|small intestine lymphoma
616028|NCT00646152|Antiviral|antiviral
616029|NCT00646152|Influenza|influenza
616033|NCT00646152|Healthy Volunteer|healthy volunteer
616035|NCT00646165|Leukemia, CLL|leukemia, cll
616036|NCT00646204|Parkinson's disease|parkinson's disease
616037|NCT00646204|non-motor symptoms|non-motor symptoms
616038|NCT00646217|SELF Care Talk|self care talk
616039|NCT00646217|stroke|stroke
616040|NCT00646217|caregivers|caregivers
616041|NCT00646217|Caregiving as experienced by older adults caring for a spouse/partner with a first-ever stroke|caregiving as experienced by older adults caring for a spouse/partner with a first-ever stroke
616042|NCT00646230|recurrent neuroblastoma|recurrent neuroblastoma
616043|NCT00646243|Heart failure|heart failure
616044|NCT00646243|echocardiography|echocardiography
616045|NCT00646243|cardiac resynchronization therapy|cardiac resynchronization therapy
616046|NCT00646243|left ventricular dyssynchrony|left ventricular dyssynchrony
616047|NCT00646256|schizoaffective|schizoaffective
616048|NCT00646256|schizotypal|schizotypal
616049|NCT00646269|Dementia ; Alzheimer's Disease ; Non pharmacological treatments ; cognitive training ; reminiscence therapy ; efficacy assessment|dementia ; alzheimer's disease ; non pharmacological treatments ; cognitive training ; reminiscence therapy ; efficacy assessment
616050|NCT00646295|TRO|tro
616051|NCT00646308|growth hormone deficiency, pituitary tumors|growth hormone deficiency, pituitary tumors
616052|NCT00646321|asthma|asthma
616053|NCT00646321|children|children
616054|NCT00646321|adolescents|adolescents
616055|NCT00646321|Symbicort|symbicort
616056|NCT00646321|budesonide/ formoterol|budesonide/ formoterol
616057|NCT00646321|budesonide|budesonide
616058|NCT00646334|Large Pore Size Propylene Mesh|large pore size propylene mesh
616059|NCT00646334|Incisional Hernia|incisional hernia
616060|NCT00646334|Randomized Controlled Double-blind Study|randomized controlled double-blind study
616061|NCT00646347|stroke|stroke
616062|NCT00646347|upper limb rehabilitation|upper limb rehabilitation
616063|NCT00646347|treatment|treatment
616064|NCT00646347|movement recovery from sever paralytic upper limb|movement recovery from sever paralytic upper limb
616065|NCT00646347|neuro hand orthosis|neuro hand orthosis
616066|NCT00646347|self practice program|self practice program
616067|NCT00646347|subacute|subacute
616068|NCT00646360|birth size, gestational age, development, child growth,|birth size, gestational age, development, child growth,
616071|NCT00646373|Pump prime|pump prime
616072|NCT00646373|Blood transfusions|blood transfusions
616073|NCT00646399|Staphylococcal|staphylococcal
616074|NCT00646399|Coagulase Negative Staphylococcus|coagulase negative staphylococcus
616075|NCT00646399|Monoclonal antibodies|monoclonal antibodies
616076|NCT00646399|Very Low Birth Weight Infants|very low birth weight infants
616077|NCT00646399|Prophylaxis|prophylaxis
616078|NCT00646412|randomized, controlled, single-blind study|randomized, controlled, single-blind study
616079|NCT00646412|Adhesion Prophylaxis|adhesion prophylaxis
616080|NCT00646412|Abdominal Surgery|abdominal surgery
616081|NCT00646412|Laparotomy, median|laparotomy, median
616082|NCT00646425|Non-infectious uveitis|non-infectious uveitis
616083|NCT00646438|Diabetes|diabetes
616084|NCT00646438|CABG|cabg
616085|NCT00646451|Essential tremor|essential tremor
616086|NCT00646451|Activities of Daily Living (ADL's)|activities of daily living (adl's)
616088|NCT00646464|ADHD|adhd
616089|NCT00646490|serum, pleural effusion, procalcitonin, pneumonia|serum, pleural effusion, procalcitonin, pneumonia
616090|NCT00646503|Hepatitis B, Chronic|hepatitis b, chronic
616091|NCT00646503|Telbivudine|telbivudine
616092|NCT00646503|Polymerase Chain reaction|polymerase chain reaction
616093|NCT00646516|Asthma|asthma
616094|NCT00646516|inhaled corticosteroids|inhaled corticosteroids
616095|NCT00646516|Symbicort|symbicort
616096|NCT00646516|budesonide/formoterol|budesonide/formoterol
616097|NCT00646516|budesonide|budesonide
616098|NCT00646529|asthma|asthma
616099|NCT00646529|children|children
616100|NCT00646529|Symbicort|symbicort
616101|NCT00646529|budesonide/formoterol|budesonide/formoterol
616102|NCT00646529|Pulmicort|pulmicort
616103|NCT00646529|budesonide|budesonide
616104|NCT00646542|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
616105|NCT00646555|Tissue Samples|tissue samples
616106|NCT00646555|VEGF Receptors|vegf receptors
616109|NCT00646555|Hypoxia Inducible Factor|hypoxia inducible factor
616110|NCT00646555|Inflammatory Breast Cancer|inflammatory breast cancer
616111|NCT00646555|IBC|ibc
616112|NCT00646568|IVF|ivf
616113|NCT00646568|ovarian reserve|ovarian reserve
616114|NCT00646568|androgens|androgens
616115|NCT00646568|thecal cells|thecal cells
616116|NCT00646568|Fertility Agents, Female|fertility agents, female
616117|NCT00646581|Schizophrenia|schizophrenia
616118|NCT00646581|Memory|memory
616119|NCT00646581|Concentration|concentration
616120|NCT00646581|Insulin|insulin
616121|NCT00646594|Asthma|asthma
616122|NCT00646594|inhaled cortocisteroids|inhaled cortocisteroids
616123|NCT00646594|Symbicort|symbicort
616124|NCT00646594|budesonide/formoterol|budesonide/formoterol
616125|NCT00646594|Advair|advair
616126|NCT00646594|fluticasone/salmeterol|fluticasone/salmeterol
616127|NCT00646607|colorectal neoplasm|colorectal neoplasm
616128|NCT00646607|high risk|high risk
616129|NCT00646607|stage II/III|stage ii/iii
616131|NCT00646620|bronchodilatation|bronchodilatation
616132|NCT00646620|Symbicort|symbicort
616133|NCT00646620|budesonide/formoterol|budesonide/formoterol
616134|NCT00646620|Advair Diskus|advair diskus
616135|NCT00646620|Ventolin|ventolin
616136|NCT00646633|Cancer|cancer
616137|NCT00646633|Acupuncture|acupuncture
616138|NCT00646646|Sedation|sedation
616139|NCT00646646|Eye Movements|eye movements
616140|NCT00646659|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
616141|NCT00646659|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
616142|NCT00646659|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
616143|NCT00646659|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
616144|NCT00646659|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
616145|NCT00646659|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
616146|NCT00646659|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
616147|NCT00646659|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
616148|NCT00646659|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
616149|NCT00646672|ECMO|ecmo
616150|NCT00646672|Cerebral Perfusion|cerebral perfusion
616151|NCT00646672|Carotid Artery|carotid artery
616152|NCT00646672|Aneurysm|aneurysm
616153|NCT00646672|Cerebral Circulation|cerebral circulation
616154|NCT00646672|Common Carotid Artery Occlusion|common carotid artery occlusion
616155|NCT00646698|VLDL-TG kinetics|vldl-tg kinetics
616156|NCT00646698|Obesity|obesity
616157|NCT00646698|Body composition|body composition
616158|NCT00646698|Tracers|tracers
616159|NCT00646698|Tissue biopsies|tissue biopsies
616160|NCT00646724|Islets of Langerhans Transplantation|islets of langerhans transplantation
616161|NCT00646724|Mesenchymal Stem Cells|mesenchymal stem cells
616162|NCT00646724|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
616163|NCT00646737|Kidney transplantation|kidney transplantation
616164|NCT00646737|conversion|conversion
616165|NCT00646737|mycophenolate mofetil|mycophenolate mofetil
616166|NCT00646737|mycophenolate sodium,|mycophenolate sodium,
616167|NCT00646737|tacrolimus|tacrolimus
616168|NCT00646750|Z-BEAM|z-beam
616169|NCT00646750|Autologous|autologous
616170|NCT00646750|Lymphoma|lymphoma
616171|NCT00646750|GELTAMO|geltamo
616172|NCT00646815|insulin sensitivity|insulin sensitivity
616173|NCT00646815|substrate metabolism|substrate metabolism
616174|NCT00646815|fatty liver|fatty liver
616175|NCT00646815|intramyocellular lipids|intramyocellular lipids
616176|NCT00646815|growth hormone deficiency|growth hormone deficiency
616177|NCT00646815|Growth hormone deficiency (Adult)|growth hormone deficiency (adult)
616178|NCT00646828|Pseudohypoaldosteronism type 1|pseudohypoaldosteronism type 1
616179|NCT00646828|Mineralocorticoid receptor|mineralocorticoid receptor
616180|NCT00646828|Aldosterone|aldosterone
616181|NCT00646828|Cardiovascular disease|cardiovascular disease
616182|NCT00646841|Essential hypertension, doxazosin, ambulatory blood pressure monitoring|essential hypertension, doxazosin, ambulatory blood pressure monitoring
616183|NCT00646854|Lymphoma, T-Cell|lymphoma, t-cell
616184|NCT00646854|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
616185|NCT00646854|MabCampath|mabcampath
616186|NCT00646854|Campath|campath
616187|NCT00646854|CHOP-14|chop-14
616188|NCT00646854|CD52 expression|cd52 expression
616189|NCT00646867|Tetrix cream, contact dermatitis, effect on burning and itching|tetrix cream, contact dermatitis, effect on burning and itching
616190|NCT00646893|aneuploidy|aneuploidy
616191|NCT00646893|miscarriage|miscarriage
616192|NCT00646893|pregnancy loss|pregnancy loss
616193|NCT00646893|PGD|pgd
616194|NCT00646893|PGS|pgs
616195|NCT00646893|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
616196|NCT00646893|chromosome abnormalities|chromosome abnormalities
616197|NCT00646893|IVF|ivf
616198|NCT00646893|ART|art
616199|NCT00646906|acetaminophen|acetaminophen
616200|NCT00646906|low dose aspirin|low dose aspirin
616201|NCT00646906|cyclooxygenase|cyclooxygenase
616202|NCT00646906|prostaglandin|prostaglandin
616203|NCT00646906|drug interaction|drug interaction
616204|NCT00646906|platelet inhibition|platelet inhibition
617057|NCT00651547|Asthma|asthma
616205|NCT00646906|urinary prostaglandin metabolites|urinary prostaglandin metabolites
616206|NCT00646906|oxidant stress|oxidant stress
616208|NCT00646945|Patient in a oncology unit who has to undergo a painful or invasive procedure|patient in a oncology unit who has to undergo a painful or invasive procedure
616209|NCT00646971|Isoprostane|isoprostane
616210|NCT00646971|Alkane|alkane
616211|NCT00646971|Exhaled condensate|exhaled condensate
616212|NCT00646971|Peripheral arterial tonometry|peripheral arterial tonometry
616213|NCT00646971|Polysomnography|polysomnography
616214|NCT00646971|Obstructive Sleep Apnea|obstructive sleep apnea
616215|NCT00646971|Hypoxia|hypoxia
616216|NCT00646984|Lipodystrophy|lipodystrophy
616217|NCT00646984|Treatment interruption|treatment interruption
616218|NCT00646984|HIV|hiv
616219|NCT00646997|atrial fibrillation, left atrium, velocity vector imaging|atrial fibrillation, left atrium, velocity vector imaging
616220|NCT00647036|Parenteral nutrition, Infants, Dipeotiven, Microbial invasion|parenteral nutrition, infants, dipeotiven, microbial invasion
616221|NCT00647075|Breast cancer|breast cancer
616222|NCT00647075|undergoing|undergoing
616223|NCT00647075|adjuvant/neoadjuvant chemotherapy|adjuvant/neoadjuvant chemotherapy
616224|NCT00647075|symptomatic therapy|symptomatic therapy
616225|NCT00647088|Aortic Valve stenosis|aortic valve stenosis
616226|NCT00647088|Genetic|genetic
616227|NCT00647088|Mineralisation inhibitors|mineralisation inhibitors
616228|NCT00647114|Cancers expressing HER-2 and/or CEA|cancers expressing her-2 and/or cea
616229|NCT00647127|Buprenorphine|buprenorphine
616230|NCT00647127|Fentanyl|fentanyl
616231|NCT00647127|Analgesic effect|analgesic effect
616232|NCT00647127|Anti-hyperalgesic effect|anti-hyperalgesic effect
616233|NCT00647127|Experimental pain|experimental pain
616234|NCT00647140|Thyroid neoplasm|thyroid neoplasm
616235|NCT00647140|Thyroid carcinoma|thyroid carcinoma
616236|NCT00647140|Medullary carcinoma|medullary carcinoma
616237|NCT00647140|Positron Emission Tomography (PET)|positron emission tomography (pet)
616238|NCT00647140|18F-L DOPA|18f-l dopa
616239|NCT00647140|Calcitonin|calcitonin
616240|NCT00647140|Carcinoembryonic Antibodies|carcinoembryonic antibodies
616241|NCT00647140|Cervical ultrasonography|cervical ultrasonography
616242|NCT00647140|Cervical-chest-abdomen tomography|cervical-chest-abdomen tomography
616243|NCT00647140|Cervical-chest-abdomen magnetic resonance imaging|cervical-chest-abdomen magnetic resonance imaging
616244|NCT00647140|Osseous radionuclide imaging|osseous radionuclide imaging
616245|NCT00647140|Post-PET surgery|post-pet surgery
616246|NCT00647140|Post-PET biopsy|post-pet biopsy
616247|NCT00647140|Post-PET histology|post-pet histology
616248|NCT00647153|stage I colon cancer|stage i colon cancer
616249|NCT00647153|stage II colon cancer|stage ii colon cancer
616250|NCT00647153|stage III colon cancer|stage iii colon cancer
616251|NCT00647153|stage IV colon cancer|stage iv colon cancer
616252|NCT00647153|stage I rectal cancer|stage i rectal cancer
616253|NCT00647153|stage II rectal cancer|stage ii rectal cancer
616254|NCT00647153|stage III rectal cancer|stage iii rectal cancer
616255|NCT00647153|stage IV rectal cancer|stage iv rectal cancer
616256|NCT00647166|Vasculitis|vasculitis
616257|NCT00647166|Polyarteritis nodosa (PAN)|polyarteritis nodosa (pan)
616258|NCT00647166|Microscopic polyangiitis (MPA)|microscopic polyangiitis (mpa)
616259|NCT00647166|Eosinophilic granulomatosis with polyangiitis (EGPA)|eosinophilic granulomatosis with polyangiitis (egpa)
616260|NCT00647166|Churg Strauss syndrome (CSS)|churg strauss syndrome (css)
616261|NCT00647166|Azathioprine|azathioprine
616262|NCT00647179|Acromegaly|acromegaly
616263|NCT00647179|Growth Hormone|growth hormone
616264|NCT00647179|Insulin resistance|insulin resistance
616265|NCT00647179|Glucose tolerance|glucose tolerance
616266|NCT00647179|Body Composition|body composition
616267|NCT00647179|Substrate metabolism|substrate metabolism
616268|NCT00647192|atrial fibrillation|atrial fibrillation
616269|NCT00647192|electrical cardioversion|electrical cardioversion
616270|NCT00647192|prevention of atrial fibrillation recurrence|prevention of atrial fibrillation recurrence
616271|NCT00647192|mineralocorticoid receptor blocker|mineralocorticoid receptor blocker
616272|NCT00647192|eplerenone|eplerenone
616273|NCT00647192|Recurrence of atrial fibrillation after cardioversion|recurrence of atrial fibrillation after cardioversion
616274|NCT00647205|Interferon, gamma|interferon, gamma
616275|NCT00647205|HIV Infections|hiv infections
616276|NCT00647205|Tuberculosis|tuberculosis
616277|NCT00647218|stage II breast cancer|stage ii breast cancer
616278|NCT00647218|stage IIIA breast cancer|stage iiia breast cancer
616279|NCT00647218|stage IIIB breast cancer|stage iiib breast cancer
616280|NCT00647218|stage IIIC breast cancer|stage iiic breast cancer
616281|NCT00647231|Osteoarthritis,Knee,Ketoprofen,Pain,Patch,Analgesic|osteoarthritis,knee,ketoprofen,pain,patch,analgesic
616282|NCT00647244|Tenofovir|tenofovir
616283|NCT00647244|Abacavir|abacavir
616284|NCT00647244|Antiretroviral therapy|antiretroviral therapy
616286|NCT00647244|Nucleoside analogue reverse transcriptase inhibitor|nucleoside analogue reverse transcriptase inhibitor
616287|NCT00647257|Sick Sinus Syndrome; Atrial Fibrillation; Pacemaker|sick sinus syndrome; atrial fibrillation; pacemaker
616288|NCT00647283|Liver Transplantation|liver transplantation
616289|NCT00647283|Tolerance|tolerance
616290|NCT00647283|Allograft tolerance|allograft tolerance
616291|NCT00647283|Immunosuppression minimization|immunosuppression minimization
616292|NCT00647283|Immunosuppression weaning|immunosuppression weaning
616293|NCT00647283|Immunological tolerance|immunological tolerance
616294|NCT00647296|ALS|als
616295|NCT00647296|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
616296|NCT00647296|Lou Gehrig|lou gehrig
616297|NCT00647296|Lou Gehrig's|lou gehrig's
616298|NCT00647296|Lou Gehrig's disease|lou gehrig's disease
616299|NCT00647296|Motor Neuron Disease|motor neuron disease
616300|NCT00647296|Nervous System Diseases|nervous system diseases
616301|NCT00647296|KNS-760704|kns-760704
616302|NCT00647322|Intractable epilepsy, Drug Reduction, Antiepileptic medication|intractable epilepsy, drug reduction, antiepileptic medication
616303|NCT00647348|Secondary progressive Multiple Sclerosis|secondary progressive multiple sclerosis
616304|NCT00647348|Simvastatin|simvastatin
616305|NCT00647348|MRI|mri
616508|NCT00639054|mortality|mortality
616306|NCT00647361|respiratory insufficiency|respiratory insufficiency
616307|NCT00647361|respiration|respiration
616308|NCT00647361|ventilators|ventilators
616309|NCT00647361|diaphragm|diaphragm
616310|NCT00647361|electromyography|electromyography
616311|NCT00647361|mechanical ventilation|mechanical ventilation
616312|NCT00647387|muscular|muscular
616313|NCT00647387|ventricular|ventricular
616314|NCT00647387|septal|septal
616315|NCT00647387|defects|defects
616316|NCT00647387|VSD|vsd
616317|NCT00647400|Psoriasis|psoriasis
616318|NCT00647413|smoking|smoking
616319|NCT00647413|passive smoking|passive smoking
616320|NCT00647413|exposure to environmental smoke|exposure to environmental smoke
616321|NCT00647413|home smoking ban|home smoking ban
616322|NCT00647413|urinary cotinine|urinary cotinine
616323|NCT00647426|Stage IIIB/IV|stage iiib/iv
616324|NCT00647439|OCULAR INFLAMMATORY DISEASE|ocular inflammatory disease
616325|NCT00647439|Immune Mediated|immune mediated
616326|NCT00647439|Gene Expression Patterns|gene expression patterns
616327|NCT00647439|Diabetic Retinopathy|diabetic retinopathy
616328|NCT00647439|Age-Related Macular Degeneration|age-related macular degeneration
616329|NCT00647439|AMD|amd
616330|NCT00647439|Uveitis|uveitis
616331|NCT00647452|Lipid metabolism|lipid metabolism
616332|NCT00647452|VLDL|vldl
616333|NCT00647452|Exercise|exercise
616334|NCT00647452|Lipid metabolism in exercise|lipid metabolism in exercise
616335|NCT00647465|Influenza vaccine|influenza vaccine
616336|NCT00647465|interferon|interferon
616337|NCT00647465|adjuvant|adjuvant
616338|NCT00647465|the elderly|the elderly
616339|NCT00647478|Insulin-like Growth Factor|insulin-like growth factor
616340|NCT00647478|Insulin-like Growth Factor binding protein 3|insulin-like growth factor binding protein 3
616341|NCT00647478|Insulin-like Growth Factor-I system component levels|insulin-like growth factor-i system component levels
616342|NCT00647478|Insulin-like Growth Factor-I polymorphism|insulin-like growth factor-i polymorphism
616343|NCT00647478|Alzheimer's disease|alzheimer's disease
616344|NCT00647478|Mild Cognitive Impairment|mild cognitive impairment
616345|NCT00647478|Normal cognitive function|normal cognitive function
616346|NCT00647478|Observational cross sectional study|observational cross sectional study
616347|NCT00647504|stent thrombosis|stent thrombosis
616348|NCT00647504|stent restenosis|stent restenosis
616349|NCT00647504|intravascular ultrasound|intravascular ultrasound
616350|NCT00647530|adenocarcinoma of the colon|adenocarcinoma of the colon
616351|NCT00647530|stage I colon cancer|stage i colon cancer
616352|NCT00647530|stage II colon cancer|stage ii colon cancer
616353|NCT00647530|stage III colon cancer|stage iii colon cancer
616354|NCT00647569|vertical rectus abdominis musculocutaneus flap|vertical rectus abdominis musculocutaneus flap
616355|NCT00647569|mesh repair|mesh repair
616356|NCT00647569|salvage surgery|salvage surgery
616357|NCT00647582|stage I breast cancer|stage i breast cancer
616358|NCT00647582|stage II breast cancer|stage ii breast cancer
616359|NCT00647595|Obesity|obesity
616360|NCT00647595|Physical activity|physical activity
616361|NCT00647595|Pregnancy|pregnancy
616362|NCT00647595|Diabetes mellitus|diabetes mellitus
616363|NCT00647699|keratoconus|keratoconus
616364|NCT00647699|cross-linking|cross-linking
616365|NCT00647699|riboflavin|riboflavin
616366|NCT00647699|UVA light|uva light
616367|NCT00647699|cornea|cornea
616368|NCT00647725|Epidural analgesia|epidural analgesia
616369|NCT00647725|Latent analgesia|latent analgesia
616370|NCT00647725|Active analgesia|active analgesia
616371|NCT00647725|Labor delivery|labor delivery
616372|NCT00647790|PET imaging|pet imaging
616373|NCT00647790|invasive breast cancer|invasive breast cancer
616374|NCT00647829|pharyngitis, sore throat|pharyngitis, sore throat
616375|NCT00647868|pharmacokinetics|pharmacokinetics
616376|NCT00647868|testosterone|testosterone
616377|NCT00647868|hypogonadism|hypogonadism
616378|NCT00647933|Females|females
616379|NCT00647933|Corifollitropin alfa|corifollitropin alfa
616380|NCT00647933|Antibodies|antibodies
616381|NCT00647933|Pharmacokinetics|pharmacokinetics
616382|NCT00647933|Pharmacodynamics|pharmacodynamics
616383|NCT00647946|lipodystrophy|lipodystrophy
616384|NCT00638521|lipids|lipids
616385|NCT00638521|proteins|proteins
616386|NCT00638521|membrane|membrane
616387|NCT00638521|lipid raft|lipid raft
616388|NCT00638534|Acute Otitis Media|acute otitis media
616390|NCT00638534|children|children
616391|NCT00638534|Child|child
616392|NCT00638547|Hurler Syndrome|hurler syndrome
616393|NCT00638547|mucopolysaccharidosis type I|mucopolysaccharidosis type i
616394|NCT00638547|Iduronidase deficiency|iduronidase deficiency
616395|NCT00638560|PGC-1alpha|pgc-1alpha
616396|NCT00638560|PPARgamma|ppargamma
616397|NCT00638560|oxidative stress|oxidative stress
616398|NCT00638560|training intervention|training intervention
616399|NCT00638599|Intubation, intratracheal|intubation, intratracheal
616400|NCT00638599|Homeostasis|homeostasis
616401|NCT00638599|Mastectomy, modified radical|mastectomy, modified radical
616402|NCT00638599|Breast Neoplasms|breast neoplasms
616403|NCT00638612|Immunotherapy|immunotherapy
616404|NCT00638612|Gene Therapy|gene therapy
616405|NCT00638612|Cytotoxicity|cytotoxicity
616406|NCT00638612|Tumor vaccine|tumor vaccine
616407|NCT00638612|Radiation|radiation
616408|NCT00638612|Surgery|surgery
616409|NCT00638612|Chemoradiation|chemoradiation
616410|NCT00638625|Needle biopsy|needle biopsy
616411|NCT00638625|CT Scan|ct scan
616412|NCT00638625|Lung Tumor|lung tumor
616413|NCT00638625|Lung Mass|lung mass
616414|NCT00638638|Myocardial infarction|myocardial infarction
616415|NCT00638638|Angioplasty|angioplasty
616416|NCT00638638|Coronary stenting|coronary stenting
616417|NCT00638638|Abciximab|abciximab
616418|NCT00638638|Myocardial reperfusion|myocardial reperfusion
616419|NCT00638638|Microcirculation|microcirculation
616420|NCT00638638|EKG|ekg
616421|NCT00638638|ST elevation myocardial infarction within 6 h of symptom onset|st elevation myocardial infarction within 6 h of symptom onset
616422|NCT00638651|Tattoos|tattoos
616423|NCT00638651|Black/blue tattoos|black/blue tattoos
616424|NCT00638664|conventional pulse sequences for MR|conventional pulse sequences for mr
616425|NCT00638664|cardiac chambers and walls|cardiac chambers and walls
616426|NCT00638664|cardio-thoracic vasculature|cardio-thoracic vasculature
616427|NCT00638664|the great vessels|the great vessels
616428|NCT00638664|coronary vasculature|coronary vasculature
616429|NCT00638664|cardiac|cardiac
616430|NCT00638664|great vessels|great vessels
616431|NCT00638677|Oral microbiology|oral microbiology
616432|NCT00638690|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
616433|NCT00638690|CRPC|crpc
616434|NCT00638690|Abiraterone Acetate|abiraterone acetate
616435|NCT00638690|CB7630|cb7630
616436|NCT00638703|hyperoxaluria|hyperoxaluria
616437|NCT00638703|PH|ph
616438|NCT00638703|oxalate|oxalate
616439|NCT00638716|Type 2 Diabetes Mellitus, incretins, GLP-1, HbA1c, metformin|type 2 diabetes mellitus, incretins, glp-1, hba1c, metformin
616440|NCT00638729|bispectral index|bispectral index
616441|NCT00638729|sedation|sedation
616442|NCT00638729|stress hormones|stress hormones
616443|NCT00638729|cognitive function|cognitive function
616444|NCT00638742|Latanoprost Pediatrics Pharmacokinetics Safety|latanoprost pediatrics pharmacokinetics safety
616445|NCT00638755|Allergic Rhinitis|allergic rhinitis
616446|NCT00638755|Perennial Allergic Rhinitis|perennial allergic rhinitis
616447|NCT00638755|Allergies to perennial allergens|allergies to perennial allergens
616448|NCT00638755|Allergies to perennial allergens (e.g. dog, cat, dust mites, etc.)|allergies to perennial allergens (e.g. dog, cat, dust mites, etc.)
616449|NCT00638768|physical therapy|physical therapy
616450|NCT00638768|rehabilitation|rehabilitation
616451|NCT00638768|pain|pain
616452|NCT00638768|osteoporosis|osteoporosis
616453|NCT00638768|vertebral fracture|vertebral fracture
616454|NCT00638781|Acute ischemic stroke|acute ischemic stroke
616455|NCT00638794|Myocardial Infarction|myocardial infarction
616456|NCT00638794|Myocardial Ischemia|myocardial ischemia
616457|NCT00638820|osteopetrosis|osteopetrosis
616458|NCT00638833|Multiple Sclerosis|multiple sclerosis
616459|NCT00638846|toric contact lenses|toric contact lenses
616460|NCT00638846|vision|vision
616461|NCT00638846|comfort|comfort
616462|NCT00638846|toric fit characteristics|toric fit characteristics
616463|NCT00638846|slit lamp findings|slit lamp findings
616464|NCT00638859|Community-Acquired pneumonia|community-acquired pneumonia
616465|NCT00638859|CAP|cap
616466|NCT00638859|children|children
616467|NCT00638859|Child|child
616468|NCT00638872|diabetes|diabetes
616469|NCT00638872|foot ulcer|foot ulcer
616470|NCT00638872|polydeoxyribonucleotide|polydeoxyribonucleotide
616471|NCT00638885|PTSD|ptsd
616472|NCT00638885|hippocampus|hippocampus
616473|NCT00638885|twins|twins
616474|NCT00638924|healthy sedentary women|healthy sedentary women
616475|NCT00638950|n-3 LC-PUFA|n-3 lc-pufa
616476|NCT00638950|Rheumatoid arthritis|rheumatoid arthritis
616477|NCT00638950|disease activity|disease activity
616478|NCT00638950|inflammation|inflammation
616479|NCT00638950|oxidative stress|oxidative stress
616480|NCT00638950|immune system|immune system
616481|NCT00638976|Eptifibatide|eptifibatide
616482|NCT00638976|IV eptifibatide|iv eptifibatide
616483|NCT00638976|GP IIB/IIIA inhibitors|gp iib/iiia inhibitors
616484|NCT00638976|DES stent|des stent
616485|NCT00638989|Asthma|asthma
616486|NCT00638989|CAT-354|cat-354
616487|NCT00638989|Tralokinumab|tralokinumab
616488|NCT00638989|Healthy|healthy
616489|NCT00639015|Sepsis|sepsis
616490|NCT00639015|Septic Shock|septic shock
616491|NCT00639015|phenylephrine|phenylephrine
616492|NCT00639015|norepinephrine|norepinephrine
616493|NCT00639015|catecholamine|catecholamine
616494|NCT00639028|ankle|ankle
616495|NCT00639028|diagnosis|diagnosis
616496|NCT00639028|sprain|sprain
616497|NCT00639028|care|care
616498|NCT00639028|injury|injury
616499|NCT00639028|stress radiography|stress radiography
616500|NCT00639028|ultrasonography|ultrasonography
616501|NCT00639041|n-3 LC-PUFA|n-3 lc-pufa
616502|NCT00639041|hypertriglyceridemic|hypertriglyceridemic
616503|NCT00639041|human|human
616504|NCT00639041|TAG|tag
616505|NCT00639054|classification|classification
616506|NCT00639054|diagnosis|diagnosis
616507|NCT00639054|genetics|genetics
616510|NCT00639067|Cancer of Lung|cancer of lung
616511|NCT00639067|Cancer of the Lung|cancer of the lung
616512|NCT00639067|Lung Cancer|lung cancer
616513|NCT00639067|Neoplasms, Lung|neoplasms, lung
616514|NCT00639067|Neoplasms, Pulmonary|neoplasms, pulmonary
616515|NCT00639067|Pulmonary Cancer|pulmonary cancer
616516|NCT00639067|Pulmonary Neoplasms|pulmonary neoplasms
616517|NCT00639080|Type 2 diabetes|type 2 diabetes
616518|NCT00639080|Dyslipidemia|dyslipidemia
616519|NCT00639093|cigarette smoking|cigarette smoking
616520|NCT00639093|psychoeducational and motivational program|psychoeducational and motivational program
616521|NCT00639093|virtual reality|virtual reality
616522|NCT00639106|Breast expander|breast expander
616523|NCT00639106|Breast reconstruction|breast reconstruction
616524|NCT00639106|implants|implants
616525|NCT00639106|08-024|08-024
616526|NCT00639132|Natural History|natural history
616527|NCT00639132|Metachromatic Leukodystrophy|metachromatic leukodystrophy
616528|NCT00639132|Disease Progression|disease progression
616529|NCT00639145|HIV|hiv
616530|NCT00639145|Pregnancy|pregnancy
616531|NCT00639145|Antiretrovirals|antiretrovirals
616532|NCT00639145|HIV Seronegativity|hiv seronegativity
616533|NCT00639145|Treatment Experienced|treatment experienced
616534|NCT00639171|breast|breast
616535|NCT00639171|diagnostic radiology|diagnostic radiology
616536|NCT00639171|suspicious breast tumors|suspicious breast tumors
616537|NCT00639171|MRI|mri
616538|NCT00639184|asphyxia|asphyxia
616539|NCT00639184|neurodevelopmental outcome|neurodevelopmental outcome
616540|NCT00639184|home counseling|home counseling
618793|NCT00649883|children|children
618794|NCT00649909|Diabetes Mellitus|diabetes mellitus
618795|NCT00649909|Type II|type ii
618796|NCT00649909|Aspirin|aspirin
618797|NCT00649909|Resistance|resistance
618798|NCT00649922|Vaccines with adalimumab dosing|vaccines with adalimumab dosing
618799|NCT00649961|Premature Birth|premature birth
618800|NCT00649961|Brain injury|brain injury
616541|NCT00639197|Tunneling|tunneling
616542|NCT00639197|Short term|short term
616543|NCT00639197|central venous catheters|central venous catheters
616544|NCT00639197|Ultrasound Guided|ultrasound guided
616545|NCT00639197|Internal jugular|internal jugular
616546|NCT00639197|Assess safety and improve technical difficulty|assess safety and improve technical difficulty
616547|NCT00639210|breast cancer|breast cancer
616548|NCT00639210|exercise|exercise
616549|NCT00639210|osteoporosis|osteoporosis
616550|NCT00639210|fracture|fracture
616551|NCT00639210|quality of life|quality of life
616552|NCT00639223|Statin related myalgia|statin related myalgia
616553|NCT00639223|Hyperlipidemia|hyperlipidemia
616554|NCT00639223|Red yeast rice|red yeast rice
616555|NCT00639223|Cardiovascular Diseases|cardiovascular diseases
616556|NCT00639223|Nutritional and Metabolic Diseases|nutritional and metabolic diseases
616557|NCT00639236|COPD|copd
616558|NCT00639236|Hypertonic saline|hypertonic saline
616559|NCT00639236|Quality of life|quality of life
616560|NCT00639236|Dyspnoea.|dyspnoea.
616561|NCT00639262|Sorafenib|sorafenib
616562|NCT00639262|Radiation Therapy|radiation therapy
616563|NCT00639262|Radiotherapy|radiotherapy
616564|NCT00639262|Temozolomide|temozolomide
616565|NCT00639262|Brain Metastases|brain metastases
616566|NCT00639262|Brain Tumors|brain tumors
616567|NCT00639288|Alcohol Dependence|alcohol dependence
616568|NCT00639288|PTSD|ptsd
616569|NCT00639288|CPT-C|cpt-c
616570|NCT00639301|Survivor|survivor
616571|NCT00639301|Quality of Life|quality of life
616573|NCT00639314|pylorus-preserving pancreaticoduodenectomy|pylorus-preserving pancreaticoduodenectomy
616574|NCT00639314|pylorus-resecting pancreaticoduodenectomy|pylorus-resecting pancreaticoduodenectomy
616575|NCT00639314|randomized controlled trial|randomized controlled trial
616576|NCT00639314|delayed gastric empty|delayed gastric empty
616577|NCT00639314|quality of life|quality of life
616578|NCT00639327|Stomach Neoplasms|stomach neoplasms
616579|NCT00639327|Second line chemotherapy|second line chemotherapy
616580|NCT00639327|Refractory to S-1|refractory to s-1
616581|NCT00639327|irinotecan|irinotecan
616582|NCT00639327|S-1 and Irinotecan Combination|s-1 and irinotecan combination
616583|NCT00639327|Phase III study|phase iii study
616584|NCT00639366|recurrent breast cancer|recurrent breast cancer
616585|NCT00639366|stage IIIA breast cancer|stage iiia breast cancer
616586|NCT00639366|stage IIIB breast cancer|stage iiib breast cancer
616587|NCT00639366|stage IIIC breast cancer|stage iiic breast cancer
616588|NCT00639366|stage IV breast cancer|stage iv breast cancer
616589|NCT00639379|toric contact lenses|toric contact lenses
616590|NCT00639379|vision|vision
616591|NCT00639379|comfort|comfort
616592|NCT00639379|toric fit characteristics|toric fit characteristics
616593|NCT00639379|slit lamp findings|slit lamp findings
616594|NCT00639392|Sickle cell disease|sickle cell disease
616595|NCT00639405|Parathyroid|parathyroid
616596|NCT00639405|MRI|mri
616597|NCT00639405|SPECT|spect
616598|NCT00639431|phantom limb pain|phantom limb pain
616599|NCT00639431|limb amputation|limb amputation
616600|NCT00639431|Amputation|amputation
616601|NCT00639431|Phantom Limb|phantom limb
616602|NCT00639431|Pain|pain
616603|NCT00639457|PPAR-gamma agonist|ppar-gamma agonist
616604|NCT00639457|glucose metabolism|glucose metabolism
616605|NCT00639457|inflammation|inflammation
616606|NCT00639457|adipose tissue distribution|adipose tissue distribution
616607|NCT00639457|cardiac function|cardiac function
616608|NCT00639457|vascular function|vascular function
616609|NCT00639457|mass spectrometry|mass spectrometry
616610|NCT00639457|Treatment Experienced|treatment experienced
616611|NCT00639470|Patient Education Handout|patient education handout
616612|NCT00639470|Parents|parents
616613|NCT00639470|Patient Education|patient education
616614|NCT00639496|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
616615|NCT00639522|Liposomal paclitaxel|liposomal paclitaxel
616616|NCT00639522|Maximum tolerated dose|maximum tolerated dose
616617|NCT00639522|Pharmacokinetics|pharmacokinetics
616618|NCT00639522|Gastric carcinoma|gastric carcinoma
616619|NCT00639535|Radiology|radiology
616620|NCT00639535|MRI|mri
616621|NCT00639535|Positron emission tomography|positron emission tomography
616622|NCT00639535|Breast Abnormalities|breast abnormalities
616623|NCT00639535|Dense Breast Tissue|dense breast tissue
616624|NCT00639548|Deep Sedation|deep sedation
616625|NCT00639548|EEG|eeg
616626|NCT00639548|Event-Related Potentials|event-related potentials
616627|NCT00639548|Evoked potentials, auditory|evoked potentials, auditory
616628|NCT00639548|BIS-Index|bis-index
616629|NCT00639548|Entropy|entropy
616630|NCT00639548|ICU|icu
616631|NCT00639561|digestive system|digestive system
616632|NCT00639561|Diet|diet
616633|NCT00639574|Pain, morphine, nefopam, co analgesia, ureteral calculi, emergency|pain, morphine, nefopam, co analgesia, ureteral calculi, emergency
616634|NCT00639587|Cetirizine|cetirizine
616635|NCT00639587|Zyrtec|zyrtec
616636|NCT00639639|adult giant cell glioblastoma|adult giant cell glioblastoma
616637|NCT00639639|adult gliosarcoma|adult gliosarcoma
616638|NCT00639652|Carcinoma, Basal Cell|carcinoma, basal cell
616639|NCT00639652|3D-histology|3d-histology
616640|NCT00639652|Micrographic surgery|micrographic surgery
616641|NCT00639652|Mohs surgery|mohs surgery
616642|NCT00639652|Shave excision|shave excision
616643|NCT00639652|Recurrence|recurrence
616644|NCT00639652|Esthetic outcome|esthetic outcome
616645|NCT00639665|Cocoa, diabetes, polyphenols|cocoa, diabetes, polyphenols
616646|NCT00639678|healthy volunteers|healthy volunteers
616647|NCT00639691|Asthma, Anti-immunoglobin E, omalizumab|asthma, anti-immunoglobin e, omalizumab
616648|NCT00639704|MRI|mri
616649|NCT00639704|SPECT|spect
616650|NCT00639704|Cardiac function|cardiac function
616651|NCT00639717|GVHD|gvhd
616652|NCT00639730|Epilepsy|epilepsy
616653|NCT00639743|Pulmonary embolism|pulmonary embolism
616654|NCT00639743|Heparin|heparin
616655|NCT00639743|Thrombolytic therapy|thrombolytic therapy
616656|NCT00639743|Bleeding|bleeding
616657|NCT00639756|Uric acid|uric acid
616658|NCT00639756|Fructose|fructose
616659|NCT00639756|Hypertension|hypertension
616660|NCT00639756|Insulin|insulin
616661|NCT00639756|Glucose|glucose
616662|NCT00639756|HOMA|homa
616663|NCT00639769|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
616664|NCT00639769|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
616665|NCT00639769|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
616666|NCT00639769|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
616667|NCT00639769|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
616668|NCT00639769|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
616669|NCT00639769|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
616670|NCT00639769|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
616671|NCT00639769|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
616672|NCT00639769|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
616673|NCT00639769|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
616762|NCT00640081|stage IV colon cancer|stage iv colon cancer
616674|NCT00639769|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
616675|NCT00639769|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
616676|NCT00639769|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
616796|NCT00640263|lopinavir/ritonavir|lopinavir/ritonavir
616677|NCT00639769|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
616678|NCT00639769|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
616679|NCT00639769|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
616680|NCT00639769|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
616681|NCT00639769|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
616682|NCT00639769|recurrent salivary gland cancer|recurrent salivary gland cancer
616683|NCT00639769|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
616684|NCT00639769|stage IV salivary gland cancer|stage iv salivary gland cancer
616685|NCT00639782|thromboembolism|thromboembolism
616686|NCT00639782|mechanical heart valves|mechanical heart valves
616687|NCT00639782|randomized|randomized
616688|NCT00639795|Thoracic paravertebral block|thoracic paravertebral block
616689|NCT00639795|Cytokines|cytokines
616988|NCT00651248|Oral health|oral health
616690|NCT00639795|Video assisted thorascopic surgery|video assisted thorascopic surgery
616691|NCT00639795|Pain|pain
616692|NCT00639808|delayed gastric emptying|delayed gastric emptying
616693|NCT00639808|symptomatic gastroparesis|symptomatic gastroparesis
616694|NCT00639808|diabetes mellitus|diabetes mellitus
616695|NCT00639821|Gene expression microarray|gene expression microarray
616696|NCT00639821|Inflammatory bowel disease|inflammatory bowel disease
616697|NCT00639821|Infliximab|infliximab
616698|NCT00639834|rheumatoid|rheumatoid
616699|NCT00639834|arthritis|arthritis
616701|NCT00639834|joint inflammation|joint inflammation
616702|NCT00639834|autoimmune|autoimmune
616703|NCT00639834|Medarex|medarex
616704|NCT00639834|Rheumatology|rheumatology
616705|NCT00639847|Asthma management|asthma management
616706|NCT00639847|cost|cost
616707|NCT00639847|disease management|disease management
616708|NCT00639847|respiratory care|respiratory care
616709|NCT00639847|nursing|nursing
616710|NCT00639847|health care utilization|health care utilization
616711|NCT00639847|health related quality of life|health related quality of life
616712|NCT00639860|extraction|extraction
616713|NCT00639860|implant|implant
616714|NCT00639860|alveolar ridge preservation|alveolar ridge preservation
616715|NCT00639873|Uncomplicated P. falciparum malaria|uncomplicated p. falciparum malaria
616716|NCT00639899|Varicocele|varicocele
616717|NCT00639912|contrast induced nephropathy STEMI PCI|contrast induced nephropathy stemi pci
616718|NCT00639938|Pregnancy, High-Risk|pregnancy, high-risk
616719|NCT00639938|HIV Seronegativity|hiv seronegativity
616720|NCT00639951|Snake Bite|snake bite
616721|NCT00639951|Antivenin Treatment|antivenin treatment
616722|NCT00639964|diabetes|diabetes
616723|NCT00639964|pregnancy|pregnancy
616724|NCT00639964|macrosomia|macrosomia
616725|NCT00639964|lipidics markers|lipidics markers
616726|NCT00639964|nutritional factors|nutritional factors
616727|NCT00639964|placenta|placenta
616728|NCT00639964|umbilical blood cord|umbilical blood cord
616729|NCT00639977|Intraocular Pressure|intraocular pressure
616730|NCT00639977|Acupuncture|acupuncture
616731|NCT00639977|Healthy Volunteers|healthy volunteers
616732|NCT00639990|Intraabdominal pressure|intraabdominal pressure
616733|NCT00640003|AT|at
616734|NCT00640003|Ataxia|ataxia
616735|NCT00640003|Telangiectasia|telangiectasia
616736|NCT00640016|Asthma|asthma
616737|NCT00640016|CAT-354|cat-354
616738|NCT00640016|Tralokinumab|tralokinumab
616739|NCT00640029|Arthroplasty|arthroplasty
616740|NCT00640029|Arthrodesis|arthrodesis
616741|NCT00640029|Prosthesis|prosthesis
616742|NCT00640029|Disc replacement|disc replacement
616743|NCT00640029|Spine|spine
616744|NCT00640029|Lumbar|lumbar
616745|NCT00640029|Cervical|cervical
616746|NCT00640029|Intervertebral disk|intervertebral disk
616747|NCT00640029|Cervical or lumbar intervertebral disk|cervical or lumbar intervertebral disk
616748|NCT00640029|Degenerative pathology|degenerative pathology
616749|NCT00640042|pain|pain
616750|NCT00640042|opioid|opioid
616751|NCT00640042|abuse|abuse
616752|NCT00640042|moderate-severe pain requiring continuous, around-the-clock opioid therapy for an extended period of time|moderate-severe pain requiring continuous, around-the-clock opioid therapy for an extended period of time
616753|NCT00640055|verbal autopsy|verbal autopsy
616754|NCT00640055|stillbirth|stillbirth
616755|NCT00640055|neonatal death|neonatal death
617984|NCT00654433|ALD|ald
616756|NCT00640068|coronary artery disease|coronary artery disease
616757|NCT00640068|chest pain|chest pain
616758|NCT00640068|coronary artery bypass graft|coronary artery bypass graft
616759|NCT00640068|stress test|stress test
616760|NCT00640068|Coronary Angiography|coronary angiography
616761|NCT00640081|adenocarcinoma of the colon|adenocarcinoma of the colon
616763|NCT00640081|adenocarcinoma of the rectum|adenocarcinoma of the rectum
616764|NCT00640081|stage IV rectal cancer|stage iv rectal cancer
616765|NCT00640081|stage III colon cancer|stage iii colon cancer
616766|NCT00640081|stage III rectal cancer|stage iii rectal cancer
616767|NCT00640081|recurrent colon cancer|recurrent colon cancer
616768|NCT00640081|recurrent rectal cancer|recurrent rectal cancer
616769|NCT00640094|Melatonin|melatonin
616770|NCT00640094|Acute myocardial infarction|acute myocardial infarction
616771|NCT00640094|Primary angioplasty|primary angioplasty
616772|NCT00640107|Magnetic Resonance Imaging|magnetic resonance imaging
616773|NCT00640120|wheeze detection|wheeze detection
616774|NCT00640133|Deep Brain Stimulation|deep brain stimulation
616775|NCT00640133|Treatment Refractory|treatment refractory
616776|NCT00640133|Ventral Internal Capsule/Ventral Striatum|ventral internal capsule/ventral striatum
616777|NCT00640133|Neurosurgery|neurosurgery
616778|NCT00640133|Neuroimaging|neuroimaging
616779|NCT00640159|Parkinson's disease|parkinson's disease
616780|NCT00640159|selegiline to Zelapar switch|selegiline to zelapar switch
616781|NCT00640159|orally disintegrating formulation|orally disintegrating formulation
616782|NCT00640198|Aphasia|aphasia
616783|NCT00640198|Memantine|memantine
616784|NCT00640198|Constraint-induced language therapy|constraint-induced language therapy
616785|NCT00640198|Event-related potentials|event-related potentials
616786|NCT00640211|Prophylaxis|prophylaxis
616989|NCT00651248|Aged|aged
616787|NCT00640211|pandemic influenza|pandemic influenza
616788|NCT00640211|influenza A|influenza a
616789|NCT00640211|H5N1 virus|h5n1 virus
616790|NCT00640237|Vitamine D State|vitamine d state
616791|NCT00640250|Dermatitis, Contact, Bronopol, Disperse Blue 106|dermatitis, contact, bronopol, disperse blue 106
616792|NCT00640263|HIV-1|hiv-1
616793|NCT00640263|Breastfeeding|breastfeeding
616794|NCT00640263|Prevention|prevention
616795|NCT00640263|lamivudine|lamivudine
616797|NCT00640276|pitavastatin|pitavastatin
616798|NCT00640276|metabolic syndrome|metabolic syndrome
616799|NCT00640276|metabolic syndrome risk score|metabolic syndrome risk score
616800|NCT00640276|hypercholesterolemia|hypercholesterolemia
616801|NCT00640289|Factor XIII Deficiency|factor xiii deficiency
616802|NCT00640289|Rare Bleeding Disorder|rare bleeding disorder
616803|NCT00640289|Hemophilia|hemophilia
616804|NCT00640289|Fibrogammin P|fibrogammin p
616805|NCT00640302|Index cases|index cases
616806|NCT00640302|pandemic influenza|pandemic influenza
616807|NCT00640302|influenza A|influenza a
616808|NCT00640302|H5N1 virus|h5n1 virus
616809|NCT00640315|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
616810|NCT00640315|COPD|copd
616811|NCT00640315|Pulmonary hypertension|pulmonary hypertension
616812|NCT00640328|relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
616813|NCT00640328|ofatumumab|ofatumumab
616814|NCT00640328|multiple sclerosis|multiple sclerosis
616815|NCT00647998|Surgical complications|surgical complications
616816|NCT00647998|Spinal ischemia|spinal ischemia
616817|NCT00647998|Stroke|stroke
616818|NCT00647998|Neuroprotection|neuroprotection
616819|NCT00648037|RITUXIMAB|rituximab
616820|NCT00648037|Lymphoma|lymphoma
616821|NCT00648089|Acute ST Elevation Myocardial Infarction|acute st elevation myocardial infarction
616822|NCT00648102|Breast cancer|breast cancer
616823|NCT00648102|Colorectal cancer|colorectal cancer
616824|NCT00648102|Pancreatic cancer|pancreatic cancer
616825|NCT00648102|Bladder cancer|bladder cancer
616826|NCT00648102|Ovarian cancer|ovarian cancer
616827|NCT00648102|Metastatic cancer|metastatic cancer
616828|NCT00648102|Locally advanced cancer|locally advanced cancer
616829|NCT00648102|Cancer Vaccine|cancer vaccine
616830|NCT00648102|Vaccine|vaccine
616831|NCT00648115|Veterans|veterans
616832|NCT00648115|Substance-Related Disorders|substance-related disorders
616833|NCT00648115|Mental Health|mental health
616834|NCT00648167|ESRD|esrd
616835|NCT00648167|end-stage renal disease|end-stage renal disease
616836|NCT00648167|end stage renal disease|end stage renal disease
616837|NCT00648167|hemodialysis|hemodialysis
616838|NCT00648167|dialysis|dialysis
616839|NCT00648167|kidney failure|kidney failure
616840|NCT00648167|renal failure|renal failure
616841|NCT00648167|kidney|kidney
616842|NCT00648167|renal|renal
616843|NCT00648167|phosphate binder|phosphate binder
616844|NCT00648167|phosphorus|phosphorus
616845|NCT00648206|driving under the influence|driving under the influence
616846|NCT00648206|psychoactive substances|psychoactive substances
616847|NCT00648206|blood samples|blood samples
616848|NCT00648206|Prevalence of psychoactive substances in road traffic|prevalence of psychoactive substances in road traffic
616850|NCT00648232|AIDS|aids
616851|NCT00648232|Prevention|prevention
616853|NCT00648232|Voluntary Counseling and Testing|voluntary counseling and testing
616854|NCT00648245|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
616855|NCT00648245|COPD|copd
616856|NCT00648245|Chronic bronchitis|chronic bronchitis
616857|NCT00648258|osteoarthritis, knee|osteoarthritis, knee
616858|NCT00648258|osteoarthritis, hip|osteoarthritis, hip
616859|NCT00648284|Type 2 diabetes|type 2 diabetes
616860|NCT00648284|CV risk|cv risk
616861|NCT00648284|rosiglitazone|rosiglitazone
616862|NCT00648284|AVANDIA|avandia
616863|NCT00650455|valdecoxib, severe rheumatoid arthritis|valdecoxib, severe rheumatoid arthritis
616864|NCT00650468|Renal Transplantation|renal transplantation
616865|NCT00650468|Prograf|prograf
616866|NCT00650507|children|children
616867|NCT00650507|cardiac surgery|cardiac surgery
616868|NCT00650507|remote ischemic preconditioning|remote ischemic preconditioning
616870|NCT00650507|ischemia-reperfusion|ischemia-reperfusion
616871|NCT00650546|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
616872|NCT00650546|NASH|nash
616873|NCT00650559|COPD|copd
616874|NCT00650559|Emphysema|emphysema
616875|NCT00650559|thorax enlargement|thorax enlargement
616876|NCT00650559|LVRS|lvrs
616877|NCT00650572|human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
616878|NCT00650572|epidermal growth factor receptor|epidermal growth factor receptor
616879|NCT00650572|EGFR|egfr
616880|NCT00650572|type I receptor tyrosine kinase|type i receptor tyrosine kinase
616881|NCT00650585|smoking|smoking
616882|NCT00650585|alcohol|alcohol
616883|NCT00650585|prevention|prevention
616884|NCT00650585|prevention & control|prevention & control
616885|NCT00650598|anterior cruciate ligament, arthroscopy, knee, post-surgical pain|anterior cruciate ligament, arthroscopy, knee, post-surgical pain
616886|NCT00650624|knee osteoarthritis; Japan|knee osteoarthritis; japan
616887|NCT00650702|glaucoma, ocular hypertension, IOP|glaucoma, ocular hypertension, iop
616888|NCT00650715|Fibromyalgia|fibromyalgia
616889|NCT00650715|Whole-Body vibration|whole-body vibration
616890|NCT00650715|Exercise|exercise
616891|NCT00650715|IGF-1|igf-1
616892|NCT00650728|radiofrequency ablation|radiofrequency ablation
616893|NCT00650741|Endothelial Dysfunction|endothelial dysfunction
616895|NCT00650754|DHEA|dhea
616896|NCT00650754|Pregnancy|pregnancy
616897|NCT00650780|Viatmin D, 25-hydroxyvitamin D, Vitamin D binding protein|viatmin d, 25-hydroxyvitamin d, vitamin d binding protein
616898|NCT00650793|Schizophrenia|schizophrenia
616899|NCT00650793|paliperidone|paliperidone
616900|NCT00650806|Obesity|obesity
616901|NCT00650806|Overweight|overweight
616902|NCT00650806|Weight loss|weight loss
616903|NCT00650806|Anti-Obesity Agents|anti-obesity agents
616904|NCT00650806|Human|human
616905|NCT00650832|HIV, anti-infectives|hiv, anti-infectives
616906|NCT00650845|contrast-induced nephropathy, creatinemia|contrast-induced nephropathy, creatinemia
616907|NCT00650858|Intraventricular hemorrhage (IVH)|intraventricular hemorrhage (ivh)
616908|NCT00650858|rt-PA|rt-pa
616909|NCT00650871|sleep,|sleep,
616910|NCT00650871|polysomnography.|polysomnography.
616911|NCT00650871|GW679769,|gw679769,
616912|NCT00650871|primary insomnia,|primary insomnia,
616913|NCT00650871|cognitive function,|cognitive function,
616914|NCT00650884|Dynamic Splinting for low-load, prolonged-duration stretch|dynamic splinting for low-load, prolonged-duration stretch
616915|NCT00650897|Efficacy|efficacy
616916|NCT00650897|Antidepressant|antidepressant
616917|NCT00650897|Escitalopram|escitalopram
616918|NCT00650897|Major Depression|major depression
616919|NCT00650897|Diabetes Mellitus|diabetes mellitus
616920|NCT00650897|Self Care|self care
616921|NCT00650910|lapatinib|lapatinib
616922|NCT00650910|Metastatic ErbB2 positive breast cancer|metastatic erbb2 positive breast cancer
616923|NCT00650910|digoxin|digoxin
616924|NCT00650936|Atrial|atrial
616925|NCT00650936|Septal|septal
616926|NCT00650936|Defect|defect
616927|NCT00650949|Glioblastoma multiforme|glioblastoma multiforme
616928|NCT00650949|Glioma|glioma
616929|NCT00650949|Phase Ib/II|phase ib/ii
616930|NCT00650949|CYT997|cyt997
616931|NCT00650962|CPR|cpr
616932|NCT00650962|Preshock CPR|preshock cpr
616933|NCT00650962|OHCA|ohca
616934|NCT00650962|EMS|ems
616935|NCT00650975|STEMI|stemi
616936|NCT00650975|Laser|laser
616937|NCT00650975|Thrombus|thrombus
616938|NCT00650975|Thrombectomy|thrombectomy
616939|NCT00650988|Barrett's Esophagus|barrett's esophagus
616940|NCT00650988|Cryospray ablation|cryospray ablation
616941|NCT00650988|High Grade Dysplasia|high grade dysplasia
616942|NCT00650988|Early Esophageal Cancers|early esophageal cancers
616943|NCT00650988|Esophageal Neoplasms|esophageal neoplasms
616944|NCT00650988|Esophageal Intramucosal Cancer (IMCA)|esophageal intramucosal cancer (imca)
616945|NCT00650988|Esophageal Cancer limited to esophageal wall|esophageal cancer limited to esophageal wall
616946|NCT00650988|Barretts esophagus High Grade Dysplasia (HGD)|barretts esophagus high grade dysplasia (hgd)
616947|NCT00651001|fructose|fructose
616948|NCT00651001|leptin|leptin
616949|NCT00651001|metabolic syndrome|metabolic syndrome
616950|NCT00651001|blood pressure|blood pressure
616951|NCT00651001|inflammation|inflammation
616952|NCT00651001|Relationship of fructose intake to leptin levels|relationship of fructose intake to leptin levels
616953|NCT00651001|Relationship of fructose to metabolic syndrome|relationship of fructose to metabolic syndrome
616954|NCT00651001|Relationship of fructose to inflammation parameters|relationship of fructose to inflammation parameters
616955|NCT00651001|Relationship of fructose to blood pressure|relationship of fructose to blood pressure
616956|NCT00651040|Polymyositis|polymyositis
616957|NCT00651040|Dermatomyositis|dermatomyositis
616958|NCT00651040|Glucocorticoids|glucocorticoids
616959|NCT00651040|Methotrexate|methotrexate
616960|NCT00651066|HIV|hiv
616961|NCT00651066|Tuberculosis|tuberculosis
616962|NCT00651066|Rifabutin|rifabutin
616963|NCT00651066|Pharmacokinetics|pharmacokinetics
616964|NCT00651066|Vietnam|vietnam
616965|NCT00651079|GSK1247303,|gsk1247303,
616966|NCT00651079|Integrase,|integrase,
616967|NCT00651079|First Time in Human|first time in human
616968|NCT00651092|turbinectomy|turbinectomy
616969|NCT00651105|Diabetes|diabetes
616970|NCT00651105|Hyperglycemia|hyperglycemia
616971|NCT00651105|Healthy|healthy
616972|NCT00651105|Vildagliptin|vildagliptin
616973|NCT00651105|Adults|adults
616974|NCT00651131|post-surgical|post-surgical
616975|NCT00651131|wound infection|wound infection
616976|NCT00651131|superficial|superficial
616977|NCT00651131|deep|deep
616978|NCT00651131|surgical|surgical
616979|NCT00651170|Median block nerve|median block nerve
616980|NCT00651170|Ultrasound|ultrasound
616981|NCT00651196|Type 1 diabetes|type 1 diabetes
616982|NCT00651196|bone|bone
616983|NCT00651209|Hepatitis B, chronic|hepatitis b, chronic
616984|NCT00651209|Telbivudine|telbivudine
616985|NCT00651209|Tenofovir|tenofovir
616986|NCT00651209|Roadmap Concept|roadmap concept
616987|NCT00651248|Saliva|saliva
616990|NCT00651261|adult acute basophilic leukemia|adult acute basophilic leukemia
616991|NCT00651261|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
616992|NCT00651261|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
616993|NCT00651261|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
616994|NCT00651261|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
616995|NCT00651261|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
616996|NCT00651261|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
616997|NCT00651261|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
751793|NCT01170468|DM|dm
616998|NCT00651261|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
616999|NCT00651261|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
617000|NCT00651261|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
617001|NCT00651261|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
617002|NCT00651261|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
617003|NCT00651261|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
617004|NCT00651261|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
617005|NCT00651261|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
617006|NCT00651261|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
617007|NCT00651313|Dysmenorrhea|dysmenorrhea
617009|NCT00651313|Menstrual|menstrual
617010|NCT00651313|Primary dysmenorrhea in women with recurrent dysmenorrhea|primary dysmenorrhea in women with recurrent dysmenorrhea
617011|NCT00651326|adenocarcinoma of the prostate|adenocarcinoma of the prostate
617012|NCT00651326|stage I prostate cancer|stage i prostate cancer
617013|NCT00651326|stage II prostate cancer|stage ii prostate cancer
617014|NCT00651326|stage III prostate cancer|stage iii prostate cancer
617015|NCT00651326|stage IV prostate cancer|stage iv prostate cancer
617016|NCT00651339|Cerebral Palsy|cerebral palsy
617017|NCT00651339|Balance|balance
617018|NCT00651339|Gait|gait
617019|NCT00651352|NRT|nrt
617020|NCT00651352|Bioequivalence|bioequivalence
617021|NCT00651352|Nicotine|nicotine
617022|NCT00651365|Advanced solid tumors|advanced solid tumors
617023|NCT00651365|Refractory solid tumor|refractory solid tumor
617024|NCT00651365|Antineoplastic protocol|antineoplastic protocol
617025|NCT00651365|Drug therapy|drug therapy
617026|NCT00651365|Pharmacokinetics|pharmacokinetics
617027|NCT00651365|Met inhibitor|met inhibitor
617028|NCT00651417|Organic germanium|organic germanium
617029|NCT00651417|fatigue|fatigue
617030|NCT00651417|radiation therapy|radiation therapy
617031|NCT00651417|breast cancer|breast cancer
617032|NCT00651417|prostate cancer|prostate cancer
617033|NCT00651430|Balance|balance
617034|NCT00651430|Voluntary stepping|voluntary stepping
617035|NCT00651430|function|function
617036|NCT00651430|disability|disability
617037|NCT00651430|fear of falls|fear of falls
617038|NCT00651430|Total Hip Arthroplasty|total hip arthroplasty
617039|NCT00651443|galiximab|galiximab
617040|NCT00651443|Untreated NHL|untreated nhl
617041|NCT00651443|antibody|antibody
617042|NCT00651443|open-label|open-label
617043|NCT00651469|Moderate Acne Vulgaris|moderate acne vulgaris
617044|NCT00651469|Acne|acne
617045|NCT00651495|Decision aids|decision aids
617046|NCT00651495|Seniors|seniors
617047|NCT00651495|Chronic disease management|chronic disease management
617048|NCT00651495|Advance directives|advance directives
617049|NCT00651508|Patients with Advanced or Metastatic stage IIIB/IV Non-Small Cell Lung Cancer|patients with advanced or metastatic stage iiib/iv non-small cell lung cancer
617050|NCT00651521|Angiographic CAD|angiographic cad
617051|NCT00651521|Chronic kidney disease|chronic kidney disease
617052|NCT00651521|Left ventricular dysfunction|left ventricular dysfunction
617053|NCT00651521|Body mass index|body mass index
617054|NCT00651521|Cardiovascular mortality|cardiovascular mortality
617055|NCT00651521|Coronary angiography|coronary angiography
617056|NCT00651534|Formulation Drug Study, healthy postmenopausal|formulation drug study, healthy postmenopausal
617058|NCT00651547|Symbicort|symbicort
617059|NCT00651547|budesonide/formoterol|budesonide/formoterol
617060|NCT00651547|budesonide|budesonide
617061|NCT00651547|formoterol|formoterol
617062|NCT00651547|children|children
617063|NCT00651573|Surgery|surgery
617064|NCT00651573|Cardiopulmonary bypass|cardiopulmonary bypass
617065|NCT00651573|Coronary artery bypass graft|coronary artery bypass graft
617066|NCT00651573|Valve procedure|valve procedure
617067|NCT00651573|Hematocrit level|hematocrit level
617068|NCT00651573|Outcomes|outcomes
617069|NCT00651599|Vasomotor symptoms|vasomotor symptoms
617070|NCT00651599|Vasomotor System|vasomotor system
617071|NCT00651625|arthrocentesis|arthrocentesis
617072|NCT00651625|injections|injections
617073|NCT00651625|anesthesia|anesthesia
617074|NCT00651625|biopsy|biopsy
617075|NCT00651625|aspiration|aspiration
617076|NCT00651625|syringe|syringe
617077|NCT00651625|safety|safety
617078|NCT00651625|pain|pain
617226|NCT00651820|collagenase|collagenase
617079|NCT00651638|PK and safety profile of ARQ 197|pk and safety profile of arq 197
617080|NCT00651651|Asthma|asthma
617081|NCT00651651|Symbicort|symbicort
617082|NCT00651651|budesonide/formoterol|budesonide/formoterol
617083|NCT00651651|budesonide|budesonide
617084|NCT00651651|formoterol|formoterol
617085|NCT00651677|hand assisted laparoscopy|hand assisted laparoscopy
617086|NCT00651677|rectal cancer|rectal cancer
617087|NCT00651677|short term outcomes|short term outcomes
617088|NCT00651677|straight laparoscopy|straight laparoscopy
617089|NCT00651716|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
751794|NCT01170468|vitamin D|vitamin d
617090|NCT00651716|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
617091|NCT00651716|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
617092|NCT00651716|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
617093|NCT00651716|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
617094|NCT00651716|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
617095|NCT00651716|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
617096|NCT00651716|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
617097|NCT00651716|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
617098|NCT00651716|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
617099|NCT00651716|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
617100|NCT00651716|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
617101|NCT00651716|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
617102|NCT00651716|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
617103|NCT00651716|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
617104|NCT00651716|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
617105|NCT00651716|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
617106|NCT00651716|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
617107|NCT00651716|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
617108|NCT00651716|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
617109|NCT00651716|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
617110|NCT00651716|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
617111|NCT00651716|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
617112|NCT00651716|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
617113|NCT00651716|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
617114|NCT00651716|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
617115|NCT00651716|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
617116|NCT00651716|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
617117|NCT00651716|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
617118|NCT00651716|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
617119|NCT00651716|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
617120|NCT00651716|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
617121|NCT00651716|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
617122|NCT00651716|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
617123|NCT00651716|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
617124|NCT00651716|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
617125|NCT00651716|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
617126|NCT00651716|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
617127|NCT00651716|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
617128|NCT00651716|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
617129|NCT00651716|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
617194|NCT00651755|Cytoxan|cytoxan
617130|NCT00651716|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
617131|NCT00651716|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
617132|NCT00651716|splenic marginal zone lymphoma|splenic marginal zone lymphoma
617133|NCT00651716|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
617203|NCT00651755|Aprepitant|aprepitant
617134|NCT00651716|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
617135|NCT00651716|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
617136|NCT00651716|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
617137|NCT00651716|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
617138|NCT00651716|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
617139|NCT00651716|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
617140|NCT00651716|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
617141|NCT00651716|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
617142|NCT00651716|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
617143|NCT00651716|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
617144|NCT00651716|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
617145|NCT00651716|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
617146|NCT00651716|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
617147|NCT00651716|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
617148|NCT00651716|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
617149|NCT00651716|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
617150|NCT00651716|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
617151|NCT00651716|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
617152|NCT00651716|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
617153|NCT00651716|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
617154|NCT00651716|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
617155|NCT00651716|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
617156|NCT00651716|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
617157|NCT00651716|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
617158|NCT00651716|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
617159|NCT00651716|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
617160|NCT00651716|refractory hairy cell leukemia|refractory hairy cell leukemia
617161|NCT00651716|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
617162|NCT00651716|secondary acute myeloid leukemia|secondary acute myeloid leukemia
617163|NCT00651716|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
617164|NCT00651716|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
617165|NCT00651716|chronic eosinophilic leukemia|chronic eosinophilic leukemia
617166|NCT00651716|primary myelofibrosis|primary myelofibrosis
617167|NCT00651716|chronic neutrophilic leukemia|chronic neutrophilic leukemia
617168|NCT00651716|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
617169|NCT00651716|disseminated neuroblastoma|disseminated neuroblastoma
617170|NCT00651716|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
617171|NCT00651716|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
617172|NCT00651716|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
617173|NCT00651716|recurrent neuroblastoma|recurrent neuroblastoma
617174|NCT00651716|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
617175|NCT00651716|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
617176|NCT00651716|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
617177|NCT00651716|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
617178|NCT00651716|stage I multiple myeloma|stage i multiple myeloma
617179|NCT00651716|stage II multiple myeloma|stage ii multiple myeloma
617180|NCT00651716|stage III multiple myeloma|stage iii multiple myeloma
617181|NCT00651716|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
617182|NCT00651716|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
617183|NCT00651716|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
617184|NCT00651716|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
617185|NCT00651716|stage IIIA breast cancer|stage iiia breast cancer
617186|NCT00651716|stage IIIB breast cancer|stage iiib breast cancer
617187|NCT00651716|stage IIIC breast cancer|stage iiic breast cancer
617188|NCT00651716|stage IV breast cancer|stage iv breast cancer
617189|NCT00651716|refractory multiple myeloma|refractory multiple myeloma
617190|NCT00651755|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
617191|NCT00651755|Lymphoma|lymphoma
617192|NCT00651755|Nausea|nausea
617193|NCT00651755|Cyclophosphamide|cyclophosphamide
617195|NCT00651755|Neosar|neosar
617196|NCT00651755|Doxorubicin|doxorubicin
617198|NCT00651755|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
617199|NCT00651755|Vincristine|vincristine
617200|NCT00651755|Prednisone|prednisone
617201|NCT00651755|Rituximab|rituximab
617202|NCT00651755|Rituxan|rituxan
617204|NCT00651755|Emend|emend
617205|NCT00651755|L754030|l754030
617206|NCT00651755|MK869|mk869
617207|NCT00651755|Drug Metabolism|drug metabolism
617208|NCT00651755|CHOP|chop
617209|NCT00651755|R-CHOP|r-chop
617210|NCT00651755|NHL|nhl
617211|NCT00651768|asthma|asthma
617212|NCT00651768|adults|adults
617213|NCT00651768|adolescents|adolescents
617214|NCT00651768|safety|safety
617215|NCT00651768|Symbicort|symbicort
617216|NCT00651768|budesonide/formoterol|budesonide/formoterol
617217|NCT00651768|budesonide|budesonide
617218|NCT00651781|Acute Myeloid Leukemia|acute myeloid leukemia
617219|NCT00651781|Relapsed|relapsed
617220|NCT00651781|Refractory|refractory
617221|NCT00651794|Neonatal Resuscitation|neonatal resuscitation
617222|NCT00651794|Patient Care Team|patient care team
617223|NCT00651794|Medical Errors|medical errors
617224|NCT00651820|wound healing|wound healing
617225|NCT00651820|scarring|scarring
617228|NCT00651846|Contraception|contraception
617229|NCT00651846|Hemostasis|hemostasis
617230|NCT00651846|Blood Coagulation|blood coagulation
617231|NCT00651872|Posttraumatic Stress Disorder|posttraumatic stress disorder
617232|NCT00651872|Functional Impairment|functional impairment
617233|NCT00651872|Veterans|veterans
617234|NCT00651872|Military Personnel|military personnel
617236|NCT00651885|Peripheral Vascular Disease|peripheral vascular disease
617237|NCT00651885|Treprostinil|treprostinil
617238|NCT00651898|abdominal surgery|abdominal surgery
617239|NCT00651898|hypothermia|hypothermia
617240|NCT00651898|circulating water mattress|circulating water mattress
617241|NCT00651924|chronic pain|chronic pain
617242|NCT00651924|IVR|ivr
617243|NCT00651924|cognitive-behavior therapy|cognitive-behavior therapy
617244|NCT00651937|Multiple Myeloma|multiple myeloma
617245|NCT00651937|Primary Amyloidosis|primary amyloidosis
617246|NCT00651937|Cytokine Modulation|cytokine modulation
617247|NCT00651937|Melphalan|melphalan
617248|NCT00651937|Alkeran|alkeran
617249|NCT00651937|Transplant Induced Symptoms|transplant induced symptoms
617250|NCT00651937|Stem Cell Infusion|stem cell infusion
617251|NCT00651937|Autologous stem cell transplant|autologous stem cell transplant
617252|NCT00651937|ASCT|asct
617253|NCT00651937|Granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
617254|NCT00651937|G-CSF|g-csf
617255|NCT00651937|Apheresis|apheresis
617256|NCT00651950|Hydrocephalus|hydrocephalus
617257|NCT00651950|shunt dysfunction|shunt dysfunction
617258|NCT00651950|shunt flow|shunt flow
617259|NCT00651976|stage IA breast cancer|stage ia breast cancer
617260|NCT00651976|stage IB breast cancer|stage ib breast cancer
617261|NCT00651976|stage II breast cancer|stage ii breast cancer
617262|NCT00651976|stage III breast cancer|stage iii breast cancer
617263|NCT00651976|HER2-negative breast cancer|her2-negative breast cancer
617264|NCT00651976|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
617265|NCT00651989|optical coherence tomography|optical coherence tomography
617266|NCT00651989|spectral domain|spectral domain
617267|NCT00651989|time domain|time domain
617268|NCT00652002|Asthma|asthma
617269|NCT00652002|Symbicort|symbicort
617270|NCT00652002|budesonide/formoterol|budesonide/formoterol
617271|NCT00652002|budesonide|budesonide
617272|NCT00652002|formoterol|formoterol
617273|NCT00652015|in-stent-thrombosis|in-stent-thrombosis
617274|NCT00652015|CD39|cd39
617275|NCT00652015|CD73|cd73
617276|NCT00652015|EPC|epc
617277|NCT00652028|Pharmacokinetics|pharmacokinetics
617278|NCT00652028|Pharmacodynamics|pharmacodynamics
617279|NCT00652028|Escalating dose|escalating dose
617280|NCT00652028|Dexmedotimidine|dexmedotimidine
617281|NCT00652028|Intubated|intubated
617282|NCT00652028|Mechanically ventilated|mechanically ventilated
617283|NCT00652028|Pediatrics|pediatrics
617284|NCT00652041|Multiple Myeloma|multiple myeloma
617285|NCT00652041|Relapsed|relapsed
617286|NCT00652041|Refractary|refractary
617287|NCT00652067|Mycobacterium avium-intracellulare|mycobacterium avium-intracellulare
617288|NCT00652119|Ovarian Cancer|ovarian cancer
617289|NCT00652119|Peritoneal Cancer|peritoneal cancer
617290|NCT00652119|Fallopian Tube Cancer|fallopian tube cancer
617291|NCT00652119|Carcinoma of Mullerian Origin|carcinoma of mullerian origin
617292|NCT00652119|Paclitaxel|paclitaxel
617293|NCT00652119|Taxol|taxol
617294|NCT00652119|Carboplatin|carboplatin
617295|NCT00652119|Paraplatin®|paraplatin®
617296|NCT00652119|Avastin|avastin
617297|NCT00652119|Bevacizumab|bevacizumab
617298|NCT00652119|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
617299|NCT00652119|rhuMAb-VEGF|rhumab-vegf
617300|NCT00652132|ototoxicity|ototoxicity
617301|NCT00652132|childhood hepatoblastoma|childhood hepatoblastoma
617302|NCT00652132|stage I childhood liver cancer|stage i childhood liver cancer
617303|NCT00652132|stage II childhood liver cancer|stage ii childhood liver cancer
617304|NCT00652132|stage III childhood liver cancer|stage iii childhood liver cancer
617305|NCT00652145|ulcerative colitis|ulcerative colitis
617306|NCT00652145|inflammatory bowel disease|inflammatory bowel disease
617307|NCT00652171|Treatment|treatment
617308|NCT00652171|Augmentation|augmentation
617309|NCT00652171|Resistant depression|resistant depression
617310|NCT00652171|Lamotrigine|lamotrigine
617311|NCT00652184|antiviral|antiviral
617312|NCT00652184|herpes zoster|herpes zoster
617313|NCT00652184|postherpetic neuralgia|postherpetic neuralgia
617314|NCT00652184|varicella zoster virus|varicella zoster virus
617315|NCT00652184|shingles|shingles
617316|NCT00652197|Hydrocephalus|hydrocephalus
617317|NCT00652197|shunt dysfunction|shunt dysfunction
617318|NCT00652197|shunt flow|shunt flow
617319|NCT00652210|Bladder cancer|bladder cancer
617320|NCT00652210|prostate cancer|prostate cancer
617321|NCT00652210|multiphoton microscopy|multiphoton microscopy
617322|NCT00652236|Low back pain|low back pain
617323|NCT00652236|Economics|economics
617324|NCT00652236|Cost-effectiveness|cost-effectiveness
617325|NCT00652249|Hydrocephalus|hydrocephalus
617326|NCT00652249|shunt dysfunction|shunt dysfunction
617327|NCT00652249|shunt flow|shunt flow
617329|NCT00652262|PDE5 inhibitor|pde5 inhibitor
617330|NCT00652262|Erectile dysfunction|erectile dysfunction
617331|NCT00652262|Spinal cord injury|spinal cord injury
617332|NCT00652275|Malaria|malaria
617333|NCT00652275|vaccine|vaccine
617334|NCT00652275|Merozoite surface Antigene|merozoite surface antigene
617335|NCT00652275|Mali|mali
617336|NCT00652275|Children|children
617337|NCT00652288|Type I Diabetes Mellitus|type i diabetes mellitus
617338|NCT00652314|Hemostatic products|hemostatic products
617339|NCT00652314|Surgical hemostasis|surgical hemostasis
617340|NCT00652314|Thrombi-gel|thrombi-gel
617341|NCT00652314|Gelatin Sponge|gelatin sponge
617342|NCT00652314|Time to hemostasis|time to hemostasis
617343|NCT00652353|Clinical decision rule|clinical decision rule
617344|NCT00652353|Ottawa Ankle Rule|ottawa ankle rule
617345|NCT00652353|Ottawa Foot Rule|ottawa foot rule
617346|NCT00652353|Ankle|ankle
617347|NCT00652353|Trauma|trauma
617348|NCT00652353|Education|education
617349|NCT00652353|Foot Trauma|foot trauma
617350|NCT00652379|Acromegaly|acromegaly
617351|NCT00652379|Insulin sensitivity|insulin sensitivity
617352|NCT00652379|Glucose tolerance|glucose tolerance
617353|NCT00652379|Body composition|body composition
617354|NCT00652379|Growth Hormone|growth hormone
617355|NCT00652392|asthma|asthma
617356|NCT00652392|adolescents|adolescents
617357|NCT00652392|adults|adults
617358|NCT00652392|Symbicort|symbicort
617359|NCT00652392|budesonide/formoterol|budesonide/formoterol
617360|NCT00652392|budesonide|budesonide
617361|NCT00652405|cephalic phase reflex|cephalic phase reflex
617362|NCT00652405|gene expression|gene expression
617363|NCT00652405|inflammation|inflammation
617364|NCT00652405|adiponectin|adiponectin
617365|NCT00652405|pancreatic polypeptide|pancreatic polypeptide
617366|NCT00652418|Magnevist|magnevist
617367|NCT00652418|Magnetic Resonance Angiography|magnetic resonance angiography
617368|NCT00652418|Meglumine gadopentetate|meglumine gadopentetate
617369|NCT00652418|Determination of effective dose in MRA|determination of effective dose in mra
617370|NCT00652470|infants|infants
617371|NCT00652470|Hydrocephalus|hydrocephalus
617372|NCT00652470|Cerebrospinal Fluid Shunt|cerebrospinal fluid shunt
617373|NCT00652470|Ventriculostomy|ventriculostomy
617374|NCT00652470|neurosurgery|neurosurgery
617375|NCT00652522|AF ablation|af ablation
617376|NCT00652522|Pulmonary vein isolation(PVI)|pulmonary vein isolation(pvi)
617377|NCT00652522|reduced LV ejection fraction|reduced lv ejection fraction
617378|NCT00652522|symptomatic atrial fibrillation|symptomatic atrial fibrillation
617379|NCT00652522|persistent AF|persistent af
617380|NCT00652548|Clavicle|clavicle
617381|NCT00652548|Fracture|fracture
617382|NCT00652548|Ultrasound|ultrasound
617383|NCT00652548|Radiation|radiation
617384|NCT00652574|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
617385|NCT00652574|Dasatinib|dasatinib
617386|NCT00652574|BMS-354825|bms-354825
617387|NCT00652574|Sprycel|sprycel
617389|NCT00652587|hepatocellular carcinoma|hepatocellular carcinoma
617390|NCT00652587|hepatectomy|hepatectomy
617391|NCT00652587|chemoembolization|chemoembolization
617392|NCT00652587|randomized controlled trial|randomized controlled trial
617393|NCT00652587|prognosis|prognosis
753141|NCT01175629|Anxiety Disorders|anxiety disorders
617394|NCT00652600|Bioequivalence, Propranolol ER capsules, fed|bioequivalence, propranolol er capsules, fed
617395|NCT00652613|3DCRT|3dcrt
617396|NCT00652613|IMRT|imrt
617397|NCT00652613|HNSCC|hnscc
617398|NCT00652613|Quality of life|quality of life
617399|NCT00652613|Major salivary gland sparing|major salivary gland sparing
617400|NCT00652613|Pattern of local and loco-regional recurrence|pattern of local and loco-regional recurrence
617401|NCT00652613|Disease Free Survival (DFS) & Overall Survival (OAS)|disease free survival (dfs) & overall survival (oas)
617402|NCT00652613|Dose reduction to normal structures with IMRT|dose reduction to normal structures with imrt
617403|NCT00652626|MDS|mds
617404|NCT00652626|AML|aml
617405|NCT00652626|Solid Tumors|solid tumors
617406|NCT00652626|Azacitidine|azacitidine
617407|NCT00652626|PK|pk
617408|NCT00652626|Pharmacokinetics|pharmacokinetics
617803|NCT00644930|mortality,|mortality,
617409|NCT00652626|Renal Impairment|renal impairment
617410|NCT00652626|Multiple Myeloma|multiple myeloma
617411|NCT00652626|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
617412|NCT00652626|Hodgkin's Disease|hodgkin's disease
617413|NCT00652639|bioequivalence, Clonazepam tablets, fasting|bioequivalence, clonazepam tablets, fasting
617414|NCT00652652|Congestive Heart Failure (CHF)|congestive heart failure (chf)
617415|NCT00652652|Heart Failure|heart failure
617416|NCT00652652|Chronic Heart Failure|chronic heart failure
617417|NCT00652652|Dyspnea|dyspnea
617418|NCT00652652|nesiritide|nesiritide
617419|NCT00652652|Natrecor|natrecor
617420|NCT00652665|Bioequivalence, single-dose, fasting|bioequivalence, single-dose, fasting
617421|NCT00652678|Breast cancer|breast cancer
617422|NCT00652678|Radiation effects|radiation effects
617423|NCT00652691|peritoneal cavity cancer|peritoneal cavity cancer
617424|NCT00652691|ovarian clear cell tumor with proliferating activity|ovarian clear cell tumor with proliferating activity
617425|NCT00652691|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
617519|NCT00643526|Psoriasis|psoriasis
617426|NCT00652691|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
617427|NCT00652691|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
617428|NCT00652691|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
617429|NCT00652691|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
617430|NCT00652691|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
617431|NCT00652704|Bioequivalence|bioequivalence
617432|NCT00652704|Doxycycline Monohydrate|doxycycline monohydrate
617434|NCT00652730|bioequivalence|bioequivalence
617435|NCT00652730|buspirone HCl|buspirone hcl
617436|NCT00652730|fed|fed
617437|NCT00652743|immunogenicity|immunogenicity
617438|NCT00652743|safety|safety
617439|NCT00652743|GSK pandemic candidate vaccine|gsk pandemic candidate vaccine
617440|NCT00652756|Respiration, Artificial|respiration, artificial
617441|NCT00652756|Transportation of Patients|transportation of patients
617442|NCT00652756|Intubation, Intratracheal|intubation, intratracheal
617443|NCT00652756|Tracheostomy|tracheostomy
617444|NCT00652769|Lung|lung
617445|NCT00652769|Cancer|cancer
617446|NCT00652769|Staging|staging
617447|NCT00652769|Endobronchial|endobronchial
617448|NCT00652769|Ultrasound|ultrasound
617449|NCT00652769|Endoscopic|endoscopic
617450|NCT00652795|bioequivalence|bioequivalence
617451|NCT00652795|doxycycline monohydrate|doxycycline monohydrate
617452|NCT00652795|fasting|fasting
617453|NCT00652808|knee, OA patients|knee, oa patients
617454|NCT00643188|Atrial fibrillation|atrial fibrillation
617455|NCT00643188|Ablation|ablation
617456|NCT00643188|Heart failure|heart failure
617457|NCT00643188|Home Monitoring|home monitoring
617458|NCT00643214|Tetrix Cream|tetrix cream
617459|NCT00643214|Antigen reaction|antigen reaction
617460|NCT00643214|effect on healing|effect on healing
617461|NCT00643214|To determine if application of Tetrix Cream to lesions of contact dermatitis interferes with their rate of healing|to determine if application of tetrix cream to lesions of contact dermatitis interferes with their rate of healing
617462|NCT00643240|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
617463|NCT00643240|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
617464|NCT00643240|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
617465|NCT00643253|exclusive breastfeeding|exclusive breastfeeding
617466|NCT00643253|breastfeeding promotion|breastfeeding promotion
617467|NCT00643253|health promotion|health promotion
617468|NCT00643266|recollection training|recollection training
617469|NCT00643266|aging|aging
617470|NCT00643266|amnestic mild cognitive impairment|amnestic mild cognitive impairment
617471|NCT00643266|fMRI|fmri
617472|NCT00643279|implantable hemodynamic monitor|implantable hemodynamic monitor
617473|NCT00643279|Intracardiac pressures|intracardiac pressures
617474|NCT00643305|HIV|hiv
617475|NCT00643305|Motivational Interviewing|motivational interviewing
617476|NCT00643305|Skills|skills
617477|NCT00643305|Prevention|prevention
617478|NCT00643305|Mental illness|mental illness
617479|NCT00643305|Risk reduction|risk reduction
617480|NCT00643305|HIV/AIDS|hiv/aids
617481|NCT00643305|HIV Seronegativity|hiv seronegativity
617482|NCT00643318|lung cancer|lung cancer
617483|NCT00643318|lung tumor|lung tumor
617484|NCT00643318|non-small cell lung cancer|non-small cell lung cancer
617485|NCT00643318|NSCLC|nsclc
617486|NCT00643318|CyberKnife|cyberknife
617487|NCT00643318|radiosurgery|radiosurgery
617488|NCT00643318|lung surgery|lung surgery
617489|NCT00643331|Osteoporosis|osteoporosis
617490|NCT00643331|Exercise|exercise
617491|NCT00643331|Low bone density|low bone density
617492|NCT00643331|Falls|falls
617493|NCT00643344|obesity|obesity
617494|NCT00643344|mindfulness based stress reduction|mindfulness based stress reduction
617495|NCT00643344|diet and exercise|diet and exercise
617496|NCT00643344|mindful eating|mindful eating
617497|NCT00643344|stress|stress
617498|NCT00643357|children with burns|children with burns
617499|NCT00643357|Child between 5 and 15 years of age , burned for many days and who has to undergo at least 3 procedures of care|child between 5 and 15 years of age , burned for many days and who has to undergo at least 3 procedures of care
617500|NCT00643370|lung cancer|lung cancer
617501|NCT00643370|tumor motion|tumor motion
617502|NCT00643396|small cell lung cancer|small cell lung cancer
617503|NCT00643396|radiotherapy|radiotherapy
617504|NCT00643422|normal eyes|normal eyes
617505|NCT00643435|self-efficacy|self-efficacy
617506|NCT00643435|chronic illness|chronic illness
617507|NCT00643435|health behavior|health behavior
617508|NCT00643435|education, medical, residency|education, medical, residency
617509|NCT00643487|Observe the mechanical behavior of the IPP|observe the mechanical behavior of the ipp
617510|NCT00643500|Levetiracetam|levetiracetam
617511|NCT00643500|Keppra|keppra
617512|NCT00643513|QUALITY OF LIFE|quality of life
617513|NCT00643513|POSTMENOPAUSAL WOMEN|postmenopausal women
617514|NCT00643513|HORMONE RECEPTOR POSITIVE DISSEMINATED BREAST CANCER|hormone receptor positive disseminated breast cancer
617515|NCT00643513|FASLODEX|faslodex
617516|NCT00643526|Rheumatoid arthritis|rheumatoid arthritis
617517|NCT00643526|Psoriatic arthritis|psoriatic arthritis
617518|NCT00643526|Ankylosing spondylitis|ankylosing spondylitis
617520|NCT00643526|Autoinjector|autoinjector
617521|NCT00643552|Muscle Strength|muscle strength
617522|NCT00643578|formoterol|formoterol
617523|NCT00643578|methacholine challenge|methacholine challenge
617524|NCT00643591|high grade glioma|high grade glioma
617525|NCT00643591|FDG-PET-CT|fdg-pet-ct
617526|NCT00643591|blood proteins|blood proteins
617527|NCT00643591|prognosis|prognosis
617528|NCT00643604|Pulmonary arterial hypertension|pulmonary arterial hypertension
617529|NCT00643604|treatment satisfaction|treatment satisfaction
617530|NCT00643604|rapid switch|rapid switch
617531|NCT00643604|remodulin|remodulin
617532|NCT00643604|Quality of life|quality of life
617533|NCT00643617|Prostate Cancer|prostate cancer
617534|NCT00643617|CyberKnife|cyberknife
617535|NCT00643617|Stereotactic Radiosurgery|stereotactic radiosurgery
617536|NCT00643617|Radiosurgery|radiosurgery
617537|NCT00643617|Prostate Tumor|prostate tumor
617538|NCT00643617|Prostate Surgery|prostate surgery
617539|NCT00643630|Tetrix crea|tetrix crea
617540|NCT00643630|skin barrier|skin barrier
617541|NCT00643630|antigen reaction|antigen reaction
617542|NCT00643630|prevention|prevention
617543|NCT00643630|The efficacy of Tetrix Cream to prevent an antigen reaction on the skin.|the efficacy of tetrix cream to prevent an antigen reaction on the skin.
617544|NCT00643643|HIV|hiv
617545|NCT00643643|Treatment Naïve|treatment naïve
617546|NCT00643656|Liver biopsy|liver biopsy
617547|NCT00643682|colonoscopy|colonoscopy
617548|NCT00643682|bowel preparation|bowel preparation
617549|NCT00643682|patient education|patient education
617550|NCT00643682|polyp detection|polyp detection
617551|NCT00643695|hepatitis C|hepatitis c
617552|NCT00643695|depression|depression
617553|NCT00643695|exercise|exercise
617554|NCT00643708|anovulation|anovulation
617555|NCT00643708|laser|laser
617556|NCT00643708|ovarian interstitial|ovarian interstitial
617557|NCT00643708|polycystic ovary syndrome|polycystic ovary syndrome
617558|NCT00643708|ultrasound-guided|ultrasound-guided
617559|NCT00643721|Young healthy athletes|young healthy athletes
617560|NCT00643747|retinal dystrophy|retinal dystrophy
617561|NCT00643747|Leber congenital amaurosis|leber congenital amaurosis
617562|NCT00643747|RPE65|rpe65
617563|NCT00643747|gene therapy|gene therapy
617564|NCT00643760|Peripheral Diabetic Neuropathy (PDN)|peripheral diabetic neuropathy (pdn)
617565|NCT00643760|Neuropathic Pain|neuropathic pain
617566|NCT00643773|Elderly|elderly
617567|NCT00643812|Firearm storage|firearm storage
617568|NCT00643812|Suicide|suicide
617569|NCT00643812|Unintentional injury|unintentional injury
617570|NCT00643812|Alaska Native|alaska native
617571|NCT00643812|Suicide Attempt|suicide attempt
617572|NCT00643825|Temozolomide|temozolomide
617573|NCT00643825|Phase II|phase ii
617574|NCT00643825|Chemotherapy|chemotherapy
617575|NCT00643825|Glioblastoma|glioblastoma
617576|NCT00643825|Progression-free Survival|progression-free survival
617577|NCT00643864|mirror training|mirror training
617578|NCT00643864|stroke|stroke
617579|NCT00643864|hemiparesis|hemiparesis
617580|NCT00643864|rehabilitation|rehabilitation
617581|NCT00643877|Colorectal Neoplasms|colorectal neoplasms
617582|NCT00643877|Regional|regional
617583|NCT00643877|Liver|liver
617584|NCT00643877|Neoplasm Metastasis|neoplasm metastasis
617585|NCT00643890|Keywords:|keywords:
617586|NCT00643890|Parkinson's disease|parkinson's disease
617587|NCT00643890|Gene transfer|gene transfer
617588|NCT00643890|Gene therapy|gene therapy
617589|NCT00643890|Subthalamic nucleus|subthalamic nucleus
617590|NCT00643890|Adeno-associated virus|adeno-associated virus
617591|NCT00643890|Study placed in the following topic categories:|study placed in the following topic categories:
617592|NCT00643890|Ganglion Cysts|ganglion cysts
617593|NCT00643890|Movement Disorders|movement disorders
617594|NCT00643890|Parkinson Disease|parkinson disease
617595|NCT00643890|Basal Ganglia Diseases|basal ganglia diseases
617596|NCT00643890|Central Nervous System Diseases|central nervous system diseases
617597|NCT00643890|Parkinsonian Disorders|parkinsonian disorders
617598|NCT00643890|Neurodegenerative Diseases|neurodegenerative diseases
617599|NCT00643890|Brain Diseases|brain diseases
617600|NCT00643890|Additional relevant MeSH terms:|additional relevant mesh terms:
617601|NCT00643890|Nervous System Diseases|nervous system diseases
617602|NCT00643903|Side Effects|side effects
617603|NCT00643903|Adherence|adherence
617604|NCT00643903|Coping|coping
617605|NCT00643903|HIV|hiv
617606|NCT00643903|AIDS|aids
617607|NCT00643903|Complementary Therapies|complementary therapies
617608|NCT00643916|Meningitis; Meningococcal Infection|meningitis; meningococcal infection
617609|NCT00643929|thrombopoietin receptor agonist|thrombopoietin receptor agonist
617610|NCT00643929|ocular safety|ocular safety
617611|NCT00643929|HCV|hcv
617612|NCT00643929|SB-497115-GR|sb-497115-gr
617613|NCT00643929|CIT|cit
617614|NCT00643929|ITP|itp
617615|NCT00643929|cataract|cataract
617616|NCT00643929|eltrombopag olamine|eltrombopag olamine
617617|NCT00643929|lens opacity|lens opacity
617618|NCT00643955|Evaluation of muscle strength and central activation|evaluation of muscle strength and central activation
617619|NCT00643968|HIV virological control|hiv virological control
617620|NCT00643968|Lipid profile and morphological fat distribution|lipid profile and morphological fat distribution
617621|NCT00643968|Treatment Experienced|treatment experienced
617622|NCT00643994|Prostate Cancer|prostate cancer
617623|NCT00643994|CyberKnife|cyberknife
617624|NCT00643994|Stereotactic Radiosurgery|stereotactic radiosurgery
617625|NCT00643994|Radiotherapy|radiotherapy
617626|NCT00643994|Radiation|radiation
617627|NCT00643994|Prostate Tumor|prostate tumor
617628|NCT00643994|Prostate Surgery|prostate surgery
617629|NCT00644007|Erectile dysfunction|erectile dysfunction
617630|NCT00644007|Hypertension|hypertension
617631|NCT00644007|SK3530|sk3530
617632|NCT00644020|Hepatocellular carcinoma|hepatocellular carcinoma
617633|NCT00644020|recurrence|recurrence
617634|NCT00644046|Chronic Kidney Disease|chronic kidney disease
617635|NCT00644046|Prevention|prevention
617636|NCT00644046|Cardiovascular disease|cardiovascular disease
617637|NCT00644059|Influenza|influenza
617638|NCT00644059|vaccine|vaccine
617639|NCT00644059|children|children
617640|NCT00644072|Hsp90 Inhibitor|hsp90 inhibitor
617641|NCT00644072|Her2|her2
617642|NCT00644072|Neoplasms|neoplasms
617643|NCT00644072|Advanced Cancer|advanced cancer
617644|NCT00644072|Cancer|cancer
617645|NCT00644072|Solid Tumor|solid tumor
617646|NCT00644072|Lymphoma|lymphoma
617647|NCT00644085|IVF and ICSI|ivf and icsi
617648|NCT00644111|Minimally Invasive Decompression and Fusion|minimally invasive decompression and fusion
617649|NCT00644111|Postoperative analgesia|postoperative analgesia
617650|NCT00644111|Epidural|epidural
617651|NCT00644111|Lumbar|lumbar
617652|NCT00644124|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
617653|NCT00644124|angiogenesis inhibitors|angiogenesis inhibitors
617654|NCT00644124|CHOP protocol|chop protocol
617655|NCT00644137|smoking sensations|smoking sensations
617656|NCT00644137|no cravings|no cravings
617657|NCT00644137|desire to smoke|desire to smoke
617658|NCT00644150|Risk Reduction Counseling|risk reduction counseling
617659|NCT00644150|Anhui, China|anhui, china
617660|NCT00644150|HIV|hiv
617661|NCT00644150|STI|sti
617662|NCT00644163|HIV|hiv
617663|NCT00644163|STI|sti
617664|NCT00644163|Risk Reduction|risk reduction
617665|NCT00644163|Couples|couples
617666|NCT00644163|African American|african american
617667|NCT00644163|HIV Seronegativity|hiv seronegativity
617668|NCT00644189|clofarabine|clofarabine
617669|NCT00644189|Clolar|clolar
617670|NCT00644189|lymphoma|lymphoma
617671|NCT00644189|NHL|nhl
617672|NCT00644189|oral chemotherapy|oral chemotherapy
617673|NCT00644202|weight control|weight control
617674|NCT00644215|injected bleb|injected bleb
617675|NCT00644215|mitomycin drop|mitomycin drop
617676|NCT00644215|5-Fu injection|5-fu injection
617677|NCT00644215|early bleb failure|early bleb failure
617678|NCT00644241|stem cell therapy|stem cell therapy
617679|NCT00644241|T2DM|t2dm
617680|NCT00644241|Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus|efficacy of autologous bone marrow derived stem cell transplantation in patients with type 2 diabetes mellitus
617681|NCT00644254|Prognosis|prognosis
617682|NCT00644254|Extracapsular lymph node involvement|extracapsular lymph node involvement
617683|NCT00644267|hypertension|hypertension
617684|NCT00644267|cardiovascular risk|cardiovascular risk
617685|NCT00644267|risk score|risk score
617686|NCT00644280|Glaucoma,Ahmed Valve|glaucoma,ahmed valve
617687|NCT00644306|Multiple Myeloma, very elderly patients, thalidomide|multiple myeloma, very elderly patients, thalidomide
617688|NCT00644319|malignant pleural effusion|malignant pleural effusion
617689|NCT00644345|Microvolt T wave alternans|microvolt t wave alternans
617690|NCT00644345|reproducibility|reproducibility
617691|NCT00644371|Allogeneic|allogeneic
617692|NCT00644371|Lymphoma|lymphoma
617693|NCT00644371|GELTAMO|geltamo
617694|NCT00644371|Z-RIC|z-ric
617695|NCT00644384|basal cell carcinoma of the skin|basal cell carcinoma of the skin
617696|NCT00644384|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
617697|NCT00644397|distal femur fracture|distal femur fracture
617698|NCT00644397|locked plates|locked plates
617699|NCT00644397|functional outcomes|functional outcomes
617700|NCT00644397|cost management|cost management
617701|NCT00644397|femur head|femur head
617702|NCT00644397|femur neck|femur neck
617703|NCT00644410|heart failure|heart failure
617704|NCT00644410|stem cell|stem cell
617705|NCT00644410|mesenchymal stromal cell|mesenchymal stromal cell
617706|NCT00644410|mesenchymal stem cell|mesenchymal stem cell
617707|NCT00644423|PTSD|ptsd
617708|NCT00644423|Cognition|cognition
617709|NCT00644423|Fish Oil|fish oil
617710|NCT00644423|Omega-3 Fatty Acid|omega-3 fatty acid
617711|NCT00644436|tetrix cream|tetrix cream
617712|NCT00644436|substantivity|substantivity
617713|NCT00644436|resistance to a gentle wash|resistance to a gentle wash
617714|NCT00644436|Tetrix Cream remaining on hands after gentle washing with soap and water.|tetrix cream remaining on hands after gentle washing with soap and water.
617715|NCT00644462|wheeze detection|wheeze detection
617716|NCT00644475|Hypertension|hypertension
617717|NCT00644475|Insulin sensitivity|insulin sensitivity
617718|NCT00644475|Fibrinolysis|fibrinolysis
617719|NCT00644501|type 1 diabetes|type 1 diabetes
617720|NCT00644501|beta cells|beta cells
617721|NCT00644501|immunomodulation|immunomodulation
617722|NCT00644501|immunointervention|immunointervention
617723|NCT00644514|LPS endotoxin|lps endotoxin
617724|NCT00644514|Asthma|asthma
617725|NCT00644527|depression|depression
617726|NCT00644527|music|music
617727|NCT00644527|sound|sound
617728|NCT00644527|randomized controlled trial|randomized controlled trial
620060|NCT00661453|SMA|sma
617729|NCT00644540|Influenza|influenza
617730|NCT00644540|vaccines|vaccines
617731|NCT00644540|children|children
617732|NCT00644566|ADHD|adhd
617733|NCT00644566|Primary Care|primary care
617734|NCT00644566|Pediatrics|pediatrics
617735|NCT00644566|Health services|health services
617736|NCT00644566|shared care|shared care
617737|NCT00644566|care manager|care manager
617738|NCT00644566|screening|screening
617739|NCT00644579|wart|wart
617740|NCT00644579|cutaneous|cutaneous
617741|NCT00644579|transplant|transplant
617742|NCT00644579|Cutaneous warts in immune suppressed, kidney transplant patients|cutaneous warts in immune suppressed, kidney transplant patients
617743|NCT00644592|Healthy Volunteers|healthy volunteers
617744|NCT00644618|pancreatic cancer|pancreatic cancer
617745|NCT00644618|locally advanced|locally advanced
617746|NCT00644644|NTX|ntx
617747|NCT00644644|Nihon Kohden|nihon kohden
617748|NCT00644644|mobile monitoring|mobile monitoring
617749|NCT00644657|Platelets, platelet aggregation inhibitors|platelets, platelet aggregation inhibitors
617750|NCT00644683|premenopausal women with breast cancer|premenopausal women with breast cancer
617751|NCT00644696|Neuroblastoma|neuroblastoma
617752|NCT00644696|Irinotecan|irinotecan
617753|NCT00644696|Bortezomib|bortezomib
617754|NCT00644722|Intubation|intubation
617755|NCT00644722|Out-of-hospital|out-of-hospital
617756|NCT00644722|Laryngoscope|laryngoscope
617757|NCT00644722|Blades|blades
617758|NCT00644722|Emergency|emergency
617759|NCT00644735|Erosive Esophagitis|erosive esophagitis
617760|NCT00644735|Nexium|nexium
617761|NCT00644735|Esomeprazole|esomeprazole
617762|NCT00644735|Lansoprazole|lansoprazole
617763|NCT00644735|Heartburn|heartburn
617764|NCT00644761|Hepatitis B|hepatitis b
617765|NCT00644761|Post-Liver Transplantation|post-liver transplantation
617766|NCT00644761|Adefovir Dipivoxil|adefovir dipivoxil
617767|NCT00644761|Tacrolimus|tacrolimus
617768|NCT00644761|Cyclosporine|cyclosporine
617769|NCT00644774|pediatric taste test|pediatric taste test
617770|NCT00644774|antibiotic taste test|antibiotic taste test
617771|NCT00644774|cefdinir|cefdinir
617772|NCT00644774|azithromycin|azithromycin
617773|NCT00644787|Pain|pain
617774|NCT00644787|Cancer|cancer
617775|NCT00644787|Fentanyl|fentanyl
617776|NCT00644787|JNS020QD|jns020qd
617777|NCT00644787|JNS005|jns005
617778|NCT00644826|randomized controlled trial|randomized controlled trial
617779|NCT00644826|public health|public health
617780|NCT00644826|Preventive Health Services|preventive health services
617781|NCT00644852|Schizophrenia|schizophrenia
617782|NCT00644852|Schizoaffective disorder|schizoaffective disorder
752354|NCT01172613|concentration of diagnostic reagent|concentration of diagnostic reagent
617783|NCT00644852|Risperidone long-acting injectable, Long-term evaluation|risperidone long-acting injectable, long-term evaluation
617784|NCT00644878|leukemia|leukemia
617785|NCT00644878|chronic myelogenous leukemia|chronic myelogenous leukemia
617786|NCT00644878|chronic phase|chronic phase
617787|NCT00644878|molecular response|molecular response
617788|NCT00644878|nilotinib|nilotinib
617789|NCT00644878|ENABL|enabl
617790|NCT00644891|Pediatric taste test|pediatric taste test
617791|NCT00644891|Antibiotic taste test|antibiotic taste test
617792|NCT00644891|cefdinir|cefdinir
617793|NCT00644891|amoxicillin|amoxicillin
617794|NCT00644904|Multiple Sclerosis|multiple sclerosis
617795|NCT00644904|Vitamin D|vitamin d
617796|NCT00644904|Safety|safety
617797|NCT00644917|wound healing|wound healing
617798|NCT00644917|phototoxicity|phototoxicity
617799|NCT00644917|Healthy Subjects|healthy subjects
617800|NCT00644930|ARDS,|ards,
617801|NCT00644930|noninvasive ventilation,|noninvasive ventilation,
617802|NCT00644930|intubation,|intubation,
617804|NCT00644930|intensive care|intensive care
617805|NCT00644995|Depression|depression
617807|NCT00644995|Physical Activity|physical activity
617808|NCT00645008|Stressors|stressors
617809|NCT00645008|Patient Satisfaction|patient satisfaction
617810|NCT00645008|Cardiothoracic-Intensive Care Unit|cardiothoracic-intensive care unit
617811|NCT00645008|Coronary bypass patient|coronary bypass patient
617812|NCT00645047|PTSD|ptsd
617813|NCT00645047|Telemedicine|telemedicine
617814|NCT00645047|Patient-Centered Care|patient-centered care
617815|NCT00645047|Professional Patient Relationship|professional patient relationship
617816|NCT00645047|Psychotherapy|psychotherapy
617817|NCT00645047|Cognitive Therapy|cognitive therapy
617818|NCT00645060|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
617819|NCT00645073|Acute Bacterial Sinusitis|acute bacterial sinusitis
617820|NCT00645099|Paliperidone ER|paliperidone er
617821|NCT00645099|Olanzapine|olanzapine
617822|NCT00645099|Schizophrenia|schizophrenia
617823|NCT00645125|pediatric taste test|pediatric taste test
617824|NCT00645125|antibiotic taste test|antibiotic taste test
617825|NCT00645125|cefdinir|cefdinir
617826|NCT00645125|amoxicillin|amoxicillin
617827|NCT00645138|breast carcinoma|breast carcinoma
617828|NCT00645138|breast cancer|breast cancer
617829|NCT00645138|paravertebral block|paravertebral block
617830|NCT00645138|comparison of paravertebral block and general anesthesia|comparison of paravertebral block and general anesthesia
617831|NCT00645138|ultrasound|ultrasound
617832|NCT00645164|wound healing|wound healing
617833|NCT00645164|photoallergenicity|photoallergenicity
617834|NCT00645164|Healthy subjects|healthy subjects
617835|NCT00645177|Breast Cancer|breast cancer
617836|NCT00645190|Alzheimer Disease|alzheimer disease
617837|NCT00645190|galantamine|galantamine
617838|NCT00645294|Hepatitis B|hepatitis b
617839|NCT00645294|Adefovir dipivoxil|adefovir dipivoxil
617840|NCT00645294|Children|children
617841|NCT00645294|Adolescents|adolescents
617842|NCT00645294|Pharmacokinetics|pharmacokinetics
617843|NCT00645307|paliperidone|paliperidone
617844|NCT00645307|Schizophrenia|schizophrenia
617845|NCT00645333|breast cancer|breast cancer
617846|NCT00645333|Phase I clinical trial|phase i clinical trial
617847|NCT00645333|cancer stem cells|cancer stem cells
617848|NCT00645333|agents with other mechanisms of action|agents with other mechanisms of action
617849|NCT00645333|Notch inhibitors|notch inhibitors
617850|NCT00645346|GBS|gbs
617851|NCT00645359|dMRI|dmri
617852|NCT00645359|diffusion MRI|diffusion mri
617853|NCT00645359|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
617854|NCT00645359|DLBCL|dlbcl
617855|NCT00645385|GBM|gbm
617856|NCT00645385|AA|aa
617857|NCT00645385|AO|ao
617858|NCT00645385|Brain|brain
617859|NCT00645385|Tumors|tumors
617860|NCT00645385|Malignant|malignant
617861|NCT00645385|Glioblastoma|glioblastoma
617862|NCT00645385|Multiforme|multiforme
617863|NCT00645385|Carmustine|carmustine
617864|NCT00645385|implant|implant
617865|NCT00645385|BCNU|bcnu
617866|NCT00645385|Gliadel|gliadel
617867|NCT00645385|Wafers|wafers
617868|NCT00645385|MRS|mrs
617869|NCT00645385|Spectroscopy|spectroscopy
617870|NCT00645411|Influenza|influenza
617871|NCT00645411|Flu|flu
617872|NCT00645411|Cell Culture-Derived|cell culture-derived
617873|NCT00645411|Egg-Derived|egg-derived
617874|NCT00645411|Healthy Children|healthy children
617875|NCT00645411|Healthy Adolescents|healthy adolescents
617876|NCT00645411|Safety|safety
617877|NCT00645411|Immunogenicity|immunogenicity
617878|NCT00645411|Trivalent|trivalent
617879|NCT00645411|Inactivated|inactivated
617880|NCT00645411|Vaccination|vaccination
617881|NCT00645437|renal diseases|renal diseases
617882|NCT00645437|levofloxacin|levofloxacin
617883|NCT00652821|bioequivalence, single-dose, fed|bioequivalence, single-dose, fed
617884|NCT00652834|Renal transplant recipients|renal transplant recipients
617885|NCT00652834|Gastrointestinal findings in small bowel capsule endoscopy|gastrointestinal findings in small bowel capsule endoscopy
617886|NCT00652834|Mycophenolic acid|mycophenolic acid
617887|NCT00652834|Mycophenolate Mofetil|mycophenolate mofetil
617888|NCT00652834|Mycophenolate Sodium|mycophenolate sodium
617889|NCT00652860|lung metastases|lung metastases
617890|NCT00652860|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
617891|NCT00652873|Bioequivalence|bioequivalence
617892|NCT00652873|Cabergoline|cabergoline
617893|NCT00652873|Fed|fed
617894|NCT00652886|Bioequivalence, Oxandrolone,fasting|bioequivalence, oxandrolone,fasting
617895|NCT00652899|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
617896|NCT00652899|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
617897|NCT00652899|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
617898|NCT00652899|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
617899|NCT00652899|fallopian tube cancer|fallopian tube cancer
617900|NCT00652899|peritoneal cavity cancer|peritoneal cavity cancer
617901|NCT00652912|bioequivalence, Clonazepam ODT , fasting|bioequivalence, clonazepam odt , fasting
617902|NCT00652925|arthritis|arthritis
617903|NCT00652925|juvenile|juvenile
617904|NCT00652938|Co-administration|co-administration
617905|NCT00652938|HPV vaccine|hpv vaccine
617906|NCT00652938|Cervical cancer|cervical cancer
617907|NCT00652964|sleep apnea, PHOX2B, hypoventilation, polysomnography|sleep apnea, phox2b, hypoventilation, polysomnography
617908|NCT00652977|sphincter tears|sphincter tears
617909|NCT00652977|Ritgen maneuver|ritgen maneuver
617910|NCT00652977|perineal tears|perineal tears
617911|NCT00652977|prevention|prevention
617912|NCT00652977|delivery|delivery
617913|NCT00653003|Bioequivalence, Leflunomide, fed|bioequivalence, leflunomide, fed
617914|NCT00653016|Contraception|contraception
617915|NCT00653016|norelgestromin|norelgestromin
617916|NCT00653016|ethinyl estradiol|ethinyl estradiol
617917|NCT00653016|transdermal contraceptive patch|transdermal contraceptive patch
617918|NCT00653016|EVRA|evra
617919|NCT00653016|ORTHO EVRA|ortho evra
617920|NCT00653029|Post concussion syndrome|post concussion syndrome
617921|NCT00653029|Mild traumatic brain injury|mild traumatic brain injury
617922|NCT00653029|Effort|effort
617924|NCT00653042|Myocardial Ischemia|myocardial ischemia
617925|NCT00653042|kidney failure|kidney failure
617926|NCT00653042|CABG|cabg
617927|NCT00653042|cardiopulmonary bypass (CPB) pump|cardiopulmonary bypass (cpb) pump
617928|NCT00653042|Coronary Artery Bypass Surgery|coronary artery bypass surgery
617929|NCT00653042|heart surgery|heart surgery
617930|NCT00653042|nesiritide|nesiritide
617931|NCT00653042|Coronary Heart Disease|coronary heart disease
617932|NCT00653055|Bioequivalence|bioequivalence
617933|NCT00653055|Cabergoline|cabergoline
617934|NCT00653055|Fasting|fasting
617935|NCT00653081|Shoulder pain|shoulder pain
617936|NCT00653081|Supervised Exercises|supervised exercises
617937|NCT00653081|Radial Shock Wave Therapy|radial shock wave therapy
617938|NCT00653094|crohn|crohn
617939|NCT00653094|fistula|fistula
617940|NCT00653094|surgery|surgery
617941|NCT00653094|fibrin glue|fibrin glue
617942|NCT00653094|seton drainage|seton drainage
617943|NCT00653107|Palliation|palliation
617944|NCT00653107|Cancer oesophagus|cancer oesophagus
617945|NCT00653107|Stent|stent
617946|NCT00653107|Brachytherapy|brachytherapy
617947|NCT00653107|Randomized|randomized
617948|NCT00653120|Bioequivalence, Propranolol ER capsules, fasting|bioequivalence, propranolol er capsules, fasting
617949|NCT00653133|ultrasonography|ultrasonography
617950|NCT00653133|peripheral nerve block|peripheral nerve block
617951|NCT00653133|peripheral nerve stimulation|peripheral nerve stimulation
617952|NCT00653146|cervical cancer|cervical cancer
617953|NCT00653146|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
617954|NCT00653146|human papilloma virus infection|human papilloma virus infection
617955|NCT00653146|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
617956|NCT00653146|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
617957|NCT00653159|Intrauterine device, contraception, unplanned pregnancy|intrauterine device, contraception, unplanned pregnancy
617958|NCT00654394|Cholesterol|cholesterol
617959|NCT00654394|Carotid Artery Stenosis|carotid artery stenosis
617960|NCT00654394|Hypercholesterolemia|hypercholesterolemia
617961|NCT00654394|Rosuvastatin|rosuvastatin
617962|NCT00654394|Crestor|crestor
617963|NCT00654407|Cholesterol|cholesterol
617964|NCT00654407|hypercholesterolemia|hypercholesterolemia
617965|NCT00654407|Coronary Heart disease|coronary heart disease
617966|NCT00654407|low density lipoproteins|low density lipoproteins
617967|NCT00654407|Rosuvastatin|rosuvastatin
617968|NCT00654407|Atorvastatin|atorvastatin
617969|NCT00654407|simvastatin|simvastatin
617970|NCT00654433|Hurler Syndrome|hurler syndrome
617971|NCT00654433|MPS I|mps i
617972|NCT00654433|Hurler-Scheie Syndrome|hurler-scheie syndrome
617973|NCT00654433|Hunter Syndrome|hunter syndrome
617974|NCT00654433|MPS II|mps ii
617975|NCT00654433|Sanfilippo Syndrome|sanfilippo syndrome
617976|NCT00654433|MPS III|mps iii
617977|NCT00654433|Maroteaux-Lamy Syndrome|maroteaux-lamy syndrome
617978|NCT00654433|MPS VI|mps vi
617979|NCT00654433|Krabbe Disease|krabbe disease
617980|NCT00654433|Globoid Leukodystrophy|globoid leukodystrophy
617981|NCT00654433|Metachromatic Leukodystrophy|metachromatic leukodystrophy
617983|NCT00654433|Adrenoleukodystrophy|adrenoleukodystrophy
617985|NCT00654433|Adrenomyeloneuropathy|adrenomyeloneuropathy
617986|NCT00654433|AMN|amn
617987|NCT00654433|Sandhoff Disease|sandhoff disease
617988|NCT00654433|Tay Sachs Disease|tay sachs disease
617989|NCT00654433|Pelizaeus Merzbacher|pelizaeus merzbacher
617990|NCT00654433|PMD|pmd
617991|NCT00654433|Niemann-Pick Disease A|niemann-pick disease a
617992|NCT00654433|Niemann-Pick Disease B|niemann-pick disease b
617993|NCT00654433|Alpha-mannosidosis|alpha-mannosidosis
617994|NCT00654433|Inherited metabolic diseases|inherited metabolic diseases
617995|NCT00654433|Inborn errors of metabolism|inborn errors of metabolism
617996|NCT00654433|Lysosomal storage diseases|lysosomal storage diseases
617997|NCT00654433|Peroxisomal storage diseases|peroxisomal storage diseases
617998|NCT00654433|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
617999|NCT00654433|Umbilical cord blood transplantation|umbilical cord blood transplantation
618000|NCT00654433|Mucopolysaccharidosis|mucopolysaccharidosis
618001|NCT00654433|Mucopolysaccharidosis I|mucopolysaccharidosis i
618002|NCT00654433|Mucopolysaccharidosis II|mucopolysaccharidosis ii
618003|NCT00654433|Mucopolysaccharidosis III|mucopolysaccharidosis iii
618004|NCT00654433|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
618005|NCT00654433|I Cell disease|i cell disease
618006|NCT00654433|Fucosidosis|fucosidosis
618007|NCT00654433|GM1 Gangliosidosis|gm1 gangliosidosis
618008|NCT00654433|Canavan Disease|canavan disease
618009|NCT00654446|Cholesterol|cholesterol
618010|NCT00654446|low density lipoproteins|low density lipoproteins
618011|NCT00654446|dyslipidaemia|dyslipidaemia
618012|NCT00654446|Rosuvastatin|rosuvastatin
618014|NCT00654446|Simvastatin|simvastatin
618015|NCT00654446|Zocor|zocor
618016|NCT00654446|Renal|renal
618017|NCT00654446|kidney|kidney
618018|NCT00654472|magnetic resonance imaging, mitral valve area|magnetic resonance imaging, mitral valve area
618019|NCT00654485|Cholesterol|cholesterol
618020|NCT00654485|hypercholesterolemia|hypercholesterolemia
618021|NCT00654485|low density lipoproteins|low density lipoproteins
618022|NCT00654485|metabolic syndrome|metabolic syndrome
618023|NCT00654485|Rosuvastatin|rosuvastatin
618024|NCT00654511|Dexmedetomidine,|dexmedetomidine,
618025|NCT00654511|fentanyl,|fentanyl,
618026|NCT00654511|tonsillectomy|tonsillectomy
618027|NCT00654511|and adenoidectomy,|and adenoidectomy,
618028|NCT00654524|Endometriosis|endometriosis
618029|NCT00654524|Recurrence|recurrence
618030|NCT00654524|Pregnancy Rate|pregnancy rate
618031|NCT00654524|Laparoscopy|laparoscopy
618032|NCT00654524|Gonadotropin-Releasing Hormone|gonadotropin-releasing hormone
618033|NCT00654537|Cholesterol|cholesterol
618034|NCT00654537|hypercholesterolemia|hypercholesterolemia
618035|NCT00654537|low density lipoproteins|low density lipoproteins
618036|NCT00654550|Photorefractive keratectomy|photorefractive keratectomy
618037|NCT00654550|Re-epithelialization|re-epithelialization
618038|NCT00654550|Nexagon|nexagon
618039|NCT00654550|PRK|prk
618040|NCT00654550|Coda|coda
618041|NCT00654563|Memory Disorders|memory disorders
618042|NCT00654563|Memory loss|memory loss
618043|NCT00654563|Age Associated Memory Impairment|age associated memory impairment
618044|NCT00654576|schizophrenia|schizophrenia
618045|NCT00654576|antipsychotic|antipsychotic
618046|NCT00654576|outcome|outcome
618047|NCT00654576|psychosocial intervention|psychosocial intervention
618048|NCT00654589|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
618049|NCT00654589|HCT|hct
618050|NCT00654589|iron overload|iron overload
618051|NCT00654589|chelators|chelators
618052|NCT00654589|ICL670|icl670
618053|NCT00654589|deferasirox|deferasirox
618054|NCT00654589|serum ferritin|serum ferritin
618055|NCT00654589|LIC|lic
618056|NCT00654589|transfusional hemosiderosis|transfusional hemosiderosis
618057|NCT00654589|blood transfusions|blood transfusions
618058|NCT00654589|adults|adults
618059|NCT00654589|iron chelation|iron chelation
618060|NCT00654589|3-6 months|3-6 months
618061|NCT00654589|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
618062|NCT00654602|cholesterol|cholesterol
618063|NCT00654602|low density lipoproteins|low density lipoproteins
618064|NCT00654602|dyslipidaemia|dyslipidaemia
618065|NCT00654602|Rosuvastatin|rosuvastatin
618066|NCT00654602|Crestor|crestor
618067|NCT00654615|unstable metaphyseal distal radius fractures|unstable metaphyseal distal radius fractures
618068|NCT00654615|randomized controlled trial|randomized controlled trial
618069|NCT00654615|surgical fixation|surgical fixation
618070|NCT00654615|volar plate|volar plate
618071|NCT00654615|intramedullary distal radius fixation system|intramedullary distal radius fixation system
618072|NCT00654641|Surgical Wound Dehiscence|surgical wound dehiscence
618073|NCT00654641|Wound Infection|wound infection
618074|NCT00654641|Obesity|obesity
618075|NCT00654641|Cesarean Delivery|cesarean delivery
618076|NCT00654641|Wound Closure|wound closure
618077|NCT00654641|Negative Pressure wound closure|negative pressure wound closure
618078|NCT00654667|Resveratrol|resveratrol
618079|NCT00654667|Insulin Resistance|insulin resistance
618080|NCT00654667|Metabolic Syndrome|metabolic syndrome
618081|NCT00654667|Sirtuin 1|sirtuin 1
618082|NCT00654667|IGF-1|igf-1
618083|NCT00654667|Satiety|satiety
618084|NCT00654667|Leptin|leptin
618085|NCT00654667|Adiponectin|adiponectin
618086|NCT00654680|Erectile Dysfunction|erectile dysfunction
618087|NCT00654680|Traumatic spinal cord injury|traumatic spinal cord injury
618088|NCT00654680|Vardenafil|vardenafil
618089|NCT00654693|NTX|ntx
618090|NCT00654693|Nihon Kohden|nihon kohden
618091|NCT00654693|mobile monitoring|mobile monitoring
618092|NCT00654693|monitoring|monitoring
618093|NCT00654693|nihon|nihon
618094|NCT00654693|kohden|kohden
618095|NCT00654693|monitoring device|monitoring device
618096|NCT00654693|remote monitoring|remote monitoring
618097|NCT00654693|wireless|wireless
618098|NCT00654706|Schizophrenia|schizophrenia
618099|NCT00654706|Cognition|cognition
618302|NCT00655486|Epilepsy|epilepsy
618100|NCT00654706|MATRICS Consensus Cognitive Battery|matrics consensus cognitive battery
618101|NCT00654719|Heart failure|heart failure
618102|NCT00654719|cachexia|cachexia
618103|NCT00654732|Hodgkin Lymphoma|hodgkin lymphoma
618104|NCT00654732|Lymphoma|lymphoma
618105|NCT00654732|Adriamycin|adriamycin
618106|NCT00654732|Doxorubicin Hydrochloride|doxorubicin hydrochloride
618107|NCT00654732|Adriamycin PFS®|adriamycin pfs®
618108|NCT00654732|Adriamycin RDF™|adriamycin rdf™
618109|NCT00654732|Rituxan|rituxan
618110|NCT00654732|Rituximab|rituximab
618111|NCT00654732|Bleomycin|bleomycin
618112|NCT00654732|Bleomycin sulfate|bleomycin sulfate
618113|NCT00654732|Blenoxane®|blenoxane®
618115|NCT00654732|Vinblastine|vinblastine
618116|NCT00654732|Velban|velban
618117|NCT00654732|Dacarbazine|dacarbazine
618118|NCT00654732|DTIC|dtic
618119|NCT00654732|DTIC-Dome®|dtic-dome®
618120|NCT00654732|R-ABVD|r-abvd
618121|NCT00654732|ABVD|abvd
618122|NCT00654745|blood pressure reduction|blood pressure reduction
618123|NCT00654758|cancer|cancer
618124|NCT00654758|carcinoma|carcinoma
618125|NCT00654758|chemotherapy|chemotherapy
618126|NCT00654758|monoclonal antibody therapy|monoclonal antibody therapy
618127|NCT00654758|anti-angiogenesis|anti-angiogenesis
618128|NCT00654771|protein/creatinine ratio|protein/creatinine ratio
618129|NCT00654771|clean catch urine|clean catch urine
618130|NCT00654771|catheterized urine|catheterized urine
618131|NCT00654784|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
618133|NCT00654784|Duchenne|duchenne
618134|NCT00654797|Glucose|glucose
618135|NCT00654797|Insulin|insulin
618136|NCT00654797|computer|computer
618137|NCT00654797|critical care|critical care
618138|NCT00654810|functional ability|functional ability
618139|NCT00654810|gait|gait
618140|NCT00654810|musculoskeletal disorder therapy|musculoskeletal disorder therapy
618141|NCT00654810|peripheral blood vessel disorder|peripheral blood vessel disorder
618142|NCT00654836|recurrent breast cancer|recurrent breast cancer
618143|NCT00654836|stage III breast cancer|stage iii breast cancer
618144|NCT00654836|stage IV breast cancer|stage iv breast cancer
618145|NCT00654849|Electrosurgery|electrosurgery
618146|NCT00654849|Gyrus Pk|gyrus pk
618147|NCT00654849|abdominal hysterectomy|abdominal hysterectomy
618148|NCT00654849|Blood Loss, Surgical|blood loss, surgical
618149|NCT00654849|Length of stay|length of stay
618150|NCT00654849|Overall cost|overall cost
618151|NCT00654875|Essential Hypertension|essential hypertension
618152|NCT00654888|cataract extraction|cataract extraction
618153|NCT00654888|surgery|surgery
618154|NCT00654888|corneal disease|corneal disease
618155|NCT00654901|Diphtheria|diphtheria
618156|NCT00654901|Tetanus|tetanus
618157|NCT00654901|Pertussis|pertussis
618158|NCT00654901|Hepatitis B|hepatitis b
618159|NCT00654901|Poliomyelitis|poliomyelitis
618160|NCT00654901|Invasive Haemophilus influenzae type b.|invasive haemophilus influenzae type b.
618161|NCT00654901|Haemophilus Influenzae Type B Infection|haemophilus influenzae type b infection
618162|NCT00654914|Sexual Dysfunction|sexual dysfunction
618163|NCT00654927|multiple sclerosis|multiple sclerosis
618164|NCT00654927|MS|ms
618165|NCT00654927|walking|walking
618166|NCT00654927|leg strength|leg strength
618167|NCT00654927|demyelination|demyelination
618168|NCT00654953|cocaine dependence|cocaine dependence
618169|NCT00654953|depressive symptoms|depressive symptoms
618170|NCT00654953|relapse|relapse
618171|NCT00654953|sertraline|sertraline
618172|NCT00654953|gabapentin|gabapentin
618173|NCT00654966|Urotensin II|urotensin ii
618174|NCT00654966|Soluble epoxide hydrolase|soluble epoxide hydrolase
618175|NCT00654966|Iontophoresis|iontophoresis
618176|NCT00654966|Healthy volunteers|healthy volunteers
618177|NCT00655005|head and neck cancer|head and neck cancer
618178|NCT00655018|Non-Alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
618179|NCT00655018|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
618180|NCT00655018|Liver histology|liver histology
618181|NCT00655018|Insulin Resistance|insulin resistance
618182|NCT00655018|Weight loss|weight loss
618183|NCT00655018|Alpha-tocopherol|alpha-tocopherol
618184|NCT00655018|ascorbic acid|ascorbic acid
618185|NCT00655031|Punicaceae|punicaceae
618186|NCT00655031|Pomegranate|pomegranate
618187|NCT00655057|Dopamine Transporter|dopamine transporter
618188|NCT00655057|Biomarker|biomarker
618189|NCT00655057|SPECT Brain Imaging|spect brain imaging
618190|NCT00655057|Antidepressant Therapy|antidepressant therapy
618191|NCT00655070|Hibernating Myocardium|hibernating myocardium
618192|NCT00655070|Blood Flow|blood flow
618193|NCT00655070|Ultrasound|ultrasound
618194|NCT00655070|PET imaging|pet imaging
618195|NCT00655083|Infantile colic|infantile colic
618196|NCT00655083|Abdominal Cramps|abdominal cramps
618197|NCT00655083|Colicky Pain|colicky pain
618198|NCT00655083|Functional gastrointestinal disorders|functional gastrointestinal disorders
618199|NCT00655096|Screening Protocol|screening protocol
618200|NCT00655096|Eye Diseases|eye diseases
618201|NCT00655109|Allergic conjunctivitis|allergic conjunctivitis
618202|NCT00655109|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
618203|NCT00655148|DTaP-IPV|dtap-ipv
618204|NCT00655148|Clinical Trial|clinical trial
618205|NCT00655148|Safety|safety
618206|NCT00655148|Immunogenicity|immunogenicity
618207|NCT00655161|NSCLC|nsclc
618208|NCT00655161|Cancer Immunotherapy|cancer immunotherapy
618209|NCT00655174|autism|autism
618210|NCT00655174|fluvoxamine|fluvoxamine
618211|NCT00655174|sertraline|sertraline
618212|NCT00655174|selective seratonin reuptake inhibitors|selective seratonin reuptake inhibitors
618213|NCT00655174|paediatrics|paediatrics
618214|NCT00655213|Pacing, AV conduction disorders, minimized ventricular pacing, AF|pacing, av conduction disorders, minimized ventricular pacing, af
618215|NCT00655226|Cognitive Behavior Therapy|cognitive behavior therapy
618216|NCT00655226|Interferon-alpha|interferon-alpha
618217|NCT00655226|Communicable Diseases|communicable diseases
618218|NCT00655226|Liver Diseases|liver diseases
618219|NCT00655226|Depression|depression
618220|NCT00655226|Hepatitis, Chronic|hepatitis, chronic
618221|NCT00655226|Interferons|interferons
618222|NCT00655226|Ribavirin|ribavirin
618223|NCT00655226|Hepatitis, Viral, Human|hepatitis, viral, human
618226|NCT00655226|Mood Disorders|mood disorders
618227|NCT00655226|Peginterferon alfa-2a|peginterferon alfa-2a
618228|NCT00655226|Hepatitis C|hepatitis c
618229|NCT00655226|Interferon Alfa-2a|interferon alfa-2a
618230|NCT00655226|Interferon Alfa-2b|interferon alfa-2b
618231|NCT00655226|Depressive Disorder, Major|depressive disorder, major
618232|NCT00655226|Depressive Disorder|depressive disorder
618233|NCT00655239|Ultra High Risk of Schizophrenia|ultra high risk of schizophrenia
618234|NCT00655239|Prodrome|prodrome
618235|NCT00655239|Psychosis|psychosis
618236|NCT00655239|Schizophrenia|schizophrenia
618237|NCT00655239|Cognitive Remediation|cognitive remediation
618238|NCT00655252|Expanded access|expanded access
618239|NCT00655252|metastatic renal cell cancer|metastatic renal cell cancer
618240|NCT00655252|progression despite VEGF receptors|progression despite vegf receptors
618241|NCT00655278|Movement Disorder|movement disorder
618242|NCT00655291|pain|pain
618243|NCT00655317|acupuncture|acupuncture
618244|NCT00655317|colon surgery|colon surgery
618245|NCT00655317|post operative ileus|post operative ileus
618246|NCT00655317|post ileus|post ileus
618247|NCT00655317|ileus|ileus
618248|NCT00655317|colectomy|colectomy
618249|NCT00655317|colorectal pathology|colorectal pathology
618250|NCT00655330|Type 2 diabetes mellitus|type 2 diabetes mellitus
618251|NCT00655330|Nephropathy|nephropathy
618252|NCT00655330|valsartan|valsartan
618253|NCT00655330|probucol|probucol
618254|NCT00655330|Proteinuria|proteinuria
618255|NCT00655343|GvHD|gvhd
618256|NCT00655343|aGvHD prophylaxis|agvhd prophylaxis
618257|NCT00655343|Matched unrelated donor|matched unrelated donor
618258|NCT00655343|ATG|atg
618259|NCT00655343|SCT|sct
618260|NCT00655343|BMT|bmt
618261|NCT00655343|polyclonal antibody|polyclonal antibody
618262|NCT00655343|GvHD prophylaxis for patients with ALL, AML, CML, MDS, OMF|gvhd prophylaxis for patients with all, aml, cml, mds, omf
618263|NCT00655343|Patients with allogeneic BM or PBSC transplantation|patients with allogeneic bm or pbsc transplantation
618264|NCT00655343|Patients with a matched unrelated donor|patients with a matched unrelated donor
618265|NCT00655356|Treatment of moderate to severe bilateral nasolabial fold wrinkles|treatment of moderate to severe bilateral nasolabial fold wrinkles
618266|NCT00655382|dynamic pelvic mri|dynamic pelvic mri
618267|NCT00655382|dynamic mri|dynamic mri
618268|NCT00655382|STARR procedure|starr procedure
618269|NCT00655382|STARR|starr
618270|NCT00655382|ODS|ods
618271|NCT00655382|obstructive defecation syndrome|obstructive defecation syndrome
618272|NCT00655382|outlet obstruction|outlet obstruction
618273|NCT00655382|obstructed defecation|obstructed defecation
618274|NCT00655382|stapled trans anal rectal resection|stapled trans anal rectal resection
618275|NCT00655395|Leukemia|leukemia
618276|NCT00655395|MDS|mds
618277|NCT00655408|Infants|infants
618278|NCT00655408|Prevalence|prevalence
618279|NCT00655408|Iron|iron
618280|NCT00655408|Deficiency|deficiency
618281|NCT00655408|Treatment|treatment
618282|NCT00655421|screening|screening
618283|NCT00655421|oral precancers|oral precancers
618284|NCT00655421|tobacco users|tobacco users
618285|NCT00655421|VELScope|velscope
618286|NCT00655421|Visual Inspection|visual inspection
618287|NCT00655421|Toluidine Blue|toluidine blue
618288|NCT00655434|Herpes simplex virus 2|herpes simplex virus 2
618289|NCT00655434|HSV 2|hsv 2
618290|NCT00655434|Antibody status to Herpesvirus 2, Human|antibody status to herpesvirus 2, human
618291|NCT00655447|oophorectomy|oophorectomy
618292|NCT00655447|ovarian conservation|ovarian conservation
618293|NCT00655447|stroke|stroke
618294|NCT00655447|breast cancer|breast cancer
618295|NCT00655447|ovarian cancer|ovarian cancer
618296|NCT00655447|other cancer|other cancer
618297|NCT00655447|hip fracture|hip fracture
618298|NCT00655460|Glucose|glucose
618299|NCT00655460|Insulin|insulin
618300|NCT00655460|computer|computer
618301|NCT00655460|critical care|critical care
618303|NCT00655486|seizures|seizures
618304|NCT00655486|antiepileptic|antiepileptic
618305|NCT00655486|Lacosamide|lacosamide
618306|NCT00655486|Vimpat|vimpat
618307|NCT00655486|safety|safety
618308|NCT00655486|adjunctive|adjunctive
618309|NCT00655499|adenocarcinoma of the colon|adenocarcinoma of the colon
618310|NCT00655499|adenocarcinoma of the rectum|adenocarcinoma of the rectum
618311|NCT00655499|stage IV colon cancer|stage iv colon cancer
618312|NCT00655499|recurrent rectal cancer|recurrent rectal cancer
618313|NCT00655499|stage IV rectal cancer|stage iv rectal cancer
618314|NCT00655499|recurrent colon cancer|recurrent colon cancer
618315|NCT00655512|pimecrolimus|pimecrolimus
618316|NCT00655512|hydrocortison|hydrocortison
618317|NCT00655512|betamethasone|betamethasone
618318|NCT00655512|clobetasol-17-Propionat|clobetasol-17-propionat
618319|NCT00655512|Optical Coherence Tomography|optical coherence tomography
618320|NCT00655512|skin healthy probands|skin healthy probands
618321|NCT00655525|inflammation|inflammation
618322|NCT00655525|end stage renal disease|end stage renal disease
618323|NCT00655551|epilepsy|epilepsy
618324|NCT00655551|seizures|seizures
618325|NCT00655551|Lacosamide|lacosamide
618326|NCT00655551|Vimpat|vimpat
618327|NCT00655551|intravenous|intravenous
618329|NCT00655577|Osteoporosis|osteoporosis
618330|NCT00655577|Exercise|exercise
618331|NCT00655577|Population based|population based
618332|NCT00655577|Randomized trial|randomized trial
618333|NCT00655577|Falls|falls
618334|NCT00655577|Fractures|fractures
618335|NCT00655590|Erectile Dysfunction|erectile dysfunction
618337|NCT00655590|Vardenafil|vardenafil
618338|NCT00655590|Spermatogenesis|spermatogenesis
618339|NCT00655590|Sperm concentration|sperm concentration
618340|NCT00655590|Sperm count|sperm count
618341|NCT00655590|Morphology|morphology
618342|NCT00655590|Motility|motility
618343|NCT00655590|Reproductive hormonal|reproductive hormonal
618344|NCT00655603|GLP-1|glp-1
618345|NCT00655603|Glucagon secretion|glucagon secretion
618346|NCT00655603|Glucose turn-over|glucose turn-over
618347|NCT00655629|Erectile Dysfunction|erectile dysfunction
618348|NCT00655668|NHL, Non-Hodgkin's Lymphoma, T-cell Lymphoma|nhl, non-hodgkin's lymphoma, t-cell lymphoma
618349|NCT00655681|pediatric osteoporosis|pediatric osteoporosis
618350|NCT00655681|pediatric osteopenia|pediatric osteopenia
618351|NCT00655681|pamidronate|pamidronate
618352|NCT00655681|post operative osteopenia|post operative osteopenia
618353|NCT00655694|COPD|copd
618354|NCT00655694|smokers|smokers
618355|NCT00655694|healthy volunteers|healthy volunteers
618356|NCT00655707|Adult stem cell therapy|adult stem cell therapy
618357|NCT00655720|infant formula|infant formula
618358|NCT00655746|Healthy Subjects|healthy subjects
618359|NCT00655772|chlorine|chlorine
618360|NCT00655772|dioxide|dioxide
618361|NCT00655772|mouthwash|mouthwash
618362|NCT00655772|organoleptic|organoleptic
618363|NCT00655772|measurements|measurements
618364|NCT00655772|volatile|volatile
618365|NCT00655772|sulfur|sulfur
618366|NCT00655772|compounds|compounds
618367|NCT00655785|Epitope peptide|epitope peptide
618368|NCT00655785|CTL|ctl
618369|NCT00655785|Pancreatic cancer|pancreatic cancer
618370|NCT00655785|Vaccination VEGFR1|vaccination vegfr1
618371|NCT00655785|VEGFR2|vegfr2
618372|NCT00655811|Healthy volunteers|healthy volunteers
618373|NCT00655837|Antigens, CD40|antigens, cd40
618374|NCT00655837|Antibodies, Monoclonal|antibodies, monoclonal
618375|NCT00655837|Combined Modality Therapy|combined modality therapy
618376|NCT00655837|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
618377|NCT00655837|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
618378|NCT00655837|Hematologic Diseases|hematologic diseases
618379|NCT00655837|Immunoproliferative Disorders|immunoproliferative disorders
618380|NCT00655837|Lymphatic Diseases|lymphatic diseases
618381|NCT00655837|Lymphoproliferative Disorders|lymphoproliferative disorders
618382|NCT00655837|Lymphoma|lymphoma
618383|NCT00655850|Lung Cancer|lung cancer
618384|NCT00655850|Non-Small Cell Lung Cancer|non-small cell lung cancer
618385|NCT00655850|Metronomic Chemotherapy|metronomic chemotherapy
618386|NCT00655863|Glucose Metabolism Disorder|glucose metabolism disorder
618387|NCT00655863|Dysmetabolic Syndrome|dysmetabolic syndrome
618388|NCT00655863|Type II Diabetes|type ii diabetes
618389|NCT00655863|Diabetes Mellitus|diabetes mellitus
618390|NCT00655863|Lipoatrophic; Dyslipidemia|lipoatrophic; dyslipidemia
618391|NCT00655863|Drug Therapy|drug therapy
618392|NCT00655876|stage IIA esophageal cancer|stage iia esophageal cancer
618393|NCT00655876|stage IIB esophageal cancer|stage iib esophageal cancer
618394|NCT00655876|stage IIIA esophageal cancer|stage iiia esophageal cancer
618395|NCT00655876|stage IIIB esophageal cancer|stage iiib esophageal cancer
618396|NCT00655876|stage IIIC esophageal cancer|stage iiic esophageal cancer
618397|NCT00655876|stage IV esophageal cancer|stage iv esophageal cancer
618398|NCT00655876|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
618399|NCT00655902|Trans fat|trans fat
618400|NCT00655902|Obesity|obesity
618401|NCT00655902|Insulin sensitivity|insulin sensitivity
618402|NCT00655928|Acute lung injury|acute lung injury
618403|NCT00655928|Lung resection|lung resection
618404|NCT00655941|Osteoarthritis|osteoarthritis
618405|NCT00655941|Obesity|obesity
618406|NCT00655941|Weight loss|weight loss
618407|NCT00655941|Dietary instruction|dietary instruction
618408|NCT00655941|Exercise|exercise
618409|NCT00655941|Attention|attention
618410|NCT00655954|COPD|copd
618411|NCT00655954|asthma|asthma
618412|NCT00655954|smokers|smokers
618413|NCT00655954|healthy volunteers|healthy volunteers
618414|NCT00655954|bronchiectasis|bronchiectasis
618415|NCT00655954|cystic fibrosis|cystic fibrosis
618416|NCT00655993|COPD|copd
618417|NCT00655993|Inflammation|inflammation
618418|NCT00655993|CRP levels|crp levels
618419|NCT00655993|simvastatin|simvastatin
618420|NCT00656006|Hepatitis C|hepatitis c
618421|NCT00656006|Chronic|chronic
618422|NCT00656006|Genotype 2 or 3|genotype 2 or 3
618423|NCT00656006|Treatment naive|treatment naive
618424|NCT00656032|insulin resistance|insulin resistance
618425|NCT00656032|end stage renal disease|end stage renal disease
618426|NCT00656045|Obesity|obesity
618427|NCT00656045|Physical Activity|physical activity
618428|NCT00656045|Weight Loss|weight loss
618429|NCT00656045|Exercise|exercise
618430|NCT00656045|Dietary Intake|dietary intake
618433|NCT00656045|Healthy Eating|healthy eating
618434|NCT00656058|Leukotriene|leukotriene
618435|NCT00656058|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
618436|NCT00656058|Montelukast|montelukast
618437|NCT00656058|Stem Cell Transplant|stem cell transplant
618438|NCT00656058|Bronchiolitis Obliterans|bronchiolitis obliterans
618439|NCT00656071|ARDS|ards
618440|NCT00656071|Acute respiratory distress syndrome|acute respiratory distress syndrome
618441|NCT00656071|Adult respiratory distress syndrome|adult respiratory distress syndrome
618442|NCT00656071|respiratory distress|respiratory distress
618443|NCT00656097|Rabies post-exposure prophylaxis|rabies post-exposure prophylaxis
618444|NCT00656110|Restless legs syndrome|restless legs syndrome
618445|NCT00656110|Morton's neuroma|morton's neuroma
618446|NCT00656110|Randomized controlled trial|randomized controlled trial
618447|NCT00656123|adenocarcinoma of the colon|adenocarcinoma of the colon
618448|NCT00656123|adenocarcinoma of the rectum|adenocarcinoma of the rectum
618449|NCT00656123|stage IV colon cancer|stage iv colon cancer
618450|NCT00656123|stage IV rectal cancer|stage iv rectal cancer
618451|NCT00656123|liver metastases|liver metastases
618452|NCT00656149|telerehabilitation|telerehabilitation
618453|NCT00656149|functional electrical stimulation|functional electrical stimulation
618454|NCT00656149|spinal cord injury|spinal cord injury
618455|NCT00656149|hand function rehabilitation|hand function rehabilitation
618456|NCT00656175|lipodystrophy|lipodystrophy
618457|NCT00656175|fat|fat
618458|NCT00656175|visceral fat|visceral fat
618459|NCT00656175|HIV|hiv
618460|NCT00656175|women|women
618461|NCT00656175|raltegravir|raltegravir
618462|NCT00656175|ART|art
618463|NCT00656175|anti HIV therapy|anti hiv therapy
618464|NCT00656175|NNRTI|nnrti
618465|NCT00656175|Protease inhibitor|protease inhibitor
618466|NCT00656175|integrase inhibitor|integrase inhibitor
618467|NCT00656175|treatment experienced|treatment experienced
618468|NCT00656188|Erectile Dysfunction|erectile dysfunction
618469|NCT00656188|Vardenafil|vardenafil
618470|NCT00656201|Infertility|infertility
618471|NCT00656201|In vitro fertilization|in vitro fertilization
618472|NCT00656201|Embryo transfer|embryo transfer
618473|NCT00656201|Crinone|crinone
618474|NCT00656201|Intramuscular Progesterone|intramuscular progesterone
618475|NCT00656201|Progesterone support|progesterone support
618476|NCT00656214|Lichen Planus|lichen planus
618477|NCT00656266|renal insufficiency and/or renal failure after liver transplantation|renal insufficiency and/or renal failure after liver transplantation
618478|NCT00656279|chronic kidney disease|chronic kidney disease
618479|NCT00656279|predialysis|predialysis
618480|NCT00656279|hyperphosphatemia|hyperphosphatemia
618481|NCT00656279|dietary intervention|dietary intervention
618482|NCT00656279|intensive dietary education|intensive dietary education
618483|NCT00656279|low phosphorus diet|low phosphorus diet
618484|NCT00656292|Plasma concentrations of inflammatory markers|plasma concentrations of inflammatory markers
618485|NCT00656292|C-Reactive Protein (CRP)|c-reactive protein (crp)
618486|NCT00656292|Interleukin-6 (IL-6)|interleukin-6 (il-6)
618487|NCT00656292|Tumor Necrosis Factor-Alpha (TNF)|tumor necrosis factor-alpha (tnf)
618488|NCT00656292|Aspartate Aminotransferase (AST)|aspartate aminotransferase (ast)
618489|NCT00656292|Alanine Aminotransferase (ALT)|alanine aminotransferase (alt)
618490|NCT00656292|Creatine Kinase (CK)|creatine kinase (ck)
618491|NCT00656305|Bone Cancer|bone cancer
618492|NCT00656305|Pain Palliation|pain palliation
618493|NCT00656305|Metastasis|metastasis
618494|NCT00656305|Multiple Myeloma|multiple myeloma
618495|NCT00656305|Breast Cancer|breast cancer
618496|NCT00656305|Lung Cancer|lung cancer
618497|NCT00656305|Prostate Cancer|prostate cancer
618498|NCT00656305|cancer related Pain|cancer related pain
618499|NCT00656305|Tumors|tumors
618500|NCT00656318|women|women
618501|NCT00656318|menses|menses
618502|NCT00656318|oral contraceptives|oral contraceptives
618596|NCT00656656|immunoadsorption|immunoadsorption
618503|NCT00656318|Healthy menstruating females|healthy menstruating females
618504|NCT00656344|PTSD|ptsd
618505|NCT00656344|Substance Abuse|substance abuse
618506|NCT00656344|WTC attacks|wtc attacks
618507|NCT00656344|Iraq War|iraq war
618508|NCT00656370|Hylenex|hylenex
618509|NCT00656370|subcutaneous infusion|subcutaneous infusion
618510|NCT00656370|hyaluronidase|hyaluronidase
618511|NCT00656370|rHuPH20|rhuph20
618512|NCT00656370|recombinant human hyaluronidase|recombinant human hyaluronidase
618513|NCT00656383|venous ulcer, leg ulcer, stasis ulcer|venous ulcer, leg ulcer, stasis ulcer
618514|NCT00656396|Blood loss|blood loss
618515|NCT00656396|Point of care monitoring|point of care monitoring
618516|NCT00656396|FFP|ffp
618517|NCT00656396|Major surgery|major surgery
618518|NCT00656396|Prothrombin Time|prothrombin time
618519|NCT00656396|Blood coagulation tests|blood coagulation tests
618520|NCT00656409|Ataxia telangiectasia,|ataxia telangiectasia,
618521|NCT00656409|Conjugated pneumococcal,|conjugated pneumococcal,
618522|NCT00656409|Prevenar,|prevenar,
618523|NCT00656409|Immunogenicity ,|immunogenicity ,
618524|NCT00656409|Vaccine|vaccine
618525|NCT00656422|insulin therapy|insulin therapy
618526|NCT00656422|hepatic fat|hepatic fat
618527|NCT00656422|type 2 diabetes|type 2 diabetes
618528|NCT00656422|body composition|body composition
618529|NCT00656422|comparison of insulin detemir and insulin glargine|comparison of insulin detemir and insulin glargine
618530|NCT00656422|Changes in Hepatic Fat|changes in hepatic fat
618531|NCT00656422|Obesity|obesity
618532|NCT00656435|proliferative diabetic retinopathy|proliferative diabetic retinopathy
618533|NCT00656435|bevacizumab (Avastin)|bevacizumab (avastin)
618534|NCT00656435|vitreous hemorrhage|vitreous hemorrhage
618535|NCT00656435|long acting gas|long acting gas
618536|NCT00656448|Acute Myelogenous Leukemia|acute myelogenous leukemia
618537|NCT00656448|AML|aml
618538|NCT00656448|Myelodysplastic Syndrome|myelodysplastic syndrome
618539|NCT00656448|MDS|mds
618540|NCT00656448|Leukemia|leukemia
618541|NCT00656448|Procrit|procrit
618542|NCT00656448|Epoetin Alfa|epoetin alfa
618543|NCT00656448|Epogen|epogen
618544|NCT00656461|Advanced cancer|advanced cancer
618545|NCT00656474|burn wounds|burn wounds
618546|NCT00656474|wound healing|wound healing
618547|NCT00656487|Cannabis Dependence|cannabis dependence
618548|NCT00656487|Marijuana Dependence|marijuana dependence
618549|NCT00656487|Cannabis Withdrawal|cannabis withdrawal
618550|NCT00656487|Rimonabant|rimonabant
618551|NCT00656487|cannabinoid receptor type 1 (CB1) inverse agonist|cannabinoid receptor type 1 (cb1) inverse agonist
618552|NCT00656487|Neuropsychology|neuropsychology
618553|NCT00656487|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
618554|NCT00656487|Endocannabinoids|endocannabinoids
618555|NCT00656487|Cortisol|cortisol
618556|NCT00656500|surgical patients|surgical patients
618557|NCT00656500|cigarette smoking|cigarette smoking
618558|NCT00656500|postoperative complications|postoperative complications
618559|NCT00656500|telephone counseling|telephone counseling
618560|NCT00656500|quitlines|quitlines
618561|NCT00656513|hypopharyngeal cancer|hypopharyngeal cancer
618562|NCT00656513|laryngeal cancer|laryngeal cancer
618563|NCT00656513|lip and oral cavity cancer|lip and oral cavity cancer
618564|NCT00656513|nasopharyngeal cancer|nasopharyngeal cancer
618565|NCT00656513|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
618566|NCT00656513|oropharyngeal cancer|oropharyngeal cancer
618567|NCT00656513|salivary gland cancer|salivary gland cancer
618568|NCT00656513|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
618569|NCT00656513|xerostomia|xerostomia
618570|NCT00656513|tongue cancer|tongue cancer
618571|NCT00656526|analgesia, postlaminectomy , lidocaine, dorsal root|analgesia, postlaminectomy , lidocaine, dorsal root
618572|NCT00656565|measure inspiratory spirometry with dry powder inhaler device in series with the spirometer|measure inspiratory spirometry with dry powder inhaler device in series with the spirometer
618573|NCT00656578|Foot|foot
618574|NCT00656578|Bunion|bunion
618575|NCT00656578|Bunionectomy|bunionectomy
618576|NCT00656578|Hallux Valgus Deformity|hallux valgus deformity
618577|NCT00656578|Surgery for Transpositional first metatarsal osteotomy - Bunionectomy|surgery for transpositional first metatarsal osteotomy - bunionectomy
618578|NCT00656591|Child mortality, Nepal, Community, care practices|child mortality, nepal, community, care practices
618579|NCT00656604|recurrent breast cancer|recurrent breast cancer
618580|NCT00656604|stage I breast cancer|stage i breast cancer
618581|NCT00656604|stage II breast cancer|stage ii breast cancer
618582|NCT00656604|stage IIIA breast cancer|stage iiia breast cancer
618583|NCT00656604|stage IIIB breast cancer|stage iiib breast cancer
618584|NCT00656604|stage IIIC breast cancer|stage iiic breast cancer
618585|NCT00656617|Acute Myeloid Leukemia|acute myeloid leukemia
618586|NCT00656617|(AML)|(aml)
618587|NCT00656617|Myelodysplastic syndrome|myelodysplastic syndrome
618588|NCT00656617|(MDS)|(mds)
618589|NCT00656617|Leukemia|leukemia
618590|NCT00656617|Idarubicin|idarubicin
618591|NCT00656617|Cytarabine|cytarabine
618592|NCT00656617|Vorinostat|vorinostat
618593|NCT00656617|Ara-C|ara-c
618594|NCT00656656|pemphigus|pemphigus
618595|NCT00656656|rituximab|rituximab
618597|NCT00656656|dexamethasone|dexamethasone
618598|NCT00656656|treatment|treatment
618599|NCT00656656|management|management
618600|NCT00656669|newly diagnosed breast cancer|newly diagnosed breast cancer
618601|NCT00656669|neoadjuvant therapy|neoadjuvant therapy
618602|NCT00656682|Prevention & Control|prevention & control
618603|NCT00656682|Hyperglycemia|hyperglycemia
618604|NCT00656682|Obesity|obesity
618605|NCT00656682|Diabetes Mellitus|diabetes mellitus
618606|NCT00656682|Cost Benefit Analysis|cost benefit analysis
618607|NCT00656695|Iminoral|iminoral
618608|NCT00656695|Neoral|neoral
618609|NCT00656695|Acute renal transplant rejection|acute renal transplant rejection
618610|NCT00656708|Burns|burns
618611|NCT00656708|Wounds|wounds
618612|NCT00656708|Healthcare associated infections|healthcare associated infections
618613|NCT00656708|MRSA|mrsa
618614|NCT00656708|VRE|vre
618615|NCT00656721|bronchiectasis|bronchiectasis
618616|NCT00656721|physiotherapy|physiotherapy
618617|NCT00656721|flutter valve|flutter valve
618618|NCT00656721|impulse oscillation technique|impulse oscillation technique
618619|NCT00656734|Medarex Inc.|medarex inc.
618620|NCT00656747|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
619028|NCT00658242|craniotomy|craniotomy
618621|NCT00656747|Acute exacerbation of COPD (AECOPD)|acute exacerbation of copd (aecopd)
618622|NCT00656747|chronic bronchitis|chronic bronchitis
618623|NCT00656747|bronchitis|bronchitis
618624|NCT00656747|chest infection|chest infection
618625|NCT00656747|smoking|smoking
618626|NCT00656747|lung disease|lung disease
618627|NCT00656747|lung|lung
618628|NCT00656747|lungs|lungs
618629|NCT00656760|unknown primary, head and neck cancer, squamous cell carcinoma|unknown primary, head and neck cancer, squamous cell carcinoma
618630|NCT00656760|Unknown primary head and neck cancer|unknown primary head and neck cancer
618631|NCT00656773|morphine, sufentanil, acute pain, opioid, Prehospital Emergency Care|morphine, sufentanil, acute pain, opioid, prehospital emergency care
618632|NCT00656812|advanced MALT lymphoma|advanced malt lymphoma
618633|NCT00656812|Rituximab|rituximab
618634|NCT00656812|2CdA|2cda
618635|NCT00656812|chemotherapy|chemotherapy
618636|NCT00656812|immunotherapy|immunotherapy
618637|NCT00656825|P144|p144
618638|NCT00656825|TGF-β1|tgf-β1
618639|NCT00656825|Healthy volunteers|healthy volunteers
618640|NCT00656825|Cutaneous tolerability|cutaneous tolerability
618641|NCT00656825|Skin fibrosis|skin fibrosis
618642|NCT00656825|systemic scleroderma|systemic scleroderma
618643|NCT00656825|systemic sclerosis|systemic sclerosis
618644|NCT00656825|Safety|safety
618645|NCT00656838|colon|colon
618646|NCT00656838|rectal|rectal
618647|NCT00656838|cancer|cancer
618648|NCT00656838|screening|screening
618649|NCT00656851|HIV/AIDS|hiv/aids
618650|NCT00656851|Heart disease|heart disease
618651|NCT00656851|Diabetes|diabetes
618652|NCT00656851|Cardiovascular disease risk|cardiovascular disease risk
618653|NCT00656851|Dyslipidemia|dyslipidemia
618654|NCT00656851|Visceral adiposity|visceral adiposity
618655|NCT00656851|treatment experienced|treatment experienced
618656|NCT00656864|Diabetes|diabetes
618657|NCT00656864|pioglitazone|pioglitazone
618658|NCT00656864|GIP|gip
618659|NCT00648323|Benign Prostate Hyperplasia|benign prostate hyperplasia
618660|NCT00648375|Propanolol|propanolol
618661|NCT00648375|Beta Blockers|beta blockers
618662|NCT00648375|Reconsolidation|reconsolidation
618663|NCT00648375|Cognitive Therapy|cognitive therapy
618664|NCT00648375|PTSD|ptsd
618665|NCT00648453|Fontain II-III stage|fontain ii-iii stage
618666|NCT00648479|Fracture Fixation|fracture fixation
618667|NCT00648609|Community based self management of COPD with palliative care|community based self management of copd with palliative care
618668|NCT00648635|Rectal Cancer|rectal cancer
618669|NCT00648635|Recurrent Rectal Adenocarcinoma|recurrent rectal adenocarcinoma
618670|NCT00648635|Quality of Life|quality of life
618671|NCT00648635|QOL|qol
618672|NCT00648635|Questionnaire|questionnaire
618673|NCT00648635|Survey|survey
618674|NCT00648687|prematurity|prematurity
618675|NCT00648687|retinopathy of prematurity|retinopathy of prematurity
618676|NCT00648687|pain|pain
618677|NCT00648687|very low birth weight infants|very low birth weight infants
618678|NCT00648739|B-cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
618679|NCT00648739|Leukemia|leukemia
618680|NCT00648739|Multiple Myeloma|multiple myeloma
618681|NCT00648739|CD200|cd200
618682|NCT00648739|Anti-CD200|anti-cd200
618683|NCT00648817|HIV-1|hiv-1
618684|NCT00648817|tenofovir DF|tenofovir df
618685|NCT00648869|pharmaceutical preparations|pharmaceutical preparations
618686|NCT00648895|Hypertension|hypertension
618687|NCT00648895|Blood pressure|blood pressure
618688|NCT00648895|Nebivolol|nebivolol
618689|NCT00648895|Bystolic (TM)|bystolic (tm)
618690|NCT00648895|Metoprolol ER (TM)|metoprolol er (tm)
618691|NCT00648908|multiple sclerosis|multiple sclerosis
618692|NCT00648908|MS|ms
618693|NCT00648908|walking|walking
618694|NCT00648908|leg strength|leg strength
618695|NCT00648908|demyelination|demyelination
618801|NCT00649961|Neuroprotection|neuroprotection
618696|NCT00648973|Seasonal Allergic Rhinitis, nasal congestion|seasonal allergic rhinitis, nasal congestion
618697|NCT00648986|brittle nails|brittle nails
618698|NCT00648986|Tazarotene|tazarotene
618699|NCT00648986|Tazorac|tazorac
618700|NCT00648999|Kaletra|kaletra
618701|NCT00649025|Asthma|asthma
618702|NCT00649025|Asthma Moderate to Severe|asthma moderate to severe
618703|NCT00649142|Groin hernia|groin hernia
618704|NCT00649142|Chronic postsurgical pain|chronic postsurgical pain
618705|NCT00649142|open mesh repair|open mesh repair
618706|NCT00649142|laparoscopic mesh glue fixation|laparoscopic mesh glue fixation
618707|NCT00649142|Sensory changes after groin hernia repair|sensory changes after groin hernia repair
618708|NCT00649207|WBRT|wbrt
618709|NCT00649207|Brain Metastases|brain metastases
618710|NCT00649207|Radiation|radiation
618711|NCT00649207|ABT-888|abt-888
618712|NCT00649207|PARP|parp
618713|NCT00649246|genetics|genetics
618714|NCT00649246|type 1 diabetes|type 1 diabetes
618715|NCT00649246|biomarkers|biomarkers
618716|NCT00649246|autoimmunity|autoimmunity
618717|NCT00649298|Randomized Controlled Trial|randomized controlled trial
618718|NCT00649298|Clinical Trial|clinical trial
618719|NCT00649298|Controlled Clinical Trial|controlled clinical trial
618720|NCT00649298|Clinical Trial, Phase IV|clinical trial, phase iv
619030|NCT00658255|adults|adults
618721|NCT00649298|Multicenter Study|multicenter study
618722|NCT00649298|End Stage Kidney Disease|end stage kidney disease
618723|NCT00649298|Hemodialysis|hemodialysis
618724|NCT00649298|Renal Dialysis|renal dialysis
618725|NCT00649298|Renal Replacement Therapy|renal replacement therapy
618726|NCT00649298|Nocturnal Dialysis|nocturnal dialysis
618727|NCT00649298|Extended dialysis|extended dialysis
618728|NCT00649298|Quality of Life|quality of life
618729|NCT00649298|Quality Adjusted Life Year|quality adjusted life year
618730|NCT00649298|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
618731|NCT00649298|Blood Pressure|blood pressure
618732|NCT00649298|Hypertension|hypertension
618733|NCT00649298|Anemia|anemia
618734|NCT00649298|Hematinics|hematinics
618735|NCT00649298|Erythropoiesis Stimulating Agents|erythropoiesis stimulating agents
618736|NCT00649298|Cost-utility Analysis|cost-utility analysis
618737|NCT00649298|Economic Evaluation|economic evaluation
618738|NCT00649298|Health Care Utilisation|health care utilisation
618739|NCT00649298|Health Care Costs|health care costs
618740|NCT00649298|Health Expenditures|health expenditures
618741|NCT00649298|Hospitalization|hospitalization
618742|NCT00649298|Cost Analysis|cost analysis
618743|NCT00649298|Cardiovascular Diseases|cardiovascular diseases
618744|NCT00649298|Acute Coronary Syndrome|acute coronary syndrome
618745|NCT00649298|Myocardial Infarction|myocardial infarction
618746|NCT00649298|Stroke|stroke
618747|NCT00649298|Cerebrovascular Disorders|cerebrovascular disorders
618748|NCT00649298|Mortality|mortality
618749|NCT00649298|Arteriovenous Fistula|arteriovenous fistula
618750|NCT00649298|Arteriovenous Shunt, Surgical|arteriovenous shunt, surgical
618751|NCT00649298|Thrombosis|thrombosis
618752|NCT00649298|Infection|infection
618753|NCT00649337|mammography|mammography
618754|NCT00649337|ultrasound|ultrasound
618755|NCT00649337|breast cancer|breast cancer
618756|NCT00649337|screening|screening
618757|NCT00649428|Treatment of moderate to severe bilateral nasolabial fold wrinkles|treatment of moderate to severe bilateral nasolabial fold wrinkles
618758|NCT00649584|Antigens, CD30|antigens, cd30
618759|NCT00649584|Antibody-Drug Conjugate|antibody-drug conjugate
618760|NCT00649584|Antibodies, Monoclonal|antibodies, monoclonal
618761|NCT00649584|monomethyl auristatin E|monomethyl auristatin e
618762|NCT00649584|Combined Modality Therapy|combined modality therapy
618763|NCT00649584|Drug Therapy|drug therapy
618764|NCT00649584|Immunotherapy|immunotherapy
618765|NCT00649584|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
618766|NCT00649584|Disease, Hodgkin|disease, hodgkin
618767|NCT00649584|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
618768|NCT00649584|Hematologic Diseases|hematologic diseases
618769|NCT00649584|Lymphoma|lymphoma
618770|NCT00649610|acute low back pain|acute low back pain
618771|NCT00649701|HIV|hiv
618772|NCT00649701|Internet|internet
618773|NCT00649701|MSM|msm
618774|NCT00649701|Condom Use|condom use
618775|NCT00649701|Disclosure|disclosure
618776|NCT00649753|sacroiliac joint dysfunction|sacroiliac joint dysfunction
618777|NCT00649753|algometer|algometer
618778|NCT00649753|Chiropractic|chiropractic
618779|NCT00649753|Manual Therapy|manual therapy
618780|NCT00649753|indicator points associated with sacroiliac joint dysfunction|indicator points associated with sacroiliac joint dysfunction
618781|NCT00649766|tailored health messages|tailored health messages
618782|NCT00649766|glaucoma|glaucoma
618783|NCT00649766|diabetic retinopathy|diabetic retinopathy
618784|NCT00649766|dilated fundus exams|dilated fundus exams
618785|NCT00649766|health behavior|health behavior
618786|NCT00649792|multiple sclerosis|multiple sclerosis
618787|NCT00649792|MS|ms
618788|NCT00649792|walking|walking
618789|NCT00649792|leg strength|leg strength
618790|NCT00649792|demyelination|demyelination
618791|NCT00649883|Influenza|influenza
618792|NCT00649883|vaccine|vaccine
618802|NCT00649961|Melatonin|melatonin
618803|NCT00649961|Pharmacokinetics|pharmacokinetics
618804|NCT00650039|Post surgical pain|post surgical pain
618805|NCT00650039|Anterior Cruciate ligament reconstruction|anterior cruciate ligament reconstruction
618806|NCT00650039|Arthroscopy|arthroscopy
618807|NCT00650039|Perioperative pain|perioperative pain
618808|NCT00650078|Signs and Symptoms|signs and symptoms
618809|NCT00650078|Autoimmune Diseases|autoimmune diseases
618810|NCT00650078|Joint Diseases|joint diseases
618811|NCT00650078|Arthritis|arthritis
618812|NCT00650078|Connective Tissue Diseases|connective tissue diseases
618813|NCT00650078|Arthritis, Rheumatoid|arthritis, rheumatoid
618814|NCT00650078|Rheumatic Diseases|rheumatic diseases
618815|NCT00650078|Predniso(lo)ne|predniso(lo)ne
618816|NCT00650091|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
618817|NCT00650091|Prednisone|prednisone
618818|NCT00650091|Azathioprine|azathioprine
618819|NCT00650091|NAC|nac
618820|NCT00650091|N-acetylcysteine|n-acetylcysteine
618821|NCT00650104|ropinirole IR|ropinirole ir
618822|NCT00650104|efficacy|efficacy
618823|NCT00650104|safety|safety
618824|NCT00650104|open-label|open-label
618825|NCT00650104|long term safety; REQUIP|long term safety; requip
618826|NCT00650104|ropinirole XL|ropinirole xl
618827|NCT00650104|ropinirole CR|ropinirole cr
618828|NCT00650104|Parkinson's disease|parkinson's disease
618829|NCT00650130|driving under the influence|driving under the influence
618830|NCT00650130|psychoactive substances|psychoactive substances
618832|NCT00650130|whole blood|whole blood
618833|NCT00650130|plasma|plasma
618834|NCT00650130|Ratio of psychoactive substances in whole blood-plasma-oral fluid|ratio of psychoactive substances in whole blood-plasma-oral fluid
618835|NCT00650130|Prevalence of psychoactive substances in road traffic|prevalence of psychoactive substances in road traffic
618836|NCT00650143|Stem cell|stem cell
618837|NCT00650143|Myocardial infarction|myocardial infarction
618838|NCT00650143|G-CSF|g-csf
618839|NCT00650143|CD26-inhibition|cd26-inhibition
618840|NCT00650182|patch|patch
618841|NCT00650182|fentanyl|fentanyl
618842|NCT00650182|chronic pain|chronic pain
618843|NCT00650260|intraoperative warming|intraoperative warming
618844|NCT00650260|anesthesia|anesthesia
618845|NCT00650260|hypothermia|hypothermia
618846|NCT00650260|body temperature|body temperature
618847|NCT00656877|Fat Embolism Total Knee Arthroplasty|fat embolism total knee arthroplasty
618848|NCT00656890|ulcerative colitis, rectal bleeding|ulcerative colitis, rectal bleeding
618849|NCT00656903|Lucentis|lucentis
618850|NCT00656903|Indocyanine Green Angiography|indocyanine green angiography
618851|NCT00656903|Choroidal Neovascularization|choroidal neovascularization
618852|NCT00656903|Macular Degeneration|macular degeneration
618853|NCT00656903|Ranibizumab|ranibizumab
618854|NCT00656903|Age-Related Macular Degeneration|age-related macular degeneration
618855|NCT00656903|AMD|amd
618856|NCT00656916|Post-Transplant Constrictive Bronchiolitis|post-transplant constrictive bronchiolitis
618857|NCT00656916|Bronchiolitis|bronchiolitis
618858|NCT00656916|Fluticasone Propionate|fluticasone propionate
618859|NCT00656916|Inhaled Corticosteroids|inhaled corticosteroids
618860|NCT00656916|Lung Condition|lung condition
618861|NCT00656916|PTCB|ptcb
618862|NCT00656929|Vitamin D|vitamin d
618863|NCT00656929|Viral URI|viral uri
618864|NCT00656929|Influenza|influenza
618865|NCT00656929|Colds|colds
618866|NCT00656942|Pain|pain
618875|NCT00656968|peptic ulcer disease|peptic ulcer disease
618876|NCT00656968|gastric cancer|gastric cancer
618877|NCT00656968|therapeutics|therapeutics
618878|NCT00656981|Moderate Acne Vulgaris|moderate acne vulgaris
618879|NCT00656981|Acne|acne
618880|NCT00656994|Sleep Disorder|sleep disorder
618881|NCT00656994|Insomnia|insomnia
618882|NCT00657007|lupus|lupus
618883|NCT00657007|SLE|sle
618884|NCT00657020|nicotine|nicotine
618885|NCT00657020|therapy|therapy
618886|NCT00657020|fMRI/EEG|fmri/eeg
618887|NCT00657020|replacement|replacement
618888|NCT00657033|Erectile Dysfunction|erectile dysfunction
618889|NCT00657059|IgA nephropathy|iga nephropathy
618890|NCT00657059|mycophenolate mofetil|mycophenolate mofetil
618891|NCT00657072|scapholunate instability|scapholunate instability
618892|NCT00657072|neural networks|neural networks
618893|NCT00657072|scaphoid|scaphoid
618895|NCT00657072|Suspected torn scapholunate interosseous ligament|suspected torn scapholunate interosseous ligament
618896|NCT00657072|Suspected other torn wrist ligaments|suspected other torn wrist ligaments
618897|NCT00657085|Laser hair removal|laser hair removal
618898|NCT00657098|Side effects|side effects
618899|NCT00657098|Angiogenesis inhibitors|angiogenesis inhibitors
618900|NCT00657098|Epidermal growth factor receptor inhibitors|epidermal growth factor receptor inhibitors
618901|NCT00657098|Tyrosinekinase inhibitors|tyrosinekinase inhibitors
618902|NCT00657111|influenza, elderly, United Kingdom|influenza, elderly, united kingdom
618903|NCT00657124|AEN|aen
618904|NCT00657137|HER2/neu positive|her2/neu positive
618905|NCT00657137|locally advanced or metastatic|locally advanced or metastatic
618906|NCT00657163|Stroke recovery|stroke recovery
618907|NCT00657163|Pharmacological modulation|pharmacological modulation
619210|NCT00659113|stage IIB esophageal cancer|stage iib esophageal cancer
618908|NCT00657163|Selective Serotonin Reuptake Inhibitor (SSRI)|selective serotonin reuptake inhibitor (ssri)
618909|NCT00657163|Fluoxetine|fluoxetine
618910|NCT00657163|Brain plasticity|brain plasticity
618911|NCT00657163|Ischemic Stroke and Motor impairment|ischemic stroke and motor impairment
618912|NCT00657163|Modulation of recovery and cerebral plasticity by Fluoxetine|modulation of recovery and cerebral plasticity by fluoxetine
618913|NCT00657189|Sifalimumab|sifalimumab
618914|NCT00657189|MEDI-545|medi-545
618915|NCT00657189|Lupus erythematosus, systemic|lupus erythematosus, systemic
618916|NCT00657202|NF1|nf1
618917|NCT00657202|neurofibroma|neurofibroma
618918|NCT00657202|ranibizumab|ranibizumab
618919|NCT00657202|Lucentis|lucentis
618920|NCT00657787|Posttraumatic Stress Disorder|posttraumatic stress disorder
618921|NCT00657787|Veterans|veterans
618922|NCT00657787|Health Services|health services
618923|NCT00657800|diabetes, inpatient, education,|diabetes, inpatient, education,
618924|NCT00657813|Alzheimer|alzheimer
618925|NCT00657813|SPECT|spect
618926|NCT00657826|Diseased Heart Valve, Replacement|diseased heart valve, replacement
618927|NCT00657839|Benign Prostate Hyperplasia|benign prostate hyperplasia
618928|NCT00657839|Vardenafil|vardenafil
618929|NCT00657839|Genital Disease|genital disease
619029|NCT00658255|stable asthma|stable asthma
618930|NCT00657839|Male: Signs and symptoms of Benign Prostate Hyperplasia|male: signs and symptoms of benign prostate hyperplasia
618931|NCT00657852|pamidronate,bone loss, liver transplantation|pamidronate,bone loss, liver transplantation
618932|NCT00657878|platinum free interval|platinum free interval
618934|NCT00657891|Allergic Asthma|allergic asthma
618935|NCT00657891|Anti IgE|anti ige
618936|NCT00657891|Xolair|xolair
618937|NCT00657891|Basophil|basophil
618938|NCT00657891|IL-13|il-13
618939|NCT00657891|IL-4|il-4
618940|NCT00657891|Histamine|histamine
618941|NCT00657904|androgen antagonists|androgen antagonists
618942|NCT00657904|prostate neoplasms|prostate neoplasms
618943|NCT00657917|leishmaniasis|leishmaniasis
618944|NCT00657917|cutaneous|cutaneous
618945|NCT00657917|Old World|old world
618946|NCT00657917|Leishmania major|leishmania major
618947|NCT00657917|Treatment|treatment
618948|NCT00657943|carotid|carotid
618949|NCT00657943|intima|intima
618950|NCT00657943|media|media
618951|NCT00657943|thickness|thickness
618952|NCT00657943|insulin|insulin
618953|NCT00657943|metformin|metformin
618954|NCT00657956|osteoarthritis|osteoarthritis
618955|NCT00657956|arthroplasty|arthroplasty
618956|NCT00657956|knee joint|knee joint
618957|NCT00657956|radiography|radiography
618958|NCT00657956|surgery|surgery
618959|NCT00657956|Bone Density|bone density
618960|NCT00657956|Outcome Assessment (Health Care)|outcome assessment (health care)
618961|NCT00657969|Polymorphism, genetic|polymorphism, genetic
618962|NCT00657969|Risk factors|risk factors
618963|NCT00657969|Carotid Artery, Internal, Dissection|carotid artery, internal, dissection
618964|NCT00657969|Vertebral Artery Dissection|vertebral artery dissection
618965|NCT00657969|Genetic predisposition|genetic predisposition
618966|NCT00657969|Outcome|outcome
618967|NCT00657969|Therapy|therapy
618968|NCT00657995|pancreatogenic|pancreatogenic
618969|NCT00657995|diabetes|diabetes
618970|NCT00657995|artificial|artificial
618971|NCT00657995|pancreas|pancreas
618972|NCT00658008|PD 0332334 phase 3 pivotal trial|pd 0332334 phase 3 pivotal trial
618973|NCT00658021|diabetes|diabetes
618974|NCT00658021|adolescents|adolescents
618975|NCT00658021|exenatide|exenatide
618976|NCT00658021|Astra Zeneca|astra zeneca
618977|NCT00658034|Cancer|cancer
618978|NCT00658034|Fatigue|fatigue
618979|NCT00658034|Acupuncture|acupuncture
618980|NCT00658047|Arthritis, Rheumatoid|arthritis, rheumatoid
618981|NCT00658047|Phase II|phase ii
618982|NCT00658047|Rheumatoid Arthritis|rheumatoid arthritis
618983|NCT00658060|FMF, Exertional leg pain|fmf, exertional leg pain
618984|NCT00658073|Kidney transplant|kidney transplant
618985|NCT00658073|Mesenchymal stem cell (MSC)|mesenchymal stem cell (msc)
618986|NCT00658086|ALN-RSV01|aln-rsv01
618987|NCT00658086|Respiratory Syncytial Virus|respiratory syncytial virus
618988|NCT00658151|focus|focus
618989|NCT00658151|study|study
618990|NCT00658151|evaluate|evaluate
618991|NCT00658151|sonographic|sonographic
618992|NCT00658151|findings|findings
618993|NCT00658151|colon|colon
618994|NCT00658151|patients|patients
618995|NCT00658151|developed|developed
618996|NCT00658164|Nonalcoholic fatty liver disease associated with increased iron stores|nonalcoholic fatty liver disease associated with increased iron stores
618997|NCT00658177|Erectile dysfunction|erectile dysfunction
618998|NCT00658177|Vardenafil|vardenafil
618999|NCT00658190|Cervical cancer, automation, Internet, telecytology|cervical cancer, automation, internet, telecytology
619000|NCT00658203|CRT-P|crt-p
619001|NCT00658203|PEA|pea
619002|NCT00658203|Severe Heart Failure (NYHA Class III or IV)|severe heart failure (nyha class iii or iv)
619003|NCT00658203|Cardiomyopathy of any etiology|cardiomyopathy of any etiology
619004|NCT00658203|Sinus rhythm|sinus rhythm
619005|NCT00658203|Reduced Left-Ventricular Ejection Fraction|reduced left-ventricular ejection fraction
619006|NCT00658203|LVEDD>30 mm/m2|lvedd>30 mm/m2
619007|NCT00658203|QRS Duration: > 150 ms or > 120 ms|qrs duration: > 150 ms or > 120 ms
619008|NCT00658203|Aortic Pre-Ejection Delay > 140 ms|aortic pre-ejection delay > 140 ms
619009|NCT00658203|Interventricular Mechanical Delay > 40 ms|interventricular mechanical delay > 40 ms
619010|NCT00658203|Delayed activation of postero-lateral Left Ventricular wall|delayed activation of postero-lateral left ventricular wall
619011|NCT00658203|Optimal and stable pharmacological treatment|optimal and stable pharmacological treatment
619012|NCT00658216|Diagnosis and prognosis|diagnosis and prognosis
619013|NCT00658216|Very elderly population|very elderly population
619014|NCT00658216|Heart failure|heart failure
619015|NCT00658216|Brain natriuretic peptide|brain natriuretic peptide
619016|NCT00658216|Observational prospective study|observational prospective study
619017|NCT00658216|Older|older
619018|NCT00658216|Dyspneic patients aged 80|dyspneic patients aged 80
619019|NCT00658229|Exercise|exercise
619020|NCT00658229|Prostatic|prostatic
619021|NCT00658229|Neoplasm|neoplasm
619022|NCT00658229|Androgen|androgen
619023|NCT00658229|Deprivation|deprivation
619024|NCT00658242|craniofacial|craniofacial
619025|NCT00658242|maxillofacial|maxillofacial
619026|NCT00658242|osteotomy|osteotomy
619027|NCT00658242|craniectomy|craniectomy
619033|NCT00658255|Oxis Turbuhaler|oxis turbuhaler
619034|NCT00658255|bronchodilation|bronchodilation
619035|NCT00658268|Surgical procedures operative|surgical procedures operative
619036|NCT00658268|Prosthesis implantation|prosthesis implantation
619037|NCT00658268|Arthroplasty replacement|arthroplasty replacement
619038|NCT00658281|Breast Cancer|breast cancer
619039|NCT00658281|On Board Imager Kilovoltage|on board imager kilovoltage
619040|NCT00658281|Cone Beam Computed Tomography|cone beam computed tomography
619041|NCT00658281|Electronic Portal Imaging Device|electronic portal imaging device
619042|NCT00658281|Lymph Nodes|lymph nodes
619043|NCT00658281|CBCT|cbct
619044|NCT00658281|OBI KV|obi kv
619045|NCT00658307|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
619046|NCT00658307|double-blind|double-blind
619047|NCT00658307|sham-controlled|sham-controlled
619048|NCT00658307|randomized|randomized
619049|NCT00658320|Renal transplantation|renal transplantation
619050|NCT00658320|everolimus|everolimus
619051|NCT00658320|mycophenolate mofetil|mycophenolate mofetil
619052|NCT00658320|cyclosporine|cyclosporine
619053|NCT00658320|corticosteroid|corticosteroid
619054|NCT00658320|basiliximab|basiliximab
619055|NCT00658320|Banff diagnosis|banff diagnosis
619056|NCT00658320|Acute rejection|acute rejection
619057|NCT00658320|Therapeutic drug monitoring (TDM)|therapeutic drug monitoring (tdm)
619058|NCT00658320|de novo renal transplant recipient|de novo renal transplant recipient
619059|NCT00658333|Renal Transplantation|renal transplantation
619060|NCT00658333|Immunosuppression|immunosuppression
619061|NCT00658333|Renal transplant recipients|renal transplant recipients
619062|NCT00658333|Gastrointestinal symptoms associated with MMF therapy|gastrointestinal symptoms associated with mmf therapy
619063|NCT00658346|HIV-1 group O|hiv-1 group o
619064|NCT00658346|HIV-1 group M|hiv-1 group m
619065|NCT00658346|Cameroon|cameroon
619066|NCT00658346|HIV-1 infection|hiv-1 infection
619067|NCT00658346|treatment naïve|treatment naïve
619068|NCT00658359|Immunosuppression|immunosuppression
619069|NCT00658359|JAK3 inhibitor|jak3 inhibitor
619070|NCT00658359|kidney transplantation|kidney transplantation
619071|NCT00658372|PD 0332334 phase 3 pivotal trial|pd 0332334 phase 3 pivotal trial
619072|NCT00658385|GCSF|gcsf
619073|NCT00658398|Alcohol|alcohol
619074|NCT00658398|dependency|dependency
619076|NCT00658411|ALL|all
619077|NCT00658411|MDS|mds
619078|NCT00658411|iron overload|iron overload
619079|NCT00658411|deferoxamine|deferoxamine
619080|NCT00658437|Melanoma, Stage IV, Phase II|melanoma, stage iv, phase ii
619081|NCT00658450|Malaria, Cerebral|malaria, cerebral
619082|NCT00658463|Diabetes|diabetes
619083|NCT00658463|Triglycerides|triglycerides
619084|NCT00658463|HDL-cholesterol|hdl-cholesterol
619085|NCT00658463|kinetic|kinetic
619086|NCT00658463|rosuvastatin|rosuvastatin
619087|NCT00658476|Adolescent Depression|adolescent depression
619088|NCT00658476|Depression|depression
619089|NCT00658476|Teenage Depression|teenage depression
619090|NCT00658476|Los Angeles|los angeles
619091|NCT00658528|GERD|gerd
619092|NCT00658528|erosive GERD|erosive gerd
619093|NCT00658528|erosive esophagitis|erosive esophagitis
619094|NCT00658580|Small cell lung carcinoma|small cell lung carcinoma
619095|NCT00658580|Chemotherapy|chemotherapy
619096|NCT00658580|Phase III randomised study|phase iii randomised study
619097|NCT00658593|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
619098|NCT00658593|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
619099|NCT00658593|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
619100|NCT00658593|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
619101|NCT00658593|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
619102|NCT00658593|unresectable gallbladder cancer|unresectable gallbladder cancer
619103|NCT00658593|recurrent gallbladder cancer|recurrent gallbladder cancer
619478|NCT00660062|Major depression|major depression
619104|NCT00658593|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
619105|NCT00658606|plaque psoriasis|plaque psoriasis
619106|NCT00658606|alefacept|alefacept
619107|NCT00658606|Amevive|amevive
619108|NCT00658606|narrow band ultraviolet B|narrow band ultraviolet b
619109|NCT00658606|phototherapy|phototherapy
619110|NCT00658632|GERD|gerd
619111|NCT00658632|erosive GERD|erosive gerd
619112|NCT00658632|erosive esophagitis|erosive esophagitis
619113|NCT00658645|Schizophrenia|schizophrenia
619114|NCT00658645|Antipsychotic|antipsychotic
619115|NCT00658645|Bifeprunox|bifeprunox
619116|NCT00658658|Epidermal Growth Factor|epidermal growth factor
619117|NCT00658658|Pediatric|pediatric
619118|NCT00658658|Solid Tumors|solid tumors
619119|NCT00658658|Panitumumab|panitumumab
619120|NCT00658658|Dose Limiting Toxicity|dose limiting toxicity
619121|NCT00658697|Rising PSA|rising psa
619122|NCT00658697|androgen deprivation|androgen deprivation
619123|NCT00658697|bevacizumab (avastin)|bevacizumab (avastin)
619124|NCT00658697|docetaxel|docetaxel
619125|NCT00658697|lupron|lupron
619126|NCT00658697|zoladex|zoladex
619127|NCT00658697|bicalutamide|bicalutamide
619128|NCT00658710|hemiplegia|hemiplegia
619132|NCT00658749|Altair Therapeutics|altair therapeutics
619133|NCT00658749|IL4|il4
619134|NCT00658749|IL13|il13
619135|NCT00658749|IL-4|il-4
619137|NCT00658775|GERD|gerd
619138|NCT00658775|erosive GERD|erosive gerd
619139|NCT00658775|erosive esophagitis|erosive esophagitis
619140|NCT00658827|Inflammatory Bowel Disease|inflammatory bowel disease
619141|NCT00658827|Rheumatoid Arthritis|rheumatoid arthritis
619142|NCT00658827|Psoriatic Arthritis|psoriatic arthritis
619143|NCT00658827|Ankylosing Spondylitis|ankylosing spondylitis
619144|NCT00658827|Psoriasis|psoriasis
619145|NCT00658827|Pregnant women exposed to infliximab|pregnant women exposed to infliximab
619146|NCT00658853|COPD|copd
619147|NCT00658853|training|training
619148|NCT00658853|VO2peak|vo2peak
619149|NCT00658853|performance|performance
619150|NCT00658853|ventilation|ventilation
619151|NCT00658853|high aerobic intensity treadmill walking|high aerobic intensity treadmill walking
619152|NCT00658853|one leg training by cycling|one leg training by cycling
619153|NCT00658866|ertapenem tissue PK|ertapenem tissue pk
619154|NCT00658892|recurrent melanoma|recurrent melanoma
619155|NCT00658892|stage IV melanoma|stage iv melanoma
619156|NCT00658905|Preterm infants|preterm infants
619157|NCT00658905|Replacement therapy|replacement therapy
619158|NCT00658905|Infant formula|infant formula
619159|NCT00658905|BSSL|bssl
619160|NCT00658905|BSSL is present in fresh mother's milk but not in infant formula.|bssl is present in fresh mother's milk but not in infant formula.
619161|NCT00658918|Perennial Allergic Rhinitis|perennial allergic rhinitis
619162|NCT00658918|Ciclesonide|ciclesonide
619163|NCT00658918|Hay Fever|hay fever
619165|NCT00658931|Depression|depression
619166|NCT00658931|Bereavement|bereavement
619167|NCT00658931|Pilot Projects|pilot projects
619168|NCT00658931|Antidepressant Drugs|antidepressant drugs
619169|NCT00658944|Stress urinary incontinence|stress urinary incontinence
619170|NCT00658944|Mixed urinary incontinence|mixed urinary incontinence
619171|NCT00658944|surgery|surgery
619172|NCT00658944|trans obturator tape|trans obturator tape
619173|NCT00658944|Maximum urethral closure pressure|maximum urethral closure pressure
619174|NCT00658944|Valsalva leak point pressure|valsalva leak point pressure
619175|NCT00658944|outcome|outcome
619176|NCT00658957|Diabetes|diabetes
619177|NCT00658957|Foot Ulcer|foot ulcer
619178|NCT00658970|Open label|open label
619179|NCT00658970|Dose escalation|dose escalation
619180|NCT00659009|environmental|environmental
619181|NCT00659009|hypobaric hypoxia|hypobaric hypoxia
619182|NCT00659009|sleep|sleep
619183|NCT00659009|respiratory-disturbance|respiratory-disturbance
619184|NCT00659009|neurobehavioral performance|neurobehavioral performance
619286|NCT00659451|Heart|heart
619185|NCT00659009|Effect of altitude on sleep-related respiratory disturbance|effect of altitude on sleep-related respiratory disturbance
619186|NCT00659022|colorectal cancer|colorectal cancer
619187|NCT00659022|liver metastases|liver metastases
619188|NCT00659022|angiogenesis|angiogenesis
619189|NCT00659022|metabolism|metabolism
619190|NCT00659035|driving|driving
619191|NCT00659035|opioids|opioids
619192|NCT00659035|impairment|impairment
619193|NCT00659035|ability|ability
619194|NCT00659035|patients|patients
619195|NCT00659035|receiving|receiving
619196|NCT00659035|oral morphine|oral morphine
619197|NCT00659035|severe|severe
619198|NCT00659048|Perennial Allergic Rhinitis|perennial allergic rhinitis
619199|NCT00659048|Ciclesonide|ciclesonide
619200|NCT00659048|PAR|par
619201|NCT00659061|micronutrients|micronutrients
619202|NCT00659074|bioequivalence|bioequivalence
619203|NCT00659074|Ondansetron ODT|ondansetron odt
619204|NCT00659074|Fasting|fasting
619205|NCT00659074|To Determine Bioequivalence Under Fasting Conditions|to determine bioequivalence under fasting conditions
619206|NCT00659087|Total Knee|total knee
619207|NCT00659087|Range of Motion|range of motion
619208|NCT00659087|Pain|pain
619209|NCT00659113|stage IIA esophageal cancer|stage iia esophageal cancer
619211|NCT00659113|stage IIIA esophageal cancer|stage iiia esophageal cancer
619212|NCT00659113|stage IIIB esophageal cancer|stage iiib esophageal cancer
619213|NCT00659113|stage IIIC esophageal cancer|stage iiic esophageal cancer
619214|NCT00659113|stage IV esophageal cancer|stage iv esophageal cancer
619215|NCT00659152|ALI/ARDS|ali/ards
619216|NCT00659165|diabetes|diabetes
619217|NCT00659165|insulin dependent diabetes|insulin dependent diabetes
619218|NCT00659165|diabetes mellitus|diabetes mellitus
619219|NCT00659165|detemir|detemir
619220|NCT00659165|levemir|levemir
619221|NCT00659165|glargine|glargine
619222|NCT00659165|lantus|lantus
619223|NCT00659165|insulin|insulin
619224|NCT00659165|appetite|appetite
619225|NCT00659165|satiety|satiety
619226|NCT00659165|centrally acting mediators of satiety|centrally acting mediators of satiety
619227|NCT00659165|three factor eating questionnaire|three factor eating questionnaire
619228|NCT00659165|PYY|pyy
619229|NCT00659165|ghrelin|ghrelin
619230|NCT00659165|leptin|leptin
619231|NCT00659178|Doxil,|doxil,
619232|NCT00659178|pegylated liposomal doxorubicin,|pegylated liposomal doxorubicin,
619233|NCT00659178|ovarian cancer|ovarian cancer
619234|NCT00659178|IL-18,|il-18,
619235|NCT00659178|combination study,|combination study,
619236|NCT00659178|immunotherapy,|immunotherapy,
619237|NCT00659178|cytokine,|cytokine,
619238|NCT00659191|Healthy volunteer,|healthy volunteer,
619239|NCT00659191|HIV infected subjects|hiv infected subjects
619240|NCT00659217|Mesenchymal Stem Cells|mesenchymal stem cells
619241|NCT00659217|lupus Nephritis|lupus nephritis
619242|NCT00659230|PTSD|ptsd
619243|NCT00659230|Veterans|veterans
619244|NCT00659230|Nepicastat|nepicastat
619245|NCT00659230|OIF/OEF|oif/oef
619246|NCT00659243|Replacement therapy|replacement therapy
619247|NCT00659243|Pasteurized breast milk|pasteurized breast milk
619248|NCT00659243|Preterm infants|preterm infants
619249|NCT00659243|BSSL|bssl
619250|NCT00659256|Hepatitis C Virus|hepatitis c virus
619251|NCT00659256|Atherosclerosis|atherosclerosis
619252|NCT00659256|Intima-Media Thickness|intima-media thickness
619253|NCT00659256|Coronary Artery Calcium Score|coronary artery calcium score
619254|NCT00659256|Hepatitis C|hepatitis c
619255|NCT00659269|Vitamin B-12|vitamin b-12
619256|NCT00659269|Vitamin B-6|vitamin b-6
619257|NCT00659269|Chemotherapy-Induced Neuropathy|chemotherapy-induced neuropathy
619258|NCT00659269|Taxanes|taxanes
619259|NCT00659269|Vinca alkaloid|vinca alkaloid
619260|NCT00659269|Heavy metals|heavy metals
619261|NCT00659269|Neuropathy|neuropathy
619262|NCT00659269|Nerve pain|nerve pain
619263|NCT00659308|pain|pain
619264|NCT00659308|bullous keratopathy|bullous keratopathy
619265|NCT00659308|amniotic membrane|amniotic membrane
619266|NCT00659308|anterior stromal puncture|anterior stromal puncture
619267|NCT00659334|Combidex|combidex
619268|NCT00659334|Diagnostic imaging|diagnostic imaging
619269|NCT00659373|cognitive/functional effects|cognitive/functional effects
619270|NCT00659373|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
619271|NCT00659373|fatigue|fatigue
619272|NCT00659373|sleep disorders|sleep disorders
619273|NCT00659373|stage IA breast cancer|stage ia breast cancer
619274|NCT00659373|stage IB breast cancer|stage ib breast cancer
619275|NCT00659373|stage II breast cancer|stage ii breast cancer
619276|NCT00659373|stage IIIA breast cancer|stage iiia breast cancer
619277|NCT00659386|Heart failure|heart failure
619278|NCT00659386|Parvovirus B19|parvovirus b19
619279|NCT00659386|Intravenous immuneglobulin|intravenous immuneglobulin
619280|NCT00659399|Pretreated Ovarian Carcinoma|pretreated ovarian carcinoma
619281|NCT00659412|Psoriatic arthritis|psoriatic arthritis
619282|NCT00659412|psoriasis|psoriasis
619283|NCT00659412|Alefacept|alefacept
619284|NCT00659451|Hypertension|hypertension
619285|NCT00659451|Diabetes mellitus|diabetes mellitus
619287|NCT00659464|Infrared Spectroscopy|infrared spectroscopy
619288|NCT00659464|Syncope|syncope
619289|NCT00659464|Tilt Table Testing|tilt table testing
619290|NCT00659490|Analgesic effect|analgesic effect
619291|NCT00659490|Molar extraction|molar extraction
619292|NCT00659503|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
619293|NCT00659503|Ciclesonide|ciclesonide
619294|NCT00659503|Hay Fever|hay fever
619295|NCT00659503|SAR|sar
619296|NCT00659529|cystic fibrosis|cystic fibrosis
619297|NCT00659529|inflammation|inflammation
619298|NCT00659529|pH|ph
619299|NCT00659529|EBC|ebc
619300|NCT00659529|sputum biomarkers|sputum biomarkers
619301|NCT00659529|phosphodiesterase inhibitors|phosphodiesterase inhibitors
619302|NCT00659542|inguinal hernia|inguinal hernia
619303|NCT00659542|inguinal hernioplasty|inguinal hernioplasty
619304|NCT00659542|mesh fixation|mesh fixation
619305|NCT00659542|Lichtenstein hernioplasty|lichtenstein hernioplasty
619306|NCT00659555|vascular endothelial growth factor,|vascular endothelial growth factor,
619307|NCT00659555|drug interaction,|drug interaction,
619308|NCT00659555|angiogenesis,|angiogenesis,
619309|NCT00659555|pharmacokinetics,|pharmacokinetics,
619310|NCT00659555|age-related macular degeneration,|age-related macular degeneration,
619311|NCT00659555|pazopanib,|pazopanib,
619312|NCT00659555|ketoconazole|ketoconazole
619313|NCT00659568|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
619314|NCT00659568|stage III renal cell cancer|stage iii renal cell cancer
619315|NCT00659568|stage IV renal cell cancer|stage iv renal cell cancer
619316|NCT00659568|recurrent renal cell cancer|recurrent renal cell cancer
619317|NCT00659568|recurrent endometrial carcinoma|recurrent endometrial carcinoma
619318|NCT00659568|stage III endometrial carcinoma|stage iii endometrial carcinoma
619319|NCT00659568|stage IV endometrial carcinoma|stage iv endometrial carcinoma
619320|NCT00659568|recurrent breast cancer|recurrent breast cancer
619321|NCT00659568|stage IIIA breast cancer|stage iiia breast cancer
619322|NCT00659568|stage IIIB breast cancer|stage iiib breast cancer
619323|NCT00659568|stage IIIC breast cancer|stage iiic breast cancer
619324|NCT00659568|stage IV breast cancer|stage iv breast cancer
619325|NCT00659568|recurrent small cell lung cancer|recurrent small cell lung cancer
619326|NCT00659568|extensive stage small cell lung cancer|extensive stage small cell lung cancer
619327|NCT00659568|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
619328|NCT00659568|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
619329|NCT00659568|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
752177|NCT01172028|stage IV esophageal cancer|stage iv esophageal cancer
619330|NCT00659568|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
619331|NCT00659568|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
619332|NCT00659568|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
619333|NCT00659568|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
619334|NCT00659568|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
619335|NCT00659568|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
619336|NCT00659568|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
619337|NCT00659568|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
619338|NCT00659568|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
619339|NCT00659568|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
619340|NCT00659568|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
619341|NCT00659568|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
619342|NCT00659568|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
619343|NCT00659568|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
619344|NCT00659568|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
619345|NCT00659568|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
619346|NCT00659568|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
619347|NCT00659568|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
619348|NCT00659568|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
619349|NCT00659568|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
619350|NCT00659568|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
619351|NCT00659568|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
619352|NCT00659568|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
619353|NCT00659568|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
619354|NCT00659568|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
619355|NCT00659568|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
619356|NCT00659568|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
619357|NCT00659568|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
619358|NCT00659568|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
619359|NCT00659568|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
619360|NCT00659568|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
619361|NCT00659568|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
619362|NCT00659568|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
619363|NCT00659568|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
619364|NCT00659568|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
619365|NCT00659568|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
619366|NCT00659568|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
619367|NCT00659568|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
619490|NCT00660101|autologous|autologous
619368|NCT00659568|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
619369|NCT00659568|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
619370|NCT00659568|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
619371|NCT00659568|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
619372|NCT00659568|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
619373|NCT00659568|anaplastic large cell lymphoma|anaplastic large cell lymphoma
619374|NCT00659568|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
619375|NCT00659568|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
619376|NCT00659568|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
619377|NCT00659568|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
619378|NCT00659568|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
619379|NCT00659568|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
619380|NCT00659568|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
619381|NCT00659568|splenic marginal zone lymphoma|splenic marginal zone lymphoma
619382|NCT00659568|Waldenström macroglobulinemia|waldenström macroglobulinemia
619383|NCT00659594|Seasonal Allergic rhinitis|seasonal allergic rhinitis
619384|NCT00659594|Ciclesonide|ciclesonide
619385|NCT00659594|Hay Fever|hay fever
619387|NCT00659620|Kidney Transplant|kidney transplant
619388|NCT00659620|Chronic Allograft Nephropathy|chronic allograft nephropathy
619389|NCT00659620|Mesenchymal Stem Cell infusion|mesenchymal stem cell infusion
619390|NCT00659633|lidocaine|lidocaine
619391|NCT00659633|allodynia|allodynia
619392|NCT00659633|chronic regional pain syndrome|chronic regional pain syndrome
619393|NCT00659633|pain|pain
619394|NCT00659646|Diabetes|diabetes
619395|NCT00659646|ulcers|ulcers
619396|NCT00659646|ulcerations|ulcerations
619397|NCT00659646|infection|infection
619398|NCT00659672|hypertension|hypertension
619399|NCT00659672|prehypertension|prehypertension
619400|NCT00659672|high blood pressure|high blood pressure
619401|NCT00659672|blood pressure|blood pressure
619402|NCT00659672|heart disease|heart disease
619403|NCT00659685|Bioequivalence|bioequivalence
619404|NCT00659685|Ondansetron ODT|ondansetron odt
619405|NCT00659685|Fasting|fasting
619406|NCT00659685|To Determine Bioequivalence Under Fasting conditions|to determine bioequivalence under fasting conditions
619407|NCT00659698|surgical|surgical
619408|NCT00659698|site|site
619409|NCT00659698|infection|infection
619410|NCT00659724|Dialyzer|dialyzer
619411|NCT00659737|Post-operative Nausea and Vomiting (PONV)|post-operative nausea and vomiting (ponv)
619412|NCT00659750|Perennial Allergic Rhinitis|perennial allergic rhinitis
619413|NCT00659750|Ciclesonide|ciclesonide
619414|NCT00659750|PAR|par
619415|NCT00659763|IBS|ibs
619416|NCT00659763|Diagnosis|diagnosis
619417|NCT00659776|ferumoxytol|ferumoxytol
619418|NCT00659828|Congenital leptin deficiency|congenital leptin deficiency
619419|NCT00659828|Obesity|obesity
619420|NCT00659828|Metabolic Syndrome|metabolic syndrome
619421|NCT00659828|Diabetes|diabetes
619422|NCT00659841|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
619423|NCT00659841|Ciclesonide|ciclesonide
619424|NCT00659841|Hay Fever|hay fever
619425|NCT00659841|SAR|sar
619426|NCT00659854|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
619427|NCT00659854|The study examines the response of infants diagnosed with obstructive sleep apnea syndrome to diet changes|the study examines the response of infants diagnosed with obstructive sleep apnea syndrome to diet changes
619428|NCT00659867|Ulcerative Colitis|ulcerative colitis
619429|NCT00659867|Endomicroscopy|endomicroscopy
619430|NCT00659867|Chromoendoscopy|chromoendoscopy
619431|NCT00659867|Confocal colonoscope|confocal colonoscope
619432|NCT00659867|Surveillance colonoscopy|surveillance colonoscopy
619433|NCT00659880|Meniscus transplant|meniscus transplant
619434|NCT00659880|Meniscal allograft|meniscal allograft
619435|NCT00659880|MAT|mat
619436|NCT00659880|Knee|knee
619437|NCT00659893|Peplin|peplin
619438|NCT00659893|PEP005|pep005
619439|NCT00659893|Actinic Keratosis|actinic keratosis
619440|NCT00659906|randomized clinical trial|randomized clinical trial
619441|NCT00659906|cancer survivor|cancer survivor
619442|NCT00659906|bone health|bone health
619443|NCT00659906|body composition|body composition
619444|NCT00659906|signs and symptoms|signs and symptoms
619445|NCT00659932|diabetes|diabetes
619446|NCT00659932|cognitive behavioural therapy|cognitive behavioural therapy
619447|NCT00659945|Postoperation, nausea, vomiting, anesthesia, plastic surgery|postoperation, nausea, vomiting, anesthesia, plastic surgery
619449|NCT00659958|partial onset seizures|partial onset seizures
619450|NCT00659958|effectiveness|effectiveness
619451|NCT00659958|tolerability|tolerability
619452|NCT00659971|oral candidiasis|oral candidiasis
619453|NCT00659984|recurrent neuroblastoma|recurrent neuroblastoma
619454|NCT00659997|Ascariasis|ascariasis
619455|NCT00659997|Trichuriasis|trichuriasis
619456|NCT00659997|Drug resistance|drug resistance
619457|NCT00660010|CPP|cpp
619458|NCT00660010|central precocious puberty|central precocious puberty
619459|NCT00660010|pediatrics|pediatrics
619460|NCT00660010|suppression of LH|suppression of lh
619461|NCT00660010|Lupron|lupron
619462|NCT00660010|leuprolide acetate|leuprolide acetate
619463|NCT00660010|depot formulation|depot formulation
619464|NCT00660010|GnRHa|gnrha
619465|NCT00660010|GnRH agonist|gnrh agonist
619466|NCT00660010|GNRH analog|gnrh analog
619467|NCT00660010|LH|lh
619468|NCT00660010|Tanner staging|tanner staging
619469|NCT00660036|Acute myeloid leukemia|acute myeloid leukemia
619470|NCT00660036|Refractory|refractory
619471|NCT00660036|Relapsed|relapsed
619472|NCT00660036|Second line|second line
619473|NCT00660036|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
619474|NCT00660036|Mitoxantrone|mitoxantrone
619475|NCT00660036|Etoposide|etoposide
619476|NCT00660036|Phase I|phase i
619477|NCT00660036|Phase II|phase ii
619479|NCT00660062|relapse prevention|relapse prevention
619480|NCT00660062|ECT|ect
619481|NCT00660062|escitalopram|escitalopram
619482|NCT00660062|nortriptyline|nortriptyline
619483|NCT00660075|Diabetes mellitus|diabetes mellitus
619484|NCT00660075|Postprandial|postprandial
619485|NCT00660075|Hyperlipidemia|hyperlipidemia
619486|NCT00660075|Atherosclerosis|atherosclerosis
619487|NCT00660101|ovarian cancer|ovarian cancer
619488|NCT00660101|vaccine|vaccine
619489|NCT00660101|immunotherapy|immunotherapy
619491|NCT00660114|Cough variant asthma|cough variant asthma
619492|NCT00660114|Pulmicort® Respules®|pulmicort® respules®
619493|NCT00660114|Chinese patient Eligibility|chinese patient eligibility
619494|NCT00660140|Cholangiocarcinoma|cholangiocarcinoma
619495|NCT00660140|Gallbladder|gallbladder
619496|NCT00660140|Cancer|cancer
619497|NCT00660153|Advanced Colorectal Cancer and Other Gastrointestinal Cancers|advanced colorectal cancer and other gastrointestinal cancers
619498|NCT00660153|tivozanib|tivozanib
619499|NCT00660153|AV-951|av-951
619500|NCT00660166|Natural killer cells|natural killer cells
621639|NCT00667186|HIV|hiv
619501|NCT00660166|autologous stem cell transplant|autologous stem cell transplant
619502|NCT00660166|immunotherapy|immunotherapy
619503|NCT00660179|pulmonary arterial hypertension SERAPHIN|pulmonary arterial hypertension seraphin
619504|NCT00660192|Migraine, refractory migraine, Pain, Botulinum Toxin , Botox|migraine, refractory migraine, pain, botulinum toxin , botox
619505|NCT00660205|DVT|dvt
619506|NCT00660205|PE|pe
619507|NCT00660205|D-dimer|d-dimer
619508|NCT00660205|cancer|cancer
619509|NCT00660205|VTE|vte
619510|NCT00660218|Stage III and IV head and neck cancer|stage iii and iv head and neck cancer
619511|NCT00660231|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
619512|NCT00660231|stage IB mycosis fungoides/Sezary syndrome|stage ib mycosis fungoides/sezary syndrome
619513|NCT00660231|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
619514|NCT00660231|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
619515|NCT00660231|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
619516|NCT00660231|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
619517|NCT00660231|stage IB cutaneous T-cell non-Hodgkin lymphoma|stage ib cutaneous t-cell non-hodgkin lymphoma
619518|NCT00660231|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
619519|NCT00660231|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
619520|NCT00660231|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
619521|NCT00660244|Arimidex|arimidex
619522|NCT00660244|Post menopausal|post menopausal
619523|NCT00660244|arthralgia|arthralgia
619524|NCT00653172|CAP|cap
619525|NCT00653172|community acquired pneumonia|community acquired pneumonia
619526|NCT00653185|Glucose Metabolism Disorder|glucose metabolism disorder
619527|NCT00653185|Dysmetabolic Syndrome|dysmetabolic syndrome
619528|NCT00653185|Type II Diabetes|type ii diabetes
619529|NCT00653185|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
619530|NCT00653185|Dyslipidemia|dyslipidemia
619531|NCT00653185|Hyperglycemia|hyperglycemia
619532|NCT00653198|Rotavirus severe gastroenteritis (RV SGE)|rotavirus severe gastroenteritis (rv sge)
619533|NCT00653224|levocetirizine|levocetirizine
619534|NCT00653224|Xyzal|xyzal
619535|NCT00653224|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
619536|NCT00653224|total symptom score|total symptom score
619537|NCT00653224|quality of life|quality of life
619538|NCT00653250|stage I non-small cell lung cancer|stage i non-small cell lung cancer
619539|NCT00653250|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
619540|NCT00653250|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
619541|NCT00653263|methamphetamine|methamphetamine
619542|NCT00653263|drug abuse|drug abuse
619543|NCT00653263|withdrawal|withdrawal
619544|NCT00653315|Bioequivalence, Tramadol APAP, fasting|bioequivalence, tramadol apap, fasting
619545|NCT00653328|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
619546|NCT00653328|fallopian tube cancer|fallopian tube cancer
619547|NCT00653328|peritoneal cavity cancer|peritoneal cavity cancer
619548|NCT00653341|insulin naive|insulin naive
619549|NCT00653354|hallux valgus|hallux valgus
619550|NCT00653367|Thoracotomy|thoracotomy
619551|NCT00653367|Nerve section|nerve section
619552|NCT00653367|QST|qst
619553|NCT00653367|Quantitative Sensory Test|quantitative sensory test
619554|NCT00653367|Muscle sparing Posterolateral thoracotomy|muscle sparing posterolateral thoracotomy
619555|NCT00653367|Chest|chest
619556|NCT00653367|Wall|wall
619557|NCT00653367|Surgical|surgical
619558|NCT00653367|Incision|incision
619559|NCT00653367|Tumors or cancer of the lung|tumors or cancer of the lung
619560|NCT00653380|bioequivalence|bioequivalence
619561|NCT00653380|doxycycline monohydrate|doxycycline monohydrate
619562|NCT00653380|fasting|fasting
619563|NCT00653393|bioequivalence, single- dose, fasting|bioequivalence, single- dose, fasting
619564|NCT00653406|Schizophrenia|schizophrenia
619565|NCT00653406|Risperidone|risperidone
619566|NCT00653406|Intramuscular injection|intramuscular injection
619567|NCT00653406|Pharmacokinetics|pharmacokinetics
619568|NCT00653419|bioequivalence|bioequivalence
619569|NCT00653419|buspirone HCl|buspirone hcl
619570|NCT00653419|fasting|fasting
619571|NCT00653432|Treatment|treatment
619572|NCT00653432|Osteoarthritis|osteoarthritis
619573|NCT00653445|Low density lipoproteins|low density lipoproteins
619574|NCT00653445|Hypercholesterolemia|hypercholesterolemia
619575|NCT00653445|Coronary Heart Disease|coronary heart disease
619576|NCT00653445|Rosuvastatin|rosuvastatin
619577|NCT00653445|Crestor|crestor
619578|NCT00653445|Ezetimibe|ezetimibe
619579|NCT00653458|bioequivalence|bioequivalence
619580|NCT00653458|Ondansetron ODT|ondansetron odt
619581|NCT00653458|fed|fed
619582|NCT00653458|To determine bioequivalence under fed conditions|to determine bioequivalence under fed conditions
619583|NCT00653471|obesity|obesity
619584|NCT00653471|osa|osa
619585|NCT00653471|capnography|capnography
619586|NCT00653471|general anesthesia|general anesthesia
619587|NCT00653484|colon cancer|colon cancer
619588|NCT00653484|rectal cancer|rectal cancer
619589|NCT00653484|obesity|obesity
619590|NCT00653497|Osteoarthritis|osteoarthritis
619591|NCT00653510|Type 2 diabetes|type 2 diabetes
619592|NCT00653510|Dysregulation|dysregulation
619593|NCT00653510|Metabolism|metabolism
619594|NCT00653510|Cardiac output|cardiac output
619596|NCT00653536|neuroflo|neuroflo
619598|NCT00653536|failure to recanalize|failure to recanalize
619599|NCT00653549|Bioequivalence|bioequivalence
619600|NCT00653549|Torsemide Tablets|torsemide tablets
619601|NCT00653549|fasting|fasting
619602|NCT00653562|polysomnography|polysomnography
619603|NCT00653562|zolpidem|zolpidem
619604|NCT00653562|Sleep disorders|sleep disorders
619605|NCT00653562|adolescent|adolescent
619606|NCT00653575|Sexual Behavior|sexual behavior
619607|NCT00653575|HIV|hiv
619608|NCT00653575|Sexually Transmitted Diseases|sexually transmitted diseases
619609|NCT00653588|Cholesterol|cholesterol
619610|NCT00653588|low density lipoproteins|low density lipoproteins
619611|NCT00653588|Hypercholesterolemia|hypercholesterolemia
619612|NCT00653588|Coronary Heart Disease|coronary heart disease
619613|NCT00653588|Rosuvastatin|rosuvastatin
619614|NCT00653588|Crestor|crestor
619615|NCT00653588|Atorvastatin|atorvastatin
619616|NCT00653588|Lipitor|lipitor
619617|NCT00653601|GPI|gpi
619618|NCT00653601|glycoprotein IIb/IIIa inhibitor|glycoprotein iib/iiia inhibitor
619619|NCT00653601|Aggrastat|aggrastat
619620|NCT00653601|Tirofiban|tirofiban
619621|NCT00653601|Verify now|verify now
619622|NCT00653601|platelet function testing|platelet function testing
619623|NCT00653601|bridge therapy|bridge therapy
619624|NCT00653614|Oral contraception|oral contraception
619625|NCT00653640|rehabilitation|rehabilitation
619626|NCT00653640|head injury|head injury
619627|NCT00653640|3 months post injury|3 months post injury
619628|NCT00653640|require manual assistance or walking aids to walk|require manual assistance or walking aids to walk
619629|NCT00653640|very slow walking speed|very slow walking speed
619630|NCT00653640|able to follow two step commands|able to follow two step commands
619631|NCT00653653|pharmacogenetics|pharmacogenetics
619632|NCT00653653|pharmacoeconomics|pharmacoeconomics
619633|NCT00653653|adverse events|adverse events
619634|NCT00653653|drug metabolism|drug metabolism
619635|NCT00653666|CPT1A|cpt1a
619636|NCT00653666|steatosis|steatosis
619637|NCT00653666|deficiency|deficiency
619638|NCT00653666|metabolic|metabolic
619639|NCT00653666|response|response
619640|NCT00653666|fasting|fasting
619641|NCT00653679|exercise|exercise
619642|NCT00653679|muscle protein signalling|muscle protein signalling
619643|NCT00653679|protein synthesis|protein synthesis
619644|NCT00653692|Substance abuse|substance abuse
619645|NCT00653692|fetal development|fetal development
619646|NCT00653692|vagal tone|vagal tone
619647|NCT00653705|Probiotics|probiotics
619648|NCT00653705|Children|children
619649|NCT00653705|Child Care Center|child care center
619650|NCT00653705|Nutrition|nutrition
619651|NCT00653705|Health promotion|health promotion
619652|NCT00653718|Pain|pain
619653|NCT00653718|Characterize musculoskeletal pain|characterize musculoskeletal pain
753142|NCT01175642|Schizophrenia|schizophrenia
619654|NCT00653718|Breast cancer patients treated with aromatase inhibitors|breast cancer patients treated with aromatase inhibitors
619655|NCT00653731|dementia|dementia
619656|NCT00653731|snoezelen|snoezelen
619657|NCT00653731|structured reminiscence therapy|structured reminiscence therapy
619658|NCT00653731|10-minutes activation|10-minutes activation
619659|NCT00653731|apathy|apathy
619660|NCT00653744|Cholesterol|cholesterol
619661|NCT00653744|low density lipoproteins|low density lipoproteins
619662|NCT00653744|dyslipidaemia|dyslipidaemia
619663|NCT00653744|Rosuvastatin|rosuvastatin
619664|NCT00653744|Crestor|crestor
619665|NCT00653744|Atorvastatin|atorvastatin
619666|NCT00653744|Lipitor|lipitor
619667|NCT00653744|African American|african american
619668|NCT00653757|stage I prostate cancer|stage i prostate cancer
619669|NCT00653757|stage II prostate cancer|stage ii prostate cancer
619670|NCT00653757|stage III prostate cancer|stage iii prostate cancer
619671|NCT00653757|stage IV prostate cancer|stage iv prostate cancer
619672|NCT00653783|Parkinson disease|parkinson disease
619673|NCT00653783|Multiple System Atrophy|multiple system atrophy
619675|NCT00653783|Progressive Supranuclear Palsy|progressive supranuclear palsy
619676|NCT00653783|PSP|psp
619677|NCT00653783|observational|observational
619678|NCT00653783|biomarker|biomarker
619679|NCT00653822|Amevive|amevive
619680|NCT00653822|alefacept|alefacept
619681|NCT00653822|pharmacokinetics|pharmacokinetics
619682|NCT00653822|Japanese|japanese
619683|NCT00653848|Adjuvant treatment, intermediate and high risk, radical radiotherapy|adjuvant treatment, intermediate and high risk, radical radiotherapy
619684|NCT00653861|Aesthetic correction|aesthetic correction
619685|NCT00653874|jaundice|jaundice
619686|NCT00653874|neonates|neonates
619687|NCT00653874|transcutaneous bilirubinometry|transcutaneous bilirubinometry
619688|NCT00653874|clinical assessment of bilirubin|clinical assessment of bilirubin
619689|NCT00653887|Biofeedback|biofeedback
619690|NCT00653887|anal sphincter|anal sphincter
619691|NCT00653887|cortical excitability|cortical excitability
619692|NCT00653887|magnetic stimulation|magnetic stimulation
619693|NCT00653887|incontinence|incontinence
619694|NCT00653887|constipation|constipation
619695|NCT00653900|Verify now|verify now
619696|NCT00653900|platelet function|platelet function
619697|NCT00653900|platelet function testing|platelet function testing
619698|NCT00653900|bleeding risk|bleeding risk
619699|NCT00653900|periprocedural bleeding|periprocedural bleeding
619700|NCT00653900|clopidogrel|clopidogrel
619701|NCT00653900|Our initial goal is to establish if a certain degree of|our initial goal is to establish if a certain degree of
619702|NCT00653900|platelet function abnormality can predict a higher bleeding|platelet function abnormality can predict a higher bleeding
619703|NCT00653900|or higher transfusions.|or higher transfusions.
619704|NCT00653926|Postoperative pain|postoperative pain
619705|NCT00653926|Local infiltration analgesia|local infiltration analgesia
619706|NCT00653926|Knee arthroplasty|knee arthroplasty
619707|NCT00653926|Postoperative pain management following unicompartmental knee arthroplasty|postoperative pain management following unicompartmental knee arthroplasty
619708|NCT00653939|non-small cell lung cancer|non-small cell lung cancer
619709|NCT00653939|non-small cell lung carcinoma|non-small cell lung carcinoma
619710|NCT00653939|neoplasms, lung|neoplasms, lung
619711|NCT00653939|lung cancer|lung cancer
619712|NCT00653939|tumors|tumors
619713|NCT00653939|NSCLC|nsclc
619714|NCT00653952|Paclitaxel HCl|paclitaxel hcl
619715|NCT00653952|CAELYX|caelyx
619716|NCT00653952|DOXIL|doxil
619717|NCT00653952|Ovarian Carcinoma|ovarian carcinoma
619718|NCT00653952|Doxorubicin HCl|doxorubicin hcl
619719|NCT00653965|Cholesterol|cholesterol
619720|NCT00653965|low density lipoproteins|low density lipoproteins
619721|NCT00653965|dyslipidaemia|dyslipidaemia
619722|NCT00653965|Rosuvastatin|rosuvastatin
619723|NCT00653965|Crestor|crestor
619724|NCT00653965|Atorvastatin|atorvastatin
619725|NCT00653965|Lipitor|lipitor
619726|NCT00653965|Hispanic|hispanic
619727|NCT00653978|ERCP|ercp
619728|NCT00653978|cholangiocarcinoma|cholangiocarcinoma
619729|NCT00653978|hilar stricture|hilar stricture
619730|NCT00653991|HIV/AIDS Prevention|hiv/aids prevention
619731|NCT00653991|Men Who Have Sex With Men (MSM)|men who have sex with men (msm)
619732|NCT00653991|Risky Sexual Behavior|risky sexual behavior
619733|NCT00653991|Socially Optimized Learning in a Virtual Environment (SOLVE)|socially optimized learning in a virtual environment (solve)
619734|NCT00653991|HIV Seronegativity|hiv seronegativity
619735|NCT00654004|trifunctional|trifunctional
619736|NCT00654004|protein|protein
619737|NCT00654004|deficiency|deficiency
619738|NCT00654004|TFP|tfp
619739|NCT00654004|weight|weight
619740|NCT00654004|regulation|regulation
619741|NCT00654030|Lung Cancer Vaccine|lung cancer vaccine
619742|NCT00654030|Early Stage Lung Cancer|early stage lung cancer
619743|NCT00654030|Lung Cancer|lung cancer
619744|NCT00654043|Bioequivalence|bioequivalence
619745|NCT00654043|Torsemide Tablets|torsemide tablets
619746|NCT00654043|fed|fed
619747|NCT00654043|To determine bioequivalence under fed conditions.|to determine bioequivalence under fed conditions.
619748|NCT00654056|Type 2 diabetes|type 2 diabetes
619749|NCT00654056|Severe insulin resistance|severe insulin resistance
619750|NCT00654069|Pain|pain
619751|NCT00654108|Escherichia coli, cholera, diarrhea, vaccine|escherichia coli, cholera, diarrhea, vaccine
619752|NCT00654121|prevention|prevention
619753|NCT00654147|HIV|hiv
619754|NCT00654147|antiretroviral therapy naive|antiretroviral therapy naive
619755|NCT00654147|Integrase inhibitor|integrase inhibitor
619756|NCT00654147|HIV/AIDS|hiv/aids
619757|NCT00654147|treatment naïve|treatment naïve
619758|NCT00654160|stage IIIB anal cancer|stage iiib anal cancer
619759|NCT00654160|stage IV anal cancer|stage iv anal cancer
619760|NCT00654160|recurrent anal cancer|recurrent anal cancer
619761|NCT00654160|carcinoma of the appendix|carcinoma of the appendix
619762|NCT00654160|stage III colon cancer|stage iii colon cancer
619763|NCT00654160|stage IV colon cancer|stage iv colon cancer
619764|NCT00654160|recurrent colon cancer|recurrent colon cancer
619765|NCT00654160|stage III rectal cancer|stage iii rectal cancer
619766|NCT00654160|stage IV rectal cancer|stage iv rectal cancer
619767|NCT00654160|recurrent rectal cancer|recurrent rectal cancer
619965|NCT00660959|Euvolemic|euvolemic
619768|NCT00654160|stage III esophageal cancer|stage iii esophageal cancer
619769|NCT00654160|stage IV esophageal cancer|stage iv esophageal cancer
619770|NCT00654160|recurrent esophageal cancer|recurrent esophageal cancer
619771|NCT00654160|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
619772|NCT00654160|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
619773|NCT00654160|unresectable gallbladder cancer|unresectable gallbladder cancer
619774|NCT00654160|recurrent gallbladder cancer|recurrent gallbladder cancer
619775|NCT00654160|stage III gastric cancer|stage iii gastric cancer
619776|NCT00654160|stage IV gastric cancer|stage iv gastric cancer
619777|NCT00654160|recurrent gastric cancer|recurrent gastric cancer
619778|NCT00654160|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
619779|NCT00654160|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
619780|NCT00654160|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
619781|NCT00654160|gastrointestinal stromal tumor|gastrointestinal stromal tumor
619782|NCT00654160|advanced adult primary liver cancer|advanced adult primary liver cancer
619783|NCT00654160|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
619784|NCT00654160|recurrent adult primary liver cancer|recurrent adult primary liver cancer
619785|NCT00654160|stage II pancreatic cancer|stage ii pancreatic cancer
619786|NCT00654160|stage III pancreatic cancer|stage iii pancreatic cancer
619787|NCT00654160|stage IV pancreatic cancer|stage iv pancreatic cancer
619788|NCT00654160|recurrent pancreatic cancer|recurrent pancreatic cancer
619789|NCT00654160|recurrent small intestine cancer|recurrent small intestine cancer
619790|NCT00654160|small intestine adenocarcinoma|small intestine adenocarcinoma
619791|NCT00654160|small intestine leiomyosarcoma|small intestine leiomyosarcoma
619792|NCT00654160|small intestine lymphoma|small intestine lymphoma
619793|NCT00654173|Cholesterol|cholesterol
619794|NCT00654173|low density lipoproteins|low density lipoproteins
619795|NCT00654173|dyslipidaemia|dyslipidaemia
619796|NCT00654173|Rosuvastatin|rosuvastatin
619797|NCT00654173|Crestor|crestor
619798|NCT00654173|Atorvastatin|atorvastatin
619799|NCT00654173|Lipitor|lipitor
619800|NCT00654173|Zocor|zocor
619801|NCT00654173|simvastatin|simvastatin
619802|NCT00654186|Androgen Independent Prostate Cancer (AIPC)|androgen independent prostate cancer (aipc)
619803|NCT00654186|Chemo naive|chemo naive
619804|NCT00654199|CABG|cabg
619805|NCT00654199|Ventricular Asynchrony|ventricular asynchrony
619806|NCT00654199|Normal Sinus Rhythm|normal sinus rhythm
619807|NCT00654212|stenting, laparoscopic surgery, colon cancer|stenting, laparoscopic surgery, colon cancer
619808|NCT00654225|Cholesterol|cholesterol
619809|NCT00654225|low density lipoproteins|low density lipoproteins
619810|NCT00654225|dyslipidaemia|dyslipidaemia
619811|NCT00654225|Rosuvastatin|rosuvastatin
619812|NCT00654225|Crestor|crestor
619813|NCT00654225|Atorvastatin|atorvastatin
619814|NCT00654225|Lipitor|lipitor
619815|NCT00654225|South Asian|south asian
619816|NCT00654238|Thyroid Cancer|thyroid cancer
619817|NCT00654238|Anaplastic|anaplastic
619818|NCT00654238|Medullary|medullary
619819|NCT00654238|sorafenib|sorafenib
619820|NCT00654251|Spinocerebellar ataxia|spinocerebellar ataxia
619821|NCT00654251|Machado-Joseph disease|machado-joseph disease
619822|NCT00654251|Gait monitoring|gait monitoring
619823|NCT00654251|Functional vision assessment|functional vision assessment
619824|NCT00654277|bioequivalence|bioequivalence
619825|NCT00654277|Ondansetron ODT|ondansetron odt
619826|NCT00654277|Fasting|fasting
619827|NCT00654277|To determine bioequivalence under fasting conditions|to determine bioequivalence under fasting conditions
619828|NCT00654290|Atrial fibrillation|atrial fibrillation
619829|NCT00654290|coronary bypass|coronary bypass
619830|NCT00654290|Amiodarone|amiodarone
619831|NCT00654290|Propranolol|propranolol
619832|NCT00654290|Coronary Artery Bypass Graft (CABG)|coronary artery bypass graft (cabg)
619833|NCT00654303|Cholesterol|cholesterol
619834|NCT00654303|Hypercholesterolaemia|hypercholesterolaemia
619835|NCT00654303|Statins|statins
619836|NCT00654316|TB|tb
619837|NCT00654316|Tuberculosis|tuberculosis
619838|NCT00654316|MVA85A|mva85a
619839|NCT00654316|Vaccine|vaccine
619840|NCT00654316|BCG|bcg
619841|NCT00654329|Dexmedetomidine, transmucosal, myringotomy,|dexmedetomidine, transmucosal, myringotomy,
619842|NCT00654342|Sentinel lymph node-colon cancer|sentinel lymph node-colon cancer
619843|NCT00654355|atopic dermatitis|atopic dermatitis
619844|NCT00654355|eczema|eczema
619845|NCT00654368|Amgen|amgen
619846|NCT00660270|Chemotherapy|chemotherapy
619847|NCT00660270|Radiation|radiation
619848|NCT00660283|GBM|gbm
619849|NCT00660283|Newly|newly
619850|NCT00660283|diagnosed|diagnosed
619851|NCT00660283|malignant|malignant
619852|NCT00660283|high grade|high grade
619853|NCT00660296|CO2|co2
619854|NCT00660296|pain|pain
619855|NCT00660296|colonoscopy|colonoscopy
619856|NCT00660296|cancer|cancer
619857|NCT00660296|screening|screening
619858|NCT00660309|Type 2 diabetes mellitus|type 2 diabetes mellitus
619859|NCT00660309|renal disease|renal disease
619860|NCT00660309|hypertension|hypertension
619861|NCT00660309|renal blood flow|renal blood flow
621749|NCT00667602|Infants|infants
619862|NCT00660309|retinal blood flow|retinal blood flow
619863|NCT00660309|aliskiren|aliskiren
619864|NCT00660309|irbesartan|irbesartan
619865|NCT00660309|captopril|captopril
619866|NCT00660322|Asthma|asthma
619867|NCT00660322|Telemedicine|telemedicine
619868|NCT00660322|Randomized controlled trial|randomized controlled trial
619869|NCT00660335|secretin, RG1068, MRCP, pancreas|secretin, rg1068, mrcp, pancreas
619870|NCT00660348|recurrent pancreatic cancer|recurrent pancreatic cancer
619871|NCT00660348|stage III pancreatic cancer|stage iii pancreatic cancer
619872|NCT00660348|stage IV pancreatic cancer|stage iv pancreatic cancer
619873|NCT00660348|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
619874|NCT00660348|pain|pain
619875|NCT00660348|stage II pancreatic cancer|stage ii pancreatic cancer
619877|NCT00660361|HBV|hbv
619878|NCT00660361|co-infection|co-infection
619879|NCT00660361|drug resistance|drug resistance
619880|NCT00660361|tenofovir|tenofovir
619881|NCT00660361|HIV-HBV co-infection|hiv-hbv co-infection
619882|NCT00660387|levodopa-carbidopa|levodopa-carbidopa
619883|NCT00660387|Carbidopa|carbidopa
619887|NCT00660387|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
619888|NCT00660387|Severe Motor Fluctuations|severe motor fluctuations
619889|NCT00660387|levodopa/carbidopa suspension|levodopa/carbidopa suspension
619890|NCT00660387|DUOPA|duopa
619891|NCT00660400|Myeloid|myeloid
619892|NCT00660400|Monocytic|monocytic
619893|NCT00660413|Acceleromyography|acceleromyography
619894|NCT00660413|Mechanomyography|mechanomyography
619895|NCT00660413|Neuromuscular block|neuromuscular block
619896|NCT00660413|Neuromuscular monitoring|neuromuscular monitoring
619897|NCT00660413|Dose-response|dose-response
619898|NCT00660413|Potency|potency
619899|NCT00660413|Rocuronium|rocuronium
619900|NCT00660426|cancer|cancer
619901|NCT00660426|gastrointestinal|gastrointestinal
619902|NCT00660426|tumor|tumor
619903|NCT00660439|PTSD|ptsd
619904|NCT00660452|Allergy|allergy
619905|NCT00660452|SLIT|slit
619906|NCT00660452|Asthma|asthma
619907|NCT00660452|House Dust Mites|house dust mites
619908|NCT00660465|Regional BOLD signal dependency on arterial PaCO2.|regional bold signal dependency on arterial paco2.
619909|NCT00660465|Effect of breathing exercises on brain regional O2 level.|effect of breathing exercises on brain regional o2 level.
619910|NCT00660465|Healthy subjects|healthy subjects
619911|NCT00660491|flow mediated dilatation|flow mediated dilatation
619912|NCT00660491|maximal oxygen uptake|maximal oxygen uptake
619913|NCT00660491|blood lipid|blood lipid
619914|NCT00660504|Extensive Disease-Small Cell Lung Cancer|extensive disease-small cell lung cancer
619915|NCT00660530|stage 5|stage 5
619916|NCT00660530|chronic|chronic
619917|NCT00660530|hemodialysis|hemodialysis
619918|NCT00660569|asthma treatment|asthma treatment
619919|NCT00660569|utilization|utilization
619920|NCT00660569|real life practice|real life practice
619921|NCT00660582|Erbitux|erbitux
619922|NCT00660582|Colorectal cancer|colorectal cancer
619923|NCT00660582|Oxaliplatin|oxaliplatin
619924|NCT00660582|Flox|flox
619925|NCT00660582|Fluorouracil + folinic acid|fluorouracil + folinic acid
619926|NCT00660582|K-RAS|k-ras
619927|NCT00660595|Schizophrenia|schizophrenia
619928|NCT00660595|Schizoaffective psychosis|schizoaffective psychosis
619929|NCT00660595|Schizophreniformic psychosis|schizophreniformic psychosis
619930|NCT00660595|Pilot study|pilot study
619931|NCT00660595|Quetiapine Prolong|quetiapine prolong
619932|NCT00660595|Risperidone|risperidone
619933|NCT00660803|Advanced Breast Cancer|advanced breast cancer
619934|NCT00660803|Hormone Therapy|hormone therapy
620351|NCT00662168|familial|familial
619935|NCT00660816|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
619936|NCT00660816|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
619937|NCT00660816|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
619938|NCT00660842|quality of life|quality of life
619939|NCT00660842|weekly therapy|weekly therapy
619940|NCT00660842|neurotoxicity|neurotoxicity
619941|NCT00660855|laparoscopy|laparoscopy
619942|NCT00660868|smell|smell
619943|NCT00660868|olfaction|olfaction
619944|NCT00660868|olfactory sensitivity|olfactory sensitivity
619945|NCT00660868|smell loss|smell loss
619946|NCT00660868|chemoreception|chemoreception
619947|NCT00660881|Lupus|lupus
619948|NCT00660881|Monoclonal antibody|monoclonal antibody
619949|NCT00660881|B-Cell immunotherapy|b-cell immunotherapy
619950|NCT00660894|adenocarcinoma of the colon|adenocarcinoma of the colon
619951|NCT00660894|stage III colon cancer|stage iii colon cancer
619952|NCT00660907|Dapagliflozin|dapagliflozin
619953|NCT00660907|efficacy|efficacy
619954|NCT00660907|safety|safety
619955|NCT00660907|metformin|metformin
619956|NCT00660907|Type 2 diabetes|type 2 diabetes
619957|NCT00660933|postpartum anemia|postpartum anemia
619958|NCT00660933|intravenous iron|intravenous iron
619959|NCT00660946|anticoagulation in dialysis patients|anticoagulation in dialysis patients
619960|NCT00660946|chronic anticoagulation|chronic anticoagulation
619961|NCT00660946|warfarin|warfarin
619962|NCT00660946|hemodialysis|hemodialysis
619964|NCT00660946|Point of Care|point of care
619966|NCT00660959|Hyponatremia|hyponatremia
619967|NCT00660959|Serum Sodium|serum sodium
619968|NCT00660959|Fluid Overload|fluid overload
619969|NCT00660959|Vasopressin Antagonist|vasopressin antagonist
619970|NCT00660972|HIV Integrase Inhibitors|hiv integrase inhibitors
619971|NCT00660972|HIV Nucleoside Reverse Transcriptase Inhibitors|hiv nucleoside reverse transcriptase inhibitors
619972|NCT00660972|Treatment Naive|treatment naive
619973|NCT00660972|Viral Load|viral load
619974|NCT00660985|Acne vulgaris|acne vulgaris
619975|NCT00660985|Differin|differin
619976|NCT00660985|Adapalene|adapalene
619977|NCT00660998|Erectile dysfunction|erectile dysfunction
619978|NCT00660998|Diabetes mellitus type 1|diabetes mellitus type 1
619979|NCT00660998|Vardenafil|vardenafil
619980|NCT00661011|Non-small cell lung carcinoma|non-small cell lung carcinoma
619981|NCT00661011|Concomitant radiochemotherapy|concomitant radiochemotherapy
619982|NCT00661011|Cisplatin|cisplatin
619983|NCT00661011|Vinorelbine|vinorelbine
619984|NCT00661011|Radiotherapy|radiotherapy
619985|NCT00661011|Chemotherapy|chemotherapy
619986|NCT00661011|Unresectable stage III non-small cell lung carcinoma|unresectable stage iii non-small cell lung carcinoma
619987|NCT00661011|Surgery|surgery
619988|NCT00661011|Unresectable stage III non-small cell lung carcinoma not suitable for radical radiotherapy after objective response to induction chemotherapy|unresectable stage iii non-small cell lung carcinoma not suitable for radical radiotherapy after objective response to induction chemotherapy
619989|NCT00661024|thyroid surgery|thyroid surgery
619990|NCT00661024|recurrent laryngeal nerves visualization|recurrent laryngeal nerves visualization
619991|NCT00661024|intraoperative neuromonitoring|intraoperative neuromonitoring
619992|NCT00661024|predictive values|predictive values
619993|NCT00661063|neuropathic pain|neuropathic pain
619994|NCT00661063|ketamine|ketamine
619995|NCT00661063|clonidine|clonidine
619996|NCT00661063|association|association
619997|NCT00661089|stroke|stroke
619998|NCT00661089|shoulder pain|shoulder pain
619999|NCT00661089|spasticity|spasticity
620000|NCT00661115|Erectile dysfunction|erectile dysfunction
620001|NCT00661115|Sexual Dysfunction|sexual dysfunction
620002|NCT00661128|Sudden Cardiac Arrest|sudden cardiac arrest
620003|NCT00661141|acetaldehyde|acetaldehyde
620004|NCT00661141|ethanol|ethanol
620005|NCT00661141|ALDH2|aldh2
620006|NCT00661193|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
620007|NCT00661193|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
620008|NCT00661193|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
620009|NCT00661193|adenocarcinoma of the lung|adenocarcinoma of the lung
620010|NCT00661193|large cell lung cancer|large cell lung cancer
620011|NCT00661193|squamous cell lung cancer|squamous cell lung cancer
620012|NCT00661206|Clopidogrel|clopidogrel
620013|NCT00661206|Drug-eluting stent|drug-eluting stent
620014|NCT00661232|Myocardial Viability|myocardial viability
620015|NCT00661232|Delayed Enhancement Magnetic Resonance Imaging|delayed enhancement magnetic resonance imaging
620016|NCT00661232|Functional Recovery|functional recovery
620017|NCT00661258|HIV antiretroviral treatment adherence intervention China|hiv antiretroviral treatment adherence intervention china
620018|NCT00661258|adherence to antiretroviral treatment|adherence to antiretroviral treatment
620019|NCT00661258|treatment experienced|treatment experienced
620020|NCT00661271|mindfulness|mindfulness
620021|NCT00661271|meditation|meditation
620022|NCT00661271|urban youth|urban youth
620023|NCT00661271|stress reduction|stress reduction
620024|NCT00661271|adolescent|adolescent
620025|NCT00661271|Stress reduction for urban youth|stress reduction for urban youth
620852|NCT00664729|obesity|obesity
620026|NCT00661297|Erectile Dysfunction|erectile dysfunction
620027|NCT00661297|Vardenafil|vardenafil
620028|NCT00661310|re-admissions|re-admissions
620029|NCT00661310|medicines|medicines
620030|NCT00661310|management|management
620031|NCT00661310|patients|patients
620032|NCT00661310|80 years and older|80 years and older
620033|NCT00661310|acute|acute
620034|NCT00661310|admissions|admissions
620035|NCT00661310|hospital|hospital
620036|NCT00661336|stage III melanoma|stage iii melanoma
620037|NCT00661336|recurrent melanoma|recurrent melanoma
620038|NCT00661349|Kaletra|kaletra
620039|NCT00661349|Nevirapina|nevirapina
620040|NCT00661349|HCV chronic infection|hcv chronic infection
620041|NCT00661349|Fibroscan|fibroscan
620042|NCT00661349|hepatic fibrosis|hepatic fibrosis
620043|NCT00661349|treatment experienced|treatment experienced
620044|NCT00661362|DPP-4 inhibitors|dpp-4 inhibitors
620045|NCT00661362|HbA1c|hba1c
620046|NCT00661362|Incretins|incretins
620047|NCT00661375|BAY 43-9006|bay 43-9006
620048|NCT00661375|Phase II|phase ii
620049|NCT00661375|Renal cell carcinoma|renal cell carcinoma
620050|NCT00661375|Response rate|response rate
620051|NCT00661401|gammaglobulin|gammaglobulin
620052|NCT00661401|subcutaneous infusion|subcutaneous infusion
620053|NCT00661401|specific antibodies|specific antibodies
620054|NCT00661401|primary antibody deficiency|primary antibody deficiency
620055|NCT00661414|Cancer|cancer
620056|NCT00661414|Solid tumors|solid tumors
620057|NCT00661427|Head and Neck cancer|head and neck cancer
620058|NCT00661427|Cetuximab|cetuximab
620059|NCT00661453|Spinal Muscular Atrophy|spinal muscular atrophy
620061|NCT00661453|Valproic Acid|valproic acid
620062|NCT00661466|Gastrointestinal surgery|gastrointestinal surgery
620063|NCT00661466|Post operative pain|post operative pain
620064|NCT00661492|Androgen-independent prostate cancer(AIPC)|androgen-independent prostate cancer(aipc)
620065|NCT00661531|Breast cancer|breast cancer
620066|NCT00661531|Metastatic breast cancer|metastatic breast cancer
620067|NCT00661531|ER positive breast cancer|er positive breast cancer
620068|NCT00661531|Hormonal therapy|hormonal therapy
620069|NCT00661544|Multiple Myeloma|multiple myeloma
620070|NCT00661544|Ascorbic Acid|ascorbic acid
620071|NCT00661544|Vitamin C|vitamin c
620072|NCT00661544|Arsenic Trioxide|arsenic trioxide
620073|NCT00661544|Trisenox|trisenox
620074|NCT00661544|Melphalan|melphalan
620075|NCT00661544|Autologous Stem Cell Transplant|autologous stem cell transplant
620076|NCT00661544|Stem Cell Transplantation|stem cell transplantation
620077|NCT00661557|Booster vaccination|booster vaccination
620078|NCT00661557|Meningococcal vaccine|meningococcal vaccine
620079|NCT00661557|Meningococcal disease|meningococcal disease
620080|NCT00661557|Safety|safety
620081|NCT00661557|immunogenicity|immunogenicity
620082|NCT00661570|laryngectomy|laryngectomy
620083|NCT00661570|larynx cancer|larynx cancer
620084|NCT00661583|trabeculectomy|trabeculectomy
620085|NCT00661583|glaucoma|glaucoma
620086|NCT00661583|ranibizumab|ranibizumab
620087|NCT00661596|Erectile Dysfunction|erectile dysfunction
620088|NCT00661596|Vardenafil|vardenafil
620089|NCT00661609|Anti-mitotic|anti-mitotic
620090|NCT00661609|Eg5 Inhibitor|eg5 inhibitor
620091|NCT00661609|Kinesin Spindle Protein Inhibitor|kinesin spindle protein inhibitor
620092|NCT00661609|Urothelial Cancer|urothelial cancer
620093|NCT00661609|Bladder Cancer|bladder cancer
620094|NCT00661609|Renal Pelvis Cancer|renal pelvis cancer
620095|NCT00661609|Urethra Cancer|urethra cancer
620096|NCT00661609|Ureter Cancer|ureter cancer
620097|NCT00661609|Recurrent|recurrent
620098|NCT00661609|Advanced|advanced
620099|NCT00661609|Stage IV|stage iv
620100|NCT00661635|Laparoscopic Cholecystectomy Surgery, Acute Pain, Perioperative Pain|laparoscopic cholecystectomy surgery, acute pain, perioperative pain
620101|NCT00661648|surgery|surgery
620102|NCT00661661|Long term open label study in Japan|long term open label study in japan
620103|NCT00661661|CP-690|cp-690
620104|NCT00661661|550|550
620105|NCT00661661|tofacitinib|tofacitinib
620106|NCT00661674|Palonosetron|palonosetron
620107|NCT00661674|Hydroxyzine|hydroxyzine
620108|NCT00661674|Acute opioid withdrawal|acute opioid withdrawal
620109|NCT00661700|Erectile Dysfunction|erectile dysfunction
620110|NCT00661700|Quality of Life|quality of life
620111|NCT00661713|Meningococcal disease|meningococcal disease
620112|NCT00661713|Neisseria meningitidis serogroup B|neisseria meningitidis serogroup b
620113|NCT00661713|prevention|prevention
620114|NCT00661713|vaccination|vaccination
620115|NCT00661713|adolescents|adolescents
620116|NCT00661726|Thalassemia Intermedia|thalassemia intermedia
620117|NCT00661739|palliative|palliative
620118|NCT00661739|Breast cancer|breast cancer
620119|NCT00661739|metastatic|metastatic
620120|NCT00661739|Bendamustine|bendamustine
620121|NCT00661739|phase I|phase i
620122|NCT00661765|varenicline bioavailability transdermal smoking cessation|varenicline bioavailability transdermal smoking cessation
620123|NCT00661791|preterm infants|preterm infants
620124|NCT00661791|massage|massage
620125|NCT00661791|physical activity|physical activity
620126|NCT00661791|weight gain|weight gain
620127|NCT00661791|length of hospital stay|length of hospital stay
620128|NCT00661791|NICU|nicu
620129|NCT00661817|Exercise|exercise
620130|NCT00661817|Physical Fitness|physical fitness
620131|NCT00661817|Patient Compliance|patient compliance
620132|NCT00661817|Health Behavior|health behavior
620133|NCT00661830|advanced|advanced
620134|NCT00661830|metastatic|metastatic
620135|NCT00661830|biliary|biliary
620136|NCT00661830|tract|tract
620137|NCT00661843|insomnia|insomnia
620138|NCT00661843|geriatric|geriatric
620139|NCT00661843|yoga|yoga
620140|NCT00661843|sleep|sleep
620141|NCT00661843|electrocardiogram|electrocardiogram
620142|NCT00661856|Soy Isoflavones, Bone Mineral Density, Post menopausal women|soy isoflavones, bone mineral density, post menopausal women
620143|NCT00661882|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
620144|NCT00661882|recurrent pancreatic cancer|recurrent pancreatic cancer
620145|NCT00661882|stage I pancreatic cancer|stage i pancreatic cancer
620146|NCT00661882|stage II pancreatic cancer|stage ii pancreatic cancer
620147|NCT00661882|stage III pancreatic cancer|stage iii pancreatic cancer
620148|NCT00661895|African American|african american
620149|NCT00661921|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
620150|NCT00661921|AMG 108|amg 108
620151|NCT00661921|HbA1C|hba1c
620152|NCT00661921|glucose|glucose
620153|NCT00661921|metformin|metformin
620154|NCT00661921|sulfonylurea|sulfonylurea
620155|NCT00661921|IL-1 Inhibitor|il-1 inhibitor
620156|NCT00661921|biologic|biologic
620157|NCT00661921|subcutaneous injection|subcutaneous injection
620283|NCT00661999|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
620158|NCT00661934|Subject undergoing Dialysis and Subject suffering from Cardiac Malfunction|subject undergoing dialysis and subject suffering from cardiac malfunction
620159|NCT00661947|fructose|fructose
620160|NCT00661947|sucrose|sucrose
620161|NCT00661947|high fructose corn syrup|high fructose corn syrup
620162|NCT00661947|serum uric acid|serum uric acid
620163|NCT00661947|lactate|lactate
620164|NCT00661947|glucose|glucose
620165|NCT00661947|triglycerides|triglycerides
620166|NCT00661947|Bioavailability of fructose from two formulations|bioavailability of fructose from two formulations
620167|NCT00661960|HIV Positive|hiv positive
620168|NCT00661960|AIDS|aids
620169|NCT00661960|Antiretroviral Therapy|antiretroviral therapy
620170|NCT00661960|Gastrointestinal-Associated Lymphoid Tissue|gastrointestinal-associated lymphoid tissue
620171|NCT00661960|Immune Reconstitution|immune reconstitution
620172|NCT00661960|treatment experienced|treatment experienced
620173|NCT00661973|asthma|asthma
620174|NCT00661973|airway smooth muscle|airway smooth muscle
620175|NCT00661973|inhaled corticosteroids|inhaled corticosteroids
620700|NCT00657566|sepsis|sepsis
620176|NCT00661999|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
620177|NCT00661999|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
620178|NCT00661999|extramedullary plasmacytoma|extramedullary plasmacytoma
620179|NCT00661999|isolated plasmacytoma of bone|isolated plasmacytoma of bone
620180|NCT00661999|refractory multiple myeloma|refractory multiple myeloma
620181|NCT00661999|stage I multiple myeloma|stage i multiple myeloma
620182|NCT00661999|stage II multiple myeloma|stage ii multiple myeloma
620183|NCT00661999|stage III multiple myeloma|stage iii multiple myeloma
620184|NCT00661999|primary systemic amyloidosis|primary systemic amyloidosis
620185|NCT00661999|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
620186|NCT00661999|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
620187|NCT00661999|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
620188|NCT00661999|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
620189|NCT00661999|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
620190|NCT00661999|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
620191|NCT00661999|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
620192|NCT00661999|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
620193|NCT00661999|anaplastic large cell lymphoma|anaplastic large cell lymphoma
620194|NCT00661999|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
620195|NCT00661999|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
620196|NCT00661999|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
620197|NCT00661999|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
620198|NCT00661999|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
620199|NCT00661999|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
620200|NCT00661999|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
620201|NCT00661999|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
620202|NCT00661999|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
620203|NCT00661999|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
620204|NCT00661999|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
620205|NCT00661999|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
620206|NCT00661999|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
620207|NCT00661999|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
620208|NCT00661999|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
620209|NCT00661999|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
620210|NCT00661999|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
620211|NCT00661999|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
620212|NCT00661999|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
620213|NCT00661999|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
752355|NCT01172613|allergen extract, house dust mites (Dp)|allergen extract, house dust mites (dp)
620214|NCT00661999|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
620308|NCT00662038|fibrosis|fibrosis
620215|NCT00661999|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
620216|NCT00661999|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
620217|NCT00661999|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
620218|NCT00661999|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
620219|NCT00661999|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
620220|NCT00661999|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
620221|NCT00661999|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
620222|NCT00661999|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
620223|NCT00661999|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
620970|NCT00665145|Stem Cells|stem cells
620224|NCT00661999|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
620225|NCT00661999|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
620226|NCT00661999|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
620227|NCT00661999|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
620228|NCT00661999|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
620229|NCT00661999|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
620230|NCT00661999|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
620231|NCT00661999|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
620232|NCT00661999|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
620233|NCT00661999|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
620234|NCT00661999|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
622421|NCT00664157|L-Dopa|l-dopa
620235|NCT00661999|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
620395|NCT00662298|severe asthma|severe asthma
620236|NCT00661999|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
620237|NCT00661999|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
620238|NCT00661999|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
620239|NCT00661999|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
620240|NCT00661999|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
620241|NCT00661999|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
620242|NCT00661999|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
620243|NCT00661999|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
620244|NCT00661999|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
620245|NCT00661999|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
620246|NCT00661999|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
620247|NCT00661999|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
620248|NCT00661999|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
620249|NCT00661999|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
620250|NCT00661999|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
620251|NCT00661999|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
620252|NCT00661999|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
620253|NCT00661999|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
620254|NCT00661999|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
620255|NCT00661999|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
620256|NCT00661999|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
620257|NCT00661999|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
620258|NCT00661999|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
620259|NCT00661999|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
620260|NCT00661999|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
620261|NCT00661999|stage I mantle cell lymphoma|stage i mantle cell lymphoma
620262|NCT00661999|stage I marginal zone lymphoma|stage i marginal zone lymphoma
620263|NCT00661999|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
620264|NCT00661999|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
620265|NCT00661999|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
620266|NCT00661999|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
620267|NCT00661999|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
620445|NCT00662558|Chronic low back pain|chronic low back pain
620268|NCT00661999|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
620269|NCT00661999|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
752356|NCT01172613|skin prick test|skin prick test
753143|NCT01175642|Psychosis|psychosis
620270|NCT00661999|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
620271|NCT00661999|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
620272|NCT00661999|splenic marginal zone lymphoma|splenic marginal zone lymphoma
620273|NCT00661999|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
620274|NCT00661999|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
620275|NCT00661999|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
620276|NCT00661999|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
620277|NCT00661999|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
620278|NCT00661999|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
620279|NCT00661999|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
620280|NCT00661999|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
620281|NCT00661999|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
620282|NCT00661999|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
620284|NCT00661999|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
620285|NCT00661999|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
620286|NCT00661999|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
620287|NCT00661999|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
620288|NCT00661999|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
620289|NCT00661999|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
620290|NCT00661999|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
620291|NCT00661999|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
620292|NCT00661999|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
620293|NCT00661999|refractory hairy cell leukemia|refractory hairy cell leukemia
620294|NCT00661999|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
620295|NCT00661999|prolymphocytic leukemia|prolymphocytic leukemia
620296|NCT00661999|anemia|anemia
620297|NCT00661999|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
620298|NCT00661999|acute undifferentiated leukemia|acute undifferentiated leukemia
620299|NCT00661999|mast cell leukemia|mast cell leukemia
620596|NCT00663143|capacity|capacity
620300|NCT00661999|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
620301|NCT00661999|untreated hairy cell leukemia|untreated hairy cell leukemia
620302|NCT00662012|Leishmaniasis|leishmaniasis
620303|NCT00662012|Sodium stibogluconate|sodium stibogluconate
620304|NCT00662012|Pentostam|pentostam
620305|NCT00662012|sand fly|sand fly
620306|NCT00662038|idiopathic|idiopathic
620307|NCT00662038|pulmonary|pulmonary
620309|NCT00662051|Asthma|asthma
620310|NCT00662051|Exhaled Nitric Oxide|exhaled nitric oxide
620311|NCT00662051|Asthma Control Test|asthma control test
620312|NCT00662064|Lower urinary tract|lower urinary tract
620313|NCT00662064|Physiology|physiology
620314|NCT00662064|Pathology|pathology
620315|NCT00662064|Immunohistochemistry|immunohistochemistry
620316|NCT00662064|Urinary bladder|urinary bladder
620317|NCT00662077|osteoporosis|osteoporosis
620318|NCT00662077|bifosfonates|bifosfonates
620319|NCT00662077|ibandronate|ibandronate
620321|NCT00662090|JMML|jmml
620322|NCT00662090|EWOG-MDS|ewog-mds
620323|NCT00662090|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
620324|NCT00662090|Juvenile Myelomonocytic Leukemia (JMML)|juvenile myelomonocytic leukemia (jmml)
620325|NCT00662103|fatigue|fatigue
620326|NCT00662103|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
620327|NCT00662103|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
620328|NCT00662103|cancer survivor|cancer survivor
620329|NCT00662103|stage IA breast cancer|stage ia breast cancer
620330|NCT00662103|stage IB breast cancer|stage ib breast cancer
620331|NCT00662103|stage II breast cancer|stage ii breast cancer
620332|NCT00662103|stage IIIA breast cancer|stage iiia breast cancer
620333|NCT00662103|stage IIIB breast cancer|stage iiib breast cancer
620334|NCT00662103|stage IIIC breast cancer|stage iiic breast cancer
620335|NCT00662103|breast cancer in situ|breast cancer in situ
620336|NCT00662116|diastolic heart failure|diastolic heart failure
620337|NCT00662129|stage IV breast cancer|stage iv breast cancer
620338|NCT00662129|male breast cancer|male breast cancer
620339|NCT00662129|recurrent breast cancer|recurrent breast cancer
620340|NCT00662142|DHA|dha
620341|NCT00662142|fMRI|fmri
620342|NCT00662155|Primary Insomnia|primary insomnia
620343|NCT00662155|Cognitive Behavioral Therapy|cognitive behavioral therapy
620344|NCT00662155|Insomnia|insomnia
620345|NCT00662155|Sleep|sleep
620346|NCT00662155|Zolpidem|zolpidem
620347|NCT00662155|Ambien|ambien
620348|NCT00662155|CBT|cbt
620349|NCT00662155|CBT-I|cbt-i
620350|NCT00662168|carcinoid|carcinoid
752357|NCT01172613|nasal allergen provocation test|nasal allergen provocation test
752358|NCT01172626|epilepsy|epilepsy
620352|NCT00662168|Collect and describe information about the medical and environmental factors associated with each cases of carcinoid carcinoma|collect and describe information about the medical and environmental factors associated with each cases of carcinoid carcinoma
620353|NCT00662168|Develop a genogram representing the family cancer history of cases of Carcinoid.|develop a genogram representing the family cancer history of cases of carcinoid.
620354|NCT00662181|growth hormone|growth hormone
620355|NCT00662181|quality of life|quality of life
620356|NCT00662181|fat redistribution|fat redistribution
620357|NCT00662181|sugar metabolism|sugar metabolism
620358|NCT00662181|fat metabolism|fat metabolism
620359|NCT00662181|cytokines|cytokines
620360|NCT00662194|HIV|hiv
620361|NCT00662194|HBV|hbv
620362|NCT00662194|HCV|hcv
620363|NCT00662194|co-infection|co-infection
620364|NCT00662194|innate immunity|innate immunity
620365|NCT00662207|electric stimulation|electric stimulation
620366|NCT00662207|urethral obstruction|urethral obstruction
620367|NCT00662207|urodynamics|urodynamics
620368|NCT00662207|urology|urology
620369|NCT00662220|chronic|chronic
620370|NCT00662220|hepatitis C|hepatitis c
620371|NCT00662220|ribavirin|ribavirin
620372|NCT00662220|SVR|svr
620373|NCT00662220|genotype one|genotype one
620374|NCT00662220|genotype four|genotype four
620375|NCT00662233|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
620376|NCT00662233|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
620377|NCT00662233|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
620378|NCT00662233|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
620379|NCT00662233|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
620380|NCT00662233|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
620381|NCT00662233|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
620382|NCT00662233|ovarian sarcoma|ovarian sarcoma
620383|NCT00662233|stage II uterine sarcoma|stage ii uterine sarcoma
620384|NCT00662233|stage III uterine sarcoma|stage iii uterine sarcoma
620385|NCT00662233|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
620386|NCT00662259|Anxiety disorders|anxiety disorders
620387|NCT00662259|Generalized anxiety|generalized anxiety
620388|NCT00662272|Flu|flu
620389|NCT00662272|Influenza vaccine|influenza vaccine
620390|NCT00662272|Adjuvant|adjuvant
620391|NCT00662272|Safety of an adjuvanted vaccine|safety of an adjuvanted vaccine
620392|NCT00662272|Immune response to an adjuvanted vaccine|immune response to an adjuvanted vaccine
620393|NCT00662285|iron status|iron status
620394|NCT00662285|blood donors|blood donors
620396|NCT00662298|prednisolone pharmacokinetics|prednisolone pharmacokinetics
620397|NCT00662298|anti-inflammatory effects|anti-inflammatory effects
620398|NCT00662337|Bioequivalence, diphenhydramine hydrochloride|bioequivalence, diphenhydramine hydrochloride
620399|NCT00662350|BPH|bph
620400|NCT00662363|constipation|constipation
620401|NCT00662363|opioid|opioid
620402|NCT00662363|rehabilitation|rehabilitation
620403|NCT00662363|post-operative|post-operative
620404|NCT00662363|orthopedic|orthopedic
620405|NCT00662389|skin laxity, wrinkles, rhytids|skin laxity, wrinkles, rhytids
620406|NCT00662402|K Grant|k grant
620407|NCT00662402|Career Advancement|career advancement
620408|NCT00662402|Award|award
620409|NCT00662402|Consultation|consultation
620410|NCT00662402|Application|application
620411|NCT00662402|K|k
620412|NCT00662402|The NIH priority score of the reviewed proposal.|the nih priority score of the reviewed proposal.
620413|NCT00662402|Percent of subjects who obtain funding for proposal.|percent of subjects who obtain funding for proposal.
620414|NCT00662402|Percent of subjects who submit proposals for funding.|percent of subjects who submit proposals for funding.
620415|NCT00662415|phantom limb pain|phantom limb pain
620416|NCT00662415|fMRI|fmri
620417|NCT00662415|mirror therapy|mirror therapy
620418|NCT00662428|cost-benefit analysis|cost-benefit analysis
620419|NCT00662428|practice guideline|practice guideline
620420|NCT00662428|inpatients|inpatients
620421|NCT00662441|Erectile Dysfunction|erectile dysfunction
620422|NCT00662441|Vardenafil|vardenafil
620423|NCT00662454|contraceptive|contraceptive
620424|NCT00662454|efficacy|efficacy
620425|NCT00662454|body weight|body weight
620426|NCT00662467|Myocardial Infarction|myocardial infarction
620427|NCT00662467|Hemorrhage|hemorrhage
620428|NCT00662467|Thromboembolism|thromboembolism
620429|NCT00662467|Clopidogrel|clopidogrel
620430|NCT00662467|Aspirin|aspirin
620431|NCT00662467|Warfarin|warfarin
620432|NCT00662480|population|population
620433|NCT00662480|screening|screening
620434|NCT00662480|abdominal aortic aneurysms|abdominal aortic aneurysms
620435|NCT00662480|peripheral arterial disease|peripheral arterial disease
620436|NCT00662480|hypertension|hypertension
620437|NCT00662480|Prevention|prevention
620438|NCT00662493|knee pain|knee pain
620439|NCT00662493|exercise|exercise
620440|NCT00662493|rehabilitation|rehabilitation
620441|NCT00662532|Peri-implantitis; antibiotic|peri-implantitis; antibiotic
620442|NCT00662545|HIV|hiv
620443|NCT00662545|Hepatitis B|hepatitis b
620444|NCT00662545|treatment experienced|treatment experienced
620446|NCT00662571|nucleotide polymorphisms|nucleotide polymorphisms
620447|NCT00662571|disequilibrium haplotype|disequilibrium haplotype
620448|NCT00662571|acamprosate|acamprosate
620449|NCT00662571|differentiate|differentiate
620450|NCT00662571|pharmacogenomic|pharmacogenomic
620451|NCT00662571|effective individualized treatment|effective individualized treatment
620452|NCT00662571|alcohol dependent|alcohol dependent
620453|NCT00662571|N-methyl-D-aspartate receptor (NMDA)|n-methyl-d-aspartate receptor (nmda)
620454|NCT00662571|metabotropic glutamate receptor|metabotropic glutamate receptor
620455|NCT00662571|decreasing craving|decreasing craving
620456|NCT00662571|abstinence maintenance|abstinence maintenance
620457|NCT00662584|repetitive magnetic transcranial stimulation (rTMS)|repetitive magnetic transcranial stimulation (rtms)
620458|NCT00662584|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
620459|NCT00662597|Tumor vascular disrupting agent|tumor vascular disrupting agent
620460|NCT00662597|VDA|vda
620461|NCT00662597|ASA404|asa404
620462|NCT00662597|non-small cell lung cancer|non-small cell lung cancer
620463|NCT00662597|NSCLC|nsclc
620464|NCT00662623|Chronic Obstructive Sleep Apnea|chronic obstructive sleep apnea
620465|NCT00662623|Sleep Apnea|sleep apnea
620466|NCT00662623|Sleep Apnea Treatment|sleep apnea treatment
620467|NCT00662649|Multiple sclerosis.|multiple sclerosis.
620468|NCT00662649|Relapse-remitting|relapse-remitting
620469|NCT00662649|Fingolimod|fingolimod
620470|NCT00662662|Oropharyngeal Cancer|oropharyngeal cancer
620471|NCT00662662|Non-Oropharyngeal Cancer|non-oropharyngeal cancer
620472|NCT00662662|Head and Neck Cancer|head and neck cancer
620473|NCT00662662|Squamous Cell Carcinoma|squamous cell carcinoma
620474|NCT00662662|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
620475|NCT00662662|SCCHN|scchn
620476|NCT00662662|HPV-16|hpv-16
620477|NCT00662662|Questionnaire|questionnaire
620478|NCT00662662|Sexual Behavior|sexual behavior
620479|NCT00662662|Survey|survey
620480|NCT00662675|Exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
620481|NCT00662675|Steatorrhea|steatorrhea
620482|NCT00662675|Malabsorption syndromes|malabsorption syndromes
620483|NCT00662675|Cystic fibrosis|cystic fibrosis
620484|NCT00662675|Pediatrics|pediatrics
620485|NCT00662675|Adult|adult
620486|NCT00662675|Pancrelipase|pancrelipase
620487|NCT00662688|thromboembolism|thromboembolism
620488|NCT00662688|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
620489|NCT00662688|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
620490|NCT00662688|stage IV pancreatic cancer|stage iv pancreatic cancer
620491|NCT00662688|recurrent pancreatic cancer|recurrent pancreatic cancer
620597|NCT00663143|bone marrow|bone marrow
620492|NCT00662701|Atrial Fibrillation|atrial fibrillation
620493|NCT00662727|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
620494|NCT00662727|Myocardial Ischemia|myocardial ischemia
620495|NCT00662727|Refractory Angina|refractory angina
620496|NCT00662753|hypertension|hypertension
620497|NCT00662753|home blood pressure monitoring|home blood pressure monitoring
620498|NCT00662753|nurse telephone follow up|nurse telephone follow up
620499|NCT00662753|medically underserved populations|medically underserved populations
620500|NCT00662766|Black currant|black currant
620501|NCT00662766|Berry seed|berry seed
620502|NCT00662766|Press residue|press residue
620503|NCT00662766|Tocopherol|tocopherol
620504|NCT00662766|Fatty acids|fatty acids
620506|NCT00662766|Total phenols|total phenols
620507|NCT00662766|TEAC|teac
620508|NCT00662766|Comet assay|comet assay
620509|NCT00662766|Dihydroxybenzoic acid|dihydroxybenzoic acid
620510|NCT00662779|asthma|asthma
620511|NCT00662779|exercise induced bronchospasm|exercise induced bronchospasm
620512|NCT00662779|prevention|prevention
620513|NCT00662779|EIB|eib
620514|NCT00662779|children|children
620515|NCT00662805|pharmacovigilance|pharmacovigilance
620516|NCT00662805|COPD|copd
620517|NCT00662831|Diabetic Foot Ulcers Neuroischaemic|diabetic foot ulcers neuroischaemic
620518|NCT00662844|Vitamin D insufficiency,vitamin D3 treatment,young women|vitamin d insufficiency,vitamin d3 treatment,young women
620519|NCT00662857|Diabetic adult male, diabetic adult female|diabetic adult male, diabetic adult female
620520|NCT00662870|DAPTACEL|daptacel
620521|NCT00662870|Diphtheria|diphtheria
620522|NCT00662870|Tetanus|tetanus
620523|NCT00662870|Whooping Cough|whooping cough
620524|NCT00662870|Polio|polio
620525|NCT00662870|Haemophilus influenzae type b|haemophilus influenzae type b
620526|NCT00662870|Pertussis|pertussis
620527|NCT00662883|ketamine|ketamine
620528|NCT00662883|corticosteroid|corticosteroid
620529|NCT00662883|intranasal|intranasal
620530|NCT00662883|phase I|phase i
620531|NCT00662883|Healthy volunteers|healthy volunteers
620532|NCT00662909|Overactive bladder (OAB)|overactive bladder (oab)
620533|NCT00662909|Frequency|frequency
620534|NCT00662909|Micturition|micturition
620535|NCT00662909|Urgency|urgency
620536|NCT00662909|Urinary incontinence|urinary incontinence
620537|NCT00662909|Urinary urge incontinence|urinary urge incontinence
620538|NCT00662909|YM178|ym178
620539|NCT00662922|critical illness|critical illness
620540|NCT00662922|hypoglycemia|hypoglycemia
620541|NCT00662922|neurocognitive dysfunction|neurocognitive dysfunction
620542|NCT00662922|intensive insulin therapy|intensive insulin therapy
620543|NCT00662935|deep brain stimulation|deep brain stimulation
620544|NCT00662935|cluster headache|cluster headache
620545|NCT00662935|hypothalamus|hypothalamus
620546|NCT00662948|Folicular Lymphoma|folicular lymphoma
620547|NCT00662948|Consolidation|consolidation
620548|NCT00662948|Maintenance|maintenance
620549|NCT00662961|Plastic Surgery|plastic surgery
620550|NCT00662987|tonsillectomy|tonsillectomy
620551|NCT00662987|antibiotics|antibiotics
620552|NCT00663000|acromegaly|acromegaly
620553|NCT00663000|diabetes|diabetes
620554|NCT00663000|insulin resistance|insulin resistance
620555|NCT00663000|impaired glucose tolerance|impaired glucose tolerance
620556|NCT00663013|burn|burn
620557|NCT00663013|pain|pain
620558|NCT00663013|anxiety|anxiety
620559|NCT00663026|antibody|antibody
620560|NCT00663026|immunotherapy|immunotherapy
620561|NCT00663039|Schizophrenia|schizophrenia
620562|NCT00663039|Eye movements|eye movements
620563|NCT00663039|phenotype|phenotype
620564|NCT00663039|biochemical|biochemical
620565|NCT00663039|relatives|relatives
620566|NCT00663052|Enbrel|enbrel
620567|NCT00663052|Psoriasis|psoriasis
620568|NCT00663052|Topical Psoriasis|topical psoriasis
620569|NCT00663052|Wyeth Psoriasis|wyeth psoriasis
620570|NCT00663052|Active Psoriasis|active psoriasis
620571|NCT00663065|Healthy subjects over 65|healthy subjects over 65
620572|NCT00663065|healthy subjects|healthy subjects
620573|NCT00663078|Cognitive Behavioral Therapy|cognitive behavioral therapy
620574|NCT00663078|expert patient programme|expert patient programme
620575|NCT00663078|deprived population|deprived population
620576|NCT00663078|women|women
620577|NCT00663091|WPP-201|wpp-201
620578|NCT00663104|early menopause|early menopause
620579|NCT00663104|exercise|exercise
620580|NCT00663104|phytoestrogen|phytoestrogen
620581|NCT00663104|bone|bone
620582|NCT00663104|CHD-risk factors|chd-risk factors
620583|NCT00663117|naltrexone|naltrexone
620584|NCT00663117|LDN|ldn
620585|NCT00663117|IBD|ibd
620586|NCT00663117|Inflammatory bowel disease|inflammatory bowel disease
620587|NCT00663130|Erectile Dysfunction|erectile dysfunction
622748|NCT00670956|hydrops|hydrops
620588|NCT00663130|Vardenafil|vardenafil
620589|NCT00663143|investigate|investigate
620590|NCT00663143|TZD exposure|tzd exposure
620591|NCT00663143|in vitro|in vitro
620592|NCT00663143|alters|alters
620593|NCT00663143|bone|bone
620594|NCT00663143|formation|formation
620595|NCT00663143|differentiation|differentiation
620598|NCT00663143|stromal cells|stromal cells
620599|NCT00663156|lipoaugmentation|lipoaugmentation
620600|NCT00663156|breast augmentation|breast augmentation
620601|NCT00663156|fat grafting|fat grafting
620602|NCT00663156|liposuction|liposuction
620603|NCT00663156|lipoinfiltration|lipoinfiltration
620604|NCT00663156|Spear|spear
620605|NCT00663156|breast implants|breast implants
620606|NCT00663156|ASERF|aserf
620607|NCT00663156|Lipivage|lipivage
620608|NCT00663156|Baker|baker
620609|NCT00663156|harvest|harvest
620610|NCT00663156|autologous|autologous
620611|NCT00663156|Georgetown|georgetown
620612|NCT00663169|Arthritis Gouty|arthritis gouty
620613|NCT00663169|ACZ885|acz885
620614|NCT00663169|IL1B protein|il1b protein
620615|NCT00663169|Pain|pain
620616|NCT00663182|Entecavir|entecavir
620617|NCT00663182|cirrhosis|cirrhosis
620618|NCT00663182|anti-viral|anti-viral
620619|NCT00663182|therapy|therapy
620620|NCT00663195|heart failure|heart failure
620621|NCT00663195|fibrosis|fibrosis
620622|NCT00663195|MMP|mmp
620623|NCT00663195|spironolactone|spironolactone
620624|NCT00663195|furosemide|furosemide
620625|NCT00663221|Osteoporosis prevention|osteoporosis prevention
620626|NCT00663234|Treatment Experienced|treatment experienced
620627|NCT00663247|Diverticular disease|diverticular disease
620628|NCT00663247|Inflammation|inflammation
620629|NCT00663247|Mesalazine|mesalazine
620630|NCT00657228|Anaphylaxis|anaphylaxis
620631|NCT00657228|Anaphylactoid reactions|anaphylactoid reactions
620632|NCT00657241|cardiac work|cardiac work
620633|NCT00657241|coreg cr|coreg cr
620634|NCT00657241|valsartan|valsartan
620635|NCT00657241|tonometry|tonometry
620636|NCT00657254|Extension|extension
620637|NCT00657254|Sorafenib|sorafenib
620638|NCT00657254|Survival|survival
620639|NCT00657267|recurrent glioblastoma|recurrent glioblastoma
620640|NCT00657267|temodar|temodar
620641|NCT00657267|temozolomide|temozolomide
620642|NCT00657293|COPD|copd
620643|NCT00657293|arm training|arm training
620644|NCT00657293|dyspnoea|dyspnoea
620645|NCT00657293|quality of life|quality of life
620646|NCT00657306|Cirrhosis|cirrhosis
620647|NCT00657306|Ascites|ascites
620648|NCT00657306|Adrenal insufficiency|adrenal insufficiency
620649|NCT00657306|Hepatorenal syndrome|hepatorenal syndrome
620650|NCT00657306|Portal hypertension|portal hypertension
620651|NCT00657345|trastuzumab|trastuzumab
620652|NCT00657345|breast cancer|breast cancer
620653|NCT00657345|her2 positive breast cancer|her2 positive breast cancer
620654|NCT00657358|lidocaine|lidocaine
620655|NCT00657358|allodynia|allodynia
620656|NCT00657358|chronic regional pain syndrome|chronic regional pain syndrome
620657|NCT00657358|pain|pain
620658|NCT00657371|Colorectal Cancer|colorectal cancer
620659|NCT00657371|Colonoscopy|colonoscopy
620660|NCT00657371|Third Eye Retroscope|third eye retroscope
620661|NCT00657371|Third Eye Retroscope Auxiliary Imaging System|third eye retroscope auxiliary imaging system
620662|NCT00657371|Polypectomy|polypectomy
620663|NCT00657384|Specify the primary condition or disease being studied Major Hepatectomy|specify the primary condition or disease being studied major hepatectomy
620664|NCT00657397|Methadone|methadone
620665|NCT00657397|Substance Dependence|substance dependence
620666|NCT00657410|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
620667|NCT00657423|Lung Neoplasms|lung neoplasms
620668|NCT00657423|Endostatins|endostatins
620669|NCT00657423|Vascular Endothelial Growth Factors|vascular endothelial growth factors
620670|NCT00657423|Fibroblast Growth Factors|fibroblast growth factors
620671|NCT00657423|Survival Rate|survival rate
620672|NCT00657436|Acute Coronary Syndrome|acute coronary syndrome
620673|NCT00657436|Myocardial Infarction|myocardial infarction
621549|NCT00667043|propofol|propofol
620674|NCT00657436|Coronary Artery Disease|coronary artery disease
620675|NCT00657449|sprains and strains|sprains and strains
620676|NCT00657462|Medical Informatics Applications|medical informatics applications
620677|NCT00657462|Software|software
620678|NCT00657462|Utilization|utilization
620679|NCT00657475|Heparin low dose|heparin low dose
620680|NCT00657475|Inflammation|inflammation
620681|NCT00657475|Blood loss|blood loss
620682|NCT00657488|Multiple Myeloma, Thalidomide, dose, dexamethasone|multiple myeloma, thalidomide, dose, dexamethasone
620683|NCT00657501|testosterone|testosterone
620684|NCT00657501|hypoactive sexual desire disorder|hypoactive sexual desire disorder
620685|NCT00657501|menopause|menopause
620686|NCT00657514|hemoglobin desaturation kinetics|hemoglobin desaturation kinetics
620687|NCT00657514|peripheral arterial disease|peripheral arterial disease
620688|NCT00657514|chronic angina|chronic angina
620689|NCT00657514|exercise tolerance|exercise tolerance
620690|NCT00657527|Crestor|crestor
620691|NCT00657527|Rosuvastatin|rosuvastatin
620692|NCT00657527|Cholesterol|cholesterol
620693|NCT00657527|Coronary artery disease|coronary artery disease
620694|NCT00657527|Myocardial ischaemia.|myocardial ischaemia.
620695|NCT00657540|black widow spider|black widow spider
620696|NCT00657540|antivenom|antivenom
620697|NCT00657540|latrodectism|latrodectism
620698|NCT00657566|intraabdominal|intraabdominal
620699|NCT00657566|peritonitis|peritonitis
620703|NCT00657605|Congenital leptin deficiency|congenital leptin deficiency
620704|NCT00657605|Obesity|obesity
620705|NCT00657605|Metabolic syndrome|metabolic syndrome
620706|NCT00657605|Diabetes|diabetes
620707|NCT00657618|Leishmaniasis, Sodium stibogluconate, Pentostam, sand fly|leishmaniasis, sodium stibogluconate, pentostam, sand fly
620708|NCT00657631|Acceptance and Commitment Therapy|acceptance and commitment therapy
620709|NCT00657631|Delusions|delusions
620710|NCT00657644|Erectile Dysfunction|erectile dysfunction
620711|NCT00657657|Hepatitis|hepatitis
620712|NCT00657657|vaccine|vaccine
620713|NCT00657670|refractive error|refractive error
620714|NCT00657670|spectacles|spectacles
620715|NCT00657670|ready made spectacles|ready made spectacles
620716|NCT00657670|vision|vision
620717|NCT00657670|cost effectiveness|cost effectiveness
620718|NCT00657683|GBS|gbs
620719|NCT00657683|GBS prevention|gbs prevention
620720|NCT00657696|primary health care|primary health care
620721|NCT00657696|organizations|organizations
620722|NCT00657696|learning|learning
620723|NCT00657696|quality of health care|quality of health care
620724|NCT00657709|infant|infant
620725|NCT00657709|Meningococcal disease|meningococcal disease
620726|NCT00657709|prevention|prevention
620727|NCT00657709|vaccination|vaccination
620728|NCT00657722|Pulmonary hypertension|pulmonary hypertension
620729|NCT00657722|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
620730|NCT00657722|Operability|operability
620731|NCT00657722|Thromboendarteriectomy|thromboendarteriectomy
620732|NCT00657722|Operative mortality rate|operative mortality rate
620733|NCT00657722|Technical failure|technical failure
620734|NCT00657722|Pulmonary angiography|pulmonary angiography
620735|NCT00657722|Computed tomography|computed tomography
620736|NCT00657735|bipolar|bipolar
620737|NCT00657735|depression|depression
620738|NCT00657735|prefrontal|prefrontal
620739|NCT00657735|cortex|cortex
620740|NCT00657735|antidepressant|antidepressant
620741|NCT00657735|response|response
620742|NCT00657748|Leukodystrophy|leukodystrophy
620743|NCT00657748|Canavan disease,|canavan disease,
620744|NCT00657748|Aspartoacylase,|aspartoacylase,
620745|NCT00657748|Lithium,|lithium,
620746|NCT00657748|Glyceryl Triacetate|glyceryl triacetate
620747|NCT00657774|Asthma|asthma
620748|NCT00657774|Mild to Moderate|mild to moderate
620749|NCT00663299|Intracranial aneurysm|intracranial aneurysm
620750|NCT00663312|Idiopathic Parkinson's disease|idiopathic parkinson's disease
621967|NCT00668356|HIV|hiv
620751|NCT00663312|Deep Brain stimulation|deep brain stimulation
620752|NCT00663312|Hepatic glucose production|hepatic glucose production
620753|NCT00663312|Insulin|insulin
620754|NCT00663312|Weight gain|weight gain
620755|NCT00663312|Patient with an Idiopathic Parkinson's disease|patient with an idiopathic parkinson's disease
620756|NCT00663338|Stroke|stroke
620757|NCT00663338|Hemispatial neglect|hemispatial neglect
620758|NCT00663338|Unilateral neglect|unilateral neglect
620759|NCT00663338|Spatial neglect|spatial neglect
620760|NCT00663338|Motor|motor
620761|NCT00663338|Weakness|weakness
620762|NCT00663351|Arthritis|arthritis
620763|NCT00663351|Osteoarthritis|osteoarthritis
620764|NCT00663351|Traumatic Arthritis|traumatic arthritis
620765|NCT00663351|Degenerative Joint Disease|degenerative joint disease
620766|NCT00663351|Avascular Necrosis|avascular necrosis
620767|NCT00663364|dry skin|dry skin
620768|NCT00663377|Heart Failure|heart failure
620769|NCT00663377|Insulin Resistance|insulin resistance
620770|NCT00663377|Losartan|losartan
620771|NCT00663377|ACE inhibitor|ace inhibitor
620772|NCT00663377|Inflammatory cytokine|inflammatory cytokine
620773|NCT00663403|daptomycin|daptomycin
620774|NCT00663403|pharmacokinetics|pharmacokinetics
620775|NCT00663403|renal replacement therapy|renal replacement therapy
620776|NCT00663403|critical illness|critical illness
620777|NCT00663403|intensive care units|intensive care units
620778|NCT00663442|ADHD|adhd
620779|NCT00663442|side effects|side effects
620780|NCT00663442|sleep|sleep
620781|NCT00663442|dopamine|dopamine
620782|NCT00663442|pharmacogenetics|pharmacogenetics
620783|NCT00663455|kidney transplant recipients|kidney transplant recipients
620784|NCT00663455|children and adolescents with kidney transplants|children and adolescents with kidney transplants
620785|NCT00663468|determine changes in patient pain level|determine changes in patient pain level
620786|NCT00663468|determine changes in patient functionality|determine changes in patient functionality
620787|NCT00663468|determine changes in patient life quality|determine changes in patient life quality
620788|NCT00663481|CoFactor|cofactor
620789|NCT00663481|ANX-510|anx-510
620790|NCT00663494|heart failure|heart failure
620791|NCT00663494|MMP|mmp
620792|NCT00663494|coronary sinus|coronary sinus
620793|NCT00663507|Sickle Cell Disease|sickle cell disease
620794|NCT00663507|Immunosuppression|immunosuppression
620795|NCT00663507|Organ & Tissue Transplantation|organ & tissue transplantation
620796|NCT00663507|Transplantation Immunology|transplantation immunology
620797|NCT00663520|Cardiac disease|cardiac disease
620798|NCT00663520|vascular dysfunction|vascular dysfunction
620799|NCT00663520|women|women
620800|NCT00663520|chest pain|chest pain
621188|NCT00666146|Eyetracking|eyetracking
620801|NCT00663520|echocardiography|echocardiography
620802|NCT00663533|Vasectomy|vasectomy
620803|NCT00663533|Contraception|contraception
620804|NCT00663546|Malaria|malaria
620805|NCT00663546|Plasmodium|plasmodium
620806|NCT00663546|Hemoglobin E|hemoglobin e
620807|NCT00663546|Alpha-thalssemia|alpha-thalssemia
620808|NCT00663546|G6PD Deficiency|g6pd deficiency
620809|NCT00663559|renal|renal
620810|NCT00663559|Sunitinib|sunitinib
620811|NCT00663559|Unresectable and/or metastatic renal cell cancer|unresectable and/or metastatic renal cell cancer
620812|NCT00663572|Newborn|newborn
620813|NCT00663572|nutrition|nutrition
620814|NCT00663572|genetic|genetic
620815|NCT00663572|feeding behaviour|feeding behaviour
620816|NCT00663572|psychomotor development|psychomotor development
620817|NCT00663572|long-term effects|long-term effects
620818|NCT00663572|nutritional imprinting.|nutritional imprinting.
620819|NCT00663585|Migraine|migraine
620820|NCT00663585|Headache|headache
620821|NCT00663585|Vipassana|vipassana
620822|NCT00663585|Meditation|meditation
620823|NCT00663585|Intensive|intensive
620824|NCT00663598|Erectile Dysfunction|erectile dysfunction
620825|NCT00663598|Vardenafil|vardenafil
620826|NCT00664677|Adult|adult
620827|NCT00664677|Leukemia|leukemia
620828|NCT00664677|Terameprocol|terameprocol
620829|NCT00664677|Survivin|survivin
620830|NCT00664677|AML|aml
620831|NCT00664677|ALL|all
620832|NCT00664677|ATL|atl
620833|NCT00664677|CML|cml
620834|NCT00664677|CLL|cll
620835|NCT00664677|CMML|cmml
620836|NCT00664677|MDS|mds
620837|NCT00664690|shoulder surgery|shoulder surgery
620838|NCT00664690|analgesia|analgesia
620839|NCT00664703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors
620840|NCT00664703|Dopamine|dopamine
620841|NCT00664703|Methylphenidate|methylphenidate
620842|NCT00664703|Mental Disorders Diagnosed in Childhood|mental disorders diagnosed in childhood
620843|NCT00664703|Neurologic Manifestations|neurologic manifestations
620844|NCT00664703|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
620845|NCT00664703|Hyperkinesis|hyperkinesis
620846|NCT00664703|Dyskinesias|dyskinesias
620847|NCT00664716|Rheumatoid Arthritis|rheumatoid arthritis
620848|NCT00664716|RA|ra
620849|NCT00664716|DMARD inadequate response|dmard inadequate response
620850|NCT00664716|Methotrexate|methotrexate
620851|NCT00664729|Abdominal|abdominal
620853|NCT00664729|exercise|exercise
620854|NCT00664729|intensity|intensity
620855|NCT00664729|weight loss|weight loss
620856|NCT00664729|women|women
620857|NCT00664742|Metabolic syndrome,dyslipidemia,fluvastatin extended release|metabolic syndrome,dyslipidemia,fluvastatin extended release
620858|NCT00664755|Menstrual Cycle effects|menstrual cycle effects
620859|NCT00664755|Cue Reactivity|cue reactivity
620860|NCT00664755|Smoking Cessation|smoking cessation
620861|NCT00664755|Impulsivity|impulsivity
620862|NCT00664768|hypoallergenicity|hypoallergenicity
620863|NCT00664768|Cow Milk Allergy|cow milk allergy
620864|NCT00664768|DBPCFC|dbpcfc
620865|NCT00664768|Stool microflora|stool microflora
620866|NCT00664768|Stool characteristics|stool characteristics
620867|NCT00664781|stage IIIA breast cancer|stage iiia breast cancer
620868|NCT00664781|stage IIIB breast cancer|stage iiib breast cancer
620869|NCT00664781|stage IIIC breast cancer|stage iiic breast cancer
620870|NCT00664781|stage IV breast cancer|stage iv breast cancer
620871|NCT00664781|recurrent breast cancer|recurrent breast cancer
620872|NCT00664781|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
620873|NCT00664781|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
620874|NCT00664781|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
621550|NCT00667043|fentanyl|fentanyl
620875|NCT00664781|ovarian stromal cancer|ovarian stromal cancer
620876|NCT00664781|ovarian sarcoma|ovarian sarcoma
620877|NCT00664781|BRCA1 mutation carrier|brca1 mutation carrier
620878|NCT00664781|BRCA2 mutation carrier|brca2 mutation carrier
620879|NCT00664781|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
620880|NCT00664781|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
620881|NCT00664781|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
620882|NCT00664781|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
620883|NCT00664781|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
620884|NCT00664781|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
620885|NCT00664781|ovarian papillary serous carcinoma|ovarian papillary serous carcinoma
620886|NCT00664820|Rheumatoid Arthritics|rheumatoid arthritics
620887|NCT00664820|probiotics|probiotics
622989|NCT00671658|Cytarabine|cytarabine
620888|NCT00664820|Lactobacillus|lactobacillus
620889|NCT00664833|Erectile dysfunction|erectile dysfunction
620890|NCT00664833|Phosphodiesterase Type 5 Inhibitors|phosphodiesterase type 5 inhibitors
620891|NCT00664833|Patient education|patient education
620892|NCT00664833|Impotence|impotence
620893|NCT00664833|Vardenafil|vardenafil
620894|NCT00664846|Stroke|stroke
620895|NCT00664846|Prevention Therapy|prevention therapy
620896|NCT00664859|LCP-AtorFen|lcp-atorfen
620897|NCT00664859|Non-HDL cholesterol|non-hdl cholesterol
620898|NCT00664859|Triglycerides|triglycerides
620899|NCT00664859|HDL cholesterol|hdl cholesterol
620900|NCT00664859|LDL cholesterol|ldl cholesterol
620901|NCT00664859|Atorvastatin|atorvastatin
620902|NCT00664859|Fenofibrate|fenofibrate
620903|NCT00664872|case manager|case manager
620904|NCT00664872|suicide|suicide
620905|NCT00664872|attempt|attempt
620906|NCT00664872|effectiveness|effectiveness
620907|NCT00664885|non-psychiatric|non-psychiatric
620908|NCT00664885|clinics|clinics
620909|NCT00664898|anti-CD40|anti-cd40
620910|NCT00664898|Myeloma|myeloma
620912|NCT00664950|intertrochanteric hip fracture fixation|intertrochanteric hip fracture fixation
620913|NCT00664950|interTAN IM Nail|intertan im nail
620914|NCT00664950|sliding hip screw|sliding hip screw
620915|NCT00664963|Arterial Occlusive Diseases|arterial occlusive diseases
620916|NCT00664963|Peripheral Vascular Diseases|peripheral vascular diseases
620917|NCT00664963|Drug eluting stent|drug eluting stent
620918|NCT00664963|Restenosis|restenosis
620919|NCT00664963|Below the knee|below the knee
620920|NCT00664963|Intervention|intervention
620921|NCT00664976|bipolar depression|bipolar depression
620922|NCT00664976|Electroconvulsive therapy|electroconvulsive therapy
620923|NCT00664989|Hemiarthroplasty Stemmed Resurfacing Conventional Shoulder|hemiarthroplasty stemmed resurfacing conventional shoulder
620924|NCT00665002|Myeloid|myeloid
620925|NCT00665002|Monocytic|monocytic
620926|NCT00665002|Hematopoietic|hematopoietic
620927|NCT00665002|Neoplasms|neoplasms
620928|NCT00665002|Acute Myelogenous Leukemia|acute myelogenous leukemia
620929|NCT00665002|AML|aml
620930|NCT00665002|Myelodysplastic Syndrome|myelodysplastic syndrome
620931|NCT00665002|MDS|mds
620932|NCT00665015|pleural effusion|pleural effusion
620933|NCT00665015|coronary artery bypass|coronary artery bypass
620934|NCT00665015|heart valve replacement|heart valve replacement
620935|NCT00665028|Anesthesia|anesthesia
620936|NCT00665028|Postoperative myocardial ischemia|postoperative myocardial ischemia
620937|NCT00665028|ST monitoring|st monitoring
620938|NCT00665054|Vardenafil|vardenafil
620939|NCT00665054|Erectile dysfunction|erectile dysfunction
620940|NCT00665054|SSES-E (sexual self-efficacy scale - erectile function)|sses-e (sexual self-efficacy scale - erectile function)
620941|NCT00665067|Myeloproliferative Disease|myeloproliferative disease
620942|NCT00665067|Myelofibrosis|myelofibrosis
620943|NCT00665067|Idiopathic Myelofibrosis|idiopathic myelofibrosis
620944|NCT00665067|Essential Thrombocythemia|essential thrombocythemia
620945|NCT00665067|Polycythemia Vera|polycythemia vera
620946|NCT00665067|Biomarkers|biomarkers
620947|NCT00665067|Philadelphia Chromosome Negative|philadelphia chromosome negative
620948|NCT00665067|Clonal Hematopoietic malignancies|clonal hematopoietic malignancies
620949|NCT00665106|Diabetic macular edema|diabetic macular edema
620950|NCT00665106|Diabetes|diabetes
620951|NCT00665106|Diabetic retinopathy|diabetic retinopathy
620952|NCT00665119|Respiratory Insufficiency|respiratory insufficiency
620953|NCT00665119|Respiration, Artificial|respiration, artificial
620954|NCT00665119|Remifentanil|remifentanil
620955|NCT00665119|Respiratory Mechanics|respiratory mechanics
620956|NCT00665119|Work of Breathing|work of breathing
620957|NCT00665132|wrist|wrist
620958|NCT00665132|hand|hand
620959|NCT00665132|pain|pain
620960|NCT00665132|failed CTR|failed ctr
620961|NCT00665132|carpal tunnel syndrome|carpal tunnel syndrome
620962|NCT00665132|CTS|cts
620963|NCT00665132|CTR|ctr
620964|NCT00665132|carpel tunnel release|carpel tunnel release
620965|NCT00665132|Peripheral nerve|peripheral nerve
620966|NCT00665132|Median nerve|median nerve
620967|NCT00665145|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
620968|NCT00665145|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
620969|NCT00665145|Diabetic Polyneuropathy|diabetic polyneuropathy
620971|NCT00665158|Abdominal obesity, exercise, behaviour modification|abdominal obesity, exercise, behaviour modification
620972|NCT00665171|Polycystic ovary syndrome|polycystic ovary syndrome
620973|NCT00665171|Single nucleotide polymorphism|single nucleotide polymorphism
620974|NCT00665171|Whole genome analysis|whole genome analysis
620975|NCT00665171|Multigenerational family study|multigenerational family study
620976|NCT00665184|Hypokinesia|hypokinesia
620977|NCT00665184|Gait|gait
620978|NCT00665184|Quality of life|quality of life
620979|NCT00665184|Dopamine replacement|dopamine replacement
620980|NCT00665184|Resistance training|resistance training
620981|NCT00665197|Esophageal cancer|esophageal cancer
620982|NCT00665197|Brachytherapy|brachytherapy
620983|NCT00665197|Radiotherapy|radiotherapy
620984|NCT00665197|Palliation|palliation
620985|NCT00665197|Dysphagia|dysphagia
620986|NCT00665210|hip arthritis|hip arthritis
620987|NCT00665210|implant sizing|implant sizing
620988|NCT00665223|Huntington's Disease|huntington's disease
620989|NCT00665236|Migraine|migraine
620990|NCT00665249|problem drinking|problem drinking
620991|NCT00665249|heavy drinking|heavy drinking
620992|NCT00665249|Alcohol|alcohol
620993|NCT00665249|moderation|moderation
620994|NCT00665249|motivational interviewing|motivational interviewing
620995|NCT00665262|analgesia|analgesia
620996|NCT00665262|hip arthroplasty|hip arthroplasty
620997|NCT00665262|knee arthroplasty|knee arthroplasty
620998|NCT00665275|complementary|complementary
620999|NCT00665275|alternative|alternative
621000|NCT00665275|medicine|medicine
621001|NCT00665288|cardiac arrest|cardiac arrest
621002|NCT00665288|heart arrest|heart arrest
621004|NCT00665288|resuscitation|resuscitation
621005|NCT00665288|bystander CPR|bystander cpr
621006|NCT00665301|Non-invasive Cardiac Output|non-invasive cardiac output
621007|NCT00665314|Mobilisation stem cells|mobilisation stem cells
621008|NCT00665314|G-CSF Mobilisation Regimen|g-csf mobilisation regimen
621009|NCT00665314|Lymphoma|lymphoma
621010|NCT00665314|Multiple Myeloma|multiple myeloma
621011|NCT00665314|Adult patients with lymphoma (Non Hodgkin's Lymphoma, Hodgkin's Disease) or Multiple Myeloma who previously failed Stem Cell Collections or Collection attempts.|adult patients with lymphoma (non hodgkin's lymphoma, hodgkin's disease) or multiple myeloma who previously failed stem cell collections or collection attempts.
621012|NCT00665327|Community Acquired Pneumonia|community acquired pneumonia
621013|NCT00665327|Pneumonia,|pneumonia,
621014|NCT00665327|CAP|cap
621015|NCT00665340|Erectile Dysfunction|erectile dysfunction
621016|NCT00665340|Vardenafil|vardenafil
621017|NCT00665353|HIV|hiv
621018|NCT00665353|HCV|hcv
621019|NCT00665379|leg lymphedema|leg lymphedema
621020|NCT00665379|volume measurement|volume measurement
621021|NCT00665379|compression therapy|compression therapy
621022|NCT00665379|interface pressure|interface pressure
621023|NCT00665379|static stiffness index (SSI)|static stiffness index (ssi)
621024|NCT00665379|volume change|volume change
621025|NCT00665392|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
621026|NCT00665392|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
621027|NCT00665392|tongue cancer|tongue cancer
621028|NCT00665405|Delivery, obstetric|delivery, obstetric
621029|NCT00665405|Atelectasis|atelectasis
621030|NCT00665418|Anesthesia|anesthesia
621031|NCT00665418|children|children
621032|NCT00665418|Larynx|larynx
621033|NCT00665444|bipolar disorder|bipolar disorder
621034|NCT00665444|sedation|sedation
621035|NCT00665444|overweight|overweight
621036|NCT00665444|Abilify|abilify
621037|NCT00665444|medication|medication
621038|NCT00665457|stage II breast cancer|stage ii breast cancer
621039|NCT00665457|stage IIIA breast cancer|stage iiia breast cancer
621040|NCT00665457|stage IIIB breast cancer|stage iiib breast cancer
621041|NCT00665457|stage IIIC breast cancer|stage iiic breast cancer
621042|NCT00665470|Malignant Melanoma|malignant melanoma
621043|NCT00665470|HLA-A2|hla-a2
621044|NCT00665470|Immunotherapy|immunotherapy
621045|NCT00665470|Clinical Response|clinical response
621046|NCT00665470|Skin Cancer|skin cancer
621047|NCT00665496|Erectile Dysfunction|erectile dysfunction
621048|NCT00665496|Vardenafil|vardenafil
621049|NCT00665496|Onset of action|onset of action
621050|NCT00665509|Influenza|influenza
621051|NCT00665509|Vaccine|vaccine
621052|NCT00665509|CHMP criteria|chmp criteria
621053|NCT00665522|Pain|pain
621054|NCT00665522|Postoperative Analgesia|postoperative analgesia
621055|NCT00665522|Patient-Controlled Opioids|patient-controlled opioids
621056|NCT00665535|Pressure ulcers|pressure ulcers
621057|NCT00665535|Nursing facilities|nursing facilities
621058|NCT00665535|Elderly|elderly
621059|NCT00665535|At risk for pressure ulcers|at risk for pressure ulcers
621060|NCT00665548|Knee Osteoarthritis|knee osteoarthritis
621061|NCT00665548|magnetic resonance imaging|magnetic resonance imaging
621062|NCT00665548|x rays|x rays
621063|NCT00665561|Maraviroc|maraviroc
621064|NCT00665561|HIV-1|hiv-1
621065|NCT00665561|Safety|safety
621066|NCT00665561|Non-interventional|non-interventional
621067|NCT00665587|Atrial fibrillation|atrial fibrillation
621068|NCT00665587|Maze procedure|maze procedure
621551|NCT00667043|midazolam|midazolam
621069|NCT00665587|Mid-term results|mid-term results
621070|NCT00665587|Long-term results|long-term results
621071|NCT00665587|Surgical ablation|surgical ablation
621072|NCT00665600|COPD|copd
621073|NCT00665600|Chronic Bronchitis|chronic bronchitis
621074|NCT00665600|Chronic Emphysema|chronic emphysema
621075|NCT00665613|warfarin use|warfarin use
621076|NCT00665639|Micafungin|micafungin
621077|NCT00665639|Esophageal Candidiasis|esophageal candidiasis
621078|NCT00665639|caspofungin|caspofungin
621079|NCT00665652|Neuropathy|neuropathy
621080|NCT00665652|Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)|nonmalignant monoclonal gammopathy of undetermined significance (mgus)
623209|NCT00672490|Lithium|lithium
621081|NCT00665652|MGUS|mgus
621082|NCT00665691|All Malignancies|all malignancies
621083|NCT00665704|Smoking Cessation|smoking cessation
621084|NCT00665704|Internet|internet
621085|NCT00665704|Intervention Studies|intervention studies
621086|NCT00665704|Health Services Accessibility|health services accessibility
621087|NCT00665717|interaction|interaction
621088|NCT00665717|statins|statins
621089|NCT00665717|pharmacokinetics|pharmacokinetics
621090|NCT00665756|Glaucoma|glaucoma
621091|NCT00665756|Drainage implant|drainage implant
621092|NCT00665756|Ahmed valve|ahmed valve
621093|NCT00665756|Second trabeculectomy|second trabeculectomy
621094|NCT00665769|hypercapnia|hypercapnia
621095|NCT00665769|normocapnia|normocapnia
621096|NCT00665769|chronic lung disease|chronic lung disease
621097|NCT00665769|periventricular leukomalacia|periventricular leukomalacia
621098|NCT00665769|intraventricular hemorrhage|intraventricular hemorrhage
621099|NCT00665769|hypotension|hypotension
621100|NCT00665769|cerebral autoregulation|cerebral autoregulation
621101|NCT00665769|heart rate variability|heart rate variability
621102|NCT00665769|autonomic nervous system|autonomic nervous system
621103|NCT00665769|detrended fluctuation analysis|detrended fluctuation analysis
621104|NCT00665782|anxiety disorder|anxiety disorder
621105|NCT00665782|depression|depression
621106|NCT00665782|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
621107|NCT00665782|ductal breast carcinoma in situ|ductal breast carcinoma in situ
621108|NCT00665782|breast cancer in situ|breast cancer in situ
621109|NCT00665782|stage I breast cancer|stage i breast cancer
621110|NCT00665782|stage II breast cancer|stage ii breast cancer
621111|NCT00665782|stage IIIA breast cancer|stage iiia breast cancer
621112|NCT00665782|stage IIIB breast cancer|stage iiib breast cancer
621113|NCT00665782|stage IIIC breast cancer|stage iiic breast cancer
621114|NCT00665795|Dysthyroid Optic Neuropathy|dysthyroid optic neuropathy
621115|NCT00665795|multidetector computed tomography|multidetector computed tomography
621116|NCT00665795|color doppler|color doppler
621117|NCT00665795|Grave´s Orbitopathy|grave´s orbitopathy
621118|NCT00665795|Grave´s Disease|grave´s disease
621119|NCT00665795|morphometric analysis|morphometric analysis
621120|NCT00665821|nonspecific low back pain|nonspecific low back pain
621121|NCT00665821|disability|disability
621122|NCT00665821|sick leave|sick leave
621123|NCT00665821|catastrophizing|catastrophizing
621124|NCT00665821|workers|workers
621125|NCT00665847|HIV-1|hiv-1
621126|NCT00665847|TMC125-TiDP35-C213|tmc125-tidp35-c213
621127|NCT00665847|TMC125-C213|tmc125-c213
621128|NCT00665860|Osteoporosis|osteoporosis
621129|NCT00665860|Soy isoflavones|soy isoflavones
621130|NCT00665860|Postmenopausal women|postmenopausal women
621131|NCT00665860|Safety|safety
621132|NCT00665860|Efficacy|efficacy
621133|NCT00665860|Effective dosage|effective dosage
621134|NCT00665873|Totally Implantable Venous Access Devices|totally implantable venous access devices
621135|NCT00665873|Infections|infections
621136|NCT00665873|Chemotherapy|chemotherapy
621137|NCT00665873|Valuated infections TIVAD|valuated infections tivad
621138|NCT00665886|Peripheral venous catheter|peripheral venous catheter
623090|NCT00671970|Tarceva|tarceva
621139|NCT00665886|Catheter-related complication|catheter-related complication
621140|NCT00665886|Bacterial Colonization|bacterial colonization
621141|NCT00665886|Dwell time|dwell time
621142|NCT00665886|Closed system|closed system
621143|NCT00665886|Costs|costs
621144|NCT00665886|Polyurethane|polyurethane
621145|NCT00665886|Teflon|teflon
621146|NCT00665899|breast cancer|breast cancer
621147|NCT00665899|couples|couples
621148|NCT00665899|cognitive behavioral therapy|cognitive behavioral therapy
621149|NCT00665899|Women with early stage breast cancer and their partners.|women with early stage breast cancer and their partners.
621150|NCT00665938|Physical development|physical development
621151|NCT00665951|pediatric|pediatric
621152|NCT00665951|pharmacokinetics|pharmacokinetics
621153|NCT00665951|HIV infection|hiv infection
621154|NCT00665964|osteoarthritis|osteoarthritis
621155|NCT00665964|knee|knee
621156|NCT00665964|total knee arthroplasty|total knee arthroplasty
621157|NCT00665964|gonarthrrsis|gonarthrrsis
621158|NCT00665964|polyethylene|polyethylene
621159|NCT00665964|posterior stabilized|posterior stabilized
621160|NCT00665977|Obstructive Sleep Apnea|obstructive sleep apnea
621161|NCT00665977|Nasal Congestion|nasal congestion
621162|NCT00665977|Sinus congestion|sinus congestion
621163|NCT00666003|Hemodynamics|hemodynamics
621164|NCT00666016|non alcoholic steatohepatitis nash hepatoprotective hepatoprotection ALT AST new drug candidate interventional study TRO19622 Trophos cholest-4-en-3-one oxime|non alcoholic steatohepatitis nash hepatoprotective hepatoprotection alt ast new drug candidate interventional study tro19622 trophos cholest-4-en-3-one oxime
621165|NCT00666029|metabolic syndrome|metabolic syndrome
621166|NCT00666029|Volunteers recruited from the community|volunteers recruited from the community
621167|NCT00666055|Sex|sex
621168|NCT00666055|Aging|aging
621169|NCT00666055|Antiretroviral|antiretroviral
621170|NCT00666055|Pharmacokinetics|pharmacokinetics
621171|NCT00666055|post-menopausal women with HIV infection|post-menopausal women with hiv infection
621172|NCT00666055|pre-menopausal women with HIV infection|pre-menopausal women with hiv infection
621173|NCT00666068|Patients with hypopituitarism|patients with hypopituitarism
621174|NCT00666081|Pazopanib, paclitaxel, carboplatin|pazopanib, paclitaxel, carboplatin
621175|NCT00666094|Type 2-diabetes|type 2-diabetes
621176|NCT00666094|exercise therapy|exercise therapy
621177|NCT00666094|RCT|rct
621178|NCT00666094|Norway|norway
621179|NCT00666107|HPV|hpv
621180|NCT00666107|HIV|hiv
621181|NCT00666107|Gardasil|gardasil
621182|NCT00666107|Vaccine|vaccine
621183|NCT00666133|Preeclampsia|preeclampsia
621184|NCT00666133|Eclampsia|eclampsia
621185|NCT00666133|Magnesium Sulfate|magnesium sulfate
621186|NCT00666146|Schizophrenia|schizophrenia
621187|NCT00666146|Genetics|genetics
621189|NCT00666159|Atopic Dermatitis|atopic dermatitis
621190|NCT00666159|Protopic|protopic
621191|NCT00666159|Pediatric|pediatric
621192|NCT00666172|Women's Health|women's health
621193|NCT00666172|Obesity|obesity
621194|NCT00666172|Metabolic Syndrome|metabolic syndrome
621195|NCT00666172|Arterial Function|arterial function
621196|NCT00666172|Lipoproteins|lipoproteins
621197|NCT00666172|Overweight|overweight
621198|NCT00666185|Micafungin|micafungin
621199|NCT00666185|Esophageal Candidiasis|esophageal candidiasis
621200|NCT00666185|Fluconazole|fluconazole
621201|NCT00666211|pain|pain
621202|NCT00666211|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
621203|NCT00666211|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
621204|NCT00666211|acute undifferentiated leukemia|acute undifferentiated leukemia
621205|NCT00666211|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
621206|NCT00666211|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
621207|NCT00666211|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
621208|NCT00666211|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
621209|NCT00666211|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
621210|NCT00666211|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
621211|NCT00666211|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
621212|NCT00666211|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
621213|NCT00666211|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
621214|NCT00666211|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
621215|NCT00666211|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
621216|NCT00666211|mast cell leukemia|mast cell leukemia
621217|NCT00666211|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
621218|NCT00666211|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
621219|NCT00666211|prolymphocytic leukemia|prolymphocytic leukemia
621220|NCT00666211|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
621221|NCT00666211|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
621222|NCT00666211|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
623189|NCT00672386|HbA1c|hba1c
621223|NCT00666211|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
621224|NCT00666211|refractory hairy cell leukemia|refractory hairy cell leukemia
621225|NCT00666211|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
621226|NCT00666211|secondary acute myeloid leukemia|secondary acute myeloid leukemia
621227|NCT00666211|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
621228|NCT00666211|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
621229|NCT00666211|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
621230|NCT00666211|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
621231|NCT00666211|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
621232|NCT00666211|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
621233|NCT00666211|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
621234|NCT00666211|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
621235|NCT00666211|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
621236|NCT00666211|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
621237|NCT00666211|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
621238|NCT00666211|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
621239|NCT00666211|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
621240|NCT00666211|anaplastic large cell lymphoma|anaplastic large cell lymphoma
621241|NCT00666211|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
621242|NCT00666211|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
621243|NCT00666211|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
621244|NCT00666211|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
621245|NCT00666211|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
752178|NCT01172028|recurrent esophageal cancer|recurrent esophageal cancer
621246|NCT00666211|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
621247|NCT00666211|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
621248|NCT00666211|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
621249|NCT00666211|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
621250|NCT00666211|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
621251|NCT00666211|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
621252|NCT00666211|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
621253|NCT00666211|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
621254|NCT00666211|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
621255|NCT00666211|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
621256|NCT00666211|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
621257|NCT00666211|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
621258|NCT00666211|splenic marginal zone lymphoma|splenic marginal zone lymphoma
621259|NCT00666211|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
621260|NCT00666211|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
621261|NCT00666211|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
621262|NCT00666211|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
621263|NCT00666211|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
621264|NCT00666211|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
621265|NCT00666211|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
621266|NCT00666211|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
621267|NCT00666211|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
621268|NCT00666211|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
621269|NCT00666211|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
621270|NCT00666211|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
621271|NCT00666211|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
621272|NCT00666211|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
621273|NCT00666211|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
621274|NCT00666211|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
621372|NCT00666328|Intracranial Pressure|intracranial pressure
621275|NCT00666211|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
621276|NCT00666211|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
621277|NCT00666211|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
621278|NCT00666211|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
621279|NCT00666211|stage I mantle cell lymphoma|stage i mantle cell lymphoma
621280|NCT00666211|stage I marginal zone lymphoma|stage i marginal zone lymphoma
621281|NCT00666211|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
621282|NCT00666211|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
621283|NCT00666211|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
621348|NCT00666211|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
621284|NCT00666211|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
621285|NCT00666211|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
621286|NCT00666211|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
621287|NCT00666211|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
621288|NCT00666211|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
621289|NCT00666211|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
621290|NCT00666211|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
621291|NCT00666211|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
621292|NCT00666211|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
621293|NCT00666211|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
621294|NCT00666211|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
621295|NCT00666211|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
621296|NCT00666211|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
621297|NCT00666211|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
621298|NCT00666211|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
621299|NCT00666211|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
621300|NCT00666211|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
621301|NCT00666211|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
623496|NCT00673530|Hospital malnutrition|hospital malnutrition
623497|NCT00673530|Nutritional Status|nutritional status
623498|NCT00673530|Nutrition Assessment|nutrition assessment
623499|NCT00673530|Enteral Nutrition|enteral nutrition
623500|NCT00673530|Parenteral Nutrition|parenteral nutrition
623501|NCT00673530|Severity of illness index|severity of illness index
623502|NCT00673530|cost analysis|cost analysis
623504|NCT00673543|Pregnancy|pregnancy
621302|NCT00666211|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
621303|NCT00666211|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
621304|NCT00666211|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
621305|NCT00666211|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
621306|NCT00666211|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
621307|NCT00666211|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
621308|NCT00666211|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
621309|NCT00666211|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
621310|NCT00666211|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
621311|NCT00666211|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
621312|NCT00666211|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
621313|NCT00666211|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
621314|NCT00666211|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
621315|NCT00666211|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
621316|NCT00666211|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
621317|NCT00666211|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
621318|NCT00666211|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
621319|NCT00666211|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
621320|NCT00666211|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
621321|NCT00666211|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
621322|NCT00666211|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
621323|NCT00666211|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
621324|NCT00666211|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
621325|NCT00666211|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
621326|NCT00666211|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
621327|NCT00666211|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
621328|NCT00666211|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
621329|NCT00666211|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
621330|NCT00666211|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
621331|NCT00666211|intraocular lymphoma|intraocular lymphoma
621332|NCT00666211|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
621333|NCT00666211|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
621334|NCT00666211|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
621335|NCT00666211|chronic eosinophilic leukemia|chronic eosinophilic leukemia
621336|NCT00666211|chronic neutrophilic leukemia|chronic neutrophilic leukemia
621337|NCT00666211|primary myelofibrosis|primary myelofibrosis
621338|NCT00666211|essential thrombocythemia|essential thrombocythemia
621339|NCT00666211|polycythemia vera|polycythemia vera
621340|NCT00666211|extramedullary plasmacytoma|extramedullary plasmacytoma
621341|NCT00666211|isolated plasmacytoma of bone|isolated plasmacytoma of bone
621342|NCT00666211|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
621343|NCT00666211|stage I multiple myeloma|stage i multiple myeloma
621344|NCT00666211|stage II multiple myeloma|stage ii multiple myeloma
621345|NCT00666211|stage III multiple myeloma|stage iii multiple myeloma
621346|NCT00666211|primary systemic amyloidosis|primary systemic amyloidosis
621347|NCT00666211|refractory multiple myeloma|refractory multiple myeloma
622217|NCT00669591|bavituximab|bavituximab
621349|NCT00666211|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
621350|NCT00666211|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
621351|NCT00666211|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
621352|NCT00666211|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
621353|NCT00666224|Clinically Definite Multiple Sclerosis|clinically definite multiple sclerosis
621354|NCT00666224|Clinically Isolated Syndrome|clinically isolated syndrome
621355|NCT00666224|Multiple Sclerosis|multiple sclerosis
621356|NCT00666237|Glaucoma|glaucoma
621357|NCT00666237|Tube shunt surgery|tube shunt surgery
621358|NCT00666237|Trabeculectomy|trabeculectomy
621359|NCT00666250|blood pressure|blood pressure
621748|NCT00667602|Toddlers|toddlers
621360|NCT00666250|dyslipidemia|dyslipidemia
621361|NCT00666250|hyperglycemia|hyperglycemia
621362|NCT00666289|polycythemia vera|polycythemia vera
621363|NCT00666289|essential thrombocythemia|essential thrombocythemia
621364|NCT00666289|idiopathic myelofibrosis|idiopathic myelofibrosis
621365|NCT00666289|family clusters|family clusters
621366|NCT00666302|Atopic Dermatitis|atopic dermatitis
621367|NCT00666302|Protopic|protopic
621368|NCT00666302|Elidel|elidel
621369|NCT00666315|Consecutive euthyroid patients with multinodular goiter for whom a total Thyroidectomy under general anesthesia is indicated|consecutive euthyroid patients with multinodular goiter for whom a total thyroidectomy under general anesthesia is indicated
621370|NCT00666328|Hypertension|hypertension
621371|NCT00666328|Hemorrhage|hemorrhage
621373|NCT00666328|Antihypertensive Agent|antihypertensive agent
621374|NCT00666328|Calcium Channel Blocker|calcium channel blocker
621375|NCT00666354|Nail Psoriasis|nail psoriasis
621376|NCT00666354|Psoriasis|psoriasis
621377|NCT00666354|Fingernail Psoriasis|fingernail psoriasis
621378|NCT00666354|Methotrexate|methotrexate
621379|NCT00666367|COPD|copd
621380|NCT00666380|Malaria|malaria
621381|NCT00666380|Vaccine|vaccine
621382|NCT00666380|MSP-1 (merozoite surface protein-1)|msp-1 (merozoite surface protein-1)
621383|NCT00666380|Phase 1|phase 1
621384|NCT00666393|IONSYS™|ionsys™
621385|NCT00666393|Pain, Postoperative|pain, postoperative
621386|NCT00666393|Analgesia, Patient-Controlled|analgesia, patient-controlled
621387|NCT00666393|Opioids|opioids
621388|NCT00666393|Pediatrics|pediatrics
621389|NCT00666419|nonspecific low back pain|nonspecific low back pain
621390|NCT00666419|schoolchildren|schoolchildren
621391|NCT00666419|prevalence|prevalence
621392|NCT00666432|schizophrenia|schizophrenia
621393|NCT00666432|bipolar|bipolar
621394|NCT00666432|eye movements|eye movements
621395|NCT00666432|phenotype|phenotype
621396|NCT00666432|biochemical|biochemical
621397|NCT00666432|relatives|relatives
621398|NCT00666445|Alzheimer's Disease|alzheimer's disease
621400|NCT00666445|Neuronal function|neuronal function
621401|NCT00666445|Cognitive Impairment|cognitive impairment
621402|NCT00666445|Magnetoencephalography|magnetoencephalography
621403|NCT00666458|Type 2 diabetes|type 2 diabetes
621404|NCT00666458|metformin|metformin
621405|NCT00666471|epistaxis|epistaxis
621406|NCT00666471|Epistaxis refractory to emergency physician treatment|epistaxis refractory to emergency physician treatment
621407|NCT00666484|neurotoxicity|neurotoxicity
621408|NCT00666484|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
621409|NCT00666484|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
621410|NCT00666484|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
621411|NCT00666484|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
621412|NCT00666484|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
621413|NCT00666484|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
621414|NCT00666484|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
621415|NCT00666484|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
621416|NCT00666497|Acute Myeloid Leukemia|acute myeloid leukemia
621417|NCT00666497|Myelodysplastic Syndrome|myelodysplastic syndrome
621418|NCT00666497|Azacitidine|azacitidine
621419|NCT00666497|Vidaza|vidaza
621420|NCT00666497|MGCD0103|mgcd0103
621421|NCT00666497|Histone deacetylase inhibitor|histone deacetylase inhibitor
621422|NCT00666497|DNA methyltransferase inhibitor|dna methyltransferase inhibitor
621423|NCT00666497|Epigenetic Therapy|epigenetic therapy
621424|NCT00666510|nitric oxide|nitric oxide
621425|NCT00666510|bronchospasm|bronchospasm
621426|NCT00666510|anesthesia|anesthesia
621427|NCT00666510|induced sputum|induced sputum
621428|NCT00666510|asthma|asthma
621429|NCT00666523|osteoarthritis, knee or hip|osteoarthritis, knee or hip
621430|NCT00666536|Hypertension|hypertension
621431|NCT00666536|adults|adults
621432|NCT00666536|Valsartan + Amlodipine|valsartan + amlodipine
621433|NCT00666536|Angiotensin Receptor Blockers|angiotensin receptor blockers
621434|NCT00666549|Myeloproliferative Disease|myeloproliferative disease
621435|NCT00666549|Myelofibrosis|myelofibrosis
621436|NCT00666549|Idiopathic Myelofibrosis|idiopathic myelofibrosis
621437|NCT00666549|Essential Thrombocythemia|essential thrombocythemia
621438|NCT00666549|Polycythemia Vera|polycythemia vera
621439|NCT00666601|Microdialysis|microdialysis
621440|NCT00666601|Antibiotic|antibiotic
621441|NCT00666601|Healthy subjects|healthy subjects
621442|NCT00666614|Sleep|sleep
621443|NCT00666614|Fatigue|fatigue
621444|NCT00666614|High Dose Chemotherapy|high dose chemotherapy
621445|NCT00666627|Osteoporosis|osteoporosis
621446|NCT00666627|Post-menopausal osteoporosis|post-menopausal osteoporosis
621447|NCT00666627|Bisphosphonates|bisphosphonates
621448|NCT00666627|Alendronate|alendronate
621449|NCT00666627|Ibandronate|ibandronate
621450|NCT00666627|Risedronate|risedronate
621451|NCT00666640|Osteoporosis|osteoporosis
621452|NCT00666640|Fracture|fracture
621453|NCT00666640|DXA|dxa
621454|NCT00666640|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
621455|NCT00666640|Computed tomography|computed tomography
621456|NCT00666640|3D DXA|3d dxa
621457|NCT00666653|Parkinson's disease|parkinson's disease
621458|NCT00666653|Dopamine Agonist|dopamine agonist
621459|NCT00666653|Levodopa|levodopa
621460|NCT00666653|Pharmacokinetics|pharmacokinetics
621461|NCT00666653|Dyskinesia|dyskinesia
621462|NCT00666666|prostate Cancer|prostate cancer
621463|NCT00666666|adenocarcinoma of the prostate|adenocarcinoma of the prostate
621464|NCT00666666|stage IV prostate cancer|stage iv prostate cancer
621465|NCT00666666|newly diagnosed stage IV prostate cancer|newly diagnosed stage iv prostate cancer
621466|NCT00666692|cancer|cancer
621467|NCT00666692|carcinoma|carcinoma
621468|NCT00666692|monoclonal antibody therapy|monoclonal antibody therapy
621469|NCT00666692|anti-angiogenesis|anti-angiogenesis
621470|NCT00666705|maraviroc|maraviroc
621471|NCT00666705|raltegravir|raltegravir
621472|NCT00666705|drug interaction study|drug interaction study
621473|NCT00666705|healthy volunteers|healthy volunteers
621474|NCT00666731|male breast cancer|male breast cancer
621475|NCT00666731|breast cancer|breast cancer
621476|NCT00666731|ductal breast carcinoma in situ|ductal breast carcinoma in situ
621477|NCT00666731|lobular breast carcinoma in situ|lobular breast carcinoma in situ
621478|NCT00666731|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
621479|NCT00666744|exercise|exercise
621480|NCT00666744|frequency|frequency
621481|NCT00666744|duration|duration
621482|NCT00666757|Severe Depressive Episode|severe depressive episode
621483|NCT00666809|Vardenafil,|vardenafil,
621484|NCT00666809|Tinnitus|tinnitus
621485|NCT00666822|stage I breast cancer|stage i breast cancer
621486|NCT00666822|stage II breast cancer|stage ii breast cancer
621487|NCT00666822|stage IIIA breast cancer|stage iiia breast cancer
621488|NCT00666835|Treatment of anemia in hemodialysis patients|treatment of anemia in hemodialysis patients
621489|NCT00666848|Metabolic syndrome|metabolic syndrome
621490|NCT00666848|Hypertension|hypertension
621491|NCT00666848|Sitagliptin|sitagliptin
621492|NCT00666848|Enalapril|enalapril
621782|NCT00667667|bone|bone
621493|NCT00666874|Obesity, lifestyle, vascular inflammation|obesity, lifestyle, vascular inflammation
621494|NCT00666887|Multiple Sclerosis|multiple sclerosis
621495|NCT00666887|Clinically Isolated Syndrome|clinically isolated syndrome
621496|NCT00666887|Minocycline|minocycline
621497|NCT00666887|Placebo|placebo
621498|NCT00666913|breast cancer in situ|breast cancer in situ
621499|NCT00666913|stage I breast cancer|stage i breast cancer
621500|NCT00666913|stage II breast cancer|stage ii breast cancer
621501|NCT00666913|stage IIIA breast cancer|stage iiia breast cancer
621502|NCT00666913|stage IIIB breast cancer|stage iiib breast cancer
621503|NCT00666913|stage IIIC breast cancer|stage iiic breast cancer
621504|NCT00666913|hot flashes|hot flashes
621505|NCT00666926|Pancreatic Neoplasm|pancreatic neoplasm
621506|NCT00666926|Head and Neck neoplasm|head and neck neoplasm
621507|NCT00666926|Prostatic neoplasms; Focal Adhesion Kinase|prostatic neoplasms; focal adhesion kinase
621508|NCT00666926|Phase 1|phase 1
621509|NCT00666926|Pharmacodynamics|pharmacodynamics
621510|NCT00666926|FDG-PET|fdg-pet
621511|NCT00666965|SPM 962|spm 962
621512|NCT00666965|rotigotine|rotigotine
621513|NCT00666965|Idiopathic Restless Legs Syndrome|idiopathic restless legs syndrome
621514|NCT00666965|RLS|rls
621515|NCT00666978|bladder cancer|bladder cancer
621516|NCT00666978|cervical cancer|cervical cancer
621517|NCT00666978|esophageal cancer|esophageal cancer
621518|NCT00666978|gastric cancer|gastric cancer
621519|NCT00666978|renal cell carcinoma|renal cell carcinoma
621520|NCT00666978|adult primary liver cancer|adult primary liver cancer
621521|NCT00666978|non-small cell lung cancer|non-small cell lung cancer
621522|NCT00666978|small cell lung cancer|small cell lung cancer
621523|NCT00666978|pancreatic cancer|pancreatic cancer
621524|NCT00666978|hypopharyngeal cancer|hypopharyngeal cancer
621525|NCT00666978|laryngeal cancer|laryngeal cancer
621526|NCT00666978|lip and oral cavity cancer|lip and oral cavity cancer
621527|NCT00666978|nasopharyngeal cancer|nasopharyngeal cancer
621528|NCT00666978|oropharyngeal cancer|oropharyngeal cancer
621529|NCT00666978|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
621530|NCT00666978|adult acute myeloid leukemia|adult acute myeloid leukemia
621531|NCT00666978|tobacco use disorder|tobacco use disorder
621532|NCT00666991|ovarian cancer|ovarian cancer
621533|NCT00666991|Mullerian tumors|mullerian tumors
621534|NCT00666991|peritoneal cavity carcinoma|peritoneal cavity carcinoma
621535|NCT00666991|gastrointestinal tract tumor|gastrointestinal tract tumor
621536|NCT00666991|GI tract tumor|gi tract tumor
621537|NCT00666991|pancreatic cancer|pancreatic cancer
621538|NCT00666991|colon cancer|colon cancer
621539|NCT00667017|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
621540|NCT00667017|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
621541|NCT00667030|Inflammation|inflammation
621542|NCT00667030|Aging|aging
621543|NCT00667030|Metabolism|metabolism
621544|NCT00667030|Exercise|exercise
621545|NCT00667043|therapeutic hypothermia|therapeutic hypothermia
621546|NCT00667043|cardiac arrest|cardiac arrest
623788|NCT00676052|COPD|copd
621547|NCT00667043|sedation|sedation
621548|NCT00667043|remifentanil|remifentanil
621552|NCT00667056|Chronic Allergic Contact Dermatitis|chronic allergic contact dermatitis
621553|NCT00667056|Protopic|protopic
621554|NCT00667069|adenocarcinoma of the prostate|adenocarcinoma of the prostate
621555|NCT00667069|stage III prostate cancer|stage iii prostate cancer
621556|NCT00667069|stage IV prostate cancer|stage iv prostate cancer
621557|NCT00667082|Non small Cell Lung Cancer|non small cell lung cancer
621558|NCT00667082|Pancreatic Cancer|pancreatic cancer
621559|NCT00667082|Melanoma|melanoma
621560|NCT00667082|Lymphoma|lymphoma
621561|NCT00667082|Multiple Myeloma|multiple myeloma
621562|NCT00667095|OAB|oab
621563|NCT00667095|Over Active Bladder|over active bladder
621564|NCT00667095|overactive bladder|overactive bladder
621565|NCT00667095|Urinary Urge Incontinence|urinary urge incontinence
621566|NCT00667095|Urinary Incontinence|urinary incontinence
621567|NCT00667095|Botox|botox
621568|NCT00667095|DMSO|dmso
621569|NCT00667095|bladder instillation|bladder instillation
621570|NCT00667095|instillation|instillation
621571|NCT00667095|detrusor hyperreflexia|detrusor hyperreflexia
621572|NCT00667095|urge incontinence|urge incontinence
621573|NCT00667121|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
621574|NCT00667121|breast cancer|breast cancer
621575|NCT00667121|hot flashes|hot flashes
621576|NCT00667121|depression|depression
621577|NCT00667134|systemic sclerosis autoantibodies|systemic sclerosis autoantibodies
621578|NCT00660608|Transfusion regulation|transfusion regulation
621579|NCT00660621|High Grade|high grade
621580|NCT00660621|Malignant|malignant
621581|NCT00660621|GBM|gbm
621582|NCT00660634|Peripheral arterial obstructive disease|peripheral arterial obstructive disease
621583|NCT00660634|Intermittent Claudication|intermittent claudication
621584|NCT00660634|Endovascular treatment|endovascular treatment
621585|NCT00660634|Flow-mediated dilation|flow-mediated dilation
621687|NCT00667355|Ankylosing Spondylitis|ankylosing spondylitis
621586|NCT00660647|Rheumatoid arthritis, adalimumab, efficacy, adverse events|rheumatoid arthritis, adalimumab, efficacy, adverse events
621587|NCT00660660|GERD|gerd
621588|NCT00660660|Esophageal Reflux|esophageal reflux
621589|NCT00660660|Gastro-Esophageal Reflux|gastro-esophageal reflux
621590|NCT00660660|Regurgitation|regurgitation
621591|NCT00660660|Gastric|gastric
621592|NCT00660673|levodopa/carbidopa intestinal gel|levodopa/carbidopa intestinal gel
621593|NCT00660673|Dyskinesia|dyskinesia
621594|NCT00660673|Carbidopa|carbidopa
621595|NCT00660673|Parkinson's Disease|parkinson's disease
621596|NCT00660673|Severe Motor Fluctuations|severe motor fluctuations
621597|NCT00660673|Levodopa|levodopa
621598|NCT00660686|randomized clinical trial|randomized clinical trial
621599|NCT00660686|elderly|elderly
621600|NCT00660686|cancer survivor|cancer survivor
621601|NCT00660686|bone health|bone health
621602|NCT00660686|body composition|body composition
621603|NCT00660686|signs and symptoms|signs and symptoms
621604|NCT00660686|Androgen Deprivation Therapy|androgen deprivation therapy
621605|NCT00660699|Cholangiocarcinoma|cholangiocarcinoma
621606|NCT00660699|Gallbladder|gallbladder
621607|NCT00660699|Pancreatic|pancreatic
621608|NCT00660699|Ampullary|ampullary
621609|NCT00660699|Cancer|cancer
621610|NCT00660712|Bipolar disorder|bipolar disorder
621611|NCT00660712|patient characteristics|patient characteristics
621612|NCT00660712|treatment characteristics|treatment characteristics
621613|NCT00660725|Gemcitabine|gemcitabine
621614|NCT00660725|Oxaliplatin|oxaliplatin
621615|NCT00660725|Vandetanib|vandetanib
621616|NCT00660725|Phase I|phase i
621617|NCT00660738|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
621618|NCT00660738|walking|walking
621619|NCT00660738|exercise test|exercise test
621620|NCT00660738|quality of life|quality of life
621621|NCT00660738|dyspnea|dyspnea
621622|NCT00660738|desaturation|desaturation
621623|NCT00660751|Physiology of Serotonergic and Adrenergic systems|physiology of serotonergic and adrenergic systems
621624|NCT00660764|cholesterol|cholesterol
621625|NCT00660764|coronary heart disease|coronary heart disease
621626|NCT00660764|rosuvastatin|rosuvastatin
621627|NCT00660764|LDL-C goal|ldl-c goal
621628|NCT00660764|hypercholesterolemia|hypercholesterolemia
621629|NCT00660764|secondary prevention|secondary prevention
621630|NCT00660764|primary prevention|primary prevention
621631|NCT00660764|CVA|cva
621632|NCT00660777|oropharyngeal exercises|oropharyngeal exercises
623190|NCT00672386|Body Weight|body weight
621633|NCT00660777|obstructive sleep apnea|obstructive sleep apnea
621634|NCT00660777|speech therapy|speech therapy
621635|NCT00660790|diabetes mellitus type II, therapy non-responders|diabetes mellitus type ii, therapy non-responders
621636|NCT00667160|Mild Atopic Dermatitis|mild atopic dermatitis
621637|NCT00667160|Protopic|protopic
621638|NCT00667160|Pediatric|pediatric
621640|NCT00667186|Prevention|prevention
621641|NCT00667186|Public Health|public health
621642|NCT00667186|Screening|screening
621643|NCT00667199|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
621644|NCT00667199|Bone Metastases|bone metastases
621645|NCT00667199|Radium-223|radium-223
621646|NCT00667199|Palliation of bone pain|palliation of bone pain
621647|NCT00667212|anger|anger
621648|NCT00667212|intermittent|intermittent
621649|NCT00667212|explosive|explosive
621650|NCT00667251|recurrent breast cancer|recurrent breast cancer
621651|NCT00667251|HER2-positive breast cancer|her2-positive breast cancer
621652|NCT00667251|stage IV breast cancer|stage iv breast cancer
621653|NCT00667264|pain|pain
621654|NCT00667264|phantom limb|phantom limb
621655|NCT00667264|stump pain|stump pain
621656|NCT00667264|catheter|catheter
621657|NCT00667264|nerve block|nerve block
621658|NCT00667264|peripheral nerve block|peripheral nerve block
621659|NCT00667264|ucsd|ucsd
621660|NCT00667264|Post-amputation phantom limb or stump pain|post-amputation phantom limb or stump pain
621661|NCT00667277|Myelofibrosis|myelofibrosis
621662|NCT00667277|Idiopathic|idiopathic
621663|NCT00667277|Bevacizumab|bevacizumab
621664|NCT00667277|Avastin|avastin
621665|NCT00667277|bone marrow fibrosis|bone marrow fibrosis
621666|NCT00667277|bone marrow angiogenesis|bone marrow angiogenesis
621667|NCT00667277|JAK2|jak2
621668|NCT00667290|functional ability|functional ability
621669|NCT00667290|gait|gait
621670|NCT00667290|musculoskeletal disorder therapy|musculoskeletal disorder therapy
621671|NCT00667290|peripheral blood vessel disorder|peripheral blood vessel disorder
621672|NCT00667303|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
621673|NCT00667316|low back pain|low back pain
621674|NCT00667316|workers|workers
621675|NCT00667316|disability|disability
621676|NCT00667316|sick leave|sick leave
621677|NCT00667329|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
621678|NCT00667329|Lymphoma|lymphoma
621679|NCT00667329|2CdA|2cda
621680|NCT00667329|Cladribine|cladribine
621681|NCT00667329|Leustatin|leustatin
621682|NCT00667329|Cyclophosphamide|cyclophosphamide
621683|NCT00667329|Cytoxan|cytoxan
621684|NCT00667329|Neosar|neosar
621685|NCT00667329|Rituxan|rituxan
621686|NCT00667329|Rituximab|rituximab
621688|NCT00667368|bacterial vaginosis, women, chlamydia, gonorrhea, mentronidazole, vaginal, children|bacterial vaginosis, women, chlamydia, gonorrhea, mentronidazole, vaginal, children
621689|NCT00667381|Ultrasound guidance|ultrasound guidance
621690|NCT00667381|Vascular access|vascular access
621691|NCT00667381|Vascular complications|vascular complications
621692|NCT00667394|Brain Tumor|brain tumor
621693|NCT00667394|Chemotherapy|chemotherapy
621694|NCT00667394|Radiation|radiation
621695|NCT00667394|Anti-Angiogenesis|anti-angiogenesis
621696|NCT00667394|Glioblastoma|glioblastoma
621697|NCT00667394|Glioma|glioma
621698|NCT00667407|Asthma|asthma
621699|NCT00667420|gastric|gastric
621700|NCT00667420|esophageal|esophageal
621701|NCT00667420|panitumumab|panitumumab
621702|NCT00667433|HIV|hiv
621703|NCT00667433|African American|african american
621704|NCT00667433|treatment naïve|treatment naïve
621705|NCT00667446|GnRH analog|gnrh analog
621706|NCT00667446|Luteinizing hormone (LH)|luteinizing hormone (lh)
621707|NCT00667446|Gonadotrophin-releasing hormone agonist(GnRHa)|gonadotrophin-releasing hormone agonist(gnrha)
621708|NCT00667446|Suppression of LH|suppression of lh
621709|NCT00667446|Gonadotrophin-releasing hormone (GnRH)|gonadotrophin-releasing hormone (gnrh)
621710|NCT00667446|CPP|cpp
621711|NCT00667446|Leuprolide acetate|leuprolide acetate
621712|NCT00667446|Central Precocious Puberty|central precocious puberty
621713|NCT00667446|Depot formulation|depot formulation
621714|NCT00667446|Lupron|lupron
621715|NCT00667446|Tanner staging|tanner staging
621716|NCT00667446|Pediatrics|pediatrics
621717|NCT00667459|Cervical Disc|cervical disc
621718|NCT00667472|port wine stain birthmarks|port wine stain birthmarks
621719|NCT00667524|Eosinophilic Esophagitis|eosinophilic esophagitis
621720|NCT00667524|Dysphagia|dysphagia
621721|NCT00667524|Esophageal bougienage|esophageal bougienage
621722|NCT00667524|Esophageal Dilation|esophageal dilation
621723|NCT00667550|Lower urinary tract symptoms|lower urinary tract symptoms
621724|NCT00667550|Colorectal disorders|colorectal disorders
621725|NCT00667550|Urinary incontinence|urinary incontinence
621726|NCT00667550|Fecal incontinence|fecal incontinence
621727|NCT00667550|Voiding dysfunction|voiding dysfunction
621728|NCT00667550|Urgency frequency|urgency frequency
621729|NCT00667550|Sexual dysfunction|sexual dysfunction
621730|NCT00667550|Colorectal malignancies|colorectal malignancies
621731|NCT00667550|Inflammatory bowel disease|inflammatory bowel disease
621732|NCT00667563|human papilloma virus infection|human papilloma virus infection
621733|NCT00667563|cervical cancer|cervical cancer
621734|NCT00667563|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
621735|NCT00667563|HIV infection|hiv infection
621736|NCT00667576|chronic kidney disease|chronic kidney disease
621737|NCT00667576|secondary hyperparathyroidism|secondary hyperparathyroidism
621738|NCT00667576|hemodialysis|hemodialysis
621739|NCT00667576|paricalcitol|paricalcitol
621740|NCT00667576|maxacalcitol|maxacalcitol
621741|NCT00667589|sorafenib|sorafenib
621742|NCT00667589|rash|rash
621743|NCT00667589|hand foot skin reaction|hand foot skin reaction
621744|NCT00667602|Meningococcal|meningococcal
621745|NCT00667602|ACWY|acwy
621746|NCT00667602|Conjugate Vaccine|conjugate vaccine
621747|NCT00667602|Meningitis|meningitis
621750|NCT00667602|Concomitant Vaccination|concomitant vaccination
621751|NCT00667615|vorinostat|vorinostat
621752|NCT00667615|rituximab|rituximab
621753|NCT00667615|cyclophosphamide|cyclophosphamide
621754|NCT00667615|etoposide|etoposide
621755|NCT00667615|prednisone|prednisone
621756|NCT00667615|Quality of life|quality of life
621757|NCT00667615|08-045|08-045
621758|NCT00667641|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
621759|NCT00667641|recurrent breast cancer|recurrent breast cancer
621760|NCT00667641|stage IV breast cancer|stage iv breast cancer
621761|NCT00667641|recurrent prostate cancer|recurrent prostate cancer
621762|NCT00667641|stage IV prostate cancer|stage iv prostate cancer
621763|NCT00667641|recurrent colon cancer|recurrent colon cancer
621764|NCT00667641|stage IV colon cancer|stage iv colon cancer
621765|NCT00667641|recurrent pancreatic cancer|recurrent pancreatic cancer
621766|NCT00667641|stage IV pancreatic cancer|stage iv pancreatic cancer
621767|NCT00667641|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
621768|NCT00667641|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
621769|NCT00667641|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
621770|NCT00667641|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
621771|NCT00667641|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
621772|NCT00667641|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
621773|NCT00667641|recurrent melanoma|recurrent melanoma
621774|NCT00667641|stage IV melanoma|stage iv melanoma
621775|NCT00667641|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
621776|NCT00667641|recurrent thyroid cancer|recurrent thyroid cancer
621777|NCT00667654|Osteoarthritis, Knee|osteoarthritis, knee
621778|NCT00667667|whole body vibration|whole body vibration
621779|NCT00667667|exercise|exercise
621780|NCT00667667|postmenopausal|postmenopausal
621781|NCT00667667|BMD|bmd
621783|NCT00667667|elderly females|elderly females
621784|NCT00667667|Caucasian race|caucasian race
621785|NCT00667680|tDCS, major depression|tdcs, major depression
621786|NCT00667693|intubation|intubation
621787|NCT00667693|obese|obese
621788|NCT00667719|essential hypertension|essential hypertension
621789|NCT00667719|high blood pressure|high blood pressure
621790|NCT00667732|diabetes|diabetes
621791|NCT00667732|insulin|insulin
621792|NCT00667732|byetta|byetta
621793|NCT00667732|glucose|glucose
621794|NCT00667732|blood sugar|blood sugar
621795|NCT00667732|metformin|metformin
621796|NCT00667732|A1c|a1c
621797|NCT00667745|Lithium|lithium
621798|NCT00667745|Symptoms|symptoms
621799|NCT00667745|Medication Changes|medication changes
621800|NCT00667771|Alcohol|alcohol
621801|NCT00667771|Naltrexone|naltrexone
621802|NCT00667771|fMRI|fmri
621803|NCT00667771|Alcoholism|alcoholism
621804|NCT00667771|Alcoholics|alcoholics
621805|NCT00667771|Alcohol Dependence|alcohol dependence
621806|NCT00667784|pediatric stem cell donor|pediatric stem cell donor
621807|NCT00667784|emotional sequelae|emotional sequelae
621808|NCT00667784|physical sequelae|physical sequelae
621809|NCT00667784|psychological consequences of minor donation|psychological consequences of minor donation
621810|NCT00667784|Bone Marrow Transplantation|bone marrow transplantation
621811|NCT00667784|Questionnaire|questionnaire
621812|NCT00667784|Survey|survey
621813|NCT00667784|Sibling Donor|sibling donor
622948|NCT00671593|Allergy|allergy
621814|NCT00667784|Stem Cell Transplant|stem cell transplant
621815|NCT00667784|Well-Being|well-being
621816|NCT00667797|Asthma|asthma
621817|NCT00667797|COPD|copd
621818|NCT00667797|chronic emphysema|chronic emphysema
621819|NCT00667797|chronic bronchitis|chronic bronchitis
621820|NCT00667810|antibody|antibody
621821|NCT00667810|immunotherapy|immunotherapy
621822|NCT00667823|SERAPHIN|seraphin
621823|NCT00667823|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
621824|NCT00667823|ACT-064992|act-064992
621825|NCT00667836|Neurofibromatosis Type 1|neurofibromatosis type 1
621826|NCT00667836|NF1|nf1
621827|NCT00667836|Spinal Anomalies|spinal anomalies
621828|NCT00667849|Tibia|tibia
621829|NCT00667862|Prostate|prostate
621830|NCT00667862|Cancer|cancer
621831|NCT00667862|Adenocarcinoma|adenocarcinoma
621832|NCT00667862|Prostate-Specific Antigen|prostate-specific antigen
621833|NCT00667862|metastatic|metastatic
621834|NCT00667862|male|male
621835|NCT00667862|HRPC|hrpc
621836|NCT00667862|DACi|daci
621837|NCT00667875|Alcohol Dependence|alcohol dependence
621838|NCT00667875|Alcoholism|alcoholism
621839|NCT00667875|Naltrexone|naltrexone
621840|NCT00667875|Aripiprazole|aripiprazole
621841|NCT00667875|Substance Abuse|substance abuse
621842|NCT00667888|Prostate Cancer|prostate cancer
621843|NCT00667888|Radiation|radiation
621844|NCT00667888|Radiotherapy|radiotherapy
621845|NCT00667888|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
621846|NCT00667888|IMRT|imrt
621847|NCT00667888|Hypofractionated Intensity Modulated Radiotherapy|hypofractionated intensity modulated radiotherapy
621848|NCT00667888|HIMRT|himrt
621849|NCT00667901|stage III melanoma|stage iii melanoma
621943|NCT00668252|menopause|menopause
621850|NCT00667901|stage IV melanoma|stage iv melanoma
621851|NCT00667914|Hip-unit|hip-unit
621852|NCT00667914|Geriatric care|geriatric care
621853|NCT00667914|Mobility|mobility
621854|NCT00667914|Site of residence|site of residence
621855|NCT00667927|Autologous bone marrow transplant|autologous bone marrow transplant
621856|NCT00667927|gene marking|gene marking
621857|NCT00667940|Medical education|medical education
621858|NCT00667940|faculty development|faculty development
621859|NCT00667940|rater training|rater training
621860|NCT00667940|clinical competence|clinical competence
621861|NCT00667940|assessment|assessment
621862|NCT00667953|Temzolomide|temzolomide
621863|NCT00667953|Gleevec|gleevec
621864|NCT00667953|Melanoma|melanoma
621865|NCT00667953|Advanced melanoma|advanced melanoma
621866|NCT00667953|Phase II|phase ii
621867|NCT00667966|Spinal cord injury|spinal cord injury
621868|NCT00667966|Urodynamic|urodynamic
621869|NCT00667966|Erectile dysfunction|erectile dysfunction
621870|NCT00667966|Vardenafil|vardenafil
621871|NCT00667979|Erectile Dysfunction|erectile dysfunction
621872|NCT00667979|Vardenafil|vardenafil
621873|NCT00667992|Asthma hyperreactivity|asthma hyperreactivity
621874|NCT00668005|Erectile Dysfunction|erectile dysfunction
621875|NCT00668005|Arterial hypertension|arterial hypertension
621876|NCT00668005|Vardenafil|vardenafil
621877|NCT00668018|Male Erectile Dysfunction|male erectile dysfunction
621878|NCT00668018|Vardenafil|vardenafil
621879|NCT00668031|Transfusion requirements|transfusion requirements
621880|NCT00668031|Hip replacement surgery|hip replacement surgery
621881|NCT00668031|Prevention of blood loss|prevention of blood loss
621882|NCT00668031|Bloodloss|bloodloss
621883|NCT00668044|Ciprofloxacin regimen in compromised patients|ciprofloxacin regimen in compromised patients
621884|NCT00668044|Ciprofloxacin|ciprofloxacin
621885|NCT00668044|Burned patients|burned patients
621886|NCT00668057|Male Erectile Dysfunction|male erectile dysfunction
621888|NCT00668070|Chronic liver disease|chronic liver disease
621889|NCT00668083|second line|second line
621890|NCT00668083|Prostate Cancer|prostate cancer
621891|NCT00668083|bicalutamide|bicalutamide
621892|NCT00668083|biochemical relapse/progression in patients with Prostate Cancer treated with bicalutamide 150mg|biochemical relapse/progression in patients with prostate cancer treated with bicalutamide 150mg
621893|NCT00668096|Erectile Dysfunction|erectile dysfunction
621894|NCT00668096|PDE5 inhibitors|pde5 inhibitors
621895|NCT00668109|Erectile Dysfunction|erectile dysfunction
621896|NCT00668109|Diabetes mellitus|diabetes mellitus
621897|NCT00668109|Hypertension|hypertension
621898|NCT00668109|Hyperlipidemia|hyperlipidemia
621899|NCT00668109|Vardenafil|vardenafil
621900|NCT00668135|Erectile Dysfunction|erectile dysfunction
621901|NCT00668135|Vardenafil|vardenafil
621902|NCT00668148|Sarcoma|sarcoma
621903|NCT00668148|Ewing's sarcoma / peripheral neuroectodermal tumor (PNET);|ewing's sarcoma / peripheral neuroectodermal tumor (pnet);
621904|NCT00668148|rhabdomyosarcoma;|rhabdomyosarcoma;
621905|NCT00668148|leiomyosarcoma;|leiomyosarcoma;
621906|NCT00668148|adipocytic sarcoma|adipocytic sarcoma
621907|NCT00668148|synovial sarcoma|synovial sarcoma
621908|NCT00668187|Tay-Sachs disease|tay-sachs disease
621909|NCT00668187|Sandhoff disease|sandhoff disease
621910|NCT00668187|Late Onset Tay-Sachs disease|late onset tay-sachs disease
621911|NCT00668187|LOTS|lots
621912|NCT00668187|hexosaminidase A deficiency|hexosaminidase a deficiency
752359|NCT01172626|valproate sodium|valproate sodium
621913|NCT00668187|hexosaminidase A and B deficiency|hexosaminidase a and b deficiency
621914|NCT00668187|infantile Tay-Sachs disease|infantile tay-sachs disease
621915|NCT00668187|adult-onset Tay-Sachs disease|adult-onset tay-sachs disease
621916|NCT00668187|prospective|prospective
621917|NCT00668187|natural history|natural history
621918|NCT00668187|GM1 gangliosidosis|gm1 gangliosidosis
621919|NCT00668187|gangliosidoses|gangliosidoses
621920|NCT00668187|β-galactosidase|β-galactosidase
621921|NCT00668187|β-galactosidase deficiency|β-galactosidase deficiency
621922|NCT00668187|hexosaminidase|hexosaminidase
621923|NCT00668187|hexosaminidase deficiency|hexosaminidase deficiency
621924|NCT00668187|Tay-Sachs|tay-sachs
621925|NCT00668187|Sandhoff|sandhoff
621926|NCT00668187|juvenile Tay-Sachs|juvenile tay-sachs
621927|NCT00668187|juvenile Tay-Sachs disease|juvenile tay-sachs disease
623191|NCT00672386|Metformin|metformin
621928|NCT00668187|late onset Tay-Sachs|late onset tay-sachs
621929|NCT00668187|juvenile Sandhoff|juvenile sandhoff
621930|NCT00668187|juvenile Sandhoff disease|juvenile sandhoff disease
621931|NCT00668187|GM2 gangliosidosis|gm2 gangliosidosis
621932|NCT00668200|Paget's|paget's
621933|NCT00668200|hypocalcemia|hypocalcemia
621934|NCT00668200|zoledronic acid|zoledronic acid
621935|NCT00668200|serum calcium|serum calcium
621936|NCT00668213|Macular Degeneration|macular degeneration
621937|NCT00668226|Hygiene|hygiene
621938|NCT00668239|diffuse macular oedema|diffuse macular oedema
624198|NCT00677677|Lung transplant|lung transplant
624202|NCT00677677|HPV|hpv
621939|NCT00668239|type 2 diabetes mellitus|type 2 diabetes mellitus
621940|NCT00668239|laser therapy|laser therapy
621941|NCT00668252|endothelial progenitor cells|endothelial progenitor cells
621942|NCT00668252|estrogen|estrogen
621944|NCT00668252|cardiovascular risk|cardiovascular risk
621945|NCT00668265|Generalized Anxiety Disorder|generalized anxiety disorder
621946|NCT00668265|Opiate Dependence|opiate dependence
621947|NCT00668265|Methadone-Maintenance|methadone-maintenance
621948|NCT00668265|Drug Addiction Treatment|drug addiction treatment
621949|NCT00668278|Supraglottic airway|supraglottic airway
621950|NCT00668278|I-gel|i-gel
621951|NCT00668278|Laryngeal mask|laryngeal mask
621952|NCT00668278|Controlled ventilation|controlled ventilation
621953|NCT00668278|Peak airway pressure|peak airway pressure
621954|NCT00668278|Seal pressure|seal pressure
621955|NCT00668278|Anaesthesia|anaesthesia
621956|NCT00668278|Surgery|surgery
621957|NCT00668291|Endocrinology, CARNEY Complex,|endocrinology, carney complex,
621958|NCT00668291|primary pigmented nodular adrenocortical disease (PPNAD),|primary pigmented nodular adrenocortical disease (ppnad),
621959|NCT00668291|PRKAR1A|prkar1a
621960|NCT00668304|Sinusitis|sinusitis
621961|NCT00668317|Hyper-responsiveness, reflux cough|hyper-responsiveness, reflux cough
621962|NCT00668330|Bone mineral density|bone mineral density
621963|NCT00668330|ibandronate|ibandronate
621964|NCT00668330|alfacalcidol|alfacalcidol
621965|NCT00668343|edss attack|edss attack
621966|NCT00668356|HIV disease in children|hiv disease in children
621968|NCT00668356|children|children
621969|NCT00668356|didanosine|didanosine
621970|NCT00668356|bioequivalence|bioequivalence
621971|NCT00668356|pharmacokinetics|pharmacokinetics
621972|NCT00668356|treatment experienced|treatment experienced
621973|NCT00668369|Liver Transplantation|liver transplantation
621974|NCT00668369|Tolerance|tolerance
621975|NCT00668369|Hepatitis C virus infection|hepatitis c virus infection
621976|NCT00668369|Immune responses|immune responses
621977|NCT00668369|Allograft tolerance|allograft tolerance
621978|NCT00668369|Immunosuppression weaning|immunosuppression weaning
621979|NCT00668369|Immunosuppression minimization|immunosuppression minimization
621980|NCT00668382|Cancerous solid tumors|cancerous solid tumors
621981|NCT00668382|Alpha-Gal Glycosphingolipids|alpha-gal glycosphingolipids
621982|NCT00668395|CYP2B6|cyp2b6
621983|NCT00668395|Efavirenz|efavirenz
621984|NCT00668395|Pharmacokinetics|pharmacokinetics
621985|NCT00668395|Pharmacogenetics|pharmacogenetics
621986|NCT00668395|Drug-Interactions|drug-interactions
621987|NCT00668408|OTLT|otlt
621988|NCT00668408|COPD|copd
621989|NCT00668408|CHRONIC HYPOXEMIA|chronic hypoxemia
621990|NCT00668408|CHF|chf
621991|NCT00668421|Myelofibrosis|myelofibrosis
621992|NCT00668421|Essential Thrombocythemia|essential thrombocythemia
621993|NCT00668421|Polycythemia Vera|polycythemia vera
621994|NCT00668421|JAK2 V617F Mutation|jak2 v617f mutation
621995|NCT00668421|Lestaurtinib|lestaurtinib
621996|NCT00668434|Back Pain|back pain
621997|NCT00668434|Leg Pain|leg pain
621998|NCT00668447|bone density|bone density
621999|NCT00668447|bone loss|bone loss
622000|NCT00668447|postmenopausal|postmenopausal
622001|NCT00668460|hygiene|hygiene
622002|NCT00668473|systemic sclerosis angiogenesis|systemic sclerosis angiogenesis
622003|NCT00668486|Hygiene|hygiene
622004|NCT00668512|metastatic cutaneous melanoma|metastatic cutaneous melanoma
622005|NCT00668512|alpha-gal glycolipids|alpha-gal glycolipids
622006|NCT00668525|Depression|depression
622007|NCT00668525|Major Depressive Disorder|major depressive disorder
622008|NCT00668525|Escitalopram|escitalopram
622009|NCT00668538|Miconazole|miconazole
622010|NCT00668538|CYP1A2|cyp1a2
622011|NCT00668538|CYP3A4|cyp3a4
622012|NCT00668538|Women|women
622013|NCT00668538|Healthy Subjects|healthy subjects
622014|NCT00668551|Parkinson disease|parkinson disease
622015|NCT00668551|Telemedicine|telemedicine
622016|NCT00668564|Inborn errors of metabolism|inborn errors of metabolism
622017|NCT00668564|Sphingolipidoses|sphingolipidoses
622018|NCT00668564|Recessive Leukodystrophies- GLD, Krabbe disease, MLD|recessive leukodystrophies- gld, krabbe disease, mld
622019|NCT00668564|Peroxisomal Disorders|peroxisomal disorders
622020|NCT00668564|Wolman syndrome|wolman syndrome
622021|NCT00668564|Niemann-Pick B patients|niemann-pick b patients
622022|NCT00668564|Niemann-Pick C subtype 2|niemann-pick c subtype 2
622023|NCT00668577|Hygiene|hygiene
622024|NCT00668590|Diabetes|diabetes
622025|NCT00668603|Postmenopausal vasomotor symptoms|postmenopausal vasomotor symptoms
622026|NCT00668603|Hot flush|hot flush
622027|NCT00668603|Vascular function|vascular function
622028|NCT00668603|Cardiac function|cardiac function
622029|NCT00668603|Cardiovascular risk factor|cardiovascular risk factor
622030|NCT00668616|breast cancer with 1-3 afflicted axillary lymph nodes|breast cancer with 1-3 afflicted axillary lymph nodes
622031|NCT00668629|Hygiene|hygiene
622032|NCT00668655|Rosacea, metronidazole|rosacea, metronidazole
622033|NCT00668681|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
622034|NCT00668694|Psychosocial stimulation in addition to iron supplementation will improve mental and psychomotor development, language, behavior and growth of IDA infants.|psychosocial stimulation in addition to iron supplementation will improve mental and psychomotor development, language, behavior and growth of ida infants.
622035|NCT00668694|With the addition of stimulation IDA infants will catch up to the non-anemic infants.|with the addition of stimulation ida infants will catch up to the non-anemic infants.
622036|NCT00668707|melatonin|melatonin
622037|NCT00668707|natural health product (NHP)|natural health product (nhp)
622038|NCT00668707|lung cancer|lung cancer
622039|NCT00668707|complementary and alternative medicine (CAM)|complementary and alternative medicine (cam)
622040|NCT00668707|randomized clinical trial|randomized clinical trial
622041|NCT00668720|tinnitus|tinnitus
622042|NCT00668720|transcranial magnetic stimulation|transcranial magnetic stimulation
622043|NCT00668733|Actinic keratoses|actinic keratoses
622044|NCT00668733|Dermatologic disease|dermatologic disease
622045|NCT00668746|chronic periodontitis, antibiotic resistance|chronic periodontitis, antibiotic resistance
622046|NCT00668759|atrial fibrillation|atrial fibrillation
622047|NCT00668759|atrial fib|atrial fib
622049|NCT00668785|Ranibizumab|ranibizumab
622050|NCT00668785|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
622051|NCT00668785|Macular Edema following Panretinal Photocoagulation|macular edema following panretinal photocoagulation
622052|NCT00668785|Safety and Efficacy|safety and efficacy
622053|NCT00668785|Intravitreal Injection|intravitreal injection
622054|NCT00668798|cytomegalovirus breast milk preterm infants transmission|cytomegalovirus breast milk preterm infants transmission
622055|NCT00668798|transmission of CMV via thawed frozen breast milk|transmission of cmv via thawed frozen breast milk
622056|NCT00668811|thyroid cancer|thyroid cancer
622057|NCT00668811|metastatic thyroid cancer|metastatic thyroid cancer
622058|NCT00668811|differentiated thyroid cancer|differentiated thyroid cancer
622059|NCT00668811|papillary thyroid cancer|papillary thyroid cancer
622060|NCT00668811|follicular thyroid cancer|follicular thyroid cancer
622061|NCT00668811|Histologically confirmed|histologically confirmed
622062|NCT00668811|metastatic stage 2,stage 3, or stage 4 differentiated thyroid cancer|metastatic stage 2,stage 3, or stage 4 differentiated thyroid cancer
622063|NCT00668824|Congenital Heart Disease (CHD)|congenital heart disease (chd)
622064|NCT00668837|Paliperidone|paliperidone
622065|NCT00668837|schizophrenia|schizophrenia
622066|NCT00668876|immunonutrition|immunonutrition
622067|NCT00668876|pancreaticoduodenectomy|pancreaticoduodenectomy
622073|NCT00668902|Pantoprazole|pantoprazole
622074|NCT00668902|Genotype|genotype
622075|NCT00668902|Pharmacokinetics|pharmacokinetics
622076|NCT00668902|Metabolism|metabolism
622077|NCT00668941|Bone Density|bone density
622078|NCT00668941|Bone Turnover|bone turnover
622079|NCT00668941|Histomorphometry|histomorphometry
622080|NCT00668954|Diabetes|diabetes
622081|NCT00668954|Pomegranate|pomegranate
622082|NCT00668954|Biomarkers|biomarkers
622083|NCT00668954|Antioxidant|antioxidant
622084|NCT00668967|Cardiovascular Diseases|cardiovascular diseases
622085|NCT00668967|Hypertension|hypertension
622086|NCT00668980|Down syndrome|down syndrome
622087|NCT00668980|symbolic representation|symbolic representation
622088|NCT00668980|gestures|gestures
622089|NCT00668980|expressive language development|expressive language development
622090|NCT00669006|neuropathic pain|neuropathic pain
622091|NCT00669006|database|database
622092|NCT00669006|prospective|prospective
622093|NCT00669006|national|national
622094|NCT00669045|TNKase|tnkase
622096|NCT00669058|hygiene|hygiene
622097|NCT00669084|Innate Immunity|innate immunity
622098|NCT00669084|Malaria|malaria
622099|NCT00669084|Plasmodium|plasmodium
622100|NCT00669084|Hemoglobinopathy|hemoglobinopathy
622101|NCT00669084|G6PD Deficiency|g6pd deficiency
622102|NCT00669097|ADME|adme
622103|NCT00669097|TKI258|tki258
622104|NCT00669097|RTKs inhibitor|rtks inhibitor
622105|NCT00669097|PDGRF inhibitor|pdgrf inhibitor
622106|NCT00669097|VEGFER inhibitor|vegfer inhibitor
622107|NCT00669110|MDD|mdd
622108|NCT00669110|Depression|depression
622109|NCT00669110|Pediatrics|pediatrics
622110|NCT00669110|Major Depressive Disorder|major depressive disorder
622111|NCT00669123|Chondroitin sulphate|chondroitin sulphate
622112|NCT00669123|Knee osteoarthritis|knee osteoarthritis
622113|NCT00669123|Psoriasis|psoriasis
622114|NCT00669136|AFP + GM-CSF Plasmid Prime and AFP Adenoviral Vector Boost|afp + gm-csf plasmid prime and afp adenoviral vector boost
622115|NCT00669136|AFP Immunization|afp immunization
622116|NCT00669149|ptca|ptca
623192|NCT00672399|Amylin|amylin
622117|NCT00669149|antiaggregant therapy|antiaggregant therapy
622118|NCT00669149|anticoagulant therapy|anticoagulant therapy
622119|NCT00669175|Naloxone|naloxone
622120|NCT00669175|Neonate|neonate
622121|NCT00669175|Pain|pain
622122|NCT00669188|Patient Provider Interaction|patient provider interaction
622123|NCT00669188|Physician Training|physician training
622124|NCT00669188|Patient Provider Training|patient provider training
622125|NCT00669201|cartilage|cartilage
622126|NCT00669201|osteoarthritis|osteoarthritis
622127|NCT00669201|T2 mapping|t2 mapping
622128|NCT00669201|MRI|mri
622129|NCT00669201|Wrist|wrist
622130|NCT00669214|Raptiva|raptiva
622131|NCT00669214|Moderate plaque psoriasis|moderate plaque psoriasis
622132|NCT00669214|Severe plaque psoriasis|severe plaque psoriasis
622133|NCT00669214|Scalp|scalp
622134|NCT00669292|esophageal cancer|esophageal cancer
622135|NCT00669292|peptide|peptide
622136|NCT00669292|URLC10|urlc10
622138|NCT00669292|CpG7909|cpg7909
622139|NCT00669305|Genetics|genetics
622140|NCT00669305|Blood cells|blood cells
622141|NCT00669305|Vector-mediated gene transfer|vector-mediated gene transfer
622142|NCT00669305|Bone marrow|bone marrow
622143|NCT00669305|CD34 cells|cd34 cells
622144|NCT00669318|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
622145|NCT00669318|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
622146|NCT00669318|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
622147|NCT00669331|randomized clinical trial|randomized clinical trial
622148|NCT00669331|mannitol|mannitol
622149|NCT00669331|mucoactive|mucoactive
622150|NCT00669344|cognition|cognition
622151|NCT00669344|stroke|stroke
622152|NCT00669344|VCI|vci
622153|NCT00669344|VCIND|vcind
622154|NCT00669344|Cognitive Impairment, No Dementia|cognitive impairment, no dementia
622155|NCT00669357|End stage heart disease|end stage heart disease
622156|NCT00669370|advanced gastric cancer|advanced gastric cancer
622157|NCT00669370|adenocarcinoma|adenocarcinoma
622158|NCT00669383|premature delivery|premature delivery
622159|NCT00669383|respiratory distress syndrome|respiratory distress syndrome
622160|NCT00669396|contraception|contraception
622161|NCT00669396|emergency contraception|emergency contraception
622162|NCT00669396|pregnancy prevention after unprotected intercourse|pregnancy prevention after unprotected intercourse
622163|NCT00669409|monoclonal antibody|monoclonal antibody
622164|NCT00669422|Ovarian Cancer|ovarian cancer
622165|NCT00669422|Fallopian Tube Cancer|fallopian tube cancer
622166|NCT00669422|Peritoneal Cancer|peritoneal cancer
622167|NCT00669422|Uterine Neoplasms|uterine neoplasms
622168|NCT00669422|Vulvar Cancer|vulvar cancer
622169|NCT00669422|Endometrial Cancer|endometrial cancer
622170|NCT00669422|Cervical Cancer|cervical cancer
622171|NCT00669422|Assay|assay
622172|NCT00669422|Chemotherapy|chemotherapy
622173|NCT00669422|Recurrent|recurrent
622174|NCT00669422|Refractory|refractory
622175|NCT00669422|Persistent|persistent
622176|NCT00669422|Chemoresponse|chemoresponse
622177|NCT00669422|Sensitivity|sensitivity
622178|NCT00669422|Precision Therapeutics|precision therapeutics
622180|NCT00669435|Essential hypertension|essential hypertension
622181|NCT00669435|Liver steatosis|liver steatosis
622182|NCT00669448|Multiple chemical sensitivities|multiple chemical sensitivities
622183|NCT00669448|MCS|mcs
622184|NCT00669448|Mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
622185|NCT00669448|MBCT|mbct
622186|NCT00669448|Behavioural intervention|behavioural intervention
622187|NCT00669448|Stress|stress
622188|NCT00669448|Illness perceptions|illness perceptions
622189|NCT00669448|Pilot trial|pilot trial
622190|NCT00669461|Constipation|constipation
622191|NCT00669461|Parkinson's Disease|parkinson's disease
622192|NCT00669487|HIV/AIDS patients|hiv/aids patients
622193|NCT00669500|dietary intake|dietary intake
622194|NCT00669500|genetic predisposition|genetic predisposition
622195|NCT00669500|body composition|body composition
622196|NCT00669513|partial sleep deprivation|partial sleep deprivation
622197|NCT00669513|endothelial dysfunction|endothelial dysfunction
622198|NCT00669513|sympathetic activity|sympathetic activity
622199|NCT00669513|inflammation|inflammation
622200|NCT00669526|anxiety|anxiety
622201|NCT00669526|depression|depression
622202|NCT00669526|Major Depressive Disorder|major depressive disorder
622203|NCT00669526|child|child
622204|NCT00669526|adolescent|adolescent
622205|NCT00669526|CBT|cbt
622206|NCT00669526|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
622207|NCT00669526|primary care|primary care
622208|NCT00669539|Amblyopia associated with strabismus|amblyopia associated with strabismus
622209|NCT00669539|Refractive error|refractive error
622210|NCT00669565|Locally Advanced or Metastatic Breast Cancer|locally advanced or metastatic breast cancer
622211|NCT00669578|secondary myelofibrosis|secondary myelofibrosis
622212|NCT00669578|polycythemia vera|polycythemia vera
622213|NCT00669578|essential thrombocythemia|essential thrombocythemia
622214|NCT00669578|primary myelofibrosis|primary myelofibrosis
622215|NCT00669591|breast cancer|breast cancer
622216|NCT00669591|docetaxel chemotherapy|docetaxel chemotherapy
622218|NCT00669591|monoclonal antibody|monoclonal antibody
622219|NCT00669604|Mother to child transmission of HIV|mother to child transmission of hiv
622220|NCT00669604|HIV infected children|hiv infected children
622221|NCT00669617|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
622222|NCT00669617|COPD|copd
622223|NCT00669617|indacaterol|indacaterol
622224|NCT00669617|adults|adults
622225|NCT00669630|Community-based Participatory Research (CBPR)|community-based participatory research (cbpr)
622226|NCT00669630|Vulnerable population|vulnerable population
622227|NCT00669630|High-risk population|high-risk population
622228|NCT00669630|African-Americans|african-americans
622229|NCT00669630|Health Disparities|health disparities
622230|NCT00669630|Clinical Trial|clinical trial
622232|NCT00669643|Communicable Diseases|communicable diseases
622233|NCT00669643|Skin Diseases|skin diseases
622234|NCT00669643|Multidrug Therapy|multidrug therapy
622235|NCT00669643|MDT|mdt
622236|NCT00669643|Uniform Multidrug Therapy|uniform multidrug therapy
622237|NCT00669643|U-MDT|u-mdt
622238|NCT00669695|statins|statins
622239|NCT00669695|cardiovascular risk|cardiovascular risk
622240|NCT00669695|Obstructive sleep apnea syndrome (OSAS) patients|obstructive sleep apnea syndrome (osas) patients
622241|NCT00669708|dry skin|dry skin
622242|NCT00669708|cooling|cooling
622243|NCT00669708|itch|itch
622244|NCT00669721|osteoprotegerin|osteoprotegerin
622245|NCT00669721|RANKL|rankl
622246|NCT00669721|heparin|heparin
622247|NCT00669721|hemodialysis|hemodialysis
622248|NCT00669721|anticoagulation|anticoagulation
622249|NCT00669721|vascular calcification|vascular calcification
622250|NCT00669747|Ductal Carcinoma In Situ|ductal carcinoma in situ
622251|NCT00669747|DCIS|dcis
622252|NCT00669747|Breast Cancer|breast cancer
622253|NCT00669747|Carboplatin|carboplatin
622254|NCT00669747|Intraductal|intraductal
622255|NCT00669760|cystic fibrosis|cystic fibrosis
622256|NCT00669760|Staphylococcus aureus|staphylococcus aureus
622257|NCT00669760|persistent colonization-infection|persistent colonization-infection
622258|NCT00669760|clinical status|clinical status
622259|NCT00669760|lung function|lung function
622260|NCT00669786|Ongoing Pregnancy Rate|ongoing pregnancy rate
622261|NCT00669812|small intestine lymphoma|small intestine lymphoma
622262|NCT00669812|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
622263|NCT00669812|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
622264|NCT00669812|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
622265|NCT00669812|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
622266|NCT00669825|Celiac Disease|celiac disease
622267|NCT00669838|Anesthesia, Local|anesthesia, local
622268|NCT00669838|Lidocaine|lidocaine
622269|NCT00669838|Dental care|dental care
622270|NCT00669838|Arrhythmias, Cardiac|arrhythmias, cardiac
622271|NCT00669838|Anxiety|anxiety
622272|NCT00669851|coronary artery disease|coronary artery disease
622273|NCT00669851|echocardiography|echocardiography
622274|NCT00669851|cardiac imaging|cardiac imaging
622275|NCT00669851|heart disease|heart disease
622276|NCT00669851|ultrasound contrast agent|ultrasound contrast agent
622277|NCT00669851|myocardial contrast enhancement|myocardial contrast enhancement
622278|NCT00669851|myocardial perfusion|myocardial perfusion
622279|NCT00669877|Burkitt's Lymphoma|burkitt's lymphoma
622280|NCT00669877|Burkitt's Like Lymphoma|burkitt's like lymphoma
622281|NCT00669877|Leukemia|leukemia
622282|NCT00669877|Hyper-CVAD|hyper-cvad
622283|NCT00669877|Rituximab|rituximab
622284|NCT00669877|Methotrexate|methotrexate
622285|NCT00669877|Cytarabine|cytarabine
622287|NCT00669890|JMML|jmml
622288|NCT00669890|MDS|mds
622289|NCT00669890|Allogenic Atem Cell Transplant|allogenic atem cell transplant
622290|NCT00669890|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
622291|NCT00669916|Plaque psoriasis|plaque psoriasis
622292|NCT00669929|Cost effectiveness analysis of rotavirus vaccination|cost effectiveness analysis of rotavirus vaccination
622293|NCT00669942|Rheumatoid Arthritis|rheumatoid arthritis
622294|NCT00669955|H. Pylori|h. pylori
622295|NCT00669955|Quadruple therapy|quadruple therapy
622296|NCT00669955|Eradication rate|eradication rate
622297|NCT00669955|Multinational trial|multinational trial
622298|NCT00669955|Resistance to antibiotics|resistance to antibiotics
622299|NCT00669955|Subjects with confirmed Helicobacter Pylori infection|subjects with confirmed helicobacter pylori infection
622300|NCT00669968|PET myocardial perfusion imaging|pet myocardial perfusion imaging
622301|NCT00669968|Cardiac PET|cardiac pet
622302|NCT00669968|Rubidium|rubidium
622303|NCT00669968|Coronary Artery CT Angiogram|coronary artery ct angiogram
622304|NCT00669968|Coronary Flow Reserve|coronary flow reserve
622305|NCT00669968|Adenosine stress test|adenosine stress test
622306|NCT00669981|PTSD|ptsd
622307|NCT00669981|Relationship Distress|relationship distress
622308|NCT00669981|Couple Therapy|couple therapy
622309|NCT00663611|Immune Function|immune function
622310|NCT00663611|Metabolism|metabolism
622311|NCT00663611|Pulsatile Growth Hormone|pulsatile growth hormone
622312|NCT00663637|endotracheal tube obstruction, occlusion|endotracheal tube obstruction, occlusion
623193|NCT00672399|Eli Lilly|eli lilly
622313|NCT00663637|mechanical ventilation, complication|mechanical ventilation, complication
622314|NCT00663637|work of breathing|work of breathing
622315|NCT00663637|airway resistance|airway resistance
622316|NCT00663637|secretions|secretions
622317|NCT00663637|pneumonia, ventilator associated|pneumonia, ventilator associated
622318|NCT00663637|biofilms|biofilms
622319|NCT00663637|endotracheal tube|endotracheal tube
622320|NCT00663650|Basal Cell Carcinoma|basal cell carcinoma
622321|NCT00663650|BCC|bcc
622322|NCT00663650|Periocular BCC|periocular bcc
622323|NCT00663650|Frozen Section Control|frozen section control
622324|NCT00663650|Permanent Section Control|permanent section control
622325|NCT00663650|Recurrence Rates|recurrence rates
622326|NCT00663689|erlotinib|erlotinib
622327|NCT00663715|Sciatic Nerve|sciatic nerve
622328|NCT00663715|Peripheral Nerve Block|peripheral nerve block
622329|NCT00663715|Lower extremity surgery|lower extremity surgery
622330|NCT00663715|Local Anesthesia|local anesthesia
622331|NCT00663715|Ultrasound guided nerve blocks|ultrasound guided nerve blocks
622332|NCT00663728|Erectile Dysfunction|erectile dysfunction
622333|NCT00663728|Vardenafil|vardenafil
622334|NCT00663741|Unresectable / recurrent gastric cancer|unresectable / recurrent gastric cancer
622335|NCT00663741|Sorafenib|sorafenib
622336|NCT00663741|S-1|s-1
622337|NCT00663741|Gastric|gastric
622338|NCT00663741|Cisplatin|cisplatin
622339|NCT00663741|CDDP|cddp
622340|NCT00663754|Body Image|body image
622341|NCT00663780|pharmacogenomics|pharmacogenomics
622342|NCT00663780|polymorphisms|polymorphisms
622343|NCT00663780|wound healing|wound healing
622344|NCT00663793|Male Contraception|male contraception
622345|NCT00663793|Hypogonadism|hypogonadism
622346|NCT00663793|Testosterone|testosterone
622347|NCT00663806|UTI|uti
622348|NCT00663819|Low anterior colon resection|low anterior colon resection
622349|NCT00663819|Proctectomy|proctectomy
622350|NCT00663819|Proctocolectomy|proctocolectomy
622351|NCT00663819|Anastomosis|anastomosis
622352|NCT00663819|Rectal Cancer|rectal cancer
622353|NCT00663819|Ileostomy|ileostomy
622354|NCT00663832|Male|male
622355|NCT00663832|Prostate|prostate
622356|NCT00663832|Cancer|cancer
622357|NCT00663832|HRPC|hrpc
622358|NCT00663832|DACi|daci
622359|NCT00663845|Male Erectile Dysfunction|male erectile dysfunction
622360|NCT00663845|Dyslipidemia|dyslipidemia
622361|NCT00663845|Vardenafil|vardenafil
622362|NCT00663871|Fish Oil|fish oil
622363|NCT00663871|Omega-3 fatty acids|omega-3 fatty acids
622364|NCT00663871|Affect|affect
622365|NCT00663871|Depression|depression
622366|NCT00663871|Anger|anger
622367|NCT00663871|Nutrition|nutrition
622368|NCT00663871|Impulsivity|impulsivity
622369|NCT00663871|Aggression|aggression
622370|NCT00663871|Cognition|cognition
622371|NCT00663871|Behavior|behavior
622372|NCT00663884|diabetes mellitus, Type 2|diabetes mellitus, type 2
622374|NCT00663897|functional dyspepsia|functional dyspepsia
622375|NCT00663897|epigastric pain syndrome|epigastric pain syndrome
622376|NCT00663897|postprandial distress syndrome|postprandial distress syndrome
622377|NCT00663897|proton pump inhibitor|proton pump inhibitor
622378|NCT00663897|5 HT-4 receptor agonist|5 ht-4 receptor agonist
622379|NCT00663910|basal cell carcinoma of the skin|basal cell carcinoma of the skin
622380|NCT00663910|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
622381|NCT00663910|recurrent skin cancer|recurrent skin cancer
622382|NCT00663923|Excimer Laser|excimer laser
622383|NCT00663923|photorefractive keratectomy|photorefractive keratectomy
622384|NCT00663923|astigmatism|astigmatism
622385|NCT00663936|Alzheimer's Disease|alzheimer's disease
622386|NCT00663936|Alzheimer's|alzheimer's
622387|NCT00663949|diabetes|diabetes
622388|NCT00663949|proteinuria|proteinuria
622389|NCT00663949|pentoxifylline|pentoxifylline
622390|NCT00663962|Thoracotomy|thoracotomy
622391|NCT00663962|Post-surgical|post-surgical
622392|NCT00663962|Pregabalin|pregabalin
622393|NCT00663975|cystic fibrosis|cystic fibrosis
622394|NCT00663975|pancreatic insufficiency|pancreatic insufficiency
622395|NCT00663975|pancreatic enzymes|pancreatic enzymes
622396|NCT00663975|pediatrics|pediatrics
622397|NCT00663988|face transplantation|face transplantation
622398|NCT00664014|hyponatremia|hyponatremia
622399|NCT00664014|Non-acute and non hypovolemic hyponatremia|non-acute and non hypovolemic hyponatremia
622400|NCT00664053|bone mineral density|bone mineral density
622401|NCT00664053|bone turnover markers|bone turnover markers
622402|NCT00664053|strength|strength
622404|NCT00664079|Thyroid Deficiency|thyroid deficiency
622405|NCT00664079|Thyroid Stimulating Hormone|thyroid stimulating hormone
622406|NCT00664092|Substance Abuse|substance abuse
622407|NCT00664092|Ex-Offenders|ex-offenders
622408|NCT00664092|Substance Abuse Recovery|substance abuse recovery
622409|NCT00664105|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
622410|NCT00664105|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
622411|NCT00664118|Doula|doula
622412|NCT00664118|Patient-controlled epidural analgesia|patient-controlled epidural analgesia
622413|NCT00664118|Neuraxial analgesia|neuraxial analgesia
622414|NCT00664118|Labor analgesia|labor analgesia
622415|NCT00664131|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
622416|NCT00664131|ALL survivors|all survivors
622417|NCT00664131|ALL neurologic symptoms|all neurologic symptoms
622418|NCT00664131|ALL neurologic disability|all neurologic disability
622419|NCT00664131|ALL late effects|all late effects
622420|NCT00664157|Idiopathic Parkinson's disease|idiopathic parkinson's disease
622422|NCT00664157|Deep Brain stimulation|deep brain stimulation
622423|NCT00664157|Facial expression recognition of emotion|facial expression recognition of emotion
622424|NCT00664157|Frequency levels|frequency levels
622425|NCT00664157|Automatic and voluntary information treatment|automatic and voluntary information treatment
622426|NCT00664157|Patient with an Idiopathic Parkinson's disease|patient with an idiopathic parkinson's disease
622427|NCT00664183|diabetic retinopathy|diabetic retinopathy
622429|NCT00664196|T cells|t cells
622430|NCT00664196|Gene Transfer|gene transfer
622431|NCT00664209|Parkinson's disease|parkinson's disease
622432|NCT00664209|levodopa|levodopa
622433|NCT00664209|Helicobacter pylori|helicobacter pylori
622434|NCT00664222|heart failure|heart failure
622435|NCT00664222|insulin resistance|insulin resistance
622436|NCT00664222|inflammatory cytokine|inflammatory cytokine
622437|NCT00664222|spironolactone|spironolactone
622438|NCT00664222|furosemide|furosemide
622439|NCT00664235|Pressure Ulcers|pressure ulcers
622440|NCT00664235|Tissue Injury|tissue injury
622441|NCT00664261|tobacco use disorder|tobacco use disorder
622442|NCT00664300|Gilles de la Tourette's syndrome|gilles de la tourette's syndrome
622443|NCT00664300|Facial expression recognition of emotion|facial expression recognition of emotion
622444|NCT00664300|Frequency levels|frequency levels
622445|NCT00664300|Automatic and voluntary information treatment|automatic and voluntary information treatment
622446|NCT00664300|Patient with Gilles de la Tourette's syndrome|patient with gilles de la tourette's syndrome
622447|NCT00664313|Linezolid|linezolid
622448|NCT00664313|Zyvox|zyvox
622449|NCT00664313|Peripheral Neuropathy|peripheral neuropathy
622450|NCT00664313|Optic Neuropathy|optic neuropathy
622451|NCT00664313|Anemia|anemia
622452|NCT00664313|Thrombocytopenia|thrombocytopenia
622453|NCT00664326|Renal Cell Carcinoma|renal cell carcinoma
622454|NCT00664339|Heart failure,|heart failure,
622455|NCT00664339|infection,|infection,
622456|NCT00664339|immune system,|immune system,
622457|NCT00664339|atherosclerosis|atherosclerosis
622458|NCT00664352|Double blind|double blind
622459|NCT00664352|Placebo controlled|placebo controlled
622460|NCT00664352|wound healing|wound healing
622461|NCT00664365|Premature ejaculation.|premature ejaculation.
622462|NCT00664365|FTIH,|ftih,
622463|NCT00664365|GSK958108,|gsk958108,
622464|NCT00664365|5HT1a antagonist,|5ht1a antagonist,
622465|NCT00664378|Multiple myeloma, relapsed, refractory|multiple myeloma, relapsed, refractory
622466|NCT00664404|Smoking|smoking
622467|NCT00664404|Smoking Cessation|smoking cessation
622468|NCT00664404|Nicotine Withdrawal|nicotine withdrawal
622469|NCT00664404|Nicotine Dependence|nicotine dependence
622470|NCT00664404|Neuroregulatory Effects|neuroregulatory effects
622471|NCT00664404|Magnetic Resonance Imaging|magnetic resonance imaging
622472|NCT00664404|MRI|mri
622473|NCT00664417|Influenza|influenza
622474|NCT00664417|A/H5N1|a/h5n1
622475|NCT00664417|Orthomyxoviridae Infections|orthomyxoviridae infections
622476|NCT00664417|Influenza Pandemics|influenza pandemics
622477|NCT00664430|Dialysis|dialysis
622478|NCT00664430|Calcitriol Resistant|calcitriol resistant
622479|NCT00664430|Secondary Hyperparathyroidism|secondary hyperparathyroidism
622480|NCT00664443|cardiac arrest|cardiac arrest
622481|NCT00664443|CPR|cpr
622482|NCT00664443|resuscitation|resuscitation
622483|NCT00664443|bystander CPR|bystander cpr
622484|NCT00664443|dispatch-assisted CPR|dispatch-assisted cpr
622485|NCT00664456|stage IIB prostate cancer|stage iib prostate cancer
622486|NCT00664456|stage IIA prostate cancer|stage iia prostate cancer
622487|NCT00664456|stage I prostate cancer|stage i prostate cancer
622488|NCT00664495|Obesity, exercise, diet, insulin resistance|obesity, exercise, diet, insulin resistance
622489|NCT00664508|Arthroplasty|arthroplasty
622490|NCT00664508|Hip Replacement|hip replacement
622491|NCT00664508|motion analysis|motion analysis
622492|NCT00664547|obesity, exercise, diet, insulin resistance|obesity, exercise, diet, insulin resistance
622493|NCT00664573|Safety|safety
622494|NCT00664573|Rheumatoid Arthritis|rheumatoid arthritis
622495|NCT00664573|Baminercept alfa|baminercept alfa
622496|NCT00664573|Methotrexate|methotrexate
622497|NCT00664573|BG9924|bg9924
622498|NCT00664573|Efficacy|efficacy
622499|NCT00664586|Terameprocol (EM-1421)|terameprocol (em-1421)
622500|NCT00664586|Phase 1|phase 1
622501|NCT00664586|Infusion|infusion
622502|NCT00664586|Refractory Solid Tumors|refractory solid tumors
622503|NCT00664586|Lymphoma|lymphoma
622504|NCT00664586|Maximum Tolerated Dose|maximum tolerated dose
622505|NCT00664586|Tumor Response|tumor response
622506|NCT00664586|Tumor Markers|tumor markers
622507|NCT00664586|Pharmacokinetics|pharmacokinetics
622508|NCT00664599|Ocular lesions, Visual Acuity, Retinal Vasculitis|ocular lesions, visual acuity, retinal vasculitis
622509|NCT00664612|Cervical Spine|cervical spine
622510|NCT00664651|joint contracture|joint contracture
622511|NCT00664651|total knee arthroplasty|total knee arthroplasty
622512|NCT00664664|insomnia|insomnia
622513|NCT00664664|sleep maintenance insomnia|sleep maintenance insomnia
622514|NCT00664664|sleep quality|sleep quality
622515|NCT00664664|non-restorative sleep|non-restorative sleep
622516|NCT00664664|multiple awakenings|multiple awakenings
622517|NCT00669994|UTI|uti
622518|NCT00669994|Urinary Tract Infection|urinary tract infection
622519|NCT00670007|Alpha1-proteinase inhibitor deficiency|alpha1-proteinase inhibitor deficiency
622520|NCT00670007|Chronic augmentation and maintenance therapy|chronic augmentation and maintenance therapy
622521|NCT00670007|Emphysema|emphysema
622522|NCT00670007|Emphysema due to Alpha 1-proteinase inhibitor deficiency|emphysema due to alpha 1-proteinase inhibitor deficiency
622523|NCT00670020|Women undergoing Cesarean section after the onset of labor|women undergoing cesarean section after the onset of labor
622524|NCT00670033|IOP|iop
622525|NCT00670033|Open-angle glaucoma|open-angle glaucoma
622526|NCT00670033|Ocular Hypertension|ocular hypertension
622527|NCT00670046|recurrent prostate cancer|recurrent prostate cancer
622528|NCT00670046|stage I prostate cancer|stage i prostate cancer
622529|NCT00670046|stage IIB prostate cancer|stage iib prostate cancer
622530|NCT00670046|stage IIA prostate cancer|stage iia prostate cancer
622531|NCT00670046|stage III prostate cancer|stage iii prostate cancer
622532|NCT00670046|stage IV prostate cancer|stage iv prostate cancer
622533|NCT00670059|Single embryo transfer/ aneuploidy screening|single embryo transfer/ aneuploidy screening
622534|NCT00670111|Heart failure|heart failure
622535|NCT00670111|exercise capacity|exercise capacity
622536|NCT00670111|ejection fraction|ejection fraction
622537|NCT00670111|Heart failure normal ejection fraction|heart failure normal ejection fraction
622538|NCT00670163|Men Who Have Sex With Men|men who have sex with men
622539|NCT00670202|Patients scheduled for elective carotid endarterectomy|patients scheduled for elective carotid endarterectomy
622540|NCT00670215|Prevention of infectious complications|prevention of infectious complications
622541|NCT00670215|transrectal needle biopsies of the prostate|transrectal needle biopsies of the prostate
622542|NCT00670215|TRNBP|trnbp
622543|NCT00670254|Sepsis|sepsis
622544|NCT00670254|Septic|septic
622545|NCT00670254|Shock|shock
622546|NCT00670254|Glucocorticoids|glucocorticoids
622547|NCT00670254|Hydrocortisone|hydrocortisone
622548|NCT00670267|Asthma|asthma
622549|NCT00670267|hyperresponsiveness|hyperresponsiveness
622550|NCT00670280|Neonatal Intensive Care Units|neonatal intensive care units
622551|NCT00670280|Infant Morbidity|infant morbidity
622552|NCT00670280|Low Birth Weight|low birth weight
622553|NCT00670280|Low Income Populations|low income populations
622554|NCT00670280|MCH Research|mch research
622555|NCT00670280|Respiratory Illnesses|respiratory illnesses
622556|NCT00670280|Substance Exposed Infants|substance exposed infants
622557|NCT00670280|Counseling|counseling
622558|NCT00670293|Anorexia Nervosa|anorexia nervosa
622563|NCT00670332|coronary artery disease|coronary artery disease
622564|NCT00670332|echocardiography|echocardiography
622565|NCT00670332|cardiac imaging|cardiac imaging
622566|NCT00670332|heart disease|heart disease
622567|NCT00670332|ultrasound contrast agent|ultrasound contrast agent
622568|NCT00670332|prognosis|prognosis
622569|NCT00670345|tranexamic acid|tranexamic acid
622570|NCT00670345|prostatectomy|prostatectomy
622571|NCT00670345|surgery|surgery
622572|NCT00670839|Hepatitis B vaccination|hepatitis b vaccination
622573|NCT00670839|GenHevac-B Pasteur|genhevac-b pasteur
622574|NCT00670839|HIV infection|hiv infection
622575|NCT00670852|Glenoid component|glenoid component
622576|NCT00670852|radiolucent lines|radiolucent lines
622577|NCT00670852|Glenoid loosening|glenoid loosening
622578|NCT00670852|glenohumeral arthritis|glenohumeral arthritis
622579|NCT00670852|autologous bone graft|autologous bone graft
622580|NCT00670865|Hospitalization|hospitalization
622581|NCT00670865|Continuity of care|continuity of care
622582|NCT00670865|Discharge summary|discharge summary
622583|NCT00670865|Quality improvement|quality improvement
622584|NCT00670865|Medical records systems|medical records systems
622585|NCT00670865|Hospital information systems|hospital information systems
622586|NCT00670904|Smoking cessation|smoking cessation
622587|NCT00670904|Pharmacist-delivered|pharmacist-delivered
622588|NCT00670917|pain|pain
622589|NCT00670917|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
622590|NCT00670917|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
622591|NCT00670917|acute undifferentiated leukemia|acute undifferentiated leukemia
622592|NCT00670917|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
622593|NCT00670917|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
622594|NCT00670917|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
622718|NCT00670917|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
622595|NCT00670917|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
622596|NCT00670917|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
622597|NCT00670917|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
622598|NCT00670917|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
622599|NCT00670917|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
622600|NCT00670917|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
622601|NCT00670917|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
622602|NCT00670917|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
622603|NCT00670917|mast cell leukemia|mast cell leukemia
622604|NCT00670917|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
622605|NCT00670917|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
622606|NCT00670917|prolymphocytic leukemia|prolymphocytic leukemia
622607|NCT00670917|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
622608|NCT00670917|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
622609|NCT00670917|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
622610|NCT00670917|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
622611|NCT00670917|refractory hairy cell leukemia|refractory hairy cell leukemia
622612|NCT00670917|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
623120|NCT00672178|RCC|rcc
622613|NCT00670917|secondary acute myeloid leukemia|secondary acute myeloid leukemia
622614|NCT00670917|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
622615|NCT00670917|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
622616|NCT00670917|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
622617|NCT00670917|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
622618|NCT00670917|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
622619|NCT00670917|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
622620|NCT00670917|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
622621|NCT00670917|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
622622|NCT00670917|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
622623|NCT00670917|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
622624|NCT00670917|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
622625|NCT00670917|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
622626|NCT00670917|untreated hairy cell leukemia|untreated hairy cell leukemia
622627|NCT00670917|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
622628|NCT00670917|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
622629|NCT00670917|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
622630|NCT00670917|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
622631|NCT00670917|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
622632|NCT00670917|anaplastic large cell lymphoma|anaplastic large cell lymphoma
622633|NCT00670917|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
622634|NCT00670917|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
623057|NCT00671918|melanoma|melanoma
622635|NCT00670917|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
622636|NCT00670917|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
622637|NCT00670917|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
622638|NCT00670917|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
622639|NCT00670917|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
622640|NCT00670917|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
622641|NCT00670917|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
622642|NCT00670917|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
622643|NCT00670917|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
622644|NCT00670917|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
622645|NCT00670917|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
622646|NCT00670917|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
622647|NCT00670917|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
622648|NCT00670917|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
622649|NCT00670917|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
623912|NCT00676559|DME|dme
622650|NCT00670917|splenic marginal zone lymphoma|splenic marginal zone lymphoma
622651|NCT00670917|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
622652|NCT00670917|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
622653|NCT00670917|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
622654|NCT00670917|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
622655|NCT00670917|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
622656|NCT00670917|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
622987|NCT00671658|Asparaginase|asparaginase
622657|NCT00670917|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
622658|NCT00670917|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
622659|NCT00670917|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
622660|NCT00670917|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
622661|NCT00670917|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
622662|NCT00670917|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
752247|NCT01172132|Septic shock|septic shock
622663|NCT00670917|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
622664|NCT00670917|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
622665|NCT00670917|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
622666|NCT00670917|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
622667|NCT00670917|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
622668|NCT00670917|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
622669|NCT00670917|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
622670|NCT00670917|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
622671|NCT00670917|stage I mantle cell lymphoma|stage i mantle cell lymphoma
622672|NCT00670917|stage I marginal zone lymphoma|stage i marginal zone lymphoma
622673|NCT00670917|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
622674|NCT00670917|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
622675|NCT00670917|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
622676|NCT00670917|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
622677|NCT00670917|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
622678|NCT00670917|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
622679|NCT00670917|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
622680|NCT00670917|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
622681|NCT00670917|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
622682|NCT00670917|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
622683|NCT00670917|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
622684|NCT00670917|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
622685|NCT00670917|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
622686|NCT00670917|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
622687|NCT00670917|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
622688|NCT00670917|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
622689|NCT00670917|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
622690|NCT00670917|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
622691|NCT00670917|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
622692|NCT00670917|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
623058|NCT00671918|surgery|surgery
622693|NCT00670917|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
622694|NCT00670917|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
622695|NCT00670917|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
622696|NCT00670917|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
622697|NCT00670917|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
622698|NCT00670917|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
622699|NCT00670917|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
622700|NCT00670917|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
622701|NCT00670917|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
622702|NCT00670917|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
622703|NCT00670917|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
622704|NCT00670917|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
622705|NCT00670917|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
622706|NCT00670917|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
622707|NCT00670917|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
622708|NCT00670917|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
622709|NCT00670917|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
622710|NCT00670917|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
622711|NCT00670917|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
622712|NCT00670917|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
622713|NCT00670917|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
622714|NCT00670917|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
622715|NCT00670917|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
622716|NCT00670917|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
622717|NCT00670917|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
623089|NCT00671970|Erlotinib|erlotinib
622719|NCT00670917|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
622720|NCT00670917|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
622721|NCT00670917|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
622722|NCT00670917|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
622723|NCT00670917|intraocular lymphoma|intraocular lymphoma
622724|NCT00670917|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
622725|NCT00670917|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
622726|NCT00670917|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
622727|NCT00670917|chronic eosinophilic leukemia|chronic eosinophilic leukemia
622728|NCT00670917|chronic neutrophilic leukemia|chronic neutrophilic leukemia
622729|NCT00670917|primary myelofibrosis|primary myelofibrosis
622730|NCT00670917|essential thrombocythemia|essential thrombocythemia
622731|NCT00670917|polycythemia vera|polycythemia vera
622732|NCT00670917|extramedullary plasmacytoma|extramedullary plasmacytoma
622733|NCT00670917|isolated plasmacytoma of bone|isolated plasmacytoma of bone
622734|NCT00670917|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
622735|NCT00670917|stage I multiple myeloma|stage i multiple myeloma
622736|NCT00670917|stage II multiple myeloma|stage ii multiple myeloma
623121|NCT00672178|metastatic|metastatic
622737|NCT00670917|stage III multiple myeloma|stage iii multiple myeloma
622738|NCT00670917|primary systemic amyloidosis|primary systemic amyloidosis
622739|NCT00670917|refractory multiple myeloma|refractory multiple myeloma
622740|NCT00670917|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
622741|NCT00670917|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
622742|NCT00670917|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
622743|NCT00670917|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
622744|NCT00670930|Asthma, adults, anti-immunoglobulin E ( IgE), omalizumab, airway inflammation, airway remodeling, allergy|asthma, adults, anti-immunoglobulin e ( ige), omalizumab, airway inflammation, airway remodeling, allergy
622745|NCT00670943|Clopidogrel discontinuation|clopidogrel discontinuation
622746|NCT00670943|Platelet aggregation|platelet aggregation
622747|NCT00670956|prenatal steroids|prenatal steroids
622749|NCT00670956|congenital cystic adenomatoid malformation of the lung|congenital cystic adenomatoid malformation of the lung
622750|NCT00670956|prenatal intervention|prenatal intervention
622751|NCT00670956|betamethasone|betamethasone
622752|NCT00670956|prenatal diagnosis|prenatal diagnosis
622753|NCT00670969|Obesity|obesity
622754|NCT00670982|HER2 positive|her2 positive
622755|NCT00670982|bevacizumab|bevacizumab
622756|NCT00670982|vinorelbine|vinorelbine
622757|NCT00670982|trastuzumab|trastuzumab
622758|NCT00670995|Tobacco use among middle and junior high school students remains a concern among health educators.|tobacco use among middle and junior high school students remains a concern among health educators.
622759|NCT00670995|The use of tobacco prevention programs and their integration into school-based curricula has been lacking due to a number of factors.|the use of tobacco prevention programs and their integration into school-based curricula has been lacking due to a number of factors.
622760|NCT00671021|platelet aggregation|platelet aggregation
622761|NCT00671021|aspirin|aspirin
622762|NCT00671047|Autoimmune Diseases|autoimmune diseases
622763|NCT00671047|Lupus|lupus
622764|NCT00671060|intrauterine fetal death|intrauterine fetal death
622765|NCT00671060|misoprostol|misoprostol
622766|NCT00671073|Airflow Obstruction, Chronic|airflow obstruction, chronic
622767|NCT00671073|Chronic Airflow Obstruction|chronic airflow obstruction
622768|NCT00671073|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
622769|NCT00671073|Chronic Obstructive Airway Disease|chronic obstructive airway disease
622770|NCT00671073|Chronic Obstructive Lung Disease|chronic obstructive lung disease
622771|NCT00671073|COPD|copd
622772|NCT00671073|COAD|coad
622773|NCT00671086|Chronic Insomnia|chronic insomnia
622774|NCT00671086|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
622775|NCT00671086|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
622776|NCT00671086|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
624094|NCT00677287|RNF43|rnf43
622777|NCT00671086|Transient Insomnia|transient insomnia
622778|NCT00671086|Drug Therapy|drug therapy
622779|NCT00671086|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
622780|NCT00671099|Patients|patients
622781|NCT00671099|with high-energy|with high-energy
622782|NCT00671099|admitted|admitted
622783|NCT00671099|intensive care unit|intensive care unit
622784|NCT00671099|motor vehicle accident|motor vehicle accident
622785|NCT00671099|falling from height|falling from height
622786|NCT00671099|other accident|other accident
622787|NCT00671112|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
622788|NCT00671112|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
622789|NCT00671112|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
622790|NCT00671112|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
622791|NCT00671112|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
622792|NCT00671112|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
622793|NCT00671112|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
622794|NCT00671112|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
622795|NCT00671112|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
622796|NCT00671112|splenic marginal zone lymphoma|splenic marginal zone lymphoma
622797|NCT00671112|refractory hairy cell leukemia|refractory hairy cell leukemia
622798|NCT00671112|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
622799|NCT00671112|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
622800|NCT00671112|hairy cell leukemia|hairy cell leukemia
622801|NCT00671112|cutaneous B and T cell lymphoma|cutaneous b and t cell lymphoma
622802|NCT00671112|transformed lymphoma|transformed lymphoma
622803|NCT00671112|transformed B and T cell cutaneous lymphoma|transformed b and t cell cutaneous lymphoma
622804|NCT00671112|relapsed or refractory diffuse large B cell lymphoma|relapsed or refractory diffuse large b cell lymphoma
622805|NCT00671112|extranodal T cell lymphomas|extranodal t cell lymphomas
622806|NCT00671112|anaplastic large cell lymphoma|anaplastic large cell lymphoma
622807|NCT00671112|angioimmunoblastic T cell lymphoma|angioimmunoblastic t cell lymphoma
622808|NCT00671112|PTCL-NOS|ptcl-nos
622809|NCT00671112|nasal or disseminated extranodal T/NK lymphoma|nasal or disseminated extranodal t/nk lymphoma
622810|NCT00671112|enteropathy-associated T cell lymphoma|enteropathy-associated t cell lymphoma
623122|NCT00672178|sorafenib|sorafenib
622811|NCT00671112|hepatosplenic gamma/delta T cell lymphoma|hepatosplenic gamma/delta t cell lymphoma
622812|NCT00671112|subcutaneous panniculitis-like T cell lymphoma|subcutaneous panniculitis-like t cell lymphoma
622813|NCT00671112|T-prolymphocytic leukemia|t-prolymphocytic leukemia
622814|NCT00671112|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
622815|NCT00671112|large granular lymphocytic leukemia|large granular lymphocytic leukemia
622816|NCT00671112|aggressive NK leukemia|aggressive nk leukemia
622817|NCT00671125|Sleep Disorder|sleep disorder
622818|NCT00671125|Insomnia|insomnia
622819|NCT00671125|Drug Therapy|drug therapy
622820|NCT00671138|Celiac disease|celiac disease
622821|NCT00671138|Parasitic infections|parasitic infections
622822|NCT00671138|necator americanus|necator americanus
622823|NCT00671138|Immunity|immunity
622824|NCT00671151|COPD exacerbation|copd exacerbation
622826|NCT00671151|steroid resistance|steroid resistance
622827|NCT00671151|inflammation|inflammation
622828|NCT00671151|theophylline|theophylline
622829|NCT00671177|colonoscopy|colonoscopy
622830|NCT00671177|diagnostic techniques|diagnostic techniques
622831|NCT00671177|digestive system|digestive system
622832|NCT00671177|endoscopy|endoscopy
622833|NCT00671177|gastrointestinal|gastrointestinal
622834|NCT00671190|Sleep Disorder|sleep disorder
622835|NCT00671190|Circadian Rhythm Sleep Disorder|circadian rhythm sleep disorder
622836|NCT00671190|Drug Therapy|drug therapy
622837|NCT00671203|Tissue oximetry|tissue oximetry
622838|NCT00671203|Ischemia|ischemia
622839|NCT00671203|Aortic Aneurysm Repair|aortic aneurysm repair
622840|NCT00671203|Aortic Stent|aortic stent
622841|NCT00671203|Vascular Stent|vascular stent
622842|NCT00671203|Aortic graft|aortic graft
622843|NCT00671203|Vascular graft|vascular graft
622844|NCT00671216|safety|safety
622845|NCT00671216|pharmacodynamics|pharmacodynamics
622846|NCT00671216|Muscarinic Receptor Antagonist|muscarinic receptor antagonist
622847|NCT00671216|tolerability|tolerability
622848|NCT00671216|healthy subjects|healthy subjects
622849|NCT00671216|GS642444|gs642444
622850|NCT00671216|GSK233705|gsk233705
622851|NCT00671216|Anticholinergic|anticholinergic
622852|NCT00671216|ß2 agonist|ß2 agonist
622853|NCT00671216|pharmacokinetics|pharmacokinetics
622854|NCT00671229|Healthy|healthy
622855|NCT00671229|Asthma|asthma
622856|NCT00671229|Nitric Oxide|nitric oxide
622857|NCT00671242|Fluorine-18-α-methyltyrosine,|fluorine-18-α-methyltyrosine,
622858|NCT00671242|Positron emission tomography,|positron emission tomography,
622859|NCT00671242|Fluorine-18-fluorodeoxyglucose,|fluorine-18-fluorodeoxyglucose,
622860|NCT00671242|Lung cancer,|lung cancer,
622861|NCT00671242|Angiogenesis|angiogenesis
622862|NCT00671242|The median VEGF rate was 45% (range, 10-78%).|the median vegf rate was 45% (range, 10-78%).
622863|NCT00671242|High expression was seen in 30 patients (81%, 30/37).|high expression was seen in 30 patients (81%, 30/37).
622864|NCT00671242|VEGF expression was statistically associated with progressively growing microvessel count.|vegf expression was statistically associated with progressively growing microvessel count.
622865|NCT00671255|Chronic Insomnia|chronic insomnia
622866|NCT00671255|Drug Therapy|drug therapy
622867|NCT00671255|Elderly|elderly
622868|NCT00671268|Grass pollen allergy|grass pollen allergy
622869|NCT00671268|specific immunotherapy|specific immunotherapy
622870|NCT00671281|FESS|fess
622871|NCT00671281|Tranexamic acid|tranexamic acid
622872|NCT00671281|Hemostasis|hemostasis
622873|NCT00671281|Visualization|visualization
622874|NCT00671294|Insomnia|insomnia
622875|NCT00671307|Gelsolin|gelsolin
622876|NCT00671307|Trauma|trauma
622877|NCT00671307|Pneumonia|pneumonia
622878|NCT00671307|Peritonitis|peritonitis
622879|NCT00671307|Burn|burn
622880|NCT00671307|Infection|infection
622881|NCT00671307|Sepsis|sepsis
622882|NCT00671307|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
622883|NCT00671320|acute ankle sprain, acute pain, South America|acute ankle sprain, acute pain, south america
622884|NCT00671333|Randomized|randomized
622885|NCT00671333|Prospective|prospective
622886|NCT00671333|Procedure / Surgery|procedure / surgery
622887|NCT00671346|Cancer|cancer
622888|NCT00671346|Coronary artery disease|coronary artery disease
622889|NCT00671346|Myocardial infarction|myocardial infarction
622890|NCT00671346|Cerebrovascular stroke|cerebrovascular stroke
622891|NCT00671346|Homocysteine|homocysteine
622892|NCT00671346|Vitamin B Complex|vitamin b complex
622893|NCT00671346|Folic acid|folic acid
622894|NCT00671346|Vitamin B12|vitamin b12
622895|NCT00671346|Vitamin B6|vitamin b6
622896|NCT00671346|Pyridoxal phosphate|pyridoxal phosphate
622897|NCT00671346|Osteoporotic fractures|osteoporotic fractures
622898|NCT00671346|Diabetes|diabetes
622899|NCT00671359|Food effects|food effects
622901|NCT00671372|Metastatic CRC|metastatic crc
622902|NCT00671372|APO2L/TRAIL|apo2l/trail
622903|NCT00671385|screening|screening
622904|NCT00671385|compositional analysis|compositional analysis
622905|NCT00671385|metabolism|metabolism
622906|NCT00671385|breast|breast
622907|NCT00671385|breast cyst|breast cyst
622908|NCT00671385|breast infection|breast infection
622909|NCT00671385|breast inflammation|breast inflammation
622910|NCT00671385|lipoma|lipoma
622911|NCT00671385|benign growth|benign growth
622912|NCT00671385|Women without a diagnosis for a region of interest in the breast|women without a diagnosis for a region of interest in the breast
622913|NCT00671398|Insomnia|insomnia
622914|NCT00671398|Sleep Disorder|sleep disorder
622915|NCT00671398|Drug Therapy|drug therapy
622916|NCT00671411|Ultrasound|ultrasound
622917|NCT00671411|07-165|07-165
622918|NCT00671424|Interaction,|interaction,
622919|NCT00671424|Diabetes,|diabetes,
622920|NCT00671424|healthy male subjects|healthy male subjects
622921|NCT00671424|GSK189075,|gsk189075,
622922|NCT00671424|Diuretics,|diuretics,
622923|NCT00671437|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
622924|NCT00671463|Pancreas surgery|pancreas surgery
622925|NCT00671463|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
622926|NCT00671463|Pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
622927|NCT00671463|Pancreatic duct stenting|pancreatic duct stenting
622928|NCT00671476|ductal breast carcinoma in situ|ductal breast carcinoma in situ
622929|NCT00671489|Patients|patients
622930|NCT00671489|high-energy|high-energy
622931|NCT00671489|admitted|admitted
622932|NCT00671489|intensive care unit|intensive care unit
622933|NCT00671489|motor vehicle accident|motor vehicle accident
622934|NCT00671489|falling from height|falling from height
622935|NCT00671489|other accident|other accident
622936|NCT00671515|Depressive Disorder, Major|depressive disorder, major
622937|NCT00671515|Metabolic Syndrome X|metabolic syndrome x
622938|NCT00671515|pioglitazone|pioglitazone
622939|NCT00671528|Impetiginous|impetiginous
622940|NCT00671554|Melanoma|melanoma
622941|NCT00671554|Dendritic cells|dendritic cells
622942|NCT00671554|Cell therapy|cell therapy
622943|NCT00671554|BCG vaccine|bcg vaccine
622944|NCT00671567|Sleep Disorder|sleep disorder
622945|NCT00671567|Insomnia|insomnia
622946|NCT00671580|Skin Infections|skin infections
622947|NCT00671580|Complicated Skin and Skin Structure Infections|complicated skin and skin structure infections
622949|NCT00671593|Asthma|asthma
622950|NCT00671593|healthy|healthy
622951|NCT00671593|Normal|normal
622952|NCT00671606|Endometrial Cancer|endometrial cancer
622953|NCT00671606|Lymphatic Mapping|lymphatic mapping
622954|NCT00671606|Sentinel Node Identification|sentinel node identification
622955|NCT00671606|Lymph Node|lymph node
622956|NCT00671606|Intraoperative lymphatic mapping|intraoperative lymphatic mapping
622957|NCT00671606|Total hysterectomy|total hysterectomy
622958|NCT00671606|Bilateral salpingooophorectomy|bilateral salpingooophorectomy
622959|NCT00671606|Lymph node staging|lymph node staging
622960|NCT00671606|Laparotomy|laparotomy
622961|NCT00671606|Laparoscopy|laparoscopy
622962|NCT00671619|opthalmology|opthalmology
622963|NCT00671619|antibody fragment|antibody fragment
622964|NCT00671619|TNF alpha|tnf alpha
622965|NCT00671632|Addiction|addiction
622966|NCT00671645|pilot study|pilot study
622967|NCT00671645|rectal|rectal
622968|NCT00671645|carcinoma|carcinoma
622969|NCT00671645|phase II|phase ii
622970|NCT00671645|preoperative|preoperative
622971|NCT00671645|RadioChemo|radiochemo
622972|NCT00671645|molecular|molecular
622973|NCT00671645|target|target
622974|NCT00671645|therapy|therapy
622975|NCT00671645|T3|t3
622976|NCT00671645|ABCSG|abcsg
622977|NCT00671645|TAKO|tako
622978|NCT00671645|R04|r04
622979|NCT00671645|08|08
622980|NCT00671658|Lymphoma|lymphoma
622981|NCT00671658|HYPER-CVAD|hyper-cvad
622982|NCT00671658|Leukemia|leukemia
622983|NCT00671658|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
622984|NCT00671658|ALL|all
622985|NCT00671658|Remission Duration|remission duration
622986|NCT00671658|Chemotherapy|chemotherapy
622988|NCT00671658|Cyclophosphamide|cyclophosphamide
622990|NCT00671658|Dexamethasone|dexamethasone
622991|NCT00671658|Doxorubicin|doxorubicin
622992|NCT00671658|Leukine|leukine
622993|NCT00671658|Methotrexate|methotrexate
622994|NCT00671658|Rituximab|rituximab
622995|NCT00671658|Vincristine|vincristine
622996|NCT00671684|Hirschsprung's disease|hirschsprung's disease
622997|NCT00671684|Constipation|constipation
622998|NCT00671684|Endoscopy, digestive system|endoscopy, digestive system
622999|NCT00671684|Diagnosis|diagnosis
623000|NCT00671684|Colonoscopy|colonoscopy
623001|NCT00671697|MDS|mds
623002|NCT00671697|hypomethylating agent|hypomethylating agent
623003|NCT00671697|oxidative stress|oxidative stress
623004|NCT00671710|malignant glial brain tumors|malignant glial brain tumors
623005|NCT00671723|Atelectasis|atelectasis
623006|NCT00671736|cystic fibrosis|cystic fibrosis
623007|NCT00671736|Moli1901|moli1901
623008|NCT00671736|Lancovutide|lancovutide
623009|NCT00671736|2622U90|2622u90
623010|NCT00671736|duramycin|duramycin
623011|NCT00671736|lung|lung
623012|NCT00671775|Bariatric Surgery|bariatric surgery
623013|NCT00671775|Obesity|obesity
623014|NCT00671775|Cognitive Function|cognitive function
623015|NCT00671801|Malignant Gliomas|malignant gliomas
623016|NCT00671801|Glioblastoma Multiforme|glioblastoma multiforme
623017|NCT00671801|Gliosarcoma|gliosarcoma
623018|NCT00671801|Anaplastic Astrocytoma|anaplastic astrocytoma
623019|NCT00671801|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
623020|NCT00671801|Anaplastic Oligoastrocytoma|anaplastic oligoastrocytoma
623021|NCT00671801|Camptosar|camptosar
623022|NCT00671801|Irinotecan|irinotecan
623023|NCT00671801|CPT-11|cpt-11
623024|NCT00671801|Lenalidomide|lenalidomide
623025|NCT00671801|Revlimid|revlimid
623026|NCT00671801|CC-5013|cc-5013
623028|NCT00671827|Gynecologic Cancer|gynecologic cancer
623029|NCT00671827|Cervical Cancer|cervical cancer
623030|NCT00671827|Endometrial Cancer|endometrial cancer
623031|NCT00671827|Fallopian Tube Cancer|fallopian tube cancer
623032|NCT00671827|Ovarian Cancer|ovarian cancer
623033|NCT00671827|Uterine Cancer|uterine cancer
623034|NCT00671827|Vaginal Cancer|vaginal cancer
623035|NCT00671827|Vulvar Cancer|vulvar cancer
623036|NCT00671827|Questionnaire|questionnaire
623037|NCT00671827|Survey|survey
623038|NCT00671827|Robot-Assisted Surgery|robot-assisted surgery
623039|NCT00671853|Bipolar Disorder|bipolar disorder
623040|NCT00671853|Anxiety|anxiety
623041|NCT00671853|Anxiety Disorders|anxiety disorders
623042|NCT00671853|Substance Use Disorders|substance use disorders
623043|NCT00671866|OP|op
623044|NCT00671866|Pesticides|pesticides
623045|NCT00671866|Long-Term Low Level Exposure|long-term low level exposure
623046|NCT00671866|Occupational Health|occupational health
623047|NCT00671866|Neurobehavioral Effects|neurobehavioral effects
623048|NCT00671892|LPS endotoxin|lps endotoxin
623049|NCT00671892|asthma|asthma
623050|NCT00671905|atrial fibrillation|atrial fibrillation
623051|NCT00671905|PV isolation|pv isolation
623052|NCT00671905|ablation|ablation
623053|NCT00671905|ganglionic plexi|ganglionic plexi
623054|NCT00671905|parasympathetic denervation|parasympathetic denervation
623055|NCT00671918|breast cancer|breast cancer
623056|NCT00671918|lymph nodes|lymph nodes
623059|NCT00671931|dexmedetomidine|dexmedetomidine
623060|NCT00671931|neuromonitoring|neuromonitoring
623061|NCT00671931|spine procedures|spine procedures
623062|NCT00671931|safe dose|safe dose
623063|NCT00671931|1- safe dose of dexmedetomidine when used in total intravenous anesthesia for procedures require neuromonitoring|1- safe dose of dexmedetomidine when used in total intravenous anesthesia for procedures require neuromonitoring
623064|NCT00671931|2- safe dose of propofol when uses in comination with dexmedetomidine in neuromontoring|2- safe dose of propofol when uses in comination with dexmedetomidine in neuromontoring
623065|NCT00671931|3effect of dexmedetomidine on somatosensory evoked potential and motor evoked potentials|3effect of dexmedetomidine on somatosensory evoked potential and motor evoked potentials
623066|NCT00671944|protein|protein
623067|NCT00671944|calcium|calcium
623068|NCT00671944|parathyroid hormone|parathyroid hormone
623069|NCT00671944|bone markers|bone markers
623070|NCT00671944|calcium kinetics|calcium kinetics
623071|NCT00671944|absorption|absorption
623072|NCT00671957|Obesity|obesity
623073|NCT00671957|Bariatric|bariatric
623074|NCT00671957|Surgery|surgery
623075|NCT00671957|Activity|activity
623076|NCT00671970|Glioblastoma|glioblastoma
623077|NCT00671970|Gliosarcoma|gliosarcoma
623078|NCT00671970|Recurrent MG|recurrent mg
623079|NCT00671970|Malignant glioma|malignant glioma
623080|NCT00671970|Glioma|glioma
623081|NCT00671970|Glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
623082|NCT00671970|GBM|gbm
623083|NCT00671970|Brain tumor|brain tumor
623084|NCT00671970|Anaplastic astrocytoma|anaplastic astrocytoma
623085|NCT00671970|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
623086|NCT00671970|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
623087|NCT00671970|Bevacizumab|bevacizumab
623088|NCT00671970|Avastin|avastin
623091|NCT00672009|prostate cancer|prostate cancer
623092|NCT00672009|radical prostatectomy|radical prostatectomy
623093|NCT00672009|ixabepilone|ixabepilone
623095|NCT00672035|Healthy Adults|healthy adults
623096|NCT00672035|Dose Ranging|dose ranging
623097|NCT00672035|Patch|patch
623098|NCT00672035|Vaccine|vaccine
623099|NCT00672048|glaucoma|glaucoma
623100|NCT00672048|optometrists|optometrists
623101|NCT00672061|Sleep Apnea, Obstructive|sleep apnea, obstructive
623102|NCT00672061|Insomnia|insomnia
623103|NCT00672061|Drug Therapy|drug therapy
623104|NCT00672074|Postoperative Ileus|postoperative ileus
623105|NCT00672087|Chronic Prostatitis with Chronic Pelvic Pain Syndrome|chronic prostatitis with chronic pelvic pain syndrome
623106|NCT00672087|Chronic Bacterial Prostatitis|chronic bacterial prostatitis
623107|NCT00672087|Asymptomatic Inflammatory Prostatitis|asymptomatic inflammatory prostatitis
623108|NCT00672087|Painful Bladder Syndrome|painful bladder syndrome
623109|NCT00672087|Cystitis, Interstitial|cystitis, interstitial
623110|NCT00672100|Peripheral Nerve Infusion,|peripheral nerve infusion,
623111|NCT00672100|continuous brachial plexus block,|continuous brachial plexus block,
623112|NCT00672100|post-operative pain|post-operative pain
623113|NCT00672100|diaphragmatic paresis|diaphragmatic paresis
623114|NCT00672139|Opioid-Induced Constipation|opioid-induced constipation
623115|NCT00672152|Autologous transplantation|autologous transplantation
623116|NCT00672152|Allogeneic transplantation|allogeneic transplantation
623117|NCT00672165|MAB HUM 195 ACTINIUM-225 LABELED|mab hum 195 actinium-225 labeled
623118|NCT00672165|HEMATOPOIETIC SYSTEM|hematopoietic system
623119|NCT00672165|02-017|02-017
623123|NCT00672191|HIV|hiv
623124|NCT00672191|Human immunodeficiency virus|human immunodeficiency virus
623125|NCT00672191|Immunodeficiency Virus, Human|immunodeficiency virus, human
623126|NCT00672191|HIV-1|hiv-1
623127|NCT00672191|ART|art
623128|NCT00672191|antiretroviral therapy|antiretroviral therapy
623129|NCT00672191|HAART|haart
623130|NCT00672191|highly active retroviral therapy|highly active retroviral therapy
623131|NCT00672191|cluster of differentiation CD 4+ T cell counts|cluster of differentiation cd 4+ t cell counts
623132|NCT00672191|HIV-1 Subjects successfully ART treated|hiv-1 subjects successfully art treated
623133|NCT00672191|Treatment Experienced|treatment experienced
623134|NCT00672204|Islet transplant|islet transplant
623135|NCT00672204|Diabetes Mellitus|diabetes mellitus
623136|NCT00672204|Hypoglycemia|hypoglycemia
623137|NCT00672217|Breast cancer survivors, insomnia, quality of life|breast cancer survivors, insomnia, quality of life
623138|NCT00672230|Lactation|lactation
623139|NCT00672230|Breast milk|breast milk
623140|NCT00672230|Lutein|lutein
623141|NCT00672230|Lutein supplement|lutein supplement
623142|NCT00672243|GBM|gbm
623143|NCT00672243|Brain tumor|brain tumor
623144|NCT00672243|Erlotinib|erlotinib
623145|NCT00672243|Sirolimus|sirolimus
623146|NCT00672243|Glioblastoma multiforme|glioblastoma multiforme
623147|NCT00672243|Glioblastoma|glioblastoma
623148|NCT00672243|Gliosarcoma3|gliosarcoma3
623149|NCT00672243|Tarceva|tarceva
623150|NCT00672243|Rapamune|rapamune
623151|NCT00672256|Smoking|smoking
623152|NCT00672256|fMRI|fmri
623153|NCT00672269|carcinoid|carcinoid
623154|NCT00672269|family members|family members
623155|NCT00672269|familial|familial
623156|NCT00672269|tumors|tumors
623158|NCT00672282|androgen antagonists|androgen antagonists
623159|NCT00672282|prostate neoplasms|prostate neoplasms
623160|NCT00672295|Ovarian Cancer|ovarian cancer
623161|NCT00672295|Peritoneal Cancer|peritoneal cancer
623162|NCT00672295|Tubal Cancer|tubal cancer
623163|NCT00672295|Fallopian Tube Cancer|fallopian tube cancer
623164|NCT00672295|Dasatinib|dasatinib
623165|NCT00672295|Sprycel|sprycel
623166|NCT00672295|Paclitaxel|paclitaxel
623167|NCT00672295|Taxol|taxol
623168|NCT00672295|Carboplatin|carboplatin
623169|NCT00672295|Paraplatin|paraplatin
623170|NCT00672308|Cholera, benefiber, ORS|cholera, benefiber, ors
623171|NCT00672321|recurrent melanoma|recurrent melanoma
623172|NCT00672321|stage IB melanoma|stage ib melanoma
623173|NCT00672321|stage II melanoma|stage ii melanoma
623174|NCT00672321|stage IIIA melanoma|stage iiia melanoma
623175|NCT00672334|Cardiac surgery|cardiac surgery
623176|NCT00672334|Cardiopulmonary bypass|cardiopulmonary bypass
623177|NCT00672334|Oxidative stress|oxidative stress
623178|NCT00672334|Acute renal dysfunction|acute renal dysfunction
623179|NCT00672334|Sodium bicarbonate|sodium bicarbonate
623180|NCT00672347|caudal anesthesia, clonidine, morphine, bupivacaine|caudal anesthesia, clonidine, morphine, bupivacaine
623181|NCT00672360|Autism Spectrum Disorder|autism spectrum disorder
623182|NCT00672373|Tardive Dyskinesia|tardive dyskinesia
623183|NCT00672373|Schizophrenia|schizophrenia
623184|NCT00672373|Extract of Gingko Biloba|extract of gingko biloba
623185|NCT00672386|Diabetes|diabetes
623186|NCT00672386|Type 2 Diabetes|type 2 diabetes
623187|NCT00672386|Adult-Onset Diabetes Mellitus|adult-onset diabetes mellitus
623188|NCT00672386|Metabolic Syndrome|metabolic syndrome
623194|NCT00672399|exenatide|exenatide
623195|NCT00672399|moxifloxacin|moxifloxacin
623196|NCT00672412|Treatment Experienced|treatment experienced
623197|NCT00672451|diabetic kidney disease|diabetic kidney disease
623198|NCT00672451|albuminuria|albuminuria
623199|NCT00672464|Schizophrenia|schizophrenia
623200|NCT00672464|Schizoaffective|schizoaffective
623201|NCT00672464|Cardiovascular|cardiovascular
623202|NCT00672464|Olanzapine|olanzapine
623203|NCT00672464|Metformin|metformin
623204|NCT00672464|Simvastatin|simvastatin
623205|NCT00672477|opioid-induced constipation|opioid-induced constipation
623206|NCT00672490|Acute Mania|acute mania
623207|NCT00672490|Bipolar Disorder|bipolar disorder
623208|NCT00672490|Quetiapine Fumarate|quetiapine fumarate
623210|NCT00672503|indwelling urinary catheters|indwelling urinary catheters
623211|NCT00672503|urinary tract infections|urinary tract infections
623212|NCT00672503|foley-catheter related infections|foley-catheter related infections
623213|NCT00672503|hospital acquired CA-UTI|hospital acquired ca-uti
623214|NCT00672516|hemorrhage|hemorrhage
623215|NCT00672516|cardiopulmonary bypass|cardiopulmonary bypass
623216|NCT00672516|blood component transfusion|blood component transfusion
623217|NCT00672516|hemostasis, surgical|hemostasis, surgical
623218|NCT00672529|Childhood Asthma|childhood asthma
623219|NCT00672529|Inhaled Corticosteroids|inhaled corticosteroids
623220|NCT00672529|Alternative Medicine|alternative medicine
623221|NCT00672529|Vitamins, minerals, and fish oil as Add-on Treatment|vitamins, minerals, and fish oil as add-on treatment
623222|NCT00672542|melanoma|melanoma
623223|NCT00672542|dendritic cell|dendritic cell
623224|NCT00672542|immunoproteasome|immunoproteasome
623225|NCT00672542|vaccine|vaccine
623226|NCT00672555|pilonidal sinus|pilonidal sinus
623227|NCT00672555|recurrence|recurrence
623228|NCT00672555|Limberg flap|limberg flap
623229|NCT00672568|Rotator cuff, Shoulder, Arthroscopic shoulder surgery|rotator cuff, shoulder, arthroscopic shoulder surgery
623230|NCT00672581|Hepatic Impairment|hepatic impairment
623231|NCT00672607|premenstual syndrome, PMS, clinical trial|premenstual syndrome, pms, clinical trial
623232|NCT00672620|Major Depressive Disorder|major depressive disorder
623233|NCT00672620|Depression|depression
623234|NCT00672620|Drug Therapy|drug therapy
623235|NCT00672620|Major Depressive Episode|major depressive episode
623236|NCT00672633|Omega 3 Fatty Acids|omega 3 fatty acids
623237|NCT00672633|Triglycerides|triglycerides
623238|NCT00672633|Lovaza|lovaza
623239|NCT00672633|Trial|trial
623240|NCT00672646|Analgesic effect|analgesic effect
623241|NCT00672659|Lost of interest, Depressed Mood|lost of interest, depressed mood
623242|NCT00672672|Wound healing of surgical site treated with autologous platlet gel|wound healing of surgical site treated with autologous platlet gel
623243|NCT00672685|Cognitive decline|cognitive decline
623244|NCT00672685|omega-3 fatty acids|omega-3 fatty acids
623245|NCT00672685|nutrition|nutrition
623246|NCT00672685|physical exercise|physical exercise
623247|NCT00672685|cognitive training|cognitive training
623248|NCT00672685|social activities|social activities
623249|NCT00672685|frailty|frailty
623250|NCT00672698|SURGICAL RISK|surgical risk
623251|NCT00672698|ELDERLY|elderly
623252|NCT00672698|MAJOR SURGERY|major surgery
623253|NCT00672698|P-POSSUM|p-possum
623254|NCT00672698|SAPS II|saps ii
623255|NCT00672711|Complex Regional Pain Syndrome|complex regional pain syndrome
623256|NCT00672711|Chronic Post-surgical Pain|chronic post-surgical pain
623257|NCT00672711|Genetic susceptibility|genetic susceptibility
623258|NCT00672711|COMT|comt
623259|NCT00672724|Insomnia|insomnia
623260|NCT00672724|Sleep Disorder|sleep disorder
623261|NCT00672724|Drug Therapy|drug therapy
623262|NCT00672750|laparoscopic|laparoscopic
623263|NCT00672750|myomectomy|myomectomy
623264|NCT00672750|menorrhagia|menorrhagia
623265|NCT00672750|pelvic pain|pelvic pain
623266|NCT00672763|Crohn's Disease|crohn's disease
623267|NCT00672763|Inflammatory Bowel Disease|inflammatory bowel disease
623268|NCT00672763|Vitamin D|vitamin d
623269|NCT00672763|Randomised|randomised
623270|NCT00672763|Placebo|placebo
623271|NCT00672776|hippocampus|hippocampus
623272|NCT00672776|paroxetine|paroxetine
623273|NCT00672776|stress|stress
623274|NCT00672776|PTSD|ptsd
623275|NCT00672789|Sickle cell anemia|sickle cell anemia
623276|NCT00672789|Children|children
623277|NCT00672789|Hydroxyurea|hydroxyurea
623278|NCT00672789|Treatment Adherence|treatment adherence
752360|NCT01172626|metabolic enzymes|metabolic enzymes
623279|NCT00672802|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
623280|NCT00672802|COPD|copd
623281|NCT00672802|Insomnia|insomnia
623282|NCT00672802|Drug Therapy|drug therapy
623283|NCT00672815|coordinated school health|coordinated school health
623284|NCT00672815|school health policy evaluation|school health policy evaluation
623285|NCT00672815|physical activity|physical activity
623286|NCT00672828|colon cancer|colon cancer
623287|NCT00672828|rectal cancer|rectal cancer
623288|NCT00672841|candidemia|candidemia
623289|NCT00672841|invasive candidiasis|invasive candidiasis
623290|NCT00672841|preemptive antifungal therapy|preemptive antifungal therapy
623291|NCT00672841|surveillance|surveillance
623292|NCT00672841|β-D-Glucan (BDG)|β-d-glucan (bdg)
623293|NCT00672854|parenteral nutrition|parenteral nutrition
623294|NCT00672854|lipid emulsion|lipid emulsion
623295|NCT00672854|nosocomial infection|nosocomial infection
623296|NCT00672854|mortality|mortality
623297|NCT00672854|endothelial function|endothelial function
623298|NCT00672854|inflammatory markers|inflammatory markers
623299|NCT00672854|oxidative stress|oxidative stress
623300|NCT00672854|immune function|immune function
623301|NCT00672854|autonomic nervous system|autonomic nervous system
623302|NCT00672854|insulin sensitivity|insulin sensitivity
623303|NCT00672854|carbohydrate metabolism|carbohydrate metabolism
623304|NCT00672880|Chronic low back pain accompanied by depression|chronic low back pain accompanied by depression
623305|NCT00672893|central airway stenosis, lung sounds, airway obstruction, bronchial obstruction, bronchoscopic treatment|central airway stenosis, lung sounds, airway obstruction, bronchial obstruction, bronchoscopic treatment
623306|NCT00672906|anorexia nervosa|anorexia nervosa
623307|NCT00672906|group parent training|group parent training
623308|NCT00672906|caregiver burden|caregiver burden
623309|NCT00672906|eating disorders|eating disorders
623310|NCT00672906|treatment|treatment
623311|NCT00672919|Glucose Metabolism Disorder|glucose metabolism disorder
623312|NCT00672919|Dysmetabolic Syndrome|dysmetabolic syndrome
623313|NCT00672919|Type II Diabetes|type ii diabetes
623314|NCT00672919|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
623315|NCT00672919|Dyslipidemia|dyslipidemia
623316|NCT00672919|Drug Therapy|drug therapy
623317|NCT00672932|raltegravir|raltegravir
623318|NCT00672932|central nervous system (CNS)|central nervous system (cns)
623319|NCT00672932|HIV-1|hiv-1
623320|NCT00672932|AIDS|aids
623321|NCT00672932|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
623322|NCT00672932|immunoactivation|immunoactivation
623323|NCT00672932|antiretroviral therapy|antiretroviral therapy
623324|NCT00672932|suppression|suppression
623325|NCT00672958|Major Depressive Disorder|major depressive disorder
623326|NCT00672958|Depression|depression
623327|NCT00672958|Drug Therapy|drug therapy
623328|NCT00672958|Major Depressive Episode|major depressive episode
623329|NCT00672984|QT/QTc|qt/qtc
623330|NCT00672997|Glaucoma|glaucoma
623331|NCT00672997|Hypertension|hypertension
623332|NCT00673010|124-IODINE|124-iodine
623333|NCT00673010|I-131 METAIODOBENZ SULF (MIBG)|i-131 metaiodobenz sulf (mibg)
623334|NCT00673010|Thyroid|thyroid
623335|NCT00673010|Parathyroid|parathyroid
623336|NCT00673036|Coronary syndrome|coronary syndrome
623337|NCT00673036|Myocardial infarction|myocardial infarction
623338|NCT00673036|French registry|french registry
623339|NCT00673049|IGR-1R|igr-1r
623340|NCT00673049|Non small cell lung cancer|non small cell lung cancer
623341|NCT00673049|CP-751|cp-751
623343|NCT00673049|Figitumumab|figitumumab
623344|NCT00673075|carvedilol|carvedilol
623345|NCT00673075|Coreg (TM)|coreg (tm)
623346|NCT00673075|hypertension|hypertension
623347|NCT00673075|blood pressure|blood pressure
623348|NCT00673075|coronary artery disease|coronary artery disease
623349|NCT00673075|Nebivolol|nebivolol
623350|NCT00673075|BYSTOLIC (TM)|bystolic (tm)
623351|NCT00673101|liver fibrosis, cirrhosis|liver fibrosis, cirrhosis
623352|NCT00673101|FibroScan|fibroscan
623353|NCT00673101|transient elastography|transient elastography
623354|NCT00673101|elastometry|elastometry
623355|NCT00673101|methotrexate|methotrexate
623356|NCT00673101|non invasive blood markers|non invasive blood markers
623357|NCT00673101|FibroTest|fibrotest
623358|NCT00673101|treatment|treatment
623359|NCT00673114|Haplo/cord|haplo/cord
623360|NCT00673114|hematologic malignancy|hematologic malignancy
623362|NCT00673114|Aplastic Anemia|aplastic anemia
623363|NCT00673114|AML|aml
623364|NCT00673114|ALL|all
623365|NCT00673114|CML|cml
623366|NCT00673127|hormone refractory|hormone refractory
623367|NCT00673127|KHAD|khad
623368|NCT00673127|ketoconazole|ketoconazole
623369|NCT00673127|dutasteride|dutasteride
623370|NCT00673127|hydrocortisone|hydrocortisone
623371|NCT00673140|ALS (Amyotrophic Lateral Sclerosis)|als (amyotrophic lateral sclerosis)
623372|NCT00673140|Amyotrophic Lateral Sclerosis With Dementia|amyotrophic lateral sclerosis with dementia
623373|NCT00673140|Amyotrophic Lateral Sclerosis, Guam Form|amyotrophic lateral sclerosis, guam form
623374|NCT00673140|Dementia With Amyotrophic Lateral Sclerosis|dementia with amyotrophic lateral sclerosis
623375|NCT00673140|Gehrig's Disease|gehrig's disease
752361|NCT01172626|adverse effects|adverse effects
623376|NCT00673140|Guam Form of Amyotrophic Lateral Sclerosis|guam form of amyotrophic lateral sclerosis
623377|NCT00673140|Lou Gehrig Disease|lou gehrig disease
623378|NCT00673166|Staff motivation|staff motivation
623379|NCT00673166|Hospital mortality|hospital mortality
623380|NCT00673166|Perception of quality of care|perception of quality of care
623381|NCT00673179|Doxorubicin|doxorubicin
623382|NCT00673179|AD|ad
623383|NCT00673179|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
623384|NCT00673179|Cisplatin|cisplatin
623385|NCT00673179|Paraplatin®|paraplatin®
623386|NCT00673179|Methotrexate|methotrexate
623387|NCT00673179|Ifosfamide|ifosfamide
623388|NCT00673179|Osteosarcoma|osteosarcoma
623389|NCT00673179|Sargramostim|sargramostim
623390|NCT00673179|Leukine™|leukine™
623391|NCT00673179|Leucovorin|leucovorin
623392|NCT00673179|Gemcitabine|gemcitabine
623393|NCT00673179|Gemzar|gemzar
623394|NCT00673179|Gemcitabine Hydrochloride|gemcitabine hydrochloride
623395|NCT00673179|GM-CSF|gm-csf
623396|NCT00673179|Questionnaire|questionnaire
623397|NCT00673179|Survey|survey
623398|NCT00673205|androgen antagonists|androgen antagonists
623399|NCT00673205|prostate neoplasms|prostate neoplasms
623400|NCT00673218|IL13|il13
623401|NCT00673218|Cytokines|cytokines
623402|NCT00673218|Basophil stimulation|basophil stimulation
623403|NCT00673231|Dapagliflozin|dapagliflozin
623404|NCT00673231|efficacy|efficacy
623405|NCT00673231|safety|safety
623406|NCT00673231|add on to insulin|add on to insulin
625808|NCT00683150|DTM|dtm
623407|NCT00673231|Oral AntiDiabetic|oral antidiabetic
623408|NCT00673231|Type 2 diabetes|type 2 diabetes
623409|NCT00673244|Renal Replacement Therapy|renal replacement therapy
623410|NCT00673244|Dialysis|dialysis
623411|NCT00673257|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
623412|NCT00673283|lung cancer|lung cancer
623413|NCT00673283|nodules|nodules
623414|NCT00673283|radiography|radiography
623415|NCT00673283|CT|ct
623416|NCT00673283|Stereoscopy|stereoscopy
623417|NCT00673296|Bevacizumab|bevacizumab
623418|NCT00673296|Diabetic premacular hemorrhage|diabetic premacular hemorrhage
623419|NCT00673296|Intravitreal gas|intravitreal gas
623420|NCT00673309|burns|burns
623421|NCT00673322|Colorectal Cancer|colorectal cancer
623422|NCT00673322|T cells|t cells
623423|NCT00673322|Gene Transfer|gene transfer
623424|NCT00673335|breast cancer|breast cancer
623425|NCT00673335|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
623426|NCT00673335|BRCA1 mutation carrier|brca1 mutation carrier
623427|NCT00673335|BRCA2 mutation carrier|brca2 mutation carrier
623428|NCT00673348|Mycoses|mycoses
623429|NCT00673348|Voriconazole|voriconazole
623430|NCT00667498|Pediatric Obesity|pediatric obesity
623431|NCT00667498|Insulin Resistance|insulin resistance
623432|NCT00667498|Hyperinsulinemia|hyperinsulinemia
623433|NCT00667498|Metformin|metformin
623434|NCT00667498|Glucose Tolerance|glucose tolerance
623435|NCT00667498|Microalbuminuria|microalbuminuria
623436|NCT00667498|Adolescents|adolescents
623437|NCT00667498|Visceral Fat|visceral fat
623438|NCT00667511|ESRD|esrd
623439|NCT00667511|End Stage Renal Disease|end stage renal disease
623440|NCT00667511|Daily Hemodialysis|daily hemodialysis
623441|NCT00667511|Nocturnal Hemodialysis|nocturnal hemodialysis
623442|NCT00667511|Hemodialysis|hemodialysis
623443|NCT00667511|Kidney Failure|kidney failure
623444|NCT00667511|Kidney Disease|kidney disease
623445|NCT00673374|emergency|emergency
623446|NCT00673374|acute|acute
623447|NCT00673374|nontraumatic|nontraumatic
623448|NCT00673374|abdominal pain|abdominal pain
623449|NCT00673374|tenderness|tenderness
623450|NCT00673374|CT scan|ct scan
623451|NCT00673374|radiation|radiation
623452|NCT00673374|diagnosis|diagnosis
623453|NCT00673387|overweight|overweight
623454|NCT00673387|obesity|obesity
623455|NCT00673387|pramlintide|pramlintide
623456|NCT00673387|metreleptin|metreleptin
623457|NCT00673387|Amylin|amylin
623458|NCT00673400|Obstructed defecation syndrome|obstructed defecation syndrome
623459|NCT00673400|ODS|ods
623460|NCT00673400|Rectocele|rectocele
623461|NCT00673400|Intussusception|intussusception
623462|NCT00673400|STARR|starr
623463|NCT00673413|Perception|perception
623468|NCT00673426|chronic renal disease|chronic renal disease
623469|NCT00673426|Anticoagulant activity of enoxaparin sodic|anticoagulant activity of enoxaparin sodic
623470|NCT00673439|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
623471|NCT00673439|thrombocytopenia|thrombocytopenia
623472|NCT00673439|HIT|hit
623473|NCT00673439|thrombosis|thrombosis
623474|NCT00673439|blood clot|blood clot
623475|NCT00673439|blood thinner|blood thinner
623476|NCT00673439|anticoagulant|anticoagulant
623477|NCT00673439|heparin|heparin
623478|NCT00673439|warfarin|warfarin
623479|NCT00673439|fondaparinux|fondaparinux
623480|NCT00673439|Arixtra|arixtra
623481|NCT00673491|Critical Pathways|critical pathways
623482|NCT00673491|Stroke|stroke
623483|NCT00673491|Randomized Controlled Trial|randomized controlled trial
623484|NCT00673491|Effectiveness|effectiveness
623485|NCT00673504|cancer|cancer
623486|NCT00673504|pancreatic cancer|pancreatic cancer
623487|NCT00673504|gemcitabine|gemcitabine
623488|NCT00673504|sunitinib|sunitinib
623489|NCT00673504|Phase 2|phase 2
623490|NCT00673517|Acute respiratory distress syndrome|acute respiratory distress syndrome
623491|NCT00673517|Ventilator induced lung injury|ventilator induced lung injury
623492|NCT00673517|High frequency oscillation|high frequency oscillation
623493|NCT00673517|Lung protective ventilation|lung protective ventilation
623494|NCT00673517|Biomarkers|biomarkers
623495|NCT00673517|Biotrauma|biotrauma
623503|NCT00673543|Corticosteroids|corticosteroids
623505|NCT00673543|Glucose control|glucose control
623506|NCT00673556|Chronic Plaque Psoriasis|chronic plaque psoriasis
623507|NCT00673556|Alefacept|alefacept
623508|NCT00673569|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
623509|NCT00673569|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
623510|NCT00673569|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
623511|NCT00673569|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
623512|NCT00673582|Statins|statins
623513|NCT00673582|Intima Media Thickness|intima media thickness
623514|NCT00673582|Plaque Area|plaque area
623515|NCT00673595|smoking|smoking
623516|NCT00673595|varenicline|varenicline
623517|NCT00673595|flow-mediated dilation|flow-mediated dilation
623518|NCT00673595|blood pressure|blood pressure
623519|NCT00673595|baroreflex|baroreflex
623520|NCT00673608|Haemoglobinopathies,|haemoglobinopathies,
623521|NCT00673608|Myelodysplastic Syndromes,|myelodysplastic syndromes,
623522|NCT00673608|Transfusional iron overload,|transfusional iron overload,
623523|NCT00673608|cardiac iron load|cardiac iron load
623524|NCT00673621|Asthmatics and non-asthmatic male and female subjects|asthmatics and non-asthmatic male and female subjects
623525|NCT00673634|preoxygenation|preoxygenation
623526|NCT00673634|method|method
623527|NCT00673634|efficiency|efficiency
623528|NCT00673634|obesity|obesity
623529|NCT00673634|BiPAP|bipap
623530|NCT00673634|FeO2|feo2
623531|NCT00673647|cannabis|cannabis
623532|NCT00673647|dependence|dependence
623533|NCT00673647|marijuana|marijuana
623534|NCT00673647|CBT|cbt
623535|NCT00673647|efficacy of CBT for cannabis use disorders|efficacy of cbt for cannabis use disorders
623536|NCT00673660|Statins|statins
623537|NCT00673660|Compliance|compliance
623538|NCT00673660|Dyslipidemia|dyslipidemia
623539|NCT00673686|Oral contraceptive|oral contraceptive
623540|NCT00673686|Ovulation|ovulation
623541|NCT00673686|Missing pills|missing pills
623542|NCT00673686|Intake compliance|intake compliance
623543|NCT00673686|Cycle control|cycle control
623544|NCT00673699|NBI|nbi
623545|NCT00673699|gastroscopy|gastroscopy
623546|NCT00673699|biopsy|biopsy
623547|NCT00673699|intestinal metaplasia|intestinal metaplasia
623553|NCT00675246|corticoid therapy|corticoid therapy
623554|NCT00675246|fetal lung maturation|fetal lung maturation
623555|NCT00675246|late preterm|late preterm
623556|NCT00675246|respiratory distress syndrome|respiratory distress syndrome
623557|NCT00675246|neonatal death|neonatal death
623558|NCT00675259|stage II breast cancer|stage ii breast cancer
623559|NCT00675259|stage IIIA breast cancer|stage iiia breast cancer
623560|NCT00675259|stage IIIB breast cancer|stage iiib breast cancer
623561|NCT00675259|stage IIIC breast cancer|stage iiic breast cancer
623562|NCT00675272|brain death|brain death
623563|NCT00675272|subarachnoid hemorrhage|subarachnoid hemorrhage
623564|NCT00675272|traumatic brain injury|traumatic brain injury
623565|NCT00675272|brain injury|brain injury
623566|NCT00675272|intracerebral hemorrhage|intracerebral hemorrhage
623567|NCT00675272|organ donation|organ donation
623568|NCT00675285|airway inflammation|airway inflammation
623569|NCT00675285|childhood asthma|childhood asthma
623570|NCT00675285|fractional exhaled nitric oxide|fractional exhaled nitric oxide
623571|NCT00675285|leukotriene receptor antagonists|leukotriene receptor antagonists
623572|NCT00675285|lung function|lung function
623573|NCT00675298|Prostatitis|prostatitis
623574|NCT00675298|Cystitis, Interstitial|cystitis, interstitial
623575|NCT00675298|Urinary Bladder, Overactive|urinary bladder, overactive
623576|NCT00675298|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
623577|NCT00675298|Painful bladder syndrome|painful bladder syndrome
623578|NCT00675298|Urgency|urgency
623580|NCT00675311|Remote monitoring|remote monitoring
623581|NCT00675311|Type 1 Diabetes|type 1 diabetes
623582|NCT00675311|Type 2 diabetes|type 2 diabetes
623583|NCT00675324|Colonoscopy|colonoscopy
623584|NCT00675324|Bowel preparation|bowel preparation
623585|NCT00675324|Salt and electrolyte balance|salt and electrolyte balance
623586|NCT00675324|Patients undergoing colonoscopy|patients undergoing colonoscopy
623587|NCT00675324|Complication with traditional bowel preparation|complication with traditional bowel preparation
623785|NCT00676039|Generic|generic
623588|NCT00675324|Bowel purity degree without traditional bowel preparation|bowel purity degree without traditional bowel preparation
623589|NCT00675337|iron stores|iron stores
623590|NCT00675337|anemia|anemia
623591|NCT00675337|iron deficiency|iron deficiency
623592|NCT00675337|infancy|infancy
623593|NCT00675337|placental transfusion|placental transfusion
623594|NCT00675337|iron deficiency in infancy|iron deficiency in infancy
623595|NCT00675337|anemia in infancy|anemia in infancy
623596|NCT00675337|placement of neonate|placement of neonate
623597|NCT00675350|Omacetaxine|omacetaxine
623598|NCT00675350|Homoharringtonine|homoharringtonine
623599|NCT00675350|HHT|hht
623600|NCT00675350|Solid and hematologic malignant tumors|solid and hematologic malignant tumors
623601|NCT00675363|ICU|icu
623602|NCT00675363|Sedation strategies|sedation strategies
623603|NCT00675363|Daily sedative interruption|daily sedative interruption
623604|NCT00675363|Sedation protocols|sedation protocols
623605|NCT00675363|Mechanical Ventilation|mechanical ventilation
623606|NCT00675363|Sedation|sedation
623607|NCT00675376|COPD|copd
623608|NCT00675376|Lung Transplant|lung transplant
623609|NCT00675376|Quality of Life|quality of life
623610|NCT00675376|End Stage Lung Disease|end stage lung disease
623611|NCT00675389|HIV|hiv
623612|NCT00675389|AIDS|aids
623613|NCT00675389|Community Health Workers|community health workers
623614|NCT00675389|Mobile Phones|mobile phones
623615|NCT00675389|Adherence|adherence
623616|NCT00675389|Antiretroviral Therapy|antiretroviral therapy
623617|NCT00675415|Hypoxemia|hypoxemia
623618|NCT00675415|Capnography|capnography
623619|NCT00675415|Apnea|apnea
623620|NCT00675415|Sedation|sedation
623621|NCT00675415|ERCP|ercp
623622|NCT00675415|EUS|eus
623623|NCT00675428|Relapsed or refractory Multiple Myeloma|relapsed or refractory multiple myeloma
623624|NCT00675441|Chronic Graft-versus-Host Disease|chronic graft-versus-host disease
623625|NCT00675441|cGVHD|cgvhd
623626|NCT00675441|GVHD|gvhd
623627|NCT00675441|Lenalidomide|lenalidomide
623628|NCT00675441|Revlimid|revlimid
623629|NCT00675441|CC-5013|cc-5013
623630|NCT00675441|Stem Cell Transplant|stem cell transplant
623631|NCT00675441|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
623632|NCT00675441|Allogeneic HSCT|allogeneic hsct
623633|NCT00675441|HSCT|hsct
623634|NCT00675441|Post-Transplant Prophylactic Immunosuppressive Therapy|post-transplant prophylactic immunosuppressive therapy
623635|NCT00675441|Steroids|steroids
623636|NCT00675441|Standard-of-care steroid treatment|standard-of-care steroid treatment
623637|NCT00675441|Corticosteroids|corticosteroids
623638|NCT00675441|Prednisone|prednisone
623639|NCT00675441|Medrol|medrol
623640|NCT00675454|COPD|copd
623641|NCT00675454|Lung Volume Reduction Surgery|lung volume reduction surgery
623642|NCT00675454|Lung Transplant|lung transplant
624357|NCT00677820|trivalent|trivalent
623643|NCT00675454|Quality of Life|quality of life
623644|NCT00675467|Pediatric Cancer|pediatric cancer
623645|NCT00675467|Focus Group|focus group
623646|NCT00675467|Pediatric cancer patients|pediatric cancer patients
623647|NCT00675467|Parents of Pediatric cancer patients|parents of pediatric cancer patients
623648|NCT00675467|Pediatric Palliative Care Program|pediatric palliative care program
623649|NCT00675480|myocardial infarction, thrombectomy, salvage index|myocardial infarction, thrombectomy, salvage index
623650|NCT00675506|Growth Hormone Releasing Hormone|growth hormone releasing hormone
623651|NCT00675506|Growth Hormone Pulse|growth hormone pulse
623652|NCT00675506|Visceral Adipose Tissue|visceral adipose tissue
623653|NCT00675506|Carotid Intima-Media Thickness|carotid intima-media thickness
623654|NCT00675519|problem drinkers|problem drinkers
623655|NCT00675532|Opioids, vivitrol, naltrexone, primary care|opioids, vivitrol, naltrexone, primary care
623656|NCT00675558|Obesity|obesity
623657|NCT00675558|morbid obesity|morbid obesity
623658|NCT00675558|bariatric surgery|bariatric surgery
623659|NCT00675597|Bevacizumab (Avastin)|bevacizumab (avastin)
623660|NCT00675597|Taxotere (Docetaxel)|taxotere (docetaxel)
623661|NCT00675597|Vinorelbine Tartrate (Navelbine)|vinorelbine tartrate (navelbine)
623662|NCT00675597|07-178|07-178
623663|NCT00675610|communication|communication
623664|NCT00675610|HIV/AIDS|hiv/aids
623665|NCT00675610|Treatment Experienced|treatment experienced
623666|NCT00675623|Alzheimer's disease, clinical trial, memory loss, mitochondria,|alzheimer's disease, clinical trial, memory loss, mitochondria,
623667|NCT00675623|investigational drug, neurodegenerative disease, dementia|investigational drug, neurodegenerative disease, dementia
623668|NCT00675636|colon cancer|colon cancer
623669|NCT00675636|hereditary non-polyposis colon cancer|hereditary non-polyposis colon cancer
623670|NCT00675636|rectal cancer|rectal cancer
623671|NCT00675636|familial adenomatous polyposis|familial adenomatous polyposis
623673|NCT00675649|Severe, persistent asthma|severe, persistent asthma
623674|NCT00675662|Obesity|obesity
623675|NCT00675662|overweight|overweight
623676|NCT00675662|BMI|bmi
623677|NCT00675662|ifestyle|ifestyle
623678|NCT00675662|diet|diet
623679|NCT00675662|nutrition|nutrition
623680|NCT00675662|physical activity|physical activity
623681|NCT00675662|pre-school|pre-school
623682|NCT00675662|toddlers|toddlers
623683|NCT00675662|children|children
623684|NCT00675662|Prevention of overweight and obesity in pre-school children|prevention of overweight and obesity in pre-school children
623685|NCT00675675|Tourette Syndrome|tourette syndrome
623686|NCT00675675|Chronic Tic Disorder|chronic tic disorder
623687|NCT00675675|Tics|tics
623688|NCT00675675|Behavior Therapy|behavior therapy
623689|NCT00675675|Habit Reversal Training|habit reversal training
623690|NCT00675675|Child|child
623691|NCT00675675|Adolescent|adolescent
623692|NCT00675675|Neuroimaging|neuroimaging
623693|NCT00675688|Menopause|menopause
623694|NCT00675701|To determine whether lixivaptan administration at supratherapeutic or therapeutic doses results in the prolongation of the QTc interval.|to determine whether lixivaptan administration at supratherapeutic or therapeutic doses results in the prolongation of the qtc interval.
623695|NCT00675714|anabolic agents|anabolic agents
623696|NCT00675714|exercise|exercise
623697|NCT00675727|Melanoma|melanoma
623698|NCT00675727|Mycobacterium w|mycobacterium w
623699|NCT00675753|Genes|genes
623700|NCT00675753|Ethnology|ethnology
623701|NCT00675753|Cytokines|cytokines
623702|NCT00675753|prematurity|prematurity
623703|NCT00675779|endometriosis|endometriosis
623704|NCT00675779|atorvastatin|atorvastatin
623705|NCT00675779|oral|oral
623706|NCT00675779|contraception|contraception
623707|NCT00675779|pain|pain
623708|NCT00675779|relief|relief
623709|NCT00675779|pelvic pain in women with endometriosis|pelvic pain in women with endometriosis
623710|NCT00675805|intravenous immunoglobulin|intravenous immunoglobulin
623711|NCT00675805|IVIG|ivig
623712|NCT00675805|adverse reactions|adverse reactions
623713|NCT00675818|acute kidney injury|acute kidney injury
623714|NCT00675818|renal replacement therapy|renal replacement therapy
623715|NCT00675818|critical care unit|critical care unit
626108|NCT00684398|NF1|nf1
623716|NCT00675818|hemodialysis|hemodialysis
623717|NCT00675818|hemofiltration|hemofiltration
623718|NCT00675831|CD25+|cd25+
623719|NCT00675831|Tregs|tregs
623721|NCT00675831|Donor lymphocyte infusion|donor lymphocyte infusion
623722|NCT00675844|Extension study|extension study
623723|NCT00675844|HIV-1 infection|hiv-1 infection
623724|NCT00675844|Treatment Naive|treatment naive
623725|NCT00675857|Type II diabetes|type ii diabetes
623726|NCT00675857|Metabolic syndrome|metabolic syndrome
623727|NCT00675870|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
623728|NCT00675870|Cancer|cancer
623729|NCT00675870|Leukemia|leukemia
623730|NCT00675870|APL|apl
623731|NCT00675870|ATRA|atra
623732|NCT00675870|Tretinoid|tretinoid
623733|NCT00675870|Vesanoid|vesanoid
623734|NCT00675870|Retinoic Acid Receptor Alpha|retinoic acid receptor alpha
623735|NCT00675870|All Trans Retinoic Acid|all trans retinoic acid
623736|NCT00675870|Arsenic Trioxide|arsenic trioxide
623737|NCT00675870|Trisenox|trisenox
623738|NCT00675870|Retinoid|retinoid
623739|NCT00675870|Relapsed or Refractory Acute Promyelocytic Leukemia|relapsed or refractory acute promyelocytic leukemia
623740|NCT00675896|major depression with comorbid fibromyalgia.|major depression with comorbid fibromyalgia.
623741|NCT00675909|Sedation|sedation
623742|NCT00675909|Anxiety|anxiety
623743|NCT00675909|Minor procedures|minor procedures
623744|NCT00675909|Emergency Department|emergency department
623745|NCT00675922|Burn|burn
623746|NCT00675922|Wounds|wounds
623747|NCT00675922|Wound infection|wound infection
623748|NCT00675922|Topical antimicrobials|topical antimicrobials
623749|NCT00675922|Cerium|cerium
623750|NCT00675922|Dakins|dakins
623751|NCT00675922|Sulfamylon Soaks|sulfamylon soaks
623752|NCT00675922|Silver Nitrate|silver nitrate
623753|NCT00675935|Patient falls|patient falls
623754|NCT00675935|fall risk|fall risk
623755|NCT00675935|fall prevention|fall prevention
623756|NCT00675948|Palliative Care|palliative care
623757|NCT00675948|Pain|pain
623758|NCT00675948|Cancer|cancer
623759|NCT00675961|Tomsk|tomsk
623760|NCT00675961|TB-Alcohol|tb-alcohol
623761|NCT00675961|Alcohol and co-occurring disease|alcohol and co-occurring disease
623762|NCT00675961|Brief counseling intervention|brief counseling intervention
623763|NCT00675961|Naltrexone|naltrexone
623764|NCT00675974|Burn|burn
623765|NCT00675974|Scar|scar
623766|NCT00675974|Pressure garments|pressure garments
623767|NCT00675974|Wound healing|wound healing
623768|NCT00675974|Burn Injury|burn injury
623769|NCT00675987|Impaired Fasting Glucose FPG >100-<126 mg/dL|impaired fasting glucose fpg >100-<126 mg/dl
623770|NCT00676013|Burns|burns
623771|NCT00676013|Skin grafting|skin grafting
623772|NCT00676013|AlloDerm|alloderm
623773|NCT00676013|Integra|integra
623774|NCT00676013|Homograft|homograft
623775|NCT00676013|Autograft|autograft
623776|NCT00676013|Burn Scar|burn scar
623779|NCT00676026|healthy controls|healthy controls
623780|NCT00676026|Healthy females with regular menstrual cycles|healthy females with regular menstrual cycles
623781|NCT00676039|Therapeutic Equivalency|therapeutic equivalency
623782|NCT00676039|Human Experimentation|human experimentation
623783|NCT00676039|Bioequivalence|bioequivalence
623784|NCT00676039|Brand name|brand name
623786|NCT00676039|Antidepressant|antidepressant
623787|NCT00676039|Healthy volunteers|healthy volunteers
623789|NCT00676052|Multicenter|multicenter
623790|NCT00676052|GSK233705B|gsk233705b
623791|NCT00676052|double-blind|double-blind
623792|NCT00676052|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
623793|NCT00676052|randomized|randomized
623794|NCT00676065|Contraception|contraception
623795|NCT00676065|Thromboembolism|thromboembolism
623796|NCT00676065|Breast Cancer|breast cancer
623797|NCT00676091|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
623798|NCT00676104|Traumatic Brain Injury|traumatic brain injury
623799|NCT00676104|Trauma|trauma
623800|NCT00676104|Hypothermia|hypothermia
623801|NCT00676117|male|male
623802|NCT00676117|Japan|japan
623803|NCT00676117|Japanese|japanese
623804|NCT00676117|Healthy volunteers|healthy volunteers
623805|NCT00676130|Cellulitis|cellulitis
623806|NCT00676130|Bactrim|bactrim
623807|NCT00676130|Trimethoprim Sulfamethoxazole|trimethoprim sulfamethoxazole
623808|NCT00676130|MRSA|mrsa
623809|NCT00676130|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
623810|NCT00676143|antibody|antibody
623811|NCT00676143|immunotherapy|immunotherapy
623812|NCT00676156|multiple sclerosis|multiple sclerosis
623813|NCT00676156|lipoic acid|lipoic acid
623814|NCT00676156|LA|la
623815|NCT00676156|pharmacokinetics|pharmacokinetics
623816|NCT00676156|immunological effects|immunological effects
623817|NCT00676169|Pseudomonas aeruginosa|pseudomonas aeruginosa
623818|NCT00676169|EPIC|epic
623819|NCT00676195|N-Acetyl Cysteine|n-acetyl cysteine
623820|NCT00676208|Shared Medical Appointments|shared medical appointments
623821|NCT00676208|Diabetes|diabetes
623822|NCT00676208|Education|education
626188|NCT00678236|RSA|rsa
623823|NCT00676221|Renal transplant recipient|renal transplant recipient
623824|NCT00676221|Immunosuppression|immunosuppression
623825|NCT00676221|Gastro-intestinal symptoms|gastro-intestinal symptoms
623826|NCT00676221|Quality of life|quality of life
623827|NCT00676221|Cellcept|cellcept
623828|NCT00676221|Myfortic|myfortic
623829|NCT00676221|Kidney transplant patients.|kidney transplant patients.
623830|NCT00676234|erythropoietin|erythropoietin
623831|NCT00676247|Ultrasonography|ultrasonography
623832|NCT00676247|Doppler|doppler
623833|NCT00676247|Hemodynamics|hemodynamics
623834|NCT00676247|Neurobehavioral development|neurobehavioral development
623835|NCT00676260|Glucose Metabolism Disorder|glucose metabolism disorder
623836|NCT00676260|Dysmetabolic Syndrome|dysmetabolic syndrome
623837|NCT00676260|Type II Diabetes|type ii diabetes
623838|NCT00676260|Diabetes Mellitus|diabetes mellitus
623839|NCT00676260|Lipoatrophic|lipoatrophic
623840|NCT00676260|Dyslipidemia|dyslipidemia
623841|NCT00676260|Drug Therapy|drug therapy
623842|NCT00676286|Prostate cancer active surveillance|prostate cancer active surveillance
624457|NCT00679185|fatigue|fatigue
623843|NCT00676286|3 Tesla MR biological imaging in prostate cancer|3 tesla mr biological imaging in prostate cancer
623844|NCT00676286|tumor gene re-arrangements in prostate cancer|tumor gene re-arrangements in prostate cancer
623845|NCT00676299|Advanced Solid Cancers|advanced solid cancers
623846|NCT00676299|Refractory Solid Cancers|refractory solid cancers
623847|NCT00676299|Protein Kinase Inhibitors|protein kinase inhibitors
623848|NCT00676299|Phase 1 Study|phase 1 study
623849|NCT00676299|Oral Chemotherapy|oral chemotherapy
623850|NCT00676312|Osteoporosis|osteoporosis
623851|NCT00676312|parathyroid hormone|parathyroid hormone
623852|NCT00676312|pharmacodynamic|pharmacodynamic
623853|NCT00676312|pharmacokinetic|pharmacokinetic
623854|NCT00676325|anterior vaginal prolapse|anterior vaginal prolapse
623855|NCT00676325|traditional treatment|traditional treatment
623856|NCT00676325|mesh, graft|mesh, graft
623857|NCT00676325|NAZCA TC™ POP REPAIR SYSTEM|nazca tc™ pop repair system
623858|NCT00676325|colporrhaphy|colporrhaphy
623859|NCT00676338|Amylin|amylin
623860|NCT00676338|Lilly|lilly
623861|NCT00676338|exenatide once weekly|exenatide once weekly
623862|NCT00676338|Byetta|byetta
623863|NCT00676338|Januvia|januvia
623864|NCT00676338|sitagliptin|sitagliptin
623865|NCT00676338|thiazolidinedione|thiazolidinedione
623866|NCT00676364|pediatric patients|pediatric patients
623867|NCT00676364|pain|pain
623868|NCT00676364|anxiety|anxiety
623869|NCT00676364|topical anesthetic|topical anesthetic
623870|NCT00676364|randomized control trial|randomized control trial
623871|NCT00676377|Neostigmine, Post Operative, Ileus|neostigmine, post operative, ileus
623872|NCT00676390|Heart Failure|heart failure
623873|NCT00676403|pregabalin, RLS, efficacy, safety|pregabalin, rls, efficacy, safety
623874|NCT00676416|General anesthesia|general anesthesia
623875|NCT00676416|Propofol|propofol
623876|NCT00676416|Immunity|immunity
623877|NCT00676416|Alveolar Macrophages|alveolar macrophages
623878|NCT00676455|CT Software|ct software
623880|NCT00676455|Metastatic pulmonary and hepatic lesion growth|metastatic pulmonary and hepatic lesion growth
623881|NCT00676468|Asthma|asthma
623882|NCT00676468|Inflammation|inflammation
623883|NCT00676468|Airway|airway
623884|NCT00676468|Fish Oil|fish oil
623885|NCT00676468|Singulair|singulair
623886|NCT00676481|Patient Education|patient education
623887|NCT00676481|Emergency Medicine|emergency medicine
623888|NCT00676481|HIV Prevention|hiv prevention
623889|NCT00676481|HIV Seronegativity|hiv seronegativity
623890|NCT00676507|Gene therapy|gene therapy
623891|NCT00676507|Flow cytometry|flow cytometry
623892|NCT00676507|Immunoenzyme technique|immunoenzyme technique
623893|NCT00676507|Laboratory biomarker analysis|laboratory biomarker analysis
623894|NCT00676507|Quality-of-life-assessment|quality-of-life-assessment
623895|NCT00676507|Tumor cell-derivative vaccine therapy|tumor cell-derivative vaccine therapy
623896|NCT00676520|Angioplasty|angioplasty
623897|NCT00676520|Coronary Restenosis|coronary restenosis
623898|NCT00676520|Coronary Artery Disease|coronary artery disease
623899|NCT00676520|Coronary Artery Restenosis|coronary artery restenosis
623900|NCT00676520|Coronary Artery Stenosis|coronary artery stenosis
623901|NCT00676520|Total Artery Occlusion|total artery occlusion
623902|NCT00676520|Stents|stents
623903|NCT00676520|Stent Thrombosis|stent thrombosis
623904|NCT00676520|Total Coronary Occlusion|total coronary occlusion
623905|NCT00676520|Vascular Disease|vascular disease
623906|NCT00676520|Myocardial Ischemia|myocardial ischemia
623907|NCT00676533|Cipro|cipro
623908|NCT00676533|Urinary Tract Infection|urinary tract infection
623909|NCT00676559|Diabetic|diabetic
623910|NCT00676559|Macular|macular
623911|NCT00676559|Edema|edema
624040|NCT00677105|Solid Tumors|solid tumors
623913|NCT00676559|Clinically Significant Macular Edema (CSME)|clinically significant macular edema (csme)
623914|NCT00676572|severe asthma|severe asthma
623915|NCT00676572|corticosteroid insensitivity|corticosteroid insensitivity
623916|NCT00676585|Cardiac Arrest, Shock, Steroids|cardiac arrest, shock, steroids
623917|NCT00676598|therapeutic hypothermia|therapeutic hypothermia
623918|NCT00676611|Acetabular Fractures|acetabular fractures
623920|NCT00676624|vitrectomy|vitrectomy
623921|NCT00676624|infection|infection
623922|NCT00676624|severe|severe
623923|NCT00676637|Adherence|adherence
623924|NCT00676637|Compliance|compliance
623925|NCT00676637|Glaucoma|glaucoma
623926|NCT00676637|Ocular Hypertension|ocular hypertension
623927|NCT00676650|Docetaxel-refractory mCRPC|docetaxel-refractory mcrpc
623928|NCT00676650|Second-line treatment with sunitinib and prednisone|second-line treatment with sunitinib and prednisone
623929|NCT00676663|Breast Neoplasms|breast neoplasms
623930|NCT00676663|Breast Tumor|breast tumor
623931|NCT00676663|Mammary Neoplasms|mammary neoplasms
623932|NCT00676676|Depression|depression
623933|NCT00676676|Major Depressive Disorder|major depressive disorder
623934|NCT00676689|Pulmonic|pulmonic
623935|NCT00676689|Regurgitation|regurgitation
623936|NCT00676689|Pulmonary Valve Conduit|pulmonary valve conduit
623937|NCT00676689|Stenosis|stenosis
623938|NCT00676689|Congenital Heart Defect|congenital heart defect
623939|NCT00676702|Pancrelipase|pancrelipase
623940|NCT00676702|PANCREASE MT|pancrease mt
624764|NCT00680303|Efficiency|efficiency
623941|NCT00676702|Cross-Over Studies|cross-over studies
623942|NCT00676702|Duodenum|duodenum
623943|NCT00676702|Intestine, Small|intestine, small
623944|NCT00676702|Lipase|lipase
623945|NCT00676702|Amylases|amylases
623946|NCT00676702|Peptide Hydrolases|peptide hydrolases
623947|NCT00676702|Intubation|intubation
623948|NCT00676702|Safety|safety
623949|NCT00676702|Capsules|capsules
623950|NCT00676728|Advanced or Refractory Leukemia|advanced or refractory leukemia
623951|NCT00676728|Myelodysplastic Syndromes|myelodysplastic syndromes
623952|NCT00676728|JNJ 26481585|jnj 26481585
623953|NCT00676728|Histone-Deacetylase Inhibitor|histone-deacetylase inhibitor
623954|NCT00676728|Advanced Leukemia|advanced leukemia
623955|NCT00676728|Refractory Leukemia|refractory leukemia
623956|NCT00676754|Multidrug-Resistant Tuberculosis, tuberculosis, Peru|multidrug-resistant tuberculosis, tuberculosis, peru
623957|NCT00676767|Aging|aging
623958|NCT00676767|Diabetes|diabetes
623959|NCT00676767|Diet|diet
623960|NCT00676767|Fiber|fiber
623961|NCT00676780|EGCG|egcg
623962|NCT00676780|polyphenols|polyphenols
623963|NCT00676780|biomarkers|biomarkers
623964|NCT00676780|prostate specific antigen|prostate specific antigen
623965|NCT00676793|breast cancer|breast cancer
623966|NCT00676793|EGCG|egcg
623967|NCT00676793|Polyphenon E|polyphenon e
623968|NCT00676793|c-Met|c-met
623969|NCT00676793|VEGF|vegf
623970|NCT00676793|HGF|hgf
623971|NCT00676806|Umbilical cord blood transplantation|umbilical cord blood transplantation
623972|NCT00676806|full ablation conditioning|full ablation conditioning
623973|NCT00676806|reduced intensity conditioning|reduced intensity conditioning
623974|NCT00676832|colitis|colitis
623975|NCT00676832|ulcerative|ulcerative
623976|NCT00676832|moderate|moderate
623977|NCT00676832|severe|severe
623978|NCT00676845|Arterial stiffness|arterial stiffness
623979|NCT00676845|Vascular protection|vascular protection
623980|NCT00676858|Embolism|embolism
623981|NCT00676858|Argon|argon
623982|NCT00676884|atopic eczema|atopic eczema
623983|NCT00676884|atopic dermatitis|atopic dermatitis
623984|NCT00676884|allergy|allergy
623985|NCT00676897|statin, sepsis, septic shock, simvastatin|statin, sepsis, septic shock, simvastatin
623986|NCT00676910|Advanced Cancer|advanced cancer
623987|NCT00676910|Malignancies|malignancies
623988|NCT00676910|Neoplasms|neoplasms
623989|NCT00676910|Incurable Solid Cancers|incurable solid cancers
623990|NCT00676936|Cancer|cancer
623991|NCT00676936|pain|pain
623992|NCT00676936|corticosteroids|corticosteroids
623993|NCT00676936|palliative|palliative
623994|NCT00676936|supportive care|supportive care
623995|NCT00676936|Cancer patients with pain|cancer patients with pain
623996|NCT00676949|epitope peptide|epitope peptide
623997|NCT00676949|cyclophosphamide|cyclophosphamide
623998|NCT00676949|interleukin-2|interleukin-2
623999|NCT00676962|Implementation|implementation
624000|NCT00676962|facilitation|facilitation
624001|NCT00676962|psychotherapy|psychotherapy
624002|NCT00676962|training|training
624003|NCT00676975|Irritable Bowel disease|irritable bowel disease
624004|NCT00676975|Traditional Chinese Medicine|traditional chinese medicine
624005|NCT00676988|Luminal Crohn's Disease|luminal crohn's disease
624006|NCT00676988|Infliximab|infliximab
624007|NCT00677001|Solid tumors|solid tumors
624008|NCT00677001|solid malignancies|solid malignancies
624009|NCT00677001|neoplasms|neoplasms
624010|NCT00677001|refractory solid tumors|refractory solid tumors
624011|NCT00677001|advanced solid tumors|advanced solid tumors
624012|NCT00677014|Heart Failure|heart failure
624014|NCT00677014|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
624015|NCT00677014|CRT|crt
624016|NCT00677014|Optimization|optimization
624017|NCT00677014|SmartDelay|smartdelay
624018|NCT00677014|Echocardiography|echocardiography
624019|NCT00677014|AV Delay|av delay
624020|NCT00677027|Beta-glucan|beta-glucan
624021|NCT00677027|immune system|immune system
626446|NCT00684853|AMD|amd
624022|NCT00677027|Healthy subjects|healthy subjects
624023|NCT00677053|Unstable Angina|unstable angina
624024|NCT00677053|Myocardial Infarction|myocardial infarction
624025|NCT00677053|Thrombolysis|thrombolysis
624026|NCT00677053|Anticoagulant|anticoagulant
624027|NCT00677053|Acute Coronary Syndrome|acute coronary syndrome
624028|NCT00677066|bronchiolitis|bronchiolitis
624029|NCT00677066|oxygen|oxygen
624030|NCT00677066|children|children
624031|NCT00677079|BRCA-1 or BRCA-2 associated advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer|brca-1 or brca-2 associated advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer
624032|NCT00677079|BRCA-1|brca-1
624033|NCT00677079|BRCA-2|brca-2
624034|NCT00677092|Treatment|treatment
624035|NCT00677092|Chronic kidney disease|chronic kidney disease
624036|NCT00677092|Fibrosing disorders|fibrosing disorders
624037|NCT00677092|Imatinib mesylate|imatinib mesylate
624038|NCT00677105|Lymphoma|lymphoma
624039|NCT00677105|Neoplasms|neoplasms
624041|NCT00677105|Advanced Cancer|advanced cancer
624042|NCT00677118|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
624043|NCT00677118|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
624044|NCT00677118|Adjuvant chemotherapy|adjuvant chemotherapy
624045|NCT00677118|Clinical trial|clinical trial
624046|NCT00677131|pediatrics|pediatrics
624047|NCT00677131|antibiotics|antibiotics
624048|NCT00677131|patient education|patient education
624049|NCT00677144|Colorectal Neoplasm|colorectal neoplasm
624050|NCT00677144|S-1|s-1
624051|NCT00677144|Capecitabine|capecitabine
624052|NCT00677144|Oxaliplatin|oxaliplatin
624053|NCT00677157|Fatigue|fatigue
624054|NCT00677157|Fibromyalgia|fibromyalgia
624055|NCT00677157|Pain|pain
624056|NCT00677157|Complex Regional Pain Syndrome|complex regional pain syndrome
624057|NCT00677157|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
624058|NCT00677157|CPRS|cprs
624059|NCT00677157|RSD|rsd
624060|NCT00677183|NASH|nash
624061|NCT00677183|Biomarker|biomarker
624062|NCT00677196|PNL|pnl
624063|NCT00677196|Lithoclast|lithoclast
624064|NCT00677196|Stonebreaker|stonebreaker
624065|NCT00677196|efficiency stone fragmentation|efficiency stone fragmentation
624066|NCT00677209|house dust mite|house dust mite
624067|NCT00677209|asthma|asthma
624068|NCT00677209|autovaccine|autovaccine
624069|NCT00677209|allergy|allergy
624070|NCT00677222|Acute Myocardial Infarction, Heart Attack|acute myocardial infarction, heart attack
624071|NCT00677235|Hemodialysis|hemodialysis
624072|NCT00677235|Vascular Prosthesis|vascular prosthesis
624073|NCT00677235|Stenosis|stenosis
624074|NCT00677235|End-stage Renal Disease (ESRD)|end-stage renal disease (esrd)
624075|NCT00677248|Eprotirome|eprotirome
624076|NCT00677248|KB2115|kb2115
624077|NCT00677248|dyslipidemia|dyslipidemia
624078|NCT00677248|hypercholesterolemia|hypercholesterolemia
624079|NCT00677248|hypertriglyceridemia|hypertriglyceridemia
624080|NCT00677261|Knee|knee
624081|NCT00677261|Arthroplasty|arthroplasty
624082|NCT00677261|Sciatic|sciatic
624087|NCT00677261|Infiltration|infiltration
624088|NCT00677261|Local Anesthetic|local anesthetic
624089|NCT00677261|Analgesia|analgesia
624090|NCT00677274|Epidural analgesia|epidural analgesia
624091|NCT00677274|Patient-controlled analgesia|patient-controlled analgesia
624092|NCT00677287|HLA-A*2402|hla-a*2402
624093|NCT00677287|Peptide Vaccine|peptide vaccine
624095|NCT00677287|TOMM34|tomm34
624096|NCT00677287|VEGFR1|vegfr1
624097|NCT00677287|VEGFR2|vegfr2
624098|NCT00677300|HIV|hiv
624099|NCT00677300|Treatment Naive|treatment naive
624100|NCT00677313|metreleptin|metreleptin
624101|NCT00677313|leptin|leptin
624102|NCT00677313|Amylin|amylin
624103|NCT00677313|diabetes mellitus|diabetes mellitus
624104|NCT00677313|hypertriglyceridemia|hypertriglyceridemia
624105|NCT00677313|lipodystrophy|lipodystrophy
624106|NCT00677326|HLA-A*0201|hla-a*0201
624107|NCT00677326|Peptide Vaccine|peptide vaccine
624108|NCT00677326|VEGFR1|vegfr1
624109|NCT00677326|VEGFR2|vegfr2
624110|NCT00677339|Tuberculosis|tuberculosis
624111|NCT00677339|Adjunctive therapy|adjunctive therapy
624112|NCT00677339|L-arginine|l-arginine
624113|NCT00677339|Nitric oxide|nitric oxide
624114|NCT00677339|Vitamin D|vitamin d
624115|NCT00677352|Panic Disorder|panic disorder
624116|NCT00677378|TRPV1|trpv1
624117|NCT00677378|Nerve growth factor|nerve growth factor
624118|NCT00677378|Capsaicin|capsaicin
624119|NCT00677378|TrkA|trka
624120|NCT00677378|Retrosternal pain|retrosternal pain
624121|NCT00677378|Epigastric pain|epigastric pain
624122|NCT00677378|Esophagitis|esophagitis
624123|NCT00677378|Gastrointestinal symptoms|gastrointestinal symptoms
624124|NCT00677391|Obesity|obesity
624125|NCT00677404|Peripheral vascular diseases|peripheral vascular diseases
624126|NCT00677404|chronic lower limb ischemia|chronic lower limb ischemia
624127|NCT00677430|Breast Cancer|breast cancer
624128|NCT00677430|Breast Reconstruction|breast reconstruction
624129|NCT00677430|Digital Imaging|digital imaging
624130|NCT00677430|Questionnaire|questionnaire
624131|NCT00677430|Survey|survey
624132|NCT00677443|metastatic colorectal cancer|metastatic colorectal cancer
624133|NCT00677443|S-1|s-1
624134|NCT00677443|Capecitabine|capecitabine
624135|NCT00677443|Oxaliplatin|oxaliplatin
624136|NCT00677443|non-inferiority study|non-inferiority study
624137|NCT00677456|Gastric Cancer|gastric cancer
624138|NCT00677456|total gastrectomy|total gastrectomy
624139|NCT00677456|reconstruction|reconstruction
624140|NCT00677456|life quality|life quality
624141|NCT00677469|Hyperthyroidism|hyperthyroidism
624142|NCT00677469|Cholestyramine|cholestyramine
624143|NCT00677482|liver transplant|liver transplant
624144|NCT00677482|lung transplant|lung transplant
624145|NCT00677482|kidney transplant|kidney transplant
624146|NCT00677482|heart transplant|heart transplant
624147|NCT00677482|CMV microRNA|cmv microrna
624148|NCT00677495|Gluten-free diet|gluten-free diet
624149|NCT00677495|Celiac Disease|celiac disease
624150|NCT00677495|Genetic predisposition|genetic predisposition
624151|NCT00677495|Phage display library|phage display library
624152|NCT00677495|Autoimmune diseases|autoimmune diseases
624153|NCT00677508|Constipation|constipation
624154|NCT00677508|Fecal incontinence|fecal incontinence
624155|NCT00677508|Quality of life|quality of life
624156|NCT00677508|Health related quality of life|health related quality of life
624157|NCT00677534|Endstage renal disease|endstage renal disease
624158|NCT00677534|Vitamin D|vitamin d
624159|NCT00677534|Monocyte function|monocyte function
624160|NCT00677547|Kidney|kidney
624161|NCT00677547|Influenza vaccine|influenza vaccine
624162|NCT00677547|CMI|cmi
624163|NCT00677560|resistance|resistance
624164|NCT00677560|reactance|reactance
624165|NCT00677560|inflammation|inflammation
624166|NCT00677573|ART|art
624167|NCT00677573|poor responder|poor responder
624168|NCT00677573|GnRH antagonist|gnrh antagonist
624169|NCT00677573|Gonadotropins|gonadotropins
624170|NCT00677586|colorectal neoplasms|colorectal neoplasms
624171|NCT00677586|liver metastasis|liver metastasis
624172|NCT00677586|surgery|surgery
624173|NCT00677599|Cardiovascular disease|cardiovascular disease
624174|NCT00677599|type 2 diabetes|type 2 diabetes
624175|NCT00677599|flavonoids|flavonoids
624176|NCT00677599|cocoa|cocoa
624177|NCT00677599|soy|soy
624178|NCT00677599|epicatechin|epicatechin
624179|NCT00677599|postmenopausal|postmenopausal
624180|NCT00677599|carotid intima media thickness|carotid intima media thickness
624181|NCT00677599|plaque volume|plaque volume
624182|NCT00677612|HLA-A*0201|hla-a*0201
624183|NCT00677612|Peptide Vaccine|peptide vaccine
624184|NCT00677612|VEGFR1|vegfr1
624185|NCT00677612|VEGFR2|vegfr2
624186|NCT00677625|Liver|liver
624187|NCT00677625|Transplant|transplant
624188|NCT00677651|adipose|adipose
624189|NCT00677651|lean|lean
624190|NCT00677651|obese|obese
624191|NCT00677651|overweight|overweight
624192|NCT00677651|healthy|healthy
624193|NCT00677664|diabetic retinopathy|diabetic retinopathy
624194|NCT00677664|panretinal photocoagulation|panretinal photocoagulation
624196|NCT00677664|nerve fiber layer thickness|nerve fiber layer thickness
624197|NCT00677664|retinal function|retinal function
624199|NCT00677677|Liver transplant|liver transplant
624200|NCT00677677|Kidney transplant|kidney transplant
624201|NCT00677677|Pancreas transplant|pancreas transplant
624203|NCT00677677|Human Papillomavirus Quadrivalent Vaccine|human papillomavirus quadrivalent vaccine
624204|NCT00677690|COPD|copd
624205|NCT00677703|birth control pills|birth control pills
624206|NCT00677703|contraception|contraception
624207|NCT00677703|continuation|continuation
624208|NCT00677703|text messaging|text messaging
624209|NCT00677703|contraceptive continuation|contraceptive continuation
624210|NCT00677703|contraceptive knowledge|contraceptive knowledge
624211|NCT00670358|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
752362|NCT01172626|systemic adverse effects|systemic adverse effects
624212|NCT00670358|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
624213|NCT00670358|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
624214|NCT00670358|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
624215|NCT00670358|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
624216|NCT00670358|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
624217|NCT00670358|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
624218|NCT00670358|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
624219|NCT00670371|Caregiver burden|caregiver burden
624220|NCT00670384|SLIT|slit
624221|NCT00670384|Immunotherapy|immunotherapy
624222|NCT00670384|Short ragweed|short ragweed
624223|NCT00670384|SAR|sar
624224|NCT00670384|Seasonal allergic rhinitis|seasonal allergic rhinitis
624225|NCT00670397|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
624226|NCT00670397|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
624227|NCT00670397|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
624228|NCT00670410|Neuroblastoma|neuroblastoma
624229|NCT00670410|Autologous Transplant|autologous transplant
752248|NCT01172145|apathy|apathy
624230|NCT00670410|Allogeneic Transplant|allogeneic transplant
624231|NCT00670410|Immunotherapy|immunotherapy
624232|NCT00670423|Tacrolimus|tacrolimus
624233|NCT00670423|Sirolimus|sirolimus
624234|NCT00670423|Bortezomib|bortezomib
624235|NCT00670423|Acute Graft Versus Host Disease|acute graft versus host disease
624236|NCT00670423|Allogeneic Peripheral Blood Stem Cell Transplantation|allogeneic peripheral blood stem cell transplantation
624237|NCT00670449|FTY720|fty720
624238|NCT00670449|multiple sclerosis|multiple sclerosis
624239|NCT00670449|MS|ms
624240|NCT00670462|obesity, weight loss, treatment|obesity, weight loss, treatment
624241|NCT00670475|osteoarthritis|osteoarthritis
624242|NCT00670475|Knee|knee
624243|NCT00670475|virgin olive oil|virgin olive oil
624244|NCT00670475|piroxicam|piroxicam
624245|NCT00670475|Topical|topical
624246|NCT00670514|RCT|rct
624247|NCT00670514|tobacco|tobacco
624248|NCT00670514|treatment intensity|treatment intensity
624249|NCT00670514|dentistry|dentistry
624250|NCT00670514|follow-up|follow-up
624251|NCT00670514|Smoking cessation|smoking cessation
624252|NCT00670514|Cost effectiveness|cost effectiveness
624253|NCT00670527|Prostate cancer|prostate cancer
624254|NCT00670527|[18F] Fluorocholine PET/CT|[18f] fluorocholine pet/ct
624255|NCT00670527|FCH|fch
624256|NCT00670527|lymph node metastasis|lymph node metastasis
624257|NCT00670527|staging|staging
624258|NCT00670527|sensitivity|sensitivity
624259|NCT00670527|specificity|specificity
624260|NCT00670527|PROPET|propet
624261|NCT00670540|pulmonary embolism|pulmonary embolism
624262|NCT00670540|duplex ultrasound examination|duplex ultrasound examination
624263|NCT00670540|recurrence|recurrence
624264|NCT00670553|Prostate,|prostate,
624265|NCT00670553|Head & Neck,|head & neck,
624266|NCT00670553|Esophageal|esophageal
624267|NCT00670579|TIVAD|tivad
624268|NCT00670579|complications|complications
624269|NCT00670579|nursing|nursing
624270|NCT00670579|cystic fibrosis|cystic fibrosis
624271|NCT00670579|implanted|implanted
624272|NCT00670592|HCD122|hcd122
624273|NCT00670592|CD40|cd40
624274|NCT00670592|NHL|nhl
624275|NCT00670592|HL|hl
624276|NCT00670605|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
624277|NCT00670605|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
624280|NCT00670644|male breast cancer|male breast cancer
624281|NCT00670644|recurrent breast cancer|recurrent breast cancer
624282|NCT00670644|stage I breast cancer|stage i breast cancer
624283|NCT00670644|stage II breast cancer|stage ii breast cancer
624284|NCT00670644|stage IIIA breast cancer|stage iiia breast cancer
624285|NCT00670644|stage IIIB breast cancer|stage iiib breast cancer
624286|NCT00670644|stage IIIC breast cancer|stage iiic breast cancer
624287|NCT00670644|stage IV breast cancer|stage iv breast cancer
624288|NCT00670657|candidemia|candidemia
624289|NCT00670657|invasive candidiasis|invasive candidiasis
624290|NCT00670657|Ambisome|ambisome
624699|NCT00680043|Hematide™|hematide™
624700|NCT00680043|hemoglobin|hemoglobin
624291|NCT00670657|liposomal amphotericin B|liposomal amphotericin b
624292|NCT00670696|Topical anesthesia|topical anesthesia
624293|NCT00670696|Rapydan|rapydan
624294|NCT00670696|Topical anaesthesia for venous cannulation|topical anaesthesia for venous cannulation
624295|NCT00670709|encephalography|encephalography
624296|NCT00670709|quantitative|quantitative
624297|NCT00670709|biomarkers|biomarkers
624298|NCT00670735|Pediatric Hydrocephalus|pediatric hydrocephalus
624299|NCT00670748|Metastatic Cancer|metastatic cancer
624300|NCT00670748|Gene Therapy|gene therapy
624301|NCT00670748|Immunotherapy|immunotherapy
624302|NCT00670748|Tumor Regression|tumor regression
624303|NCT00670748|Metastatic Melanoma|metastatic melanoma
624304|NCT00670748|Metastatic Renal Cell Cancer|metastatic renal cell cancer
624305|NCT00670761|misoprostol|misoprostol
624306|NCT00670761|incomplete abortion|incomplete abortion
624307|NCT00670761|sublingual|sublingual
624308|NCT00670761|postabortion care|postabortion care
624309|NCT00670761|MVA|mva
624310|NCT00670774|Kidney|kidney
624311|NCT00670774|Transplant|transplant
624312|NCT00670774|donor|donor
624313|NCT00670787|Hypertension|hypertension
624314|NCT00670787|combination pill|combination pill
624315|NCT00670787|compliance|compliance
624316|NCT00670800|Polycystic Ovary Syndrome|polycystic ovary syndrome
624317|NCT00670800|Insulin resistance|insulin resistance
624318|NCT00670800|Metformin|metformin
624319|NCT00670800|Brain function|brain function
624320|NCT00670813|Depression|depression
624321|NCT00670813|(total) sleep deprivation|(total) sleep deprivation
624322|NCT00670813|Modafinil|modafinil
624323|NCT00670813|polysomnography sleep|polysomnography sleep
624324|NCT00670826|Patient warming|patient warming
624325|NCT00677716|glioblastoma multiforme|glioblastoma multiforme
624326|NCT00677716|GBM|gbm
624327|NCT00677716|brain cancer|brain cancer
624328|NCT00677716|Cotara|cotara
624329|NCT00677716|radioactive isotope|radioactive isotope
624330|NCT00677716|monoclonal antibody|monoclonal antibody
624331|NCT00677716|Glioblastoma multiforme at first relapse|glioblastoma multiforme at first relapse
624332|NCT00677729|bronchiolitis|bronchiolitis
624333|NCT00677729|hypertonic saline|hypertonic saline
624334|NCT00677729|infants|infants
624335|NCT00677742|oral contraception|oral contraception
624336|NCT00677742|hormonal contraception|hormonal contraception
624337|NCT00677742|contraceptive behavior|contraceptive behavior
624338|NCT00677742|patient compliance|patient compliance
624339|NCT00677755|Medical abortion|medical abortion
624340|NCT00677755|emergency contraception|emergency contraception
624341|NCT00677755|mifepristone|mifepristone
624342|NCT00677768|Biomarkers|biomarkers
624343|NCT00677768|Plasma|plasma
624344|NCT00677768|Cerebrospinal Fluid|cerebrospinal fluid
624345|NCT00677768|DNA|dna
624346|NCT00677768|Serum|serum
624347|NCT00677794|Video Capsule Endoscopy|video capsule endoscopy
624348|NCT00677794|Small Bowel|small bowel
624349|NCT00677807|COPD|copd
624350|NCT00677807|adults|adults
624351|NCT00677807|β2-agonist|β2-agonist
624352|NCT00677807|indacaterol|indacaterol
624353|NCT00677820|Influenza|influenza
624354|NCT00677820|FluMist|flumist
624355|NCT00677820|vaccine|vaccine
624356|NCT00677820|prevention|prevention
624358|NCT00677833|P. Falciparum Malaria|p. falciparum malaria
624359|NCT00677833|drug treatment|drug treatment
624360|NCT00677833|clinical trial|clinical trial
624361|NCT00677846|contrast agent ultrasound, vein thrombosis, vascularization|contrast agent ultrasound, vein thrombosis, vascularization
624362|NCT00677859|Leukemia|leukemia
624363|NCT00677859|Graft vs. Host Disease|graft vs. host disease
624364|NCT00677859|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
624365|NCT00677859|Bone Marrow Transplant|bone marrow transplant
624366|NCT00677859|Myelodysplasia|myelodysplasia
624367|NCT00677872|Moderate to severe COPD and coincident pulmonary hypertension|moderate to severe copd and coincident pulmonary hypertension
624368|NCT00677885|Alzheimer Disease|alzheimer disease
624369|NCT00677885|Parkinson's Disease|parkinson's disease
624370|NCT00677885|Frontotemporal Dementia|frontotemporal dementia
624371|NCT00677885|PET Imaging|pet imaging
624372|NCT00677885|AD|ad
624373|NCT00677885|Parkinson Disease|parkinson disease
624374|NCT00677885|PD|pd
624375|NCT00677898|Patient-Centered Care|patient-centered care
624376|NCT00677898|Adverse effects|adverse effects
624377|NCT00677898|Antipsychotics|antipsychotics
624378|NCT00677911|Chronic pain|chronic pain
624379|NCT00677911|Interleukin-6|interleukin-6
624380|NCT00677911|pain catastrophizing|pain catastrophizing
624381|NCT00677911|cytokines|cytokines
624382|NCT00677911|cortisol|cortisol
624383|NCT00677924|Colorectal Neoplasms|colorectal neoplasms
624384|NCT00677924|Colorectal Tumors|colorectal tumors
624385|NCT00677924|Colorectal Carcinoma|colorectal carcinoma
624386|NCT00677937|diabetes mellitus|diabetes mellitus
624387|NCT00677937|prevention|prevention
624388|NCT00677937|education|education
624389|NCT00677937|impaired glucose tolerance|impaired glucose tolerance
624390|NCT00677937|multi-ethnic|multi-ethnic
624391|NCT00677950|Degenerative Disc Disease|degenerative disc disease
624392|NCT00677963|carotid|carotid
624393|NCT00677963|atherosclerosis|atherosclerosis
624394|NCT00677963|arteriosclerosis|arteriosclerosis
624395|NCT00677963|plaque|plaque
624396|NCT00677963|neovascularization|neovascularization
624397|NCT00677963|carotid endarterectomy|carotid endarterectomy
624398|NCT00677976|fMRI|fmri
624399|NCT00677976|IBS|ibs
624400|NCT00677976|Brain Activation|brain activation
624401|NCT00677989|perforated appendicitis|perforated appendicitis
624402|NCT00677989|laparoscopic appendectomy|laparoscopic appendectomy
624403|NCT00677989|open appendectomy|open appendectomy
624404|NCT00677989|cytokines|cytokines
624405|NCT00677989|free radicals|free radicals
624406|NCT00677989|oxidized proteins|oxidized proteins
624407|NCT00678002|solid organ transplant|solid organ transplant
624408|NCT00678015|NDGA|ndga
624409|NCT00678015|Prostate Cancer|prostate cancer
624410|NCT00678028|MBL, UTI|mbl, uti
624411|NCT00678041|urinary catheterization|urinary catheterization
624412|NCT00678041|urinary tract infection|urinary tract infection
624413|NCT00678041|urinary incontinence|urinary incontinence
624414|NCT00678041|pelvic floor prolapse|pelvic floor prolapse
624415|NCT00678041|antibiotics|antibiotics
624416|NCT00678912|mechanical ventilation|mechanical ventilation
624417|NCT00678912|automated weaning|automated weaning
624418|NCT00678912|children|children
624419|NCT00678938|smoking reduction|smoking reduction
624420|NCT00678938|smoking cessation|smoking cessation
624421|NCT00678938|stages of change|stages of change
624422|NCT00678938|expert system interventions|expert system interventions
624423|NCT00678964|NSCLC|nsclc
624424|NCT00678964|Elderly patients|elderly patients
624425|NCT00678977|pharmacokinetics|pharmacokinetics
624426|NCT00678977|cisplatin|cisplatin
624427|NCT00678977|pazopanib (GW786034)|pazopanib (gw786034)
624428|NCT00678977|Solid tumors|solid tumors
624429|NCT00678977|anti-angiogenesis|anti-angiogenesis
624430|NCT00678977|gemcitabine|gemcitabine
624431|NCT00678990|Islets of Langerhans|islets of langerhans
624432|NCT00678990|islets|islets
624433|NCT00678990|heparin|heparin
624434|NCT00679003|Crohn's disease|crohn's disease
624435|NCT00679003|Ulcerative colitis|ulcerative colitis
624436|NCT00679003|Inflammatory bowel disease|inflammatory bowel disease
624437|NCT00679003|Illness behavior|illness behavior
624438|NCT00679003|Cognitive behavioral therapy|cognitive behavioral therapy
624439|NCT00679042|Diabetes Mellitus Type 1|diabetes mellitus type 1
624440|NCT00679042|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
624441|NCT00679042|Islets of Langerhans Transplantation|islets of langerhans transplantation
624442|NCT00679042|Allogeneic Islet transplantation|allogeneic islet transplantation
624443|NCT00679068|respiratory mechanics|respiratory mechanics
624444|NCT00679068|bosentan|bosentan
624445|NCT00679068|exercise capacity|exercise capacity
624446|NCT00679107|Degenerative Disc Disease|degenerative disc disease
624447|NCT00679120|Unicompartmental osteoarthrosis|unicompartmental osteoarthrosis
624448|NCT00679120|RSA|rsa
624449|NCT00679120|Bone-remodelling|bone-remodelling
624450|NCT00679133|c-Met|c-met
624451|NCT00679133|VEGFR|vegfr
624452|NCT00679133|Ron|ron
624453|NCT00679133|Cancer|cancer
624454|NCT00679133|Tumor|tumor
624455|NCT00679133|Safety|safety
624456|NCT00679133|Phase 1|phase 1
624458|NCT00679185|stage I breast cancer|stage i breast cancer
624459|NCT00679185|stage II breast cancer|stage ii breast cancer
624460|NCT00679185|stage IIIA breast cancer|stage iiia breast cancer
624461|NCT00679185|stage IIIB breast cancer|stage iiib breast cancer
624462|NCT00679185|stage IIIC breast cancer|stage iiic breast cancer
624463|NCT00679185|lymphedema|lymphedema
624464|NCT00679198|osteoporosis|osteoporosis
624465|NCT00679198|fracture|fracture
624466|NCT00679198|communication|communication
624467|NCT00679198|prescription medication|prescription medication
624468|NCT00679211|HER2-positive breast cancer|her2-positive breast cancer
624469|NCT00679211|HER2|her2
624470|NCT00679211|MBC|mbc
624471|NCT00679211|Trastuzumab emtansine|trastuzumab emtansine
624472|NCT00679224|Pulmonary Arterial Hypertesion|pulmonary arterial hypertesion
624473|NCT00679224|observational safety|observational safety
624474|NCT00679250|allergic rhinitis|allergic rhinitis
624475|NCT00679250|levocetirizine|levocetirizine
624476|NCT00679250|nasal provocation testing|nasal provocation testing
624477|NCT00679250|nasal allergen challenge|nasal allergen challenge
624478|NCT00679250|nasal adenosine monophosphate challenge|nasal adenosine monophosphate challenge
624479|NCT00679263|asthma|asthma
624480|NCT00679263|randomized|randomized
624481|NCT00679263|placebo controlled|placebo controlled
624482|NCT00679263|dose escalation|dose escalation
624483|NCT00679263|safety|safety
624484|NCT00679263|efficacy|efficacy
624485|NCT00679263|single blind|single blind
624486|NCT00679263|MN-221|mn-221
624487|NCT00679276|vaginal prolapse|vaginal prolapse
624488|NCT00679289|KW2871|kw2871
624489|NCT00679289|ecromeximab|ecromeximab
624490|NCT00679289|anti-ganglioside|anti-ganglioside
624491|NCT00679289|antibody|antibody
624492|NCT00679289|interferon alpha|interferon alpha
624493|NCT00679289|Metastatic melanoma|metastatic melanoma
624494|NCT00679302|skin abscess|skin abscess
624495|NCT00679302|CA-MRSA|ca-mrsa
624496|NCT00679315|female voiding dysfunction|female voiding dysfunction
624497|NCT00679315|alpha adrenoreceptor antagonists|alpha adrenoreceptor antagonists
624498|NCT00679315|IPSS or American Urological Association symptom index|ipss or american urological association symptom index
624499|NCT00679341|HER2-positive breast cancer|her2-positive breast cancer
624500|NCT00679341|HER2|her2
624501|NCT00679341|Herceptin|herceptin
624502|NCT00679341|Taxotere|taxotere
624503|NCT00679341|MBC|mbc
624504|NCT00679341|Breast cancer|breast cancer
624505|NCT00679341|TDM1|tdm1
624506|NCT00679341|TDM-1|tdm-1
752363|NCT01172639|CoBRA|cobra
624507|NCT00679341|HER2-positive|her2-positive
624508|NCT00679341|HER2+|her2+
624509|NCT00679341|HER2 positive breast cancer|her2 positive breast cancer
624510|NCT00679341|HER2+ breast cancer|her2+ breast cancer
624511|NCT00679341|Armed Herceptin|armed herceptin
624512|NCT00679341|Trastuzumab emtansine|trastuzumab emtansine
624513|NCT00679341|Trastuzumab DM1|trastuzumab dm1
624514|NCT00679367|primary systemic amyloidosis|primary systemic amyloidosis
624515|NCT00679380|Ulcerative colitis|ulcerative colitis
624516|NCT00679393|Calcaneus|calcaneus
624517|NCT00679393|Intra-articular fracture|intra-articular fracture
624518|NCT00679393|open reduction internal fixation|open reduction internal fixation
624519|NCT00679393|primary subtalar fusion|primary subtalar fusion
624520|NCT00679406|Chronic Insomnia lasting more than 1 month|chronic insomnia lasting more than 1 month
624521|NCT00679432|Ulcerative colitis|ulcerative colitis
624522|NCT00679445|Macular|macular
624523|NCT00679445|Degeneration|degeneration
624524|NCT00679445|AMD|amd
624525|NCT00679445|Wet Age-related macular degeneration|wet age-related macular degeneration
624526|NCT00679458|analgesia|analgesia
624527|NCT00679458|pain|pain
624528|NCT00679458|buprenorphine|buprenorphine
624529|NCT00679458|opioid|opioid
624530|NCT00679458|naloxone|naloxone
624531|NCT00679471|pre-term infants|pre-term infants
624532|NCT00679471|full-term infants|full-term infants
624533|NCT00679471|MRI|mri
624534|NCT00679471|brain structure development|brain structure development
624535|NCT00679471|pre term|pre term
624536|NCT00679471|full term|full term
624537|NCT00679497|Low risk HIV infection|low risk hiv infection
624538|NCT00679497|HIV Seronegativity|hiv seronegativity
624539|NCT00679497|HIV Preventive Vaccine|hiv preventive vaccine
624540|NCT00679510|Rheumatoid Arthritis|rheumatoid arthritis
624541|NCT00679510|Rosuvastatin|rosuvastatin
624542|NCT00679510|Cardiovascular|cardiovascular
624543|NCT00679510|Intima media thickness|intima media thickness
624544|NCT00679523|Onychomycosis|onychomycosis
624545|NCT00679523|Fungal Nail|fungal nail
624546|NCT00679536|Reduced Toxicity|reduced toxicity
624547|NCT00679536|Toxicity|toxicity
624548|NCT00679536|Event Free Survival|event free survival
624549|NCT00679536|Graft vs Host Disease|graft vs host disease
624550|NCT00679549|Heart Failure|heart failure
624551|NCT00679549|Obstructive Sleep Apnea|obstructive sleep apnea
624552|NCT00679549|OSA|osa
624553|NCT00679549|CHF|chf
624554|NCT00679549|Sleep apnea|sleep apnea
624555|NCT00679549|CHD|chd
624556|NCT00679575|statins|statins
624557|NCT00679575|myocardial infarction|myocardial infarction
624558|NCT00679575|case-referent study|case-referent study
624559|NCT00679575|France|france
624560|NCT00679588|Digestive System Surgical Procedure|digestive system surgical procedure
624561|NCT00679588|Urologic Surgical Procedure|urologic surgical procedure
624562|NCT00679588|Prevention of venous thromboembolism|prevention of venous thromboembolism
624563|NCT00679588|Abdominal surgery|abdominal surgery
624564|NCT00679601|Onychomycosis|onychomycosis
624565|NCT00679601|Fungal Nail|fungal nail
624566|NCT00679614|Tramacet|tramacet
624567|NCT00679614|naloxone|naloxone
624568|NCT00679614|morphine|morphine
624569|NCT00679614|analgesia|analgesia
624570|NCT00679614|elderly|elderly
624571|NCT00679614|elderly patients|elderly patients
624572|NCT00679627|Alzheimer's Disease|alzheimer's disease
624573|NCT00679627|Galantamine|galantamine
624574|NCT00679627|Dementia, Alzheimer type|dementia, alzheimer type
624575|NCT00679627|Memory loss|memory loss
624576|NCT00679640|candesartan|candesartan
624577|NCT00679640|heart failure|heart failure
624578|NCT00679640|cohort study|cohort study
624579|NCT00679640|France|france
624580|NCT00679666|keratoconus|keratoconus
624581|NCT00679666|ectasia|ectasia
624582|NCT00679666|cross-linking|cross-linking
624583|NCT00679666|riboflavin|riboflavin
624584|NCT00679666|UVA light|uva light
624585|NCT00679666|cornea|cornea
624586|NCT00679679|Polycystic ovary syndrome|polycystic ovary syndrome
624587|NCT00679679|Treatment|treatment
624588|NCT00679679|Metformin|metformin
624589|NCT00679692|GH,IGF-1, IGFBP-3|gh,igf-1, igfbp-3
624590|NCT00679705|Hemodynamics and arterial function of healthy females|hemodynamics and arterial function of healthy females
624591|NCT00679731|Psoriasis|psoriasis
624592|NCT00679744|Tay-Sachs disease.|tay-sachs disease.
624593|NCT00679744|Sandhoff disease.|sandhoff disease.
624594|NCT00679744|GM2 Gangliosidosis.|gm2 gangliosidosis.
624595|NCT00679744|β-hexosaminidase deficiency.|β-hexosaminidase deficiency.
624596|NCT00679744|Hexosaminidase|hexosaminidase
624597|NCT00679744|Phase I clinical trial.|phase i clinical trial.
624598|NCT00679757|Sleep apnea|sleep apnea
624599|NCT00679757|Obstructive sleep apnea|obstructive sleep apnea
624600|NCT00679757|Wound healing|wound healing
624601|NCT00679757|Non-healing wounds|non-healing wounds
624602|NCT00679770|Onychomycosis|onychomycosis
624603|NCT00679770|Fungal Nail|fungal nail
624604|NCT00679783|Breast cancer|breast cancer
624605|NCT00679783|Ovarian cancer|ovarian cancer
624606|NCT00679783|BRCA|brca
624607|NCT00679783|Triple negative|triple negative
625910|NCT00683618|CHD|chd
624608|NCT00679783|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
624609|NCT00679783|Known BRCA or Recurrent High Grade Serious/ Undifferentiated Tubo- Ovarian Carcinoma|known brca or recurrent high grade serious/ undifferentiated tubo- ovarian carcinoma
624610|NCT00679783|Known BRCA or Triple Negative Breast Cancer|known brca or triple negative breast cancer
624611|NCT00679796|varicella|varicella
624612|NCT00679796|case-control|case-control
624613|NCT00679809|Resident|resident
624614|NCT00679809|Safety|safety
624615|NCT00679809|Fatigue|fatigue
624616|NCT00679809|Continuity|continuity
624617|NCT00679809|ICU|icu
624618|NCT00679822|OSA|osa
624619|NCT00679822|sleep apnea|sleep apnea
624620|NCT00679822|heart failure|heart failure
624621|NCT00679822|CHF|chf
624622|NCT00679822|heart clinic|heart clinic
624623|NCT00679822|clinic|clinic
624624|NCT00679822|obstructive sleep apnea|obstructive sleep apnea
624625|NCT00679848|Weight Loss|weight loss
624626|NCT00679848|Transoral Suturing|transoral suturing
624627|NCT00679848|Experimental|experimental
624628|NCT00679861|primary medical care|primary medical care
624629|NCT00679861|computer expert system|computer expert system
624630|NCT00679861|motivational interviewing|motivational interviewing
624631|NCT00679861|health behavior change counselling|health behavior change counselling
624632|NCT00679861|stages of change|stages of change
752249|NCT01172145|Alzheimer's disease|alzheimer's disease
624633|NCT00679874|Cardiovascular Magnetic Resonance Imaging|cardiovascular magnetic resonance imaging
624634|NCT00679874|Cardiotoxicity|cardiotoxicity
624635|NCT00679874|Anthracyclines|anthracyclines
624636|NCT00679874|Trastuzumab|trastuzumab
624637|NCT00679874|Breast cancer|breast cancer
624638|NCT00679874|Toxicity|toxicity
624639|NCT00679887|chiropractic|chiropractic
624640|NCT00679887|myofascial trigger points|myofascial trigger points
624641|NCT00679887|ischemic compression|ischemic compression
624642|NCT00679887|shoulder pain|shoulder pain
624643|NCT00679900|Primary Insomnia|primary insomnia
624644|NCT00679900|Sleep Maintenance Difficulties|sleep maintenance difficulties
624645|NCT00679913|Pancreatic cancer|pancreatic cancer
624646|NCT00679913|Pancreaticoduodenectomy|pancreaticoduodenectomy
624647|NCT00679913|Extended lymphadenectomy|extended lymphadenectomy
624648|NCT00679926|HIV|hiv
624649|NCT00679926|AIDS|aids
624650|NCT00679926|HIV/AIDS|hiv/aids
624651|NCT00679926|Treatment Naive|treatment naive
624652|NCT00679939|Type 2 diabetes mellitus|type 2 diabetes mellitus
624653|NCT00679939|bone|bone
624654|NCT00679939|x-ray absorptiometry|x-ray absorptiometry
624655|NCT00679939|bone biomarkers|bone biomarkers
624656|NCT00679939|dual-energy|dual-energy
624657|NCT00679939|bone mineral density|bone mineral density
624658|NCT00679952|Pancreatic fistula|pancreatic fistula
624659|NCT00679952|Pancreatic duct stent|pancreatic duct stent
624660|NCT00679952|Closed suction drainage|closed suction drainage
624661|NCT00679965|Onychomycosis|onychomycosis
624662|NCT00679965|Fungal Nail|fungal nail
624663|NCT00679978|osteoporosis|osteoporosis
624664|NCT00679978|glucocorticoid|glucocorticoid
624665|NCT00679978|bone mineral density|bone mineral density
624666|NCT00679978|osteonecrosis of the femoral head|osteonecrosis of the femoral head
624667|NCT00679991|arteriovenous fistula|arteriovenous fistula
624668|NCT00679991|AVF|avf
624669|NCT00679991|hemodialysis|hemodialysis
624670|NCT00679991|vascular access|vascular access
624671|NCT00679991|PRT 201|prt 201
624672|NCT00679991|dose escalation|dose escalation
624673|NCT00679991|dialysis|dialysis
624674|NCT00679991|fistula|fistula
624675|NCT00679991|access|access
624676|NCT00679991|vonapanitase|vonapanitase
624677|NCT00679991|kidney|kidney
624678|NCT00679991|renal|renal
624679|NCT00680004|Dynamic CTA|dynamic cta
624680|NCT00680004|follow-up|follow-up
624681|NCT00680004|EVAR|evar
624682|NCT00680017|Dyslipidemia|dyslipidemia
624683|NCT00680017|Kidney Disease|kidney disease
624684|NCT00680030|impedance|impedance
624685|NCT00680030|manometry|manometry
624686|NCT00680030|motility disorders|motility disorders
624687|NCT00680030|ineffective motility|ineffective motility
624688|NCT00680030|diffuse esophageal spasms|diffuse esophageal spasms
624689|NCT00680030|achlasia-like dysmotility|achlasia-like dysmotility
624690|NCT00680043|anemia|anemia
624691|NCT00680043|chronic kidney disease|chronic kidney disease
624692|NCT00680043|CKD|ckd
624693|NCT00680043|chronic renal failure|chronic renal failure
624694|NCT00680043|CRF|crf
624695|NCT00680043|erythropoietin|erythropoietin
624696|NCT00680043|EPO|epo
624697|NCT00680043|erythropoiesis stimulating agent|erythropoiesis stimulating agent
624698|NCT00680043|ESA|esa
624704|NCT00680043|peginesatide|peginesatide
624705|NCT00680043|red blood cell|red blood cell
624706|NCT00680043|red blood cell production|red blood cell production
624707|NCT00680056|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
624708|NCT00680056|Tiotropium|tiotropium
624709|NCT00680056|Formoterol|formoterol
624710|NCT00680056|Bronchodilator Agents|bronchodilator agents
624711|NCT00680056|Exercise Tolerance|exercise tolerance
624712|NCT00680056|Randomized Controlled Trial [Publication Type]|randomized controlled trial [publication type]
624713|NCT00680056|COPD|copd
624714|NCT00680069|avian influenza,H5N1,Influenza,parent protocol|avian influenza,h5n1,influenza,parent protocol
624715|NCT00680082|statins|statins
624716|NCT00680082|rosuvastatin|rosuvastatin
624717|NCT00680082|cross sectional study|cross sectional study
624718|NCT00680082|France|france
624719|NCT00680082|CV risk factors|cv risk factors
624720|NCT00680095|Onychomycosis|onychomycosis
624721|NCT00680095|Fungal Nail|fungal nail
624722|NCT00680121|Alcoholism|alcoholism
624723|NCT00680121|Benfotiamine|benfotiamine
624724|NCT00680121|Thiamine|thiamine
624725|NCT00680134|Onychomycosis|onychomycosis
624726|NCT00680134|Fungal Nail|fungal nail
624727|NCT00680147|HPV|hpv
624728|NCT00680147|Gardasil|gardasil
624729|NCT00680147|African-American|african-american
624730|NCT00680147|adolescent|adolescent
624731|NCT00680147|health behavior|health behavior
624732|NCT00680147|sexually transmitted infections|sexually transmitted infections
624733|NCT00680147|This will enroll 300 mothers of teenage girls and boys to identify barriers to HPV vaccination among low-income, African-American teens.|this will enroll 300 mothers of teenage girls and boys to identify barriers to hpv vaccination among low-income, african-american teens.
624734|NCT00680160|Onychomycosis|onychomycosis
624735|NCT00680160|Fungal Nail|fungal nail
624736|NCT00680173|Chronic Hepatitis C|chronic hepatitis c
624737|NCT00680173|Single nucleotide polymorphisms|single nucleotide polymorphisms
624738|NCT00680173|Sustained virological response|sustained virological response
624740|NCT00680173|Ribavirin|ribavirin
624741|NCT00680199|Insomnia|insomnia
624742|NCT00680199|Primary Insomnia|primary insomnia
624743|NCT00680199|Good Sleepers|good sleepers
624744|NCT00680199|ERP|erp
624745|NCT00680212|dietary beta-carotene|dietary beta-carotene
624746|NCT00680212|vitamin A status|vitamin a status
624747|NCT00680212|intrinsically labeled plant foods|intrinsically labeled plant foods
624748|NCT00680225|Choroidal melanoma|choroidal melanoma
624749|NCT00680225|Lucentis|lucentis
624750|NCT00680225|TTT-ICG|ttt-icg
624751|NCT00680238|Pregnancy|pregnancy
624752|NCT00680238|implantation|implantation
624753|NCT00680238|miscarriage|miscarriage
624754|NCT00680238|sHLA-G|shla-g
624755|NCT00680264|Treatment Outcomes|treatment outcomes
624756|NCT00680264|Scoliosis|scoliosis
624757|NCT00680264|Cerebral Palsy|cerebral palsy
624758|NCT00680277|spirulina|spirulina
624759|NCT00680277|carotenoids|carotenoids
624760|NCT00680290|exercise, quality of life, cpx|exercise, quality of life, cpx
624761|NCT00680303|Early Stuttering|early stuttering
624762|NCT00680303|Lidcombe Program|lidcombe program
624763|NCT00680303|Stuttering Treatment|stuttering treatment
624765|NCT00680303|Efficacy|efficacy
624766|NCT00680303|Service Delivery|service delivery
624767|NCT00680303|Models of intervention|models of intervention
624768|NCT00680316|Pulmozyme|pulmozyme
624769|NCT00680316|CF|cf
624770|NCT00680329|Adherence|adherence
624771|NCT00680329|Compliance|compliance
624772|NCT00680329|Glaucoma|glaucoma
624773|NCT00680329|Ocular Hypertension|ocular hypertension
624774|NCT00680342|hepatitis C|hepatitis c
624775|NCT00680355|golden rice carotenoids|golden rice carotenoids
624776|NCT00680355|healthy volunteers|healthy volunteers
624777|NCT00680355|retinol equivalence|retinol equivalence
624778|NCT00680368|Feasibility|feasibility
624779|NCT00680368|Supervision|supervision
624780|NCT00680368|Assessing|assessing
624781|NCT00680381|adolescent substance abuse|adolescent substance abuse
624782|NCT00680394|abortion|abortion
624783|NCT00680394|medical abortion|medical abortion
624784|NCT00680394|mifepristone|mifepristone
624785|NCT00680394|misoprostol|misoprostol
624786|NCT00680407|NASH|nash
624787|NCT00680407|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
624788|NCT00680420|pancreas cancer|pancreas cancer
624789|NCT00680420|pancreas cyst|pancreas cyst
624790|NCT00680420|DNA microarray|dna microarray
624791|NCT00680446|Primary Immune Deficiency|primary immune deficiency
624792|NCT00680446|Subcutaneous|subcutaneous
624793|NCT00680446|Immunoglobulin G|immunoglobulin g
624794|NCT00680459|central line infection|central line infection
624795|NCT00680459|70% ethanol|70% ethanol
624796|NCT00680459|Sepsis|sepsis
624797|NCT00680472|Shoulder pain|shoulder pain
624798|NCT00680472|Pain|pain
624799|NCT00680472|Ketoprofen|ketoprofen
624800|NCT00680472|Topical Patch|topical patch
624801|NCT00680485|GSK580416|gsk580416
624802|NCT00680485|ketoconazole interaction|ketoconazole interaction
624803|NCT00680485|pleuromutilin|pleuromutilin
624804|NCT00680485|oral dose|oral dose
624805|NCT00680498|Age-Related Macular Degeneration|age-related macular degeneration
624806|NCT00680498|Ranibizumab|ranibizumab
624807|NCT00680498|Lucentis|lucentis
624808|NCT00680498|Photodynamic Therapy|photodynamic therapy
624809|NCT00680498|Verteporfin|verteporfin
624810|NCT00680498|Visudyne|visudyne
624811|NCT00680511|methamphetamine abuse|methamphetamine abuse
624812|NCT00680524|telephone-based intervention for PTSD|telephone-based intervention for ptsd
624813|NCT00680537|physical therapy program|physical therapy program
624814|NCT00680550|Atrial Fibrillation|atrial fibrillation
624815|NCT00680550|Risk of cardiac Arrhythmias|risk of cardiac arrhythmias
624816|NCT00680550|Loop recorder|loop recorder
624817|NCT00680576|adolescent substance abuse|adolescent substance abuse
624818|NCT00680589|TYRP2 DNA Vaccine|tyrp2 dna vaccine
624819|NCT00680602|behavior therapy|behavior therapy
624820|NCT00680602|group therapy|group therapy
624821|NCT00680602|psychopharmacology|psychopharmacology
624822|NCT00680615|Smokeless tobacco|smokeless tobacco
624823|NCT00680628|Pulmonary Embolism|pulmonary embolism
624824|NCT00680628|Tenecteplase|tenecteplase
624825|NCT00680628|Enoxaparin|enoxaparin
624826|NCT00680628|Thrombosis|thrombosis
624827|NCT00680628|Fibrinolytics|fibrinolytics
624828|NCT00680641|COPD|copd
624829|NCT00680641|Emphysema|emphysema
624830|NCT00680641|Simvastatin|simvastatin
624831|NCT00680654|Pulmonary hypertension|pulmonary hypertension
624832|NCT00680667|ductal breast carcinoma|ductal breast carcinoma
624833|NCT00680667|stage I breast cancer|stage i breast cancer
624834|NCT00680667|stage II breast cancer|stage ii breast cancer
624835|NCT00680667|stage IIIA breast cancer|stage iiia breast cancer
624836|NCT00680667|stage IIIB breast cancer|stage iiib breast cancer
624837|NCT00680667|stage IIIC breast cancer|stage iiic breast cancer
624838|NCT00680667|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
624839|NCT00680667|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
624840|NCT00680680|Urinary retention secondary to benign prostatic hyperplasia|urinary retention secondary to benign prostatic hyperplasia
624841|NCT00680693|IBS, functional gastrointestinal disease|ibs, functional gastrointestinal disease
624842|NCT00680719|substance abuse|substance abuse
624843|NCT00680719|HIV risk|hiv risk
624844|NCT00680719|Behavior and Mental Disorders|behavior and mental disorders
624845|NCT00680719|HIV Seronegativity|hiv seronegativity
624846|NCT00680732|Malaria|malaria
624847|NCT00680732|Pregnancy|pregnancy
624848|NCT00680732|Prevention|prevention
624849|NCT00680732|Chloroquine|chloroquine
624850|NCT00680732|Sulphadoxine pyrimethamine|sulphadoxine pyrimethamine
624851|NCT00680732|Maternal anaemia|maternal anaemia
624852|NCT00680732|Birth weight|birth weight
624853|NCT00680732|Foetal anaemia|foetal anaemia
624854|NCT00680745|Dapagliflozin|dapagliflozin
624855|NCT00680745|efficacy|efficacy
624856|NCT00680745|safety|safety
624857|NCT00680745|sulphonylurea|sulphonylurea
624858|NCT00680745|Type 2 diabetes|type 2 diabetes
624859|NCT00680758|male breast cancer|male breast cancer
624860|NCT00680758|stage IV breast cancer|stage iv breast cancer
624861|NCT00680771|Primary Insomnia|primary insomnia
624862|NCT00680771|Insomnia|insomnia
624863|NCT00680771|Good Sleepers|good sleepers
624864|NCT00680771|Hep B|hep b
624865|NCT00680771|Vaccine|vaccine
624866|NCT00680784|sprain|sprain
624867|NCT00680784|ankle|ankle
624868|NCT00680784|pain|pain
624869|NCT00680797|Aging|aging
624870|NCT00680797|Hormones|hormones
624871|NCT00680797|Insulin resistance|insulin resistance
624872|NCT00680823|Headache|headache
624873|NCT00680823|Migraine|migraine
624874|NCT00680823|Ropivacaine|ropivacaine
624875|NCT00680836|Irritable Bowel Syndrome|irritable bowel syndrome
624876|NCT00680836|Diarrhea|diarrhea
624877|NCT00680836|Gulf War|gulf war
624878|NCT00680836|Veterans|veterans
624879|NCT00680836|Small intestinal bacterial overgrowth (SIBO)|small intestinal bacterial overgrowth (sibo)
624880|NCT00680849|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
624881|NCT00680849|Coronary Disease|coronary disease
624883|NCT00680862|screening|screening
624884|NCT00680875|School Based Services|school based services
624885|NCT00680875|Prevention|prevention
624886|NCT00680875|Children|children
624887|NCT00680888|Psychosis|psychosis
624888|NCT00680888|adolescents|adolescents
624889|NCT00680888|adherence|adherence
624890|NCT00680888|quetiapine|quetiapine
624891|NCT00680901|unresectable|unresectable
624892|NCT00680901|HER2|her2
624893|NCT00680901|TYVERB|tyverb
624894|NCT00680901|ErbB2|erbb2
624895|NCT00680901|TYKERB|tykerb
624896|NCT00680901|capecitabine|capecitabine
624897|NCT00680901|CapeOx|capeox
624898|NCT00680901|gastric/esophageal cancer|gastric/esophageal cancer
624899|NCT00680901|GE junction|ge junction
624900|NCT00680901|metastatic|metastatic
624901|NCT00680901|lapatinib|lapatinib
624902|NCT00680901|oxaliplatin|oxaliplatin
624903|NCT00680914|Streptococcus pneumoniae|streptococcus pneumoniae
624904|NCT00680914|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
624905|NCT00680927|Atrial Fibrillation|atrial fibrillation
625695|NCT00682786|carcinoma|carcinoma
624906|NCT00680927|Risk of cardiac arrhythmias|risk of cardiac arrhythmias
624907|NCT00680927|Loop recorder|loop recorder
624908|NCT00680940|NSCLC|nsclc
624909|NCT00680966|Treatment efficacy|treatment efficacy
624910|NCT00680966|Family therapy|family therapy
624911|NCT00680966|Teens|teens
624912|NCT00680966|Substance abuse|substance abuse
624913|NCT00680966|Substance dependence|substance dependence
624914|NCT00680979|Prevention|prevention
624915|NCT00680979|Obesity|obesity
624916|NCT00680979|Binge Eating|binge eating
624917|NCT00680979|Adolescents|adolescents
624918|NCT00680979|Overweight|overweight
624919|NCT00680979|Weight Gain|weight gain
624920|NCT00680992|Giant Cell Tumor of Bone|giant cell tumor of bone
624921|NCT00681005|PPI test|ppi test
624922|NCT00681005|gastroesophageal reflux disease|gastroesophageal reflux disease
624923|NCT00681005|CYP2C19|cyp2c19
624924|NCT00681005|rabeprazole|rabeprazole
624925|NCT00681005|pantoprazole|pantoprazole
624926|NCT00681018|premature|premature
624927|NCT00681018|infants|infants
624928|NCT00681044|monoclonal immunoglobulin deposition disease|monoclonal immunoglobulin deposition disease
624929|NCT00681044|light chain deposition disease|light chain deposition disease
624930|NCT00681070|laceration|laceration
624931|NCT00681070|wound management|wound management
624932|NCT00681070|absorbable sutures|absorbable sutures
624933|NCT00681070|cosmetic outcomes|cosmetic outcomes
624934|NCT00681083|Obstructive Sleep Apnea|obstructive sleep apnea
624935|NCT00681083|Humidification|humidification
624936|NCT00681083|Continuous Positive Airway Pressure|continuous positive airway pressure
624937|NCT00681096|Low back pain in nurses|low back pain in nurses
624938|NCT00681122|Breast Cancer|breast cancer
624939|NCT00681122|hormone therapy|hormone therapy
624940|NCT00681122|aromatase inhibitor|aromatase inhibitor
624941|NCT00681135|orthodontics|orthodontics
624942|NCT00681135|toothbrush|toothbrush
624943|NCT00681135|interdental brush|interdental brush
624944|NCT00681135|oral hygiene|oral hygiene
624945|NCT00681148|Prostate specific antigen (PSA)|prostate specific antigen (psa)
624946|NCT00681148|Prostate cancer|prostate cancer
624947|NCT00681148|Lower urinary tract symptoms|lower urinary tract symptoms
624948|NCT00681148|Radioactive seed implantation|radioactive seed implantation
624949|NCT00681161|obstructive sleep apnea|obstructive sleep apnea
624951|NCT00681161|diabetes|diabetes
624952|NCT00681161|pre-diabetic condition|pre-diabetic condition
624953|NCT00681161|obesity|obesity
624954|NCT00681161|blood glucose|blood glucose
624955|NCT00681161|continuous positive airway pressure|continuous positive airway pressure
624956|NCT00681161|CPAP|cpap
624957|NCT00681174|Care, Postoperative|care, postoperative
624958|NCT00681174|Analgesia|analgesia
624959|NCT00681174|Analgesics, Opioid|analgesics, opioid
624960|NCT00681174|Morphine|morphine
624961|NCT00681174|Remifentanil|remifentanil
624962|NCT00681174|Oxycodone|oxycodone
624963|NCT00681174|Anesthesia, Regional|anesthesia, regional
624964|NCT00681174|Anesthesia, Intravenous|anesthesia, intravenous
624965|NCT00681174|Preanesthetic Medication|preanesthetic medication
624966|NCT00681174|Analgesia, Patient-Controlled|analgesia, patient-controlled
624967|NCT00681200|Blood Pressure Reduction|blood pressure reduction
624968|NCT00681200|Stress Reactivity and Recovery|stress reactivity and recovery
624969|NCT00681200|Meditation|meditation
624970|NCT00681200|Transcendental Meditation|transcendental meditation
624971|NCT00681200|Stress Reduction|stress reduction
624972|NCT00681200|Stress Management|stress management
624973|NCT00681226|peripheral arterial disease|peripheral arterial disease
624974|NCT00681226|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
624975|NCT00681226|exercise|exercise
624976|NCT00681239|childhood|childhood
624977|NCT00681239|epilepsy|epilepsy
624978|NCT00681239|intractable|intractable
624979|NCT00681239|seizures|seizures
624980|NCT00681239|Atkins|atkins
624981|NCT00681239|ketogenic|ketogenic
624982|NCT00681252|Peptide Vaccine|peptide vaccine
624983|NCT00681252|URLC10|urlc10
624984|NCT00681252|VEGFR1|vegfr1
624985|NCT00681252|VEGFR2|vegfr2
624986|NCT00681265|ocular lubricants|ocular lubricants
624987|NCT00681278|Hypertension|hypertension
624988|NCT00681278|Type II DM|type ii dm
624989|NCT00681278|JNC7|jnc7
624990|NCT00681278|2007 ESH-ESC guidelines|2007 esh-esc guidelines
624991|NCT00681278|survey|survey
624992|NCT00681291|surgical mesh|surgical mesh
624993|NCT00681291|inguinal hernia repair|inguinal hernia repair
624994|NCT00681291|chronic groin pain|chronic groin pain
624995|NCT00681304|Resected Breast Cancer|resected breast cancer
624996|NCT00681304|Breast Cancer|breast cancer
624997|NCT00681317|Phase I|phase i
624998|NCT00681317|Pharmacokinetics|pharmacokinetics
624999|NCT00681330|Peptide Vaccine|peptide vaccine
625000|NCT00681330|URLC10|urlc10
625001|NCT00681330|TTK|ttk
625002|NCT00681330|KOC1|koc1
625003|NCT00681343|Randomized|randomized
625004|NCT00681343|study|study
625005|NCT00681343|effectiveness/toxicity|effectiveness/toxicity
625210|NCT00674479|ALL|all
625006|NCT00681343|induction therapy|induction therapy
625007|NCT00681343|recipients|recipients
625008|NCT00681356|TKA|tka
625009|NCT00681356|Total knee arthroplasty|total knee arthroplasty
625010|NCT00681356|Total knee replacement|total knee replacement
625011|NCT00681356|Knee surgery|knee surgery
625012|NCT00681369|breast cancer|breast cancer
625013|NCT00681369|fulvestrant|fulvestrant
625014|NCT00681369|longitudinal study|longitudinal study
625015|NCT00681369|France|france
625016|NCT00681382|Asthma|asthma
625017|NCT00681382|use of asthma medication|use of asthma medication
625018|NCT00681382|asthma control|asthma control
625019|NCT00681382|telephone survey|telephone survey
625020|NCT00681382|patient's perception|patient's perception
625021|NCT00681408|Steatohepatitis|steatohepatitis
625022|NCT00681408|NASH|nash
625023|NCT00681408|NAFLD|nafld
625024|NCT00681408|omega 3 fatty acids|omega 3 fatty acids
625025|NCT00681408|Exercise conditioning|exercise conditioning
625026|NCT00673712|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
625027|NCT00673712|Pneumonia|pneumonia
625028|NCT00673712|Surgical Site Infection|surgical site infection
625029|NCT00673725|Atopic Dermatitis|atopic dermatitis
625030|NCT00673738|Lung|lung
625031|NCT00673738|Thoracic|thoracic
625032|NCT00673738|Immunotherapy|immunotherapy
625033|NCT00673738|Radiotherapy|radiotherapy
625034|NCT00673738|LA - NSCLC|la - nsclc
625035|NCT00673738|Non-Small Cell Lung Cancer|non-small cell lung cancer
625036|NCT00673751|mesenteric blood flow|mesenteric blood flow
625037|NCT00673751|GLP-2|glp-2
625038|NCT00673751|short bowel syndrome|short bowel syndrome
625039|NCT00673751|Glucagon-Like Peptide 2|glucagon-like peptide 2
625040|NCT00673777|HLA-A*0201|hla-a*0201
625041|NCT00673777|Peptide Vaccine|peptide vaccine
625042|NCT00673777|URLC10|urlc10
625043|NCT00673777|VEGFR1|vegfr1
625044|NCT00673777|VEGFR2|vegfr2
625045|NCT00673790|nebivolol|nebivolol
625046|NCT00673790|BYSTOLIC ™|bystolic ™
625047|NCT00673790|hydrochlorothiazide|hydrochlorothiazide
625048|NCT00673790|lisinopril|lisinopril
625049|NCT00673790|Prinivil (TM)|prinivil (tm)
625050|NCT00673790|Zestril (TM)|zestril (tm)
625051|NCT00673790|losartan|losartan
625052|NCT00673790|Cozaar (TM)|cozaar (tm)
625053|NCT00673790|Impaired Fasting Glucose|impaired fasting glucose
625054|NCT00673790|Impaired Glucose Tolerance|impaired glucose tolerance
625055|NCT00673790|hypertension|hypertension
625056|NCT00673803|posterior capsule opacification|posterior capsule opacification
625057|NCT00673803|micro incision|micro incision
625058|NCT00673803|sharp optic edge|sharp optic edge
625059|NCT00673816|Von Hippel Lindau|von hippel lindau
625060|NCT00673816|Sunitinib Malate|sunitinib malate
625062|NCT00673816|Von Hippel-Lindau Syndrome|von hippel-lindau syndrome
625063|NCT00673816|VHL|vhl
625064|NCT00673829|Breast Cancer|breast cancer
625065|NCT00673829|T cells|t cells
625066|NCT00673829|Gene Transfer|gene transfer
625067|NCT00673842|Noninvasive assessment|noninvasive assessment
625068|NCT00673842|Holter|holter
625069|NCT00673855|Dry eye|dry eye
625070|NCT00673855|Artificial tear|artificial tear
625071|NCT00673907|Wood smoke|wood smoke
625072|NCT00673907|Health effects|health effects
625073|NCT00673907|Human|human
626540|NCT00686179|TQT|tqt
625074|NCT00673907|Airway inflammation|airway inflammation
625075|NCT00673907|Cardiovascular effects|cardiovascular effects
625076|NCT00673920|RA|ra
625077|NCT00673946|bronchiolitis|bronchiolitis
625078|NCT00673946|hospitalization|hospitalization
625079|NCT00673946|oximetry|oximetry
625080|NCT00673946|pediatrics|pediatrics
625081|NCT00673959|Dry eye|dry eye
625082|NCT00673959|artificial tears|artificial tears
625083|NCT00673972|Functional dyspepsia|functional dyspepsia
625084|NCT00673972|Gastric emptying|gastric emptying
625085|NCT00673972|Helicobacter pylori|helicobacter pylori
625086|NCT00673972|Lansoprazole|lansoprazole
625087|NCT00673972|Epigastric pain syndrome|epigastric pain syndrome
625088|NCT00673972|Postprandial distress syndrome|postprandial distress syndrome
625089|NCT00673985|SFA, Edwards, Popliteal, LifeStent, PTA, Nitinol|sfa, edwards, popliteal, lifestent, pta, nitinol
625090|NCT00673998|Isokinetic|isokinetic
625091|NCT00673998|Fatigue|fatigue
625092|NCT00673998|Strength|strength
625093|NCT00673998|Older|older
625094|NCT00674011|hypertension|hypertension
625095|NCT00674011|bevacizumab|bevacizumab
625096|NCT00674011|metastatic breast cancer|metastatic breast cancer
625097|NCT00674024|Pazopanib|pazopanib
625098|NCT00674024|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
625099|NCT00674024|Advanced Cancer|advanced cancer
625100|NCT00674024|Pharmacokinetics|pharmacokinetics
625101|NCT00674024|Cancer|cancer
625102|NCT00674024|Solid Tumor|solid tumor
625103|NCT00674024|Lymphoma|lymphoma
625104|NCT00674037|recruitment|recruitment
625105|NCT00674037|physicians participating in the recruitment of patients|physicians participating in the recruitment of patients
625106|NCT00674050|Healthy Males or Females subjects|healthy males or females subjects
625107|NCT00674063|Chronic Plaque Psoriasis|chronic plaque psoriasis
625108|NCT00674063|Alefacept|alefacept
625109|NCT00674089|IMR|imr
625110|NCT00674089|Newborn Mortality|newborn mortality
625111|NCT00674089|Vitamin A Effectiveness|vitamin a effectiveness
625112|NCT00674089|Premature Mortality|premature mortality
625113|NCT00674089|Mortality|mortality
625114|NCT00674102|Vascular disrupting agent|vascular disrupting agent
625115|NCT00674102|Non-small cell lung cancer|non-small cell lung cancer
625116|NCT00674128|pacemaker|pacemaker
625117|NCT00674128|cardioverter-defibrillator|cardioverter-defibrillator
625118|NCT00674128|ICD|icd
625119|NCT00674128|cardiac resynchronization device|cardiac resynchronization device
625120|NCT00674128|cyanoacrylate|cyanoacrylate
625121|NCT00674128|suture|suture
625122|NCT00674128|Dermabond|dermabond
625123|NCT00674128|Vicryl|vicryl
625124|NCT00674141|Multiple Sclerosis, relapsing remitting, Dexamethasone|multiple sclerosis, relapsing remitting, dexamethasone
625125|NCT00674154|Vitamin D|vitamin d
625126|NCT00674154|Primary hyperparathyroidism|primary hyperparathyroidism
625127|NCT00674154|hypercalcemia|hypercalcemia
625128|NCT00674206|Metastatic breast cancer|metastatic breast cancer
625129|NCT00674219|GAD|gad
625130|NCT00674232|incomplete abortion|incomplete abortion
625131|NCT00674232|spontaneous miscarriage|spontaneous miscarriage
625132|NCT00674245|heartburn|heartburn
625133|NCT00674245|acid reflux|acid reflux
625134|NCT00674245|GERD|gerd
625135|NCT00674245|spectrum analysis|spectrum analysis
625136|NCT00674245|electroencephalogram|electroencephalogram
625137|NCT00674245|esophagitis|esophagitis
625138|NCT00674245|peptic|peptic
625139|NCT00674258|HLA-A*2402|hla-a*2402
625140|NCT00674258|Peptide Vaccine|peptide vaccine
625141|NCT00674258|URLC10|urlc10
625142|NCT00674258|TTK|ttk
625143|NCT00674258|KOC1|koc1
625144|NCT00674271|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
625145|NCT00674271|Mannose-Binding lectin|mannose-binding lectin
625146|NCT00674271|Toll-Like Receptors|toll-like receptors
625147|NCT00674271|Atherosclerosis|atherosclerosis
625148|NCT00674271|Carotid Arteries|carotid arteries
625149|NCT00674271|Diabetes Complications|diabetes complications
625150|NCT00674271|Diabetic Angiopathies|diabetic angiopathies
625151|NCT00674297|Persistently Antiphospholipid Antibody Positive Patients|persistently antiphospholipid antibody positive patients
625152|NCT00674323|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
625153|NCT00674323|PCV|pcv
625154|NCT00674323|Age-related macular degeneration (AMD) variant|age-related macular degeneration (amd) variant
625155|NCT00674323|vision|vision
625156|NCT00674323|polyps|polyps
625157|NCT00674323|indocyanine green angiography|indocyanine green angiography
625158|NCT00674323|verteporfin|verteporfin
625159|NCT00674323|ranibizumab|ranibizumab
625160|NCT00674323|photodynamic therapy|photodynamic therapy
625161|NCT00674336|Norovirus|norovirus
625162|NCT00674336|Gastroenteritis|gastroenteritis
625163|NCT00674336|Clinical Trial|clinical trial
625164|NCT00674336|Stomach flu|stomach flu
625165|NCT00674336|Oysters|oysters
625166|NCT00674336|Shellfish|shellfish
625167|NCT00674336|high hydrostatic pressures|high hydrostatic pressures
625168|NCT00674362|Rheumatoid Arthritis|rheumatoid arthritis
625169|NCT00674362|Moderate to Low Disease activity|moderate to low disease activity
625170|NCT00674362|Certolizumab pegol|certolizumab pegol
625171|NCT00674375|Chest Pain|chest pain
625172|NCT00674375|Acute Myocardial Infarction|acute myocardial infarction
625173|NCT00674375|Patient Safety|patient safety
625174|NCT00674375|Misdiagnosis|misdiagnosis
625175|NCT00674388|Children|children
625176|NCT00674388|Anesthesia|anesthesia
625177|NCT00674388|Surgery|surgery
625178|NCT00674388|Complication|complication
625179|NCT00674414|stage IA breast cancer|stage ia breast cancer
625180|NCT00674414|stage IB breast cancer|stage ib breast cancer
625181|NCT00674414|stage II breast cancer|stage ii breast cancer
625182|NCT00674414|stage IIIA breast cancer|stage iiia breast cancer
625183|NCT00674414|HER2-positive breast cancer|her2-positive breast cancer
625184|NCT00674427|AML|aml
625185|NCT00674427|ALL|all
625186|NCT00674427|MDS|mds
625187|NCT00674427|CLL|cll
625188|NCT00674427|Multiple Myeloma|multiple myeloma
625189|NCT00674440|Congenital Hyperinsulinism|congenital hyperinsulinism
625190|NCT00674440|Hyperinsulinism|hyperinsulinism
625191|NCT00674440|Persistent Hyperinsulinemic Hypoglycemia of Infancy|persistent hyperinsulinemic hypoglycemia of infancy
625192|NCT00674440|CHI|chi
625193|NCT00674440|PHHI|phhi
625194|NCT00674440|F-DOPA|f-dopa
625195|NCT00674440|L-fluoro-dihydroxyphenylalanine|l-fluoro-dihydroxyphenylalanine
625196|NCT00674453|Osteoporosis|osteoporosis
625197|NCT00674453|lasofoxifene|lasofoxifene
625198|NCT00674453|bone density|bone density
625199|NCT00674453|bone markers|bone markers
625200|NCT00674466|GLP-1, incretin, type 2 diabetes|glp-1, incretin, type 2 diabetes
625201|NCT00674479|Advanced Hematologic Malignancies|advanced hematologic malignancies
625202|NCT00674479|Cancer|cancer
625203|NCT00674479|Blood|blood
625204|NCT00674479|Bone marrow|bone marrow
625205|NCT00674479|Lymph nodes|lymph nodes
625206|NCT00674479|JAK kinase inhibitor INCB018424 phosphate|jak kinase inhibitor incb018424 phosphate
625207|NCT00674479|Acute Myeloid Leukemia|acute myeloid leukemia
625208|NCT00674479|AML|aml
625209|NCT00674479|Acute Lymphocytic leukemia|acute lymphocytic leukemia
625211|NCT00674479|Myelodysplastic Syndrome|myelodysplastic syndrome
625212|NCT00674479|MDS|mds
625213|NCT00674479|Chronic myelogenous leukemia - Blast Crisis|chronic myelogenous leukemia - blast crisis
625214|NCT00674479|CML|cml
625215|NCT00674479|INCB018424|incb018424
625216|NCT00674518|Health Promotion|health promotion
625217|NCT00674518|Health Behavior Change|health behavior change
625218|NCT00674518|Physical Activity|physical activity
625219|NCT00674518|Dietary Change|dietary change
625220|NCT00674518|Weight Loss|weight loss
625221|NCT00674518|Obesity|obesity
625222|NCT00674531|Arteriosclerosis|arteriosclerosis
625223|NCT00674531|Arterial Occlusive Diseases|arterial occlusive diseases
625224|NCT00674531|Enterovirus|enterovirus
625225|NCT00674531|Artery resection|artery resection
625226|NCT00674544|childhood|childhood
625227|NCT00674544|children|children
625228|NCT00674544|obesity|obesity
625229|NCT00674544|physical activity|physical activity
625230|NCT00674544|nutrition|nutrition
625231|NCT00674544|fitness|fitness
625232|NCT00674544|family|family
625233|NCT00674557|recurrent breast cancer|recurrent breast cancer
625234|NCT00674557|stage IIIA breast cancer|stage iiia breast cancer
625235|NCT00674557|stage IIIB breast cancer|stage iiib breast cancer
625236|NCT00674557|stage IIIC breast cancer|stage iiic breast cancer
625237|NCT00674557|stage IV breast cancer|stage iv breast cancer
625238|NCT00674557|HER2-negative breast cancer|her2-negative breast cancer
625239|NCT00674557|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
625240|NCT00674557|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
625241|NCT00674570|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
625242|NCT00674570|Hydrocortisone|hydrocortisone
625243|NCT00674570|Cycloserine|cycloserine
625244|NCT00674570|Extinction, Psychological|extinction, psychological
625245|NCT00674570|PTSD|ptsd
625246|NCT00674570|San Francisco|san francisco
625247|NCT00674583|Conjugate vaccine|conjugate vaccine
625248|NCT00674583|Meningococcal disease|meningococcal disease
625249|NCT00674583|Immunogenicity|immunogenicity
625250|NCT00674583|Meningococcal vaccine|meningococcal vaccine
625251|NCT00674583|Safety|safety
625252|NCT00674596|PTX3, ramipril, endothelial dysfunction|ptx3, ramipril, endothelial dysfunction
625253|NCT00674596|1- Diabetic proteinuria|1- diabetic proteinuria
625254|NCT00674596|2- The aim of this study was to find out whether the|2- the aim of this study was to find out whether the
625255|NCT00674596|beneficial effects of RAS blockage in diabetic|beneficial effects of ras blockage in diabetic
625256|NCT00674596|proteinuria has any relation with the alteration|proteinuria has any relation with the alteration
625257|NCT00674596|of PTX3 levels.|of ptx3 levels.
625258|NCT00674609|Palliative Care|palliative care
625259|NCT00674609|Pain|pain
625260|NCT00674609|Cancer|cancer
625261|NCT00674622|Lateral epicondylitis|lateral epicondylitis
625262|NCT00674622|Tennis elbow|tennis elbow
625263|NCT00674622|Prolotherapy|prolotherapy
625264|NCT00674635|adaptive study,|adaptive study,
625265|NCT00674635|DAS28,|das28,
625266|NCT00674635|monoclonal antibody|monoclonal antibody
625267|NCT00674635|GSK315234A;|gsk315234a;
625268|NCT00674635|rheumatoid arthritis,|rheumatoid arthritis,
625269|NCT00674648|Multiple Diseases|multiple diseases
625270|NCT00674648|Hematopoietic System|hematopoietic system
625271|NCT00674648|CMV-PP65 PROTEIN SPECIFIC T CELLS|cmv-pp65 protein specific t cells
625272|NCT00674661|ectasia|ectasia
625273|NCT00674661|cross-linking|cross-linking
625274|NCT00674661|crosslinking|crosslinking
625275|NCT00674661|cornea|cornea
625276|NCT00674661|riboflavin|riboflavin
625277|NCT00674661|UVA|uva
625278|NCT00674674|topotecan|topotecan
625279|NCT00674674|pharmacokinetics|pharmacokinetics
625280|NCT00674674|neoplastic|neoplastic
625281|NCT00674674|meningitis|meningitis
625282|NCT00674700|House dust mites allergy|house dust mites allergy
625283|NCT00674713|Patients undergoing laparoscopic cholecystectomy for cholelithiasis|patients undergoing laparoscopic cholecystectomy for cholelithiasis
625284|NCT00674726|appendicitis|appendicitis
625285|NCT00674726|gastroenteritis|gastroenteritis
625286|NCT00674726|temperature|temperature
625287|NCT00674726|fever|fever
625288|NCT00674726|acute abdomen|acute abdomen
625289|NCT00674726|Axilo-rectal temperature in appendicitis|axilo-rectal temperature in appendicitis
625290|NCT00674726|Axilo-rectal temperature in gastroenteritis|axilo-rectal temperature in gastroenteritis
625291|NCT00674739|external genital warts|external genital warts
625292|NCT00674739|perianal warts|perianal warts
625293|NCT00674739|condylomata acuminata|condylomata acuminata
625294|NCT00674739|venereal warts|venereal warts
625295|NCT00674739|HPV types 6 and 11|hpv types 6 and 11
625296|NCT00674778|Radial|radial
625297|NCT00674778|Femoral|femoral
625298|NCT00674778|artery|artery
625299|NCT00674778|Invasive cardiology safety|invasive cardiology safety
625300|NCT00674791|Immunotherapeutic vaccine|immunotherapeutic vaccine
625301|NCT00674791|breast cancer|breast cancer
625302|NCT00674791|TxN2-3M0 breast cancer|txn2-3m0 breast cancer
625303|NCT00674791|metastatic breast cancer|metastatic breast cancer
625304|NCT00674791|immunotherapy|immunotherapy
625305|NCT00674791|antigen|antigen
625391|NCT00675116|GW823296,|gw823296,
625306|NCT00674791|Histologically confirmed, TxN2-3M0 or metastatic breast cancer|histologically confirmed, txn2-3m0 or metastatic breast cancer
625307|NCT00674804|Communicating a Diagnosis|communicating a diagnosis
625308|NCT00674804|Cancer Diagnosis|cancer diagnosis
625309|NCT00674804|Recurrence of Cancer|recurrence of cancer
625310|NCT00674804|Initial Cancer Diagnosis|initial cancer diagnosis
625311|NCT00674817|salbutamol,|salbutamol,
625312|NCT00674817|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
625313|NCT00674817|GSK961081 muscarinic receptor antagonist,|gsk961081 muscarinic receptor antagonist,
625314|NCT00674817|COPD|copd
625315|NCT00674817|ipratropium bromide,|ipratropium bromide,
625316|NCT00674817|Asthma|asthma
625317|NCT00674817|ß2-adrenergic agonist,|ß2-adrenergic agonist,
625318|NCT00674843|MYOTONIC DYSTROPHY|myotonic dystrophy
625319|NCT00674843|MYOPATHIES|myopathies
625320|NCT00674843|Distal Myopathies|distal myopathies
625321|NCT00674843|Muscular Dystrophy, Duchenne|muscular dystrophy, duchenne
625322|NCT00674843|Phosphorylase Deficiency (McArdle Disease)|phosphorylase deficiency (mcardle disease)
625323|NCT00674869|sealant|sealant
625324|NCT00674869|pit|pit
625325|NCT00674869|child|child
625326|NCT00674869|over|over
625327|NCT00674869|6 years old|6 years old
625328|NCT00674869|least|least
625329|NCT00674882|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
625330|NCT00674882|Follow-up studies|follow-up studies
625331|NCT00674882|Outcomes research|outcomes research
625332|NCT00674882|Data collection|data collection
625333|NCT00674895|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
625334|NCT00674895|Lewy Body Parkinson's Disease|lewy body parkinson's disease
625335|NCT00674895|Paralysis Agitans|paralysis agitans
625336|NCT00674895|Parkinson's Disease, Idiopathic|parkinson's disease, idiopathic
625337|NCT00674895|Parkinson's Disease, Lewy Body|parkinson's disease, lewy body
625338|NCT00674895|Primary Parkinsonism|primary parkinsonism
625339|NCT00674908|Vaccine|vaccine
625340|NCT00674908|Prevention|prevention
625341|NCT00674908|Diphtheria|diphtheria
625342|NCT00674908|Tetanus|tetanus
625343|NCT00674908|Pertussis|pertussis
625344|NCT00674908|Hepatitis B|hepatitis b
625345|NCT00674908|Haemophilus influenzae type b|haemophilus influenzae type b
625346|NCT00674908|Vaccine interchangeability|vaccine interchangeability
625347|NCT00674908|Single vs mixed sequence|single vs mixed sequence
625348|NCT00674908|Healthy infants|healthy infants
625349|NCT00674921|Opportunistic Infections|opportunistic infections
625350|NCT00674921|AIDS|aids
625351|NCT00674921|HIV|hiv
625352|NCT00674921|Treatment Experienced|treatment experienced
625353|NCT00674934|MS (Multiple Sclerosis)|ms (multiple sclerosis)
625354|NCT00674934|Multiple Sclerosis, Acute Fulminating|multiple sclerosis, acute fulminating
625355|NCT00674934|Sclerosis, Disseminated|sclerosis, disseminated
625356|NCT00674947|Relapsed|relapsed
625357|NCT00674947|Refractory|refractory
625358|NCT00674960|Brain Atrophy, Circumscribed Lobar|brain atrophy, circumscribed lobar
625359|NCT00674960|Circumscribed Lobar Atrophy of the Brain|circumscribed lobar atrophy of the brain
625360|NCT00674960|Lobar Atrophy (Brain)|lobar atrophy (brain)
625361|NCT00674960|Pick Disease|pick disease
625362|NCT00674960|Pick's Disease|pick's disease
625363|NCT00674960|Picks Disease of Brain|picks disease of brain
625364|NCT00674999|Burn|burn
625365|NCT00674999|Partial thickness burn|partial thickness burn
625366|NCT00675012|NGR-hTNF|ngr-htnf
625367|NCT00675012|Capecitabine|capecitabine
625368|NCT00675012|Oxaliplatin|oxaliplatin
625369|NCT00675012|Colon cancer|colon cancer
625370|NCT00675051|To determine if there is a trans-pulmonary gradient in the levels of EMPs in patients with PH|to determine if there is a trans-pulmonary gradient in the levels of emps in patients with ph
625371|NCT00675051|To determine if the EMPs measured at the pulmonary capillary wedge position correlates even more strongly with the severity of PH than the circulating levels|to determine if the emps measured at the pulmonary capillary wedge position correlates even more strongly with the severity of ph than the circulating levels
625372|NCT00675051|To determine if PH therapy with ET-1 receptor blocker will modify EMPs levels|to determine if ph therapy with et-1 receptor blocker will modify emps levels
625373|NCT00675064|pharmacokinetics,|pharmacokinetics,
625374|NCT00675064|safety|safety
625375|NCT00675064|single ascending dose,|single ascending dose,
625376|NCT00675064|Healthy volunteers,|healthy volunteers,
625377|NCT00675077|Akinetic-Rigid Variant of Huntington Disease|akinetic-rigid variant of huntington disease
625378|NCT00675077|Chorea, Chronic Progressive Hereditary (Huntington)|chorea, chronic progressive hereditary (huntington)
625379|NCT00675077|Chronic Progressive Hereditary Chorea (Huntington)|chronic progressive hereditary chorea (huntington)
625380|NCT00675077|Huntington Chorea|huntington chorea
625381|NCT00675077|Huntington Chronic Progressive Hereditary Chorea|huntington chronic progressive hereditary chorea
625382|NCT00675077|Huntington Disease, Akinetic-Rigid Variant|huntington disease, akinetic-rigid variant
625383|NCT00675077|Huntington Disease, Juvenile|huntington disease, juvenile
625384|NCT00675077|Huntington Disease, Juvenile-Onset|huntington disease, juvenile-onset
625385|NCT00675090|Alzheimers Disease|alzheimers disease
625386|NCT00675103|Gout|gout
625387|NCT00675103|Gouty Arthritis|gouty arthritis
625388|NCT00675103|Anti-Gout preparations|anti-gout preparations
625389|NCT00675116|safety,|safety,
625390|NCT00675116|healthy volunteers,|healthy volunteers,
625392|NCT00675116|pharmacokinetics|pharmacokinetics
625393|NCT00675142|Infertility|infertility
625394|NCT00675142|Intra-uterine insemination|intra-uterine insemination
625395|NCT00675142|ovarian stimulation|ovarian stimulation
625396|NCT00675155|Apoplexy|apoplexy
625397|NCT00675155|Cerebral Stroke|cerebral stroke
625398|NCT00675155|Cerebrovascular Accident|cerebrovascular accident
625399|NCT00675155|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
625400|NCT00675155|Cerebrovascular Apoplexy|cerebrovascular apoplexy
625401|NCT00675155|Cerebrovascular Stroke|cerebrovascular stroke
625402|NCT00675168|Lung Cancer|lung cancer
625403|NCT00675168|PET/CT|pet/ct
625404|NCT00675168|Diagnosis|diagnosis
625405|NCT00675181|melatonin|melatonin
625406|NCT00675181|skin blood flow|skin blood flow
625407|NCT00675181|choroidal blood flow|choroidal blood flow
625408|NCT00675181|vasospastic subjects|vasospastic subjects
625409|NCT00675181|normal subjects|normal subjects
625410|NCT00675194|cisplatin|cisplatin
625411|NCT00675194|capecitabine|capecitabine
625412|NCT00675194|gastric|gastric
625413|NCT00675194|irinotecan|irinotecan
625414|NCT00675194|metastatic|metastatic
625415|NCT00675194|chemotherapy|chemotherapy
625416|NCT00675207|glaucoma|glaucoma
625417|NCT00675207|ocular hypertension|ocular hypertension
625418|NCT00675207|adjunctive treatment|adjunctive treatment
625419|NCT00675207|prostaglandin|prostaglandin
625420|NCT00675207|prostaglandin analog|prostaglandin analog
625421|NCT00675207|brimonidine|brimonidine
625422|NCT00675207|dorzolamide|dorzolamide
625423|NCT00675207|brinzolamide|brinzolamide
625424|NCT00675207|alpha agonist|alpha agonist
625425|NCT00675207|carbonic anhydrase inhibitor|carbonic anhydrase inhibitor
625426|NCT00675207|intraocular pressure|intraocular pressure
625427|NCT00681421|Peptide Vaccine|peptide vaccine
625428|NCT00681421|URLC10|urlc10
625429|NCT00681421|VEGFR1|vegfr1
625430|NCT00681421|VEGFR2|vegfr2
625431|NCT00681434|stroke|stroke
625432|NCT00681434|upper extremity|upper extremity
625433|NCT00681434|hemiparesis|hemiparesis
625434|NCT00681447|lumbar disc herniation|lumbar disc herniation
625435|NCT00681447|discogenic pain|discogenic pain
625436|NCT00681447|lumbar interlaminar epidural|lumbar interlaminar epidural
625437|NCT00681447|injections|injections
625438|NCT00681460|gestational diabetes|gestational diabetes
625439|NCT00681460|birth weight|birth weight
625440|NCT00681460|fetal growth|fetal growth
625441|NCT00681460|insulin resistance|insulin resistance
625442|NCT00681460|oxidative stress|oxidative stress
625443|NCT00681460|inflammatory reaction|inflammatory reaction
625444|NCT00681460|Fetal Development|fetal development
625445|NCT00681473|proton radiation therapy|proton radiation therapy
625446|NCT00681473|photon radiation therapy|photon radiation therapy
625447|NCT00681486|Ghrelin|ghrelin
625448|NCT00681486|Nutrition|nutrition
625449|NCT00681486|Cancer patients|cancer patients
625450|NCT00681486|Survival|survival
625451|NCT00681499|Quality of Life|quality of life
625452|NCT00681499|Liver Neoplasms|liver neoplasms
625453|NCT00681499|Surgical procedures, Operative|surgical procedures, operative
625454|NCT00681512|NSCLC|nsclc
625455|NCT00681512|lung cancer|lung cancer
625456|NCT00681512|non small cell lung cancer|non small cell lung cancer
625457|NCT00681512|lung carcinoma|lung carcinoma
625458|NCT00681538|Spasticity|spasticity
625459|NCT00681538|Multiple Sclerosis|multiple sclerosis
625460|NCT00681551|Detection of brain metastasis by MRI|detection of brain metastasis by mri
625461|NCT00681551|Magnevist|magnevist
625462|NCT00681551|Brain metastasis|brain metastasis
625463|NCT00681551|Meglumine gadopentetate|meglumine gadopentetate
625464|NCT00681564|Periodontitis|periodontitis
625465|NCT00681564|Oral health|oral health
625466|NCT00681564|Cardiovascular disease|cardiovascular disease
625467|NCT00681577|Peptide Vaccine|peptide vaccine
625468|NCT00681577|URLC10|urlc10
625469|NCT00681577|KOC1|koc1
625470|NCT00681577|VEGFR1|vegfr1
625471|NCT00681577|VEGFR2|vegfr2
625472|NCT00681590|vitamin D|vitamin d
625473|NCT00681590|deficiency|deficiency
625474|NCT00681590|elderly|elderly
625475|NCT00681603|corneal neovascularization|corneal neovascularization
625476|NCT00681603|lipid keratopathy|lipid keratopathy
625477|NCT00681603|penetrating keratopathy|penetrating keratopathy
625478|NCT00681603|bevacizumab|bevacizumab
625479|NCT00681603|Avastin|avastin
625480|NCT00681603|subconjunctival injection|subconjunctival injection
625481|NCT00681616|Anterior compartment syndrome|anterior compartment syndrome
625482|NCT00681616|Tibia|tibia
625483|NCT00681616|Trauma|trauma
625484|NCT00681616|Blood circulation|blood circulation
625485|NCT00681616|Nerve compression syndromes|nerve compression syndromes
625486|NCT00681629|Schizophrenia|schizophrenia
625487|NCT00681629|Integrated Care|integrated care
625488|NCT00681629|Quetiapine|quetiapine
625489|NCT00681642|Corneal epithelial wound|corneal epithelial wound
625490|NCT00681642|Human autoserum|human autoserum
625491|NCT00681642|Cord blood|cord blood
625492|NCT00681668|Postpartum Depression|postpartum depression
625493|NCT00681668|Quetiapine|quetiapine
625494|NCT00681668|Psychotic Symptoms|psychotic symptoms
625495|NCT00681681|stroke|stroke
625496|NCT00681681|vascular marker|vascular marker
625497|NCT00681681|stroke risk|stroke risk
625498|NCT00681681|risk factors|risk factors
625499|NCT00681681|sex differences|sex differences
625500|NCT00681694|brachytherapy|brachytherapy
625501|NCT00681694|radioactive seed implants|radioactive seed implants
625502|NCT00681707|Hypertension|hypertension
625503|NCT00681707|Post stroke|post stroke
625504|NCT00681707|JNC7|jnc7
625505|NCT00681707|2007 ESH-ESC guidelines|2007 esh-esc guidelines
625506|NCT00681707|survey|survey
625507|NCT00681720|Anxiety|anxiety
625508|NCT00681720|GABA receptors|gaba receptors
625509|NCT00681720|Positron Emission Tomography|positron emission tomography
625510|NCT00681720|PET|pet
625511|NCT00681720|phase I|phase i
625512|NCT00681733|NASH Pentoxifylline Pioglitazone|nash pentoxifylline pioglitazone
625513|NCT00681746|Anxiety|anxiety
625514|NCT00681746|GABA receptors|gaba receptors
625515|NCT00681746|Positron Emission Tomography|positron emission tomography
625516|NCT00681746|PET|pet
625517|NCT00681746|phase I|phase i
625518|NCT00682084|Cushing's syndrome|cushing's syndrome
625519|NCT00682084|Glucose tolerance|glucose tolerance
625520|NCT00682084|Insulin sensitivity|insulin sensitivity
625521|NCT00682084|Substrate metabolism|substrate metabolism
625522|NCT00682084|Body composition|body composition
625523|NCT00682110|End-stage liver disease|end-stage liver disease
625524|NCT00682110|Hemodynamic measurements|hemodynamic measurements
625525|NCT00682110|Hyperdynamic circulation|hyperdynamic circulation
625526|NCT00682110|Pulmonary artery catheter|pulmonary artery catheter
625527|NCT00682110|Cardiac output|cardiac output
625528|NCT00682123|19-norandrostenedione|19-norandrostenedione
625529|NCT00682123|steroids|steroids
625530|NCT00682123|drugs in sport|drugs in sport
625531|NCT00682123|World Anti-Doping Agency|world anti-doping agency
625532|NCT00682136|postoperative analgesia|postoperative analgesia
625533|NCT00682136|abdominal surgery|abdominal surgery
625534|NCT00682136|ropivacaine|ropivacaine
625535|NCT00682136|local anaesthesia|local anaesthesia
625536|NCT00682136|tap block|tap block
625537|NCT00682136|pain management|pain management
625538|NCT00682149|Oxidative stress|oxidative stress
625539|NCT00682149|malondialdehyde|malondialdehyde
625540|NCT00682149|glutathione|glutathione
625541|NCT00682149|diabetes|diabetes
625542|NCT00682149|polyphenol containing antioxidants|polyphenol containing antioxidants
625543|NCT00682149|diet rich in vegetables|diet rich in vegetables
625544|NCT00682149|weekly aerobic exercise|weekly aerobic exercise
625545|NCT00682162|acupuncture|acupuncture
625546|NCT00682162|randomised controlled trial|randomised controlled trial
625547|NCT00682162|placebo|placebo
625548|NCT00682162|sham laser|sham laser
625549|NCT00682162|vasomotor rhinitis|vasomotor rhinitis
625550|NCT00682175|Congestive Heart Failure|congestive heart failure
625551|NCT00682188|Overweight|overweight
625552|NCT00682188|Obesity|obesity
625553|NCT00682188|Adolescents|adolescents
625554|NCT00682188|Youth|youth
625555|NCT00682188|School health|school health
625556|NCT00682188|Randomized controlled trial|randomized controlled trial
625557|NCT00682188|Intervention study|intervention study
625558|NCT00682201|Pregnancy|pregnancy
625559|NCT00682201|Blood pressure|blood pressure
625560|NCT00682201|Cardiac output|cardiac output
625561|NCT00682214|25(OH)D, muscle strength|25(oh)d, muscle strength
625562|NCT00682227|Epitope peptide, CTL, Esophageal cancer, Vaccination|epitope peptide, ctl, esophageal cancer, vaccination
625563|NCT00682240|retinal morphology|retinal morphology
625564|NCT00682240|laser treatment|laser treatment
625565|NCT00682240|pascal laser|pascal laser
625566|NCT00682240|HD-OCT|hd-oct
625567|NCT00682253|SPECT/CT|spect/ct
625568|NCT00682253|MRI|mri
625569|NCT00682253|Breast neoplasms|breast neoplasms
625570|NCT00682266|Adolescent|adolescent
625571|NCT00682266|Overweight|overweight
625572|NCT00682266|Exercise|exercise
625573|NCT00682266|multidisciplinary approach|multidisciplinary approach
625574|NCT00682266|Oxygen uptake|oxygen uptake
625575|NCT00682266|Flow mediated dilatation|flow mediated dilatation
625576|NCT00682266|Cardiovascular Risk Factors|cardiovascular risk factors
625577|NCT00682279|lapatinib|lapatinib
625578|NCT00682279|GW572016|gw572016
625579|NCT00682279|topotecan|topotecan
625580|NCT00682279|oral topotecan|oral topotecan
625581|NCT00682279|SK&F-104864|sk&f-104864
625582|NCT00682279|EGFR|egfr
625583|NCT00682279|ErbB1|erbb1
625584|NCT00682279|HER-2/neu|her-2/neu
625585|NCT00682279|ErbB2|erbb2
625586|NCT00682279|BCRP|bcrp
625587|NCT00682292|Renal transplantation|renal transplantation
625588|NCT00682292|Immunisation|immunisation
625589|NCT00682292|Acute rejection|acute rejection
625590|NCT00682292|Induction therapy|induction therapy
625591|NCT00682292|Thymoglobulin|thymoglobulin
625592|NCT00682292|Daclizumab|daclizumab
625593|NCT00682292|Rejection in sensitized renal transplant recipients|rejection in sensitized renal transplant recipients
625594|NCT00682305|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
625595|NCT00682305|Hematopoeitic Stem Cell Transplantation|hematopoeitic stem cell transplantation
625596|NCT00682318|Fish oil|fish oil
625597|NCT00682318|red wine|red wine
625598|NCT00682318|alcohol|alcohol
625599|NCT00682318|oxidative stress|oxidative stress
625600|NCT00682318|Healthy volunteers|healthy volunteers
625601|NCT00682357|Osteoarthritis, intra articular steroids|osteoarthritis, intra articular steroids
625602|NCT00682383|Advanced NSCLC|advanced nsclc
625603|NCT00682383|Lung Cancer|lung cancer
625604|NCT00682383|Mount Sinai Medical Center CCOP|mount sinai medical center ccop
625605|NCT00682422|pediatrics, overweight, obese, behavioral intervention|pediatrics, overweight, obese, behavioral intervention
625606|NCT00682435|Nonedlerly patients with acute moderate to severe pain|nonedlerly patients with acute moderate to severe pain
625607|NCT00682448|Olanzapine|olanzapine
625608|NCT00682448|Zyprexa|zyprexa
625609|NCT00682448|Weight Gain|weight gain
625610|NCT00682448|Antipsychotics|antipsychotics
625611|NCT00682448|Metformin|metformin
625612|NCT00682448|Glucophage|glucophage
625613|NCT00682448|Bipolar Disorder|bipolar disorder
625614|NCT00682448|Schizophrenia|schizophrenia
625615|NCT00682448|Depression|depression
625616|NCT00682448|Diabetes|diabetes
625617|NCT00682448|Side effects|side effects
625618|NCT00682448|Metabolic complications|metabolic complications
625619|NCT00682448|Prevention|prevention
625620|NCT00682448|Treatment|treatment
625621|NCT00682448|Metabolic side effects of olanzapine|metabolic side effects of olanzapine
625622|NCT00682461|Nicotine Tolerability NRT|nicotine tolerability nrt
625623|NCT00682474|Cigarette smoking|cigarette smoking
625624|NCT00682474|Nicotine dependence|nicotine dependence
625625|NCT00682474|Adolescents|adolescents
625626|NCT00682474|Youth|youth
625627|NCT00682474|School health|school health
625628|NCT00682474|Randomized controlled trial|randomized controlled trial
625629|NCT00682487|Myocardial infarction|myocardial infarction
625630|NCT00682487|Stress|stress
625631|NCT00682487|Hair Cortisol|hair cortisol
625632|NCT00682500|Pneumonia|pneumonia
625633|NCT00682500|Aspiration|aspiration
625634|NCT00682500|Drowning|drowning
625635|NCT00682500|inhalation|inhalation
625636|NCT00682513|dystonia|dystonia
625637|NCT00682513|parkinsonism|parkinsonism
625638|NCT00682513|rapid-onset dystonia-parkinsonism|rapid-onset dystonia-parkinsonism
625639|NCT00682513|RDP|rdp
625640|NCT00682513|Alternating Hemiplegia of Childhood|alternating hemiplegia of childhood
625641|NCT00682513|AHC|ahc
625642|NCT00682526|EMS patients with intention to treat with coronary reperfusion therapy (PCI or thrombolytics) based on their initial presentation|ems patients with intention to treat with coronary reperfusion therapy (pci or thrombolytics) based on their initial presentation
625643|NCT00682539|diabetic retinopathy|diabetic retinopathy
625644|NCT00682539|macular edema|macular edema
625645|NCT00682539|intravitreal Avastin/ Triamcinolone / Lucentis|intravitreal avastin/ triamcinolone / lucentis
625646|NCT00682578|falciparum malaria|falciparum malaria
625647|NCT00682578|vivax malaria|vivax malaria
625648|NCT00682578|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
625649|NCT00682591|hepatitis C|hepatitis c
625650|NCT00682591|drug substitution|drug substitution
625651|NCT00682591|neurocognitive|neurocognitive
625652|NCT00682591|patients with stable drug substitution therapy|patients with stable drug substitution therapy
625653|NCT00682591|patients with interferon-based antiviral therapy|patients with interferon-based antiviral therapy
626541|NCT00686179|ECG|ecg
625654|NCT00682604|Family Health Program; Food consumption; Nutritional status|family health program; food consumption; nutritional status
625655|NCT00682617|hip|hip
625656|NCT00682617|osteoarthritis|osteoarthritis
625657|NCT00682617|exercise|exercise
625658|NCT00682617|disability|disability
625659|NCT00682617|physical function|physical function
625660|NCT00682630|Malaria|malaria
625661|NCT00682630|anti-malarial|anti-malarial
625662|NCT00682630|pyronaridine|pyronaridine
625663|NCT00682630|ACT|act
625664|NCT00682643|Perennial Allergic Rhinitis|perennial allergic rhinitis
625665|NCT00682643|fluticasone furoate|fluticasone furoate
625666|NCT00682643|ocular safety|ocular safety
625667|NCT00682656|cutaneous leishmaniasis|cutaneous leishmaniasis
625668|NCT00682656|azithromycin|azithromycin
625669|NCT00682656|N- methyl glucamine|n- methyl glucamine
625670|NCT00682669|Asthma|asthma
625671|NCT00682669|Mindfulness-based stress reduction|mindfulness-based stress reduction
625672|NCT00682669|Peak expiratory flow rate|peak expiratory flow rate
625673|NCT00682669|Spirometry|spirometry
625674|NCT00682669|Quality of life|quality of life
625675|NCT00682682|Pain distraction|pain distraction
625676|NCT00682682|Analgesic interventions|analgesic interventions
625677|NCT00682682|Burn patients|burn patients
625678|NCT00682695|stroke|stroke
625679|NCT00682695|brain attack|brain attack
625680|NCT00682695|hemorrhagic stroke|hemorrhagic stroke
625681|NCT00682695|risk factors|risk factors
625682|NCT00682708|malnutrition|malnutrition
625683|NCT00682708|ready to use food|ready to use food
625684|NCT00682708|Niger|niger
625685|NCT00682721|Bacterial Vaginosis|bacterial vaginosis
625686|NCT00682721|Herpes Simplex Virus Type II|herpes simplex virus type ii
625687|NCT00682747|xerostomia|xerostomia
625688|NCT00682747|hyperbaric oxygenation|hyperbaric oxygenation
625689|NCT00682747|radiotherapy|radiotherapy
625690|NCT00682760|Botulinum Toxin Type A|botulinum toxin type a
625691|NCT00682760|Blepharospasm|blepharospasm
625692|NCT00682786|rectal|rectal
625693|NCT00682786|rectum|rectum
625694|NCT00682786|cancer|cancer
625705|NCT00682838|Treatment compliance|treatment compliance
625706|NCT00682838|Self-management|self-management
625707|NCT00682838|Telemedicine|telemedicine
625708|NCT00682877|gastroparesis|gastroparesis
625709|NCT00682877|Digestive|digestive
625710|NCT00682877|Gastrointestinal|gastrointestinal
625712|NCT00682877|Motility|motility
625713|NCT00682877|Non-Invasive|non-invasive
625714|NCT00682877|Capsule|capsule
625715|NCT00682877|GI|gi
625716|NCT00682877|Device|device
625717|NCT00682877|Digestive System Diseases|digestive system diseases
625718|NCT00682903|glucose|glucose
625719|NCT00682903|diabetes|diabetes
625720|NCT00682903|glycemia|glycemia
625721|NCT00682916|Obesity|obesity
625722|NCT00682916|Diabetes|diabetes
625723|NCT00682916|Soluble Fiber|soluble fiber
625724|NCT00682916|Overweight|overweight
625725|NCT00682929|cannabis|cannabis
625726|NCT00682929|marijuana|marijuana
625727|NCT00682929|Multiple Sclerosis|multiple sclerosis
625728|NCT00682929|spasticity|spasticity
625729|NCT00682955|Diarrhea|diarrhea
625730|NCT00682955|Zinc Sulphate|zinc sulphate
625731|NCT00682955|Efficacy|efficacy
625732|NCT00682968|patient non-adherence|patient non-adherence
625733|NCT00682968|antihypertensive agents|antihypertensive agents
625734|NCT00682968|hypertension|hypertension
625735|NCT00682981|ES-SCLC|es-sclc
625736|NCT00682981|Obatoclax|obatoclax
625737|NCT00682994|Advanced Cancer|advanced cancer
625738|NCT00682994|Family Member|family member
625739|NCT00682994|Palliative Care|palliative care
625740|NCT00682994|Decision Making|decision making
625741|NCT00682994|Information Disclosure|information disclosure
625742|NCT00682994|Interview|interview
625743|NCT00682994|Survey|survey
625744|NCT00682994|Questionnaire|questionnaire
625745|NCT00683007|TE echo|te echo
625746|NCT00683007|hemodilution|hemodilution
625747|NCT00683007|hypertonic|hypertonic
625748|NCT00683007|saline|saline
625749|NCT00683007|Arterial Pressure Cardiac Output|arterial pressure cardiac output
625750|NCT00683020|Chronic Diseases|chronic diseases
625751|NCT00683020|Diabetes|diabetes
625752|NCT00683020|Vulnerable population|vulnerable population
625753|NCT00683020|Urban populations|urban populations
625754|NCT00683020|Disease Management|disease management
625755|NCT00683020|Health Information Technology|health information technology
625756|NCT00683020|Safety|safety
625757|NCT00683020|Health Literacy|health literacy
625758|NCT00683020|Level of English Proficiency|level of english proficiency
625759|NCT00683033|Contingency Management|contingency management
625760|NCT00683033|Cigarette Smoking Cessation|cigarette smoking cessation
625761|NCT00683033|Substance Abusers|substance abusers
625762|NCT00683046|Relapsed or refractory acute myelogenous or lymphoid leukemia.|relapsed or refractory acute myelogenous or lymphoid leukemia.
625763|NCT00683046|Acute myeloid or lymphocytic leukemia in first remission at high-risk for recurrence.Chronic myelogenous leukemia in accelerated phase or blast-crisis.|acute myeloid or lymphocytic leukemia in first remission at high-risk for recurrence.chronic myelogenous leukemia in accelerated phase or blast-crisis.
625857|NCT00683358|Pancreas Cancer|pancreas cancer
625764|NCT00683046|Chronic myelogenous leukemia in chronic phase|chronic myelogenous leukemia in chronic phase
625765|NCT00683046|Chronic myelogenous leukemia in accelerated phase or blast-crisis|chronic myelogenous leukemia in accelerated phase or blast-crisis
625766|NCT00683046|Recurrent or refractory malignant lymphoma or Hodgkin's disease.|recurrent or refractory malignant lymphoma or hodgkin's disease.
625767|NCT00683046|Chronic lymphocytic leukemia, relapsed or with poor prognostic features.|chronic lymphocytic leukemia, relapsed or with poor prognostic features.
625768|NCT00683046|Myeloproliferative disorder (polycythemia vera, myelofibrosis) with poor prognostic features.|myeloproliferative disorder (polycythemia vera, myelofibrosis) with poor prognostic features.
625769|NCT00683046|Severe aplastic anemia after failure of immunosuppressive therapy.|severe aplastic anemia after failure of immunosuppressive therapy.
625770|NCT00683046|Myelodysplastic syndromes (including PNH)|myelodysplastic syndromes (including pnh)
625771|NCT00683046|Multiple myeloma at high risk for disease recurrence.|multiple myeloma at high risk for disease recurrence.
625772|NCT00683072|Ventilator|ventilator
625773|NCT00683072|patient-ventilator asynchrony|patient-ventilator asynchrony
625774|NCT00683085|cancer|cancer
625775|NCT00683085|pancreas|pancreas
625776|NCT00683085|advanced|advanced
625777|NCT00683085|peptide|peptide
625778|NCT00683085|vaccination|vaccination
625779|NCT00683085|VEGFR1|vegfr1
625780|NCT00683085|HLA|hla
625781|NCT00683085|gemcitabine|gemcitabine
625782|NCT00683085|IFA|ifa
625783|NCT00683085|Cancer of Pancreas|cancer of pancreas
625784|NCT00683085|Neoplasms, Pancreas|neoplasms, pancreas
625785|NCT00683085|Pancreas Cancer|pancreas cancer
625786|NCT00683098|recurrent hernia|recurrent hernia
625983|NCT00683839|5 As|5 as
625787|NCT00683098|endoscopic total extraperitoneal repair|endoscopic total extraperitoneal repair
625788|NCT00683098|inguinal pain|inguinal pain
625789|NCT00683098|questionnaire|questionnaire
625790|NCT00683111|acute coronary syndrome|acute coronary syndrome
625791|NCT00683111|acute myocardial infarction|acute myocardial infarction
625792|NCT00683111|aspirin|aspirin
625793|NCT00683111|clopidogrel|clopidogrel
625794|NCT00683111|heparin|heparin
625795|NCT00683111|thrombolytic|thrombolytic
625797|NCT00683111|esomeprazole|esomeprazole
625798|NCT00683124|Marfan Syndrome|marfan syndrome
625799|NCT00683124|Losartan|losartan
625800|NCT00683124|Nebivolol|nebivolol
625801|NCT00683124|Transforming Growth Factor Beta|transforming growth factor beta
625802|NCT00683124|Aortic Root Dilation|aortic root dilation
625803|NCT00683150|Endothelial Function|endothelial function
625804|NCT00683150|Abdominal Surgery|abdominal surgery
625805|NCT00683150|Thoracic Surgery|thoracic surgery
625806|NCT00683150|Vendy's-DTM Machine|vendy's-dtm machine
625807|NCT00683150|Digital Thermal Monitoring|digital thermal monitoring
625809|NCT00683163|Combination of PTH and ibandronate|combination of pth and ibandronate
625810|NCT00683163|Bone marker formation|bone marker formation
625811|NCT00683163|Postmenopausal|postmenopausal
625812|NCT00683163|Trabecular spine BMD|trabecular spine bmd
625813|NCT00683176|Diabetic Macular Edema|diabetic macular edema
625814|NCT00683176|OCT|oct
625815|NCT00683189|MLD|mld
625816|NCT00683202|Assisted reproduction|assisted reproduction
625817|NCT00683202|Ovarian response|ovarian response
625818|NCT00683202|Uteroplacental hemodynamics|uteroplacental hemodynamics
625819|NCT00683202|Doppler ultrasonography|doppler ultrasonography
625820|NCT00683202|Implantation rate|implantation rate
625821|NCT00683202|Pregnancy rate|pregnancy rate
625822|NCT00683202|Live birth rate|live birth rate
625823|NCT00683228|Second hand Smoke|second hand smoke
625824|NCT00683241|Vaccine|vaccine
625825|NCT00683241|Ovarian|ovarian
625826|NCT00683241|Peritoneal|peritoneal
625827|NCT00683254|nasal obstruction|nasal obstruction
625828|NCT00683254|nasal stent|nasal stent
625829|NCT00683267|THA, Total hip arthroplasty, total hip replacement|tha, total hip arthroplasty, total hip replacement
625830|NCT00683280|Contingency Management|contingency management
625831|NCT00683280|Cigarette Smoking Cessation|cigarette smoking cessation
625832|NCT00683280|varenicline|varenicline
625833|NCT00683293|Laparoscopic Hysterectomy|laparoscopic hysterectomy
625834|NCT00683293|Robot-assisted Laparoscopic Hysterectomy|robot-assisted laparoscopic hysterectomy
625835|NCT00683293|Robot-assisted Surgery|robot-assisted surgery
625836|NCT00683319|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
625837|NCT00683319|cognitive/functional effects|cognitive/functional effects
625838|NCT00683319|ototoxicity|ototoxicity
625839|NCT00683319|childhood infratentorial ependymoma|childhood infratentorial ependymoma
625840|NCT00683319|childhood supratentorial ependymoma|childhood supratentorial ependymoma
625841|NCT00683332|Observational study|observational study
625842|NCT00683332|Tigecycline|tigecycline
625843|NCT00683332|infection|infection
625844|NCT00683332|skin|skin
625845|NCT00683332|abdominal|abdominal
625846|NCT00683358|cancer|cancer
625847|NCT00683358|pancreas|pancreas
625848|NCT00683358|advanced|advanced
625849|NCT00683358|peptide|peptide
625850|NCT00683358|vaccination|vaccination
625851|NCT00683358|VEGFR1|vegfr1
625852|NCT00683358|HLA|hla
625853|NCT00683358|gemcitabine|gemcitabine
625854|NCT00683358|IFA|ifa
625855|NCT00683358|Cancer of Pancreas|cancer of pancreas
625856|NCT00683358|Neoplasms, Pancreatic|neoplasms, pancreatic
625858|NCT00683371|Chronic Rhinosinusitis|chronic rhinosinusitis
625859|NCT00683371|Sinus Disease|sinus disease
625860|NCT00683371|Allergy|allergy
625861|NCT00683371|Maxillary Sinus|maxillary sinus
625862|NCT00683371|Microarray|microarray
625863|NCT00683384|Arthritis|arthritis
625864|NCT00683384|psoriatic|psoriatic
625865|NCT00683397|assess|assess
625866|NCT00683397|prevalence|prevalence
625867|NCT00683397|thrombophilia|thrombophilia
625868|NCT00683397|common|common
625869|NCT00683397|VTE|vte
625870|NCT00683397|risk factors|risk factors
625871|NCT00683397|patients|patients
625872|NCT00683436|insomnia|insomnia
625873|NCT00683449|Asthma|asthma
625874|NCT00683449|Dose-Escalation|dose-escalation
625875|NCT00683449|Controlled|controlled
625876|NCT00683449|MN-221|mn-221
625877|NCT00683475|Prostate Cancer|prostate cancer
625878|NCT00683488|Substance Abuse|substance abuse
625879|NCT00683488|Adolescent community reinforcement approach|adolescent community reinforcement approach
625880|NCT00683488|Adolescent Risk Behavior Assessment|adolescent risk behavior assessment
625881|NCT00683488|Child and Adolescent Services Assessment|child and adolescent services assessment
625882|NCT00683488|Cognitive behavioral therapy|cognitive behavioral therapy
625883|NCT00683488|Cognitive Therapy Rating Scale|cognitive therapy rating scale
625884|NCT00683488|Individual behavior therapy|individual behavior therapy
625885|NCT00683488|Individual cognitive problem solving|individual cognitive problem solving
625886|NCT00683488|Motivational enhancement therapy|motivational enhancement therapy
625887|NCT00683488|HIV-Positive Youth With Substance Abuse|hiv-positive youth with substance abuse
625888|NCT00683488|Complementary Therapies|complementary therapies
625889|NCT00683501|ocular hypertension|ocular hypertension
625890|NCT00683501|elevated IOP|elevated iop
625891|NCT00683501|glaucoma|glaucoma
625892|NCT00683501|neuroprotection|neuroprotection
625993|NCT00683891|Weight gain|weight gain
625994|NCT00683891|Sialorrhea|sialorrhea
625995|NCT00683891|Treatment refractory schizophrenia|treatment refractory schizophrenia
625893|NCT00683514|Untreated locally advanced inoperable stage IIIA or stage IIIB NSCLC amenable to radical radiotherapy to a dose of 66 Gy|untreated locally advanced inoperable stage iiia or stage iiib nsclc amenable to radical radiotherapy to a dose of 66 gy
625894|NCT00683527|Iron supplementation|iron supplementation
625895|NCT00683527|Timing|timing
625896|NCT00683527|Serum ferritin|serum ferritin
627183|NCT00682058|fat|fat
625897|NCT00683527|Very low birth weight infants|very low birth weight infants
625898|NCT00683540|implementation|implementation
625899|NCT00683540|evaluation|evaluation
625900|NCT00683540|research methodology|research methodology
625901|NCT00683540|intervention|intervention
625902|NCT00683553|Acute Renal Failure|acute renal failure
625903|NCT00683553|Acute Kidney Injury|acute kidney injury
625904|NCT00683566|parkinson|parkinson
625905|NCT00683579|HAART|haart
625906|NCT00683579|DHHS guidelines|dhhs guidelines
625907|NCT00683579|Treatment Naive|treatment naive
625908|NCT00683618|HMG-CoA|hmg-coa
625909|NCT00683618|LDL-C|ldl-c
625911|NCT00683631|liver cancer|liver cancer
625912|NCT00683631|liver tumor|liver tumor
625913|NCT00683631|HCC|hcc
625914|NCT00683631|hepatocellular carcinoma|hepatocellular carcinoma
625915|NCT00683631|hepatoma|hepatoma
625916|NCT00683683|cardiac arrest, hypothermia, knowledge translation|cardiac arrest, hypothermia, knowledge translation
625917|NCT00683696|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
625918|NCT00683696|Heart Failure|heart failure
625919|NCT00683696|Ventricular Dyssynchrony|ventricular dyssynchrony
625920|NCT00683696|Mechanical Dyssynchrony|mechanical dyssynchrony
625921|NCT00683696|Intraventricular Dyssynchrony|intraventricular dyssynchrony
625922|NCT00683696|Echocardiography|echocardiography
625923|NCT00683696|Normal QRS|normal qrs
625924|NCT00683696|Heart Disease|heart disease
625925|NCT00683696|EchoCRT|echocrt
625926|NCT00683709|Bipolar and Schizoaffective Disorder|bipolar and schizoaffective disorder
625928|NCT00683709|Metabolic Side Effects|metabolic side effects
625929|NCT00683709|Diet & Exercise|diet & exercise
625930|NCT00683709|BMI|bmi
625931|NCT00683722|COPD|copd
625932|NCT00683722|Airflow Obstruction, Chronic|airflow obstruction, chronic
625933|NCT00683722|Chronic Airflow Obstruction|chronic airflow obstruction
625934|NCT00683722|Chronic Obstructive Airway Disease|chronic obstructive airway disease
625935|NCT00683722|Chronic Obstructive Lung Disease|chronic obstructive lung disease
625936|NCT00683722|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
625937|NCT00683722|Pulmonary Emphysema|pulmonary emphysema
625938|NCT00683722|Chronic Bronchitis|chronic bronchitis
625939|NCT00683722|Mesenchymal Stem Cells|mesenchymal stem cells
625940|NCT00683722|MSCs|mscs
625941|NCT00683722|Adult Human Stem Cells|adult human stem cells
625942|NCT00683722|Osiris|osiris
625943|NCT00683722|Prochymal|prochymal
625944|NCT00683735|Incretin, DPP-4, metformin, sitagliptin, insulin secretion|incretin, dpp-4, metformin, sitagliptin, insulin secretion
625945|NCT00683748|Transplantation|transplantation
625946|NCT00683748|Immunological monitoring|immunological monitoring
625947|NCT00683748|Immunological risk|immunological risk
625948|NCT00683748|T cell reactivity|t cell reactivity
625949|NCT00683748|Cellular immunity|cellular immunity
625950|NCT00683761|High grade recurrent glioma|high grade recurrent glioma
625951|NCT00683761|Phase 2|phase 2
625952|NCT00683761|Phase 1|phase 1
625953|NCT00683761|Multi-center|multi-center
625954|NCT00683761|Open label|open label
625955|NCT00683761|Multiple dose|multiple dose
625956|NCT00683761|Brain Cancer|brain cancer
625957|NCT00683761|Brain Tumor|brain tumor
625958|NCT00683761|GBM|gbm
625959|NCT00683761|glioma|glioma
625960|NCT00683761|glioblastoma|glioblastoma
625961|NCT00683761|astrocytoma|astrocytoma
625962|NCT00683761|oligodendroglioma|oligodendroglioma
625963|NCT00683761|131I-TM601|131i-tm601
625964|NCT00683761|TM601|tm601
625965|NCT00683787|recurrent gastric cancer|recurrent gastric cancer
625966|NCT00683787|stage IV gastric cancer|stage iv gastric cancer
625967|NCT00683787|adenocarcinoma of the stomach|adenocarcinoma of the stomach
625968|NCT00683800|Menopause|menopause
625969|NCT00683800|Hot Flush|hot flush
625970|NCT00683800|Hot Flash|hot flash
625971|NCT00683800|Desvenlafaxine succinate Sustained Release|desvenlafaxine succinate sustained release
625972|NCT00683813|cardiac rehabilitation|cardiac rehabilitation
625973|NCT00683813|telehealth|telehealth
625974|NCT00683813|Internet|internet
625975|NCT00683826|Leucine|leucine
625976|NCT00683826|Weight Loss|weight loss
625977|NCT00683839|Tobacco|tobacco
625978|NCT00683839|Smoking|smoking
625979|NCT00683839|Smokeless|smokeless
625980|NCT00683839|Cessation|cessation
625981|NCT00683839|Public health clinic|public health clinic
625982|NCT00683839|Dental patients|dental patients
625985|NCT00683839|Tobacco Quit Line|tobacco quit line
625986|NCT00683839|Smokeless tobacco|smokeless tobacco
625987|NCT00683852|Depression|depression
625988|NCT00683865|Antibiotic treatment|antibiotic treatment
625989|NCT00683865|Pelvic infection|pelvic infection
625990|NCT00683865|Interventional study|interventional study
625991|NCT00683865|Female|female
625992|NCT00683891|FOCUS|focus
625997|NCT00683891|Treatment resistant schizophrenia|treatment resistant schizophrenia
625998|NCT00683891|clozapine|clozapine
625999|NCT00683891|Hypersalivation|hypersalivation
626000|NCT00683917|Uterine fibroids|uterine fibroids
626001|NCT00683917|Fibroids|fibroids
626002|NCT00683943|Spinocerebellar Ataxia|spinocerebellar ataxia
626003|NCT00683943|Lithium|lithium
627279|NCT00688831|SAD|sad
626004|NCT00683982|nitazoxanide|nitazoxanide
626005|NCT00683982|Probiotics|probiotics
626006|NCT00683982|Diarrhea|diarrhea
626007|NCT00683982|Rotavirus|rotavirus
626008|NCT00683982|Children|children
626009|NCT00683995|Pain, Cancer|pain, cancer
626010|NCT00684008|interleukin-7|interleukin-7
626011|NCT00684008|immune based therapies|immune based therapies
626012|NCT00684008|graft vs host disease|graft vs host disease
626013|NCT00684008|immune reconstitution|immune reconstitution
626014|NCT00684008|infection|infection
626015|NCT00684008|lymphopenia|lymphopenia
626016|NCT00684008|hematopoetic stem cell transplantation|hematopoetic stem cell transplantation
626017|NCT00684008|bone marrow transplantation|bone marrow transplantation
626018|NCT00684008|peripheral blood stem cell transplant|peripheral blood stem cell transplant
626019|NCT00684008|immunosuppression|immunosuppression
626020|NCT00684021|Acute Myocardial Infarction|acute myocardial infarction
626021|NCT00684021|Global Left Ventricular Ejection Fraction|global left ventricular ejection fraction
626022|NCT00684021|Regional Left Ventricular Ejection Fraction|regional left ventricular ejection fraction
626023|NCT00684021|Left Ventricular Mass|left ventricular mass
626024|NCT00684021|Infarct Size|infarct size
626025|NCT00684021|End Systolic Volume|end systolic volume
626026|NCT00684021|End Diastolic Volume|end diastolic volume
626027|NCT00684034|Redox state in the course of chronic renal insufficiency and hemodialysis.|redox state in the course of chronic renal insufficiency and hemodialysis.
626028|NCT00684047|Fibrin Sealant|fibrin sealant
626029|NCT00684047|Hemostasis|hemostasis
626030|NCT00684047|Peripheral Vascular Surgery|peripheral vascular surgery
626031|NCT00684060|Acute Myocardial Infarction|acute myocardial infarction
626032|NCT00684060|Global Left Ventricular Ejection Fraction|global left ventricular ejection fraction
626033|NCT00684060|Regional Left Ventricular Ejection Fraction|regional left ventricular ejection fraction
626034|NCT00684060|Left Ventricular Mass|left ventricular mass
626035|NCT00684060|Infarct Size|infarct size
626036|NCT00684060|End Systolic Volume|end systolic volume
626037|NCT00684060|End Diastolic Volume|end diastolic volume
626038|NCT00684073|Suboxone|suboxone
626039|NCT00684073|Subutex|subutex
626040|NCT00684073|Buprenorphine|buprenorphine
626041|NCT00684073|Naloxone|naloxone
626042|NCT00684099|NSCLC|nsclc
626043|NCT00684099|Pemetrexed|pemetrexed
626044|NCT00684099|Docetaxel|docetaxel
626045|NCT00684112|pediatrics|pediatrics
626046|NCT00684112|Scoliosis|scoliosis
626047|NCT00684112|Gabapentin|gabapentin
626048|NCT00684125|late cardiac tamponade|late cardiac tamponade
626049|NCT00684138|cataract|cataract
626050|NCT00684138|cataract surgery|cataract surgery
626051|NCT00684138|IOL|iol
626052|NCT00684138|intraocular lens|intraocular lens
626053|NCT00684138|ReSTOR|restor
626054|NCT00684138|Replacement of cataract|replacement of cataract
626055|NCT00684151|Lipid-lowering|lipid-lowering
626056|NCT00684164|Euvolemic Hyponatremia|euvolemic hyponatremia
626057|NCT00684164|Hypervolemic Hyponatremia|hypervolemic hyponatremia
626058|NCT00684164|Neurological injury|neurological injury
626059|NCT00684177|infection|infection
626060|NCT00684177|retapamulin|retapamulin
626061|NCT00684177|secondarily-infected traumatic lesions|secondarily-infected traumatic lesions
626062|NCT00684177|placebo|placebo
626063|NCT00684190|Reflux Inhibitor|reflux inhibitor
626064|NCT00684190|GERD|gerd
626065|NCT00684190|PPI Interaction|ppi interaction
626066|NCT00684216|metastatic|metastatic
626067|NCT00684216|ER positive|er positive
626068|NCT00684216|PD during/after first line hormonal treatment|pd during/after first line hormonal treatment
626069|NCT00684229|Anesthesia; regional|anesthesia; regional
626070|NCT00684229|Cancer recurrence|cancer recurrence
626071|NCT00684229|Anesthesia; inhalational|anesthesia; inhalational
626072|NCT00684229|Analgesia; opioid|analgesia; opioid
626073|NCT00684242|Advanced Cancer|advanced cancer
626074|NCT00684242|Refractory Cancer Pain|refractory cancer pain
626075|NCT00684242|Lenalidomide|lenalidomide
626076|NCT00684242|Revlimid|revlimid
626077|NCT00684242|CC-5103|cc-5103
626078|NCT00684255|Autoimmune Disease|autoimmune disease
626079|NCT00684255|Reduced Intensity Transplant|reduced intensity transplant
626080|NCT00684268|silibinin|silibinin
626081|NCT00684268|chronic hepatitis C|chronic hepatitis c
626082|NCT00684268|peginterferon|peginterferon
626083|NCT00684268|ribavirin|ribavirin
626084|NCT00684268|nonresponders|nonresponders
626085|NCT00684268|efficacy of iv. silibinin|efficacy of iv. silibinin
626086|NCT00684268|safety|safety
626087|NCT00684294|cancer|cancer
626088|NCT00684294|oncology|oncology
626089|NCT00684294|solid tumor|solid tumor
626090|NCT00684307|Anticoagulant Treatment|anticoagulant treatment
626091|NCT00684307|Risk Factors For Stroke|risk factors for stroke
626092|NCT00684320|Social Anxiety Disorder|social anxiety disorder
626093|NCT00684320|Information Processing|information processing
626094|NCT00684320|Attention Bias|attention bias
626095|NCT00684333|painless Injections|painless injections
626096|NCT00684333|Subcutaneous Injections|subcutaneous injections
626097|NCT00684333|Subcutaneous Injections to healthy volunteers|subcutaneous injections to healthy volunteers
626098|NCT00684346|18FDG-PET imaging|18fdg-pet imaging
626099|NCT00684346|airway inflammation|airway inflammation
626100|NCT00684346|cystic fibrosis|cystic fibrosis
626101|NCT00684346|pediatric|pediatric
626102|NCT00684346|pulmonary exacerbation|pulmonary exacerbation
626103|NCT00684359|Patients having PCI with a drug eluting stent|patients having pci with a drug eluting stent
626104|NCT00684398|Neurofibromatosis Type 1|neurofibromatosis type 1
626105|NCT00684398|Quality of Life|quality of life
626106|NCT00684398|Adaptation|adaptation
626107|NCT00684398|Stress and Coping Model|stress and coping model
626109|NCT00684398|Survey|survey
626110|NCT00684411|T NHL|t nhl
626111|NCT00684411|Gleevec|gleevec
626112|NCT00684411|imatinib mesylate|imatinib mesylate
626113|NCT00684437|Health Literacy|health literacy
626114|NCT00684437|Smoking Risk|smoking risk
626115|NCT00684437|Focus Group|focus group
626116|NCT00684437|Questionnaire|questionnaire
626117|NCT00684437|Survey|survey
626118|NCT00684450|titration of protamine|titration of protamine
626119|NCT00684450|exact dose|exact dose
626120|NCT00684450|protamine|protamine
626121|NCT00684450|neutralize heparin|neutralize heparin
626122|NCT00684463|Antiemetic|antiemetic
626123|NCT00684489|hypertension|hypertension
626124|NCT00684489|renin-guided therapeutics|renin-guided therapeutics
626125|NCT00684502|Safety|safety
626126|NCT00684502|tolerability|tolerability
626127|NCT00684502|AZD2066|azd2066
626128|NCT00684502|Pain conditions|pain conditions
626129|NCT00684528|DM 2|dm 2
626130|NCT00684528|Metformin|metformin
626131|NCT00684528|Januvia|januvia
626132|NCT00684528|Community setting|community setting
626133|NCT00684528|newly diagnosed diadetics, or diabetes patients not treated during the last year|newly diagnosed diadetics, or diabetes patients not treated during the last year
626134|NCT00684541|Social Anxiety|social anxiety
626135|NCT00684541|Information Processing|information processing
626136|NCT00684541|Interpretation|interpretation
626137|NCT00684554|Heroin Dependence|heroin dependence
626138|NCT00684554|Opioid Dependence|opioid dependence
626139|NCT00684554|Primary Care|primary care
626140|NCT00684554|Buprenorphine|buprenorphine
626141|NCT00684580|St. Jude Alumni|st. jude alumni
626142|NCT00684580|St. Jude Life Participants|st. jude life participants
626143|NCT00684606|Induction of Labor|induction of labor
626144|NCT00684606|Low Bishop Score|low bishop score
626145|NCT00684606|Transcervical Foley Catheter.|transcervical foley catheter.
626146|NCT00684606|IV Oxytocin|iv oxytocin
626147|NCT00678067|Hypercholesterolemic children|hypercholesterolemic children
626148|NCT00678067|Docosahexaenoic acid|docosahexaenoic acid
626149|NCT00678067|Eicosapentaenoic acid|eicosapentaenoic acid
626150|NCT00678067|Blood lipid profile|blood lipid profile
626151|NCT00678080|Type 2 diabetes mellitus|type 2 diabetes mellitus
626152|NCT00678080|Pregnancy|pregnancy
626153|NCT00678080|Metformin|metformin
626154|NCT00678080|Insulin|insulin
626155|NCT00678080|Pregnant women|pregnant women
626156|NCT00678093|Low back pain|low back pain
626157|NCT00678093|Manual therapy|manual therapy
626158|NCT00678093|Mulligan snag|mulligan snag
626159|NCT00678106|dalbavancin adolescent subjects|dalbavancin adolescent subjects
626160|NCT00678119|Kidney cancer|kidney cancer
626161|NCT00678119|Renal cancer|renal cancer
626162|NCT00678119|Renal Cell Carcinoma|renal cell carcinoma
626163|NCT00678132|PARP Inhibitor|parp inhibitor
626164|NCT00678132|Combination Study|combination study
626165|NCT00678132|Chemotherapy|chemotherapy
626166|NCT00678132|Advanced Cancer|advanced cancer
626167|NCT00678132|Neoplasms|neoplasms
626168|NCT00678132|Cancer|cancer
626169|NCT00678132|Solid Tumor|solid tumor
626170|NCT00678145|Diabetes|diabetes
626171|NCT00678145|Hypoglycemia|hypoglycemia
626172|NCT00678145|HAAF|haaf
626173|NCT00678145|Counterregulation|counterregulation
626174|NCT00678158|High Does Single Fraction IGRT|high does single fraction igrt
626175|NCT00678158|Bone|bone
626176|NCT00678158|Lymph Nodes|lymph nodes
626177|NCT00678158|Soft Tissue|soft tissue
626178|NCT00678171|Degenerative Disc Disease|degenerative disc disease
626179|NCT00678184|Atorvastatin|atorvastatin
626180|NCT00678184|healthy|healthy
626181|NCT00678184|sodium excretion|sodium excretion
626182|NCT00678184|hemodynamics|hemodynamics
626183|NCT00678184|tubular function|tubular function
626184|NCT00678197|Quality of care|quality of care
626185|NCT00678197|Access to care|access to care
626186|NCT00678197|Health Outcomes|health outcomes
626187|NCT00678210|dose response; PASI 75 response endpoint; subjects with moderate to severe chronic plaque psoriasis|dose response; pasi 75 response endpoint; subjects with moderate to severe chronic plaque psoriasis
626189|NCT00678236|Gonarthritis|gonarthritis
626190|NCT00678236|Bone Cement|bone cement
626191|NCT00678249|Hemodialysis|hemodialysis
626192|NCT00678249|Vascular Prosthesis|vascular prosthesis
626193|NCT00678249|stenoses|stenoses
626194|NCT00678249|grafts|grafts
626195|NCT00678262|pain|pain
626197|NCT00678262|Heart rate variability|heart rate variability
626198|NCT00678262|wavelets|wavelets
626199|NCT00678275|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
626200|NCT00678288|Renal Cell Cancer|renal cell cancer
626201|NCT00678288|Interferon|interferon
626202|NCT00678301|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
626203|NCT00678301|Streptococcus pneumoniae|streptococcus pneumoniae
626204|NCT00678314|Anesthetics|anesthetics
626205|NCT00678314|Local|local
626206|NCT00678314|ropivacaine|ropivacaine
626207|NCT00678314|Surgery|surgery
626208|NCT00678314|Hand|hand
626209|NCT00678314|carpel tunnel|carpel tunnel
626210|NCT00678314|Carpal tunnel surgery|carpal tunnel surgery
626211|NCT00678327|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
626212|NCT00678327|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
626213|NCT00678327|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
626214|NCT00678327|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
626215|NCT00678327|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
626216|NCT00678327|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
626217|NCT00678327|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
626218|NCT00678340|Randomized Controlled Trial|randomized controlled trial
626219|NCT00678340|Single-Blind Study|single-blind study
626220|NCT00678340|Catheter Ablation|catheter ablation
626221|NCT00678353|Degenerative disc disease|degenerative disc disease
626222|NCT00678366|laparoscopy|laparoscopy
626223|NCT00678366|carbon dioxide|carbon dioxide
626224|NCT00678366|oxygen|oxygen
626225|NCT00678366|pain|pain
626226|NCT00678366|inflammation|inflammation
626227|NCT00678379|Tonsillectomy|tonsillectomy
626228|NCT00678379|Postoperative Pain|postoperative pain
626229|NCT00678379|Clonidine|clonidine
626230|NCT00678379|Anesthetics, Local|anesthetics, local
626231|NCT00678392|Axitinib in Second Line Treatment of Patients With Metastatic Renal Cell Cancer|axitinib in second line treatment of patients with metastatic renal cell cancer
626232|NCT00678405|Breathlessness|breathlessness
626233|NCT00678405|Dyspnoea|dyspnoea
626234|NCT00678405|Dyspnea|dyspnea
626235|NCT00678405|Palliative care|palliative care
626236|NCT00678405|RCT|rct
626237|NCT00678405|Randomised controlled trial|randomised controlled trial
626238|NCT00678405|Lung cancer|lung cancer
626239|NCT00678405|COPD|copd
626240|NCT00678405|Heart failure|heart failure
626241|NCT00678405|Chronic respiratory disease|chronic respiratory disease
626242|NCT00678418|Addiction|addiction
626243|NCT00678418|Opiate dependence|opiate dependence
626244|NCT00678418|Inpatient detoxification|inpatient detoxification
626245|NCT00678418|opioid dependence|opioid dependence
626246|NCT00678418|heroin dependence|heroin dependence
626247|NCT00678431|Alzheimer's Disease|alzheimer's disease
626248|NCT00678431|Dementia|dementia
626249|NCT00678431|Nutritional Supplement|nutritional supplement
626250|NCT00678431|Resveratrol|resveratrol
626251|NCT00678444|Anxiety|anxiety
626252|NCT00678444|Satisfaction|satisfaction
626253|NCT00678444|Incomplete bladder emptying|incomplete bladder emptying
626254|NCT00678444|Clean Intermittent Self-catheterization|clean intermittent self-catheterization
626255|NCT00678444|Prolapse/incontinence surgery|prolapse/incontinence surgery
626256|NCT00678457|alcohol dependence|alcohol dependence
626257|NCT00678457|alcohol abuse|alcohol abuse
626258|NCT00678457|drinking|drinking
626259|NCT00678457|alcohol|alcohol
626260|NCT00678483|Cholesterol|cholesterol
626261|NCT00678483|HDL|hdl
626262|NCT00678483|triglycerides|triglycerides
626263|NCT00678483|insulin|insulin
626264|NCT00678483|blood glucose|blood glucose
626265|NCT00678496|CBT-software|cbt-software
626266|NCT00678496|Computerised Cognitive Behavioural Therapy|computerised cognitive behavioural therapy
626267|NCT00678496|CCBT|ccbt
626268|NCT00678496|Cognitive Therapy|cognitive therapy
626269|NCT00678496|Therapy, Computer-Assisted|therapy, computer-assisted
626270|NCT00678496|Depression|depression
626271|NCT00678496|Multiple Sclerosis|multiple sclerosis
626272|NCT00678509|HLA-A*2402|hla-a*2402
626273|NCT00678509|Peptide Vaccine|peptide vaccine
626274|NCT00678509|TTK|ttk
626275|NCT00678522|Atorvastatin|atorvastatin
626276|NCT00678522|Renal function|renal function
626277|NCT00678522|Hemodynamics|hemodynamics
626278|NCT00678522|Diabetes type II|diabetes type ii
626279|NCT00678522|sodium excretion|sodium excretion
626280|NCT00678535|1st line treatment for Gastric Cancer|1st line treatment for gastric cancer
626281|NCT00678535|Cetuximab|cetuximab
626282|NCT00678535|Capecitabine|capecitabine
626283|NCT00678535|Xeloda|xeloda
626284|NCT00678535|Cisplatin|cisplatin
626285|NCT00678535|Progression-free survival|progression-free survival
626286|NCT00678561|chronic plaque psoriasis, topical treatment|chronic plaque psoriasis, topical treatment
626287|NCT00678574|hormones|hormones
626288|NCT00678574|menses|menses
626289|NCT00678574|PMS|pms
626290|NCT00678574|PMDD|pmdd
626291|NCT00678587|elective invasive procedure.|elective invasive procedure.
626292|NCT00678587|platelet transfusion|platelet transfusion
626390|NCT00684658|Children and Teenagers|children and teenagers
626293|NCT00678587|chronic liver disease-related thrombocytopenia|chronic liver disease-related thrombocytopenia
626294|NCT00678587|platelets|platelets
626295|NCT00678587|thrombopoietin|thrombopoietin
626296|NCT00678600|Informatics|informatics
626297|NCT00678600|Alerts|alerts
626298|NCT00678600|Toxicity|toxicity
626299|NCT00678600|Virologic failure|virologic failure
626300|NCT00678600|Suboptimal follow up|suboptimal follow up
626301|NCT00678613|probiotics|probiotics
626302|NCT00678613|cirrhosis|cirrhosis
626303|NCT00678613|prophylaxis|prophylaxis
626304|NCT00678613|cirrhotic|cirrhotic
626305|NCT00678613|patients|patients
626306|NCT00678613|with|with
626307|NCT00678613|ascites|ascites
626308|NCT00678613|using|using
626309|NCT00678626|Key words: Docetaxel; breast cancer; breast diseases; breast neoplasms; antineoplastic agents; neoplasms;HER-2 negative; Stage IIIB or IV breast cancer.|key words: docetaxel; breast cancer; breast diseases; breast neoplasms; antineoplastic agents; neoplasms;her-2 negative; stage iiib or iv breast cancer.
626311|NCT00678639|Acute Coronary Syndrome|acute coronary syndrome
626312|NCT00678639|Chest pain|chest pain
626313|NCT00678639|Cardiac MRI|cardiac mri
626314|NCT00678639|CMR|cmr
626315|NCT00678639|Risk Stratification|risk stratification
626316|NCT00678639|Emergency Department|emergency department
626317|NCT00678652|Meningococcal vaccine|meningococcal vaccine
626318|NCT00678652|Neisseria meningitidis|neisseria meningitidis
626319|NCT00678665|ecg|ecg
626320|NCT00678665|TSA2000|tsa2000
626321|NCT00678665|Heart rate variability|heart rate variability
626322|NCT00678665|wavelets|wavelets
626323|NCT00678678|Physiotherapy|physiotherapy
626324|NCT00678678|Breathing exercises|breathing exercises
626325|NCT00678678|Bariatric Surgery|bariatric surgery
626326|NCT00678678|Laparoscopy|laparoscopy
626327|NCT00678691|fibromyalgia|fibromyalgia
626328|NCT00678691|fatigue|fatigue
628566|NCT00697554|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
628567|NCT00697567|Herpes simplex|herpes simplex
628568|NCT00697567|Herpes simplex vaccine|herpes simplex vaccine
628569|NCT00697580|Obesity|obesity
628570|NCT00697580|Type 2 Diabetes|type 2 diabetes
628571|NCT00697580|Cardiovascular risk|cardiovascular risk
628572|NCT00697580|Cancer|cancer
626329|NCT00678704|Vardenafil|vardenafil
626330|NCT00678704|PDE5 inhibitor|pde5 inhibitor
626331|NCT00678704|Erectile Dysfunction|erectile dysfunction
626332|NCT00678704|Diabetes Mellitus|diabetes mellitus
626333|NCT00678704|Sexual Dysfunction|sexual dysfunction
626334|NCT00678717|abdominal|abdominal
626335|NCT00678717|Pelvic|pelvic
626336|NCT00678717|Pain|pain
626337|NCT00678717|SCS|scs
626338|NCT00678717|Healthy and Chronic Visceral Pain patients|healthy and chronic visceral pain patients
626339|NCT00678717|Chronic Visceral Pain and spinal cord stimulator|chronic visceral pain and spinal cord stimulator
626340|NCT00678730|THC|thc
626341|NCT00678730|COMT gene polymorphism|comt gene polymorphism
626342|NCT00678730|schizophrenia|schizophrenia
626343|NCT00678730|cannabis use|cannabis use
626344|NCT00678743|cholesterol|cholesterol
626345|NCT00678743|dyslipidemia|dyslipidemia
626346|NCT00678743|omega 3|omega 3
626347|NCT00678756|Psoriasis vulgaris,|psoriasis vulgaris,
626348|NCT00678756|vitamin D, UVB-phototherapy, ketokonazol,|vitamin d, uvb-phototherapy, ketokonazol,
626349|NCT00678756|Optical Coherence Tomography,|optical coherence tomography,
626350|NCT00678756|local PASI, Nizoral|local pasi, nizoral
626351|NCT00678782|knee|knee
626352|NCT00678782|synovitis|synovitis
626353|NCT00678782|arthritis|arthritis
626354|NCT00678782|rheumatoid arthritis|rheumatoid arthritis
626355|NCT00678782|psoriatic arthritis|psoriatic arthritis
626356|NCT00678782|spondyloarthropathies|spondyloarthropathies
626357|NCT00678782|intraarticular|intraarticular
626358|NCT00678782|etanercept|etanercept
626359|NCT00678795|Detrusor overactivity|detrusor overactivity
626360|NCT00678795|Multiple Sclerosis|multiple sclerosis
626361|NCT00678821|Exercise|exercise
626362|NCT00678821|Pulmonary Hypertension|pulmonary hypertension
626363|NCT00678821|Pulmonary Rehabilitation|pulmonary rehabilitation
626364|NCT00678821|Interstitial Lung Disease|interstitial lung disease
626365|NCT00678847|bio-electrical stimulation therapy|bio-electrical stimulation therapy
626366|NCT00678847|chronic venous ulcers|chronic venous ulcers
626367|NCT00678847|microcurrent|microcurrent
626368|NCT00678847|chronic wounds|chronic wounds
626369|NCT00678847|complete healing|complete healing
626370|NCT00678860|Questionnaire|questionnaire
626371|NCT00678860|Computer Assisted Interface|computer assisted interface
626372|NCT00678860|Quality of Life|quality of life
626373|NCT00678860|Dry Eye|dry eye
626374|NCT00678860|Ocular Surface Disease|ocular surface disease
626375|NCT00678860|Healthy Volunteer|healthy volunteer
626376|NCT00678860|HV|hv
626377|NCT00678873|Single Incision|single incision
626378|NCT00678873|Single Access|single access
626379|NCT00678873|Surgery|surgery
626380|NCT00678873|Cholecystectomy|cholecystectomy
626381|NCT00678886|Type 1 diabetes|type 1 diabetes
626382|NCT00678886|new onset type 1 diabetes|new onset type 1 diabetes
626383|NCT00678886|T1DM|t1dm
626384|NCT00678886|Type l diabetes|type l diabetes
626385|NCT00678886|juvenile diabetes|juvenile diabetes
626386|NCT00678899|High frequency severe to profound|high frequency severe to profound
626387|NCT00684632|Pain, cancer|pain, cancer
626388|NCT00684645|Safety and tolerability of SUTENT® in patients with metastatic or advanced renal cell carcinoma after failure of cytokines in real-life setting.|safety and tolerability of sutent® in patients with metastatic or advanced renal cell carcinoma after failure of cytokines in real-life setting.
626389|NCT00684658|Type 1 Diabetes|type 1 diabetes
626391|NCT00684658|Coping with Chronic Illness|coping with chronic illness
626392|NCT00684658|Adolescence|adolescence
626393|NCT00684658|Internet psychosocial program|internet psychosocial program
626394|NCT00684658|Coping Skills Training|coping skills training
626395|NCT00684671|Immune memory|immune memory
626396|NCT00684671|Combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
626397|NCT00684671|> 41 years old|> 41 years old
626398|NCT00684684|Bronchoscopy|bronchoscopy
626399|NCT00684684|Clinically indicated for routine diagnostic bronchoscopy|clinically indicated for routine diagnostic bronchoscopy
626400|NCT00684697|premature infants iron neurodevelopment|premature infants iron neurodevelopment
626401|NCT00684710|Alzheimer Disease|alzheimer disease
626402|NCT00684723|Therapeutic Equivalency|therapeutic equivalency
626403|NCT00684736|septic shock|septic shock
626404|NCT00684736|shock|shock
626405|NCT00684736|serotonin|serotonin
626406|NCT00684736|kynurenine|kynurenine
626407|NCT00684736|tryptophan|tryptophan
626408|NCT00684749|Mentor BodyLogic TM System|mentor bodylogic tm system
626409|NCT00684749|Breast augmentation|breast augmentation
626411|NCT00684749|Reoperation rates|reoperation rates
626412|NCT00684788|opiate dependence|opiate dependence
626413|NCT00684788|naltrexone|naltrexone
626414|NCT00684788|reinforcement|reinforcement
626415|NCT00684788|behavior therapy|behavior therapy
626416|NCT00684788|cocaine dependence|cocaine dependence
626417|NCT00684788|risk reduction behavior|risk reduction behavior
626418|NCT00684801|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
626419|NCT00684801|recurrent small cell lung cancer|recurrent small cell lung cancer
626420|NCT00684801|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
626421|NCT00684801|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
626422|NCT00684801|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
626423|NCT00684801|extensive stage small cell lung cancer|extensive stage small cell lung cancer
626424|NCT00684801|recurrent pancreatic cancer|recurrent pancreatic cancer
626425|NCT00684801|stage III pancreatic cancer|stage iii pancreatic cancer
626426|NCT00684801|stage IV pancreatic cancer|stage iv pancreatic cancer
626427|NCT00684801|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
626428|NCT00684801|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
626429|NCT00684801|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
626430|NCT00684801|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
626431|NCT00684801|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
626432|NCT00684801|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
626433|NCT00684801|recurrent colon cancer|recurrent colon cancer
626434|NCT00684801|stage III colon cancer|stage iii colon cancer
626435|NCT00684801|stage IV colon cancer|stage iv colon cancer
626436|NCT00684801|recurrent rectal cancer|recurrent rectal cancer
626437|NCT00684801|stage III rectal cancer|stage iii rectal cancer
626438|NCT00684801|stage IV rectal cancer|stage iv rectal cancer
626439|NCT00684814|equivalency|equivalency
626440|NCT00684814|Therapeutic equivalency|therapeutic equivalency
626441|NCT00684827|Asthma|asthma
626442|NCT00684827|Racemic albuterol|racemic albuterol
626443|NCT00684840|Behavioral Economics|behavioral economics
626444|NCT00684840|Drug self administration|drug self administration
626445|NCT00684840|Opioid|opioid
626447|NCT00684853|PDT|pdt
626448|NCT00684853|Avastin|avastin
626449|NCT00684853|Bevacizumab|bevacizumab
626450|NCT00684853|Full fluence|full fluence
626451|NCT00684853|exudative|exudative
626452|NCT00684853|CNV|cnv
626453|NCT00684853|Drusen|drusen
626454|NCT00684853|ARMD|armd
626455|NCT00684853|Vetaporfin|vetaporfin
626456|NCT00684853|efficacy|efficacy
626457|NCT00684853|treatment|treatment
626458|NCT00684866|Asthma|asthma
626459|NCT00684866|Levalbuterol|levalbuterol
626460|NCT00684866|Racemic Albuterol|racemic albuterol
626461|NCT00684879|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
626462|NCT00684879|Health Belief Model|health belief model
626463|NCT00684879|Illness Perceptions|illness perceptions
626464|NCT00684879|Screening|screening
626465|NCT00684879|HHT|hht
626466|NCT00684892|Emphysema|emphysema
626467|NCT00684892|Endobronchial Lung Volume Reduction|endobronchial lung volume reduction
626468|NCT00684905|adenocarcinoma of the prostate|adenocarcinoma of the prostate
626469|NCT00684905|recurrent prostate cancer|recurrent prostate cancer
626470|NCT00684905|stage I prostate cancer|stage i prostate cancer
626471|NCT00684905|stage II prostate cancer|stage ii prostate cancer
626472|NCT00684905|stage III prostate cancer|stage iii prostate cancer
626473|NCT00684918|AML, obatoclax|aml, obatoclax
626474|NCT00684931|Attention|attention
626475|NCT00684931|Deficit|deficit
626476|NCT00684931|Disorder|disorder
626477|NCT00684931|Hyperactivity|hyperactivity
626478|NCT00684931|cerebellum|cerebellum
626479|NCT00684931|alteration|alteration
626480|NCT00684931|fronto-cerebello-frontal loops|fronto-cerebello-frontal loops
626481|NCT00685997|Malignant lymphoma|malignant lymphoma
626482|NCT00685997|Hodgkin's disease|hodgkin's disease
626483|NCT00685997|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
626484|NCT00685997|Imaging|imaging
626485|NCT00685997|Whole-Body MRI|whole-body mri
626486|NCT00685997|CT|ct
626487|NCT00685997|Radiation|radiation
626488|NCT00686010|CETP Inhibitor|cetp inhibitor
626489|NCT00686010|HDL-C|hdl-c
626490|NCT00686010|LDL-C|ldl-c
626491|NCT00686010|Apolipoprotein|apolipoprotein
626492|NCT00686023|pertrochanteric femur fracture|pertrochanteric femur fracture
626493|NCT00686023|DHS|dhs
626494|NCT00686023|IMN|imn
626495|NCT00686036|prostate cancer|prostate cancer
626496|NCT00686036|hormone treatment|hormone treatment
626497|NCT00686049|HIV Treatment Readiness Measure (HTRM)|hiv treatment readiness measure (htrm)
626498|NCT00686049|Highly Active Antiretroviral Treatment (HAART)|highly active antiretroviral treatment (haart)
626499|NCT00686049|Adherence|adherence
626500|NCT00686049|Treatment readiness|treatment readiness
626501|NCT00686049|HIV|hiv
626502|NCT00686062|Prenatal testing|prenatal testing
626503|NCT00686062|Amniocentesis|amniocentesis
626504|NCT00686062|Decision making|decision making
626505|NCT00686062|Down syndrome|down syndrome
626506|NCT00686075|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
626507|NCT00686075|Parainfluenza Virus Type 3 (PIV3)|parainfluenza virus type 3 (piv3)
626508|NCT00686075|MEDI-534|medi-534
626509|NCT00686088|prostate cancer|prostate cancer
626510|NCT00686088|locally recurrent|locally recurrent
626511|NCT00686088|PRX302|prx302
626512|NCT00686101|Perception of risk|perception of risk
626513|NCT00686101|Smoking risks|smoking risks
626514|NCT00686101|Smoking consequences|smoking consequences
626515|NCT00686101|Quitting smoking|quitting smoking
626516|NCT00686101|Motivation to quit smoking|motivation to quit smoking
626517|NCT00686101|Schizophrenia|schizophrenia
626518|NCT00686114|Esophageal cancer|esophageal cancer
626519|NCT00686114|chemoradiation|chemoradiation
626520|NCT00686114|radiosensitivity|radiosensitivity
626521|NCT00686114|EGFR inhibition|egfr inhibition
626522|NCT00686127|breast cancer|breast cancer
626523|NCT00686127|neuropathic pain|neuropathic pain
626524|NCT00686127|topical lidocaine|topical lidocaine
626525|NCT00686127|postmastectomy pain|postmastectomy pain
626526|NCT00686127|breast symptoms|breast symptoms
626527|NCT00686127|breast pain|breast pain
626528|NCT00686140|Schizophrenia|schizophrenia
626529|NCT00686140|clinical trial|clinical trial
626530|NCT00686140|risperidone|risperidone
626531|NCT00686140|immune|immune
626532|NCT00686140|celecoxib|celecoxib
626533|NCT00686166|adenocarcinoma of the rectum|adenocarcinoma of the rectum
626534|NCT00686166|stage IIA rectal cancer|stage iia rectal cancer
626535|NCT00686166|stage IIB rectal cancer|stage iib rectal cancer
626536|NCT00686166|stage IIC rectal cancer|stage iic rectal cancer
626537|NCT00686166|stage IIIA rectal cancer|stage iiia rectal cancer
626538|NCT00686166|stage IIIB rectal cancer|stage iiib rectal cancer
626539|NCT00686166|stage IIIC rectal cancer|stage iiic rectal cancer
626542|NCT00686179|QT|qt
626543|NCT00686179|QTc|qtc
626544|NCT00686179|AZD3480|azd3480
626545|NCT00686179|ECG(QTc effects)|ecg(qtc effects)
626546|NCT00686192|Obesity|obesity
626547|NCT00686192|Calcium carbonate|calcium carbonate
626548|NCT00686192|Dietary Supplements|dietary supplements
626549|NCT00686192|Lipolysis|lipolysis
626550|NCT00686205|healthy donors|healthy donors
626551|NCT00686205|HIV positives|hiv positives
626552|NCT00686218|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
626553|NCT00686231|To determine if topical nitroglycerin acts to vasodilate the radial artery by a direct local action, or by systemic vasodilation|to determine if topical nitroglycerin acts to vasodilate the radial artery by a direct local action, or by systemic vasodilation
626554|NCT00686231|To determine if topical nitroglycerin dilates the radial artery in the presence of local anesthetic agents used in cardiac catheterization|to determine if topical nitroglycerin dilates the radial artery in the presence of local anesthetic agents used in cardiac catheterization
626555|NCT00686244|metabolic syndrome|metabolic syndrome
626556|NCT00686244|physical activity|physical activity
626557|NCT00686244|overweight|overweight
626558|NCT00686244|malnutrition|malnutrition
626559|NCT00686244|prevention|prevention
626560|NCT00686257|acute respiratory insufficiency|acute respiratory insufficiency
626561|NCT00686257|noninvasive ventilation|noninvasive ventilation
626562|NCT00686257|oronasal face mask|oronasal face mask
626563|NCT00686257|total face mask|total face mask
626564|NCT00686270|HIV-1 infection|hiv-1 infection
626565|NCT00686270|NRTI resistance|nrti resistance
626566|NCT00686270|M184V mutation|m184v mutation
626567|NCT00686270|reverse transcriptase|reverse transcriptase
626568|NCT00686270|apricitabine|apricitabine
626569|NCT00686270|drug resistance|drug resistance
626570|NCT00686270|safety and tolerability|safety and tolerability
626571|NCT00686270|therapy failure|therapy failure
626572|NCT00686270|Treatment Experienced|treatment experienced
626573|NCT00686283|Adolescents|adolescents
626574|NCT00686283|Diabetes|diabetes
626575|NCT00686283|Exercise|exercise
626576|NCT00686296|soft tissue abscess requiring incision and drainage|soft tissue abscess requiring incision and drainage
626577|NCT00686309|exhaled NO|exhaled no
626578|NCT00686309|off line|off line
626579|NCT00686309|on line|on line
626580|NCT00686309|comparison|comparison
626581|NCT00686309|Bland altman method|bland altman method
626582|NCT00686322|chemotherapy|chemotherapy
626583|NCT00686322|radiotherapy|radiotherapy
626584|NCT00686322|lung cancer|lung cancer
626585|NCT00686335|asthma|asthma
626586|NCT00686335|nocturnal asthma|nocturnal asthma
626587|NCT00686335|glucocorticoid dependent persistent asthma|glucocorticoid dependent persistent asthma
626588|NCT00686335|signs and symptoms|signs and symptoms
626589|NCT00686335|lung function|lung function
626590|NCT00686335|prednisone|prednisone
626591|NCT00686348|acromegaly|acromegaly
626592|NCT00686361|Cystic Fibrosis|cystic fibrosis
626593|NCT00686361|choline nutrition|choline nutrition
626594|NCT00686361|choline and methyl metabolism|choline and methyl metabolism
626595|NCT00686361|CF and oxidative stress|cf and oxidative stress
626596|NCT00686374|Crohn's Disease|crohn's disease
626597|NCT00686374|adalimumab|adalimumab
626598|NCT00686387|Tissue Bank|tissue bank
626599|NCT00686387|Glioblastoma Multiforme|glioblastoma multiforme
626600|NCT00686387|NAT2|nat2
626601|NCT00686387|EGFR|egfr
626602|NCT00686387|MGMT|mgmt
626603|NCT00686387|Brain and Spinal TumorGliomas|brain and spinal tumorgliomas
626604|NCT00686400|schizophrenia|schizophrenia
626605|NCT00686400|first-episode|first-episode
626606|NCT00686400|infection|infection
626607|NCT00686400|Toxoplasma gondii|toxoplasma gondii
626608|NCT00686400|levels of IgG antibodies to TG|levels of igg antibodies to tg
626610|NCT00686413|AZD3480|azd3480
626611|NCT00686413|PET examination|pet examination
626612|NCT00686426|Obesity|obesity
626613|NCT00686426|Weight gain|weight gain
626614|NCT00686426|regain|regain
626615|NCT00686426|dairy|dairy
626616|NCT00686426|calcium|calcium
626617|NCT00686439|osteoarthritis|osteoarthritis
626618|NCT00686439|adalimumab|adalimumab
626619|NCT00686439|mri|mri
626620|NCT00686452|Asthma|asthma
626621|NCT00686452|Airway hyperresponsiveness|airway hyperresponsiveness
626622|NCT00686452|Swimmers|swimmers
626623|NCT00686452|Airway inflammation|airway inflammation
626624|NCT00686452|Airway remodelling|airway remodelling
626625|NCT00686465|recurrent cancer|recurrent cancer
626626|NCT00686465|PET/CT|pet/ct
626627|NCT00686465|FDG|fdg
626628|NCT00686465|planned management|planned management
626629|NCT00686465|actual treatment|actual treatment
626630|NCT00686478|burn|burn
626631|NCT00686478|hypertrophic scar|hypertrophic scar
626632|NCT00686478|fibroproliferative disorder|fibroproliferative disorder
626633|NCT00686491|Asthma|asthma
626634|NCT00686491|Environment|environment
626635|NCT00686491|Type of sport|type of sport
626636|NCT00686491|Cardiovascular disease|cardiovascular disease
626637|NCT00686491|Athletes|athletes
626638|NCT00686504|Pain|pain
626639|NCT00686504|PET|pet
626640|NCT00686504|Phase 1|phase 1
626641|NCT00686504|Analgesia|analgesia
626642|NCT00686504|Positron Emission Tomography|positron emission tomography
626643|NCT00686504|mGlu5 receptor|mglu5 receptor
626644|NCT00686504|Dose finding|dose finding
626645|NCT00686504|Analgesia/Pain|analgesia/pain
626646|NCT00686530|Fetal Death|fetal death
626647|NCT00686530|Magnetic Resonance Imaging|magnetic resonance imaging
626648|NCT00686530|Autopsy|autopsy
626649|NCT00686530|Telencephalon|telencephalon
626650|NCT00686530|Pyramidal Tracts|pyramidal tracts
626651|NCT00686543|Antifungal Agents|antifungal agents
626652|NCT00686543|Anti-Infective Agents|anti-infective agents
626653|NCT00686556|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
626654|NCT00686556|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
626655|NCT00686556|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
626656|NCT00686556|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
626657|NCT00686556|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
626658|NCT00686556|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
626659|NCT00686556|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
626660|NCT00686556|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
626661|NCT00686556|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
626662|NCT00686556|ALL|all
626663|NCT00686556|MDS|mds
626664|NCT00686608|Obesity|obesity
626665|NCT00686634|sitagliptin|sitagliptin
626666|NCT00686634|type 2 diabetes|type 2 diabetes
626667|NCT00686634|combination therapy|combination therapy
626668|NCT00686647|Coronary Angioplasty|coronary angioplasty
626669|NCT00686647|Coronary Stents|coronary stents
626670|NCT00686647|Scoring Balloons|scoring balloons
626671|NCT00686647|Coronary Artery Bifurcation Lesions|coronary artery bifurcation lesions
626672|NCT00686660|copd|copd
626673|NCT00686660|rehabilitation|rehabilitation
626674|NCT00686660|quality of life|quality of life
626675|NCT00686660|inflammation|inflammation
626676|NCT00686673|DECISION AIDS|decision aids
626677|NCT00686699|Anti-Dyskinesia Agents|anti-dyskinesia agents
626678|NCT00686699|Antipsychotic Agents|antipsychotic agents
626679|NCT00686712|Glargine|glargine
626680|NCT00686712|Type 2 diabetes|type 2 diabetes
626681|NCT00686712|Basal insulin|basal insulin
626682|NCT00686738|osteosarcoma|osteosarcoma
626683|NCT00686738|transforming growth factor-beta 1|transforming growth factor-beta 1
626684|NCT00686738|nuclear factor-kappa B|nuclear factor-kappa b
626685|NCT00686738|positron emission tomography/computed tomography|positron emission tomography/computed tomography
626686|NCT00686738|magnetic resonance spectroscopy|magnetic resonance spectroscopy
626687|NCT00686738|predicting response to neoadjuvant chemotherapy|predicting response to neoadjuvant chemotherapy
626688|NCT00686764|trans-femoral amputation|trans-femoral amputation
626689|NCT00686777|hepatitis C|hepatitis c
626690|NCT00686790|Hepatitis D|hepatitis d
626691|NCT00686790|Hepatitis B|hepatitis b
626692|NCT00686803|hypertension|hypertension
626693|NCT00686803|controlled hypertension|controlled hypertension
626694|NCT00686803|hypertensives|hypertensives
626695|NCT00686816|pre-diabetic|pre-diabetic
626696|NCT00686816|obese|obese
626697|NCT00686829|HIV|hiv
626698|NCT00686829|Treatment Experienced|treatment experienced
626699|NCT00686842|HIV infection|hiv infection
626700|NCT00686842|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
626701|NCT00686842|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
626702|NCT00686842|Treatment Experienced|treatment experienced
626703|NCT00686855|tacrolimus|tacrolimus
626704|NCT00686855|dexamethasone|dexamethasone
626705|NCT00686855|oral rinse|oral rinse
626706|NCT00686868|GSK1841157;|gsk1841157;
626707|NCT00686868|rheumatoid arthritis,|rheumatoid arthritis,
626708|NCT00686868|B-cell depletion|b-cell depletion
626709|NCT00686868|anti-CD20 monoclonal antibody,|anti-cd20 monoclonal antibody,
626710|NCT00686881|hepatitis C|hepatitis c
626711|NCT00686907|melatonin, circadian rhythms, sleep|melatonin, circadian rhythms, sleep
626712|NCT00686933|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
626713|NCT00686946|Severe mental illness|severe mental illness
626714|NCT00686946|Antipsychotic medications|antipsychotic medications
626715|NCT00686946|Pregnancy|pregnancy
626716|NCT00686946|Evidence-based guidelines|evidence-based guidelines
626717|NCT00686946|Maternal and infant health and wellbeing|maternal and infant health and wellbeing
626718|NCT00686972|Bariatric Surgery|bariatric surgery
626719|NCT00686972|Glucose Regulation|glucose regulation
626720|NCT00686972|Cardiac Function|cardiac function
626721|NCT00686972|Body Composition|body composition
626722|NCT00686985|Docetaxel|docetaxel
626723|NCT00686985|Carboplatin|carboplatin
626724|NCT00686985|chemotherapy|chemotherapy
626725|NCT00686985|relapse SCLC|relapse sclc
626726|NCT00686998|Schizophrenia|schizophrenia
626727|NCT00687011|Antiemetic|antiemetic
626728|NCT00687024|Epilepsy|epilepsy
626729|NCT00687024|Magnetic Resonance Imaging|magnetic resonance imaging
626730|NCT00687024|Magnetoencephalography|magnetoencephalography
626731|NCT00687037|oral hygiene|oral hygiene
626732|NCT00687050|end-stage renal disease|end-stage renal disease
626733|NCT00687050|chronic kidney disease|chronic kidney disease
626734|NCT00687076|Endovascular Intervention|endovascular intervention
626735|NCT00687076|MRI|mri
626736|NCT00687076|Ultrasound|ultrasound
626737|NCT00687076|Cholesterol Medications|cholesterol medications
626738|NCT00687076|High Cholesterol|high cholesterol
626739|NCT00687076|Peripheral Arterial disease|peripheral arterial disease
626740|NCT00687076|Claudication|claudication
626741|NCT00687076|Leg Pain|leg pain
626742|NCT00687076|Niaspan|niaspan
626743|NCT00687076|Extended Release Niacin|extended release niacin
626744|NCT00687076|Zetia|zetia
626745|NCT00687076|Ezetimibe|ezetimibe
626746|NCT00687076|Simvastatin|simvastatin
626747|NCT00687076|Zocor|zocor
626748|NCT00687076|Atorvastatin|atorvastatin
626749|NCT00687076|Lipitor|lipitor
626750|NCT00687089|Opiates|opiates
626751|NCT00687089|Subutex|subutex
626752|NCT00687089|Buprenorphine|buprenorphine
626753|NCT00687089|Patients who addicted to opiates|patients who addicted to opiates
626754|NCT00687102|breast cancer|breast cancer
626755|NCT00687102|Tamoxifen|tamoxifen
626756|NCT00687102|Raloxifene|raloxifene
626757|NCT00687102|hormone therapy|hormone therapy
626758|NCT00687115|24 Hour Energy Expenditure|24 hour energy expenditure
626759|NCT00687115|Respiratory Chamber|respiratory chamber
626760|NCT00687115|Obesity|obesity
626761|NCT00687115|Weight Loss|weight loss
626762|NCT00687115|Overfeeding|overfeeding
626763|NCT00687128|Insulin resistance|insulin resistance
626764|NCT00687128|Metabolic syndrome|metabolic syndrome
626765|NCT00687128|Aerobic exercise|aerobic exercise
626766|NCT00687128|Exercise behavior|exercise behavior
626767|NCT00687141|Safety|safety
626768|NCT00687141|tolerability|tolerability
626769|NCT00687141|AZD0328|azd0328
626770|NCT00687154|DME|dme
626771|NCT00687154|Laser|laser
626772|NCT00687154|macular edema|macular edema
626773|NCT00687154|retinopathy|retinopathy
626774|NCT00687154|scatter photocoagulation|scatter photocoagulation
626775|NCT00687167|Therapeutic Equivalency|therapeutic equivalency
626776|NCT00687180|Prednisolone dosage|prednisolone dosage
626777|NCT00687193|Phase 2 monotherapy in Japan|phase 2 monotherapy in japan
626778|NCT00687219|hepatitis C|hepatitis c
626779|NCT00687232|Phase I|phase i
626780|NCT00687232|Japan|japan
626788|NCT00687258|Oxidative Stress|oxidative stress
626789|NCT00687258|Erythropoietin|erythropoietin
626790|NCT00687258|dialyser membrane|dialyser membrane
626791|NCT00687258|Vitamin E|vitamin e
626792|NCT00687258|Erythropoietin responsiveness|erythropoietin responsiveness
626793|NCT00687258|Erythropoietin resistance|erythropoietin resistance
626794|NCT00687258|hemodialysis|hemodialysis
626795|NCT00687297|Stage IIIB Non Small Cell Lung Cancer|stage iiib non small cell lung cancer
626796|NCT00687297|Stage IV Non Small Cell Lung Cancer|stage iv non small cell lung cancer
626797|NCT00687297|Vandetanib|vandetanib
626798|NCT00687297|Docetaxel plus carboplatin|docetaxel plus carboplatin
626799|NCT00687310|Asthma education|asthma education
626800|NCT00687310|satisfaction adherence|satisfaction adherence
626801|NCT00687310|Quality of Life|quality of life
626802|NCT00687310|PIKO meter cluster|piko meter cluster
626803|NCT00687310|Symbicort® Turbuhaler®|symbicort® turbuhaler®
626804|NCT00687336|Helicobacter pylori|helicobacter pylori
626805|NCT00687336|Treatment|treatment
626806|NCT00687336|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
626807|NCT00687349|End-of-Life issues|end-of-life issues
626808|NCT00687349|Talking with your doctor|talking with your doctor
626809|NCT00687349|Coping with chronic illness|coping with chronic illness
626810|NCT00687375|Inguinal|inguinal
626811|NCT00687375|Groin hernia|groin hernia
626812|NCT00687375|TAPP|tapp
626813|NCT00687375|TEP|tep
626814|NCT00687375|Comparing|comparing
626815|NCT00687375|Two|two
626816|NCT00687375|Techniques|techniques
626817|NCT00687388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors
626818|NCT00687388|Alpha Blockers|alpha blockers
626819|NCT00687388|Treatment Outcome|treatment outcome
626820|NCT00687414|gene expression|gene expression
626821|NCT00687414|gene sequencing|gene sequencing
626822|NCT00687414|gene encoding|gene encoding
626823|NCT00687414|MPD|mpd
626824|NCT00687414|MDS|mds
626825|NCT00687414|AML|aml
626826|NCT00687414|mDia|mdia
626827|NCT00687453|Glargine|glargine
626828|NCT00687453|Type 2 diabetes|type 2 diabetes
626829|NCT00687453|Basal insulin|basal insulin
626830|NCT00687466|Cystic Fibrosis|cystic fibrosis
626831|NCT00687466|Glucose Intolerance|glucose intolerance
626832|NCT00687479|insulin sensitivity|insulin sensitivity
626833|NCT00687479|insulin secretion|insulin secretion
626834|NCT00687479|infant outcome|infant outcome
626835|NCT00687492|hypercholesterolemia|hypercholesterolemia
626836|NCT00687492|NCEP ATP III guidelines|ncep atp iii guidelines
626837|NCT00687492|survey|survey
626838|NCT00687544|HIV|hiv
626839|NCT00687570|patients with rectal cancer undergoing surgery|patients with rectal cancer undergoing surgery
626840|NCT00687570|Bowel purity degree|bowel purity degree
626841|NCT00687570|Bowel preparation|bowel preparation
626842|NCT00687570|Rectal cancer|rectal cancer
626843|NCT00687570|Nutritional status|nutritional status
626939|NCT00687882|Children|children
626844|NCT00687570|complications with traditional bowel preparation|complications with traditional bowel preparation
626845|NCT00687570|Complications|complications
626846|NCT00687570|Physiological status|physiological status
626847|NCT00687583|pediatrics|pediatrics
626848|NCT00687583|anesthesia|anesthesia
626849|NCT00687583|head movements|head movements
626850|NCT00687583|endotracheal tube|endotracheal tube
626851|NCT00687609|Attention Deficit Hyperactivity Disorder with Cannabis Abuse|attention deficit hyperactivity disorder with cannabis abuse
626852|NCT00687609|Marihuana Abuse|marihuana abuse
626853|NCT00687609|Comorbid Cannabis Abuse|comorbid cannabis abuse
626854|NCT00687622|GSK1120212|gsk1120212
626855|NCT00687622|Oncology|oncology
626856|NCT00687622|melanoma|melanoma
626857|NCT00687622|MEK inhibitor|mek inhibitor
626858|NCT00687622|solid tumors|solid tumors
626859|NCT00687622|First Time in Human|first time in human
626860|NCT00687648|stage IV breast cancer|stage iv breast cancer
626861|NCT00687648|recurrent breast cancer|recurrent breast cancer
626862|NCT00687648|HER2-negative breast cancer|her2-negative breast cancer
626863|NCT00687648|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
626864|NCT00687648|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
626865|NCT00687661|Chronic Kidney Failure|chronic kidney failure
626866|NCT00687661|Vascular Calcification|vascular calcification
626867|NCT00687661|Bisphosphonates|bisphosphonates
626868|NCT00687674|refractory multiple myeloma|refractory multiple myeloma
626869|NCT00687687|Patients must have advanced (stage III or IV), persistent or recurrent uterine carcinosarcoma with documented disease progression.|patients must have advanced (stage iii or iv), persistent or recurrent uterine carcinosarcoma with documented disease progression.
626870|NCT00687700|propranolol|propranolol
626871|NCT00687700|B2-agonist,|b2-agonist,
626872|NCT00687700|B-antagonist,|b-antagonist,
626873|NCT00687726|osteoarthritis|osteoarthritis
626874|NCT00687726|knee|knee
626875|NCT00687726|exercise|exercise
626876|NCT00687726|balance|balance
626877|NCT00687739|hormone therapy|hormone therapy
626878|NCT00687739|obesity|obesity
626879|NCT00687739|postmenopause|postmenopause
626880|NCT00687739|disease /disorder proneness /risk|disease /disorder proneness /risk
626881|NCT00687739|insulin sensitivity /resistance|insulin sensitivity /resistance
626882|NCT00687739|metabolic syndrome|metabolic syndrome
626883|NCT00687739|women's health|women's health
626884|NCT00687752|fetal deglutition|fetal deglutition
626885|NCT00687752|larynx|larynx
626886|NCT00687752|fetal CNS pathology|fetal cns pathology
626887|NCT00687752|sonography|sonography
626888|NCT00687752|hydramnios|hydramnios
626889|NCT00687765|patients with newly diagnosed glioblastoma|patients with newly diagnosed glioblastoma
626890|NCT00687778|C11-Acetate|c11-acetate
626891|NCT00687778|FDG|fdg
626892|NCT00687778|sarcoma|sarcoma
626893|NCT00687778|Measurement of C11-Acetate uptake in tumors which are often non-FDG avid.|measurement of c11-acetate uptake in tumors which are often non-fdg avid.
626894|NCT00687778|Soft tissue sarcomas|soft tissue sarcomas
626895|NCT00687778|well-differentiated thyroid cancer|well-differentiated thyroid cancer
626896|NCT00687778|well-differentiated and bronchoalveolar lung cancer|well-differentiated and bronchoalveolar lung cancer
626897|NCT00687778|indolent lymphomas, neuroendocrine tumors|indolent lymphomas, neuroendocrine tumors
626899|NCT00687778|uterine malignancies|uterine malignancies
626900|NCT00687778|mucin-producing cancer|mucin-producing cancer
626901|NCT00687778|teratoma, hepatoma|teratoma, hepatoma
626902|NCT00687778|HCC|hcc
626903|NCT00687778|lobular breast carcinoma|lobular breast carcinoma
626904|NCT00687791|patients with cataract and glaucoma|patients with cataract and glaucoma
626905|NCT00687791|ologen|ologen
626906|NCT00687791|oculusgen|oculusgen
626907|NCT00687791|collagen matrix|collagen matrix
626908|NCT00687791|Phacotrabeculectomy|phacotrabeculectomy
626909|NCT00687791|Aeon Astron|aeon astron
626910|NCT00687791|trabeculectomy|trabeculectomy
626911|NCT00687791|tissue engineering|tissue engineering
626912|NCT00687791|mitomycin-C|mitomycin-c
626913|NCT00687804|DME|dme
626914|NCT00687804|Diabetic|diabetic
626915|NCT00687804|macula|macula
626916|NCT00687804|edema|edema
626917|NCT00687804|ranibizumab|ranibizumab
626918|NCT00687804|RESTORE|restore
626919|NCT00687817|NSCLC|nsclc
626920|NCT00687830|Afternoon colonoscopy|afternoon colonoscopy
626921|NCT00687830|Morning|morning
626922|NCT00687830|Evening|evening
626923|NCT00687830|Bowel Preparation|bowel preparation
626924|NCT00687830|Efficacy|efficacy
626925|NCT00687830|Satisfaction|satisfaction
626926|NCT00687843|Gastric Cancer|gastric cancer
626927|NCT00687843|TS-1|ts-1
626928|NCT00687843|PSK|psk
626929|NCT00687843|Relapse-free survival|relapse-free survival
626930|NCT00687856|Left Ventricular Assist Device|left ventricular assist device
626931|NCT00687869|stroke|stroke
626932|NCT00687869|rehabilitation|rehabilitation
626933|NCT00687869|patient care management|patient care management
626934|NCT00687869|patient participation|patient participation
626935|NCT00687882|Venous Thromboembolism|venous thromboembolism
626936|NCT00687882|Postthrombotic Syndrome|postthrombotic syndrome
626937|NCT00687882|Antithrombotic Therapy|antithrombotic therapy
626938|NCT00687882|Duration of Therapy|duration of therapy
626940|NCT00687895|malaria microscopy primary health care children|malaria microscopy primary health care children
626941|NCT00687908|Acne|acne
626942|NCT00687921|Knee trauma|knee trauma
626943|NCT00687921|MRI|mri
626944|NCT00687921|arthroscopy|arthroscopy
626945|NCT00687921|Patients over the age of 18 who had knee trauma intent to or had MRI assessment scheduled for arthroscopy|patients over the age of 18 who had knee trauma intent to or had mri assessment scheduled for arthroscopy
626946|NCT00687934|metastatic cancer|metastatic cancer
626947|NCT00687934|solid tumor|solid tumor
626948|NCT00687934|histologically or cytologically confirmed non-hematological|histologically or cytologically confirmed non-hematological
626949|NCT00687934|malignancy that is metastatic or unresectable for which no|malignancy that is metastatic or unresectable for which no
626950|NCT00687934|standard therapy exists|standard therapy exists
626951|NCT00687934|STA-9090|sta-9090
626952|NCT00687934|ganetespib|ganetespib
626953|NCT00687947|FHM|fhm
626954|NCT00687947|MA|ma
626955|NCT00687947|healthy controls|healthy controls
626956|NCT00687947|CGRP|cgrp
626957|NCT00687960|Diabetes|diabetes
626958|NCT00687960|Diet|diet
626959|NCT00687960|Fiber|fiber
626960|NCT00687960|Age|age
626961|NCT00687986|surgery|surgery
626962|NCT00687986|stereotactic radiotherapy|stereotactic radiotherapy
626963|NCT00687986|tumor control|tumor control
626964|NCT00687986|quality of life|quality of life
626965|NCT00687999|Chronic hepatitis C|chronic hepatitis c
626966|NCT00687999|diabetes|diabetes
626967|NCT00687999|Insulin resistance|insulin resistance
626968|NCT00687999|combination therapy|combination therapy
626969|NCT00688012|antisense|antisense
626970|NCT00688012|microRna antagonist|microrna antagonist
626971|NCT00688012|anti-miR-122|anti-mir-122
626972|NCT00688012|Safety in healthy volunteers|safety in healthy volunteers
626973|NCT00688012|Hepatitis C|hepatitis c
626974|NCT00688038|Advanced Cancer|advanced cancer
626975|NCT00688038|Bone Metastases|bone metastases
626976|NCT00688038|Laser Ablation|laser ablation
626977|NCT00688038|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
626978|NCT00688038|Laser Induced Thermal Therapy|laser induced thermal therapy
626979|NCT00688038|MRTI|mrti
626980|NCT00688038|LITT|litt
626981|NCT00688051|Cystic Fibrosis|cystic fibrosis
626982|NCT00688051|Adherence to treatment|adherence to treatment
626983|NCT00688064|Acne|acne
626984|NCT00688077|Fibroblast growth factor - 23|fibroblast growth factor - 23
626985|NCT00688077|Calcitonin|calcitonin
626986|NCT00688090|Immunotherapy, Melanoma, Cancer Vaccine|immunotherapy, melanoma, cancer vaccine
626987|NCT00688116|metastatic cancer|metastatic cancer
626988|NCT00688116|solid tumor|solid tumor
626989|NCT00688116|histologically or cytologically confirmed non-hematological malignancy that is metastatic or unresectable|histologically or cytologically confirmed non-hematological malignancy that is metastatic or unresectable
626990|NCT00688116|STA-9090|sta-9090
626991|NCT00688116|ganetespib|ganetespib
626992|NCT00688129|school readiness|school readiness
626993|NCT00688129|foster care|foster care
626994|NCT00688129|maltreatment|maltreatment
626995|NCT00688129|literacy|literacy
626996|NCT00688129|social emotional skills|social emotional skills
626997|NCT00688129|self regulation|self regulation
626998|NCT00688129|caregiver involvement|caregiver involvement
626999|NCT00688168|Multiple Myeloma|multiple myeloma
627000|NCT00688168|Phone Call|phone call
627001|NCT00688168|Treatment Naive|treatment naive
627002|NCT00688168|Inflammatory Cytokines|inflammatory cytokines
627003|NCT00688168|Questionnaire|questionnaire
627004|NCT00688168|Survey|survey
627005|NCT00688168|Interactive Voice Response|interactive voice response
627006|NCT00688168|Symptom Production|symptom production
627007|NCT00688168|Pain|pain
627008|NCT00688168|IVR|ivr
627009|NCT00688168|MM|mm
627010|NCT00688194|stage IV breast cancer|stage iv breast cancer
627011|NCT00688194|recurrent breast cancer|recurrent breast cancer
627012|NCT00688207|PPAR agonist,|ppar agonist,
627013|NCT00688207|Rosiglitazone XR,|rosiglitazone xr,
627014|NCT00688207|BRL-049653.|brl-049653.
627015|NCT00688207|Alzheimer's disease,|alzheimer's disease,
627016|NCT00688220|Arthritis|arthritis
627017|NCT00688220|Carpel tunnel syndrome|carpel tunnel syndrome
627018|NCT00688220|Epicondylitis|epicondylitis
627019|NCT00688233|Seifi's Functional, Class II/1, Mandibular Retrognathism|seifi's functional, class ii/1, mandibular retrognathism
627020|NCT00688246|osteoporosis|osteoporosis
627021|NCT00688246|breast cancer|breast cancer
627022|NCT00688259|clinical trials|clinical trials
627023|NCT00688259|psychotherapy|psychotherapy
627024|NCT00688272|Safety|safety
627025|NCT00688272|Photoirritant|photoirritant
627026|NCT00688272|Placebo control|placebo control
627027|NCT00688272|Photosensitivity|photosensitivity
627028|NCT00688272|Ciprofloxacin|ciprofloxacin
627029|NCT00688272|Eltrombopag|eltrombopag
627030|NCT00688285|chronic kidney disease|chronic kidney disease
627031|NCT00688285|clinical alerts|clinical alerts
627032|NCT00688285|late referral|late referral
627033|NCT00688285|electronic medical record|electronic medical record
627034|NCT00688285|Computerized clinical decision support systems (CDSS)|computerized clinical decision support systems (cdss)
627035|NCT00688311|HIV|hiv
627036|NCT00688311|synbiotic|synbiotic
627037|NCT00688311|probiotic|probiotic
627038|NCT00688311|immune activation|immune activation
627039|NCT00688311|blood CD4 count|blood cd4 count
627040|NCT00688311|bacterial translocation|bacterial translocation
627041|NCT00688311|Human Immunodeficiency Virus|human immunodeficiency virus
627042|NCT00688324|schizophrenia|schizophrenia
627043|NCT00688324|schizoaffective disorder|schizoaffective disorder
627044|NCT00688324|glutamate|glutamate
627045|NCT00688324|NMDA receptor|nmda receptor
627046|NCT00688324|magnetic resonance spectroscopy|magnetic resonance spectroscopy
627047|NCT00688324|acamprosate|acamprosate
627048|NCT00688337|Breast cancer|breast cancer
627049|NCT00688337|lymph nodes|lymph nodes
627050|NCT00688337|gene-expression|gene-expression
627051|NCT00688337|oncotype|oncotype
627052|NCT00688337|Age over 18|age over 18
627053|NCT00688337|Newly diagnosed breast cancer prior to surgery or treatment.|newly diagnosed breast cancer prior to surgery or treatment.
627054|NCT00688337|No evidence of clinical nodal disease|no evidence of clinical nodal disease
627055|NCT00688350|Hypertension|hypertension
627056|NCT00688350|Aging|aging
627057|NCT00688350|Medication adherence|medication adherence
627058|NCT00688350|Medication compliance|medication compliance
627059|NCT00688363|Diabetes control|diabetes control
627060|NCT00688363|glycated haemoglobin|glycated haemoglobin
627061|NCT00688363|blood-glucose-self-monitoring|blood-glucose-self-monitoring
627062|NCT00688363|type 2-diabetes|type 2-diabetes
627063|NCT00688363|conventional insulin therapy|conventional insulin therapy
627064|NCT00688376|Attention|attention
627065|NCT00688376|cancer|cancer
627066|NCT00688376|chemotherapy|chemotherapy
627067|NCT00688376|donepezil|donepezil
627068|NCT00688376|acetylcholinesterase|acetylcholinesterase
627069|NCT00688376|inhibitor|inhibitor
627070|NCT00688389|Dengue fever, CLEC5A, Mannose receptor, DC-SIGN, NALP,|dengue fever, clec5a, mannose receptor, dc-sign, nalp,
627071|NCT00688389|decoy receptor 3 (DcR3), Toll-like receptors(TLRs),|decoy receptor 3 (dcr3), toll-like receptors(tlrs),
627072|NCT00688389|(Nod)-like receptors (NLRs)|(nod)-like receptors (nlrs)
627073|NCT00688402|Reflux Inhibitor|reflux inhibitor
627074|NCT00688402|GERD|gerd
627075|NCT00688402|formulations|formulations
627076|NCT00688428|esomeprazole|esomeprazole
627077|NCT00688428|upper gi symptoms|upper gi symptoms
627078|NCT00688428|low dose Aspirin treatment|low dose aspirin treatment
627079|NCT00688441|Randomized|randomized
627080|NCT00688441|Double-Blind|double-blind
627081|NCT00688441|Multi-Center|multi-center
627082|NCT00688441|Placebo-Controlled|placebo-controlled
627083|NCT00688441|Phase II|phase ii
627084|NCT00688441|Nasal Carbon Dioxide|nasal carbon dioxide
627085|NCT00688441|Carbon Dioxide|carbon dioxide
627086|NCT00688441|Efficacy|efficacy
627087|NCT00688441|Safety|safety
627088|NCT00688441|Total Nasal Symptom Score|total nasal symptom score
627089|NCT00688441|RQLQ|rqlq
627090|NCT00688454|Hyperlipidemia|hyperlipidemia
627091|NCT00688454|Rosuvastatin|rosuvastatin
627092|NCT00688454|Efficacy|efficacy
627093|NCT00688454|tolerability|tolerability
627094|NCT00688454|CRESTOR therapy|crestor therapy
627095|NCT00688467|Neutrophilic Asthma|neutrophilic asthma
627096|NCT00688480|CKD|ckd
627097|NCT00688480|LVH|lvh
627098|NCT00688480|Echo LVH|echo lvh
627099|NCT00688480|Chronic Stage 3|chronic stage 3
627100|NCT00688493|QT|qt
627101|NCT00688493|Healthy volunteers|healthy volunteers
627102|NCT00681759|Low Dose Aspirin (LDA)|low dose aspirin (lda)
627103|NCT00681759|Cardiovascular disease|cardiovascular disease
627104|NCT00681759|Low Dose Aspirin (LDA) use in in subjects with cardiovascular risk or disease|low dose aspirin (lda) use in in subjects with cardiovascular risk or disease
627105|NCT00681772|Erectile Dysfunction|erectile dysfunction
627106|NCT00681772|Vardenafil|vardenafil
627107|NCT00681785|thrombophylaxis and transurethral surgery|thrombophylaxis and transurethral surgery
627108|NCT00681798|pancreatic cancer|pancreatic cancer
627109|NCT00681798|pancreatic adenocarcinoma|pancreatic adenocarcinoma
627110|NCT00681798|pancreas cancer|pancreas cancer
627111|NCT00681798|dose escalation study|dose escalation study
627112|NCT00681798|locally advanced unresectable pancreatic adenocarcinoma|locally advanced unresectable pancreatic adenocarcinoma
627113|NCT00681798|Zactima|zactima
627114|NCT00681798|Vandetanib|vandetanib
627115|NCT00681798|ZD6474|zd6474
627116|NCT00681811|Metazyme|metazyme
627117|NCT00681811|Late Infantile Metachromatic Leukodystrophy|late infantile metachromatic leukodystrophy
627118|NCT00681837|gastroesophageal reflux|gastroesophageal reflux
627119|NCT00681837|prevalence|prevalence
627120|NCT00681837|childhood|childhood
627121|NCT00681837|France|france
627122|NCT00681850|Diabetes|diabetes
627123|NCT00681850|Benchmarking|benchmarking
627124|NCT00681850|quality of patient care|quality of patient care
627125|NCT00681850|Diabetic Population|diabetic population
627126|NCT00681876|Metastatic colorectal cancer|metastatic colorectal cancer
627127|NCT00681876|Second line|second line
627128|NCT00681876|Irinotecan|irinotecan
627129|NCT00681876|Erbitux (Cetuximab)|erbitux (cetuximab)
627130|NCT00681876|Avastin (Bevacizumab)|avastin (bevacizumab)
627131|NCT00681902|Pediatric|pediatric
627132|NCT00681902|Pain|pain
627133|NCT00681902|Needle|needle
627134|NCT00681902|Emergency|emergency
627135|NCT00681902|Phlebotomy|phlebotomy
627136|NCT00681902|Intravenous|intravenous
627137|NCT00681902|Lidocaine|lidocaine
627138|NCT00681902|Local|local
627139|NCT00681902|Anesthesia|anesthesia
627140|NCT00681915|Phase I|phase i
627141|NCT00681915|Pharmacokinetics|pharmacokinetics
627142|NCT00681928|stage I breast cancer|stage i breast cancer
627143|NCT00681928|stage II breast cancer|stage ii breast cancer
627144|NCT00681928|stage IIIA breast cancer|stage iiia breast cancer
627145|NCT00681928|stage IIIB breast cancer|stage iiib breast cancer
627146|NCT00681928|stage IIIC breast cancer|stage iiic breast cancer
627147|NCT00681954|TRALI|trali
627148|NCT00681954|Randomized Autologous Transfusion|randomized autologous transfusion
627149|NCT00681954|Intra-Operative Testing of Pulmonary Function|intra-operative testing of pulmonary function
627150|NCT00681967|squamous cell cancer of the head & neck|squamous cell cancer of the head & neck
627151|NCT00681967|Gefitinib|gefitinib
627152|NCT00681967|IRESSA|iressa
627153|NCT00681967|EGFR Inhibitor|egfr inhibitor
627352|NCT00689832|Tacrolimus|tacrolimus
627154|NCT00681967|EGFR-tyrosine kinase inhibitor|egfr-tyrosine kinase inhibitor
627155|NCT00681967|Subjects with histologically proven squamous cell cancer of the head & neck|subjects with histologically proven squamous cell cancer of the head & neck
627156|NCT00681967|Cohort 1:qualifying for postoperative radiotherapy|cohort 1:qualifying for postoperative radiotherapy
627157|NCT00681967|(pT3, pT4, pN2b, pN2c, pN3).|(pt3, pt4, pn2b, pn2c, pn3).
627158|NCT00681967|Cohort 2:qualifying for definite chemoradiotherapy|cohort 2:qualifying for definite chemoradiotherapy
627159|NCT00681967|(Lateral oropharynx, tonsils: T1N2b-3, T2N1-3, T3any N;|(lateral oropharynx, tonsils: t1n2b-3, t2n1-3, t3any n;
627286|NCT00689572|cocaine dependence|cocaine dependence
627160|NCT00681967|Base of tongue, vallecula: T1N1-3, T2-4 any N; Oral cavity,|base of tongue, vallecula: t1n1-3, t2-4 any n; oral cavity,
627161|NCT00681967|glottic and supraglottic larynx; Any TN1-3, T3-4 any N;|glottic and supraglottic larynx; any tn1-3, t3-4 any n;
627162|NCT00681967|Hypopharynx: T1N1-3, T2-4 and N)|hypopharynx: t1n1-3, t2-4 and n)
627163|NCT00681980|TSP/HAM, HTLV-1, treatment|tsp/ham, htlv-1, treatment
627164|NCT00681993|cosmetic|cosmetic
627165|NCT00681993|effect|effect
627166|NCT00681993|breast|breast
627167|NCT00681993|irradiation|irradiation
627169|NCT00681993|chemotherapy|chemotherapy
627170|NCT00681993|potential acute|potential acute
627171|NCT00681993|late skin|late skin
627172|NCT00681993|subcutaneous toxicities|subcutaneous toxicities
627173|NCT00682006|Omphalitis|omphalitis
627174|NCT00682006|4% Chlorhexidine|4% chlorhexidine
627175|NCT00682006|Newborns|newborns
627176|NCT00682019|Erectile Dysfunction|erectile dysfunction
627177|NCT00682019|Vardenafil|vardenafil
627178|NCT00682032|NSCLC|nsclc
627179|NCT00682045|tuberculosis|tuberculosis
627180|NCT00682045|transplantation|transplantation
627181|NCT00682058|body composition|body composition
627182|NCT00682058|weight loss|weight loss
627184|NCT00682058|fat distribution|fat distribution
627185|NCT00682058|fat free mass|fat free mass
627186|NCT00682058|organ|organ
627187|NCT00682058|resting energy expenditure|resting energy expenditure
627188|NCT00682071|Ultrasound-guided|ultrasound-guided
627189|NCT00682071|embryo transfer|embryo transfer
627190|NCT00682071|in-vitro fertilization|in-vitro fertilization
627191|NCT00688506|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
627192|NCT00688506|Neuromodulation|neuromodulation
627193|NCT00688506|Brain effects|brain effects
627194|NCT00688506|Neuroimaging|neuroimaging
627195|NCT00688519|Plaque-type Psoriasis|plaque-type psoriasis
627196|NCT00688519|Psoriasis|psoriasis
627197|NCT00688532|Prostate cancer|prostate cancer
627198|NCT00688532|pharmacoepidemiology study|pharmacoepidemiology study
627199|NCT00688545|Celecoxib|celecoxib
627200|NCT00688545|COX-2|cox-2
627201|NCT00688545|NSAIDs|nsaids
627202|NCT00688545|observational study|observational study
627203|NCT00688545|noninterventional study|noninterventional study
627204|NCT00688545|cohort study|cohort study
627205|NCT00688545|registry|registry
627206|NCT00688545|epidemiologic study|epidemiologic study
627207|NCT00688545|pediatrics|pediatrics
627208|NCT00688545|rheumatology|rheumatology
627209|NCT00688545|phase iv study|phase iv study
627210|NCT00688571|Pulmonary Valve|pulmonary valve
627211|NCT00688571|Congenital Heart Disease|congenital heart disease
627212|NCT00688584|problem drinking|problem drinking
627213|NCT00688584|randomized control trial|randomized control trial
627214|NCT00688584|Pamphlet-based personalized alcohol feedback (PAF)|pamphlet-based personalized alcohol feedback (paf)
627215|NCT00688597|Pompe Disease|pompe disease
627216|NCT00688610|primary care|primary care
627217|NCT00688610|procalcitonin|procalcitonin
627218|NCT00688610|antibiotic prescription|antibiotic prescription
627219|NCT00688623|Neuroendocrine tumors|neuroendocrine tumors
627220|NCT00688623|non-functioning neuroendocrine tumors carcinoids|non-functioning neuroendocrine tumors carcinoids
627221|NCT00688623|non-functioning carcinoids|non-functioning carcinoids
627222|NCT00688623|adults|adults
627223|NCT00688623|everolimus|everolimus
627224|NCT00688662|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
627225|NCT00688662|Pancreatitis|pancreatitis
627226|NCT00688662|Sphincterotomy|sphincterotomy
627227|NCT00688675|GERD|gerd
627228|NCT00688675|Pharmacoepidemiology|pharmacoepidemiology
627229|NCT00688688|Overactive Bladder|overactive bladder
627230|NCT00688688|Frequency|frequency
627231|NCT00688688|Micturition|micturition
627232|NCT00688688|Urgency|urgency
627233|NCT00688688|Urinary incontinence|urinary incontinence
627234|NCT00688688|Urinary urge incontinence|urinary urge incontinence
627235|NCT00688701|hyperglycemia, GLP-1|hyperglycemia, glp-1
627236|NCT00688714|Antiplatelet|antiplatelet
627237|NCT00688727|non epileptic seizures|non epileptic seizures
627238|NCT00688727|cognitive behavioural therapy|cognitive behavioural therapy
627239|NCT00688727|dissociative disorders|dissociative disorders
627240|NCT00688727|Seizure disorders|seizure disorders
627241|NCT00688727|randomised controlled trial|randomised controlled trial
627242|NCT00688740|adjuvant treatment|adjuvant treatment
627243|NCT00688753|renal cell carcinoma|renal cell carcinoma
627244|NCT00688753|non clear cell carcinoma|non clear cell carcinoma
627353|NCT00689832|Calcineurin|calcineurin
627245|NCT00688753|papillary cell renal carcinoma|papillary cell renal carcinoma
627246|NCT00688753|adults|adults
627247|NCT00688753|everolimus|everolimus
627248|NCT00688766|GIST|gist
627249|NCT00688766|Metastatic and/or Unresectable Gastrointestinal Stromal|metastatic and/or unresectable gastrointestinal stromal
627250|NCT00688779|Healthy male|healthy male
627251|NCT00688779|allergic rhinitis|allergic rhinitis
627252|NCT00688779|tolerability|tolerability
627253|NCT00688779|safety|safety
627254|NCT00688779|intranasally|intranasally
627255|NCT00688779|Healthy subjects|healthy subjects
627256|NCT00688792|Asthma|asthma
627257|NCT00688792|Children|children
627258|NCT00688792|Adherence|adherence
627259|NCT00688792|Maternal factors|maternal factors
627260|NCT00688805|Propanolol|propanolol
627261|NCT00688805|Substance Abuse|substance abuse
627262|NCT00688805|Craving|craving
627263|NCT00688805|Imagery|imagery
627264|NCT00688805|Drug Cues|drug cues
627265|NCT00688805|Cocaine|cocaine
627266|NCT00688818|Co-morbid depressive and anxiety disorders|co-morbid depressive and anxiety disorders
627267|NCT00688818|Quetiapine|quetiapine
627269|NCT00688818|Placebo-controlled|placebo-controlled
627270|NCT00688818|Double-blind|double-blind
627271|NCT00688818|Major depressive disorder|major depressive disorder
627272|NCT00688818|Dysthymic disorder|dysthymic disorder
627273|NCT00688818|Anxiety disorders|anxiety disorders
627274|NCT00688818|Generalized anxiety disorder|generalized anxiety disorder
627275|NCT00688818|Social anxiety disorder|social anxiety disorder
627276|NCT00688818|Panic disorder|panic disorder
627277|NCT00688818|Post-traumatic stress disorder|post-traumatic stress disorder
627278|NCT00688831|AZD1305|azd1305
627280|NCT00688831|safety|safety
627281|NCT00688831|pharmcokinetics|pharmcokinetics
627282|NCT00688831|Safety and tolerability|safety and tolerability
627283|NCT00689559|Alzheimer's disease|alzheimer's disease
627284|NCT00689559|AZD3480|azd3480
627285|NCT00689559|Aripiprazole|aripiprazole
627287|NCT00689572|cocaine abuse|cocaine abuse
627288|NCT00689572|cocaine|cocaine
627290|NCT00689585|Complex Regional Pain Syndrome|complex regional pain syndrome
627291|NCT00689585|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
627292|NCT00689585|RSD|rsd
627293|NCT00689585|Chronic Pain|chronic pain
627294|NCT00689585|Ethosuximide|ethosuximide
627295|NCT00689585|Zarontin|zarontin
627296|NCT00689585|Anticonvulsant|anticonvulsant
627297|NCT00689598|Atrial fibrillation, spironolactone|atrial fibrillation, spironolactone
627298|NCT00689611|Acute coronary syndrome|acute coronary syndrome
627299|NCT00689611|Myocardial infarction|myocardial infarction
627300|NCT00689611|Smoking cessation|smoking cessation
627301|NCT00689611|Zyban|zyban
627302|NCT00689611|Secondary intervention post-ACS|secondary intervention post-acs
627303|NCT00689624|Colorectal Cancer|colorectal cancer
627304|NCT00689624|Cetuximab|cetuximab
627305|NCT00689624|FOLFOXIRI|folfoxiri
627306|NCT00689637|AZD3480|azd3480
627307|NCT00689637|Warfarin|warfarin
627308|NCT00689637|Drug interaction|drug interaction
627309|NCT00689663|cholecystectomy|cholecystectomy
627310|NCT00689676|expressive language|expressive language
627311|NCT00689676|cognition|cognition
627312|NCT00689676|early development|early development
627313|NCT00689676|very low birt weight|very low birt weight
627314|NCT00689676|prematurity|prematurity
627315|NCT00689702|cetuximab|cetuximab
627316|NCT00689702|capecitabine|capecitabine
627317|NCT00689702|radiotherapy|radiotherapy
627318|NCT00689702|rectal cancer|rectal cancer
627319|NCT00689715|Cystic tumor|cystic tumor
627320|NCT00689715|Pancreas|pancreas
627321|NCT00689715|EUS|eus
627322|NCT00689741|HPV|hpv
627323|NCT00689741|vaccine|vaccine
627324|NCT00689754|gastrointestinal hemorrhage|gastrointestinal hemorrhage
627325|NCT00689754|gastrointestinal intubation|gastrointestinal intubation
627326|NCT00689754|endoscopy|endoscopy
627327|NCT00689767|drug eluting stent|drug eluting stent
627328|NCT00689780|Pain|pain
627329|NCT00689780|safety|safety
627330|NCT00689780|chronic low back pain|chronic low back pain
627331|NCT00689793|Fatigue|fatigue
627633|NCT00690755|Diabetic|diabetic
627332|NCT00689793|Blood donation|blood donation
627333|NCT00689793|Iron deficiency|iron deficiency
627334|NCT00689793|Ferrous sulphate|ferrous sulphate
627335|NCT00689793|Donation|donation
627336|NCT00689793|Donors|donors
627337|NCT00689793|Iron|iron
627338|NCT00689793|Ferritin|ferritin
627339|NCT00689793|Hemoglobin|hemoglobin
627340|NCT00689793|Anemia|anemia
627341|NCT00689793|Anaemia|anaemia
627342|NCT00689793|Haemoglobin|haemoglobin
627343|NCT00689793|Don|don
627344|NCT00689793|Women blood donors|women blood donors
627345|NCT00689806|Asthma|asthma
627346|NCT00689819|Hypertension|hypertension
627347|NCT00689819|High blood pressure|high blood pressure
627348|NCT00689819|Pre-clinical cardiac dysfunction|pre-clinical cardiac dysfunction
627349|NCT00689832|Dermatitis, Atopic|dermatitis, atopic
627350|NCT00689832|Dermatologic Agents|dermatologic agents
627351|NCT00689832|Topical Drug Administration|topical drug administration
627354|NCT00689832|Corticosteroid|corticosteroid
627355|NCT00689832|Fluticasone propionate|fluticasone propionate
627356|NCT00689832|Child|child
627357|NCT00689845|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
627358|NCT00689845|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
627359|NCT00689845|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
627360|NCT00689845|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
627361|NCT00689845|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
627362|NCT00689858|Healthy volunteers|healthy volunteers
627363|NCT00689897|Primary Dysmenorrhea|primary dysmenorrhea
627364|NCT00689897|Deqi|deqi
627365|NCT00689897|acupuncture|acupuncture
627366|NCT00689897|psychology|psychology
627367|NCT00689910|pharmacokinetics|pharmacokinetics
627368|NCT00689910|pregnancy|pregnancy
627369|NCT00689910|Raltegravir|raltegravir
627370|NCT00689910|HIV|hiv
627371|NCT00689910|antiretroviral|antiretroviral
627372|NCT00689910|Treatment of HIV in pregnant women with Raltegravir|treatment of hiv in pregnant women with raltegravir
627373|NCT00689936|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
627374|NCT00689936|Lenalidomide|lenalidomide
627375|NCT00689936|Revlimid|revlimid
627376|NCT00689936|phase III|phase iii
627377|NCT00689949|folic acid|folic acid
627378|NCT00689949|folate|folate
627379|NCT00689949|p-aminobenzoylglutamate|p-aminobenzoylglutamate
627380|NCT00689949|formiminoglutamate|formiminoglutamate
627381|NCT00689949|homocysteine|homocysteine
627382|NCT00689949|experimental validation of a new biomarker|experimental validation of a new biomarker
627383|NCT00689962|Lisfranc|lisfranc
627384|NCT00689962|fracture|fracture
627385|NCT00689962|dislocation|dislocation
627386|NCT00689962|bioabsorbable|bioabsorbable
627387|NCT00689975|stage IA breast cancer|stage ia breast cancer
627388|NCT00689975|stage IB breast cancer|stage ib breast cancer
627389|NCT00689975|stage II breast cancer|stage ii breast cancer
627390|NCT00689975|stage IIIA breast cancer|stage iiia breast cancer
627391|NCT00689975|stage IIIB breast cancer|stage iiib breast cancer
627392|NCT00689975|stage IIIC breast cancer|stage iiic breast cancer
627393|NCT00689988|Down syndrome|down syndrome
627394|NCT00689988|communication AIDS for disabled|communication aids for disabled
627395|NCT00689988|language development disorders|language development disorders
627396|NCT00689988|vocabulary|vocabulary
627397|NCT00689988|gestures|gestures
627398|NCT00689988|language tests|language tests
627399|NCT00689988|child|child
627400|NCT00690001|HIV-1 infection|hiv-1 infection
627401|NCT00690001|Treatment Experienced|treatment experienced
627402|NCT00690014|OAT|oat
627403|NCT00690014|GFR|gfr
627404|NCT00690014|renal function|renal function
627405|NCT00690014|PAH|pah
627406|NCT00690040|Induction of labor|induction of labor
627407|NCT00690040|Ripening|ripening
627408|NCT00690040|Single balloon catheter|single balloon catheter
627409|NCT00690040|Double balloon catheter|double balloon catheter
627410|NCT00690053|Toxicity|toxicity
627411|NCT00690053|PET|pet
627412|NCT00690053|HX-4|hx-4
627413|NCT00690053|cancer|cancer
627414|NCT00690066|T1DM|t1dm
627415|NCT00690066|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
627416|NCT00690066|Type 1 Diabetes|type 1 diabetes
627417|NCT00690066|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
627418|NCT00690066|Juvenile Diabetes|juvenile diabetes
627419|NCT00690066|Adult Human Stem Cells|adult human stem cells
627420|NCT00690066|Mesenchymal Stem Cells|mesenchymal stem cells
627421|NCT00690066|MSCs|mscs
627422|NCT00690066|Insulin|insulin
627423|NCT00690066|Osiris|osiris
627424|NCT00690066|Prochymal|prochymal
627426|NCT00690079|Multiple ascending dose|multiple ascending dose
627427|NCT00690079|Chronic pain|chronic pain
627428|NCT00690079|pain|pain
627429|NCT00690092|Coccidioidin|coccidioidin
627430|NCT00690092|Coccidioidin SD|coccidioidin sd
627431|NCT00690092|Spherule-derived coccidioidin|spherule-derived coccidioidin
627432|NCT00690092|Coccidioidomycosis|coccidioidomycosis
627433|NCT00690092|Valley Fever|valley fever
627434|NCT00690092|Coccidioides immitis|coccidioides immitis
627435|NCT00690105|Dermatitis, Atopic|dermatitis, atopic
627436|NCT00690105|Dermatologic Agents|dermatologic agents
627437|NCT00690105|Topical Drug Administration|topical drug administration
627438|NCT00690105|Tacrolimus|tacrolimus
627439|NCT00690105|Calcineurin|calcineurin
627440|NCT00690105|Corticosteroid|corticosteroid
627441|NCT00690105|Fluticasone propionate|fluticasone propionate
627442|NCT00690105|Face|face
627443|NCT00690118|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
627444|NCT00690118|survival time|survival time
627445|NCT00690118|ALS functioning Rating Scale|als functioning rating scale
627446|NCT00690118|quality of life|quality of life
627447|NCT00690118|non-invasive ventilation|non-invasive ventilation
627448|NCT00690118|clinical tolerability|clinical tolerability
627449|NCT00690118|survival|survival
627450|NCT00690131|Smoking cessation, severe mental illness, behavioral treatment|smoking cessation, severe mental illness, behavioral treatment
627451|NCT00690144|simulation|simulation
627452|NCT00690144|medical education|medical education
627453|NCT00690144|performance of clinical reasoning and skills|performance of clinical reasoning and skills
627454|NCT00690157|heart failure, prognosis, markers,heart transplantation|heart failure, prognosis, markers,heart transplantation
627455|NCT00690170|ketamine|ketamine
627456|NCT00690170|nicotine|nicotine
627457|NCT00690170|schizophrenia|schizophrenia
627458|NCT00690170|cognitive deficits|cognitive deficits
627459|NCT00690170|P300 oddball paradigm|p300 oddball paradigm
627460|NCT00690170|Mismatch Negativity|mismatch negativity
627461|NCT00690170|P50 gating|p50 gating
627462|NCT00690183|physical activity|physical activity
627463|NCT00690183|stem cells|stem cells
627464|NCT00690183|lifestyle|lifestyle
627465|NCT00690209|Chronic ischemic cardiomyopathy with residual viability|chronic ischemic cardiomyopathy with residual viability
627466|NCT00690209|surgical coronary revascularization|surgical coronary revascularization
627467|NCT00690209|stem cell therapy|stem cell therapy
627468|NCT00690209|Chronic ischemic heart disease|chronic ischemic heart disease
627469|NCT00690209|severe impairment of global contractility left ventricular dilation|severe impairment of global contractility left ventricular dilation
627470|NCT00690209|residual viability|residual viability
627471|NCT00690222|cataract surgery|cataract surgery
627472|NCT00690222|phacoemulsification|phacoemulsification
627473|NCT00690222|pupil|pupil
627474|NCT00690222|dilation|dilation
627475|NCT00690222|mydriasis|mydriasis
627476|NCT00690222|intracameral|intracameral
627477|NCT00690222|topical|topical
627478|NCT00690222|pseudoexfoliation syndrome|pseudoexfoliation syndrome
627479|NCT00690235|Schizophrenia|schizophrenia
627480|NCT00690235|Schizoaffective|schizoaffective
627481|NCT00690235|Olanzapine|olanzapine
627482|NCT00690235|Zyprexa|zyprexa
627483|NCT00690235|Clozapine|clozapine
627484|NCT00690235|Clozaril|clozaril
627485|NCT00690235|Pramlintide|pramlintide
627486|NCT00690235|Diabetes|diabetes
627487|NCT00690235|Weight Gain|weight gain
627488|NCT00690235|Obesity|obesity
627489|NCT00690235|Metabolic Syndrome|metabolic syndrome
627490|NCT00690248|Acute mania|acute mania
627492|NCT00690248|depressive symptoms|depressive symptoms
627493|NCT00690248|mixed mania|mixed mania
627494|NCT00690261|tumor associated macrophage|tumor associated macrophage
627495|NCT00690261|lung cancer|lung cancer
627496|NCT00690261|outcome|outcome
627497|NCT00690274|schizophrenia|schizophrenia
627498|NCT00690274|cognitive deficients|cognitive deficients
627499|NCT00690274|cognitive enhancing|cognitive enhancing
627500|NCT00690274|antipsychotics|antipsychotics
627501|NCT00690287|Type 2 diabetes|type 2 diabetes
627502|NCT00690300|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
627503|NCT00690300|pancreatic cancer|pancreatic cancer
627504|NCT00690300|pancreas carcinoma|pancreas carcinoma
627505|NCT00690300|advanced pancreatic cancer|advanced pancreatic cancer
627506|NCT00690300|metastatic pancreatic cancer|metastatic pancreatic cancer
627507|NCT00690300|second line|second line
627508|NCT00690300|palliative|palliative
627509|NCT00690300|Oxaliplatin|oxaliplatin
627510|NCT00690300|Docetaxel|docetaxel
627511|NCT00690300|Taxotere|taxotere
627512|NCT00690300|Eloxatin|eloxatin
627513|NCT00690300|Cancer of pancreas|cancer of pancreas
627514|NCT00690300|Pancreas cancer|pancreas cancer
627515|NCT00690313|Vigamox, topical antibiotics, Intravitreal injections, macular degeneration, endophthalmitis|vigamox, topical antibiotics, intravitreal injections, macular degeneration, endophthalmitis
627516|NCT00690326|physical activity|physical activity
627517|NCT00690326|Diabetes mellitus|diabetes mellitus
627518|NCT00690326|Behavioral change communication|behavioral change communication
627519|NCT00690326|Household physical activity|household physical activity
627520|NCT00690352|Specialized Substance Abuse Supervision|specialized substance abuse supervision
627521|NCT00690352|SSAS|ssas
627522|NCT00690352|substance use disorder|substance use disorder
627523|NCT00690352|felony drug offender|felony drug offender
627524|NCT00690352|probation|probation
627525|NCT00690352|parole|parole
627526|NCT00690352|cognitive behavioral therapy|cognitive behavioral therapy
627527|NCT00690352|CBT|cbt
627528|NCT00690365|Switching|switching
627529|NCT00690365|Quetiapine|quetiapine
627530|NCT00690365|schizophrenia|schizophrenia
627531|NCT00690365|unsuccessfully treated|unsuccessfully treated
627532|NCT00690365|antipsychotics|antipsychotics
627533|NCT00690391|surgery|surgery
627534|NCT00690391|prognostic|prognostic
627535|NCT00690391|palliation|palliation
627536|NCT00690404|formulation|formulation
627537|NCT00690404|pharmacokinetic|pharmacokinetic
627538|NCT00690404|crossover formulation|crossover formulation
627539|NCT00690404|food effect|food effect
627540|NCT00690404|oral solution|oral solution
627541|NCT00690404|healthy volunteers|healthy volunteers
627542|NCT00690430|Carcinoid|carcinoid
627543|NCT00690430|neuroendocrine|neuroendocrine
627544|NCT00690430|gastroenteropancreatic|gastroenteropancreatic
627545|NCT00690430|somatostatin analogue|somatostatin analogue
627546|NCT00690430|Symptomatic Refractory Resistant Carcinoid Disease|symptomatic refractory resistant carcinoid disease
627547|NCT00690443|Hyperlipidemia|hyperlipidemia
628665|NCT00697957|female|female
627548|NCT00690456|Randomized Controlled Trial|randomized controlled trial
627549|NCT00690456|Metformin|metformin
627550|NCT00690482|COPD|copd
627551|NCT00690495|Anesthesia|anesthesia
627552|NCT00690495|Induction|induction
627553|NCT00690495|Pain|pain
627554|NCT00690508|Intubation, Trachea, Sternum,|intubation, trachea, sternum,
627555|NCT00690508|Tube tip, Tube placement, Tube tip palpation,|tube tip, tube placement, tube tip palpation,
627556|NCT00690508|Validate|validate
627557|NCT00690508|use|use
627558|NCT00690508|SSTTP|ssttp
627559|NCT00690508|corrrect|corrrect
627560|NCT00690508|placement|placement
627561|NCT00690521|congestive heart failure|congestive heart failure
627562|NCT00690521|diuretics|diuretics
627563|NCT00690521|combination|combination
627564|NCT00690534|sarcopenia|sarcopenia
627565|NCT00690534|aging|aging
627566|NCT00690534|muscle metabolism|muscle metabolism
627567|NCT00690547|Functionality|functionality
627568|NCT00690547|Deliberately|deliberately
627569|NCT00690547|Activated|activated
627570|NCT00690547|Quadriceps|quadriceps
627571|NCT00690547|Femoris|femoris
627576|NCT00690560|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
628820|NCT00698542|PSST|psst
627577|NCT00690560|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
627578|NCT00690560|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
627579|NCT00690560|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
627580|NCT00690560|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
627581|NCT00690573|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
627582|NCT00690586|Nephrotic syndrome|nephrotic syndrome
627583|NCT00690586|Underfill and overfill theory|underfill and overfill theory
627584|NCT00690586|Steroid resistance|steroid resistance
627585|NCT00690586|Urine proteomics|urine proteomics
627586|NCT00690586|AVP|avp
627587|NCT00690586|ANP|anp
627588|NCT00690586|Angiotensin II|angiotensin ii
627589|NCT00690586|Renin and Aldosterone|renin and aldosterone
629864|NCT00694213|T Cells|t cells
627590|NCT00690599|Patient satisfaction|patient satisfaction
627591|NCT00690599|Dentist-Patient relations|dentist-patient relations
627592|NCT00690599|Answering services|answering services
627593|NCT00690612|pediatric|pediatric
627594|NCT00690612|renal disease|renal disease
627595|NCT00690612|high blood pressure|high blood pressure
627596|NCT00690625|Myofacial pain|myofacial pain
627597|NCT00690625|Omega 3 fatty acids|omega 3 fatty acids
627598|NCT00690638|dutogliptin|dutogliptin
627599|NCT00690638|PHX1149|phx1149
627600|NCT00690638|DPP4 inhibitor|dpp4 inhibitor
627601|NCT00690651|ankle|ankle
627602|NCT00690651|fracture|fracture
627603|NCT00690651|mobilisation|mobilisation
627604|NCT00690651|bed rest|bed rest
627605|NCT00690651|internal fixation|internal fixation
627606|NCT00690664|Hair characteristics|hair characteristics
627607|NCT00690677|LBH589|lbh589
627608|NCT00690677|Metastatic Colorectal Cancer|metastatic colorectal cancer
627609|NCT00690677|Refractory Colorectal Cancer|refractory colorectal cancer
627610|NCT00690690|HIV Seronegativity|hiv seronegativity
627611|NCT00690690|HIV risk behavior|hiv risk behavior
627612|NCT00690690|Unprotected sex|unprotected sex
627613|NCT00690690|men who have sex with men|men who have sex with men
627614|NCT00690690|gay|gay
627615|NCT00690690|Latino|latino
627616|NCT00690690|unsafe sex|unsafe sex
627617|NCT00690690|high risk sex|high risk sex
627618|NCT00690703|non small cell lung cancer|non small cell lung cancer
627619|NCT00690703|pulmonary metastases|pulmonary metastases
627620|NCT00690703|radiofrequency ablation|radiofrequency ablation
627621|NCT00690716|Nasal CO2|nasal co2
627622|NCT00690716|Phase II|phase ii
627623|NCT00690716|Adaptive|adaptive
627624|NCT00690716|Randomized|randomized
627625|NCT00690716|Double-Blind|double-blind
627626|NCT00690716|Placebo-Controlled|placebo-controlled
627627|NCT00690716|Multiple-Dose|multiple-dose
627628|NCT00690716|Multi-center|multi-center
627629|NCT00690716|Safety|safety
627630|NCT00690716|Efficacy|efficacy
627631|NCT00690716|Mild Headache|mild headache
627632|NCT00690716|Migraineur|migraineur
627634|NCT00690768|Diabetic Retinopathy|diabetic retinopathy
627635|NCT00690768|Retinal detachment|retinal detachment
627636|NCT00690768|Vitreous Hemorrhage|vitreous hemorrhage
627637|NCT00690768|Bevacizumab|bevacizumab
627638|NCT00690768|preoperative|preoperative
627639|NCT00690768|pars plana vitrectomy|pars plana vitrectomy
627640|NCT00690781|casein|casein
627641|NCT00690781|milk soluble proteins|milk soluble proteins
627642|NCT00690781|protein feeding pattern|protein feeding pattern
627643|NCT00690781|overweight|overweight
627644|NCT00690781|obesity|obesity
627645|NCT00690781|energy restriction|energy restriction
627646|NCT00690781|protein metabolism|protein metabolism
627647|NCT00690781|lean body mass|lean body mass
627648|NCT00690781|body composition|body composition
627649|NCT00690781|nitrogen balance|nitrogen balance
627650|NCT00690781|protein synthesis|protein synthesis
627651|NCT00690781|proteolysis|proteolysis
627652|NCT00690781|spread|spread
627653|NCT00690781|pulse|pulse
627654|NCT00690807|eczema|eczema
627655|NCT00690820|Cystic Fibrosis|cystic fibrosis
627656|NCT00690820|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
627657|NCT00690859|Bipolar disorders|bipolar disorders
627658|NCT00690859|Predictors of recurrence|predictors of recurrence
627659|NCT00690872|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
627660|NCT00690872|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
627661|NCT00690872|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
627662|NCT00690872|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
627663|NCT00690885|chronic cough|chronic cough
627664|NCT00690885|COPD|copd
627665|NCT00690885|IPF|ipf
627666|NCT00690885|interferon alpha|interferon alpha
627667|NCT00690924|lung cancer|lung cancer
627668|NCT00690924|tobacco use disorder|tobacco use disorder
627669|NCT00690924|squamous lung dysplasia|squamous lung dysplasia
627670|NCT00690937|hypercholesterolemia, bile acid sequestrant, LDL-cholesterol|hypercholesterolemia, bile acid sequestrant, ldl-cholesterol
627672|NCT00690963|Radiotherapy|radiotherapy
627673|NCT00690963|Intensity-Modulated|intensity-modulated
627674|NCT00690963|Dose Fractionation|dose fractionation
627675|NCT00690976|HIV Seronegativity|hiv seronegativity
627676|NCT00690976|HIV risk behavior|hiv risk behavior
627677|NCT00690976|Unprotected sex|unprotected sex
627678|NCT00690976|men who have sex with men|men who have sex with men
627680|NCT00690976|Latino|latino
627681|NCT00690976|Unsafe Sex|unsafe sex
627682|NCT00690989|Headache|headache
627683|NCT00690989|Adherence|adherence
627684|NCT00690989|Followup|followup
627685|NCT00691015|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
627686|NCT00691015|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
627687|NCT00691015|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
627688|NCT00691015|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
627689|NCT00691015|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
627690|NCT00691015|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
627691|NCT00691015|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
627692|NCT00691015|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
627693|NCT00691015|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
627694|NCT00691015|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
627695|NCT00691015|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
627696|NCT00691015|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
627697|NCT00691015|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
627698|NCT00691015|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
627699|NCT00691015|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
627700|NCT00691015|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
627701|NCT00691015|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
627702|NCT00691015|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
627703|NCT00691015|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
627704|NCT00691015|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
627705|NCT00691015|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
627706|NCT00691015|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
627707|NCT00691015|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
627708|NCT00691015|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
627709|NCT00691015|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
627710|NCT00691015|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
627711|NCT00691015|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
627712|NCT00691015|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
627713|NCT00691015|splenic marginal zone lymphoma|splenic marginal zone lymphoma
627714|NCT00691015|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
627715|NCT00691015|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
627716|NCT00691015|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
627717|NCT00691015|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
627718|NCT00691015|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
627719|NCT00691015|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
627720|NCT00691015|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
627721|NCT00691015|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
627722|NCT00691015|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
627723|NCT00691015|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
627724|NCT00691015|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
627725|NCT00691015|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
627726|NCT00691015|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
627727|NCT00691015|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
627728|NCT00691015|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
627729|NCT00691015|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
627730|NCT00691015|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
627731|NCT00691015|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
627732|NCT00691015|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
627733|NCT00691015|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
627734|NCT00691015|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
627735|NCT00691015|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
627736|NCT00691015|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
627737|NCT00691015|secondary acute myeloid leukemia|secondary acute myeloid leukemia
627738|NCT00691015|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
627739|NCT00691015|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
627740|NCT00691015|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
627741|NCT00691015|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
627742|NCT00691015|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
627743|NCT00691015|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
627744|NCT00691015|stage I multiple myeloma|stage i multiple myeloma
627745|NCT00691015|stage II multiple myeloma|stage ii multiple myeloma
627746|NCT00691015|stage III multiple myeloma|stage iii multiple myeloma
627747|NCT00691015|primary myelofibrosis|primary myelofibrosis
627748|NCT00691015|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
627749|NCT00691015|chronic eosinophilic leukemia|chronic eosinophilic leukemia
627750|NCT00691015|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
627751|NCT00691015|chronic neutrophilic leukemia|chronic neutrophilic leukemia
627752|NCT00691028|Rheumatoid Arthritis|rheumatoid arthritis
627753|NCT00691028|RA|ra
627754|NCT00691028|Infliximab|infliximab
627755|NCT00691028|TA-650|ta-650
627756|NCT00691028|Remicade|remicade
627757|NCT00691041|HIV Prevention|hiv prevention
627758|NCT00691041|Men who have sex with men|men who have sex with men
627759|NCT00691041|African American|african american
627760|NCT00691041|Unprotected sex|unprotected sex
627761|NCT00691041|HIV Seronegativity|hiv seronegativity
627762|NCT00691054|recurrent pancreatic cancer|recurrent pancreatic cancer
627763|NCT00691054|stage III pancreatic cancer|stage iii pancreatic cancer
627764|NCT00691054|stage IV pancreatic cancer|stage iv pancreatic cancer
627765|NCT00691080|Melatonin|melatonin
627766|NCT00691080|Sleep|sleep
627767|NCT00691080|Autism|autism
627768|NCT00691080|ASD|asd
627769|NCT00691080|Sleep problems in children with autism spectrum disorder|sleep problems in children with autism spectrum disorder
627770|NCT00691093|observational|observational
627771|NCT00691119|breast cancer|breast cancer
627772|NCT00691119|radiation|radiation
627773|NCT00691119|Relaxation and Visualization Therapy|relaxation and visualization therapy
627774|NCT00691119|relaxation|relaxation
627775|NCT00691119|visualization|visualization
627776|NCT00691119|RVT|rvt
627777|NCT00691119|complementary and alternative medicine|complementary and alternative medicine
627778|NCT00691119|CAM|cam
627779|NCT00691119|alternative medicine|alternative medicine
627780|NCT00691132|non-small cell lung cancer|non-small cell lung cancer
627781|NCT00691132|small cell lung cancer|small cell lung cancer
627782|NCT00691132|tobacco use disorder|tobacco use disorder
627783|NCT00691145|Atopic dermatitis|atopic dermatitis
627784|NCT00691145|Tacrolimus ointment|tacrolimus ointment
627785|NCT00691171|gastroesophageal reflux disease|gastroesophageal reflux disease
627786|NCT00691171|GERD|gerd
627787|NCT00691171|nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
627788|NCT00691171|peptic ulcer|peptic ulcer
627789|NCT00691171|Diagnosed GERD|diagnosed gerd
627790|NCT00691171|Atypical GERD symptoms|atypical gerd symptoms
627791|NCT00691171|chronic NSAID therapy|chronic nsaid therapy
627792|NCT00691171|Risk for ulcer|risk for ulcer
627793|NCT00691184|Onychomycosis, Toenail fungal infection, Terbinafine HCl, Pharmacokinetics|onychomycosis, toenail fungal infection, terbinafine hcl, pharmacokinetics
627794|NCT00691210|Hodgkin's Disease|hodgkin's disease
627795|NCT00691210|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
627796|NCT00691223|Focal dermal hypoplasia|focal dermal hypoplasia
627797|NCT00691223|Goltz syndrome|goltz syndrome
627798|NCT00691223|X linked disorders|x linked disorders
627799|NCT00691223|PORCN|porcn
627800|NCT00691223|Wnt signaling|wnt signaling
627801|NCT00691236|osteosarcoma|osteosarcoma
627802|NCT00691236|zoledronic acid|zoledronic acid
627803|NCT00691236|bisphosphonates|bisphosphonates
627804|NCT00691236|adjuvant to chemotherapy|adjuvant to chemotherapy
627805|NCT00691249|Diabetes|diabetes
627806|NCT00691249|Diet|diet
627807|NCT00691249|Fiber|fiber
627808|NCT00691262|Atopic dermatitis|atopic dermatitis
627809|NCT00691262|Prograf|prograf
627810|NCT00691262|Tacrolimus|tacrolimus
627811|NCT00691262|FK506|fk506
627812|NCT00691262|Tacrolimus ointment|tacrolimus ointment
627813|NCT00691275|dehydration|dehydration
627814|NCT00691275|acute gastroenteritis|acute gastroenteritis
627815|NCT00691275|ondansetron|ondansetron
627816|NCT00691275|rehydration|rehydration
627817|NCT00691288|omega-3 fatty acid|omega-3 fatty acid
627818|NCT00691288|hypertriglyceridemia|hypertriglyceridemia
627819|NCT00691288|HIV|hiv
627820|NCT00691288|pediatric|pediatric
627821|NCT00691288|HAART|haart
627822|NCT00691301|cervical squamous cell carcinoma|cervical squamous cell carcinoma
627823|NCT00691301|recurrent cervical cancer|recurrent cervical cancer
627824|NCT00691301|stage III cervical cancer|stage iii cervical cancer
627825|NCT00691301|stage IVA cervical cancer|stage iva cervical cancer
627826|NCT00691301|stage IVB cervical cancer|stage ivb cervical cancer
627827|NCT00691314|Stroke|stroke
627828|NCT00691314|Transietn Ischemic Attack|transietn ischemic attack
627831|NCT00691327|Revision of augmentation or reconstruction|revision of augmentation or reconstruction
627832|NCT00691340|POAG|poag
627833|NCT00691340|Alzheimer's disease|alzheimer's disease
627834|NCT00691340|cellular proteome|cellular proteome
627835|NCT00691340|human leucocytes|human leucocytes
627836|NCT00691340|vasospasm|vasospasm
627837|NCT00691340|Healthy subjects|healthy subjects
627838|NCT00691353|Bipolar Disorder|bipolar disorder
627839|NCT00691353|antipsychotics|antipsychotics
627840|NCT00691353|social functioning|social functioning
627841|NCT00691353|mood stabilizers|mood stabilizers
627842|NCT00691353|Bipolar Disorder Type I|bipolar disorder type i
627843|NCT00691353|atypical antipsychotics|atypical antipsychotics
627844|NCT00691353|monotherapy|monotherapy
630194|NCT00695487|THC|thc
627845|NCT00691353|cotherapy|cotherapy
627846|NCT00691379|Breast cancer|breast cancer
627847|NCT00691379|Triple negative|triple negative
627848|NCT00691379|Chemotherapy|chemotherapy
627849|NCT00691379|Anti-angiogenesis therapy|anti-angiogenesis therapy
627850|NCT00691392|Multi-Drug Resistant Tuberculosis|multi-drug resistant tuberculosis
627851|NCT00691392|Extensively Drug Resistant Tuberculosis|extensively drug resistant tuberculosis
627852|NCT00691392|MDR TB|mdr tb
627853|NCT00691392|XDR TB|xdr tb
627854|NCT00691392|MDR|mdr
627855|NCT00691392|XDR|xdr
627856|NCT00691405|Arformoterol|arformoterol
627857|NCT00691405|(R,R)-formoterol|(r,r)-formoterol
627858|NCT00691418|perinatal|perinatal
627859|NCT00691418|premature|premature
627860|NCT00691418|pregnancy|pregnancy
627861|NCT00691418|gestation|gestation
627862|NCT00691444|melatonin|melatonin
627863|NCT00691444|circadian rhythms|circadian rhythms
627864|NCT00691444|sleep|sleep
627865|NCT00691457|Contact lens|contact lens
627866|NCT00691457|solution|solution
627867|NCT00691457|confocal microscope|confocal microscope
627868|NCT00691470|Anticoagulation|anticoagulation
627869|NCT00691470|Vitamin K-dependent clotting factor inhibitor|vitamin k-dependent clotting factor inhibitor
627870|NCT00691470|Coumadin|coumadin
627871|NCT00691470|Warfarin|warfarin
627872|NCT00691470|Atrial fibrillation|atrial fibrillation
627873|NCT00691470|Prosthetic heart valve|prosthetic heart valve
627874|NCT00691470|Venous thromboembolic disease|venous thromboembolic disease
627875|NCT00691470|Myocardial infarction or cardiomyopathy|myocardial infarction or cardiomyopathy
627876|NCT00691470|Patients with one or more of the following indications for chronic warfarin anticoagulation:|patients with one or more of the following indications for chronic warfarin anticoagulation:
627877|NCT00691470|Atrial fibrillation (paroxysmal, persistent or permanent, not due to a reversible cause, documented by ECG) or atrial flutter;|atrial fibrillation (paroxysmal, persistent or permanent, not due to a reversible cause, documented by ecg) or atrial flutter;
627878|NCT00691470|A prosthetic heart valve in the aortic or mitral position that requires chronic anticoagulation;|a prosthetic heart valve in the aortic or mitral position that requires chronic anticoagulation;
627879|NCT00691470|A history of venous thromboembolic disease (DVT and/or PE) requiring long term anticoagulation (> 6 months);|a history of venous thromboembolic disease (dvt and/or pe) requiring long term anticoagulation (> 6 months);
627997|NCT00691938|methylation|methylation
627880|NCT00691470|A history of myocardial infarction or cardiomyopathy requiring anticoagulation.|a history of myocardial infarction or cardiomyopathy requiring anticoagulation.
627881|NCT00691470|Currently receiving chronic warfarin therapy for another indication not listed, with Sponsor approval.|currently receiving chronic warfarin therapy for another indication not listed, with sponsor approval.
627882|NCT00691483|smoking cessation|smoking cessation
627883|NCT00691483|smoking treatment|smoking treatment
627884|NCT00691483|patient self-selected quit date|patient self-selected quit date
627885|NCT00691496|HIV Prevention|hiv prevention
627886|NCT00691496|African-American|african-american
627888|NCT00691496|bisexual|bisexual
627889|NCT00691496|intervention trial|intervention trial
627890|NCT00691496|HIV Seronegativity|hiv seronegativity
627891|NCT00691509|breast cancer|breast cancer
629167|NCT00699127|prematurity|prematurity
627892|NCT00691522|PERITUMORAL BRAIN EDEMA|peritumoral brain edema
627893|NCT00691522|PRIMARY MALIGNANT BRAIN TUMORS|primary malignant brain tumors
627894|NCT00691522|METASTATIC BRAIN TUMORS|metastatic brain tumors
627895|NCT00691548|Stage IV cancer|stage iv cancer
627896|NCT00691561|HIV Prevention|hiv prevention
627897|NCT00691561|African American|african american
627898|NCT00691561|Black|black
627899|NCT00691561|gay|gay
627900|NCT00691561|Men who have sex men|men who have sex men
627901|NCT00691561|HIV Seronegativity|hiv seronegativity
627902|NCT00691574|Smith-Magenis Syndrome|smith-magenis syndrome
627903|NCT00691574|melatonin|melatonin
627904|NCT00691574|circadian rhythm|circadian rhythm
627905|NCT00691574|sleep|sleep
627906|NCT00691587|mechanical ventilation|mechanical ventilation
627907|NCT00691587|mechanically ventilated|mechanically ventilated
627908|NCT00691587|Pseudomonas aeruginosa|pseudomonas aeruginosa
627909|NCT00691587|ventilator associated pneumonia|ventilator associated pneumonia
627910|NCT00691600|abscess|abscess
627911|NCT00691600|Abscesses in the pediatric emergency population|abscesses in the pediatric emergency population
627912|NCT00691613|Apoptosis|apoptosis
627913|NCT00691613|Annexin|annexin
627914|NCT00691613|Hypoxia|hypoxia
627915|NCT00691613|Ischemia-Reperfusion Injury|ischemia-reperfusion injury
627916|NCT00691626|posttraumatic stress|posttraumatic stress
627919|NCT00691626|psychotherapy|psychotherapy
627920|NCT00691626|imagery rehearsal|imagery rehearsal
627921|NCT00691626|insomnia|insomnia
627922|NCT00691626|behavioral treatment|behavioral treatment
627923|NCT00691626|veterans|veterans
627924|NCT00691626|Operation Iraqi Freedom|operation iraqi freedom
627925|NCT00691626|Operation Enduring Freedom|operation enduring freedom
627926|NCT00691639|Open-angle glaucoma|open-angle glaucoma
627927|NCT00691639|IOP|iop
627928|NCT00691652|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
627929|NCT00691652|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
627930|NCT00691652|splenic marginal zone lymphoma|splenic marginal zone lymphoma
627931|NCT00691652|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
627932|NCT00691652|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
627933|NCT00691652|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
627934|NCT00691652|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
627935|NCT00691652|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
627936|NCT00691652|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
627937|NCT00691652|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
627938|NCT00691652|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
627939|NCT00691652|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
627940|NCT00691652|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
627941|NCT00691652|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
627942|NCT00691652|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
627943|NCT00691652|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
627944|NCT00691652|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
627945|NCT00691665|Rhinitis|rhinitis
627946|NCT00691665|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
627947|NCT00691665|allergies|allergies
627948|NCT00691678|breast cancer|breast cancer
627949|NCT00691678|aromatase inhibitor|aromatase inhibitor
627950|NCT00691678|supportive care|supportive care
627951|NCT00691691|Liver malignancy|liver malignancy
627952|NCT00691691|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
627953|NCT00691691|Efficacy of SBRT in liver tumors|efficacy of sbrt in liver tumors
627954|NCT00691691|Hepatic toxicity with SBRT|hepatic toxicity with sbrt
627955|NCT00691704|Multiple Myeloma|multiple myeloma
627956|NCT00691717|Anecortave acetate|anecortave acetate
627957|NCT00691717|Open-angle glaucoma|open-angle glaucoma
627959|NCT00691717|OHT|oht
627960|NCT00691743|Upper GI Symptoms|upper gi symptoms
627961|NCT00691743|GERD|gerd
627962|NCT00691743|NSAIDs|nsaids
627963|NCT00691756|renal failure|renal failure
627964|NCT00691756|thoracoabdominal aortic aneurysm repair|thoracoabdominal aortic aneurysm repair
627965|NCT00691756|cold crystalloid|cold crystalloid
627966|NCT00691756|cold blood|cold blood
627967|NCT00691756|renal perfusion|renal perfusion
627968|NCT00691769|alopecia|alopecia
627969|NCT00691769|lupus|lupus
628064|NCT00685334|Atypical Antipsychotics|atypical antipsychotics
627970|NCT00691782|African American females between the ages of 21 and 60|african american females between the ages of 21 and 60
627971|NCT00691795|Analgesia|analgesia
627972|NCT00691795|Epidural|epidural
627973|NCT00691795|Pregnancy|pregnancy
627974|NCT00691795|Labor|labor
627975|NCT00691795|Clonidine|clonidine
627976|NCT00691795|Fentanyl|fentanyl
627977|NCT00691795|Bupivacaine|bupivacaine
627978|NCT00691795|Childbirth|childbirth
627979|NCT00691821|Negative-Pressure Wound Therapy|negative-pressure wound therapy
627980|NCT00691821|Bandages|bandages
627981|NCT00691821|Community Health Services|community health services
627982|NCT00691834|Magnetic resonance Imaging|magnetic resonance imaging
627983|NCT00691847|Refractive surgery|refractive surgery
627984|NCT00691860|Parastomal hernias|parastomal hernias
627985|NCT00691860|Tolerance of lightweight meshes|tolerance of lightweight meshes
627986|NCT00691860|Paracolostomy hernias|paracolostomy hernias
627987|NCT00691860|Peristomal hernias|peristomal hernias
627988|NCT00691873|Allergic|allergic
627989|NCT00691873|Asthma|asthma
627990|NCT00691873|Immunotherapy|immunotherapy
627991|NCT00691886|sedation|sedation
627992|NCT00691925|refractive surgery|refractive surgery
627993|NCT00691938|LBH589|lbh589
627994|NCT00691938|Decitabine|decitabine
627995|NCT00691938|panobinostat|panobinostat
627996|NCT00691938|histone deacetylase|histone deacetylase
627998|NCT00691938|hypomethylation|hypomethylation
627999|NCT00691977|Radiation Therapy|radiation therapy
628000|NCT00691990|Goiter [C19.874.283]|goiter [c19.874.283]
628001|NCT00691990|Thyroid Neoplasms [C19.874.788]|thyroid neoplasms [c19.874.788]
628002|NCT00692016|Naproxen Sodium|naproxen sodium
628003|NCT00692029|Normal|normal
628004|NCT00692029|Healthy Volunteers|healthy volunteers
628005|NCT00684970|CRPC|crpc
628006|NCT00684970|HRPC|hrpc
628007|NCT00684970|metastatic prostate cancer|metastatic prostate cancer
628008|NCT00684983|IGF-1R|igf-1r
628009|NCT00684983|IMC-A12|imc-a12
628010|NCT00685009|Cognition|cognition
628011|NCT00685009|Memory|memory
628012|NCT00685009|Hormone Therapy|hormone therapy
628013|NCT00685022|Asthma|asthma
628014|NCT00685022|Racemic albuterol|racemic albuterol
628015|NCT00685035|high frequency chest wall oscillation, cystic fibrosis|high frequency chest wall oscillation, cystic fibrosis
628016|NCT00685048|Gambling|gambling
628017|NCT00685048|Brief Therapies|brief therapies
628018|NCT00685048|Substance Abuse|substance abuse
628019|NCT00685061|Adult, primary deceased donor kidney transplant recipients|adult, primary deceased donor kidney transplant recipients
628020|NCT00685074|Motivational Interview|motivational interview
628021|NCT00685074|Computer based intervention|computer based intervention
628022|NCT00685074|Substance abuse|substance abuse
628023|NCT00685074|post-partum|post-partum
628024|NCT00685087|To define the natural history and the clinical, laboratory and histomorphometric features of chronic pancreatitis (CP).|to define the natural history and the clinical, laboratory and histomorphometric features of chronic pancreatitis (cp).
628025|NCT00685087|To identify clinical and laboratory parameters that correlate with the pathophysiologic state in patients with CP.|to identify clinical and laboratory parameters that correlate with the pathophysiologic state in patients with cp.
628026|NCT00685087|To quantify the behavioral abnormalities associated with CP.|to quantify the behavioral abnormalities associated with cp.
628027|NCT00685087|To determine psychological and behavioral correlates of CP disease progression and outcomes.|to determine psychological and behavioral correlates of cp disease progression and outcomes.
628028|NCT00685100|IVTA; CNV; age-related macular degeneration; PDT|ivta; cnv; age-related macular degeneration; pdt
628030|NCT00685126|Reactive Airways Disease|reactive airways disease
628031|NCT00685126|Levalbuterol|levalbuterol
628032|NCT00685126|Racemic albuterol|racemic albuterol
628033|NCT00685139|Therapeutic Equivalency|therapeutic equivalency
628034|NCT00685178|addiction|addiction
628035|NCT00685178|drug dependence|drug dependence
628036|NCT00685178|stimulant|stimulant
628037|NCT00685191|Raltegravir|raltegravir
628038|NCT00685191|HIV|hiv
628039|NCT00685191|dynamics|dynamics
628040|NCT00685191|viral load|viral load
628041|NCT00685191|Treatment Experienced|treatment experienced
628042|NCT00685230|scorpion sting|scorpion sting
628043|NCT00685230|envenomation|envenomation
628044|NCT00685230|alacramyn|alacramyn
628045|NCT00685243|Fraxel|fraxel
628046|NCT00685243|Pulsed dye laser|pulsed dye laser
628047|NCT00685243|Surgical scars|surgical scars
628048|NCT00685256|breast cancer|breast cancer
628049|NCT00685256|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
628050|NCT00685269|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
628051|NCT00685269|OSAS|osas
628052|NCT00685295|Emergency Department|emergency department
628053|NCT00685295|acute|acute
628054|NCT00685308|Atherosclerosis|atherosclerosis
628055|NCT00685308|Intracranial artery|intracranial artery
628056|NCT00685308|Angioplasty|angioplasty
628057|NCT00685308|Stent|stent
628058|NCT00685321|schizophrenia|schizophrenia
628059|NCT00685321|TMS|tms
628060|NCT00685321|brain stimulation|brain stimulation
628061|NCT00685321|negative symptoms|negative symptoms
628062|NCT00685321|clinical improvement|clinical improvement
628063|NCT00685321|cognitive improvement|cognitive improvement
628160|NCT00685594|diabetes|diabetes
628065|NCT00685334|Anorexia Nervosa|anorexia nervosa
628066|NCT00685347|Asthma|asthma
628067|NCT00685347|Exercised induced bronchoconstriction|exercised induced bronchoconstriction
628068|NCT00685360|Tuberculosis|tuberculosis
628069|NCT00685360|Pulmonary|pulmonary
628070|NCT00685360|Multidrug resistant|multidrug resistant
628071|NCT00685360|Antitubercular Agents|antitubercular agents
628072|NCT00685360|OPC 67683|opc 67683
628073|NCT00685373|Cryopyrin-associated periodic syndromes (CAPS):|cryopyrin-associated periodic syndromes (caps):
628074|NCT00685373|Familial Cold Autoinflammatory Syndrome (FCAS),|familial cold autoinflammatory syndrome (fcas),
628075|NCT00685373|Muckle-Wells Syndrome (MWS),|muckle-wells syndrome (mws),
628076|NCT00685373|MWS with overlapping symptoms of Neonatal Onset Multisystem Inflammatory Disease (NOMID) or Neonatal Onset Multisystem Inflammatory Disease (NOMID),|mws with overlapping symptoms of neonatal onset multisystem inflammatory disease (nomid) or neonatal onset multisystem inflammatory disease (nomid),
628077|NCT00685373|children,|children,
628078|NCT00685373|systemic autoinflammatory disease,|systemic autoinflammatory disease,
628079|NCT00685373|CIAS-1 gene,|cias-1 gene,
628080|NCT00685373|NALP-3,|nalp-3,
628081|NCT00685373|ACZ885,|acz885,
628082|NCT00685373|human monoclonal anti-human interleukin-1beta (IL-1beta),|human monoclonal anti-human interleukin-1beta (il-1beta),
628083|NCT00685373|antibody,|antibody,
628084|NCT00685373|autosomal dominant,|autosomal dominant,
628085|NCT00685373|familial autoinflammatory syndrome|familial autoinflammatory syndrome
628086|NCT00685386|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
628087|NCT00685386|carbon dioxide|carbon dioxide
628088|NCT00685386|randomized controlled clinical trial|randomized controlled clinical trial
628089|NCT00685399|Uveitis|uveitis
628090|NCT00685399|eye|eye
628091|NCT00685399|IL-17|il-17
628092|NCT00685399|IL-17A|il-17a
628093|NCT00685399|IL17|il17
628094|NCT00685399|AIN457|ain457
628095|NCT00685399|Vogt-Koyanagi-Harada|vogt-koyanagi-harada
628096|NCT00685399|Behcet's|behcet's
628097|NCT00685399|Behcet|behcet
628398|NCT00696813|Invega®|invega®
628098|NCT00685399|Sympathetic ophthalmia|sympathetic ophthalmia
628099|NCT00685399|Multifocal choroiditis|multifocal choroiditis
628100|NCT00685399|Birdshot|birdshot
628101|NCT00685399|HLA-B27|hla-b27
628102|NCT00685399|Birdshot retinochoroiditis|birdshot retinochoroiditis
628103|NCT00685399|Retinal vasculitis|retinal vasculitis
628104|NCT00685399|Sarcoidosis|sarcoidosis
628105|NCT00685399|Intermediate uveitis|intermediate uveitis
628106|NCT00685399|Panuveitis|panuveitis
628107|NCT00685399|Posterior uveitis|posterior uveitis
628108|NCT00685412|CIN 2 or 3|cin 2 or 3
628109|NCT00685412|cervical cancer|cervical cancer
628110|NCT00685425|Asthma|asthma
628111|NCT00685425|Exercised induced bronchoconstriction|exercised induced bronchoconstriction
628112|NCT00685438|Environmental Medicine|environmental medicine
628113|NCT00685438|Altitude|altitude
628114|NCT00685438|Ultraviolet Rays|ultraviolet rays
628115|NCT00685438|Antioxidants|antioxidants
628116|NCT00685438|Oxidative Stress|oxidative stress
628117|NCT00685438|Erythema|erythema
628118|NCT00685451|cognitive behavior therapy|cognitive behavior therapy
628119|NCT00685451|addiction|addiction
628120|NCT00685451|PTSD|ptsd
628121|NCT00685464|Abciximab|abciximab
628122|NCT00685464|Reo-Pro|reo-pro
628123|NCT00685464|Intracoronary|intracoronary
628125|NCT00685477|CCK infusion|cck infusion
628126|NCT00685477|Gallbladder ejection fraction|gallbladder ejection fraction
628127|NCT00685477|Normal volunteers|normal volunteers
628128|NCT00685490|branch retinal vein occlusion|branch retinal vein occlusion
628129|NCT00685490|internal limiting membrane|internal limiting membrane
628130|NCT00685490|macular edema|macular edema
628131|NCT00685490|vitrectomy|vitrectomy
628132|NCT00685503|Macular Telangiectasia|macular telangiectasia
628133|NCT00685503|Vascular Endothelial Growth Factor|vascular endothelial growth factor
628134|NCT00685503|Ranibizumab|ranibizumab
628135|NCT00685503|Neovascularization|neovascularization
628136|NCT00685516|adenocarcinoma of the prostate|adenocarcinoma of the prostate
628137|NCT00685516|recurrent prostate cancer|recurrent prostate cancer
628138|NCT00685516|stage I prostate cancer|stage i prostate cancer
628139|NCT00685516|stage II prostate cancer|stage ii prostate cancer
628140|NCT00685516|stage III prostate cancer|stage iii prostate cancer
628141|NCT00685516|stage IV prostate cancer|stage iv prostate cancer
628142|NCT00685529|COPD|copd
628143|NCT00685529|Arformoterol|arformoterol
628144|NCT00685529|formoterol|formoterol
628145|NCT00685542|diacerein|diacerein
628146|NCT00685542|osteoarthritis|osteoarthritis
628147|NCT00685542|hand|hand
628148|NCT00685555|Screen time|screen time
628149|NCT00685555|Fruits and Vegetable Consumption|fruits and vegetable consumption
628150|NCT00685555|Physical Activity|physical activity
628151|NCT00685555|Obesity|obesity
628152|NCT00685555|Overweight|overweight
628153|NCT00685568|colon cancer|colon cancer
628154|NCT00685568|rectal cancer|rectal cancer
628155|NCT00685568|familial adenomatous polyposis|familial adenomatous polyposis
628156|NCT00685581|TFA|tfa
628157|NCT00685581|SFA|sfa
628158|NCT00685581|Clinical trial|clinical trial
628159|NCT00685581|fat milk|fat milk
628161|NCT00685594|vitamin D|vitamin d
628162|NCT00685594|cholecalciferol|cholecalciferol
628163|NCT00685594|glucose tolerance|glucose tolerance
628164|NCT00685607|Pilot Study|pilot study
628165|NCT00685607|Outcome Measures|outcome measures
628166|NCT00685633|stage I prostate cancer|stage i prostate cancer
628167|NCT00685633|stage II prostate cancer|stage ii prostate cancer
628168|NCT00685633|stage III prostate cancer|stage iii prostate cancer
628169|NCT00685633|recurrent prostate cancer|recurrent prostate cancer
628170|NCT00685646|bone metastases|bone metastases
628171|NCT00685646|stage IV prostate cancer|stage iv prostate cancer
628172|NCT00685659|cocaine dependence|cocaine dependence
628173|NCT00685659|treatment|treatment
628174|NCT00685659|continuing care|continuing care
628175|NCT00685659|outcomes|outcomes
628176|NCT00685659|incentives|incentives
628177|NCT00685659|adaptive|adaptive
628178|NCT00685672|labor analgesia|labor analgesia
628179|NCT00685672|fentanyl|fentanyl
628180|NCT00685672|epinephrine|epinephrine
628181|NCT00685685|Therapeutic Equivalency|therapeutic equivalency
628182|NCT00685698|Diabetic Foot Infections, DFI, Nemonoxacin|diabetic foot infections, dfi, nemonoxacin
628183|NCT00685711|Cat allergy|cat allergy
628184|NCT00685711|Immunotherapy|immunotherapy
628185|NCT00685711|Cat-PAD|cat-pad
628186|NCT00685724|pathological gambling|pathological gambling
628187|NCT00685724|cognitive-behavioral therapy|cognitive-behavioral therapy
628188|NCT00685724|motivational enhancement therapy|motivational enhancement therapy
628189|NCT00685737|Hyperlipidemia|hyperlipidemia
628190|NCT00685750|tumor antigen|tumor antigen
628191|NCT00685750|biomarkers|biomarkers
628192|NCT00685763|Pancreatic cancer|pancreatic cancer
628193|NCT00685763|Unresectable|unresectable
628194|NCT00685763|Proton radiation|proton radiation
628195|NCT00685763|Chemotherapy|chemotherapy
628196|NCT00685776|CHD/CHD risk-equivalent disease|chd/chd risk-equivalent disease
628197|NCT00685776|Coronary Heart Disease (CHD)|coronary heart disease (chd)
628492|NCT00697229|Hepatitis B|hepatitis b
628198|NCT00685789|Bell's palsy，deqi，acupuncture, neuropsychology|bell's palsy，deqi，acupuncture, neuropsychology
628199|NCT00685815|IV Iron|iv iron
628200|NCT00685815|Restless Legs Syndrome|restless legs syndrome
628201|NCT00685815|RLS|rls
628202|NCT00685815|Iron|iron
628203|NCT00685828|gastrointestinal stromal tumor|gastrointestinal stromal tumor
628204|NCT00685841|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
628205|NCT00685854|Macular Telangiectasia|macular telangiectasia
628206|NCT00685854|Vascular Endothelial Growth Factor|vascular endothelial growth factor
628207|NCT00685854|Ranibizumab|ranibizumab
628208|NCT00685867|Staphylococcus aureus|staphylococcus aureus
628209|NCT00685867|Resistance|resistance
628210|NCT00685867|Prevention|prevention
628211|NCT00685880|thumb carpo metacarpal joint osteoarthritis|thumb carpo metacarpal joint osteoarthritis
628212|NCT00685880|prolotherapy|prolotherapy
628213|NCT00685880|intra articular steroid|intra articular steroid
628214|NCT00685880|hand therapy|hand therapy
628215|NCT00685893|End-of-life issues|end-of-life issues
628216|NCT00685893|Talking with your doctor|talking with your doctor
628217|NCT00685893|Coping with chronic illness|coping with chronic illness
628218|NCT00685906|oral contraceptive|oral contraceptive
628219|NCT00685906|birth control|birth control
628220|NCT00685906|Healthy volunteers|healthy volunteers
628221|NCT00685919|Dopamine|dopamine
628222|NCT00685919|Natriuresis|natriuresis
628223|NCT00685919|Catecholamines|catecholamines
628224|NCT00685932|Cesarean section|cesarean section
628225|NCT00685932|Postpartum pain|postpartum pain
628226|NCT00685932|Post-cesarean pain|post-cesarean pain
628227|NCT00685932|Surgical retractor|surgical retractor
628228|NCT00685932|Elastic retractor|elastic retractor
628229|NCT00685945|Bradykinin|bradykinin
628230|NCT00685945|Obesity|obesity
628231|NCT00685945|Nitric Oxide Donor|nitric oxide donor
628232|NCT00685945|tissue type plasminogen activator|tissue type plasminogen activator
628233|NCT00685945|isosorbide dinitrate|isosorbide dinitrate
628234|NCT00685945|phosphodiesterase inhibitor|phosphodiesterase inhibitor
628235|NCT00685945|Renin-Angiotensin Aldosterone System|renin-angiotensin aldosterone system
628236|NCT00685945|Fibrinolysis|fibrinolysis
628237|NCT00685945|Angiotensin converting enzyme|angiotensin converting enzyme
628238|NCT00685958|Blood thinner|blood thinner
628239|NCT00685958|enoxaparin|enoxaparin
628240|NCT00685958|hip fracture surgery|hip fracture surgery
628241|NCT00685958|bleeding|bleeding
628242|NCT00685958|thromboembolism|thromboembolism
628243|NCT00685971|Cystic Fibrosis|cystic fibrosis
628244|NCT00685971|Vitamin D deficiency|vitamin d deficiency
628245|NCT00685984|Type 2 diabetes|type 2 diabetes
628246|NCT00685984|silent myocardial ischemia|silent myocardial ischemia
628247|NCT00685984|endothelial function|endothelial function
628248|NCT00692042|Safety|safety
628249|NCT00692042|tolerability|tolerability
628250|NCT00692068|residual renal function|residual renal function
628251|NCT00692068|oxidative stress|oxidative stress
628252|NCT00692068|carbonyl stress|carbonyl stress
628253|NCT00692068|peritoneal dialysis|peritoneal dialysis
628254|NCT00692081|adolescents|adolescents
628255|NCT00692081|borderline intellectual functioning|borderline intellectual functioning
628256|NCT00692081|social competence training|social competence training
628257|NCT00692081|vocational training|vocational training
628258|NCT00692081|group intervention|group intervention
628259|NCT00692081|cognitive behavioral therapy|cognitive behavioral therapy
628260|NCT00692081|Adolescents with borderline intellectual functioning|adolescents with borderline intellectual functioning
628261|NCT00692094|melatonin|melatonin
628262|NCT00692094|circadian rhythms|circadian rhythms
628263|NCT00692094|sleep|sleep
628264|NCT00692107|Radiotherapy|radiotherapy
628265|NCT00692107|Dose|dose
628266|NCT00692133|schizophrenia|schizophrenia
628267|NCT00692133|bipolar disorder|bipolar disorder
628268|NCT00692133|antipsychotic treatment|antipsychotic treatment
628269|NCT00692133|patients´preferences|patients´preferences
628270|NCT00692146|Proof of Mechanism|proof of mechanism
628271|NCT00692146|Capsaicin evoked pain|capsaicin evoked pain
628272|NCT00692159|TRC102|trc102
628273|NCT00692159|Methoxyamine HCL|methoxyamine hcl
628274|NCT00692159|Pemetrexed|pemetrexed
628275|NCT00692159|Alimta|alimta
628276|NCT00692159|Tracon|tracon
628277|NCT00692159|Phase 1|phase 1
628278|NCT00692159|Cancer|cancer
628279|NCT00692159|BER|ber
628280|NCT00692159|Base Excision Repair|base excision repair
628281|NCT00692159|Small Molecule|small molecule
628282|NCT00692159|Anti-folate|anti-folate
628283|NCT00692159|Solid Tumor|solid tumor
628284|NCT00692159|Neoplastic Processes|neoplastic processes
628285|NCT00692159|Pathologic Processes|pathologic processes
628286|NCT00692159|Pathological Conditions, Signs and Symptoms|pathological conditions, signs and symptoms
628287|NCT00692172|psoriasis|psoriasis
628288|NCT00692172|alefacept|alefacept
628289|NCT00692172|intramuscular|intramuscular
628290|NCT00692185|Anorexia Nervosa|anorexia nervosa
628291|NCT00692198|COPD|copd
628292|NCT00692211|screening|screening
628293|NCT00692224|neonatal jaundice|neonatal jaundice
628294|NCT00692224|zinc|zinc
628295|NCT00692224|hyperbilirubinemia|hyperbilirubinemia
628296|NCT00692224|enterohepatic circulation|enterohepatic circulation
628297|NCT00692224|bilirubin|bilirubin
628298|NCT00692237|Type 2 diabetes mellitus|type 2 diabetes mellitus
628299|NCT00692237|Endothelial dysfunction|endothelial dysfunction
628300|NCT00692237|Sildenafil|sildenafil
628301|NCT00692250|Familial Hypercholesterolemia|familial hypercholesterolemia
628302|NCT00692263|Healthy subjects|healthy subjects
628303|NCT00692289|Quality of Life|quality of life
628304|NCT00692302|Suicide Attempts|suicide attempts
628305|NCT00692302|Adolescents|adolescents
628306|NCT00692302|Suicidal|suicidal
628307|NCT00692302|Adolescent Suicide Attempters|adolescent suicide attempters
628308|NCT00692315|glutathione|glutathione
628309|NCT00692315|methionine|methionine
628310|NCT00692315|folinic acid|folinic acid
628311|NCT00692315|redox|redox
628312|NCT00692315|oxidative stress|oxidative stress
628313|NCT00692315|behavior|behavior
628314|NCT00692328|fatigue; TMS; MEP|fatigue; tms; mep
628315|NCT00692341|hepatic impairment|hepatic impairment
628316|NCT00692354|Advanced|advanced
628317|NCT00692354|Solid|solid
628318|NCT00692354|Tumour|tumour
628319|NCT00692354|Tumor|tumor
628320|NCT00692354|Oral|oral
628321|NCT00692367|Body fat|body fat
628322|NCT00692367|Exercise|exercise
628323|NCT00692367|Fatty acids|fatty acids
628324|NCT00692367|Impaired glucose tolerance|impaired glucose tolerance
628325|NCT00692367|Insulin resistance|insulin resistance
628326|NCT00692367|Insulin Sensitivity|insulin sensitivity
628327|NCT00692367|Metabolic syndrome|metabolic syndrome
628328|NCT00692367|Obesity|obesity
628329|NCT00692367|Physical activity|physical activity
628330|NCT00692367|Weight Loss|weight loss
628331|NCT00696527|Infiltrative breast cancer-Clinical practice|infiltrative breast cancer-clinical practice
628332|NCT00696527|Women with infiltrative breast cancer|women with infiltrative breast cancer
628333|NCT00696540|Bronchiolitis, respiratory distress, hypertonic saline|bronchiolitis, respiratory distress, hypertonic saline
628334|NCT00696566|Thrombosis|thrombosis
628335|NCT00696566|Platelet aggregation inhibitor|platelet aggregation inhibitor
628336|NCT00696566|Blood platelets|blood platelets
628337|NCT00696566|P2 receptor|p2 receptor
628338|NCT00696566|Cytochrome P450|cytochrome p450
628339|NCT00696579|BCG|bcg
628340|NCT00696579|Gemcitabine|gemcitabine
628341|NCT00696579|Intravesical|intravesical
628342|NCT00696579|Therapy|therapy
628343|NCT00696579|Superficial|superficial
628344|NCT00696579|Transitional|transitional
628345|NCT00696579|Cell carcinoma|cell carcinoma
628346|NCT00696592|Age-Related Macular Degeneration|age-related macular degeneration
628347|NCT00696592|Choroidal Neovascularization|choroidal neovascularization
628348|NCT00696592|Bevacizumab|bevacizumab
628349|NCT00696592|Photodynamic Therapy|photodynamic therapy
628350|NCT00696605|Hypoosmolality|hypoosmolality
628351|NCT00696605|Hyperosmolality|hyperosmolality
628352|NCT00696605|Copeptin|copeptin
628353|NCT00696605|Vasopressin|vasopressin
628354|NCT00696618|HIV prevention|hiv prevention
628355|NCT00696618|MSM|msm
628356|NCT00696618|Enema|enema
628357|NCT00696618|HIV Seronegativity|hiv seronegativity
628358|NCT00696631|Heart disease|heart disease
628359|NCT00696631|morbidity|morbidity
628360|NCT00696683|scorpion|scorpion
628361|NCT00696683|sting|sting
628362|NCT00696683|envenomation|envenomation
628363|NCT00696683|antivenom|antivenom
628364|NCT00696696|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
628365|NCT00696696|metastatic|metastatic
628366|NCT00696696|EGRF inhibitor|egrf inhibitor
628367|NCT00696696|targeted therapy|targeted therapy
628368|NCT00696696|combined cancer therapy|combined cancer therapy
628369|NCT00696696|kinase inhibitor|kinase inhibitor
628370|NCT00696696|VEGF-R inhibitor|vegf-r inhibitor
628371|NCT00696709|Herpes Zoster (Shingles)|herpes zoster (shingles)
628372|NCT00696735|Phase III study patients with follicular lymphoma|phase iii study patients with follicular lymphoma
628373|NCT00696748|metabolic syndrome|metabolic syndrome
628374|NCT00696748|hypogonadism|hypogonadism
628375|NCT00696748|testosterone undecanoate|testosterone undecanoate
628376|NCT00696761|LUTS|luts
628378|NCT00696761|bladder outlet obstruction|bladder outlet obstruction
628379|NCT00696761|bladder contractility|bladder contractility
628380|NCT00696800|Infertility|infertility
628381|NCT00696800|Pharmacological effect of drugs|pharmacological effect of drugs
628382|NCT00696800|Hormones|hormones
628383|NCT00696800|Hormone substitutes and hormone antagonists|hormone substitutes and hormone antagonists
628384|NCT00696800|Pharmacological actions|pharmacological actions
628385|NCT00696800|Randomized|randomized
628386|NCT00696800|Multi-center|multi-center
628387|NCT00696800|Multi-national|multi-national
628388|NCT00696800|Double-blind|double-blind
628389|NCT00696800|Active-controlled|active-controlled
628390|NCT00696800|Non-inferiority|non-inferiority
628391|NCT00696813|Registry|registry
629718|NCT00701753|DNA|dna
628392|NCT00696813|Healthcare Utilization|healthcare utilization
628393|NCT00696813|Outcome|outcome
628394|NCT00696813|Safety|safety
628395|NCT00696813|Efficacy|efficacy
628396|NCT00696813|Cost-effectiveness|cost-effectiveness
628397|NCT00696813|Paliperidone ER|paliperidone er
628399|NCT00696813|Oral antipsychotics|oral antipsychotics
628400|NCT00696839|Behavior Therapy|behavior therapy
628401|NCT00696839|Anti-Retroviral Agents|anti-retroviral agents
628402|NCT00696839|Relaxation|relaxation
628403|NCT00696839|Clinical Nursing Research|clinical nursing research
628404|NCT00696839|Complementary Therapies|complementary therapies
628405|NCT00696852|Mindfulness|mindfulness
628406|NCT00696852|Meditation|meditation
628407|NCT00696852|Yoga|yoga
628408|NCT00696852|Inflammatory Markers|inflammatory markers
628409|NCT00696865|Safety|safety
628410|NCT00696865|Tolerability|tolerability
628411|NCT00696865|Phase I|phase i
628412|NCT00696878|Infertility|infertility
628413|NCT00696878|Pharmacological effects of drugs|pharmacological effects of drugs
628414|NCT00696878|Hormones, Hormone Substitutes and Hormone Antagonists|hormones, hormone substitutes and hormone antagonists
628415|NCT00696878|Pharmacological Actions|pharmacological actions
628416|NCT00696878|Multi-center|multi-center
628417|NCT00696891|Adjuvanted hepatitis B vaccine, hepatitis B, Engerix™-B|adjuvanted hepatitis b vaccine, hepatitis b, engerix™-b
628418|NCT00696917|Hepatitis B|hepatitis b
628419|NCT00696917|Adjuvanted Hepatitis B vaccine|adjuvanted hepatitis b vaccine
628420|NCT00696917|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
628421|NCT00696930|Malignant Carcinoid Tumors|malignant carcinoid tumors
628422|NCT00696943|cell death|cell death
628423|NCT00696943|PET imaging|pet imaging
628424|NCT00696943|brain metastases|brain metastases
628425|NCT00696943|stereotactic radiosurgery|stereotactic radiosurgery
628426|NCT00696956|local drug delivery|local drug delivery
628427|NCT00696956|balloon angioplasty|balloon angioplasty
628428|NCT00696956|safety and tolerance of paclitaxel coated PTA balloons|safety and tolerance of paclitaxel coated pta balloons
628429|NCT00696956|in inhibiting restenosis of below the knee arteries|in inhibiting restenosis of below the knee arteries
628430|NCT00696956|Efficacy of paclitaxel coated PTA balloons|efficacy of paclitaxel coated pta balloons
628431|NCT00696956|in inhibiting restenosis of below the knee arteries (late lumen loss)|in inhibiting restenosis of below the knee arteries (late lumen loss)
628432|NCT00696982|Arterial stiffness|arterial stiffness
628433|NCT00696982|Augmentation index|augmentation index
628434|NCT00696982|diabetes mellitus|diabetes mellitus
628435|NCT00697008|GERD|gerd
628436|NCT00697008|CLINICAL GUIDELINE|clinical guideline
628437|NCT00697008|Symptoms|symptoms
628438|NCT00697008|clinical outcome|clinical outcome
628439|NCT00697021|Thromboelastography|thromboelastography
628440|NCT00697021|Aspirin|aspirin
628441|NCT00697021|Clopidogrel|clopidogrel
628442|NCT00697021|Plavix|plavix
628443|NCT00697021|Resistance|resistance
628444|NCT00697021|Platelet|platelet
628445|NCT00697021|Coronary Stenting|coronary stenting
628446|NCT00697021|Bare Metal Stent|bare metal stent
628447|NCT00697021|Dual antiplatelet therapy|dual antiplatelet therapy
628448|NCT00697021|Overreactivity|overreactivity
628449|NCT00697021|Primary Coronary Intervention|primary coronary intervention
628450|NCT00697047|Colorectal Neoplasms|colorectal neoplasms
628451|NCT00697047|Mass Screening|mass screening
628452|NCT00697047|Population Surveillance|population surveillance
629063|NCT00689247|ADME|adme
628453|NCT00697047|Randomized controlled trial|randomized controlled trial
628454|NCT00697047|Occult Blood|occult blood
628455|NCT00697047|Colonoscopy|colonoscopy
628456|NCT00697047|Sigmoidoscopy|sigmoidoscopy
628457|NCT00697047|Health Behavior|health behavior
628458|NCT00697047|Colorectal Screening|colorectal screening
628459|NCT00697060|Metastatic|metastatic
628460|NCT00697060|Previously treated|previously treated
628461|NCT00697073|Friedreich's Ataxia|friedreich's ataxia
628462|NCT00697073|Idebenone|idebenone
628463|NCT00697073|ICARS|icars
628464|NCT00697086|Heart disease|heart disease
628465|NCT00697099|VTE prevention|vte prevention
628466|NCT00697099|Total Hip Replacement|total hip replacement
630333|NCT00696059|Radiography|radiography
628467|NCT00697099|Heparin Low-Molecular-Weight|heparin low-molecular-weight
628468|NCT00697125|Hepatitis B|hepatitis b
628469|NCT00697125|Engerix™-B|engerix™-b
628470|NCT00697125|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
628471|NCT00697138|Cocaine|cocaine
628472|NCT00697138|Dependence|dependence
628473|NCT00697138|Pharmacotherapies|pharmacotherapies
628474|NCT00697151|cerebrovascular diseases|cerebrovascular diseases
628475|NCT00697151|ischemic stroke|ischemic stroke
628476|NCT00697151|patent foramen ovale|patent foramen ovale
628477|NCT00697151|warfarin|warfarin
628478|NCT00697151|aspirin|aspirin
628479|NCT00697151|transesophageal echocardiography|transesophageal echocardiography
628480|NCT00697164|Malaria|malaria
628481|NCT00697164|Treatment|treatment
628482|NCT00697164|Adjunctive|adjunctive
628483|NCT00697164|Erythropoietin|erythropoietin
628484|NCT00697164|Survival|survival
628485|NCT00697177|Gastro-oesophageal reflux|gastro-oesophageal reflux
628486|NCT00697177|24 hour oesophageal pH monitoring|24 hour oesophageal ph monitoring
628487|NCT00697177|Physiotherapy Airway clearance techniques|physiotherapy airway clearance techniques
628488|NCT00697177|Exercise|exercise
628489|NCT00697216|Hepatitis B|hepatitis b
628490|NCT00697216|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
628491|NCT00697216|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
628493|NCT00697229|Engerix™-B|engerix™-b
628494|NCT00697229|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
628495|NCT00697242|Hepatitis B|hepatitis b
628496|NCT00697242|Engerix™-B|engerix™-b
628497|NCT00697242|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
628498|NCT00697255|Pharmacological effects of drugs|pharmacological effects of drugs
628499|NCT00697255|Hormones|hormones
628500|NCT00697255|Hormone Substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
628501|NCT00697255|Pharmacological Actions|pharmacological actions
628502|NCT00697255|Monofollicular growth|monofollicular growth
628503|NCT00697255|Randomized|randomized
628504|NCT00697255|Open-label|open-label
628505|NCT00697255|Active-controlled|active-controlled
628506|NCT00697268|Depression|depression
628507|NCT00697268|Depression Treatment|depression treatment
628508|NCT00697268|Unipolar Depression|unipolar depression
628509|NCT00697268|Citalopram|citalopram
628510|NCT00697268|Serotonin|serotonin
628511|NCT00697268|Major Depression|major depression
628512|NCT00697268|Healthy Volunteer|healthy volunteer
628513|NCT00697268|HV|hv
628514|NCT00697281|allergic rhinitis|allergic rhinitis
628515|NCT00697281|human|human
628516|NCT00697281|clinical trial|clinical trial
628517|NCT00697281|efficacy|efficacy
628518|NCT00697281|safety|safety
628519|NCT00697281|challenge test|challenge test
628520|NCT00697294|Vitamin D deficiency|vitamin d deficiency
628521|NCT00697294|Infants|infants
628522|NCT00697294|Breast feeding|breast feeding
628523|NCT00697307|bioequivalence|bioequivalence
628524|NCT00697307|contraception|contraception
628525|NCT00697307|contraceptive patch|contraceptive patch
628526|NCT00697307|ORTHO EVRA|ortho evra
628527|NCT00697307|norelgestromin|norelgestromin
628528|NCT00697307|NGMN|ngmn
628529|NCT00697307|ethinyl estradiol|ethinyl estradiol
628530|NCT00697307|EE|ee
628531|NCT00697333|NSCLC|nsclc
628532|NCT00697333|FDG-PET|fdg-pet
628533|NCT00697333|Radiotherapy|radiotherapy
628534|NCT00697333|planning|planning
628535|NCT00697333|target volumes|target volumes
628536|NCT00697346|Drug therapy|drug therapy
628537|NCT00697359|Atrial fibrillation|atrial fibrillation
628538|NCT00697359|Monitoring|monitoring
628539|NCT00697359|Pulmonary vein isolation|pulmonary vein isolation
628540|NCT00697359|Implantable loop recorder|implantable loop recorder
628541|NCT00697372|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
628542|NCT00697372|Drug-Eluting Stents|drug-eluting stents
628543|NCT00697411|Aicardi syndrome|aicardi syndrome
628544|NCT00697411|Microphthalmia with linear skin defects (MLS) syndrome|microphthalmia with linear skin defects (mls) syndrome
628545|NCT00697411|X-linked disorders|x-linked disorders
628546|NCT00697463|Teriparatide|teriparatide
628547|NCT00697463|Forteo|forteo
628548|NCT00697463|Osteopenia|osteopenia
628549|NCT00697463|Osteoporosis|osteoporosis
628550|NCT00697463|Fracture|fracture
628551|NCT00697463|Low Bone Density|low bone density
628552|NCT00697463|Premenopausal women|premenopausal women
628553|NCT00697476|second line chemotherapy|second line chemotherapy
628554|NCT00697489|Pelvic organ prolapse|pelvic organ prolapse
628555|NCT00697489|Urinary incontinence|urinary incontinence
628556|NCT00697489|Mesh|mesh
628557|NCT00697528|Graves|graves
628558|NCT00697528|Color Doppler Imaging|color doppler imaging
628559|NCT00697528|Graves' Ophthalmopathy|graves' ophthalmopathy
628560|NCT00697528|Orbital Venous Flow|orbital venous flow
628561|NCT00697541|erythematous rosacea|erythematous rosacea
628562|NCT00697541|facial gel|facial gel
628563|NCT00697541|brimonidine|brimonidine
628564|NCT00697541|ophthalmic solution|ophthalmic solution
628565|NCT00697554|Hepatitis B|hepatitis b
628666|NCT00697957|fragility fractures|fragility fractures
628573|NCT00697580|Latino|latino
628574|NCT00697580|Adolescents|adolescents
628575|NCT00697580|Strength Training|strength training
628576|NCT00697580|Circuit Training|circuit training
628577|NCT00697580|Nutrition|nutrition
628578|NCT00697593|Efalizumab|efalizumab
628579|NCT00697593|Chronic Plaque Psoriasis|chronic plaque psoriasis
628580|NCT00697593|Transition from systemic therapies on to Efalizumab|transition from systemic therapies on to efalizumab
628581|NCT00697606|Seprafilm®|seprafilm®
628582|NCT00697606|cesarean|cesarean
628583|NCT00697606|adhesions|adhesions
628584|NCT00697606|primary|primary
628585|NCT00697606|repeat|repeat
628595|NCT00697645|Stroke,|stroke,
628596|NCT00697645|Cerebrovascular disease,|cerebrovascular disease,
628597|NCT00697645|Transcranial magnetic stimulation,|transcranial magnetic stimulation,
628598|NCT00697645|rehabilitation|rehabilitation
628599|NCT00697658|Paliperidone ER|paliperidone er
628600|NCT00697658|Schizophrenia|schizophrenia
628601|NCT00697671|NK cell infusion|nk cell infusion
628602|NCT00697671|Immunotherapy|immunotherapy
628603|NCT00697671|hematologic malignancy|hematologic malignancy
628604|NCT00697671|Miltenyi Biotec device|miltenyi biotec device
628605|NCT00697671|haploidentical donor|haploidentical donor
628606|NCT00697684|Reduced Intensity Allogeneic Stem Cell Transplant|reduced intensity allogeneic stem cell transplant
628607|NCT00697684|Clofarabine|clofarabine
628608|NCT00697684|Rabbit Antithymocyte Globulin|rabbit antithymocyte globulin
628609|NCT00697684|Total Lymphoid Radiation|total lymphoid radiation
628610|NCT00697697|asthmatic children|asthmatic children
628611|NCT00697710|Atopic Dermatitis|atopic dermatitis
628612|NCT00697723|Coronary artery bypass graft|coronary artery bypass graft
628613|NCT00697723|Intra-aortic balloon pump|intra-aortic balloon pump
628614|NCT00697723|transit-time flowmetry|transit-time flowmetry
628615|NCT00697736|Systemic Scleroderma|systemic scleroderma
628616|NCT00697736|Echocardiography|echocardiography
628617|NCT00697749|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
628618|NCT00697749|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
628619|NCT00697749|Hepatitis B|hepatitis b
628620|NCT00697762|Partial onset seizure|partial onset seizure
628621|NCT00697762|Adjunctive therapy|adjunctive therapy
628622|NCT00697775|Hepatitis B|hepatitis b
628623|NCT00697775|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
628624|NCT00697775|Adjuvant|adjuvant
628625|NCT00697788|pediatric|pediatric
628627|NCT00697788|sedation|sedation
628628|NCT00697814|Hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
628629|NCT00697814|Prolactinoma|prolactinoma
628630|NCT00697840|Hepatitis B|hepatitis b
628631|NCT00697840|Engerix™-B|engerix™-b
628632|NCT00697840|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
628633|NCT00697840|Adjuvant|adjuvant
628634|NCT00697853|Hepatitis B|hepatitis b
628635|NCT00697853|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
628636|NCT00697853|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
628637|NCT00697866|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
628638|NCT00697866|Hepatitis B|hepatitis b
628639|NCT00697866|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
628640|NCT00697879|tumour|tumour
628641|NCT00697879|Solid tumour|solid tumour
628642|NCT00697879|histone deacetylase inhibitor|histone deacetylase inhibitor
628643|NCT00697879|dose escalation|dose escalation
628644|NCT00697879|cancer|cancer
628645|NCT00697892|Human Immunodeficiency Virus|human immunodeficiency virus
628646|NCT00697892|Drug Interactions|drug interactions
628647|NCT00697905|nasopharyngeal carcinoma|nasopharyngeal carcinoma
628648|NCT00697905|Gemcitabine-Carboplatin|gemcitabine-carboplatin
628649|NCT00697918|Partial onset seizure|partial onset seizure
628650|NCT00697918|Adjunctive therapy|adjunctive therapy
628651|NCT00697931|Hepatitis B|hepatitis b
628652|NCT00697931|Engerix™-B|engerix™-b
628653|NCT00697931|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
628654|NCT00697931|Adjuvant|adjuvant
628655|NCT00697944|FUNGAL INFECTION|fungal infection
628656|NCT00697944|SEPSIS|sepsis
628657|NCT00697944|INTENSIVE CARE|intensive care
628658|NCT00697944|AMBISOME|ambisome
628659|NCT00697944|PREEMPTIVE TREATMENT|preemptive treatment
628660|NCT00697944|Sepsis with candida colonisation|sepsis with candida colonisation
628661|NCT00697957|acceleration|acceleration
628662|NCT00697957|bone density|bone density
628663|NCT00697957|cardiovascular diseases|cardiovascular diseases
628664|NCT00697957|exercise|exercise
628667|NCT00697957|impact intensity|impact intensity
628668|NCT00697957|intervention studies|intervention studies
628669|NCT00697957|osteoporosis|osteoporosis
628670|NCT00697957|premenopause|premenopause
628671|NCT00697970|Hepatitis B|hepatitis b
628672|NCT00697970|Engerix™-B|engerix™-b
628673|NCT00697970|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
628674|NCT00697970|Adjuvant|adjuvant
628675|NCT00697983|Osteoporosis|osteoporosis
628676|NCT00697983|ATP|atp
628677|NCT00697983|Purinergic receptors|purinergic receptors
628678|NCT00697983|Bone mineral density|bone mineral density
628679|NCT00697983|Single nucleotide polymorphism|single nucleotide polymorphism
628680|NCT00698009|Neuroblastoma|neuroblastoma
628681|NCT00698009|Natural Killer Cell|natural killer cell
628682|NCT00698009|NK Cell Infusion|nk cell infusion
628683|NCT00698009|Haploidentical Natural Killer (NK) Cells|haploidentical natural killer (nk) cells
628684|NCT00698009|Fludarabine|fludarabine
628685|NCT00698009|Fludarabine Phosphate|fludarabine phosphate
628686|NCT00698009|Fludara|fludara
628687|NCT00698009|Cyclophosphamide|cyclophosphamide
628688|NCT00698009|Cytoxan|cytoxan
628689|NCT00698009|Neosar|neosar
628690|NCT00698009|Interleukin-2|interleukin-2
628691|NCT00698009|IL-2|il-2
628692|NCT00698009|Proleukin|proleukin
628693|NCT00698009|Mesna|mesna
628694|NCT00698009|Mesnex|mesnex
628695|NCT00698009|Infusion of NK cells|infusion of nk cells
628696|NCT00698009|Pediatric NK Cell Infusion|pediatric nk cell infusion
628697|NCT00698009|Pediatric Neuroblastoma|pediatric neuroblastoma
628698|NCT00698009|Pediatric NK|pediatric nk
628699|NCT00698009|Pediatric|pediatric
628700|NCT00698022|healthy|healthy
628701|NCT00698022|weight gain|weight gain
628702|NCT00698022|anti-psychotic|anti-psychotic
628703|NCT00698022|risperidone|risperidone
628704|NCT00698022|mifepristone|mifepristone
628705|NCT00698022|mitigation|mitigation
628706|NCT00698022|weight loss|weight loss
628707|NCT00698035|Vaginal Testosterone Cream|vaginal testosterone cream
628708|NCT00698035|ESTRING|estring
628709|NCT00698048|Sepsis|sepsis
628710|NCT00698048|Septic Shock|septic shock
628711|NCT00698048|Vasopressin|vasopressin
628712|NCT00698048|Copeptin|copeptin
628713|NCT00698048|Paediatrics|paediatrics
628714|NCT00698061|Hepatitis B|hepatitis b
628715|NCT00698061|Adjuvanted vaccine|adjuvanted vaccine
628716|NCT00698087|Hepatitis B|hepatitis b
628717|NCT00698087|Engerix™-B|engerix™-b
628718|NCT00698087|Adjuvanted recombinant hepatitis B vaccine|adjuvanted recombinant hepatitis b vaccine
628719|NCT00698100|DNA|dna
628720|NCT00698100|HU & MOUSE|hu & mouse
628721|NCT00698100|TYROSINASE|tyrosinase
628722|NCT00698113|anxiety|anxiety
628723|NCT00698113|depression|depression
628724|NCT00698113|stress|stress
628725|NCT00698113|cancer symptoms|cancer symptoms
628726|NCT00698113|pediatric cancer|pediatric cancer
628727|NCT00698113|massage|massage
628728|NCT00698113|parent delivered massage|parent delivered massage
628729|NCT00698139|heart failure|heart failure
628730|NCT00698139|chronotropic incompetence|chronotropic incompetence
628731|NCT00698152|Total Hip Arthroplasty|total hip arthroplasty
628732|NCT00698152|Total Hip Replacement|total hip replacement
628733|NCT00698152|Hip Arthritis|hip arthritis
628734|NCT00698152|Polyethylene|polyethylene
628735|NCT00698178|Gastroesophageal reflux disease|gastroesophageal reflux disease
628736|NCT00698178|Waist circumference|waist circumference
628737|NCT00698178|Body mass index|body mass index
628738|NCT00698178|Obesity|obesity
628739|NCT00698191|Lupus Erythematosus,Systemic|lupus erythematosus,systemic
628740|NCT00698191|Lupus Nephritis|lupus nephritis
628741|NCT00698191|Mesenchymal Stem Cells|mesenchymal stem cells
628742|NCT00698191|Transplantation|transplantation
628743|NCT00698204|Mucositis|mucositis
628744|NCT00698204|Head and Neck Cancer|head and neck cancer
628745|NCT00698204|Head and Neck Neoplasms|head and neck neoplasms
628746|NCT00698204|Stomatitis|stomatitis
628747|NCT00698243|OSI-027|osi-027
628748|NCT00698243|Solid tumor|solid tumor
628749|NCT00698243|Lymphoma|lymphoma
628750|NCT00698295|schizophrenia|schizophrenia
628751|NCT00698295|atypical antipsychotics|atypical antipsychotics
628752|NCT00698295|EEG|eeg
628753|NCT00698321|HIV/STD Prevention|hiv/std prevention
628754|NCT00698321|HIV Seronegativity|hiv seronegativity
628755|NCT00698334|HIV infection|hiv infection
628756|NCT00698334|Acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
628757|NCT00698334|Tuberculosis|tuberculosis
628758|NCT00698347|Total Knee Replacement|total knee replacement
628759|NCT00698347|Total Knee Arthroplasty|total knee arthroplasty
628760|NCT00698347|Hip Arthritis|hip arthritis
628761|NCT00698360|chronic kidney disease|chronic kidney disease
628762|NCT00698360|melatonin|melatonin
628763|NCT00698360|erythropoietin|erythropoietin
628764|NCT00698360|circadian rhythm|circadian rhythm
628765|NCT00698373|Fluorine-18-α-methyltyrosine,|fluorine-18-α-methyltyrosine,
628766|NCT00698373|Positron emission tomography,|positron emission tomography,
628767|NCT00698373|Fluorine-18-fluorodeoxyglucose,|fluorine-18-fluorodeoxyglucose,
628768|NCT00698373|Lung cancer,|lung cancer,
628769|NCT00698386|Micronutrient Zinc|micronutrient zinc
628770|NCT00698386|Category I PTB|category i ptb
628771|NCT00698386|RNTCP|rntcp
628772|NCT00698386|DOTS|dots
628773|NCT00698386|Sputum smear conversion|sputum smear conversion
628774|NCT00698386|Reduced relapse|reduced relapse
628775|NCT00698386|Immunopathogenesis|immunopathogenesis
628776|NCT00698386|Category-I|category-i
628777|NCT00698399|liver|liver
628778|NCT00698399|transplant|transplant
628779|NCT00698399|TMAO|tmao
628780|NCT00698399|NGAL|ngal
628781|NCT00698399|cystatin-C|cystatin-c
628782|NCT00698399|Ischemia Reperfusion Injury|ischemia reperfusion injury
628783|NCT00698399|Liver Transplant|liver transplant
628784|NCT00698399|LTx|ltx
628785|NCT00698399|allantion|allantion
628786|NCT00698412|Knee osteoarthritis|knee osteoarthritis
628787|NCT00698412|Daily cane use|daily cane use
628788|NCT00698412|Pain|pain
628789|NCT00698412|Function|function
628790|NCT00698412|Quality of life|quality of life
628791|NCT00698412|Energy consumption during the gait|energy consumption during the gait
628792|NCT00698425|Iontophoresis|iontophoresis
628793|NCT00698425|Ophthalmology|ophthalmology
628794|NCT00698438|At least 18 years of age|at least 18 years of age
628795|NCT00698438|Open-angle glaucoma|open-angle glaucoma
628796|NCT00698451|Ovarian cancer|ovarian cancer
628797|NCT00698451|fallopian tube cancer|fallopian tube cancer
628798|NCT00698451|primary peritoneal cancer|primary peritoneal cancer
628799|NCT00698451|DOXIL|doxil
628800|NCT00698451|carboplatin|carboplatin
628801|NCT00698451|bevacizumab|bevacizumab
628802|NCT00698464|Pasireotide|pasireotide
628803|NCT00698464|PK profile,|pk profile,
628804|NCT00698464|Single dose|single dose
628805|NCT00698464|Pasireotide subcutaneous injection|pasireotide subcutaneous injection
628806|NCT00698464|Safety|safety
628807|NCT00698464|Mild hepatic impaired patients|mild hepatic impaired patients
628808|NCT00698464|Moderate hepatic impaired patients|moderate hepatic impaired patients
628809|NCT00698464|Severe hepatic impaired patients|severe hepatic impaired patients
628810|NCT00698490|Herpes simplex|herpes simplex
628811|NCT00698490|Herpes simplex candidate vaccine|herpes simplex candidate vaccine
628812|NCT00698503|Metal on Metal|metal on metal
628813|NCT00698503|Total Hip Arthroplasty|total hip arthroplasty
628814|NCT00698503|Total Hip Replacement|total hip replacement
628815|NCT00698516|Bevacizumab|bevacizumab
628816|NCT00698516|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
628817|NCT00698516|Topotecan|topotecan
628818|NCT00698529|Technology Transfer|technology transfer
628819|NCT00698529|HIV Seronegativity|hiv seronegativity
628821|NCT00698542|sepsis|sepsis
628822|NCT00698542|Neuro Care Unit|neuro care unit
628823|NCT00698542|Surviving Sepsis Campaign|surviving sepsis campaign
628824|NCT00698542|SSC|ssc
628825|NCT00698555|Hepatitis B|hepatitis b
628826|NCT00698555|HBV-MPL|hbv-mpl
628827|NCT00698555|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
628828|NCT00698568|Herpes simplex, Herpes simplex candidate vaccine|herpes simplex, herpes simplex candidate vaccine
628829|NCT00698581|Epilepsy; Monotherapy|epilepsy; monotherapy
628830|NCT00698581|Partial Onset Seizures|partial onset seizures
628831|NCT00698581|Adults and Adolescents|adults and adolescents
628832|NCT00698607|Everolimus|everolimus
628833|NCT00698607|Sirolimus|sirolimus
628834|NCT00698607|drug eluting stent|drug eluting stent
628835|NCT00698607|Clopidogrel|clopidogrel
628836|NCT00698633|Hip arthroplasty|hip arthroplasty
628837|NCT00698646|Systolic blood pressure|systolic blood pressure
628838|NCT00698646|Diastolic blood pressure|diastolic blood pressure
628839|NCT00698646|Valsartan|valsartan
628840|NCT00698646|Hydrochlorothiazide|hydrochlorothiazide
628841|NCT00698672|RSA|rsa
628842|NCT00698685|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
628843|NCT00698685|Preparative Regimen|preparative regimen
628844|NCT00698685|Pentostatin|pentostatin
628845|NCT00698685|Alemtuzumab|alemtuzumab
628846|NCT00698685|Hodgkin Disease and Lymphoma, non-Hodgkin|hodgkin disease and lymphoma, non-hodgkin
628847|NCT00698685|leukemia, myeloid, acute|leukemia, myeloid, acute
628848|NCT00698685|leukemia, lymphocytic, acute|leukemia, lymphocytic, acute
628849|NCT00698685|leukemia, myeloid, chronic|leukemia, myeloid, chronic
628850|NCT00698685|leukemia, lymphocytic, chronic|leukemia, lymphocytic, chronic
628851|NCT00698685|Multiple Myeloma|multiple myeloma
628852|NCT00698685|Myelodysplastic Syndromes|myelodysplastic syndromes
628853|NCT00698685|Carcinoma, Renal Cell|carcinoma, renal cell
628854|NCT00698698|tear proteins|tear proteins
628855|NCT00698698|diabetic retinopathy|diabetic retinopathy
628856|NCT00698698|HPLC|hplc
628857|NCT00698698|Mass spectroscopy|mass spectroscopy
628858|NCT00698711|Prostate cancer|prostate cancer
628859|NCT00698711|MUC-2-KLH|muc-2-klh
628860|NCT00698711|QS 21|qs 21
628861|NCT00698737|Opioid|opioid
628862|NCT00698737|Cocaine|cocaine
628863|NCT00698750|Fractured Humeral Head|fractured humeral head
628864|NCT00698750|Traumatic Arthritis|traumatic arthritis
628865|NCT00698750|Resurfacing Shoulder|resurfacing shoulder
628866|NCT00698750|Shoulder Replacement|shoulder replacement
628867|NCT00698750|Shoulder Arthritis|shoulder arthritis
628960|NCT00688974|adjustable gastric banding|adjustable gastric banding
631109|NCT00692770|Adjuvant|adjuvant
628868|NCT00698763|An ischaemic cerebrovascular event (stroke or TIA)|an ischaemic cerebrovascular event (stroke or tia)
628869|NCT00698828|Cachexia, COPD, Chronic Obstructive Pulmonary Disease|cachexia, copd, chronic obstructive pulmonary disease
628870|NCT00698854|Total Knee Arthroplasty|total knee arthroplasty
628871|NCT00698854|Total Knee Replacement|total knee replacement
628872|NCT00698854|Knee Arthritis|knee arthritis
628873|NCT00698867|Total Elbow Arthroplasty|total elbow arthroplasty
628874|NCT00698867|Total Elbow Replacement|total elbow replacement
628875|NCT00698867|Osteoarthritis|osteoarthritis
628876|NCT00698867|Elbow arthritis|elbow arthritis
628877|NCT00698880|Portal vein embolization|portal vein embolization
628878|NCT00698880|Hepatic vein embolization|hepatic vein embolization
628879|NCT00698880|Liver regeneration|liver regeneration
628880|NCT00698893|Herpes simplex|herpes simplex
628881|NCT00698893|Herpes simplex candidate (gD) vaccine|herpes simplex candidate (gd) vaccine
628882|NCT00698906|Hepatitis B|hepatitis b
628883|NCT00698906|HBV-MPL|hbv-mpl
628884|NCT00698906|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
628885|NCT00698919|Bacterial DNA|bacterial dna
628886|NCT00698919|Systemic inflammatory response syndrome|systemic inflammatory response syndrome
628887|NCT00698919|Infection|infection
628888|NCT00698919|Intensive Care Unit|intensive care unit
628889|NCT00698932|DPP-4 inhibitors|dpp-4 inhibitors
628890|NCT00698932|HBA1c|hba1c
628891|NCT00698932|Incretins|incretins
628892|NCT00698958|Respiratory insufficiency|respiratory insufficiency
628893|NCT00698958|Hypercapnic chronic respiratory failure secondary to neuromuscular diseases or alterations of thoracic cage|hypercapnic chronic respiratory failure secondary to neuromuscular diseases or alterations of thoracic cage
752364|NCT01172652|Bipolar disorder|bipolar disorder
752365|NCT01172652|Anxiety|anxiety
752366|NCT01172652|Panic|panic
628894|NCT00698984|Soy Isoflavones, Bone Mineral Density, Bone Mineral Content, postmenopausal Women, Bone Markers, Bone Health, Phytoestrogens|soy isoflavones, bone mineral density, bone mineral content, postmenopausal women, bone markers, bone health, phytoestrogens
628895|NCT00698997|autism|autism
628896|NCT00698997|autism spectrum disorder|autism spectrum disorder
628897|NCT00698997|intensive intervention for toddlers with autism|intensive intervention for toddlers with autism
628898|NCT00698997|PDD NOS|pdd nos
628899|NCT00698997|early steps study|early steps study
628900|NCT00698997|early start denver model|early start denver model
628901|NCT00698997|early intervention for infants and toddlers with autism|early intervention for infants and toddlers with autism
628902|NCT00698997|toddler treatment|toddler treatment
628903|NCT00698997|Sally Rogers|sally rogers
628904|NCT00698997|University of California, Davis|university of california, davis
628905|NCT00698997|University of Michigan|university of michigan
628906|NCT00698997|MIND Institute|mind institute
628907|NCT00699010|Abuse Liability|abuse liability
628908|NCT00699010|Abuse Prevention|abuse prevention
628909|NCT00699010|Abuse Resistance|abuse resistance
628910|NCT00699010|Abuse Deterrence|abuse deterrence
628911|NCT00699023|postprandial lipemia|postprandial lipemia
628912|NCT00699023|type 2 diabetes|type 2 diabetes
628913|NCT00699023|ezetimibe|ezetimibe
628914|NCT00699023|hypercholesterolemia|hypercholesterolemia
628915|NCT00699036|nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
628916|NCT00699036|fatty liver|fatty liver
628917|NCT00699036|insulin resistance|insulin resistance
628918|NCT00699049|Alpha blocker|alpha blocker
628919|NCT00699049|Tamsulosin|tamsulosin
628920|NCT00699049|Solifenacin|solifenacin
628921|NCT00699049|Overactive Bladder|overactive bladder
628922|NCT00699049|Urgency incontinence|urgency incontinence
628923|NCT00688844|PKU|pku
628924|NCT00688844|Phenylketonuria|phenylketonuria
628925|NCT00688844|BH4|bh4
628926|NCT00688844|Kuvan|kuvan
628927|NCT00688844|Tetrahydrobiopterin|tetrahydrobiopterin
628928|NCT00688844|Sapropterin Dihydrochloride|sapropterin dihydrochloride
628929|NCT00688844|Nutrition|nutrition
628930|NCT00688844|PHE|phe
628931|NCT00688844|Phenylalanine|phenylalanine
628932|NCT00688844|PAH|pah
628933|NCT00688844|Phenylalanine hydroxylase|phenylalanine hydroxylase
628934|NCT00688844|Neurotransmitters|neurotransmitters
628935|NCT00688844|Serotonin|serotonin
628936|NCT00688844|Catecholamines|catecholamines
628937|NCT00688844|Diet|diet
628938|NCT00688844|Body Fat|body fat
628939|NCT00688844|Bone Density|bone density
628940|NCT00688870|Prevention against pneumococcal disease|prevention against pneumococcal disease
628941|NCT00688883|Fludarabine|fludarabine
628942|NCT00688883|Purine analog|purine analog
628943|NCT00688883|Indolent lymphoma|indolent lymphoma
628944|NCT00688909|breast cancer|breast cancer
628945|NCT00688909|adjuvant treatment in post menopausal women|adjuvant treatment in post menopausal women
628946|NCT00688909|letrozole|letrozole
628947|NCT00688909|arthralgia-myalgia|arthralgia-myalgia
628948|NCT00688935|melatonin|melatonin
628949|NCT00688935|circadian rhythms|circadian rhythms
628950|NCT00688935|sleep|sleep
628951|NCT00688935|sleep disorders|sleep disorders
628952|NCT00688948|pilot clinical trial|pilot clinical trial
628953|NCT00688961|omega-3 fatty acids|omega-3 fatty acids
628954|NCT00688961|aspirin|aspirin
628955|NCT00688961|platelet aggregation|platelet aggregation
628956|NCT00688961|Healthy volunteers; no disease|healthy volunteers; no disease
628957|NCT00688974|type 2 diabetes|type 2 diabetes
628958|NCT00688974|obesity|obesity
628959|NCT00688974|gastric bypass|gastric bypass
628962|NCT00688974|obesity for more than 5 years|obesity for more than 5 years
628963|NCT00689000|Leukemia|leukemia
628964|NCT00689000|AML|aml
628965|NCT00689000|MDS|mds
628966|NCT00689000|MM|mm
628967|NCT00689000|Acute Myeloid Leukemia|acute myeloid leukemia
628968|NCT00689000|Myelodysplastic Syndrome|myelodysplastic syndrome
628969|NCT00689000|Multiple Myeloma|multiple myeloma
628970|NCT00689000|Cancer|cancer
628971|NCT00689000|Hematological malignancies|hematological malignancies
628972|NCT00689000|Elderly|elderly
628973|NCT00689000|Refractory|refractory
628974|NCT00689000|Blood|blood
628975|NCT00689013|Herpes Zoster|herpes zoster
628976|NCT00689013|Prevention & control|prevention & control
628977|NCT00689013|Pharmacists|pharmacists
628978|NCT00689013|Pharmacy|pharmacy
628979|NCT00689013|Pharmacies|pharmacies
628980|NCT00689013|Aged|aged
628981|NCT00689013|Immunization|immunization
628982|NCT00689013|Vaccination|vaccination
628983|NCT00689026|Colonoscopy|colonoscopy
628984|NCT00689026|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
628985|NCT00689026|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
628986|NCT00689026|Cleansing|cleansing
628987|NCT00689026|Preparation|preparation
628988|NCT00689026|PEG|peg
628989|NCT00689026|Quality|quality
628990|NCT00689039|AZD1305|azd1305
628991|NCT00689039|safety|safety
628992|NCT00689039|pharmacokinetics|pharmacokinetics
628993|NCT00689039|multiple ascending doses|multiple ascending doses
628994|NCT00689039|Safety and pharmacokinetics|safety and pharmacokinetics
628995|NCT00689065|siRNA|sirna
628996|NCT00689065|RNA interference (RNAi)|rna interference (rnai)
628997|NCT00689065|Cyclodextrin|cyclodextrin
628998|NCT00689065|Cancer|cancer
628999|NCT00689065|Neoplasms|neoplasms
629000|NCT00689065|Solid Tumor|solid tumor
629001|NCT00689065|Ovarian Cancer|ovarian cancer
629002|NCT00689065|Lung Cancer|lung cancer
629003|NCT00689065|Non Small Cell Lung Cancer|non small cell lung cancer
629004|NCT00689065|Pancreatic Cancer|pancreatic cancer
629005|NCT00689065|Breast Cancer|breast cancer
629006|NCT00689065|Colon Cancer|colon cancer
629007|NCT00689065|Endometrial Cancer|endometrial cancer
629008|NCT00689065|Kidney (Renal Cell) Cancer|kidney (renal cell) cancer
629009|NCT00689065|Melanoma|melanoma
629010|NCT00689065|Prostate Cancer|prostate cancer
629011|NCT00689065|Skin Cancer|skin cancer
629012|NCT00689065|Thyroid Cancer|thyroid cancer
629013|NCT00689065|Solid Malignancies|solid malignancies
629014|NCT00689078|Allergic conjunctivitis|allergic conjunctivitis
629015|NCT00689091|Awareness|awareness
629016|NCT00689091|BIS Monitor|bis monitor
629017|NCT00689091|electronic alerts|electronic alerts
629018|NCT00689091|minimum|minimum
629019|NCT00689091|alveolar|alveolar
629020|NCT00689091|concentration|concentration
629021|NCT00689104|Overactive bladder (OAB)|overactive bladder (oab)
629022|NCT00689104|Frequency|frequency
629023|NCT00689104|Micturition|micturition
629024|NCT00689104|Urgency|urgency
629025|NCT00689104|Urinary incontinence|urinary incontinence
629026|NCT00689104|Urinary urge incontinence|urinary urge incontinence
629027|NCT00689104|YM178|ym178
629028|NCT00689117|Acne Vulgaris|acne vulgaris
629029|NCT00689117|Acne|acne
629030|NCT00689130|Analgesia|analgesia
629031|NCT00689130|Bispectral Index|bispectral index
629032|NCT00689130|BIS Variability|bis variability
629033|NCT00689130|Electroencephalography|electroencephalography
629034|NCT00689130|Electromyography|electromyography
629035|NCT00689130|Monitoring, Intraoperative|monitoring, intraoperative
629036|NCT00689130|Movement|movement
629037|NCT00689130|Pain, Postoperative|pain, postoperative
629038|NCT00689130|Somatic Events|somatic events
629039|NCT00689130|Patients under general anesthesia undergoing a moderately painful procedure.|patients under general anesthesia undergoing a moderately painful procedure.
629040|NCT00689156|Epirubicin|epirubicin
629041|NCT00689156|docetaxel|docetaxel
629042|NCT00689156|Adjuvant chemotherapy|adjuvant chemotherapy
629043|NCT00689156|DNA Topoisomerases, Type II|dna topoisomerases, type ii
629044|NCT00689169|Lymphoma|lymphoma
629045|NCT00689169|Lymphoma Diffuse|lymphoma diffuse
629046|NCT00689169|B-Cell lymphoma|b-cell lymphoma
629047|NCT00689169|Aggressive lymphoma|aggressive lymphoma
629048|NCT00689182|iron reduction|iron reduction
629049|NCT00689182|iron overload|iron overload
629050|NCT00689182|phlebotomy|phlebotomy
629051|NCT00689182|hematopoietic stem cell transplant|hematopoietic stem cell transplant
629052|NCT00689195|Curcumin|curcumin
629053|NCT00689195|Ashwagandha|ashwagandha
629054|NCT00689195|osteosarcoma|osteosarcoma
629055|NCT00689195|Pharmacokinetics of curcumin and ashwagandha formulation|pharmacokinetics of curcumin and ashwagandha formulation
629056|NCT00689195|response|response
629057|NCT00689208|Clamp|clamp
629058|NCT00689221|newly diagnosed Glioblastoma (WHO Grade IV)|newly diagnosed glioblastoma (who grade iv)
629059|NCT00689221|Cilengitide|cilengitide
629060|NCT00689221|Temozolomide|temozolomide
629061|NCT00689221|Radiotherapy|radiotherapy
629062|NCT00689247|AZD1305|azd1305
629064|NCT00689247|pharmacokinetic|pharmacokinetic
629065|NCT00689247|Absorption|absorption
629066|NCT00689247|distribution|distribution
629067|NCT00689247|metabolism|metabolism
629068|NCT00689247|excretion|excretion
629069|NCT00689273|PF-04136309 CCR2 osteoarthritic pain knee, phase 2 placebo multicenter double-blind placebo-controlled|pf-04136309 ccr2 osteoarthritic pain knee, phase 2 placebo multicenter double-blind placebo-controlled
629070|NCT00689286|Knee Osteoarthritis|knee osteoarthritis
629071|NCT00689286|Neuromuscular stimulator|neuromuscular stimulator
629072|NCT00689299|Sublingual Immunotherapy (SLIT)|sublingual immunotherapy (slit)
629073|NCT00689299|Non-seasonal allergic rhinitis|non-seasonal allergic rhinitis
629074|NCT00689299|Immunotherapy|immunotherapy
629075|NCT00689299|Allergic rhinitis|allergic rhinitis
629077|NCT00689299|Perennial allergy|perennial allergy
629078|NCT00689299|Non-seasonal allergy|non-seasonal allergy
629079|NCT00689312|Gastroenteritis|gastroenteritis
629080|NCT00689312|Pediatrics|pediatrics
629081|NCT00689312|Rehydration therapy|rehydration therapy
629082|NCT00689325|Schizophrenia|schizophrenia
629083|NCT00689325|remission|remission
629084|NCT00689325|subjective well-being and effectiveness|subjective well-being and effectiveness
629085|NCT00689325|Quality of Life|quality of life
629086|NCT00689338|Candida|candida
629087|NCT00689338|Candidemia|candidemia
629088|NCT00689338|Systemic Candidiasis|systemic candidiasis
629090|NCT00689338|Intensive Care Unit|intensive care unit
629091|NCT00689338|Critical Care Unit|critical care unit
629092|NCT00689338|Anidulafungin|anidulafungin
629093|NCT00689338|Ecalta|ecalta
629094|NCT00689338|Eraxis|eraxis
629095|NCT00689338|Fluconazole|fluconazole
629096|NCT00689338|Voriconazole|voriconazole
629097|NCT00689351|Prevention|prevention
629098|NCT00689351|against|against
629099|NCT00689351|pneumococcal|pneumococcal
629100|NCT00689351|disease|disease
629101|NCT00689351|Vaccine|vaccine
629102|NCT00689364|Cohort Study|cohort study
629103|NCT00689364|Colorectal Cancer|colorectal cancer
629104|NCT00689364|Traditional Chinese Medicine|traditional chinese medicine
629105|NCT00689364|Risk of recurrence and metastasis|risk of recurrence and metastasis
629106|NCT00689377|Peripheral Arterial Disease (PAD)|peripheral arterial disease (pad)
629107|NCT00689377|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
629108|NCT00689377|Atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
629109|NCT00689377|Atherosclerosis|atherosclerosis
629110|NCT00689377|Primary CVD prevention|primary cvd prevention
629111|NCT00689403|AZD1305|azd1305
629112|NCT00689403|pharmacokinetics|pharmacokinetics
629243|NCT00699634|Pain|pain
629113|NCT00689403|Properties of different ER formulations|properties of different er formulations
629114|NCT00689416|imaging biomarkers|imaging biomarkers
629115|NCT00689416|MRI|mri
629116|NCT00689416|FDG-PET/CT scanning|fdg-pet/ct scanning
629117|NCT00689416|Crestor|crestor
629118|NCT00689429|Pilon Fractures|pilon fractures
629119|NCT00689455|Metabolic Syndrome|metabolic syndrome
629120|NCT00689455|Lipids|lipids
629121|NCT00689455|Waist Circumference|waist circumference
629122|NCT00689468|Otitis media|otitis media
629123|NCT00689468|Echinacea|echinacea
629124|NCT00689468|Osteopathic Medicine|osteopathic medicine
629125|NCT00689481|Plaque-type Psoriasis|plaque-type psoriasis
629126|NCT00689481|psoriasis|psoriasis
629127|NCT00689494|Nanopaz device|nanopaz device
629128|NCT00689494|Blood progesterone measure in using the device|blood progesterone measure in using the device
629129|NCT00689494|Delivery progesterone|delivery progesterone
629130|NCT00689494|Progesterone levonorgestrel|progesterone levonorgestrel
629131|NCT00689507|Multiple Myeloma|multiple myeloma
629132|NCT00689507|Relapsed|relapsed
629133|NCT00689507|Refractory|refractory
629134|NCT00689507|Bortezomib|bortezomib
629135|NCT00689507|Velcade|velcade
629136|NCT00689520|Venous thromboembolism|venous thromboembolism
629137|NCT00689520|low molecular weight heparin|low molecular weight heparin
629138|NCT00689520|Vitamin K antagonist|vitamin k antagonist
629139|NCT00689520|Longterm|longterm
629140|NCT00689533|VEPTR|veptr
629141|NCT00689533|TIS|tis
629142|NCT00689533|scoliosis|scoliosis
629143|NCT00689533|juvenile|juvenile
629144|NCT00699062|antileukotriene|antileukotriene
629145|NCT00699062|small airway|small airway
629146|NCT00699062|airway remodeling|airway remodeling
629147|NCT00699062|HRCT|hrct
629148|NCT00699088|Total Hip Arthroplasty|total hip arthroplasty
629149|NCT00699088|Total Hip Replacement|total hip replacement
629150|NCT00699088|Minimally Invasive|minimally invasive
629151|NCT00699088|Microplasty|microplasty
629152|NCT00699101|Breast Cancer|breast cancer
629153|NCT00699101|Conture®|conture®
629154|NCT00699101|Brachytherapy|brachytherapy
629155|NCT00699114|Pain|pain
629156|NCT00699114|Analgesics|analgesics
629157|NCT00699114|Molar|molar
629158|NCT00699114|Third|third
629159|NCT00699114|Acetaminophen|acetaminophen
629160|NCT00699114|Paracetamol|paracetamol
629161|NCT00699114|Ibuprofen|ibuprofen
629162|NCT00699114|Codeine|codeine
629163|NCT00699114|Placebo|placebo
629164|NCT00699127|anxiety|anxiety
629165|NCT00699127|parents|parents
629166|NCT00699127|NICU|nicu
629168|NCT00699127|Anxiety of parents to NICU infants|anxiety of parents to nicu infants
629169|NCT00699166|IBS|ibs
629170|NCT00699166|Diarrhea|diarrhea
629171|NCT00699166|gastrointestinal functional disorder|gastrointestinal functional disorder
629172|NCT00699166|IBS-D|ibs-d
629173|NCT00699192|Blood pressure|blood pressure
629174|NCT00699192|hypertension|hypertension
629175|NCT00699192|elderly|elderly
629176|NCT00699218|Bipolar|bipolar
629177|NCT00699218|Depression|depression
629178|NCT00699218|TMS|tms
629179|NCT00699218|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
629180|NCT00699218|treatment|treatment
629181|NCT00699218|Efficacy|efficacy
629182|NCT00699218|Safety|safety
629183|NCT00699231|Hepatitis B|hepatitis b
629184|NCT00699231|Engerix™-B|engerix™-b
629185|NCT00699231|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
629186|NCT00699231|Adjuvant|adjuvant
629187|NCT00699244|forearm|forearm
629188|NCT00699244|hand|hand
629189|NCT00699244|elbow|elbow
629190|NCT00699244|wrist|wrist
629191|NCT00699244|brachial plexus|brachial plexus
629192|NCT00699244|infraclavicular block|infraclavicular block
629193|NCT00699257|Partial Knee Arthroplasty|partial knee arthroplasty
629194|NCT00699257|Partial Knee Replacement|partial knee replacement
629195|NCT00699257|Arthritis of Medial Compartment of the Knee|arthritis of medial compartment of the knee
629196|NCT00699257|Oxford Knee|oxford knee
629197|NCT00699270|Total Shoulder Arthroplasty|total shoulder arthroplasty
629198|NCT00699270|Total Shoulder Replacement|total shoulder replacement
629199|NCT00699270|Shoulder Arthritis|shoulder arthritis
629200|NCT00699283|Epilepsy; Monotherapy|epilepsy; monotherapy
629201|NCT00699283|Partial Onset Seizures|partial onset seizures
629202|NCT00699283|Adults and Adolescents|adults and adolescents
629203|NCT00699296|LBH589|lbh589
629204|NCT00699296|HDAC inhibitor|hdac inhibitor
629205|NCT00699296|cutaneous T-ceII lymphoma|cutaneous t-ceii lymphoma
629206|NCT00699296|adult T-cell leukemia|adult t-cell leukemia
629207|NCT00699309|Total Hip Replacement|total hip replacement
629208|NCT00699309|Total Hip Arthroplasty|total hip arthroplasty
629209|NCT00699309|Minimally Invasive|minimally invasive
629210|NCT00699309|Microplasty|microplasty
629211|NCT00699309|Hip Arthritis|hip arthritis
629212|NCT00699322|glucose variability|glucose variability
629213|NCT00699322|oxidative stress|oxidative stress
629214|NCT00699322|sitagliptin|sitagliptin
629215|NCT00699322|glimepiride|glimepiride
629216|NCT00699335|pain|pain
629217|NCT00699335|fentanyl|fentanyl
629218|NCT00699335|transdermal patch|transdermal patch
629219|NCT00699361|Pantoprazole|pantoprazole
629220|NCT00699361|congestive heart failure|congestive heart failure
629221|NCT00699374|sunitinib|sunitinib
629222|NCT00699374|phase 3|phase 3
629223|NCT00699374|randomized|randomized
629224|NCT00699374|hepatocellular|hepatocellular
629225|NCT00699374|liver|liver
629226|NCT00699387|Chagas disease|chagas disease
629227|NCT00699387|Pediatrics|pediatrics
629228|NCT00699387|benznidazole|benznidazole
629229|NCT00699387|population pharmacokinetics|population pharmacokinetics
629230|NCT00699387|neglected diseases|neglected diseases
629231|NCT00699387|parasitology|parasitology
629232|NCT00699387|pediatric clinical pharmacology|pediatric clinical pharmacology
629233|NCT00699608|Zopiclone|zopiclone
629234|NCT00699608|Hypnotic|hypnotic
629235|NCT00699608|Residual effects|residual effects
629236|NCT00699608|Eszopiclone|eszopiclone
629237|NCT00699621|Intracerebral hemorrhage|intracerebral hemorrhage
629238|NCT00699621|Hematoma enlargement|hematoma enlargement
629239|NCT00699621|Antiplatelet agent|antiplatelet agent
629240|NCT00699621|Platelet transfusion|platelet transfusion
629241|NCT00699621|Outcome|outcome
629242|NCT00699634|Neuropathic|neuropathic
629244|NCT00699634|Phantom|phantom
629245|NCT00699634|Limb|limb
629246|NCT00699660|Disability Examination|disability examination
629247|NCT00699660|Clinician Administered PTSD Scale|clinician administered ptsd scale
629248|NCT00699660|Quality of Care|quality of care
629249|NCT00699673|Brain natriuretic peptide|brain natriuretic peptide
629250|NCT00699673|EuroScore|euroscore
629251|NCT00699673|Cardiac surgery|cardiac surgery
629252|NCT00699673|Cardiopulmonary bypass|cardiopulmonary bypass
629253|NCT00699673|Coronary artery disease|coronary artery disease
629254|NCT00699673|Valvular disease|valvular disease
629255|NCT00699673|Risk stratification in cardiac surgery|risk stratification in cardiac surgery
629256|NCT00699686|Diabetes|diabetes
629257|NCT00699686|Insulin|insulin
629258|NCT00699686|Endothelium|endothelium
629259|NCT00699686|Cardiovascular disease|cardiovascular disease
629260|NCT00699686|Stem cells|stem cells
629261|NCT00699699|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
629262|NCT00699712|ADHF|adhf
629263|NCT00699712|AHF|ahf
629264|NCT00699712|HF|hf
629265|NCT00699725|Compliance|compliance
629266|NCT00699725|gastroprotector therapy|gastroprotector therapy
629267|NCT00699725|NSAID|nsaid
629268|NCT00699725|risk factors|risk factors
629269|NCT00699738|Healthy women during pregnancy and in the postpartum period|healthy women during pregnancy and in the postpartum period
629270|NCT00699751|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
629271|NCT00699751|Bone Metastases|bone metastases
629272|NCT00699751|Radium-223|radium-223
629273|NCT00699764|Herpes simplex candidate vaccine|herpes simplex candidate vaccine
629274|NCT00699764|Herpes simplex|herpes simplex
629275|NCT00699790|Diabetes|diabetes
629276|NCT00699790|NOS|nos
629277|NCT00699842|Myelodysplastic Syndrome|myelodysplastic syndrome
629278|NCT00699842|MDS|mds
629279|NCT00699842|Low to Intermediate-1 MDS|low to intermediate-1 mds
629280|NCT00699842|Non-deletion 5q|non-deletion 5q
629281|NCT00699842|Lenalidomide|lenalidomide
629282|NCT00699855|Growth Hormon Deficiency and|growth hormon deficiency and
629283|NCT00699855|Turner Syndrome in pre-pubertal children|turner syndrome in pre-pubertal children
629284|NCT00699855|Long term follow-up of predictive markers|long term follow-up of predictive markers
629285|NCT00699881|Time to Progression|time to progression
629286|NCT00699881|Toxicity|toxicity
629287|NCT00699881|Overall survival|overall survival
629288|NCT00699881|Response rate|response rate
629289|NCT00699881|Quality of live|quality of live
629290|NCT00699894|PONV|ponv
629291|NCT00699894|prevention of postoperative nausea and vomiting|prevention of postoperative nausea and vomiting
629292|NCT00699894|aprepitant|aprepitant
629293|NCT00699894|ondansetron|ondansetron
629294|NCT00699894|orthognathic surgery|orthognathic surgery
629295|NCT00699907|ovarian epithelial cancer|ovarian epithelial cancer
629296|NCT00699933|acute pancreatitis|acute pancreatitis
629297|NCT00699933|interventional therapy|interventional therapy
629298|NCT00699933|CT-guided drainage therapy|ct-guided drainage therapy
629299|NCT00699933|percutaneous necrosectomy|percutaneous necrosectomy
629300|NCT00699933|Comparison of different diagnostic procedures: MRI, CT, Ultrasound|comparison of different diagnostic procedures: mri, ct, ultrasound
629301|NCT00699933|Evaluation of interventional therapy including percutaneous drainage techniques und necrosectomies|evaluation of interventional therapy including percutaneous drainage techniques und necrosectomies
629302|NCT00699946|delirium, atypical antipsychotics, olanzapine, orthopedic|delirium, atypical antipsychotics, olanzapine, orthopedic
629303|NCT00699959|Coronary patients|coronary patients
629406|NCT00700310|E2007|e2007
629304|NCT00699959|heart failure|heart failure
629305|NCT00699959|dyslipidemia|dyslipidemia
629306|NCT00699972|E2007|e2007
629307|NCT00699972|perampanel|perampanel
629308|NCT00699972|refractory partial seizures|refractory partial seizures
629309|NCT00699972|adjunctive therapy|adjunctive therapy
629310|NCT00699972|seizure frequency|seizure frequency
629311|NCT00699972|partial onset seizures|partial onset seizures
629312|NCT00699972|reduction in seizure frequency|reduction in seizure frequency
629313|NCT00699972|safety|safety
629314|NCT00699972|concomitant AED(s)|concomitant aed(s)
629315|NCT00699985|Psychological Symptoms|psychological symptoms
629316|NCT00699985|Behcet's Disease|behcet's disease
629317|NCT00699998|ACS|acs
629318|NCT00700011|Myelodysplastic Syndromes|myelodysplastic syndromes
629319|NCT00700024|Body composition|body composition
629320|NCT00700024|Physical activity|physical activity
629321|NCT00700024|Metabolic syndrome|metabolic syndrome
629322|NCT00700050|Cystic Fibrosis|cystic fibrosis
629323|NCT00700050|Sex hormones|sex hormones
629324|NCT00700050|Pseudomonas aeruginosa|pseudomonas aeruginosa
629325|NCT00700050|Paediatrics|paediatrics
629326|NCT00700063|Peplin|peplin
629327|NCT00700063|Actinic keratosis|actinic keratosis
629328|NCT00700063|PEP005|pep005
629329|NCT00700076|ORG 25935|org 25935
629330|NCT00700076|Ketamine|ketamine
629331|NCT00700076|healthy subjects|healthy subjects
629332|NCT00700089|Attempted suicide|attempted suicide
629333|NCT00700089|Assertive intervention|assertive intervention
629334|NCT00700089|Prevention|prevention
629335|NCT00700089|Treatment|treatment
629336|NCT00700115|HAART|haart
629337|NCT00700115|lopinavir/ritonavir|lopinavir/ritonavir
629338|NCT00700115|raltegravir|raltegravir
629339|NCT00700115|HIV/AIDS patients on HAART|hiv/aids patients on haart
629340|NCT00700115|Treatment Experienced|treatment experienced
629341|NCT00700128|headaches|headaches
629342|NCT00700128|migraines|migraines
629343|NCT00700128|breakthrough bleeding|breakthrough bleeding
629344|NCT00700128|breakthrough spotting|breakthrough spotting
629345|NCT00700128|menstrually associated migraines|menstrually associated migraines
629346|NCT00700128|breakthrough bleeding or breakthrough spotting|breakthrough bleeding or breakthrough spotting
629347|NCT00700141|Tachosil|tachosil
629348|NCT00700141|thyroid|thyroid
629349|NCT00700141|parathyroid|parathyroid
629350|NCT00700141|fleece-bound hemostasispathologic processes|fleece-bound hemostasispathologic processes
629351|NCT00700141|hemorrhage|hemorrhage
629352|NCT00700141|thyroid surgery|thyroid surgery
629353|NCT00700154|Vascular Surgery|vascular surgery
629354|NCT00700154|Complications|complications
629355|NCT00700154|Hyperglycemia|hyperglycemia
629356|NCT00700154|Insulin infusion|insulin infusion
629357|NCT00700154|Diabetic ulcers|diabetic ulcers
629358|NCT00700154|Infection|infection
629359|NCT00700167|ANTIGENBEARING DENDRITIC CELLS|antigenbearing dendritic cells
629360|NCT00700167|98-098|98-098
629361|NCT00700206|Hematology|hematology
629362|NCT00700206|MDS|mds
630232|NCT00695682|CNV|cnv
629363|NCT00700206|Myelodysplastic Syndrome|myelodysplastic syndrome
629364|NCT00700206|Low Risk MDS|low risk mds
629365|NCT00700206|Intermediate-1 risk MDS|intermediate-1 risk mds
629366|NCT00700206|Int-1 risk MDS|int-1 risk mds
629367|NCT00700206|Telintra|telintra
629368|NCT00700206|ezatiostat hydrochloride|ezatiostat hydrochloride
629369|NCT00700206|ezatiostat|ezatiostat
629370|NCT00700206|TLK199|tlk199
629371|NCT00700206|Glutathione|glutathione
629372|NCT00700206|Glutathione analog|glutathione analog
629373|NCT00700206|Glutathione Transferase|glutathione transferase
629374|NCT00700206|Glutathione Transferase inhibitor|glutathione transferase inhibitor
629375|NCT00700206|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
629376|NCT00700206|GSTp1-1 inhibitor|gstp1-1 inhibitor
629377|NCT00700206|Apoptosis|apoptosis
629378|NCT00700206|Differentiation|differentiation
629379|NCT00700206|Enzyme inhibitor|enzyme inhibitor
629380|NCT00700219|Preterm Labor|preterm labor
629381|NCT00700219|Preterm Birth|preterm birth
629382|NCT00700219|Intra-amniotic Infection|intra-amniotic infection
629383|NCT00700219|Pregnancy|pregnancy
629384|NCT00700219|Women|women
629385|NCT00700232|genetics|genetics
629386|NCT00700232|gene expression|gene expression
629387|NCT00700232|MDR3|mdr3
629388|NCT00700232|estrogens|estrogens
629389|NCT00700232|cholestasis|cholestasis
629390|NCT00700232|pregnancy|pregnancy
629391|NCT00700232|controls|controls
629392|NCT00700245|Obese|obese
629393|NCT00700245|Adults|adults
629394|NCT00700271|Hypertension|hypertension
629395|NCT00700271|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
629396|NCT00700284|HIV-I|hiv-i
629397|NCT00700284|Reverse transcriptase inhibitors|reverse transcriptase inhibitors
629398|NCT00700284|HIV Seronegativity|hiv seronegativity
629399|NCT00700297|Oral aphthosis|oral aphthosis
629400|NCT00700297|Genital aphthosis|genital aphthosis
629401|NCT00700297|Psuedofolliculitis|psuedofolliculitis
629402|NCT00700297|Erythem nodusom|erythem nodusom
629403|NCT00700297|Joint manifestations|joint manifestations
629404|NCT00700297|Colchicine|colchicine
629405|NCT00700310|Partial onset seizures|partial onset seizures
629408|NCT00700310|refractory partial seizures|refractory partial seizures
629409|NCT00700310|adjunctive therapy|adjunctive therapy
629410|NCT00700310|seizure frequency|seizure frequency
629411|NCT00700310|reduction in seizure frequency|reduction in seizure frequency
629412|NCT00700310|safety|safety
629413|NCT00700310|concomitant AED(s)|concomitant aed(s)
629414|NCT00700323|ADHD|adhd
629415|NCT00700323|ADHD diagnosed children|adhd diagnosed children
629416|NCT00700336|malignant pleural mesothelioma|malignant pleural mesothelioma
629417|NCT00700336|solid tumors|solid tumors
629418|NCT00700349|depression|depression
629419|NCT00700349|stress|stress
629420|NCT00700349|microcredit|microcredit
629421|NCT00700349|poverty|poverty
629422|NCT00700349|South Africa|south africa
629423|NCT00700362|Complications|complications
629424|NCT00700362|Hyperglycemia|hyperglycemia
629425|NCT00700362|Insulin infusion|insulin infusion
629426|NCT00700375|Patients undergoing an emergent coronary procedure|patients undergoing an emergent coronary procedure
629427|NCT00700388|Chronic bronchitis|chronic bronchitis
629428|NCT00700388|COPD|copd
629429|NCT00700388|Bronchiectasis|bronchiectasis
629430|NCT00700427|ADHD|adhd
629431|NCT00700427|Adult|adult
629432|NCT00700427|long term|long term
629433|NCT00700427|maintenance of response|maintenance of response
629434|NCT00700427|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
629435|NCT00700440|Radiotherapy|radiotherapy
629436|NCT00700440|chemotherapy|chemotherapy
629437|NCT00700440|Drug Targeting|drug targeting
629438|NCT00700440|loco-regionally advanced nasopharyngeal carcinoma|loco-regionally advanced nasopharyngeal carcinoma
629439|NCT00700440|Safety.|safety.
629440|NCT00700440|efficacy|efficacy
629441|NCT00700466|Outcome assessment, patients;|outcome assessment, patients;
629442|NCT00700466|autonomic nervous system;|autonomic nervous system;
629443|NCT00700466|perioperative care;|perioperative care;
629444|NCT00700466|adrenergic beta antagonist|adrenergic beta antagonist
629445|NCT00700466|Autonomic regulation|autonomic regulation
629446|NCT00700466|Perioperative beta-blockade|perioperative beta-blockade
629447|NCT00700466|outcome|outcome
629448|NCT00700479|vascular endothelium|vascular endothelium
629449|NCT00700479|nitric oxide|nitric oxide
629450|NCT00700479|aldosterone|aldosterone
629451|NCT00700479|vascular biology|vascular biology
629452|NCT00700492|subfertility|subfertility
629453|NCT00700492|pregnancy rate|pregnancy rate
629454|NCT00700492|miscarriage|miscarriage
629455|NCT00700505|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
629456|NCT00700505|BPH|bph
629457|NCT00700505|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
629458|NCT00700505|Urinary Retention|urinary retention
629459|NCT00700505|Shy Bladder|shy bladder
629460|NCT00700505|Urinary Hesitancy|urinary hesitancy
629461|NCT00700505|Bashful Bladder|bashful bladder
629462|NCT00700505|Paruresis|paruresis
629463|NCT00700518|Raynaud's Syndrome|raynaud's syndrome
631108|NCT00692770|Sorafenib|sorafenib
629464|NCT00700518|Raynaud's Disease|raynaud's disease
629465|NCT00700518|RP|rp
629466|NCT00700531|Hemodialysis|hemodialysis
629467|NCT00700531|Multiple myeloma|multiple myeloma
629468|NCT00700531|Cast nephropathy|cast nephropathy
629469|NCT00700531|Kidney failure|kidney failure
629470|NCT00700544|AML|aml
629471|NCT00700544|elderly patients|elderly patients
629472|NCT00700544|Treatment outcome|treatment outcome
629473|NCT00700557|Antibiotic Associated Diarrhea|antibiotic associated diarrhea
629474|NCT00700557|probiotics|probiotics
629475|NCT00700557|treatment|treatment
629476|NCT00700583|nocturia|nocturia
629477|NCT00700583|bladder|bladder
629478|NCT00700583|urination disorders|urination disorders
629479|NCT00700583|hydrochlorothiazide|hydrochlorothiazide
629480|NCT00700583|terazosin|terazosin
629481|NCT00700596|Salvia|salvia
629482|NCT00700596|SA|sa
629483|NCT00700596|Salvinorin|salvinorin
629484|NCT00700596|Psychotomimetic Effects|psychotomimetic effects
629485|NCT00700609|Depression|depression
629486|NCT00700609|Family Therapy|family therapy
629487|NCT00700609|Adolescents|adolescents
629488|NCT00700635|Meningitis; Meningococcal infection, Neisseria meningitidis|meningitis; meningococcal infection, neisseria meningitidis
629489|NCT00700674|EEG entropy|eeg entropy
629490|NCT00700674|Elderly|elderly
629491|NCT00700674|Decreases|decreases
629492|NCT00700674|POCD|pocd
629493|NCT00700674|Use of EEG entropy|use of eeg entropy
629494|NCT00700674|Geriatric|geriatric
629495|NCT00700687|cardiovascular prophylactic therapy|cardiovascular prophylactic therapy
629496|NCT00700700|Congestive Heart Failure|congestive heart failure
629497|NCT00700700|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
629498|NCT00700700|Dyspnea|dyspnea
629499|NCT00700700|Exercise Tolerance|exercise tolerance
629500|NCT00700713|Meningitis|meningitis
629501|NCT00700713|Meningococcemia|meningococcemia
629502|NCT00700713|Neisseria meningitidis|neisseria meningitidis
629503|NCT00700713|Menactra®|menactra®
629504|NCT00700726|blood test|blood test
629505|NCT00700726|asthma|asthma
629506|NCT00700726|skin test|skin test
629507|NCT00700739|Cervical|cervical
629508|NCT00700739|Disc|disc
629509|NCT00700739|Arthroplasty|arthroplasty
629510|NCT00700739|Spinal|spinal
629511|NCT00700778|breast cancer|breast cancer
629512|NCT00700778|BRCA1 mutation carrier|brca1 mutation carrier
629513|NCT00700791|Single and bilateral body contouring surgical sites.|single and bilateral body contouring surgical sites.
629514|NCT00700804|Calcium retention|calcium retention
629515|NCT00700804|dietary protein|dietary protein
629516|NCT00700804|dietary calcium|dietary calcium
629517|NCT00700843|bariatric surgery|bariatric surgery
629518|NCT00700843|long term follow up|long term follow up
629519|NCT00700843|gastric partitioning surgery|gastric partitioning surgery
629520|NCT00700843|Roux-en-Y gastric bypass surgery|roux-en-y gastric bypass surgery
629521|NCT00700843|obesity|obesity
629522|NCT00700856|diabetes|diabetes
629523|NCT00700856|cardiovascular disease|cardiovascular disease
629524|NCT00700856|pioglitazone|pioglitazone
629525|NCT00700856|sulphonylurea|sulphonylurea
629526|NCT00700856|metformin monotherapy|metformin monotherapy
629527|NCT00700856|hypoglycemic therapy|hypoglycemic therapy
629528|NCT00700869|Altered level of consciousness|altered level of consciousness
629529|NCT00700869|Tracheal tube withdrawal|tracheal tube withdrawal
629530|NCT00700869|Respiration|respiration
629531|NCT00700869|Artificial Respiration|artificial respiration
629532|NCT00700869|Physiology|physiology
629533|NCT00700882|stage IV melanoma|stage iv melanoma
629534|NCT00700882|acral lentiginous malignant melanoma|acral lentiginous malignant melanoma
629535|NCT00700882|mucosal melanoma|mucosal melanoma
629536|NCT00700882|recurrent melanoma|recurrent melanoma
629537|NCT00700882|stage IIIA melanoma|stage iiia melanoma
629538|NCT00700882|stage IIIB melanoma|stage iiib melanoma
629539|NCT00700882|stage IIIC melanoma|stage iiic melanoma
629540|NCT00700908|type 2 diabetes|type 2 diabetes
629541|NCT00700908|telephone intervention|telephone intervention
629542|NCT00700908|automated|automated
629543|NCT00700934|FEV1|fev1
629544|NCT00700934|mortality|mortality
629545|NCT00700934|Quality of life|quality of life
629546|NCT00700947|Heart Disease|heart disease
629547|NCT00700947|Mitral Regurgitation|mitral regurgitation
629548|NCT00700947|Heart Valve Disease|heart valve disease
629549|NCT00700947|Mitral Valve Insufficiency|mitral valve insufficiency
629550|NCT00700947|Heart Surgery|heart surgery
629551|NCT00700947|Heart Valve Surgery|heart valve surgery
629552|NCT00700973|anger|anger
629553|NCT00700973|psychotherapy, brief|psychotherapy, brief
629554|NCT00700973|diagnosis, dual|diagnosis, dual
629555|NCT00700986|Electroretinography|electroretinography
629556|NCT00700986|Rheumatoid Arthritis|rheumatoid arthritis
629557|NCT00700986|Anti-TNF|anti-tnf
629558|NCT00700986|Disease Modifying Anti-Rheumatic Drugs (DMARD)|disease modifying anti-rheumatic drugs (dmard)
629559|NCT00701012|low or high ligation|low or high ligation
629560|NCT00701025|inflammation in asthmatic and non-asthmatic participants|inflammation in asthmatic and non-asthmatic participants
629561|NCT00701038|Sleep apnea,|sleep apnea,
629562|NCT00701038|obstructive sleep apnea,|obstructive sleep apnea,
629563|NCT00701038|heart failure,|heart failure,
629564|NCT00701038|CHF|chf
629565|NCT00701064|posttraumatic stress disorder|posttraumatic stress disorder
629566|NCT00701064|phototherapy|phototherapy
629567|NCT00701064|anxiety|anxiety
629568|NCT00701064|depression|depression
629569|NCT00701064|sleep|sleep
629570|NCT00701064|negative ion generator|negative ion generator
629571|NCT00701077|Brugada syndrome|brugada syndrome
629572|NCT00701077|Electrophysiological study|electrophysiological study
629573|NCT00701077|Ion channel blockade|ion channel blockade
629574|NCT00701090|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
629575|NCT00701090|Non Insulin Dependent|non insulin dependent
629576|NCT00701129|Glycogenesis 2|glycogenesis 2
629577|NCT00701129|Acid|acid
629578|NCT00701129|Maltase|maltase
629579|NCT00701129|Deficiency|deficiency
629580|NCT00701181|Phase II|phase ii
629581|NCT00701181|Prospective|prospective
629582|NCT00701181|Randomized|randomized
629583|NCT00701181|Diabetic Macular Edema|diabetic macular edema
629584|NCT00701181|PF-04523655|pf-04523655
629585|NCT00701181|Laser|laser
629586|NCT00701194|placement instability|placement instability
629587|NCT00701194|disruptive behavior disorders|disruptive behavior disorders
629588|NCT00701194|school readiness|school readiness
629589|NCT00701194|developmental delays|developmental delays
629590|NCT00701194|cortisol|cortisol
629591|NCT00701194|executive functioning|executive functioning
629592|NCT00701194|therapeutic foster care|therapeutic foster care
629593|NCT00701194|prevention|prevention
629594|NCT00701194|early intervention|early intervention
752368|NCT01172652|Generalized Anxiety Disorder|generalized anxiety disorder
629595|NCT00701207|To determine if nicotine treatment reduces lung inflammation|to determine if nicotine treatment reduces lung inflammation
629596|NCT00701220|Cardiovascular Disease|cardiovascular disease
629597|NCT00701220|Cardiomyopathy|cardiomyopathy
629598|NCT00701220|Heart Disease|heart disease
629599|NCT00701220|Myocardial Disease|myocardial disease
629600|NCT00701220|Myocardial Ischemia|myocardial ischemia
629601|NCT00701246|Anemia|anemia
629602|NCT00701246|Iron deficiency anemia|iron deficiency anemia
629603|NCT00701246|Infants|infants
629604|NCT00701246|Children|children
629998|NCT00694811|Diet|diet
629605|NCT00701246|Clinical trials|clinical trials
629606|NCT00701246|Ferrous sulfate|ferrous sulfate
629607|NCT00701246|Folic acid|folic acid
629608|NCT00701246|Daycare centers|daycare centers
629609|NCT00701246|Anaemia in children|anaemia in children
629610|NCT00701246|born at term|born at term
629611|NCT00701246|non-twins|non-twins
629612|NCT00701246|with parental approval for participation in the study|with parental approval for participation in the study
629614|NCT00701259|Frequent heartburn, proton pump inhibitor, lansoprazole|frequent heartburn, proton pump inhibitor, lansoprazole
629615|NCT00701259|Treatment of|treatment of
629616|NCT00701259|over 14 days|over 14 days
629617|NCT00701285|heart failure|heart failure
629618|NCT00701285|pitavastatin|pitavastatin
629619|NCT00701285|pravastatin|pravastatin
629620|NCT00701285|statin|statin
629621|NCT00701311|Prostatitis|prostatitis
629622|NCT00701311|Pelvic pain|pelvic pain
629623|NCT00701337|Estrogen Replacement Therapy|estrogen replacement therapy
629624|NCT00701337|menopausal women|menopausal women
629625|NCT00701350|Pregnancy|pregnancy
629626|NCT00701350|Intra-amniotic Infection|intra-amniotic infection
629627|NCT00701350|Preterm Birth|preterm birth
629628|NCT00701350|Preterm Premature Rupture of Membranes|preterm premature rupture of membranes
629629|NCT00701376|Gastric Bypass surgery|gastric bypass surgery
629630|NCT00701376|Hepatic disease|hepatic disease
629631|NCT00701376|Hepatic function|hepatic function
629632|NCT00701402|time to lipid-lowering drug implementation|time to lipid-lowering drug implementation
629633|NCT00701402|dyslipidemic patients|dyslipidemic patients
629634|NCT00701415|α-GAL, α-Galactosidase-A, r-hαGAL|α-gal, α-galactosidase-a, r-hαgal
629635|NCT00701428|Hypertension|hypertension
629636|NCT00701428|Sleep Apnea|sleep apnea
629637|NCT00701428|Angiotensin II antagonist|angiotensin ii antagonist
629638|NCT00701428|CPAP|cpap
629639|NCT00701441|sleep apnea,|sleep apnea,
629640|NCT00701441|oxidative stress|oxidative stress
629641|NCT00701454|Thai-muslim|thai-muslim
629642|NCT00701454|Thai-HALAL|thai-halal
629643|NCT00701454|Diabetes|diabetes
629644|NCT00701454|Hypertension|hypertension
629645|NCT00701454|Hyperlipidemia|hyperlipidemia
629646|NCT00701454|Metabolic syndrome|metabolic syndrome
629647|NCT00701467|ICD|icd
629648|NCT00701467|ICD implanted patients|icd implanted patients
629649|NCT00701480|acne|acne
629650|NCT00701480|skin cleanser|skin cleanser
629651|NCT00701480|Hibiscus sabdariffa|hibiscus sabdariffa
629652|NCT00701480|Roselle|roselle
629653|NCT00701480|safety|safety
629654|NCT00701480|efficacy|efficacy
629655|NCT00701493|Topiramate|topiramate
629656|NCT00701493|Topiramate oral liquid|topiramate oral liquid
629657|NCT00701493|TOPAMAX Sprinkle capsule|topamax sprinkle capsule
629658|NCT00701493|topiramate capsules|topiramate capsules
629659|NCT00701506|Knee|knee
629660|NCT00701506|Osteoarthritis|osteoarthritis
629661|NCT00701506|Treatment|treatment
629662|NCT00701506|Electrostimulation|electrostimulation
629663|NCT00701519|CHF,|chf,
629664|NCT00701519|Sleep apnea,|sleep apnea,
629665|NCT00701519|Obstructive sleep apnea,|obstructive sleep apnea,
629666|NCT00701519|Heart failure|heart failure
629667|NCT00701532|Cocaine|cocaine
629668|NCT00701532|Substance abuse|substance abuse
629669|NCT00701532|Addiction|addiction
629670|NCT00701532|Dependence|dependence
629671|NCT00701532|Modafinil|modafinil
629672|NCT00701532|Brain imaging|brain imaging
629673|NCT00701545|von Willebrand disease|von willebrand disease
629674|NCT00701545|VWD, Humate-P®|vwd, humate-p®
629675|NCT00701545|Infusion volume reduced|infusion volume reduced
629676|NCT00701545|ivr|ivr
629677|NCT00701571|Virtual Reality|virtual reality
629678|NCT00701571|Oncology|oncology
629679|NCT00701571|Lumbar puncture|lumbar puncture
629680|NCT00701584|Phytoestrogens|phytoestrogens
629681|NCT00701584|Isoflavones|isoflavones
629682|NCT00701584|Lignans|lignans
629683|NCT00701584|Breast cancer survival|breast cancer survival
629684|NCT00701584|breast cancer recurrence|breast cancer recurrence
629685|NCT00701597|ocular blood flow dysregulation, glaucoma, endothelin-1|ocular blood flow dysregulation, glaucoma, endothelin-1
629686|NCT00701610|Von Willebramd Factor (VWF)|von willebramd factor (vwf)
629687|NCT00701610|All infants born in our hospital since August 2007 ill august 2009 will enter.|all infants born in our hospital since august 2007 ill august 2009 will enter.
629688|NCT00701610|Therombocytopenia, maternal aspirin will be excluded|therombocytopenia, maternal aspirin will be excluded
629689|NCT00701623|The intention of this work is to verify the effectiveness and safety of sodium heparin in the treatment of burns of the skin.|the intention of this work is to verify the effectiveness and safety of sodium heparin in the treatment of burns of the skin.
629690|NCT00701636|Daptomycin|daptomycin
629691|NCT00701636|Antibiotic Prophylaxis|antibiotic prophylaxis
629692|NCT00701636|Pharmacokinetics|pharmacokinetics
629693|NCT00701636|Surgical Wound Infection|surgical wound infection
629694|NCT00701636|Staphylococcus aureus|staphylococcus aureus
629695|NCT00701636|Cardiopulmonary Bypass Surgery|cardiopulmonary bypass surgery
629696|NCT00701649|mild essential hypertension|mild essential hypertension
629697|NCT00701649|moderate essential hypertension|moderate essential hypertension
629698|NCT00701675|sertraline|sertraline
629699|NCT00701675|pharmacotherapy|pharmacotherapy
629700|NCT00701675|geriatric|geriatric
629701|NCT00701688|Mucositis, Oral|mucositis, oral
629702|NCT00701688|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
629703|NCT00701688|Allogeneic Transplantation|allogeneic transplantation
629704|NCT00701688|Pharmacokinetics|pharmacokinetics
629705|NCT00701688|Maximum Tolerated Dose|maximum tolerated dose
629706|NCT00701714|Treatment|treatment
629707|NCT00701714|associated|associated
629708|NCT00701714|with CRI|with cri
629709|NCT00701727|metabolic diseases|metabolic diseases
629710|NCT00701727|metabolic disorder|metabolic disorder
629711|NCT00701727|dyslipidemias|dyslipidemias
629712|NCT00701727|lipid metabolism disorders|lipid metabolism disorders
629713|NCT00701740|photoaging|photoaging
629714|NCT00701740|isotretinoin|isotretinoin
629715|NCT00701740|profilometry|profilometry
629716|NCT00701740|digital analysis|digital analysis
629717|NCT00701753|Pharmacogenetic|pharmacogenetic
629720|NCT00701753|Antipsychotic|antipsychotic
629721|NCT00701753|Olanzapine|olanzapine
629722|NCT00701753|Risperidone|risperidone
629723|NCT00701753|Quetiapine|quetiapine
629724|NCT00701753|Personalized medicine|personalized medicine
629725|NCT00701779|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
629726|NCT00701779|Dutasteride|dutasteride
629727|NCT00701779|Tamsulosin|tamsulosin
629728|NCT00701792|cirrhosis transplantation|cirrhosis transplantation
629729|NCT00701805|Secondary hyperparathyroidism|secondary hyperparathyroidism
629730|NCT00701805|Hemodialysis|hemodialysis
629731|NCT00701805|paricalcitol|paricalcitol
629732|NCT00701844|Aplastic Anemia|aplastic anemia
629733|NCT00701844|Lymphatic Diseases|lymphatic diseases
629734|NCT00701844|Leukemia|leukemia
629735|NCT00701844|Leukemia, Lymphoid|leukemia, lymphoid
629736|NCT00701844|Immunoproliferative Disorders|immunoproliferative disorders
629737|NCT00701844|Precursor Cell Lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
629738|NCT00701844|Anemia|anemia
629739|NCT00701844|Quality of Life|quality of life
629740|NCT00701844|Lymphoproliferative Disorders|lymphoproliferative disorders
629741|NCT00701844|Lymphoma|lymphoma
629742|NCT00701844|Multiple Myeloma|multiple myeloma
629743|NCT00701857|stage III esophageal cancer|stage iii esophageal cancer
629744|NCT00701857|stage IV esophageal cancer|stage iv esophageal cancer
629745|NCT00701870|NSCLC|nsclc
629746|NCT00701870|Chemotherapy induced neutropenia|chemotherapy induced neutropenia
629747|NCT00701870|CIN|cin
629748|NCT00701883|Cholesterol|cholesterol
629749|NCT00701883|Hyperlipidemia|hyperlipidemia
629750|NCT00701883|HDL|hdl
629751|NCT00701883|LDL|ldl
629752|NCT00701883|Triglycerides|triglycerides
629753|NCT00701883|Dyslipidemia|dyslipidemia
629754|NCT00701896|HIV|hiv
629755|NCT00701896|Positive|positive
629756|NCT00701896|Smokers|smokers
629757|NCT00701896|Varenicline|varenicline
629758|NCT00701909|wound care|wound care
630233|NCT00695682|AMD|amd
629759|NCT00701909|procedural pain intensity|procedural pain intensity
629760|NCT00701909|procedural hyperalgesia|procedural hyperalgesia
629761|NCT00701909|wound care pain intensity|wound care pain intensity
629762|NCT00701909|wound care hyperalgesia|wound care hyperalgesia
629763|NCT00701909|Wound care pain quality|wound care pain quality
629764|NCT00701909|Level of drowsiness|level of drowsiness
629765|NCT00701909|level of nausea|level of nausea
629766|NCT00701909|Level of vomiting|level of vomiting
629767|NCT00701909|Level of hallucinations|level of hallucinations
629768|NCT00701909|Level of dysphoria|level of dysphoria
629769|NCT00701922|lung transplantation|lung transplantation
629770|NCT00701922|Bronchiolitis Obliterans|bronchiolitis obliterans
629771|NCT00701922|Epstein-Barr Virus Infections|epstein-barr virus infections
629772|NCT00701922|Paramyxoviridae Infections|paramyxoviridae infections
629773|NCT00701922|Herpesviridae|herpesviridae
629774|NCT00701935|diabetes mellitus|diabetes mellitus
629775|NCT00701935|Amylin|amylin
629776|NCT00701935|Lilly|lilly
629777|NCT00701948|Late onset neonatal sepsis|late onset neonatal sepsis
629778|NCT00701948|Nosocomial bacterial infection|nosocomial bacterial infection
629779|NCT00701948|Inflammatory markers|inflammatory markers
629780|NCT00701948|multiplex dosage|multiplex dosage
629781|NCT00701961|Mefloquine-artesunate|mefloquine-artesunate
629782|NCT00701961|Malaria|malaria
629783|NCT00701961|Pregnancy|pregnancy
629784|NCT00701961|Pharmacokinetics|pharmacokinetics
629785|NCT00701961|Sub-Saharan Africa|sub-saharan africa
629786|NCT00701961|P falciparum malaria infection in pregnancy|p falciparum malaria infection in pregnancy
629787|NCT00701974|Non-inferiority based on efficiency|non-inferiority based on efficiency
629788|NCT00701987|Cutaneous Metastatic Melanoma|cutaneous metastatic melanoma
629789|NCT00702000|ICU acquired paresis|icu acquired paresis
629790|NCT00702013|P-glycoprotein|p-glycoprotein
629791|NCT00702013|lymphocyte|lymphocyte
629792|NCT00702013|HIV|hiv
629793|NCT00702013|children|children
629794|NCT00702013|ontogenesis|ontogenesis
629795|NCT00702013|Ontogenesis P-gp in human lymphocytes|ontogenesis p-gp in human lymphocytes
629796|NCT00702013|Study of the influence of HIV infection|study of the influence of hiv infection
629797|NCT00702013|Antiretroviral treatments on P-gp activity|antiretroviral treatments on p-gp activity
629798|NCT00702013|Expression in human lymphocytes|expression in human lymphocytes
629799|NCT00702026|Irritable Bowel Syndrome|irritable bowel syndrome
629800|NCT00702026|Hypersensitivity|hypersensitivity
629801|NCT00702026|Probiotics|probiotics
629802|NCT00702026|Multispecies|multispecies
629803|NCT00702052|Mantle Cell Lymphoma|mantle cell lymphoma
629804|NCT00702052|Lymphoma|lymphoma
629805|NCT00702052|B-Cell Lymphoma|b-cell lymphoma
629806|NCT00702052|Mantle Zone Lymphoma|mantle zone lymphoma
629807|NCT00702052|Refractory Lymphoma|refractory lymphoma
629808|NCT00702052|Aggressive Lymphoma|aggressive lymphoma
629809|NCT00702052|PILLAR-1|pillar-1
629810|NCT00702065|Multiple Sclerosis Quality of life|multiple sclerosis quality of life
629811|NCT00702078|COPD|copd
629812|NCT00702078|home-based treatment|home-based treatment
629813|NCT00702078|early intervention|early intervention
629814|NCT00694018|randomized trial|randomized trial
629815|NCT00694018|walking|walking
629816|NCT00694031|Mortality|mortality
629817|NCT00694031|Convective therapies|convective therapies
629818|NCT00694031|On-line Hemodiafiltration|on-line hemodiafiltration
629819|NCT00694031|Dialysis Adequacy|dialysis adequacy
629820|NCT00694031|Age 18 or older|age 18 or older
629821|NCT00694031|Undergoing hemodialysis|undergoing hemodialysis
629822|NCT00694044|Safety, Tolerability, Pharmacokinetics, Cognition|safety, tolerability, pharmacokinetics, cognition
629823|NCT00694057|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
629824|NCT00694057|Metformin|metformin
629825|NCT00694057|HbA1c|hba1c
629826|NCT00694109|Familial Hypercholesterolemia|familial hypercholesterolemia
629827|NCT00694109|FH|fh
629828|NCT00694109|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
629829|NCT00694109|HeFH|hefh
629830|NCT00694109|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
629831|NCT00694109|HoFH|hofh
629832|NCT00694122|glucose|glucose
629833|NCT00694122|cortisol|cortisol
629834|NCT00694122|growth hormone|growth hormone
629835|NCT00694122|glucagon|glucagon
629836|NCT00694122|insulin|insulin
629837|NCT00694135|Iontophoresis|iontophoresis
629838|NCT00694135|Non-Infectious Acute Anterior Segment Uveitis|non-infectious acute anterior segment uveitis
629839|NCT00694135|Ophthalmology|ophthalmology
629840|NCT00694148|Treatment of glabellar frown lines|treatment of glabellar frown lines
629841|NCT00694161|Transthyretin|transthyretin
629842|NCT00694161|TTR|ttr
629843|NCT00694161|ATTR|attr
629844|NCT00694161|TTR amyloidosis|ttr amyloidosis
629845|NCT00694161|cardiomyopathy|cardiomyopathy
629846|NCT00694161|V122I|v122i
629847|NCT00694161|wild-type TTR|wild-type ttr
629848|NCT00694161|SSA|ssa
629849|NCT00694161|Patients with V122I or wild-type TTR amyloid cardiomyopathy|patients with v122i or wild-type ttr amyloid cardiomyopathy
629850|NCT00694174|Procedural Pain in Newborn Infants|procedural pain in newborn infants
629851|NCT00694174|newborn infant|newborn infant
629852|NCT00694174|acute procedural pain|acute procedural pain
629853|NCT00694174|skin blood flow changes|skin blood flow changes
629854|NCT00694174|sucrose analgesia|sucrose analgesia
629855|NCT00694174|laser doppler imager|laser doppler imager
629856|NCT00694174|neonatal infant pain scale|neonatal infant pain scale
629857|NCT00694200|breast cancer|breast cancer
629858|NCT00694200|chemotherapy|chemotherapy
629859|NCT00694200|anti-angiogenesis therapy|anti-angiogenesis therapy
629860|NCT00694213|Pandemic Influenza|pandemic influenza
629861|NCT00694213|Avian Influenza|avian influenza
629862|NCT00694213|DNA Vaccines|dna vaccines
629863|NCT00694213|Antibody|antibody
629865|NCT00694213|HA/NP/M2|ha/np/m2
629866|NCT00694213|Biojector|biojector
629867|NCT00694226|Adolescent|adolescent
629868|NCT00694226|Substance use|substance use
629869|NCT00694226|Brief intervention|brief intervention
629870|NCT00694226|Child psychiatry|child psychiatry
629871|NCT00694239|hypertension|hypertension
629872|NCT00694239|compliance|compliance
629873|NCT00694252|Breast cancer|breast cancer
629874|NCT00694252|Tykerb|tykerb
629875|NCT00694252|CTCs|ctcs
629876|NCT00694265|Carpal Tunnel Syndrome|carpal tunnel syndrome
629877|NCT00694265|Median Nerve|median nerve
629878|NCT00694265|Ultrasonography|ultrasonography
629879|NCT00694265|Prospective cohort study|prospective cohort study
629880|NCT00694291|Rising PSA|rising psa
629881|NCT00694304|Major Depressive Disorder|major depressive disorder
629882|NCT00694304|Long-term|long-term
629883|NCT00694304|Safety|safety
629884|NCT00694304|Open-label|open-label
629885|NCT00694330|vaccine|vaccine
629886|NCT00694330|GM-K562|gm-k562
629887|NCT00694330|malignant glioma|malignant glioma
629888|NCT00694343|Cesarean section|cesarean section
629889|NCT00694343|spinal anesthesia|spinal anesthesia
629890|NCT00694343|hypotension|hypotension
629891|NCT00694369|Postoperative Dental Pain|postoperative dental pain
629892|NCT00694382|chemotherapy|chemotherapy
629893|NCT00694395|Qualitative study|qualitative study
629894|NCT00694395|stroke|stroke
629895|NCT00694395|20 patients, Family or caregivers|20 patients, family or caregivers
629896|NCT00694395|acute ischemic stroke|acute ischemic stroke
629897|NCT00694395|delayed to receive thrombolytic therapy.|delayed to receive thrombolytic therapy.
629898|NCT00694408|End stage liver disease|end stage liver disease
629899|NCT00694408|Paediatric liver transplantation|paediatric liver transplantation
752349|NCT01172600|epidural block|epidural block
629900|NCT00694408|Steroid free immunosuppression|steroid free immunosuppression
629901|NCT00694421|otitis|otitis
629902|NCT00694421|Eustachian tube|eustachian tube
629903|NCT00694421|virus|virus
629904|NCT00694421|Middle ear disease|middle ear disease
629905|NCT00694434|Cryopreservation|cryopreservation
629906|NCT00694434|Frozen embryo transfer|frozen embryo transfer
629907|NCT00694434|Graduated Embryo Score|graduated embryo score
629908|NCT00694460|rabies vaccination|rabies vaccination
629909|NCT00694460|pre-exposure prophylaxis|pre-exposure prophylaxis
629910|NCT00694460|rabies virus neutralizing antibody|rabies virus neutralizing antibody
629911|NCT00694473|hyperglycemia|hyperglycemia
629912|NCT00694473|hypoglycemia|hypoglycemia
629913|NCT00694473|insulin|insulin
629914|NCT00694473|critical illness|critical illness
629915|NCT00694473|intensive insulin therapy|intensive insulin therapy
629916|NCT00694473|continuous glucose monitoring|continuous glucose monitoring
629917|NCT00694473|CGM|cgm
629918|NCT00694473|interstitial fluid glucose|interstitial fluid glucose
629919|NCT00694473|intensive care unit|intensive care unit
629920|NCT00694473|Blood glucose|blood glucose
629921|NCT00694486|otitis|otitis
629922|NCT00694486|Eustachian tube function|eustachian tube function
629923|NCT00694486|Normal middle ear status|normal middle ear status
629924|NCT00694499|Morbidity|morbidity
629925|NCT00694499|Mortality|mortality
629926|NCT00694525|21OHD|21ohd
629927|NCT00694525|21-hydroxylase deficiency|21-hydroxylase deficiency
629928|NCT00694525|CAH|cah
629929|NCT00694538|Interferential laser therapy|interferential laser therapy
629930|NCT00694551|vaccine|vaccine
629931|NCT00694551|PSMA|psma
629932|NCT00694551|TARP|tarp
629933|NCT00694551|immunology|immunology
629934|NCT00694551|PSA|psa
629935|NCT00694564|abdominal pain|abdominal pain
629936|NCT00694564|children|children
629937|NCT00694577|non-invasive breast cancer|non-invasive breast cancer
629938|NCT00694577|early invasive breast cancer|early invasive breast cancer
629939|NCT00694577|radiation|radiation
629940|NCT00694577|PBI|pbi
629941|NCT00694590|AMD3100|amd3100
629942|NCT00694590|Rituximab|rituximab
629943|NCT00694590|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
629944|NCT00694590|CLL|cll
629945|NCT00694590|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
629946|NCT00694590|SLL|sll
629947|NCT00694603|cetuximab|cetuximab
629948|NCT00694603|tyrosine kinase inhibitor|tyrosine kinase inhibitor
629949|NCT00694616|Obstructive sleep apnea|obstructive sleep apnea
629950|NCT00694616|Metabolic syndrome|metabolic syndrome
629951|NCT00694616|Insulin resistance|insulin resistance
629952|NCT00694616|Hypertension|hypertension
629953|NCT00694616|Dyslipidemia|dyslipidemia
630234|NCT00695695|Parents|parents
629954|NCT00694616|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
629955|NCT00694629|pulmonary tuberculosis|pulmonary tuberculosis
629956|NCT00694629|treatment|treatment
629957|NCT00694642|Refractory angina|refractory angina
629958|NCT00694655|Yellow Fever|yellow fever
629959|NCT00694655|Vaccine|vaccine
629960|NCT00694655|Immunity|immunity
629961|NCT00694655|yellow fever vaccine|yellow fever vaccine
629962|NCT00694655|CD8 T cell responses|cd8 t cell responses
629963|NCT00694668|Deliberate Self-Harm|deliberate self-harm
629964|NCT00694668|Self-Injurious Behaviour|self-injurious behaviour
629965|NCT00694668|Suicidal Behaviour|suicidal behaviour
629966|NCT00694668|Cognitive behavioural therapy|cognitive behavioural therapy
629967|NCT00694668|Mindfulness Based cognitive therapy|mindfulness based cognitive therapy
629968|NCT00694681|Telephonic care management|telephonic care management
629969|NCT00694694|Malaria|malaria
629970|NCT00694694|Africa|africa
629971|NCT00694694|Child|child
629972|NCT00694720|Cheyne-stokes breathing|cheyne-stokes breathing
629973|NCT00694733|Obesity|obesity
629974|NCT00694733|Menopausal Syndrome|menopausal syndrome
629975|NCT00694733|Cortisol|cortisol
629976|NCT00694746|ALT|alt
629977|NCT00694746|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
629978|NCT00694746|Adolescents|adolescents
629979|NCT00694746|Overweight|overweight
629980|NCT00694746|Treatment|treatment
629981|NCT00694759|Polycystic ovary syndrome|polycystic ovary syndrome
629982|NCT00694759|insulin|insulin
629983|NCT00694759|PCOS|pcos
629984|NCT00694759|cortisol regulation|cortisol regulation
629985|NCT00694759|regulation|regulation
629986|NCT00694772|Obstructive sleep apnea|obstructive sleep apnea
629987|NCT00694772|OSA|osa
629988|NCT00694772|Apnea hypopnea index|apnea hypopnea index
629989|NCT00694772|AHI|ahi
629990|NCT00694772|Coblation|coblation
629991|NCT00694772|Electrocautery|electrocautery
629992|NCT00694772|Tonsillectomy|tonsillectomy
629993|NCT00694772|Tonsillotomy|tonsillotomy
629994|NCT00694798|STCC|stcc
629995|NCT00694798|Superficial Transitional Cell Carcinoma- BCG refractor|superficial transitional cell carcinoma- bcg refractor
629996|NCT00694811|Obesity|obesity
629997|NCT00694811|Weight loss|weight loss
629999|NCT00694811|Very-low-energy diet|very-low-energy diet
630000|NCT00694811|Predictive factors|predictive factors
630001|NCT00694811|Re-feeding|re-feeding
630002|NCT00694824|Coronary artery calcification|coronary artery calcification
630003|NCT00694824|calcium score|calcium score
630004|NCT00694824|(TGF) b1,|(tgf) b1,
630005|NCT00694824|fetuin A|fetuin a
630006|NCT00694824|osteoprotegerin (OPG)|osteoprotegerin (opg)
630007|NCT00694824|fibroblast growth factor (FGF) 23,|fibroblast growth factor (fgf) 23,
630008|NCT00694824|matrix gla protein (MGP)|matrix gla protein (mgp)
630009|NCT00694824|hemodialysis patients|hemodialysis patients
630010|NCT00694837|glioblastoma|glioblastoma
630011|NCT00694837|nelfinavir|nelfinavir
630012|NCT00694837|functional imaging|functional imaging
630013|NCT00694837|AKT pathway|akt pathway
630014|NCT00694850|Interstitial lung disease associated pulmonary hypertension|interstitial lung disease associated pulmonary hypertension
630015|NCT00694863|high risk for ESRD|high risk for esrd
630016|NCT00694863|immunosuppressive treatment|immunosuppressive treatment
630017|NCT00694863|membranous nephropathy|membranous nephropathy
630018|NCT00694863|ACTH|acth
630019|NCT00694876|Health Literacy|health literacy
630020|NCT00694876|Patient Nonadherence|patient nonadherence
630021|NCT00694876|Patient Noncompliance|patient noncompliance
630022|NCT00694876|Follow Up|follow up
630023|NCT00694876|India|india
630024|NCT00694876|Glaucoma|glaucoma
630025|NCT00694889|Psychosis|psychosis
630026|NCT00694889|First Episode|first episode
630027|NCT00694889|Schizophrenia|schizophrenia
630028|NCT00694889|Cognitive Remediation|cognitive remediation
630029|NCT00694902|Healthy Volunteers|healthy volunteers
630030|NCT00694915|STCC (Superficial Transitional Cell Carcinoma)|stcc (superficial transitional cell carcinoma)
630031|NCT00694941|ONO-2506PO|ono-2506po
630032|NCT00694941|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
630033|NCT00694941|ALS|als
630034|NCT00694954|Iron deficiency anemia|iron deficiency anemia
630035|NCT00694954|Wireless capsule endoscopy|wireless capsule endoscopy
630036|NCT00694954|Obscure-occult gastrointestinal bleeding|obscure-occult gastrointestinal bleeding
630037|NCT00694967|short cervix, cervical funneling, spontaneous preterm birth, cerclage, progesterone|short cervix, cervical funneling, spontaneous preterm birth, cerclage, progesterone
630038|NCT00694980|UC|uc
630039|NCT00694980|Ulcerative Colitis|ulcerative colitis
630040|NCT00694993|first time in human|first time in human
630041|NCT00694993|Allergic rhinitis,|allergic rhinitis,
630042|NCT00695006|manual therapy, cervical traction, cervical radiculopathy|manual therapy, cervical traction, cervical radiculopathy
630043|NCT00695019|Prevention of Relapse|prevention of relapse
630044|NCT00695019|HCV genotype 1b|hcv genotype 1b
630045|NCT00695019|Recurrence|recurrence
630046|NCT00695032|renal toxicity|renal toxicity
630047|NCT00695032|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
630048|NCT00695032|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
630049|NCT00695045|Pain, Postoperative|pain, postoperative
630050|NCT00695045|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
630051|NCT00695045|Morphine|morphine
630052|NCT00695045|Injections, Intrathecal|injections, intrathecal
630053|NCT00695058|Stress incontinence|stress incontinence
630054|NCT00695058|urge incontinence|urge incontinence
630055|NCT00695058|overactive bladder syndrome|overactive bladder syndrome
630056|NCT00695058|vibration|vibration
630057|NCT00695058|nerve stimulation|nerve stimulation
630058|NCT00695071|Healthy Volunteers|healthy volunteers
630059|NCT00695084|multiple sclerosis|multiple sclerosis
630060|NCT00695097|Rituximab|rituximab
630061|NCT00695097|Renal Transplant Rejection|renal transplant rejection
630062|NCT00695097|B cells|b cells
630063|NCT00695097|Patients with biopsy proven acute rejection cellular infiltrate, B cells|patients with biopsy proven acute rejection cellular infiltrate, b cells
630064|NCT00695110|testosterone|testosterone
630065|NCT00695110|male hypogonadism|male hypogonadism
630066|NCT00695110|low testosterone|low testosterone
630067|NCT00695123|Bone Marrow Transplant|bone marrow transplant
630068|NCT00695123|Sickle Cell Disease|sickle cell disease
630069|NCT00695123|G-CSF|g-csf
630070|NCT00695123|Apheresis|apheresis
630071|NCT00695123|SD|sd
630072|NCT00695123|Healthy Volunteer|healthy volunteer
630073|NCT00695123|HV|hv
630074|NCT00695136|Autism|autism
630075|NCT00695136|Cognitive Disorder|cognitive disorder
630076|NCT00695136|Sleep|sleep
630077|NCT00695136|Autism Spectrum Disorder|autism spectrum disorder
630078|NCT00695136|ASD|asd
630079|NCT00695149|Spinal cord Injury|spinal cord injury
630080|NCT00695149|Central nervous system|central nervous system
630081|NCT00695149|Regeneration|regeneration
630082|NCT00695149|Bone marrow stromal cells|bone marrow stromal cells
630083|NCT00695149|Transplantation|transplantation
630084|NCT00695162|noise|noise
630085|NCT00695162|speech intelligibility|speech intelligibility
630086|NCT00695162|cognition|cognition
630087|NCT00695175|Hypertension|hypertension
630088|NCT00695175|Private cardiology consultation|private cardiology consultation
630089|NCT00695175|Patients with hypertension|patients with hypertension
630090|NCT00695188|rheumatoid arthritis|rheumatoid arthritis
630756|NCT00703677|tau|tau
630091|NCT00695188|MTX polyglutamates|mtx polyglutamates
630092|NCT00695188|clinical outcome|clinical outcome
630093|NCT00695201|DEXAMETHASONE|dexamethasone
630094|NCT00695201|FLOXURIDINE|floxuridine
630095|NCT00695201|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
630096|NCT00695201|OXALIPLATIN|oxaliplatin
630097|NCT00695214|Obstructive Sleep Apnea|obstructive sleep apnea
630098|NCT00695214|Propofol|propofol
630099|NCT00695214|Sleep Endoscopy|sleep endoscopy
630100|NCT00695227|laryngopharyngeal reflux|laryngopharyngeal reflux
630101|NCT00695227|extraesophageal reflux symptoms|extraesophageal reflux symptoms
630102|NCT00695240|Continuous bupivacaine infusion|continuous bupivacaine infusion
630103|NCT00695240|Analgesia|analgesia
630104|NCT00695253|AAA|aaa
630105|NCT00695279|Gene therapy|gene therapy
630106|NCT00695292|Small Cell Lung Cancer|small cell lung cancer
630107|NCT00695292|Extensive Stage|extensive stage
630108|NCT00695292|irinotecan|irinotecan
630109|NCT00695292|carboplatin|carboplatin
630110|NCT00695292|sunitinib|sunitinib
630111|NCT00695305|rilapladib,|rilapladib,
630112|NCT00695305|Lp-PLA2,|lp-pla2,
630113|NCT00695305|atherosclerosis|atherosclerosis
630114|NCT00695305|SB-659032,|sb-659032,
630115|NCT00695305|FDG-PET,|fdg-pet,
630116|NCT00695318|AMD|amd
630117|NCT00695318|Age-Related Macular Degeneration|age-related macular degeneration
630118|NCT00695318|Geographic Atrophy|geographic atrophy
630119|NCT00695318|GA|ga
630120|NCT00695331|Labor Augmentation|labor augmentation
630121|NCT00695331|Misoprostol|misoprostol
630122|NCT00695331|Oxytocin|oxytocin
630123|NCT00695344|Effect of everolimus in graft vascular cardiac illness|effect of everolimus in graft vascular cardiac illness
630124|NCT00695357|Asthma treatment|asthma treatment
630125|NCT00695357|GINA 2006|gina 2006
630126|NCT00695357|patient perception|patient perception
630127|NCT00695370|Children|children
630128|NCT00695370|cancer|cancer
630129|NCT00695370|Bone marrow transplantation|bone marrow transplantation
630130|NCT00695370|Mobilization|mobilization
630131|NCT00695370|G-CSF|g-csf
630132|NCT00695370|Children with solid malignancies|children with solid malignancies
630133|NCT00695383|Exercise therapy|exercise therapy
630134|NCT00695383|Physiotherapy|physiotherapy
630135|NCT00695383|Critical illness|critical illness
630136|NCT00695383|Intensive care|intensive care
630137|NCT00695383|Muscle weakness|muscle weakness
630138|NCT00695383|Mechanical ventilation|mechanical ventilation
630139|NCT00695396|MDS|mds
630140|NCT00695396|Myelodysplastic syndromes|myelodysplastic syndromes
630141|NCT00695396|Anemia|anemia
630142|NCT00695396|Epoetin alfa|epoetin alfa
630143|NCT00695396|EPO|epo
630144|NCT00695409|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
630145|NCT00695409|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
630146|NCT00695409|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
630147|NCT00695409|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
630532|NCT00702806|Hormones|hormones
630148|NCT00695409|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
630149|NCT00695409|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
630150|NCT00695409|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
630151|NCT00695409|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
630152|NCT00695409|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
630153|NCT00695409|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
630154|NCT00695409|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
630155|NCT00695409|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
630156|NCT00695409|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
630157|NCT00695409|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
630158|NCT00695409|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
630159|NCT00695409|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
630160|NCT00695409|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
630161|NCT00695409|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
630162|NCT00695422|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
630163|NCT00695422|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
630164|NCT00695422|human papilloma virus infection|human papilloma virus infection
630165|NCT00695422|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
630166|NCT00695422|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
631449|NCT00699504|ECG|ecg
630167|NCT00695422|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
630168|NCT00695422|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
630169|NCT00695422|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
630170|NCT00695422|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
630171|NCT00695422|AIDS-related malignancies|aids-related malignancies
630172|NCT00695422|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
630173|NCT00695422|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
630174|NCT00695422|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
632616|NCT00712582|Doxorubicin|doxorubicin
630175|NCT00695422|multicentric Castleman disease|multicentric castleman disease
630176|NCT00695422|HIV Infections|hiv infections
630177|NCT00695435|normal volunteers|normal volunteers
630178|NCT00695435|anti-infective|anti-infective
630179|NCT00695435|tobramycin|tobramycin
630180|NCT00695448|Phosphoinositide 3-kinase inhibitor|phosphoinositide 3-kinase inhibitor
630181|NCT00695448|solid tumors|solid tumors
630182|NCT00695461|Colorectal surgery|colorectal surgery
630183|NCT00695461|Probiotics|probiotics
630184|NCT00695461|Lactobacillus|lactobacillus
630185|NCT00695461|Bacterial translocation|bacterial translocation
630186|NCT00695461|Postoperative complications|postoperative complications
630187|NCT00695461|Inflammatory reaction|inflammatory reaction
630188|NCT00695474|Hypovitaminosis D|hypovitaminosis d
630189|NCT00695474|Type 2 diabetes|type 2 diabetes
630190|NCT00695474|Glycemic control|glycemic control
630191|NCT00695474|Inflammation|inflammation
630192|NCT00695474|Blood pressure|blood pressure
630193|NCT00695487|Anesthesia|anesthesia
630195|NCT00695487|Postoperative Nausea|postoperative nausea
630196|NCT00695500|Varenicline|varenicline
630197|NCT00695500|Alcohol|alcohol
630198|NCT00695500|Alcohol Use|alcohol use
630199|NCT00695513|Food supplement|food supplement
630200|NCT00695513|Haemodialysis|haemodialysis
630201|NCT00695526|cranberry|cranberry
630202|NCT00695526|total to HDL cholesterol ratio|total to hdl cholesterol ratio
630203|NCT00695526|type 2 diabetes|type 2 diabetes
630204|NCT00695539|Rosuvastatin|rosuvastatin
630205|NCT00695539|hypercholesterolaemia|hypercholesterolaemia
630206|NCT00695552|Major depression, exercise|major depression, exercise
630207|NCT00695591|Home sleep testing neuromuscular disease|home sleep testing neuromuscular disease
630208|NCT00695591|Neuromuscular disease patients with FEV1<50% of predicted|neuromuscular disease patients with fev1<50% of predicted
630209|NCT00695604|Acute asthma|acute asthma
630210|NCT00695604|fluticasone|fluticasone
630211|NCT00695604|inhaled corticosteroids|inhaled corticosteroids
630212|NCT00695617|MARS treatment|mars treatment
630213|NCT00695617|Citrate anticoagulation|citrate anticoagulation
630214|NCT00695630|conscious sedation|conscious sedation
630215|NCT00695630|dental anxiety/drug therapy|dental anxiety/drug therapy
630216|NCT00695630|behavior/drug effects|behavior/drug effects
630217|NCT00695656|Hypertension|hypertension
630218|NCT00695656|general practitioner consultation|general practitioner consultation
630219|NCT00695656|Patients with hypertension|patients with hypertension
630220|NCT00695669|H5N1|h5n1
630221|NCT00695669|immunogenicity|immunogenicity
630222|NCT00695669|influenza|influenza
630223|NCT00695669|Avian|avian
630224|NCT00695669|pandemic|pandemic
630225|NCT00695669|vaccines|vaccines
630226|NCT00695669|human|human
630227|NCT00695669|safety|safety
630228|NCT00695682|Remicade|remicade
630229|NCT00695682|Infliximab|infliximab
630230|NCT00695682|CSME|csme
630231|NCT00695682|BDR|bdr
630235|NCT00695695|Down Syndrome|down syndrome
630236|NCT00695695|Hope|hope
630237|NCT00695695|Uncertainty|uncertainty
630238|NCT00695695|Adaptation|adaptation
630239|NCT00695695|DS|ds
630240|NCT00695695|Survey|survey
630241|NCT00695708|schizophrenia|schizophrenia
630242|NCT00695708|neuroplasticity|neuroplasticity
630243|NCT00695708|sensory gating|sensory gating
630244|NCT00695708|cognitive impairment|cognitive impairment
630245|NCT00695708|MEG|meg
630246|NCT00695708|Disorders with Psychotic Features|disorders with psychotic features
630247|NCT00695734|hemodialysis|hemodialysis
630248|NCT00695734|end stage renal failure|end stage renal failure
630249|NCT00695734|tuberculosis|tuberculosis
630250|NCT00695734|latent tuberculosis infection|latent tuberculosis infection
630251|NCT00695734|Patients under hemodialysis for end stage renal failure|patients under hemodialysis for end stage renal failure
630252|NCT00695747|Glaucoma|glaucoma
630253|NCT00695747|Cataracts|cataracts
630254|NCT00695747|Phacoemulsification(IOL)|phacoemulsification(iol)
630255|NCT00695747|Trabeculectomy|trabeculectomy
630256|NCT00695773|Prostate Cancer Surgery|prostate cancer surgery
630257|NCT00695773|Laparoscopic surgery for Prostate Cancer|laparoscopic surgery for prostate cancer
630258|NCT00695773|Prostatectomy|prostatectomy
630259|NCT00695773|Urologic Surgical Procedures|urologic surgical procedures
630260|NCT00695786|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
630261|NCT00695786|Lymphoma|lymphoma
630262|NCT00695786|Lenalidomide|lenalidomide
630263|NCT00695786|Revlimid|revlimid
630264|NCT00695786|Rituximab|rituximab
630265|NCT00695786|Rituxan|rituxan
630266|NCT00695799|Propofol|propofol
630267|NCT00695799|Anesthesia care provider|anesthesia care provider
630268|NCT00695799|Pollution|pollution
630269|NCT00695799|Operating room|operating room
630270|NCT00695799|Environment|environment
630271|NCT00695812|Neurodevelopmental disorders|neurodevelopmental disorders
630272|NCT00695812|Autism Spectrum Disorders|autism spectrum disorders
630273|NCT00695812|Broader autism phenotype|broader autism phenotype
630274|NCT00695812|Siblings|siblings
630376|NCT00696306|Susceptibility Weighted Imaging|susceptibility weighted imaging
630275|NCT00695812|Cognitive language and social emotional development|cognitive language and social emotional development
752350|NCT01172600|steroid|steroid
630276|NCT00695812|to identify siblings who manifest any autism or broader autism phenotype characteristics|to identify siblings who manifest any autism or broader autism phenotype characteristics
630277|NCT00695838|GERD symptoms- Waist circumference|gerd symptoms- waist circumference
630278|NCT00695838|Patients with symptomatic GERD|patients with symptomatic gerd
630280|NCT00695851|Prostate|prostate
630281|NCT00695877|HIV Seronegativity|hiv seronegativity
630282|NCT00695877|HIV Preventive Vaccine|hiv preventive vaccine
630283|NCT00695890|Pupillometry|pupillometry
630284|NCT00695890|Sevoflorane|sevoflorane
630285|NCT00695890|Propofol|propofol
630286|NCT00695903|Gram-positive bacterial infections|gram-positive bacterial infections
630287|NCT00695903|Staph Aureus|staph aureus
630288|NCT00695903|Bacteremia|bacteremia
630289|NCT00695903|MRSA|mrsa
630290|NCT00695903|Infective Endocarditis|infective endocarditis
630291|NCT00695903|Right-sided Infective endocarditis|right-sided infective endocarditis
630292|NCT00695903|SABIE|sabie
630293|NCT00695903|SAIE|saie
630294|NCT00695903|RIE|rie
630295|NCT00695929|cardiac surgery with cardiopulmonary bypass|cardiac surgery with cardiopulmonary bypass
630296|NCT00695942|preeclampsia|preeclampsia
630297|NCT00695942|eclampsia|eclampsia
630298|NCT00695942|retroplacental hematoma|retroplacental hematoma
630299|NCT00695942|vascular IUGR|vascular iugr
630300|NCT00695942|IUFD|iufd
630301|NCT00695942|VTE|vte
630302|NCT00695955|Essential Hypertension|essential hypertension
630303|NCT00695955|Cardiovascular Disease|cardiovascular disease
630304|NCT00695955|High Blood Pressure|high blood pressure
630305|NCT00695955|Drug Therapy|drug therapy
630306|NCT00695981|Rotator cuff|rotator cuff
630307|NCT00695981|Arthroscopic surgery|arthroscopic surgery
630308|NCT00695981|Open surgery|open surgery
630309|NCT00695981|Physiotherapy|physiotherapy
630310|NCT00695981|Physical therapy|physical therapy
630311|NCT00695981|Effectiveness|effectiveness
630312|NCT00695981|RCT|rct
630313|NCT00695981|cost-effectiveness|cost-effectiveness
630314|NCT00696007|Upper GU Tract Transitional Cell Carinoma|upper gu tract transitional cell carinoma
630315|NCT00696007|Nephroureterectomy|nephroureterectomy
630316|NCT00696007|Chemotherapy|chemotherapy
630317|NCT00696007|Gemcitabine|gemcitabine
630318|NCT00696007|Cisplatin|cisplatin
630319|NCT00696033|Benzodiazepines|benzodiazepines
630320|NCT00696033|Lorazepam|lorazepam
630321|NCT00696033|Diazepam|diazepam
630322|NCT00696033|Memory|memory
630323|NCT00696033|Perceptual priming|perceptual priming
630324|NCT00696033|Functional brain imaging|functional brain imaging
630325|NCT00696033|FMRI|fmri
630326|NCT00696046|CORD BLOOD CELLS|cord blood cells
630327|NCT00696046|INTRA BONE MARROW INJECTION|intra bone marrow injection
630328|NCT00696046|ENGRAFTMENT|engraftment
630329|NCT00696046|transplants|transplants
630330|NCT00696059|Rheumatoid arthritis|rheumatoid arthritis
630331|NCT00696059|Computed tomography|computed tomography
630332|NCT00696059|Magnetic resonance imaging|magnetic resonance imaging
630334|NCT00696059|Tumor necrosis factor alpha antagonists|tumor necrosis factor alpha antagonists
630335|NCT00696085|fetal alcohol exposure|fetal alcohol exposure
630336|NCT00696085|blood markers of alcohol use|blood markers of alcohol use
630337|NCT00696085|brief intervention|brief intervention
630338|NCT00696111|PCOS|pcos
630339|NCT00696111|OSA|osa
630340|NCT00696111|Metabolism|metabolism
630341|NCT00696111|Diabetes|diabetes
630342|NCT00696124|lower leg ischemia|lower leg ischemia
630343|NCT00696124|peripheral artery disease|peripheral artery disease
630344|NCT00696150|ultrasound|ultrasound
630345|NCT00696150|hip|hip
630346|NCT00696150|pain|pain
630347|NCT00696176|STAT 3 DECOY|stat 3 decoy
630348|NCT00696189|Post operative visual loss (POVL)|post operative visual loss (povl)
630349|NCT00696189|Intraocular pressure (IOP)|intraocular pressure (iop)
630350|NCT00696189|Nitrous oxide|nitrous oxide
630351|NCT00696202|Mirena|mirena
630352|NCT00696202|Levonorgestrel|levonorgestrel
630353|NCT00696202|Intrauterine device|intrauterine device
630354|NCT00696202|Efficacy|efficacy
630355|NCT00696202|Tolerability|tolerability
630356|NCT00696202|First year of use|first year of use
630357|NCT00696215|Parkinson's disease|parkinson's disease
630358|NCT00696215|rasagiline|rasagiline
630359|NCT00696215|cognition|cognition
630360|NCT00696215|MAO-B|mao-b
630361|NCT00696241|Essential Hypertension|essential hypertension
630362|NCT00696241|Cardiovascular Disease|cardiovascular disease
630363|NCT00696241|High Blood Pressure|high blood pressure
630364|NCT00696241|Drug Therapy|drug therapy
630365|NCT00696280|nausea|nausea
630366|NCT00696280|vomiting|vomiting
630367|NCT00696280|Carboplatin|carboplatin
630368|NCT00696280|cancer|cancer
630369|NCT00696280|delayed emesis following treatment with carboplatin|delayed emesis following treatment with carboplatin
630370|NCT00696306|Acute Ischemic Stroke|acute ischemic stroke
630371|NCT00696306|Stroke|stroke
630373|NCT00696306|DTI|dti
630374|NCT00696306|Diffusion Tensor Imaging|diffusion tensor imaging
630375|NCT00696306|SWI|swi
630377|NCT00696306|Outcome|outcome
630378|NCT00696306|Axonal Injury|axonal injury
630379|NCT00696319|Rupture of the anterior cruciate ligament of the knee|rupture of the anterior cruciate ligament of the knee
630381|NCT00696345|colorectal cancer|colorectal cancer
630382|NCT00696345|screening|screening
630383|NCT00696345|biomarker|biomarker
630384|NCT00696345|plasma|plasma
630385|NCT00696345|blood|blood
630386|NCT00696358|Vitiligo|vitiligo
630387|NCT00696371|Neuroinflammation|neuroinflammation
630388|NCT00696371|PBR28|pbr28
630389|NCT00696371|PET Imaging|pet imaging
630390|NCT00696371|Health Volunteer|health volunteer
630391|NCT00696371|HV|hv
630392|NCT00696384|Essential Hypertension|essential hypertension
630393|NCT00696384|Cardiovascular Disease|cardiovascular disease
630394|NCT00696384|High Blood Pressure|high blood pressure
630395|NCT00696384|Drug Therapy|drug therapy
630396|NCT00696410|Heart Failure|heart failure
630397|NCT00696410|Cardiomyopathy|cardiomyopathy
630398|NCT00696410|Remodeling|remodeling
630399|NCT00696410|Antioxidant|antioxidant
630400|NCT00696410|Zinc|zinc
630401|NCT00696410|Copper|copper
630402|NCT00696423|Infanrix/Hib|infanrix/hib
630403|NCT00696423|Chinese children|chinese children
630404|NCT00696436|Essential Hypertension|essential hypertension
630405|NCT00696436|Cardiovascular Disease|cardiovascular disease
630406|NCT00696436|High Blood Pressure|high blood pressure
630407|NCT00696436|Drug Therapy|drug therapy
630408|NCT00696462|forced-air warming|forced-air warming
630409|NCT00696462|Bair Hugger|bair hugger
630410|NCT00696462|cesarean section|cesarean section
630411|NCT00696462|postoperative infection|postoperative infection
630412|NCT00696462|surgical site infections|surgical site infections
630413|NCT00696501|Neuromuscular mapping|neuromuscular mapping
630414|NCT00696501|Spinal surgery|spinal surgery
630415|NCT00696501|Neurodiagnostics|neurodiagnostics
630416|NCT00696501|Segmental root innervation|segmental root innervation
630417|NCT00696501|Dermatomal innervation|dermatomal innervation
630418|NCT00696501|Myotomal innervation|myotomal innervation
630419|NCT00696501|Nerve roots|nerve roots
630420|NCT00696501|Sensory|sensory
630421|NCT00696501|Signs and Symptoms|signs and symptoms
630422|NCT00696514|fracture|fracture
630423|NCT00696514|cognition|cognition
630424|NCT00702104|prostate cancer|prostate cancer
630425|NCT00702130|Ventilator Associated Pneumonia|ventilator associated pneumonia
630426|NCT00702156|Heart Failure|heart failure
630427|NCT00702156|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
630428|NCT00702156|Beta-blockers|beta-blockers
630429|NCT00702156|Pulmonary Function|pulmonary function
630430|NCT00702169|high frequency ventilation monitoring|high frequency ventilation monitoring
630431|NCT00702169|lung disease|lung disease
630432|NCT00702169|Respiratory distress syndrome|respiratory distress syndrome
630433|NCT00702169|lung barotrauma|lung barotrauma
630434|NCT00702169|mechanical ventilation|mechanical ventilation
630435|NCT00702169|endotracheal tube displacement|endotracheal tube displacement
630436|NCT00702169|endotracheal tube occlusion|endotracheal tube occlusion
630437|NCT00702169|one lung intubation|one lung intubation
630438|NCT00702182|Lung Cancer|lung cancer
630439|NCT00702182|Vinorelbine|vinorelbine
630440|NCT00702182|Erlotinib|erlotinib
630441|NCT00702182|Phase 1|phase 1
630442|NCT00702195|Neonatal outcome|neonatal outcome
630443|NCT00702195|Congenital malformations|congenital malformations
630444|NCT00702195|In-Vitro Fertilization|in-vitro fertilization
630445|NCT00702195|Controlled ovarian stimulation|controlled ovarian stimulation
630446|NCT00702195|Follow-up|follow-up
630447|NCT00702195|Ovulation Induction|ovulation induction
630448|NCT00702195|Neonates|neonates
630449|NCT00702208|cervical cytology|cervical cytology
630450|NCT00702208|Pap smear|pap smear
630451|NCT00702208|self-sampling|self-sampling
630452|NCT00702208|abnormal|abnormal
630453|NCT00702208|normal|normal
630454|NCT00702221|high blood pressure|high blood pressure
630455|NCT00702221|vaccines|vaccines
630456|NCT00702234|Neonatal outcome|neonatal outcome
630457|NCT00702234|Congenital malformations|congenital malformations
630458|NCT00702234|In-Vitro fertilization|in-vitro fertilization
630459|NCT00702234|Controlled ovarian stimulation|controlled ovarian stimulation
630460|NCT00702234|Follow-up|follow-up
630461|NCT00702247|Multiple Myeloma - Nonmyeloablative transplantation - Autologous Transplant - Graft versus myeloma|multiple myeloma - nonmyeloablative transplantation - autologous transplant - graft versus myeloma
630462|NCT00702247|Newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
630463|NCT00702247|Tandem Auto-Allo Transplant|tandem auto-allo transplant
630464|NCT00702247|Overall survival|overall survival
630465|NCT00702247|Event free survival|event free survival
630466|NCT00702247|Disease response|disease response
630467|NCT00702273|In-vitro fertilization|in-vitro fertilization
630468|NCT00702273|Controlled Ovarian Stimulation|controlled ovarian stimulation
630469|NCT00702273|Cumulative pregnancy data|cumulative pregnancy data
630470|NCT00702273|Follow-up|follow-up
630471|NCT00702286|Surface acoustic ultrasound|surface acoustic ultrasound
630472|NCT00702286|biofilm formation|biofilm formation
630473|NCT00702286|percoutaneous nephrostomy tube|percoutaneous nephrostomy tube
630474|NCT00702286|Patients requiring per coetaneous drainage due to urinary|patients requiring per coetaneous drainage due to urinary
630475|NCT00702286|tract obstruction|tract obstruction
630476|NCT00702286|To evaluate the efficacy of surface acoustic wave in|to evaluate the efficacy of surface acoustic wave in
630477|NCT00702286|reducing pain and improving drainage|reducing pain and improving drainage
630478|NCT00702299|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
630479|NCT00702299|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
630480|NCT00702299|peritoneal cavity cancer|peritoneal cavity cancer
630481|NCT00702299|fallopian tube cancer|fallopian tube cancer
630482|NCT00702312|Blood pressure|blood pressure
630484|NCT00702338|Neonatal outcome|neonatal outcome
630485|NCT00702338|Congenital malformations|congenital malformations
630486|NCT00702338|Ovulation Induction|ovulation induction
630487|NCT00702338|Follow-up|follow-up
630488|NCT00702351|Infertility|infertility
630489|NCT00702351|Pharmacological effects of drugs|pharmacological effects of drugs
630490|NCT00702351|Drug therapy|drug therapy
630491|NCT00702351|Hormones|hormones
630492|NCT00702351|GnRH agonist|gnrh agonist
630493|NCT00702351|RecFSH|recfsh
630494|NCT00702351|Corifollitropin alfa|corifollitropin alfa
630495|NCT00702351|Open-label|open-label
630496|NCT00702364|Attention|attention
630497|NCT00702364|Traumatic Brain INjury|traumatic brain injury
630498|NCT00702364|Atomoxetine|atomoxetine
630499|NCT00702364|Strattera|strattera
630500|NCT00702416|Analgesia, Patient-controlled|analgesia, patient-controlled
630501|NCT00702416|Anesthesia, Regional|anesthesia, regional
630502|NCT00702416|Ultrasound|ultrasound
630503|NCT00702416|Postoperative Pain|postoperative pain
630504|NCT00702416|Brachial Plexus|brachial plexus
630505|NCT00702442|Nausea, Vomiting|nausea, vomiting
630506|NCT00702442|Vomiting episodes|vomiting episodes
630507|NCT00702728|Contrast induced nephropathy|contrast induced nephropathy
630508|NCT00702728|Furosemide|furosemide
630509|NCT00702728|Percutaneous coronary interventions|percutaneous coronary interventions
630510|NCT00702728|Saline hydration|saline hydration
630511|NCT00702741|Knee|knee
630512|NCT00702741|Meniscus|meniscus
630513|NCT00702741|Meniscectomy|meniscectomy
630514|NCT00702741|Mesenchymal Stem Cells|mesenchymal stem cells
630515|NCT00702741|MSCs|mscs
630516|NCT00702741|Adult Human Stem Cells|adult human stem cells
630517|NCT00702741|Osiris|osiris
630518|NCT00702741|Chondrogen|chondrogen
630519|NCT00702767|This study was completed in October 2006|this study was completed in october 2006
630520|NCT00702780|Alzheimer's disease|alzheimer's disease
630521|NCT00702780|escitalopram|escitalopram
630522|NCT00702780|MRI|mri
630523|NCT00702793|Smoking cessation|smoking cessation
630524|NCT00702793|schizophrenia|schizophrenia
630525|NCT00702793|schizoaffective|schizoaffective
630526|NCT00702793|psychosis|psychosis
630527|NCT00702793|varenicline|varenicline
630528|NCT00702793|champix|champix
630529|NCT00702793|chantix|chantix
630530|NCT00702793|nicotine dependence|nicotine dependence
630531|NCT00702806|Pharmacological effects of drugs|pharmacological effects of drugs
630533|NCT00702806|Hormone substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
630534|NCT00702806|Pharmacological Actions|pharmacological actions
630535|NCT00702806|Randomized|randomized
630536|NCT00702806|Multi-center|multi-center
630537|NCT00702806|Multi-national|multi-national
630538|NCT00702819|Pan-Vascular Endothelial Growth Factor Blockade|pan-vascular endothelial growth factor blockade
630539|NCT00702819|Safety|safety
630540|NCT00702832|Vestibular rehabilitation|vestibular rehabilitation
630541|NCT00702832|acute vestibular injury|acute vestibular injury
630542|NCT00702832|Dizziness|dizziness
630543|NCT00702832|Nausea|nausea
630544|NCT00702832|Nystagmus|nystagmus
630545|NCT00702832|Daily life activities|daily life activities
630546|NCT00702832|Balance|balance
630547|NCT00702832|physiotherapy|physiotherapy
630548|NCT00702845|In vitro fertilization|in vitro fertilization
630549|NCT00702845|Pharmacological effects of drugs|pharmacological effects of drugs
630550|NCT00702845|Hormones|hormones
630551|NCT00702845|Hormone Substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
630552|NCT00702845|Pharmacological Actions|pharmacological actions
630553|NCT00702845|Randomized|randomized
630554|NCT00702845|Multi-center|multi-center
630555|NCT00702845|Multi-national|multi-national
630556|NCT00702845|Double-blind|double-blind
630557|NCT00702845|Active-controlled|active-controlled
630558|NCT00702845|Equivalence|equivalence
630559|NCT00702858|Breast Cancer|breast cancer
630560|NCT00702858|Joint Pain|joint pain
630561|NCT00702858|Aromatase Inhibitors|aromatase inhibitors
630562|NCT00702871|Ventilator Associated Pneumonia|ventilator associated pneumonia
630563|NCT00702871|antimicrobial susceptibility pattern|antimicrobial susceptibility pattern
630564|NCT00702871|stress ulcer prophylaxis|stress ulcer prophylaxis
630565|NCT00702884|recurrent esophageal cancer|recurrent esophageal cancer
630566|NCT00702884|stage IIIA esophageal cancer|stage iiia esophageal cancer
630567|NCT00702884|stage IIIB esophageal cancer|stage iiib esophageal cancer
630568|NCT00702884|stage IIIC esophageal cancer|stage iiic esophageal cancer
630569|NCT00702884|stage IV esophageal cancer|stage iv esophageal cancer
630570|NCT00702910|Asthma patients|asthma patients
630571|NCT00702910|Magnesium stearate|magnesium stearate
630572|NCT00702910|Tolerability|tolerability
630573|NCT00702910|Safety|safety
630574|NCT00702910|Lactose|lactose
630575|NCT00702910|GW642444M|gw642444m
630576|NCT00702910|Pharmacodynamics|pharmacodynamics
630577|NCT00702910|Efficacy|efficacy
630578|NCT00702910|Pharmacokinetics|pharmacokinetics
630579|NCT00702923|Stage D0 Prostate Cancer|stage d0 prostate cancer
630580|NCT00702923|Rising PSA|rising psa
630581|NCT00702923|Casodex|casodex
630582|NCT00702923|Tremelimumab|tremelimumab
630583|NCT00702949|breast cancer|breast cancer
630584|NCT00702949|hot flashes|hot flashes
630585|NCT00702962|lung cancer|lung cancer
630586|NCT00702962|small cell lung cancer|small cell lung cancer
630587|NCT00702975|phase II|phase ii
630588|NCT00702975|NSCLC|nsclc
630589|NCT00702975|bevacizumab|bevacizumab
630590|NCT00702975|erlotinib|erlotinib
630591|NCT00702975|metastatic NSCLC|metastatic nsclc
630592|NCT00702988|Neonatal outcome|neonatal outcome
630593|NCT00702988|Congenital malformations|congenital malformations
630594|NCT00702988|In-Vitro Fertilization|in-vitro fertilization
630595|NCT00702988|Controlled ovarian stimulation|controlled ovarian stimulation
630596|NCT00702988|Follow-up|follow-up
630597|NCT00703014|Neonatal outcome|neonatal outcome
630598|NCT00703014|Congenital malformations|congenital malformations
630599|NCT00703014|In-Vitro fertilization|in-vitro fertilization
630600|NCT00703014|Controlled ovarian stimulation|controlled ovarian stimulation
630601|NCT00703014|Follow-up|follow-up
630602|NCT00703027|diabetes mellitus|diabetes mellitus
630603|NCT00703027|care decision|care decision
630604|NCT00703027|data mining|data mining
630605|NCT00703040|Care engagement|care engagement
630606|NCT00703040|Linkage to care|linkage to care
630607|NCT00703040|HIV Infections|hiv infections
630608|NCT00703053|influenza, H5N1, vaccine, avian influenza, parent protocol|influenza, h5n1, vaccine, avian influenza, parent protocol
630609|NCT00703066|Malaria|malaria
630610|NCT00703066|Vaccine|vaccine
630611|NCT00703066|GMZ2|gmz2
630612|NCT00703066|Safety|safety
630613|NCT00703066|African|african
630614|NCT00703066|immunogenicity|immunogenicity
630615|NCT00703079|Acromegaly|acromegaly
630616|NCT00703079|GH|gh
630617|NCT00703079|IGF-I|igf-i
630618|NCT00703079|Octreotide-LAR|octreotide-lar
630619|NCT00703079|Lanreotide|lanreotide
630620|NCT00703079|Transsphenoidal surgery|transsphenoidal surgery
630621|NCT00703105|ovarian cancer|ovarian cancer
630622|NCT00703105|Tregs|tregs
630623|NCT00703105|vaccine|vaccine
630624|NCT00703105|Recurrent Ovarian Cancer|recurrent ovarian cancer
630625|NCT00703118|Hepatitis C, Chronic|hepatitis c, chronic
630626|NCT00703118|Telaprevir|telaprevir
630627|NCT00703118|Peg-IFN-alfa-2a|peg-ifn-alfa-2a
630628|NCT00703118|Ribavirin|ribavirin
630629|NCT00703131|fistula|fistula
630630|NCT00703131|anal fistula|anal fistula
630631|NCT00703144|Pharmacokinetics|pharmacokinetics
630632|NCT00703144|piperacillin/tazobactam.|piperacillin/tazobactam.
630633|NCT00703144|Septic patients|septic patients
630634|NCT00703144|oliguric renal failure|oliguric renal failure
630635|NCT00703144|continuous veno-venous hemodiafiltration.|continuous veno-venous hemodiafiltration.
630636|NCT00703196|cervical cancer|cervical cancer
630637|NCT00703196|human papilloma virus infection|human papilloma virus infection
630638|NCT00703196|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
630639|NCT00703196|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
630640|NCT00703196|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
630641|NCT00703196|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
630642|NCT00703196|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
630643|NCT00703196|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
630644|NCT00703209|symptomatic diabetic neuropathy|symptomatic diabetic neuropathy
630645|NCT00703209|diabetes|diabetes
630646|NCT00703209|burning feet|burning feet
630647|NCT00703209|Diabetic Neuropathy|diabetic neuropathy
630648|NCT00703209|Loss of sensation in the foot|loss of sensation in the foot
630649|NCT00703209|Neuropathy|neuropathy
630650|NCT00703209|Painful Diabetic Neuropathy|painful diabetic neuropathy
630651|NCT00703222|high-risk neuroblastoma|high-risk neuroblastoma
630652|NCT00703222|single autologous stem cell rescue|single autologous stem cell rescue
630653|NCT00703248|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
630654|NCT00703248|complementary therapies|complementary therapies
630655|NCT00703274|ischemic stroke|ischemic stroke
630656|NCT00703274|stroke|stroke
630657|NCT00703274|cerebrovascular stroke|cerebrovascular stroke
630658|NCT00703274|cerebrovascular accident|cerebrovascular accident
630659|NCT00703274|CVA|cva
630660|NCT00703274|community health services|community health services
630661|NCT00703274|community health workers|community health workers
630662|NCT00703274|navigators|navigators
630663|NCT00703274|health education|health education
630664|NCT00703274|barriers to care|barriers to care
630755|NCT00703677|lithium|lithium
630665|NCT00703274|healthcare access|healthcare access
630666|NCT00703274|healthcare disparities|healthcare disparities
630667|NCT00703313|Study drug concentration in human tears|study drug concentration in human tears
630668|NCT00703326|Metastatic breast cancer|metastatic breast cancer
630669|NCT00703326|HER2 negative breast cancer|her2 negative breast cancer
630670|NCT00703326|locally recurrent breast cancer|locally recurrent breast cancer
630671|NCT00703339|fibrosis, pulmonary|fibrosis, pulmonary
630672|NCT00703339|hypertension, pulmonary|hypertension, pulmonary
630673|NCT00703339|exercise, aerobic|exercise, aerobic
630674|NCT00703352|Transposition of the great arteries.|transposition of the great arteries.
630675|NCT00703352|Transposition of the great vessels.|transposition of the great vessels.
630676|NCT00703352|Mustard.|mustard.
630677|NCT00703352|Senning.|senning.
630678|NCT00703365|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
630679|NCT00703391|Chronic|chronic
630680|NCT00703391|obstructive|obstructive
630681|NCT00703391|pulmonary|pulmonary
630682|NCT00703391|lung|lung
630683|NCT00703391|respiratory disease|respiratory disease
630684|NCT00703391|tolerability|tolerability
630685|NCT00703391|placebo-controlled|placebo-controlled
630686|NCT00703391|pharmacokinetics|pharmacokinetics
630687|NCT00703391|COPD|copd
630688|NCT00703404|Anti-Retroviral Therapy|anti-retroviral therapy
630689|NCT00703404|HIV|hiv
630690|NCT00703404|Virologic Response|virologic response
630691|NCT00703404|Treatment Naïve|treatment naïve
630692|NCT00703417|osteoporosis|osteoporosis
630693|NCT00703417|diabetes|diabetes
630694|NCT00703430|Alzheimer's disease, agitation, aggression, dementia|alzheimer's disease, agitation, aggression, dementia
630695|NCT00703443|Genetics|genetics
630696|NCT00703443|Dilated Cardiomyopathy|dilated cardiomyopathy
630697|NCT00703443|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
630698|NCT00703443|Mitochondrial Cardiomyopathy|mitochondrial cardiomyopathy
630699|NCT00703443|Noncompaction Cardiomyopathy|noncompaction cardiomyopathy
630700|NCT00703443|Restrictive Cardiomyopathy|restrictive cardiomyopathy
630701|NCT00703443|Heart Failure|heart failure
630702|NCT00703456|Functional ankle instability|functional ankle instability
630703|NCT00703456|Balance training|balance training
630704|NCT00703469|Hep C|hep c
630705|NCT00703482|Ventricular diastolic Function|ventricular diastolic function
630706|NCT00703482|Diabetes|diabetes
630707|NCT00703495|traumatic|traumatic
630708|NCT00703495|brain injury|brain injury
630709|NCT00703495|brain regional oxygen saturation (rSO2)|brain regional oxygen saturation (rso2)
630710|NCT00703495|brain tissue oxygenation (PbtO2)|brain tissue oxygenation (pbto2)
630711|NCT00703495|cerebral perfusion pressure (CPP)|cerebral perfusion pressure (cpp)
630712|NCT00703508|PCOS|pcos
630713|NCT00703521|rabies vaccination|rabies vaccination
630714|NCT00703521|pre-exposure prophylaxis|pre-exposure prophylaxis
630715|NCT00703521|rabies virus neutralizing antibody|rabies virus neutralizing antibody
630716|NCT00703521|Antibody response|antibody response
630839|NCT00704093|oxidative metabolism|oxidative metabolism
631007|NCT00705146|AUSCAN-HI 3.1|auscan-hi 3.1
630717|NCT00703521|immunologic memory of rabies vaccination|immunologic memory of rabies vaccination
630718|NCT00703521|Safety of rabies vaccination administered in pre-exposure regimens both intramuscular and intradermal routes|safety of rabies vaccination administered in pre-exposure regimens both intramuscular and intradermal routes
630719|NCT00703534|GERD|gerd
630720|NCT00703534|Acid Reflux|acid reflux
630721|NCT00703534|Heartburn|heartburn
630722|NCT00703534|Regurgitation|regurgitation
630723|NCT00703534|non-acid reflux|non-acid reflux
630724|NCT00703534|PRO measures|pro measures
630725|NCT00703547|Depression|depression
630726|NCT00703560|HCV|hcv
630727|NCT00703560|Genotype 1|genotype 1
630728|NCT00703560|HIV co-infection|hiv co-infection
630729|NCT00703560|viral kinetics|viral kinetics
630730|NCT00703560|HCV quasi-species|hcv quasi-species
630731|NCT00703560|Hepatitis C genotype 1|hepatitis c genotype 1
630732|NCT00703560|HIV Infections|hiv infections
630733|NCT00703573|Atopic Dermatitis|atopic dermatitis
630734|NCT00703586|Maraviroc|maraviroc
630735|NCT00703586|Treatment Experienced|treatment experienced
630736|NCT00703599|Diabetes Mellitus|diabetes mellitus
630737|NCT00703599|Adipose-derived stem cells|adipose-derived stem cells
630738|NCT00703599|Adipose stromal vascular fraction|adipose stromal vascular fraction
630739|NCT00703599|Autologous|autologous
630740|NCT00703599|Insulin-dependence|insulin-dependence
630741|NCT00703612|Diabetes Mellitus|diabetes mellitus
630742|NCT00703612|Adipose-derived stem cells|adipose-derived stem cells
630743|NCT00703612|Adipose stromal vascular fraction|adipose stromal vascular fraction
630744|NCT00703612|Autologous|autologous
630745|NCT00703612|Hyperglycemia|hyperglycemia
630746|NCT00703651|Influenza|influenza
630747|NCT00703651|Orthomyxoviridae Infection|orthomyxoviridae infection
630748|NCT00703651|Inactivated, Split-virion influenza vaccine|inactivated, split-virion influenza vaccine
630749|NCT00703651|Intradermal injection|intradermal injection
630750|NCT00703651|Adults.|adults.
630751|NCT00703677|progressive supranuclear palsy|progressive supranuclear palsy
630752|NCT00703677|corticobasal degeneration|corticobasal degeneration
633065|NCT00705796|Hypogonadism|hypogonadism
633066|NCT00705796|Spermatogenesis|spermatogenesis
633067|NCT00705796|Quality of Life|quality of life
630753|NCT00703677|PSP|psp
630754|NCT00703677|CBD|cbd
630757|NCT00703703|Heart rate, overactive bladder|heart rate, overactive bladder
630758|NCT00703716|mini-invasive|mini-invasive
630759|NCT00703716|dynamic screw-plate|dynamic screw-plate
630760|NCT00703716|Surfix|surfix
630761|NCT00703716|Lock-screw|lock-screw
630762|NCT00703755|Diabetes|diabetes
630763|NCT00703755|Hypertriglyceridaemia|hypertriglyceridaemia
630764|NCT00703755|Metabolic Syndrome|metabolic syndrome
630765|NCT00703768|Quality of Life|quality of life
630766|NCT00703768|Androgen Deprivation Therapy|androgen deprivation therapy
630767|NCT00703768|Goserelin|goserelin
630768|NCT00703781|Cataract extraction with intraocular lens implantation|cataract extraction with intraocular lens implantation
630769|NCT00703794|ev3 Neurovascular|ev3 neurovascular
630770|NCT00703794|aneurysms|aneurysms
630771|NCT00703794|cerebrovascular|cerebrovascular
630772|NCT00703794|endovascular|endovascular
630773|NCT00703794|neurovascular therapies|neurovascular therapies
630774|NCT00703794|RACER|racer
630775|NCT00703794|AXIUM|axium
630776|NCT00703794|The AXIUM Progressive Coil System|the axium progressive coil system
630777|NCT00703794|ev3|ev3
630778|NCT00703794|MTI|mti
630779|NCT00703794|Micro Therapeutics|micro therapeutics
630780|NCT00703794|FX detachable coil system|fx detachable coil system
630781|NCT00703794|K060747|k060747
630782|NCT00703794|brain diseases|brain diseases
630783|NCT00703846|Phase 4|phase 4
630784|NCT00703846|Seborrheic|seborrheic
630785|NCT00703846|Ketoconazole|ketoconazole
630786|NCT00703846|Dermatitis|dermatitis
630787|NCT00703859|Radiotherapy plus temozolomide plus DCA|radiotherapy plus temozolomide plus dca
630788|NCT00703859|PK profile of DCA|pk profile of dca
630789|NCT00703859|MGMT promoter methylation status|mgmt promoter methylation status
630790|NCT00703859|Newly diagnosed Glioblastoma multiform tumours|newly diagnosed glioblastoma multiform tumours
630791|NCT00703872|Chronic Hepatitis C|chronic hepatitis c
630792|NCT00703872|Naive|naive
630793|NCT00703872|Nonresponders|nonresponders
630794|NCT00703872|Interferon|interferon
630795|NCT00703872|Patients with Chronic Hepatitis C|patients with chronic hepatitis c
630796|NCT00703885|functional magnetic resonance imaging|functional magnetic resonance imaging
630797|NCT00703885|fMRI|fmri
630798|NCT00703885|alprazolam|alprazolam
630799|NCT00703885|anxiety disorders|anxiety disorders
630800|NCT00703898|HIV|hiv
630801|NCT00703898|nevirapine|nevirapine
630802|NCT00703898|durability|durability
630803|NCT00703898|AIDS|aids
630804|NCT00703898|Treatment Naïve|treatment naïve
630805|NCT00703924|cutaneous leishmaniasis topical treatment safety efficacy|cutaneous leishmaniasis topical treatment safety efficacy
630806|NCT00703950|Sucking patterns|sucking patterns
630807|NCT00703950|preterm infants|preterm infants
630808|NCT00703950|breastfeeding|breastfeeding
630809|NCT00703963|International normalized ratio (INR)|international normalized ratio (inr)
630810|NCT00703976|head and neck cancers|head and neck cancers
630811|NCT00703989|hyperglycemia|hyperglycemia
630812|NCT00703989|diabetic complications|diabetic complications
630813|NCT00703989|advanced glycation endproducts|advanced glycation endproducts
630814|NCT00703989|hexosamine pathway|hexosamine pathway
630815|NCT00703989|prostacyclin synthase|prostacyclin synthase
630816|NCT00703989|reactive oxygen species|reactive oxygen species
630817|NCT00704002|neck fracture of the fifth metacarpal|neck fracture of the fifth metacarpal
630818|NCT00704002|displacement|displacement
630819|NCT00704002|antegrade intramedullary splinting|antegrade intramedullary splinting
630820|NCT00704002|conservative treatment|conservative treatment
630821|NCT00704015|Smoking cessation|smoking cessation
630822|NCT00704015|Acute injury|acute injury
630823|NCT00704015|Musculoskeletal|musculoskeletal
630824|NCT00704015|Postoperative complications|postoperative complications
630825|NCT00704054|Pediatric|pediatric
630826|NCT00704054|Solid Tumor|solid tumor
630827|NCT00704054|CNS Tumor|cns tumor
630828|NCT00704054|Lymphoma|lymphoma
630829|NCT00704067|vocational rehabilitation|vocational rehabilitation
630830|NCT00704067|supported employment|supported employment
630831|NCT00704067|cognitive training|cognitive training
630832|NCT00704067|cognitive remediation|cognitive remediation
630833|NCT00704067|cognitive rehabilitation|cognitive rehabilitation
630834|NCT00704067|veterans|veterans
630835|NCT00704080|GBM|gbm
630836|NCT00704080|Anaplastic glioma|anaplastic glioma
630837|NCT00704093|pacing|pacing
630838|NCT00704093|perfusion|perfusion
630840|NCT00704093|efficiency|efficiency
630841|NCT00704106|Hepatitis B|hepatitis b
630842|NCT00704106|HBV|hbv
630843|NCT00704106|Treatment|treatment
630844|NCT00704119|Rhudex|rhudex
630845|NCT00704119|pharmacokinetic study|pharmacokinetic study
630846|NCT00704145|Drug Eluting Stents|drug eluting stents
630847|NCT00704145|Percutaneous Coronary Interventions|percutaneous coronary interventions
630848|NCT00704145|Optical Coherence Tomography|optical coherence tomography
630849|NCT00704158|CR011-vcMMAE|cr011-vcmmae
630850|NCT00704158|locally advanced breast cancer|locally advanced breast cancer
630851|NCT00704158|metastatic breast cancer|metastatic breast cancer
630852|NCT00704158|breast cancer|breast cancer
630853|NCT00704158|CuraGen|curagen
630954|NCT00704821|Angiogenesis|angiogenesis
632617|NCT00712582|Vincristine|vincristine
630854|NCT00704171|Elective pulmonary resection via open thoracotomy.|elective pulmonary resection via open thoracotomy.
630855|NCT00704210|Low Back Pain|low back pain
630856|NCT00704236|Traditional Chinese Treatment|traditional chinese treatment
630857|NCT00704249|HIV infection|hiv infection
630858|NCT00704249|nevirapine|nevirapine
630859|NCT00704249|Treatment Experienced|treatment experienced
630860|NCT00704275|dry eye|dry eye
630861|NCT00704288|GBM|gbm
630862|NCT00704288|Malignant gliomas|malignant gliomas
630863|NCT00704301|Delirium|delirium
630864|NCT00704301|Confusion|confusion
630865|NCT00704314|Insulin resistance|insulin resistance
630866|NCT00704314|Statins|statins
630867|NCT00704314|Muscle and liver triglycerides|muscle and liver triglycerides
630868|NCT00704327|Cognitive Functions|cognitive functions
630869|NCT00704327|Brain Ischemia|brain ischemia
630870|NCT00704327|Cerebral Atrophy|cerebral atrophy
630871|NCT00704327|Dementia|dementia
630872|NCT00704327|Intracranial atherosclerosis|intracranial atherosclerosis
630873|NCT00704327|Memory impairment|memory impairment
630874|NCT00704366|Advanced carcinoma|advanced carcinoma
630875|NCT00704379|traumatic brain injury|traumatic brain injury
630876|NCT00704379|TBI|tbi
630877|NCT00704379|mood disorders|mood disorders
630878|NCT00704379|anxiety disorders|anxiety disorders
630879|NCT00704379|community reintegration|community reintegration
630880|NCT00704379|executive function|executive function
630881|NCT00704379|sertraline|sertraline
630882|NCT00704379|diffusion tensor imaging|diffusion tensor imaging
630883|NCT00704392|Solid tumors|solid tumors
630884|NCT00704392|NSCLC|nsclc
630885|NCT00704405|hepatitis C|hepatitis c
630886|NCT00704418|Cataract extraction|cataract extraction
630887|NCT00704418|intraocular lens implantation|intraocular lens implantation
630888|NCT00704431|SB-480848|sb-480848
630889|NCT00704431|darapladib|darapladib
630890|NCT00704431|tolerability|tolerability
630891|NCT00704457|Interstitial Cystitis|interstitial cystitis
630892|NCT00704457|IC|ic
630893|NCT00704457|Sacral Nerve Stimulation|sacral nerve stimulation
630894|NCT00704470|Patient Simulation|patient simulation
630895|NCT00704470|Education, Medical, Continuing|education, medical, continuing
630896|NCT00704470|Education, Medical, Graduate|education, medical, graduate
630897|NCT00704470|Stress|stress
630898|NCT00704483|Chronic Kidney Disease|chronic kidney disease
630899|NCT00704483|hemodialysis|hemodialysis
630900|NCT00704483|hyperphosphatemia|hyperphosphatemia
630901|NCT00704483|hemodiafiltration|hemodiafiltration
630902|NCT00704496|Sleep, Pseudoephedrine|sleep, pseudoephedrine
630903|NCT00704509|Schizophrenia|schizophrenia
630904|NCT00704509|Antipsychotic|antipsychotic
630905|NCT00704509|Bifeprunox|bifeprunox
630906|NCT00704561|Acute Myocardial Infarction|acute myocardial infarction
630907|NCT00704561|Percutaneous Coronary Interventions|percutaneous coronary interventions
630908|NCT00704561|Optical Coherence Tomography|optical coherence tomography
630909|NCT00704561|Thrombus|thrombus
630910|NCT00704587|cancer occurence|cancer occurence
630911|NCT00704587|cancer recurrence|cancer recurrence
630912|NCT00704587|neo-adjuvant treatment response measurement|neo-adjuvant treatment response measurement
630913|NCT00704600|Locally advanced rectal cancer|locally advanced rectal cancer
630914|NCT00704600|nelfinavir|nelfinavir
630915|NCT00704600|radiosensitivity|radiosensitivity
630916|NCT00704600|chemoradiation|chemoradiation
630917|NCT00704626|Multiple Sclerosis|multiple sclerosis
630918|NCT00704626|Autoimmune disease|autoimmune disease
630919|NCT00704626|Inflammatory disease|inflammatory disease
630920|NCT00704626|Myasthenia Gravis|myasthenia gravis
630921|NCT00704626|Transverse Myelitis|transverse myelitis
630922|NCT00704639|Head and Neck|head and neck
630923|NCT00704639|Cetuximab|cetuximab
630924|NCT00704639|Carboplatin|carboplatin
630925|NCT00704639|Radiotherapy|radiotherapy
630926|NCT00704665|Diffuse Scleroderma|diffuse scleroderma
630927|NCT00704665|Skin score|skin score
630928|NCT00704678|Chronic Kidney Disease|chronic kidney disease
630929|NCT00704678|hemodialysis|hemodialysis
630930|NCT00704678|hyperphosphatemia|hyperphosphatemia
630931|NCT00704678|Asian|asian
630932|NCT00704678|patients|patients
630933|NCT00704704|high risk MDS|high risk mds
630934|NCT00704704|IPSS|ipss
630935|NCT00704704|5-AZA-Cytidine|5-aza-cytidine
630936|NCT00704704|Thalidomide|thalidomide
630937|NCT00704704|response rate|response rate
630938|NCT00704704|cytogenetic response|cytogenetic response
630939|NCT00704704|QOL questionaries|qol questionaries
630940|NCT00704704|INT-2 or High risk MDS|int-2 or high risk mds
630941|NCT00704730|Medullary Thyroid Cancer|medullary thyroid cancer
630942|NCT00704730|MTC|mtc
630943|NCT00704743|Colles fracture treatment|colles fracture treatment
630944|NCT00704743|Displaced fracture of distal radius|displaced fracture of distal radius
630945|NCT00704743|distal radius fracture treatment|distal radius fracture treatment
630946|NCT00704743|RCT|rct
630947|NCT00704743|Emergency Department|emergency department
630948|NCT00704743|cast|cast
630949|NCT00704743|splint|splint
630950|NCT00704743|treatment|treatment
630951|NCT00704821|Cancer|cancer
630952|NCT00704821|PTC299|ptc299
630953|NCT00704821|VEGF|vegf
630955|NCT00704821|Post-transcriptional control|post-transcriptional control
630956|NCT00704821|Docetaxel|docetaxel
630957|NCT00704834|Multiple Sclerosis|multiple sclerosis
630958|NCT00704834|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
630959|NCT00704834|Chronic Progressive Multiple Sclerosis|chronic progressive multiple sclerosis
630960|NCT00704834|Clinically Isolated Syndrome|clinically isolated syndrome
630961|NCT00704834|Normal Controls|normal controls
630962|NCT00704834|Blood Draw|blood draw
630963|NCT00704847|Osteoarthritis, oral salmon calcitonin, treatment, efficacy,|osteoarthritis, oral salmon calcitonin, treatment, efficacy,
630964|NCT00704847|tolerability|tolerability
630965|NCT00704860|healthy volunteers treatment resistant major depression hippocampus atrophy MRI serotonin genotyping|healthy volunteers treatment resistant major depression hippocampus atrophy mri serotonin genotyping
630966|NCT00704886|dementia|dementia
630967|NCT00704912|Polycystic Ovary Syndrome|polycystic ovary syndrome
630968|NCT00704925|Lambert Eaton Myasthenic Syndrome|lambert eaton myasthenic syndrome
630970|NCT00704925|3,4 Diaminopyridine|3,4 diaminopyridine
630971|NCT00704938|recurrent renal cell cancer|recurrent renal cell cancer
630972|NCT00704938|stage IV renal cell cancer|stage iv renal cell cancer
630973|NCT00704938|recurrent melanoma|recurrent melanoma
630974|NCT00704938|stage IV melanoma|stage iv melanoma
630975|NCT00704938|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
630976|NCT00704990|Attention Deficit Disorder|attention deficit disorder
630977|NCT00704990|Pediatrics|pediatrics
630978|NCT00704990|Attention|attention
630979|NCT00704990|Impulsivity|impulsivity
630980|NCT00704990|Complementary Therapies|complementary therapies
630981|NCT00705003|depression|depression
630982|NCT00705016|Randomized treatment|randomized treatment
630983|NCT00705016|open-label|open-label
630984|NCT00705016|controlled|controlled
630985|NCT00705016|recurrent|recurrent
630986|NCT00705016|metastatic|metastatic
630987|NCT00705016|SCCHN|scchn
630988|NCT00705016|suitable|suitable
630989|NCT00705016|for local therapy|for local therapy
630990|NCT00705055|Anthropometry|anthropometry
630991|NCT00705055|face recognition|face recognition
630992|NCT00705055|genetic disease|genetic disease
630993|NCT00705055|newborn infant|newborn infant
630994|NCT00705094|cardiovascular risk factors|cardiovascular risk factors
630995|NCT00705094|cardiac function|cardiac function
630996|NCT00705094|VO2peak|vo2peak
630997|NCT00705094|Chemotherapy|chemotherapy
630998|NCT00705120|Osteogenesis Imperfecta|osteogenesis imperfecta
630999|NCT00705120|Bone Marrow Cell Transplantation|bone marrow cell transplantation
631000|NCT00705120|Mesenchymal Stem Cells|mesenchymal stem cells
631001|NCT00705120|Stem Cell Transplantation, Mesenchymal|stem cell transplantation, mesenchymal
631002|NCT00705133|pulmonary hypertension|pulmonary hypertension
631003|NCT00705133|pulmonary fibrosis|pulmonary fibrosis
631004|NCT00705133|interstitial lung disease|interstitial lung disease
631005|NCT00705146|Osteoarthritis, carpometacarpal joint|osteoarthritis, carpometacarpal joint
631006|NCT00705146|Thumb splints|thumb splints
631008|NCT00705146|Grip and pinch strength|grip and pinch strength
631009|NCT00705159|Blepharokeratoconjunctivitis|blepharokeratoconjunctivitis
631010|NCT00705185|Major Depressive Disorder|major depressive disorder
631011|NCT00705185|Blood Test|blood test
631012|NCT00705237|sinusitis|sinusitis
631013|NCT00692380|gated IMRT|gated imrt
631014|NCT00692419|pain|pain
631015|NCT00692419|sexual dysfunction|sexual dysfunction
631016|NCT00692419|depression|depression
631017|NCT00692419|symptoms|symptoms
631018|NCT00692432|Macrophage Migration Inhibitory Factor|macrophage migration inhibitory factor
631019|NCT00692432|MIF|mif
631020|NCT00692432|Cardiopulmonary bypass|cardiopulmonary bypass
631021|NCT00692432|CPB|cpb
631022|NCT00692432|inflammation|inflammation
631023|NCT00692432|inflammatory marker|inflammatory marker
631024|NCT00692432|myocardial depression|myocardial depression
631025|NCT00692432|myocardial depressant factor|myocardial depressant factor
631026|NCT00692445|depression|depression
631027|NCT00692471|Sleep|sleep
631028|NCT00692471|Orthostatic tachycardia|orthostatic tachycardia
631029|NCT00692471|POTS|pots
631030|NCT00692484|Antimicrobial|antimicrobial
631031|NCT00692484|Antisepsis|antisepsis
631032|NCT00692484|Topical antisepsis|topical antisepsis
631033|NCT00692497|One-Stop|one-stop
631034|NCT00692497|Public Health Research|public health research
631035|NCT00692497|Delivery of Health Care/*standards|delivery of health care/*standards
631036|NCT00692497|Evaluation Studies|evaluation studies
631037|NCT00692497|Referral|referral
631038|NCT00692497|Surgery, Outpatient|surgery, outpatient
631039|NCT00692497|Surgery, Day|surgery, day
631040|NCT00692497|Telemedicine|telemedicine
631041|NCT00692510|AZD3480|azd3480
633387|NCT00707330|mda|mda
631042|NCT00692510|Cocktail|cocktail
631043|NCT00692510|caffeine|caffeine
631044|NCT00692510|bupropion|bupropion
631045|NCT00692510|omeprazole|omeprazole
631046|NCT00692510|midazolam|midazolam
631047|NCT00692510|rosiglitazone|rosiglitazone
631048|NCT00692510|metabolism|metabolism
631049|NCT00692510|Drug Drug Interaction|drug drug interaction
631050|NCT00692523|Stroke|stroke
631051|NCT00692523|rehabilitation|rehabilitation
631052|NCT00692523|Nintendo Wii|nintendo wii
631053|NCT00692536|Obesity|obesity
631054|NCT00692536|Postmenopausal|postmenopausal
631055|NCT00692536|Diet intervention|diet intervention
631056|NCT00692549|ultrasound|ultrasound
631057|NCT00692549|iv access|iv access
631058|NCT00692549|Patients with difficult iv access in emergency departments.|patients with difficult iv access in emergency departments.
631059|NCT00692562|Islets of Langerhans Transplantation|islets of langerhans transplantation
631060|NCT00692562|Kidney Transplantation|kidney transplantation
631061|NCT00692562|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
631062|NCT00692562|alemtuzumab|alemtuzumab
631063|NCT00692575|Brain Injuries, Traumatic|brain injuries, traumatic
631064|NCT00692575|Caregivers|caregivers
631065|NCT00692588|Alzheimer's Disease|alzheimer's disease
631066|NCT00692588|Magnetic Resonance Imaging|magnetic resonance imaging
631067|NCT00692588|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
631068|NCT00692588|Diffusion Tensor Imaging|diffusion tensor imaging
631069|NCT00692588|Susceptibility Weighted Imaging|susceptibility weighted imaging
631070|NCT00692588|Doxycycline|doxycycline
631071|NCT00692588|Rifampicin|rifampicin
631072|NCT00692601|Acute Exercise protocol|acute exercise protocol
631073|NCT00692601|Crossover design|crossover design
631074|NCT00692601|Oxygen consumption (VO2)|oxygen consumption (vo2)
631075|NCT00692601|Respiratory Exchange Ratio (RER)|respiratory exchange ratio (rer)
631076|NCT00692601|Adrenergic System Agonism|adrenergic system agonism
631077|NCT00692601|Capsiate Natura|capsiate natura
631078|NCT00692601|Young|young
631079|NCT00692601|Male|male
631080|NCT00692627|Falciparum|falciparum
631081|NCT00692627|malaria|malaria
631082|NCT00692627|volume|volume
631083|NCT00692627|haemodynamics|haemodynamics
631084|NCT00692640|Cancer|cancer
631085|NCT00692640|Solid Tumors|solid tumors
631086|NCT00692640|NSCLC|nsclc
631087|NCT00692653|Localized prostate cancer|localized prostate cancer
631088|NCT00692653|Treatment decision making|treatment decision making
631089|NCT00692653|Tailored decision aid|tailored decision aid
631090|NCT00692705|Alzheimer´s Disease|alzheimer´s disease
631091|NCT00692705|amyloid deposits|amyloid deposits
631092|NCT00692705|Positron Emission Tomography|positron emission tomography
631093|NCT00692705|phase I|phase i
631094|NCT00692731|green tea,|green tea,
631095|NCT00692731|polyphenols,|polyphenols,
631096|NCT00692731|weight loss,|weight loss,
631097|NCT00692731|body fat|body fat
631098|NCT00692744|Subarachnoid hemorrhage|subarachnoid hemorrhage
631099|NCT00692744|Cerebral aneurysm|cerebral aneurysm
631100|NCT00692744|Elderly|elderly
631101|NCT00692757|Hypochlorous Acid|hypochlorous acid
631102|NCT00692757|Colony forming units|colony forming units
631103|NCT00692757|surgical site infection|surgical site infection
631104|NCT00692757|nosocomial infection|nosocomial infection
631105|NCT00692757|bacterial bioburden|bacterial bioburden
631106|NCT00692757|wound healing|wound healing
631107|NCT00692770|Hepatocellular carcinoma|hepatocellular carcinoma
631110|NCT00692770|Surgical resection|surgical resection
631111|NCT00692770|Ablation|ablation
631112|NCT00692770|Nexavar|nexavar
631113|NCT00692770|Adjuvant therapy|adjuvant therapy
631114|NCT00692770|Liver cancer|liver cancer
631116|NCT00692770|STORM|storm
631117|NCT00692783|candida|candida
631118|NCT00692783|dubliniensis|dubliniensis
631119|NCT00692783|candidiasis|candidiasis
631120|NCT00692783|HIV|hiv
631121|NCT00692783|AIDS|aids
631122|NCT00692783|azole resistance.|azole resistance.
631123|NCT00692796|Pulmonary fibrosis|pulmonary fibrosis
631124|NCT00692796|Pulmonary rehabilitation|pulmonary rehabilitation
631125|NCT00692796|Dyspnea|dyspnea
631126|NCT00692796|Quality of life|quality of life
631127|NCT00692809|Latent tuberculosis infection|latent tuberculosis infection
631128|NCT00692809|Human immunodeficiency virus|human immunodeficiency virus
631129|NCT00692809|Tuberculosis|tuberculosis
631130|NCT00692809|Natural Killer T Cells|natural killer t cells
631131|NCT00692809|Invariant Natural Killer T Cells|invariant natural killer t cells
631132|NCT00692809|Regulatory T cells|regulatory t cells
631133|NCT00692809|Interferon-gamma|interferon-gamma
631134|NCT00692822|Neisseria gonorrheae|neisseria gonorrheae
631135|NCT00692822|Antimicrobial Susceptibility|antimicrobial susceptibility
631136|NCT00692822|Quinolone Resistance|quinolone resistance
631137|NCT00692822|Sexually transmitted diseases|sexually transmitted diseases
631138|NCT00692835|Goiter [C19.874.283]|goiter [c19.874.283]
631139|NCT00692835|Thyroid Neoplasms [C19.874.788]|thyroid neoplasms [c19.874.788]
631140|NCT00692848|Procalcitonin|procalcitonin
631141|NCT00692848|Antibiotic|antibiotic
631142|NCT00692848|Fever without source|fever without source
631143|NCT00692848|Fever without focus|fever without focus
631144|NCT00692848|bacteremia|bacteremia
631145|NCT00692848|Urinary tract infection|urinary tract infection
631146|NCT00692861|Celiac Disease|celiac disease
631147|NCT00692861|Ataxia|ataxia
631148|NCT00692861|Adults|adults
631149|NCT00692861|Health Volunteer|health volunteer
631151|NCT00692874|Quality of Life|quality of life
631152|NCT00692887|AMD|amd
631153|NCT00692926|ALDHbr|aldhbr
631154|NCT00692926|Umbilical Cord Blood|umbilical cord blood
631155|NCT00692926|Transplantation|transplantation
631156|NCT00692926|Hematological malignancy|hematological malignancy
631157|NCT00692926|MDS|mds
631158|NCT00692926|severe aplastic anemia|severe aplastic anemia
631159|NCT00692926|inborn error of metabolism|inborn error of metabolism
631160|NCT00692926|congenital marrow failure or congenital immunodeficiency syndrome|congenital marrow failure or congenital immunodeficiency syndrome
631161|NCT00692926|Hurler's Disease|hurler's disease
631162|NCT00692926|Tay Sach's|tay sach's
631163|NCT00692926|PMD|pmd
631164|NCT00692926|Hunter's Syndrome|hunter's syndrome
631165|NCT00692926|Krabbe|krabbe
631166|NCT00692926|MLD|mld
631167|NCT00692926|ALD|ald
631168|NCT00692926|ALL|all
631169|NCT00692926|AML|aml
631170|NCT00692939|Stem cell transplantation|stem cell transplantation
631171|NCT00692939|Crohn's Disease|crohn's disease
631172|NCT00692952|contraceptive efficacy|contraceptive efficacy
631173|NCT00692965|HIV|hiv
631174|NCT00692965|Sleep Quality|sleep quality
631175|NCT00692965|Sleep apnea|sleep apnea
631176|NCT00692965|Berlin Questionnaire|berlin questionnaire
631177|NCT00692965|Pittsburgh Sleep Quality Index|pittsburgh sleep quality index
631178|NCT00692978|Monodisperse aerosols|monodisperse aerosols
631179|NCT00692978|Healthy Volunteers|healthy volunteers
631180|NCT00692978|Asthmatics|asthmatics
631181|NCT00692978|Pharmacokinetics|pharmacokinetics
631182|NCT00692978|Randomized|randomized
631183|NCT00692991|Microvascular Obstruction|microvascular obstruction
631184|NCT00692991|Cardiac MRI|cardiac mri
631185|NCT00692991|Alcohol Ablation|alcohol ablation
631186|NCT00692991|Diagnostic PCI|diagnostic pci
631187|NCT00693030|Coronary Artery Disease|coronary artery disease
631188|NCT00693030|Percutaneous Coronary Interventions|percutaneous coronary interventions
631189|NCT00693030|Drug-Eluting stents|drug-eluting stents
631190|NCT00693030|Optical Coherence Tomography|optical coherence tomography
631191|NCT00693030|Thrombosis|thrombosis
631192|NCT00693030|Long lesions in native vessel requiring stents in overlap|long lesions in native vessel requiring stents in overlap
631193|NCT00693043|Pain control|pain control
631194|NCT00693056|Erectile Dysfunctions|erectile dysfunctions
631195|NCT00693056|ED|ed
631196|NCT00693069|angioplasty|angioplasty
631197|NCT00693069|clopidogrel|clopidogrel
631198|NCT00693069|coronary artery disease|coronary artery disease
631199|NCT00693069|platelets|platelets
631200|NCT00693069|Percutaneous coronary intervention|percutaneous coronary intervention
631201|NCT00693082|PCOS|pcos
631202|NCT00693082|flaxseed|flaxseed
631203|NCT00693095|Grade IV Glioblastoma Multiforme|grade iv glioblastoma multiforme
631204|NCT00693095|Newly-diagnosed|newly-diagnosed
631205|NCT00693095|CMV positive|cmv positive
631206|NCT00693108|Poor|poor
631207|NCT00693108|Response|response
631208|NCT00693108|Ovarian|ovarian
631209|NCT00693108|Stimulation|stimulation
631210|NCT00693108|IVF|ivf
631211|NCT00693108|Patients|patients
631300|NCT00693355|gut health|gut health
631212|NCT00693121|Traumatic Brain Injury|traumatic brain injury
631213|NCT00693121|Posttraumatic Confusional State|posttraumatic confusional state
631214|NCT00693121|Delirium|delirium
631215|NCT00693121|Amantadine|amantadine
631216|NCT00693121|Clinical trial|clinical trial
631217|NCT00693147|Goiter [C19.874.283]|goiter [c19.874.283]
631218|NCT00693147|Thyroid Neoplasms [C19.874.788]|thyroid neoplasms [c19.874.788]
631219|NCT00693160|healthy volunteers|healthy volunteers
631220|NCT00693160|analgesia|analgesia
631221|NCT00693160|pain|pain
631222|NCT00693160|Healthy subjects|healthy subjects
631223|NCT00693173|anal|anal
631224|NCT00693173|cancer|cancer
631225|NCT00693173|rectal|rectal
631226|NCT00693173|IMRT|imrt
631227|NCT00693173|genital|genital
631228|NCT00693173|sparing|sparing
631229|NCT00693173|drop|drop
631230|NCT00693173|technique|technique
631231|NCT00693199|Amlodipine|amlodipine
631232|NCT00693199|Terazosin|terazosin
631233|NCT00693199|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
631234|NCT00693199|Essential hypertension|essential hypertension
632548|NCT00712530|HIV|hiv
631235|NCT00693199|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
631236|NCT00693199|Quality Of Life (QOL)|quality of life (qol)
631237|NCT00693212|ADHD|adhd
631238|NCT00693212|Adult|adult
631239|NCT00693212|crossover|crossover
631240|NCT00693212|randomized|randomized
631241|NCT00693212|Long-term|long-term
631242|NCT00693212|Open-label|open-label
631243|NCT00693212|methylphenidate|methylphenidate
631244|NCT00693212|Social adjustment|social adjustment
631245|NCT00693225|Erosive Esophagitis|erosive esophagitis
631246|NCT00693225|Reflux Esophagitis|reflux esophagitis
631247|NCT00693225|Gastroesophageal reflux disease|gastroesophageal reflux disease
631248|NCT00693225|GERD|gerd
631249|NCT00693225|proton pump inhibitor|proton pump inhibitor
631250|NCT00693225|omeprazole/sodium bicarbonate|omeprazole/sodium bicarbonate
631251|NCT00693238|Prostate Cancer|prostate cancer
631252|NCT00693238|Proton Radiation|proton radiation
631253|NCT00693251|stent|stent
631254|NCT00693251|bifurcation|bifurcation
631948|NCT00709800|HA/NP/M2|ha/np/m2
631255|NCT00693251|coronary artery stenosis|coronary artery stenosis
631256|NCT00693251|balloon angioplasty|balloon angioplasty
631257|NCT00693264|Human Volunteers|human volunteers
631258|NCT00693264|Hoodia|hoodia
631259|NCT00693264|Safety|safety
631260|NCT00693277|none - entry made in error|none - entry made in error
631261|NCT00693290|Colonoscopy|colonoscopy
631262|NCT00693290|Colorectal screening|colorectal screening
631263|NCT00693290|Colon preparation|colon preparation
631264|NCT00693303|single subject|single subject
631265|NCT00693303|quantitative|quantitative
631266|NCT00693316|Healthy volunteer study|healthy volunteer study
631267|NCT00693329|Contrast Induced Nephrophathy (CIN)|contrast induced nephrophathy (cin)
631268|NCT00693329|Kidney|kidney
631269|NCT00693329|NGAL|ngal
631270|NCT00693342|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
631271|NCT00693342|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
631272|NCT00693342|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
631273|NCT00693342|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
631274|NCT00693342|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
631275|NCT00693342|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
631276|NCT00693342|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
631277|NCT00693342|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
631278|NCT00693342|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
631279|NCT00693342|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
631280|NCT00693342|stage IA fallopian tube cancer|stage ia fallopian tube cancer
631281|NCT00693342|stage IB fallopian tube cancer|stage ib fallopian tube cancer
631282|NCT00693342|stage IC fallopian tube cancer|stage ic fallopian tube cancer
631283|NCT00693342|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
631284|NCT00693342|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
631285|NCT00693342|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
631286|NCT00693342|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
631287|NCT00693342|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
631288|NCT00693342|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
631289|NCT00693342|stage IV fallopian tube cancer|stage iv fallopian tube cancer
631290|NCT00693342|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
631291|NCT00693342|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
631292|NCT00693342|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
631293|NCT00693342|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
631294|NCT00693342|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
631295|NCT00693342|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
631296|NCT00693342|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
631297|NCT00693342|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
631298|NCT00693342|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
631299|NCT00693342|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
631301|NCT00693381|Transplantation|transplantation
631302|NCT00693381|Graft Rejection|graft rejection
631303|NCT00693381|Renal Transplantation|renal transplantation
631304|NCT00693446|Pancreas-kidney allograft|pancreas-kidney allograft
631305|NCT00693446|tacrolimus|tacrolimus
631306|NCT00693446|sirolimus|sirolimus
631307|NCT00693446|Pancreas-kidney allograft recipients|pancreas-kidney allograft recipients
631308|NCT00693459|Hemorrhoids|hemorrhoids
631309|NCT00693472|Antipsychotic Agents|antipsychotic agents
631310|NCT00693498|pediatrics|pediatrics
631311|NCT00693498|congenital heart disease|congenital heart disease
631312|NCT00693511|obesity|obesity
631313|NCT00693511|adolescents|adolescents
631314|NCT00693511|adiposity|adiposity
631315|NCT00693511|insulin sensitivity|insulin sensitivity
631316|NCT00693511|type 2 diabetes|type 2 diabetes
631317|NCT00693511|Latino|latino
631318|NCT00693511|circuit training|circuit training
631319|NCT00693511|physical activity|physical activity
631320|NCT00693511|motivational interviewing|motivational interviewing
631321|NCT00693524|liver allograft transplantation|liver allograft transplantation
631322|NCT00693524|sequential therapy|sequential therapy
631323|NCT00693524|tacrolimus|tacrolimus
631324|NCT00693550|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
631325|NCT00693550|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
631326|NCT00693563|Spinal Cord Injury|spinal cord injury
631327|NCT00693576|renal transplant|renal transplant
631328|NCT00693576|panel reactive antibody|panel reactive antibody
631329|NCT00693576|sensitization|sensitization
631330|NCT00693576|simvastatin|simvastatin
631331|NCT00693576|immunological|immunological
631332|NCT00693589|endothelial function|endothelial function
631333|NCT00693589|flow mediated dilatation|flow mediated dilatation
631334|NCT00693589|rosuvastatin|rosuvastatin
631335|NCT00693589|folic acid|folic acid
631336|NCT00693589|B vitamins|b vitamins
631337|NCT00693615|HPV, Vaccine|hpv, vaccine
631338|NCT00693628|volume|volume
631339|NCT00693628|healing|healing
631340|NCT00693628|shrinker|shrinker
632345|NCT00710957|Aging|aging
631341|NCT00693628|transtibial amputation|transtibial amputation
631342|NCT00693628|individuals who have undergone transtibial amputation|individuals who have undergone transtibial amputation
631343|NCT00693641|Jellyfish|jellyfish
631344|NCT00693641|Cyanea sp|cyanea sp
631345|NCT00693641|Safe Sea|safe sea
631346|NCT00693641|Prevention|prevention
631347|NCT00693641|treatment|treatment
631348|NCT00693641|Pain relief|pain relief
631349|NCT00693641|Prevention of pain|prevention of pain
631350|NCT00693654|Uremic Pruritis|uremic pruritis
631351|NCT00693667|osteoporosis|osteoporosis
631352|NCT00693667|postmenopausal women|postmenopausal women
631353|NCT00693667|botanical drug|botanical drug
631354|NCT00693680|depression|depression
631355|NCT00693680|antidepressant treatment|antidepressant treatment
631356|NCT00693680|zinc|zinc
631357|NCT00693680|placebo|placebo
631358|NCT00693706|cell culture|cell culture
631359|NCT00693706|Safety|safety
631360|NCT00693706|Influenza|influenza
631361|NCT00693706|Humans|humans
631362|NCT00693706|Adults|adults
631363|NCT00693706|Immunogenicity|immunogenicity
631364|NCT00693706|Influenza vaccine|influenza vaccine
631365|NCT00693706|Vaccine|vaccine
631366|NCT00693719|recurrent breast cancer|recurrent breast cancer
631367|NCT00693719|stage IIIA breast cancer|stage iiia breast cancer
631368|NCT00693719|stage IIIB breast cancer|stage iiib breast cancer
631369|NCT00693719|stage IIIC breast cancer|stage iiic breast cancer
631370|NCT00693719|stage IV breast cancer|stage iv breast cancer
631371|NCT00693745|Acutely|acutely
631373|NCT00693758|coronary reactivity|coronary reactivity
631374|NCT00693758|coronary physiology|coronary physiology
631375|NCT00693784|Intervertebral Disk|intervertebral disk
631376|NCT00693784|chronic low back pain|chronic low back pain
631377|NCT00693784|internal disc disruption|internal disc disruption
631378|NCT00693784|degenerative disc disease|degenerative disc disease
631379|NCT00693797|ventricular hypertrophy|ventricular hypertrophy
631380|NCT00693797|collagen|collagen
631381|NCT00693797|aortic stenosis|aortic stenosis
631382|NCT00693823|atherosclerosis|atherosclerosis
631383|NCT00693823|stent|stent
631384|NCT00693823|angioplasty|angioplasty
631385|NCT00693823|covered stent|covered stent
631386|NCT00693836|stage I non-small cell lung cancer|stage i non-small cell lung cancer
631387|NCT00693836|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
631388|NCT00693836|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
631389|NCT00693836|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
631390|NCT00693836|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
631391|NCT00693836|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
631392|NCT00693836|extensive stage small cell lung cancer|extensive stage small cell lung cancer
631393|NCT00693836|limited stage small cell lung cancer|limited stage small cell lung cancer
631394|NCT00693836|recurrent small cell lung cancer|recurrent small cell lung cancer
631395|NCT00693849|depression|depression
631396|NCT00693849|CNS|cns
631397|NCT00693849|iSPOT|ispot
631398|NCT00693849|MDD|mdd
631399|NCT00693862|Focus of the study is pharmacokinetics of the study drug|focus of the study is pharmacokinetics of the study drug
631400|NCT00693875|incidence|incidence
631401|NCT00693875|awareness|awareness
631402|NCT00693875|general anesthesia|general anesthesia
631403|NCT00693875|relevant factor|relevant factor
631404|NCT00693875|the incidence of intra-operative awareness in China|the incidence of intra-operative awareness in china
631405|NCT00693875|the relevant factors|the relevant factors
631406|NCT00693888|dementia|dementia
631407|NCT00693888|system of care|system of care
631408|NCT00693888|level of care|level of care
631409|NCT00693888|interventional study|interventional study
631410|NCT00693888|evaluation|evaluation
631411|NCT00693888|dementia diagnostic|dementia diagnostic
631412|NCT00693888|Evaluation of the care study|evaluation of the care study
631413|NCT00693914|Brain Tumor|brain tumor
631414|NCT00693914|Cognitive Late Effects|cognitive late effects
631415|NCT00693914|Radiation Therapy|radiation therapy
631416|NCT00693914|Working Memory|working memory
631417|NCT00693927|Hematopoietic cell transplantation|hematopoietic cell transplantation
631418|NCT00693927|Allogeneic|allogeneic
631419|NCT00693927|Nonmyeloablative|nonmyeloablative
631420|NCT00693927|CD8-depletion|cd8-depletion
631421|NCT00693927|PBSC|pbsc
631422|NCT00693927|GVHD|gvhd
631423|NCT00693927|Hematological malignancies and renal cell carcinoma|hematological malignancies and renal cell carcinoma
631424|NCT00693940|Peripheral Arterial Disease|peripheral arterial disease
631426|NCT00693953|Evoked Potentials|evoked potentials
631427|NCT00693953|Evoked Potentials, Auditory|evoked potentials, auditory
631428|NCT00693953|Evoked Potentials, Visual|evoked potentials, visual
631429|NCT00693953|Electroencephalography|electroencephalography
631430|NCT00693953|Brain Mapping|brain mapping
631431|NCT00693966|HPV, Vaccine|hpv, vaccine
631432|NCT00694005|stent|stent
631433|NCT00694005|bifurcation|bifurcation
631434|NCT00694005|balloon angioplasty|balloon angioplasty
631435|NCT00699439|Medical Informatics|medical informatics
631436|NCT00699439|Asthma|asthma
631437|NCT00699439|Emergency Service, Hospital|emergency service, hospital
631438|NCT00699439|Bayesian Method|bayesian method
631439|NCT00699452|aortic stenosis|aortic stenosis
631440|NCT00699452|valve|valve
631441|NCT00699452|candesartan|candesartan
631442|NCT00699465|Thromboprophylaxis|thromboprophylaxis
631443|NCT00699465|Prevention of venous thromboembolism after ICH|prevention of venous thromboembolism after ich
631444|NCT00699465|Enoxaparin|enoxaparin
631445|NCT00699465|Intermittent pneumatic compression|intermittent pneumatic compression
631446|NCT00699478|vitamin B12 deficiency|vitamin b12 deficiency
631447|NCT00699478|post total gastrectomy|post total gastrectomy
631448|NCT00699478|stomach cancer|stomach cancer
631450|NCT00699504|QT|qt
631451|NCT00699504|Effect of study drug on healthy volunteers|effect of study drug on healthy volunteers
631452|NCT00699517|tubulin modulator|tubulin modulator
631453|NCT00699517|endothelium|endothelium
631454|NCT00699517|combretastatin|combretastatin
631455|NCT00699517|cisplatin|cisplatin
631456|NCT00699530|Prolactin|prolactin
631457|NCT00699530|Insulin resistance|insulin resistance
631458|NCT00699530|Glucose tolerance|glucose tolerance
631459|NCT00699530|Body Composition|body composition
631460|NCT00699530|Substrate metabolism|substrate metabolism
631462|NCT00699556|nicotine|nicotine
631463|NCT00699556|smoking cessation|smoking cessation
631464|NCT00699556|smoking cessation medications|smoking cessation medications
631465|NCT00699569|hyperimmune colostrum|hyperimmune colostrum
631466|NCT00699569|mucositis|mucositis
631467|NCT00699582|E2007 (perampanel)|e2007 (perampanel)
631468|NCT00699582|refractory partial seizures|refractory partial seizures
631469|NCT00699582|adjunctive therapy|adjunctive therapy
631470|NCT00699582|seizure frequency|seizure frequency
631471|NCT00699582|reduction in seizure frequency|reduction in seizure frequency
631472|NCT00699582|partial onset seizures|partial onset seizures
631473|NCT00699582|safety|safety
631474|NCT00699582|concomitant AED(s)|concomitant aed(s)
631475|NCT00705250|Bendamustine HCL|bendamustine hcl
631476|NCT00705302|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
631477|NCT00705302|Outpatient|outpatient
631478|NCT00705302|Patient education|patient education
631479|NCT00705302|Pulmonary rehabilitation|pulmonary rehabilitation
631480|NCT00705302|Self-management|self-management
631481|NCT00705315|breast cancer|breast cancer
631482|NCT00705315|chemotherapy|chemotherapy
631483|NCT00705315|biological therapy|biological therapy
631484|NCT00705328|low-income families|low-income families
631485|NCT00705328|children|children
631486|NCT00705328|recreation|recreation
631487|NCT00705328|family healthy lifestyle|family healthy lifestyle
631488|NCT00705328|linkages to community resources|linkages to community resources
631489|NCT00705328|Families with low incomes|families with low incomes
631490|NCT00705328|working poor|working poor
631491|NCT00705328|welfare recipients|welfare recipients
631492|NCT00705341|Normal Controls|normal controls
631493|NCT00705354|Sinusitis|sinusitis
631494|NCT00705354|Chronic Sinusitis|chronic sinusitis
631495|NCT00705354|Nasal Surgery|nasal surgery
631496|NCT00705354|Functional Endoscopic Sinus Surgery (FESS)|functional endoscopic sinus surgery (fess)
631497|NCT00705354|Enoscopic Sinus Surgery (ESS)|enoscopic sinus surgery (ess)
631498|NCT00705419|Treatment Experienced|treatment experienced
631499|NCT00705445|Malnutrition|malnutrition
631500|NCT00705445|Diarrhea|diarrhea
631501|NCT00705445|Pneumonia|pneumonia
631502|NCT00705445|Growth|growth
631503|NCT00705445|Zinc Supplements|zinc supplements
631504|NCT00705445|Microbiome|microbiome
631505|NCT00705458|stress myocardial perfusion imaging|stress myocardial perfusion imaging
631506|NCT00705458|coronary computed tomography angiography|coronary computed tomography angiography
631507|NCT00705497|Radiofrequency tumor ablation|radiofrequency tumor ablation
631508|NCT00705497|RFA|rfa
631509|NCT00705510|Cyclosporine|cyclosporine
631510|NCT00705510|Unstable tear film|unstable tear film
631511|NCT00705510|Meibomian gland|meibomian gland
631512|NCT00705510|Meibomian gland dysfunction|meibomian gland dysfunction
631513|NCT00705523|alcohol|alcohol
631514|NCT00705523|treatment|treatment
631515|NCT00705523|nicotinic acetylcholine receptors|nicotinic acetylcholine receptors
631516|NCT00705523|pharmacotherapy|pharmacotherapy
631517|NCT00705523|outpatient|outpatient
631518|NCT00705536|rHuPH20|rhuph20
631519|NCT00705536|Hyaluronidase|hyaluronidase
631520|NCT00705536|Insulin|insulin
631521|NCT00705549|Advanced|advanced
631522|NCT00705549|NSCLC|nsclc
631523|NCT00705549|ERCC1|ercc1
631524|NCT00705549|RRM1|rrm1
631525|NCT00705549|BCRA1|bcra1
631526|NCT00705549|Alimta|alimta
631527|NCT00705549|Gemcitabine|gemcitabine
631528|NCT00705575|Essential Hypertension|essential hypertension
631529|NCT00705575|Stage II|stage ii
631530|NCT00708227|Asthma|asthma
631531|NCT00708227|Pharmacogenetics|pharmacogenetics
631532|NCT00708227|Salmeterol|salmeterol
631533|NCT00708227|African American|african american
631534|NCT00708227|White|white
631535|NCT00708253|balloon assisted enteroscopy|balloon assisted enteroscopy
631536|NCT00708253|single balloon enteroscopy|single balloon enteroscopy
631537|NCT00708253|double balloon enteroscopy|double balloon enteroscopy
631538|NCT00708253|insertion depth|insertion depth
631539|NCT00708266|Obesity|obesity
631540|NCT00708266|Diabetes|diabetes
631541|NCT00708266|Non-esterified fatty acids|non-esterified fatty acids
631542|NCT00708266|Cytokines|cytokines
631543|NCT00708266|Inflammation|inflammation
631544|NCT00708266|Subcutaneous fat|subcutaneous fat
631545|NCT00708266|Adipose tissue|adipose tissue
631546|NCT00708279|angina pectoris, osteopathic manipulation|angina pectoris, osteopathic manipulation
631547|NCT00708292|AUY922|auy922
631548|NCT00708292|Multiple Myeloma|multiple myeloma
631549|NCT00708292|HSP90 inhibitors|hsp90 inhibitors
631550|NCT00708292|Phase I/II|phase i/ii
631551|NCT00708305|toothpaste|toothpaste
631552|NCT00708305|plaque fluid|plaque fluid
631553|NCT00708305|fluoride|fluoride
631554|NCT00708318|AeroLEF|aerolef
631555|NCT00708318|fentanyl|fentanyl
631556|NCT00708318|pharmacokinetic|pharmacokinetic
631557|NCT00708318|liposome|liposome
631558|NCT00708318|encapsulated|encapsulated
631559|NCT00708331|Cataract|cataract
631560|NCT00708331|Extraction|extraction
631561|NCT00708331|Intraocular Lens|intraocular lens
631562|NCT00708331|Hydrophilic Acrylic|hydrophilic acrylic
631563|NCT00708357|eNOS Gene Polymorphism|enos gene polymorphism
631564|NCT00708357|ocular blood flow|ocular blood flow
631565|NCT00708370|Interventional|interventional
631566|NCT00708370|Non-drug|non-drug
631567|NCT00708370|Disease Management Program|disease management program
631568|NCT00708370|Cardiovascular Risk Control|cardiovascular risk control
631569|NCT00708370|Dyslipidemias|dyslipidemias
631570|NCT00708370|Primary Care Centers|primary care centers
631571|NCT00708383|embryo development|embryo development
631572|NCT00708383|embryo quality|embryo quality
631573|NCT00708383|implantation|implantation
631574|NCT00708383|IVF/ICSI outcome|ivf/icsi outcome
631575|NCT00708383|multiple pregnancy|multiple pregnancy
631576|NCT00708396|Patients|patients
631577|NCT00708396|suffer|suffer
631578|NCT00708396|from|from
631579|NCT00708409|Ross operation|ross operation
631580|NCT00708409|autograft procedure|autograft procedure
631581|NCT00708409|pulmonary homograft|pulmonary homograft
631582|NCT00708409|root replacement technique|root replacement technique
631583|NCT00708409|subcoronary implantation technique|subcoronary implantation technique
631584|NCT00708422|Ocular surface health|ocular surface health
631585|NCT00708422|OSDI|osdi
631586|NCT00708422|TFBUT|tfbut
631587|NCT00708422|Glaucoma|glaucoma
631588|NCT00708422|Ocular hypertension|ocular hypertension
631589|NCT00708422|Corneal staining|corneal staining
631590|NCT00708435|Anticoagulant reversal|anticoagulant reversal
631591|NCT00708435|Prothrombin|prothrombin
631592|NCT00708435|Complex|complex
631593|NCT00708435|Concentrate|concentrate
631594|NCT00708435|Coagulopathy|coagulopathy
631595|NCT00708435|induced by|induced by
631596|NCT00708435|coumarin|coumarin
631597|NCT00708435|derivatives|derivatives
631598|NCT00708435|Kcentra|kcentra
631599|NCT00708448|NSCLC|nsclc
631600|NCT00708461|obesity|obesity
631601|NCT00708461|obesity prevention|obesity prevention
631602|NCT00708461|worksite|worksite
631603|NCT00708461|environment|environment
631604|NCT00708461|intervention|intervention
631605|NCT00708474|Bone graft|bone graft
631606|NCT00708474|Bone void filler|bone void filler
631607|NCT00708474|Bone plug|bone plug
631608|NCT00708474|OsseoFit™|osseofit™
631609|NCT00708474|knee|knee
631610|NCT00708474|bone graft sites in the knee|bone graft sites in the knee
631611|NCT00708487|in vitro fertilization|in vitro fertilization
631612|NCT00708487|oxygen concentration|oxygen concentration
631613|NCT00708487|blastocyst|blastocyst
631614|NCT00708487|live birth|live birth
631615|NCT00708487|embryo|embryo
631616|NCT00708500|Treatment failure|treatment failure
631617|NCT00708513|Cell Saver|cell saver
631618|NCT00708513|Liver Tumors|liver tumors
631619|NCT00708513|Liver Cancer|liver cancer
631620|NCT00708513|Surgical Oncology|surgical oncology
631621|NCT00708513|Whipple|whipple
631622|NCT00708513|Blood Transfusion|blood transfusion
631623|NCT00708513|Blood salvage|blood salvage
631624|NCT00708513|cancer surgery|cancer surgery
631625|NCT00708513|blood loss|blood loss
631626|NCT00708526|hypercapnia|hypercapnia
631627|NCT00708526|hyperpnoea|hyperpnoea
631628|NCT00708526|accelerated recovery|accelerated recovery
631629|NCT00708552|Alzheimer's disease|alzheimer's disease
631630|NCT00708552|Cognition|cognition
631631|NCT00708552|SB-742457|sb-742457
631632|NCT00708565|To study the effects of iloprost on hypoxic pulmonary vasoconstriction at high altitude|to study the effects of iloprost on hypoxic pulmonary vasoconstriction at high altitude
631633|NCT00708604|Diabetes Mellitus|diabetes mellitus
631634|NCT00708604|Kidney Transplantation|kidney transplantation
631635|NCT00708604|Islet Transplantation|islet transplantation
631636|NCT00708604|Sirolimus/Tacrolimus/MMF-based Immunosuppressive Regimen|sirolimus/tacrolimus/mmf-based immunosuppressive regimen
631637|NCT00708617|Liver fibrosis|liver fibrosis
631638|NCT00708617|Alcoholic liver disease|alcoholic liver disease
631639|NCT00708617|Non invasive diagnostic methods|non invasive diagnostic methods
632346|NCT00710957|CHS|chs
631640|NCT00708617|Transient elastography|transient elastography
631641|NCT00708617|Fibrotest|fibrotest
631642|NCT00708630|yellow fever vaccine|yellow fever vaccine
631643|NCT00708630|patient information|patient information
631644|NCT00708630|symptom reports|symptom reports
631645|NCT00708630|patient satisfaction|patient satisfaction
631647|NCT00708656|Colitis|colitis
631648|NCT00708656|UC|uc
631649|NCT00708695|nurse|nurse
631650|NCT00708695|home visits|home visits
631651|NCT00708695|pregnancy|pregnancy
631652|NCT00708695|welfare|welfare
631653|NCT00708695|child development|child development
631654|NCT00708695|Child Rearing|child rearing
631655|NCT00708695|Reproductive Behavior|reproductive behavior
631656|NCT00708695|Risk Reduction Behavior|risk reduction behavior
631657|NCT00708708|Plaque-type psoriasis|plaque-type psoriasis
631658|NCT00708721|hypomethylating therapy|hypomethylating therapy
631659|NCT00708721|CML|cml
631660|NCT00708721|myelodysplastic syndromes|myelodysplastic syndromes
631661|NCT00708734|exercise|exercise
631662|NCT00708747|Immunoglobulins|immunoglobulins
631663|NCT00708747|inhibitor proteins|inhibitor proteins
631664|NCT00708747|human albumin|human albumin
631665|NCT00708747|systemic inflammatory response syndrome|systemic inflammatory response syndrome
631666|NCT00708747|interleukins|interleukins
631667|NCT00708747|standardized serum-protein solution|standardized serum-protein solution
631668|NCT00708760|web based learning|web based learning
631669|NCT00708760|moderate sedation|moderate sedation
631670|NCT00708812|Non-small Cell Lung Cancer|non-small cell lung cancer
631671|NCT00708812|Endostar|endostar
631672|NCT00708812|Paclitaxel|paclitaxel
631673|NCT00708812|Carboplatin|carboplatin
631674|NCT00708851|psoriasis|psoriasis
631675|NCT00708877|cancer|cancer
631676|NCT00708877|cholangiocarcinoma|cholangiocarcinoma
631677|NCT00708890|Substance use disorders|substance use disorders
631678|NCT00708890|Self-help groups|self-help groups
631679|NCT00708890|Twelve Step groups|twelve step groups
631680|NCT00708903|Thorough QTc study|thorough qtc study
631681|NCT00708916|Cutaneous lupus|cutaneous lupus
631682|NCT00708916|Intervention|intervention
631683|NCT00708916|Discoid lupus|discoid lupus
631684|NCT00708916|Phosphodiesterase 5 inhibitor|phosphodiesterase 5 inhibitor
631685|NCT00708929|Age-related macular degeneration|age-related macular degeneration
631686|NCT00708929|Complement factor H|complement factor h
631687|NCT00708929|Choroidal blood flow|choroidal blood flow
631688|NCT00708942|Cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
631689|NCT00708955|Evaluation and Treatment|evaluation and treatment
631690|NCT00708955|Eye Diseases|eye diseases
631691|NCT00708968|randomized clinical trial|randomized clinical trial
631692|NCT00708968|coping|coping
631693|NCT00708968|quality of life|quality of life
631694|NCT00708968|family|family
631695|NCT00708968|family caregiver|family caregiver
631696|NCT00708968|cancer survivorship|cancer survivorship
631697|NCT00708968|communication|communication
631698|NCT00708968|uncertainty|uncertainty
631699|NCT00708968|support|support
631700|NCT00708968|family education|family education
631701|NCT00708968|Caregivers|caregivers
631702|NCT00708981|Diabetic Nephropathy|diabetic nephropathy
631703|NCT00709020|cancer survivor|cancer survivor
631704|NCT00709020|breast cancer|breast cancer
631705|NCT00709033|refractory|refractory
631706|NCT00709033|relapsed|relapsed
631707|NCT00709033|low|low
631708|NCT00709033|intermediate-grade|intermediate-grade
631709|NCT00709033|Non-Hodgkin lymphoma|non-hodgkin lymphoma
631710|NCT00709033|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
631711|NCT00709046|Endoscopic treatment|endoscopic treatment
631712|NCT00709046|Peptic ulcer|peptic ulcer
631713|NCT00709046|Bleeding|bleeding
631714|NCT00709046|Thermocoagulation|thermocoagulation
631715|NCT00709046|Proton pump inhibitors|proton pump inhibitors
631716|NCT00709059|hepatitis C|hepatitis c
631717|NCT00709072|stuttering|stuttering
631718|NCT00709072|relapse|relapse
631719|NCT00709072|Lidcombe Program|lidcombe program
631720|NCT00709072|Preschool children|preschool children
631721|NCT00709085|single nucleotide polymorphism|single nucleotide polymorphism
631722|NCT00709098|pulmonary arterial hypertension|pulmonary arterial hypertension
631723|NCT00709098|inhaled treatment|inhaled treatment
631724|NCT00709098|inhalation solution|inhalation solution
631725|NCT00709098|iloprost|iloprost
631726|NCT00709098|Ventavis|ventavis
631727|NCT00709111|CCR5 antagonist|ccr5 antagonist
631728|NCT00709111|CD4 T-cell count|cd4 t-cell count
631729|NCT00709111|immune activation|immune activation
631730|NCT00709111|treatment experienced|treatment experienced
631731|NCT00709124|Respiration, Artificial|respiration, artificial
631732|NCT00709124|Critical Illness|critical illness
631733|NCT00709124|Intensive Care Units|intensive care units
631734|NCT00709124|Electric Stimulation Therapy|electric stimulation therapy
631735|NCT00709124|Muscle Weakness|muscle weakness
631736|NCT00709124|Paresis|paresis
631737|NCT00709124|Mechanically|mechanically
631738|NCT00709124|Ventilated|ventilated
631739|NCT00709124|Patients|patients
631740|NCT00709124|Admitted|admitted
631741|NCT00709124|Medical|medical
631742|NCT00709137|resistant hypertensions|resistant hypertensions
631743|NCT00709137|spironolactone|spironolactone
631744|NCT00709137|amiloride|amiloride
631745|NCT00709137|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
631746|NCT00709150|Major Depression|major depression
631747|NCT00709150|Diabetes|diabetes
631748|NCT00709150|Hispanics|hispanics
631749|NCT00709150|Collaborative Depression Care Management|collaborative depression care management
631750|NCT00709163|Pediatric|pediatric
631751|NCT00709163|Dilated Cardiomyopathy|dilated cardiomyopathy
631752|NCT00709163|Nesiritide|nesiritide
631753|NCT00709176|Quality of Life|quality of life
631754|NCT00709176|Randomized Clinical Trial|randomized clinical trial
631755|NCT00709176|Advanced Cancer|advanced cancer
631756|NCT00709176|Breast Cancer|breast cancer
631757|NCT00709176|Colorectal Cancer|colorectal cancer
631758|NCT00709176|Lung Cancer|lung cancer
631759|NCT00709176|Prostate Cancer|prostate cancer
631760|NCT00709176|Family caregiver|family caregiver
631761|NCT00709176|cancer survivorship|cancer survivorship
631762|NCT00709176|coping|coping
631763|NCT00709176|communication|communication
631764|NCT00709176|uncertainty|uncertainty
631765|NCT00709176|support|support
631766|NCT00709176|depression|depression
631767|NCT00709176|self-efficacy|self-efficacy
631768|NCT00709176|benefits of illness|benefits of illness
631769|NCT00709176|Caregivers|caregivers
631770|NCT00709189|Pharmacokinetics|pharmacokinetics
631771|NCT00709189|Ethinyl Estradiol|ethinyl estradiol
631772|NCT00709189|Drug Interactions|drug interactions
631773|NCT00709189|Norgestimate|norgestimate
631774|NCT00709189|Contraceptives, Oral|contraceptives, oral
631775|NCT00709189|Ortho-Cyclen|ortho-cyclen
631776|NCT00709189|Folic Acid|folic acid
631777|NCT00709215|refractory TdT-positive leukemia|refractory tdt-positive leukemia
631778|NCT00709215|ALL|all
631779|NCT00709215|AML|aml
631780|NCT00709215|blastic CML|blastic cml
631781|NCT00709241|Heart failure|heart failure
631782|NCT00709241|Psychosocial factors|psychosocial factors
631783|NCT00709241|Depression|depression
631784|NCT00709241|Patient compliance|patient compliance
631785|NCT00709254|AeroLEF|aerolef
631786|NCT00709254|fentanyl|fentanyl
631787|NCT00709254|pharmacokinetics|pharmacokinetics
631788|NCT00709254|liposome|liposome
631789|NCT00709254|encapsulated|encapsulated
631790|NCT00709267|Folic Acid|folic acid
631791|NCT00709267|Chemistry, Analytical|chemistry, analytical
631792|NCT00709267|Administration, Oral|administration, oral
631793|NCT00709267|Infusions, Intravenous|infusions, intravenous
631794|NCT00709267|Biological Availability|biological availability
631795|NCT00709267|Safety|safety
631796|NCT00709280|Cystic Fibrosis|cystic fibrosis
631797|NCT00709280|hypertonic saline|hypertonic saline
631798|NCT00709280|inhaled saline|inhaled saline
631799|NCT00709293|Ischemia Reperfusion Injury|ischemia reperfusion injury
631800|NCT00709293|Pediatric Heart Transplant|pediatric heart transplant
631801|NCT00709293|ATG|atg
631802|NCT00709293|Induction Therapy|induction therapy
631803|NCT00709319|Diabetic retinopathy|diabetic retinopathy
631804|NCT00709319|Diabetic macular edema|diabetic macular edema
631805|NCT00709319|dme|dme
631806|NCT00709319|vitrectomy|vitrectomy
631807|NCT00709332|Norgestimate|norgestimate
631808|NCT00709332|Folic Acid|folic acid
631809|NCT00709332|Ortho-Cyclen|ortho-cyclen
631810|NCT00709332|Female contraception|female contraception
631811|NCT00709332|Ethinyl Estradiol|ethinyl estradiol
631812|NCT00709332|Drug Interactions|drug interactions
631813|NCT00709332|Pharmacokinetics|pharmacokinetics
631814|NCT00709332|Contraceptives, Oral|contraceptives, oral
631815|NCT00709345|Antipsychotic Medications|antipsychotic medications
631816|NCT00709345|Behavioral Interventions|behavioral interventions
631817|NCT00709358|bacteria|bacteria
631818|NCT00709358|fungi|fungi
631819|NCT00709358|real time PCR|real time pcr
631820|NCT00709358|adequate antimicrobial therapy|adequate antimicrobial therapy
631821|NCT00709358|microbial DNA|microbial dna
631822|NCT00709358|microbial diagnosis|microbial diagnosis
631823|NCT00709371|obesity|obesity
631824|NCT00709371|zonisamide|zonisamide
631825|NCT00709371|bupropion|bupropion
631826|NCT00709397|HIV-1|hiv-1
631827|NCT00709397|drug resistance|drug resistance
631828|NCT00709397|raltegravir|raltegravir
631829|NCT00709397|integrase inhibitor|integrase inhibitor
631830|NCT00709410|Cholera, Diarrhea, Vaccination, Vaccines|cholera, diarrhea, vaccination, vaccines
631831|NCT00709436|orthopedic|orthopedic
631832|NCT00709436|ketamine|ketamine
631833|NCT00709436|pain|pain
631834|NCT00709449|Age-related macular degeneration|age-related macular degeneration
631835|NCT00709449|Glaucoma|glaucoma
631836|NCT00709462|Breast cancer|breast cancer
631837|NCT00709462|Colorectal cancer|colorectal cancer
631838|NCT00709462|Pancreatic cancer|pancreatic cancer
631839|NCT00709462|Bladder cancer|bladder cancer
631840|NCT00709462|Ovarian cancer|ovarian cancer
631841|NCT00709462|Metastatic cancer|metastatic cancer
631842|NCT00709462|Locally advanced cancer|locally advanced cancer
631843|NCT00709462|Cancer Vaccine|cancer vaccine
631844|NCT00709462|Vaccine|vaccine
631845|NCT00709488|Litx™ BPH System|litx™ bph system
631846|NCT00709488|LS11|ls11
631847|NCT00709488|Talaporfin sodium|talaporfin sodium
631848|NCT00709501|weight loss|weight loss
631849|NCT00709501|obesity|obesity
631850|NCT00709501|overweight|overweight
631851|NCT00709514|Oneness|oneness
631852|NCT00709514|DCB-WH1|dcb-wh1
631853|NCT00709514|DCB-WH1-CP001|dcb-wh1-cp001
631854|NCT00709514|chronic|chronic
631855|NCT00709514|diabetic|diabetic
631856|NCT00709514|foot ulcers|foot ulcers
631857|NCT00709514|topical ointment|topical ointment
631858|NCT00709527|AMD|amd
631859|NCT00709553|ZD4054|zd4054
631860|NCT00709553|Healthy Volunteers|healthy volunteers
631861|NCT00709566|Hip|hip
631862|NCT00709566|osteoarthritis|osteoarthritis
631863|NCT00709566|exercise|exercise
631864|NCT00709566|manual therapy|manual therapy
631865|NCT00709579|Patients needing an oral corticotherapy|patients needing an oral corticotherapy
631866|NCT00709579|Patients needing a topical corticotherapy|patients needing a topical corticotherapy
631867|NCT00709579|Corticotherapy|corticotherapy
631868|NCT00709592|total body irradiation|total body irradiation
631869|NCT00709592|Allogeneic Peripheral Blood Stem Cell Transplantation|allogeneic peripheral blood stem cell transplantation
631870|NCT00709592|thymoglobulin|thymoglobulin
631871|NCT00709605|HIV Negative|hiv negative
631872|NCT00709605|Healthy|healthy
631873|NCT00709605|Immunity|immunity
631874|NCT00709605|Preventive|preventive
631875|NCT00709605|Virus|virus
631876|NCT00709605|Healthy Volunteer|healthy volunteer
631877|NCT00709605|HV|hv
631878|NCT00709618|Erbb2|erbb2
631879|NCT00709618|MBC|mbc
631880|NCT00709618|First or Second line therapy|first or second line therapy
631881|NCT00709618|Metastatic Breast Cancer|metastatic breast cancer
631882|NCT00709618|Vinorelbine|vinorelbine
631883|NCT00709618|Tykerb|tykerb
631884|NCT00709631|Malignant transformation of leg ulcer|malignant transformation of leg ulcer
631885|NCT00709631|MARJOLIN's ulcer|marjolin's ulcer
631886|NCT00709631|Biopsy|biopsy
631887|NCT00709631|Leg ulcer|leg ulcer
631888|NCT00709631|Chronic wound|chronic wound
631889|NCT00709631|Squamous cell carcinoma|squamous cell carcinoma
631890|NCT00709631|Basal cell carcinoma|basal cell carcinoma
631891|NCT00709644|Ortho Tri-Cyclen Lo|ortho tri-cyclen lo
631892|NCT00709644|Contraceptives, Oral|contraceptives, oral
631893|NCT00709644|Norgestimate|norgestimate
631894|NCT00709644|Ethinyl Estradiol|ethinyl estradiol
631895|NCT00709644|Folic Acid|folic acid
631896|NCT00709644|Female Contraception|female contraception
631897|NCT00709657|Age-related macular degeneration|age-related macular degeneration
631898|NCT00709657|anti-VEGF|anti-vegf
631899|NCT00709670|MSCT|msct
631900|NCT00709670|Echocardiography|echocardiography
631901|NCT00709670|Coronarography|coronarography
631902|NCT00709670|Acute coronary syndrome without ST segment elevation|acute coronary syndrome without st segment elevation
631903|NCT00709670|normal ECG|normal ecg
631904|NCT00709670|normal troponin|normal troponin
631905|NCT00709670|Acute|acute
631906|NCT00709696|Tobacco|tobacco
631907|NCT00709696|nicotine|nicotine
631908|NCT00709696|smoking|smoking
631909|NCT00709696|varenicline|varenicline
631910|NCT00709696|human laboratory study|human laboratory study
631911|NCT00709696|stress tolerance|stress tolerance
631912|NCT00709696|startle response|startle response
631913|NCT00709696|cognitive assessment|cognitive assessment
631914|NCT00709696|progressive ratio|progressive ratio
631915|NCT00709709|stenosis|stenosis
631916|NCT00709709|coronaropathy|coronaropathy
631917|NCT00709709|stent|stent
631918|NCT00709709|bypass surgery|bypass surgery
631919|NCT00709709|suspect|suspect
631920|NCT00709709|known|known
631921|NCT00709722|Lupus nephritis|lupus nephritis
631922|NCT00709722|Deoxyspergualin|deoxyspergualin
631923|NCT00709722|Immunosuppression|immunosuppression
631924|NCT00709735|stress disorders|stress disorders
631925|NCT00709735|post-traumatic|post-traumatic
631926|NCT00709735|memory|memory
631927|NCT00709735|propranolol|propranolol
631928|NCT00709735|psychophysiology|psychophysiology
631929|NCT00709748|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
631930|NCT00709748|TENS|tens
631931|NCT00709748|Empi|empi
631932|NCT00709748|Electrotherapy|electrotherapy
631933|NCT00709748|Back pain|back pain
631934|NCT00709748|Lower back pain|lower back pain
631935|NCT00709748|Chronic lower back pain|chronic lower back pain
631936|NCT00709761|Erbb2|erbb2
631937|NCT00709761|ABRAXANE|abraxane
631938|NCT00709761|MBC|mbc
631939|NCT00709761|first or second line therapy|first or second line therapy
631940|NCT00709761|Metastatic Breast Cancer|metastatic breast cancer
631941|NCT00709761|TYKERB|tykerb
631942|NCT00709787|Epidemiology, hypertension, risk factors, coronary heart disease, patient management, compliance with medication|epidemiology, hypertension, risk factors, coronary heart disease, patient management, compliance with medication
631943|NCT00709800|Pandemic Influenza|pandemic influenza
631944|NCT00709800|Avian Influenza|avian influenza
631945|NCT00709800|DNA Vaccines|dna vaccines
631946|NCT00709800|Antibody|antibody
631947|NCT00709800|T Cells|t cells
631949|NCT00709813|Symptom management|symptom management
631950|NCT00709813|Cancer|cancer
631951|NCT00709813|Patient-centered care|patient-centered care
631952|NCT00709839|glucocorticoid|glucocorticoid
631953|NCT00709839|hydrocortisone|hydrocortisone
631954|NCT00709839|carbohydrate metabolism|carbohydrate metabolism
631955|NCT00709839|appetite-regulatory hormones|appetite-regulatory hormones
631956|NCT00709852|Patients referred for a contrast-enhanced MRI of the CNS|patients referred for a contrast-enhanced mri of the cns
631957|NCT00709852|CNS Imaging|cns imaging
631958|NCT00709865|renal insufficiency|renal insufficiency
631959|NCT00709865|diuretic|diuretic
631960|NCT00709865|congestive heart failure|congestive heart failure
631961|NCT00709865|acute decompensated heart failure|acute decompensated heart failure
631962|NCT00709878|skin rash, lapatinib, cetuximab, erlotinib, panitumumab|skin rash, lapatinib, cetuximab, erlotinib, panitumumab
631963|NCT00709904|venous thromboprophylaxis|venous thromboprophylaxis
631964|NCT00709904|primary prevention|primary prevention
631965|NCT00709904|orthopedic surgery|orthopedic surgery
631966|NCT00709956|Ventavis|ventavis
631967|NCT00709956|iloprost|iloprost
631968|NCT00709956|inhaled treatment|inhaled treatment
631969|NCT00709956|pulmonary arterial hypertension|pulmonary arterial hypertension
631970|NCT00709969|Malaria|malaria
631971|NCT00709969|co-artemether|co-artemether
631972|NCT00709969|auditory|auditory
631973|NCT00709969|Plasmodium falciparum|plasmodium falciparum
631974|NCT00709969|marsh fever|marsh fever
631975|NCT00709969|remittent fever|remittent fever
631976|NCT00709969|artemether|artemether
631977|NCT00709969|artemisinins|artemisinins
631978|NCT00709969|lumefantrine|lumefantrine
631979|NCT00709969|child|child
631980|NCT00709969|infant|infant
631981|NCT00709969|Africa|africa
631982|NCT00709982|Norgestimate|norgestimate
631983|NCT00709982|Contraceptives, Oral|contraceptives, oral
631984|NCT00709982|Ortho-Cyclen|ortho-cyclen
631985|NCT00709982|Folic Acid|folic acid
631986|NCT00709982|Ethinyl Estradiol|ethinyl estradiol
631987|NCT00710008|type 2 diabetes,|type 2 diabetes,
631988|NCT00710008|exercise training,|exercise training,
631989|NCT00710008|ATP-synthesis,|atp-synthesis,
631990|NCT00710008|intramyocellular lipids,|intramyocellular lipids,
631991|NCT00710008|hepatocellular lipids|hepatocellular lipids
631992|NCT00710008|first degree relatives of|first degree relatives of
631993|NCT00710008|patients|patients
631994|NCT00710021|Systemic lupus erythematosus|systemic lupus erythematosus
631995|NCT00710021|SLE|sle
631996|NCT00710021|Vitamin D3|vitamin d3
631997|NCT00710021|Vitamin D deficiency|vitamin d deficiency
631998|NCT00710021|IFN alpha expression|ifn alpha expression
631999|NCT00710034|Oral Tobacco Products|oral tobacco products
632000|NCT00710034|Snus|snus
632001|NCT00710034|Smoking Substitution|smoking substitution
632002|NCT00710034|Harm Reduction|harm reduction
632003|NCT00710034|Biomarkers of Tobacco Exposure|biomarkers of tobacco exposure
632004|NCT00710047|ZD4054|zd4054
632005|NCT00710047|Zibotentan|zibotentan
632006|NCT00710047|Healthy Volunteers|healthy volunteers
632007|NCT00710060|HIV|hiv
632008|NCT00710060|Popular Opinion Leader|popular opinion leader
632009|NCT00710060|POL|pol
632010|NCT00710060|Behavioral Intervention|behavioral intervention
632011|NCT00710060|STD|std
632012|NCT00710060|STI|sti
632013|NCT00710060|Community|community
632014|NCT00710060|Prevention|prevention
632015|NCT00710060|International|international
632016|NCT00710060|Global|global
632017|NCT00710073|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
632018|NCT00710073|Neuromodulation|neuromodulation
632019|NCT00710086|Remifentanil|remifentanil
632020|NCT00710086|Patient-controlled analgesia|patient-controlled analgesia
632021|NCT00710086|Intravenous analgesia|intravenous analgesia
632022|NCT00710099|iontophoresis|iontophoresis
632023|NCT00710099|cutaneous microcirculation|cutaneous microcirculation
632024|NCT00710099|sildenafil|sildenafil
632025|NCT00710099|Healthy volunteers|healthy volunteers
632026|NCT00710112|CLD|cld
632027|NCT00710112|VLBW infants|vlbw infants
632028|NCT00710112|Toll like Receptors|toll like receptors
632029|NCT00710112|Biomarkers|biomarkers
632030|NCT00710138|Cobalamin deficiency|cobalamin deficiency
632031|NCT00710138|Infant|infant
632032|NCT00710138|Nutrition|nutrition
632033|NCT00710138|Cobalamin supplementation|cobalamin supplementation
632034|NCT00710138|Neurodevelopment|neurodevelopment
632035|NCT00710138|Neurological symptoms|neurological symptoms
632036|NCT00710151|neurotoxicity|neurotoxicity
632037|NCT00710151|cognition in survivors|cognition in survivors
632038|NCT00710151|diagnostic imaging|diagnostic imaging
632039|NCT00710177|PPHN|pphn
632040|NCT00710177|PTGS1|ptgs1
632041|NCT00710177|NSAID|nsaid
632042|NCT00710190|Drug Resistant Hypertension|drug resistant hypertension
632043|NCT00710190|Refractory Hypertension|refractory hypertension
632044|NCT00710190|High Blood Pressure|high blood pressure
632045|NCT00710190|Baroreflex Hypertension Therapy|baroreflex hypertension therapy
632046|NCT00710203|Dermatosis Papulosa Nigra|dermatosis papulosa nigra
632047|NCT00710203|seborrheic keratoses|seborrheic keratoses
632048|NCT00710216|Viral kinetics|viral kinetics
632049|NCT00710216|Viral dynamics|viral dynamics
632050|NCT00710216|Telbivudine|telbivudine
632051|NCT00710216|Lamivudine|lamivudine
632052|NCT00710229|age related macular degeneration|age related macular degeneration
632053|NCT00710229|Ranibizumab-Lucentis|ranibizumab-lucentis
632054|NCT00710229|Bevacizumab-Avastin|bevacizumab-avastin
632055|NCT00710242|prolonged labor|prolonged labor
632056|NCT00710255|Asthma|asthma
632057|NCT00710255|Exercise induced bronchospasm|exercise induced bronchospasm
632058|NCT00710255|Hyperpnea induced bronchospasm|hyperpnea induced bronchospasm
632059|NCT00710255|leukotrienes|leukotrienes
632060|NCT00710255|adenosine|adenosine
632061|NCT00710255|exhaled breath condensate|exhaled breath condensate
632062|NCT00710268|Bevacizumab|bevacizumab
632063|NCT00710268|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
632064|NCT00710268|Metastatic Solid Tumours|metastatic solid tumours
632065|NCT00710268|PARP inhibitor|parp inhibitor
632066|NCT00710281|Intracranial Aneurysm|intracranial aneurysm
632067|NCT00710281|Subarachnoid arterial aneurysm|subarachnoid arterial aneurysm
632068|NCT00710281|Aneurysm|aneurysm
632069|NCT00710281|Brain Aneurysm|brain aneurysm
632070|NCT00710281|Cerebral Aneurysm|cerebral aneurysm
632071|NCT00710281|Wall Shear Stress(WSS)|wall shear stress(wss)
632072|NCT00710281|Hemodynamic Stress|hemodynamic stress
632073|NCT00710281|Subarachnoid Hemorrhage(SAH)|subarachnoid hemorrhage(sah)
632074|NCT00710294|Refractory Hypertension|refractory hypertension
632075|NCT00710294|High Blood Pressure|high blood pressure
632076|NCT00710294|Uncontrolled Blood Pressure|uncontrolled blood pressure
632077|NCT00710320|Children core temperature,|children core temperature,
632078|NCT00710320|Pediatric surgery,|pediatric surgery,
632079|NCT00710320|Anesthesia induction|anesthesia induction
632080|NCT00710346|Leiomyoma|leiomyoma
632081|NCT00710346|Uterus|uterus
632082|NCT00710346|Fibroids|fibroids
632083|NCT00710346|Surgical|surgical
632084|NCT00710359|Cobalamin deficiency|cobalamin deficiency
632085|NCT00710359|Infant|infant
632086|NCT00710359|Nutrition|nutrition
632087|NCT00710359|Cobalamin supplementation|cobalamin supplementation
632088|NCT00710359|Feeding problems|feeding problems
632089|NCT00710359|Gastrointestinal symptoms|gastrointestinal symptoms
632090|NCT00710398|Dairy Products|dairy products
632091|NCT00710398|Dietary Protein|dietary protein
632092|NCT00710398|Body Composition|body composition
632093|NCT00710398|Fat mass loss|fat mass loss
632094|NCT00710398|Lean mass gain|lean mass gain
632095|NCT00710398|Pre-menopausal Women|pre-menopausal women
632096|NCT00710411|humans|humans
632097|NCT00710411|patients|patients
632098|NCT00710411|polytrauma|polytrauma
632099|NCT00710411|complement|complement
632100|NCT00710411|inflammation|inflammation
632101|NCT00710411|inflammatory response|inflammatory response
632102|NCT00710411|biomarkers|biomarkers
632103|NCT00710411|cytokines|cytokines
632104|NCT00710411|cell surface markers|cell surface markers
632105|NCT00710411|apoptosis|apoptosis
632106|NCT00710411|NF-kappaB|nf-kappab
632107|NCT00710411|functional polymorphisms|functional polymorphisms
632108|NCT00710411|mesenchymal stem cell|mesenchymal stem cell
632109|NCT00710411|severity of injury|severity of injury
632111|NCT00710411|infections|infections
632112|NCT00710411|systemic inflammatory response syndrome|systemic inflammatory response syndrome
632113|NCT00710411|SIRS|sirs
632114|NCT00710411|sepsis|sepsis
632115|NCT00710411|severe sepsis|severe sepsis
632116|NCT00710411|shock|shock
632117|NCT00710411|organ dysfunctions|organ dysfunctions
632118|NCT00710411|SOFA|sofa
632119|NCT00710411|severity of disease|severity of disease
632120|NCT00710411|APACHEII|apacheii
632121|NCT00710411|SAPSII|sapsii
632122|NCT00710411|SPAPS3|spaps3
632123|NCT00710411|length of stay|length of stay
632124|NCT00710411|wound healing|wound healing
632125|NCT00710411|outcome|outcome
632126|NCT00710411|mortality|mortality
632127|NCT00710424|Pain|pain
632128|NCT00710424|diabetic neuropathy|diabetic neuropathy
632129|NCT00710437|Dexmedetomidine|dexmedetomidine
632130|NCT00710437|Carotid Endarterectomy|carotid endarterectomy
632131|NCT00710437|Electroencephalogram|electroencephalogram
632132|NCT00710450|IL13|il13
632133|NCT00710450|leukotriene|leukotriene
632134|NCT00710450|histamine|histamine
632136|NCT00710450|Must be allergic asthma or allergic rhinitis|must be allergic asthma or allergic rhinitis
632137|NCT00710463|COPD|copd
632138|NCT00710463|non invasive ventilation|non invasive ventilation
632139|NCT00710463|pulmonary rehabilitation|pulmonary rehabilitation
632140|NCT00710489|Acne|acne
632141|NCT00710489|Actinic Keratosis|actinic keratosis
632142|NCT00710489|Dysplastic Nevi|dysplastic nevi
632143|NCT00710489|Eczema|eczema
632144|NCT00710489|Psoriasis|psoriasis
632145|NCT00710489|Vitiligo|vitiligo
632146|NCT00710489|Skin Cancer|skin cancer
632147|NCT00710489|Rosacea|rosacea
632148|NCT00710489|Leg or Foot Ulcers|leg or foot ulcers
632149|NCT00710489|Atopic Dermatosis|atopic dermatosis
632150|NCT00710502|Transvaginal|transvaginal
632151|NCT00710502|NOTES|notes
632152|NCT00710502|Cholecystectomy|cholecystectomy
632153|NCT00710502|Laparoscopic|laparoscopic
632154|NCT00710515|Melanoma|melanoma
632155|NCT00710515|Phase I|phase i
632156|NCT00710515|AZD6244|azd6244
632157|NCT00710528|CLL|cll
632158|NCT00710528|NHL|nhl
632159|NCT00710528|AML|aml
632160|NCT00710528|MM|mm
632161|NCT00710528|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
632162|NCT00710541|non invasive ventilation|non invasive ventilation
632163|NCT00710541|COPD|copd
632164|NCT00710541|hypercapnia|hypercapnia
632165|NCT00710541|GOLD stage IV|gold stage iv
632166|NCT00710554|Pain|pain
632167|NCT00710554|Peripheral Neuropathy|peripheral neuropathy
632168|NCT00710554|Allodynia|allodynia
632169|NCT00710567|Heart Failure|heart failure
632170|NCT00710567|LVAS|lvas
632171|NCT00710567|LVAD|lvad
632172|NCT00710567|Rotary Pump|rotary pump
632173|NCT00710593|Highly-active antiretroviral therapy|highly-active antiretroviral therapy
632174|NCT00710593|Human papillomavirus|human papillomavirus
632175|NCT00710593|HPV vaccine|hpv vaccine
632176|NCT00710606|contraceptive ring|contraceptive ring
632177|NCT00710606|obesity|obesity
632178|NCT00710606|pharmacokinetics|pharmacokinetics
632179|NCT00710606|pharmacodynamics|pharmacodynamics
632180|NCT00710606|Pharmacokinetics of the contraceptive ring in obese women.|pharmacokinetics of the contraceptive ring in obese women.
632181|NCT00710632|cachexia|cachexia
632182|NCT00710632|lung cancer|lung cancer
632183|NCT00710632|gastrointestinal cancer|gastrointestinal cancer
632184|NCT00710632|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
632185|NCT00710632|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
632186|NCT00710645|Multiple Sclerosis|multiple sclerosis
632187|NCT00710645|Spasticity|spasticity
632188|NCT00710658|Internet support|internet support
632189|NCT00710658|Tailored information|tailored information
632190|NCT00710658|Self-management|self-management
632191|NCT00710658|Quality of life|quality of life
632192|NCT00710658|Online messaging|online messaging
632193|NCT00710658|Online discussion groups|online discussion groups
632194|NCT00710671|HIV positive|hiv positive
632195|NCT00710671|YMSM|ymsm
632196|NCT00710671|risk factors|risk factors
632197|NCT00710671|coping|coping
632198|NCT00710671|identity development|identity development
632199|NCT00710671|psychosocial needs|psychosocial needs
632200|NCT00710684|Alzheimer's disease cognition SB-742457|alzheimer's disease cognition sb-742457
632201|NCT00710697|Bladder Cancer|bladder cancer
632202|NCT00710697|Breast Cancer|breast cancer
632203|NCT00710697|Colorectal Cancer|colorectal cancer
632204|NCT00710697|Gastrointestinal Neoplasm|gastrointestinal neoplasm
632205|NCT00710697|Head and Neck Cancer|head and neck cancer
632206|NCT00710697|Lung Cancer|lung cancer
632207|NCT00710697|Ovarian Cancer|ovarian cancer
632208|NCT00710697|Pancreatic Cancer|pancreatic cancer
632209|NCT00710697|Prostrate Cancer|prostrate cancer
632210|NCT00702455|Weight loss maintenance.|weight loss maintenance.
634082|NCT00716872|Internet|internet
632211|NCT00702455|Interactive phone and mail-based intervention.|interactive phone and mail-based intervention.
632212|NCT00702468|Spasticity|spasticity
632213|NCT00702468|Multiple Sclerosis|multiple sclerosis
632214|NCT00702481|Head and Neck Squamous Cell Cancer|head and neck squamous cell cancer
632215|NCT00702481|Chemoradiation|chemoradiation
632216|NCT00702481|EGFR monoclonal antibody|egfr monoclonal antibody
632217|NCT00702494|placental growth factor|placental growth factor
632218|NCT00702494|monoclonal antibody|monoclonal antibody
632219|NCT00702494|Phase I|phase i
632220|NCT00702494|solid tumors|solid tumors
632221|NCT00702494|Patients with solid tumors|patients with solid tumors
632222|NCT00702507|Diaper dermatitis complicated by candidiasis|diaper dermatitis complicated by candidiasis
632223|NCT00702520|Neonatal outcome|neonatal outcome
632224|NCT00702520|Congenital malformations|congenital malformations
632225|NCT00702520|In-Vitro fertilization|in-vitro fertilization
632226|NCT00702520|Controlled ovarian stimulation|controlled ovarian stimulation
632227|NCT00702520|Follow-up|follow-up
632228|NCT00702533|Hyper/Hyposecretion|hyper/hyposecretion
632229|NCT00702533|Gastric Analysis|gastric analysis
632230|NCT00702533|Gastric pH|gastric ph
632231|NCT00702533|SmartPill|smartpill
632232|NCT00702533|ph Monitoring|ph monitoring
632233|NCT00702533|Gastric Secretion|gastric secretion
632234|NCT00702533|Gastric Acid Output|gastric acid output
632235|NCT00702533|Healthy Volunteer|healthy volunteer
632236|NCT00702533|HV|hv
632237|NCT00702546|In-vitro fertilization|in-vitro fertilization
632238|NCT00702546|Controlled Ovarian Stimulation|controlled ovarian stimulation
632239|NCT00702546|Cumulative pregnancy data|cumulative pregnancy data
632240|NCT00702546|Follow-up|follow-up
632241|NCT00702572|Phase I|phase i
632242|NCT00702572|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
632243|NCT00702585|Ovulation Induction|ovulation induction
632244|NCT00702585|Pharmacological effects of drugs|pharmacological effects of drugs
632245|NCT00702585|Hormones|hormones
632246|NCT00702585|Hormone substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
632247|NCT00702585|Pharmacological Actions|pharmacological actions
632248|NCT00702585|Randomized|randomized
632249|NCT00702585|Multi-center|multi-center
632250|NCT00702585|Multi-national|multi-national
632251|NCT00702598|Depression|depression
632252|NCT00702598|occupational function|occupational function
632253|NCT00702598|rating scales|rating scales
632255|NCT00702598|cognitive behaviour therapy|cognitive behaviour therapy
632256|NCT00702598|CBT|cbt
632257|NCT00702598|escitalopram|escitalopram
632258|NCT00702598|antidepressants|antidepressants
632259|NCT00702611|Ulcerative Colitis|ulcerative colitis
632260|NCT00702611|Inflammatory Bowel disease|inflammatory bowel disease
632261|NCT00702611|Steroid dependent|steroid dependent
632262|NCT00702611|Adacolumn|adacolumn
632263|NCT00702611|Apheresis|apheresis
632264|NCT00702611|Granulocyte Monocyte apheresis|granulocyte monocyte apheresis
632265|NCT00702611|GMA apheresis|gma apheresis
632266|NCT00702611|Granulocytapheresis|granulocytapheresis
632267|NCT00702624|Neonatal outcome|neonatal outcome
632268|NCT00702624|Congenital malformations|congenital malformations
632269|NCT00702624|In-Vitro fertilization|in-vitro fertilization
632270|NCT00702624|Controlled ovarian stimulation|controlled ovarian stimulation
632271|NCT00702624|Follow-up|follow-up
632272|NCT00702637|Traumatic Brain Injury|traumatic brain injury
632273|NCT00702637|Fatigue|fatigue
632274|NCT00702637|Modafinil|modafinil
632275|NCT00702637|Somnolence|somnolence
632276|NCT00702663|Hepatitis B|hepatitis b
632277|NCT00702663|Hepatitis B vaccination|hepatitis b vaccination
632278|NCT00702663|booster effect|booster effect
632279|NCT00702663|Taiwan|taiwan
632280|NCT00702663|young adults|young adults
632281|NCT00702676|Healthy Volunteers|healthy volunteers
632282|NCT00702689|Skin Sclerosis|skin sclerosis
632283|NCT00702689|Graft Versus Host Disease|graft versus host disease
632284|NCT00702702|Uterine fibroids|uterine fibroids
632285|NCT00702702|Anemia|anemia
632286|NCT00710749|Lower urinary tract symptoms leading to lower flow rates|lower urinary tract symptoms leading to lower flow rates
632287|NCT00710775|Aortic valve stenosis|aortic valve stenosis
632288|NCT00710775|Heart surgery|heart surgery
632289|NCT00710775|Endovascular techniques|endovascular techniques
632290|NCT00710788|QT interval|qt interval
632291|NCT00710788|QT dispersion|qt dispersion
632292|NCT00710788|arrhythmias|arrhythmias
632293|NCT00710788|death|death
632294|NCT00710788|TC score|tc score
632295|NCT00710801|Hepatitis C Virus|hepatitis c virus
632296|NCT00710801|HCV|hcv
632297|NCT00710801|Liver Transplant|liver transplant
632298|NCT00710801|Cyclosporine|cyclosporine
632299|NCT00710801|Tacrolimus|tacrolimus
632300|NCT00710801|Myfortic|myfortic
632301|NCT00710814|Roux-en-Y gastric bypass|roux-en-y gastric bypass
632302|NCT00710814|Leptin|leptin
632303|NCT00710814|Bariatric surgery|bariatric surgery
632304|NCT00710814|Overweight after Roux-en-Y gastric bypass surgery|overweight after roux-en-y gastric bypass surgery
632305|NCT00710827|NEBIDO,|nebido,
632306|NCT00710827|Hypogonadism,|hypogonadism,
632307|NCT00710827|Symptomatic late onset,|symptomatic late onset,
632308|NCT00710827|Testosterone deficiency|testosterone deficiency
632309|NCT00710840|Knee Replacement|knee replacement
632310|NCT00710840|Knee OA|knee oa
632312|NCT00710853|Geriatric|geriatric
632313|NCT00710853|Qi gong|qi gong
632314|NCT00710853|Yoga|yoga
632315|NCT00710853|Tai chi|tai chi
632316|NCT00710853|Geriatric Assessment|geriatric assessment
632317|NCT00710866|Influenza Vaccines|influenza vaccines
632318|NCT00710866|Infant|infant
632319|NCT00710866|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
632320|NCT00710879|Efficacy|efficacy
632321|NCT00710892|suicide gene-modified allodepleted donor lymphocytes|suicide gene-modified allodepleted donor lymphocytes
632322|NCT00710892|given to recipients of haploidentical stem cell transplants|given to recipients of haploidentical stem cell transplants
632323|NCT00710892|Stage III|stage iii
632324|NCT00710892|Stage IV|stage iv
632325|NCT00710892|Myelodysplastic syndrome|myelodysplastic syndrome
632326|NCT00710892|AML after first relapse|aml after first relapse
632327|NCT00710892|primary refractory disease|primary refractory disease
632328|NCT00710892|CML|cml
632329|NCT00710892|Hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
632330|NCT00710892|familial hemophagocytic lymphohistiocytosis (FLH)|familial hemophagocytic lymphohistiocytosis (flh)
752351|NCT01172600|recurrent low back pain|recurrent low back pain
632331|NCT00710892|viral-associated hemophagocytic syndrome (VAHS)|viral-associated hemophagocytic syndrome (vahs)
632332|NCT00710892|Severe chronic active Epstein Barr virus infection (SCAEBV)|severe chronic active epstein barr virus infection (scaebv)
632333|NCT00710892|T or NK cell malignancy|t or nk cell malignancy
632334|NCT00710892|X-linked lymphoproliferative disease (XLP)|x-linked lymphoproliferative disease (xlp)
632335|NCT00710905|Cataract IOL ReSTOR Aspheric|cataract iol restor aspheric
632336|NCT00710905|Bilateral cataract|bilateral cataract
632337|NCT00710931|Bilateral Cataract|bilateral cataract
632338|NCT00710931|IOL|iol
632339|NCT00710931|ReSTOR|restor
632340|NCT00710931|Aspheric|aspheric
632341|NCT00710944|Jaw, Edentulous, Partially (missing/extracted/avulsed teeth in the maxilla within zone 15(4)-25(13))|jaw, edentulous, partially (missing/extracted/avulsed teeth in the maxilla within zone 15(4)-25(13))
632342|NCT00710957|Vitamin D|vitamin d
632343|NCT00710957|Physical Function|physical function
632344|NCT00710957|Falls|falls
632347|NCT00710970|Urinary Bladder Neoplasms|urinary bladder neoplasms
632348|NCT00710970|Previous Chemotherapy|previous chemotherapy
632349|NCT00710970|Tamoxifen|tamoxifen
632350|NCT00710970|Anti-tumor activity|anti-tumor activity
632351|NCT00710983|Mortality|mortality
632352|NCT00710983|Morbidity|morbidity
632353|NCT00710983|Growth|growth
632354|NCT00710983|Immunology|immunology
632355|NCT00710996|AcrySof IQ IOL|acrysof iq iol
632356|NCT00711009|Human Immunodeficiency Virus infection|human immunodeficiency virus infection
632357|NCT00711022|Jaw, Edentulous (maxilla, with poor bone quality and quantity)|jaw, edentulous (maxilla, with poor bone quality and quantity)
632358|NCT00711035|CMV|cmv
632359|NCT00711035|Adenovirus|adenovirus
632360|NCT00711035|EBV|ebv
632361|NCT00711035|non-myeloablative transplants|non-myeloablative transplants
632362|NCT00711035|Prior allogeneic hematopoietic stem cell transplant|prior allogeneic hematopoietic stem cell transplant
632363|NCT00711048|GERD|gerd
632364|NCT00711048|healthy volunteer|healthy volunteer
632365|NCT00711048|esophagus|esophagus
632366|NCT00711048|pain|pain
632367|NCT00711932|Ovarian Cancer|ovarian cancer
632368|NCT00711932|TRA-8|tra-8
632369|NCT00711932|Monoclonal Antibody|monoclonal antibody
632370|NCT00711932|Tissue Slice Technology|tissue slice technology
632371|NCT00711945|Crohn's disease|crohn's disease
632372|NCT00711945|Relapse|relapse
632373|NCT00711945|outcomes|outcomes
632374|NCT00711945|growth|growth
632375|NCT00711958|Chemotherapy associated anemia in cancer patients|chemotherapy associated anemia in cancer patients
632376|NCT00711984|renal artery stenosis|renal artery stenosis
632377|NCT00711984|stent|stent
632378|NCT00711984|comparison of treatments|comparison of treatments
632379|NCT00711984|progression|progression
632380|NCT00711984|atherosclerosis|atherosclerosis
632381|NCT00711984|peripheral artery disease|peripheral artery disease
632382|NCT00711984|major cardiovascular events|major cardiovascular events
632383|NCT00711997|H19 gene, plasmid, diphtheria toxin, pancreatic cancer|h19 gene, plasmid, diphtheria toxin, pancreatic cancer
632384|NCT00712010|Glucose|glucose
632385|NCT00712010|Insulin|insulin
632386|NCT00712023|Hypothermia|hypothermia
632387|NCT00712023|Vascular surgery|vascular surgery
632388|NCT00712023|Forced-air warming mattress|forced-air warming mattress
632389|NCT00712023|Circulating-water mattress|circulating-water mattress
632390|NCT00712036|Heroin dependence|heroin dependence
632391|NCT00712036|Interim Methadone Treatment|interim methadone treatment
632392|NCT00712036|Counseling|counseling
632393|NCT00712049|intima-media-thickness|intima-media-thickness
632394|NCT00712049|dyslipidemia|dyslipidemia
632395|NCT00712049|progression of atherosclerosis|progression of atherosclerosis
632396|NCT00712049|peripheral artery disease|peripheral artery disease
632397|NCT00712049|major cardiovascular events|major cardiovascular events
632398|NCT00712062|PCNSL|pcnsl
632399|NCT00712062|Pemetrexed|pemetrexed
632400|NCT00712062|Alimta|alimta
632401|NCT00712062|Recurrent|recurrent
632402|NCT00712062|Progressive|progressive
632403|NCT00712075|Cognitive Behavioral Therapy|cognitive behavioral therapy
632404|NCT00712075|Social Skills Training|social skills training
632405|NCT00712075|Experience Sampling Method|experience sampling method
632406|NCT00712075|Computer-assisted therapy|computer-assisted therapy
632407|NCT00712075|schizophrenia|schizophrenia
632408|NCT00712088|HIV|hiv
632409|NCT00712088|Unsafe Sex|unsafe sex
632410|NCT00712088|High Risk Sex|high risk sex
632411|NCT00712088|HIV Prevention|hiv prevention
632412|NCT00712088|African-American|african-american
632413|NCT00712088|gay|gay
632414|NCT00712088|bisexual|bisexual
632415|NCT00712088|intervention trial|intervention trial
632416|NCT00712101|infarction|infarction
632417|NCT00712101|intervention|intervention
632418|NCT00712101|stent|stent
632419|NCT00712101|abciximab|abciximab
632420|NCT00712101|platelets|platelets
632421|NCT00712114|phase I|phase i
632422|NCT00712114|safety|safety
632423|NCT00712114|tolerance|tolerance
632424|NCT00712114|rheumatoid arthritis|rheumatoid arthritis
632425|NCT00712114|pharmacokinetics|pharmacokinetics
632426|NCT00712114|methotrexate|methotrexate
632427|NCT00712114|anti-inflammatory|anti-inflammatory
632428|NCT00712127|Body Fat|body fat
632429|NCT00712127|Exercise|exercise
632430|NCT00712127|Metabolic syndrome|metabolic syndrome
632431|NCT00712127|Obesity|obesity
632432|NCT00712127|Nutrition|nutrition
632433|NCT00712127|Physical Activity|physical activity
632434|NCT00712127|Weight Loss|weight loss
632435|NCT00712140|stage IA breast cancer|stage ia breast cancer
632436|NCT00712140|stage IB breast cancer|stage ib breast cancer
632437|NCT00712140|stage II breast cancer|stage ii breast cancer
632438|NCT00712140|stage IIIA breast cancer|stage iiia breast cancer
632439|NCT00712140|HER2-positive breast cancer|her2-positive breast cancer
632440|NCT00712153|multislice computed tomography|multislice computed tomography
632441|NCT00712153|coronary artery bypass grafting|coronary artery bypass grafting
632442|NCT00712153|Patients|patients
632443|NCT00712153|underwent|underwent
632444|NCT00712153|surgeries|surgeries
632445|NCT00712166|cystic fibrosis|cystic fibrosis
632446|NCT00712166|pseudomonas aeruginosa|pseudomonas aeruginosa
632447|NCT00712166|lung infection|lung infection
632448|NCT00712166|CFQ-R|cfq-r
632449|NCT00712166|inhaled antibiotic|inhaled antibiotic
632450|NCT00712166|aztreonam lysine|aztreonam lysine
632451|NCT00712179|Stroke|stroke
632452|NCT00712179|walking|walking
632453|NCT00712179|Treadmill|treadmill
632454|NCT00712179|body weight support system|body weight support system
632455|NCT00712192|coronary artery bypass grafting|coronary artery bypass grafting
632456|NCT00712192|endoscopic vein harvest|endoscopic vein harvest
632457|NCT00712192|saphenous vein|saphenous vein
632458|NCT00712192|endothelial cells|endothelial cells
632459|NCT00712192|eNOS|enos
632460|NCT00712192|ET-1|et-1
632461|NCT00712205|Asthma|asthma
632462|NCT00712205|Vitamin D|vitamin d
632463|NCT00712218|Ovarian cancer, FIGO stage IIB-IV|ovarian cancer, figo stage iib-iv
632464|NCT00712231|pseudophakic|pseudophakic
632465|NCT00712231|anterior chamber depth|anterior chamber depth
632466|NCT00712231|Pentacam|pentacam
632467|NCT00712244|Discovisc|discovisc
632468|NCT00712244|Ophthalmic Viscosurgical Device|ophthalmic viscosurgical device
632469|NCT00712257|treatment of superficial femoral artery instent restenosis|treatment of superficial femoral artery instent restenosis
632470|NCT00712270|Schizophrenia|schizophrenia
632471|NCT00712270|Antipsychotic drug treatment response|antipsychotic drug treatment response
632472|NCT00712270|Risperidone|risperidone
632473|NCT00712270|Aripiprazole|aripiprazole
632474|NCT00712270|Fallypride|fallypride
632475|NCT00712270|Positron emission tomography|positron emission tomography
632476|NCT00712270|Magnetic Resonance Imaging|magnetic resonance imaging
632477|NCT00712270|Dopamine D2 Receptors|dopamine d2 receptors
632478|NCT00712283|fitness to drive|fitness to drive
632479|NCT00712283|operate machines|operate machines
632480|NCT00712283|To determine the fitness to drive and operate machines.|to determine the fitness to drive and operate machines.
632481|NCT00712296|Asthma|asthma
632482|NCT00712296|alternative medicine|alternative medicine
632483|NCT00712296|complementary medicine|complementary medicine
632484|NCT00712296|herbal therapy|herbal therapy
632485|NCT00712309|atherosclerotic|atherosclerotic
632486|NCT00712309|lesions|lesions
632487|NCT00712322|Pediatric, Children, Urodynamics, Oral Suspension, Overactive bladder, Dose-finding, Neurogenic Detrusor Overactivity, Meningomyelocele, Spinal cord injury|pediatric, children, urodynamics, oral suspension, overactive bladder, dose-finding, neurogenic detrusor overactivity, meningomyelocele, spinal cord injury
632488|NCT00712335|asthmatics|asthmatics
632489|NCT00712335|smokers|smokers
632490|NCT00712335|inhaled corticosteroids|inhaled corticosteroids
632491|NCT00712335|leukotriene receptor antagonists|leukotriene receptor antagonists
632492|NCT00712348|Gaucher disease|gaucher disease
632493|NCT00712348|imiglucerase|imiglucerase
632494|NCT00712348|glucocerebrosidase|glucocerebrosidase
632495|NCT00712348|enzyme replacement therapy|enzyme replacement therapy
632496|NCT00712348|lysosomal storage disorder|lysosomal storage disorder
632497|NCT00712361|Invasive|invasive
632498|NCT00712361|Non-Invasive|non-invasive
632499|NCT00712361|Peripheral blood parameters|peripheral blood parameters
632500|NCT00712361|Finger mounted device|finger mounted device
632501|NCT00712361|Blood tissue|blood tissue
632502|NCT00712361|Tissue color distribution|tissue color distribution
632503|NCT00712361|Accuracy|accuracy
632504|NCT00712361|Tissue pigmentation|tissue pigmentation
632505|NCT00712361|pH|ph
632506|NCT00712361|Hemoglobin|hemoglobin
632507|NCT00712361|Hematocrit|hematocrit
632508|NCT00712361|SpO2|spo2
632509|NCT00712361|Blood pressure|blood pressure
632510|NCT00712361|Pulse|pulse
632511|NCT00712361|CO2|co2
632512|NCT00712374|Malaria|malaria
632513|NCT00712374|All causes mortality|all causes mortality
632514|NCT00712374|Cost effectiveness|cost effectiveness
632515|NCT00712400|Latanoprost|latanoprost
632516|NCT00712400|Choroidal Blood Flow|choroidal blood flow
632517|NCT00712400|Intraocular Pressure|intraocular pressure
632518|NCT00712413|Helicobacter pylori infection|helicobacter pylori infection
632519|NCT00712413|Quadruple therapy|quadruple therapy
632520|NCT00712413|Safety|safety
632521|NCT00712413|Efficacy|efficacy
632522|NCT00712413|Tolerability|tolerability
632523|NCT00712413|BID dosing|bid dosing
632524|NCT00712426|Huntington's disease|huntington's disease
632525|NCT00712426|Creatine|creatine
632526|NCT00712426|Mitochondrial Dysfunction|mitochondrial dysfunction
632527|NCT00712426|Total Functional Capacity|total functional capacity
632529|NCT00712439|DPN,|dpn,
632530|NCT00712439|Diabetic|diabetic
632531|NCT00712439|Peripheral|peripheral
632532|NCT00712439|Neuropathy|neuropathy
632533|NCT00712439|Painful|painful
632534|NCT00712452|fertility|fertility
632535|NCT00712452|chemotherapy|chemotherapy
632536|NCT00712465|Atrial fibrillation|atrial fibrillation
632537|NCT00712465|interaction|interaction
632538|NCT00712465|pharmacokinetic|pharmacokinetic
632539|NCT00712491|wet AMD|wet amd
632540|NCT00712491|CNV|cnv
632541|NCT00712504|advanced solid tumors, non small cell lung cancer, pulmonary neoplasms, sunitinib (SUTENT), docetaxel (Taxotere), Angiogenesis Inhibitors|advanced solid tumors, non small cell lung cancer, pulmonary neoplasms, sunitinib (sutent), docetaxel (taxotere), angiogenesis inhibitors
632542|NCT00712517|postoperative pain|postoperative pain
632543|NCT00712517|Piritramid|piritramid
632544|NCT00712517|propofol|propofol
632545|NCT00712517|sevoflurane|sevoflurane
632546|NCT00712517|varicose vein|varicose vein
632547|NCT00712517|Anesthesia|anesthesia
632549|NCT00712530|Vaccine|vaccine
632550|NCT00712530|Immune Therapy|immune therapy
632551|NCT00712530|DermaVir|dermavir
632552|NCT00712543|constipation|constipation
632553|NCT00712543|laxative|laxative
632554|NCT00712543|lactulose|lactulose
632555|NCT00712543|Kristalose®|kristalose®
632556|NCT00712556|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
632557|NCT00712556|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
632558|NCT00712556|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
632559|NCT00712556|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
632560|NCT00712556|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
632561|NCT00712556|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
632562|NCT00712556|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
632563|NCT00712556|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
632564|NCT00712556|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
632565|NCT00712556|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
632566|NCT00712556|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
632567|NCT00712556|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
632568|NCT00712556|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
632569|NCT00712556|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
632570|NCT00712556|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
632571|NCT00712556|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
632572|NCT00712556|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
632573|NCT00712556|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
632574|NCT00712556|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
632575|NCT00712556|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
632576|NCT00712556|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
632577|NCT00712556|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
632578|NCT00712556|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
632579|NCT00712556|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
632580|NCT00712556|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
632581|NCT00712556|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
632582|NCT00712556|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
633167|NCT00706290|depression|depression
632583|NCT00712556|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
632584|NCT00712556|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
634083|NCT00716872|SHUTi|shuti
632585|NCT00712556|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
632586|NCT00712556|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
632587|NCT00712556|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
632588|NCT00712556|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
632589|NCT00712556|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
632590|NCT00712556|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
632591|NCT00712556|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
632592|NCT00712556|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
632593|NCT00712556|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
632594|NCT00712556|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
633947|NCT00716196|EUS|eus
632595|NCT00712556|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
632596|NCT00712556|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
632597|NCT00712556|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
632598|NCT00712556|splenic marginal zone lymphoma|splenic marginal zone lymphoma
632599|NCT00712556|NC stage II adult immunoblastic large cell lymphoma|nc stage ii adult immunoblastic large cell lymphoma
632600|NCT00712556|NC stage II adult lymphoblastic lymphoma|nc stage ii adult lymphoblastic lymphoma
632601|NCT00712556|NC stage II grade 1 follicular lymphoma|nc stage ii grade 1 follicular lymphoma
632602|NCT00712556|NC stage II grade 2 follicular lymphoma|nc stage ii grade 2 follicular lymphoma
632603|NCT00712556|NC stage II grade 3 follicular lymphoma|nc stage ii grade 3 follicular lymphoma
632604|NCT00712556|NC stage II mantle cell lymphoma|nc stage ii mantle cell lymphoma
632605|NCT00712556|NC stage II marginal zone lymphoma|nc stage ii marginal zone lymphoma
632606|NCT00712556|NC stage II small lymphocytic lymphoma|nc stage ii small lymphocytic lymphoma
632607|NCT00712569|Communication|communication
632608|NCT00712569|Internet|internet
632609|NCT00712569|Physician|physician
632611|NCT00712569|08-079|08-079
632612|NCT00712582|Non-Hodgkin|non-hodgkin
632613|NCT00712582|Lymphoma|lymphoma
632614|NCT00712582|Rituximab|rituximab
632615|NCT00712582|Cyclophosphamide|cyclophosphamide
632621|NCT00712582|stem cell transplant|stem cell transplant
632622|NCT00712582|08-026|08-026
632623|NCT00712595|Uterine fibroids|uterine fibroids
632624|NCT00712595|mifepristone|mifepristone
632625|NCT00712595|antiprogestins|antiprogestins
632626|NCT00712608|Term|term
632627|NCT00712608|Infant|infant
632628|NCT00712608|Formula|formula
632629|NCT00712621|Genetics Home Reference related topics|genetics home reference related topics
632630|NCT00712621|breast cancer|breast cancer
632631|NCT00712621|breast cancer related to depression|breast cancer related to depression
632632|NCT00712621|Condition|condition
632633|NCT00712621|Stage I-IV Carcinoma of Breast|stage i-iv carcinoma of breast
632634|NCT00712634|cytomegalovirus infection|cytomegalovirus infection
632635|NCT00712660|prevention|prevention
632636|NCT00712660|relapse|relapse
632637|NCT00712660|schizophrenia|schizophrenia
632638|NCT00712673|hyperglycemia, GLP-1, metformin|hyperglycemia, glp-1, metformin
632639|NCT00712699|Preschool|preschool
632640|NCT00712699|Children|children
632641|NCT00712699|ADHD|adhd
632642|NCT00712699|Medication|medication
632643|NCT00712699|Controlled Study|controlled study
632644|NCT00712699|Placebo|placebo
632645|NCT00712699|Mixed Amphetamine Salts|mixed amphetamine salts
632646|NCT00712712|bone metastases|bone metastases
632647|NCT00712712|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
632648|NCT00712712|pain|pain
632649|NCT00712738|Nifedipine|nifedipine
632650|NCT00712738|Thalassemia|thalassemia
632651|NCT00712738|Hemochromatosis|hemochromatosis
632652|NCT00712738|Iron Overload|iron overload
632653|NCT00712738|Iron Excretion|iron excretion
632654|NCT00712751|Rectum|rectum
632655|NCT00712751|Quality of Life|quality of life
632656|NCT00712751|Sexual Health|sexual health
632657|NCT00712751|08-073|08-073
632658|NCT00712764|Adenosine|adenosine
632659|NCT00712764|Choroidal blood flow|choroidal blood flow
632660|NCT00712764|Suction cup|suction cup
632661|NCT00712777|Brimonidine|brimonidine
632662|NCT00712777|alpha 2 receptor polymorphism|alpha 2 receptor polymorphism
632663|NCT00712777|Intraocular Pressure|intraocular pressure
632664|NCT00712790|First line treatment for Hepatocellular Carcinoma|first line treatment for hepatocellular carcinoma
632665|NCT00712816|osteoarthritis|osteoarthritis
632666|NCT00712816|total knee arthroplasty|total knee arthroplasty
632667|NCT00712816|cryotherapy|cryotherapy
632668|NCT00712829|Prostate cancer|prostate cancer
632669|NCT00712829|Imaging|imaging
632670|NCT00712842|Diabetes|diabetes
632671|NCT00712842|ocular blood flow|ocular blood flow
632672|NCT00712855|Liver Cancer|liver cancer
632673|NCT00712894|Acute myocardial infarction|acute myocardial infarction
632674|NCT00712894|Percutaneous coronary intervention|percutaneous coronary intervention
632675|NCT00712894|No-reflow phenomenon|no-reflow phenomenon
632676|NCT00712894|Vasodilator agents|vasodilator agents
632677|NCT00712907|vitamin C|vitamin c
632678|NCT00712907|retinal blood flow|retinal blood flow
632679|NCT00712907|intraocular pressure|intraocular pressure
632680|NCT00712907|retinal vessel diameter|retinal vessel diameter
632682|NCT00712933|Belimumab|belimumab
632683|NCT00712933|Antibodies|antibodies
632684|NCT00712933|Systemic Lupus Erythematosus|systemic lupus erythematosus
632685|NCT00712933|Lupus|lupus
632686|NCT00712933|Autoimmune Diseases|autoimmune diseases
632687|NCT00712959|Pertussis|pertussis
632688|NCT00712959|Tetanus|tetanus
632689|NCT00712959|Diphtheria|diphtheria
632690|NCT00712959|Acellular pertussis|acellular pertussis
632691|NCT00712959|ADACEL®,|adacel®,
632692|NCT00712959|Tdap vaccine|tdap vaccine
632693|NCT00712972|knee injection|knee injection
632694|NCT00712972|parapatellar|parapatellar
632695|NCT00712985|Breast cancer|breast cancer
632696|NCT00712985|aromatase inhibitors|aromatase inhibitors
634042|NCT00716729|Hip|hip
632697|NCT00712998|radiation injuries|radiation injuries
632698|NCT00712998|free radicals|free radicals
632699|NCT00712998|reactive oxygen species|reactive oxygen species
632700|NCT00712998|radiation injury from X-ray computed tomography|radiation injury from x-ray computed tomography
632701|NCT00712998|free radical production|free radical production
632702|NCT00712998|blood reactive oxygen species level|blood reactive oxygen species level
632703|NCT00713011|Adalat XL|adalat xl
632704|NCT00713011|Diltiazem|diltiazem
632705|NCT00713011|Tiazac XC|tiazac xc
632706|NCT00713011|Proteinuria|proteinuria
632707|NCT00713024|Pain; Functional neuroimaging; Neuropathy; Thermal sensation|pain; functional neuroimaging; neuropathy; thermal sensation
632708|NCT00713037|fluoromisonidazole|fluoromisonidazole
632709|NCT00713037|PET scan|pet scan
632710|NCT00713037|Hypoxia-PET|hypoxia-pet
632711|NCT00713037|IMPT|impt
632712|NCT00713050|stroke|stroke
632713|NCT00713050|aphasia|aphasia
632714|NCT00713050|imitation|imitation
632715|NCT00713050|mirror neuron|mirror neuron
632716|NCT00713063|smoking cessation|smoking cessation
632717|NCT00713063|exercise|exercise
632718|NCT00713063|physical activity|physical activity
632719|NCT00713063|health education|health education
632720|NCT00713076|multi-purpose solution|multi-purpose solution
632721|NCT00713076|contact lens wearers|contact lens wearers
633318|NCT00706953|relapsed|relapsed
632722|NCT00713076|Contact lense wearers|contact lense wearers
632723|NCT00713089|Eczema|eczema
632724|NCT00713089|Asthma|asthma
632725|NCT00713089|Allergic rhinitis|allergic rhinitis
632726|NCT00713089|Singapore|singapore
632727|NCT00713089|Indonesia|indonesia
632728|NCT00713089|Gastrointestinal Flora|gastrointestinal flora
632729|NCT00713102|in-flight emergency|in-flight emergency
632730|NCT00713115|laparoscopy, needlescopy, adrenalectomy|laparoscopy, needlescopy, adrenalectomy
632731|NCT00713128|nausea vomiting colorectal cancer|nausea vomiting colorectal cancer
632732|NCT00713154|Radiotherapy|radiotherapy
632733|NCT00713154|induced|induced
632734|NCT00713167|Grape Seed Extract|grape seed extract
632735|NCT00713167|Hyperlipidemia|hyperlipidemia
632736|NCT00713193|Idiopathic TTP|idiopathic ttp
632737|NCT00713193|Treatment|treatment
632738|NCT00713193|Exacerbation|exacerbation
632739|NCT00713193|Relapse|relapse
632740|NCT00713193|Plasma Exchange|plasma exchange
632741|NCT00713206|Dental implants, maxilla, sinus lift, augmentation|dental implants, maxilla, sinus lift, augmentation
632742|NCT00713219|IMRT|imrt
632743|NCT00713219|cetuximab|cetuximab
632744|NCT00713219|docetaxel|docetaxel
632745|NCT00713232|naming test|naming test
632746|NCT00713245|Pompe disease|pompe disease
632747|NCT00713245|late onset|late onset
632748|NCT00713258|Postmenopausal women|postmenopausal women
632749|NCT00713258|Back pain|back pain
632750|NCT00713258|Osteoporosis related fracture|osteoporosis related fracture
632751|NCT00713271|Healthy male|healthy male
632752|NCT00713271|tolerability|tolerability
632753|NCT00713271|safety|safety
632754|NCT00713271|inhalation|inhalation
632755|NCT00713284|Kidney transplantation|kidney transplantation
632756|NCT00713284|Sirolimus|sirolimus
632757|NCT00713284|Immunosuppression|immunosuppression
632758|NCT00713284|Tacrolimus|tacrolimus
632759|NCT00713297|medication errors|medication errors
632760|NCT00713297|computerized physician order entry|computerized physician order entry
632761|NCT00713297|pharmaceutical care|pharmaceutical care
632762|NCT00713297|chemotherapeutic agents|chemotherapeutic agents
632763|NCT00713297|reengineering|reengineering
632764|NCT00713323|Pain|pain
632765|NCT00713323|Peripheral Neuropathy|peripheral neuropathy
632766|NCT00713336|ZD4054|zd4054
632767|NCT00713336|Healthy Volunteers|healthy volunteers
632768|NCT00713336|QT interval|qt interval
632769|NCT00713349|White|white
632770|NCT00713349|Petrolatum|petrolatum
632771|NCT00713349|Xenaderm|xenaderm
632772|NCT00713349|Vehicle|vehicle
632773|NCT00713349|Partial thickness wounds|partial thickness wounds
632774|NCT00713349|Healing|healing
633357|NCT00707200|death|death
632775|NCT00713349|Cryo-surgery|cryo-surgery
632776|NCT00713362|Aspiration, chest tube, pneumothorax, thoracoscopic surgery|aspiration, chest tube, pneumothorax, thoracoscopic surgery
632777|NCT00713375|Autonomic Nervous System|autonomic nervous system
632778|NCT00713375|Subarachnoid Hemorrhage|subarachnoid hemorrhage
634349|NCT00717691|Dynasplint|dynasplint
632779|NCT00713375|Intracranial Hemorrhages|intracranial hemorrhages
632780|NCT00713375|Cerebral Hemorrhage|cerebral hemorrhage
632781|NCT00713414|Spasmodic Dysphonia|spasmodic dysphonia
632782|NCT00713414|Dystonia|dystonia
632783|NCT00713414|Basal Ganglia|basal ganglia
632784|NCT00713414|PET Imaging|pet imaging
632785|NCT00713414|fMRI|fmri
632786|NCT00713414|Voice Disorder|voice disorder
632787|NCT00713414|Healthy Volunteer|healthy volunteer
632788|NCT00713414|HV|hv
632789|NCT00713427|Biliary|biliary
632790|NCT00713427|Strictures|strictures
632791|NCT00713427|Malignant|malignant
632792|NCT00713427|Neoplasm|neoplasm
632793|NCT00713427|Palliation|palliation
632794|NCT00713440|Incretin Effect|incretin effect
632795|NCT00713440|Steroids|steroids
632796|NCT00713440|Glucagon-Like Peptide 1|glucagon-like peptide 1
632797|NCT00713440|Gastric Inhibitory Peptide|gastric inhibitory peptide
632798|NCT00713440|Glucose-dependent Insulinotropic Polypeptide|glucose-dependent insulinotropic polypeptide
632799|NCT00713440|Insulin|insulin
632800|NCT00713440|C-peptide|c-peptide
632801|NCT00713440|Glucagon|glucagon
632802|NCT00713453|Pompe disease|pompe disease
632803|NCT00713453|muscle|muscle
632804|NCT00713453|enzyme replacement therapy|enzyme replacement therapy
632805|NCT00713466|CLIPP cases|clipp cases
632806|NCT00713466|Pediatric clerkship|pediatric clerkship
632807|NCT00713466|Standardizing|standardizing
632808|NCT00713466|Students' exposure|students' exposure
632809|NCT00713466|Essential|essential
632810|NCT00713466|Enhancing|enhancing
632811|NCT00713466|Experience|experience
632812|NCT00713479|methamphetamine|methamphetamine
632813|NCT00713479|varenicline|varenicline
632814|NCT00713479|Chantix|chantix
632815|NCT00713479|stimulant|stimulant
632816|NCT00713479|crystal meth|crystal meth
632817|NCT00713492|Alcohol|alcohol
632818|NCT00713492|Self -Administration|self -administration
632819|NCT00713492|Intoxication|intoxication
632820|NCT00713492|Healthy Volunteer|healthy volunteer
632821|NCT00713492|HV|hv
632822|NCT00713505|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
632917|NCT00713869|Oocyte cryopreservation|oocyte cryopreservation
632918|NCT00713869|Slow freeze|slow freeze
632823|NCT00713505|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
632824|NCT00713505|cancer survivor|cancer survivor
632825|NCT00713505|cognitive/functional effects|cognitive/functional effects
632826|NCT00713505|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
632827|NCT00713505|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
632828|NCT00713505|childhood anaplastic large cell lymphoma|childhood anaplastic large cell lymphoma
632829|NCT00713505|childhood large cell lymphoma|childhood large cell lymphoma
632830|NCT00713505|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
632831|NCT00713505|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
632832|NCT00713505|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
632833|NCT00713505|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
632834|NCT00713505|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
632835|NCT00713518|AMD Age Related Macular Degeneration Choroidal Neovascularization Monet|amd age related macular degeneration choroidal neovascularization monet
632836|NCT00713531|HIV-negative|hiv-negative
632837|NCT00713531|male and female clients|male and female clients
632838|NCT00713531|ages 18-50 years|ages 18-50 years
632839|NCT00713531|seeking HIV counseling|seeking hiv counseling
632840|NCT00713531|testing at TRCARC|testing at trcarc
632841|NCT00713544|Rheumatoid Arthritis|rheumatoid arthritis
632842|NCT00713544|RA|ra
632843|NCT00713544|AZD5672|azd5672
632844|NCT00713557|coronary angioplasty|coronary angioplasty
632845|NCT00713570|intellectual functioning|intellectual functioning
632846|NCT00713570|memory,visual-spatial and perceptual functions|memory,visual-spatial and perceptual functions
632847|NCT00713570|cognitive abilities|cognitive abilities
632848|NCT00713570|COMT|comt
632849|NCT00713570|BDNF|bdnf
632850|NCT00713570|neuron biological systemic pathway candidate genes|neuron biological systemic pathway candidate genes
632851|NCT00713570|Chinese|chinese
632852|NCT00713570|Taiwan|taiwan
632853|NCT00713570|Healthy subjects|healthy subjects
632854|NCT00713583|Cocaine, levodopa, contingency management|cocaine, levodopa, contingency management
632855|NCT00713596|Nasal Surgery|nasal surgery
632856|NCT00713596|Septorhinoplasty|septorhinoplasty
632857|NCT00713596|fibrin glue|fibrin glue
632858|NCT00713596|fibrinogen|fibrinogen
632859|NCT00713596|Swelling|swelling
632860|NCT00713596|fibrin|fibrin
632861|NCT00713596|tisseel|tisseel
632862|NCT00713609|Acne|acne
632863|NCT00713609|Acne Vulgaris|acne vulgaris
632864|NCT00713609|Pimples|pimples
632865|NCT00713622|Partial|partial
632866|NCT00713622|onset|onset
632867|NCT00713622|seizures|seizures
632868|NCT00713635|Congenital Heart Disease|congenital heart disease
632869|NCT00713661|Colorectal Anastomosis|colorectal anastomosis
632870|NCT00713661|Colorectal Resection|colorectal resection
632871|NCT00713661|Tachosil|tachosil
635164|NCT00719654|Proteome|proteome
632872|NCT00713674|Methicillin resistance|methicillin resistance
632873|NCT00713687|photodynamic therapy|photodynamic therapy
632874|NCT00713687|PDT|pdt
632875|NCT00713687|gemcitabine|gemcitabine
632876|NCT00713687|oxaliplatin|oxaliplatin
632877|NCT00713687|cholangiocarcinoma|cholangiocarcinoma
632878|NCT00713700|patent ductus arteriosus|patent ductus arteriosus
632879|NCT00713700|PDA|pda
632880|NCT00713713|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
632881|NCT00713713|Tidal volume|tidal volume
632882|NCT00713713|cardiac output|cardiac output
632883|NCT00713713|Respiration, Artificial|respiration, artificial
632884|NCT00713713|Protective ventilation|protective ventilation
632885|NCT00713726|Pain|pain
632886|NCT00713726|Analgesia|analgesia
632887|NCT00713726|Newborn Infant|newborn infant
632888|NCT00713726|Opioids|opioids
632889|NCT00713726|Side-effects|side-effects
632890|NCT00713726|Intensive care|intensive care
632891|NCT00713726|Postoperative|postoperative
632892|NCT00713739|kidney stones|kidney stones
632893|NCT00713739|ureteral stones|ureteral stones
632894|NCT00713739|medical expulsion therapy|medical expulsion therapy
632895|NCT00713752|HIV-negative|hiv-negative
632896|NCT00713765|Healthy volunteers|healthy volunteers
632897|NCT00713778|Ovarian Cysts|ovarian cysts
632898|NCT00713778|Electrocoagulation|electrocoagulation
632899|NCT00713778|Ovarian Function Tests|ovarian function tests
632900|NCT00713778|Laparoscopy|laparoscopy
632901|NCT00713791|Healthy Volunteers|healthy volunteers
632903|NCT00713804|Schizophrenia|schizophrenia
632904|NCT00713804|Bipolar Disorder|bipolar disorder
632905|NCT00713804|Schizoaffective disorder|schizoaffective disorder
632906|NCT00713804|Genetic Counseling|genetic counseling
632907|NCT00713804|Risk perception|risk perception
632908|NCT00713804|Stigma|stigma
632909|NCT00713804|Control|control
632910|NCT00713804|Knowledge|knowledge
632911|NCT00713817|Pain|pain
632912|NCT00713817|Peripheral Neuropathy|peripheral neuropathy
632913|NCT00713830|hyperglycemia, GLP-1|hyperglycemia, glp-1
632914|NCT00713843|Neck Pain|neck pain
632915|NCT00713843|Manuel Therapy Utrecht|manuel therapy utrecht
632916|NCT00713843|Physiotherapy|physiotherapy
632919|NCT00713882|Survivors|survivors
632920|NCT00713882|Quality of Life|quality of life
632921|NCT00713895|smoking cessation|smoking cessation
632922|NCT00713895|randomized trial|randomized trial
632923|NCT00713895|Asian|asian
632924|NCT00713895|Chinese American|chinese american
632925|NCT00713895|stages of change|stages of change
632926|NCT00713908|Voiding dysfunction following TVT placement|voiding dysfunction following tvt placement
632927|NCT00713921|Female|female
632928|NCT00713921|Diabetics|diabetics
632929|NCT00713921|Stroke|stroke
632930|NCT00713934|Autologous Bone marrow stem cells|autologous bone marrow stem cells
632931|NCT00713934|Cirrhosis|cirrhosis
632932|NCT00713947|Gastric lesions induced by low dose of aspirin|gastric lesions induced by low dose of aspirin
632933|NCT00713947|Helicobacter pylori|helicobacter pylori
632934|NCT00713960|Quality development project|quality development project
632935|NCT00713960|primary care nurses|primary care nurses
632936|NCT00713960|cardiovascular disease|cardiovascular disease
632937|NCT00713960|secondary prevention|secondary prevention
632938|NCT00713960|follow-up|follow-up
632939|NCT00713986|Pain|pain
632940|NCT00713986|Newborn Infant|newborn infant
632941|NCT00713986|Analgesia|analgesia
632942|NCT00713999|Sexually transmitted infections|sexually transmitted infections
632943|NCT00713999|Urogenital schistosomiasis|urogenital schistosomiasis
632944|NCT00713999|Schistosoma haematobium|schistosoma haematobium
632945|NCT00713999|Reproductive health|reproductive health
632946|NCT00713999|Pelvic examination|pelvic examination
632947|NCT00713999|Ultrasonography|ultrasonography
632948|NCT00713999|Questionnaire|questionnaire
632949|NCT00713999|Madagascar|madagascar
632950|NCT00714012|Display development|display development
632951|NCT00714012|Intuitive display use|intuitive display use
632952|NCT00714012|visualizations are intuitive|visualizations are intuitive
632953|NCT00714025|RAD001|rad001
632954|NCT00714025|TCC|tcc
632955|NCT00714025|Palliative treatment|palliative treatment
632956|NCT00714025|advance or metastatic TCC|advance or metastatic tcc
632957|NCT00714025|Failure after Platinum-based chemotherapy|failure after platinum-based chemotherapy
632958|NCT00714038|Quality development project|quality development project
632959|NCT00714038|primary care nurses|primary care nurses
632960|NCT00714038|asthma|asthma
632961|NCT00714038|patient compliance|patient compliance
632962|NCT00714038|follow-up|follow-up
632963|NCT00714077|rectal cancer|rectal cancer
632964|NCT00714077|concurrent chemoradiotherapy|concurrent chemoradiotherapy
632965|NCT00714077|adjuvant therapy|adjuvant therapy
632966|NCT00714077|phase III study|phase iii study
632967|NCT00714090|repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
632968|NCT00714090|Major depressive disorders|major depressive disorders
632969|NCT00714090|Depression|depression
632970|NCT00714090|Venlafaxine|venlafaxine
632971|NCT00714103|Leukemia|leukemia
632972|NCT00714103|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
632974|NCT00714103|8-Chloro-Adenosine|8-chloro-adenosine
632975|NCT00714103|purine analogues|purine analogues
632976|NCT00714103|Cancer|cancer
632977|NCT00714116|safety|safety
632978|NCT00714116|pharmacokinetics|pharmacokinetics
632979|NCT00714129|Steatosis|steatosis
632980|NCT00714129|Diabetes|diabetes
632981|NCT00714142|Renal blood flow|renal blood flow
632982|NCT00714142|PET imaging|pet imaging
632983|NCT00714155|Colpocleisis|colpocleisis
632984|NCT00714168|Weight Loss|weight loss
632985|NCT00714168|Weight Control|weight control
632986|NCT00714181|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
632987|NCT00714194|sedation|sedation
632988|NCT00714194|delirium|delirium
632989|NCT00714194|sleep|sleep
632990|NCT00714194|sedation withdrawal|sedation withdrawal
632991|NCT00714194|ICU patients|icu patients
632992|NCT00714207|adolescents|adolescents
632993|NCT00714207|smoking|smoking
632994|NCT00714207|smoking cessation|smoking cessation
632995|NCT00714207|tobacco use|tobacco use
632996|NCT00714220|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
632997|NCT00714220|Gastric Motility|gastric motility
632998|NCT00714220|Autonomic Nervous System|autonomic nervous system
632999|NCT00714220|Neurodegenerative Diseases|neurodegenerative diseases
633000|NCT00714220|Movement Disorders|movement disorders
633001|NCT00714220|Substrate Utilization|substrate utilization
633002|NCT00714233|Polycystic Ovary Syndrome|polycystic ovary syndrome
633003|NCT00714233|Overweight Adolescent Girls|overweight adolescent girls
633004|NCT00714233|Irregular Menstrual Cycles|irregular menstrual cycles
633005|NCT00714246|advanced non small cell lung cancer|advanced non small cell lung cancer
633006|NCT00714259|Low Grade B Cell Malignancies|low grade b cell malignancies
633007|NCT00714259|nonmyeloablative transplant|nonmyeloablative transplant
633008|NCT00714259|allogeneic|allogeneic
633009|NCT00714285|Primary study|primary study
633010|NCT00714285|immunogenicity|immunogenicity
633012|NCT00714298|biological markers|biological markers
633013|NCT00714298|emergency service hospital|emergency service hospital
633014|NCT00714298|heart fatty acid binding protein|heart fatty acid binding protein
633015|NCT00714298|ischemia modified albumin|ischemia modified albumin
633317|NCT00706953|DOXIL|doxil
633016|NCT00714311|borderline personality disorder|borderline personality disorder
633017|NCT00714311|randomized controlled trial|randomized controlled trial
633018|NCT00714311|Transference-Focused Psychotherapy|transference-focused psychotherapy
633019|NCT00714311|treatment by experienced community psychotherapists|treatment by experienced community psychotherapists
633020|NCT00714324|Nutrition|nutrition
633021|NCT00714324|Screening|screening
633022|NCT00714337|Formulation|formulation
633023|NCT00714337|pharmacokinetics|pharmacokinetics
633024|NCT00714350|Information Display|information display
633025|NCT00714350|situational awareness|situational awareness
633026|NCT00714350|Create intuitive visualization|create intuitive visualization
633027|NCT00714376|Prostate cancer|prostate cancer
633028|NCT00714376|High-risk prostate cancer|high-risk prostate cancer
633029|NCT00714376|Radical prostatectomy|radical prostatectomy
633030|NCT00714376|Early rising PSA|early rising psa
633031|NCT00714376|Taxotere|taxotere
633032|NCT00714376|Docetaxel|docetaxel
633033|NCT00714389|Urogynecology|urogynecology
633035|NCT00705679|Microbicide|microbicide
633036|NCT00705679|HIV Seronegativity|hiv seronegativity
633037|NCT00705692|Tetanus|tetanus
633038|NCT00705692|Vaccines|vaccines
633039|NCT00705692|Renal Dialysis|renal dialysis
633040|NCT00705692|Levamisole|levamisole
633041|NCT00705705|High-Risk Behavior|high-risk behavior
633042|NCT00705705|Men Who Have Sex With Men|men who have sex with men
633043|NCT00705705|HIV Seronegativity|hiv seronegativity
633044|NCT00705718|Endurant Stent Graft System|endurant stent graft system
633045|NCT00705718|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
633046|NCT00705718|Endovascular Treatment|endovascular treatment
633047|NCT00705731|Colorectal cancer (CRC)|colorectal cancer (crc)
633048|NCT00705731|Colorectal cancer screening|colorectal cancer screening
633049|NCT00705731|Colonoscopy|colonoscopy
633050|NCT00705731|Fecal occult blood test (FOBT)|fecal occult blood test (fobt)
633051|NCT00705731|Cost-effectiveness|cost-effectiveness
633052|NCT00705757|periocular skin pigmentation|periocular skin pigmentation
633053|NCT00705757|Lumigan|lumigan
633054|NCT00705757|Travatan|travatan
633055|NCT00705757|Xalatan|xalatan
633056|NCT00705757|latanoprost|latanoprost
633057|NCT00705757|bimatoprost|bimatoprost
633058|NCT00705757|travoprost|travoprost
633059|NCT00705770|Open-Angle Glaucoma|open-angle glaucoma
633060|NCT00705770|Intraocular Pressure|intraocular pressure
633061|NCT00705770|Anecortave Acetate|anecortave acetate
633062|NCT00705783|Aripiprazole|aripiprazole
633063|NCT00705783|Intramuscular (IM) depot|intramuscular (im) depot
633064|NCT00705783|Schizophrenia|schizophrenia
633068|NCT00705809|Epidemiology|epidemiology
633069|NCT00705809|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
633070|NCT00705835|Prostate|prostate
633071|NCT00705835|ALHYDROGEL|alhydrogel
633072|NCT00705835|RS-PSMA|rs-psma
633073|NCT00705848|trachea|trachea
633074|NCT00705848|malacia|malacia
633075|NCT00705848|stenosis|stenosis
633076|NCT00705861|Erectile dysfunction|erectile dysfunction
633077|NCT00705861|Diabetes Mellitus|diabetes mellitus
633078|NCT00705861|SK3530|sk3530
633079|NCT00705874|cancer|cancer
633080|NCT00705874|advanced cancer|advanced cancer
633081|NCT00705874|solid tumors|solid tumors
633082|NCT00705874|lymphoma|lymphoma
633083|NCT00705874|CGC-11047|cgc-11047
633084|NCT00705887|Ultraviolet Rays|ultraviolet rays
633085|NCT00705887|Motivation|motivation
633086|NCT00705887|Health Education|health education
633087|NCT00705887|Randomized Controlled Trial|randomized controlled trial
633088|NCT00705887|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
633089|NCT00705900|psoriasis|psoriasis
633090|NCT00705913|aortic valve|aortic valve
633091|NCT00705913|heart valve|heart valve
633092|NCT00705913|valve replacement|valve replacement
633093|NCT00705913|valve disease|valve disease
633098|NCT00705939|Gaucher Disease|gaucher disease
633099|NCT00705939|Enzyme replacement therapy|enzyme replacement therapy
633100|NCT00705952|No diabetes medications|no diabetes medications
633101|NCT00705952|New onset|new onset
633102|NCT00705965|Coronary artery disease|coronary artery disease
633103|NCT00705965|depression|depression
633104|NCT00705965|psychotherapy|psychotherapy
633105|NCT00705965|randomized controlled trial|randomized controlled trial
633106|NCT00705978|Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis|pancreatic exocrine insufficiency due to chronic pancreatitis
633107|NCT00706004|constipation|constipation
633108|NCT00706004|cystic fibrosis|cystic fibrosis
633109|NCT00706004|lubiprostone|lubiprostone
633110|NCT00706004|Constipation in adults with cystic fibrosis|constipation in adults with cystic fibrosis
633111|NCT00706030|Metastatic breast cancer|metastatic breast cancer
633112|NCT00706043|Low back pain|low back pain
633113|NCT00706069|Metastatic Breast Cancer|metastatic breast cancer
633114|NCT00706069|Vinorelbine oral|vinorelbine oral
633115|NCT00706069|Capecitabine|capecitabine
633117|NCT00706095|advanced solid tumors|advanced solid tumors
633118|NCT00706121|colon cancer|colon cancer
633119|NCT00706121|rectal cancer|rectal cancer
633120|NCT00706121|adenomatous polyp|adenomatous polyp
633121|NCT00706134|Hypertension|hypertension
633122|NCT00706134|≥ 65 years|≥ 65 years
633123|NCT00706134|aliskiren|aliskiren
633125|NCT00706134|light meal|light meal
633126|NCT00706147|Hereditary ALS|hereditary als
633127|NCT00706147|Hereditary neurological disease|hereditary neurological disease
633128|NCT00706147|Lou Gehrig's Disease|lou gehrig's disease
633129|NCT00706147|Motor Neuron Disease|motor neuron disease
633130|NCT00706147|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
633131|NCT00706147|Familial ALS|familial als
633132|NCT00706147|Neuromuscular disease|neuromuscular disease
633133|NCT00706147|SOD1 mutation|sod1 mutation
633134|NCT00706147|Superoxide dismutase|superoxide dismutase
633135|NCT00706147|SOD1 positive ALS|sod1 positive als
633136|NCT00706147|inherited ALS|inherited als
633137|NCT00706160|Epilepsy|epilepsy
633138|NCT00706160|Language|language
633139|NCT00706160|fMRI|fmri
633140|NCT00706160|Magnetoencephalogram|magnetoencephalogram
633141|NCT00706160|Temporal Lobe Epilepsy|temporal lobe epilepsy
633142|NCT00706160|Partial Epilepsy|partial epilepsy
633143|NCT00706160|Healthy Volunteer|healthy volunteer
633144|NCT00706160|HV|hv
633145|NCT00706173|Post-traumatic stress disorder|post-traumatic stress disorder
633146|NCT00706173|PTSD|ptsd
633147|NCT00706173|Cortisol|cortisol
633148|NCT00706173|hydrocortisone|hydrocortisone
633149|NCT00706173|pharmacological treatment|pharmacological treatment
633150|NCT00706186|Mild Alzheimer's|mild alzheimer's
633151|NCT00706186|Disease|disease
633152|NCT00706199|bone marrow|bone marrow
633153|NCT00706199|volunteers|volunteers
633154|NCT00706199|antigen expression|antigen expression
633155|NCT00706238|metastatic,|metastatic,
633156|NCT00706238|Melanoma,|melanoma,
633157|NCT00706238|Antigen-Specific Cancer Immunotherapeutic,|antigen-specific cancer immunotherapeutic,
633158|NCT00706238|ASCI|asci
633159|NCT00706238|MAGE-A3|mage-a3
633160|NCT00706238|tumor antigen,|tumor antigen,
633161|NCT00706264|Short cervix|short cervix
633162|NCT00706264|preterm birth|preterm birth
633163|NCT00706264|arabin pessary|arabin pessary
633164|NCT00706277|forced vital capacity|forced vital capacity
633165|NCT00706277|forced expired volume in 1 s|forced expired volume in 1 s
633166|NCT00706290|anxiety|anxiety
633168|NCT00706290|quality of life|quality of life
633169|NCT00706290|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
633170|NCT00706290|advanced cancer|advanced cancer
633171|NCT00706290|metastatic cancer|metastatic cancer
633172|NCT00706290|stage IV cancer|stage iv cancer
633173|NCT00706290|cognitive behavioral therapy|cognitive behavioral therapy
633174|NCT00706303|COPD|copd
633175|NCT00706303|self management|self management
633176|NCT00706316|Nasopharygneal Cancer|nasopharygneal cancer
633177|NCT00706316|Epstein Barr Virus|epstein barr virus
633178|NCT00706316|(EBV)-Specific Cytotoxic T-Lymphocytes|(ebv)-specific cytotoxic t-lymphocytes
633179|NCT00706316|Recurrent|recurrent
633180|NCT00706316|Metastatic|metastatic
633181|NCT00706316|EBV-Positive Nasopharygneal Cancer|ebv-positive nasopharygneal cancer
633182|NCT00706329|Minimally invasive surgery|minimally invasive surgery
633183|NCT00706329|Umbilical hernia|umbilical hernia
633184|NCT00706329|Infant|infant
633185|NCT00706342|Adult Refractory Immune Thrombocytopenic Purpura (ITP)|adult refractory immune thrombocytopenic purpura (itp)
633186|NCT00706368|Sexually transmitted infections|sexually transmitted infections
633187|NCT00706368|Acceptability|acceptability
633188|NCT00706368|Adolescent vaginitis|adolescent vaginitis
633189|NCT00706381|Deiodinase|deiodinase
633190|NCT00706381|Bile Acids|bile acids
633191|NCT00706381|Cholecystokinin|cholecystokinin
633192|NCT00706381|Thyroid Hormones|thyroid hormones
633193|NCT00706381|Energy Expenditure|energy expenditure
633194|NCT00706381|Health Volunteer|health volunteer
633195|NCT00706381|HV|hv
633196|NCT00706394|Powerlink|powerlink
633197|NCT00706394|34mm|34mm
633198|NCT00706394|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
633199|NCT00706394|EVAR|evar
633200|NCT00706420|Diabetes Mellitus|diabetes mellitus
633201|NCT00706420|Islet Transplantation Alone|islet transplantation alone
633202|NCT00706420|Glucocorticoid-free Immunosuppressive Regimen|glucocorticoid-free immunosuppressive regimen
633203|NCT00706433|Photodynamic Therapy|photodynamic therapy
633204|NCT00706446|Asthma|asthma
633205|NCT00706446|Pharmacogenetics|pharmacogenetics
633206|NCT00706446|Beta agonists|beta agonists
633207|NCT00706446|salmeterol|salmeterol
633208|NCT00706446|formoterol|formoterol
633209|NCT00706446|tiotropium|tiotropium
633210|NCT00706446|beta adrenergic receptor|beta adrenergic receptor
633211|NCT00706446|single nucleotide polymorphism|single nucleotide polymorphism
633212|NCT00706485|Y-90 plaque applicator|y-90 plaque applicator
633213|NCT00706485|dural brachytherapy|dural brachytherapy
633214|NCT00706511|OSA|osa
633215|NCT00706511|Diabetes|diabetes
633216|NCT00706511|Metabolism|metabolism
633217|NCT00706511|Gender|gender
633218|NCT00706537|Pharmacokinetic safety NASH patients|pharmacokinetic safety nash patients
633219|NCT00706550|pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
633220|NCT00706576|Hepatocellular cancer|hepatocellular cancer
633222|NCT00706576|Opioid growth factor|opioid growth factor
633223|NCT00706576|OGF|ogf
633224|NCT00706576|Cirrhosis|cirrhosis
633225|NCT00706589|Chronic Motor Tic disorder|chronic motor tic disorder
633226|NCT00706589|Chronic Phonic Tic disorder|chronic phonic tic disorder
633227|NCT00706589|Tourette's disorder|tourette's disorder
633228|NCT00706589|Aripiprazole|aripiprazole
633229|NCT00706589|Abilify|abilify
633230|NCT00706589|Children|children
633231|NCT00706589|Adolescent|adolescent
633232|NCT00706602|COPD|copd
633233|NCT00706602|prognosis|prognosis
633234|NCT00706602|prediction rule|prediction rule
633235|NCT00706602|health-related quality of life|health-related quality of life
633236|NCT00706602|risk factors|risk factors
633237|NCT00706602|derivation|derivation
633238|NCT00706602|validation|validation
633239|NCT00706602|exacerbation|exacerbation
633240|NCT00706602|mortality|mortality
633241|NCT00706602|primary care|primary care
633242|NCT00706602|treatment|treatment
633243|NCT00706602|decision making|decision making
633244|NCT00706615|stage IV breast cancer|stage iv breast cancer
633245|NCT00706615|recurrent breast cancer|recurrent breast cancer
633246|NCT00706654|Aripiprazole|aripiprazole
633247|NCT00706654|Intramuscular (IM) depot|intramuscular (im) depot
633248|NCT00706654|Schizophrenia|schizophrenia
633249|NCT00706693|hypoglycemia|hypoglycemia
633250|NCT00706693|treatment|treatment
633251|NCT00706693|glucose|glucose
633252|NCT00706693|sucrose|sucrose
633253|NCT00706693|fructose|fructose
633254|NCT00706706|sunitinib Phase IV metastatic renal cell carcinoma Chinese|sunitinib phase iv metastatic renal cell carcinoma chinese
633255|NCT00706719|Adult Onset Idiopathic Hypothalamic Hypogonadism (AIHH)|adult onset idiopathic hypothalamic hypogonadism (aihh)
633256|NCT00706719|Secondary hypogonadism|secondary hypogonadism
633257|NCT00706719|Semen volume|semen volume
633258|NCT00706719|Sperm count|sperm count
633259|NCT00706719|Sperm motility|sperm motility
633260|NCT00706732|Influenza|influenza
633261|NCT00706732|Flu|flu
633262|NCT00706732|A/Wyoming/03/2003|a/wyoming/03/2003
633263|NCT00706732|Alphavirus|alphavirus
633264|NCT00706745|atherosclerosis|atherosclerosis
633265|NCT00706745|dietary supplements|dietary supplements
633358|NCT00707200|transfusion|transfusion
633266|NCT00706745|randomised controlled trial|randomised controlled trial
633267|NCT00706745|arterial stiffness|arterial stiffness
633268|NCT00706745|linoleic acid|linoleic acid
633269|NCT00706758|Irritable bowel syndrome|irritable bowel syndrome
633270|NCT00706758|Patient education|patient education
633271|NCT00706771|sodium bicarbonate|sodium bicarbonate
633272|NCT00706771|serum neutrophil gelatinase associated lipocalin|serum neutrophil gelatinase associated lipocalin
633273|NCT00706771|renal impairment|renal impairment
633274|NCT00706771|renal failure|renal failure
633275|NCT00706771|systemic inflammatory response syndrome|systemic inflammatory response syndrome
633276|NCT00706771|defined|defined
633277|NCT00706771|by serum NGAL ≥ 100 ng/ml.|by serum ngal ≥ 100 ng/ml.
633278|NCT00706784|Healthy women 18-40 years of age|healthy women 18-40 years of age
635165|NCT00719654|Pregnancy|pregnancy
633279|NCT00706797|Moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
633280|NCT00706810|Cancer|cancer
633281|NCT00706810|Brain cancer|brain cancer
633282|NCT00706810|Meningioma|meningioma
633283|NCT00706823|Endotracheal Intubation|endotracheal intubation
633284|NCT00706823|Supraglottic Airway|supraglottic airway
633285|NCT00706836|anxiety|anxiety
633286|NCT00706836|functional magnetic resonance imaging|functional magnetic resonance imaging
633287|NCT00706836|fMRI|fmri
633288|NCT00706836|pregabalin|pregabalin
633289|NCT00706836|Lyrica|lyrica
633290|NCT00706849|familial hypercholesterolemia|familial hypercholesterolemia
633291|NCT00706862|Non small cell lung cancer|non small cell lung cancer
633292|NCT00706862|Talactoferrin|talactoferrin
752369|NCT01172665|Celiac Disease|celiac disease
633293|NCT00706862|Dendritic cell recruiter and activator|dendritic cell recruiter and activator
633294|NCT00706862|DCRA|dcra
633295|NCT00706862|Immunomodulatory agent|immunomodulatory agent
633296|NCT00706862|Lactoferrin|lactoferrin
633297|NCT00706875|GTD survivors|gtd survivors
633298|NCT00706875|questionnaires|questionnaires
633299|NCT00706875|GTD|gtd
633300|NCT00706888|Reduction of cardiovascular factor of risk|reduction of cardiovascular factor of risk
633301|NCT00706901|MI|mi
633302|NCT00706901|IHMD|ihmd
633303|NCT00706914|Airflow Obstruction, Chronic|airflow obstruction, chronic
633304|NCT00706914|Chronic Airflow Obstruction|chronic airflow obstruction
633305|NCT00706914|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
633306|NCT00706914|Chronic Obstructive Airway Disease|chronic obstructive airway disease
633307|NCT00706914|Chronic Obstructive Lung Disease|chronic obstructive lung disease
633308|NCT00706914|COPD|copd
633309|NCT00706914|COAD|coad
633310|NCT00706927|xalacom|xalacom
633311|NCT00706927|combigan|combigan
633312|NCT00706927|ocular blood flow|ocular blood flow
633313|NCT00706940|dry eye|dry eye
633314|NCT00706940|Optical coherence tomography|optical coherence tomography
633315|NCT00706953|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
633316|NCT00706953|VELCADE|velcade
633319|NCT00706953|Multiple Myeloma|multiple myeloma
633320|NCT00706966|adenocarcinoma of the prostate|adenocarcinoma of the prostate
633321|NCT00706966|stage IIB prostate cancer|stage iib prostate cancer
633322|NCT00706966|stage IIA prostate cancer|stage iia prostate cancer
633323|NCT00706966|benign prostatic hyperplasia|benign prostatic hyperplasia
633324|NCT00706979|smoking|smoking
633325|NCT00706979|smoking cessation|smoking cessation
633326|NCT00706979|nicotine replacement therapy|nicotine replacement therapy
633327|NCT00706992|MART-1 Peptide|mart-1 peptide
633328|NCT00706992|Melanoma|melanoma
633329|NCT00706992|Adjuvant Therapy|adjuvant therapy
633330|NCT00706992|Gene Therapy|gene therapy
633331|NCT00706992|T Cell Persistence|t cell persistence
633332|NCT00707005|antibiotic susceptibility|antibiotic susceptibility
633333|NCT00707005|bacterial flora|bacterial flora
633334|NCT00707005|fluoroquinolone|fluoroquinolone
633335|NCT00707005|LASIK|lasik
633336|NCT00707005|refractive surgery|refractive surgery
633337|NCT00707031|hyperglycemia, GLP-1, metformin|hyperglycemia, glp-1, metformin
633338|NCT00707070|psoriasis|psoriasis
633339|NCT00707070|acitretin|acitretin
633340|NCT00707070|efalizumab|efalizumab
633341|NCT00707083|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
633342|NCT00707083|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
633343|NCT00707083|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
633344|NCT00707083|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
633345|NCT00707122|serum albumin, severe sepsis, septic shock, fluid therapy, hypoalbuminemia, critically ill|serum albumin, severe sepsis, septic shock, fluid therapy, hypoalbuminemia, critically ill
633346|NCT00707148|pertussis, diptheria, tetanus, vaccine, Tdap|pertussis, diptheria, tetanus, vaccine, tdap
633347|NCT00707174|Lentigo Maligna|lentigo maligna
633348|NCT00707187|systemic sclerosis|systemic sclerosis
633349|NCT00707187|scleroderma|scleroderma
633350|NCT00707187|raynaud phenomenon|raynaud phenomenon
633351|NCT00707200|severe malarial anemia (SMA)|severe malarial anemia (sma)
633352|NCT00707200|cerebral malarial (CM)|cerebral malarial (cm)
633353|NCT00707200|lactic acidosis|lactic acidosis
633354|NCT00707200|hyperparasitemia|hyperparasitemia
633355|NCT00707200|respiratory distress|respiratory distress
633356|NCT00707200|hypoxia|hypoxia
633359|NCT00707226|Laser Doppler flowmetry|laser doppler flowmetry
633360|NCT00707226|Choroidal blood flow|choroidal blood flow
633361|NCT00707226|Fundus pulsation amplitude|fundus pulsation amplitude
633362|NCT00707226|Intraocular Pressure|intraocular pressure
633363|NCT00707239|Hospital-acquired pneumonia|hospital-acquired pneumonia
633364|NCT00707239|Ventilator-associated pneumonia|ventilator-associated pneumonia
633365|NCT00707252|Non-small cell lung cancer|non-small cell lung cancer
633366|NCT00707252|Erlotinib|erlotinib
633367|NCT00707252|Polyphenon E|polyphenon e
633368|NCT00707252|Tarceva|tarceva
633369|NCT00707252|Advanced Non-small Cell Lung Cancer Stage IIIb or IV|advanced non-small cell lung cancer stage iiib or iv
633370|NCT00707291|contact lens|contact lens
633371|NCT00707291|normal|normal
633372|NCT00707304|Non Small Cell Lung Cancer|non small cell lung cancer
633373|NCT00707304|Talactoferrin|talactoferrin
633374|NCT00707304|Dendritic Cell Recruiter and Activator|dendritic cell recruiter and activator
633375|NCT00707304|Immunomodulatory agent|immunomodulatory agent
633376|NCT00707317|M. tuberculosis|m. tuberculosis
633377|NCT00707317|latent tuberculosis infection|latent tuberculosis infection
633378|NCT00707317|Quantiferon assay|quantiferon assay
633379|NCT00707317|ELISPOT assay|elispot assay
633380|NCT00707317|tuberculin skin test|tuberculin skin test
633381|NCT00707317|immunocompromised patients|immunocompromised patients
633382|NCT00707330|oxidative stress|oxidative stress
633383|NCT00707330|8-oxo-deoxyguanine|8-oxo-deoxyguanine
633384|NCT00707330|8-oxodG|8-oxodg
633385|NCT00707330|clarithromycin|clarithromycin
633386|NCT00707330|malondialdehyde|malondialdehyde
633388|NCT00707330|vitamine C|vitamine c
633389|NCT00707330|ascorbic acid|ascorbic acid
633390|NCT00707356|Prostatic disease|prostatic disease
633391|NCT00707356|genital neoplasm, male|genital neoplasm, male
633392|NCT00707356|Urogenital neoplasm|urogenital neoplasm
633393|NCT00707356|Genital disease|genital disease
633394|NCT00707356|male|male
633395|NCT00707356|Male urogenital disease|male urogenital disease
633396|NCT00707356|Neoplasms|neoplasms
633397|NCT00707356|Neoplasm by site|neoplasm by site
633398|NCT00707356|prostatic neoplasm|prostatic neoplasm
633399|NCT00707356|Carcinoma|carcinoma
633400|NCT00707369|Periodontitis|periodontitis
633401|NCT00707369|Mechanical Debridement|mechanical debridement
633402|NCT00707369|Antibiotics|antibiotics
633403|NCT00707369|Attachment loss|attachment loss
633404|NCT00707369|Randomized controlled trial|randomized controlled trial
633405|NCT00707382|Pharmacogenetics|pharmacogenetics
633406|NCT00707382|Compliance|compliance
633407|NCT00707382|Antipsychotic drugs|antipsychotic drugs
633408|NCT00707382|Schizophrenia|schizophrenia
633409|NCT00707434|Continuous Glucose Monitor|continuous glucose monitor
633410|NCT00707434|Medtronic Guardian|medtronic guardian
633411|NCT00707434|Guardian® blood-sugar monitoring device|guardian® blood-sugar monitoring device
633412|NCT00707434|Glucose Monitoring|glucose monitoring
633413|NCT00707434|Critically Ill|critically ill
633414|NCT00707434|ICU|icu
633415|NCT00707434|Intensive Care Unit|intensive care unit
633416|NCT00707434|Glycemic Excursions|glycemic excursions
633417|NCT00707434|Glucose Control|glucose control
633418|NCT00707434|Glucose Testing|glucose testing
633419|NCT00707434|Hyperglycemia|hyperglycemia
633420|NCT00707434|Hypoglycemia|hypoglycemia
633421|NCT00707434|Insulin Infusion|insulin infusion
633422|NCT00707447|diabetes-prevention|diabetes-prevention
633423|NCT00707447|lifestyle modification|lifestyle modification
633424|NCT00707447|behavior therapy|behavior therapy
633425|NCT00707447|self-management|self-management
633426|NCT00707460|Diabetes|diabetes
633427|NCT00707460|Cardiovascular|cardiovascular
633428|NCT00707460|Obesity|obesity
633429|NCT00707460|First.Nation|first.nation
633430|NCT00707460|Aboriginal (Health)|aboriginal (health)
633431|NCT00707460|Dietary|dietary
633432|NCT00707460|Intervention|intervention
633433|NCT00707460|Nutrition|nutrition
633434|NCT00707460|Traditional (Diet)|traditional (diet)
633435|NCT00707460|Sandy Lake (Health & Diabetes Project)|sandy lake (health & diabetes project)
633436|NCT00707460|(High) protein|(high) protein
633437|NCT00707460|(High) fibre (er)|(high) fibre (er)
633438|NCT00707460|(Low) carbohydrate|(low) carbohydrate
633439|NCT00707473|Carcinoma of Paranasal Sinuses|carcinoma of paranasal sinuses
633440|NCT00707473|Paranasal Sinuses|paranasal sinuses
633441|NCT00707473|Nasal Sinuses|nasal sinuses
633442|NCT00707473|Nasal Cavity|nasal cavity
633443|NCT00707473|Squamous Cell Carcinoma|squamous cell carcinoma
633444|NCT00707473|Undifferentiated Carcinoma|undifferentiated carcinoma
633445|NCT00707473|Poorly Differentiated Carcinoma|poorly differentiated carcinoma
633446|NCT00707473|Docetaxel|docetaxel
633447|NCT00707473|5-Fluorouracil|5-fluorouracil
633448|NCT00707473|Cisplatin|cisplatin
633449|NCT00707473|Platinol®|platinol®
633450|NCT00707473|Platinol®-AQ|platinol®-aq
633451|NCT00707486|Hemostasis, tooth extractions, third molar|hemostasis, tooth extractions, third molar
633452|NCT00707525|aneuploidies, natural cycle, stimulated cycle, preimplantation genetic diagnosis|aneuploidies, natural cycle, stimulated cycle, preimplantation genetic diagnosis
633453|NCT00707551|AZD1305|azd1305
633454|NCT00707551|Verapamil|verapamil
633455|NCT00707551|Ketoconazole|ketoconazole
633456|NCT00707551|pharmacokinetics|pharmacokinetics
633457|NCT00707564|hemostasis|hemostasis
633458|NCT00707564|tooth extractions|tooth extractions
633459|NCT00707577|Worksite Wellness|worksite wellness
633460|NCT00707577|Weight loss and maintenance|weight loss and maintenance
633461|NCT00707577|Physical Activity|physical activity
633462|NCT00707577|Health and Fitness interventions|health and fitness interventions
633463|NCT00707577|Healthy eating|healthy eating
633464|NCT00707577|Weight loss|weight loss
633465|NCT00707577|Maintenance programs|maintenance programs
633466|NCT00707603|Insulin resistance|insulin resistance
633467|NCT00707603|Liver fat|liver fat
633468|NCT00707603|Muscle fat|muscle fat
633469|NCT00707603|Abdominal fat|abdominal fat
633470|NCT00707603|Cytokines|cytokines
633471|NCT00707629|type 1 diabetes|type 1 diabetes
633472|NCT00707629|neurocognitive measures|neurocognitive measures
633473|NCT00707629|behavioral measures|behavioral measures
633474|NCT00707642|West Nile Virus|west nile virus
633475|NCT00707642|West Nile Vaccine|west nile vaccine
633476|NCT00707642|West Nile virus disease|west nile virus disease
633477|NCT00707642|Hawaii Biotech|hawaii biotech
633478|NCT00707668|Diabetes|diabetes
633479|NCT00707668|metabolic syndrome|metabolic syndrome
633480|NCT00707668|dyslipidemia|dyslipidemia
633481|NCT00707668|osteoporosis|osteoporosis
633482|NCT00707681|microbio, MS-20, Hepatoma, Advanced Hepatocellular Carcinoma|microbio, ms-20, hepatoma, advanced hepatocellular carcinoma
633483|NCT00707694|95 years of age and older|95 years of age and older
633484|NCT00707707|breast cancer|breast cancer
633485|NCT00707707|triple negative|triple negative
633486|NCT00707707|metastatic|metastatic
633487|NCT00707746|statin intolerant|statin intolerant
633488|NCT00707746|hypercholesterolemia|hypercholesterolemia
751795|NCT01170481|anterior and intermediate uveitis|anterior and intermediate uveitis
633489|NCT00707759|Pediatric renal transplantation,Bone metabolism (DXA-pQCT)|pediatric renal transplantation,bone metabolism (dxa-pqct)
633490|NCT00707759|mRNAFOXP3/IL-17,Steroid withdrawal|mrnafoxp3/il-17,steroid withdrawal
633491|NCT00707772|Hepatitis C|hepatitis c
633492|NCT00707772|Hemophilia|hemophilia
633493|NCT00707772|Pegasys|pegasys
633494|NCT00707772|Ribavirin|ribavirin
633495|NCT00707785|vitamin A|vitamin a
633496|NCT00707785|Treatment|treatment
633497|NCT00707785|neonates|neonates
633498|NCT00707785|newborn|newborn
633499|NCT00707785|sepsis|sepsis
633500|NCT00707785|necrotizing enterocolitis|necrotizing enterocolitis
633501|NCT00707785|meningitis|meningitis
633502|NCT00707785|pneumonia|pneumonia
633503|NCT00707798|Young adults|young adults
633504|NCT00707798|Pneumococcal vaccine,|pneumococcal vaccine,
633505|NCT00707798|Streptococcus pneumoniae,|streptococcus pneumoniae,
633506|NCT00707811|Dyspnea|dyspnea
633507|NCT00707811|Shortness of Breath|shortness of breath
633508|NCT00707811|Trouble Breathing|trouble breathing
633509|NCT00707811|ST2|st2
633510|NCT00707811|IL-33|il-33
633511|NCT00707824|pruritus|pruritus
633512|NCT00707824|epidural morphine|epidural morphine
633514|NCT00707850|Thalassemia|thalassemia
633515|NCT00707850|Pegasys|pegasys
633516|NCT00707850|Ribavirin|ribavirin
633517|NCT00707863|Escitalopram|escitalopram
633518|NCT00707863|Lexapro|lexapro
633519|NCT00707863|fMRI|fmri
633520|NCT00707863|pictures|pictures
633521|NCT00707876|Peripheral arterial disease (PAD); Magnetic Resonance Angiography (MRA); Magnetic Resonance Imaging (MRI), imaging agent or biomarker|peripheral arterial disease (pad); magnetic resonance angiography (mra); magnetic resonance imaging (mri), imaging agent or biomarker
633522|NCT00707902|Sore throats,|sore throats,
633523|NCT00707902|Pharyngitis|pharyngitis
633524|NCT00707902|Acute|acute
633525|NCT00707915|aged|aged
633526|NCT00707915|benzodiazepines|benzodiazepines
633527|NCT00707915|hypnotics|hypnotics
633528|NCT00707915|cognition|cognition
633529|NCT00707915|posture|posture
633530|NCT00707928|retained placenta|retained placenta
633531|NCT00707941|Influenza like illness|influenza like illness
633532|NCT00707941|Pneumonia|pneumonia
633533|NCT00707941|Bronchiolitis|bronchiolitis
633534|NCT00707941|Upper respiratory tract illness|upper respiratory tract illness
633535|NCT00707941|Otitis media|otitis media
633536|NCT00707941|Viral shedding|viral shedding
633537|NCT00707941|Nasopharyngeal wash|nasopharyngeal wash
633538|NCT00707941|Viral culture|viral culture
633539|NCT00707941|PCR|pcr
633540|NCT00707954|Diabetes|diabetes
633541|NCT00707954|TA-7284|ta-7284
633542|NCT00707967|Tuberculosis vaccine|tuberculosis vaccine
633543|NCT00707980|Major Depressive Disorder|major depressive disorder
633544|NCT00707980|Depression|depression
633545|NCT00707980|Melancholia|melancholia
633546|NCT00707980|Mood Disorder|mood disorder
633547|NCT00707980|Dysthymic Disorder|dysthymic disorder
633548|NCT00707980|Drug Therapy|drug therapy
633549|NCT00707993|Glucose Metabolism Disorder|glucose metabolism disorder
633550|NCT00707993|Dysmetabolic Syndrome|dysmetabolic syndrome
633551|NCT00707993|Type II Diabetes|type ii diabetes
633552|NCT00707993|Diabetes Mellitus|diabetes mellitus
633553|NCT00707993|Lipoatrophic|lipoatrophic
633554|NCT00707993|Dyslipidemia|dyslipidemia
633860|NCT00715858|doxycycline|doxycycline
633555|NCT00707993|Drug Therapy|drug therapy
633556|NCT00708019|cancer pain|cancer pain
633557|NCT00708019|bone metastasis|bone metastasis
633558|NCT00708019|psychoeducational intervention|psychoeducational intervention
633559|NCT00708019|nurse coaching|nurse coaching
633560|NCT00708019|patient education|patient education
633561|NCT00708019|breast cancer|breast cancer
633688|NCT00714675|aged|aged
633563|NCT00708058|Implanted cardiac defibrillators|implanted cardiac defibrillators
633564|NCT00708058|Congestive Heart Failure|congestive heart failure
633565|NCT00708058|Emergency Department|emergency department
633566|NCT00708084|Rabies post-exposure prophylaxis|rabies post-exposure prophylaxis
633567|NCT00708084|Monoclonal antibody|monoclonal antibody
633568|NCT00708097|fluoride|fluoride
633569|NCT00708097|in situ|in situ
635166|NCT00719667|OPCAB|opcab
633570|NCT00708097|remineralization|remineralization
633571|NCT00708097|enamel|enamel
633572|NCT00708097|caries|caries
633573|NCT00708110|dose-ranging study|dose-ranging study
633574|NCT00708110|phase IIa|phase iia
633575|NCT00708110|integrase inhibitor|integrase inhibitor
633576|NCT00708110|HIV-1 infection|hiv-1 infection
633577|NCT00708123|remineralization|remineralization
633578|NCT00708123|enamel|enamel
633579|NCT00708123|fluoride|fluoride
633580|NCT00708123|caries|caries
633581|NCT00708123|in situ|in situ
633582|NCT00708136|Falls|falls
633583|NCT00708136|elderly|elderly
633584|NCT00708136|Balance|balance
633585|NCT00708136|speed of stepping|speed of stepping
633586|NCT00708136|Stability|stability
633587|NCT00708136|ELDERLY FALLERS|elderly fallers
633588|NCT00708149|lansoprazole, weaning,stress ulcer prophylaxis|lansoprazole, weaning,stress ulcer prophylaxis
633589|NCT00708162|HIV|hiv
633590|NCT00708162|HIV I|hiv i
633591|NCT00708162|Treatment Experienced|treatment experienced
633592|NCT00708175|Glucose Metabolism Disorder|glucose metabolism disorder
633593|NCT00708175|Dysmetabolic Syndrome|dysmetabolic syndrome
633594|NCT00708175|Type II Diabetes|type ii diabetes
633595|NCT00708175|Diabetes Mellitus|diabetes mellitus
633596|NCT00708175|Lipoatrophic|lipoatrophic
633597|NCT00708175|Postmenopausal|postmenopausal
633598|NCT00708188|Stroke, ischemic, etiology, TOAST, CT, multidetector|stroke, ischemic, etiology, toast, ct, multidetector
633600|NCT00708201|POI|poi
633601|NCT00714428|Traumatic Brain Injury|traumatic brain injury
633602|NCT00714428|Quality of Life|quality of life
633603|NCT00714441|Diabetes Type 2|diabetes type 2
633604|NCT00714441|Distress|distress
633605|NCT00714441|Problem Solving Therapy|problem solving therapy
633606|NCT00714441|Computer Automated Self-Management (CASM)|computer automated self-management (casm)
633607|NCT00714467|smoking cessation|smoking cessation
633608|NCT00714467|Asian|asian
633609|NCT00714467|Chinese American|chinese american
633610|NCT00714467|family support|family support
633611|NCT00714467|social support|social support
633612|NCT00714467|stage-based intervention|stage-based intervention
633613|NCT00714480|Thymoglobulin|thymoglobulin
633614|NCT00714480|Renal Transplant|renal transplant
633615|NCT00714480|Kidney Transplant|kidney transplant
633616|NCT00714480|Immunosuppression|immunosuppression
633617|NCT00714480|Induction therapy|induction therapy
633618|NCT00714493|rheumatoid arthritis|rheumatoid arthritis
633619|NCT00714493|remicade|remicade
633620|NCT00714493|infliximab|infliximab
633621|NCT00714493|Centocor|centocor
633622|NCT00714493|etanercept|etanercept
633623|NCT00714493|enbrel|enbrel
633624|NCT00714493|adalimumab|adalimumab
633625|NCT00714493|humira|humira
633626|NCT00714493|restart|restart
633627|NCT00714493|swollen joints|swollen joints
633628|NCT00714493|tender joints.|tender joints.
633629|NCT00714506|obesity|obesity
633630|NCT00714506|physical activity|physical activity
633631|NCT00714506|older adults|older adults
633632|NCT00714506|functional disability|functional disability
633633|NCT00714519|Xenaderm|xenaderm
633634|NCT00714519|partial|partial
633635|NCT00714519|thickness|thickness
633636|NCT00714519|wounds|wounds
633637|NCT00714519|Nursing Homes|nursing homes
633638|NCT00714532|smoking cessation|smoking cessation
633639|NCT00714532|Asian American|asian american
633640|NCT00714532|Chinese American|chinese american
633641|NCT00714532|smoking reduction|smoking reduction
633642|NCT00714532|stage-based intervention|stage-based intervention
633643|NCT00714532|expert system|expert system
633644|NCT00714532|nicotine replacement|nicotine replacement
633645|NCT00714532|counseling|counseling
633646|NCT00714545|Coronary Artery Disease|coronary artery disease
633647|NCT00714545|Coronary Restenosis|coronary restenosis
633648|NCT00714545|Brachytherapy|brachytherapy
633649|NCT00714558|Pharmacokinetics|pharmacokinetics
633650|NCT00714558|Administration, Oral|administration, oral
633651|NCT00714558|Naltrexone|naltrexone
633652|NCT00714558|Biological Availability|biological availability
633653|NCT00714558|Infusions, Intravenous|infusions, intravenous
633654|NCT00714558|Fentanyl|fentanyl
633655|NCT00714558|Safety|safety
633656|NCT00714558|Naloxone|naloxone
633861|NCT00715858|rifampin|rifampin
633657|NCT00714571|cognitive rehabilitation|cognitive rehabilitation
633658|NCT00714571|explicit memory training|explicit memory training
633659|NCT00714571|mild cognitive impairment|mild cognitive impairment
633660|NCT00714571|Alzheimer's disease|alzheimer's disease
633661|NCT00714571|traumatic brain injury|traumatic brain injury
633662|NCT00714571|veterans|veterans
633663|NCT00714584|Infusions, Intravenous|infusions, intravenous
633664|NCT00714584|Safety|safety
633665|NCT00714584|Pharmacokinetics|pharmacokinetics
633666|NCT00714584|Naltrexone|naltrexone
633667|NCT00714584|Administration, Oral|administration, oral
633668|NCT00714597|Venous thrombosis|venous thrombosis
633669|NCT00714597|Primary prevention|primary prevention
633670|NCT00714610|Serum metal ion concentration|serum metal ion concentration
633671|NCT00714623|Coronary Artery Disease|coronary artery disease
633672|NCT00714623|Coronary Restenosis|coronary restenosis
633673|NCT00714623|Coronary Thrombosis|coronary thrombosis
633674|NCT00714623|Drug-Eluting Stents|drug-eluting stents
633675|NCT00714623|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
633676|NCT00714636|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
633677|NCT00714636|Cerebrospinal Fluid|cerebrospinal fluid
633678|NCT00714636|Neurodegenerative Disease|neurodegenerative disease
633679|NCT00714636|Motor Neuron Disease|motor neuron disease
633680|NCT00714636|Autonomic Nervous System|autonomic nervous system
633681|NCT00714636|Neurodegenerative Diseases|neurodegenerative diseases
633682|NCT00714636|Movement Disorders|movement disorders
633683|NCT00714649|Head and Neck Squamous Cell Carcinoma treated with surgery|head and neck squamous cell carcinoma treated with surgery
633684|NCT00714649|and/or radiotherapy|and/or radiotherapy
633685|NCT00714662|high flux hemodialysis|high flux hemodialysis
633686|NCT00714675|citrulline|citrulline
633687|NCT00714675|protein-energy malnutrition|protein-energy malnutrition
633689|NCT00714675|protein biosynthesis|protein biosynthesis
633690|NCT00714675|amino acid|amino acid
633691|NCT00714688|Adult|adult
633692|NCT00714688|ADHD|adhd
633693|NCT00714688|Concerta|concerta
633694|NCT00714714|acne|acne
633695|NCT00714714|irritation|irritation
633696|NCT00714714|objective sensory methods|objective sensory methods
633697|NCT00714727|migraine|migraine
633698|NCT00714727|headache|headache
633699|NCT00714727|acupuncture|acupuncture
633700|NCT00714740|apnea, sleep, altitude, hypoxia|apnea, sleep, altitude, hypoxia
633701|NCT00715312|Inflammation|inflammation
633702|NCT00715312|LDL|ldl
633703|NCT00715312|Oleic acid|oleic acid
633704|NCT00715312|Palmitic acid|palmitic acid
633705|NCT00715312|trans fatty acid|trans fatty acid
633706|NCT00715312|C-reactive protein|c-reactive protein
633707|NCT00715325|colonoscopy|colonoscopy
633708|NCT00715325|disposable|disposable
633709|NCT00715325|single use|single use
633710|NCT00715338|Exhaled Breath Condensate|exhaled breath condensate
633711|NCT00715338|elective surgery|elective surgery
633712|NCT00715338|mechanical ventilation|mechanical ventilation
633713|NCT00715338|Isofurans|isofurans
633714|NCT00715338|thrombomodulin|thrombomodulin
633715|NCT00715338|requiring|requiring
633716|NCT00715338|mechanical|mechanical
633717|NCT00715338|ventilation|ventilation
633718|NCT00715377|benztropine|benztropine
633719|NCT00715377|Anticholinergic antiparkinsonian agents|anticholinergic antiparkinsonian agents
633720|NCT00715377|antipsychotics|antipsychotics
633721|NCT00715377|elderly population|elderly population
633722|NCT00715377|side-effects|side-effects
633723|NCT00715390|Children|children
633724|NCT00715390|Cardiac Arrhythmia|cardiac arrhythmia
633725|NCT00715390|General Anesthesia|general anesthesia
633726|NCT00715416|peripheral vascular diseases|peripheral vascular diseases
633727|NCT00715416|Intermittent Claudication|intermittent claudication
633728|NCT00715416|Angioplasty|angioplasty
633729|NCT00715429|leg cramps|leg cramps
633730|NCT00715429|vitamin D deficiency|vitamin d deficiency
633731|NCT00715442|Kidney|kidney
633732|NCT00715442|Renal Cell Carcinoma|renal cell carcinoma
633733|NCT00715442|RCC|rcc
633734|NCT00715442|Sutent|sutent
633735|NCT00715442|Sunitinib malate|sunitinib malate
633736|NCT00715442|Clear cell|clear cell
633737|NCT00715442|SU011248|su011248
633738|NCT00715442|Nephrectomy|nephrectomy
633739|NCT00715442|Surgical removal of kidney|surgical removal of kidney
633740|NCT00715442|Cytoreductive nephrectomy|cytoreductive nephrectomy
633741|NCT00715455|CAD|cad
633742|NCT00715455|PCI|pci
633743|NCT00715455|ANTICOAGULANT|anticoagulant
633744|NCT00715481|Type 2 diabetes|type 2 diabetes
633745|NCT00715481|Cardiovascular disease|cardiovascular disease
633746|NCT00715481|Diabetic Nephropathy|diabetic nephropathy
633747|NCT00715481|Glomerular filtration rate|glomerular filtration rate
633748|NCT00715481|Albuminuria|albuminuria
633749|NCT00715494|brain injuries, dementia, myopathies, muscle disorders|brain injuries, dementia, myopathies, muscle disorders
633750|NCT00715507|decision making|decision making
633751|NCT00715507|graphic display|graphic display
633752|NCT00715520|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
633753|NCT00715520|Rehabilitation|rehabilitation
633754|NCT00715520|Stroke|stroke
633755|NCT00715520|Plasticity|plasticity
633756|NCT00715533|acute (< 24 hours) stroke|acute (< 24 hours) stroke
633757|NCT00715533|stroke|stroke
633758|NCT00715533|TIA|tia
633759|NCT00715533|MRI|mri
633760|NCT00715533|imaging|imaging
633761|NCT00715533|acute|acute
633762|NCT00715546|Adipose-derived stem cell|adipose-derived stem cell
633763|NCT00715546|Lipodystrophy|lipodystrophy
633764|NCT00715559|Major depressive disorder, depression|major depressive disorder, depression
633765|NCT00715559|neurotrophic|neurotrophic
633766|NCT00715559|brain-derived neurotrophic factor|brain-derived neurotrophic factor
633767|NCT00715559|antidepressant|antidepressant
633768|NCT00715559|cysteamine|cysteamine
633769|NCT00715572|hypothyroidism, treatment, thyroxine, triiodothyronine|hypothyroidism, treatment, thyroxine, triiodothyronine
633770|NCT00715585|diabetes|diabetes
633771|NCT00715585|education|education
633772|NCT00715585|health literacy|health literacy
633773|NCT00715598|Pain Assessment|pain assessment
633774|NCT00715598|Measurement|measurement
633775|NCT00715611|pemetrexed|pemetrexed
633776|NCT00715611|cisplatin|cisplatin
633777|NCT00715611|IMRT|imrt
633778|NCT00715611|PLEURA|pleura
633779|NCT00715611|Malignant|malignant
633780|NCT00715611|08-053|08-053
633781|NCT00715624|hyperglycemia, GLP-1, metformin, insulin|hyperglycemia, glp-1, metformin, insulin
633782|NCT00715637|AML|aml
633783|NCT00715637|Leukemia|leukemia
633784|NCT00715637|MDS|mds
633785|NCT00715637|Amonafide|amonafide
633786|NCT00715637|Cytarabine|cytarabine
633787|NCT00715637|Daunorubicin|daunorubicin
633788|NCT00715637|Lymphatic disorders|lymphatic disorders
633789|NCT00715650|Rehabilitation, Vocational|rehabilitation, vocational
633790|NCT00715650|Compensation and Redress|compensation and redress
633791|NCT00715650|disability evaluation|disability evaluation
633792|NCT00715676|Osteoporosis|osteoporosis
633793|NCT00715676|2-methylene-19-nor-(20S)-1a, 25-dihydroxyvitamin D3|2-methylene-19-nor-(20s)-1a, 25-dihydroxyvitamin d3
633794|NCT00715676|Vitamin D|vitamin d
633795|NCT00715676|Bone Density Conservation Agents|bone density conservation agents
633796|NCT00715676|Bone Regeneration|bone regeneration
633797|NCT00715702|AZD5672|azd5672
633798|NCT00715715|Hepatitis B e Antigen|hepatitis b e antigen
633799|NCT00715715|HBeAg-positive chronic hepatitis B|hbeag-positive chronic hepatitis b
633800|NCT00715728|Plastic surgery|plastic surgery
633801|NCT00715728|Warming|warming
633802|NCT00715728|Core temperature|core temperature
633803|NCT00715728|Bair Hugger|bair hugger
633804|NCT00715728|Hot Dog heating system|hot dog heating system
633805|NCT00715741|atelectasis|atelectasis
633806|NCT00715741|oxygen|oxygen
633807|NCT00715741|saturation|saturation
633808|NCT00715767|BLS training|bls training
633809|NCT00715767|CPR|cpr
633810|NCT00715767|post graduate education|post graduate education
633811|NCT00715767|resource-limited settings|resource-limited settings
633812|NCT00715767|medical education|medical education
633813|NCT00715767|CPR retention|cpr retention
633814|NCT00715767|cultural barriers|cultural barriers
633815|NCT00715793|Decitabine|decitabine
633816|NCT00715793|Temozolomide|temozolomide
633817|NCT00715793|Metastatic|metastatic
633818|NCT00715793|Melanoma|melanoma
633819|NCT00715793|Non-resectable|non-resectable
633820|NCT00715793|Stage IIIB melanoma|stage iiib melanoma
633821|NCT00715793|stage IV melanoma|stage iv melanoma
633822|NCT00715793|TMZ|tmz
633823|NCT00715793|DTIC|dtic
633824|NCT00715793|promoter methylation|promoter methylation
633825|NCT00715793|skin cancer|skin cancer
633826|NCT00715793|chemotherapy|chemotherapy
633827|NCT00715806|claustrophobia|claustrophobia
633828|NCT00715806|magnetic resonance imaging|magnetic resonance imaging
633829|NCT00715806|MRI|mri
633830|NCT00715806|anxiety|anxiety
633831|NCT00715806|open design|open design
633832|NCT00715806|severely anxious patients|severely anxious patients
633833|NCT00715832|Breast cancer|breast cancer
633834|NCT00715832|Dendritic cell vaccine|dendritic cell vaccine
633835|NCT00715832|OFA/iLRP|ofa/ilrp
633836|NCT00715832|Patients|patients
633837|NCT00715832|Line|line
633838|NCT00715832|Chemotherapy|chemotherapy
633839|NCT00715832|Setting|setting
633840|NCT00715832|Four different lines|four different lines
633841|NCT00715845|cardiovascular disease|cardiovascular disease
633842|NCT00715845|embolism|embolism
633843|NCT00715845|microemboli|microemboli
633844|NCT00715845|cognitive decline|cognitive decline
633845|NCT00715845|mitral valve repair|mitral valve repair
633846|NCT00715845|cerebral microemboli|cerebral microemboli
633847|NCT00715845|coronary artery bypass graft|coronary artery bypass graft
633848|NCT00715845|CABG|cabg
633849|NCT00715845|transcranial doppler|transcranial doppler
633850|NCT00715845|transesophageal echocardiogram|transesophageal echocardiogram
633851|NCT00715845|magnetic resonance imaging|magnetic resonance imaging
633852|NCT00715845|carbon dioxide|carbon dioxide
633853|NCT00715858|Alzheimer's disease|alzheimer's disease
633854|NCT00715858|dementia|dementia
633855|NCT00715858|inflammation|inflammation
633856|NCT00715858|cytokine|cytokine
633857|NCT00715858|biomarker|biomarker
633858|NCT00715858|cerebrospinal fluid|cerebrospinal fluid
633859|NCT00715858|serum|serum
633862|NCT00715871|smoking|smoking
633863|NCT00715871|smoke cessation|smoke cessation
633864|NCT00715871|stop smoking|stop smoking
633865|NCT00715871|quit smoking|quit smoking
633866|NCT00715871|nicotine replacement therapy|nicotine replacement therapy
633867|NCT00715871|Smoke Break|smoke break
633868|NCT00715871|liquid cigarette|liquid cigarette
633869|NCT00715871|liquid nicotine cigarette|liquid nicotine cigarette
633870|NCT00715884|Atherosclerosis|atherosclerosis
633871|NCT00715884|de novo native coronary lesion|de novo native coronary lesion
633872|NCT00715897|chronic neurological deficient due to stroke|chronic neurological deficient due to stroke
633873|NCT00715910|Meningococcal vaccine|meningococcal vaccine
633874|NCT00715910|Booster vaccination|booster vaccination
633875|NCT00715910|Immunogenicity|immunogenicity
633876|NCT00715910|Meningococcal disease|meningococcal disease
633877|NCT00715910|Safety|safety
633878|NCT00715923|informed consent document|informed consent document
633879|NCT00715923|ethics|ethics
633880|NCT00715936|Integrated early child development, growth and health|integrated early child development, growth and health
633881|NCT00715936|Psychosocial stimulation|psychosocial stimulation
633882|NCT00715936|Care for child development|care for child development
633883|NCT00715949|traumatic brain injury|traumatic brain injury
633884|NCT00715949|pediatric|pediatric
633885|NCT00715949|neurocognitive|neurocognitive
633886|NCT00715949|concussion|concussion
633887|NCT00715962|Hospitalization|hospitalization
633888|NCT00715962|Aged|aged
633889|NCT00715975|clobetasol|clobetasol
633890|NCT00715975|halobetasol|halobetasol
633891|NCT00715975|psoriasis|psoriasis
633892|NCT00715975|evaluating the efficacy and tolerability of the drug Halobetasol propionate|evaluating the efficacy and tolerability of the drug halobetasol propionate
633893|NCT00715988|Methadone|methadone
633895|NCT00715988|newborns|newborns
633896|NCT00715988|QT prolongation|qt prolongation
633897|NCT00715988|Young Infants|young infants
633898|NCT00716001|patients with chronic renal failure undergoing elective percutaneous coronary intervention|patients with chronic renal failure undergoing elective percutaneous coronary intervention
633899|NCT00716014|Pachyonychia Congenita|pachyonychia congenita
633900|NCT00716014|siRNA|sirna
633901|NCT00716040|AIDS treatment|aids treatment
633902|NCT00716040|HAART adherence|haart adherence
633903|NCT00716040|intervention|intervention
633904|NCT00716053|emphysema|emphysema
633905|NCT00716053|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
633906|NCT00716053|COPD|copd
633907|NCT00716053|lung volume reduction|lung volume reduction
633908|NCT00716053|LVRS|lvrs
633909|NCT00716053|BLVR|blvr
633910|NCT00716053|Aeris|aeris
633911|NCT00716079|Cerebral Hemorrhage|cerebral hemorrhage
633912|NCT00716079|Stroke|stroke
633913|NCT00716079|antihypertensive drugs|antihypertensive drugs
633914|NCT00716079|blood pressure|blood pressure
633915|NCT00716079|disability|disability
633916|NCT00716079|clinical trial|clinical trial
633917|NCT00716079|outcomes|outcomes
633918|NCT00716105|Infant formula|infant formula
633919|NCT00716105|Protein metabolism|protein metabolism
633920|NCT00716118|Oocyte Cryopreservation|oocyte cryopreservation
633921|NCT00716118|Slow-Freeze|slow-freeze
633922|NCT00716118|Egg Freezing|egg freezing
633923|NCT00716118|Meiotic Spindle|meiotic spindle
633924|NCT00716118|Mitochondria|mitochondria
633925|NCT00716118|Human Oocytes Freezing.|human oocytes freezing.
633926|NCT00716131|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
633927|NCT00716131|Cerebrospinal Fluid|cerebrospinal fluid
633928|NCT00716131|Neurodegenerative Disease|neurodegenerative disease
633929|NCT00716131|Motor Neuron Disease|motor neuron disease
633930|NCT00716131|Autonomic Nervous System|autonomic nervous system
633931|NCT00716131|Neurodegenerative Diseases|neurodegenerative diseases
633932|NCT00716131|Movement Disorders|movement disorders
633933|NCT00716144|Psoriasis|psoriasis
633934|NCT00716170|Diabetes Mellitus|diabetes mellitus
633935|NCT00716170|Glucagon|glucagon
633936|NCT00716170|Insulin|insulin
633937|NCT00716170|Incretin hormones|incretin hormones
633938|NCT00716170|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
633939|NCT00716170|Glucagon-like peptide-1|glucagon-like peptide-1
633940|NCT00716170|Glucagon-like peptide-2|glucagon-like peptide-2
633941|NCT00716183|mastitis|mastitis
633942|NCT00716183|Staphylococcus|staphylococcus
633943|NCT00716183|Streptococcus|streptococcus
633944|NCT00716183|lactation|lactation
633945|NCT00716183|breastfeeding|breastfeeding
633946|NCT00716196|thin prep|thin prep
633948|NCT00716235|ADHD|adhd
633949|NCT00716235|ASD|asd
633950|NCT00716235|PDD|pdd
633951|NCT00716235|DCD|dcd
633952|NCT00716235|Executive Functions|executive functions
633953|NCT00716261|Parkinson's disease|parkinson's disease
633954|NCT00716261|Audio feedback|audio feedback
633955|NCT00716261|postural control|postural control
633956|NCT00716300|obesity|obesity
633957|NCT00716300|CVD|cvd
633958|NCT00716300|HDL kinetics|hdl kinetics
633959|NCT00716300|Anti-inflammatory and anti-oxidation studies|anti-inflammatory and anti-oxidation studies
634819|NCT00718822|low oxygen|low oxygen
633960|NCT00716300|30 subjects recruited (15 MetS and 15 lean controls)|30 subjects recruited (15 mets and 15 lean controls)
633961|NCT00716326|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
633962|NCT00716326|Chronic pain|chronic pain
633963|NCT00716326|Neuropathic pain|neuropathic pain
633964|NCT00716326|Short-term efficacy|short-term efficacy
633965|NCT00716326|Long-term efficacy|long-term efficacy
633966|NCT00716339|pseudophakic accommodation|pseudophakic accommodation
633967|NCT00716352|non-ST elevation acute coronary syndrome|non-st elevation acute coronary syndrome
633968|NCT00716352|educational intervention|educational intervention
633969|NCT00716352|evidence based practice|evidence based practice
633970|NCT00716352|guidelines|guidelines
633971|NCT00716365|angiography|angiography
633972|NCT00716365|hemostasis|hemostasis
633973|NCT00716365|femoral artery|femoral artery
633975|NCT00716378|Simulated Driving|simulated driving
633976|NCT00716378|Risky Driving Behavior|risky driving behavior
633977|NCT00716378|Social Influences|social influences
633978|NCT00716391|Head and Neck Cancer|head and neck cancer
633979|NCT00716404|FlowMedica|flowmedica
633980|NCT00716404|Benephit|benephit
633981|NCT00716404|TRT|trt
633982|NCT00716404|Patients|patients
633983|NCT00716404|Components|components
633984|NCT00716404|Benephit Infusion System|benephit infusion system
633985|NCT00716404|Planned|planned
633986|NCT00716404|To be used|to be used
633987|NCT00716430|acute coronary syndromes|acute coronary syndromes
633988|NCT00716430|quality improvement|quality improvement
633989|NCT00716443|Nasolabial folds|nasolabial folds
633990|NCT00716443|wrinkles|wrinkles
633991|NCT00716443|topical anesthetic|topical anesthetic
633992|NCT00716456|MAB C225(CETUXIMAB)(ANTI-EGFR)|mab c225(cetuximab)(anti-egfr)
633993|NCT00716456|OSI-774, TARCEVA (ERLOTINIB)|osi-774, tarceva (erlotinib)
633995|NCT00716456|Adenocarcinoma|adenocarcinoma
633996|NCT00716456|Lung cancer|lung cancer
633997|NCT00716469|Neurofibroma|neurofibroma
633998|NCT00716469|Plexiform|plexiform
633999|NCT00716469|NF1|nf1
634000|NCT00716469|Photo dynamic therapy|photo dynamic therapy
634001|NCT00716482|breast|breast
634002|NCT00716482|lesion|lesion
634003|NCT00716482|ultrasound|ultrasound
634004|NCT00716482|BI-RADS|bi-rads
634005|NCT00716482|malignancy|malignancy
634006|NCT00716482|women|women
634007|NCT00716508|Patella tendon rupute, suture anchors, repair patella tendon|patella tendon rupute, suture anchors, repair patella tendon
634008|NCT00716521|mobile actigraphy inpatient polysomnography actigraphy ambien|mobile actigraphy inpatient polysomnography actigraphy ambien
634009|NCT00716573|Cardiac transplantation|cardiac transplantation
634010|NCT00716573|Chronic renal insufficiency|chronic renal insufficiency
634011|NCT00716573|Everolimus|everolimus
634012|NCT00716599|malaria|malaria
634013|NCT00716599|diagnosis|diagnosis
634014|NCT00716599|rapid diagnostic test|rapid diagnostic test
634015|NCT00716599|rapid diagnostic tests|rapid diagnostic tests
634016|NCT00716599|fever case management|fever case management
634017|NCT00716599|training|training
634018|NCT00716599|fever case management in malaria-endemic areas|fever case management in malaria-endemic areas
634019|NCT00716612|Coenzyme Q 10|coenzyme q 10
634020|NCT00716612|Statin|statin
634021|NCT00716612|Myalgia|myalgia
634022|NCT00716664|cystic fibrosis|cystic fibrosis
634023|NCT00716664|musculoskeletal|musculoskeletal
634024|NCT00716664|exercise capacity|exercise capacity
634025|NCT00716664|posture|posture
634026|NCT00716664|lung function|lung function
634027|NCT00716664|physical functioning|physical functioning
634028|NCT00716677|difficult asthma|difficult asthma
634029|NCT00716677|respiratory inductance plethysmography|respiratory inductance plethysmography
634030|NCT00716690|Stem cell transplantation|stem cell transplantation
634031|NCT00716690|GVHD|gvhd
634032|NCT00716703|Appendicitis|appendicitis
634033|NCT00716703|Computed tomography|computed tomography
634034|NCT00716703|pediatric|pediatric
634035|NCT00716703|child|child
634036|NCT00716703|sensitivity|sensitivity
634037|NCT00716703|specificity|specificity
634038|NCT00716703|contrast administration route|contrast administration route
634039|NCT00716703|time factors|time factors
634040|NCT00716716|Hemophilia B severe, previously treated patients|hemophilia b severe, previously treated patients
634041|NCT00716729|Questionnaire|questionnaire
634043|NCT00716729|Groin|groin
634044|NCT00716729|Disability|disability
634045|NCT00716729|Strength|strength
634046|NCT00716729|To develop two new outcome measures for patients with hip and groin disability|to develop two new outcome measures for patients with hip and groin disability
634047|NCT00716755|Positron emission tomography|positron emission tomography
634048|NCT00716755|antipsychotics|antipsychotics
634049|NCT00716755|risperidone|risperidone
634050|NCT00716755|olanzapine|olanzapine
634051|NCT00716755|Dopamine|dopamine
634052|NCT00716755|D2 receptor|d2 receptor
634053|NCT00716755|elderly|elderly
634054|NCT00716755|schizophrenia|schizophrenia
634055|NCT00716755|schizoaffective disorder|schizoaffective disorder
634056|NCT00716755|schizophreniform disorder|schizophreniform disorder
634057|NCT00716755|delusional disorder|delusional disorder
634058|NCT00716755|psychotic disorder NOS|psychotic disorder nos
634059|NCT00716768|Laparoscopic|laparoscopic
634060|NCT00716768|Inguinal Hernia|inguinal hernia
634061|NCT00716768|Infants|infants
634062|NCT00716781|Group B streptococcus|group b streptococcus
634063|NCT00716781|Sepsis|sepsis
634064|NCT00716781|Infants|infants
634065|NCT00716781|Diagnosis|diagnosis
634066|NCT00716781|Physical examination|physical examination
634067|NCT00716781|Laboratory tests|laboratory tests
634068|NCT00716794|Prostate cancer|prostate cancer
634069|NCT00716794|HE3235|he3235
634070|NCT00716794|Apoptone|apoptone
634072|NCT00716807|TMD|tmd
634073|NCT00716833|pain|pain
634074|NCT00716833|coxibe|coxibe
634075|NCT00716833|preemptive|preemptive
634076|NCT00716833|abdominothoracic|abdominothoracic
634077|NCT00716833|sensibilisation|sensibilisation
634078|NCT00716833|Analgesia|analgesia
634079|NCT00716872|cancer|cancer
634080|NCT00716872|sleep|sleep
634081|NCT00716872|insomnia|insomnia
634084|NCT00716885|Heart failure|heart failure
634085|NCT00716885|Oxidative stress|oxidative stress
634086|NCT00716885|Endothelial Progenitor Cells|endothelial progenitor cells
634087|NCT00716885|White blood cells|white blood cells
634088|NCT00716898|Condition|condition
634089|NCT00716898|Cancer|cancer
634090|NCT00716898|Patients|patients
634091|NCT00716898|Thrombosis|thrombosis
634092|NCT00716898|Unstable|unstable
634093|NCT00716898|Angina|angina
634094|NCT00716898|Pectoris|pectoris
634095|NCT00716911|cytomegalovirus infection|cytomegalovirus infection
634096|NCT00716911|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
634097|NCT00716911|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
634098|NCT00716911|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
634099|NCT00716911|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
634100|NCT00716911|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
634101|NCT00716911|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
634102|NCT00716911|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
634103|NCT00716911|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
634104|NCT00716911|refractory hairy cell leukemia|refractory hairy cell leukemia
634105|NCT00716911|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
634106|NCT00716911|secondary acute myeloid leukemia|secondary acute myeloid leukemia
634107|NCT00716911|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
634108|NCT00716911|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
634109|NCT00716911|splenic marginal zone lymphoma|splenic marginal zone lymphoma
634178|NCT00716976|localized unresectable neuroblastoma|localized unresectable neuroblastoma
634110|NCT00716911|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
634111|NCT00716911|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
634112|NCT00716911|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
634113|NCT00716911|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
634114|NCT00716911|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
634115|NCT00716911|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
634116|NCT00716911|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
634117|NCT00716911|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
634118|NCT00716911|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
634119|NCT00716911|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
634120|NCT00716911|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
634121|NCT00716911|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
634122|NCT00716911|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
634123|NCT00716911|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
634124|NCT00716911|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
634125|NCT00716911|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
634126|NCT00716911|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
634127|NCT00716911|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
634128|NCT00716911|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
634129|NCT00716911|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
634130|NCT00716911|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
634131|NCT00716911|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
634132|NCT00716911|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
634133|NCT00716911|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
634134|NCT00716911|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
634135|NCT00716911|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
634136|NCT00716911|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
634137|NCT00716911|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
634138|NCT00716911|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
634139|NCT00716911|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
634140|NCT00716911|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
634141|NCT00716911|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
634142|NCT00716911|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
634143|NCT00716911|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
634144|NCT00716911|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
634145|NCT00716911|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
634146|NCT00716911|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
634147|NCT00716911|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
634148|NCT00716911|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
634149|NCT00716911|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
634150|NCT00716911|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
634151|NCT00716911|chronic eosinophilic leukemia|chronic eosinophilic leukemia
634152|NCT00716911|chronic neutrophilic leukemia|chronic neutrophilic leukemia
634153|NCT00716911|primary myelofibrosis|primary myelofibrosis
634154|NCT00716911|stage II multiple myeloma|stage ii multiple myeloma
634155|NCT00716911|stage III multiple myeloma|stage iii multiple myeloma
634156|NCT00716911|refractory multiple myeloma|refractory multiple myeloma
634157|NCT00716911|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
634158|NCT00716911|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
752370|NCT01172691|Liver transplant|liver transplant
634159|NCT00716911|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
634160|NCT00716911|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
634161|NCT00716911|stage I multiple myeloma|stage i multiple myeloma
634162|NCT00716937|pilonidal sinus|pilonidal sinus
634163|NCT00716937|karydakis|karydakis
634164|NCT00716937|laying open|laying open
634165|NCT00716963|late allergic response|late allergic response
634166|NCT00716963|fluticasone propionate|fluticasone propionate
634167|NCT00716976|ototoxicity|ototoxicity
634168|NCT00716976|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
634169|NCT00716976|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
634170|NCT00716976|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
634171|NCT00716976|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
634172|NCT00716976|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
634173|NCT00716976|childhood teratoma|childhood teratoma
634174|NCT00716976|childhood medulloblastoma|childhood medulloblastoma
634175|NCT00716976|disseminated neuroblastoma|disseminated neuroblastoma
634176|NCT00716976|regional neuroblastoma|regional neuroblastoma
634177|NCT00716976|localized resectable neuroblastoma|localized resectable neuroblastoma
634179|NCT00716976|stage 4S neuroblastoma|stage 4s neuroblastoma
634180|NCT00716976|localized osteosarcoma|localized osteosarcoma
634181|NCT00716976|metastatic osteosarcoma|metastatic osteosarcoma
634182|NCT00716976|childhood hepatoblastoma|childhood hepatoblastoma
634183|NCT00716976|stage I childhood liver cancer|stage i childhood liver cancer
634184|NCT00716976|stage II childhood liver cancer|stage ii childhood liver cancer
634185|NCT00716976|stage III childhood liver cancer|stage iii childhood liver cancer
634186|NCT00716976|stage IV childhood liver cancer|stage iv childhood liver cancer
634187|NCT00716989|Cutaneous immune system|cutaneous immune system
634188|NCT00716989|innate immunity|innate immunity
634189|NCT00716989|tuberculin skin tests|tuberculin skin tests
634190|NCT00716989|intradermal vaccination|intradermal vaccination
634191|NCT00716989|pathophysiology|pathophysiology
634192|NCT00716989|Healthy subjects|healthy subjects
634193|NCT00716989|Immunosuppressed patients|immunosuppressed patients
634194|NCT00717015|Hormone Receptor Positive Breast Cancer|hormone receptor positive breast cancer
634195|NCT00717028|Cerebral palsy|cerebral palsy
634196|NCT00717028|Dysphagia|dysphagia
634197|NCT00717028|Deglutition|deglutition
634198|NCT00717028|Endoscopy|endoscopy
634199|NCT00717041|Depression|depression
634200|NCT00717041|Anxiety|anxiety
634201|NCT00717041|Cognitive Impairment|cognitive impairment
634202|NCT00717041|Emergency medicine|emergency medicine
634203|NCT00717041|prehospital care|prehospital care
634204|NCT00717054|postoperative nausea and vomiting|postoperative nausea and vomiting
634205|NCT00717067|maraviroc, pharmacokinetics, renal impairment|maraviroc, pharmacokinetics, renal impairment
634206|NCT00717080|Retinitis Pigmentosa|retinitis pigmentosa
634207|NCT00717080|Cataract|cataract
634208|NCT00717106|ILR|ilr
634209|NCT00717106|ECG monitoring|ecg monitoring
634210|NCT00717106|cardiac arrhythmia|cardiac arrhythmia
634211|NCT00717106|syncope|syncope
634212|NCT00717106|presyncope|presyncope
634213|NCT00717106|fainting|fainting
634214|NCT00717119|GI|gi
634215|NCT00717119|NSAID|nsaid
634216|NCT00717119|Complications|complications
634217|NCT00717119|Treated|treated
634218|NCT00717119|Patients|patients
634219|NCT00717132|weight|weight
634925|NCT00719264|Nephrectomy|nephrectomy
634220|NCT00717132|cost effectiveness|cost effectiveness
634221|NCT00717132|obesity|obesity
634222|NCT00717132|family based behavioral treatment|family based behavioral treatment
634223|NCT00717145|bioequivalence|bioequivalence
634224|NCT00717158|Health Behavior|health behavior
634225|NCT00717158|Lifestyle|lifestyle
634226|NCT00717158|health care costs|health care costs
634227|NCT00717158|quality of life|quality of life
634228|NCT00717171|electrical stimulation|electrical stimulation
634229|NCT00717171|pain|pain
634230|NCT00717171|medication|medication
634231|NCT00717171|edema|edema
634232|NCT00717171|interferential|interferential
634233|NCT00717171|neuromuscular|neuromuscular
634234|NCT00717171|high voltage pulsed current|high voltage pulsed current
634235|NCT00717171|knee|knee
634236|NCT00717197|HGG|hgg
634237|NCT00717197|anaplastic astrocytoma|anaplastic astrocytoma
634238|NCT00717197|anaplastic oligodendroglioma|anaplastic oligodendroglioma
634239|NCT00717197|anaplastic mixed glioma|anaplastic mixed glioma
634240|NCT00717197|glioblastoma multiforme|glioblastoma multiforme
634241|NCT00717197|GBM|gbm
634242|NCT00717197|Xeloda|xeloda
634243|NCT00717197|capecitabine|capecitabine
634244|NCT00717210|1p/19q loss|1p/19q loss
634245|NCT00717210|MGMT|mgmt
634246|NCT00717210|prognostic factors|prognostic factors
634247|NCT00717210|PCV|pcv
634248|NCT00717210|temozolomide|temozolomide
634249|NCT00717223|Diabetes|diabetes
634250|NCT00717223|Type 1 diabetes mellitus|type 1 diabetes mellitus
634251|NCT00717223|Type 2 diabetes mellitus|type 2 diabetes mellitus
634252|NCT00717223|Literacy|literacy
635445|NCT00720551|STISIM|stisim
634253|NCT00717223|Glycemic control|glycemic control
634254|NCT00717236|Certolizumab pegol|certolizumab pegol
634256|NCT00717236|Rheumatoid Arthritis|rheumatoid arthritis
634257|NCT00717236|Joint Disease|joint disease
634258|NCT00717236|Chronic Arthritis|chronic arthritis
634259|NCT00717275|Brain Metastases|brain metastases
634260|NCT00717275|Temozolomide|temozolomide
634261|NCT00717275|Temodar|temodar
634262|NCT00717275|TMZ|tmz
634263|NCT00717275|Stereotactic Radiosurgery|stereotactic radiosurgery
634264|NCT00717275|SRS|srs
634265|NCT00717288|diabetes|diabetes
634266|NCT00717288|hyperglycemia|hyperglycemia
634267|NCT00717288|open heart surgery|open heart surgery
634268|NCT00717288|cardiothoracic surgery|cardiothoracic surgery
634269|NCT00717288|detemir|detemir
634270|NCT00717288|insulin infusion|insulin infusion
634271|NCT00717288|intravenous insulin|intravenous insulin
634272|NCT00717301|TBI, traumatic brain injury, S100B, head CT scan|tbi, traumatic brain injury, s100b, head ct scan
634273|NCT00717327|MRL|mrl
634274|NCT00717327|Adolescents|adolescents
634275|NCT00717327|Health Literacy|health literacy
634276|NCT00717340|tivozanib|tivozanib
634277|NCT00717340|AV-951|av-951
634278|NCT00717379|Organ Transplantation|organ transplantation
634279|NCT00717379|Tacrolimus|tacrolimus
634280|NCT00717379|Prograf|prograf
634282|NCT00717379|Immunosuppression|immunosuppression
634283|NCT00717392|ADHD|adhd
634284|NCT00717392|ASD|asd
634285|NCT00717431|Deep Brain Stimulation|deep brain stimulation
634286|NCT00717431|Seizures|seizures
634287|NCT00717431|Epilepsy|epilepsy
634288|NCT00717444|Substance Abuse|substance abuse
634289|NCT00717444|HIV|hiv
634290|NCT00717444|Contingency Management|contingency management
634291|NCT00717444|Physical Activity|physical activity
634292|NCT00717470|Kidney|kidney
634293|NCT00717470|Transplant|transplant
634294|NCT00717470|Immunosuppression|immunosuppression
634295|NCT00717470|Advagraf|advagraf
634296|NCT00717470|Prograf|prograf
634297|NCT00717470|FK506|fk506
634298|NCT00717496|Breastfeeding|breastfeeding
634299|NCT00717496|Telephone Support|telephone support
634300|NCT00717496|Latino|latino
634301|NCT00717509|schizophrenia|schizophrenia
634302|NCT00717509|metabolic side effect|metabolic side effect
634303|NCT00717509|clozapine|clozapine
634304|NCT00717509|genetic polymorphism|genetic polymorphism
634305|NCT00717522|Soft Tissue Sarcoma|soft tissue sarcoma
634306|NCT00717522|CC-4047|cc-4047
634307|NCT00717522|Pomalidomide|pomalidomide
634308|NCT00717535|health status unknown|health status unknown
634309|NCT00717548|Somatic Complaints|somatic complaints
634310|NCT00717561|CAP|cap
634311|NCT00717561|Community-acquired pneumonia|community-acquired pneumonia
634312|NCT00717574|depth of sedation|depth of sedation
634313|NCT00717574|nitrous oxide|nitrous oxide
634314|NCT00717574|general anesthesia|general anesthesia
634315|NCT00717574|anesthesia indices|anesthesia indices
634316|NCT00717587|stage IV renal cell cancer|stage iv renal cell cancer
634317|NCT00717587|recurrent renal cell cancer|recurrent renal cell cancer
634318|NCT00717600|bacteriuria|bacteriuria
634319|NCT00717600|urinary tract infection|urinary tract infection
634320|NCT00717600|probiotics|probiotics
634321|NCT00717600|lactobacillus|lactobacillus
634322|NCT00717600|vagina|vagina
634323|NCT00717600|bladder|bladder
634324|NCT00717600|neurogenic bladder|neurogenic bladder
634325|NCT00717600|spina bifida|spina bifida
634326|NCT00717600|myelomeningocele|myelomeningocele
634327|NCT00717600|neuropathic bladder|neuropathic bladder
634328|NCT00717626|Hemophilia|hemophilia
634329|NCT00717626|Prophylaxis|prophylaxis
634330|NCT00717626|Youth|youth
634331|NCT00717626|Young Adults|young adults
634332|NCT00717626|Feasibility|feasibility
634333|NCT00717639|diagnostic accuracy|diagnostic accuracy
634334|NCT00717639|magnetic resonance angiography|magnetic resonance angiography
634335|NCT00717639|steady state|steady state
634336|NCT00717639|digital subtraction angiography|digital subtraction angiography
634337|NCT00717639|peripheral arteries|peripheral arteries
634338|NCT00717665|Hypertension|hypertension
634339|NCT00717665|Telemanagement|telemanagement
634340|NCT00717665|Home blood pressure monitoring|home blood pressure monitoring
634341|NCT00717665|Self care|self care
634342|NCT00717678|Immunosuppressant|immunosuppressant
634343|NCT00717678|Combination drug therapy|combination drug therapy
634344|NCT00717678|Graft loss|graft loss
634345|NCT00717678|Randomized controlled trial|randomized controlled trial
634346|NCT00717678|Open level method|open level method
634347|NCT00717691|Hallux Limitus|hallux limitus
634348|NCT00717691|Dynamic Splinting|dynamic splinting
634350|NCT00717704|Malignant solid tumor|malignant solid tumor
634351|NCT00717704|Phase 1|phase 1
634352|NCT00717704|Dose escalation|dose escalation
634353|NCT00717704|Metastatic or locally advanced/unresectable|metastatic or locally advanced/unresectable
634354|NCT00717704|Disease progression through standard therapy|disease progression through standard therapy
634355|NCT00717717|Cancer Survivor|cancer survivor
634356|NCT00717717|Physical Activity|physical activity
634357|NCT00717717|Health Behavior|health behavior
634358|NCT00717717|Psychosocial Well-being|psychosocial well-being
634359|NCT00717717|Coaching|coaching
634360|NCT00717717|Long Term|long term
634361|NCT00717717|Consequences|consequences
634362|NCT00717717|Chemotherapy|chemotherapy
634363|NCT00717717|Motivation|motivation
634364|NCT00717730|Nutrition|nutrition
634365|NCT00717730|Children|children
634367|NCT00717730|Vitamin B12|vitamin b12
634368|NCT00717730|India|india
634369|NCT00717730|Homocysteine|homocysteine
634370|NCT00717730|Methyl Malonic Acid|methyl malonic acid
634371|NCT00717743|RCC|rcc
634372|NCT00717743|patients|patients
634373|NCT00717743|scheduled|scheduled
634374|NCT00717743|nephrectomy|nephrectomy
634375|NCT00717756|liver cancer, second line|liver cancer, second line
634376|NCT00705601|Nonrestorative Sleep, Restorative Sleep Questionnaire Refinement|nonrestorative sleep, restorative sleep questionnaire refinement
634377|NCT00705627|nasopharyngeal carcinoma|nasopharyngeal carcinoma
634378|NCT00705627|neoadjuvant chemotherapy|neoadjuvant chemotherapy
634379|NCT00705627|concurrent chemotherapy|concurrent chemotherapy
634380|NCT00705627|randomized controlled clinical trials|randomized controlled clinical trials
634381|NCT00705640|stage II melanoma|stage ii melanoma
634382|NCT00705640|stage III melanoma|stage iii melanoma
634882|NCT00719056|teicoplanin|teicoplanin
634383|NCT00705640|stage IV melanoma|stage iv melanoma
634384|NCT00705640|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
634385|NCT00705640|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
634386|NCT00705640|conjunctival melanoma|conjunctival melanoma
634387|NCT00705640|extraocular extension melanoma|extraocular extension melanoma
634388|NCT00705640|iris melanoma|iris melanoma
634389|NCT00705640|metastatic intraocular melanoma|metastatic intraocular melanoma
634390|NCT00705640|recurrent intraocular melanoma|recurrent intraocular melanoma
634391|NCT00705653|cancer|cancer
634392|NCT00705653|advanced cancer|advanced cancer
634393|NCT00705653|solid tumors|solid tumors
634394|NCT00705653|CGC-11047|cgc-11047
634395|NCT00705653|PG-11047|pg-11047
634396|NCT00711074|pharmacokinetics|pharmacokinetics
634397|NCT00711074|mass balance|mass balance
634398|NCT00711074|radiolabel|radiolabel
634399|NCT00711074|AZD5672|azd5672
634400|NCT00711087|Spinal Cord Injury|spinal cord injury
634401|NCT00711087|Bladder|bladder
634402|NCT00711087|Botulinum toxin (BOTOX-A|botulinum toxin (botox-a
634403|NCT00711087|Detrusor External Sphincter Dyssynergia|detrusor external sphincter dyssynergia
634404|NCT00711100|Substitution for cigarettes|substitution for cigarettes
634405|NCT00711100|Oral tobacco products|oral tobacco products
634406|NCT00711113|Jaw, Edentulous, Partially (posterior maxilla)|jaw, edentulous, partially (posterior maxilla)
634407|NCT00711126|intravenous,|intravenous,
634408|NCT00711126|tolerability|tolerability
634409|NCT00711126|pharmacokinetics,|pharmacokinetics,
634410|NCT00711126|oral,|oral,
634411|NCT00711126|pharmacodynamics,|pharmacodynamics,
634412|NCT00711126|safety,|safety,
634413|NCT00711126|GW642444,|gw642444,
634414|NCT00711126|inhaled,|inhaled,
634415|NCT00711139|Alzheimer|alzheimer
634416|NCT00711139|Morbus Alzheimer|morbus alzheimer
634417|NCT00711139|Alzheimer Vaccine|alzheimer vaccine
634418|NCT00711139|Vaccine|vaccine
634419|NCT00711139|AD|ad
634420|NCT00711139|A-beta immunotherapy|a-beta immunotherapy
634421|NCT00711152|diabetes|diabetes
634422|NCT00711152|protocol-driven structured care|protocol-driven structured care
634423|NCT00711152|web-based|web-based
634424|NCT00711152|joint asia diabetes evaluation|joint asia diabetes evaluation
634425|NCT00711165|Asthma|asthma
634426|NCT00711165|Nitric Oxide|nitric oxide
634427|NCT00711165|Exhaled Breath Condensate|exhaled breath condensate
634428|NCT00711165|Methacholine Challenge|methacholine challenge
634429|NCT00711191|pancreas cancer; cancer of the pancreas; gemcitabine; chemotherapy; monoclonal antibody; immunotherapy; CD40|pancreas cancer; cancer of the pancreas; gemcitabine; chemotherapy; monoclonal antibody; immunotherapy; cd40
634430|NCT00711204|Severe|severe
634431|NCT00711204|Alzheimer's Disease|alzheimer's disease
634433|NCT00711230|Vaccine|vaccine
634434|NCT00711230|Immune Therapy|immune therapy
634435|NCT00711230|DermaVir|dermavir
634436|NCT00711243|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
634437|NCT00711243|adenocarcinoma of the stomach|adenocarcinoma of the stomach
634438|NCT00711243|stage III gastric cancer|stage iii gastric cancer
634439|NCT00711243|stage IV gastric cancer|stage iv gastric cancer
634440|NCT00711256|Sunscreen|sunscreen
634441|NCT00711256|Application|application
634442|NCT00711256|Vitamin D|vitamin d
634443|NCT00711256|Sun protection factor|sun protection factor
634444|NCT00711256|Clothing|clothing
634445|NCT00711282|Replacement of non-restorable single tooth/teeth|replacement of non-restorable single tooth/teeth
634446|NCT00711295|Influenza (Pandemic)|influenza (pandemic)
634447|NCT00711308|pulmonary embolism|pulmonary embolism
634448|NCT00711308|low molecular weight heparin|low molecular weight heparin
634449|NCT00711308|vitamin K antagonist|vitamin k antagonist
634450|NCT00711308|Longterm|longterm
634451|NCT00711321|Alzheimer|alzheimer
634452|NCT00711321|Morbus Alzheimer|morbus alzheimer
634453|NCT00711321|Vaccine|vaccine
634454|NCT00711321|Alzheimer Vaccine|alzheimer vaccine
634455|NCT00711321|A-beta immunotherapy|a-beta immunotherapy
634456|NCT00711347|Discovisc|discovisc
634457|NCT00711347|Ophthalmic Visco Surgical Device|ophthalmic visco surgical device
634458|NCT00711360|heart failure|heart failure
634459|NCT00711360|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
634460|NCT00711360|intrathoracic impedance|intrathoracic impedance
634461|NCT00711360|cardiac resynchronization therapy|cardiac resynchronization therapy
634462|NCT00711360|home monitoring|home monitoring
634463|NCT00711373|VCA|vca
634464|NCT00711373|composite tissue allotransplantation|composite tissue allotransplantation
634465|NCT00711373|amputation|amputation
634466|NCT00711373|Hand|hand
634467|NCT00711386|pharmacokinetics|pharmacokinetics
634468|NCT00711386|CCR5|ccr5
634469|NCT00711386|Healthy volunteers|healthy volunteers
634470|NCT00711386|GSK706769|gsk706769
634471|NCT00711399|Respiratory sounds|respiratory sounds
634472|NCT00711399|Wheeze|wheeze
634473|NCT00711399|Cough|cough
634474|NCT00711412|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
634475|NCT00711412|stage I esophageal cancer|stage i esophageal cancer
634476|NCT00711412|stage II esophageal cancer|stage ii esophageal cancer
634883|NCT00719056|prophylaxis|prophylaxis
634477|NCT00711412|stage III esophageal cancer|stage iii esophageal cancer
634478|NCT00711412|stage IV esophageal cancer|stage iv esophageal cancer
634479|NCT00711425|Jaw, Edentulous, Partially (posterior mandible)|jaw, edentulous, partially (posterior mandible)
634480|NCT00711438|Breathlessness|breathlessness
634481|NCT00711438|Dyspnoea|dyspnoea
634482|NCT00711438|Dyspnea|dyspnea
634483|NCT00711438|Palliative care|palliative care
634484|NCT00711438|RCT|rct
634485|NCT00711438|Randomised controlled trial|randomised controlled trial
634486|NCT00711438|COPD|copd
634487|NCT00711438|Chronic respiratory disease|chronic respiratory disease
634488|NCT00711451|systemic vascular resistance|systemic vascular resistance
634489|NCT00711451|pregnancy|pregnancy
634490|NCT00711451|scheduled cesarean delivery|scheduled cesarean delivery
634491|NCT00711451|syncytiotrophoblast apoptosis|syncytiotrophoblast apoptosis
634492|NCT00711451|continuous wave Doppler|continuous wave doppler
634493|NCT00711464|cognition, pharmacology, memory, attention|cognition, pharmacology, memory, attention
634494|NCT00711477|obesity|obesity
634495|NCT00711477|overweight|overweight
634496|NCT00711477|magnetic resonance imaging|magnetic resonance imaging
634497|NCT00711477|naltrexone|naltrexone
634498|NCT00711477|bupropion|bupropion
634499|NCT00711490|Diabetic Macular Edema|diabetic macular edema
634500|NCT00711490|Diabetic Retinopathy|diabetic retinopathy
634501|NCT00711490|Rapamycin|rapamycin
634502|NCT00711490|Sirolimus|sirolimus
634503|NCT00711490|Diabetes|diabetes
634504|NCT00711503|endogenous insulin production|endogenous insulin production
634505|NCT00711503|C-peptide level|c-peptide level
634506|NCT00711503|insulin requirement|insulin requirement
634507|NCT00711529|hot flashes|hot flashes
634508|NCT00711529|breast cancer|breast cancer
634509|NCT00711529|Hypnotherapy|hypnotherapy
634510|NCT00711529|Quality of Life|quality of life
634511|NCT00711529|Gabapentin|gabapentin
634512|NCT00711542|intracoronary progenitor cell therapy|intracoronary progenitor cell therapy
634513|NCT00711542|NSTEMI|nstemi
634514|NCT00711542|coronary flow reserve|coronary flow reserve
634515|NCT00711542|randomized doubleblind Placebo-controlled trial|randomized doubleblind placebo-controlled trial
634516|NCT00711555|nausea|nausea
634517|NCT00711555|vomiting|vomiting
634518|NCT00711555|multiple days|multiple days
634519|NCT00711555|chemotherapy|chemotherapy
634520|NCT00711555|serotonin receptor antagonist|serotonin receptor antagonist
634521|NCT00711555|quality of life|quality of life
634522|NCT00711555|therapy|therapy
634523|NCT00711555|corticosteroids|corticosteroids
634524|NCT00711555|aprepitant|aprepitant
634525|NCT00711555|rescue therapy|rescue therapy
634526|NCT00711568|depression|depression
634527|NCT00711568|magnetic stimulation|magnetic stimulation
634528|NCT00711581|Cholecystectomy|cholecystectomy
634529|NCT00711581|Cholecystectomy, Laparoscopic|cholecystectomy, laparoscopic
634530|NCT00711581|Laparoscopy|laparoscopy
634531|NCT00711607|pharmacokinetics (PK)|pharmacokinetics (pk)
634532|NCT00711607|combined oral contraceptive|combined oral contraceptive
634533|NCT00711607|nomegestrol acetate|nomegestrol acetate
634534|NCT00711607|estradiol|estradiol
634535|NCT00711607|NOMAC|nomac
634536|NCT00711607|E2|e2
634537|NCT00711607|NOMAC-E2|nomac-e2
634538|NCT00711607|pharmacokinetics|pharmacokinetics
634539|NCT00711620|sepsis|sepsis
634540|NCT00711620|Immunotherapy|immunotherapy
634541|NCT00711620|Thymosin|thymosin
634542|NCT00711633|Premature birth,|premature birth,
634543|NCT00711633|infant,|infant,
634544|NCT00711633|infant formula,|infant formula,
634545|NCT00711633|bacterial colonization,|bacterial colonization,
634546|NCT00711633|Bifidobacterium,|bifidobacterium,
634547|NCT00711633|calprotectin|calprotectin
634548|NCT00711646|Spasticity|spasticity
634550|NCT00711659|Physical exam|physical exam
634551|NCT00711659|Pediatric clerkship|pediatric clerkship
634552|NCT00711659|Medical students|medical students
634553|NCT00711672|Personal Communication|personal communication
634554|NCT00711672|Doctor Patient Relations|doctor patient relations
634555|NCT00711672|Narrative Medicine|narrative medicine
634556|NCT00711685|Topical vancomycin|topical vancomycin
634557|NCT00711685|mediastinitis|mediastinitis
634558|NCT00711685|coronary|coronary
634559|NCT00711685|artery|artery
634560|NCT00711685|bypass|bypass
634561|NCT00711685|graft|graft
634562|NCT00711685|Patients|patients
634563|NCT00711711|Physical Therapy - Therapeutics - Edema|physical therapy - therapeutics - edema
634564|NCT00711711|Arthroplasty replacement knee|arthroplasty replacement knee
634565|NCT00711711|Treatment outcome|treatment outcome
634566|NCT00711724|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
634567|NCT00711724|Adolescent|adolescent
634568|NCT00711737|metabolic parameters|metabolic parameters
634569|NCT00711737|escitalopram|escitalopram
634570|NCT00711737|metabolic syndrome|metabolic syndrome
634571|NCT00711737|antidepressant|antidepressant
634572|NCT00711750|underwent|underwent
634573|NCT00711750|specific|specific
634574|NCT00711750|creation|creation
634575|NCT00711750|hospital|hospital
634576|NCT00711750|November 2003|november 2003
634577|NCT00711750|October 2005|october 2005
634578|NCT00711763|Preterm Infant|preterm infant
634579|NCT00711763|Parenteral nutrition cycling|parenteral nutrition cycling
634580|NCT00711763|TPN cycling|tpn cycling
634581|NCT00711763|Hypercalcuria|hypercalcuria
634582|NCT00711776|Aciclovir cream 5%|aciclovir cream 5%
634583|NCT00711776|Volunteer|volunteer
634584|NCT00711776|Japanese|japanese
634585|NCT00711776|Male|male
634586|NCT00711776|Bioequivalence|bioequivalence
634587|NCT00711789|Acute renal failure|acute renal failure
634588|NCT00711789|Septic shock|septic shock
634589|NCT00711789|angiotensin II|angiotensin ii
634590|NCT00711789|neutrophil gelatinase associated lipocalin (NGAL)|neutrophil gelatinase associated lipocalin (ngal)
634591|NCT00711789|cystatin C|cystatin c
634592|NCT00711802|Complicated|complicated
634593|NCT00711802|Skin|skin
634594|NCT00711802|Structure|structure
634595|NCT00711815|Women of the state of Alabama|women of the state of alabama
634596|NCT00711815|CIN 1|cin 1
634597|NCT00711815|negative biopsy|negative biopsy
634598|NCT00711815|normal colposcopy|normal colposcopy
634599|NCT00711815|HPV|hpv
634600|NCT00711841|HELLP syndrome|hellp syndrome
634601|NCT00711841|dexamethasone|dexamethasone
634602|NCT00711841|postpartum period|postpartum period
634603|NCT00711841|class I HELLP syndrome|class i hellp syndrome
634604|NCT00711854|Staphylococcal infection|staphylococcal infection
634605|NCT00711880|Pain|pain
634606|NCT00711880|Peripheral Neuropathy|peripheral neuropathy
634607|NCT00711906|Malaria|malaria
634608|NCT00711906|Pregnancy|pregnancy
634609|NCT00711906|HIV|hiv
634610|NCT00711906|Intermittent Preventive Treatment|intermittent preventive treatment
634611|NCT00711906|Safety|safety
634612|NCT00711906|Efficacy|efficacy
634613|NCT00717769|Atopic Dermatitis|atopic dermatitis
634614|NCT00717782|botulinum toxin|botulinum toxin
634615|NCT00717782|thrombosed external haemorrhoids|thrombosed external haemorrhoids
634616|NCT00717782|pain|pain
634617|NCT00717795|Survivor|survivor
634618|NCT00717795|Physical Activity|physical activity
634619|NCT00717795|NED|ned
634620|NCT00717795|08-067|08-067
634621|NCT00717808|Tranilast|tranilast
634622|NCT00717808|Rheumatoid Arthritis|rheumatoid arthritis
634623|NCT00717808|Pharmacokinetics|pharmacokinetics
634624|NCT00717808|Methotrexate|methotrexate
634625|NCT00717873|Mucus Clearance|mucus clearance
634626|NCT00717873|Secretion Clearance|secretion clearance
634627|NCT00717873|HFCWO|hfcwo
634628|NCT00717886|Breast|breast
634629|NCT00717886|Lymph Nodes|lymph nodes
634630|NCT00717899|Asthma|asthma
634631|NCT00717899|Allergy|allergy
634632|NCT00717899|Respiratory|respiratory
634633|NCT00717899|Pollution|pollution
634634|NCT00717899|Children|children
634635|NCT00717899|Air pollution|air pollution
634636|NCT00717912|BLOOD GLUCOSE|blood glucose
634637|NCT00717912|glycemic index|glycemic index
634638|NCT00717912|rates of digestion and absorption of food|rates of digestion and absorption of food
634639|NCT00717925|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
634640|NCT00717925|NHL|nhl
634641|NCT00717951|advanced breast cancer|advanced breast cancer
634642|NCT00717951|docetaxol|docetaxol
634643|NCT00717951|capecitabine|capecitabine
634644|NCT00717951|cisplatin|cisplatin
634645|NCT00717990|Colorectal cancer|colorectal cancer
634646|NCT00717990|Bevacizumab|bevacizumab
634647|NCT00717990|XELIRI|xeliri
634648|NCT00718003|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
634649|NCT00718003|Cerebrospinal Fluid|cerebrospinal fluid
634650|NCT00718003|Neurodegenerative Disease|neurodegenerative disease
634651|NCT00718003|Motor Neuron Disease|motor neuron disease
634652|NCT00718003|Autonomic Nervous System|autonomic nervous system
634653|NCT00718003|Neurodegenerative Diseases|neurodegenerative diseases
634654|NCT00718003|Movement Disorders|movement disorders
634655|NCT00718016|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
634656|NCT00718016|Cerebrospinal Fluid|cerebrospinal fluid
634657|NCT00718016|Neurodegenerative Disease|neurodegenerative disease
634658|NCT00718016|Motor Neuron Disease|motor neuron disease
634659|NCT00718016|Autonomic Nervous System|autonomic nervous system
634660|NCT00718016|Neurodegenerative Diseases|neurodegenerative diseases
634661|NCT00718016|Movement Disorders|movement disorders
634662|NCT00718029|Human Immunodeficiency Virus|human immunodeficiency virus
634663|NCT00718029|Cerebrospinal Fluid|cerebrospinal fluid
634664|NCT00718029|Raltegravir|raltegravir
634665|NCT00718029|Drug Concentrations|drug concentrations
634666|NCT00718042|healthy donors|healthy donors
634667|NCT00718055|MRI|mri
634668|NCT00718055|liverspecific|liverspecific
634669|NCT00718055|contrast|contrast
634670|NCT00718055|colorectal|colorectal
634671|NCT00718055|metastases|metastases
634672|NCT00718068|Potassium chloride|potassium chloride
634673|NCT00718068|Preparations, Pharmaceutical|preparations, pharmaceutical
634674|NCT00718068|Hypokalemia|hypokalemia
634675|NCT00718068|Critical Care|critical care
634676|NCT00718068|Adult|adult
634677|NCT00718068|Randomized Controlled Trial|randomized controlled trial
634678|NCT00718094|Ulcerative colitis|ulcerative colitis
634679|NCT00718094|EGCG|egcg
634680|NCT00718094|Green tea polyphenols|green tea polyphenols
634681|NCT00718094|Inflammatory bowel disease|inflammatory bowel disease
634682|NCT00718094|Colitis|colitis
634683|NCT00718094|IBD|ibd
634684|NCT00718094|Green tea|green tea
634685|NCT00718107|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
634686|NCT00718107|Cerebrospinal Fluid|cerebrospinal fluid
634687|NCT00718107|Neurodegenerative Disease|neurodegenerative disease
634688|NCT00718107|Motor Neuron Disease|motor neuron disease
634689|NCT00718107|Autonomic Nervous System|autonomic nervous system
634690|NCT00718107|Neurodegenerative Diseases|neurodegenerative diseases
634691|NCT00718107|Movement Disorders|movement disorders
634692|NCT00718107|Quality of Life|quality of life
634693|NCT00718393|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
634694|NCT00718393|Cerebrospinal Fluid|cerebrospinal fluid
634695|NCT00718393|Neurodegenerative Disease|neurodegenerative disease
634696|NCT00718393|Motor Neuron Disease|motor neuron disease
634697|NCT00718393|Autonomic Nervous System|autonomic nervous system
634698|NCT00718393|Neurodegenerative Diseases|neurodegenerative diseases
634699|NCT00718393|Movement Disorders|movement disorders
634700|NCT00718406|Acute coronary syndrome|acute coronary syndrome
634701|NCT00718406|Chest pain|chest pain
634702|NCT00718406|Betablockers|betablockers
634703|NCT00718406|Morphine|morphine
634704|NCT00718406|Prehospital phase|prehospital phase
634705|NCT00718419|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
634706|NCT00718419|Multiple Myeloma|multiple myeloma
634707|NCT00718432|Frailty|frailty
634708|NCT00718432|Osteoporosis|osteoporosis
634709|NCT00718432|Depression|depression
634710|NCT00718445|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
634711|NCT00718445|Cerebrospinal Fluid|cerebrospinal fluid
634712|NCT00718445|Neurodegenerative Disease|neurodegenerative disease
634713|NCT00718445|Motor Neuron Disease|motor neuron disease
634714|NCT00718445|Autonomic Nervous System|autonomic nervous system
634715|NCT00718445|Neurodegenerative Diseases|neurodegenerative diseases
634716|NCT00718445|Movement Disorders|movement disorders
634717|NCT00718458|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
634718|NCT00718458|Cerebrospinal Fluid|cerebrospinal fluid
634719|NCT00718458|Neurodegenerative Disease|neurodegenerative disease
634720|NCT00718458|Motor Neuron Disease|motor neuron disease
634721|NCT00718458|Autonomic Nervous System|autonomic nervous system
634722|NCT00718458|Neurodegenerative Diseases|neurodegenerative diseases
634723|NCT00718458|Movement Disorders|movement disorders
634724|NCT00718471|STEMI|stemi
634725|NCT00718471|Primary PCI|primary pci
634726|NCT00718471|Anticoagulation|anticoagulation
634727|NCT00718484|Sarcoma|sarcoma
634728|NCT00718484|Soft Tissue Sarcoma|soft tissue sarcoma
634729|NCT00718484|Doxorubicin|doxorubicin
634730|NCT00718484|anthracyclin|anthracyclin
634731|NCT00718484|Palifosfamide|palifosfamide
634732|NCT00718484|IFOS|ifos
634733|NCT00718497|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
634734|NCT00718497|Cerebrospinal Fluid|cerebrospinal fluid
634735|NCT00718497|Neurodegenerative Disease|neurodegenerative disease
634736|NCT00718497|Motor Neuron Disease|motor neuron disease
634737|NCT00718497|Autonomic Nervous System|autonomic nervous system
634738|NCT00718497|Neurodegenerative Diseases|neurodegenerative diseases
634739|NCT00718497|Movement Disorders|movement disorders
634740|NCT00718536|Atazanavir|atazanavir
634741|NCT00718536|Raltegravir|raltegravir
634742|NCT00718536|once-daily|once-daily
634743|NCT00718536|pharmacokinetics|pharmacokinetics
634745|NCT00718562|nilotinib|nilotinib
634746|NCT00718562|AMN107|amn107
634747|NCT00718562|Sunitinib|sunitinib
634748|NCT00718562|Sunitinib malate|sunitinib malate
634749|NCT00718562|Imatinib|imatinib
634750|NCT00718562|Imatinib mesylate|imatinib mesylate
634751|NCT00718562|Tyrosine|tyrosine
634752|NCT00718575|Liver Disease|liver disease
634753|NCT00718575|Transplantation|transplantation
634754|NCT00718588|RA|ra
634755|NCT00718601|Myeloma|myeloma
634756|NCT00718601|Multiple Myeloma|multiple myeloma
634757|NCT00718601|Relapsed Multiple Myeloma|relapsed multiple myeloma
634758|NCT00718601|Refractory Multiple Myeloma|refractory multiple myeloma
634759|NCT00718601|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
634760|NCT00718614|Choroidal blood flow|choroidal blood flow
634761|NCT00718614|Laser Doppler flowmetry|laser doppler flowmetry
634762|NCT00718614|Diabetic Retinopathy|diabetic retinopathy
634763|NCT00718614|Diabetic Neuropathy|diabetic neuropathy
634764|NCT00718627|Urea cycle Disorders|urea cycle disorders
634765|NCT00718627|Carbamoylphosphate synthetase I deficiency|carbamoylphosphate synthetase i deficiency
634766|NCT00718627|Ornithine transcarbamoylase deficiency|ornithine transcarbamoylase deficiency
634767|NCT00718627|Argininosuccinate synthase deficiency|argininosuccinate synthase deficiency
634768|NCT00718627|Citrullinemia|citrullinemia
634769|NCT00718627|newborns|newborns
634770|NCT00718627|infants|infants
634771|NCT00718627|liver cell transplantation|liver cell transplantation
634772|NCT00718627|liver cell infusion|liver cell infusion
634773|NCT00718640|Multiple Myeloma|multiple myeloma
634774|NCT00718640|Velcade|velcade
634775|NCT00718640|Bortezomib|bortezomib
634776|NCT00718640|Dexamethasone|dexamethasone
634777|NCT00718653|Macular pigment, lutein, green tea extract, antioxidant|macular pigment, lutein, green tea extract, antioxidant
634778|NCT00718666|Safety|safety
634779|NCT00718666|Vaccines, conjugate|vaccines, conjugate
634780|NCT00718666|Immunogenicity|immunogenicity
634781|NCT00718666|Meningococcal vaccine|meningococcal vaccine
634782|NCT00718666|Booster vaccination|booster vaccination
634783|NCT00718666|Primary vaccination|primary vaccination
634784|NCT00718666|Neisseria meningitides|neisseria meningitides
634785|NCT00718666|Toddlers|toddlers
634786|NCT00718666|Humans|humans
634787|NCT00718666|Meningococcal disease|meningococcal disease
634788|NCT00718692|Idiopathic|idiopathic
634789|NCT00718692|ITP|itp
634790|NCT00718705|Prematurity|prematurity
634791|NCT00718705|Ureaplasma spp|ureaplasma spp
634792|NCT00718705|Mycoplasma Hominis|mycoplasma hominis
634793|NCT00718705|Amniotic fluid|amniotic fluid
634794|NCT00718705|Josamycine|josamycine
634795|NCT00718718|Arthritis, Rheumatoid|arthritis, rheumatoid
634796|NCT00718718|Rheumatoid Arthritis|rheumatoid arthritis
634797|NCT00718718|Active Rheumatoid Arthritis|active rheumatoid arthritis
634798|NCT00718718|CNTO 136|cnto 136
634799|NCT00718718|Interleukin-6|interleukin-6
634800|NCT00718718|Anti-interleukin-6 monoclonal antibody|anti-interleukin-6 monoclonal antibody
634801|NCT00718718|Methotrexate|methotrexate
634802|NCT00718718|Placebo|placebo
634803|NCT00718731|Alzheimer Disease|alzheimer disease
634804|NCT00718744|Allergen-extract|allergen-extract
634805|NCT00718744|Standardization|standardization
634806|NCT00718770|Not respond|not respond
634807|NCT00718770|Radioactive iodine|radioactive iodine
634808|NCT00718770|Therapy|therapy
634809|NCT00718770|Shows signs|shows signs
634810|NCT00718770|Aggressive behavior|aggressive behavior
634811|NCT00718796|cardiovascular disease|cardiovascular disease
634812|NCT00718796|naturopathic medicine|naturopathic medicine
634813|NCT00718796|natural health products|natural health products
634814|NCT00718796|lifestyle intervention|lifestyle intervention
634815|NCT00718796|dietary advice|dietary advice
634816|NCT00718796|coronary heart disease|coronary heart disease
634817|NCT00718822|clinical outcome|clinical outcome
634818|NCT00718822|ICSI cycles|icsi cycles
634820|NCT00718822|poor responders|poor responders
634821|NCT00718822|pregnancy rate|pregnancy rate
634822|NCT00718822|prospective randomized study|prospective randomized study
634823|NCT00718835|smoking cessation|smoking cessation
634824|NCT00718835|behavioral treatment|behavioral treatment
634825|NCT00718835|contingency management|contingency management
634826|NCT00718835|opioid maintenance|opioid maintenance
634827|NCT00718835|methadone|methadone
634828|NCT00718835|buprenorphine|buprenorphine
634829|NCT00718848|hemodialysis|hemodialysis
634830|NCT00718848|left ventricular hypertrophy|left ventricular hypertrophy
634831|NCT00718848|left ventricular systolic function|left ventricular systolic function
634832|NCT00718861|Osteoporosis|osteoporosis
634833|NCT00718861|zoledronic acid|zoledronic acid
634834|NCT00718861|post-menopausal|post-menopausal
634835|NCT00718874|obesity, puberty, diabetes,insulin dynamics|obesity, puberty, diabetes,insulin dynamics
634836|NCT00718913|Adjuvant Gastric Cancer|adjuvant gastric cancer
634837|NCT00718913|Adjuvant chemotherapy|adjuvant chemotherapy
634838|NCT00718913|Adjuvant chemo-radiation|adjuvant chemo-radiation
634839|NCT00718913|Capecitabine|capecitabine
634840|NCT00718926|dry eye|dry eye
634841|NCT00718926|Thiol redox|thiol redox
635167|NCT00719667|coronary|coronary
634842|NCT00718926|Oxidative stress|oxidative stress
634843|NCT00718939|Diastolic Heart Failure|diastolic heart failure
634844|NCT00718939|Cardiac dysfunction|cardiac dysfunction
634845|NCT00718939|Heart Failure|heart failure
634846|NCT00718952|Pulmonary Hypertension|pulmonary hypertension
634847|NCT00718965|Primary hypercholesterolemia|primary hypercholesterolemia
634848|NCT00718978|bioengineered|bioengineered
634850|NCT00718978|keratinocytes|keratinocytes
634851|NCT00718978|fibroblasts|fibroblasts
634852|NCT00718978|skin|skin
634853|NCT00718978|culture|culture
634854|NCT00718978|autologous|autologous
634855|NCT00718978|CSS|css
634856|NCT00718978|full-thickness loss of substance from:|full-thickness loss of substance from:
634857|NCT00718978|burns|burns
634858|NCT00718978|ulcers|ulcers
634859|NCT00718978|giant nevi|giant nevi
634860|NCT00718978|cicatricial outcomes|cicatricial outcomes
634861|NCT00718991|CLI|cli
634862|NCT00718991|excimer laser|excimer laser
634863|NCT00718991|debulking|debulking
634864|NCT00719004|Anatomy|anatomy
634865|NCT00719004|Foot|foot
634866|NCT00719004|Sonography|sonography
634867|NCT00719004|Medical|medical
634868|NCT00719017|Brachytherapy|brachytherapy
634869|NCT00719017|Early stage edometrial cancer|early stage edometrial cancer
634870|NCT00719017|Quality of life|quality of life
634871|NCT00719017|Recurrence|recurrence
634872|NCT00719017|Treatment|treatment
634873|NCT00719017|Vaginectomy|vaginectomy
634874|NCT00719043|Influenza|influenza
634875|NCT00719043|H5N1|h5n1
634876|NCT00719043|Avian|avian
634877|NCT00719043|Vaccines|vaccines
634878|NCT00719043|Safety|safety
634879|NCT00719043|Immunogenicity|immunogenicity
634880|NCT00719043|Pandemic|pandemic
634881|NCT00719043|Human|human
634884|NCT00719056|arthroplasty|arthroplasty
634885|NCT00719056|surgical site infections|surgical site infections
634886|NCT00719069|healthy subjects who smoke|healthy subjects who smoke
634887|NCT00719069|healthy subjects|healthy subjects
634888|NCT00719082|Human Stability|human stability
634889|NCT00719082|Geriatric|geriatric
634890|NCT00719082|Posturography|posturography
634891|NCT00719095|prescription opioid|prescription opioid
634892|NCT00719095|opioid detoxification|opioid detoxification
634893|NCT00719095|buprenorphine|buprenorphine
634894|NCT00719095|naltrexone|naltrexone
634895|NCT00719095|community reinforcement approach|community reinforcement approach
634896|NCT00719095|prescription opioid abuse|prescription opioid abuse
634897|NCT00719108|Diabetes, Healthy Volunteers|diabetes, healthy volunteers
634898|NCT00719160|Gastric acid|gastric acid
634899|NCT00719160|Dietary protein|dietary protein
634900|NCT00719160|Calcium|calcium
634901|NCT00719160|Intestinal absorption|intestinal absorption
634902|NCT00719160|Calcium sensing receptor|calcium sensing receptor
634903|NCT00719173|nausea and vomiting|nausea and vomiting
634904|NCT00719173|breast cancer|breast cancer
634905|NCT00719186|Polycystic Ovary Syndrome|polycystic ovary syndrome
634906|NCT00719186|Infertility|infertility
634907|NCT00719186|Pregnancy|pregnancy
634908|NCT00719186|Women|women
634909|NCT00719199|Colorectal cancer|colorectal cancer
634910|NCT00719199|metastatic cancer|metastatic cancer
634911|NCT00719199|prior therapy|prior therapy
634912|NCT00719199|1b|1b
634913|NCT00719251|Complications of Diabetes Mellitus|complications of diabetes mellitus
634914|NCT00719251|Electric stimulation|electric stimulation
634915|NCT00719251|Low-Level Laser Therapy|low-level laser therapy
634916|NCT00719264|Renal cell carcinoma|renal cell carcinoma
634917|NCT00719264|Adults|adults
634918|NCT00719264|Bevacizumab|bevacizumab
634919|NCT00719264|RAD001|rad001
634920|NCT00719264|Everolimus|everolimus
634921|NCT00719264|Interferon|interferon
634922|NCT00719264|Clear|clear
634923|NCT00719264|Roferon|roferon
634924|NCT00719264|Avastin|avastin
634926|NCT00719264|newly diagnosed|newly diagnosed
634927|NCT00719277|cardiac arrhythmia|cardiac arrhythmia
634928|NCT00719277|syncope|syncope
634929|NCT00719277|ECG|ecg
634930|NCT00719277|implantable ECG monitor|implantable ecg monitor
634931|NCT00719277|ILR|ilr
634932|NCT00719290|Primary Angle Closure Glaucoma|primary angle closure glaucoma
634933|NCT00719290|Phacoemulsification|phacoemulsification
634934|NCT00719290|Goniosynechialysis|goniosynechialysis
634935|NCT00719290|Outflow facility|outflow facility
634936|NCT00719316|Renin inhibitor|renin inhibitor
634937|NCT00719316|Patients|patients
634938|NCT00719316|ACE inhibitor or ARB|ace inhibitor or arb
634939|NCT00719316|Chronic Kidney Disease|chronic kidney disease
634940|NCT00719316|Hypertension|hypertension
634941|NCT00719329|chlorhexidine|chlorhexidine
634942|NCT00719329|umbilical cord|umbilical cord
634943|NCT00719342|Retinal vessel diameter|retinal vessel diameter
634944|NCT00719342|Flicker-induced vasodilatation|flicker-induced vasodilatation
634945|NCT00719342|Optic nerve head blood flow|optic nerve head blood flow
634946|NCT00719342|Ocular Physiology|ocular physiology
634947|NCT00719342|Regional Blood Flow|regional blood flow
634948|NCT00719368|Groin hernia|groin hernia
634949|NCT00719368|pain|pain
634950|NCT00719368|chronic|chronic
635168|NCT00719667|bypass|bypass
634951|NCT00719368|quantitative sensory testing|quantitative sensory testing
634952|NCT00719368|Persistent postoperative pain|persistent postoperative pain
634953|NCT00719394|alzheimer Disease|alzheimer disease
634954|NCT00719407|birth asphyxia|birth asphyxia
634955|NCT00719407|neonatal encephalopathy|neonatal encephalopathy
634956|NCT00719407|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
634957|NCT00719407|neuroprotection|neuroprotection
634958|NCT00719407|neonate|neonate
634959|NCT00719420|Randomized clinical trial|randomized clinical trial
634960|NCT00719420|Helicobacter pylori|helicobacter pylori
634961|NCT00719420|clarithromycin|clarithromycin
634962|NCT00719420|metronidazole|metronidazole
634963|NCT00719420|amoxicillin|amoxicillin
634964|NCT00719420|proton pump inhibitor|proton pump inhibitor
634965|NCT00719420|Colombia|colombia
634966|NCT00719433|stroke|stroke
634967|NCT00719433|chronic|chronic
634968|NCT00719433|rehabilitation|rehabilitation
634969|NCT00719433|robot therapy|robot therapy
634970|NCT00719433|arm therapy|arm therapy
634971|NCT00719446|Acute Lung Injury|acute lung injury
634972|NCT00719472|Follicular NHL|follicular nhl
634973|NCT00719472|NHL|nhl
634974|NCT00719472|Large B-Cell NHL|large b-cell nhl
634975|NCT00719485|lumbar decompression|lumbar decompression
634976|NCT00719498|Epo-alpha|epo-alpha
634977|NCT00719498|Cardiac arrest|cardiac arrest
634978|NCT00719498|Mild hypothermia|mild hypothermia
634979|NCT00719511|Rhinoconjunctivitis|rhinoconjunctivitis
634980|NCT00719511|Allergic|allergic
634981|NCT00719524|Neoplasms|neoplasms
634982|NCT00719524|Antineoplastic Combined Chemotherapy Protocol|antineoplastic combined chemotherapy protocol
634983|NCT00719537|preeclampsia|preeclampsia
634984|NCT00719537|progesterone|progesterone
634985|NCT00719537|aspirin|aspirin
634986|NCT00719537|prevent|prevent
634987|NCT00719537|soluble fms-like tyrosine kinase (sFlt-1)|soluble fms-like tyrosine kinase (sflt-1)
634988|NCT00719537|Placental Growth Factor (PlGF)|placental growth factor (plgf)
634989|NCT00719537|risk|risk
634990|NCT00719550|Locally Advanced|locally advanced
634991|NCT00719550|Metastatic|metastatic
634992|NCT00719563|fatigue|fatigue
634993|NCT00719563|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
634994|NCT00719563|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
634995|NCT00719563|acute undifferentiated leukemia|acute undifferentiated leukemia
634996|NCT00719563|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
634997|NCT00719563|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
634998|NCT00719563|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
634999|NCT00719563|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
635000|NCT00719563|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
635001|NCT00719563|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
635002|NCT00719563|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
635003|NCT00719563|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
635004|NCT00719563|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
635005|NCT00719563|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
635006|NCT00719563|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
635007|NCT00719563|mast cell leukemia|mast cell leukemia
635008|NCT00719563|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
635009|NCT00719563|prolymphocytic leukemia|prolymphocytic leukemia
635010|NCT00719563|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
635011|NCT00719563|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
635012|NCT00719563|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
635013|NCT00719563|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
635014|NCT00719563|refractory hairy cell leukemia|refractory hairy cell leukemia
635015|NCT00719563|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
635016|NCT00719563|secondary acute myeloid leukemia|secondary acute myeloid leukemia
635017|NCT00719563|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
635018|NCT00719563|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
635019|NCT00719563|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
635020|NCT00719563|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
635021|NCT00719563|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
635022|NCT00719563|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
635023|NCT00719563|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
635024|NCT00719563|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
635025|NCT00719563|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
635026|NCT00719563|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
635027|NCT00719563|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
635028|NCT00719563|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
635029|NCT00719563|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
635030|NCT00719563|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
635031|NCT00719563|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
635032|NCT00719563|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
635033|NCT00719563|anaplastic large cell lymphoma|anaplastic large cell lymphoma
635034|NCT00719563|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
635035|NCT00719563|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
635036|NCT00719563|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
635037|NCT00719563|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
635038|NCT00719563|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
635039|NCT00719563|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
635040|NCT00719563|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
635041|NCT00719563|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
635042|NCT00719563|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
635043|NCT00719563|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
635044|NCT00719563|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
635045|NCT00719563|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
635046|NCT00719563|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
635047|NCT00719563|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
635048|NCT00719563|Waldenström macroglobulinemia|waldenström macroglobulinemia
635049|NCT00719563|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
635050|NCT00719563|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
635051|NCT00719563|splenic marginal zone lymphoma|splenic marginal zone lymphoma
635052|NCT00719563|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
635053|NCT00719563|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
635054|NCT00719563|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
635055|NCT00719563|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
635056|NCT00719563|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
635057|NCT00719563|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
635058|NCT00719563|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
635059|NCT00719563|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
635060|NCT00719563|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
635061|NCT00719563|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
635062|NCT00719563|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
635063|NCT00719563|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
635064|NCT00719563|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
635065|NCT00719563|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
635066|NCT00719563|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
635067|NCT00719563|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
635068|NCT00719563|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
635069|NCT00719563|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
635070|NCT00719563|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
635071|NCT00719563|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
635072|NCT00719563|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
635073|NCT00719563|stage I mantle cell lymphoma|stage i mantle cell lymphoma
635074|NCT00719563|stage I marginal zone lymphoma|stage i marginal zone lymphoma
635075|NCT00719563|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
635140|NCT00719563|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
635076|NCT00719563|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
635077|NCT00719563|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
635078|NCT00719563|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
635079|NCT00719563|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
635080|NCT00719563|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
635081|NCT00719563|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
635082|NCT00719563|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
635083|NCT00719563|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
635084|NCT00719563|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
635085|NCT00719563|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
635086|NCT00719563|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
635087|NCT00719563|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
635088|NCT00719563|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
635089|NCT00719563|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
635090|NCT00719563|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
635091|NCT00719563|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
635092|NCT00719563|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
635093|NCT00719563|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
635094|NCT00719563|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
635095|NCT00719563|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
635096|NCT00719563|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
635097|NCT00719563|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
635098|NCT00719563|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
635099|NCT00719563|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
635100|NCT00719563|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
635101|NCT00719563|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
635102|NCT00719563|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
635103|NCT00719563|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
635104|NCT00719563|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
635105|NCT00719563|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
635106|NCT00719563|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
635107|NCT00719563|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
635108|NCT00719563|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
635109|NCT00719563|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
635110|NCT00719563|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
635204|NCT00719784|Lung|lung
635111|NCT00719563|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
635112|NCT00719563|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
635113|NCT00719563|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
635114|NCT00719563|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
635115|NCT00719563|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
635116|NCT00719563|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
635117|NCT00719563|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
635118|NCT00719563|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
635119|NCT00719563|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
635120|NCT00719563|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
635121|NCT00719563|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
635122|NCT00719563|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
635123|NCT00719563|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
635124|NCT00719563|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
635125|NCT00719563|intraocular lymphoma|intraocular lymphoma
635126|NCT00719563|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
635127|NCT00719563|chronic eosinophilic leukemia|chronic eosinophilic leukemia
635128|NCT00719563|chronic neutrophilic leukemia|chronic neutrophilic leukemia
635129|NCT00719563|primary myelofibrosis|primary myelofibrosis
635130|NCT00719563|essential thrombocythemia|essential thrombocythemia
635131|NCT00719563|polycythemia vera|polycythemia vera
635132|NCT00719563|extramedullary plasmacytoma|extramedullary plasmacytoma
635133|NCT00719563|isolated plasmacytoma of bone|isolated plasmacytoma of bone
635134|NCT00719563|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
635135|NCT00719563|stage I multiple myeloma|stage i multiple myeloma
635136|NCT00719563|stage II multiple myeloma|stage ii multiple myeloma
635137|NCT00719563|stage III multiple myeloma|stage iii multiple myeloma
635138|NCT00719563|primary systemic amyloidosis|primary systemic amyloidosis
635139|NCT00719563|refractory multiple myeloma|refractory multiple myeloma
635141|NCT00719563|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
635142|NCT00719563|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
635143|NCT00719563|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
635144|NCT00719576|Cartilage legions,|cartilage legions,
635145|NCT00719576|symptomatic focal cartilage defects,|symptomatic focal cartilage defects,
635146|NCT00719576|microfracture,|microfracture,
635148|NCT00719576|autologous chondrocyte|autologous chondrocyte
635149|NCT00719589|Voiding Dysfunction|voiding dysfunction
635150|NCT00719589|Interstim|interstim
635151|NCT00719602|Coinfection|coinfection
635152|NCT00719615|Thyroid Cancer|thyroid cancer
635153|NCT00719615|Thyroid Nodules|thyroid nodules
635154|NCT00719615|Vitamin D|vitamin d
635155|NCT00719628|Postoperative|postoperative
635156|NCT00719628|Cognitive|cognitive
635157|NCT00719628|Dysfunction|dysfunction
635158|NCT00719641|Colonoscopy|colonoscopy
635159|NCT00719641|Looping|looping
635160|NCT00719641|Prevent Looping|prevent looping
635161|NCT00719641|Colon Cancer Screening|colon cancer screening
635162|NCT00719641|Segmental Stiffening Wire|segmental stiffening wire
635163|NCT00719654|Preeclampsia|preeclampsia
635169|NCT00719667|grafting|grafting
635170|NCT00719667|off pump|off pump
635171|NCT00719680|CVID|cvid
635172|NCT00719680|XLA|xla
635173|NCT00719693|Food effect, phase I|food effect, phase i
635174|NCT00719693|adverse events|adverse events
635175|NCT00719706|Bipolar disorder|bipolar disorder
635176|NCT00719706|Bipolar depression|bipolar depression
635177|NCT00719706|Natural substances|natural substances
635178|NCT00719706|Depression|depression
635179|NCT00719719|Mast Cell|mast cell
635180|NCT00719719|Tryptase|tryptase
635181|NCT00719719|Bone Marrow|bone marrow
635182|NCT00719719|Hives|hives
635183|NCT00719719|Adult|adult
635184|NCT00719719|Anaphylaxis|anaphylaxis
635185|NCT00719732|ReSTOR Aspheric +3 IOL|restor aspheric +3 iol
635186|NCT00719745|Organ transplantation|organ transplantation
635187|NCT00719745|Tacrolimus|tacrolimus
635188|NCT00719745|Prograf|prograf
635189|NCT00719745|MR4|mr4
635190|NCT00719758|TRK-100STP,|trk-100stp,
635191|NCT00719758|beraprost sodium,|beraprost sodium,
635192|NCT00719758|Careload LA|careload la
635193|NCT00719758|AST-120|ast-120
635194|NCT00719758|Spherical carbon adsorbent|spherical carbon adsorbent
635195|NCT00719758|Drug-drug interaction|drug-drug interaction
635196|NCT00719771|Osteoarthritis|osteoarthritis
635197|NCT00719771|Glenohumeral joint|glenohumeral joint
635198|NCT00719771|Glenoid|glenoid
635199|NCT00719771|Shoulder arthroplasty|shoulder arthroplasty
635200|NCT00719784|Respiratory|respiratory
635201|NCT00719784|Pulmonary|pulmonary
635202|NCT00719784|Thoracic|thoracic
635203|NCT00719784|Chest|chest
635205|NCT00719797|stage IV rectal cancer|stage iv rectal cancer
635206|NCT00719797|stage IV colon cancer|stage iv colon cancer
635207|NCT00719797|stage III rectal cancer|stage iii rectal cancer
635208|NCT00719797|stage III colon cancer|stage iii colon cancer
635209|NCT00719810|complicated|complicated
635210|NCT00719810|skin|skin
635211|NCT00719823|Maraviroc Compassionate Use|maraviroc compassionate use
635212|NCT00719836|SB1518|sb1518
635213|NCT00719836|Chronic Idiopathic Myelofibrosis|chronic idiopathic myelofibrosis
635214|NCT00719836|JAK2 Inhibitor|jak2 inhibitor
635215|NCT00719849|chronic myelogenous leukemia|chronic myelogenous leukemia
635216|NCT00719849|acute lymphoblastic leukemia|acute lymphoblastic leukemia
635217|NCT00719849|acute myeloid leukemia|acute myeloid leukemia
635218|NCT00719849|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
635219|NCT00719849|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
635220|NCT00719849|anaplastic large cell lymphoma|anaplastic large cell lymphoma
635221|NCT00719849|splenic marginal zone lymphoma|splenic marginal zone lymphoma
635222|NCT00719849|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
635223|NCT00719849|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
635224|NCT00719849|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
635225|NCT00719849|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
635226|NCT00719849|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
635227|NCT00719849|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
635228|NCT00719849|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
635229|NCT00719849|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
635230|NCT00719849|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
635231|NCT00719849|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
635232|NCT00719849|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
635233|NCT00719849|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
635234|NCT00719849|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
635308|NCT00719992|Coronary angiography|coronary angiography
635235|NCT00719849|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
635236|NCT00719849|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
635237|NCT00719849|refractory multiple myeloma|refractory multiple myeloma
635238|NCT00719849|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
635239|NCT00719849|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
635240|NCT00719849|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
635241|NCT00719849|myelodysplastic/myeloproliferative disease|myelodysplastic/myeloproliferative disease
635242|NCT00719849|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
635243|NCT00719849|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
635244|NCT00719849|refractory anemia|refractory anemia
635245|NCT00719849|refractory anemia with excess blasts|refractory anemia with excess blasts
635246|NCT00719849|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
635247|NCT00719849|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
635248|NCT00719849|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
635249|NCT00719849|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
751796|NCT01170481|papilloedema|papilloedema
635250|NCT00719849|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
635251|NCT00719849|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
635252|NCT00719849|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
635253|NCT00719849|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
635254|NCT00719849|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
635255|NCT00719849|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
635256|NCT00719849|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
635257|NCT00719849|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
635258|NCT00719849|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
635259|NCT00719849|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
635260|NCT00719849|stage II multiple myeloma|stage ii multiple myeloma
635261|NCT00719849|stage III multiple myeloma|stage iii multiple myeloma
635262|NCT00719849|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
635263|NCT00719849|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
635264|NCT00719849|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
635265|NCT00719849|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
635266|NCT00719849|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
635267|NCT00719849|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
635268|NCT00719849|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
635269|NCT00719849|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
635270|NCT00719849|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
635271|NCT00719849|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
635272|NCT00719849|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
635273|NCT00719849|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
635274|NCT00719849|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
635275|NCT00719849|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
635276|NCT00719849|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
635277|NCT00719849|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
635278|NCT00719849|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
635279|NCT00719849|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
635280|NCT00719849|chronic eosinophilic leukemia|chronic eosinophilic leukemia
635281|NCT00719849|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
635282|NCT00719849|chronic neutrophilic leukemia|chronic neutrophilic leukemia
635283|NCT00719849|essential thrombocythemia|essential thrombocythemia
635285|NCT00719914|eptifibatide|eptifibatide
635286|NCT00719914|Integrilin|integrilin
635287|NCT00719914|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
635288|NCT00719914|Acute Myocardial Infarction|acute myocardial infarction
635289|NCT00719927|Social Support|social support
635290|NCT00719940|tinnitus, cognitive behavioral therapy, CBT|tinnitus, cognitive behavioral therapy, cbt
635291|NCT00719953|Cognitex|cognitex
635292|NCT00719953|subjects|subjects
635293|NCT00719966|stage IA breast cancer|stage ia breast cancer
635294|NCT00719966|stage IB breast cancer|stage ib breast cancer
635295|NCT00719966|stage II breast cancer|stage ii breast cancer
635296|NCT00719966|stage IIIA breast cancer|stage iiia breast cancer
635297|NCT00719966|stage IIIB breast cancer|stage iiib breast cancer
635298|NCT00719966|stage IIIC breast cancer|stage iiic breast cancer
635299|NCT00719966|stage IV breast cancer|stage iv breast cancer
635300|NCT00719966|ductal breast carcinoma in situ|ductal breast carcinoma in situ
635301|NCT00719979|Major Depressive Disorder|major depressive disorder
635302|NCT00719979|Cognitive Behavior Therapy|cognitive behavior therapy
635303|NCT00719979|Technology Assisted|technology assisted
635304|NCT00719979|Internet|internet
635305|NCT00719979|Primary Care|primary care
635306|NCT00719992|Exercise tolerance test|exercise tolerance test
635307|NCT00719992|HS-CRP|hs-crp
635309|NCT00719992|Patients|patients
635310|NCT00720005|Cataract|cataract
635311|NCT00720005|cataract extraction|cataract extraction
635312|NCT00720005|intraocular lens|intraocular lens
635313|NCT00720005|age related|age related
635314|NCT00720031|Melanoma,|melanoma,
635315|NCT00720031|Melan-A tumor reactive T cell clones,|melan-a tumor reactive t cell clones,
635316|NCT00720031|immunotherapy|immunotherapy
635317|NCT00720031|HLA-A2 melanoma patients with|hla-a2 melanoma patients with
635318|NCT00720031|either loco-regional or lymphnode metastasis|either loco-regional or lymphnode metastasis
635319|NCT00720031|transit nodules not surgically resectable|transit nodules not surgically resectable
635320|NCT00720031|-measurable cutaneous or visceral metastasis .|-measurable cutaneous or visceral metastasis .
635321|NCT00720031|Patients' tumor express Melan-A/MART-1 antigen.|patients' tumor express melan-a/mart-1 antigen.
635322|NCT00720057|Dental Pain|dental pain
635323|NCT00720057|Analgesia|analgesia
635324|NCT00720070|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
635325|NCT00720070|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
635326|NCT00720070|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
635327|NCT00720070|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
635328|NCT00720070|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
635329|NCT00720070|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
635330|NCT00720070|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
635331|NCT00720070|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
635332|NCT00720070|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
635333|NCT00720070|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
635334|NCT00720070|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
635335|NCT00720070|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
635336|NCT00720070|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
635337|NCT00720070|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
635338|NCT00720070|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
635339|NCT00720070|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
635340|NCT00720070|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
635341|NCT00720070|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
635342|NCT00720070|tongue cancer|tongue cancer
635343|NCT00720083|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
635344|NCT00720083|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
635345|NCT00720083|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
635346|NCT00720083|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
635347|NCT00720083|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
635348|NCT00720083|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
635349|NCT00720083|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
635350|NCT00720083|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
635351|NCT00720096|Persistent Ovarian Cancer|persistent ovarian cancer
635352|NCT00720096|Genomic directed salvage chemotherapy|genomic directed salvage chemotherapy
635353|NCT00720096|Genomic Microarray|genomic microarray
635354|NCT00720122|Bone density|bone density
635355|NCT00720122|Bone turnover markers|bone turnover markers
635357|NCT00720122|Bone structure|bone structure
635358|NCT00720122|Anorexia nervosa|anorexia nervosa
635359|NCT00720148|Solid tumors|solid tumors
635360|NCT00720161|metformin, spina bifida, duchenne, insulin resistance|metformin, spina bifida, duchenne, insulin resistance
635361|NCT00720200|Communication|communication
635362|NCT00720200|Intensive Care Units|intensive care units
635363|NCT00720200|Palliative Care|palliative care
635364|NCT00720200|End-of-Life Issues|end-of-life issues
635365|NCT00720200|Talking with Your Doctor|talking with your doctor
635366|NCT00720200|Coping with Chronic Illness|coping with chronic illness
635367|NCT00720226|COPD|copd
635368|NCT00720226|emphysema|emphysema
635369|NCT00720226|angiotensin receptor blocker|angiotensin receptor blocker
635370|NCT00720265|Organ Transplantation|organ transplantation
635371|NCT00720265|Tacrolimus|tacrolimus
635372|NCT00720265|Prograf|prograf
635373|NCT00720265|FK506MR|fk506mr
635374|NCT00720291|Metronidazole|metronidazole
635375|NCT00720291|BV|bv
635376|NCT00720291|Pregnancy|pregnancy
635377|NCT00720304|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
635378|NCT00720304|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
635379|NCT00720304|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
635380|NCT00720304|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
635467|NCT00720629|hematological malignancies|hematological malignancies
635381|NCT00720304|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
635382|NCT00720304|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
635383|NCT00720304|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
635384|NCT00720304|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
635385|NCT00720304|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
635386|NCT00720304|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
635387|NCT00720304|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
635388|NCT00720304|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
635389|NCT00720304|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
635390|NCT00720304|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
635391|NCT00720304|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
635392|NCT00720317|Diabetic Retinopathy|diabetic retinopathy
635393|NCT00720317|Sickle Cell Trait|sickle cell trait
635394|NCT00720317|Vision Loss|vision loss
635395|NCT00720317|Eye disease|eye disease
635396|NCT00720330|Inguinal Herniorrhaphy|inguinal herniorrhaphy
635397|NCT00720330|Pain assessment|pain assessment
635398|NCT00720330|Outcomes|outcomes
635399|NCT00720356|adult glioblastoma|adult glioblastoma
635400|NCT00720356|adult gliosarcoma|adult gliosarcoma
635401|NCT00720369|Bipolar depression|bipolar depression
635402|NCT00720369|elderly|elderly
635403|NCT00720369|Coenzyme Q10|coenzyme q10
635404|NCT00720369|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
635405|NCT00720395|Psychiatry|psychiatry
635406|NCT00720395|Pregnancy|pregnancy
635407|NCT00720408|Immunosuppressant|immunosuppressant
635408|NCT00720408|Graft loss|graft loss
635409|NCT00720408|Combination drug therapy|combination drug therapy
635410|NCT00720408|Randomized controlled trial|randomized controlled trial
635411|NCT00720408|Open level method|open level method
635412|NCT00720421|Phase I|phase i
635413|NCT00720421|pharmacodynamic study|pharmacodynamic study
635414|NCT00720447|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
635415|NCT00720447|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
635416|NCT00720460|Magnetic Resonance Imaging|magnetic resonance imaging
635417|NCT00720460|Minimally Invasive Therapy|minimally invasive therapy
635418|NCT00720460|Heart Catheterization|heart catheterization
635419|NCT00720460|Healthy Volunteers|healthy volunteers
635420|NCT00720460|Gadolinium Contrast|gadolinium contrast
635421|NCT00720460|Healthy Volunteer|healthy volunteer
635422|NCT00720460|HV|hv
635423|NCT00720473|Bipolar depression|bipolar depression
635424|NCT00720473|Elderly|elderly
635425|NCT00720473|Lamotrigine|lamotrigine
635426|NCT00720473|Brain energy metabolism|brain energy metabolism
635427|NCT00720512|adenocarcinoma of the colon|adenocarcinoma of the colon
635428|NCT00720512|adenocarcinoma of the rectum|adenocarcinoma of the rectum
635429|NCT00720512|recurrent colon cancer|recurrent colon cancer
635430|NCT00720512|recurrent rectal cancer|recurrent rectal cancer
635431|NCT00720512|stage IV colon cancer|stage iv colon cancer
635432|NCT00720512|stage IV rectal cancer|stage iv rectal cancer
635433|NCT00720512|stage III rectal cancer|stage iii rectal cancer
635434|NCT00720512|stage III colon cancer|stage iii colon cancer
635435|NCT00720525|arterial stiffness|arterial stiffness
635436|NCT00720525|arterial wave reflections|arterial wave reflections
635437|NCT00720525|diastolic heart failure|diastolic heart failure
635438|NCT00720538|Inflammatory bowel diseases.|inflammatory bowel diseases.
635439|NCT00720538|Crohn disease.|crohn disease.
635440|NCT00720538|Ulcerative, colitis.|ulcerative, colitis.
635441|NCT00720538|Randomised controlled trial.|randomised controlled trial.
635442|NCT00720538|Therapy.|therapy.
635443|NCT00720538|Thalidomide.|thalidomide.
635444|NCT00720538|Children.|children.
635446|NCT00720551|Alcohol|alcohol
635447|NCT00720564|adult glioblastoma|adult glioblastoma
635448|NCT00720564|adult anaplastic astrocytoma|adult anaplastic astrocytoma
635449|NCT00720564|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
635450|NCT00720564|adult gliosarcoma|adult gliosarcoma
635451|NCT00720564|adult mixed glioma|adult mixed glioma
635452|NCT00720577|Peripheral Arterial Disease|peripheral arterial disease
635453|NCT00720577|PAD|pad
635454|NCT00720577|Lower extremity peripheral arterial atherosclerotic plaque|lower extremity peripheral arterial atherosclerotic plaque
635455|NCT00720577|RNA Expression|rna expression
635456|NCT00720577|Lipid Biomarkers|lipid biomarkers
635457|NCT00720603|Autologous Stem Cell Transplant|autologous stem cell transplant
635458|NCT00720616|Growth hormone|growth hormone
635459|NCT00720616|Metabolic syndrome|metabolic syndrome
635460|NCT00720616|Insulin sensitivity|insulin sensitivity
635461|NCT00720629|graft versus host disease|graft versus host disease
635462|NCT00720629|GVHD|gvhd
635463|NCT00720629|allogeneic transplant|allogeneic transplant
635464|NCT00720629|GVHD prevention|gvhd prevention
635465|NCT00720629|unrelated donors|unrelated donors
635466|NCT00720629|mismatched unrelated donors|mismatched unrelated donors
635468|NCT00720629|Leukemia|leukemia
635469|NCT00720629|Lymphoma|lymphoma
635470|NCT00720629|Myelodysplastic Syndrome|myelodysplastic syndrome
635471|NCT00720629|Myelofibrosis|myelofibrosis
635472|NCT00720629|Aplastic Anemia|aplastic anemia
635473|NCT00720629|Multiple Myeloma|multiple myeloma
635474|NCT00720655|coronary heart disease|coronary heart disease
635475|NCT00720668|hepatitis B|hepatitis b
635476|NCT00720668|hepatocellular carcinoma|hepatocellular carcinoma
635477|NCT00720668|radiofrequency ablation|radiofrequency ablation
635478|NCT00720668|reactivation|reactivation
635479|NCT00720707|Coronally advanced flap|coronally advanced flap
635480|NCT00720707|gingival recession|gingival recession
635481|NCT00720707|enamel matrix protein|enamel matrix protein
635482|NCT00720707|acellular dermal matrix|acellular dermal matrix
635483|NCT00720707|root coverage|root coverage
635485|NCT00720733|Mood|mood
635486|NCT00720733|Emotion|emotion
635487|NCT00720733|Coping|coping
635488|NCT00720733|Aids|aids
635489|NCT00720733|Affect|affect
635490|NCT00720733|Adults|adults
635491|NCT00720733|Diagnosed|diagnosed
635492|NCT00720759|stroke|stroke
635493|NCT00720759|hemiparesis|hemiparesis
635494|NCT00720759|randomized controlled trial|randomized controlled trial
635495|NCT00720759|d-cycloserine|d-cycloserine
635496|NCT00720759|distributed practice|distributed practice
635497|NCT00720759|constraint induced movement therapy|constraint induced movement therapy
635498|NCT00720772|coronary calcification|coronary calcification
635499|NCT00720772|vascular calcification|vascular calcification
635500|NCT00720772|sodium thiosulfate|sodium thiosulfate
635501|NCT00720785|Metastatic Solid Tumor|metastatic solid tumor
635502|NCT00720785|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
635503|NCT00720785|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
635504|NCT00720785|Tumor Cytotoxicity|tumor cytotoxicity
635505|NCT00720785|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
635506|NCT00720785|Lung Cancer|lung cancer
635507|NCT00720785|Prostate Cancer|prostate cancer
635508|NCT00720785|Colon Cancer|colon cancer
635509|NCT00720785|Kidney Cancer|kidney cancer
635510|NCT00720785|Pancreatic Cancer|pancreatic cancer
635511|NCT00720785|Leukemia|leukemia
635512|NCT00720785|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
635513|NCT00720785|CML|cml
635514|NCT00720785|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
635515|NCT00720785|SLL|sll
635516|NCT00720785|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
635517|NCT00720785|CLL|cll
635518|NCT00720811|Malaria ACT|malaria act
635519|NCT00720811|Rapid|rapid
635520|NCT00720811|Diagnosis|diagnosis
635521|NCT00720811|Community|community
635522|NCT00720811|health|health
635523|NCT00720811|worker|worker
635524|NCT00720811|Artemesinin|artemesinin
635525|NCT00720811|based|based
635526|NCT00720811|Combination|combination
635527|NCT00720811|Therapy|therapy
635528|NCT00720811|Anti Malarial|anti malarial
635529|NCT00720811|Treatment|treatment
635530|NCT00720811|antibiotics|antibiotics
635531|NCT00720824|Immunizations|immunizations
635532|NCT00720824|Children|children
635533|NCT00720824|Injections|injections
635534|NCT00720824|aged 4-6 Years|aged 4-6 years
635535|NCT00720824|Hypnosis|hypnosis
635536|NCT00720837|Brain Tumor|brain tumor
635537|NCT00720837|Brain Cancer|brain cancer
635538|NCT00720837|MR-guided laser thermal ablation of brain tumors|mr-guided laser thermal ablation of brain tumors
635539|NCT00720837|Visualase® Thermal Therapy System|visualase® thermal therapy system
635540|NCT00720837|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
635541|NCT00720837|MRTI|mrti
635542|NCT00720837|Visualase Cooled Laser Application System|visualase cooled laser application system
635543|NCT00720837|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
635544|NCT00720837|LITT|litt
635545|NCT00720850|MDS|mds
635546|NCT00720850|AML|aml
635547|NCT00720850|Lenalidomide|lenalidomide
635548|NCT00720850|monosomy 5|monosomy 5
635549|NCT00720850|monosomy del5q|monosomy del5q
635550|NCT00720876|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
635551|NCT00720876|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
635552|NCT00720876|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
635553|NCT00720876|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
635554|NCT00720876|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
635555|NCT00720876|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
635556|NCT00720876|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
635557|NCT00720876|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
635558|NCT00720876|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
635559|NCT00720876|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
635560|NCT00720876|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
635561|NCT00720876|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
635648|NCT00714948|GEMCITABINE|gemcitabine
635562|NCT00720876|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
635563|NCT00720876|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
635564|NCT00720876|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
635565|NCT00720876|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
635566|NCT00720876|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
635567|NCT00720876|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
635568|NCT00720876|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
635569|NCT00720876|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
635570|NCT00720876|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
635571|NCT00720876|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
635572|NCT00720876|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
635573|NCT00720876|splenic marginal zone lymphoma|splenic marginal zone lymphoma
635574|NCT00720876|stage I marginal zone lymphoma|stage i marginal zone lymphoma
635575|NCT00720876|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
635576|NCT00720876|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
635577|NCT00720876|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
635578|NCT00720876|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
635579|NCT00720876|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
635580|NCT00720876|stage I mantle cell lymphoma|stage i mantle cell lymphoma
635873|NCT00722644|Stress Management|stress management
635581|NCT00720876|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
635582|NCT00720876|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
635583|NCT00720889|short sleep duration|short sleep duration
635584|NCT00720889|glucose clamp technique|glucose clamp technique
635585|NCT00720889|insulin secretion|insulin secretion
635586|NCT00720889|insulin action|insulin action
635587|NCT00720889|lipid turnover|lipid turnover
635588|NCT00720889|free fatty acids|free fatty acids
635589|NCT00714753|stage I prostate cancer|stage i prostate cancer
635590|NCT00714753|stage II prostate cancer|stage ii prostate cancer
635591|NCT00714753|adenocarcinoma of the prostate|adenocarcinoma of the prostate
635592|NCT00714779|Major depressive Disorder|major depressive disorder
635593|NCT00714779|fluoxetine|fluoxetine
635594|NCT00714779|short-term psychodynamic psychotherapy|short-term psychodynamic psychotherapy
635595|NCT00714779|PET|pet
635596|NCT00714805|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
635597|NCT00714805|Gastric Motility|gastric motility
635598|NCT00714805|Autonomic Nervous System|autonomic nervous system
635599|NCT00714805|Neurodegenerative Diseases|neurodegenerative diseases
635600|NCT00714805|Movement Disorders|movement disorders
635601|NCT00714805|Gastrointestinal Motility|gastrointestinal motility
635602|NCT00714818|Schizophrenia|schizophrenia
635603|NCT00714818|Bipolar Disorder|bipolar disorder
635604|NCT00714818|Schizoaffective disorder|schizoaffective disorder
635605|NCT00714818|Genetic Counseling|genetic counseling
635606|NCT00714818|Risk perception|risk perception
635607|NCT00714818|Stigma|stigma
635608|NCT00714818|Control|control
635609|NCT00714818|Knowledge|knowledge
635610|NCT00714818|family members|family members
635611|NCT00714818|Sibling parent or child with schizophrenia|sibling parent or child with schizophrenia
635612|NCT00714818|Sibling parent or child with bipolar disorder|sibling parent or child with bipolar disorder
635613|NCT00714818|Sibling parent or child with schizoaffective disorder|sibling parent or child with schizoaffective disorder
635614|NCT00714831|Physical activity promotion|physical activity promotion
635615|NCT00714831|Primary health care|primary health care
635616|NCT00714831|Adherence|adherence
635617|NCT00714844|insulin therapy|insulin therapy
635618|NCT00714844|insulin detemir|insulin detemir
635619|NCT00714844|waist circumference|waist circumference
635620|NCT00714857|ICU patients|icu patients
635621|NCT00714857|Dexmedetomidine|dexmedetomidine
635622|NCT00714857|Sedation|sedation
635623|NCT00714857|Judged|judged
635624|NCT00714857|Attending|attending
635625|NCT00714857|Physician|physician
635626|NCT00714870|BMI|bmi
635627|NCT00714870|Quality of life|quality of life
635628|NCT00714883|drug-eluting stents|drug-eluting stents
635629|NCT00714883|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
635630|NCT00714896|smoking cessation|smoking cessation
635631|NCT00714896|nicotine dependence|nicotine dependence
635632|NCT00714896|stage-based intervention|stage-based intervention
635633|NCT00714896|nicotine replacement medications|nicotine replacement medications
635634|NCT00714896|counseling|counseling
635635|NCT00714896|substance abuse treatment|substance abuse treatment
635636|NCT00714909|Breast cancer|breast cancer
635637|NCT00714909|Catheter related thrombosis|catheter related thrombosis
635638|NCT00714909|Diagnosis|diagnosis
635639|NCT00714909|Echography doppler|echography doppler
635640|NCT00714909|Risk factors|risk factors
635641|NCT00714935|Risk Factors|risk factors
635642|NCT00714935|Risk Reduction Behavior|risk reduction behavior
635643|NCT00714935|Counseling|counseling
635644|NCT00714948|Bladder|bladder
635645|NCT00714948|Urinary|urinary
635646|NCT00714948|SORAFENIB|sorafenib
635647|NCT00714948|CISPLATIN|cisplatin
635649|NCT00714974|Neuromuscular blocking agents|neuromuscular blocking agents
635650|NCT00714974|Bispectral analysis|bispectral analysis
635651|NCT00714987|ARDS|ards
635652|NCT00714987|Mechanical ventilation|mechanical ventilation
635653|NCT00714987|PEEP with low level|peep with low level
635654|NCT00714987|PEEP with high level|peep with high level
635655|NCT00714987|EVLW|evlw
635656|NCT00714987|Picco® system|picco® system
635657|NCT00714987|PaO2/FiO2 ratio|pao2/fio2 ratio
635658|NCT00715000|Preterm babies hydration|preterm babies hydration
635659|NCT00715000|Oral rehydration solution|oral rehydration solution
635660|NCT00715000|Continuous gastric drip|continuous gastric drip
635661|NCT00715000|Fluid therapy|fluid therapy
635662|NCT00715000|Premature babies comfort|premature babies comfort
635663|NCT00715000|Infant care|infant care
635664|NCT00715000|Technical challenge for the nurses/doctors in charge|technical challenge for the nurses/doctors in charge
635665|NCT00715013|recurrent Glioblastoma|recurrent glioblastoma
635666|NCT00715026|Arthritis|arthritis
635667|NCT00715026|Total Hip|total hip
635668|NCT00715026|Ceramic|ceramic
635669|NCT00715026|Hip Replacement|hip replacement
635670|NCT00715026|Total Hip Arthroplasty (THA)|total hip arthroplasty (tha)
635671|NCT00715026|Joint Disease|joint disease
635672|NCT00715039|generalized anxiety disorder|generalized anxiety disorder
635673|NCT00715039|onset of efficacy|onset of efficacy
635674|NCT00715039|Daily Assessment of Symptoms-Anxiety (DAS-A)|daily assessment of symptoms-anxiety (das-a)
635675|NCT00715039|Methods|methods
635676|NCT00715052|neurologic deficiency due traumatic brain injury|neurologic deficiency due traumatic brain injury
635677|NCT00715065|syncope|syncope
635678|NCT00715065|faint|faint
635679|NCT00715065|blood|blood
635680|NCT00715065|blood injury phobia|blood injury phobia
635681|NCT00715065|phobia|phobia
635682|NCT00715078|prostate cancer|prostate cancer
635683|NCT00715078|prostate|prostate
635684|NCT00715078|immune therapy|immune therapy
635685|NCT00715078|immunotherapy|immunotherapy
635686|NCT00715078|vaccine|vaccine
635687|NCT00715078|dendritic cells|dendritic cells
635688|NCT00715078|antigen-presenting cells|antigen-presenting cells
635689|NCT00715078|antigen presenting cells|antigen presenting cells
635690|NCT00715078|cancer vaccine|cancer vaccine
635691|NCT00715078|prostate specific antigen (PSA)|prostate specific antigen (psa)
635692|NCT00715078|prostatic adenocarcinoma|prostatic adenocarcinoma
635693|NCT00715091|NSAIDS|nsaids
635694|NCT00715091|ankylosing spondylitis|ankylosing spondylitis
635696|NCT00715091|Spondyloarthritis|spondyloarthritis
635697|NCT00715091|radiographic changes|radiographic changes
635698|NCT00715117|children|children
635699|NCT00715117|pediatric|pediatric
635700|NCT00715117|Crohn's Disease|crohn's disease
635701|NCT00715117|naltrexone|naltrexone
635702|NCT00715117|LDN|ldn
635703|NCT00715117|IBD|ibd
635704|NCT00715117|Inflammatory bowel disease|inflammatory bowel disease
635705|NCT00715130|Energy|energy
635706|NCT00715130|Obesity|obesity
635707|NCT00715130|Energy Balance|energy balance
635708|NCT00715130|Physical Activity|physical activity
635709|NCT00715130|Dietary Intake|dietary intake
635713|NCT00715130|Body Mass Index|body mass index
635714|NCT00715130|Weight Maintenance|weight maintenance
635715|NCT00715143|hip|hip
635716|NCT00715143|replacement|replacement
635717|NCT00715143|ceramic|ceramic
635718|NCT00715143|orthopaedic|orthopaedic
635719|NCT00715143|joint|joint
635720|NCT00715143|degenerative|degenerative
635721|NCT00715143|non-inflammatory|non-inflammatory
635722|NCT00715143|osteoarthritis|osteoarthritis
635723|NCT00715143|avascular necrosis|avascular necrosis
635724|NCT00715143|congenital hip dysplasia|congenital hip dysplasia
635725|NCT00715143|traumatic arthritis|traumatic arthritis
635726|NCT00715156|allergy, peach, birch|allergy, peach, birch
635727|NCT00715156|recombinants allergens diagnosis|recombinants allergens diagnosis
635728|NCT00715156|OAS|oas
635729|NCT00715156|LTP|ltp
635730|NCT00715156|systemic reactions|systemic reactions
635731|NCT00715156|subjects with severe reaction to other fruits|subjects with severe reaction to other fruits
635732|NCT00715182|Renal Cell Cancer|renal cell cancer
635733|NCT00715195|Cognitive behavioral|cognitive behavioral
635734|NCT00715195|Long-term study|long-term study
635735|NCT00715195|Education|education
635736|NCT00715221|Diabetes|diabetes
635737|NCT00715234|adolescent reminder/recall|adolescent reminder/recall
635738|NCT00715234|adolescent vaccines|adolescent vaccines
635739|NCT00715234|Tdap|tdap
635740|NCT00715234|Meningococcal|meningococcal
635741|NCT00715234|HPV|hpv
635742|NCT00715234|Reminder cards|reminder cards
635743|NCT00715234|Recall messages|recall messages
635744|NCT00715234|vaccine|vaccine
635745|NCT00715234|conjugate|conjugate
635746|NCT00715247|Myeloproliferative Disorders|myeloproliferative disorders
635747|NCT00715247|Hematological Malignancies|hematological malignancies
635748|NCT00715247|Polycythemia Vera|polycythemia vera
635749|NCT00715247|Essential Thrombocythemia|essential thrombocythemia
635750|NCT00715247|Myelofibrosis|myelofibrosis
635751|NCT00715247|Genetics|genetics
635752|NCT00715247|Chronic Leukemia|chronic leukemia
635753|NCT00715273|Magnetic Resonance Imaging|magnetic resonance imaging
635754|NCT00715273|Atherosclerotic Plaque|atherosclerotic plaque
635755|NCT00715273|Lipid Lowering Therapy|lipid lowering therapy
635756|NCT00715286|epithelial ovarian cancer|epithelial ovarian cancer
635757|NCT00715286|neoadjuvant chemotherapy|neoadjuvant chemotherapy
635758|NCT00715286|randomized study|randomized study
635759|NCT00720915|unprovoked deep vein thrombosis|unprovoked deep vein thrombosis
635760|NCT00720915|unprovoked pulmonary embolism|unprovoked pulmonary embolism
635761|NCT00720915|anticoagulant therapy|anticoagulant therapy
635762|NCT00720928|Behcet's disease|behcet's disease
635763|NCT00720928|posterior uveitis|posterior uveitis
635764|NCT00720928|flucinolone acetonide|flucinolone acetonide
635765|NCT00720928|RETISERT|retisert
635766|NCT00720941|SUTENT|sutent
635767|NCT00720941|Locally advanced and/or metastatic renal cell carcinoma|locally advanced and/or metastatic renal cell carcinoma
635768|NCT00720941|Pazopanib|pazopanib
635769|NCT00720941|Sunitinib|sunitinib
635770|NCT00720941|GW786034|gw786034
635771|NCT00720941|Renal cell carcinoma|renal cell carcinoma
635772|NCT00720954|Thoracoscopy|thoracoscopy
635773|NCT00720954|Pleural needle biopsy|pleural needle biopsy
635774|NCT00720954|Malignant pleural diseases|malignant pleural diseases
635775|NCT00720954|Mesothelioma|mesothelioma
635776|NCT00720954|Diagnosis|diagnosis
635777|NCT00720954|Pleurisy tuberculosis|pleurisy tuberculosis
635874|NCT00722644|CD4/Viral Loads|cd4/viral loads
635875|NCT00722644|Cognitive Behavioral Treatment|cognitive behavioral treatment
635778|NCT00720954|Patients with pleural diseases and pleural effusion should have been included in the study.|patients with pleural diseases and pleural effusion should have been included in the study.
635779|NCT00720967|Renal dysfunction|renal dysfunction
635780|NCT00720967|Hemodialysis|hemodialysis
635781|NCT00720967|Modified ultrafiltration|modified ultrafiltration
635782|NCT00720967|Open heart surgery|open heart surgery
635783|NCT00720980|granuloma annulare, ROM|granuloma annulare, rom
635784|NCT00720993|Colorectal cancer screening|colorectal cancer screening
635785|NCT00720993|Gene expression|gene expression
635786|NCT00720993|RTPCR|rtpcr
635787|NCT00721006|peripheral artery disease|peripheral artery disease
635788|NCT00721006|peripheral vascular disease|peripheral vascular disease
635789|NCT00721006|PAD|pad
635790|NCT00721006|PVD|pvd
635791|NCT00721019|short sleep duration|short sleep duration
635792|NCT00721019|glucose clamp technique|glucose clamp technique
635793|NCT00721019|insulin secretion|insulin secretion
635794|NCT00721019|insulin action|insulin action
635795|NCT00721019|lipid turnover|lipid turnover
635796|NCT00721019|free fatty acids|free fatty acids
635797|NCT00721032|Ventricular tachycardia (VT)|ventricular tachycardia (vt)
635798|NCT00721032|Implantable cardioverter-defibrillator (ICD)|implantable cardioverter-defibrillator (icd)
635799|NCT00721032|Ablation|ablation
635800|NCT00721032|Cardiomyopathy|cardiomyopathy
635801|NCT00721032|Electrophysiology study|electrophysiology study
635802|NCT00721045|Heart Failure|heart failure
635803|NCT00721045|Congestive Heart Failure|congestive heart failure
635804|NCT00721058|Eligible|eligible
635805|NCT00721058|Operable|operable
635806|NCT00721058|Disease|disease
635807|NCT00721058|Conserving|conserving
635808|NCT00721058|Therapy|therapy
636007|NCT00723216|Prevention|prevention
635809|NCT00721058|Visible mass on mammography|visible mass on mammography
635810|NCT00721058|Ultrasound > 0.5 cm|ultrasound > 0.5 cm
635811|NCT00721058|Histologically|histologically
635812|NCT00721058|Proven|proven
635813|NCT00721071|Pediatrics|pediatrics
635814|NCT00721071|Cystic Fibrosis|cystic fibrosis
635815|NCT00721071|Hypertonic Saline|hypertonic saline
635816|NCT00721071|Induced Sputum|induced sputum
635817|NCT00721071|Expectorated Sputum|expectorated sputum
635818|NCT00721084|short sleep duration|short sleep duration
635819|NCT00721084|maximal aerobic capacity|maximal aerobic capacity
635820|NCT00721084|body fat|body fat
635821|NCT00721084|visceral adiposity|visceral adiposity
635822|NCT00721084|activity-related energy expenditure|activity-related energy expenditure
635823|NCT00721084|energy metabolism|energy metabolism
635824|NCT00721097|Severe asthma|severe asthma
635825|NCT00721097|exacerbation|exacerbation
635826|NCT00721097|predictive factors|predictive factors
635827|NCT00721097|Severe|severe
635828|NCT00721110|pain control|pain control
635829|NCT00721110|nausea|nausea
635830|NCT00721110|surgery recovery|surgery recovery
635831|NCT00721136|bleeding|bleeding
635832|NCT00721136|anticoagulation|anticoagulation
635833|NCT00721136|pacemaker|pacemaker
635834|NCT00721136|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
635835|NCT00721136|"patients undergoing implantation of a pacemaker or defibrillator (ICD)"|"patients undergoing implantation of a pacemaker or defibrillator (icd)"
635836|NCT00721149|Atrial Fibrillation|atrial fibrillation
635837|NCT00721149|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
635838|NCT00721149|Ablation|ablation
635839|NCT00721149|Non-randomized|non-randomized
635840|NCT00721162|Ovarian Cancer,|ovarian cancer,
635841|NCT00721162|Fallopian Tube Cancer|fallopian tube cancer
635842|NCT00721162|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
635843|NCT00721175|biliary stent|biliary stent
635844|NCT00721175|plastic stent|plastic stent
635845|NCT00721175|metallic stent|metallic stent
635846|NCT00721175|Complex hilar cholangiocarcinoma (Bismuth type II,III,IV)|complex hilar cholangiocarcinoma (bismuth type ii,iii,iv)
635847|NCT00721201|subclinical Cushing's|subclinical cushing's
635848|NCT00721214|Myelodysplastic Syndrome|myelodysplastic syndrome
635849|NCT00721214|5-azacytidine|5-azacytidine
635850|NCT00721214|allogeneic stem cell transplantation|allogeneic stem cell transplantation
635851|NCT00722553|Transitional Cell Carcinoma of the Urinary Bladder|transitional cell carcinoma of the urinary bladder
635852|NCT00722553|Transitional Cell Carcinoma|transitional cell carcinoma
635853|NCT00722553|Bladder Cancer|bladder cancer
635854|NCT00722553|Urinary Bladder Cancer|urinary bladder cancer
635855|NCT00722553|Bladder|bladder
635856|NCT00722553|Carcinoma|carcinoma
635857|NCT00722553|Urinary|urinary
635858|NCT00722553|Metastatic|metastatic
635859|NCT00722553|Relapsed|relapsed
635860|NCT00722579|Coronary Artery Disease|coronary artery disease
635861|NCT00722592|cancer|cancer
635862|NCT00722592|ovarian|ovarian
635863|NCT00722592|platinum-resistant|platinum-resistant
635864|NCT00722592|Phase II|phase ii
635865|NCT00722592|EC145|ec145
635866|NCT00722592|EC20|ec20
635867|NCT00722605|lung|lung
635868|NCT00722605|esophageal|esophageal
635869|NCT00722605|cone beam ct scan|cone beam ct scan
635870|NCT00722618|Infertility|infertility
635871|NCT00722644|HIV|hiv
635872|NCT00722644|Medication Adherence|medication adherence
635876|NCT00722657|asthma|asthma
635877|NCT00722657|epidemiology|epidemiology
635878|NCT00722670|risk reduction|risk reduction
635879|NCT00722670|prevention|prevention
635880|NCT00722670|HIV prevention|hiv prevention
635881|NCT00722696|Metabolism|metabolism
635882|NCT00722696|Muscles|muscles
635883|NCT00722696|Exercise|exercise
635884|NCT00722709|Pain|pain
635885|NCT00722709|Fatigue|fatigue
635886|NCT00722709|Colon|colon
635887|NCT00722709|Surgery|surgery
635888|NCT00722709|ERAS|eras
635889|NCT00722709|Fastrack|fastrack
635890|NCT00722709|Local anaesthetic|local anaesthetic
635891|NCT00722709|Peritoneum|peritoneum
635892|NCT00722709|Metabolic|metabolic
635893|NCT00722709|Endocrine|endocrine
635894|NCT00722709|Post surgical metabolic response|post surgical metabolic response
635895|NCT00722709|Complications|complications
635896|NCT00722709|Time to passage of flatus|time to passage of flatus
635897|NCT00722709|Time to passage of stool|time to passage of stool
635898|NCT00722709|Time to discharge from facility|time to discharge from facility
635899|NCT00722709|Re-admission rate|re-admission rate
635900|NCT00722735|uncomplicated Urinary Tract Infection in Women|uncomplicated urinary tract infection in women
635901|NCT00722735|Antibacterial Chemotherapy|antibacterial chemotherapy
635902|NCT00722735|Proof-of-Concept|proof-of-concept
635903|NCT00722748|Genebank|genebank
635904|NCT00722748|Gene registry|gene registry
635905|NCT00722748|Cardiac Arrythmia Disease|cardiac arrythmia disease
635906|NCT00722761|YAZ|yaz
635907|NCT00722761|oral contraceptive|oral contraceptive
636675|NCT00727636|Gardasil|gardasil
635908|NCT00722761|Acne vulgaris|acne vulgaris
635909|NCT00722774|Vaccine|vaccine
635910|NCT00722774|Influenza|influenza
635911|NCT00722800|YAZ|yaz
635912|NCT00722800|oral contraceptive|oral contraceptive
635913|NCT00722800|hidradenitis suppurativa|hidradenitis suppurativa
635914|NCT00722826|Pulmonary Regurgitation|pulmonary regurgitation
635915|NCT00722826|Tetralogy of Fallot|tetralogy of fallot
635916|NCT00722839|cytomegalovirus infection|cytomegalovirus infection
635917|NCT00722865|Avastin|avastin
635918|NCT00722865|bevacizumab|bevacizumab
635919|NCT00722865|ABVD|abvd
635920|NCT00722865|angiogenesis|angiogenesis
635921|NCT00722865|antiangiogenic|antiangiogenic
635922|NCT00722865|Hodgkin|hodgkin
635923|NCT00722878|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
635924|NCT00722891|Eye Diseases|eye diseases
635925|NCT00722904|post-intervention surveillance of aortic coarctation|post-intervention surveillance of aortic coarctation
635926|NCT00722904|MRA and 2D phase contrast imaging|mra and 2d phase contrast imaging
635927|NCT00722904|4D Flow velocity mapping|4d flow velocity mapping
635928|NCT00722904|Patients undergoing routine post-intervention surveillance of aortic coarctation|patients undergoing routine post-intervention surveillance of aortic coarctation
635929|NCT00722904|Healthy volunteers|healthy volunteers
635930|NCT00722917|Glucose Metabolism Disorder|glucose metabolism disorder
635931|NCT00722917|Dysmetabolic Syndrome|dysmetabolic syndrome
635932|NCT00722917|Type II Diabetes|type ii diabetes
635933|NCT00722917|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
635934|NCT00722917|Dyslipidemia|dyslipidemia
635935|NCT00722917|Drug Therapy|drug therapy
635936|NCT00722930|Follicular Lymphoma|follicular lymphoma
635937|NCT00722930|High-risk FLIPI|high-risk flipi
635938|NCT00722930|R-CHOP|r-chop
635939|NCT00722930|GOTEL|gotel
635940|NCT00722930|Partial|partial
635941|NCT00722930|Complete|complete
635942|NCT00722930|Response|response
635943|NCT00722930|Induction|induction
635944|NCT00722930|Chemotherapy|chemotherapy
635946|NCT00722943|premature|premature
635947|NCT00722943|message|message
635948|NCT00722943|therapy|therapy
635949|NCT00722943|NICU|nicu
635950|NCT00722943|neonatal intensive care unit|neonatal intensive care unit
635951|NCT00722943|cortisol level|cortisol level
635952|NCT00722943|stress|stress
635953|NCT00722943|postnatal|postnatal
635954|NCT00722943|weight gain|weight gain
635955|NCT00722943|DMT|dmt
635956|NCT00722943|Development Message Therapy|development message therapy
635957|NCT00722943|growth|growth
635958|NCT00722956|atorvastatin|atorvastatin
635959|NCT00722956|AZD5672|azd5672
635960|NCT00722969|non-small cell lung cancer|non-small cell lung cancer
635961|NCT00722969|erlotinib|erlotinib
635962|NCT00722969|sorafenib|sorafenib
635963|NCT00722982|coxarthrosis|coxarthrosis
635964|NCT00722982|hip|hip
635965|NCT00722982|RSA|rsa
635966|NCT00722982|DXA|dxa
635967|NCT00722982|C-stem AMT|c-stem amt
635968|NCT00722982|Marathon|marathon
635969|NCT00722995|Morbid obesity|morbid obesity
635970|NCT00722995|Sleeve gastrectomy|sleeve gastrectomy
635971|NCT00722995|Gastric bypass|gastric bypass
635972|NCT00722995|Complications|complications
635974|NCT00722995|Safety|safety
635975|NCT00722995|Compare|compare
635976|NCT00723008|anxiety|anxiety
635977|NCT00723008|insomnia|insomnia
635978|NCT00723008|pain|pain
635979|NCT00723008|Alpha Stim|alpha stim
635980|NCT00723008|Cranial electrotherapy stimulation|cranial electrotherapy stimulation
635981|NCT00723021|Bronchodilator|bronchodilator
635982|NCT00723047|Patients|patients
635983|NCT00723047|CD complicated|cd complicated
635984|NCT00723047|least|least
635985|NCT00723047|One perianal fistula|one perianal fistula
635986|NCT00723047|Draining|draining
635987|NCT00723047|2 months duration|2 months duration
635988|NCT00723073|micafungin, caspofungin, febrile neutropenia|micafungin, caspofungin, febrile neutropenia
635989|NCT00723086|docetaxel, prednisolone, drug combination|docetaxel, prednisolone, drug combination
635990|NCT00723112|Myelodysplastic Syndrome|myelodysplastic syndrome
635991|NCT00723112|Erythropoiesis|erythropoiesis
635992|NCT00723112|Ineffective Hematopoiesis|ineffective hematopoiesis
635993|NCT00723112|Erythroid Progenitors|erythroid progenitors
635994|NCT00723112|Dyserythropoiesis|dyserythropoiesis
635995|NCT00723125|Breast Cancer|breast cancer
635996|NCT00723164|Sevoflurane induction|sevoflurane induction
635997|NCT00723164|Premedication|premedication
635998|NCT00723164|laryngeal mask airway|laryngeal mask airway
635999|NCT00723164|Anesthesia, inhalation [E03.155.197.197]|anesthesia, inhalation [e03.155.197.197]
636000|NCT00723177|opioid withdrawal, analgesia|opioid withdrawal, analgesia
636001|NCT00723190|CLONICEL|clonicel
636002|NCT00723190|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
636003|NCT00723190|clonidine HCl sustained release|clonidine hcl sustained release
636004|NCT00723203|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
636005|NCT00723203|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
636006|NCT00723203|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
636008|NCT00723216|venous thromboembolism|venous thromboembolism
636009|NCT00723216|curative surgery|curative surgery
636010|NCT00723268|Oral ulcers|oral ulcers
636011|NCT00723281|transplant coronary artery disease|transplant coronary artery disease
636012|NCT00723281|CT angiography|ct angiography
636013|NCT00723281|conventional angiography|conventional angiography
636014|NCT00723281|intravascular ultrasound|intravascular ultrasound
636015|NCT00723281|Heart transplant patients with known transplant coronary artery disease|heart transplant patients with known transplant coronary artery disease
636016|NCT00723294|invasive ductal breast carcinoma|invasive ductal breast carcinoma
636017|NCT00723294|male breast cancer|male breast cancer
636018|NCT00723294|stage IA breast cancer|stage ia breast cancer
636019|NCT00723294|stage IB breast cancer|stage ib breast cancer
636020|NCT00723294|stage II breast cancer|stage ii breast cancer
636021|NCT00723307|No diabetes mellitus|no diabetes mellitus
636022|NCT00723307|Elevated waist circumference|elevated waist circumference
636023|NCT00723320|Atherosclerosis|atherosclerosis
636024|NCT00723320|Atorvastatin|atorvastatin
636025|NCT00723320|Therapeutic lifestyle change|therapeutic lifestyle change
636026|NCT00723320|CIMT|cimt
636027|NCT00723320|ABI|abi
636028|NCT00723320|PWV|pwv
636029|NCT00723333|Bone Marrow Transplant|bone marrow transplant
636030|NCT00723333|Myelofibrosis|myelofibrosis
636031|NCT00723333|Stem Cell Transplant|stem cell transplant
636032|NCT00723333|Allogenic Transplant|allogenic transplant
636033|NCT00723346|Relapse|relapse
636034|NCT00723346|Lymphoma lymphoblastic|lymphoma lymphoblastic
636035|NCT00723359|Multiple Myeloma|multiple myeloma
636036|NCT00723359|Refractory|refractory
636037|NCT00723359|Relapsed|relapsed
636038|NCT00723385|cholesterol|cholesterol
636039|NCT00723385|LDL-cholesterol|ldl-cholesterol
636040|NCT00723385|cholecalciferol|cholecalciferol
636041|NCT00723385|lipids|lipids
636042|NCT00723385|C-reactive protein|c-reactive protein
636043|NCT00723398|omega-3 fatty acids|omega-3 fatty acids
636044|NCT00723398|antiestrogens|antiestrogens
636045|NCT00723398|breast cancer prevention|breast cancer prevention
636046|NCT00723398|breast density|breast density
636047|NCT00723398|biomarkers of mammary carcinogenesis|biomarkers of mammary carcinogenesis
636048|NCT00723411|Diabetes|diabetes
636049|NCT00723411|Juvenile Diabetes|juvenile diabetes
636050|NCT00723411|Diabetes type 1|diabetes type 1
636051|NCT00723411|Autoimmune Diabetes|autoimmune diabetes
636052|NCT00723411|Insulin dependent Diabetes|insulin dependent diabetes
636053|NCT00723411|Type 1 diabetes|type 1 diabetes
636054|NCT00723411|Type 1 diabetes mellitus|type 1 diabetes mellitus
636056|NCT00723411|rhGAD65|rhgad65
636057|NCT00723411|GAD|gad
636058|NCT00723411|GAD-alum|gad-alum
636059|NCT00723424|AZD5672|azd5672
636060|NCT00723424|digoxin|digoxin
636061|NCT00723437|nail, psoriasis, NAPSI,acitretin|nail, psoriasis, napsi,acitretin
636062|NCT00723450|Bipolar I pediatric lamictal adolescent|bipolar i pediatric lamictal adolescent
636063|NCT00723476|Quality of Life|quality of life
636064|NCT00723476|Adolescent|adolescent
636065|NCT00723476|Advance Care Planning|advance care planning
636066|NCT00723476|Palliative Care|palliative care
636067|NCT00723476|End-of-Life Care|end-of-life care
636068|NCT00723476|HIV/AIDS|hiv/aids
636069|NCT00723476|Psychological Adjustment|psychological adjustment
636070|NCT00723489|Yellow Fever Vaccine|yellow fever vaccine
636071|NCT00723489|Scarification Method|scarification method
636072|NCT00723489|Atopic Dermatitis|atopic dermatitis
636073|NCT00723489|IgG antibodies|igg antibodies
636074|NCT00723502|Helicobacter pylori|helicobacter pylori
636075|NCT00723502|Eradication|eradication
636076|NCT00723502|Dyspepsia|dyspepsia
636077|NCT00723515|White spot lesion|white spot lesion
636078|NCT00723515|Tooth remineralization|tooth remineralization
636079|NCT00723515|Fluoride varnishes|fluoride varnishes
636080|NCT00723528|Psoriasis|psoriasis
636081|NCT00723528|Ustekinumab|ustekinumab
636082|NCT00723528|CNTO 1275|cnto 1275
636083|NCT00723554|pulmonary arterial hypertension|pulmonary arterial hypertension
636084|NCT00723554|inhaled therapy|inhaled therapy
636085|NCT00723554|power disc-15|power disc-15
636086|NCT00723567|Spectrin Gene|spectrin gene
636087|NCT00723567|Hereditary Elliptocytosis (HE)|hereditary elliptocytosis (he)
636088|NCT00723567|Hereditary Pyropoikilocytosis (HPP)|hereditary pyropoikilocytosis (hpp)
636089|NCT00723567|Genetics|genetics
636090|NCT00723580|Kabuki Syndrome|kabuki syndrome
636091|NCT00723580|Actigraphy|actigraphy
636092|NCT00723580|Treatment Response Measurement|treatment response measurement
636093|NCT00723593|Graft-Versus-Host Disease|graft-versus-host disease
636094|NCT00723593|Gastrointestinal|gastrointestinal
636095|NCT00723593|Apoptotic Assay|apoptotic assay
636096|NCT00723593|Serum Proteomic Pattern Analysis|serum proteomic pattern analysis
636097|NCT00723593|Mucosal Biopsy|mucosal biopsy
636098|NCT00723593|Graft Versus Host Disease|graft versus host disease
636099|NCT00723593|GVHD|gvhd
636100|NCT00723606|Intramuscular ziprasidone, agitation, efficacy and safety|intramuscular ziprasidone, agitation, efficacy and safety
636101|NCT00723619|asthma|asthma
636102|NCT00723619|spirometry|spirometry
636103|NCT00723619|FENO|feno
636104|NCT00723619|normal values for spirometry in childhood|normal values for spirometry in childhood
636105|NCT00723619|normal values for FENO in childhood|normal values for feno in childhood
636106|NCT00723658|Waldenström macroglobulinemia|waldenström macroglobulinemia
636107|NCT00723684|ADHD|adhd
636108|NCT00723684|Children|children
636109|NCT00723684|EEG-Neurofeedback|eeg-neurofeedback
636110|NCT00723697|Subutex|subutex
636111|NCT00723749|Suboxone|suboxone
636112|NCT00723749|Subutex|subutex
636113|NCT00723749|Buprenorphine|buprenorphine
636114|NCT00723749|Naloxone|naloxone
636115|NCT00723762|Valproic acid|valproic acid
636116|NCT00723762|Urea cycle|urea cycle
636117|NCT00723762|Ornithine|ornithine
636118|NCT00723762|Valproate|valproate
636119|NCT00723762|Side effect|side effect
636120|NCT00723775|KALETRA|kaletra
636121|NCT00723775|GSK706769|gsk706769
636122|NCT00723775|HIV|hiv
636123|NCT00723775|healthy volunteers|healthy volunteers
636124|NCT00723788|Appendicitis|appendicitis
636125|NCT00723788|Children|children
636126|NCT00723788|Magnetic Resonance Imaging|magnetic resonance imaging
636127|NCT00723801|Marfan syndrome|marfan syndrome
636128|NCT00723801|Losartan|losartan
636129|NCT00723801|Atenolol|atenolol
636130|NCT00723801|Diastolic Function|diastolic function
636131|NCT00723801|Aortic Stiffness|aortic stiffness
636132|NCT00723814|normal|normal
636133|NCT00723840|EuroQOL (EQ-5D)|euroqol (eq-5d)
636134|NCT00723853|Obesity|obesity
636135|NCT00723853|Type 2 diabetes|type 2 diabetes
636136|NCT00723853|African American children|african american children
636137|NCT00723853|African American youth|african american youth
636138|NCT00723853|Community based|community based
636139|NCT00723853|Family oriented|family oriented
636140|NCT00723853|Obesity & Risk of type 2 diabetes|obesity & risk of type 2 diabetes
636235|NCT00724256|Ceftibuten.|ceftibuten.
636141|NCT00723866|Botulinum toxin, Spasticity, Stroke, Rehabilitation.|botulinum toxin, spasticity, stroke, rehabilitation.
636142|NCT00723905|Crohn's Disease, Rheumatoid Arthritis|crohn's disease, rheumatoid arthritis
636143|NCT00723918|HIV-associated neuropathy|hiv-associated neuropathy
636144|NCT00723918|HIV|hiv
636145|NCT00723918|AIDS|aids
636146|NCT00723918|cannabinoid|cannabinoid
636147|NCT00723918|Cannabis|cannabis
636148|NCT00723918|methadone|methadone
636149|NCT00723918|distal sensory polyneuropathy|distal sensory polyneuropathy
636150|NCT00723918|polyneuropathy|polyneuropathy
636151|NCT00723944|dental implants|dental implants
636152|NCT00723944|Osseotite Certain Prevail|osseotite certain prevail
636153|NCT00723944|Lateralized|lateralized
636154|NCT00723944|non-lateralized|non-lateralized
636155|NCT00723944|Osseotite Certain|osseotite certain
636156|NCT00723944|multicenter|multicenter
636157|NCT00723944|randomized|randomized
636158|NCT00723944|clinical study|clinical study
636159|NCT00723944|partial edentulism|partial edentulism
636160|NCT00723944|single stage|single stage
636161|NCT00723944|early loading|early loading
636162|NCT00723944|crestal bone level|crestal bone level
636163|NCT00723944|short fixed bridge|short fixed bridge
636164|NCT00723970|Major Depressive Disorder|major depressive disorder
636166|NCT00723970|Hot Flashes|hot flashes
636167|NCT00723970|Menopause|menopause
636168|NCT00723970|Quetiapine|quetiapine
636169|NCT00724022|Kidney transplant status|kidney transplant status
636170|NCT00724022|Steroid free|steroid free
636171|NCT00724022|Reduced|reduced
636172|NCT00724022|Calcineurin|calcineurin
636173|NCT00724022|Inhibitor|inhibitor
636174|NCT00724022|Immunosuppression|immunosuppression
636175|NCT00724035|Anesthesia|anesthesia
636176|NCT00724035|Upper extremity|upper extremity
636177|NCT00724035|Nerve block|nerve block
636178|NCT00724035|Ultrasound|ultrasound
636179|NCT00724035|Brachial plexus|brachial plexus
636180|NCT00724048|Huntington Disease|huntington disease
636181|NCT00724061|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
636182|NCT00724061|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
636183|NCT00724061|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
636184|NCT00724061|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
636185|NCT00724061|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
636186|NCT00724061|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
636187|NCT00724061|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
636188|NCT00724061|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
636189|NCT00724061|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
636190|NCT00724061|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
636191|NCT00724074|Arthritis of the knee|arthritis of the knee
636192|NCT00724074|Knee replacement|knee replacement
636193|NCT00724074|Osteoarthritis, knee|osteoarthritis, knee
636194|NCT00724074|Arthroplasty, knee|arthroplasty, knee
636195|NCT00724087|short sleep duration|short sleep duration
636196|NCT00724087|energy expenditure|energy expenditure
636197|NCT00724087|insulin secretion|insulin secretion
636198|NCT00724087|insulin action|insulin action
636199|NCT00724087|lipid turnover|lipid turnover
636676|NCT00727636|vaccine|vaccine
636200|NCT00724087|free fatty acids|free fatty acids
636201|NCT00724100|Malignancy|malignancy
636202|NCT00724100|Solid tumor|solid tumor
636203|NCT00724100|Tubulin inhibitor|tubulin inhibitor
636204|NCT00724113|Shoulder capsulitis|shoulder capsulitis
636205|NCT00724113|ARTHRO distension|arthro distension
636206|NCT00724113|Mobilisation|mobilisation
636207|NCT00724113|Randomised clinical trial|randomised clinical trial
636208|NCT00724126|Diarrhea|diarrhea
636209|NCT00724126|Rifaximin|rifaximin
636211|NCT00724126|Abdominal pain|abdominal pain
636212|NCT00724126|Bloating|bloating
636213|NCT00724152|coping skills|coping skills
636214|NCT00724152|psychology|psychology
636215|NCT00724152|audiology|audiology
636216|NCT00724152|veterans|veterans
636217|NCT00724152|tinnitus|tinnitus
636218|NCT00724152|adult|adult
636219|NCT00724152|intervention studies|intervention studies
636220|NCT00724152|tinnitus, noise induced|tinnitus, noise induced
636221|NCT00724152|noise|noise
636222|NCT00724152|auditory perception|auditory perception
636223|NCT00724165|physical activity|physical activity
636224|NCT00724165|Latinas|latinas
636225|NCT00724178|Pediatric HIV infection, bone mineral content, bone mineral density, Vitamin D, calcium Dual x-ray absorptiometry|pediatric hiv infection, bone mineral content, bone mineral density, vitamin d, calcium dual x-ray absorptiometry
636226|NCT00724204|probiotics|probiotics
636227|NCT00724204|safety|safety
636228|NCT00724204|fecal microbiota|fecal microbiota
636229|NCT00724204|infections|infections
636230|NCT00724256|Pyelonephritis.|pyelonephritis.
636231|NCT00724256|Urinary Tract Infections.|urinary tract infections.
636232|NCT00724256|Children.|children.
636233|NCT00724256|Randomised controlled trial.|randomised controlled trial.
636234|NCT00724256|Therapy.|therapy.
636236|NCT00724269|Contact lens wear|contact lens wear
636237|NCT00724269|multi-purpose solution|multi-purpose solution
636238|NCT00724269|corneal staining|corneal staining
636240|NCT00724282|eszopiclone|eszopiclone
636241|NCT00724282|insulin secretion|insulin secretion
636242|NCT00724282|insulin action|insulin action
636243|NCT00724282|glucose tolerance|glucose tolerance
636244|NCT00724308|Smoking|smoking
636245|NCT00724308|Smoking Cessation|smoking cessation
636246|NCT00724308|Tobacco|tobacco
636247|NCT00724308|Mental Health|mental health
636248|NCT00724321|iloprost|iloprost
636249|NCT00724321|hypoxic|hypoxic
636250|NCT00724321|pulmonary|pulmonary
636251|NCT00724321|vasoconstriction|vasoconstriction
636252|NCT00724321|altitude|altitude
636253|NCT00724334|myelofibrosis|myelofibrosis
636254|NCT00724347|Auditory Perception|auditory perception
636255|NCT00724347|Hearing Loss|hearing loss
636256|NCT00724347|Presbycusis|presbycusis
636257|NCT00724347|Perceptual Learning|perceptual learning
636258|NCT00724347|Hearing Prosthesis|hearing prosthesis
636259|NCT00724347|Speech Discrimination|speech discrimination
636260|NCT00724347|Delayed Treatment|delayed treatment
636261|NCT00724360|relapsed/refractory|relapsed/refractory
636263|NCT00724360|positive|positive
636264|NCT00724360|B-ALL|b-all
636265|NCT00724360|trastuzumab|trastuzumab
636266|NCT00724412|Dry Eye|dry eye
636267|NCT00724412|Corneal Staining|corneal staining
636268|NCT00724438|Contraception|contraception
636269|NCT00724438|Implanon|implanon
636270|NCT00724438|Obesity|obesity
636271|NCT00724438|Blood spots|blood spots
636272|NCT00724438|Implant|implant
636273|NCT00724438|Pharmacokinetics|pharmacokinetics
636274|NCT00724490|Deep Brain Stimulation|deep brain stimulation
636275|NCT00724490|Obsessive Compulsive Disorder|obsessive compulsive disorder
636276|NCT00724490|Nucleus Accumbens|nucleus accumbens
636277|NCT00724503|colon cancer|colon cancer
636278|NCT00724503|Colorectal carcinoma|colorectal carcinoma
636279|NCT00724503|liver metastases|liver metastases
636280|NCT00724503|SIR-Spheres microspheres|sir-spheres microspheres
636281|NCT00724503|yttrium-90|yttrium-90
636282|NCT00724503|FOLFOX|folfox
636283|NCT00724503|bevacizumab|bevacizumab
636284|NCT00724503|metastatic colorectal cancer|metastatic colorectal cancer
636285|NCT00724516|Mammogram|mammogram
636286|NCT00724516|Biopsy|biopsy
636287|NCT00724516|Needle|needle
636288|NCT00724516|Wire|wire
636289|NCT00724516|Localization|localization
636290|NCT00724516|Compression|compression
636291|NCT00724516|Paddle|paddle
636292|NCT00724529|Crohn's Disease|crohn's disease
636293|NCT00724529|Ankylosing Spondylitis|ankylosing spondylitis
636294|NCT00724555|stroke|stroke
636295|NCT00724555|tissue plasminogen activator|tissue plasminogen activator
636296|NCT00724555|tPA|tpa
636297|NCT00724568|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
636298|NCT00724581|Atrial fibrillation, amiodarone|atrial fibrillation, amiodarone
636299|NCT00724594|chorioamnionitis|chorioamnionitis
636300|NCT00724594|maternal chorioamnionitis|maternal chorioamnionitis
636301|NCT00724594|neonatal white matter injury|neonatal white matter injury
636302|NCT00724594|N-acetylcysteine|n-acetylcysteine
636303|NCT00724594|NAC|nac
636304|NCT00724594|anti-oxidant treatment|anti-oxidant treatment
636305|NCT00724607|Concussion, traumatic brain injury|concussion, traumatic brain injury
636306|NCT00724607|Screening|screening
636307|NCT00724607|neuroimaging|neuroimaging
636308|NCT00724607|Posttraumatic stress disorder|posttraumatic stress disorder
636309|NCT00724633|dialysate|dialysate
636310|NCT00724633|sodium|sodium
636311|NCT00724633|hemodialysis|hemodialysis
636312|NCT00724633|blood pressure|blood pressure
636313|NCT00724633|thirst|thirst
636314|NCT00724633|intradialytic symptoms|intradialytic symptoms
636315|NCT00724633|interdialytic weight gain|interdialytic weight gain
636316|NCT00724633|extracellular fluid balance|extracellular fluid balance
636317|NCT00724633|mechanisms|mechanisms
636318|NCT00724646|parents|parents
636319|NCT00724646|medically fragile|medically fragile
636320|NCT00724646|death|death
636321|NCT00724646|end-of-life care|end-of-life care
636322|NCT00724646|surveys|surveys
636323|NCT00724659|Arthrogram|arthrogram
636324|NCT00724659|Contrast|contrast
636325|NCT00724659|Joint|joint
636326|NCT00724659|Ultrasound|ultrasound
636327|NCT00724685|Ropivacaine|ropivacaine
636328|NCT00724685|elastomeric pump|elastomeric pump
636329|NCT00724685|patient controlled analgesia|patient controlled analgesia
636330|NCT00724685|morphine consumption|morphine consumption
636331|NCT00724711|HIV|hiv
636332|NCT00724711|HIV 1|hiv 1
636333|NCT00724724|Stroke|stroke
636334|NCT00724724|Transient Ischemic Attack|transient ischemic attack
636335|NCT00724763|acupuncture, high blood pressure, HRV|acupuncture, high blood pressure, hrv
636336|NCT00724776|Chronic hepatitis C, Albinterferon alfa 2b, phase I, Japan|chronic hepatitis c, albinterferon alfa 2b, phase i, japan
636337|NCT00724789|Neonatal outcome|neonatal outcome
636338|NCT00724789|Congenital malformations|congenital malformations
636339|NCT00724789|In-Vitro fertilization|in-vitro fertilization
636340|NCT00724789|Controlled ovarian stimulation|controlled ovarian stimulation
636341|NCT00724789|Follow-up|follow-up
636342|NCT00724802|babies with canavan disease|babies with canavan disease
636343|NCT00724828|Bacterial otitis media|bacterial otitis media
636344|NCT00724828|pneumoniae|pneumoniae
636345|NCT00724828|sepsis|sepsis
636346|NCT00724828|bacteremia|bacteremia
636347|NCT00724828|meningitis|meningitis
636348|NCT00724828|Streptococcus pneumoniae carriage rate|streptococcus pneumoniae carriage rate
636349|NCT00724867|Systemic Lupus Erythematosus|systemic lupus erythematosus
636350|NCT00724867|Belimumab|belimumab
636351|NCT00724867|SLE|sle
636352|NCT00724867|Antibodies|antibodies
636353|NCT00724867|Lupus|lupus
636354|NCT00724867|Autoimmune Diseases|autoimmune diseases
636355|NCT00724880|coronary artery bypass grafting|coronary artery bypass grafting
636356|NCT00724880|clopidogrel|clopidogrel
636357|NCT00724880|post-operative bleeding|post-operative bleeding
636358|NCT00724906|Essential Tremor|essential tremor
636359|NCT00724906|Parkinsonian Tremor|parkinsonian tremor
636360|NCT00724906|Parkinson Disease|parkinson disease
636361|NCT00724906|Upper Extremity Tremor with duration of less than 2 years|upper extremity tremor with duration of less than 2 years
636362|NCT00724906|Diagnosis|diagnosis
636363|NCT00724906|Subjects|subjects
636364|NCT00724906|Upper|upper
636365|NCT00724906|Extremity|extremity
636366|NCT00724906|Tremor|tremor
636367|NCT00724906|Less|less
636368|NCT00724906|Than 2 years|than 2 years
636369|NCT00724919|ESBL|esbl
636370|NCT00724971|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
636371|NCT00724971|NHL|nhl
636372|NCT00724984|PCI-24781|pci-24781
636373|NCT00724984|Lymphoma|lymphoma
636374|NCT00724984|Hodgkin Disease|hodgkin disease
636375|NCT00724984|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
636376|NCT00724984|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
636377|NCT00724984|Lymphoma, Follicular|lymphoma, follicular
636378|NCT00724984|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
636379|NCT00724984|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
636380|NCT00724984|Lymphoma, Mantle Cell|lymphoma, mantle cell
636381|NCT00724984|Lymphoma, T-Cell, Cutaneous|lymphoma, t-cell, cutaneous
636382|NCT00724984|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
636383|NCT00724997|live attenuated flu vaccines|live attenuated flu vaccines
636384|NCT00724997|Influenza A (H1N1)|influenza a (h1n1)
636385|NCT00724997|intranasally application|intranasally application
636386|NCT00724997|replication-deficient influenza virus|replication-deficient influenza virus
636387|NCT00725023|Pain, chronic pain, tennis elbow, lateral epicondylitis|pain, chronic pain, tennis elbow, lateral epicondylitis
636388|NCT00725049|dental implants|dental implants
636389|NCT00725049|Nanotite Certain implant|nanotite certain implant
636390|NCT00725049|Osseotite|osseotite
636391|NCT00725049|multicenter|multicenter
636392|NCT00725049|randomized|randomized
636393|NCT00725049|clinical study|clinical study
636394|NCT00725049|partial edentulism|partial edentulism
636395|NCT00725049|crestal bone level|crestal bone level
636396|NCT00725049|short fixed bridge|short fixed bridge
636397|NCT00725049|cost analysis|cost analysis
636398|NCT00725062|graft versus host disease|graft versus host disease
636399|NCT00725062|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
636572|NCT00725283|Immunotherapy|immunotherapy
636400|NCT00725062|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
636401|NCT00725062|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
636402|NCT00725062|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
636403|NCT00725062|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
636404|NCT00725062|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
636405|NCT00725062|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
636406|NCT00725062|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
636407|NCT00725062|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
636408|NCT00725062|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
636409|NCT00725062|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
636410|NCT00725062|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
636411|NCT00725062|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
636412|NCT00725062|stage I multiple myeloma|stage i multiple myeloma
636413|NCT00725062|stage II multiple myeloma|stage ii multiple myeloma
636414|NCT00725062|stage III multiple myeloma|stage iii multiple myeloma
636415|NCT00725062|refractory multiple myeloma|refractory multiple myeloma
636416|NCT00725062|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
636417|NCT00725062|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
636418|NCT00725062|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
636419|NCT00725062|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
636420|NCT00725062|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
636421|NCT00725062|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
636422|NCT00725062|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
636423|NCT00725062|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
636424|NCT00725062|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
636425|NCT00725062|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
636426|NCT00725062|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
636427|NCT00725062|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
636428|NCT00725062|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
636429|NCT00725062|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
636430|NCT00725062|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
636431|NCT00725062|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
636432|NCT00725062|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
636433|NCT00725062|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
636434|NCT00725062|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
636435|NCT00725062|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
636436|NCT00725062|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
636437|NCT00725062|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
636438|NCT00725062|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
636439|NCT00725062|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
636440|NCT00725062|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
636441|NCT00725062|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
636442|NCT00725062|splenic marginal zone lymphoma|splenic marginal zone lymphoma
636443|NCT00725062|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
636444|NCT00725062|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
636542|NCT00725166|Genetic markers|genetic markers
636445|NCT00725062|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
636446|NCT00725062|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
636447|NCT00725062|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
636448|NCT00725062|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
636449|NCT00725062|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
636450|NCT00725062|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
636451|NCT00725062|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
636452|NCT00725062|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
636453|NCT00725062|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
636454|NCT00725062|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
636455|NCT00725062|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
636456|NCT00725062|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
636457|NCT00718120|Fluviral|fluviral
636458|NCT00718120|Influenza|influenza
636459|NCT00718133|Asthma|asthma
636460|NCT00718133|Allergy|allergy
636461|NCT00718133|Respiratory|respiratory
636462|NCT00718133|Pollution|pollution
636463|NCT00718133|Children|children
636464|NCT00718133|Air pollution|air pollution
636465|NCT00718146|Influenza|influenza
636466|NCT00718146|Orthomyxoviridae Infections|orthomyxoviridae infections
636467|NCT00718146|Orthomyxoviruses|orthomyxoviruses
636573|NCT00725283|adult|adult
636468|NCT00718146|Split-virion influenza vaccine|split-virion influenza vaccine
636469|NCT00718159|Acute Myeloid Leukemia|acute myeloid leukemia
636470|NCT00718159|Myeloid Leukemia|myeloid leukemia
636471|NCT00718159|Relapsed|relapsed
636472|NCT00718159|Refractory|refractory
636473|NCT00718172|Ribavirin Pretreatment|ribavirin pretreatment
636474|NCT00718172|Gene Expression|gene expression
636475|NCT00718172|Peginterferon|peginterferon
636476|NCT00718172|Hepatitis C|hepatitis c
636477|NCT00718172|Liver Biopsy|liver biopsy
636478|NCT00718172|HCV|hcv
636479|NCT00718185|Sildenafil|sildenafil
636480|NCT00718185|Pediatrics|pediatrics
636481|NCT00718198|Inpatient|inpatient
636482|NCT00718198|Computer Physician Order Entry|computer physician order entry
636483|NCT00718198|Diabetes Mellitus|diabetes mellitus
636484|NCT00718224|Knee surgery|knee surgery
636485|NCT00718224|VTE prevention|vte prevention
636486|NCT00718237|Gastroenteritis|gastroenteritis
636487|NCT00718237|Rotavirus|rotavirus
636488|NCT00718250|Acute myeloid leukaemia|acute myeloid leukaemia
636489|NCT00718250|Cancer vaccines|cancer vaccines
636490|NCT00718250|Immunotherapy|immunotherapy
636491|NCT00718276|Healthy postmenopausal women|healthy postmenopausal women
636492|NCT00718289|Citric acid|citric acid
636493|NCT00718289|citrate|citrate
636494|NCT00718289|acetic acid|acetic acid
636495|NCT00718289|acetate|acetate
636496|NCT00718289|haemodialysis|haemodialysis
636497|NCT00718289|calcium|calcium
636498|NCT00718289|hypotension|hypotension
636499|NCT00718289|haemodynamics|haemodynamics
636500|NCT00718289|Dialysate for Haemodialysis|dialysate for haemodialysis
636501|NCT00718302|Ankle Fractures|ankle fractures
636502|NCT00718302|Displaced Lateral Malleolus Fractures|displaced lateral malleolus fractures
636503|NCT00718302|Antiglide Plating|antiglide plating
636504|NCT00718302|Lateral Plating|lateral plating
636505|NCT00718328|Intracerebral|intracerebral
636506|NCT00718328|Hemorrhage|hemorrhage
636507|NCT00718328|Edema|edema
636508|NCT00718328|Statins|statins
636509|NCT00718341|Fragile X Syndrome, adults, efficacy|fragile x syndrome, adults, efficacy
636510|NCT00718354|Bleeding events|bleeding events
636511|NCT00725075|Negative symptoms|negative symptoms
636512|NCT00725075|Glycine Uptake inhibitor|glycine uptake inhibitor
636513|NCT00725075|Add-on treatment|add-on treatment
636514|NCT00725075|Second Generation Antipsychotic|second generation antipsychotic
636515|NCT00725088|ST-Elevated Myocardial Infarction|st-elevated myocardial infarction
636516|NCT00725088|Exercise Training|exercise training
636517|NCT00725088|Rehabilitation|rehabilitation
636518|NCT00725114|due|due
636519|NCT00725114|cancer|cancer
636520|NCT00725114|treatment|treatment
636521|NCT00725127|Aspirin|aspirin
636522|NCT00725127|Chronotherapy|chronotherapy
636523|NCT00725127|Primary prevention|primary prevention
636524|NCT00725127|Impaired fasting glucose|impaired fasting glucose
636525|NCT00725127|Type 2 diabetes|type 2 diabetes
636526|NCT00725127|Total mortality|total mortality
636527|NCT00725127|Myocardial infarction|myocardial infarction
636528|NCT00725127|Stroke|stroke
636529|NCT00725127|Angina pectoris|angina pectoris
636530|NCT00725127|Chronic kidney disease|chronic kidney disease
636531|NCT00725140|Migraine|migraine
636532|NCT00725140|Early intervention|early intervention
636533|NCT00725140|Primary Care|primary care
636534|NCT00725140|Almotriptan|almotriptan
636535|NCT00725153|Contact lens deposits|contact lens deposits
636536|NCT00725153|Soft contact lenses|soft contact lenses
636537|NCT00725153|Myopia|myopia
636538|NCT00725166|Aging|aging
636539|NCT00725166|Biopsy|biopsy
636540|NCT00725166|Skeletal muscle|skeletal muscle
636541|NCT00725166|Molecular biology|molecular biology
636543|NCT00725166|Gene expression regulation|gene expression regulation
636544|NCT00725166|Young and old men|young and old men
636545|NCT00725166|Healthy volunteers|healthy volunteers
636546|NCT00725179|acetaminophen toxicity|acetaminophen toxicity
636547|NCT00725179|n-acetylcysteine|n-acetylcysteine
636548|NCT00725179|liver toxicity|liver toxicity
636549|NCT00725192|PTSD|ptsd
636550|NCT00725192|Posttraumatic Stress Disorder|posttraumatic stress disorder
636551|NCT00725192|Physical Assault|physical assault
636552|NCT00725192|Physical Abuse|physical abuse
636553|NCT00725192|Sexual Assault|sexual assault
636554|NCT00725192|Sexual Abuse|sexual abuse
636555|NCT00725192|Interpersonal Assault|interpersonal assault
636556|NCT00725192|Cognitive Processing Therapy|cognitive processing therapy
636557|NCT00725192|Sleep Impairment|sleep impairment
636558|NCT00725192|Insomnia|insomnia
636559|NCT00725192|Hypnosis|hypnosis
636561|NCT00725218|Postoperative pain|postoperative pain
636562|NCT00725218|Analgesia|analgesia
636563|NCT00725218|Abortion|abortion
636564|NCT00725231|T cell lymphoma|t cell lymphoma
636565|NCT00725244|Radiation Injuries|radiation injuries
636566|NCT00725244|Telangiectasis|telangiectasis
636567|NCT00725244|Bipolar Eletrocoagulation|bipolar eletrocoagulation
636568|NCT00725244|Argon Plasma Coagulation|argon plasma coagulation
636569|NCT00725283|Leukemia|leukemia
636570|NCT00725283|ASCI|asci
636571|NCT00725283|Complete remission|complete remission
636574|NCT00725283|Acute Myeloid Leukemia|acute myeloid leukemia
636575|NCT00725283|Tumor antigen|tumor antigen
636576|NCT00725283|WT1|wt1
636577|NCT00725309|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
636578|NCT00725309|COPD|copd
636579|NCT00725309|Elastin|elastin
636580|NCT00725309|ELN|eln
636581|NCT00725335|ischemia|ischemia
636582|NCT00725335|liver cancer|liver cancer
636583|NCT00725335|radical excision|radical excision
636584|NCT00725335|prognosis|prognosis
636585|NCT00725348|Psoriasis|psoriasis
636586|NCT00725400|Colorectal Cancer|colorectal cancer
636587|NCT00725400|Erbitux|erbitux
636588|NCT00725400|Cetuximab|cetuximab
636589|NCT00725400|Surgery|surgery
636590|NCT00725400|Radiation|radiation
636591|NCT00727324|Ulcerative Colitis|ulcerative colitis
636592|NCT00727324|UC|uc
636593|NCT00727324|moderate|moderate
636594|NCT00727324|severe|severe
636595|NCT00727324|LPS|lps
636596|NCT00727324|Alkaline Phosphatase|alkaline phosphatase
636597|NCT00727324|AP|ap
636598|NCT00727324|BIAP|biap
636599|NCT00727324|Mucositis|mucositis
636600|NCT00727337|auditory perception|auditory perception
636601|NCT00727337|rehabilitation of hearing impaired|rehabilitation of hearing impaired
636602|NCT00727350|NSCLC|nsclc
636603|NCT00727350|Novalis|novalis
636604|NCT00727350|Stereotactic|stereotactic
636605|NCT00727350|SBRT|sbrt
636606|NCT00727350|T1, T2 or T3NO NSCLC|t1, t2 or t3no nsclc
636607|NCT00727363|probiotics|probiotics
636608|NCT00727363|lactobacillus reuteri|lactobacillus reuteri
636609|NCT00727363|preterm infants|preterm infants
636610|NCT00727363|nosocomial infection|nosocomial infection
636708|NCT00727766|Clofarabine|clofarabine
636611|NCT00727363|necrotizing enterocolitis|necrotizing enterocolitis
636612|NCT00727376|esophageal|esophageal
636613|NCT00727376|stenting|stenting
636614|NCT00727389|Prevention|prevention
636615|NCT00727389|Quality of Health Care|quality of health care
636616|NCT00727389|Health Care Evaluation Mechanisms|health care evaluation mechanisms
636617|NCT00727415|advanced or progressive chronic lymphocytic leukemia|advanced or progressive chronic lymphocytic leukemia
636618|NCT00727415|Lenalidomide|lenalidomide
636619|NCT00727415|Fludarabine|fludarabine
636620|NCT00727428|FluLaval® TF|flulaval® tf
636621|NCT00727428|Safety|safety
636622|NCT00727428|Immunogenicity|immunogenicity
636623|NCT00727428|Influenza|influenza
636624|NCT00727441|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
636625|NCT00727441|stage I pancreatic cancer|stage i pancreatic cancer
636626|NCT00727441|stage II pancreatic cancer|stage ii pancreatic cancer
636627|NCT00727454|Obstructive sleep apnea|obstructive sleep apnea
636628|NCT00727454|CPAP|cpap
636629|NCT00727454|Heart remodeling|heart remodeling
636630|NCT00727454|Cardiovascular disease|cardiovascular disease
636631|NCT00727454|MRI|mri
636632|NCT00727467|auditory cueing device|auditory cueing device
636633|NCT00727467|Parkinson's disease|parkinson's disease
636634|NCT00727467|freezing|freezing
636635|NCT00727467|gait|gait
636636|NCT00727467|mobility|mobility
636637|NCT00727480|vascularity|vascularity
636638|NCT00727480|fingertips|fingertips
636639|NCT00727493|osteoporosis,|osteoporosis,
636640|NCT00727493|bisphosphonate|bisphosphonate
636641|NCT00727493|therapy|therapy
636642|NCT00727493|dental implant|dental implant
636643|NCT00727519|Hemodialysis|hemodialysis
636644|NCT00727519|Nephrology|nephrology
636645|NCT00727519|Pomegranate Juice|pomegranate juice
636646|NCT00727519|Israel|israel
636647|NCT00727532|clear cell renal cell carcinoma|clear cell renal cell carcinoma
636648|NCT00727532|hereditary clear cell renal cell carcinoma|hereditary clear cell renal cell carcinoma
636649|NCT00727532|recurrent renal cell cancer|recurrent renal cell cancer
636650|NCT00727532|stage I renal cell cancer|stage i renal cell cancer
636651|NCT00727532|stage II renal cell cancer|stage ii renal cell cancer
636652|NCT00727532|stage III renal cell cancer|stage iii renal cell cancer
636653|NCT00727532|stage IV renal cell cancer|stage iv renal cell cancer
636654|NCT00727558|refractive error|refractive error
636655|NCT00727571|Anemia|anemia
636656|NCT00727571|Chronic Kidney Disease|chronic kidney disease
636657|NCT00727571|Quality of Life|quality of life
636658|NCT00727571|CKD|ckd
636659|NCT00727571|Chronic Renal Insufficiency|chronic renal insufficiency
636660|NCT00727584|spinal cord compression|spinal cord compression
636661|NCT00727584|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
636662|NCT00727610|Adverse drug event|adverse drug event
636663|NCT00727610|harm|harm
636664|NCT00727610|patient safety|patient safety
636665|NCT00727610|clinical decision support|clinical decision support
636666|NCT00727610|Adverse drug related event|adverse drug related event
636667|NCT00727623|acute coronary syndrome|acute coronary syndrome
636668|NCT00727623|myocardial infarction|myocardial infarction
636669|NCT00727623|predictors of mortality|predictors of mortality
636670|NCT00727623|reperfusion therapy|reperfusion therapy
636671|NCT00727636|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
636672|NCT00727636|immunogenicity|immunogenicity
636673|NCT00727636|safety|safety
636674|NCT00727636|HPV|hpv
636677|NCT00727649|fecal incontinence|fecal incontinence
636678|NCT00727649|adults|adults
636679|NCT00727649|diarrhea|diarrhea
636680|NCT00727662|Breast Cancer|breast cancer
636681|NCT00727662|Fatigue|fatigue
636682|NCT00727662|Proinflammatory Cytokines|proinflammatory cytokines
636683|NCT00727662|Physical functioning|physical functioning
636684|NCT00727662|Quality of life|quality of life
636685|NCT00727675|chronic pain|chronic pain
636686|NCT00727675|opioid dependence|opioid dependence
636687|NCT00727675|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
636688|NCT00727701|varicose ulcer|varicose ulcer
636689|NCT00727701|veteran|veteran
636690|NCT00727701|recurrence|recurrence
636691|NCT00727701|aftercare|aftercare
636692|NCT00727714|Cement dust exposure|cement dust exposure
636693|NCT00727714|Cross-shift study|cross-shift study
636694|NCT00727714|Lung function indices|lung function indices
636695|NCT00727714|Exhaled nitric oxide|exhaled nitric oxide
636696|NCT00727714|Serum inflammatory markers|serum inflammatory markers
636697|NCT00727727|Piribedil (trade name: Clarium)|piribedil (trade name: clarium)
636698|NCT00727727|non-ergot dopamine agonist|non-ergot dopamine agonist
636699|NCT00727727|Morbus Parkinson|morbus parkinson
636700|NCT00727727|Tolerability|tolerability
636701|NCT00727727|Efficacy|efficacy
636702|NCT00727727|Post Marketing Surveillance|post marketing surveillance
636703|NCT00727740|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
636704|NCT00727740|Pancreatitis|pancreatitis
636705|NCT00727740|Indomethacin|indomethacin
636706|NCT00727753|Macular Degeneration|macular degeneration
636707|NCT00727753|Age-Related Maculopathies|age-related maculopathies
636709|NCT00727766|Clolar|clolar
636710|NCT00727766|AML|aml
636711|NCT00727766|Consolidation|consolidation
636712|NCT00727779|diabetes, metabolic syndrome, type 2 diabetes|diabetes, metabolic syndrome, type 2 diabetes
636713|NCT00727792|participants|participants
636714|NCT00727792|scheduled|scheduled
636715|NCT00727792|clinically|clinically
636716|NCT00727792|ordered|ordered
636717|NCT00727792|MRI|mri
636718|NCT00727831|neurotoxicity|neurotoxicity
636719|NCT00727831|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
636720|NCT00727831|mucositis|mucositis
636721|NCT00727831|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
636722|NCT00727831|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
636723|NCT00727831|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
636724|NCT00727831|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
636725|NCT00727831|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
636726|NCT00727831|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
636727|NCT00727844|XDR-TB|xdr-tb
636728|NCT00727844|Linezolid|linezolid
636729|NCT00727844|Drug Resistance|drug resistance
636730|NCT00727844|Computed Tomography|computed tomography
636731|NCT00727844|Pharmacokinetics|pharmacokinetics
636732|NCT00727844|Tuberculosis|tuberculosis
636733|NCT00727844|Drug Resistance Tuberculosis|drug resistance tuberculosis
636734|NCT00727844|MDR-TB|mdr-tb
636735|NCT00727857|Glucose Metabolism Disorder|glucose metabolism disorder
636736|NCT00727857|Dysmetabolic Syndrome|dysmetabolic syndrome
636737|NCT00727857|Type II Diabetes|type ii diabetes
636738|NCT00727857|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
636739|NCT00727857|Dyslipidemia|dyslipidemia
636740|NCT00727857|Drug Therapy|drug therapy
636741|NCT00727870|Shave Biopsy management|shave biopsy management
636742|NCT00727870|"Biopsy/adverse effects[Mesh]"|"biopsy/adverse effects[mesh]"
636743|NCT00727870|"Biopsy/complications[Mesh])"|"biopsy/complications[mesh])"
636744|NCT00727883|Breast Cancer|breast cancer
636745|NCT00727883|Adjuvant TAM|adjuvant tam
636746|NCT00727883|post-menopausal|post-menopausal
636747|NCT00727883|women|women
636748|NCT00727896|Life style modification,|life style modification,
636749|NCT00727896|Type 2 diabetes,|type 2 diabetes,
636750|NCT00727896|SMS,|sms,
636751|NCT00727896|Patient adherence|patient adherence
636752|NCT00727909|Hearing loss|hearing loss
636753|NCT00727909|Hearing Aids|hearing aids
636754|NCT00727909|Speech Perception|speech perception
636755|NCT00727909|Persons with Hearing Impairment|persons with hearing impairment
636756|NCT00727922|Neuropathy|neuropathy
636757|NCT00727922|Oxaliplatin|oxaliplatin
636758|NCT00727922|Mangafodipir|mangafodipir
636759|NCT00727935|Women|women
636760|NCT00727935|parturients|parturients
636761|NCT00727935|with|with
636762|NCT00727935|realization|realization
636763|NCT00727935|episiotomy|episiotomy
636764|NCT00727948|Breast cancer|breast cancer
636765|NCT00727948|Angiogenesis|angiogenesis
636766|NCT00727948|Aspirin|aspirin
636767|NCT00727948|Tamoxifen|tamoxifen
636768|NCT00727974|Genome Wide Scan (GWS)|genome wide scan (gws)
636769|NCT00727974|Mitochondrial scan|mitochondrial scan
636770|NCT00727974|Family trios|family trios
636771|NCT00727987|Rheumatoid arthritis|rheumatoid arthritis
636772|NCT00727987|Fully Human anti-TNFa monoclonal antibody|fully human anti-tnfa monoclonal antibody
636775|NCT00728000|Pancreatic Cancer|pancreatic cancer
636776|NCT00728013|Acute coronary syndrome|acute coronary syndrome
636777|NCT00728013|intensive lipid-lowering|intensive lipid-lowering
636778|NCT00728013|statins|statins
636779|NCT00728026|Chart must reveal the following procedures:|chart must reveal the following procedures:
636780|NCT00728026|Heart rate variability,|heart rate variability,
636781|NCT00728026|Deep Breathing Test,|deep breathing test,
636782|NCT00728026|Valsalva maneuver,|valsalva maneuver,
636783|NCT00728026|Table test,|table test,
636784|NCT00728026|Thermoregulatory Sweat Testing,|thermoregulatory sweat testing,
636785|NCT00728026|Quantitative Sudomotor Axon Reflex Test (QSART),|quantitative sudomotor axon reflex test (qsart),
636786|NCT00728026|Vital signs,|vital signs,
636787|NCT00728026|postural changes in heart rate and blood pressure,|postural changes in heart rate and blood pressure,
636788|NCT00728026|composite autonomic score|composite autonomic score
636789|NCT00728039|Youth|youth
636790|NCT00728039|Consensus|consensus
636791|NCT00728039|Criteria|criteria
636792|NCT00728039|CVS|cvs
636793|NCT00728052|Tolerability|tolerability
636794|NCT00728052|dose escalation|dose escalation
636795|NCT00728052|GSK598809|gsk598809
636796|NCT00728052|Pharmacodynamics|pharmacodynamics
636797|NCT00728052|Safety|safety
636798|NCT00728052|single|single
636799|NCT00728052|placebo|placebo
636800|NCT00728052|Smokers|smokers
636801|NCT00728052|Pharmacokinetics|pharmacokinetics
636802|NCT00728078|hepatocellular carcinoma|hepatocellular carcinoma
636803|NCT00728078|liver cancer|liver cancer
636804|NCT00728078|radiofrequency ablation|radiofrequency ablation
636805|NCT00728078|thalidomide|thalidomide
636806|NCT00728091|aquaretic|aquaretic
636807|NCT00728091|SIADH|siadh
636808|NCT00728104|Learn|learn
636809|NCT00728104|L-Carnitine|l-carnitine
636810|NCT00728104|Co-enzyme Q10|co-enzyme q10
636811|NCT00728104|Effective|effective
636812|NCT00728104|These supplements|these supplements
636813|NCT00728104|Compared|compared
636814|NCT00728104|Standard|standard
636815|NCT00728117|indomethacin|indomethacin
636816|NCT00728117|ibuprofen|ibuprofen
636817|NCT00728117|preterm infant|preterm infant
636818|NCT00728130|carcinoma|carcinoma
636819|NCT00728130|upper|upper
636820|NCT00728130|aerodigestive|aerodigestive
636821|NCT00728130|tract|tract
636822|NCT00728130|submandibular|submandibular
636823|NCT00728130|gland|gland
636824|NCT00728156|Type 2 Diabetes mellitus|type 2 diabetes mellitus
636825|NCT00728156|Coronary artery disease|coronary artery disease
636826|NCT00728156|Platelet dependent thrombogenicity|platelet dependent thrombogenicity
636827|NCT00728156|Aspirin|aspirin
636828|NCT00728156|Clopidogrel|clopidogrel
636829|NCT00728156|Badimon Chamber|badimon chamber
636830|NCT00728169|Asthma|asthma
636831|NCT00728169|Focus Group|focus group
636832|NCT00728169|Community Based Participatory Research|community based participatory research
636834|NCT00728182|Vascular cognitive impairment|vascular cognitive impairment
636835|NCT00728182|Coiling|coiling
636836|NCT00728182|Endovascular repair|endovascular repair
636837|NCT00728182|Brain aneurysm|brain aneurysm
636838|NCT00728182|NA-1|na-1
636839|NCT00728195|Schizophrenia|schizophrenia
636840|NCT00728195|Central Nervous System|central nervous system
636841|NCT00728195|JNJ-37822681|jnj-37822681
636842|NCT00728208|Young|young
636843|NCT00728208|Elderly|elderly
636844|NCT00728208|Randomised|randomised
636845|NCT00728208|GSK372475|gsk372475
636846|NCT00728221|Ginseng|ginseng
636847|NCT00728221|Korean Red Ginseng|korean red ginseng
636848|NCT00728221|Ginsenoside|ginsenoside
636849|NCT00728221|Flow Mediated Dilation|flow mediated dilation
636850|NCT00728221|Endothelial Function|endothelial function
636851|NCT00728221|Hypertension|hypertension
636852|NCT00728234|aEEG|aeeg
636853|NCT00728234|preterm infants|preterm infants
636854|NCT00728234|predictive value|predictive value
636855|NCT00728234|outcome|outcome
636856|NCT00728247|Cervical Spine|cervical spine
636857|NCT00728247|Kinematics|kinematics
636858|NCT00728247|Manipulation|manipulation
636859|NCT00728247|Biomechanics|biomechanics
636860|NCT00728260|Meningitis|meningitis
636861|NCT00728260|Meningococcal disease|meningococcal disease
636862|NCT00728260|Menactra vaccine|menactra vaccine
636863|NCT00728273|Efficacy|efficacy
636864|NCT00728273|Vietnam|vietnam
636865|NCT00728273|school children|school children
636866|NCT00728273|anemia|anemia
636867|NCT00728273|fortification|fortification
636868|NCT00728273|micronutrient|micronutrient
636869|NCT00728286|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
636870|NCT00728286|Acute Coronary Syndrome|acute coronary syndrome
636871|NCT00728286|Platelet dependent thrombogenicity|platelet dependent thrombogenicity
636872|NCT00728299|Coronary artery disease, carotid intima-media thickness|coronary artery disease, carotid intima-media thickness
636873|NCT00728312|Methamphetamine|methamphetamine
636874|NCT00728312|Therapeutics|therapeutics
636875|NCT00728312|Psychopharmacology|psychopharmacology
636876|NCT00728312|Amphetamine|amphetamine
636877|NCT00728325|PTSD|ptsd
637556|NCT00722293|Soft Tissue|soft tissue
636878|NCT00728325|Vocational Rehabilitation|vocational rehabilitation
636879|NCT00728325|Supported Employment|supported employment
636880|NCT00728338|docosahexenoic acid (DHA)|docosahexenoic acid (dha)
636881|NCT00728338|dietary supplement|dietary supplement
636882|NCT00728338|n-3 polyunsaturated fatty acid|n-3 polyunsaturated fatty acid
636883|NCT00728338|cardiovascular disease|cardiovascular disease
636884|NCT00728351|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
636885|NCT00728364|Anderson Fabry disease|anderson fabry disease
636886|NCT00728364|chronic kidney disease|chronic kidney disease
636887|NCT00728364|prevalence|prevalence
636888|NCT00728377|gestational diabetes|gestational diabetes
636889|NCT00728377|physical activity|physical activity
636890|NCT00728377|behavior change|behavior change
636891|NCT00728377|glucose tolerance|glucose tolerance
636892|NCT00728377|pregnancy|pregnancy
636893|NCT00728390|advanced cancer refractory advanced non-small cell lung cancer|advanced cancer refractory advanced non-small cell lung cancer
636894|NCT00728429|cardiac toxicity|cardiac toxicity
636895|NCT00728429|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
636896|NCT00728429|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
636897|NCT00728442|Clinical practice guidelines|clinical practice guidelines
636898|NCT00728442|Guideline adherence|guideline adherence
636899|NCT00728442|Clinical decision support systems|clinical decision support systems
636900|NCT00728442|Randomized controlled trial|randomized controlled trial
636901|NCT00728442|Intervention study|intervention study
636902|NCT00728468|Phase 1|phase 1
636903|NCT00728468|PF-00299804|pf-00299804
636904|NCT00728468|Dextromethorphan|dextromethorphan
636905|NCT00728468|CYP2D6 Inhibition|cyp2d6 inhibition
636906|NCT00728468|Cancer Patients|cancer patients
636907|NCT00728507|Tuberculosis|tuberculosis
636908|NCT00728507|Moxifloxacin|moxifloxacin
636909|NCT00728507|Rifapentine|rifapentine
636910|NCT00728520|Leukemia|leukemia
636911|NCT00728520|Azacitidine|azacitidine
636912|NCT00728520|Untreated|untreated
636913|NCT00728520|Elderly|elderly
636914|NCT00728533|Prostate Cancer requiring Androgen Ablation Therapy|prostate cancer requiring androgen ablation therapy
636915|NCT00728546|tuberculosis|tuberculosis
636916|NCT00728546|isoniazid|isoniazid
636917|NCT00728546|Arylamine N-acetyl transferase|arylamine n-acetyl transferase
636918|NCT00728546|genotyping|genotyping
636919|NCT00728546|hepatotoxicity|hepatotoxicity
636920|NCT00728546|pharmacogenetics|pharmacogenetics
636921|NCT00728559|laparoscopy|laparoscopy
636922|NCT00728559|preemptive|preemptive
636923|NCT00728559|postoperative|postoperative
636924|NCT00728559|pain|pain
636925|NCT00728559|trocar|trocar
636926|NCT00728559|site|site
636927|NCT00728585|mucositis|mucositis
636928|NCT00728585|graft versus host disease|graft versus host disease
636929|NCT00728585|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
636930|NCT00728585|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
636931|NCT00728585|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
636932|NCT00728585|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
636933|NCT00728585|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
638249|NCT00733928|Knee,|knee,
636934|NCT00728585|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
636935|NCT00728585|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
636936|NCT00728585|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
636937|NCT00728585|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
636938|NCT00728585|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
636939|NCT00728585|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
636940|NCT00728585|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
636941|NCT00728585|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
636942|NCT00728585|secondary acute myeloid leukemia|secondary acute myeloid leukemia
636943|NCT00728585|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
636944|NCT00728585|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
636945|NCT00728585|disseminated neuroblastoma|disseminated neuroblastoma
636946|NCT00728585|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
636947|NCT00728585|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
636948|NCT00728585|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
636949|NCT00728585|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
636950|NCT00728585|recurrent neuroblastoma|recurrent neuroblastoma
636951|NCT00728585|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
636952|NCT00728585|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
636953|NCT00728585|stage I multiple myeloma|stage i multiple myeloma
636954|NCT00728585|stage II multiple myeloma|stage ii multiple myeloma
636955|NCT00728585|stage III multiple myeloma|stage iii multiple myeloma
636956|NCT00728585|refractory multiple myeloma|refractory multiple myeloma
636957|NCT00728585|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
636958|NCT00728585|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
636959|NCT00728585|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
636960|NCT00728585|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
636961|NCT00728585|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
636962|NCT00728585|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
636963|NCT00728585|stage IIIA breast cancer|stage iiia breast cancer
636964|NCT00728585|stage IIIB breast cancer|stage iiib breast cancer
636965|NCT00728585|stage IIIC breast cancer|stage iiic breast cancer
636966|NCT00728585|stage IV breast cancer|stage iv breast cancer
636967|NCT00728585|recurrent breast cancer|recurrent breast cancer
636968|NCT00728598|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
636969|NCT00728598|Angiogenesis|angiogenesis
636970|NCT00728598|Vitreous levels|vitreous levels
636971|NCT00728598|Vascular endothelial growth factor|vascular endothelial growth factor
636972|NCT00728598|Fractalkine|fractalkine
636973|NCT00728598|Growth factor|growth factor
636974|NCT00728624|Antibiotic susceptibility; beta lactamase; ESBLs|antibiotic susceptibility; beta lactamase; esbls
636975|NCT00728637|Prevention|prevention
636976|NCT00728650|hepatocellular carcinoma|hepatocellular carcinoma
636977|NCT00728650|colorectal carcinoma metastatic to liver|colorectal carcinoma metastatic to liver
636978|NCT00728650|primary liver cancer|primary liver cancer
636979|NCT00728663|adenocarcinoma of the prostate|adenocarcinoma of the prostate
636980|NCT00728663|recurrent prostate cancer|recurrent prostate cancer
636981|NCT00728663|stage IV prostate cancer|stage iv prostate cancer
636983|NCT00728676|Phe,|phe,
636984|NCT00728676|PAH,|pah,
636985|NCT00728676|Kuvan,|kuvan,
636986|NCT00728676|Trp,|trp,
636987|NCT00728676|Tyr|tyr
636988|NCT00728689|Orthopoxviral|orthopoxviral
636989|NCT00728689|Smallpox|smallpox
636990|NCT00728689|Monkey pox|monkey pox
636991|NCT00728715|Budesonide|budesonide
636992|NCT00728715|Formoterol|formoterol
636993|NCT00728715|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
636994|NCT00728728|pregnenolone|pregnenolone
636995|NCT00728728|schizophrenia|schizophrenia
636996|NCT00728728|cognitive|cognitive
636997|NCT00728728|positive symptom|positive symptom
636998|NCT00728728|negative symptom|negative symptom
636999|NCT00728728|placebo control|placebo control
637000|NCT00728741|Neural Networks|neural networks
637001|NCT00728741|Cortical Activation|cortical activation
637002|NCT00728741|Strategy|strategy
637003|NCT00728741|fMRI|fmri
637004|NCT00728741|Healthy Volunteer|healthy volunteer
637005|NCT00728741|HV|hv
637006|NCT00728754|dental implants|dental implants
637007|NCT00728754|Osseotite Certain Prevail|osseotite certain prevail
637008|NCT00728754|Lateralized|lateralized
637010|NCT00728754|Osseotite Certain|osseotite certain
637011|NCT00728754|multicenter|multicenter
637012|NCT00728754|randomized|randomized
637013|NCT00728754|clinical study|clinical study
637014|NCT00728754|partial edentulism|partial edentulism
637015|NCT00728754|single stage|single stage
637016|NCT00728754|early loading|early loading
637017|NCT00728754|crestal bone level|crestal bone level
637018|NCT00728754|short fixed bridge|short fixed bridge
637019|NCT00728767|Heavy drinking|heavy drinking
637020|NCT00728767|Brief intervention|brief intervention
637021|NCT00728767|Alcohol prevention|alcohol prevention
637022|NCT00728767|Randomized trial|randomized trial
637023|NCT00728767|Motivational interviewing|motivational interviewing
637024|NCT00728767|Intervention Studies|intervention studies
637025|NCT00728767|prevention & control|prevention & control
637026|NCT00728780|Adverse events|adverse events
637027|NCT00728780|Pharmacokinetic variables|pharmacokinetic variables
637028|NCT00728793|Advanced Solid Tumors|advanced solid tumors
637029|NCT00728793|EGFR|egfr
637030|NCT00728793|HDAC|hdac
637031|NCT00728793|Her2|her2
637032|NCT00728793|Open-Label|open-label
637033|NCT00728793|Dose-Escalation|dose-escalation
637034|NCT00728806|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
637035|NCT00728806|Ultrafiltration failure|ultrafiltration failure
637036|NCT00728806|Biomarker|biomarker
637037|NCT00728806|Proteomics|proteomics
637038|NCT00728819|Inpatients|inpatients
637039|NCT00728819|Requiring|requiring
637040|NCT00728819|DL PICC|dl picc
637041|NCT00728819|Access|access
637042|NCT00728819|Medications|medications
637043|NCT00728819|Blood|blood
637044|NCT00728832|extended release epidural morphine|extended release epidural morphine
637045|NCT00728832|morphine|morphine
637046|NCT00728832|thoracic epidural|thoracic epidural
637047|NCT00728832|pharmacokinetics|pharmacokinetics
637048|NCT00728832|pharmacodynamics|pharmacodynamics
637049|NCT00728832|postoperative pain|postoperative pain
637050|NCT00728832|upper abdominal surgery|upper abdominal surgery
637051|NCT00728845|adenocarcinoma of the lung|adenocarcinoma of the lung
637052|NCT00728845|large cell lung cancer|large cell lung cancer
637053|NCT00728845|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
637054|NCT00728845|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
637055|NCT00728845|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
637056|NCT00728858|Hypertension|hypertension
637057|NCT00728858|SNP|snp
637058|NCT00728858|Nifedipine|nifedipine
637059|NCT00728858|Barnidipine|barnidipine
637060|NCT00728871|cervical cancer, HPV, immunity|cervical cancer, hpv, immunity
637061|NCT00728884|dental implants|dental implants
637062|NCT00728884|Certain Prevail|certain prevail
637063|NCT00728884|multicenter|multicenter
637064|NCT00728884|clinical study|clinical study
637065|NCT00728884|partial edentulism|partial edentulism
637066|NCT00728884|total edentulism|total edentulism
637067|NCT00728884|platform switching|platform switching
637068|NCT00728884|single stage|single stage
637069|NCT00728884|early loading|early loading
637070|NCT00728884|crestal bone level|crestal bone level
637071|NCT00728884|single tooth replacements|single tooth replacements
637072|NCT00728884|short or long fixed bridges|short or long fixed bridges
637073|NCT00728884|overdenture|overdenture
637074|NCT00728884|fixed denture|fixed denture
637075|NCT00728897|Healthy volunteer|healthy volunteer
637076|NCT00728897|relative bioavailability.|relative bioavailability.
637077|NCT00728910|Low HDL cholesterol|low hdl cholesterol
637078|NCT00728910|High triglycerides|high triglycerides
637079|NCT00728910|niacin|niacin
637080|NCT00728910|fibrate|fibrate
637081|NCT00728923|OCD|ocd
637082|NCT00728936|Hepatitis C|hepatitis c
637083|NCT00728936|unresponsive to pegylated interferon and ribavirin therapy|unresponsive to pegylated interferon and ribavirin therapy
637084|NCT00728936|HCV|hcv
637085|NCT00728949|breast cancer|breast cancer
637086|NCT00728949|Postmenopausal|postmenopausal
637087|NCT00728949|Hormones|hormones
637088|NCT00728949|Antiestrogen|antiestrogen
637089|NCT00728962|dental implants|dental implants
637090|NCT00728962|Osseotite Certain Prevail|osseotite certain prevail
637091|NCT00728962|multicenter|multicenter
637092|NCT00728962|observational|observational
637093|NCT00728962|clinical study|clinical study
637094|NCT00728962|partial edentulism|partial edentulism
637095|NCT00728962|single stage|single stage
637096|NCT00728962|immediate occlusal loading|immediate occlusal loading
637097|NCT00728962|crestal bone level|crestal bone level
637098|NCT00728962|short fixed bridge|short fixed bridge
637099|NCT00728975|constipation|constipation
637100|NCT00728975|cancer|cancer
637101|NCT00728975|palliative care|palliative care
637102|NCT00728975|terminal|terminal
637103|NCT00728975|bowel|bowel
637104|NCT00728988|Asia Lipitor Pre-treatment in Acute Coronary Syndrome|asia lipitor pre-treatment in acute coronary syndrome
637105|NCT00729001|Rotavirus Gastroenteritis|rotavirus gastroenteritis
637106|NCT00729001|Human rotavirus vaccine|human rotavirus vaccine
637107|NCT00729014|herbal nephropathy|herbal nephropathy
637108|NCT00729014|Chinese herbal nephropathy|chinese herbal nephropathy
637109|NCT00729014|nephrotoxicity|nephrotoxicity
637110|NCT00729014|renal disease|renal disease
637111|NCT00729014|adverse drug reaction|adverse drug reaction
637112|NCT00729014|Chinese herbal medicine|chinese herbal medicine
637113|NCT00729027|hypercholesterolemia|hypercholesterolemia
637114|NCT00729040|heart|heart
637115|NCT00729040|weight|weight
637116|NCT00729040|Overweight|overweight
637117|NCT00729040|bmi|bmi
637118|NCT00729040|diabetes|diabetes
637119|NCT00729040|type 2|type 2
637120|NCT00729040|diabetic|diabetic
637121|NCT00729040|walk|walk
637122|NCT00729040|walk*|walk*
637123|NCT00729040|diab*|diab*
637124|NCT00729040|obese|obese
637125|NCT00729040|exercise|exercise
637126|NCT00729040|activity|activity
637127|NCT00729040|coronary|coronary
637128|NCT00729040|pedometer|pedometer
637129|NCT00729053|renal|renal
637130|NCT00729053|cell|cell
637131|NCT00729053|renal carcinoma|renal carcinoma
637132|NCT00729053|metastatic|metastatic
637133|NCT00729053|recurrent|recurrent
637134|NCT00729053|treatment naive|treatment naive
637135|NCT00729079|Diabetes Prevention|diabetes prevention
637136|NCT00729079|Pre-Diabetes|pre-diabetes
637137|NCT00729079|Exercise|exercise
637138|NCT00729079|Fat Intake|fat intake
637139|NCT00729079|Fasting blood sugar|fasting blood sugar
637140|NCT00729079|tobacco cessation|tobacco cessation
637141|NCT00729092|PET SCAN|pet scan
637142|NCT00729092|PAIN LEVELS|pain levels
637143|NCT00729118|stage I multiple myeloma|stage i multiple myeloma
637144|NCT00729118|stage II multiple myeloma|stage ii multiple myeloma
637145|NCT00729118|stage III multiple myeloma|stage iii multiple myeloma
637146|NCT00729118|refractory multiple myeloma|refractory multiple myeloma
637147|NCT00729131|Ozone, TNF, TNF promoter polymorphism, airway hyperresponsiveness.|ozone, tnf, tnf promoter polymorphism, airway hyperresponsiveness.
637148|NCT00729144|fecal incontinence|fecal incontinence
637149|NCT00729144|bowel incontinence|bowel incontinence
637150|NCT00729144|pelvic floor disorder|pelvic floor disorder
637151|NCT00729170|Milk|milk
637152|NCT00729170|Calcium|calcium
637153|NCT00729170|Weight loss|weight loss
637154|NCT00729170|Bone density|bone density
637155|NCT00729170|Appetite|appetite
637156|NCT00729196|Obesity|obesity
637157|NCT00729196|Type 2 Diabetes|type 2 diabetes
637158|NCT00729196|Glycemic Load|glycemic load
637159|NCT00729196|Weight Loss|weight loss
637160|NCT00729196|Glycated Hemoglobin|glycated hemoglobin
637161|NCT00729235|Slow VT, CRT-D, ATP therapy|slow vt, crt-d, atp therapy
637162|NCT00729235|Incidence|incidence
637163|NCT00729235|of slow VTs|of slow vts
637164|NCT00729235|in CRT-D patients|in crt-d patients
637165|NCT00729235|Clinical|clinical
637166|NCT00729235|relevance|relevance
637167|NCT00729235|treatment|treatment
637168|NCT00729235|VTs|vts
637170|NCT00729235|2-years|2-years
637171|NCT00729235|follow-up|follow-up
637172|NCT00729248|Transplants|transplants
637173|NCT00729248|Kidney Transplantation|kidney transplantation
637174|NCT00729248|Immunosuppression|immunosuppression
637175|NCT00729248|Assay|assay
637176|NCT00729248|Graft Rejection|graft rejection
637177|NCT00729261|mechanical ventilation|mechanical ventilation
637178|NCT00729261|extubation|extubation
637179|NCT00729261|outcomes|outcomes
637180|NCT00729261|brain injury|brain injury
637181|NCT00729287|stage 0 bladder cancer|stage 0 bladder cancer
637182|NCT00729287|stage I bladder cancer|stage i bladder cancer
637183|NCT00729287|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
637184|NCT00729300|cocaine|cocaine
637185|NCT00729300|disulfiram|disulfiram
637186|NCT00729300|antabuse|antabuse
637187|NCT00729300|addiction|addiction
637188|NCT00729300|stimulant|stimulant
637189|NCT00729313|Treatment|treatment
637190|NCT00729326|diabetes|diabetes
637191|NCT00729326|exenatide|exenatide
637192|NCT00729326|sitagliptin|sitagliptin
637193|NCT00729326|Amylin|amylin
637194|NCT00729326|Lilly|lilly
637195|NCT00729326|metformin|metformin
637196|NCT00729326|thiazolidinedione|thiazolidinedione
637197|NCT00729339|Gastroesophageal reflux disease|gastroesophageal reflux disease
637198|NCT00729339|Mosapride|mosapride
637199|NCT00729339|Lansoprazole|lansoprazole
637200|NCT00729352|NQO1, ozone, airway mucociliary clearance.|nqo1, ozone, airway mucociliary clearance.
637201|NCT00729365|Urine albumin excretion rates|urine albumin excretion rates
637202|NCT00729365|Nighttime and daytime blood pressure|nighttime and daytime blood pressure
637203|NCT00729365|Endothelial Dysfunction|endothelial dysfunction
637204|NCT00729391|HIV|hiv
637205|NCT00729391|Sexual Risk|sexual risk
637206|NCT00729391|Substance Abuse|substance abuse
637207|NCT00729391|Victimization|victimization
637208|NCT00729391|Violence|violence
637209|NCT00729391|Voluntary Counseling and Testing (VCT)|voluntary counseling and testing (vct)
637210|NCT00729404|Female Contraception|female contraception
637211|NCT00729404|Ovulation Inhibition|ovulation inhibition
637212|NCT00729417|incontinence|incontinence
637213|NCT00729417|obstetric risk factors|obstetric risk factors
637215|NCT00729417|of age 18|of age 18
637216|NCT00729417|above|above
637217|NCT00729430|Heart Attack|heart attack
637218|NCT00729430|Sudden Cardiac Death|sudden cardiac death
637219|NCT00729430|Peri-infarct Zone|peri-infarct zone
637220|NCT00729430|Omega-3 Fatty Acids|omega-3 fatty acids
637221|NCT00729430|Biological Markers|biological markers
637222|NCT00729430|Cytogenetic Analysis|cytogenetic analysis
637223|NCT00729430|Cardiac Arrest|cardiac arrest
637224|NCT00729443|Single dose|single dose
637225|NCT00729443|Phase 1|phase 1
637226|NCT00729443|Safety of AZD3241|safety of azd3241
637227|NCT00729443|tolerability of AZD3241|tolerability of azd3241
637228|NCT00729456|Diabetes|diabetes
637229|NCT00729456|Education|education
637230|NCT00729456|Ulcer|ulcer
637231|NCT00729456|Foot|foot
637232|NCT00729456|Behaviour|behaviour
637233|NCT00729469|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
637234|NCT00729469|Menopausal symptoms|menopausal symptoms
637235|NCT00729469|Vaginal atrophy|vaginal atrophy
637236|NCT00729469|Urogenital atrophy|urogenital atrophy
637237|NCT00729482|RAD001 (everolimus)|rad001 (everolimus)
637238|NCT00729482|second-line treatment|second-line treatment
637239|NCT00729482|advanced gastric cancer|advanced gastric cancer
637240|NCT00729495|Phase I,|phase i,
637241|NCT00729495|Healthy|healthy
637242|NCT00729495|Volunteer|volunteer
637243|NCT00729495|Study|study
637244|NCT00729508|Cat allergy|cat allergy
637245|NCT00729508|Immunotherapy|immunotherapy
637246|NCT00729508|Cat-PAD|cat-pad
637247|NCT00729508|Environmental Exposure Chamber|environmental exposure chamber
637248|NCT00729521|Fall injury hospitalization|fall injury hospitalization
637249|NCT00729521|Fall injury emergency department visit|fall injury emergency department visit
637250|NCT00729521|Fall injury death|fall injury death
637251|NCT00729534|Perception|perception
637252|NCT00729534|Focus Group|focus group
637253|NCT00729534|Perception of Clinical Research Participation|perception of clinical research participation
637254|NCT00729547|Depression|depression
637255|NCT00729547|Biofeedback|biofeedback
637256|NCT00729547|Psychophysiology|psychophysiology
637257|NCT00729560|PCOS|pcos
637258|NCT00729573|Microbicide|microbicide
637259|NCT00729573|HIV Seronegativity|hiv seronegativity
637260|NCT00729573|Bone Mineral Density|bone mineral density
637261|NCT00729612|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
637262|NCT00729612|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
637263|NCT00729612|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
637264|NCT00729612|squamous cell lung cancer|squamous cell lung cancer
637265|NCT00729625|stroke, rehabilitation, robotics|stroke, rehabilitation, robotics
637266|NCT00729638|relapsed multiple myeloma|relapsed multiple myeloma
637267|NCT00729638|refractory multiple myeloma|refractory multiple myeloma
637268|NCT00729638|RAD001|rad001
637269|NCT00729638|lenalidomide|lenalidomide
637270|NCT00729677|nausea and vomiting|nausea and vomiting
637271|NCT00729677|colon cancer|colon cancer
637272|NCT00729677|rectal cancer|rectal cancer
637273|NCT00729690|Pregabalin|pregabalin
637274|NCT00729690|CSF|csf
637275|NCT00729690|Neurotransmitter|neurotransmitter
637276|NCT00729703|ICD|icd
637277|NCT00729703|Minimized|minimized
637278|NCT00729703|ventricular|ventricular
637279|NCT00729703|pacing|pacing
637280|NCT00729703|indication|indication
637281|NCT00729703|Clinical outcome|clinical outcome
637282|NCT00729703|Inappropriate shock|inappropriate shock
637283|NCT00729716|Microfracture|microfracture
637284|NCT00729716|Cartilage repair|cartilage repair
637285|NCT00729716|Autologous chondrocyte implantation|autologous chondrocyte implantation
637286|NCT00729729|Comparative|comparative
637287|NCT00729729|bioavailability|bioavailability
637288|NCT00729729|of PCA|of pca
637289|NCT00729729|formulations|formulations
637290|NCT00729755|Creatine|creatine
637291|NCT00729755|Augmentation|augmentation
637292|NCT00729755|Major Depressive Disorder|major depressive disorder
637293|NCT00729755|Efficacy|efficacy
637294|NCT00729755|Brain Energy Metabolism|brain energy metabolism
637295|NCT00729768|Renal transplant|renal transplant
637296|NCT00729768|Raptiva|raptiva
637297|NCT00729781|nasal obstruction|nasal obstruction
637298|NCT00729781|airway resistance|airway resistance
637299|NCT00729781|soft tissue collapse|soft tissue collapse
637300|NCT00729781|cosmetic contour deformity|cosmetic contour deformity
637301|NCT00729794|Vasopressin|vasopressin
637302|NCT00729794|Epinephrine|epinephrine
637303|NCT00729794|Adrenal Cortex Hormones|adrenal cortex hormones
637304|NCT00729794|Heart Arrest|heart arrest
637305|NCT00729807|recurrent melanoma|recurrent melanoma
637306|NCT00721240|responder|responder
637307|NCT00721240|leucotriene antagonist|leucotriene antagonist
637308|NCT00721253|ReSTOR|restor
637309|NCT00721305|Type 1 human immunodeficiency virus infection|type 1 human immunodeficiency virus infection
637310|NCT00721305|Lovastatin|lovastatin
637311|NCT00721305|Adaptive Immunity|adaptive immunity
637312|NCT00721305|Cellular cholesterol|cellular cholesterol
637313|NCT00721305|Rho GTPases|rho gtpases
637314|NCT00721305|Lymphocyte function-associated antigen-1|lymphocyte function-associated antigen-1
637315|NCT00721318|chronic widespread pain|chronic widespread pain
637316|NCT00721318|fibromyalgia|fibromyalgia
637317|NCT00721318|rheumatoid arthritis|rheumatoid arthritis
637319|NCT00721331|CombinatoRx|combinatorx
637320|NCT00721331|Atopic|atopic
637321|NCT00721331|Dermatitis|dermatitis
637322|NCT00721331|Topical|topical
637323|NCT00721331|CRx-197|crx-197
637324|NCT00721331|Normal Healthy Volunteers|normal healthy volunteers
637325|NCT00721344|Healthy males and females|healthy males and females
637326|NCT00721357|muscles|muscles
637327|NCT00721357|work|work
637328|NCT00721357|Magnetic Resonance Imaging|magnetic resonance imaging
637329|NCT00721357|control groups|control groups
637330|NCT00721370|sentinel lymph node mapping|sentinel lymph node mapping
637331|NCT00721370|breast cancer|breast cancer
637332|NCT00721370|near infrared imaging|near infrared imaging
637333|NCT00721383|caregiving, Alzheimer's disease, physical activity|caregiving, alzheimer's disease, physical activity
637334|NCT00721396|Meningococcal disease,|meningococcal disease,
637335|NCT00721396|Neisseria meningitidis serogroup B,|neisseria meningitidis serogroup b,
637336|NCT00721396|Prevention,|prevention,
637337|NCT00721396|Vaccination,|vaccination,
637338|NCT00721396|Infants|infants
637339|NCT00721409|hormone-receptor positive advanced breast cancer|hormone-receptor positive advanced breast cancer
637340|NCT00721422|Pharmacokinetics of PD 0332334 in subjects with renal insufficiency|pharmacokinetics of pd 0332334 in subjects with renal insufficiency
637341|NCT00721448|Pharmacokinetics|pharmacokinetics
637342|NCT00721461|Assess|assess
637343|NCT00721461|Tolerability|tolerability
637344|NCT00721461|MedPulser DDS device|medpulser dds device
637345|NCT00721487|C. albicans|c. albicans
637346|NCT00721487|fluconazole|fluconazole
637347|NCT00721513|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
637348|NCT00721513|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
637349|NCT00721513|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
637350|NCT00721513|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
637351|NCT00721513|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
637352|NCT00721513|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
637353|NCT00721513|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
637354|NCT00721513|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
637355|NCT00721526|alcohol dependence|alcohol dependence
637356|NCT00721526|alcoholism|alcoholism
637357|NCT00721526|anxiety disorder|anxiety disorder
637358|NCT00721526|pharmacotherapy|pharmacotherapy
637359|NCT00721526|disulfiram|disulfiram
637360|NCT00721526|lorazepam|lorazepam
637361|NCT00721552|beta-cell function|beta-cell function
637362|NCT00721552|glucocorticoid-induced diabetes|glucocorticoid-induced diabetes
637363|NCT00721552|glucocorticoid|glucocorticoid
637364|NCT00721552|DPP-4 inhibitors|dpp-4 inhibitors
637365|NCT00721552|sitagliptin|sitagliptin
637366|NCT00721552|diabetes mellitus|diabetes mellitus
637367|NCT00721552|steroid diabetes|steroid diabetes
637368|NCT00721552|insulin resistance|insulin resistance
637369|NCT00721552|insulin sensitivity|insulin sensitivity
637370|NCT00721565|Breast Cancer|breast cancer
637371|NCT00721565|Exercise|exercise
637372|NCT00721565|Social Cognitive Theory|social cognitive theory
637373|NCT00721565|Adherence|adherence
637374|NCT00721565|Symptoms|symptoms
637375|NCT00721565|Body Composition|body composition
637376|NCT00721578|Observational study|observational study
637377|NCT00721578|Effectiveness|effectiveness
637379|NCT00721578|Tolerability|tolerability
637380|NCT00721578|Systemic Fungal Infection|systemic fungal infection
637381|NCT00721591|Recurrent Pregnancy Loss|recurrent pregnancy loss
637382|NCT00721591|Habitual abortion|habitual abortion
637383|NCT00721591|Fetal demise|fetal demise
637384|NCT00721591|Antiphospholipid antibodies|antiphospholipid antibodies
637485|NCT00722020|HFCWO|hfcwo
637385|NCT00721591|Inherited thrombophilia|inherited thrombophilia
637386|NCT00721604|shock|shock
637387|NCT00721604|fluid responsiveness|fluid responsiveness
637388|NCT00721604|volume expansion|volume expansion
637389|NCT00721630|CAPECITABINE|capecitabine
637390|NCT00721630|LAPATINIB|lapatinib
637391|NCT00721643|Angelica keiskei|angelica keiskei
637392|NCT00721643|absorption kinetics|absorption kinetics
637393|NCT00721643|quercetin|quercetin
637394|NCT00721656|Dry eye syndromes|dry eye syndromes
637395|NCT00721656|Corneal diseases|corneal diseases
637396|NCT00721656|Conjunctival Diseases|conjunctival diseases
637397|NCT00721669|solid tumor|solid tumor
637398|NCT00721682|Pediatry|pediatry
637399|NCT00721682|Ill-treatment|ill-treatment
637400|NCT00721682|Pain|pain
637401|NCT00721682|maltreated children|maltreated children
637402|NCT00721695|Cataract|cataract
637403|NCT00721695|Cataract Extraction|cataract extraction
637404|NCT00721695|Lens Implantation|lens implantation
637405|NCT00721695|Phacoemulsification|phacoemulsification
637406|NCT00721708|histidine dipeptides|histidine dipeptides
637407|NCT00721708|carnosine|carnosine
637408|NCT00721708|anserine|anserine
637409|NCT00721721|Dietary Sodium|dietary sodium
637410|NCT00721721|Dietary Potassium|dietary potassium
637411|NCT00721721|Genes|genes
637412|NCT00721721|Genomics|genomics
637413|NCT00721734|Myeloma|myeloma
637414|NCT00721734|Renal Insufficiency|renal insufficiency
637415|NCT00721734|Proteasome|proteasome
637416|NCT00721734|Hematological|hematological
637417|NCT00721734|carfilzomib|carfilzomib
637418|NCT00721734|PR-171|pr-171
752371|NCT01172704|Motivational Interviewing|motivational interviewing
637419|NCT00721747|breast cancer patients her2 negative pathological responses|breast cancer patients her2 negative pathological responses
637420|NCT00721760|Hip fractures|hip fractures
637421|NCT00721760|Heparin Low-Molecular-Weight|heparin low-molecular-weight
637422|NCT00721760|Randomized Controlled Trial|randomized controlled trial
637423|NCT00721773|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
637424|NCT00721773|Angiotensin-converting Enzyme Inhibitor|angiotensin-converting enzyme inhibitor
637425|NCT00721773|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
637426|NCT00721773|Renin angiotensin system inhibitor|renin angiotensin system inhibitor
637427|NCT00721773|Residual Renal Function|residual renal function
637428|NCT00721786|Smoking cessation|smoking cessation
637429|NCT00721786|Cigarette smoking|cigarette smoking
637430|NCT00721786|Tobacco smoking|tobacco smoking
637431|NCT00721786|Internet interventions|internet interventions
637432|NCT00721786|Spanish-speaking|spanish-speaking
637433|NCT00721799|Positron-Emission Tomography|positron-emission tomography
637434|NCT00721812|pharmacokinetics|pharmacokinetics
637435|NCT00721812|Phase 1|phase 1
637436|NCT00721812|first time in humans|first time in humans
637438|NCT00721812|safety|safety
637439|NCT00721812|human volunteers|human volunteers
637440|NCT00721825|Stroke|stroke
637441|NCT00721825|Cerebral infarct|cerebral infarct
637442|NCT00721825|Rehabilitation|rehabilitation
637443|NCT00721825|Double blind Randomized|double blind randomized
637444|NCT00721825|Placebo controlled|placebo controlled
637445|NCT00721825|Traditional Chinese Medicine|traditional chinese medicine
637446|NCT00721825|Neuroaid|neuroaid
637447|NCT00721838|adolescent obesity|adolescent obesity
637448|NCT00721838|eating behavior|eating behavior
637449|NCT00721838|dietary intake|dietary intake
637450|NCT00721864|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
637451|NCT00721864|PIG-A Mutation|pig-a mutation
637452|NCT00721864|Prion Protein|prion protein
637453|NCT00721864|Hematopoietic stem cells|hematopoietic stem cells
637454|NCT00721864|Clonal disorder|clonal disorder
637455|NCT00721890|chemoprevention|chemoprevention
637456|NCT00721890|green tea|green tea
637457|NCT00721890|relapse free-survival|relapse free-survival
637458|NCT00721890|proteases|proteases
637459|NCT00721929|adrenal glands, adrenal masses|adrenal glands, adrenal masses
637460|NCT00721955|Bipolar 1 disorder,|bipolar 1 disorder,
637461|NCT00721955|agitation,|agitation,
637462|NCT00721955|acute,|acute,
637463|NCT00721955|treatment|treatment
637464|NCT00721968|Open angle|open angle
637465|NCT00721968|Glaucoma|glaucoma
637466|NCT00721968|Cataract|cataract
637467|NCT00721968|Surgery|surgery
637468|NCT00721981|patient preference|patient preference
637469|NCT00721981|oncology|oncology
637470|NCT00721981|chemotherapy|chemotherapy
637471|NCT00721981|NSCLC|nsclc
637472|NCT00721994|hip resurfacing|hip resurfacing
637473|NCT00721994|osteoarthritis|osteoarthritis
637474|NCT00721994|avascular necrosis|avascular necrosis
637475|NCT00721994|rheumatoid arthritis|rheumatoid arthritis
637476|NCT00722007|hip resurfacing|hip resurfacing
637477|NCT00722007|osteoarthritis|osteoarthritis
637478|NCT00722007|avascular necrosis|avascular necrosis
637479|NCT00722007|rheumatoid arthritis|rheumatoid arthritis
637480|NCT00722020|Asthma|asthma
637481|NCT00722020|Bronchial Disease|bronchial disease
637482|NCT00722020|Status Asthmaticus|status asthmaticus
637483|NCT00722020|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
637484|NCT00722020|the Vest|the vest
637486|NCT00722033|preterm|preterm
637487|NCT00722033|aEEG|aeeg
637488|NCT00722033|apneas|apneas
637489|NCT00722033|surfactant|surfactant
637490|NCT00722033|indomethacin|indomethacin
637491|NCT00722033|aminophyline|aminophyline
637492|NCT00722046|Alzheimer's disease|alzheimer's disease
637493|NCT00722046|antibody|antibody
637494|NCT00722046|amyloid|amyloid
637495|NCT00722072|male breast cancer|male breast cancer
637496|NCT00722072|stage IIIA breast cancer|stage iiia breast cancer
637497|NCT00722072|stage IIIB breast cancer|stage iiib breast cancer
637498|NCT00722072|stage IIIC breast cancer|stage iiic breast cancer
637499|NCT00722072|stage IV breast cancer|stage iv breast cancer
637500|NCT00722072|recurrent breast cancer|recurrent breast cancer
637501|NCT00722085|Amniotic Fluid Sludge|amniotic fluid sludge
637502|NCT00722085|Cerclage|cerclage
637503|NCT00722085|Ultrasound|ultrasound
637504|NCT00722085|Preterm Delivery|preterm delivery
637505|NCT00722085|Neonatal|neonatal
637506|NCT00722098|Melanoma|melanoma
637507|NCT00722098|Dendritic Cell|dendritic cell
637508|NCT00722098|Vaccine|vaccine
637509|NCT00722098|Immunotherapy|immunotherapy
637510|NCT00722098|Cyclophosphamide|cyclophosphamide
637511|NCT00722111|tongue|tongue
637512|NCT00722111|pressure|pressure
637513|NCT00722124|tobacco use|tobacco use
637514|NCT00722124|cigarettes|cigarettes
637515|NCT00722124|smokers|smokers
637516|NCT00722150|Artesunate|artesunate
637517|NCT00722150|Plasmodium Falciparum|plasmodium falciparum
637518|NCT00722150|Cambodia|cambodia
637519|NCT00722163|Cognitive Behavioural therapy|cognitive behavioural therapy
637520|NCT00722163|Psychosis|psychosis
637521|NCT00722176|Schizophrenia|schizophrenia
637522|NCT00722189|Mycoses|mycoses
637523|NCT00722215|Endothelin antagonist|endothelin antagonist
637524|NCT00722215|Chronic kidney disease|chronic kidney disease
637525|NCT00722215|Proteinuria|proteinuria
637526|NCT00722215|Cardiovascular disease|cardiovascular disease
637527|NCT00722215|Blood pressure|blood pressure
637528|NCT00722215|Arterial stiffness|arterial stiffness
637529|NCT00722215|Endothelial function|endothelial function
637530|NCT00722241|Continuous Glucose Monitoring|continuous glucose monitoring
637531|NCT00722241|Interstitial Fluid|interstitial fluid
637532|NCT00722241|Diabetes Mellitus|diabetes mellitus
637533|NCT00722254|Myeloproliferative Disorder|myeloproliferative disorder
637534|NCT00722254|Primary Myelofibrosis|primary myelofibrosis
637535|NCT00722254|Primary Pulmonary Hypertension|primary pulmonary hypertension
637536|NCT00722254|Secondary Myelofibrosis|secondary myelofibrosis
637537|NCT00722254|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
637538|NCT00722254|Flolan|flolan
637539|NCT00722254|Clonality|clonality
637540|NCT00722254|CD34+ cells|cd34+ cells
637541|NCT00722254|Hematologic abnormalities|hematologic abnormalities
637542|NCT00722267|severe COPD|severe copd
637543|NCT00722267|COPD symptoms|copd symptoms
637544|NCT00722267|variability of symptoms|variability of symptoms
637545|NCT00722267|patient's perception|patient's perception
637546|NCT00722280|Amputation, upper limb, composite tissue, immunosuppression|amputation, upper limb, composite tissue, immunosuppression
637547|NCT00722293|Solid tumors|solid tumors
637548|NCT00722293|Cancer|cancer
637549|NCT00722293|Neoplasms, Ovarian|neoplasms, ovarian
637550|NCT00722293|doxorubicin|doxorubicin
637551|NCT00722293|epirubicin|epirubicin
637552|NCT00722293|anti-angiogenesis|anti-angiogenesis
637553|NCT00722293|pharmacodynamics|pharmacodynamics
637554|NCT00722293|pazopanib (GW786034)|pazopanib (gw786034)
637555|NCT00722293|pharmacokinetics|pharmacokinetics
637558|NCT00722306|non-restorative|non-restorative
637559|NCT00722306|sleep|sleep
637560|NCT00722319|oral anticoagulation|oral anticoagulation
637561|NCT00722319|warfarin|warfarin
637562|NCT00722319|percutaneous coronary intervention|percutaneous coronary intervention
637563|NCT00722319|stent|stent
637564|NCT00722319|antiplatelet agents|antiplatelet agents
637565|NCT00722332|HBIG (Hepatitis B Immune Globulin)|hbig (hepatitis b immune globulin)
637566|NCT00722332|Chronic Hepatitis B Recurrence|chronic hepatitis b recurrence
637567|NCT00722332|Liver Transplant|liver transplant
637568|NCT00722345|Obesity|obesity
637569|NCT00722345|Physical activity|physical activity
637570|NCT00722345|Adolescents|adolescents
637571|NCT00722345|Exercise counseling intervention|exercise counseling intervention
637572|NCT00722384|AMD|amd
637573|NCT00722384|Macular Degeneration|macular degeneration
637574|NCT00722384|Opko Health|opko health
637575|NCT00722384|Acuity Pharmaceuticals|acuity pharmaceuticals
637576|NCT00722384|bevasiranib|bevasiranib
637577|NCT00722384|Cand5|cand5
637578|NCT00722384|Age-Related|age-related
637579|NCT00722397|genetics, pediatrics|genetics, pediatrics
637580|NCT00722410|Carbapenem|carbapenem
637581|NCT00722410|resistant|resistant
637582|NCT00722410|Klebsiella pneumoniae|klebsiella pneumoniae
637583|NCT00722410|Carpapenemases|carpapenemases
637584|NCT00722410|Probiotics|probiotics
637585|NCT00722410|VSL3|vsl3
637586|NCT00722423|Hepatitis C|hepatitis c
637587|NCT00722423|integrated care|integrated care
637588|NCT00722423|alpha interferon|alpha interferon
637589|NCT00722423|mental health|mental health
637590|NCT00722436|antifibrinolytic, tranexamic acid|antifibrinolytic, tranexamic acid
637591|NCT00722462|Infertility|infertility
637592|NCT00722462|IVF|ivf
637593|NCT00722462|Acupuncture|acupuncture
637594|NCT00722475|recurrent miscarriage|recurrent miscarriage
637595|NCT00722475|immunology|immunology
637596|NCT00722475|intravenous immunoglobulin|intravenous immunoglobulin
637597|NCT00722475|miscarriage|miscarriage
637598|NCT00722527|Primary Familial and Congenital Polycythemia|primary familial and congenital polycythemia
637599|NCT00722527|Polycythemia|polycythemia
637600|NCT00722527|Molecular Biology|molecular biology
637601|NCT00722527|Genetics|genetics
637602|NCT00722527|Erythropoiesis|erythropoiesis
637603|NCT00722527|EPOR mutation|epor mutation
637604|NCT00722527|Thrombocytosis|thrombocytosis
637605|NCT00722527|Hypoxia|hypoxia
637606|NCT00729820|PERSONALITY|personality
637607|NCT00729820|COGNITIVE PERFORMANCE|cognitive performance
751797|NCT01170494|vitamin D2, vitamin D3, 25 Oh vitamin D2, 25 Oh vitamin D3|vitamin d2, vitamin d3, 25 oh vitamin d2, 25 oh vitamin d3
637608|NCT00729820|the practical usefulness (validity) of processing speed, accuracy of performance and personality measures in predicting impulsive behavior|the practical usefulness (validity) of processing speed, accuracy of performance and personality measures in predicting impulsive behavior
637609|NCT00729846|choroidal neovascularization|choroidal neovascularization
637610|NCT00729846|macular degeneration|macular degeneration
637611|NCT00729846|macular edema|macular edema
637612|NCT00729846|intravitreal bevacizumab|intravitreal bevacizumab
637613|NCT00729846|vegf|vegf
637614|NCT00729846|verteporfin PDT|verteporfin pdt
637615|NCT00729859|HDL|hdl
637616|NCT00729859|Insulin sensitivity|insulin sensitivity
637617|NCT00729859|testosterone|testosterone
637618|NCT00729859|estradiol|estradiol
637619|NCT00729859|cholesterol|cholesterol
637620|NCT00729872|AG011|ag011
637621|NCT00729872|Ulcerative Colitis|ulcerative colitis
637622|NCT00729872|human Interleukin-10|human interleukin-10
637623|NCT00729885|Vertigo|vertigo
637624|NCT00729885|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
637625|NCT00729885|BPPV|bppv
637626|NCT00729885|Positional Vertigo|positional vertigo
637627|NCT00729911|Atrial fibrillation Ablation|atrial fibrillation ablation
637628|NCT00729924|Raltegravir|raltegravir
637629|NCT00729924|CSF|csf
637630|NCT00729924|ABCB1 SNP|abcb1 snp
637631|NCT00729924|HIV/AIDS|hiv/aids
637632|NCT00729937|Methicillin, Staphylococcus aureus, MRSA|methicillin, staphylococcus aureus, mrsa
637633|NCT00729976|Ibuprofen|ibuprofen
637634|NCT00729976|Suppository|suppository
637635|NCT00729976|febrile children|febrile children
637636|NCT00729989|Meconium Aspiration|meconium aspiration
637637|NCT00729989|Respiratory Distress|respiratory distress
637638|NCT00729989|Meconium Stained Amniotic Fluid|meconium stained amniotic fluid
637639|NCT00730002|Lupus|lupus
637640|NCT00730028|Methicillin-resistant Staphylococcus aureus (MRSA), cellulitis, abscess, children, elderly|methicillin-resistant staphylococcus aureus (mrsa), cellulitis, abscess, children, elderly
637641|NCT00730041|obstructive sleep apnea|obstructive sleep apnea
637642|NCT00730041|continuous positive air pressure|continuous positive air pressure
637643|NCT00730054|Remifentanil|remifentanil
637644|NCT00730054|clonidine|clonidine
637645|NCT00730054|acute pain|acute pain
637646|NCT00730054|respiration|respiration
637647|NCT00730054|sedation|sedation
637648|NCT00730054|cognitive function|cognitive function
637649|NCT00730067|COPD|copd
637650|NCT00730067|Pulmonary hypertension|pulmonary hypertension
637651|NCT00730067|Sildenafil|sildenafil
637652|NCT00730067|NT-pro BNP|nt-pro bnp
637653|NCT00730067|apelin|apelin
637654|NCT00730080|phenylketonuria|phenylketonuria
637655|NCT00730080|sapropterin|sapropterin
637658|NCT00730080|executive abilities|executive abilities
637659|NCT00730080|brain|brain
637660|NCT00730093|Vitamin B12 absorption|vitamin b12 absorption
637661|NCT00730093|Pregnancy|pregnancy
637662|NCT00730106|Gastroesophageal reflux disease|gastroesophageal reflux disease
637663|NCT00730106|Alarm symptoms|alarm symptoms
637664|NCT00730106|Gastrointestinal endoscopy|gastrointestinal endoscopy
637665|NCT00730119|Non-invasive Blood Pressure (NIBP)|non-invasive blood pressure (nibp)
637666|NCT00730119|GE Monitor|ge monitor
637667|NCT00730119|Temperature|temperature
637668|NCT00730119|SpO2|spo2
637669|NCT00730119|Respiration, ECG|respiration, ecg
637670|NCT00730145|pharmacokinetics, PD-0332334, hemodialysis, renal dialysis|pharmacokinetics, pd-0332334, hemodialysis, renal dialysis
637671|NCT00731601|shock|shock
637672|NCT00731601|peptic ulcer bleeding|peptic ulcer bleeding
637673|NCT00731601|rebleeding|rebleeding
637674|NCT00731614|cognitive therapy|cognitive therapy
637675|NCT00731614|mirror training|mirror training
637676|NCT00731614|nondirective therapy|nondirective therapy
637677|NCT00731614|veterans|veterans
637678|NCT00731614|amputees|amputees
637679|NCT00731627|intracranial aneurysm|intracranial aneurysm
637680|NCT00731640|AcrySof|acrysof
637681|NCT00731640|ReSTOR|restor
637682|NCT00731640|Multifocal|multifocal
637683|NCT00731640|Intraocular Lens|intraocular lens
637684|NCT00731653|depression|depression
637685|NCT00731653|combination|combination
637686|NCT00731666|penile length|penile length
637687|NCT00731666|IPP|ipp
637688|NCT00731666|Erectile dysfunction|erectile dysfunction
637689|NCT00731679|IBS|ibs
637690|NCT00731679|Abdominal pain|abdominal pain
637691|NCT00731679|Bloating|bloating
637692|NCT00731679|Diarrhea|diarrhea
637693|NCT00731679|Rifaximin|rifaximin
637694|NCT00731692|FTY720, primary progressive multiple sclerosis,PPMS|fty720, primary progressive multiple sclerosis,ppms
637695|NCT00731718|Head Lice|head lice
637696|NCT00731770|COPD|copd
637697|NCT00731770|sleep|sleep
637698|NCT00731770|daytime somnolence|daytime somnolence
637699|NCT00731783|Abscesses|abscesses
637700|NCT00731783|Furunculosis|furunculosis
637701|NCT00731783|Staphylococcus aureus colonization|staphylococcus aureus colonization
637702|NCT00731783|Staphylococcal Skin Infections|staphylococcal skin infections
637703|NCT00731783|MRSA|mrsa
637704|NCT00731796|Stroke|stroke
637705|NCT00731796|Retrochiasmatic|retrochiasmatic
637706|NCT00731796|Vision|vision
637707|NCT00731796|VFD|vfd
637708|NCT00731809|Crohn's disease|crohn's disease
637709|NCT00731822|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
637710|NCT00731822|Novel Dry Powder Inhaler|novel dry powder inhaler
637711|NCT00731822|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
637712|NCT00731822|GW685698/GW642444|gw685698/gw642444
637713|NCT00731835|Vascular|vascular
637714|NCT00731848|prostate cancer|prostate cancer
637715|NCT00731848|prostate-specific antigens|prostate-specific antigens
637717|NCT00731874|Kidney transplantation|kidney transplantation
637718|NCT00731874|Immunosuppression|immunosuppression
637719|NCT00731874|Minimization|minimization
637720|NCT00731874|Tacrolimus|tacrolimus
637721|NCT00731874|Prograf|prograf
637722|NCT00731874|Thymoglobulin|thymoglobulin
637723|NCT00731887|Burn injury|burn injury
637724|NCT00731887|Burn recovery|burn recovery
637725|NCT00731900|pharmacogenetic|pharmacogenetic
637726|NCT00731900|study|study
637727|NCT00731900|Topirmate|topirmate
637728|NCT00731900|induced|induced
637729|NCT00731913|Surgical wounds|surgical wounds
637730|NCT00731913|Sutures|sutures
637731|NCT00731939|Erectile Dysfunction|erectile dysfunction
637732|NCT00731939|Penile implant|penile implant
637733|NCT00731939|Titan|titan
637734|NCT00731952|surgically resectable|surgically resectable
637735|NCT00731965|Arthritis, Juvenile Rheumatoid|arthritis, juvenile rheumatoid
637736|NCT00731965|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
637737|NCT00731965|Serology|serology
637738|NCT00731965|Lymphocytes|lymphocytes
637739|NCT00731978|Near-Infrared Spectroscopy|near-infrared spectroscopy
637740|NCT00731978|Intraoperative Care|intraoperative care
637741|NCT00731991|Muscle|muscle
637742|NCT00732017|Sprain|sprain
637743|NCT00732017|Electric stimulation|electric stimulation
637744|NCT00732017|Physical trauma|physical trauma
637745|NCT00732017|Inflammation|inflammation
637746|NCT00732030|Toric IOL|toric iol
637747|NCT00732043|prostate cancer|prostate cancer
637748|NCT00732043|prostate-specific antigen|prostate-specific antigen
637749|NCT00732043|PSA|psa
637750|NCT00732043|pomegranate|pomegranate
637751|NCT00732056|Metastatic Breast Cancer|metastatic breast cancer
637752|NCT00732056|Recurrent Breast Cancer|recurrent breast cancer
637753|NCT00732069|hemodialysis|hemodialysis
637754|NCT00732069|oxidative stress|oxidative stress
637755|NCT00732069|inflammation|inflammation
637756|NCT00732069|kallikrein-kinin|kallikrein-kinin
637757|NCT00732069|angiotensin receptor blockade|angiotensin receptor blockade
637758|NCT00732069|angiotensin converting enzyme inhibition|angiotensin converting enzyme inhibition
637759|NCT00732069|RAAS|raas
637760|NCT00732069|fibrinolysis|fibrinolysis
637761|NCT00732069|endothelial dysfunction|endothelial dysfunction
637762|NCT00732082|LAG-3 and gemcitabine treatment for advanced pancreas cancer|lag-3 and gemcitabine treatment for advanced pancreas cancer
637763|NCT00732095|Self-change|self-change
637764|NCT00732095|Natural recovery|natural recovery
637765|NCT00732095|Alcohol Drinking|alcohol drinking
637766|NCT00732095|Mechanisms of Change|mechanisms of change
637767|NCT00732095|Advertisements|advertisements
637768|NCT00732108|migraine|migraine
637769|NCT00732108|headache|headache
637770|NCT00732108|dizziness|dizziness
637771|NCT00732108|vertigo|vertigo
637772|NCT00732108|topiramate|topiramate
637773|NCT00732108|Topamax|topamax
637774|NCT00732121|Type 2 Diabetes|type 2 diabetes
637775|NCT00732147|triglycerides|triglycerides
637776|NCT00732147|endogenous|endogenous
637777|NCT00732147|glucose|glucose
637778|NCT00732147|production|production
637779|NCT00732160|Glucose|glucose
637780|NCT00732160|Insulin|insulin
637781|NCT00732173|stage I endometrial carcinoma|stage i endometrial carcinoma
637782|NCT00732173|stage II endometrial carcinoma|stage ii endometrial carcinoma
637783|NCT00732199|apneic threshold|apneic threshold
637784|NCT00732199|central apnea|central apnea
637785|NCT00732199|intermittent hypoxia|intermittent hypoxia
637786|NCT00732199|aging|aging
637787|NCT00732199|ventilation|ventilation
637788|NCT00732199|chemoresponsiveness|chemoresponsiveness
637789|NCT00732199|carbon-dioxide reserve|carbon-dioxide reserve
637790|NCT00732212|UGI Bleeding|ugi bleeding
637791|NCT00732212|Ulcer or variceal hemorrhage|ulcer or variceal hemorrhage
637792|NCT00732212|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
637793|NCT00732212|Endoscopy|endoscopy
637794|NCT00732212|Randomized Controlled Trial|randomized controlled trial
637795|NCT00732212|Non-variceal UGI hemorrhage|non-variceal ugi hemorrhage
637796|NCT00732212|Variceal hemorrhage|variceal hemorrhage
637797|NCT00732225|DisCoVisc OVD|discovisc ovd
637798|NCT00732225|Ophthalmic Viscosurgical Device|ophthalmic viscosurgical device
637799|NCT00732238|Spinal Cord Injury|spinal cord injury
637800|NCT00732238|Urinary Tract Infection|urinary tract infection
637801|NCT00732238|Catheter Dependent|catheter dependent
637802|NCT00732251|Bipolar Disorder|bipolar disorder
637803|NCT00732251|Stable Bipolar Disorder|stable bipolar disorder
637804|NCT00732251|Mania|mania
637805|NCT00732251|Mixed mania|mixed mania
637806|NCT00732251|Allopurinol|allopurinol
637807|NCT00732277|sepsis|sepsis
637808|NCT00732277|septicaemia|septicaemia
637809|NCT00732277|septicemia|septicemia
637810|NCT00732277|paediatric|paediatric
637811|NCT00732277|pediatric|pediatric
637812|NCT00732277|children|children
637813|NCT00732290|Healthy volunteer|healthy volunteer
637814|NCT00732290|Pharmacokinetic|pharmacokinetic
637815|NCT00732290|pharmacodynamic|pharmacodynamic
637816|NCT00732290|Polymorphism, Genetic|polymorphism, genetic
637817|NCT00732316|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
637818|NCT00732316|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
637819|NCT00732316|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
637820|NCT00732316|acute undifferentiated leukemia|acute undifferentiated leukemia
637821|NCT00732316|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
637822|NCT00732316|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
637823|NCT00732316|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
637824|NCT00732316|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
637825|NCT00732316|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
637826|NCT00732316|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
637827|NCT00732316|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
637828|NCT00732316|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
637829|NCT00732316|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
637830|NCT00732316|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
637831|NCT00732316|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
637832|NCT00732316|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
637833|NCT00732316|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
637834|NCT00732316|refractory anemia with excess blasts|refractory anemia with excess blasts
637835|NCT00732316|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
637836|NCT00732316|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
637837|NCT00732316|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
637838|NCT00732342|Alcohol Abuse|alcohol abuse
637839|NCT00732342|Contingency Management|contingency management
637840|NCT00732342|Treatment Duration|treatment duration
637841|NCT00732355|syphilis|syphilis
637842|NCT00732407|aliskiren|aliskiren
637843|NCT00732407|arteial stiffness|arteial stiffness
637844|NCT00732407|platelet function|platelet function
637845|NCT00732407|diabetes mellitus|diabetes mellitus
637846|NCT00732420|pazopanib|pazopanib
637847|NCT00732420|Phase I|phase i
637848|NCT00732420|topotecan|topotecan
637849|NCT00732420|Advanced Solid Tumors|advanced solid tumors
637850|NCT00732446|moxifloxacin|moxifloxacin
637851|NCT00732446|dexamethasone|dexamethasone
637852|NCT00732446|ocular inflammation|ocular inflammation
637853|NCT00732446|ocular infection|ocular infection
637854|NCT00732459|myocardial protection|myocardial protection
637855|NCT00732459|cardiac surgery|cardiac surgery
637856|NCT00732459|heart valve replacement|heart valve replacement
637857|NCT00732472|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
637858|NCT00732472|Magnesium stearate|magnesium stearate
637859|NCT00732472|GSK573719|gsk573719
637860|NCT00732485|Burn injury|burn injury
637861|NCT00732485|Fenofibrate|fenofibrate
637862|NCT00732485|Insulin resistance|insulin resistance
637863|NCT00732485|Mitochondrial function|mitochondrial function
637864|NCT00732485|Fat oxidation|fat oxidation
637866|NCT00732485|Protein|protein
637867|NCT00732485|Glucose|glucose
637868|NCT00732485|Wound|wound
637869|NCT00732498|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
637870|NCT00732498|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
637871|NCT00732498|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
637872|NCT00732498|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
637873|NCT00732498|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
637874|NCT00732498|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
637875|NCT00732498|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
637876|NCT00732498|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
637877|NCT00732498|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
637878|NCT00732498|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
637879|NCT00732498|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
637880|NCT00732498|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
637881|NCT00732498|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
637882|NCT00732498|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
637883|NCT00732498|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
637884|NCT00732511|Endothelial dysfunction|endothelial dysfunction
637885|NCT00732511|Blood vessel stiffness|blood vessel stiffness
637886|NCT00732511|Nitric oxide|nitric oxide
637887|NCT00732511|Oxidative stress|oxidative stress
637888|NCT00732524|Hyperglycemia|hyperglycemia
637889|NCT00732524|Glucose toxicity|glucose toxicity
637890|NCT00732524|Glargine|glargine
637891|NCT00732524|Glipizide|glipizide
637892|NCT00732537|Hypoxia|hypoxia
637893|NCT00732537|Respiratory failure|respiratory failure
637894|NCT00732537|Infant, term|infant, term
637895|NCT00732537|Nitric oxide|nitric oxide
637896|NCT00732550|cholelithiasis|cholelithiasis
637897|NCT00732550|cholecystitis|cholecystitis
637898|NCT00732563|stage I non-small cell lung cancer|stage i non-small cell lung cancer
637899|NCT00732563|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
637900|NCT00732576|Cardiovascular|cardiovascular
637901|NCT00732576|Calcification|calcification
637902|NCT00732589|suprascapular nerve block|suprascapular nerve block
637903|NCT00732589|shoulder pain|shoulder pain
637904|NCT00732589|hemiplegia|hemiplegia
637905|NCT00732602|Glucagon|glucagon
637906|NCT00732602|Glucose-dependent Insulinotropic Polypeptide|glucose-dependent insulinotropic polypeptide
637907|NCT00732602|Glucagon-Like peptide 2|glucagon-like peptide 2
637908|NCT00732615|Hypoparathyroidism|hypoparathyroidism
637909|NCT00732654|Food Allergy|food allergy
637910|NCT00732654|Oral Immunotherapy|oral immunotherapy
637911|NCT00732654|Immunoglobulin E|immunoglobulin e
637912|NCT00732680|Empty nose syndrome|empty nose syndrome
638015|NCT00732992|phase 1|phase 1
637913|NCT00732680|Over resection of turbinate|over resection of turbinate
637914|NCT00732680|Atrophic rhinitis|atrophic rhinitis
637915|NCT00732693|Premature ovarian failure|premature ovarian failure
637916|NCT00732693|Sex hormone replacement|sex hormone replacement
637918|NCT00732693|Blood pressure|blood pressure
637919|NCT00732693|Bone mineral density|bone mineral density
637920|NCT00732693|Bone metabolism|bone metabolism
637921|NCT00732693|Uterine function|uterine function
637922|NCT00732706|FNB|fnb
637923|NCT00732706|Femoral Nerve|femoral nerve
637924|NCT00732706|Sartorius Twitch|sartorius twitch
637925|NCT00732706|Quadriceps Twitch|quadriceps twitch
637926|NCT00732706|Analgesia|analgesia
637927|NCT00732706|Anesthesia|anesthesia
637928|NCT00732732|diarrhea|diarrhea
637929|NCT00732732|Plantain|plantain
637930|NCT00732732|Green banana|green banana
637931|NCT00732732|Infants|infants
637932|NCT00732732|Children|children
637933|NCT00732745|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
637934|NCT00732745|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
637935|NCT00732745|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
637936|NCT00732745|stage III esophageal cancer|stage iii esophageal cancer
637937|NCT00732745|stage IV esophageal cancer|stage iv esophageal cancer
637938|NCT00732745|recurrent esophageal cancer|recurrent esophageal cancer
637939|NCT00732758|Vitamin D Deficiency|vitamin d deficiency
637940|NCT00732758|Vitamin D Insufficiency|vitamin d insufficiency
637941|NCT00732758|Child|child
637942|NCT00732758|Adolescent|adolescent
637943|NCT00732758|African American|african american
637944|NCT00732758|Caucasian|caucasian
637945|NCT00732758|Definition|definition
637946|NCT00732758|Preadolescent|preadolescent
637947|NCT00732771|primary hyperaldosteronism|primary hyperaldosteronism
637948|NCT00732771|hypokalemia|hypokalemia
637949|NCT00732771|hypertension|hypertension
637950|NCT00732771|aldosterone synthase inhibitor|aldosterone synthase inhibitor
637951|NCT00732784|Pharmacokinetics|pharmacokinetics
637952|NCT00732784|Healthy volunteers|healthy volunteers
637953|NCT00732784|No condition|no condition
637954|NCT00732784|Pharmacokinetics study|pharmacokinetics study
637955|NCT00732797|Dizziness|dizziness
637956|NCT00732797|Self-management|self-management
637957|NCT00732797|booklet-based|booklet-based
637958|NCT00732797|vestibular rehabilitation|vestibular rehabilitation
637959|NCT00732836|Liver Cancer|liver cancer
637960|NCT00732836|Solid Cancer|solid cancer
637961|NCT00732836|Abraxane|abraxane
637962|NCT00732836|nab paclitaxel|nab paclitaxel
637963|NCT00732836|HAI abraxane|hai abraxane
637964|NCT00732836|HAI|hai
637965|NCT00732836|hepatic arterial infusion|hepatic arterial infusion
637966|NCT00732836|hepatic metastases|hepatic metastases
637967|NCT00732849|immunonutrition|immunonutrition
637968|NCT00732849|surgical patients|surgical patients
637969|NCT00732849|postoperative period|postoperative period
637970|NCT00732862|Type 2 diabetes|type 2 diabetes
637971|NCT00732862|intensive therapy|intensive therapy
637972|NCT00732888|Pharmacokinetics|pharmacokinetics
637973|NCT00732888|Healthy volunteers|healthy volunteers
637974|NCT00732888|No condition|no condition
637975|NCT00732888|Pharmacokinetics study|pharmacokinetics study
637976|NCT00732901|substance abuse|substance abuse
637977|NCT00732901|cocaine|cocaine
637978|NCT00732901|impulsivity|impulsivity
637979|NCT00732901|serotonin|serotonin
637980|NCT00732901|Remeron|remeron
637981|NCT00732901|Mirtzapine|mirtzapine
637982|NCT00732901|Lexapro|lexapro
637983|NCT00732901|Escatilopram|escatilopram
637984|NCT00732914|Renal Cell Carcinoma|renal cell carcinoma
637985|NCT00732914|Sunitinib|sunitinib
637986|NCT00732914|Sorafenib|sorafenib
637987|NCT00732914|Sequential|sequential
637988|NCT00732927|thrombosis, vein, retina|thrombosis, vein, retina
637989|NCT00732940|SLE|sle
637990|NCT00732940|Lupus|lupus
637991|NCT00732940|Systemic Lupus Erythematosus|systemic lupus erythematosus
637992|NCT00732940|Antibodies|antibodies
637993|NCT00732940|Autoimmune Diseases|autoimmune diseases
637994|NCT00732940|Belimumab|belimumab
637995|NCT00732953|patients with coronary artery disease|patients with coronary artery disease
637996|NCT00732953|percutaneous coronary intervention|percutaneous coronary intervention
637997|NCT00732953|stent implantation|stent implantation
637998|NCT00732953|paclitaxel eluting balloon|paclitaxel eluting balloon
639272|NCT00735618|HRV|hrv
637999|NCT00732953|angiographic follow-up|angiographic follow-up
638000|NCT00732953|clinical follow-up|clinical follow-up
638001|NCT00732966|cyp2c9|cyp2c9
638002|NCT00732966|losartan|losartan
638003|NCT00732966|pharmacogenetics|pharmacogenetics
638004|NCT00732966|pharmacokinetics|pharmacokinetics
638005|NCT00732966|pharmacodynamics|pharmacodynamics
638006|NCT00732979|Elective|elective
638007|NCT00732979|hepatic|hepatic
638008|NCT00732979|resection|resection
638009|NCT00732979|due to any|due to any
638010|NCT00732979|reason.|reason.
638011|NCT00732992|Solid tumor|solid tumor
638012|NCT00732992|malignancy|malignancy
638013|NCT00732992|sunitinib|sunitinib
638014|NCT00732992|pemetrexed|pemetrexed
638016|NCT00732992|neoplasms|neoplasms
638017|NCT00733018|Nutrigenomics|nutrigenomics
638018|NCT00733018|Gene Expression|gene expression
638019|NCT00733018|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
638020|NCT00733018|Life Style|life style
638021|NCT00733018|Health Behavior|health behavior
638022|NCT00733031|Phase I,|phase i,
638023|NCT00733031|cancer,|cancer,
638024|NCT00733031|solid tumors,|solid tumors,
638025|NCT00733031|advanced solid malignancies,|advanced solid malignancies,
638026|NCT00733031|dose escalation,|dose escalation,
638027|NCT00733031|combination treatment,|combination treatment,
638028|NCT00733031|TRK inhibitor|trk inhibitor
638029|NCT00733044|Objective tinnitus|objective tinnitus
638030|NCT00733044|Tinnitus|tinnitus
638031|NCT00733044|RCT|rct
638032|NCT00733044|Specialised treatment|specialised treatment
638033|NCT00733044|Usual care|usual care
638034|NCT00733044|Cost-effectiveness|cost-effectiveness
638035|NCT00733057|Minocycline|minocycline
638036|NCT00733057|Schizophrenia|schizophrenia
638037|NCT00733057|Negative symptoms|negative symptoms
638038|NCT00733057|Cognitive|cognitive
638039|NCT00733070|CTO|cto
638040|NCT00733070|Chronic Total Occlusion|chronic total occlusion
638041|NCT00733070|Revascularization|revascularization
638042|NCT00733083|tonsillectomy|tonsillectomy
638050|NCT00733083|dexamethasone|dexamethasone
638051|NCT00733096|radiculopathy|radiculopathy
638052|NCT00733096|sciatica|sciatica
638053|NCT00733096|low back pain|low back pain
638055|NCT00733109|management|management
638056|NCT00733135|peripheral vascular disease|peripheral vascular disease
638057|NCT00733135|atherectomy|atherectomy
638058|NCT00733135|atherosclerosis|atherosclerosis
638059|NCT00733135|calcified lesions|calcified lesions
638060|NCT00733148|glucose, interstitial, intensive care|glucose, interstitial, intensive care
638061|NCT00733161|passive leg exercise|passive leg exercise
638062|NCT00733161|congestive heart failure|congestive heart failure
638063|NCT00733161|endothelium-derived factors|endothelium-derived factors
638064|NCT00733161|elderly|elderly
638065|NCT00733174|IGT|igt
638066|NCT00733200|Minor Liver Resection|minor liver resection
638067|NCT00733200|Major Liver Resection|major liver resection
638068|NCT00733200|Hilar|hilar
638069|NCT00733213|Prostate Cancer, Treatment alternatives, Metastasis|prostate cancer, treatment alternatives, metastasis
638070|NCT00733226|wheezing|wheezing
638071|NCT00733226|asthma|asthma
638072|NCT00733226|childhood|childhood
638073|NCT00733226|OM-85 BV|om-85 bv
638074|NCT00733226|Broncho-Vaxom|broncho-vaxom
638075|NCT00733239|methadone|methadone
638076|NCT00733239|opioid dependence|opioid dependence
638077|NCT00733239|opioid|opioid
638078|NCT00733252|non-small cell lung cancer|non-small cell lung cancer
638079|NCT00733252|small cell lung cancer|small cell lung cancer
638080|NCT00733252|benign respiratory tract neoplasm|benign respiratory tract neoplasm
638081|NCT00733252|lung papilloma|lung papilloma
638082|NCT00733252|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
638083|NCT00733252|squamous lung dysplasia|squamous lung dysplasia
638084|NCT00733252|malignant mesothelioma|malignant mesothelioma
638085|NCT00733252|pulmonary carcinoid tumor|pulmonary carcinoid tumor
638086|NCT00733252|lung metastases|lung metastases
638087|NCT00733265|Renal Impairment|renal impairment
638088|NCT00733278|Postpartum contraception|postpartum contraception
638089|NCT00733278|Copper IUD|copper iud
638090|NCT00733291|Daily disposable contact lenses|daily disposable contact lenses
638091|NCT00733291|Multi-purpose disinfecting solutions|multi-purpose disinfecting solutions
638092|NCT00733304|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
638093|NCT00733304|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
752748|NCT01174017|prostate cancer|prostate cancer
638094|NCT00733304|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
638095|NCT00733304|pazopanib|pazopanib
638096|NCT00733304|angiogenesis|angiogenesis
638097|NCT00733317|Wheezing|wheezing
638098|NCT00733317|Acute asthma|acute asthma
638099|NCT00733317|Children|children
638100|NCT00733317|Budesonide|budesonide
638101|NCT00733317|Emergency room|emergency room
638102|NCT00733330|Arthroplasty, Knee, TKA, TKR, CAS, minimally invasive|arthroplasty, knee, tka, tkr, cas, minimally invasive
638103|NCT00733343|heart failure|heart failure
638104|NCT00733343|sleep disordered breathing|sleep disordered breathing
638105|NCT00733343|sleep apnea|sleep apnea
638106|NCT00733343|left ventricular systolic dysfunction|left ventricular systolic dysfunction
638107|NCT00733343|SBAS|sbas
638108|NCT00733343|HF|hf
638109|NCT00733356|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
638110|NCT00733356|ADHD|adhd
638111|NCT00733356|ADD|add
638112|NCT00733356|reading|reading
638113|NCT00733356|brain hemodynamics|brain hemodynamics
638114|NCT00733356|brain imaging|brain imaging
638115|NCT00733356|attention|attention
638116|NCT00733356|Near-Infrared Spectroscopy|near-infrared spectroscopy
638117|NCT00733356|NIRS|nirs
638118|NCT00733356|MSIT|msit
638119|NCT00733369|Arthroplasty|arthroplasty
638120|NCT00733369|Replacement|replacement
638121|NCT00733369|Knee|knee
638122|NCT00733369|PFC Sigma RPF|pfc sigma rpf
638123|NCT00733369|PFC Sigma RP|pfc sigma rp
638124|NCT00733382|migraine|migraine
638125|NCT00733382|dexamethasone|dexamethasone
638126|NCT00733382|dihydroergotamine|dihydroergotamine
638127|NCT00733395|Muscle pain|muscle pain
638128|NCT00733421|Day surgery|day surgery
638129|NCT00733421|Hallux Valgus|hallux valgus
638130|NCT00733421|Pain|pain
638131|NCT00733421|Analgesics|analgesics
638132|NCT00733434|Microsurgery|microsurgery
638133|NCT00733434|Head and neck|head and neck
638134|NCT00733434|Prostaglandin E1|prostaglandin e1
638135|NCT00733434|Thrombosis|thrombosis
638136|NCT00733434|Complication|complication
638137|NCT00733447|Biventricular failure|biventricular failure
638138|NCT00733460|BFPET|bfpet
638139|NCT00733460|Coronary Artery Disease|coronary artery disease
638140|NCT00733460|Myocardial Perfusion Imaging|myocardial perfusion imaging
638141|NCT00733460|Radiation Dosimetry|radiation dosimetry
638142|NCT00733473|Wheezing|wheezing
638143|NCT00733473|Acute asthma|acute asthma
638144|NCT00733473|Children|children
638145|NCT00733486|Arthroplasty, Replacement, Knee, LCS Complete APG (MeSH);|arthroplasty, replacement, knee, lcs complete apg (mesh);
638146|NCT00733499|Arthroplasty, replacement, Knee, LCS Duofix, Porocoat|arthroplasty, replacement, knee, lcs duofix, porocoat
638147|NCT00733512|ReSTOR Aspheric +4 IOL|restor aspheric +4 iol
638148|NCT00733525|Bulimia Nervosa|bulimia nervosa
638149|NCT00733538|stage I multiple myeloma|stage i multiple myeloma
638150|NCT00733551|motilin|motilin
638151|NCT00733551|gastric emptying|gastric emptying
638152|NCT00733551|GSK962040|gsk962040
638153|NCT00733551|oral dose|oral dose
638154|NCT00733564|Local anesthetic|local anesthetic
638155|NCT00733564|Propofol|propofol
638156|NCT00733564|Sevoflurane|sevoflurane
638157|NCT00733577|diabetes|diabetes
638158|NCT00733577|pharmacodynamics|pharmacodynamics
638159|NCT00733577|safety|safety
638160|NCT00733577|pharmacokinetics|pharmacokinetics
638161|NCT00733590|defibrillator, implanted|defibrillator, implanted
638162|NCT00733590|genomics|genomics
638163|NCT00733590|electrocardiography|electrocardiography
638164|NCT00733590|electrophysiological study|electrophysiological study
638165|NCT00733590|proteomics|proteomics
638166|NCT00733603|Interstitial Cystitis|interstitial cystitis
638167|NCT00733603|IC|ic
638168|NCT00733603|Painful Bladder Syndrome|painful bladder syndrome
638169|NCT00733603|PBS|pbs
638170|NCT00733603|Bladder Pain|bladder pain
638171|NCT00733603|Pelvic Pain|pelvic pain
638172|NCT00733616|advanced gastric adenocarcinoma|advanced gastric adenocarcinoma
638173|NCT00733616|docetaxel|docetaxel
638174|NCT00733616|oxaliplatin|oxaliplatin
638175|NCT00733616|capecitabine|capecitabine
638176|NCT00733616|intermediate general status|intermediate general status
638177|NCT00733642|antibody amyloid Alzheimer's Disease AD|antibody amyloid alzheimer's disease ad
638178|NCT00733668|considered|considered
638179|NCT00733668|entry|entry
638180|NCT00733668|into|into
638181|NCT00733668|the study|the study
638182|NCT00733668|SSRI|ssri
638183|NCT00733668|Seroquel|seroquel
638184|NCT00733668|Quetiapine|quetiapine
638185|NCT00733668|fumarate|fumarate
638186|NCT00733668|antipsychotic|antipsychotic
638187|NCT00733681|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
638188|NCT00733681|Prosthesis Failure|prosthesis failure
638189|NCT00733681|Revision surgery|revision surgery
638190|NCT00733694|Arthroplasty, Replacement, Knee,LCS|arthroplasty, replacement, knee,lcs
638191|NCT00733707|adherence|adherence
638192|NCT00733707|oral contraceptive pills|oral contraceptive pills
638193|NCT00733707|contraception|contraception
638194|NCT00733707|text messaging|text messaging
638195|NCT00733733|kidney|kidney
638196|NCT00733733|transplantation|transplantation
638197|NCT00733733|non-heart-beating donor|non-heart-beating donor
638198|NCT00733733|delayed graft function|delayed graft function
638199|NCT00733733|Antithymocyte globulin|antithymocyte globulin
638200|NCT00733733|ischemia-reperfusion damage|ischemia-reperfusion damage
638201|NCT00733746|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
638202|NCT00733746|stage I pancreatic cancer|stage i pancreatic cancer
638203|NCT00733746|stage II pancreatic cancer|stage ii pancreatic cancer
638204|NCT00733772|flaxseed|flaxseed
638205|NCT00733772|lignans|lignans
638206|NCT00733772|alpha-Linolenic Acid|alpha-linolenic acid
638207|NCT00733772|LDL Cholesterol|ldl cholesterol
638208|NCT00733785|Rosiglitazone XR|rosiglitazone xr
638209|NCT00733785|Pharmacokinetics|pharmacokinetics
638210|NCT00733785|Strength Equivalence.|strength equivalence.
638211|NCT00733785|Alzheimers Disease|alzheimers disease
638212|NCT00733785|Repeat dose|repeat dose
638213|NCT00733785|Dose proportionality|dose proportionality
638214|NCT00733798|Melanoma|melanoma
638215|NCT00733798|Malignant melanoma|malignant melanoma
638216|NCT00733798|metastatic melanoma|metastatic melanoma
638217|NCT00733798|Phase 1|phase 1
638218|NCT00733798|Phase 2|phase 2
638219|NCT00733811|thalassemia major|thalassemia major
638220|NCT00733811|chelation treatment|chelation treatment
638221|NCT00733811|secondary hemochromatosis|secondary hemochromatosis
638222|NCT00733824|Plerixafor|plerixafor
638223|NCT00733824|Lymphoma|lymphoma
638224|NCT00733824|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
638225|NCT00733824|Transplantation, Autologous|transplantation, autologous
638226|NCT00733824|Receptors, CXCR4|receptors, cxcr4
638227|NCT00733863|Active immunization|active immunization
638228|NCT00733863|Alzheimer disease|alzheimer disease
638229|NCT00733863|Antibody|antibody
638230|NCT00733863|Central Nervous System Diseases|central nervous system diseases
638231|NCT00733863|Neurodegenerative diseases|neurodegenerative diseases
638232|NCT00733863|Vaccine|vaccine
638233|NCT00733876|Acute Renal Failure Cardiac Surgery Stem Cell|acute renal failure cardiac surgery stem cell
638234|NCT00733889|esophageal carcinoma|esophageal carcinoma
638235|NCT00733889|cetuximab|cetuximab
638236|NCT00733889|docetaxel|docetaxel
638237|NCT00733889|cisplatin|cisplatin
638238|NCT00733889|5-fluorouracil|5-fluorouracil
638239|NCT00733902|monoclonal antibody|monoclonal antibody
638240|NCT00733902|RN624|rn624
638241|NCT00733902|PF-04383119|pf-04383119
638242|NCT00733902|nerve growth factor|nerve growth factor
638243|NCT00733902|anti-nerve growth factor|anti-nerve growth factor
638245|NCT00733902|pain|pain
638246|NCT00733915|Arthroplasty, knee, TKA, TKR, Duofix, Porocoat, LCS|arthroplasty, knee, tka, tkr, duofix, porocoat, lcs
638247|NCT00733928|Arthroplasty,|arthroplasty,
638248|NCT00733928|Replacement,|replacement,
638250|NCT00733928|P.F.C.|p.f.c.
638251|NCT00733928|Sigma|sigma
638252|NCT00733928|all-polyethylene|all-polyethylene
638253|NCT00733941|Exercise test|exercise test
638254|NCT00733941|Running|running
638255|NCT00733941|Arterial diameter|arterial diameter
638256|NCT00733941|Monitoring, physiologic|monitoring, physiologic
638257|NCT00733941|Oxygen Consumption|oxygen consumption
638258|NCT00733967|Methamphetamine|methamphetamine
638259|NCT00733967|Chantix|chantix
638260|NCT00733967|Varenicline|varenicline
638261|NCT00733980|Depressive Disorder, Major|depressive disorder, major
638262|NCT00733993|substance abuse|substance abuse
638263|NCT00733993|cocaine|cocaine
638264|NCT00733993|caffeine|caffeine
638265|NCT00733993|impulsivity|impulsivity
638266|NCT00734006|Cortico-cortical|cortico-cortical
638267|NCT00734006|connectivity|connectivity
638268|NCT00734006|Transcranial|transcranial
638269|NCT00734006|Magnetic|magnetic
638270|NCT00734006|Stimulation|stimulation
638271|NCT00734019|Arthroplasty, Replacement, Knee, TKR, PFC Sigma|arthroplasty, replacement, knee, tkr, pfc sigma
638272|NCT00734032|SB-480848|sb-480848
638273|NCT00734032|Dyslipidaemia|dyslipidaemia
638274|NCT00734045|Congestive Heart Failure (CHF)|congestive heart failure (chf)
638275|NCT00734045|NT-proBNP|nt-probnp
638276|NCT00734058|Ablation|ablation
638277|NCT00734058|AF|af
638278|NCT00734058|Atrial Fibrillation|atrial fibrillation
638279|NCT00734058|Cardiac|cardiac
638280|NCT00734058|Endocardial|endocardial
638281|NCT00734058|Endocardium|endocardium
638282|NCT00734058|EP|ep
638283|NCT00734058|Electrophysiology|electrophysiology
638284|NCT00734058|Epicardial|epicardial
638285|NCT00734058|Epicardium|epicardium
638286|NCT00734058|Heart|heart
638287|NCT00734058|Interventional|interventional
638288|NCT00734058|Lesion|lesion
638289|NCT00734058|PVI|pvi
638290|NCT00734058|Pulmonary Vein|pulmonary vein
638291|NCT00734058|MAZE|maze
638292|NCT00734058|Surgery|surgery
638293|NCT00734058|Surgical|surgical
638294|NCT00734058|Treatment|treatment
638295|NCT00734058|Patients with persistent AF with 3 months duration|patients with persistent af with 3 months duration
638296|NCT00734058|Requiring concomitant open heart surgery|requiring concomitant open heart surgery
638297|NCT00734071|Generalized Anxiety Disorder|generalized anxiety disorder
638298|NCT00734071|Mood Disorder|mood disorder
638299|NCT00734071|Affective Disorder|affective disorder
638300|NCT00734071|Anxiety Disorder|anxiety disorder
638301|NCT00734071|Drug Therapy|drug therapy
638302|NCT00725426|healthy subjects|healthy subjects
638303|NCT00725465|laparoscopy|laparoscopy
638304|NCT00725465|CO2 colonoscopy|co2 colonoscopy
638305|NCT00725465|intraoperative CO2 colonoscopy|intraoperative co2 colonoscopy
638306|NCT00725465|combined Lap-CO2 procedure|combined lap-co2 procedure
639542|NCT00736775|AD|ad
752372|NCT01172704|Serious Mental Illness|serious mental illness
752373|NCT01172704|HIV/AIDS|hiv/aids
752374|NCT01172704|HIV Testing|hiv testing
638307|NCT00725465|to evaluate simultaneous CO2 laparoscopy and colonoscopy safety and physiologic effects on patients from the additional CO2 insufflation|to evaluate simultaneous co2 laparoscopy and colonoscopy safety and physiologic effects on patients from the additional co2 insufflation
638308|NCT00725478|Piribedil (trade name: CLARIUM)|piribedil (trade name: clarium)
638309|NCT00725478|non-ergot dopamine agonist|non-ergot dopamine agonist
638310|NCT00725478|Morbus Parkinson|morbus parkinson
638311|NCT00725478|Tolerability|tolerability
638312|NCT00725478|Efficacy|efficacy
638313|NCT00725478|Post Marketing Surveillance|post marketing surveillance
638314|NCT00725491|Reproductive|reproductive
638315|NCT00725491|techniques|techniques
638316|NCT00725491|assisted|assisted
638317|NCT00725517|Icodextrin|icodextrin
638318|NCT00725517|ultrafiltration|ultrafiltration
638319|NCT00725517|creatinine clearance|creatinine clearance
638320|NCT00725517|urea nitrogen clearance|urea nitrogen clearance
638321|NCT00725530|Lens deposits|lens deposits
638322|NCT00725530|Soft contact lens wearers|soft contact lens wearers
638323|NCT00725556|Autism|autism
638324|NCT00725556|Asperger Syndrome|asperger syndrome
638325|NCT00725569|Caesarian Section|caesarian section
638326|NCT00725569|Homeopathy|homeopathy
638327|NCT00725569|Pain|pain
638328|NCT00725569|Analgesia|analgesia
638329|NCT00725595|Cheyne Stocks respiration|cheyne stocks respiration
638330|NCT00725595|heart failure|heart failure
638331|NCT00725595|sleep apnea|sleep apnea
638332|NCT00725595|ventilator|ventilator
638333|NCT00725608|Suboxone|suboxone
638334|NCT00725608|Subutex|subutex
638335|NCT00725608|Buprenorphine|buprenorphine
638336|NCT00725608|Naloxone|naloxone
638337|NCT00725634|Neoplasms,|neoplasms,
638338|NCT00725634|Lymphoma,|lymphoma,
638339|NCT00725634|Multiple Myeloma,|multiple myeloma,
638340|NCT00725634|Neoplasms, Plasma Cell,|neoplasms, plasma cell,
638341|NCT00725634|Neoplasms by Histologic Type,|neoplasms by histologic type,
638342|NCT00725634|Lymphoproliferative Disorders,|lymphoproliferative disorders,
638343|NCT00725634|Lymphatic Diseases, Immunoproliferative Disorders|lymphatic diseases, immunoproliferative disorders
638344|NCT00725634|Immune System Diseases Hemostatic Disorders|immune system diseases hemostatic disorders
638345|NCT00725634|Vascular Diseases|vascular diseases
638346|NCT00725634|Cardiovascular Diseases|cardiovascular diseases
638347|NCT00725634|Paraproteinemias|paraproteinemias
638348|NCT00725634|Blood Protein Disorders|blood protein disorders
638349|NCT00725634|Hematologic Diseases|hematologic diseases
638350|NCT00725634|Hemorrhagic Disorders|hemorrhagic disorders
638351|NCT00725634|Erlotinib|erlotinib
638352|NCT00725634|Protein Kinase Inhibitors|protein kinase inhibitors
638353|NCT00725634|Enzyme Inhibitors,|enzyme inhibitors,
638354|NCT00725634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
638355|NCT00725634|Pharmacologic Actions|pharmacologic actions
638356|NCT00725647|N terminal B type natriuretic peptide|n terminal b type natriuretic peptide
638357|NCT00725647|echocardiography|echocardiography
638358|NCT00725647|diagnosis|diagnosis
638359|NCT00725647|atrial natriuretic peptides|atrial natriuretic peptides
638360|NCT00725647|preterm infant|preterm infant
638361|NCT00725660|pre eclampsia|pre eclampsia
638362|NCT00725660|doppler|doppler
638363|NCT00725660|uterine|uterine
638364|NCT00725660|arteries|arteries
638365|NCT00725660|angiogenic|angiogenic
638366|NCT00725660|factors|factors
638367|NCT00725673|COPD|copd
638368|NCT00725673|Osteoporosis|osteoporosis
638370|NCT00725673|DEXA-scan|dexa-scan
638371|NCT00725686|"Choroidal Neovascularization (CNV) WET AMD"|"choroidal neovascularization (cnv) wet amd"
638372|NCT00725712|c-Met|c-met
638373|NCT00725712|Metastatic Gastric Carcinoma|metastatic gastric carcinoma
638374|NCT00725712|adenocarcinoma|adenocarcinoma
638375|NCT00725712|Gastric cancer|gastric cancer
638376|NCT00725712|GSK1363089|gsk1363089
638377|NCT00725712|XL880|xl880
638378|NCT00725712|MET inhibitor|met inhibitor
638379|NCT00725738|Myocardial|myocardial
638380|NCT00725738|Infarction,|infarction,
638381|NCT00725738|Stem|stem
638382|NCT00725738|Cell|cell
638383|NCT00725738|Therapy|therapy
638384|NCT00725764|VEGFR2|vegfr2
638385|NCT00725764|XL880|xl880
638386|NCT00725764|foretinib|foretinib
638387|NCT00725764|Squamous Cell Cancer of the Head and Neck|squamous cell cancer of the head and neck
638388|NCT00725764|MET|met
638389|NCT00725764|GSK1363089|gsk1363089
638390|NCT00725790|Erectile Dysfunction|erectile dysfunction
638391|NCT00725790|Spinal Cord Injury|spinal cord injury
638392|NCT00725803|Hepatitis C|hepatitis c
638393|NCT00725803|HCV|hcv
638394|NCT00725803|Fibrosis|fibrosis
638395|NCT00725803|Apoptosis|apoptosis
638396|NCT00725803|GS-9450|gs-9450
638397|NCT00725829|coagulation|coagulation
638399|NCT00725829|acute ischemia|acute ischemia
638400|NCT00725829|fibrin clot|fibrin clot
638401|NCT00725855|Schizophrenia|schizophrenia
638402|NCT00725855|P50 Sensory Gating|p50 sensory gating
638403|NCT00725855|Mismatched Negativity|mismatched negativity
638404|NCT00725868|Major adverse|major adverse
638405|NCT00725881|PAD|pad
638406|NCT00725881|Peripheral arterial disease|peripheral arterial disease
638407|NCT00725881|Peripheral artery disease|peripheral artery disease
638408|NCT00725881|Intermittent claudication|intermittent claudication
638409|NCT00725881|IC|ic
638410|NCT00725881|atherosclerosis|atherosclerosis
638411|NCT00725881|leg pain|leg pain
638412|NCT00725881|walking pain|walking pain
638413|NCT00725907|PRP|prp
638414|NCT00725907|ATFL|atfl
638415|NCT00725920|PTSD,|ptsd,
638416|NCT00725920|posttraumatic|posttraumatic
638417|NCT00725920|stress|stress
638418|NCT00725920|disorder,|disorder,
638419|NCT00725920|randomization,|randomization,
638420|NCT00725920|placebo,|placebo,
638421|NCT00725920|controlled|controlled
638422|NCT00725959|HIV Prevention|hiv prevention
638423|NCT00725959|Social Networking|social networking
638424|NCT00725959|Technology Based Intervention|technology based intervention
638425|NCT00725972|Improve|improve
638426|NCT00725972|Patient care|patient care
638427|NCT00725972|Applying|applying
638428|NCT00725972|Systematic|systematic
638429|NCT00725972|Fashion|fashion
638430|NCT00725972|Proven|proven
638431|NCT00725972|Resuscitation|resuscitation
638432|NCT00725972|Algorithms|algorithms
638433|NCT00725972|High risk|high risk
638434|NCT00725972|Surgical|surgical
638435|NCT00725985|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
638436|NCT00725985|Early MS|early ms
638437|NCT00725985|Multiple Sclerosis|multiple sclerosis
638438|NCT00725998|Cochlear Implantation.|cochlear implantation.
638439|NCT00725998|Cochlear nerve.|cochlear nerve.
638440|NCT00725998|Child.|child.
638441|NCT00725998|study|study
638442|NCT00725998|ECAP|ecap
638443|NCT00725998|During|during
638444|NCT00725998|First year|first year
638445|NCT00726011|due|due
638446|NCT00726011|cancer treatment|cancer treatment
638447|NCT00726037|Denileukin diftitox|denileukin diftitox
638448|NCT00726037|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
638449|NCT00726037|Ontak|ontak
638450|NCT00726037|Regulatory T-cell|regulatory t-cell
638451|NCT00726050|Theta Burst Stimulation|theta burst stimulation
638452|NCT00726050|Somatosensory Stimulation|somatosensory stimulation
638453|NCT00726050|Somatosensory Cortex|somatosensory cortex
638454|NCT00726050|Tactile Discrimination|tactile discrimination
638455|NCT00726050|Healthy Volunteer|healthy volunteer
638457|NCT00726063|dental implants|dental implants
638458|NCT00726063|Nanotite implant|nanotite implant
638459|NCT00726063|Osseotite implants|osseotite implants
638460|NCT00726063|multicenter|multicenter
638461|NCT00726063|randomized|randomized
638462|NCT00726063|clinical study|clinical study
638463|NCT00726063|partial edentulism|partial edentulism
638464|NCT00726063|prosthesis|prosthesis
638465|NCT00726076|Epilepsy|epilepsy
638466|NCT00726076|Medication|medication
638467|NCT00726076|Stress|stress
638468|NCT00726076|Sleep|sleep
638469|NCT00726076|Lifestyle Management|lifestyle management
638470|NCT00726102|Zinc nutrition|zinc nutrition
638471|NCT00726102|Growth|growth
638472|NCT00726102|Development|development
638473|NCT00726102|China|china
638474|NCT00726102|Infants|infants
638475|NCT00726102|Toddlers|toddlers
638476|NCT00726128|DDD|ddd
638477|NCT00726141|Brief Intervention|brief intervention
638478|NCT00726141|Smoking Cessation|smoking cessation
638479|NCT00726141|Motivational Interviewing|motivational interviewing
638480|NCT00726141|Expert System|expert system
638481|NCT00726141|Readiness to Change|readiness to change
638482|NCT00726141|Hormonal Contraceptive|hormonal contraceptive
638483|NCT00726141|Adolescents|adolescents
638484|NCT00726154|Bipolar Disorder|bipolar disorder
638485|NCT00726154|Circadian Rhythm|circadian rhythm
638486|NCT00726154|Moderators|moderators
638487|NCT00726154|Lithium|lithium
638488|NCT00726154|Quetiapine|quetiapine
638489|NCT00726167|Ventilator associated Pneumonia|ventilator associated pneumonia
638490|NCT00726167|mechanically ventilated|mechanically ventilated
638491|NCT00726167|procalcitonin|procalcitonin
638492|NCT00726167|pneumonia scores|pneumonia scores
638493|NCT00726180|Breast cancer|breast cancer
638494|NCT00726180|Women|women
638495|NCT00726180|w/Her2|w/her2
638496|NCT00726180|positive|positive
638497|NCT00726180|ERnegative|ernegative
638498|NCT00726180|not metastasized|not metastasized
638499|NCT00726219|Major|major
638500|NCT00726219|knee|knee
638501|NCT00726219|surgery|surgery
638502|NCT00726271|obesity|obesity
638503|NCT00726271|appetite set point|appetite set point
638504|NCT00726284|HNP|hnp
638505|NCT00726310|Spondylolisthesis|spondylolisthesis
638506|NCT00726310|Instability|instability
638507|NCT00726323|c-Met|c-met
638508|NCT00726323|Papillary Renal Cell Carcinoma(PRC)|papillary renal cell carcinoma(prc)
638509|NCT00726323|Sporadic papillary renal cell carcinoma,|sporadic papillary renal cell carcinoma,
638510|NCT00726323|Clear cell renal carcinoma|clear cell renal carcinoma
638511|NCT00726323|Hereditary papillary renal cell carcinoma,|hereditary papillary renal cell carcinoma,
638512|NCT00726336|healthy volunteer|healthy volunteer
638513|NCT00726336|pharmacokinetics|pharmacokinetics
638514|NCT00726336|GSK1349572|gsk1349572
638515|NCT00726336|integrase|integrase
638516|NCT00726362|Statin|statin
638517|NCT00726362|LDL-C|ldl-c
638518|NCT00726375|(GVHD)|(gvhd)
638519|NCT00726388|safety|safety
638520|NCT00726388|diclofenac|diclofenac
638521|NCT00726388|pain, postoperative|pain, postoperative
638522|NCT00726401|Allergies|allergies
638523|NCT00726401|Nasal|nasal
638524|NCT00726401|Congestion|congestion
638525|NCT00726401|Sneezing|sneezing
638526|NCT00726401|Pruritus|pruritus
638527|NCT00726401|Teary|teary
638528|NCT00726401|Eyes|eyes
638529|NCT00726414|Bioavailability|bioavailability
638530|NCT00726427|pharmacokinetics|pharmacokinetics
638531|NCT00726427|pharmacodynamics|pharmacodynamics
638532|NCT00726427|AZD1656|azd1656
638533|NCT00726427|safety|safety
638534|NCT00726427|tolerability|tolerability
638535|NCT00726427|Healthy Volunteers|healthy volunteers
638536|NCT00726440|Type 1 Diabetes|type 1 diabetes
638537|NCT00726440|Real Time Continuous Glucose Monitoring System|real time continuous glucose monitoring system
638538|NCT00726440|HbA1c|hba1c
638539|NCT00726440|Navigator®|navigator®
638540|NCT00726453|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
638541|NCT00726453|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
638542|NCT00726453|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
639221|NCT00735423|Behavior|behavior
638543|NCT00726453|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
638544|NCT00726453|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
638545|NCT00726453|STENT THROMBOSIS|stent thrombosis
638546|NCT00726453|RESTENOTIC LESION|restenotic lesion
638547|NCT00726453|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
638548|NCT00726466|Age Related Macular Degeneration|age related macular degeneration
638549|NCT00726466|AMD|amd
638550|NCT00726466|CNV|cnv
638551|NCT00726531|Falls prevention|falls prevention
638552|NCT00726531|Exercise promotion|exercise promotion
638553|NCT00726531|Older people|older people
638554|NCT00726544|thrombocytopenia|thrombocytopenia
638555|NCT00726544|microangiopathic hemolytic anemia|microangiopathic hemolytic anemia
638556|NCT00726544|von Willebrand Factor|von willebrand factor
638558|NCT00726570|Disorders, Blood coagulation|disorders, blood coagulation
638559|NCT00726570|Deep Vein Thrombosis|deep vein thrombosis
638560|NCT00726570|Perioperative Care|perioperative care
638561|NCT00726570|Digestive System Surgical Procedures|digestive system surgical procedures
638562|NCT00726583|Cancer|cancer
638563|NCT00726583|Solid Tumors|solid tumors
638564|NCT00726583|Carcinoma|carcinoma
638565|NCT00726583|PI-3K|pi-3k
638566|NCT00726583|PI3 kinase|pi3 kinase
638567|NCT00726583|PI3K|pi3k
638568|NCT00726596|recurrent prostate cancer|recurrent prostate cancer
638569|NCT00726596|stage IV prostate cancer|stage iv prostate cancer
638570|NCT00726596|Prostate-Specific Antigen|prostate-specific antigen
638571|NCT00726622|rectal cancer|rectal cancer
638572|NCT00726622|adenocarcinoma of the rectum|adenocarcinoma of the rectum
638573|NCT00726648|CDP323|cdp323
638574|NCT00726648|Relapsing multiple sclerosis|relapsing multiple sclerosis
638575|NCT00726648|Blood biomarkers|blood biomarkers
638576|NCT00726661|Metastatic Breast Cancer|metastatic breast cancer
638577|NCT00726661|Locally Recurrent Breast Cancer|locally recurrent breast cancer
638578|NCT00726661|Avastin|avastin
638579|NCT00726674|Diabetes HbA1C|diabetes hba1c
638580|NCT00726687|Cancer|cancer
638581|NCT00726687|Indibulin|indibulin
638582|NCT00726687|Capecitabine|capecitabine
638583|NCT00726687|Xeloda|xeloda
638584|NCT00726700|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
638585|NCT00726700|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
638586|NCT00726700|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
638587|NCT00726700|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
638588|NCT00726700|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
638589|NCT00726700|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
638590|NCT00726700|anaplastic large cell lymphoma|anaplastic large cell lymphoma
638591|NCT00726700|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
638592|NCT00726700|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
638593|NCT00726700|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
638594|NCT00726700|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
638595|NCT00726700|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
752749|NCT01174017|Iodine 125 brachytherapy|iodine 125 brachytherapy
638596|NCT00726700|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
638597|NCT00726700|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
638598|NCT00726700|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
638599|NCT00726700|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
638600|NCT00726700|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
638601|NCT00726700|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
638602|NCT00726700|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
638603|NCT00726700|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
638604|NCT00726700|stage I mantle cell lymphoma|stage i mantle cell lymphoma
638605|NCT00726700|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
638606|NCT00726700|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
638607|NCT00726700|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
638608|NCT00726700|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
638609|NCT00726700|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
638610|NCT00726700|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
638611|NCT00726700|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
638612|NCT00726700|stage I marginal zone lymphoma|stage i marginal zone lymphoma
638750|NCT00726830|refractory multiple myeloma|refractory multiple myeloma
638613|NCT00726700|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
638614|NCT00726700|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
638616|NCT00726713|diabetes|diabetes
638617|NCT00726713|neuropathy|neuropathy
638618|NCT00726713|folic acid|folic acid
638619|NCT00726713|folate|folate
638620|NCT00726713|L-methylfolate|l-methylfolate
638621|NCT00726713|vitamin B6|vitamin b6
638622|NCT00726713|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
638623|NCT00726713|vitamin B12|vitamin b12
638624|NCT00726713|methylcobalamin|methylcobalamin
638625|NCT00726739|recurrent melanoma|recurrent melanoma
638626|NCT00726752|solid tumor|solid tumor
638627|NCT00726752|Axitinib|axitinib
638628|NCT00726752|Pharmacokinetics|pharmacokinetics
638629|NCT00726752|Phase 1|phase 1
638630|NCT00726778|race/ethnicity|race/ethnicity
638631|NCT00726778|insulin senistivity|insulin senistivity
638632|NCT00726778|genetic admixture|genetic admixture
638633|NCT00726778|type 2 diabetes|type 2 diabetes
638634|NCT00726778|obesity|obesity
638635|NCT00726778|body composition|body composition
638636|NCT00726778|Insulin dynamics|insulin dynamics
638637|NCT00726778|Racial/ethnic differences|racial/ethnic differences
638638|NCT00726791|chronic pain|chronic pain
638639|NCT00726791|pain disorder|pain disorder
639338|NCT00735904|axitinib|axitinib
638640|NCT00726817|butyrate, visceral perception, compliance|butyrate, visceral perception, compliance
638641|NCT00726830|pain|pain
638642|NCT00726830|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
638643|NCT00726830|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
638644|NCT00726830|acute undifferentiated leukemia|acute undifferentiated leukemia
638645|NCT00726830|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
638646|NCT00726830|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
638647|NCT00726830|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
638648|NCT00726830|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
638649|NCT00726830|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
638650|NCT00726830|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
638651|NCT00726830|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
638652|NCT00726830|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
638653|NCT00726830|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
638654|NCT00726830|mast cell leukemia|mast cell leukemia
638655|NCT00726830|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
638656|NCT00726830|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
638657|NCT00726830|prolymphocytic leukemia|prolymphocytic leukemia
638658|NCT00726830|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
638659|NCT00726830|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
638660|NCT00726830|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
638661|NCT00726830|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
638662|NCT00726830|refractory hairy cell leukemia|refractory hairy cell leukemia
638663|NCT00726830|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
638664|NCT00726830|secondary acute myeloid leukemia|secondary acute myeloid leukemia
638665|NCT00726830|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
638666|NCT00726830|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
638667|NCT00726830|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
638668|NCT00726830|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
638669|NCT00726830|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
638670|NCT00726830|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
638671|NCT00726830|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
638672|NCT00726830|untreated hairy cell leukemia|untreated hairy cell leukemia
638673|NCT00726830|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
638674|NCT00726830|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
638675|NCT00726830|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
638676|NCT00726830|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
638677|NCT00726830|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
638678|NCT00726830|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
638679|NCT00726830|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
638680|NCT00726830|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
638681|NCT00726830|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
638682|NCT00726830|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
638683|NCT00726830|anaplastic large cell lymphoma|anaplastic large cell lymphoma
638684|NCT00726830|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
638685|NCT00726830|splenic marginal zone lymphoma|splenic marginal zone lymphoma
638751|NCT00726830|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
638686|NCT00726830|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
638687|NCT00726830|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
638688|NCT00726830|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
638689|NCT00726830|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
638690|NCT00726830|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
638691|NCT00726830|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
638692|NCT00726830|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
638693|NCT00726830|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
638694|NCT00726830|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
638695|NCT00726830|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
638696|NCT00726830|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
638697|NCT00726830|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
638698|NCT00726830|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
638699|NCT00726830|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
638700|NCT00726830|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
638701|NCT00726830|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
638702|NCT00726830|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
639339|NCT00735904|cisplatin|cisplatin
638703|NCT00726830|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
638704|NCT00726830|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
638705|NCT00726830|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
638706|NCT00726830|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
638707|NCT00726830|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
638708|NCT00726830|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
638709|NCT00726830|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
638710|NCT00726830|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
638711|NCT00726830|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
638712|NCT00726830|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
638713|NCT00726830|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
638714|NCT00726830|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
638715|NCT00726830|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
638716|NCT00726830|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
638717|NCT00726830|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
638718|NCT00726830|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
638719|NCT00726830|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
638720|NCT00726830|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
638721|NCT00726830|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
638722|NCT00726830|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
638723|NCT00726830|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
638724|NCT00726830|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
638725|NCT00726830|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
638726|NCT00726830|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
638727|NCT00726830|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
638728|NCT00726830|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
638729|NCT00726830|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
638730|NCT00726830|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
638731|NCT00726830|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
638732|NCT00726830|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
638733|NCT00726830|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
638734|NCT00726830|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
638735|NCT00726830|intraocular lymphoma|intraocular lymphoma
638736|NCT00726830|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
638737|NCT00726830|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
638738|NCT00726830|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
638739|NCT00726830|chronic eosinophilic leukemia|chronic eosinophilic leukemia
638740|NCT00726830|chronic neutrophilic leukemia|chronic neutrophilic leukemia
638741|NCT00726830|primary myelofibrosis|primary myelofibrosis
638742|NCT00726830|essential thrombocythemia|essential thrombocythemia
638743|NCT00726830|polycythemia vera|polycythemia vera
638744|NCT00726830|extramedullary plasmacytoma|extramedullary plasmacytoma
638745|NCT00726830|isolated plasmacytoma of bone|isolated plasmacytoma of bone
639222|NCT00735436|Malignant glioma|malignant glioma
638746|NCT00726830|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
638747|NCT00726830|stage II multiple myeloma|stage ii multiple myeloma
638748|NCT00726830|stage III multiple myeloma|stage iii multiple myeloma
638749|NCT00726830|primary systemic amyloidosis|primary systemic amyloidosis
638752|NCT00726830|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
638753|NCT00726830|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
638754|NCT00726830|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
638755|NCT00726830|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
638756|NCT00726830|Waldenström macroglobulinemia|waldenström macroglobulinemia
638757|NCT00726843|Headache|headache
638758|NCT00726843|Complementary and Alternative Medicine|complementary and alternative medicine
638759|NCT00726843|Pediatric|pediatric
638761|NCT00726869|Patients After One to three Prior Therapies|patients after one to three prior therapies
638762|NCT00726882|HCV Infection|hcv infection
638763|NCT00726895|Bioavailability|bioavailability
638764|NCT00726908|Obesity|obesity
638765|NCT00726908|diet|diet
638766|NCT00726908|carbohydrate|carbohydrate
638767|NCT00726908|insulin|insulin
638768|NCT00726934|Neutropenic Diet|neutropenic diet
638769|NCT00726934|Food Safety Guidelines|food safety guidelines
638770|NCT00726934|child|child
638771|NCT00726934|cancer|cancer
638772|NCT00726960|Heroin abuse|heroin abuse
638773|NCT00726960|Opioids|opioids
638774|NCT00726960|Opiates|opiates
638775|NCT00726960|Substance abuse|substance abuse
638776|NCT00726960|Addiction|addiction
638777|NCT00726973|Macular edema|macular edema
638778|NCT00726986|extensive stage small cell lung cancer|extensive stage small cell lung cancer
638779|NCT00726999|Gabapentin|gabapentin
638780|NCT00726999|Pediatric Spinal Fusion|pediatric spinal fusion
638781|NCT00726999|Narcotic Use|narcotic use
638782|NCT00727012|mitral valve|mitral valve
638783|NCT00727012|heart valve|heart valve
638784|NCT00727012|valve repair|valve repair
638785|NCT00727012|valve disorder|valve disorder
638786|NCT00727012|valve disease|valve disease
638787|NCT00727012|cardiac surgery|cardiac surgery
638788|NCT00727025|skin closure devices|skin closure devices
638789|NCT00727025|linear scars|linear scars
638790|NCT00727038|glaucoma|glaucoma
638791|NCT00727038|neovascular glaucoma|neovascular glaucoma
638792|NCT00727038|new onset glaucoma|new onset glaucoma
638793|NCT00727038|retinal ischemia|retinal ischemia
638794|NCT00727038|central retinal vein occlusion|central retinal vein occlusion
638795|NCT00727038|proliferative diabetic retinopathy|proliferative diabetic retinopathy
638796|NCT00727038|ocular ischemic syndrome|ocular ischemic syndrome
638797|NCT00727038|carotid stenosis|carotid stenosis
638798|NCT00727038|vascular endothelial growth factor|vascular endothelial growth factor
638799|NCT00727038|neovascular|neovascular
638901|NCT00734279|Delayed|delayed
638800|NCT00727051|invasive coronary angiography|invasive coronary angiography
638801|NCT00727051|multidetector coronary CTA|multidetector coronary cta
638802|NCT00727051|coronary artery disease|coronary artery disease
638803|NCT00727051|detecting coronary artery disease|detecting coronary artery disease
638804|NCT00727064|Healthy Subjects|healthy subjects
638805|NCT00727103|Varenicline|varenicline
638806|NCT00727103|Smoking cessation|smoking cessation
638807|NCT00727103|Schizophrenia|schizophrenia
638808|NCT00727103|Schizoaffective disorder|schizoaffective disorder
638809|NCT00727103|Alcohol dependence|alcohol dependence
638810|NCT00727103|Nicotine dependence|nicotine dependence
638811|NCT00727129|vasomotor symptoms|vasomotor symptoms
638812|NCT00727129|estrogen|estrogen
638813|NCT00727129|estradiol|estradiol
638814|NCT00727129|hot flashes|hot flashes
638816|NCT00727142|Hydrocephalus|hydrocephalus
638817|NCT00727142|Shunt|shunt
638818|NCT00727168|prevalence study|prevalence study
638819|NCT00727168|glaucoma|glaucoma
638820|NCT00727181|aortic valve|aortic valve
638821|NCT00727181|heart valve|heart valve
638822|NCT00727181|tissue valve|tissue valve
638823|NCT00727181|bioprosthesis|bioprosthesis
638824|NCT00727181|valve disorder|valve disorder
638825|NCT00727181|valve disease|valve disease
638826|NCT00727181|cardiac surgery|cardiac surgery
638827|NCT00727181|aortic valve stenosis|aortic valve stenosis
638828|NCT00727181|aortic valve regurgitation|aortic valve regurgitation
638829|NCT00727207|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
638830|NCT00727207|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
638831|NCT00727207|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
638832|NCT00727207|stage I mantle cell lymphoma|stage i mantle cell lymphoma
638833|NCT00727207|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
638834|NCT00727207|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
638835|NCT00727220|type 1 diabetes|type 1 diabetes
638836|NCT00727220|continuous glucose sensor monitoring|continuous glucose sensor monitoring
638837|NCT00727233|Neuroblastosis Type I|neuroblastosis type i
638838|NCT00727233|Plexiform Neurofibromas|plexiform neurofibromas
638839|NCT00727233|Angiogenesis Inhibitor|angiogenesis inhibitor
638840|NCT00727233|Kinase Inhibitor|kinase inhibitor
638841|NCT00727233|Neurofibromatosis Type 1|neurofibromatosis type 1
638842|NCT00727233|NF1|nf1
638843|NCT00727233|Plexiform Neurofibroma|plexiform neurofibroma
638844|NCT00727246|Traumatic Brain Injury|traumatic brain injury
638845|NCT00727246|FMRI|fmri
638846|NCT00727246|Memory|memory
638847|NCT00727246|Cognition|cognition
638848|NCT00727246|Neuropsychology|neuropsychology
638849|NCT00727272|Bioavailability|bioavailability
638850|NCT00727285|Cystic Fibrosis|cystic fibrosis
638851|NCT00727285|pulmonary exacerbation|pulmonary exacerbation
638852|NCT00727285|gene expression|gene expression
638853|NCT00727285|biomarker|biomarker
638854|NCT00727285|inflammation|inflammation
638855|NCT00727285|CF pulmonary exacerbation|cf pulmonary exacerbation
638856|NCT00734084|Arthroplasty|arthroplasty
638857|NCT00734084|Knee|knee
638858|NCT00734084|UKA|uka
638859|NCT00734084|Partial|partial
638860|NCT00734084|Preservation|preservation
638861|NCT00734097|heartburn|heartburn
638862|NCT00734097|reflux|reflux
638863|NCT00734097|proton|proton
638864|NCT00734097|pump|pump
638865|NCT00734097|inhibitor|inhibitor
638866|NCT00734110|Arthroplasty, Replacement, Knee, P.F.C. Sigma RPF, Sigma RP|arthroplasty, replacement, knee, p.f.c. sigma rpf, sigma rp
638867|NCT00734123|Atherosclerosis|atherosclerosis
638868|NCT00734123|Cardiovascular Prevention|cardiovascular prevention
638869|NCT00734123|Carotid Intima-Media Thickness|carotid intima-media thickness
638870|NCT00734123|Ankle-Brachial Index|ankle-brachial index
638871|NCT00734136|Angiogenic Factors|angiogenic factors
638872|NCT00734136|Hepatorenal Syndrome|hepatorenal syndrome
638873|NCT00734136|Liver Disease|liver disease
638874|NCT00734136|Renal Failure|renal failure
638875|NCT00734136|Liver Cirrhosis|liver cirrhosis
638877|NCT00734149|Multiple myeloma|multiple myeloma
638878|NCT00734162|tenofovir|tenofovir
638879|NCT00734162|adolescents|adolescents
638880|NCT00734162|chronic hepatitis B|chronic hepatitis b
638881|NCT00734175|Vaccine|vaccine
638882|NCT00734175|Influenza|influenza
638883|NCT00734201|Study effects on blood pressure and weight in obese subjects|study effects on blood pressure and weight in obese subjects
638884|NCT00734214|Parenteral Fluids|parenteral fluids
638885|NCT00734214|Isotonic|isotonic
638886|NCT00734214|Hypotonic|hypotonic
638887|NCT00734214|Pediatric|pediatric
638888|NCT00734214|Fluid overload|fluid overload
638889|NCT00734227|Survival and control of hemorrhage|survival and control of hemorrhage
638890|NCT00734253|Nephropathy|nephropathy
638891|NCT00734253|Kidney Disease|kidney disease
638892|NCT00734253|Diabetes|diabetes
638893|NCT00734253|Pyridoxamine|pyridoxamine
638894|NCT00734253|Pyridorin|pyridorin
638895|NCT00734253|NephroGenex|nephrogenex
638896|NCT00734253|PYR-210|pyr-210
638897|NCT00734266|COPD|copd
638898|NCT00734266|CPB|cpb
638899|NCT00734266|Leukotrienes|leukotrienes
638900|NCT00734279|Puberty|puberty
638902|NCT00734279|Early|early
638903|NCT00734279|Precocious|precocious
638904|NCT00734279|Peripubertal|peripubertal
638905|NCT00734279|Gonadotropin|gonadotropin
638906|NCT00734279|FSH|fsh
638907|NCT00734279|LH|lh
638908|NCT00734292|Asthma|asthma
638909|NCT00734292|Asthma Mild to Moderate|asthma mild to moderate
638910|NCT00734305|cancer, solid tumors, oncology, Phase I, ErbB3, HER3|cancer, solid tumors, oncology, phase i, erbb3, her3
638911|NCT00734305|(erbB-3, HER-3)|(erbb-3, her-3)
638912|NCT00734318|Severe asthma|severe asthma
638913|NCT00734318|Fluticasone|fluticasone
638914|NCT00734318|Formoterol|formoterol
638915|NCT00734331|inflammatory bowel disease|inflammatory bowel disease
638916|NCT00734331|micro RNA|micro rna
638917|NCT00734331|cholinergic tone|cholinergic tone
638918|NCT00734331|inflammation|inflammation
638920|NCT00734357|ct|ct
638921|NCT00734357|cat scan|cat scan
638922|NCT00734357|kidney|kidney
638923|NCT00734357|nephrotoxicity|nephrotoxicity
638924|NCT00734357|Computerized Emission Tomography|computerized emission tomography
638925|NCT00734370|Panic Disorder and Agoraphobia|panic disorder and agoraphobia
638926|NCT00734370|Virtual Reality Exposure Therapy|virtual reality exposure therapy
638927|NCT00734383|coronary artery bypass surgery|coronary artery bypass surgery
638928|NCT00734383|coronary artery bypass grafting|coronary artery bypass grafting
638929|NCT00734383|cardiopulmonary bypass|cardiopulmonary bypass
638930|NCT00734383|diabetes|diabetes
638931|NCT00734383|myocardial injury markers,|myocardial injury markers,
638932|NCT00734383|sex differences|sex differences
638933|NCT00734383|cardiac anesthesia|cardiac anesthesia
638934|NCT00734383|inhalational anesthetics|inhalational anesthetics
638935|NCT00734396|Mesenchymal stem cells|mesenchymal stem cells
638936|NCT00734396|Allograft rejection|allograft rejection
638937|NCT00734396|Subclinical rejection|subclinical rejection
638938|NCT00734409|Mechanical ventilation|mechanical ventilation
638939|NCT00734409|Human|human
638940|NCT00734409|conscious sedation|conscious sedation
638941|NCT00734409|bispectral index|bispectral index
638942|NCT00734409|monitoring|monitoring
638943|NCT00734409|critical care|critical care
638944|NCT00734409|propofol|propofol
638945|NCT00734773|neurotoxicity|neurotoxicity
638946|NCT00734773|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
638947|NCT00734773|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
638948|NCT00734786|gonyautoxin|gonyautoxin
638949|NCT00734799|Posttraumatic Stress Disorder|posttraumatic stress disorder
638950|NCT00734799|Insomnia,|insomnia,
638951|NCT00734799|Imagery Rehearsal Therapy,|imagery rehearsal therapy,
638952|NCT00734799|IRT,|irt,
638953|NCT00734799|Cognitive Behavioral Therapy for Insomnia,|cognitive behavioral therapy for insomnia,
638954|NCT00734799|CBTI.|cbti.
638955|NCT00734812|Hysterectomy|hysterectomy
638956|NCT00734812|Laparoscopic|laparoscopic
638957|NCT00734825|Appendicitis|appendicitis
638958|NCT00734825|IV Contrast|iv contrast
638959|NCT00734825|Oral Contrast|oral contrast
638960|NCT00734825|CT scan|ct scan
638961|NCT00734838|Breast Cancer|breast cancer
638962|NCT00734838|Breast Biopsy|breast biopsy
638963|NCT00734838|Reduction mammoplasty|reduction mammoplasty
638964|NCT00734851|prostate cancer|prostate cancer
638965|NCT00734851|sunitinib|sunitinib
638966|NCT00734851|docetaxel|docetaxel
638967|NCT00734851|PSA|psa
638968|NCT00734851|radiation|radiation
638969|NCT00734851|PSA recurrence|psa recurrence
638970|NCT00734851|No metastatic disease|no metastatic disease
638971|NCT00734864|Dasatinib|dasatinib
638972|NCT00734864|Sprycel|sprycel
638973|NCT00734864|Temozolomide|temozolomide
638974|NCT00734864|Temodar|temodar
638975|NCT00734864|Recurrent Malignant Glioma|recurrent malignant glioma
638976|NCT00734864|Malignant Glioma|malignant glioma
638977|NCT00734864|glioblastoma multiforme|glioblastoma multiforme
638978|NCT00734864|gliosarcoma|gliosarcoma
638979|NCT00734864|anaplastic astrocytoma|anaplastic astrocytoma
638980|NCT00734864|anaplastic oligodendroglioma|anaplastic oligodendroglioma
638981|NCT00734864|anaplastic mixed glioma|anaplastic mixed glioma
638982|NCT00734864|glioma|glioma
638983|NCT00734890|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
638984|NCT00734890|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
638985|NCT00734890|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
638986|NCT00734890|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
638987|NCT00734890|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
638988|NCT00734890|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
638989|NCT00734890|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
638990|NCT00734890|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
638991|NCT00734890|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
638992|NCT00734890|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
638993|NCT00734890|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
639159|NCT00735241|yttrium-90|yttrium-90
639160|NCT00735241|FOLFOX|folfox
638994|NCT00734890|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
638995|NCT00734890|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
638996|NCT00734890|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
638997|NCT00734890|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
638998|NCT00734890|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
638999|NCT00734890|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
639000|NCT00734890|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
639001|NCT00734890|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
639002|NCT00734890|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
639003|NCT00734890|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
639004|NCT00734890|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
639005|NCT00734890|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
639006|NCT00734890|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
639007|NCT00734890|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
639008|NCT00734890|anaplastic large cell lymphoma|anaplastic large cell lymphoma
639009|NCT00734890|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
639010|NCT00734890|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
639011|NCT00734890|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
639012|NCT00734890|Waldenström macroglobulinemia|waldenström macroglobulinemia
639013|NCT00734890|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
639014|NCT00734890|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
639015|NCT00734890|splenic marginal zone lymphoma|splenic marginal zone lymphoma
639016|NCT00734890|intraocular lymphoma|intraocular lymphoma
639017|NCT00734890|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
639018|NCT00734890|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
639019|NCT00734890|small intestine lymphoma|small intestine lymphoma
639020|NCT00734890|adenocarcinoma of the lung|adenocarcinoma of the lung
639021|NCT00734890|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
639022|NCT00734890|large cell lung cancer|large cell lung cancer
639023|NCT00734890|adenosquamous cell lung cancer|adenosquamous cell lung cancer
639024|NCT00734890|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
639025|NCT00734890|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
639026|NCT00734890|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
639027|NCT00734890|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
639028|NCT00734890|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
639029|NCT00734890|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
639030|NCT00734890|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
639031|NCT00734890|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
639032|NCT00734890|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
639033|NCT00734890|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
639034|NCT00734890|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
639035|NCT00734890|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
639036|NCT00734890|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
639037|NCT00734890|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
639038|NCT00734890|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
639039|NCT00734890|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
639040|NCT00734890|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
639041|NCT00734890|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
639133|NCT00735176|Radiculopathy, cervical|radiculopathy, cervical
639042|NCT00734890|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
639043|NCT00734890|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
639044|NCT00734890|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
639045|NCT00734890|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
639046|NCT00734890|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
639047|NCT00734890|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
639048|NCT00734890|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
639049|NCT00734890|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
639050|NCT00734890|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
639051|NCT00734890|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
639052|NCT00734890|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
639053|NCT00734890|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
639054|NCT00734890|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
639055|NCT00734890|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
639056|NCT00734890|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
639057|NCT00734890|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
639058|NCT00734890|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
639059|NCT00734890|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
639060|NCT00734903|Women|women
639061|NCT00734903|Substance Use Disorders|substance use disorders
639062|NCT00734903|Treatment Efficacy|treatment efficacy
639063|NCT00734903|Women's Health|women's health
639064|NCT00734903|Outcome Assessment (Health Care)|outcome assessment (health care)
639065|NCT00734916|total parenteral nutrition|total parenteral nutrition
639066|NCT00734916|infections|infections
639067|NCT00734916|Infectious complications related to parenteral nutrition|infectious complications related to parenteral nutrition
639068|NCT00734929|PONV|ponv
639069|NCT00734929|nausea|nausea
639070|NCT00734929|emesis|emesis
639071|NCT00734929|antiemetics|antiemetics
639072|NCT00734929|aprepitant|aprepitant
639073|NCT00734929|ondansetron|ondansetron
639074|NCT00734929|dexamethasone|dexamethasone
639075|NCT00734942|young carers|young carers
639076|NCT00734942|family support|family support
639077|NCT00734942|children (up to the age of 18) of chronically ill parents|children (up to the age of 18) of chronically ill parents
639078|NCT00734955|Partial Mastectomy|partial mastectomy
639079|NCT00734955|Lumpectomy|lumpectomy
639080|NCT00734955|Mastectomy|mastectomy
639081|NCT00734968|Urinary tract infection (UTI)|urinary tract infection (uti)
639082|NCT00734968|suburethral sling|suburethral sling
639083|NCT00734968|Prevention|prevention
639084|NCT00734968|Nitrofurantoin|nitrofurantoin
639085|NCT00734968|Prophylaxis|prophylaxis
639086|NCT00735007|Multiple Sclerosis|multiple sclerosis
639087|NCT00735020|influenza|influenza
639088|NCT00735020|vaccine|vaccine
639089|NCT00735020|adjuvants|adjuvants
639090|NCT00735020|flu|flu
639091|NCT00735033|Physical therapy|physical therapy
639092|NCT00735033|Physical therapy modalities|physical therapy modalities
639223|NCT00735436|Glioblastoma multiforme|glioblastoma multiforme
639093|NCT00735033|Cerebral Vascular Accident (CVA)|cerebral vascular accident (cva)
639094|NCT00735046|Early dementia in Alzheimer's disease (MMSE ≥ 21)|early dementia in alzheimer's disease (mmse ≥ 21)
639095|NCT00735059|dialysis membrane|dialysis membrane
639096|NCT00735059|Polynephron|polynephron
639097|NCT00735059|Elisio H|elisio h
639098|NCT00735059|Polyethersulfone|polyethersulfone
639099|NCT00735059|Diapes|diapes
639100|NCT00735059|PES-DS|pes-ds
639101|NCT00735059|online post-dilution hemodiafiltration|online post-dilution hemodiafiltration
639102|NCT00735059|hemodialysis|hemodialysis
639103|NCT00735059|protein-bound toxins|protein-bound toxins
639104|NCT00735059|beta-2-microglobulin|beta-2-microglobulin
639311|NCT00735813|Infection|infection
639105|NCT00735059|hemodialysis patients|hemodialysis patients
639106|NCT00735072|HIV infection|hiv infection
639107|NCT00735072|T cell activation|t cell activation
639108|NCT00735072|Antiretroviral Therapy|antiretroviral therapy
639109|NCT00735072|CCR5|ccr5
639110|NCT00735072|Maraviroc|maraviroc
639111|NCT00735085|Brain Injury|brain injury
639112|NCT00735098|Knee Osteoarthritis|knee osteoarthritis
639113|NCT00735098|arthritis|arthritis
639115|NCT00735111|Quality of Life|quality of life
639116|NCT00735111|KPS|kps
639117|NCT00735111|Karnofsky Performance Status|karnofsky performance status
639118|NCT00735111|Cancer|cancer
639119|NCT00735124|analgesia requirement and post operative pain|analgesia requirement and post operative pain
639120|NCT00735137|Twins|twins
639121|NCT00735137|Short cervix|short cervix
639122|NCT00735137|Preterm birth|preterm birth
639123|NCT00735137|Vaginal pessary|vaginal pessary
639124|NCT00735150|Breast|breast
639125|NCT00735150|Ovary|ovary
639126|NCT00735150|Mutation carrier|mutation carrier
639127|NCT00735163|algorithm|algorithm
639128|NCT00735163|tight glycemic control|tight glycemic control
639129|NCT00735163|glucose control|glucose control
639130|NCT00735163|intensive care|intensive care
639131|NCT00735163|insulin|insulin
639132|NCT00735163|ICU|icu
639134|NCT00735176|Nerve Root Compression|nerve root compression
639135|NCT00735176|Disc, intervertebral|disc, intervertebral
639136|NCT00735176|Intervertebral Disk Displacement|intervertebral disk displacement
639137|NCT00735176|Spondylosis|spondylosis
639138|NCT00735176|Spinal Osteophytosis|spinal osteophytosis
639139|NCT00735176|Arthroplasty, replacement|arthroplasty, replacement
639140|NCT00735176|Diskectomy|diskectomy
639141|NCT00735176|Spinal Fusion|spinal fusion
639142|NCT00735189|warfarin|warfarin
639143|NCT00735189|anticoagulation|anticoagulation
639144|NCT00735189|anticoagulation clinics|anticoagulation clinics
639145|NCT00735215|Breast cancer,|breast cancer,
639146|NCT00735215|fulvestrant,|fulvestrant,
639147|NCT00735215|postmenopausal,|postmenopausal,
639148|NCT00735215|women|women
639149|NCT00735215|locally advanced,|locally advanced,
639150|NCT00735215|hormone receptor-positive.|hormone receptor-positive.
639151|NCT00735228|surgery|surgery
639152|NCT00735228|artificial pancreas|artificial pancreas
639153|NCT00735228|tight glycemic control|tight glycemic control
639154|NCT00735228|Liver|liver
639155|NCT00735241|colon cancer|colon cancer
639156|NCT00735241|colorectal cancer|colorectal cancer
639157|NCT00735241|liver metastases|liver metastases
639158|NCT00735241|SIR-Spheres Microspheres|sir-spheres microspheres
639161|NCT00735241|Bevacizumab|bevacizumab
639162|NCT00735241|chemo-radiation|chemo-radiation
639163|NCT00735254|post|post
639164|NCT00735254|surgical|surgical
639165|NCT00735267|Generalized Anxiety Disorder|generalized anxiety disorder
639166|NCT00735280|Coronary artery disease, stent, heparin|coronary artery disease, stent, heparin
639167|NCT00735293|hyperhidrosis|hyperhidrosis
639168|NCT00735293|bromidrosis|bromidrosis
639169|NCT00735293|bromhidrosis|bromhidrosis
639170|NCT00735293|osmidrosis|osmidrosis
639171|NCT00735293|hircismus|hircismus
639172|NCT00735293|excessive|excessive
639173|NCT00735293|underarm|underarm
639174|NCT00735293|sweat|sweat
639175|NCT00735293|perspiration|perspiration
639176|NCT00735293|Body Odor|body odor
639177|NCT00735306|Locally advanced|locally advanced
639178|NCT00735306|Unresectable|unresectable
639179|NCT00735319|Neonatal Jaundice|neonatal jaundice
639180|NCT00735319|Physiological Neonatal Jaundice|physiological neonatal jaundice
639181|NCT00735319|Neonatal Hyperbilirubinemia|neonatal hyperbilirubinemia
639182|NCT00735319|Transcutaneous Bilirubinometer|transcutaneous bilirubinometer
639183|NCT00735332|Melanoma|melanoma
639184|NCT00735332|Metastatic Melanoma|metastatic melanoma
639185|NCT00735332|Phase II|phase ii
639186|NCT00735332|Skin Cancer|skin cancer
639187|NCT00735345|Esophageal cancer|esophageal cancer
640567|NCT00742027|HL|hl
639188|NCT00735345|Pre-operative|pre-operative
639189|NCT00735345|Chemo-immunotherapy|chemo-immunotherapy
639190|NCT00735345|Radiochemo-immunotherapy|radiochemo-immunotherapy
639191|NCT00735345|EGFR|egfr
639192|NCT00735345|Radiosensitivity|radiosensitivity
639193|NCT00735345|Resection|resection
639194|NCT00735358|gastric variceal bleeding|gastric variceal bleeding
639195|NCT00735358|cyanoacrylate|cyanoacrylate
639196|NCT00735358|rebleeding|rebleeding
639197|NCT00735358|complication|complication
639198|NCT00735358|survival|survival
639199|NCT00735358|acute gastric variceal bleeding|acute gastric variceal bleeding
639200|NCT00735384|sepsis|sepsis
639201|NCT00735384|critical illness|critical illness
639202|NCT00735384|muscle, skeletal|muscle, skeletal
639203|NCT00735384|myopathy|myopathy
639204|NCT00735384|isometric contraction|isometric contraction
639205|NCT00735384|intensive care units|intensive care units
639206|NCT00735384|torque|torque
639207|NCT00735384|muscular atrophy|muscular atrophy
639208|NCT00735384|malignant hyperthermia|malignant hyperthermia
639209|NCT00735384|skin resistance|skin resistance
639210|NCT00735397|Partial onset seizures|partial onset seizures
639211|NCT00735410|Influenza vaccine|influenza vaccine
639212|NCT00735410|Seasonal|seasonal
639213|NCT00735410|Split|split
639214|NCT00735423|Healthy children|healthy children
639215|NCT00735423|Brain Function|brain function
639216|NCT00735423|Diet|diet
639217|NCT00735423|Nutrition|nutrition
639218|NCT00735423|Language|language
639219|NCT00735423|fMRI|fmri
639220|NCT00735423|ERP|erp
639224|NCT00735436|GBM|gbm
639225|NCT00735436|Gliosarcoma|gliosarcoma
639226|NCT00735436|Gliadel|gliadel
639227|NCT00735436|Carmustine|carmustine
639228|NCT00735436|Irinotecan|irinotecan
639229|NCT00735436|CPT-11|cpt-11
639230|NCT00735436|Camptosar|camptosar
639231|NCT00735436|Avastin|avastin
639232|NCT00735436|Bevacizumab|bevacizumab
639233|NCT00735462|external genital warts|external genital warts
639234|NCT00735462|perianal warts|perianal warts
639235|NCT00735462|condylomata acuminata|condylomata acuminata
639236|NCT00735462|human papilloma virus|human papilloma virus
639237|NCT00735462|HPV types 6 and 11|hpv types 6 and 11
639238|NCT00735488|Thalassemia|thalassemia
639239|NCT00735488|Sickle cell anemia|sickle cell anemia
639240|NCT00735488|Carrier detection|carrier detection
639241|NCT00735488|Prenatal Diagnosis|prenatal diagnosis
639242|NCT00735488|Genetic counseling|genetic counseling
639243|NCT00735514|radiation toxicity|radiation toxicity
639244|NCT00735514|sexuality and reproductive issues|sexuality and reproductive issues
639245|NCT00735514|stage I endometrial carcinoma|stage i endometrial carcinoma
639246|NCT00735514|stage II endometrial carcinoma|stage ii endometrial carcinoma
639247|NCT00735514|stage IB cervical cancer|stage ib cervical cancer
639248|NCT00735514|stage IIA cervical cancer|stage iia cervical cancer
639249|NCT00735514|stage IIB cervical cancer|stage iib cervical cancer
639250|NCT00735514|stage III cervical cancer|stage iii cervical cancer
639251|NCT00735527|seizures|seizures
639252|NCT00735527|status epilepticus|status epilepticus
639253|NCT00735527|lorazepam|lorazepam
639254|NCT00735527|intra-nasal|intra-nasal
639255|NCT00735553|Uterine Fibroids|uterine fibroids
639256|NCT00735566|gastric cancer|gastric cancer
639257|NCT00735566|antiangiogenic factors|antiangiogenic factors
639258|NCT00735566|TNM stage|tnm stage
639259|NCT00735579|major abdominal surgery|major abdominal surgery
639260|NCT00735579|coagulation|coagulation
639261|NCT00735579|extracellular matrix proteins|extracellular matrix proteins
639262|NCT00735579|wound healing after major abdominal surgery|wound healing after major abdominal surgery
639263|NCT00735592|X rays findings|x rays findings
639264|NCT00735605|obstructed defecation|obstructed defecation
639265|NCT00735605|constipation|constipation
639266|NCT00735605|puborectalis|puborectalis
639267|NCT00735618|Advanced Cancer|advanced cancer
639268|NCT00735618|Cancer Patients|cancer patients
639269|NCT00735618|Relaxation Therapy|relaxation therapy
639270|NCT00735618|Relaxation and Heart Rate Variability|relaxation and heart rate variability
639271|NCT00735618|Guided Relaxation|guided relaxation
639273|NCT00735618|Stress, Anxiety, and Panic Disorder|stress, anxiety, and panic disorder
751798|NCT01170507|vitamin D3, 25 OH vitamin D3 level|vitamin d3, 25 oh vitamin d3 level
751799|NCT01170520|adolescent resistant depression|adolescent resistant depression
639274|NCT00735631|Patients entering the post-operative cardiac intensive care unit following coronary artery reconstruction surgery.|patients entering the post-operative cardiac intensive care unit following coronary artery reconstruction surgery.
639275|NCT00735644|Japanese encephalitis, Hepatitis A, Inactivated Mouse-Brain|japanese encephalitis, hepatitis a, inactivated mouse-brain
639276|NCT00735657|Efficiency|efficiency
639277|NCT00735657|Pars|pars
639278|NCT00735657|Plana|plana
639279|NCT00735657|Vitrectomy|vitrectomy
639280|NCT00735670|SCI|sci
639281|NCT00735683|Weight loss|weight loss
639282|NCT00735683|Weight-loss drugs|weight-loss drugs
639283|NCT00735683|Obesity|obesity
639284|NCT00735683|Overweight|overweight
639285|NCT00735683|Body weight|body weight
639286|NCT00735683|Diet|diet
639287|NCT00735683|Metabolic Disorder|metabolic disorder
639288|NCT00735683|Nutrition Disorder|nutrition disorder
639289|NCT00735696|Non Small Cell Lung Cancer|non small cell lung cancer
639290|NCT00735696|Lung|lung
639291|NCT00735696|NSCLC|nsclc
639292|NCT00735709|Depression|depression
639293|NCT00735709|Depressive Disorder|depressive disorder
639294|NCT00735709|Mood Disorder|mood disorder
639295|NCT00735709|Mental Disorder|mental disorder
639296|NCT00735709|Melancholia, Involutional|melancholia, involutional
639297|NCT00735709|Paraphrenia, Involutional|paraphrenia, involutional
639298|NCT00735709|Drug Therapy|drug therapy
639299|NCT00735722|AF|af
639300|NCT00735722|CAD|cad
639301|NCT00735735|low back pain|low back pain
639302|NCT00735735|chronic|chronic
639303|NCT00735735|Substance P|substance p
639304|NCT00735748|Patients who will undergo a general anesthesia for a procedure in short stay|patients who will undergo a general anesthesia for a procedure in short stay
639305|NCT00735774|Healthy volunteer study|healthy volunteer study
639306|NCT00735800|Dementia|dementia
639307|NCT00735800|Caregivers|caregivers
639308|NCT00735800|Alzheimer's disease|alzheimer's disease
639309|NCT00735813|Catheterization, Central|catheterization, central
639310|NCT00735813|Catheterization, Peripheral|catheterization, peripheral
639312|NCT00735813|Methods|methods
639313|NCT00735813|Sepsis|sepsis
639314|NCT00735813|Microscopy, Electron, Scanning|microscopy, electron, scanning
639315|NCT00735813|Sonication|sonication
639316|NCT00735813|Taurolidine|taurolidine
639317|NCT00735813|Catheters, Indwelling|catheters, indwelling
639318|NCT00735813|Pediatrics|pediatrics
639319|NCT00735826|resectable|resectable
639320|NCT00735826|stage I-III|stage i-iii
639321|NCT00735826|NSCLC|nsclc
639322|NCT00735826|non-small cell lung cancer|non-small cell lung cancer
639323|NCT00735826|vorinostat|vorinostat
639324|NCT00735826|proof of principle|proof of principle
639325|NCT00735826|resectable stage I to III NSCLC|resectable stage i to iii nsclc
639326|NCT00735852|endometriosis|endometriosis
639327|NCT00735852|chronic cyclical pelvic pain|chronic cyclical pelvic pain
639328|NCT00735865|Dry Eye Syndrome|dry eye syndrome
639329|NCT00735865|Punctal Occlusion|punctal occlusion
639330|NCT00735865|Punctal Plugs|punctal plugs
639331|NCT00735865|Tear Drainage duct blockage|tear drainage duct blockage
639332|NCT00735878|Lung Cancer|lung cancer
639333|NCT00735878|Advanced Lung Cancer|advanced lung cancer
639334|NCT00735878|NSCLC|nsclc
639335|NCT00735891|Stage IIIB non small cell lung cancer|stage iiib non small cell lung cancer
639336|NCT00735891|Stage IV non small cell lung cancer|stage iv non small cell lung cancer
639337|NCT00735904|AG-013736|ag-013736
639342|NCT00735904|squamous cell|squamous cell
639343|NCT00735904|lung cancer|lung cancer
639344|NCT00735943|Pegaptanib|pegaptanib
639345|NCT00735943|macular degeneration|macular degeneration
639346|NCT00735943|vascular endothelial growth factor|vascular endothelial growth factor
639347|NCT00735956|Screening|screening
639348|NCT00735956|Brief Intervention|brief intervention
639349|NCT00735969|Non-Responder|non-responder
639350|NCT00735969|Relapser|relapser
639351|NCT00735969|High Dose Ribavirin|high dose ribavirin
639352|NCT00735969|Peginterferon|peginterferon
639353|NCT00735969|Chronic Hepatitis C|chronic hepatitis c
639354|NCT00736008|Factor V Leiden|factor v leiden
639355|NCT00736008|Prothrombin Mutation|prothrombin mutation
639356|NCT00736008|Hypercoagulability|hypercoagulability
639357|NCT00736008|Pediatrics|pediatrics
639358|NCT00736021|PTSD|ptsd
639359|NCT00736021|Pharmacological Treatment|pharmacological treatment
639360|NCT00736021|SSRI|ssri
639361|NCT00736021|Escitalopram|escitalopram
639362|NCT00736021|Anxiety Disorders|anxiety disorders
639363|NCT00736034|Age Associated Memory Impairment|age associated memory impairment
639364|NCT00736047|Smokers|smokers
639365|NCT00736047|smoking cessation|smoking cessation
639366|NCT00736047|vaccine|vaccine
639367|NCT00736047|antibodies|antibodies
639368|NCT00736047|anti-nicotine|anti-nicotine
639369|NCT00736060|Fever|fever
639370|NCT00736060|Blood cultures|blood cultures
639371|NCT00736073|pancreatitis|pancreatitis
639372|NCT00736086|femoral artery|femoral artery
639373|NCT00736086|post-percutaneous cardiac catheterization|post-percutaneous cardiac catheterization
639374|NCT00736086|post-percutaneous peripheral vascular catheterization|post-percutaneous peripheral vascular catheterization
752750|NCT01174017|seed migration|seed migration
639375|NCT00736086|post-percutaneous diagnostic catheterization|post-percutaneous diagnostic catheterization
639376|NCT00736086|early ambulation|early ambulation
639377|NCT00736086|vascular closure|vascular closure
639378|NCT00736112|Food Allergy in Children|food allergy in children
639379|NCT00736112|Otitis Media with Effusion (OME)|otitis media with effusion (ome)
639380|NCT00736112|Recurrent Middle Ear Infections|recurrent middle ear infections
639381|NCT00736112|Middle Ear Fluid|middle ear fluid
639382|NCT00736112|Food Allergy and Otitis Media with Effusion|food allergy and otitis media with effusion
639383|NCT00736112|Recurrent middle ear fluid in children <4 years old|recurrent middle ear fluid in children <4 years old
639384|NCT00736112|Chronic ear infections in children <4 years old|chronic ear infections in children <4 years old
752375|NCT01172717|Carcinoid|carcinoid
639385|NCT00736125|postoperative cognitive dysfunction|postoperative cognitive dysfunction
639386|NCT00736125|total knee arthroplasty|total knee arthroplasty
639387|NCT00736125|cerebral emboli|cerebral emboli
639388|NCT00736125|carbon dioxide lavage|carbon dioxide lavage
639389|NCT00736125|pulsatile saline lavage|pulsatile saline lavage
639390|NCT00736164|stage I prostate cancer|stage i prostate cancer
639391|NCT00736164|stage II prostate cancer|stage ii prostate cancer
639392|NCT00736164|adenocarcinoma of the prostate|adenocarcinoma of the prostate
639393|NCT00736177|IVF|ivf
639394|NCT00736177|blastocyst transfer|blastocyst transfer
639395|NCT00736177|endometrium|endometrium
639396|NCT00736177|embryo cryopreservation|embryo cryopreservation
639397|NCT00736190|Hepatitis B|hepatitis b
639398|NCT00736190|Hepatitis|hepatitis
639399|NCT00736190|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
639400|NCT00736190|Tenofovir DF|tenofovir df
639401|NCT00736190|Asian-American|asian-american
639402|NCT00736203|fMRI|fmri
639403|NCT00736203|non-smokers|non-smokers
639404|NCT00736216|cervical cancer|cervical cancer
639405|NCT00736216|human papilloma virus infection|human papilloma virus infection
639406|NCT00736229|hyperglycemia|hyperglycemia
639407|NCT00736229|acute coronary syndromes|acute coronary syndromes
639408|NCT00736229|myocardial infarction|myocardial infarction
639409|NCT00736242|HIV|hiv
639410|NCT00736255|ADHD|adhd
639411|NCT00736255|Smoking|smoking
639412|NCT00736268|Lung Disease|lung disease
639413|NCT00736268|Chronic Bronchitis|chronic bronchitis
639414|NCT00736268|Emphysema|emphysema
639415|NCT00736268|Caregiver stress|caregiver stress
639416|NCT00736268|COPD|copd
639417|NCT00736268|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
639418|NCT00736281|Sublingual Immunotherapy for Food Allergy|sublingual immunotherapy for food allergy
639419|NCT00736281|Food Drops for Food Allergy|food drops for food allergy
639420|NCT00736294|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
639421|NCT00736294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
639422|NCT00736307|limbal stem cell deficiency|limbal stem cell deficiency
639423|NCT00736320|Hodgkin Lymphoma|hodgkin lymphoma
639424|NCT00736320|early stage|early stage
639425|NCT00736320|PET|pet
639426|NCT00736346|Panic Disorder|panic disorder
639427|NCT00736346|anxiety|anxiety
639428|NCT00736346|chest pain|chest pain
639429|NCT00736346|emergency department|emergency department
639430|NCT00736346|cognitive-behavioral treatment|cognitive-behavioral treatment
639431|NCT00736372|cancer|cancer
639432|NCT00736372|metastatic cancer|metastatic cancer
639433|NCT00736372|advanced or metastatic cancer|advanced or metastatic cancer
639434|NCT00736385|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
639435|NCT00736411|infertility|infertility
639442|NCT00736437|Herpes labialis|herpes labialis
639443|NCT00736437|time to healing|time to healing
639444|NCT00736463|HDL cholesterol|hdl cholesterol
639446|NCT00736463|inflammation|inflammation
639447|NCT00736463|atherosclerosis|atherosclerosis
639448|NCT00736463|prevention|prevention
639449|NCT00736463|patients with low baseline HDL cholesterol|patients with low baseline hdl cholesterol
639450|NCT00736476|helicobacter pylori infection|helicobacter pylori infection
639451|NCT00736476|vaccination|vaccination
639452|NCT00736476|adults|adults
639453|NCT00736489|Asthma|asthma
639454|NCT00736489|airway obstruction|airway obstruction
639455|NCT00736489|beta2-agonist|beta2-agonist
639456|NCT00736489|efficacy|efficacy
639457|NCT00736489|inhalation|inhalation
639458|NCT00736515|combination therapy,monotherapy,gliclazide MR,insulin,CGMS|combination therapy,monotherapy,gliclazide mr,insulin,cgms
640037|NCT00731419|obstruction|obstruction
639459|NCT00736528|safety, tolerability, pharmacokinetics, cognition|safety, tolerability, pharmacokinetics, cognition
639460|NCT00736541|ARF|arf
639461|NCT00736541|OLT|olt
639462|NCT00736541|NAC|nac
639463|NCT00736541|I/R injury|i/r injury
639464|NCT00736554|Staphylococcus aureus|staphylococcus aureus
639465|NCT00736554|CA-MRSA|ca-mrsa
639466|NCT00736554|skin and soft tissue infections|skin and soft tissue infections
639467|NCT00736554|resistance|resistance
639468|NCT00736554|emergency department|emergency department
639469|NCT00736567|Diarrhea|diarrhea
639470|NCT00736567|Diagnostic|diagnostic
639471|NCT00736567|Pediatric|pediatric
639472|NCT00736580|Cesarean delivery|cesarean delivery
639473|NCT00736580|Surgical Needles|surgical needles
639474|NCT00736580|blunt-tip needles|blunt-tip needles
639475|NCT00736580|surgical glove perforation|surgical glove perforation
639476|NCT00736593|Wound|wound
639477|NCT00736593|Healing|healing
639478|NCT00736606|simvastatin|simvastatin
639479|NCT00736606|AZD5672|azd5672
639480|NCT00736619|MAB C225(CETUXIMAB)(ANTI-EGFR)|mab c225(cetuximab)(anti-egfr)
639481|NCT00736619|TAXOL (PACLITAXEL)|taxol (paclitaxel)
639482|NCT00736619|Radiation Therapy|radiation therapy
639483|NCT00736619|08-084|08-084
639484|NCT00736632|Vitamin D|vitamin d
639485|NCT00736632|Insulin Resistance|insulin resistance
639486|NCT00736632|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
639487|NCT00736632|Cardiovascular Disease|cardiovascular disease
639488|NCT00736645|adenocarcinoma of the prostate|adenocarcinoma of the prostate
639489|NCT00736645|stage I prostate cancer|stage i prostate cancer
639490|NCT00736645|stage II prostate cancer|stage ii prostate cancer
639491|NCT00736658|Japanese|japanese
639492|NCT00736658|MAD|mad
639493|NCT00736658|Multiple ascending dose|multiple ascending dose
639494|NCT00736658|Chronic pain|chronic pain
639495|NCT00736684|Femoral fractures [MeSH]|femoral fractures [mesh]
639496|NCT00736684|hip fractures [MeSH]|hip fractures [mesh]
639497|NCT00736684|trochanteric fractures (femoral neck fractures [MeSH])|trochanteric fractures (femoral neck fractures [mesh])
639498|NCT00736684|intramedullary nailing (fracture fixation, intramedullary [MeSH])|intramedullary nailing (fracture fixation, intramedullary [mesh])
639499|NCT00736684|complex femoral fractures|complex femoral fractures
639500|NCT00736684|femoral nail|femoral nail
639501|NCT00736684|surgical treatment (surgical procedures, operative [MeSH])|surgical treatment (surgical procedures, operative [mesh])
639502|NCT00736684|complications|complications
639503|NCT00736710|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
639504|NCT00736710|Cigarette smoking|cigarette smoking
639505|NCT00736710|Schizophrenia|schizophrenia
639506|NCT00736710|Randomized|randomized
639507|NCT00736710|Double-blind|double-blind
639508|NCT00736710|Placebo-controlled|placebo-controlled
639509|NCT00736710|longitudinal|longitudinal
639510|NCT00736710|nicotine patch|nicotine patch
639511|NCT00736723|NT-proBNP|nt-probnp
639512|NCT00736723|myocardial dysfunction|myocardial dysfunction
639513|NCT00736723|humans|humans
639514|NCT00736723|patients|patients
639515|NCT00736723|polytrauma|polytrauma
639516|NCT00736723|complement|complement
639517|NCT00736723|inflammation|inflammation
639518|NCT00736723|inflammatory response|inflammatory response
639519|NCT00736723|biomarkers|biomarkers
639520|NCT00736723|cytokines|cytokines
639521|NCT00736723|cell surface markers|cell surface markers
639522|NCT00736723|functional polymorphisms|functional polymorphisms
639523|NCT00736723|infections|infections
639524|NCT00736723|systemic inflammatory response syndrome|systemic inflammatory response syndrome
639525|NCT00736723|SIRS|sirs
639526|NCT00736723|sepsis|sepsis
639527|NCT00736723|severe sepsis|severe sepsis
639528|NCT00736723|shock|shock
639529|NCT00736723|organ dysfunctions|organ dysfunctions
639530|NCT00736723|SOFA|sofa
639531|NCT00736723|severity of disease|severity of disease
639532|NCT00736723|APACHEII|apacheii
639533|NCT00736723|SAPSII|sapsii
639534|NCT00736723|SPAPS3|spaps3
639535|NCT00736723|length of stay|length of stay
639536|NCT00736723|outcome|outcome
639537|NCT00736723|mortality|mortality
639538|NCT00736762|Global postural re-education|global postural re-education
639539|NCT00736762|Balance|balance
639540|NCT00736762|Physical therapy|physical therapy
639541|NCT00736762|older people|older people
639543|NCT00736775|Alzheimer's|alzheimer's
639544|NCT00736775|Alzheimers|alzheimers
639545|NCT00736788|AZD1704,|azd1704,
639546|NCT00736788|Japanese|japanese
639547|NCT00736788|Healthy|healthy
639548|NCT00736788|Volunteers,|volunteers,
639549|NCT00736788|Phase I study,|phase i study,
639550|NCT00736788|Single Ascending Dose|single ascending dose
639551|NCT00736788|Safety,|safety,
639552|NCT00736788|Tolerability|tolerability
639553|NCT00736788|Pharmacokinetics|pharmacokinetics
639554|NCT00736801|Airway hyperresponsiveness|airway hyperresponsiveness
639555|NCT00736814|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
639556|NCT00736814|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
639557|NCT00736827|BK virus|bk virus
639558|NCT00736827|acute renal failure|acute renal failure
639559|NCT00736827|hemodiafiltration|hemodiafiltration
639560|NCT00736827|humans|humans
639561|NCT00736827|patients|patients
639562|NCT00736827|polytrauma|polytrauma
639563|NCT00736827|surgery|surgery
639564|NCT00736827|complement|complement
639565|NCT00736827|inflammation|inflammation
639566|NCT00736827|inflammatory response|inflammatory response
639567|NCT00736827|biomarkers|biomarkers
639568|NCT00736827|cytokines|cytokines
639569|NCT00736827|cell surface markers|cell surface markers
639570|NCT00736827|functional polymorphisms|functional polymorphisms
639571|NCT00736827|infections|infections
639572|NCT00736827|systemic inflammatory response syndrome|systemic inflammatory response syndrome
639573|NCT00736827|SIRS|sirs
639574|NCT00736827|sepsis|sepsis
639575|NCT00736827|severe sepsis|severe sepsis
639576|NCT00736827|shock|shock
639577|NCT00736827|organ dysfunctions|organ dysfunctions
639578|NCT00736827|SOFA|sofa
639579|NCT00736827|severity of disease|severity of disease
639580|NCT00736827|APACHEII|apacheii
639581|NCT00736827|SAPSII|sapsii
639582|NCT00736827|SPAPS3|spaps3
639583|NCT00736827|length of stay|length of stay
639584|NCT00736827|outcome|outcome
639585|NCT00736827|mortality|mortality
639586|NCT00736840|Methacetin|methacetin
639587|NCT00736840|Breath|breath
639588|NCT00736840|Test|test
639589|NCT00736840|Cirrhosis|cirrhosis
639590|NCT00736853|Chronic pain|chronic pain
639591|NCT00736853|Acetoaminophen|acetoaminophen
639592|NCT00736853|Tramadol|tramadol
639593|NCT00736853|Osteoarthritis of the knee|osteoarthritis of the knee
639594|NCT00736853|Low back pain|low back pain
639595|NCT00736866|acetylcysteine|acetylcysteine
639596|NCT00736866|contrast-induced nephropathy|contrast-induced nephropathy
639597|NCT00736866|angiography|angiography
639598|NCT00736866|angioplasty with or without Stent|angioplasty with or without stent
639599|NCT00736879|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
639600|NCT00736879|Diabetes Mellitus|diabetes mellitus
639601|NCT00736879|Endocrine System Diseases|endocrine system diseases
639602|NCT00736879|Glucose Metabolism Disorders|glucose metabolism disorders
639603|NCT00736879|Metabolic Diseases|metabolic diseases
639604|NCT00736892|Acute lung injury|acute lung injury
639605|NCT00736892|Acute respiratory distress syndrome|acute respiratory distress syndrome
639606|NCT00736892|Mechanical ventilation|mechanical ventilation
639607|NCT00736892|Prognosis|prognosis
639608|NCT00736892|Definitions|definitions
639609|NCT00736905|TMC278-TiDP6-C130|tmc278-tidp6-c130
639610|NCT00736905|TMC278-C130|tmc278-c130
639611|NCT00736905|healthy volunteer|healthy volunteer
639612|NCT00736905|hepatic impairment|hepatic impairment
639613|NCT00736905|HIV Infections|hiv infections
639614|NCT00736918|Suicide Attempt|suicide attempt
639615|NCT00736931|Brivaracetam|brivaracetam
639616|NCT00736931|Cognitive neurophysiological tests (CNT)|cognitive neurophysiological tests (cnt)
639617|NCT00736931|Neuropsychological assessments|neuropsychological assessments
639618|NCT00736957|Chronic Pain|chronic pain
639619|NCT00736957|Acetaminophen|acetaminophen
639620|NCT00736957|Tramadol|tramadol
639621|NCT00736957|JNS013|jns013
639622|NCT00736970|ridaforolimus|ridaforolimus
639623|NCT00736970|deforolimus|deforolimus
639624|NCT00736970|AP23573|ap23573
639625|NCT00736970|breast cancer|breast cancer
639626|NCT00736983|Perianal fistulas|perianal fistulas
639627|NCT00736983|Crohn's disease|crohn's disease
639628|NCT00736996|Metabolic Syndrome|metabolic syndrome
639629|NCT00736996|Mild Cognitive Impairment|mild cognitive impairment
639630|NCT00736996|Insulin Resistance|insulin resistance
639631|NCT00736996|Endurance Exercise|endurance exercise
639632|NCT00737009|Breast cancer|breast cancer
639633|NCT00737009|adherence|adherence
639634|NCT00737009|anastrozole|anastrozole
639635|NCT00737009|post-menopausal women|post-menopausal women
639636|NCT00737022|Diabetic vitrectomy|diabetic vitrectomy
639637|NCT00737022|Epiretinal membrane (ERM)|epiretinal membrane (erm)
639638|NCT00737022|Macular appearance|macular appearance
639639|NCT00737022|Optical coherence tomography (OCT)|optical coherence tomography (oct)
639640|NCT00737022|Visual function|visual function
639641|NCT00737035|Intimate Partner Homicide|intimate partner homicide
639642|NCT00737035|Parental Homicide|parental homicide
639643|NCT00737035|Guardians of Child Survivors of Parental Homicide|guardians of child survivors of parental homicide
639644|NCT00737035|Post-Traumatic Stress Disorder|post-traumatic stress disorder
639645|NCT00737035|Uxoricide Project|uxoricide project
639646|NCT00737048|Pain|pain
639647|NCT00737048|Tooth extraction|tooth extraction
639648|NCT00737048|Oral surgery|oral surgery
639649|NCT00737048|Postoperative pain|postoperative pain
639650|NCT00737048|JNS013|jns013
639651|NCT00737048|Tramadol hydrochloride|tramadol hydrochloride
639652|NCT00737048|Acetaminophen|acetaminophen
639653|NCT00737061|Female|female
639654|NCT00737061|Sterilization|sterilization
639655|NCT00737074|Fibrovascular proliferation|fibrovascular proliferation
639656|NCT00737074|Internal limiting membrane peeling|internal limiting membrane peeling
639657|NCT00737074|Macular detachment|macular detachment
639658|NCT00737074|Macular hole|macular hole
640038|NCT00731419|malignant|malignant
639659|NCT00737074|Proliferative diabetic retinopathy.|proliferative diabetic retinopathy.
639660|NCT00737087|total shoulder replacement|total shoulder replacement
639661|NCT00737087|rotator cuff|rotator cuff
639662|NCT00737087|osteoarthritis|osteoarthritis
639663|NCT00737087|rheumatoid arthritis|rheumatoid arthritis
639664|NCT00737087|Delta Extend|delta extend
639665|NCT00737113|allogeneic stem cell transplantation|allogeneic stem cell transplantation
639666|NCT00737113|Engrafted|engrafted
639667|NCT00737113|subjects|subjects
639668|NCT00737126|Diabetic nephropathies|diabetic nephropathies
639669|NCT00737126|Hyperhomocysteinemia|hyperhomocysteinemia
639670|NCT00737126|Folic acid|folic acid
639671|NCT00737126|Endothelial dysfunction|endothelial dysfunction
639673|NCT00737139|Knee|knee
639674|NCT00737139|Arthroplasty|arthroplasty
639675|NCT00737139|Epinephrine|epinephrine
639676|NCT00737139|Hemostasis|hemostasis
639677|NCT00737152|RAS 130|ras 130
639678|NCT00737152|Exercise|exercise
639679|NCT00737152|Diabetes Mellitus|diabetes mellitus
639680|NCT00737152|Type II Diabetes|type ii diabetes
639681|NCT00737152|Diabetes|diabetes
639682|NCT00737152|Aerobic|aerobic
639683|NCT00737165|Suicide, Prevention|suicide, prevention
639684|NCT00737165|Community|community
639685|NCT00737178|IUD|iud
639686|NCT00737178|Intrauterine device|intrauterine device
639687|NCT00737178|Intrauterine contraception|intrauterine contraception
639688|NCT00737178|Medication abortion|medication abortion
639689|NCT00737178|Medical abortion|medical abortion
639690|NCT00737191|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
639691|NCT00737191|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
639692|NCT00737191|pain|pain
639693|NCT00737204|HIV|hiv
639694|NCT00737204|AIDS|aids
639695|NCT00737204|Armodafinil|armodafinil
639696|NCT00737204|Depression|depression
639697|NCT00737230|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
639698|NCT00737230|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
639699|NCT00737230|gastrointestinal complications|gastrointestinal complications
639700|NCT00737230|radiation toxicity|radiation toxicity
639701|NCT00737230|prostate cancer|prostate cancer
639702|NCT00737230|bladder cancer|bladder cancer
639703|NCT00737230|vulvar cancer|vulvar cancer
639704|NCT00737230|vaginal cancer|vaginal cancer
639705|NCT00737230|cervical cancer|cervical cancer
639706|NCT00737230|endometrial cancer|endometrial cancer
639707|NCT00737230|anal cancer|anal cancer
639708|NCT00737230|rectal cancer|rectal cancer
639709|NCT00737230|malignant testicular germ cell tumor|malignant testicular germ cell tumor
639710|NCT00737243|Carcinoma of Unknown Primary Site|carcinoma of unknown primary site
639711|NCT00737243|Molecular profiling assay|molecular profiling assay
639712|NCT00737243|Bevacizumab|bevacizumab
639713|NCT00737243|Erlotinib|erlotinib
639714|NCT00737243|Paclitaxel|paclitaxel
639715|NCT00737243|Carboplatin|carboplatin
639716|NCT00737269|Complicated Skin and Soft-Tissue Infection|complicated skin and soft-tissue infection
639717|NCT00737269|Skin Infection|skin infection
639718|NCT00737269|Skin Infection Registry|skin infection registry
639719|NCT00737269|cSSTI Registry|cssti registry
639720|NCT00730184|acid-base|acid-base
639721|NCT00730184|potassium|potassium
639722|NCT00730184|acidosis|acidosis
639723|NCT00730184|osteoporosis|osteoporosis
639724|NCT00730184|sarcopenia|sarcopenia
639725|NCT00730184|calcium absorption|calcium absorption
639726|NCT00730184|dietary protein|dietary protein
639727|NCT00730210|Hypoparathyroidism|hypoparathyroidism
639728|NCT00730210|HypoPTH|hypopth
639729|NCT00730210|PTH|pth
639730|NCT00730223|Nevirapine|nevirapine
639731|NCT00730223|Efavirenz|efavirenz
639732|NCT00730223|pharmacokinetics|pharmacokinetics
639733|NCT00730223|healthy|healthy
639734|NCT00730223|CYP2B6|cyp2b6
639735|NCT00730223|HIV/AIDS|hiv/aids
639736|NCT00730249|ADHD|adhd
639737|NCT00730249|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
639738|NCT00730249|adult|adult
639739|NCT00730249|methylphenidate hydrochloride|methylphenidate hydrochloride
639740|NCT00730249|Medikinet retard|medikinet retard
639741|NCT00730249|controlled clinical trial|controlled clinical trial
639742|NCT00730249|safety|safety
639743|NCT00730249|randomized, double-blind, placebo-controlled trial|randomized, double-blind, placebo-controlled trial
639744|NCT00730249|treatment|treatment
639745|NCT00730249|central nervous system stimulants|central nervous system stimulants
639746|NCT00730249|therapeutic uses|therapeutic uses
639747|NCT00730262|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
639748|NCT00730262|Phase II|phase ii
639749|NCT00730262|Brain Cancer|brain cancer
639750|NCT00730288|Dengue|dengue
639751|NCT00730288|Dengue fever|dengue fever
639752|NCT00730288|Dengue hemorrhagic fever|dengue hemorrhagic fever
639753|NCT00730288|Dengue virus|dengue virus
639754|NCT00730301|Emphysema|emphysema
639755|NCT00730301|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
639756|NCT00730301|Lung volume reduction|lung volume reduction
640039|NCT00731419|stent|stent
639757|NCT00730301|Lung function|lung function
639758|NCT00730314|unrelated|unrelated
639759|NCT00730314|BMT|bmt
639760|NCT00730314|HSCT|hsct
639761|NCT00730314|bone marrow transplantation|bone marrow transplantation
639762|NCT00730314|sickle cell disease|sickle cell disease
639763|NCT00730314|thalassemia|thalassemia
639764|NCT00730314|CGD|cgd
639765|NCT00730314|HLH|hlh
639766|NCT00730314|Blackfan-Diamond anemia|blackfan-diamond anemia
639767|NCT00730314|Hurler|hurler
639768|NCT00730314|leukodystrophy|leukodystrophy
639769|NCT00730314|LAD I|lad i
639770|NCT00730314|Genetic diseases|genetic diseases
639771|NCT00730314|Red blood cell defects|red blood cell defects
639772|NCT00730314|Leukocyte defects and immune deficiencies|leukocyte defects and immune deficiencies
639773|NCT00730314|Hereditary Lymphohistiocytosis|hereditary lymphohistiocytosis
639774|NCT00730314|chronic granulomatous disease|chronic granulomatous disease
639775|NCT00730314|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
639776|NCT00730314|Chediak Higashi syndrome|chediak higashi syndrome
639777|NCT00730314|CD40 ligand deficiency|cd40 ligand deficiency
639778|NCT00730314|Hyper IgM syndrome|hyper igm syndrome
639779|NCT00730314|leucocytes adhesion defect type 1|leucocytes adhesion defect type 1
639780|NCT00730314|Osteopetrosis|osteopetrosis
639781|NCT00730314|congenital neutropenia|congenital neutropenia
639782|NCT00730314|X-linked lymphoproliferative disease|x-linked lymphoproliferative disease
639783|NCT00730314|Platelets defects|platelets defects
639784|NCT00730314|Congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
639785|NCT00730314|Metabolic and storage disorders|metabolic and storage disorders
639786|NCT00730314|Hurler disease|hurler disease
639787|NCT00730314|leukodystrophies|leukodystrophies
639788|NCT00730314|Niemann-Pick disease|niemann-pick disease
639789|NCT00730314|Fucosidosis|fucosidosis
639790|NCT00730314|Stem cell defects|stem cell defects
639791|NCT00730314|reticular agenesis|reticular agenesis
639792|NCT00730340|Tonsillectomy, tonsillar fossa, wound closure|tonsillectomy, tonsillar fossa, wound closure
639793|NCT00730366|Malaria|malaria
639794|NCT00730366|Pregnancy|pregnancy
639795|NCT00730366|Intermittent Preventive Treatment|intermittent preventive treatment
639796|NCT00730392|Type 1 diabetes, Etanercept, honeymoon period|type 1 diabetes, etanercept, honeymoon period
639797|NCT00730405|Distal, Subungual onychomycosis|distal, subungual onychomycosis
639798|NCT00730405|onychomycosis|onychomycosis
639799|NCT00730405|nail fungus|nail fungus
639800|NCT00730405|Toenail fungus|toenail fungus
639801|NCT00730418|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
639802|NCT00730418|alpha Adrenergic Blockers|alpha adrenergic blockers
639803|NCT00730418|alpha-1 Adrenergic Receptor|alpha-1 adrenergic receptor
639804|NCT00730431|Hepatitis C, healthy volunteers|hepatitis c, healthy volunteers
639805|NCT00730444|Neuroblastoma|neuroblastoma
639806|NCT00730444|Nuclear medicine|nuclear medicine
639807|NCT00730444|Diagnostic scintigraphy|diagnostic scintigraphy
639808|NCT00730444|Known and suspected neuroblastoma|known and suspected neuroblastoma
639809|NCT00730457|influenza|influenza
639810|NCT00730457|recombinant|recombinant
639811|NCT00730457|hemagglutinin|hemagglutinin
639812|NCT00730457|vaccine|vaccine
639813|NCT00730470|Human Epidermal Growth Factor Receptor 3|human epidermal growth factor receptor 3
639814|NCT00730470|HER3|her3
639815|NCT00730470|Heregulin|heregulin
639816|NCT00730470|erb B3|erb b3
639817|NCT00730470|Solid Tumors|solid tumors
639818|NCT00730470|Phase I Clinical Study|phase i clinical study
639819|NCT00730483|liver metastases|liver metastases
639820|NCT00730483|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
639821|NCT00730483|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
639822|NCT00730483|islet cell carcinoma|islet cell carcinoma
639823|NCT00730483|gastrinoma|gastrinoma
639824|NCT00730483|insulinoma|insulinoma
639825|NCT00730483|glucagonoma|glucagonoma
639826|NCT00730483|pancreatic polypeptide tumor|pancreatic polypeptide tumor
639827|NCT00730483|somatostatinoma|somatostatinoma
639828|NCT00730496|Embryo culture supernatant|embryo culture supernatant
639829|NCT00730496|injection|injection
639830|NCT00730496|embryo transfer|embryo transfer
639831|NCT00730496|embryo implantation rate|embryo implantation rate
639832|NCT00730509|cystic fibrosis|cystic fibrosis
639833|NCT00730509|folate|folate
639834|NCT00730509|vitamin B12|vitamin b12
639835|NCT00730522|Methamphetamine|methamphetamine
639836|NCT00730522|Dependency|dependency
639837|NCT00730522|Addiction|addiction
639838|NCT00730522|vigabatrin|vigabatrin
639839|NCT00730535|Overactive bladder, Tolterodine,Symptoms Relapse, Predictor|overactive bladder, tolterodine,symptoms relapse, predictor
639840|NCT00730561|nerve conduction velocity|nerve conduction velocity
639841|NCT00730561|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
639842|NCT00730587|Nutrition|nutrition
639843|NCT00730587|Body Fat|body fat
639844|NCT00730587|Infant|infant
639845|NCT00730587|Healthy Babies|healthy babies
639846|NCT00730600|Thai Traditional massage|thai traditional massage
639847|NCT00730600|Bone Formation|bone formation
639848|NCT00730600|Bone Resorption|bone resorption
639849|NCT00730613|adult anaplastic astrocytoma|adult anaplastic astrocytoma
640040|NCT00731419|palliation|palliation
639850|NCT00730613|adult diffuse astrocytoma|adult diffuse astrocytoma
639851|NCT00730613|adult pilocytic astrocytoma|adult pilocytic astrocytoma
639852|NCT00730613|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
639853|NCT00730613|adult anaplastic ependymoma|adult anaplastic ependymoma
639854|NCT00730613|adult ependymoma|adult ependymoma
639855|NCT00730613|adult myxopapillary ependymoma|adult myxopapillary ependymoma
639856|NCT00730613|adult subependymoma|adult subependymoma
639857|NCT00730613|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
639858|NCT00730613|adult oligodendroglioma|adult oligodendroglioma
639859|NCT00730613|adult brain stem glioma|adult brain stem glioma
639860|NCT00730613|adult giant cell glioblastoma|adult giant cell glioblastoma
639861|NCT00730613|adult glioblastoma|adult glioblastoma
639862|NCT00730613|recurrent adult brain tumor|recurrent adult brain tumor
639863|NCT00730613|adult gliosarcoma|adult gliosarcoma
639864|NCT00730613|adult mixed glioma|adult mixed glioma
639865|NCT00730613|adult pineal gland astrocytoma|adult pineal gland astrocytoma
639866|NCT00730626|Probiotics|probiotics
639867|NCT00730626|Immunity|immunity
639868|NCT00730626|Immune response|immune response
639869|NCT00730626|Intestinal microflora|intestinal microflora
639870|NCT00730626|Blood lipids|blood lipids
639871|NCT00730626|Phagocytosis activity|phagocytosis activity
639872|NCT00730652|Medarex Inc.|medarex inc.
639873|NCT00730665|PPI partial responders with non-erosive GERD.|ppi partial responders with non-erosive gerd.
639874|NCT00730678|Metabolism|metabolism
639875|NCT00730678|Pharmacogenetic testing|pharmacogenetic testing
639876|NCT00730691|Generalized Anxiety Disorder|generalized anxiety disorder
639877|NCT00730691|Mood Disorder|mood disorder
639878|NCT00730691|Affective Disorder|affective disorder
639879|NCT00730691|Anxiety Disorder|anxiety disorder
639880|NCT00730691|Drug Therapy|drug therapy
639881|NCT00730704|Human Papilloma Virus vaccines|human papilloma virus vaccines
639882|NCT00730704|HPV|hpv
639883|NCT00730704|Gardasil|gardasil
639884|NCT00730704|Post partum|post partum
639885|NCT00730730|Iliac Artery, Peripheral Vascular Disease (PVD)|iliac artery, peripheral vascular disease (pvd)
639886|NCT00730756|Adolescents|adolescents
639887|NCT00730756|Irritant(non-allergic)rhinitis|irritant(non-allergic)rhinitis
639888|NCT00730756|Adults|adults
639889|NCT00730756|GW685698|gw685698
639890|NCT00730756|Air Pollution|air pollution
639891|NCT00730769|Valganciclovir|valganciclovir
639892|NCT00730769|Ganciclovir|ganciclovir
639893|NCT00730769|Pharmacokinetics|pharmacokinetics
639894|NCT00730769|Solid organ transplantation|solid organ transplantation
639895|NCT00730769|Transplant|transplant
639896|NCT00730795|Tuberculosis vaccine|tuberculosis vaccine
639897|NCT00730808|Enteral nutritional regimen prior to surgery|enteral nutritional regimen prior to surgery
639898|NCT00730834|tinnitus|tinnitus
639899|NCT00730834|ringing in the ears|ringing in the ears
639900|NCT00730834|buzzing|buzzing
639901|NCT00730834|static|static
639902|NCT00730834|hyperacusis|hyperacusis
639903|NCT00730834|loudness discomfort|loudness discomfort
639904|NCT00730834|Clinically|clinically
639905|NCT00730834|significant|significant
639906|NCT00730834|discomfort|discomfort
639907|NCT00730847|PMS|pms
639908|NCT00730847|Post-marketing surveillance|post-marketing surveillance
639909|NCT00730847|Safety|safety
639910|NCT00730847|Prescribing Information|prescribing information
639911|NCT00730847|Philippines|philippines
639912|NCT00730847|HPV|hpv
639913|NCT00730847|Human papillomavirus|human papillomavirus
639914|NCT00730860|radiofrequency ablation|radiofrequency ablation
639915|NCT00730860|Cancer of Liver|cancer of liver
639916|NCT00730860|postoperative|postoperative
639917|NCT00730860|transhepatic arterial chemoembolization|transhepatic arterial chemoembolization
639918|NCT00730860|prospective|prospective
639919|NCT00730886|Uterine Fibroids|uterine fibroids
639920|NCT00730886|Unexplained Infertility|unexplained infertility
639921|NCT00730886|MRgFUS|mrgfus
639922|NCT00730886|ExAblate|exablate
639923|NCT00730886|Focused Ultrasound|focused ultrasound
639924|NCT00730886|Myomectomy|myomectomy
639925|NCT00730938|fibrin|fibrin
639926|NCT00730938|endophthalmitis|endophthalmitis
639927|NCT00730938|cataract extraction|cataract extraction
639929|NCT00730938|implantation,|implantation,
639930|NCT00730938|intraocular|intraocular
639931|NCT00730964|Surveillance|surveillance
639932|NCT00730964|Optison|optison
639933|NCT00730964|Perflutren|perflutren
639934|NCT00730964|Echocardiography|echocardiography
639935|NCT00730964|Subjects receive Optison during enhanced echocardiography|subjects receive optison during enhanced echocardiography
639936|NCT00730990|Positron Emission Tomography study in healthy volunteers for ligand qualification and receptor occupancy determination.|positron emission tomography study in healthy volunteers for ligand qualification and receptor occupancy determination.
639937|NCT00731003|serotonin|serotonin
639938|NCT00731003|gut permeability|gut permeability
639939|NCT00731003|visceral sensitivity|visceral sensitivity
639940|NCT00731003|irritable bowel syndrome|irritable bowel syndrome
639941|NCT00731029|Influenza|influenza
639942|NCT00731029|Thiomersal-free influenza split vaccine 2002/2003|thiomersal-free influenza split vaccine 2002/2003
640142|NCT00737529|Mantle Cell Lymphoma|mantle cell lymphoma
639943|NCT00731029|Influsplit SSW®/Fluarix™ 2002/2003|influsplit ssw®/fluarix™ 2002/2003
639944|NCT00731042|Skin health|skin health
639945|NCT00731068|Achilles tendon|achilles tendon
639946|NCT00731094|overweight|overweight
639947|NCT00731094|sedentary lifestyle|sedentary lifestyle
639948|NCT00731094|exercise|exercise
639949|NCT00731094|primary health care|primary health care
639950|NCT00731094|controlled clinical trials, randomized|controlled clinical trials, randomized
639951|NCT00731107|Veress Needle|veress needle
639952|NCT00731107|XCEL bladeless trocar|xcel bladeless trocar
639953|NCT00731107|Laparoscopic entry techniques|laparoscopic entry techniques
639954|NCT00731120|Generalized Anxiety Disorder|generalized anxiety disorder
639955|NCT00731120|Mood Disorder|mood disorder
639956|NCT00731120|Affective Disorder|affective disorder
639957|NCT00731120|Anxiety Disorder|anxiety disorder
639958|NCT00731120|Drug Therapy|drug therapy
639960|NCT00731133|methamphetamine dependence|methamphetamine dependence
639961|NCT00731133|open label|open label
639962|NCT00731146|Interscalene Brachial Plexus Block|interscalene brachial plexus block
639963|NCT00731146|Regional Anesthesia|regional anesthesia
640089|NCT00737321|Impact of stress and|impact of stress and
639964|NCT00731146|Ultrasound guided peripheral nerve block|ultrasound guided peripheral nerve block
639965|NCT00731146|Minimum Effective Anesthetic Volume|minimum effective anesthetic volume
639966|NCT00731146|Nerve Stimulator guided peripheral nerve block|nerve stimulator guided peripheral nerve block
639967|NCT00731172|crohns disease|crohns disease
639968|NCT00731185|functional|functional
639969|NCT00731185|endoscopic|endoscopic
639970|NCT00731185|sinus|sinus
639971|NCT00731185|surgery|surgery
639972|NCT00731198|ERCP|ercp
639973|NCT00731198|Drotaverine hydrochloride|drotaverine hydrochloride
639974|NCT00731198|Hyoscine-N-butylbromide|hyoscine-n-butylbromide
639975|NCT00731211|Renal Cell Carcinoma|renal cell carcinoma
639976|NCT00731211|Metastatic|metastatic
639977|NCT00731211|Pazopanib|pazopanib
639978|NCT00731211|Previously-treated|previously-treated
639979|NCT00731224|Alzheimer's disease, rivastigmine, patch|alzheimer's disease, rivastigmine, patch
639980|NCT00731237|Drug Eluting Stent|drug eluting stent
639981|NCT00731237|Percutaneous Coronary Intervention|percutaneous coronary intervention
639982|NCT00731237|Everolimus|everolimus
639983|NCT00731250|Capsaicin challenge|capsaicin challenge
639984|NCT00731263|Cancer|cancer
639985|NCT00731263|Advance solid tumours|advance solid tumours
639986|NCT00731263|Dose Escalation|dose escalation
639987|NCT00731263|Preliminary efficacy|preliminary efficacy
639988|NCT00731263|AZD8055|azd8055
639989|NCT00731263|Tor kinase inhibitor|tor kinase inhibitor
639990|NCT00731263|Oral administration|oral administration
639991|NCT00731276|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
639992|NCT00731289|Osteoarthritis|osteoarthritis
639993|NCT00731289|Knee|knee
639994|NCT00731289|Hyaluronan|hyaluronan
639995|NCT00731289|Gait Analysis|gait analysis
639996|NCT00731315|UTI|uti
639997|NCT00731315|Kiosk|kiosk
639998|NCT00731315|Computer Assisted Care|computer assisted care
639999|NCT00731315|cystitis|cystitis
640000|NCT00731328|refractory anemia|refractory anemia
640001|NCT00731328|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
640002|NCT00731328|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
640003|NCT00731328|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
640004|NCT00731328|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
640005|NCT00731328|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
640006|NCT00731328|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
640007|NCT00731328|aplastic anemia|aplastic anemia
640008|NCT00731328|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
640009|NCT00731341|Uterine fibroids|uterine fibroids
640010|NCT00731341|Leiomyoma|leiomyoma
640011|NCT00731341|Menorrhagia|menorrhagia
640012|NCT00731341|Hysteroscopic cryoablation|hysteroscopic cryoablation
640013|NCT00731341|Minimally invasive|minimally invasive
640014|NCT00731354|lipoplasty|lipoplasty
640015|NCT00731354|liposuction|liposuction
640016|NCT00731354|VASER|vaser
640017|NCT00731354|body contouring|body contouring
640018|NCT00731354|body sculpting|body sculpting
640019|NCT00731354|Any patient|any patient
640020|NCT00731354|expressing|expressing
640021|NCT00731354|interest|interest
640022|NCT00731354|in elective surgery|in elective surgery
640023|NCT00731380|Abraxane|abraxane
640024|NCT00731380|Head and Neck Cancer|head and neck cancer
640025|NCT00731380|Determine|determine
640026|NCT00731380|Maximum|maximum
640027|NCT00731380|Tolerated dose|tolerated dose
640028|NCT00731380|ABI-007|abi-007
640029|NCT00731380|Combination|combination
640030|NCT00731380|Cisplatin|cisplatin
640031|NCT00731380|5-Fluorouracil|5-fluorouracil
640032|NCT00731380|Patients|patients
640033|NCT00731393|Thiomersal-free influenza split vaccine 2003/2004|thiomersal-free influenza split vaccine 2003/2004
640034|NCT00731393|Influsplit SSW®/Fluarix™ 2003/2004|influsplit ssw®/fluarix™ 2003/2004
640035|NCT00731393|Influenza|influenza
640036|NCT00731419|biliary|biliary
640041|NCT00731432|gingivitis, diabetes mellitus, herbal, oral inflammation|gingivitis, diabetes mellitus, herbal, oral inflammation
640042|NCT00731445|Z-208|z-208
640043|NCT00731458|OCT;|oct;
640044|NCT00731458|Cirrus;|cirrus;
640045|NCT00731458|Stratus;|stratus;
640046|NCT00731458|macular thickness|macular thickness
640047|NCT00731484|Dry Eye Disease|dry eye disease
640048|NCT00731484|Tear Osmolarity|tear osmolarity
640049|NCT00731484|Tear Osmolality|tear osmolality
640050|NCT00731497|SODIS|sodis
640051|NCT00731497|Drinking Water|drinking water
640052|NCT00731497|Disinfection|disinfection
640053|NCT00731497|Intervention Trial|intervention trial
640054|NCT00731510|Acute mountain sickness|acute mountain sickness
640055|NCT00731510|Body composition,Hypoxia|body composition,hypoxia
640056|NCT00731510|Carbohydrate supplementation|carbohydrate supplementation
640058|NCT00731510|Hydration,|hydration,
640059|NCT00731510|Hypoxia|hypoxia
640060|NCT00731510|Performance|performance
640061|NCT00731523|FTY720, Pharmacokinetics, Renal insufficiency|fty720, pharmacokinetics, renal insufficiency
640062|NCT00731536|Hepatosplenic T-cell Lymphoma|hepatosplenic t-cell lymphoma
640063|NCT00731536|Remicade|remicade
640064|NCT00731536|Infliximab|infliximab
640065|NCT00731536|Dutch national database of pathology|dutch national database of pathology
640066|NCT00731536|PALGA|palga
640067|NCT00731536|Autoimmune disease|autoimmune disease
640068|NCT00731536|Non-Hodgkin lymphoma|non-hodgkin lymphoma
640069|NCT00731549|Aripiprazole|aripiprazole
640070|NCT00731549|IM Depot|im depot
640071|NCT00731549|Schizophrenia|schizophrenia
640072|NCT00731549|Intramuscular|intramuscular
640073|NCT00731562|food, varenicline, pharmacokinetics, bioavailability|food, varenicline, pharmacokinetics, bioavailability
640074|NCT00731575|asthma|asthma
640075|NCT00731575|child|child
640076|NCT00731575|pathogenesis|pathogenesis
640077|NCT00731575|rhinovirus|rhinovirus
640078|NCT00731575|prednisolone|prednisolone
640079|NCT00731575|Prevention|prevention
640080|NCT00731575|pediatric|pediatric
640081|NCT00737282|Uterine Fibroids|uterine fibroids
640082|NCT00737295|Biliary|biliary
640083|NCT00737295|Dyskinesia|dyskinesia
640084|NCT00737295|Gallbladder|gallbladder
640085|NCT00737295|Cholecystitis|cholecystitis
640086|NCT00737308|crowns|crowns
640087|NCT00737308|ceramics|ceramics
640088|NCT00737321|Impact of ischemia|impact of ischemia
640090|NCT00737321|Identify patterns of gene expression|identify patterns of gene expression
640091|NCT00737334|Carotid stenosis|carotid stenosis
640092|NCT00737334|EEGo|eego
640093|NCT00737334|nonlinear EEG|nonlinear eeg
640094|NCT00737334|BIS|bis
640095|NCT00737334|cerebral oximetry|cerebral oximetry
640096|NCT00737334|FORE-SIGHT cerebral oximeter|fore-sight cerebral oximeter
640097|NCT00737334|cerebral monitoring|cerebral monitoring
640098|NCT00737334|arterial jugular venous lactate difference|arterial jugular venous lactate difference
640099|NCT00737334|cerebral ischemia|cerebral ischemia
640100|NCT00737334|carotid endarterectomy|carotid endarterectomy
640101|NCT00737347|type 2 diabetes|type 2 diabetes
640102|NCT00737347|obesity|obesity
640103|NCT00737347|weight gain|weight gain
640104|NCT00737347|thiazolidinediones|thiazolidinediones
640105|NCT00737386|Leishmania tropica|leishmania tropica
640106|NCT00737386|Hyrax|hyrax
640107|NCT00737386|Sandfly|sandfly
640108|NCT00737399|depression|depression
640109|NCT00737399|anxiety|anxiety
640110|NCT00737399|pain|pain
640111|NCT00737399|insomnia|insomnia
640112|NCT00737399|cancer|cancer
640113|NCT00737399|cholangiocarcinoma|cholangiocarcinoma
640114|NCT00737399|EFT (Emotional Freedom Techniques)|eft (emotional freedom techniques)
640115|NCT00737412|Bio-K+CL1285|bio-k+cl1285
640116|NCT00737412|Probiotics|probiotics
640117|NCT00737412|Traveler's Diarrhea|traveler's diarrhea
640118|NCT00737412|Lactobacillus Acidophilus|lactobacillus acidophilus
640119|NCT00737412|Lactobacillus Casei|lactobacillus casei
640120|NCT00737425|laparoscopic-assisted surgery|laparoscopic-assisted surgery
640121|NCT00737425|abdominal|abdominal
640122|NCT00737425|pain relief|pain relief
640123|NCT00737425|wound healing|wound healing
640332|NCT00741260|metastatic|metastatic
640124|NCT00737425|low intensity ultrasound|low intensity ultrasound
640125|NCT00737438|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
640126|NCT00737438|CAPECITABINE (ORAL)|capecitabine (oral)
640127|NCT00737438|CISPLATIN|cisplatin
640128|NCT00737438|EPIRUBICIN|epirubicin
640129|NCT00737438|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
640130|NCT00737438|TAXOTERE (DOCETAXEL)|taxotere (docetaxel)
640131|NCT00737438|ESOPHAGUS|esophagus
640132|NCT00737438|STOMACH|stomach
640133|NCT00737438|08-081|08-081
640134|NCT00737451|urticaria|urticaria
640135|NCT00737451|goiter|goiter
640136|NCT00737503|vaccine effectiveness, rotavirus, diarrhoea, Bangladesh|vaccine effectiveness, rotavirus, diarrhoea, bangladesh
640137|NCT00737516|Registry|registry
640138|NCT00737516|Unrelated Umbilical Cord Blood donor|unrelated umbilical cord blood donor
640139|NCT00737516|Hematopoietic Reconstitution|hematopoietic reconstitution
640140|NCT00737516|Center for Cord Blood|center for cord blood
640141|NCT00737516|Bone Marrow Transplantation|bone marrow transplantation
640143|NCT00737529|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
640144|NCT00737529|CC-5013|cc-5013
640145|NCT00737529|Revlimid|revlimid
640146|NCT00737529|Lenalidomide|lenalidomide
640147|NCT00737542|management|management
640148|NCT00737542|post|post
640149|NCT00737555|Solid tumour|solid tumour
640150|NCT00737555|Solid tumor|solid tumor
640151|NCT00737555|Pharmacokinetic|pharmacokinetic
640152|NCT00737555|Interaction|interaction
640153|NCT00737555|dose escalation|dose escalation
640154|NCT00737555|cancer|cancer
640155|NCT00737555|paclitaxel|paclitaxel
640156|NCT00737568|Tenofovir DF|tenofovir df
640157|NCT00737568|Emtricitabine|emtricitabine
640158|NCT00737568|Chronic hepatitis B|chronic hepatitis b
640159|NCT00737568|Combination therapy|combination therapy
640160|NCT00737581|Subject's|subject's
640161|NCT00737581|response|response
640163|NCT00737581|in spinal|in spinal
640164|NCT00737581|cord|cord
640165|NCT00737581|stimulation|stimulation
640166|NCT00737581|during|during
640167|NCT00737581|postural|postural
640168|NCT00737607|outcome|outcome
640169|NCT00737607|surgery|surgery
640170|NCT00737607|lumbar spinal stenosis|lumbar spinal stenosis
640171|NCT00737607|minimally invasive|minimally invasive
640172|NCT00740662|morbid obesity|morbid obesity
640173|NCT00740662|small bowel|small bowel
640174|NCT00740662|gastric bypass|gastric bypass
640175|NCT00740662|weight loss|weight loss
640176|NCT00740675|adverse drug events|adverse drug events
640177|NCT00740675|outpatient|outpatient
640178|NCT00740701|TMS|tms
640179|NCT00740701|fMRI|fmri
640180|NCT00740701|verbal working memory|verbal working memory
640181|NCT00740701|classical conditioning|classical conditioning
640182|NCT00740701|eyeblink|eyeblink
640183|NCT00740701|classical eyeblink conditioning|classical eyeblink conditioning
640184|NCT00740701|Healthy subjects|healthy subjects
640185|NCT00740701|Memory|memory
640186|NCT00740714|Parkinson disease|parkinson disease
640187|NCT00740714|PD|pd
640188|NCT00740714|Coenzyme Q10|coenzyme q10
640189|NCT00740714|CoQ|coq
640190|NCT00740727|Disaster|disaster
640191|NCT00740727|Mass casualty incident|mass casualty incident
640192|NCT00740727|Prehospital|prehospital
640193|NCT00740727|Rehydration|rehydration
640194|NCT00740727|Intravascular access|intravascular access
640195|NCT00740740|Aneurysm|aneurysm
640196|NCT00740740|Rupture|rupture
640197|NCT00740753|liver tumor|liver tumor
640198|NCT00740753|cancer|cancer
640199|NCT00740753|hepatoma|hepatoma
640200|NCT00740753|yttrium|yttrium
640201|NCT00740766|Perinatal Outcomes|perinatal outcomes
640202|NCT00740766|Obesity|obesity
640203|NCT00740766|Pregnant women|pregnant women
640204|NCT00740779|prostatitis, chronic pelvic pain|prostatitis, chronic pelvic pain
640205|NCT00740831|Uterine Myomas|uterine myomas
640305|NCT00741182|Teriparatide|teriparatide
640206|NCT00740844|Intermittent pneumatic compression|intermittent pneumatic compression
640207|NCT00740844|Hospitalization|hospitalization
640208|NCT00740844|Intensive care unit|intensive care unit
640209|NCT00740844|High bleeding risk|high bleeding risk
640210|NCT00740844|Venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
640211|NCT00740857|Dental pain analgesia|dental pain analgesia
640212|NCT00740883|venous thromboembolism|venous thromboembolism
640213|NCT00740883|warfarin|warfarin
640214|NCT00740883|duration of anticoagulation|duration of anticoagulation
640215|NCT00740883|recurrent venous thromboembolism|recurrent venous thromboembolism
640216|NCT00740883|anticoagulant-related bleeding|anticoagulant-related bleeding
640217|NCT00740896|Cigarette Smoking|cigarette smoking
640218|NCT00740896|Airway dendritic cells|airway dendritic cells
640219|NCT00740909|Trich|trich
640220|NCT00740909|Hair Pulling|hair pulling
640221|NCT00740909|Cognitive Behavioral Therapy|cognitive behavioral therapy
640222|NCT00740909|Behavioral Therapy|behavioral therapy
640223|NCT00740922|Becaplermin gel|becaplermin gel
640224|NCT00740922|Target Ulcer|target ulcer
640225|NCT00740922|Retrospective Studies|retrospective studies
640226|NCT00740922|Diabetic Foot|diabetic foot
640227|NCT00740922|Neoplasms|neoplasms
640228|NCT00740922|Long-Term Safety|long-term safety
640229|NCT00740922|Topical Administration|topical administration
640230|NCT00740935|prevention|prevention
640231|NCT00740935|rotavirus vaccine|rotavirus vaccine
640232|NCT00740935|gastroenteritis|gastroenteritis
640233|NCT00740935|systematic vaccination|systematic vaccination
640234|NCT00740935|infants|infants
640235|NCT00740935|aged 6 to 12 weeks|aged 6 to 12 weeks
640236|NCT00740948|Sjogren's disease|sjogren's disease
640237|NCT00740948|Rituximab|rituximab
640238|NCT00740948|Treatment|treatment
640239|NCT00740948|anti CD20|anti cd20
640240|NCT00740961|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
640241|NCT00740961|cognitive/functional effects|cognitive/functional effects
640242|NCT00740961|breast cancer|breast cancer
640243|NCT00740961|colon cancer|colon cancer
640244|NCT00740987|Mechanical device|mechanical device
640245|NCT00740987|Intermittent pneumatic compression|intermittent pneumatic compression
640246|NCT00740987|Venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
640247|NCT00740987|Intensive care unit|intensive care unit
640248|NCT00740987|Hospitalization|hospitalization
640249|NCT00740987|Intensive|intensive
640250|NCT00740987|Care|care
640251|NCT00740987|Unit|unit
640252|NCT00741013|randomized|randomized
640253|NCT00741013|positron emission tomography|positron emission tomography
640254|NCT00741013|lung inflammation|lung inflammation
640255|NCT00741013|lovastatin|lovastatin
640256|NCT00741013|recombinant human activated protein C|recombinant human activated protein c
640257|NCT00741013|endotoxin|endotoxin
640258|NCT00741013|fluorodeoxyglucose|fluorodeoxyglucose
640259|NCT00741026|Insulin Resistance|insulin resistance
640260|NCT00741026|Diabetes mellitus|diabetes mellitus
640261|NCT00741026|Antipsychotic|antipsychotic
640262|NCT00741039|Breast|breast
640263|NCT00741039|Lung|lung
640264|NCT00741039|Prostate|prostate
640265|NCT00741039|Vaccine|vaccine
640266|NCT00741052|V. cholerae,|v. cholerae,
640267|NCT00741052|ciprofloxacin,|ciprofloxacin,
640268|NCT00741052|azithromycin,|azithromycin,
640269|NCT00741052|randomized|randomized
640270|NCT00741065|Coronary Artery Bypass Grafting|coronary artery bypass grafting
640271|NCT00741065|Myocardial Regeneration|myocardial regeneration
640272|NCT00741078|endothelial|endothelial
640273|NCT00741078|function|function
640274|NCT00741078|insulin|insulin
640275|NCT00741078|sensitivity|sensitivity
640276|NCT00741091|Cerebrovascular Disease|cerebrovascular disease
640277|NCT00741091|Carotid Stent|carotid stent
640278|NCT00741091|Stent|stent
640279|NCT00741091|Carotid Endarterectomy (CEA)|carotid endarterectomy (cea)
640280|NCT00741117|Pulse Oximetry|pulse oximetry
640281|NCT00741117|Blood Gas Analysis|blood gas analysis
640282|NCT00741117|Liver Disease|liver disease
640283|NCT00741117|Hyperbilirubinemia|hyperbilirubinemia
640284|NCT00741130|retinal nerve fiber layer|retinal nerve fiber layer
640285|NCT00741130|optic nerve head|optic nerve head
640286|NCT00741130|Cirrus OCT|cirrus oct
640287|NCT00741143|Food Fortification|food fortification
640288|NCT00741143|Iron deficiency|iron deficiency
640289|NCT00741143|NaFeEdta|nafeedta
640290|NCT00741143|Iron deficiency anemia|iron deficiency anemia
640291|NCT00741143|Cognition|cognition
640292|NCT00741156|pediatric|pediatric
640293|NCT00741156|hypertension|hypertension
640294|NCT00741156|congestive cardiomyopathy|congestive cardiomyopathy
640295|NCT00741156|angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
640296|NCT00741156|cardiac catheterization|cardiac catheterization
640297|NCT00741169|TMC435350-TiDP16-C105|tmc435350-tidp16-c105
640298|NCT00741169|TMC435350-C105|tmc435350-c105
640299|NCT00741169|Hepatitis C|hepatitis c
640300|NCT00741169|HCV|hcv
640301|NCT00741169|Rifampin|rifampin
640302|NCT00741182|Fracture|fracture
640303|NCT00741182|Osteoporosis|osteoporosis
640304|NCT00741182|Forsteo|forsteo
640306|NCT00741182|Fracture healing|fracture healing
640307|NCT00741195|Cancer|cancer
640308|NCT00741195|NSCLC|nsclc
640309|NCT00741195|Docetaxel|docetaxel
640310|NCT00741195|Bevacizumab|bevacizumab
640311|NCT00741208|asthma|asthma
640312|NCT00741208|soy isoflavone|soy isoflavone
640313|NCT00741208|genistein|genistein
640314|NCT00741208|soy|soy
640315|NCT00741221|Cancer|cancer
640316|NCT00741221|NSCLC|nsclc
640317|NCT00741221|Docetaxel|docetaxel
640318|NCT00741221|Bevacizumab|bevacizumab
640319|NCT00741234|SB939|sb939
640320|NCT00741234|Myelodysplastic Syndrome|myelodysplastic syndrome
640321|NCT00741234|Combination with azacitidine|combination with azacitidine
640322|NCT00741234|Solid malignancies|solid malignancies
640323|NCT00741234|Hematologic malignancies|hematologic malignancies
640324|NCT00741234|HDAC inhibitor|hdac inhibitor
640325|NCT00741234|Refractory to standard therapy|refractory to standard therapy
640326|NCT00741247|staging|staging
640327|NCT00741247|Endobronchial ultrasound|endobronchial ultrasound
640328|NCT00741247|Endoscopic ultrasound|endoscopic ultrasound
640329|NCT00741260|solid tumor|solid tumor
640330|NCT00741260|erbB2+ breast cancer|erbb2+ breast cancer
640331|NCT00741260|prior Herceptin|prior herceptin
640333|NCT00741286|Cerebral infarction|cerebral infarction
640334|NCT00741286|Cilostazol|cilostazol
640335|NCT00741286|Aspirin|aspirin
640336|NCT00741286|Transcranial Doppler|transcranial doppler
640337|NCT00741286|Pulsatile Index|pulsatile index
640338|NCT00741299|bipolar affective disorder, Smoking|bipolar affective disorder, smoking
640339|NCT00741312|pregnancy|pregnancy
640340|NCT00741312|preeclampsia|preeclampsia
640341|NCT00741312|exercise|exercise
640342|NCT00741338|MPS I, Mucopolysaccharidosis, Hurler syndrome|mps i, mucopolysaccharidosis, hurler syndrome
640343|NCT00741351|Anesthesia|anesthesia
640344|NCT00741351|Craniotomy|craniotomy
640345|NCT00741351|Neurosurgery|neurosurgery
640346|NCT00741364|vitamin D|vitamin d
640347|NCT00741364|prostate cancer|prostate cancer
640348|NCT00741364|prostatectomy|prostatectomy
640349|NCT00741364|pathology|pathology
640350|NCT00741364|immunohistochemistry|immunohistochemistry
640351|NCT00741377|Multiple myeloma|multiple myeloma
640352|NCT00741377|bone disease|bone disease
640353|NCT00741377|antibody|antibody
640354|NCT00741390|Diabetes|diabetes
640355|NCT00741390|Lancets|lancets
640356|NCT00741390|Pain|pain
640357|NCT00741403|Phase I|phase i
640358|NCT00741403|malignancies|malignancies
640359|NCT00741403|refractory|refractory
640360|NCT00741403|relapsed|relapsed
640361|NCT00741416|Heart Disease|heart disease
640362|NCT00741416|Biorepository|biorepository
640363|NCT00741416|Biobank|biobank
640364|NCT00741455|Non-myeloablative transplant|non-myeloablative transplant
640365|NCT00741455|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
640366|NCT00741455|Acute Myelogenous Leukemia|acute myelogenous leukemia
640367|NCT00741455|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
640368|NCT00741455|Multiple Myeloma|multiple myeloma
640369|NCT00741455|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
640370|NCT00741455|Myelodysplastic syndrome|myelodysplastic syndrome
640371|NCT00741455|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
640372|NCT00741455|Hodgkin's Disease|hodgkin's disease
640373|NCT00741468|Drug-drug interactions|drug-drug interactions
640375|NCT00741481|metastatic colorectal cancer|metastatic colorectal cancer
640376|NCT00741481|fdg pet|fdg pet
640377|NCT00741481|response evaluation|response evaluation
640378|NCT00741494|infertility|infertility
640379|NCT00741494|ICSI|icsi
640380|NCT00741494|hyaluronan binding|hyaluronan binding
640381|NCT00741494|sperm|sperm
640382|NCT00741494|sperm selection|sperm selection
640383|NCT00741494|male factor|male factor
640384|NCT00741494|hyaluronan|hyaluronan
640385|NCT00741494|sperm maturity|sperm maturity
640386|NCT00741494|clinical pregnancy rates|clinical pregnancy rates
640387|NCT00741494|hyaluronan binding assay|hyaluronan binding assay
640388|NCT00741494|HBA|hba
640389|NCT00741494|PICSI|picsi
640390|NCT00741507|Anesthetics|anesthetics
640391|NCT00741507|Sedatives|sedatives
640392|NCT00741507|Analgesics|analgesics
640393|NCT00741520|Obstructive Sleep Apnea|obstructive sleep apnea
640394|NCT00741520|Blood Pressure|blood pressure
640395|NCT00741520|PreHypertension|prehypertension
640396|NCT00741520|Masked Hypertension|masked hypertension
640397|NCT00741546|Vitamin D|vitamin d
640398|NCT00741546|malnutrition|malnutrition
640399|NCT00741546|cardiac surgery|cardiac surgery
640400|NCT00741546|study|study
640401|NCT00741546|emphasize|emphasize
640402|NCT00741546|importance|importance
640403|NCT00741546|significant|significant
640404|NCT00741546|high risk patient|high risk patient
640405|NCT00741559|epilepsy|epilepsy
640406|NCT00741559|pediatrics|pediatrics
640407|NCT00741559|magnetoencephalography|magnetoencephalography
640408|NCT00741559|electroencephalography|electroencephalography
640409|NCT00741559|positron emission tomography|positron emission tomography
640410|NCT00741572|sarcoidosis|sarcoidosis
640411|NCT00741572|fibrosis|fibrosis
640515|NCT00741923|obesity|obesity
640412|NCT00741572|oxidative stress|oxidative stress
640413|NCT00741572|inflammation|inflammation
640414|NCT00741572|triggers|triggers
640415|NCT00741572|individual sensitivity|individual sensitivity
640416|NCT00741585|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
640417|NCT00741585|Chronotherapy|chronotherapy
640418|NCT00741585|Circadian|circadian
640419|NCT00741585|Non-dipper|non-dipper
640420|NCT00741585|Type 2 diabetes|type 2 diabetes
640421|NCT00741585|Resistant hypertension|resistant hypertension
640422|NCT00741585|Total mortality|total mortality
640423|NCT00741624|refractive surgery|refractive surgery
640424|NCT00741637|Vibrio Cholerae|vibrio cholerae
640425|NCT00741637|Diarrhea|diarrhea
640426|NCT00741637|Live oral Vaccines|live oral vaccines
640427|NCT00741637|Immunogenicity|immunogenicity
640428|NCT00741637|Safety|safety
640429|NCT00741637|HIV|hiv
640430|NCT00741650|Musculoskeletal pain|musculoskeletal pain
640431|NCT00741650|Brief cognitive intervention|brief cognitive intervention
640432|NCT00741650|Cognitive behavior therapy|cognitive behavior therapy
640433|NCT00741650|Intervention Study|intervention study
640434|NCT00741650|Health prevention|health prevention
640435|NCT00741650|workplace intervention|workplace intervention
640438|NCT00741663|diuretic therapy|diuretic therapy
640439|NCT00741663|potassium canrenoate|potassium canrenoate
640440|NCT00741663|furosemide|furosemide
640441|NCT00741663|hyperkalemia|hyperkalemia
640442|NCT00741663|plasma renin activity|plasma renin activity
640443|NCT00741663|nitric oxide|nitric oxide
640444|NCT00741663|serum sodium concentration|serum sodium concentration
640445|NCT00741663|refractory ascites|refractory ascites
640446|NCT00741663|Nonazotemic patients with cirrhosis and moderate ascites|nonazotemic patients with cirrhosis and moderate ascites
640447|NCT00741689|Japanese|japanese
640448|NCT00741689|healthy|healthy
640449|NCT00741689|volunteers|volunteers
640450|NCT00741702|Hypertension|hypertension
640451|NCT00741702|Type 2 diabetes|type 2 diabetes
640452|NCT00741702|First Nations populations|first nations populations
640453|NCT00741715|primary hypercholesterolemia|primary hypercholesterolemia
640454|NCT00741728|epidemiology|epidemiology
640455|NCT00741728|risk factors|risk factors
640456|NCT00741728|heart rate|heart rate
640457|NCT00741728|baroreflex sensitivity|baroreflex sensitivity
640458|NCT00741728|sudden death|sudden death
640459|NCT00741741|TMC278-C150|tmc278-c150
640460|NCT00741741|TMC278-TiDP15-C150|tmc278-tidp15-c150
640461|NCT00741741|HIV-1 infected patients|hiv-1 infected patients
640462|NCT00741741|Intramuscular or subcutaneous injection|intramuscular or subcutaneous injection
640463|NCT00741741|Nanosuspension|nanosuspension
640464|NCT00741741|Therapy|therapy
640465|NCT00741741|Prevention|prevention
640466|NCT00741741|Healthy volunteers|healthy volunteers
640467|NCT00741741|HIV Infections|hiv infections
640468|NCT00741754|salivary flow|salivary flow
640469|NCT00741754|oral neoplasm|oral neoplasm
640470|NCT00741754|calcium hydroxide|calcium hydroxide
640471|NCT00741754|sodium dodecylsulphate|sodium dodecylsulphate
640472|NCT00741754|radiotherapy.|radiotherapy.
640473|NCT00741767|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
640475|NCT00741767|Sleep|sleep
640476|NCT00741767|Sleep quality|sleep quality
640477|NCT00741767|Lung hyperinflation|lung hyperinflation
640478|NCT00741793|Rheumatoid arthritis; psoriatic arthritis; axial spondyloarthritis|rheumatoid arthritis; psoriatic arthritis; axial spondyloarthritis
640479|NCT00741793|Remicade®|remicade®
640480|NCT00741793|Simponi®|simponi®
640481|NCT00741793|Simponi® I.V|simponi® i.v
640482|NCT00741793|Stelara®|stelara®
640483|NCT00741793|Registry|registry
640484|NCT00741793|BioTRAC|biotrac
640485|NCT00741806|vaccination|vaccination
640486|NCT00741806|avian|avian
640487|NCT00741819|pulmonary arterial hypertension|pulmonary arterial hypertension
640488|NCT00741819|PAH|pah
640489|NCT00741819|treprostinil sodium|treprostinil sodium
640490|NCT00741819|inhalation|inhalation
640491|NCT00741819|ventavis|ventavis
640492|NCT00741819|iloprost|iloprost
640493|NCT00741832|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
640494|NCT00741832|dynamic hyperinflation|dynamic hyperinflation
640495|NCT00741832|dyspnea|dyspnea
640496|NCT00741832|recovery|recovery
640497|NCT00741832|positive expiratory pressure|positive expiratory pressure
640498|NCT00741832|exercise|exercise
640499|NCT00741858|Chiari malformation;|chiari malformation;
640500|NCT00741858|Duraplasty;|duraplasty;
640501|NCT00741858|Posterior fossa decompression;|posterior fossa decompression;
640502|NCT00741858|Duragen;|duragen;
640503|NCT00741858|Duraguard|duraguard
640504|NCT00741871|Lymphoid malignancies|lymphoid malignancies
640505|NCT00741871|Hodgkin's Lymphoma|hodgkin's lymphoma
640506|NCT00741871|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
640507|NCT00741910|Crohn's Disease|crohn's disease
640508|NCT00741910|TNF-alpha inhibitor|tnf-alpha inhibitor
640509|NCT00741910|MAP Kinase inhibitor|map kinase inhibitor
640510|NCT00741910|CNI-1493|cni-1493
640511|NCT00741923|beans|beans
640512|NCT00741923|pulses|pulses
640513|NCT00741923|satiety|satiety
640514|NCT00741923|appetite|appetite
640516|NCT00741923|overweight|overweight
640517|NCT00741923|diabetes|diabetes
640518|NCT00741923|metabolic syndrome|metabolic syndrome
640519|NCT00741923|hypertension|hypertension
640520|NCT00741923|blood glucose|blood glucose
640521|NCT00741923|insulin|insulin
640522|NCT00741923|cholesterol|cholesterol
640523|NCT00741923|HDL|hdl
640524|NCT00741923|LDL|ldl
640525|NCT00741923|leptin|leptin
640526|NCT00741923|GLP-1|glp-1
640527|NCT00741923|adiponectin|adiponectin
640528|NCT00741923|Peptide YY|peptide yy
640529|NCT00741923|diet|diet
640530|NCT00741936|Functional Constipation|functional constipation
640531|NCT00741936|Chinese Herbal Medicine|chinese herbal medicine
640532|NCT00741936|MaZiRenWan|mazirenwan
640533|NCT00741936|Hemp Seed Pill|hemp seed pill
640534|NCT00741936|Traditional Chinese Medicine|traditional chinese medicine
640535|NCT00741936|Herbal Medicine|herbal medicine
640536|NCT00741949|Respiratory failure|respiratory failure
640537|NCT00741949|Target Controlled Infusion|target controlled infusion
640538|NCT00741949|TCI|tci
640539|NCT00741949|Propofol|propofol
640540|NCT00741949|Noninvasive ventilation|noninvasive ventilation
640541|NCT00741949|Broncho-alveolar lavage|broncho-alveolar lavage
640542|NCT00741975|HIV prevention|hiv prevention
640543|NCT00741988|Non-Small Cell Lung Cancer|non-small cell lung cancer
640544|NCT00741988|Advanced Disease|advanced disease
640545|NCT00741988|Untreated|untreated
640546|NCT00741988|Ixabepilone|ixabepilone
640547|NCT00741988|Carboplatin|carboplatin
640548|NCT00741988|Bevacizumab|bevacizumab
640549|NCT00742001|red blood cells|red blood cells
640550|NCT00742001|transfusion|transfusion
640551|NCT00742001|recovery|recovery
640552|NCT00742001|feasibility|feasibility
640553|NCT00742001|white blood cell inactivation|white blood cell inactivation
640554|NCT00742014|Pulmonary arterial hypertension|pulmonary arterial hypertension
640555|NCT00742014|Pediatrics|pediatrics
640556|NCT00742014|Sildenafil|sildenafil
640557|NCT00742014|Catheterization|catheterization
640759|NCT00742664|Treatment|treatment
640558|NCT00742014|Right ventricular contractility|right ventricular contractility
640559|NCT00742027|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
640560|NCT00742027|Classical Hodgkin's Lymphoma|classical hodgkin's lymphoma
640561|NCT00742027|Hodgkin Lymphoma|hodgkin lymphoma
640562|NCT00742027|Hodgkin's Lymphoma|hodgkin's lymphoma
640563|NCT00742027|Nodular sclerosing|nodular sclerosing
640564|NCT00742027|Mixed-cellularity|mixed-cellularity
640565|NCT00742027|Lymphocyte-rich|lymphocyte-rich
640566|NCT00742027|Lymphocyte depleted|lymphocyte depleted
640568|NCT00742027|Classical HL|classical hl
640569|NCT00742027|Refractory Hodgkin's Lymphoma|refractory hodgkin's lymphoma
640570|NCT00742027|Refractory Hodgkin Lymphoma|refractory hodgkin lymphoma
640571|NCT00742027|Refractory HL|refractory hl
640572|NCT00742040|up-titration|up-titration
640573|NCT00742040|captopril|captopril
640574|NCT00742040|pediatric|pediatric
640575|NCT00742040|cardiac patients|cardiac patients
640576|NCT00742053|ECG PICC|ecg picc
640577|NCT00742053|Patients undergoing PICC placement|patients undergoing picc placement
640578|NCT00742066|Hypertension|hypertension
640579|NCT00742066|Insulin resistance|insulin resistance
640580|NCT00742066|Microcirculation|microcirculation
640581|NCT00742066|Angiotensin II receptor blocker|angiotensin ii receptor blocker
640582|NCT00742079|Paranoid Schizophrenia|paranoid schizophrenia
640583|NCT00742079|Paranoid Delusions|paranoid delusions
640584|NCT00742079|CBT|cbt
640585|NCT00742079|D-Cycloserine|d-cycloserine
640586|NCT00742105|PI3K|pi3k
640587|NCT00742105|mTOR|mtor
640588|NCT00742105|Advanced solid tumor|advanced solid tumor
640589|NCT00742105|Adult|adult
640590|NCT00742131|MET inhibitor|met inhibitor
640591|NCT00742131|c-Met|c-met
640592|NCT00742131|XL880|xl880
640593|NCT00742131|GSK1363089|gsk1363089
640594|NCT00742131|Solid Tumors|solid tumors
640595|NCT00742144|CD20 positive|cd20 positive
640596|NCT00742144|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
640597|NCT00742144|Follicular lymphoma|follicular lymphoma
640598|NCT00742144|GSK1841157|gsk1841157
640599|NCT00742144|Japanese patient|japanese patient
640600|NCT00742144|Ofatumumab|ofatumumab
640601|NCT00742157|Growth Hormone|growth hormone
640602|NCT00742157|TPN|tpn
640603|NCT00742157|Total Parenteral Nutrition|total parenteral nutrition
640604|NCT00742157|Glutamine|glutamine
640605|NCT00742157|Short Bowel Syndrome|short bowel syndrome
640606|NCT00742157|Increase in absorption of small bowel.|increase in absorption of small bowel.
640607|NCT00742170|opioid dependence|opioid dependence
640608|NCT00742170|opioid detoxification|opioid detoxification
640609|NCT00742170|electroacupuncture|electroacupuncture
640610|NCT00742170|adjunctive treatment|adjunctive treatment
640611|NCT00742170|alternative/complementary medicine|alternative/complementary medicine
640612|NCT00742196|Parapapillary atrophy|parapapillary atrophy
640613|NCT00742196|Retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
640614|NCT00742196|Glaucoma|glaucoma
640615|NCT00742196|Cirrus OCT|cirrus oct
640616|NCT00742209|migraine|migraine
640617|NCT00742209|prophylaxis|prophylaxis
640618|NCT00742209|prevention|prevention
640619|NCT00742222|Electronic brachytherapy registry|electronic brachytherapy registry
640620|NCT00742222|Multi-society registry|multi-society registry
640621|NCT00742222|Breast cancer registry|breast cancer registry
640622|NCT00742248|COPD|copd
640623|NCT00742261|Pharmacokinetics|pharmacokinetics
640624|NCT00742261|Safety|safety
640625|NCT00742261|MET|met
640626|NCT00742261|Bioavailability|bioavailability
640627|NCT00742261|Patients|patients
640628|NCT00742261|GSK1363089A|gsk1363089a
640629|NCT00742261|GSK1363089G|gsk1363089g
640630|NCT00742261|GSK1363089|gsk1363089
640631|NCT00742261|Relative|relative
640632|NCT00742287|smoking|smoking
640633|NCT00742287|oligomeric proanthocyanidins|oligomeric proanthocyanidins
640634|NCT00742287|polyphenols|polyphenols
640635|NCT00742287|supplementation|supplementation
640636|NCT00742287|vascular function|vascular function
640637|NCT00742287|oxidative stress|oxidative stress
640638|NCT00742287|inflammation|inflammation
640639|NCT00742300|ASCT|asct
640640|NCT00742300|Tolerance induction|tolerance induction
640641|NCT00742300|SLE|sle
640642|NCT00742300|Transplantation|transplantation
640643|NCT00742300|Autoimmune diseases|autoimmune diseases
640644|NCT00742313|Endoscopic|endoscopic
640645|NCT00742313|saphenous|saphenous
640646|NCT00742313|vein|vein
640647|NCT00742313|harvest|harvest
640648|NCT00742326|HIV|hiv
640649|NCT00742326|Hepatitis C|hepatitis c
640650|NCT00742326|Liver Disease|liver disease
640651|NCT00742326|Fatty Liver|fatty liver
640652|NCT00742326|Steatosis|steatosis
640653|NCT00742339|cirrhosis|cirrhosis
640654|NCT00742339|hepatorenal syndrome|hepatorenal syndrome
640655|NCT00742339|terlipressin|terlipressin
640656|NCT00742339|midodrine|midodrine
640657|NCT00742339|octreotide|octreotide
640658|NCT00742339|human albumin|human albumin
640659|NCT00742339|effective circulating volume|effective circulating volume
640760|NCT00742664|genetically|genetically
640761|NCT00742664|confirmed|confirmed
640660|NCT00742339|The criteria which will be used for the diagnosis of HRS will be the criteria which were recently published by the International Ascites Club|the criteria which will be used for the diagnosis of hrs will be the criteria which were recently published by the international ascites club
640661|NCT00742339|Patients with cirrhosis and type 2 HRS only with serum creatinine value > 2.5 mg/dl|patients with cirrhosis and type 2 hrs only with serum creatinine value > 2.5 mg/dl
640662|NCT00742339|All patients with cirrhosis and type 1 HRS|all patients with cirrhosis and type 1 hrs
640663|NCT00742365|Seasonal Affective Disorder|seasonal affective disorder
640664|NCT00742365|Light Therapy|light therapy
640665|NCT00742365|Seasonal Depression|seasonal depression
640666|NCT00742365|Psychiatric Disorder|psychiatric disorder
640667|NCT00742365|Bright Light|bright light
640668|NCT00742365|Major Depressive Disorder|major depressive disorder
640669|NCT00742365|Bipolar Disorder|bipolar disorder
640670|NCT00742378|Glaucoma|glaucoma
640671|NCT00742378|Retinal nerve fiber layer|retinal nerve fiber layer
640672|NCT00742378|Cirrus OCT|cirrus oct
640673|NCT00742391|Peplin|peplin
640674|NCT00742391|Actinic keratosis|actinic keratosis
640675|NCT00742391|PEP005|pep005
640676|NCT00742404|stage I multiple myeloma|stage i multiple myeloma
640677|NCT00742404|stage II multiple myeloma|stage ii multiple myeloma
640678|NCT00742404|stage III multiple myeloma|stage iii multiple myeloma
640679|NCT00742417|Alzheimer's|alzheimer's
640680|NCT00742417|Dementia|dementia
640681|NCT00742417|Senile|senile
640682|NCT00742417|Loss of cognitive abilities|loss of cognitive abilities
640683|NCT00742417|Old age|old age
640684|NCT00742417|Elderly|elderly
640685|NCT00742417|Aging|aging
640686|NCT00742417|Albumin|albumin
640687|NCT00742417|Caregiver|caregiver
640688|NCT00742417|amyloid|amyloid
640689|NCT00742417|beta amyloid|beta amyloid
640690|NCT00742417|Central Nervous System Diseases|central nervous system diseases
640691|NCT00742417|Brain Disease|brain disease
640692|NCT00742417|Mental Disorders|mental disorders
640693|NCT00742417|Plasma Exchange|plasma exchange
640694|NCT00742430|aspirin resistance|aspirin resistance
640695|NCT00742430|coronary artery disease|coronary artery disease
640696|NCT00742430|clopidogrel resistance|clopidogrel resistance
640697|NCT00742430|major adverse cardiac events|major adverse cardiac events
640698|NCT00742430|multiplate platelet function analyser|multiplate platelet function analyser
640699|NCT00742430|percutaneous coronary intervention|percutaneous coronary intervention
640700|NCT00742443|Scar Revision|scar revision
640701|NCT00742456|Microcirculation|microcirculation
640702|NCT00742456|Insulin|insulin
640703|NCT00742456|Hypertension|hypertension
640704|NCT00742456|Obesity|obesity
640705|NCT00742469|TD|td
640706|NCT00742469|traveller's diarrhea|traveller's diarrhea
640707|NCT00742469|campylobacter|campylobacter
640708|NCT00742469|shigella|shigella
640709|NCT00742469|salmonella|salmonella
640710|NCT00742469|E. coli|e. coli
640711|NCT00742469|diarrhea|diarrhea
640712|NCT00742508|carvedilol phosphate|carvedilol phosphate
640713|NCT00742508|ß-blocker|ß-blocker
640714|NCT00742508|SK&F-105517-D|sk&f-105517-d
640715|NCT00742508|Chronic heart failure(CHF)|chronic heart failure(chf)
640716|NCT00742521|cortisol|cortisol
640717|NCT00742521|catecholamines|catecholamines
640718|NCT00742521|Type 1 DM|type 1 dm
640719|NCT00742534|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
640720|NCT00742534|Prematurity|prematurity
640721|NCT00742534|Lung Disease|lung disease
640722|NCT00742534|preterm infants|preterm infants
640723|NCT00742547|prevention|prevention
640724|NCT00742547|health services research|health services research
640725|NCT00742560|Multiple Myeloma|multiple myeloma
640726|NCT00742573|Major Depressive Disorder|major depressive disorder
640727|NCT00742573|Mood Disorders|mood disorders
640728|NCT00742573|Hispanic|hispanic
640729|NCT00742586|Gene Expression Changes in Blood Cells|gene expression changes in blood cells
640730|NCT00742586|RNA|rna
640731|NCT00742586|Pure Autonomic Failure|pure autonomic failure
640732|NCT00742586|Multiply System Atrophy|multiply system atrophy
640733|NCT00742586|Parkinson's Plus|parkinson's plus
640734|NCT00742599|Stomach Diseases|stomach diseases
640735|NCT00742612|Carotid Endarterectomy|carotid endarterectomy
640736|NCT00742612|von Willebrand Factor|von willebrand factor
641042|NCT00743379|Hypoxia|hypoxia
640737|NCT00742612|Microembolic Signal|microembolic signal
640738|NCT00742638|CCMD-3,|ccmd-3,
640739|NCT00742638|CRF,|crf,
640740|NCT00742638|EPS,|eps,
640741|NCT00742638|GCP,|gcp,
640742|NCT00742638|ICH,|ich,
640743|NCT00742638|ITT,|itt,
640744|NCT00742638|LOCF,|locf,
640745|NCT00742638|MADRS,|madrs,
640746|NCT00742638|PANSS,|panss,
640747|NCT00742638|YMRS.|ymrs.
640748|NCT00742638|Acute|acute
640749|NCT00742638|manic|manic
640750|NCT00742638|patients|patients
640751|NCT00742638|with|with
640752|NCT00742638|bipolar|bipolar
640753|NCT00742638|disorder|disorder
640754|NCT00742664|Prader-Willi Syndrome|prader-willi syndrome
640755|NCT00742664|Compulsive behavior|compulsive behavior
640756|NCT00742664|Hoarding|hoarding
640757|NCT00742664|Obsessive-compulsive disorder|obsessive-compulsive disorder
640758|NCT00742664|Children|children
640762|NCT00742664|diagnosis|diagnosis
640763|NCT00742677|female reproductive cancer|female reproductive cancer
640764|NCT00742690|cirrhosis|cirrhosis
640765|NCT00742690|type 1 hepatorenal syndrome|type 1 hepatorenal syndrome
640766|NCT00742690|terlipressin|terlipressin
640767|NCT00742690|albumin|albumin
640768|NCT00742690|effective circulating volume|effective circulating volume
640769|NCT00742690|Patients|patients
640770|NCT00742690|with|with
640771|NCT00742716|Parathyroid Diseases|parathyroid diseases
640772|NCT00742716|Renal Insufficiency|renal insufficiency
640773|NCT00742716|Kidney Failure, Chronic|kidney failure, chronic
640774|NCT00742716|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
640776|NCT00742716|Hyperparathyroidism|hyperparathyroidism
640777|NCT00742716|Renal Insufficiency, Chronic|renal insufficiency, chronic
640778|NCT00742716|Kidney Diseases|kidney diseases
640779|NCT00742716|Kidney Failure|kidney failure
640780|NCT00742729|Colorectal cancer screening|colorectal cancer screening
640781|NCT00742729|Fecal occult blood test|fecal occult blood test
640782|NCT00742729|Endoscopies|endoscopies
640783|NCT00742729|Filipino American immigrants|filipino american immigrants
640784|NCT00742729|Community based organizations and churches|community based organizations and churches
640785|NCT00742742|Walnut|walnut
640786|NCT00742742|Lipids|lipids
640787|NCT00742742|Blood Glucose|blood glucose
640788|NCT00742755|Follow-up of breast abnormalities|follow-up of breast abnormalities
640789|NCT00742755|Korean American immigrants|korean american immigrants
640790|NCT00742768|absorption|absorption
640791|NCT00742768|encapsulation|encapsulation
640792|NCT00742768|menaquinone|menaquinone
640793|NCT00742768|Bio-availability|bio-availability
640794|NCT00742781|Crohn's|crohn's
640795|NCT00742781|vitamin D|vitamin d
640796|NCT00742807|sensation|sensation
640797|NCT00742807|relief|relief
640798|NCT00742807|during|during
640799|NCT00742807|surgery|surgery
640800|NCT00742820|bioequivalence|bioequivalence
640801|NCT00742833|Overactive bladder|overactive bladder
640802|NCT00742833|Frequency|frequency
640803|NCT00742833|Micturition|micturition
640804|NCT00742833|Urgency|urgency
640805|NCT00742833|Urge urinary incontinence|urge urinary incontinence
640806|NCT00742833|β3-agonist|β3-agonist
640807|NCT00742846|Adhesive Capsulitis|adhesive capsulitis
640808|NCT00742846|Subacromial injection|subacromial injection
640809|NCT00742846|Intraarticular injection|intraarticular injection
640810|NCT00742859|Atrial Fibrillation|atrial fibrillation
640811|NCT00742859|Betrixaban|betrixaban
640812|NCT00742859|Factor Xa inhibitor|factor xa inhibitor
640813|NCT00742859|Warfarin|warfarin
640814|NCT00742872|Mosapride|mosapride
640815|NCT00742872|Irritable Bowel Syndrome|irritable bowel syndrome
640816|NCT00742872|Constipation|constipation
640817|NCT00742885|Immunogenicity|immunogenicity
640818|NCT00742885|Safety|safety
640819|NCT00742885|Pandemic Influenza|pandemic influenza
640820|NCT00742898|Quasi-experimental design|quasi-experimental design
640821|NCT00742898|Non-targeted opt-out rapid HIV screening|non-targeted opt-out rapid hiv screening
640822|NCT00742898|Diagnostic rapid HIV testing|diagnostic rapid hiv testing
640823|NCT00742898|Emergency department|emergency department
640824|NCT00742898|Effectiveness|effectiveness
640825|NCT00742898|Efficiency|efficiency
640826|NCT00742898|Health services research|health services research
640827|NCT00742898|Program evaluation|program evaluation
640828|NCT00742898|Effectiveness and efficiency of non-targeted rapid HIV screening in the ED|effectiveness and efficiency of non-targeted rapid hiv screening in the ed
640829|NCT00742911|Solid Tumors, Liver|solid tumors, liver
640830|NCT00742924|metastatic osteosarcoma|metastatic osteosarcoma
640831|NCT00742937|Hypovitaminosis A|hypovitaminosis a
640832|NCT00742950|Corneal incision|corneal incision
640833|NCT00742950|Cataract surgery|cataract surgery
640834|NCT00742950|Phacoemulsification|phacoemulsification
640835|NCT00742950|Surgically induced astigmatism|surgically induced astigmatism
640836|NCT00742950|Corneal Topography|corneal topography
640837|NCT00742963|TH-302|th-302
640838|NCT00742963|Advanced Soft Tissue Sarcoma|advanced soft tissue sarcoma
640839|NCT00742963|Doxorubicin|doxorubicin
640840|NCT00742963|Phase 1/2|phase 1/2
641043|NCT00743379|Prodrug|prodrug
640841|NCT00742976|Weight gain in insulin treated type 2 diabetes|weight gain in insulin treated type 2 diabetes
640842|NCT00742976|extracellular volume|extracellular volume
640843|NCT00742976|insulin treatment|insulin treatment
640844|NCT00742976|sodium retention|sodium retention
640845|NCT00742989|osteopathic|osteopathic
640846|NCT00742989|lymphatic|lymphatic
640847|NCT00742989|treatment|treatment
640849|NCT00742989|normal|normal
640850|NCT00743002|TT223|tt223
640851|NCT00743028|Other hematological and non-hematological malignancies|other hematological and non-hematological malignancies
640852|NCT00743041|PTSD, EFT, depression, anxiety, telephone|ptsd, eft, depression, anxiety, telephone
640853|NCT00743054|Carcinoma, Renal Cell|carcinoma, renal cell
640854|NCT00743054|MicroRNAs|micrornas
640855|NCT00743067|XL880|xl880
640856|NCT00743067|MET inhibitor|met inhibitor
640857|NCT00743067|GSK1363089|gsk1363089
640858|NCT00743067|Solid Tumors|solid tumors
640859|NCT00743067|c-Met|c-met
640860|NCT00743080|laparoscopy|laparoscopy
640861|NCT00743080|myomectomy|myomectomy
640862|NCT00743080|myomas|myomas
640863|NCT00743080|morcellator|morcellator
640864|NCT00743080|supracervical hysterectomy|supracervical hysterectomy
640865|NCT00743080|surgery|surgery
640866|NCT00743080|symptomatic uterine myomas|symptomatic uterine myomas
640867|NCT00743093|acetaminophen|acetaminophen
640868|NCT00743093|protein adducts|protein adducts
640869|NCT00743093|drug safety|drug safety
640870|NCT00743093|alanine aminotransferase|alanine aminotransferase
640871|NCT00743093|Alanine Amino Transferase|alanine amino transferase
640872|NCT00743106|nephrectomy|nephrectomy
640873|NCT00743106|fenoldopam|fenoldopam
640874|NCT00743106|atrophic minimally functioning kidney|atrophic minimally functioning kidney
640875|NCT00743119|oral thc|oral thc
640876|NCT00743119|smoked marijuana|smoked marijuana
640877|NCT00743119|pain|pain
640878|NCT00743119|analgesic effects|analgesic effects
640879|NCT00743132|evaluation|evaluation
640880|NCT00743132|incidence|incidence
640881|NCT00743132|liver surgery|liver surgery
640882|NCT00743132|resection|resection
640883|NCT00743132|impact|impact
640884|NCT00743132|postoperative|postoperative
640885|NCT00743132|mortality|mortality
640886|NCT00734422|Phobic Disorders (Fear of Flying)|phobic disorders (fear of flying)
640887|NCT00734422|Virtual Reality Exposure Therapy|virtual reality exposure therapy
640888|NCT00734422|Fear extinction|fear extinction
640889|NCT00734422|Yohimbine|yohimbine
640890|NCT00734435|schizophrenia|schizophrenia
640891|NCT00734435|schizophreniform|schizophreniform
640892|NCT00734435|schizoaffective disorder|schizoaffective disorder
640893|NCT00734435|Zyprexa|zyprexa
640894|NCT00734435|olanzapine|olanzapine
640895|NCT00734448|gestational diabetes mellitus|gestational diabetes mellitus
640896|NCT00734448|carbohydrate intolerance|carbohydrate intolerance
640897|NCT00734448|myo-inositol|myo-inositol
640898|NCT00734448|insulin resistance|insulin resistance
640899|NCT00734461|Non-physically dependent subjects|non-physically dependent subjects
640900|NCT00734461|history of opioid abuse|history of opioid abuse
640901|NCT00734474|Diabetes, type 2 diabetes|diabetes, type 2 diabetes
640902|NCT00734487|Spectral Domain Optical Coherence Tomography|spectral domain optical coherence tomography
640903|NCT00734487|Optical Coherence Tomography|optical coherence tomography
640904|NCT00734487|AREDS2|areds2
640905|NCT00734487|AMD|amd
640906|NCT00734487|Age-related macular degeneration|age-related macular degeneration
640907|NCT00734487|Drusen|drusen
640908|NCT00734513|GI Cancer|gi cancer
640909|NCT00734513|Emotional Disclosure|emotional disclosure
640910|NCT00734513|Behavioral Intervention|behavioral intervention
640911|NCT00734513|Partner|partner
640912|NCT00734513|Couples|couples
640913|NCT00734526|Glioblastoma|glioblastoma
640914|NCT00734526|Gliosarcoma|gliosarcoma
640915|NCT00734526|Brain Cancer|brain cancer
640916|NCT00734526|Sorafenib|sorafenib
640917|NCT00734526|Temozolomide|temozolomide
640918|NCT00734526|Radiation|radiation
640919|NCT00734526|Radiotherapy|radiotherapy
640920|NCT00734526|XRT|xrt
640921|NCT00734539|Candida|candida
640922|NCT00734539|Neonate|neonate
640923|NCT00734539|Fluconazole|fluconazole
640924|NCT00734539|Prophylaxis|prophylaxis
640925|NCT00734539|Colonization|colonization
640926|NCT00734539|Resistance|resistance
640927|NCT00734552|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
640928|NCT00734552|α-Keto Acid|α-keto acid
640929|NCT00734552|Low Protein Diet|low protein diet
640930|NCT00734552|Residual Renal Function|residual renal function
640931|NCT00734565|vaccine|vaccine
640932|NCT00734565|prevention|prevention
640933|NCT00734565|haemophilus influenzae type b|haemophilus influenzae type b
640934|NCT00734565|children|children
640935|NCT00734591|Observational Study Exubera|observational study exubera
640936|NCT00734617|Cigarette|cigarette
640937|NCT00734617|Nicotine|nicotine
640938|NCT00734630|nebivolol|nebivolol
640939|NCT00734630|Bystolic ™|bystolic ™
640940|NCT00734630|lisinopril|lisinopril
640941|NCT00734630|losartan|losartan
640942|NCT00734630|Hypertension|hypertension
641345|NCT00746447|mesalazine|mesalazine
640943|NCT00734643|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
640944|NCT00734643|Family coping|family coping
640945|NCT00734643|Complex Congenital Heart Disease|complex congenital heart disease
640946|NCT00734656|steroid 5Alpha Reductase|steroid 5alpha reductase
640947|NCT00734656|dutasteride|dutasteride
640948|NCT00734656|neuroactive steroid|neuroactive steroid
640949|NCT00734669|Diabetes|diabetes
640950|NCT00734669|Hypoglycemia|hypoglycemia
640951|NCT00734682|Glioblastoma|glioblastoma
640952|NCT00734682|Gliosarcoma|gliosarcoma
640953|NCT00734682|Anaplastic Astrocytoma|anaplastic astrocytoma
640954|NCT00734682|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
640955|NCT00734682|Anaplastic Mixed Oligoastrocytoma|anaplastic mixed oligoastrocytoma
640956|NCT00734682|Malignant Astrocytoma NOS|malignant astrocytoma nos
640957|NCT00734682|Nanoliposomal CPT-11|nanoliposomal cpt-11
640958|NCT00734682|liposomal irinotecan|liposomal irinotecan
640959|NCT00734695|BURN|burn
640961|NCT00734695|VITAMIN C|vitamin c
640962|NCT00734695|ASCORBIC ACID|ascorbic acid
640963|NCT00734721|intravitreal injection|intravitreal injection
640964|NCT00734734|Prophylaxis of Influenza|prophylaxis of influenza
640965|NCT00734734|Influenza Vaccines|influenza vaccines
640966|NCT00734734|MF59C.1|mf59c.1
640967|NCT00734747|GERD|gerd
640968|NCT00734747|Gastroesophageal Reflux|gastroesophageal reflux
640969|NCT00734747|Fundoplication|fundoplication
640970|NCT00734747|Endoluminal|endoluminal
640971|NCT00734747|Gastroesophageal Flap Valve|gastroesophageal flap valve
640972|NCT00734760|patient education|patient education
640973|NCT00734760|acute coronary syndrome|acute coronary syndrome
640974|NCT00734760|prehospital delay to treatment|prehospital delay to treatment
640975|NCT00743145|naltrexone|naltrexone
640976|NCT00743145|smoked marijuana|smoked marijuana
640977|NCT00743145|marijuana use|marijuana use
640978|NCT00743158|ztr|ztr
640979|NCT00743158|transfer impedance|transfer impedance
640980|NCT00743158|cystic fibrosis|cystic fibrosis
640981|NCT00743158|pulmonary function test|pulmonary function test
640982|NCT00743158|pft|pft
640983|NCT00743171|Lung transplantation|lung transplantation
640984|NCT00743171|Home spirometry|home spirometry
640985|NCT00743171|non-adherence|non-adherence
640986|NCT00743171|outcomes|outcomes
640987|NCT00743171|bronchiolitis obliterans|bronchiolitis obliterans
640988|NCT00743184|BPH|bph
640989|NCT00743184|LUTS|luts
640990|NCT00743184|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
640991|NCT00743197|coronary artery disease (CAD)|coronary artery disease (cad)
640992|NCT00743197|chest pain|chest pain
640993|NCT00743197|myocardial ischemia|myocardial ischemia
640994|NCT00743197|endothelial function|endothelial function
640995|NCT00743210|pregnancy|pregnancy
640996|NCT00743210|obesity|obesity
640997|NCT00743210|asymmetric dimethylarginine|asymmetric dimethylarginine
640998|NCT00743210|L-arginine|l-arginine
640999|NCT00743210|L-citrulline|l-citrulline
641000|NCT00743223|temporomandibular disorder|temporomandibular disorder
641001|NCT00743223|orofacial pain|orofacial pain
641002|NCT00743223|posture of the head|posture of the head
641003|NCT00743236|perioperative/postoperative complications|perioperative/postoperative complications
641004|NCT00743236|urinary complications|urinary complications
641005|NCT00743236|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
641006|NCT00743236|stage I renal cell cancer|stage i renal cell cancer
641007|NCT00743249|Dry eye|dry eye
641008|NCT00743249|Tear duct|tear duct
641009|NCT00743249|Punctal plug|punctal plug
641010|NCT00743262|laryngectomy|laryngectomy
641011|NCT00743262|larynx cancer|larynx cancer
641012|NCT00743275|Influenza|influenza
641013|NCT00743288|stage I multiple myeloma|stage i multiple myeloma
641014|NCT00743288|stage II multiple myeloma|stage ii multiple myeloma
641015|NCT00743288|stage III multiple myeloma|stage iii multiple myeloma
641016|NCT00743288|refractory multiple myeloma|refractory multiple myeloma
641017|NCT00743301|CVD|cvd
641018|NCT00743301|Palm olein|palm olein
641019|NCT00743301|Olive oil|olive oil
641020|NCT00743301|Lard|lard
641021|NCT00743301|healthy men|healthy men
641022|NCT00743301|metabolic syndrome|metabolic syndrome
641023|NCT00743301|Risk of cardiovascular disease and metabolic syndrome|risk of cardiovascular disease and metabolic syndrome
641024|NCT00743314|lymphedema|lymphedema
641025|NCT00743314|stage I breast cancer|stage i breast cancer
641026|NCT00743314|stage II breast cancer|stage ii breast cancer
641027|NCT00743327|hormone therapy|hormone therapy
641028|NCT00743340|HIV-1 infection|hiv-1 infection
641029|NCT00743340|emtricitabine|emtricitabine
641030|NCT00743340|pediatrics|pediatrics
641031|NCT00743340|pediatric patients|pediatric patients
641032|NCT00743353|laryngeal|laryngeal
641033|NCT00743353|squamous cell|squamous cell
641034|NCT00743353|anaplastic astrocytoma|anaplastic astrocytoma
641035|NCT00743353|oligodendroglioma|oligodendroglioma
641036|NCT00743353|glioblastoma multiforme|glioblastoma multiforme
641037|NCT00743366|quetiapine|quetiapine
641038|NCT00743366|smoked marijuana|smoked marijuana
641039|NCT00743366|marijuana use|marijuana use
641040|NCT00743379|Phase 1/2|phase 1/2
641041|NCT00743379|Advanced Solid Tumors|advanced solid tumors
641044|NCT00743379|Dose-Escalation|dose-escalation
641045|NCT00743379|Evofosfamide|evofosfamide
641046|NCT00743405|schizophrenia|schizophrenia
641047|NCT00743405|M1 receptor agonist|m1 receptor agonist
641048|NCT00743405|safety|safety
641049|NCT00743405|pharmacokinetics|pharmacokinetics
641050|NCT00743405|GSK1034702|gsk1034702
641051|NCT00743444|GERD|gerd
641052|NCT00743444|transient lower esophageal sphincter relaxations (TLESRs)|transient lower esophageal sphincter relaxations (tlesrs)
641053|NCT00743444|reflux|reflux
641054|NCT00743457|Possible VPS failure with symptom such as headache|possible vps failure with symptom such as headache
641055|NCT00743457|vomiting|vomiting
641056|NCT00743457|lethargy|lethargy
641057|NCT00743457|VPS failure|vps failure
641058|NCT00743470|HIV co-infected with tuberculosis|hiv co-infected with tuberculosis
641059|NCT00745316|Heart Failure|heart failure
641060|NCT00745316|Renal Insufficiency|renal insufficiency
641061|NCT00745316|Congestive Heart Failure|congestive heart failure
641062|NCT00745342|type 1 diabetes|type 1 diabetes
641063|NCT00745342|glycemic control|glycemic control
641064|NCT00745342|family conflict|family conflict
641065|NCT00745342|quality of life|quality of life
641066|NCT00745342|parental involvement|parental involvement
641067|NCT00745355|Quality of Life|quality of life
641068|NCT00745355|Questionnaires|questionnaires
641069|NCT00745355|08-076|08-076
641071|NCT00745368|Raltegravir|raltegravir
641072|NCT00745368|pharmacokinetics|pharmacokinetics
641073|NCT00745368|Treatment Experienced|treatment experienced
641074|NCT00745381|PANCREAS|pancreas
641075|NCT00745381|STOMACH|stomach
641076|NCT00745381|Questionnaire|questionnaire
641077|NCT00745381|08-105|08-105
641078|NCT00745394|NIRS|nirs
641079|NCT00745394|bypass|bypass
641080|NCT00745394|cardiopulmonary|cardiopulmonary
641081|NCT00745394|CPB|cpb
641082|NCT00745394|monitoring|monitoring
641083|NCT00745394|system|system
641084|NCT00745407|adipocytokines|adipocytokines
641085|NCT00745407|insulin sensitivity|insulin sensitivity
641086|NCT00745407|hypertriglyceridemic patients|hypertriglyceridemic patients
641087|NCT00745420|Sickle Cell Disease|sickle cell disease
641088|NCT00745420|Sickle Cell Anemia|sickle cell anemia
641089|NCT00745446|Air pollution|air pollution
641090|NCT00745446|Diesel exhaust|diesel exhaust
641091|NCT00745446|Endothelial function|endothelial function
641092|NCT00745446|Vascular function|vascular function
641093|NCT00745446|Particle trap|particle trap
641094|NCT00745446|Thrombosis|thrombosis
641095|NCT00745446|effects|effects
641096|NCT00745446|inhalation|inhalation
641097|NCT00745459|Patients|patients
641098|NCT00745459|undergoing|undergoing
641099|NCT00745459|gastric|gastric
641100|NCT00745459|endoscopy|endoscopy
641101|NCT00745472|AEP|aep
641102|NCT00745472|experimental pain|experimental pain
641103|NCT00745472|healthy volunteers|healthy volunteers
641104|NCT00745485|Osteoporosis|osteoporosis
641105|NCT00745485|zoledronic acid|zoledronic acid
641106|NCT00745485|postmenopausal women|postmenopausal women
641230|NCT00746018|uterus|uterus
641107|NCT00745498|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
641108|NCT00745498|vitrectomy|vitrectomy
641109|NCT00745498|bevacizumab|bevacizumab
641110|NCT00745498|vitreous hemorrhage|vitreous hemorrhage
641111|NCT00745511|AMD|amd
641112|NCT00745511|Avastin|avastin
641113|NCT00745511|ORA102|ora102
641114|NCT00745511|macular degeneration|macular degeneration
641115|NCT00745511|neo-vascular age related macular degeneration (AMD)|neo-vascular age related macular degeneration (amd)
641116|NCT00745524|Attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
641117|NCT00745524|adolescent|adolescent
641118|NCT00745524|adult|adult
641119|NCT00745524|high risk population|high risk population
641120|NCT00745524|functional impairment|functional impairment
641121|NCT00745524|quality of life|quality of life
641122|NCT00745537|postpartum major depression|postpartum major depression
641123|NCT00745537|adolescent mothers|adolescent mothers
641220|NCT00745966|atypical antipsychotics|atypical antipsychotics
641124|NCT00745537|telephone depression care management|telephone depression care management
641125|NCT00745537|barriers to depression care|barriers to depression care
641126|NCT00745550|SB1518|sb1518
641127|NCT00745550|Chronic Idiopathic Myelofibrosis|chronic idiopathic myelofibrosis
641128|NCT00745550|Myeloproliferative disorders|myeloproliferative disorders
641129|NCT00745550|Polycythemia Vera|polycythemia vera
641130|NCT00745550|Essential Thrombocythemia|essential thrombocythemia
641131|NCT00745550|JAK2 inhibitor|jak2 inhibitor
641132|NCT00745563|infertility|infertility
641133|NCT00745563|insemination|insemination
641134|NCT00745563|slow release|slow release
641135|NCT00745589|vascular,|vascular,
641136|NCT00745589|valvular calcification,|valvular calcification,
641137|NCT00745589|phosphate binder,|phosphate binder,
641138|NCT00745589|sevelamer,|sevelamer,
641139|NCT00745589|endstage renal disease|endstage renal disease
641140|NCT00745589|peritoneal dialysis|peritoneal dialysis
641141|NCT00745602|direct current cardioversion, cerebral blood flow|direct current cardioversion, cerebral blood flow
641142|NCT00745628|coronary heart disease|coronary heart disease
641656|NCT00747682|Electrical|electrical
641143|NCT00745628|secondary prevention|secondary prevention
641144|NCT00745641|radiation injury|radiation injury
641145|NCT00745641|computed tomography|computed tomography
641146|NCT00745641|reactive oxygen species|reactive oxygen species
641147|NCT00745641|free radicals|free radicals
641148|NCT00745654|Lung Transplantation|lung transplantation
641149|NCT00745654|Chronic pain|chronic pain
641150|NCT00745654|Thoracotomy|thoracotomy
641151|NCT00745667|laparoscopic|laparoscopic
641152|NCT00745667|peptic ulcer|peptic ulcer
641153|NCT00745680|Left ventricular remodeling, acute myocardial infarction|left ventricular remodeling, acute myocardial infarction
641154|NCT00745693|Endothelin|endothelin
641155|NCT00745693|Air pollution|air pollution
641156|NCT00745693|Diesel exhaust|diesel exhaust
641157|NCT00745693|Vascular function|vascular function
641158|NCT00745693|exposure|exposure
641159|NCT00745719|parathyroidectomy|parathyroidectomy
641160|NCT00745719|cardiovascular|cardiovascular
641161|NCT00745719|bone|bone
641162|NCT00745719|endstage renal disease|endstage renal disease
641163|NCT00745732|Non-Small Cell Lung Cancer|non-small cell lung cancer
641164|NCT00745732|Lung Cancer|lung cancer
641165|NCT00745732|NSCLC|nsclc
641166|NCT00745732|ZD6474|zd6474
641167|NCT00745732|ZACTIMA|zactima
641168|NCT00745732|Vandetanib|vandetanib
641169|NCT00745732|Inoperable NSCLC|inoperable nsclc
641170|NCT00745732|Unresectable NSCLC|unresectable nsclc
641171|NCT00745732|Radiation Therapy|radiation therapy
641172|NCT00745732|Palliative radiation therapy|palliative radiation therapy
641173|NCT00745732|Angiogenesis|angiogenesis
641174|NCT00745758|SAH, vasospasm, ADMA|sah, vasospasm, adma
641175|NCT00745771|pharmacokinetics|pharmacokinetics
641176|NCT00745771|of Diractin®|of diractin®
641177|NCT00745771|safety|safety
641178|NCT00745771|efficacy|efficacy
641179|NCT00745771|exercise|exercise
641180|NCT00745784|Young Bereaved Spouses|young bereaved spouses
641181|NCT00745797|nonsmall cell lung cancer|nonsmall cell lung cancer
641182|NCT00745797|brain metastasis|brain metastasis
641183|NCT00745797|prophylactic cranial irradiation|prophylactic cranial irradiation
641184|NCT00745810|cardiopulmonary bypass|cardiopulmonary bypass
641185|NCT00745810|oxidative injuries|oxidative injuries
641186|NCT00745823|HIV Infections|hiv infections
641187|NCT00745823|Treatment Naïve|treatment naïve
641188|NCT00745836|insulin sensitivity|insulin sensitivity
641189|NCT00745849|non-allergic rhinitis, laryngopharyngeal reflux|non-allergic rhinitis, laryngopharyngeal reflux
641190|NCT00745862|Skin|skin
641191|NCT00745875|NSCLC|nsclc
641192|NCT00745875|Phase II|phase ii
641193|NCT00745875|ZD4054|zd4054
641194|NCT00745875|Pemetrexed|pemetrexed
641195|NCT00745875|Lung Cancer|lung cancer
641196|NCT00745888|oxidative stress|oxidative stress
641197|NCT00745888|intensive care|intensive care
641198|NCT00745888|Postoperative intensive care|postoperative intensive care
641199|NCT00745901|contraception|contraception
641200|NCT00745901|bleeding|bleeding
641201|NCT00745901|cycle control|cycle control
641202|NCT00745914|PPAR-gamma, diabetic, kidney disease, atherosclerosis|ppar-gamma, diabetic, kidney disease, atherosclerosis
641203|NCT00745927|Colorectal neoplasm|colorectal neoplasm
641204|NCT00745927|Colorectal cancer|colorectal cancer
641205|NCT00745927|Screening colonoscopy|screening colonoscopy
641206|NCT00745927|CO2 insufflations|co2 insufflations
641207|NCT00745927|Colonoscopy|colonoscopy
641208|NCT00745940|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
641209|NCT00745940|MBCT|mbct
641210|NCT00745940|Depression|depression
641211|NCT00745940|Traumatic Brain Injury|traumatic brain injury
641212|NCT00745940|TBI|tbi
641213|NCT00745953|Metabolic syndrome|metabolic syndrome
641214|NCT00745953|Lipotoxicity|lipotoxicity
641215|NCT00745953|Insulin sensitivity|insulin sensitivity
641216|NCT00745953|Myocardial triglyceride levels|myocardial triglyceride levels
641217|NCT00745953|Hepatic triglyceride levels|hepatic triglyceride levels
641218|NCT00745953|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
641219|NCT00745966|Bipolar|bipolar
641221|NCT00745966|quality of life|quality of life
641222|NCT00745966|observational|observational
641223|NCT00745992|Voriconazole|voriconazole
641224|NCT00745992|Antifungal Agents|antifungal agents
641225|NCT00745992|Invasive fungal infections|invasive fungal infections
641226|NCT00745992|Therapeutic drug monitoring|therapeutic drug monitoring
641227|NCT00745992|CYP Genetic polymorphism|cyp genetic polymorphism
641228|NCT00746005|mild cognitive impairment|mild cognitive impairment
641229|NCT00746018|ovary|ovary
641232|NCT00746018|08-092|08-092
641233|NCT00746031|MTI|mti
641234|NCT00746031|Fibroids|fibroids
641235|NCT00746031|Novel|novel
641236|NCT00746031|MR imaging|mr imaging
641237|NCT00746031|techniques|techniques
641238|NCT00746044|Healthy|healthy
641239|NCT00746057|Renal graft|renal graft
641240|NCT00746057|chronic rejection|chronic rejection
641241|NCT00746057|tolerance|tolerance
641242|NCT00746057|DNA chip|dna chip
641243|NCT00746057|biopsy|biopsy
641346|NCT00746447|ulcerative colitis|ulcerative colitis
641657|NCT00747682|Activity|activity
641244|NCT00746070|cardiovascular disease, endothelium function, aldosterone|cardiovascular disease, endothelium function, aldosterone
641245|NCT00746083|pediatric|pediatric
641246|NCT00746083|obesity|obesity
641247|NCT00746083|African American|african american
641248|NCT00746083|adolescents|adolescents
641249|NCT00746083|intervention|intervention
641250|NCT00746083|home-based|home-based
641251|NCT00746083|community-based|community-based
641252|NCT00746109|randomized|randomized
641253|NCT00746109|clinical trial|clinical trial
641254|NCT00746109|ultrasound|ultrasound
641255|NCT00746109|prospective|prospective
641256|NCT00746109|abscess|abscess
641257|NCT00746109|packing|packing
641258|NCT00746109|incision and drainage|incision and drainage
641259|NCT00746109|superficial soft tissue infection|superficial soft tissue infection
641260|NCT00746135|Heart failure (NYHA class III and IV)|heart failure (nyha class iii and iv)
641261|NCT00746135|Ventricular Dyssynchrony|ventricular dyssynchrony
641262|NCT00746148|Polycystic Ovary Syndrome|polycystic ovary syndrome
641263|NCT00746148|Reflexology|reflexology
641264|NCT00746148|Complementary and Alternative Medicine|complementary and alternative medicine
641265|NCT00746148|Endocrinopathy|endocrinopathy
641266|NCT00746148|Oligo|oligo
641267|NCT00746148|Amenorrhoea|amenorrhoea
641268|NCT00746161|total gastrectomy|total gastrectomy
641269|NCT00746161|double tract reconstruction|double tract reconstruction
641270|NCT00746161|gastric cancer|gastric cancer
641271|NCT00746161|Total gastrectomy in patients with gastric cancer|total gastrectomy in patients with gastric cancer
641272|NCT00746174|insulin sensitivity|insulin sensitivity
641273|NCT00746174|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
641274|NCT00746174|lipotoxicity|lipotoxicity
641275|NCT00746174|lipid oxidation|lipid oxidation
641276|NCT00746174|thiazolidinediones|thiazolidinediones
641277|NCT00746174|intracellular|intracellular
641278|NCT00746174|triglyceride|triglyceride
641279|NCT00746174|content|content
641280|NCT00746200|chronic constipation|chronic constipation
641281|NCT00746200|electroacupuncture|electroacupuncture
641282|NCT00746200|randomized controlled trial|randomized controlled trial
641283|NCT00746213|Thoracotomy|thoracotomy
641284|NCT00746213|Chronic Pain|chronic pain
641285|NCT00746226|birch pollen|birch pollen
641286|NCT00746239|insomnia|insomnia
641287|NCT00746239|sleep difficulty|sleep difficulty
641288|NCT00746239|panic disorder|panic disorder
641289|NCT00746239|nocturnal panic attacks|nocturnal panic attacks
641290|NCT00746239|anxiety|anxiety
641291|NCT00746252|bipolar|bipolar
641292|NCT00746252|children|children
641293|NCT00746252|antipsychotic|antipsychotic
641294|NCT00746252|side effect|side effect
641295|NCT00746265|behavioral interventions for weight loss|behavioral interventions for weight loss
641296|NCT00746278|Ovarian Cysts|ovarian cysts
641297|NCT00746278|Electrocoagulation|electrocoagulation
641298|NCT00746278|Ovarian Function Tests|ovarian function tests
641299|NCT00746278|Laparoscopy|laparoscopy
641300|NCT00746304|botulinum|botulinum
641301|NCT00746304|esotropia|esotropia
641302|NCT00746330|Asthma|asthma
641303|NCT00746330|Children|children
641304|NCT00746330|Persistent asthma|persistent asthma
641305|NCT00746343|Bipolar I Disorder|bipolar i disorder
641306|NCT00746343|Medical Risks|medical risks
641307|NCT00746343|Integrated Risk Reduction Intervention|integrated risk reduction intervention
641308|NCT00746343|Currently in Remission|currently in remission
641309|NCT00746343|BMI|bmi
641310|NCT00746356|heart failure|heart failure
641311|NCT00746356|cardiac resynchronization therapy|cardiac resynchronization therapy
641312|NCT00746356|autocapture|autocapture
641313|NCT00746356|Current RF|current rf
641314|NCT00746356|Promote RF|promote rf
641315|NCT00746369|HIV|hiv
641316|NCT00746369|Prevention|prevention
641317|NCT00746369|Adolescents|adolescents
641318|NCT00746369|HIV Seronegativity|hiv seronegativity
641319|NCT00746382|Mild atopic dermatitis, Roflumilast cream 0.5%|mild atopic dermatitis, roflumilast cream 0.5%
641320|NCT00746395|capsule|capsule
641321|NCT00746395|endoscopy|endoscopy
641322|NCT00746395|prokinetic|prokinetic
641323|NCT00746395|lubiprostone|lubiprostone
641324|NCT00746395|Normal|normal
641325|NCT00746395|volunteers|volunteers
641326|NCT00746408|Internet|internet
641327|NCT00746408|Information supply|information supply
641328|NCT00746408|Tailoring|tailoring
641329|NCT00746408|Patient empowerment|patient empowerment
641330|NCT00746408|Headaches|headaches
641331|NCT00746408|Consumer Health Information|consumer health information
641332|NCT00746408|Information Services|information services
641333|NCT00746408|Information Storage and Retrieval|information storage and retrieval
641334|NCT00746408|Information Systems|information systems
641335|NCT00746421|Cognition|cognition
641336|NCT00746421|attention|attention
641337|NCT00746421|bipolar|bipolar
641338|NCT00746421|disability|disability
641339|NCT00746434|Mild plaque psoriasis,|mild plaque psoriasis,
641340|NCT00746434|Moderate plaque psoriasis,|moderate plaque psoriasis,
641341|NCT00746434|0.5% Roflumilast cream|0.5% roflumilast cream
641342|NCT00746447|maintenance|maintenance
641343|NCT00746447|5-ASA|5-asa
641344|NCT00746447|mesalamine|mesalamine
641347|NCT00746460|primary prevention|primary prevention
641348|NCT00746460|patient knowledge|patient knowledge
641349|NCT00746460|nurse|nurse
641350|NCT00746460|exercise|exercise
641351|NCT00746460|smoking cessation|smoking cessation
641352|NCT00746460|weight loss|weight loss
641353|NCT00746525|stroke|stroke
641354|NCT00746525|motor learning|motor learning
641355|NCT00746525|rehabilitation of upper extremity|rehabilitation of upper extremity
641356|NCT00746525|functional electrical stimulation|functional electrical stimulation
641357|NCT00746525|FES|fes
641358|NCT00746525|brain computer interface|brain computer interface
641360|NCT00746525|coordination|coordination
641361|NCT00746525|motor control|motor control
641362|NCT00746538|Hilar cholangiocarcinoma|hilar cholangiocarcinoma
641363|NCT00746538|biliary stent|biliary stent
641468|NCT00746941|PML|pml
641364|NCT00746538|plastic stent|plastic stent
641365|NCT00746538|metallic stent|metallic stent
641366|NCT00746538|quality of life|quality of life
641367|NCT00746551|iron deficiency anemia|iron deficiency anemia
641368|NCT00746551|pregnancy|pregnancy
641369|NCT00746551|third trimester|third trimester
641370|NCT00746551|intravenous iron|intravenous iron
641371|NCT00746551|efficacy|efficacy
641372|NCT00746551|a randomized trial|a randomized trial
641373|NCT00746551|Female|female
641374|NCT00746551|Ferric Compounds/therapeutic use*|ferric compounds/therapeutic use*
641375|NCT00746551|Infusions, Intravenous|infusions, intravenous
641376|NCT00746551|Hematologic/therapy*|hematologic/therapy*
641377|NCT00746564|Implantable Cardiac Monitor|implantable cardiac monitor
641378|NCT00746564|Arrhythmias|arrhythmias
641379|NCT00746564|Atrial Fibrillation|atrial fibrillation
641380|NCT00746590|hepatocellular carcinoma|hepatocellular carcinoma
641381|NCT00746590|liver cancer|liver cancer
641382|NCT00746590|Prolarix|prolarix
641383|NCT00746590|tretazicar|tretazicar
641384|NCT00746590|caricotamide|caricotamide
641385|NCT00746590|Phase 2|phase 2
641386|NCT00746590|tumor|tumor
641387|NCT00746590|chemotherapy|chemotherapy
641388|NCT00746616|Total Hip Arthroplasty,|total hip arthroplasty,
641389|NCT00746616|Acetabular Cup,|acetabular cup,
641390|NCT00746616|Hip Resurfacing|hip resurfacing
641391|NCT00746616|Young,|young,
641392|NCT00746616|active|active
641393|NCT00746616|patients|patients
641394|NCT00746642|glucose measurements|glucose measurements
641395|NCT00746655|Hepatocellular|hepatocellular
641396|NCT00746668|Reading|reading
641397|NCT00746668|Macular Degeneration|macular degeneration
641398|NCT00746668|Rehabilitation|rehabilitation
641399|NCT00746668|Vision, Low|vision, low
641400|NCT00746707|adhesive glue, perineal tear, suture|adhesive glue, perineal tear, suture
641401|NCT00746720|hip replacement|hip replacement
641402|NCT00746720|osteoarthritis|osteoarthritis
641403|NCT00746720|etoricoxib|etoricoxib
641404|NCT00746720|pain|pain
641405|NCT00746720|cerebrospinal fluid|cerebrospinal fluid
641406|NCT00746720|pharmacokinetics|pharmacokinetics
641407|NCT00746733|Drug|drug
641408|NCT00746733|Interaction|interaction
641409|NCT00746733|Study|study
641410|NCT00746746|Advanced Melanoma|advanced melanoma
641411|NCT00746759|Lung Cancer|lung cancer
641412|NCT00746759|Smoker|smoker
641413|NCT00746759|Former Smoker|former smoker
641414|NCT00746759|Gene Expression|gene expression
641415|NCT00746759|Bronchoscopy|bronchoscopy
641416|NCT00746772|antioxidant|antioxidant
641417|NCT00746772|oral lichen planus|oral lichen planus
641418|NCT00746772|treatment|treatment
641419|NCT00746772|purslane|purslane
641420|NCT00746785|Olanzapine|olanzapine
641421|NCT00746798|West Nile Fever|west nile fever
641422|NCT00746798|ChimeriVax|chimerivax
641423|NCT00746798|West Nile Virus Vaccine|west nile virus vaccine
641424|NCT00746811|cholesterol|cholesterol
641425|NCT00746811|hypercholesterolemia|hypercholesterolemia
641426|NCT00746811|omega 3|omega 3
641427|NCT00746824|Obesity|obesity
641428|NCT00746824|weight loss|weight loss
641429|NCT00746824|7TM Pharma|7tm pharma
641430|NCT00746824|TM30339|tm30339
641431|NCT00746824|Y4 receptor antagonist|y4 receptor antagonist
641432|NCT00746837|AZD5672|azd5672
641433|NCT00746850|acute cholecystitis|acute cholecystitis
641434|NCT00746850|laparoscopic cholecystectomy|laparoscopic cholecystectomy
641435|NCT00746850|conversion rate|conversion rate
641436|NCT00746850|morbidity|morbidity
641437|NCT00746850|mortality|mortality
641438|NCT00746850|postoperative pain|postoperative pain
641439|NCT00746850|hospital stay|hospital stay
641440|NCT00746863|mid-urethral sling|mid-urethral sling
641441|NCT00746863|pubovaginal sling|pubovaginal sling
641442|NCT00746863|postoperative pain|postoperative pain
641443|NCT00746863|visual analog scale|visual analog scale
641444|NCT00746863|suprapubic approach|suprapubic approach
641445|NCT00746863|SPARC sling|sparc sling
641446|NCT00746876|Hip|hip
641447|NCT00746876|Fracture|fracture
641448|NCT00746876|Femoral neck|femoral neck
641449|NCT00746876|Hemiarthroplasty|hemiarthroplasty
641450|NCT00746876|Bipolar|bipolar
641451|NCT00746876|Unipolar|unipolar
641452|NCT00746876|Displaced femoral neck fractures|displaced femoral neck fractures
641453|NCT00746889|osteoarthritis|osteoarthritis
641454|NCT00746889|knee|knee
641455|NCT00746889|corticosteroids|corticosteroids
641456|NCT00746889|ultrasound|ultrasound
641457|NCT00746902|Refractory hypertension|refractory hypertension
641458|NCT00746902|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
641459|NCT00746902|Obesity|obesity
641460|NCT00746902|Leptinemia|leptinemia
641461|NCT00746902|RHOOSAS study|rhoosas study
641462|NCT00746915|Patients undergoing elective pain relief treatment of lumbar epidural steroid injection under fluoroscopy|patients undergoing elective pain relief treatment of lumbar epidural steroid injection under fluoroscopy
641463|NCT00746928|Blood pressure|blood pressure
641464|NCT00746928|Hypertension|hypertension
641465|NCT00746928|sympathetic control|sympathetic control
641466|NCT00746928|chemosensitivity|chemosensitivity
641467|NCT00746928|baroreflex|baroreflex
641469|NCT00746941|Human Polyomavirus JC|human polyomavirus jc
641471|NCT00746941|Central Nervous System Disease|central nervous system disease
641472|NCT00746941|Mefloquine|mefloquine
641473|NCT00746941|JC Virus|jc virus
641474|NCT00746954|buspirone|buspirone
641475|NCT00746954|acetazolamide|acetazolamide
641476|NCT00746980|alopecia|alopecia
641477|NCT00746980|areata|areata
641478|NCT00746980|universalis|universalis
641479|NCT00746980|severe|severe
641480|NCT00746980|ophiasis|ophiasis
641481|NCT00746980|variants|variants
641482|NCT00746993|Contraception|contraception
641483|NCT00746993|Counseling|counseling
641484|NCT00747045|Chronic Thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
641485|NCT00747045|Lung Injury|lung injury
641486|NCT00747045|Ventilation Strategies|ventilation strategies
641487|NCT00747058|phase 1, human study, healthy volunteers|phase 1, human study, healthy volunteers
641488|NCT00747071|Clostridium difficile|clostridium difficile
641489|NCT00747071|diarrhea|diarrhea
641490|NCT00747071|colostrum|colostrum
641491|NCT00747084|unsedated colonoscopy|unsedated colonoscopy
641492|NCT00747110|5-ASA|5-asa
641493|NCT00747110|mesalamine|mesalamine
641494|NCT00747110|mesalazine|mesalazine
641495|NCT00747110|budesonide|budesonide
641496|NCT00747110|ulcerative colitis|ulcerative colitis
641497|NCT00747136|Barrett's|barrett's
641498|NCT00747136|Dysplasia|dysplasia
641499|NCT00747136|esophageal cancer|esophageal cancer
641500|NCT00747136|Patients|patients
641501|NCT00747149|diabetes|diabetes
641502|NCT00747149|type 2|type 2
641503|NCT00747162|Compartment Syndrome|compartment syndrome
641504|NCT00747162|Muscle Oxygenation|muscle oxygenation
641505|NCT00747162|Skin Pigmentation|skin pigmentation
641506|NCT00747175|Type 2 diabetes|type 2 diabetes
641507|NCT00747188|Problem-based learning (PBL)|problem-based learning (pbl)
641508|NCT00747188|lecture|lecture
641509|NCT00747188|nursing|nursing
641510|NCT00747188|education|education
641511|NCT00747188|none of students had any prior exposure to PBL|none of students had any prior exposure to pbl
641512|NCT00747201|Replicating Effective Programs|replicating effective programs
641513|NCT00747201|Care Management|care management
641514|NCT00747201|Implementation|implementation
641515|NCT00747201|Intervention|intervention
641516|NCT00747214|Rheumatoid Arthritis|rheumatoid arthritis
641518|NCT00747214|DMARD|dmard
641519|NCT00747214|CRP|crp
641520|NCT00747227|cataract|cataract
641521|NCT00747227|monofocal|monofocal
641522|NCT00747227|intraocular lens|intraocular lens
641523|NCT00747227|acrylic|acrylic
641524|NCT00747240|Ile198Thr|ile198thr
641525|NCT00747240|Ala379Val|ala379val
641526|NCT00747240|variants|variants
641527|NCT00747240|PAF-AH|paf-ah
641528|NCT00747253|laser interstitial thermal therapy|laser interstitial thermal therapy
641529|NCT00747253|laser therapy|laser therapy
641530|NCT00747253|thermal therapy|thermal therapy
641531|NCT00747253|brain tumors|brain tumors
641532|NCT00747253|recurrent brain tumor|recurrent brain tumor
641533|NCT00747253|progressive brain tumor|progressive brain tumor
641534|NCT00747253|glioblastoma multiforme tumor|glioblastoma multiforme tumor
641535|NCT00747292|laparoscopic|laparoscopic
641536|NCT00747292|colon|colon
641537|NCT00747292|analgesia|analgesia
641538|NCT00747292|fluid optimised|fluid optimised
641539|NCT00747305|stage IV renal cell cancer|stage iv renal cell cancer
641540|NCT00747305|clear cell renal cell carcinoma|clear cell renal cell carcinoma
641541|NCT00747305|recurrent renal cell cancer|recurrent renal cell cancer
641542|NCT00747318|Moderate to Severe|moderate to severe
641543|NCT00747331|Cardiopulmonary bypass|cardiopulmonary bypass
641544|NCT00747331|Lactic acidosis|lactic acidosis
641545|NCT00747331|Oxygen delivery|oxygen delivery
641546|NCT00747331|Acute renal failure|acute renal failure
641547|NCT00747331|outcome|outcome
641548|NCT00747331|cardiac|cardiac
641549|NCT00747331|surgery|surgery
641550|NCT00747344|Psoriasis|psoriasis
641551|NCT00747344|Psoriatic Arthritis|psoriatic arthritis
641552|NCT00747344|Ustekinumab|ustekinumab
641553|NCT00747344|CNTO 1275|cnto 1275
641554|NCT00747370|stress urinary incontinence|stress urinary incontinence
641555|NCT00747370|Tension free vaginal tape|tension free vaginal tape
641556|NCT00747370|tension free vaginal tape obturator|tension free vaginal tape obturator
641557|NCT00747370|genital prolapse|genital prolapse
641558|NCT00747383|Diabetes Mellitus|diabetes mellitus
641560|NCT00747383|DPP4|dpp4
641561|NCT00747396|Romania,|romania,
641562|NCT00747396|children,|children,
641563|NCT00747396|foster care,|foster care,
641564|NCT00747396|institutionalization,|institutionalization,
641565|NCT00747396|brain function,|brain function,
641566|NCT00747396|MRI,|mri,
641567|NCT00747396|attachment,|attachment,
641568|NCT00747396|language,|language,
641569|NCT00747396|growth,|growth,
641570|NCT00747396|IQ,|iq,
641571|NCT00747396|psychiatric symptomatology|psychiatric symptomatology
641572|NCT00747396|early intervention|early intervention
641671|NCT00747708|intracoronary injection|intracoronary injection
641573|NCT00747409|postprandial glucose, diastolic function, analogue insulins|postprandial glucose, diastolic function, analogue insulins
641574|NCT00747435|sensorineural hearing loss|sensorineural hearing loss
641575|NCT00747435|ski slope audiogram|ski slope audiogram
641576|NCT00747435|electric acoustic stimulation|electric acoustic stimulation
641577|NCT00747448|Barrett's Esophagus|barrett's esophagus
641578|NCT00747448|High Grade Dysplasia|high grade dysplasia
641579|NCT00747448|Low Grade Dysplasia|low grade dysplasia
641580|NCT00747448|Squamous Dysplasia|squamous dysplasia
641581|NCT00747448|Esophageal Cancer|esophageal cancer
641582|NCT00747448|CryoSpray Ablation|cryospray ablation
641583|NCT00747448|Cryotherapy|cryotherapy
641584|NCT00747448|Cryospray|cryospray
641585|NCT00747461|Benign Airway Disease|benign airway disease
641586|NCT00747461|Airway Injury|airway injury
641587|NCT00747461|Sarcoidosis|sarcoidosis
641588|NCT00747461|Wegener's Granulomatosis|wegener's granulomatosis
641589|NCT00747461|Rhinoscleroma|rhinoscleroma
641590|NCT00747461|Recurrent Respiratory Papillomatosis(RRP)|recurrent respiratory papillomatosis(rrp)
641591|NCT00747487|Leber|leber
641592|NCT00747487|LHON|lhon
641593|NCT00747487|Leber's Hereditary Optic Neuropathy|leber's hereditary optic neuropathy
641594|NCT00747487|Idebenone|idebenone
641595|NCT00747513|school|school
641596|NCT00747513|prevention|prevention
641597|NCT00747513|overweight|overweight
641598|NCT00747513|children|children
641599|NCT00747513|diet|diet
641600|NCT00747513|physical activity|physical activity
641601|NCT00747513|fitness|fitness
641602|NCT00747526|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
641603|NCT00747526|Pediatrics|pediatrics
641604|NCT00747526|Pharmacokinetics|pharmacokinetics
641605|NCT00747526|Pharmacodynamics|pharmacodynamics
641606|NCT00747526|Rabeprazole|rabeprazole
641607|NCT00747526|GERD|gerd
641608|NCT00747526|Aciphex|aciphex
641609|NCT00747539|Hepatitis C Virus|hepatitis c virus
641610|NCT00747539|HCV|hcv
641611|NCT00747539|Human Immunodeficiency Virus|human immunodeficiency virus
641612|NCT00747539|Coinfection|coinfection
641613|NCT00747552|IAP measurements|iap measurements
641614|NCT00747552|Abdominal compartment syndrome|abdominal compartment syndrome
641615|NCT00747552|NICU patients|nicu patients
641616|NCT00747552|Intra-abdominal Hypertension|intra-abdominal hypertension
641617|NCT00747565|cataract, tecnis, multifocal, intraocular lens|cataract, tecnis, multifocal, intraocular lens
641618|NCT00747578|ankylosing spondylitis (AS), costs,|ankylosing spondylitis (as), costs,
641619|NCT00747578|rheumatoid arthritis (RA),|rheumatoid arthritis (ra),
641620|NCT00747578|systemic lupus erythematosus (SLE),|systemic lupus erythematosus (sle),
641621|NCT00747578|health-related|health-related
641622|NCT00747578|quality of life (HRQOL)|quality of life (hrqol)
641623|NCT00747578|compare|compare
641624|NCT00747578|utility|utility
641625|NCT00747578|patients|patients
641626|NCT00747591|urine|urine
641627|NCT00747591|concentration|concentration
641628|NCT00747591|of S100B|of s100b
641629|NCT00747604|Growth Hormone (GH) Insensitivity Syndrome|growth hormone (gh) insensitivity syndrome
641630|NCT00747604|Insulin-like Growth Factor Deficiency (IGFD)|insulin-like growth factor deficiency (igfd)
641631|NCT00747604|Short Stature|short stature
641632|NCT00747604|Insulin-like Growth Factor (IGF-1)|insulin-like growth factor (igf-1)
641633|NCT00747604|Growth|growth
641634|NCT00747617|polycystic ovary syndrome|polycystic ovary syndrome
641635|NCT00747617|androgens|androgens
641636|NCT00747617|ovary|ovary
641637|NCT00747617|LH|lh
641638|NCT00747630|Fetal Alcohol Syndrome|fetal alcohol syndrome
641639|NCT00747630|Teen pregnancy|teen pregnancy
641640|NCT00747643|tobacco|tobacco
641641|NCT00747643|nicotine|nicotine
641642|NCT00747643|smoking|smoking
641643|NCT00747643|reward|reward
641644|NCT00747643|reinforcement|reinforcement
641645|NCT00747643|craving|craving
641646|NCT00747643|cues|cues
641647|NCT00747643|conditioned stimuli|conditioned stimuli
641648|NCT00747643|cue reactivity|cue reactivity
641649|NCT00747656|Electrocardiography|electrocardiography
641650|NCT00747656|Emergency medical services|emergency medical services
641651|NCT00747656|Emergency medicine|emergency medicine
641652|NCT00747656|Health services|health services
641653|NCT00747656|Cost effectiveness|cost effectiveness
641654|NCT00747682|Cerebral Perfusion,|cerebral perfusion,
641655|NCT00747682|Oxygenation,|oxygenation,
641658|NCT00747695|Pediatric Pharmacokinetics|pediatric pharmacokinetics
641659|NCT00747695|Pediatric Pharmacodynamics|pediatric pharmacodynamics
641660|NCT00747695|Rabeprazole|rabeprazole
641661|NCT00747695|Pediatric GERD|pediatric gerd
641662|NCT00747695|Aciphex|aciphex
641663|NCT00747708|heart failure|heart failure
641664|NCT00747708|coronary heart disease|coronary heart disease
641665|NCT00747708|adult stem cells|adult stem cells
641666|NCT00747708|bone marrow progenitor cells|bone marrow progenitor cells
641667|NCT00747708|bone marrow stem cells|bone marrow stem cells
641668|NCT00747708|autologous|autologous
641669|NCT00747708|granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
641670|NCT00747708|left ventricular function|left ventricular function
641672|NCT00747708|intramyocardial injection|intramyocardial injection
641673|NCT00747734|Neuropilin-1|neuropilin-1
641674|NCT00747734|NRP1|nrp1
641675|NCT00747734|anti-NRP1|anti-nrp1
641676|NCT00747734|anti-angiogenic|anti-angiogenic
641677|NCT00747747|Sinusitis|sinusitis
641678|NCT00747760|TSH Receptor, resistance TSH, Hyperthyrortropinemia|tsh receptor, resistance tsh, hyperthyrortropinemia
641679|NCT00747773|Lung Cancer|lung cancer
641680|NCT00747773|CryoPsray Ablation|cryopsray ablation
641681|NCT00747773|CSA therapy|csa therapy
641682|NCT00747773|CSA treatment|csa treatment
641683|NCT00747773|Lobectomy|lobectomy
641684|NCT00747773|lung resection|lung resection
641685|NCT00738127|Acute trans-scaphoid perilunate dislocations|acute trans-scaphoid perilunate dislocations
641686|NCT00738127|Open reduction and internal fixation|open reduction and internal fixation
641687|NCT00738127|Kirschner-wire|kirschner-wire
641688|NCT00738127|Range of motion|range of motion
641689|NCT00738140|insulin sensitivity|insulin sensitivity
641690|NCT00738140|Diabetes Prevention Program|diabetes prevention program
641691|NCT00738140|lifestyle intervention|lifestyle intervention
641692|NCT00738166|diet, organic, health|diet, organic, health
641693|NCT00738166|healthy people|healthy people
641694|NCT00738179|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
641695|NCT00738179|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
641696|NCT00738179|Cardiovascular (CV)|cardiovascular (cv)
641697|NCT00738179|Cardiovascular Disease|cardiovascular disease
641698|NCT00738179|Clinical Trial|clinical trial
641699|NCT00738192|Postoperative analgesia|postoperative analgesia
641700|NCT00738192|Opioids|opioids
641701|NCT00738192|Laparoscopic surgery|laparoscopic surgery
641702|NCT00738205|Electronic device|electronic device
641703|NCT00738205|Growth hormone treatment|growth hormone treatment
641704|NCT00738218|Coronary Artery Disease|coronary artery disease
641705|NCT00738218|Computed Tomography|computed tomography
641706|NCT00738218|Angiography|angiography
641707|NCT00738231|risk factors; coronary arterial hearth disease|risk factors; coronary arterial hearth disease
641708|NCT00738244|hearing aid algorithm|hearing aid algorithm
641709|NCT00738244|wind-noise suppression|wind-noise suppression
641710|NCT00738257|Renal|renal
641711|NCT00738257|transplant,|transplant,
641712|NCT00738257|pamidronate,|pamidronate,
641713|NCT00738257|ciclosporin,|ciclosporin,
641714|NCT00738257|Ciclosporin A,|ciclosporin a,
641715|NCT00738257|steroids,|steroids,
641716|NCT00738257|bone mineral density,|bone mineral density,
641717|NCT00738257|fracture rates|fracture rates
641718|NCT00738257|immunosuppressive|immunosuppressive
641719|NCT00738257|regimen|regimen
641720|NCT00738283|Zinc|zinc
641721|NCT00738283|Copper|copper
641722|NCT00738283|Neonate|neonate
641723|NCT00738309|Treatment Outcomes|treatment outcomes
641724|NCT00738309|Spinal Deformity|spinal deformity
641725|NCT00738309|Scheuermann's Kyphosis|scheuermann's kyphosis
641726|NCT00738322|AZD1305|azd1305
641727|NCT00738322|safety|safety
641728|NCT00738322|pharmacokinetics|pharmacokinetics
641729|NCT00738322|single ascending doses|single ascending doses
641730|NCT00738322|Japanese|japanese
641731|NCT00738322|male|male
641732|NCT00738335|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
641733|NCT00738335|tumors metastatic to brain|tumors metastatic to brain
641734|NCT00738335|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
641735|NCT00738348|surgery|surgery
641736|NCT00738361|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
641737|NCT00738361|iris melanoma|iris melanoma
641738|NCT00738361|metastatic intraocular melanoma|metastatic intraocular melanoma
641739|NCT00738361|recurrent intraocular melanoma|recurrent intraocular melanoma
641740|NCT00738361|extraocular extension melanoma|extraocular extension melanoma
641741|NCT00738387|Tumor vascular disrupting agent|tumor vascular disrupting agent
641743|NCT00738387|ASA404|asa404
641744|NCT00738387|non-small cell lung cancer|non-small cell lung cancer
641745|NCT00738387|NSCLC|nsclc
641746|NCT00738400|Vardenafil|vardenafil
641747|NCT00738400|Erectile Dysfunction|erectile dysfunction
641748|NCT00738400|Double-blind study|double-blind study
641749|NCT00738413|Iron chelation|iron chelation
641750|NCT00738413|Iron balance|iron balance
641751|NCT00738413|Secondary iron overload|secondary iron overload
641752|NCT00738413|deferoxamine|deferoxamine
641753|NCT00738413|deferasirox|deferasirox
641937|NCT00739063|Erlotinib|erlotinib
641754|NCT00738426|non-invasive body contouring of waists hips and thighs|non-invasive body contouring of waists hips and thighs
641755|NCT00738439|scoliosis|scoliosis
641756|NCT00738439|kyphosis|kyphosis
641757|NCT00738439|treatment outcomes|treatment outcomes
641758|NCT00738439|spinal deformity|spinal deformity
641759|NCT00738452|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
641760|NCT00738452|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
641761|NCT00738452|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
641762|NCT00738452|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
641763|NCT00738478|distal gastrectomy|distal gastrectomy
641764|NCT00738478|quality of life|quality of life
641765|NCT00738491|Angina pectoris|angina pectoris
641766|NCT00738491|Exercise capacity|exercise capacity
641767|NCT00738491|Myocardial ischaemia|myocardial ischaemia
641768|NCT00738491|Air pollution|air pollution
641769|NCT00738504|Intensive insulin therapy|intensive insulin therapy
641770|NCT00738504|Carbohydrate restrictive strategy|carbohydrate restrictive strategy
641771|NCT00738504|RIFLE Criteria|rifle criteria
641772|NCT00738504|Acute Kidney Injury|acute kidney injury
641773|NCT00738504|Critically ill patients|critically ill patients
641774|NCT00738504|Acute|acute
641775|NCT00738517|heart failure|heart failure
641776|NCT00738517|coronary heart disease|coronary heart disease
641777|NCT00738517|autoantibodies|autoantibodies
641778|NCT00738517|immunoadsorption|immunoadsorption
641779|NCT00738517|immunoglobulin substitution|immunoglobulin substitution
641780|NCT00738543|Antiseptics|antiseptics
641781|NCT00738543|Administration, cutaneous|administration, cutaneous
641782|NCT00738543|Iodophors|iodophors
641783|NCT00738543|Chlorine compounds|chlorine compounds
641784|NCT00738543|Anti-infecting agents, local|anti-infecting agents, local
641785|NCT00738569|Chronic inflammation|chronic inflammation
641786|NCT00738569|memory cells|memory cells
641787|NCT00738569|activated t-lymphocytes|activated t-lymphocytes
641788|NCT00738595|Smoking Cessation|smoking cessation
641789|NCT00738608|morphine|morphine
641790|NCT00738608|consumption|consumption
641791|NCT00738608|postoperative|postoperative
641792|NCT00738608|pain|pain
641793|NCT00738608|Pain during 24h postoperative|pain during 24h postoperative
641794|NCT00738608|Morphine consumption in 24h postoperative|morphine consumption in 24h postoperative
641795|NCT00738621|PONV|ponv
641796|NCT00738621|breast surgery|breast surgery
641797|NCT00738621|prevention|prevention
641798|NCT00738621|antiemetics|antiemetics
641799|NCT00738634|Depression|depression
641800|NCT00738634|Motor Activity|motor activity
641801|NCT00738634|Adolescent|adolescent
641802|NCT00738647|Filling materials|filling materials
641803|NCT00738647|Restorative materials|restorative materials
641804|NCT00738647|clinical trial|clinical trial
641805|NCT00738647|Resin based composite|resin based composite
641806|NCT00738660|type1 DM|type1 dm
641807|NCT00738660|microalbuminuria|microalbuminuria
641808|NCT00738660|nephropathy|nephropathy
641809|NCT00738660|albumin excretion rate|albumin excretion rate
641810|NCT00738660|dual blockade|dual blockade
641811|NCT00738660|ACEI|acei
641813|NCT00738673|Hormone refractory prostate cancer|hormone refractory prostate cancer
641814|NCT00738673|Agonist treatment failure|agonist treatment failure
641815|NCT00738686|coronary artery disease|coronary artery disease
641816|NCT00738686|drug-eluting stent|drug-eluting stent
641817|NCT00738686|percutaneous coronary intervention|percutaneous coronary intervention
641818|NCT00738686|major adverse cardiac event|major adverse cardiac event
641819|NCT00738686|in-stent restenosis|in-stent restenosis
641820|NCT00738686|stent thrombosis|stent thrombosis
641821|NCT00738699|ovarian cancer|ovarian cancer
641822|NCT00738699|relapsed ovarian cancer|relapsed ovarian cancer
641823|NCT00738699|refractory ovarian cancer|refractory ovarian cancer
641824|NCT00738712|Vascular MRI|vascular mri
641825|NCT00738712|Abdominal MRI|abdominal mri
641826|NCT00738712|Pelvic MRI|pelvic mri
641827|NCT00738712|Breast MRI|breast mri
641828|NCT00738712|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
641829|NCT00738725|High risk plaque|high risk plaque
641830|NCT00738725|High-risk plaque|high-risk plaque
641831|NCT00738725|Vulnerable plaque|vulnerable plaque
641832|NCT00738725|Atherosclerotic Disease|atherosclerotic disease
641833|NCT00738725|Heart Disease|heart disease
641834|NCT00738725|Stroke|stroke
641835|NCT00738738|Generalized Anxiety Disorder Elderly|generalized anxiety disorder elderly
641836|NCT00738751|NSCLC|nsclc
641837|NCT00738751|Metastatic|metastatic
641838|NCT00738751|erlotinib|erlotinib
641839|NCT00738751|aerodigestive tract cancers|aerodigestive tract cancers
641840|NCT00738751|non-small cell lung cancer|non-small cell lung cancer
641841|NCT00738751|H&N cancer|h&n cancer
641842|NCT00738764|cancer|cancer
641843|NCT00738764|antibody|antibody
641844|NCT00738764|Phase 1 Clinical Trial|phase 1 clinical trial
641845|NCT00738777|pre-operative|pre-operative
641846|NCT00738777|endocrine treatment|endocrine treatment
641847|NCT00738777|drug resistance|drug resistance
641848|NCT00738790|rectal cancer|rectal cancer
641938|NCT00739063|Tarceva|tarceva
641849|NCT00738790|preoperative radiotherapy and local excision|preoperative radiotherapy and local excision
641850|NCT00738803|leg length|leg length
641851|NCT00738803|hip arthroplasty|hip arthroplasty
641852|NCT00738803|offset|offset
641853|NCT00738816|Medication review|medication review
641854|NCT00738816|Patient|patient
641855|NCT00738816|Safety|safety
641856|NCT00738816|Drug|drug
641857|NCT00738816|Prescriptions|prescriptions
641858|NCT00738816|Drug-use|drug-use
641859|NCT00738829|CLL|cll
641860|NCT00738829|untreated|untreated
641861|NCT00738829|immune therapy|immune therapy
641862|NCT00738829|dose escalation|dose escalation
641863|NCT00738829|maximum tolerated dose|maximum tolerated dose
641864|NCT00738829|maintenance therapy|maintenance therapy
641865|NCT00738829|Lenalidomide|lenalidomide
641866|NCT00738829|Rituximab|rituximab
641867|NCT00738829|Fludarabine|fludarabine
641868|NCT00738842|Uric|uric
641869|NCT00738842|Acid|acid
641870|NCT00738842|Level|level
641871|NCT00738855|Adhesions|adhesions
641872|NCT00738855|Oral contrast|oral contrast
641873|NCT00738855|Exploration|exploration
641874|NCT00738868|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
641875|NCT00738868|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
641876|NCT00738868|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
641877|NCT00738868|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
641878|NCT00738868|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
641879|NCT00738868|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
641880|NCT00738868|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
641881|NCT00738868|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
641882|NCT00738868|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
641883|NCT00738868|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
641884|NCT00738868|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
641885|NCT00738868|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
641886|NCT00738868|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
641887|NCT00738868|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
641888|NCT00738868|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
641889|NCT00738868|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
641890|NCT00738868|recurrent salivary gland cancer|recurrent salivary gland cancer
641891|NCT00738868|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
641892|NCT00738868|stage III salivary gland cancer|stage iii salivary gland cancer
641893|NCT00738894|cryptogenic|cryptogenic
641894|NCT00738894|stroke|stroke
641895|NCT00738894|transient ischemic attack|transient ischemic attack
641896|NCT00738894|TIA|tia
641897|NCT00738894|PFO|pfo
641898|NCT00738894|Patent foramen ovale|patent foramen ovale
641899|NCT00738894|HELEX|helex
641900|NCT00738894|Septal Occluder|septal occluder
641901|NCT00738894|PFO Occluder|pfo occluder
641902|NCT00738907|Type 1 diabetes|type 1 diabetes
641903|NCT00738933|Atherosclerosis|atherosclerosis
641904|NCT00738933|Plant sterols|plant sterols
641905|NCT00738933|Plant stanols|plant stanols
641906|NCT00738933|Aortic valve|aortic valve
641907|NCT00738946|Intermittent Preventive treatment|intermittent preventive treatment
641908|NCT00738946|insecticide treated bednets|insecticide treated bednets
641909|NCT00738946|malaria|malaria
641910|NCT00738959|AZD0328|azd0328
641911|NCT00738959|Japanese|japanese
641912|NCT00738959|Caucasian|caucasian
641913|NCT00738959|pharmacokinetics|pharmacokinetics
641914|NCT00738959|safety|safety
641915|NCT00738959|tolerability|tolerability
641916|NCT00738998|Breast Cancer|breast cancer
641917|NCT00738998|Aromatase Inhibitors|aromatase inhibitors
642117|NCT00739596|amlodipine|amlodipine
641918|NCT00738998|Symptom Assessment|symptom assessment
641919|NCT00738998|Questionnaire|questionnaire
641920|NCT00738998|Survey|survey
641921|NCT00738998|Phone Call|phone call
641922|NCT00738998|Arimidex|arimidex
641923|NCT00738998|Anastrozole|anastrozole
641924|NCT00739024|Migraine|migraine
641925|NCT00739024|Headache|headache
641926|NCT00739063|Breast cancer|breast cancer
641927|NCT00739063|Carcinoma of the breast|carcinoma of the breast
641928|NCT00739063|Stage IV|stage iv
641929|NCT00739063|Triple receptor-negative|triple receptor-negative
641930|NCT00739063|Triple receptor-negative breast cancer|triple receptor-negative breast cancer
641931|NCT00739063|Metastatic triple receptor-negative breast cancer|metastatic triple receptor-negative breast cancer
641932|NCT00739063|Epidermal growth factor receptor|epidermal growth factor receptor
641933|NCT00739063|EGFR|egfr
641934|NCT00739063|EGFR-overexpressing|egfr-overexpressing
641935|NCT00739063|GFR inhibitor erlotinib|gfr inhibitor erlotinib
641936|NCT00739063|Erlotinib hydrochloride|erlotinib hydrochloride
641940|NCT00739089|hemodynamics|hemodynamics
641941|NCT00739089|oxygen|oxygen
641942|NCT00739089|renal dialysis|renal dialysis
641943|NCT00739089|shock|shock
641944|NCT00739089|sepsis|sepsis
641945|NCT00739089|hypotension|hypotension
641946|NCT00739089|lactic acidosis|lactic acidosis
641947|NCT00739102|Superficial Femoral Artery|superficial femoral artery
641948|NCT00739102|Nitinol Self-Expandable Stent System|nitinol self-expandable stent system
641949|NCT00739115|Respiratory|respiratory
641950|NCT00739115|Distress|distress
641951|NCT00739115|Prematurity|prematurity
641952|NCT00739115|Heliox|heliox
641953|NCT00739115|CPAP|cpap
641954|NCT00739128|celiac disease|celiac disease
641955|NCT00739128|hepatitis B vaccine|hepatitis b vaccine
641956|NCT00739141|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
641957|NCT00739141|CYCLOSPORINE A|cyclosporine a
641958|NCT00739141|FLUDARABINE|fludarabine
641959|NCT00739141|G-CSF|g-csf
641960|NCT00739141|MYCOPHENOLATE MOFETIL (MMF)|mycophenolate mofetil (mmf)
641961|NCT00739141|THI0TEPA|thi0tepa
641962|NCT00739141|UMBILICAL CORD BLOOD (UCB)|umbilical cord blood (ucb)
641963|NCT00739141|08-087|08-087
641964|NCT00739154|glaucoma|glaucoma
641965|NCT00739154|Phenytoin|phenytoin
641966|NCT00739154|retinal nerve fiber layer|retinal nerve fiber layer
641967|NCT00739154|corrected pattern standard deviation|corrected pattern standard deviation
641968|NCT00739154|visual acuity|visual acuity
641969|NCT00739154|optic disc cupping|optic disc cupping
641970|NCT00739167|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
641971|NCT00739167|advanced adult primary liver cancer|advanced adult primary liver cancer
641972|NCT00739167|liver metastases|liver metastases
641973|NCT00739167|recurrent adult primary liver cancer|recurrent adult primary liver cancer
641974|NCT00739180|Childhood obesity|childhood obesity
641975|NCT00739180|Abdominal obesity|abdominal obesity
641976|NCT00739180|Visceral fat|visceral fat
641977|NCT00739180|Insulin resistance|insulin resistance
641978|NCT00739180|Liver fat|liver fat
641979|NCT00739180|Skeletal muscle lipid|skeletal muscle lipid
641980|NCT00739180|Fitness|fitness
641981|NCT00739193|Blood Pressure|blood pressure
641982|NCT00739206|uncomplicated|uncomplicated
641983|NCT00739206|severe|severe
641984|NCT00739206|treatment|treatment
641985|NCT00739206|Plasmodium Falciparum|plasmodium falciparum
641986|NCT00739219|Asthma|asthma
641987|NCT00739219|inflammation|inflammation
641988|NCT00739219|nitric oxide|nitric oxide
641989|NCT00739219|eNO|eno
641990|NCT00739219|FENO|feno
641991|NCT00739232|Safety and tolerability of HSD-016|safety and tolerability of hsd-016
641992|NCT00739258|HIV-infected person|hiv-infected person
641993|NCT00739258|Entamoeba|entamoeba
641994|NCT00739258|Cryptosporidium|cryptosporidium
641995|NCT00739258|Giardia|giardia
641996|NCT00739258|ELISA|elisa
641997|NCT00739258|PCR|pcr
641998|NCT00739258|IDU|idu
641999|NCT00739258|Gonorrhea|gonorrhea
642000|NCT00739258|Chlamydial trachomatis|chlamydial trachomatis
642001|NCT00739258|Syphilis|syphilis
642002|NCT00739258|Genital warts|genital warts
642003|NCT00739258|Herpes simplex virus|herpes simplex virus
642004|NCT00739284|preferred|preferred
642005|NCT00739284|procedure|procedure
642006|NCT00739284|drainage|drainage
642007|NCT00739284|obstructed|obstructed
642008|NCT00739284|kidney|kidney
642009|NCT00739284|stone|stone
642010|NCT00739297|Chronic asthma|chronic asthma
642011|NCT00739310|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
642012|NCT00739310|Cerebral Palsy|cerebral palsy
642013|NCT00739310|Restrictive lung disease|restrictive lung disease
642014|NCT00739336|diabetes mellitus|diabetes mellitus
642015|NCT00739336|obesity|obesity
642016|NCT00739336|prevention|prevention
642017|NCT00739349|Dry Eye|dry eye
642018|NCT00739349|Cyclosporine|cyclosporine
642019|NCT00739362|Behavioral Weight Loss Treatment|behavioral weight loss treatment
642020|NCT00739362|Obesity|obesity
642021|NCT00739362|Appetite Control|appetite control
642022|NCT00739362|Weight Loss|weight loss
642118|NCT00739596|stage 2|stage 2
642023|NCT00739362|Transcranial Direct Current Stimulation (TDCS)|transcranial direct current stimulation (tdcs)
642024|NCT00739375|Influence|influence
642025|NCT00739375|of av access|of av access
642026|NCT00739375|flow|flow
642027|NCT00739375|development|development
642028|NCT00739388|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
642029|NCT00739388|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
642030|NCT00739388|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
642031|NCT00739388|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
642032|NCT00739388|secondary acute myeloid leukemia|secondary acute myeloid leukemia
642033|NCT00739388|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
642034|NCT00739388|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
642035|NCT00739388|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
642036|NCT00739388|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
642037|NCT00739388|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
642038|NCT00739388|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
642039|NCT00739388|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
642040|NCT00739388|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
642041|NCT00739388|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
642043|NCT00739401|Aneurysm|aneurysm
642044|NCT00739401|Suprarenal|suprarenal
642045|NCT00739401|Proximal|proximal
642046|NCT00739401|Cuff|cuff
642047|NCT00739401|Extension|extension
642048|NCT00739401|Endograft|endograft
642252|NCT00740220|hypoxemia|hypoxemia
642049|NCT00739401|Endovascular repair|endovascular repair
642050|NCT00739401|EVAR|evar
642051|NCT00739401|Endoleak|endoleak
642052|NCT00739401|Type I|type i
642053|NCT00739414|Histone Deacetylases|histone deacetylases
642054|NCT00739414|HDAC inhibitor|hdac inhibitor
642055|NCT00739414|LBH589|lbh589
642056|NCT00739414|Advanced solid tumor|advanced solid tumor
642057|NCT00739414|Adult|adult
642058|NCT00739453|Advanced cancer|advanced cancer
642059|NCT00739453|Non-small cell lung cancer|non-small cell lung cancer
642061|NCT00739453|Colorectal cancer|colorectal cancer
642062|NCT00739453|Prostate cancer|prostate cancer
642063|NCT00739466|Liposomal Alendronate|liposomal alendronate
642064|NCT00739466|Percutaneous coronary intervention|percutaneous coronary intervention
642065|NCT00739466|Coronary stenting|coronary stenting
642066|NCT00739466|de novo stenotic lesions|de novo stenotic lesions
642067|NCT00739466|Native coronary arteries|native coronary arteries
642068|NCT00739466|Restenosis|restenosis
642069|NCT00739466|Bare metal stent|bare metal stent
642070|NCT00739466|Presillion CoCr coronary stent|presillion cocr coronary stent
642071|NCT00739479|Metabolic Syndrome|metabolic syndrome
642072|NCT00739479|METS|mets
642073|NCT00739479|Obesity|obesity
642074|NCT00739479|Partially Hydrolyzed Whey Protein|partially hydrolyzed whey protein
642075|NCT00739479|Partially Hydrolyzed Gelatin|partially hydrolyzed gelatin
642076|NCT00739479|PHWP|phwp
642077|NCT00739479|PHG|phg
642078|NCT00739479|Weight Loss|weight loss
642079|NCT00739492|weight loss, obesity, financial incentives|weight loss, obesity, financial incentives
642080|NCT00739505|Hypophosphatasia|hypophosphatasia
642081|NCT00739505|Bone Disease|bone disease
642082|NCT00739505|Soft Bones|soft bones
642083|NCT00739505|Low Alkaline Phosphatase|low alkaline phosphatase
642084|NCT00739505|genetic metabolic disorder|genetic metabolic disorder
642085|NCT00739505|alkaline phosphatase|alkaline phosphatase
642086|NCT00739505|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
642087|NCT00739505|rickets|rickets
642088|NCT00739505|osteomalacia|osteomalacia
642089|NCT00739518|Neurological|neurological
642090|NCT00739518|MRI|mri
642091|NCT00739531|Asthma|asthma
642092|NCT00739531|nitric oxide|nitric oxide
642093|NCT00739531|eNO|eno
642094|NCT00739531|FENO|feno
642095|NCT00739531|Apieron INSIGHT|apieron insight
642096|NCT00739531|Aerocrine NIOX|aerocrine niox
642097|NCT00739544|Reference Values|reference values
642098|NCT00739544|Sensory Thresholds|sensory thresholds
642099|NCT00739544|Pain Threshold|pain threshold
642100|NCT00739544|Breast Neoplasms|breast neoplasms
642101|NCT00739557|elective TAAA repair|elective taaa repair
642102|NCT00739570|Activator|activator
642103|NCT00739570|EMG|emg
642104|NCT00739570|Thermography|thermography
642105|NCT00739570|Diagnostic|diagnostic
642106|NCT00739570|X-Rays|x-rays
642107|NCT00739583|Skin preparation|skin preparation
642108|NCT00739583|Skin marking|skin marking
642109|NCT00739583|site marking|site marking
642110|NCT00739583|Site identification|site identification
642111|NCT00739596|Hypertension|hypertension
642112|NCT00739596|African American|african american
642113|NCT00739596|aliskiren|aliskiren
642114|NCT00739596|hydrochlorothiazide|hydrochlorothiazide
642115|NCT00739596|systolic blood pressure|systolic blood pressure
642116|NCT00739596|diastolic blood pressure|diastolic blood pressure
642119|NCT00739622|TMC278-TiDP6-C136|tmc278-tidp6-c136
642120|NCT00739622|TMC278-C136|tmc278-c136
642121|NCT00739622|Healthy Volunteer|healthy volunteer
642122|NCT00739648|COPD|copd
642123|NCT00739648|Patients|patients
642124|NCT00739661|Systemic Hedgehog|systemic hedgehog
642125|NCT00739661|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
642126|NCT00739687|Chronic Heart Failure|chronic heart failure
642127|NCT00739700|hemodynamics|hemodynamics
642128|NCT00739700|blood pressure|blood pressure
642129|NCT00739700|blood pressure monitors|blood pressure monitors
642130|NCT00739713|dry eye|dry eye
642131|NCT00739713|sea buckthorn|sea buckthorn
642132|NCT00739713|Hippophaë|hippophaë
642133|NCT00739752|Attitude to Health|attitude to health
642134|NCT00739752|Communication|communication
642135|NCT00739752|Intervention Studies|intervention studies
642136|NCT00739752|Health Promotion|health promotion
642137|NCT00739752|Psychology, Medical|psychology, medical
642138|NCT00739752|Sexual Behavior|sexual behavior
642139|NCT00739752|Behavioral Research|behavioral research
642140|NCT00739752|Vaccination|vaccination
642141|NCT00739765|Trauma|trauma
642142|NCT00739765|Psychotherapy|psychotherapy
642143|NCT00739765|Anxiety|anxiety
642144|NCT00739791|adenocarcinoma of the prostate|adenocarcinoma of the prostate
642145|NCT00739791|stage I prostate cancer|stage i prostate cancer
642146|NCT00739791|stage IIB prostate cancer|stage iib prostate cancer
642147|NCT00739791|stage IIA prostate cancer|stage iia prostate cancer
642148|NCT00739843|Dementia,|dementia,
642149|NCT00739843|Cognitive Disorders,|cognitive disorders,
642150|NCT00739843|Hemodialysis|hemodialysis
642151|NCT00739856|posttraumatic stress disorder|posttraumatic stress disorder
642152|NCT00739856|electroconvulsive therapy|electroconvulsive therapy
642153|NCT00739856|medication refractoriness|medication refractoriness
642154|NCT00739869|Silent Infarcts|silent infarcts
642155|NCT00739869|Magnetic Resonance Imaging|magnetic resonance imaging
642156|NCT00739869|MRI|mri
642157|NCT00739869|Subclinical Cerebrovascular Disease|subclinical cerebrovascular disease
642158|NCT00739869|White Matter Grade Abnormalities|white matter grade abnormalities
642159|NCT00739869|Total Brain Volume|total brain volume
642160|NCT00739869|Ventricular and Hippocampal Volume|ventricular and hippocampal volume
642161|NCT00739869|Subclinical Vascular Abnormalities|subclinical vascular abnormalities
642162|NCT00739869|Cerebrovascular Disease|cerebrovascular disease
642163|NCT00739869|CVD|cvd
642164|NCT00739869|Subclinical CVD|subclinical cvd
642165|NCT00739882|Efalizumab,|efalizumab,
642166|NCT00739882|Chronic plaque psoriasis|chronic plaque psoriasis
642167|NCT00739882|moderate to severe|moderate to severe
642168|NCT00739882|involving|involving
642169|NCT00739882|hands|hands
642170|NCT00739882|feet|feet
642171|NCT00739895|athletes|athletes
642172|NCT00739908|MDD|mdd
642173|NCT00739921|PCR Analysis|pcr analysis
642174|NCT00739921|Allergic fungal sinusitis|allergic fungal sinusitis
642175|NCT00739921|Chronic rhinosinusitis|chronic rhinosinusitis
642176|NCT00739921|Nasal Polyps|nasal polyps
642177|NCT00739934|Open-Label|open-label
642178|NCT00739934|Pharmacokinetics|pharmacokinetics
642179|NCT00739934|Intravenous to oral switch|intravenous to oral switch
642180|NCT00739934|Safety|safety
642181|NCT00739934|Voriconazole|voriconazole
642182|NCT00739934|Immunocompromise|immunocompromise
642183|NCT00739934|Children|children
642184|NCT00739934|High Risk For Systemic Fungal Infection.|high risk for systemic fungal infection.
642185|NCT00739947|Observational|observational
642186|NCT00739947|rotator cuff tear|rotator cuff tear
642187|NCT00739947|arthroscopic|arthroscopic
642188|NCT00739947|surgical|surgical
642189|NCT00739947|outcome study|outcome study
642190|NCT00739973|Hypertension, Aliskiren, Amlodipine|hypertension, aliskiren, amlodipine
642191|NCT00739986|Crohn's Disease|crohn's disease
642192|NCT00739986|TNF-alpha|tnf-alpha
642193|NCT00739986|IL-6|il-6
642194|NCT00739986|MAP Kinase|map kinase
642195|NCT00739986|CNI-1493|cni-1493
642196|NCT00739999|heterozygous familial hypercholesterolemia (HeFH); atorvastatin; pediatric|heterozygous familial hypercholesterolemia (hefh); atorvastatin; pediatric
642197|NCT00740012|Nocturnal glucose profiles|nocturnal glucose profiles
642198|NCT00740012|continuous glucose profiles|continuous glucose profiles
642199|NCT00740025|QD dose|qd dose
642200|NCT00740025|BID dosing|bid dosing
642201|NCT00740025|peak estradiol|peak estradiol
642202|NCT00740025|oocytes|oocytes
642203|NCT00740025|implantation rate|implantation rate
642204|NCT00740025|pregnancy rate|pregnancy rate
642205|NCT00740038|Stress Management|stress management
642206|NCT00740038|Quality of Life|quality of life
642207|NCT00740038|Exercise|exercise
642208|NCT00740038|Cancer|cancer
642209|NCT00740038|Chemotherapy|chemotherapy
642210|NCT00740064|HIV infections|hiv infections
642211|NCT00740077|cranberry|cranberry
642212|NCT00740077|flavonoid|flavonoid
642213|NCT00740077|phenolic acid|phenolic acid
642214|NCT00740077|phytochemical|phytochemical
642215|NCT00740077|bioavailability|bioavailability
642216|NCT00740090|Malaria|malaria
642217|NCT00740090|Reactogenicity, Safety, Immunogenicity|reactogenicity, safety, immunogenicity
642218|NCT00740090|Maleria Endemic|maleria endemic
642219|NCT00740090|Plasmodium Falciparum|plasmodium falciparum
642220|NCT00740090|Dose Escalating|dose escalating
642221|NCT00740103|Semapimod|semapimod
642222|NCT00740103|Crohn's Disease|crohn's disease
642223|NCT00740103|TNF-alpha inhibitor|tnf-alpha inhibitor
642224|NCT00740103|MAP Kinase inhibitor|map kinase inhibitor
642225|NCT00740103|CNI-1493|cni-1493
642226|NCT00740116|Tumor of ovary|tumor of ovary
642227|NCT00740116|Surgical blood loss|surgical blood loss
642228|NCT00740116|Postoperative blood loss|postoperative blood loss
642229|NCT00740116|Preventive therapy|preventive therapy
642230|NCT00740116|Thromboembolism|thromboembolism
642231|NCT00740129|Paget's Disease|paget's disease
642232|NCT00740129|Zoledronic acid|zoledronic acid
642233|NCT00740129|Reclast®/Aclasta®|reclast®/aclasta®
642234|NCT00740129|infusion|infusion
642235|NCT00740129|re-treatment|re-treatment
642236|NCT00740129|re-lapse|re-lapse
642237|NCT00740142|L ornithine L aspartate|l ornithine l aspartate
642238|NCT00740142|Lactulose|lactulose
642239|NCT00740142|Hepatic encephalopathy|hepatic encephalopathy
642240|NCT00740142|LOLA|lola
642241|NCT00740155|Dengue virus|dengue virus
642242|NCT00740155|Dengue fever|dengue fever
642243|NCT00740155|Dengue hemorrhagic fever|dengue hemorrhagic fever
642244|NCT00740155|Dengue diseases|dengue diseases
642245|NCT00740168|bevacizumab|bevacizumab
642246|NCT00740168|cancer|cancer
642247|NCT00740181|myelodysplasia|myelodysplasia
642248|NCT00740181|refractory leukemia|refractory leukemia
642249|NCT00740181|acute leukemia|acute leukemia
642250|NCT00740194|Physiology|physiology
642251|NCT00740194|males|males
642253|NCT00740220|anoxia|anoxia
642254|NCT00740220|oxygen|oxygen
642255|NCT00740220|dyspnea|dyspnea
642256|NCT00740220|pulmonary disease|pulmonary disease
642257|NCT00740220|chronic obstructive|chronic obstructive
642258|NCT00740233|fibromyalgia|fibromyalgia
642259|NCT00740233|irritable bowel syndrome|irritable bowel syndrome
642260|NCT00740233|interstitial cystitis|interstitial cystitis
642261|NCT00740233|chronic fatigue syndrome|chronic fatigue syndrome
642262|NCT00740233|vulvodynia|vulvodynia
642263|NCT00740233|chronic stress|chronic stress
642264|NCT00740233|chronic pain|chronic pain
642265|NCT00740233|stress-related conditions|stress-related conditions
642266|NCT00740233|functional GI disorders|functional gi disorders
642267|NCT00740259|flunarizine|flunarizine
642268|NCT00740259|schizophrenia|schizophrenia
642269|NCT00740259|antipsychotic|antipsychotic
642270|NCT00740272|brady-tachy syndrome|brady-tachy syndrome
642271|NCT00740272|AF ablation|af ablation
642272|NCT00740285|scleroderma|scleroderma
642273|NCT00740285|scleroderma - limited or diffuse types|scleroderma - limited or diffuse types
642274|NCT00740285|lidocaine|lidocaine
642275|NCT00740285|effectiveness|effectiveness
642276|NCT00740298|infants|infants
642277|NCT00740298|undergoing|undergoing
642278|NCT00740298|vaccinations|vaccinations
642279|NCT00740311|Prevention of the reduction of the alveolar crest|prevention of the reduction of the alveolar crest
642280|NCT00740324|During|during
642281|NCT00740324|Endoscopy|endoscopy
642282|NCT00740324|Gastric|gastric
642283|NCT00740324|Peristalsis|peristalsis
642284|NCT00740337|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
642285|NCT00740337|COPD|copd
642286|NCT00740337|Emphysema|emphysema
642287|NCT00740337|Natural Killer T-cell|natural killer t-cell
642288|NCT00740337|Interleukin-13|interleukin-13
642289|NCT00740337|Innate Immune Signaling|innate immune signaling
642290|NCT00740363|renal transplantation|renal transplantation
642291|NCT00740363|diabetes|diabetes
642292|NCT00740363|glucose intolerance|glucose intolerance
642293|NCT00740363|impaired glucose tolerance|impaired glucose tolerance
642294|NCT00740376|osteoarthritis|osteoarthritis
642295|NCT00740389|TMC125-C187|tmc125-c187
642296|NCT00740389|TMC125-TiDP2-C187|tmc125-tidp2-c187
642297|NCT00740389|HIV|hiv
642298|NCT00740389|AIDS|aids
642299|NCT00740389|Fungal Infection|fungal infection
642300|NCT00740389|Pharmacokinetics|pharmacokinetics
642301|NCT00740415|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
642302|NCT00740415|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
642303|NCT00740415|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
642304|NCT00740415|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
642305|NCT00740428|Pelvic floor,|pelvic floor,
642306|NCT00740428|muscular dysfunction,|muscular dysfunction,
642307|NCT00740428|urinary incontinence|urinary incontinence
642308|NCT00740441|renal cell carcinoma|renal cell carcinoma
642309|NCT00740441|rcc|rcc
642310|NCT00740441|kidney cancer|kidney cancer
642311|NCT00740454|pregnancy|pregnancy
642312|NCT00740454|postpartum|postpartum
642313|NCT00740454|deep vein thrombosis|deep vein thrombosis
642314|NCT00740454|venous thromboembolism|venous thromboembolism
642315|NCT00740454|diagnosis|diagnosis
642316|NCT00740454|compression ultrasonography|compression ultrasonography
642317|NCT00740467|graft versus host disease|graft versus host disease
642318|NCT00740467|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
642498|NCT00748839|venous thrombosis|venous thrombosis
642319|NCT00740467|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
642320|NCT00740467|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
642321|NCT00740467|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
642322|NCT00740467|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
642323|NCT00740467|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
642324|NCT00740467|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
642325|NCT00740467|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
642326|NCT00740467|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
642327|NCT00740467|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
642328|NCT00740467|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
642329|NCT00740467|refractory multiple myeloma|refractory multiple myeloma
642330|NCT00740467|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
642331|NCT00740467|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
642332|NCT00740467|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
642333|NCT00740467|anaplastic large cell lymphoma|anaplastic large cell lymphoma
642334|NCT00740467|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
642335|NCT00740467|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
642336|NCT00740467|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
642337|NCT00740467|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
642428|NCT00747877|stage II multiple myeloma|stage ii multiple myeloma
642338|NCT00740467|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
642339|NCT00740467|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
642340|NCT00740467|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
751834|NCT01170663|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
642341|NCT00740467|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
642342|NCT00740467|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
642343|NCT00740467|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
642344|NCT00740467|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
642345|NCT00740467|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
642346|NCT00740467|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
642347|NCT00740467|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
642348|NCT00740467|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
642349|NCT00740467|recurrent grade I lymphomatoid granulomatosis|recurrent grade i lymphomatoid granulomatosis
642350|NCT00740467|recurrent grade II lymphomatoid granulomatosis|recurrent grade ii lymphomatoid granulomatosis
642351|NCT00740467|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
642352|NCT00740467|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
642353|NCT00740467|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
642354|NCT00740467|splenic marginal zone lymphoma|splenic marginal zone lymphoma
642355|NCT00740467|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
642357|NCT00740480|ENTact™|entact™
642358|NCT00740480|Septal|septal
642359|NCT00740480|Staple|staple
642360|NCT00740480|System|system
642361|NCT00740480|tissue|tissue
642362|NCT00740480|approximation|approximation
642363|NCT00740480|during|during
642364|NCT00740480|septoplasties|septoplasties
642365|NCT00740493|recurrent venous thromboembolism|recurrent venous thromboembolism
642366|NCT00740493|idiopathic deep vein thrombosis|idiopathic deep vein thrombosis
642367|NCT00740493|optimal duration of anticoagulation|optimal duration of anticoagulation
642368|NCT00740506|Behavioral|behavioral
642369|NCT00740506|Environmental|environmental
642370|NCT00740506|Delivery|delivery
642371|NCT00740506|Pregnancy|pregnancy
642372|NCT00740532|EGFR, HER-2, HER-3, MET, KRAS|egfr, her-2, her-3, met, kras
642373|NCT00740558|HRV|hrv
642374|NCT00740558|Activator|activator
642375|NCT00740558|Chiropractic|chiropractic
642376|NCT00740558|VLF|vlf
642377|NCT00740558|HF|hf
642378|NCT00740558|LF|lf
642379|NCT00740558|LF/HF|lf/hf
642380|NCT00740571|neuralgia|neuralgia
642381|NCT00740571|off-label|off-label
642382|NCT00740571|cancer|cancer
642383|NCT00740584|Prevention|prevention
642384|NCT00740597|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
642385|NCT00740597|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
642386|NCT00740597|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
642387|NCT00740597|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
642388|NCT00740597|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
642389|NCT00740597|adult epithelioid sarcoma|adult epithelioid sarcoma
642390|NCT00740597|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
642391|NCT00740597|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
642392|NCT00740597|adult fibrosarcoma|adult fibrosarcoma
642499|NCT00748839|arterial thrombosis|arterial thrombosis
642393|NCT00740597|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
642394|NCT00740597|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
642395|NCT00740597|adult malignant mesenchymoma|adult malignant mesenchymoma
642396|NCT00740597|adult neurofibrosarcoma|adult neurofibrosarcoma
642397|NCT00740597|adult rhabdomyosarcoma|adult rhabdomyosarcoma
642398|NCT00740597|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
642399|NCT00740623|Partial Onset Seizures|partial onset seizures
642400|NCT00740623|Simple Partial Seizures|simple partial seizures
642401|NCT00740623|Complex Partial Seizures|complex partial seizures
642402|NCT00740636|TEMOZOLOMIDE|temozolomide
642403|NCT00740636|Lung|lung
642404|NCT00747799|recurrent or metastatic Nasopharyngeal Neoplasms|recurrent or metastatic nasopharyngeal neoplasms
642405|NCT00747812|Headache|headache
642406|NCT00747812|Migraine|migraine
642407|NCT00747812|Refractory|refractory
642408|NCT00747812|Chronic|chronic
642409|NCT00747812|Pain|pain
642410|NCT00747825|cancer|cancer
642411|NCT00747825|oncology|oncology
642415|NCT00747838|Atrial Fibrillation|atrial fibrillation
642416|NCT00747838|Maze|maze
642417|NCT00747838|Mini-Maze|mini-maze
642418|NCT00747851|protein|protein
642419|NCT00747851|synthesis|synthesis
642420|NCT00747851|response|response
642421|NCT00747851|PAF-stimulated|paf-stimulated
642422|NCT00747851|PMNs|pmns
642423|NCT00747851|collected|collected
642424|NCT00747864|Gestational Age|gestational age
642425|NCT00747864|Urine|urine
642426|NCT00747864|Concentration|concentration
642427|NCT00747864|of S100B|of s100b
643307|NCT00737685|Pediatric|pediatric
642429|NCT00747877|stage III multiple myeloma|stage iii multiple myeloma
642430|NCT00747877|refractory multiple myeloma|refractory multiple myeloma
642431|NCT00747877|stage I multiple myeloma|stage i multiple myeloma
642432|NCT00747903|basal cell carcinoma of the skin|basal cell carcinoma of the skin
642433|NCT00747903|recurrent skin cancer|recurrent skin cancer
642434|NCT00747916|Parietal pleura|parietal pleura
642436|NCT00747916|Pleural Surface|pleural surface
642437|NCT00747916|Pleural Neoplasms|pleural neoplasms
642438|NCT00747916|Lung Cancer|lung cancer
642439|NCT00747929|Obesity|obesity
642440|NCT00747942|overweight|overweight
642441|NCT00747942|physical inactivity|physical inactivity
642442|NCT00747942|physical fitness|physical fitness
642443|NCT00747942|lifestyle change|lifestyle change
642444|NCT00747955|Human Performance|human performance
642445|NCT00747955|Physical Disability|physical disability
642446|NCT00747955|Functional Outcome Measures|functional outcome measures
642447|NCT00747955|Health Volunteer|health volunteer
642449|NCT00747981|CT Scan|ct scan
642450|NCT00747981|Endoscopy|endoscopy
642451|NCT00747981|Aspiration|aspiration
642452|NCT00747981|Foreign Bodies|foreign bodies
642453|NCT00747994|Paget's disease of bone|paget's disease of bone
642454|NCT00747994|Relatives|relatives
642455|NCT00747994|Mutations screening|mutations screening
642456|NCT00747994|Haplotypes analysis|haplotypes analysis
642457|NCT00747994|Linkage analysis|linkage analysis
642458|NCT00747994|< 55 years|< 55 years
642459|NCT00747994|4 > or = WAFFECTED Bones|4 > or = waffected bones
642460|NCT00747994|bone deformity|bone deformity
642461|NCT00748007|Down syndrome, cholinesterase inhibitor, Rivastigmine|down syndrome, cholinesterase inhibitor, rivastigmine
642462|NCT00748046|Biodistribution|biodistribution
642463|NCT00748046|Radiation dosimetry|radiation dosimetry
642464|NCT00748046|Pharmacokinetics|pharmacokinetics
642465|NCT00748046|Safety|safety
642466|NCT00748059|autonomic nervous system diseases|autonomic nervous system diseases
642467|NCT00748059|blood pressure|blood pressure
642468|NCT00748059|congenital|congenital
642469|NCT00748059|orthostasis|orthostasis
642470|NCT00748059|catecholamines|catecholamines
642471|NCT00748072|Vasopressin|vasopressin
642472|NCT00748072|bleeding|bleeding
642473|NCT00748072|biopsy|biopsy
642474|NCT00748072|ultrasonography|ultrasonography
642475|NCT00748085|Malignant Airway Disease|malignant airway disease
642476|NCT00748085|Lung Cancer|lung cancer
642477|NCT00748085|Inoperable Lung Cancer|inoperable lung cancer
642478|NCT00748085|Mesothelioma|mesothelioma
642479|NCT00748085|Endoluminal Tumor|endoluminal tumor
642480|NCT00748098|PSG|psg
642481|NCT00748098|Restless Legs Syndrome|restless legs syndrome
642482|NCT00748098|gabapentin enacarbil|gabapentin enacarbil
642483|NCT00748098|XP13512|xp13512
642484|NCT00748098|GSK1838262|gsk1838262
642485|NCT00748098|sleep disturbance|sleep disturbance
642486|NCT00748098|RLS|rls
642487|NCT00748098|polysomnography|polysomnography
642488|NCT00748111|Sudden death|sudden death
642489|NCT00748111|Out of hospital cardiac arrest|out of hospital cardiac arrest
642490|NCT00748111|Acute myocardial infarction|acute myocardial infarction
642491|NCT00748111|Acute coronary syndrome|acute coronary syndrome
642492|NCT00748800|HIV prevention|hiv prevention
642493|NCT00748800|HIV seronegativity|hiv seronegativity
642494|NCT00748813|Influenza vaccine|influenza vaccine
642495|NCT00748839|HIT|hit
642496|NCT00748839|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
642497|NCT00748839|heparin treatment|heparin treatment
643593|NCT00744042|Soft Bones|soft bones
642500|NCT00748839|predictive clinical score|predictive clinical score
642501|NCT00748839|biological test|biological test
642502|NCT00748839|anti-H-PF4 antibodies|anti-h-pf4 antibodies
642503|NCT00748865|Dry Eye|dry eye
642504|NCT00748865|Artificial Tears|artificial tears
642505|NCT00748878|To better understand platelet function during ECMO|to better understand platelet function during ecmo
642506|NCT00748891|Cancer|cancer
642507|NCT00748891|tumour|tumour
642508|NCT00748891|advanced sold tumour|advanced sold tumour
642509|NCT00748891|imaging|imaging
642510|NCT00748891|DCE-CT Scan|dce-ct scan
642511|NCT00748891|DCE-MRI scan|dce-mri scan
642512|NCT00748891|Cediranib|cediranib
642513|NCT00748891|Recentin|recentin
642514|NCT00748904|cirrhosis of liver and progressive renal failure|cirrhosis of liver and progressive renal failure
642515|NCT00748943|chlorine|chlorine
642516|NCT00748943|dioxide|dioxide
642517|NCT00748943|mouthwash|mouthwash
642521|NCT00748956|Mood Disorder|mood disorder
642522|NCT00748956|Anxiety Disorders|anxiety disorders
642523|NCT00748969|MPS I|mps i
642524|NCT00748969|MPS II|mps ii
642525|NCT00748969|MPS VI|mps vi
642526|NCT00748969|growth hormone|growth hormone
642527|NCT00748969|short stature|short stature
642528|NCT00748982|AZD1305|azd1305
642529|NCT00748982|anti-arrhythmics|anti-arrhythmics
642530|NCT00748982|safety|safety
642531|NCT00749008|Cerebral palsy|cerebral palsy
642532|NCT00749008|Generalized movements|generalized movements
642533|NCT00749008|Fidgety movements|fidgety movements
642534|NCT00749008|Prechtl|prechtl
642535|NCT00749021|choroidal neovascularization|choroidal neovascularization
642536|NCT00749021|vascularized|vascularized
642537|NCT00749034|Safety|safety
642538|NCT00749034|Immunogenicity|immunogenicity
642539|NCT00749034|Tuberculosis|tuberculosis
642540|NCT00749034|Vaccination|vaccination
642541|NCT00749034|Vaccination against tuberculosis|vaccination against tuberculosis
642542|NCT00749034|Safety and immunogenicity of VPM1002 in comparison with BCG|safety and immunogenicity of vpm1002 in comparison with bcg
642543|NCT00749047|Pioglitazone|pioglitazone
642544|NCT00749047|Open study|open study
642545|NCT00749047|Proteinuria|proteinuria
642546|NCT00749047|Glomerular selectivity indices|glomerular selectivity indices
642547|NCT00749060|osteoporosis|osteoporosis
642548|NCT00749060|non-traumatic vertebral fracture|non-traumatic vertebral fracture
642549|NCT00749060|vertebral compression|vertebral compression
642550|NCT00749060|Balloon kyphoplasty|balloon kyphoplasty
642551|NCT00749060|vertebroplasty|vertebroplasty
642552|NCT00749073|Spinal Stenosis|spinal stenosis
642553|NCT00749073|Lumbar Spinal Stenosis|lumbar spinal stenosis
642554|NCT00749073|Laminotomy|laminotomy
642555|NCT00749073|Laminectomy|laminectomy
642556|NCT00749073|Spine Surgery|spine surgery
642557|NCT00749086|Osteoporosis|osteoporosis
642558|NCT00749086|Non-traumatic vertebral fracture|non-traumatic vertebral fracture
642559|NCT00749086|Vertebral compression|vertebral compression
642560|NCT00749086|Balloon kyphoplasty|balloon kyphoplasty
642561|NCT00749086|Vertebroplasty|vertebroplasty
642562|NCT00749112|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
642563|NCT00749112|Anemia|anemia
642564|NCT00749112|Hemolytic|hemolytic
642565|NCT00749112|Autoimmune|autoimmune
642566|NCT00749112|Alemtuzumab|alemtuzumab
642567|NCT00749112|Rituximab|rituximab
642568|NCT00749125|Emotional Circuitry|emotional circuitry
642569|NCT00749125|fMRI|fmri
642570|NCT00749138|hepatitis C, tamoxifen|hepatitis c, tamoxifen
642571|NCT00749151|smoking cessation|smoking cessation
642572|NCT00749151|telephone help line|telephone help line
642573|NCT00749164|Mesenchymal stem cells|mesenchymal stem cells
642574|NCT00749164|Umbilical cord|umbilical cord
642575|NCT00749164|graft-vs-host disease|graft-vs-host disease
642576|NCT00749164|Steroid resistant|steroid resistant
642577|NCT00749177|traditional healing|traditional healing
642578|NCT00749177|anxiety|anxiety
642579|NCT00749177|depression|depression
642580|NCT00749177|aboriginal|aboriginal
642581|NCT00749177|children|children
642582|NCT00749177|youth|youth
642583|NCT00749203|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
642584|NCT00749203|PTSD|ptsd
642585|NCT00749203|anxiety disorder|anxiety disorder
642586|NCT00749203|ketamine|ketamine
642587|NCT00749203|depression|depression
642588|NCT00749203|depressed mood|depressed mood
642589|NCT00749229|Traumatic vertebral fracture|traumatic vertebral fracture
642590|NCT00749229|Balloon Kyphoplasty|balloon kyphoplasty
642591|NCT00749229|type A3.2, or A3.3 or B1 or C1 in the MAGERL CLASSIFICATION|type a3.2, or a3.3 or b1 or c1 in the magerl classification
642592|NCT00749242|Traumatic vertebral fracture|traumatic vertebral fracture
642593|NCT00749242|Vertebroplasty|vertebroplasty
642594|NCT00749242|Balloon kyphoplasty|balloon kyphoplasty
642595|NCT00749242|Bohler bracing|bohler bracing
642596|NCT00749255|Breast Cancer|breast cancer
642597|NCT00749255|Digital archiver software|digital archiver software
642598|NCT00749268|hernia|hernia
642599|NCT00749281|atherosclerosis|atherosclerosis
642600|NCT00749281|ngal|ngal
642601|NCT00749281|coronary artery disease|coronary artery disease
642602|NCT00749307|Heart rate variability|heart rate variability
642603|NCT00749307|Docosahexaenoic acid|docosahexaenoic acid
642604|NCT00749307|DHA|dha
642605|NCT00749307|Long chain fatty acids|long chain fatty acids
642606|NCT00749307|Long chain polyunsaturated fatty acids|long chain polyunsaturated fatty acids
642607|NCT00749307|Algal fatty acids|algal fatty acids
642608|NCT00749307|Schizochytrium|schizochytrium
642609|NCT00749307|Omega 3|omega 3
642610|NCT00749307|Death, Sudden, Cardiac|death, sudden, cardiac
642611|NCT00749307|Arrhythmias, Cardiac|arrhythmias, cardiac
642612|NCT00749320|MRI|mri
642613|NCT00749320|Sunitinib|sunitinib
642614|NCT00749320|Pazopanib|pazopanib
642615|NCT00749333|Healthy Volunteer|healthy volunteer
642616|NCT00749333|Safety|safety
642617|NCT00749333|Tolerability|tolerability
642618|NCT00749333|AZD8566|azd8566
642619|NCT00749333|study|study
642620|NCT00749346|TTFields|ttfields
642621|NCT00749346|NSCLC|nsclc
642622|NCT00749346|Alimta|alimta
642624|NCT00749359|healthy volunteers|healthy volunteers
642625|NCT00749359|paroxetine|paroxetine
642626|NCT00749411|COPD|copd
642627|NCT00749411|long-acting beta agonist|long-acting beta agonist
642628|NCT00749411|Emphysema|emphysema
642629|NCT00749411|Chronic Bronchitis|chronic bronchitis
642630|NCT00749411|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
642631|NCT00749411|bronchodilator|bronchodilator
642632|NCT00749411|long acting muscarinic antagonist|long acting muscarinic antagonist
642633|NCT00749437|stage I breast cancer|stage i breast cancer
642634|NCT00749437|stage II breast cancer|stage ii breast cancer
642635|NCT00749437|ductal breast carcinoma in situ|ductal breast carcinoma in situ
642636|NCT00749437|invasive ductal breast carcinoma|invasive ductal breast carcinoma
642637|NCT00749437|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
642638|NCT00749437|papillary ductal breast carcinoma|papillary ductal breast carcinoma
642639|NCT00749437|tubular ductal breast carcinoma|tubular ductal breast carcinoma
642640|NCT00749437|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
642641|NCT00749437|breast cancer in situ|breast cancer in situ
642642|NCT00749450|stage II colon cancer|stage ii colon cancer
642643|NCT00749450|stage III colon cancer|stage iii colon cancer
642644|NCT00749450|stage II rectal cancer|stage ii rectal cancer
642645|NCT00749450|stage III rectal cancer|stage iii rectal cancer
642646|NCT00749463|nicotine dependence, smoking cessation, NRT|nicotine dependence, smoking cessation, nrt
642647|NCT00749489|Pain|pain
642648|NCT00749489|Hip Fractures|hip fractures
642649|NCT00749489|Femoral Fractures|femoral fractures
642650|NCT00749489|Analgesics|analgesics
642651|NCT00749489|Opioid|opioid
642652|NCT00749489|Nerve Block|nerve block
642653|NCT00749489|Geriatric|geriatric
642654|NCT00749489|Nerve Stimulation|nerve stimulation
642655|NCT00749502|Neoplasms|neoplasms
642656|NCT00749502|Ovarian neoplasms|ovarian neoplasms
642657|NCT00749502|Prostatic neoplasms|prostatic neoplasms
642658|NCT00749502|Endocrine gland neoplasms|endocrine gland neoplasms
642659|NCT00749502|Ovarian diseases|ovarian diseases
642660|NCT00749502|Adnexal diseases|adnexal diseases
642661|NCT00749502|Genital diseases, female|genital diseases, female
642662|NCT00749502|Genital diseases, male|genital diseases, male
642663|NCT00749502|Genital neoplasms, female|genital neoplasms, female
642664|NCT00749502|Urogenital neoplasms|urogenital neoplasms
642665|NCT00749502|Endocrine system diseases|endocrine system diseases
642666|NCT00749502|Gonadal disorders|gonadal disorders
642667|NCT00749502|Genital neoplasms, male|genital neoplasms, male
642668|NCT00749502|Prostatic diseases|prostatic diseases
642669|NCT00749515|Thalassemia|thalassemia
642670|NCT00749515|Iron|iron
642671|NCT00749515|Chelation|chelation
642672|NCT00749528|Wheezing|wheezing
642673|NCT00749528|Hair trace elements|hair trace elements
642674|NCT00749528|Hair toxic metals|hair toxic metals
642675|NCT00749528|Oxidative stress|oxidative stress
642676|NCT00749541|vitamin d coronary catheterization|vitamin d coronary catheterization
642677|NCT00749554|Cooled Radiofrequency|cooled radiofrequency
642678|NCT00749554|Disc biacuplasty|disc biacuplasty
642679|NCT00749554|TransDiscal system|transdiscal system
642680|NCT00749554|Discogenic pain|discogenic pain
642681|NCT00749567|NSCLC|nsclc
642682|NCT00749567|TKI's|tki's
642683|NCT00749567|Anti-VEGF|anti-vegf
642684|NCT00749580|Safety|safety
642685|NCT00749593|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
642686|NCT00749593|Quality of Life|quality of life
642687|NCT00749593|Genotype|genotype
642688|NCT00749593|Metabolic outcomes|metabolic outcomes
642689|NCT00749606|Obesity|obesity
642690|NCT00749606|Metabolic syndrome|metabolic syndrome
642691|NCT00749606|Weight loss|weight loss
642692|NCT00749606|Diabetes prevention|diabetes prevention
642693|NCT00749619|Tunneled Cuffed Catheter|tunneled cuffed catheter
642694|NCT00749619|Catheter Lock Solution|catheter lock solution
642695|NCT00749619|Catheter Related Bacteremia|catheter related bacteremia
642696|NCT00749632|urinary incontinence, urge|urinary incontinence, urge
642697|NCT00749632|urinary urge incontinence|urinary urge incontinence
642698|NCT00749632|urge incontinence|urge incontinence
642699|NCT00749632|over active bladder|over active bladder
642700|NCT00749645|Arthritis, Rheumatoid, Andrographolides treatment, Efficacy.|arthritis, rheumatoid, andrographolides treatment, efficacy.
642701|NCT00749658|Tobacco|tobacco
642702|NCT00749658|Nicotine|nicotine
642703|NCT00749658|Smoking|smoking
642704|NCT00749658|Varenicline|varenicline
642705|NCT00749658|Bupropion|bupropion
642706|NCT00749658|Human laboratory study|human laboratory study
642707|NCT00749658|Stress tolerance|stress tolerance
642708|NCT00749658|Startle response|startle response
642709|NCT00749658|Cognitive assessment|cognitive assessment
642710|NCT00749658|Progressive ratio|progressive ratio
642711|NCT00749658|Motivation|motivation
642712|NCT00749684|interferon-alpha|interferon-alpha
642713|NCT00749697|radioiodine|radioiodine
642714|NCT00749697|differentiated thyroid cancers|differentiated thyroid cancers
642715|NCT00749697|dosimetry|dosimetry
642716|NCT00749697|metastases|metastases
642717|NCT00749710|femoral neck fractures|femoral neck fractures
642718|NCT00749710|pertrochanteric fractures|pertrochanteric fractures
642719|NCT00749710|antiaggregant therapy|antiaggregant therapy
642720|NCT00749710|clopidogrel|clopidogrel
642721|NCT00749710|plavix|plavix
642722|NCT00749723|brain tumor|brain tumor
642723|NCT00749723|relapse|relapse
642724|NCT00749723|children|children
642725|NCT00749723|etoposide|etoposide
643308|NCT00737685|UBMT|ubmt
642726|NCT00749723|intraventricular|intraventricular
642727|NCT00749723|temozolomide|temozolomide
642728|NCT00749736|vitamin D|vitamin d
642729|NCT00749736|determine|determine
642730|NCT00749736|normal|normal
642731|NCT00749736|intrapatient|intrapatient
642732|NCT00749736|interpatient|interpatient
642733|NCT00749736|variability|variability
642735|NCT00749736|immune system|immune system
642736|NCT00749749|Abdominal Hysterectomy|abdominal hysterectomy
642737|NCT00749749|Postoperative pain|postoperative pain
642738|NCT00749762|DURING|during
642739|NCT00749762|PRONE|prone
642740|NCT00749762|SUPINE|supine
642741|NCT00749762|POSITIONING|positioning
642742|NCT00749775|Eplerenone|eplerenone
642743|NCT00749775|Selara|selara
642744|NCT00749775|Hypertension|hypertension
642745|NCT00749775|Good post-marketing study Practice|good post-marketing study practice
642746|NCT00749775|Drug use Investigation|drug use investigation
642747|NCT00749775|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
642748|NCT00749775|ESSENCE|essence
642749|NCT00749801|drug naive|drug naive
642750|NCT00749801|Dyslipidemic|dyslipidemic
642751|NCT00749801|nattokinase|nattokinase
642752|NCT00749801|fibrinolytic|fibrinolytic
642753|NCT00749814|sleep patterns in children in the night prior to surgery and post surgery.|sleep patterns in children in the night prior to surgery and post surgery.
642754|NCT00749814|the influence of melatonin on sleep patterns|the influence of melatonin on sleep patterns
642755|NCT00749827|Contrast Induced Nephropathy, fluid prophylaxis|contrast induced nephropathy, fluid prophylaxis
642756|NCT00749840|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
642757|NCT00749840|Human Immunodeficiency Virus|human immunodeficiency virus
642758|NCT00749840|Questionnaire|questionnaire
642759|NCT00749840|AIDS|aids
642760|NCT00749840|HIV|hiv
642761|NCT00749840|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
642762|NCT00749840|HAART|haart
642763|NCT00749840|Steps of HIV Care|steps of hiv care
642764|NCT00749840|CDC|cdc
642765|NCT00749853|ovarian stimulation|ovarian stimulation
642766|NCT00749853|FSH|fsh
642767|NCT00749853|genotyping|genotyping
642768|NCT00749853|polymorphism|polymorphism
642769|NCT00749866|Nebulised antibiotics|nebulised antibiotics
642770|NCT00749866|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
642771|NCT00749866|Bacterial Load|bacterial load
642772|NCT00749866|Inflammation|inflammation
642773|NCT00749866|Quality of Life|quality of life
642774|NCT00749866|Side Effects|side effects
642775|NCT00749879|PK|pk
642776|NCT00749879|Pharmacokinetics|pharmacokinetics
642777|NCT00749892|Transitional Cell Carcinoma|transitional cell carcinoma
642778|NCT00749892|Bladder Cancer|bladder cancer
642779|NCT00749892|Urothelial Cancer|urothelial cancer
642780|NCT00749892|Erlotinib Hydrochloride|erlotinib hydrochloride
642781|NCT00749892|Tarceva|tarceva
642782|NCT00749892|OSI-774|osi-774
642783|NCT00749892|TCC|tcc
642784|NCT00749918|vitamin D|vitamin d
642785|NCT00749918|Cholecalciferol|cholecalciferol
642786|NCT00749918|Insulin sensitivity|insulin sensitivity
642787|NCT00749918|MinMod Millennium|minmod millennium
642788|NCT00749918|FSIGT|fsigt
642789|NCT00749918|modified frequently sampled IV glucose tolerance test|modified frequently sampled iv glucose tolerance test
642790|NCT00749931|IDC, DCIS, ILC|idc, dcis, ilc
642791|NCT00749944|nicotine withdrawal, smoking cessation, varenicline|nicotine withdrawal, smoking cessation, varenicline
642792|NCT00749957|AAV|aav
642793|NCT00749957|adeno-associated virus|adeno-associated virus
642794|NCT00749957|RPE65|rpe65
642795|NCT00749957|Leber congenital amaurosis|leber congenital amaurosis
642796|NCT00749957|LCA|lca
642797|NCT00749957|gene therapy|gene therapy
642798|NCT00749957|human gene transfer|human gene transfer
642799|NCT00749970|schizophrenia|schizophrenia
642800|NCT00749970|subjective well-being|subjective well-being
642801|NCT00749970|psychometric validation|psychometric validation
642802|NCT00750009|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
642803|NCT00750009|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
642804|NCT00750009|acute undifferentiated leukemia|acute undifferentiated leukemia
642805|NCT00750009|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
642806|NCT00750009|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
642807|NCT00750009|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
642808|NCT00750009|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
642809|NCT00750009|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
642810|NCT00750009|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
642811|NCT00750009|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
642812|NCT00750009|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
642813|NCT00750009|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
642814|NCT00750009|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
643309|NCT00737685|Severe|severe
642815|NCT00750009|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
642816|NCT00750009|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
642817|NCT00750009|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
642818|NCT00750009|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
642819|NCT00750009|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
642820|NCT00750009|mast cell leukemia|mast cell leukemia
642821|NCT00750009|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
642822|NCT00750009|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
642823|NCT00750009|prolymphocytic leukemia|prolymphocytic leukemia
642824|NCT00750009|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
642825|NCT00750009|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
642826|NCT00750009|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
642827|NCT00750009|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
642828|NCT00750009|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
642829|NCT00750009|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
642830|NCT00750009|refractory hairy cell leukemia|refractory hairy cell leukemia
643017|NCT00750074|mechanical ventilation|mechanical ventilation
642831|NCT00750009|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
642832|NCT00750009|secondary acute myeloid leukemia|secondary acute myeloid leukemia
642833|NCT00750009|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
642834|NCT00750009|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
642835|NCT00750009|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
642836|NCT00750009|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
642837|NCT00750009|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
642838|NCT00750009|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
642839|NCT00750009|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
642840|NCT00750009|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
642841|NCT00750009|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
642842|NCT00750009|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
642843|NCT00750009|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
642844|NCT00750009|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
642845|NCT00750009|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
642846|NCT00750009|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
642847|NCT00750009|untreated hairy cell leukemia|untreated hairy cell leukemia
642848|NCT00750009|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
642849|NCT00750009|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
642850|NCT00750009|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
642851|NCT00750009|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
642852|NCT00750009|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
642853|NCT00750009|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
642854|NCT00750009|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
642855|NCT00750009|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
642856|NCT00750009|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
642857|NCT00750009|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
642858|NCT00750009|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
642859|NCT00750009|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
642860|NCT00750009|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
642861|NCT00750009|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
642862|NCT00750009|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
642863|NCT00750009|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
642864|NCT00750009|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
642865|NCT00750009|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
642866|NCT00750009|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
642867|NCT00750009|anaplastic large cell lymphoma|anaplastic large cell lymphoma
642868|NCT00750009|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
642869|NCT00750009|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
642870|NCT00750009|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
642871|NCT00750009|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
642872|NCT00750009|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
642873|NCT00750009|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
642874|NCT00750009|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
642875|NCT00750009|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
642876|NCT00750009|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
642877|NCT00750009|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
643104|NCT00750451|fertilization in vitro|fertilization in vitro
642878|NCT00750009|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
642879|NCT00750009|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
642880|NCT00750009|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
642881|NCT00750009|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
642882|NCT00750009|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
642883|NCT00750009|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
642884|NCT00750009|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
642885|NCT00750009|splenic marginal zone lymphoma|splenic marginal zone lymphoma
642886|NCT00750009|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
642887|NCT00750009|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
642888|NCT00750009|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
642889|NCT00750009|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
642890|NCT00750009|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
642891|NCT00750009|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
642892|NCT00750009|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
642893|NCT00750009|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
642894|NCT00750009|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
642895|NCT00750009|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
642896|NCT00750009|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
642897|NCT00750009|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
642898|NCT00750009|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
642899|NCT00750009|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
752376|NCT01172717|Carcinoid syndrome|carcinoid syndrome
642900|NCT00750009|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
642901|NCT00750009|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
642902|NCT00750009|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
642903|NCT00750009|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
642904|NCT00750009|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
642905|NCT00750009|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
642906|NCT00750009|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
642907|NCT00750009|stage I mantle cell lymphoma|stage i mantle cell lymphoma
642908|NCT00750009|stage I marginal zone lymphoma|stage i marginal zone lymphoma
642909|NCT00750009|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
642910|NCT00750009|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
642911|NCT00750009|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
642912|NCT00750009|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
642913|NCT00750009|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
642914|NCT00750009|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
642915|NCT00750009|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
642916|NCT00750009|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
642917|NCT00750009|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
642918|NCT00750009|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
642919|NCT00750009|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
643070|NCT00750334|Oral Clofarabine,|oral clofarabine,
642920|NCT00750009|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
642921|NCT00750009|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
642922|NCT00750009|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
642923|NCT00750009|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
642924|NCT00750009|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
642925|NCT00750009|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
642926|NCT00750009|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
642927|NCT00750009|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
642928|NCT00750009|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
642929|NCT00750009|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
642930|NCT00750009|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
642931|NCT00750009|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
642932|NCT00750009|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
642933|NCT00750009|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
642934|NCT00750009|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
642935|NCT00750009|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
642936|NCT00750009|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
642937|NCT00750009|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
642938|NCT00750009|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
642939|NCT00750009|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
642940|NCT00750009|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
642941|NCT00750009|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
642942|NCT00750009|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
642943|NCT00750009|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
642944|NCT00750009|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
642945|NCT00750009|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
642946|NCT00750009|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
642947|NCT00750009|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
642948|NCT00750009|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
642949|NCT00750009|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
642950|NCT00750009|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
642951|NCT00750009|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
642952|NCT00750009|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
642953|NCT00750009|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
642954|NCT00750009|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
642955|NCT00750009|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
642956|NCT00750009|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
642957|NCT00750009|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
642958|NCT00750009|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
642959|NCT00750009|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
642960|NCT00750009|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
642961|NCT00750009|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
642962|NCT00750009|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
642963|NCT00750009|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
642964|NCT00750009|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
642965|NCT00750009|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
642966|NCT00750009|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
642967|NCT00750009|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
642968|NCT00750009|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
642969|NCT00750009|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
642970|NCT00750009|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
642971|NCT00750009|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
642972|NCT00750009|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
642973|NCT00750009|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
642974|NCT00750009|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
642975|NCT00750009|Burkitt lymphoma|burkitt lymphoma
642976|NCT00750009|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
642977|NCT00750009|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
642978|NCT00750009|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
642979|NCT00750009|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
642980|NCT00750009|intraocular lymphoma|intraocular lymphoma
642981|NCT00750009|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
643071|NCT00750334|relapsed/refractory MDS,|relapsed/refractory mds,
642982|NCT00750009|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
642983|NCT00750009|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
642984|NCT00750009|chronic eosinophilic leukemia|chronic eosinophilic leukemia
642985|NCT00750009|chronic neutrophilic leukemia|chronic neutrophilic leukemia
642986|NCT00750009|primary myelofibrosis|primary myelofibrosis
642987|NCT00750009|essential thrombocythemia|essential thrombocythemia
642988|NCT00750009|polycythemia vera|polycythemia vera
642989|NCT00750009|extramedullary plasmacytoma|extramedullary plasmacytoma
642990|NCT00750009|isolated plasmacytoma of bone|isolated plasmacytoma of bone
642991|NCT00750009|stage I multiple myeloma|stage i multiple myeloma
642992|NCT00750009|stage II multiple myeloma|stage ii multiple myeloma
642993|NCT00750009|stage III multiple myeloma|stage iii multiple myeloma
642994|NCT00750009|primary systemic amyloidosis|primary systemic amyloidosis
642995|NCT00750009|refractory multiple myeloma|refractory multiple myeloma
642996|NCT00750009|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
642997|NCT00750009|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
642998|NCT00750009|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
642999|NCT00750009|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
643000|NCT00750009|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
751835|NCT01170754|PEG-3350, polyethylene glycol, colonoscopy|peg-3350, polyethylene glycol, colonoscopy
643001|NCT00750009|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
643002|NCT00750009|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
643003|NCT00750009|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
643004|NCT00750009|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
643005|NCT00750009|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
643006|NCT00750035|Total hysterectomy|total hysterectomy
643007|NCT00750035|subtotal hysterectomy|subtotal hysterectomy
643008|NCT00750035|urinary function|urinary function
643009|NCT00750035|bowel function|bowel function
643010|NCT00750035|sexual function|sexual function
643011|NCT00750035|Quality of life|quality of life
643012|NCT00750035|Psychological function|psychological function
643014|NCT00750048|sensitization,|sensitization,
643015|NCT00750048|analgesia|analgesia
643016|NCT00750061|Spinal Cord Injury|spinal cord injury
643018|NCT00750087|Schizophrenia|schizophrenia
643019|NCT00750100|infertility|infertility
643020|NCT00750100|IVF|ivf
643021|NCT00750100|hCG|hcg
643022|NCT00750100|primary infertility|primary infertility
643023|NCT00750100|secondary infertility|secondary infertility
643024|NCT00750100|patients requiring in-vitro fertilisation|patients requiring in-vitro fertilisation
643025|NCT00750126|Allograft|allograft
643026|NCT00750126|Children|children
643027|NCT00750126|malignancy|malignancy
643028|NCT00750126|Reduced Intensity Conditioning|reduced intensity conditioning
643029|NCT00750126|Fludarabin|fludarabin
643030|NCT00750126|Busulfex|busulfex
643031|NCT00750126|Thymoglobulin|thymoglobulin
643032|NCT00750139|Tinea Pedis|tinea pedis
643033|NCT00750139|Athlete's foot|athlete's foot
643034|NCT00750152|tinea cruris|tinea cruris
643035|NCT00750152|jock itch|jock itch
643036|NCT00750165|Obstructive Sleep Apnea|obstructive sleep apnea
643037|NCT00750165|Humidification|humidification
643038|NCT00750165|Continuous Positive Airway Pressure|continuous positive airway pressure
643039|NCT00750191|Lower Back Pain|lower back pain
643040|NCT00750204|Acute Lung Injury|acute lung injury
643041|NCT00750204|ALI|ali
643042|NCT00750204|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
643043|NCT00750204|Mechanical Ventilation|mechanical ventilation
643044|NCT00750204|Sedation|sedation
643045|NCT00750204|Critical Illness|critical illness
643046|NCT00750204|Ventilator Induced Lung Injury|ventilator induced lung injury
643047|NCT00750204|VILI|vili
643048|NCT00750204|Cytokines|cytokines
643049|NCT00750204|Protective Ventilation|protective ventilation
643050|NCT00750204|Airway Pressure Release Ventilation|airway pressure release ventilation
643051|NCT00750204|APRV|aprv
643052|NCT00750204|Breathing Comfort|breathing comfort
643053|NCT00750204|Dyssynchrony|dyssynchrony
643054|NCT00750204|Asynchrony|asynchrony
643055|NCT00750217|transfer methadone buprenorphine patch heroin addiction|transfer methadone buprenorphine patch heroin addiction
643056|NCT00750230|arthritis|arthritis
643057|NCT00750230|osteoarthritis|osteoarthritis
643058|NCT00750230|fibromyalgia|fibromyalgia
643059|NCT00750230|connective tissue disorder|connective tissue disorder
643060|NCT00750256|tolerability|tolerability
643061|NCT00750256|Safety|safety
643062|NCT00750256|pharmacokinetics|pharmacokinetics
643063|NCT00750269|stage I non-small cell lung cancer|stage i non-small cell lung cancer
643064|NCT00750282|Alzheimer Disease|alzheimer disease
643065|NCT00750282|Amyloid beta-Protein|amyloid beta-protein
643066|NCT00750295|Chronic kidney disease,|chronic kidney disease,
643067|NCT00750295|hemodialysis,|hemodialysis,
643068|NCT00750295|serum phosphorus,|serum phosphorus,
643069|NCT00750295|phosphate binders|phosphate binders
643279|NCT00751270|Radiation|radiation
643072|NCT00750334|Myelodysplastic|myelodysplastic
643073|NCT00750347|pain,|pain,
643074|NCT00750347|analgesia|analgesia
643075|NCT00750347|Healthy volunteers|healthy volunteers
643076|NCT00750360|Influenza|influenza
643077|NCT00750360|Korea|korea
643078|NCT00750360|FluarixTM|fluarixtm
643079|NCT00750373|Endocarditis|endocarditis
643080|NCT00750386|Cancer|cancer
643081|NCT00750386|Ovarian cancer|ovarian cancer
643082|NCT00750386|Dose-dense chemotherapy|dose-dense chemotherapy
643083|NCT00750399|radiation|radiation
643084|NCT00750399|retinopathy|retinopathy
643085|NCT00750399|ranibizumab|ranibizumab
643086|NCT00750399|melanoma|melanoma
643087|NCT00750399|choroid|choroid
643088|NCT00750412|TeenScreen|teenscreen
643089|NCT00750412|Mental Health|mental health
643090|NCT00750412|Adolescent Mental Health|adolescent mental health
643091|NCT00750412|Social Work|social work
643092|NCT00750425|advanced cancer,|advanced cancer,
643093|NCT00750425|metastatic|metastatic
643094|NCT00750425|ketoconazole|ketoconazole
643095|NCT00750425|pharmacokinetics|pharmacokinetics
643098|NCT00750438|Short chain fatty acids|short chain fatty acids
643099|NCT00750438|Appetite|appetite
643100|NCT00750438|Body weight|body weight
643101|NCT00750438|Insulin sensitivity|insulin sensitivity
643102|NCT00750438|Propionate|propionate
643103|NCT00750438|Propionate ester|propionate ester
643105|NCT00750451|assisted reproduction|assisted reproduction
643106|NCT00750451|recurrent implantation failure|recurrent implantation failure
643107|NCT00750451|low molecular weight heparin|low molecular weight heparin
643108|NCT00750451|heparin|heparin
643109|NCT00750451|luteal phase|luteal phase
643110|NCT00750477|osteoarthritis|osteoarthritis
643111|NCT00750477|arthritis|arthritis
643112|NCT00750477|knee|knee
643113|NCT00750477|eggshell|eggshell
643114|NCT00750477|membrane|membrane
643115|NCT00750477|OPTION|option
643116|NCT00750503|tobacco cessation|tobacco cessation
643117|NCT00750503|behavioral therapy|behavioral therapy
643118|NCT00750503|pharmacotherapy|pharmacotherapy
643119|NCT00750503|workplace|workplace
643120|NCT00750503|oral cancer screening|oral cancer screening
643121|NCT00750503|Tobacco Quit rates|tobacco quit rates
643122|NCT00750516|Lactic acid|lactic acid
643123|NCT00750516|hypotension|hypotension
643124|NCT00750516|sepsis|sepsis
643125|NCT00750529|sleep|sleep
643126|NCT00750529|Alzheimer|alzheimer
643127|NCT00750529|old patients|old patients
643128|NCT00750555|squamous cell cancer of head and neck|squamous cell cancer of head and neck
643129|NCT00750555|SCCHN|scchn
643130|NCT00750568|Bronchial asthma|bronchial asthma
643131|NCT00750568|Asthma, bronchial|asthma, bronchial
643132|NCT00750568|Status Asthmaticus|status asthmaticus
643133|NCT00750568|Terbutaline sulfate|terbutaline sulfate
643134|NCT00750581|Patent Ductus Arteriosus|patent ductus arteriosus
643135|NCT00750594|Children|children
643136|NCT00750594|Migraine headaches|migraine headaches
643137|NCT00750620|mild, moderate, and severe renal impaired subjects|mild, moderate, and severe renal impaired subjects
643138|NCT00750620|normal renal function subjects|normal renal function subjects
643139|NCT00750620|Glomerular filtration rate (GFR)|glomerular filtration rate (gfr)
643140|NCT00750620|Modification of Diet in Renal Disease (MDRD) formula|modification of diet in renal disease (mdrd) formula
643141|NCT00750620|YM178|ym178
643142|NCT00750620|pharmacokinetics|pharmacokinetics
643143|NCT00750633|swimmer's ear|swimmer's ear
643144|NCT00750633|ear drops|ear drops
643145|NCT00750633|ear infection|ear infection
643146|NCT00750633|ear pain|ear pain
643147|NCT00750633|ear inflammation|ear inflammation
643148|NCT00750646|compliance|compliance
643149|NCT00750646|eye drop administration|eye drop administration
643150|NCT00750646|MEMS|mems
643151|NCT00750646|adherence|adherence
643152|NCT00750659|Chronic myeloid leukemia|chronic myeloid leukemia
643153|NCT00750659|Ph+ acute lymphoblastic leukemia|ph+ acute lymphoblastic leukemia
643154|NCT00750659|stem cell transplantation|stem cell transplantation
643155|NCT00750659|nilotinib|nilotinib
643156|NCT00750672|Endometrial neoplasia|endometrial neoplasia
643157|NCT00750672|Follow-up care|follow-up care
643158|NCT00750672|survivorship|survivorship
643159|NCT00750672|Primary care provider|primary care provider
643160|NCT00750685|Primary Breast Reconstruction|primary breast reconstruction
643161|NCT00750698|lung cancer|lung cancer
643162|NCT00750698|non small cell lung cancer|non small cell lung cancer
643163|NCT00750724|Hyaluronic acid,|hyaluronic acid,
643164|NCT00750724|OA knee,|oa knee,
643166|NCT00750737|Hematologic Malignancies|hematologic malignancies
643167|NCT00750737|Blood Cancer|blood cancer
643168|NCT00750737|Lymphatic Cancer|lymphatic cancer
643169|NCT00750737|Amphotericin B Lipid Complex|amphotericin b lipid complex
643170|NCT00750737|Amphotericin B|amphotericin b
643171|NCT00750737|ABLC|ablc
643172|NCT00750737|Fungizone|fungizone
643173|NCT00750737|Noxafil|noxafil
643174|NCT00750737|SCH56592|sch56592
643175|NCT00750737|Posaconazole|posaconazole
643176|NCT00750737|Invasive fungal infections|invasive fungal infections
643177|NCT00750737|IFI|ifi
643178|NCT00750737|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
643179|NCT00750737|HSCT|hsct
643180|NCT00750737|Bone Marrow Transplant|bone marrow transplant
643181|NCT00750737|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
643182|NCT00750763|Mucosal inflammation|mucosal inflammation
643183|NCT00750763|Fleet|fleet
643184|NCT00750763|Picoprep|picoprep
643185|NCT00750763|Colonlytely|colonlytely
643186|NCT00750763|Colonoscopy|colonoscopy
643187|NCT00750763|tolerability|tolerability
643188|NCT00750763|efficacy|efficacy
643189|NCT00750776|Quality assurance|quality assurance
643190|NCT00750776|medical treatment|medical treatment
643191|NCT00750776|Patient satisfaction|patient satisfaction
643192|NCT00750802|Phase I|phase i
643193|NCT00750815|B Cell|b cell
643194|NCT00750815|hematologic malignancy|hematologic malignancy
643195|NCT00750815|plasma|plasma
643196|NCT00750815|bone marrow|bone marrow
643197|NCT00750828|Saliva|saliva
643198|NCT00750828|Sjögren's Syndrome|sjögren's syndrome
643199|NCT00750828|GCF|gcf
643301|NCT00737659|MPA|mpa
643200|NCT00750828|Oral Mucosal Wetness|oral mucosal wetness
643201|NCT00750841|advanced cancer|advanced cancer
643202|NCT00750841|metastatic|metastatic
643203|NCT00750841|rifampicin|rifampicin
643204|NCT00750841|pharmacokinetics|pharmacokinetics
643205|NCT00750841|Phase I|phase i
643206|NCT00750841|Advanced solid tumours|advanced solid tumours
643207|NCT00750854|arthritis|arthritis
643208|NCT00750854|osteoarthritis|osteoarthritis
643209|NCT00750854|fibromyalgia|fibromyalgia
643210|NCT00750854|connective tissue disorder|connective tissue disorder
643211|NCT00750867|multiple system atrophy, MSA,|multiple system atrophy, msa,
643212|NCT00750867|intravenous immunoglobulin, IVIg|intravenous immunoglobulin, ivig
643213|NCT00750893|Gastroenteritis|gastroenteritis
643214|NCT00750945|Parkinson's disease|parkinson's disease
643215|NCT00750945|Cueing training|cueing training
643216|NCT00750945|Treadmill training|treadmill training
643217|NCT00750945|Music|music
643218|NCT00750958|cardiac rhythm changes|cardiac rhythm changes
643219|NCT00750971|ASSIST|assist
643220|NCT00750971|SLE|sle
643221|NCT00750971|Stem Cell Transplantation|stem cell transplantation
643222|NCT00750971|Tolerance|tolerance
643223|NCT00751010|Vulvar pain|vulvar pain
643224|NCT00751010|Vulvodynia|vulvodynia
643225|NCT00751010|Interstitial cystitis|interstitial cystitis
643226|NCT00751023|Methamphetamine|methamphetamine
643227|NCT00751023|Modafinil|modafinil
643228|NCT00751023|Addiction|addiction
643229|NCT00751023|Craving|craving
643230|NCT00751023|Cognitive|cognitive
643231|NCT00751036|GIST|gist
643232|NCT00751049|open angle glaucoma ocular hypertension|open angle glaucoma ocular hypertension
643233|NCT00751062|open angle glaucoma ocular hypertension|open angle glaucoma ocular hypertension
643234|NCT00751088|single-incision|single-incision
643235|NCT00751088|sling|sling
643236|NCT00751088|stress incontinence|stress incontinence
643237|NCT00751088|surgery|surgery
643238|NCT00751088|treatment|treatment
643239|NCT00751088|Female urinary stress incontinence|female urinary stress incontinence
643240|NCT00751101|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
643241|NCT00751101|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
643242|NCT00751101|stage IV breast cancer|stage iv breast cancer
643243|NCT00751101|recurrent breast cancer|recurrent breast cancer
643244|NCT00751127|open angle glaucoma|open angle glaucoma
643245|NCT00751127|ocular hypertension|ocular hypertension
643246|NCT00751140|surgical candidates|surgical candidates
643247|NCT00751140|upper urinary tract|upper urinary tract
643248|NCT00751140|urothelial carcinoma|urothelial carcinoma
643249|NCT00751140|lymph node dissection|lymph node dissection
643250|NCT00751153|drug substitution|drug substitution
643251|NCT00751153|Raltegravir|raltegravir
643252|NCT00751153|Atazanavir|atazanavir
643253|NCT00751153|treatment Experienced|treatment experienced
643254|NCT00751192|Men who have sex with men|men who have sex with men
643255|NCT00751192|Peru|peru
643256|NCT00751192|HIV testing|hiv testing
643257|NCT00751192|video|video
643258|NCT00751192|online|online
643259|NCT00751192|Internet|internet
643260|NCT00751192|HIV Seronegativity|hiv seronegativity
643261|NCT00751205|Peripheral Neuropathy|peripheral neuropathy
643262|NCT00751205|Prostate Carcinoma|prostate carcinoma
643263|NCT00751205|Ovarian Carcinoma|ovarian carcinoma
643264|NCT00751231|PCI|pci
643265|NCT00751231|percutaneous coronary intervention|percutaneous coronary intervention
643266|NCT00751244|women|women
643267|NCT00751244|posttraumatic stress disorder|posttraumatic stress disorder
643268|NCT00751244|PTSD|ptsd
643269|NCT00751244|psychotherapy|psychotherapy
643270|NCT00751244|clinical trial|clinical trial
643271|NCT00751244|emotion regulation|emotion regulation
643272|NCT00751257|Nicotine|nicotine
643273|NCT00751257|N-acetylcysteine|n-acetylcysteine
643274|NCT00751257|smoking reduction|smoking reduction
643275|NCT00751270|Immunotherapy|immunotherapy
643276|NCT00751270|Gene therapy|gene therapy
643277|NCT00751270|Tumor Vaccine|tumor vaccine
643278|NCT00751270|Cytotoxicity|cytotoxicity
643280|NCT00751296|Lenalidomide|lenalidomide
643281|NCT00751296|immunomodulatory drug (IMiD®)|immunomodulatory drug (imid®)
643282|NCT00751296|Thalidomide analogues|thalidomide analogues
643283|NCT00737620|Renal Failure, End Stage|renal failure, end stage
643284|NCT00737620|Blood Vessel Grafting|blood vessel grafting
643285|NCT00737620|Hemodialysis|hemodialysis
643286|NCT00737620|Surgical Arteriovenous Shunt|surgical arteriovenous shunt
643287|NCT00737633|Diabetes|diabetes
643288|NCT00737633|Type 2 Diabetes|type 2 diabetes
643289|NCT00737633|Diabetes Mellitus|diabetes mellitus
643290|NCT00737633|Metabolic Diseases|metabolic diseases
643291|NCT00737633|Glucose Metabolism Disorders|glucose metabolism disorders
643292|NCT00737633|Glycemic Control|glycemic control
643293|NCT00737646|Cancer|cancer
643294|NCT00737646|Colorectal cancer|colorectal cancer
643295|NCT00737646|Patient education|patient education
643296|NCT00737646|Physician education|physician education
643297|NCT00737659|Renal Transplant|renal transplant
643298|NCT00737659|Renal|renal
643299|NCT00737659|Transplant|transplant
643300|NCT00737659|MMF|mmf
643303|NCT00737672|Hemodialysis|hemodialysis
643304|NCT00737672|Stent Graft|stent graft
643305|NCT00737672|Venous Anastomosis|venous anastomosis
643306|NCT00737672|Arteriovenous Grafts|arteriovenous grafts
643310|NCT00737698|COPD|copd
643311|NCT00737698|exercise|exercise
643312|NCT00737698|repetitive magnetic stimulation|repetitive magnetic stimulation
643313|NCT00737698|quadriceps strength|quadriceps strength
643314|NCT00737724|Enzyme-Linked ImmunoSpot|enzyme-linked immunospot
643315|NCT00737724|Deferred treatment|deferred treatment
643316|NCT00737724|Immune Recovery Inflammatory Syndrome|immune recovery inflammatory syndrome
643317|NCT00737737|Analgesia|analgesia
643318|NCT00737737|Chronic Pain|chronic pain
643319|NCT00737737|Neuroendocrine Axis|neuroendocrine axis
643320|NCT00737737|Degenerative Diseases|degenerative diseases
643321|NCT00737750|Neuromuscular electrical stimulation (NMES)|neuromuscular electrical stimulation (nmes)
643322|NCT00737750|Knee Surgery|knee surgery
643323|NCT00737750|Anterior cruciate ligament|anterior cruciate ligament
643324|NCT00737750|Atrophy Prevention|atrophy prevention
643325|NCT00737750|Accelerated Recovery|accelerated recovery
643326|NCT00737763|efalizumab|efalizumab
643327|NCT00737763|Raptiva|raptiva
643328|NCT00737763|Diabetes|diabetes
643329|NCT00737763|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
643330|NCT00737802|GERD|gerd
643331|NCT00737802|Heartburn|heartburn
643332|NCT00737802|Esophageal reflux|esophageal reflux
643333|NCT00737802|Barretts esophagus|barretts esophagus
643334|NCT00737802|Normal subjects|normal subjects
643335|NCT00737815|Randomized Controlled Trial|randomized controlled trial
643336|NCT00737815|Magnesium|magnesium
643337|NCT00737815|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
643338|NCT00737815|Inflammation|inflammation
643339|NCT00737828|Cardiopulmonary exercise test|cardiopulmonary exercise test
643341|NCT00737828|CPEX|cpex
643342|NCT00737828|surgical outcome|surgical outcome
643343|NCT00737828|colorectal surgery|colorectal surgery
643344|NCT00737828|risk stratification|risk stratification
643345|NCT00737841|stress|stress
643346|NCT00737841|brain-gut interactions|brain-gut interactions
643347|NCT00737841|visceral perception|visceral perception
643348|NCT00737841|gastrointestinal motility|gastrointestinal motility
643349|NCT00737841|emotion|emotion
643350|NCT00737854|OLP|olp
643351|NCT00737854|Free Soft Tissue Graft|free soft tissue graft
643352|NCT00737854|Treatment|treatment
643353|NCT00737867|lung cancer|lung cancer
643354|NCT00737867|chemotherapy|chemotherapy
643355|NCT00737867|vinorelbine|vinorelbine
643356|NCT00737867|gemcitabine|gemcitabine
643357|NCT00737867|carboplatin|carboplatin
643358|NCT00737867|advanced lung cancer|advanced lung cancer
643359|NCT00737867|non-small cell lung cancer|non-small cell lung cancer
643360|NCT00737880|Pancreas Clinical, Donor|pancreas clinical, donor
643361|NCT00737880|Pancreas Clinical, Preservation Solutions|pancreas clinical, preservation solutions
643362|NCT00737880|Organ Preservation and Procurement, Surgery|organ preservation and procurement, surgery
643363|NCT00737880|Organ Procurement, Ischemia reperfusion Injury|organ procurement, ischemia reperfusion injury
643364|NCT00737880|Organ Preservation and Procurement|organ preservation and procurement
643365|NCT00737893|Erythropoietin|erythropoietin
643366|NCT00737893|Radical Prostatectomy|radical prostatectomy
643367|NCT00737893|Erectile Dysfunction|erectile dysfunction
643368|NCT00737893|Prostate Cancer|prostate cancer
643369|NCT00737906|Chronic rhinitis|chronic rhinitis
643370|NCT00737906|Nasal Obstruction|nasal obstruction
643371|NCT00737906|Nasal Obstruction Symptoms|nasal obstruction symptoms
643372|NCT00737906|Failed Medical Management for Nasal Obstruction|failed medical management for nasal obstruction
643373|NCT00737906|Inflammation of the nasal mucosa|inflammation of the nasal mucosa
643374|NCT00737906|Pediatric Turbinate reduction|pediatric turbinate reduction
643375|NCT00737906|Coblation|coblation
643376|NCT00737906|Arthrocare|arthrocare
643377|NCT00737906|ENT|ent
643378|NCT00737906|Failed Medical Management for Chronic Sinusitis|failed medical management for chronic sinusitis
643379|NCT00737906|Turbinate|turbinate
643380|NCT00737906|Inferior Turbinate Hypertrophy|inferior turbinate hypertrophy
643381|NCT00737906|Bilateral Inferior Turbinate Hypertrophy|bilateral inferior turbinate hypertrophy
643382|NCT00737906|Turbinate Hypertrophy|turbinate hypertrophy
643383|NCT00737906|Inferior Turbinate|inferior turbinate
643384|NCT00737906|Bilateral Inferior Turbinate|bilateral inferior turbinate
643385|NCT00737919|Cholesterol|cholesterol
643386|NCT00737919|Plant sterols|plant sterols
643387|NCT00737919|Atherosclerotic carotid plaques|atherosclerotic carotid plaques
643388|NCT00737958|Angina pectoris|angina pectoris
643389|NCT00737958|Air pollution|air pollution
643390|NCT00737958|Diesel exhaust|diesel exhaust
643391|NCT00737958|Myocardial ischaemia|myocardial ischaemia
643392|NCT00737958|Exercise capacity|exercise capacity
643393|NCT00737971|avastin|avastin
643394|NCT00737971|bevacizumab|bevacizumab
643395|NCT00737971|triamcinolone|triamcinolone
643396|NCT00737971|diabetic macular edema|diabetic macular edema
643397|NCT00737971|macular edema|macular edema
643398|NCT00737971|intravitreal injection|intravitreal injection
643399|NCT00737984|Infertility|infertility
643400|NCT00737984|Clinical pregnancy rate|clinical pregnancy rate
643408|NCT00738010|Atrophy Prevention|atrophy prevention
643409|NCT00738010|Accelerated Recovery|accelerated recovery
643410|NCT00738010|Knee Surgery|knee surgery
643411|NCT00738023|diabetes,|diabetes,
643412|NCT00738023|hypertension,|hypertension,
643413|NCT00738023|free-fatty acids|free-fatty acids
643414|NCT00738036|Analgesics|analgesics
643415|NCT00738036|Opioid|opioid
643416|NCT00738036|Opioid maintenance therapy|opioid maintenance therapy
643417|NCT00738036|Acute pain|acute pain
643418|NCT00738049|atherosclerosis|atherosclerosis
643419|NCT00738049|coronary artery disease|coronary artery disease
643420|NCT00738049|myocardial perfusion defect|myocardial perfusion defect
643421|NCT00738049|endothelial dysfunction|endothelial dysfunction
643422|NCT00738049|endothelin receptor blockade|endothelin receptor blockade
643423|NCT00738062|NOH|noh
643424|NCT00738062|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
643425|NCT00738062|Orthostatic hypotension|orthostatic hypotension
643426|NCT00738062|PAF|paf
643427|NCT00738062|Pure Autonomic Failure|pure autonomic failure
643428|NCT00738062|MSA|msa
643429|NCT00738062|Multiple System Atrophy|multiple system atrophy
643430|NCT00738062|Neuropathy|neuropathy
643431|NCT00738062|Autonomic Failure|autonomic failure
643432|NCT00738062|Parkinson|parkinson
643433|NCT00738062|Dopamine Deficiency|dopamine deficiency
643434|NCT00738062|Dopamine|dopamine
643435|NCT00738062|Droxidopa|droxidopa
643436|NCT00738088|Sulphonylurea|sulphonylurea
643437|NCT00738088|Pharmacogenetics|pharmacogenetics
643438|NCT00738101|Omega-3|omega-3
643439|NCT00738101|Omegaven|omegaven
643440|NCT00738101|Cholestasis|cholestasis
643441|NCT00738101|Liver damage|liver damage
643442|NCT00738114|non-cardiac|non-cardiac
643443|NCT00738114|surgery|surgery
643444|NCT00738114|mortality|mortality
643445|NCT00738114|morbidity|morbidity
643446|NCT00738114|perioperative|perioperative
643447|NCT00738114|period|period
643448|NCT00743483|cystic fibrosis|cystic fibrosis
643449|NCT00743483|pancreatic insufficiency|pancreatic insufficiency
643450|NCT00743483|bucelipase alfa|bucelipase alfa
643451|NCT00743483|bile salt stimulating lipase|bile salt stimulating lipase
643452|NCT00743483|BSSL|bssl
643453|NCT00743483|coefficient of fat absorption|coefficient of fat absorption
643454|NCT00743509|sarcoma|sarcoma
643455|NCT00743509|Cyclophosphamide|cyclophosphamide
643456|NCT00743509|Sirolimus|sirolimus
643457|NCT00743509|Progressive or recurrent, advanced (unresectable or metastatic) high-grade osteosarcoma, Ewing's or soft tissue sarcoma previously treated with chemotherapy.|progressive or recurrent, advanced (unresectable or metastatic) high-grade osteosarcoma, ewing's or soft tissue sarcoma previously treated with chemotherapy.
643458|NCT00743522|Reducing shocks|reducing shocks
643459|NCT00743535|Cystocele|cystocele
643460|NCT00743535|Mesh|mesh
643461|NCT00743535|Prolapse|prolapse
643462|NCT00743535|Sling|sling
643463|NCT00743535|Stress incontinence|stress incontinence
643464|NCT00743535|Surgery|surgery
643465|NCT00743535|TOT|tot
643466|NCT00743535|TVT|tvt
643467|NCT00743535|Treatment|treatment
643468|NCT00743548|interdental self-care aids|interdental self-care aids
643469|NCT00743548|plaque|plaque
643470|NCT00743548|bleeding gums|bleeding gums
643471|NCT00743561|MSA|msa
643472|NCT00743561|sleep apnea|sleep apnea
643473|NCT00743561|ambulatory polygraphy|ambulatory polygraphy
643474|NCT00743561|polysomnography|polysomnography
643475|NCT00743600|ultrasound|ultrasound
643476|NCT00743600|rotator cuff|rotator cuff
643477|NCT00743613|Erectile Dysfunction|erectile dysfunction
643478|NCT00743613|ED|ed
643479|NCT00743613|Peripheral Arterial Disease|peripheral arterial disease
643480|NCT00743613|PAD|pad
643481|NCT00743613|Ankle-Brachial Index|ankle-brachial index
643482|NCT00743613|ABI|abi
643483|NCT00743626|Pap test|pap test
643484|NCT00743626|HPV|hpv
643485|NCT00743626|Healthy patients screened for cervical cancer tests.|healthy patients screened for cervical cancer tests.
643486|NCT00743639|Cardiomyopathy|cardiomyopathy
643487|NCT00743639|stem cell|stem cell
643488|NCT00743639|cardiac failure|cardiac failure
643489|NCT00743652|13 valent Pneumococcal Conjugate Vaccine|13 valent pneumococcal conjugate vaccine
643490|NCT00743652|Antibody Response|antibody response
643491|NCT00743652|safety|safety
643492|NCT00743652|Alaskan Native Children|alaskan native children
643493|NCT00743665|Youth|youth
643494|NCT00743665|consensus|consensus
643495|NCT00743665|criteria|criteria
643496|NCT00743665|CVS|cvs
643497|NCT00743678|Colorectal Cancer|colorectal cancer
643498|NCT00743678|Unresectable liver metastasis|unresectable liver metastasis
643499|NCT00743678|FOLFOX6|folfox6
643500|NCT00743678|Cetuximab|cetuximab
643501|NCT00743678|Neoadjuvant therapy|neoadjuvant therapy
643502|NCT00743691|Ethiopia|ethiopia
643503|NCT00743691|Community|community
643504|NCT00743691|Community based|community based
643505|NCT00743691|Health extension Worker|health extension worker
643506|NCT00743691|Health Extension Program|health extension program
643507|NCT00743717|total knee arthroplasty|total knee arthroplasty
643508|NCT00743717|osteoarthritis|osteoarthritis
643509|NCT00743717|ceramic bearing|ceramic bearing
643510|NCT00743717|zirconia|zirconia
643511|NCT00743730|developmental delay|developmental delay
643512|NCT00743730|cognitive impairment|cognitive impairment
643513|NCT00743730|pain control|pain control
643514|NCT00743730|post operative pain|post operative pain
643515|NCT00743730|opioid|opioid
643517|NCT00743730|Parent Nurse controlled Analgesic|parent nurse controlled analgesic
643518|NCT00743730|patient controlled analgesic|patient controlled analgesic
643519|NCT00743730|children|children
643520|NCT00743730|pain|pain
643521|NCT00743730|analgesic|analgesic
643522|NCT00743730|safety|safety
643523|NCT00743730|parent satisfaction|parent satisfaction
643524|NCT00743730|nurse satisfaction|nurse satisfaction
643525|NCT00743730|Pediatric|pediatric
643526|NCT00743743|dementia|dementia
643527|NCT00743743|Alzheimer disease|alzheimer disease
643528|NCT00743743|cognition|cognition
643529|NCT00743743|function|function
643530|NCT00743743|behavior|behavior
643531|NCT00743743|treatment|treatment
643532|NCT00743756|obesity|obesity
643533|NCT00743756|diabetes|diabetes
643534|NCT00743756|endothelial function|endothelial function
643535|NCT00743756|insulin sensitivity|insulin sensitivity
643536|NCT00743769|Myocardial Infarction|myocardial infarction
643537|NCT00743769|Myocardial Ischemia|myocardial ischemia
643538|NCT00743769|Myocardial Diseases|myocardial diseases
643539|NCT00743769|Infarction|infarction
643540|NCT00743782|Hypoparathyroidism|hypoparathyroidism
643541|NCT00743782|Parathyroid Hormone 1-34|parathyroid hormone 1-34
643542|NCT00743795|Hepatitis C|hepatitis c
643543|NCT00743795|HCV|hcv
643544|NCT00743795|Rapid Virologic Response|rapid virologic response
643545|NCT00743795|Sustained Virologic Response|sustained virologic response
643546|NCT00743795|HCV RNA|hcv rna
643547|NCT00743795|Polymerase inhibitor|polymerase inhibitor
643548|NCT00743795|GS-9190|gs-9190
643549|NCT00743808|hypertension|hypertension
643550|NCT00743808|diabetes|diabetes
643551|NCT00743808|quality improvement|quality improvement
643552|NCT00743808|blood pressure|blood pressure
643553|NCT00743847|schizophrenia, treatment, cognition|schizophrenia, treatment, cognition
643554|NCT00743860|darapladib|darapladib
643555|NCT00743860|pharmacokinetics|pharmacokinetics
643556|NCT00743860|metabolite|metabolite
643557|NCT00743860|SB-480848|sb-480848
643558|NCT00743873|medial retinaculum tear s/p patella dislocation|medial retinaculum tear s/p patella dislocation
643559|NCT00743899|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
643560|NCT00743899|Everolimus-eluting stent|everolimus-eluting stent
643561|NCT00743912|rifaximin|rifaximin
643562|NCT00743912|midazolam|midazolam
643563|NCT00743912|pharmacokinetics|pharmacokinetics
643564|NCT00743925|Unstable Angina|unstable angina
643565|NCT00743925|STEMI|stemi
643566|NCT00743925|NSTEMI|nstemi
643567|NCT00743925|ACS|acs
643568|NCT00743925|Acute Coronary Syndrome|acute coronary syndrome
643569|NCT00743925|C14.280.647.124|c14.280.647.124
643570|NCT00743925|C14.280.647.500|c14.280.647.500
643571|NCT00743951|patient decision aids|patient decision aids
643572|NCT00743951|patient preferences|patient preferences
643573|NCT00743951|osteoarthritis|osteoarthritis
643574|NCT00743951|joint replacement|joint replacement
643575|NCT00743951|waiting times|waiting times
643576|NCT00743990|Cough symptoms|cough symptoms
643577|NCT00743990|Cold symptoms|cold symptoms
643578|NCT00743990|Congestion|congestion
643579|NCT00743990|Children|children
643580|NCT00743990|URI|uri
643581|NCT00743990|Alternative cough symptom treatment|alternative cough symptom treatment
643582|NCT00744016|UC|uc
643583|NCT00744016|Ulcerative colitis|ulcerative colitis
643584|NCT00744016|IBD|ibd
643585|NCT00744016|Inflammatory bowel disease|inflammatory bowel disease
643586|NCT00744029|prehospital delays|prehospital delays
643587|NCT00744029|intervention|intervention
643588|NCT00744029|population-based|population-based
643589|NCT00744029|stroke|stroke
643590|NCT00744042|Hypophosphatasia|hypophosphatasia
643591|NCT00744042|HPP|hpp
643592|NCT00744042|Bone Disease|bone disease
643594|NCT00744042|Low Alkaline Phosphatase|low alkaline phosphatase
643595|NCT00744042|genetic metabolic disorder|genetic metabolic disorder
643596|NCT00744042|alkaline phosphatase|alkaline phosphatase
643597|NCT00744042|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
643598|NCT00744042|rickets|rickets
643599|NCT00744042|osteomalacia|osteomalacia
643600|NCT00744055|alcohol dependence|alcohol dependence
643601|NCT00744055|post traumatic stress disorder|post traumatic stress disorder
643602|NCT00744055|treatment|treatment
643603|NCT00744055|prazosin|prazosin
643604|NCT00744068|Stimulant|stimulant
643605|NCT00744068|Drug treatment|drug treatment
643606|NCT00744068|Continuing care|continuing care
643607|NCT00744068|Telephone support|telephone support
643608|NCT00744068|Aftercare|aftercare
643609|NCT00744094|resistance training|resistance training
643998|NCT00751517|Vasculitis|vasculitis
643610|NCT00744094|protein supplementation|protein supplementation
643611|NCT00744094|hypertrophy|hypertrophy
644227|NCT00752206|Saracatinib|saracatinib
643612|NCT00744107|Ischemic coronary artery disease in native coronary arteries|ischemic coronary artery disease in native coronary arteries
643613|NCT00744107|Single stent|single stent
643614|NCT00744107|RVD 2.5- 4.0mm|rvd 2.5- 4.0mm
643615|NCT00744107|Lesion length up to 26mm|lesion length up to 26mm
643616|NCT00744107|de novo or previously unstented lesions|de novo or previously unstented lesions
643617|NCT00744120|cancer|cancer
643618|NCT00744133|Plasmodium falciparum, NF54, Anopheles stephensi, mosquito, malaria|plasmodium falciparum, nf54, anopheles stephensi, mosquito, malaria
643619|NCT00744159|colon cancer|colon cancer
643620|NCT00744159|laparoscopic colorectal surgery|laparoscopic colorectal surgery
643621|NCT00744159|cellular immunity|cellular immunity
643622|NCT00744159|HLA-DR expression on monocyte|hla-dr expression on monocyte
643623|NCT00744172|hysterectomy|hysterectomy
643624|NCT00744172|vaginal|vaginal
643625|NCT00744172|laparoscopy|laparoscopy
643626|NCT00744172|abdominal|abdominal
643627|NCT00744172|complication|complication
643628|NCT00744172|quality of life|quality of life
643629|NCT00744172|cost-effectiveness|cost-effectiveness
643630|NCT00744172|Morbidity of three types of hysterectomy|morbidity of three types of hysterectomy
643631|NCT00744185|infantile capillary hemangiomas|infantile capillary hemangiomas
643632|NCT00744185|propranolol|propranolol
643633|NCT00744185|ultrasonography|ultrasonography
643634|NCT00744198|Autologous|autologous
643635|NCT00744198|Biological|biological
643636|NCT00744198|Mesh|mesh
643637|NCT00744198|Polypropylene|polypropylene
643638|NCT00744198|Sling|sling
643639|NCT00744198|Synthetic|synthetic
643640|NCT00744198|Stress incontinence|stress incontinence
643641|NCT00744198|Surgery|surgery
643642|NCT00744198|TOT|tot
643643|NCT00744198|Treatment|treatment
643644|NCT00744237|nebivolol|nebivolol
643645|NCT00744237|Bystolic ™|bystolic ™
643646|NCT00744237|Hypertension|hypertension
643647|NCT00744237|Diabetes|diabetes
643648|NCT00744250|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
643649|NCT00744250|Chronic Pancreatitis|chronic pancreatitis
643650|NCT00744250|Cystic fibrosis|cystic fibrosis
643651|NCT00744250|Pancrelipase|pancrelipase
643652|NCT00744250|Pancrecarb|pancrecarb
643653|NCT00744250|Intraduodenal aspiration|intraduodenal aspiration
643654|NCT00744250|Bioavailability|bioavailability
643655|NCT00744276|fibrocystic breast disease|fibrocystic breast disease
643656|NCT00744276|fibrocystic disease of breast|fibrocystic disease of breast
643657|NCT00744276|breast pain|breast pain
643658|NCT00744276|mastalgia|mastalgia
643659|NCT00744276|cyclic mastalgia|cyclic mastalgia
643660|NCT00744276|cystic breast disease|cystic breast disease
643661|NCT00744289|Hepatitis B|hepatitis b
643662|NCT00744289|People who inject drugs|people who inject drugs
643663|NCT00744289|Financial incentive|financial incentive
643664|NCT00744289|Vaccine completion|vaccine completion
643665|NCT00744302|Dialysate calcium|dialysate calcium
643666|NCT00744302|Mineral metabolism|mineral metabolism
643667|NCT00744302|Parathyroid hormone|parathyroid hormone
643668|NCT00744302|Calcification|calcification
643669|NCT00744302|Cardiovascular disease|cardiovascular disease
643670|NCT00744302|Haemodialysis|haemodialysis
643671|NCT00744315|myocardial revascularization|myocardial revascularization
643672|NCT00744315|myocardial ischemia|myocardial ischemia
643673|NCT00744315|genetics, medical|genetics, medical
643674|NCT00744315|Angiogenesis Inducing Agents|angiogenesis inducing agents
643675|NCT00744328|Postpartum depression|postpartum depression
643676|NCT00744328|estradiol|estradiol
643677|NCT00744328|Postpartum major depressive disorder|postpartum major depressive disorder
643678|NCT00744341|SLV320; Acute Decompensated Heart Failure (ADHF); chronic heart failure; renal failure; I.V. doses; hospitalization|slv320; acute decompensated heart failure (adhf); chronic heart failure; renal failure; i.v. doses; hospitalization
643679|NCT00744354|refractory multiple myeloma|refractory multiple myeloma
643680|NCT00744354|stage I multiple myeloma|stage i multiple myeloma
643681|NCT00744354|stage II multiple myeloma|stage ii multiple myeloma
643682|NCT00744354|stage III multiple myeloma|stage iii multiple myeloma
643683|NCT00744380|Analgesia|analgesia
643684|NCT00744380|Mechanical ventilation|mechanical ventilation
643685|NCT00744393|sleep|sleep
643686|NCT00744393|critically ill|critically ill
643687|NCT00744393|mechanical ventilation|mechanical ventilation
643688|NCT00744406|recurrent depression|recurrent depression
643689|NCT00744406|major depressive disorder|major depressive disorder
643690|NCT00744406|interpersonal therapy|interpersonal therapy
643691|NCT00744406|cognitive behavioral therapy|cognitive behavioral therapy
643692|NCT00744406|antidepressant treatment|antidepressant treatment
643693|NCT00744406|outcome predictors|outcome predictors
643694|NCT00744406|personality dimensions|personality dimensions
643695|NCT00744419|GERD|gerd
643696|NCT00744419|pharmacokinetics|pharmacokinetics
643697|NCT00744419|pantoprazole|pantoprazole
643698|NCT00744419|neonates|neonates
643699|NCT00744419|infants|infants
643700|NCT00744445|hemodialysis|hemodialysis
643701|NCT00744445|erythropoietin|erythropoietin
643702|NCT00744458|Primary Health care in rural Africa|primary health care in rural africa
643703|NCT00744458|Chronic non-communicable diseases|chronic non-communicable diseases
644332|NCT00752544|TMC435350|tmc435350
643704|NCT00744458|Patient Compliance|patient compliance
643705|NCT00744458|Treatment adherence|treatment adherence
643706|NCT00744471|monoclonal antibody RN624 PF-04383119 nerve growth factor anti-nerve growth OA|monoclonal antibody rn624 pf-04383119 nerve growth factor anti-nerve growth oa
643707|NCT00744484|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
643708|NCT00744484|COPD|copd
643709|NCT00744484|Physical group training|physical group training
643710|NCT00744484|Water exercise|water exercise
643711|NCT00744484|Cardiorespiratory fitness|cardiorespiratory fitness
643712|NCT00744484|Functional exercise capacity|functional exercise capacity
643713|NCT00744484|Health related quality of life|health related quality of life
643714|NCT00744510|Polycystic Ovary Syndrome|polycystic ovary syndrome
643715|NCT00744510|Reflexology|reflexology
643716|NCT00744510|Complementary and Alternative Medicine|complementary and alternative medicine
643717|NCT00744510|Endocrinopathy|endocrinopathy
643718|NCT00744510|Oligo|oligo
643719|NCT00744510|Amenorrhoea|amenorrhoea
643720|NCT00744523|carotid artery stenting|carotid artery stenting
643721|NCT00744523|stroke|stroke
643722|NCT00744523|cerebral protection|cerebral protection
643723|NCT00744523|high surgical risk|high surgical risk
643724|NCT00744536|Myelodysplastic syndrome|myelodysplastic syndrome
643725|NCT00744536|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
643726|NCT00744536|High intermediate risk and high risk IPSS score|high intermediate risk and high risk ipss score
643727|NCT00744536|Angiogenesis|angiogenesis
643728|NCT00744536|Metronomic chemotherapy|metronomic chemotherapy
643729|NCT00744536|Myelodysplastic Myeloproliferative Diseases|myelodysplastic myeloproliferative diseases
643730|NCT00744549|Male Urogenital Diseases|male urogenital diseases
643731|NCT00744549|Antioxidants|antioxidants
643732|NCT00744549|Vitamin E|vitamin e
643733|NCT00744549|Vitamin D|vitamin d
643734|NCT00744549|Lycopene|lycopene
643735|NCT00744549|Selenium|selenium
643736|NCT00744562|Phase 1,|phase 1,
643737|NCT00744562|dose escalation,|dose escalation,
643738|NCT00744562|histologically|histologically
643739|NCT00744562|confirmed|confirmed
643740|NCT00744562|malignancy|malignancy
643741|NCT00744562|metastatic|metastatic
643742|NCT00744575|back pain|back pain
643743|NCT00744575|eeg|eeg
643744|NCT00744575|chronic pain|chronic pain
643745|NCT00744588|substance abuse|substance abuse
643746|NCT00744588|alcohol dependence|alcohol dependence
643747|NCT00744588|hypothalamic-pituitary-adrenal (HPA) system|hypothalamic-pituitary-adrenal (hpa) system
643748|NCT00744588|cosyntropin|cosyntropin
643749|NCT00744588|corticotropin-releasing Hormone (CRH)|corticotropin-releasing hormone (crh)
643750|NCT00744588|pituitary-adrenal system|pituitary-adrenal system
643751|NCT00744588|stress|stress
643752|NCT00744588|trauma|trauma
643753|NCT00744588|neurosteroids|neurosteroids
643754|NCT00744588|cortisol|cortisol
643755|NCT00744588|relapse|relapse
643756|NCT00744601|impulsivity|impulsivity
643757|NCT00744601|cocaine dependence|cocaine dependence
643758|NCT00744601|relapse|relapse
643759|NCT00744601|neuroimaging|neuroimaging
643760|NCT00744601|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
643761|NCT00744601|single photon emission computed tomography (SPECT)|single photon emission computed tomography (spect)
643762|NCT00744614|PC02|pc02
643763|NCT00744614|Respiratory Rate|respiratory rate
643764|NCT00744614|Arterial blood gas|arterial blood gas
643765|NCT00744614|Intubation|intubation
643766|NCT00744614|Capnography|capnography
643767|NCT00744627|Generalized Anxiety Disorder|generalized anxiety disorder
643768|NCT00744627|Anxiety Disorders|anxiety disorders
643769|NCT00744627|Drug Therapy|drug therapy
643770|NCT00744640|advanced pancreatic cancer|advanced pancreatic cancer
643771|NCT00744640|palliative chemotherapy|palliative chemotherapy
643772|NCT00744640|first-line therapy|first-line therapy
643773|NCT00744640|capecitabine|capecitabine
643774|NCT00744640|oxaliplatin|oxaliplatin
643775|NCT00744640|gemcitabine|gemcitabine
643776|NCT00744640|dose-finding study|dose-finding study
643777|NCT00744640|Phase II|phase ii
643778|NCT00744653|Breast Cancer|breast cancer
643779|NCT00744653|Recurrence|recurrence
643780|NCT00744666|Intravitreal triamcinolone acetonide|intravitreal triamcinolone acetonide
643781|NCT00744666|Side-effects|side-effects
643782|NCT00744666|Ocular hypertension|ocular hypertension
643783|NCT00744666|Glaucoma|glaucoma
643784|NCT00744666|Prevention|prevention
643785|NCT00744666|Vitreoretinal diseases requiring IVTA for treatment|vitreoretinal diseases requiring ivta for treatment
643786|NCT00744679|MS|ms
643787|NCT00744679|Multiple Sclerosis|multiple sclerosis
643788|NCT00744692|Immunodeficiencies|immunodeficiencies
643789|NCT00744692|Congenital Marrow Failures|congenital marrow failures
643790|NCT00744692|Hemoglobinopathies|hemoglobinopathies
643791|NCT00744692|Inborn Errors of Metabolism|inborn errors of metabolism
643792|NCT00744692|SCIDS|scids
643793|NCT00744692|Wiskott Aldrich|wiskott aldrich
643794|NCT00744692|FEL|fel
643795|NCT00744692|HLH|hlh
643796|NCT00744692|IPEX|ipex
643797|NCT00744692|LAD|lad
643798|NCT00744692|Sickle Cell|sickle cell
643799|NCT00744692|Thalassemia|thalassemia
643800|NCT00744692|Omenn's Syndrome|omenn's syndrome
643801|NCT00744692|Hurler's Syndrome|hurler's syndrome
643802|NCT00744692|MLD|mld
643803|NCT00744692|ALD|ald
643804|NCT00744692|Sanfilippo|sanfilippo
643805|NCT00744692|Krabbe|krabbe
643806|NCT00744692|Hunter's syndrome|hunter's syndrome
643807|NCT00744692|TaySachs|taysachs
643808|NCT00744692|Diamond Blackfan Anemia|diamond blackfan anemia
643809|NCT00744692|transplant|transplant
643810|NCT00744692|MPS|mps
643811|NCT00744692|Gaucher|gaucher
643812|NCT00744705|Retinal nerve fiber layer|retinal nerve fiber layer
643813|NCT00744705|Glaucoma|glaucoma
643814|NCT00744705|Myopia|myopia
643815|NCT00744731|Partial-onset Seizures|partial-onset seizures
643816|NCT00744731|Simple Partial Seizures|simple partial seizures
643817|NCT00744731|Complex Partial Seizures|complex partial seizures
643818|NCT00744744|stage 0 bladder cancer|stage 0 bladder cancer
643819|NCT00744757|5-aza-2'-deoxycytidine|5-aza-2'-deoxycytidine
643820|NCT00744757|decitabine|decitabine
643821|NCT00744757|dacogen|dacogen
643822|NCT00744757|Myelodysplastic Syndrome|myelodysplastic syndrome
643823|NCT00744770|TMC278-TiDP6-C121|tmc278-tidp6-c121
643824|NCT00744770|TMC278-C121|tmc278-c121
643825|NCT00744770|open-label|open-label
643826|NCT00744770|drug-drug interaction|drug-drug interaction
643827|NCT00744770|methadone|methadone
643828|NCT00744770|TMC278|tmc278
643829|NCT00744796|Endothelial Dystrophy|endothelial dystrophy
643830|NCT00744796|Fuchs' Endothelial Corneal Dystrophy|fuchs' endothelial corneal dystrophy
643831|NCT00744809|TMC278-C152|tmc278-c152
643832|NCT00744809|TMC278-TiDP6-C152|tmc278-tidp6-c152
643833|NCT00744809|Healthy Volunteers|healthy volunteers
643834|NCT00744809|QT/QTc interval|qt/qtc interval
643835|NCT00744822|Lung Transplantation|lung transplantation
643836|NCT00744822|Infections|infections
643837|NCT00744822|Graft Rejection|graft rejection
643838|NCT00744835|atrial fibrillation|atrial fibrillation
643839|NCT00744848|hemorrhoids|hemorrhoids
643840|NCT00744861|Lumbar Fusion|lumbar fusion
643841|NCT00744861|exospine|exospine
643842|NCT00744861|Exo-Spine|exo-spine
643843|NCT00744874|atrial fibrillation|atrial fibrillation
643844|NCT00744887|TMC114-TiDP3-C181|tmc114-tidp3-c181
643845|NCT00744887|TMC114-C181, health volunteers, Darunavir, ritonavir oral solution|tmc114-c181, health volunteers, darunavir, ritonavir oral solution
643846|NCT00744900|Pemetrexed, Non-Small Cell Lung Cancer, brain metastasis|pemetrexed, non-small cell lung cancer, brain metastasis
643847|NCT00744913|Pregnancy|pregnancy
643848|NCT00744913|Women|women
643849|NCT00744913|Nicotine replacement therapy|nicotine replacement therapy
643850|NCT00744913|Smoking cessation|smoking cessation
643851|NCT00744939|Gadolinium|gadolinium
643852|NCT00744939|NSF|nsf
643853|NCT00744939|Renal Impairment|renal impairment
643854|NCT00744939|chemically induced|chemically induced
643855|NCT00744939|adverse effects|adverse effects
643856|NCT00744939|Contrast Media|contrast media
643857|NCT00744939|complications|complications
643858|NCT00744952|Large-vessel vasculitis|large-vessel vasculitis
643859|NCT00744978|Efficacy|efficacy
643860|NCT00744978|Safety|safety
643861|NCT00744978|Pharmacokinetics|pharmacokinetics
643862|NCT00744978|Alzheimer's disease|alzheimer's disease
643863|NCT00745004|IBS D|ibs d
643864|NCT00745017|recurrent depression|recurrent depression
643865|NCT00745017|major depressive disorder|major depressive disorder
643866|NCT00745017|interpersonal therapy|interpersonal therapy
643867|NCT00745017|cognitive behavioral therapy|cognitive behavioral therapy
643868|NCT00745017|antidepressant therapies|antidepressant therapies
643869|NCT00745017|outome predictors|outome predictors
643870|NCT00745017|personality dimensions|personality dimensions
643871|NCT00745030|Parkinson's disease|parkinson's disease
643872|NCT00745030|Multiple Systems Atrophy|multiple systems atrophy
643873|NCT00745030|Lewy Body Dementia|lewy body dementia
643874|NCT00745043|COPD|copd
643875|NCT00745043|Betablockers|betablockers
643876|NCT00745043|bronchodilator|bronchodilator
643877|NCT00745043|exercise capacity|exercise capacity
643878|NCT00745043|methacholine challenge|methacholine challenge
643879|NCT00745056|Cognition|cognition
643880|NCT00745056|Memory|memory
643881|NCT00745056|Hormone Therapy|hormone therapy
643882|NCT00745056|HT|ht
643883|NCT00745069|Tapentadol|tapentadol
643884|NCT00745069|Osteoarthritis|osteoarthritis
643885|NCT00745069|Analgesia|analgesia
643886|NCT00745069|Chronic pain|chronic pain
643887|NCT00745095|Safety|safety
643888|NCT00745095|Efficacy|efficacy
643889|NCT00745095|Colonoscopy|colonoscopy
643890|NCT00745095|PIEE|piee
643891|NCT00745095|MoviPrep|moviprep
643892|NCT00745095|Neostigmine|neostigmine
643893|NCT00745095|Glycopyrrolate|glycopyrrolate
643894|NCT00745134|Rectum|rectum
643895|NCT00745134|Rectal Cancer|rectal cancer
643896|NCT00745134|Colon Cancer|colon cancer
643897|NCT00745134|Curcumin|curcumin
643898|NCT00745134|Diferuloylmethane|diferuloylmethane
643899|NCT00745134|Capecitabine|capecitabine
643900|NCT00745134|Radiation Therapy|radiation therapy
643901|NCT00745134|RT|rt
643902|NCT00745134|XRT|xrt
644329|NCT00752518|relapse|relapse
643903|NCT00745134|Surgery for Rectal Cancer|surgery for rectal cancer
643904|NCT00745147|constipation|constipation
643905|NCT00745147|traditional Chinese medicine|traditional chinese medicine
643906|NCT00745147|Chinese herbal formula|chinese herbal formula
643907|NCT00745147|lactulose|lactulose
643908|NCT00745147|cost-effective|cost-effective
643909|NCT00745147|long-term care|long-term care
643910|NCT00745160|Questionaires|questionaires
643911|NCT00745199|End Stage Renal Disease|end stage renal disease
643912|NCT00745199|Cromolyn Sodium|cromolyn sodium
643913|NCT00745199|Pruritus|pruritus
643914|NCT00745199|Tryptase|tryptase
643915|NCT00745212|venous thromboembolism diseases|venous thromboembolism diseases
643916|NCT00745212|placental vascular pathologies|placental vascular pathologies
643917|NCT00745212|antithrombotic treatment|antithrombotic treatment
643918|NCT00745212|symptomatic thromboembolic events|symptomatic thromboembolic events
643919|NCT00745212|pregnant women|pregnant women
643920|NCT00745212|score|score
643921|NCT00745212|therapeutic strategies|therapeutic strategies
643922|NCT00745212|heparin|heparin
643923|NCT00745212|aspirin|aspirin
643924|NCT00745212|pregnancy pathology|pregnancy pathology
643925|NCT00745225|peritoneal dialysis, cardiovascular, PPAR-gamma|peritoneal dialysis, cardiovascular, ppar-gamma
643926|NCT00745238|endothelial function|endothelial function
643927|NCT00745238|peripheral arterial tone|peripheral arterial tone
643928|NCT00745238|systemic inflammation|systemic inflammation
643929|NCT00745238|oxidative stress|oxidative stress
643930|NCT00745238|respiratory and peripheral muscular function|respiratory and peripheral muscular function
643931|NCT00745251|Sleep apnea; obesity|sleep apnea; obesity
643932|NCT00745264|heat|heat
643933|NCT00745264|exercise|exercise
643934|NCT00745277|carbidopa|carbidopa
643935|NCT00745277|levodopa|levodopa
643936|NCT00745277|Parkinson's disease|parkinson's disease
643937|NCT00745290|Total knee arthroplasty|total knee arthroplasty
643938|NCT00745290|Pain|pain
643939|NCT00745290|Analgesia|analgesia
643940|NCT00745303|Tai Chi Chuan; Lipid; Cytokine|tai chi chuan; lipid; cytokine
643941|NCT00751309|allograft|allograft
643942|NCT00751309|rejection|rejection
643943|NCT00751309|biopsy|biopsy
643944|NCT00751309|gene|gene
643945|NCT00751309|expression|expression
643946|NCT00751309|pulmonary|pulmonary
643947|NCT00751309|lung|lung
643948|NCT00751309|transplant|transplant
643949|NCT00751322|Pulmonary|pulmonary
643950|NCT00751322|Protein|protein
643951|NCT00751335|Obstructive Sleep Apnea|obstructive sleep apnea
643952|NCT00751335|Humidification|humidification
643953|NCT00751335|Continuous Positive Airway Pressure|continuous positive airway pressure
643954|NCT00751348|second year of life|second year of life
643955|NCT00751348|one-dose schedule|one-dose schedule
643956|NCT00751348|varicella|varicella
643957|NCT00751348|rubella|rubella
643958|NCT00751348|measles|measles
643959|NCT00751348|mumps|mumps
643960|NCT00751361|Rheopheresis|rheopheresis
643961|NCT00751361|Dry Age Related Macular Degeneration|dry age related macular degeneration
643963|NCT00751361|apheresis|apheresis
643964|NCT00751361|microcirculation|microcirculation
643965|NCT00751400|Non-prescription|non-prescription
643966|NCT00751426|Interferon-alpha|interferon-alpha
643967|NCT00751426|hepatitis c|hepatitis c
643968|NCT00751426|Drug addiction|drug addiction
643969|NCT00751426|methadone|methadone
643970|NCT00751426|psychiatric disorder|psychiatric disorder
643971|NCT00751426|Safety and efficacy of Interferon-alpha i patients with a psychiatric disorder.|safety and efficacy of interferon-alpha i patients with a psychiatric disorder.
643972|NCT00751439|Oximeter|oximeter
643973|NCT00751439|Arterial blood gas|arterial blood gas
643974|NCT00751439|comparison|comparison
643975|NCT00751452|Children|children
643976|NCT00751452|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
643977|NCT00751452|Intestinal damage|intestinal damage
643978|NCT00751452|Citrulline|citrulline
643979|NCT00751452|Graft versus Host Disease|graft versus host disease
643980|NCT00751452|0 to 18 years old|0 to 18 years old
643981|NCT00751465|Social Anxiety Disorder|social anxiety disorder
643982|NCT00751465|Social Phobia|social phobia
643983|NCT00751465|Fear of blushing|fear of blushing
643984|NCT00751465|attention|attention
643985|NCT00751465|attention training|attention training
643986|NCT00751465|cognitive behavior therapy|cognitive behavior therapy
643987|NCT00751478|ALO-01|alo-01
643988|NCT00751478|morphine|morphine
643989|NCT00751478|Determination of the relative pharmacodynamic effects|determination of the relative pharmacodynamic effects
643990|NCT00751478|(including drug-liking), pharmacokinetics, and safety of|(including drug-liking), pharmacokinetics, and safety of
643991|NCT00751478|ALO-01 when administered whole or crushed and compared to|alo-01 when administered whole or crushed and compared to
643992|NCT00751478|equivalent doses of immediate release morphine and placebo|equivalent doses of immediate release morphine and placebo
643993|NCT00751491|Stable angina|stable angina
643994|NCT00751491|Percutaneous Coronary Intervention|percutaneous coronary intervention
643995|NCT00751491|Myonecrosis|myonecrosis
643996|NCT00751504|Quetiapine|quetiapine
643997|NCT00751504|Psychotic depression|psychotic depression
643999|NCT00751517|Cyclophosphamide|cyclophosphamide
644000|NCT00751517|Methotrexate|methotrexate
644001|NCT00751517|Systemic Necrotizing Vasculitides|systemic necrotizing vasculitides
644002|NCT00751530|HIV|hiv
644003|NCT00751530|AIDS|aids
644004|NCT00751530|raltegravir|raltegravir
644005|NCT00751530|BRAVO|bravo
644006|NCT00751530|protease inhibitor|protease inhibitor
644007|NCT00751530|treatment Experienced|treatment experienced
644008|NCT00751543|To evaluate the longitudinal change of tumor perfusion in the course of radiation therapy in adenocarcinoma and squamous cell carcinoma using perfusion MDCT|to evaluate the longitudinal change of tumor perfusion in the course of radiation therapy in adenocarcinoma and squamous cell carcinoma using perfusion mdct
644009|NCT00751543|Comparison between adenocarcinoma and squamous cell carcinoma will be evaluated according to the derived perfusion parameter obtained from perfusion MDCT|comparison between adenocarcinoma and squamous cell carcinoma will be evaluated according to the derived perfusion parameter obtained from perfusion mdct
644010|NCT00751556|Naproxen Sodium|naproxen sodium
644011|NCT00751556|Bioavailability|bioavailability
644012|NCT00751569|umbilical cord blood|umbilical cord blood
644013|NCT00751582|nutrition|nutrition
644014|NCT00751582|education|education
644015|NCT00751582|supplementation|supplementation
644016|NCT00751595|HIV|hiv
644017|NCT00751595|Tat protein|tat protein
644018|NCT00751595|Therapeutic vaccine|therapeutic vaccine
644019|NCT00751595|HAART|haart
644020|NCT00751595|HIV Therapeutic Vaccine|hiv therapeutic vaccine
644021|NCT00751595|Treatment Experienced|treatment experienced
644022|NCT00751608|Familial hypercholesterolemia, endothelial function, venous occlusion plethysmography, forearm blood flow, ApoAI-mimetic, endothelial dependent vasodilation|familial hypercholesterolemia, endothelial function, venous occlusion plethysmography, forearm blood flow, apoai-mimetic, endothelial dependent vasodilation
644023|NCT00751621|Immune globulin subcutaneous|immune globulin subcutaneous
644024|NCT00751621|SCIG|scig
644025|NCT00751621|primary immunodeficiency|primary immunodeficiency
644026|NCT00751621|PID|pid
644027|NCT00751634|subarachnoid hemorrhage|subarachnoid hemorrhage
645398|NCT00759603|SLL|sll
644028|NCT00751634|intracerebral hemorrhage|intracerebral hemorrhage
644029|NCT00751634|fever|fever
644030|NCT00751790|triptorelin, 6-month formulation, advanced prostate cancer|triptorelin, 6-month formulation, advanced prostate cancer
644031|NCT00751816|musculoskeletal complications|musculoskeletal complications
644032|NCT00751816|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
644033|NCT00751816|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
644034|NCT00751816|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
644035|NCT00751816|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
644036|NCT00751816|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
644037|NCT00751816|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
644038|NCT00751816|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
644039|NCT00751816|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
644040|NCT00751816|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
644041|NCT00751816|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
644042|NCT00751816|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
644043|NCT00751816|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
644044|NCT00751816|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
644045|NCT00751816|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
644046|NCT00751816|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
644047|NCT00751816|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
644048|NCT00751816|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
644049|NCT00751816|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
644050|NCT00751816|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
644051|NCT00751816|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
644052|NCT00751816|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
644053|NCT00751816|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
644054|NCT00751816|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
644055|NCT00751816|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
644056|NCT00751816|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
644057|NCT00751816|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
644058|NCT00751816|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
644059|NCT00751816|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
644060|NCT00751816|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
644061|NCT00751816|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
644062|NCT00751816|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
644526|NCT00753324|Pregnancy|pregnancy
644124|NCT00751894|Bone marrow transplantation|bone marrow transplantation
644063|NCT00751816|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
644064|NCT00751816|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
644065|NCT00751816|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
644066|NCT00751816|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
644067|NCT00751816|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
644068|NCT00751816|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
644069|NCT00751816|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
644070|NCT00751816|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
644071|NCT00751816|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
644072|NCT00751816|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
644073|NCT00751816|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
644074|NCT00751816|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
644075|NCT00751816|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
644076|NCT00751816|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
644077|NCT00751816|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
644078|NCT00751816|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
644079|NCT00751816|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
644080|NCT00751816|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
644081|NCT00751816|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
644082|NCT00751816|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
644083|NCT00751816|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
644084|NCT00751816|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
644085|NCT00751816|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
644086|NCT00751816|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
644087|NCT00751816|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
644088|NCT00751816|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
644089|NCT00751816|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
644090|NCT00751816|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
644091|NCT00751816|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
644092|NCT00751816|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
644093|NCT00751816|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
644094|NCT00751816|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
644095|NCT00751816|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
644096|NCT00751816|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
644097|NCT00751816|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
644098|NCT00751816|salivary gland acinic cell tumor|salivary gland acinic cell tumor
644099|NCT00751816|salivary gland adenocarcinoma|salivary gland adenocarcinoma
644100|NCT00751816|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
644101|NCT00751816|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
644102|NCT00751816|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
644204|NCT00752128|Drug Eluting Stent|drug eluting stent
644103|NCT00751816|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
644104|NCT00751816|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
644105|NCT00751816|stage I salivary gland cancer|stage i salivary gland cancer
644106|NCT00751816|stage II salivary gland cancer|stage ii salivary gland cancer
644107|NCT00751816|stage III salivary gland cancer|stage iii salivary gland cancer
644108|NCT00751816|stage IV salivary gland cancer|stage iv salivary gland cancer
644109|NCT00751842|Diabetes|diabetes
644110|NCT00751842|Juvenile Diabetes|juvenile diabetes
644111|NCT00751842|Diabetes type 1|diabetes type 1
644112|NCT00751842|Autoimmune Diabetes|autoimmune diabetes
644113|NCT00751842|Insulin dependent Diabetes|insulin dependent diabetes
644114|NCT00751842|Type 1 diabetes|type 1 diabetes
644115|NCT00751842|Type 1 diabetes mellitus|type 1 diabetes mellitus
644116|NCT00751842|Diamyd|diamyd
644117|NCT00751842|rhGAD65|rhgad65
644119|NCT00751842|GAD-alum|gad-alum
644120|NCT00751868|breast cancer|breast cancer
644121|NCT00751881|relapsing multiple sclerosis|relapsing multiple sclerosis
644122|NCT00751894|Children|children
644123|NCT00751894|cancer|cancer
644125|NCT00751894|Stem cell mobilization|stem cell mobilization
644126|NCT00751894|G-CSF|g-csf
644127|NCT00751894|Children with solid malignancies|children with solid malignancies
644128|NCT00751907|Cerebral blood flow|cerebral blood flow
644129|NCT00751920|Magnetic Resonance Imaging|magnetic resonance imaging
644130|NCT00751920|Pediatrics|pediatrics
644131|NCT00751920|Multi-Detector Computed Tomography|multi-detector computed tomography
644132|NCT00751920|Computed Tomography|computed tomography
644133|NCT00751920|Detection|detection
644134|NCT00751933|Ulcerative colitis|ulcerative colitis
644135|NCT00751933|Vaccines|vaccines
644136|NCT00751933|Oats|oats
644137|NCT00751946|Posttraumatic Stress Disorder|posttraumatic stress disorder
644138|NCT00751946|PTSD|ptsd
644139|NCT00751946|psychotherapy|psychotherapy
644140|NCT00751946|adolescents|adolescents
644141|NCT00751946|clinical trial|clinical trial
644142|NCT00751959|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
644143|NCT00751959|extremely preterm infant|extremely preterm infant
644144|NCT00751959|Idiopathic respiratory distress syndrome (IRDS)|idiopathic respiratory distress syndrome (irds)
644145|NCT00751959|Surfactant|surfactant
644146|NCT00751985|Heavy drinking|heavy drinking
644147|NCT00751985|Ultra-brief intervention|ultra-brief intervention
644148|NCT00751985|Brief intervention|brief intervention
644149|NCT00751985|Alcohol prevention|alcohol prevention
644150|NCT00751985|Randomized trial|randomized trial
644151|NCT00751985|Personal normative feedback|personal normative feedback
644152|NCT00751985|Self-help material|self-help material
644153|NCT00751985|Web-based|web-based
644154|NCT00751985|Intervention Studies|intervention studies
644155|NCT00751985|prevention & control|prevention & control
644156|NCT00751998|biliary|biliary
644157|NCT00751998|ERCP|ercp
644158|NCT00751998|cholangioscopy|cholangioscopy
644159|NCT00751998|pancreatic|pancreatic
644160|NCT00752011|Cancer|cancer
644161|NCT00752011|Solid Tumors|solid tumors
644162|NCT00752011|Advanced Cancer|advanced cancer
644163|NCT00752011|Carboplatin|carboplatin
644164|NCT00752011|Paraplatin|paraplatin
644165|NCT00752011|TAS-106|tas-106
644166|NCT00752011|Antitumor Activity|antitumor activity
644167|NCT00752011|Biomarkers|biomarkers
644168|NCT00752024|HICH|hich
644169|NCT00752024|Suction drainages|suction drainages
644170|NCT00752024|TTAC|ttac
644172|NCT00752037|Protease Inhibitor|protease inhibitor
644173|NCT00752037|Integrase Inhibitor|integrase inhibitor
644174|NCT00752037|Treatment Experienced|treatment experienced
644175|NCT00752037|Naive|naive
644176|NCT00752050|Botulinum Toxin Type A|botulinum toxin type a
644177|NCT00752050|Botulinum Toxin|botulinum toxin
644178|NCT00752050|Glabellar Rhytides|glabellar rhytides
644179|NCT00752050|Rhytides|rhytides
644180|NCT00752050|Frown Lines|frown lines
644181|NCT00752050|Neuromuscular Agents|neuromuscular agents
644182|NCT00752050|Neurotoxin|neurotoxin
644183|NCT00752050|Forehead|forehead
644184|NCT00752050|Eyebrow|eyebrow
644185|NCT00752050|Wrinkle|wrinkle
644186|NCT00752063|Sorafenib|sorafenib
644187|NCT00752063|Capecitabine|capecitabine
644188|NCT00752063|Oxaliplatin|oxaliplatin
644189|NCT00752063|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
644190|NCT00752063|Metastatic Hepatocellular Carcinoma|metastatic hepatocellular carcinoma
644191|NCT00752076|EGFR mutation|egfr mutation
644192|NCT00752076|NSCLC cell line|nsclc cell line
644193|NCT00752076|Malignant pleural effusion|malignant pleural effusion
644194|NCT00752089|enamel fluoride uptake|enamel fluoride uptake
644195|NCT00752089|erosion|erosion
644196|NCT00752089|enamel remineralization|enamel remineralization
644197|NCT00752102|Secondary Hyperparathryoidism|secondary hyperparathryoidism
644198|NCT00752102|Chronic Kidney Disease|chronic kidney disease
644199|NCT00752102|Vitamin D|vitamin d
644200|NCT00752102|Coronary Calcification|coronary calcification
644201|NCT00752102|Bone metabolism|bone metabolism
644202|NCT00752115|non-small cell lung cancer|non-small cell lung cancer
644203|NCT00752115|previously untreated|previously untreated
644205|NCT00752128|Interventional Cardiology|interventional cardiology
644206|NCT00752128|Percutaneous Coronary Intervention|percutaneous coronary intervention
644207|NCT00752154|Subjects|subjects
644208|NCT00752154|active|active
644209|NCT00752154|Rheumatoid|rheumatoid
644210|NCT00752154|Arthritis|arthritis
644211|NCT00752154|revised|revised
644212|NCT00752154|American|american
644213|NCT00752154|College|college
644214|NCT00752154|Rheumatology|rheumatology
644215|NCT00752154|Criteria|criteria
644216|NCT00752167|exercise induced bronchospasm|exercise induced bronchospasm
644217|NCT00752167|asthma|asthma
644218|NCT00752167|athlete|athlete
644219|NCT00752167|sports|sports
644220|NCT00752167|eucapnic voluntary hyperventilation|eucapnic voluntary hyperventilation
644221|NCT00752167|albuterol|albuterol
644222|NCT00752180|pharmacokinetics|pharmacokinetics
644223|NCT00752180|pharmacodynamics|pharmacodynamics
644224|NCT00752180|type 1 diabetics|type 1 diabetics
644225|NCT00752180|recombinant human insulin|recombinant human insulin
644226|NCT00752206|AZD0530|azd0530
644228|NCT00752206|Osteosarcoma|osteosarcoma
644229|NCT00752206|Recurrent|recurrent
644230|NCT00752206|Localized|localized
644231|NCT00752206|to the Lung|to the lung
644232|NCT00752232|Phase IIa|phase iia
644233|NCT00752232|multiple ascending dose study of ACC-001|multiple ascending dose study of acc-001
644234|NCT00752245|ICU patients with acute renal failure with sepsis/multi-organ failure|icu patients with acute renal failure with sepsis/multi-organ failure
644235|NCT00752258|Botulinum Toxin Type A|botulinum toxin type a
644236|NCT00752258|Botulinum Toxin|botulinum toxin
644237|NCT00752258|Glabellar Rhytides|glabellar rhytides
644238|NCT00752258|Rhytides|rhytides
644239|NCT00752258|Frown Lines|frown lines
644240|NCT00752258|Neuromuscular Agents|neuromuscular agents
644241|NCT00752258|Neurotoxin|neurotoxin
644242|NCT00752258|Forehead|forehead
644243|NCT00752258|Eyebrow|eyebrow
644244|NCT00752258|Wrinkle|wrinkle
644245|NCT00752258|Frown Lines Between the Eyebrows|frown lines between the eyebrows
644246|NCT00752271|Arthroscopic|arthroscopic
644247|NCT00752284|coronectomy|coronectomy
644248|NCT00752284|neurosensory deficit|neurosensory deficit
644249|NCT00752284|third molar surgery|third molar surgery
644250|NCT00752297|Botulinum Toxin Type A|botulinum toxin type a
644251|NCT00752297|Botulinum Toxin|botulinum toxin
644252|NCT00752297|Glabellar Rhytides|glabellar rhytides
644253|NCT00752297|Rhytides|rhytides
644254|NCT00752297|Frown Lines|frown lines
644255|NCT00752297|Neuromuscular Agents|neuromuscular agents
644256|NCT00752297|Neurotoxin|neurotoxin
644257|NCT00752297|Forehead|forehead
644258|NCT00752297|Eyebrow|eyebrow
644259|NCT00752297|Wrinkle|wrinkle
644260|NCT00752310|TMC114-TiDP29-C169|tmc114-tidp29-c169
644261|NCT00752310|TMC114-C169|tmc114-c169
644262|NCT00752310|Darunavir (suspension formulation)|darunavir (suspension formulation)
644263|NCT00752323|adult giant cell glioblastoma|adult giant cell glioblastoma
644264|NCT00752323|adult glioblastoma|adult glioblastoma
644265|NCT00752323|adult gliosarcoma|adult gliosarcoma
644266|NCT00752323|recurrent adult brain tumor|recurrent adult brain tumor
644267|NCT00752336|HRQoL|hrqol
644268|NCT00752336|exercise capacity|exercise capacity
644269|NCT00752349|Videofluoroscopic|videofluoroscopic
644270|NCT00752349|swallowing|swallowing
644271|NCT00752349|study|study
644272|NCT00752349|(VFSS)|(vfss)
644273|NCT00752349|ultrasound|ultrasound
644274|NCT00752362|Supralimus®,|supralimus®,
644275|NCT00752362|Infinnium®,|infinnium®,
644276|NCT00752362|Matrix®,|matrix®,
644277|NCT00752362|Restenosis|restenosis
644278|NCT00752362|Percutaneous|percutaneous
644279|NCT00752362|Revascularization|revascularization
644280|NCT00752362|Techniques|techniques
644281|NCT00752362|Metallic|metallic
644282|NCT00752362|Platform|platform
644283|NCT00752362|Agents|agents
644284|NCT00752362|Antiproliferative|antiproliferative
644285|NCT00752362|Properties|properties
644286|NCT00752375|pyelonephritis|pyelonephritis
644287|NCT00752375|pediatric pyelonephritis|pediatric pyelonephritis
644288|NCT00752375|vesicoureteral reflux|vesicoureteral reflux
644289|NCT00752375|DMSA scan|dmsa scan
644290|NCT00752401|Vitamin D|vitamin d
644291|NCT00752401|Cholecalciferol|cholecalciferol
644292|NCT00752401|Vitamin D3|vitamin d3
644293|NCT00752401|25-hydroxyvitamin D3|25-hydroxyvitamin d3
644294|NCT00752401|Immunomodulation|immunomodulation
644295|NCT00752401|Vitamin D deficiency|vitamin d deficiency
644296|NCT00752401|Kidney transplantation|kidney transplantation
644297|NCT00752401|Renal transplantation|renal transplantation
644298|NCT00752401|Graft function|graft function
644299|NCT00752401|Acute rejection|acute rejection
644300|NCT00752401|Renal osteodystrophy|renal osteodystrophy
644301|NCT00752401|Posttransplant bone loss|posttransplant bone loss
644302|NCT00752414|COPD|copd
644303|NCT00752414|Patients|patients
644304|NCT00752427|Schizophrenia: paliperidone|schizophrenia: paliperidone
644305|NCT00752440|Diabetes Mellitus|diabetes mellitus
644306|NCT00752440|Autonomic Neuropathy|autonomic neuropathy
644307|NCT00752440|Inspiratory Muscle training|inspiratory muscle training
644309|NCT00752453|patients|patients
644310|NCT00752453|lactate|lactate
644311|NCT00752453|acidosis|acidosis
644312|NCT00752466|Healthy volunteers|healthy volunteers
644313|NCT00752466|drug interaction|drug interaction
644314|NCT00752466|Flunarizine|flunarizine
644315|NCT00752466|Topiramate|topiramate
644316|NCT00752466|Migraine|migraine
644317|NCT00752479|living|living
644318|NCT00752479|related|related
644319|NCT00752492|Isocapnic hyperpnoea|isocapnic hyperpnoea
644320|NCT00752492|obesity|obesity
644321|NCT00752492|isoflurane|isoflurane
644322|NCT00752492|Recovery of obese patient from isoflurane anesthesia|recovery of obese patient from isoflurane anesthesia
644323|NCT00752505|Fibromyalgia|fibromyalgia
644324|NCT00752518|bolus|bolus
644325|NCT00752518|intravenous|intravenous
644326|NCT00752518|proteasome inhibitor|proteasome inhibitor
644327|NCT00752518|multiple myeloma|multiple myeloma
644328|NCT00752518|refractory|refractory
644330|NCT00752531|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
644331|NCT00752531|COPD|copd
644335|NCT00752544|TMC435350-TiDP16-C109|tmc435350-tidp16-c109
644336|NCT00752544|TMC435350-C109|tmc435350-c109
644337|NCT00752557|Bone mineral density|bone mineral density
644338|NCT00752557|bone morphogenetic protein|bone morphogenetic protein
644339|NCT00752557|osteoporosis|osteoporosis
644340|NCT00752570|Metastatic Colorectal Cancer|metastatic colorectal cancer
644341|NCT00752570|colorectal cancer|colorectal cancer
644342|NCT00752570|colon cancer|colon cancer
644343|NCT00752583|Chronic renal insufficiency (patients under dialysis)|chronic renal insufficiency (patients under dialysis)
644344|NCT00752596|patients|patients
644345|NCT00752596|with ICD|with icd
644346|NCT00752609|Anemia|anemia
644347|NCT00752609|Drug Therapy|drug therapy
644348|NCT00752609|Hemodialysis|hemodialysis
644349|NCT00752609|Kidney Failure|kidney failure
644350|NCT00752635|TriCilest|tricilest
644351|NCT00752635|acne vulgaris|acne vulgaris
644352|NCT00752648|TMC435350-TiDP16-C106|tmc435350-tidp16-c106
644353|NCT00752648|TMC435350-C106|tmc435350-c106
644354|NCT00752648|Bioavailability|bioavailability
644355|NCT00752648|Pharmacokinetics|pharmacokinetics
644356|NCT00752661|osteoarthritis|osteoarthritis
644357|NCT00752661|low back pain|low back pain
644358|NCT00752661|oral drug|oral drug
644359|NCT00752661|tramadol|tramadol
644360|NCT00752674|Low back pain|low back pain
644361|NCT00752674|physical therapy|physical therapy
644362|NCT00752674|pain|pain
644363|NCT00752687|Phase 1|phase 1
644364|NCT00752700|Patients|patients
644365|NCT00752700|radically|radically
644366|NCT00752700|treated|treated
644367|NCT00752713|AMI,|ami,
644368|NCT00752713|Reperfusion|reperfusion
644369|NCT00752713|successful|successful
644370|NCT00752726|overweight, orlistat, body composition|overweight, orlistat, body composition
644371|NCT00752739|adenocarcinoma of the prostate|adenocarcinoma of the prostate
644372|NCT00752739|stage I prostate cancer|stage i prostate cancer
644373|NCT00752739|stage II prostate cancer|stage ii prostate cancer
644374|NCT00752739|stage III prostate cancer|stage iii prostate cancer
644375|NCT00752739|stage IV prostate cancer|stage iv prostate cancer
644376|NCT00752752|Marathon Running|marathon running
644377|NCT00752752|Cardiac Ischemia|cardiac ischemia
644378|NCT00752752|Magnetic Resonance Imaging|magnetic resonance imaging
644379|NCT00752765|knee osteoarthritis|knee osteoarthritis
644380|NCT00752765|bariatric surgery|bariatric surgery
644381|NCT00752765|weight loss|weight loss
644382|NCT00752765|knee pain|knee pain
644383|NCT00752778|MRI, PET scan|mri, pet scan
644384|NCT00752791|Anemia|anemia
644385|NCT00752791|Drug Therapy|drug therapy
644386|NCT00752791|Peritoneal Dialysis.|peritoneal dialysis.
644387|NCT00752804|ICU patients with acute renal failure after cardiac surgery|icu patients with acute renal failure after cardiac surgery
644388|NCT00752817|Virtual Reality|virtual reality
644389|NCT00752817|Simulator|simulator
644390|NCT00752817|Proficiency|proficiency
644391|NCT00752817|Laparoscopic|laparoscopic
644392|NCT00752817|Colectomy|colectomy
644393|NCT00752817|Education|education
644394|NCT00752817|Surgical Training|surgical training
644395|NCT00752830|AZD0328|azd0328
644396|NCT00752830|Food Effect|food effect
644397|NCT00752843|mifepristone|mifepristone
644398|NCT00752843|CORLUX|corlux
644399|NCT00752843|fluvastatin|fluvastatin
644400|NCT00752843|Lescol|lescol
644401|NCT00752843|drug-drug interaction|drug-drug interaction
644402|NCT00752843|DDI|ddi
644403|NCT00752843|pharmacokinetics|pharmacokinetics
644404|NCT00752856|HIV treatment|hiv treatment
644405|NCT00752856|Treatment-naive|treatment-naive
644406|NCT00752856|Adult|adult
644407|NCT00752869|low testosterone|low testosterone
644408|NCT00752882|Ceftazidime|ceftazidime
644409|NCT00752882|Pharmacokinetics|pharmacokinetics
644410|NCT00752882|Pseudomonas|pseudomonas
644411|NCT00752882|aeruginosa|aeruginosa
644412|NCT00752882|Meningitis|meningitis
644413|NCT00752882|Patients|patients
644414|NCT00752882|hospitalised|hospitalised
644415|NCT00752882|cerebrolesion|cerebrolesion
644416|NCT00752882|acquired|acquired
644417|NCT00752882|pneumopathy|pneumopathy
644418|NCT00752882|mechanic|mechanic
644419|NCT00752882|ventilation|ventilation
644420|NCT00752895|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
644421|NCT00752895|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
644422|NCT00752895|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
644423|NCT00752895|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
644424|NCT00752921|Etoricoxib, Fasting Headache, Headache, Yom Kippur|etoricoxib, fasting headache, headache, yom kippur
644425|NCT00752934|nursing homes|nursing homes
644426|NCT00752934|children|children
644427|NCT00752934|ages 1-18 years|ages 1-18 years
644428|NCT00752934|spastic quadriplegia|spastic quadriplegia
644527|NCT00753324|HIV Infection|hiv infection
644528|NCT00753324|HIV Transmission|hiv transmission
751800|NCT01170520|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
752850|NCT01174472|drug eluting balloon|drug eluting balloon
644429|NCT00752960|single nucleotide polymorphism, SNP, aripiprazole, olanzapine, quetiapine, risperidone, ziprasidone, metabolic syndrome|single nucleotide polymorphism, snp, aripiprazole, olanzapine, quetiapine, risperidone, ziprasidone, metabolic syndrome
644430|NCT00752973|Head Lice|head lice
644436|NCT00752986|Breast Cancer|breast cancer
644437|NCT00752986|Advanced, Metastatic|advanced, metastatic
644438|NCT00752986|Hormone Receptor Positive|hormone receptor positive
644439|NCT00752986|Post-Menopausal Patients|post-menopausal patients
644440|NCT00752986|post-menopausal women with hormone receptor positive advanced breast cancer|post-menopausal women with hormone receptor positive advanced breast cancer
644442|NCT00752999|Lupus|lupus
644443|NCT00753012|cardiovascular testing|cardiovascular testing
644444|NCT00753012|home blood pressure monitoring|home blood pressure monitoring
644445|NCT00753012|office home blood pressure monitoring|office home blood pressure monitoring
644446|NCT00753012|cardiopulmonary exercise testing|cardiopulmonary exercise testing
644447|NCT00753012|transthoracic echocardiography|transthoracic echocardiography
644448|NCT00753012|Lisdexamfetamine|lisdexamfetamine
644449|NCT00753012|Vyvanse|vyvanse
644450|NCT00753012|normotensive and hypertensive adults with ADHD|normotensive and hypertensive adults with adhd
644451|NCT00753012|ADHD medication.|adhd medication.
644452|NCT00753025|lower extremity ischemia|lower extremity ischemia
644453|NCT00753025|Bone marrow|bone marrow
644454|NCT00753025|Progenitor cells|progenitor cells
644455|NCT00753025|Neoangiogenesis|neoangiogenesis
644456|NCT00753038|carcinoma|carcinoma
644457|NCT00753038|squamous cell|squamous cell
644458|NCT00753038|head|head
644459|NCT00753038|neck|neck
644460|NCT00753038|REOLYSIN|reolysin
644461|NCT00753038|chemotherapy|chemotherapy
644462|NCT00753038|Carboplatin|carboplatin
644463|NCT00753038|Paclitaxel|paclitaxel
752377|NCT01172730|Post operative pain|post operative pain
644464|NCT00753051|clozapine-resistant schizophrenics|clozapine-resistant schizophrenics
644465|NCT00753051|haloperidol augmenting clozapine|haloperidol augmenting clozapine
644466|NCT00753051|electroconvulsive therapy augmenting clozapine|electroconvulsive therapy augmenting clozapine
644467|NCT00753064|Red Scorpion envenomation|red scorpion envenomation
644468|NCT00753064|Composite clinical scoring system|composite clinical scoring system
644469|NCT00753064|AScVS|ascvs
644470|NCT00753064|Prazosin|prazosin
644471|NCT00753064|Superiority|superiority
644472|NCT00753103|Infliximab|infliximab
644473|NCT00753103|Vasculitis|vasculitis
644474|NCT00753103|antitnf monoclonal antibody|antitnf monoclonal antibody
644475|NCT00753129|Prone position|prone position
644476|NCT00753129|ALI/ARDS|ali/ards
644477|NCT00753129|Head elevation|head elevation
644478|NCT00753142|Hyperglycemia|hyperglycemia
644479|NCT00753155|HRQoL;|hrqol;
644480|NCT00753155|exercise|exercise
644481|NCT00753155|capacity|capacity
644482|NCT00753168|glaucoma, open angle, ocular hypertension, beta blocker, beta adrenergic, intraocular pressure|glaucoma, open angle, ocular hypertension, beta blocker, beta adrenergic, intraocular pressure
644483|NCT00753194|hearing|hearing
644484|NCT00753194|newborn|newborn
644485|NCT00753194|otoacoustic emissions|otoacoustic emissions
644486|NCT00753207|stage IV breast cancer|stage iv breast cancer
644487|NCT00753207|recurrent breast cancer|recurrent breast cancer
644488|NCT00753220|Metastatic|metastatic
644489|NCT00753220|Androgen|androgen
644490|NCT00753220|Independent|independent
644491|NCT00753220|Prostate Cancer|prostate cancer
644492|NCT00753220|(AIPC),|(aipc),
644493|NCT00753220|Hormone-refractory|hormone-refractory
644494|NCT00753220|(HRPC),|(hrpc),
644495|NCT00753220|cryotherapy,|cryotherapy,
644496|NCT00753220|dendritic cell,|dendritic cell,
644497|NCT00753220|immunotherapy|immunotherapy
644498|NCT00753220|Chemo-naïve|chemo-naïve
644499|NCT00753220|lymph nodes|lymph nodes
644500|NCT00753220|bone|bone
644501|NCT00753233|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
644502|NCT00753233|Children|children
644503|NCT00753233|Sudden Death|sudden death
644504|NCT00753233|Arrhythmias|arrhythmias
644505|NCT00753233|Electrophysiology Study|electrophysiology study
644506|NCT00753246|glioblastoma multiforma|glioblastoma multiforma
644507|NCT00753259|atrial fibrillation|atrial fibrillation
644508|NCT00753259|disease management program|disease management program
644509|NCT00753259|integrated chronic care program|integrated chronic care program
644510|NCT00753259|guideline|guideline
644511|NCT00753259|stroke|stroke
644512|NCT00753259|heart failure|heart failure
644513|NCT00753259|quality of life|quality of life
644514|NCT00753259|costs|costs
644515|NCT00753272|Efficacy|efficacy
644516|NCT00753272|Influenza Vaccines|influenza vaccines
644517|NCT00753272|Influenza|influenza
644518|NCT00753272|Vaccine|vaccine
644519|NCT00753272|Elderly|elderly
644520|NCT00753311|migraine|migraine
644521|NCT00753311|rizatriptan|rizatriptan
644522|NCT00753311|unilateral trigeminal autonomic symptoms|unilateral trigeminal autonomic symptoms
644523|NCT00753311|Migraine with or without aura|migraine with or without aura
644524|NCT00753324|PMTCT|pmtct
644525|NCT00753324|HAART|haart
644529|NCT00753324|HIV Seronegativity|hiv seronegativity
644530|NCT00753350|obesity|obesity
644531|NCT00753363|Glucose Metabolism|glucose metabolism
644532|NCT00753389|Postoperative residual curarization,|postoperative residual curarization,
644533|NCT00753389|muscle relaxants,|muscle relaxants,
644534|NCT00753389|morbidity mortality|morbidity mortality
644535|NCT00753415|Urinary Bladder Neoplasms|urinary bladder neoplasms
644536|NCT00753415|Breast Neoplasms|breast neoplasms
644537|NCT00753415|Renal Cell carcinoma|renal cell carcinoma
644538|NCT00753415|Melanoma|melanoma
644539|NCT00753415|Prostatic Neoplasms|prostatic neoplasms
644540|NCT00753415|Colonic Neoplasms|colonic neoplasms
644541|NCT00753415|Urologic Neoplasms|urologic neoplasms
644542|NCT00753415|Urogenital Neoplasms|urogenital neoplasms
644543|NCT00753415|Urinary Bladder Diseases|urinary bladder diseases
644544|NCT00753415|Urologic Diseases|urologic diseases
644545|NCT00753415|Breast Diseases|breast diseases
644546|NCT00753415|Skin Diseases|skin diseases
644547|NCT00753415|Neoplasms|neoplasms
644548|NCT00753415|Glandular and Epithelial Neoplasms by Histologic Type|glandular and epithelial neoplasms by histologic type
644549|NCT00753415|Adenocarcinoma|adenocarcinoma
644550|NCT00753415|Kidney Neoplasms|kidney neoplasms
644551|NCT00753415|Kidney Diseases|kidney diseases
644552|NCT00753415|Neuroendocrine Tumors|neuroendocrine tumors
644553|NCT00753415|Neuroectodermal Tumors|neuroectodermal tumors
644554|NCT00753415|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
644555|NCT00753415|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
644556|NCT00753415|Nevi and Melanomas|nevi and melanomas
644557|NCT00753415|Genital Neoplasms|genital neoplasms
644558|NCT00753415|Male Genital Diseases|male genital diseases
644559|NCT00753415|Male, Prostatic Diseases|male, prostatic diseases
644560|NCT00753415|Colorectal Neoplasms|colorectal neoplasms
644561|NCT00753415|Intestinal Neoplasms|intestinal neoplasms
644562|NCT00753428|HIV-free survival|hiv-free survival
644563|NCT00753428|Community based evaluation|community based evaluation
644564|NCT00753428|Pregnancy|pregnancy
644565|NCT00753428|Under 2 child survival|under 2 child survival
644566|NCT00753428|PMTCT|pmtct
644567|NCT00753428|Pediatric HIV infection|pediatric hiv infection
644568|NCT00753428|HAART|haart
644569|NCT00753428|Routine ART|routine art
644570|NCT00753428|HIV Seronegativity|hiv seronegativity
644571|NCT00753441|Pancreatic cancer|pancreatic cancer
644572|NCT00753441|Bile duct obstruction|bile duct obstruction
644573|NCT00753441|Stent|stent
644574|NCT00753441|Bypass|bypass
644575|NCT00753454|Rheumatoid Arthritis|rheumatoid arthritis
644576|NCT00753454|Joint Disease|joint disease
644577|NCT00753454|Arthritis|arthritis
644578|NCT00753454|Certolizumab pegol|certolizumab pegol
644579|NCT00753454|Cimzia|cimzia
644580|NCT00753467|HBV|hbv
644581|NCT00753467|Treatment|treatment
644582|NCT00753467|Interferon-gamma|interferon-gamma
644583|NCT00753467|combination|combination
644584|NCT00753467|Hepsera|hepsera
644585|NCT00753467|Actimmune|actimmune
644586|NCT00753467|HBV DNA|hbv dna
644587|NCT00753480|EOC|eoc
644588|NCT00753480|PPC|ppc
644589|NCT00753480|FTC|ftc
644590|NCT00753519|Parkinson's Disease|parkinson's disease
644591|NCT00753519|Brain Stimulation|brain stimulation
644592|NCT00753519|Motor Cortex|motor cortex
644593|NCT00753519|Bradykinesia|bradykinesia
644594|NCT00753519|Parkinson Disease|parkinson disease
644595|NCT00753519|PD|pd
644596|NCT00753532|Carotid artery stenoses|carotid artery stenoses
644597|NCT00753532|Brain ischaemia|brain ischaemia
644598|NCT00753532|stroke|stroke
644599|NCT00753532|Lipid abnormalities|lipid abnormalities
644600|NCT00753532|Fatty Liver|fatty liver
644601|NCT00753545|Serous,|serous,
644602|NCT00753545|Ovarian cancer,|ovarian cancer,
644603|NCT00753545|PARP,|parp,
644604|NCT00753545|BRCA1,|brca1,
644605|NCT00753545|BRCA2,|brca2,
644606|NCT00753545|Poly(ADP ribose) polymerases,|poly(adp ribose) polymerases,
644607|NCT00753545|Platinum sensitive,|platinum sensitive,
644608|NCT00753545|Homologous Recombination Deficiency (HRD)|homologous recombination deficiency (hrd)
644609|NCT00753571|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
644610|NCT00753571|Cistanche Total Glycosides|cistanche total glycosides
644611|NCT00753571|Randomized Control Trial Study|randomized control trial study
644612|NCT00753597|B cell depletion|b cell depletion
644718|NCT00753935|thromboxane|thromboxane
644613|NCT00753597|steroidogenesis|steroidogenesis
644614|NCT00753610|EPC|epc
644615|NCT00753610|CCRT|ccrt
644616|NCT00753610|Cervical cancer|cervical cancer
644617|NCT00753623|Pain|pain
644618|NCT00753623|Neuropathic pain|neuropathic pain
644619|NCT00753623|Pain scores|pain scores
644620|NCT00753636|Parkinson's disease|parkinson's disease
644621|NCT00753636|Isradipine|isradipine
644622|NCT00753636|Neuroprotection|neuroprotection
644623|NCT00753649|Infant|infant
644624|NCT00753649|First nation|first nation
644625|NCT00753649|Aboriginal|aboriginal
644626|NCT00753649|Canada|canada
644627|NCT00753662|TMS AD H2 coil|tms ad h2 coil
644628|NCT00753675|Intrahepatic|intrahepatic
644629|NCT00753675|Cholangiocarcinoma|cholangiocarcinoma
644630|NCT00753675|Vandetanib|vandetanib
644631|NCT00753675|Zactima|zactima
644632|NCT00753675|Advanced|advanced
644633|NCT00753675|Biliary|biliary
644634|NCT00753675|Tract|tract
644635|NCT00753675|Gallbladder|gallbladder
644636|NCT00753675|Extrahepatic Bile Duct|extrahepatic bile duct
644637|NCT00753675|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
644638|NCT00753675|Ampullary Carcinoma|ampullary carcinoma
644743|NCT00754065|Oral contraceptive|oral contraceptive
644639|NCT00753688|metastatic soft-tissue sarcoma|metastatic soft-tissue sarcoma
644640|NCT00753688|pazopanib|pazopanib
644641|NCT00753688|Soft Tissue Sarcoma|soft tissue sarcoma
644642|NCT00753688|placebo|placebo
644643|NCT00753714|ZD6474|zd6474
644644|NCT00753714|VANDETANIB|vandetanib
644645|NCT00753714|ZACTIMA|zactima
644646|NCT00753714|ADVANCED|advanced
644647|NCT00753714|NSCLC|nsclc
644648|NCT00753714|LUNG CANCER|lung cancer
644649|NCT00753714|ELDERLY PATIENTS|elderly patients
644650|NCT00753714|GEMCITABINE|gemcitabine
644651|NCT00753714|PHASE II|phase ii
644652|NCT00753714|RANDOMIZED|randomized
644653|NCT00753714|DOUBLE-BLIND|double-blind
644654|NCT00753714|histologically or cytologically-confirmed advanced (stage IIIB with supraclavicular lymph node metastases or pleural effusion or stage IV) NSCLC|histologically or cytologically-confirmed advanced (stage iiib with supraclavicular lymph node metastases or pleural effusion or stage iv) nsclc
644655|NCT00753727|soft tissue|soft tissue
644656|NCT00753727|Sarcoma|sarcoma
644657|NCT00753727|Sunitinib|sunitinib
644658|NCT00753727|neoadjuvant|neoadjuvant
644659|NCT00753727|radiotherapy|radiotherapy
644660|NCT00753740|Cancer|cancer
644661|NCT00753740|Neoplasms|neoplasms
644662|NCT00753740|Solid Tumor|solid tumor
644663|NCT00753740|Ovarian Cancer|ovarian cancer
644664|NCT00753740|Solid Malignancies|solid malignancies
644665|NCT00753753|stent thrombosis|stent thrombosis
644666|NCT00753753|clopidogrel|clopidogrel
644667|NCT00753753|aspirin|aspirin
644668|NCT00753753|bleeding|bleeding
644669|NCT00753753|coronary|coronary
644670|NCT00753753|angioplasty|angioplasty
644672|NCT00753766|Blood Glucose Management|blood glucose management
644673|NCT00753766|Blood Pressure|blood pressure
644674|NCT00753766|Case Management|case management
644675|NCT00753766|Diabetes Mellitus|diabetes mellitus
644676|NCT00753766|Intervention study|intervention study
644677|NCT00753766|Multifactorial|multifactorial
644678|NCT00753766|Peri-operative complications|peri-operative complications
644679|NCT00753766|Pre-operative|pre-operative
644680|NCT00753792|multiple sclerosis|multiple sclerosis
644681|NCT00753792|relapse|relapse
644682|NCT00753792|methylprednisolone|methylprednisolone
644683|NCT00753805|mare's milk|mare's milk
644684|NCT00753805|atopic dermatitis|atopic dermatitis
644685|NCT00753805|endogenous eczema|endogenous eczema
644686|NCT00753805|SCORAD|scorad
644687|NCT00753805|Bifidobacteria|bifidobacteria
644688|NCT00753818|infant formula|infant formula
644689|NCT00753818|visual development|visual development
644690|NCT00753831|Blepharoptosis|blepharoptosis
644691|NCT00753831|Ophthalmoplegia|ophthalmoplegia
644692|NCT00753831|Blepharospasm|blepharospasm
644693|NCT00753844|peptide vaccine|peptide vaccine
644694|NCT00753844|URLC10|urlc10
644695|NCT00753857|risk communication|risk communication
644696|NCT00753857|probability sample by random digit dialing|probability sample by random digit dialing
644697|NCT00753870|current|current
644698|NCT00753870|no health problems|no health problems
644699|NCT00753870|no daily cough from smoking|no daily cough from smoking
644700|NCT00753896|Amylin|amylin
644701|NCT00753896|Lilly|lilly
644702|NCT00753896|exenatide once weekly|exenatide once weekly
644703|NCT00753896|thiazolidinedione|thiazolidinedione
644704|NCT00753896|metformin|metformin
644705|NCT00753909|Non Small Cell Lung Cancer|non small cell lung cancer
644706|NCT00753909|Paclitaxel|paclitaxel
644707|NCT00753909|Carboplatin|carboplatin
644708|NCT00753909|Bevacizumab|bevacizumab
644709|NCT00753922|Breast Reconstruction|breast reconstruction
644710|NCT00753922|Breast Augmentation|breast augmentation
644711|NCT00753922|Revision|revision
644712|NCT00753922|Silicone breast implants|silicone breast implants
644713|NCT00753922|Round low-bleed|round low-bleed
644714|NCT00753935|aspirin|aspirin
644715|NCT00753935|aspirin resistance|aspirin resistance
644716|NCT00753935|aspirin nonresponse|aspirin nonresponse
644717|NCT00753935|cyclooxygenase|cyclooxygenase
644719|NCT00753935|oxidative stress|oxidative stress
644720|NCT00753948|Tetraplegia|tetraplegia
644721|NCT00753948|Mild asthma|mild asthma
644722|NCT00753948|Exhaled Nitric Oxide|exhaled nitric oxide
644723|NCT00753948|NOS inhibitor|nos inhibitor
644724|NCT00753948|Spinal cord injury|spinal cord injury
644725|NCT00753948|Pulmonary Function|pulmonary function
644726|NCT00753961|Shiftworkers|shiftworkers
644727|NCT00753961|volunteers|volunteers
644728|NCT00753987|Cystic Fibrosis|cystic fibrosis
644729|NCT00753987|Hypertonic Saline|hypertonic saline
644730|NCT00753987|Infants|infants
644731|NCT00754013|pediatric|pediatric
644732|NCT00754013|Down syndrome|down syndrome
644733|NCT00754013|cognitive dysfunction|cognitive dysfunction
644734|NCT00754013|Downs|downs
644735|NCT00754013|Aricept|aricept
644736|NCT00754013|children with Down syndrome|children with down syndrome
644737|NCT00754026|Shoulder surgery|shoulder surgery
644738|NCT00754039|Mixed hyperlipidemia|mixed hyperlipidemia
644739|NCT00754052|Pediatric|pediatric
644740|NCT00754052|Down syndrome|down syndrome
644741|NCT00754052|Downs|downs
644742|NCT00754052|Cognitive Dysfunction of Down syndrome|cognitive dysfunction of down syndrome
644744|NCT00754065|Estradiol valerate and dienogest|estradiol valerate and dienogest
644745|NCT00754065|EV/DNG|ev/dng
644746|NCT00754065|comparative tolerability|comparative tolerability
644747|NCT00754078|tomotherapy|tomotherapy
644748|NCT00754117|diffuse large b cell lymphoma|diffuse large b cell lymphoma
644749|NCT00754117|newly diagnosed|newly diagnosed
644750|NCT00754143|Type 1 or Type 2 diabetes|type 1 or type 2 diabetes
644751|NCT00754143|proteinuria|proteinuria
644752|NCT00754156|Closure, Wounds|closure, wounds
644753|NCT00754169|Traumatic Brain Injury|traumatic brain injury
644754|NCT00754169|Brain Imaging|brain imaging
644755|NCT00754169|Brain Plasticity|brain plasticity
644756|NCT00754169|Neuroplasticity|neuroplasticity
644757|NCT00754169|Neuropsychological Testing|neuropsychological testing
644758|NCT00754169|Head Injury|head injury
644759|NCT00754169|Healthy Volunteer|healthy volunteer
644760|NCT00754182|thyroidectomy|thyroidectomy
644761|NCT00754182|surgery|surgery
644762|NCT00754182|synthetic glue|synthetic glue
644763|NCT00754182|subcuticular suture|subcuticular suture
644764|NCT00754195|Thoracotomy|thoracotomy
644765|NCT00754208|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
644766|NCT00754208|Stimulant Treatment|stimulant treatment
644767|NCT00754208|Young Children|young children
644768|NCT00754221|Phase 3, safety study, [S,S]-Reboxetine, Fibromyalgia|phase 3, safety study, [s,s]-reboxetine, fibromyalgia
644769|NCT00754234|iron absorption|iron absorption
644770|NCT00754234|iron requirements|iron requirements
644771|NCT00754234|dietary guidelines|dietary guidelines
644772|NCT00754234|MyPyramid|mypyramid
644773|NCT00754247|Keloid|keloid
644774|NCT00754247|Hypertrophic scar|hypertrophic scar
644775|NCT00754247|Hydrocortisone, silicone, vitamin E lotion|hydrocortisone, silicone, vitamin e lotion
644777|NCT00754247|Onion extract gel|onion extract gel
644778|NCT00754247|OE|oe
644779|NCT00754247|Cetearyl alcohol lotion|cetearyl alcohol lotion
644780|NCT00754247|CEA|cea
644781|NCT00748137|Type 1 Diabetes|type 1 diabetes
644782|NCT00748137|Youth|youth
644783|NCT00748137|Insulin dose|insulin dose
644784|NCT00748150|flu|flu
644785|NCT00748150|influenza|influenza
644786|NCT00748150|influenza vaccine antigen|influenza vaccine antigen
644787|NCT00748150|immunogenicity|immunogenicity
644788|NCT00748150|antibody response|antibody response
644789|NCT00748150|intra muscular|intra muscular
644790|NCT00748150|elderly|elderly
644791|NCT00748150|non-elderly|non-elderly
644792|NCT00748163|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
644793|NCT00748189|Safety|safety
644794|NCT00748189|Untreated|untreated
644795|NCT00748189|Efficacy|efficacy
644796|NCT00748189|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
644797|NCT00748189|Chronic Lymphocytic Leukemia (CLL), untreated|chronic lymphocytic leukemia (cll), untreated
644798|NCT00748189|Ofatumumab|ofatumumab
644799|NCT00748189|Oncology|oncology
644800|NCT00748202|Hereditary angioedema|hereditary angioedema
644801|NCT00748202|C1-Esterase inhibitor|c1-esterase inhibitor
644802|NCT00748202|intravenous|intravenous
644803|NCT00748202|subcutaneous|subcutaneous
644804|NCT00748202|pharmacokinetic|pharmacokinetic
644805|NCT00748215|diarrhea|diarrhea
644806|NCT00748215|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
644807|NCT00748215|recurrent colon cancer|recurrent colon cancer
644808|NCT00748215|recurrent rectal cancer|recurrent rectal cancer
644809|NCT00748215|stage IV colon cancer|stage iv colon cancer
644810|NCT00748215|stage IV rectal cancer|stage iv rectal cancer
644811|NCT00748254|Rheumatoid arthritis|rheumatoid arthritis
644812|NCT00748267|anxiety disorder|anxiety disorder
644813|NCT00748267|pain|pain
644814|NCT00748267|nausea and vomiting|nausea and vomiting
644815|NCT00748267|breast cancer|breast cancer
644816|NCT00748280|Endodontics|endodontics
644817|NCT00748280|CEM cement|cem cement
644818|NCT00748280|Calcium enriched mixture|calcium enriched mixture
644819|NCT00748280|MTA|mta
644820|NCT00748280|Root Canal Therapy|root canal therapy
644821|NCT00748280|Pain|pain
644822|NCT00748280|Pulpotomy|pulpotomy
644823|NCT00748280|Human|human
644824|NCT00748280|Permanent|permanent
644825|NCT00748280|Molar teeth|molar teeth
644826|NCT00748293|Colonoscopy|colonoscopy
644827|NCT00748293|Colon cleansing|colon cleansing
644828|NCT00748293|Low-reside diet|low-reside diet
644829|NCT00748293|Compliance|compliance
644830|NCT00748293|PEG-ELS|peg-els
644831|NCT00748306|challenge|challenge
644832|NCT00748306|early asthmatic response|early asthmatic response
644833|NCT00748306|mild asthmatics|mild asthmatics
644834|NCT00748306|Allergen|allergen
644835|NCT00748306|methacholine|methacholine
644836|NCT00748319|Receptors KIR|receptors kir
644837|NCT00748319|Polymerase chain reaction|polymerase chain reaction
644838|NCT00748319|Diagnosis|diagnosis
644839|NCT00748319|Lymphoma T-cell cutaneous|lymphoma t-cell cutaneous
644840|NCT00748319|Mycosis fungicides|mycosis fungicides
644841|NCT00748319|Sezary syndrome|sezary syndrome
644842|NCT00748319|Differential diagnosis from dermatitis|differential diagnosis from dermatitis
644843|NCT00748345|Caspofungin,|caspofungin,
644844|NCT00748345|burn patients,|burn patients,
644845|NCT00748345|pharmacokinetics,|pharmacokinetics,
644846|NCT00748345|optimal dose,|optimal dose,
644847|NCT00748345|antifungal treatment|antifungal treatment
644848|NCT00748358|metastatic prostate carcinoma|metastatic prostate carcinoma
644849|NCT00748358|sunitinib [Substance Name]|sunitinib [substance name]
644850|NCT00748358|Clinical Trial, Phase II [Publication Type]|clinical trial, phase ii [publication type]
644851|NCT00748371|platelet aggregation|platelet aggregation
644852|NCT00748371|granule secretion|granule secretion
644853|NCT00748371|thromboxane production|thromboxane production
644854|NCT00748371|prostacyclin production|prostacyclin production
644972|NCT00754442|vitamin D|vitamin d
644855|NCT00748384|HMP, CNV, AMD, PHP, HPHP, foresee|hmp, cnv, amd, php, hphp, foresee
644856|NCT00748410|CD11b|cd11b
644857|NCT00748410|Ulcerative colitis|ulcerative colitis
644858|NCT00748410|99mTc-HMPAO-labelled leukocyte scintigraphy|99mtc-hmpao-labelled leukocyte scintigraphy
644859|NCT00748423|Inhaled drug|inhaled drug
644860|NCT00748423|Acute lung injury|acute lung injury
644861|NCT00748423|Nitric oxide|nitric oxide
644862|NCT00748423|Sickle cell|sickle cell
644863|NCT00748436|Obese females|obese females
644864|NCT00748436|Weight loss|weight loss
644865|NCT00748436|Betahistine|betahistine
644866|NCT00748449|Colorectal advanced adenoma|colorectal advanced adenoma
644867|NCT00748449|Colorectal cancer polypectomy (endoscopic)|colorectal cancer polypectomy (endoscopic)
644868|NCT00748449|Colectomy|colectomy
644869|NCT00748449|Colonoscopy with anaesthesia|colonoscopy with anaesthesia
644870|NCT00748449|CT-colonography|ct-colonography
644871|NCT00748462|Acne scar, Wrinkle, Pigmentation, Fractional CO2 laser|acne scar, wrinkle, pigmentation, fractional co2 laser
644872|NCT00748488|Parkinson|parkinson
644873|NCT00748488|Physical Therapy|physical therapy
644874|NCT00748488|Physical Activity|physical activity
644875|NCT00748501|Amyotrophic Lateral Sclerosis,|amyotrophic lateral sclerosis,
644876|NCT00748501|ALS,|als,
644877|NCT00748501|Lou Gehrig's Disease|lou gehrig's disease
644878|NCT00748514|capsular incision|capsular incision
644879|NCT00748514|biochemical recurrence|biochemical recurrence
644880|NCT00748514|radical perineal prostatectomy|radical perineal prostatectomy
644881|NCT00748527|fallopian tube cancer|fallopian tube cancer
644882|NCT00748527|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
644883|NCT00748527|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
644884|NCT00748527|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
644885|NCT00748527|peritoneal cavity cancer|peritoneal cavity cancer
644886|NCT00748540|sensorineural hearing loss|sensorineural hearing loss
644887|NCT00748540|conductive hearing loss|conductive hearing loss
644888|NCT00748540|mixed hearing loss|mixed hearing loss
644889|NCT00748566|Ziprasidone|ziprasidone
644890|NCT00748566|metabolic syndrome|metabolic syndrome
644891|NCT00748566|risk factors|risk factors
644892|NCT00748566|schizophrenia|schizophrenia
644893|NCT00748566|psychotic disorders.|psychotic disorders.
644894|NCT00748592|Insomnia, Primary Insomnia, Chronic Insomnia, DIMS (Disorders of Initiating and Maintaining Sleep), Disorders of Initiating and Maintaining Sleep|insomnia, primary insomnia, chronic insomnia, dims (disorders of initiating and maintaining sleep), disorders of initiating and maintaining sleep
644895|NCT00748605|Obesity|obesity
644896|NCT00748618|Kidney transplantation (KTX)|kidney transplantation (ktx)
644897|NCT00748618|Vitamin D deficiency|vitamin d deficiency
644898|NCT00748618|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
644899|NCT00748618|Vascular risk|vascular risk
644900|NCT00748618|Parathyroid hormone (PTH)|parathyroid hormone (pth)
644901|NCT00748618|Carotid intima media thickness (CIMT)|carotid intima media thickness (cimt)
644902|NCT00748618|Insulin resistance (IR)|insulin resistance (ir)
644903|NCT00748631|Vertebral fracture|vertebral fracture
644904|NCT00748631|Vertebral compression fracture|vertebral compression fracture
644905|NCT00748631|Multiple Myeloma Bone marrow diseases|multiple myeloma bone marrow diseases
644906|NCT00748631|Vertebral metastases|vertebral metastases
644907|NCT00748631|Balloon Kyphoplasty|balloon kyphoplasty
644908|NCT00748644|Wegener's granulomatosis,|wegener's granulomatosis,
645092|NCT00757887|plasmodium|plasmodium
644909|NCT00748644|microscopic polyangiitis,|microscopic polyangiitis,
644910|NCT00748644|ANCA-associated vasculitis,|anca-associated vasculitis,
644911|NCT00748644|rituximab,|rituximab,
644912|NCT00748644|azathioprine|azathioprine
644913|NCT00748683|elderly|elderly
644914|NCT00748683|longterm care|longterm care
644915|NCT00748696|sarcopenia|sarcopenia
644916|NCT00748696|elderly|elderly
644917|NCT00748696|resistance training|resistance training
644918|NCT00748696|oral nutritional supplement|oral nutritional supplement
644919|NCT00748722|Breast reconstruction|breast reconstruction
644920|NCT00748722|Perforator flaps|perforator flaps
644921|NCT00748722|CT Angiography|ct angiography
644922|NCT00748735|cardiac resynchronization therapy|cardiac resynchronization therapy
644923|NCT00748735|echocardiography|echocardiography
644924|NCT00748735|heart failure|heart failure
752851|NCT01174485|Liposuction|liposuction
644925|NCT00748735|left ventricular function|left ventricular function
644926|NCT00748735|pacing|pacing
644927|NCT00748735|myocardial deformation imaging|myocardial deformation imaging
644928|NCT00748735|Optimal Definition of Left Ventricular Lead Position in Cardiac Resynchronization Therapy|optimal definition of left ventricular lead position in cardiac resynchronization therapy
644929|NCT00748761|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
645117|NCT00758108|Nociception|nociception
644931|NCT00748761|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
644933|NCT00748761|MRSI|mrsi
644934|NCT00748761|Glutamate|glutamate
644935|NCT00748774|Primary Brain Tumor|primary brain tumor
644936|NCT00748774|Caregivers|caregivers
644937|NCT00748774|Symptom Severity|symptom severity
644938|NCT00748774|Questionnaire|questionnaire
644939|NCT00748774|M.D. Anderson Symptom Inventory-Brain Tumor|m.d. anderson symptom inventory-brain tumor
644940|NCT00748774|MDASI-BT|mdasi-bt
644941|NCT00754286|Aromatherapy|aromatherapy
644942|NCT00754299|nonunion/malunion osseous fractures|nonunion/malunion osseous fractures
644943|NCT00754299|nicotine dependent|nicotine dependent
644944|NCT00754299|chronic osseous infection|chronic osseous infection
644945|NCT00754299|infected osseous nonunions|infected osseous nonunions
644946|NCT00754299|Fracture nonunion or infection|fracture nonunion or infection
644947|NCT00754312|breast cancer|breast cancer
644948|NCT00754338|comfort|comfort
644949|NCT00754338|wetability|wetability
644950|NCT00754338|protein deposit|protein deposit
644951|NCT00754338|lipid deposit|lipid deposit
644952|NCT00754351|docetaxel|docetaxel
644953|NCT00754351|gemcitabine|gemcitabine
644954|NCT00754351|bevacizumab|bevacizumab
644955|NCT00754351|chemotherapy|chemotherapy
644956|NCT00754377|Education|education
644957|NCT00754377|Program Evaluation|program evaluation
644958|NCT00754377|Quality of Health Care|quality of health care
644959|NCT00754377|Medical Residents|medical residents
644960|NCT00754390|dietary zinc absorption|dietary zinc absorption
644961|NCT00754390|dietary phytic acid|dietary phytic acid
644962|NCT00754390|dietary calcium|dietary calcium
644963|NCT00754403|Glucose Metabolism Disorder|glucose metabolism disorder
644964|NCT00754403|Dysmetabolic Syndrome|dysmetabolic syndrome
644965|NCT00754403|Type II Diabetes|type ii diabetes
644966|NCT00754403|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
644967|NCT00754403|Dyslipidemia|dyslipidemia
644968|NCT00754403|Drug Therapy|drug therapy
644969|NCT00754416|Shoulder Replacement|shoulder replacement
644970|NCT00754442|hyperparathyroidism|hyperparathyroidism
644971|NCT00754442|parathyroid|parathyroid
644973|NCT00754442|vitamin D deficiency|vitamin d deficiency
644974|NCT00754468|Barrett's Esophagus|barrett's esophagus
644975|NCT00754468|Esophageal Cancer|esophageal cancer
644976|NCT00754468|Esophageal Dysplasia|esophageal dysplasia
644977|NCT00754468|Low Grade Dysplasia|low grade dysplasia
644978|NCT00754468|High Grade Dysplasia|high grade dysplasia
644979|NCT00754481|Paediatrics|paediatrics
644980|NCT00754533|cardiac rehabilitation|cardiac rehabilitation
644981|NCT00754533|coronary heart disease|coronary heart disease
644982|NCT00754533|interval training|interval training
644983|NCT00754533|continuous training|continuous training
644984|NCT00754533|ventilatory threshold|ventilatory threshold
644985|NCT00754546|exercise;|exercise;
644986|NCT00754546|treadmill;|treadmill;
644987|NCT00754546|cycle ergometer;|cycle ergometer;
644988|NCT00754546|breathlessness;|breathlessness;
644989|NCT00754546|leg discomfort|leg discomfort
644990|NCT00757497|Treatment Study|treatment study
644991|NCT00757497|Psychosis|psychosis
644992|NCT00757497|Electrical Stimulation|electrical stimulation
644993|NCT00757497|Refractory|refractory
644994|NCT00757497|Novel|novel
644995|NCT00757497|Childhood Onset Psychotic Disorders|childhood onset psychotic disorders
644996|NCT00757497|Schizophrenia|schizophrenia
644997|NCT00757510|Congenital Heart Disease|congenital heart disease
644998|NCT00757523|Acne Vulgaris|acne vulgaris
644999|NCT00757523|Akne|akne
645000|NCT00757523|Acne|acne
645001|NCT00757523|Akne Vulgaris|akne vulgaris
645002|NCT00757536|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
645003|NCT00757536|primary vitrectomy|primary vitrectomy
645004|NCT00757536|encircling band|encircling band
645005|NCT00757536|endolaser treatment|endolaser treatment
645093|NCT00757887|falciparum|falciparum
645006|NCT00757549|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
645007|NCT00757549|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
645008|NCT00757549|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
645009|NCT00757549|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
645010|NCT00757549|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
645011|NCT00757549|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
645012|NCT00757549|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
645013|NCT00757549|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
645014|NCT00757549|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
645015|NCT00757575|PNEUMONET JAPAN STUDY|pneumonet japan study
645016|NCT00757614|AIDS-related lymphoma|aids-related lymphoma
645017|NCT00757614|cutaneous lymphoma|cutaneous lymphoma
645018|NCT00757614|adult Hodgkin lymphoma|adult hodgkin lymphoma
645019|NCT00757614|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
645020|NCT00757614|intraocular lymphoma|intraocular lymphoma
645021|NCT00757614|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
645118|NCT00758108|Obesity|obesity
645022|NCT00757614|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
645023|NCT00757614|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
645024|NCT00757614|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
645025|NCT00757614|adult astrocytic tumors|adult astrocytic tumors
645026|NCT00757614|adult brain stem glioma|adult brain stem glioma
645027|NCT00757614|adult choroid plexus tumor|adult choroid plexus tumor
645028|NCT00757614|adult craniopharyngioma|adult craniopharyngioma
645029|NCT00757614|adult embryonal tumor|adult embryonal tumor
645030|NCT00757614|adult ependymal tumors|adult ependymal tumors
645031|NCT00757614|adult meningeal tumor|adult meningeal tumor
645032|NCT00757614|adult oligodendroglial tumors|adult oligodendroglial tumors
645033|NCT00757614|adult pineal parenchymal tumor|adult pineal parenchymal tumor
645034|NCT00757614|adult brain tumor|adult brain tumor
645035|NCT00757614|intraocular melanoma|intraocular melanoma
645036|NCT00757614|bladder cancer|bladder cancer
645037|NCT00757614|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
645038|NCT00757614|congenital mesoblastic nephroma|congenital mesoblastic nephroma
645039|NCT00757614|esophageal cancer|esophageal cancer
645040|NCT00757614|melanoma|melanoma
645041|NCT00757614|pancreatic cancer|pancreatic cancer
645042|NCT00757614|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
645043|NCT00757614|renal cell carcinoma|renal cell carcinoma
645044|NCT00757614|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
645045|NCT00757614|transitional cell cancer of the renal pelvis and ureter|transitional cell cancer of the renal pelvis and ureter
645046|NCT00757640|gastric cancer, surgery, prophylactic cholecystectomy|gastric cancer, surgery, prophylactic cholecystectomy
645047|NCT00757666|Pacemaker|pacemaker
645048|NCT00757692|Vandetanib (ZD6474)|vandetanib (zd6474)
645049|NCT00757692|Hormone|hormone
645050|NCT00757692|Refractory|refractory
645051|NCT00757692|Prostate Cancer|prostate cancer
645052|NCT00757692|Chemotherapy|chemotherapy
645053|NCT00757692|Naïve|naïve
645054|NCT00757705|Schizophrenia|schizophrenia
645055|NCT00757705|Paliperidone Extended-Release|paliperidone extended-release
645056|NCT00757718|Sleep Disordered Breathing|sleep disordered breathing
645057|NCT00757718|Obstructive Sleep Apnea|obstructive sleep apnea
645058|NCT00757718|Gestational Hypertension|gestational hypertension
645059|NCT00757718|Preeclampsia|preeclampsia
645060|NCT00757744|drug counseling|drug counseling
645061|NCT00757744|HIV risks|hiv risks
645062|NCT00757744|methadone maintenance|methadone maintenance
645063|NCT00757744|HIV Seronegativity|hiv seronegativity
645064|NCT00757757|Prostate cancer|prostate cancer
645065|NCT00757757|bone metastases|bone metastases
645066|NCT00757757|anti-M-CSF|anti-m-csf
645067|NCT00757757|M-CSF antibody|m-csf antibody
645068|NCT00757757|M-CSF|m-csf
645069|NCT00757757|Prostate Cancer with bone metastases|prostate cancer with bone metastases
645070|NCT00757770|Gastroenteritis|gastroenteritis
645072|NCT00757783|AIDS|aids
645073|NCT00757783|Immunodeficiency Virus, Human|immunodeficiency virus, human
645074|NCT00757783|PREZISTA|prezista
645075|NCT00757783|darunavir|darunavir
645076|NCT00757783|TMC114|tmc114
645077|NCT00757783|Protease Inhibitor|protease inhibitor
645078|NCT00757783|Truvada|truvada
645079|NCT00757783|Atazanavir|atazanavir
645080|NCT00757783|REYATAZ|reyataz
645081|NCT00757783|HIV Infections|hiv infections
645082|NCT00757783|Treatment Naïve|treatment naïve
645083|NCT00757835|24-hour IOP|24-hour iop
645084|NCT00757835|exfoliative glaucoma|exfoliative glaucoma
645085|NCT00757835|travoprost/timolol|travoprost/timolol
645086|NCT00757835|latanoprost/timolol|latanoprost/timolol
645087|NCT00757835|fixed combinations|fixed combinations
645088|NCT00757848|cystic fibrosis|cystic fibrosis
645089|NCT00757874|Female urogenital disease|female urogenital disease
645090|NCT00757874|skin disease|skin disease
645091|NCT00757887|malaria|malaria
645094|NCT00757887|human|human
645095|NCT00757887|experimental infection|experimental infection
645096|NCT00757900|influenza, human|influenza, human
645097|NCT00757939|Alzheimer's Disease, MRI, PET|alzheimer's disease, mri, pet
645098|NCT00757952|ovarian epithelial cancer|ovarian epithelial cancer
645099|NCT00757965|colon cancer|colon cancer
645100|NCT00757965|rectal cancer|rectal cancer
645101|NCT00757978|Schizophrenia|schizophrenia
645102|NCT00757978|negative symptoms|negative symptoms
645103|NCT00757978|clozapine|clozapine
645104|NCT00757991|healthy, no evidence of disease|healthy, no evidence of disease
645105|NCT00758004|Cardiovascular Diseases|cardiovascular diseases
645106|NCT00758017|low back pain|low back pain
645107|NCT00758017|acupuncture|acupuncture
645108|NCT00758030|Schizophrenia|schizophrenia
645109|NCT00758030|Paliperidone|paliperidone
645110|NCT00758043|Genotype 1|genotype 1
645111|NCT00758056|endometrial cancer|endometrial cancer
645112|NCT00758082|type 1 diabetes|type 1 diabetes
645113|NCT00758082|PDA phone (Personal Digital Assistant)|pda phone (personal digital assistant)
645114|NCT00758082|HbA1c|hba1c
645115|NCT00758108|Genotype/Phenotype Correlation|genotype/phenotype correlation
645116|NCT00758108|Energy Homeostasis|energy homeostasis
645119|NCT00758108|Behavior and Neurocognition|behavior and neurocognition
645120|NCT00758108|WAGR Syndrome|wagr syndrome
645121|NCT00758108|Wilm's Tumor|wilm's tumor
645122|NCT00758108|Aniridia|aniridia
645123|NCT00758108|Mental Retardation|mental retardation
645124|NCT00758108|Urogenital Abnormalities|urogenital abnormalities
645125|NCT00758108|Healthy Volunteer|healthy volunteer
645126|NCT00758147|force feedback joystick|force feedback joystick
645127|NCT00758147|stroke|stroke
645128|NCT00758147|haptics|haptics
645129|NCT00758147|kinematics|kinematics
645130|NCT00758147|rehabilitation|rehabilitation
645131|NCT00758147|robotics|robotics
645132|NCT00758147|Force feedback joystick in stroke rehabilitation|force feedback joystick in stroke rehabilitation
645133|NCT00758160|Attention Deficit Disorder With Hyperactivity|attention deficit disorder with hyperactivity
645134|NCT00758160|Methylphenidate|methylphenidate
645135|NCT00758160|Concerta|concerta
645136|NCT00758173|prostate cancer|prostate cancer
645137|NCT00758186|Colorectal cancer|colorectal cancer
645138|NCT00758186|Endoscopic stent|endoscopic stent
645139|NCT00758186|Intestinal obstruction|intestinal obstruction
645140|NCT00758186|Laparoscopy|laparoscopy
645141|NCT00758212|Influenza in Humans|influenza in humans
645142|NCT00758212|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
645143|NCT00758212|Immunization, Active|immunization, active
645144|NCT00758225|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
645145|NCT00758225|DMD|dmd
645146|NCT00758225|Duchenne|duchenne
645147|NCT00758225|Idebenone|idebenone
645148|NCT00758238|hypertension|hypertension
645149|NCT00758238|self-management|self-management
645150|NCT00758238|e-health|e-health
645151|NCT00758251|Schizophrenia|schizophrenia
645152|NCT00758251|Seroquel XR|seroquel xr
645153|NCT00758251|CGI|cgi
645154|NCT00758264|Safety|safety
645155|NCT00758264|Routine infancy vaccination|routine infancy vaccination
645156|NCT00758264|Meningococcal vaccine|meningococcal vaccine
645157|NCT00758264|Immunogenicity|immunogenicity
645158|NCT00758264|Pneumococcal vaccine|pneumococcal vaccine
645159|NCT00758277|prevention of alcohol relapse|prevention of alcohol relapse
645160|NCT00758303|Triglycerides|triglycerides
645161|NCT00758303|Cholesterol|cholesterol
645162|NCT00758316|Malignant|malignant
645163|NCT00758316|Pleural|pleural
645164|NCT00758316|Effusions|effusions
645165|NCT00758316|Thoracoscopy|thoracoscopy
645166|NCT00758316|Catheter|catheter
645167|NCT00758342|IOP lowering efficacy and safety of Azopt plus Travatan|iop lowering efficacy and safety of azopt plus travatan
645168|NCT00758368|Parkinson's disease|parkinson's disease
645169|NCT00758368|PD|pd
645170|NCT00758368|pulsatile apomorphine|pulsatile apomorphine
645171|NCT00758368|dyskinesia|dyskinesia
645172|NCT00758368|apomorphine|apomorphine
645173|NCT00758368|continuous dopaminergic stimulation|continuous dopaminergic stimulation
645174|NCT00758381|pancreatic cancer|pancreatic cancer
645175|NCT00758381|advanced or metastatic|advanced or metastatic
645176|NCT00758381|sorafenib|sorafenib
645177|NCT00758407|Fatigue, Cancer, Methylphenidate,|fatigue, cancer, methylphenidate,
645178|NCT00758420|Varicose Veins|varicose veins
645179|NCT00758433|Adverse Events|adverse events
645180|NCT00758433|Erythema Rating|erythema rating
645181|NCT00758433|Pharmacokinetics|pharmacokinetics
645182|NCT00758433|Civamide|civamide
645183|NCT00758433|Phase 1|phase 1
645184|NCT00758433|Pain|pain
645185|NCT00758433|Patch|patch
645186|NCT00758459|COPD|copd
645187|NCT00758511|cortisol|cortisol
645188|NCT00758511|pain|pain
645189|NCT00758511|pain management|pain management
645190|NCT00758511|preterm infants|preterm infants
645191|NCT00758511|sucrose|sucrose
645192|NCT00758511|facilitated tucking|facilitated tucking
645193|NCT00758524|Essential hypertension|essential hypertension
645194|NCT00758524|phase 2 study|phase 2 study
645195|NCT00758524|antihypertensive agent|antihypertensive agent
645297|NCT00759122|mdd|mdd
645196|NCT00758537|Assessment of tryptophan and tryptophan catabolites and IDO-activity in patients with chronic kidney disease|assessment of tryptophan and tryptophan catabolites and ido-activity in patients with chronic kidney disease
645197|NCT00758550|Visual function;|visual function;
645198|NCT00758550|Refractive cylinder;|refractive cylinder;
645199|NCT00758550|AcrySof® Toric;|acrysof® toric;
645200|NCT00758550|AcrySof® Natural|acrysof® natural
645201|NCT00758576|Cataract|cataract
645202|NCT00758589|Asthma|asthma
645203|NCT00758615|Obesity|obesity
645204|NCT00758615|Physical activity|physical activity
645205|NCT00758615|Injury Prevention|injury prevention
645206|NCT00758615|Pedestrian safety|pedestrian safety
645207|NCT00758615|Self efficacy|self efficacy
645208|NCT00758615|School|school
752852|NCT01174485|exercise|exercise
645209|NCT00758615|Walking School Bus|walking school bus
645210|NCT00758615|Safe Routes to School|safe routes to school
645211|NCT00758641|plantar fasciitis|plantar fasciitis
645212|NCT00758641|platelet rich plasma|platelet rich plasma
645213|NCT00758641|GPS|gps
645214|NCT00758654|myocardial strain|myocardial strain
645215|NCT00758654|Strain-Encoded MRI|strain-encoded mri
645216|NCT00758654|dobutamine stress MRI|dobutamine stress mri
645217|NCT00758654|ischemia|ischemia
645218|NCT00758654|strain rate reserve|strain rate reserve
645219|NCT00758667|capsular contracture|capsular contracture
645220|NCT00758667|capsulectomy|capsulectomy
645221|NCT00758667|mesna|mesna
645222|NCT00758667|Capsular contracture after breast implant placement|capsular contracture after breast implant placement
645223|NCT00758693|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
645224|NCT00758693|Bendamustine|bendamustine
645225|NCT00758693|Treanda|treanda
645226|NCT00758693|Rituximab|rituximab
645227|NCT00758693|Rituxan|rituxan
645228|NCT00758706|COPD|copd
645229|NCT00758719|Spinal Fusion|spinal fusion
645230|NCT00758719|DDD|ddd
645231|NCT00758732|Cancer|cancer
645232|NCT00758732|Ovarian cancer|ovarian cancer
645233|NCT00758732|Chemotherapy|chemotherapy
645234|NCT00758732|Docetaxel|docetaxel
645235|NCT00758732|Carboplatin|carboplatin
645236|NCT00758732|Pegylated doxorubicin|pegylated doxorubicin
645237|NCT00758732|Platinum sensitive|platinum sensitive
645238|NCT00758745|Cataract|cataract
645239|NCT00758745|Patients|patients
645240|NCT00758745|bilateral|bilateral
645241|NCT00758745|age related|age related
645242|NCT00758745|undergoing|undergoing
645243|NCT00758745|phacoemulsification|phacoemulsification
645244|NCT00758758|Anterior Cervical Discectomy and Fusion,|anterior cervical discectomy and fusion,
645245|NCT00758758|Degenerative Disc Disease,|degenerative disc disease,
645246|NCT00758758|Cervical Spine,|cervical spine,
645247|NCT00758758|Herniated Disc|herniated disc
645248|NCT00758797|metastatic melanoma|metastatic melanoma
645249|NCT00758810|Health Education|health education
645250|NCT00758810|Myocardial Infarction|myocardial infarction
645251|NCT00758810|Acute Coronary Syndrome|acute coronary syndrome
645252|NCT00758810|Quality of Life|quality of life
645253|NCT00758823|head lice|head lice
645254|NCT00758849|NOH|noh
645255|NCT00758849|Orthostatic hypotension|orthostatic hypotension
645256|NCT00758849|PAF|paf
645257|NCT00758849|MSA|msa
645258|NCT00758849|Shy-Drager syndrome|shy-drager syndrome
645259|NCT00758849|Olivopontocerebellar atrophy|olivopontocerebellar atrophy
645260|NCT00758849|Striatonigral degeneration|striatonigral degeneration
645261|NCT00758849|Autonomic Failure|autonomic failure
645262|NCT00758849|Parkinson|parkinson
645263|NCT00758849|Fipamezole|fipamezole
645264|NCT00758849|JP-1730|jp-1730
645265|NCT00758914|Vitamin E|vitamin e
645266|NCT00758927|diabetes mellitus|diabetes mellitus
645267|NCT00758927|combined hyperlipidemia|combined hyperlipidemia
645268|NCT00758927|OMACOR|omacor
645269|NCT00758927|small dense LDL|small dense ldl
645270|NCT00758927|HDL subfraction|hdl subfraction
645271|NCT00758940|Clinical|clinical
645272|NCT00758940|assessment|assessment
645273|NCT00758940|of visual|of visual
645274|NCT00758940|function|function
645275|NCT00758940|with the Acrysof ReSTOR|with the acrysof restor
645276|NCT00758940|multifocal IOL|multifocal iol
645277|NCT00758966|OCD,|ocd,
645278|NCT00758966|naltrexone,|naltrexone,
645279|NCT00758966|fluoxetine,|fluoxetine,
645280|NCT00758966|obsessive-compulsive disorder|obsessive-compulsive disorder
645281|NCT00758992|gene transfer|gene transfer
645282|NCT00759018|GVHD|gvhd
645283|NCT00759018|Prochymal|prochymal
645284|NCT00759018|Graft vs Host Disease|graft vs host disease
645285|NCT00759057|Spinal Stenosis|spinal stenosis
645286|NCT00759057|Spinal Instability|spinal instability
645287|NCT00759057|Leg Pain|leg pain
645288|NCT00759070|Treatment Naïve|treatment naïve
645289|NCT00759083|HIT|hit
645290|NCT00759083|HITTS|hitts
645291|NCT00759096|bilateral implantation|bilateral implantation
645292|NCT00759096|ReSTOR Aspheric IOL|restor aspheric iol
645293|NCT00759096|uniocular unaided distance|uniocular unaided distance
645294|NCT00759096|binocular unaided distance|binocular unaided distance
645295|NCT00759096|intermediate visual acuity|intermediate visual acuity
645296|NCT00759096|near visual acuity|near visual acuity
645298|NCT00759122|major depressive disorder|major depressive disorder
645299|NCT00759122|depression|depression
645300|NCT00759135|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
645301|NCT00759135|BPH|bph
645302|NCT00759135|Enlarged Prostate|enlarged prostate
645303|NCT00759148|pink eye|pink eye
645304|NCT00759148|conjunctivitis|conjunctivitis
645305|NCT00759148|moxifloxacin|moxifloxacin
645306|NCT00759148|fluoroquinolone|fluoroquinolone
645307|NCT00759161|Plaque Type Psoriasis|plaque type psoriasis
645308|NCT00759161|Topical|topical
645309|NCT00759174|Optic Neuropathy Acute NAION PDE5 Inhibitor|optic neuropathy acute naion pde5 inhibitor
645310|NCT00759200|Chronic hepatitis C|chronic hepatitis c
645311|NCT00759200|genotype 2|genotype 2
645312|NCT00759200|genotype 3|genotype 3
645313|NCT00759200|albumin interferon alfa-2b|albumin interferon alfa-2b
645314|NCT00759200|alb-interferon|alb-interferon
645315|NCT00759213|Discharge planning|discharge planning
645316|NCT00759213|Family needs|family needs
645317|NCT00759213|Family concerns|family concerns
645318|NCT00759213|NICU|nicu
645319|NCT00759213|Infants|infants
645320|NCT00759226|esophageal cancer|esophageal cancer
645321|NCT00759226|Gemcitabine|gemcitabine
645322|NCT00759226|Cisplatin|cisplatin
645323|NCT00759226|5-FU|5-fu
645324|NCT00759226|Folinic Acid|folinic acid
645325|NCT00759226|inoperable esophageal cancer|inoperable esophageal cancer
645326|NCT00759239|Open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component), or ocular hypertension|open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component), or ocular hypertension
645327|NCT00759252|diagnosis of dementia|diagnosis of dementia
645328|NCT00759252|perceptions of risk|perceptions of risk
645329|NCT00759252|dementia screening|dementia screening
645330|NCT00759265|Muscle strength|muscle strength
645331|NCT00759265|Physical activity|physical activity
645332|NCT00759265|Mobility|mobility
645333|NCT00759265|Gait analysis|gait analysis
645334|NCT00759278|pregnancy|pregnancy
645335|NCT00759278|umbilical artery systolic to diastolic flow ratio|umbilical artery systolic to diastolic flow ratio
645336|NCT00759278|middle cerebral artery peak systolic flow|middle cerebral artery peak systolic flow
645337|NCT00759278|antihypertensive medication|antihypertensive medication
645338|NCT00759291|free fatty acids|free fatty acids
645339|NCT00759291|insulin-mediated|insulin-mediated
645340|NCT00759291|endothelium-dependent vasodilation|endothelium-dependent vasodilation
645341|NCT00759291|metabolic syndrome|metabolic syndrome
645342|NCT00759304|Aging|aging
645343|NCT00759304|cardiovascular risk factors|cardiovascular risk factors
645344|NCT00759304|Autonomic nervous system|autonomic nervous system
645345|NCT00759304|stroke|stroke
645346|NCT00759304|Myocardiac infarction|myocardiac infarction
645347|NCT00759304|Neuropsychological evaluation|neuropsychological evaluation
645348|NCT00759304|Prospective cohort|prospective cohort
645349|NCT00759317|normal controls|normal controls
645350|NCT00759330|Flurbiprofen, low back pain, chronic low back pain|flurbiprofen, low back pain, chronic low back pain
645351|NCT00759343|Kidney stones|kidney stones
645352|NCT00759343|urinary stone disease|urinary stone disease
645353|NCT00759343|urinary stones|urinary stones
645354|NCT00759343|urine|urine
645355|NCT00759343|serum|serum
645356|NCT00759356|bioavailability|bioavailability
645357|NCT00759356|KADIAN|kadian
645358|NCT00759356|200 mg|200 mg
645359|NCT00759356|morphine sulfate sustained release capsules|morphine sulfate sustained release capsules
645360|NCT00759356|100 mg|100 mg
645361|NCT00759356|fed conditions|fed conditions
645362|NCT00759369|ADPKD|adpkd
645363|NCT00759382|Non small cell lung carcinoma|non small cell lung carcinoma
645364|NCT00759382|PET scan|pet scan
645365|NCT00759382|Observational study|observational study
645366|NCT00759382|Non metastatic|non metastatic
645367|NCT00759382|treated|treated
645368|NCT00759382|curative intent|curative intent
645369|NCT00759395|Anxious Major Depressive Disorder|anxious major depressive disorder
645370|NCT00759408|primary pulmonary hypertension|primary pulmonary hypertension
645371|NCT00759408|secondary pulmonary hypertension due to left heart failure|secondary pulmonary hypertension due to left heart failure
645372|NCT00759408|secondary pulmonary hypertension due to other causes|secondary pulmonary hypertension due to other causes
645373|NCT00759408|patients without pulmonary disease or pulmonary hypertension|patients without pulmonary disease or pulmonary hypertension
645374|NCT00759421|Schizophrenia|schizophrenia
645375|NCT00759434|Varicose veins|varicose veins
645376|NCT00759434|Chronic venous insufficiency|chronic venous insufficiency
645377|NCT00759434|Venous ulceration|venous ulceration
645378|NCT00759434|Surgery|surgery
645379|NCT00759434|Endovenous Laser|endovenous laser
645380|NCT00759460|Schizophrenia|schizophrenia
645381|NCT00759473|substance-related disorders|substance-related disorders
645382|NCT00759486|craniofacial fracture|craniofacial fracture
645383|NCT00759486|Subjects who are in the active phase of craniofacial skeletal growth, and have sustained a craniofacial fracture|subjects who are in the active phase of craniofacial skeletal growth, and have sustained a craniofacial fracture
645384|NCT00759499|study of debridement tissue for research purposes.|study of debridement tissue for research purposes.
645385|NCT00759499|open wound|open wound
645386|NCT00759538|Lung Transplantation|lung transplantation
645788|NCT00762710|Medicine|medicine
645387|NCT00759538|Pulmonary Rehabilitation|pulmonary rehabilitation
645388|NCT00759538|Exercise tolerance|exercise tolerance
645389|NCT00759538|Quality of Life|quality of life
645390|NCT00759551|Blood Pressure|blood pressure
645391|NCT00759551|Drug Therapy|drug therapy
645392|NCT00759551|Systolic Pressure|systolic pressure
645393|NCT00759551|Diastolic Pressure|diastolic pressure
645394|NCT00759551|Vascular Diseases|vascular diseases
645395|NCT00759603|Leukemia|leukemia
645397|NCT00759603|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
645399|NCT00759603|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
645400|NCT00759603|Lenalidomide|lenalidomide
645401|NCT00759603|Revlimid|revlimid
645402|NCT00759603|Rituximab|rituximab
645403|NCT00759603|Rituxan|rituxan
645404|NCT00759616|Knee Replacement|knee replacement
645405|NCT00759642|breast cancer|breast cancer
645406|NCT00759642|hormone receptor positive|hormone receptor positive
645407|NCT00759642|HER-2 negative|her-2 negative
645408|NCT00759655|hemophilia A|hemophilia a
645409|NCT00759655|Xyntha|xyntha
645410|NCT00759655|ReFacto|refacto
645411|NCT00759655|moroctocog alfa|moroctocog alfa
645412|NCT00759655|bleeding disorder|bleeding disorder
645413|NCT00759681|Arterial Surgery|arterial surgery
645414|NCT00759681|Open vascular Surgery|open vascular surgery
645415|NCT00759681|Sealant|sealant
645416|NCT00759707|saphenous vein bypass grafts|saphenous vein bypass grafts
645417|NCT00759707|flow-mediated vasodilation|flow-mediated vasodilation
645418|NCT00759720|Glucose Metabolism Disorder|glucose metabolism disorder
645419|NCT00759720|Dysmetabolic Syndrome|dysmetabolic syndrome
645420|NCT00759720|Type II Diabetes|type ii diabetes
645421|NCT00759720|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
645422|NCT00759720|Dyslipidemia|dyslipidemia
645423|NCT00759720|Drug Therapy|drug therapy
645424|NCT00759733|pregnancy|pregnancy
645425|NCT00759733|heart disease|heart disease
645426|NCT00759733|heart function testing|heart function testing
645427|NCT00759733|echocardiography|echocardiography
645428|NCT00759733|B-type natriuretic peptide|b-type natriuretic peptide
645429|NCT00759733|obstetrical care|obstetrical care
645430|NCT00759746|Weight loss maintenance|weight loss maintenance
645431|NCT00759759|bioequivalence|bioequivalence
645432|NCT00759759|morphine sulfate sustained release capsules|morphine sulfate sustained release capsules
645433|NCT00759759|KADIAN capsules|kadian capsules
645434|NCT00759759|200 mg|200 mg
645435|NCT00759772|Anorexia Nervosa|anorexia nervosa
645436|NCT00759772|Disordered Eating|disordered eating
645437|NCT00759772|Osteoporosis|osteoporosis
645438|NCT00759772|Parathyroid Hormone|parathyroid hormone
645439|NCT00759772|Bone|bone
645440|NCT00759798|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
645441|NCT00759798|Leukemia|leukemia
645442|NCT00759798|FCR|fcr
645443|NCT00759798|Fludarabine|fludarabine
645444|NCT00759798|Cyclophosphamide|cyclophosphamide
645445|NCT00759798|Rituximab|rituximab
645446|NCT00759811|Heart Failure|heart failure
645447|NCT00759811|Myocardial Ischemia|myocardial ischemia
645448|NCT00759811|Methotrexate|methotrexate
645449|NCT00759811|Inflammation|inflammation
645450|NCT00759811|Anti-Inflammatory Agents|anti-inflammatory agents
645451|NCT00759811|Inflammation Mediators|inflammation mediators
645452|NCT00759824|Small cell lung carcinoma|small cell lung carcinoma
645453|NCT00759824|Valproic acid|valproic acid
645454|NCT00759824|Adriamycin|adriamycin
645455|NCT00759824|Cyclophosphamide|cyclophosphamide
645456|NCT00759824|Vindesine|vindesine
645457|NCT00759824|Second-line chemotherapy|second-line chemotherapy
645458|NCT00759850|Acute Myocardial Infarction|acute myocardial infarction
645459|NCT00759850|Drug Eluting Stent|drug eluting stent
645460|NCT00759850|Primary PCI|primary pci
645461|NCT00759876|Duchenne muscular dystrophy|duchenne muscular dystrophy
645462|NCT00759876|Nonsense mutation|nonsense mutation
645463|NCT00759876|Premature stop codon|premature stop codon
645464|NCT00759876|DMD|dmd
645465|NCT00759876|PTC124|ptc124
645466|NCT00759876|Ataluren|ataluren
645467|NCT00759889|venous leg ulcer|venous leg ulcer
645468|NCT00759902|bioequivalence|bioequivalence
645469|NCT00759902|10 mg|10 mg
645470|NCT00759902|KADIAN capsules|kadian capsules
645471|NCT00759902|20 mg|20 mg
645472|NCT00759902|under fasted conditions|under fasted conditions
645473|NCT00759915|10 mg|10 mg
645474|NCT00759915|KADIAN capsules|kadian capsules
645475|NCT00759915|20 mg|20 mg
645476|NCT00759915|fed conditions|fed conditions
645477|NCT00759915|bioequivalence|bioequivalence
645478|NCT00759928|Refractory Solid Tumors|refractory solid tumors
645479|NCT00759928|Unresectable Stage III/IV|unresectable stage iii/iv
645480|NCT00759928|Sorafenib|sorafenib
645481|NCT00759928|Erlotinib|erlotinib
645482|NCT00759928|Pharmacokinetics|pharmacokinetics
645483|NCT00759941|Glaucoma|glaucoma
645484|NCT00759954|bioequivalence|bioequivalence
645485|NCT00759954|morphine sulfate sustained release capsules|morphine sulfate sustained release capsules
645486|NCT00759954|KADIAN capsules|kadian capsules
645487|NCT00759954|200 mg|200 mg
645488|NCT00759954|applesauce|applesauce
645489|NCT00751647|CF|cf
645490|NCT00751660|small cell lung cancer|small cell lung cancer
645491|NCT00751660|non-small cell lung cancer|non-small cell lung cancer
645492|NCT00751660|tobacco use disorder|tobacco use disorder
645493|NCT00751686|Gastroenteritis|gastroenteritis
645494|NCT00751686|Burden|burden
645495|NCT00751686|Rotavirus|rotavirus
645496|NCT00751686|< 5 years|< 5 years
645497|NCT00751686|Greece|greece
645498|NCT00751686|Children|children
645499|NCT00751699|Pharmacokinetics|pharmacokinetics
645500|NCT00751712|Aortic Arch|aortic arch
645501|NCT00759967|Randomized|randomized
645502|NCT00759967|Cross-Over|cross-over
645503|NCT00759967|Conventional|conventional
645504|NCT00759967|Daily|daily
645505|NCT00759967|Hemodialysis|hemodialysis
645506|NCT00759980|Thrombocytopenia|thrombocytopenia
645507|NCT00759980|Platelet transfusion|platelet transfusion
645508|NCT00759993|weight gain|weight gain
645509|NCT00759993|Obesity|obesity
645510|NCT00759993|Psychiatry|psychiatry
645511|NCT00759993|Medication|medication
645512|NCT00759993|Induced|induced
645513|NCT00760006|cleft secondary palate|cleft secondary palate
645514|NCT00760006|Patients undergoing primary closure of a cleft secondary palate|patients undergoing primary closure of a cleft secondary palate
645515|NCT00760019|vascular inflammation|vascular inflammation
645516|NCT00760019|endothelium-dependent flow-mediated blood vessel function|endothelium-dependent flow-mediated blood vessel function
645517|NCT00760032|Cirrhosis|cirrhosis
645518|NCT00760032|Ascites|ascites
645519|NCT00760032|Lipopolysaccharide binding protein|lipopolysaccharide binding protein
645520|NCT00760032|Infections|infections
645521|NCT00760032|Cytokines|cytokines
645522|NCT00760032|Ciprofloxacin|ciprofloxacin
645523|NCT00760058|cataract, intraocular lens|cataract, intraocular lens
645524|NCT00760071|cystic fibrosis,|cystic fibrosis,
645525|NCT00760071|lung disease,|lung disease,
645526|NCT00760071|MRI,|mri,
645527|NCT00760071|morphology,|morphology,
645528|NCT00760071|function|function
645529|NCT00760071|morphological MRI|morphological mri
645530|NCT00760071|functional MRI|functional mri
645531|NCT00760071|correlation to clinical data|correlation to clinical data
645532|NCT00760084|Acute Myelogenous Leukemia|acute myelogenous leukemia
645533|NCT00760084|Myelodysplastic Syndrome|myelodysplastic syndrome
645534|NCT00760084|Dacogen|dacogen
645535|NCT00760084|Decitabine|decitabine
645536|NCT00760110|Morning BP|morning bp
645537|NCT00760110|Clinic BP|clinic bp
645538|NCT00760110|micro- and macrovascular complications|micro- and macrovascular complications
645539|NCT00760123|Lymphedema|lymphedema
645540|NCT00760123|Prevention|prevention
645541|NCT00760123|Breast cancer|breast cancer
645542|NCT00760123|Physical therapy|physical therapy
645543|NCT00760136|patellofemoral pain|patellofemoral pain
645544|NCT00760136|quadriceps contraction|quadriceps contraction
645545|NCT00760149|tuberculosis|tuberculosis
645546|NCT00760149|rifampicin|rifampicin
645547|NCT00760149|pharmacokinetics|pharmacokinetics
645548|NCT00760149|pharmacodynamics|pharmacodynamics
645549|NCT00760162|Chronic Kidney failure stage three and four|chronic kidney failure stage three and four
645550|NCT00760162|Probiotics|probiotics
645551|NCT00760162|Kibow Biotics|kibow biotics
645552|NCT00760162|Enteric Dialysis|enteric dialysis
645553|NCT00760162|Gut based removal uremic toxin removal|gut based removal uremic toxin removal
645554|NCT00760175|Lung transplant Recipients|lung transplant recipients
645555|NCT00760175|Vaxigrip|vaxigrip
645556|NCT00760188|knee replacement|knee replacement
645557|NCT00760201|executive|executive
645558|NCT00760201|administrator|administrator
645559|NCT00760201|perceptions|perceptions
645560|NCT00760201|legal counsel|legal counsel
645561|NCT00760201|end of life|end of life
645562|NCT00760214|Essential Hypertension|essential hypertension
645563|NCT00760214|Hypertension|hypertension
645564|NCT00760214|Drug Therapy|drug therapy
645565|NCT00760214|Blood Pressure, High|blood pressure, high
645566|NCT00760214|Vascular Disease|vascular disease
645567|NCT00760214|Cardiovascular Disease|cardiovascular disease
645568|NCT00760240|compliance|compliance
645569|NCT00760240|eyedrop instillation|eyedrop instillation
645570|NCT00760240|How patients with low vision due to glaucoma or retinal pathology instill eyedrops into their own eyes.|how patients with low vision due to glaucoma or retinal pathology instill eyedrops into their own eyes.
645571|NCT00760253|target control infusion|target control infusion
645572|NCT00760253|alfentanyl|alfentanyl
645573|NCT00760253|propofol|propofol
645575|NCT00760266|Hypertension|hypertension
645576|NCT00760266|older population|older population
645577|NCT00760266|aliskiren|aliskiren
645578|NCT00760266|hydrochlorothiazide|hydrochlorothiazide
645579|NCT00760266|systolic blood pressure|systolic blood pressure
645580|NCT00760266|diastolic blood pressure|diastolic blood pressure
645581|NCT00760266|amlodipine, stage 2|amlodipine, stage 2
645582|NCT00760279|Bacterial infection|bacterial infection
645583|NCT00760279|Azithromycin|azithromycin
645584|NCT00760292|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
645585|NCT00760292|Genetic Variants|genetic variants
645586|NCT00760292|SNP|snp
645587|NCT00760292|DNA microarray|dna microarray
645588|NCT00761722|Acute Myeloid Leukemia|acute myeloid leukemia
645589|NCT00761722|Myelodysplastic Syndromes|myelodysplastic syndromes
645590|NCT00761722|Lymphoma|lymphoma
645591|NCT00761722|Multiple Myeloma|multiple myeloma
645592|NCT00761722|Chronic Myelomonocytic Leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
645593|NCT00761748|Urostomy,|urostomy,
645594|NCT00761748|2-piece,|2-piece,
645595|NCT00761748|preference,|preference,
645596|NCT00761761|Sensoril|sensoril
645597|NCT00761761|Bipolar Illness|bipolar illness
645598|NCT00761761|Cognitive enhancement|cognitive enhancement
645599|NCT00761774|Epilepsy|epilepsy
645600|NCT00761774|Monotherapy|monotherapy
645601|NCT00761774|Partial Onset Seizures|partial onset seizures
645602|NCT00761787|allograft|allograft
645603|NCT00761787|rejection|rejection
645604|NCT00761787|biopsy|biopsy
645605|NCT00761787|gene|gene
645606|NCT00761787|expression|expression
645607|NCT00761787|cardiology|cardiology
645608|NCT00761787|heart|heart
645609|NCT00761787|transplant|transplant
645610|NCT00761813|Sliding Hip Screw Fixation|sliding hip screw fixation
645611|NCT00761813|Cannulated Screw Fixation|cannulated screw fixation
645612|NCT00761826|Mixed Astigmatism|mixed astigmatism
645613|NCT00761826|Laser In Situ Keratomileusis|laser in situ keratomileusis
645614|NCT00761826|Laser Therapy|laser therapy
645615|NCT00761826|Laser Corneal Surgery|laser corneal surgery
645616|NCT00761826|Refractive Surgical Procedures|refractive surgical procedures
645617|NCT00761826|Ophthalmologic Surgical Procedure|ophthalmologic surgical procedure
645618|NCT00761826|Operative Surgical Procedures|operative surgical procedures
645619|NCT00761826|Therapeutics|therapeutics
645620|NCT00761839|wound healing|wound healing
645621|NCT00761839|self-management|self-management
645622|NCT00761839|patient education|patient education
645623|NCT00761865|Lateral Ankle Sprin|lateral ankle sprin
645624|NCT00761865|Air Cast Stirrup Brace|air cast stirrup brace
645625|NCT00761865|High Tide Fracture Boot|high tide fracture boot
645626|NCT00761878|Skin aging|skin aging
645627|NCT00761878|Skin wrinkling|skin wrinkling
645628|NCT00761891|aspirin|aspirin
645629|NCT00761891|cyclooxygenase-1|cyclooxygenase-1
645630|NCT00761891|aspirin resistance|aspirin resistance
645631|NCT00761891|aspirin nonresponse|aspirin nonresponse
645632|NCT00761891|platelet|platelet
645633|NCT00761891|Normal volunteers|normal volunteers
645634|NCT00761904|hypertension|hypertension
645635|NCT00761904|hyperlipidemia|hyperlipidemia
645636|NCT00761904|free generic samples|free generic samples
645637|NCT00761943|Adhesive Capsulitis|adhesive capsulitis
645638|NCT00761943|Bursitis|bursitis
645639|NCT00761943|Frozen Shoulder|frozen shoulder
645640|NCT00761956|Total Knee Arthroplasty|total knee arthroplasty
645641|NCT00761956|Osteoarthritis|osteoarthritis
645642|NCT00761956|Knee|knee
645643|NCT00761969|peripheral arterial disease|peripheral arterial disease
645644|NCT00761969|secondary prevention|secondary prevention
645645|NCT00761969|cardiovascular /atherothrombotic events|cardiovascular /atherothrombotic events
645646|NCT00761969|European guidelines|european guidelines
645647|NCT00761969|Cardiovascular disease prevention|cardiovascular disease prevention
645648|NCT00761995|Raised IOP|raised iop
645649|NCT00762008|biomarkers|biomarkers
645650|NCT00762021|cataract|cataract
645651|NCT00762047|Fecal Incontinence|fecal incontinence
645652|NCT00762060|colorectal surgery|colorectal surgery
645653|NCT00762073|eosinophilic esophagitis|eosinophilic esophagitis
645654|NCT00762086|Peripheral Arterial Disease|peripheral arterial disease
645655|NCT00762086|intermittent pneumatic compression treatment|intermittent pneumatic compression treatment
645656|NCT00762086|Initial claudication|initial claudication
645657|NCT00762099|Arthroplasty, Hip|arthroplasty, hip
645658|NCT00762099|Hip replacement|hip replacement
645659|NCT00762099|Pain Management|pain management
645660|NCT00762099|Functional Rehabilitation|functional rehabilitation
645661|NCT00762099|Anxiety|anxiety
645662|NCT00762099|Perioperative|perioperative
645663|NCT00762099|Pregabalin|pregabalin
645664|NCT00762099|Arthroplasty|arthroplasty
645665|NCT00762112|Glucose Metabolism Disorder|glucose metabolism disorder
645666|NCT00762112|Dysmetabolic Syndrome|dysmetabolic syndrome
645667|NCT00762112|Type II Diabetes|type ii diabetes
645668|NCT00762112|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
645669|NCT00762112|Dyslipidemia|dyslipidemia
645670|NCT00762112|Drug Therapy.|drug therapy.
645671|NCT00762125|Fibromyalgia Syndrome|fibromyalgia syndrome
645673|NCT00762125|Physical Therapy|physical therapy
645674|NCT00762125|Psychotherapy|psychotherapy
645675|NCT00762125|Group Counseling|group counseling
645676|NCT00762125|Individual Counseling|individual counseling
645677|NCT00762125|Chronic Pain|chronic pain
645678|NCT00762138|Platelet rich plasma|platelet rich plasma
645679|NCT00762138|wounds|wounds
645680|NCT00762138|leg ulcers|leg ulcers
645681|NCT00762138|pressure ulcers|pressure ulcers
645682|NCT00762138|diabetic ulcers|diabetic ulcers
645683|NCT00762138|management of mechanically or surgically-debrided wounds|management of mechanically or surgically-debrided wounds
645684|NCT00762151|Dental Plaque|dental plaque
645685|NCT00762164|Hypercholesterolemia|hypercholesterolemia
645686|NCT00762164|Statins|statins
645687|NCT00762164|Ezetimibe|ezetimibe
645688|NCT00762190|Glucose Metabolism Disorder|glucose metabolism disorder
645689|NCT00762190|Dysmetabolic Syndrome|dysmetabolic syndrome
645690|NCT00762190|Type II Diabetes|type ii diabetes
645691|NCT00762190|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
645692|NCT00762190|Dyslipidemia|dyslipidemia
645693|NCT00762190|Drug Therapy|drug therapy
645694|NCT00762216|Cataract|cataract
645695|NCT00762229|Cholesterol|cholesterol
645696|NCT00762229|Ezetimibe|ezetimibe
645697|NCT00762242|metabolomics|metabolomics
645698|NCT00762242|flow-mediated vasodilation|flow-mediated vasodilation
645699|NCT00762255|recurrent glioblastoma|recurrent glioblastoma
645700|NCT00762255|multiple agents|multiple agents
645701|NCT00762255|immunotherapy|immunotherapy
645702|NCT00762255|chemotherapy|chemotherapy
645703|NCT00762255|brain and nervous system|brain and nervous system
645704|NCT00762268|SAMe|same
645705|NCT00762268|alternative treatments|alternative treatments
645706|NCT00762268|bipolar disorder|bipolar disorder
645707|NCT00762268|depression|depression
645708|NCT00762268|bipolar depression|bipolar depression
645709|NCT00762268|treatment-resistant depression|treatment-resistant depression
645710|NCT00762281|Hyperopia|hyperopia
645711|NCT00762281|Laser In Situ Keratomileusis|laser in situ keratomileusis
645712|NCT00762281|Laser Therapy|laser therapy
645713|NCT00762281|Laser Corneal Surgery|laser corneal surgery
645714|NCT00762281|Refractive Surgical Procedures|refractive surgical procedures
645715|NCT00762281|Ophthalmologic Surgical Procedure|ophthalmologic surgical procedure
645716|NCT00762281|Operative Surgical Procedures|operative surgical procedures
645717|NCT00762281|Therapeutics|therapeutics
645718|NCT00762294|breast cancer|breast cancer
645719|NCT00762294|arimidex|arimidex
645720|NCT00762294|femara|femara
645721|NCT00762294|bone health|bone health
645722|NCT00762320|HIV|hiv
645723|NCT00762320|Kaletra|kaletra
645724|NCT00762320|treatment Experienced|treatment experienced
645725|NCT00762346|non small cell lung cancer|non small cell lung cancer
645726|NCT00762346|NTX|ntx
645727|NCT00762346|zometa|zometa
645728|NCT00762359|Curling Ulcer|curling ulcer
645729|NCT00762359|Gastric Ulcer|gastric ulcer
645730|NCT00762359|Aspirin|aspirin
645731|NCT00762359|Acetylsalicylic Acid|acetylsalicylic acid
645732|NCT00762359|Drug Therapy|drug therapy
645733|NCT00762372|anesthesia|anesthesia
645734|NCT00762372|desflurane|desflurane
645735|NCT00762398|Major surgery, excpected blood loss, arterial line|major surgery, excpected blood loss, arterial line
645736|NCT00762411|Alzheimer's Disease|alzheimer's disease
645737|NCT00762424|Kidney stone|kidney stone
645738|NCT00762424|Ureterolithiasis|ureterolithiasis
645739|NCT00762424|Tamsulosin|tamsulosin
645740|NCT00762424|Flowmax|flowmax
645741|NCT00762424|Emergency Department|emergency department
645742|NCT00762476|cold, common|cold, common
645743|NCT00762476|rhinovirus|rhinovirus
645744|NCT00762489|Temporal artery thermometry|temporal artery thermometry
645745|NCT00762489|Rectal temperature|rectal temperature
645746|NCT00762489|Axillary temperature|axillary temperature
645747|NCT00762489|Newborns|newborns
645748|NCT00762489|Temperature measurement|temperature measurement
645749|NCT00762541|Myopia|myopia
645750|NCT00762541|Laser In Situ Keratomileusis|laser in situ keratomileusis
645751|NCT00762541|Laser Therapy|laser therapy
645752|NCT00762541|Laser Corneal Surgery|laser corneal surgery
645753|NCT00762541|Refractive Surgical Procedures|refractive surgical procedures
645754|NCT00762541|Ophthalmologic Surgical Procedure|ophthalmologic surgical procedure
645755|NCT00762541|Operative Surgical Procedures|operative surgical procedures
645756|NCT00762541|Therapeutics|therapeutics
645757|NCT00762554|analgesia|analgesia
645758|NCT00762554|cesarean section|cesarean section
645759|NCT00762554|fentanyl|fentanyl
645760|NCT00762554|Depodur|depodur
645761|NCT00762554|Post-cesarean section analgesia|post-cesarean section analgesia
645762|NCT00762580|rotator cuff|rotator cuff
645763|NCT00762580|rehabilitation|rehabilitation
645764|NCT00762593|urinary stress incontinence|urinary stress incontinence
645765|NCT00762593|urinary stress incontinence in women|urinary stress incontinence in women
645766|NCT00762606|Cataract|cataract
645767|NCT00762632|patients with c-kit+ AML|patients with c-kit+ aml
645768|NCT00762645|IOP lowering efficacy|iop lowering efficacy
645769|NCT00762645|CACG|cacg
645770|NCT00762658|Plaque Type Psoriasis|plaque type psoriasis
645771|NCT00762658|Topical|topical
645772|NCT00762684|Glucose Metabolism Disorder|glucose metabolism disorder
645773|NCT00762684|Dysmetabolic Syndrome|dysmetabolic syndrome
645774|NCT00762684|Type II Diabetes|type ii diabetes
645775|NCT00762684|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
645776|NCT00762684|Dyslipidemia|dyslipidemia
645777|NCT00762697|diabetic, venous insufficiency|diabetic, venous insufficiency
645778|NCT00762710|Alcohol|alcohol
645779|NCT00762710|Abuse|abuse
645780|NCT00762710|Use|use
645781|NCT00762710|Disorder|disorder
645782|NCT00762710|Dependence|dependence
645783|NCT00762710|Symptoms|symptoms
645784|NCT00762710|Alcoholic|alcoholic
645785|NCT00762710|Alcoholism|alcoholism
645786|NCT00762710|Prazosin|prazosin
645787|NCT00762710|Drug|drug
645789|NCT00762710|Medication|medication
645790|NCT00762710|Treatment|treatment
645791|NCT00762710|Study|study
645792|NCT00762710|Placebo|placebo
645793|NCT00762710|Medical|medical
645794|NCT00762710|Management|management
645795|NCT00762710|Craving|craving
645796|NCT00762710|Consumption|consumption
645797|NCT00762710|Binge|binge
645798|NCT00762710|Drinking|drinking
645799|NCT00762710|Drink|drink
645800|NCT00762710|Heavy|heavy
645801|NCT00762723|Degenerative Disc Disease|degenerative disc disease
645802|NCT00762723|Spinal Stenosis|spinal stenosis
645896|NCT00763035|copd|copd
645803|NCT00762723|Spondylolisthesis|spondylolisthesis
645804|NCT00762723|ALIF|alif
645805|NCT00762723|fusion success|fusion success
645806|NCT00762723|Anterior Lumbar Plate|anterior lumbar plate
645807|NCT00762723|fixed versus variable screw configurations|fixed versus variable screw configurations
645808|NCT00762723|Anterior Lumbar Interbody Fusion to treat spinal instability|anterior lumbar interbody fusion to treat spinal instability
645809|NCT00762736|Glucose Metabolism Disorder|glucose metabolism disorder
645810|NCT00762736|Dysmetabolic Syndrome|dysmetabolic syndrome
645811|NCT00762736|Type II Diabetes|type ii diabetes
645812|NCT00762736|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
645813|NCT00762736|Dyslipidemia|dyslipidemia
645814|NCT00762736|Drug Therapy|drug therapy
645815|NCT00762775|Bone resorption|bone resorption
645816|NCT00762775|Calcium homeostasis|calcium homeostasis
645817|NCT00762775|Bone markers|bone markers
645818|NCT00762775|Calcium and Vitamin D supplementation|calcium and vitamin d supplementation
645819|NCT00762775|Parathyroid hormone levels|parathyroid hormone levels
645820|NCT00762775|Interaction between calcium and vitamin D supplementation|interaction between calcium and vitamin d supplementation
645821|NCT00762801|RLIP76|rlip76
645822|NCT00762801|Cancer|cancer
645823|NCT00762801|apoptosis|apoptosis
645824|NCT00762814|Parkinson disease|parkinson disease
645825|NCT00762814|Individuals|individuals
645826|NCT00762814|frequent|frequent
645827|NCT00762814|freezing|freezing
645828|NCT00762814|during|during
645829|NCT00762814|gait|gait
645830|NCT00762840|Periapical lesions|periapical lesions
645831|NCT00762840|Apical Periodontitis|apical periodontitis
645832|NCT00762840|endodontic procedure|endodontic procedure
645833|NCT00762840|root canal treatment|root canal treatment
645834|NCT00762866|Major Depressive Disorder|major depressive disorder
645835|NCT00762866|Depression|depression
645836|NCT00762866|Bipolar I Disorder|bipolar i disorder
645837|NCT00762866|Bipolar II Disorder|bipolar ii disorder
645838|NCT00762866|Bipolar Disorder NOS|bipolar disorder nos
645839|NCT00762866|Psychotic Disorder|psychotic disorder
645840|NCT00762866|Schizophrenia|schizophrenia
645841|NCT00762866|Schizoaffective Disorder|schizoaffective disorder
645842|NCT00762879|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
645843|NCT00762879|JIA|jia
645844|NCT00762879|Arthritis|arthritis
645845|NCT00762879|Osteoporosis|osteoporosis
645846|NCT00762879|Osteoporosis in Children|osteoporosis in children
645847|NCT00762892|Raltegravir|raltegravir
645848|NCT00762892|Integrase inhibitor|integrase inhibitor
645849|NCT00762892|Protease inhibitor|protease inhibitor
645850|NCT00762892|Naive patients|naive patients
645851|NCT00762892|HIV disease|hiv disease
645852|NCT00762892|Lipids|lipids
645853|NCT00762892|Treatment Naïve|treatment naïve
645854|NCT00762905|cyanoacrylate|cyanoacrylate
645855|NCT00762905|LiquiBand Laparoscopic|liquiband laparoscopic
645856|NCT00762905|Dermabond|dermabond
645857|NCT00762905|The rate of complete dermal apposition|the rate of complete dermal apposition
645858|NCT00762905|The rate of wound infections and wound dehiscence|the rate of wound infections and wound dehiscence
645859|NCT00762905|The rate of optimal cosmesis|the rate of optimal cosmesis
645860|NCT00762918|cystic fibrosis|cystic fibrosis
645861|NCT00762918|vitamin d|vitamin d
645862|NCT00762918|inflammation|inflammation
645863|NCT00762931|bronchoconstriction|bronchoconstriction
645864|NCT00762931|neuromodulation|neuromodulation
645865|NCT00762931|neurostimulation|neurostimulation
645866|NCT00762931|vagus nerve stimulation|vagus nerve stimulation
645867|NCT00762931|vagal nerve stimulation|vagal nerve stimulation
645868|NCT00762931|nVNS|nvns
645869|NCT00762931|VNS|vns
645870|NCT00762931|non invasive|non invasive
645871|NCT00762931|gammacore|gammacore
645872|NCT00762944|Patients requiring total joint reconstruction due to:|patients requiring total joint reconstruction due to:
645873|NCT00762944|Arthritis (osteo-, rheumatoid, traumatic) malignancy|arthritis (osteo-, rheumatoid, traumatic) malignancy
645874|NCT00762944|Ankylosis functional deformity|ankylosis functional deformity
645875|NCT00762944|Avascular necrosis revisions|avascular necrosis revisions
645876|NCT00762944|Benign neoplasms fracture|benign neoplasms fracture
645877|NCT00762944|Multiple operated joints|multiple operated joints
645878|NCT00762957|Glucose Metabolism Disorder|glucose metabolism disorder
645879|NCT00762957|Dysmetabolic Syndrome|dysmetabolic syndrome
645880|NCT00762957|Type II Diabetes|type ii diabetes
645881|NCT00762957|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
645882|NCT00762957|Dyslipidemia|dyslipidemia
645883|NCT00762957|Drug Therapy|drug therapy
645884|NCT00763022|Glucose Metabolism Disorder|glucose metabolism disorder
645885|NCT00763022|Dysmetabolic Syndrome|dysmetabolic syndrome
645886|NCT00763022|Type II Diabetes|type ii diabetes
645887|NCT00763022|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
645888|NCT00763022|Dyslipidemia|dyslipidemia
645889|NCT00763022|Drug Therapy|drug therapy
645890|NCT00763035|Coronary Artery Disease|coronary artery disease
645891|NCT00763035|Coronary Vessels|coronary vessels
645892|NCT00763035|Myocardial Ischemia|myocardial ischemia
645893|NCT00763035|Coronary Disease|coronary disease
645894|NCT00763035|Ischemic heart disease|ischemic heart disease
645895|NCT00763035|asthma|asthma
645897|NCT00763061|Glaucoma|glaucoma
645898|NCT00763074|Intra-Abdominal Fat|intra-abdominal fat
645899|NCT00763074|Adipokines|adipokines
645900|NCT00763074|Exercise|exercise
645901|NCT00763074|Diet therapy|diet therapy
645902|NCT00763087|diabetes mellitus|diabetes mellitus
645903|NCT00763087|peripheral neuropathy|peripheral neuropathy
645904|NCT00763087|exercise|exercise
645905|NCT00763100|Breast cancer|breast cancer
646009|NCT00763568|Chronic hepatitis C|chronic hepatitis c
645906|NCT00763100|Three dimensional versus two dimensional|three dimensional versus two dimensional
645907|NCT00763100|Breast cancer surveillance|breast cancer surveillance
645908|NCT00763100|Tomosynthesis|tomosynthesis
645909|NCT00763126|parturient|parturient
645910|NCT00763126|epidural analgesia|epidural analgesia
645912|NCT00763126|spouse|spouse
645913|NCT00763126|Stress levels|stress levels
645914|NCT00763126|Salivary amylase|salivary amylase
645915|NCT00763139|RA|ra
645916|NCT00763139|Rheumatoid Arthritis|rheumatoid arthritis
645917|NCT00763152|prostate|prostate
645918|NCT00763152|prostate bed|prostate bed
645919|NCT00763152|periprostatic|periprostatic
645920|NCT00763178|PTSD|ptsd
645921|NCT00763204|Plaque Type Psoriasis|plaque type psoriasis
645922|NCT00763204|Topical|topical
645923|NCT00763217|inflammation|inflammation
645924|NCT00763217|coagulation|coagulation
645925|NCT00763217|neuroprotection|neuroprotection
645926|NCT00763217|drugs|drugs
645927|NCT00763217|clinical neurology|clinical neurology
645928|NCT00763217|pharmacology|pharmacology
645929|NCT00763217|biological factors|biological factors
645930|NCT00763230|Depression|depression
645931|NCT00763230|Treatment|treatment
645932|NCT00763230|Transcranial direct current stimulation|transcranial direct current stimulation
645933|NCT00763243|profound bilateral hearing loss with cochlear implants|profound bilateral hearing loss with cochlear implants
645934|NCT00763282|Spinal cord injuries|spinal cord injuries
645935|NCT00763282|Pressure ulcers|pressure ulcers
645936|NCT00763282|Health behavior|health behavior
645937|NCT00763282|self management|self management
645938|NCT00763282|Rehabilitation|rehabilitation
645939|NCT00763282|Outcome assessment|outcome assessment
645940|NCT00763282|QUERI|queri
645941|NCT00763282|Veterans|veterans
645942|NCT00763295|latent tuberculosis|latent tuberculosis
645943|NCT00763295|HIV|hiv
645944|NCT00763295|IFN-γ based assay|ifn-γ based assay
645945|NCT00763308|Weight|weight
645946|NCT00763308|Blood Pressure|blood pressure
645947|NCT00763308|Smoking Status|smoking status
645948|NCT00763308|Cardiovascular Risk Profile|cardiovascular risk profile
645949|NCT00763321|Effect on sleep interference by pain|effect on sleep interference by pain
645950|NCT00763347|Glucose Metabolism Disorder|glucose metabolism disorder
645951|NCT00763347|Dysmetabolic Syndrome|dysmetabolic syndrome
645952|NCT00763347|Type II Diabetes|type ii diabetes
645953|NCT00763347|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
645954|NCT00763347|Dyslipidemia|dyslipidemia
645955|NCT00763347|Drug Therapy|drug therapy
645956|NCT00763360|Cataract|cataract
645957|NCT00763373|Lower respiratory infection|lower respiratory infection
645958|NCT00763373|Upper respiratory infection|upper respiratory infection
645959|NCT00763373|Urinary tract infection|urinary tract infection
645960|NCT00763373|Soft tissue infection|soft tissue infection
645961|NCT00763373|Hepatobiliary infection|hepatobiliary infection
645962|NCT00763386|Total Knee Arthroplasty|total knee arthroplasty
645963|NCT00763386|Osteoarthritis|osteoarthritis
645964|NCT00763386|Knee|knee
645965|NCT00763399|probiotics|probiotics
645966|NCT00763412|Cystic Fibrosis|cystic fibrosis
645967|NCT00763412|Diabetes|diabetes
645968|NCT00763412|Cystic Fibrosis Related Diabetes|cystic fibrosis related diabetes
645969|NCT00763412|Pre-diabetes|pre-diabetes
645970|NCT00763412|oral hypoglycemic agents|oral hypoglycemic agents
645971|NCT00763412|Repaglinide|repaglinide
645972|NCT00763412|treatment|treatment
645973|NCT00763412|inflammatory markers|inflammatory markers
645974|NCT00763412|Lung function|lung function
645975|NCT00763412|nutrition|nutrition
645976|NCT00763425|polypectomy|polypectomy
645977|NCT00763425|colonic polyp|colonic polyp
645978|NCT00763425|colorectal polyp|colorectal polyp
645979|NCT00763425|colorectal cancer prevention|colorectal cancer prevention
645980|NCT00763438|Schizophrenia|schizophrenia
645981|NCT00763438|Sertindole|sertindole
645982|NCT00763438|Safety study|safety study
645983|NCT00763451|hyperglycemia, GLP-1|hyperglycemia, glp-1
646511|NCT00755898|urine|urine
645984|NCT00763464|Coronary Artery Disease|coronary artery disease
645985|NCT00763464|ischemia diagnostic|ischemia diagnostic
645986|NCT00763477|Cystic fibrosis|cystic fibrosis
645987|NCT00763477|Weight|weight
645988|NCT00763477|Appetite|appetite
645989|NCT00763477|Ghrelin|ghrelin
645990|NCT00763477|Cystic fibrosis with low BMI|cystic fibrosis with low bmi
645991|NCT00763490|umbilical cord blood|umbilical cord blood
645992|NCT00763490|stem cell transplant|stem cell transplant
645993|NCT00763490|leukemia|leukemia
645994|NCT00763490|multiple myeloma|multiple myeloma
645995|NCT00763490|lymphoma|lymphoma
645996|NCT00763503|psoriasis|psoriasis
645997|NCT00763503|PK|pk
645998|NCT00763503|calcitriol|calcitriol
645999|NCT00763516|Pancreatic Cancer|pancreatic cancer
646000|NCT00763516|Proton radiation|proton radiation
646001|NCT00763516|Chemotherapy|chemotherapy
646002|NCT00763516|Xeloda|xeloda
646003|NCT00763516|Gemzar|gemzar
646004|NCT00763516|Resectable|resectable
646005|NCT00763516|Surgery|surgery
646006|NCT00763555|psoriasis|psoriasis
646007|NCT00763555|spray|spray
646008|NCT00763555|calcitriol|calcitriol
646010|NCT00763568|Viral hepatitis|viral hepatitis
646011|NCT00763581|Patient Non-Adherence|patient non-adherence
646012|NCT00763581|Patient Non-Compliance|patient non-compliance
646013|NCT00763581|Patient Nonadherence|patient nonadherence
646014|NCT00763581|Patient Noncompliance|patient noncompliance
646015|NCT00763581|Patient Refusal of Treatment|patient refusal of treatment
646016|NCT00763581|Treatment Refusal|treatment refusal
646017|NCT00763581|Refusal of Treatment|refusal of treatment
646018|NCT00763594|Major Depression|major depression
646019|NCT00763594|Interpersonal Psychotherapy|interpersonal psychotherapy
646020|NCT00763594|Brief Relational Therapy|brief relational therapy
646021|NCT00763594|Outcome research|outcome research
646022|NCT00763607|non small cell lung cancer patients|non small cell lung cancer patients
646023|NCT00763620|Community acquired pneumonia|community acquired pneumonia
646024|NCT00763620|Nosocomial pneumonia|nosocomial pneumonia
646025|NCT00763620|Mini bronchoalveolar lavage|mini bronchoalveolar lavage
646026|NCT00763620|Endotracheal aspirates|endotracheal aspirates
646027|NCT00763620|Expectorated sputum|expectorated sputum
646028|NCT00763633|nausea|nausea
646029|NCT00763633|vomiting|vomiting
646030|NCT00763633|pregnancy|pregnancy
646031|NCT00763633|B6|b6
646032|NCT00763646|Gastric or Gastroesophageal Junction Adenocarcinoma|gastric or gastroesophageal junction adenocarcinoma
646033|NCT00763672|Preeclampsia|preeclampsia
646034|NCT00763672|Hypertension|hypertension
646035|NCT00763672|Intra uterine growth retardation|intra uterine growth retardation
646036|NCT00763672|Antiangiogenic factor|antiangiogenic factor
646037|NCT00763672|Prevention|prevention
646038|NCT00763685|preoperative pain prophylaxis|preoperative pain prophylaxis
646039|NCT00763685|postoperative pain|postoperative pain
646040|NCT00763698|Left heart pacing lead|left heart pacing lead
646041|NCT00763698|Cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
646042|NCT00763698|Heart failure|heart failure
646043|NCT00763698|ICD|icd
646044|NCT00763711|Urinary Incontinence|urinary incontinence
646045|NCT00763711|ISD|isd
646046|NCT00763737|congenital diaphragmatic hernia|congenital diaphragmatic hernia
646047|NCT00763737|fetal surgery|fetal surgery
646048|NCT00763737|pulmonary hypoplasia|pulmonary hypoplasia
646049|NCT00763737|observed/expected lung to head ratio|observed/expected lung to head ratio
646050|NCT00763737|liver position|liver position
646051|NCT00763737|feto|feto
646052|NCT00763737|fetoscopic endoluminal tracheal occlusion|fetoscopic endoluminal tracheal occlusion
646053|NCT00763737|standardized neonatal care|standardized neonatal care
646054|NCT00763750|glioblastoma multiforme or anaplastic glioma|glioblastoma multiforme or anaplastic glioma
646055|NCT00763763|Imatinib mesylate|imatinib mesylate
646056|NCT00763763|Combination therapy|combination therapy
646057|NCT00763763|Leukemia, Lymphocytic, Acute|leukemia, lymphocytic, acute
646058|NCT00763763|Philadelphia Chromosome|philadelphia chromosome
646059|NCT00763763|Blast Crisis|blast crisis
646060|NCT00763763|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
646061|NCT00763776|Liver cirrhosis|liver cirrhosis
646062|NCT00763776|Hepatectomy|hepatectomy
646063|NCT00763776|Liver parenchyma transection|liver parenchyma transection
646064|NCT00763776|Randomized controlled trial|randomized controlled trial
646065|NCT00763789|conscious sedation|conscious sedation
646066|NCT00763789|remifentanil|remifentanil
646067|NCT00763789|hysteroscopic surgery|hysteroscopic surgery
646068|NCT00763789|anesthesia recovery period|anesthesia recovery period
646069|NCT00763789|ambulatory surgery|ambulatory surgery
646070|NCT00763789|patient satisfaction|patient satisfaction
646071|NCT00763789|length of stay|length of stay
646072|NCT00763815|hyperglycemia GLP-1 pioglitazone|hyperglycemia glp-1 pioglitazone
646073|NCT00763828|Myocardial Infarction|myocardial infarction
646074|NCT00763828|Hypothermia, Induced|hypothermia, induced
646075|NCT00763841|Auditory hallucinations|auditory hallucinations
646076|NCT00763867|Heart Failure, Diastolic|heart failure, diastolic
646077|NCT00763867|Decompensated Heart Failure|decompensated heart failure
646078|NCT00763867|Sildenafil|sildenafil
646713|NCT00756730|AIDS|aids
646079|NCT00763867|Exercise Capacity|exercise capacity
646080|NCT00763880|Hematoma block|hematoma block
646081|NCT00763880|Lidocaine|lidocaine
646082|NCT00763880|Forearm fracture|forearm fracture
646083|NCT00763880|Radius fracture|radius fracture
646084|NCT00763880|Ulna fracture|ulna fracture
646085|NCT00763880|Ketamine|ketamine
646086|NCT00763880|Midazolam|midazolam
646087|NCT00763880|Procedural sedation|procedural sedation
646088|NCT00763893|Marfan syndrome|marfan syndrome
646089|NCT00763893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
646090|NCT00763893|Aortic Aneurysm, Thoracic|aortic aneurysm, thoracic
646091|NCT00763906|septic shock|septic shock
646092|NCT00763906|fuzzy logic|fuzzy logic
646093|NCT00763906|norepinephrine weaning|norepinephrine weaning
646094|NCT00763919|Patient Non-Adherence|patient non-adherence
646095|NCT00763919|Patient Non-Compliance|patient non-compliance
646096|NCT00763919|Patient Nonadherence|patient nonadherence
646097|NCT00763919|Patient Noncompliance|patient noncompliance
646098|NCT00763919|Patient Refusal of Treatment|patient refusal of treatment
646099|NCT00763919|Refusal of Treatment|refusal of treatment
646100|NCT00763919|Treatment Refusal|treatment refusal
646101|NCT00763945|Acute coronary Syndrome|acute coronary syndrome
646102|NCT00763945|STEMI|stemi
646103|NCT00763945|NSTEMI|nstemi
646104|NCT00763945|Registry|registry
646105|NCT00763958|opiates|opiates
646106|NCT00763958|HIV|hiv
646107|NCT00763984|Bladder Control for Women|bladder control for women
646108|NCT00763984|Exercising Your Pelvic Muscles|exercising your pelvic muscles
646109|NCT00763984|Kegel Exercises: How to Strengthen Pelvic Floor Muscles|kegel exercises: how to strengthen pelvic floor muscles
646110|NCT00763984|Kegel Exercises for Your Pelvic Muscles|kegel exercises for your pelvic muscles
646111|NCT00763984|Pelvic Floor Disorders|pelvic floor disorders
646112|NCT00763984|Pelvic Support Problems|pelvic support problems
646113|NCT00763984|Pregnancy|pregnancy
646114|NCT00763984|Pregnancy Childbirth and Bladder Control|pregnancy childbirth and bladder control
646115|NCT00763984|Urinary Incontinence|urinary incontinence
646116|NCT00763984|Urinary Incontinence: Embarrassing but Treatable|urinary incontinence: embarrassing but treatable
646117|NCT00763997|dipyrone|dipyrone
646118|NCT00763997|platelet aggregation|platelet aggregation
646119|NCT00763997|neuraxial blockage|neuraxial blockage
646120|NCT00763997|ibuprofen|ibuprofen
646121|NCT00763997|platelet aggregation under dipyrone compared to ibuprofen, acetaminophen and parecoxib/valdecoxib|platelet aggregation under dipyrone compared to ibuprofen, acetaminophen and parecoxib/valdecoxib
646122|NCT00763997|neuraxial blockage in patients receiving ibuprofen is critical in special circumstances, but traditionally not fpr dipyrone|neuraxial blockage in patients receiving ibuprofen is critical in special circumstances, but traditionally not fpr dipyrone
646123|NCT00764023|wound debridement|wound debridement
646124|NCT00764023|removed orthopedic implants|removed orthopedic implants
646125|NCT00764023|removed catheters or shunts|removed catheters or shunts
646126|NCT00764023|excised tonsils, amputated tissue|excised tonsils, amputated tissue
646127|NCT00764023|sputum|sputum
646128|NCT00764023|stool|stool
646129|NCT00764023|other excretions.|other excretions.
646130|NCT00764036|phase I|phase i
646131|NCT00764036|safety|safety
646132|NCT00764049|Albumin dialysis|albumin dialysis
646133|NCT00764049|Artificial liver support|artificial liver support
646134|NCT00764049|Acute on chronic liver failure|acute on chronic liver failure
646135|NCT00764062|Amoxicillin|amoxicillin
646136|NCT00764062|Drug resistance, microbial|drug resistance, microbial
646137|NCT00764062|Streptococcus|streptococcus
646138|NCT00764062|Surgery, oral|surgery, oral
646139|NCT00764075|heart failure; EF<35%; NYHA II, III or IV|heart failure; ef<35%; nyha ii, iii or iv
646140|NCT00764088|full Thickness wounds|full thickness wounds
646141|NCT00764114|Spondylodiscitis|spondylodiscitis
646142|NCT00764114|Duration treatment|duration treatment
646143|NCT00764114|Antibiotic|antibiotic
646144|NCT00764114|men or women more than 18 years|men or women more than 18 years
646145|NCT00764114|proved bacterial spondylodiscitis|proved bacterial spondylodiscitis
646146|NCT00764114|patient for which is decided a treatment antibiotic|patient for which is decided a treatment antibiotic
646147|NCT00764114|the diagnosis on clinical|the diagnosis on clinical
646148|NCT00764114|Radiological|radiological
646149|NCT00764114|microbiological criteria|microbiological criteria
646150|NCT00764127|adolescent|adolescent
646151|NCT00764127|obesity|obesity
646152|NCT00764127|bariatric surgery|bariatric surgery
646153|NCT00764127|eating|eating
646154|NCT00764140|tumor growth factor|tumor growth factor
646155|NCT00764153|Displaced Femoral Neck Fractures|displaced femoral neck fractures
646156|NCT00764153|Treatment|treatment
646157|NCT00764153|Function|function
646158|NCT00764153|Pain|pain
646159|NCT00764153|Quality of life|quality of life
646160|NCT00764153|Complications|complications
646161|NCT00764153|Reoperations|reoperations
646162|NCT00764153|Internal Fixation|internal fixation
646163|NCT00764153|Hemiarthroplasty|hemiarthroplasty
646164|NCT00764153|Activities of Daily Living|activities of daily living
646165|NCT00764166|PSA (biochemical)|psa (biochemical)
646166|NCT00764166|Progression- free Survival|progression- free survival
646167|NCT00764166|Clinical progress|clinical progress
646714|NCT00756730|HIV|hiv
646168|NCT00764166|Overall survival|overall survival
646169|NCT00764166|Tolerance to the treatment|tolerance to the treatment
646170|NCT00764166|Quality of Live|quality of live
646171|NCT00764179|Neonates with intra-uterine growth delay|neonates with intra-uterine growth delay
646172|NCT00764192|hemodialysis|hemodialysis
646173|NCT00764192|Flow-mediated dilation|flow-mediated dilation
646174|NCT00764192|nictric oxide|nictric oxide
646175|NCT00764192|endothelial function|endothelial function
646176|NCT00764205|ACS|acs
646177|NCT00764205|non STEMI|non stemi
646178|NCT00764205|ECG troponin|ecg troponin
646179|NCT00764205|iSTAT|istat
646245|NCT00755040|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
646180|NCT00764205|Acute coronary syndrome without ST-segment elevation|acute coronary syndrome without st-segment elevation
646181|NCT00764218|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
646182|NCT00764218|Hypertension|hypertension
646183|NCT00764218|Cardiovascular phenotype|cardiovascular phenotype
646184|NCT00764231|acute myeloid leukemia|acute myeloid leukemia
646185|NCT00764231|exercise|exercise
646186|NCT00764231|fatigue|fatigue
646187|NCT00764231|quality of life|quality of life
646188|NCT00764231|home-based|home-based
646190|NCT00755001|Total Hip Replacement|total hip replacement
646191|NCT00755027|Parkinson's disease|parkinson's disease
646192|NCT00755027|Apathy|apathy
646193|NCT00755027|Rasagiline|rasagiline
646194|NCT00755040|graft versus host disease|graft versus host disease
646195|NCT00755040|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
646196|NCT00755040|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
646197|NCT00755040|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
646198|NCT00755040|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
646199|NCT00755040|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
646200|NCT00755040|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
646303|NCT00755196|Topical|topical
646201|NCT00755040|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
646202|NCT00755040|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
646203|NCT00755040|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
646204|NCT00755040|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
646205|NCT00755040|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
646206|NCT00755040|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
646207|NCT00755040|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
646208|NCT00755040|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
646209|NCT00755040|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
646210|NCT00755040|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
646211|NCT00755040|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
646212|NCT00755040|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
646213|NCT00755040|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
646214|NCT00755040|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
646215|NCT00755040|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
646216|NCT00755040|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
646217|NCT00755040|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
646218|NCT00755040|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
646219|NCT00755040|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
646220|NCT00755040|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
646221|NCT00755040|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
646222|NCT00755040|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
646223|NCT00755040|splenic marginal zone lymphoma|splenic marginal zone lymphoma
646224|NCT00755040|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
646225|NCT00755040|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
646226|NCT00755040|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
646227|NCT00755040|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
646228|NCT00755040|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
646229|NCT00755040|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
646230|NCT00755040|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
646231|NCT00755040|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
646232|NCT00755040|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
646233|NCT00755040|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
646234|NCT00755040|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
646235|NCT00755040|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
646236|NCT00755040|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
646321|NCT00755248|Coronary Artery Bypass Grafting (CABG)|coronary artery bypass grafting (cabg)
646237|NCT00755040|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
646238|NCT00755040|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
646239|NCT00755040|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
646240|NCT00755040|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
646241|NCT00755040|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
646242|NCT00755040|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
752853|NCT01174485|metabolism|metabolism
646243|NCT00755040|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
646244|NCT00755040|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
646246|NCT00755040|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
646247|NCT00755040|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
646248|NCT00755040|secondary acute myeloid leukemia|secondary acute myeloid leukemia
646249|NCT00755040|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
646250|NCT00755040|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
646251|NCT00755040|chronic eosinophilic leukemia|chronic eosinophilic leukemia
646252|NCT00755040|primary myelofibrosis|primary myelofibrosis
646632|NCT00756405|Supplements|supplements
646253|NCT00755040|chronic neutrophilic leukemia|chronic neutrophilic leukemia
646254|NCT00755040|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
646255|NCT00755040|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
646256|NCT00755040|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
646257|NCT00755040|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
646258|NCT00755040|stage I multiple myeloma|stage i multiple myeloma
646259|NCT00755040|stage II multiple myeloma|stage ii multiple myeloma
646260|NCT00755040|stage III multiple myeloma|stage iii multiple myeloma
646261|NCT00755053|Clotrimazole|clotrimazole
646262|NCT00755053|Ovule|ovule
646263|NCT00755053|Tablet|tablet
646264|NCT00755053|Vulvovaginal candidiasis|vulvovaginal candidiasis
646265|NCT00755053|Non-inferiority|non-inferiority
646266|NCT00755079|spinal cord injury|spinal cord injury
646267|NCT00755079|beta-2 agonist|beta-2 agonist
646268|NCT00755079|respiratory muscle strength|respiratory muscle strength
646269|NCT00755079|pulmonary function test|pulmonary function test
646270|NCT00755092|Doula|doula
646271|NCT00755092|Psychological care|psychological care
646272|NCT00755092|Labor analgesia|labor analgesia
646273|NCT00755105|body iron excretion|body iron excretion
646274|NCT00755105|Iron isotopes|iron isotopes
646275|NCT00755118|Metastatic colorectal cancer|metastatic colorectal cancer
646276|NCT00755118|Second line|second line
646277|NCT00755118|Irinotecan|irinotecan
646278|NCT00755118|Cetuximab|cetuximab
646279|NCT00755118|Bevacizumab|bevacizumab
646280|NCT00755131|Cardiac Rehabilitation|cardiac rehabilitation
646281|NCT00755131|High Mobility Group Box proteins|high mobility group box proteins
646282|NCT00755131|Inflammatory markers|inflammatory markers
646283|NCT00755131|Cardiopulmonary Functional Capacity|cardiopulmonary functional capacity
646284|NCT00755131|Maximal Oxygen Consumption|maximal oxygen consumption
646285|NCT00755131|Echocardiography|echocardiography
646286|NCT00755131|Left Ventricular Ejection Fraction|left ventricular ejection fraction
646287|NCT00755131|Left Ventricular Chambers Dilation|left ventricular chambers dilation
646288|NCT00755131|Left Ventricular Remodeling|left ventricular remodeling
646289|NCT00755131|Left Atrium Remodeling|left atrium remodeling
646290|NCT00755131|Cardiac Remodeling|cardiac remodeling
646291|NCT00755131|Exercise Training|exercise training
646292|NCT00755157|Cancer|cancer
646293|NCT00755157|SCLC|sclc
646294|NCT00755157|Docetaxel|docetaxel
646295|NCT00755157|Bevacizumab|bevacizumab
646296|NCT00755157|Chemotherapy|chemotherapy
646297|NCT00755170|Vinorelbine|vinorelbine
646298|NCT00755170|Bevacizumab|bevacizumab
646299|NCT00755170|Chemotherapy|chemotherapy
646300|NCT00755183|Meibomian Gland Dysfunction|meibomian gland dysfunction
646301|NCT00755183|Dry Eye Syndrome|dry eye syndrome
646302|NCT00755196|Plaque Type Psoriasis|plaque type psoriasis
646304|NCT00755209|Traumatic brain injury (TBI)|traumatic brain injury (tbi)
646306|NCT00755209|Moderately severe TBI|moderately severe tbi
646307|NCT00755209|Delayed traumatic intracranial haemorrhage|delayed traumatic intracranial haemorrhage
646308|NCT00755209|Expanding traumatic intracranial haemorrhage|expanding traumatic intracranial haemorrhage
646309|NCT00755209|Progressive intracranial haemorrhage (PIH)|progressive intracranial haemorrhage (pih)
646310|NCT00755209|Antifibrinolytic agent|antifibrinolytic agent
646311|NCT00755209|Tranexamic acid (TXA)|tranexamic acid (txa)
646312|NCT00755209|Randomised, placebo-controlled trial|randomised, placebo-controlled trial
646313|NCT00755209|Human|human
646314|NCT00755222|Peyronie's disease|peyronie's disease
646315|NCT00755222|penile plaque|penile plaque
646316|NCT00755222|penile curvature|penile curvature
646317|NCT00755235|Depression|depression
646318|NCT00755235|Primary care|primary care
646319|NCT00755235|Effectiveness|effectiveness
646320|NCT00755235|Care management|care management
646322|NCT00755248|outcome|outcome
646323|NCT00755248|saphenous graft patency|saphenous graft patency
646324|NCT00755248|biochemical factors|biochemical factors
646325|NCT00755248|genomics|genomics
646326|NCT00755261|STS|sts
646327|NCT00755274|Influenza|influenza
646328|NCT00755274|Orthomyxoviruses|orthomyxoviruses
646329|NCT00755274|Orthomyxoviridae Infections|orthomyxoviridae infections
646330|NCT00755274|Influenza vaccine|influenza vaccine
646331|NCT00755300|Total knee replacement|total knee replacement
646332|NCT00755300|esophageal echocardiography|esophageal echocardiography
646333|NCT00755313|cognitive/functional effects|cognitive/functional effects
646334|NCT00755313|fatigue|fatigue
646335|NCT00755313|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
647105|NCT00767754|PET|pet
646336|NCT00755313|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
646337|NCT00755313|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
646338|NCT00755313|neurotoxicity|neurotoxicity
646339|NCT00755313|stage IA breast cancer|stage ia breast cancer
646340|NCT00755313|stage IB breast cancer|stage ib breast cancer
646341|NCT00755313|stage II breast cancer|stage ii breast cancer
646342|NCT00755313|stage IIIA breast cancer|stage iiia breast cancer
646343|NCT00755313|stage IIIB breast cancer|stage iiib breast cancer
646344|NCT00755313|stage IIIC breast cancer|stage iiic breast cancer
646345|NCT00755313|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
646346|NCT00755313|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
646347|NCT00755313|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
646348|NCT00755313|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
646349|NCT00755326|OA|oa
646350|NCT00755339|Repetitive TMS (rTMS)|repetitive tms (rtms)
646351|NCT00755339|Magnetoencephalogram|magnetoencephalogram
646352|NCT00755339|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
646353|NCT00755339|Tourette Syndrome|tourette syndrome
646354|NCT00755339|Tic Disorder|tic disorder
646355|NCT00755339|Tourete Syndrome|tourete syndrome
646356|NCT00755365|pelvic fractures|pelvic fractures
646357|NCT00755365|angioembolism|angioembolism
646358|NCT00755365|Treatment at Hershey Medical Center|treatment at hershey medical center
646359|NCT00755365|Angioembolization in Operating Room|angioembolization in operating room
646360|NCT00755378|Phase I|phase i
646361|NCT00755391|BN and subthreshold BN|bn and subthreshold bn
646362|NCT00755404|Peritoneal dialysis|peritoneal dialysis
646363|NCT00755404|L-carnitine|l-carnitine
646364|NCT00755404|Diabetes|diabetes
646365|NCT00755404|Glucose homeostasis|glucose homeostasis
646366|NCT00755404|Dyslipidemia|dyslipidemia
646367|NCT00755417|Hot flashes|hot flashes
646368|NCT00755417|Hot flushes|hot flushes
646369|NCT00755417|Postmenopausal symptoms|postmenopausal symptoms
646370|NCT00755417|Vasomotor symptoms|vasomotor symptoms
646371|NCT00755430|autism spectrum disorders (ASD)|autism spectrum disorders (asd)
646372|NCT00755430|structural and functional connectivity|structural and functional connectivity
646373|NCT00755430|diffusion spectrum imaging (DSI)|diffusion spectrum imaging (dsi)
646374|NCT00755430|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
646375|NCT00755430|siblings|siblings
646376|NCT00755430|repeated follow-up measurement|repeated follow-up measurement
646377|NCT00755456|Peritoneal dialysis|peritoneal dialysis
646378|NCT00755456|L-carnitine|l-carnitine
646379|NCT00755456|Insulin resistance|insulin resistance
646380|NCT00755456|Glucose homeostasis|glucose homeostasis
646381|NCT00755456|Dyslipidemia|dyslipidemia
646382|NCT00755469|Reperfusion injury|reperfusion injury
646383|NCT00755469|Post-Conditioning|post-conditioning
646384|NCT00755469|Infarct size|infarct size
646385|NCT00755482|Osteoarthritis|osteoarthritis
646386|NCT00755482|Clinical trial|clinical trial
646387|NCT00755482|Aquamin F|aquamin f
646388|NCT00755482|NSAID|nsaid
646389|NCT00755495|Chronic Insomnia|chronic insomnia
646390|NCT00755495|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
646391|NCT00755495|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
646392|NCT00755495|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
646393|NCT00755495|Transient Insomnia|transient insomnia
646394|NCT00755495|Drug Therapy|drug therapy
646395|NCT00755495|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
646396|NCT00755508|Chronic Insomnia|chronic insomnia
646397|NCT00755508|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
646398|NCT00755508|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
646399|NCT00755508|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
646400|NCT00755508|Transient Insomnia|transient insomnia
646401|NCT00755508|Drug Therapy|drug therapy
646402|NCT00755508|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
646403|NCT00755521|Fibromyalgia|fibromyalgia
646404|NCT00755521|tenderness|tenderness
646405|NCT00755521|widespread pain|widespread pain
646406|NCT00755521|comrbidity|comrbidity
646407|NCT00755534|Metastatic colorectal cancer|metastatic colorectal cancer
646408|NCT00755534|Second line|second line
646409|NCT00755534|Irinotecan|irinotecan
646410|NCT00755534|Cetuximab (Erbitux)|cetuximab (erbitux)
646411|NCT00755534|Capecitabine (Xeloda)|capecitabine (xeloda)
646412|NCT00755547|Childhood|childhood
646413|NCT00755547|insulin sensitivity|insulin sensitivity
646414|NCT00755547|steatosis, spectroscopy|steatosis, spectroscopy
646415|NCT00755560|Toxocara|toxocara
646416|NCT00755560|Pediatrics|pediatrics
646417|NCT00755560|Albendazole|albendazole
646418|NCT00755560|eosinophilia|eosinophilia
646419|NCT00755560|parasitology|parasitology
646420|NCT00755560|pediatric clinical pharmacology|pediatric clinical pharmacology
646421|NCT00755573|Pain|pain
646422|NCT00755573|Neuropathic pain|neuropathic pain
646423|NCT00755586|Brachial plexus|brachial plexus
646424|NCT00755586|Muscle denervation|muscle denervation
646425|NCT00755586|Stem cell transplantation|stem cell transplantation
646426|NCT00755586|Bone marrow cells|bone marrow cells
646427|NCT00755586|Satellite cells|satellite cells
646428|NCT00755586|Fibrosis|fibrosis
646429|NCT00755599|Papanicolaou Smear|papanicolaou smear
646430|NCT00755599|Vaginitis|vaginitis
646431|NCT00755599|Patient Satisfaction|patient satisfaction
646432|NCT00755651|Menorrhagia|menorrhagia
646433|NCT00755651|Uterine fibroids|uterine fibroids
646434|NCT00755651|Endometrial polyps|endometrial polyps
646435|NCT00755651|Endometrial cancer|endometrial cancer
646436|NCT00755664|homocysteine|homocysteine
646437|NCT00755664|folate acid,|folate acid,
646438|NCT00755664|vitamin B|vitamin b
646439|NCT00755664|random controlled trail|random controlled trail
646440|NCT00755690|Chronic Kidney Disease|chronic kidney disease
646441|NCT00755690|CKD|ckd
646442|NCT00755690|Diet|diet
646443|NCT00755690|Dietary Phosphate|dietary phosphate
646444|NCT00755690|Mineral Metabolism|mineral metabolism
646445|NCT00755690|FGF-23|fgf-23
646446|NCT00755703|Influenza|influenza
646447|NCT00755703|Vaccine|vaccine
646448|NCT00755703|Pandemic|pandemic
646449|NCT00755703|Avian influenza|avian influenza
646450|NCT00755703|Adenovirus strain 5|adenovirus strain 5
646451|NCT00755703|Vectored vaccine|vectored vaccine
646452|NCT00755703|Intranasal|intranasal
646453|NCT00755703|Tissue-culture derived|tissue-culture derived
646454|NCT00755703|Non-replicating|non-replicating
646455|NCT00755716|nicotine patch|nicotine patch
646456|NCT00755716|smoking|smoking
646457|NCT00755716|topiramate|topiramate
646458|NCT00755729|Preoperative oral carbohydrate|preoperative oral carbohydrate
646459|NCT00755729|Insulin resistance|insulin resistance
646460|NCT00755729|phosphatidylinositol-3-kinase|phosphatidylinositol-3-kinase
646461|NCT00755742|obesity|obesity
646462|NCT00755742|insulin resistance|insulin resistance
646463|NCT00755742|metabolic syndrome|metabolic syndrome
646464|NCT00755742|hepatitis C|hepatitis c
646465|NCT00755742|adipokine|adipokine
646466|NCT00755742|TNF|tnf
646467|NCT00755742|leptin|leptin
646468|NCT00755742|adiponectin|adiponectin
646469|NCT00755742|fatigue|fatigue
646470|NCT00755742|mood|mood
646471|NCT00755742|depression|depression
646472|NCT00755742|exercise|exercise
646473|NCT00755742|diet|diet
646474|NCT00755742|counseling|counseling
646475|NCT00755742|behavior modification|behavior modification
646476|NCT00755768|hemodialysis|hemodialysis
646477|NCT00755768|phosphate|phosphate
646478|NCT00755768|calcium phosphate product|calcium phosphate product
646479|NCT00755768|dietician|dietician
646480|NCT00755768|dietetic advice|dietetic advice
646481|NCT00755781|lung transplant|lung transplant
646482|NCT00755781|lung transplant recipient|lung transplant recipient
646483|NCT00755781|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
646484|NCT00755781|bronchiolitis obliterans|bronchiolitis obliterans
646485|NCT00755781|single lung transplant|single lung transplant
646486|NCT00755781|double lung transplant|double lung transplant
646487|NCT00755781|heart-lung transplant|heart-lung transplant
646488|NCT00755781|Aerosol|aerosol
646489|NCT00755807|Central Neuropathic Pain|central neuropathic pain
646490|NCT00755807|Multiple Sclerosis|multiple sclerosis
646491|NCT00755846|Diabetes Mellitus|diabetes mellitus
646492|NCT00755846|Drug Therapy|drug therapy
646493|NCT00755846|Diabetes Mellitus, Type II|diabetes mellitus, type ii
646494|NCT00755846|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
646495|NCT00755846|Hyperinsulinism|hyperinsulinism
646496|NCT00755846|Insulin Resistance|insulin resistance
646497|NCT00755859|IgA nephropathy|iga nephropathy
646498|NCT00755859|steroids|steroids
646499|NCT00755859|azathioprine|azathioprine
646500|NCT00755859|chronic kidney disease progression|chronic kidney disease progression
646501|NCT00755859|proteinuria|proteinuria
646502|NCT00755885|stage IIIA breast cancer|stage iiia breast cancer
646503|NCT00755885|stage IIIB breast cancer|stage iiib breast cancer
646504|NCT00755885|stage IIIC breast cancer|stage iiic breast cancer
646505|NCT00755885|stage IV breast cancer|stage iv breast cancer
646506|NCT00755885|recurrent breast cancer|recurrent breast cancer
646507|NCT00755885|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
646508|NCT00755885|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
646509|NCT00755898|cancer|cancer
646510|NCT00755898|diagnostic test|diagnostic test
646512|NCT00755898|amantadine acetylation|amantadine acetylation
646513|NCT00755911|dental|dental
646514|NCT00755911|tooth|tooth
646515|NCT00755911|implant|implant
646516|NCT00755911|extraction|extraction
646517|NCT00755911|Oral|oral
646518|NCT00755911|Surgical|surgical
646519|NCT00755911|Procedures|procedures
646520|NCT00755950|Acute|acute
646521|NCT00755950|Hepatitis|hepatitis
646522|NCT00755950|Silymarin|silymarin
646523|NCT00755950|Global Health|global health
646524|NCT00755976|stage IV melanoma|stage iv melanoma
646525|NCT00756002|Chronic Insomnia|chronic insomnia
646526|NCT00756002|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
646527|NCT00756002|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
646528|NCT00756002|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
646529|NCT00756002|Transient Insomnia|transient insomnia
646530|NCT00756002|Drug Therapy|drug therapy
646531|NCT00756002|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
646532|NCT00756015|rotator cuff|rotator cuff
646533|NCT00756015|post-operative immobilization protocol|post-operative immobilization protocol
646834|NCT00757276|Vasopressin|vasopressin
646534|NCT00756015|post-operative early motion protocol|post-operative early motion protocol
646535|NCT00756015|physical therapy|physical therapy
646536|NCT00756015|cuff repair integrity|cuff repair integrity
646537|NCT00756015|ultrasound|ultrasound
646538|NCT00756028|OHSS|ohss
646539|NCT00756028|quality of life|quality of life
646540|NCT00756028|IVF|ivf
646541|NCT00756028|ICSI|icsi
646542|NCT00756028|GnRH-agonist|gnrh-agonist
646543|NCT00756028|GnRH-antagonist|gnrh-antagonist
646544|NCT00756041|Diabetic Mononeuropathy|diabetic mononeuropathy
646545|NCT00756041|Diabetic Neuralgia|diabetic neuralgia
646546|NCT00756041|Mononeuropathy, Diabetic|mononeuropathy, diabetic
646547|NCT00756041|Neuralgia, Diabetic|neuralgia, diabetic
646548|NCT00756041|Diabetic Polyneuropathy|diabetic polyneuropathy
646549|NCT00756041|Drug Therapy|drug therapy
646550|NCT00756067|Streptococcus pneumoniae|streptococcus pneumoniae
646551|NCT00756067|pneumococcal vaccine|pneumococcal vaccine
646552|NCT00756093|Dry Eye, Artificial Tears,|dry eye, artificial tears,
646553|NCT00756106|adult glioblastoma|adult glioblastoma
646554|NCT00756106|adult giant cell glioblastoma|adult giant cell glioblastoma
646555|NCT00756106|adult gliosarcoma|adult gliosarcoma
646556|NCT00756106|adult anaplastic astrocytoma|adult anaplastic astrocytoma
646557|NCT00756106|adult anaplastic ependymoma|adult anaplastic ependymoma
646558|NCT00756106|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
646559|NCT00756106|adult mixed glioma|adult mixed glioma
646560|NCT00756132|Breast|breast
646561|NCT00756132|Neoplasm|neoplasm
646562|NCT00756132|Locally Advanced|locally advanced
646563|NCT00756132|Stage IV|stage iv
646564|NCT00756132|Stage III|stage iii
646565|NCT00756132|Cognitive Function|cognitive function
646566|NCT00756132|Cytokines|cytokines
646567|NCT00756132|Inflammatory|inflammatory
646568|NCT00756132|Node positive|node positive
646569|NCT00756145|stage V|stage v
646570|NCT00756145|treated|treated
646571|NCT00756145|hemodiafiltration|hemodiafiltration
646572|NCT00756158|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
646573|NCT00756158|dopaminergic|dopaminergic
646574|NCT00756158|noradrenergic|noradrenergic
646575|NCT00756158|endophenotype|endophenotype
646576|NCT00756158|molecular genetics|molecular genetics
646577|NCT00756158|candidate gene|candidate gene
646578|NCT00756158|Family-based Association study|family-based association study
646579|NCT00756171|Cholestatic|cholestatic
646580|NCT00756171|pruritus|pruritus
646581|NCT00756171|of any cause|of any cause
646582|NCT00756184|Glaucoma|glaucoma
646583|NCT00756184|Adherence|adherence
646584|NCT00756184|Teaching|teaching
646585|NCT00756197|Radiation Proctitis|radiation proctitis
646586|NCT00756197|Radiation Induced Proctitis|radiation induced proctitis
646587|NCT00756249|Acute ischemic stroke|acute ischemic stroke
646588|NCT00756249|Erythropoietin|erythropoietin
646589|NCT00756249|Carbamylated|carbamylated
646590|NCT00756249|Neuroprotection|neuroprotection
646591|NCT00756262|Vancomycin Resistant enterococcal colonization|vancomycin resistant enterococcal colonization
646592|NCT00756262|Probiotics|probiotics
646593|NCT00756262|LGG|lgg
646594|NCT00756262|Lactobacillus rhamnosus|lactobacillus rhamnosus
646595|NCT00756275|Tobacco Smoking|tobacco smoking
646596|NCT00756275|Smoking Cessation|smoking cessation
646597|NCT00756275|Nicotine Dependence|nicotine dependence
646598|NCT00756275|Tobacco Use Disorder|tobacco use disorder
646599|NCT00756288|Actinic Keratoses|actinic keratoses
646600|NCT00756288|Blue light therapy|blue light therapy
646601|NCT00756288|photosensitizer|photosensitizer
646602|NCT00756288|Retinoid|retinoid
646603|NCT00756314|Ambulatory Care Facilities|ambulatory care facilities
646604|NCT00756314|abortion care|abortion care
646605|NCT00756314|contraception|contraception
646606|NCT00756314|counseling|counseling
646607|NCT00756314|outpatient clinic|outpatient clinic
646608|NCT00756327|pediatric eyes|pediatric eyes
646715|NCT00756730|LARD|lard
646609|NCT00756327|bilateral cataract|bilateral cataract
646610|NCT00756327|IOL implantation|iol implantation
646611|NCT00756327|Aqualase capsule wash|aqualase capsule wash
646612|NCT00756327|posterior capsule opacification|posterior capsule opacification
646613|NCT00756353|Heroin|heroin
646614|NCT00756353|Buprenorphine use|buprenorphine use
646615|NCT00756366|positron emission tomography|positron emission tomography
646616|NCT00756366|myocardial energetics|myocardial energetics
752854|NCT01174485|adiposity|adiposity
646617|NCT00756366|sympathetic nerve function|sympathetic nerve function
646618|NCT00756379|Cardiovascular disease|cardiovascular disease
646619|NCT00756379|Atherosclerosis|atherosclerosis
646620|NCT00756379|Coronary artery disease|coronary artery disease
646621|NCT00756379|Coronary perfusion defect|coronary perfusion defect
646622|NCT00756379|Absolute coronary flow|absolute coronary flow
646623|NCT00756379|Lifestyle management|lifestyle management
646624|NCT00756379|Cardiovascular rehabilitation|cardiovascular rehabilitation
646625|NCT00756379|Cardiovascular dietary guidelines|cardiovascular dietary guidelines
646626|NCT00756392|3T MR Spectroscopy|3t mr spectroscopy
646627|NCT00756392|Prostate Imaging|prostate imaging
646629|NCT00756405|Antioxidants|antioxidants
646630|NCT00756405|Inflammatory markers|inflammatory markers
646631|NCT00756405|Diet|diet
646633|NCT00756444|PK Study, Metastatic Recurrent|pk study, metastatic recurrent
646634|NCT00756457|PTTD|pttd
646635|NCT00756457|Tendinopathy|tendinopathy
646636|NCT00756457|Tendon Injuries|tendon injuries
646637|NCT00756457|Muscular Diseases|muscular diseases
646638|NCT00756457|Foot Diseases|foot diseases
646639|NCT00756470|Breast Cancer|breast cancer
646640|NCT00756470|Inflammatory Breast Cancer|inflammatory breast cancer
646641|NCT00756470|IBC|ibc
646642|NCT00756470|ErbB2 overexpression|erbb2 overexpression
646643|NCT00756470|Lapatinib|lapatinib
646644|NCT00756470|Paclitaxel|paclitaxel
646645|NCT00756470|5-Fluorouracil|5-fluorouracil
646646|NCT00756470|Epirubicin|epirubicin
646647|NCT00756470|Cyclophosphamide|cyclophosphamide
646648|NCT00756470|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
646649|NCT00756483|Resistance|resistance
646650|NCT00756483|Exercise|exercise
646651|NCT00756509|unresectable or metastatic GIST|unresectable or metastatic gist
646652|NCT00756509|1st. line treatment|1st. line treatment
646653|NCT00756522|COPD|copd
646654|NCT00756535|Exercise Therapy|exercise therapy
646655|NCT00756535|Length of Stay|length of stay
646656|NCT00756535|Disability Evaluation|disability evaluation
646657|NCT00756548|colonoscopy|colonoscopy
646658|NCT00756548|screening|screening
646659|NCT00756561|Fine Needle Aspiration|fine needle aspiration
646660|NCT00756561|Male Health|male health
646661|NCT00756561|Male Contraception|male contraception
646662|NCT00756574|N95|n95
646663|NCT00756574|Respirator|respirator
646664|NCT00756574|mask|mask
646665|NCT00756574|influenza|influenza
646666|NCT00756574|efficacy|efficacy
646667|NCT00756587|Cup Feeding|cup feeding
646668|NCT00756587|late Preterm|late preterm
646669|NCT00756600|Infants|infants
646670|NCT00756600|scheduled|scheduled
646671|NCT00756600|unilateral|unilateral
646672|NCT00756600|bilateral|bilateral
646673|NCT00756600|repair|repair
646674|NCT00756626|Bottle Weaning|bottle weaning
646675|NCT00756626|Bottle Feeding|bottle feeding
646676|NCT00756626|Overweight in toddlers|overweight in toddlers
646677|NCT00756626|Bottle use|bottle use
646678|NCT00756626|excess weight for length|excess weight for length
646679|NCT00756639|small cell carcinoma of the bladder|small cell carcinoma of the bladder
646680|NCT00756639|urothelial carcinoma|urothelial carcinoma
646681|NCT00756639|genitourinary bladder|genitourinary bladder
646682|NCT00756639|urothelium|urothelium
646683|NCT00756639|bladder|bladder
646684|NCT00756639|bladder cancer|bladder cancer
646685|NCT00756639|prophylactic cranial irradiation|prophylactic cranial irradiation
646686|NCT00756639|PCI|pci
646687|NCT00756639|brain metastasis|brain metastasis
646688|NCT00756639|genitourinary|genitourinary
646689|NCT00756639|radiation|radiation
646690|NCT00756639|TCC|tcc
646691|NCT00756639|adenocarcinoma|adenocarcinoma
646692|NCT00756665|prostate|prostate
646693|NCT00756665|cancer|cancer
646694|NCT00756691|18F-FAZA|18f-faza
646695|NCT00756691|Positron Emission Tomography|positron emission tomography
646696|NCT00756691|Radiation dosimetry|radiation dosimetry
646697|NCT00756691|Pharmacokinetics|pharmacokinetics
646698|NCT00756704|Smoking Cessation|smoking cessation
646699|NCT00756704|Emergency Medicine|emergency medicine
646700|NCT00756704|Emergency Nursing|emergency nursing
646701|NCT00756704|Effectiveness Trial|effectiveness trial
646702|NCT00756704|Implementation|implementation
646703|NCT00756704|Relapse prevention|relapse prevention
646704|NCT00756717|MK-0752|mk-0752
646705|NCT00756717|Tamoxifen|tamoxifen
646706|NCT00756717|Letroxole|letroxole
646707|NCT00756730|lopinavir|lopinavir
646708|NCT00756730|ritonavir|ritonavir
646709|NCT00756730|atazanavir|atazanavir
646710|NCT00756730|fosamprenavir|fosamprenavir
646711|NCT00756730|darunavir|darunavir
646712|NCT00756730|anti-retroviral|anti-retroviral
646716|NCT00756730|triglyceride|triglyceride
646717|NCT00756730|protease inhibitors|protease inhibitors
646718|NCT00756730|treatment Experienced|treatment experienced
646719|NCT00756743|PF-04802540 multiple dose safety study|pf-04802540 multiple dose safety study
646720|NCT00756756|G-CSF|g-csf
646721|NCT00756756|Myocardial infarction|myocardial infarction
646722|NCT00756782|hepatocellular carcinoma|hepatocellular carcinoma
646723|NCT00756808|latent tuberculosis in elderly|latent tuberculosis in elderly
646724|NCT00756821|Spinal Muscular Atrophy|spinal muscular atrophy
646725|NCT00756821|Blood Biomarkers|blood biomarkers
646726|NCT00756821|Urine Biomarkers|urine biomarkers
646727|NCT00756821|Type I Spinal Muscular Atrophy|type i spinal muscular atrophy
646728|NCT00756821|Type II Spinal Muscular Atrophy|type ii spinal muscular atrophy
646729|NCT00756821|Type III Spinal Muscular Atrophy|type iii spinal muscular atrophy
646730|NCT00756821|Modified Hammersmith Functional Motor Scale|modified hammersmith functional motor scale
646731|NCT00756821|Disease severity|disease severity
646732|NCT00756821|Biomarkers|biomarkers
646733|NCT00756847|Solid Tumors|solid tumors
646734|NCT00756847|NSCLC|nsclc
646735|NCT00756847|Ovarian Cancer|ovarian cancer
647591|NCT00760773|Pediatric|pediatric
646736|NCT00756847|Endometrial Cancer|endometrial cancer
646737|NCT00756873|Elective tonsillectomy|elective tonsillectomy
646738|NCT00756899|Vitamin D deficiency, insulin resistance, obesity, bone|vitamin d deficiency, insulin resistance, obesity, bone
646741|NCT00756912|graft versus leukemia|graft versus leukemia
646742|NCT00756912|graft vs. host disease|graft vs. host disease
646743|NCT00756912|MD2 (endotoxin binding-protein)|md2 (endotoxin binding-protein)
646744|NCT00756912|undergo allogeneic BMT|undergo allogeneic bmt
646745|NCT00756912|myeloablative|myeloablative
646746|NCT00756912|conditioning|conditioning
646747|NCT00756912|therapy|therapy
646748|NCT00756925|CRH|crh
646749|NCT00756925|cocaine|cocaine
646750|NCT00756925|functional magnetic resonance imaging|functional magnetic resonance imaging
646751|NCT00756925|gender differences|gender differences
646752|NCT00756951|SCV-07|scv-07
646753|NCT00756951|Oral Mucositis|oral mucositis
646754|NCT00756964|cardiac surgery|cardiac surgery
646755|NCT00756964|hyperuricemia|hyperuricemia
646756|NCT00756977|Colonoscopy|colonoscopy
646757|NCT00756977|screening|screening
646758|NCT00757016|low back pain|low back pain
646759|NCT00757016|randomised controlled trial|randomised controlled trial
646760|NCT00757016|slow release corticosteroid|slow release corticosteroid
646761|NCT00757016|injection treatment|injection treatment
646762|NCT00757029|ADHD,|adhd,
646763|NCT00757029|norepinephrine transporter|norepinephrine transporter
646764|NCT00757029|pharmacogenetics|pharmacogenetics
646765|NCT00757042|atopic dermatitis|atopic dermatitis
646766|NCT00757042|skin diseases|skin diseases
646767|NCT00757042|healthy volunteer|healthy volunteer
646768|NCT00757055|Heart failure|heart failure
646769|NCT00757055|Diastolic heart failure|diastolic heart failure
646770|NCT00757055|Heart failure with preserved systolic function|heart failure with preserved systolic function
646771|NCT00757055|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
646772|NCT00757055|Ivabradine|ivabradine
646773|NCT00757055|Diastolic dysfunction|diastolic dysfunction
646774|NCT00757068|Non-smoking|non-smoking
646775|NCT00757068|Women|women
646776|NCT00757068|Pregnancy|pregnancy
646777|NCT00757068|Treatment|treatment
646778|NCT00757068|Mood|mood
646779|NCT00757068|Weight|weight
646780|NCT00757068|Supportive|supportive
646781|NCT00757068|Adjustment|adjustment
646782|NCT00757094|Fasting|fasting
646783|NCT00757094|Chemotherapy|chemotherapy
646784|NCT00757094|Cancer|cancer
646785|NCT00757107|Short femoral stem|short femoral stem
646786|NCT00757107|Stress shielding|stress shielding
646787|NCT00757107|Stem migration|stem migration
646788|NCT00757107|Implant Survival|implant survival
646789|NCT00757107|DEXA|dexa
646790|NCT00757107|Radiostereometric analysis|radiostereometric analysis
646791|NCT00757120|COPD|copd
646792|NCT00757120|Cigarette Smoke-Induced Inflammation|cigarette smoke-induced inflammation
646793|NCT00757120|EMMPRIN|emmprin
646794|NCT00757120|Matrix Metalloproteinase|matrix metalloproteinase
646795|NCT00757146|chronic lung disease|chronic lung disease
646796|NCT00757146|bronchopulmonary dysplasia|bronchopulmonary dysplasia
646797|NCT00757146|inhaled nitric oxide|inhaled nitric oxide
646798|NCT00757146|premature infants|premature infants
646799|NCT00757159|Periodontal disease|periodontal disease
646800|NCT00757159|Hydroxyapatite|hydroxyapatite
646801|NCT00757159|Enamel matrix protein|enamel matrix protein
646802|NCT00757159|Regeneration|regeneration
646804|NCT00757172|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
646805|NCT00757172|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
646806|NCT00757172|stage II esophageal cancer|stage ii esophageal cancer
646807|NCT00757172|stage III esophageal cancer|stage iii esophageal cancer
646808|NCT00757172|stage IV esophageal cancer|stage iv esophageal cancer
646809|NCT00757185|skin blood flow|skin blood flow
646810|NCT00757185|microcirculation|microcirculation
646811|NCT00757198|pain, postoperative, opioid, PCA, cardiac surgery|pain, postoperative, opioid, pca, cardiac surgery
646812|NCT00757211|breast cancer|breast cancer
646813|NCT00757211|male breast cancer|male breast cancer
646814|NCT00757237|aztreonam lysine|aztreonam lysine
646815|NCT00757237|tobramycin inhalation solution|tobramycin inhalation solution
646816|NCT00757237|tobramycin nebuliser solution|tobramycin nebuliser solution
646817|NCT00757237|cystic fibrosis|cystic fibrosis
646818|NCT00757237|pseudomonas aeruginosa|pseudomonas aeruginosa
646819|NCT00757237|lung infection|lung infection
646820|NCT00757237|CFQ-R|cfq-r
646821|NCT00757237|inhaled antibiotic|inhaled antibiotic
646822|NCT00757250|HIV|hiv
646823|NCT00757250|AIDS|aids
646824|NCT00757250|Human Immunodeficiency Virus|human immunodeficiency virus
646825|NCT00757250|CD4+ T-lymphocytes|cd4+ t-lymphocytes
646826|NCT00757250|treatment Experienced|treatment experienced
646827|NCT00757263|ovarian epithelial cancer|ovarian epithelial cancer
646828|NCT00757263|ovarian germ cell tumor|ovarian germ cell tumor
646829|NCT00757263|ovarian sarcoma|ovarian sarcoma
646830|NCT00757263|ovarian stromal cancer|ovarian stromal cancer
646831|NCT00757276|Copeptin|copeptin
646832|NCT00757276|Diabetes insipidus|diabetes insipidus
646833|NCT00757276|diagnostic marker|diagnostic marker
646835|NCT00757276|antidiuretic hormone (ADH)|antidiuretic hormone (adh)
646836|NCT00757289|Tennis Elbow|tennis elbow
646837|NCT00757302|breast cancer|breast cancer
646838|NCT00757302|CarolIReS|carolires
646839|NCT00757302|intraoperative gamma camera|intraoperative gamma camera
646840|NCT00757302|lymphoscintigraphy|lymphoscintigraphy
646841|NCT00757302|sentinel lymph node|sentinel lymph node
646842|NCT00757302|Hundred and ten patients with infiltrative breast cancer or ductal carcinoma in situ (DCIS), diagnosed preoperatively by core biopsy or cytology.|hundred and ten patients with infiltrative breast cancer or ductal carcinoma in situ (dcis), diagnosed preoperatively by core biopsy or cytology.
646843|NCT00757315|acne keloidalis nuchae|acne keloidalis nuchae
646844|NCT00757315|NdYag laser|ndyag laser
646846|NCT00757315|acne keloidalis|acne keloidalis
646848|NCT00757315|dermatitis papillaris capillitii|dermatitis papillaris capillitii
646849|NCT00757315|folliculitis keloidalis nuchae|folliculitis keloidalis nuchae
646850|NCT00757315|sycosis nuchae|sycosis nuchae
646851|NCT00757315|acne keloid|acne keloid
646852|NCT00757315|keloidal folliculitis|keloidal folliculitis
646853|NCT00757315|lichen keloidalis nuchae|lichen keloidalis nuchae
646854|NCT00757315|folliculitis nuchae scleroticans|folliculitis nuchae scleroticans
646855|NCT00757315|sycosis framboesiformis|sycosis framboesiformis
646856|NCT00757328|Bipolar depression Treatment|bipolar depression treatment
646857|NCT00757367|Healthy subjects|healthy subjects
646858|NCT00757367|insulin|insulin
646859|NCT00757367|bronchoscope|bronchoscope
646860|NCT00757367|serum insulin|serum insulin
646861|NCT00757367|serum C-Peptide|serum c-peptide
646862|NCT00757367|BAL fluid|bal fluid
646863|NCT00757367|FDKP|fdkp
646864|NCT00757380|epiretinal membranes|epiretinal membranes
646865|NCT00757380|vitreoretinal dyes|vitreoretinal dyes
646866|NCT00757380|membranepeeling|membranepeeling
646867|NCT00757393|Growth hormone|growth hormone
646868|NCT00757393|Pediatrics|pediatrics
646869|NCT00757393|Vitamin D|vitamin d
646870|NCT00757393|Calcium|calcium
646871|NCT00757393|Exercise|exercise
646872|NCT00757406|Lymphedema|lymphedema
646873|NCT00757406|Bioimpedance|bioimpedance
646874|NCT00757419|Safety|safety
646875|NCT00757419|tolerability|tolerability
646876|NCT00757419|healthy subjects|healthy subjects
646877|NCT00757445|Antibiotic therapy|antibiotic therapy
646878|NCT00757445|Microbiological diagnosis|microbiological diagnosis
646879|NCT00757458|Propofol|propofol
646880|NCT00757458|Bacterial growth|bacterial growth
646881|NCT00757458|Fungal growth|fungal growth
646882|NCT00757458|EDTA|edta
646883|NCT00757458|Target controlled infusion|target controlled infusion
646884|NCT00757471|Macular hole surgery|macular hole surgery
646885|NCT00757471|membranepeeling|membranepeeling
646886|NCT00757471|closure rate|closure rate
646887|NCT00757471|vitreoretinal dyes|vitreoretinal dyes
646888|NCT00764244|Diabetes|diabetes
646889|NCT00764244|Macular edema|macular edema
646890|NCT00764244|Optical Coherence tomography|optical coherence tomography
646891|NCT00764244|VitrectomyLaser therapy|vitrectomylaser therapy
646892|NCT00764244|Intravitreal triamcinolone injection|intravitreal triamcinolone injection
646893|NCT00764270|atherosclerosis|atherosclerosis
646894|NCT00764270|lipoic acid|lipoic acid
646895|NCT00764270|thioctic acid|thioctic acid
646896|NCT00764270|triglycerides|triglycerides
646897|NCT00764270|overweight|overweight
646898|NCT00764270|obesity|obesity
646899|NCT00764270|oxidative stress|oxidative stress
646900|NCT00764270|inflammation|inflammation
646901|NCT00764296|acute wounds and chronic wounds|acute wounds and chronic wounds
646902|NCT00764322|menopausal symptoms|menopausal symptoms
646903|NCT00764322|recurrent breast cancer|recurrent breast cancer
646904|NCT00764322|stage I breast cancer|stage i breast cancer
646905|NCT00764322|stage II breast cancer|stage ii breast cancer
646906|NCT00764322|stage IIIA breast cancer|stage iiia breast cancer
646907|NCT00764322|stage IIIB breast cancer|stage iiib breast cancer
646908|NCT00764322|stage IIIC breast cancer|stage iiic breast cancer
646909|NCT00764322|stage IV breast cancer|stage iv breast cancer
646910|NCT00764322|ductal breast carcinoma in situ|ductal breast carcinoma in situ
646911|NCT00764322|breast cancer in situ|breast cancer in situ
646912|NCT00764348|Acute and Chronic Wounds|acute and chronic wounds
646913|NCT00764361|Diabetic|diabetic
646914|NCT00764361|Ulcer|ulcer
646915|NCT00764361|Wound|wound
646916|NCT00764374|YM443|ym443
646917|NCT00764374|Z-338|z-338
649084|NCT00766402|Voltaren|voltaren
649085|NCT00766402|Tramadol/acetaminophen|tramadol/acetaminophen
649086|NCT00766415|COPD|copd
646918|NCT00764374|Acotiamide|acotiamide
646919|NCT00764374|Rome III|rome iii
646920|NCT00764374|Signs and symptoms, digestive|signs and symptoms, digestive
646921|NCT00764387|Neoplastic CNS lesions|neoplastic cns lesions
646922|NCT00764387|Contrast enhanced MRI|contrast enhanced mri
646923|NCT00764387|Comparison|comparison
646924|NCT00764400|aphasia|aphasia
646925|NCT00764400|anomia|anomia
646926|NCT00764400|speech therapy|speech therapy
646927|NCT00764400|rehabilitation|rehabilitation
646928|NCT00764413|EDSS|edss
646929|NCT00764413|methylprednisolone|methylprednisolone
646930|NCT00764413|circadian rhythms|circadian rhythms
646931|NCT00764413|MSFC|msfc
646932|NCT00764426|alcoholic beverages|alcoholic beverages
646933|NCT00764426|non-alcoholic beverages|non-alcoholic beverages
646934|NCT00764426|inflammation|inflammation
646935|NCT00764426|Serum concentration of inflammatory markers before and after intervention|serum concentration of inflammatory markers before and after intervention
646936|NCT00764465|Healthy Subjects|healthy subjects
646937|NCT00764465|Pharmacokinetics study|pharmacokinetics study
646938|NCT00764465|Pharmacokinetics of medications|pharmacokinetics of medications
646939|NCT00764543|To measure 24-hour ambulatory blood pressure in children who have unilateral hydronephrosis or multicystic-dysplastic kidneys|to measure 24-hour ambulatory blood pressure in children who have unilateral hydronephrosis or multicystic-dysplastic kidneys
646940|NCT00764543|To compare these blood pressure measurements between the children who require surgical correction and those who do not need surgical correction.|to compare these blood pressure measurements between the children who require surgical correction and those who do not need surgical correction.
646941|NCT00764556|Glucose|glucose
646942|NCT00764556|Insulin|insulin
646943|NCT00764556|COPD|copd
646944|NCT00764556|Exacerbations|exacerbations
646945|NCT00764556|Tight glycaemic control|tight glycaemic control
646946|NCT00764556|Acute hospital ward|acute hospital ward
646947|NCT00764569|oral tissue|oral tissue
646948|NCT00766909|Insulin pulsatility|insulin pulsatility
646949|NCT00766909|Insulin secretion|insulin secretion
646950|NCT00766909|Insulin sensitivity|insulin sensitivity
646951|NCT00766909|Calcineurin inhibitor|calcineurin inhibitor
646952|NCT00766909|Cyclosporine|cyclosporine
646953|NCT00766909|Tacrolimus|tacrolimus
646954|NCT00766935|Lymphedema|lymphedema
646955|NCT00766935|Bioimpedance|bioimpedance
646956|NCT00766961|Peptic ulcer bleeding uncontrolled by endoscopic therapy.|peptic ulcer bleeding uncontrolled by endoscopic therapy.
646957|NCT00766974|Chronic Venous Disease|chronic venous disease
646958|NCT00766974|C3|c3
646959|NCT00766974|Edema|edema
646960|NCT00766974|Compression Garments|compression garments
646961|NCT00766974|Compression Stockings|compression stockings
646962|NCT00766974|Bioimpedance|bioimpedance
646963|NCT00766987|coronary artery disease|coronary artery disease
646964|NCT00766987|FDG PET viability imaging|fdg pet viability imaging
646965|NCT00766987|morbidity and mortality|morbidity and mortality
646966|NCT00766987|revascularization|revascularization
646967|NCT00766987|resource utilization|resource utilization
646968|NCT00767013|DSCT, coronary artery disease, aortic valve stenosis|dsct, coronary artery disease, aortic valve stenosis
646969|NCT00767026|Epilepsy|epilepsy
646970|NCT00767026|Caregiver Burden|caregiver burden
646971|NCT00767026|Parenting a Child with a Chronic Illness|parenting a child with a chronic illness
646972|NCT00767039|Very Premature|very premature
646973|NCT00767039|RDS|rds
646974|NCT00767039|Surfactant|surfactant
646975|NCT00767052|Healthy Volunteer|healthy volunteer
646976|NCT00767052|Safety|safety
646977|NCT00767052|Tolerability|tolerability
646978|NCT00767052|Pharmacokinetics|pharmacokinetics
646979|NCT00767052|AZD1236|azd1236
646980|NCT00767091|Parkinson's disease|parkinson's disease
646981|NCT00767091|Apathy|apathy
646982|NCT00767091|Rivastigmine|rivastigmine
646983|NCT00767091|transdermal patch|transdermal patch
646984|NCT00767091|anticholinesterasic|anticholinesterasic
646985|NCT00767091|acetylcholine|acetylcholine
646986|NCT00767117|TMC125-C197|tmc125-c197
646987|NCT00767117|TMC125-TiDP2-C197|tmc125-tidp2-c197
646988|NCT00767117|HIV|hiv
646989|NCT00767117|DDI|ddi
646990|NCT00767117|Lopinavir|lopinavir
646991|NCT00767117|Intelence|intelence
646992|NCT00767117|Kaletra|kaletra
646993|NCT00767117|Ritonavir|ritonavir
646994|NCT00767117|Etravirine|etravirine
646995|NCT00767117|Interaction|interaction
646996|NCT00767117|Pharmacokinetics|pharmacokinetics
646997|NCT00767117|Steady-state|steady-state
646998|NCT00767130|single nucleotide polymorphisms, SNP, LDL cholesterol, statin myopathy, atorvastatin, simvastatin, rosuvastatin|single nucleotide polymorphisms, snp, ldl cholesterol, statin myopathy, atorvastatin, simvastatin, rosuvastatin
647089|NCT00767702|Human Genetic Variation|human genetic variation
646999|NCT00767156|Sea buckthorn oil, Oral and topical treatment, Skin aging|sea buckthorn oil, oral and topical treatment, skin aging
647000|NCT00767169|Edentatio (Toothlessness)|edentatio (toothlessness)
647001|NCT00767182|preeclampsia|preeclampsia
647002|NCT00767182|eclampsia|eclampsia
647003|NCT00767182|retroplacental hematoma|retroplacental hematoma
647004|NCT00767182|vascular IUGR|vascular iugr
647005|NCT00767182|IUFD|iufd
647006|NCT00767182|placental volume|placental volume
647007|NCT00767195|pulmonary edema|pulmonary edema
647008|NCT00767195|cardiogenic|cardiogenic
647009|NCT00767195|non-cardiogenic|non-cardiogenic
647010|NCT00767195|mortality|mortality
647011|NCT00767195|length of stay|length of stay
647012|NCT00767208|type 2 diabetic subjects|type 2 diabetic subjects
647013|NCT00767247|Arterial Hypertension|arterial hypertension
647014|NCT00767260|type 2 diabetes mellitus|type 2 diabetes mellitus
647015|NCT00767260|bone marrow mononuclear cell|bone marrow mononuclear cell
647016|NCT00767260|hyperbaric oxygen therapy|hyperbaric oxygen therapy
647017|NCT00767286|stage IIB prostate cancer|stage iib prostate cancer
647018|NCT00767286|stage IIA prostate cancer|stage iia prostate cancer
647019|NCT00767286|stage III prostate cancer|stage iii prostate cancer
647020|NCT00767286|stage IV prostate cancer|stage iv prostate cancer
647021|NCT00767312|HIV|hiv
648345|NCT00771199|Fentanyl|fentanyl
647022|NCT00767312|Antiretrovial Therapy|antiretrovial therapy
647023|NCT00767312|Viremia|viremia
647024|NCT00767312|Genetic Analysis|genetic analysis
647025|NCT00767312|Single Copy Assay|single copy assay
647026|NCT00767338|Infertility|infertility
647027|NCT00767338|Pregnancy|pregnancy
647028|NCT00767338|Men|men
647029|NCT00767338|Palpable varicocele|palpable varicocele
647030|NCT00767338|Abnormal semen analysis|abnormal semen analysis
647031|NCT00767338|Intrauterine insemination|intrauterine insemination
647032|NCT00767338|Microsurgical varicocelectomy|microsurgical varicocelectomy
647033|NCT00767364|Infant|infant
647034|NCT00767377|Time to Progression|time to progression
647035|NCT00767377|Overall survival|overall survival
647036|NCT00767377|Response rate|response rate
647037|NCT00767377|Quality of Live|quality of live
647038|NCT00767377|Toxicities|toxicities
647039|NCT00767390|ACL Patch Placement|acl patch placement
647040|NCT00767416|MEDI-559|medi-559
647041|NCT00767416|Respiratory Syncytial Virus|respiratory syncytial virus
647042|NCT00767416|RSV|rsv
647043|NCT00767416|Pediatric|pediatric
647044|NCT00767416|Vaccine|vaccine
647045|NCT00767416|respiratory syncytial virus, RSV, pediatric, vaccine|respiratory syncytial virus, rsv, pediatric, vaccine
647046|NCT00767429|accelerometer|accelerometer
647047|NCT00767429|fall risk|fall risk
647048|NCT00767429|target group|target group
647049|NCT00767429|field measurements|field measurements
647050|NCT00767455|cumulative irritation|cumulative irritation
647051|NCT00767455|healthy adult volunteers|healthy adult volunteers
647052|NCT00767468|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
647053|NCT00767468|advanced adult primary liver cancer|advanced adult primary liver cancer
647054|NCT00767468|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
647055|NCT00767468|recurrent adult primary liver cancer|recurrent adult primary liver cancer
647056|NCT00767481|glaucoma|glaucoma
647057|NCT00767481|Patients with open-angle glaucoma or ocular hypertension|patients with open-angle glaucoma or ocular hypertension
647058|NCT00767494|OAG|oag
647059|NCT00767494|OH|oh
647060|NCT00767494|Open-angle glaucoma or ocular hypertension|open-angle glaucoma or ocular hypertension
647061|NCT00767520|Advanced Estrogen Receptor Positive Breast Cancer|advanced estrogen receptor positive breast cancer
647062|NCT00767546|seborrhic dermatitis|seborrhic dermatitis
647063|NCT00767546|parkinson's disease|parkinson's disease
647064|NCT00767546|Parkinson disease parkinsonism and seborrhic dermatitis|parkinson disease parkinsonism and seborrhic dermatitis
647065|NCT00767559|Deep Vein Thrombosis, anticoagulants, surgery, pulmonary embolus, warfarin, fondaparinox|deep vein thrombosis, anticoagulants, surgery, pulmonary embolus, warfarin, fondaparinox
647066|NCT00767572|Coarctation of the aorta|coarctation of the aorta
647067|NCT00767572|cross over design|cross over design
647068|NCT00767572|atorvastatin|atorvastatin
647069|NCT00767572|endothelial function|endothelial function
647070|NCT00767585|breast cancer|breast cancer
647071|NCT00767585|aromatase inhibitors|aromatase inhibitors
647072|NCT00767585|bone mineral density|bone mineral density
647073|NCT00767585|osteoporosis|osteoporosis
647074|NCT00767598|CYP3A5|cyp3a5
647075|NCT00767598|sildenafil|sildenafil
647076|NCT00767598|udenafil|udenafil
647077|NCT00767598|vardenafil|vardenafil
647078|NCT00767611|Infertility|infertility
647079|NCT00767611|Sperm|sperm
647080|NCT00767611|Embryo Development|embryo development
647081|NCT00767611|In Vitro Fertilization|in vitro fertilization
647082|NCT00767650|Aplastic Anemia|aplastic anemia
647083|NCT00767650|Cyclosporine|cyclosporine
647084|NCT00767650|Campath|campath
647085|NCT00767650|Neurophyschological Side Effect|neurophyschological side effect
647086|NCT00767676|Contact sensitization|contact sensitization
647087|NCT00767676|Healthy Adult Volunteers|healthy adult volunteers
647088|NCT00767702|Genetic/Genomic Researchers|genetic/genomic researchers
647090|NCT00767702|Interviews|interviews
647091|NCT00767702|Research Design|research design
647092|NCT00767702|Race/Ethnicity|race/ethnicity
647093|NCT00767702|Interview|interview
647094|NCT00767728|UC|uc
647095|NCT00767728|ulcerative colitis|ulcerative colitis
647096|NCT00767728|IBD|ibd
647097|NCT00767728|Inflammatory Bowel Disease|inflammatory bowel disease
647098|NCT00767741|diabetes|diabetes
647099|NCT00767741|post prandial glucose level|post prandial glucose level
647100|NCT00767741|insulin|insulin
647101|NCT00767741|pharmacokinetics|pharmacokinetics
647102|NCT00767741|pharmacodynamics|pharmacodynamics
647103|NCT00767754|panic disorder|panic disorder
647104|NCT00767754|paroxetine|paroxetine
647106|NCT00767767|anesthetic drugs, associative memory, fear|anesthetic drugs, associative memory, fear
647107|NCT00767819|progressive GIST|progressive gist
647108|NCT00767819|progressive sarcoma|progressive sarcoma
647109|NCT00767845|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
647110|NCT00767845|stage I prostate cancer|stage i prostate cancer
647111|NCT00767845|stage II prostate cancer|stage ii prostate cancer
647112|NCT00767845|stage III prostate cancer|stage iii prostate cancer
647113|NCT00767858|Genetic|genetic
647114|NCT00767858|Genetic Literacy|genetic literacy
647115|NCT00767858|Human Genetic Research|human genetic research
647116|NCT00767858|Cultural Congruence|cultural congruence
647117|NCT00767858|Interview|interview
647118|NCT00767871|Panic disorder|panic disorder
647119|NCT00767871|PET|pet
647120|NCT00767871|Escitaopram|escitaopram
647121|NCT00767884|panretinal photocoagulation|panretinal photocoagulation
647122|NCT00767884|diabetic retinopathy|diabetic retinopathy
647123|NCT00767884|optic nerve head changes|optic nerve head changes
647124|NCT00767897|Dose response relationship|dose response relationship
647125|NCT00767897|immunity|immunity
647126|NCT00767923|hyperspectral imaging|hyperspectral imaging
647127|NCT00767923|tissue oxygenation|tissue oxygenation
647128|NCT00767923|foot amputation|foot amputation
647129|NCT00767923|critical limb ischemia|critical limb ischemia
647130|NCT00767923|tissue necrosis|tissue necrosis
647131|NCT00767949|wet|wet
647132|NCT00767949|AMD|amd
647133|NCT00767962|recurrent primary spontaneous pneumothorax|recurrent primary spontaneous pneumothorax
647134|NCT00767988|Probiotics|probiotics
647135|NCT00767988|Spina Bifida|spina bifida
647136|NCT00767988|Dietary Supplements|dietary supplements
647137|NCT00767988|Bacteriuria|bacteriuria
647138|NCT00767988|Urinary Tract Infection (UTI)|urinary tract infection (uti)
647139|NCT00768027|hyperspectral imaging|hyperspectral imaging
647140|NCT00768027|tissue oxygenation|tissue oxygenation
647141|NCT00768027|wounds|wounds
647142|NCT00768027|wound healing|wound healing
647143|NCT00768027|prevention|prevention
647144|NCT00768027|hyperbaric|hyperbaric
647145|NCT00768040|Diabetes|diabetes
647146|NCT00768040|Macular edema|macular edema
647147|NCT00768040|Aliskiren|aliskiren
647148|NCT00768040|Diabetic retinopathy|diabetic retinopathy
647149|NCT00768040|Diabetes mellitus type 1|diabetes mellitus type 1
647150|NCT00768040|Diabetes mellitus type 2|diabetes mellitus type 2
647151|NCT00768053|EULAR-RAID|eular-raid
647152|NCT00768053|active rheumatoid arthritis|active rheumatoid arthritis
647153|NCT00768053|etanercept|etanercept
647154|NCT00768066|Chronic Ischemic Left Ventricular Dysfunction|chronic ischemic left ventricular dysfunction
647155|NCT00768079|Benralizumab|benralizumab
647156|NCT00768079|MEDI-563|medi-563
647157|NCT00768079|Asthma|asthma
647158|NCT00768105|Type 2 diabetes|type 2 diabetes
647159|NCT00768118|healthy, no evidence of disease|healthy, no evidence of disease
647160|NCT00768144|Sutent|sutent
647161|NCT00768144|sunitinib|sunitinib
647162|NCT00768157|hepatocellular carcinoma|hepatocellular carcinoma
647163|NCT00768157|hepatitis B virus|hepatitis b virus
647164|NCT00768157|surgery|surgery
647165|NCT00768157|anti-virus|anti-virus
647166|NCT00768157|recurrence|recurrence
647167|NCT00768183|KADIAN|kadian
647168|NCT00768183|morphine|morphine
647169|NCT00768183|alcohol|alcohol
647170|NCT00768183|water|water
647171|NCT00768183|Ethanol|ethanol
647172|NCT00768183|solution|solution
647174|NCT00768183|fasting|fasting
647175|NCT00768196|GERD|gerd
647176|NCT00768196|Korea|korea
647177|NCT00768196|typical symptom|typical symptom
647178|NCT00768196|quality of life|quality of life
647179|NCT00768196|Naturalistic|naturalistic
647180|NCT00768196|epidemiological|epidemiological
647181|NCT00768209|Pharmacokinetics|pharmacokinetics
647182|NCT00768222|wound healing|wound healing
647183|NCT00768235|Sedentary elderly women that had medical assignment|sedentary elderly women that had medical assignment
647184|NCT00768248|pain|pain
647185|NCT00768248|phantom limb|phantom limb
647186|NCT00768248|stump pain|stump pain
647187|NCT00768248|catheter|catheter
647188|NCT00768248|nerve block|nerve block
647189|NCT00768248|peripheral nerve block|peripheral nerve block
647190|NCT00768248|NMCSD|nmcsd
647191|NCT00768248|Post-Amputation Phantom Limb or Stump Pain|post-amputation phantom limb or stump pain
647192|NCT00768261|Dementia of the Alzheimer type|dementia of the alzheimer type
647193|NCT00768274|Cholesterol|cholesterol
647293|NCT00768781|insomnia|insomnia
647194|NCT00768274|High density lipoprotein|high density lipoprotein
647195|NCT00768274|Dyslipidemia|dyslipidemia
647196|NCT00768274|Atherosclerosis|atherosclerosis
647197|NCT00768274|Apolipoprotein A-I|apolipoprotein a-i
647198|NCT00768300|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
647199|NCT00768300|interstitial lung disease|interstitial lung disease
647200|NCT00768300|ambrisentan|ambrisentan
647201|NCT00768313|scoliosis correction rod strength adolescent|scoliosis correction rod strength adolescent
647202|NCT00768326|Schizophrenia|schizophrenia
647203|NCT00768326|Antipsychotic|antipsychotic
647204|NCT00768326|Lu 31-130|lu 31-130
647205|NCT00768339|antisense|antisense
647206|NCT00768339|AEG35156|aeg35156
647207|NCT00768339|lymphocytic|lymphocytic
647208|NCT00768339|lymphoma|lymphoma
647209|NCT00768339|leukemia|leukemia
647210|NCT00768339|B-cell|b-cell
647211|NCT00768352|Pediatric|pediatric
647212|NCT00768352|Resident|resident
647213|NCT00768352|Depression|depression
647214|NCT00768352|Screening|screening
647215|NCT00768352|Substance Abuse|substance abuse
647216|NCT00768352|Pediatric Resident knowledge of mental health topics|pediatric resident knowledge of mental health topics
647217|NCT00768352|Pediatric Resident current practices for screening and treating mental health disorders|pediatric resident current practices for screening and treating mental health disorders
647218|NCT00768352|Pediatric Resident mental health care competency|pediatric resident mental health care competency
647219|NCT00768365|adrenal incidentaloma|adrenal incidentaloma
647220|NCT00768365|cardiovascular risk|cardiovascular risk
647221|NCT00768378|Physical Therapy (Specialty)|physical therapy (specialty)
647222|NCT00768378|Balance dysfunction or disorder|balance dysfunction or disorder
647223|NCT00768378|Vestibular|vestibular
647224|NCT00768378|Rehabilitation|rehabilitation
647225|NCT00768391|Tumors|tumors
647226|NCT00768391|Lymphoma|lymphoma
647227|NCT00768391|Antibodies, Monoclonal|antibodies, monoclonal
647228|NCT00768417|Nuts|nuts
647229|NCT00768417|Lipids|lipids
647230|NCT00768417|Mastication|mastication
647231|NCT00768417|Bioaccessibility|bioaccessibility
647232|NCT00768417|Satiety|satiety
647233|NCT00768417|Hormones|hormones
647234|NCT00768417|Human|human
647235|NCT00768443|GERD|gerd
647236|NCT00768443|PPI|ppi
647237|NCT00768469|HKI-272|hki-272
647238|NCT00768469|Paclitaxel|paclitaxel
647239|NCT00768469|Combination|combination
647240|NCT00768469|Solid Tumor|solid tumor
647241|NCT00768482|opioid dependence|opioid dependence
647242|NCT00768482|opioid addiction|opioid addiction
647243|NCT00768482|buprenorphine|buprenorphine
647244|NCT00768482|methadone|methadone
647245|NCT00768482|heroin|heroin
647246|NCT00768482|implant|implant
647247|NCT00768482|opioid withdrawal|opioid withdrawal
647248|NCT00768482|opioid pain medication|opioid pain medication
647249|NCT00768482|suboxone|suboxone
647250|NCT00768495|revascularization|revascularization
647251|NCT00768495|claudication|claudication
647252|NCT00768495|hyperspectral|hyperspectral
647253|NCT00768495|oxygenation|oxygenation
647254|NCT00768495|limb ischemia|limb ischemia
647255|NCT00768508|Alcohol|alcohol
647256|NCT00768508|Alcohol Dependence|alcohol dependence
647257|NCT00768508|Alcoholism|alcoholism
647258|NCT00768534|Acute Otitis Media|acute otitis media
647259|NCT00768534|Serotype distribution|serotype distribution
647260|NCT00768573|taste test|taste test
647261|NCT00768599|Econazole|econazole
647262|NCT00768599|Foam|foam
647263|NCT00768599|Quinnova|quinnova
647264|NCT00768612|Acute, Schizophrenia, Phase2a, Vabicaserin|acute, schizophrenia, phase2a, vabicaserin
647265|NCT00768638|Chronic kidney disease|chronic kidney disease
647266|NCT00768664|recurrent or metastatic squamous cell cancer of the Head and Neck; no prior systemic therapy for recurrence|recurrent or metastatic squamous cell cancer of the head and neck; no prior systemic therapy for recurrence
647267|NCT00768677|binge eating behavior|binge eating behavior
647268|NCT00768677|adolescents|adolescents
647269|NCT00768703|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
647270|NCT00768703|lung-head ratio|lung-head ratio
647271|NCT00768703|percutaneous tracheal occlusion|percutaneous tracheal occlusion
647272|NCT00768703|fetal intervention|fetal intervention
647273|NCT00768729|End stage renal disease|end stage renal disease
647274|NCT00768729|Kidney transplantation|kidney transplantation
647275|NCT00768729|Renal transplantation|renal transplantation
647276|NCT00768729|Kidney failure|kidney failure
647277|NCT00768729|Children|children
647278|NCT00768729|Adolescents|adolescents
647279|NCT00768729|Sirolimus|sirolimus
647280|NCT00768729|Rapamycin|rapamycin
647281|NCT00768729|CellCept|cellcept
647282|NCT00768729|Mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
647283|NCT00768729|Azathioprine|azathioprine
647284|NCT00768742|Uterine Fibroid RF Ablation|uterine fibroid rf ablation
647285|NCT00768742|Intrauterine Ultrasound|intrauterine ultrasound
647286|NCT00768742|VizAblate|vizablate
647287|NCT00768755|non-squamous NSCLC|non-squamous nsclc
647288|NCT00768755|axitinib|axitinib
647289|NCT00768755|pemetrexed/cisplatin|pemetrexed/cisplatin
647290|NCT00768768|iontophoresis|iontophoresis
647291|NCT00768768|terbinafine|terbinafine
647292|NCT00768768|onychomycosis|onychomycosis
647294|NCT00768781|hyperarousal|hyperarousal
647295|NCT00768781|mindfulness meditation|mindfulness meditation
647296|NCT00768781|complementary and alternative medicine|complementary and alternative medicine
647297|NCT00768781|cognitive-behavioral therapy|cognitive-behavioral therapy
647298|NCT00768794|thrush|thrush
647299|NCT00768820|Velocardiofacial syndrome|velocardiofacial syndrome
647300|NCT00768820|Williams syndrome|williams syndrome
647301|NCT00768820|fragile X syndrome|fragile x syndrome
647302|NCT00768820|cognitive phenotype|cognitive phenotype
647303|NCT00768820|psychiatric phenotype|psychiatric phenotype
647304|NCT00768833|S.pneumoniae healthy subjects|s.pneumoniae healthy subjects
647305|NCT00768833|Healthy subjects|healthy subjects
647307|NCT00768846|Stent|stent
647308|NCT00768846|DES|des
647309|NCT00768846|CAD|cad
647310|NCT00768859|breast cancer|breast cancer
647311|NCT00768859|HER2 positive|her2 positive
647312|NCT00768859|neo-adjuvant|neo-adjuvant
647313|NCT00768859|trastuzumab|trastuzumab
647314|NCT00768859|paclitaxel|paclitaxel
647315|NCT00768859|carboplatin|carboplatin
647316|NCT00768872|activity, spinal cord stimulation, pain|activity, spinal cord stimulation, pain
647317|NCT00768898|conjunctival|conjunctival
647318|NCT00768898|staining|staining
647319|NCT00768911|glioblastoma|glioblastoma
647320|NCT00768911|Glioblastoma multiforme (newly diagnosed)|glioblastoma multiforme (newly diagnosed)
647321|NCT00768924|Bone Void Filler|bone void filler
647322|NCT00768924|Post-Harvest Iliac Crest|post-harvest iliac crest
647323|NCT00768924|Ability of CopiOs to fill the post-harvest iliac crest bone void created by a surgeon during spinal fusion.|ability of copios to fill the post-harvest iliac crest bone void created by a surgeon during spinal fusion.
647324|NCT00768937|hepatocellular carcinoma|hepatocellular carcinoma
647325|NCT00768937|sorafenib|sorafenib
647326|NCT00768937|transarterial chemoembolization|transarterial chemoembolization
647327|NCT00768937|tumor angiogenesis|tumor angiogenesis
647328|NCT00768937|angiogenic factors|angiogenic factors
647329|NCT00768950|Seronegative spondyloarthropathies|seronegative spondyloarthropathies
752378|NCT01172730|thoracic epidural|thoracic epidural
647330|NCT00768950|Endoscopic capsule examination|endoscopic capsule examination
647331|NCT00768950|Small bowel and colon lesions|small bowel and colon lesions
647332|NCT00768950|Nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
647333|NCT00768950|Anti TNF Alpha Drugs|anti tnf alpha drugs
647334|NCT00768963|ranibizumab|ranibizumab
647335|NCT00768963|pterygium|pterygium
647336|NCT00768976|Participant must have participated in a clinical trial conducted by the Summa Health System Hospitals Cancer Research Program.|participant must have participated in a clinical trial conducted by the summa health system hospitals cancer research program.
647337|NCT00768976|Participant should have been registered for clinical trial participation three months prior to receiving the satisfaction survey.|participant should have been registered for clinical trial participation three months prior to receiving the satisfaction survey.
647338|NCT00768989|Combination Therapy|combination therapy
647339|NCT00769002|influenza|influenza
647340|NCT00769002|flu|flu
647341|NCT00769002|vaccine|vaccine
647342|NCT00769002|vaccination|vaccination
647343|NCT00769002|immune response|immune response
647344|NCT00769002|FluShield|flushield
647345|NCT00769002|FluMist|flumist
647346|NCT00769002|PET-CT|pet-ct
647347|NCT00769002|Healthy Volunteers|healthy volunteers
647348|NCT00769015|age-related macular degeneration|age-related macular degeneration
647349|NCT00769015|depression|depression
647350|NCT00769015|vision loss|vision loss
647351|NCT00769028|Systemic sclerosis|systemic sclerosis
647352|NCT00769028|Diffuse cutaneous systemic sclerosis|diffuse cutaneous systemic sclerosis
647353|NCT00769028|Scleroderma|scleroderma
647354|NCT00769028|Biological|biological
647355|NCT00769028|Hyperimmune caprine serum|hyperimmune caprine serum
647356|NCT00769028|Goat Serum|goat serum
647357|NCT00769054|Postoperative pain|postoperative pain
647358|NCT00769054|PONV|ponv
647359|NCT00769067|Lung cancer|lung cancer
647360|NCT00769067|advanced|advanced
647361|NCT00769067|second or third line|second or third line
647362|NCT00769080|PSP|psp
647363|NCT00769080|Standard Treatment|standard treatment
647364|NCT00769080|Standard Treatment plus PSP|standard treatment plus psp
647365|NCT00769093|ferumoxytol|ferumoxytol
647366|NCT00769093|diagnostic imaging|diagnostic imaging
647367|NCT00769106|hepatocellular carcinoma|hepatocellular carcinoma
647368|NCT00769106|recurrent|recurrent
647369|NCT00769106|cytokine-induced killer cell|cytokine-induced killer cell
647370|NCT00769119|bronchiectasis|bronchiectasis
647371|NCT00769119|Phase II|phase ii
647372|NCT00769145|Corneal neovascularization|corneal neovascularization
647373|NCT00769145|Ranibizumab|ranibizumab
647374|NCT00769145|Corneal transplantation|corneal transplantation
647375|NCT00769158|Alcohol|alcohol
647376|NCT00769158|Alcoholism|alcoholism
647377|NCT00769158|Alcohol Dependence|alcohol dependence
647378|NCT00769171|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
647379|NCT00769184|chronic plaque psoriasis|chronic plaque psoriasis
647380|NCT00769197|optic disc cupping|optic disc cupping
647381|NCT00769197|cerebral palsy|cerebral palsy
647382|NCT00769197|static encephalopathy|static encephalopathy
647383|NCT00769197|optic disc|optic disc
647384|NCT00769197|optic nerve|optic nerve
647385|NCT00769197|periventricular Leukomalacia|periventricular leukomalacia
647386|NCT00769223|radiation toxicity|radiation toxicity
647387|NCT00769223|recurrent prostate cancer|recurrent prostate cancer
647388|NCT00769223|stage IIB prostate cancer|stage iib prostate cancer
647389|NCT00769223|stage IIA prostate cancer|stage iia prostate cancer
647390|NCT00769223|stage III prostate cancer|stage iii prostate cancer
647391|NCT00769223|stage I prostate cancer|stage i prostate cancer
647392|NCT00769223|stage IV prostate cancer|stage iv prostate cancer
647393|NCT00769223|adenocarcinoma of the prostate|adenocarcinoma of the prostate
647394|NCT00769249|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
647395|NCT00769249|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
647396|NCT00769262|Premature neonates|premature neonates
647397|NCT00769262|Thermoregulation|thermoregulation
647398|NCT00769262|Isolette|isolette
647399|NCT00769262|Feeding status|feeding status
647400|NCT00769275|silent ischemia|silent ischemia
647401|NCT00769275|type 2 diabetes mellitus|type 2 diabetes mellitus
647402|NCT00769275|screening|screening
647403|NCT00769275|cardiac outcome|cardiac outcome
647521|NCT00760383|Rehabilitation|rehabilitation
647404|NCT00769275|Prevalence silent myocardial ischemia|prevalence silent myocardial ischemia
647405|NCT00769275|Cardiac outcome in screened and not-screened subjects|cardiac outcome in screened and not-screened subjects
647406|NCT00769301|Symptoms|symptoms
647407|NCT00769301|pain|pain
647408|NCT00769301|fatigue|fatigue
647409|NCT00769301|depression|depression
647410|NCT00769301|sleeplessness|sleeplessness
647411|NCT00769301|genetic markers|genetic markers
647412|NCT00769301|caregiver burden.|caregiver burden.
647413|NCT00769327|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
647414|NCT00769327|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
647415|NCT00769392|Macular Degeneration|macular degeneration
647416|NCT00769392|Intravitreal injections|intravitreal injections
752379|NCT01172730|acute pain|acute pain
647417|NCT00769392|Eye anesthesia-Topical/subconjunctival|eye anesthesia-topical/subconjunctival
647418|NCT00769392|Eye-surgical procedures|eye-surgical procedures
647419|NCT00769392|Ophthalmologic anesthesia methods|ophthalmologic anesthesia methods
647420|NCT00769405|recurrent colon cancer|recurrent colon cancer
647421|NCT00769405|stage IV colon cancer|stage iv colon cancer
647422|NCT00769405|recurrent rectal cancer|recurrent rectal cancer
647423|NCT00769405|stage IV rectal cancer|stage iv rectal cancer
647424|NCT00769405|peritoneal carcinomatosis|peritoneal carcinomatosis
647425|NCT00754637|Joint|joint
647426|NCT00754637|Osteoarthritis|osteoarthritis
647427|NCT00754637|Avascular Necrosis|avascular necrosis
647428|NCT00754663|exercise|exercise
647429|NCT00754663|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
647430|NCT00754663|arrhythmia|arrhythmia
647431|NCT00754689|Rimonabant/metformin combination|rimonabant/metformin combination
647432|NCT00754702|Vinorelbine metronomic-lapatinib|vinorelbine metronomic-lapatinib
647433|NCT00754702|Chemotherapy|chemotherapy
647434|NCT00754702|Targeted therapy|targeted therapy
647435|NCT00754715|Multiple dosing study,|multiple dosing study,
647436|NCT00754715|safety|safety
647437|NCT00754741|medication adherence|medication adherence
647438|NCT00754741|motivational interviewing|motivational interviewing
647439|NCT00754754|brain|brain
647440|NCT00754754|surgery|surgery
647441|NCT00754754|retraction|retraction
647442|NCT00754754|injury|injury
647443|NCT00754754|monitoring|monitoring
647444|NCT00754767|neurotoxicity|neurotoxicity
647445|NCT00754767|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
647446|NCT00754767|stage IV breast cancer|stage iv breast cancer
647447|NCT00754767|recurrent breast cancer|recurrent breast cancer
647448|NCT00754780|NF1|nf1
647449|NCT00754780|plexiform neurofibroma|plexiform neurofibroma
647450|NCT00754806|HALS|hals
647451|NCT00754806|open splenectomy|open splenectomy
647452|NCT00754806|splenomegaly|splenomegaly
647453|NCT00754806|HALS as a hybrid approach of pure laparoscopy and open surgery has some definite advantages over open surgery|hals as a hybrid approach of pure laparoscopy and open surgery has some definite advantages over open surgery
647454|NCT00754806|In the HALS group, incision length is significantly shorter|in the hals group, incision length is significantly shorter
647455|NCT00754806|In the HALS group, postoperative pain is less than with open surgery|in the hals group, postoperative pain is less than with open surgery
647456|NCT00754806|In the HALS group, postoperative hospital stay is shorter than with open surgery|in the hals group, postoperative hospital stay is shorter than with open surgery
647457|NCT00754832|Multiple sclerosis|multiple sclerosis
647458|NCT00754832|fatigue|fatigue
647459|NCT00754832|ginseng|ginseng
647460|NCT00754845|stage I breast cancer|stage i breast cancer
647461|NCT00754845|stage II breast cancer|stage ii breast cancer
647462|NCT00754845|stage IIIA breast cancer|stage iiia breast cancer
647463|NCT00754845|stage IIIB breast cancer|stage iiib breast cancer
647464|NCT00754845|stage IIIC breast cancer|stage iiic breast cancer
647465|NCT00754858|extensive stage small cell lung cancer|extensive stage small cell lung cancer
647466|NCT00754884|salmon calcitonin|salmon calcitonin
647467|NCT00754884|endorphins|endorphins
647468|NCT00754884|treatment|treatment
647469|NCT00754884|fibromyalgia|fibromyalgia
649659|NCT00774514|NO2|no2
647470|NCT00754897|Phone Interview|phone interview
647471|NCT00754897|Anesthesia|anesthesia
647472|NCT00754897|Siblings|siblings
647473|NCT00754897|Inguinal Hernia|inguinal hernia
647474|NCT00754897|Neurologic Examination|neurologic examination
647475|NCT00754897|Developmental Delay Disorders|developmental delay disorders
647476|NCT00754910|stage I non-small cell lung cancer|stage i non-small cell lung cancer
647477|NCT00754910|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
647478|NCT00754910|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
647479|NCT00754910|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
647578|NCT00760721|Hepatitis B Screening|hepatitis b screening
647480|NCT00754910|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
647481|NCT00754910|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
647482|NCT00754923|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
647483|NCT00754923|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
647484|NCT00754923|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
647485|NCT00754923|adenocarcinoma of the lung|adenocarcinoma of the lung
647486|NCT00754923|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
647487|NCT00754923|large cell lung cancer|large cell lung cancer
647488|NCT00754936|Depression|depression
647489|NCT00754949|Blepharoconjunctivitis,|blepharoconjunctivitis,
647490|NCT00754949|Ophthalmology|ophthalmology
647491|NCT00760305|cancer pain|cancer pain
647492|NCT00760305|bone metastasis|bone metastasis
647493|NCT00760305|patient education|patient education
647494|NCT00760305|psychoeducational education|psychoeducational education
647495|NCT00760305|side effects|side effects
647496|NCT00760305|analgesics|analgesics
647497|NCT00760318|cervical dystonia, keppra, botox, spasmodic torticollis|cervical dystonia, keppra, botox, spasmodic torticollis
647498|NCT00760331|HNF1B|hnf1b
647499|NCT00760331|TCF2|tcf2
647500|NCT00760331|MODY-5|mody-5
647501|NCT00760331|CAKUT|cakut
647502|NCT00760331|Anomaly of renal development|anomaly of renal development
647503|NCT00760344|Glucose Metabolism Disorder|glucose metabolism disorder
647504|NCT00760344|Dysmetabolic Syndrome|dysmetabolic syndrome
647505|NCT00760344|Type II Diabetes|type ii diabetes
647506|NCT00760344|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
647507|NCT00760344|Dyslipidemia|dyslipidemia
647508|NCT00760344|Drug Therapy|drug therapy
647509|NCT00760357|Critical Ischemia|critical ischemia
647510|NCT00760370|bone marker|bone marker
647511|NCT00760370|bisphosphonate|bisphosphonate
647512|NCT00760370|Zometa|zometa
647513|NCT00760370|retention|retention
647514|NCT00760370|breast cancer|breast cancer
647515|NCT00760370|multiple myeloma|multiple myeloma
647516|NCT00760370|CTX|ctx
647517|NCT00760370|bone specific ALP|bone specific alp
647518|NCT00760383|Total Knee Arthroplasty|total knee arthroplasty
647519|NCT00760383|Osteoarthritis|osteoarthritis
647520|NCT00760383|Muscle Metabolism|muscle metabolism
647522|NCT00760383|Physical Therapy|physical therapy
647523|NCT00760396|healthy volunteers|healthy volunteers
647524|NCT00760409|recurrent tumor|recurrent tumor
647525|NCT00760435|Kawasaki disease|kawasaki disease
647526|NCT00760435|Infliximab|infliximab
647527|NCT00760435|Remicade|remicade
647528|NCT00760435|Pediatrics|pediatrics
647529|NCT00760474|Fibromyalgia; fMRI; pain; pregabalin; Lyrica; imaging|fibromyalgia; fmri; pain; pregabalin; lyrica; imaging
647530|NCT00760487|Cataract AcrySof Toric IOL|cataract acrysof toric iol
647531|NCT00760487|Bilateral cataract|bilateral cataract
647532|NCT00760513|non alcoholic fatty liver disease|non alcoholic fatty liver disease
647533|NCT00760513|NAFLD|nafld
647534|NCT00760513|fish oil|fish oil
647535|NCT00760513|intervention|intervention
647537|NCT00760513|biomarkers|biomarkers
647538|NCT00760526|Continuous Glucose Monitor|continuous glucose monitor
647539|NCT00760539|Glaucoma|glaucoma
647540|NCT00760539|Hypertension|hypertension
647541|NCT00760552|Hypertension|hypertension
647542|NCT00760552|Adherence|adherence
647543|NCT00760552|Pharmacist|pharmacist
647544|NCT00760552|Interdisciplinary|interdisciplinary
647545|NCT00760552|Randomized Controlled|randomized controlled
647546|NCT00760552|Primary Care|primary care
647547|NCT00760591|Acute kidney failure|acute kidney failure
647548|NCT00760591|Colonoscopy|colonoscopy
647549|NCT00760591|Neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
647550|NCT00760604|Esophageal neoplasms|esophageal neoplasms
647551|NCT00760604|Esophagectomy|esophagectomy
647552|NCT00760617|Influenza|influenza
647553|NCT00760617|Elderly|elderly
647554|NCT00760630|abnormal stress test|abnormal stress test
647555|NCT00760630|fractional flow reserve|fractional flow reserve
647556|NCT00760630|pressure drop coefficient|pressure drop coefficient
647557|NCT00760630|lesion flow coefficient|lesion flow coefficient
647558|NCT00760656|Health outcomes in adults who survived pediatric cancer|health outcomes in adults who survived pediatric cancer
647559|NCT00760656|Survivors of Pediatric Cancer|survivors of pediatric cancer
647560|NCT00760669|Spondylitis, Ankylosing|spondylitis, ankylosing
647561|NCT00760669|Arthritis, Rheumatoid|arthritis, rheumatoid
647562|NCT00760669|Psoriasis|psoriasis
647563|NCT00760669|Arthritis, Psoriatic|arthritis, psoriatic
647564|NCT00760669|Infliximab|infliximab
647565|NCT00760669|Remicade|remicade
647566|NCT00760682|osteoradionecrosis|osteoradionecrosis
647567|NCT00760682|hyperbaric oxygen|hyperbaric oxygen
647568|NCT00760682|sequestrectomy|sequestrectomy
647569|NCT00760695|anorexia nervosa|anorexia nervosa
647571|NCT00760695|dronabinol|dronabinol
647572|NCT00760695|weight gain|weight gain
647573|NCT00760695|EDI|edi
647574|NCT00760708|nucleosides|nucleosides
647575|NCT00760708|neurotransmitter|neurotransmitter
647576|NCT00760708|myocardial ischemia|myocardial ischemia
647577|NCT00760708|Adenosine|adenosine
647579|NCT00760721|Korean Americans|korean americans
647580|NCT00760734|Chronic traumatic brain injury|chronic traumatic brain injury
647581|NCT00760734|Post concussion syndrome|post concussion syndrome
647582|NCT00760734|Post traumatic stress disorder|post traumatic stress disorder
647583|NCT00760734|Chronic post traumatic stress disorder|chronic post traumatic stress disorder
647584|NCT00760747|ADHD|adhd
647585|NCT00760747|Children|children
647586|NCT00760747|Stimulant|stimulant
647587|NCT00760747|Atomoxetine|atomoxetine
647588|NCT00760747|Adolescents|adolescents
647589|NCT00760773|Probiotic treatment|probiotic treatment
647590|NCT00760773|Daycare attendance|daycare attendance
647592|NCT00760773|Emergency department|emergency department
647593|NCT00760786|IVUS-VH|ivus-vh
647594|NCT00760786|Plaque characterization|plaque characterization
647595|NCT00760786|Omega3-fatty acid|omega3-fatty acid
647596|NCT00760786|Atorvastatin|atorvastatin
647597|NCT00760799|Lumbar Disc Herniation|lumbar disc herniation
647598|NCT00760812|Autism|autism
647599|NCT00760812|Autism Spectrum Disorders|autism spectrum disorders
647600|NCT00760812|Pervasive Developmental Disorders|pervasive developmental disorders
647601|NCT00760812|Toddlers|toddlers
647602|NCT00760812|Intervention|intervention
647603|NCT00760825|cholera|cholera
647604|NCT00760825|vibrios|vibrios
647605|NCT00760825|oral cholera vaccine|oral cholera vaccine
647606|NCT00760838|Inadequately controlled severe asthma|inadequately controlled severe asthma
647607|NCT00760851|Probiotics|probiotics
647608|NCT00760851|Child, preschool|child, preschool
647609|NCT00760851|Child Day Care Centers|child day care centers
647610|NCT00760851|Health|health
647611|NCT00760851|Immune system|immune system
647612|NCT00760864|Rheumatoid Arthritis|rheumatoid arthritis
647613|NCT00760864|Drug Therapy|drug therapy
647614|NCT00760877|MYELOGENOUS|myelogenous
647615|NCT00760877|LEUKEMIA|leukemia
647616|NCT00760877|Chronic Phase|chronic phase
647617|NCT00760877|CML|cml
647618|NCT00760890|Iron, breastfed infant|iron, breastfed infant
647619|NCT00760903|Moderate brain trauma|moderate brain trauma
647620|NCT00760916|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
647621|NCT00760942|Low birth weight|low birth weight
647622|NCT00760942|neonates|neonates
647623|NCT00760942|premature infants|premature infants
647624|NCT00760942|nutrition|nutrition
647625|NCT00760942|human milk fortification|human milk fortification
647626|NCT00760942|Infant|infant
647627|NCT00760955|Asymmetric Diabetic Proximal Motor Neuropathy|asymmetric diabetic proximal motor neuropathy
647628|NCT00760955|Diabetic Amyotrophy|diabetic amyotrophy
647629|NCT00760955|Diabetic Autonomic Neuropathy|diabetic autonomic neuropathy
647630|NCT00760955|Diabetic Polyneuropathy|diabetic polyneuropathy
647631|NCT00760955|Neuralgia, Diabetic|neuralgia, diabetic
647632|NCT00760955|Symmetric Diabetic Proximal Motor Neuropathy|symmetric diabetic proximal motor neuropathy
647633|NCT00760955|Drug Therapy|drug therapy
647634|NCT00760968|Rheumatoid Arthritis|rheumatoid arthritis
647635|NCT00760968|Drug Therapy|drug therapy
647636|NCT00760994|Alcohol|alcohol
647637|NCT00760994|Alcoholic|alcoholic
647638|NCT00760994|Alcoholism|alcoholism
647639|NCT00760994|Post-traumatic stress disorder|post-traumatic stress disorder
647640|NCT00760994|PTSD|ptsd
647641|NCT00760994|Experiential acceptance|experiential acceptance
647642|NCT00760994|Mindfulness|mindfulness
647643|NCT00760994|Meditation|meditation
647644|NCT00760994|Meditate|meditate
647645|NCT00760994|Cognitive restructuring|cognitive restructuring
647646|NCT00760994|Cognitive|cognitive
647647|NCT00760994|Behavioral|behavioral
647648|NCT00760994|Therapy|therapy
647649|NCT00760994|Treatment|treatment
647650|NCT00760994|Study|study
647651|NCT00760994|Intervention|intervention
647652|NCT00761007|Irritable Bowel Syndrome|irritable bowel syndrome
647653|NCT00761007|Bowel disease|bowel disease
647654|NCT00761020|Malaria|malaria
647655|NCT00761020|Diagnosis|diagnosis
647656|NCT00761020|Biomarker|biomarker
647657|NCT00761033|children undergoing intravenous placement in the pediatric emergency department|children undergoing intravenous placement in the pediatric emergency department
647658|NCT00761059|analgesia|analgesia
647659|NCT00761059|infant, premature|infant, premature
647660|NCT00761059|glucose|glucose
647661|NCT00761059|nasopharyngeal suctioning|nasopharyngeal suctioning
647662|NCT00761072|Propofol|propofol
647663|NCT00761072|Remifentanil|remifentanil
647664|NCT00761072|Total Intravenous Anesthesia|total intravenous anesthesia
647665|NCT00761098|Cirrhosis|cirrhosis
647667|NCT00761111|information booklet|information booklet
647668|NCT00761111|low back beliefs|low back beliefs
647669|NCT00761111|education|education
647670|NCT00761111|disc hernia|disc hernia
647671|NCT00761111|discectomy|discectomy
647672|NCT00761111|A common monoradicular sciatica|a common monoradicular sciatica
647673|NCT00761111|on a slipped disc|on a slipped disc
647674|NCT00761111|with a clinical radio|with a clinical radio
647675|NCT00761111|agreement requiring a surgical treatment|agreement requiring a surgical treatment
647676|NCT00761111|carried out|carried out
647677|NCT00761111|one duration|one duration
648532|NCT00771927|trial|trial
647678|NCT00761111|of evolution higher|of evolution higher
647679|NCT00761111|than four weeks|than four weeks
647680|NCT00761111|at naive subjects|at naive subjects
647681|NCT00761111|of any rachidian interventional treatment|of any rachidian interventional treatment
647682|NCT00761111|after failure of an good ambulatory|after failure of an good ambulatory
647683|NCT00761124|PSA screening|psa screening
647684|NCT00761124|Prostate cancer and Latino men|prostate cancer and latino men
647685|NCT00761137|sialorrhea|sialorrhea
647686|NCT00761137|drooling|drooling
647687|NCT00761137|excessive salivation|excessive salivation
647688|NCT00761137|parkinson's disease|parkinson's disease
647785|NCT00761605|Antipsychotics Agents|antipsychotics agents
647689|NCT00761150|Effect on sleep interference by pain|effect on sleep interference by pain
647690|NCT00761163|The purpose of this study is to identify the body's response to aerobic vs. resistance exercise|the purpose of this study is to identify the body's response to aerobic vs. resistance exercise
647691|NCT00761176|Diabetes|diabetes
647692|NCT00761176|Ulcers|ulcers
647693|NCT00761176|Wounds|wounds
647694|NCT00761189|Paliperidone|paliperidone
647695|NCT00761189|R076477|r076477
647696|NCT00761189|Schizophrenia|schizophrenia
647697|NCT00761215|Skin|skin
647698|NCT00761215|Infection|infection
647699|NCT00761215|Complicated Skin and Skin Structure Infection|complicated skin and skin structure infection
647700|NCT00761228|Vegetative State|vegetative state
647701|NCT00761228|Minimally Conscious State|minimally conscious state
647702|NCT00761228|Coma|coma
647703|NCT00761228|Traumatic Brain Injury|traumatic brain injury
647704|NCT00761241|pancreas cancer|pancreas cancer
647705|NCT00761241|combined modality therapy|combined modality therapy
647706|NCT00761254|Domperidone|domperidone
647707|NCT00761254|Gastroparesis|gastroparesis
647708|NCT00761267|Anidulafungin|anidulafungin
647709|NCT00761267|pediatrics|pediatrics
647710|NCT00761267|candidemia|candidemia
647711|NCT00761267|invasive candidiasis|invasive candidiasis
647712|NCT00761267|safety|safety
647713|NCT00761280|Anaplastic astrocytoma|anaplastic astrocytoma
647714|NCT00761280|Glioblastoma|glioblastoma
647715|NCT00761280|Antisense|antisense
647716|NCT00761280|Cancer|cancer
647717|NCT00761280|Transforming Growth Factor beta 2|transforming growth factor beta 2
647718|NCT00761280|Targeted therapy|targeted therapy
647719|NCT00761280|Brain tumor|brain tumor
647720|NCT00761280|Glioma|glioma
647721|NCT00761280|Central Nervous System (CNS)|central nervous system (cns)
647722|NCT00761280|Convection Enhanced Delivery (CED)|convection enhanced delivery (ced)
647723|NCT00761280|Intratumoral administration|intratumoral administration
647724|NCT00761306|Major Depressive Disorder|major depressive disorder
647725|NCT00761306|Long-term|long-term
647726|NCT00761306|Safety|safety
647727|NCT00761306|Open-label|open-label
647728|NCT00761319|Open-angle glaucoma|open-angle glaucoma
647729|NCT00761319|ocular hypertension|ocular hypertension
647730|NCT00761345|pancreatic cancer|pancreatic cancer
647731|NCT00761345|locally advanced|locally advanced
647732|NCT00761345|unresectable|unresectable
647733|NCT00761345|metastatic pancreatic cancer|metastatic pancreatic cancer
647734|NCT00761358|Acotiamide|acotiamide
647735|NCT00761371|external genital and perianal warts|external genital and perianal warts
647736|NCT00761384|B-cell lymphoma|b-cell lymphoma
647737|NCT00761384|Refractory|refractory
647738|NCT00761384|Recurrent|recurrent
647739|NCT00761384|90Y-ibritumomab|90y-ibritumomab
647740|NCT00761384|Stem cells support|stem cells support
647741|NCT00761384|Dosimetry study|dosimetry study
647742|NCT00761397|Oropharyngeal cancer|oropharyngeal cancer
647743|NCT00761397|Dysphagic|dysphagic
647744|NCT00761397|Swallowing exercises|swallowing exercises
647745|NCT00761397|Swallowing rehabilitative regimens|swallowing rehabilitative regimens
647746|NCT00761397|PREPARE|prepare
647747|NCT00761397|Patients' Radiation Expectations|patients' radiation expectations
647748|NCT00761397|Prevention, Adherence, Rehabilitative Exercises|prevention, adherence, rehabilitative exercises
647749|NCT00761410|Arthroplasty|arthroplasty
647750|NCT00761410|Knee|knee
647751|NCT00761410|Replacement|replacement
647752|NCT00761410|High Flexion|high flexion
647753|NCT00761410|PFC Sigma RP-F|pfc sigma rp-f
647755|NCT00761449|AML|aml
647756|NCT00761449|Lenalidomide|lenalidomide
647757|NCT00761449|monosomy 5|monosomy 5
647758|NCT00761449|del5q|del5q
647759|NCT00761462|Pediatrics|pediatrics
647760|NCT00761462|Safety|safety
647761|NCT00761462|Musculoskeletal System|musculoskeletal system
648422|NCT00771602|PLL|pll
647762|NCT00761462|Neurologic Manifestations|neurologic manifestations
647763|NCT00761462|Joint Diseases|joint diseases
647764|NCT00761462|Joint Deformities, Acquired|joint deformities, acquired
647765|NCT00761475|incisional hernia|incisional hernia
647766|NCT00761488|Visual acuity,|visual acuity,
647767|NCT00761488|corneal and|corneal and
647768|NCT00761488|refractive|refractive
647769|NCT00761488|cylinder|cylinder
647770|NCT00761488|following|following
647771|NCT00761488|implantation of the|implantation of the
647772|NCT00761488|AcrySof® Toric|acrysof® toric
647773|NCT00761501|Phase I|phase i
647774|NCT00761501|Healthy Volunteer|healthy volunteer
647867|NCT00769587|smoldering systemic mastocytosis|smoldering systemic mastocytosis
647775|NCT00761553|The study is designed to determine the effects of food supplements and strength training.|the study is designed to determine the effects of food supplements and strength training.
647776|NCT00761566|Elite swimmers|elite swimmers
647777|NCT00761566|Exercise|exercise
647778|NCT00761566|Preconditioning|preconditioning
647779|NCT00761579|Schizophrenia|schizophrenia
647780|NCT00761579|Paliperidone|paliperidone
647781|NCT00761579|Antipsychotics Agents|antipsychotics agents
647782|NCT00761605|Schizophrenia|schizophrenia
647783|NCT00761605|Paliperidone|paliperidone
647784|NCT00761605|Paliperidone extended-release|paliperidone extended-release
648344|NCT00771199|Pain|pain
647786|NCT00761618|Intrapleural catheter|intrapleural catheter
647787|NCT00761618|IPC|ipc
647788|NCT00761618|Pleurodesis|pleurodesis
647789|NCT00761618|PD|pd
647790|NCT00761618|Pleural effusion|pleural effusion
647791|NCT00761618|Fluid in the chest cavity|fluid in the chest cavity
647792|NCT00761618|Recurrent malignant pleural effusion|recurrent malignant pleural effusion
647793|NCT00761618|MPE|mpe
647794|NCT00761618|Pleural inflammatory response|pleural inflammatory response
647795|NCT00761644|Metastatic cancer|metastatic cancer
647796|NCT00761644|Doxil|doxil
647797|NCT00761644|Liposomal doxorubicin|liposomal doxorubicin
647798|NCT00761644|Doxorubicin hydrochloride (liposomal)|doxorubicin hydrochloride (liposomal)
647799|NCT00761644|Avastin|avastin
647800|NCT00761644|Bevacizumab|bevacizumab
647801|NCT00761644|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
647802|NCT00761644|rhuMAb-VEGF|rhumab-vegf
647803|NCT00761644|Torisel|torisel
647804|NCT00761644|Temsirolimus|temsirolimus
647805|NCT00761644|CCI-779|cci-779
647806|NCT00761644|Dynamic contrast-enhanced magnetic resonance imaging|dynamic contrast-enhanced magnetic resonance imaging
647807|NCT00761644|DCE-MRI scan|dce-mri scan
647808|NCT00761657|Kidney|kidney
647809|NCT00761657|Chronic Kidney Disease|chronic kidney disease
647810|NCT00761657|CKD|ckd
647811|NCT00761657|Stage 3 or 4 Chronic Kidney Disease|stage 3 or 4 chronic kidney disease
647812|NCT00761657|Renal|renal
647813|NCT00761657|Anemia|anemia
647814|NCT00761657|Oral anemia treatment|oral anemia treatment
647815|NCT00761657|Hemoglobin levels|hemoglobin levels
647816|NCT00761657|Blood count|blood count
647817|NCT00761657|Erythropoietin|erythropoietin
647818|NCT00761683|Endometriosis|endometriosis
647819|NCT00761696|solid tumor malignancies|solid tumor malignancies
647820|NCT00761709|Open Angle Glaucoma|open angle glaucoma
647821|NCT00761709|Ocular Hypertension|ocular hypertension
647822|NCT00769431|stage I prostate cancer|stage i prostate cancer
647823|NCT00769431|stage IIB prostate cancer|stage iib prostate cancer
647824|NCT00769431|stage IIA prostate cancer|stage iia prostate cancer
647825|NCT00769470|stage I breast cancer|stage i breast cancer
647826|NCT00769470|stage II breast cancer|stage ii breast cancer
647827|NCT00769470|stage IIIA breast cancer|stage iiia breast cancer
647828|NCT00769470|stage IIIB breast cancer|stage iiib breast cancer
647829|NCT00769470|stage IIIC breast cancer|stage iiic breast cancer
647830|NCT00769470|HER2-positive breast cancer|her2-positive breast cancer
647831|NCT00769483|Pancreas|pancreas
647832|NCT00769483|Pancreatic Cancer|pancreatic cancer
647833|NCT00769483|Advanced cancer of the pancreas|advanced cancer of the pancreas
647834|NCT00769483|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
647835|NCT00769483|MK-0646|mk-0646
647836|NCT00769483|Gemcitabine|gemcitabine
647837|NCT00769483|Gemzar|gemzar
647838|NCT00769483|Erlotinib hydrochloride|erlotinib hydrochloride
647839|NCT00769483|Erlotinib|erlotinib
647840|NCT00769483|OSI-774|osi-774
647841|NCT00769483|Tarceva|tarceva
647842|NCT00769509|energy expenditure|energy expenditure
647843|NCT00769509|indirect calorimetry|indirect calorimetry
647844|NCT00769509|human milk|human milk
647845|NCT00769509|preterm formula|preterm formula
647846|NCT00769509|premature infant|premature infant
647847|NCT00769522|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
647848|NCT00769522|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
647849|NCT00769522|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
647850|NCT00769522|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
647851|NCT00769522|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
647852|NCT00769522|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
647853|NCT00769535|heat shock protein70|heat shock protein70
647854|NCT00769535|tumor necrosis factor-alpha promoter|tumor necrosis factor-alpha promoter
647855|NCT00769535|polymorphism|polymorphism
647856|NCT00769548|adenocarcinoma of the prostate|adenocarcinoma of the prostate
647857|NCT00769548|stage I prostate cancer|stage i prostate cancer
647858|NCT00769548|stage IIB prostate cancer|stage iib prostate cancer
647859|NCT00769548|stage IIA prostate cancer|stage iia prostate cancer
647860|NCT00769548|stage III prostate cancer|stage iii prostate cancer
647861|NCT00769548|stage IV prostate cancer|stage iv prostate cancer
647862|NCT00769561|Temporomandibular disorders|temporomandibular disorders
647863|NCT00769561|Biofeedback|biofeedback
647864|NCT00769561|Cognitive behavioral therapy|cognitive behavioral therapy
647865|NCT00769561|Pain|pain
647866|NCT00769587|aggressive systemic mastocytosis|aggressive systemic mastocytosis
647868|NCT00769600|Recurrent Non-Small Cell Lung Cancer|recurrent non-small cell lung cancer
647869|NCT00769613|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
647870|NCT00769613|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
647871|NCT00769613|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
647872|NCT00769613|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
647873|NCT00769613|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
647874|NCT00769613|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
647875|NCT00769613|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
647876|NCT00769613|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
647877|NCT00769613|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
647878|NCT00769613|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
647879|NCT00769613|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
647880|NCT00769613|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
647881|NCT00769613|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
647882|NCT00769613|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
647883|NCT00769613|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
647884|NCT00769613|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
647885|NCT00769613|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
647886|NCT00769613|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
647887|NCT00769613|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
647888|NCT00769613|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
647889|NCT00769613|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
647890|NCT00769613|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
647891|NCT00769613|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
647892|NCT00769613|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
647893|NCT00769613|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
647894|NCT00769613|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
647895|NCT00769613|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
647896|NCT00769613|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
647897|NCT00769613|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
647898|NCT00769613|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
647899|NCT00769613|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
647900|NCT00769613|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
647901|NCT00769613|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
647902|NCT00769613|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
647903|NCT00769613|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
647904|NCT00769613|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
647905|NCT00769613|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
647906|NCT00769613|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
647907|NCT00769613|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
647908|NCT00769613|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
647909|NCT00769613|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
647910|NCT00769613|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
647911|NCT00769613|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
647912|NCT00769613|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
647913|NCT00769613|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
647914|NCT00769613|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
647915|NCT00769613|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
647916|NCT00769613|splenic marginal zone lymphoma|splenic marginal zone lymphoma
647917|NCT00769613|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
647918|NCT00769613|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
647919|NCT00769613|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
647920|NCT00769613|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
647984|NCT00769613|cytomegalovirus infection|cytomegalovirus infection
647921|NCT00769613|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
647922|NCT00769613|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
647923|NCT00769613|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
647924|NCT00769613|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
647925|NCT00769613|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
647926|NCT00769613|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
647927|NCT00769613|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
647928|NCT00769613|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
648533|NCT00771927|study|study
647929|NCT00769613|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
647930|NCT00769613|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
647931|NCT00769613|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
647932|NCT00769613|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
647933|NCT00769613|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
647934|NCT00769613|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
647935|NCT00769613|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
647936|NCT00769613|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
647937|NCT00769613|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
647938|NCT00769613|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
647939|NCT00769613|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
647940|NCT00769613|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
647941|NCT00769613|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
647942|NCT00769613|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
647943|NCT00769613|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
647944|NCT00769613|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
647945|NCT00769613|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
647946|NCT00769613|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
647947|NCT00769613|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
647948|NCT00769613|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
647949|NCT00769613|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
647950|NCT00769613|refractory hairy cell leukemia|refractory hairy cell leukemia
647951|NCT00769613|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
647952|NCT00769613|secondary acute myeloid leukemia|secondary acute myeloid leukemia
647953|NCT00769613|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
647954|NCT00769613|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
647955|NCT00769613|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
647956|NCT00769613|chronic eosinophilic leukemia|chronic eosinophilic leukemia
647957|NCT00769613|primary myelofibrosis|primary myelofibrosis
647958|NCT00769613|chronic neutrophilic leukemia|chronic neutrophilic leukemia
647959|NCT00769613|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
647960|NCT00769613|disseminated neuroblastoma|disseminated neuroblastoma
647961|NCT00769613|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
647962|NCT00769613|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
647963|NCT00769613|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
647964|NCT00769613|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
647965|NCT00769613|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
647966|NCT00769613|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
647967|NCT00769613|recurrent neuroblastoma|recurrent neuroblastoma
647968|NCT00769613|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
647969|NCT00769613|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
647970|NCT00769613|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
647971|NCT00769613|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
647972|NCT00769613|stage I multiple myeloma|stage i multiple myeloma
647973|NCT00769613|stage II multiple myeloma|stage ii multiple myeloma
647974|NCT00769613|stage III multiple myeloma|stage iii multiple myeloma
647975|NCT00769613|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
647976|NCT00769613|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
647977|NCT00769613|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
647978|NCT00769613|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
647979|NCT00769613|stage IIIA breast cancer|stage iiia breast cancer
647980|NCT00769613|stage IIIB breast cancer|stage iiib breast cancer
647981|NCT00769613|stage IIIC breast cancer|stage iiic breast cancer
647982|NCT00769613|stage IV breast cancer|stage iv breast cancer
647983|NCT00769613|refractory multiple myeloma|refractory multiple myeloma
647985|NCT00769626|Low Back Pain|low back pain
647986|NCT00769626|Clinical Practice Guidelines|clinical practice guidelines
647987|NCT00769626|Spinal Manipulation|spinal manipulation
647988|NCT00769626|Physical Therapy Techniques|physical therapy techniques
647989|NCT00769652|malnutrition|malnutrition
647990|NCT00769652|non-small cell lung cancer|non-small cell lung cancer
647991|NCT00769652|small cell lung cancer|small cell lung cancer
647992|NCT00769652|stage III prostate cancer|stage iii prostate cancer
647993|NCT00769652|stage IV prostate cancer|stage iv prostate cancer
647994|NCT00769652|pancreatic cancer|pancreatic cancer
647995|NCT00769652|weight changes|weight changes
647997|NCT00769665|re-wetting drops|re-wetting drops
647998|NCT00769678|Biventricular Pacing|biventricular pacing
647999|NCT00769691|Cardiac surgery|cardiac surgery
648000|NCT00769691|Cerebral blood flow autoregulation|cerebral blood flow autoregulation
648001|NCT00769704|Melanoma|melanoma
648002|NCT00769704|OncoVEX^GM-CSF|oncovex^gm-csf
648003|NCT00769704|GM-CSF|gm-csf
648004|NCT00769704|Stage IIIb, IIIc and IV Disease|stage iiib, iiic and iv disease
648005|NCT00769704|oncolytic|oncolytic
648006|NCT00769704|OncoVex|oncovex
648007|NCT00769704|T-Vec|t-vec
648008|NCT00769704|talimogene laherparepvec|talimogene laherparepvec
648009|NCT00769717|obesity|obesity
648010|NCT00769717|wellness|wellness
648011|NCT00769717|cardiovascular disease prevention|cardiovascular disease prevention
648012|NCT00769717|health at every size|health at every size
648013|NCT00769717|weight loss|weight loss
648014|NCT00769730|hepatocellular carcinoma|hepatocellular carcinoma
648015|NCT00769730|hepatitis B virus|hepatitis b virus
648016|NCT00769730|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
648017|NCT00769756|Different Strategies to Fight Obesity in Families|different strategies to fight obesity in families
648018|NCT00769769|Health Status|health status
648019|NCT00769782|gastrointestinal stromal tumor|gastrointestinal stromal tumor
648020|NCT00769782|liver metastases|liver metastases
648021|NCT00769795|prostate cancer|prostate cancer
648022|NCT00769795|prostatic neoplasm|prostatic neoplasm
648023|NCT00769795|androgen deprivation therapy|androgen deprivation therapy
648024|NCT00769795|insulin-like growth factor receptor I|insulin-like growth factor receptor i
648025|NCT00769795|neoadjuvant|neoadjuvant
648026|NCT00769795|prostatectomy|prostatectomy
648027|NCT00770003|patients|patients
648028|NCT00770003|allergic rhinitis|allergic rhinitis
648029|NCT00770003|tolerability|tolerability
648030|NCT00770003|safety|safety
648031|NCT00770003|nasal symptoms|nasal symptoms
648032|NCT00770016|insulin sensitivity|insulin sensitivity
648033|NCT00770016|Substrate metabolism|substrate metabolism
648034|NCT00770016|Fatty liver|fatty liver
648035|NCT00770016|intramyocellular lipid|intramyocellular lipid
648036|NCT00770016|intracellular signaling|intracellular signaling
648037|NCT00770055|stage IV breast cancer|stage iv breast cancer
648038|NCT00770055|recurrent breast cancer|recurrent breast cancer
648039|NCT00770068|Mood Disorders|mood disorders
648040|NCT00770068|Major Depressive Disorder|major depressive disorder
648041|NCT00770068|Bipolar Disorder|bipolar disorder
648042|NCT00770068|Tree Pollen|tree pollen
648043|NCT00770068|Ragweed Pollen|ragweed pollen
648044|NCT00770068|Rhinitis|rhinitis
648045|NCT00770068|Allergic|allergic
648046|NCT00770068|Seasonal|seasonal
648047|NCT00770068|Allergens|allergens
648048|NCT00770081|Type 2 diabetes|type 2 diabetes
648049|NCT00770081|vildagliptin|vildagliptin
648050|NCT00770094|LASIK|lasik
648051|NCT00770094|Laser Vision correction|laser vision correction
648052|NCT00770094|Myopia|myopia
648053|NCT00770094|Myopia with astigmatism|myopia with astigmatism
648054|NCT00770094|Nearsighted|nearsighted
648055|NCT00770120|recurrent malignant mesothelioma|recurrent malignant mesothelioma
648056|NCT00770120|stage II malignant mesothelioma|stage ii malignant mesothelioma
648057|NCT00770120|stage III malignant mesothelioma|stage iii malignant mesothelioma
648058|NCT00770120|stage IV malignant mesothelioma|stage iv malignant mesothelioma
648059|NCT00770172|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
648060|NCT00770172|neutropenia|neutropenia
648061|NCT00770172|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
648062|NCT00770185|endometrial adenocarcinoma|endometrial adenocarcinoma
648063|NCT00770185|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
648064|NCT00770185|endometrial clear cell carcinoma|endometrial clear cell carcinoma
648065|NCT00770185|endometrial papillary carcinoma|endometrial papillary carcinoma
648066|NCT00770185|recurrent endometrial carcinoma|recurrent endometrial carcinoma
648067|NCT00770185|stage III endometrial carcinoma|stage iii endometrial carcinoma
648068|NCT00770185|stage IV endometrial carcinoma|stage iv endometrial carcinoma
648069|NCT00770198|liver|liver
648070|NCT00770198|alcohol|alcohol
648072|NCT00770224|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
752855|NCT01174498|discomfort|discomfort
648073|NCT00770224|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
648074|NCT00770224|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
648075|NCT00770224|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
648076|NCT00770224|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
648077|NCT00770224|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
648078|NCT00770224|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
648079|NCT00770224|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
648080|NCT00770224|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
648081|NCT00770224|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
648082|NCT00770224|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
648083|NCT00770224|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
648084|NCT00770237|Smoking|smoking
648085|NCT00770237|Nicotine|nicotine
648086|NCT00770237|Schizophrenia|schizophrenia
648087|NCT00770250|asthma symptoms|asthma symptoms
648088|NCT00770250|words used by patients and physicians|words used by patients and physicians
648089|NCT00770250|express asthma symptoms|express asthma symptoms
648090|NCT00770263|any solid tumors|any solid tumors
648091|NCT00770276|obesity WHO I-III|obesity who i-iii
648092|NCT00770276|metabolic syndrome|metabolic syndrome
648093|NCT00770276|Framingham risk score|framingham risk score
648094|NCT00770276|subclinical atherosclerosis|subclinical atherosclerosis
648095|NCT00770276|endothelial dysfunction|endothelial dysfunction
648096|NCT00770302|DPP-4 inhibitors|dpp-4 inhibitors
648097|NCT00770302|HBA1c|hba1c
648098|NCT00770302|Incretins|incretins
648099|NCT00770302|Pharmacokinetics|pharmacokinetics
648100|NCT00770328|Plasma PAI-1 level at 0, 4, 8 weeks|plasma pai-1 level at 0, 4, 8 weeks
648101|NCT00770328|Plasma hsCRP level at 0, 4, 8 weeks|plasma hscrp level at 0, 4, 8 weeks
648102|NCT00770328|Plasma TNF-a level at 0, 4, 8 weeks|plasma tnf-a level at 0, 4, 8 weeks
648103|NCT00770354|Breast cancer|breast cancer
648104|NCT00770367|Cardiovascular risk|cardiovascular risk
648105|NCT00770367|biological markers|biological markers
648106|NCT00770380|smoking|smoking
648107|NCT00770393|squamous cell carcinoma of the pyriform sinus|squamous cell carcinoma of the pyriform sinus
648108|NCT00770393|laryngeal preservation|laryngeal preservation
648109|NCT00770393|patients with biopsy-proven previously untreated resectable T3 with fixed cord involvement squamous cell carcinoma of the pyriform sinus|patients with biopsy-proven previously untreated resectable t3 with fixed cord involvement squamous cell carcinoma of the pyriform sinus
648110|NCT00770419|depression|depression
648111|NCT00770419|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
648112|NCT00770419|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
648113|NCT00770419|acute undifferentiated leukemia|acute undifferentiated leukemia
648114|NCT00770419|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
648115|NCT00770419|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
648116|NCT00770419|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
648117|NCT00770419|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
648118|NCT00770419|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
648119|NCT00770419|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
648120|NCT00770419|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
648121|NCT00770419|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
648122|NCT00770419|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
648123|NCT00770419|mast cell leukemia|mast cell leukemia
648124|NCT00770419|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
648125|NCT00770419|prolymphocytic leukemia|prolymphocytic leukemia
648126|NCT00770419|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
648127|NCT00770419|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
648128|NCT00770419|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
648129|NCT00770419|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
648130|NCT00770419|refractory hairy cell leukemia|refractory hairy cell leukemia
648131|NCT00770419|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
648132|NCT00770419|secondary acute myeloid leukemia|secondary acute myeloid leukemia
648133|NCT00770419|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
648134|NCT00770419|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
648135|NCT00770419|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
648136|NCT00770419|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
648137|NCT00770419|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
648138|NCT00770419|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
648139|NCT00770419|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
648140|NCT00770419|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
752856|NCT01174498|distress|distress
648141|NCT00770419|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
648142|NCT00770419|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
648143|NCT00770419|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
648144|NCT00770419|anaplastic large cell lymphoma|anaplastic large cell lymphoma
648420|NCT00771602|Leukemia|leukemia
648145|NCT00770419|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
648146|NCT00770419|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
648147|NCT00770419|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
648148|NCT00770419|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
648149|NCT00770419|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
648150|NCT00770419|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
648151|NCT00770419|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
648152|NCT00770419|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
648153|NCT00770419|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
648154|NCT00770419|splenic marginal zone lymphoma|splenic marginal zone lymphoma
648155|NCT00770419|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
648156|NCT00770419|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
648157|NCT00770419|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
648158|NCT00770419|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
648159|NCT00770419|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
648160|NCT00770419|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
648161|NCT00770419|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
648162|NCT00770419|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
648163|NCT00770419|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
648164|NCT00770419|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
648165|NCT00770419|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
648166|NCT00770419|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
648167|NCT00770419|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
648168|NCT00770419|intraocular lymphoma|intraocular lymphoma
648169|NCT00770419|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
648170|NCT00770419|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
648171|NCT00770419|chronic eosinophilic leukemia|chronic eosinophilic leukemia
648172|NCT00770419|chronic neutrophilic leukemia|chronic neutrophilic leukemia
648173|NCT00770419|primary myelofibrosis|primary myelofibrosis
648174|NCT00770419|primary systemic amyloidosis|primary systemic amyloidosis
648175|NCT00770419|refractory multiple myeloma|refractory multiple myeloma
648176|NCT00770419|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
648177|NCT00770419|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
648178|NCT00770419|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
648179|NCT00770432|Human Experimentation|human experimentation
648180|NCT00770445|Glucose Metabolism Disorder|glucose metabolism disorder
648181|NCT00770445|Dysmetabolic Syndrome|dysmetabolic syndrome
648182|NCT00770445|Type II Diabetes|type ii diabetes
648183|NCT00770445|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
648184|NCT00770445|Dyslipidemia|dyslipidemia
648185|NCT00770445|Drug Therapy|drug therapy
648186|NCT00770458|Down Syndrome|down syndrome
648187|NCT00770471|adult glioblastoma|adult glioblastoma
648188|NCT00770471|adult gliosarcoma|adult gliosarcoma
648189|NCT00770471|adult giant cell glioblastoma|adult giant cell glioblastoma
648190|NCT00770484|Exercise|exercise
648191|NCT00770484|Propanolol|propanolol
648192|NCT00770484|Beta blockers|beta blockers
648193|NCT00770497|drug effects|drug effects
648194|NCT00770497|Hypertension|hypertension
648195|NCT00770497|Vascular Resistance|vascular resistance
648196|NCT00770497|Drug Therapy|drug therapy
648197|NCT00770497|physiopathology, vascular|physiopathology, vascular
648198|NCT00770510|Primary insomnia|primary insomnia
648199|NCT00770523|patients without comorbidity|patients without comorbidity
648200|NCT00770536|fallopian tube cancer|fallopian tube cancer
648201|NCT00770536|Gynecological Malignancy|gynecological malignancy
648202|NCT00770536|primary peritoneal cancer of predominantly epithelial origin|primary peritoneal cancer of predominantly epithelial origin
648203|NCT00770536|Stage II to IV ovarian cancer|stage ii to iv ovarian cancer
648204|NCT00770575|Biological Markers|biological markers
648205|NCT00770575|Biochemical Markers|biochemical markers
648206|NCT00770575|Carotid Artery, Internal|carotid artery, internal
648207|NCT00770575|Carotid Artery, Common|carotid artery, common
648208|NCT00770575|Marker, Surrogate|marker, surrogate
648209|NCT00770575|Vascular Diseases|vascular diseases
648210|NCT00770575|Diabetes Mellitus|diabetes mellitus
648211|NCT00770575|Drug Therapy|drug therapy
648212|NCT00770588|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
648213|NCT00770588|Gefitinib|gefitinib
648214|NCT00770601|NOMID|nomid
648215|NCT00770601|CINCA Syndrome|cinca syndrome
648216|NCT00770601|Canakinumab|canakinumab
648217|NCT00770614|Contrast Induced Nephropathy|contrast induced nephropathy
648218|NCT00770627|160 children|160 children
648219|NCT00770627|parallel group|parallel group
648220|NCT00770640|Glucose Metabolism Disorder|glucose metabolism disorder
648221|NCT00770640|Dysmetabolic Syndrome|dysmetabolic syndrome
648222|NCT00770640|Type II Diabetes|type ii diabetes
648223|NCT00770640|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
648224|NCT00770640|Dyslipidemia|dyslipidemia
648225|NCT00770640|Drug Therapy|drug therapy
648226|NCT00770653|Glucose Metabolism Disorder|glucose metabolism disorder
648227|NCT00770653|Dysmetabolic Syndrome|dysmetabolic syndrome
648228|NCT00770653|Type II Diabetes|type ii diabetes
648229|NCT00770653|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
648230|NCT00770653|Dyslipidemia|dyslipidemia
648231|NCT00770653|Hyperlipidemias|hyperlipidemias
648232|NCT00770653|Drug Therapy|drug therapy
648233|NCT00770666|Tobacco dependence treatment|tobacco dependence treatment
648234|NCT00770692|insomnia|insomnia
648235|NCT00770692|primary insomnia|primary insomnia
648331|NCT00771134|Randomised controlled|randomised controlled
648332|NCT00771134|Multicenter|multicenter
648236|NCT00770692|insomnia associated with psychiatric or physical disorder(s)|insomnia associated with psychiatric or physical disorder(s)
648237|NCT00770718|intracranial hemorrhage|intracranial hemorrhage
648238|NCT00770718|warfarin|warfarin
648239|NCT00770718|anticoagulant|anticoagulant
648240|NCT00770718|Factor VII|factor vii
648241|NCT00770718|Prothrombin|prothrombin
648242|NCT00770731|Torisel|torisel
648243|NCT00770731|Temsirolimus|temsirolimus
648244|NCT00770731|Hycamtin|hycamtin
648245|NCT00770731|Topotecan hydrochloride|topotecan hydrochloride
648246|NCT00770731|Velcade|velcade
648247|NCT00770731|Bortezomib|bortezomib
648248|NCT00770731|FDG-PET Scans|fdg-pet scans
648249|NCT00770731|18F-Fluoro-2-Deoxyglucose Positron Emission Tomography|18f-fluoro-2-deoxyglucose positron emission tomography
648250|NCT00770744|Schizophrenia|schizophrenia
648251|NCT00770744|Antipsychotic|antipsychotic
648252|NCT00770744|Olanzapine|olanzapine
648253|NCT00770744|Lu 31-130|lu 31-130
648254|NCT00770770|Macular edema secondary to RVO|macular edema secondary to rvo
648255|NCT00770796|Contrast induced nephropathy|contrast induced nephropathy
648256|NCT00770822|Primary|primary
648257|NCT00770822|Prostate|prostate
648258|NCT00770822|Cancer|cancer
648259|NCT00770822|Primary T1c/T2a organ confined prostate cancer|primary t1c/t2a organ confined prostate cancer
648260|NCT00770822|organ-confined|organ-confined
648261|NCT00770835|Glucose Metabolism Disorder|glucose metabolism disorder
648262|NCT00770835|Dysmetabolic Syndrome|dysmetabolic syndrome
648263|NCT00770835|Type II Diabetes|type ii diabetes
648264|NCT00770835|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
648265|NCT00770835|Dyslipidemia|dyslipidemia
648266|NCT00770835|Drug Therapy|drug therapy
648267|NCT00770848|CRPC|crpc
648268|NCT00770861|nebivolol|nebivolol
648269|NCT00770861|Bystolic ™|bystolic ™
648270|NCT00770861|Hypertension|hypertension
648271|NCT00770861|Hispanic|hispanic
648272|NCT00770861|Hypertension in Hispanic patients|hypertension in hispanic patients
648273|NCT00770887|Undesired fertility|undesired fertility
648274|NCT00770913|reflux esophagitis|reflux esophagitis
648275|NCT00770913|rabeprazole|rabeprazole
648276|NCT00770913|GERD|gerd
648277|NCT00770913|Japan|japan
648278|NCT00770926|risk reduction|risk reduction
648279|NCT00770926|minority|minority
648280|NCT00770926|diabetes prevention|diabetes prevention
648281|NCT00770926|lifestyle program|lifestyle program
648282|NCT00770926|behavior change|behavior change
648283|NCT00770939|Complete healing of chronic diabetic foot ulcers|complete healing of chronic diabetic foot ulcers
648284|NCT00770939|Platelet Rich Fibrin|platelet rich fibrin
648285|NCT00770939|Vivostat|vivostat
648286|NCT00770939|Growth factor treatment|growth factor treatment
648287|NCT00770939|Treatment of chronic diabetic foot ulcers|treatment of chronic diabetic foot ulcers
648288|NCT00770952|Glucose Metabolism Disorder|glucose metabolism disorder
648289|NCT00770952|Dysmetabolic Syndrome|dysmetabolic syndrome
648290|NCT00770952|Type II Diabetes|type ii diabetes
648291|NCT00770952|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
648292|NCT00770952|Dyslipidemia|dyslipidemia
648293|NCT00770952|Drug Therapy|drug therapy
648294|NCT00770965|Plaque psoriasis, skin condition, thickening, flaking, skin disease, autoimmune disease|plaque psoriasis, skin condition, thickening, flaking, skin disease, autoimmune disease
648295|NCT00770978|ICU|icu
648296|NCT00770991|Polyp, Familial Adenomatous Polyposis, Prevention|polyp, familial adenomatous polyposis, prevention
648297|NCT00771004|drug effects|drug effects
648298|NCT00771004|Type II Diabetes|type ii diabetes
648299|NCT00771004|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
648300|NCT00771004|Drug Therapy|drug therapy
648301|NCT00771004|Heart|heart
648302|NCT00771004|physiology|physiology
648303|NCT00771004|function|function
648304|NCT00771017|adenocarcinoma of the prostate|adenocarcinoma of the prostate
648305|NCT00771017|recurrent prostate cancer|recurrent prostate cancer
648306|NCT00771017|stage II prostate cancer|stage ii prostate cancer
648307|NCT00771017|stage III prostate cancer|stage iii prostate cancer
648308|NCT00771017|stage I prostate cancer|stage i prostate cancer
648309|NCT00771056|untreated|untreated
648310|NCT00771069|Hypertension|hypertension
648311|NCT00771069|Type II DM|type ii dm
648312|NCT00771069|DM related complication|dm related complication
648421|NCT00771602|CLL|cll
648314|NCT00771069|2007 ESH-ESC guidelines|2007 esh-esc guidelines
648315|NCT00771069|survey|survey
648316|NCT00771082|inflammatory markers|inflammatory markers
648317|NCT00771082|bone markers|bone markers
648318|NCT00771082|OA|oa
648319|NCT00771095|weight loss|weight loss
648320|NCT00771095|elaboration|elaboration
648321|NCT00771095|self efficacy|self efficacy
648322|NCT00771108|NAFLD|nafld
648323|NCT00771108|Obesity|obesity
648324|NCT00771108|Metabolic Syndrome|metabolic syndrome
648325|NCT00771108|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
648326|NCT00771134|Depression|depression
648327|NCT00771134|Bipolar I Disorder|bipolar i disorder
648328|NCT00771134|Bipolar II Disorder|bipolar ii disorder
648329|NCT00771134|Placebo-controlled|placebo-controlled
648330|NCT00771134|Double-blind|double-blind
648435|NCT00771615|H5N1|h5n1
648333|NCT00771134|Clinical study|clinical study
648334|NCT00771134|Mania|mania
648335|NCT00771147|Advanced Renal Cell Carcinoma ( RCC)|advanced renal cell carcinoma ( rcc)
648336|NCT00771173|Phenazopyrdine|phenazopyrdine
648337|NCT00771173|post operative bladder catheritization|post operative bladder catheritization
648338|NCT00771173|VAS scores|vas scores
648339|NCT00771173|Bladder pain related to indwelling foley catheters.|bladder pain related to indwelling foley catheters.
648340|NCT00771173|Bladder irritaion related to indwelling foley catheters.|bladder irritaion related to indwelling foley catheters.
648341|NCT00771186|pediatric|pediatric
648342|NCT00771186|Laryngeal EMG|laryngeal emg
648343|NCT00771199|Cancer pain|cancer pain
648350|NCT00771212|Observational|observational
648351|NCT00771212|Taiwan|taiwan
648352|NCT00771225|genital prolapse|genital prolapse
648353|NCT00771225|surgery|surgery
648354|NCT00771225|fascial repair|fascial repair
648355|NCT00771225|mesh|mesh
648356|NCT00771225|prolift|prolift
648357|NCT00771238|pressure ulcers|pressure ulcers
648358|NCT00771238|Therapy mattresses|therapy mattresses
648359|NCT00771238|Incidence of pressure ulcers|incidence of pressure ulcers
648360|NCT00771251|Rheumatoid arthritis|rheumatoid arthritis
648361|NCT00771251|Fully Human anti-TNFa monoclonal antibody|fully human anti-tnfa monoclonal antibody
648362|NCT00771251|CNTO148|cnto148
648363|NCT00771251|Golimumab|golimumab
648364|NCT00771264|Overactive Bladder|overactive bladder
648365|NCT00771277|Brain Injuries|brain injuries
648366|NCT00771277|Caregivers|caregivers
648367|NCT00771277|Volunteer Workers|volunteer workers
648368|NCT00771277|Social Networks|social networks
648369|NCT00771290|Rectal sparing|rectal sparing
648370|NCT00771290|Colon cancer|colon cancer
648371|NCT00771303|Pregnancy|pregnancy
648372|NCT00771303|Pulmonary embolism|pulmonary embolism
648373|NCT00771303|MSCT|msct
648374|NCT00771381|18F-FAZA|18f-faza
648375|NCT00771381|18F-FDG|18f-fdg
648376|NCT00771381|Positron Emission Tomography|positron emission tomography
648377|NCT00771381|Cell Hypoxia|cell hypoxia
648378|NCT00771394|Vesicare|vesicare
648379|NCT00771394|Solifenacin succinate|solifenacin succinate
648380|NCT00771394|Tamsulosin|tamsulosin
648381|NCT00771394|Overactive Bladder|overactive bladder
648382|NCT00771394|BPH|bph
648383|NCT00771407|Ostomy creation|ostomy creation
648384|NCT00771407|Parastomal hernia|parastomal hernia
648385|NCT00771433|neutropenia|neutropenia
648386|NCT00771433|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
648387|NCT00771433|recurrent breast cancer|recurrent breast cancer
648388|NCT00771433|stage I breast cancer|stage i breast cancer
648389|NCT00771433|stage II breast cancer|stage ii breast cancer
648390|NCT00771433|stage IIIA breast cancer|stage iiia breast cancer
648391|NCT00771433|stage IIIB breast cancer|stage iiib breast cancer
648392|NCT00771433|stage IIIC breast cancer|stage iiic breast cancer
648393|NCT00771433|stage IV breast cancer|stage iv breast cancer
648394|NCT00771446|Hepatitis, acute|hepatitis, acute
648395|NCT00771446|Acute Hepatitis OR Chronic Hepatitis|acute hepatitis or chronic hepatitis
648396|NCT00771459|Local infiltration analgesia|local infiltration analgesia
648397|NCT00771459|postoperative pain|postoperative pain
648398|NCT00771459|ropivacaine|ropivacaine
648399|NCT00771498|rifampin|rifampin
648400|NCT00771498|lopinavir|lopinavir
648401|NCT00771498|drug interaction|drug interaction
648402|NCT00771498|pharmacokinetic|pharmacokinetic
648403|NCT00771524|Pharmacokinetics|pharmacokinetics
648404|NCT00771524|Hip replacement|hip replacement
648405|NCT00771524|Ceftobiprole|ceftobiprole
648406|NCT00771537|HIV Testing|hiv testing
648407|NCT00771537|Persuasion|persuasion
648408|NCT00771537|Health Communication|health communication
648409|NCT00771537|Clinical Trials Participation|clinical trials participation
648410|NCT00771537|Attitudes toward Health|attitudes toward health
648411|NCT00771537|Diagnostic Tests|diagnostic tests
648412|NCT00771537|Behavioral Research|behavioral research
648413|NCT00771537|Intervention Studies|intervention studies
648414|NCT00771563|Non-Small Cell Lung Cancer|non-small cell lung cancer
648415|NCT00771563|chemotherapy|chemotherapy
648416|NCT00771563|Low Molecular Weight Heparin|low molecular weight heparin
648417|NCT00771576|Diabetes Mellitus|diabetes mellitus
648418|NCT00771576|T1DM|t1dm
648419|NCT00771602|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
648423|NCT00771602|SLL|sll
648424|NCT00771602|Rituximab|rituximab
648425|NCT00771602|Rituxan|rituxan
648426|NCT00771602|Alemtuzumab|alemtuzumab
648427|NCT00771602|Campath|campath
648428|NCT00771615|human|human
648429|NCT00771615|Avian|avian
648430|NCT00771615|safety|safety
648431|NCT00771615|vaccines|vaccines
648432|NCT00771615|influenza|influenza
648433|NCT00771615|pandemic|pandemic
648434|NCT00771615|immunogenicity|immunogenicity
648436|NCT00771628|Intubation, Flex-It, stylet, GlideScope|intubation, flex-it, stylet, glidescope
648437|NCT00771641|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
648438|NCT00771641|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
648439|NCT00771641|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
648440|NCT00771641|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
648441|NCT00771641|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
648442|NCT00771641|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
648443|NCT00771641|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
648444|NCT00771641|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
648445|NCT00771641|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
648446|NCT00771641|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
648447|NCT00771641|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
648448|NCT00771641|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
648449|NCT00771641|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
648450|NCT00771667|Interleukin-12|interleukin-12
648451|NCT00771667|Inflammation|inflammation
648452|NCT00771667|Research study|research study
648453|NCT00771667|Ustekinumab|ustekinumab
648454|NCT00771667|CNTO1275|cnto1275
648455|NCT00771667|Interleukin-23|interleukin-23
648457|NCT00771693|Platelet Activation|platelet activation
648458|NCT00771693|Postprandial hyperglycemia|postprandial hyperglycemia
648459|NCT00771693|insulin|insulin
648460|NCT00771706|Pediatric Cough, Quality of Life|pediatric cough, quality of life
648461|NCT00771706|Drug (including placebo)|drug (including placebo)
648463|NCT00771732|toe nail fungus|toe nail fungus
648464|NCT00771758|Vertebral compression fracture|vertebral compression fracture
648465|NCT00771758|Osteoporosis|osteoporosis
648466|NCT00771758|Acute pain|acute pain
648467|NCT00771758|Analgesic|analgesic
648468|NCT00771758|Oxycodone|oxycodone
648469|NCT00771758|Tapentadol|tapentadol
648470|NCT00771771|Stroke|stroke
648471|NCT00771771|Rehabilitation|rehabilitation
648472|NCT00771771|Early Supported Discharge|early supported discharge
648473|NCT00771771|ESD|esd
648474|NCT00771771|RCT|rct
648475|NCT00771784|Endotracheal intubation|endotracheal intubation
648476|NCT00771784|tracheostomy|tracheostomy
648477|NCT00771784|laryngeal mask|laryngeal mask
648478|NCT00771797|PAOD|paod
648479|NCT00771797|diabetis|diabetis
648480|NCT00771797|vascular function|vascular function
648481|NCT00771797|in diabetics with PAOD|in diabetics with paod
648482|NCT00771810|Ovarian Cancer|ovarian cancer
648483|NCT00771810|Thrombocytopenia|thrombocytopenia
648484|NCT00771810|Cytopenia|cytopenia
648485|NCT00771810|Chemotherapy|chemotherapy
648486|NCT00771836|Stem cell transplantation|stem cell transplantation
648487|NCT00771836|Airway hyper-reactivity|airway hyper-reactivity
648488|NCT00771836|methacholine|methacholine
648489|NCT00771836|pediatric|pediatric
648490|NCT00771849|Meningitis|meningitis
648491|NCT00771849|Meningococcemia|meningococcemia
648492|NCT00771849|Neisseria meningitidis|neisseria meningitidis
648493|NCT00771862|pain|pain
648494|NCT00771862|amputation|amputation
648495|NCT00771862|phantom limb|phantom limb
648496|NCT00771862|stump pain|stump pain
648497|NCT00771862|catheter|catheter
648498|NCT00771862|nerve block|nerve block
648499|NCT00771862|peripheral nerve block|peripheral nerve block
648500|NCT00771862|ucsd|ucsd
648501|NCT00771862|post-amputation phantom limb or stump pain|post-amputation phantom limb or stump pain
648502|NCT00771901|obesity|obesity
648503|NCT00771901|insulin resistance|insulin resistance
648504|NCT00771901|type II diabetes|type ii diabetes
648505|NCT00771914|aspirin|aspirin
648506|NCT00771914|omega 3 fatty acids|omega 3 fatty acids
648507|NCT00771914|Lovaza|lovaza
648508|NCT00771914|myocardial infarction|myocardial infarction
648509|NCT00771914|aspirin resistance|aspirin resistance
648510|NCT00771914|cardiovascular disease|cardiovascular disease
648511|NCT00771927|Vimpat®|vimpat®
648512|NCT00771927|Lacosamide|lacosamide
648514|NCT00771927|epilepsy|epilepsy
648515|NCT00771927|epilepsies|epilepsies
648516|NCT00771927|seizure|seizure
648517|NCT00771927|partial seizure|partial seizure
648518|NCT00771927|partial onset|partial onset
648519|NCT00771927|seizure disorder|seizure disorder
648520|NCT00771927|single seizure|single seizure
648521|NCT00771927|motor seizure|motor seizure
648522|NCT00771927|convulsions|convulsions
648523|NCT00771927|add-on|add-on
648524|NCT00771927|AED|aed
648525|NCT00771927|anti-epileptic|anti-epileptic
648526|NCT00771927|anti-epileptic drug|anti-epileptic drug
648527|NCT00771927|seizure control|seizure control
648528|NCT00771927|open-label|open-label
648529|NCT00771927|post authorization|post authorization
648530|NCT00771927|PASS|pass
648531|NCT00771927|late stage|late stage
648534|NCT00771927|phase 4|phase 4
648535|NCT00771927|phase IV|phase iv
648536|NCT00771953|apricoxib|apricoxib
648537|NCT00771953|docetaxel|docetaxel
648538|NCT00771953|pemetrexed|pemetrexed
648539|NCT00771953|Stage IIIb or Stage IV|stage iiib or stage iv
648540|NCT00771966|patients with cancer in the prostate|patients with cancer in the prostate
648541|NCT00771979|Healthy Volunteers|healthy volunteers
648542|NCT00771979|Relative Bioavailability|relative bioavailability
648543|NCT00771992|Asthma GINA 1|asthma gina 1
648544|NCT00772018|stage 0 bladder cancer|stage 0 bladder cancer
648545|NCT00772031|chronic migraine, migraine prevention, chronic headache|chronic migraine, migraine prevention, chronic headache
648546|NCT00772044|OSA|osa
648547|NCT00772044|sleep apnea|sleep apnea
648548|NCT00772044|apnea|apnea
648549|NCT00772044|AHI|ahi
648550|NCT00772070|Menactra®|menactra®
648551|NCT00772070|Menomune®|menomune®
648553|NCT00772070|Meningococcemia|meningococcemia
648554|NCT00772070|Neisseria meningitidis|neisseria meningitidis
648555|NCT00772109|Influenza|influenza
648556|NCT00772109|Orthomyxoviruses|orthomyxoviruses
649871|NCT00775190|generic|generic
648557|NCT00772109|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
648558|NCT00772109|Fluzone®|fluzone®
648559|NCT00772109|Adults|adults
648560|NCT00772122|Recurrent Miscarriage|recurrent miscarriage
648561|NCT00772122|G-CSF|g-csf
648562|NCT00772122|pregnancy outcome|pregnancy outcome
648563|NCT00772122|pregnancy outcome of pregnancies treated with G-CSF|pregnancy outcome of pregnancies treated with g-csf
648564|NCT00772122|treatment of recurrent miscarriage|treatment of recurrent miscarriage
648565|NCT00772135|pulmonary hypertension|pulmonary hypertension
648566|NCT00772135|congenital heart defects|congenital heart defects
648567|NCT00772135|exercise|exercise
648568|NCT00772135|phosphodiesterase inhibitors|phosphodiesterase inhibitors
648569|NCT00772135|Exercise induced pulmonary arterial hypertensive response in congenital heart disease|exercise induced pulmonary arterial hypertensive response in congenital heart disease
648570|NCT00772148|Liver|liver
648571|NCT00772148|Hepatic|hepatic
648572|NCT00772148|Transplantation|transplantation
648573|NCT00772148|Immunosuppression|immunosuppression
648574|NCT00772148|Tacrolimus|tacrolimus
648575|NCT00772148|Prograf|prograf
648576|NCT00772161|ADHD|adhd
648577|NCT00772161|Attention Deficit Disorder|attention deficit disorder
648578|NCT00772161|Attention Deficit an Disruptive Behavior Disorders|attention deficit an disruptive behavior disorders
648579|NCT00772161|Children|children
648580|NCT00772161|Central Nervous System Stimulants|central nervous system stimulants
648581|NCT00772161|Methylphenidate|methylphenidate
648582|NCT00772161|Pharmacokinetics|pharmacokinetics
648583|NCT00772161|Area Under Curve|area under curve
648584|NCT00772161|Therapeutic Equivalency|therapeutic equivalency
648585|NCT00772161|Psychopharmacology|psychopharmacology
648586|NCT00772174|Glucose Metabolism Disorder|glucose metabolism disorder
648587|NCT00772174|Dysmetabolic Syndrome|dysmetabolic syndrome
648588|NCT00772174|Type II Diabetes|type ii diabetes
648589|NCT00772174|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
648590|NCT00772174|Dyslipidemia|dyslipidemia
648591|NCT00772174|Drug Therapy|drug therapy
648592|NCT00772187|Laparoscopic surgery (general surgery).|laparoscopic surgery (general surgery).
648593|NCT00772213|multiple trauma|multiple trauma
648594|NCT00772213|outcome and process assessment|outcome and process assessment
648595|NCT00772226|laparoscopic cholecystectomy|laparoscopic cholecystectomy
648596|NCT00772226|pain|pain
648597|NCT00772226|PONV|ponv
648598|NCT00772226|music|music
648599|NCT00772226|therapy|therapy
648600|NCT00772226|fatigue after elective laparoscopic cholecystectomy|fatigue after elective laparoscopic cholecystectomy
648601|NCT00772239|Coagulation Management|coagulation management
648602|NCT00772239|Cardiac surgery|cardiac surgery
648603|NCT00772239|Bleeding|bleeding
648604|NCT00772239|Rotem|rotem
648605|NCT00772252|Liver support treatment|liver support treatment
648606|NCT00772265|Bioequivalence|bioequivalence
648607|NCT00772265|pharmacokinetic|pharmacokinetic
648608|NCT00772265|Pharmacodynamic|pharmacodynamic
648609|NCT00772265|Isophane insulin|isophane insulin
648610|NCT00772278|carotid stenosis|carotid stenosis
648611|NCT00772278|asymptomatic|asymptomatic
648612|NCT00772278|carotid stenting|carotid stenting
648613|NCT00772278|carotid endarterectomy|carotid endarterectomy
648614|NCT00772291|inguinal|inguinal
648615|NCT00772291|hernia|hernia
648616|NCT00772291|chronic|chronic
648617|NCT00772291|pain|pain
648618|NCT00772291|pregabalin|pregabalin
648619|NCT00772291|chronic pain after inguinal herniorraphy|chronic pain after inguinal herniorraphy
648620|NCT00772304|rhinitis|rhinitis
648621|NCT00772317|Recurrent|recurrent
648622|NCT00772317|prostate cancer|prostate cancer
648623|NCT00772317|ebrt|ebrt
648624|NCT00772317|hifu|hifu
648625|NCT00772330|MIDI Arrow|midi arrow
648626|NCT00772330|Glaucoma Drainage Device|glaucoma drainage device
648628|NCT00772330|InnFocus|innfocus
648629|NCT00772330|Glaucoma treatment|glaucoma treatment
648630|NCT00772343|Diarrhea|diarrhea
648883|NCT00765609|Paediatric|paediatric
648631|NCT00772343|Clostridium difficile infection|clostridium difficile infection
648632|NCT00772343|Clostridium difficile toxoid|clostridium difficile toxoid
648633|NCT00772369|Pertussis|pertussis
648634|NCT00772369|Whooping cough|whooping cough
648635|NCT00772369|Diphtheria|diphtheria
648636|NCT00772369|Tetanus|tetanus
648637|NCT00772369|Haemophilus influenzae|haemophilus influenzae
648638|NCT00772369|Poliovirus Types 1, 2, and 3.|poliovirus types 1, 2, and 3.
648639|NCT00772382|Chronic Kidney Disease|chronic kidney disease
648640|NCT00772382|Dialysis|dialysis
648641|NCT00772382|Hyperphosphatemia|hyperphosphatemia
648642|NCT00772382|Phosphate binder|phosphate binder
648643|NCT00772395|Periprosthetic bone loss risedronate bisphosphonates|periprosthetic bone loss risedronate bisphosphonates
648644|NCT00772408|pulmonary tuberculosis|pulmonary tuberculosis
648645|NCT00772408|Toll-like receptor 2 gene polymorphisms|toll-like receptor 2 gene polymorphisms
648646|NCT00772408|blood lymphocyte subsets|blood lymphocyte subsets
648647|NCT00772408|systemic symptoms|systemic symptoms
648648|NCT00772408|pleural effusion|pleural effusion
648649|NCT00772421|Epilepsy|epilepsy
648650|NCT00772421|Recruitment rhythm|recruitment rhythm
648651|NCT00772421|DBS|dbs
648652|NCT00772447|Skin Infections|skin infections
648653|NCT00772447|Complicated Bacterial Skin and Skin Structure Infection due to Gram-positive Pathogens|complicated bacterial skin and skin structure infection due to gram-positive pathogens
648654|NCT00772460|patient warming|patient warming
648655|NCT00772460|convective warming|convective warming
648656|NCT00772460|conductive warming|conductive warming
648657|NCT00772460|intraoperative normothermia|intraoperative normothermia
648658|NCT00772460|accidental hypothermia|accidental hypothermia
648659|NCT00772460|intraoperative hypothermia|intraoperative hypothermia
648660|NCT00772486|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
648661|NCT00772486|Leukemia|leukemia
648662|NCT00772486|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
648663|NCT00772486|Leukemia, B-Cell|leukemia, b-cell
648664|NCT00772486|Immune System Diseases|immune system diseases
648665|NCT00772486|Rituximab|rituximab
648666|NCT00772486|Fludarabine|fludarabine
648667|NCT00772486|Cyclophosphamide|cyclophosphamide
648668|NCT00772486|ISF35|isf35
648669|NCT00772486|Ad-ISF35|ad-isf35
648670|NCT00772486|Refractory|refractory
648671|NCT00772486|Resistant|resistant
648672|NCT00772486|17p-|17p-
648673|NCT00772486|del 17p|del 17p
648674|NCT00772486|17p|17p
648675|NCT00772486|Resistant CLL|resistant cll
648676|NCT00772486|Refractory CLL|refractory cll
648677|NCT00772486|17p- CLL|17p- cll
648678|NCT00772486|CLL|cll
648679|NCT00764582|Corneal penetration of levofloxacin and moxifloxacin|corneal penetration of levofloxacin and moxifloxacin
648680|NCT00764595|gastrointestinal stromal tumor|gastrointestinal stromal tumor
648681|NCT00764595|liver metastases|liver metastases
648682|NCT00764621|Gadolinium ethoxybenzyl DTPA|gadolinium ethoxybenzyl dtpa
648683|NCT00764621|Contrast media|contrast media
648684|NCT00764621|Outcome Assessment (Health Care)|outcome assessment (health care)
648685|NCT00764621|Magnetic Resonance Imaging|magnetic resonance imaging
648686|NCT00764621|Tomography, X-Ray Computed|tomography, x-ray computed
648687|NCT00764621|Liver|liver
648688|NCT00764647|family caregivers|family caregivers
648689|NCT00764647|caregiver education|caregiver education
648690|NCT00764647|caregiver burden|caregiver burden
648691|NCT00764647|caregiver hardiness|caregiver hardiness
648692|NCT00764647|caregiver depressive symptoms|caregiver depressive symptoms
648693|NCT00764686|Exercise|exercise
648694|NCT00764686|Education|education
648695|NCT00764686|Hydrotherapy|hydrotherapy
648696|NCT00764686|Physical Therapy Modalities|physical therapy modalities
648697|NCT00764699|poor growth|poor growth
648698|NCT00764699|inflammatory bowel disease|inflammatory bowel disease
648699|NCT00764712|Tight glycemia control|tight glycemia control
648700|NCT00764712|cardiac surgery patients|cardiac surgery patients
648701|NCT00764738|ARMD|armd
648702|NCT00764738|AMD|amd
648703|NCT00764738|exudative AMD|exudative amd
648704|NCT00764764|shoulder pain|shoulder pain
648705|NCT00764764|rotator cuff|rotator cuff
648706|NCT00764764|impingement|impingement
648707|NCT00764764|cervical referred pain|cervical referred pain
648708|NCT00764764|neural tension|neural tension
648709|NCT00764777|Peripheral Vascular Disease|peripheral vascular disease
648710|NCT00764777|Intermittent Claudication|intermittent claudication
648711|NCT00764777|Critical limb Ischemia|critical limb ischemia
648712|NCT00764777|TASC A|tasc a
648713|NCT00764777|TASC B|tasc b
648714|NCT00764777|TASC C|tasc c
648715|NCT00764777|TASC D|tasc d
648716|NCT00764777|balloon-expandable stent|balloon-expandable stent
648717|NCT00764777|Self-expanding stent|self-expanding stent
648718|NCT00764777|TASC|tasc
648719|NCT00764816|Chronic kidney disease, stages 3 and 4|chronic kidney disease, stages 3 and 4
648720|NCT00764816|phosphaturia|phosphaturia
648721|NCT00764816|phosphorus|phosphorus
648722|NCT00764816|PTH|pth
648723|NCT00764816|FGF23|fgf23
648724|NCT00764816|Dietary protein source|dietary protein source
648725|NCT00764829|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
648726|NCT00764829|fludarabine|fludarabine
648727|NCT00764829|mycophenolate mofetil|mycophenolate mofetil
648728|NCT00764829|mycophenolic acid|mycophenolic acid
648729|NCT00764829|biomarkers|biomarkers
648730|NCT00764881|Oral contraceptive|oral contraceptive
648731|NCT00764881|Sexual dysfunction|sexual dysfunction
648732|NCT00764881|Libido|libido
648733|NCT00764907|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
648734|NCT00764907|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
648735|NCT00764907|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
648736|NCT00764920|human skin|human skin
648737|NCT00764933|information programme|information programme
648738|NCT00764933|anxiety reduction|anxiety reduction
648739|NCT00764933|multicenter trial|multicenter trial
648740|NCT00764933|intensive care|intensive care
648741|NCT00764933|critical care|critical care
648827|NCT00765440|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
648742|NCT00764972|To evaluate the use of sorafenib added to vinorelbine chemotherapy, to find out which are the doses of two drugs can be safely combined|to evaluate the use of sorafenib added to vinorelbine chemotherapy, to find out which are the doses of two drugs can be safely combined
648743|NCT00764985|Syncope|syncope
648744|NCT00764985|Pre-Syncope|pre-syncope
648745|NCT00764985|Fainting|fainting
648746|NCT00764998|Influenza|influenza
648747|NCT00764998|HIV|hiv
648748|NCT00764998|Influenza Vaccine|influenza vaccine
648749|NCT00764998|Efficacy|efficacy
648750|NCT00765011|Head and Neck Cancer|head and neck cancer
648751|NCT00765024|strongyloidiasis, ivermectin, albendazole|strongyloidiasis, ivermectin, albendazole
648752|NCT00765050|Cellular therapy|cellular therapy
648753|NCT00765050|CD133+|cd133+
648754|NCT00765063|Diabetic Foot Ulcers Neuroischaemic|diabetic foot ulcers neuroischaemic
648755|NCT00765076|Vaccine|vaccine
648756|NCT00765076|Elderly|elderly
648757|NCT00765076|Influenza|influenza
648758|NCT00765102|Multiple Myelonoma|multiple myelonoma
648759|NCT00765102|Romidepsin|romidepsin
648760|NCT00765102|Bortezomib|bortezomib
648761|NCT00765128|Percutaneous|percutaneous
648762|NCT00765128|Nephrolithotomy|nephrolithotomy
648763|NCT00765128|Kidney stones|kidney stones
648764|NCT00765141|wound debridement|wound debridement
648765|NCT00765141|removed orthopedic implants|removed orthopedic implants
648766|NCT00765141|removed catheters or shunts|removed catheters or shunts
648767|NCT00765141|excised tonsils|excised tonsils
648768|NCT00765141|amputated tissue|amputated tissue
648769|NCT00765141|sputum, stool|sputum, stool
648770|NCT00765141|or other excretions.|or other excretions.
648771|NCT00765180|colonoscopy|colonoscopy
648772|NCT00765180|hood|hood
648773|NCT00765180|NBI|nbi
648774|NCT00765219|Generalized Anxiety Disorder|generalized anxiety disorder
648775|NCT00765219|Geriatric|geriatric
648776|NCT00765232|laparoscopic|laparoscopic
648777|NCT00765232|donor|donor
648778|NCT00765232|nephrectomy|nephrectomy
648779|NCT00765245|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
648780|NCT00765245|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
648781|NCT00765245|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
648782|NCT00765245|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
648783|NCT00765245|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
648784|NCT00765284|HDL|hdl
648785|NCT00765284|RCT|rct
648786|NCT00765284|Cholesterol|cholesterol
648787|NCT00765297|fall risk|fall risk
648788|NCT00765297|movement characteristics|movement characteristics
648789|NCT00765297|stumble detection|stumble detection
648790|NCT00765297|accelerometry|accelerometry
648791|NCT00765310|atherosclerosis|atherosclerosis
648792|NCT00765310|lipoic acid|lipoic acid
648793|NCT00765310|thioctic acid|thioctic acid
648794|NCT00765310|triglycerides|triglycerides
648795|NCT00765310|overweight|overweight
648796|NCT00765310|obesity|obesity
648797|NCT00765310|oxidative stress|oxidative stress
648798|NCT00765310|inflammation|inflammation
648799|NCT00765323|Octreotide|octreotide
648800|NCT00765323|Sandostatin LAR|sandostatin lar
648801|NCT00765323|Growth hormone|growth hormone
648802|NCT00765323|IGF-1|igf-1
648803|NCT00765336|Spermatogenesis in Healthy Males|spermatogenesis in healthy males
648804|NCT00765375|acne|acne
648805|NCT00765375|Botox|botox
648806|NCT00765375|cosmetic treatments|cosmetic treatments
648807|NCT00765388|urostomy, 1-piece, cross-over, randomised, preference|urostomy, 1-piece, cross-over, randomised, preference
648808|NCT00765401|Abdominal Pain|abdominal pain
648809|NCT00765401|Cystic Fibrosis|cystic fibrosis
648810|NCT00765401|H. pylori|h. pylori
648811|NCT00765401|Children|children
648812|NCT00765440|infection|infection
648813|NCT00765440|malnutrition|malnutrition
648814|NCT00765440|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
648815|NCT00765440|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
648816|NCT00765440|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
648817|NCT00765440|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
648881|NCT00765596|Gastric tube|gastric tube
648818|NCT00765440|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
648819|NCT00765440|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
648820|NCT00765440|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
648821|NCT00765440|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
648822|NCT00765440|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
648823|NCT00765440|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
648824|NCT00765440|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
648825|NCT00765440|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
648826|NCT00765440|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
648902|NCT00765674|aliskiren|aliskiren
648828|NCT00765440|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
648829|NCT00765440|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
648830|NCT00765440|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
648831|NCT00765440|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
648832|NCT00765440|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
648833|NCT00765440|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
648834|NCT00765440|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
648835|NCT00765440|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
648836|NCT00765440|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
648837|NCT00765440|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
648838|NCT00765440|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
648839|NCT00765440|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
648840|NCT00765440|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
648841|NCT00765440|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
648842|NCT00765440|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
648843|NCT00765440|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
648844|NCT00765440|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
648845|NCT00765440|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
648846|NCT00765440|tongue cancer|tongue cancer
648847|NCT00765453|Heart attack|heart attack
648848|NCT00765453|Anterior Myocardial infarction (MI)|anterior myocardial infarction (mi)
648849|NCT00765453|adult stem cells|adult stem cells
648850|NCT00765453|bone marrow progenitor cells|bone marrow progenitor cells
648851|NCT00765453|bone marrow stem cells|bone marrow stem cells
648852|NCT00765453|autologous|autologous
648853|NCT00765453|left ventricular function|left ventricular function
648854|NCT00765453|intracoronary injection|intracoronary injection
648855|NCT00765466|Explore the effect of AVR118 4.0 mL, given subcutaneously on appetite|explore the effect of avr118 4.0 ml, given subcutaneously on appetite
648856|NCT00765479|stage IIB prostate cancer|stage iib prostate cancer
648857|NCT00765479|stage IIA prostate cancer|stage iia prostate cancer
648858|NCT00765492|Phase I|phase i
648859|NCT00765505|Insulin Resistance|insulin resistance
648860|NCT00765505|Obesity|obesity
648861|NCT00765505|Exercise Training|exercise training
648862|NCT00765505|Physical Activity|physical activity
648863|NCT00765518|Ischemic Dilated Cardiomyopathy|ischemic dilated cardiomyopathy
648864|NCT00765518|Non-Ischemic Dilated Cardiomyopathy|non-ischemic dilated cardiomyopathy
648865|NCT00765518|ixmyelocel-T|ixmyelocel-t
648866|NCT00765531|To determine the prevalence of genetic mutations in a population.|to determine the prevalence of genetic mutations in a population.
648867|NCT00765531|To identify stone formers with significant family history of stones.|to identify stone formers with significant family history of stones.
648868|NCT00765531|To follow a cohort of pediatric stone formers an their families to report the long-term recurrence rats and therapeutic outcomes.|to follow a cohort of pediatric stone formers an their families to report the long-term recurrence rats and therapeutic outcomes.
648870|NCT00765544|Rehabilitation|rehabilitation
648871|NCT00765544|Treadmill|treadmill
648872|NCT00765544|Robot|robot
648873|NCT00765544|Foot-drop|foot-drop
648874|NCT00765557|To determine if laxative therapy can resolve Urge Syndrome, and if so, in which patients.|to determine if laxative therapy can resolve urge syndrome, and if so, in which patients.
648875|NCT00765557|To determine usefulness of KUB, an abdominal X-ray of the kidneys, ureters, and bladder.|to determine usefulness of kub, an abdominal x-ray of the kidneys, ureters, and bladder.
649070|NCT00766350|quetiapine|quetiapine
648876|NCT00765557|To predict the bowel activity of children with Urge Syndrome, who are most likely to respond to laxatives, with the use of the Bowel/Bladder questionnaire.|to predict the bowel activity of children with urge syndrome, who are most likely to respond to laxatives, with the use of the bowel/bladder questionnaire.
648877|NCT00765570|large tumors in the head & neck, lung, abdomen or pelvis|large tumors in the head & neck, lung, abdomen or pelvis
648878|NCT00765583|Wrinkles (Nasolabial Folds)|wrinkles (nasolabial folds)
648879|NCT00765596|Obesity|obesity
648880|NCT00765596|Insulin resistance|insulin resistance
648882|NCT00765596|Ghrelin|ghrelin
648884|NCT00765609|Analgesic|analgesic
648885|NCT00765609|Prescribing|prescribing
648886|NCT00765609|Parents|parents
648887|NCT00765622|Urinary incontinence|urinary incontinence
648888|NCT00765622|pelvic floor|pelvic floor
648889|NCT00765622|functional evaluation|functional evaluation
648890|NCT00765635|complete occlusion of the ear canal due to cerumen|complete occlusion of the ear canal due to cerumen
648891|NCT00765648|hypertension|hypertension
648892|NCT00765648|emergency department|emergency department
648893|NCT00765648|Nicardipine|nicardipine
648894|NCT00765648|Labetalol|labetalol
648895|NCT00765648|hypertensive emergency|hypertensive emergency
648896|NCT00765648|hypertensive urgency|hypertensive urgency
648897|NCT00765661|Kidney|kidney
648898|NCT00765661|Transplantation|transplantation
648899|NCT00765661|Immunosuppression|immunosuppression
648900|NCT00765661|Tacrolimus|tacrolimus
648901|NCT00765661|Prograf|prograf
648903|NCT00765674|antihypertensive|antihypertensive
648904|NCT00765674|hypertension|hypertension
648905|NCT00765674|renin inhibitor|renin inhibitor
648906|NCT00765674|moderate-severe hypertension|moderate-severe hypertension
648907|NCT00765700|Sprain|sprain
648908|NCT00765700|Strain|strain
648909|NCT00765700|Pain|pain
648910|NCT00765700|Ankle Pain|ankle pain
648911|NCT00765700|Shoulder Pain|shoulder pain
648912|NCT00765700|Elbow Pain|elbow pain
648913|NCT00765700|Tennis Elbow|tennis elbow
648914|NCT00765700|Knee pain|knee pain
648915|NCT00765700|Wrist Pain|wrist pain
648916|NCT00765700|Hand Pain|hand pain
648917|NCT00765700|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
648918|NCT00765713|Sleep apnea|sleep apnea
648919|NCT00765713|CPAP|cpap
648920|NCT00765713|Ventricular arrhythmias|ventricular arrhythmias
648921|NCT00765713|Defibrillator therapies|defibrillator therapies
648922|NCT00765726|hemophilia|hemophilia
648923|NCT00765726|hemophilia A|hemophilia a
648924|NCT00765726|ReFacto|refacto
648925|NCT00765726|Xyntha|xyntha
648926|NCT00765726|moroctocog alfa|moroctocog alfa
648927|NCT00765726|bleeding disorder|bleeding disorder
648928|NCT00765739|muscle fibers|muscle fibers
648929|NCT00765739|aging|aging
648930|NCT00765752|Insomnia|insomnia
648931|NCT00765752|depression|depression
648932|NCT00765752|GABA|gaba
648933|NCT00765752|magnetic resonance spectroscopy|magnetic resonance spectroscopy
648935|NCT00765752|Sleep|sleep
648936|NCT00765752|antidepressant medication use|antidepressant medication use
648937|NCT00765765|stage IV breast cancer|stage iv breast cancer
648938|NCT00765765|recurrent breast cancer|recurrent breast cancer
648939|NCT00765765|male breast cancer|male breast cancer
648940|NCT00765778|resistant bacteria rehabilitation centers|resistant bacteria rehabilitation centers
648941|NCT00765791|head and neck cancer|head and neck cancer
648942|NCT00765791|oral cancer|oral cancer
648943|NCT00765791|oropharyngeal cancer|oropharyngeal cancer
648944|NCT00765791|laryngeal cancer|laryngeal cancer
648945|NCT00765791|selective neck dissection|selective neck dissection
648946|NCT00765791|submuscular recess|submuscular recess
648947|NCT00765791|level 2b|level 2b
648948|NCT00765804|Dry Eye|dry eye
648949|NCT00765804|Iontophoresis|iontophoresis
648950|NCT00765804|Ophthalmic Delivery|ophthalmic delivery
648951|NCT00765817|diabetes|diabetes
648952|NCT00765817|exenatide|exenatide
648953|NCT00765817|Amylin|amylin
648954|NCT00765817|Lilly|lilly
648955|NCT00765817|metformin|metformin
648956|NCT00765817|pioglitazone|pioglitazone
648957|NCT00765817|insulin glargine|insulin glargine
648958|NCT00765830|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
648959|NCT00765843|heel pain|heel pain
648960|NCT00765856|Opioid tolerant|opioid tolerant
648961|NCT00765856|Pediatric|pediatric
648962|NCT00765856|Male 6-17 years of age|male 6-17 years of age
648963|NCT00765856|Female 6-17 years of age|female 6-17 years of age
648964|NCT00765856|Pain|pain
648965|NCT00765856|Non malignant|non malignant
648966|NCT00765856|Malignant|malignant
648967|NCT00765869|Decision support techniques|decision support techniques
648968|NCT00765882|Constipation|constipation
648969|NCT00765882|Chronic Constipation|chronic constipation
648970|NCT00765882|Linaclotide|linaclotide
648971|NCT00765895|idiopathic gastroparesis|idiopathic gastroparesis
648972|NCT00765921|glaucoma, neovascular|glaucoma, neovascular
648973|NCT00765921|macular edema|macular edema
648974|NCT00765921|eye enucleation|eye enucleation
648975|NCT00765921|antibodies, monoclonal|antibodies, monoclonal
648976|NCT00765921|radiation oncology|radiation oncology
648977|NCT00765934|Healthy|healthy
649727|NCT00774748|Lovenox|lovenox
648978|NCT00765947|Essential Hypertension ( mild to moderate)|essential hypertension ( mild to moderate)
648979|NCT00765960|Vision|vision
648980|NCT00765973|Other Advanced Solid Tumors|other advanced solid tumors
648981|NCT00765986|18F-FAZA|18f-faza
648982|NCT00765986|18F-FDG|18f-fdg
648983|NCT00765986|Positron Emission Tomography|positron emission tomography
648984|NCT00765999|Constipation|constipation
648985|NCT00765999|Chronic Constipation|chronic constipation
649082|NCT00766402|Ultracet|ultracet
648986|NCT00765999|Irritable Bowel Syndrome With Constipation|irritable bowel syndrome with constipation
648987|NCT00765999|Linaclotide|linaclotide
648988|NCT00766012|safety|safety
648989|NCT00766012|tolerability|tolerability
648990|NCT00766012|pharmacokinetics|pharmacokinetics
648991|NCT00766012|AZD2066|azd2066
648992|NCT00766012|Japanese|japanese
648993|NCT00766025|Taiwanese Subjects|taiwanese subjects
648994|NCT00766025|CYP2C19|cyp2c19
648995|NCT00766025|Poor Metabolizers|poor metabolizers
648996|NCT00766025|Extensive Metabolizers|extensive metabolizers
648997|NCT00766025|Taiwanese Subjects identified as CYP2C19 Poor or Extensive Metabolizers|taiwanese subjects identified as cyp2c19 poor or extensive metabolizers
648998|NCT00766038|Mood disorders|mood disorders
648999|NCT00766038|Cognitive disorders|cognitive disorders
649000|NCT00766038|Fatigue|fatigue
649001|NCT00766038|Metabolic disorders|metabolic disorders
649102|NCT00766493|carotid artery stenosis|carotid artery stenosis
650326|NCT00777257|Pertussis|pertussis
649002|NCT00766051|Neurophysiologically Based Occupational Therapy Intervention (NBOTI)|neurophysiologically based occupational therapy intervention (nboti)
649003|NCT00766051|NBOTI|nboti
649004|NCT00766051|NICU|nicu
649005|NCT00766051|NCCU|nccu
649006|NCT00766051|Developmental Biology|developmental biology
649007|NCT00766051|Critical Period|critical period
649008|NCT00766051|Brain Development|brain development
649009|NCT00766051|Sensory Integration|sensory integration
649010|NCT00766051|Neurodevelopment|neurodevelopment
649011|NCT00766051|Sensitive Period|sensitive period
649012|NCT00766064|posttraumatic stress disorder|posttraumatic stress disorder
649013|NCT00766103|Cerebral metabolism, perfusion, induced hypothermia|cerebral metabolism, perfusion, induced hypothermia
649014|NCT00766116|AML|aml
649015|NCT00766129|saphenous vein graft, TAXUS stent, Chopin stent|saphenous vein graft, taxus stent, chopin stent
649016|NCT00766142|adenocarcinoma of the colon|adenocarcinoma of the colon
649017|NCT00766142|recurrent colon cancer|recurrent colon cancer
649018|NCT00766142|stage IV colon cancer|stage iv colon cancer
649019|NCT00766142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
649020|NCT00766142|recurrent rectal cancer|recurrent rectal cancer
649021|NCT00766142|stage IV rectal cancer|stage iv rectal cancer
649022|NCT00766142|peritoneal carcinomatosis|peritoneal carcinomatosis
649023|NCT00766155|stage II rectal cancer|stage ii rectal cancer
649024|NCT00766155|stage III rectal cancer|stage iii rectal cancer
649025|NCT00766155|adenocarcinoma of the rectum|adenocarcinoma of the rectum
649026|NCT00766168|contact lens|contact lens
649027|NCT00766168|rigid gas permeable|rigid gas permeable
649028|NCT00766168|refractive index|refractive index
649029|NCT00766181|IV placement; Parent satisfaction level|iv placement; parent satisfaction level
649030|NCT00766207|Teratogens|teratogens
649031|NCT00766207|Abnormalities, Drug-Induced|abnormalities, drug-induced
649032|NCT00766207|Contraception|contraception
649033|NCT00766220|Colon|colon
649034|NCT00766220|Liver|liver
649035|NCT00766220|Colorectal cancer|colorectal cancer
649036|NCT00766220|Colorectal cancer metastases to the liver|colorectal cancer metastases to the liver
649037|NCT00766220|Metastases to the liver|metastases to the liver
649038|NCT00766220|Colorectal cancer mets to liver|colorectal cancer mets to liver
649039|NCT00766220|Colon cancer metastasized to liver|colon cancer metastasized to liver
649040|NCT00766220|Yttrium microspheres|yttrium microspheres
649041|NCT00766220|SIR-Spheres|sir-spheres
649042|NCT00766220|Yttrium-90|yttrium-90
649043|NCT00766220|Cetuximab|cetuximab
649044|NCT00766220|C225|c225
649045|NCT00766220|Erbitux|erbitux
649046|NCT00766220|IMC-C225|imc-c225
649047|NCT00766220|Irinotecan|irinotecan
649048|NCT00766220|CPT-11|cpt-11
649049|NCT00766220|Liver directed therapy|liver directed therapy
649050|NCT00766233|Hyperthermia|hyperthermia
649051|NCT00766233|superficial tumor treatment|superficial tumor treatment
649052|NCT00766233|superficial tumors|superficial tumors
649053|NCT00766246|Non-Small Cell Lung Cancer|non-small cell lung cancer
649054|NCT00766246|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
649055|NCT00766246|Lung Cancer|lung cancer
649056|NCT00766259|methicillin-resistant Staphylococcus|methicillin-resistant staphylococcus
649057|NCT00766259|colonization|colonization
649058|NCT00766272|Rehabilitation|rehabilitation
649059|NCT00766272|Treadmill|treadmill
649061|NCT00766272|Gait|gait
649062|NCT00766272|Robot|robot
649063|NCT00766285|Baculovirus, influenza, stem cell transplant|baculovirus, influenza, stem cell transplant
649064|NCT00766298|Exercise|exercise
649065|NCT00766298|Weight Loss|weight loss
649066|NCT00766298|Physical Activity|physical activity
649067|NCT00766298|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
649068|NCT00766337|wet AMD|wet amd
649069|NCT00766350|fibromyalgia|fibromyalgia
649071|NCT00766350|amitriptyline|amitriptyline
649072|NCT00766363|Alzheimer's Disease|alzheimer's disease
649073|NCT00766363|Central Nervous System Diseases|central nervous system diseases
649074|NCT00766363|Pharmacokinetics|pharmacokinetics
649075|NCT00766363|Cognition|cognition
649076|NCT00766389|Glaucoma|glaucoma
649077|NCT00766389|Retinal nerve fiber layer|retinal nerve fiber layer
649078|NCT00766389|Cirrus OCT|cirrus oct
649079|NCT00766389|Stratus OCT|stratus oct
649080|NCT00766402|Spondylitis, ankylosing|spondylitis, ankylosing
649081|NCT00766402|Pain|pain
649087|NCT00766415|Moderate to severe COPD|moderate to severe copd
649088|NCT00766441|diabetes|diabetes
649089|NCT00766441|hypoglycemia|hypoglycemia
649090|NCT00766441|ramadan|ramadan
649091|NCT00766441|fasting|fasting
649092|NCT00766454|breast cancer|breast cancer
649093|NCT00766467|armodafinil|armodafinil
649094|NCT00766467|Nuvigil|nuvigil
649095|NCT00766467|fatigue|fatigue
649096|NCT00766480|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
649097|NCT00766480|stage IIA esophageal cancer|stage iia esophageal cancer
649098|NCT00766480|stage IIB esophageal cancer|stage iib esophageal cancer
649099|NCT00766480|stage IIIA esophageal cancer|stage iiia esophageal cancer
649100|NCT00766480|stage IIIB esophageal cancer|stage iiib esophageal cancer
649101|NCT00766480|stage IIIC esophageal cancer|stage iiic esophageal cancer
649299|NCT00772993|myopia|myopia
649103|NCT00766493|embolic protection device|embolic protection device
649104|NCT00766493|distal embolic filter|distal embolic filter
649105|NCT00766493|minimizing risks of carotid artery stenting|minimizing risks of carotid artery stenting
649106|NCT00766506|IONSYS|ionsys
649107|NCT00766506|Fentanyl|fentanyl
649108|NCT00766506|Morphine|morphine
649109|NCT00766506|PCA|pca
649110|NCT00766506|Postoperative pain|postoperative pain
649111|NCT00766506|Mobilization|mobilization
649112|NCT00766519|fluid responsiveness|fluid responsiveness
649113|NCT00766519|monitoring|monitoring
649114|NCT00766519|arterial pulse pressure|arterial pulse pressure
649115|NCT00766558|anorexia|anorexia
649116|NCT00766558|bulimia|bulimia
649117|NCT00766558|eating disorder not otherwise specified|eating disorder not otherwise specified
649118|NCT00766571|VACTERL Association|vacterl association
649119|NCT00766571|VATER Association|vater association
649120|NCT00766571|Multiple Congenital Anomalies|multiple congenital anomalies
649121|NCT00766571|VACTERL|vacterl
649122|NCT00766571|Congenital Defects|congenital defects
649123|NCT00766571|Birth Defects|birth defects
649124|NCT00766571|Congenital Abnormalities|congenital abnormalities
649125|NCT00766584|Aging|aging
649126|NCT00766584|Autonomic nervous system|autonomic nervous system
649127|NCT00766584|stroke|stroke
649128|NCT00766584|Myocardiac infarction|myocardiac infarction
649129|NCT00766584|Prospective cohort|prospective cohort
649130|NCT00766584|Sleep apnea/hypopnea|sleep apnea/hypopnea
649131|NCT00766597|Treatment Experienced|treatment experienced
649132|NCT00766623|endothelium,|endothelium,
649133|NCT00766623|postprandial|postprandial
649134|NCT00766623|microvascular|microvascular
649135|NCT00766623|macrovascular|macrovascular
649136|NCT00766636|Adenocarcinoma of the pancreatic head|adenocarcinoma of the pancreatic head
649137|NCT00766636|Pancreaticoduodenectomy|pancreaticoduodenectomy
649138|NCT00766636|Preoperative chemotherapy|preoperative chemotherapy
649139|NCT00766636|Chemoradiation|chemoradiation
649140|NCT00766636|Resectable pancreatic cancer|resectable pancreatic cancer
649141|NCT00766636|Surgical removal of the pancreas and duodenum|surgical removal of the pancreas and duodenum
649142|NCT00766636|External-beam radiation therapy|external-beam radiation therapy
649143|NCT00766636|EBRT|ebrt
649144|NCT00766636|Gemcitabine|gemcitabine
649145|NCT00766636|Erlotinib|erlotinib
649146|NCT00766649|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
649147|NCT00766649|Geographic Atrophy|geographic atrophy
649148|NCT00766649|Sirolimus|sirolimus
649149|NCT00766649|Age-Related Macular Degeneration|age-related macular degeneration
649150|NCT00766649|AMD|amd
649151|NCT00766662|Malaria|malaria
649152|NCT00766662|Intermittent Preventive Treatment|intermittent preventive treatment
649153|NCT00766662|EPI vaccine coverage|epi vaccine coverage
649154|NCT00766662|Resistance of P. falciparum to Sulfadoxine- Pyrimethamine|resistance of p. falciparum to sulfadoxine- pyrimethamine
649155|NCT00766675|Pain|pain
649156|NCT00766675|Fibromyalgia|fibromyalgia
649157|NCT00766675|Ultracet|ultracet
649158|NCT00766675|Tramadol Hydrochloride|tramadol hydrochloride
649159|NCT00766675|Acetaminophen|acetaminophen
649160|NCT00766740|ST elevation myocardial infarction|st elevation myocardial infarction
649161|NCT00766740|thrombectomy|thrombectomy
649162|NCT00766740|primary PCI|primary pci
649163|NCT00766753|HLA-A2 positive|hla-a2 positive
649164|NCT00766753|Malignant Gliomas|malignant gliomas
649165|NCT00766753|Vaccine|vaccine
649166|NCT00766766|Environmental Tobacco Exposure|environmental tobacco exposure
649170|NCT00766831|Cancer pain|cancer pain
649171|NCT00766831|Hydromorphone OROS|hydromorphone oros
649172|NCT00766831|Jurnista|jurnista
649173|NCT00766844|vasospasm|vasospasm
649174|NCT00766844|spinal cord stimulation|spinal cord stimulation
649175|NCT00766844|aneurysm|aneurysm
649176|NCT00766844|subarachnoid hemorrhage|subarachnoid hemorrhage
649177|NCT00766857|Exenatide|exenatide
649178|NCT00766857|Type 2 diabetes mellitus|type 2 diabetes mellitus
649179|NCT00766857|Congestive heart failure|congestive heart failure
649180|NCT00766857|Incretin hormones|incretin hormones
649181|NCT00766857|GLP-1 agonist|glp-1 agonist
649182|NCT00766857|Cardiac metabolism|cardiac metabolism
649183|NCT00766857|Insulin resistance|insulin resistance
649184|NCT00766857|Cardiac MRI|cardiac mri
649185|NCT00766870|Efficacy|efficacy
649186|NCT00766870|Safety|safety
649187|NCT00766870|Depression|depression
649188|NCT00766870|Interventional|interventional
649189|NCT00766870|Placebo|placebo
649190|NCT00766870|Short-term|short-term
649191|NCT00766870|Major Depressive Disorder|major depressive disorder
649192|NCT00766870|Major Depressive Episode|major depressive episode
649193|NCT00766883|Allogeneic HSCT|allogeneic hsct
649194|NCT00766883|Psychosocial Distress|psychosocial distress
649195|NCT00766883|Coping|coping
649196|NCT00766883|Cognitive Behavior Therapy|cognitive behavior therapy
649197|NCT00766883|Self Efficacy|self efficacy
649198|NCT00766883|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
649199|NCT00766896|Stroke|stroke
649200|NCT00766896|Cerebral Infarction|cerebral infarction
649201|NCT00766896|Acute Coronary Syndrome|acute coronary syndrome
649202|NCT00766896|Cardiovascular Diseases|cardiovascular diseases
649203|NCT00766896|Vascular Diseases|vascular diseases
649204|NCT00766896|Platelet Activation|platelet activation
649205|NCT00766896|Platelets|platelets
649206|NCT00766896|Platelet Function Tests|platelet function tests
649207|NCT00766896|Aspirin|aspirin
649208|NCT00766896|Atherosclerosis|atherosclerosis
649209|NCT00766896|Ischemia|ischemia
649210|NCT00766896|Thrombosis|thrombosis
649211|NCT00772512|PF-04802540, polysomnography, REM, cross over|pf-04802540, polysomnography, rem, cross over
649212|NCT00772525|Visual acuity|visual acuity
649213|NCT00772525|Contrast sensitivity|contrast sensitivity
649214|NCT00772525|Visual Evoked Potentials|visual evoked potentials
649215|NCT00772525|Optical Coherence Tomography|optical coherence tomography
649216|NCT00772564|Acute ST Elevation Myocardial Infarction|acute st elevation myocardial infarction
649217|NCT00772577|Hypertension, Obese, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, ramipril, stage 2|hypertension, obese, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, ramipril, stage 2
649218|NCT00772590|HIV|hiv
649219|NCT00772590|antiretroviral therapy intensification|antiretroviral therapy intensification
649220|NCT00772590|suboptimal CD4+ T cell response|suboptimal cd4+ t cell response
649221|NCT00772590|virological suppression|virological suppression
649222|NCT00772590|bovine colostrum|bovine colostrum
649223|NCT00772590|raltegravir|raltegravir
649224|NCT00772603|Partial onset epilepsy|partial onset epilepsy
649225|NCT00772603|Partial onset seizures|partial onset seizures
649226|NCT00772616|Anesthesia|anesthesia
649227|NCT00772616|Analgesia|analgesia
649228|NCT00772616|Patient-Controlled Analgesia|patient-controlled analgesia
649229|NCT00772616|Hyperalgesia|hyperalgesia
649230|NCT00772629|Menactra®|menactra®
649231|NCT00772629|Meningitis|meningitis
649232|NCT00772629|Meningococcemia|meningococcemia
649233|NCT00772629|Neisseria meningitidis|neisseria meningitidis
649234|NCT00772642|Cross-Sectional|cross-sectional
649235|NCT00772642|Plasmodium Falciparum Malaria|plasmodium falciparum malaria
649236|NCT00772642|Cord Blood|cord blood
649237|NCT00772642|Immunology|immunology
649238|NCT00772642|Mali|mali
649239|NCT00772642|Malaria|malaria
649240|NCT00772655|Follicular Lymphoma|follicular lymphoma
649241|NCT00772655|First line therapy|first line therapy
649242|NCT00772655|Zevalin|zevalin
649243|NCT00772655|90Yttrium-Ibritumomab Tiuxetan|90yttrium-ibritumomab tiuxetan
649244|NCT00772655|Yttrium|yttrium
649245|NCT00772655|Rituximab|rituximab
649246|NCT00772655|Radio-immuno therapy|radio-immuno therapy
649247|NCT00772668|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
649248|NCT00772668|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
649249|NCT00772668|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
649250|NCT00772668|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
649251|NCT00772668|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
649252|NCT00772668|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
649253|NCT00772694|testicular cancer|testicular cancer
649254|NCT00772694|germ cell cancer|germ cell cancer
649255|NCT00772694|sorafenib|sorafenib
649256|NCT00772707|contact lens solution|contact lens solution
649257|NCT00772707|OPTI-FREE RepleniSH|opti-free replenish
649258|NCT00772707|contact lenses|contact lenses
649259|NCT00772733|Quality assurance|quality assurance
649260|NCT00772733|rehabilitation|rehabilitation
649261|NCT00772733|chronic care model|chronic care model
649262|NCT00772733|COPD|copd
649263|NCT00772746|panic|panic
649264|NCT00772746|respiration|respiration
649265|NCT00772746|anxiety|anxiety
649266|NCT00772746|exercise|exercise
649267|NCT00772746|cognition|cognition
649268|NCT00772759|AZD3199|azd3199
649269|NCT00772759|Japanese Healthy Volunteers|japanese healthy volunteers
649270|NCT00772759|Phase I study|phase i study
649271|NCT00772759|Single and Multiple Ascending Dose|single and multiple ascending dose
649272|NCT00772759|safety|safety
649273|NCT00772759|tolerability|tolerability
649275|NCT00772772|Vitamin D3 repletion|vitamin d3 repletion
649276|NCT00772772|levels of endotoxin|levels of endotoxin
649277|NCT00772772|intestinal permeability|intestinal permeability
649278|NCT00772772|accelerated atherosclerosis|accelerated atherosclerosis
649279|NCT00772785|opioid dependence|opioid dependence
649280|NCT00772785|opioid addiction|opioid addiction
649281|NCT00772785|buprenorphine|buprenorphine
649282|NCT00772785|methadone|methadone
649283|NCT00772785|heroin|heroin
649284|NCT00772785|implant|implant
649285|NCT00772785|opioid withdrawal|opioid withdrawal
649286|NCT00772785|opioid pain medication|opioid pain medication
649287|NCT00772785|suboxone|suboxone
649288|NCT00772798|ovarian cancer|ovarian cancer
649289|NCT00772798|HDAC inhibitor|hdac inhibitor
649290|NCT00772798|vorinostat|vorinostat
649291|NCT00772824|Breast cancer|breast cancer
649292|NCT00772824|Chemotherapy|chemotherapy
649293|NCT00772824|Epirubicin|epirubicin
649294|NCT00772824|Glutamine|glutamine
649295|NCT00772824|FEC chemotherapy|fec chemotherapy
649296|NCT00772954|Clostridium difficile diarrhea|clostridium difficile diarrhea
649297|NCT00772954|Clostridium difficile toxoid vaccine|clostridium difficile toxoid vaccine
649298|NCT00772993|glaucoma|glaucoma
649300|NCT00772993|myopia with glaucoma|myopia with glaucoma
649301|NCT00772993|normal control|normal control
649302|NCT00773006|coronary artery disease|coronary artery disease
649303|NCT00773006|percutaneous coronary intervention|percutaneous coronary intervention
649304|NCT00773006|anticoagulation|anticoagulation
649305|NCT00773019|infusion pump|infusion pump
649306|NCT00773019|implantable|implantable
649307|NCT00773019|performance|performance
649308|NCT00773045|pain scores|pain scores
649309|NCT00773045|critically ill patients|critically ill patients
649310|NCT00773045|ICU|icu
649311|NCT00773045|pain management|pain management
649312|NCT00773045|pain measurement|pain measurement
649313|NCT00773058|acute respiratory distress syndrome|acute respiratory distress syndrome
649314|NCT00773058|glucocorticoid|glucocorticoid
649315|NCT00773058|adrenal insufficiency|adrenal insufficiency
649316|NCT00773071|Cervical cancer, vulvar cancer, LM/SL, SPECT/CT|cervical cancer, vulvar cancer, lm/sl, spect/ct
649317|NCT00773084|Diastolic Heart Failure|diastolic heart failure
649318|NCT00773084|Hispanic Americans|hispanic americans
649319|NCT00773084|Aliskiren|aliskiren
649320|NCT00773084|Spironolactone|spironolactone
649321|NCT00773084|Lisinopril|lisinopril
649322|NCT00773084|Diastolic Heart Failure in Hispanic Americans|diastolic heart failure in hispanic americans
649323|NCT00773097|Prevention|prevention
649324|NCT00773097|Colorectal Cancer|colorectal cancer
649325|NCT00773110|hemolysis|hemolysis
649326|NCT00773110|systemic inflammatory response syndrome|systemic inflammatory response syndrome
649327|NCT00773110|cardiopulmonary bypass|cardiopulmonary bypass
649328|NCT00773110|albumin|albumin
649329|NCT00773123|RT-View|rt-view
649330|NCT00773123|Spectral domain OCT|spectral domain oct
649331|NCT00773123|Ganglion cell layer|ganglion cell layer
649332|NCT00773123|RNFL|rnfl
649333|NCT00773123|Visual field defect|visual field defect
649334|NCT00773136|Bimatoprost|bimatoprost
649335|NCT00773136|Eyelash lengthening|eyelash lengthening
649336|NCT00773136|Prostaglandin Analogs|prostaglandin analogs
649337|NCT00773136|Cosmetics|cosmetics
649338|NCT00773149|Adult Acute Lymphocytic Leukemia|adult acute lymphocytic leukemia
649339|NCT00773149|Alemtuzumab|alemtuzumab
649340|NCT00773175|pediatric|pediatric
649341|NCT00773175|hylenex|hylenex
649342|NCT00773175|subcutaneous infusion|subcutaneous infusion
649343|NCT00773175|hyaluronidase|hyaluronidase
649344|NCT00773175|rHuPH20|rhuph20
649345|NCT00773175|recombinant human hyaluronidase|recombinant human hyaluronidase
649346|NCT00773201|Long QT syndrome|long qt syndrome
649347|NCT00773201|Cardiac repolarisation|cardiac repolarisation
649348|NCT00773201|Genome-wide association|genome-wide association
649349|NCT00773201|Electrophysiology|electrophysiology
649350|NCT00773201|Drugs/adverse effects|drugs/adverse effects
649351|NCT00773214|Obesity|obesity
649352|NCT00773214|Appetite|appetite
649353|NCT00773214|Body composition|body composition
649354|NCT00773214|Energy compensation|energy compensation
649355|NCT00773227|Oculopharyngeal muscular dystrophy|oculopharyngeal muscular dystrophy
649356|NCT00773227|Swallowing disorders, dysphagia|swallowing disorders, dysphagia
649357|NCT00773227|Pharyngeal propulsion|pharyngeal propulsion
649358|NCT00773227|Upper oesophageal sphincter|upper oesophageal sphincter
649359|NCT00773227|Cricopharyngeal muscle|cricopharyngeal muscle
649360|NCT00773227|Autologous myoblasts|autologous myoblasts
649361|NCT00773227|Autograft|autograft
649362|NCT00773227|Myotomy of the upper oesophageal sphincter|myotomy of the upper oesophageal sphincter
649363|NCT00773227|Fibroscopy of swallowing|fibroscopy of swallowing
649364|NCT00773227|Videofluoroscopy of swallowing|videofluoroscopy of swallowing
649365|NCT00773253|dystonia|dystonia
649366|NCT00773253|cervical dystonia|cervical dystonia
649367|NCT00773253|Botox|botox
649368|NCT00773253|idiopathic primary cervical dystonia|idiopathic primary cervical dystonia
649369|NCT00773266|Aphakia|aphakia
649370|NCT00773266|Secondary IOL-Implantation|secondary iol-implantation
649371|NCT00773266|Iris-Fixated IOL|iris-fixated iol
649372|NCT00773266|Artisan|artisan
649373|NCT00773266|Anterior Segment OCT|anterior segment oct
649374|NCT00773266|Aphakia - secondary iris-fixated IOL position|aphakia - secondary iris-fixated iol position
649375|NCT00773292|HAM/TSP|ham/tsp
649376|NCT00773305|seed implantation|seed implantation
649377|NCT00773318|LM/SL|lm/sl
649378|NCT00773318|SPECT/low-dose multislice CT|spect/low-dose multislice ct
649379|NCT00773344|Solid Tumors (dose escalation/Phase 1)|solid tumors (dose escalation/phase 1)
649380|NCT00773344|Breast Cancer (recommended dose phase/Phase 2)|breast cancer (recommended dose phase/phase 2)
649381|NCT00773357|smoking lapse behavior|smoking lapse behavior
649382|NCT00773357|smoking cessation|smoking cessation
649383|NCT00773357|guanfacine|guanfacine
649384|NCT00773357|carvedilol|carvedilol
649385|NCT00773357|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
649386|NCT00773357|medication effect on smoking cessation|medication effect on smoking cessation
649387|NCT00773357|stress|stress
649388|NCT00773357|gender differences|gender differences
649389|NCT00773370|stroke|stroke
649390|NCT00773370|exercise|exercise
649391|NCT00773422|smoking lapse behavior|smoking lapse behavior
649392|NCT00773422|smoking cessation|smoking cessation
649393|NCT00773422|varenicline|varenicline
649394|NCT00773422|naltrexone|naltrexone
649395|NCT00773422|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
649396|NCT00773435|Upper respiratory tract infections|upper respiratory tract infections
649397|NCT00773435|Children|children
649398|NCT00773435|Echinacea|echinacea
649399|NCT00773435|Prevention|prevention
649400|NCT00773435|Immune modulation|immune modulation
649401|NCT00773448|Cancer|cancer
649402|NCT00773448|Screening|screening
649403|NCT00773487|Asthma GINA 1|asthma gina 1
649404|NCT00773487|Mild intermittant asthma|mild intermittant asthma
649405|NCT00773500|Medication Errors|medication errors
649406|NCT00773539|atrial fibrillation|atrial fibrillation
649407|NCT00773539|pulmonary veins|pulmonary veins
649408|NCT00773539|ablation|ablation
649410|NCT00773552|overactive bladder|overactive bladder
649411|NCT00773552|urinary urge|urinary urge
649412|NCT00773552|urge incontinence|urge incontinence
649413|NCT00773552|urge|urge
649414|NCT00773565|patients with obesity (BMI > 30 kg/m2)|patients with obesity (bmi > 30 kg/m2)
649415|NCT00773578|Children|children
649416|NCT00773578|Tobacco smoke exposure|tobacco smoke exposure
649417|NCT00773578|Exhaled nitric oxide|exhaled nitric oxide
649418|NCT00773578|Nasal lavage|nasal lavage
649419|NCT00773578|Cytokines|cytokines
649420|NCT00773591|Sleep-related breathing disorders|sleep-related breathing disorders
649421|NCT00773591|Snoring|snoring
649422|NCT00773604|blepharospasm|blepharospasm
649423|NCT00773604|Deep brain Stimulation|deep brain stimulation
649424|NCT00773604|cervical dystonia|cervical dystonia
649425|NCT00773604|cranial dystonia|cranial dystonia
649426|NCT00773604|generalized dystonia|generalized dystonia
649427|NCT00773604|subthalamic nucleus|subthalamic nucleus
649429|NCT00773617|Bulimia Nervosa|bulimia nervosa
649430|NCT00773617|Treatment Efficacy|treatment efficacy
649431|NCT00773617|Integrative Cognitive Affective Therapy|integrative cognitive affective therapy
649432|NCT00773617|Cognitive Behavior Therapy|cognitive behavior therapy
649433|NCT00773643|to procure human temporalis muscle, subcutaneous adipose (fat), and bone tissue samples from children with craniosynostosis,|to procure human temporalis muscle, subcutaneous adipose (fat), and bone tissue samples from children with craniosynostosis,
649434|NCT00773643|to grow cells from these tissues in vitro|to grow cells from these tissues in vitro
649435|NCT00773643|to evaluate the osteogenic potentials of these cell types.|to evaluate the osteogenic potentials of these cell types.
649436|NCT00773656|Radiotherapy|radiotherapy
649437|NCT00773656|Biologically effective dose|biologically effective dose
649438|NCT00773656|Radiation injury|radiation injury
649439|NCT00773669|male breast cancer|male breast cancer
649440|NCT00773669|Male breast cancer patients diagnosed and/or|male breast cancer patients diagnosed and/or
649441|NCT00773669|treated at Summa Health System/Akron City Hospital|treated at summa health system/akron city hospital
649442|NCT00773669|from the reference year of 1995 through 2007.|from the reference year of 1995 through 2007.
649443|NCT00773682|osteoarthritis|osteoarthritis
649445|NCT00773682|mud-packs therapy|mud-packs therapy
649446|NCT00773682|balneotherapy|balneotherapy
649447|NCT00773682|Osteoarthritis of the hands|osteoarthritis of the hands
649448|NCT00773708|HIV infection|hiv infection
649449|NCT00773708|Discordant patient|discordant patient
649450|NCT00773708|CD4 recovery|cd4 recovery
649451|NCT00773708|intensification antiretroviral therapy|intensification antiretroviral therapy
649452|NCT00773708|raltegravir|raltegravir
649453|NCT00773708|"HIV-1 infected patient classified as discordant who showed high level of CD8+HLADR+CD38+ and cell death values at the screening"|"hiv-1 infected patient classified as discordant who showed high level of cd8+hladr+cd38+ and cell death values at the screening"
649454|NCT00773734|moderate-to-severe plaque-type psoriasis|moderate-to-severe plaque-type psoriasis
649455|NCT00773747|Neoplasms, Plasma Cell|neoplasms, plasma cell
649456|NCT00773747|Neoplasms by Histologic Type|neoplasms by histologic type
649457|NCT00773747|Neoplasms|neoplasms
649728|NCT00774748|Insuflon|insuflon
649458|NCT00773747|Hemostatic Disorders|hemostatic disorders
649459|NCT00773747|Vascular Diseases|vascular diseases
649460|NCT00773747|Cardiovascular Diseases|cardiovascular diseases
649461|NCT00773747|Paraproteinemias|paraproteinemias
649462|NCT00773747|Blood Protein Disorders|blood protein disorders
649463|NCT00773747|Hematologic Diseases|hematologic diseases
649464|NCT00773747|Hemorrhagic Disorders|hemorrhagic disorders
649465|NCT00773747|Lymphoproliferative Disorders|lymphoproliferative disorders
649466|NCT00773747|Immunoproliferative Disorders|immunoproliferative disorders
649467|NCT00773747|Immune System Diseases|immune system diseases
649468|NCT00773747|Vorinostat|vorinostat
649469|NCT00773747|Bortezomib|bortezomib
649470|NCT00773747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
649471|NCT00773747|Analgesics, Non-Narcotic|analgesics, non-narcotic
649472|NCT00773747|Analgesics|analgesics
649473|NCT00773747|Sensory System Agents|sensory system agents
649474|NCT00773747|Peripheral Nervous System Agents|peripheral nervous system agents
649475|NCT00773747|Physiological Effects of Drugs|physiological effects of drugs
649476|NCT00773747|Pharmacologic Actions|pharmacologic actions
649477|NCT00773747|Anti-Inflammatory Agents|anti-inflammatory agents
649478|NCT00773747|Therapeutic Uses|therapeutic uses
649479|NCT00773747|Antirheumatic Agents|antirheumatic agents
649480|NCT00773747|Antineoplastic Agents|antineoplastic agents
649753|NCT00774813|Anxiety|anxiety
649481|NCT00773747|Enzyme Inhibitors|enzyme inhibitors
649482|NCT00773747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
649483|NCT00773747|Anticarcinogenic Agents|anticarcinogenic agents
649484|NCT00773760|opioids|opioids
649485|NCT00773760|COMT|comt
649486|NCT00773760|SNP|snp
649487|NCT00773760|analgesia|analgesia
649488|NCT00773760|postoperative pain|postoperative pain
649489|NCT00773773|Biomarkers - PSA, hK2 and solubilized|biomarkers - psa, hk2 and solubilized
649490|NCT00773773|urokinase-receptor forms (su-PAR)|urokinase-receptor forms (su-par)
649491|NCT00773773|08-114|08-114
649492|NCT00773786|COPD|copd
649493|NCT00773786|Bronchodilator|bronchodilator
649494|NCT00773786|arformoterol|arformoterol
649495|NCT00773786|tiotropium|tiotropium
649496|NCT00773799|To define activities and patient characteristics likely to lead to dissemination of resistant bacteria in rehabilitation centers and|to define activities and patient characteristics likely to lead to dissemination of resistant bacteria in rehabilitation centers and
649497|NCT00773799|To define specific risk factors for acquisition of resistant bacteria (ESBL producers and MRSA) in rehabilitation centers.|to define specific risk factors for acquisition of resistant bacteria (esbl producers and mrsa) in rehabilitation centers.
649498|NCT00773799|ESBL producers|esbl producers
649499|NCT00773799|MRSA|mrsa
649500|NCT00773812|Autistic Disorder|autistic disorder
649501|NCT00773812|Autism|autism
649502|NCT00773812|Mecamylamine|mecamylamine
649503|NCT00773812|Pervasive Developmental Disorder-Not Otherwise Specified|pervasive developmental disorder-not otherwise specified
649504|NCT00773825|Genomic imprinting|genomic imprinting
649505|NCT00773825|Reproductive techniques, assisted|reproductive techniques, assisted
649506|NCT00773825|Beckwith-Wiedemann syndrome|beckwith-wiedemann syndrome
649507|NCT00773825|Angelman syndrome|angelman syndrome
649508|NCT00773851|ventral hernia|ventral hernia
649509|NCT00773851|laparoscopy|laparoscopy
649510|NCT00773851|mesh|mesh
649511|NCT00773851|recurrence|recurrence
649512|NCT00773864|Healthcare employees who work in the rehabilitation center|healthcare employees who work in the rehabilitation center
649513|NCT00773877|RNFL thickness|rnfl thickness
649514|NCT00773916|Attention Deficit Disorder|attention deficit disorder
649515|NCT00773916|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
649516|NCT00773916|Hyperkinetic Syndrome|hyperkinetic syndrome
649517|NCT00773916|Family Function|family function
649518|NCT00773916|Adverse Factors|adverse factors
649519|NCT00773916|Parental Psychopathology|parental psychopathology
649520|NCT00773942|Medication therapy management|medication therapy management
649521|NCT00773942|Pharmacist|pharmacist
649522|NCT00773942|Chronic care|chronic care
649523|NCT00773942|Medicare|medicare
649524|NCT00773942|Medicaid|medicaid
649525|NCT00773942|Medication reconciliation|medication reconciliation
649526|NCT00773942|Adverse drug events|adverse drug events
649527|NCT00773942|Drug related problems|drug related problems
649528|NCT00773981|anastomotic leakage|anastomotic leakage
649529|NCT00773994|anterior palatal eminence|anterior palatal eminence
649530|NCT00773994|palatal elevation above the maxillary plane|palatal elevation above the maxillary plane
649531|NCT00773994|anterior uvular prolapse|anterior uvular prolapse
649532|NCT00773994|"inverted-V present in base view."|"inverted-v present in base view."
649533|NCT00774007|Irritable bowel syndrome, abdominal pain, abdominal bloating, immune cells, mast cells|irritable bowel syndrome, abdominal pain, abdominal bloating, immune cells, mast cells
649534|NCT00774020|Paget's Disease of Bone|paget's disease of bone
649535|NCT00774020|Serum Alkaline Phosphatase|serum alkaline phosphatase
649536|NCT00774033|Keratinocytes|keratinocytes
649537|NCT00774033|Cell spray|cell spray
649538|NCT00774033|Deep partial thickness burns|deep partial thickness burns
649539|NCT00774033|Full thickness burns|full thickness burns
649630|NCT00774384|T regulatory cells|t regulatory cells
650101|NCT00776269|Trichiasis|trichiasis
649540|NCT00774046|Therapy-related myelodysplastic syndrome/ Therapy -related Acute myeloid leukemia|therapy-related myelodysplastic syndrome/ therapy -related acute myeloid leukemia
649541|NCT00774046|Myelodysplastic syndrome|myelodysplastic syndrome
649542|NCT00774046|Acute myeloid leukemia|acute myeloid leukemia
649543|NCT00774059|Breast ptosis, Breast lift|breast ptosis, breast lift
649544|NCT00774072|subjects with cystic fibrosis and pseudomonas aeruginosa colonization in the upper airways|subjects with cystic fibrosis and pseudomonas aeruginosa colonization in the upper airways
649545|NCT00774085|Schizophrenia|schizophrenia
649546|NCT00774085|Risperidone|risperidone
649547|NCT00774085|Risperdal Consta|risperdal consta
649548|NCT00774085|Propective|propective
649549|NCT00774085|Retrospective|retrospective
649550|NCT00774085|Mental disorders|mental disorders
649551|NCT00774085|Observational|observational
649552|NCT00774098|all adult patients (>18 years) planned to undergo a major liver resection|all adult patients (>18 years) planned to undergo a major liver resection
649553|NCT00774111|healthy volunteer|healthy volunteer
649554|NCT00774111|pharmacokinetics|pharmacokinetics
649555|NCT00774111|GSK1349572|gsk1349572
649556|NCT00774111|integrase|integrase
649557|NCT00774111|etravirine|etravirine
649558|NCT00774124|GDM, pregnancy, macrosomia|gdm, pregnancy, macrosomia
649559|NCT00774137|Acute Kidney Injury|acute kidney injury
649560|NCT00774137|IL-18|il-18
649561|NCT00774137|NGAL|ngal
649562|NCT00774137|Cystatin C|cystatin c
649563|NCT00774137|Biomarkers|biomarkers
649564|NCT00774137|Dialysis|dialysis
649565|NCT00774150|Neural correlates of pediatric anxiety disorder|neural correlates of pediatric anxiety disorder
649566|NCT00774150|Social correlates of pediatric anxiety disorder|social correlates of pediatric anxiety disorder
649567|NCT00774150|Generalized Anxiety Disorder in pediatric populations|generalized anxiety disorder in pediatric populations
649568|NCT00774150|Separation Anxiety Disorder in pediatric populations|separation anxiety disorder in pediatric populations
649569|NCT00774150|Social Phobia in pediatric populations|social phobia in pediatric populations
649570|NCT00774163|probiotics|probiotics
649571|NCT00774163|lactobacillus|lactobacillus
649573|NCT00774163|none (safety only)|none (safety only)
649574|NCT00774176|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
649575|NCT00774176|COPD|copd
649576|NCT00774176|COPD Exacerbation|copd exacerbation
649577|NCT00774176|Genetic markers COPD|genetic markers copd
649578|NCT00774176|Gene expression in COPD exacerbations|gene expression in copd exacerbations
649579|NCT00774176|COPD Exacerbation Symptom Reporting|copd exacerbation symptom reporting
649580|NCT00774176|COPD Exacerbation Disease Management|copd exacerbation disease management
649581|NCT00774176|COPD Treatment|copd treatment
649582|NCT00774176|Breathing disorders|breathing disorders
649583|NCT00774176|Emphysema|emphysema
649584|NCT00774176|COPD with Healthy Control comparators for genetic association studies.|copd with healthy control comparators for genetic association studies.
649585|NCT00774189|Bioequivalence clarithromycin 250mg tablets fasting|bioequivalence clarithromycin 250mg tablets fasting
649586|NCT00774202|Pts w/ Chronic ITP who have fail/relap after Rituxan rx|pts w/ chronic itp who have fail/relap after rituxan rx
649587|NCT00774215|Pelvic Organ Prolapse|pelvic organ prolapse
649588|NCT00774215|Cystocele|cystocele
649589|NCT00774215|Rectocele|rectocele
649590|NCT00774215|Enterocele|enterocele
649591|NCT00774215|Synthetic Mesh|synthetic mesh
649592|NCT00774215|Vaginal Mesh|vaginal mesh
649593|NCT00774215|Transobturator|transobturator
649594|NCT00774228|Cataract or intraocular lens placement surgery|cataract or intraocular lens placement surgery
649595|NCT00774254|Health Disparities|health disparities
649596|NCT00774254|Risk Communication|risk communication
649597|NCT00774254|Numeracy|numeracy
649598|NCT00774254|Doctor-Patient Communication|doctor-patient communication
649599|NCT00774254|Virtual Reality Technology|virtual reality technology
649600|NCT00774254|Communication|communication
649601|NCT00774293|Homoeopathic treatment,|homoeopathic treatment,
649602|NCT00774293|heart surgery,|heart surgery,
649603|NCT00774293|randomized clinical trial|randomized clinical trial
649604|NCT00774306|vascular risk|vascular risk
649605|NCT00774306|lipid fractions|lipid fractions
649606|NCT00774306|lipoprotein(a)|lipoprotein(a)
649607|NCT00774306|C-reactive protein|c-reactive protein
649608|NCT00774306|subarachnoid hemorrhage|subarachnoid hemorrhage
649609|NCT00774306|antiepileptic drug|antiepileptic drug
649610|NCT00774306|randomized|randomized
649611|NCT00774306|seizure|seizure
649612|NCT00774306|cholesterol|cholesterol
649613|NCT00774319|HNSCC|hnscc
649614|NCT00774319|neo Adjuvant|neo adjuvant
649615|NCT00774319|Chemoradiation therapy|chemoradiation therapy
649617|NCT00774358|Primary Immunodeficiency|primary immunodeficiency
649618|NCT00774371|Overweight|overweight
649619|NCT00774371|Obese|obese
649620|NCT00774371|Breast cancer survivors|breast cancer survivors
649621|NCT00774371|Weight loss|weight loss
649622|NCT00774371|Physical activity|physical activity
649623|NCT00774371|Exercise|exercise
649624|NCT00774371|Cognitive behavioral therapy|cognitive behavioral therapy
649625|NCT00774384|Neisseria meningitidis|neisseria meningitidis
649626|NCT00774384|Mucosal|mucosal
649627|NCT00774384|Vaccination|vaccination
649628|NCT00774384|Immunity|immunity
649629|NCT00774384|T cells|t cells
649726|NCT00774748|enoxaparin|enoxaparin
649631|NCT00774423|Spinal muscular atrophies (SMA)|spinal muscular atrophies (sma)
649632|NCT00774423|Degeneration of the motor neurons|degeneration of the motor neurons
649633|NCT00774423|Anterior horn of the spinal cord|anterior horn of the spinal cord
649634|NCT00774423|Riluzole|riluzole
649635|NCT00774436|focal cryotherapy|focal cryotherapy
649636|NCT00774436|low-risk prostate cancer|low-risk prostate cancer
649637|NCT00774449|lung transplantation|lung transplantation
649638|NCT00774449|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
649639|NCT00774449|broncholaveolar lavage|broncholaveolar lavage
649640|NCT00774449|high-resolution computertomography|high-resolution computertomography
649641|NCT00774449|quality of life|quality of life
649642|NCT00774462|Myositis|myositis
649643|NCT00774462|Anti-synthetase|anti-synthetase
649644|NCT00774462|Anti-SRP|anti-srp
649645|NCT00774462|Myasthenia gravis|myasthenia gravis
649646|NCT00774462|Rituximab|rituximab
649647|NCT00774475|Clopidogrel therapy|clopidogrel therapy
649648|NCT00774475|platelet function inhibition|platelet function inhibition
649649|NCT00774488|Euglycemic-hyperinsulinemic clamp|euglycemic-hyperinsulinemic clamp
649650|NCT00774488|fat biopsies|fat biopsies
649651|NCT00774488|microarray analysis|microarray analysis
649652|NCT00774488|quantitative real time PCR|quantitative real time pcr
649653|NCT00774488|overnutrition|overnutrition
649654|NCT00774488|low grade-inflammation|low grade-inflammation
649655|NCT00774501|Anesthesia|anesthesia
649656|NCT00774501|suspended ventilation|suspended ventilation
649657|NCT00774514|Air Pollution|air pollution
649658|NCT00774514|Nitrogen Dioxide|nitrogen dioxide
649660|NCT00774514|Endothelial dysfunction|endothelial dysfunction
649661|NCT00774540|Acute pain|acute pain
649662|NCT00774540|Inflammatory pain|inflammatory pain
649663|NCT00774540|Inflammatory mediators|inflammatory mediators
649664|NCT00774540|Pain relief|pain relief
649665|NCT00774540|Microdialysis|microdialysis
649666|NCT00774553|Type 2 diabetes|type 2 diabetes
649667|NCT00774566|catheter ablation|catheter ablation
649668|NCT00774566|randomized|randomized
649669|NCT00774566|cryo|cryo
649670|NCT00774566|radiofrequency|radiofrequency
649671|NCT00774566|atrial fibrillation|atrial fibrillation
649672|NCT00774566|cryo-balloon|cryo-balloon
649673|NCT00774566|PV-Isolation|pv-isolation
649674|NCT00774579|growth hormone|growth hormone
649675|NCT00774579|growth hormone deficiency|growth hormone deficiency
649676|NCT00774579|liver fat|liver fat
649677|NCT00774579|liver steatosis|liver steatosis
649678|NCT00774579|growth hormone replacement|growth hormone replacement
649679|NCT00774592|Adolescent Risk Reduction|adolescent risk reduction
649680|NCT00774592|HIV/AIDS Prevention|hiv/aids prevention
649681|NCT00774592|Behavioral Change|behavioral change
649683|NCT00774605|percutaneous, transcutaneous, topical, varenicline, transdermal, transdermal delivery system, patch|percutaneous, transcutaneous, topical, varenicline, transdermal, transdermal delivery system, patch
649684|NCT00774618|Rib Fracture|rib fracture
649685|NCT00774618|Thoracic Injuries|thoracic injuries
649686|NCT00774618|Flail Chest|flail chest
649687|NCT00774618|Rib Fracture Repair|rib fracture repair
649688|NCT00774618|Rib Fracture ORIF|rib fracture orif
649689|NCT00774618|Chronic rib fractures|chronic rib fractures
649690|NCT00774618|Non-healing rib fractures|non-healing rib fractures
649691|NCT00774618|Rib Fracture Non-union|rib fracture non-union
649692|NCT00774631|Meningitis|meningitis
649693|NCT00774631|Hypothermia|hypothermia
649694|NCT00774631|Intensive care|intensive care
649695|NCT00774657|Aortic Stenosis|aortic stenosis
649696|NCT00774657|Valvular heart disease|valvular heart disease
649697|NCT00774657|Heart disease|heart disease
649698|NCT00774657|Cardiovascular disease|cardiovascular disease
649699|NCT00774657|Two dimensional echocardiography|two dimensional echocardiography
649700|NCT00774657|Three dimensional echocardiography|three dimensional echocardiography
649701|NCT00774683|Pilot|pilot
649702|NCT00774683|Pharmacokinetics|pharmacokinetics
649703|NCT00774683|Raltegravir|raltegravir
649704|NCT00774683|Cervicovaginal|cervicovaginal
649705|NCT00774683|HIV|hiv
649706|NCT00774683|Women|women
649707|NCT00774696|Bioequivalence study of clarithromycin|bioequivalence study of clarithromycin
649708|NCT00774709|Heart failure|heart failure
649709|NCT00774709|Preserved ejection fraction|preserved ejection fraction
649710|NCT00774709|Diastolic dysfunction|diastolic dysfunction
649711|NCT00774709|Dyssynchrony|dyssynchrony
649712|NCT00774709|Echocardiography|echocardiography
649713|NCT00774709|Patients with acute heart failure clinically|patients with acute heart failure clinically
649714|NCT00774709|diagnosed|diagnosed
649715|NCT00774709|BNP level > 100 ng / l or NT-proBNP > 300 ng /l|bnp level > 100 ng / l or nt-probnp > 300 ng /l
649716|NCT00774709|Preserved left ventricular ejection fraction(LVEF|preserved left ventricular ejection fraction(lvef
649717|NCT00774709|≥ 45%)|≥ 45%)
649718|NCT00774735|healthy volunteer|healthy volunteer
649719|NCT00774735|darunavir|darunavir
649720|NCT00774735|lopinavir|lopinavir
649721|NCT00774735|ritonavir|ritonavir
649722|NCT00774735|GSK1349572|gsk1349572
649723|NCT00774735|integrase|integrase
649724|NCT00774735|pharmacokinetics|pharmacokinetics
649725|NCT00774748|low molecular weight heparin|low molecular weight heparin
649729|NCT00774748|subcutaneous catheter|subcutaneous catheter
649730|NCT00774748|once or twice daily dosing of subcutaneous enoxaparin|once or twice daily dosing of subcutaneous enoxaparin
649731|NCT00774761|Chronic|chronic
649732|NCT00774761|Obstructive|obstructive
649733|NCT00774761|Pulmonary|pulmonary
649734|NCT00774761|Disease|disease
649735|NCT00774761|COPD|copd
649736|NCT00774761|Pharmacodynamic|pharmacodynamic
649737|NCT00774761|Pharmacokinetic|pharmacokinetic
649738|NCT00774774|Influenza, human|influenza, human
649739|NCT00774774|Masks|masks
649740|NCT00774774|Disease Transmission, Horizontal|disease transmission, horizontal
649741|NCT00774787|Combination treatment|combination treatment
649742|NCT00774787|Imiquimod|imiquimod
649743|NCT00774787|Cryotherapy|cryotherapy
649744|NCT00774800|Recombinant Hyaluronidase|recombinant hyaluronidase
649745|NCT00774800|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
649746|NCT00774800|Humalog|humalog
649747|NCT00774800|Humulin R|humulin r
649748|NCT00774800|rHuPH20|rhuph20
649749|NCT00774800|Hylenex|hylenex
649750|NCT00774813|Depression|depression
649751|NCT00774813|Mild|mild
649752|NCT00774813|Moderate|moderate
649754|NCT00774813|Kalaco Scientific, Inc.|kalaco scientific, inc.
649755|NCT00774826|Follicular lymphoma|follicular lymphoma
649756|NCT00774826|Rituximab|rituximab
649757|NCT00774839|Newly Diagnosed|newly diagnosed
649758|NCT00774839|Colon|colon
649759|NCT00774839|Stage II|stage ii
649760|NCT00774839|Stage III|stage iii
649761|NCT00774852|lupus|lupus
649762|NCT00774852|systemic lupus erythematosus|systemic lupus erythematosus
649763|NCT00774852|lupus nephritis|lupus nephritis
649765|NCT00774852|abatacept|abatacept
649766|NCT00774852|CTLA4|ctla4
649767|NCT00774852|CTLA4Ig|ctla4ig
649768|NCT00774852|glomerulonephritis|glomerulonephritis
649769|NCT00774865|Robotic|robotic
649770|NCT00774865|CABG|cabg
649771|NCT00774865|LITA|lita
649772|NCT00774865|Patency|patency
649773|NCT00774865|Long|long
649774|NCT00774865|Term|term
649775|NCT00774878|Breast cancer|breast cancer
649776|NCT00774878|Breast Tumors|breast tumors
649777|NCT00774878|Anti IGF-1R|anti igf-1r
649778|NCT00774878|Hormonosensitivity|hormonosensitivity
649779|NCT00774891|Echocardiography- exercise|echocardiography- exercise
649780|NCT00774891|Echocardiography- dobutamine|echocardiography- dobutamine
649781|NCT00774891|Wall stress|wall stress
649782|NCT00774891|Ventricular volume-left|ventricular volume-left
649783|NCT00774891|Ischemia|ischemia
649784|NCT00774891|Angina|angina
649785|NCT00774891|Heart diseases|heart diseases
649786|NCT00774891|Stress echocardiography|stress echocardiography
649787|NCT00774891|Ventricular volume|ventricular volume
649788|NCT00774891|Vascular diseases|vascular diseases
649789|NCT00774904|Type 2 Diabetes|type 2 diabetes
649790|NCT00774904|Diabetic Nephropathy|diabetic nephropathy
649791|NCT00774904|Glucose Metabolism|glucose metabolism
649792|NCT00774904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
649793|NCT00774917|numen|numen
649794|NCT00774917|hyperplasia|hyperplasia
649795|NCT00774930|Carcinoid tumor|carcinoid tumor
649796|NCT00774930|Somatuline Depot|somatuline depot
649797|NCT00774930|Lanreotide Autogel|lanreotide autogel
649798|NCT00774930|Neuroendocrine tumor|neuroendocrine tumor
649799|NCT00774930|NET|net
649800|NCT00774930|Diarrhea|diarrhea
649801|NCT00774930|Flushing|flushing
649802|NCT00774930|Carcinoid tumour|carcinoid tumour
649803|NCT00774930|Neuroendocrine tumour|neuroendocrine tumour
649804|NCT00774930|Diarrhoea|diarrhoea
649805|NCT00774943|Systemic lupus erythematosus|systemic lupus erythematosus
649806|NCT00774943|ICOSL|icosl
649807|NCT00774943|B7RP-1|b7rp-1
752858|NCT01174498|sting|sting
649808|NCT00774943|Costimulation|costimulation
649809|NCT00774982|Crohns Disease|crohns disease
649810|NCT00774982|Pharmacokinetics|pharmacokinetics
649811|NCT00774982|Local Targeted Delivery to the Ileum|local targeted delivery to the ileum
649812|NCT00774982|Delayed Release|delayed release
649813|NCT00774982|Immunology Measurements|immunology measurements
649814|NCT00774982|Pharmacokinetics in Crohns Disease Patients|pharmacokinetics in crohns disease patients
649815|NCT00774995|Engerix-B|engerix-b
649816|NCT00774995|Hepatitis B|hepatitis b
649817|NCT00775008|weight loss, health information, e-health|weight loss, health information, e-health
649818|NCT00775047|depo medroxyprogesterone acetate|depo medroxyprogesterone acetate
649819|NCT00775047|Depo Provera|depo provera
649820|NCT00775047|contraceptive compliance|contraceptive compliance
649821|NCT00775047|pharmacists|pharmacists
649822|NCT00775047|Compliance in receiving additional Depo Provera injections|compliance in receiving additional depo provera injections
649823|NCT00775047|Satisfaction in receiving Depo Provera injections at a pharmacy compared with usual clinic|satisfaction in receiving depo provera injections at a pharmacy compared with usual clinic
649824|NCT00775073|Liver cancer|liver cancer
649825|NCT00775073|HCC|hcc
649826|NCT00775086|ORTHO EVRA|ortho evra
649827|NCT00775086|contraception|contraception
649828|NCT00775086|NGMN|ngmn
649829|NCT00775086|contraceptive patch|contraceptive patch
649830|NCT00775086|bioequivalence|bioequivalence
649831|NCT00775086|EE|ee
649832|NCT00775086|norelgestromin|norelgestromin
649833|NCT00775086|ethinyl estradiol|ethinyl estradiol
649834|NCT00775099|Air Pollution|air pollution
649835|NCT00775099|Particles|particles
649836|NCT00775099|Particulate Matter|particulate matter
649837|NCT00775099|Vascular function|vascular function
649838|NCT00775099|Endothelial function|endothelial function
649839|NCT00775099|Thrombosis|thrombosis
649840|NCT00775112|supportive care|supportive care
649841|NCT00775112|lumbar puncture|lumbar puncture
649842|NCT00775112|childhood disease|childhood disease
649843|NCT00775112|pediatric hemato-oncology|pediatric hemato-oncology
649844|NCT00775125|VX-950-TiDP24-C124|vx-950-tidp24-c124
649845|NCT00775125|VX-950-C124|vx-950-c124
649846|NCT00775125|HCV|hcv
649847|NCT00775125|DDI|ddi
649848|NCT00775125|telaprevir|telaprevir
649849|NCT00775125|darunavir|darunavir
649850|NCT00775125|ritonavir|ritonavir
649851|NCT00775125|fosamprenavir|fosamprenavir
649852|NCT00775125|interaction|interaction
649853|NCT00775125|pharmacokinetics|pharmacokinetics
649854|NCT00775125|steady-state|steady-state
649855|NCT00775138|Bronchiectasis|bronchiectasis
649856|NCT00775138|Respiratory Infections|respiratory infections
649857|NCT00775138|Amikacin|amikacin
649858|NCT00775138|Genetic Diseases, Inborn|genetic diseases, inborn
649859|NCT00775138|Respiratory Tract Diseases|respiratory tract diseases
649860|NCT00775138|Cystic Fibrosis|cystic fibrosis
649861|NCT00775138|Respiratory Tract Infections|respiratory tract infections
649862|NCT00775138|Lung Diseases|lung diseases
649863|NCT00775138|Infant, Newborn, Diseases|infant, newborn, diseases
649864|NCT00775138|Pancreatic Diseases|pancreatic diseases
649865|NCT00775151|Bioequivalence amlodipine 10 mg tablet under fed conditions|bioequivalence amlodipine 10 mg tablet under fed conditions
649866|NCT00775164|Obese children with insulin resistance|obese children with insulin resistance
649867|NCT00775177|Bioequivalence Doxycycline monohydrate 100mg tablets fed conditions|bioequivalence doxycycline monohydrate 100mg tablets fed conditions
649868|NCT00775190|birth control pills|birth control pills
649869|NCT00775190|oral contraceptives|oral contraceptives
649870|NCT00775190|brand name|brand name
649872|NCT00775190|side effects|side effects
649873|NCT00775190|oral contraceptive side effects|oral contraceptive side effects
649994|NCT00775502|Multiple myeloma|multiple myeloma
649874|NCT00775190|dysfunctional uterine bleeding|dysfunctional uterine bleeding
649875|NCT00775190|pre-menstrual symptoms|pre-menstrual symptoms
649876|NCT00775203|Unipolar|unipolar
649877|NCT00775229|hair pulling|hair pulling
649878|NCT00775242|Menopause|menopause
649879|NCT00775242|Hormone Replacement Therapy|hormone replacement therapy
649880|NCT00775242|Microspheres|microspheres
649881|NCT00775242|Progesterone|progesterone
649882|NCT00775242|Estradiol|estradiol
649883|NCT00775242|Hot flashes|hot flashes
649884|NCT00775255|Bioequiavelnce clarithromycin|bioequiavelnce clarithromycin
649885|NCT00775268|18F Fluorothymidine|18f fluorothymidine
649886|NCT00775268|PET/CT|pet/ct
649887|NCT00775268|FLT|flt
649888|NCT00775268|Lymphoma|lymphoma
649889|NCT00775268|FDG|fdg
649890|NCT00775281|Tachykinin receptors|tachykinin receptors
649891|NCT00775281|Protein expression|protein expression
649892|NCT00775281|Contractile proteins|contractile proteins
649893|NCT00775281|Inflammatory proteins|inflammatory proteins
649894|NCT00775307|Non-small cell lung cancer|non-small cell lung cancer
649895|NCT00775307|Stage I|stage i
649896|NCT00775307|adjuvant therapy|adjuvant therapy
649897|NCT00775307|Adjuvant Drug Therapy|adjuvant drug therapy
649898|NCT00775320|Brain scan|brain scan
649899|NCT00775333|Carpal Tunnel Syndrome|carpal tunnel syndrome
649900|NCT00775333|Diabetes|diabetes
649901|NCT00775333|APB strength|apb strength
649902|NCT00775333|Sensory Function|sensory function
649903|NCT00775333|Pillar Pain|pillar pain
649904|NCT00775333|Cold Intolerance|cold intolerance
649905|NCT00775333|Patient Satisfaction|patient satisfaction
649906|NCT00775359|bioequivalence fenofibrate tablets|bioequivalence fenofibrate tablets
649907|NCT00775372|Bioequivalence study of clarithromycin 250mg/5mL powdder|bioequivalence study of clarithromycin 250mg/5ml powdder
649908|NCT00775385|Chemotherapy, Adjuvant|chemotherapy, adjuvant
649909|NCT00775398|Hemostasis|hemostasis
649910|NCT00775398|Thrombin-JMI|thrombin-jmi
649911|NCT00775398|Thrombin|thrombin
649912|NCT00775398|Blood Coagulation|blood coagulation
649913|NCT00775424|HIV infection|hiv infection
649914|NCT00775424|DNA vaccine|dna vaccine
649915|NCT00775424|IL-12 adjuvant|il-12 adjuvant
649916|NCT00775424|IL-15 adjuvant|il-15 adjuvant
649917|NCT00775437|juvenile idiopathic arthritis|juvenile idiopathic arthritis
649918|NCT00775437|compassionate use|compassionate use
649919|NCT00775437|open label|open label
649920|NCT00769821|lymphedema|lymphedema
649921|NCT00769821|perioperative/postoperative complications|perioperative/postoperative complications
649922|NCT00769821|cancer survivor|cancer survivor
649923|NCT00769821|stage I breast cancer|stage i breast cancer
649924|NCT00769821|stage II breast cancer|stage ii breast cancer
649925|NCT00769821|stage IIIA breast cancer|stage iiia breast cancer
649926|NCT00769821|stage IIIB breast cancer|stage iiib breast cancer
649927|NCT00769821|stage IIIC breast cancer|stage iiic breast cancer
649928|NCT00769821|stage IV breast cancer|stage iv breast cancer
649929|NCT00769834|chronic kidney disease|chronic kidney disease
649930|NCT00769834|chronic renal insufficiency|chronic renal insufficiency
649931|NCT00769834|uremia|uremia
649932|NCT00769834|disc edema|disc edema
649933|NCT00769834|papilledema|papilledema
649934|NCT00769834|idiopathic intracranial hypertension|idiopathic intracranial hypertension
649935|NCT00769834|pseudotumor cerebri|pseudotumor cerebri
649936|NCT00769847|Endoscopic, craniosynostosis, sagittal, synostosis|endoscopic, craniosynostosis, sagittal, synostosis
649937|NCT00769860|myositis|myositis
649938|NCT00769860|IBM|ibm
649939|NCT00769860|inclusion body myositis|inclusion body myositis
649940|NCT00769873|anticoagulation|anticoagulation
649941|NCT00769873|thrombosis|thrombosis
649942|NCT00769873|portal vein thrombosis|portal vein thrombosis
649943|NCT00769873|splenic vein thrombosis|splenic vein thrombosis
649944|NCT00769873|splenectomy|splenectomy
649945|NCT00769873|randomized|randomized
649946|NCT00769873|laparoscopic splenectomy|laparoscopic splenectomy
649947|NCT00769873|lovenox|lovenox
649948|NCT00769899|AZD7325|azd7325
649949|NCT00769899|Japanese Healthy Volunteers|japanese healthy volunteers
649950|NCT00769899|Phase I study|phase i study
649951|NCT00769899|Single Ascending Dose|single ascending dose
649952|NCT00769925|Generalized Anxiety|generalized anxiety
649953|NCT00769925|Social Phobia|social phobia
649954|NCT00769925|Separation Anxiety|separation anxiety
649955|NCT00769925|Phobia|phobia
649956|NCT00769938|Atrial fibrillation|atrial fibrillation
649957|NCT00769938|Percutaneous coronary stenting|percutaneous coronary stenting
649958|NCT00769938|Bleeding complications|bleeding complications
649959|NCT00769938|Triple therapy|triple therapy
649960|NCT00769951|pain|pain
649961|NCT00769951|depression|depression
649962|NCT00769951|weight changes|weight changes
649963|NCT00769951|cognitive/functional effects|cognitive/functional effects
649964|NCT00769951|malnutrition|malnutrition
649965|NCT00769951|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
649966|NCT00769951|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
649967|NCT00769951|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
649968|NCT00769964|Healthy (Dysmenorrhea)|healthy (dysmenorrhea)
649969|NCT00769990|bone metastases|bone metastases
649970|NCT00769990|pain|pain
649971|NCT00769990|recurrent breast cancer|recurrent breast cancer
649972|NCT00769990|stage IV breast cancer|stage iv breast cancer
649973|NCT00769990|recurrent prostate cancer|recurrent prostate cancer
649974|NCT00769990|stage IV prostate cancer|stage iv prostate cancer
649975|NCT00769990|recurrent melanoma|recurrent melanoma
649976|NCT00769990|stage IV melanoma|stage iv melanoma
649977|NCT00769990|recurrent renal cell cancer|recurrent renal cell cancer
649978|NCT00769990|stage IV renal cell cancer|stage iv renal cell cancer
649979|NCT00769990|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
649980|NCT00769990|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
649981|NCT00769990|extensive stage small cell lung cancer|extensive stage small cell lung cancer
649982|NCT00769990|recurrent small cell lung cancer|recurrent small cell lung cancer
649983|NCT00775450|Influenza|influenza
649984|NCT00775450|Orthomyxovirus Infection|orthomyxovirus infection
649985|NCT00775450|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
649986|NCT00775450|Elderly|elderly
649987|NCT00775463|Scleroderma, Diffuse|scleroderma, diffuse
649988|NCT00775463|Scleroderma, Limited|scleroderma, limited
649989|NCT00775463|Scleroderma, Systemic|scleroderma, systemic
649990|NCT00775463|Ulcer|ulcer
649991|NCT00775463|prostacyclin|prostacyclin
751836|NCT01170767|Age-related Macular Degeneration|age-related macular degeneration
649992|NCT00775476|Systemic lupus erythematosus (SLE), an autoimmune disease|systemic lupus erythematosus (sle), an autoimmune disease
649993|NCT00775489|glaucoma, steroid, nasal|glaucoma, steroid, nasal
649995|NCT00775502|GM-2 ganglioside|gm-2 ganglioside
649996|NCT00775502|monoclonal antibody|monoclonal antibody
649997|NCT00775502|Potelligent design|potelligent design
649998|NCT00775502|Treatment of subjects who have failed previous treatment|treatment of subjects who have failed previous treatment
649999|NCT00775515|chronic|chronic
650000|NCT00775515|prostatitis|prostatitis
650001|NCT00775515|prostate|prostate
650002|NCT00775515|pain|pain
650003|NCT00775515|pelvic|pelvic
650004|NCT00775515|pelvis|pelvis
650005|NCT00775515|inflamation|inflamation
650006|NCT00775528|Cystic Fibrosis|cystic fibrosis
650007|NCT00775528|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
650008|NCT00775541|Diabetes|diabetes
650009|NCT00775541|Type 2 Diabetes|type 2 diabetes
650010|NCT00775567|Fructose|fructose
650011|NCT00775567|Intolerance|intolerance
650012|NCT00775567|Adaptation|adaptation
650013|NCT00775567|Prebiotic|prebiotic
650014|NCT00775567|Healthy men or women 18-40|healthy men or women 18-40
650015|NCT00775580|bioequivalence Atenolol Tablets|bioequivalence atenolol tablets
650016|NCT00775593|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
650017|NCT00775593|adult acute basophilic leukemia|adult acute basophilic leukemia
650018|NCT00775593|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
650676|NCT00778895|Flu vaccine|flu vaccine
650019|NCT00775593|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
650020|NCT00775593|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
650021|NCT00775593|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
650022|NCT00775593|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
650023|NCT00775593|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
650024|NCT00775593|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
650025|NCT00775593|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
650026|NCT00775593|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
650027|NCT00775593|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
650028|NCT00775593|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
650029|NCT00775593|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
650030|NCT00775593|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
650031|NCT00775593|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
650032|NCT00775606|AIDS, HIV|aids, hiv
752380|NCT01172730|Ultrasound scanning of the thoracic spine|ultrasound scanning of the thoracic spine
650033|NCT00775619|bioequivalence Carvedilol 12.5 mg tablets fed conditions|bioequivalence carvedilol 12.5 mg tablets fed conditions
650034|NCT00775632|Graft Versus Host Disease|graft versus host disease
650035|NCT00775632|Alemtuzumab|alemtuzumab
650037|NCT00775632|Bone Marrow Transplants|bone marrow transplants
650038|NCT00775645|neurotoxicity|neurotoxicity
650039|NCT00775645|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
650040|NCT00775645|fatigue|fatigue
650041|NCT00775645|neuropathy|neuropathy
650042|NCT00775645|stage IA breast cancer|stage ia breast cancer
650043|NCT00775645|stage IB breast cancer|stage ib breast cancer
650044|NCT00775645|stage II breast cancer|stage ii breast cancer
650045|NCT00775645|stage IIIA breast cancer|stage iiia breast cancer
650046|NCT00775645|stage IIIB breast cancer|stage iiib breast cancer
650047|NCT00775645|stage IIIC breast cancer|stage iiic breast cancer
650048|NCT00775658|allergy|allergy
650049|NCT00775658|skin testing|skin testing
650050|NCT00775658|eye drops|eye drops
650051|NCT00775658|antihistamines|antihistamines
650052|NCT00775684|Exenatide|exenatide
650053|NCT00775684|Sitagliptin|sitagliptin
650054|NCT00775684|Glimepiride|glimepiride
650055|NCT00775684|Glucagon-Like Peptide-1|glucagon-like peptide-1
650056|NCT00775684|Impaired Fasting Glucose|impaired fasting glucose
650057|NCT00775684|Type 2 Diabetes|type 2 diabetes
650058|NCT00775684|Beta-cell Function|beta-cell function
650059|NCT00775684|Beta-cell Secretory Capacity|beta-cell secretory capacity
650060|NCT00775684|Glucose-potentiated arginine|glucose-potentiated arginine
650061|NCT00775697|wheezing|wheezing
650062|NCT00775697|children|children
650063|NCT00775697|montelukast|montelukast
650064|NCT00775697|bronchodilators|bronchodilators
650065|NCT00775697|lung function|lung function
650066|NCT00775697|Rint|rint
650067|NCT00775723|6sulphatoxymelatonin|6sulphatoxymelatonin
650068|NCT00775723|preterm infants|preterm infants
650069|NCT00775723|melatonin is low in preterm infants at least until the age of 6 months|melatonin is low in preterm infants at least until the age of 6 months
650070|NCT00775749|post operative nausea and vomiting|post operative nausea and vomiting
650071|NCT00775749|gynecological surgery|gynecological surgery
650072|NCT00775749|outpatient surgery|outpatient surgery
650073|NCT00775749|nicotine patch|nicotine patch
650074|NCT00775749|laparoscopic surgery|laparoscopic surgery
650075|NCT00775762|Symptomatic Polyvascular disease|symptomatic polyvascular disease
650076|NCT00775762|Multiple recurrent cardiovascular events|multiple recurrent cardiovascular events
650077|NCT00776126|Breast|breast
650078|NCT00776126|3D Digital Mammography|3d digital mammography
650079|NCT00776126|Digital Breast Tomosynthesis|digital breast tomosynthesis
650080|NCT00776139|Cetirizine Hydrochloride 10 mg tablet fasting conditions|cetirizine hydrochloride 10 mg tablet fasting conditions
650081|NCT00776178|Survival Study|survival study
650082|NCT00776178|Bladder Cancer|bladder cancer
650083|NCT00776178|Cancer Recurrence|cancer recurrence
650084|NCT00776178|Tumor Markers/Heterogeneity|tumor markers/heterogeneity
650085|NCT00776191|Physioneal 35|physioneal 35
650086|NCT00776191|Physioneal 40|physioneal 40
650087|NCT00776191|children|children
650088|NCT00776191|chronic peritoneal dialysis|chronic peritoneal dialysis
650089|NCT00776204|Coronary Artery Disease|coronary artery disease
650090|NCT00776204|Drug eluting stent|drug eluting stent
650091|NCT00776204|Percutaneous Coronary Interventions|percutaneous coronary interventions
650092|NCT00776204|Optical Coherence Tomography|optical coherence tomography
650093|NCT00776217|bioequivalence loratadine 10 mg orally disintegrating tablets fasting|bioequivalence loratadine 10 mg orally disintegrating tablets fasting
650094|NCT00776243|incretin|incretin
650095|NCT00776243|GLP-1|glp-1
650097|NCT00776243|intensive insulin therapy|intensive insulin therapy
650098|NCT00776256|satiety|satiety
650099|NCT00776256|food intake|food intake
650100|NCT00776269|Argon laser|argon laser
650102|NCT00776269|Radiofrequency|radiofrequency
650103|NCT00776269|Patients with trichiasis|patients with trichiasis
650104|NCT00776282|bioequivalence loratadine 10 mg orally disintegrating|bioequivalence loratadine 10 mg orally disintegrating
650105|NCT00776282|tablets fed conditions|tablets fed conditions
650106|NCT00776295|Small Cell Lung Cancer|small cell lung cancer
650107|NCT00776295|SCLC|sclc
650108|NCT00776295|Limited Stage Small Cell Lung Cancer|limited stage small cell lung cancer
650109|NCT00776308|molecular breast imaging|molecular breast imaging
650110|NCT00776308|breast cancer|breast cancer
650111|NCT00776308|mammography|mammography
650112|NCT00776321|hypercholesterolemia|hypercholesterolemia
650113|NCT00776321|dyslipidemia|dyslipidemia
650114|NCT00776321|thyroid|thyroid
650115|NCT00776321|safety|safety
650116|NCT00776334|bioequivalence Fosinopril Tablets|bioequivalence fosinopril tablets
650117|NCT00776347|Dementia with Lewy bodies (DLB)|dementia with lewy bodies (dlb)
650118|NCT00776347|FDG-PET|fdg-pet
650119|NCT00776360|oxytocin|oxytocin
650120|NCT00776360|gastroparesis|gastroparesis
650121|NCT00776360|diabetics|diabetics
650122|NCT00776360|The effect of oxytocin on gastric emptying|the effect of oxytocin on gastric emptying
650124|NCT00776373|Burkitt's Lymphoma|burkitt's lymphoma
650125|NCT00776373|Adult T-Cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
651454|NCT00783510|JIA|jia
650126|NCT00776373|Lymphoblastic leukemia|lymphoblastic leukemia
650127|NCT00776373|CML in lymphoid blast crisis patients|cml in lymphoid blast crisis patients
650128|NCT00776373|HiVAC|hivac
650129|NCT00776373|Rapamycin|rapamycin
650130|NCT00776399|Colorectal cancer|colorectal cancer
650131|NCT00776399|lung metastasis|lung metastasis
650132|NCT00776399|radiofrequency ablation|radiofrequency ablation
650133|NCT00776399|metastasectomy|metastasectomy
650134|NCT00776399|Lung metastasis from colorectal cancer|lung metastasis from colorectal cancer
650135|NCT00776412|Immunologic Non-Responder|immunologic non-responder
650136|NCT00776412|Cardiovascular Disease|cardiovascular disease
650137|NCT00776412|D-dimer|d-dimer
650138|NCT00776412|Antiretroviral|antiretroviral
650139|NCT00776412|Mortality|mortality
650140|NCT00776412|HIV Positive|hiv positive
650141|NCT00776412|HIV Negative|hiv negative
650142|NCT00776412|Healthy Volunteer|healthy volunteer
650143|NCT00776412|HV|hv
650144|NCT00776438|Influenza|influenza
650145|NCT00776438|Orthomyxoviruses|orthomyxoviruses
650146|NCT00776438|Myxovirus Infection|myxovirus infection
650147|NCT00776438|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
650148|NCT00776438|Adults|adults
650149|NCT00776438|Elderly|elderly
650150|NCT00776451|AMD|amd
650151|NCT00776490|Bioequivalence Glimepiride Tablets|bioequivalence glimepiride tablets
650152|NCT00776503|Epigenetic|epigenetic
650153|NCT00776503|Myelodysplasia|myelodysplasia
650154|NCT00776503|Cytarabine|cytarabine
650155|NCT00776516|Healthy volunteer subjects|healthy volunteer subjects
650156|NCT00776516|CYP3A4 inducer|cyp3a4 inducer
650157|NCT00776516|rifampin|rifampin
650158|NCT00776516|drug interaction|drug interaction
650159|NCT00776516|pharmacokinetics|pharmacokinetics
650160|NCT00776516|YM178|ym178
650161|NCT00776516|mirabegron|mirabegron
650162|NCT00776529|sensorimotor training|sensorimotor training
650163|NCT00776529|Strengthening|strengthening
650164|NCT00776529|Balance|balance
650165|NCT00776542|bioequivalence Minocycline Tablets|bioequivalence minocycline tablets
650166|NCT00776555|Not required|not required
650167|NCT00776581|Combined spinal-epidural analgesia|combined spinal-epidural analgesia
650168|NCT00776581|Patient-controlled analgesia|patient-controlled analgesia
650169|NCT00776581|Epidural analgesia|epidural analgesia
650170|NCT00776594|Androgen deprivation therapy|androgen deprivation therapy
650171|NCT00776594|ADT|adt
650172|NCT00776594|bevacizumab|bevacizumab
650173|NCT00776607|LADA|lada
751837|NCT01170767|Bevacizumab|bevacizumab
650174|NCT00776607|Latent autoimmune diabetes in adults|latent autoimmune diabetes in adults
650175|NCT00776607|Type 1.5|type 1.5
650176|NCT00776607|Slowly progressive type 1 diabetes|slowly progressive type 1 diabetes
650177|NCT00776620|Bioequivalence Glimepiride Tablets|bioequivalence glimepiride tablets
650178|NCT00776633|aspirin|aspirin
650179|NCT00776633|clopidogrel|clopidogrel
650180|NCT00776633|oral anticoagulation|oral anticoagulation
650181|NCT00776633|warfarin|warfarin
650182|NCT00776633|drug eluting stent|drug eluting stent
650183|NCT00776633|phenprocoumon|phenprocoumon
650184|NCT00776646|bioequivalence hydrochlorothiazide 50 mg tablet fasting conditions|bioequivalence hydrochlorothiazide 50 mg tablet fasting conditions
650185|NCT00776659|An Observational Study of Indian Breast Cancer Patients Receiving Adjuvant Therapy with Aromasin|an observational study of indian breast cancer patients receiving adjuvant therapy with aromasin
650186|NCT00776659|Antineoplastic Hormonal Drugs|antineoplastic hormonal drugs
650187|NCT00776659|Aromasin|aromasin
650188|NCT00776672|Bioequivalence Fosinopril Tablets|bioequivalence fosinopril tablets
650189|NCT00776711|Healthy|healthy
650190|NCT00776711|Avian Influenza|avian influenza
650191|NCT00776711|Immunity|immunity
650192|NCT00776711|Preventive|preventive
650193|NCT00776711|Bird Flu|bird flu
650194|NCT00776711|Healthy Volunteer|healthy volunteer
650195|NCT00776711|HV|hv
650196|NCT00776711|Influenza|influenza
650197|NCT00776724|breast ca|breast ca
650198|NCT00776724|phase III|phase iii
650199|NCT00776724|Tailored neoadjuvant chemotherapy|tailored neoadjuvant chemotherapy
650200|NCT00776724|stage II/III|stage ii/iii
650201|NCT00776737|Attention Deficit Disorder|attention deficit disorder
650202|NCT00776737|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
650203|NCT00776737|Computer Aided Learning|computer aided learning
650204|NCT00776737|Attention Deficits|attention deficits
650205|NCT00776737|Healthy Volunteer|healthy volunteer
650206|NCT00776737|HV|hv
650207|NCT00776776|BMI > 40|bmi > 40
650208|NCT00776776|Obesity|obesity
650209|NCT00776776|Adolescents|adolescents
650210|NCT00776776|Weight Loss Surgery|weight loss surgery
650211|NCT00776789|Skin to skin contact|skin to skin contact
650212|NCT00776789|Salivary cortisol|salivary cortisol
650213|NCT00776789|Breast feeding Behavior|breast feeding behavior
650214|NCT00776802|GCS-100|gcs-100
650215|NCT00776802|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
650216|NCT00776802|DLBCL|dlbcl
650217|NCT00776802|Relapsed or refractory DLBCL|relapsed or refractory dlbcl
650218|NCT00776802|Etoposide; Dexamethasone|etoposide; dexamethasone
650219|NCT00776828|cilostazol|cilostazol
650220|NCT00776828|clopidogrel|clopidogrel
650221|NCT00776828|statin|statin
650222|NCT00776828|drug-eluting stent|drug-eluting stent
650223|NCT00776841|Phase-I|phase-i
650224|NCT00776841|Hypercholesterolemia|hypercholesterolemia
650225|NCT00776841|Obesity|obesity
650226|NCT00776841|fatty liver|fatty liver
650227|NCT00776841|Part A: Healthy male volunteers Part B: Mildly overweight, otherwise healthy hypercholesterolemic male volunteers|part a: healthy male volunteers part b: mildly overweight, otherwise healthy hypercholesterolemic male volunteers
650228|NCT00776867|Pediatric|pediatric
650229|NCT00776867|solid tumors|solid tumors
650230|NCT00776867|Pediatric solid tumors|pediatric solid tumors
650231|NCT00776867|08-091|08-091
650232|NCT00776880|Surgical operation|surgical operation
650233|NCT00776919|Acne Vulgaris|acne vulgaris
650234|NCT00776919|Acne|acne
650235|NCT00776958|A Lynne Cohen Consortium Project|a lynne cohen consortium project
650236|NCT00776958|Multi-Center Database Registry|multi-center database registry
650237|NCT00776958|High Risk|high risk
650238|NCT00776958|Cancer|cancer
650239|NCT00776958|Breast|breast
650240|NCT00776958|BRCA1 or BRCA2 gene|brca1 or brca2 gene
650241|NCT00776958|Ovary|ovary
650242|NCT00776958|Questionnaire|questionnaire
650243|NCT00776997|Gastroesophageal Reflux|gastroesophageal reflux
650244|NCT00777010|memory loss|memory loss
650245|NCT00777010|mild cognitive impairment|mild cognitive impairment
650246|NCT00777010|forgetfulness|forgetfulness
650247|NCT00777023|Hot Flashes|hot flashes
650248|NCT00777023|Hot Flushes|hot flushes
650249|NCT00777023|Postmenopausal symptoms|postmenopausal symptoms
650250|NCT00777023|Vasomotor symptoms|vasomotor symptoms
650251|NCT00777036|Leukemia, Pediatric|leukemia, pediatric
650252|NCT00777062|alcohol|alcohol
650253|NCT00777062|cocaine|cocaine
650254|NCT00777062|addiction|addiction
650255|NCT00777062|alcoholism|alcoholism
650256|NCT00777062|substance dependence|substance dependence
650257|NCT00777062|substance abuse|substance abuse
650258|NCT00777075|nitrate|nitrate
650259|NCT00777075|nitric oxide|nitric oxide
650260|NCT00777075|asymmetric dimethylarginine|asymmetric dimethylarginine
650261|NCT00777075|blood pressure|blood pressure
650263|NCT00777075|IIEF|iief
650264|NCT00777088|neurovascular embolization|neurovascular embolization
650265|NCT00777088|therapeutic embolization|therapeutic embolization
650266|NCT00777101|HER2|her2
650267|NCT00777101|ErbB2|erbb2
650268|NCT00777101|metastatic|metastatic
650269|NCT00777101|neratinib|neratinib
650270|NCT00777101|lapatinib|lapatinib
650271|NCT00777101|capecitabine|capecitabine
650273|NCT00777101|Tykerb|tykerb
650274|NCT00777101|Tyverb|tyverb
650275|NCT00777101|Xeloda|xeloda
650276|NCT00777114|relapsed non-Hodgkin's lymphoma|relapsed non-hodgkin's lymphoma
650277|NCT00777127|actinic keratosis|actinic keratosis
650278|NCT00777127|invasive SCC|invasive scc
650279|NCT00777127|in situ SCC|in situ scc
650280|NCT00777127|histological classification|histological classification
650281|NCT00777127|histological progression|histological progression
650282|NCT00777127|clinical clearance|clinical clearance
650283|NCT00777127|cryotherapy|cryotherapy
650284|NCT00777140|Stroke|stroke
650285|NCT00777140|Ischemic Stroke|ischemic stroke
650286|NCT00777140|Thrombolytic treatment|thrombolytic treatment
650287|NCT00777140|Middle cerebral artery occlusion|middle cerebral artery occlusion
650288|NCT00777140|Deferoxamine|deferoxamine
650289|NCT00777140|Iron chelator|iron chelator
650290|NCT00777140|Acute Ischemic Stroke treated with Intravenous Thrombolytic|acute ischemic stroke treated with intravenous thrombolytic
650291|NCT00777153|Cancer|cancer
650292|NCT00777153|Tumour|tumour
650293|NCT00777153|Advanced Solid Tumour|advanced solid tumour
650294|NCT00777153|GBM|gbm
650295|NCT00777153|Glioblastoma|glioblastoma
650296|NCT00777166|oxytocin|oxytocin
650297|NCT00777166|ST depression|st depression
650298|NCT00777166|cesarean section|cesarean section
650299|NCT00777166|blood loss|blood loss
650300|NCT00777179|Vandetanib, NSCLC, Maintenance, Phase II|vandetanib, nsclc, maintenance, phase ii
650301|NCT00777192|colon cancer|colon cancer
650302|NCT00777192|Cancers of the colon and rectum|cancers of the colon and rectum
650303|NCT00777192|Oxaliplatin|oxaliplatin
650304|NCT00777192|oxaliplatin chemotherapy|oxaliplatin chemotherapy
650305|NCT00777192|inflammatory cytokines|inflammatory cytokines
650306|NCT00777192|neurocognitive symptoms|neurocognitive symptoms
650307|NCT00777192|neuropsychiatric symptoms|neuropsychiatric symptoms
650308|NCT00777205|Peer Support|peer support
650309|NCT00777205|Quality of Life|quality of life
650310|NCT00777205|Telephone|telephone
650311|NCT00777218|migraine|migraine
650312|NCT00777231|Sickle Cell|sickle cell
650313|NCT00777231|Stem Cell|stem cell
650314|NCT00777231|Tolerance|tolerance
650315|NCT00777231|Bone Marrow Transplant|bone marrow transplant
650316|NCT00777231|Total Body Irradiation (TBI)|total body irradiation (tbi)
650317|NCT00777231|Apheresis|apheresis
650318|NCT00777231|Aplastic Anemia|aplastic anemia
650319|NCT00777231|Hemoglobinopathies|hemoglobinopathies
650320|NCT00777231|Non Malignant|non malignant
650321|NCT00777244|mitotane|mitotane
650322|NCT00777244|adjuvant therapy|adjuvant therapy
650323|NCT00777244|disease free survival|disease free survival
650324|NCT00777257|Meningitis|meningitis
650325|NCT00777257|Meningococcemia|meningococcemia
650327|NCT00777257|Neisseria meningitidis|neisseria meningitidis
650328|NCT00777257|Tetanus|tetanus
650329|NCT00777257|Diphtheria|diphtheria
650330|NCT00777270|episiotomy|episiotomy
650331|NCT00777270|perineal lesion|perineal lesion
650332|NCT00777270|vaginal trauma|vaginal trauma
650333|NCT00777296|Cystic Fibrosis|cystic fibrosis
650334|NCT00777296|Respiratory Infections|respiratory infections
650335|NCT00777296|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
650336|NCT00777296|CFTR|cftr
650337|NCT00777309|NSCLC|nsclc
650338|NCT00777322|keratoconus|keratoconus
650339|NCT00777322|pellucid marginal degeneration|pellucid marginal degeneration
650340|NCT00777322|corneal ectasia|corneal ectasia
650341|NCT00777322|collagen cross-linking|collagen cross-linking
650342|NCT00777322|riboflavin|riboflavin
650343|NCT00777322|UV light|uv light
650344|NCT00777322|excimer laser|excimer laser
650345|NCT00777322|Topography-Computer Assisted Treatment (T-Cat)|topography-computer assisted treatment (t-cat)
650346|NCT00777322|Wavelight Allegretto laser|wavelight allegretto laser
650347|NCT00777361|Mass balance|mass balance
650348|NCT00777361|AZD3480, Pharmacokinetics, Healthy volunteers|azd3480, pharmacokinetics, healthy volunteers
650349|NCT00777387|human oocyte cryopreservation|human oocyte cryopreservation
650350|NCT00777387|slow-freeze|slow-freeze
650351|NCT00777387|vitrification|vitrification
650352|NCT00777400|Kidney transplant|kidney transplant
650353|NCT00777400|T regulatory cells|t regulatory cells
650354|NCT00777400|Efalizumab|efalizumab
650355|NCT00777400|Rejection|rejection
650356|NCT00777400|Safely convert renal transplant from mycophenolate mofetil and Calcineurin inhibitor to efalizumab and sirolimus|safely convert renal transplant from mycophenolate mofetil and calcineurin inhibitor to efalizumab and sirolimus
650357|NCT00777413|Bioequiavlence Minocycline Tablets|bioequiavlence minocycline tablets
650358|NCT00777426|HIV positive with HAD|hiv positive with had
650359|NCT00777439|Dopamine|dopamine
650360|NCT00777439|Domperidone|domperidone
650361|NCT00777439|Gastroparesis|gastroparesis
650362|NCT00777439|Gastrointestinal Diseases|gastrointestinal diseases
650363|NCT00777439|Neurologic Manifestations|neurologic manifestations
650364|NCT00777439|Stomach Diseases|stomach diseases
650365|NCT00777439|Digestive System Diseases|digestive system diseases
650366|NCT00777439|Esophagitis|esophagitis
650367|NCT00777439|Esophageal Disorders|esophageal disorders
650368|NCT00777439|Paralysis|paralysis
650369|NCT00777452|quality of life|quality of life
650370|NCT00777452|localized prostate cancer|localized prostate cancer
650372|NCT00777465|Acute kidney injury|acute kidney injury
650373|NCT00777465|Kidney failure|kidney failure
650374|NCT00777465|Risk factors|risk factors
650375|NCT00777465|Clinical outcomes|clinical outcomes
650376|NCT00777465|Cardiac valve surgery|cardiac valve surgery
650377|NCT00777465|Coronary artery bypass grafting|coronary artery bypass grafting
650378|NCT00777465|Morbidity|morbidity
650379|NCT00777465|Mortality|mortality
650380|NCT00777478|Sunitinib|sunitinib
650381|NCT00777478|Capecitabine|capecitabine
650382|NCT00777478|Irinotecan|irinotecan
650383|NCT00777478|colorectal cancer|colorectal cancer
650384|NCT00777491|stage II bladder cancer|stage ii bladder cancer
650385|NCT00777491|stage III bladder cancer|stage iii bladder cancer
650386|NCT00777491|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
650387|NCT00777504|angiogenesis|angiogenesis
650388|NCT00777504|inhibitor|inhibitor
650389|NCT00777504|duration of therapy|duration of therapy
650390|NCT00777504|GIST|gist
650391|NCT00777517|Cardiovascular Diseases|cardiovascular diseases
650392|NCT00777543|Bioavailability|bioavailability
650393|NCT00777543|Ferulic acid|ferulic acid
650394|NCT00777543|Phenolic compounds|phenolic compounds
650395|NCT00777543|Colonic metabolites|colonic metabolites
650396|NCT00777543|Immunomodulatory effects|immunomodulatory effects
650397|NCT00777543|No disease|no disease
650398|NCT00777569|Smoking|smoking
650399|NCT00777569|PREPS|preps
650400|NCT00777569|Harm reduction|harm reduction
650401|NCT00777569|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
650402|NCT00777569|Compensatory smoking|compensatory smoking
650403|NCT00777582|Poly (ADP ribose) polymerases|poly (adp ribose) polymerases
650404|NCT00777582|Homologous Recombination Deficiency (HRD)|homologous recombination deficiency (hrd)
650405|NCT00777582|Advanced solid tumours|advanced solid tumours
650406|NCT00777595|QTc|qtc
650407|NCT00777595|CHF 4226 HFA|chf 4226 hfa
650408|NCT00777595|pMDI|pmdi
650409|NCT00777595|Carmoterol|carmoterol
650410|NCT00777634|Binge Eating Disorder|binge eating disorder
650411|NCT00777634|Eating Disorder|eating disorder
650412|NCT00777673|Breast Cancer|breast cancer
650413|NCT00777673|Triple Negative|triple negative
650414|NCT00777673|Neoadjuvant|neoadjuvant
650415|NCT00777673|Neoadjuvant therapy|neoadjuvant therapy
650416|NCT00777673|ER, PR and HER2 Negative|er, pr and her2 negative
650417|NCT00777686|Intracranial Glioblastoma|intracranial glioblastoma
650418|NCT00777686|Intracranial Gliosarcoma|intracranial gliosarcoma
650419|NCT00777686|glioblastoma|glioblastoma
650420|NCT00777686|recurrent glioblastoma|recurrent glioblastoma
650421|NCT00777686|gliosarcoma|gliosarcoma
650422|NCT00777686|brain cancer|brain cancer
650700|NCT00780312|lymphoedema|lymphoedema
650423|NCT00777686|magnetic resonance spectroscopy|magnetic resonance spectroscopy
650424|NCT00777686|MRS|mrs
650425|NCT00777686|magnetic resonance imaging|magnetic resonance imaging
650426|NCT00777686|MRI|mri
650427|NCT00777686|MRI/MRS|mri/mrs
650428|NCT00777686|Recurrent Glioblastoma Treated with Antiangiogenic agents|recurrent glioblastoma treated with antiangiogenic agents
650429|NCT00777686|contrast enhanced MRI|contrast enhanced mri
650430|NCT00777686|DCE-MRI|dce-mri
650431|NCT00777686|diffusion-weighted MRI|diffusion-weighted mri
650432|NCT00777686|DSC|dsc
650433|NCT00777686|DW-MRI|dw-mri
650434|NCT00777699|Cancer|cancer
650435|NCT00777699|Solid Tumors|solid tumors
650436|NCT00777699|NSCLC|nsclc
650437|NCT00777712|Wound healing|wound healing
650438|NCT00777712|diabetes|diabetes
650439|NCT00777712|inflammatory cell|inflammatory cell
650440|NCT00777712|monocyte|monocyte
650441|NCT00777712|leukocyte|leukocyte
650442|NCT00777712|macrophage|macrophage
650443|NCT00777738|Advanced Waldenström's macroglobulinemia|advanced waldenström's macroglobulinemia
650444|NCT00777738|Bortezomib|bortezomib
650445|NCT00777738|Dexamethasone|dexamethasone
650446|NCT00777738|Safety|safety
650447|NCT00777738|Efficacy|efficacy
650448|NCT00777751|Chest Tumor|chest tumor
650449|NCT00777751|Heart|heart
650450|NCT00777751|Lung Cancer|lung cancer
650451|NCT00777751|Esophageal Cancer|esophageal cancer
650452|NCT00777751|Thymoma|thymoma
650453|NCT00777751|Radiation dose to the heart|radiation dose to the heart
650454|NCT00777751|Cardiac Enzymes|cardiac enzymes
650455|NCT00777751|Cardiac Biomarkers|cardiac biomarkers
650456|NCT00777751|Radiation Therapy|radiation therapy
650457|NCT00777751|RT|rt
650458|NCT00777751|Electrocardiograms|electrocardiograms
650459|NCT00777751|ECG|ecg
650460|NCT00777764|Xolair|xolair
650461|NCT00777764|Asthma|asthma
650462|NCT00777764|Skin Tests|skin tests
650463|NCT00777777|multi-vessel, therapy, surgery, CABG|multi-vessel, therapy, surgery, cabg
650464|NCT00777790|Meningitis|meningitis
650465|NCT00777790|Meningococcemia|meningococcemia
650466|NCT00777790|Neisseria meningitidis|neisseria meningitidis
650467|NCT00777816|Rheumatoid|rheumatoid
650468|NCT00777816|Arthritis|arthritis
650469|NCT00777829|Nap|nap
650470|NCT00777829|Pharmacology|pharmacology
650471|NCT00777829|Memory|memory
650472|NCT00777829|Visual Learning|visual learning
650473|NCT00777829|Verbal Memory|verbal memory
650474|NCT00777829|Motor Learning|motor learning
650475|NCT00777855|warfarin|warfarin
650476|NCT00777855|pharmacokinetics|pharmacokinetics
650477|NCT00777855|drug transporter|drug transporter
650478|NCT00777855|healthy volunteer|healthy volunteer
650479|NCT00777855|drug interaction|drug interaction
650480|NCT00777855|rifampin|rifampin
650481|NCT00777894|advanced adult primary liver cancer|advanced adult primary liver cancer
650482|NCT00777894|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
650483|NCT00777894|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
650484|NCT00777907|neurovascular embolization|neurovascular embolization
650485|NCT00777907|therapeutic embolization|therapeutic embolization
650486|NCT00777946|Aliskiren, Amlodipine, Non-responder to aliskiren|aliskiren, amlodipine, non-responder to aliskiren
650487|NCT00777972|Bioequivalence Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets fasting conditions|bioequivalence fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets fasting conditions
650488|NCT00777985|Cardiovascular system|cardiovascular system
650489|NCT00777985|Sleep|sleep
650490|NCT00777985|Endothelial function|endothelial function
650491|NCT00777985|Endothelin system|endothelin system
650492|NCT00777998|Multiple Myeloma|multiple myeloma
650493|NCT00777998|Stem Cell Transplantation|stem cell transplantation
650494|NCT00777998|Thalidomide|thalidomide
650496|NCT00778011|Nausea|nausea
650497|NCT00778011|Vomiting|vomiting
650498|NCT00778011|Ondansetron|ondansetron
650499|NCT00778011|Metoclopramide|metoclopramide
650500|NCT00778011|Randomized|randomized
650501|NCT00778011|Double-Blind|double-blind
650502|NCT00778011|nausea and vomiting in the emergency department|nausea and vomiting in the emergency department
650503|NCT00778024|Bioequivalence fluoxetine HCL 40 mg capsules fasting conditions|bioequivalence fluoxetine hcl 40 mg capsules fasting conditions
650504|NCT00778037|Bioequivalence Cyclobenzaprine hydrochloride 10 mg tablet fasting conditions|bioequivalence cyclobenzaprine hydrochloride 10 mg tablet fasting conditions
650505|NCT00778050|Bioequivalence, amoxicillin 600mg fasting conditions|bioequivalence, amoxicillin 600mg fasting conditions
650506|NCT00778063|dexmedetomidine|dexmedetomidine
650507|NCT00778063|pressure equalization tubes in the ear|pressure equalization tubes in the ear
650508|NCT00778063|myringotomy|myringotomy
650509|NCT00778063|sevoflurane|sevoflurane
650510|NCT00778076|Knee OA, Hyaluronic acid, Gait, Pain, Synovial fluid|knee oa, hyaluronic acid, gait, pain, synovial fluid
650511|NCT00778089|skin test|skin test
650512|NCT00778089|ArteFill|artefill
650513|NCT00778089|Skin test prior to administration of ArteFill® implant|skin test prior to administration of artefill® implant
650514|NCT00778115|Bioequivalence Loperamide HCl 2 mg and simethicone 125 mg tablets|bioequivalence loperamide hcl 2 mg and simethicone 125 mg tablets
650515|NCT00778128|CP-4126|cp-4126
650516|NCT00778128|Cancer|cancer
650517|NCT00778128|Metastatic|metastatic
650518|NCT00778128|Solid tumours|solid tumours
650519|NCT00778128|Gemzitabine|gemzitabine
650520|NCT00778128|Gemzar|gemzar
650521|NCT00778141|Bioequivalecne metformin HC1 750 mg extended-release tablets|bioequivalecne metformin hc1 750 mg extended-release tablets
650522|NCT00778180|Bioequivalence furosemide 80 mg tablets|bioequivalence furosemide 80 mg tablets
650523|NCT00778193|NSAID|nsaid
650524|NCT00778193|ulcer|ulcer
650525|NCT00778193|gastroduodenal ulcer|gastroduodenal ulcer
650526|NCT00778193|naproxen|naproxen
650527|NCT00778193|aspirin|aspirin
650528|NCT00778193|ASA|asa
650529|NCT00778193|celecoxib|celecoxib
650530|NCT00778193|clopidogrel|clopidogrel
650531|NCT00778193|healing|healing
650532|NCT00778193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors
650533|NCT00778193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
650534|NCT00778193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
650535|NCT00778193|Wound Healing|wound healing
650536|NCT00778206|Phenylketonuria|phenylketonuria
650537|NCT00778206|Hyperphenylalaninemia|hyperphenylalaninemia
650538|NCT00778206|PKU|pku
650539|NCT00778206|Phenylalanine|phenylalanine
650540|NCT00778219|heart rate variability, tracheal intubation|heart rate variability, tracheal intubation
650541|NCT00778232|Bioequivalence Gabapentin tablets 800 mg fed conditions|bioequivalence gabapentin tablets 800 mg fed conditions
650542|NCT00778245|Bioequivalence cefprozil 500mg tablets fed conditions|bioequivalence cefprozil 500mg tablets fed conditions
650543|NCT00778258|Food Allergy|food allergy
650544|NCT00778258|Milk Allergy|milk allergy
650545|NCT00778271|Bioequivalence gabapentin 400mg capsules fasting conditions|bioequivalence gabapentin 400mg capsules fasting conditions
650546|NCT00778284|Bioequivalence|bioequivalence
650547|NCT00778297|prevention|prevention
650548|NCT00778297|influenza|influenza
650549|NCT00778297|infection|infection
650550|NCT00778297|vaccine|vaccine
650551|NCT00778297|Influenza vaccine|influenza vaccine
650552|NCT00778297|Influenza in humans|influenza in humans
650553|NCT00778310|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
650554|NCT00778310|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
650555|NCT00778310|ADHD|adhd
650556|NCT00778323|remote ischemic preconditioning|remote ischemic preconditioning
650557|NCT00778323|cervical compression myelopathy|cervical compression myelopathy
650558|NCT00778323|spinal cord|spinal cord
650559|NCT00778323|neuron-specific enolase|neuron-specific enolase
650560|NCT00778323|s-100B|s-100b
650561|NCT00778336|Peripheral Thrombosis|peripheral thrombosis
650562|NCT00778336|DVT|dvt
650563|NCT00778336|Limb Ischemia|limb ischemia
650564|NCT00778336|AV Access|av access
650565|NCT00778336|AngioJet|angiojet
650566|NCT00778336|Thrombectomy|thrombectomy
650567|NCT00778349|Bioavailability Metformin solution 100 mg/mL|bioavailability metformin solution 100 mg/ml
650568|NCT00778362|OPSI|opsi
650569|NCT00778362|Splenectomy|splenectomy
650570|NCT00778375|Leukemia|leukemia
650571|NCT00778375|Acute Myeloid Leukemia|acute myeloid leukemia
650572|NCT00778375|Myelodysplastic Syndrome|myelodysplastic syndrome
650573|NCT00778375|AML|aml
650574|NCT00778375|MDS|mds
650575|NCT00778375|Clofarabine|clofarabine
650576|NCT00778375|Ara-C|ara-c
650577|NCT00778375|Cytarabine|cytarabine
650578|NCT00778375|Decitabine|decitabine
650579|NCT00778388|Pseudomonas Aeruginosa|pseudomonas aeruginosa
650580|NCT00778401|Bioequivalence Gabapentin tablets 800 mg fasting conditions|bioequivalence gabapentin tablets 800 mg fasting conditions
650581|NCT00778414|Bioequivalence Amoxicillin Clavulanic acid 600mg 42.9 mg per 5 mL oral suspension|bioequivalence amoxicillin clavulanic acid 600mg 42.9 mg per 5 ml oral suspension
650582|NCT00778427|Bioequivalence metformin hydrochloride 1000 mg tablets fasting conditions|bioequivalence metformin hydrochloride 1000 mg tablets fasting conditions
650583|NCT00778440|Injuries|injuries
650584|NCT00778440|Traffic Injuries|traffic injuries
650585|NCT00778440|Preventive medicine|preventive medicine
650677|NCT00778895|Influenza|influenza
650586|NCT00778440|Observational studies|observational studies
650587|NCT00778440|Primary care|primary care
650588|NCT00778453|stroke rehabilitation|stroke rehabilitation
650589|NCT00778453|kinematic analysis|kinematic analysis
650590|NCT00778453|upper extremity training|upper extremity training
650591|NCT00778453|predictors|predictors
650592|NCT00778466|Bioequivalence metformin hydrochloride 1000 mg tablets fed conditions|bioequivalence metformin hydrochloride 1000 mg tablets fed conditions
650593|NCT00778492|Thrombelastogram|thrombelastogram
650594|NCT00778492|Microvascular bleeding|microvascular bleeding
650595|NCT00778492|antiplatelet medication|antiplatelet medication
650596|NCT00778492|cardiac surgery|cardiac surgery
650597|NCT00778492|consumption of blood products|consumption of blood products
650598|NCT00778492|preoperative platelet mapping derived from modified TEG|preoperative platelet mapping derived from modified teg
650599|NCT00778492|postoperative bleeding|postoperative bleeding
650600|NCT00778505|Anesthesia|anesthesia
650601|NCT00778518|growth hormone|growth hormone
650602|NCT00778518|growth hormone deficiency|growth hormone deficiency
650603|NCT00778518|GHD|ghd
650604|NCT00778518|PEG|peg
650605|NCT00778518|pegylated|pegylated
650606|NCT00778518|IGF-1|igf-1
650607|NCT00778531|injectable implant|injectable implant
650608|NCT00778531|nasolabial folds|nasolabial folds
650802|NCT00780793|DMARDs|dmards
650609|NCT00778531|Correction of nasolabial folds|correction of nasolabial folds
650610|NCT00778544|Bioequivalence amoxicillin-clavulanic acid 600 mg 42.9 mg per 5 mL oral suspension|bioequivalence amoxicillin-clavulanic acid 600 mg 42.9 mg per 5 ml oral suspension
650611|NCT00778557|CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL, Bioequivalence fasting conditions|cefprozil for oral suspension usp 250 mg/ 5 ml, bioequivalence fasting conditions
650612|NCT00778583|Bioequivalence Nitrofurantoin capsules|bioequivalence nitrofurantoin capsules
650613|NCT00778596|Hepatitis B|hepatitis b
650614|NCT00778596|Telbivudine|telbivudine
650615|NCT00778596|Prednisolone|prednisolone
650616|NCT00778609|Combined Oral Contraceptives|combined oral contraceptives
650617|NCT00778609|Pelvic Pain|pelvic pain
650618|NCT00778609|Headache|headache
650619|NCT00772837|Functional Dyspepsia|functional dyspepsia
650620|NCT00772837|Helicobacter Pylori eradication|helicobacter pylori eradication
650621|NCT00772837|Quality of Life|quality of life
650622|NCT00772837|Dyspeptic Symptoms|dyspeptic symptoms
650623|NCT00772850|Humeral fracture; Antegrade nailing; Rotator cuff|humeral fracture; antegrade nailing; rotator cuff
650624|NCT00772876|P1446A-05|p1446a-05
650625|NCT00772876|Advanced refractory malignancies|advanced refractory malignancies
650626|NCT00772876|Phase I|phase i
650627|NCT00772889|Elderly|elderly
650628|NCT00772889|Vaccine|vaccine
650629|NCT00772889|Influenza|influenza
650630|NCT00772902|HIV-1|hiv-1
650631|NCT00772902|LDL|ldl
650632|NCT00772902|HDL|hdl
650633|NCT00772902|non-HDL cholesterol|non-hdl cholesterol
650634|NCT00772902|triglycerides|triglycerides
650635|NCT00772902|cholesterol|cholesterol
650636|NCT00772915|stage I multiple myeloma|stage i multiple myeloma
650637|NCT00772915|stage II multiple myeloma|stage ii multiple myeloma
650638|NCT00772915|stage III multiple myeloma|stage iii multiple myeloma
650639|NCT00772928|Pertussis|pertussis
650640|NCT00772928|Whooping cough|whooping cough
650641|NCT00772928|Diphtheria|diphtheria
650642|NCT00772928|Tetanus|tetanus
650643|NCT00772928|Haemophilus influenzae|haemophilus influenzae
650644|NCT00772928|Poliovirus Types 1, 2, and 3.|poliovirus types 1, 2, and 3.
650645|NCT00778648|Common cold|common cold
650646|NCT00778648|prevention|prevention
650647|NCT00778648|dietary supplement|dietary supplement
650648|NCT00778661|Bioequivalence|bioequivalence
650649|NCT00778674|Bioequivalence Benazepril HCl Hydrochlorothiazide Tablets|bioequivalence benazepril hcl hydrochlorothiazide tablets
650650|NCT00778713|Bioequivalence|bioequivalence
650651|NCT00778726|Bioequivalence benazepril and hydrochlorothiazide tablets|bioequivalence benazepril and hydrochlorothiazide tablets
650652|NCT00778739|bioequivalence 1) CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL fed conditions|bioequivalence 1) cefprozil for oral suspension usp 250 mg/ 5 ml fed conditions
650653|NCT00778752|Multiple Myeloma|multiple myeloma
650654|NCT00778752|Stem Cell Transplantation|stem cell transplantation
650655|NCT00778752|Revlimid|revlimid
650656|NCT00778752|Lenalidomide|lenalidomide
650657|NCT00778765|Bioequivalence gabapentin fed conditions|bioequivalence gabapentin fed conditions
650658|NCT00778778|Bioequivalence cefprozil 500mg tablets fasting conditions|bioequivalence cefprozil 500mg tablets fasting conditions
650659|NCT00778791|Bioequivalence metformin HC1 750 mg extended-release tablets|bioequivalence metformin hc1 750 mg extended-release tablets
650660|NCT00778804|CVD risk|cvd risk
650661|NCT00778804|self monitoring|self monitoring
650662|NCT00778804|Internet|internet
650663|NCT00778804|telemedicine|telemedicine
650664|NCT00778830|mCRC|mcrc
650665|NCT00778843|Chronic hepatitis C|chronic hepatitis c
650666|NCT00778843|Oxidative stress|oxidative stress
650667|NCT00778843|Antioxidant|antioxidant
650668|NCT00778843|Cytokines|cytokines
650669|NCT00778843|Nutritional supplement|nutritional supplement
650670|NCT00778882|Chronic Granulomatous Disease|chronic granulomatous disease
650671|NCT00778882|Retroviral Vector|retroviral vector
650672|NCT00778882|Gene Therapy|gene therapy
650674|NCT00778895|Safety|safety
650675|NCT00778895|Immunogenicity|immunogenicity
650678|NCT00778895|Virus|virus
650679|NCT00778908|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
650680|NCT00778908|Locally advanced disease|locally advanced disease
650681|NCT00778908|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
650682|NCT00778908|Accelerated hyperfractionation|accelerated hyperfractionation
650683|NCT00778908|Concomitant boost radiation therapy|concomitant boost radiation therapy
650684|NCT00778908|Concurrent chemotherapy|concurrent chemotherapy
650685|NCT00778921|Aliskiren|aliskiren
650686|NCT00778921|Amlodipine|amlodipine
650687|NCT00778921|Non-responder to Amlodipine|non-responder to amlodipine
650688|NCT00778947|Breast Reconstruction|breast reconstruction
650689|NCT00778947|Halmonic Scalpel|halmonic scalpel
650690|NCT00778947|diathermy|diathermy
650691|NCT00778947|Free Tissue Transfer|free tissue transfer
650692|NCT00780299|Plasma epuration|plasma epuration
650693|NCT00780299|Hemofiltration|hemofiltration
650694|NCT00780299|Cardiac arrest|cardiac arrest
650695|NCT00780299|Shock|shock
650696|NCT00780299|Inflammatory mediators|inflammatory mediators
650697|NCT00780312|radiotherapy|radiotherapy
650698|NCT00780312|trismus|trismus
650699|NCT00780312|physiotherapy|physiotherapy
650701|NCT00780312|late side effects|late side effects
650702|NCT00780312|fibrosis|fibrosis
650703|NCT00780312|decreased cervical range of motion|decreased cervical range of motion
650704|NCT00780312|quality of life|quality of life
650705|NCT00780325|Cyclooxygenase-2|cyclooxygenase-2
650706|NCT00780325|Carbonic anhydrase|carbonic anhydrase
650707|NCT00780325|Eicosanoids|eicosanoids
650708|NCT00780325|Healthy volunteers|healthy volunteers
650709|NCT00780351|vancomycin, SLEDD-f|vancomycin, sledd-f
650710|NCT00780364|stroke; sour taste; cold temperature; pharyngeal swallowing|stroke; sour taste; cold temperature; pharyngeal swallowing
650711|NCT00780377|Heart Transplant|heart transplant
650712|NCT00780377|Fibrinolysis|fibrinolysis
650713|NCT00780377|Resting conditions|resting conditions
650714|NCT00780390|RSD|rsd
650715|NCT00780390|SCS|scs
650716|NCT00780390|CRPS|crps
650845|NCT00781001|diabetic neuropathy|diabetic neuropathy
650717|NCT00780390|Complex regional pain syndrome patients before undergoing spinal cord stimulator implant and under other treatments|complex regional pain syndrome patients before undergoing spinal cord stimulator implant and under other treatments
650718|NCT00780416|Chronic Hepatitis C|chronic hepatitis c
650719|NCT00780416|Protease Inhibitor|protease inhibitor
650720|NCT00780416|Telaprevir|telaprevir
650721|NCT00780416|Peginterferon Alfa-2b|peginterferon alfa-2b
650722|NCT00780416|Ribavirin|ribavirin
650723|NCT00780429|kidney|kidney
650724|NCT00780429|transplant|transplant
650725|NCT00780429|Mycophenolic acid|mycophenolic acid
650726|NCT00780429|Inosine monophosphate dehydrogenase|inosine monophosphate dehydrogenase
650727|NCT00780442|substance related disorders|substance related disorders
650728|NCT00780455|KineSEP|kinesep
650729|NCT00780455|Rehabilitation|rehabilitation
650730|NCT00780455|Betaferon|betaferon
650731|NCT00780468|Weight loss|weight loss
650732|NCT00780468|Diet|diet
650733|NCT00780468|Obesity|obesity
650734|NCT00780481|Obesity|obesity
650735|NCT00780481|Endothelial Function|endothelial function
650736|NCT00780481|Fibrinolytic Balance|fibrinolytic balance
650737|NCT00780481|Baseline|baseline
650738|NCT00780520|glutamine inflammation HSP70 sepsis|glutamine inflammation hsp70 sepsis
650739|NCT00780546|tuberculosis|tuberculosis
650740|NCT00780546|spatial epidemiology|spatial epidemiology
650741|NCT00780546|geographic information system|geographic information system
650742|NCT00780559|Neuropathy|neuropathy
650743|NCT00780559|diabetes|diabetes
650744|NCT00780572|Safety Management|safety management
650745|NCT00780572|Risk Management|risk management
650746|NCT00780572|surveillance|surveillance
650747|NCT00780572|triggers|triggers
650748|NCT00780598|Acute Myeloid Leukemia|acute myeloid leukemia
650749|NCT00780598|AML|aml
650750|NCT00780598|Cancer|cancer
650751|NCT00780598|Hematological malignancies|hematological malignancies
650752|NCT00780598|Elderly|elderly
650753|NCT00780598|Refractory|refractory
650754|NCT00780598|Relapsed|relapsed
650755|NCT00780598|Blood disorder|blood disorder
650756|NCT00780624|RDS|rds
650757|NCT00780624|Infant, newborn|infant, newborn
650758|NCT00780624|NIPPV|nippv
650759|NCT00780624|CPAP|cpap
650760|NCT00780637|Heart Transplant|heart transplant
650761|NCT00780637|Endothelial Function|endothelial function
650762|NCT00780637|Fibrinolysis|fibrinolysis
650763|NCT00780637|Transplant recipients at baseline|transplant recipients at baseline
650764|NCT00780663|Neuroendocrine|neuroendocrine
650765|NCT00780663|Carcinoid|carcinoid
650766|NCT00780663|NET|net
650767|NCT00780663|MEN-1|men-1
650768|NCT00780663|Islet cell|islet cell
650769|NCT00780676|Dasatinib|dasatinib
650770|NCT00780676|Metastatic Breast Cancer|metastatic breast cancer
650771|NCT00780676|Sprycel|sprycel
650772|NCT00780676|BMS-354825|bms-354825
650773|NCT00780676|Genetic testing|genetic testing
650774|NCT00780676|AZD6244|azd6244
650775|NCT00780676|Selumetinib|selumetinib
650776|NCT00780702|Cocaine|cocaine
650777|NCT00780702|Treatment|treatment
650778|NCT00780702|Airpiprazole|airpiprazole
650779|NCT00780702|Methadone|methadone
650780|NCT00780702|Relapse|relapse
650781|NCT00780702|HIV|hiv
650782|NCT00780702|Ecological Momentary Assessment (EMA)|ecological momentary assessment (ema)
650783|NCT00780702|Contingency Management|contingency management
650784|NCT00780715|Diabetes therapies|diabetes therapies
650785|NCT00780715|Pharmacogenetics|pharmacogenetics
650786|NCT00780741|Nasolacrimal duct obstruction|nasolacrimal duct obstruction
650787|NCT00780741|Simple probing|simple probing
650788|NCT00780754|prostate cancer|prostate cancer
650789|NCT00780754|chemoprevention|chemoprevention
650790|NCT00780754|dutasteride|dutasteride
650791|NCT00780767|angiojet|angiojet
650792|NCT00780767|massive pulmonary embolism|massive pulmonary embolism
650793|NCT00780767|RHEOLYTIC THROMBECTOMY|rheolytic thrombectomy
650794|NCT00780767|patients presenting with massive pulmonary embolism|patients presenting with massive pulmonary embolism
650795|NCT00780780|triamcinolone|triamcinolone
650796|NCT00780780|nepafenac|nepafenac
650797|NCT00780780|DME|dme
650798|NCT00780780|edema macular|edema macular
650799|NCT00780793|Rheumatoid arthritis|rheumatoid arthritis
650800|NCT00780793|Remission|remission
650801|NCT00780793|Therapeutic strategy|therapeutic strategy
650803|NCT00780793|Biological agents|biological agents
650805|NCT00780806|rLP2086|rlp2086
650806|NCT00780806|blood collection|blood collection
650807|NCT00780806|vaccination|vaccination
650808|NCT00780832|overactive bladder|overactive bladder
650809|NCT00780832|dietary caffeine|dietary caffeine
650810|NCT00780832|anticholinergic medication|anticholinergic medication
650811|NCT00780832|lifestyle modification|lifestyle modification
650812|NCT00780832|incontinence|incontinence
650813|NCT00780832|urinary frequency|urinary frequency
650814|NCT00780845|Acute Kidney failure|acute kidney failure
650815|NCT00780845|Clinical outcomes|clinical outcomes
650816|NCT00780845|On-pump|on-pump
650817|NCT00780845|Coronary artery bypass grafting|coronary artery bypass grafting
650818|NCT00780845|Morbidity|morbidity
650819|NCT00780845|Mortality|mortality
650820|NCT00780858|GnRH antagonist|gnrh antagonist
650821|NCT00780858|IUI|iui
650822|NCT00780884|acupuncture|acupuncture
650823|NCT00780884|schizophrenia|schizophrenia
650824|NCT00780884|insomnia|insomnia
650825|NCT00780897|PREMATURE OVARIAN FAILURE (POF)|premature ovarian failure (pof)
650826|NCT00780897|GENETIC ANALYSIS|genetic analysis
650827|NCT00780897|PHYSIOPATHOLOGIC ANALYSIS|physiopathologic analysis
650828|NCT00780949|Crohn's Disease, inflammatory bowel disease, Peyer's patches|crohn's disease, inflammatory bowel disease, peyer's patches
650829|NCT00780962|NAC|nac
650830|NCT00780962|Radiocontrast Nephropathy|radiocontrast nephropathy
650831|NCT00780962|N-Acetycysteine|n-acetycysteine
650832|NCT00780962|RCN|rcn
650833|NCT00780962|RCIN|rcin
650834|NCT00780962|Creatinine|creatinine
650835|NCT00780962|Computerized Tomography|computerized tomography
650836|NCT00780962|CT|ct
650837|NCT00780962|Emergency Department|emergency department
650838|NCT00780962|ED|ed
650839|NCT00780962|Safety of IV N-Acetylcysteine|safety of iv n-acetylcysteine
650840|NCT00780975|Aplidin|aplidin
650841|NCT00780975|Plitidepsin|plitidepsin
650842|NCT00780975|Prostate|prostate
650843|NCT00780975|Cancer|cancer
650844|NCT00781001|neuropathic pain|neuropathic pain
650846|NCT00781001|cannabis|cannabis
650847|NCT00781001|marijuana|marijuana
650848|NCT00781040|Severe sepsis in neutropenic haematological patients|severe sepsis in neutropenic haematological patients
650849|NCT00781053|skin fibrosis|skin fibrosis
650850|NCT00781053|systemic scleroderma|systemic scleroderma
650851|NCT00781053|systemic sclerosis|systemic sclerosis
650852|NCT00781053|p144|p144
650853|NCT00781053|orphan drug|orphan drug
650854|NCT00781066|POSTPARTUM HEMORRHAGE|postpartum hemorrhage
650855|NCT00781066|PREVENTION|prevention
650856|NCT00781066|CORD TRACTION|cord traction
650857|NCT00781066|THIRD STAGE LABOR|third stage labor
650858|NCT00781079|Organization Innovation|organization innovation
650859|NCT00781079|Opinion Leaders|opinion leaders
650860|NCT00781079|Schizophrenia|schizophrenia
650861|NCT00781092|Dry Eyes|dry eyes
650862|NCT00781092|LASIK|lasik
650863|NCT00781092|Laser Vision Correction|laser vision correction
650864|NCT00781105|Chronic hepatitis B|chronic hepatitis b
650865|NCT00781105|Adult|adult
650866|NCT00781105|HBV DNA suppression|hbv dna suppression
650867|NCT00781105|Telbivudine|telbivudine
650868|NCT00781118|Acute Myocardial Infarction (MI)|acute myocardial infarction (mi)
650869|NCT00781118|ST Shift|st shift
650870|NCT00781118|Coronary Occlusion|coronary occlusion
650871|NCT00781118|Acute Coronary Syndrome|acute coronary syndrome
650872|NCT00781157|Spinal induced hypotension in cesarean delivery|spinal induced hypotension in cesarean delivery
650873|NCT00781170|Multiple Myeloma|multiple myeloma
650874|NCT00781170|Plasmocytoma|plasmocytoma
650875|NCT00781170|Stem Cell Transplantation|stem cell transplantation
650876|NCT00781183|COPD|copd
650877|NCT00781183|rehabilitation|rehabilitation
650878|NCT00781183|walking|walking
650879|NCT00781196|phenytoin|phenytoin
650880|NCT00781196|gum hyperplasia|gum hyperplasia
650881|NCT00781196|phenytoin induced gingival overgrowth|phenytoin induced gingival overgrowth
650882|NCT00781196|plaque index|plaque index
650883|NCT00781196|gingival overgrowth grade|gingival overgrowth grade
650884|NCT00781209|irradiation|irradiation
650885|NCT00781209|stereotactic radiosurgery|stereotactic radiosurgery
650886|NCT00781209|posterior fossa|posterior fossa
650887|NCT00781209|cerebellar metastases|cerebellar metastases
650888|NCT00781248|enteral feeding|enteral feeding
650889|NCT00781248|Subject who requires nasogastric tube|subject who requires nasogastric tube
650891|NCT00781261|collapse femoral head|collapse femoral head
650892|NCT00781261|bisphosphonates|bisphosphonates
650893|NCT00781261|osteonecrosis|osteonecrosis
650894|NCT00781287|human immunodeficiency virus|human immunodeficiency virus
650895|NCT00781287|raltegravir|raltegravir
650896|NCT00781287|primary HIV infection|primary hiv infection
650897|NCT00781287|HIV-1|hiv-1
650898|NCT00781300|Intraocular pressure|intraocular pressure
650899|NCT00781300|Pterygium|pterygium
650900|NCT00781300|Surgery|surgery
650901|NCT00781300|Steroids|steroids
650902|NCT00781300|Glaucoma|glaucoma
650903|NCT00781326|Depressive Disorder, Major|depressive disorder, major
650904|NCT00781326|Cerebrovascular Disorders|cerebrovascular disorders
650905|NCT00781326|Risk Factors|risk factors
650906|NCT00781326|Nimodipine|nimodipine
650907|NCT00781339|Bacteriuria|bacteriuria
650908|NCT00781339|Catheterized|catheterized
650909|NCT00781339|Chronically Catheterized|chronically catheterized
650910|NCT00781352|nitrous oxide|nitrous oxide
650911|NCT00781352|cancer recurrence|cancer recurrence
650912|NCT00781352|colorectal surgery|colorectal surgery
650913|NCT00781365|Hypertension|hypertension
650914|NCT00781365|Telemonitoring|telemonitoring
650915|NCT00781365|Pharmacy management|pharmacy management
650916|NCT00781378|Thrombolytic therapy|thrombolytic therapy
650917|NCT00781378|Recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
650918|NCT00781378|Efficacy|efficacy
650919|NCT00781378|Safety|safety
650920|NCT00781391|Systemic embolic events|systemic embolic events
650921|NCT00781404|adenosine|adenosine
650922|NCT00781404|angioplasty|angioplasty
650923|NCT00781404|acute myocardial infarction|acute myocardial infarction
650924|NCT00781404|acute coronary syndrome with ST segment elevation|acute coronary syndrome with st segment elevation
650925|NCT00781404|infarct size|infarct size
650926|NCT00781404|rescued myocardium|rescued myocardium
650927|NCT00781417|vitamin D|vitamin d
650928|NCT00781417|Chronic Kidney Disease|chronic kidney disease
650929|NCT00781417|parathyroid hormone|parathyroid hormone
650930|NCT00781417|Chronic kidney disease Stage II and III|chronic kidney disease stage ii and iii
650931|NCT00781443|Asthma|asthma
650932|NCT00781456|Migraine headache|migraine headache
650933|NCT00781456|menstrual|menstrual
650934|NCT00781456|oral contraceptive|oral contraceptive
650935|NCT00781456|Menstrually-Related Migraine Headache|menstrually-related migraine headache
650936|NCT00781469|Rheumatoid arthritis|rheumatoid arthritis
650937|NCT00781469|RNA|rna
650938|NCT00781469|Synovium|synovium
650939|NCT00781469|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
650940|NCT00781482|Positron Emission Tomography|positron emission tomography
650941|NCT00781482|GABA receptor binding|gaba receptor binding
650942|NCT00781482|Hypnotic Drugs|hypnotic drugs
650943|NCT00781482|Eszopiclone|eszopiclone
650944|NCT00781482|Zolpidem|zolpidem
650945|NCT00781482|[11-C] Flumazenil|[11-c] flumazenil
650946|NCT00781482|Molecular imaging of the brain|molecular imaging of the brain
650947|NCT00781495|insulin|insulin
650948|NCT00781508|heart failure, left sided|heart failure, left sided
650949|NCT00781508|ventricular dysfunction|ventricular dysfunction
650950|NCT00781508|diastolic dysfunction|diastolic dysfunction
650951|NCT00781508|sildenafil|sildenafil
650952|NCT00781534|Health Supplements|health supplements
650953|NCT00781534|Ginseng|ginseng
650954|NCT00781534|Diabetes|diabetes
650955|NCT00781547|growth hormone|growth hormone
650956|NCT00781547|obesity|obesity
650957|NCT00781547|abdominal obesity|abdominal obesity
650958|NCT00781560|Hyperlipidemia|hyperlipidemia
650959|NCT00781560|Chinese National Adult Lipid Treatment Guideline (2007)|chinese national adult lipid treatment guideline (2007)
650960|NCT00781560|Crestor®|crestor®
650961|NCT00781573|Drug Eluting Stent|drug eluting stent
650962|NCT00781573|Clopidogrel|clopidogrel
650963|NCT00781573|Optimal duration of clopidogrel post DES stent implantation|optimal duration of clopidogrel post des stent implantation
650964|NCT00781586|Energy expenditure|energy expenditure
650965|NCT00781586|Nutritional|nutritional
650966|NCT00781586|Weight control|weight control
650967|NCT00781599|African american|african american
650968|NCT00781599|smokers|smokers
650969|NCT00781599|smoking cessation|smoking cessation
650970|NCT00781599|African American smokers|african american smokers
650971|NCT00781625|probiotics|probiotics
650973|NCT00781625|inflammation|inflammation
650974|NCT00781625|nutritional factors|nutritional factors
650975|NCT00781625|prophylactic aid|prophylactic aid
650976|NCT00781625|Lactobacillus rhamnosus GR-1|lactobacillus rhamnosus gr-1
650977|NCT00781625|Lactobacillus reuteri RC-14|lactobacillus reuteri rc-14
650978|NCT00781625|Recurrent lower UTI in women|recurrent lower uti in women
651077|NCT00782067|C-Findings|c-findings
650979|NCT00781638|Pediatric UC, Adacolumn apheresis|pediatric uc, adacolumn apheresis
650980|NCT00781677|Major Depressive Disorder|major depressive disorder
650981|NCT00781677|Depression|depression
650982|NCT00781677|Anxiety|anxiety
650983|NCT00781690|Chronic kidney failure|chronic kidney failure
650984|NCT00781690|Heparin|heparin
650985|NCT00781690|Hemodialysis|hemodialysis
650986|NCT00781690|Biocompatibility|biocompatibility
650987|NCT00781716|ST elevation myocardial infarction|st elevation myocardial infarction
650988|NCT00781716|Drug eluting stents|drug eluting stents
650989|NCT00781729|Kyphosis|kyphosis
650990|NCT00781729|Yoga|yoga
650991|NCT00781729|Aging|aging
650992|NCT00781729|Physical performance|physical performance
650993|NCT00781729|Quality of Life|quality of life
650994|NCT00781742|Depression|depression
650995|NCT00781742|Depressive Disorder|depressive disorder
650996|NCT00781742|MDD|mdd
650997|NCT00781755|smoking cessation|smoking cessation
650998|NCT00781755|varenicline|varenicline
650999|NCT00781755|schizophrenia|schizophrenia
651000|NCT00781755|serious mental illness|serious mental illness
651001|NCT00781755|Nicotine addiction|nicotine addiction
651002|NCT00781755|Smoking Behavior|smoking behavior
651003|NCT00781768|Bone Marrow Transplant|bone marrow transplant
651004|NCT00781768|Nausea|nausea
651005|NCT00781768|Vomiting|vomiting
651006|NCT00781768|NK-1 antagonist|nk-1 antagonist
651007|NCT00781768|Nausea and vommitting in the stem cell/marrow transplant population.|nausea and vommitting in the stem cell/marrow transplant population.
651008|NCT00781781|Myeloid and Lymphoid malignances|myeloid and lymphoid malignances
651009|NCT00781807|Heart-Assist-Devices|heart-assist-devices
651010|NCT00781807|Rehabilitation|rehabilitation
651011|NCT00781807|Outcome Assessment (Health Care)|outcome assessment (health care)
651012|NCT00781807|Exercise Capacity|exercise capacity
651013|NCT00781807|Ergometry|ergometry
651014|NCT00781807|Social Support|social support
651015|NCT00781807|Quality of Life|quality of life
651016|NCT00781807|Nutrition Assessment|nutrition assessment
651017|NCT00781807|Nutrition Therapy|nutrition therapy
651018|NCT00781807|Neuropsychological Tests|neuropsychological tests
651019|NCT00781820|Bifonazole|bifonazole
651020|NCT00781820|Placebo|placebo
651021|NCT00781820|Urea|urea
651022|NCT00781820|Nail fungus|nail fungus
651023|NCT00781833|Therapeutic Electric Stimulation|therapeutic electric stimulation
651024|NCT00781833|Functional Electric Stimulation|functional electric stimulation
651025|NCT00781833|Implantable Stimulator|implantable stimulator
651026|NCT00781833|Muscle Strength|muscle strength
651027|NCT00781833|Muscle Spasticity|muscle spasticity
651028|NCT00781872|multiple sclerosis (MS)|multiple sclerosis (ms)
651029|NCT00781872|bone marrow stromal cells|bone marrow stromal cells
651030|NCT00781872|stem cells|stem cells
651031|NCT00781898|Depot naltrexone|depot naltrexone
651032|NCT00781898|Parolees|parolees
651033|NCT00781898|Opioid addiction prevention|opioid addiction prevention
651034|NCT00781898|Medication Treatment Alternatives|medication treatment alternatives
651035|NCT00781898|Prevention of Relapse to Opioid Addiction|prevention of relapse to opioid addiction
651036|NCT00781911|Islet Cell|islet cell
651037|NCT00781911|CARCINOMA, ISLET CELL|carcinoma, islet cell
651038|NCT00781911|Octreotide|octreotide
651039|NCT00781911|depot octreotide acetate|depot octreotide acetate
651040|NCT00781911|Insulin-Like Growth Factor (IGF) 1|insulin-like growth factor (igf) 1
651041|NCT00781911|Metastatic, Carcinoid or Islet Cell|metastatic, carcinoid or islet cell
651042|NCT00781911|Neuroendocrine Tumors|neuroendocrine tumors
651044|NCT00781950|Peripheral Arterial Disease|peripheral arterial disease
651045|NCT00781950|Diabetes|diabetes
651046|NCT00781950|Atherosclerosis|atherosclerosis
651047|NCT00781950|Flax|flax
651048|NCT00781950|Flaxseeds|flaxseeds
651049|NCT00781950|Functional Foods|functional foods
651050|NCT00781950|Essential Fatty Acids|essential fatty acids
651051|NCT00781950|Winnipeg|winnipeg
651052|NCT00781963|cognitive behavior therapy|cognitive behavior therapy
651053|NCT00781963|insomnia|insomnia
651054|NCT00781989|early rheumatoid arthritis|early rheumatoid arthritis
651055|NCT00781989|biomarkers|biomarkers
651056|NCT00781989|ultrasound|ultrasound
651057|NCT00782002|Solid Tumors|solid tumors
651058|NCT00782002|VEGF-A|vegf-a
651059|NCT00782002|stromal cells|stromal cells
651060|NCT00782002|endothelial cells|endothelial cells
651061|NCT00782002|malignant cells|malignant cells
651062|NCT00782015|almonds|almonds
651063|NCT00782015|heart disease|heart disease
651064|NCT00782015|vascular reactivity|vascular reactivity
651065|NCT00782015|inflammation|inflammation
651066|NCT00782015|dyslipidemia|dyslipidemia
651067|NCT00782015|oxidative stress|oxidative stress
651068|NCT00782028|primary care, high-risk families, maternal depression|primary care, high-risk families, maternal depression
651069|NCT00782054|pruritus|pruritus
651070|NCT00782054|itch|itch
651071|NCT00782054|burn|burn
651072|NCT00782054|endopeptidase|endopeptidase
651073|NCT00782054|moisturizer|moisturizer
651074|NCT00782054|randomized controlled|randomized controlled
651075|NCT00782067|Aggressive systemic mastocytosis|aggressive systemic mastocytosis
651076|NCT00782067|mast cell leukemia|mast cell leukemia
651078|NCT00782067|tyrosine kinase inhibitor|tyrosine kinase inhibitor
651079|NCT00782067|KIT mutation|kit mutation
651080|NCT00782067|AHNMD|ahnmd
651081|NCT00782067|Systemic|systemic
651082|NCT00782067|Aggressive|aggressive
651083|NCT00782080|ADHD|adhd
651084|NCT00782080|children|children
651085|NCT00782080|adolescents|adolescents
651086|NCT00782080|St. John`s Wort|st. john`s wort
651087|NCT00782080|Valerian extract|valerian extract
651088|NCT00782080|Safety|safety
651089|NCT00782080|Efficacy|efficacy
651090|NCT00782093|AMD|amd
651091|NCT00782132|Infertility Services, HIV, pregnancy planning|infertility services, hiv, pregnancy planning
651092|NCT00782145|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
651093|NCT00782145|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
651094|NCT00782145|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
651095|NCT00782145|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
651096|NCT00782145|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
651423|NCT00783003|ß2 agonist|ß2 agonist
651097|NCT00782145|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
651098|NCT00782145|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
651099|NCT00782145|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
651100|NCT00782145|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
651101|NCT00782145|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
651102|NCT00782145|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
651103|NCT00782145|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
651104|NCT00782145|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
651105|NCT00782145|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
651106|NCT00782145|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
651107|NCT00782145|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
651108|NCT00782145|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
651109|NCT00782145|secondary acute myeloid leukemia|secondary acute myeloid leukemia
651110|NCT00782145|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
651111|NCT00782145|primary myelofibrosis|primary myelofibrosis
651112|NCT00782145|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
651113|NCT00782145|disseminated neuroblastoma|disseminated neuroblastoma
651114|NCT00782145|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
651115|NCT00782145|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
651116|NCT00782145|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
651117|NCT00782145|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
651118|NCT00782145|recurrent neuroblastoma|recurrent neuroblastoma
651119|NCT00782145|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
651120|NCT00782145|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
651121|NCT00782158|HIV|hiv
651122|NCT00782158|Hepatitis B|hepatitis b
651123|NCT00782158|Coinfection|coinfection
651124|NCT00782158|Liver Fibrosis|liver fibrosis
651125|NCT00782158|Transient Elastography|transient elastography
651126|NCT00782171|Dental implants|dental implants
651127|NCT00782197|osteoarthritis|osteoarthritis
651128|NCT00782197|knee|knee
651129|NCT00782197|PRGF|prgf
651130|NCT00782197|autologous plasma|autologous plasma
651131|NCT00782197|plasma preparations|plasma preparations
651132|NCT00782197|treatment|treatment
651133|NCT00782223|hips, spine, lower limb, digital radiograph measurements, TraumaCad, digital software|hips, spine, lower limb, digital radiograph measurements, traumacad, digital software
651134|NCT00782223|Measurements of orthopaedic parameters on digital X-rays using particular software|measurements of orthopaedic parameters on digital x-rays using particular software
651135|NCT00782275|RCC|rcc
651136|NCT00782275|avastin|avastin
651137|NCT00782275|temsirolimus|temsirolimus
651138|NCT00782288|digitoxin|digitoxin
651139|NCT00782288|inflammatory markers|inflammatory markers
651140|NCT00782288|cytokines|cytokines
651141|NCT00782288|gene expression|gene expression
651142|NCT00782301|HIV and Hepatitis co-infection|hiv and hepatitis co-infection
651143|NCT00782314|asthma|asthma
651144|NCT00782314|SMART|smart
651145|NCT00782314|Symbicort Turbuhaler|symbicort turbuhaler
651146|NCT00782314|asthma control|asthma control
651147|NCT00782340|NOH|noh
651148|NCT00782340|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
651149|NCT00782340|Orthostatic hypotension|orthostatic hypotension
651150|NCT00782340|PAF|paf
651151|NCT00782340|Pure Autonomic Failure|pure autonomic failure
651152|NCT00782340|MSA|msa
651597|NCT00784225|cataract|cataract
651153|NCT00782340|Multiple System Atrophy|multiple system atrophy
651154|NCT00782340|Neuropathy|neuropathy
651155|NCT00782340|Autonomic Failure|autonomic failure
651156|NCT00782340|Parkinson|parkinson
651157|NCT00782340|Dopamine Deficiency|dopamine deficiency
651158|NCT00782340|Dopamine|dopamine
651159|NCT00782340|Droxidopa|droxidopa
651160|NCT00782353|HCV|hcv
651161|NCT00782366|predictive genomics|predictive genomics
651162|NCT00782366|personalized medicine|personalized medicine
651163|NCT00782366|personal genomics|personal genomics
651164|NCT00782366|direct-to-consumer genetic testing|direct-to-consumer genetic testing
651165|NCT00782366|genetic knowledge|genetic knowledge
651166|NCT00782366|genetic attitudes|genetic attitudes
651167|NCT00782379|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
651168|NCT00782379|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
651169|NCT00782379|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
651170|NCT00782379|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
651171|NCT00782379|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
651172|NCT00782379|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
752381|NCT01172743|Diabetes Mellitus|diabetes mellitus
651173|NCT00782379|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
651174|NCT00782379|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
651175|NCT00782379|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
651176|NCT00782379|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
651177|NCT00782379|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
651178|NCT00782379|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
651179|NCT00782379|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
651180|NCT00782379|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
651181|NCT00782379|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
651182|NCT00782379|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
651183|NCT00782379|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
651184|NCT00782379|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
651185|NCT00782379|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
651186|NCT00782379|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
651187|NCT00782379|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
651188|NCT00782379|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
651189|NCT00782379|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
651190|NCT00782379|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
651191|NCT00782379|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
651192|NCT00782379|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
651193|NCT00782379|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
651194|NCT00782379|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
651195|NCT00782379|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
651196|NCT00782379|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
651197|NCT00782379|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
651198|NCT00782379|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
651199|NCT00782379|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
651200|NCT00782379|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
651201|NCT00782379|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
651202|NCT00782379|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
651203|NCT00782379|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
651204|NCT00782379|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
651205|NCT00782379|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
651206|NCT00782379|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
651207|NCT00782379|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
651208|NCT00782379|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
651209|NCT00782379|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
651210|NCT00782379|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
651211|NCT00782379|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
651212|NCT00782379|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
651213|NCT00782379|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
651214|NCT00782379|secondary acute myeloid leukemia|secondary acute myeloid leukemia
651215|NCT00782379|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
651216|NCT00782379|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
651217|NCT00782379|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
651218|NCT00782379|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
651219|NCT00782379|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
651220|NCT00782379|prolymphocytic leukemia|prolymphocytic leukemia
651221|NCT00782392|Nutrition|nutrition
651222|NCT00782392|Infant Formula|infant formula
651223|NCT00782405|antidepressant action|antidepressant action
651224|NCT00782405|clinical psychopharmacology|clinical psychopharmacology
651225|NCT00782483|Diagnosis|diagnosis
651226|NCT00782483|Port Wine Stain|port wine stain
651227|NCT00782483|PWS|pws
651228|NCT00782548|KADIAN|kadian
651229|NCT00782548|morphine|morphine
651230|NCT00782548|Avinza|avinza
651231|NCT00782548|30 mg|30 mg
651232|NCT00782548|bioequivalence|bioequivalence
651233|NCT00782548|fed|fed
651234|NCT00782561|steroid resistant focal segmental glomerulosclerosis|steroid resistant focal segmental glomerulosclerosis
651235|NCT00782561|FSGS|fsgs
651236|NCT00782561|adolescent focal segmental glomerulosclerosis|adolescent focal segmental glomerulosclerosis
651237|NCT00782561|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
651238|NCT00782574|Advanced solid tumours|advanced solid tumours
651239|NCT00782574|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
651240|NCT00782574|homologous deficiency|homologous deficiency
651241|NCT00782574|BRCA1|brca1
651242|NCT00782587|Non-Muscle-Invasive Bladder Cancer|non-muscle-invasive bladder cancer
651243|NCT00782587|Superficial Bladder Cancer|superficial bladder cancer
651244|NCT00782587|recombinant human hyaluronidase|recombinant human hyaluronidase
651245|NCT00782587|rHuPH20|rhuph20
651246|NCT00782587|Chemophase®|chemophase®
651247|NCT00782587|Mitomycin|mitomycin
651629|NCT00784368|Mycoses|mycoses
651248|NCT00782600|Pharmacokinetics Immediate Release Oral Suspension Controlled Release Formulation|pharmacokinetics immediate release oral suspension controlled release formulation
651249|NCT00782613|Psoriasis|psoriasis
651250|NCT00782613|The primary objective of this study will be to evaluate the|the primary objective of this study will be to evaluate the
651251|NCT00782613|efficacy of topical ALT-2074 applied twice daily for 28|efficacy of topical alt-2074 applied twice daily for 28
651252|NCT00782613|days for treatment of chronic plaque psoriasis in adult|days for treatment of chronic plaque psoriasis in adult
651253|NCT00782613|subjects.|subjects.
651254|NCT00782613|The secondary objective will be to evaluate the safety|the secondary objective will be to evaluate the safety
651255|NCT00782613|of topical ALT-2074 applied twice daily for 28 days for|of topical alt-2074 applied twice daily for 28 days for
651256|NCT00782613|treatment of chronic plaque psoriasis in adult subjects.|treatment of chronic plaque psoriasis in adult subjects.
651257|NCT00782613|Tertiary objectives will be to provide visual documentation|tertiary objectives will be to provide visual documentation
651258|NCT00782613|of the improvement of psoriatic plaques treated with|of the improvement of psoriatic plaques treated with
651259|NCT00782613|ALT-2074 using digital photography, and to determine the|alt-2074 using digital photography, and to determine the
651260|NCT00782613|extent of systemic absorption of topically applied ALT-2074|extent of systemic absorption of topically applied alt-2074
651261|NCT00782613|based on a pharmacokinetic measurement of blood|based on a pharmacokinetic measurement of blood
651262|NCT00782613|concentration.|concentration.
651263|NCT00782626|RAD001|rad001
651264|NCT00782652|myocaridal infarction|myocaridal infarction
651265|NCT00782652|right ventricular infarction|right ventricular infarction
651266|NCT00782652|cardiogenic shock|cardiogenic shock
651267|NCT00782652|RVAD|rvad
651268|NCT00782652|Right ventricular assist device|right ventricular assist device
651269|NCT00782652|cardiac disease|cardiac disease
651270|NCT00782652|right ventricle|right ventricle
651271|NCT00782652|cardiac shock|cardiac shock
651272|NCT00782652|heart dysfunction|heart dysfunction
651273|NCT00782665|postoperative|postoperative
651274|NCT00782665|infection|infection
651275|NCT00782665|c-section|c-section
651276|NCT00782691|FDG-PET segmentation tools|fdg-pet segmentation tools
651277|NCT00782691|Head-and-neck cancer|head-and-neck cancer
651278|NCT00782691|Histological validation|histological validation
651279|NCT00782704|A self-administered questionnaire to collect data from patients, physicians and nurses about the severity of postoperative surgical complications.|a self-administered questionnaire to collect data from patients, physicians and nurses about the severity of postoperative surgical complications.
651280|NCT00782704|Based on this questionnaire we will develop the morbidity index|based on this questionnaire we will develop the morbidity index
651281|NCT00782717|diabetic retinopathy|diabetic retinopathy
651282|NCT00782717|cystoid macular edema;|cystoid macular edema;
651283|NCT00782730|bladder volume measurement|bladder volume measurement
651284|NCT00782730|pregnancy|pregnancy
651285|NCT00782730|bladder function|bladder function
651286|NCT00782730|Postvoid residual volume assessment|postvoid residual volume assessment
651287|NCT00782730|Bladder volumes|bladder volumes
651288|NCT00782743|phenprocoumon|phenprocoumon
651289|NCT00782743|anticoagulation|anticoagulation
651290|NCT00782743|acetylic salicylic acid|acetylic salicylic acid
651291|NCT00782743|Need for new anticoagulation treatment|need for new anticoagulation treatment
651292|NCT00782756|Radiation|radiation
651293|NCT00782756|BEVACIZUMAB|bevacizumab
651294|NCT00782756|AVASTIN|avastin
651295|NCT00782756|TEMOZOLOMIDE|temozolomide
651296|NCT00782756|newly diagnosed|newly diagnosed
651297|NCT00782756|Glioblastoma|glioblastoma
651298|NCT00782756|GBM|gbm
651299|NCT00782756|malignant glioma|malignant glioma
651300|NCT00782756|Radiotherapy|radiotherapy
651301|NCT00782756|08-126|08-126
651302|NCT00782795|Chronic pancreatitis|chronic pancreatitis
651303|NCT00782795|Insulin resistance|insulin resistance
651304|NCT00782808|HIV DNA in Monocytes|hiv dna in monocytes
651305|NCT00775788|Fat Injection to Breast|fat injection to breast
651306|NCT00775788|Fat Grafting to Breast|fat grafting to breast
651307|NCT00775814|Hypertension|hypertension
651308|NCT00775814|Drug Therapy|drug therapy
651309|NCT00775814|Blood Pressure|blood pressure
651310|NCT00775814|Insulin, Resistant|insulin, resistant
651311|NCT00775827|bioequivalence fenofibrate tablets|bioequivalence fenofibrate tablets
651312|NCT00775840|Cardiac Failure|cardiac failure
651313|NCT00775840|Congestive Heart Failure|congestive heart failure
651314|NCT00775840|Drug Therapy|drug therapy
651315|NCT00775840|Hypertension|hypertension
651316|NCT00775840|Diabetes Mellitus|diabetes mellitus
651317|NCT00775853|Biomarkers|biomarkers
651318|NCT00775853|Catecholamines|catecholamines
651319|NCT00775853|18F-Fluoro-L-dopa|18f-fluoro-l-dopa
651320|NCT00775853|Fluorodopamine|fluorodopamine
651321|NCT00775853|Parkinson's Disease|parkinson's disease
651322|NCT00775853|Parkinson Disease|parkinson disease
651324|NCT00775866|prostate cancer, magnetic resonance imaging, guided imagery|prostate cancer, magnetic resonance imaging, guided imagery
651325|NCT00775879|Général anesthesia|général anesthesia
651326|NCT00775879|Gynecology|gynecology
651327|NCT00775892|ACL|acl
651328|NCT00775892|Ligament|ligament
651329|NCT00775905|Bioequivalence amlodipine tablets fasting|bioequivalence amlodipine tablets fasting
651424|NCT00783003|Pharmacokinetics|pharmacokinetics
651330|NCT00775918|Bioequivalence Doxycycline monohydrate 100mg tablets fed conditions|bioequivalence doxycycline monohydrate 100mg tablets fed conditions
651331|NCT00775931|osteopetrosis|osteopetrosis
651332|NCT00775944|Tobacco|tobacco
651333|NCT00775944|Cigarette|cigarette
651334|NCT00775944|Smoking|smoking
651335|NCT00775944|Counselling|counselling
651336|NCT00775944|Nicotine Replacement Therapy|nicotine replacement therapy
651337|NCT00775944|Telephone|telephone
651338|NCT00775944|Quitline|quitline
651339|NCT00775944|Helpline|helpline
651340|NCT00775970|Obesity|obesity
651341|NCT00775970|Weight loss maintenance|weight loss maintenance
651342|NCT00775970|Spontaneous physical activity|spontaneous physical activity
651343|NCT00775970|Lipid oxydation|lipid oxydation
651344|NCT00775970|Walking|walking
651345|NCT00775996|bioequivalence Clorazepate Tablets|bioequivalence clorazepate tablets
651346|NCT00776009|ADHD, children, subjects, laboratory classroom|adhd, children, subjects, laboratory classroom
651347|NCT00776022|Bioequivalence Cetirizine Hydrochloride 10 mg tablet fed conditions|bioequivalence cetirizine hydrochloride 10 mg tablet fed conditions
651348|NCT00776035|Obesity|obesity
651349|NCT00776035|Heart|heart
651350|NCT00776035|Failure|failure
651351|NCT00776035|PET|pet
651352|NCT00776035|radiation|radiation
651353|NCT00776035|metabolism|metabolism
651354|NCT00776074|Leiomyoma|leiomyoma
651355|NCT00776074|Uterine Fibroids|uterine fibroids
651356|NCT00776074|Drug Therapy|drug therapy
651357|NCT00776074|Uterine Neoplasms|uterine neoplasms
651358|NCT00776074|Fibroid Tumor|fibroid tumor
651359|NCT00776087|Medical costs|medical costs
651360|NCT00776087|Telemonitoring|telemonitoring
651361|NCT00776087|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
651362|NCT00776100|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
651363|NCT00776100|adenosquamous cell lung cancer|adenosquamous cell lung cancer
751838|NCT01170767|Ranibizumab|ranibizumab
651364|NCT00776100|squamous cell lung cancer|squamous cell lung cancer
651365|NCT00776100|large cell lung cancer|large cell lung cancer
651366|NCT00776100|adenocarcinoma of the lung|adenocarcinoma of the lung
651367|NCT00776100|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
651368|NCT00776113|Bioequivalence Carvedilol fasting|bioequivalence carvedilol fasting
651369|NCT00782821|Kidney|kidney
651370|NCT00782821|Renal|renal
651371|NCT00782821|Rejection|rejection
651372|NCT00782821|High risk|high risk
651373|NCT00782821|Induction|induction
651374|NCT00782821|Immunology|immunology
651375|NCT00782821|Transplantation|transplantation
651376|NCT00782821|B Cell|b cell
651377|NCT00782821|Allograft|allograft
651378|NCT00782821|Desensitization|desensitization
651379|NCT00782834|GIST|gist
651380|NCT00782834|Nilotinib|nilotinib
651381|NCT00782847|diabetes mellitus|diabetes mellitus
651382|NCT00782847|diabetic nephropathy|diabetic nephropathy
651383|NCT00782847|hypertension|hypertension
651384|NCT00782860|Early pregnancy failure|early pregnancy failure
651385|NCT00782860|Misoprostol|misoprostol
651386|NCT00782860|Gestational sac volume|gestational sac volume
651387|NCT00782873|propofol|propofol
651388|NCT00782873|sedation|sedation
651389|NCT00782873|safety|safety
651390|NCT00782873|obesity|obesity
651391|NCT00782886|Pathfinder|pathfinder
651392|NCT00782886|Liver|liver
651393|NCT00782886|Resection|resection
651394|NCT00782886|Surgery|surgery
651395|NCT00782886|To evaluate the effectiveness of image-guided liver surgery by measuring variables before, during and following surgery.|to evaluate the effectiveness of image-guided liver surgery by measuring variables before, during and following surgery.
651396|NCT00782886|Completeness of resection and the accuracy of the resection, as determined by preoperative predicted RLV|completeness of resection and the accuracy of the resection, as determined by preoperative predicted rlv
651397|NCT00782899|Schizophrenia|schizophrenia
651398|NCT00782899|subjective well-being|subjective well-being
651399|NCT00782899|depressive symptoms|depressive symptoms
651400|NCT00782899|schizophrenia course|schizophrenia course
651401|NCT00782912|postpartum anemia, postpartum depression|postpartum anemia, postpartum depression
651402|NCT00782925|Low back pain|low back pain
651403|NCT00782925|recurrence|recurrence
651404|NCT00782925|chronic low back pain|chronic low back pain
651405|NCT00782925|educational program|educational program
651406|NCT00782925|physical therapy|physical therapy
651407|NCT00782925|home exercise|home exercise
651408|NCT00782925|compliance|compliance
651409|NCT00782964|Depression|depression
651410|NCT00782964|Major Depressive Disorder|major depressive disorder
651411|NCT00782964|SSRI resistant depression|ssri resistant depression
651412|NCT00782964|strategies in depression|strategies in depression
651413|NCT00782977|Apneic oxygenation|apneic oxygenation
752383|NCT01172743|Type-2|type-2
651414|NCT00782977|Apneic diffusion oxygenation|apneic diffusion oxygenation
651415|NCT00782990|stress urinary incontinence|stress urinary incontinence
651416|NCT00782990|female incontinence|female incontinence
651417|NCT00782990|surgical treatment|surgical treatment
651418|NCT00782990|Female stress urinary incontinence|female stress urinary incontinence
651419|NCT00783003|Tolerability|tolerability
651420|NCT00783003|Muscarinic Receptor Antagonist, Anticholinergic|muscarinic receptor antagonist, anticholinergic
651421|NCT00783003|Safety|safety
651422|NCT00783003|Anticholinergic|anticholinergic
651425|NCT00783016|appendicitis|appendicitis
651426|NCT00783016|diagnosis|diagnosis
651427|NCT00783029|Vasodilation|vasodilation
651428|NCT00783029|Vessel Reactivity|vessel reactivity
651429|NCT00783029|Dynamic Vessel Analyzer|dynamic vessel analyzer
651430|NCT00783029|Retina|retina
651431|NCT00783042|TTDE-CFR|ttde-cfr
651432|NCT00783042|coronary artery function|coronary artery function
651433|NCT00783042|cardiovascular biomarkers|cardiovascular biomarkers
651434|NCT00783042|rosuvastatin|rosuvastatin
651435|NCT00783042|Crestor|crestor
651436|NCT00783055|Autonomy|autonomy
651437|NCT00783055|Older people|older people
651438|NCT00783055|Physically frail|physically frail
651439|NCT00783055|Nursing home|nursing home
651440|NCT00783055|Intervention study|intervention study
651441|NCT00783068|Endotoxin|endotoxin
651442|NCT00783068|GTS-21|gts-21
651443|NCT00783068|Vagal activity|vagal activity
651444|NCT00783068|Autonomic balance|autonomic balance
651445|NCT00783081|Intermittent Claudication|intermittent claudication
651446|NCT00783081|Peripheral Arterial Disease|peripheral arterial disease
651447|NCT00783107|Gold Stage III COPD|gold stage iii copd
651448|NCT00783120|schizophrenia, negative symptoms, TMS, magnetic stimulation|schizophrenia, negative symptoms, tms, magnetic stimulation
651449|NCT00783497|High Blood Pressure|high blood pressure
651450|NCT00783497|Stress|stress
651451|NCT00783510|Polyarticular JIA|polyarticular jia
651452|NCT00783510|Juvenile Arthritis|juvenile arthritis
651453|NCT00783510|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
651455|NCT00783510|Polyarticular-course JIA|polyarticular-course jia
651456|NCT00783536|An randomized, open label, multicenter study to compare the ef|an randomized, open label, multicenter study to compare the ef
651457|NCT00783549|tolerability|tolerability
651458|NCT00783549|pharmacodynamics|pharmacodynamics
651459|NCT00783549|pharmacokinetics|pharmacokinetics
651460|NCT00783549|safety|safety
651461|NCT00783562|Low back pain|low back pain
651462|NCT00783562|Neck pain|neck pain
651463|NCT00783562|Functional disability|functional disability
651464|NCT00783562|Nursery school teachers|nursery school teachers
651465|NCT00783562|Exercise program|exercise program
651466|NCT00783562|Prevention|prevention
651467|NCT00783575|Crohn's disease|crohn's disease
651468|NCT00783575|Ulcerative colitis|ulcerative colitis
651469|NCT00783575|Inflammatory bowel disease|inflammatory bowel disease
651470|NCT00783575|NOD2,CARD 15 mutations|nod2,card 15 mutations
651471|NCT00783588|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
651472|NCT00783588|CLL|cll
651473|NCT00783588|Leukemia|leukemia
651474|NCT00783588|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
651475|NCT00783588|Leukemia, B-Cell|leukemia, b-cell
651476|NCT00783588|Immune System Diseases|immune system diseases
651477|NCT00783588|ISF35|isf35
651478|NCT00783588|Ad-ISF35|ad-isf35
651479|NCT00783588|Immunotherapy|immunotherapy
651480|NCT00783588|Immune therapy|immune therapy
651481|NCT00783588|Active immune therapy|active immune therapy
651482|NCT00783601|Chronic Asthma|chronic asthma
651483|NCT00783614|HIV|hiv
651484|NCT00783614|Cardiovascular Disease|cardiovascular disease
651485|NCT00783614|Endothelial Dysfunction|endothelial dysfunction
651486|NCT00783627|Endothelium|endothelium
651487|NCT00783627|progenitors|progenitors
651488|NCT00783627|stem cells|stem cells
651489|NCT00783627|sickle cell|sickle cell
651490|NCT00783653|AML|aml
651491|NCT00783653|FLT3|flt3
651492|NCT00783653|acute myeloid leukemia|acute myeloid leukemia
651493|NCT00783653|FLT 3 inhibitor|flt 3 inhibitor
651878|NCT00785200|MRSA|mrsa
651494|NCT00783653|FLT3 mutated AML|flt3 mutated aml
651495|NCT00783679|Cardiac output|cardiac output
651496|NCT00783679|Noninvasive cardiac output measurement|noninvasive cardiac output measurement
651497|NCT00783679|Thermodilution|thermodilution
651498|NCT00783731|intubation|intubation
651603|NCT00784251|Pain|pain
651499|NCT00783757|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
651500|NCT00783757|TOBI|tobi
651501|NCT00783757|breast imaging|breast imaging
651502|NCT00783757|optical imaging|optical imaging
651503|NCT00783770|Breastfeeding|breastfeeding
651504|NCT00783770|Infant|infant
651505|NCT00783770|Preterm|preterm
651506|NCT00783770|Nutrition|nutrition
651507|NCT00783783|Psychiatric disorders|psychiatric disorders
651508|NCT00783783|Neurodevelopmental disorders|neurodevelopmental disorders
651509|NCT00783783|Autism|autism
651510|NCT00783783|Risperidone|risperidone
651511|NCT00783783|Pharmacogenetics|pharmacogenetics
651512|NCT00783783|Pharmacokinetics|pharmacokinetics
651513|NCT00783796|Coronary artery disease|coronary artery disease
651514|NCT00783796|Atherosclerosis|atherosclerosis
651515|NCT00783796|Myocardial ischemia|myocardial ischemia
651516|NCT00783809|intracranial pressure|intracranial pressure
651517|NCT00783809|intracranial hypertension|intracranial hypertension
651518|NCT00783809|ultrasound|ultrasound
651519|NCT00783809|emergency|emergency
651520|NCT00783809|traumatic brain injury|traumatic brain injury
651521|NCT00783809|ocular ultrasound|ocular ultrasound
651522|NCT00783822|breast neoplasms|breast neoplasms
651523|NCT00783822|genetic counseling|genetic counseling
651524|NCT00783835|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
651525|NCT00783835|Methylphenidate|methylphenidate
651526|NCT00783835|Concerta|concerta
651527|NCT00783835|CONQoL|conqol
651529|NCT00783887|Cilia|cilia
651530|NCT00783887|Axoneme|axoneme
651531|NCT00783887|Dynein|dynein
651532|NCT00783887|Gene|gene
651533|NCT00783887|Ultrastructure|ultrastructure
651534|NCT00783887|Linkage analysis|linkage analysis
651535|NCT00783900|Prevention|prevention
651536|NCT00783913|Direct Current Stimulation|direct current stimulation
651537|NCT00783913|Rehabilitation|rehabilitation
651538|NCT00783913|Motor Learning|motor learning
651539|NCT00783913|Stroke|stroke
651540|NCT00783952|Mixed venous oxygen saturation|mixed venous oxygen saturation
651541|NCT00783952|Tissue oxygenation|tissue oxygenation
651542|NCT00783952|Near infrared spectroscopy|near infrared spectroscopy
651543|NCT00783965|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
651544|NCT00783965|basal cell carcinoma of the skin|basal cell carcinoma of the skin
651545|NCT00783978|Surfactant protein C|surfactant protein c
651546|NCT00783978|Interstitial|interstitial
651547|NCT00783978|lung|lung
651548|NCT00783978|Children|children
651549|NCT00783991|IVF|ivf
651550|NCT00783991|PDA|pda
651552|NCT00783991|CAT|cat
651553|NCT00783991|COPD|copd
651554|NCT00783991|MDD|mdd
651555|NCT00783991|RA|ra
651556|NCT00784004|breathing patterns,|breathing patterns,
651557|NCT00784004|unidirectional breathing,|unidirectional breathing,
651558|NCT00784004|mask ventilation,|mask ventilation,
651559|NCT00784004|respiratory physiology|respiratory physiology
651560|NCT00784017|Children with previously untreated acute lymphoblastic leukemia|children with previously untreated acute lymphoblastic leukemia
751839|NCT01170780|Inguinal hernia|inguinal hernia
651561|NCT00784030|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
651562|NCT00784030|Polycystic Kidney Disease|polycystic kidney disease
651563|NCT00784030|Water Loading|water loading
651564|NCT00784030|Biomarkers|biomarkers
651565|NCT00784043|Cochlear implant|cochlear implant
651566|NCT00784043|hearing loss|hearing loss
651567|NCT00784082|Sickle cell disease, hydroxyurea, inflammation|sickle cell disease, hydroxyurea, inflammation
651568|NCT00784095|quality of life|quality of life
651569|NCT00784134|intraventricular hemorrhage thrombolysis|intraventricular hemorrhage thrombolysis
651570|NCT00784147|HIV|hiv
651571|NCT00784147|CD4|cd4
651572|NCT00784147|experienced|experienced
651573|NCT00784147|resistant|resistant
651574|NCT00784147|resistance|resistance
651575|NCT00784147|monoclonal|monoclonal
651576|NCT00784147|antibody|antibody
651577|NCT00784147|infusion|infusion
651578|NCT00784147|ibalizumab|ibalizumab
651579|NCT00784147|TNX355|tnx355
651580|NCT00784147|TNX-355|tnx-355
651581|NCT00784147|TMB355|tmb355
651582|NCT00784147|TMB-355|tmb-355
651583|NCT00784173|Syndrome|syndrome
651584|NCT00784173|Velocardiofacial|velocardiofacial
651585|NCT00784173|Middle ear|middle ear
651586|NCT00784173|Inner ear|inner ear
651587|NCT00784173|Malformation|malformation
651588|NCT00784186|Pregnancy termination|pregnancy termination
651589|NCT00784186|abortion|abortion
651590|NCT00784186|medical abortion|medical abortion
651591|NCT00784186|2nd trimester|2nd trimester
651592|NCT00784186|mifepristone|mifepristone
651593|NCT00784186|misoprostol|misoprostol
651594|NCT00784199|MDD|mdd
651595|NCT00784199|Depression|depression
651596|NCT00784212|Photosensitive Epilepsy, photic stimulation, electroencephalogram|photosensitive epilepsy, photic stimulation, electroencephalogram
651598|NCT00784225|advanced macular degeneration|advanced macular degeneration
651599|NCT00784238|Schizophrenia|schizophrenia
651600|NCT00784238|Paliperidone Extended-release|paliperidone extended-release
651601|NCT00784238|Paliperidone|paliperidone
651602|NCT00784238|R076477|r076477
651604|NCT00784251|Leg pain|leg pain
651605|NCT00784251|Back pain|back pain
651606|NCT00784251|PROMIS|promis
651607|NCT00784264|Asymptomatic atherosclerosis|asymptomatic atherosclerosis
651608|NCT00784264|Intima media thickness (IMT)|intima media thickness (imt)
651609|NCT00784264|central obesity|central obesity
651610|NCT00784264|cardiovascular disease|cardiovascular disease
651611|NCT00784277|Pain medication|pain medication
651612|NCT00784277|Arthritis|arthritis
651613|NCT00784277|Joint pain|joint pain
651614|NCT00784277|Analgesia|analgesia
651615|NCT00784277|Analgesics|analgesics
651616|NCT00784277|tapentadol|tapentadol
651617|NCT00784277|CG5503|cg5503
651618|NCT00784277|Nucynta|nucynta
651619|NCT00784303|Thyroid Cancer|thyroid cancer
651620|NCT00784316|Prevention|prevention
651621|NCT00784329|Lung Cancer|lung cancer
651622|NCT00784329|Squamous Cell Lung Cancer|squamous cell lung cancer
651623|NCT00784329|Bronchial carcinoma in situ|bronchial carcinoma in situ
651624|NCT00784329|Central Airway Diseases|central airway diseases
651625|NCT00784342|COPD|copd
651626|NCT00784355|recurrence of idiopathic pancreatitis|recurrence of idiopathic pancreatitis
651627|NCT00784355|laparoscopic cholecystectomy|laparoscopic cholecystectomy
651628|NCT00784355|etiology of pancreatitis|etiology of pancreatitis
651631|NCT00784368|Aspergillosis|aspergillosis
651632|NCT00784368|Cryptococcosis|cryptococcosis
651633|NCT00784368|Blastomycosis|blastomycosis
651634|NCT00784368|Histoplasmosis|histoplasmosis
651635|NCT00784368|Neutropenia|neutropenia
651636|NCT00784368|Itraconazole|itraconazole
651637|NCT00784368|JK1211|jk1211
651638|NCT00784381|Renal failure|renal failure
651639|NCT00784381|Elderly|elderly
651640|NCT00784381|Drug Therapy Computer-Assisted|drug therapy computer-assisted
651641|NCT00784381|Quality of care|quality of care
651642|NCT00784381|Patients With Impaired Renal Function|patients with impaired renal function
651643|NCT00784381|Inappropriateness of target drug prescribed|inappropriateness of target drug prescribed
651644|NCT00784407|thyroid surgery|thyroid surgery
651645|NCT00784407|total thyroidectomy|total thyroidectomy
651646|NCT00784407|harmonic scalpel|harmonic scalpel
651647|NCT00784420|Drug Interaction, Pharmacokinetics|drug interaction, pharmacokinetics
651648|NCT00784433|alcohol diabetes CVD|alcohol diabetes cvd
651649|NCT00784446|AIO|aio
651650|NCT00784446|colorectal cancer|colorectal cancer
651651|NCT00784446|0205|0205
651652|NCT00784446|Capecitabine|capecitabine
651653|NCT00784446|Oxaliplatin|oxaliplatin
651654|NCT00784446|Bevacizumab|bevacizumab
651655|NCT00784446|Imatinib|imatinib
651656|NCT00784459|Asthma|asthma
651657|NCT00784459|Allergy|allergy
651658|NCT00784472|PCNL|pcnl
651659|NCT00784472|oxycodone|oxycodone
651660|NCT00784472|morphine|morphine
651661|NCT00784472|visceral pain|visceral pain
651662|NCT00784485|Asthma|asthma
651663|NCT00784485|Respiratory Tract Diseases|respiratory tract diseases
651664|NCT00784485|Lung Diseases|lung diseases
651665|NCT00784485|Dyspnea|dyspnea
651666|NCT00784498|Procedural sedation and analgesia|procedural sedation and analgesia
651667|NCT00784498|Emergency Department|emergency department
651668|NCT00784498|propofol versus ketamine and midazolam|propofol versus ketamine and midazolam
651669|NCT00784498|painful orthopedic manipulations|painful orthopedic manipulations
651670|NCT00784511|diabetes|diabetes
651671|NCT00784511|vitamin D|vitamin d
651672|NCT00784511|African Americans|african americans
651673|NCT00784511|overweight|overweight
651674|NCT00784511|insulin sensitivity|insulin sensitivity
651675|NCT00784511|glucose control|glucose control
651676|NCT00784524|stage IV breast cancer|stage iv breast cancer
651677|NCT00784524|recurrent breast cancer|recurrent breast cancer
651678|NCT00784524|metastatic breast cancer|metastatic breast cancer
651679|NCT00784537|Hodgkin's lymphoma|hodgkin's lymphoma
651681|NCT00784537|FDG-PET (18-Fluoro-deoxy-D-glucose Positron Emission Tomography)|fdg-pet (18-fluoro-deoxy-d-glucose positron emission tomography)
651682|NCT00784537|Radiotherapy|radiotherapy
651683|NCT00784550|Spirometry|spirometry
651684|NCT00784550|COPD|copd
651685|NCT00784563|Parkinson Disease|parkinson disease
651686|NCT00784563|Exercise/*physiology|exercise/*physiology
651687|NCT00784563|*Physical Fitness|*physical fitness
651688|NCT00784563|Rehabilitation|rehabilitation
651689|NCT00784563|Cognition|cognition
651690|NCT00784576|Delirium|delirium
651691|NCT00784576|Cardiac Surgery|cardiac surgery
651692|NCT00784576|Depression|depression
651693|NCT00784576|Cognitive Impairment|cognitive impairment
651694|NCT00784576|Diagnostic Criteria for Delirium|diagnostic criteria for delirium
651695|NCT00784576|Memorial Delirium Assessment Scale|memorial delirium assessment scale
651696|NCT00784576|Delirium Index|delirium index
651697|NCT00784589|Corticothérapy|corticothérapy
651698|NCT00784589|Rituximab|rituximab
651699|NCT00784589|therapeutic efficacity|therapeutic efficacity
651700|NCT00784589|therapeutic tolerance|therapeutic tolerance
651701|NCT00784602|prolapse|prolapse
651702|NCT00784602|pelvic organ prolapse|pelvic organ prolapse
651703|NCT00784615|Phenotypes of Polycystic Ovary Syndrome|phenotypes of polycystic ovary syndrome
651704|NCT00784615|Cardiovascular risk factors|cardiovascular risk factors
651705|NCT00784615|Adiponectin|adiponectin
651706|NCT00784615|C Reactive Protein|c reactive protein
651707|NCT00784667|Colorectal neoplasm|colorectal neoplasm
651708|NCT00784667|Metastasis|metastasis
651709|NCT00784693|Endometriosis|endometriosis
651711|NCT00784693|tanezumab|tanezumab
651712|NCT00784693|nerve growth factor|nerve growth factor
651713|NCT00784693|questionnaires|questionnaires
651714|NCT00784706|stroke rehabilitation|stroke rehabilitation
651715|NCT00784706|perceptual deficits|perceptual deficits
651716|NCT00784706|kinematic analysis|kinematic analysis
651717|NCT00784719|Dry eye|dry eye
651718|NCT00784732|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
651719|NCT00784732|Environmental Exposure Chamber|environmental exposure chamber
651720|NCT00784732|nasal lavage|nasal lavage
651721|NCT00784745|incretin effect|incretin effect
651722|NCT00784745|type 2 diabetes|type 2 diabetes
651723|NCT00784745|GLP-1|glp-1
651724|NCT00784745|GIP|gip
651725|NCT00784745|dexamethasone|dexamethasone
651726|NCT00784758|Asthma|asthma
651727|NCT00784758|Lung Diseases|lung diseases
651728|NCT00784758|Respiratory Tract Diseases|respiratory tract diseases
651729|NCT00784771|Hypnotherapy|hypnotherapy
651730|NCT00784771|Hypnosis|hypnosis
651731|NCT00784771|PTSD|ptsd
651732|NCT00784784|antiviral drugs|antiviral drugs
651733|NCT00784784|influenza vaccines|influenza vaccines
651734|NCT00784810|Efficacy, tolerability, moderate/severe, oxycodone/naloxone|efficacy, tolerability, moderate/severe, oxycodone/naloxone
651735|NCT00784810|codeine/paracetamol, chronic low back pain, osteoarthritis|codeine/paracetamol, chronic low back pain, osteoarthritis
651736|NCT00784836|Multiple Sclerosis - Relapsing|multiple sclerosis - relapsing
651737|NCT00784849|Breast cancer|breast cancer
651738|NCT00784849|diagnostic|diagnostic
651739|NCT00784849|lymph nodes|lymph nodes
651740|NCT00784888|aromatase inhibitor|aromatase inhibitor
651741|NCT00784888|quality of life|quality of life
651742|NCT00784888|safety|safety
651743|NCT00784888|postmenopausal breast cancer|postmenopausal breast cancer
651744|NCT00784901|Macular Thickness Analyzed by Optical Coherence Tomography in Retinitis Pigmemtosa|macular thickness analyzed by optical coherence tomography in retinitis pigmemtosa
651745|NCT00784914|adult anaplastic astrocytoma|adult anaplastic astrocytoma
651746|NCT00784914|adult diffuse astrocytoma|adult diffuse astrocytoma
651747|NCT00784914|adult craniopharyngioma|adult craniopharyngioma
651748|NCT00784914|adult choroid plexus tumor|adult choroid plexus tumor
651749|NCT00784914|adult brain stem glioma|adult brain stem glioma
651750|NCT00784914|tumors metastatic to brain|tumors metastatic to brain
651751|NCT00784914|recurrent adult brain tumor|recurrent adult brain tumor
651752|NCT00784914|adult gliosarcoma|adult gliosarcoma
651753|NCT00784914|adult giant cell glioblastoma|adult giant cell glioblastoma
651754|NCT00784914|adult ependymoblastoma|adult ependymoblastoma
651755|NCT00784914|adult medulloblastoma|adult medulloblastoma
651756|NCT00784914|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
651757|NCT00784914|adult anaplastic ependymoma|adult anaplastic ependymoma
651758|NCT00784914|adult ependymoma|adult ependymoma
651759|NCT00784914|adult myxopapillary ependymoma|adult myxopapillary ependymoma
651760|NCT00784914|adult subependymoma|adult subependymoma
651761|NCT00784914|adult mixed glioma|adult mixed glioma
651762|NCT00784914|meningeal melanocytoma|meningeal melanocytoma
651763|NCT00784914|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
651764|NCT00784914|adult grade I meningioma|adult grade i meningioma
651765|NCT00784914|adult grade II meningioma|adult grade ii meningioma
651766|NCT00784914|adult grade III meningioma|adult grade iii meningioma
651767|NCT00784914|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
651768|NCT00784914|adult oligodendroglioma|adult oligodendroglioma
651769|NCT00784914|adult pineoblastoma|adult pineoblastoma
651770|NCT00784914|adult pineocytoma|adult pineocytoma
651771|NCT00784927|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
651772|NCT00784927|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
651773|NCT00784927|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
651774|NCT00784927|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
651775|NCT00784927|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
651776|NCT00784927|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
651777|NCT00784927|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
651778|NCT00784927|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
651779|NCT00784927|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
651780|NCT00784927|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
651781|NCT00784927|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
651782|NCT00784927|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
651783|NCT00784927|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
651784|NCT00784927|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
651785|NCT00784927|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
651786|NCT00784927|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
651787|NCT00784927|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
651788|NCT00784927|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
651789|NCT00784927|splenic marginal zone lymphoma|splenic marginal zone lymphoma
651790|NCT00784927|stage I marginal zone lymphoma|stage i marginal zone lymphoma
651791|NCT00784927|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
651792|NCT00784927|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
651793|NCT00784927|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
651794|NCT00784927|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
651795|NCT00784953|Symbicort SMART|symbicort smart
651796|NCT00784953|budesonide|budesonide
651797|NCT00784953|formoterol|formoterol
651798|NCT00784953|ICS/LABA|ics/laba
651799|NCT00784953|Asthma Control Questionnaire|asthma control questionnaire
651800|NCT00784953|Not optimally controlled asthma|not optimally controlled asthma
651801|NCT00784966|Islet transplantation|islet transplantation
651802|NCT00784966|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
651803|NCT00784966|Kidney Transplantation|kidney transplantation
651804|NCT00784979|Renal|renal
651805|NCT00784979|Transplant|transplant
651807|NCT00784992|NLDO|nldo
651808|NCT00784992|DCR|dcr
651809|NCT00784992|silicone tubes|silicone tubes
651810|NCT00784992|stent|stent
651811|NCT00785005|Diabetes|diabetes
651820|NCT00785018|C1-inhibitor|c1-inhibitor
651821|NCT00785018|Inflammation|inflammation
651822|NCT00785018|Sepsis|sepsis
651823|NCT00785018|Multi organ dysfunction syndrome|multi organ dysfunction syndrome
651824|NCT00785018|Complement activation|complement activation
651825|NCT00785031|risk management|risk management
651826|NCT00785031|Self Management|self management
651827|NCT00785031|Self-Efficacy|self-efficacy
651828|NCT00785031|Disease management|disease management
651829|NCT00785031|nurse practitioner|nurse practitioner
651830|NCT00785031|internet|internet
651831|NCT00785031|risk factors|risk factors
651832|NCT00785031|vascular diseases|vascular diseases
651833|NCT00785031|economic evaluation|economic evaluation
651834|NCT00785044|Heart Failure|heart failure
651835|NCT00785044|MIBG|mibg
651836|NCT00785044|123I-mIBG|123i-mibg
651837|NCT00785057|Hypertension|hypertension
651838|NCT00785057|Stroke|stroke
651839|NCT00785057|Neurology|neurology
651840|NCT00785057|JNC7|jnc7
651841|NCT00785057|2007 ESH-ESC guidelines|2007 esh-esc guidelines
651842|NCT00785057|survey|survey
651843|NCT00785070|Perioperative|perioperative
651844|NCT00785070|Obstructive Sleep Apnea|obstructive sleep apnea
651845|NCT00785070|Screening|screening
651846|NCT00785070|Home Sleep Testing|home sleep testing
651847|NCT00785083|Asthma, adrenergic beta agonists, multiple sclerosis, pulmonary function tests, forced expiratory volume|asthma, adrenergic beta agonists, multiple sclerosis, pulmonary function tests, forced expiratory volume
651848|NCT00785096|Perception, surgical complications, patients, nurses and physicians|perception, surgical complications, patients, nurses and physicians
651849|NCT00785109|aortic valve calcification|aortic valve calcification
651850|NCT00785109|vitamin K supplementation|vitamin k supplementation
651851|NCT00785122|cancer vaccine|cancer vaccine
651852|NCT00785135|vision, binocular|vision, binocular
651853|NCT00785135|vision disparity|vision disparity
651854|NCT00785135|headache|headache
651855|NCT00785135|dizziness|dizziness
651856|NCT00785135|anxiety|anxiety
651857|NCT00785135|neck pain|neck pain
651858|NCT00785135|learning disorders|learning disorders
651859|NCT00785135|asthenopia|asthenopia
651860|NCT00785135|motion sickness|motion sickness
651861|NCT00785135|depth perception|depth perception
651862|NCT00785135|gait disorder|gait disorder
651863|NCT00785135|diplopia|diplopia
651864|NCT00785135|photophobia|photophobia
651865|NCT00785135|agoraphobia|agoraphobia
651866|NCT00785135|panic disorder|panic disorder
651867|NCT00785161|Penumbra System|penumbra system
651868|NCT00785161|Mechanical Thrombectomy|mechanical thrombectomy
651869|NCT00785161|Ischemic Stroke|ischemic stroke
651870|NCT00785161|Intervention|intervention
651871|NCT00785161|Neurovascular|neurovascular
651872|NCT00785161|Thrombus|thrombus
651873|NCT00785161|Imaging|imaging
651874|NCT00785161|Ischemic Penumbra|ischemic penumbra
651875|NCT00785161|Functional Outcome|functional outcome
651876|NCT00785174|noninvasive ventilation, continuous posi|noninvasive ventilation, continuous posi
651877|NCT00785187|UVB induced skin erythema|uvb induced skin erythema
651879|NCT00785200|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
651880|NCT00785200|Chlorhexidine|chlorhexidine
651881|NCT00785200|Asymptomatic colonization|asymptomatic colonization
651882|NCT00785200|Asymptomatic colonization, MRSA|asymptomatic colonization, mrsa
651883|NCT00785200|Skin and soft tissue infections|skin and soft tissue infections
651884|NCT00785213|rosiglitazone|rosiglitazone
651885|NCT00785213|quinine sulfate|quinine sulfate
651886|NCT00785213|drug interactions|drug interactions
651887|NCT00785213|cytochrome p450|cytochrome p450
651888|NCT00785239|Malignant Airway Disease|malignant airway disease
651889|NCT00785239|Benign Airway Disease|benign airway disease
651890|NCT00785239|Lung Cancer|lung cancer
651891|NCT00785239|Emphysema|emphysema
651892|NCT00785239|Chronic Bronchitis|chronic bronchitis
651893|NCT00785239|COPD|copd
651894|NCT00785239|Asthma|asthma
651895|NCT00785239|Sarcoidosis|sarcoidosis
651896|NCT00785239|Mesothelioma|mesothelioma
651897|NCT00785239|CryoSpray Ablation|cryospray ablation
651898|NCT00785239|Cryotherapy|cryotherapy
651899|NCT00785239|Cryospray|cryospray
651900|NCT00785239|Cryo|cryo
651901|NCT00785252|Catheters, Indwelling|catheters, indwelling
651902|NCT00785265|Live Donor Kidney Transplantation|live donor kidney transplantation
651903|NCT00785265|LDKT|ldkt
651904|NCT00785265|African Americans|african americans
651905|NCT00785265|Disparity|disparity
651906|NCT00785265|Education|education
651907|NCT00785278|Wheelchair Set-Up|wheelchair set-up
651908|NCT00785278|Shoulder Joint Forces|shoulder joint forces
651909|NCT00785278|Manual Wheelchair Users|manual wheelchair users
651910|NCT00785278|Paraplegia|paraplegia
651911|NCT00785278|Upper Limb Pain|upper limb pain
651912|NCT00785278|Secondary Injury to Spinal Cord Injury|secondary injury to spinal cord injury
651913|NCT00785278|Biomechanics|biomechanics
651914|NCT00785317|Postmenopausal Hormone Replacement Therapy|postmenopausal hormone replacement therapy
651915|NCT00785330|rituximab|rituximab
651916|NCT00785330|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
651917|NCT00785330|diffuse large B cell lymphoma|diffuse large b cell lymphoma
652123|NCT00779363|obese,|obese,
651918|NCT00785330|peripheral t cell lymphoma|peripheral t cell lymphoma
651919|NCT00785330|graft-versus-host disease|graft-versus-host disease
651920|NCT00785330|graft-versus-lymphoma effect|graft-versus-lymphoma effect
651921|NCT00785330|allogeneic haematopoietic stem cell transplantation|allogeneic haematopoietic stem cell transplantation
651922|NCT00785330|relapsed or primary progressive aggressive Non-Hodgkin's lymphoma|relapsed or primary progressive aggressive non-hodgkin's lymphoma
651923|NCT00785343|stroke|stroke
651924|NCT00785343|acute|acute
651926|NCT00785343|robot|robot
651927|NCT00785343|therapy|therapy
651928|NCT00785343|arm paresis|arm paresis
651929|NCT00785356|Uterine fibroids|uterine fibroids
651930|NCT00785356|Anemia|anemia
651931|NCT00785369|skin disorders|skin disorders
651932|NCT00785369|skin cancer|skin cancer
651933|NCT00785369|melanoma|melanoma
651934|NCT00785369|lentigo maligna|lentigo maligna
651935|NCT00785382|Pain, Pregabalin, Lyrica, Breast surgery|pain, pregabalin, lyrica, breast surgery
651936|NCT00785408|obesity|obesity
651937|NCT00785408|overweight|overweight
651938|NCT00785408|weight loss|weight loss
651939|NCT00785408|Amylin|amylin
651940|NCT00785408|AC2307|ac2307
651941|NCT00785421|heparin|heparin
651942|NCT00785421|LMWH|lmwh
651943|NCT00785421|pancreatic cancer|pancreatic cancer
651944|NCT00785434|MDD|mdd
651945|NCT00785434|escitalopram|escitalopram
651946|NCT00785447|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
651947|NCT00785447|Respiratory Physiology|respiratory physiology
651948|NCT00785447|Mouth to mouth ventilation|mouth to mouth ventilation
651949|NCT00785447|Mouth to nose ventilation|mouth to nose ventilation
651950|NCT00785486|midazolam|midazolam
651951|NCT00785486|drug interactions|drug interactions
651952|NCT00785486|cytochrome p450|cytochrome p450
651954|NCT00785499|metabolic syndrome|metabolic syndrome
651955|NCT00785499|milk components|milk components
651956|NCT00785499|casein|casein
651957|NCT00785499|whey|whey
651958|NCT00785499|children|children
651959|NCT00785499|adolescent|adolescent
651960|NCT00785512|nebivolol|nebivolol
651961|NCT00785512|Bystolic®|bystolic®
651962|NCT00785512|Hypertension|hypertension
651963|NCT00785512|blood pressure|blood pressure
651964|NCT00785512|withdrawal|withdrawal
651965|NCT00785525|Healthy Unrelated Stem Cell Donors|healthy unrelated stem cell donors
651966|NCT00785538|Tumors|tumors
651967|NCT00785538|Antibodies, Monoclonal|antibodies, monoclonal
651968|NCT00785551|male|male
651969|NCT00785551|female|female
651970|NCT00785551|pharmacokinetics|pharmacokinetics
651971|NCT00785551|normal and impaired renal function|normal and impaired renal function
651972|NCT00785564|T-wave memory|t-wave memory
651973|NCT00785564|Sick Sinus Syndrome|sick sinus syndrome
651974|NCT00785603|Depression|depression
651975|NCT00785603|pain|pain
651976|NCT00785603|CYP2D6|cyp2d6
651977|NCT00785603|interactions|interactions
651978|NCT00785603|Pupillometry|pupillometry
651979|NCT00785603|Tramadol|tramadol
651980|NCT00785603|Paroxetine|paroxetine
651981|NCT00785603|MR-ratio|mr-ratio
651983|NCT00785616|Adherence|adherence
651984|NCT00785616|MEMS|mems
651985|NCT00785629|phosphorus|phosphorus
651986|NCT00785629|secondary hyperparathyroidism|secondary hyperparathyroidism
651987|NCT00785629|vascular calcification|vascular calcification
651988|NCT00785668|Asthma|asthma
651989|NCT00785668|Allergy|allergy
651990|NCT00785668|Interleukin-4|interleukin-4
651991|NCT00785668|Interleukin-13|interleukin-13
651992|NCT00785668|IL-4|il-4
651993|NCT00785668|IL-13|il-13
651994|NCT00785668|Pharmacokinetics|pharmacokinetics
651995|NCT00785668|Safety|safety
651996|NCT00785668|Tolerability|tolerability
651997|NCT00785668|Aerovance|aerovance
651998|NCT00785668|dry powder|dry powder
651999|NCT00785707|sensorineural hearing loss|sensorineural hearing loss
652000|NCT00785707|cochlear implant|cochlear implant
652001|NCT00785733|asthma|asthma
652002|NCT00785746|elderly, balance, core, strength|elderly, balance, core, strength
652003|NCT00785759|Alzheimer's Disease|alzheimer's disease
652004|NCT00785772|Gabapentin Pharmacokinetics|gabapentin pharmacokinetics
652005|NCT00785785|Unresectable GIST|unresectable gist
652006|NCT00785785|metastatic GIST|metastatic gist
652007|NCT00785785|nilotinib|nilotinib
652008|NCT00785785|AMN107|amn107
652009|NCT00785785|imatinib|imatinib
652010|NCT00785785|STI571|sti571
652011|NCT00785798|Relapsed Lymphomas|relapsed lymphomas
652012|NCT00785798|Refractory Lymphomas|refractory lymphomas
652013|NCT00785824|Lactation|lactation
652014|NCT00785824|Endocrine System Diseases|endocrine system diseases
652015|NCT00785824|Musculoskeletal System Disease|musculoskeletal system disease
652016|NCT00785824|Hormone|hormone
652017|NCT00785824|Physiological Properties|physiological properties
652018|NCT00785837|Hydrotherapy|hydrotherapy
652019|NCT00785837|Perinatal Care|perinatal care
652020|NCT00785837|Neonatology|neonatology
652021|NCT00785863|hyperalgesia|hyperalgesia
652022|NCT00785863|remifentanil|remifentanil
652023|NCT00785863|ketorolac|ketorolac
652024|NCT00785863|parecoxib|parecoxib
652025|NCT00785863|COX-1 inhibitor|cox-1 inhibitor
652026|NCT00785863|COX-2 inhibitor|cox-2 inhibitor
652027|NCT00785876|Paediatric|paediatric
652028|NCT00785876|Emergency Department|emergency department
652029|NCT00785876|Ankle|ankle
652030|NCT00785876|Injury|injury
652031|NCT00785876|Low risk ankle rule|low risk ankle rule
652032|NCT00785889|Colorectal cancer screening|colorectal cancer screening
652033|NCT00785889|optical colonoscopy|optical colonoscopy
652034|NCT00785889|water method|water method
652035|NCT00785889|sedation|sedation
652036|NCT00785915|AZD6765|azd6765
652037|NCT00785915|Japanese and Caucasian Healthy Volunteers|japanese and caucasian healthy volunteers
652038|NCT00785915|Phase I study|phase i study
652039|NCT00785915|Single and multiple Ascending Dose|single and multiple ascending dose
652040|NCT00785915|Japanese volunteers|japanese volunteers
652041|NCT00785928|Arthritis|arthritis
652042|NCT00785941|Tumors|tumors
652043|NCT00785941|Antibodies, Monoclonal|antibodies, monoclonal
652044|NCT00785954|Heart Diseases|heart diseases
652045|NCT00785954|Myocardial Ischemia|myocardial ischemia
652046|NCT00785954|Infarction|infarction
652047|NCT00785954|Myocardial Infarction|myocardial infarction
652048|NCT00785967|V(D)J recombination; RAG-1/2 recombinase function|v(d)j recombination; rag-1/2 recombinase function
652049|NCT00785980|quinine sulfate|quinine sulfate
652050|NCT00785980|ciprofloxacin|ciprofloxacin
652051|NCT00785980|drug interactions|drug interactions
652052|NCT00785980|cytochrome p450|cytochrome p450
652053|NCT00785980|male|male
652054|NCT00785980|female|female
652055|NCT00785980|adult|adult
652056|NCT00785980|pharmacokinetics|pharmacokinetics
652057|NCT00778973|Bioequivalence sertraline 100 mg tablets under fed conditions|bioequivalence sertraline 100 mg tablets under fed conditions
652058|NCT00778986|heart failure|heart failure
652059|NCT00778986|remote patient monitoring|remote patient monitoring
652060|NCT00778986|telemonitoring|telemonitoring
652061|NCT00778986|home monitoring|home monitoring
652062|NCT00778986|randomized controlled trial|randomized controlled trial
652063|NCT00778986|self care|self care
652064|NCT00779038|IONSYS|ionsys
652065|NCT00779038|Fentanyl Iontophoretic Transdermal System|fentanyl iontophoretic transdermal system
652066|NCT00779038|Postoperative pain|postoperative pain
652067|NCT00779051|Bioequivalence Zolpidem 10mg tablets|bioequivalence zolpidem 10mg tablets
652068|NCT00779064|Atrial Fibrillation|atrial fibrillation
652069|NCT00779077|device characteristics|device characteristics
652070|NCT00779103|puberty|puberty
652071|NCT00779103|precocious puberty|precocious puberty
652072|NCT00779103|early puberty|early puberty
652073|NCT00779103|early onset puberty|early onset puberty
652074|NCT00779103|histrelin|histrelin
652075|NCT00779103|histrelin subcutaneous implant|histrelin subcutaneous implant
652076|NCT00779103|implant therapy|implant therapy
652077|NCT00779142|resistant diabetic macular edema|resistant diabetic macular edema
652078|NCT00779168|recurrent prostate cancer|recurrent prostate cancer
652079|NCT00779168|adenocarcinoma of the prostate|adenocarcinoma of the prostate
652080|NCT00779181|Hypertension|hypertension
652081|NCT00779181|High blood pressure|high blood pressure
652083|NCT00779181|Addrenex|addrenex
652084|NCT00779207|obesity|obesity
652085|NCT00779207|aging|aging
652086|NCT00779207|exercise|exercise
652087|NCT00779207|diet|diet
652088|NCT00779207|weight loss|weight loss
652089|NCT00779207|physical function|physical function
652090|NCT00779207|Obesity in the Elderly|obesity in the elderly
652091|NCT00779233|Bioequivalence|bioequivalence
652092|NCT00779246|Methicillin resistance|methicillin resistance
652093|NCT00779246|Infection control|infection control
652094|NCT00779246|Staphylococcus aureus|staphylococcus aureus
652095|NCT00779246|Cross infection|cross infection
652096|NCT00779246|Epidemiology|epidemiology
652097|NCT00779246|Chlorhexidine|chlorhexidine
652098|NCT00779259|quinine sulfate|quinine sulfate
652099|NCT00779259|theophylline|theophylline
652100|NCT00779259|drug interactions|drug interactions
652101|NCT00779259|cytochrome p450|cytochrome p450
652102|NCT00779259|humans|humans
652103|NCT00779259|male|male
652104|NCT00779259|adult|adult
652105|NCT00779272|neoadjuvant chemotherapy|neoadjuvant chemotherapy
652106|NCT00779272|clinically postoperative outcome|clinically postoperative outcome
652107|NCT00779272|liver regeneration after liver resection|liver regeneration after liver resection
652108|NCT00779298|rye whole-meal bread|rye whole-meal bread
652109|NCT00779298|white-wheat bread|white-wheat bread
652110|NCT00779298|gastric emptying rate|gastric emptying rate
652111|NCT00779298|postprandial glucose response|postprandial glucose response
652112|NCT00779298|healthy subjects|healthy subjects
652113|NCT00779311|Metastatic Colorectal Cancer|metastatic colorectal cancer
652114|NCT00779324|traumatic brain injury|traumatic brain injury
652115|NCT00779324|irritability|irritability
652116|NCT00779324|aggression|aggression
652117|NCT00779324|amantadine|amantadine
652118|NCT00779324|behavior|behavior
652119|NCT00779337|Epstein-Barr virus|epstein-barr virus
652120|NCT00779337|lymphoma|lymphoma
652121|NCT00779337|immunotherapy|immunotherapy
652122|NCT00779350|Bioequivalence sertraline 100 mg tablets fasting conditions|bioequivalence sertraline 100 mg tablets fasting conditions
652125|NCT00779376|Bioequivalence|bioequivalence
652126|NCT00779389|Head and Neck cancer|head and neck cancer
652127|NCT00779402|cancer|cancer
652128|NCT00779402|prostate cancer|prostate cancer
652129|NCT00779402|prostatectomy|prostatectomy
652131|NCT00779415|Partial Thickness|partial thickness
652132|NCT00779415|Rotator Cuff|rotator cuff
652133|NCT00779428|This is an open-label continuing treatment protocol in patients with advanced malignancies who will receive Tanespimycin|this is an open-label continuing treatment protocol in patients with advanced malignancies who will receive tanespimycin
652134|NCT00779441|Bioequivalence zolpidem 10mg tablets|bioequivalence zolpidem 10mg tablets
652135|NCT00779454|KRAS wild-type|kras wild-type
652136|NCT00779454|Cholangiocarcinoma|cholangiocarcinoma
652137|NCT00779454|Inoperable|inoperable
652138|NCT00779467|non narcotic|non narcotic
652139|NCT00779467|epidural|epidural
652140|NCT00779467|labor pain|labor pain
652141|NCT00779467|Non narcotic treatment of labor pain|non narcotic treatment of labor pain
652142|NCT00779480|Acute Myelogenous Leukemia|acute myelogenous leukemia
652143|NCT00779480|Safety|safety
652144|NCT00779480|Dose Tolerance|dose tolerance
652145|NCT00779480|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
652146|NCT00779480|FLT-3|flt-3
652147|NCT00779493|irritable bowel syndrome|irritable bowel syndrome
652148|NCT00779493|constipation|constipation
652149|NCT00779493|diarrhea|diarrhea
652150|NCT00779493|gas|gas
652151|NCT00779493|bloating|bloating
652152|NCT00779493|abdominal pain|abdominal pain
652153|NCT00779493|disturbance of defecation|disturbance of defecation
652154|NCT00779493|irritable colon|irritable colon
652155|NCT00779506|Acute schizophrenia|acute schizophrenia
652157|NCT00779519|Obesity|obesity
652158|NCT00779519|Class 1|class 1
652159|NCT00779519|Class 2|class 2
652160|NCT00779519|Weight Loss|weight loss
652161|NCT00779519|AgRP|agrp
652162|NCT00779519|TTP435|ttp435
652163|NCT00779519|alphaMSH|alphamsh
652164|NCT00779519|Agouti-Related Protein|agouti-related protein
652165|NCT00779519|alpha-melanocyte stimulating hormone|alpha-melanocyte stimulating hormone
652166|NCT00779532|Electrocardiography|electrocardiography
652167|NCT00779532|Pharmacokinetics|pharmacokinetics
652168|NCT00779571|Polycystic Ovary Syndrome|polycystic ovary syndrome
652169|NCT00779571|Morbid Obesity|morbid obesity
652170|NCT00779571|Type 2 DM|type 2 dm
652171|NCT00779571|Coronary heart disease|coronary heart disease
652172|NCT00779597|self care|self care
652173|NCT00779597|symptom management|symptom management
652174|NCT00779597|pain|pain
652175|NCT00779597|cancer|cancer
652176|NCT00779597|nurse coaching|nurse coaching
652177|NCT00779597|patient education|patient education
652178|NCT00779649|Colonoscopy,|colonoscopy,
652179|NCT00779649|Prep|prep
652180|NCT00779649|MoviPrep|moviprep
652181|NCT00779649|HalfLytely|halflytely
652182|NCT00779649|The effectiveness of colonoscopy preps|the effectiveness of colonoscopy preps
652183|NCT00779662|Rheumatic Heart Disease|rheumatic heart disease
652184|NCT00779662|Streptococcus|streptococcus
652185|NCT00779662|Fiji|fiji
652186|NCT00779688|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
652187|NCT00779688|ERCP|ercp
652188|NCT00779688|bile duct cancer|bile duct cancer
652189|NCT00779688|pancreatic duct cancer|pancreatic duct cancer
652190|NCT00779688|gall bladder|gall bladder
652191|NCT00779688|pancreas|pancreas
652192|NCT00779688|duodenoscope|duodenoscope
652193|NCT00779688|Cellvizio|cellvizio
652194|NCT00779688|endomicroscopy|endomicroscopy
652195|NCT00779688|cholangiopancreatoscopy|cholangiopancreatoscopy
652196|NCT00779688|Biliary Tract Neoplasms (suspected)|biliary tract neoplasms (suspected)
652197|NCT00779688|Biliary Tract Mass (suspected)|biliary tract mass (suspected)
652198|NCT00779688|Biliary Tract Stricture (suspected)|biliary tract stricture (suspected)
652199|NCT00779688|Pancreatic Duct Neoplasms (suspected)|pancreatic duct neoplasms (suspected)
652200|NCT00779688|Pancreatic Duct Mass (suspected)|pancreatic duct mass (suspected)
652201|NCT00779688|Pancreatic Duct Stricture (suspected)|pancreatic duct stricture (suspected)
652202|NCT00779701|Hyperglycemia|hyperglycemia
652203|NCT00779701|Glycemic control|glycemic control
652204|NCT00779714|metastatic (AJCC stage IV)|metastatic (ajcc stage iv)
652205|NCT00779714|first-line chemotherapy|first-line chemotherapy
652206|NCT00779714|ex-vivo chemosensitivity profiling|ex-vivo chemosensitivity profiling
652207|NCT00779714|evaluation of biomarkers|evaluation of biomarkers
652208|NCT00779727|women|women
652209|NCT00779727|increased|increased
653602|NCT00798902|DDD|ddd
652210|NCT00779727|risk|risk
652211|NCT00779753|Parenteral Feeding|parenteral feeding
652212|NCT00779753|Neonate|neonate
652213|NCT00779753|Lysine|lysine
652214|NCT00779766|Human papillomavirus|human papillomavirus
652215|NCT00779766|vaccine|vaccine
652216|NCT00779766|cervical cancer|cervical cancer
652217|NCT00779766|cervical infection|cervical infection
652218|NCT00779779|Gastroenteritis|gastroenteritis
652219|NCT00779792|Irritant contact dermatitis|irritant contact dermatitis
652220|NCT00779792|experimental contact dermatitis|experimental contact dermatitis
652221|NCT00779792|treatment|treatment
652223|NCT00779792|topical steroids|topical steroids
652224|NCT00779792|topical immune modulators|topical immune modulators
652225|NCT00779792|glycerol|glycerol
652226|NCT00779805|Bioequivalence Pseudoephedrine hydrochloride 120 mg ER tablets|bioequivalence pseudoephedrine hydrochloride 120 mg er tablets
652227|NCT00779831|Bioequivalence Pseudoephedrine hydrochloride 120 mg extended release tablets|bioequivalence pseudoephedrine hydrochloride 120 mg extended release tablets
652228|NCT00779844|Anesthesia|anesthesia
652229|NCT00779844|Obesity|obesity
652230|NCT00779857|left atrial appendage|left atrial appendage
652231|NCT00779857|laa|laa
652232|NCT00779857|atrial fibrillation|atrial fibrillation
652233|NCT00779857|afib|afib
652234|NCT00779857|af|af
652235|NCT00779857|stroke|stroke
652236|NCT00779857|tia|tia
652237|NCT00779870|asthma severity|asthma severity
652238|NCT00779870|airway smooth muscle|airway smooth muscle
652239|NCT00779870|oxidative stress|oxidative stress
652240|NCT00779883|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
652241|NCT00779883|CLL|cll
652242|NCT00779883|Leukemia|leukemia
652243|NCT00779883|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
652244|NCT00779883|Leukemia, B-Cell|leukemia, b-cell
652245|NCT00779883|Immune System Diseases|immune system diseases
652246|NCT00779883|ISF35|isf35
652247|NCT00779883|Ad-ISF35|ad-isf35
652248|NCT00779883|Immunotherapy|immunotherapy
652249|NCT00779883|Immune therapy|immune therapy
652250|NCT00779883|Active immune therapy|active immune therapy
751801|NCT01170520|treatment of resistant adolescent depression|treatment of resistant adolescent depression
751802|NCT01170533|proton pump inhibitor|proton pump inhibitor
751803|NCT01170533|clopidogrel|clopidogrel
652251|NCT00779896|To evaluate therapeutic potential of tazarotene 0.1% cream for the treatment of Stage I-IIA CTCL. Patients with Stage I-IIA disease are enrolled into the study|to evaluate therapeutic potential of tazarotene 0.1% cream for the treatment of stage i-iia ctcl. patients with stage i-iia disease are enrolled into the study
652252|NCT00779896|Stage I-IIA disease CTCL|stage i-iia disease ctcl
652254|NCT00779909|gingivitis|gingivitis
652255|NCT00779909|periodontal disease|periodontal disease
652256|NCT00779909|inflammation|inflammation
652257|NCT00779922|Multiple Myeloma|multiple myeloma
652258|NCT00779922|impaired renal function|impaired renal function
652259|NCT00779948|Femoral Neck Fracture|femoral neck fracture
652260|NCT00779948|Internal Fixation|internal fixation
652261|NCT00779948|Dynamic Hip Screw|dynamic hip screw
652262|NCT00779961|pediatric|pediatric
652263|NCT00779961|cleft palate|cleft palate
652264|NCT00779961|plastic surgery|plastic surgery
652265|NCT00779961|palatoplasty|palatoplasty
652266|NCT00779961|pharyngoplasty|pharyngoplasty
652267|NCT00779974|Total Shoulder Arthroplasty|total shoulder arthroplasty
652268|NCT00779974|Osteoarthritis|osteoarthritis
652269|NCT00779987|Dry eye|dry eye
652270|NCT00779987|Autologous serum|autologous serum
652271|NCT00779987|Ocular Surface Disease Index|ocular surface disease index
652472|NCT00793910|Gabapentin|gabapentin
652272|NCT00780013|Bioequivalence metformin hydrochloride|bioequivalence metformin hydrochloride
652273|NCT00780026|liver|liver
652274|NCT00780026|transplant|transplant
652275|NCT00780026|blood sugar|blood sugar
652276|NCT00780052|Hematologic Malignancies|hematologic malignancies
652277|NCT00780052|c-myb|c-myb
652278|NCT00780052|c-myb AS ODN|c-myb as odn
652279|NCT00780078|Intensive care unit|intensive care unit
652280|NCT00780078|Extubation failure|extubation failure
652281|NCT00780078|Physiotherapist|physiotherapist
652282|NCT00780078|Pre-extubation bedside tests|pre-extubation bedside tests
652283|NCT00780078|Swallowing disorders|swallowing disorders
652284|NCT00780091|optimization|optimization
652285|NCT00780091|risk scale|risk scale
652286|NCT00780091|non inferiority|non inferiority
652287|NCT00780091|cluster randomization|cluster randomization
652288|NCT00780091|monitoring strategies|monitoring strategies
652289|NCT00780104|Advanced myeloid leukemias|advanced myeloid leukemias
652290|NCT00780104|AML|aml
652291|NCT00780104|Leukemia|leukemia
652292|NCT00780104|Relapsed myeloid leukemias|relapsed myeloid leukemias
652293|NCT00780104|Refractory myeloid leukemias|refractory myeloid leukemias
652294|NCT00780104|MEC|mec
652295|NCT00780104|Rapamycin|rapamycin
652296|NCT00780104|Sirolimus|sirolimus
652297|NCT00780117|CURRARINO syndrome|currarino syndrome
652298|NCT00780117|Sacrococcygeal teratoma|sacrococcygeal teratoma
652299|NCT00780117|HLXB9 (MNX1) gene|hlxb9 (mnx1) gene
652300|NCT00780117|Alpha foeto protein|alpha foeto protein
652301|NCT00780117|Prognosis factors|prognosis factors
652302|NCT00780143|Tumor|tumor
652303|NCT00780143|Leukemia|leukemia
652304|NCT00780143|Plitidepsin|plitidepsin
652305|NCT00780143|Aplidin|aplidin
652306|NCT00780156|Drug eluting stent|drug eluting stent
652307|NCT00780156|Dual antiplatelet therapy|dual antiplatelet therapy
652308|NCT00780156|bleeding|bleeding
652309|NCT00780156|stent thrombosis|stent thrombosis
652310|NCT00780156|follow-up of the drug eluting stent|follow-up of the drug eluting stent
652311|NCT00780182|Bioavailability|bioavailability
652312|NCT00780195|hypoglycemia|hypoglycemia
652313|NCT00780195|African Americans|african americans
652314|NCT00780208|Attention Deficit Hyperactivity ADHD|attention deficit hyperactivity adhd
652315|NCT00780221|CRP|crp
652316|NCT00780221|coronary artery disease|coronary artery disease
652317|NCT00780221|polymorphisms|polymorphisms
652318|NCT00780234|chemoprevention|chemoprevention
652319|NCT00780234|lung cancer|lung cancer
652320|NCT00780234|pioglitazone|pioglitazone
652321|NCT00780247|Vitamin D|vitamin d
652322|NCT00780247|Sun|sun
652323|NCT00780247|Latitude|latitude
652324|NCT00780247|Vitamin D status|vitamin d status
652325|NCT00780260|HIV/AIDS|hiv/aids
652326|NCT00780260|African Americans|african americans
652327|NCT00780260|Women|women
652328|NCT00780260|Case Management|case management
652329|NCT00780273|subjects with edentulous mandible|subjects with edentulous mandible
652330|NCT00785993|Egg banking, clinical outcome|egg banking, clinical outcome
652331|NCT00786006|pancreatic cancer|pancreatic cancer
652332|NCT00786006|gemcitabine|gemcitabine
652333|NCT00786006|oxaliplatin|oxaliplatin
652334|NCT00786006|irinotecan|irinotecan
652335|NCT00786006|fluorouracil|fluorouracil
652336|NCT00786006|Failure to gemcitabine chemotherapy|failure to gemcitabine chemotherapy
652337|NCT00786019|Type|type
652338|NCT00786019|2|2
652339|NCT00786019|Diabetes|diabetes
652340|NCT00786019|Blood|blood
652341|NCT00786019|Vessel|vessel
652342|NCT00786019|Function|function
652343|NCT00786019|Exercise|exercise
652344|NCT00786019|Program|program
652345|NCT00786019|Intervention|intervention
652346|NCT00786019|Vitamin|vitamin
652347|NCT00786019|C|c
652348|NCT00786019|Men|men
652349|NCT00786019|Women|women
652350|NCT00786019|Blood vessel function|blood vessel function
652351|NCT00786032|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
652352|NCT00786032|Brain Computer Interface (BCI)|brain computer interface (bci)
652353|NCT00786032|Lou Gehrig's disease|lou gehrig's disease
652354|NCT00786045|stroke|stroke
652355|NCT00786045|rehabilitation|rehabilitation
652356|NCT00786045|walking|walking
652357|NCT00786058|refractory pancreatic cancer|refractory pancreatic cancer
652358|NCT00786058|gemcitabine|gemcitabine
652359|NCT00786058|phase III|phase iii
652360|NCT00786058|second line|second line
652361|NCT00786071|Rett syndrome.|rett syndrome.
652362|NCT00786071|Nutritional status.|nutritional status.
652363|NCT00786071|Metabolic alterations.|metabolic alterations.
652364|NCT00786084|Hiatal hernia|hiatal hernia
652365|NCT00786084|PEH|peh
652366|NCT00786084|paraesophageal hernia|paraesophageal hernia
652367|NCT00786084|synthetic mesh|synthetic mesh
652368|NCT00786084|small intestine submucosa|small intestine submucosa
652369|NCT00786110|Sorafenib|sorafenib
652370|NCT00786110|Paclitaxel|paclitaxel
652371|NCT00786110|Disease free survival|disease free survival
652372|NCT00786123|irritable bowel syndrome|irritable bowel syndrome
652373|NCT00786123|rectal hypersensitivity|rectal hypersensitivity
652374|NCT00786123|probiotics|probiotics
652375|NCT00786123|melatonin|melatonin
652376|NCT00786123|brain-gut axis|brain-gut axis
652377|NCT00786136|diabetes mellitus|diabetes mellitus
652378|NCT00786136|chronic kidney disease|chronic kidney disease
652379|NCT00786136|contrast induced acute kidney injury|contrast induced acute kidney injury
652380|NCT00786136|angiography|angiography
652381|NCT00786149|Underserved populations|underserved populations
652382|NCT00786149|Homelessness|homelessness
652383|NCT00786149|Nicotine replacement therapy|nicotine replacement therapy
652384|NCT00786149|Counseling|counseling
652385|NCT00786149|Cancer Prevention and control|cancer prevention and control
652386|NCT00786188|Menopause|menopause
652387|NCT00786188|Vasomotor Symptoms|vasomotor symptoms
652388|NCT00786188|Hot flash|hot flash
652389|NCT00786188|Perimenopause|perimenopause
652390|NCT00786188|Nonhormonal therapies|nonhormonal therapies
652391|NCT00786188|Climacteric symptoms|climacteric symptoms
652392|NCT00786188|Mesafem|mesafem
652393|NCT00786188|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
652394|NCT00786201|CNTO 888|cnto 888
652395|NCT00786201|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
652396|NCT00786201|IPF|ipf
652397|NCT00786214|Functional Dyspepsia|functional dyspepsia
652398|NCT00786214|Acupuncture|acupuncture
652399|NCT00786214|Traditional Chinese Medicine|traditional chinese medicine
652400|NCT00786240|Bioequivalence|bioequivalence
652401|NCT00786240|Therapeutic Equivalency|therapeutic equivalency
652402|NCT00786253|Erectile dysfunction|erectile dysfunction
652403|NCT00786253|Vardenafil|vardenafil
652404|NCT00786266|shift-work|shift-work
652405|NCT00786266|sleep|sleep
652406|NCT00786266|nurse|nurse
652407|NCT00786266|relaxation|relaxation
652408|NCT00786279|atherosclerosis|atherosclerosis
652409|NCT00786305|Nebulization|nebulization
652410|NCT00786305|ceftazidime|ceftazidime
652411|NCT00786305|amikacin|amikacin
652412|NCT00786305|pneumonia|pneumonia
652413|NCT00786305|Pseudomonas aeruginosa|pseudomonas aeruginosa
652414|NCT00786305|mechanical ventilation|mechanical ventilation
652415|NCT00786305|Ventilator-associated pneumonia|ventilator-associated pneumonia
652416|NCT00786305|treatment|treatment
652417|NCT00786318|Psychosis|psychosis
652418|NCT00786318|Agitation|agitation
652419|NCT00786318|Delirium|delirium
652420|NCT00793663|Xenon|xenon
652421|NCT00793663|Sevoflurane|sevoflurane
652520|NCT00794105|Middle ear|middle ear
652422|NCT00793663|Postoperative Nausea and vomiting|postoperative nausea and vomiting
652423|NCT00793663|Depth of anaesthesia|depth of anaesthesia
652424|NCT00793676|GPCR expression|gpcr expression
652425|NCT00793676|transcriptomic|transcriptomic
652426|NCT00793676|white blood cells|white blood cells
652427|NCT00793676|diagnostic|diagnostic
652428|NCT00793676|Control|control
652429|NCT00793689|parathyroid|parathyroid
652430|NCT00793689|thyroidectomy|thyroidectomy
652431|NCT00793689|hypoparathyroidism|hypoparathyroidism
652432|NCT00793689|Parathyroid function after total thyroidectomy|parathyroid function after total thyroidectomy
652433|NCT00793702|tuberculosis|tuberculosis
652434|NCT00793702|diagnosis|diagnosis
652435|NCT00793702|ESAT-6|esat-6
652436|NCT00793702|CFP-10|cfp-10
652437|NCT00793702|skin test|skin test
652438|NCT00793702|Skin test for the diagnosis of tuberculosis infection|skin test for the diagnosis of tuberculosis infection
652439|NCT00793715|acute pancreatitis|acute pancreatitis
652440|NCT00793715|abdominal compartment syndrome|abdominal compartment syndrome
652441|NCT00793715|decompressive laparotomy|decompressive laparotomy
652442|NCT00793715|percutaneous abdominal puncture|percutaneous abdominal puncture
652443|NCT00793715|Mortality of patients treated in both arms|mortality of patients treated in both arms
652444|NCT00793728|Morbid obesity|morbid obesity
652445|NCT00793728|High risk|high risk
652446|NCT00793741|Type 1 diabetes|type 1 diabetes
652447|NCT00793741|Hypoglycemia unawareness|hypoglycemia unawareness
652448|NCT00793741|Islet transplant|islet transplant
652449|NCT00793767|Erythropoietin|erythropoietin
652450|NCT00793767|human muscle tissue|human muscle tissue
652451|NCT00793767|insulin sensitivity|insulin sensitivity
652452|NCT00793767|substrate metabolism|substrate metabolism
652454|NCT00793780|schizophrenia|schizophrenia
652455|NCT00793780|schizoaffective disorder|schizoaffective disorder
652456|NCT00793780|weight loss|weight loss
652457|NCT00793806|chronic kidney disease|chronic kidney disease
652458|NCT00793819|nocturia|nocturia
652459|NCT00793819|BPH|bph
652460|NCT00793819|benign prostate hyperplasia|benign prostate hyperplasia
652461|NCT00793819|nocturia in men with benign prostate hyperplasia|nocturia in men with benign prostate hyperplasia
652462|NCT00793832|weight loss|weight loss
652463|NCT00793845|tandem high-dose chemotherapy for high-risk neuroblastoma|tandem high-dose chemotherapy for high-risk neuroblastoma
652464|NCT00793871|sunitinib|sunitinib
652465|NCT00793871|Phase IV|phase iv
652466|NCT00793871|gastrointestinal stomal tumor|gastrointestinal stomal tumor
652467|NCT00793871|imatinib resistant or intolerant|imatinib resistant or intolerant
652468|NCT00793871|Chinese|chinese
652469|NCT00793884|Diabetes|diabetes
652470|NCT00793884|Latino population|latino population
652471|NCT00793897|Subjects with Advanced or Metastatic Solid Tumors or Neoplasms|subjects with advanced or metastatic solid tumors or neoplasms
652474|NCT00793910|pain|pain
652475|NCT00793923|Exudative Age Related Macular Degeneration|exudative age related macular degeneration
652476|NCT00793936|Right Double Lumen Tube|right double lumen tube
652477|NCT00793962|breast cancer|breast cancer
652478|NCT00793962|mastectomy|mastectomy
652479|NCT00793962|radiotherapy|radiotherapy
652480|NCT00793962|fractionation|fractionation
652481|NCT00793975|Tumors|tumors
652482|NCT00793975|Antibodies, Monoclonal|antibodies, monoclonal
652483|NCT00793988|vibration|vibration
652484|NCT00793988|local anaesthesia|local anaesthesia
652485|NCT00793988|ptosis surgery|ptosis surgery
652486|NCT00793988|blepharoplasty|blepharoplasty
652487|NCT00793988|Upper eyelid surgery|upper eyelid surgery
652488|NCT00793988|dermatochalasis +/- blepharoptosis|dermatochalasis +/- blepharoptosis
652489|NCT00794001|myocardial infarction|myocardial infarction
652490|NCT00794001|angioplasty|angioplasty
652491|NCT00794001|data feedback|data feedback
652492|NCT00794001|continuous quality improvement|continuous quality improvement
652493|NCT00794001|STEMI|stemi
652494|NCT00794001|Feedback|feedback
652495|NCT00794001|Quality Assurance, Health Care|quality assurance, health care
652496|NCT00794001|Emergency service hospital|emergency service hospital
652497|NCT00794014|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
652498|NCT00794027|heart failure|heart failure
652499|NCT00794027|yoga|yoga
652500|NCT00794027|quality of life|quality of life
652501|NCT00794040|Irritability|irritability
652502|NCT00794040|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
652503|NCT00794040|Explosive|explosive
652504|NCT00794040|Tantrums|tantrums
652505|NCT00794040|Bipolar Mood Disorder|bipolar mood disorder
652506|NCT00794040|Mood Disorder|mood disorder
652507|NCT00794040|Childhood Mood Disorder|childhood mood disorder
652508|NCT00794040|ADHD|adhd
652509|NCT00794053|Sentinel lymph node|sentinel lymph node
652510|NCT00794053|thyroid cancer|thyroid cancer
652511|NCT00794053|neck dissection|neck dissection
652512|NCT00794066|PAD|pad
652513|NCT00794066|Stroke|stroke
652514|NCT00794066|ICH|ich
652515|NCT00794066|prevalence|prevalence
652516|NCT00794079|Healthy volunteers|healthy volunteers
652517|NCT00794079|young adults|young adults
652518|NCT00794079|Aged|aged
652519|NCT00794105|Gas|gas
652522|NCT00794131|vaccinia virus|vaccinia virus
652523|NCT00794131|vaccinia|vaccinia
652524|NCT00794131|oncolytic|oncolytic
652525|NCT00794131|oncolytic virus|oncolytic virus
652526|NCT00794131|biological|biological
652527|NCT00794131|imaging|imaging
652528|NCT00794144|Allergic Rhinitis|allergic rhinitis
652529|NCT00794144|Pediatric|pediatric
652530|NCT00794144|PATANASE|patanase
652531|NCT00794157|COPD|copd
652532|NCT00794157|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
652533|NCT00794157|indacaterol|indacaterol
652534|NCT00794157|long acting β2-agonist|long acting β2-agonist
652535|NCT00794170|Treatment Compliance|treatment compliance
652536|NCT00794183|heart failure|heart failure
652537|NCT00794183|CRT|crt
652538|NCT00794183|CHF|chf
652539|NCT00794196|Medication adherence|medication adherence
652540|NCT00794196|Antidepressive agents|antidepressive agents
652541|NCT00794196|Primary care|primary care
652542|NCT00794196|Pharmaceutical care|pharmaceutical care
652543|NCT00794209|AeroLEF, fentanyl, liposome encapsulated, opioid|aerolef, fentanyl, liposome encapsulated, opioid
652544|NCT00794222|Cellular phones|cellular phones
652545|NCT00794222|mental health|mental health
652546|NCT00794222|Early intervention|early intervention
652547|NCT00794222|prevention|prevention
652548|NCT00794222|momentary sampling|momentary sampling
652549|NCT00794222|Adolescent|adolescent
652550|NCT00794261|Myeloma|myeloma
652551|NCT00794261|lymphoma|lymphoma
652552|NCT00794261|high-dose chemotherapy|high-dose chemotherapy
652553|NCT00794261|PSC infusion, autologous|psc infusion, autologous
652554|NCT00794261|neutropenia|neutropenia
652555|NCT00794261|thrombocytopenia|thrombocytopenia
652556|NCT00794261|hospital stay|hospital stay
652557|NCT00794261|infection|infection
652558|NCT00794261|Autologous PSC transplantation for patients with lymphoma or myeloma treated with high-dose chemotherapy|autologous psc transplantation for patients with lymphoma or myeloma treated with high-dose chemotherapy
652559|NCT00794274|Sarcodiosis|sarcodiosis
652560|NCT00794274|tumor necrosis factor|tumor necrosis factor
652561|NCT00794300|reproducibility|reproducibility
652562|NCT00794300|contrast agent|contrast agent
652563|NCT00794300|magnetic resonance imaging|magnetic resonance imaging
652564|NCT00794300|infarct size|infarct size
652565|NCT00794300|myocardial salvage index|myocardial salvage index
652566|NCT00794300|myocardial salvage assessment|myocardial salvage assessment
652567|NCT00794313|Parkinsons disease|parkinsons disease
652568|NCT00794313|dyskinesia|dyskinesia
652569|NCT00794313|amantadine|amantadine
652570|NCT00794313|efficacy|efficacy
652571|NCT00794326|Chronic Kidney Failure|chronic kidney failure
652572|NCT00794326|Peritoneal Dialysis|peritoneal dialysis
652573|NCT00794326|Low sodium solution|low sodium solution
652574|NCT00794326|Hypertension|hypertension
652575|NCT00794326|Total Body Water|total body water
652576|NCT00794339|cervical squamous cell carcinoma|cervical squamous cell carcinoma
652577|NCT00794339|stage IIB cervical cancer|stage iib cervical cancer
652578|NCT00794339|stage III cervical cancer|stage iii cervical cancer
652579|NCT00794339|stage IV cervical cancer|stage iv cervical cancer
652580|NCT00794339|stage IVA cervical cancer|stage iva cervical cancer
652581|NCT00794339|stage IB cervical cancer|stage ib cervical cancer
652582|NCT00794339|stage IIA cervical cancer|stage iia cervical cancer
652583|NCT00794352|Inflammation|inflammation
652584|NCT00794352|Multiple Sclerosis|multiple sclerosis
652585|NCT00794352|Neuroimmunology|neuroimmunology
652586|NCT00794352|Immune Disorder|immune disorder
652587|NCT00794352|Neuroimaging|neuroimaging
652588|NCT00794352|Central Nervous System Disease|central nervous system disease
652589|NCT00794352|Healthy Volunteers|healthy volunteers
652591|NCT00794365|Smoking; smoking cessation; Philippines; Varenicline|smoking; smoking cessation; philippines; varenicline
652592|NCT00794391|Vulnerable Populations|vulnerable populations
652593|NCT00794391|Injecting drug users|injecting drug users
652595|NCT00794391|Risky injecting practices|risky injecting practices
652596|NCT00794391|Psychotherapy, brief|psychotherapy, brief
652597|NCT00794391|Motivational interviewing|motivational interviewing
652598|NCT00794391|Educational activities|educational activities
652599|NCT00794391|Clinical trial|clinical trial
652600|NCT00794391|Risk behavior|risk behavior
652601|NCT00794391|risk reduction behavior|risk reduction behavior
652602|NCT00794417|advanced cancer|advanced cancer
652603|NCT00794417|lung cancer|lung cancer
652604|NCT00794417|NSCLC|nsclc
652605|NCT00794417|Non-small Cell Lung Cancer|non-small cell lung cancer
652606|NCT00794417|aflibercept|aflibercept
652607|NCT00794417|chemotherapy|chemotherapy
652608|NCT00794430|Safety|safety
652609|NCT00794430|Tolerability|tolerability
652610|NCT00794430|Efficacy|efficacy
652611|NCT00794430|Patients|patients
652612|NCT00794430|Diabetic peripheral neuropathic pain.|diabetic peripheral neuropathic pain.
652613|NCT00794443|ONO-5920|ono-5920
652614|NCT00794443|YM529|ym529
652615|NCT00794443|Bone mineral density|bone mineral density
652616|NCT00794443|Minodronic acid|minodronic acid
652617|NCT00794456|Passiflora|passiflora
652618|NCT00794456|Crataegus|crataegus
652619|NCT00794456|Herbal|herbal
652620|NCT00794456|Valeriana|valeriana
652622|NCT00794469|Resting metabolic rate|resting metabolic rate
652623|NCT00794508|Severe Combined Immune Deficiency|severe combined immune deficiency
652624|NCT00794508|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
652625|NCT00794508|Gene Therapy|gene therapy
652626|NCT00794508|Hematopoietic Stem Cells|hematopoietic stem cells
652627|NCT00794508|Retroviral Vector|retroviral vector
652628|NCT00794508|ADA-deficient SCID|ada-deficient scid
652629|NCT00794547|lung cancer; nsclc|lung cancer; nsclc
652630|NCT00794560|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
652631|NCT00794560|compliance|compliance
652632|NCT00794560|drug safety|drug safety
652633|NCT00794560|self-administration|self-administration
652634|NCT00794560|ambulatory Care|ambulatory care
652635|NCT00794560|Pharmaceutical Services|pharmaceutical services
652636|NCT00794573|Smoking Cessation|smoking cessation
652637|NCT00794573|Cardiac Population|cardiac population
652638|NCT00794573|Acute Coronary Syndrome|acute coronary syndrome
652639|NCT00794573|Varenicline|varenicline
652640|NCT00794573|Champix|champix
652641|NCT00794586|cystic fibrosis|cystic fibrosis
652642|NCT00794586|CF|cf
652643|NCT00794586|inhaled antibiotic|inhaled antibiotic
652644|NCT00794586|antipseudomonal antibiotic|antipseudomonal antibiotic
652645|NCT00794586|tobramycin|tobramycin
652646|NCT00794586|fosfomycin|fosfomycin
652647|NCT00794586|lung infection|lung infection
652648|NCT00794586|pseudomonal infection|pseudomonal infection
652649|NCT00794586|FTI|fti
652650|NCT00794625|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
652651|NCT00794625|Aggressive Behavior|aggressive behavior
652652|NCT00794625|Oppositional Defiant Disorder|oppositional defiant disorder
652653|NCT00794625|Conduct Disorder|conduct disorder
652654|NCT00794638|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
652655|NCT00794638|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
652656|NCT00794638|Mantle cell Lymphoma|mantle cell lymphoma
652657|NCT00794638|Transformed lymphoma, transformed to diffuse large B-cell lymphoma|transformed lymphoma, transformed to diffuse large b-cell lymphoma
652658|NCT00794638|Follicular Lymphoma|follicular lymphoma
652659|NCT00794651|osteoarthritis|osteoarthritis
652660|NCT00794651|testing kit|testing kit
652661|NCT00794651|knee|knee
652662|NCT00794677|Hypercholesterolemia|hypercholesterolemia
652663|NCT00794677|Oxysterol|oxysterol
652664|NCT00794677|Ezetimibe|ezetimibe
652665|NCT00794677|Zetia|zetia
652666|NCT00794690|cimicifuga racemosa|cimicifuga racemosa
652667|NCT00794690|liver blood flow and functions|liver blood flow and functions
652668|NCT00794703|Antifungal|antifungal
652669|NCT00794703|micafungin|micafungin
652670|NCT00794703|itraconazole|itraconazole
652671|NCT00794729|Healthy Volunteers|healthy volunteers
652672|NCT00794729|Consents|consents
652673|NCT00794742|Burn|burn
652674|NCT00794742|Antimicrobial|antimicrobial
652675|NCT00794742|Bacteria|bacteria
652676|NCT00794742|Resistance|resistance
652677|NCT00794742|Biofilm|biofilm
652678|NCT00794742|Pathogen|pathogen
652679|NCT00794755|Vitamin K|vitamin k
652680|NCT00794755|Vitamin K1 (Phytonadione)|vitamin k1 (phytonadione)
652681|NCT00794755|Unstable INR|unstable inr
652682|NCT00794755|VTE or Thrombosis|vte or thrombosis
652683|NCT00794755|Warfarin|warfarin
652684|NCT00794755|Anticoagulation Control|anticoagulation control
652685|NCT00794755|Patients on warfarin with unstable anticoagulation control|patients on warfarin with unstable anticoagulation control
652686|NCT00794781|Cancer|cancer
652687|NCT00794781|solid tumors|solid tumors
652688|NCT00794807|Alefacept|alefacept
652689|NCT00794807|Skin Diseases|skin diseases
652690|NCT00794807|Psoriasis|psoriasis
652691|NCT00794807|Skin Diseases, Papulosquamos|skin diseases, papulosquamos
652692|NCT00794807|Therapeutic Uses|therapeutic uses
652693|NCT00794807|Dermatologic Agents|dermatologic agents
652694|NCT00794820|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
652695|NCT00794820|CLL|cll
652696|NCT00794820|Leukemia|leukemia
652697|NCT00794820|Fludarabine phosphate|fludarabine phosphate
652698|NCT00794820|Cyclophosphamide|cyclophosphamide
652699|NCT00794820|Rituximab|rituximab
652700|NCT00794820|FCR|fcr
652701|NCT00794820|Cytoxan®|cytoxan®
652702|NCT00794820|Neosar®|neosar®
652703|NCT00794820|Rituxan®|rituxan®
652704|NCT00794872|Cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
652705|NCT00794872|Chemoreflex sensitivity|chemoreflex sensitivity
652706|NCT00794872|Chronic kidney disease|chronic kidney disease
652707|NCT00794872|Sudden cardiac arrest|sudden cardiac arrest
652708|NCT00794885|hypertension|hypertension
652709|NCT00794885|stroke|stroke
652710|NCT00794885|cardiovascular events|cardiovascular events
652711|NCT00794885|enalapril|enalapril
652712|NCT00794885|folic acid|folic acid
652713|NCT00794885|randomized controlled trial|randomized controlled trial
652714|NCT00794885|MTHFR C677T genotype|mthfr c677t genotype
652715|NCT00794911|Liver Transplantation|liver transplantation
652716|NCT00794911|Quality of Life|quality of life
652717|NCT00794911|Chronic HCV|chronic hcv
652718|NCT00794911|Hepatitis C Virus|hepatitis c virus
652719|NCT00794911|Cirrhosis|cirrhosis
652720|NCT00794911|Liver disease|liver disease
652725|NCT00794950|Bladder Cancer|bladder cancer
652726|NCT00794950|High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma|high risk non-muscle invasive lower urinary tract urothelial carcinoma
652727|NCT00794989|breast cancer|breast cancer
652728|NCT00794989|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
652729|NCT00794989|lobular breast carcinoma in situ|lobular breast carcinoma in situ
652730|NCT00794989|ductal breast carcinoma in situ|ductal breast carcinoma in situ
652731|NCT00794989|breast cancer prevention|breast cancer prevention
652732|NCT00794989|high risk breast cancer|high risk breast cancer
652733|NCT00795015|postoperative blood glucose control|postoperative blood glucose control
652734|NCT00795015|IV insulin infusion|iv insulin infusion
652735|NCT00795028|older women|older women
652736|NCT00795028|hip fracture|hip fracture
652737|NCT00795028|exercise intervention|exercise intervention
652738|NCT00795041|vitrification|vitrification
652739|NCT00795041|ovarian stimulation|ovarian stimulation
652740|NCT00795041|reproductive medicine|reproductive medicine
652741|NCT00795054|Stem cell transplantation|stem cell transplantation
652742|NCT00795054|Financial impact|financial impact
652743|NCT00795080|CVJ malformations|cvj malformations
652745|NCT00795093|PPI|ppi
652746|NCT00795093|partial responders|partial responders
652747|NCT00795106|Capsaicin|capsaicin
652748|NCT00795106|hydrogel|hydrogel
652749|NCT00795106|myofascial pain syndrome|myofascial pain syndrome
652750|NCT00795106|neck pain|neck pain
652751|NCT00795119|Near Infrared Spectroscopy|near infrared spectroscopy
652752|NCT00795119|Diagnosis|diagnosis
652753|NCT00795119|Children|children
652754|NCT00795132|cancer|cancer
652755|NCT00795132|Hematologic Malignancies|hematologic malignancies
652756|NCT00795132|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
652757|NCT00795145|Linezolid, QTc interval, pharmacokinetics, therapeutic dose, supra-therapeutic dose|linezolid, qtc interval, pharmacokinetics, therapeutic dose, supra-therapeutic dose
652758|NCT00795184|Barrett's Esophagus|barrett's esophagus
652759|NCT00795184|EsoGastroDuodenoscopy|esogastroduodenoscopy
652760|NCT00795184|Barrett's Carcinoma|barrett's carcinoma
652761|NCT00795184|adenocarcinoma|adenocarcinoma
652762|NCT00795184|Cellvizio|cellvizio
652763|NCT00795184|endomicroscopy|endomicroscopy
652764|NCT00795184|random biopsy|random biopsy
652765|NCT00795197|Gaucher Disease,|gaucher disease,
652766|NCT00795197|acid B-glucosidase,|acid b-glucosidase,
653054|NCT00796211|Dermatology|dermatology
652767|NCT00795197|gluco cerebrosidase,|gluco cerebrosidase,
652768|NCT00795197|glucosylceramide,|glucosylceramide,
652769|NCT00795210|HIV lipodystrophy|hiv lipodystrophy
652770|NCT00795210|growth hormone|growth hormone
652771|NCT00795210|growth hormone releasing hormone|growth hormone releasing hormone
652772|NCT00795236|melatonin|melatonin
652773|NCT00795262|brachial artery reactivity|brachial artery reactivity
652774|NCT00795275|pre-diabetes|pre-diabetes
652775|NCT00795275|isotopes|isotopes
652776|NCT00795275|insulin secretion|insulin secretion
652777|NCT00795275|insulin action|insulin action
652778|NCT00795275|GLP-1|glp-1
652779|NCT00795275|simple obesity|simple obesity
652780|NCT00795275|impaired fasting glucose|impaired fasting glucose
652781|NCT00795288|subarachnoid hemorrhage|subarachnoid hemorrhage
652782|NCT00795288|vasospasm|vasospasm
652783|NCT00795288|cerebral blood flow|cerebral blood flow
652784|NCT00795288|cerebral metabolism|cerebral metabolism
652785|NCT00795288|autoregulation|autoregulation
652786|NCT00795288|statin|statin
652787|NCT00795288|Vasospasm associated with Subarachnoid hemorrhage|vasospasm associated with subarachnoid hemorrhage
652788|NCT00795301|tumor|tumor
652789|NCT00795314|Opioids|opioids
652790|NCT00795314|General anesthesia|general anesthesia
652791|NCT00795340|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
652792|NCT00795340|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
652793|NCT00795340|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
652794|NCT00795353|plaque psoriasis|plaque psoriasis
652795|NCT00795353|psoriasis|psoriasis
652796|NCT00795353|alefacept|alefacept
652797|NCT00795353|Amevive|amevive
652798|NCT00795366|TBI, trauma, brain|tbi, trauma, brain
652799|NCT00795379|Psychotherapy|psychotherapy
652800|NCT00795392|Psychology|psychology
652801|NCT00795392|Postoperative outcome|postoperative outcome
652802|NCT00795392|Surgical Operation|surgical operation
652803|NCT00795405|sporting events|sporting events
652804|NCT00795405|stress|stress
652805|NCT00795405|myocardial ischemia|myocardial ischemia
652806|NCT00795405|ST-segment depression|st-segment depression
652807|NCT00795405|blood pressure|blood pressure
652808|NCT00795418|Active immunization|active immunization
652809|NCT00795418|Alzheimer's disease|alzheimer's disease
652810|NCT00795418|Antibody|antibody
652811|NCT00795418|Vaccine|vaccine
652812|NCT00795418|Central Nervous System Diseases|central nervous system diseases
652813|NCT00795418|Neurodegenerative diseases|neurodegenerative diseases
652814|NCT00795444|HIV-1|hiv-1
652815|NCT00795444|CCR5 coreceptor antagonist (Maraviroc)|ccr5 coreceptor antagonist (maraviroc)
652816|NCT00795444|the cell reservoir of HIV-1|the cell reservoir of hiv-1
652817|NCT00795457|vaccine|vaccine
652818|NCT00795457|WHO Grade II Astrocytoma|who grade ii astrocytoma
652819|NCT00795457|WHO Grade II Oligo-Astrocytoma|who grade ii oligo-astrocytoma
652820|NCT00795470|urinary tract infection|urinary tract infection
652821|NCT00795470|critically ill|critically ill
652823|NCT00795470|antimicrobial|antimicrobial
652824|NCT00795470|Catheter associated urinary tract infections|catheter associated urinary tract infections
652825|NCT00795483|Osteoporosis|osteoporosis
652826|NCT00795483|HIV infection|hiv infection
652827|NCT00795483|Bisphosphonates|bisphosphonates
652828|NCT00795483|Zoledronic acid|zoledronic acid
652829|NCT00795496|Atopic dermatitis|atopic dermatitis
652830|NCT00795496|Bronchial hyperreactivity|bronchial hyperreactivity
652831|NCT00795496|Skin prick tests|skin prick tests
652832|NCT00795496|Serum IgE|serum ige
652833|NCT00795496|Mantoux test|mantoux test
652834|NCT00795535|Injury|injury
652835|NCT00795548|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
652836|NCT00795548|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
652837|NCT00795548|Stem cell transplantation|stem cell transplantation
652838|NCT00795548|5-Azacitidine|5-azacitidine
652839|NCT00795548|Donor lymphocyte infusion|donor lymphocyte infusion
652840|NCT00795548|MDS or AML relapsed after stem cell transplantation|mds or aml relapsed after stem cell transplantation
652841|NCT00795561|Hyperemesis gravidarum|hyperemesis gravidarum
652842|NCT00795561|nausea|nausea
652843|NCT00795561|vomiting|vomiting
652844|NCT00795561|pregnancy|pregnancy
652845|NCT00795561|day care|day care
652846|NCT00795561|inpatient management|inpatient management
652847|NCT00795561|Nausea and vomiting of pregnancy|nausea and vomiting of pregnancy
652848|NCT00795574|Hidradenitis Suppurativa|hidradenitis suppurativa
652849|NCT00795613|PET|pet
652850|NCT00795626|nursing education|nursing education
652851|NCT00795626|cardiovascular risk factors|cardiovascular risk factors
652852|NCT00795626|coronary heart disease|coronary heart disease
652853|NCT00795639|Sitaxsentan|sitaxsentan
652854|NCT00795639|endothelin receptor antagonist|endothelin receptor antagonist
652855|NCT00795652|Postpartum depression|postpartum depression
652856|NCT00795652|Distance therapy|distance therapy
652857|NCT00795652|depression|depression
652858|NCT00795652|Distance Treatment|distance treatment
652859|NCT00795652|Barriers to care|barriers to care
652860|NCT00795665|adult anaplastic astrocytoma|adult anaplastic astrocytoma
652861|NCT00795665|adult glioblastoma|adult glioblastoma
652862|NCT00795665|adult gliosarcoma|adult gliosarcoma
652863|NCT00795665|adult giant cell glioblastoma|adult giant cell glioblastoma
652864|NCT00795665|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
652865|NCT00795665|adult mixed glioma|adult mixed glioma
652866|NCT00795665|recurrent adult brain tumor|recurrent adult brain tumor
652867|NCT00795678|tumors metastatic to brain|tumors metastatic to brain
652868|NCT00795678|stage IV breast cancer|stage iv breast cancer
652869|NCT00795691|diabetes|diabetes
652870|NCT00795691|low-carbohydrate diet|low-carbohydrate diet
652871|NCT00795691|weight loss|weight loss
652872|NCT00795691|obesity|obesity
652873|NCT00795691|dietary intervention|dietary intervention
652874|NCT00795704|Herbal Supplement|herbal supplement
652875|NCT00795704|Type 2 Diabetes|type 2 diabetes
652876|NCT00795704|Mulberry|mulberry
652877|NCT00795704|Hemoglobin A1C|hemoglobin a1c
652879|NCT00795717|cardiovascular risk|cardiovascular risk
652880|NCT00795717|atherogenic lipid profile|atherogenic lipid profile
652881|NCT00795717|brachial artery reactivity|brachial artery reactivity
652882|NCT00795717|omega three fatty acids|omega three fatty acids
652883|NCT00795730|Alzheimer's Disease|alzheimer's disease
652884|NCT00795730|schizophrenia|schizophrenia
652885|NCT00795743|Central Venous Catheterization|central venous catheterization
652886|NCT00795743|coagulopathy|coagulopathy
652887|NCT00795743|thromboelastography|thromboelastography
652888|NCT00795756|Adults|adults
652984|NCT00796185|Mood Disorders|mood disorders
652889|NCT00795756|Central nervous system prophylaxis|central nervous system prophylaxis
652890|NCT00795756|Minimal residual disease|minimal residual disease
652891|NCT00795782|Papillary thyroid carcinoma|papillary thyroid carcinoma
652892|NCT00795782|Lymph node dissection|lymph node dissection
652893|NCT00795782|Lymph node metastasis|lymph node metastasis
652894|NCT00795782|Prophylactic node dissection|prophylactic node dissection
652895|NCT00795782|Central lymph node metastasis|central lymph node metastasis
652896|NCT00795795|Chromosomal abnormalities in preimplantation embryos|chromosomal abnormalities in preimplantation embryos
652897|NCT00795808|Polycystic ovary syndrome|polycystic ovary syndrome
652898|NCT00795808|PCOS|pcos
652899|NCT00795808|Anovulation|anovulation
652900|NCT00795808|Infertility|infertility
652901|NCT00795808|Anovulatory polycystic ovary syndrome (PCOS)|anovulatory polycystic ovary syndrome (pcos)
652902|NCT00795834|polyphenolics|polyphenolics
652903|NCT00795834|flavonols|flavonols
652904|NCT00795834|lipids|lipids
652905|NCT00795834|endothelial function|endothelial function
652906|NCT00795834|vascular risk factors|vascular risk factors
652907|NCT00795847|Hypertensive patients with morning hypertension|hypertensive patients with morning hypertension
652908|NCT00795860|Insulin sensitivity|insulin sensitivity
652909|NCT00795860|fat metabolism|fat metabolism
652910|NCT00795860|inflammation|inflammation
652911|NCT00795873|Heart failure|heart failure
652912|NCT00795873|cardiac resynchronization therapy|cardiac resynchronization therapy
652913|NCT00795886|ALL|all
652914|NCT00795886|Cancer|cancer
652915|NCT00795886|Stem Cell Transplant|stem cell transplant
652916|NCT00795899|Safety and efficacy of experimental treatment|safety and efficacy of experimental treatment
652917|NCT00795912|Systolic heart failure|systolic heart failure
652918|NCT00795912|HMG CoA reductase inhibitors|hmg coa reductase inhibitors
652919|NCT00795912|B-type natriuretic peptide|b-type natriuretic peptide
652920|NCT00795912|Inflammation|inflammation
652921|NCT00795912|Myocardial collagen turnover|myocardial collagen turnover
652922|NCT00795925|propiverine|propiverine
652923|NCT00795925|anticholinergics|anticholinergics
652924|NCT00795925|urinary incontinence|urinary incontinence
652925|NCT00795925|overactive bladder|overactive bladder
652926|NCT00795925|children|children
652927|NCT00795925|dose-finding in children aged 5-10 years|dose-finding in children aged 5-10 years
652928|NCT00795951|allergic|allergic
652929|NCT00795951|contact dermatitis|contact dermatitis
652930|NCT00795951|contact allergy|contact allergy
652931|NCT00795951|Type IV|type iv
652932|NCT00795951|Children|children
652933|NCT00795951|TRUE TEST|true test
652934|NCT00795964|tidal volume|tidal volume
652935|NCT00795964|predicted body weight|predicted body weight
652936|NCT00795964|lung function|lung function
652937|NCT00795964|respiratory outcome|respiratory outcome
652938|NCT00795964|Respiratory Function Tests|respiratory function tests
652940|NCT00795977|preoperative|preoperative
652941|NCT00795977|intratumor|intratumor
652942|NCT00795977|dendritic cells|dendritic cells
652943|NCT00795977|pancreatic cancer|pancreatic cancer
652944|NCT00795977|OK-432|ok-432
652945|NCT00795990|Efficacy of early vs late use of ibuprofen for PDA closure|efficacy of early vs late use of ibuprofen for pda closure
652946|NCT00796003|Myelodysplastic syndrome|myelodysplastic syndrome
652947|NCT00796003|MDS|mds
652948|NCT00796003|Decitabine|decitabine
652949|NCT00796003|JNJ-30979754|jnj-30979754
652950|NCT00796029|Schizophrenia|schizophrenia
652951|NCT00796029|Mood disorders|mood disorders
652952|NCT00796029|Antipsychotic drugs: 14C-paliperidone|antipsychotic drugs: 14c-paliperidone
652953|NCT00796042|Pressure Ulcer|pressure ulcer
652954|NCT00796042|Bed Sores|bed sores
652955|NCT00796042|Bedsore|bedsore
652956|NCT00796042|Decubitus Ulcer|decubitus ulcer
652957|NCT00796042|Pressure Sore|pressure sore
652958|NCT00796042|Best rest|best rest
652959|NCT00796042|mobility|mobility
652960|NCT00796042|pressure management|pressure management
652961|NCT00796081|Schizophrenia|schizophrenia
652962|NCT00796081|Schizoaffective disorder|schizoaffective disorder
652963|NCT00796081|Schizophreniform disorders|schizophreniform disorders
652964|NCT00796081|Mood disorders|mood disorders
652965|NCT00796081|Antipshychotic drugs|antipshychotic drugs
652966|NCT00796081|Pediatrics|pediatrics
652967|NCT00796081|ER OROS Paliperidone, Paliperidone ER|er oros paliperidone, paliperidone er
652968|NCT00796120|Sarcomas|sarcomas
652969|NCT00796120|Trabectedin|trabectedin
652970|NCT00796120|Doxorubicin|doxorubicin
652971|NCT00796120|Ifosfamide|ifosfamide
652972|NCT00796120|YONDELIS|yondelis
652973|NCT00796133|NES/E2|nes/e2
652974|NCT00796133|transdermal gel delivery|transdermal gel delivery
652975|NCT00796133|contraception|contraception
652976|NCT00796133|ovulation|ovulation
652977|NCT00796133|bleeding patterns|bleeding patterns
652978|NCT00796159|Efficacy; Tolerability; Safety; Essential Hypertension|efficacy; tolerability; safety; essential hypertension
652979|NCT00796172|Hypertension|hypertension
652980|NCT00796172|High Blood Pressure|high blood pressure
652981|NCT00796172|Blood Lipid Management|blood lipid management
652982|NCT00796185|Schizophrenia|schizophrenia
652983|NCT00796185|Schizoaffective Disorder|schizoaffective disorder
653280|NCT00797693|misoprostol|misoprostol
652985|NCT00796185|Antipsychotic drugs|antipsychotic drugs
652986|NCT00796185|Paliperidone ER|paliperidone er
652987|NCT00796198|Glaucoma|glaucoma
652988|NCT00796198|Intraocular pressure|intraocular pressure
652989|NCT00796198|Ocular diastolic perfusion pressure|ocular diastolic perfusion pressure
652990|NCT00796198|Dorzolamide/timolol Fixed combination|dorzolamide/timolol fixed combination
652991|NCT00796198|Heidelberg Retina Flowmeter|heidelberg retina flowmeter
652992|NCT00783159|Muscle power|muscle power
652993|NCT00783159|Frailty|frailty
652994|NCT00783159|Exercise|exercise
652995|NCT00783159|Vitamin D|vitamin d
652996|NCT00783172|pancreas|pancreas
652997|NCT00783172|pancreatic cancer|pancreatic cancer
652998|NCT00783172|cancer|cancer
652999|NCT00783172|Opioid Growth Factor|opioid growth factor
653000|NCT00783172|OGF|ogf
653001|NCT00783172|gemcitabine|gemcitabine
653002|NCT00783172|chemotherapy|chemotherapy
653003|NCT00783185|psychotic disorders|psychotic disorders
653004|NCT00783185|cannabis|cannabis
653005|NCT00783185|intervention|intervention
653006|NCT00783250|COPD|copd
653007|NCT00783250|Respiratory Mechanics|respiratory mechanics
653008|NCT00783250|Bronchodilators|bronchodilators
653009|NCT00783250|COPD patients with poor reversibility|copd patients with poor reversibility
653010|NCT00783302|CAD|cad
653013|NCT00783315|Hypertension|hypertension
653014|NCT00783315|Diabetes|diabetes
653015|NCT00783315|Hypercholesterolemia|hypercholesterolemia
653016|NCT00783328|solid tumor|solid tumor
653017|NCT00783367|Revlimid|revlimid
653018|NCT00783367|Celgene brand of lenalidomide|celgene brand of lenalidomide
653019|NCT00783367|lenalidomide|lenalidomide
653020|NCT00783367|Rituxan|rituxan
653021|NCT00783367|CD20 antibody, rituximab|cd20 antibody, rituximab
653022|NCT00783367|rituximab|rituximab
653023|NCT00783367|Follicular Lymphoma|follicular lymphoma
653024|NCT00783367|Marginal Zone B-Cell Lymphoma|marginal zone b-cell lymphoma
653025|NCT00783367|Lymphoma, Small Lymphocytic|lymphoma, small lymphocytic
653026|NCT00783367|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
653027|NCT00783367|Mantle-Cell Lymphoma|mantle-cell lymphoma
653028|NCT00783367|Antigens, CD20|antigens, cd20
653029|NCT00783367|refractory|refractory
653030|NCT00783367|resistantRefractory/progressive lymphoma less than 6 months from first rituximab dose of previous rituximab-containing regimen|resistantrefractory/progressive lymphoma less than 6 months from first rituximab dose of previous rituximab-containing regimen
653031|NCT00783367|Previously treated|previously treated
653032|NCT00783367|Treated with rituximab|treated with rituximab
653033|NCT00783380|Influenza vaccination|influenza vaccination
653034|NCT00783380|Subunit|subunit
653035|NCT00783380|Virosomal|virosomal
653036|NCT00783380|HIV/AIDS|hiv/aids
653037|NCT00783380|Renal Dialysis|renal dialysis
653038|NCT00783380|Kidney transplantation|kidney transplantation
653039|NCT00783380|Rheumatologic diseases|rheumatologic diseases
653040|NCT00783380|Immunogenicity|immunogenicity
653041|NCT00783380|Reactogenicity|reactogenicity
653042|NCT00783406|COPD|copd
653043|NCT00783419|tubo-ovarian abscess, pelvic-inflammatory disease|tubo-ovarian abscess, pelvic-inflammatory disease
653044|NCT00783445|Metabolic Cardiovascular Syndrome|metabolic cardiovascular syndrome
653045|NCT00783445|Metabolic Syndrome|metabolic syndrome
653046|NCT00783445|Obesity|obesity
653047|NCT00783445|Hyperglycemia|hyperglycemia
653048|NCT00783484|First in Human (FIH), PF-03716539, PK enhancer|first in human (fih), pf-03716539, pk enhancer
653049|NCT00796211|Psoriasis|psoriasis
653050|NCT00796211|CRx-197|crx-197
653051|NCT00796211|nortriptyline|nortriptyline
653052|NCT00796211|loratadine|loratadine
653053|NCT00796211|CombinatoRx|combinatorx
653055|NCT00796211|Erythema|erythema
653056|NCT00796211|Pruritus|pruritus
653057|NCT00796224|azithromycin, pharmacokinetics, pediatrics|azithromycin, pharmacokinetics, pediatrics
653058|NCT00796237|stroke|stroke
653059|NCT00796237|bone|bone
653060|NCT00796237|gait|gait
653061|NCT00796237|muscle|muscle
653062|NCT00796237|vibration|vibration
653063|NCT00796237|motor balance|motor balance
653064|NCT00796263|Acute HIV infection|acute hiv infection
653065|NCT00796276|Schizophrenia|schizophrenia
653066|NCT00796276|Mood disorders|mood disorders
653067|NCT00796276|Antipsychotics|antipsychotics
653068|NCT00796276|Pharmacokinetics|pharmacokinetics
653069|NCT00796276|Enantiomer|enantiomer
653070|NCT00796276|IR OROS Paliperidone|ir oros paliperidone
653071|NCT00796276|ER OROS Paliperidone|er oros paliperidone
653072|NCT00796289|anovulatory/oligoovulatory infertility|anovulatory/oligoovulatory infertility
653073|NCT00796302|Conduct Disorder|conduct disorder
653074|NCT00796302|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
653075|NCT00796315|Pharmacokinetic study|pharmacokinetic study
653076|NCT00796341|invitro-fertilization ,embryo transfer,endometrial injury|invitro-fertilization ,embryo transfer,endometrial injury
653077|NCT00796354|Constipation|constipation
653078|NCT00796354|Irritable Bowel Syndrome|irritable bowel syndrome
653079|NCT00796367|Obesity|obesity
653080|NCT00796419|Acute lung injury (ALI)|acute lung injury (ali)
653081|NCT00796419|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
653082|NCT00796419|Respiratory failure|respiratory failure
653083|NCT00796432|Schizophrenia|schizophrenia
653084|NCT00796432|mood disorders|mood disorders
653085|NCT00796432|antipsychotic drugs|antipsychotic drugs
653086|NCT00796432|dopamine|dopamine
653087|NCT00796432|receptor occupancy|receptor occupancy
653088|NCT00796432|OROS paliperidone|oros paliperidone
653089|NCT00796445|DERMA|derma
653090|NCT00796445|Tumor antigen|tumor antigen
653091|NCT00796445|Immunotherapeutic|immunotherapeutic
653092|NCT00796445|Adjuvant cancer therapy|adjuvant cancer therapy
653093|NCT00796445|Melanoma|melanoma
653094|NCT00796445|ASCI|asci
653095|NCT00796458|pain|pain
653096|NCT00796458|adenocarcinoma of the prostate|adenocarcinoma of the prostate
653097|NCT00796458|recurrent prostate cancer|recurrent prostate cancer
653098|NCT00796458|stage IV prostate cancer|stage iv prostate cancer
653099|NCT00796458|stage III prostate cancer|stage iii prostate cancer
653100|NCT00796471|Schizophrenia|schizophrenia
653101|NCT00796471|Mood Disorders|mood disorders
653102|NCT00796471|Antipsychotic drugs|antipsychotic drugs
653103|NCT00796471|Paliperidone ER|paliperidone er
653104|NCT00796484|Cancer|cancer
653105|NCT00796484|Solid Tumors|solid tumors
653106|NCT00796497|Obsessive Compulsive Disorder|obsessive compulsive disorder
653107|NCT00796497|5-ht3|5-ht3
653108|NCT00796497|ondansetron|ondansetron
653109|NCT00796510|endothelin receptor antagonist (ETRA)|endothelin receptor antagonist (etra)
653110|NCT00796510|sitaxsentan|sitaxsentan
653111|NCT00796523|colic|colic
653112|NCT00796523|crying|crying
653113|NCT00796523|clinical trial|clinical trial
653114|NCT00796536|Acute Pain|acute pain
653115|NCT00796536|Low Back Pain|low back pain
653116|NCT00796536|Back Pain|back pain
653117|NCT00796536|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
653118|NCT00796536|Cognitive Behavioral Therapy|cognitive behavioral therapy
653119|NCT00796536|Pain Education|pain education
653120|NCT00796991|Untreated Advanced Melanoma|untreated advanced melanoma
653121|NCT00797004|olfactory dysfunction|olfactory dysfunction
653122|NCT00797017|Chronic Pain|chronic pain
653123|NCT00797017|Fentanyl Matrix|fentanyl matrix
653124|NCT00797017|Spinal disorder-related pain|spinal disorder-related pain
653125|NCT00797030|dry eye syndromes|dry eye syndromes
653126|NCT00797030|keratoconjuntivitis sicca / drug therapy|keratoconjuntivitis sicca / drug therapy
653127|NCT00797030|cyclosporine|cyclosporine
653128|NCT00797030|ophthalmic solutions|ophthalmic solutions
653129|NCT00797030|HIV seropositivity|hiv seropositivity
653130|NCT00797043|Carcinoma of the skin of the head and neck|carcinoma of the skin of the head and neck
653131|NCT00797043|Proton radiation|proton radiation
653132|NCT00797043|Outcomes|outcomes
653133|NCT00797056|G-CSF|g-csf
653134|NCT00797056|angiogenesis|angiogenesis
653135|NCT00797056|endothelial progenitor cell|endothelial progenitor cell
653136|NCT00797056|limb ischemia|limb ischemia
653137|NCT00797056|revascularization|revascularization
653138|NCT00797082|Diabetic|diabetic
653139|NCT00797082|Coronary disease|coronary disease
653140|NCT00797082|Atherosclerosis|atherosclerosis
653141|NCT00797082|Magnetic resonance imaging|magnetic resonance imaging
653142|NCT00797082|Myocardial Perfusion Scintigraphy|myocardial perfusion scintigraphy
653143|NCT00797082|Coronary angiography|coronary angiography
653144|NCT00797095|Adolescence|adolescence
653145|NCT00797095|Obesity|obesity
653146|NCT00797095|Substance use|substance use
653147|NCT00797095|Prevalence|prevalence
653148|NCT00797095|Social and Environmental Contexts|social and environmental contexts
653149|NCT00797095|Survey|survey
653150|NCT00797121|Cholangiocarcinoma|cholangiocarcinoma
653151|NCT00797121|Drainage|drainage
653152|NCT00797160|propofol|propofol
653153|NCT00797160|midazolam|midazolam
653154|NCT00797160|neonate|neonate
653155|NCT00797160|tracheal intubation|tracheal intubation
653156|NCT00797186|diabetes|diabetes
653157|NCT00797186|dyslipidemia|dyslipidemia
653158|NCT00797186|microvascular dysfunction|microvascular dysfunction
653159|NCT00797186|imaging|imaging
653160|NCT00797199|Breast Cancer Risk|breast cancer risk
653161|NCT00797199|Hormone Replacement Therapy|hormone replacement therapy
653162|NCT00797199|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
653163|NCT00797199|Optical Breast Spectroscopy|optical breast spectroscopy
653164|NCT00797199|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
653165|NCT00797225|bone mineral density|bone mineral density
653166|NCT00797225|Endometriosis|endometriosis
653167|NCT00797225|Pelvic Pain|pelvic pain
653168|NCT00797238|Gene Expression|gene expression
653169|NCT00797238|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
653170|NCT00797238|Chemotherapy|chemotherapy
653171|NCT00797251|Colorectal liver metastasis|colorectal liver metastasis
653172|NCT00797251|hepatocellular carcinoma|hepatocellular carcinoma
653173|NCT00797251|liver surgery|liver surgery
653174|NCT00797251|intraoperative ultrasound|intraoperative ultrasound
653175|NCT00797251|finger-compression|finger-compression
653176|NCT00797264|Ketamine|ketamine
653177|NCT00797264|Morphine|morphine
653178|NCT00797264|PCA|pca
653179|NCT00797264|Hyperalgesia|hyperalgesia
653180|NCT00797264|Nor-ketamine|nor-ketamine
653181|NCT00797277|schizophrenia|schizophrenia
653182|NCT00797277|schizoaffective disorder|schizoaffective disorder
653183|NCT00797277|olanzapine|olanzapine
653184|NCT00797277|haloperidol|haloperidol
653185|NCT00797277|lorazepam|lorazepam
653186|NCT00797277|agitation|agitation
653187|NCT00797290|Nasopharynx Cancer, Proton Radiation, Outcomes|nasopharynx cancer, proton radiation, outcomes
653188|NCT00797303|bevacizumab|bevacizumab
653189|NCT00797303|cornea|cornea
653190|NCT00797303|neovascularization|neovascularization
653191|NCT00797316|Hypertension|hypertension
653192|NCT00797316|Metabolic Syndrome|metabolic syndrome
653193|NCT00797316|aliskiren|aliskiren
653194|NCT00797316|hydrochlorothiazide|hydrochlorothiazide
653195|NCT00797316|systolic blood pressure|systolic blood pressure
653196|NCT00797316|diastolic blood pressure|diastolic blood pressure
653197|NCT00797316|stage 2|stage 2
653198|NCT00797329|psychiatric patients with violent behavior|psychiatric patients with violent behavior
653199|NCT00797342|rheumatoid arthritis First in human safety pharmacokinetics pharmacodynamics|rheumatoid arthritis first in human safety pharmacokinetics pharmacodynamics
653200|NCT00797368|ankle sprain|ankle sprain
653201|NCT00797368|manual therapy|manual therapy
653202|NCT00797368|exercise|exercise
653203|NCT00797368|physical therapy|physical therapy
653398|NCT00798148|MIBG|mibg
653204|NCT00797368|Patients who have sustained an inversion ankle sprain|patients who have sustained an inversion ankle sprain
653205|NCT00797381|MK-0518|mk-0518
653206|NCT00797381|HIV|hiv
653207|NCT00797381|AIDS|aids
653208|NCT00797381|hemophilia|hemophilia
653209|NCT00797381|treatment experienced|treatment experienced
653210|NCT00797394|prostate|prostate
653211|NCT00797394|dietary supplements|dietary supplements
653212|NCT00797394|saw palmetto|saw palmetto
653213|NCT00797394|canada|canada
653214|NCT00797407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
653215|NCT00797407|Creatine|creatine
653216|NCT00797407|Adverse Effects|adverse effects
653217|NCT00797407|Muscle Toxicity|muscle toxicity
653218|NCT00797420|fluconazole|fluconazole
653219|NCT00797420|pharmacokinetic|pharmacokinetic
653220|NCT00797420|candidiasis|candidiasis
653221|NCT00797420|sepsis|sepsis
653222|NCT00797420|pediatric|pediatric
653223|NCT00797420|infants|infants
653224|NCT00797420|antifungal|antifungal
653225|NCT00797420|candidemia|candidemia
653226|NCT00797420|fungemia|fungemia
653227|NCT00797420|loading dose|loading dose
653228|NCT00797433|testosterone|testosterone
653229|NCT00797433|mechanical ventilation|mechanical ventilation
653230|NCT00797446|Oropharyngeal|oropharyngeal
653231|NCT00797446|cancer|cancer
653232|NCT00797446|proton|proton
653233|NCT00797446|radiation|radiation
653234|NCT00797446|outcomes|outcomes
653235|NCT00797459|Correction of Nasolabial Folds|correction of nasolabial folds
653236|NCT00797472|Hodgkin's Lymphoma|hodgkin's lymphoma
653238|NCT00797472|ABVD treatment|abvd treatment
653239|NCT00797472|Hodgkin's Disease|hodgkin's disease
653240|NCT00797485|stage IV colon cancer|stage iv colon cancer
653241|NCT00797485|stage IV rectal cancer|stage iv rectal cancer
653242|NCT00797498|Nasal Cavity|nasal cavity
653243|NCT00797498|Paranasal Sinuses|paranasal sinuses
653244|NCT00797498|Proton Radiation|proton radiation
653245|NCT00797498|Outcomes|outcomes
653246|NCT00797511|Diphtheria|diphtheria
653247|NCT00797511|Tetanus|tetanus
653248|NCT00797511|Pertussis|pertussis
653249|NCT00797511|Poliomyelitis|poliomyelitis
653250|NCT00797537|Inflammation of bone and cartilage|inflammation of bone and cartilage
653446|NCT00798330|Mediport|mediport
653251|NCT00797550|posterolateral spine fusion|posterolateral spine fusion
653252|NCT00797550|bone graft|bone graft
653253|NCT00797576|left atrial appendage thrombi|left atrial appendage thrombi
653254|NCT00797576|transesophageal echocardiogram|transesophageal echocardiogram
653255|NCT00797576|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
653256|NCT00797576|atrial fibrillation|atrial fibrillation
653257|NCT00797576|cardioversion|cardioversion
653258|NCT00797589|aorta valve|aorta valve
653259|NCT00797589|mitral valve|mitral valve
653260|NCT00797589|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
653261|NCT00797589|perfusion|perfusion
653262|NCT00797589|priming|priming
653263|NCT00797602|Chordomas|chordomas
653264|NCT00797602|Chondrosarcomas|chondrosarcomas
653265|NCT00797602|Cancer|cancer
653266|NCT00797602|Outcomes|outcomes
653267|NCT00797602|Proton radiation|proton radiation
653268|NCT00797641|bleeding|bleeding
653269|NCT00797641|ulcer|ulcer
653270|NCT00797641|hemorrhage|hemorrhage
653271|NCT00797641|gastrointestinal diseases|gastrointestinal diseases
653272|NCT00797641|digestive system disease|digestive system disease
653273|NCT00797641|peptic ulcer|peptic ulcer
653274|NCT00797641|proton pump inhibitor|proton pump inhibitor
653275|NCT00797654|Sexual Risks for HIV|sexual risks for hiv
653276|NCT00797654|Psychosocial Sequelae Relating to Childhood Sexual Abuse|psychosocial sequelae relating to childhood sexual abuse
653277|NCT00797680|Pediatric cardiac arrest|pediatric cardiac arrest
653278|NCT00797693|First trimester|first trimester
653279|NCT00797693|missed abortion|missed abortion
653281|NCT00797693|cervical ripening|cervical ripening
653282|NCT00797693|oral|oral
653283|NCT00797693|vaginal|vaginal
653284|NCT00797693|first trimester missed abortion|first trimester missed abortion
653285|NCT00797719|MPM|mpm
653286|NCT00797719|Short hemithoracic IMRT|short hemithoracic imrt
653287|NCT00797732|acupuncture|acupuncture
653288|NCT00797732|dysphagia|dysphagia
653289|NCT00797732|chemoradiation related effects|chemoradiation related effects
653290|NCT00797732|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
653291|NCT00797732|nasopharyngeal cancer|nasopharyngeal cancer
653292|NCT00797732|oropharynx cancer|oropharynx cancer
653293|NCT00797732|hypopharynx cancer|hypopharynx cancer
653294|NCT00797732|larynx cancer|larynx cancer
653295|NCT00797745|genotype 1 infection|genotype 1 infection
653296|NCT00797758|Cord blood transplantation|cord blood transplantation
653297|NCT00797758|Conditioning regimen|conditioning regimen
653298|NCT00797758|Acute myeloid leukaemia|acute myeloid leukaemia
653299|NCT00797758|SORROR comorbidity index|sorror comorbidity index
653300|NCT00797758|Quality of life|quality of life
653301|NCT00797758|Innate immunity|innate immunity
653302|NCT00797758|Immune reconstitution post transplant|immune reconstitution post transplant
653303|NCT00797758|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
653304|NCT00797758|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
653305|NCT00797771|Insulin delivery|insulin delivery
653306|NCT00797797|fibromyalgia|fibromyalgia
653307|NCT00797797|milnacipran|milnacipran
653308|NCT00797797|pregabalin|pregabalin
653309|NCT00797797|treatment|treatment
653310|NCT00797797|Forest Research Institute|forest research institute
653311|NCT00797810|Acute lymphoblastic leukemia of the mature B-cell type|acute lymphoblastic leukemia of the mature b-cell type
653312|NCT00797810|High-grade non-Hodgkin's lymphoma|high-grade non-hodgkin's lymphoma
653313|NCT00797823|diabetes|diabetes
653314|NCT00797823|pancreas|pancreas
653315|NCT00797823|beta cell|beta cell
653316|NCT00797823|glucagon|glucagon
653317|NCT00797823|insulin|insulin
653318|NCT00797823|hypoglycemia|hypoglycemia
653319|NCT00797836|Occupational Diseases|occupational diseases
653320|NCT00797836|Tuberculosis|tuberculosis
653321|NCT00797836|Tuberculin Test|tuberculin test
653322|NCT00797836|Immunoassay|immunoassay
653323|NCT00797849|phantom limb pain|phantom limb pain
653324|NCT00797849|amputees|amputees
653325|NCT00797849|Farabloc|farabloc
653326|NCT00797849|Phantom limb pain in the missing limb of Veteran amputees|phantom limb pain in the missing limb of veteran amputees
653327|NCT00797862|Aliskiren|aliskiren
653328|NCT00797862|Amlodipine|amlodipine
653329|NCT00797862|Hypertension|hypertension
653330|NCT00797862|SPA1000|spa1000
653331|NCT00797862|Norvasc|norvasc
653332|NCT00797875|proprioceptive neuromuscular facilitation stretching technique, total knee arthroplasty, range of motion|proprioceptive neuromuscular facilitation stretching technique, total knee arthroplasty, range of motion
653333|NCT00797888|diabetes|diabetes
653334|NCT00797888|behavioral intervention|behavioral intervention
653335|NCT00797888|HbA1c|hba1c
653336|NCT00797888|health disparities|health disparities
653337|NCT00797914|Colonoscopy|colonoscopy
653338|NCT00797914|Instrumentation|instrumentation
653339|NCT00797914|Force Monitoring|force monitoring
653340|NCT00797914|Quality Control|quality control
653341|NCT00797914|Training|training
653342|NCT00797927|schizophrenia|schizophrenia
653343|NCT00797927|quetiapine|quetiapine
653344|NCT00797927|conventional antipsychotics|conventional antipsychotics
653447|NCT00798330|PICC line|picc line
653345|NCT00797927|magnetic resonance spectroscopy|magnetic resonance spectroscopy
653346|NCT00797940|GBM|gbm
653347|NCT00797940|Glioblastoma|glioblastoma
653348|NCT00797940|Glioblastoma Multiforme|glioblastoma multiforme
653349|NCT00797940|Brain Tumor|brain tumor
653350|NCT00797940|Brain Cancer|brain cancer
653351|NCT00797940|Glioma|glioma
653352|NCT00797953|Angina Pectoris Treatment|angina pectoris treatment
653353|NCT00797966|OPC-34712, Major Depressive Disorder, Adjunctive Treatment|opc-34712, major depressive disorder, adjunctive treatment
653354|NCT00797979|Craniotomy|craniotomy
653355|NCT00797979|Skull fixation|skull fixation
653356|NCT00797979|Skull Grip|skull grip
653357|NCT00797979|Reconstructive cranial surgery|reconstructive cranial surgery
653358|NCT00797992|Bevacizumab|bevacizumab
653359|NCT00797992|Myopia|myopia
653360|NCT00797992|Complications|complications
653361|NCT00797992|Neovascularization|neovascularization
653362|NCT00797992|OCT|oct
653363|NCT00798005|NV1FGF|nv1fgf
653364|NCT00798005|PAOD|paod
653365|NCT00798005|CLI|cli
653366|NCT00798018|lidocaine|lidocaine
653367|NCT00798018|tetracaine|tetracaine
653368|NCT00798018|tracheal intubation|tracheal intubation
653369|NCT00798018|pharyngitis|pharyngitis
653370|NCT00798031|dental implant|dental implant
653371|NCT00798031|upper jaw|upper jaw
653372|NCT00798031|posterior tooth loss|posterior tooth loss
653373|NCT00798031|short dental implant|short dental implant
653374|NCT00798031|Adults, 18 years of age and older|adults, 18 years of age and older
653375|NCT00798031|Missing a minimum of two posterior teeth in their upper jaw|missing a minimum of two posterior teeth in their upper jaw
653376|NCT00798031|Subjects in need of dental implants|subjects in need of dental implants
653377|NCT00798031|the research study is survival and function of the implants|the research study is survival and function of the implants
653378|NCT00798044|quality improvement|quality improvement
653379|NCT00798044|feedback|feedback
653380|NCT00798044|substance use disorders|substance use disorders
653381|NCT00798057|Pituitary tumor|pituitary tumor
653382|NCT00798057|Outcomes|outcomes
653383|NCT00798057|Proton radiation|proton radiation
752384|NCT01172743|Adult Onset|adult onset
653384|NCT00798070|Lymph node positive or high risk lymph node negative breast|lymph node positive or high risk lymph node negative breast
653385|NCT00798070|cancer|cancer
653386|NCT00798096|T Cell Lymphoma|t cell lymphoma
653387|NCT00798096|Lymphoma|lymphoma
653388|NCT00798109|Schizophrenia|schizophrenia
653389|NCT00798109|Cannabis misuse comorbidity|cannabis misuse comorbidity
653390|NCT00798109|Motivational interview|motivational interview
653391|NCT00798109|Randomised open trial|randomised open trial
653392|NCT00798122|sex|sex
653393|NCT00798122|acute coronary syndromes|acute coronary syndromes
653394|NCT00798122|normal angiogram|normal angiogram
653395|NCT00798122|no obstruction at angiography|no obstruction at angiography
653396|NCT00798122|women|women
653397|NCT00798148|Neuroblastoma|neuroblastoma
653399|NCT00798148|Autologous Peripheral Stem Cell Transplantation|autologous peripheral stem cell transplantation
653400|NCT00798174|DFT|dft
653401|NCT00798174|CHF|chf
653402|NCT00798174|ICD|icd
653403|NCT00798187|Prostate Cancer|prostate cancer
653404|NCT00798187|Breast Cancer|breast cancer
653405|NCT00798187|Behavioral Intervention|behavioral intervention
653406|NCT00798187|Cancer Support Programs|cancer support programs
653407|NCT00798187|Social Comparison|social comparison
653408|NCT00798187|Heterogeneous support group|heterogeneous support group
653409|NCT00798187|Homogeneous support group|homogeneous support group
653410|NCT00798200|Cancer|cancer
653411|NCT00798200|Oncology|oncology
653412|NCT00798200|Rehabilitation|rehabilitation
653413|NCT00798200|Endurance|endurance
653414|NCT00798200|Strength|strength
653415|NCT00798226|Asthma|asthma
653416|NCT00798226|Eczema|eczema
653417|NCT00798226|Sensitization|sensitization
653418|NCT00798226|Allergy|allergy
653419|NCT00798239|DDD|ddd
653420|NCT00798239|Spondylolisthesis|spondylolisthesis
653421|NCT00798239|Spine Fusion|spine fusion
653422|NCT00798239|Lumbar Spine|lumbar spine
653423|NCT00798239|Bone Graft|bone graft
653424|NCT00798252|metastatic, chemotherapy combination|metastatic, chemotherapy combination
653425|NCT00798265|HPV Vaccination|hpv vaccination
653426|NCT00798265|HPV Immunogenicity|hpv immunogenicity
653427|NCT00798265|HIV Infection|hiv infection
653428|NCT00798265|HIV Negative|hiv negative
653429|NCT00798265|Adolescents and Young Adults|adolescents and young adults
653430|NCT00798265|Healthy Volunteer|healthy volunteer
653431|NCT00798265|HV|hv
653432|NCT00798265|Adolescent|adolescent
653433|NCT00798278|Empyema|empyema
653434|NCT00798278|Urokinase|urokinase
653435|NCT00798278|Thoracoscopic|thoracoscopic
653436|NCT00798278|Childhood|childhood
653437|NCT00798304|Meningococcal B vaccine|meningococcal b vaccine
653438|NCT00798304|infants|infants
653439|NCT00798304|safety|safety
653440|NCT00798304|immunogenicity|immunogenicity
653441|NCT00798330|Cancer|cancer
653442|NCT00798330|Blood stream infections|blood stream infections
653443|NCT00798330|Bacteremia|bacteremia
653444|NCT00798330|Dental procedure|dental procedure
653445|NCT00798330|Central venous catheters|central venous catheters
653448|NCT00798343|Influenza, heterosubtypic immune responses|influenza, heterosubtypic immune responses
653449|NCT00798356|atrial fibrillation, yoga|atrial fibrillation, yoga
653450|NCT00798369|Acute flares|acute flares
653451|NCT00798369|Gout|gout
653452|NCT00798369|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
653453|NCT00798369|Colchicine|colchicine
653454|NCT00798369|Triamcinolone acetonide|triamcinolone acetonide
653455|NCT00798408|Evaluate the effects of energy-yielding fluids and solids endocrine and metabolic response to food in the elderly|evaluate the effects of energy-yielding fluids and solids endocrine and metabolic response to food in the elderly
653456|NCT00798421|Influenza, transmission|influenza, transmission
653457|NCT00798434|Overactive bladder syndrome|overactive bladder syndrome
653458|NCT00798434|fesoterodine|fesoterodine
653459|NCT00798434|elderly|elderly
653460|NCT00798434|flexible dose regimen|flexible dose regimen
653461|NCT00798434|urgency|urgency
653462|NCT00798434|frequency|frequency
653463|NCT00798434|urge urinary incontinence|urge urinary incontinence
653464|NCT00798434|anticholinergic|anticholinergic
653465|NCT00798434|antimuscarinic|antimuscarinic
653466|NCT00798447|post OP|post op
653467|NCT00798460|Chronic hepatitis B|chronic hepatitis b
653468|NCT00798460|lamivudine resistance|lamivudine resistance
653469|NCT00798460|clevudine|clevudine
653470|NCT00798473|Crohn's disease|crohn's disease
653471|NCT00798473|Osteopenia|osteopenia
653472|NCT00798473|Osteoporosis|osteoporosis
653473|NCT00798473|Bisphosphonates|bisphosphonates
653474|NCT00798473|Zoledronate|zoledronate
653475|NCT00798499|haemophilia|haemophilia
653575|NCT00798837|IMRT|imrt
653476|NCT00798499|patients with haemophilia|patients with haemophilia
653477|NCT00798512|carotid artery stenting|carotid artery stenting
653478|NCT00798512|cerebral protection|cerebral protection
653479|NCT00798512|stroke|stroke
653480|NCT00798512|ischemic lesion|ischemic lesion
653481|NCT00798512|DW-MRI|dw-mri
653482|NCT00798525|thrombocytopenia|thrombocytopenia
653483|NCT00798525|Heparin|heparin
653484|NCT00798525|Lepirudin|lepirudin
653485|NCT00798525|Argatroban|argatroban
653486|NCT00798525|critically ill patients|critically ill patients
653487|NCT00798538|Buprenorphine|buprenorphine
653488|NCT00798538|HIV|hiv
653489|NCT00798538|Drug Abuse|drug abuse
653490|NCT00798538|Drug Addiction|drug addiction
653491|NCT00798538|Drug Dependence|drug dependence
653492|NCT00798538|Drug Use Disorders|drug use disorders
653493|NCT00798538|Drug Use Disorder|drug use disorder
653494|NCT00798538|Substance Abuse|substance abuse
653495|NCT00798538|Opiate Addiction|opiate addiction
653496|NCT00798538|Substance-related disorders|substance-related disorders
653497|NCT00798564|Exercise|exercise
653498|NCT00798564|Mannitol|mannitol
653499|NCT00798577|Bacterial Conjunctivitis|bacterial conjunctivitis
653500|NCT00798590|Intensive insulin therapy (IIT)|intensive insulin therapy (iit)
653501|NCT00798590|Insulin infusion|insulin infusion
653799|NCT00786526|Weaning|weaning
653502|NCT00798590|Tight glycemic control|tight glycemic control
653503|NCT00798590|Intensive Care Units|intensive care units
653504|NCT00798603|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
653505|NCT00798603|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
653506|NCT00798603|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
653507|NCT00798603|adenocarcinoma of the lung|adenocarcinoma of the lung
653508|NCT00798603|adenosquamous cell lung cancer|adenosquamous cell lung cancer
653509|NCT00798616|bronchiolitis|bronchiolitis
653510|NCT00798616|steroids|steroids
653511|NCT00798616|corticosteroids|corticosteroids
653512|NCT00798616|albuterol|albuterol
653513|NCT00798616|child|child
653514|NCT00798616|infant|infant
653515|NCT00798616|pediatric|pediatric
653516|NCT00798629|stage III melanoma|stage iii melanoma
653517|NCT00798629|stage IV melanoma|stage iv melanoma
653518|NCT00798629|recurrent melanoma|recurrent melanoma
653519|NCT00798629|mucosal melanoma|mucosal melanoma
653520|NCT00798642|Hypnotherapy|hypnotherapy
653521|NCT00798642|Ulcerative Colitis|ulcerative colitis
653522|NCT00798642|Inflammatory Bowel Disease|inflammatory bowel disease
653523|NCT00798642|Gastrointestinal Diseases|gastrointestinal diseases
653524|NCT00798642|Digestive System Diseases|digestive system diseases
653525|NCT00798642|Intestinal Diseases|intestinal diseases
653526|NCT00798642|Colonic Diseases|colonic diseases
653528|NCT00798655|cisplatin|cisplatin
653529|NCT00798655|radiation|radiation
653530|NCT00798668|Endocrine and Gastrointestinal Response to Food|endocrine and gastrointestinal response to food
653531|NCT00798681|parenteral nutrition|parenteral nutrition
653532|NCT00798681|ready-to-use|ready-to-use
653533|NCT00798681|customized nutrition formulation|customized nutrition formulation
653534|NCT00798681|olive oil|olive oil
653535|NCT00798681|soybean oil|soybean oil
653536|NCT00798681|LCT/MCT|lct/mct
653537|NCT00798681|Clinoleic|clinoleic
653538|NCT00798681|oliclinomel|oliclinomel
653539|NCT00798681|number of infections associated with TPN delivery system|number of infections associated with tpn delivery system
653540|NCT00798681|BSI|bsi
653541|NCT00798681|Infection rates|infection rates
653542|NCT00798694|glaucoma|glaucoma
653543|NCT00798694|impression cytology|impression cytology
653544|NCT00798694|ocular surface changes|ocular surface changes
653545|NCT00798694|prostaglandins|prostaglandins
653546|NCT00798707|Major Depressive Disorder|major depressive disorder
653547|NCT00798720|non small cell lung cancer|non small cell lung cancer
653549|NCT00798720|proteasome inhibitor|proteasome inhibitor
653550|NCT00798746|Esophageal cancer|esophageal cancer
653551|NCT00798746|pyloric drainage|pyloric drainage
653552|NCT00798746|pyloric drainage procedure|pyloric drainage procedure
653553|NCT00798746|reflux|reflux
653554|NCT00798746|reflux symptoms|reflux symptoms
653555|NCT00798746|esophagectomy|esophagectomy
653556|NCT00798746|Quality of Life|quality of life
653557|NCT00798746|Health-related quality of life|health-related quality of life
653558|NCT00798746|HRQL|hrql
653559|NCT00798759|Open-angle glaucoma|open-angle glaucoma
653560|NCT00798759|Ocular hypertension|ocular hypertension
653561|NCT00798772|HIV infection|hiv infection
653562|NCT00798772|Micronutrients|micronutrients
653563|NCT00798772|Antioxidants|antioxidants
653564|NCT00798785|diabetes mellitus type 1|diabetes mellitus type 1
653565|NCT00798785|pancreatic beta cell|pancreatic beta cell
653566|NCT00798785|transplantation|transplantation
653567|NCT00798811|brain tumor|brain tumor
653568|NCT00798811|high-dose chemotherapy|high-dose chemotherapy
653569|NCT00798811|autologous stem cell transplantation|autologous stem cell transplantation
653570|NCT00798811|infant|infant
653571|NCT00798824|tube feeding|tube feeding
653572|NCT00798824|premature infant|premature infant
653573|NCT00798837|prostate|prostate
653574|NCT00798837|cancer|cancer
653576|NCT00798837|radiation|radiation
653577|NCT00798850|Claudication|claudication
653578|NCT00798850|Vascular claudication|vascular claudication
653579|NCT00798850|Peripheral Vascular Disease|peripheral vascular disease
653580|NCT00798850|Peripheral arterial disease|peripheral arterial disease
653581|NCT00798850|Peripheral arterial occlusive disease|peripheral arterial occlusive disease
653582|NCT00798850|Angioplasty|angioplasty
653583|NCT00798850|Femoral angioplasty|femoral angioplasty
654915|NCT00790322|SBG|sbg
653584|NCT00798850|Superficial femoral artery|superficial femoral artery
653585|NCT00798850|Femoral arterial disease|femoral arterial disease
653586|NCT00798850|Exercise|exercise
653587|NCT00798850|Supervised exercise|supervised exercise
653588|NCT00798850|Exercise therapy|exercise therapy
653589|NCT00798850|Exercise programme|exercise programme
653590|NCT00798850|Infrainuginal|infrainuginal
653591|NCT00798850|Quality of life|quality of life
653592|NCT00798850|SF36|sf36
653593|NCT00798850|Questionnaire|questionnaire
653594|NCT00798850|VascuQol|vascuqol
653595|NCT00798850|Randomised|randomised
653596|NCT00798850|Randomised trial|randomised trial
653597|NCT00798850|Combination therapy|combination therapy
653598|NCT00798850|Intermittent Claudication due to Femoropopliteal Disease|intermittent claudication due to femoropopliteal disease
653599|NCT00798863|submandibular gland|submandibular gland
653600|NCT00798863|video assisted neck surgery|video assisted neck surgery
653601|NCT00798889|Solid tumors|solid tumors
653603|NCT00798902|Spondylolisthesis|spondylolisthesis
653604|NCT00798902|Spine Fusion|spine fusion
653605|NCT00798902|Lumbar Spine|lumbar spine
653606|NCT00798902|Bone Graft|bone graft
653607|NCT00798915|Diabetes|diabetes
653608|NCT00798915|Blood Sugar|blood sugar
653609|NCT00798915|Xenin-25|xenin-25
653610|NCT00798915|GIP|gip
653611|NCT00798915|Insulin|insulin
653612|NCT00798967|SBS|sbs
653613|NCT00798967|short bowel syndrome|short bowel syndrome
653614|NCT00798967|TPN|tpn
653615|NCT00798967|parenteral nutrition|parenteral nutrition
653616|NCT00798967|PN|pn
653617|NCT00798980|Mirena|mirena
653618|NCT00798980|Nulliparous|nulliparous
653619|NCT00798980|Intrauterine Devices|intrauterine devices
653620|NCT00798993|Chronic kidney failure|chronic kidney failure
653621|NCT00798993|25 hydroxyvitamin D|25 hydroxyvitamin d
653622|NCT00798993|falls|falls
653623|NCT00798993|exercise|exercise
653624|NCT00798993|quadriceps strength|quadriceps strength
653625|NCT00799006|Single Ascending Dose Study in Overweight subjects|single ascending dose study in overweight subjects
653626|NCT00799019|EPO antibody mediated PRCA|epo antibody mediated prca
653627|NCT00799019|Erythropoiesis stimulating agents|erythropoiesis stimulating agents
653628|NCT00799032|Coronary Stent|coronary stent
653629|NCT00799045|Migraine|migraine
653630|NCT00799045|atrial septal defects|atrial septal defects
653631|NCT00799045|transcatheter|transcatheter
653632|NCT00799045|clopidogrel|clopidogrel
653633|NCT00799058|HIV-1 infections|hiv-1 infections
653634|NCT00799071|prophylaxis|prophylaxis
653635|NCT00799071|CGD|cgd
653636|NCT00799071|pharmacokinetics|pharmacokinetics
653637|NCT00799084|symptom management|symptom management
653638|NCT00799084|cancer|cancer
653639|NCT00799084|chemotherapy treatment|chemotherapy treatment
653640|NCT00799084|Behavioral Research|behavioral research
653641|NCT00799084|Physiological Effects of Drugs|physiological effects of drugs
653642|NCT00799084|Clinical Trial, Phase II|clinical trial, phase ii
653643|NCT00799110|dendritic cells|dendritic cells
653644|NCT00799110|fusion vaccines|fusion vaccines
653645|NCT00799110|GM-CSF|gm-csf
653646|NCT00799110|imiquimod|imiquimod
653647|NCT00799123|NT-proBNP|nt-probnp
653648|NCT00799136|Lymphoma Large B Cell Diffuse|lymphoma large b cell diffuse
653649|NCT00799136|Acquired Immunodeficiency|acquired immunodeficiency
653650|NCT00799149|Post-operative pain|post-operative pain
653651|NCT00799149|Knee arthroscopy|knee arthroscopy
653652|NCT00799149|Gabapentin|gabapentin
653653|NCT00799149|Etoricoxib|etoricoxib
653654|NCT00799149|Elective ambulatory knee arthroscopy|elective ambulatory knee arthroscopy
653655|NCT00799175|Postoperative pain|postoperative pain
653656|NCT00799175|Local infiltration analgesia|local infiltration analgesia
653657|NCT00799175|Knee arthroplasty|knee arthroplasty
653658|NCT00799188|Cardiac Transplantation|cardiac transplantation
653659|NCT00799188|Skin cancer|skin cancer
653660|NCT00799188|Everolimus|everolimus
653661|NCT00799201|Enteral nutrition|enteral nutrition
653662|NCT00799201|Constipation|constipation
653663|NCT00799201|Gastrointestinal motility|gastrointestinal motility
653664|NCT00799201|Naloxone|naloxone
653665|NCT00799201|Docusate|docusate
653666|NCT00799201|Bowel stimulant|bowel stimulant
653667|NCT00799201|Stool softener|stool softener
653668|NCT00799214|bacterial vaginosis|bacterial vaginosis
653669|NCT00799214|intravaginal|intravaginal
653670|NCT00799214|boric acid|boric acid
653671|NCT00799214|metronidazole|metronidazole
653672|NCT00799214|placebo controlled|placebo controlled
653673|NCT00799214|double-blind|double-blind
653674|NCT00799214|randomized|randomized
653675|NCT00799214|multicenter|multicenter
653676|NCT00799214|non-inferiority|non-inferiority
653677|NCT00799240|lung cancer|lung cancer
653678|NCT00799240|stage IIIb|stage iiib
653679|NCT00799240|pleural effusion|pleural effusion
653680|NCT00799240|stage IV|stage iv
653681|NCT00799240|metastatic lung cancer|metastatic lung cancer
653682|NCT00799240|non squamous lung cancer|non squamous lung cancer
653683|NCT00799240|IGF-1R|igf-1r
653684|NCT00799240|Pemetrexed|pemetrexed
653685|NCT00799240|Cisplatin|cisplatin
752385|NCT01172756|Pulmonary Hypertension|pulmonary hypertension
653686|NCT00799266|Osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, Duchenne muscular dystrophy, glucocorticoids|osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, duchenne muscular dystrophy, glucocorticoids
653687|NCT00799279|smoking|smoking
653688|NCT00799279|cessation|cessation
653689|NCT00799279|family medicine|family medicine
653690|NCT00799279|evidence-based|evidence-based
653691|NCT00799279|knowledge translation|knowledge translation
653692|NCT00799279|smoking cessation, primary care|smoking cessation, primary care
653693|NCT00799331|Healthy volunteers|healthy volunteers
653694|NCT00799344|Coronary Stent|coronary stent
653695|NCT00799357|ultrasound|ultrasound
653696|NCT00799370|Osteotomy|osteotomy
653697|NCT00799370|Weight bearing|weight bearing
653698|NCT00799370|Opening wedge|opening wedge
653699|NCT00799383|Risperidone|risperidone
653700|NCT00799383|hyperprolactinemia|hyperprolactinemia
653701|NCT00799383|children|children
653702|NCT00799383|adolescents|adolescents
653703|NCT00799383|antipsychotics|antipsychotics
653704|NCT00799383|prevention|prevention
653705|NCT00799383|calcium|calcium
653706|NCT00799383|vitamin D|vitamin d
653707|NCT00799383|Risperidone-induced hyperprolactinemia|risperidone-induced hyperprolactinemia
653708|NCT00799409|ADHD|adhd
653709|NCT00799409|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
653710|NCT00799422|Conjunctival Staining|conjunctival staining
653711|NCT00799422|lens parameters|lens parameters
653712|NCT00799422|lens fit|lens fit
653713|NCT00799435|Diabetes|diabetes
653714|NCT00799435|Diastolic Heart Failure|diastolic heart failure
653715|NCT00799435|Aortic Stiffness|aortic stiffness
653716|NCT00799435|Exenatide|exenatide
653717|NCT00799487|ADHD|adhd
653718|NCT00799487|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
653719|NCT00799513|Lenalidomide|lenalidomide
653720|NCT00799513|revlimid|revlimid
653721|NCT00799513|large B-cell lymphoma|large b-cell lymphoma
653722|NCT00799513|relapse|relapse
653723|NCT00799526|Ex Vivo Conjunctival Epithelial Cell|ex vivo conjunctival epithelial cell
653724|NCT00799526|Transplantation|transplantation
653725|NCT00786331|second line treatment|second line treatment
653726|NCT00786331|pemetrexed|pemetrexed
653727|NCT00786331|carboplatin|carboplatin
653728|NCT00786344|Health Promotion: Wellness Programs|health promotion: wellness programs
653729|NCT00786344|Occupational Therapy|occupational therapy
653730|NCT00786344|Quality of Life|quality of life
653731|NCT00786344|Health|health
653732|NCT00786344|Biomarkers|biomarkers
653733|NCT00786357|shift-work|shift-work
653734|NCT00786357|sleep|sleep
653735|NCT00786357|nurse|nurse
653736|NCT00786357|relaxation|relaxation
653737|NCT00786370|propofol|propofol
653738|NCT00786370|dexmedetomidine|dexmedetomidine
653739|NCT00786370|cataract|cataract
653740|NCT00786370|respiratory|respiratory
653741|NCT00786370|blood pressure|blood pressure
653742|NCT00786370|Cataract surgery|cataract surgery
653743|NCT00786383|Phase I|phase i
653744|NCT00786383|cancer|cancer
654532|NCT00788827|stem cells|stem cells
653745|NCT00786383|solid tumors|solid tumors
653746|NCT00786383|1121B|1121b
653747|NCT00786383|VEGFR-2|vegfr-2
653748|NCT00786383|Anti-Vascular Endothelial Growth Factor Receptor 2|anti-vascular endothelial growth factor receptor 2
653749|NCT00786396|HIV|hiv
653750|NCT00786396|AIDS|aids
653751|NCT00786396|substance abuse|substance abuse
653752|NCT00786396|directly administered antiretroviral therapy|directly administered antiretroviral therapy
653753|NCT00786396|adherence|adherence
653754|NCT00786396|Substance Abuse and Dependency|substance abuse and dependency
653755|NCT00786409|Lupus|lupus
653756|NCT00786422|Embolism and Thrombosis|embolism and thrombosis
653757|NCT00786422|Pulmonary Embolism|pulmonary embolism
653758|NCT00786422|Embolism|embolism
653759|NCT00786422|Venous Thrombosis|venous thrombosis
653760|NCT00786422|Thrombosis|thrombosis
653761|NCT00786422|Enzyme Inducers|enzyme inducers
653762|NCT00786422|CYP Inducers|cyp inducers
653763|NCT00786422|Cohort Study|cohort study
653764|NCT00786422|Pharmacologic Actions|pharmacologic actions
653765|NCT00786422|Respiratory Tract Diseases|respiratory tract diseases
653766|NCT00786422|Lung Diseases|lung diseases
653767|NCT00786422|Vascular Diseases|vascular diseases
653768|NCT00786422|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
653769|NCT00786422|Neurologic disease|neurologic disease
653770|NCT00786422|Additional relevant MeSH terms:|additional relevant mesh terms:
653771|NCT00786422|Fibrin Modulating Agents|fibrin modulating agents
653772|NCT00786422|Anticoagulants|anticoagulants
653773|NCT00786422|Therapeutic Uses|therapeutic uses
653774|NCT00786422|Hematologic Agents|hematologic agents
653775|NCT00786422|Enzyme Inhibitors|enzyme inhibitors
653776|NCT00786422|Cardiovascular Diseases|cardiovascular diseases
653777|NCT00786422|Cardiovascular Agents|cardiovascular agents
653778|NCT00786448|Overactive Bladder|overactive bladder
653779|NCT00786461|silver nitrate|silver nitrate
653780|NCT00786461|marsupialisation|marsupialisation
653781|NCT00786474|Bridging Anticoagulation|bridging anticoagulation
653782|NCT00786487|insulin resistance|insulin resistance
653783|NCT00786487|lipid metabolism|lipid metabolism
653784|NCT00786487|lipid infusion|lipid infusion
653785|NCT00786487|glycerol infusion|glycerol infusion
653786|NCT00786487|skeletal muscle|skeletal muscle
653787|NCT00786487|diabetes|diabetes
653788|NCT00786500|Herbal medicine|herbal medicine
653789|NCT00786500|Type 2 diabetes|type 2 diabetes
653790|NCT00786500|Insulin sensitivity|insulin sensitivity
653791|NCT00786500|Insulin secretion|insulin secretion
653792|NCT00786513|Cystic fibrosis|cystic fibrosis
653793|NCT00786513|Pseudomonas aeruginosa|pseudomonas aeruginosa
653794|NCT00786513|biofilm|biofilm
653795|NCT00786513|antibiotic susceptibility testing|antibiotic susceptibility testing
653796|NCT00786513|pediatrics|pediatrics
653797|NCT00786526|Mechanical ventilation|mechanical ventilation
653798|NCT00786526|Ventilator induced diaphragmatic dysfunction|ventilator induced diaphragmatic dysfunction
653800|NCT00786526|Neuromuscular diseases- Respiratory function tests|neuromuscular diseases- respiratory function tests
653801|NCT00786526|Intubated patients in intensive care unit|intubated patients in intensive care unit
653802|NCT00786539|mitochondrial|mitochondrial
653803|NCT00786552|recurrent/advanced thyroid cancer|recurrent/advanced thyroid cancer
653804|NCT00786552|papillary or anaplastic thyroid cancer|papillary or anaplastic thyroid cancer
653805|NCT00786578|training|training
653806|NCT00786578|intramyocellular lipid|intramyocellular lipid
653807|NCT00786578|insulin resistance|insulin resistance
653808|NCT00786591|Acute pancreatitis|acute pancreatitis
653809|NCT00786591|biological markers|biological markers
653810|NCT00786591|substance P|substance p
653811|NCT00786591|hydrogen sulfide|hydrogen sulfide
653812|NCT00786591|disease severity index|disease severity index
653813|NCT00786630|Drug treatment entry and retention|drug treatment entry and retention
653814|NCT00786630|Drug injection frequency|drug injection frequency
653815|NCT00786630|HIV risk behaviors|hiv risk behaviors
653816|NCT00786630|Hepatitis C risk behaviors|hepatitis c risk behaviors
653817|NCT00786643|Gamma Interferon|gamma interferon
653818|NCT00786643|5-FU|5-fu
653819|NCT00786643|LV|lv
653820|NCT00786656|Navigation|navigation
653821|NCT00786656|Coordination|coordination
653822|NCT00786656|Cancer Care|cancer care
653823|NCT00786656|Patient Experience|patient experience
653824|NCT00786656|Cancer|cancer
653825|NCT00786656|Patient Survey|patient survey
653826|NCT00786682|stage IV prostate cancer|stage iv prostate cancer
653827|NCT00786682|recurrent prostate cancer|recurrent prostate cancer
653828|NCT00786695|noncardiac chest pain|noncardiac chest pain
653829|NCT00786695|gastroesophageal reflux disease|gastroesophageal reflux disease
653830|NCT00786695|diagnostic test|diagnostic test
653831|NCT00786695|proton pump inhibitor|proton pump inhibitor
653832|NCT00786695|esomeprazole|esomeprazole
653833|NCT00786708|renal|renal
653834|NCT00786708|kidney|kidney
653835|NCT00786708|lipocalin|lipocalin
653836|NCT00786708|urine|urine
653837|NCT00786708|biomarker|biomarker
653838|NCT00786708|Azotemia|azotemia
653839|NCT00786708|Renal insufficiency, chronic|renal insufficiency, chronic
653840|NCT00786708|Renal failure, acute|renal failure, acute
653841|NCT00786708|Hydronephrosis|hydronephrosis
653842|NCT00786721|Mitochondria and Metabolic Syndrome|mitochondria and metabolic syndrome
653843|NCT00786734|pitavastatin|pitavastatin
653845|NCT00786734|stable angina|stable angina
653846|NCT00786747|Computer-assisted instruction|computer-assisted instruction
653847|NCT00786747|Health knowledge, attitudes, practice|health knowledge, attitudes, practice
653848|NCT00786747|Mass screening|mass screening
653849|NCT00786747|Patient acceptance of health care|patient acceptance of health care
653850|NCT00786747|Patient education as topic|patient education as topic
653851|NCT00786747|Primary health care|primary health care
653852|NCT00786747|Self-efficacy|self-efficacy
653853|NCT00786760|HPV|hpv
653854|NCT00786760|Papillomavirus|papillomavirus
653855|NCT00786760|Infection|infection
653856|NCT00786760|Sexually transmitted disease|sexually transmitted disease
653857|NCT00786760|STD|std
653858|NCT00786773|GERD|gerd
653859|NCT00786773|reflux symptom|reflux symptom
653860|NCT00786773|heartburn|heartburn
653861|NCT00786773|acid regurgitation|acid regurgitation
653862|NCT00786773|PPI|ppi
653863|NCT00786773|H2RA|h2ra
653864|NCT00786773|antacid|antacid
653865|NCT00786786|Any person with a spinal cord injury|any person with a spinal cord injury
653866|NCT00786786|at least 18 years of age|at least 18 years of age
653867|NCT00786812|Leukemia|leukemia
653868|NCT00786812|adult chronic myeloid leukemia|adult chronic myeloid leukemia
653869|NCT00786812|imatinib|imatinib
653870|NCT00786812|nilotinib|nilotinib
653871|NCT00786825|Type 1 diabetes|type 1 diabetes
653872|NCT00786825|Hypoglycemia unawareness|hypoglycemia unawareness
653873|NCT00786838|Solid tumor|solid tumor
653874|NCT00786838|Advanced solid tumor|advanced solid tumor
653875|NCT00786838|Malignant tumors|malignant tumors
653876|NCT00786838|Sarcoma|sarcoma
653877|NCT00786838|Breast tumor|breast tumor
653878|NCT00786838|Ovarian tumor|ovarian tumor
653879|NCT00786838|QT interval|qt interval
653880|NCT00786838|Trabectedin|trabectedin
653881|NCT00786838|Yondelis|yondelis
653882|NCT00786838|Ecteinascidin 743|ecteinascidin 743
653883|NCT00786838|ET743|et743
653884|NCT00786851|MANTLE CELL LYMPHOMA (MCL)|mantle cell lymphoma (mcl)
653885|NCT00786851|Lenalidomide (Len)|lenalidomide (len)
653886|NCT00786851|Dexamethasone (Dex)|dexamethasone (dex)
653887|NCT00786864|Randomised controlled trial|randomised controlled trial
653888|NCT00786864|low back pain|low back pain
653889|NCT00786864|exercise|exercise
653890|NCT00786864|children|children
653891|NCT00786864|school-based|school-based
653892|NCT00786864|prevalence|prevalence
653893|NCT00786864|intensity|intensity
653894|NCT00786877|pneumonia|pneumonia
653895|NCT00786890|Prediabetes (IFG, IGT)|prediabetes (ifg, igt)
653896|NCT00786890|Hong Kong Chinese|hong kong chinese
653897|NCT00786890|Cardiovascular risk factors|cardiovascular risk factors
653898|NCT00786916|pain|pain
653899|NCT00786916|propofol|propofol
653903|NCT00786929|Conversion to more aggressive treatment of recurrent fluid collection|conversion to more aggressive treatment of recurrent fluid collection
653904|NCT00786942|osteotomy|osteotomy
653905|NCT00786942|knee|knee
653906|NCT00786942|varus deformity|varus deformity
653907|NCT00786942|bone graft|bone graft
653908|NCT00786968|mucopolysaccharidosis|mucopolysaccharidosis
653909|NCT00786968|Hurler-Scheie|hurler-scheie
653910|NCT00786968|Scheie|scheie
653911|NCT00786968|laronidase|laronidase
653912|NCT00786968|spinal cord compression|spinal cord compression
653913|NCT00786968|central nervous system|central nervous system
653914|NCT00786968|enzyme replacement therapy|enzyme replacement therapy
653915|NCT00786968|intrathecal|intrathecal
653916|NCT00786994|Actinic Keratoses|actinic keratoses
653917|NCT00787007|healthy volunteers|healthy volunteers
653918|NCT00787007|pharmacokinetics|pharmacokinetics
653919|NCT00787020|Cerebrospinal Fluid|cerebrospinal fluid
653920|NCT00787020|Ventriculostomy|ventriculostomy
653921|NCT00787020|Subarachnoid hemorrhage|subarachnoid hemorrhage
653922|NCT00787020|vasospasm|vasospasm
653923|NCT00787020|Human Subjects|human subjects
653924|NCT00787033|Focal Adhesion Kinase; Advanced Non-Hematologic Malignancies|focal adhesion kinase; advanced non-hematologic malignancies
653925|NCT00787059|Adenylyl Cyclase|adenylyl cyclase
653926|NCT00787059|AC6|ac6
653927|NCT00787059|adenovirus|adenovirus
653928|NCT00787059|gene therapy|gene therapy
653929|NCT00787059|congestive heart failure|congestive heart failure
653930|NCT00787059|intracoronary|intracoronary
653931|NCT00787059|nitroprusside|nitroprusside
653932|NCT00787085|Funguria|funguria
653933|NCT00787085|Epidemiology|epidemiology
653934|NCT00787085|Urinary Tract Infections|urinary tract infections
653935|NCT00787098|therapeutic mobility|therapeutic mobility
653936|NCT00787098|acute care|acute care
653937|NCT00787098|nursing|nursing
653938|NCT00787098|inflammatory markers|inflammatory markers
653939|NCT00787111|Drug: Fluoxetine|drug: fluoxetine
653940|NCT00787163|pPROM|pprom
653941|NCT00787163|oligohydramnios|oligohydramnios
653942|NCT00787163|amnioinfusion|amnioinfusion
653943|NCT00787163|prematurity|prematurity
653944|NCT00787163|Early premature rupture of membranes in pregnancy|early premature rupture of membranes in pregnancy
653945|NCT00787176|Oxytocin|oxytocin
653946|NCT00787176|Labor, Obstetric|labor, obstetric
653947|NCT00787176|Non-reassuring fetal heart rate|non-reassuring fetal heart rate
653948|NCT00787176|epidural|epidural
653949|NCT00787189|sensorineural hearing loss|sensorineural hearing loss
653950|NCT00787189|tinnitus|tinnitus
653951|NCT00787189|word recognition|word recognition
653952|NCT00787202|treatment of ulcerative colitis; CP 690 550|treatment of ulcerative colitis; cp 690 550
653953|NCT00787215|oral glucose tolerance test|oral glucose tolerance test
653954|NCT00787215|Hong Kong Chinese|hong kong chinese
653955|NCT00787241|Platelets|platelets
653956|NCT00787241|Labor|labor
653957|NCT00787241|Preeclampsia|preeclampsia
653958|NCT00787254|Curling Ulcer|curling ulcer
653959|NCT00787254|Gastric Ulcer|gastric ulcer
653960|NCT00787254|Nonsteroid anti-inflammatory drug|nonsteroid anti-inflammatory drug
653961|NCT00787254|Drug Therapy|drug therapy
653962|NCT00787267|NSCLC|nsclc
653963|NCT00787267|Lung Cancer|lung cancer
653964|NCT00787267|Dasatinib|dasatinib
653965|NCT00787267|Genomics|genomics
653966|NCT00787267|Genomics analysis|genomics analysis
653967|NCT00787267|Genomic signature|genomic signature
653968|NCT00787280|obese|obese
653969|NCT00787280|overweight|overweight
653970|NCT00787280|fMRI|fmri
653971|NCT00787280|Diet|diet
653972|NCT00787293|Heart Failure|heart failure
653973|NCT00787293|Mitral Regurgitation|mitral regurgitation
653974|NCT00787293|Percutaneous|percutaneous
653975|NCT00787293|Coronary sinus|coronary sinus
653976|NCT00787306|chronic disease management|chronic disease management
653977|NCT00787306|decision aids|decision aids
653978|NCT00787306|cardiovascular risk factors|cardiovascular risk factors
653979|NCT00787319|Ophthalmology|ophthalmology
653980|NCT00787319|Age-related macular degeneration|age-related macular degeneration
653981|NCT00787319|outpatients|outpatients
653982|NCT00787332|Suspected Heparin Induced Thrombocytopenia (HIT)|suspected heparin induced thrombocytopenia (hit)
753144|NCT01175642|Schizoaffective Disorder|schizoaffective disorder
653983|NCT00787345|precaution technique during central venous catheter placement.|precaution technique during central venous catheter placement.
653984|NCT00787358|osteoporosis|osteoporosis
653985|NCT00787358|intertrochanteric|intertrochanteric
653986|NCT00787358|hip fracture|hip fracture
653987|NCT00787358|compression hip screw|compression hip screw
653988|NCT00787358|surgical fixation|surgical fixation
653989|NCT00787371|alanine transaminase|alanine transaminase
653990|NCT00787384|Hypereosinophilic syndrome (HES)|hypereosinophilic syndrome (hes)
653991|NCT00787384|chronic eosinophilic leukaemia (CEL)|chronic eosinophilic leukaemia (cel)
653992|NCT00787384|chronic idiopathic hypereosinophilia (CIH)|chronic idiopathic hypereosinophilia (cih)
653993|NCT00787384|Imatinib|imatinib
653994|NCT00787384|Response|response
653995|NCT00787384|Timing to response|timing to response
653996|NCT00787397|Sleep difficulties in pediatric anxiety disorder|sleep difficulties in pediatric anxiety disorder
654092|NCT00787644|Fat|fat
653997|NCT00787397|Neural correlates of pediatric anxiety disorder|neural correlates of pediatric anxiety disorder
653998|NCT00787397|Social correlates of pediatric anxiety disorder|social correlates of pediatric anxiety disorder
653999|NCT00787397|Generalized Anxiety Disorder in pediatric populations|generalized anxiety disorder in pediatric populations
654000|NCT00787397|Separation Anxiety Disorder in pediatric populations|separation anxiety disorder in pediatric populations
654001|NCT00787397|Social Phobia in pediatric populations|social phobia in pediatric populations
654002|NCT00787410|malignant mesothelioma|malignant mesothelioma
654003|NCT00787410|IRESSA|iressa
654004|NCT00787410|ZD1839|zd1839
654005|NCT00787423|Field Tools|field tools
654006|NCT00787423|Drug Use|drug use
654007|NCT00787423|Psychological Stress|psychological stress
654008|NCT00787423|Ecological Momentary Assessment|ecological momentary assessment
654009|NCT00787423|Global Positioning Units|global positioning units
654010|NCT00787436|portal hypertension|portal hypertension
654011|NCT00787436|Gastroesophageal|gastroesophageal
654012|NCT00787436|Varices|varices
654013|NCT00787436|Liver disease|liver disease
654014|NCT00787436|cirrhosis|cirrhosis
654015|NCT00787462|Neuropathic|neuropathic
654016|NCT00787462|Neuropathic pain|neuropathic pain
654017|NCT00787462|Nerve pain|nerve pain
654019|NCT00787462|Chronic pain|chronic pain
654020|NCT00787462|Pregabalin|pregabalin
654021|NCT00787462|Lyrica|lyrica
654022|NCT00787462|Small fiber neuropathy|small fiber neuropathy
654023|NCT00787462|Neuropathy|neuropathy
654024|NCT00787475|Diabetes|diabetes
654025|NCT00787475|Community health worker|community health worker
654026|NCT00787475|Community outreach|community outreach
654027|NCT00787488|Ovarian|ovarian
654028|NCT00787488|debulked|debulked
654029|NCT00787488|recurrent|recurrent
654030|NCT00787488|Stage III|stage iii
654031|NCT00787488|Stage IV|stage iv
654032|NCT00787501|Major Depressive Disorder|major depressive disorder
654033|NCT00787501|Depression|depression
654034|NCT00787501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
654635|NCT00789230|mesh|mesh
654035|NCT00787501|Cognitive Behavior Therapy|cognitive behavior therapy
654036|NCT00787501|Cognitive Therapy|cognitive therapy
654037|NCT00787501|antidepressant medications|antidepressant medications
654038|NCT00787514|ovarian cancer, folate receptor, plasma|ovarian cancer, folate receptor, plasma
654039|NCT00787527|Lymphoma|lymphoma
654040|NCT00787527|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
654041|NCT00787527|SAHA|saha
654042|NCT00787527|Vorinostat|vorinostat
654043|NCT00787527|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
654044|NCT00787527|MSK-390|msk-390
654045|NCT00787527|CHOP|chop
654046|NCT00787527|Cyclophosphamide|cyclophosphamide
654047|NCT00787527|Doxorubicin|doxorubicin
654048|NCT00787527|AD|ad
654049|NCT00787527|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
654050|NCT00787527|Cytoxan|cytoxan
654051|NCT00787527|Neosar|neosar
654052|NCT00787527|Vincristine|vincristine
654053|NCT00787527|Prednisone|prednisone
654054|NCT00787527|Untreated T-cell|untreated t-cell
654055|NCT00787527|T-cell NHL|t-cell nhl
654056|NCT00787527|Peripheral T-cell lymphoma|peripheral t-cell lymphoma
654057|NCT00787527|PTCL|ptcl
654058|NCT00787527|CD 30|cd 30
654059|NCT00787527|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
654060|NCT00787527|Angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
654061|NCT00787527|Intestinal T-cell lymphoma|intestinal t-cell lymphoma
654062|NCT00787527|Subcutaneous panniculitic T-cell lymphoma|subcutaneous panniculitic t-cell lymphoma
654063|NCT00787540|Coronary disease|coronary disease
654064|NCT00787540|Psychosocial|psychosocial
654065|NCT00787540|Nursing|nursing
654066|NCT00787553|hysterectomy|hysterectomy
654067|NCT00787553|antibiotic prophylaxis|antibiotic prophylaxis
654068|NCT00787553|bacterial vaginosis|bacterial vaginosis
654069|NCT00787553|tinidazole|tinidazole
654070|NCT00787553|cefazolin|cefazolin
654071|NCT00787566|Highly emetogenic chemotherapy induced nausea and vomiting|highly emetogenic chemotherapy induced nausea and vomiting
654072|NCT00787579|Myopia, bifocal, children|myopia, bifocal, children
654073|NCT00787592|Burns|burns
654074|NCT00787592|children|children
654075|NCT00787592|collagenase|collagenase
654076|NCT00787592|silver sulfadiazine|silver sulfadiazine
654077|NCT00787592|Childhood burns|childhood burns
654078|NCT00787605|Hypertension, diabetes mellitus, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, amlodipine, stage 2|hypertension, diabetes mellitus, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, amlodipine, stage 2
654079|NCT00787618|Renal impairment|renal impairment
654080|NCT00787631|birch pollen pollen allergy|birch pollen pollen allergy
654081|NCT00787631|oral allergy syndrome to apple|oral allergy syndrome to apple
654082|NCT00787631|cross reactivity|cross reactivity
654083|NCT00787631|bet v 1|bet v 1
654084|NCT00787631|mal d 1|mal d 1
654085|NCT00787644|Asthma|asthma
654086|NCT00787644|Adipose Tissue|adipose tissue
654087|NCT00787644|Asthmatics|asthmatics
654088|NCT00787644|Pioglitazone|pioglitazone
654089|NCT00787644|Actos|actos
654090|NCT00787644|Obesity|obesity
654091|NCT00787644|Exacerbation|exacerbation
654100|NCT00787657|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
654101|NCT00787670|Obese|obese
654102|NCT00787670|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
654103|NCT00787670|Gastric Bypass surgery|gastric bypass surgery
654104|NCT00787670|Risk of cardiovascular diseases|risk of cardiovascular diseases
654105|NCT00787683|Patients with ventricular arrhythmias and the prevention of sudden cardiac death|patients with ventricular arrhythmias and the prevention of sudden cardiac death
654106|NCT00787696|HIV prevention|hiv prevention
654107|NCT00787696|female adolescent offenders|female adolescent offenders
654108|NCT00787696|sexual risk reduction|sexual risk reduction
654109|NCT00787696|alcohol and other drug abuse|alcohol and other drug abuse
654110|NCT00787709|Obesity prevention|obesity prevention
654111|NCT00787709|Health promotion|health promotion
654112|NCT00787709|School based curriculum|school based curriculum
654113|NCT00787722|High dose immunosuppressive therapy|high dose immunosuppressive therapy
654114|NCT00787722|Hematopoietic stem cell support|hematopoietic stem cell support
654115|NCT00787748|Cardiovascular|cardiovascular
654116|NCT00787748|COPD|copd
654117|NCT00787748|Population|population
654118|NCT00787748|Prevalence|prevalence
654119|NCT00787748|Underdiagnosis|underdiagnosis
654120|NCT00787761|accelerated phase CML|accelerated phase cml
654121|NCT00787761|blastic phase CML|blastic phase cml
654122|NCT00787761|Philadelphia chromosome positive CML|philadelphia chromosome positive cml
654123|NCT00787761|stage I CLL|stage i cll
654124|NCT00787761|stage II CLL|stage ii cll
654125|NCT00787761|stage III CLL|stage iii cll
654126|NCT00787761|stage IV CLL|stage iv cll
654127|NCT00787761|stage I multiple myeloma|stage i multiple myeloma
654128|NCT00787761|stage II multiple myeloma|stage ii multiple myeloma
654129|NCT00787761|stage III multiple myeloma|stage iii multiple myeloma
654130|NCT00787761|adult AML with 11q23 (MLL) abnormalities|adult aml with 11q23 (mll) abnormalities
654131|NCT00787761|adult CML in remission|adult cml in remission
654132|NCT00787761|adult ALL in remission|adult all in remission
654133|NCT00787761|stage IV renal cell cancer|stage iv renal cell cancer
654134|NCT00787761|de novo MDS|de novo mds
654135|NCT00787761|previously treated MDS|previously treated mds
654136|NCT00787761|secondary MDS|secondary mds
654137|NCT00787761|atypical CML, BCR-ABL negative|atypical cml, bcr-abl negative
654138|NCT00787761|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
654139|NCT00787761|MDS/myeloproliferative neoplasm, unclassifiable|mds/myeloproliferative neoplasm, unclassifiable
654140|NCT00787761|primary myelofibrosis|primary myelofibrosis
654141|NCT00787761|chronic neutrophilic leukemia|chronic neutrophilic leukemia
654142|NCT00787761|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
654143|NCT00787761|clear cell renal cell carcinoma|clear cell renal cell carcinoma
654144|NCT00787761|adult AML with inv(16)(p13;q22)|adult aml with inv(16)(p13;q22)
654145|NCT00787761|adult AML with t(15;17)(q22;q12)|adult aml with t(15;17)(q22;q12)
654146|NCT00787761|adult AML with t(16;16)(p13;q22)|adult aml with t(16;16)(p13;q22)
654147|NCT00787761|adult AML with t(8;21)(q22;q22)|adult aml with t(8;21)(q22;q22)
654148|NCT00787761|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
654149|NCT00787761|AML/transient myeloproliferative disorder|aml/transient myeloproliferative disorder
654150|NCT00787761|Burkitt lymphoma|burkitt lymphoma
654151|NCT00787761|chronic phase CML|chronic phase cml
654152|NCT00787761|extranodal marginal zone B-cell lymphoma of mucosa tissue|extranodal marginal zone b-cell lymphoma of mucosa tissue
654153|NCT00787761|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
654154|NCT00787761|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
654155|NCT00787761|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
654156|NCT00787761|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
654157|NCT00787761|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
654158|NCT00787761|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
654159|NCT00787761|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
654160|NCT00787761|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
654161|NCT00787761|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
654162|NCT00787761|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
753145|NCT01175655|Mesenchymal stromal cells|mesenchymal stromal cells
654163|NCT00787761|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
654164|NCT00787761|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
654165|NCT00787761|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
654166|NCT00787761|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
654167|NCT00787761|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
654168|NCT00787761|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
654169|NCT00787761|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
654170|NCT00787761|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
654171|NCT00787761|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
654172|NCT00787761|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
654173|NCT00787761|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
654174|NCT00787761|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
654249|NCT00787995|MPS IVA|mps iva
654499|NCT00788684|Rituximab|rituximab
654175|NCT00787761|contiguous st II adult diffuse small cleaved cell lymphoma|contiguous st ii adult diffuse small cleaved cell lymphoma
654176|NCT00787761|noncontiguous st II diffuse small cleaved cell lymphoma|noncontiguous st ii diffuse small cleaved cell lymphoma
654177|NCT00787761|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
654178|NCT00787761|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
654179|NCT00787761|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
654180|NCT00787761|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
654181|NCT00787761|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
654182|NCT00787761|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
654183|NCT00787761|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
654184|NCT00787761|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
654185|NCT00787761|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
654186|NCT00787761|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
654187|NCT00787761|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
654188|NCT00787761|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
654189|NCT00787761|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
654190|NCT00787761|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
654191|NCT00787761|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
654192|NCT00787761|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
654193|NCT00787761|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
654194|NCT00787761|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
654195|NCT00787761|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
654731|NCT00789581|Doxorubicin|doxorubicin
654196|NCT00787761|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
654197|NCT00787761|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
654198|NCT00787761|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
654199|NCT00787761|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
654200|NCT00787761|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
654201|NCT00787761|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
654202|NCT00787761|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
654203|NCT00787761|splenic marginal zone lymphoma|splenic marginal zone lymphoma
654204|NCT00787761|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
654205|NCT00787761|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
654206|NCT00787761|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
654207|NCT00787761|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
654208|NCT00787761|anaplastic large cell lymphoma|anaplastic large cell lymphoma
654209|NCT00787761|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
654211|NCT00787774|resistance|resistance
654212|NCT00787774|integrase|integrase
654213|NCT00787800|Shock prevention|shock prevention
654214|NCT00787800|Single vs. Dual Chamber|single vs. dual chamber
654215|NCT00787800|Reduce ventricular pacing|reduce ventricular pacing
654216|NCT00787800|Atrial Fibrillation|atrial fibrillation
654217|NCT00787800|Remote Monitoring|remote monitoring
654218|NCT00787800|ICD|icd
654219|NCT00787800|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
654220|NCT00787891|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
654221|NCT00787891|Erosive Gastroesophageal Reflux Disease|erosive gastroesophageal reflux disease
654222|NCT00787891|Ulcerative Gastroesophageal Reflux Disease|ulcerative gastroesophageal reflux disease
654223|NCT00787891|Endoscopy|endoscopy
654224|NCT00787891|Pediatrics|pediatrics
654225|NCT00787891|Rabeprazole|rabeprazole
654226|NCT00787904|Osteoporosis, T-cells|osteoporosis, t-cells
654227|NCT00787917|Cystic Fibrosis|cystic fibrosis
654228|NCT00787917|Allergic Bronchopulmonary Aspergillosis|allergic bronchopulmonary aspergillosis
654229|NCT00787917|omalizumab|omalizumab
654230|NCT00787917|oral corticosteroid use|oral corticosteroid use
654231|NCT00787917|anti-immunoglobulin E|anti-immunoglobulin e
654232|NCT00787930|BPD|bpd
654233|NCT00787943|Acne|acne
654234|NCT00787969|stage I mantle cell lymphoma|stage i mantle cell lymphoma
654235|NCT00787969|Stage II Contiguous Mantle Cell Lymphoma|stage ii contiguous mantle cell lymphoma
654236|NCT00787969|Stage II Non-Contiguous Mantle Cell Lymphoma|stage ii non-contiguous mantle cell lymphoma
654237|NCT00787969|Stage III Mantle Cell Lymphoma|stage iii mantle cell lymphoma
654238|NCT00787969|Stage IV Mantle Cell Lymphoma|stage iv mantle cell lymphoma
654239|NCT00787982|brain|brain
654240|NCT00787982|metastasis|metastasis
654241|NCT00787982|neoplasm|neoplasm
654242|NCT00787982|tumor|tumor
654243|NCT00787982|Patients with secondary brain neoplasms|patients with secondary brain neoplasms
654244|NCT00787982|laser therapy|laser therapy
654245|NCT00787982|laser interstitial thermal therapy|laser interstitial thermal therapy
654246|NCT00787995|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
654247|NCT00787995|MPS IV Type A|mps iv type a
654248|NCT00787995|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
654250|NCT00787995|Morquio A Syndrome|morquio a syndrome
654251|NCT00787995|Lysosomal Storage Disorder|lysosomal storage disorder
654252|NCT00787995|LSD|lsd
654253|NCT00787995|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
654254|NCT00787995|galactose-6-sulfatase|galactose-6-sulfatase
654255|NCT00787995|GALNS|galns
654256|NCT00787995|enzyme replacement therapy|enzyme replacement therapy
654257|NCT00787995|ERT|ert
654258|NCT00788008|spinal, joint|spinal, joint
654259|NCT00788021|Transplant|transplant
654260|NCT00788021|Immunity|immunity
654261|NCT00788021|Immunosuppression|immunosuppression
654262|NCT00788034|Relapse prevention|relapse prevention
654263|NCT00788034|GAD|gad
654264|NCT00788034|Maintenance|maintenance
654265|NCT00788034|Double-blind|double-blind
654266|NCT00788034|Multicentre|multicentre
654267|NCT00788060|Renal Cell Carcinoma|renal cell carcinoma
654268|NCT00788060|Rad001|rad001
654269|NCT00788060|Sutent|sutent
654270|NCT00788073|fragile X syndrome|fragile x syndrome
654271|NCT00788073|irritability|irritability
654272|NCT00788073|behavior problems|behavior problems
654274|NCT00788099|Plitidepsin|plitidepsin
654275|NCT00788099|Tumors|tumors
654276|NCT00788099|Lymphomas|lymphomas
654277|NCT00788112|ductal breast carcinoma in situ|ductal breast carcinoma in situ
654278|NCT00788125|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
654279|NCT00788125|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
654280|NCT00788125|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
654281|NCT00788125|metastatic osteosarcoma|metastatic osteosarcoma
654282|NCT00788125|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
655027|NCT00790582|ALS|als
654283|NCT00788125|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
654284|NCT00788125|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
654285|NCT00788125|recurrent osteosarcoma|recurrent osteosarcoma
654286|NCT00788125|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
654287|NCT00788125|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
654288|NCT00788125|recurrent neuroblastoma|recurrent neuroblastoma
654289|NCT00788125|stage 4S neuroblastoma|stage 4s neuroblastoma
654290|NCT00788125|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
654291|NCT00788125|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
654292|NCT00788125|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
654293|NCT00788125|childhood teratoma|childhood teratoma
654294|NCT00788125|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
654295|NCT00788125|childhood renal cell carcinoma|childhood renal cell carcinoma
654296|NCT00788125|recurrent renal cell cancer|recurrent renal cell cancer
654297|NCT00788125|congenital mesoblastic nephroma|congenital mesoblastic nephroma
654298|NCT00788125|cystic nephroma|cystic nephroma
654299|NCT00788125|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
654300|NCT00788125|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
654301|NCT00788125|disseminated neuroblastoma|disseminated neuroblastoma
654302|NCT00788125|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
654303|NCT00788125|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
654304|NCT00788125|recurrent childhood liver cancer|recurrent childhood liver cancer
654305|NCT00788125|stage IV childhood liver cancer|stage iv childhood liver cancer
654306|NCT00788125|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
654307|NCT00788125|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
654308|NCT00788125|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
654309|NCT00788125|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
654310|NCT00788125|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
654311|NCT00788125|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
654312|NCT00788125|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
654313|NCT00788125|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
654314|NCT00788125|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
654315|NCT00788125|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
654316|NCT00788125|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
654317|NCT00788125|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
654318|NCT00788125|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
654319|NCT00788125|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
654320|NCT00788125|Burkitt lymphoma|burkitt lymphoma
654321|NCT00788125|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
654322|NCT00788125|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
654323|NCT00788125|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
654324|NCT00788125|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
654325|NCT00788125|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
654326|NCT00788125|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
654327|NCT00788125|childhood central nervous system germinoma|childhood central nervous system germinoma
654328|NCT00788125|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
654329|NCT00788125|childhood central nervous system teratoma|childhood central nervous system teratoma
654330|NCT00788125|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
654331|NCT00788125|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
654332|NCT00788125|childhood choroid plexus tumor|childhood choroid plexus tumor
654333|NCT00788125|childhood craniopharyngioma|childhood craniopharyngioma
654334|NCT00788125|childhood ependymoblastoma|childhood ependymoblastoma
654335|NCT00788125|childhood medulloepithelioma|childhood medulloepithelioma
654336|NCT00788125|childhood infratentorial ependymoma|childhood infratentorial ependymoma
654337|NCT00788125|childhood supratentorial ependymoma|childhood supratentorial ependymoma
654338|NCT00788125|childhood oligodendroglioma|childhood oligodendroglioma
654339|NCT00788125|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
654340|NCT00788125|childhood grade I meningioma|childhood grade i meningioma
654341|NCT00788125|childhood grade II meningioma|childhood grade ii meningioma
654342|NCT00788125|childhood grade III meningioma|childhood grade iii meningioma
654343|NCT00788125|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
654344|NCT00788125|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
654345|NCT00788125|recurrent childhood ependymoma|recurrent childhood ependymoma
654346|NCT00788125|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
654347|NCT00788125|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
654348|NCT00788125|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
654349|NCT00788125|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
654350|NCT00788125|recurrent uterine sarcoma|recurrent uterine sarcoma
654351|NCT00788125|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
654352|NCT00788125|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
654353|NCT00788125|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
654354|NCT00788125|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
654355|NCT00788125|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
654356|NCT00788125|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
654357|NCT00788125|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
654358|NCT00788125|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
654359|NCT00788125|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
654360|NCT00788125|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
654361|NCT00788125|recurrent childhood brain tumor|recurrent childhood brain tumor
654362|NCT00788125|recurrent childhood spinal cord neoplasm|recurrent childhood spinal cord neoplasm
654363|NCT00788138|Cystic Fibrosis|cystic fibrosis
654364|NCT00788138|Vitamin D|vitamin d
654365|NCT00788138|Anti-microbial peptides|anti-microbial peptides
654366|NCT00788151|Dengue virus|dengue virus
654367|NCT00788151|Dengue fever|dengue fever
654368|NCT00788151|Dengue hemorrhagic fever|dengue hemorrhagic fever
654369|NCT00788151|Dengue diseases|dengue diseases
654370|NCT00788151|Dengue vaccine|dengue vaccine
654371|NCT00788164|cervical cancer|cervical cancer
654372|NCT00788164|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
654373|NCT00788164|therapeutic vaccine|therapeutic vaccine
654374|NCT00788164|treatment|treatment
654375|NCT00788164|CIN|cin
654376|NCT00788164|HPV|hpv
654377|NCT00788164|vaccine|vaccine
654378|NCT00788164|Hopkins|hopkins
654379|NCT00788164|Trimble|trimble
654380|NCT00788177|age-related macular degeneration|age-related macular degeneration
654381|NCT00788177|subretinal injection|subretinal injection
654382|NCT00788177|Pegaptanib|pegaptanib
654383|NCT00788177|Macugen|macugen
654384|NCT00788190|Distal Radius Fracture|distal radius fracture
654385|NCT00788190|Elderly|elderly
654386|NCT00788190|Prospective randomized trial|prospective randomized trial
654387|NCT00788190|Outcomes|outcomes
654388|NCT00788190|Pain and Function|pain and function
654389|NCT00788190|Surgical Vs. conservative management|surgical vs. conservative management
654390|NCT00788190|Fractures with borderline alignment|fractures with borderline alignment
654391|NCT00788216|Radical hysterectomy|radical hysterectomy
654392|NCT00788216|Whole pelvic radiation|whole pelvic radiation
654393|NCT00788216|Brachytherapy|brachytherapy
654394|NCT00788216|Chemoradiation|chemoradiation
654395|NCT00788216|Complications|complications
654396|NCT00788216|Quality of Life|quality of life
654397|NCT00788229|Dry Eye Syndromes|dry eye syndromes
654398|NCT00788229|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
654399|NCT00788229|artificial tears|artificial tears
654400|NCT00788229|carboxymethylcellulose sodium|carboxymethylcellulose sodium
654401|NCT00788229|sodium hyaluronate|sodium hyaluronate
654402|NCT00788242|Cardiac surgery|cardiac surgery
654403|NCT00788242|Cardioprotection|cardioprotection
654404|NCT00788242|Aortocoronary bypass graft|aortocoronary bypass graft
654405|NCT00788242|Aortic stenosis|aortic stenosis
654406|NCT00788294|Pharmacokinetics tanezumab subcutaneous bioavailability intravenous Japanese subjects|pharmacokinetics tanezumab subcutaneous bioavailability intravenous japanese subjects
654407|NCT00788307|adenocarcinoma of the prostate|adenocarcinoma of the prostate
654408|NCT00788307|recurrent prostate cancer|recurrent prostate cancer
654409|NCT00788307|stage I prostate cancer|stage i prostate cancer
654410|NCT00788307|stage II prostate cancer|stage ii prostate cancer
654411|NCT00788320|Tuberculosis|tuberculosis
654412|NCT00788320|vitamin D|vitamin d
654413|NCT00788320|immune system|immune system
654414|NCT00788333|Advanced or Metastatic Her-2-positive Breast Cancer|advanced or metastatic her-2-positive breast cancer
654415|NCT00788346|Heavily marketed medications|heavily marketed medications
654416|NCT00788346|Prescribing|prescribing
654417|NCT00788346|Health information technology|health information technology
654418|NCT00788346|Education|education
654419|NCT00788359|cystic fibrosis|cystic fibrosis
654420|NCT00788359|pulmonary exacerbation|pulmonary exacerbation
654421|NCT00788359|biomarkers|biomarkers
654422|NCT00788372|Chronic pain|chronic pain
654423|NCT00788372|Fentanyl Patch|fentanyl patch
654424|NCT00788385|Hydrocephalus|hydrocephalus
654425|NCT00788385|High Pressure|high pressure
654426|NCT00788385|Shunt Blockage|shunt blockage
654427|NCT00788424|AS101 Psoriasis|as101 psoriasis
654428|NCT00788463|administration, intranasal|administration, intranasal
654429|NCT00788463|aerosol|aerosol
654430|NCT00788463|beclomethasone|beclomethasone
654431|NCT00788463|QVAR|qvar
654432|NCT00788463|corticosteroids|corticosteroids
654433|NCT00788463|nasal polyps|nasal polyps
654434|NCT00788463|rhinomanometry|rhinomanometry
654435|NCT00788463|Rhinitis Quality of Life Questionnaire|rhinitis quality of life questionnaire
654436|NCT00788463|Quality of Life|quality of life
654437|NCT00788476|Needs Assessment Survey|needs assessment survey
654438|NCT00788476|Childhood Cancer Survivors|childhood cancer survivors
654439|NCT00788476|Parents|parents
654440|NCT00788476|Primary Caregiver|primary caregiver
654441|NCT00788476|Survey|survey
654442|NCT00788489|breast cancer|breast cancer
654443|NCT00788489|FDG-PET|fdg-pet
654444|NCT00788489|MRI|mri
654445|NCT00788489|chemotherapy|chemotherapy
654446|NCT00788489|ultrasonography|ultrasonography
654447|NCT00788515|insomnia|insomnia
654448|NCT00788515|sleep maintenance|sleep maintenance
654449|NCT00788528|Obesity|obesity
654450|NCT00788541|Open-Angle Glaucoma|open-angle glaucoma
654451|NCT00788541|Intraocular Pressure|intraocular pressure
654452|NCT00788541|Anecortave Acetate|anecortave acetate
654453|NCT00788554|groin|groin
654454|NCT00788554|inguinal|inguinal
654455|NCT00788554|hernia|hernia
654456|NCT00788554|lichtenstein|lichtenstein
654457|NCT00788554|TEP|tep
654458|NCT00788580|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
654459|NCT00788593|Chronic Pancreatitis|chronic pancreatitis
654460|NCT00788593|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
654461|NCT00788606|diffused large B cell lymphoma, DLBCL, R-Chop, bevacizumab|diffused large b cell lymphoma, dlbcl, r-chop, bevacizumab
654462|NCT00788606|Diffuse large B-cell non-Hodgkin's lymphoma.|diffuse large b-cell non-hodgkin's lymphoma.
654463|NCT00788619|Infertility|infertility
654464|NCT00788619|Assisted reproductive technology|assisted reproductive technology
654465|NCT00788619|Nitric oxide|nitric oxide
654466|NCT00788632|Osteoporosis|osteoporosis
654468|NCT00788632|Bisphosphonates|bisphosphonates
654469|NCT00788632|Educational materials|educational materials
654470|NCT00788632|Patient Stories|patient stories
654471|NCT00788645|Smoking|smoking
654472|NCT00788645|COPD|copd
654769|NCT00789672|Patching|patching
654473|NCT00788645|Chronic Obstructive Lung Disease|chronic obstructive lung disease
654474|NCT00788645|COPD Exacerbations|copd exacerbations
752386|NCT01172756|Left ventricular dysfunction|left ventricular dysfunction
654475|NCT00788645|Viruses and Bacteria associated with COPD exacerbations|viruses and bacteria associated with copd exacerbations
654476|NCT00788658|Obstructed constipation|obstructed constipation
654477|NCT00788658|Quality of life|quality of life
654478|NCT00788671|Endometrioid Endometrial Carcinoma|endometrioid endometrial carcinoma
654479|NCT00788671|Complex Atypical Hyperplasia|complex atypical hyperplasia
654480|NCT00788671|Levonorgestrel Intrauterine Device|levonorgestrel intrauterine device
654481|NCT00788671|Endometrial Biopsy|endometrial biopsy
654482|NCT00788671|Endometrium|endometrium
654483|NCT00788671|Hyperplasia of lining of the uterus (womb)|hyperplasia of lining of the uterus (womb)
654484|NCT00788671|Questionnaires|questionnaires
654485|NCT00788671|Progesterone|progesterone
654486|NCT00788671|Estrogen|estrogen
654487|NCT00788671|Postmenopausal|postmenopausal
654488|NCT00788671|Endometrial|endometrial
654489|NCT00788671|Mirena|mirena
654490|NCT00788671|Intrauterine Device|intrauterine device
654491|NCT00788671|Birth control|birth control
654492|NCT00788671|IUD|iud
654493|NCT00788671|LIUD|liud
654494|NCT00788671|CAH|cah
654495|NCT00788671|G1EEC|g1eec
654496|NCT00788671|Grade 1 endometrial cancer|grade 1 endometrial cancer
654497|NCT00788671|Early endometrial cancer|early endometrial cancer
654498|NCT00788684|Navitoclax|navitoclax
654500|NCT00788684|CD20-Positive Lymphoid Malignancies|cd20-positive lymphoid malignancies
654501|NCT00788684|ABT-263|abt-263
654502|NCT00788684|Chronic Lymphoid Leukemia|chronic lymphoid leukemia
654503|NCT00788684|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
654504|NCT00788684|Hematological Malignancies|hematological malignancies
654505|NCT00788723|Severe Brain Injury|severe brain injury
654506|NCT00788723|Excitability|excitability
654507|NCT00788723|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
654508|NCT00788736|venous thromboembolism|venous thromboembolism
654509|NCT00788736|long-term oral anticoagulant therapy|long-term oral anticoagulant therapy
654510|NCT00788736|warfarin|warfarin
654511|NCT00788736|bleeding risk|bleeding risk
654512|NCT00788736|clinical prediction rule|clinical prediction rule
654513|NCT00788736|predictors|predictors
654514|NCT00788736|deep vein thrombosis|deep vein thrombosis
654515|NCT00788736|pulmonary embolism|pulmonary embolism
654516|NCT00788736|vitamin k antagonist|vitamin k antagonist
654517|NCT00788736|side effect|side effect
654518|NCT00788749|chronic rhinosinusitis|chronic rhinosinusitis
654519|NCT00788749|nasal polyps|nasal polyps
654520|NCT00788749|oral steroid|oral steroid
654521|NCT00788749|intranasal steroid|intranasal steroid
654522|NCT00788749|medical polypectomy|medical polypectomy
654523|NCT00788762|glaucoma|glaucoma
654524|NCT00788762|myocilin|myocilin
654525|NCT00788775|nilotinib|nilotinib
654526|NCT00788788|Airway obstruction|airway obstruction
654528|NCT00788788|Different Helium content|different helium content
654529|NCT00788827|diabetes type I|diabetes type i
654530|NCT00788827|diabetes type 2|diabetes type 2
654531|NCT00788827|renal transplant|renal transplant
654533|NCT00788827|successful renal transplant|successful renal transplant
654534|NCT00788853|DiabCare Asia 2008, Cross-sectional survey, Glycemic control, Psychosocial well-being, Diabetic complications, Quality of life.|diabcare asia 2008, cross-sectional survey, glycemic control, psychosocial well-being, diabetic complications, quality of life.
654535|NCT00788866|Neuroprotection|neuroprotection
654536|NCT00788866|Antioxidants|antioxidants
654537|NCT00788866|Neonatal brain injury|neonatal brain injury
654538|NCT00788866|Pomegranate juice|pomegranate juice
654539|NCT00788879|Behavioral Journalism|behavioral journalism
654540|NCT00788879|Mexican-Americans|mexican-americans
654541|NCT00788879|Obesity|obesity
654542|NCT00788879|Nutrition|nutrition
654543|NCT00788879|Physical Activity|physical activity
654544|NCT00788879|Border Health|border health
654545|NCT00788892|Acute|acute
654546|NCT00788892|Myeloid|myeloid
654547|NCT00788892|Leukemia|leukemia
654548|NCT00788892|elderly|elderly
654549|NCT00788892|Newly|newly
654550|NCT00788892|Diagnosed|diagnosed
654551|NCT00788905|Hemodialysis|hemodialysis
654552|NCT00788918|Chronic Hepatitis C|chronic hepatitis c
654553|NCT00788918|cognitive dysfunction|cognitive dysfunction
654554|NCT00788918|MRI|mri
654555|NCT00788918|MR spectroscopy|mr spectroscopy
654556|NCT00788918|interferon|interferon
654557|NCT00788918|ribavirin|ribavirin
654558|NCT00788918|sustained virologic response, major depressive disorder|sustained virologic response, major depressive disorder
654559|NCT00788931|Breast Cancer|breast cancer
654560|NCT00788931|HER2 positive|her2 positive
654561|NCT00788931|adult-female|adult-female
654562|NCT00788931|LBH589|lbh589
654563|NCT00788931|HDAC inhibitor|hdac inhibitor
654564|NCT00788931|panobinostat|panobinostat
654565|NCT00788931|metastatic breast|metastatic breast
654566|NCT00788931|adult female patients|adult female patients
654567|NCT00788957|panitumumab|panitumumab
654568|NCT00788957|vectibix|vectibix
654569|NCT00788957|AMG 102|amg 102
654570|NCT00788957|AMG 479|amg 479
654770|NCT00789672|Levodopa|levodopa
654571|NCT00788957|colon cancer|colon cancer
654572|NCT00788957|rectal cancer|rectal cancer
654573|NCT00788957|colorectal cancer|colorectal cancer
655988|NCT00801333|ALS|als
654574|NCT00788957|metastatic colorectal cancer|metastatic colorectal cancer
654575|NCT00788957|EGFR inhibitor|egfr inhibitor
654576|NCT00788957|IGF inhibitor|igf inhibitor
654577|NCT00788957|c-MET inhibitor|c-met inhibitor
654578|NCT00788970|Acupressure|acupressure
654579|NCT00788970|Shiatsu|shiatsu
654580|NCT00788970|Schizophrenia|schizophrenia
654581|NCT00788983|Induced hypoxia|induced hypoxia
654582|NCT00788983|Pulse oximeter|pulse oximeter
654583|NCT00788983|Nonin Medical|nonin medical
654584|NCT00788983|Verification of SpO2 accuracy|verification of spo2 accuracy
654585|NCT00788996|Tobacco Smoke Pollution/prevention and control|tobacco smoke pollution/prevention and control
654586|NCT00788996|Parent-Child Relations|parent-child relations
654587|NCT00788996|Environmental Tobacco Smoke (ETS)|environmental tobacco smoke (ets)
654588|NCT00789009|HIV|hiv
654589|NCT00789009|Natural History|natural history
654590|NCT00789009|Stored Sample|stored sample
654591|NCT00789009|AIDS|aids
654592|NCT00789022|First-Psychotic-Episode (FPE)|first-psychotic-episode (fpe)
654593|NCT00789022|Glutamatergic system|glutamatergic system
654594|NCT00789022|Glycine|glycine
654595|NCT00789022|D-Serine|d-serine
654596|NCT00789022|Oxytocin|oxytocin
654597|NCT00789022|Estrogen|estrogen
654598|NCT00789048|hip|hip
654599|NCT00789048|arthroplasty|arthroplasty
654601|NCT00789061|Acute hearing loss in patients with SLC26A4 mutations|acute hearing loss in patients with slc26a4 mutations
654602|NCT00789074|Smoking cessation|smoking cessation
654603|NCT00789074|Tobacco dependence|tobacco dependence
654604|NCT00789074|Varenicline|varenicline
654605|NCT00789074|Preloading|preloading
654606|NCT00789087|Pleural Effusion.|pleural effusion.
654607|NCT00789087|Talc.|talc.
654608|NCT00789087|Pleurodesis.|pleurodesis.
654609|NCT00789087|Quality of Life.|quality of life.
654610|NCT00789087|Thoracoscopy.|thoracoscopy.
654611|NCT00789100|telehealth|telehealth
654612|NCT00789100|telemonitor|telemonitor
654613|NCT00789100|telemedicine|telemedicine
654614|NCT00789100|Co-morbidities|co-morbidities
654615|NCT00789113|lamotrigine|lamotrigine
654616|NCT00789113|epilepsy|epilepsy
654617|NCT00789113|metabolism|metabolism
656959|NCT00804427|Low-density Lipoprotein (LDL) particle size|low-density lipoprotein (ldl) particle size
656960|NCT00804427|Low-density Lipoprotein (LDL) phenotype|low-density lipoprotein (ldl) phenotype
654618|NCT00789113|bipolar disorder|bipolar disorder
654619|NCT00789113|bipolar depression|bipolar depression
654620|NCT00789113|glucuronidation|glucuronidation
654621|NCT00789165|Brugada syndrome|brugada syndrome
654622|NCT00789165|quinidine|quinidine
654623|NCT00789165|Asymptomatic Brugada Syndrome|asymptomatic brugada syndrome
654624|NCT00789178|memory disturbances|memory disturbances
654625|NCT00789204|exercise|exercise
654626|NCT00789204|low back pain|low back pain
654627|NCT00789204|posture|posture
654628|NCT00789204|rehabilitation|rehabilitation
654629|NCT00789217|Penicillin|penicillin
654630|NCT00789217|Beta-Lactams|beta-lactams
654631|NCT00789217|Allergy|allergy
654632|NCT00789217|Hypersensitivity|hypersensitivity
654633|NCT00789230|umbilical|umbilical
654634|NCT00789230|hernia|hernia
654636|NCT00789243|Ischaemia reperfusion|ischaemia reperfusion
654637|NCT00789243|t-PA|t-pa
654638|NCT00789243|Fibrinolysis|fibrinolysis
654639|NCT00789243|Endothelial function|endothelial function
654640|NCT00789243|Local and remote ischaemic preconditioning|local and remote ischaemic preconditioning
654641|NCT00789256|Acute Myelogenous Leukemia|acute myelogenous leukemia
654642|NCT00789256|AML|aml
654643|NCT00789256|Myelodysplastic Syndromes|myelodysplastic syndromes
654644|NCT00789256|MDS|mds
654645|NCT00789256|Melphalan|melphalan
654646|NCT00789256|Bortezomib|bortezomib
654647|NCT00789256|Velcade|velcade
654648|NCT00789269|lung infection after ischemic Stroke|lung infection after ischemic stroke
654649|NCT00789269|prevention of pneumonia|prevention of pneumonia
654650|NCT00789269|rhubarb|rhubarb
654651|NCT00789282|chronic disease|chronic disease
654652|NCT00789282|Family Physician|family physician
654653|NCT00789282|primary care network|primary care network
654654|NCT00789282|practice-based model|practice-based model
654655|NCT00789282|type 2 diabetes|type 2 diabetes
654656|NCT00789282|complications|complications
654657|NCT00789282|sequelae|sequelae
654658|NCT00789295|Mediterranean diet|mediterranean diet
654659|NCT00789295|Postprandial lipids|postprandial lipids
654660|NCT00789295|Postprandial glucose|postprandial glucose
654661|NCT00789295|High fibre diet|high fibre diet
654662|NCT00789295|Low- CHO diet|low- cho diet
654663|NCT00789295|High MUFA diet|high mufa diet
654664|NCT00789295|Dietary approach|dietary approach
654665|NCT00789308|Insulin dependence|insulin dependence
654666|NCT00789347|Neuropathic pain|neuropathic pain
654667|NCT00789347|Cortical excitability|cortical excitability
654668|NCT00789347|Transcranial magnetic stimulation|transcranial magnetic stimulation
654669|NCT00789347|Contact Heat evoked potential|contact heat evoked potential
654771|NCT00789685|Open label|open label
654670|NCT00789347|peripheral nerve stimulation|peripheral nerve stimulation
654671|NCT00789347|neurotrophic factors|neurotrophic factors
654672|NCT00789360|Healthy volunteers|healthy volunteers
654673|NCT00789386|Capsaicin|capsaicin
654674|NCT00789386|Remifentanil|remifentanil
654675|NCT00789386|Hyperalgesia|hyperalgesia
654676|NCT00789399|deep vein thrombosis|deep vein thrombosis
654677|NCT00789399|coronary artery bypass surgery|coronary artery bypass surgery
654678|NCT00789399|Venous thromboembolism|venous thromboembolism
654679|NCT00789412|Analgesia|analgesia
654680|NCT00789412|Sedation|sedation
654681|NCT00789412|Critical Illness|critical illness
654682|NCT00789412|Intensive Care|intensive care
654683|NCT00789425|osteoporosis|osteoporosis
654684|NCT00789425|osteopenia|osteopenia
654685|NCT00789425|olive extract|olive extract
654686|NCT00789425|oleuropein|oleuropein
654687|NCT00789438|Analgesia|analgesia
654688|NCT00789438|Sedation|sedation
654689|NCT00789438|Spinal|spinal
654690|NCT00789438|Stress|stress
654691|NCT00789438|Surgical|surgical
654692|NCT00789438|Surgical Stress|surgical stress
654693|NCT00789438|Pain|pain
654694|NCT00789451|Ischaemia reperfusion|ischaemia reperfusion
654695|NCT00789451|t-PA|t-pa
654696|NCT00789451|Fibrinolysis|fibrinolysis
654697|NCT00789451|Endothelial function|endothelial function
654698|NCT00789464|Urinary Tract Infection|urinary tract infection
654699|NCT00789464|Probiotics|probiotics
654700|NCT00789464|Dietary Supplements|dietary supplements
654701|NCT00789464|Bacteriuria|bacteriuria
654702|NCT00789490|pregnancy|pregnancy
654703|NCT00789490|relative bioavailability|relative bioavailability
654704|NCT00789490|iron|iron
654706|NCT00789490|ferric pyrophosphate|ferric pyrophosphate
654707|NCT00789490|Study focus is to compare the relative bioavailability of SuppleFem Sprinkles to the current tradtional tablet Materna in pregnant women|study focus is to compare the relative bioavailability of supplefem sprinkles to the current tradtional tablet materna in pregnant women
654708|NCT00789503|dietary fortification|dietary fortification
654709|NCT00789503|Vitamin D3|vitamin d3
654710|NCT00789503|Osteomalacia|osteomalacia
654711|NCT00789503|bread|bread
654712|NCT00789503|bone mineral density|bone mineral density
654713|NCT00789503|geriatrics|geriatrics
654714|NCT00789503|cholecalciferol|cholecalciferol
654715|NCT00789503|calcidiol|calcidiol
654716|NCT00789503|osteoporosis|osteoporosis
654717|NCT00789503|dual-energy photon absorptiometry|dual-energy photon absorptiometry
654718|NCT00789503|bread fortification|bread fortification
654840|NCT00789997|TNF alpha|tnf alpha
654719|NCT00789516|Coagulation markers, thalassemia disease post SCT|coagulation markers, thalassemia disease post sct
654720|NCT00789529|Contact lenses, wettability, Contact Lens Disinfectant Solutions, pre-lens tear film|contact lenses, wettability, contact lens disinfectant solutions, pre-lens tear film
654721|NCT00789542|stroke|stroke
654722|NCT00789542|deep vein thrombosis|deep vein thrombosis
654723|NCT00789542|doppler|doppler
654724|NCT00789555|nasal allergy|nasal allergy
654725|NCT00789555|nasal spray|nasal spray
654726|NCT00789555|seasonal allergy|seasonal allergy
654727|NCT00789555|perennial allergy|perennial allergy
654728|NCT00789568|Hyperphenylalanemia due to Phenylketonuria|hyperphenylalanemia due to phenylketonuria
654729|NCT00789581|Breast Cancer|breast cancer
654730|NCT00789581|Adjuvant|adjuvant
654732|NCT00789581|Cyclophosphamide|cyclophosphamide
654733|NCT00789581|Paclitaxel|paclitaxel
654734|NCT00789581|Ixabepilone|ixabepilone
654735|NCT00789581|TITAN|titan
654736|NCT00789594|Monitoring|monitoring
654737|NCT00789594|Testing|testing
654738|NCT00789594|Medications|medications
654739|NCT00789594|Patients receiving medications and having laboratory tests|patients receiving medications and having laboratory tests
654740|NCT00789607|prostate cancer|prostate cancer
654741|NCT00789607|individualized radiotherapy|individualized radiotherapy
654742|NCT00789607|fiducial markers|fiducial markers
654744|NCT00789607|ultrasound|ultrasound
654745|NCT00789607|High-Risk Localized Prostate Cancer|high-risk localized prostate cancer
654746|NCT00789620|intravenous lidocaine|intravenous lidocaine
654747|NCT00789620|laparoscopic urological surgery|laparoscopic urological surgery
654748|NCT00789620|hospital stay|hospital stay
654749|NCT00789620|pain|pain
654750|NCT00789620|fatigue|fatigue
654751|NCT00789620|length of stay|length of stay
654752|NCT00789633|Pancreatic cancer|pancreatic cancer
654753|NCT00789633|Advanced pancreatic cancer|advanced pancreatic cancer
654754|NCT00789633|Metastatic pancreatic cancer|metastatic pancreatic cancer
654755|NCT00789633|Gemcitabine|gemcitabine
654756|NCT00789633|Chemo-naive|chemo-naive
654757|NCT00789646|corneal ulcer|corneal ulcer
654758|NCT00789646|painless|painless
654759|NCT00789646|subconjunctival injection|subconjunctival injection
654760|NCT00789646|antibiotics|antibiotics
654761|NCT00789646|antifungal|antifungal
654762|NCT00789646|lidocaine|lidocaine
654763|NCT00789659|Fracture fixation, internal|fracture fixation, internal
654764|NCT00789659|Obesity|obesity
654765|NCT00789659|Pelvis|pelvis
654766|NCT00789659|Negative pressure wound therapy|negative pressure wound therapy
654767|NCT00789659|Vacuum-assisted closure|vacuum-assisted closure
654768|NCT00789672|Amblyopia|amblyopia
654772|NCT00789698|Schizophrenia|schizophrenia
654773|NCT00789698|SM-13496|sm-13496
654774|NCT00789698|Latuda|latuda
654775|NCT00789698|Lurasidone|lurasidone
654776|NCT00789724|acute myocardial infarction|acute myocardial infarction
654777|NCT00789763|pancreatic cancer|pancreatic cancer
654778|NCT00789763|Pancreatic cancer locally advanced|pancreatic cancer locally advanced
654779|NCT00789789|Cohort|cohort
654780|NCT00789789|HIV uninfected volunteers|hiv uninfected volunteers
654781|NCT00789789|HIV preventive vaccine|hiv preventive vaccine
654782|NCT00789789|Long term safety|long term safety
654783|NCT00789802|contraception|contraception
654784|NCT00789802|progestin contraception|progestin contraception
654785|NCT00789802|intrauterine contraception|intrauterine contraception
654786|NCT00789802|unscheduled bleeding|unscheduled bleeding
654787|NCT00789802|placebo|placebo
654788|NCT00789815|flexible bronchoscopy|flexible bronchoscopy
654789|NCT00789815|sedation|sedation
654790|NCT00789815|bispectral index|bispectral index
654791|NCT00789828|SEGA|sega
654792|NCT00789828|Tuberous Sclerosis|tuberous sclerosis
654793|NCT00789828|Subependymal Giant Cell Astrocytoma|subependymal giant cell astrocytoma
654794|NCT00789828|mTOR|mtor
654795|NCT00789828|RAD001|rad001
654796|NCT00789828|Mamalian Target Rapamycin|mamalian target rapamycin
654797|NCT00789828|Everolimus|everolimus
654798|NCT00789828|TSC|tsc
654799|NCT00789841|Neuroendocrine tumor|neuroendocrine tumor
654800|NCT00789841|Carcinoid syndrome|carcinoid syndrome
654801|NCT00789841|Motility|motility
654802|NCT00789841|Transit time|transit time
654809|NCT00789867|Gene expression|gene expression
654810|NCT00789867|Tolerability|tolerability
654811|NCT00789867|CFTR gene|cftr gene
654812|NCT00789867|Cystic fibrosis|cystic fibrosis
654813|NCT00789867|Non-viral|non-viral
654814|NCT00789880|Vitamin D3|vitamin d3
654815|NCT00789880|Atopic Dermatitis|atopic dermatitis
654816|NCT00789880|Antimicrobial Peptide Expression|antimicrobial peptide expression
654817|NCT00789893|external beam pelvic radiation|external beam pelvic radiation
654818|NCT00789893|brachytherapy|brachytherapy
654819|NCT00789906|Computerized Neuropsychological Assessment|computerized neuropsychological assessment
654820|NCT00789906|Development of Population Norms of the Computerized Neuropsychological Assessment|development of population norms of the computerized neuropsychological assessment
654821|NCT00789919|Mild Preeclampsia|mild preeclampsia
654822|NCT00789945|type 1 diabetes|type 1 diabetes
654823|NCT00789945|continuous glucose monitoring|continuous glucose monitoring
654824|NCT00789945|Intensive Insulin therapy|intensive insulin therapy
654825|NCT00789958|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
654826|NCT00789958|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
654827|NCT00789958|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
654828|NCT00789958|localized gallbladder cancer|localized gallbladder cancer
654829|NCT00789958|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
654830|NCT00789958|unresectable gallbladder cancer|unresectable gallbladder cancer
654831|NCT00789958|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
654832|NCT00789958|metastatic gallbladder cancer|metastatic gallbladder cancer
654833|NCT00789971|orbital floor triamcinolone|orbital floor triamcinolone
654834|NCT00789971|phacoemulsification|phacoemulsification
654835|NCT00789971|post op inflammation|post op inflammation
654836|NCT00789971|cmo|cmo
654837|NCT00789984|Keratic precipitates|keratic precipitates
654838|NCT00789997|COPD Exacerbation|copd exacerbation
654839|NCT00789997|Etanercept|etanercept
654841|NCT00789997|Randomized|randomized
654842|NCT00790010|bevacizumab|bevacizumab
654843|NCT00790010|ipilimumab|ipilimumab
654844|NCT00790010|unresectable stage III melanoma|unresectable stage iii melanoma
654845|NCT00790010|unresectable stage IV melanoma|unresectable stage iv melanoma
654846|NCT00790023|SAR|sar
654847|NCT00790036|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
654848|NCT00790036|DLBCL|dlbcl
654849|NCT00790036|poor risk|poor risk
654850|NCT00790036|R-IPI 3-5|r-ipi 3-5
654851|NCT00790036|adjuvant therapy|adjuvant therapy
654852|NCT00790036|after R-CHOP or R-EPOCH|after r-chop or r-epoch
654853|NCT00790036|after R-CHOP|after r-chop
654854|NCT00790036|B-cell lymphoma|b-cell lymphoma
654855|NCT00790036|lymphoma|lymphoma
654856|NCT00790036|b cells|b cells
654857|NCT00790036|blood cancer|blood cancer
654858|NCT00790036|lymph nodes|lymph nodes
654859|NCT00790036|Hodgkin's|hodgkin's
654860|NCT00790036|non-Hodgkin|non-hodgkin
654861|NCT00790062|Uterine atony|uterine atony
654862|NCT00790062|Postpartum hemorrhage|postpartum hemorrhage
654863|NCT00790062|clinical trial|clinical trial
654864|NCT00790062|Prophylactic oxytocin|prophylactic oxytocin
654865|NCT00790075|agitation|agitation
654866|NCT00790075|Episodes of agitation regardless of diagnosis|episodes of agitation regardless of diagnosis
654867|NCT00790088|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
654868|NCT00790088|continuous glucose monitoring|continuous glucose monitoring
654869|NCT00790088|sensor-augmented pump therapy|sensor-augmented pump therapy
654870|NCT00790114|Phase I|phase i
654871|NCT00790140|Esophageal Cancer|esophageal cancer
654872|NCT00790140|esophagectomy|esophagectomy
654873|NCT00790140|enteral feeding|enteral feeding
654874|NCT00790140|body composition|body composition
654875|NCT00790140|immunology|immunology
654876|NCT00790153|Type 2 diabetes, hormonal response|type 2 diabetes, hormonal response
654877|NCT00790179|Continuous lumbar plexus,Femoral,hydromorphone|continuous lumbar plexus,femoral,hydromorphone
654878|NCT00790192|Schizophrenia|schizophrenia
654879|NCT00790192|SM-13496|sm-13496
654880|NCT00790192|Latuda|latuda
654881|NCT00790192|Lurasidone|lurasidone
654882|NCT00790218|Hepatocellular carcinoma|hepatocellular carcinoma
654883|NCT00790218|Hepatoma|hepatoma
654884|NCT00790218|HCC|hcc
654885|NCT00790231|urinary bladder|urinary bladder
654886|NCT00790231|thoracic epidural analgesia|thoracic epidural analgesia
654887|NCT00790231|urodynamics|urodynamics
654888|NCT00790231|open kidney surgery with lumbotomy|open kidney surgery with lumbotomy
654889|NCT00790244|Soft-tissue sarcomas|soft-tissue sarcomas
654890|NCT00790244|prognostic factors|prognostic factors
654891|NCT00790244|adjuvant|adjuvant
654892|NCT00790244|chemotherapy|chemotherapy
654893|NCT00790244|radiotherapy|radiotherapy
654894|NCT00790244|metastases-free survival|metastases-free survival
654895|NCT00790244|toxicity|toxicity
654896|NCT00790244|High malignancy grade|high malignancy grade
654897|NCT00790244|High-risk for metastases|high-risk for metastases
654898|NCT00790244|Adult|adult
654899|NCT00790257|Diabetes|diabetes
654900|NCT00790257|Islets transplantation|islets transplantation
654901|NCT00790257|Encapsulation|encapsulation
654902|NCT00790270|Cervical strain|cervical strain
654905|NCT00790270|cyclobenzaprine|cyclobenzaprine
654906|NCT00790283|Treatment of de novo lesions in native coronary arteries|treatment of de novo lesions in native coronary arteries
654907|NCT00790296|cancer fatigue|cancer fatigue
654908|NCT00790309|Obesity|obesity
654909|NCT00790309|Diabetes|diabetes
654910|NCT00790309|Bariatric surgery|bariatric surgery
654911|NCT00790322|Cancer|cancer
654912|NCT00790322|Radiation therapy|radiation therapy
654913|NCT00790322|Radiotherapy|radiotherapy
654914|NCT00790322|Oral Mucositis|oral mucositis
654916|NCT00790335|deep vein thrombosis|deep vein thrombosis
654917|NCT00790335|deep venous thrombosis|deep venous thrombosis
654918|NCT00790335|post thrombotic syndrome|post thrombotic syndrome
654919|NCT00790335|blood clot|blood clot
654920|NCT00790335|thrombolysis|thrombolysis
654921|NCT00790335|tissue plasminogen activator|tissue plasminogen activator
654922|NCT00790335|rt-PA|rt-pa
654923|NCT00790335|Activase|activase
654924|NCT00790335|mechanical thrombectomy|mechanical thrombectomy
654925|NCT00790335|pharmacomechanical|pharmacomechanical
654926|NCT00790335|ATTRACT|attract
654927|NCT00790361|cervical spondylotic myelopathy|cervical spondylotic myelopathy
654928|NCT00790361|spinal cord compression|spinal cord compression
655505|NCT00793104|knee injury|knee injury
654929|NCT00790361|magnetic resonance spectroscopy|magnetic resonance spectroscopy
654930|NCT00790361|functional magnetic resonance imaging|functional magnetic resonance imaging
654931|NCT00790361|brain plasticity|brain plasticity
654932|NCT00790374|Pharmacodynamic profile and safety of BN83495|pharmacodynamic profile and safety of bn83495
654933|NCT00790387|enoxaparin|enoxaparin
654934|NCT00790387|tirofiban|tirofiban
654935|NCT00790387|percutaneous intervention|percutaneous intervention
654936|NCT00790387|platelet inhibition|platelet inhibition
654937|NCT00790387|CD40L|cd40l
654938|NCT00790387|Mac-1|mac-1
654939|NCT00790387|prothrombin fragment 1+2.|prothrombin fragment 1+2.
654940|NCT00790400|Angiomyolipoma|angiomyolipoma
654941|NCT00790400|AML|aml
654942|NCT00790400|Tuberous Sclerosis Complex|tuberous sclerosis complex
654943|NCT00790400|TSC|tsc
654944|NCT00790400|mTOR|mtor
654945|NCT00790400|RAD001|rad001
654946|NCT00790400|Mammalian Target of Rapamycin|mammalian target of rapamycin
654947|NCT00790400|Everolimus|everolimus
654948|NCT00790400|Afinitor|afinitor
654949|NCT00790400|SEGA|sega
654950|NCT00790400|Subependymal Giant Cell Astrocytoma|subependymal giant cell astrocytoma
654951|NCT00790400|Seizures|seizures
654952|NCT00790400|Tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
654953|NCT00790400|Tuberous sclerosis|tuberous sclerosis
654954|NCT00790400|benign tumors of brain|benign tumors of brain
654955|NCT00790400|kidney|kidney
654956|NCT00790400|heart|heart
654957|NCT00790400|eyes|eyes
654958|NCT00790400|lungs|lungs
654959|NCT00790400|skinTSC1|skintsc1
654960|NCT00790400|TSC2|tsc2
654961|NCT00790400|hamaratin|hamaratin
654962|NCT00790400|tuberin, tumor growth suppressors|tuberin, tumor growth suppressors
654963|NCT00790400|gyri|gyri
654964|NCT00790400|tubers|tubers
654965|NCT00790400|Sporadic Lymphangioleiomyomatosis.|sporadic lymphangioleiomyomatosis.
654966|NCT00790400|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
654967|NCT00790400|rare lung disease|rare lung disease
654968|NCT00790413|Radiotherapy|radiotherapy
654969|NCT00790413|Immunotherapy|immunotherapy
654970|NCT00790413|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
654971|NCT00790426|Advanced urothelial cancer|advanced urothelial cancer
654972|NCT00790439|Insulin dependence|insulin dependence
654973|NCT00790452|Brain|brain
654974|NCT00790452|Hematologic Disorder|hematologic disorder
654975|NCT00790452|Venous Thromboembolism|venous thromboembolism
654976|NCT00790452|Glioblastoma|glioblastoma
654977|NCT00790452|Aspirin|aspirin
654978|NCT00790452|Placebo|placebo
654979|NCT00790452|VTE|vte
654980|NCT00790452|ASA|asa
654981|NCT00790452|DVT|dvt
654982|NCT00790465|achalasia|achalasia
654983|NCT00790465|lower esophageal sphincter|lower esophageal sphincter
654984|NCT00790465|nitric oxide|nitric oxide
654985|NCT00790465|dark chocolate|dark chocolate
654986|NCT00790465|flavanols|flavanols
654987|NCT00790478|Ulcerative Colitis|ulcerative colitis
654988|NCT00790478|Melatonin|melatonin
654989|NCT00790478|Gastrointestinal|gastrointestinal
654990|NCT00790478|Irritable Bowel syndrome|irritable bowel syndrome
654991|NCT00790478|Sleep|sleep
654992|NCT00790478|Pilot Study|pilot study
654993|NCT00790491|reduction in risk of heart disease and diabetes|reduction in risk of heart disease and diabetes
654994|NCT00790504|Pelvic floor|pelvic floor
654995|NCT00790504|Transperineal ultrasound|transperineal ultrasound
654996|NCT00790504|Multiple pregnancy|multiple pregnancy
654997|NCT00790504|Singleton pregnancy|singleton pregnancy
654998|NCT00790504|Female pelvic floor|female pelvic floor
654999|NCT00790517|Weight loss|weight loss
655000|NCT00790517|Diabetes prevention|diabetes prevention
655001|NCT00790517|Serious mental illness|serious mental illness
655002|NCT00790517|Antipsychotic medications|antipsychotic medications
655003|NCT00790517|Lifestyle intervention|lifestyle intervention
655004|NCT00790517|Antipsychotic Agents|antipsychotic agents
655005|NCT00790530|Diabetes|diabetes
655006|NCT00790530|Information Technology|information technology
655007|NCT00790530|Health Plans|health plans
655008|NCT00790543|Crohn's Disease|crohn's disease
655009|NCT00790543|Inflammatory Bowel Disease|inflammatory bowel disease
655010|NCT00790569|bladder cancer|bladder cancer
655011|NCT00790569|cervical cancer|cervical cancer
655012|NCT00790569|esophageal cancer|esophageal cancer
655013|NCT00790569|gastric cancer|gastric cancer
655014|NCT00790569|renal cell carcinoma|renal cell carcinoma
655015|NCT00790569|adult primary liver cancer|adult primary liver cancer
655016|NCT00790569|non-small cell lung cancer|non-small cell lung cancer
655017|NCT00790569|small cell lung cancer|small cell lung cancer
655018|NCT00790569|pancreatic cancer|pancreatic cancer
655019|NCT00790569|hypopharyngeal cancer|hypopharyngeal cancer
655020|NCT00790569|laryngeal cancer|laryngeal cancer
655021|NCT00790569|lip and oral cavity cancer|lip and oral cavity cancer
655022|NCT00790569|nasopharyngeal cancer|nasopharyngeal cancer
655023|NCT00790569|oropharyngeal cancer|oropharyngeal cancer
655024|NCT00790569|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
655025|NCT00790569|adult acute myeloid leukemia|adult acute myeloid leukemia
655026|NCT00790569|tobacco use disorder|tobacco use disorder
655028|NCT00790582|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
655029|NCT00790582|Lou Gehrig's Disease|lou gehrig's disease
655030|NCT00790582|Lithium|lithium
655031|NCT00790582|Lithium Carbonate|lithium carbonate
655032|NCT00790595|Prostatectomy|prostatectomy
655033|NCT00790647|primary systemic amyloidosis|primary systemic amyloidosis
655034|NCT00790660|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
655035|NCT00790660|ASP1941|asp1941
655036|NCT00790673|Hepatitis C|hepatitis c
655037|NCT00790673|Viral hepatitis|viral hepatitis
655038|NCT00790686|Ureteral obstruction|ureteral obstruction
655039|NCT00790686|Urologic surgical procedure|urologic surgical procedure
655040|NCT00790686|Stents|stents
655041|NCT00790686|Endoscopy|endoscopy
655042|NCT00790686|Urology|urology
655043|NCT00790699|diabetes|diabetes
655044|NCT00790699|Symlin|symlin
655045|NCT00790699|pramlintide acetate|pramlintide acetate
655046|NCT00790699|insulin|insulin
655047|NCT00790699|multiple injection port|multiple injection port
655048|NCT00790699|I-PORT|i-port
655049|NCT00791141|Head and Neck Cancer|head and neck cancer
655050|NCT00791141|Radiation therapy|radiation therapy
655051|NCT00791141|Chemotherapy|chemotherapy
655052|NCT00791141|Chemoradiotherapy|chemoradiotherapy
655053|NCT00791141|adjuvant cetuximab administration|adjuvant cetuximab administration
655054|NCT00791154|Extensive disease|extensive disease
655055|NCT00791154|Extrathoracic metasasis|extrathoracic metasasis
655056|NCT00791154|Malignant pericardial effusion|malignant pericardial effusion
655057|NCT00791154|Malignant pleural effusion|malignant pleural effusion
655058|NCT00791154|Contralateral hilar adenopathy|contralateral hilar adenopathy
655059|NCT00791167|Mood Disorders, Antipsychotic drugs|mood disorders, antipsychotic drugs
655060|NCT00791167|Schizophrenia|schizophrenia
655061|NCT00791167|Paliperidone ER|paliperidone er
655062|NCT00791180|dynamic stabilization|dynamic stabilization
655063|NCT00791180|Dynesys|dynesys
655064|NCT00791180|fusion success|fusion success
655065|NCT00791180|Immobilization of spinal segments as an adjunct to fusion in the treatment of the following:|immobilization of spinal segments as an adjunct to fusion in the treatment of the following:
655066|NCT00791180|acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine|acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine
655166|NCT00791505|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
655067|NCT00791180|degenerative spondylolisthesis with objective evidence of neurologic impairment|degenerative spondylolisthesis with objective evidence of neurologic impairment
655068|NCT00791180|failed previous fusion (pseudarthrosis).|failed previous fusion (pseudarthrosis).
655069|NCT00791193|Paliperidone ER|paliperidone er
655070|NCT00791193|Antipsychotic drugs|antipsychotic drugs
655071|NCT00791193|Schizophrenia|schizophrenia
655072|NCT00791193|Mood disorders|mood disorders
655073|NCT00791206|exercise|exercise
655074|NCT00791206|ischemia|ischemia
655076|NCT00791206|MRI spectroscopy|mri spectroscopy
655077|NCT00791206|Ischemia preconditioning|ischemia preconditioning
655078|NCT00791219|Onychomycosis|onychomycosis
655079|NCT00791232|Extended-release paliperidone|extended-release paliperidone
655080|NCT00791232|Schizophrenia, Mood disorders, Antipsychotic drugs|schizophrenia, mood disorders, antipsychotic drugs
655081|NCT00791232|ER OROS paliperidone|er oros paliperidone
655082|NCT00791245|ISTO Technologies, Inc|isto technologies, inc
655083|NCT00791245|cartilage repair|cartilage repair
655084|NCT00791245|arthroscopy|arthroscopy
655085|NCT00791245|361 HCT/P|361 hct/p
655086|NCT00791245|human tissue|human tissue
655087|NCT00791245|biologic|biologic
655088|NCT00791245|knee|knee
655089|NCT00791271|Melanoma|melanoma
655090|NCT00791271|Malignant melanoma|malignant melanoma
655091|NCT00791271|Unresectable|unresectable
655092|NCT00791271|Decitabine|decitabine
655093|NCT00791271|PEG Interferon Alpha-2b|peg interferon alpha-2b
655094|NCT00791271|PEG Intron|peg intron
655095|NCT00791271|5-Aza-Deoxycytidine|5-aza-deoxycytidine
655096|NCT00791271|Dacogen|dacogen
655097|NCT00791284|Schizophrenia|schizophrenia
655098|NCT00791284|Mood disorders|mood disorders
655099|NCT00791284|Antipsychotic drugs|antipsychotic drugs
655100|NCT00791284|intermediate release (IR) Paliperidone|intermediate release (ir) paliperidone
655101|NCT00791297|CDB-2914|cdb-2914
655102|NCT00791297|Contraceptive Vaginal Rings|contraceptive vaginal rings
655103|NCT00791297|ovulation|ovulation
655104|NCT00791297|endometrial changes|endometrial changes
655105|NCT00791297|bleeding patterns|bleeding patterns
655106|NCT00791297|normal cycling women|normal cycling women
655107|NCT00791297|Inhibition of ovulation, endometrial changes and bleeding patterns in normal cycling women|inhibition of ovulation, endometrial changes and bleeding patterns in normal cycling women
655108|NCT00791310|Medical ICU|medical icu
655109|NCT00791310|Severe sepsis|severe sepsis
655110|NCT00791336|NSCLC|nsclc
655111|NCT00791336|chemotherapy|chemotherapy
655112|NCT00791336|radiation therapy|radiation therapy
655113|NCT00791336|nelfinavir|nelfinavir
655115|NCT00791349|Schizophrenia|schizophrenia
655116|NCT00791349|Schizoaffective Disorder|schizoaffective disorder
655117|NCT00791349|Mood Disorders|mood disorders
655118|NCT00791349|Antipsychotic drugs|antipsychotic drugs
655119|NCT00791349|Cardiovascular|cardiovascular
655607|NCT00793598|CMX001|cmx001
655120|NCT00791349|Immediate release (IR) Paliperidone|immediate release (ir) paliperidone
655121|NCT00791362|accreditation|accreditation
655122|NCT00791362|cardiovascular disease|cardiovascular disease
655123|NCT00791362|primary care|primary care
655124|NCT00791375|young adult|young adult
655125|NCT00791375|cancer|cancer
655126|NCT00791375|exercise|exercise
655127|NCT00791375|physical activity|physical activity
655128|NCT00791388|Pharmacokinetics|pharmacokinetics
655129|NCT00791401|Schizophrenia|schizophrenia
655130|NCT00791401|Mood disorders|mood disorders
655131|NCT00791401|Antipsychotic drugs|antipsychotic drugs
655132|NCT00791401|ER OROS Paliperidone|er oros paliperidone
655133|NCT00791440|Schizophrenia|schizophrenia
655134|NCT00791440|Schizoaffective|schizoaffective
655135|NCT00791440|Schizophreniform|schizophreniform
655136|NCT00791440|Psychosis|psychosis
655137|NCT00791440|Psychotic|psychotic
655138|NCT00791440|Hallucinations|hallucinations
655139|NCT00791440|Delusions|delusions
655140|NCT00791440|Paranoia|paranoia
655141|NCT00791440|Paranoid|paranoid
655142|NCT00791440|Voices|voices
655143|NCT00791440|CBT|cbt
655144|NCT00791440|Cognitive Behavior Therapy|cognitive behavior therapy
655145|NCT00791440|Cognitive Therapy|cognitive therapy
655146|NCT00791453|Diabetic patients at the Clarksdale Diabetes|diabetic patients at the clarksdale diabetes
655147|NCT00791453|and Metabolism Clinic and must be between the|and metabolism clinic and must be between the
655148|NCT00791453|ages of 18 and 64 years of age.|ages of 18 and 64 years of age.
655149|NCT00791466|Iodine deficiency|iodine deficiency
655150|NCT00791466|Pregnancy|pregnancy
655151|NCT00791466|Thyroid function|thyroid function
655152|NCT00791466|Infant development|infant development
655153|NCT00791466|Growth|growth
655154|NCT00791479|Diabetes, type 2 diabetes|diabetes, type 2 diabetes
655155|NCT00791492|FAP|fap
655156|NCT00791492|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
655157|NCT00791492|ATTR-PN|attr-pn
655158|NCT00791492|transthyretin|transthyretin
655159|NCT00791492|TTR|ttr
655160|NCT00791492|amyloid|amyloid
655161|NCT00791492|polyneuropathy|polyneuropathy
655162|NCT00791492|familial|familial
655163|NCT00791492|hereditary|hereditary
655164|NCT00791492|amyloidosis|amyloidosis
655165|NCT00791492|FoldRx|foldrx
655167|NCT00791505|pulmonary infection|pulmonary infection
655168|NCT00791505|antibiotic|antibiotic
655169|NCT00791518|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
655170|NCT00791518|Spirometry|spirometry
655171|NCT00791531|Methotrexate|methotrexate
655172|NCT00791531|Malaria|malaria
655173|NCT00791544|monoclonal antibody, anti IGF1R|monoclonal antibody, anti igf1r
655174|NCT00791583|Emergency Medicine (EM)|emergency medicine (em)
655175|NCT00791583|Central Venous Catheter (CVC)|central venous catheter (cvc)
655176|NCT00791583|Maximal Barrier Precaution (MBP)|maximal barrier precaution (mbp)
655177|NCT00791583|Precaution Technique during Central Venous Cathether Placement|precaution technique during central venous cathether placement
655178|NCT00791596|Ergonomic intervention|ergonomic intervention
655179|NCT00791596|Musculoskeletal disorders|musculoskeletal disorders
655180|NCT00791596|Low back pain|low back pain
655181|NCT00791596|Posture|posture
655182|NCT00791596|Video display terminal|video display terminal
655183|NCT00791609|cancer|cancer
655184|NCT00791622|Paliperidone ER|paliperidone er
655185|NCT00791622|Schizophernia|schizophernia
655186|NCT00791622|Mood Disorders, Antipsychotic drugs|mood disorders, antipsychotic drugs
655187|NCT00791622|Cardiovascular|cardiovascular
655188|NCT00791622|Schizoaffective Disorder|schizoaffective disorder
655189|NCT00791635|Cervical Cancer|cervical cancer
655190|NCT00791635|Vaginal Cancer|vaginal cancer
655191|NCT00791635|Endometrial Cancer|endometrial cancer
655192|NCT00791635|Cervix|cervix
655193|NCT00791635|Endometrial|endometrial
655194|NCT00791635|Pelvic Exenteration|pelvic exenteration
655195|NCT00791635|Pelvic Exenteration Surgery|pelvic exenteration surgery
655196|NCT00791635|Questionnaire|questionnaire
655197|NCT00791635|Gynecologic Cancer|gynecologic cancer
655198|NCT00791635|Vagina|vagina
655199|NCT00791635|Vulva|vulva
655200|NCT00791635|Gynecologic Malignancy|gynecologic malignancy
655202|NCT00791648|delirium|delirium
655203|NCT00791648|statin|statin
655204|NCT00791648|short-term|short-term
655205|NCT00791648|cardiac|cardiac
657510|NCT00807625|Women|women
655206|NCT00791674|Opiates|opiates
655207|NCT00791674|sleep apnea|sleep apnea
655208|NCT00791674|ventilatory failure|ventilatory failure
655209|NCT00791687|Antioxidant enzymes|antioxidant enzymes
655210|NCT00791687|Glutathione|glutathione
655211|NCT00791687|Oxidative stress|oxidative stress
655212|NCT00791687|Prematurity|prematurity
655213|NCT00791687|Respiratory distress|respiratory distress
655214|NCT00791687|Non enzymatic antioxidant defense system|non enzymatic antioxidant defense system
655215|NCT00791687|Enzymatic antioxidant defense system|enzymatic antioxidant defense system
655216|NCT00791700|Open label pharmacokinetic safety and efficacy in HIV-1 infected pediatrics|open label pharmacokinetic safety and efficacy in hiv-1 infected pediatrics
655217|NCT00791713|Paliperidone ER|paliperidone er
655218|NCT00791713|Antipsychotic drugs|antipsychotic drugs
655219|NCT00791713|Selective serotonin reuptake inhibitors|selective serotonin reuptake inhibitors
655220|NCT00791713|Mood disorders|mood disorders
655221|NCT00791713|Schizophrenia|schizophrenia
655222|NCT00791726|microperimetry|microperimetry
655223|NCT00791726|macular edema|macular edema
655224|NCT00791726|uveitis|uveitis
655225|NCT00791726|Retinal sensitivity as measured with fundus related microperimetry|retinal sensitivity as measured with fundus related microperimetry
655226|NCT00791739|fibromyalgia|fibromyalgia
655227|NCT00791739|trazodone|trazodone
655228|NCT00791739|pregabalin|pregabalin
655229|NCT00791739|Fibromyalgia Impact Questionnaire (FIQ)|fibromyalgia impact questionnaire (fiq)
655230|NCT00791739|Pittsburgh Sleep Quality Inventory (PSQI)|pittsburgh sleep quality inventory (psqi)
655231|NCT00791739|Brief Pain Inventory (BPI)|brief pain inventory (bpi)
655232|NCT00791752|Safety and Tolerability|safety and tolerability
655233|NCT00791765|Scalp|scalp
655234|NCT00791765|Psoriasis|psoriasis
655235|NCT00791765|Plaque Psoriasis|plaque psoriasis
655236|NCT00791765|Skin Diseases|skin diseases
655237|NCT00791765|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
655238|NCT00791765|etanercept|etanercept
655239|NCT00791778|Peritoneal Neoplasma|peritoneal neoplasma
655240|NCT00791791|Anesthesia General|anesthesia general
655241|NCT00791791|Anesthetics Inhalation|anesthetics inhalation
655242|NCT00791791|Stress measurement|stress measurement
655243|NCT00791791|Surgical Stress|surgical stress
655244|NCT00791791|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
655245|NCT00791804|Pain|pain
655246|NCT00791804|Post Op pain|post op pain
655247|NCT00791804|Fentanyl|fentanyl
655248|NCT00791804|Pain Control|pain control
655249|NCT00791804|Surgery|surgery
655250|NCT00791817|pharmacokinetics study|pharmacokinetics study
655251|NCT00791830|Residual renal function|residual renal function
655252|NCT00791830|Haemodialysis|haemodialysis
655253|NCT00791830|Applanation tonometry|applanation tonometry
655254|NCT00791830|Cardiac output|cardiac output
655255|NCT00791830|Quality of life|quality of life
655256|NCT00791830|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
655258|NCT00791869|bupropion|bupropion
655259|NCT00791869|smoking|smoking
655260|NCT00791869|pharmacokinetics|pharmacokinetics
655261|NCT00791869|Pharmacokinetics of bupropion|pharmacokinetics of bupropion
655262|NCT00791921|Rheumatoid Arthritis|rheumatoid arthritis
655263|NCT00791921|Certolizumab Pegol|certolizumab pegol
655264|NCT00791921|Cimzia|cimzia
655265|NCT00791960|Cesarean Section|cesarean section
655266|NCT00791960|Dimenhydrinate|dimenhydrinate
655267|NCT00791960|Gravol|gravol
655268|NCT00791960|Antiemetics|antiemetics
655269|NCT00791986|Breathing exercise|breathing exercise
655270|NCT00791986|blood pressure|blood pressure
655271|NCT00791986|hypertension|hypertension
655272|NCT00791999|Rheumatoid Arthritis|rheumatoid arthritis
655273|NCT00791999|Certolizumab Pegol|certolizumab pegol
655274|NCT00791999|Cimzia|cimzia
655275|NCT00792012|Glioblastoma Multiforme|glioblastoma multiforme
655276|NCT00792025|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
655277|NCT00792025|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
655278|NCT00792025|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
655279|NCT00792025|stage III bladder cancer|stage iii bladder cancer
655280|NCT00792025|stage IV bladder cancer|stage iv bladder cancer
655281|NCT00792025|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
655282|NCT00792025|recurrent bladder cancer|recurrent bladder cancer
655283|NCT00792038|Psychological tests|psychological tests
655284|NCT00792038|Magnetic Resonance Imaging|magnetic resonance imaging
655285|NCT00792038|Cognitive therapy|cognitive therapy
655286|NCT00792051|influenza|influenza
655289|NCT00792051|Influenza-like illness|influenza-like illness
655290|NCT00792064|quality of life|quality of life
655291|NCT00792064|adverse effects|adverse effects
655292|NCT00792077|Leukemia|leukemia
655293|NCT00792077|Lenalidomide|lenalidomide
655294|NCT00792077|Actigraph|actigraph
655295|NCT00792077|Sleep Test Study|sleep test study
655296|NCT00792077|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
655297|NCT00792077|CC-5013|cc-5013
655298|NCT00792077|Revlimid|revlimid
657601|NCT00807937|GAD|gad
655299|NCT00792090|allergy|allergy
655300|NCT00792090|cow's milk|cow's milk
655301|NCT00792090|sensibilisation|sensibilisation
655302|NCT00792090|fermented milk|fermented milk
655303|NCT00792090|infant formula|infant formula
655304|NCT00792129|MIS|mis
655305|NCT00792129|Minimally invasive|minimally invasive
655306|NCT00792129|Atavi|atavi
655307|NCT00792129|Flex Posure|flex posure
655308|NCT00792129|retractor|retractor
655309|NCT00792129|Patients with chronic low back and/or leg pain who are candidates for elective lumbar interbody fusion through a posterior unilateral approach,|patients with chronic low back and/or leg pain who are candidates for elective lumbar interbody fusion through a posterior unilateral approach,
655310|NCT00792129|for inclusion in the study.|for inclusion in the study.
655311|NCT00792129|If the patient meets all of the eligibility criteria,|if the patient meets all of the eligibility criteria,
655312|NCT00792129|they will be enrolled into the study and have either the MiLIF or open procedure depending on the surgeon they present to|they will be enrolled into the study and have either the milif or open procedure depending on the surgeon they present to
655313|NCT00792129|(i.e., what group their surgeon agreed to participate in.)|(i.e., what group their surgeon agreed to participate in.)
655314|NCT00792142|neurotoxicity|neurotoxicity
655315|NCT00792142|stage I multiple myeloma|stage i multiple myeloma
655316|NCT00792142|stage II multiple myeloma|stage ii multiple myeloma
655317|NCT00792142|stage III multiple myeloma|stage iii multiple myeloma
655318|NCT00792155|PKD|pkd
655319|NCT00792181|The focus is the pain reduce in the first 15 minutes for patients suffering an acute myocardial infarction, treated by caregivers in Ambulance service.|the focus is the pain reduce in the first 15 minutes for patients suffering an acute myocardial infarction, treated by caregivers in ambulance service.
655320|NCT00792194|Cystic fibrosis|cystic fibrosis
655321|NCT00792194|Exercise training|exercise training
655322|NCT00792194|Home training|home training
655323|NCT00792194|Aerobic capacity|aerobic capacity
655324|NCT00792220|stroke|stroke
655325|NCT00792220|mobile stroke unit|mobile stroke unit
655326|NCT00792220|thrombolysis|thrombolysis
655327|NCT00792220|stroke management|stroke management
655328|NCT00792220|computerized tomography|computerized tomography
655329|NCT00792233|Poly JIA|poly jia
655330|NCT00792233|TNF|tnf
655331|NCT00792233|Remission|remission
655332|NCT00792246|pharmacokinetics|pharmacokinetics
655333|NCT00792246|pediatric|pediatric
655334|NCT00792246|bioavailability|bioavailability
655335|NCT00792272|aspirin resistance|aspirin resistance
655336|NCT00792272|aspirin resistance in hemodialysis patients|aspirin resistance in hemodialysis patients
655337|NCT00792285|Colon cancer|colon cancer
655338|NCT00792285|Prevention|prevention
655339|NCT00792285|Screening|screening
655340|NCT00792285|Telephone|telephone
655341|NCT00792311|Tsui test|tsui test
655342|NCT00792311|Epidural Analgesia|epidural analgesia
655343|NCT00792350|Carcinoma, Hepatocellular|carcinoma, hepatocellular
655344|NCT00792350|Sorafenib|sorafenib
655345|NCT00792363|KRAS|kras
655346|NCT00792376|NSAID|nsaid
655347|NCT00792376|tendon|tendon
655348|NCT00792376|pain|pain
655349|NCT00792376|stiffness|stiffness
655350|NCT00792376|Achilles|achilles
655351|NCT00792389|Gallstones|gallstones
655352|NCT00792389|Gallbladder|gallbladder
655353|NCT00792389|Cholecystectomy|cholecystectomy
655354|NCT00792389|Gallstone disease|gallstone disease
655355|NCT00792402|chronic heart failure|chronic heart failure
655356|NCT00792402|Computerized clinical guidelines|computerized clinical guidelines
655357|NCT00792402|Primary care|primary care
655358|NCT00792415|Abstinence syndrome symptoms|abstinence syndrome symptoms
655359|NCT00792415|Withdrawal symptoms|withdrawal symptoms
655360|NCT00792415|Opioid dependence|opioid dependence
655361|NCT00792428|Stroke|stroke
655362|NCT00792428|Ischemia|ischemia
655363|NCT00792428|Infarction|infarction
655364|NCT00792428|Cerebrovascular Disorder|cerebrovascular disorder
655365|NCT00792428|Central Nervous System Diseases|central nervous system diseases
655366|NCT00792428|Brain Infarction|brain infarction
655367|NCT00792428|Brain Ischemia|brain ischemia
655368|NCT00792428|Rehabilitation|rehabilitation
655369|NCT00792428|Recovery|recovery
655370|NCT00792428|Neurorehabilitation|neurorehabilitation
655371|NCT00792428|Plasticity|plasticity
655372|NCT00792441|Specific inspiratory muscle training(SIMT)|specific inspiratory muscle training(simt)
655373|NCT00792441|Loaded deep breathing|loaded deep breathing
655374|NCT00792441|Weaning|weaning
655375|NCT00792441|Mechanical ventilation|mechanical ventilation
655376|NCT00792441|Respiratory muscle|respiratory muscle
655377|NCT00792454|Chronic kidney disease|chronic kidney disease
655378|NCT00792454|End stage renal disease|end stage renal disease
655379|NCT00792454|Exercise|exercise
655380|NCT00792454|Cardiovascular disease|cardiovascular disease
655385|NCT00792480|obesity in pregnancy|obesity in pregnancy
655386|NCT00792493|Healthy volunteer study|healthy volunteer study
655387|NCT00792519|alcohol use|alcohol use
655388|NCT00792519|HIV|hiv
655389|NCT00792519|cognitive behavioral treatment|cognitive behavioral treatment
655390|NCT00792519|Kenya|kenya
655391|NCT00792519|hazardous/binge drinking|hazardous/binge drinking
655392|NCT00792519|alcohol abuse/dependence|alcohol abuse/dependence
655394|NCT00792584|efavirenz|efavirenz
655395|NCT00792584|anxiety|anxiety
655396|NCT00792584|depression|depression
655397|NCT00792584|sleep quality|sleep quality
655398|NCT00792584|HIV|hiv
655399|NCT00792584|NNRTI|nnrti
655400|NCT00792584|Tritherapy|tritherapy
655401|NCT00792584|compliance|compliance
655402|NCT00792584|stocrin|stocrin
655403|NCT00792584|To replace efavirenz in long-term users with etravirine|to replace efavirenz in long-term users with etravirine
655506|NCT00793104|cartilage injury|cartilage injury
655608|NCT00793598|Kidney transplant|kidney transplant
655404|NCT00792584|To investigate effect of such replacement on patient preference, sleep quality, daytime sleepiness, and anxiety|to investigate effect of such replacement on patient preference, sleep quality, daytime sleepiness, and anxiety
655405|NCT00792610|youth|youth
655406|NCT00792610|hepatitis B|hepatitis b
655407|NCT00792610|vaccination|vaccination
655408|NCT00792610|booster|booster
655409|NCT00792610|immunity response|immunity response
655410|NCT00792623|Varicella|varicella
655411|NCT00792623|VarilrixTM|varilrixtm
655412|NCT00792636|sumatriptan and naproxen sodium|sumatriptan and naproxen sodium
655413|NCT00792636|migraine with or without aura|migraine with or without aura
655414|NCT00792636|naproxen sodium|naproxen sodium
655415|NCT00792636|sumatriptan|sumatriptan
655416|NCT00792636|blood pressure|blood pressure
655417|NCT00792636|migraine headaches|migraine headaches
655418|NCT00792662|Diabetes Mellitus|diabetes mellitus
655419|NCT00792662|Alzheimer's Disease|alzheimer's disease
655420|NCT00792662|Apathy|apathy
655421|NCT00792662|Methylphenidate|methylphenidate
655422|NCT00792662|Dementia|dementia
655423|NCT00792675|exercise|exercise
655424|NCT00792675|disease activity|disease activity
655425|NCT00792675|inflammation|inflammation
655426|NCT00792675|resistance training|resistance training
655427|NCT00792675|rehabilitation|rehabilitation
655428|NCT00792688|burn wounds|burn wounds
655429|NCT00792688|wound healing|wound healing
655430|NCT00792701|stage I non-small cell lung cancer|stage i non-small cell lung cancer
655431|NCT00792727|Pain|pain
655432|NCT00792727|Knee|knee
655433|NCT00792727|Arthritis|arthritis
655434|NCT00792727|Knee pain|knee pain
655435|NCT00792753|Coronary Artery Disease|coronary artery disease
655436|NCT00792766|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
655437|NCT00792766|Angiolipoma|angiolipoma
655438|NCT00792766|mTOR|mtor
655439|NCT00792766|Everolimus|everolimus
655440|NCT00792779|Morbid obesity|morbid obesity
655441|NCT00792779|General anaesthesia|general anaesthesia
655442|NCT00792779|Propofol|propofol
655443|NCT00792779|Sevoflurane|sevoflurane
655444|NCT00792792|tissue transfer|tissue transfer
655445|NCT00792805|COPD|copd
655446|NCT00792805|indacaterol|indacaterol
655447|NCT00792805|long-acting β2-agonist|long-acting β2-agonist
655448|NCT00792805|adults|adults
655449|NCT00792818|Osteoarthritis, Knee, Curcumin, Multicenter, RCT|osteoarthritis, knee, curcumin, multicenter, rct
655450|NCT00792857|Parathyroid Diseases|parathyroid diseases
655451|NCT00792857|Renal Insufficiency|renal insufficiency
655452|NCT00792857|Kidney Failure, Chronic|kidney failure, chronic
655453|NCT00792857|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
655454|NCT00792857|Vitamin D|vitamin d
655455|NCT00792857|Hyperparathyroidism|hyperparathyroidism
655456|NCT00792857|Renal Insufficiency, Chronic|renal insufficiency, chronic
655457|NCT00792857|Kidney Diseases|kidney diseases
655458|NCT00792857|Kidney Failure|kidney failure
655459|NCT00792870|Obesity|obesity
655460|NCT00792870|Weight loss|weight loss
655461|NCT00792870|Internet|internet
655462|NCT00792883|PICU|picu
655463|NCT00792883|BIA|bia
655464|NCT00792883|Phase angle|phase angle
655465|NCT00792883|RQ|rq
655466|NCT00792883|EEM|eem
655467|NCT00792883|Compliance|compliance
655468|NCT00792883|Resistance|resistance
655469|NCT00792883|Curves|curves
655470|NCT00792883|Polymorphisms|polymorphisms
655471|NCT00792883|NF-kappa B|nf-kappa b
655472|NCT00792883|Scores|scores
655473|NCT00792883|PIM 2|pim 2
655474|NCT00792883|PRISM I|prism i
655475|NCT00792909|Pneumococcal vaccine|pneumococcal vaccine
655476|NCT00792909|Pneumococcal disease|pneumococcal disease
655477|NCT00792909|Safety|safety
655478|NCT00792909|Immunogenicity|immunogenicity
655479|NCT00792922|Trachoma|trachoma
655480|NCT00792922|Azithromycin|azithromycin
655481|NCT00792922|Mass treatment|mass treatment
655482|NCT00792961|Prostate cancer|prostate cancer
655483|NCT00792961|Robotic surgery|robotic surgery
655484|NCT00792961|Endomicroscopy|endomicroscopy
655485|NCT00792974|Cognitive behavioral education|cognitive behavioral education
655585|NCT00793455|education|education
655486|NCT00792974|COPD (Chronic Obstructive Pulmonary Disease), GOLD II-IV|copd (chronic obstructive pulmonary disease), gold ii-iv
655487|NCT00793000|Safety tolerability pharmacokinetics PK first in human FIH|safety tolerability pharmacokinetics pk first in human fih
655488|NCT00793013|Acute Lung Injury|acute lung injury
655489|NCT00793013|Adult Respiratory Distress Syndrome|adult respiratory distress syndrome
655490|NCT00793013|Airway Pressure Release Ventilation|airway pressure release ventilation
655491|NCT00793013|Acute Kidney Injury|acute kidney injury
655492|NCT00793013|Pressure Trial|pressure trial
655494|NCT00793052|Edema|edema
655495|NCT00793052|pain|pain
655496|NCT00793065|electronic health records|electronic health records
655497|NCT00793065|health information technology|health information technology
655498|NCT00793065|physician incentives|physician incentives
655499|NCT00793065|quality of health care|quality of health care
655500|NCT00793078|sepsis|sepsis
655501|NCT00793078|arterial blood pressure|arterial blood pressure
655502|NCT00793078|complexity|complexity
655503|NCT00793078|variability|variability
655504|NCT00793104|allograft|allograft
655507|NCT00793104|Osteochondral defects in the articular femoral cartilage|osteochondral defects in the articular femoral cartilage
655508|NCT00793117|chronic sinusitis|chronic sinusitis
655509|NCT00793117|FESS|fess
655510|NCT00793117|packing|packing
655511|NCT00793130|Ulcerative|ulcerative
655512|NCT00793130|Colitis|colitis
655513|NCT00793130|Coltect|coltect
655514|NCT00793130|Curcumin|curcumin
655515|NCT00793130|Green tea|green tea
655516|NCT00793130|Selenium|selenium
655517|NCT00793130|inflammation|inflammation
655518|NCT00793130|bowel|bowel
655519|NCT00793143|morbid obesity|morbid obesity
655520|NCT00793143|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
655521|NCT00793143|LSG|lsg
655522|NCT00793143|laparoscopic gastric bypass|laparoscopic gastric bypass
655523|NCT00793143|LGB|lgb
655524|NCT00793143|comorbidities|comorbidities
655525|NCT00793143|diabetes|diabetes
655526|NCT00793143|excessive weight loss|excessive weight loss
655527|NCT00793143|weight loss|weight loss
655528|NCT00793156|uremic pruritus|uremic pruritus
655529|NCT00793169|squamous cell carcinoma of the head or neck|squamous cell carcinoma of the head or neck
655530|NCT00793182|Renal|renal
655531|NCT00793182|Kidney|kidney
655532|NCT00793182|Contrast Induced Nephropathy|contrast induced nephropathy
655533|NCT00793195|Neonates|neonates
655534|NCT00793195|Short Bowel Syndrome|short bowel syndrome
655535|NCT00793195|Intestinal Failure|intestinal failure
655536|NCT00793195|Liver Failure|liver failure
655537|NCT00793195|Parenteral Nutrition|parenteral nutrition
655538|NCT00793195|Intralipid|intralipid
655539|NCT00793195|SMOF|smof
655540|NCT00793208|Lung cancer|lung cancer
655541|NCT00793208|non small cell|non small cell
655542|NCT00793208|vaccine|vaccine
655543|NCT00793208|carcinoma|carcinoma
655544|NCT00793208|immunization|immunization
655545|NCT00793208|autologous Tumor|autologous tumor
655546|NCT00793208|vaccination|vaccination
655547|NCT00793221|Coronary stent.|coronary stent.
655548|NCT00793221|Restenosis.|restenosis.
655549|NCT00793221|Coronary artery disease.|coronary artery disease.
655550|NCT00793221|Chronic total occlusion.|chronic total occlusion.
655551|NCT00793234|TKR|tkr
655552|NCT00793234|VTE|vte
655553|NCT00793234|DVT|dvt
655554|NCT00793286|inguinal hernia|inguinal hernia
655555|NCT00793286|laparoscopy|laparoscopy
655556|NCT00793286|mesh|mesh
655557|NCT00793338|Heart failure|heart failure
655558|NCT00793338|Sildenafil|sildenafil
655559|NCT00793338|Cardiopulmonary exercise test|cardiopulmonary exercise test
655560|NCT00793338|quality of life|quality of life
655561|NCT00793338|6 minute walk test|6 minute walk test
655562|NCT00793351|reduced intensity stem cell transplantation for neuroblastoma|reduced intensity stem cell transplantation for neuroblastoma
655563|NCT00793351|relapsed neuroblastoma after high-dose chemotherapy and autologous stem cell rescue|relapsed neuroblastoma after high-dose chemotherapy and autologous stem cell rescue
655564|NCT00793364|Cholesterol, stanol-ester, mediterranean diet, cardiac risk|cholesterol, stanol-ester, mediterranean diet, cardiac risk
655565|NCT00793390|Case-Control|case-control
655566|NCT00793390|Inflammatory Breast Cancer|inflammatory breast cancer
655567|NCT00793390|North Africa|north africa
655568|NCT00793390|IBC|ibc
655569|NCT00793403|Observational cohort|observational cohort
655570|NCT00793403|prospectives|prospectives
655571|NCT00793403|multicentre|multicentre
655572|NCT00793403|the Italian study RA patient CLARA and PRO-CLARA|the italian study ra patient clara and pro-clara
655573|NCT00793416|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
655574|NCT00793416|Valve Adjustment|valve adjustment
655575|NCT00793416|Blocked Shunt in NPH patients|blocked shunt in nph patients
655576|NCT00793416|Diagnosis of blockage|diagnosis of blockage
655577|NCT00793429|electrocardiographic safety|electrocardiographic safety
655578|NCT00793429|pharmacokinetics|pharmacokinetics
655579|NCT00793442|sepsis|sepsis
655580|NCT00793442|severe sepsis|severe sepsis
655581|NCT00793442|septic shock|septic shock
655582|NCT00793442|endothelium|endothelium
655583|NCT00793442|microcirculation|microcirculation
655584|NCT00793442|biomarkers|biomarkers
655586|NCT00793455|preventive service|preventive service
655587|NCT00793455|screening|screening
655588|NCT00793468|nicotine dependence|nicotine dependence
655589|NCT00793468|smoking|smoking
655590|NCT00793468|pharmacological treatment|pharmacological treatment
655591|NCT00793468|relapse prevention|relapse prevention
655592|NCT00793481|Metabolic Syndrome|metabolic syndrome
655593|NCT00793494|Irritable bowel syndrome|irritable bowel syndrome
655594|NCT00793494|Children|children
655595|NCT00793494|Pediatrics|pediatrics
655596|NCT00793494|Probiotics|probiotics
655597|NCT00793507|childhood caries|childhood caries
655598|NCT00793520|fibromyalgia|fibromyalgia
655599|NCT00793520|milnacipran|milnacipran
655600|NCT00793520|Forest Laboratories|forest laboratories
655601|NCT00793546|Bosutinib|bosutinib
655602|NCT00793546|Exemestane|exemestane
655603|NCT00793546|postmenopausal|postmenopausal
655604|NCT00793546|breast cancer|breast cancer
655605|NCT00793559|septic shock refractory to catecholamines|septic shock refractory to catecholamines
655606|NCT00793585|IgA nephropathy|iga nephropathy
655609|NCT00793598|HSCT transplant|hsct transplant
655610|NCT00793598|BK Virus|bk virus
655611|NCT00793598|Post kidney transplant patients with BK virus viruria > 10^4|post kidney transplant patients with bk virus viruria > 10^4
655612|NCT00793598|Post HSCT transplant patients with BK virus viruria > 10^4|post hsct transplant patients with bk virus viruria > 10^4
655613|NCT00793611|Overactive Bladder|overactive bladder
655614|NCT00793611|Hypnotherapy|hypnotherapy
655615|NCT00793637|Angular stable locking system|angular stable locking system
655616|NCT00793637|Handling test|handling test
655617|NCT00793637|Complications|complications
655618|NCT00793650|Cancer|cancer
655619|NCT00793650|Multiple Myeloma|multiple myeloma
655620|NCT00793650|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
655621|NCT00787813|N-acetyl cysteine (NAC)|n-acetyl cysteine (nac)
655622|NCT00787813|Cervical cerclage|cervical cerclage
655623|NCT00787813|cervical cerclage for cervical insufficiency|cervical cerclage for cervical insufficiency
655624|NCT00787826|Live Vaccine Strain (LVS)|live vaccine strain (lvs)
655625|NCT00787839|type 2 diabetes mellitus|type 2 diabetes mellitus
655626|NCT00787839|prediabetic state|prediabetic state
655627|NCT00787839|mass screening|mass screening
655628|NCT00787839|glucose tolerance test|glucose tolerance test
655629|NCT00787852|dasatinib|dasatinib
655630|NCT00787852|radiation|radiation
655631|NCT00787852|paclitaxel|paclitaxel
655632|NCT00787852|carboplatin|carboplatin
655633|NCT00787852|NSCLC|nsclc
655634|NCT00787852|safety addition of dasatinib to chemo RT stage III NSCLC|safety addition of dasatinib to chemo rt stage iii nsclc
655635|NCT00787865|Diffusion Tensor Imaging|diffusion tensor imaging
655637|NCT00787865|Newborn|newborn
655638|NCT00787865|Krabbe Disease|krabbe disease
655639|NCT00787865|Motor Development|motor development
655640|NCT00787865|Motor Disability|motor disability
655641|NCT00799539|Prednisone|prednisone
655642|NCT00799539|Bortezomib|bortezomib
655643|NCT00799539|Melphalan|melphalan
655644|NCT00799552|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
655645|NCT00799552|Dry eye|dry eye
655646|NCT00799552|Resolvin|resolvin
655647|NCT00799565|Mitral Valve prolapse|mitral valve prolapse
655648|NCT00799565|echography|echography
655649|NCT00799565|genetic study|genetic study
655650|NCT00799565|study case-witness|study case-witness
655651|NCT00799565|Patients with a Mitral Valve Prolapse|patients with a mitral valve prolapse
655652|NCT00799578|NASH, NAFLD,nonalcoholic steatohepatitis|nash, nafld,nonalcoholic steatohepatitis
655653|NCT00799591|Registre MONTRAVERS|registre montravers
655654|NCT00799604|Hypertension|hypertension
655655|NCT00799604|Antihypertensive Agent|antihypertensive agent
656424|NCT00791011|SAHA|saha
655656|NCT00799604|Calcium Channel Blocker|calcium channel blocker
655657|NCT00799617|Testosterone|testosterone
655658|NCT00799617|Mobility disability|mobility disability
655659|NCT00799617|Decreased libido|decreased libido
655660|NCT00799617|Age associated memory impairment|age associated memory impairment
655661|NCT00799617|Low vitality|low vitality
655662|NCT00799617|Anemia|anemia
655663|NCT00799630|energy drink|energy drink
655664|NCT00799630|exercise|exercise
655665|NCT00799630|BCAA|bcaa
655666|NCT00799630|peripheral and central fatigue|peripheral and central fatigue
655667|NCT00799643|Type 2 Diabetes Mellitus (T2D)|type 2 diabetes mellitus (t2d)
655668|NCT00799643|Inflammation|inflammation
655669|NCT00799643|Obesity|obesity
655670|NCT00799643|Metabolic Syndrome|metabolic syndrome
655671|NCT00799643|Salicylates|salicylates
655672|NCT00799656|Diabetic neuropathy|diabetic neuropathy
655673|NCT00799656|painful pain|painful pain
655674|NCT00799656|postoperative|postoperative
655675|NCT00799669|hypopharyngeal cancer|hypopharyngeal cancer
655676|NCT00799669|laryngeal cancer|laryngeal cancer
655677|NCT00799669|lip and oral cavity cancer|lip and oral cavity cancer
655678|NCT00799669|nasopharyngeal cancer|nasopharyngeal cancer
655679|NCT00799669|oropharyngeal cancer|oropharyngeal cancer
655680|NCT00799669|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
655681|NCT00799669|tobacco use disorder|tobacco use disorder
655682|NCT00799682|Dry Eye|dry eye
655784|NCT00800501|Infusion|infusion
655683|NCT00799682|Monotherapy for Ocular Hypertension, Glaucoma|monotherapy for ocular hypertension, glaucoma
655684|NCT00799682|Ocular Hypertension|ocular hypertension
655685|NCT00799682|Chronic Open-Angle Glaucoma|chronic open-angle glaucoma
655686|NCT00799682|Chronic Angle-Closure Glaucoma|chronic angle-closure glaucoma
655687|NCT00799682|Iridotomy|iridotomy
655688|NCT00799682|Iridectomy|iridectomy
655689|NCT00799682|Pseudo Exfoliate|pseudo exfoliate
655690|NCT00799682|Pigmentary Glaucoma|pigmentary glaucoma
655691|NCT00799682|Systemic Non-Glaucoma Medications|systemic non-glaucoma medications
655692|NCT00799682|Hyperemia|hyperemia
655693|NCT00799695|diabetic retinopathy|diabetic retinopathy
655694|NCT00799695|screening|screening
655695|NCT00799695|annual|annual
655696|NCT00799708|Biomarkers of estrogen receptor beta activation|biomarkers of estrogen receptor beta activation
655697|NCT00799721|ROP|rop
655698|NCT00799721|VLBW|vlbw
655699|NCT00799721|Epo|epo
655700|NCT00799721|IUGR|iugr
655701|NCT00799721|VEGF|vegf
655702|NCT00799721|sFLT-1|sflt-1
655703|NCT00799721|very low birth weight infants|very low birth weight infants
655704|NCT00799721|retinopathy of prematurity|retinopathy of prematurity
655705|NCT00799721|erythropoietin therapy and risk of ROP|erythropoietin therapy and risk of rop
655706|NCT00799734|hot flushes|hot flushes
655707|NCT00799734|night sweats|night sweats
655708|NCT00799734|menopausal symptoms|menopausal symptoms
655709|NCT00799734|osteoporosis|osteoporosis
655710|NCT00799734|complementary and alternative medicine|complementary and alternative medicine
655711|NCT00799747|safety|safety
655712|NCT00799747|tolerability|tolerability
655713|NCT00799747|pharmacokinetics|pharmacokinetics
655714|NCT00799747|AZD4017Japanese|azd4017japanese
655715|NCT00799760|influenza A|influenza a
655716|NCT00799760|neuraminidase inhibitor|neuraminidase inhibitor
655717|NCT00799760|oseltamivir|oseltamivir
655718|NCT00799760|zanamivir|zanamivir
655719|NCT00799760|treatment outcome|treatment outcome
655720|NCT00799760|resistance|resistance
655721|NCT00799760|mutation|mutation
655722|NCT00799760|combination therapy|combination therapy
655723|NCT00799760|monotherapy|monotherapy
655724|NCT00799760|pandemic|pandemic
655725|NCT00799760|primary care|primary care
655726|NCT00799760|randomized controlled trials|randomized controlled trials
655727|NCT00799760|antiviral agent|antiviral agent
655728|NCT00799773|TTP|ttp
655729|NCT00799773|Rituximab|rituximab
655730|NCT00799773|Plasma Exchange|plasma exchange
655731|NCT00799799|Nk cells infusion|nk cells infusion
655732|NCT00799799|minimal residual disease in AML patients|minimal residual disease in aml patients
655733|NCT00799799|trafficking of NK cells after infusion|trafficking of nk cells after infusion
655734|NCT00799799|cytolytic effects on leukemic cells|cytolytic effects on leukemic cells
655735|NCT00799812|antimicrobial|antimicrobial
655736|NCT00799812|antisepsis|antisepsis
655737|NCT00799825|papillomavirus|papillomavirus
655738|NCT00799825|HPV vaccine|hpv vaccine
655739|NCT00799825|cervical cancer|cervical cancer
655740|NCT00799825|HPV|hpv
655741|NCT00799825|human papillomavirus|human papillomavirus
655742|NCT00799851|advanced liver disease|advanced liver disease
655743|NCT00799851|esophageal varices|esophageal varices
655744|NCT00799851|band ligation|band ligation
655745|NCT00799851|cyanoacrylate injection|cyanoacrylate injection
655746|NCT00799864|HIV Infection|hiv infection
655747|NCT00799864|Antiretroviral|antiretroviral
655748|NCT00799864|HIV-1|hiv-1
655749|NCT00799864|AIDS|aids
655750|NCT00799864|Children|children
655751|NCT00799864|Rilpivirine (TMC278)|rilpivirine (tmc278)
655752|NCT00799864|Pediatric|pediatric
655753|NCT00800332|Rhinoconjunctivitis due to house dust mite allergy|rhinoconjunctivitis due to house dust mite allergy
655754|NCT00800345|Gynecologic tumors|gynecologic tumors
655755|NCT00800358|Secondary hyperparathyroidism|secondary hyperparathyroidism
655756|NCT00800358|End stage renal disease|end stage renal disease
655757|NCT00800358|Haemodialysis|haemodialysis
655758|NCT00800358|Peritoneal dialysis|peritoneal dialysis
655759|NCT00800358|Paricalcitol (Zemplar)|paricalcitol (zemplar)
655760|NCT00800358|Calcitriol|calcitriol
655761|NCT00800371|JIA|jia
655762|NCT00800410|Randomized Controlled Trial|randomized controlled trial
655763|NCT00800423|corneal edema|corneal edema
655764|NCT00800423|postoperative corneal edema|postoperative corneal edema
655765|NCT00800423|central corneal thickness|central corneal thickness
655766|NCT00800423|visual acuity|visual acuity
655767|NCT00800423|postoperative|postoperative
655768|NCT00800423|brimonidine|brimonidine
655769|NCT00800423|timolol|timolol
655770|NCT00800423|cataract surgery|cataract surgery
655771|NCT00800449|Haptoglobin|haptoglobin
655772|NCT00800449|sepsis|sepsis
655773|NCT00800449|premature babies|premature babies
655774|NCT00800475|bioavailability|bioavailability
655775|NCT00800475|Gemfibrozil|gemfibrozil
655776|NCT00800488|Fever|fever
655777|NCT00800488|Infant|infant
655778|NCT00800488|Procalcitonin|procalcitonin
655779|NCT00800488|Serious Bacterial Infection|serious bacterial infection
655780|NCT00800501|ALS|als
655781|NCT00800501|VEGF165|vegf165
655782|NCT00800501|Safety|safety
655783|NCT00800501|Intracerebroventricular|intracerebroventricular
655786|NCT00800514|perception of time, traumatic brain injury, amantadine|perception of time, traumatic brain injury, amantadine
655787|NCT00800527|sternotomy|sternotomy
655788|NCT00800527|pain|pain
655789|NCT00800527|paresthesia|paresthesia
655790|NCT00800527|Poststernotomy chest pain|poststernotomy chest pain
658089|NCT00809809|HSL|hsl
655791|NCT00800527|Poststernotomy chest paresthesia|poststernotomy chest paresthesia
655792|NCT00800540|glaucoma|glaucoma
655793|NCT00800540|ocular perfusion pressure|ocular perfusion pressure
655794|NCT00800540|ocular blood flow|ocular blood flow
655795|NCT00800540|open angle glaucoma requiring more than one IOP-lowering medication|open angle glaucoma requiring more than one iop-lowering medication
655796|NCT00800553|sleep deprivation|sleep deprivation
655797|NCT00800553|fMRI|fmri
655798|NCT00800553|double blind crossover study|double blind crossover study
655799|NCT00800566|Clofarabine|clofarabine
655800|NCT00800566|Leukemia|leukemia
655801|NCT00800566|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
655802|NCT00800579|cystic fibrosis|cystic fibrosis
655803|NCT00800579|CF|cf
655804|NCT00800579|mucociliary clearance|mucociliary clearance
655805|NCT00800579|amiloride|amiloride
655806|NCT00800579|ENaC|enac
655807|NCT00800579|ENaC Inhibitor|enac inhibitor
655808|NCT00800579|airway hydration|airway hydration
655809|NCT00800579|epithelial sodium channel inhibitor|epithelial sodium channel inhibitor
655810|NCT00800592|Sildenafil, Revatio, PAH, IV, Bolus|sildenafil, revatio, pah, iv, bolus
655811|NCT00800644|Cervical Cancer|cervical cancer
655812|NCT00800644|Endometrial Cancer|endometrial cancer
655813|NCT00800644|Vaginal Cancer|vaginal cancer
655814|NCT00800644|Cervix|cervix
655815|NCT00800644|Endometrial|endometrial
655816|NCT00800644|X-ray|x-ray
655817|NCT00800644|Computed tomography|computed tomography
655818|NCT00800644|Magnetic resonance imaging|magnetic resonance imaging
655819|NCT00800644|Vagina|vagina
655820|NCT00800644|Pelvic radiation therapy|pelvic radiation therapy
655821|NCT00800644|Bone density|bone density
655822|NCT00800644|Bone mineral density test|bone mineral density test
655823|NCT00800644|Pelvic fractures|pelvic fractures
655824|NCT00800644|Gynecologic Oncology|gynecologic oncology
655825|NCT00800644|Bone turnover|bone turnover
655826|NCT00800657|Cardiac Resynchronization|cardiac resynchronization
655827|NCT00800657|Dilated Cardiomyopathy|dilated cardiomyopathy
655828|NCT00800657|Stem Cells Therapy|stem cells therapy
655829|NCT00800657|Heart Failure|heart failure
655830|NCT00800657|Stem Cells/Cardiac Pacing, Artificial|stem cells/cardiac pacing, artificial
655831|NCT00800670|tuberculosis|tuberculosis
655832|NCT00800670|vaccine|vaccine
655833|NCT00800670|adenovirus|adenovirus
655834|NCT00800696|antibiotics|antibiotics
655835|NCT00800696|Hospitalization|hospitalization
655836|NCT00800696|oral care|oral care
655837|NCT00800709|Alzheimer's Disease|alzheimer's disease
655838|NCT00800709|tau protein|tau protein
655839|NCT00800709|PET|pet
655840|NCT00800709|Memantine|memantine
655841|NCT00800722|hypervascular anomalies|hypervascular anomalies
655842|NCT00800774|LASIK|lasik
655843|NCT00800774|safety|safety
655844|NCT00800774|efficacy|efficacy
655845|NCT00800774|stability|stability
655846|NCT00800774|high anisometropia|high anisometropia
655847|NCT00800774|patients 8 to 15 years old|patients 8 to 15 years old
655848|NCT00800774|conventional treatments have failed|conventional treatments have failed
655849|NCT00800787|Chronic hepatitis B liver disease|chronic hepatitis b liver disease
655850|NCT00800800|progression of aortic stenosis|progression of aortic stenosis
655851|NCT00800813|Prostate|prostate
655852|NCT00800813|Erectile function|erectile function
655853|NCT00800813|Peyronie's Plaque|peyronie's plaque
655854|NCT00800813|08-135|08-135
655855|NCT00800839|Post-allogeneic transplantation|post-allogeneic transplantation
655856|NCT00800839|Graft-versus-Host Disease Prophylaxis|graft-versus-host disease prophylaxis
655857|NCT00800839|Graft-versus-Host Disease|graft-versus-host disease
655858|NCT00800839|GVHD|gvhd
655859|NCT00800839|Hematologic malignancies|hematologic malignancies
655860|NCT00800839|Leukemia|leukemia
655861|NCT00800839|Lymphoma|lymphoma
655862|NCT00800839|Myeloma|myeloma
655863|NCT00800839|Human Leukocyte Antigen|human leukocyte antigen
655864|NCT00800839|HLA|hla
655865|NCT00800839|Busulfan|busulfan
655866|NCT00800839|Cyclophosphamide|cyclophosphamide
655867|NCT00800839|Fludarabine|fludarabine
655868|NCT00800839|Mesna|mesna
655869|NCT00800839|Cytoxan®|cytoxan®
655870|NCT00800839|Neosar®|neosar®
655871|NCT00800839|Busulfex|busulfex
655872|NCT00800839|Myleran®|myleran®
655873|NCT00800839|Fludarabine Phosphate|fludarabine phosphate
655874|NCT00800852|adiponectin|adiponectin
655875|NCT00800852|adiponectin receptor|adiponectin receptor
655876|NCT00800852|Prader-Willi syndrome|prader-willi syndrome
655877|NCT00800878|Chronic Kidney Disease|chronic kidney disease
655878|NCT00800878|Renal insufficiency|renal insufficiency
655879|NCT00800904|Asthma|asthma
655880|NCT00800904|Inhaled corticosteroid|inhaled corticosteroid
655881|NCT00800904|Thai patient eligibility|thai patient eligibility
655882|NCT00800904|Persistent asthma|persistent asthma
655883|NCT00800930|Shigellosis|shigellosis
655884|NCT00800930|sodium butyrate|sodium butyrate
655885|NCT00800930|antimicrobial peptides|antimicrobial peptides
655886|NCT00800930|LL-37|ll-37
655887|NCT00800930|innate immunity|innate immunity
751804|NCT01170533|platelet function|platelet function
655888|NCT00800930|The aims are to assess efficacy of sodium butyrate enema in|the aims are to assess efficacy of sodium butyrate enema in
655889|NCT00800930|marked improvement in clinical features|marked improvement in clinical features
655890|NCT00800930|endoscopic findings|endoscopic findings
655891|NCT00800930|histological features|histological features
655892|NCT00800930|Induction of LL-37 in the rectum.|induction of ll-37 in the rectum.
655893|NCT00800943|Leukemia|leukemia
655894|NCT00800943|Chronic|chronic
655895|NCT00800943|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
655896|NCT00800943|CAMPATH|campath
655897|NCT00800943|Alemtuzumab|alemtuzumab
655898|NCT00800943|MabCampath|mabcampath
655899|NCT00800943|Subcutaneous|subcutaneous
655900|NCT00800943|CLL|cll
655901|NCT00800943|C-CLL|c-cll
655902|NCT00800943|Residual|residual
655903|NCT00800956|Radiolabel ADME study Healthy volunteers|radiolabel adme study healthy volunteers
655904|NCT00800969|Adenocarcinoma of the stomach and esophagogastric junction|adenocarcinoma of the stomach and esophagogastric junction
655905|NCT00800982|Obese patients (BMI>30)|obese patients (bmi>30)
655906|NCT00800982|Patients with moderate to severe psoriasis|patients with moderate to severe psoriasis
655908|NCT00800995|SOD|sod
655909|NCT00801008|young adult|young adult
655910|NCT00801008|cancer|cancer
655911|NCT00801008|exercise|exercise
655912|NCT00801008|relaxation|relaxation
655913|NCT00801021|Cystitis|cystitis
655914|NCT00801021|Urinary Tract Infections|urinary tract infections
655915|NCT00801034|hypertension|hypertension
655916|NCT00801034|potassium|potassium
655917|NCT00801034|blood pressure|blood pressure
655918|NCT00801047|Epidural|epidural
655919|NCT00801047|Labor|labor
655920|NCT00801047|Remifentanil|remifentanil
655921|NCT00801060|Fludara|fludara
655922|NCT00801060|CD23|cd23
655923|NCT00801060|Cyclophosphamide|cyclophosphamide
655924|NCT00801060|Antibody|antibody
655925|NCT00801060|Fludarabine|fludarabine
655926|NCT00801060|CLL|cll
655927|NCT00801060|Rituximab|rituximab
655928|NCT00801060|Mabthera|mabthera
655929|NCT00801060|Biogen Idec|biogen idec
655930|NCT00801060|Lumiliximab|lumiliximab
655931|NCT00801060|Rituxan|rituxan
655932|NCT00801060|Cytoxan|cytoxan
655933|NCT00801060|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
655934|NCT00801073|Amniotic membrane|amniotic membrane
655935|NCT00801073|Cornea|cornea
655936|NCT00801073|Scleral thinning|scleral thinning
655937|NCT00801086|Alopecia|alopecia
655938|NCT00801086|Hair loss|hair loss
655939|NCT00801086|Radiation|radiation
655940|NCT00801086|Whole brain radiotherapy|whole brain radiotherapy
655941|NCT00801086|Radiation-induced alopecia|radiation-induced alopecia
655942|NCT00801099|Postoperative wound infection|postoperative wound infection
655943|NCT00801099|surgical site infection|surgical site infection
655944|NCT00801099|antimicrobial prophylaxis|antimicrobial prophylaxis
655945|NCT00801099|developing countries|developing countries
655946|NCT00801099|Sub-Saharan Africa|sub-saharan africa
655947|NCT00801099|reduction of SSI using preoperative antibiotics|reduction of ssi using preoperative antibiotics
655948|NCT00801112|Bioimpedance|bioimpedance
655949|NCT00801112|Fluid status|fluid status
655950|NCT00801112|Peritoneal Dialysis|peritoneal dialysis
655951|NCT00801112|Extra-cellular fluid volume|extra-cellular fluid volume
655952|NCT00801138|ropivacaine|ropivacaine
655953|NCT00801138|bupivacaine|bupivacaine
655954|NCT00801138|glucocorticoid|glucocorticoid
655955|NCT00801164|Diabetes Type 2|diabetes type 2
655956|NCT00801164|Periodontitis|periodontitis
655957|NCT00801177|Tumors|tumors
655958|NCT00801177|Antibodies, Monoclonal|antibodies, monoclonal
655959|NCT00801190|colloid|colloid
655960|NCT00801190|CABG|cabg
655961|NCT00801190|cardiopulmonary bypass|cardiopulmonary bypass
655962|NCT00801190|bleeding|bleeding
655963|NCT00801203|Stress Urinary Incontinence|stress urinary incontinence
655964|NCT00801216|B-cell lymphomas|b-cell lymphomas
655965|NCT00801216|lymphomatous meningitis|lymphomatous meningitis
655966|NCT00801216|liposomal cytarabine|liposomal cytarabine
655967|NCT00801216|autologous transplant|autologous transplant
655968|NCT00801216|CNS involvement|cns involvement
655969|NCT00801216|Secondary CNS lymphomas|secondary cns lymphomas
655970|NCT00801229|ADHD|adhd
655971|NCT00801229|young adults|young adults
655972|NCT00801229|driving|driving
655973|NCT00801229|Vyvanse|vyvanse
655974|NCT00801229|lisdexamfetamine|lisdexamfetamine
655975|NCT00801268|polycystic kidney disease|polycystic kidney disease
655976|NCT00801268|tripterygium wilfordii|tripterygium wilfordii
655977|NCT00801281|Lymphoma|lymphoma
655978|NCT00801281|Immunochemotherapy|immunochemotherapy
655979|NCT00801281|Induction therapy|induction therapy
655980|NCT00801281|Maintenance therapy|maintenance therapy
655981|NCT00801281|Follicular lymphoma grade 1,2,3a|follicular lymphoma grade 1,2,3a
655982|NCT00801281|Marginal zone lymphoma, including MALT type|marginal zone lymphoma, including malt type
655983|NCT00801281|Small lymphocytic lymphoma (BM inv. <30%)|small lymphocytic lymphoma (bm inv. <30%)
656073|NCT00801645|Exercise|exercise
655984|NCT00801307|evaluate Inspiratory Capacity (IC) measured by spirometry|evaluate inspiratory capacity (ic) measured by spirometry
655985|NCT00801320|tumor harvest|tumor harvest
655986|NCT00801320|tumor collection|tumor collection
655987|NCT00801320|tumor storage|tumor storage
655989|NCT00801346|fatigue|fatigue
655990|NCT00801346|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
655991|NCT00801346|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
655992|NCT00801346|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
655993|NCT00801346|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
655994|NCT00801359|cataract|cataract
655995|NCT00801359|phacoemulsification|phacoemulsification
655996|NCT00801359|irrigation solution|irrigation solution
655997|NCT00801359|endothelial cell density|endothelial cell density
655998|NCT00801359|corneal thickness|corneal thickness
656092|NCT00801697|HIV Preventive Vaccine|hiv preventive vaccine
655999|NCT00801372|pregnant, healthy females older than 18 who signed an informed consent for the termination of the pregnancy.|pregnant, healthy females older than 18 who signed an informed consent for the termination of the pregnancy.
656000|NCT00801372|pregnant healthy couples older than 18 who signed an informed consent for a c-section.|pregnant healthy couples older than 18 who signed an informed consent for a c-section.
656001|NCT00801372|healthy male newborns, undergoing surgical circumcision who's parents older than 18 signed an informed consent.|healthy male newborns, undergoing surgical circumcision who's parents older than 18 signed an informed consent.
656002|NCT00801385|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
656003|NCT00801385|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
656004|NCT00801385|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
656005|NCT00801398|Opioid tolerant|opioid tolerant
656006|NCT00801398|Pediatric|pediatric
656008|NCT00801398|Non malignant|non malignant
656009|NCT00801398|Malignant|malignant
656010|NCT00801411|stage II breast cancer|stage ii breast cancer
656011|NCT00801424|abdominal surgery|abdominal surgery
656012|NCT00801424|hypothermia|hypothermia
656013|NCT00801424|wound dessication|wound dessication
656014|NCT00801424|warming|warming
656015|NCT00801437|glaucoma, open-angle, non-interventional study, safety, tolerability|glaucoma, open-angle, non-interventional study, safety, tolerability
656016|NCT00801450|diabetes|diabetes
656017|NCT00801450|macular edema|macular edema
656018|NCT00801450|triamcinolone|triamcinolone
656019|NCT00801450|cataract|cataract
656020|NCT00801450|refractory diabetic macular edema|refractory diabetic macular edema
656021|NCT00801463|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
656022|NCT00801463|Prednisone|prednisone
656023|NCT00801463|Tripterygium Wilfordii|tripterygium wilfordii
656024|NCT00801476|Breast Cancer|breast cancer
656025|NCT00801476|Magnetic Resonance Imaging|magnetic resonance imaging
656026|NCT00801476|Preoperative MRI|preoperative mri
656027|NCT00801489|Leukemia|leukemia
656028|NCT00801489|Acute Myelogenous Leukemia|acute myelogenous leukemia
656029|NCT00801489|AML|aml
656030|NCT00801502|Omega-3|omega-3
656031|NCT00801502|Oily fish|oily fish
656032|NCT00801502|Antioxidant|antioxidant
656033|NCT00801502|Selenium|selenium
656034|NCT00801502|Atopic disease|atopic disease
656035|NCT00801502|Pregnancy|pregnancy
656036|NCT00801502|Nutrient status|nutrient status
656037|NCT00801515|Compassionate|compassionate
656038|NCT00801515|HIV|hiv
656039|NCT00801515|CCR5|ccr5
656040|NCT00801528|ropivacaine|ropivacaine
656041|NCT00801528|diclofenac|diclofenac
656042|NCT00801528|local anesthetic instillation|local anesthetic instillation
656043|NCT00801541|AMD|amd
656044|NCT00801554|Autism Spectrum Disorder|autism spectrum disorder
656045|NCT00801554|ASD|asd
656046|NCT00801554|Autism|autism
656047|NCT00801554|Asperger's Syndrome|asperger's syndrome
656048|NCT00801554|PDD-NOS|pdd-nos
656049|NCT00801554|Pervasive Developmental Disorders- Not Otherwise Specified|pervasive developmental disorders- not otherwise specified
656050|NCT00801554|Adults|adults
656051|NCT00801554|Children|children
656052|NCT00801567|Bipolar disorder|bipolar disorder
656053|NCT00801567|Schizophrenia|schizophrenia
656054|NCT00801567|Healthy volunteer|healthy volunteer
656055|NCT00801567|Brain imaging|brain imaging
656056|NCT00801567|Photic stimulation|photic stimulation
656057|NCT00801580|relapsed ALL|relapsed all
656058|NCT00801580|refractory ALL|refractory all
656059|NCT00801580|relapsed adult acute lymphoid leukemia|relapsed adult acute lymphoid leukemia
656060|NCT00801593|JIA|jia
656061|NCT00801606|Micronutrient|micronutrient
656062|NCT00801606|Childhood Tuberculosis|childhood tuberculosis
656063|NCT00801632|renal allograft tolerance|renal allograft tolerance
656064|NCT00801632|mixed chimerism|mixed chimerism
656065|NCT00801632|kidney transplant|kidney transplant
656066|NCT00801632|bone marrow transplant|bone marrow transplant
656067|NCT00801632|antirejection|antirejection
656068|NCT00801632|immunosuppression|immunosuppression
656069|NCT00801645|Obesity|obesity
656070|NCT00801645|Cardiovascular disease|cardiovascular disease
656071|NCT00801645|Endothelial function|endothelial function
656072|NCT00801645|Blood pressure|blood pressure
656074|NCT00801645|Physical activity|physical activity
656075|NCT00801645|Metabolic syndrome|metabolic syndrome
656076|NCT00801645|Children|children
656077|NCT00801645|Pediatric|pediatric
656078|NCT00801658|glaucoma|glaucoma
656080|NCT00801658|Laser treatment|laser treatment
656082|NCT00801658|glaucoma treated with eye drops but IOP not controlled|glaucoma treated with eye drops but iop not controlled
656083|NCT00801671|obstructive sleep apnea|obstructive sleep apnea
656084|NCT00801671|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
656085|NCT00801671|hypertension|hypertension
656086|NCT00801671|systemic hypertension|systemic hypertension
656087|NCT00801671|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
656088|NCT00801684|COPD|copd
656089|NCT00801684|pulmonary|pulmonary
656090|NCT00801684|inhalation|inhalation
656091|NCT00801697|HIV Seronegativity|hiv seronegativity
656093|NCT00801697|Adenovirus|adenovirus
656094|NCT00801723|Ulcerative Colitis|ulcerative colitis
656095|NCT00801736|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
656096|NCT00801736|Stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
656097|NCT00801736|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
656098|NCT00801775|calorimetry|calorimetry
656099|NCT00801801|Docetaxel|docetaxel
656100|NCT00801801|Sorafenib|sorafenib
656101|NCT00801814|viscous|viscous
656102|NCT00801814|fibre|fibre
656103|NCT00801814|polysaccharide|polysaccharide
656104|NCT00801814|blood glucose|blood glucose
656105|NCT00801814|post prandial|post prandial
656106|NCT00801827|Obesity|obesity
656107|NCT00801827|Addiction|addiction
656108|NCT00801827|PET imaging|pet imaging
656109|NCT00801853|asthma|asthma
656110|NCT00801853|allergy|allergy
656111|NCT00801853|atopy|atopy
656112|NCT00801853|atopic|atopic
656113|NCT00801853|wheeze|wheeze
656114|NCT00801866|Panretinal Photocoagulation|panretinal photocoagulation
656115|NCT00801866|Macular Edema|macular edema
656116|NCT00801866|Intravitreal Bevacizumab|intravitreal bevacizumab
656117|NCT00801879|mupirocin|mupirocin
656118|NCT00801879|Staphylococcus aureus|staphylococcus aureus
656119|NCT00801879|colonization|colonization
656120|NCT00801879|infection|infection
656121|NCT00801879|HIV|hiv
656122|NCT00801892|daytime sleepiness|daytime sleepiness
656123|NCT00801892|obstructive sleep apnea|obstructive sleep apnea
656124|NCT00801892|type 2 diabetes mellitus|type 2 diabetes mellitus
656125|NCT00801892|diabetes management|diabetes management
656126|NCT00801905|Macular thickening|macular thickening
656127|NCT00801905|Macular edema|macular edema
656128|NCT00801905|Pan-retinal photocoagulation|pan-retinal photocoagulation
656129|NCT00801905|Nepafenac|nepafenac
656130|NCT00801905|Topical non-steroidal anti inflammatory agents|topical non-steroidal anti inflammatory agents
656131|NCT00801918|lymphoma|lymphoma
656132|NCT00801918|pediatric|pediatric
656133|NCT00801918|adolescent|adolescent
656134|NCT00801918|relapsed|relapsed
656135|NCT00801918|refractory|refractory
656136|NCT00801918|denileukin diftitox|denileukin diftitox
656137|NCT00801918|Ontak|ontak
656138|NCT00801931|Cord Blood Transplant|cord blood transplant
656139|NCT00801931|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
656140|NCT00801944|Overactive Bladder|overactive bladder
656141|NCT00801957|atopic dermatitis|atopic dermatitis
656142|NCT00801957|meningitis|meningitis
656143|NCT00801957|vaccination|vaccination
656144|NCT00801957|tacrolimus|tacrolimus
656145|NCT00801957|steroids|steroids
656146|NCT00801957|equivalence response|equivalence response
656147|NCT00801957|meningococcal vaccine|meningococcal vaccine
656148|NCT00801970|Fear of childbirth|fear of childbirth
656149|NCT00801970|Tokophobia|tokophobia
656150|NCT00801970|Anxiety|anxiety
656151|NCT00801970|Labor|labor
656152|NCT00801970|Pregnancy|pregnancy
656153|NCT00801970|Cognitive-behavioral|cognitive-behavioral
656154|NCT00801970|Psychoanalysis|psychoanalysis
656155|NCT00801970|Group Therapy|group therapy
656156|NCT00801970|etiology|etiology
656157|NCT00801996|prostate cancer|prostate cancer
656158|NCT00801996|genetics|genetics
656159|NCT00802009|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
656160|NCT00802009|nerve block|nerve block
656161|NCT00802009|brachial plexus|brachial plexus
656162|NCT00802009|mepivicaine|mepivicaine
656163|NCT00802009|dexamethasone|dexamethasone
656164|NCT00802009|hand wrist surgery|hand wrist surgery
656165|NCT00802009|duration|duration
656166|NCT00802009|anesthetic duration following brachial plexus/nerve block for hand/wrist surgery|anesthetic duration following brachial plexus/nerve block for hand/wrist surgery
656167|NCT00802022|diabetic neuropathies|diabetic neuropathies
656168|NCT00802022|electric stimulation therapy|electric stimulation therapy
656169|NCT00802035|ALK29|alk29
656170|NCT00802035|Alcohol Dependence|alcohol dependence
656171|NCT00802035|Pharmacokinetics|pharmacokinetics
656172|NCT00802048|Sternotomy|sternotomy
656173|NCT00802048|Postoperative hyperalgesia|postoperative hyperalgesia
656174|NCT00802048|Intralesional anesthetic infusion|intralesional anesthetic infusion
656175|NCT00802048|Ropivacaïne|ropivacaïne
656176|NCT00802048|Chronic|chronic
656177|NCT00802048|Postoperative pain|postoperative pain
656178|NCT00802048|Cardiac surgery|cardiac surgery
656179|NCT00802048|Sternum|sternum
656180|NCT00802048|Cardiac surgical procedures|cardiac surgical procedures
656181|NCT00802061|progressive glaucoma despite controlled IOP|progressive glaucoma despite controlled iop
656182|NCT00802074|Healthy Subjects|healthy subjects
656183|NCT00802074|Pharmacokinetics study|pharmacokinetics study
656184|NCT00802074|Pharmacokinetics of medications|pharmacokinetics of medications
656185|NCT00802087|Hydrocodone|hydrocodone
656186|NCT00802087|Pharmacokinetics|pharmacokinetics
656187|NCT00802087|Safety & Tolerability|safety & tolerability
656188|NCT00802100|Schizoaffective Disorder|schizoaffective disorder
656189|NCT00802113|Autologous Stem Cell Transplant|autologous stem cell transplant
656190|NCT00802113|Cord Blood Transplant|cord blood transplant
656191|NCT00802113|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
656192|NCT00802113|Relapsed Lymphoma|relapsed lymphoma
656193|NCT00802139|iron deficiency anemia|iron deficiency anemia
656194|NCT00802139|pregnant women with iron deficiency anemia|pregnant women with iron deficiency anemia
656195|NCT00802152|Diabetes|diabetes
656196|NCT00802152|Hypertension|hypertension
656197|NCT00802165|Asymptomatic normals|asymptomatic normals
656198|NCT00802204|Obesity|obesity
656199|NCT00802204|Insulin Resistance|insulin resistance
656200|NCT00802204|Neuroendocrine regulation|neuroendocrine regulation
656201|NCT00802204|Eating behaviors|eating behaviors
656202|NCT00802204|Dopamine signaling|dopamine signaling
656203|NCT00802217|Pharmacokinetics|pharmacokinetics
656204|NCT00802217|Safety|safety
656205|NCT00802217|Tolerability|tolerability
656206|NCT00802217|Healthy Volunteers|healthy volunteers
656207|NCT00802243|Bullous pemphigoid|bullous pemphigoid
656208|NCT00802243|leflunomide|leflunomide
656209|NCT00802243|corticosteroid treatment reduction|corticosteroid treatment reduction
656210|NCT00802243|Patients are screened by: the physicians in different departments of the hospital, the liberal dermatologists and the general practicioners.|patients are screened by: the physicians in different departments of the hospital, the liberal dermatologists and the general practicioners.
656211|NCT00802243|Phase I: Patients will be referred to the investigators of Dupuytren Hospital Dermatology Department.|phase i: patients will be referred to the investigators of dupuytren hospital dermatology department.
656212|NCT00802243|Phase II: Patients will be referred to the investigators of Purpan (Toulouse), Haut Leveque (Pessac) and Dupuytren (Limoges) Hospitals.|phase ii: patients will be referred to the investigators of purpan (toulouse), haut leveque (pessac) and dupuytren (limoges) hospitals.
656213|NCT00802256|pulpotomy|pulpotomy
656214|NCT00802256|primary molar teeth|primary molar teeth
656215|NCT00802256|MTA|mta
656216|NCT00802256|NEC|nec
656217|NCT00802256|CEM|cem
656218|NCT00802256|Primary Molar Teeth Which Require Pulpotomy Treatment|primary molar teeth which require pulpotomy treatment
656219|NCT00802269|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
656220|NCT00802269|Laser photocoagulation|laser photocoagulation
656221|NCT00802269|Pain|pain
656222|NCT00802282|healthy volunteers|healthy volunteers
656223|NCT00802282|spirituality|spirituality
656224|NCT00802282|psilocybin|psilocybin
656225|NCT00802282|meditation|meditation
656226|NCT00802295|Ovarian|ovarian
656227|NCT00802295|hyperstimulation|hyperstimulation
656228|NCT00802295|Embryo|embryo
656229|NCT00802295|Aneuploidy|aneuploidy
656230|NCT00802295|Ovarian hyperstimulation and Embryo Aneuploidy Rates|ovarian hyperstimulation and embryo aneuploidy rates
656231|NCT00802321|steroid 5AReductase|steroid 5areductase
656232|NCT00802321|genetic polymorphism|genetic polymorphism
656233|NCT00802321|GABA receptor|gaba receptor
656234|NCT00802334|generic lopinavir/ritonavir|generic lopinavir/ritonavir
656235|NCT00802334|therapeutic drug monitoring|therapeutic drug monitoring
656236|NCT00802334|safety and efficacy|safety and efficacy
656237|NCT00802347|Delayed Graft Function|delayed graft function
656238|NCT00802347|Kidney Transplant|kidney transplant
656239|NCT00802347|Renal Transplant|renal transplant
656240|NCT00802347|small interfering ribonucleic acid (siRNA)|small interfering ribonucleic acid (sirna)
656241|NCT00802360|Healthy, pre-menopausal women, age 18-42 with a history of infertility and requiring IVF|healthy, pre-menopausal women, age 18-42 with a history of infertility and requiring ivf
656242|NCT00802373|Overactive Bladder|overactive bladder
656243|NCT00802386|BACTERIAL VAGINOSIS|bacterial vaginosis
656244|NCT00802386|IUD INSERTION|iud insertion
656245|NCT00802399|Cornea|cornea
656246|NCT00802399|Dry eye|dry eye
656247|NCT00802399|lacrimal punctual occlusion|lacrimal punctual occlusion
656248|NCT00802399|lacrimal film|lacrimal film
656249|NCT00802399|ocular surface|ocular surface
656250|NCT00802412|tobacco use disorders|tobacco use disorders
656251|NCT00802412|alcoholism|alcoholism
656252|NCT00802425|Sudden hearing loss|sudden hearing loss
656253|NCT00802425|Sudden deafness|sudden deafness
656254|NCT00802425|Acoustic trauma|acoustic trauma
656255|NCT00802425|Noise trauma|noise trauma
656256|NCT00802438|asthma|asthma
656257|NCT00802438|allergic inflammation|allergic inflammation
656258|NCT00802438|interleukin-5|interleukin-5
656259|NCT00802451|Bioavailability|bioavailability
656260|NCT00802451|Mesalamine|mesalamine
656261|NCT00802464|Cytokine|cytokine
656262|NCT00802464|Vaccine|vaccine
656263|NCT00802464|Herpes Zoster (HZ)|herpes zoster (hz)
656264|NCT00802464|Cell mediated immunity (CMI)|cell mediated immunity (cmi)
656265|NCT00802464|Antibody response|antibody response
656266|NCT00802464|Varicella Zoster Virus (VZV)|varicella zoster virus (vzv)
656267|NCT00802464|Shingles|shingles
656268|NCT00802477|mastectomy|mastectomy
656269|NCT00802477|seroma|seroma
656270|NCT00802477|lymph node dissection|lymph node dissection
656271|NCT00802490|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
656272|NCT00802490|Electroencephalogram biofeedback|electroencephalogram biofeedback
656273|NCT00802490|Inattention|inattention
656274|NCT00802490|Brain-Computer Interface System|brain-computer interface system
656275|NCT00802503|Critically ill|critically ill
656276|NCT00802503|nutrition|nutrition
656277|NCT00802503|randomised controlled clinical trial|randomised controlled clinical trial
656278|NCT00802503|human|human
656279|NCT00802503|adult|adult
656280|NCT00802503|Supplemental parenteral nutrition|supplemental parenteral nutrition
656281|NCT00802529|Meniere's disease|meniere's disease
656282|NCT00802529|transtympanic steroids|transtympanic steroids
656283|NCT00802529|Randomised controlled trial|randomised controlled trial
656284|NCT00802542|Hypertension|hypertension
656285|NCT00802542|blood pressure|blood pressure
656286|NCT00802542|Atacand|atacand
656288|NCT00802555|Cirrhotic Patients with Hepatocellular Carcinoma|cirrhotic patients with hepatocellular carcinoma
656289|NCT00802568|stage I multiple myeloma|stage i multiple myeloma
656290|NCT00802568|stage II multiple myeloma|stage ii multiple myeloma
656291|NCT00802568|stage III multiple myeloma|stage iii multiple myeloma
656292|NCT00802568|refractory multiple myeloma|refractory multiple myeloma
656293|NCT00802568|osteolytic lesions of multiple myeloma|osteolytic lesions of multiple myeloma
656294|NCT00802581|sciatic nerve block|sciatic nerve block
656295|NCT00802581|local anesthetic|local anesthetic
656296|NCT00802581|lidocaine|lidocaine
656297|NCT00802581|ankle surgery|ankle surgery
656298|NCT00802581|foot surgery|foot surgery
656299|NCT00802581|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
656300|NCT00802581|circumferential spread|circumferential spread
656301|NCT00802581|anesthetic infiltration|anesthetic infiltration
656302|NCT00802594|first stage|first stage
656303|NCT00802594|T.b. gambiense|t.b. gambiense
656304|NCT00802594|sleeping sickness|sleeping sickness
656305|NCT00802594|Patients with first stage T.b. gambiense sleeping sickness|patients with first stage t.b. gambiense sleeping sickness
656306|NCT00802607|Bone Diseases|bone diseases
656307|NCT00802607|Connective Tissue Diseases|connective tissue diseases
656308|NCT00802620|Amniotic membrane|amniotic membrane
656309|NCT00802620|Conjunctival autograft|conjunctival autograft
656310|NCT00802620|Recurrent pterygia|recurrent pterygia
656311|NCT00802620|compare amniotic membrane associated with conjunctival autograft versus conjunctival autograft alone in the treatment of recurrent pterygia|compare amniotic membrane associated with conjunctival autograft versus conjunctival autograft alone in the treatment of recurrent pterygia
656312|NCT00802633|Tissue sealing device|tissue sealing device
656313|NCT00802633|Articulating stapling device|articulating stapling device
656314|NCT00802633|Radical cystectomy|radical cystectomy
656315|NCT00802646|first-time mother|first-time mother
656316|NCT00802646|epidural request|epidural request
656317|NCT00802646|vaginal childbirth|vaginal childbirth
656318|NCT00802672|Tinea Pedis|tinea pedis
656319|NCT00802672|Ciclopirox Olamine|ciclopirox olamine
656320|NCT00802685|Patent ductus arteriosus|patent ductus arteriosus
656321|NCT00802685|Respiratory outcome|respiratory outcome
656322|NCT00802698|Biphasic waveform|biphasic waveform
656323|NCT00802698|Central retinal artery occlusion|central retinal artery occlusion
656425|NCT00791011|Velcade|velcade
656426|NCT00791024|Analgesia Tests|analgesia tests
656324|NCT00802698|To describe the effect of Transcorneal Electrical Stimulation (TES) with a non conventional biphasic bipolar waveform|to describe the effect of transcorneal electrical stimulation (tes) with a non conventional biphasic bipolar waveform
656325|NCT00802698|in central retinal artery occlusion|in central retinal artery occlusion
656326|NCT00802711|stage IA breast cancer|stage ia breast cancer
656327|NCT00802711|stage IB breast cancer|stage ib breast cancer
656328|NCT00802711|stage II breast cancer|stage ii breast cancer
656329|NCT00802711|invasive ductal breast carcinoma|invasive ductal breast carcinoma
656330|NCT00802724|low back pain|low back pain
656331|NCT00802724|classification|classification
656332|NCT00802724|spine|spine
656333|NCT00802737|Maintenance|maintenance
656334|NCT00802737|Retreatment|retreatment
656335|NCT00802737|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
656336|NCT00802737|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
656337|NCT00802737|Ofatumumab|ofatumumab
656338|NCT00802763|VAGINAL INFECTION|vaginal infection
656339|NCT00802763|COLOR APPEARANCE|color appearance
656340|NCT00802763|ELEVATED Ph|elevated ph
656341|NCT00790738|bipolar disorder|bipolar disorder
656342|NCT00790738|depression|depression
656343|NCT00790738|treatment|treatment
656344|NCT00790738|randomized controlled trial|randomized controlled trial
656345|NCT00790751|ED|ed
656346|NCT00790751|Erectile Dysfunction|erectile dysfunction
656347|NCT00790751|Dysfunction|dysfunction
656348|NCT00790751|Erectile|erectile
656349|NCT00790777|Paliperidone ER|paliperidone er
656453|NCT00796562|MDS|mds
656350|NCT00790777|Schizophrenia, Mood disorders, Antipsychotic drugs|schizophrenia, mood disorders, antipsychotic drugs
656351|NCT00790803|uveitis|uveitis
656352|NCT00790803|cystoid macular edema|cystoid macular edema
656353|NCT00790816|Cancer|cancer
656354|NCT00790816|lapatinib|lapatinib
656355|NCT00790816|Combination therapy|combination therapy
656356|NCT00790816|Chronic administration|chronic administration
656357|NCT00790829|preemptive|preemptive
656358|NCT00790829|Nicotine Patch|nicotine patch
656359|NCT00790829|Open Abdominal Surgery|open abdominal surgery
656360|NCT00790842|Refractory Multiple Myeloma|refractory multiple myeloma
656361|NCT00790842|Relapsed Multiple Myeloma|relapsed multiple myeloma
656362|NCT00790842|Multiple Myeloma with Renal Dysfunction|multiple myeloma with renal dysfunction
656363|NCT00790842|Stage I Multiple Myeloma|stage i multiple myeloma
656364|NCT00790842|Stage II Multiple Myeloma|stage ii multiple myeloma
656365|NCT00790842|Stage III Multiple Myeloma|stage iii multiple myeloma
656366|NCT00790855|Bendamustine|bendamustine
656367|NCT00790855|Acute Leukemia|acute leukemia
656368|NCT00790855|Leukemia|leukemia
656369|NCT00790855|Acute myeloid leukemia|acute myeloid leukemia
656370|NCT00790855|Myelodysplastic Syndrome|myelodysplastic syndrome
656371|NCT00790855|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
656372|NCT00790855|Chronic myeloid leukemia|chronic myeloid leukemia
656373|NCT00790855|MDS|mds
656374|NCT00790855|ALL|all
656375|NCT00790855|AML|aml
656376|NCT00790855|CML|cml
656377|NCT00790868|Panic Disorder|panic disorder
656378|NCT00790868|Anxiety|anxiety
656379|NCT00790868|D-cycloserine|d-cycloserine
656380|NCT00790868|DCS|dcs
656381|NCT00790868|Cognitive Behavioral Therapy|cognitive behavioral therapy
656382|NCT00790868|CBT|cbt
656383|NCT00790881|malaria|malaria
656384|NCT00790881|HIV|hiv
656385|NCT00790881|AIDS|aids
656386|NCT00790881|nevirapine|nevirapine
656387|NCT00790881|lumefantrine|lumefantrine
656388|NCT00790881|artemether|artemether
656389|NCT00790881|drug interaction|drug interaction
656390|NCT00790881|pharmacokinetics|pharmacokinetics
656391|NCT00790907|Unstable angina|unstable angina
656392|NCT00790907|Non ST elevation myocardial infarction|non st elevation myocardial infarction
656393|NCT00790907|PCI|pci
656394|NCT00790907|unfractionated heparin|unfractionated heparin
656395|NCT00790907|fondaparinux|fondaparinux
656396|NCT00790907|acute coronary syndrome|acute coronary syndrome
656397|NCT00790920|Acute ischemic stroke|acute ischemic stroke
656398|NCT00790920|Angiography|angiography
656399|NCT00790920|Desmoteplase|desmoteplase
656400|NCT00790920|Thrombolytic|thrombolytic
656401|NCT00790933|Drug therapy|drug therapy
656402|NCT00790946|valsartan|valsartan
656403|NCT00790946|Metabolic syndrome|metabolic syndrome
656404|NCT00790959|Intimate Partner Violence|intimate partner violence
656405|NCT00790959|HIV/AIDS|hiv/aids
656406|NCT00790959|Gender|gender
656407|NCT00790959|Prevention|prevention
656408|NCT00790959|Community mobilisation|community mobilisation
656409|NCT00790959|Uganda|uganda
656410|NCT00790972|MRSA|mrsa
656411|NCT00790972|sinofresh|sinofresh
656412|NCT00790972|nasal spray|nasal spray
656413|NCT00790998|onchocerciasis|onchocerciasis
656414|NCT00790998|river blindness|river blindness
656415|NCT00790998|onchocerca volvulus|onchocerca volvulus
656416|NCT00790998|moxidectin|moxidectin
656417|NCT00790998|ivermectin|ivermectin
656418|NCT00791011|Lymphoma|lymphoma
656419|NCT00791011|AMG 655|amg 655
656420|NCT00791011|Trail receptor|trail receptor
656421|NCT00791011|Apoptosis|apoptosis
656422|NCT00791011|Vorinostat|vorinostat
656423|NCT00791011|Bortezomib|bortezomib
656427|NCT00791024|Analog Pain Scale|analog pain scale
656428|NCT00791024|Pain Measurement|pain measurement
656429|NCT00791050|Hypothermia/complications/etiology|hypothermia/complications/etiology
656430|NCT00791050|coronary artery bypass/adverse effects|coronary artery bypass/adverse effects
656431|NCT00791063|cell death|cell death
656432|NCT00791063|Apoptosis|apoptosis
656433|NCT00791063|PET imaging|pet imaging
656434|NCT00791063|brain metastases|brain metastases
656435|NCT00791063|whole brain radiation therapy|whole brain radiation therapy
656436|NCT00791076|Insulin pump therapy|insulin pump therapy
656437|NCT00791076|Type 1 diabetic|type 1 diabetic
656438|NCT00791076|Chronic pancreatitis|chronic pancreatitis
656439|NCT00791076|Pancreatic resection|pancreatic resection
656440|NCT00791076|Pancreatic polypeptide|pancreatic polypeptide
656441|NCT00791089|Radiofrequency Ablation|radiofrequency ablation
656442|NCT00791089|atrial fibrillation|atrial fibrillation
656443|NCT00791115|Prostate cancer|prostate cancer
656444|NCT00791115|prostatectomy|prostatectomy
656445|NCT00791115|radiotherapy|radiotherapy
656446|NCT00791115|prostatectomy after radiotherapy|prostatectomy after radiotherapy
656447|NCT00791128|Type 2 Diabetes|type 2 diabetes
656448|NCT00796562|Leukemia|leukemia
656449|NCT00796562|Lymphoma|lymphoma
656450|NCT00796562|Hematologic malignancies|hematologic malignancies
656451|NCT00796562|ALL|all
656452|NCT00796562|AML|aml
656454|NCT00796562|Transplantation|transplantation
656455|NCT00796562|Mismatched|mismatched
656456|NCT00796562|Haploidentical|haploidentical
656457|NCT00796562|Busulfan|busulfan
656458|NCT00796562|Cyclophosphamide|cyclophosphamide
656459|NCT00796562|Cellcept|cellcept
656460|NCT00796562|Tacrolimus|tacrolimus
656461|NCT00796562|TBI|tbi
656462|NCT00796562|CMMOL|cmmol
656463|NCT00796562|CML|cml
656464|NCT00796562|JMML|jmml
656465|NCT00796575|multiple ascending dose healthy volunteers|multiple ascending dose healthy volunteers
656466|NCT00796575|pharmacokinetics|pharmacokinetics
656467|NCT00796575|pharmacodynamics|pharmacodynamics
656468|NCT00796588|preconditioning|preconditioning
656469|NCT00796588|remote|remote
656470|NCT00796601|double-blind placebo-controlled maintenance of efficacy|double-blind placebo-controlled maintenance of efficacy
656471|NCT00796614|tamsulosin|tamsulosin
656472|NCT00796614|pediatric|pediatric
656576|NCT00802854|efficacy|efficacy
656473|NCT00796614|neurogenic bladder|neurogenic bladder
656474|NCT00796627|Wound Healing|wound healing
656475|NCT00796627|Burns|burns
656476|NCT00796627|HIF-1|hif-1
656477|NCT00796627|EPC|epc
656478|NCT00796640|Schizophrenia|schizophrenia
656479|NCT00796640|Mood disorders|mood disorders
656480|NCT00796640|Antipsychotic drugs|antipsychotic drugs
656481|NCT00796640|ER Paliperidone|er paliperidone
656482|NCT00796666|endothelin receptor antagonist (ETRA)|endothelin receptor antagonist (etra)
656483|NCT00796666|Sitaxsentan|sitaxsentan
656484|NCT00796679|paricalcitol|paricalcitol
656485|NCT00796679|chronic kidney disease|chronic kidney disease
656486|NCT00796679|cardiac hypertrophy|cardiac hypertrophy
656487|NCT00796692|Heparin|heparin
656488|NCT00796692|Low molecular weight heparin|low molecular weight heparin
656489|NCT00796692|Safety|safety
656490|NCT00796692|Efficacy|efficacy
656491|NCT00796692|Cost effective|cost effective
656492|NCT00796731|B-cell lymphoma|b-cell lymphoma
656493|NCT00796731|NHL|nhl
656494|NCT00796744|Diabetes mellitus|diabetes mellitus
656495|NCT00796744|Diabetic neuropathy|diabetic neuropathy
656496|NCT00796744|Peripheral vascular disease|peripheral vascular disease
656497|NCT00796744|Infection|infection
656498|NCT00796744|Topical application|topical application
656499|NCT00796744|plantar foot ulcers|plantar foot ulcers
656500|NCT00796770|HIV|hiv
656501|NCT00796770|Vaccine|vaccine
656502|NCT00796770|HAART|haart
656503|NCT00796770|HIV-1|hiv-1
656504|NCT00796770|AIDS|aids
656505|NCT00796770|Dendritic Cells|dendritic cells
656506|NCT00796770|DALIA|dalia
656507|NCT00796783|Cushing's Disease|cushing's disease
656508|NCT00796783|Cushing's Syndrome|cushing's syndrome
656509|NCT00796783|Cushings|cushings
656510|NCT00796783|Pituitary|pituitary
656511|NCT00796783|ACTH|acth
656512|NCT00796783|Adrenocorticotropic hormone|adrenocorticotropic hormone
656513|NCT00796783|Ectopic|ectopic
656514|NCT00796783|Adrenal adenoma|adrenal adenoma
656515|NCT00796783|Adrenal carcinoma|adrenal carcinoma
656516|NCT00796783|Adrenal autonomy|adrenal autonomy
656517|NCT00796783|Cortisol|cortisol
656518|NCT00796783|Hypercortisolemia|hypercortisolemia
656519|NCT00796783|Cushinoid|cushinoid
656520|NCT00796783|Moon facies|moon facies
656521|NCT00796783|Dorsalcervical fat|dorsalcervical fat
656522|NCT00796783|Plethora|plethora
656523|NCT00796783|Hirsutism|hirsutism
656524|NCT00796783|Violaceous striae|violaceous striae
656525|NCT00796783|Hormone|hormone
656526|NCT00796783|Contraceptive|contraceptive
656527|NCT00796783|Endocrine|endocrine
656528|NCT00796783|Cushing Syndrome|cushing syndrome
656529|NCT00796783|Ectopic ACTH Secretion|ectopic acth secretion
656530|NCT00796796|Non-small cell lung cancer|non-small cell lung cancer
656531|NCT00796796|temsirolimus|temsirolimus
656532|NCT00796796|radiation therapy|radiation therapy
656533|NCT00796809|TNF inhibitors|tnf inhibitors
656534|NCT00796809|Biologic agents|biologic agents
656535|NCT00796809|coccidioidomycosis|coccidioidomycosis
656536|NCT00796809|Rheumatoid arthritis|rheumatoid arthritis
656537|NCT00796822|Endothelial Function|endothelial function
656538|NCT00796822|Inflammation|inflammation
656539|NCT00796835|Schizophrenia|schizophrenia
656540|NCT00796835|Mood disorders|mood disorders
656541|NCT00796835|Antipsychotic drugs|antipsychotic drugs
656542|NCT00796835|ER OROS Paliperidone|er oros paliperidone
656543|NCT00796861|malignant ascites|malignant ascites
656544|NCT00796874|stage I prostate cancer|stage i prostate cancer
656545|NCT00796874|stage II prostate cancer|stage ii prostate cancer
656546|NCT00796887|Ischemic Stroke|ischemic stroke
656547|NCT00796887|Recovery of Function|recovery of function
656548|NCT00796887|Extended-release niacin|extended-release niacin
656549|NCT00796900|Hyperthermia|hyperthermia
656550|NCT00796900|subarachnoidal hemorrhage|subarachnoidal hemorrhage
656551|NCT00796900|placebo controlled|placebo controlled
656552|NCT00796900|double blinded|double blinded
656553|NCT00796900|Dantrolene|dantrolene
656554|NCT00796939|Delayed Sleep Phase Syndrome|delayed sleep phase syndrome
656555|NCT00796939|Sleep|sleep
656556|NCT00796952|Head/ neck cancer|head/ neck cancer
656557|NCT00796952|Swallowing|swallowing
656558|NCT00796952|behavioral treatment|behavioral treatment
656559|NCT00796965|Phase 1|phase 1
656560|NCT00796978|stage I breast cancer|stage i breast cancer
656561|NCT00796978|stage II breast cancer|stage ii breast cancer
656562|NCT00796978|stage IIIA breast cancer|stage iiia breast cancer
656563|NCT00796978|stage IIIB breast cancer|stage iiib breast cancer
656564|NCT00796978|stage IIIC breast cancer|stage iiic breast cancer
656814|NCT00803907|Carcinoma, Basal Cell|carcinoma, basal cell
656565|NCT00796978|HER2-positive breast cancer|her2-positive breast cancer
656566|NCT00802828|bioavailability|bioavailability
656567|NCT00802828|famotidine|famotidine
656568|NCT00802841|Chronic|chronic
656569|NCT00802841|Myelogenous|myelogenous
656570|NCT00802841|Leukemia|leukemia
656571|NCT00802841|CML|cml
656572|NCT00802841|Chronic Phase|chronic phase
656573|NCT00802841|Suboptimal Response|suboptimal response
656574|NCT00802854|anidulafungin|anidulafungin
656575|NCT00802854|safety|safety
656577|NCT00802867|DAPTACEL®|daptacel®
656578|NCT00802867|PENTACEL™|pentacel™
656579|NCT00802867|Diphtheria|diphtheria
656580|NCT00802867|Tetanus|tetanus
656581|NCT00802867|Pertussis|pertussis
656582|NCT00802867|Haemophilus influenzae type b|haemophilus influenzae type b
656583|NCT00802893|Isolated Systolic Hypertension with Endothelial Dysfunction|isolated systolic hypertension with endothelial dysfunction
656584|NCT00802906|micropulselaserphotocoagulation|micropulselaserphotocoagulation
656585|NCT00802906|bevacizumab|bevacizumab
656586|NCT00802906|CSC|csc
656587|NCT00802919|schizophrenia|schizophrenia
656588|NCT00802919|smoking|smoking
656589|NCT00802919|nicotine|nicotine
656590|NCT00802919|cognitive deficits|cognitive deficits
656591|NCT00802919|DNMT1 mRNA|dnmt1 mrna
656592|NCT00802919|nicotinic receptors|nicotinic receptors
656593|NCT00802919|Cognitive Deficits in Schizophrenia|cognitive deficits in schizophrenia
656594|NCT00802932|breast cancer|breast cancer
656595|NCT00802932|female|female
656596|NCT00802932|metallic markers|metallic markers
656597|NCT00802932|image guided radiation therapy|image guided radiation therapy
656598|NCT00802932|IGRT|igrt
656599|NCT00802958|Bioequivalence|bioequivalence
656600|NCT00802958|Halobetasol Propionate|halobetasol propionate
656601|NCT00802971|Reactive hypoglycaemia|reactive hypoglycaemia
656602|NCT00802971|Fiber|fiber
656603|NCT00802971|Prevalence|prevalence
656604|NCT00802971|Randomised controlled trial|randomised controlled trial
656605|NCT00802971|Idiopathic reactive hypoglycemia|idiopathic reactive hypoglycemia
656606|NCT00803010|Acute Graft Versus Host Disease (aGVHD)|acute graft versus host disease (agvhd)
656607|NCT00803010|GVHD|gvhd
656608|NCT00803010|graft-versus-host disease|graft-versus-host disease
656609|NCT00803010|tacrolimus|tacrolimus
656610|NCT00803010|sirolimus|sirolimus
656611|NCT00803010|methotrexate|methotrexate
656612|NCT00803010|combination therapy|combination therapy
656613|NCT00803010|GVHD prophylaxis|gvhd prophylaxis
656614|NCT00803036|spreading cortical depression|spreading cortical depression
656615|NCT00803036|electroencephalography|electroencephalography
656616|NCT00803036|traumatic brain injury|traumatic brain injury
656617|NCT00803036|intensive care|intensive care
656618|NCT00803036|vascular hypotension|vascular hypotension
656619|NCT00803036|intracranial hypertension|intracranial hypertension
656620|NCT00803049|Multiple Sclerosis|multiple sclerosis
656621|NCT00803049|Oral treatment|oral treatment
656622|NCT00803101|Anticoagulant reversal|anticoagulant reversal
656623|NCT00803101|Prothrombin Complex Concentrate|prothrombin complex concentrate
656624|NCT00803101|Coagulopathy|coagulopathy
656625|NCT00803101|Coumarin derivatives|coumarin derivatives
656626|NCT00803101|Emergency surgery|emergency surgery
656627|NCT00803101|Invasive procedures|invasive procedures
656628|NCT00803101|Vitamin K|vitamin k
656723|NCT00803491|Rheumatic diseases|rheumatic diseases
656629|NCT00803101|Reversal of coagulopathy induced by coumarin derivatives|reversal of coagulopathy induced by coumarin derivatives
656630|NCT00803101|Kcentra|kcentra
656631|NCT00803114|Postpartum perineal pain|postpartum perineal pain
656632|NCT00803114|Epidural morphine|epidural morphine
656633|NCT00803114|Randomised clinical trial|randomised clinical trial
656634|NCT00803127|vaginal infection, color appearance|vaginal infection, color appearance
656635|NCT00803140|scarring|scarring
656636|NCT00803153|Panretinal photocoagulation|panretinal photocoagulation
656637|NCT00803153|Bruch rupture|bruch rupture
656638|NCT00803153|Choroidal detachment|choroidal detachment
656639|NCT00803153|complication rates|complication rates
656640|NCT00803166|Bioequivalence|bioequivalence
656641|NCT00803166|Halobetasol Propionate|halobetasol propionate
656642|NCT00803179|CF|cf
656643|NCT00803192|bioavailability|bioavailability
656644|NCT00803192|famotidine|famotidine
656645|NCT00803205|Cystic fibrosis|cystic fibrosis
656646|NCT00803205|Nonsense mutation|nonsense mutation
656647|NCT00803205|Premature stop codon|premature stop codon
656648|NCT00803205|PTC124|ptc124
656649|NCT00803205|Ataluren|ataluren
656650|NCT00803218|Bioequivalence|bioequivalence
656651|NCT00803218|Fluticasone Propionate|fluticasone propionate
656652|NCT00803244|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
656653|NCT00803257|Carpal Tunnel Syndrome|carpal tunnel syndrome
656654|NCT00803257|Splint|splint
656852|NCT00804076|enkephalin|enkephalin
656655|NCT00803257|Hand exercises|hand exercises
656656|NCT00803270|Stress urinary incontinence, Mixed, Urge|stress urinary incontinence, mixed, urge
656657|NCT00803283|Pain|pain
656658|NCT00803283|Hydromorphone hydrochloride OROS|hydromorphone hydrochloride oros
656659|NCT00803283|Morphine|morphine
656660|NCT00803309|Chronic HCV-genotype 2/3|chronic hcv-genotype 2/3
656661|NCT00803309|Efficacy of treatment extension|efficacy of treatment extension
656662|NCT00803309|PegIntron|pegintron
656663|NCT00803309|pegylated interferon alpha-2b|pegylated interferon alpha-2b
656664|NCT00803309|Rebetol|rebetol
656665|NCT00803309|ribavirin|ribavirin
656666|NCT00803322|TB|tb
656667|NCT00803322|community|community
656668|NCT00803322|community health workers|community health workers
656669|NCT00803322|Ethiopia|ethiopia
656670|NCT00803322|identify suspects of pulmonary tuberculosis|identify suspects of pulmonary tuberculosis
656671|NCT00803322|collect sputum specimen for examination|collect sputum specimen for examination
656768|NCT00803647|Eloxatin|eloxatin
656672|NCT00803322|treat smear positive cases in the community|treat smear positive cases in the community
656673|NCT00803335|pelvic organ prolapse|pelvic organ prolapse
656674|NCT00803335|vaginal atrophy|vaginal atrophy
656675|NCT00803335|atrophic vaginitis|atrophic vaginitis
656676|NCT00803335|postmenopausal|postmenopausal
656677|NCT00803335|posthysterectomy|posthysterectomy
656678|NCT00803335|vaginal health|vaginal health
656679|NCT00803335|vaginal cytology|vaginal cytology
656680|NCT00803335|vaginal maturity index|vaginal maturity index
656681|NCT00803335|vaginal histology|vaginal histology
656682|NCT00803335|quality of life questionnaires|quality of life questionnaires
656683|NCT00803348|continuous femoral nerve blockade|continuous femoral nerve blockade
656684|NCT00803348|knee arthroplasty|knee arthroplasty
656685|NCT00803348|knee replacement|knee replacement
656686|NCT00803348|regional anesthesia|regional anesthesia
656687|NCT00803348|readiness to discharge|readiness to discharge
656688|NCT00803348|Femoral nerve blockade for total knee arthroplasty|femoral nerve blockade for total knee arthroplasty
656689|NCT00803361|anxiety|anxiety
656690|NCT00803387|ocular dryness|ocular dryness
656691|NCT00803387|ocular irritation|ocular irritation
656692|NCT00803387|open-angle glaucoma|open-angle glaucoma
656693|NCT00803387|ocular hypertension|ocular hypertension
656694|NCT00803387|TravatanZ|travatanz
656695|NCT00803387|Xalatan|xalatan
656696|NCT00803400|Panic disorder|panic disorder
656697|NCT00803400|Exercise|exercise
656698|NCT00803400|Alprazolam|alprazolam
656699|NCT00803400|Aerobic|aerobic
656700|NCT00803413|Chronic low back pain|chronic low back pain
656701|NCT00803413|Back School|back school
656702|NCT00803413|Walking|walking
656703|NCT00803413|Physical activity|physical activity
656704|NCT00803426|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
656705|NCT00803426|nerve block|nerve block
656706|NCT00803426|popliteal fossa|popliteal fossa
656707|NCT00803426|sciatic nerve|sciatic nerve
656708|NCT00803426|common peroneal nerve|common peroneal nerve
656709|NCT00803426|tibial nerve|tibial nerve
656710|NCT00803426|onset time|onset time
656711|NCT00803426|ankle surgery|ankle surgery
656712|NCT00803426|foot surgery|foot surgery
656713|NCT00803439|Bioequivalence|bioequivalence
656714|NCT00803439|Clobetasol Propionate|clobetasol propionate
656715|NCT00803452|Meibomian gland dysfunction|meibomian gland dysfunction
656716|NCT00803452|Lid margin disease|lid margin disease
656717|NCT00803452|doxycycline|doxycycline
656718|NCT00803452|azithromycin|azithromycin
656719|NCT00803452|essential fatty acid|essential fatty acid
656720|NCT00803465|Bioequivalence|bioequivalence
656721|NCT00803465|Fluticasone Propionate|fluticasone propionate
656722|NCT00803478|IntraLase LASIK for primary myopia|intralase lasik for primary myopia
656724|NCT00803491|Problem based learning|problem based learning
656725|NCT00803491|Health-related quality of life|health-related quality of life
656726|NCT00803491|Empowerment|empowerment
656727|NCT00803491|Self-care|self-care
656728|NCT00803504|optic disc morphology|optic disc morphology
656729|NCT00803504|ocular blood flow|ocular blood flow
656730|NCT00803504|retina|retina
656731|NCT00803504|ocular physiology|ocular physiology
656732|NCT00803517|chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
656733|NCT00803517|multifocal electroretinogram|multifocal electroretinogram
656734|NCT00803517|central retinal function after treatment in chronic serous chorioretinopathy|central retinal function after treatment in chronic serous chorioretinopathy
656735|NCT00803530|myelodysplastic syndromes|myelodysplastic syndromes
656736|NCT00803530|arsenic trioxide|arsenic trioxide
656737|NCT00803530|ascorbic acid|ascorbic acid
656738|NCT00803543|HSV-2|hsv-2
656739|NCT00803543|Herpes Simplex|herpes simplex
656740|NCT00803543|HSV Type 2|hsv type 2
656741|NCT00803543|HIV|hiv
656742|NCT00803543|HIV/HSV|hiv/hsv
656743|NCT00803543|treatment experienced|treatment experienced
656744|NCT00803569|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
656745|NCT00803569|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
656746|NCT00803569|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
656853|NCT00804076|intradermal|intradermal
751805|NCT01170546|anterior cruciate ligament|anterior cruciate ligament
656747|NCT00803569|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
656748|NCT00803569|fallopian tube cancer|fallopian tube cancer
656749|NCT00803569|peritoneal cavity cancer|peritoneal cavity cancer
656750|NCT00803595|Influenza|influenza
656751|NCT00803595|Neuraminidase inhibitor|neuraminidase inhibitor
656752|NCT00803608|Plantar|plantar
656753|NCT00803608|Ulcer|ulcer
656754|NCT00803608|Diabetes|diabetes
656755|NCT00803634|Hypertension|hypertension
656756|NCT00803634|Antihypertensive Agent|antihypertensive agent
656757|NCT00803634|Calcium Channel Blocker|calcium channel blocker
656758|NCT00803647|NSABP|nsabp
656759|NCT00803647|Cetuximab|cetuximab
656760|NCT00803647|FOLFOX7|folfox7
656761|NCT00803647|Oxaliplatin|oxaliplatin
656762|NCT00803647|Leucovorin|leucovorin
656763|NCT00803647|5-FU|5-fu
656764|NCT00803647|colorectal cancer|colorectal cancer
656765|NCT00803647|KRAS wild type|kras wild type
656766|NCT00803647|metastatic colorectal cancer|metastatic colorectal cancer
656767|NCT00803647|Erbitux|erbitux
656769|NCT00803647|Liver resection|liver resection
656770|NCT00803647|Liver ablation|liver ablation
656771|NCT00803647|Metastasectomy|metastasectomy
656772|NCT00803660|hypertension|hypertension
656773|NCT00803660|BP|bp
656774|NCT00803660|diabetes|diabetes
656775|NCT00803660|anti-hypertensive treatment|anti-hypertensive treatment
656776|NCT00803660|ACE-I|ace-i
656777|NCT00803660|ARB|arb
656778|NCT00803673|Healthy volunteers|healthy volunteers
656779|NCT00803673|New formulation|new formulation
656780|NCT00803699|selenium|selenium
656781|NCT00803725|spinal anesthesia|spinal anesthesia
656782|NCT00803725|mepivacaine|mepivacaine
656783|NCT00803725|fentanyl|fentanyl
656784|NCT00803725|duration of anesthesia|duration of anesthesia
656785|NCT00803725|knee arthroscopy|knee arthroscopy
656786|NCT00803725|regional anesthesia|regional anesthesia
656787|NCT00803725|Spinal anesthesia for knee arthroscopy|spinal anesthesia for knee arthroscopy
656788|NCT00803738|Vulvovaginal Candidiasis|vulvovaginal candidiasis
656789|NCT00803738|Terconazole|terconazole
656790|NCT00803751|Laryngoscopy [E04.580.373]|laryngoscopy [e04.580.373]
656791|NCT00803764|bioequivalency|bioequivalency
656792|NCT00803764|naproxen|naproxen
656793|NCT00803803|Pilocarpine|pilocarpine
656794|NCT00803803|POAG|poag
656795|NCT00803803|IOP|iop
656796|NCT00803803|Concentration|concentration
656797|NCT00803803|Frequency|frequency
656798|NCT00803803|Primary open-angle glaucoma|primary open-angle glaucoma
656799|NCT00803803|Primary open-angle glaucoma suspect|primary open-angle glaucoma suspect
656800|NCT00803816|endogoneous|endogoneous
656801|NCT00803816|posterior|posterior
656802|NCT00803816|intermediate|intermediate
656803|NCT00803842|erlotinib|erlotinib
656804|NCT00803842|rash|rash
656805|NCT00803842|supportive care|supportive care
656806|NCT00803855|single dose|single dose
656807|NCT00803855|pharmacokinetics|pharmacokinetics
656808|NCT00803855|safety|safety
656809|NCT00803855|healthy volunteers|healthy volunteers
656810|NCT00803855|food interaction|food interaction
656811|NCT00803855|AZD1446|azd1446
656812|NCT00803894|Biomarkers of Notch inhibition|biomarkers of notch inhibition
656813|NCT00803907|immunomodulator|immunomodulator
656815|NCT00803920|exenatide twice daily or once weekly|exenatide twice daily or once weekly
656816|NCT00803920|continuous glucose monitoring|continuous glucose monitoring
656817|NCT00803933|first stage|first stage
656818|NCT00803933|Trypanosoma brucei gambiense|trypanosoma brucei gambiense
656819|NCT00803933|T. b. gambiense|t. b. gambiense
656820|NCT00803933|sleeping sickness|sleeping sickness
656821|NCT00803933|First stage T. b. gambiense sleeping sickness|first stage t. b. gambiense sleeping sickness
656822|NCT00803946|bioequivalency|bioequivalency
656823|NCT00803946|ibuprofen|ibuprofen
656824|NCT00803959|Stress urinary incontinence, Mixed, Urge|stress urinary incontinence, mixed, urge
656825|NCT00803972|Humalog|humalog
656826|NCT00803972|Humulin R|humulin r
656827|NCT00803972|rHuPH20|rhuph20
656828|NCT00803972|Hylenex|hylenex
656829|NCT00803985|Inguinal hernia|inguinal hernia
656830|NCT00803985|TEP|tep
656831|NCT00803985|Lichtenstein|lichtenstein
656832|NCT00803985|mesh|mesh
656833|NCT00803985|Randomized|randomized
656834|NCT00803985|Chronic pain|chronic pain
656835|NCT00803985|Sexual dysfunction|sexual dysfunction
656836|NCT00804011|Snakebite|snakebite
656837|NCT00804011|Weaning|weaning
656838|NCT00804011|Mechanical ventilation|mechanical ventilation
656839|NCT00804024|Heart Diseases. Vascular Diseases.|heart diseases. vascular diseases.
656840|NCT00804037|Snoring and Mild Apnea|snoring and mild apnea
656841|NCT00804050|Myelodysplastic Syndromes|myelodysplastic syndromes
656842|NCT00804050|Erythropoietin|erythropoietin
656843|NCT00804050|Acid 13-Cis-Retinoic|acid 13-cis-retinoic
656844|NCT00804050|Dihydroxyvitamin D3|dihydroxyvitamin d3
656845|NCT00804050|low or intermediate-1 IPSS|low or intermediate-1 ipss
656846|NCT00804050|MDS low risk|mds low risk
656847|NCT00804063|glaucoma|glaucoma
656848|NCT00804063|citrate|citrate
656849|NCT00804076|gene therapy|gene therapy
656850|NCT00804076|replication defective HSV vector|replication defective hsv vector
656851|NCT00804076|pain|pain
656854|NCT00804089|Low Back Pain, Chronic|low back pain, chronic
656855|NCT00804089|Acupuncture|acupuncture
656856|NCT00804089|Dry Needling|dry needling
656857|NCT00804089|Acupressure|acupressure
656858|NCT00804089|Acupuncture Points|acupuncture points
656859|NCT00804089|Trigger Points, Myofascial|trigger points, myofascial
656860|NCT00804102|Retinitis pigmentosa|retinitis pigmentosa
656861|NCT00804102|Macula off|macula off
656862|NCT00804102|Primary open angle Glaucoma|primary open angle glaucoma
656863|NCT00804102|Hereditary Macular Degeneration|hereditary macular degeneration
656864|NCT00804102|Treated Retina detachment|treated retina detachment
656865|NCT00804102|Retinal Artery Occlusion|retinal artery occlusion
656866|NCT00804102|Retinal Vein Occlusion,|retinal vein occlusion,
656867|NCT00804102|Non-Arthritic-Anterior-Ischemic Optic-Neuropathy|non-arthritic-anterior-ischemic optic-neuropathy
656868|NCT00804102|Hereditary autosomal dominant Optic atrophy|hereditary autosomal dominant optic atrophy
657157|NCT00805259|technology|technology
656869|NCT00804102|dry Age-related Macular Degeneration|dry age-related macular degeneration
656870|NCT00804102|Ischemic Macula edema|ischemic macula edema
656871|NCT00804115|Exfoliation Syndrome|exfoliation syndrome
656872|NCT00804115|Latanoprost|latanoprost
656873|NCT00804115|Timolol|timolol
656874|NCT00804115|Pilocarpine|pilocarpine
656875|NCT00804128|ductal breast carcinoma in situ|ductal breast carcinoma in situ
656876|NCT00804141|treatment for opioid-induced constipation|treatment for opioid-induced constipation
656877|NCT00804154|Pain|pain
656878|NCT00804154|Vanilloid|vanilloid
656879|NCT00804154|Capsaicin|capsaicin
656880|NCT00804154|Cancer Pain|cancer pain
656881|NCT00804154|Resiniferatoxin|resiniferatoxin
656882|NCT00804167|Hypertensive patients aged of 75 years and older|hypertensive patients aged of 75 years and older
656883|NCT00804167|renal damage|renal damage
656884|NCT00804167|Clinical characteristics of hypertensive patients aged of 75 years and older seen in general practitioner consultation according to their renal damage|clinical characteristics of hypertensive patients aged of 75 years and older seen in general practitioner consultation according to their renal damage
656885|NCT00804180|anxiety|anxiety
656886|NCT00804180|injection|injection
656887|NCT00804180|needle|needle
656888|NCT00804180|pediatric|pediatric
656889|NCT00804180|youth|youth
656890|NCT00804180|children|children
656891|NCT00804180|adolescents|adolescents
656892|NCT00804180|cognitive behavioral|cognitive behavioral
656893|NCT00804180|behavioral|behavioral
656894|NCT00804180|exposure|exposure
656895|NCT00804180|group|group
656896|NCT00804180|treatment|treatment
656897|NCT00804180|chronic illness|chronic illness
656898|NCT00804180|adherence|adherence
656899|NCT00804193|Tinea Pedis|tinea pedis
656900|NCT00804193|Ciclopirox Olamine|ciclopirox olamine
656901|NCT00804206|Intravitreal injection of Bevacizumab|intravitreal injection of bevacizumab
656902|NCT00804206|Visual acuity|visual acuity
656903|NCT00804206|central retinal thickness|central retinal thickness
656904|NCT00804206|color studies, Farnsworth-Munsell|color studies, farnsworth-munsell
656905|NCT00804206|electroretinogram studies|electroretinogram studies
656906|NCT00804219|low responsiveness after vaccination|low responsiveness after vaccination
656907|NCT00804232|Diabetes type1; children|diabetes type1; children
656908|NCT00804245|adenocarcinoma of the prostate|adenocarcinoma of the prostate
656909|NCT00804245|stage I prostate cancer|stage i prostate cancer
656910|NCT00804245|stage II prostate cancer|stage ii prostate cancer
752387|NCT01172769|HNSCC|hnscc
656911|NCT00804245|stage III prostate cancer|stage iii prostate cancer
656912|NCT00804245|stage IV prostate cancer|stage iv prostate cancer
656913|NCT00804258|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
656914|NCT00804258|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
657008|NCT00804674|pain|pain
656915|NCT00804258|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
656916|NCT00804258|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
656917|NCT00804258|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
656918|NCT00804258|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
656919|NCT00804258|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
656920|NCT00804258|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
656921|NCT00804258|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
656922|NCT00804258|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
656923|NCT00804284|DAPTACEL®|daptacel®
656924|NCT00804284|PENTACEL®|pentacel®
656925|NCT00804284|Diphtheria|diphtheria
656926|NCT00804284|Tetanus|tetanus
656927|NCT00804284|Pertussis|pertussis
656928|NCT00804284|Haemophilus influenzae type b|haemophilus influenzae type b
656929|NCT00804297|Hypoglycemia|hypoglycemia
656930|NCT00804297|Diabetes Mellitus|diabetes mellitus
656931|NCT00804297|Octreotide|octreotide
656932|NCT00804310|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
656933|NCT00804336|pasireotide|pasireotide
656934|NCT00804336|SOM230|som230
656935|NCT00804336|RAD001|rad001
656936|NCT00804349|Heart Decompensation|heart decompensation
656937|NCT00804349|Heart Failure, Congestive|heart failure, congestive
656938|NCT00804349|Heart Failure, Left-Sided|heart failure, left-sided
656939|NCT00804349|Heart Failure, Right-Sided|heart failure, right-sided
656940|NCT00804349|Apnea, Sleep|apnea, sleep
656941|NCT00804349|Sleep Apnea, Mixed Central and Obstructive|sleep apnea, mixed central and obstructive
656942|NCT00804349|Sleep Hypopnea|sleep hypopnea
656943|NCT00804349|Sleep-Disordered Breathing|sleep-disordered breathing
656944|NCT00804375|stump pain|stump pain
656945|NCT00804388|Vitamine E|vitamine e
656946|NCT00804388|E-poly|e-poly
656948|NCT00804388|Degenerative joint disease|degenerative joint disease
656949|NCT00804401|bioequivalency|bioequivalency
656950|NCT00804401|Naproxen|naproxen
656951|NCT00804414|Diabetes|diabetes
656952|NCT00804414|Diabetic ulcer|diabetic ulcer
656953|NCT00804414|Chronic ulcer|chronic ulcer
656954|NCT00804414|SBG|sbg
656955|NCT00804427|Fish oil|fish oil
656956|NCT00804427|Triglycerides|triglycerides
656957|NCT00804427|Low-density Lipoprotein (LDL) cholesterol|low-density lipoprotein (ldl) cholesterol
656958|NCT00804427|Low-density Lipoprotein (LDL) subclass|low-density lipoprotein (ldl) subclass
657055|NCT00804804|cognitives processes|cognitives processes
656961|NCT00804440|bioequivalency|bioequivalency
656962|NCT00804440|ibuprofen|ibuprofen
656963|NCT00804453|Chronic Kidney Failure|chronic kidney failure
656964|NCT00804453|Hemodialysis|hemodialysis
656965|NCT00804453|Biocompatibility|biocompatibility
656966|NCT00804466|Human Papillomavirus|human papillomavirus
656967|NCT00804466|Natural History|natural history
656968|NCT00804466|Cervical Cancer|cervical cancer
656969|NCT00804466|Screening|screening
656970|NCT00804492|To organize a multidisciplinary team for integrated falls prevention|to organize a multidisciplinary team for integrated falls prevention
656971|NCT00804492|To draft a guideline for falls prevention in the elderly|to draft a guideline for falls prevention in the elderly
656972|NCT00804492|To set up a multidisciplinary fall clinic|to set up a multidisciplinary fall clinic
656973|NCT00804492|To set up a falls prevention classroom|to set up a falls prevention classroom
656974|NCT00804492|To enhance cooperate between hospitals and primary care units for falls prevention|to enhance cooperate between hospitals and primary care units for falls prevention
656975|NCT00804505|Substantial equivalence to control device|substantial equivalence to control device
656976|NCT00804518|Aging|aging
656977|NCT00804518|Diastolic dysfunction|diastolic dysfunction
656978|NCT00804518|Systolic function|systolic function
656979|NCT00804518|Exercise|exercise
656980|NCT00804518|Echocardiography|echocardiography
656981|NCT00804518|tissue Doppler imaging|tissue doppler imaging
656982|NCT00804518|Cardiac function|cardiac function
656983|NCT00804531|Low back pain|low back pain
656984|NCT00804531|steroid injection|steroid injection
656985|NCT00804531|inter-vertebral disc|inter-vertebral disc
656986|NCT00804531|randomized trial|randomized trial
656987|NCT00804531|Lack of efficacy of usual recommended treatments|lack of efficacy of usual recommended treatments
656988|NCT00804531|More than 40 on the pain numeric scale (0-100)|more than 40 on the pain numeric scale (0-100)
656989|NCT00804531|Inflammatory discopathy (MODIC I) on MRI|inflammatory discopathy (modic i) on mri
656990|NCT00804544|Integrated SPECT/CT|integrated spect/ct
656991|NCT00804544|99mTc-sestMIBI|99mtc-sestmibi
656992|NCT00804544|Chemosensitivity|chemosensitivity
656993|NCT00804557|Male Urinary Disorders|male urinary disorders
656994|NCT00804557|Urinary catheterization|urinary catheterization
656995|NCT00804557|Urinary retention|urinary retention
656999|NCT00804622|HBeAg positive compensated chronic hepatitis B|hbeag positive compensated chronic hepatitis b
657000|NCT00804661|sleep|sleep
657001|NCT00804661|nocturnal hypoventilation|nocturnal hypoventilation
657002|NCT00804661|sleep quality|sleep quality
657003|NCT00804661|lung function|lung function
657004|NCT00804674|bupivacain|bupivacain
657005|NCT00804674|breast|breast
657006|NCT00804674|reconstruction|reconstruction
657007|NCT00804674|diep|diep
657009|NCT00804674|postoperative|postoperative
657010|NCT00804674|catheter|catheter
657011|NCT00804674|anesthesia|anesthesia
657012|NCT00804687|Allergy|allergy
657013|NCT00804687|Rhinitis|rhinitis
657014|NCT00804687|Allergic Rhinitis|allergic rhinitis
657015|NCT00804687|JNJ-39220675|jnj-39220675
657016|NCT00804687|Pseudoephedrine|pseudoephedrine
657017|NCT00804700|synchronous|synchronous
657018|NCT00804700|exercise|exercise
657019|NCT00804700|music|music
657020|NCT00804700|heartbeat|heartbeat
657021|NCT00804700|tunes|tunes
657022|NCT00804713|TB|tb
657023|NCT00804713|tuberculosis diagnosis|tuberculosis diagnosis
657024|NCT00804713|TB screening|tb screening
657025|NCT00804726|Cataract extraction|cataract extraction
657026|NCT00804726|Phacoemulsification|phacoemulsification
657027|NCT00804739|Major Depression|major depression
657028|NCT00804739|Postpartum Depression|postpartum depression
657029|NCT00804739|Perinatal Depression|perinatal depression
657030|NCT00804739|Treatment Feasibility|treatment feasibility
657031|NCT00804739|Treatment Engagement|treatment engagement
657032|NCT00804739|Treatment Adherence|treatment adherence
657033|NCT00804739|Postpartum|postpartum
657034|NCT00804739|Interpersonal Psychotherapy|interpersonal psychotherapy
657035|NCT00804739|IPT|ipt
657036|NCT00804739|Sertraline|sertraline
657037|NCT00804739|Zoloft|zoloft
657038|NCT00804752|Patients with Chronic Hepatitis C|patients with chronic hepatitis c
657039|NCT00804765|Prevention|prevention
657040|NCT00804765|child obesity|child obesity
657041|NCT00804765|pregnancy|pregnancy
657042|NCT00804765|overweight women|overweight women
657043|NCT00804765|obese women|obese women
657044|NCT00804778|CAD|cad
657045|NCT00804778|CABG|cabg
657046|NCT00804778|CO|co
657047|NCT00804778|CI|ci
657048|NCT00804778|thermodilution|thermodilution
657049|NCT00804778|USCOM|uscom
657050|NCT00804791|dry eye|dry eye
657051|NCT00804791|autofluorescence|autofluorescence
657052|NCT00804791|residence time|residence time
657053|NCT00804804|Sleep|sleep
657054|NCT00804804|aging|aging
657056|NCT00804804|constant routine|constant routine
657057|NCT00804817|self management|self management
657058|NCT00804817|adherence|adherence
657059|NCT00804817|activity enhancement|activity enhancement
657060|NCT00804817|oral mucositis prevention|oral mucositis prevention
657061|NCT00804817|and mal nutrition prevention|and mal nutrition prevention
657062|NCT00804817|cancer|cancer
657063|NCT00804817|hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
657064|NCT00804817|loss of activity|loss of activity
657065|NCT00804830|adjuvant|adjuvant
657066|NCT00804830|Anaplastic thyroid cancer|anaplastic thyroid cancer
657067|NCT00804882|Metabolic syndrome|metabolic syndrome
657068|NCT00804882|Heart failure|heart failure
657069|NCT00804882|Mexican Americans|mexican americans
657070|NCT00804882|Ethnic differences|ethnic differences
657071|NCT00804882|Echocardiography|echocardiography
657072|NCT00804895|cluster headache|cluster headache
657073|NCT00804895|greater occipital nerve block|greater occipital nerve block
657074|NCT00804895|cortivazol|cortivazol
657075|NCT00804908|Temozolomide|temozolomide
657076|NCT00804908|Skin cancer|skin cancer
657077|NCT00804908|Melanoma|melanoma
657078|NCT00804908|Metastatic Melanoma|metastatic melanoma
657079|NCT00804908|ABT-888|abt-888
657080|NCT00804908|MM|mm
657081|NCT00804921|bevacizumab|bevacizumab
657082|NCT00804921|intra-ocular pressure|intra-ocular pressure
657083|NCT00804921|acetazolamide|acetazolamide
657084|NCT00804921|anterior chamber paracentesis|anterior chamber paracentesis
657085|NCT00804921|brimonidine|brimonidine
657086|NCT00804921|macular edema secondary to diabetic retinopathy or macular degeneration|macular edema secondary to diabetic retinopathy or macular degeneration
657087|NCT00804947|Autologous transplantation|autologous transplantation
657088|NCT00804947|Multiple Myeloma|multiple myeloma
657089|NCT00804947|Intravenous Busulfan|intravenous busulfan
657090|NCT00804960|Cost of Infertility Treatment|cost of infertility treatment
657091|NCT00804960|Ovulation Induction|ovulation induction
657092|NCT00804960|Letrozole|letrozole
657093|NCT00804960|In Vitro Fertilization|in vitro fertilization
657094|NCT00804973|Migraine|migraine
657095|NCT00804973|Headache|headache
657096|NCT00804999|confocal microscopy|confocal microscopy
657097|NCT00804999|contact lens wear|contact lens wear
657098|NCT00804999|contact lens solutions|contact lens solutions
657099|NCT00804999|sodium fluorescein|sodium fluorescein
657100|NCT00805012|S-1|s-1
657101|NCT00805012|docetaxel|docetaxel
657102|NCT00805012|head and neck cancer|head and neck cancer
657103|NCT00805012|Recurrent or metastatic head and neck squamous cell carcinoma|recurrent or metastatic head and neck squamous cell carcinoma
657104|NCT00805051|Aortic stenosis|aortic stenosis
657105|NCT00805051|aortic valve replacement|aortic valve replacement
657106|NCT00805051|von Willebrand disease|von willebrand disease
657107|NCT00805051|blood loss|blood loss
657108|NCT00805077|interoperative care|interoperative care
657109|NCT00805077|Tidal volume|tidal volume
657110|NCT00805077|Postoperative complications|postoperative complications
657111|NCT00805077|Pneumonectomy|pneumonectomy
657112|NCT00805077|Lobectomy|lobectomy
657113|NCT00805077|Mechanical ventilation|mechanical ventilation
657114|NCT00805090|Renal|renal
657115|NCT00805090|Hepatic|hepatic
657116|NCT00805090|Healthy|healthy
657117|NCT00805103|Brain Metastases|brain metastases
657118|NCT00805103|Stereotactic radiosurgery (SRS)|stereotactic radiosurgery (srs)
657119|NCT00805103|Hypofractionated stereotactic radiotherapy (HSRT)|hypofractionated stereotactic radiotherapy (hsrt)
657120|NCT00805103|Recurrent Brain Metastases|recurrent brain metastases
657121|NCT00805129|URETER|ureter
657122|NCT00805129|URINARY BLADDER|urinary bladder
657123|NCT00805129|RAD001|rad001
657124|NCT00805129|Everolimus|everolimus
657125|NCT00805129|Urothelium|urothelium
657126|NCT00805129|08-123|08-123
657127|NCT00805142|Pain|pain
657128|NCT00805142|Cancer|cancer
657129|NCT00805142|Tapentadol|tapentadol
657130|NCT00805155|Bioequivalence|bioequivalence
657131|NCT00805155|Mometasone Furoate|mometasone furoate
657132|NCT00805168|Gram-negative Pneumonia|gram-negative pneumonia
657133|NCT00805168|Pneumonia|pneumonia
657134|NCT00805168|Intubation|intubation
657135|NCT00805168|Mechanical ventilation|mechanical ventilation
657136|NCT00805168|Amikacin|amikacin
657137|NCT00805207|PCOS|pcos
657138|NCT00805207|sleep apnea|sleep apnea
657139|NCT00805207|obese|obese
657140|NCT00805207|VLDL metabolism|vldl metabolism
657141|NCT00805207|isotope tracer|isotope tracer
657142|NCT00805207|women|women
657143|NCT00805220|frail elderly walking capacity walk training Nordic Walking|frail elderly walking capacity walk training nordic walking
657144|NCT00805233|Neovascular|neovascular
657145|NCT00805233|AMD|amd
657146|NCT00805233|Treatment|treatment
657147|NCT00805233|Lucentis|lucentis
657148|NCT00805233|Bromfenac|bromfenac
657149|NCT00805246|Pulmonary embolism|pulmonary embolism
657150|NCT00805246|PE|pe
657151|NCT00805246|CT|ct
657152|NCT00805246|Biomarker|biomarker
657153|NCT00805246|Prognosis|prognosis
657154|NCT00805246|Risk Prediction|risk prediction
657155|NCT00805259|cognitive function|cognitive function
657156|NCT00805259|elderly|elderly
657158|NCT00805259|financial incentives|financial incentives
657159|NCT00805259|General maintenance of cognitive function|general maintenance of cognitive function
657160|NCT00805272|HIV|hiv
657161|NCT00805272|tuberculosis|tuberculosis
657162|NCT00805272|IGRA|igra
657163|NCT00805272|diagnosis|diagnosis
657164|NCT00805272|treatment naive|treatment naive
657165|NCT00805285|Inflammatory Bowel Disease|inflammatory bowel disease
657166|NCT00805285|Ulcerative Colitis|ulcerative colitis
657167|NCT00805285|Budesonide|budesonide
657168|NCT00805285|Corticosteroids|corticosteroids
657169|NCT00805298|third molar|third molar
657170|NCT00805298|postoperative pain|postoperative pain
657171|NCT00805298|thermography|thermography
657172|NCT00805298|postoperative inflammation|postoperative inflammation
657173|NCT00805298|methylprednisolone|methylprednisolone
657174|NCT00805298|local anaesthetic|local anaesthetic
657175|NCT00805298|postoperative pain after removal of lower third molars|postoperative pain after removal of lower third molars
657176|NCT00805298|inflammation after removal of lower third molars|inflammation after removal of lower third molars
657177|NCT00805311|Internal Carotid Artery Stenosis|internal carotid artery stenosis
657178|NCT00805311|Carotid Endarterectomy|carotid endarterectomy
657179|NCT00805311|Stroke|stroke
657180|NCT00805311|Cerebrovascular|cerebrovascular
657181|NCT00805311|Atherosclerosis|atherosclerosis
657182|NCT00805337|Cancer amplitude-modulated electromagnetic fields|cancer amplitude-modulated electromagnetic fields
657183|NCT00805350|Insomnia|insomnia
657184|NCT00805350|Sleep Maintenance|sleep maintenance
657185|NCT00805350|Polysomnography|polysomnography
657186|NCT00805376|Brain|brain
657187|NCT00805376|Brain Cancer|brain cancer
657188|NCT00805376|Central Nervous System Diseases|central nervous system diseases
657189|NCT00805376|CNS|cns
657190|NCT00805376|Conditionally Replication-Competent Adenovirus|conditionally replication-competent adenovirus
657191|NCT00805376|Delta-24-RGD|delta-24-rgd
657192|NCT00805376|DNX-2401|dnx-2401
657193|NCT00805376|Recurrent Malignant Gliomas|recurrent malignant gliomas
657194|NCT00805376|malignant brain tumor|malignant brain tumor
657195|NCT00805389|Adjuvant Systems|adjuvant systems
657196|NCT00805389|Hepatitis B|hepatitis b
657197|NCT00805415|Oral Contraceptive|oral contraceptive
657198|NCT00805415|Ovulation Inhibition|ovulation inhibition
657199|NCT00805441|Alcoholic|alcoholic
657200|NCT00805454|Healthy Volunteers|healthy volunteers
657201|NCT00805454|Phase I|phase i
657202|NCT00805454|Pet Scan|pet scan
657203|NCT00805467|RA|ra
657204|NCT00805480|Plaque|plaque
657205|NCT00805480|psoriasis|psoriasis
657206|NCT00805480|inflammatory skin disease|inflammatory skin disease
657207|NCT00805480|skin condition, thickening|skin condition, thickening
657208|NCT00805480|flaking|flaking
657209|NCT00805480|scaly patches|scaly patches
657210|NCT00805480|skin disease|skin disease
657211|NCT00805493|Mania|mania
657212|NCT00805493|Bipolar|bipolar
657213|NCT00805493|Bipolar Disorder|bipolar disorder
657214|NCT00805493|Bipolar Manic-Depressive Illness|bipolar manic-depressive illness
657215|NCT00805493|Bipolar Mood Disorder|bipolar mood disorder
657216|NCT00805506|continuous glucose monitoring accuracy|continuous glucose monitoring accuracy
657217|NCT00805519|Osteoarthritis of the Knee|osteoarthritis of the knee
657218|NCT00805519|Glucosamine Chondroitin sulfate|glucosamine chondroitin sulfate
657219|NCT00805519|Prednisolone|prednisolone
657220|NCT00805519|Chloroquine|chloroquine
657221|NCT00805532|PTSD|ptsd
657222|NCT00805532|depression|depression
657223|NCT00805532|behavior therapy|behavior therapy
657224|NCT00805532|veterans|veterans
657225|NCT00805532|behavioral activation|behavioral activation
657226|NCT00805532|usual care|usual care
657227|NCT00805558|Chronic Periodontitis|chronic periodontitis
657228|NCT00805558|antibiotics|antibiotics
657229|NCT00805571|Rejection|rejection
657230|NCT00805571|Infection|infection
657231|NCT00805571|Side effect of immunosuppressive drug (nephrotoxicity)|side effect of immunosuppressive drug (nephrotoxicity)
657232|NCT00805597|breast cancer|breast cancer
657233|NCT00805597|mastectomy|mastectomy
657234|NCT00805597|one to three positive nodes|one to three positive nodes
657235|NCT00805597|radiotherapy|radiotherapy
657236|NCT00805610|Liver Failure|liver failure
657237|NCT00805610|Hepatocyte Transplantation|hepatocyte transplantation
657238|NCT00805610|Liver Transplantation|liver transplantation
657239|NCT00805623|sucrose|sucrose
657240|NCT00805623|sucking|sucking
657241|NCT00805623|pain relief|pain relief
657242|NCT00805623|infant|infant
659478|NCT00815256|CXL|cxl
657494|NCT00807612|AMG 479|amg 479
657243|NCT00805623|require venous puncture|require venous puncture
657244|NCT00805636|cell death|cell death
657245|NCT00805636|PET imaging|pet imaging
657246|NCT00805636|brain metastases|brain metastases
657247|NCT00805636|stereotactic radiosurgery|stereotactic radiosurgery
657248|NCT00799877|Chronic Plaque Psoriasis|chronic plaque psoriasis
657249|NCT00799877|Severe Chronic Plaque Psoriasis|severe chronic plaque psoriasis
657250|NCT00799877|Registry|registry
657251|NCT00799877|Psoriasis|psoriasis
657252|NCT00799877|Severe Psoriasis|severe psoriasis
657253|NCT00799877|Moderate Psoriasis|moderate psoriasis
657254|NCT00799890|primary or secondary chronic-progressive|primary or secondary chronic-progressive
657255|NCT00799890|sunphenon egcg|sunphenon egcg
657256|NCT00799890|brain atrophy|brain atrophy
657257|NCT00799890|T2 lesions|t2 lesions
657258|NCT00799903|heart disease|heart disease
657259|NCT00799903|Lp-PLA2 inhibitor|lp-pla2 inhibitor
657260|NCT00799903|cardiovascular disease|cardiovascular disease
657261|NCT00799903|coronary heart disease|coronary heart disease
657262|NCT00799903|CV risk|cv risk
657263|NCT00799903|Atherosclerosis|atherosclerosis
657264|NCT00799916|Sepsis|sepsis
657265|NCT00799916|Fluid resuscitation|fluid resuscitation
657266|NCT00799916|Voluven|voluven
657267|NCT00799916|Colloids|colloids
657268|NCT00799916|Saline solution|saline solution
657269|NCT00799916|Crystalloids|crystalloids
657270|NCT00799916|Sublingual microcirculation|sublingual microcirculation
657271|NCT00799929|IVF Research Study|ivf research study
657272|NCT00799929|Infertility Sudy|infertility sudy
657273|NCT00799929|in vitro fertilization|in vitro fertilization
657274|NCT00799929|Mini IVF|mini ivf
657275|NCT00799929|Conventional IVF|conventional ivf
657276|NCT00799942|Nystagmus, congenital idiopathic|nystagmus, congenital idiopathic
657277|NCT00799955|Cesarean delivery|cesarean delivery
657278|NCT00799955|post-operative analgesia|post-operative analgesia
657279|NCT00799955|TAP block|tap block
657280|NCT00799955|ultrasound|ultrasound
657281|NCT00799968|Thrombolytic therapy|thrombolytic therapy
657282|NCT00799968|Urokinase|urokinase
657283|NCT00799968|Efficacy|efficacy
657284|NCT00799968|Safety|safety
657285|NCT00799994|glaucoma|glaucoma
657286|NCT00799994|intraocular pressure|intraocular pressure
657287|NCT00799994|multifocal visually evoked potentials|multifocal visually evoked potentials
657288|NCT00800007|Hepatitis C, HCV, ANZ-521, Listeria|hepatitis c, hcv, anz-521, listeria
657289|NCT00800033|metabolic syndrome|metabolic syndrome
657290|NCT00800033|lipids|lipids
657291|NCT00800033|blood pressure|blood pressure
657292|NCT00800033|body composition|body composition
657293|NCT00800046|Mitral valve|mitral valve
657294|NCT00800046|Mitral regurgitation|mitral regurgitation
657295|NCT00800046|Functional mitral regurgitation|functional mitral regurgitation
657296|NCT00800046|MR|mr
657297|NCT00800046|FMR|fmr
657298|NCT00800046|Heart valve|heart valve
657299|NCT00800046|Mitral valve insufficiency|mitral valve insufficiency
657300|NCT00800046|Valve repair|valve repair
657301|NCT00800046|Valve disorder|valve disorder
657302|NCT00800046|Cardiac surgery|cardiac surgery
657303|NCT00800059|Relapse|relapse
657304|NCT00800059|Refractory|refractory
657305|NCT00800072|to verify accurrancy of data collected by the NOWOX|to verify accurrancy of data collected by the nowox
753146|NCT01175655|Bronchiolitis obliterans|bronchiolitis obliterans
657306|NCT00800085|first degree relatives of type 1 diabetes patients|first degree relatives of type 1 diabetes patients
657307|NCT00800085|hyperglycemic clamp test|hyperglycemic clamp test
657308|NCT00800111|failed penetrating keratoplasty|failed penetrating keratoplasty
657309|NCT00800124|hip fracture|hip fracture
657310|NCT00800124|hemiprosthesis|hemiprosthesis
657311|NCT00800124|bone cement|bone cement
657312|NCT00800124|clinical outcome|clinical outcome
657313|NCT00800137|coumadin|coumadin
657314|NCT00800137|device surgery|device surgery
657315|NCT00800137|pocket hematoma|pocket hematoma
657316|NCT00800137|Pocket hematoma and device surgery|pocket hematoma and device surgery
657317|NCT00800150|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
657318|NCT00800150|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
657319|NCT00800150|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
657320|NCT00800150|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
657321|NCT00800150|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
657322|NCT00800150|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
657323|NCT00800150|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
657324|NCT00800150|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
657325|NCT00800150|secondary acute myeloid leukemia|secondary acute myeloid leukemia
657326|NCT00800150|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
657327|NCT00800150|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
657328|NCT00800150|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
657329|NCT00800150|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
657330|NCT00800150|anaplastic large cell lymphoma|anaplastic large cell lymphoma
657495|NCT00807612|IGF-1R|igf-1r
657331|NCT00800150|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
657332|NCT00800150|splenic marginal zone lymphoma|splenic marginal zone lymphoma
657333|NCT00800150|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
657334|NCT00800150|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
657335|NCT00800150|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
657336|NCT00800150|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
657337|NCT00800150|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
657338|NCT00800150|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
657339|NCT00800150|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
657340|NCT00800150|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
657341|NCT00800150|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
657342|NCT00800150|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
657343|NCT00800150|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
657344|NCT00800150|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
657345|NCT00800150|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
657346|NCT00800150|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
657347|NCT00800150|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
657348|NCT00800150|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
657349|NCT00800150|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
657350|NCT00800150|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
657351|NCT00800150|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
657352|NCT00800150|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
657353|NCT00800150|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
657354|NCT00800150|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
657355|NCT00800150|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
657356|NCT00800150|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
657357|NCT00800150|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
657358|NCT00800150|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
657359|NCT00800150|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
657360|NCT00800150|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
657361|NCT00800150|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
657362|NCT00800150|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
657363|NCT00800150|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
657364|NCT00800150|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
657365|NCT00800150|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
657366|NCT00800150|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
657367|NCT00800150|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
657368|NCT00800150|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
657369|NCT00800150|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
657370|NCT00800150|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
657371|NCT00800150|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
657372|NCT00800150|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
657373|NCT00800150|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
657374|NCT00800150|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
657375|NCT00800150|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
657376|NCT00800150|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
657377|NCT00800150|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
657378|NCT00800150|intraocular lymphoma|intraocular lymphoma
657379|NCT00800150|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
657380|NCT00800150|primary myelofibrosis|primary myelofibrosis
657381|NCT00800150|stage II multiple myeloma|stage ii multiple myeloma
657382|NCT00800150|stage III multiple myeloma|stage iii multiple myeloma
657383|NCT00800150|refractory multiple myeloma|refractory multiple myeloma
657384|NCT00800150|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
657385|NCT00800150|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
657386|NCT00800150|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
657387|NCT00800150|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
657388|NCT00800150|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
657389|NCT00800150|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
657390|NCT00800215|Epilepsy|epilepsy
657391|NCT00800228|salt|salt
657392|NCT00800228|blood pressure|blood pressure
657393|NCT00800228|breathing|breathing
657394|NCT00800241|Asthma|asthma
657395|NCT00800241|Symbicort SMART|symbicort smart
657396|NCT00800241|Thai patient eligibility|thai patient eligibility
657397|NCT00800241|Persistent asthma|persistent asthma
657398|NCT00800254|electrical stimulation|electrical stimulation
657399|NCT00800254|total knee arthroplasty|total knee arthroplasty
657400|NCT00800254|quadriceps|quadriceps
657401|NCT00800254|muscle|muscle
657402|NCT00800254|arthroscopy|arthroscopy
657403|NCT00800267|glaucoma|glaucoma
657404|NCT00800267|ocular hypertension|ocular hypertension
657405|NCT00800267|Fixed combination latanoprost-timolol|fixed combination latanoprost-timolol
657406|NCT00800267|latanoprost|latanoprost
657407|NCT00800267|timolol|timolol
657408|NCT00800280|cimetidine, PD 0332334, organic cation transporter, OCT2, pharmacokinetics|cimetidine, pd 0332334, organic cation transporter, oct2, pharmacokinetics
657409|NCT00800293|bioequivalence|bioequivalence
657410|NCT00800293|betamethasone dipropionate|betamethasone dipropionate
657411|NCT00800293|Bioequivalency|bioequivalency
657412|NCT00800306|sepsis|sepsis
657413|NCT00800306|septic shock|septic shock
657414|NCT00800306|microcirculation|microcirculation
657415|NCT00800306|levosimendan|levosimendan
657416|NCT00800306|dobutamine|dobutamine
657417|NCT00800306|inotropes|inotropes
657418|NCT00800306|inhaled nitric oxide|inhaled nitric oxide
657419|NCT00800319|Alcohol dependence|alcohol dependence
657420|NCT00800319|Opioid antagonist|opioid antagonist
657421|NCT00800319|RDC-0313|rdc-0313
657422|NCT00805649|ARMD|armd
657423|NCT00805649|combined therapy|combined therapy
657424|NCT00805649|efficacy|efficacy
657425|NCT00805649|safety|safety
657426|NCT00805662|IUI|iui
657427|NCT00805662|oxytocin|oxytocin
657428|NCT00805675|Chronic HBV|chronic hbv
657429|NCT00805675|Asian adult subjects with chronic HBV, in immune tolerant phase, and positive for hepatitis B e antigen (HBeAg)|asian adult subjects with chronic hbv, in immune tolerant phase, and positive for hepatitis b e antigen (hbeag)
657430|NCT00805688|Questionnaire|questionnaire
657431|NCT00805688|Pancreas|pancreas
657432|NCT00805688|Pancreatic Cancer|pancreatic cancer
657433|NCT00805688|Metastatic Disease|metastatic disease
657434|NCT00805688|symptom outcomes|symptom outcomes
657435|NCT00805688|Biomarkers|biomarkers
657436|NCT00805688|Pedometer|pedometer
657437|NCT00805688|MDASI-GI symptom assessment|mdasi-gi symptom assessment
657438|NCT00805688|interactive voice response telephone system|interactive voice response telephone system
657439|NCT00805688|IVRS|ivrs
657440|NCT00805701|prostate|prostate
657441|NCT00805701|cancer|cancer
657442|NCT00805701|avodart|avodart
657443|NCT00805701|dutasteride|dutasteride
657444|NCT00805701|mitcheson|mitcheson
657445|NCT00805714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
657446|NCT00805740|Candidiasis; Invasive Candidiasis; Deep Tissue Candidiasis; Candida; Candidemia; Fungal Infection|candidiasis; invasive candidiasis; deep tissue candidiasis; candida; candidemia; fungal infection
657447|NCT00805766|Infliximab|infliximab
657448|NCT00805766|REMICADE|remicade
657449|NCT00805766|Crohn's disease|crohn's disease
657450|NCT00805779|Overactive Bladder|overactive bladder
657451|NCT00805779|Overactive Urinary Bladder|overactive urinary bladder
657452|NCT00805779|Bladder, Overactive|bladder, overactive
657453|NCT00805779|Overactive Detrusor|overactive detrusor
657454|NCT00805779|Detrusor, Overactive|detrusor, overactive
657455|NCT00805779|Overactive Detrusor Function|overactive detrusor function
657456|NCT00805779|Detrusor Function, Overactive|detrusor function, overactive
657457|NCT00805792|Ischemic stroke|ischemic stroke
657458|NCT00805792|treatment|treatment
657459|NCT00805792|recovery|recovery
657460|NCT00805792|donepezil|donepezil
657461|NCT00805792|Aricept|aricept
657462|NCT00805805|Copper|copper
657463|NCT00805805|ceruloplasmin|ceruloplasmin
657464|NCT00805805|tetrathiomolybdate|tetrathiomolybdate
657465|NCT00805831|sutureless vascular bypass|sutureless vascular bypass
657466|NCT00805844|Spine|spine
657467|NCT00805844|Motor Evoked Potentials|motor evoked potentials
657468|NCT00805883|Prostate Neoplasm|prostate neoplasm
657469|NCT00805883|Localized|localized
657470|NCT00805883|Photothermal|photothermal
657471|NCT00805883|Radical Prostatectomy|radical prostatectomy
657472|NCT00805935|pre-menopausal women|pre-menopausal women
657473|NCT00805935|PCOS|pcos
657474|NCT00805935|polycystic ovarian syndrome|polycystic ovarian syndrome
657475|NCT00805935|infertility|infertility
657476|NCT00805935|IVF|ivf
657477|NCT00805935|in vitro fertilization|in vitro fertilization
657478|NCT00805948|thoracic aneurysm|thoracic aneurysm
657479|NCT00805948|thoracic aortic aneurysms|thoracic aortic aneurysms
657480|NCT00805948|Thoracic Endovascular Aneurysm Repair (TEVAR)|thoracic endovascular aneurysm repair (tevar)
657481|NCT00805948|Talent Thoracic Stent Graft|talent thoracic stent graft
657482|NCT00805961|Glioblastoma Multiforme|glioblastoma multiforme
657483|NCT00805961|Radiation Therapy|radiation therapy
657484|NCT00805961|Temozolomide|temozolomide
657485|NCT00805961|Bevacizumab|bevacizumab
657486|NCT00805961|Everolimus|everolimus
657487|NCT00805974|diapasom|diapasom
657488|NCT00805974|sleep quality|sleep quality
657489|NCT00805974|type I diabete|type i diabete
657490|NCT00805974|blood pressure|blood pressure
657491|NCT00805974|plasma glucose|plasma glucose
751806|NCT01170546|agility|agility
657492|NCT00805974|daytime and nighttime variations|daytime and nighttime variations
657493|NCT00806000|Prevalence of Exercised induced asthma in athletes|prevalence of exercised induced asthma in athletes
657497|NCT00807612|Monoclonal Antibody|monoclonal antibody
657498|NCT00807612|Advanced Squamous Non-Small Cell Lung Cancer|advanced squamous non-small cell lung cancer
657499|NCT00807612|antibody 1st-line|antibody 1st-line
657500|NCT00807625|HIV/AIDS|hiv/aids
657501|NCT00807625|Contraception|contraception
657502|NCT00807625|Birth control|birth control
657503|NCT00807625|CD4+|cd4+
657504|NCT00807625|Viral Load|viral load
657505|NCT00807625|T-cell activation|t-cell activation
657506|NCT00807625|B-cell activation|b-cell activation
657507|NCT00807625|Hormonal|hormonal
658157|NCT00810108|Kaletra®|kaletra®
657508|NCT00807625|Intrauterine device|intrauterine device
657509|NCT00807625|Depo Provera|depo provera
657511|NCT00807625|IUCD|iucd
657512|NCT00807625|treatment naive|treatment naive
657513|NCT00807651|Diabetes Mellitus|diabetes mellitus
657514|NCT00807651|Stem cells|stem cells
657515|NCT00807651|Autologous stem cell transplantation|autologous stem cell transplantation
657516|NCT00807651|Autoimmune diseases|autoimmune diseases
657517|NCT00807677|Chronic myelogenous leukemia (CML) in chronic phase, accelerated phase, or blast crisis|chronic myelogenous leukemia (cml) in chronic phase, accelerated phase, or blast crisis
657518|NCT00807677|Intermediate or high risk myelodysplastic syndrome|intermediate or high risk myelodysplastic syndrome
657519|NCT00807677|Philadelphia chromosome-negative CML (including blast phase)|philadelphia chromosome-negative cml (including blast phase)
657520|NCT00807677|All subtypes of myeloid metaplasia with myelofibrosis; advanced polycythemia|all subtypes of myeloid metaplasia with myelofibrosis; advanced polycythemia
657521|NCT00807690|vitiligo|vitiligo
657522|NCT00807690|tacrolimus ointment 0.1%|tacrolimus ointment 0.1%
657523|NCT00807690|narrowband UVB (TL01)|narrowband uvb (tl01)
657524|NCT00807703|Parkinson|parkinson
657525|NCT00807703|deep brain stimulation (DBS)|deep brain stimulation (dbs)
657526|NCT00807703|subthalamic nucleus (STN)|subthalamic nucleus (stn)
657527|NCT00807703|Parkinson patients|parkinson patients
657528|NCT00807716|physiotherapy|physiotherapy
657529|NCT00807716|functional outcome|functional outcome
657530|NCT00807716|activity level|activity level
657531|NCT00807716|self efficacy|self efficacy
657532|NCT00807716|task oriented exercises|task oriented exercises
657533|NCT00807729|Laparoscopy|laparoscopy
657534|NCT00807729|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
657535|NCT00807729|Sphincterotomy|sphincterotomy
657536|NCT00807729|Common bile duct stones|common bile duct stones
657537|NCT00807729|Laparoscoopic common bile duct exploration|laparoscoopic common bile duct exploration
657538|NCT00807729|Cost efficiency|cost efficiency
657539|NCT00807729|Examination of efficacy, safety, cost of intervention for patients with choleclithiasis and likely common bile duct stones|examination of efficacy, safety, cost of intervention for patients with choleclithiasis and likely common bile duct stones
657540|NCT00807742|Contingency management for smoking for substance abusers|contingency management for smoking for substance abusers
657541|NCT00807742|Contingency reinforcement for smoking abstinence|contingency reinforcement for smoking abstinence
657542|NCT00807742|Contingency Management|contingency management
657543|NCT00807742|Noncontingent Reinforcement|noncontingent reinforcement
657544|NCT00807755|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
657545|NCT00807755|extensive stage small cell lung cancer|extensive stage small cell lung cancer
753147|NCT01175655|Lung transplant|lung transplant
657546|NCT00807755|recurrent small cell lung cancer|recurrent small cell lung cancer
657547|NCT00807807|Plasma Homocysteine Concentration|plasma homocysteine concentration
657548|NCT00807807|Folate|folate
657549|NCT00807807|Homocysteine|homocysteine
657550|NCT00807807|Supplements|supplements
657551|NCT00807807|Folic Acid|folic acid
657552|NCT00807820|Prostate Cancer|prostate cancer
657553|NCT00807833|SAH|sah
657554|NCT00807833|TBI|tbi
657555|NCT00807846|Juvenile Arthritis; Juvenile Rheumatoid Arthritis;Blood Pressure;Juvenile Idiopathic Arthritis|juvenile arthritis; juvenile rheumatoid arthritis;blood pressure;juvenile idiopathic arthritis
657556|NCT00807859|AMG 386|amg 386
657557|NCT00807859|Paclitaxel|paclitaxel
657558|NCT00807859|Trastuzumab|trastuzumab
657559|NCT00807859|Capecitabine|capecitabine
657560|NCT00807859|Lapatinib|lapatinib
657561|NCT00807859|HER2-positive|her2-positive
657562|NCT00807859|metastatic breast cancer|metastatic breast cancer
657563|NCT00807859|locally recurrent breast cancer|locally recurrent breast cancer
657564|NCT00807859|Taxol|taxol
657565|NCT00807859|Herceptin|herceptin
657566|NCT00807859|Xeloda|xeloda
657567|NCT00807859|Tykerb|tykerb
657568|NCT00807859|anti-angiogenic therapy|anti-angiogenic therapy
657569|NCT00807872|Radioimmunoimaging|radioimmunoimaging
657570|NCT00807872|AL Amyloidosis|al amyloidosis
657571|NCT00807872|PET/CT|pet/ct
657572|NCT00807885|dehydration|dehydration
657573|NCT00807885|fluid therapy|fluid therapy
657574|NCT00807885|hyaluronoglucosaminidase|hyaluronoglucosaminidase
657575|NCT00807885|hyaluronidase|hyaluronidase
657576|NCT00807885|hypodermoclysis|hypodermoclysis
657577|NCT00807885|clysis|clysis
657578|NCT00807885|subcutaneous hydration|subcutaneous hydration
657579|NCT00807885|subcutaneous rehydration|subcutaneous rehydration
657580|NCT00807885|hyaluronan|hyaluronan
657581|NCT00807885|rHuPH20|rhuph20
657582|NCT00807898|Gardasil|gardasil
657583|NCT00807898|HPV vaccine|hpv vaccine
657584|NCT00807898|decision making|decision making
657587|NCT00807911|rectal cancer|rectal cancer
657588|NCT00807911|adjuvant chemotherapy|adjuvant chemotherapy
657589|NCT00807911|FOLFOX|folfox
657590|NCT00807924|Fibroadenomas|fibroadenomas
657591|NCT00807924|Papillomas|papillomas
657592|NCT00807924|Breast|breast
657593|NCT00807924|Minimally invasive|minimally invasive
657594|NCT00807924|Interstitial laser therapy|interstitial laser therapy
657595|NCT00807924|Laser ablation|laser ablation
657596|NCT00807924|Benign|benign
657597|NCT00807924|Non-cancerous|non-cancerous
657598|NCT00807924|Breast lesion|breast lesion
657599|NCT00807924|Breast tumor|breast tumor
657600|NCT00807937|Generalized Anxiety Disorder|generalized anxiety disorder
657602|NCT00807937|Anxiety|anxiety
657603|NCT00807963|Pharmacokinetics|pharmacokinetics
657604|NCT00807963|rHuPH20|rhuph20
657605|NCT00807976|Diabetes mellitus|diabetes mellitus
657606|NCT00807976|Elderly|elderly
657607|NCT00807976|Orthostatic hypotension|orthostatic hypotension
657608|NCT00808002|Maraviroc|maraviroc
657609|NCT00808002|CCR5 antagonists|ccr5 antagonists
657610|NCT00808002|Primary HIV Infection|primary hiv infection
657611|NCT00808002|HIV-1 reservoir|hiv-1 reservoir
657612|NCT00808002|eradication|eradication
657613|NCT00808002|treatment naive|treatment naive
657614|NCT00808015|Observational non-interventional trial|observational non-interventional trial
657615|NCT00808041|Neoadjuvant Treatment|neoadjuvant treatment
657616|NCT00808041|Therapy Response|therapy response
657617|NCT00808041|Breast Computed Tomography|breast computed tomography
657618|NCT00808054|Pain|pain
657619|NCT00808054|preterm neonate|preterm neonate
657620|NCT00808054|pain assessment|pain assessment
657621|NCT00808054|EMLA|emla
657622|NCT00808054|oral glucose|oral glucose
657624|NCT00808093|Food Effect|food effect
657625|NCT00808093|GSK256073F|gsk256073f
657626|NCT00808093|TRIS Salt|tris salt
657627|NCT00808106|Albinism|albinism
657628|NCT00808106|Oculocutaneous Albinism|oculocutaneous albinism
657629|NCT00808106|Pigmentation|pigmentation
657630|NCT00808106|Natural History|natural history
657631|NCT00808106|Vesical Biology|vesical biology
657632|NCT00808132|Postmenopausal Women|postmenopausal women
657633|NCT00808132|Bazedoxifene/Conjugated Estrogens|bazedoxifene/conjugated estrogens
657634|NCT00808145|Treatment of advanced liver cancer|treatment of advanced liver cancer
657635|NCT00808171|lumbar punction|lumbar punction
657636|NCT00808171|myelogram|myelogram
657637|NCT00808171|pain assessment|pain assessment
657638|NCT00808171|nitrous oxide and EMLA|nitrous oxide and emla
657639|NCT00808171|Leukemia and non Hodgkin lymphoma|leukemia and non hodgkin lymphoma
657640|NCT00808184|Histologically or cytologically proven solid tumour for which CPT-11 given by the Folfiri regimen|histologically or cytologically proven solid tumour for which cpt-11 given by the folfiri regimen
657641|NCT00808197|AMD|amd
657642|NCT00808197|choroidal blood flow|choroidal blood flow
657643|NCT00808197|fellow eye in patients with unilateral choroidal neovascularisation|fellow eye in patients with unilateral choroidal neovascularisation
657644|NCT00808210|RA|ra
657645|NCT00808210|Arthritis|arthritis
657646|NCT00808223|alefacept|alefacept
657647|NCT00808223|adolescent|adolescent
657648|NCT00808223|psoriasis|psoriasis
657649|NCT00808236|Cardiac Arrest|cardiac arrest
657650|NCT00808236|Pre-hospital|pre-hospital
657651|NCT00808236|Mild hypothermia|mild hypothermia
657652|NCT00808236|Resuscitation|resuscitation
657653|NCT00808249|Generalized Anxiety Disorder|generalized anxiety disorder
657655|NCT00808249|Anxiety|anxiety
657656|NCT00808262|anti-TNFa|anti-tnfa
657657|NCT00808262|immunization|immunization
657658|NCT00808262|kinoid|kinoid
657659|NCT00808262|crohn's disease|crohn's disease
657660|NCT00808275|dietary calcium|dietary calcium
657661|NCT00808275|weight loss|weight loss
657662|NCT00808288|COPD Respiratory Long acting beta agonist|copd respiratory long acting beta agonist
657663|NCT00808301|Coeliac disease|coeliac disease
657664|NCT00808301|Oat|oat
657665|NCT00808314|Lexiscan(TM)|lexiscan(tm)
657666|NCT00808314|Dipyridamole|dipyridamole
657667|NCT00808314|Myocardial Perfusion|myocardial perfusion
657668|NCT00808314|Positron Emission Computed Tomography|positron emission computed tomography
657669|NCT00808327|Cesarean section|cesarean section
657670|NCT00808327|Spinal|spinal
657671|NCT00808353|CVD|cvd
657672|NCT00808379|Unresectable rectal cancers|unresectable rectal cancers
657673|NCT00808392|vaccine|vaccine
657674|NCT00808392|prevention|prevention
657675|NCT00808392|haemophilus influenzae type b|haemophilus influenzae type b
657676|NCT00808392|children|children
657677|NCT00808405|herpes simplex virus|herpes simplex virus
657678|NCT00808405|acyclovir|acyclovir
657679|NCT00808405|HSV shedding|hsv shedding
657680|NCT00808405|women|women
657681|NCT00808405|Africa|africa
657682|NCT00808418|prostate|prostate
657683|NCT00808418|cancer|cancer
657684|NCT00808418|metastatic|metastatic
657685|NCT00808418|castration|castration
657686|NCT00808418|refractory|refractory
657687|NCT00808418|elesclomol|elesclomol
657688|NCT00808418|sodium|sodium
657689|NCT00808418|docetaxel|docetaxel
657690|NCT00808418|prednisone|prednisone
657693|NCT00808431|Physical Activity|physical activity
657694|NCT00808431|Child Feeding|child feeding
657695|NCT00808431|Growth Trajectories|growth trajectories
657696|NCT00808431|Family based|family based
657697|NCT00808444|Pneumococcal vaccine|pneumococcal vaccine
657698|NCT00808444|Immunogenicity|immunogenicity
657699|NCT00808444|Primary vaccination|primary vaccination
657701|NCT00808444|Pneumococcal disease|pneumococcal disease
657702|NCT00808457|chest ultrasound|chest ultrasound
657703|NCT00808457|pneumonia|pneumonia
657704|NCT00808457|X-ray|x-ray
657705|NCT00808457|CT|ct
657706|NCT00808457|Sensitivity and specificity of chest ultrasound in diagnosing pneumonia|sensitivity and specificity of chest ultrasound in diagnosing pneumonia
657707|NCT00808470|Noise|noise
657708|NCT00808470|Hearing Loss|hearing loss
657709|NCT00808470|Tinnitus|tinnitus
657710|NCT00808470|Antioxidant|antioxidant
657711|NCT00808470|Vasodilator|vasodilator
657712|NCT00808470|Beta-Carotene|beta-carotene
657713|NCT00808470|Vitamin C|vitamin c
657714|NCT00808470|Vitamin E|vitamin e
657715|NCT00808470|Magnesium|magnesium
657716|NCT00808483|total hip arthroplasty|total hip arthroplasty
657717|NCT00808483|physical functioning|physical functioning
657718|NCT00808483|training program|training program
657719|NCT00808483|self-efficacy|self-efficacy
657720|NCT00808483|exercise therapy|exercise therapy
657721|NCT00808483|walking|walking
657722|NCT00808496|Magnetic resonance imaging|magnetic resonance imaging
657723|NCT00808496|Radiography|radiography
657724|NCT00808496|Randomized controlled trial|randomized controlled trial
657725|NCT00808496|Antirheumatic agents|antirheumatic agents
657726|NCT00808509|adalimumab,Remission,drug discontinuation|adalimumab,remission,drug discontinuation
657727|NCT00808522|Breast Cancer|breast cancer
657728|NCT00808522|Chemoprevention|chemoprevention
657729|NCT00808522|Tamoxifen|tamoxifen
657730|NCT00808522|Breast density|breast density
657731|NCT00808522|Hcg|hcg
657732|NCT00808535|Endothelial dysfunction|endothelial dysfunction
657733|NCT00808535|Cardiac Perfusion MRI|cardiac perfusion mri
657734|NCT00808535|Vasomotor Stress|vasomotor stress
657735|NCT00808535|Cold Pressor Test|cold pressor test
657736|NCT00808535|Adenosine Stress|adenosine stress
657737|NCT00808548|stress|stress
657738|NCT00808548|carer's experiences|carer's experiences
657739|NCT00808548|Prader-willi syndrome|prader-willi syndrome
657740|NCT00808548|personal experiences|personal experiences
657741|NCT00808574|Obstructive sleep apnea|obstructive sleep apnea
657742|NCT00808574|Internet|internet
657743|NCT00808574|Screening|screening
657744|NCT00808574|Health belief model|health belief model
657745|NCT00808587|Genomic Scan|genomic scan
657746|NCT00808587|Personalized Medicine|personalized medicine
657747|NCT00808587|Gene testing|gene testing
657748|NCT00808600|lung transplantation|lung transplantation
657749|NCT00808600|heart-lung transplantation|heart-lung transplantation
657750|NCT00808600|rehabilitation|rehabilitation
657751|NCT00808600|resource-activating training|resource-activating training
657752|NCT00808600|anaerobic exercise training|anaerobic exercise training
657753|NCT00808639|pegfilgrastim|pegfilgrastim
657754|NCT00808639|MVAC|mvac
657755|NCT00808665|Lumbar Fusion|lumbar fusion
657756|NCT00808665|Inflammation|inflammation
657757|NCT00808665|Dexmedetomidine|dexmedetomidine
657758|NCT00808665|Length of Hospital Stay|length of hospital stay
657759|NCT00808665|General Anesthesia|general anesthesia
657760|NCT00808665|Anti-inflammatory|anti-inflammatory
657761|NCT00808665|GPCR|gpcr
657762|NCT00808665|Cytokine|cytokine
657763|NCT00808665|Immune Response|immune response
657764|NCT00808678|Adverse Events|adverse events
657765|NCT00808704|asphyxia|asphyxia
657766|NCT00808704|erythropoietin|erythropoietin
657767|NCT00808704|neonates|neonates
657768|NCT00808717|Myocardial Infarction|myocardial infarction
657769|NCT00808717|Coronary Angioplasty|coronary angioplasty
657770|NCT00808717|Myocardial infarction, Angioplasty, Transluminal, Percutaneous Coronary|myocardial infarction, angioplasty, transluminal, percutaneous coronary
657771|NCT00808730|Asthma, airway remodelling, smooth muscle, mitochondria|asthma, airway remodelling, smooth muscle, mitochondria
657772|NCT00808743|Familial adenomatous polyposis|familial adenomatous polyposis
657773|NCT00808743|Adenomatous Polyposis Coli|adenomatous polyposis coli
657774|NCT00808743|Digestive System Neoplasms|digestive system neoplasms
657775|NCT00808743|Gastrointestinal Disease|gastrointestinal disease
657776|NCT00808743|Intestinal disease|intestinal disease
657777|NCT00808743|Intestinal neoplasms|intestinal neoplasms
657778|NCT00808743|Gastrointestinal neoplasms|gastrointestinal neoplasms
657779|NCT00808743|Polyps|polyps
657780|NCT00808743|Adenoma|adenoma
657781|NCT00808743|Adenomatous Polyps|adenomatous polyps
657782|NCT00808743|Neoplastic Syndromes, Hereditary|neoplastic syndromes, hereditary
657783|NCT00808743|Digestive System Diseases|digestive system diseases
657784|NCT00808743|Genetic Diseases, Inborn|genetic diseases, inborn
657785|NCT00808743|Chemoprevention|chemoprevention
657786|NCT00808743|Celecoxib|celecoxib
657787|NCT00808743|Ursodeoxycholic acid|ursodeoxycholic acid
657788|NCT00808743|Anti-Inflammatory agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
657789|NCT00808743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
657790|NCT00808756|Carbohydrates|carbohydrates
657791|NCT00808756|Infant|infant
657792|NCT00808756|Intestine|intestine
657793|NCT00808756|Faeces|faeces
657794|NCT00808756|Growth|growth
657795|NCT00808756|Diet|diet
657796|NCT00808782|Pervasive Developmental Disorders|pervasive developmental disorders
658446|NCT00812578|Pulsatility|pulsatility
657797|NCT00808782|Asperger Syndrome|asperger syndrome
657798|NCT00808782|Autism|autism
657799|NCT00808795|Acute kidney injury|acute kidney injury
657800|NCT00808795|contrast-induced nephropathy|contrast-induced nephropathy
657801|NCT00808795|Chronic kidney disease|chronic kidney disease
657802|NCT00808795|Diabetes mellitus|diabetes mellitus
657803|NCT00808795|N-acetylcysteine|n-acetylcysteine
657804|NCT00808808|FluMist, TIV, vaccination rates|flumist, tiv, vaccination rates
657805|NCT00808860|Herbal medicine|herbal medicine
657806|NCT00808860|Type 2 diabetes|type 2 diabetes
657807|NCT00808860|Gynostemma pentaphyllum Tea|gynostemma pentaphyllum tea
657808|NCT00808860|Insulin sensitivity|insulin sensitivity
657809|NCT00808860|add-on|add-on
657810|NCT00808873|attempted suicide|attempted suicide
657811|NCT00808873|socio-educational intervention|socio-educational intervention
657812|NCT00808873|follow up study|follow up study
657813|NCT00808886|cataract|cataract
657814|NCT00808886|locs3|locs3
657815|NCT00808886|pentacam|pentacam
657816|NCT00808899|Neuroblastoma|neuroblastoma
657817|NCT00808912|phosphodiesterase|phosphodiesterase
657818|NCT00808912|sildenafil|sildenafil
657819|NCT00808912|pulmonary hypertension|pulmonary hypertension
657820|NCT00808912|exercise performance|exercise performance
657821|NCT00808912|air pollution|air pollution
657822|NCT00808925|acclimation|acclimation
657823|NCT00808925|heat|heat
657824|NCT00808925|cytokines|cytokines
657825|NCT00808925|stress|stress
657826|NCT00808925|inflammation|inflammation
657827|NCT00808951|Uncomplicated malaria|uncomplicated malaria
657828|NCT00808951|P falciparum|p falciparum
657829|NCT00808951|Children|children
657830|NCT00808951|National treatment protocol|national treatment protocol
657831|NCT00808951|Burkina Faso|burkina faso
657832|NCT00808951|Artemether-lumefantrine|artemether-lumefantrine
657833|NCT00808951|Artesunate-amodiaquine|artesunate-amodiaquine
657834|NCT00808951|In vivo efficacy|in vivo efficacy
657835|NCT00808951|In vitro efficacy|in vitro efficacy
657836|NCT00808964|CABG|cabg
657837|NCT00808964|anticoagulant|anticoagulant
657838|NCT00808964|Off-Pump CABG|off-pump cabg
657839|NCT00808990|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
657840|NCT00808990|Non Alcoholic SteatoHepatitis|non alcoholic steatohepatitis
657841|NCT00808990|Small bowel bacterial overgrowth|small bowel bacterial overgrowth
657842|NCT00808990|Probiotics|probiotics
657843|NCT00808990|Patients with Non Alcoholic Fatty Liver Disease|patients with non alcoholic fatty liver disease
657844|NCT00809003|Non dry eyed(normals)|non dry eyed(normals)
657845|NCT00809016|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
657846|NCT00809016|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
657847|NCT00809016|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
753148|NCT01175681|rheumatic heart disease|rheumatic heart disease
657848|NCT00809016|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
657849|NCT00809016|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
657850|NCT00809016|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
658017|NCT00809471|Dysfunction|dysfunction
657851|NCT00809016|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
657852|NCT00809016|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
657853|NCT00809016|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
657854|NCT00809016|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
657855|NCT00809016|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
657856|NCT00809016|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
657857|NCT00809016|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
657858|NCT00809016|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
657859|NCT00809016|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
657860|NCT00809016|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
657861|NCT00809016|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
657862|NCT00809016|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
657863|NCT00809016|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
657864|NCT00809016|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
657865|NCT00809016|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
657866|NCT00809016|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
657867|NCT00809016|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
657868|NCT00809016|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
657869|NCT00809016|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
657870|NCT00809016|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
657871|NCT00809016|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
659511|NCT00815438|NOTES|notes
657872|NCT00809016|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
657873|NCT00809016|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
657874|NCT00809016|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
657875|NCT00809016|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
657876|NCT00809016|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
657877|NCT00809016|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
657878|NCT00809016|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
657879|NCT00809016|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
657880|NCT00809016|recurrent salivary gland cancer|recurrent salivary gland cancer
657881|NCT00809016|salivary gland acinic cell tumor|salivary gland acinic cell tumor
657882|NCT00809016|salivary gland adenocarcinoma|salivary gland adenocarcinoma
657883|NCT00809016|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
657884|NCT00809016|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
657885|NCT00809016|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
657886|NCT00809016|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
657887|NCT00809016|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
657888|NCT00809016|stage III salivary gland cancer|stage iii salivary gland cancer
657889|NCT00809016|stage IV salivary gland cancer|stage iv salivary gland cancer
657890|NCT00809029|GIP|gip
657891|NCT00809029|OBESITY|obesity
657892|NCT00809029|HSL|hsl
657893|NCT00809029|LPL|lpl
657894|NCT00809029|ADIPOCYTOKINES|adipocytokines
657895|NCT00809029|BARIATRIC SURGERY|bariatric surgery
657896|NCT00809042|Hydroxyurea|hydroxyurea
657897|NCT00809042|magnesium chloride|magnesium chloride
657898|NCT00809042|L-carnitine|l-carnitine
657899|NCT00809042|β-thalassemia intermedia|β-thalassemia intermedia
657900|NCT00809068|Menopause|menopause
657901|NCT00809068|menopausal symptoms|menopausal symptoms
657902|NCT00809068|tibolone|tibolone
657903|NCT00809068|HDL-C|hdl-c
657904|NCT00809068|fenofibrate|fenofibrate
657905|NCT00809081|periampullar carcinoma|periampullar carcinoma
657906|NCT00809081|Pancreaticoduodenectomy|pancreaticoduodenectomy
657907|NCT00809081|Enteral feeding|enteral feeding
657908|NCT00809081|Total Parenteral Support|total parenteral support
657909|NCT00809107|natural cycle|natural cycle
657910|NCT00809107|FET|fet
657911|NCT00809107|spontaneous LH pic|spontaneous lh pic
657912|NCT00809107|HCG|hcg
657913|NCT00809120|Electrostimulation|electrostimulation
657914|NCT00809120|COPD|copd
657915|NCT00809120|Tolerance|tolerance
657916|NCT00809120|Muscle fatigue|muscle fatigue
657917|NCT00809120|Cardio-respiratory response|cardio-respiratory response
657918|NCT00809146|Status Epilepticus|status epilepticus
657919|NCT00809146|Emergency Medical Services|emergency medical services
657920|NCT00809146|Anticonvulsants|anticonvulsants
657921|NCT00809146|Drug Administration Routes|drug administration routes
657922|NCT00809146|Seizures|seizures
657923|NCT00809159|ankylosing spondylitis|ankylosing spondylitis
657924|NCT00809172|Atopic-dermatitis|atopic-dermatitis
657925|NCT00809172|scorad|scorad
657926|NCT00809172|methotrexate|methotrexate
657927|NCT00809172|ciclosporin|ciclosporin
657928|NCT00809185|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
657929|NCT00809185|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
657930|NCT00809185|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
657931|NCT00809198|Sodium Hyaluronate, Kynex, Carboxymethylcellulose sodium|sodium hyaluronate, kynex, carboxymethylcellulose sodium
657932|NCT00809198|Refresh Plus|refresh plus
657933|NCT00809198|Dry Eye|dry eye
657934|NCT00809198|Cornea Staining|cornea staining
657935|NCT00809198|TBUT|tbut
657936|NCT00809211|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
657937|NCT00809211|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
657938|NCT00809224|ALS|als
657939|NCT00809224|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
657940|NCT00809224|brain-computer interface|brain-computer interface
657941|NCT00809224|functional magnetic resonance imaging|functional magnetic resonance imaging
657942|NCT00809224|radiology|radiology
657943|NCT00809224|fMRI|fmri
657944|NCT00809237|Non-small cell lung cancer|non-small cell lung cancer
657945|NCT00809237|Gefitinib|gefitinib
657946|NCT00809237|Hydroxychloroquine|hydroxychloroquine
657947|NCT00809250|vaccination|vaccination
657948|NCT00809250|AML|aml
657949|NCT00809250|CMML|cmml
657950|NCT00809250|MDS-RAEB|mds-raeb
657951|NCT00809263|homeopathy|homeopathy
657952|NCT00809263|homeopathic drug proving|homeopathic drug proving
658343|NCT00812097|Siltex®|siltex®
657953|NCT00809263|Document symptoms associated with administration of a homeopathic remedy.|document symptoms associated with administration of a homeopathic remedy.
657954|NCT00809276|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
657955|NCT00809276|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
657956|NCT00809276|Acute Leukemia|acute leukemia
657957|NCT00809276|Refractory or Relapsed AML|refractory or relapsed aml
659512|NCT00815438|Endoscopic|endoscopic
657958|NCT00809276|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
657959|NCT00809276|Chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
657960|NCT00809276|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
657961|NCT00809276|Hodgkin's Lymphoma|hodgkin's lymphoma
657962|NCT00809276|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
657963|NCT00809276|Philadelphia-negative myeloproliferative disorder|philadelphia-negative myeloproliferative disorder
657964|NCT00809276|Hematologic Malignancies|hematologic malignancies
657965|NCT00809276|Transplantation|transplantation
657966|NCT00809276|Busulfan|busulfan
657967|NCT00809276|Fludarabine|fludarabine
657968|NCT00809276|Cytoxan|cytoxan
657969|NCT00809276|Bone Marrow|bone marrow
657970|NCT00809276|Allogeneic|allogeneic
657971|NCT00809276|Related donor|related donor
657972|NCT00809276|unrelated donor|unrelated donor
657973|NCT00809289|Thorough QT/QTc study|thorough qt/qtc study
657974|NCT00809315|Child abuse and neglect|child abuse and neglect
657975|NCT00809315|Out-of-home care|out-of-home care
657976|NCT00809315|Mentoring|mentoring
657977|NCT00809315|Skills groups|skills groups
657978|NCT00809315|Assessment|assessment
657979|NCT00809315|Functioning as a result of maltreatment and placement in out-of-home care|functioning as a result of maltreatment and placement in out-of-home care
657980|NCT00809341|B-Cell|b-cell
657981|NCT00809341|non-Hodgkin's|non-hodgkin's
657982|NCT00809341|Lymphoma|lymphoma
657983|NCT00809354|monoclonal antibody|monoclonal antibody
657984|NCT00809354|nerve growth factor (NGF)|nerve growth factor (ngf)
657985|NCT00809354|anti-NGF|anti-ngf
657986|NCT00809354|tanezumab|tanezumab
657987|NCT00809354|PF-04383119|pf-04383119
657988|NCT00809354|RN624|rn624
657989|NCT00809354|osteoarthritis (OA)|osteoarthritis (oa)
657990|NCT00809367|MDS|mds
657991|NCT00809367|AML|aml
657992|NCT00809367|banking study|banking study
657993|NCT00809380|Conscious sedation|conscious sedation
657994|NCT00809380|Parental presence|parental presence
657995|NCT00809380|Invasive procedure|invasive procedure
657996|NCT00809380|Children|children
657997|NCT00809380|Anxiety|anxiety
657998|NCT00809393|Antifibrinolytic|antifibrinolytic
657999|NCT00809393|Tranexamic acid|tranexamic acid
658000|NCT00809393|Cardiopulmonary bypass|cardiopulmonary bypass
658001|NCT00809393|Transfusion|transfusion
658002|NCT00809393|Hemorrhage|hemorrhage
658003|NCT00809419|Brachytherapy|brachytherapy
658004|NCT00809419|EpiRad|epirad
658005|NCT00809419|Macular Degeneration|macular degeneration
658006|NCT00809419|Ranibizumab|ranibizumab
658007|NCT00809432|Air pollution|air pollution
658008|NCT00809432|Heart rate|heart rate
658009|NCT00809432|Heart rate variability|heart rate variability
658010|NCT00809432|Blood pressure|blood pressure
658011|NCT00809432|Face mask|face mask
658012|NCT00809458|Vitamin E|vitamin e
658013|NCT00809458|Prostate Cancer|prostate cancer
658014|NCT00809458|Alpha-tocopherol (α-tocopherol)|alpha-tocopherol (α-tocopherol)
658015|NCT00809471|ED|ed
658016|NCT00809471|Erectile Dysfunction|erectile dysfunction
658018|NCT00809471|Diabetic|diabetic
658019|NCT00809471|Erectile|erectile
658020|NCT00809484|Arimidex|arimidex
658021|NCT00809484|Bone Mineral density|bone mineral density
658022|NCT00809484|Bisphosphonates|bisphosphonates
658023|NCT00809484|Aromatase Inhibitors|aromatase inhibitors
658024|NCT00809497|PLC for treatment of peripheral arterial diseases|plc for treatment of peripheral arterial diseases
658025|NCT00809523|SAD|sad
658026|NCT00809523|winter depression|winter depression
658027|NCT00809536|metformin, PD 0332334, organic cation transporter, OCT2, pharmacokinetics|metformin, pd 0332334, organic cation transporter, oct2, pharmacokinetics
658028|NCT00809549|Stroke|stroke
658029|NCT00809549|GCSF|gcsf
658030|NCT00809549|Hematopoeitic|hematopoeitic
658031|NCT00809549|Neupogen|neupogen
658032|NCT00809549|Filgrastim|filgrastim
658033|NCT00809575|adult|adult
658034|NCT00809575|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
658035|NCT00809575|Quality of life|quality of life
658036|NCT00809575|Patient reported outcomes|patient reported outcomes
658037|NCT00809588|vaccination|vaccination
658038|NCT00809588|GM-CSF|gm-csf
658039|NCT00809588|autologous|autologous
658040|NCT00809588|irradiated|irradiated
658041|NCT00809614|Psoriatic arthritis|psoriatic arthritis
658042|NCT00809614|IgG1K monoclonal antibody|igg1k monoclonal antibody
658043|NCT00809614|Interleukin -17A neutralizing|interleukin -17a neutralizing
658044|NCT00809627|headache|headache
658045|NCT00809627|caffeine|caffeine
658046|NCT00809627|pain|pain
658047|NCT00809640|low back pain|low back pain
658048|NCT00809640|prevention|prevention
658049|NCT00809640|schoolchildren|schoolchildren
658050|NCT00809640|education campaign|education campaign
658051|NCT00809653|Air pollution|air pollution
658052|NCT00809653|Face mask|face mask
658053|NCT00809653|Myocardial ischaemia|myocardial ischaemia
658054|NCT00809653|Heart rate variability|heart rate variability
658055|NCT00809653|Angina pectoris|angina pectoris
658056|NCT00809653|Coronary heart disease|coronary heart disease
658057|NCT00809666|pregnancy|pregnancy
658058|NCT00809666|hypertension|hypertension
658059|NCT00809666|mercury sphygmomanometry|mercury sphygmomanometry
658060|NCT00809666|blood pressure|blood pressure
658061|NCT00809666|automated blood pressure|automated blood pressure
658062|NCT00809666|pre eclampsia|pre eclampsia
658063|NCT00809666|Hypertension in pregnancy|hypertension in pregnancy
658064|NCT00809679|Postherpetic neuralgia|postherpetic neuralgia
658065|NCT00809679|Varicella Zoster|varicella zoster
658066|NCT00809679|Shingles|shingles
658067|NCT00809679|Neuropathic pain|neuropathic pain
658068|NCT00809679|Analgesia|analgesia
658069|NCT00809679|Pain|pain
658070|NCT00809692|histamine biotransformation|histamine biotransformation
658071|NCT00809692|laser Doppler flowimetry|laser doppler flowimetry
658072|NCT00809692|pediatric pharmacology|pediatric pharmacology
658073|NCT00809718|Raltegravir|raltegravir
658074|NCT00809718|Pharmacokinetics|pharmacokinetics
658075|NCT00809718|Rifapentine|rifapentine
658076|NCT00809718|Drug Kinetics|drug kinetics
658077|NCT00809731|Schizophrenia remission status by 8-item PANSS|schizophrenia remission status by 8-item panss
658078|NCT00809757|Asthma|asthma
658079|NCT00809770|stimulant abuse|stimulant abuse
658080|NCT00809770|drug abuse|drug abuse
658081|NCT00809770|schizophrenia|schizophrenia
658082|NCT00809770|bipolar disorder|bipolar disorder
658083|NCT00809770|major depressive disorder|major depressive disorder
658084|NCT00809770|contingency management|contingency management
658085|NCT00809770|psychosocial treatment|psychosocial treatment
658086|NCT00809783|Tanezumab OA arthritis|tanezumab oa arthritis
658087|NCT00809809|Cold sores|cold sores
658088|NCT00809809|Zinc|zinc
658090|NCT00809809|Herpes simple labialis|herpes simple labialis
658091|NCT00809822|IVIG in pemphigoid|ivig in pemphigoid
658092|NCT00809822|Patients with bullous pemphigoid unresponsive to corticosteroids|patients with bullous pemphigoid unresponsive to corticosteroids
658093|NCT00809835|Cocaine|cocaine
658094|NCT00809835|Methadone|methadone
658095|NCT00809835|CBT|cbt
658096|NCT00809874|Postprandial Period|postprandial period
658097|NCT00809874|Postprandial Lipaemia|postprandial lipaemia
658098|NCT00809874|Incretins|incretins
658099|NCT00809874|Subclinical Inflammation|subclinical inflammation
658100|NCT00809874|Obesity|obesity
658101|NCT00809874|Atherosclerosis|atherosclerosis
658102|NCT00809874|Triglyceride|triglyceride
658103|NCT00809874|Lipoproteins|lipoproteins
658104|NCT00809887|catheter fungal infections, antimicrobial lock therapy, micafungin, central venous catheter|catheter fungal infections, antimicrobial lock therapy, micafungin, central venous catheter
658105|NCT00809913|Urinary Tract Infection|urinary tract infection
658106|NCT00809913|Fever|fever
658107|NCT00809913|Acute Pyelonephritis|acute pyelonephritis
658108|NCT00809913|Treatment duration|treatment duration
658109|NCT00809913|Febrile Urinary Tract Infection Treatment Duration|febrile urinary tract infection treatment duration
658110|NCT00809926|Hypertension, aliskiren and valsartan|hypertension, aliskiren and valsartan
658111|NCT00809939|preterm delivery|preterm delivery
658112|NCT00809939|short cervical length|short cervical length
658113|NCT00809939|progesterone|progesterone
658114|NCT00809965|Rivaroxaban|rivaroxaban
658115|NCT00809965|Acute Coronary Syndrome|acute coronary syndrome
658116|NCT00809965|ACS|acs
658117|NCT00809965|Aspirin|aspirin
658118|NCT00809965|Thienopyridine|thienopyridine
658119|NCT00809965|Unstable Angina|unstable angina
658120|NCT00809965|Myocardial Infarction|myocardial infarction
658121|NCT00809965|Anticoagulation|anticoagulation
658122|NCT00809965|Clopidogrel (Plavix)|clopidogrel (plavix)
658123|NCT00809991|Prostate Cancer|prostate cancer
658124|NCT00810017|Her2 Positive|her2 positive
658125|NCT00810017|Breast Cancer|breast cancer
658126|NCT00810017|Metastatic|metastatic
658127|NCT00810030|ferric carboxymaltose|ferric carboxymaltose
658128|NCT00810030|iron sucrose|iron sucrose
658129|NCT00810030|Iron-Deficiency Anemia|iron-deficiency anemia
658130|NCT00810030|Crohn's Disease|crohn's disease
658131|NCT00810030|Ulcerative Colitis|ulcerative colitis
658132|NCT00810030|Ferritin|ferritin
658133|NCT00810030|Transferrin|transferrin
658134|NCT00810056|Child abuse and neglect|child abuse and neglect
658135|NCT00810056|Out-of-home care|out-of-home care
658136|NCT00810056|Mentoring|mentoring
658137|NCT00810056|Skills groups|skills groups
658138|NCT00810056|Assessment|assessment
658139|NCT00810069|Major Depressive Disorder|major depressive disorder
658140|NCT00810069|MDD|mdd
658141|NCT00810069|Depression|depression
658142|NCT00810095|Cerebral Infarction|cerebral infarction
658143|NCT00810095|Stroke|stroke
658144|NCT00810095|Vascular Diseases|vascular diseases
658145|NCT00810095|Central Nervous System Diseases|central nervous system diseases
658146|NCT00810095|Penumbra|penumbra
658147|NCT00810095|Functional Outcome|functional outcome
658148|NCT00810095|Aphasia|aphasia
658149|NCT00810095|Hemiplegia|hemiplegia
658153|NCT00810108|pediatrics|pediatrics
658154|NCT00810108|resource-limited settings|resource-limited settings
658155|NCT00810108|lopinavir|lopinavir
658156|NCT00810108|ritonavir|ritonavir
658158|NCT00810108|antiretroviral treatment|antiretroviral treatment
658159|NCT00810108|crushed tablets|crushed tablets
658160|NCT00810108|treatment experienced|treatment experienced
658161|NCT00810134|Superficial femoral artery occlusion (TASC II B or C)|superficial femoral artery occlusion (tasc ii b or c)
658162|NCT00810160|probiotic|probiotic
658163|NCT00810160|prebiotic|prebiotic
658164|NCT00810160|oligosaccharides|oligosaccharides
658165|NCT00810160|GOS|gos
658166|NCT00810160|galacto oligosaccharides|galacto oligosaccharides
658167|NCT00810160|Bifidobacterium infantis|bifidobacterium infantis
658168|NCT00810160|Bifidobacterium animalis|bifidobacterium animalis
658169|NCT00810173|type 2 diabetes|type 2 diabetes
658170|NCT00810173|physical activity|physical activity
658171|NCT00810173|behavior change|behavior change
658172|NCT00810173|profile personality|profile personality
658173|NCT00810173|phone call support|phone call support
658174|NCT00810212|Degenerative disc disease|degenerative disc disease
658175|NCT00810212|Spondylolisthesis|spondylolisthesis
658176|NCT00810212|Spinal stenosis|spinal stenosis
658177|NCT00810212|Stem cell|stem cell
658178|NCT00810212|Spinal Fusion|spinal fusion
658179|NCT00810225|CNDP1|cndp1
658180|NCT00810225|carnosine dipeptidase 1|carnosine dipeptidase 1
658181|NCT00810225|Persian Gulf War|persian gulf war
658182|NCT00810225|Gulf War Syndrome|gulf war syndrome
658183|NCT00810225|GWI|gwi
658184|NCT00810225|Gulf War Illness|gulf war illness
658185|NCT00810225|Exercise|exercise
658186|NCT00810225|Chronic Fatigue|chronic fatigue
658187|NCT00810225|Fibromyalgia|fibromyalgia
658188|NCT00810225|Veterans|veterans
658189|NCT00810225|Irritable Bowel Syndrome|irritable bowel syndrome
658190|NCT00810225|Migraine headaches|migraine headaches
658191|NCT00810225|Neuropathy|neuropathy
658192|NCT00810225|Multiple Chemical Sensitivity|multiple chemical sensitivity
658193|NCT00810238|Heart failure|heart failure
658194|NCT00810238|Cell therapy|cell therapy
658195|NCT00810251|rib fracture|rib fracture
658196|NCT00810251|flail chest|flail chest
658197|NCT00810251|plate|plate
658198|NCT00810251|chest trauma|chest trauma
658199|NCT00810251|osteosynthesis|osteosynthesis
658200|NCT00810251|mechanical ventilation|mechanical ventilation
658201|NCT00810251|respirator|respirator
658203|NCT00810290|Metabolic syndrome|metabolic syndrome
658204|NCT00810290|Latino health|latino health
658205|NCT00810290|Community participatory research|community participatory research
658206|NCT00810290|Translational Research|translational research
658207|NCT00810316|Alprazolam|alprazolam
658208|NCT00810316|Alprazolam extended release|alprazolam extended release
658209|NCT00810316|Clonazepam|clonazepam
658210|NCT00810316|Pharmacokinetics|pharmacokinetics
658211|NCT00810316|Mexican population|mexican population
658212|NCT00810316|Healthy|healthy
658213|NCT00810329|CFS,FM,CSF,Proteomics,Pain,Fatigue,GWI,IBS,IC,MCS.|cfs,fm,csf,proteomics,pain,fatigue,gwi,ibs,ic,mcs.
658214|NCT00810342|physical activity standard|physical activity standard
658215|NCT00810342|exercise|exercise
658216|NCT00810355|Schizophrenia Spectrum Disorders|schizophrenia spectrum disorders
658217|NCT00810355|Cognitive Behavior Therapy|cognitive behavior therapy
658218|NCT00810355|work|work
658219|NCT00810368|Carnosine|carnosine
658220|NCT00810368|antioxidant|antioxidant
658221|NCT00810368|Persian Gulf War|persian gulf war
658222|NCT00810368|Gulf War Syndrome|gulf war syndrome
658223|NCT00810368|GWI|gwi
658224|NCT00810368|Gulf War Illness|gulf war illness
658225|NCT00810368|Exercise|exercise
658226|NCT00810368|Chronic Fatigue|chronic fatigue
658227|NCT00810368|Fibromyalgia|fibromyalgia
658228|NCT00810368|Veterans|veterans
658229|NCT00810368|Irritable Bowel Syndrome|irritable bowel syndrome
658230|NCT00810368|Migraine headaches|migraine headaches
658231|NCT00810368|Neuropathy|neuropathy
658232|NCT00810368|Multiple Chemical Sensitivity|multiple chemical sensitivity
658233|NCT00810381|Nitrovasodilators|nitrovasodilators
658234|NCT00810381|ONH blood flow|onh blood flow
658235|NCT00810381|Choroidal blood flow|choroidal blood flow
658236|NCT00810381|Nitroglycerin|nitroglycerin
658237|NCT00810381|Isosorbide Dinitrate|isosorbide dinitrate
658238|NCT00810381|Sodium nitroprusside|sodium nitroprusside
658239|NCT00810381|Laser-Doppler Flowmetry|laser-doppler flowmetry
658240|NCT00810381|Regional Blood Flow|regional blood flow
658241|NCT00810394|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
658242|NCT00810420|Hypoglycemia|hypoglycemia
658243|NCT00810420|EEG|eeg
658244|NCT00810420|type 1 diabetes|type 1 diabetes
658245|NCT00810420|neuroglycopenia|neuroglycopenia
658246|NCT00810420|Hypoglycemia is a potential dangerous condition|hypoglycemia is a potential dangerous condition
658247|NCT00810420|EEG is changed during hypoglycemia|eeg is changed during hypoglycemia
658371|NCT00812227|Neuroimaging|neuroimaging
658248|NCT00810420|A hypoglycemia alarm based on EEG-measures may prevent development of severe hypoglycemia|a hypoglycemia alarm based on eeg-measures may prevent development of severe hypoglycemia
658249|NCT00811655|tumors metastatic to brain|tumors metastatic to brain
658250|NCT00811655|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
658251|NCT00811668|Sleep Apnea Syndromes|sleep apnea syndromes
658252|NCT00811668|heart diseases|heart diseases
658253|NCT00811681|Friedreich's ataxia|friedreich's ataxia
658254|NCT00811681|Pioglitazone|pioglitazone
658255|NCT00811694|glaucoma|glaucoma
658256|NCT00811694|ficker stimulation|ficker stimulation
658257|NCT00811694|ocular blood flow|ocular blood flow
658258|NCT00811707|ultrasound image|ultrasound image
658259|NCT00811707|epidural space|epidural space
658260|NCT00811720|Alcohol-Related Disorders|alcohol-related disorders
658261|NCT00811720|Alcoholism|alcoholism
658262|NCT00811720|Mental Disorders|mental disorders
658263|NCT00811720|Central Nervous System Agents|central nervous system agents
658264|NCT00811733|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
658265|NCT00811733|Ofatumumab|ofatumumab
658266|NCT00811746|obstructive sleep apnea|obstructive sleep apnea
658267|NCT00811746|eszopiclone|eszopiclone
658268|NCT00811746|ramelteon|ramelteon
658269|NCT00811746|polysomnography|polysomnography
658270|NCT00811759|stage IV melanoma|stage iv melanoma
658271|NCT00811759|stage III melanoma|stage iii melanoma
658272|NCT00811759|recurrent melanoma|recurrent melanoma
658273|NCT00811772|Randomized controlled trial|randomized controlled trial
658274|NCT00811772|Bare metal stent|bare metal stent
658275|NCT00811772|Drug eluting stent|drug eluting stent
658276|NCT00811785|Copper Deficiency|copper deficiency
658277|NCT00811785|Menkes Disease|menkes disease
658278|NCT00811785|Neurodevelopment|neurodevelopment
658279|NCT00811785|Occipital Horn Syndrome|occipital horn syndrome
658280|NCT00811798|Hong Kong|hong kong
658281|NCT00811798|Human papillomavirus|human papillomavirus
658282|NCT00811798|Safety|safety
658283|NCT00811811|Hypertension|hypertension
658284|NCT00811811|Biofeedback|biofeedback
658285|NCT00811811|Relaxation training|relaxation training
658286|NCT00811824|Weight loss|weight loss
658287|NCT00811824|Physical activity|physical activity
658288|NCT00811824|Dietary change|dietary change
658289|NCT00811837|Sunburn|sunburn
658290|NCT00811837|Remifentanil|remifentanil
658291|NCT00811837|Hyperalgesia|hyperalgesia
658292|NCT00811863|Nephrogenic Systemic Fibrosis|nephrogenic systemic fibrosis
658293|NCT00811863|Renal Insufficiency|renal insufficiency
658294|NCT00811863|Gadoversetamide|gadoversetamide
658295|NCT00811863|OptiMARK|optimark
658296|NCT00811863|Magnetic Resonance Imaging|magnetic resonance imaging
658297|NCT00811876|Prostate cancer|prostate cancer
658298|NCT00811902|Multiple sclerosis|multiple sclerosis
658299|NCT00811915|Sirolimus|sirolimus
658300|NCT00811915|Tacrolimus|tacrolimus
658301|NCT00811915|Kidney transplantation|kidney transplantation
658302|NCT00811915|Kidney Transplant Recipients|kidney transplant recipients
658303|NCT00811928|high-risk leukopenic patients|high-risk leukopenic patients
658304|NCT00811941|Pharmacologic Actions|pharmacologic actions
658305|NCT00811941|Alcohol-Related Disorders|alcohol-related disorders
658306|NCT00811941|Alcoholism|alcoholism
658307|NCT00811941|Mental Disorders|mental disorders
658308|NCT00811941|Central Nervous System Agents|central nervous system agents
658309|NCT00811954|Treatment naive|treatment naive
658310|NCT00811954|Treatment inexperienced|treatment inexperienced
658311|NCT00812019|H5N1 Influenza|h5n1 influenza
658312|NCT00812019|Pandemic Flu|pandemic flu
658313|NCT00812019|MF59 Adjuvant|mf59 adjuvant
658314|NCT00812019|Cell Culture-Derived|cell culture-derived
658315|NCT00812019|Safety|safety
658316|NCT00812019|Immunogenicity|immunogenicity
658317|NCT00812019|Vaccination|vaccination
658318|NCT00812019|H5N1 influenza pandemic|h5n1 influenza pandemic
658319|NCT00812032|NIDDM|niddm
658320|NCT00812032|Aspirin|aspirin
658321|NCT00812032|platelet inhibition|platelet inhibition
658322|NCT00812032|Aspirin treatment|aspirin treatment
658323|NCT00812045|Induced sputum|induced sputum
658324|NCT00812045|cystic fibrosis|cystic fibrosis
658325|NCT00812045|biomarker|biomarker
658326|NCT00812045|CYBER|cyber
658327|NCT00812058|Bipolar Depression|bipolar depression
658328|NCT00812058|Bipolar Disease|bipolar disease
658329|NCT00812058|Bipolar Disorder|bipolar disorder
658330|NCT00812058|Bipolar|bipolar
658331|NCT00812058|Manic Depression|manic depression
658332|NCT00812058|Manic Depressive Disorder|manic depressive disorder
658333|NCT00812071|volunteers|volunteers
658334|NCT00812084|Quality of life|quality of life
658335|NCT00812084|health resources|health resources
658336|NCT00812084|costs|costs
658337|NCT00812084|community-acquired pneumonia|community-acquired pneumonia
658338|NCT00812097|Breast Augmentation|breast augmentation
658339|NCT00812097|Breast Reconstruction|breast reconstruction
658340|NCT00812097|Breast Revision|breast revision
658341|NCT00812097|Silicone gel|silicone gel
658342|NCT00812097|Contour Profile Gel|contour profile gel
658344|NCT00812110|Influenza prevention|influenza prevention
658345|NCT00812123|kidney transplantation|kidney transplantation
658346|NCT00812123|calcineurin inhibitor free|calcineurin inhibitor free
658347|NCT00812123|protocol biopsy|protocol biopsy
658348|NCT00812123|Cyclosporin A|cyclosporin a
658349|NCT00812123|Sirolimus|sirolimus
658350|NCT00812136|Using Parent Mentors to Improve Asthma Care for Urban Minority Children|using parent mentors to improve asthma care for urban minority children
658351|NCT00812149|Type-2 Deiodinase|type-2 deiodinase
658352|NCT00812149|Genetic Polymorphism|genetic polymorphism
658353|NCT00812149|Triiodothyronine (T3)|triiodothyronine (t3)
658354|NCT00812149|Thyrotropin Releasing Hormone (TRH) Test|thyrotropin releasing hormone (trh) test
658355|NCT00812175|Hepatocellular Carcinoma|hepatocellular carcinoma
658357|NCT00812175|Sorafenib|sorafenib
658358|NCT00812188|Morphea|morphea
658359|NCT00812188|Plaque morphea|plaque morphea
658360|NCT00812188|Localized Scleroderma|localized scleroderma
658361|NCT00812201|Heart failure|heart failure
658362|NCT00812201|auto threshold|auto threshold
658363|NCT00812201|pacing|pacing
658364|NCT00812201|CRT-P or CRT-D recipients, threshold measurements|crt-p or crt-d recipients, threshold measurements
658365|NCT00812214|insomnia|insomnia
658366|NCT00812214|migraine|migraine
658367|NCT00812214|eszopiclone|eszopiclone
658368|NCT00812214|insomnia in migraineurs|insomnia in migraineurs
658369|NCT00812227|Depression|depression
658370|NCT00812227|Psychotherapy|psychotherapy
658372|NCT00812227|Subjects with Major Depressive Disorder (MDD)|subjects with major depressive disorder (mdd)
658373|NCT00812240|Gastro-Intestinal Stromal Tumour|gastro-intestinal stromal tumour
658374|NCT00812240|GIST|gist
658375|NCT00812240|non resectable|non resectable
658376|NCT00812240|recurrent post-surgery|recurrent post-surgery
658377|NCT00812240|first line of treatment|first line of treatment
658378|NCT00812240|metastatic|metastatic
658379|NCT00812240|locally advanced|locally advanced
658380|NCT00812253|Heart failure|heart failure
658381|NCT00812253|Hyperglycemia|hyperglycemia
658382|NCT00812253|Hospital|hospital
658383|NCT00812253|Diabetes Mellitus|diabetes mellitus
658384|NCT00812266|SCLC|sclc
658385|NCT00812266|Extensive disease|extensive disease
658386|NCT00812266|topotecan|topotecan
658387|NCT00812279|Smokers with acceptable health conditions|smokers with acceptable health conditions
658388|NCT00812292|TMC278|tmc278
658389|NCT00812292|TMC278-C145|tmc278-c145
658390|NCT00812292|TMC278-TiDP38-C145|tmc278-tidp38-c145
658391|NCT00812292|concept pediatric formulations of TMC278|concept pediatric formulations of tmc278
658392|NCT00812292|HIV Infections|hiv infections
658393|NCT00812318|HIV infected subjects|hiv infected subjects
658394|NCT00812318|Healthy volunteer|healthy volunteer
658395|NCT00812318|GSK1265744.|gsk1265744.
658396|NCT00812331|Hepatitis C|hepatitis c
658397|NCT00812331|TMC435|tmc435
658398|NCT00812344|pharmacokinetics|pharmacokinetics
658399|NCT00812357|Symbicort Turbuhaler|symbicort turbuhaler
658400|NCT00812357|asthma|asthma
658401|NCT00812357|cohort study|cohort study
658402|NCT00812357|France|france
658403|NCT00812370|DVT|dvt
658404|NCT00812370|Deep Venous Thrombosis|deep venous thrombosis
658405|NCT00812370|UNBLOCK|unblock
658406|NCT00812370|Bivalirudin|bivalirudin
658407|NCT00812370|Angiomax|angiomax
658408|NCT00812396|Biomarkers of muscle anabolism|biomarkers of muscle anabolism
752388|NCT01172795|Whiplash associated disorder|whiplash associated disorder
658409|NCT00812409|Measuring markers of metabolic syndrome in overweight and obese adults.|measuring markers of metabolic syndrome in overweight and obese adults.
658410|NCT00812422|Fever due to acute upper respiratory tract infection|fever due to acute upper respiratory tract infection
658411|NCT00812435|STEMI|stemi
658412|NCT00812435|Patients|patients
658413|NCT00812435|male or female|male or female
658509|NCT00812851|cramps|cramps
658414|NCT00812435|greater than 18 years of age|greater than 18 years of age
658415|NCT00812435|presenting with ST elevation myocardial infarction|presenting with st elevation myocardial infarction
658416|NCT00812448|prophylaxis|prophylaxis
658417|NCT00812448|influenza infection|influenza infection
658418|NCT00812448|catechins|catechins
658419|NCT00812448|prophylaxis of influenza infection|prophylaxis of influenza infection
658420|NCT00812461|Pharmacologic Actions|pharmacologic actions
658421|NCT00812461|Alcohol-Related Disorders|alcohol-related disorders
658422|NCT00812461|Alcoholism|alcoholism
658423|NCT00812461|Mental Disorders|mental disorders
658424|NCT00812461|Central Nervous System Agents|central nervous system agents
658425|NCT00812474|cerebral blood flow|cerebral blood flow
658426|NCT00812487|congestive heart failure|congestive heart failure
658427|NCT00812487|diabetes mellitus|diabetes mellitus
658428|NCT00812487|hyperglycemia|hyperglycemia
658429|NCT00812500|assess the effect of age on the EAR and RDA for protein|assess the effect of age on the ear and rda for protein
658430|NCT00812513|rhPDGF-BB|rhpdgf-bb
658431|NCT00812513|Platelet derived growth factor|platelet derived growth factor
658432|NCT00812513|Burns|burns
658433|NCT00812513|Thermal burns|thermal burns
658434|NCT00812513|Electric burns|electric burns
658435|NCT00812526|Choroid|choroid
658436|NCT00812526|Regional blood flow|regional blood flow
658437|NCT00812526|Autoregulation|autoregulation
658438|NCT00812526|Laser Doppler flowmetry|laser doppler flowmetry
658439|NCT00812539|Diabetes|diabetes
658440|NCT00812539|Blood glucose monitoring|blood glucose monitoring
658441|NCT00812539|Internet|internet
658442|NCT00812578|Type 2 diabetes|type 2 diabetes
658443|NCT00812578|Vitamin D insufficiency|vitamin d insufficiency
658444|NCT00812578|Insulin secretion|insulin secretion
658445|NCT00812578|Insulin sensitivity|insulin sensitivity
658447|NCT00812630|male hormonal contraception|male hormonal contraception
658448|NCT00812630|Blood pressure, sperm concentration|blood pressure, sperm concentration
658449|NCT00812643|pharmacokinetics|pharmacokinetics
658450|NCT00812669|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
658451|NCT00812669|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
658452|NCT00812669|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
658453|NCT00812669|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
658454|NCT00812669|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
658455|NCT00812669|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
658456|NCT00812682|SYMBICORT AMD|symbicort amd
658457|NCT00812695|Obstructive sleep apnea|obstructive sleep apnea
658458|NCT00812695|Refractory hypertension|refractory hypertension
658459|NCT00812695|Heart remodeling|heart remodeling
658460|NCT00812695|Arterial stiffness|arterial stiffness
658461|NCT00812695|CPAP|cpap
658462|NCT00812708|aniridia|aniridia
658463|NCT00812708|Morcher iris diaphragms|morcher iris diaphragms
658464|NCT00812708|modified capsule tension ring|modified capsule tension ring
658465|NCT00812708|artificial iris|artificial iris
658466|NCT00812708|iris reconstruction lens|iris reconstruction lens
658467|NCT00812708|glare sensitivity|glare sensitivity
658468|NCT00812708|photophobia|photophobia
658469|NCT00812721|higher order aberrations|higher order aberrations
658470|NCT00812721|tear blur|tear blur
658471|NCT00812734|Neuropathic pain|neuropathic pain
658472|NCT00812734|chronic pain|chronic pain
658473|NCT00812734|postoperative|postoperative
658474|NCT00812734|surgery|surgery
658475|NCT00812734|anesthesiology|anesthesiology
658476|NCT00812734|Scheduled surgery|scheduled surgery
658477|NCT00812747|surgical wound infection|surgical wound infection
658478|NCT00812747|risk factor|risk factor
658479|NCT00812760|Electroretinography|electroretinography
658480|NCT00812760|levodopa|levodopa
658481|NCT00812773|GSK2190915|gsk2190915
658482|NCT00812773|Repeat|repeat
658483|NCT00812773|Oral|oral
658484|NCT00812773|Dose|dose
658485|NCT00812773|Challenge|challenge
658486|NCT00812773|Asthma|asthma
658487|NCT00812773|Allergen|allergen
658488|NCT00812786|heart transplantation|heart transplantation
658489|NCT00812786|immunosuppressive drugs|immunosuppressive drugs
658490|NCT00812786|individual dose adjustment|individual dose adjustment
658491|NCT00812786|harmacokinetics|harmacokinetics
658492|NCT00812786|modelling|modelling
658493|NCT00812799|randomised|randomised
658494|NCT00812799|double-blind|double-blind
658495|NCT00812799|placebo-controlled|placebo-controlled
658496|NCT00812799|efficacy and safety|efficacy and safety
658497|NCT00812799|Oralgen® Grass Pollen|oralgen® grass pollen
658498|NCT00812799|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
658499|NCT00812799|allergy|allergy
658500|NCT00812799|rhinoconjunctivitis|rhinoconjunctivitis
658501|NCT00812799|immunotherapy|immunotherapy
658502|NCT00812799|grass pollen extract|grass pollen extract
658503|NCT00812812|paroxetine|paroxetine
658504|NCT00812812|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
658505|NCT00812812|CDRS-R|cdrs-r
658506|NCT00812812|children and adolescents|children and adolescents
658507|NCT00812825|Safety Tolerability Pharmacokinetics/pharmacodynamics|safety tolerability pharmacokinetics/pharmacodynamics
658508|NCT00812851|ALS|als
658510|NCT00812851|THC|thc
658511|NCT00812851|Dronabinol|dronabinol
658512|NCT00812864|Capecitabine|capecitabine
658513|NCT00812864|pharmacocinetics|pharmacocinetics
658514|NCT00812864|Breast metastatic cancer|breast metastatic cancer
658515|NCT00812864|colorectal metastatic cancer|colorectal metastatic cancer
658516|NCT00812864|Elderly patients|elderly patients
658517|NCT00812877|pulp capping|pulp capping
658518|NCT00812877|MTA|mta
658519|NCT00812877|CaOH|caoh
658520|NCT00812877|Mineral Trioxide Aggregate|mineral trioxide aggregate
658521|NCT00812877|Calcium Hydroxide|calcium hydroxide
658522|NCT00812903|Neck|neck
658523|NCT00812903|Pain|pain
658524|NCT00812903|Exercise|exercise
658525|NCT00812903|Pilots|pilots
658526|NCT00812903|Crew|crew
658527|NCT00812916|Persistent or longstanding persistent atrial fibrillation|persistent or longstanding persistent atrial fibrillation
658528|NCT00812929|Asthma, Exercise Induced Asthma, Exercise Induced Bronchospasm|asthma, exercise induced asthma, exercise induced bronchospasm
658529|NCT00812942|average-risk subjects for|average-risk subjects for
658530|NCT00812955|Dyslipidemia|dyslipidemia
658531|NCT00812955|Hypercholesterolemia|hypercholesterolemia
658532|NCT00812955|Hypertriglyceridemia|hypertriglyceridemia
658533|NCT00812968|Myelodysplastic Syndromes|myelodysplastic syndromes
658534|NCT00812968|Lenalidomide|lenalidomide
658535|NCT00812981|Pandemic influenza|pandemic influenza
658536|NCT00812994|Depression|depression
658538|NCT00812994|neurotrophic factor|neurotrophic factor
658539|NCT00812994|neurosetroid|neurosetroid
658540|NCT00812994|allopregnanolone|allopregnanolone
658541|NCT00813007|Cervical Cancer|cervical cancer
658542|NCT00813007|Cervix|cervix
659865|NCT00816530|U-Systems|u-systems
658543|NCT00813007|Questionnaire|questionnaire
658544|NCT00813007|Adenocarcinoma of uterine cervix|adenocarcinoma of uterine cervix
658545|NCT00813007|Squamous cell carcinoma of uterine cervix|squamous cell carcinoma of uterine cervix
658546|NCT00813007|Adenosquamous carcinoma of uterine cervix|adenosquamous carcinoma of uterine cervix
658547|NCT00813007|Abdominal radical trachelectomy|abdominal radical trachelectomy
658548|NCT00813007|Trachelectomy|trachelectomy
658549|NCT00813007|Quality of life|quality of life
658550|NCT00813007|Sexual functioning|sexual functioning
658551|NCT00813033|create a patient decision aid for endoscopy|create a patient decision aid for endoscopy
658552|NCT00813033|evaluate efficacy of a patient decision aid for endoscopy|evaluate efficacy of a patient decision aid for endoscopy
658553|NCT00813059|NAION|naion
658554|NCT00813059|bevacizumab|bevacizumab
658555|NCT00813072|Gastric Cancer|gastric cancer
658556|NCT00813072|Stomach Cancer|stomach cancer
658557|NCT00813072|Gastroesophageal|gastroesophageal
658558|NCT00813072|Gastroesophageal Junction|gastroesophageal junction
658559|NCT00813072|Esophageal Cancer|esophageal cancer
658560|NCT00813072|phase II|phase ii
658561|NCT00813072|PEP02|pep02
658562|NCT00813072|randomization|randomization
658563|NCT00813072|randomisation|randomisation
658564|NCT00813072|adenocarcinoma|adenocarcinoma
658565|NCT00813072|locally advanced|locally advanced
658566|NCT00813072|metastatic|metastatic
658567|NCT00813072|simon's two|simon's two
658568|NCT00813085|Diabetes|diabetes
658569|NCT00813085|Computerized clinical decision support|computerized clinical decision support
658570|NCT00813085|shared care|shared care
658571|NCT00813085|patient self-monitoring|patient self-monitoring
658572|NCT00813085|quality of care|quality of care
658573|NCT00813085|complex interventions|complex interventions
658574|NCT00813085|composite outcomes|composite outcomes
658575|NCT00813111|Postsurgical pain|postsurgical pain
658576|NCT00813111|Analgesia|analgesia
658577|NCT00813111|Breast augmentation|breast augmentation
658578|NCT00813124|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
658579|NCT00813124|CML|cml
658580|NCT00813124|Donor stem cell transplant|donor stem cell transplant
658581|NCT00813124|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
658582|NCT00813124|Stem cell transplant|stem cell transplant
658583|NCT00813124|ATG|atg
658584|NCT00813124|Antithymocyte globulin|antithymocyte globulin
658585|NCT00813124|Vidaza|vidaza
658586|NCT00813124|Azacitidine|azacitidine
658587|NCT00813124|5-Azacitidine|5-azacitidine
658588|NCT00813124|5-Aza|5-aza
658589|NCT00813124|5-AZC|5-azc
658590|NCT00813124|Ladakamycin|ladakamycin
658591|NCT00813124|NSC-102816|nsc-102816
658592|NCT00813124|allotx|allotx
658593|NCT00813124|Busulfan|busulfan
658594|NCT00813124|Busulfex|busulfex
658595|NCT00813124|Myleran|myleran
658596|NCT00813124|Fludarabine|fludarabine
658597|NCT00813124|Fludarabine Phosphate|fludarabine phosphate
658598|NCT00813124|Tacrolimus|tacrolimus
658599|NCT00813124|Methotrexate|methotrexate
658600|NCT00813124|Azacitidine maintenance therapy|azacitidine maintenance therapy
658601|NCT00813124|molecular remission|molecular remission
658602|NCT00813124|HLA compatible donor|hla compatible donor
658603|NCT00813124|Engraftment|engraftment
658604|NCT00813124|Chimerism|chimerism
658605|NCT00813124|Graft vs host disease|graft vs host disease
658606|NCT00813124|GVHD|gvhd
658607|NCT00813137|Colorectal Cancer|colorectal cancer
658608|NCT00813137|chemotherapy|chemotherapy
658609|NCT00813137|recombinant human endostatin|recombinant human endostatin
658610|NCT00813150|Multiple myeloma|multiple myeloma
658611|NCT00813150|Bortezomib|bortezomib
658612|NCT00813150|Dexamethasone|dexamethasone
658613|NCT00813150|Cyclophosphamide|cyclophosphamide
658614|NCT00813150|Oncology|oncology
658615|NCT00813163|Phase II study|phase ii study
658616|NCT00813163|Second line|second line
658617|NCT00813163|Pancreatic cancer|pancreatic cancer
658618|NCT00813163|Metastatic|metastatic
658619|NCT00813176|Obesity|obesity
658620|NCT00813176|One-Lung Ventilation|one-lung ventilation
658621|NCT00813176|Anesthesia|anesthesia
658622|NCT00813176|Thoracic|thoracic
658623|NCT00813176|One-lung ventilation in the morbidly obese patient|one-lung ventilation in the morbidly obese patient
658624|NCT00813189|glucocorticoid therapy|glucocorticoid therapy
658625|NCT00813189|muscle function|muscle function
658626|NCT00813189|growth hormone treatment|growth hormone treatment
658627|NCT00813202|Nesiritide|nesiritide
658628|NCT00813202|Natrecor|natrecor
658629|NCT00813202|Quanke|quanke
658630|NCT00813202|Acute Decompensated Heart Failure|acute decompensated heart failure
658631|NCT00813215|Type 2 diabetes mellitus|type 2 diabetes mellitus
658632|NCT00813215|Postprandial dysmetabolism|postprandial dysmetabolism
658633|NCT00813215|Postprandial inflammation|postprandial inflammation
658634|NCT00813215|Relatives|relatives
658635|NCT00813215|Meal challenge|meal challenge
658636|NCT00813228|Immune Function|immune function
658637|NCT00813228|DDP-4|ddp-4
658638|NCT00813228|Sitagliptin|sitagliptin
658639|NCT00813228|GLP-1|glp-1
658640|NCT00813228|TGF Beta|tgf beta
658728|NCT00813501|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
658641|NCT00813241|Ankylosing spondylitis,Rheumatoid Arthritis,Adenomatous Polyposis Coli,Osteoarthritis,Dysmenorrhoea,pharmacokinetic study|ankylosing spondylitis,rheumatoid arthritis,adenomatous polyposis coli,osteoarthritis,dysmenorrhoea,pharmacokinetic study
658642|NCT00813254|Platinum-Resistant Ovarian Cancer|platinum-resistant ovarian cancer
658643|NCT00813254|Platinum-based chemotherapy|platinum-based chemotherapy
658644|NCT00813254|Ovarian Cancer|ovarian cancer
658645|NCT00813254|Ovary|ovary
658646|NCT00813254|Epithelial ovarian cancer|epithelial ovarian cancer
658647|NCT00813254|Quality of Life|quality of life
658648|NCT00813254|Cost Utility Analysis|cost utility analysis
658649|NCT00813254|Sexual functioning|sexual functioning
658650|NCT00813254|Questionnaire|questionnaire
658651|NCT00813254|Caregiver|caregiver
658652|NCT00813267|Mesenchymal Stem Cells|mesenchymal stem cells
658653|NCT00813267|Osteonecrosis of the Femoral Head|osteonecrosis of the femoral head
658654|NCT00813293|Hepatocellular Cancer|hepatocellular cancer
658655|NCT00813293|HCC|hcc
658656|NCT00813293|Liver Cancer|liver cancer
658657|NCT00813293|radiofrequency ablation|radiofrequency ablation
658658|NCT00813293|RFA|rfa
658659|NCT00813293|sorafenib|sorafenib
658660|NCT00813293|nexavaar|nexavaar
658661|NCT00813293|liver directed therapy|liver directed therapy
658662|NCT00813293|interventional radiology|interventional radiology
658663|NCT00813306|GERD|gerd
658664|NCT00813306|TLESR|tlesr
658665|NCT00813306|reflux|reflux
658666|NCT00813319|GARDASIL|gardasil
658667|NCT00813319|HPV|hpv
658668|NCT00813319|Vaccination|vaccination
658669|NCT00813332|Endostar|endostar
658670|NCT00813332|NSCLC|nsclc
658671|NCT00813332|Docetaxel|docetaxel
658672|NCT00813332|Combined therapy|combined therapy
658673|NCT00813332|second-line chemotherapy|second-line chemotherapy
658674|NCT00813345|anesthesia propofol ambulatory rhythm|anesthesia propofol ambulatory rhythm
658675|NCT00813358|Endovascular Aneurysm Repair|endovascular aneurysm repair
658676|NCT00813358|Aortic Aneurysm|aortic aneurysm
658677|NCT00813358|Thoracic|thoracic
658678|NCT00813371|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
658679|NCT00813371|acute lung injury|acute lung injury
658680|NCT00813371|Airway Pressure Release Ventilation|airway pressure release ventilation
658681|NCT00813371|ARDSnet|ardsnet
658682|NCT00813371|Bi-level|bi-level
658683|NCT00813371|respiratory failure|respiratory failure
658684|NCT00813371|trauma|trauma
658685|NCT00813371|APRV|aprv
658686|NCT00813384|Cancer|cancer
658687|NCT00813384|Solid Tumors|solid tumors
658688|NCT00813384|Phase 1|phase 1
658689|NCT00813384|C-met inhibitor|c-met inhibitor
658690|NCT00813384|Clinical Trial|clinical trial
658691|NCT00813436|ToM|tom
658692|NCT00813436|Theory of Mind|theory of mind
658693|NCT00813436|Simulation|simulation
658694|NCT00813436|Empathy|empathy
658695|NCT00813436|Oxytocin|oxytocin
658696|NCT00813436|Schizophrenia|schizophrenia
658697|NCT00813449|Endostar|endostar
658698|NCT00813449|advanced melanoma|advanced melanoma
658699|NCT00813449|combined chemotherapy|combined chemotherapy
658700|NCT00813475|cardio vascular outcome|cardio vascular outcome
658701|NCT00813488|Breakthrough Pain|breakthrough pain
658702|NCT00813488|Opioid-tolerant|opioid-tolerant
658703|NCT00813488|Chronic Pain|chronic pain
658704|NCT00813501|graft versus host disease|graft versus host disease
658705|NCT00813501|infection|infection
658706|NCT00813501|therapy-related toxicity|therapy-related toxicity
658956|NCT00806234|Weight Gain|weight gain
658707|NCT00813501|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
658708|NCT00813501|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
658709|NCT00813501|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
658710|NCT00813501|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
658711|NCT00813501|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
658712|NCT00813501|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
658713|NCT00813501|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
658714|NCT00813501|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
658715|NCT00813501|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
658716|NCT00813501|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
658717|NCT00813501|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
658718|NCT00813501|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
658719|NCT00813501|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
658720|NCT00813501|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
658721|NCT00813501|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
658722|NCT00813501|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
658723|NCT00813501|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
658724|NCT00813501|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
658725|NCT00813501|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
658726|NCT00813501|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
658727|NCT00813501|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
658889|NCT00813943|Radiotherapy|radiotherapy
658729|NCT00813501|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
658730|NCT00813501|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
658731|NCT00813501|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
658732|NCT00813501|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
658733|NCT00813501|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
658734|NCT00813501|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
658735|NCT00813501|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
658736|NCT00813501|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
658737|NCT00813501|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
658738|NCT00813501|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
658739|NCT00813501|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
658740|NCT00813501|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
658741|NCT00813501|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
658742|NCT00813501|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
658743|NCT00813501|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
658744|NCT00813501|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
658745|NCT00813501|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
658746|NCT00813501|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
658747|NCT00813501|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
658748|NCT00813501|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
658749|NCT00813501|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
658750|NCT00813501|splenic marginal zone lymphoma|splenic marginal zone lymphoma
658751|NCT00813501|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
658752|NCT00813501|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
658753|NCT00813501|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
658754|NCT00813501|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
658755|NCT00813501|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
658756|NCT00813501|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
658757|NCT00813501|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
658758|NCT00813501|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
658759|NCT00813501|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
658760|NCT00813501|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
658761|NCT00813501|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
658762|NCT00813501|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
658763|NCT00813501|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
658764|NCT00813501|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
658765|NCT00813501|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
658766|NCT00813501|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
658767|NCT00813501|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
658957|NCT00806234|Obesity|obesity
658768|NCT00813501|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
658769|NCT00813501|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
658770|NCT00813501|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
658771|NCT00813501|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
658772|NCT00813501|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
658773|NCT00813501|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
658774|NCT00813501|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
658775|NCT00813501|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
658776|NCT00813501|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
658777|NCT00813501|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
658778|NCT00813501|refractory hairy cell leukemia|refractory hairy cell leukemia
658779|NCT00813501|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
658780|NCT00813501|secondary acute myeloid leukemia|secondary acute myeloid leukemia
658781|NCT00813501|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
658782|NCT00813501|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
658783|NCT00813501|chronic eosinophilic leukemia|chronic eosinophilic leukemia
658784|NCT00813501|primary myelofibrosis|primary myelofibrosis
658785|NCT00813501|chronic neutrophilic leukemia|chronic neutrophilic leukemia
658987|NCT00806260|psychomotor|psychomotor
658786|NCT00813501|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
658787|NCT00813501|disseminated neuroblastoma|disseminated neuroblastoma
658788|NCT00813501|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
658789|NCT00813501|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
658790|NCT00813501|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
658791|NCT00813501|stage I multiple myeloma|stage i multiple myeloma
658792|NCT00813501|stage II multiple myeloma|stage ii multiple myeloma
658793|NCT00813501|stage III multiple myeloma|stage iii multiple myeloma
658794|NCT00813501|refractory multiple myeloma|refractory multiple myeloma
658795|NCT00813514|AMD|amd
658796|NCT00813514|VEGF genotyping|vegf genotyping
658797|NCT00813514|complement H gene polymorphism|complement h gene polymorphism
658798|NCT00813514|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
658799|NCT00813527|Drug Therapy|drug therapy
658800|NCT00813527|Lipid Metabolism Disorders|lipid metabolism disorders
658801|NCT00813527|Hyperlipidemias|hyperlipidemias
658802|NCT00813527|Hypercholesterolemia|hypercholesterolemia
658803|NCT00813527|Hypertriglyceridemia|hypertriglyceridemia
658804|NCT00813540|Colonic Neoplasms|colonic neoplasms
658805|NCT00813540|Aerobic Exercise|aerobic exercise
658806|NCT00813540|Weight Lifting|weight lifting
658807|NCT00813540|Body Composition|body composition
658808|NCT00813553|physical fitness|physical fitness
658809|NCT00813553|exercise|exercise
658810|NCT00813553|amino acid|amino acid
658811|NCT00813566|cancer|cancer
658812|NCT00813566|imaging|imaging
658813|NCT00813566|PET scanning|pet scanning
658814|NCT00813579|assess the safety of living kidney donation|assess the safety of living kidney donation
658815|NCT00813592|meningioma|meningioma
658816|NCT00813592|brain|brain
658817|NCT00813605|AMG 655|amg 655
658818|NCT00813605|AMG 479|amg 479
658819|NCT00813605|Colon Cancer|colon cancer
658820|NCT00813605|Rectal Cancer|rectal cancer
658821|NCT00813605|Monoclonal Antibody|monoclonal antibody
658822|NCT00813605|Clinical Trial|clinical trial
658823|NCT00813605|Colorectal Cancer|colorectal cancer
658824|NCT00813605|metastatic colorectal cancer|metastatic colorectal cancer
658825|NCT00813605|metastatic cancer|metastatic cancer
658826|NCT00813605|antibody-2nd line|antibody-2nd line
658827|NCT00813605|KRAS|kras
658828|NCT00813605|adenocarcinoma|adenocarcinoma
658829|NCT00813618|Acute GvHD of at least Grade II severity|acute gvhd of at least grade ii severity
658830|NCT00813631|Malignant fungating wound|malignant fungating wound
658831|NCT00813631|Head and neck|head and neck
658832|NCT00813631|Ionic silver-releasing dressing|ionic silver-releasing dressing
658833|NCT00813631|Wound care|wound care
658834|NCT00813631|RCT|rct
658835|NCT00813683|Acupuncture, moxybustion,|acupuncture, moxybustion,
658836|NCT00813683|Cephalic version,|cephalic version,
658837|NCT00813683|Breech presentation|breech presentation
658838|NCT00813696|chemotherapy|chemotherapy
658839|NCT00813696|advanced cancer|advanced cancer
658840|NCT00813696|inoperable|inoperable
658841|NCT00813696|Stage II, III, IV|stage ii, iii, iv
658842|NCT00813709|Interferon 1-beta|interferon 1-beta
752389|NCT01172795|chronic pain|chronic pain
658843|NCT00813709|Clinical Definite Multiple Sclerosis|clinical definite multiple sclerosis
658844|NCT00813722|adherence|adherence
658845|NCT00813722|blood pressure|blood pressure
658846|NCT00813722|hypertension|hypertension
658847|NCT00813722|compliance|compliance
658848|NCT00813722|atenolol|atenolol
658849|NCT00813722|hydrochlorothiazide|hydrochlorothiazide
658850|NCT00813722|amlodipine|amlodipine
658851|NCT00813722|losartan|losartan
658852|NCT00813735|Insomnia|insomnia
658853|NCT00813735|Major Depression|major depression
658854|NCT00813735|Geriatric|geriatric
658855|NCT00813748|Asthma|asthma
658856|NCT00813748|Anaphylaxis|anaphylaxis
658857|NCT00813774|Cimzia|cimzia
658858|NCT00813774|certolizumab pegol|certolizumab pegol
658859|NCT00813774|Bioavailability|bioavailability
658860|NCT00813774|Healthy volunteers|healthy volunteers
658861|NCT00813787|Magnetic Resonance Imaging|magnetic resonance imaging
658862|NCT00813787|Glioma|glioma
658863|NCT00813800|Smoking|smoking
658864|NCT00813800|Bipolar Disorder|bipolar disorder
658865|NCT00813800|Depression|depression
658867|NCT00813826|Pain after Shingles|pain after shingles
658868|NCT00813839|SmartCare|smartcare
658869|NCT00813839|Spontaneous Breathing Trials|spontaneous breathing trials
658870|NCT00813839|Mechanical Ventilation|mechanical ventilation
658871|NCT00813839|Weaning|weaning
658872|NCT00813839|Patients requiring prolonged mechanical ventilation (>72 hours)|patients requiring prolonged mechanical ventilation (>72 hours)
658873|NCT00813852|obstructive sleep apnea|obstructive sleep apnea
658874|NCT00813852|skeletal muscle|skeletal muscle
658875|NCT00813852|magnetic stimulation|magnetic stimulation
658876|NCT00813852|magnetic resonance spectroscopy|magnetic resonance spectroscopy
658877|NCT00813852|inflammatory markers|inflammatory markers
658878|NCT00813852|exercise|exercise
658879|NCT00813878|breast cancer|breast cancer
658880|NCT00813878|breast cancer in situ|breast cancer in situ
658881|NCT00813891|ranibizumab|ranibizumab
658882|NCT00813891|verteporfin|verteporfin
658883|NCT00813930|Diabetes|diabetes
658884|NCT00813930|Lifestyle Intervention|lifestyle intervention
658885|NCT00813930|Cardiovascular risk reduction|cardiovascular risk reduction
658886|NCT00813943|Newly diagnosed Glioblastoma (WHO Grade IV)|newly diagnosed glioblastoma (who grade iv)
658887|NCT00813943|Cilengitide|cilengitide
658888|NCT00813943|Temozolomide|temozolomide
658890|NCT00813956|triple negative breast cancer|triple negative breast cancer
658891|NCT00813969|Mesenchymal Stem Cell|mesenchymal stem cell
658893|NCT00813969|Autologous|autologous
658894|NCT00813969|Multiple Sclerosis|multiple sclerosis
658895|NCT00814021|recurrent renal cell cancer|recurrent renal cell cancer
658896|NCT00814021|stage IV renal cell cancer|stage iv renal cell cancer
658897|NCT00814021|tumors metastatic to brain|tumors metastatic to brain
658898|NCT00814034|Aromatase Inhibitors|aromatase inhibitors
658899|NCT00814034|Coagulation parameters|coagulation parameters
658900|NCT00814034|Tamoxifen|tamoxifen
658901|NCT00814047|ultrasonography|ultrasonography
658902|NCT00814073|Mastocytosis with handicap|mastocytosis with handicap
658903|NCT00814073|Mastocytosis|mastocytosis
658904|NCT00814073|Smouldering systemic mastocytosis|smouldering systemic mastocytosis
658905|NCT00814073|Indolent systemic mastocytosis|indolent systemic mastocytosis
658906|NCT00814073|Cutaneous mastocytosis|cutaneous mastocytosis
658907|NCT00814073|Mast cell|mast cell
658908|NCT00814073|Mast cell infiltration|mast cell infiltration
658910|NCT00814073|Bone marrow|bone marrow
658911|NCT00814073|Pruritus|pruritus
658912|NCT00814073|Flushes|flushes
658913|NCT00814073|c-kit|c-kit
658914|NCT00814073|c-kit mutation|c-kit mutation
658915|NCT00814073|Wild Type|wild type
658916|NCT00814073|Mutation Asp-816-Val(D816V)|mutation asp-816-val(d816v)
658917|NCT00814099|Acute Respiratory Failure|acute respiratory failure
658918|NCT00814099|Acute Lung Injury|acute lung injury
658919|NCT00814125|Endometrial|endometrial
658920|NCT00814125|Endometrial histological findings|endometrial histological findings
658921|NCT00806013|genotype|genotype
658922|NCT00806026|RLS|rls
658923|NCT00806039|Kidney Failure, Acute|kidney failure, acute
658924|NCT00806039|Renal Insufficiency, Acute|renal insufficiency, acute
658925|NCT00806039|Kidney Failure|kidney failure
658926|NCT00806039|Renal Insufficiency|renal insufficiency
658927|NCT00806078|Healthy|healthy
658928|NCT00806078|Bioequivalence|bioequivalence
658929|NCT00806078|Pharmacokinetics|pharmacokinetics
658930|NCT00806091|AM proteomes will be compared between smokers with and without COPD|am proteomes will be compared between smokers with and without copd
658931|NCT00806117|Cervical cancer|cervical cancer
658932|NCT00806117|Concurrent chemoradiation|concurrent chemoradiation
658933|NCT00806117|Randomized controlled clinical trials|randomized controlled clinical trials
658934|NCT00806143|Depression|depression
658935|NCT00806143|TMS|tms
658936|NCT00806169|combined therapy|combined therapy
658937|NCT00806169|DRP|drp
658938|NCT00806169|efficacy|efficacy
658939|NCT00806169|safety|safety
658940|NCT00806169|sustainability|sustainability
658941|NCT00806169|macular edema due to DRP|macular edema due to drp
658942|NCT00806182|paraneoplastic|paraneoplastic
658943|NCT00806182|neuroblastoma|neuroblastoma
658944|NCT00806182|Kinsbourne syndrome|kinsbourne syndrome
658945|NCT00806182|autoimmune disease|autoimmune disease
658946|NCT00806182|immunotherapy|immunotherapy
658947|NCT00806182|ataxia|ataxia
658948|NCT00806195|vaccine|vaccine
658949|NCT00806195|infants|infants
658950|NCT00806195|healthy|healthy
658951|NCT00806195|meningitis|meningitis
658952|NCT00806195|meningococcal|meningococcal
658953|NCT00806221|Atopic Dermatitis|atopic dermatitis
658954|NCT00806221|Prevention|prevention
658955|NCT00806221|Skin Barrier|skin barrier
658958|NCT00806234|IMPACT|impact
658959|NCT00806234|Antipsychotic Treatment|antipsychotic treatment
658960|NCT00806234|Excessive Weight Gain Associated With Antipsychotic Treatment|excessive weight gain associated with antipsychotic treatment
658961|NCT00806234|Hybrid Efficacy/Effectiveness Design|hybrid efficacy/effectiveness design
658962|NCT00806234|Reducing Weight Gain|reducing weight gain
658963|NCT00806234|Improving Metabolic Parameters|improving metabolic parameters
658964|NCT00806234|Aripiprazole|aripiprazole
658965|NCT00806234|Metformin|metformin
658966|NCT00806234|Risperdal|risperdal
658967|NCT00806234|Seroquel|seroquel
658968|NCT00806234|Quetiapine|quetiapine
658969|NCT00806234|Olanzapine|olanzapine
658970|NCT00806234|Zyprexa|zyprexa
658971|NCT00806234|Geodon|geodon
658972|NCT00806234|Risperidone|risperidone
658973|NCT00806234|Abilify|abilify
658974|NCT00806234|Trilafon|trilafon
658975|NCT00806234|Perphenazine|perphenazine
658976|NCT00806234|Glucophage|glucophage
658977|NCT00806234|Paliperidone|paliperidone
658978|NCT00806234|Olanzapine/fluoxetine|olanzapine/fluoxetine
658979|NCT00806247|Tapentadol|tapentadol
658980|NCT00806247|Bunionectomy|bunionectomy
658981|NCT00806247|Analgesia|analgesia
658983|NCT00806247|Postsurgical pain|postsurgical pain
658984|NCT00806260|Overweight|overweight
658985|NCT00806260|Obesity|obesity
658986|NCT00806260|coordination|coordination
658991|NCT00806312|pulmonary arterial hypertension|pulmonary arterial hypertension
658992|NCT00806325|Severe Sepsis|severe sepsis
658993|NCT00806325|Acute Myeloid Leukemia|acute myeloid leukemia
658994|NCT00806325|Sepsis in patients being treated for Acute Myeloid Leukemia|sepsis in patients being treated for acute myeloid leukemia
658995|NCT00806351|Candidiasis; Invasive Candidiasis; Candida; Candidemia; Fungal Infection; Neutropenia|candidiasis; invasive candidiasis; candida; candidemia; fungal infection; neutropenia
658996|NCT00806364|Healthy Volunteers|healthy volunteers
658997|NCT00806364|Allergy|allergy
658998|NCT00806364|Bone Marrow|bone marrow
658999|NCT00806364|Buccal Mucosa|buccal mucosa
659000|NCT00806364|HV|hv
659001|NCT00806364|Healthy Volunteer|healthy volunteer
659002|NCT00806377|Electromagnetic field|electromagnetic field
659003|NCT00806377|Oversensing|oversensing
659004|NCT00806377|Non-thoracic surgery|non-thoracic surgery
659005|NCT00806390|ejection fraction|ejection fraction
659006|NCT00806390|anthracyclines|anthracyclines
659007|NCT00806390|beta-adrenergic blockade|beta-adrenergic blockade
659008|NCT00806390|Patients receiving anthracyclines|patients receiving anthracyclines
659009|NCT00806403|thrombolysis|thrombolysis
659010|NCT00806403|primary PCI|primary pci
659011|NCT00806403|abciximab|abciximab
659012|NCT00806403|ST-segment resolution|st-segment resolution
659013|NCT00806403|TIMI flow|timi flow
659014|NCT00806429|appendicitis|appendicitis
659015|NCT00806429|surgery|surgery
659016|NCT00806429|laparoscopy|laparoscopy
659017|NCT00806429|natural orifice transluminal surgery|natural orifice transluminal surgery
659018|NCT00806442|Asthma|asthma
659019|NCT00806442|Fatty acids|fatty acids
659020|NCT00806442|Leukotrienes|leukotrienes
659021|NCT00806442|Diet|diet
659022|NCT00806455|to determine how often exercise-induced bronchospasm|to determine how often exercise-induced bronchospasm
659023|NCT00806455|occurs in cystic fibrosis|occurs in cystic fibrosis
659024|NCT00806455|Exercise-induced bronchospasm in cystic fibrosis|exercise-induced bronchospasm in cystic fibrosis
659025|NCT00806468|nycturia|nycturia
659026|NCT00806468|Parkinson syndrome|parkinson syndrome
659027|NCT00806468|desmopressin|desmopressin
659028|NCT00806468|Nocturnal polyuria in patients with Parkinson syndrome|nocturnal polyuria in patients with parkinson syndrome
659029|NCT00806481|Phosphate|phosphate
659030|NCT00806494|Fesoterodine|fesoterodine
659031|NCT00806494|Open Label|open label
659032|NCT00806494|Flexible Dose|flexible dose
659033|NCT00806494|OAB|oab
659034|NCT00806507|Tissue Doppler Imaging|tissue doppler imaging
659035|NCT00806507|B-type natriuretic peptide|b-type natriuretic peptide
659036|NCT00806507|Advia Centaur immunoassay system|advia centaur immunoassay system
659037|NCT00806507|GE Vivid ultrasound machine|ge vivid ultrasound machine
659038|NCT00806507|Roche 2010 system|roche 2010 system
659039|NCT00806507|Echocardiography|echocardiography
659040|NCT00806507|Herceptin|herceptin
659041|NCT00806520|Continuous Glucose Monitoring|continuous glucose monitoring
659042|NCT00806520|Exenatide Once Weekly or|exenatide once weekly or
659043|NCT00806520|Januvia or|januvia or
659044|NCT00806520|Actos|actos
659045|NCT00806559|effects clinical space|effects clinical space
659046|NCT00806559|follow-up appointments|follow-up appointments
752390|NCT01172795|neural inhibition|neural inhibition
659047|NCT00806572|Diabetes, juvenile diabetes, teplizumab|diabetes, juvenile diabetes, teplizumab
659048|NCT00806598|Myelodysplastic Syndrome|myelodysplastic syndrome
659049|NCT00806598|Aplastic Anemia|aplastic anemia
659050|NCT00806598|Thymoglobulin|thymoglobulin
659051|NCT00806598|Cyclosporine|cyclosporine
659052|NCT00806598|Methylprednisolone|methylprednisolone
659053|NCT00806598|G-CSF|g-csf
659054|NCT00806611|pancreatic cancer|pancreatic cancer
659055|NCT00806611|periampullary cancer|periampullary cancer
659056|NCT00806611|resectable|resectable
659057|NCT00806611|unresectable|unresectable
659058|NCT00806611|celiac plexus neurolysis|celiac plexus neurolysis
659059|NCT00806611|surgery|surgery
659060|NCT00806637|Vessel sealing system|vessel sealing system
659061|NCT00806637|uvulopalatoplasty|uvulopalatoplasty
659062|NCT00806637|UPPP|uppp
659063|NCT00806637|uvulopalatal flap|uvulopalatal flap
659064|NCT00806637|bleeding|bleeding
659065|NCT00806637|operative time|operative time
659066|NCT00806637|adverse effects|adverse effects
659067|NCT00806650|stage I renal cell cancer|stage i renal cell cancer
659068|NCT00806650|stage II renal cell cancer|stage ii renal cell cancer
659069|NCT00806650|stage III renal cell cancer|stage iii renal cell cancer
659070|NCT00806650|stage IV renal cell cancer|stage iv renal cell cancer
659071|NCT00806663|mCRC|mcrc
659072|NCT00806663|colorectal cancer|colorectal cancer
659073|NCT00806663|FOLFIRI|folfiri
659074|NCT00806663|sunitinib|sunitinib
659075|NCT00806663|DCE-MRI|dce-mri
659076|NCT00806663|DCE-USI|dce-usi
659077|NCT00806676|chronic kidney disease|chronic kidney disease
659078|NCT00806676|children|children
659079|NCT00806676|dialysis|dialysis
659081|NCT00806676|human papilloma virus|human papilloma virus
659082|NCT00806676|Gardasil|gardasil
659083|NCT00806676|Chronic kidney disease (non-dialysis, dialysis, and kidney transplant) secondary to any cause.|chronic kidney disease (non-dialysis, dialysis, and kidney transplant) secondary to any cause.
659704|NCT00816179|Whipple|whipple
659084|NCT00806689|heart rhythm surveillance|heart rhythm surveillance
659085|NCT00806689|follow-up|follow-up
659086|NCT00806689|atrial fibrillation success|atrial fibrillation success
659087|NCT00806715|hemochromatosis|hemochromatosis
659088|NCT00806715|Iron overload|iron overload
659089|NCT00806715|Stem cell transplant|stem cell transplant
659090|NCT00806715|Pediatrics|pediatrics
659091|NCT00806715|Pediatric Stem cell transplant|pediatric stem cell transplant
659092|NCT00806741|L-NG-Monomethyl Arginine|l-ng-monomethyl arginine
659093|NCT00806741|Optic Nerve Head blood flow|optic nerve head blood flow
659094|NCT00806741|Intraocular Pressure|intraocular pressure
659095|NCT00806741|Regional blood flow|regional blood flow
659096|NCT00806741|Ocular Physiology|ocular physiology
659097|NCT00806741|Optic Disk|optic disk
659098|NCT00806754|Perennial Allergic Rhinitis|perennial allergic rhinitis
659099|NCT00806754|Ciclesonide|ciclesonide
659101|NCT00806767|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
659102|NCT00806767|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
659103|NCT00806767|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
659104|NCT00806767|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
659105|NCT00806767|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
659106|NCT00806767|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
659107|NCT00806767|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
659108|NCT00806767|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
659109|NCT00806767|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
659110|NCT00806767|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
659111|NCT00806767|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
659112|NCT00806767|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
659113|NCT00806767|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
659114|NCT00806767|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
659115|NCT00806767|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
659116|NCT00806767|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
659117|NCT00806767|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
659118|NCT00806767|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
659119|NCT00806767|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
659120|NCT00806767|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
659121|NCT00806767|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
659122|NCT00806767|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
659123|NCT00806767|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
659124|NCT00806767|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
659125|NCT00806767|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
659126|NCT00806767|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
659127|NCT00806767|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
659128|NCT00806767|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
752391|NCT01172795|neuropsychological tests|neuropsychological tests
659129|NCT00806767|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
659130|NCT00806767|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
659131|NCT00806767|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
659132|NCT00806767|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
659133|NCT00806767|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
659134|NCT00806767|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
659135|NCT00806767|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
659299|NCT00807430|EMG|emg
659136|NCT00806767|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
659137|NCT00806767|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
659138|NCT00806767|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
659139|NCT00806767|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
659140|NCT00806767|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
659141|NCT00806767|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
659142|NCT00806767|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
659143|NCT00806767|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
659144|NCT00806767|splenic marginal zone lymphoma|splenic marginal zone lymphoma
659145|NCT00806767|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
659146|NCT00806767|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
659147|NCT00806767|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
659148|NCT00806767|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
659149|NCT00806767|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
659150|NCT00806767|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
659151|NCT00806767|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
660331|NCT00811200|uveal|uveal
659152|NCT00806767|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
659153|NCT00806767|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
659154|NCT00806767|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
659155|NCT00806767|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
659156|NCT00806767|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
659157|NCT00806767|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
659158|NCT00806767|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
659159|NCT00806767|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
659160|NCT00806767|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
659161|NCT00806767|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
659162|NCT00806767|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
659163|NCT00806767|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
659164|NCT00806767|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
659165|NCT00806767|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
659166|NCT00806767|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
659167|NCT00806767|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
659168|NCT00806767|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
659169|NCT00806767|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
659170|NCT00806767|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
659171|NCT00806767|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
659172|NCT00806767|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
659173|NCT00806767|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
659174|NCT00806767|refractory hairy cell leukemia|refractory hairy cell leukemia
659175|NCT00806767|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
659176|NCT00806767|secondary acute myeloid leukemia|secondary acute myeloid leukemia
659177|NCT00806767|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
659178|NCT00806767|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
659179|NCT00806767|chronic eosinophilic leukemia|chronic eosinophilic leukemia
659180|NCT00806767|primary myelofibrosis|primary myelofibrosis
659181|NCT00806767|chronic neutrophilic leukemia|chronic neutrophilic leukemia
659182|NCT00806767|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
659183|NCT00806767|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
659184|NCT00806767|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
659185|NCT00806767|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
659186|NCT00806767|stage I multiple myeloma|stage i multiple myeloma
659187|NCT00806767|stage II multiple myeloma|stage ii multiple myeloma
659188|NCT00806767|stage III multiple myeloma|stage iii multiple myeloma
659189|NCT00806767|refractory multiple myeloma|refractory multiple myeloma
659190|NCT00806780|gallstones|gallstones
659191|NCT00806780|cholangiography|cholangiography
659192|NCT00806806|pain management|pain management
659193|NCT00806806|postoperative|postoperative
659194|NCT00806832|Medical clowns|medical clowns
659195|NCT00806832|Cataract surgery|cataract surgery
659196|NCT00806832|Blood pressure|blood pressure
659197|NCT00806832|Heart rate|heart rate
659199|NCT00806845|B-lymphocyte|b-lymphocyte
659200|NCT00806884|Cystic Fibrosis|cystic fibrosis
659201|NCT00806884|Musculoskeletal Physiotherapy|musculoskeletal physiotherapy
659202|NCT00806884|Manual therapy|manual therapy
659203|NCT00806884|Posture|posture
659204|NCT00806884|Pain|pain
659205|NCT00806910|Heart Failure|heart failure
659206|NCT00806910|conivaptan|conivaptan
659207|NCT00806910|Diuresis|diuresis
659208|NCT00806988|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
659209|NCT00806988|Mitral Valve Regurgitation|mitral valve regurgitation
659210|NCT00807001|Hepatitis C, HCV, treatment-naive|hepatitis c, hcv, treatment-naive
659211|NCT00807014|Differin|differin
659212|NCT00807014|quality of life|quality of life
659213|NCT00807014|Acne|acne
659214|NCT00807014|Duac|duac
659215|NCT00807014|Acne Vulgaris|acne vulgaris
659216|NCT00807027|Glioblastoma|glioblastoma
659217|NCT00807027|Newly diagnosed Glioblastoma|newly diagnosed glioblastoma
659218|NCT00807040|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
659219|NCT00807040|Mitral Valve Disease|mitral valve disease
659220|NCT00807040|Severe Mitral Regurgitation|severe mitral regurgitation
659221|NCT00807053|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
659223|NCT00807053|SAR|sar
659224|NCT00807066|QUALITY OF LIFE|quality of life
659225|NCT00807079|recurrent cervical cancer|recurrent cervical cancer
659226|NCT00807079|stage IVB cervical cancer|stage ivb cervical cancer
659227|NCT00807079|stage IVA cervical cancer|stage iva cervical cancer
659228|NCT00807079|cervical adenocarcinoma|cervical adenocarcinoma
660334|NCT00811200|ranibizumab|ranibizumab
659229|NCT00807079|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
659230|NCT00807079|cervical squamous cell carcinoma|cervical squamous cell carcinoma
659231|NCT00807105|MOOD EVALUATION|mood evaluation
659232|NCT00807118|bioequivalence, food effect|bioequivalence, food effect
659233|NCT00807131|pharmacy care|pharmacy care
659234|NCT00807131|hypertension|hypertension
659235|NCT00807131|primary care|primary care
659236|NCT00807131|adherence|adherence
659237|NCT00807144|Kidney transplant|kidney transplant
659238|NCT00807144|Rejection|rejection
659239|NCT00807144|Adherence|adherence
659240|NCT00807144|Quality of life|quality of life
659241|NCT00807157|PROBIOSTICK®|probiostick®
659242|NCT00807157|Probiotic|probiotic
659243|NCT00807157|Anxiety|anxiety
659244|NCT00807157|Daily stress|daily stress
659245|NCT00807170|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
659246|NCT00807170|Whole Brain Radiotherapy|whole brain radiotherapy
659247|NCT00807170|metastasis|metastasis
659248|NCT00807196|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
659249|NCT00807196|Zevalin|zevalin
659250|NCT00807196|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
659251|NCT00807209|Pain|pain
659252|NCT00807209|postoperative|postoperative
659253|NCT00807209|thoracotomy|thoracotomy
659254|NCT00807222|ADHD|adhd
659255|NCT00807222|Vyvanse|vyvanse
659256|NCT00807222|lisdexamfetamine dimesylate|lisdexamfetamine dimesylate
659257|NCT00807222|LDX|ldx
659258|NCT00807222|sleep|sleep
659259|NCT00807235|Lucinactant|lucinactant
659260|NCT00807235|Nasal continuous positive airway pressure (nCPAP)|nasal continuous positive airway pressure (ncpap)
659261|NCT00807235|Respiratory distress syndrome (RDS)|respiratory distress syndrome (rds)
659262|NCT00807235|Pediatric|pediatric
659263|NCT00807235|Premature|premature
659264|NCT00807274|Adult congenital heart disease|adult congenital heart disease
659265|NCT00807274|Heart failure|heart failure
659266|NCT00807274|Renal failure|renal failure
659267|NCT00807274|Proteinuria|proteinuria
659268|NCT00807287|jejunal tube placement|jejunal tube placement
659269|NCT00807300|percutaneous treatment|percutaneous treatment
659270|NCT00807313|Oligometastatic disease|oligometastatic disease
659271|NCT00807313|Colorectal cancer|colorectal cancer
659272|NCT00807313|Stereotactic body radiotherapy|stereotactic body radiotherapy
659273|NCT00807313|Tomotherapy|tomotherapy
659274|NCT00807313|Metabolic response|metabolic response
659275|NCT00807313|Stage IV|stage iv
659276|NCT00807326|Antidiarrheals|antidiarrheals
659277|NCT00807339|CyberKnife|cyberknife
659278|NCT00807352|Triage|triage
659279|NCT00807352|Pediatrics|pediatrics
659280|NCT00807352|Emergency Department|emergency department
659281|NCT00807365|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone
659282|NCT00807365|Growth Hormone Insufficiency|growth hormone insufficiency
659283|NCT00807365|Aging|aging
659284|NCT00807365|Growth Hormone|growth hormone
659285|NCT00807365|Physiological Effects of Drugs|physiological effects of drugs
659286|NCT00807365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
659287|NCT00807365|Hormones|hormones
659288|NCT00807378|CNS viral infection|cns viral infection
659289|NCT00807378|PCR|pcr
659290|NCT00807378|HYBRIDIZATION|hybridization
659291|NCT00807391|lung cancer|lung cancer
659292|NCT00807391|transbronchial biopsy|transbronchial biopsy
659293|NCT00807391|transbronchial catheter aspiration|transbronchial catheter aspiration
659294|NCT00807391|transbronchial needle aspiration|transbronchial needle aspiration
659295|NCT00807391|peripheral pulmonary lesion|peripheral pulmonary lesion
659296|NCT00807391|bronchoscopy|bronchoscopy
659297|NCT00807404|ductal intraepithelial neoplasia|ductal intraepithelial neoplasia
659298|NCT00807430|Bruxism|bruxism
659300|NCT00807430|Biofeedback|biofeedback
659301|NCT00807443|HIV-1|hiv-1
659542|NCT00815568|conditioning regimen|conditioning regimen
659302|NCT00807443|integrase inhibitor (raltegravir)|integrase inhibitor (raltegravir)
659303|NCT00807443|the cell reservoir of HIV-1|the cell reservoir of hiv-1
659304|NCT00807443|treatment experienced|treatment experienced
659305|NCT00807469|COPD|copd
659306|NCT00807469|smoking|smoking
659307|NCT00807469|susceptibility|susceptibility
659308|NCT00807469|inflammation|inflammation
659309|NCT00807469|genetic|genetic
659310|NCT00807482|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
659311|NCT00807482|Mucociliary Clearance|mucociliary clearance
659312|NCT00807482|Genetic Mutation|genetic mutation
659313|NCT00807495|MLN8237|mln8237
659314|NCT00807495|alisertib|alisertib
659315|NCT00807534|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
659316|NCT00807534|Exercise|exercise
659317|NCT00807534|3-min constant rate stepping test|3-min constant rate stepping test
659318|NCT00807534|3-min constant rate walking test|3-min constant rate walking test
659319|NCT00807534|Bronchodilation|bronchodilation
659320|NCT00807534|Ipratropium bromide|ipratropium bromide
659321|NCT00807560|Overweight|overweight
659322|NCT00807560|Obesity|obesity
659323|NCT00807560|Adolescents|adolescents
659324|NCT00807560|Family Therapy|family therapy
659325|NCT00807573|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
659326|NCT00807573|PEMETREXED (ALTIMA)|pemetrexed (altima)
659327|NCT00807573|TAXOL (PACLITAXEL)|taxol (paclitaxel)
659328|NCT00807573|08-109|08-109
659329|NCT00807586|Atrial Fibrillation|atrial fibrillation
659330|NCT00807586|Corticosteroid|corticosteroid
659331|NCT00807586|Radiofrequency catheter ablation for atrial fibrillation|radiofrequency catheter ablation for atrial fibrillation
659332|NCT00807599|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
659333|NCT00807599|DEXAMETHASONE|dexamethasone
659334|NCT00807599|G-CSF|g-csf
659335|NCT00807599|Lenalidomide|lenalidomide
659336|NCT00807599|MELPHALAN|melphalan
659337|NCT00807599|PEG-FILGRASTIM (NEULASTA)|peg-filgrastim (neulasta)
659338|NCT00807599|08-121|08-121
659339|NCT00814138|myasthenia gravis|myasthenia gravis
659340|NCT00814151|Blood culture|blood culture
659341|NCT00814151|Staphylococcus aureus|staphylococcus aureus
659342|NCT00814151|Bacteremia|bacteremia
659343|NCT00814151|MRSA|mrsa
659344|NCT00814151|MSSA|mssa
659345|NCT00814151|MicroPhage|microphage
659346|NCT00814164|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
659347|NCT00814164|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
659348|NCT00814164|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
659349|NCT00814164|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
659350|NCT00814164|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
659351|NCT00814164|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
659352|NCT00814164|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
659353|NCT00814164|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
659354|NCT00814164|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
659355|NCT00814164|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
659356|NCT00814164|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
659357|NCT00814164|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
659358|NCT00814164|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
659359|NCT00814164|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
659360|NCT00814164|secondary acute myeloid leukemia|secondary acute myeloid leukemia
659361|NCT00814177|warfarin|warfarin
659362|NCT00814177|dosing|dosing
659363|NCT00814177|prothrombin time|prothrombin time
659364|NCT00814177|Heart valve prosthesis|heart valve prosthesis
659365|NCT00814190|Type 2 Diabetes|type 2 diabetes
659366|NCT00814190|Internet Therapeutic Intervention|internet therapeutic intervention
659367|NCT00814203|COPD|copd
659368|NCT00814216|Efficacy|efficacy
659369|NCT00814216|safety|safety
659370|NCT00814216|QAV680|qav680
659371|NCT00814216|pharmacokinetics|pharmacokinetics
659372|NCT00814216|corticosteroid|corticosteroid
659373|NCT00814216|asthma|asthma
659374|NCT00814229|influenza|influenza
659375|NCT00814229|H9N2|h9n2
659376|NCT00814229|vaccine|vaccine
659377|NCT00814242|Hepatocellular Carcinoma|hepatocellular carcinoma
659378|NCT00814242|Adjacent to Major Blood Vessels|adjacent to major blood vessels
659379|NCT00814242|Surgical resection|surgical resection
659380|NCT00814242|Ppercutaneous radiationfrequency ablation|ppercutaneous radiationfrequency ablation
659381|NCT00814242|Time to recurrence|time to recurrence
659382|NCT00814242|Disease-free survival|disease-free survival
659383|NCT00814242|Overall survival|overall survival
659384|NCT00814255|Primary FSGS|primary fsgs
659385|NCT00814255|Steroid Resistant|steroid resistant
659386|NCT00814255|Rosiglitazone|rosiglitazone
659387|NCT00814255|Adalimumab|adalimumab
659388|NCT00814255|Resistant primary FSGS|resistant primary fsgs
659389|NCT00814255|GALACTOSE|galactose
659390|NCT00814281|particulate air pollution|particulate air pollution
659391|NCT00814281|leukotriene|leukotriene
659392|NCT00814281|asthma|asthma
659393|NCT00814281|montelukast|montelukast
659394|NCT00814281|vascular endothelial dysfunction|vascular endothelial dysfunction
659395|NCT00814281|nitric oxide(NO)endothelin (ET) system|nitric oxide(no)endothelin (et) system
659396|NCT00814294|Type 2|type 2
659397|NCT00814307|Antirheumatic Agents Clinical Trial|antirheumatic agents clinical trial
659398|NCT00814333|epistaxis|epistaxis
659399|NCT00814346|Mild Alzheimer's disease (AD) patients|mild alzheimer's disease (ad) patients
659400|NCT00814346|Memory complaint patients with cognitive impairment (MC)|memory complaint patients with cognitive impairment (mc)
751807|NCT01170546|knee stability|knee stability
659401|NCT00814346|Memory complaint patients cognitively normal (CNE)|memory complaint patients cognitively normal (cne)
659402|NCT00814359|mucositis|mucositis
659403|NCT00814359|radiation|radiation
659404|NCT00814359|magic mouthwash|magic mouthwash
659405|NCT00814359|sucralfate|sucralfate
659406|NCT00814359|benzydamine|benzydamine
659407|NCT00814359|diphenhydramine|diphenhydramine
659408|NCT00814359|dexamethasone|dexamethasone
659409|NCT00814359|nystatin|nystatin
659410|NCT00814398|Infertility|infertility
659412|NCT00814398|SET|set
659413|NCT00814398|DET|det
659414|NCT00814398|Blastocyst|blastocyst
659415|NCT00814411|contraception|contraception
659416|NCT00814411|noninferiority|noninferiority
659417|NCT00814411|intention|intention
659418|NCT00814411|family planning counseling|family planning counseling
659419|NCT00814411|post abortion care|post abortion care
659663|NCT00816049|child|child
659420|NCT00814411|Family planning intention among women with unmet need|family planning intention among women with unmet need
659421|NCT00814424|EtCO2|etco2
659422|NCT00814424|supplemental oxygen delivery|supplemental oxygen delivery
659423|NCT00814424|ERCP|ercp
659424|NCT00814450|Biopsy|biopsy
659425|NCT00814450|Fine needle aspiration|fine needle aspiration
659426|NCT00814463|tumors metastatic to brain|tumors metastatic to brain
659427|NCT00814463|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
659428|NCT00815087|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
659429|NCT00815087|functional electrical stimulation|functional electrical stimulation
659430|NCT00815100|Ivabradine|ivabradine
659431|NCT00815100|Acute coronary syndrome.|acute coronary syndrome.
659432|NCT00815100|Inflammation|inflammation
659433|NCT00815100|C-reactive protein|c-reactive protein
659434|NCT00815100|Atherosclerosis|atherosclerosis
659435|NCT00815113|Gastric cancer|gastric cancer
659436|NCT00815113|screening|screening
659437|NCT00815113|high-risk|high-risk
659438|NCT00815113|relatives|relatives
659439|NCT00815113|gastroscopy|gastroscopy
659440|NCT00815139|Coronary artery disease, stent|coronary artery disease, stent
659441|NCT00815152|high grade glioma|high grade glioma
659442|NCT00815152|Coping skills intervention|coping skills intervention
659443|NCT00815152|caregivers|caregivers
659444|NCT00815165|cytomegalovirus, CMV, cell-mediated immunity, children, sub-study|cytomegalovirus, cmv, cell-mediated immunity, children, sub-study
659445|NCT00815178|inspiratory muscle weakness|inspiratory muscle weakness
659446|NCT00815178|autonomic modulation|autonomic modulation
659447|NCT00815178|diabetes mellitus|diabetes mellitus
659448|NCT00815178|heart rate variability|heart rate variability
659449|NCT00815178|functional capacity|functional capacity
659450|NCT00815191|temperature|temperature
659451|NCT00815191|surgery|surgery
659452|NCT00815191|heating device|heating device
659453|NCT00815204|PTSD|ptsd
659454|NCT00815204|HPA axis|hpa axis
659455|NCT00815204|Pituitary volume|pituitary volume
659456|NCT00815217|Lipoaspirate|lipoaspirate
659457|NCT00815217|Diabetes Mellitus|diabetes mellitus
659458|NCT00815217|Mesenchymal Stem cells|mesenchymal stem cells
659459|NCT00815217|Fat grafts|fat grafts
659460|NCT00815217|venous stasis|venous stasis
659461|NCT00815230|radiation injury|radiation injury
659462|NCT00815230|computed tomography|computed tomography
659463|NCT00815230|reactive oxygen species|reactive oxygen species
659464|NCT00815230|free radicals|free radicals
659465|NCT00815243|fracture|fracture
659466|NCT00815243|coxarthrosis|coxarthrosis
659467|NCT00815243|complication|complication
659468|NCT00815243|congenital abnormalities|congenital abnormalities
659469|NCT00815243|bone|bone
659470|NCT00815243|joint|joint
659471|NCT00815243|telemedicine|telemedicine
659472|NCT00815243|transportation|transportation
659473|NCT00815243|decision making|decision making
659474|NCT00815243|outcomes|outcomes
659475|NCT00815256|Cornea degeneration|cornea degeneration
659476|NCT00815256|keratoconus|keratoconus
659477|NCT00815256|collagen cross linking|collagen cross linking
659479|NCT00815256|Riboflavin|riboflavin
659480|NCT00815269|Inhalant anesthetic|inhalant anesthetic
659481|NCT00815269|Vasodilation|vasodilation
659482|NCT00815269|General anesthesia|general anesthesia
659483|NCT00815269|Ultrasonography|ultrasonography
659484|NCT00815295|squamous cell cancer, head and neck|squamous cell cancer, head and neck
659485|NCT00815308|Therapeutic|therapeutic
659674|NCT00816075|recurrent|recurrent
659486|NCT00815308|Drug Therapy, combination|drug therapy, combination
659487|NCT00815308|Radiotherapy|radiotherapy
659488|NCT00815321|chronic myeloid leukemia|chronic myeloid leukemia
659489|NCT00815321|autologous cytokine induced killer cells|autologous cytokine induced killer cells
659490|NCT00815321|Chronic myeloid leukemia in blast crisis treated with chemotherapy or kinase inhibitors|chronic myeloid leukemia in blast crisis treated with chemotherapy or kinase inhibitors
659491|NCT00815321|Chronic myeloid leukemia with mutation resistant to kinase inhibitors|chronic myeloid leukemia with mutation resistant to kinase inhibitors
659492|NCT00815321|chronic myeloid leukemia with good response to kinase inhibitor and stable persistence of residual disease|chronic myeloid leukemia with good response to kinase inhibitor and stable persistence of residual disease
659493|NCT00815334|vesicoureteral reflux|vesicoureteral reflux
659494|NCT00815334|low compliant bladder|low compliant bladder
659495|NCT00815347|Asthma|asthma
659496|NCT00815360|diabetic macular edema|diabetic macular edema
659497|NCT00815373|Ocular Blood flow|ocular blood flow
659498|NCT00815373|Ocular hypertension|ocular hypertension
659499|NCT00815373|POAG|poag
659500|NCT00815373|Ocular hemodynamics|ocular hemodynamics
659501|NCT00815373|Xalacom|xalacom
659502|NCT00815373|Cosopt|cosopt
659503|NCT00815386|mitral valve|mitral valve
659504|NCT00815386|heart failure|heart failure
659505|NCT00815386|mitral regurgitation|mitral regurgitation
659506|NCT00815386|annuloplasty|annuloplasty
659507|NCT00815386|coronary sinus|coronary sinus
659508|NCT00815425|African American|african american
659509|NCT00815438|Transvaginal|transvaginal
659510|NCT00815438|Cholecystectomy|cholecystectomy
659513|NCT00815464|Chronic Hepatitis B|chronic hepatitis b
659514|NCT00815464|Liquid Acupuncture(Herb Acupoint Injection)|liquid acupuncture(herb acupoint injection)
659515|NCT00815464|Therapeutics|therapeutics
659516|NCT00815464|Herbalist|herbalist
659517|NCT00815464|Acupoint|acupoint
659518|NCT00815490|Spectroscopy, near infrared|spectroscopy, near infrared
659519|NCT00815490|Oximetry|oximetry
659520|NCT00815490|Hypoxemia|hypoxemia
659521|NCT00815490|Tissue oxygenation|tissue oxygenation
659522|NCT00815503|Anesthetics|anesthetics
659523|NCT00815503|Local infiltration|local infiltration
659524|NCT00815503|Periacetabular osteotomy|periacetabular osteotomy
659525|NCT00815516|candidiasis|candidiasis
659526|NCT00815516|candida|candida
659527|NCT00815516|Neonate|neonate
659528|NCT00815516|candidemia|candidemia
659529|NCT00815516|Micafungin|micafungin
659530|NCT00815516|Mycamine|mycamine
659531|NCT00815516|amphotericin B deoxycholate|amphotericin b deoxycholate
659532|NCT00815529|Acupuncture|acupuncture
659533|NCT00815529|Chronic low back pain|chronic low back pain
659534|NCT00815529|Qualitative study|qualitative study
659535|NCT00815555|receptor positive breast cancer|receptor positive breast cancer
659536|NCT00815555|Tamoxifen treatment|tamoxifen treatment
659537|NCT00815555|CYP2D6 status|cyp2d6 status
659538|NCT00815555|relapse|relapse
659539|NCT00815568|fludarabine|fludarabine
659540|NCT00815568|busulfan|busulfan
659541|NCT00815568|total body irradiation|total body irradiation
659543|NCT00815581|children between 1 to 10 years old|children between 1 to 10 years old
659544|NCT00815581|amblyopy|amblyopy
659545|NCT00815594|bleb|bleb
659546|NCT00815594|vascular change|vascular change
659547|NCT00815594|bevacizumab|bevacizumab
659548|NCT00815594|trabeculectomy|trabeculectomy
659549|NCT00815594|Bleb vascularity associated with increased scarring activity|bleb vascularity associated with increased scarring activity
659550|NCT00815594|Conjunctival scarring finally leads to the obstruction of the fistula tract created by the filtering surgery|conjunctival scarring finally leads to the obstruction of the fistula tract created by the filtering surgery
659551|NCT00815594|the recombinant human anti-VEGF antibody could inhibit angiogenesis of conjunctiva.|the recombinant human anti-vegf antibody could inhibit angiogenesis of conjunctiva.
659552|NCT00815607|melanoma|melanoma
659553|NCT00815607|biologic|biologic
659554|NCT00815607|immunotherapy|immunotherapy
659555|NCT00815607|cancer|cancer
659556|NCT00815620|neuroendocrine tumors|neuroendocrine tumors
659557|NCT00815620|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
659558|NCT00815620|selective internal radiotherapy|selective internal radiotherapy
659559|NCT00815620|surgery|surgery
659560|NCT00815620|radio-frequency ablation|radio-frequency ablation
659561|NCT00815620|peptide-receptor radiotherapy|peptide-receptor radiotherapy
659562|NCT00815620|progression-free survival|progression-free survival
659563|NCT00815620|quality of life|quality of life
659564|NCT00815620|overall survival|overall survival
659565|NCT00815620|weight|weight
659566|NCT00815620|time of hospitalization|time of hospitalization
659567|NCT00815633|PRP|prp
659568|NCT00815633|Pityriasis Rubra Pilaris|pityriasis rubra pilaris
659569|NCT00815633|Amevive|amevive
659570|NCT00815633|Alefacept|alefacept
659571|NCT00815633|Biologic|biologic
659572|NCT00815633|Immunosuppressant|immunosuppressant
659573|NCT00815633|Severe skin disease|severe skin disease
659574|NCT00815646|Immersion pulmonary edema|immersion pulmonary edema
659575|NCT00815646|Diving|diving
659576|NCT00815646|Swimming|swimming
659577|NCT00815646|Pulmonary edema|pulmonary edema
659578|NCT00815646|Cold water immersion|cold water immersion
659675|NCT00816075|bladder|bladder
659579|NCT00815659|plasma lipid profile|plasma lipid profile
659580|NCT00815659|metabolic syndrome|metabolic syndrome
659581|NCT00815672|Exercise|exercise
659582|NCT00815672|Prostate cancer|prostate cancer
659583|NCT00815672|Fatigue|fatigue
659584|NCT00815685|n-3 fatty acids|n-3 fatty acids
659585|NCT00815685|nutritional treatment|nutritional treatment
659586|NCT00815685|molecular pathogenesis|molecular pathogenesis
659587|NCT00815698|pain|pain
659588|NCT00815711|IPF|ipf
659589|NCT00815724|Daily Inhaled Corticosteroids|daily inhaled corticosteroids
659590|NCT00815724|Distributed Learning|distributed learning
659591|NCT00815724|E-learning|e-learning
659592|NCT00815737|Lung Infection After Cerebral Hemorrhage|lung infection after cerebral hemorrhage
659593|NCT00815737|Prevention of Pneumonia|prevention of pneumonia
659594|NCT00815737|Rhubarb|rhubarb
659595|NCT00815750|Prostate Cancer|prostate cancer
659596|NCT00815763|randomized trial|randomized trial
659597|NCT00815763|ischemic stroke|ischemic stroke
659598|NCT00815763|Ginsenoside-Rd|ginsenoside-rd
659599|NCT00815776|Temporomandibular disorders|temporomandibular disorders
659600|NCT00815802|Children in day care centers|children in day care centers
659601|NCT00815802|cytomegalovirus excretion|cytomegalovirus excretion
659602|NCT00815815|Anorexia Nervosa|anorexia nervosa
659603|NCT00815828|Gestational Diabetes|gestational diabetes
659604|NCT00815828|Resistance Exercise|resistance exercise
659605|NCT00815828|Pregnancy|pregnancy
659606|NCT00815828|Insulin|insulin
659703|NCT00816179|Endoscopic peritoneoscopy|endoscopic peritoneoscopy
659607|NCT00815841|Determine the effect of MPH on a diagnostic continuous performance task that assesses attention and on a decision making test in young healthy adults|determine the effect of mph on a diagnostic continuous performance task that assesses attention and on a decision making test in young healthy adults
659608|NCT00815854|Antipsychotic|antipsychotic
659609|NCT00815854|Metabolic Syndrome|metabolic syndrome
659610|NCT00815854|Insulin Resistance|insulin resistance
659611|NCT00815854|Endothelial Function|endothelial function
659612|NCT00815867|kidney failure|kidney failure
659613|NCT00815867|kidney transplant|kidney transplant
659614|NCT00815867|graft function|graft function
659615|NCT00815867|haemoglobin|haemoglobin
659616|NCT00815867|epoetin|epoetin
659617|NCT00815880|Heart Failure|heart failure
659618|NCT00815880|Device|device
659619|NCT00815880|Implantable|implantable
659620|NCT00815880|Active|active
659621|NCT00815880|Class III and Class IV|class iii and class iv
659622|NCT00815880|Counterpulsation|counterpulsation
659623|NCT00815893|Dexmedetomidine|dexmedetomidine
659624|NCT00815893|Fiberoptic nasal intubation|fiberoptic nasal intubation
659625|NCT00815893|satisfaction|satisfaction
659626|NCT00815919|cGVHD|cgvhd
659627|NCT00815919|Velcade|velcade
659628|NCT00815919|bortezomib|bortezomib
659629|NCT00815945|leiomyosarcoma|leiomyosarcoma
659630|NCT00815945|carcinosarcoma|carcinosarcoma
659631|NCT00815945|mixed epithelial mesenchymal tumor|mixed epithelial mesenchymal tumor
659632|NCT00815945|endometrial stroma sarcomas|endometrial stroma sarcomas
659633|NCT00815945|Müllerian mixed tumors|müllerian mixed tumors
659634|NCT00815945|carcinosarcoma of the uterus|carcinosarcoma of the uterus
659635|NCT00815945|mesenchymal tumors of the ovary or uterus|mesenchymal tumors of the ovary or uterus
659636|NCT00815945|mixed epithelial mesenchymal tumors of the ovary or uterus|mixed epithelial mesenchymal tumors of the ovary or uterus
659637|NCT00815958|knee replacement surgery|knee replacement surgery
659638|NCT00815958|Reamer-Irrigator-Aspirator|reamer-irrigator-aspirator
659639|NCT00815958|femoral reaming|femoral reaming
659640|NCT00815958|fat embolism|fat embolism
659641|NCT00815971|EGFR mutations|egfr mutations
659642|NCT00815971|EGFR inhibitor|egfr inhibitor
659643|NCT00815971|erlotinib|erlotinib
659644|NCT00815984|Asthma|asthma
659645|NCT00815984|Allergic Rhinitis|allergic rhinitis
659646|NCT00815984|Atopic Dermatitis|atopic dermatitis
659647|NCT00815984|Children|children
659648|NCT00815984|lung function|lung function
659649|NCT00815984|skin prick tests|skin prick tests
659650|NCT00815984|FeNO|feno
659651|NCT00815997|radial artery|radial artery
659652|NCT00815997|transradial intervention|transradial intervention
659653|NCT00815997|stent|stent
659654|NCT00816010|drug compliance|drug compliance
659655|NCT00816010|lifestyle modification|lifestyle modification
659656|NCT00816036|Smoking Cessation|smoking cessation
659657|NCT00816036|Practice Guidelines|practice guidelines
659658|NCT00816036|Inpatient|inpatient
659659|NCT00816036|Effectiveness Trial|effectiveness trial
659660|NCT00816036|Veterans Administration|veterans administration
659661|NCT00816036|Relapse prevention|relapse prevention
659662|NCT00816049|acute lymphoblastic leukemia|acute lymphoblastic leukemia
659664|NCT00816049|6-mercaptopurine|6-mercaptopurine
659665|NCT00816049|minimal residual disease|minimal residual disease
659666|NCT00816049|efficacy|efficacy
659667|NCT00816049|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
659668|NCT00816062|Aortic Aneurysm|aortic aneurysm
659669|NCT00816062|Aneurysm|aneurysm
659670|NCT00816062|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
659671|NCT00816062|Talent|talent
659672|NCT00816062|Medtronic|medtronic
659673|NCT00816075|distilled water|distilled water
659676|NCT00816075|mitomycin|mitomycin
659677|NCT00816088|chemotherapy|chemotherapy
659678|NCT00816088|Stem cell transplantation|stem cell transplantation
659679|NCT00816101|Curettage and electrodesiccation|curettage and electrodesiccation
659680|NCT00816101|acute wounds|acute wounds
659681|NCT00816101|partial thickness wounds|partial thickness wounds
659682|NCT00816114|Imatinib|imatinib
659683|NCT00816114|Gleevec|gleevec
659684|NCT00816114|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
659685|NCT00816114|CML|cml
659686|NCT00816127|liver cirrhosis|liver cirrhosis
659687|NCT00816127|coagulopathy|coagulopathy
659688|NCT00816127|desmopressin|desmopressin
659689|NCT00816127|blood transfusion|blood transfusion
751808|NCT01170546|hamstring|hamstring
659690|NCT00816140|Helicobacter pylori|helicobacter pylori
659691|NCT00816140|levofloxacin|levofloxacin
659692|NCT00816140|clarithromycin|clarithromycin
659693|NCT00816140|ERADICATION RATE|eradication rate
659694|NCT00816153|Pleth variability Index|pleth variability index
659695|NCT00816153|Fluid management|fluid management
659696|NCT00816153|Fluid management during surgery|fluid management during surgery
659697|NCT00816166|Ischemic stroke|ischemic stroke
659698|NCT00816166|Transient Ischemic Attack|transient ischemic attack
659699|NCT00816166|Intracranial Stenting|intracranial stenting
659700|NCT00816179|Pancreatic head mass|pancreatic head mass
659701|NCT00816179|Pancreatic cancer|pancreatic cancer
659702|NCT00816179|NOTES|notes
659864|NCT00816530|somo•v|somo•v
659705|NCT00816179|palliative gastrojejunostomy|palliative gastrojejunostomy
659706|NCT00816192|FA|fa
659707|NCT00816192|Atrial fibrillation|atrial fibrillation
659708|NCT00816192|Catheter|catheter
659709|NCT00816192|Ablation|ablation
659710|NCT00816192|RF|rf
659711|NCT00816231|Prevention Intervention|prevention intervention
659712|NCT00816231|Alcohol|alcohol
659713|NCT00816231|Tobacco|tobacco
659714|NCT00816231|Nicotine|nicotine
659715|NCT00816231|Craving|craving
659716|NCT00816231|Cue Reactivity|cue reactivity
659717|NCT00816231|Cross Cue Reactions|cross cue reactions
659718|NCT00816244|Breast cancer|breast cancer
659719|NCT00816244|Postmenopausal|postmenopausal
659720|NCT00816244|Neo-adjuvant|neo-adjuvant
659721|NCT00816244|Tumor proliferation|tumor proliferation
659722|NCT00816244|Statin|statin
659723|NCT00816244|Atorvastatin|atorvastatin
659724|NCT00816244|Ki67|ki67
659725|NCT00816244|Translational research|translational research
659726|NCT00816244|Cell cycle regulators|cell cycle regulators
659727|NCT00816244|Gene expression|gene expression
659728|NCT00816244|Genomic profiling|genomic profiling
659729|NCT00816244|Apoptosis|apoptosis
659730|NCT00816244|Window-of-opportunity|window-of-opportunity
659731|NCT00816257|lung tissue repository|lung tissue repository
659732|NCT00816270|Blepharoptosis|blepharoptosis
659733|NCT00816270|Dermatochalasis|dermatochalasis
659734|NCT00816270|octyl 2-cyanoacrylate|octyl 2-cyanoacrylate
659735|NCT00816270|Suture Techniques|suture techniques
659736|NCT00816270|Tissue Adhesive|tissue adhesive
659737|NCT00816283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
659738|NCT00816283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
659739|NCT00816283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
659740|NCT00816283|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
659741|NCT00816283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
659742|NCT00816283|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
659743|NCT00816296|NAFLD|nafld
659744|NCT00816296|Obesity|obesity
659745|NCT00816296|Microbiome|microbiome
659746|NCT00816309|physiotherapy|physiotherapy
659747|NCT00816309|bronchiectasis|bronchiectasis
659748|NCT00816335|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
659749|NCT00816348|Cholestasis|cholestasis
659750|NCT00816348|Parenteral Nutrition Associated Liver Disease|parenteral nutrition associated liver disease
659751|NCT00816374|cutaneous malignant melanoma|cutaneous malignant melanoma
659752|NCT00816374|CMM|cmm
659753|NCT00816374|total cutaneous examination|total cutaneous examination
659754|NCT00816374|TCE|tce
659755|NCT00816374|skin self-examination|skin self-examination
659756|NCT00816374|SSE|sse
659757|NCT00816374|first degree relatives|first degree relatives
659758|NCT00816374|FDR|fdr
659759|NCT00816374|skin cancer protection|skin cancer protection
659760|NCT00816374|skin cancer screening|skin cancer screening
659761|NCT00816413|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
659762|NCT00816413|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
659763|NCT00816413|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
659764|NCT00816413|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
659765|NCT00816413|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
659766|NCT00816413|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
659833|NCT00816439|Brain Imaging|brain imaging
659767|NCT00816413|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
659768|NCT00816413|secondary acute myeloid leukemia|secondary acute myeloid leukemia
659769|NCT00816413|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
659770|NCT00816413|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
659771|NCT00816413|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
659772|NCT00816413|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
659773|NCT00816413|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
659774|NCT00816413|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
659775|NCT00816413|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
659776|NCT00816413|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
659777|NCT00816413|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
659778|NCT00816413|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
659779|NCT00816413|essential thrombocythemia|essential thrombocythemia
659780|NCT00816413|polycythemia vera|polycythemia vera
659781|NCT00816413|primary myelofibrosis|primary myelofibrosis
659782|NCT00816413|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
659783|NCT00816413|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
659784|NCT00816413|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
659785|NCT00816413|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
659786|NCT00816413|splenic marginal zone lymphoma|splenic marginal zone lymphoma
659787|NCT00816413|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
659788|NCT00816413|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
659789|NCT00816413|aplastic anemia|aplastic anemia
659790|NCT00816413|chronic eosinophilic leukemia|chronic eosinophilic leukemia
659791|NCT00816413|chronic neutrophilic leukemia|chronic neutrophilic leukemia
659792|NCT00816413|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
659793|NCT00816413|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
659794|NCT00816413|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
659795|NCT00816413|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
659796|NCT00816413|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
659797|NCT00816413|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
659798|NCT00816413|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
659799|NCT00816413|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
659800|NCT00816413|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
659801|NCT00816413|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
659802|NCT00816413|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
659803|NCT00816413|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
659804|NCT00816413|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
659805|NCT00816413|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
659806|NCT00816413|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
659807|NCT00816413|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
659808|NCT00816413|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
659809|NCT00816413|stage I marginal zone lymphoma|stage i marginal zone lymphoma
659810|NCT00816413|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
659811|NCT00816413|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
659812|NCT00816413|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
659813|NCT00816413|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
659814|NCT00816413|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
659815|NCT00816413|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
659816|NCT00816413|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
659817|NCT00816413|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
659818|NCT00816413|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
659819|NCT00816413|stage I mantle cell lymphoma|stage i mantle cell lymphoma
659820|NCT00816413|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
752392|NCT01172834|Nurses|nurses
659821|NCT00816413|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
659822|NCT00816413|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
659823|NCT00816413|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
659824|NCT00816413|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
659825|NCT00816413|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
659826|NCT00816413|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
659827|NCT00816426|Tuberculosis|tuberculosis
659829|NCT00816426|Pharmacokinetics|pharmacokinetics
659830|NCT00816426|Maldistribution|maldistribution
659831|NCT00816426|Histopathology|histopathology
659832|NCT00816439|Positron Emission Tomography|positron emission tomography
659834|NCT00816439|Alcoholism|alcoholism
659835|NCT00816452|Osteoporosis|osteoporosis
659836|NCT00816452|Prostate Cancer|prostate cancer
659837|NCT00816452|Osteoporosis in male with Prostate Cancer|osteoporosis in male with prostate cancer
659838|NCT00816465|Hoodia gordoni|hoodia gordoni
659839|NCT00816465|NASH|nash
659840|NCT00816465|NAFLD|nafld
659841|NCT00816478|FSGS|fsgs
659842|NCT00816478|Permeability factor|permeability factor
659843|NCT00816478|Galactose|galactose
659844|NCT00816478|Primary FSGS, resistant to immunosuppressive medication|primary fsgs, resistant to immunosuppressive medication
659845|NCT00816491|patient with long-standing UC|patient with long-standing uc
659846|NCT00816504|FSGS|fsgs
659847|NCT00816504|Permeability factor|permeability factor
659848|NCT00816504|Galactose|galactose
659849|NCT00816504|Primary FSGS, resistant to immunosuppressive medication|primary fsgs, resistant to immunosuppressive medication
659850|NCT00816517|Psoriasis|psoriasis
659851|NCT00816517|Botulinum toxin|botulinum toxin
659852|NCT00816530|breast|breast
659853|NCT00816530|breast cancer|breast cancer
659854|NCT00816530|breast screening|breast screening
659855|NCT00816530|breast cancer screening|breast cancer screening
659856|NCT00816530|ultrasound|ultrasound
659857|NCT00816530|ultrasonography|ultrasonography
659858|NCT00816530|mammogram|mammogram
659859|NCT00816530|mammography|mammography
659860|NCT00816530|breast density|breast density
659861|NCT00816530|dense breasts|dense breasts
659862|NCT00816530|early detection|early detection
659863|NCT00816530|somo v|somo v
659866|NCT00816530|Automated Breast Ultrasound|automated breast ultrasound
659867|NCT00816530|Ultrasonography, Mammary|ultrasonography, mammary
659868|NCT00816530|Breast Neoplasms|breast neoplasms
659869|NCT00816530|Breast Density > 50% (BI-RADS III & IV)|breast density > 50% (bi-rads iii & iv)
659870|NCT00816569|Orthokeratology|orthokeratology
659871|NCT00816569|Keratoconus|keratoconus
659872|NCT00816582|Post-menopausal hormone receptor positive recurrent/metastatic breast cancer.|post-menopausal hormone receptor positive recurrent/metastatic breast cancer.
659873|NCT00816582|PET/CT|pet/ct
659874|NCT00816582|Recurrent or metastatic|recurrent or metastatic
659875|NCT00816595|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
659876|NCT00816595|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
659877|NCT00816595|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
659878|NCT00816595|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
659879|NCT00816595|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
659880|NCT00816595|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
659881|NCT00816595|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
659882|NCT00816595|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
659883|NCT00816595|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
659884|NCT00816595|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
659885|NCT00816595|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
659886|NCT00816608|diabetes|diabetes
659887|NCT00816608|prediabetes|prediabetes
659888|NCT00816608|impaired fasting glucose (IFG)|impaired fasting glucose (ifg)
659889|NCT00816608|impaired glucose tolerance (IGT)|impaired glucose tolerance (igt)
659890|NCT00816608|body weight|body weight
659891|NCT00816621|Internationally Adopted Children|internationally adopted children
659892|NCT00816621|Adoption|adoption
659893|NCT00816621|Attachment|attachment
659894|NCT00816621|Inattention|inattention
659895|NCT00816621|Prevention|prevention
659896|NCT00816634|First line chemotherapy|first line chemotherapy
659897|NCT00816634|Advanced or recurrent esophageal squamous cell carcinoma|advanced or recurrent esophageal squamous cell carcinoma
659898|NCT00816647|Patella|patella
659899|NCT00816647|Dislocation|dislocation
659900|NCT00816647|Knee|knee
659901|NCT00816647|Medial Patellofemoral Ligament|medial patellofemoral ligament
659902|NCT00816673|Insomnia|insomnia
659903|NCT00816673|Primary insomnia|primary insomnia
659904|NCT00816673|sleep latency|sleep latency
659905|NCT00816673|non restorative sleep|non restorative sleep
659906|NCT00816673|sleep quality|sleep quality
659907|NCT00816673|Double-Blind|double-blind
659908|NCT00816673|Placebo Controlled|placebo controlled
659909|NCT00816673|Parallel-Group|parallel-group
659910|NCT00816673|Sleep Laboratory Study|sleep laboratory study
752393|NCT01172860|Inoperable|inoperable
659911|NCT00816686|clinical trial, phase 1|clinical trial, phase 1
659912|NCT00816686|carcinoma, advanced renal cell|carcinoma, advanced renal cell
659913|NCT00816686|kidney|kidney
659914|NCT00816686|pharmacokinetics|pharmacokinetics
659915|NCT00816686|safety|safety
659916|NCT00816686|AGS-16M18|ags-16m18
659917|NCT00816699|Anxiety|anxiety
659918|NCT00816699|preprint anesthetic risk information|preprint anesthetic risk information
659919|NCT00816712|Males with low-normal serum total testosterone levels.|males with low-normal serum total testosterone levels.
659920|NCT00816725|Postnatal Depression|postnatal depression
659921|NCT00816725|Cognitive Behavioral Therapy|cognitive behavioral therapy
659922|NCT00816725|Mood Management|mood management
659923|NCT00816725|Self-help|self-help
659924|NCT00816725|Internet|internet
659925|NCT00816738|Nd: YAG laser|nd: yag laser
659926|NCT00816738|recurrent corneal erosions|recurrent corneal erosions
659927|NCT00816738|trauma|trauma
659928|NCT00816738|anterior stromal puncture|anterior stromal puncture
659929|NCT00816751|Local anesthesia|local anesthesia
659930|NCT00816751|Paracervical|paracervical
659931|NCT00816751|Intracervical|intracervical
659932|NCT00816751|Abortion|abortion
659933|NCT00816751|Pain|pain
659934|NCT00816751|Local anesthesia for elective first trimester abortion|local anesthesia for elective first trimester abortion
659935|NCT00816764|clinical trial, phase 1|clinical trial, phase 1
659936|NCT00816764|carcinoma|carcinoma
659937|NCT00816764|pharmacokinetics|pharmacokinetics
659938|NCT00816764|safety|safety
659940|NCT00816777|Cancer|cancer
659941|NCT00816777|Carcinoma|carcinoma
659942|NCT00816777|Colon Cancer|colon cancer
659943|NCT00816777|Colorectal Cancer|colorectal cancer
659944|NCT00816777|Gastric Cancer|gastric cancer
659945|NCT00816777|Gastrointestinal Cancer|gastrointestinal cancer
659946|NCT00816777|Metastases|metastases
659947|NCT00816777|Metastatic Cancer|metastatic cancer
659948|NCT00816777|Metastatic Colorectal Cancer|metastatic colorectal cancer
659949|NCT00816777|Oncology|oncology
659950|NCT00816777|Rectal Cancer|rectal cancer
659951|NCT00816790|Septic shock|septic shock
659952|NCT00816790|Acute Renal Failure|acute renal failure
659953|NCT00816790|Antimicrobial|antimicrobial
659954|NCT00816790|Drug Dosing|drug dosing
659955|NCT00816790|Feasibility Study|feasibility study
659956|NCT00816803|Spinal cord injury|spinal cord injury
659957|NCT00816816|Phase 2 Clinical Trial|phase 2 clinical trial
659958|NCT00816816|NPC|npc
659959|NCT00816816|neoadjuvant chemotherapy|neoadjuvant chemotherapy
659960|NCT00816816|concurrent chemoradiation|concurrent chemoradiation
659961|NCT00816829|Dyslipidemia|dyslipidemia
659962|NCT00816829|Sleep Apnea Syndromes|sleep apnea syndromes
659963|NCT00816829|Fenofibrate|fenofibrate
659964|NCT00816829|Obese|obese
659965|NCT00816829|Overweight or obese patients|overweight or obese patients
659966|NCT00816842|citrulline|citrulline
659967|NCT00816842|malabsorption|malabsorption
659968|NCT00816842|Villous atrophy|villous atrophy
659969|NCT00816842|enteropathy|enteropathy
659970|NCT00816855|Phase 2 Clinical Trial|phase 2 clinical trial
659971|NCT00816855|NPC|npc
659972|NCT00816855|neoadjuvant chemotherapy|neoadjuvant chemotherapy
659973|NCT00816855|concurrent chemoradiation|concurrent chemoradiation
659974|NCT00816868|stage IIIB/IV adenocarcinoma non-small cell lung cancer|stage iiib/iv adenocarcinoma non-small cell lung cancer
659975|NCT00816881|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
659976|NCT00816881|flutter|flutter
659977|NCT00816881|airway clearance|airway clearance
659978|NCT00816881|sputum|sputum
659979|NCT00816881|Physical Therapy Techniques|physical therapy techniques
659980|NCT00816894|schizophrenia|schizophrenia
659981|NCT00816894|treatment resistance|treatment resistance
659982|NCT00816894|D-serine|d-serine
659983|NCT00816894|Olanzapine|olanzapine
659984|NCT00816894|treatment refractory schizophrenia|treatment refractory schizophrenia
659985|NCT00816907|Schizoaffective Disorder|schizoaffective disorder
659986|NCT00816920|distal DVT|distal dvt
659987|NCT00816920|calf DVT|calf dvt
659988|NCT00816920|DVT diagnosis|dvt diagnosis
659989|NCT00816920|management of patients with suspected leg DVT|management of patients with suspected leg dvt
659990|NCT00816933|pain|pain
659991|NCT00816933|operative times|operative times
659992|NCT00816933|complication|complication
659993|NCT00816933|time to return for normal life|time to return for normal life
659994|NCT00816933|pain using VAS score|pain using vas score
659995|NCT00816946|malnutrition|malnutrition
659996|NCT00816946|growth|growth
659997|NCT00816959|Lymphocytic Predominant Hodgkin's Lymphoma|lymphocytic predominant hodgkin's lymphoma
659998|NCT00816959|Late, widespread and recurrent LPHD|late, widespread and recurrent lphd
659999|NCT00816985|Female|female
660000|NCT00816985|Lymphedema|lymphedema
660001|NCT00816998|Radius fractures|radius fractures
660002|NCT00817011|depression|depression
660003|NCT00817011|pharmacogenomics|pharmacogenomics
660004|NCT00817011|antidepressant response|antidepressant response
660005|NCT00817011|biological markers|biological markers
660006|NCT00817011|clinical variables|clinical variables
660007|NCT00817024|Coronary Heart Disease|coronary heart disease
660008|NCT00817024|PCI|pci
660009|NCT00817024|Traditional Chinese Medicine|traditional chinese medicine
660010|NCT00817024|Quality of Life|quality of life
660011|NCT00817037|Chronic kidney disease|chronic kidney disease
660012|NCT00817037|Proteinuria|proteinuria
660013|NCT00817037|Blood pressure|blood pressure
660014|NCT00817037|Arterial stiffness|arterial stiffness
660015|NCT00817037|Endothelin antagonist|endothelin antagonist
660016|NCT00817037|Sitaxsentan|sitaxsentan
660017|NCT00817063|retinoid treatment|retinoid treatment
660018|NCT00817063|fingertip dermatitis|fingertip dermatitis
660019|NCT00817063|hyperkeratotic hand eczema|hyperkeratotic hand eczema
660020|NCT00817063|vesicular hand eczema|vesicular hand eczema
660021|NCT00817063|pompholyx|pompholyx
660022|NCT00817102|coronary artery stenoses|coronary artery stenoses
660023|NCT00817115|Region-of-Interest Imaging|region-of-interest imaging
660024|NCT00817115|X-ray Fovea Imaging|x-ray fovea imaging
660025|NCT00817115|Cardiovascular Diseases|cardiovascular diseases
660026|NCT00817115|Radiation Dosage|radiation dosage
660027|NCT00817115|Radiographic Image Enhancement|radiographic image enhancement
660028|NCT00817115|Radiography, Interventional|radiography, interventional
660029|NCT00817128|Complex Regional Pain Syndrome Type I|complex regional pain syndrome type i
660030|NCT00817128|Sympathetic Reflex Dystrophy|sympathetic reflex dystrophy
660031|NCT00817128|Pain Exposure Physical Therapy|pain exposure physical therapy
660032|NCT00817128|Pharmacological treatment|pharmacological treatment
660033|NCT00817128|Functional recovery|functional recovery
660034|NCT00817154|Older persons with SMI|older persons with smi
660035|NCT00817167|Known or suspected lung disease|known or suspected lung disease
660036|NCT00817167|Candidates for non-emergency bronchoscopy|candidates for non-emergency bronchoscopy
660037|NCT00817180|physiotherapy|physiotherapy
660038|NCT00817180|airway clearance techniques|airway clearance techniques
660039|NCT00817180|Positive Expiratory Pressure Technique|positive expiratory pressure technique
660040|NCT00817180|high frequency Chest Wall Oscillation|high frequency chest wall oscillation
660041|NCT00817180|vest|vest
660042|NCT00817193|Clinical trial|clinical trial
660043|NCT00817193|Short Physical Performance Battery|short physical performance battery
660044|NCT00817193|Disability|disability
660045|NCT00817193|Senior Housing|senior housing
660046|NCT00817193|Aging|aging
660047|NCT00817206|kidney transplantation|kidney transplantation
660048|NCT00817206|renal transplantation|renal transplantation
660332|NCT00811200|melanoma|melanoma
660049|NCT00817206|maintenance immunosuppression|maintenance immunosuppression
660050|NCT00817206|tacrolimus|tacrolimus
660051|NCT00817206|Prevention of acute allograft rejection|prevention of acute allograft rejection
660052|NCT00817232|tennis elbow|tennis elbow
660053|NCT00817232|microcurrent|microcurrent
660054|NCT00817232|tissue healing|tissue healing
660055|NCT00817245|CSR|csr
660056|NCT00817245|Helicobacter pylori|helicobacter pylori
660057|NCT00817258|Phase 2 Clinical Trial|phase 2 clinical trial
660058|NCT00817258|NPC|npc
660059|NCT00817258|radiation therapy|radiation therapy
660060|NCT00817258|chemotherapy|chemotherapy
660061|NCT00817271|Type II Diabetes|type ii diabetes
660062|NCT00817271|Counter-regulatory response|counter-regulatory response
660063|NCT00817271|Hypoglycemia|hypoglycemia
660064|NCT00817284|Newly diagnosed patients with glioblastoma multiforme.|newly diagnosed patients with glioblastoma multiforme.
660065|NCT00817284|Performance status 0-2.|performance status 0-2.
660066|NCT00817297|noninvasive ventilation|noninvasive ventilation
660067|NCT00817323|bipolar depression|bipolar depression
660068|NCT00817323|atypical antipsychotic|atypical antipsychotic
660069|NCT00817323|remission|remission
660070|NCT00817323|depletion|depletion
660071|NCT00817323|mood|mood
660072|NCT00817336|biomarker|biomarker
660073|NCT00817336|EEG|eeg
660074|NCT00817336|schizophrenia|schizophrenia
660075|NCT00817336|NMDA|nmda
660076|NCT00817336|D-serine|d-serine
660077|NCT00817349|Angio-Seal|angio-seal
660078|NCT00817349|Peripheral vascular disease|peripheral vascular disease
660079|NCT00817349|Vascular closure device|vascular closure device
660080|NCT00817349|Arterial closure|arterial closure
660081|NCT00817349|Coronary artery disease|coronary artery disease
660082|NCT00817349|Arterial hemostasis|arterial hemostasis
660083|NCT00817349|Coronary cardiac catheterization|coronary cardiac catheterization
660084|NCT00817349|Percutaneous coronary intervention|percutaneous coronary intervention
660085|NCT00817349|Interventional catheterization|interventional catheterization
660086|NCT00817349|Diagnostic catheterization|diagnostic catheterization
660087|NCT00817349|Common femoral artery|common femoral artery
660088|NCT00817349|Manual compression|manual compression
660089|NCT00817349|Vascular intervention|vascular intervention
660090|NCT00817349|Angiogram|angiogram
660091|NCT00817349|Coronary intervention|coronary intervention
660092|NCT00817349|Coronary angioplasty|coronary angioplasty
660093|NCT00817349|Angiography|angiography
660094|NCT00817349|Arteriotomy|arteriotomy
660095|NCT00817349|Vascular access|vascular access
660096|NCT00817362|Breast Cancer|breast cancer
660097|NCT00817362|Advanced Breast Cancer|advanced breast cancer
660098|NCT00817362|Metastatic Breast Cancer|metastatic breast cancer
660099|NCT00817362|HER2 Positive Breast Cancer|her2 positive breast cancer
660100|NCT00817362|Cancer of the breast|cancer of the breast
660101|NCT00817362|Trastuzumab|trastuzumab
660102|NCT00817362|Herceptin|herceptin
660103|NCT00817375|Pharmacogenomics|pharmacogenomics
660104|NCT00817375|Prediction of Antidepressant Response|prediction of antidepressant response
660105|NCT00817375|Depressed Patients|depressed patients
660106|NCT00817388|Interstitial cystitis|interstitial cystitis
660107|NCT00817388|pelvic pain|pelvic pain
660108|NCT00817401|asphyxia|asphyxia
660109|NCT00817401|hypothermia|hypothermia
660110|NCT00817401|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
660111|NCT00817401|neonates|neonates
660112|NCT00817414|Blood Pressure|blood pressure
660113|NCT00817414|Hypertension|hypertension
660114|NCT00817414|Cortisol|cortisol
660115|NCT00817427|Chronic Kidney Disease|chronic kidney disease
660116|NCT00817427|Poor sleep|poor sleep
660117|NCT00817427|CKD|ckd
660118|NCT00817427|Kidney Failure|kidney failure
660119|NCT00817440|growth hormone insulin signaltransduction signalpathways|growth hormone insulin signaltransduction signalpathways
660120|NCT00817440|growth hormone and insulin signalpathways|growth hormone and insulin signalpathways
660121|NCT00817453|Parkinson's Disease|parkinson's disease
660122|NCT00817466|bronchiolitis|bronchiolitis
660123|NCT00817466|infants|infants
660124|NCT00817466|racemic adrenaline|racemic adrenaline
660125|NCT00817466|inhalations|inhalations
660126|NCT00817466|treatment|treatment
660127|NCT00817479|Subject has intraabdominal disease either proven or strongly|subject has intraabdominal disease either proven or strongly
660128|NCT00817479|suspected to be ovarian or primary peritoneal cancer|suspected to be ovarian or primary peritoneal cancer
660129|NCT00817492|Sleep|sleep
660130|NCT00817492|CKD|ckd
660131|NCT00817492|kidney|kidney
660132|NCT00817492|PSG|psg
660133|NCT00817492|polysomnography|polysomnography
660134|NCT00817492|Decreased sleep time|decreased sleep time
660135|NCT00817492|Decreased sleep quality|decreased sleep quality
660136|NCT00817505|Type I diabetes|type i diabetes
660137|NCT00817505|bioavailability|bioavailability
660138|NCT00817531|Breast Cancer|breast cancer
660139|NCT00817544|3098004|3098004
660140|NCT00817544|Healthy volunteers|healthy volunteers
660141|NCT00810472|Penetrating keratoplasty|penetrating keratoplasty
660142|NCT00810472|HLA matching|hla matching
660143|NCT00810472|Corneal diseases that require penetrating keratoplasty|corneal diseases that require penetrating keratoplasty
660144|NCT00810485|Gastroesophageal reflux|gastroesophageal reflux
660145|NCT00810485|Proton pump inhibitor|proton pump inhibitor
660146|NCT00810485|Heartburn|heartburn
660147|NCT00810485|Regurgitation|regurgitation
660148|NCT00810524|Chronic hepatitis B|chronic hepatitis b
660149|NCT00810524|antiviral treatment|antiviral treatment
660150|NCT00810524|long term prognosis|long term prognosis
660151|NCT00810563|pain|pain
660152|NCT00810563|tubal ligation|tubal ligation
660153|NCT00810563|bupivacaine|bupivacaine
660154|NCT00810563|laparoscopy|laparoscopy
660155|NCT00810576|Relapsed T-Cell Non-Hodgkin's Lymphoma|relapsed t-cell non-hodgkin's lymphoma
660156|NCT00810576|Refractory T-Cell Non-Hodgkin's Lymphoma|refractory t-cell non-hodgkin's lymphoma
660157|NCT00810576|NHL|nhl
660158|NCT00810576|T-cell NHL|t-cell nhl
660159|NCT00810576|vorinostat|vorinostat
660160|NCT00810576|SAHA|saha
660161|NCT00810576|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
660162|NCT00810576|MSK-390|msk-390
660163|NCT00810576|Zolinza|zolinza
660164|NCT00810576|Bortezomib|bortezomib
660165|NCT00810576|Velcade|velcade
660166|NCT00810576|LDP-341|ldp-341
660167|NCT00810576|MLN341|mln341
660168|NCT00810576|PS-341|ps-341
660169|NCT00810576|Peripheral T-cell lymphoma|peripheral t-cell lymphoma
660170|NCT00810576|CD 30 + anaplastic large cell lymphoma|cd 30 + anaplastic large cell lymphoma
660171|NCT00810576|Angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
660172|NCT00810576|Angiocentric/nasal type T/NK-cell lymphoma|angiocentric/nasal type t/nk-cell lymphoma
660173|NCT00810576|Intestinal T-cell lymphoma|intestinal t-cell lymphoma
660174|NCT00810576|Hepatosplenic gamma delta T-cell lymphoma|hepatosplenic gamma delta t-cell lymphoma
660175|NCT00810576|Subcutaneous panniculitic T-cell lymphoma|subcutaneous panniculitic t-cell lymphoma
660176|NCT00810576|Transformed Mycosis fungoides|transformed mycosis fungoides
660177|NCT00810615|chronic TBI|chronic tbi
660178|NCT00810615|cognitive function|cognitive function
660179|NCT00810615|PTSD|ptsd
660180|NCT00810615|HBO|hbo
660181|NCT00810615|hyperbaric|hyperbaric
660182|NCT00810615|oxygen|oxygen
660183|NCT00810615|chronic brain injury|chronic brain injury
660184|NCT00810628|Parkinson's disease|parkinson's disease
660185|NCT00810628|depression|depression
660186|NCT00810628|Parkinson's disease with mild to moderate depression.|parkinson's disease with mild to moderate depression.
660187|NCT00810641|BPPV(benign paroxysmal positional vertigo)|bppv(benign paroxysmal positional vertigo)
660188|NCT00810641|HC-BPPV(BPPV involving the horizontal semicircular canal)|hc-bppv(bppv involving the horizontal semicircular canal)
660189|NCT00810641|Nystagmus|nystagmus
660190|NCT00810641|Treatment outcome|treatment outcome
660191|NCT00810641|Horizontal Canal Benign Paroxysmal Positional Vertigo|horizontal canal benign paroxysmal positional vertigo
660192|NCT00810654|Celiac disease|celiac disease
660193|NCT00810654|Coeliac disease|coeliac disease
660194|NCT00810654|treatment|treatment
660195|NCT00810654|AN-PEP|an-pep
660196|NCT00810654|prolyl endoprotease|prolyl endoprotease
660197|NCT00810654|gluten|gluten
660198|NCT00810667|Schizophrenia|schizophrenia
660199|NCT00810667|Cognition|cognition
660200|NCT00810667|BACS|bacs
660201|NCT00810667|Risperidone|risperidone
660202|NCT00810667|Augmentation therapy|augmentation therapy
660203|NCT00810667|Add-on therapy|add-on therapy
660204|NCT00810667|Lu AE58054|lu ae58054
660205|NCT00810680|chronic lymphocytic leukemia|chronic lymphocytic leukemia
660206|NCT00810680|relapsed|relapsed
660207|NCT00810680|refractory|refractory
660208|NCT00810680|valproic acid|valproic acid
660209|NCT00810680|valproate|valproate
660210|NCT00810693|Pulmonary arterial hypertension|pulmonary arterial hypertension
660211|NCT00810693|PH|ph
660212|NCT00810693|Stimulator|stimulator
660213|NCT00810706|Breast Cancer|breast cancer
660214|NCT00810706|Aromatase inhibitors|aromatase inhibitors
660215|NCT00810706|Exemestane|exemestane
660216|NCT00810706|Tamoxifen|tamoxifen
660217|NCT00810706|Lipids|lipids
660218|NCT00810719|recurrent pancreatic cancer|recurrent pancreatic cancer
660219|NCT00810719|stage IV pancreatic cancer|stage iv pancreatic cancer
660220|NCT00810732|This study is being conducted to evaluate sitaxsentan dosing in subjects with chronic kidney disease.|this study is being conducted to evaluate sitaxsentan dosing in subjects with chronic kidney disease.
660221|NCT00810732|B1321005|b1321005
660222|NCT00810745|ODS|ods
660223|NCT00810745|stapled transanal rectal resection|stapled transanal rectal resection
660224|NCT00810758|HCV|hcv
660225|NCT00810758|Toll-like receptor 7|toll-like receptor 7
660226|NCT00810758|Multiple oral dose escalation study of PF-04878691|multiple oral dose escalation study of pf-04878691
660227|NCT00810771|Hospitals, Veterans|hospitals, veterans
660228|NCT00810771|Mass Screening/utilization|mass screening/utilization
660229|NCT00810771|Patient Preference|patient preference
660230|NCT00810771|Prevention & Control|prevention & control
660231|NCT00810771|Epidemiology|epidemiology
660232|NCT00810784|Venous Thromboembolism|venous thromboembolism
660233|NCT00810784|Prevention|prevention
660234|NCT00810784|Quality Improvement|quality improvement
660235|NCT00810784|Education|education
660236|NCT00810784|Compliance with VTE prophylaxis|compliance with vte prophylaxis
660237|NCT00810797|recurrent breast cancer|recurrent breast cancer
660238|NCT00810797|stage IV breast cancer|stage iv breast cancer
660333|NCT00811200|lucentis|lucentis
660239|NCT00810810|Blood Component Transfusion|blood component transfusion
660240|NCT00810810|Leukoreduction|leukoreduction
660241|NCT00810810|HLA antibody|hla antibody
660242|NCT00810810|Immunosuppression|immunosuppression
660243|NCT00810823|Diabetes|diabetes
660244|NCT00810823|gastric bypass|gastric bypass
660245|NCT00810823|type 2 diabetes and gastric bypass|type 2 diabetes and gastric bypass
660246|NCT00810849|Tuberculosis, pericardium|tuberculosis, pericardium
660247|NCT00810862|African American children|african american children
660248|NCT00810875|pregnancy|pregnancy
660249|NCT00810875|immunity|immunity
660250|NCT00810875|cord blood|cord blood
660251|NCT00810875|influenza vaccines|influenza vaccines
660252|NCT00810875|disease transmission, vertical|disease transmission, vertical
660253|NCT00810888|intracerebral hemorrhage|intracerebral hemorrhage
660254|NCT00810888|ICH|ich
660255|NCT00810888|computed tomography angiography|computed tomography angiography
660256|NCT00810888|CTA|cta
660257|NCT00810888|recombinant activated factor seven|recombinant activated factor seven
660258|NCT00810888|rFVIIa|rfviia
660259|NCT00810888|NovoSeven|novoseven
660260|NCT00810888|recombinant activated factor VII|recombinant activated factor vii
660261|NCT00810901|ethnic minority adolescents|ethnic minority adolescents
660262|NCT00810901|designated organ donor|designated organ donor
660263|NCT00810914|Patient controlled epidural anesthesia|patient controlled epidural anesthesia
660264|NCT00810914|Pain control in labor|pain control in labor
660265|NCT00810940|TBI|tbi
660266|NCT00810940|closed head injury|closed head injury
660267|NCT00810940|severe head trauma|severe head trauma
660268|NCT00810940|traumatic brain injury|traumatic brain injury
660269|NCT00810992|dietary, behavior|dietary, behavior
660270|NCT00810992|IDF criteria|idf criteria
660271|NCT00810992|coronary artery disease|coronary artery disease
660272|NCT00810992|Traditional Tibetan Medicine|traditional tibetan medicine
660273|NCT00810992|coronary artery disease in patients, who have an increased cardiovascular risk profile according to the criteria by the International Diabetes Federation (IDF)|coronary artery disease in patients, who have an increased cardiovascular risk profile according to the criteria by the international diabetes federation (idf)
660274|NCT00811005|acitretin|acitretin
660275|NCT00811005|fumaric acid ester|fumaric acid ester
660276|NCT00811005|pustular palmoplantar psoriasis|pustular palmoplantar psoriasis
660277|NCT00811005|PUVA|puva
660278|NCT00811018|Open-label study|open-label study
660279|NCT00811031|Prostate|prostate
660280|NCT00811031|prostate gland|prostate gland
660281|NCT00811031|prostate cancer markers|prostate cancer markers
660282|NCT00811031|Taxotere®|taxotere®
660283|NCT00811031|Docetaxel|docetaxel
660284|NCT00811031|Prednisone|prednisone
752394|NCT01172860|Colorectal|colorectal
660285|NCT00811031|Castration Resistant Prostate Cancer|castration resistant prostate cancer
660286|NCT00811031|adenocarcinoma of the prostate|adenocarcinoma of the prostate
660287|NCT00811044|diabetes|diabetes
660288|NCT00811044|genetics|genetics
660289|NCT00811044|oral glucose tolerance testing|oral glucose tolerance testing
660290|NCT00811044|family history of diabetes|family history of diabetes
660291|NCT00811044|gestational diabetes|gestational diabetes
660292|NCT00811057|Preterm Labor in Pregnancy|preterm labor in pregnancy
660293|NCT00811070|CML. Chronic myelocytic leukemia. Philadelphia Chromosome. Japanese. SKI-606. Bosutinib. Imatinib resistant. Imatinib intolerant|cml. chronic myelocytic leukemia. philadelphia chromosome. japanese. ski-606. bosutinib. imatinib resistant. imatinib intolerant
660294|NCT00811083|autism|autism
660295|NCT00811083|toxic metals|toxic metals
660296|NCT00811083|DMSA|dmsa
660297|NCT00811083|dimercaptosuccinic acid|dimercaptosuccinic acid
660298|NCT00811083|chelation|chelation
660299|NCT00811096|Malaria, Vivax/*drug therapy|malaria, vivax/*drug therapy
660300|NCT00811096|Tinidazole/pharmacology/*therapeutic use|tinidazole/pharmacology/*therapeutic use
660301|NCT00811096|Recurrence|recurrence
660302|NCT00811096|Plasmodium vivax/*drug effects|plasmodium vivax/*drug effects
660303|NCT00811109|Acute Kidney Injury|acute kidney injury
660304|NCT00811109|Critical care|critical care
660305|NCT00811109|Hypotension|hypotension
660306|NCT00811109|Renal replacement therapy|renal replacement therapy
660307|NCT00811109|Efficacy|efficacy
660308|NCT00811109|Tolerance|tolerance
660309|NCT00811109|Outcome|outcome
660310|NCT00811122|Alzheimer's disease|alzheimer's disease
660311|NCT00811122|AD|ad
660312|NCT00811122|Frontotemporal dementia|frontotemporal dementia
660313|NCT00811122|FTD|ftd
660314|NCT00811148|Brain Neoplasms|brain neoplasms
660315|NCT00811148|Central Nervous System Diseases|central nervous system diseases
660316|NCT00811148|Central Nervous System Neoplasms|central nervous system neoplasms
660317|NCT00811148|Brain Diseases|brain diseases
660318|NCT00811148|Nervous System Neoplasms|nervous system neoplasms
660319|NCT00811161|Remodeling|remodeling
660320|NCT00811161|Airgent|airgent
660321|NCT00811161|Hyaluronic acid|hyaluronic acid
660322|NCT00811161|Collagen formation|collagen formation
660323|NCT00811187|Hysteroscopy|hysteroscopy
660324|NCT00811187|Pain medication|pain medication
660325|NCT00811187|Lidocaine|lidocaine
660326|NCT00811187|Office Procedures|office procedures
660327|NCT00811200|radiation|radiation
660328|NCT00811200|retinopathy|retinopathy
660329|NCT00811200|maculopathy|maculopathy
660330|NCT00811200|choroidopathy|choroidopathy
660336|NCT00811200|triamcinolone acetonide|triamcinolone acetonide
660337|NCT00811200|radiation retinopathy after irradiation of uveal melanoma|radiation retinopathy after irradiation of uveal melanoma
660338|NCT00811200|radiation maculopathy after irradiation of uveal melanoma|radiation maculopathy after irradiation of uveal melanoma
660339|NCT00811200|radiation choroidopathy after irradiation of uveal melanoma|radiation choroidopathy after irradiation of uveal melanoma
660340|NCT00811226|Hypertension Stage I|hypertension stage i
660341|NCT00811226|Hypertension Stage II|hypertension stage ii
660342|NCT00811239|antivenom|antivenom
660343|NCT00811239|snake bite|snake bite
660344|NCT00811239|Bungarus multicinctus|bungarus multicinctus
660345|NCT00811239|Vietnam|vietnam
660346|NCT00811252|Depression|depression
660347|NCT00811252|Elderly|elderly
660348|NCT00811252|Acute treatment|acute treatment
660349|NCT00811265|ExAblate MRgFUS|exablate mrgfus
660350|NCT00811265|Focused ultrasound|focused ultrasound
660351|NCT00811265|Magnetic resonance imaging|magnetic resonance imaging
660352|NCT00811265|Prostate cancer|prostate cancer
660353|NCT00811265|Radical prostatectomy candidate|radical prostatectomy candidate
660354|NCT00811278|inhaled corticosteroids|inhaled corticosteroids
660355|NCT00811291|B-vitamins|b-vitamins
660356|NCT00811291|Folic-Acid|folic-acid
660357|NCT00811291|kindergarten kids|kindergarten kids
660358|NCT00811291|cognitive tests|cognitive tests
660359|NCT00811291|Healthy kids|healthy kids
660360|NCT00811291|second part low urine vitamine-B-metabolites|second part low urine vitamine-b-metabolites
660361|NCT00811304|ultrasound|ultrasound
660362|NCT00811304|labor epidural|labor epidural
660363|NCT00811304|failed epidural|failed epidural
660364|NCT00811304|outcome|outcome
660365|NCT00811304|Epidural insertion under realtime ultrasound guidance|epidural insertion under realtime ultrasound guidance
660366|NCT00811317|diabetes|diabetes
660367|NCT00811317|glucose|glucose
660368|NCT00811317|hyperglycemia|hyperglycemia
660369|NCT00811317|hypoglycemia|hypoglycemia
660370|NCT00811317|insulin|insulin
660371|NCT00811317|glucagon|glucagon
660372|NCT00811317|counter-regulation|counter-regulation
660373|NCT00811317|closed-loop|closed-loop
660374|NCT00811317|feedback|feedback
660375|NCT00811317|control|control
660376|NCT00811317|dual-infusion|dual-infusion
660377|NCT00811317|subcutaneous|subcutaneous
660378|NCT00811317|automated|automated
660379|NCT00811317|artificial pancreas|artificial pancreas
660380|NCT00811317|intensive insulin therapy|intensive insulin therapy
660381|NCT00811330|Left ventricular hypertrophy|left ventricular hypertrophy
660382|NCT00811330|Aortic valve stenosis|aortic valve stenosis
660383|NCT00811330|Aortic valve replacement|aortic valve replacement
660384|NCT00811330|Cardiopulmonary bypass|cardiopulmonary bypass
660385|NCT00811330|Statins|statins
660386|NCT00811330|Myocardial preconditioning|myocardial preconditioning
660387|NCT00811330|Left ventricular reverse remodeling|left ventricular reverse remodeling
660388|NCT00811343|anti TNF Therapy|anti tnf therapy
660389|NCT00811343|Tuberculosis|tuberculosis
660390|NCT00811343|Tuberculin test|tuberculin test
660391|NCT00811343|QFTB-G|qftb-g
660392|NCT00811343|T-SPOT.TB|t-spot.tb
660393|NCT00811343|Need anti TNF Therapy|need anti tnf therapy
660394|NCT00811356|Food Effect|food effect
660395|NCT00811356|Drug-Drug Interaction|drug-drug interaction
660396|NCT00811356|Antimalarial|antimalarial
660397|NCT00811356|First Time In Human|first time in human
660398|NCT00811356|Single Dose|single dose
660399|NCT00811356|Repeat Dose|repeat dose
660400|NCT00811369|Breast Cancer|breast cancer
660401|NCT00811369|Bone Metastases|bone metastases
660402|NCT00811369|Telopeptide|telopeptide
660403|NCT00811369|Zactima|zactima
660404|NCT00811369|Fulvestrant|fulvestrant
660406|NCT00811382|therapy of AF|therapy of af
660407|NCT00811382|telecardiology|telecardiology
660408|NCT00811382|home monitoring|home monitoring
660409|NCT00811382|cardiovascular hospitalization|cardiovascular hospitalization
660410|NCT00811382|cardiovascular mortality|cardiovascular mortality
660411|NCT00811408|human papilloma virus infection|human papilloma virus infection
660412|NCT00811408|cervical squamous cell carcinoma|cervical squamous cell carcinoma
660413|NCT00811408|cervical adenocarcinoma|cervical adenocarcinoma
660414|NCT00811408|stage IB cervical cancer|stage ib cervical cancer
660415|NCT00811408|stage II cervical cancer|stage ii cervical cancer
660416|NCT00811408|stage III cervical cancer|stage iii cervical cancer
660417|NCT00811408|stage IVA cervical cancer|stage iva cervical cancer
660418|NCT00811421|Malaria|malaria
660419|NCT00811421|Pregnancy|pregnancy
660420|NCT00811421|HIV|hiv
660421|NCT00811421|Prevention|prevention
660422|NCT00811421|Malaria prevention|malaria prevention
660423|NCT00811434|encephalopathy|encephalopathy
660424|NCT00811434|pediatric liver disease|pediatric liver disease
660425|NCT00811434|pediatric cirrhosis|pediatric cirrhosis
660426|NCT00811434|serum ammonia levels|serum ammonia levels
660427|NCT00811473|Bipolar Depression|bipolar depression
660428|NCT00811473|Depression|depression
660429|NCT00811473|Children|children
660430|NCT00811473|Adolescents|adolescents
660431|NCT00811473|Seroquel|seroquel
660531|NCT00817726|PD|pd
660432|NCT00811473|Bipolar Depression in Children and Adolescents|bipolar depression in children and adolescents
660436|NCT00811525|Breast Augmentation|breast augmentation
660437|NCT00811525|Breast Reconstruction|breast reconstruction
660438|NCT00811525|Breast Revision|breast revision
660439|NCT00811525|Silicone gel|silicone gel
660440|NCT00811525|Contour Profile Gel|contour profile gel
660441|NCT00811525|Siltex|siltex
660442|NCT00811538|ischemic stroke|ischemic stroke
660443|NCT00811538|endovascular treatment|endovascular treatment
660444|NCT00811538|Thrombolysis|thrombolysis
660445|NCT00811538|outcome|outcome
660446|NCT00811551|Heart Failure|heart failure
660447|NCT00811551|Impedance Monitoring|impedance monitoring
660448|NCT00811551|Wedge Pressure|wedge pressure
660449|NCT00811577|AZX100|azx100
660450|NCT00811577|Patient and Observer Scar Assessment Scale|patient and observer scar assessment scale
660451|NCT00811577|POSAS|posas
660452|NCT00811577|Visual Analog Scale|visual analog scale
660453|NCT00811577|VAS|vas
660454|NCT00811577|Trocar|trocar
660455|NCT00811577|Scarring|scarring
660456|NCT00811577|Scar reduction|scar reduction
660457|NCT00811577|Scar prevention|scar prevention
660458|NCT00811590|Cancer|cancer
660459|NCT00811590|Polyps|polyps
660460|NCT00811603|Antibiotic|antibiotic
660461|NCT00811603|Prophylaxis|prophylaxis
660462|NCT00811603|Cesarean|cesarean
660463|NCT00811603|Infection|infection
660464|NCT00811603|Antibiotic prophylaxis|antibiotic prophylaxis
660465|NCT00811616|Coronary artery disease|coronary artery disease
660466|NCT00811616|Supralimus-Core™|supralimus-core™
660467|NCT00811616|de novo native coronary artery lesion|de novo native coronary artery lesion
660468|NCT00811629|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
660469|NCT00811629|Soluble RAGE (sRAGE)|soluble rage (srage)
660470|NCT00811629|Acute Lung Injury (ALI)|acute lung injury (ali)
660471|NCT00811629|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
660472|NCT00811629|Severe sepsis|severe sepsis
660473|NCT00811629|Septic shock|septic shock
660474|NCT00811629|Alveolar epithelium|alveolar epithelium
660475|NCT00811629|Mechanical ventilation|mechanical ventilation
660476|NCT00811629|Intensive Care Unit (ICU)|intensive care unit (icu)
660477|NCT00811642|refractory or first line medication intolerable invasive fungal infection|refractory or first line medication intolerable invasive fungal infection
660478|NCT00817557|Contact lenses|contact lenses
660479|NCT00817557|Loteprednol|loteprednol
660480|NCT00817557|Effect on CL dryness|effect on cl dryness
660481|NCT00817570|Trans Femoral Amputees Balance Reactions|trans femoral amputees balance reactions
660482|NCT00817583|Phase 2 Clinical Trial|phase 2 clinical trial
660483|NCT00817583|NPC|npc
752395|NCT01172860|Endoscopic|endoscopic
660484|NCT00817583|neoadjuvant chemotherapy|neoadjuvant chemotherapy
660485|NCT00817583|concurrent chemoradiation|concurrent chemoradiation
660486|NCT00817609|Angongniuhuang Pill|angongniuhuang pill
660487|NCT00817609|consciousness level of patients who suffered from a stroke|consciousness level of patients who suffered from a stroke
660488|NCT00817622|diabetes mellitus type 2|diabetes mellitus type 2
660489|NCT00817622|EPA|epa
660490|NCT00817622|leptin|leptin
660491|NCT00817622|adiponectin|adiponectin
660492|NCT00817635|Blood Pressure|blood pressure
660493|NCT00817635|Hypertension|hypertension
660494|NCT00817635|Resistant Hypertension|resistant hypertension
660495|NCT00817648|schizophrenia|schizophrenia
660496|NCT00817648|antipsychotics|antipsychotics
660497|NCT00817648|quetiapine|quetiapine
660498|NCT00817648|risperidone|risperidone
660499|NCT00817648|efficacy|efficacy
660500|NCT00817648|safety|safety
660501|NCT00817648|multicenter|multicenter
660502|NCT00817648|rater-blind|rater-blind
660503|NCT00817648|randomized|randomized
660504|NCT00817648|chinese|chinese
660505|NCT00817648|han|han
660506|NCT00817661|vitamin A|vitamin a
660507|NCT00817661|influenza vaccine|influenza vaccine
660508|NCT00817661|passive immunity|passive immunity
660509|NCT00817661|pregnant mothers|pregnant mothers
660510|NCT00817661|vitamin A suplementation|vitamin a suplementation
660511|NCT00817661|Influenza vaccination|influenza vaccination
660512|NCT00817661|Infant immune responses|infant immune responses
660513|NCT00817674|CKD|ckd
660514|NCT00817674|Kidney Disease|kidney disease
660515|NCT00817674|poor sleep|poor sleep
660516|NCT00817674|CKD progression|ckd progression
660517|NCT00817700|Sleep|sleep
660518|NCT00817700|young adults|young adults
660519|NCT00817700|middle-age adults|middle-age adults
660520|NCT00817700|older adults|older adults
660521|NCT00817713|Human Immunodeficiency Virus|human immunodeficiency virus
660522|NCT00817713|Helminthiasis|helminthiasis
660523|NCT00817713|treatment naive|treatment naive
660524|NCT00817713|co-infection|co-infection
660525|NCT00817713|immune modulation|immune modulation
660526|NCT00817726|Rapid Eye Movement Sleep Behavior Disorder|rapid eye movement sleep behavior disorder
660527|NCT00817726|Parkinson's Disease|parkinson's disease
660528|NCT00817726|Parkinsonian Syndromes|parkinsonian syndromes
660529|NCT00817726|Atypical Parkinson's|atypical parkinson's
660530|NCT00817726|RBD|rbd
660532|NCT00817726|fMRI|fmri
660533|NCT00817726|PSP|psp
660534|NCT00817726|MSA|msa
660535|NCT00817739|Drug therapy|drug therapy
660536|NCT00817752|stress|stress
660537|NCT00817752|inflammation|inflammation
660538|NCT00817752|natural remedy|natural remedy
660539|NCT00817752|cytokines|cytokines
660540|NCT00817752|interleukin|interleukin
660541|NCT00817752|inflammatory conditions|inflammatory conditions
660542|NCT00817752|auto-immune disorders|auto-immune disorders
660543|NCT00817765|interaction|interaction
660544|NCT00817765|pharmacokinetics|pharmacokinetics
660545|NCT00817765|boosting|boosting
660546|NCT00817765|drug-drug interaction|drug-drug interaction
660547|NCT00817765|safety|safety
660548|NCT00817778|Type II Diabetes|type ii diabetes
660549|NCT00817791|CABG|cabg
660550|NCT00817791|hyperbaric oxygen|hyperbaric oxygen
660551|NCT00817791|preconditioning|preconditioning
660552|NCT00817791|S100B|s100b
660553|NCT00817791|NSE|nse
660554|NCT00817791|Troponin I|troponin i
660555|NCT00817791|CABG surgery|cabg surgery
660556|NCT00817791|neuroprotection|neuroprotection
660557|NCT00817804|noninvasive ventilation|noninvasive ventilation
660558|NCT00817830|Coronaropathy|coronaropathy
660559|NCT00817830|lodenafil carbonate|lodenafil carbonate
660560|NCT00817830|Erectile dysfunction|erectile dysfunction
660561|NCT00817830|Treatment|treatment
660562|NCT00817830|QT interval|qt interval
660563|NCT00817830|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
660564|NCT00817830|Cardiac arrhythmia|cardiac arrhythmia
660565|NCT00817830|Effort testPhosphodiesterase 5 inhibitors|effort testphosphodiesterase 5 inhibitors
660566|NCT00817830|Cardiovascular test|cardiovascular test
660567|NCT00817843|Postprandial hypertriglyceridemia|postprandial hypertriglyceridemia
660568|NCT00817843|Metabolic syndrome|metabolic syndrome
660569|NCT00817843|Endothelial function|endothelial function
660570|NCT00817843|Flow mediated dilatation|flow mediated dilatation
660571|NCT00817843|EndoPAT|endopat
660572|NCT00817843|Simvastatin|simvastatin
660573|NCT00817843|Ezetimibe|ezetimibe
660574|NCT00817869|Floors and Floorcoverings|floors and floorcoverings
660575|NCT00817869|Health Services for the Aged|health services for the aged
660576|NCT00817869|Fractures, bone|fractures, bone
660577|NCT00817869|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
660578|NCT00817869|Frail Elderly|frail elderly
660579|NCT00817869|Aged, 80 and over|aged, 80 and over
660580|NCT00817882|vocational|vocational
660581|NCT00817882|rehabilitation|rehabilitation
660582|NCT00817882|work|work
660583|NCT00817882|ability|ability
660584|NCT00817882|low back pain|low back pain
660585|NCT00817895|hepatocellular carcinoma|hepatocellular carcinoma
660586|NCT00817895|liver resection|liver resection
660587|NCT00817895|intraoperative chemotherapy|intraoperative chemotherapy
660588|NCT00818467|Skin tone|skin tone
660589|NCT00818467|Vitamin D|vitamin d
660590|NCT00818480|prostate cancer|prostate cancer
660591|NCT00818480|melanoma|melanoma
660592|NCT00818480|lymphoma|lymphoma
660593|NCT00818480|YM155|ym155
660594|NCT00818493|total knee arthroplasty|total knee arthroplasty
660595|NCT00818493|total hip arthroplasty|total hip arthroplasty
660596|NCT00818506|Depression|depression
660597|NCT00818506|Major depressive disorder|major depressive disorder
660598|NCT00818506|Coronary artery disease|coronary artery disease
660599|NCT00818506|White Matter Hyperintensities|white matter hyperintensities
660600|NCT00818506|White Matter Lesions|white matter lesions
660601|NCT00818506|Coronary artery calcification|coronary artery calcification
660602|NCT00818519|Moderate Acne Vulgaris|moderate acne vulgaris
660603|NCT00818519|Oral contraceptive|oral contraceptive
660604|NCT00818519|Female|female
660605|NCT00818532|Corneal astigmatism|corneal astigmatism
660606|NCT00818532|Low diopter|low diopter
660607|NCT00818532|Corneal measurement|corneal measurement
660608|NCT00818532|Corneal astigmatism < 1 Diopter|corneal astigmatism < 1 diopter
660609|NCT00818545|aging|aging
660610|NCT00818545|barrier function|barrier function
660611|NCT00818545|transcriptomic|transcriptomic
660612|NCT00818558|non small cell lung cancer|non small cell lung cancer
660613|NCT00818571|Renal impairment|renal impairment
660614|NCT00818571|Diabetes|diabetes
660615|NCT00818571|vildagliptin|vildagliptin
660616|NCT00818571|Galvus|galvus
660617|NCT00818571|Eucreas|eucreas
660618|NCT00818584|Micafungin|micafungin
660619|NCT00818584|Candida|candida
660620|NCT00818584|Neonates|neonates
660621|NCT00818584|Mycamine|mycamine
660622|NCT00818584|FK463|fk463
660623|NCT00818597|septic shock|septic shock
660624|NCT00818597|immunoparalysis|immunoparalysis
660625|NCT00818597|extracorporeal|extracorporeal
660626|NCT00818597|granulocyte bioreactor|granulocyte bioreactor
660627|NCT00818597|plasmapheresis|plasmapheresis
660628|NCT00818610|Community-acquired infections|community-acquired infections
660629|NCT00818610|Pneumonia|pneumonia
660630|NCT00818610|Clinical Stability|clinical stability
660631|NCT00818610|Antibiotics|antibiotics
660632|NCT00818610|Combination therapy|combination therapy
660633|NCT00818610|Atypical bacteria|atypical bacteria
661365|NCT00814580|opioid|opioid
660634|NCT00818636|expressive writing|expressive writing
660635|NCT00818636|ruminating|ruminating
660636|NCT00818636|ruminative thinking|ruminative thinking
661474|NCT00814970|stent|stent
660637|NCT00818636|experiential avoidance|experiential avoidance
660638|NCT00818636|depression|depression
660639|NCT00818636|alcohol|alcohol
660640|NCT00818636|drinking|drinking
660641|NCT00818636|emotional processing|emotional processing
660642|NCT00818649|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
660643|NCT00818649|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
660644|NCT00818649|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
660645|NCT00818649|refractory anemia with excess blasts|refractory anemia with excess blasts
660646|NCT00818649|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
660647|NCT00818649|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
660648|NCT00818649|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
660649|NCT00818649|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
660650|NCT00818649|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
660651|NCT00818649|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
660652|NCT00818649|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
660653|NCT00818649|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
660654|NCT00818649|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
660655|NCT00818649|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
660656|NCT00818649|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
660657|NCT00818649|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
660658|NCT00818649|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
660659|NCT00818649|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
660660|NCT00818649|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
660661|NCT00818662|Alzheimer´s|alzheimer´s
660662|NCT00818662|Dementia|dementia
660663|NCT00818662|Dementia of Alzheimer Type|dementia of alzheimer type
660664|NCT00818662|Immunoglobulins|immunoglobulins
660665|NCT00818662|Gammaglobulins|gammaglobulins
660666|NCT00818662|Immune Globulin Intravenous (IGIV)|immune globulin intravenous (igiv)
660667|NCT00818662|Intravenous Immune Globulin (IVIG)|intravenous immune globulin (ivig)
660668|NCT00818662|Antibodies|antibodies
660669|NCT00818662|Amyloid|amyloid
660670|NCT00818662|Immunotherapy|immunotherapy
660671|NCT00818688|Superficial thrombophlebitis (ST)|superficial thrombophlebitis (st)
660672|NCT00818688|Deep-vein thrombosis|deep-vein thrombosis
660673|NCT00818688|Symptomatic pulmonary embolism|symptomatic pulmonary embolism
660674|NCT00818688|Symptomatic Superficial Thrombophlebitis of the lower limbs|symptomatic superficial thrombophlebitis of the lower limbs
660675|NCT00818701|Congestive Heart Failure|congestive heart failure
660676|NCT00818701|Congestive Heart Failure with a NYHF Class 2-3|congestive heart failure with a nyhf class 2-3
660677|NCT00818701|Ejection Fraction of 35 or less|ejection fraction of 35 or less
660678|NCT00818714|IIIA, selected IIIB|iiia, selected iiib
660679|NCT00818714|(T1N2-3M0, T2N2-3M0, T3N1-3M0)|(t1n2-3m0, t2n2-3m0, t3n1-3m0)
660680|NCT00818727|Bone density|bone density
660681|NCT00818727|SSRI|ssri
660682|NCT00818727|newborn infants|newborn infants
660683|NCT00818766|Thoracic Surgery|thoracic surgery
660684|NCT00818766|Antibiotic Prophylaxis|antibiotic prophylaxis
660685|NCT00818766|Chest Tube|chest tube
660686|NCT00818779|diabetes|diabetes
660687|NCT00818779|heart disease|heart disease
660688|NCT00818779|atherosclerosis|atherosclerosis
660835|NCT00819104|Primary hypertension|primary hypertension
660689|NCT00818792|Percutaneous coronary intervention|percutaneous coronary intervention
660690|NCT00818792|Drug-eluting stent|drug-eluting stent
660691|NCT00818792|Chronic kidney disease|chronic kidney disease
660692|NCT00818792|Restenosis|restenosis
660693|NCT00818805|conjunctivitis|conjunctivitis
660694|NCT00818818|Leishmaniasis|leishmaniasis
660695|NCT00818818|Cutaneous leishmaniasis|cutaneous leishmaniasis
660696|NCT00818818|Leishmania braziliensis|leishmania braziliensis
660697|NCT00818818|Pentavalent antimonial|pentavalent antimonial
660698|NCT00818818|Glucantime|glucantime
660699|NCT00818831|Advanced, refractory solid tumors|advanced, refractory solid tumors
660700|NCT00818844|Nepafenac|nepafenac
660701|NCT00818844|vitrectomy surgery|vitrectomy surgery
660702|NCT00818844|Epiretinal membrane surgery|epiretinal membrane surgery
660703|NCT00818857|cancer screening|cancer screening
660704|NCT00818857|screening disparities|screening disparities
660705|NCT00818857|underserved populations|underserved populations
660706|NCT00818870|Gastroesophageal Reflux|gastroesophageal reflux
660707|NCT00818870|GERD|gerd
660708|NCT00818870|Nocturnal GERD|nocturnal gerd
660709|NCT00818870|Heartburn|heartburn
660710|NCT00818870|Nighttime Heartburn|nighttime heartburn
660711|NCT00818870|Nocturnal Heartburn|nocturnal heartburn
660712|NCT00818883|Essential Hypertension|essential hypertension
660713|NCT00818883|Hypertensive|hypertensive
660714|NCT00818883|Blood Pressure, High|blood pressure, high
660715|NCT00818883|Vascular Disease|vascular disease
660716|NCT00818883|Cardiovascular Disease|cardiovascular disease
661468|NCT00814944|sirolimus|sirolimus
660717|NCT00818883|Drug Therapy|drug therapy
660718|NCT00818896|thyroid deficiency|thyroid deficiency
660719|NCT00818896|pregnancy|pregnancy
660720|NCT00818896|post-partum thyroid dysfunction|post-partum thyroid dysfunction
660721|NCT00818896|permanent hypothyroidism|permanent hypothyroidism
660722|NCT00818909|Dry eye|dry eye
660723|NCT00818909|Systane|systane
660724|NCT00818909|Moderate to severe dry eye|moderate to severe dry eye
660725|NCT00818948|Lupus|lupus
660726|NCT00818948|Nephritis|nephritis
660727|NCT00818961|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
660728|NCT00818961|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
660729|NCT00818961|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
660730|NCT00818961|adult AML with 11q23 (MLL) abnormalities|adult aml with 11q23 (mll) abnormalities
660731|NCT00818961|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
660732|NCT00818961|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
660733|NCT00818961|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
660734|NCT00818961|prolymphocytic leukemia|prolymphocytic leukemia
660735|NCT00818961|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
660736|NCT00818961|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
660737|NCT00818961|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
660738|NCT00818961|secondary acute myeloid leukemia|secondary acute myeloid leukemia
660739|NCT00818961|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
660740|NCT00818961|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
660741|NCT00818961|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
660742|NCT00818961|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
660743|NCT00818961|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
660744|NCT00818961|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
660745|NCT00818961|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
660746|NCT00818961|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
660747|NCT00818961|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
660748|NCT00818961|anaplastic large cell lymphoma|anaplastic large cell lymphoma
660749|NCT00818961|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
660750|NCT00818961|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
660751|NCT00818961|recurrent cutaneous T-cell NHL|recurrent cutaneous t-cell nhl
660752|NCT00818961|stage I cutaneous T-cell NHL|stage i cutaneous t-cell nhl
660753|NCT00818961|stage II cutaneous T-cell NHL|stage ii cutaneous t-cell nhl
660754|NCT00818961|stage III cutaneous T-cell NHL|stage iii cutaneous t-cell nhl
660755|NCT00818961|stage IV cutaneous T-cell NHL|stage iv cutaneous t-cell nhl
660756|NCT00818961|extranodal marginal zone B-cell lymphoma of mucosal tissue|extranodal marginal zone b-cell lymphoma of mucosal tissue
660757|NCT00818961|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
660758|NCT00818961|splenic marginal zone lymphoma|splenic marginal zone lymphoma
660759|NCT00818961|contiguous st II adult diffuse large cell lymphoma|contiguous st ii adult diffuse large cell lymphoma
660760|NCT00818961|contiguous st II adult diffuse mixed cell lymphoma|contiguous st ii adult diffuse mixed cell lymphoma
660761|NCT00818961|contiguous st II adult diffuse sm cleaved cell lymphoma|contiguous st ii adult diffuse sm cleaved cell lymphoma
660762|NCT00818961|contiguous st II grade 1 follicular lymphoma|contiguous st ii grade 1 follicular lymphoma
660763|NCT00818961|contiguous st II grade 2 follicular lymphoma|contiguous st ii grade 2 follicular lymphoma
660764|NCT00818961|contiguous st II grade 3 follicular lymphoma|contiguous st ii grade 3 follicular lymphoma
660765|NCT00818961|contiguous st II mantle cell lymphoma|contiguous st ii mantle cell lymphoma
660766|NCT00818961|contiguous st II marginal zone lymphoma|contiguous st ii marginal zone lymphoma
660767|NCT00818961|contiguous st II small lymphocytic lymphoma|contiguous st ii small lymphocytic lymphoma
660768|NCT00818961|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
660769|NCT00818961|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
660770|NCT00818961|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
660771|NCT00818961|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
660772|NCT00818961|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
660773|NCT00818961|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
660774|NCT00818961|stage I mantle cell lymphoma|stage i mantle cell lymphoma
660775|NCT00818961|stage I marginal zone lymphoma|stage i marginal zone lymphoma
660776|NCT00818961|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
660777|NCT00818961|noncontiguous st II adult diffuse large cell lymphoma|noncontiguous st ii adult diffuse large cell lymphoma
660778|NCT00818961|noncontiguous st II adult diffuse mixed cell lymphoma|noncontiguous st ii adult diffuse mixed cell lymphoma
660779|NCT00818961|noncontiguous st II adult diffuse sm cleaved cell lymphoma|noncontiguous st ii adult diffuse sm cleaved cell lymphoma
660780|NCT00818961|noncontiguous st II grade 1 follicular lymphoma|noncontiguous st ii grade 1 follicular lymphoma
660781|NCT00818961|noncontiguous st II grade 2 follicular lymphoma|noncontiguous st ii grade 2 follicular lymphoma
660782|NCT00818961|noncontiguous st II grade 3 follicular lymphoma|noncontiguous st ii grade 3 follicular lymphoma
660783|NCT00818961|noncontiguous st II mantle cell lymphoma|noncontiguous st ii mantle cell lymphoma
660866|NCT00819208|stage III colon cancer|stage iii colon cancer
660784|NCT00818961|noncontiguous st II marginal zone lymphoma|noncontiguous st ii marginal zone lymphoma
660869|NCT00819221|solid tumors|solid tumors
660785|NCT00818961|noncontiguous st II small lymphocytic lymphoma|noncontiguous st ii small lymphocytic lymphoma
660786|NCT00818961|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
660787|NCT00818961|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
660788|NCT00818961|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
660789|NCT00818961|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
660790|NCT00818961|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
660791|NCT00818961|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
660792|NCT00818961|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
660793|NCT00818961|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
660794|NCT00818961|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
660795|NCT00818961|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
660796|NCT00818961|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
660797|NCT00818961|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
660798|NCT00818961|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
660799|NCT00818961|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
660800|NCT00818961|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
660801|NCT00818961|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
660802|NCT00818961|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
660803|NCT00818961|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
660804|NCT00818961|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
660805|NCT00818961|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
660806|NCT00818961|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
660807|NCT00818961|recurrent adult gr III lymphomatoid granulomatosis|recurrent adult gr iii lymphomatoid granulomatosis
660808|NCT00818961|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
660809|NCT00818961|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
660810|NCT00818961|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
660811|NCT00818961|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
660812|NCT00818961|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
660813|NCT00818961|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
660814|NCT00818961|de novo MDS|de novo mds
660815|NCT00818961|previously treated MDS|previously treated mds
660816|NCT00818961|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
660817|NCT00818961|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
660818|NCT00818961|myelodysplastic/myeloproliferative disease|myelodysplastic/myeloproliferative disease
660819|NCT00818987|Operative|operative
660820|NCT00818987|Non operative|non operative
660821|NCT00819000|Specialty Pharmacy|specialty pharmacy
660822|NCT00819000|Therapy Management|therapy management
660823|NCT00819000|Medication Compliance|medication compliance
660824|NCT00819000|Medication Adherence|medication adherence
660825|NCT00819000|Medication Persistence|medication persistence
660826|NCT00819000|Health Outcomes|health outcomes
660827|NCT00819065|Botulinum toxin A|botulinum toxin a
660828|NCT00819065|Spasticity|spasticity
660829|NCT00819065|Randomized Clinical Trial|randomized clinical trial
660830|NCT00819078|adolescent|adolescent
660831|NCT00819078|bupropion|bupropion
660832|NCT00819078|smoking|smoking
660833|NCT00819078|cessation|cessation
660834|NCT00819078|depression|depression
660836|NCT00819104|Metoprolol XL|metoprolol xl
660837|NCT00819104|Amlodipine|amlodipine
660838|NCT00819117|Epicardial leads|epicardial leads
660839|NCT00819117|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
660840|NCT00819143|Tissue Procurement|tissue procurement
660841|NCT00819143|Sample Collection|sample collection
660842|NCT00819143|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
660843|NCT00819143|Laboratory Research|laboratory research
660844|NCT00819169|AMG 655|amg 655
660845|NCT00819169|AMG 479|amg 479
660846|NCT00819169|Apoptosis|apoptosis
660847|NCT00819169|Monoclonal Antibody|monoclonal antibody
660848|NCT00819169|Tumor Necrosis Factor|tumor necrosis factor
660849|NCT00819169|Insulin-like Growth Factor|insulin-like growth factor
660850|NCT00819182|Menopause|menopause
660851|NCT00819182|Breast Cancer|breast cancer
660852|NCT00819182|Hot Flash|hot flash
660853|NCT00819182|Night Sweats|night sweats
660854|NCT00819195|relapsing-remitting|relapsing-remitting
660855|NCT00819195|multiple sclerosis|multiple sclerosis
660856|NCT00819195|Copaxone|copaxone
660857|NCT00819195|glatiramer acetate|glatiramer acetate
660858|NCT00819195|MS|ms
660859|NCT00819208|fatigue|fatigue
660860|NCT00819208|sleep disorders|sleep disorders
660861|NCT00819208|depression|depression
660862|NCT00819208|anxiety disorder|anxiety disorder
660863|NCT00819208|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
660864|NCT00819208|cognitive/functional effects|cognitive/functional effects
660865|NCT00819208|stage II colon cancer|stage ii colon cancer
660867|NCT00819208|adenocarcinoma of the colon|adenocarcinoma of the colon
660868|NCT00819221|advanced tumors|advanced tumors
660870|NCT00819221|dose escalation|dose escalation
660871|NCT00819221|combination|combination
660872|NCT00819221|AZD2281|azd2281
660873|NCT00819221|liposomal doxorubicin|liposomal doxorubicin
660874|NCT00819221|pharmacology|pharmacology
660875|NCT00819221|phase I|phase i
660876|NCT00819221|multicenter|multicenter
660877|NCT00819234|Leptin|leptin
660878|NCT00819234|Pramlintide|pramlintide
660879|NCT00819234|Obese|obese
660880|NCT00819234|Symlin|symlin
660881|NCT00819234|Amylin|amylin
660882|NCT00819260|Mammaplasty|mammaplasty
660883|NCT00819260|Electrocoagulation|electrocoagulation
660884|NCT00819260|Breast|breast
660885|NCT00819273|hsCRP|hscrp
660886|NCT00819286|open heart surgery|open heart surgery
660887|NCT00819312|Contraceptives,|contraceptives,
660888|NCT00819312|Oral Hormonal;|oral hormonal;
660889|NCT00819312|Contraceptive Methods;|contraceptive methods;
660890|NCT00819312|Female|female
660891|NCT00819325|diabetes|diabetes
660892|NCT00819325|stents|stents
660893|NCT00819325|restenosis|restenosis
660894|NCT00819325|thiazolidinediones|thiazolidinediones
660895|NCT00819325|coronary atherosclerosis|coronary atherosclerosis
660896|NCT00819338|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
660897|NCT00819338|Polyunsaturated fatty acids|polyunsaturated fatty acids
660898|NCT00819338|Omega-3|omega-3
660899|NCT00819351|acute lymphoblastic leukemia|acute lymphoblastic leukemia
660900|NCT00819351|child|child
660901|NCT00819351|PEG-Asparaginase|peg-asparaginase
660902|NCT00819351|EFS|efs
660903|NCT00819351|efficacy|efficacy
660904|NCT00819351|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
660905|NCT00819364|Autism|autism
660906|NCT00819364|early intervention|early intervention
660907|NCT00819364|BCRI model|bcri model
660908|NCT00819377|Valvular surgery|valvular surgery
660909|NCT00819377|pulmonary artery pressure|pulmonary artery pressure
660910|NCT00819403|triglycerides|triglycerides
660911|NCT00819403|hypertension|hypertension
660912|NCT00819403|low hdl|low hdl
660913|NCT00819403|obesity|obesity
660914|NCT00819416|randomized controlled trial|randomized controlled trial
660915|NCT00819416|clinical trial|clinical trial
660916|NCT00819429|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
660917|NCT00819429|Conduct Disorder|conduct disorder
660918|NCT00819429|Oppositional Defiant Disorder|oppositional defiant disorder
660919|NCT00819429|Omega 3 Supplements|omega 3 supplements
660920|NCT00819429|Social Skills Training|social skills training
660921|NCT00819429|Dietary Intake|dietary intake
660922|NCT00819429|Aggression|aggression
660923|NCT00819429|Nutrition|nutrition
660924|NCT00819429|Disruptive Behaviors Disorder|disruptive behaviors disorder
660925|NCT00819442|heart failure|heart failure
660926|NCT00819442|desmin|desmin
660927|NCT00819442|ubiquitin|ubiquitin
660928|NCT00819455|Diabetes|diabetes
660929|NCT00819455|Prevention of Diabetes|prevention of diabetes
660930|NCT00819455|Lifestyle Modification|lifestyle modification
660931|NCT00819455|Text messages|text messages
660932|NCT00819481|Total knee replacement|total knee replacement
660933|NCT00819494|Contrast media skin test|contrast media skin test
660934|NCT00819494|Skin test|skin test
660935|NCT00819494|hypersensitivity|hypersensitivity
660936|NCT00819494|contrast media|contrast media
660937|NCT00819507|Skin barrier|skin barrier
660938|NCT00819507|Atopic Dermatitis|atopic dermatitis
660939|NCT00819507|Corticosteroid|corticosteroid
660940|NCT00819507|Effects on skin severity and barrier function|effects on skin severity and barrier function
660941|NCT00819520|pediculosis capitis|pediculosis capitis
660942|NCT00819520|pediculus|pediculus
660943|NCT00819546|AML|aml
660944|NCT00819546|MDS|mds
660945|NCT00819559|Rectal neoplasm|rectal neoplasm
660946|NCT00819559|Clinical stage|clinical stage
660947|NCT00819559|T3N0|t3n0
660948|NCT00819559|Preoperative chemoradiotherapy|preoperative chemoradiotherapy
660949|NCT00819559|Laparoscopic|laparoscopic
660950|NCT00819559|Open resection|open resection
660951|NCT00819572|Osteoarthritis|osteoarthritis
660952|NCT00819572|TNF-alpha|tnf-alpha
660953|NCT00819572|DLX105|dlx105
660954|NCT00819572|scFv antibody fragment|scfv antibody fragment
660955|NCT00819572|pain|pain
660956|NCT00819572|fragment|fragment
660957|NCT00819572|antibody fragment|antibody fragment
660958|NCT00819585|Gout|gout
660959|NCT00819585|Chronic Gout|chronic gout
660960|NCT00819585|Gouty arthritis|gouty arthritis
660961|NCT00819585|Gout flares|gout flares
660962|NCT00819611|Attention deficit disorder with hyperactivity|attention deficit disorder with hyperactivity
660963|NCT00819611|Working memory training|working memory training
660964|NCT00819611|Placebo|placebo
660965|NCT00819611|Behavioral symptoms|behavioral symptoms
660966|NCT00819611|Neuropsychology|neuropsychology
660967|NCT00819611|Electropsychophysiology|electropsychophysiology
660968|NCT00819624|fibromyalgia methodology pain sleep fatigue|fibromyalgia methodology pain sleep fatigue
660969|NCT00819637|Acute asthma|acute asthma
660970|NCT00819637|Arformoterol|arformoterol
660971|NCT00819637|Long acting beta agonists|long acting beta agonists
660972|NCT00819650|hepatocellular carcinoma|hepatocellular carcinoma
660973|NCT00819650|adjuvant therapy|adjuvant therapy
660974|NCT00819650|Licartin|licartin
660975|NCT00819650|time to recurrence|time to recurrence
660976|NCT00819650|overall survival|overall survival
660977|NCT00819702|child abuse prevention|child abuse prevention
660978|NCT00819702|primary care|primary care
660979|NCT00819702|professional education in primary care|professional education in primary care
660980|NCT00819715|Preterm infants|preterm infants
660981|NCT00819715|small for gestational age|small for gestational age
660982|NCT00819715|electrogastrography|electrogastrography
660983|NCT00819767|hypertension|hypertension
660984|NCT00819767|systolic blood pressure|systolic blood pressure
660985|NCT00819767|exercise test|exercise test
660986|NCT00819767|cardiovascular disease|cardiovascular disease
660987|NCT00819767|aliskiren|aliskiren
660988|NCT00819767|valsartan|valsartan
660989|NCT00819780|Colon Cancer|colon cancer
660990|NCT00819780|Colorectal Cancer|colorectal cancer
660991|NCT00819780|Rectal Cancer|rectal cancer
660992|NCT00819780|Panitumumab|panitumumab
660993|NCT00819780|Vectibix|vectibix
660994|NCT00819780|modified FOLFOX 6|modified folfox 6
660995|NCT00819780|mFOLFOX 6|mfolfox 6
660996|NCT00819780|FOLFOX|folfox
660997|NCT00819780|Bevacizumab|bevacizumab
660998|NCT00819780|Avastin|avastin
660999|NCT00819780|First-Line|first-line
661000|NCT00819780|metastatic|metastatic
661001|NCT00819793|Cardiac Dysfunction|cardiac dysfunction
661002|NCT00819793|Failure-to-wean from CPB|failure-to-wean from cpb
661003|NCT00819793|CentriMag|centrimag
661004|NCT00819793|Levitronix|levitronix
661005|NCT00819793|Thoratec Corporation|thoratec corporation
661006|NCT00819832|vertebral compression fractures|vertebral compression fractures
661008|NCT00819832|Spinal|spinal
661009|NCT00819832|Broken spinal bones|broken spinal bones
661010|NCT00819832|Kyphoplasty|kyphoplasty
661011|NCT00819832|vertebroplasty|vertebroplasty
661012|NCT00819832|Cavity SpineWand|cavity spinewand
661013|NCT00819832|Circulating Tumor Cell Burden|circulating tumor cell burden
661014|NCT00819832|CTCB|ctcb
661015|NCT00819832|Spine pain|spine pain
661016|NCT00819832|Coblation|coblation
661017|NCT00819832|plasma radiofrequency ablation|plasma radiofrequency ablation
661018|NCT00819832|Plasma-mediated ablation technology|plasma-mediated ablation technology
661019|NCT00819832|precise molecular dissociation (ablation) process|precise molecular dissociation (ablation) process
661020|NCT00819832|medical cement|medical cement
661021|NCT00819845|Duchenne|duchenne
661022|NCT00819845|Becker muscular dystrophy|becker muscular dystrophy
661023|NCT00819845|cardioprotective therapy|cardioprotective therapy
661024|NCT00819845|cardiac magnetic resonance|cardiac magnetic resonance
661025|NCT00819845|ultrasound tissue characterization|ultrasound tissue characterization
661026|NCT00819858|weight loss|weight loss
661027|NCT00819858|weight gain|weight gain
661028|NCT00819858|malnutrition|malnutrition
661029|NCT00819858|convalescence|convalescence
661030|NCT00819858|malaria|malaria
661031|NCT00819858|RUTF|rutf
661032|NCT00819858|RUF|ruf
661033|NCT00819858|supplementation|supplementation
661034|NCT00819858|nutrition|nutrition
661035|NCT00819884|Type II Diabetes|type ii diabetes
661036|NCT00819884|24 hour glucose profile|24 hour glucose profile
661037|NCT00819897|MS|ms
661038|NCT00819897|CIS|cis
661039|NCT00819897|IFN|ifn
661040|NCT00819897|MRI|mri
661041|NCT00819897|OCT|oct
661042|NCT00819897|QOL|qol
661237|NCT00820586|Refractory|refractory
661043|NCT00819910|Type 4 hyperlipidemia|type 4 hyperlipidemia
661044|NCT00819910|Rosiglitazone|rosiglitazone
661045|NCT00819910|Fenofibrate|fenofibrate
661046|NCT00819923|Titanium|titanium
661047|NCT00819923|everolimus|everolimus
661048|NCT00819923|drug eluting stent|drug eluting stent
661049|NCT00819923|stent thrombosis|stent thrombosis
661050|NCT00819923|restenosis|restenosis
661051|NCT00819923|percutaneous coronary intervention|percutaneous coronary intervention
661052|NCT00819923|acute coronary syndrome|acute coronary syndrome
661053|NCT00819936|abdominal aorta surgery|abdominal aorta surgery
661054|NCT00819936|Physical Training|physical training
661055|NCT00819936|backward walking|backward walking
661056|NCT00819936|physiotherapy|physiotherapy
661057|NCT00819949|Robot|robot
661058|NCT00819949|Treadmill|treadmill
661059|NCT00819949|Rehabilitation|rehabilitation
661060|NCT00819949|Freezing of gait|freezing of gait
661061|NCT00819975|Casein|casein
661062|NCT00819975|Whey|whey
661063|NCT00819975|postprandial|postprandial
661064|NCT00819975|Triglyceride|triglyceride
661065|NCT00819975|Free fatty acids|free fatty acids
661066|NCT00819975|Retinyl palmitate|retinyl palmitate
661067|NCT00819975|Incretins|incretins
661068|NCT00819975|Type 2 Diabetes|type 2 diabetes
661069|NCT00819988|Postoperative|postoperative
661070|NCT00819988|Perioperative|perioperative
661071|NCT00819988|Orthopedic surgery|orthopedic surgery
661072|NCT00819988|Vascular surgery|vascular surgery
661073|NCT00819988|Gabapentinoid|gabapentinoid
661074|NCT00820001|Cognitive Behavioral Therapy|cognitive behavioral therapy
661075|NCT00820001|Multimodal Treatment|multimodal treatment
661369|NCT00814580|oxycodone|oxycodone
661076|NCT00820001|Physiological Parameters|physiological parameters
661077|NCT00820001|Hormone Concentration in pubertal development|hormone concentration in pubertal development
661078|NCT00820001|Treatment as usual comparison|treatment as usual comparison
661079|NCT00820014|ESBA105|esba105
661080|NCT00820014|scFv antibody fragment|scfv antibody fragment
661081|NCT00820014|cataract surgery|cataract surgery
661082|NCT00820014|pharmacokinetics|pharmacokinetics
661083|NCT00820014|biodistribution|biodistribution
661084|NCT00820014|Irvine-Gass syndrome|irvine-gass syndrome
661085|NCT00820053|hepatocellular carcinoma|hepatocellular carcinoma
661086|NCT00820053|adjuvant therapy|adjuvant therapy
661087|NCT00820053|TACE|tace
661088|NCT00820053|time to recurrence|time to recurrence
661089|NCT00820053|overall survival|overall survival
661090|NCT00820079|Gastroesophageal reflux|gastroesophageal reflux
661091|NCT00820079|Heartburn|heartburn
661092|NCT00820079|Regurgitation|regurgitation
661093|NCT00820092|Xerecept|xerecept
661094|NCT00820092|Pharmacokinetics|pharmacokinetics
661095|NCT00820092|Japanese versus Caucasians|japanese versus caucasians
661096|NCT00820105|Migraine|migraine
661097|NCT00820105|Aura|aura
661098|NCT00820105|Migraine headache|migraine headache
661099|NCT00820118|ANTIRETROVIRAL THERAPY|antiretroviral therapy
661100|NCT00820118|STRUCTURED TREATMENT INTERRUPTIONS|structured treatment interruptions
661101|NCT00820118|treatment naive|treatment naive
661102|NCT00820144|immune response|immune response
661103|NCT00820144|b-subunit of cholera toxin|b-subunit of cholera toxin
661104|NCT00820144|mucosal way|mucosal way
661105|NCT00820144|healthy volonteers|healthy volonteers
661106|NCT00820144|vaccine|vaccine
661107|NCT00820157|Carcinoma, Hepatocellular|carcinoma, hepatocellular
661108|NCT00820157|Chemoembolization, Therapeutic|chemoembolization, therapeutic
661109|NCT00820157|Cytoreductive|cytoreductive
661110|NCT00820170|Breast|breast
661111|NCT00820170|Cancer|cancer
661112|NCT00820170|DASATINIB|dasatinib
661113|NCT00820170|TAXOL (PACLITAXEL)|taxol (paclitaxel)
661114|NCT00820170|08-122|08-122
661115|NCT00820183|Hypertension|hypertension
661116|NCT00820183|Intervention|intervention
661117|NCT00820183|Primary Care|primary care
661118|NCT00820183|Quality improvement|quality improvement
661119|NCT00820196|Venous ulcer|venous ulcer
661120|NCT00820196|Nexagon|nexagon
661121|NCT00820196|CoDa|coda
661122|NCT00820222|ErbB2|erbb2
661123|NCT00820222|HERCEPTIN|herceptin
661124|NCT00820222|XELODA|xeloda
661125|NCT00820222|ErbB1|erbb1
661126|NCT00820222|TYKERB|tykerb
661127|NCT00820222|metastatic breast cancer|metastatic breast cancer
661128|NCT00820222|trastuzumab|trastuzumab
661129|NCT00820222|breast cancer|breast cancer
661130|NCT00820222|capecitabine|capecitabine
661131|NCT00820222|lapatinib|lapatinib
661132|NCT00820222|brain metastases|brain metastases
661133|NCT00820222|HER2 positive|her2 positive
661134|NCT00820222|TYVERB|tyverb
661135|NCT00820248|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
661136|NCT00820248|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
661137|NCT00820248|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
661138|NCT00820248|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
661139|NCT00820248|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
661238|NCT00820586|Angina|angina
661140|NCT00820248|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
661141|NCT00820248|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
661142|NCT00820248|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
661143|NCT00820248|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
661144|NCT00820248|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
661145|NCT00820248|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
661146|NCT00820248|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
661147|NCT00820261|Genotypes|genotypes
661148|NCT00820261|Epidemiology|epidemiology
661149|NCT00820261|Diarrhea|diarrhea
661150|NCT00820287|Testicular cancer|testicular cancer
661151|NCT00820287|incidence|incidence
661152|NCT00820287|young men|young men
661153|NCT00820313|Coronary Heart Disease|coronary heart disease
661154|NCT00820313|Biomarkers of Cardiovascular Disease|biomarkers of cardiovascular disease
661155|NCT00820313|Health Related Quality of Life|health related quality of life
661156|NCT00820313|Diabetes|diabetes
661157|NCT00820313|Diet|diet
661158|NCT00820339|hepatocellular carcinoma|hepatocellular carcinoma
661159|NCT00820339|hepatic vein|hepatic vein
661160|NCT00820339|Surgical resection|surgical resection
661161|NCT00820339|occlusion|occlusion
661162|NCT00820339|time to recurrence|time to recurrence
661163|NCT00820339|overall survival|overall survival
661164|NCT00820352|HFNEF|hfnef
661165|NCT00820352|HFPEF|hfpef
661166|NCT00820352|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
661167|NCT00820352|Endothelin Receptor Blockade|endothelin receptor blockade
661168|NCT00820365|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
661169|NCT00820365|Crohn's Disease|crohn's disease
661170|NCT00820365|Ulcerative Colitis|ulcerative colitis
661171|NCT00820365|SC12267|sc12267
661172|NCT00820365|4SC-101|4sc-101
661173|NCT00820365|Phase II|phase ii
661174|NCT00820378|Aortic dimension|aortic dimension
661175|NCT00820378|Atherosclerosis|atherosclerosis
661176|NCT00820378|Vascular disease|vascular disease
661177|NCT00820378|Risk factors|risk factors
661178|NCT00820391|Post-traumatic Stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
661179|NCT00820417|cetuximab|cetuximab
661180|NCT00820417|monoclonal|monoclonal
661181|NCT00820417|antibody|antibody
661182|NCT00820417|epidermal|epidermal
661183|NCT00820417|growth|growth
661184|NCT00820417|factor|factor
661185|NCT00820417|receptor|receptor
661186|NCT00820417|EGFR|egfr
661187|NCT00820417|Gefitinib|gefitinib
661188|NCT00820417|tyrosine|tyrosine
661189|NCT00820417|kinase|kinase
661190|NCT00820417|inhibitor|inhibitor
661191|NCT00820417|advanced|advanced
661192|NCT00820417|cancer|cancer
661193|NCT00820430|osteoarthritis|osteoarthritis
661194|NCT00820430|knee|knee
661195|NCT00820430|magnetic resonance imaging|magnetic resonance imaging
661196|NCT00820430|knee cartilage|knee cartilage
661197|NCT00820430|reproducibility|reproducibility
661198|NCT00820456|colorectal cancer|colorectal cancer
661199|NCT00820456|colorectal neoplasm|colorectal neoplasm
661200|NCT00820456|colorectal neoplasms|colorectal neoplasms
661201|NCT00820456|metastasis|metastasis
661202|NCT00820456|metastases|metastases
661203|NCT00820456|liver|liver
661204|NCT00820456|hepatic metastasis|hepatic metastasis
661205|NCT00820456|liver metastasis|liver metastasis
661206|NCT00820456|perfusion imaging|perfusion imaging
661208|NCT00820456|magnetic resonance imaging|magnetic resonance imaging
661209|NCT00820456|dynamic contrast enhanced MRI|dynamic contrast enhanced mri
661210|NCT00820456|dynamic contrast enhanced magnetic resonance imaging|dynamic contrast enhanced magnetic resonance imaging
661211|NCT00820469|Rituximab|rituximab
661212|NCT00820469|Plasma exchange|plasma exchange
661213|NCT00820469|Autoimmune diseases|autoimmune diseases
661214|NCT00820495|Smokeless tobacco|smokeless tobacco
661215|NCT00820495|Chewing Tobacco|chewing tobacco
661216|NCT00820495|Internet|internet
661217|NCT00820495|Adolescent|adolescent
661218|NCT00820508|Haematological disease|haematological disease
661219|NCT00820508|Lymphoid malignancy|lymphoid malignancy
661220|NCT00820508|Histone deacetylase inhibitor|histone deacetylase inhibitor
661221|NCT00820508|dose escalation|dose escalation
661222|NCT00820534|cold sore|cold sore
661223|NCT00820547|inflammatory breast cancer|inflammatory breast cancer
661224|NCT00820547|stage IIIA breast cancer|stage iiia breast cancer
661225|NCT00820547|stage IIIB breast cancer|stage iiib breast cancer
661226|NCT00820547|stage IIIC breast cancer|stage iiic breast cancer
661227|NCT00820547|male breast cancer|male breast cancer
661228|NCT00820547|HER2-negative breast cancer|her2-negative breast cancer
661229|NCT00820573|Diabetes|diabetes
661230|NCT00820586|Intramyocardial|intramyocardial
661231|NCT00820586|Autologous|autologous
661232|NCT00820586|Bone|bone
661233|NCT00820586|Marrow|marrow
661234|NCT00820586|Randomized|randomized
661235|NCT00820586|Percutaneous|percutaneous
661236|NCT00820586|CD34+|cd34+
661239|NCT00820586|Pectoris.|pectoris.
661240|NCT00820599|Sapien Valve|sapien valve
661241|NCT00820599|Cardiovascular Diseases|cardiovascular diseases
661242|NCT00820599|Valvular Heart Disease|valvular heart disease
661243|NCT00820599|Aortic Stenosis|aortic stenosis
661244|NCT00820599|Heart Valve Therapy|heart valve therapy
661245|NCT00820599|Transfemoral|transfemoral
661246|NCT00820599|Transcatheter|transcatheter
661247|NCT00820638|neurorobotics|neurorobotics
661248|NCT00820638|occupational therapy|occupational therapy
661249|NCT00820651|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
661250|NCT00820651|Insulinresistance|insulinresistance
661251|NCT00820651|Diet and exercise|diet and exercise
661252|NCT00820651|Nutritional supplement|nutritional supplement
661253|NCT00820651|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
661254|NCT00820651|Lifestyle modifications|lifestyle modifications
661255|NCT00820690|neoadjuvant chemotherapy|neoadjuvant chemotherapy
661256|NCT00820690|advanced breast cancer|advanced breast cancer
661257|NCT00820690|microarray|microarray
661258|NCT00820690|correlation analysis|correlation analysis
661259|NCT00820690|oncoplastic surgery|oncoplastic surgery
661260|NCT00820703|Nexagon|nexagon
661261|NCT00820703|CoDa|coda
661262|NCT00820703|ulcer|ulcer
661263|NCT00820703|diabetic|diabetic
661264|NCT00820703|foot|foot
661265|NCT00820716|Asthma|asthma
661266|NCT00820716|Asthmatic subjects|asthmatic subjects
661267|NCT00820716|Exercise training|exercise training
661268|NCT00820716|Constant load|constant load
661269|NCT00820716|Alternate load|alternate load
661270|NCT00820729|interstitial lung disease|interstitial lung disease
661370|NCT00814580|tapentadol|tapentadol
661271|NCT00820729|pulmonary hypertension|pulmonary hypertension
661272|NCT00820729|biomarkers|biomarkers
661273|NCT00820729|NT-pro-BNP|nt-pro-bnp
661274|NCT00820729|von Willebrand factor|von willebrand factor
661275|NCT00820729|D-dimer|d-dimer
661276|NCT00820729|Exhaled NO|exhaled no
661277|NCT00820729|Troponin-t|troponin-t
661278|NCT00820742|A5751025|a5751025
661279|NCT00820781|bleeding gastric varices|bleeding gastric varices
661280|NCT00820781|cirrhosis of the liver|cirrhosis of the liver
661281|NCT00820781|portacaval shunt|portacaval shunt
661282|NCT00820781|endoscopic variceal sclerotherapy|endoscopic variceal sclerotherapy
661283|NCT00820781|endoscopic variceal ligation|endoscopic variceal ligation
661284|NCT00820781|Bleeding gastric varices due to cirrhosis of the liver|bleeding gastric varices due to cirrhosis of the liver
661285|NCT00820794|Drug-drug interaction, lithium, PD 0332334, pharmacokinetics|drug-drug interaction, lithium, pd 0332334, pharmacokinetics
661286|NCT00820807|dietary fiber|dietary fiber
661287|NCT00820807|fiber|fiber
661288|NCT00820807|insulin sensitivity|insulin sensitivity
661289|NCT00820807|insulin resistance|insulin resistance
661290|NCT00820807|glucose metabolism|glucose metabolism
661291|NCT00820820|Atopic Dermatitis|atopic dermatitis
661292|NCT00820820|immunosuppression|immunosuppression
661293|NCT00820820|Measles vaccine|measles vaccine
661294|NCT00820820|T lymphocytes|t lymphocytes
661295|NCT00820820|Atopic Dermatitis in adults|atopic dermatitis in adults
661296|NCT00820833|infant formula|infant formula
661297|NCT00820833|obesity|obesity
661298|NCT00820833|growth|growth
661299|NCT00820846|HIV Seronegativity|hiv seronegativity
661300|NCT00820846|HIV Preventive Vaccine|hiv preventive vaccine
661301|NCT00820859|Cognition disorder|cognition disorder
661302|NCT00820859|nursing home residents|nursing home residents
661303|NCT00820859|agitation|agitation
661304|NCT00820859|behavior disorder|behavior disorder
661305|NCT00820872|male breast cancer|male breast cancer
661306|NCT00820872|stage I breast cancer|stage i breast cancer
661307|NCT00820872|stage II breast cancer|stage ii breast cancer
661308|NCT00820872|stage IIIA breast cancer|stage iiia breast cancer
661309|NCT00820872|stage IIIB breast cancer|stage iiib breast cancer
661310|NCT00820911|Kidney transplant|kidney transplant
661311|NCT00820911|AEB071|aeb071
661312|NCT00820924|HER-2|her-2
661313|NCT00820924|Circulating Tumour Cell (CTC)|circulating tumour cell (ctc)
661314|NCT00820924|EGFR|egfr
661315|NCT00820924|Lapatinib (GW572016)|lapatinib (gw572016)
661316|NCT00820924|Breast Cancer|breast cancer
661317|NCT00820963|adult giant cell glioblastoma|adult giant cell glioblastoma
661318|NCT00820963|adult glioblastoma|adult glioblastoma
661319|NCT00820963|adult gliosarcoma|adult gliosarcoma
661320|NCT00820976|G-CSF|g-csf
661322|NCT00820976|survival|survival
661323|NCT00814476|Medtronic CareLink|medtronic carelink
661324|NCT00814476|therapy management|therapy management
661325|NCT00814476|diabetes|diabetes
661326|NCT00814476|insulin pump|insulin pump
661327|NCT00814476|Blood glucose monitor|blood glucose monitor
661328|NCT00814489|Non-typable Haemophilus influenzae|non-typable haemophilus influenzae
661329|NCT00814489|protein vaccine|protein vaccine
661330|NCT00814489|Streptococcus pneumoniae|streptococcus pneumoniae
661331|NCT00814489|young adults|young adults
661332|NCT00814502|Alzheimer disease|alzheimer disease
661333|NCT00814502|Dementia, vascular|dementia, vascular
661334|NCT00814502|Actigraphy|actigraphy
661335|NCT00814502|Circadian dysregulation|circadian dysregulation
661336|NCT00814502|Sleep Disorders|sleep disorders
661337|NCT00814502|Circadian rhythm|circadian rhythm
661338|NCT00814515|Moderate|moderate
661339|NCT00814515|Severe|severe
661340|NCT00814515|Dry|dry
661341|NCT00814515|Eye|eye
661342|NCT00814515|Ciclosporin|ciclosporin
661343|NCT00814515|Cyclosporine|cyclosporine
661344|NCT00814528|actinic keratosis|actinic keratosis
661345|NCT00814528|skin lesions|skin lesions
661346|NCT00814528|5-ALA|5-ala
661347|NCT00814528|AK|ak
661348|NCT00814528|Blu-Light|blu-light
661349|NCT00814541|refractory multiple myeloma|refractory multiple myeloma
661350|NCT00814541|stage I multiple myeloma|stage i multiple myeloma
661351|NCT00814541|stage II multiple myeloma|stage ii multiple myeloma
661352|NCT00814541|stage III multiple myeloma|stage iii multiple myeloma
661353|NCT00814554|obesity|obesity
661354|NCT00814554|nutrition|nutrition
661355|NCT00814554|cluster randomized trial|cluster randomized trial
661356|NCT00814554|high school|high school
661357|NCT00814554|primary prevention|primary prevention
661358|NCT00814567|recurrent breast cancer|recurrent breast cancer
661359|NCT00814567|stage IA breast cancer|stage ia breast cancer
661360|NCT00814567|stage II breast cancer|stage ii breast cancer
661361|NCT00814567|invasive ductal breast carcinoma|invasive ductal breast carcinoma
661362|NCT00814567|invasive ductal breast carcinoma with predominant intraductal component|invasive ductal breast carcinoma with predominant intraductal component
661363|NCT00814580|analgesia|analgesia
661364|NCT00814580|postoperative pain|postoperative pain
661366|NCT00814580|rotator cuff repair|rotator cuff repair
661367|NCT00814580|labral tear repair|labral tear repair
661368|NCT00814580|Bankart procedure|bankart procedure
661371|NCT00814580|arthroscopic shoulder surgery|arthroscopic shoulder surgery
661372|NCT00814593|adult giant cell glioblastoma|adult giant cell glioblastoma
661373|NCT00814593|adult gliosarcoma|adult gliosarcoma
661374|NCT00814593|adult glioblastoma|adult glioblastoma
661375|NCT00814606|genotype 1 hepatitis C|genotype 1 hepatitis c
661376|NCT00814606|hepatitis C|hepatitis c
661377|NCT00814606|HCV|hcv
661378|NCT00814606|liver|liver
661379|NCT00814619|adenocarcinoma of the rectum|adenocarcinoma of the rectum
661380|NCT00814619|stage III rectal cancer|stage iii rectal cancer
661381|NCT00814619|stage II rectal cancer|stage ii rectal cancer
661382|NCT00814632|vulvodynia|vulvodynia
661383|NCT00814632|pelvic pain|pelvic pain
661384|NCT00814632|vulvar pain|vulvar pain
661385|NCT00814658|Dementia|dementia
661386|NCT00814658|Mixed Dementia|mixed dementia
661387|NCT00814658|Galantamine|galantamine
661388|NCT00814658|Reminyl ER|reminyl er
661389|NCT00814658|Nimodipine|nimodipine
661390|NCT00814671|Tuberculosis|tuberculosis
661391|NCT00814671|Pharmacokinetics|pharmacokinetics
661392|NCT00814697|Alzheimer|alzheimer
661393|NCT00814697|Language|language
661394|NCT00814697|Treatment|treatment
661395|NCT00814697|TMS|tms
661396|NCT00814697|rTMS|rtms
661397|NCT00814710|Pneumococcal disease|pneumococcal disease
661398|NCT00814710|Pneumococcal vaccine|pneumococcal vaccine
661399|NCT00814710|Safety|safety
661400|NCT00814710|Primary vaccination|primary vaccination
661401|NCT00814710|Immunogenicity|immunogenicity
661402|NCT00814749|stress urinary incontinence|stress urinary incontinence
661403|NCT00814749|urodynamics|urodynamics
661404|NCT00814749|randomized clinical trial|randomized clinical trial
661405|NCT00814749|surgery|surgery
661406|NCT00814762|immunogenicity|immunogenicity
661407|NCT00814762|HIV|hiv
661408|NCT00814762|reactogenicity|reactogenicity
661409|NCT00814762|safety|safety
661410|NCT00814762|vaccine|vaccine
661411|NCT00814762|HIV Infections|hiv infections
661412|NCT00814775|Laryngeal mask|laryngeal mask
661413|NCT00814775|Difficult intubation|difficult intubation
661414|NCT00814788|stage IV prostate cancer|stage iv prostate cancer
661415|NCT00814788|adenocarcinoma of the prostate|adenocarcinoma of the prostate
661416|NCT00814788|recurrent prostate cancer|recurrent prostate cancer
661417|NCT00814801|Alzheimer's Disease|alzheimer's disease
661418|NCT00814801|Cognitive dysfunction|cognitive dysfunction
661419|NCT00814801|Dementia|dementia
661420|NCT00814801|Galantamine|galantamine
661421|NCT00814801|R113675|r113675
661422|NCT00814827|Interferon-Gamma|interferon-gamma
661423|NCT00814827|Autoantibodies|autoantibodies
661424|NCT00814827|Mycobacteria|mycobacteria
661425|NCT00814827|Opportunistic Infections|opportunistic infections
661426|NCT00814827|Immunodeficiency|immunodeficiency
661427|NCT00814840|Heart failure|heart failure
661428|NCT00814840|Dyssynchrony|dyssynchrony
661429|NCT00814840|Cardiac resynchronization|cardiac resynchronization
661430|NCT00814840|Triple-site pacing|triple-site pacing
661431|NCT00814853|Extubation|extubation
661432|NCT00814853|testing|testing
661433|NCT00814853|ventilator weaning|ventilator weaning
661434|NCT00814853|Pediatric extubation|pediatric extubation
661435|NCT00814866|Rheumatoid arthritis|rheumatoid arthritis
661436|NCT00814866|arthritis|arthritis
661437|NCT00814866|osteoclasts|osteoclasts
661438|NCT00814866|bone|bone
661439|NCT00814879|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
661440|NCT00814879|AIDS|aids
661441|NCT00814879|Anti-Infective Agents|anti-infective agents
661442|NCT00814879|Antiretroviral|antiretroviral
661443|NCT00814879|Antiviral Agents|antiviral agents
661444|NCT00814879|Atazanavir|atazanavir
661445|NCT00814879|Human Immunodeficiency Virus|human immunodeficiency virus
661446|NCT00814879|HIV|hiv
661447|NCT00814879|HIV Protease Inhibitors|hiv protease inhibitors
661448|NCT00814879|NRTI|nrti
661449|NCT00814879|Nucleoside Reverse Transcriptase Inhibitors|nucleoside reverse transcriptase inhibitors
661450|NCT00814879|Raltegravir|raltegravir
661451|NCT00814879|Resistance|resistance
661452|NCT00814879|treatment experienced|treatment experienced
661453|NCT00814892|adenocarcinoma of the prostate|adenocarcinoma of the prostate
661454|NCT00814892|recurrent prostate cancer|recurrent prostate cancer
661455|NCT00814892|stage I prostate cancer|stage i prostate cancer
661456|NCT00814892|stage IIB prostate cancer|stage iib prostate cancer
661457|NCT00814892|stage IIA prostate cancer|stage iia prostate cancer
661458|NCT00814892|stage III prostate cancer|stage iii prostate cancer
661459|NCT00814892|stage IV prostate cancer|stage iv prostate cancer
661460|NCT00814905|chorioamnionitis|chorioamnionitis
661461|NCT00814905|antibiotics|antibiotics
661462|NCT00814905|cesarean|cesarean
661463|NCT00814905|vaginal delivery|vaginal delivery
661464|NCT00814918|acne vulgaris|acne vulgaris
661465|NCT00814918|acne|acne
661466|NCT00814918|dermatalogy|dermatalogy
661467|NCT00814944|dry eye|dry eye
661469|NCT00814944|rapamycin|rapamycin
661470|NCT00814957|positron emission tomography|positron emission tomography
661471|NCT00814957|addiction|addiction
661472|NCT00814970|PAD|pad
661473|NCT00814970|peripheral arterial disease|peripheral arterial disease
661477|NCT00814983|myeloablative|myeloablative
661478|NCT00814983|stem cell|stem cell
661479|NCT00814983|naive T-cell depleted|naive t-cell depleted
661480|NCT00814983|allogeneic|allogeneic
661481|NCT00815009|NAFLD|nafld
661482|NCT00815009|NASH|nash
661483|NCT00815022|Temperature|temperature
661484|NCT00815022|Spinal anesthesia|spinal anesthesia
661485|NCT00815022|Cesarean section|cesarean section
661486|NCT00815022|Cephalad sensory blockade|cephalad sensory blockade
661487|NCT00815022|Regional anesthesia|regional anesthesia
661488|NCT00815035|Peanut Allergy|peanut allergy
661489|NCT00815048|Remifentanil|remifentanil
661490|NCT00815048|Endotracheal intubation|endotracheal intubation
661491|NCT00815048|Premedication|premedication
661492|NCT00815048|Sedation|sedation
661493|NCT00815048|Endotracheal Intubation in Neonates|endotracheal intubation in neonates
661494|NCT00815061|prevalence|prevalence
661495|NCT00815061|Incidence|incidence
661496|NCT00815061|crohn's disease|crohn's disease
661497|NCT00815061|ulcerative colitis|ulcerative colitis
661498|NCT00815061|Epidemiology|epidemiology
661499|NCT00815074|Military Women|military women
661500|NCT00815074|Women's Health|women's health
661501|NCT00815074|Genitourinary Symptoms|genitourinary symptoms
661502|NCT00815074|Illness Behaviors|illness behaviors
661503|NCT00815074|To determine how women manage genitourinary symptoms while deployed.|to determine how women manage genitourinary symptoms while deployed.
661504|NCT00820989|Healthy Immune System|healthy immune system
661505|NCT00821002|Glaucoma|glaucoma
661506|NCT00821015|cryoablation|cryoablation
661507|NCT00821015|recurring arrhythmia|recurring arrhythmia
661508|NCT00821015|stroke|stroke
661509|NCT00821015|RF ablation|rf ablation
661510|NCT00821015|LA ablation|la ablation
661511|NCT00821015|nodal ablation|nodal ablation
661512|NCT00821015|catheter ablation|catheter ablation
661513|NCT00821028|atherosclerosis|atherosclerosis
661514|NCT00821028|angioplasty|angioplasty
661515|NCT00821028|peripheral arterial disease|peripheral arterial disease
661516|NCT00821041|insomnia|insomnia
661517|NCT00821041|online systems|online systems
661518|NCT00821054|Phase I Food Effect|phase i food effect
661519|NCT00821080|vandetanib|vandetanib
661520|NCT00821080|sirolimus|sirolimus
661521|NCT00821080|recurrent glioblastoma|recurrent glioblastoma
661522|NCT00821093|respiratory|respiratory
661523|NCT00821093|dyspnea|dyspnea
661524|NCT00821093|breathlessness|breathlessness
661525|NCT00821093|COPD|copd
661526|NCT00821093|indacaterol|indacaterol
661527|NCT00821093|long-acting β2-agonist|long-acting β2-agonist
661528|NCT00821106|Coronary angiography|coronary angiography
661529|NCT00821106|percutaneous coronary intervention|percutaneous coronary intervention
661530|NCT00821106|Transradial approach|transradial approach
661531|NCT00821119|non invasive ventilation|non invasive ventilation
661532|NCT00821119|mechanical ventilation|mechanical ventilation
661533|NCT00821119|pulmonary morbidity|pulmonary morbidity
661534|NCT00821119|preterm infant|preterm infant
661535|NCT00821119|Respiratory distress syndrome|respiratory distress syndrome
661536|NCT00821119|nasal intermittent positive pressure|nasal intermittent positive pressure
661537|NCT00821119|nasal continuous positive pressure|nasal continuous positive pressure
661538|NCT00821119|bronchopulmonary dysplasia|bronchopulmonary dysplasia
661539|NCT00821132|FALS|fals
661540|NCT00821132|ALS|als
661541|NCT00821132|ALS/FTD|als/ftd
661542|NCT00821132|SALS|sals
661543|NCT00821132|MND|mnd
661544|NCT00821132|PLS|pls
661545|NCT00821145|abdominal aortic aneurysms|abdominal aortic aneurysms
661546|NCT00821184|urinary incontinence|urinary incontinence
661547|NCT00821184|overactive bladder|overactive bladder
661548|NCT00821184|urinary frequency|urinary frequency
661549|NCT00821197|obesity|obesity
661550|NCT00821197|laparoscopy|laparoscopy
661551|NCT00821197|bariatric|bariatric
661552|NCT00821197|super obesity|super obesity
661553|NCT00821210|Obstructive sleep apnea|obstructive sleep apnea
661554|NCT00821210|myocardial infarction|myocardial infarction
661555|NCT00821223|phacoemulsification|phacoemulsification
661556|NCT00821223|manual small incision cataract surgery|manual small incision cataract surgery
661557|NCT00821223|visual acuity|visual acuity
661558|NCT00821223|contrast sensitivity|contrast sensitivity
661559|NCT00821223|quality of vision|quality of vision
661560|NCT00821236|Myopia|myopia
661561|NCT00821236|LASIK|lasik
661562|NCT00821236|Astigmatism|astigmatism
661563|NCT00821236|Laser Vision Correction|laser vision correction
661564|NCT00821236|Excimer Laser|excimer laser
661565|NCT00821249|plasma cell dyscrasia|plasma cell dyscrasia
661566|NCT00821249|plasmacytoma|plasmacytoma
661567|NCT00821249|kinesin spindle protein|kinesin spindle protein
661568|NCT00821249|anti-mitotic|anti-mitotic
661569|NCT00821262|Sevoflurane|sevoflurane
661570|NCT00821262|Anesthesia|anesthesia
661571|NCT00821262|Troponin|troponin
661572|NCT00821262|Myocardial Preconditioning|myocardial preconditioning
661573|NCT00821262|Surgery, Cardiac|surgery, cardiac
661574|NCT00821262|Stents|stents
661575|NCT00821262|Non-cardiac Surgery|non-cardiac surgery
661576|NCT00821262|Surgery|surgery
661577|NCT00821275|Uterine Artery Embolization|uterine artery embolization
661580|NCT00821275|hysterectomy|hysterectomy
661581|NCT00821275|pregnancy|pregnancy
661582|NCT00821275|complication|complication
661583|NCT00821275|ovarian function|ovarian function
661584|NCT00821275|quality of life|quality of life
661585|NCT00821288|cancer survivorship|cancer survivorship
661586|NCT00821288|survivorship prescription|survivorship prescription
661587|NCT00821288|cancer related anxiety|cancer related anxiety
661588|NCT00821301|Multiple myeloma|multiple myeloma
661589|NCT00822393|Treosulfan|treosulfan
661590|NCT00822393|Busulfan|busulfan
661591|NCT00822393|Conditioning|conditioning
661592|NCT00822393|Allogeneic|allogeneic
661593|NCT00822393|Transplantation|transplantation
661594|NCT00822406|allergy|allergy
661595|NCT00822406|rhinitis|rhinitis
661596|NCT00822406|homeopathy|homeopathy
661597|NCT00822406|double-blind|double-blind
661598|NCT00822419|sternotomy pain|sternotomy pain
661599|NCT00822432|biomarkers|biomarkers
661600|NCT00822432|ABC transporters|abc transporters
661601|NCT00822432|MRP2|mrp2
661602|NCT00822432|MTX pharmacokinetics|mtx pharmacokinetics
661603|NCT00822445|Biomarker|biomarker
661604|NCT00822445|S100 protein|s100 protein
661605|NCT00822445|Traumatic brain injury|traumatic brain injury
661606|NCT00822445|Craniocerebral tomodensitometry|craniocerebral tomodensitometry
661607|NCT00822445|Neurological sequelae|neurological sequelae
661608|NCT00822471|Diabetes|diabetes
661609|NCT00822471|Self-Management Education|self-management education
661610|NCT00822471|Library|library
661611|NCT00822471|Emergency Department Visits|emergency department visits
661612|NCT00822471|African American|african american
661613|NCT00822471|CVD prevention|cvd prevention
661614|NCT00822471|Prevention|prevention
661615|NCT00822471|Uncontrolled diabetes|uncontrolled diabetes
661616|NCT00822497|music therapy|music therapy
661617|NCT00822497|pain|pain
661618|NCT00822497|anxiety|anxiety
661619|NCT00822497|muscle tension|muscle tension
661620|NCT00822510|Psychosocial Intervention|psychosocial intervention
661621|NCT00822510|Men with Prostate Cancer & Partners|men with prostate cancer & partners
661622|NCT00822536|Drug-eluting stent|drug-eluting stent
661623|NCT00822536|Clopidogrel|clopidogrel
661624|NCT00822536|Stent thrombosis|stent thrombosis
661625|NCT00822536|Myocardial infarction|myocardial infarction
661626|NCT00822549|Morphine titration|morphine titration
661627|NCT00822549|Sub acute pain|sub acute pain
661628|NCT00822549|Major orthopaedic surgery|major orthopaedic surgery
661629|NCT00822549|Pharmacokinetics|pharmacokinetics
661630|NCT00822549|Pharmacodynamics|pharmacodynamics
661631|NCT00822549|Genetic polymorphism|genetic polymorphism
661632|NCT00822549|PACU|pacu
661633|NCT00822549|Patients undergoing major scheduled orthopaedic surgery|patients undergoing major scheduled orthopaedic surgery
661634|NCT00822562|hepatocellular carcinoma|hepatocellular carcinoma
661635|NCT00822562|surgery|surgery
661636|NCT00822575|mosquito bites|mosquito bites
661637|NCT00822575|itching|itching
661638|NCT00822601|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
661639|NCT00822601|Supplementary Motor Area|supplementary motor area
661640|NCT00822601|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
661641|NCT00822601|Sham rTMS|sham rtms
661642|NCT00822601|Placebo-controlled|placebo-controlled
661643|NCT00822601|Randomized|randomized
661644|NCT00822601|Double-blind|double-blind
661645|NCT00822601|fMRI|fmri
661646|NCT00822601|DSM-IV Obsessive-Compulsive Disorder|dsm-iv obsessive-compulsive disorder
661647|NCT00822614|Pain|pain
661648|NCT00822627|Influenza|influenza
661649|NCT00822627|vaccination|vaccination
661650|NCT00822627|Emergency Department|emergency department
661651|NCT00822640|Prosthesis Design|prosthesis design
661652|NCT00822640|Range of Motion, Articular|range of motion, articular
661653|NCT00822640|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
661654|NCT00822653|hemodialysis treatment|hemodialysis treatment
661655|NCT00822653|pump stimulation|pump stimulation
661656|NCT00822653|reduce hypotensive episodes|reduce hypotensive episodes
661657|NCT00822666|Platelet aggregation|platelet aggregation
661658|NCT00822666|Platelet|platelet
661659|NCT00822666|Thrombosis|thrombosis
661660|NCT00822666|Clopidogrel|clopidogrel
661661|NCT00822679|Acute Coronary Syndrome|acute coronary syndrome
661662|NCT00822679|cytokines|cytokines
661663|NCT00822679|pro-coagulant mediators|pro-coagulant mediators
661664|NCT00822679|sleep disorders|sleep disorders
661665|NCT00822692|Abscess|abscess
661666|NCT00822692|Cellulitis|cellulitis
661667|NCT00822692|Antibiotics|antibiotics
661668|NCT00822692|MRSA|mrsa
661669|NCT00822705|Appetite, energy consumption, gastrointestinal hormones|appetite, energy consumption, gastrointestinal hormones
661670|NCT00822718|obestatin|obestatin
661671|NCT00822718|ghrelin|ghrelin
661672|NCT00822718|stomach cancer|stomach cancer
661673|NCT00822718|distal gastrectomy|distal gastrectomy
661674|NCT00822731|Lymphoma|lymphoma
661675|NCT00822731|prognosis|prognosis
661676|NCT00822731|morbidity|morbidity
661677|NCT00822744|Depression|depression
661678|NCT00822744|Major Depressive Episode|major depressive episode
661679|NCT00822744|Antidepressant|antidepressant
661680|NCT00822757|study in healthy subjects|study in healthy subjects
661681|NCT00822770|Blood Stem Cell Transplantation|blood stem cell transplantation
661682|NCT00822770|Bone Marrow Transplantation|bone marrow transplantation
661683|NCT00822770|Bone Marrow Cell Transplantation|bone marrow cell transplantation
661684|NCT00822770|Stem Cell Transplantation|stem cell transplantation
661685|NCT00822770|Allogeneic Hematopoietic Transplantation|allogeneic hematopoietic transplantation
661686|NCT00822770|Advanced Myeloid Leukemia|advanced myeloid leukemia
661687|NCT00822770|Acute Myeloid Leukemia|acute myeloid leukemia
661688|NCT00822770|AML|aml
661689|NCT00822770|Myelodysplastic syndrome|myelodysplastic syndrome
661690|NCT00822770|MDS|mds
661691|NCT00822770|Chronic Myeloid Leukemia|chronic myeloid leukemia
661692|NCT00822770|CML|cml
661693|NCT00822770|Graft Versus Host Disease|graft versus host disease
661694|NCT00822770|GVHD|gvhd
661695|NCT00822770|ATG|atg
661696|NCT00822770|Busulfan|busulfan
661697|NCT00822770|Busulfex™|busulfex™
661698|NCT00822770|Myleran®|myleran®
661699|NCT00822770|Filgrastim|filgrastim
661700|NCT00822770|Neupogen|neupogen
661701|NCT00822770|Fludarabine|fludarabine
661702|NCT00822770|Fludarabine Phosphate|fludarabine phosphate
661703|NCT00822770|Fludara™|fludara™
661704|NCT00822770|G-CSF|g-csf
661705|NCT00822770|Plerixafor|plerixafor
661706|NCT00822770|Antithymocyte globulin|antithymocyte globulin
661707|NCT00822770|Thymoglobulin|thymoglobulin
661708|NCT00822783|Serum IgE levels|serum ige levels
661709|NCT00822783|inflammatory cells in the skin|inflammatory cells in the skin
661710|NCT00822783|inflammatory cells in the blood|inflammatory cells in the blood
661711|NCT00822783|IgE|ige
661712|NCT00822783|IgE depletion|ige depletion
661713|NCT00822783|atopic dermatitis|atopic dermatitis
661714|NCT00822783|atopic eczema|atopic eczema
661715|NCT00822783|Omalizumab|omalizumab
661716|NCT00822796|Hypothermia|hypothermia
661717|NCT00822796|Severe burns|severe burns
661718|NCT00822796|Warming catheter|warming catheter
661719|NCT00822796|Thermogard™|thermogard™
661720|NCT00822796|Coagulopathy|coagulopathy
661721|NCT00822809|Cancer|cancer
661722|NCT00822809|Neoplasms|neoplasms
661723|NCT00822809|Carcinoma|carcinoma
661724|NCT00822809|Malignant Ascites|malignant ascites
661725|NCT00822809|Drug therapy|drug therapy
661726|NCT00822809|Antineoplastic Protocols|antineoplastic protocols
661727|NCT00822809|Immunotherapy|immunotherapy
661728|NCT00822809|Phase III|phase iii
661729|NCT00822809|trifunctional antibody|trifunctional antibody
661730|NCT00822809|monoclonal antibody|monoclonal antibody
661731|NCT00822809|EpCAM|epcam
661732|NCT00822822|Questionnaire|questionnaire
661733|NCT00822822|Electronic Health History|electronic health history
661734|NCT00822848|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
661735|NCT00822848|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
661736|NCT00822874|PCOS and normal ovulatory patients|pcos and normal ovulatory patients
661737|NCT00822874|aneuploidy|aneuploidy
661738|NCT00822874|in-vitro maturation of oocytes|in-vitro maturation of oocytes
661739|NCT00822887|malignant|malignant
661740|NCT00822887|gliomas|gliomas
661741|NCT00822900|Trauma|trauma
661742|NCT00822900|Brain Injury|brain injury
661743|NCT00822913|Botulinum A toxin|botulinum a toxin
661744|NCT00822913|Parkinson's disease|parkinson's disease
661745|NCT00822965|Pacemakers|pacemakers
661746|NCT00822965|PM|pm
661747|NCT00822965|Implantable cardioverter-defibrillators|implantable cardioverter-defibrillators
661748|NCT00822965|ICD|icd
661749|NCT00822965|Implantable pulse generators|implantable pulse generators
661750|NCT00822965|Educational Interventions|educational interventions
661751|NCT00822978|healthy|healthy
661752|NCT00822978|volunteers|volunteers
661753|NCT00822978|subjects|subjects
661754|NCT00822991|Sonazoid|sonazoid
661755|NCT00822991|Early detection|early detection
661756|NCT00822991|Hepatocellular carcinoma|hepatocellular carcinoma
661757|NCT00822991|Liver cirrhosis|liver cirrhosis
661758|NCT00823004|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
661759|NCT00823004|pregnancy rate|pregnancy rate
661760|NCT00823004|Poor responders|poor responders
661761|NCT00823004|GnRH antagonist|gnrh antagonist
661762|NCT00823004|GnRH agonist|gnrh agonist
661763|NCT00823004|letrozole|letrozole
661764|NCT00823004|in vitro fertilization|in vitro fertilization
661765|NCT00823017|ICU environment|icu environment
661766|NCT00823017|Auditory stimulation|auditory stimulation
661767|NCT00823017|Properties of relaxation music|properties of relaxation music
661768|NCT00823017|music|music
661769|NCT00823017|music therapy|music therapy
661770|NCT00823017|pain|pain
661771|NCT00823017|anxiety|anxiety
661772|NCT00823017|cortisol|cortisol
661773|NCT00823017|IgA|iga
661774|NCT00823017|biomarkers|biomarkers
661775|NCT00823017|relaxation music|relaxation music
661776|NCT00823030|Interstitial Cystitis|interstitial cystitis
661777|NCT00823030|Intravesical Lidocaine|intravesical lidocaine
661778|NCT00823056|Probiotics|probiotics
661779|NCT00823056|Infections|infections
661780|NCT00823056|Children|children
662026|NCT00823654|Blood draw|blood draw
661781|NCT00823069|Correction of Nasolabial Folds|correction of nasolabial folds
661782|NCT00823082|antithrombin|antithrombin
661783|NCT00823082|ATIII|atiii
661784|NCT00823082|acquired deficiency|acquired deficiency
661785|NCT00823082|anticoagulants|anticoagulants
661786|NCT00823082|cardiopulmonary bypass|cardiopulmonary bypass
661787|NCT00823082|surgery|surgery
661788|NCT00823082|complications|complications
661789|NCT00823082|postoperative outcomes|postoperative outcomes
661790|NCT00823095|chronic cutaneous ulcers|chronic cutaneous ulcers
661791|NCT00823095|Nitric Oxide|nitric oxide
661792|NCT00823095|topically applied|topically applied
661793|NCT00823095|Biofilm|biofilm
661794|NCT00823095|Colonized chronic non-healing ulcers|colonized chronic non-healing ulcers
661795|NCT00823108|GIK, septic shock, sepsis|gik, septic shock, sepsis
661796|NCT00823121|Fresh embryo transfer|fresh embryo transfer
661797|NCT00823121|frozen- thawed embryo transfer|frozen- thawed embryo transfer
661798|NCT00823121|vitrification|vitrification
661799|NCT00823121|endometrial receptivity|endometrial receptivity
661800|NCT00823121|implantation rate|implantation rate
661801|NCT00823121|pregnancy|pregnancy
661802|NCT00823121|ART|art
661803|NCT00823147|Pain|pain
661804|NCT00823147|Systemic Inflammation|systemic inflammation
661805|NCT00823147|Pain Catastrophizing|pain catastrophizing
661806|NCT00823160|Pericardial window|pericardial window
661807|NCT00823160|Sternotomy|sternotomy
661808|NCT00823160|Haemopericardium|haemopericardium
661809|NCT00823173|Uveitis|uveitis
661810|NCT00823173|TNF-alpha|tnf-alpha
661811|NCT00823173|Topical|topical
661812|NCT00823173|ESBA105|esba105
661813|NCT00823173|scFv antibody fragment|scfv antibody fragment
661814|NCT00823173|ocular inflammation|ocular inflammation
661815|NCT00823186|cervical carcinoma|cervical carcinoma
661816|NCT00823186|neoadjuvant chemotherapy|neoadjuvant chemotherapy
661817|NCT00823212|drug-eluting stents|drug-eluting stents
661818|NCT00823212|DES|des
661819|NCT00823212|atherosclerotic|atherosclerotic
661820|NCT00823225|Diabetes|diabetes
661821|NCT00823225|urokinase|urokinase
661822|NCT00823225|ulcer healing|ulcer healing
661823|NCT00823225|major amputation|major amputation
661824|NCT00823225|survival|survival
661825|NCT00823264|Anticonvulsants|anticonvulsants
661826|NCT00823264|Toxicology|toxicology
661827|NCT00823264|multidose charcoal|multidose charcoal
661828|NCT00823264|phenytoin|phenytoin
661829|NCT00823290|HCC|hcc
661830|NCT00823290|sorafenib|sorafenib
661831|NCT00823290|HDAC|hdac
661832|NCT00823290|LBH589|lbh589
661833|NCT00823290|Panobinostat|panobinostat
661834|NCT00823303|PTH|pth
661835|NCT00823303|Active Vitamin D|active vitamin d
661836|NCT00823303|hypercalcemia|hypercalcemia
661837|NCT00823303|Chronic Kidney Disease|chronic kidney disease
661838|NCT00823316|Mesenchymal Stem Cells|mesenchymal stem cells
661839|NCT00823316|Allogeneic Transplantation|allogeneic transplantation
661840|NCT00823316|Engraftment|engraftment
661841|NCT00823316|GvHD|gvhd
661842|NCT00823316|Childhood|childhood
661843|NCT00823316|unrelated HSCT|unrelated hsct
662057|NCT00823758|Parental administration|parental administration
661844|NCT00823329|measurement of energy expenditure of physical activity|measurement of energy expenditure of physical activity
661845|NCT00823329|analysis of body composition and hydration status|analysis of body composition and hydration status
661846|NCT00823342|HBe, Hepatitis, Vireda (TENOFOVIR, CLEVUDINE), HBV, HBe Ag negative|hbe, hepatitis, vireda (tenofovir, clevudine), hbv, hbe ag negative
661847|NCT00823368|fragile X syndrome|fragile x syndrome
661848|NCT00823368|biomarkers|biomarkers
661849|NCT00823381|obesity|obesity
661850|NCT00823381|metabolic syndrome|metabolic syndrome
661851|NCT00823381|diabetes|diabetes
661852|NCT00823381|aging|aging
661853|NCT00823381|calorie restriction|calorie restriction
661854|NCT00823381|resveratrol|resveratrol
661855|NCT00823381|antioxidant|antioxidant
661856|NCT00823394|African American|african american
661857|NCT00823394|Adults|adults
661858|NCT00823394|African American Cancer Prevention Project|african american cancer prevention project
661859|NCT00823394|Health Disparities|health disparities
661860|NCT00823394|Questionnaire|questionnaire
661861|NCT00823394|Body Measurements|body measurements
661862|NCT00823394|Self-help|self-help
661863|NCT00823394|Cancer Rates|cancer rates
661864|NCT00823394|Prevention|prevention
661866|NCT00823407|MDMA|mdma
661867|NCT00823407|Ecstasy|ecstasy
661868|NCT00823407|entactogen|entactogen
661869|NCT00823407|pharmacokinetics|pharmacokinetics
661870|NCT00823407|pharmacodynamics|pharmacodynamics
661871|NCT00823407|Pharmacokinetics and pharmacodynamics of MDA studies in healthy volunteers|pharmacokinetics and pharmacodynamics of mda studies in healthy volunteers
661872|NCT00823420|PCOS and normal ovulatory patients|pcos and normal ovulatory patients
661873|NCT00823420|aneuploidy|aneuploidy
661874|NCT00823420|in-vitro maturation of oocytes|in-vitro maturation of oocytes
661875|NCT00823433|Penicillin|penicillin
661876|NCT00823433|Group B Streptococcus|group b streptococcus
661877|NCT00823433|Pregnancy|pregnancy
661878|NCT00823433|Labor|labor
661879|NCT00823459|Low-grade glioma|low-grade glioma
661880|NCT00823459|astrocytoma|astrocytoma
661881|NCT00823459|oligodendroglioma|oligodendroglioma
661882|NCT00823459|mixed oligoastrocytoma|mixed oligoastrocytoma
661883|NCT00823472|embryonic structures|embryonic structures
661884|NCT00823472|sperm injections, intracytoplasmic|sperm injections, intracytoplasmic
661886|NCT00823472|GnRH antagonist|gnrh antagonist
661887|NCT00823472|ovarian stimulation|ovarian stimulation
661888|NCT00823472|cycle day 2 versus cycle day 5|cycle day 2 versus cycle day 5
661889|NCT00823498|Cancer Prevention|cancer prevention
661890|NCT00823498|African American|african american
661891|NCT00823498|African American Parents|african american parents
661892|NCT00823498|African American Youth|african american youth
661893|NCT00823498|Public Housing|public housing
661894|NCT00823498|Physical Activity|physical activity
661895|NCT00823498|Focus Groups|focus groups
661896|NCT00823498|Housing Developments|housing developments
661897|NCT00823498|Houston Public Housing|houston public housing
661898|NCT00823498|Photovoice Project|photovoice project
661899|NCT00823498|Prevention|prevention
661900|NCT00823511|HPV|hpv
661901|NCT00823511|Human Papillomavirus Infection|human papillomavirus infection
661902|NCT00823511|Cervix Uteri|cervix uteri
661903|NCT00823511|Cancer Control|cancer control
661904|NCT00823511|Risk Assessment, Detection & Intervention|risk assessment, detection & intervention
661905|NCT00823511|Sexually Transmitted|sexually transmitted
661906|NCT00823511|Neoplasia|neoplasia
661907|NCT00823511|Carcinogenesis|carcinogenesis
661908|NCT00823511|Cervix|cervix
661909|NCT00823524|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
661910|NCT00823524|acute undifferentiated leukemia|acute undifferentiated leukemia
661911|NCT00823524|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
661912|NCT00823524|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
661913|NCT00823524|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
661914|NCT00823524|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
661915|NCT00823524|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
661916|NCT00823524|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
661917|NCT00823524|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
661918|NCT00823524|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
661919|NCT00823524|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
661920|NCT00823524|mast cell leukemia|mast cell leukemia
661921|NCT00823524|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
661922|NCT00823524|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
661923|NCT00823524|prolymphocytic leukemia|prolymphocytic leukemia
661924|NCT00823524|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
661925|NCT00823524|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
661926|NCT00823524|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
661927|NCT00823524|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
661928|NCT00823524|refractory hairy cell leukemia|refractory hairy cell leukemia
661929|NCT00823524|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
661930|NCT00823524|secondary acute myeloid leukemia|secondary acute myeloid leukemia
661931|NCT00823524|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
661932|NCT00823524|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
661933|NCT00823524|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
661934|NCT00823524|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
661935|NCT00823524|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
661936|NCT00823524|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
661937|NCT00823524|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
661938|NCT00823524|anaplastic large cell lymphoma|anaplastic large cell lymphoma
661939|NCT00823524|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
661940|NCT00823524|splenic marginal zone lymphoma|splenic marginal zone lymphoma
661941|NCT00823524|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
661942|NCT00823524|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
661943|NCT00823524|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
661944|NCT00823524|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
661945|NCT00823524|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
661946|NCT00823524|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
661947|NCT00823524|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
661948|NCT00823524|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
661949|NCT00823524|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
661950|NCT00823524|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
661951|NCT00823524|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
661952|NCT00823524|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
661953|NCT00823524|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
661954|NCT00823524|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
661955|NCT00823524|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
661956|NCT00823524|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
661957|NCT00823524|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
661958|NCT00823524|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
661959|NCT00823524|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
661960|NCT00823524|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
661961|NCT00823524|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
661962|NCT00823524|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
661963|NCT00823524|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
661964|NCT00823524|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
661965|NCT00823524|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
661966|NCT00823524|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
661967|NCT00823524|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
661968|NCT00823524|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
661969|NCT00823524|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
661970|NCT00823524|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
661971|NCT00823524|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
661972|NCT00823524|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
661973|NCT00823524|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
661974|NCT00823524|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
661975|NCT00823524|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
661976|NCT00823524|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
661977|NCT00823524|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
661978|NCT00823524|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
661979|NCT00823524|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
661980|NCT00823524|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
661981|NCT00823524|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
661982|NCT00823524|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
661983|NCT00823524|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
661984|NCT00823524|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
661985|NCT00823524|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
661986|NCT00823524|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
661987|NCT00823524|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
661988|NCT00823524|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
661989|NCT00823524|intraocular lymphoma|intraocular lymphoma
661990|NCT00823524|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
661991|NCT00823524|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
661992|NCT00823524|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
661993|NCT00823524|chronic eosinophilic leukemia|chronic eosinophilic leukemia
661994|NCT00823524|chronic neutrophilic leukemia|chronic neutrophilic leukemia
661995|NCT00823524|primary myelofibrosis|primary myelofibrosis
661996|NCT00823524|essential thrombocythemia|essential thrombocythemia
661997|NCT00823524|polycythemia vera|polycythemia vera
661998|NCT00823524|extramedullary plasmacytoma|extramedullary plasmacytoma
661999|NCT00823524|isolated plasmacytoma of bone|isolated plasmacytoma of bone
662000|NCT00823524|stage II multiple myeloma|stage ii multiple myeloma
662001|NCT00823524|stage III multiple myeloma|stage iii multiple myeloma
662002|NCT00823524|primary systemic amyloidosis|primary systemic amyloidosis
662003|NCT00823524|refractory multiple myeloma|refractory multiple myeloma
662004|NCT00823524|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
662005|NCT00823524|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
662006|NCT00823524|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
662007|NCT00823524|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
662008|NCT00823524|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
662009|NCT00823524|Waldenström macroglobulinemia|waldenström macroglobulinemia
662010|NCT00823524|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
662011|NCT00823550|Chronic hepatitis B|chronic hepatitis b
662012|NCT00823550|Advanced fibrosis|advanced fibrosis
662013|NCT00823550|Lamivudine|lamivudine
662014|NCT00823550|Entecavir|entecavir
662015|NCT00823576|Arthodeses rachis lombar|arthodeses rachis lombar
662016|NCT00823576|Spinal Surgery|spinal surgery
662017|NCT00823589|ELDERLY POPULATION|elderly population
662018|NCT00823602|GnRH antagonist|gnrh antagonist
662019|NCT00823602|GnRH agonist|gnrh agonist
662020|NCT00823602|pregnancy rate|pregnancy rate
662021|NCT00823602|Ovarian stimulation|ovarian stimulation
662024|NCT00823654|Breast|breast
662025|NCT00823654|Questionaires|questionaires
662030|NCT00823667|stage I non-small cell lung cancer|stage i non-small cell lung cancer
662031|NCT00823667|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
662032|NCT00823667|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
662033|NCT00823706|chronic angle closure hyperopia|chronic angle closure hyperopia
662034|NCT00823719|Salvage chemotherapy|salvage chemotherapy
662035|NCT00823719|relapsed|relapsed
662036|NCT00823719|grade 3B follicular lymphoma|grade 3b follicular lymphoma
662037|NCT00823719|efficacy|efficacy
662038|NCT00823719|safety|safety
662039|NCT00823719|DHAP|dhap
662040|NCT00823719|ofatumumab|ofatumumab
662041|NCT00823719|refractory|refractory
662042|NCT00823719|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
662043|NCT00823719|Diffuse Large B Cell Lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
662044|NCT00823719|Oncology|oncology
662045|NCT00823719|ICE|ice
662046|NCT00823719|Transformed follicular lymphoma|transformed follicular lymphoma
662047|NCT00823732|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
662048|NCT00823732|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
662049|NCT00823732|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
662050|NCT00823758|Acetaminophen|acetaminophen
662051|NCT00823758|Liver|liver
662052|NCT00823758|Centers for Education and Research on Therapeutics|centers for education and research on therapeutics
662053|NCT00823758|CERTS|certs
662054|NCT00823758|Over-the-counter Acetaminophen|over-the-counter acetaminophen
662055|NCT00823758|OTC|otc
662056|NCT00823758|Self-administration|self-administration
662058|NCT00823758|Houston|houston
662059|NCT00823758|Texas|texas
662060|NCT00823758|Liver toxicity|liver toxicity
662061|NCT00823758|Qualitative study|qualitative study
662062|NCT00823758|Pharmacists|pharmacists
662063|NCT00823758|Adolescents|adolescents
662064|NCT00823758|Primary care physicians|primary care physicians
662065|NCT00823758|Family Practitioners|family practitioners
662066|NCT00823758|General Internist|general internist
662067|NCT00823784|hemorrhoids|hemorrhoids
662068|NCT00823784|stapler|stapler
662069|NCT00823784|Doppler|doppler
662070|NCT00823784|artery ligation|artery ligation
662071|NCT00823784|outcome|outcome
662072|NCT00823784|recurrence|recurrence
662073|NCT00823810|Colorectal cancer|colorectal cancer
662074|NCT00823810|Response to treatment|response to treatment
662075|NCT00823810|FDG PET/CT|fdg pet/ct
662076|NCT00823823|Casting techniques|casting techniques
662077|NCT00823823|Bivalved cast|bivalved cast
662078|NCT00823823|Circumferential cast|circumferential cast
662079|NCT00823823|Displaced distal radius fracture|displaced distal radius fracture
662080|NCT00823823|Children|children
662081|NCT00823836|Ropinirole, advanced Parkinson's disease, L-dopa adjunctive therapy|ropinirole, advanced parkinson's disease, l-dopa adjunctive therapy
662082|NCT00823849|type 2 diabetes mellitus, with Arteriosclerosis obliterans|type 2 diabetes mellitus, with arteriosclerosis obliterans
662083|NCT00823862|HCV|hcv
662084|NCT00823862|Immunostimulatory sequence (ISS)|immunostimulatory sequence (iss)
662085|NCT00823862|TLR9 (toll-like receptor 9)|tlr9 (toll-like receptor 9)
662086|NCT00823862|interferon (IFN)|interferon (ifn)
662087|NCT00823862|ribavirin|ribavirin
662088|NCT00823888|Knee Osteoarthritis|knee osteoarthritis
662089|NCT00823888|pneumatic bracing|pneumatic bracing
662090|NCT00823901|rosacea|rosacea
662092|NCT00823901|tretinoin|tretinoin
662093|NCT00823901|clinical study|clinical study
662094|NCT00823901|treatment|treatment
662095|NCT00823914|Psoriasis|psoriasis
662096|NCT00823914|Quality of Life|quality of life
662097|NCT00823927|lung damage|lung damage
662098|NCT00823927|cigarette smoking|cigarette smoking
662099|NCT00823927|HIV-seropositive|hiv-seropositive
662100|NCT00823927|emphysema|emphysema
662101|NCT00823940|FTIH|ftih
662102|NCT00823940|Glucagon|glucagon
662103|NCT00823940|Safety|safety
662104|NCT00823940|GSK1362885|gsk1362885
662105|NCT00823940|Pharmacokinetics|pharmacokinetics
662106|NCT00823940|Tolerability|tolerability
662107|NCT00823940|Pharmacodynamics|pharmacodynamics
662108|NCT00823953|diabetes type 2|diabetes type 2
662109|NCT00823979|HIV-1 NNRTI Treatment Experienced|hiv-1 nnrti treatment experienced
662110|NCT00823979|may have Protease inhibitor experience|may have protease inhibitor experience
662111|NCT00824005|Congestive Heart Failure|congestive heart failure
662112|NCT00824005|Regional Wall Motion|regional wall motion
662113|NCT00824005|Perfusion Defects|perfusion defects
662114|NCT00824031|schizophrenia|schizophrenia
662115|NCT00824031|medical mental care|medical mental care
662116|NCT00824031|caregiver|caregiver
662117|NCT00824031|Sapin|sapin
662217|NCT00824421|HIV Infections|hiv infections
662118|NCT00824044|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
662119|NCT00824044|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
662120|NCT00824044|Escitalopram|escitalopram
662121|NCT00824044|Quantitative EEG (QEEG)|quantitative eeg (qeeg)
662122|NCT00824057|Phase I|phase i
662123|NCT00824070|Bioavailability|bioavailability
662124|NCT00824083|bone tumors|bone tumors
662125|NCT00824083|long-term function|long-term function
662126|NCT00824083|daily activity|daily activity
662127|NCT00824083|late sequelae|late sequelae
662128|NCT00824096|endotracheal intubation|endotracheal intubation
662129|NCT00824096|cuff-leak test|cuff-leak test
662130|NCT00824096|post-extubation stridor|post-extubation stridor
662131|NCT00824096|bronchoscopy|bronchoscopy
662132|NCT00824096|corticosteroids|corticosteroids
662133|NCT00824096|Cuff-leak volume less than 24%|cuff-leak volume less than 24%
662134|NCT00824109|Aneurysmal disease of the abdominal aorta|aneurysmal disease of the abdominal aorta
662135|NCT00824109|Occlusive disease of the abdominal aorta|occlusive disease of the abdominal aorta
662136|NCT00824135|Stem Cell Transplantation, Hematopoietic|stem cell transplantation, hematopoietic
662137|NCT00824135|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
662138|NCT00824135|Maximal Tolerated Dose|maximal tolerated dose
662139|NCT00824135|Clofarabine|clofarabine
662140|NCT00824135|Hematological Malignancies|hematological malignancies
662141|NCT00824135|Apheresis|apheresis
662142|NCT00824148|Real-time glucose monitoring system|real-time glucose monitoring system
662143|NCT00824148|HbA1c|hba1c
662144|NCT00824148|Quality of life|quality of life
662145|NCT00824148|Hypoglycemia|hypoglycemia
662146|NCT00824174|Questionnaire|questionnaire
662147|NCT00824174|Head and Neck Cancer|head and neck cancer
662148|NCT00824174|Skin Cancer|skin cancer
662149|NCT00824174|Body Image|body image
662150|NCT00824174|Surgical Treatment|surgical treatment
662151|NCT00824174|Oral Cavity Cancer|oral cavity cancer
662152|NCT00824174|Cutaneous Cancer|cutaneous cancer
662153|NCT00824187|Premenstrual Dysphoric Disorder ( PMDD)|premenstrual dysphoric disorder ( pmdd)
662154|NCT00824187|Oral contraceptive|oral contraceptive
662155|NCT00824200|Sleep|sleep
662156|NCT00824200|Quality of life|quality of life
662157|NCT00824200|nocturia|nocturia
662158|NCT00824213|Whole Body SPECT imaging|whole body spect imaging
662159|NCT00824226|primary hypoparathyroidism|primary hypoparathyroidism
662160|NCT00824226|secondary hypoparathyroidism|secondary hypoparathyroidism
662161|NCT00824226|magnesium|magnesium
662162|NCT00824239|critical care|critical care
662163|NCT00824239|sedation|sedation
662164|NCT00824239|Mechanically ventilated patients|mechanically ventilated patients
662165|NCT00824252|Head And Neck Cancer|head and neck cancer
662166|NCT00824252|HNC|hnc
662167|NCT00824252|Radiation Therapy|radiation therapy
662168|NCT00824252|Spousal Support|spousal support
662169|NCT00824252|Emotional Disclosure|emotional disclosure
662170|NCT00824252|Observational|observational
662171|NCT00824252|Social Constraints|social constraints
662172|NCT00824252|Questionnaires|questionnaires
662173|NCT00824252|Videotaped Interview|videotaped interview
662174|NCT00824252|Quality of Life|quality of life
662175|NCT00824265|Relapsed|relapsed
662176|NCT00824265|Oncology|oncology
662177|NCT00824265|Safety|safety
662178|NCT00824265|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
662179|NCT00824265|Ofatumumab|ofatumumab
662180|NCT00824265|Efficacy|efficacy
662181|NCT00824278|Pediatrics|pediatrics
662182|NCT00824278|Distresss Screening|distresss screening
662183|NCT00824278|Cancer|cancer
662184|NCT00824278|Neurofibromatosis|neurofibromatosis
662185|NCT00824278|HIV|hiv
662186|NCT00824278|Pediatric Cancer|pediatric cancer
662187|NCT00824278|Distress Screening|distress screening
662188|NCT00824291|Major Depressive Disorder|major depressive disorder
662189|NCT00824304|cognitive performance|cognitive performance
662190|NCT00824304|growth|growth
662191|NCT00824304|iron|iron
662192|NCT00824304|zinc|zinc
662193|NCT00824330|Aging|aging
662194|NCT00824330|Type 2 diabetes|type 2 diabetes
662195|NCT00824330|exercise|exercise
662196|NCT00824330|walking|walking
662197|NCT00824330|glucose metabolism|glucose metabolism
662198|NCT00824330|arterial baroreceptors|arterial baroreceptors
662199|NCT00824330|heart rate variability|heart rate variability
662200|NCT00824330|cerebral autoregulation|cerebral autoregulation
662201|NCT00824330|tilt table study|tilt table study
662202|NCT00824330|transcranial Doppler|transcranial doppler
662203|NCT00824330|autonomic nervous system|autonomic nervous system
662204|NCT00824356|Allergic Rhinitis|allergic rhinitis
662205|NCT00824356|Proof-of-Concept|proof-of-concept
662206|NCT00824369|HIV-1|hiv-1
662207|NCT00824369|Rollover|rollover
662208|NCT00824369|Safety.|safety.
662209|NCT00824369|HIV Infections|hiv infections
662210|NCT00824369|treatment experienced|treatment experienced
662211|NCT00824395|diabetes|diabetes
662212|NCT00824395|type 1|type 1
662213|NCT00824395|type 2|type 2
662214|NCT00824395|metabolic syndrome|metabolic syndrome
662215|NCT00824395|mitochondria|mitochondria
662216|NCT00824421|HIV-1. Treatment Naive|hiv-1. treatment naive
662218|NCT00824421|treatment naive|treatment naive
662219|NCT00824434|Atherosclerosis|atherosclerosis
662220|NCT00824434|Coronary Artery Disease|coronary artery disease
662221|NCT00824447|randomised|randomised
662222|NCT00824447|double-blind|double-blind
662223|NCT00824447|placebo-controlled|placebo-controlled
662224|NCT00824447|long-term efficacy and safety|long-term efficacy and safety
662225|NCT00824447|Oralgen® Grass Pollen|oralgen® grass pollen
662226|NCT00824447|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
662228|NCT00824447|Rhinoconjunctivitis|rhinoconjunctivitis
662229|NCT00824447|Immunotherapy|immunotherapy
662230|NCT00824447|Grass pollen extract|grass pollen extract
662231|NCT00824460|Hemodialysis|hemodialysis
662232|NCT00824486|child|child
662233|NCT00824486|injury prevention|injury prevention
662234|NCT00824538|stage IA breast cancer|stage ia breast cancer
662235|NCT00824538|stage IB breast cancer|stage ib breast cancer
662236|NCT00824538|stage II breast cancer|stage ii breast cancer
662237|NCT00824538|stage IIIA breast cancer|stage iiia breast cancer
662238|NCT00824538|stage IIIB breast cancer|stage iiib breast cancer
662239|NCT00824538|stage IIIC breast cancer|stage iiic breast cancer
662240|NCT00824551|Acute Thermal Burns|acute thermal burns
662241|NCT00824551|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
662242|NCT00824551|Burns conversion|burns conversion
662243|NCT00824564|Tranexamic Acid|tranexamic acid
662244|NCT00824564|Blood Loss|blood loss
662245|NCT00824564|Long Bone Fracture Surgery|long bone fracture surgery
662246|NCT00824577|heart rate variability|heart rate variability
662247|NCT00824577|autonomic function|autonomic function
662248|NCT00824577|heart function|heart function
662249|NCT00824590|Dimebon|dimebon
662250|NCT00824590|renal impairment|renal impairment
662251|NCT00824590|pharmacokinetics|pharmacokinetics
662252|NCT00824629|Embryo transfer|embryo transfer
662253|NCT00824629|IVF|ivf
662254|NCT00824629|Ultrasound embryo transfer|ultrasound embryo transfer
662255|NCT00824642|Asthma|asthma
662256|NCT00824642|Exercise training|exercise training
662257|NCT00824642|TENS|tens
662258|NCT00824642|Acupuncture|acupuncture
662259|NCT00824642|FEV1|fev1
662260|NCT00824655|Healthy Subjects|healthy subjects
662261|NCT00824655|Vaccines|vaccines
662262|NCT00824655|Pneumococcal|pneumococcal
662263|NCT00824681|Psychological adjustment of family|psychological adjustment of family
662264|NCT00824681|family of patients|family of patients
662265|NCT00824681|children of patients|children of patients
662266|NCT00824681|intensive care unit|intensive care unit
662267|NCT00824681|burn|burn
662268|NCT00824681|music therapy|music therapy
662269|NCT00824681|music|music
662270|NCT00824681|music program|music program
662271|NCT00824681|anxiety|anxiety
662272|NCT00824681|coping|coping
662273|NCT00824681|adjustment|adjustment
662274|NCT00824681|psychological stressor|psychological stressor
662275|NCT00824681|emotional stressor|emotional stressor
662276|NCT00824694|Glucose|glucose
662277|NCT00824694|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
662278|NCT00824694|HbA1c|hba1c
662279|NCT00824707|primary liver cancer|primary liver cancer
662280|NCT00824707|hepatitis B virus|hepatitis b virus
662281|NCT00824707|anti-virus therapy|anti-virus therapy
662282|NCT00824733|recurrent breast cancer|recurrent breast cancer
662283|NCT00824733|stage IV breast cancer|stage iv breast cancer
662284|NCT00824733|stage IIIA breast cancer|stage iiia breast cancer
662285|NCT00824733|stage IIIB breast cancer|stage iiib breast cancer
662286|NCT00824733|stage IIIC breast cancer|stage iiic breast cancer
662287|NCT00824733|HER2-positive breast cancer|her2-positive breast cancer
662288|NCT00824733|male breast cancer|male breast cancer
662289|NCT00824746|Gefitinib|gefitinib
662290|NCT00824746|Recurrence|recurrence
662291|NCT00824746|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
662292|NCT00824759|Healthy subjects|healthy subjects
662293|NCT00824759|CABG|cabg
662294|NCT00824759|Patients undergoing coronary artery bypass graft under cardiopulmonary bypass|patients undergoing coronary artery bypass graft under cardiopulmonary bypass
662295|NCT00824772|pharmacogenetics|pharmacogenetics
662296|NCT00824785|epirubicin|epirubicin
662297|NCT00824785|oxaliplatin|oxaliplatin
662298|NCT00824785|capecitabine|capecitabine
662299|NCT00824785|panitumumab|panitumumab
662300|NCT00824798|gait|gait
662301|NCT00824798|haemophilia|haemophilia
662302|NCT00824798|arthropathy|arthropathy
662303|NCT00824811|Epiphora|epiphora
662304|NCT00824811|Breast Cancer|breast cancer
662305|NCT00824811|Lung Cancer|lung cancer
662306|NCT00824811|Prostate Cancer|prostate cancer
662307|NCT00824811|Non-small cell lung cancer|non-small cell lung cancer
662308|NCT00824811|Bladder Cancer|bladder cancer
662309|NCT00824811|Esophageal Cancer|esophageal cancer
662310|NCT00824811|Head and Neck Cancer|head and neck cancer
662311|NCT00824811|HNC|hnc
662312|NCT00824811|Small Cell Lung Cancer|small cell lung cancer
662313|NCT00824811|SCLC|sclc
662314|NCT00824811|Ovarian Cancer|ovarian cancer
662315|NCT00824811|Stomach Cancer|stomach cancer
662316|NCT00824811|Canalicular Stenosis|canalicular stenosis
662317|NCT00824811|Excessive tearing|excessive tearing
662318|NCT00824811|Eye inflammation|eye inflammation
662319|NCT00824811|Cyclosporine Ophthalmic Emulsion 0.05%|cyclosporine ophthalmic emulsion 0.05%
662320|NCT00824811|Docetaxel|docetaxel
662321|NCT00824811|Taxotere|taxotere
662322|NCT00824811|Restasis®|restasis®
662323|NCT00824811|Cyclosporine|cyclosporine
662324|NCT00824811|Cyclosporine eye drops|cyclosporine eye drops
662325|NCT00824811|FML Forte®|fml forte®
662326|NCT00824811|Fluorometholone 0.25% ophthalmic suspension|fluorometholone 0.25% ophthalmic suspension
662426|NCT00818220|sepsis|sepsis
662327|NCT00824811|Fluorometholone eye drops|fluorometholone eye drops
662328|NCT00824811|Fluorometholone|fluorometholone
662329|NCT00824811|Refresh Endura™|refresh endura™
662330|NCT00824811|Lubricant eye drops|lubricant eye drops
662331|NCT00824811|Eye drops|eye drops
662332|NCT00824824|Retinal Vascular Autoregulation|retinal vascular autoregulation
662333|NCT00824837|beta 2 microglobulin|beta 2 microglobulin
662334|NCT00824837|haemodialysis|haemodialysis
662335|NCT00824837|albumin|albumin
662336|NCT00824850|Single site|single site
662337|NCT00824850|single dose|single dose
662338|NCT00824850|Participated in Wyeth D118-P8|participated in wyeth d118-p8
662339|NCT00824863|pityrosporum folliculitis|pityrosporum folliculitis
662340|NCT00824863|ketoconazole 2% foam|ketoconazole 2% foam
662341|NCT00824876|Mammae cancer patients|mammae cancer patients
662342|NCT00817908|liver transplant|liver transplant
662343|NCT00817908|lung transplant|lung transplant
662344|NCT00817908|kidney transplant|kidney transplant
662345|NCT00817908|heart transplant|heart transplant
662346|NCT00817908|CMV CMI|cmv cmi
662347|NCT00817908|Transplant|transplant
662348|NCT00817921|premature renal function|premature renal function
662349|NCT00817921|ibuprofen|ibuprofen
662350|NCT00817921|blood pressure|blood pressure
662351|NCT00817921|Renal function|renal function
662352|NCT00817934|Efficacy|efficacy
662353|NCT00817934|patient's tolerance|patient's tolerance
662354|NCT00817934|patient's safety|patient's safety
662355|NCT00817947|Airway clearance|airway clearance
662356|NCT00817947|Cystic fibrosis|cystic fibrosis
662357|NCT00817947|High frequency chest wall oscillation|high frequency chest wall oscillation
662358|NCT00817960|Dual tasking|dual tasking
662359|NCT00817960|Postural Control|postural control
662360|NCT00817960|Methylphenidate (Ritalin)|methylphenidate (ritalin)
662361|NCT00817960|old adults|old adults
662362|NCT00817973|Whey protein|whey protein
662363|NCT00817973|gluten|gluten
662364|NCT00817973|casein|casein
662365|NCT00817973|cod protein|cod protein
662366|NCT00817973|GLP-1|glp-1
662367|NCT00817973|postprandial|postprandial
662368|NCT00817973|triglyceride|triglyceride
662369|NCT00817973|free fatty acids|free fatty acids
662370|NCT00817973|chylomicrons|chylomicrons
662371|NCT00817973|retinyl palmitate|retinyl palmitate
662372|NCT00817973|type 2 diabetes|type 2 diabetes
662374|NCT00817973|Postprandial incretins|postprandial incretins
662375|NCT00817986|Acute back pain in the lumbar region|acute back pain in the lumbar region
662376|NCT00817999|Platelet Aggregation Inhibition|platelet aggregation inhibition
662377|NCT00818012|atrial fibrillation|atrial fibrillation
662378|NCT00818012|atrial electromechanical interval|atrial electromechanical interval
662379|NCT00818012|direct current cardioversion|direct current cardioversion
662380|NCT00818012|pulse wave velocity|pulse wave velocity
662381|NCT00818025|Transplantation|transplantation
662382|NCT00818025|Self-care agency|self-care agency
662383|NCT00818025|Self-care behaviors|self-care behaviors
662384|NCT00818025|Hand-held device|hand-held device
662385|NCT00818038|RRMS|rrms
662386|NCT00818038|Relapsing Remitting|relapsing remitting
662387|NCT00818038|MS|ms
662388|NCT00818051|stage IA breast cancer|stage ia breast cancer
662389|NCT00818051|stage IB breast cancer|stage ib breast cancer
662390|NCT00818051|stage II breast cancer|stage ii breast cancer
662391|NCT00818051|stage IIIA breast cancer|stage iiia breast cancer
662392|NCT00818090|thymic epithelial tumor|thymic epithelial tumor
662393|NCT00818090|paclitaxel|paclitaxel
662394|NCT00818090|cisplatin|cisplatin
662395|NCT00818090|thymic carcinoma|thymic carcinoma
662396|NCT00818090|invasive thymoma|invasive thymoma
662397|NCT00818103|Multiple Sclerosis,Genetics,Pathogenesis,Pathology,Therapy|multiple sclerosis,genetics,pathogenesis,pathology,therapy
662398|NCT00818116|Cataract|cataract
662399|NCT00818116|visual acuity|visual acuity
662400|NCT00818116|AcrySof ReSTOR Aspheric Intraoculare Lens|acrysof restor aspheric intraoculare lens
662401|NCT00818116|Bilateral cataract|bilateral cataract
662402|NCT00818129|Phase I|phase i
662403|NCT00818129|Japan|japan
662404|NCT00818129|Japanese|japanese
662405|NCT00818129|oral solution|oral solution
662406|NCT00818181|Type I - Allergy, rhinoconjunctivitis|type i - allergy, rhinoconjunctivitis
662407|NCT00818194|Tacrolimus|tacrolimus
662408|NCT00818194|cyclosporine A|cyclosporine a
662409|NCT00818194|renal plasma flow|renal plasma flow
662410|NCT00818194|glomerular filtration rate|glomerular filtration rate
662411|NCT00818194|human|human
662412|NCT00818194|pharmacodynamics|pharmacodynamics
662413|NCT00818194|pharmacokinetics|pharmacokinetics
662414|NCT00818194|Pharmacodynamics of tacrolimus|pharmacodynamics of tacrolimus
662415|NCT00818207|Smoking cessation|smoking cessation
662416|NCT00818207|quit rates|quit rates
662417|NCT00818207|reimbursement|reimbursement
662418|NCT00818207|drug coverage|drug coverage
662419|NCT00818207|effectiveness|effectiveness
662420|NCT00818207|cost-effectiveness|cost-effectiveness
662421|NCT00818207|health policy|health policy
662422|NCT00818207|drug utilization|drug utilization
662423|NCT00818207|adherence|adherence
662424|NCT00818207|urine cotinine.|urine cotinine.
662425|NCT00818220|intraventricular hemorrhage|intraventricular hemorrhage
662427|NCT00818220|motor function|motor function
662428|NCT00818220|motor functioning at 7 months corrected age|motor functioning at 7 months corrected age
662429|NCT00818220|cytokines in cord blood and at 6 and 20 hours of age|cytokines in cord blood and at 6 and 20 hours of age
662430|NCT00818220|stem cells in cord blood and at 20 hours of age|stem cells in cord blood and at 20 hours of age
662431|NCT00818233|dynamic contour tonometry|dynamic contour tonometry
662432|NCT00818233|variability|variability
662433|NCT00818233|pulse amplitude|pulse amplitude
662434|NCT00818233|Ocular pulse amplitude|ocular pulse amplitude
662435|NCT00818298|schizophrenia|schizophrenia
662436|NCT00818298|schizoaffective disorder|schizoaffective disorder
662437|NCT00818298|PET Scan|pet scan
662438|NCT00818298|ziprasidone|ziprasidone
662439|NCT00818298|dopamine|dopamine
662440|NCT00818298|D2|d2
662441|NCT00818298|receptor|receptor
662442|NCT00818298|antagonist|antagonist
662443|NCT00818298|occupancy|occupancy
662444|NCT00818298|dissociation|dissociation
662445|NCT00818298|affinity|affinity
662446|NCT00818298|constant|constant
662447|NCT00818298|Ki|ki
662448|NCT00818298|ligand|ligand
662449|NCT00818298|raclopride|raclopride
662450|NCT00818298|half-life|half-life
662451|NCT00818298|striatal|striatal
662452|NCT00818298|plasma dynamics|plasma dynamics
662453|NCT00818298|central dynamics|central dynamics
662454|NCT00818298|plasma drug level|plasma drug level
662455|NCT00818298|compliance|compliance
662456|NCT00818298|antipsychotic|antipsychotic
662457|NCT00818298|pharmacotherapy|pharmacotherapy
662458|NCT00818298|twice daily dosing|twice daily dosing
662459|NCT00818298|BID dosing|bid dosing
662460|NCT00818298|once daily dosing|once daily dosing
662461|NCT00818298|od dosing|od dosing
662462|NCT00818298|qd dosing|qd dosing
662463|NCT00818298|dosing schedule|dosing schedule
662464|NCT00818311|Light emitting diode|light emitting diode
662465|NCT00818311|tolerance|tolerance
662466|NCT00818311|photomodulation|photomodulation
662467|NCT00818363|Postoperative pain|postoperative pain
662468|NCT00818363|shoulder surgery|shoulder surgery
662469|NCT00818363|opioid|opioid
662470|NCT00818376|Chlorhexidine|chlorhexidine
662471|NCT00818376|adverse effects|adverse effects
662472|NCT00818376|staining|staining
662473|NCT00818376|dental calculus|dental calculus
662474|NCT00818376|dental plaque|dental plaque
662475|NCT00818389|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
662476|NCT00818389|ALS|als
662477|NCT00818389|Lou Gehrig's disease|lou gehrig's disease
662478|NCT00818389|riluzole|riluzole
662479|NCT00818389|lithium|lithium
662480|NCT00818389|neurodegeneration|neurodegeneration
662481|NCT00818402|Quality of life|quality of life
662482|NCT00818402|symptoms|symptoms
662483|NCT00818428|Phonological Awareness|phonological awareness
662484|NCT00818428|Speech Articulation Disorder|speech articulation disorder
662485|NCT00818428|Development Articulation Disorder|development articulation disorder
662486|NCT00818428|Phonological Impairment|phonological impairment
662487|NCT00818428|Dyslexia|dyslexia
662488|NCT00818428|Speech Therapy|speech therapy
662489|NCT00818428|School Transition|school transition
662490|NCT00818441|lung cancer adenocarcinoma HER2|lung cancer adenocarcinoma her2
662491|NCT00824902|Prostate Cancer|prostate cancer
662492|NCT00824902|Prostate|prostate
662493|NCT00824902|Radical Prostatectomy|radical prostatectomy
662494|NCT00824902|Tissue Elastography|tissue elastography
662495|NCT00824902|Tissue Elastography Imaging|tissue elastography imaging
662496|NCT00824902|Software Program Measuring Prostate Elasticity|software program measuring prostate elasticity
662497|NCT00824902|Elasticity/Tissue Strain-Hardening Imaging|elasticity/tissue strain-hardening imaging
662498|NCT00824902|Ultrasound|ultrasound
662499|NCT00824915|Lead Integrity Algorithm|lead integrity algorithm
662500|NCT00824928|Prostate Cancer|prostate cancer
662501|NCT00824928|Recurrent Prostate Cancer|recurrent prostate cancer
662502|NCT00824928|Prostate Cancer Recurrence|prostate cancer recurrence
662503|NCT00824928|Radiation Failure|radiation failure
662504|NCT00824928|Salvage Cryotherapy|salvage cryotherapy
662505|NCT00824941|Abdominal Pain|abdominal pain
662506|NCT00824941|Women's Health and Disease|women's health and disease
662507|NCT00824941|Gut|gut
662508|NCT00824941|Symptoms|symptoms
662509|NCT00824941|Brain|brain
662510|NCT00824941|Chronic Abdominal Pain|chronic abdominal pain
662511|NCT00824954|0 to 30 years|0 to 30 years
662512|NCT00824954|Refractory Acute GVHD|refractory acute gvhd
662513|NCT00824993|Blood Cancer|blood cancer
662514|NCT00824993|Calcium|calcium
662515|NCT00824993|Vitamin D|vitamin d
662516|NCT00824993|Ibandronate|ibandronate
662518|NCT00824993|Hematological Malignancies|hematological malignancies
662519|NCT00824993|Bone Marrow Transplantation|bone marrow transplantation
662520|NCT00824993|BMT|bmt
662521|NCT00824993|Osteoporosis|osteoporosis
662522|NCT00824993|Bone Loss|bone loss
662523|NCT00824993|Allogeneic Bone Marrow Transplantation|allogeneic bone marrow transplantation
662524|NCT00825006|Cardiac resynchronization therapy|cardiac resynchronization therapy
662525|NCT00825006|Anodal stimulation|anodal stimulation
662526|NCT00825019|Depression|depression
663097|NCT00827424|diet|diet
662527|NCT00825032|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
662528|NCT00825032|Upper extremity|upper extremity
662529|NCT00825032|Exercise therapy|exercise therapy
662530|NCT00825045|dopamine|dopamine
662531|NCT00825045|D2|d2
662532|NCT00825045|D3|d3
662533|NCT00825045|caudate|caudate
662534|NCT00825045|putamen|putamen
662535|NCT00825045|globus pallidus|globus pallidus
662536|NCT00825045|antipsychotic|antipsychotic
662537|NCT00825045|risperidone|risperidone
662538|NCT00825045|geriatric|geriatric
662539|NCT00825045|Brief Psychiatric Rating Scale|brief psychiatric rating scale
662540|NCT00825045|PET|pet
662541|NCT00825045|radiotracer|radiotracer
662542|NCT00825045|[11C]-(+)-PHNO|[11c]-(+)-phno
662543|NCT00825045|[11C]-raclopride|[11c]-raclopride
662544|NCT00825058|Depression|depression
662545|NCT00825071|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
662546|NCT00825071|Ondansetron|ondansetron
662547|NCT00825071|Dexamethasone|dexamethasone
662548|NCT00825084|Dimebon, Japanese and Western population, pharmacokinetics|dimebon, japanese and western population, pharmacokinetics
662549|NCT00825097|Spastic equinovarus foot|spastic equinovarus foot
662550|NCT00825097|Stroke|stroke
662551|NCT00825097|Tibial neurotomy|tibial neurotomy
662552|NCT00825097|Botulinum toxin type A|botulinum toxin type a
662553|NCT00825097|Selective tibial neurotomy|selective tibial neurotomy
662554|NCT00825110|colorectal|colorectal
662555|NCT00825110|cancer|cancer
662556|NCT00825110|gene expression|gene expression
662557|NCT00825110|biomarker|biomarker
662558|NCT00825110|genomic mismatch repair|genomic mismatch repair
662559|NCT00825123|healthy individuals|healthy individuals
662560|NCT00825136|Panic Disorder|panic disorder
662561|NCT00825136|Temperature Biofeedback|temperature biofeedback
662562|NCT00825136|Internet|internet
662563|NCT00825175|Down syndrome|down syndrome
662564|NCT00825175|Gait|gait
662565|NCT00825175|Motor Development|motor development
662566|NCT00825175|Orthoses|orthoses
664038|NCT00831142|MRI|mri
662567|NCT00825201|peritoneal carcinomatosis|peritoneal carcinomatosis
662568|NCT00825201|peritoneal cavity cancer|peritoneal cavity cancer
662569|NCT00825201|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
662570|NCT00825201|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
662571|NCT00825201|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
662572|NCT00825552|Risperidone|risperidone
662573|NCT00825552|Severe mood dysregulation|severe mood dysregulation
662574|NCT00825552|bipolar|bipolar
662575|NCT00825552|children|children
662576|NCT00825565|Epidermolysis bullosa|epidermolysis bullosa
662577|NCT00825578|intrabronchial valve|intrabronchial valve
662578|NCT00825578|heterogeneous emphysema|heterogeneous emphysema
662579|NCT00825578|non-upper lobe|non-upper lobe
662580|NCT00825591|optic nerve hypoplasia|optic nerve hypoplasia
662581|NCT00825591|septo-optic dysplasia|septo-optic dysplasia
662582|NCT00825591|melatonin|melatonin
662583|NCT00825591|circadian rhythm|circadian rhythm
662584|NCT00825604|stable coronary artery disease|stable coronary artery disease
662585|NCT00825604|quality of life|quality of life
662586|NCT00825604|target achievement|target achievement
662588|NCT00825604|percutaneous coronary intervention|percutaneous coronary intervention
662589|NCT00825617|TS|ts
662590|NCT00825617|HRT|hrt
662591|NCT00825617|Liver function tests|liver function tests
662592|NCT00825630|HP|hp
662593|NCT00825630|UBT|ubt
662594|NCT00825630|PPI|ppi
662595|NCT00825656|Allergic Rhinitis|allergic rhinitis
662596|NCT00825656|Capsaicin|capsaicin
662597|NCT00825656|Homeopathic|homeopathic
662598|NCT00825656|Sinol|sinol
662599|NCT00825656|Sinol-M|sinol-m
662600|NCT00825669|hepatocellular carcinoma|hepatocellular carcinoma
662601|NCT00825669|Portal vein tumor thrombus|portal vein tumor thrombus
662602|NCT00825669|laser ablation|laser ablation
662603|NCT00825682|Breast cancer|breast cancer
662604|NCT00825682|Radiation therapy|radiation therapy
662605|NCT00825682|Reflexology|reflexology
662606|NCT00825682|Fatigue|fatigue
662607|NCT00825682|Quality of life|quality of life
662608|NCT00825682|Sleep disturbance|sleep disturbance
662609|NCT00825708|ADHD|adhd
662610|NCT00825721|Cataract Study|cataract study
662611|NCT00825721|Ophthalmic Study|ophthalmic study
662612|NCT00825721|Agerelated cataract|agerelated cataract
662613|NCT00825721|Nuclear Cataract|nuclear cataract
662614|NCT00825721|Low grade nuclear cataracts|low grade nuclear cataracts
662615|NCT00825734|Metastatic Breast Cancer|metastatic breast cancer
662616|NCT00825734|Sorafenib|sorafenib
662617|NCT00825734|Nexavar|nexavar
662618|NCT00825734|Ixabepilone|ixabepilone
662619|NCT00825734|Ixempra|ixempra
662620|NCT00825747|Cataract|cataract
662621|NCT00825747|Cataract surgery|cataract surgery
662622|NCT00825747|intraocular lens|intraocular lens
662623|NCT00825747|Aspheric lens|aspheric lens
662624|NCT00825760|Antimicrobial Photodynamic Therapy|antimicrobial photodynamic therapy
662625|NCT00825760|Photodynamic Therapy|photodynamic therapy
662626|NCT00825760|PDT|pdt
662627|NCT00825760|Red light|red light
662628|NCT00825760|Visible light|visible light
662629|NCT00825760|Antimicrobial|antimicrobial
662630|NCT00825760|Antibacterial|antibacterial
662631|NCT00825760|Wound healing|wound healing
662632|NCT00825760|Wound management|wound management
662633|NCT00825760|Leg ulcer|leg ulcer
662634|NCT00825760|Chronic venous leg ulcer|chronic venous leg ulcer
662635|NCT00825760|Chronic wound|chronic wound
662636|NCT00825760|Wound therapy|wound therapy
662637|NCT00825760|Antimicrobial therapy|antimicrobial therapy
662638|NCT00825773|TVF|tvf
662639|NCT00825773|TLF|tlf
662640|NCT00825773|MACE|mace
662641|NCT00825773|Ischemia-driven Target Vessel Failure (TVF) at 12 months.|ischemia-driven target vessel failure (tvf) at 12 months.
662642|NCT00825773|Ischemia-driven Target Lesion Failure (TLF) at 12 months defined as a|ischemia-driven target lesion failure (tlf) at 12 months defined as a
662643|NCT00825773|composite of cardiac death that can not be clearly attributed to a vessel|composite of cardiac death that can not be clearly attributed to a vessel
662644|NCT00825773|other than the target vessel, target vessel MI (Q and Non-Q wave) and|other than the target vessel, target vessel mi (q and non-q wave) and
662645|NCT00825773|ischemia-driven TLR.|ischemia-driven tlr.
662646|NCT00825773|Rates of stent thrombosis, defined (per ARC definition) as definite or probable|rates of stent thrombosis, defined (per arc definition) as definite or probable
662647|NCT00825773|and categorized as early, late or very late.|and categorized as early, late or very late.
662648|NCT00825773|Major Adverse Cardiac Events (MACE) defined as cardiac death, target|major adverse cardiac events (mace) defined as cardiac death, target
662649|NCT00825773|vessel MI (Q and Non-Q wave), or target lesion revascularization (TLR) at 30|vessel mi (q and non-q wave), or target lesion revascularization (tlr) at 30
662650|NCT00825773|days, 6 months, 12 months and 2 to 5 years annually.|days, 6 months, 12 months and 2 to 5 years annually.
662651|NCT00825786|surgery for arm hand or elbow|surgery for arm hand or elbow
662652|NCT00825786|mepivacaine|mepivacaine
662653|NCT00825786|ropivacaine|ropivacaine
662654|NCT00825786|hand surgery|hand surgery
662655|NCT00825786|elbow surgery|elbow surgery
662656|NCT00825786|forearm surgery|forearm surgery
662657|NCT00825799|biomarker|biomarker
662658|NCT00825799|depression|depression
662659|NCT00825799|blood test|blood test
662660|NCT00825825|Citalopram|citalopram
662661|NCT00825825|Escitalopram|escitalopram
662662|NCT00825825|Celexa|celexa
662663|NCT00825825|Lexapro|lexapro
662664|NCT00825825|fMRI|fmri
662665|NCT00825825|antidepressant|antidepressant
662666|NCT00825825|healthy volunteers|healthy volunteers
662667|NCT00825838|Body weight|body weight
662668|NCT00825838|Body composition|body composition
662669|NCT00825838|Resting metabolic rate and fat oxidation in men|resting metabolic rate and fat oxidation in men
662670|NCT00825838|class I obese|class i obese
662671|NCT00825877|Hepatitis C|hepatitis c
662672|NCT00825877|Sustained Virological Response|sustained virological response
662673|NCT00825877|HALT-C|halt-c
662674|NCT00825877|Peginterferon and Ribavirin|peginterferon and ribavirin
662675|NCT00825877|HCV RNA|hcv rna
662676|NCT00825890|high cup disc ratio|high cup disc ratio
662677|NCT00825890|glaucoma suspect|glaucoma suspect
662678|NCT00825903|aquatic exercise|aquatic exercise
662679|NCT00825903|asthma|asthma
662680|NCT00825916|AZX100|azx100
662681|NCT00825916|Patient and Observer Scar Assessment Scale|patient and observer scar assessment scale
662683|NCT00825916|Visual Analog Scale|visual analog scale
662684|NCT00825916|VAS|vas
662685|NCT00825916|Keloid|keloid
662686|NCT00825916|Scarring|scarring
662687|NCT00825916|Scar reduction|scar reduction
662688|NCT00825916|Scar prevention|scar prevention
662689|NCT00825929|pharmacokinetics|pharmacokinetics
662690|NCT00825929|pregnancy|pregnancy
662691|NCT00825929|antiretrovirals|antiretrovirals
662692|NCT00825929|neonates|neonates
662693|NCT00825929|HIV|hiv
662694|NCT00825929|treatment experienced|treatment experienced
662695|NCT00825942|Asteroid hyalosis|asteroid hyalosis
662696|NCT00825942|Opthalmic Study|opthalmic study
662697|NCT00825968|Electrophysiological|electrophysiological
662698|NCT00825968|Heart Disease|heart disease
662699|NCT00825968|Cardiology|cardiology
662700|NCT00825968|Atrial Fibrillation|atrial fibrillation
662701|NCT00825968|Risk Factors|risk factors
662702|NCT00825968|Follow-up|follow-up
662703|NCT00825968|Outcomes|outcomes
662704|NCT00825994|menopause|menopause
662705|NCT00825994|perimenopause|perimenopause
662706|NCT00825994|postmenopause|postmenopause
662707|NCT00825994|depression|depression
662708|NCT00825994|mood|mood
662709|NCT00825994|sleep|sleep
662710|NCT00825994|hot flashes|hot flashes
662915|NCT00826800|OXALIPLATIN|oxaliplatin
662711|NCT00826007|perioperative hypoglycemia diabetes surgery|perioperative hypoglycemia diabetes surgery
662712|NCT00826007|surgery|surgery
662713|NCT00826020|PN|pn
662714|NCT00826020|parenteral nutrition|parenteral nutrition
662715|NCT00826020|fat emulsions|fat emulsions
662716|NCT00826020|omega-6 fatty acid|omega-6 fatty acid
662717|NCT00826020|liver disease|liver disease
662718|NCT00826020|fatty acid deficiency|fatty acid deficiency
662719|NCT00826033|Fluorine-18-α-methyltyrosine|fluorine-18-α-methyltyrosine
662720|NCT00826033|Positron emission tomography|positron emission tomography
662721|NCT00826033|Lung cancer|lung cancer
662722|NCT00826033|chemotherapy|chemotherapy
662723|NCT00826033|monitoring|monitoring
662724|NCT00826046|GVHD|gvhd
662725|NCT00826046|Prochymal|prochymal
662726|NCT00826046|Graft vs Host Disease|graft vs host disease
662727|NCT00826059|acute ischemic stroke|acute ischemic stroke
662728|NCT00826059|randomized clinical trial|randomized clinical trial
662729|NCT00826059|effectiveness|effectiveness
662730|NCT00826059|safety|safety
662731|NCT00826072|Single Nucleotide Polymorphism|single nucleotide polymorphism
662732|NCT00826072|cardiopulmonary bypass|cardiopulmonary bypass
662733|NCT00826072|cardiac surgery|cardiac surgery
662734|NCT00826085|Breast Cancer|breast cancer
662735|NCT00826085|Recurrent Chest Wall Cancer|recurrent chest wall cancer
662736|NCT00826085|Loco-regional Recurrent Breast Cancer|loco-regional recurrent breast cancer
662737|NCT00826085|Breast Cancer Recurrence at the Chest Wall|breast cancer recurrence at the chest wall
662738|NCT00826098|Total knee replacement|total knee replacement
662739|NCT00826098|Platelet Rich Plasma|platelet rich plasma
662740|NCT00826098|PRP|prp
662741|NCT00826098|Biologic|biologic
662742|NCT00826098|Randomized|randomized
662743|NCT00826111|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
662744|NCT00826111|Glutamate|glutamate
662745|NCT00826111|Glutamine|glutamine
662746|NCT00826111|GABA|gaba
662747|NCT00826111|Lexapro|lexapro
662748|NCT00826111|Lunesta|lunesta
662749|NCT00826111|Escitalopram|escitalopram
662750|NCT00826111|Eszopiclone|eszopiclone
662751|NCT00826124|low back pain|low back pain
662752|NCT00826124|radiculopathy|radiculopathy
662753|NCT00826124|sciatica|sciatica
662754|NCT00826137|prebiotics|prebiotics
662755|NCT00826137|Antibiotic-associated diarrhea|antibiotic-associated diarrhea
662756|NCT00826150|ovarian cancer|ovarian cancer
662757|NCT00826150|H19 gene|h19 gene
662758|NCT00826150|plasmid|plasmid
662759|NCT00826189|Probiotics|probiotics
662760|NCT00826189|Asthma|asthma
662761|NCT00826189|Allergic Rhinitis|allergic rhinitis
662762|NCT00826202|schizophrenia|schizophrenia
662763|NCT00826202|d-serine|d-serine
662764|NCT00826202|prodrome|prodrome
662765|NCT00826215|mechanical|mechanical
662766|NCT00826215|neck pain|neck pain
662767|NCT00826215|chronic|chronic
662768|NCT00826215|acupuncture|acupuncture
662769|NCT00826215|chronic mechanical neck pain|chronic mechanical neck pain
662770|NCT00826241|Brain Tumor|brain tumor
662771|NCT00826241|Central Nervous System|central nervous system
662772|NCT00826241|CNS|cns
662773|NCT00826241|Spinal Cord Tumor|spinal cord tumor
662774|NCT00826241|Anaplastic Ependymoma|anaplastic ependymoma
662775|NCT00826241|Supratentorial Ependymoma|supratentorial ependymoma
662776|NCT00826241|Infratentorial Ependymoma|infratentorial ependymoma
662777|NCT00826241|Spinal Cord Ependymoma|spinal cord ependymoma
662778|NCT00826241|Lapatinib|lapatinib
662779|NCT00826241|GW572016|gw572016
662780|NCT00826241|Temozolomide|temozolomide
662781|NCT00826241|Temodar|temodar
662782|NCT00826254|vitamin K|vitamin k
662783|NCT00826254|Bone Mineral Density|bone mineral density
662784|NCT00826254|undercarboxylated osteocalcin|undercarboxylated osteocalcin
662785|NCT00826280|coronary artery disease (CAD)|coronary artery disease (cad)
662786|NCT00826280|ischemia|ischemia
662787|NCT00826280|pharmacologic stress|pharmacologic stress
662788|NCT00826306|patient education|patient education
662789|NCT00826306|dermatology patient education|dermatology patient education
662790|NCT00826306|sunscreen|sunscreen
662791|NCT00826306|sunscreen education|sunscreen education
662792|NCT00826306|skin cancer|skin cancer
662793|NCT00826319|Chronic Kidney Disease|chronic kidney disease
662794|NCT00826319|Renal Insufficiency|renal insufficiency
662795|NCT00826319|Biomarkers|biomarkers
662796|NCT00826319|Observational|observational
662797|NCT00826332|ultrasound|ultrasound
662798|NCT00826332|IVF|ivf
662799|NCT00826332|Embryo transfer|embryo transfer
662800|NCT00826332|Pregnancy rate|pregnancy rate
662801|NCT00826332|female patient undergoing IVF|female patient undergoing ivf
662802|NCT00826345|Peripheral Neuropathy|peripheral neuropathy
662803|NCT00826345|Neuropathy|neuropathy
662804|NCT00826345|HIV|hiv
662805|NCT00826345|AIDS|aids
662806|NCT00826345|DSP|dsp
662807|NCT00826345|alternative therapies|alternative therapies
662808|NCT00826358|Adverse events|adverse events
662809|NCT00826358|Pharmacokinetic|pharmacokinetic
662810|NCT00826371|AMD|amd
662811|NCT00826371|Ranibizumab|ranibizumab
662812|NCT00826384|hepatocellular carcinoma|hepatocellular carcinoma
663085|NCT00827398|Adults|adults
662813|NCT00826384|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
662814|NCT00826384|overall survival|overall survival
662815|NCT00826397|Aromatase Inhibitors|aromatase inhibitors
662816|NCT00826397|Joint Pain|joint pain
662817|NCT00826397|Symptoms Control|symptoms control
662818|NCT00826397|Acupuncture|acupuncture
662819|NCT00826410|Laparotomy|laparotomy
662820|NCT00826410|Surgical site infection|surgical site infection
662821|NCT00826410|Drainage|drainage
662822|NCT00826423|treatment with Triple antibiotic therapy|treatment with triple antibiotic therapy
662823|NCT00826449|Advanced Solid Tumors|advanced solid tumors
662824|NCT00826449|Advanced Cancer|advanced cancer
662825|NCT00826449|Non-Small Cell Lung Cancer|non-small cell lung cancer
662826|NCT00826449|NSCLC|nsclc
662827|NCT00826449|Solid Tumor Malignancy|solid tumor malignancy
662828|NCT00826449|Dasatinib|dasatinib
662829|NCT00826449|BMS-354825|bms-354825
662830|NCT00826449|Sprycel®|sprycel®
662831|NCT00826449|Erlotinib|erlotinib
662832|NCT00826449|Erlotinib hydrochloride|erlotinib hydrochloride
662833|NCT00826449|Tarceva|tarceva
662834|NCT00826449|OSI-774|osi-774
662835|NCT00826462|Randomised|randomised
662836|NCT00826462|Placebo-controlled|placebo-controlled
662837|NCT00826462|double blind|double blind
662838|NCT00826462|Intervention study|intervention study
662839|NCT00826462|Primary health care|primary health care
662840|NCT00826475|Migraine|migraine
662841|NCT00826475|Headache|headache
662842|NCT00826488|Breast Cancer|breast cancer
662843|NCT00826488|Mammography|mammography
662844|NCT00826488|Benign masses|benign masses
662845|NCT00826488|Breast Lump|breast lump
662846|NCT00826488|Breast Biopsy|breast biopsy
662847|NCT00826488|Breast Mass|breast mass
662848|NCT00826514|Chronic Prostatis|chronic prostatis
662849|NCT00826553|sedative|sedative
662850|NCT00826553|GABA|gaba
662851|NCT00826553|alpha 2 agonist|alpha 2 agonist
662852|NCT00826553|propofol|propofol
662853|NCT00826553|midazolam|midazolam
662854|NCT00826553|lorazepam|lorazepam
662855|NCT00826553|dexmedetomidine|dexmedetomidine
662856|NCT00826553|sleep|sleep
662857|NCT00826553|electroencephalogram|electroencephalogram
662858|NCT00826553|polysomnogram|polysomnogram
662859|NCT00826553|ICU|icu
662860|NCT00826566|COPD|copd
662861|NCT00826566|caffeine|caffeine
662862|NCT00826566|chronic systemic inflammation|chronic systemic inflammation
662863|NCT00826566|oxidative stress|oxidative stress
662864|NCT00826566|supplementation|supplementation
752396|NCT01172860|Electroporation|electroporation
662865|NCT00826566|stable COPD GOLD stage II with CRP levels ≥ 3 mg/l|stable copd gold stage ii with crp levels ≥ 3 mg/l
662866|NCT00826579|Sentinel lymph node|sentinel lymph node
662867|NCT00826579|Lymph node analysis|lymph node analysis
662868|NCT00826579|Bone marrow analysis|bone marrow analysis
662869|NCT00826592|patient education|patient education
662870|NCT00826592|dermatology patient education|dermatology patient education
662871|NCT00826592|atopic dermatitis|atopic dermatitis
662872|NCT00826592|atopic dermatitis education|atopic dermatitis education
662873|NCT00826592|atopic eczema|atopic eczema
662874|NCT00826592|infantile eczema|infantile eczema
662875|NCT00826592|hand eczema|hand eczema
662876|NCT00826605|Weight loss, urobilinogen|weight loss, urobilinogen
662877|NCT00826618|Uveitis|uveitis
662878|NCT00826618|Cystoid Macular Edema|cystoid macular edema
662879|NCT00826631|weight|weight
662880|NCT00826631|metabolism|metabolism
662881|NCT00826631|cholesterol|cholesterol
662882|NCT00826631|insulin|insulin
662883|NCT00826644|Small cell lung cancer|small cell lung cancer
662884|NCT00826644|Camptothecin|camptothecin
662885|NCT00826644|Response rate|response rate
662886|NCT00826657|B12 deficiency|b12 deficiency
662887|NCT00826657|methylmalonic acid|methylmalonic acid
662888|NCT00826657|homocystein|homocystein
662889|NCT00826657|vitamin B12 supplementation intervention|vitamin b12 supplementation intervention
662890|NCT00826670|Antibiotic resistance|antibiotic resistance
662891|NCT00826670|ESBL carriage|esbl carriage
662892|NCT00826683|Non-small cell lung cancer|non-small cell lung cancer
662893|NCT00826683|Endothelial cell progenitor|endothelial cell progenitor
662894|NCT00826683|Angiogenesis|angiogenesis
662895|NCT00826683|Vascular endothelial cell growth factor|vascular endothelial cell growth factor
662896|NCT00826683|Healthy control|healthy control
662897|NCT00826683|COPD patients|copd patients
662898|NCT00826683|NSCLC patients|nsclc patients
662899|NCT00826696|preeclampsia|preeclampsia
662900|NCT00826735|third stage of labor|third stage of labor
662901|NCT00826735|bleeding|bleeding
662902|NCT00826735|guided imagery|guided imagery
662903|NCT00826735|childbirth|childbirth
662905|NCT00826748|inhaled steroids|inhaled steroids
662906|NCT00826748|gene expression|gene expression
662907|NCT00826748|smoker's lungs|smoker's lungs
662908|NCT00826774|Body Weight|body weight
662909|NCT00826774|Overweight|overweight
662910|NCT00826774|Hypertension|hypertension
662911|NCT00826774|Hyperglycemia|hyperglycemia
662912|NCT00826800|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
662913|NCT00826800|FLUOROURACIL|fluorouracil
662914|NCT00826800|LEUCOVORIN|leucovorin
662916|NCT00826800|Chemotherapy|chemotherapy
662917|NCT00826813|Dysphagia|dysphagia
662918|NCT00826813|esophageal cancer|esophageal cancer
662919|NCT00826813|stent|stent
662920|NCT00826813|brachytherapy|brachytherapy
662921|NCT00826826|Atrial fibrillation|atrial fibrillation
662922|NCT00826826|Amiodarone|amiodarone
662923|NCT00826826|Arrhythmias, Cardiac|arrhythmias, cardiac
662924|NCT00826826|Catheter ablation|catheter ablation
662925|NCT00826839|In vitro fertilization|in vitro fertilization
662926|NCT00826839|Poor responder patients|poor responder patients
662927|NCT00826839|Randomized clinical trial|randomized clinical trial
662928|NCT00826839|Estrogen patch|estrogen patch
662929|NCT00826839|Gonadotropin-releasing hormone antagonist|gonadotropin-releasing hormone antagonist
662930|NCT00826839|Oral contraceptive pill|oral contraceptive pill
662931|NCT00826839|Microdose lupron|microdose lupron
662932|NCT00826878|tivozanib|tivozanib
662933|NCT00826878|AV-951|av-951
662934|NCT00826904|Fetal programming|fetal programming
662935|NCT00826904|Fetal macrosomia|fetal macrosomia
662936|NCT00826904|Fetal health|fetal health
662937|NCT00826904|Gestational diabetes|gestational diabetes
662938|NCT00826904|Maternal health|maternal health
662939|NCT00826904|Maternal obesity|maternal obesity
662940|NCT00826917|3D, 2D, ultrasound, volumetry, multiplanar, VOCALTM, XI VOCALTM, fetal, gestational sac, placenta|3d, 2d, ultrasound, volumetry, multiplanar, vocaltm, xi vocaltm, fetal, gestational sac, placenta
662941|NCT00826930|High Grade Glioma|high grade glioma
662942|NCT00826930|Brain Tumor|brain tumor
662943|NCT00826930|Solid Tumor|solid tumor
662944|NCT00826930|Partial Debulking|partial debulking
662945|NCT00826930|Tumor Resection|tumor resection
662946|NCT00826930|Tumor Tissue Hypoxia|tumor tissue hypoxia
662947|NCT00826930|Radiation Sensitizer|radiation sensitizer
662948|NCT00826930|Cancerous Tumor|cancerous tumor
662949|NCT00826943|Allergic Rhinitis|allergic rhinitis
662950|NCT00826969|Asthma|asthma
662951|NCT00826969|Ciclesonide|ciclesonide
662952|NCT00826995|patient Education|patient education
662953|NCT00826995|dermatology Patient Education|dermatology patient education
662954|NCT00826995|melanoma|melanoma
662955|NCT00826995|melanoma education|melanoma education
662956|NCT00826995|malignant melanoma|malignant melanoma
662957|NCT00826995|melanoma detection|melanoma detection
662958|NCT00827034|Dimebon Warfarin Drug-Drug Interaction|dimebon warfarin drug-drug interaction
662959|NCT00827047|hepatocellular carcinoma|hepatocellular carcinoma
662960|NCT00827047|Surgical resection|surgical resection
662961|NCT00827047|total hemihepatic vascular exclusion|total hemihepatic vascular exclusion
662962|NCT00827047|occlusion|occlusion
662963|NCT00827047|bleeding|bleeding
662964|NCT00827047|overall survival|overall survival
662965|NCT00827060|primary care|primary care
662966|NCT00827060|procalcitonin|procalcitonin
662967|NCT00827060|acute respiratory tract infection|acute respiratory tract infection
662968|NCT00827086|influencing factors (smoking, nutrition, education)|influencing factors (smoking, nutrition, education)
662969|NCT00827099|accelerated phase cml|accelerated phase cml
662970|NCT00827099|adult ALL in remission|adult all in remission
662971|NCT00827099|adult AML in remission|adult aml in remission
662972|NCT00827099|adult AML with 11q23 (MLL) abnormalities|adult aml with 11q23 (mll) abnormalities
662973|NCT00827099|adult AML with inv(16)(p13;q22)|adult aml with inv(16)(p13;q22)
662974|NCT00827099|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
662975|NCT00827099|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
662976|NCT00827099|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
662977|NCT00827099|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
662978|NCT00827099|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
662979|NCT00827099|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
662980|NCT00827099|prolymphocytic leukemia|prolymphocytic leukemia
662981|NCT00827099|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
662982|NCT00827099|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
662983|NCT00827099|secondary acute myeloid leukemia|secondary acute myeloid leukemia
662984|NCT00827099|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
663068|NCT00827281|smoking|smoking
662985|NCT00827099|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
662986|NCT00827099|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
662987|NCT00827099|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
662988|NCT00827099|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
662989|NCT00827099|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
662990|NCT00827099|anaplastic large cell lymphoma|anaplastic large cell lymphoma
662991|NCT00827099|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
662992|NCT00827099|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
662993|NCT00827099|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
662994|NCT00827099|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
662995|NCT00827099|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
662996|NCT00827099|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
663086|NCT00827398|Children|children
662997|NCT00827099|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
662998|NCT00827099|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
662999|NCT00827099|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
663000|NCT00827099|splenic marginal zone lymphoma|splenic marginal zone lymphoma
663001|NCT00827099|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
663002|NCT00827099|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
663003|NCT00827099|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
663004|NCT00827099|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
663005|NCT00827099|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
663006|NCT00827099|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
663007|NCT00827099|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
663008|NCT00827099|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
663009|NCT00827099|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
663010|NCT00827099|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
663011|NCT00827099|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
663012|NCT00827099|stage I multiple myeloma|stage i multiple myeloma
663013|NCT00827099|stage II multiple myeloma|stage ii multiple myeloma
663014|NCT00827099|stage III multiple myeloma|stage iii multiple myeloma
663015|NCT00827099|refractory multiple myeloma|refractory multiple myeloma
663016|NCT00827099|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
663017|NCT00827099|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
663018|NCT00827099|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
663019|NCT00827112|CCR5-tropic HIV-1 virus|ccr5-tropic hiv-1 virus
663020|NCT00827125|active stage|active stage
663021|NCT00827125|labor|labor
663022|NCT00827125|progression|progression
663023|NCT00827125|pregnant woman during active phases of labor|pregnant woman during active phases of labor
663024|NCT00827151|amenorrhea|amenorrhea
663025|NCT00827151|athletes|athletes
663026|NCT00827151|bone loss|bone loss
663027|NCT00827151|eumenorrhea|eumenorrhea
663028|NCT00827164|head and neck cancer|head and neck cancer
663029|NCT00827164|resistance training|resistance training
663030|NCT00827164|nutrition counseling|nutrition counseling
663031|NCT00827164|radiation therapy|radiation therapy
663032|NCT00827164|pharyngeal or laryngeal cancer|pharyngeal or laryngeal cancer
663033|NCT00827177|dose escalation|dose escalation
663034|NCT00827177|safety|safety
663035|NCT00827177|tolerability|tolerability
663036|NCT00827177|tumor|tumor
663037|NCT00827177|PK|pk
663038|NCT00827177|hepatocellular carcinoma|hepatocellular carcinoma
663039|NCT00827177|renal cell carcinoma|renal cell carcinoma
663040|NCT00827177|melanoma|melanoma
663041|NCT00827177|non-small cell lung cancer|non-small cell lung cancer
663042|NCT00827177|breast cancer|breast cancer
663043|NCT00827190|Acute Ischemic Stroke|acute ischemic stroke
663044|NCT00827203|cancer|cancer
663045|NCT00827203|metastatic|metastatic
663046|NCT00827203|Elesclomol Sodium|elesclomol sodium
663047|NCT00827203|tumor|tumor
663048|NCT00827203|Advanced solid tumors that are metastatic and unresectable|advanced solid tumors that are metastatic and unresectable
663049|NCT00827216|Gastric emptying|gastric emptying
663050|NCT00827216|emergency anesthesia|emergency anesthesia
663051|NCT00827216|intravenous erythromycin|intravenous erythromycin
663052|NCT00827229|Active labor|active labor
663053|NCT00827229|Term pregnancy|term pregnancy
663054|NCT00827229|Vertex presentation|vertex presentation
663055|NCT00827229|Single fetus|single fetus
663056|NCT00827242|Signs and Symptoms|signs and symptoms
663057|NCT00827242|Prostatic Hyperplasia|prostatic hyperplasia
663058|NCT00827242|Hyperplasia|hyperplasia
663059|NCT00827242|Genital Diseases, Male|genital diseases, male
663060|NCT00827242|Prostatic Diseases|prostatic diseases
663061|NCT00827242|BPH-LUTS|bph-luts
663062|NCT00827268|Dyslexia|dyslexia
663063|NCT00827268|Reading|reading
663064|NCT00827268|Aphasia|aphasia
663065|NCT00827268|Stroke|stroke
663067|NCT00827281|CBT|cbt
663069|NCT00827281|tobacco|tobacco
663070|NCT00827294|Phantom limb pain|phantom limb pain
663071|NCT00827294|Mirror therapy|mirror therapy
663072|NCT00827294|amputation|amputation
663073|NCT00827294|Limb loss|limb loss
663074|NCT00827294|treatment|treatment
663075|NCT00827307|breast carcinoma; goserelin; Mammographic density|breast carcinoma; goserelin; mammographic density
663076|NCT00827333|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
663077|NCT00827333|stage I non-small cell lung cancer|stage i non-small cell lung cancer
663078|NCT00827333|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
663079|NCT00827333|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
663080|NCT00827333|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
663081|NCT00827333|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
663082|NCT00827359|everolimus|everolimus
663083|NCT00827398|MSC|msc
663084|NCT00827398|GVHD|gvhd
663087|NCT00827398|steroid refractory acute GVHD occurring after allogeneic stem cell transplantation|steroid refractory acute gvhd occurring after allogeneic stem cell transplantation
663088|NCT00827411|Drug Eluting Stent|drug eluting stent
663089|NCT00827411|Percutaneous coronary intervention|percutaneous coronary intervention
663090|NCT00827411|Oral antiplatelet therapy|oral antiplatelet therapy
663091|NCT00827411|Clopidogrel/Aspirin|clopidogrel/aspirin
663092|NCT00827411|Acute Coronary Syndrome|acute coronary syndrome
663093|NCT00827424|physical activity (PA)|physical activity (pa)
663095|NCT00827424|life style modification|life style modification
663096|NCT00827424|physical activity|physical activity
663098|NCT00827424|BMI reduction|bmi reduction
663099|NCT00827424|clinical and metabolic measure|clinical and metabolic measure
663100|NCT00827424|health expenditure|health expenditure
663101|NCT00827424|improvement of patient readiness for lifestyle change|improvement of patient readiness for lifestyle change
663102|NCT00827450|hepatic steatosis|hepatic steatosis
663103|NCT00827450|coffee|coffee
663104|NCT00827450|fructose|fructose
663105|NCT00827450|lipids|lipids
663106|NCT00827463|aneamia|aneamia
663107|NCT00827463|aneamia during the maternity|aneamia during the maternity
663108|NCT00827476|ovary|ovary
663109|NCT00827476|human|human
663110|NCT00827476|transplantaion|transplantaion
663111|NCT00827476|ovarian failure|ovarian failure
663112|NCT00827489|schizophrenia|schizophrenia
663113|NCT00827502|TRULIMAX (AZITHROMYCIN ) NON-INTERVENTIONAL STUDY|trulimax (azithromycin ) non-interventional study
663114|NCT00827515|Relative Bioavailability Effect of food|relative bioavailability effect of food
663115|NCT00827528|Pelvic Organ Prolapse|pelvic organ prolapse
663116|NCT00827528|Surgical Treatment|surgical treatment
663117|NCT00827541|tigecycline|tigecycline
663118|NCT00827541|complicated intra-abdominal infections (cIAI)|complicated intra-abdominal infections (ciai)
663119|NCT00827541|complicated skin and soft tissue infections (cSSTI).|complicated skin and soft tissue infections (cssti).
663120|NCT00827554|Liver Neoplasms|liver neoplasms
663121|NCT00827554|Liver Diseases|liver diseases
663122|NCT00827554|Digestive System Diseases|digestive system diseases
663123|NCT00827554|Digestive System Neoplasms|digestive system neoplasms
663124|NCT00827554|Carcinoma, Hepatocellular|carcinoma, hepatocellular
663125|NCT00827554|Gastrointestinal Neoplasms|gastrointestinal neoplasms
663126|NCT00827554|Adenocarcinoma|adenocarcinoma
663127|NCT00827554|Hepatocellular carcinoma|hepatocellular carcinoma
663128|NCT00827554|Neoplasms|neoplasms
663129|NCT00827554|Transarterial chemoembolization|transarterial chemoembolization
663130|NCT00827554|Nadroparin|nadroparin
663131|NCT00827554|low-molecular-weight heparin|low-molecular-weight heparin
663132|NCT00827554|chemoembolization|chemoembolization
663133|NCT00827567|Breast cancer|breast cancer
663134|NCT00827567|metastatic breast|metastatic breast
663135|NCT00827567|triple negative|triple negative
663136|NCT00827567|ER/PR negative|er/pr negative
663137|NCT00827567|Her2 Neu negative|her2 neu negative
663138|NCT00827580|HFS|hfs
663139|NCT00827580|patients with breast or colon cancer receiving capecitabine|patients with breast or colon cancer receiving capecitabine
663140|NCT00827606|pediatric heterozygous familial hypercholesterolemia|pediatric heterozygous familial hypercholesterolemia
663141|NCT00827619|Peripheral Arterial Disease|peripheral arterial disease
663142|NCT00827632|Ovarian Suppression|ovarian suppression
663143|NCT00827632|Oral Contraceptives|oral contraceptives
663144|NCT00827632|Obese and Normal BMI|obese and normal bmi
663145|NCT00827658|anesthesia, local|anesthesia, local
663146|NCT00827658|ulnar nerve|ulnar nerve
663147|NCT00827658|hand|hand
663148|NCT00827658|surgery, plastic|surgery, plastic
663149|NCT00827658|blinded|blinded
663150|NCT00827658|randomized|randomized
663151|NCT00827658|prospective|prospective
663152|NCT00827658|local anesthesia|local anesthesia
663153|NCT00827658|volar wrist block|volar wrist block
663154|NCT00827658|hypothenar palm block|hypothenar palm block
663155|NCT00827658|hand surgery|hand surgery
663156|NCT00827684|KRAS mutation|kras mutation
663157|NCT00827697|Gonorrhea|gonorrhea
663158|NCT00827697|Chlamydia|chlamydia
663159|NCT00827697|Rectal|rectal
663160|NCT00827710|diabetes|diabetes
663161|NCT00827710|registry|registry
663162|NCT00827710|computer|computer
663163|NCT00827710|self management|self management
663164|NCT00827723|Hepatic functional reserve|hepatic functional reserve
663165|NCT00827723|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
663166|NCT00827723|Indocyanine Green retention rate at 15 minutes (ICG-R15')|indocyanine green retention rate at 15 minutes (icg-r15')
663167|NCT00827723|Portal Pressure (PP)|portal pressure (pp)
663168|NCT00827723|Hepatic Portal Venous Gradient (HPVG)|hepatic portal venous gradient (hpvg)
663169|NCT00827723|Alcoholic and Viral Cirrhosis|alcoholic and viral cirrhosis
663170|NCT00827723|Makuuchi criteria|makuuchi criteria
663171|NCT00827723|Barcelona Clinic of Liver Cancer (BCLC)|barcelona clinic of liver cancer (bclc)
663172|NCT00827723|Hepatic resection|hepatic resection
663173|NCT00827736|anal fissure|anal fissure
663174|NCT00827736|fissura ani|fissura ani
663175|NCT00827736|botox|botox
663176|NCT00827736|ISDN|isdn
663177|NCT00827736|Nitric oxide donor|nitric oxide donor
663178|NCT00827749|swallowing disorders|swallowing disorders
663179|NCT00827749|geriatrics|geriatrics
663180|NCT00827762|phenylketonuria|phenylketonuria
663182|NCT00827762|sapropterin|sapropterin
663183|NCT00827762|behavior|behavior
663184|NCT00827762|cognition|cognition
663185|NCT00827762|executive abilities|executive abilities
663186|NCT00827762|attention|attention
663187|NCT00827775|Hypertension|hypertension
663188|NCT00827775|Hemodialysis|hemodialysis
663189|NCT00827788|contrast media|contrast media
663190|NCT00827788|angiography|angiography
663191|NCT00827788|percutaneous coronary intervention|percutaneous coronary intervention
663192|NCT00827801|Cancer|cancer
663385|NCT00821964|topical|topical
663193|NCT00827801|Heart Failure|heart failure
663194|NCT00827801|HF|hf
663195|NCT00827801|Cancer and Concurrent Heart Failure|cancer and concurrent heart failure
663196|NCT00827801|MDASI-HF Symptom Management Program|mdasi-hf symptom management program
663197|NCT00827801|MDASI-HF|mdasi-hf
663198|NCT00827801|MDASI-HF questionnaire|mdasi-hf questionnaire
663199|NCT00827801|M. D. Anderson Symptom Inventory - Heart Failure|m. d. anderson symptom inventory - heart failure
663200|NCT00827801|Questionnaire|questionnaire
663201|NCT00827801|Symptom Management Gap|symptom management gap
663202|NCT00827827|Stroke|stroke
663203|NCT00827827|Exercise|exercise
663204|NCT00827827|Strength Training|strength training
663205|NCT00827827|Skeletal Muscle|skeletal muscle
663206|NCT00827827|Insulin Sensitivity|insulin sensitivity
663207|NCT00827853|Diabetes|diabetes
663208|NCT00827853|Peripheral Vascular Disease (PVD)|peripheral vascular disease (pvd)
663209|NCT00827853|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
663210|NCT00827853|Cryoplasty|cryoplasty
663211|NCT00827853|Restenosis|restenosis
663212|NCT00827866|Tobacco quitline|tobacco quitline
663213|NCT00827866|Childhood cancer survivors|childhood cancer survivors
663214|NCT00827866|Adult-onset cancer survivors|adult-onset cancer survivors
663215|NCT00827879|Intimate partner aggression|intimate partner aggression
663216|NCT00827879|Couples intervention|couples intervention
663217|NCT00827879|PTSD|ptsd
663218|NCT00827879|Veterans|veterans
663219|NCT00827879|Prevention|prevention
663220|NCT00827879|Violence Prevention|violence prevention
663221|NCT00827879|Prevention of pertetration of intimate partner aggression.|prevention of pertetration of intimate partner aggression.
663222|NCT00827892|Intracerebral Hemorrhage|intracerebral hemorrhage
663223|NCT00827892|Treatment|treatment
663224|NCT00827892|MRI|mri
663225|NCT00827905|Non-Contact|non-contact
663226|NCT00827905|Radar|radar
663227|NCT00827905|Respiratory|respiratory
663228|NCT00827905|Respiration|respiration
663229|NCT00827905|Breathing|breathing
663230|NCT00827905|Rate|rate
663231|NCT00827905|Frequency|frequency
663232|NCT00827905|Respiratory Mechanics|respiratory mechanics
663233|NCT00827905|Respiratory Rate Measurement|respiratory rate measurement
663234|NCT00827918|Acute Exacerbation of Schizophrenia|acute exacerbation of schizophrenia
663235|NCT00827931|tranexamic acid|tranexamic acid
663236|NCT00827931|major abdominal surgery|major abdominal surgery
663237|NCT00827931|blood loss|blood loss
663238|NCT00827944|Uncomplicated primary inguinal hernias|uncomplicated primary inguinal hernias
663239|NCT00827957|Hypothermia|hypothermia
663240|NCT00827957|Internal cooling|internal cooling
663241|NCT00827957|External cooling|external cooling
663242|NCT00827957|Cardiac arrest|cardiac arrest
663243|NCT00827970|mass screening|mass screening
663244|NCT00827983|Luteal Phase Support in IVF patients|luteal phase support in ivf patients
663245|NCT00827996|Apocrine glands|apocrine glands
663246|NCT00827996|abcesses|abcesses
663247|NCT00828009|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
663248|NCT00828009|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
663249|NCT00828009|adenocarcinoma of the lung|adenocarcinoma of the lung
663250|NCT00828009|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
663251|NCT00828009|large cell lung cancer|large cell lung cancer
663252|NCT00821340|Leber congenital amaurosis|leber congenital amaurosis
663254|NCT00821340|RPE65|rpe65
663255|NCT00821340|RPE65-associated Leber congenital amaurosis|rpe65-associated leber congenital amaurosis
663256|NCT00821340|Retinal disease due to RPE65 mutations|retinal disease due to rpe65 mutations
663257|NCT00821353|Atrial fibrillation|atrial fibrillation
663353|NCT00821847|creatinine|creatinine
663258|NCT00821353|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
663259|NCT00821353|RF ablation|rf ablation
663260|NCT00821353|Antiarrhythmic drugs|antiarrhythmic drugs
663261|NCT00821366|HIV/AIDS|hiv/aids
663262|NCT00821366|Food security|food security
663263|NCT00821366|treatment experienced|treatment experienced
663264|NCT00821379|PCOS|pcos
663265|NCT00821379|Polycystic Ovary Syndrome|polycystic ovary syndrome
663266|NCT00821379|Pregnancy Complications|pregnancy complications
663267|NCT00821379|Gestational Diabetes|gestational diabetes
663268|NCT00821379|Pre eclampsia|pre eclampsia
663269|NCT00821379|Prediction Model|prediction model
663270|NCT00821379|Pre conceptional|pre conceptional
663271|NCT00821405|Number : 250~300 patients|number : 250~300 patients
663366|NCT00821860|stage IV malignant mesothelioma|stage iv malignant mesothelioma
663272|NCT00821405|Correlation between PET, glucose loading and peritoneal thickness/calcification|correlation between pet, glucose loading and peritoneal thickness/calcification
663273|NCT00821444|schizophrenia, pharmacokinetics, bioavailability, food effect|schizophrenia, pharmacokinetics, bioavailability, food effect
663274|NCT00821457|existing scars the are two to six months old|existing scars the are two to six months old
663275|NCT00821470|osteonecrosis|osteonecrosis
663276|NCT00821470|bone marrow|bone marrow
663277|NCT00821470|core decompression|core decompression
663278|NCT00821470|femoral head|femoral head
663279|NCT00821496|Multiple dose administration|multiple dose administration
663280|NCT00821496|Oral Contraceptives|oral contraceptives
663281|NCT00821509|virus infection|virus infection
663283|NCT00821509|transmission|transmission
663284|NCT00821509|intervention|intervention
663285|NCT00821522|Acute Kidney Insufficiency|acute kidney insufficiency
663286|NCT00821522|Acute Renal Insufficiency|acute renal insufficiency
663287|NCT00821522|Acute Kidney Injury|acute kidney injury
663288|NCT00821522|Cardiac Surgical Procedures|cardiac surgical procedures
663289|NCT00821522|Ischemic Preconditioning|ischemic preconditioning
663290|NCT00821535|pharmacokinetics, Japanese, healthy volunteer, maraviroc|pharmacokinetics, japanese, healthy volunteer, maraviroc
663291|NCT00821548|facioscapulohumeral muscular dystrophy|facioscapulohumeral muscular dystrophy
663292|NCT00821548|electrostimulation|electrostimulation
663293|NCT00821548|training|training
663294|NCT00821561|Persistent|persistent
663296|NCT00821561|defect|defect
663297|NCT00821561|Nexagon|nexagon
663298|NCT00821561|Coda|coda
663299|NCT00821574|Hypertension, dyslipidemia|hypertension, dyslipidemia
663300|NCT00821587|Hepatitis C Post Liver Transplant|hepatitis c post liver transplant
663301|NCT00821600|Risperidone|risperidone
663302|NCT00821600|Antipsychotic|antipsychotic
663303|NCT00821600|Pharmacokinetic|pharmacokinetic
663304|NCT00821600|Long-acting Injectable|long-acting injectable
663305|NCT00821626|Influenza|influenza
663306|NCT00821626|Rapid flu test|rapid flu test
663307|NCT00821626|Returning travelers with fever|returning travelers with fever
663308|NCT00821652|Tumor|tumor
663309|NCT00821652|NY-ESO-1 expression|ny-eso-1 expression
663310|NCT00821652|Tumors that often express NY-ESO-1.|tumors that often express ny-eso-1.
663311|NCT00821665|Type 2 diabetes|type 2 diabetes
663312|NCT00821665|Glycemic control|glycemic control
663313|NCT00821665|(postprandial) Hyperglycemia|(postprandial) hyperglycemia
663314|NCT00821665|Sucrose|sucrose
663315|NCT00821678|telemedicine|telemedicine
663316|NCT00821678|rural|rural
663317|NCT00821678|veterans|veterans
663318|NCT00821678|care management|care management
663319|NCT00821678|psychotherapy|psychotherapy
663320|NCT00821691|cerebral infarction|cerebral infarction
663321|NCT00821717|Chronic Heart Failure|chronic heart failure
663322|NCT00821717|Iron deficiency|iron deficiency
663323|NCT00821717|Iron deficiency anaemia|iron deficiency anaemia
663324|NCT00821717|Anaemia|anaemia
663325|NCT00821717|Heart disease|heart disease
663326|NCT00821730|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
663327|NCT00821730|Peer support|peer support
663328|NCT00821730|Early inflammatory arthritis|early inflammatory arthritis
663329|NCT00821730|Self-management|self-management
663330|NCT00821730|Patient education|patient education
663331|NCT00821756|Suicidal behaviour|suicidal behaviour
663332|NCT00821756|Attempted suicide|attempted suicide
663333|NCT00821756|Self harm|self harm
663334|NCT00821756|Suicide|suicide
663335|NCT00821756|Health system contacts|health system contacts
663336|NCT00821756|Contacts with health system|contacts with health system
663337|NCT00821782|Bacteria|bacteria
663338|NCT00821782|Oral flora bacteria|oral flora bacteria
663339|NCT00821782|Resistance|resistance
663340|NCT00821795|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
663341|NCT00821795|insulin|insulin
663342|NCT00821795|therapy|therapy
663343|NCT00821834|Old Myocardial infarction|old myocardial infarction
663344|NCT00821834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
663345|NCT00821834|Angioplasty|angioplasty
663346|NCT00821834|Transluminal|transluminal
663347|NCT00821834|Percutaneous Coronary|percutaneous coronary
663348|NCT00821834|Stents|stents
663349|NCT00821847|HIV|hiv
663350|NCT00821847|glomerular filtration rate|glomerular filtration rate
663351|NCT00821847|cockcroft|cockcroft
663352|NCT00821847|MDRD formula|mdrd formula
663354|NCT00821847|cystatin C|cystatin c
663355|NCT00821847|isotopic clearance|isotopic clearance
663356|NCT00821847|EDTA-51Cr|edta-51cr
663357|NCT00821847|DEXA scan|dexa scan
663358|NCT00821860|epithelial mesothelioma|epithelial mesothelioma
663359|NCT00821860|recurrent malignant mesothelioma|recurrent malignant mesothelioma
663360|NCT00821860|sarcomatous mesothelioma|sarcomatous mesothelioma
663361|NCT00821860|malignant pleural effusion|malignant pleural effusion
663362|NCT00821860|stage IA malignant mesothelioma|stage ia malignant mesothelioma
663363|NCT00821860|stage IB malignant mesothelioma|stage ib malignant mesothelioma
663364|NCT00821860|stage II malignant mesothelioma|stage ii malignant mesothelioma
663365|NCT00821860|stage III malignant mesothelioma|stage iii malignant mesothelioma
663367|NCT00821873|Cartilage injury|cartilage injury
663368|NCT00821873|OATS|oats
663369|NCT00821873|Knee injury|knee injury
663370|NCT00821873|allograft|allograft
663371|NCT00821873|autograft|autograft
663372|NCT00821886|Breast Cancer|breast cancer
663373|NCT00821886|Neoadjuvant|neoadjuvant
663374|NCT00821886|Ixabepilone|ixabepilone
663375|NCT00821886|Carboplatin|carboplatin
663376|NCT00821886|Trastuzumab|trastuzumab
663377|NCT00821899|diabetes type 1|diabetes type 1
663378|NCT00821899|bone marrow transplantation|bone marrow transplantation
663379|NCT00821925|osteoporosis|osteoporosis
663380|NCT00821938|Narrow QRS|narrow qrs
663381|NCT00821938|CRT|crt
663382|NCT00821964|Breast Cancer|breast cancer
663383|NCT00821964|Stage IV|stage iv
663384|NCT00821964|cream|cream
663386|NCT00821977|Type 2 Diabetes|type 2 diabetes
663387|NCT00821977|Vildagliptin|vildagliptin
663388|NCT00821990|Failed after previous chemotherapy|failed after previous chemotherapy
663389|NCT00822003|GLP-1|glp-1
663390|NCT00822003|insulin|insulin
663391|NCT00822003|glucose|glucose
663392|NCT00822016|Best Supportive Care|best supportive care
663393|NCT00822016|Protocol of Standard Practice|protocol of standard practice
663394|NCT00822016|Carcinoma of the Lung|carcinoma of the lung
663395|NCT00822042|Lipodystrophy|lipodystrophy
663396|NCT00822042|Adipokines|adipokines
663397|NCT00822042|Glucocorticoids|glucocorticoids
663398|NCT00822042|Patients with glucocorticoids|patients with glucocorticoids
663399|NCT00822068|stroke|stroke
663400|NCT00822068|aphasia|aphasia
663401|NCT00822068|rehabilitation|rehabilitation
663402|NCT00822068|transcranial direct current stimulation|transcranial direct current stimulation
663403|NCT00822068|intensive training|intensive training
663404|NCT00822068|chronic aphasia after stroke|chronic aphasia after stroke
663405|NCT00822094|Acute|acute
663406|NCT00822094|Myeloid|myeloid
663407|NCT00822094|Leukemia|leukemia
663408|NCT00822094|Adult|adult
663409|NCT00822094|First|first
663410|NCT00822094|Relapse|relapse
663411|NCT00822094|AML|aml
663412|NCT00822094|Acute Myelogenous leukemia|acute myelogenous leukemia
663413|NCT00822094|Leukemia, Myeloid|leukemia, myeloid
663414|NCT00822094|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
663415|NCT00822094|Acute myelocytic leukemia|acute myelocytic leukemia
663416|NCT00822107|Hypokalemia|hypokalemia
663417|NCT00822107|Bartter Syndrome|bartter syndrome
663418|NCT00822107|Salt Wasting|salt wasting
663419|NCT00822120|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
663420|NCT00822120|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
663421|NCT00822120|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
752397|NCT01172860|Outpatient|outpatient
663422|NCT00822120|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
663423|NCT00822120|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
663424|NCT00822120|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
663425|NCT00822120|HIV infection|hiv infection
663426|NCT00822133|ketamine|ketamine
663427|NCT00822133|preemption|preemption
663428|NCT00822133|postoperative|postoperative
663429|NCT00822133|pain|pain
663430|NCT00822133|safety|safety
663431|NCT00822146|CRT|crt
663432|NCT00822159|Fixation failure|fixation failure
663433|NCT00822159|Bone strength|bone strength
663434|NCT00822159|DensiProbe|densiprobe
663435|NCT00822172|Peripheral Vascular Disease|peripheral vascular disease
663436|NCT00822172|Peripheral Arterial Disease|peripheral arterial disease
663437|NCT00822172|Intermittent Claudication|intermittent claudication
663438|NCT00822172|Peak Walking Time|peak walking time
663439|NCT00822172|Claudication Onset Time|claudication onset time
663440|NCT00822172|Cilostazol|cilostazol
663441|NCT00822172|Carnitine|carnitine
663442|NCT00822198|peripheral neuropathy|peripheral neuropathy
663443|NCT00822198|diabetes|diabetes
663444|NCT00822198|plantar vibration|plantar vibration
663445|NCT00822211|Diabetes Mellitus|diabetes mellitus
663446|NCT00822211|HbA1c reduction|hba1c reduction
663447|NCT00822211|vildagliptin|vildagliptin
663448|NCT00822211|add-on to metformin|add-on to metformin
663449|NCT00822211|Chinese patients|chinese patients
663450|NCT00822224|acute pain|acute pain
663451|NCT00822224|MEOPA|meopa
663452|NCT00822224|Dementia|dementia
663453|NCT00822263|mild traumatic brain injury|mild traumatic brain injury
663454|NCT00822263|anti-oxidant|anti-oxidant
663455|NCT00822263|early treatment|early treatment
663456|NCT00822276|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
663457|NCT00822276|MRSA|mrsa
663458|NCT00822276|Methicillin-sensitive Staphylococcus aureus|methicillin-sensitive staphylococcus aureus
663459|NCT00822276|MSSA|mssa
663460|NCT00822276|Atopic Dermatitis|atopic dermatitis
663461|NCT00822276|Eczema Herpeticum|eczema herpeticum
663462|NCT00822289|radioactive iodine|radioactive iodine
663463|NCT00822289|Helicobacter pylori|helicobacter pylori
663464|NCT00822289|Thyroid diseases|thyroid diseases
663465|NCT00822289|CagA|caga
663466|NCT00822302|atherosclerosis|atherosclerosis
663467|NCT00822302|stroke|stroke
663468|NCT00822302|ischaemia|ischaemia
663469|NCT00822315|HIV|hiv
663470|NCT00822315|Tuberculosis|tuberculosis
663471|NCT00822315|Pharmacokinetics|pharmacokinetics
663472|NCT00822315|Raltegravir|raltegravir
663473|NCT00822315|France|france
663474|NCT00822315|Brazil|brazil
663475|NCT00822315|treatment naive|treatment naive
663476|NCT00822328|Probiotics|probiotics
663477|NCT00822328|Lactobacillus|lactobacillus
663478|NCT00822328|Intestine|intestine
663479|NCT00822328|Flora|flora
663480|NCT00822354|Secondary Raynaud's Phenomenon|secondary raynaud's phenomenon
663481|NCT00822380|Anemia|anemia
663482|NCT00822380|Iron|iron
663483|NCT00822380|Children|children
663484|NCT00822380|Micronutrients|micronutrients
663485|NCT00828022|measles-positive NSCLC|measles-positive nsclc
663486|NCT00828022|measles vaccine|measles vaccine
663487|NCT00828022|consolidation|consolidation
663488|NCT00828022|Stage 3B with pleural effusion or stage 4 non-small cell lung cancer in remission|stage 3b with pleural effusion or stage 4 non-small cell lung cancer in remission
663489|NCT00828035|robotics|robotics
663490|NCT00828035|laparoscopy|laparoscopy
663491|NCT00828035|surgery|surgery
663492|NCT00828035|computer assisted|computer assisted
663493|NCT00828074|stage IV breast cancer|stage iv breast cancer
663494|NCT00828074|recurrent breast cancer|recurrent breast cancer
663495|NCT00828087|acute myocardial infarction|acute myocardial infarction
663496|NCT00828087|primary percutaneous coronary intervention|primary percutaneous coronary intervention
663497|NCT00828087|drug-eluting stent|drug-eluting stent
663498|NCT00828113|smoking|smoking
663499|NCT00828113|relapse|relapse
663500|NCT00828113|withdrawal|withdrawal
663501|NCT00828126|Metastatic Melanoma|metastatic melanoma
663502|NCT00828126|AJCC Stage III Melanoma|ajcc stage iii melanoma
663503|NCT00828126|AJCC stage IV Melanoma|ajcc stage iv melanoma
663504|NCT00828126|PET-CT|pet-ct
663505|NCT00828126|Positron Emission Tomography-Computed Tomography|positron emission tomography-computed tomography
663506|NCT00828126|Contrast-enhanced Computed Tomography Scan|contrast-enhanced computed tomography scan
663507|NCT00828126|CT|ct
663508|NCT00828126|Conventional Imaging|conventional imaging
663509|NCT00828126|False Positive Rate|false positive rate
663510|NCT00828126|Fluorodeoxyglucose|fluorodeoxyglucose
663511|NCT00828126|FDG|fdg
663512|NCT00828126|Surgery|surgery
663513|NCT00828178|SLE|sle
663514|NCT00828178|atherosclerosis|atherosclerosis
663515|NCT00828178|omega-3|omega-3
663516|NCT00828191|Luteal support in IVF|luteal support in ivf
663517|NCT00828217|adapted physical activity|adapted physical activity
663518|NCT00828217|hospital|hospital
663519|NCT00828217|health-related quality of life|health-related quality of life
663520|NCT00828217|satisfaction with care|satisfaction with care
663521|NCT00828217|child|child
663522|NCT00828217|adolescent|adolescent
663523|NCT00828217|randomized controlled trial|randomized controlled trial
663524|NCT00828217|physical activity|physical activity
663525|NCT00828217|quality of life|quality of life
663526|NCT00828230|budesonide|budesonide
663527|NCT00828230|placebo|placebo
663528|NCT00828230|acute radiation proctitis|acute radiation proctitis
663529|NCT00828230|late radiation proctitis|late radiation proctitis
663530|NCT00828230|Prevention of acute radiation proctitis|prevention of acute radiation proctitis
663531|NCT00828230|Prevention of late radiation proctitis|prevention of late radiation proctitis
663532|NCT00828243|Pulmonary surfactants|pulmonary surfactants
663533|NCT00828243|Pulmonary surfactant associated protein B|pulmonary surfactant associated protein b
663659|NCT00829634|d-MA|d-ma
663534|NCT00828243|Pulmonary surfactant associated protein C|pulmonary surfactant associated protein c
663535|NCT00828243|ATP-binding cassette protein sub member family A3|atp-binding cassette protein sub member family a3
663537|NCT00828256|rotator cuff|rotator cuff
663538|NCT00828256|tears|tears
663539|NCT00828256|shoulder|shoulder
663540|NCT00828256|chronic tear of rotator cuff|chronic tear of rotator cuff
663541|NCT00828269|Patients with Chronic Hepatitis C|patients with chronic hepatitis c
663542|NCT00828282|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
663543|NCT00828282|Simvastatin|simvastatin
663544|NCT00828282|Zocor|zocor
663545|NCT00828295|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
663546|NCT00828295|palonosetron|palonosetron
663547|NCT00828295|pediatric|pediatric
663548|NCT00828308|localized|localized
663549|NCT00828308|high risk|high risk
663550|NCT00828308|prostate cancer|prostate cancer
663551|NCT00828308|neoadjuvant treatment|neoadjuvant treatment
663552|NCT00828321|Bioequivalency|bioequivalency
663553|NCT00828321|Healthy Volunteers|healthy volunteers
663554|NCT00829153|Fistula patency|fistula patency
663555|NCT00829179|Asthma|asthma
663556|NCT00829192|Actinic keratoses (AK)|actinic keratoses (ak)
663557|NCT00829192|Squamous cell carcinomas (SCC)|squamous cell carcinomas (scc)
663558|NCT00829192|CUV1647|cuv1647
663559|NCT00829192|Afamelanotide|afamelanotide
663560|NCT00829192|Clinuvel|clinuvel
663561|NCT00829192|Photoprotection|photoprotection
663562|NCT00829192|Organ transplant|organ transplant
663563|NCT00829205|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
663564|NCT00829218|Irritable Bowel Syndrome|irritable bowel syndrome
663565|NCT00829218|Fibromyalgia|fibromyalgia
663566|NCT00829218|Glutamate|glutamate
663567|NCT00829218|Diet|diet
663568|NCT00829218|Food additives|food additives
663569|NCT00829231|Liver disease|liver disease
663570|NCT00829244|Infertility|infertility
663571|NCT00829244|Assisted reproductive technology|assisted reproductive technology
663572|NCT00829283|Experimental|experimental
663573|NCT00829283|Comparator|comparator
663574|NCT00829296|diabetes|diabetes
663575|NCT00829296|hypertension|hypertension
663576|NCT00829296|aortic impedance|aortic impedance
663577|NCT00829309|Bioequivalence|bioequivalence
663578|NCT00829309|Healthy Subjects|healthy subjects
663579|NCT00829335|Intraoperative ultrasound|intraoperative ultrasound
663580|NCT00829335|Segmentectomy|segmentectomy
663581|NCT00829335|HCC|hcc
663584|NCT00829348|Pharmacotherapy|pharmacotherapy
663585|NCT00829348|Statins|statins
663586|NCT00829361|Telemedicine|telemedicine
663587|NCT00829361|Acute stroke|acute stroke
663588|NCT00829361|Rural|rural
663589|NCT00829361|thrombosis|thrombosis
663590|NCT00829361|consultation|consultation
663591|NCT00829361|Stroke|stroke
663592|NCT00829361|Cerebral Infarction|cerebral infarction
663593|NCT00829361|Vascular diseases|vascular diseases
663594|NCT00829361|brain ischemia|brain ischemia
663595|NCT00829361|brain infarction|brain infarction
663596|NCT00829361|brain diseases|brain diseases
663597|NCT00829361|cerebrovascular disorders|cerebrovascular disorders
663598|NCT00829374|Alzheimer's disease|alzheimer's disease
663599|NCT00829374|clinical trial|clinical trial
663600|NCT00829374|mitochondria|mitochondria
663601|NCT00829374|memory loss|memory loss
663602|NCT00829374|neurodegenerative disease|neurodegenerative disease
663603|NCT00829374|dementia|dementia
663604|NCT00829374|investigational drug|investigational drug
663605|NCT00829387|Diabetes|diabetes
663606|NCT00829387|Pain|pain
663607|NCT00829387|Neuropathic Pain|neuropathic pain
663608|NCT00829400|Neuropsychology|neuropsychology
663609|NCT00829400|Cognitive Remediation|cognitive remediation
663610|NCT00829400|Vocational Rehabilitation|vocational rehabilitation
663611|NCT00829400|Schizophrenia|schizophrenia
663612|NCT00829400|Severe and persistent mental illness|severe and persistent mental illness
663613|NCT00829400|Chronic and disabling mental illness|chronic and disabling mental illness
663614|NCT00829426|Bioequivalence|bioequivalence
663615|NCT00829426|Healthy Subjects|healthy subjects
663616|NCT00829439|Angelman syndrome|angelman syndrome
663617|NCT00829439|Levodopa|levodopa
663618|NCT00829439|Carbidopa|carbidopa
663619|NCT00829439|L-dopa|l-dopa
663620|NCT00829452|Bioequivalence|bioequivalence
663621|NCT00829452|Healthy Subjects|healthy subjects
663622|NCT00829478|Atrial fibrillation|atrial fibrillation
663623|NCT00829478|Cerebrovascular accident|cerebrovascular accident
663624|NCT00829478|Anticoagulation|anticoagulation
663625|NCT00829478|Decision-making|decision-making
663626|NCT00829491|Cardiovascular Disease Prevention|cardiovascular disease prevention
663627|NCT00829491|Behavior change|behavior change
663628|NCT00829491|Risk Reduction|risk reduction
663629|NCT00829504|Bioequivalence|bioequivalence
663630|NCT00829504|Healthy Subjects|healthy subjects
663631|NCT00829517|Contraception|contraception
663632|NCT00829517|sexually transmitted diseases|sexually transmitted diseases
663633|NCT00829530|Bioequivalence|bioequivalence
663634|NCT00829530|Healthy Subjects|healthy subjects
663635|NCT00829543|Spodyloarthropathy|spodyloarthropathy
663636|NCT00829543|Guide-free sacroiliac injection|guide-free sacroiliac injection
663637|NCT00829569|Intralipid|intralipid
663638|NCT00829569|Omegaven|omegaven
663639|NCT00829569|fish oil|fish oil
663640|NCT00829569|hyperinsulinemic isoglycemic clamps|hyperinsulinemic isoglycemic clamps
663641|NCT00829569|C-peptide glucagon test|c-peptide glucagon test
663642|NCT00829569|indirect calorimetry|indirect calorimetry
663643|NCT00829569|F2-isoprostanes|f2-isoprostanes
663644|NCT00829595|inflammatory bowel disease|inflammatory bowel disease
663645|NCT00829595|Crohn disease|crohn disease
663646|NCT00829595|ulcerative colitis|ulcerative colitis
663647|NCT00829595|immunosuppression|immunosuppression
663648|NCT00829595|anti tumor necrosis alpha|anti tumor necrosis alpha
663649|NCT00829595|pneumovax|pneumovax
663650|NCT00829595|pneumococcal vaccine|pneumococcal vaccine
663651|NCT00829608|RRP|rrp
663652|NCT00829608|Recurrent Respiratory Papillomatosis|recurrent respiratory papillomatosis
663653|NCT00829608|HPV vaccine|hpv vaccine
663654|NCT00829608|HPV|hpv
663655|NCT00829621|BMP-2|bmp-2
663656|NCT00829621|Incisional Vacuum Assisted Closure (IVAC)|incisional vacuum assisted closure (ivac)
663657|NCT00829634|methamphetamine|methamphetamine
663658|NCT00829634|inpatient|inpatient
663660|NCT00829634|l-MA|l-ma
663661|NCT00829634|APRL|aprl
663662|NCT00829634|San Francisco|san francisco
663663|NCT00829634|metabolism|metabolism
663664|NCT00829634|Metabolism of methamphetamine|metabolism of methamphetamine
663666|NCT00829647|dasatinib|dasatinib
663667|NCT00829647|lenalidomide|lenalidomide
663668|NCT00829647|sprycel|sprycel
663669|NCT00829647|revlimid|revlimid
663670|NCT00829647|CLL relapsed or refractory to fludarabine|cll relapsed or refractory to fludarabine
663671|NCT00829660|Acarbose|acarbose
663672|NCT00829673|Bioequivalence|bioequivalence
663673|NCT00829673|Healthy Subjects|healthy subjects
663674|NCT00829686|abscess|abscess
663675|NCT00829686|cellulitis|cellulitis
663676|NCT00829686|antibiotics|antibiotics
663677|NCT00829686|MRSA|mrsa
663678|NCT00829699|endothelial function|endothelial function
663679|NCT00829699|fibrinolytic balance|fibrinolytic balance
663680|NCT00829712|Bioequivalence|bioequivalence
663681|NCT00829712|Healthy Subjects|healthy subjects
663682|NCT00829725|subcapital femoral fractures|subcapital femoral fractures
663683|NCT00829725|transcervical femoral fractures|transcervical femoral fractures
663684|NCT00829725|TARGON FN|targon fn
663685|NCT00829738|PPI therapy|ppi therapy
664074|NCT00831259|stroke|stroke
663686|NCT00829738|pantoprazole|pantoprazole
663687|NCT00829738|GERD (Erosive Gastroesophageal Reflux Disease)|gerd (erosive gastroesophageal reflux disease)
663688|NCT00829751|staining|staining
663689|NCT00829751|toxicity|toxicity
663690|NCT00829751|fluorometry|fluorometry
663691|NCT00829751|dye diffusion|dye diffusion
663692|NCT00829751|anterior chamber|anterior chamber
663693|NCT00829764|Bioequivalence|bioequivalence
663694|NCT00829764|Healthy Subjects|healthy subjects
663695|NCT00829777|Naloxone|naloxone
663696|NCT00829777|6β-Naltrexol|6β-naltrexol
663697|NCT00829777|Opioid-dependent|opioid-dependent
663698|NCT00829777|Pharmacokinetics|pharmacokinetics
663699|NCT00829777|peripheral effects of withdrawal|peripheral effects of withdrawal
663700|NCT00829777|central effects of withdrawal|central effects of withdrawal
663701|NCT00829790|Bioequivalence|bioequivalence
663702|NCT00829790|Healthy Subjects|healthy subjects
663703|NCT00829803|To acquire developmental data to prospectively support SNAP|to acquire developmental data to prospectively support snap
663704|NCT00829803|II index ranges at the studied anesthetic states.|ii index ranges at the studied anesthetic states.
663705|NCT00829816|Alzheimers disease|alzheimers disease
663706|NCT00829816|donepezil|donepezil
663707|NCT00829816|memantine|memantine
663708|NCT00829829|Metabolism, Inborn Errors|metabolism, inborn errors
663709|NCT00829829|Allopurinol|allopurinol
663710|NCT00829829|Metabolic Diseases|metabolic diseases
663711|NCT00829829|Genetic Diseases, Inborn|genetic diseases, inborn
663712|NCT00829829|Musculoskeletal Diseases|musculoskeletal diseases
663713|NCT00829829|Joint Diseases|joint diseases
663714|NCT00829829|Arthritis|arthritis
663715|NCT00829829|Rheumatic Diseases|rheumatic diseases
663716|NCT00829829|Metabolic disorder|metabolic disorder
663717|NCT00829829|Purine-Pyrimidine Metabolism, Inborn Errors|purine-pyrimidine metabolism, inborn errors
663718|NCT00829829|Gout|gout
663719|NCT00829842|chlorexidine|chlorexidine
663720|NCT00829842|ventilator-associated pneumonia|ventilator-associated pneumonia
663721|NCT00829842|nosocomial pneumonia|nosocomial pneumonia
663722|NCT00829842|heart surgery|heart surgery
663723|NCT00829842|oral hygiene|oral hygiene
663724|NCT00829855|pulmonary edema|pulmonary edema
663725|NCT00829855|hypertension|hypertension
663726|NCT00829855|echocardiography|echocardiography
663727|NCT00829868|Bioequivalence|bioequivalence
663728|NCT00829868|Healthy Subjects|healthy subjects
663729|NCT00829881|Attention|attention
663730|NCT00829894|Bioequivalence|bioequivalence
663731|NCT00829894|Healthy Subjects|healthy subjects
663732|NCT00829907|Healthy volunteer study|healthy volunteer study
663733|NCT00829920|Bladder cancer|bladder cancer
663734|NCT00829933|Atrial fibrillation|atrial fibrillation
663735|NCT00829933|Factor Xa inhibition|factor xa inhibition
663736|NCT00829946|Strength training|strength training
663737|NCT00829946|Anorexia|anorexia
663738|NCT00829946|Girls|girls
663739|NCT00829946|Quality of life|quality of life
663740|NCT00829946|Functional mobility|functional mobility
663741|NCT00829959|Ovary, Cancer|ovary, cancer
663742|NCT00829959|Ovarian Cancer|ovarian cancer
663743|NCT00829959|Breast Cancer|breast cancer
663744|NCT00829959|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
663745|NCT00829959|HBOC|hboc
663746|NCT00829959|Genetic testing|genetic testing
663747|NCT00829959|Pregnancy|pregnancy
663748|NCT00829959|Fertility|fertility
663749|NCT00829959|Prenatal diagnostic testing|prenatal diagnostic testing
663750|NCT00829985|Rhinitis, Allergic, Perennial|rhinitis, allergic, perennial
663751|NCT00829985|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
663752|NCT00829985|Immunotherapy|immunotherapy
663753|NCT00829985|Asthma|asthma
663754|NCT00829985|Nasal Allergies|nasal allergies
663755|NCT00829985|Hypersensitivity|hypersensitivity
663756|NCT00829998|Bioequivalence|bioequivalence
663757|NCT00829998|Healthy Subjects|healthy subjects
663758|NCT00830011|diabetes|diabetes
663759|NCT00830011|neuropathy|neuropathy
663760|NCT00830011|chronic pain|chronic pain
663761|NCT00830011|Cognitive behavioral therapy|cognitive behavioral therapy
663762|NCT00830024|Bioequivalence|bioequivalence
663763|NCT00830024|Healthy Subjects|healthy subjects
663764|NCT00830037|anemia|anemia
663765|NCT00830037|iron|iron
663766|NCT00830037|kidney disease|kidney disease
663767|NCT00830037|progression|progression
663768|NCT00830037|glomerular filtration rate|glomerular filtration rate
663769|NCT00830050|fMRI functional magnetic resonance imaging Pain|fmri functional magnetic resonance imaging pain
663770|NCT00830063|monoclonal antibody|monoclonal antibody
663771|NCT00830063|RN624|rn624
663772|NCT00830063|PF-04383119|pf-04383119
663773|NCT00830063|nerve growth factor|nerve growth factor
663774|NCT00830063|anti-nerve growth factor|anti-nerve growth factor
663775|NCT00830063|OA|oa
663776|NCT00830063|pain|pain
663777|NCT00830089|Transversus abdominis plane block|transversus abdominis plane block
663778|NCT00830089|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
663779|NCT00830089|Analgesia|analgesia
663780|NCT00830102|Mild to Moderate Asthma|mild to moderate asthma
663781|NCT00830115|PPI therapy|ppi therapy
663782|NCT00830115|Pantoprazole|pantoprazole
663783|NCT00830115|eGERD (Erosive Gastroesophageal Reflux Disease)|egerd (erosive gastroesophageal reflux disease)
663784|NCT00830115|NERD (Non-Erosive Reflux Disease)|nerd (non-erosive reflux disease)
663785|NCT00830141|Ghrelin|ghrelin
663786|NCT00830141|obesity|obesity
663787|NCT00830141|idiopathic short stature (ISS)|idiopathic short stature (iss)
663788|NCT00830154|stutter|stutter
663789|NCT00830154|stuttering|stuttering
663790|NCT00830154|Adults with a history of stuttering|adults with a history of stuttering
663791|NCT00830180|Cancer pain|cancer pain
663792|NCT00830180|NGF|ngf
663793|NCT00830180|open-label extension|open-label extension
663794|NCT00830193|N-acetylcysteine|n-acetylcysteine
663795|NCT00830193|prevention|prevention
663796|NCT00830193|contrast-induced nephropathy|contrast-induced nephropathy
663797|NCT00830193|critically ill adults|critically ill adults
663798|NCT00830206|Bioequivalence|bioequivalence
663799|NCT00830206|Healthy Subjects|healthy subjects
663800|NCT00830219|Bioequivalence|bioequivalence
663801|NCT00830219|Healthy Subjects|healthy subjects
663802|NCT00830232|Stroke|stroke
663803|NCT00830232|Carotid stenosis|carotid stenosis
663804|NCT00830232|stents|stents
663805|NCT00830245|EGFR mutation|egfr mutation
663806|NCT00830245|Erlotinib|erlotinib
663807|NCT00830245|Lung cancer|lung cancer
663808|NCT00830245|leptomeningeal carcinomatosis in EGFR mutation positive non-small cell lung cancer|leptomeningeal carcinomatosis in egfr mutation positive non-small cell lung cancer
663809|NCT00830258|Bioequivalence|bioequivalence
663810|NCT00830258|Healthy Subjects|healthy subjects
663811|NCT00830271|surgical site infection|surgical site infection
663812|NCT00830271|wound complications|wound complications
663813|NCT00830271|suture|suture
663814|NCT00830271|antiseptic|antiseptic
663815|NCT00830271|wound closure|wound closure
663816|NCT00830284|Pediatric Acute Respiratory Distress Syndrome (ARDS)|pediatric acute respiratory distress syndrome (ards)
752399|NCT01172873|DCS|dcs
663817|NCT00830284|Pediatric Acute Lung Injury (ALI)|pediatric acute lung injury (ali)
663818|NCT00830297|TIP|tip
663819|NCT00830297|NODAT|nodat
663820|NCT00830297|hyperglycemia|hyperglycemia
663821|NCT00830297|long-acting insulin|long-acting insulin
663822|NCT00830297|post-transplant hyperglycemia|post-transplant hyperglycemia
663823|NCT00830310|Patient Non-Adherence|patient non-adherence
663824|NCT00830310|Patient Non-Compliance|patient non-compliance
663825|NCT00830310|Patient Nonadherence|patient nonadherence
663826|NCT00830310|Patient Noncompliance|patient noncompliance
663827|NCT00830310|Patient Refusal of Treatment|patient refusal of treatment
663828|NCT00830310|Refusal of Treatment|refusal of treatment
663829|NCT00830310|Treatment Refusal|treatment refusal
663830|NCT00830336|Bioequivalence|bioequivalence
663831|NCT00830336|Healthy Subjects|healthy subjects
663832|NCT00830349|Bioequivalence|bioequivalence
663833|NCT00830349|Healthy Subjects|healthy subjects
663834|NCT00830362|cocaine|cocaine
663835|NCT00830362|cocaine-dependent|cocaine-dependent
663836|NCT00830362|propranolol|propranolol
663837|NCT00830362|craving|craving
663838|NCT00830362|beta-blockade|beta-blockade
663839|NCT00830362|cue exposure|cue exposure
663840|NCT00830362|drug|drug
663841|NCT00830362|addiction|addiction
663842|NCT00830362|memory|memory
663843|NCT00830362|addictive behavior|addictive behavior
663844|NCT00830375|Buying|buying
663845|NCT00830375|Shopping|shopping
663846|NCT00830375|Impulse Control|impulse control
663847|NCT00830388|tinea versicolor|tinea versicolor
663848|NCT00830388|ketoconazole|ketoconazole
663849|NCT00830401|intra-uterine abnormalities|intra-uterine abnormalities
663850|NCT00830401|intracavitary pathology|intracavitary pathology
663851|NCT00830401|hysteroscopy|hysteroscopy
663852|NCT00830401|IVF|ivf
663853|NCT00830401|ICSI|icsi
663854|NCT00830401|polyp|polyp
663855|NCT00830401|myoma|myoma
663856|NCT00830401|adhesion|adhesion
663857|NCT00830401|septum|septum
663858|NCT00830401|endometritis|endometritis
663859|NCT00830414|Bioequivalence|bioequivalence
663860|NCT00830414|Healthy Subjects|healthy subjects
663861|NCT00830427|asthma bronchial diseases|asthma bronchial diseases
663862|NCT00830453|Brain injury with sequelae from stroke, anoxia, or trauma|brain injury with sequelae from stroke, anoxia, or trauma
663863|NCT00830466|port wine stain|port wine stain
663864|NCT00830492|clomiphene citrate|clomiphene citrate
664262|NCT00831701|tamsulosin|tamsulosin
663865|NCT00830492|GnRH agonist|gnrh agonist
663866|NCT00830492|GnRH antagonist|gnrh antagonist
663867|NCT00830492|in vitro fertilization|in vitro fertilization
663868|NCT00830492|clinical pregnancy|clinical pregnancy
663869|NCT00830492|pregnancy|pregnancy
663870|NCT00830505|fluticasone|fluticasone
663871|NCT00830505|salmeterol|salmeterol
663872|NCT00830505|bronchoprotection|bronchoprotection
663873|NCT00830531|Hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
663874|NCT00830531|Neonatal stroke|neonatal stroke
663875|NCT00830531|Intracranial hemorrhage|intracranial hemorrhage
663876|NCT00830531|Perinatal asphyxia|perinatal asphyxia
663877|NCT00830531|Neonatal Seizures|neonatal seizures
663878|NCT00830544|neoadjuvant chemotherapy breast cancer|neoadjuvant chemotherapy breast cancer
663879|NCT00830544|Breast cancer patients with tumors over one cm|breast cancer patients with tumors over one cm
663880|NCT00830557|recurrent pancreatic cancer|recurrent pancreatic cancer
663881|NCT00830557|stage I pancreatic cancer|stage i pancreatic cancer
663882|NCT00830557|stage II pancreatic cancer|stage ii pancreatic cancer
663883|NCT00830557|stage III pancreatic cancer|stage iii pancreatic cancer
663884|NCT00830557|stage IV pancreatic cancer|stage iv pancreatic cancer
663885|NCT00830557|recurrent islet cell carcinoma|recurrent islet cell carcinoma
663886|NCT00830557|pancreatic alpha cell carcinoma|pancreatic alpha cell carcinoma
663887|NCT00830557|pancreatic beta islet cell carcinoma|pancreatic beta islet cell carcinoma
663888|NCT00830557|pancreatic delta cell carcinoma|pancreatic delta cell carcinoma
663889|NCT00830557|pancreatic G-cell carcinoma|pancreatic g-cell carcinoma
663890|NCT00830570|CYP2C9|cyp2c9
663891|NCT00830570|VKORC1|vkorc1
663892|NCT00830570|polymorphism|polymorphism
663893|NCT00830570|warfarin|warfarin
663894|NCT00830570|Coumadin|coumadin
663895|NCT00830609|Chronic Hepatitis C|chronic hepatitis c
663896|NCT00830609|Genotype 3|genotype 3
663897|NCT00830609|High viral load|high viral load
663898|NCT00830622|HIV/AIDS|hiv/aids
663899|NCT00830622|Adherence|adherence
663900|NCT00830622|Antiretroviral Therapy, ART, ARV|antiretroviral therapy, art, arv
663901|NCT00830622|Mobile phone, cell phone, telephone|mobile phone, cell phone, telephone
663902|NCT00830622|Text message, SMS|text message, sms
663903|NCT00830622|Telemedicine|telemedicine
663904|NCT00830622|Africa|africa
663905|NCT00830622|Resource-limited setting|resource-limited setting
663906|NCT00830622|Counseling, support|counseling, support
663907|NCT00830622|treatment experienced|treatment experienced
663908|NCT00830635|long-term effects of cancer treatment|long-term effects of cancer treatment
663909|NCT00830635|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
663910|NCT00830635|depression|depression
663911|NCT00830635|stage IA breast cancer|stage ia breast cancer
663912|NCT00830635|stage IB breast cancer|stage ib breast cancer
663913|NCT00830635|stage II breast cancer|stage ii breast cancer
663914|NCT00830635|stage I prostate cancer|stage i prostate cancer
663915|NCT00830635|stage II prostate cancer|stage ii prostate cancer
663916|NCT00830648|varicella-zoster virus|varicella-zoster virus
663917|NCT00830648|varicella|varicella
663918|NCT00830661|transsphincteric anal fistula|transsphincteric anal fistula
663919|NCT00830661|cryptoglandular origin|cryptoglandular origin
663920|NCT00830661|anal fistula repair|anal fistula repair
663921|NCT00830661|Ligation of Intersphincteric Fistula Track (LIFT) procedure|ligation of intersphincteric fistula track (lift) procedure
663922|NCT00830661|anal fistula plug (Plug)|anal fistula plug (plug)
663923|NCT00830661|surgical repair|surgical repair
663924|NCT00830674|XLH|xlh
663925|NCT00830687|subcapital femoral fractures|subcapital femoral fractures
663926|NCT00830687|transcervical femoral fractures|transcervical femoral fractures
663927|NCT00830687|TARGON FN|targon fn
663928|NCT00830700|ADHD|adhd
663929|NCT00830700|telemental health|telemental health
663930|NCT00830700|TMH|tmh
663931|NCT00830700|telepsychiatry|telepsychiatry
663932|NCT00830700|rural mental health services for children|rural mental health services for children
663933|NCT00830713|vitiligo|vitiligo
663934|NCT00830713|skin transplantation|skin transplantation
663935|NCT00830713|non-cultured|non-cultured
663936|NCT00830713|melanocyte|melanocyte
663937|NCT00830713|surgery|surgery
663938|NCT00830726|Aquaporin|aquaporin
663939|NCT00830726|Epithelial Sodium Channels|epithelial sodium channels
663940|NCT00830726|Heart Failure|heart failure
663941|NCT00830726|Valvular heart disease|valvular heart disease
663942|NCT00830726|Ischemic heart disease|ischemic heart disease
663943|NCT00830739|Smoking Cessation|smoking cessation
663944|NCT00830739|Dopamine|dopamine
663945|NCT00830739|Cognitive Control|cognitive control
663946|NCT00830739|Reward Processing|reward processing
663947|NCT00830739|Varenicline|varenicline
663948|NCT00830752|alexithymia|alexithymia
663949|NCT00830778|pancreas|pancreas
663950|NCT00830778|surgery|surgery
663951|NCT00830778|cancer|cancer
663952|NCT00830778|pancreaticoduodenectomy (PD)|pancreaticoduodenectomy (pd)
663953|NCT00830778|peri-ampullary tumours (ampulla, duodenum, distal bile duct, and miscellaneous tumours)|peri-ampullary tumours (ampulla, duodenum, distal bile duct, and miscellaneous tumours)
663954|NCT00830778|pancreatic tumors|pancreatic tumors
663955|NCT00830778|peri-ampullary tumors|peri-ampullary tumors
663956|NCT00830804|Treatment Naive|treatment naive
663957|NCT00830817|Topical cream application|topical cream application
663958|NCT00830817|Mild to moderate psoriasis|mild to moderate psoriasis
663959|NCT00830843|SAH|sah
663960|NCT00830843|sedation|sedation
663961|NCT00830843|anesthesia|anesthesia
663962|NCT00830856|Cryptococcal Meningitis|cryptococcal meningitis
663963|NCT00830856|HIV|hiv
663964|NCT00830856|Fluconazole|fluconazole
663965|NCT00830856|Antiretroviral therapy|antiretroviral therapy
663966|NCT00830856|Africa|africa
663967|NCT00830856|treatment naive|treatment naive
663968|NCT00830882|asthma|asthma
663969|NCT00830882|levosalbutamol|levosalbutamol
663970|NCT00830882|genotype|genotype
663971|NCT00830882|bronchoprotection|bronchoprotection
663972|NCT00830895|Renal cell carcinoma|renal cell carcinoma
663973|NCT00830895|Non-clear cell|non-clear cell
663974|NCT00830895|RAD001|rad001
663975|NCT00830895|Metastatic, non-clear cell, renal cell carcinoma|metastatic, non-clear cell, renal cell carcinoma
663976|NCT00830908|seborrheic dermatitis|seborrheic dermatitis
663977|NCT00830921|Histocytologically proven thoracic malignancy|histocytologically proven thoracic malignancy
663978|NCT00830934|pelvic girdle pain|pelvic girdle pain
663979|NCT00830934|symphysio pubic dysfunction|symphysio pubic dysfunction
663980|NCT00830934|group care|group care
663981|NCT00830934|individual care|individual care
663982|NCT00830947|Orthodontic|orthodontic
663983|NCT00830947|Extraction|extraction
663984|NCT00830947|Device|device
663985|NCT00830947|Space Closure|space closure
663986|NCT00830947|Orthodontic malocclusion|orthodontic malocclusion
663987|NCT00830973|Estrogen Antagonists|estrogen antagonists
663988|NCT00830973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
663989|NCT00830973|Hormone Antagonists|hormone antagonists
663990|NCT00830973|Hormones|hormones
663991|NCT00830973|Hormone Substitutes|hormone substitutes
663992|NCT00830973|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
663993|NCT00830973|Estrogen Receptor Modulators|estrogen receptor modulators
663994|NCT00830973|Neoplasms|neoplasms
663995|NCT00830973|Neoplasms by Site|neoplasms by site
663996|NCT00830986|Mental Cognition Change|mental cognition change
663997|NCT00830986|Fat Embolism|fat embolism
663998|NCT00830986|Bone Marrow Debris Emboli|bone marrow debris emboli
663999|NCT00830986|Computer Assisted Total Knee Arthroplasty|computer assisted total knee arthroplasty
664000|NCT00830986|Conventional Instrumented Total Knee Arthroplasty|conventional instrumented total knee arthroplasty
664001|NCT00830999|fat metabolism|fat metabolism
664002|NCT00830999|exercise|exercise
664003|NCT00830999|liver|liver
664004|NCT00830999|lipoproteins|lipoproteins
664005|NCT00830999|triglycerides|triglycerides
664006|NCT00831012|Dengue Vaccine|dengue vaccine
664007|NCT00831012|Dengue Virus|dengue virus
664008|NCT00831012|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
664009|NCT00831012|Dengue Shock Syndrome|dengue shock syndrome
664010|NCT00831025|Immunotherapy|immunotherapy
664011|NCT00831025|Allergoid|allergoid
664012|NCT00831025|Depigmented|depigmented
664013|NCT00831025|Polymerized|polymerized
664014|NCT00831025|Allergen-extract|allergen-extract
664015|NCT00831025|Rhinoconjunctivitis|rhinoconjunctivitis
664016|NCT00831038|pulmonary function tests|pulmonary function tests
664017|NCT00831038|infants|infants
664018|NCT00831038|chronic lung disease|chronic lung disease
664019|NCT00831038|dysphagia|dysphagia
664020|NCT00831038|chronic aspiration|chronic aspiration
664021|NCT00831051|Bunionectomy|bunionectomy
664022|NCT00831064|bowel preparation quality|bowel preparation quality
664024|NCT00831077|Healthy volunteers|healthy volunteers
664025|NCT00831103|EPB348|epb348
664026|NCT00831103|Valomaciclovir Stearate|valomaciclovir stearate
664027|NCT00831103|Valacyclovir|valacyclovir
664028|NCT00831103|Herpes Zoster|herpes zoster
664029|NCT00831103|Shingles|shingles
664030|NCT00831116|near infrared spectroscopy|near infrared spectroscopy
664031|NCT00831116|LipiScan|lipiscan
664032|NCT00831116|lipid core|lipid core
664033|NCT00831116|percutaneous coronary intervention|percutaneous coronary intervention
664034|NCT00831116|myocardial infarction|myocardial infarction
664035|NCT00831116|NIRS|nirs
664036|NCT00831116|intravascular imaging|intravascular imaging
664037|NCT00831142|Prostate Cancer|prostate cancer
664039|NCT00831142|Prostatectomy|prostatectomy
664040|NCT00831155|smoking|smoking
664041|NCT00831155|nicotine patches|nicotine patches
664042|NCT00831155|extinction based treatment|extinction based treatment
664043|NCT00831168|neonatal|neonatal
664044|NCT00831168|premature babies|premature babies
664045|NCT00831168|healthcare research|healthcare research
664046|NCT00831168|Babies born before 27 weeks gestation|babies born before 27 weeks gestation
664047|NCT00831181|stage II rectal cancer|stage ii rectal cancer
664048|NCT00831181|stage III rectal cancer|stage iii rectal cancer
664049|NCT00831181|adenocarcinoma of the rectum|adenocarcinoma of the rectum
664050|NCT00831194|Type 2 Diabetes|type 2 diabetes
664051|NCT00831194|Obesity|obesity
664052|NCT00831194|Weight loss|weight loss
664053|NCT00831194|PDA|pda
664054|NCT00831194|Stress|stress
664055|NCT00831194|Dietary lapse|dietary lapse
664056|NCT00831194|salivary alpha amylase|salivary alpha amylase
664057|NCT00831207|B-2 microglobulin|b-2 microglobulin
664058|NCT00831207|Serum cytokines|serum cytokines
664059|NCT00831207|HIV-1|hiv-1
664060|NCT00831207|Resistance|resistance
664061|NCT00831207|HAART|haart
664062|NCT00831207|Therapeutic failure|therapeutic failure
664063|NCT00831207|Genotyping.|genotyping.
664064|NCT00831220|COPD|copd
664065|NCT00831220|exacerbations|exacerbations
664066|NCT00831220|EPCs|epcs
664067|NCT00831220|Erythropoietin|erythropoietin
664068|NCT00831220|C-RP|c-rp
664069|NCT00831220|COPD and endothelial dysfunction|copd and endothelial dysfunction
664070|NCT00831246|Ileus,|ileus,
664071|NCT00831246|Gynecologic surgery,|gynecologic surgery,
664072|NCT00831246|Post-operative,|post-operative,
664073|NCT00831246|Flatus|flatus
664077|NCT00831285|Healthy volunteers|healthy volunteers
664078|NCT00831298|alzheimer disease|alzheimer disease
664079|NCT00831298|sleep disturbance|sleep disturbance
664080|NCT00831298|apathy|apathy
664081|NCT00831298|memory loss|memory loss
664082|NCT00831311|Diphtheria|diphtheria
664083|NCT00831311|Tetanus|tetanus
664084|NCT00831311|Pertussis|pertussis
664085|NCT00831311|Whooping cough|whooping cough
664086|NCT00831311|Hepatitis B|hepatitis b
664087|NCT00831311|Poliomyelitis|poliomyelitis
664088|NCT00831311|Haemophilus influenzae type b|haemophilus influenzae type b
664089|NCT00831337|VSL3|vsl3
664090|NCT00831337|Probiotics|probiotics
664091|NCT00831337|Gut microbiota|gut microbiota
664092|NCT00831337|Cytokines|cytokines
664093|NCT00831337|Portal hypertension|portal hypertension
664094|NCT00831337|Chemokines|chemokines
664095|NCT00831337|Liver cirrhosis|liver cirrhosis
664096|NCT00831350|RVO|rvo
664097|NCT00831350|PVD|pvd
664098|NCT00831363|gait analysis|gait analysis
664099|NCT00831363|minimal invasive approach|minimal invasive approach
664100|NCT00831363|transgluteal approach|transgluteal approach
664101|NCT00831363|THA|tha
664102|NCT00831376|Asthma|asthma
664103|NCT00831376|Genotype|genotype
664104|NCT00831376|Beta2adrenoreceptor|beta2adrenoreceptor
664105|NCT00831376|Levosalbutamol|levosalbutamol
664106|NCT00831402|woman|woman
664107|NCT00831415|Open-label Long-term extension study|open-label long-term extension study
664108|NCT00831428|asthma|asthma
664109|NCT00831428|rhinitis|rhinitis
664110|NCT00831428|swimmers|swimmers
664111|NCT00831428|mannitol|mannitol
664112|NCT00831441|NOS|nos
664113|NCT00831467|Hormonal refractory prostate cancer|hormonal refractory prostate cancer
664114|NCT00831467|RNA vaccine|rna vaccine
664115|NCT00831480|Renal cell carcinoma|renal cell carcinoma
664116|NCT00831480|Everolimus|everolimus
664117|NCT00831480|Neoadjuvant|neoadjuvant
664118|NCT00831480|advanced kidney cancer|advanced kidney cancer
664119|NCT00831493|Pancreas|pancreas
664120|NCT00831493|Pancreatic Cancer|pancreatic cancer
664121|NCT00831493|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
664122|NCT00831493|LAPC|lapc
664123|NCT00831493|Non-Metastatic|non-metastatic
664124|NCT00831493|Unresectable|unresectable
664125|NCT00831493|Vorinostat|vorinostat
664126|NCT00831493|XRT|xrt
664127|NCT00831493|RT|rt
664128|NCT00831493|Radiation Therapy|radiation therapy
664129|NCT00831493|SAHA|saha
664130|NCT00831493|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
664131|NCT00831493|MSK-390|msk-390
664132|NCT00831506|digoxin dimebon drug-drug interaction study|digoxin dimebon drug-drug interaction study
664133|NCT00831532|Dimebon Hepatic Impairment|dimebon hepatic impairment
664134|NCT00831571|oxaliplatin|oxaliplatin
664135|NCT00831571|hypersensitivity|hypersensitivity
664136|NCT00831597|Lymphoma|lymphoma
664137|NCT00831597|B-Cell|b-cell
664138|NCT00831610|bariatric surgery|bariatric surgery
664139|NCT00831610|plastic surgery|plastic surgery
664140|NCT00831610|abdominal wall|abdominal wall
664141|NCT00831610|skin|skin
664142|NCT00831610|sensation|sensation
664143|NCT00831610|abdominoplasty|abdominoplasty
664144|NCT00831623|hypofractionation|hypofractionation
664145|NCT00831623|proton beam radiation|proton beam radiation
664146|NCT00831636|CP-4055|cp-4055
664147|NCT00831636|Cancer|cancer
664148|NCT00831636|Metastatic|metastatic
664149|NCT00831636|Solid tumors|solid tumors
664150|NCT00831636|advanced ovarian cancer|advanced ovarian cancer
664151|NCT00831636|stage III and IV ovarian cancer|stage iii and iv ovarian cancer
664152|NCT00831636|advanced epithelian ovarian cancer|advanced epithelian ovarian cancer
664153|NCT00825227|Cancer|cancer
664154|NCT00825227|Fatigue|fatigue
664155|NCT00825227|Taxanes|taxanes
664156|NCT00825240|Colorectal Cancer|colorectal cancer
664157|NCT00825240|Cancer Survivorship Study|cancer survivorship study
664158|NCT00825240|Questionnaires|questionnaires
664159|NCT00825240|Survivorship|survivorship
664160|NCT00825240|Survivor Health|survivor health
664161|NCT00825240|Health Promotion|health promotion
664162|NCT00825240|Behavior Changes|behavior changes
664263|NCT00831701|ureter|ureter
664163|NCT00825240|Computer-assisted intervention program|computer-assisted intervention program
664164|NCT00825266|pulmonary hypertension & insulin resistance|pulmonary hypertension & insulin resistance
664165|NCT00825279|Biodegradable polymer|biodegradable polymer
664166|NCT00825279|Drug Eluting Stent|drug eluting stent
664167|NCT00825279|In stent restenosis|in stent restenosis
664168|NCT00825279|stent thrombosis|stent thrombosis
664169|NCT00825279|Bare Metal Stent|bare metal stent
664170|NCT00825292|colon polyps, colon adenomas|colon polyps, colon adenomas
664171|NCT00825305|vaccine|vaccine
664172|NCT00825305|prevention|prevention
664173|NCT00825305|rabies|rabies
664174|NCT00825305|Rabies disease|rabies disease
664175|NCT00825318|End-stage renal disease|end-stage renal disease
664176|NCT00825318|Chronic kidney disease|chronic kidney disease
664177|NCT00825318|Hemodialysis|hemodialysis
664178|NCT00825331|guide wire|guide wire
664179|NCT00825331|cardiac catheterization|cardiac catheterization
664377|NCT00832780|SBRT|sbrt
664180|NCT00825331|ultrasound-guided examination of the access site|ultrasound-guided examination of the access site
664181|NCT00825331|graduated scheme|graduated scheme
664182|NCT00825331|elective and non elective cardiac catheterization|elective and non elective cardiac catheterization
664183|NCT00825344|postoperative pain|postoperative pain
664184|NCT00825344|inguinal hernia|inguinal hernia
664185|NCT00825344|chronic postsurgical pain|chronic postsurgical pain
664186|NCT00825344|cytokine|cytokine
664187|NCT00825344|preemptive analgesia|preemptive analgesia
664188|NCT00825344|patients with inguinal hernia scheduled for surgery|patients with inguinal hernia scheduled for surgery
664189|NCT00825357|biological markers|biological markers
664191|NCT00825357|acute lung injury|acute lung injury
664192|NCT00825370|Hydromorphone|hydromorphone
664193|NCT00825370|acute pain|acute pain
664194|NCT00825370|Protocolized|protocolized
664195|NCT00825370|Efficacy|efficacy
664196|NCT00825370|Safety|safety
664197|NCT00825383|Diabetes|diabetes
664198|NCT00825383|lipids|lipids
664199|NCT00825383|fiber|fiber
664200|NCT00825422|Posterior lumbar arthrodesis|posterior lumbar arthrodesis
664201|NCT00825422|Degenerative spine|degenerative spine
664202|NCT00825422|Postoperative analgesia|postoperative analgesia
664203|NCT00825422|Local anesthesic|local anesthesic
664204|NCT00825422|Continuous wound infusion catheter|continuous wound infusion catheter
664205|NCT00825422|Pain|pain
664206|NCT00825422|lumbar vertebrae|lumbar vertebrae
664207|NCT00825422|Spinal fusion|spinal fusion
664208|NCT00825435|Coronary CT angiogram|coronary ct angiogram
664209|NCT00825435|Cardiac imaging|cardiac imaging
664210|NCT00825435|Cost analysis|cost analysis
664211|NCT00825435|acute chest pain|acute chest pain
664212|NCT00825435|risk stratification|risk stratification
664213|NCT00825435|cumulative costs over 90-days of providing treatment services|cumulative costs over 90-days of providing treatment services
664214|NCT00825448|alcohol addiction|alcohol addiction
664215|NCT00825461|Anorexia Nervosa|anorexia nervosa
664216|NCT00825474|small hepatocellular carcinoma|small hepatocellular carcinoma
664217|NCT00825474|partial hepatectomy|partial hepatectomy
664218|NCT00825474|TACE plus PEI|tace plus pei
664219|NCT00825487|metastatic|metastatic
664220|NCT00825487|hematologic|hematologic
664221|NCT00825487|malignancy|malignancy
664222|NCT00825487|multiple|multiple
664223|NCT00825487|myeloma|myeloma
664224|NCT00825487|malignant|malignant
664225|NCT00825487|lymphoma|lymphoma
664226|NCT00825487|chronic|chronic
664227|NCT00825487|lymphocytic|lymphocytic
664229|NCT00825487|acute|acute
664230|NCT00825487|myelogenous|myelogenous
664231|NCT00825487|promyelocytic|promyelocytic
664232|NCT00825487|dose escalation|dose escalation
664233|NCT00825487|safety|safety
664234|NCT00825487|tolerability|tolerability
664235|NCT00825487|pharmacodynamics|pharmacodynamics
664236|NCT00825487|tumor|tumor
664237|NCT00825487|PK|pk
664238|NCT00825500|Migraine headache|migraine headache
664239|NCT00825500|Loxapine|loxapine
664240|NCT00825500|Staccato|staccato
664241|NCT00825526|Mindfulness Based Stress Reduction (MBSR)|mindfulness based stress reduction (mbsr)
664242|NCT00825526|Stress Reduction|stress reduction
664243|NCT00825526|hypertension|hypertension
664244|NCT00825526|high blood pressure|high blood pressure
664245|NCT00825526|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
664246|NCT00825539|Schizophrenia|schizophrenia
664247|NCT00825539|Manic depression|manic depression
664248|NCT00825539|anxiety|anxiety
664249|NCT00831675|Influenza|influenza
664250|NCT00831675|Fluzone® vaccine|fluzone® vaccine
664251|NCT00831675|Infants|infants
664252|NCT00831675|Toddlers|toddlers
664253|NCT00831688|Meniere|meniere
664254|NCT00831688|vertigo|vertigo
664255|NCT00831688|overpressure treatment|overpressure treatment
664256|NCT00831688|caloric irrigation|caloric irrigation
664257|NCT00831688|hearing levels|hearing levels
664258|NCT00831688|vertigo severity|vertigo severity
664259|NCT00831688|functional disability scale|functional disability scale
664260|NCT00831701|Adrenergic alpha antagonists|adrenergic alpha antagonists
664261|NCT00831701|drug therapy|drug therapy
664264|NCT00831714|Prophylaxis of Venous Thromboembolism|prophylaxis of venous thromboembolism
664265|NCT00831727|expressive writing|expressive writing
664266|NCT00831727|trauma|trauma
664267|NCT00831727|intervention|intervention
664268|NCT00831727|posttraumatic stress|posttraumatic stress
664269|NCT00831740|Stroke|stroke
664270|NCT00831740|Communication|communication
664271|NCT00831740|Speech and Language Therapy|speech and language therapy
664272|NCT00831753|Diphtheria|diphtheria
664273|NCT00831753|Tetanus|tetanus
664274|NCT00831753|Pertussis|pertussis
664275|NCT00831753|whooping cough|whooping cough
664276|NCT00831753|Haemophilus influenzae type b|haemophilus influenzae type b
664277|NCT00831753|Hepatitis B|hepatitis b
664278|NCT00831753|Poliomyelitis|poliomyelitis
664279|NCT00831766|Hematopoietic|hematopoietic
664280|NCT00831766|Myeloid and Monocytic Leukemia|myeloid and monocytic leukemia
664281|NCT00831766|AML|aml
664282|NCT00831792|Prostate Cancer|prostate cancer
664283|NCT00831792|Advanced Prostate Cancer|advanced prostate cancer
664284|NCT00831792|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
664285|NCT00831792|Prostate Specific Antigen|prostate specific antigen
664286|NCT00831792|PSA|psa
664287|NCT00831792|Castration-Resistant Prostate Cancer Patients|castration-resistant prostate cancer patients
664288|NCT00831792|TK1258|tk1258
664289|NCT00831792|CHIR-258|chir-258
664290|NCT00831805|geriatrics|geriatrics
664291|NCT00831805|psycho-cognitive troubles|psycho-cognitive troubles
664292|NCT00831805|elderly|elderly
664293|NCT00831805|mobile unit|mobile unit
664294|NCT00831805|elderly patients|elderly patients
664295|NCT00831818|breastfeeding|breastfeeding
664296|NCT00831818|ghrelin|ghrelin
664297|NCT00831818|PYY|pyy
664298|NCT00831818|appetite-regulation|appetite-regulation
664299|NCT00831831|perinatal|perinatal
664300|NCT00831831|intimate partner violence|intimate partner violence
664301|NCT00831831|randomized controlled trial|randomized controlled trial
664302|NCT00831831|preterm|preterm
664303|NCT00831831|hemorrhage|hemorrhage
664304|NCT00831831|safety|safety
664305|NCT00831870|EndoSure Sensor|endosure sensor
664306|NCT00831870|s2 Sensor|s2 sensor
664307|NCT00831870|abdominal aortic aneurysm|abdominal aortic aneurysm
664308|NCT00831883|Adolescent|adolescent
664309|NCT00831883|Adolescent behavior|adolescent behavior
664310|NCT00831883|Health behavior|health behavior
664311|NCT00831883|Sexual Behavior|sexual behavior
664312|NCT00831883|Incarceration|incarceration
664313|NCT00831883|Behavioral Intervention|behavioral intervention
664314|NCT00831883|Risk Reduction Behavior|risk reduction behavior
664315|NCT00831909|Lung Cancer|lung cancer
664316|NCT00831909|NSCLC management|nsclc management
664317|NCT00831909|NSCLC use of health care resources|nsclc use of health care resources
664318|NCT00831922|Rheumatoid Arthritis|rheumatoid arthritis
664319|NCT00831922|DMARD failure|dmard failure
664320|NCT00831922|ACR|acr
664321|NCT00831935|Acoustic properties of voice in depression|acoustic properties of voice in depression
664322|NCT00831961|Antibiotic resistance, Conjunctival flora, Intravitreal injections|antibiotic resistance, conjunctival flora, intravitreal injections
664323|NCT00831974|mastocytosis|mastocytosis
664324|NCT00831974|indolent|indolent
664325|NCT00831974|handicap|handicap
664326|NCT00831974|wild-type|wild-type
664327|NCT00831974|systemic|systemic
664328|NCT00831974|not D816V mutated|not d816v mutated
664329|NCT00832663|Muscle regeneration|muscle regeneration
664330|NCT00832663|Satellite cells|satellite cells
664331|NCT00832663|electrical stimulation|electrical stimulation
664332|NCT00832663|eccentric contractions|eccentric contractions
664333|NCT00832663|myogenic precursor cells|myogenic precursor cells
664334|NCT00832676|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
664335|NCT00832676|Peer support|peer support
664336|NCT00832676|Early inflammatory arthritis|early inflammatory arthritis
664337|NCT00832676|Self-management|self-management
664338|NCT00832676|Patient education|patient education
664339|NCT00832689|toxicity|toxicity
664340|NCT00832702|Cardiac|cardiac
664341|NCT00832702|MRI|mri
664342|NCT00832702|Coronary Vascular Dysfunction|coronary vascular dysfunction
664343|NCT00832715|Lung|lung
664344|NCT00832715|Lung Cancer|lung cancer
664345|NCT00832715|NSCLC|nsclc
664346|NCT00832715|Non Small Cell Lung Cancer|non small cell lung cancer
664347|NCT00832715|Squamous Cell|squamous cell
664348|NCT00832715|Adenocarcinoma|adenocarcinoma
664349|NCT00832715|Large Cell|large cell
664350|NCT00832715|Endobronchial Ultrasound Transbronchial Needle Aspiration|endobronchial ultrasound transbronchial needle aspiration
664351|NCT00832715|Mediastinal lymph node negative disease|mediastinal lymph node negative disease
664352|NCT00832715|Mediastinal Nodal Metastasis|mediastinal nodal metastasis
664353|NCT00832715|EBUS-FNA|ebus-fna
664354|NCT00832715|Endobronchial Ultrasound Fine Needle Aspiration|endobronchial ultrasound fine needle aspiration
664355|NCT00832715|EBUS guided needle mediastinal lymph node biopsy|ebus guided needle mediastinal lymph node biopsy
664356|NCT00832715|Biopsy|biopsy
664357|NCT00832715|PET scan|pet scan
664358|NCT00832715|Positron Emission Tomography|positron emission tomography
664359|NCT00832715|CT Scans|ct scans
664546|NCT00833547|motor skill|motor skill
664360|NCT00832715|Computed Tomography Scans|computed tomography scans
664361|NCT00832715|Lymph node|lymph node
664362|NCT00832715|Mediastinoscopy|mediastinoscopy
664363|NCT00832715|Bronchoscope|bronchoscope
664364|NCT00832741|GLP-1|glp-1
664365|NCT00832741|Type 1 diabetes|type 1 diabetes
664366|NCT00832741|Glycemic control|glycemic control
664367|NCT00832741|Incretin hormone|incretin hormone
664368|NCT00832754|malaria|malaria
664369|NCT00832754|rapid diagnostic test|rapid diagnostic test
664370|NCT00832754|artemisinin|artemisinin
664371|NCT00832754|Ghana|ghana
664372|NCT00832767|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
664373|NCT00832767|Single Incision Laparoscopic Surgery|single incision laparoscopic surgery
664374|NCT00832767|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
664375|NCT00832780|Lung cancer|lung cancer
664376|NCT00832780|radiation therapy|radiation therapy
664378|NCT00832780|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
664379|NCT00832780|Tomotherapy|tomotherapy
664380|NCT00832780|other solid tumors|other solid tumors
664381|NCT00832793|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
664382|NCT00832793|Peer support|peer support
664383|NCT00832793|Early inflammatory arthritis|early inflammatory arthritis
664384|NCT00832793|Self-management|self-management
664385|NCT00832793|Patient education|patient education
664386|NCT00832806|smoking|smoking
664387|NCT00832806|Champix|champix
664388|NCT00832806|Integrated Voice Response technology|integrated voice response technology
664389|NCT00832819|Cancer|cancer
664390|NCT00832819|Lung Cancer|lung cancer
664391|NCT00832832|Glaucoma|glaucoma
664392|NCT00832832|Eye drop|eye drop
664393|NCT00832832|Intraocular pressure|intraocular pressure
664394|NCT00832832|Eyelid closure|eyelid closure
664395|NCT00832845|Late-life schizophrenia (LLS)|late-life schizophrenia (lls)
664396|NCT00832845|Cognitive Behavioural Social Skills Training (CBSST)|cognitive behavioural social skills training (cbsst)
664397|NCT00832845|Randomized|randomized
664398|NCT00832871|Mifepristone|mifepristone
664399|NCT00832871|RU-486|ru-486
664400|NCT00832871|Compassionate Use|compassionate use
664401|NCT00832871|Antiprogesterone|antiprogesterone
664402|NCT00832884|partial|partial
664403|NCT00832884|onset|onset
664404|NCT00832884|epilepsy|epilepsy
664405|NCT00832884|pediatric|pediatric
664406|NCT00832884|lacosamide|lacosamide
664407|NCT00832884|partial onset epilepsy|partial onset epilepsy
664408|NCT00832884|vimpat|vimpat
664409|NCT00832897|Keratoconus|keratoconus
664410|NCT00832897|riboflavin|riboflavin
664411|NCT00832897|cornea|cornea
664412|NCT00832897|crosslinking|crosslinking
664413|NCT00832910|Body image|body image
664414|NCT00832910|Rheumatoid Arthritis|rheumatoid arthritis
664415|NCT00832923|parental empowerment|parental empowerment
664416|NCT00832923|parent self-efficacy|parent self-efficacy
664417|NCT00832949|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
664418|NCT00832949|Peer support|peer support
664419|NCT00832949|Early inflammatory arthritis|early inflammatory arthritis
664420|NCT00832949|Self-management|self-management
664421|NCT00832949|Patient education|patient education
664422|NCT00832962|Rhesus D|rhesus d
664423|NCT00832962|Anti-D allo-immunization|anti-d allo-immunization
664424|NCT00832962|Fetal RHD genotyping|fetal rhd genotyping
664425|NCT00832962|anti-D immunoglobulins|anti-d immunoglobulins
664426|NCT00832962|anti-D prophylaxis|anti-d prophylaxis
664427|NCT00832988|pacing thresholds|pacing thresholds
664428|NCT00832988|sensing|sensing
664429|NCT00832988|impedance|impedance
664430|NCT00833001|Anterior vaginal prolapse (medial, lateral,apical cystocele)|anterior vaginal prolapse (medial, lateral,apical cystocele)
664431|NCT00833001|Posterior vaginal prolapse (rectocele and/or enterocele)|posterior vaginal prolapse (rectocele and/or enterocele)
664432|NCT00833001|Vault prolapse (enterocele, uterine/vaginal vault prolapse)|vault prolapse (enterocele, uterine/vaginal vault prolapse)
664433|NCT00833040|Cancer breakthrough pain|cancer breakthrough pain
664434|NCT00833066|hay fever|hay fever
664435|NCT00833066|grass pollen allergy|grass pollen allergy
664436|NCT00833079|Atopic Dermatitis|atopic dermatitis
664437|NCT00833092|magnesium|magnesium
664438|NCT00833092|Nutritional Requirements|nutritional requirements
664439|NCT00833092|Sleep|sleep
664440|NCT00833105|Incomplete Spinal Cord Injury|incomplete spinal cord injury
664441|NCT00833105|Rehabilitation|rehabilitation
664442|NCT00833105|Upper Extremity|upper extremity
664443|NCT00833105|AMES device|ames device
664444|NCT00833105|Incomplete SCI|incomplete sci
664445|NCT00833105|Quadriplegia|quadriplegia
664446|NCT00833118|Surgery|surgery
664447|NCT00833118|General Anesthesia|general anesthesia
664448|NCT00833118|Intubation|intubation
664449|NCT00833131|Rectal cancer|rectal cancer
664450|NCT00833131|Preoperative radiotherapy and consolidating chemotherapy|preoperative radiotherapy and consolidating chemotherapy
664451|NCT00833144|heart failure|heart failure
664452|NCT00833144|dyspnea|dyspnea
664453|NCT00833144|ultrasound|ultrasound
664454|NCT00833157|Knee Osteoarthritis|knee osteoarthritis
664455|NCT00833157|exercise|exercise
664456|NCT00833157|strength training|strength training
664457|NCT00833157|Glucosamine|glucosamine
664458|NCT00833157|Dietary supplement|dietary supplement
664459|NCT00833157|Ibuprofen|ibuprofen
664460|NCT00833157|NSAID|nsaid
664461|NCT00833170|pediatric inflammatory bowel disease|pediatric inflammatory bowel disease
664462|NCT00833170|multiple site study|multiple site study
664463|NCT00833209|Orbitofrontal cortex|orbitofrontal cortex
664464|NCT00833209|Medication Overuse Headache|medication overuse headache
664465|NCT00833209|Chronic headache|chronic headache
664466|NCT00833209|withdrawal|withdrawal
664467|NCT00833222|premature birth|premature birth
664468|NCT00833261|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
664469|NCT00833261|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
664470|NCT00833261|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
665106|NCT00829114|DMC|dmc
664471|NCT00833261|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
664472|NCT00833261|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
664473|NCT00833261|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
664474|NCT00833261|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
664475|NCT00833261|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
664476|NCT00833261|tongue cancer|tongue cancer
664477|NCT00833287|immunoregulatory|immunoregulatory
664478|NCT00833287|dysfunction|dysfunction
664479|NCT00833287|obesity|obesity
664480|NCT00833300|Delirium|delirium
664481|NCT00833300|Agitation|agitation
664482|NCT00833300|Intensive Care|intensive care
664483|NCT00833300|Critical Care|critical care
664484|NCT00833300|Antipsychotics|antipsychotics
664485|NCT00833300|Olanzapine|olanzapine
664486|NCT00833300|Haloperidol|haloperidol
664487|NCT00833313|Atrial fibrillation|atrial fibrillation
664488|NCT00833313|Gene expression|gene expression
664489|NCT00833313|Genetic|genetic
664490|NCT00833365|premature infants|premature infants
664491|NCT00833365|PDA|pda
664492|NCT00833365|ibuprofen|ibuprofen
664493|NCT00833378|Drug interaction, SB-497115 (eltrombopag), Kaletra (Lopinavir, Ritonavir),thrombocytopenia, pharmacokinetics|drug interaction, sb-497115 (eltrombopag), kaletra (lopinavir, ritonavir),thrombocytopenia, pharmacokinetics
664494|NCT00833391|healthy volunteer|healthy volunteer
664495|NCT00833391|formulations|formulations
664496|NCT00833391|bioavailability|bioavailability
664497|NCT00833391|pharmacokinetics|pharmacokinetics
664498|NCT00833404|Smoking|smoking
664499|NCT00833404|Smoking Cessation|smoking cessation
664500|NCT00833404|Quit Smoking|quit smoking
664501|NCT00833404|Stop Smoking|stop smoking
664502|NCT00833404|Nicotine Patch|nicotine patch
664503|NCT00833404|Nicotine Replacement Therapy|nicotine replacement therapy
664504|NCT00833404|Sexual Functioning|sexual functioning
664505|NCT00833404|Erectile Functioning|erectile functioning
664506|NCT00833404|Sexual Health|sexual health
664507|NCT00833417|BCC|bcc
664508|NCT00833417|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
664509|NCT00833417|Hedgehog|hedgehog
664510|NCT00833417|Basal Cell Cancer|basal cell cancer
664511|NCT00833430|AVN|avn
664512|NCT00833430|Femoral Head Collapse|femoral head collapse
664513|NCT00833443|Methamphetamine|methamphetamine
664514|NCT00833443|Addiction|addiction
664515|NCT00833443|Pharmacogenomics|pharmacogenomics
664516|NCT00833443|Amphetamine|amphetamine
664517|NCT00833443|Bupropion|bupropion
664518|NCT00833443|Meth|meth
664519|NCT00833443|Crank|crank
664520|NCT00833443|Crystal|crystal
664521|NCT00833456|schizophrenia|schizophrenia
664522|NCT00833456|Seroquel SR|seroquel sr
664523|NCT00833456|atypical antipsychotics|atypical antipsychotics
664524|NCT00833456|assessment of functioning|assessment of functioning
664525|NCT00833456|GAF scale|gaf scale
664526|NCT00833469|women|women
664527|NCT00833469|postpartum depression|postpartum depression
664528|NCT00833469|anxiety|anxiety
664529|NCT00833508|Exercise capacity|exercise capacity
664530|NCT00833508|Chemoradiotherapy|chemoradiotherapy
664531|NCT00833508|Colorectal cancer|colorectal cancer
664532|NCT00833521|Bioequivalence|bioequivalence
664533|NCT00833521|Healthy Subjects|healthy subjects
664534|NCT00833534|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
664535|NCT00833534|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
664536|NCT00833534|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
664537|NCT00833534|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
664538|NCT00833534|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
664539|NCT00833534|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
664540|NCT00833534|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
664541|NCT00833534|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
664542|NCT00833534|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
664543|NCT00833547|sleep|sleep
664544|NCT00833547|schizophrenia|schizophrenia
664545|NCT00833547|procedural learning|procedural learning
664547|NCT00833560|Multiple Myeloma|multiple myeloma
664548|NCT00833560|Untreated multiple myeloma|untreated multiple myeloma
664549|NCT00833560|Bortezomib|bortezomib
664550|NCT00833560|VELCADE|velcade
664551|NCT00833560|Cyclophosphamide|cyclophosphamide
664552|NCT00833560|Dexamethasone|dexamethasone
664553|NCT00833560|Chemotherapy|chemotherapy
664554|NCT00833560|Remission therapy|remission therapy
664555|NCT00833560|Induction therapy|induction therapy
664556|NCT00833560|Stem Cell Transplantation|stem cell transplantation
664557|NCT00833573|GERD digestive expression|gerd digestive expression
664558|NCT00833573|ages|ages
664559|NCT00833586|Bioequivalence|bioequivalence
664560|NCT00833586|Healthy Subjects|healthy subjects
664561|NCT00833599|Lymphedema|lymphedema
664562|NCT00833599|Genetic|genetic
664563|NCT00833599|Lymphatic Disorder|lymphatic disorder
664564|NCT00833599|Lipedema|lipedema
664565|NCT00833599|Vascular Malformation|vascular malformation
664566|NCT00833599|Vascular Anomaly|vascular anomaly
664567|NCT00833612|IABC|iabc
664568|NCT00833612|AMI|ami
664569|NCT00833625|Gastrointestinal|gastrointestinal
664570|NCT00833625|Esophagus|esophagus
664571|NCT00833625|Cancer of the esophagus|cancer of the esophagus
664572|NCT00833625|Biopsy|biopsy
664573|NCT00833625|EGD|egd
664574|NCT00833625|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
664575|NCT00833625|PET/CT|pet/ct
664576|NCT00833625|Positive Emission Tomography/Computerized Tomography|positive emission tomography/computerized tomography
664577|NCT00833625|Esophageal Cancer|esophageal cancer
664578|NCT00833625|Chemoradiation|chemoradiation
664579|NCT00833625|Chemotherapy|chemotherapy
664580|NCT00833625|Radiation Therapy|radiation therapy
664581|NCT00833638|Erectile Dysfunction|erectile dysfunction
664582|NCT00833651|Transplant|transplant
664583|NCT00833651|Immunology|immunology
664584|NCT00833651|Immunosuppression|immunosuppression
664585|NCT00833664|Bioequivalence|bioequivalence
664586|NCT00833664|Healthy Subjects|healthy subjects
664587|NCT00833677|Coping skills|coping skills
664588|NCT00833677|Chinese|chinese
664589|NCT00833677|Immigrant|immigrant
664590|NCT00833677|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
664591|NCT00833677|Family research|family research
664592|NCT00833690|Parkinson's disease|parkinson's disease
664593|NCT00833690|Parkinson disease|parkinson disease
664594|NCT00833690|PD|pd
664595|NCT00833690|inosine|inosine
664596|NCT00833690|urate|urate
664597|NCT00833690|uric acid|uric acid
664598|NCT00833690|cerebrospinal fluid|cerebrospinal fluid
664599|NCT00833703|cyanotic congenital heart disease|cyanotic congenital heart disease
664600|NCT00833703|shunt palliation|shunt palliation
664601|NCT00833703|thrombosis|thrombosis
664602|NCT00833703|clopidogrel|clopidogrel
664603|NCT00833729|psoriasis|psoriasis
664604|NCT00833729|etanercept|etanercept
664605|NCT00833729|adalimumab|adalimumab
664606|NCT00833729|moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
664607|NCT00833742|somatization|somatization
664608|NCT00833742|psychosomatic|psychosomatic
664609|NCT00833742|short-term|short-term
664610|NCT00833742|dynamic|dynamic
664611|NCT00833742|psychotherapy|psychotherapy
664612|NCT00833755|Pain|pain
664613|NCT00833755|Chronic pain|chronic pain
664614|NCT00833755|Opioid induced hyperalgesia|opioid induced hyperalgesia
664615|NCT00833755|Opioid therapy|opioid therapy
664616|NCT00833781|HIV vaccine|hiv vaccine
664617|NCT00833781|Dendritic cells|dendritic cells
664618|NCT00833781|treatment experienced|treatment experienced
664619|NCT00833807|Melanoma|melanoma
664620|NCT00833807|Metastatic Melanoma to the Liver|metastatic melanoma to the liver
664621|NCT00833807|Liver metastasis|liver metastasis
664622|NCT00833807|Nab-paclitaxel|nab-paclitaxel
664623|NCT00833807|Abraxane|abraxane
664624|NCT00833807|Paclitaxel (protein-bound)|paclitaxel (protein-bound)
664625|NCT00833807|intraarterial intrahepatic administration|intraarterial intrahepatic administration
664626|NCT00833807|Hepatic Artery|hepatic artery
664627|NCT00833807|Hepatic Arterial Infusion|hepatic arterial infusion
664628|NCT00833807|Hepatic Administration|hepatic administration
664629|NCT00833820|ALS|als
664630|NCT00833820|transcranial brain stimulation|transcranial brain stimulation
664631|NCT00833846|Mitochondria in Platelets|mitochondria in platelets
664632|NCT00833846|Mitochondria in Diabetes|mitochondria in diabetes
664633|NCT00833846|Insulin Resistance and Mitochondria|insulin resistance and mitochondria
664634|NCT00833846|Diabetes|diabetes
664635|NCT00833846|Insulin Resistance|insulin resistance
664636|NCT00833859|stereotactic radiosurgery|stereotactic radiosurgery
664637|NCT00833859|borderline resectable pancreatic cancer|borderline resectable pancreatic cancer
664638|NCT00833859|gastrointestinal|gastrointestinal
664639|NCT00833859|pancreas|pancreas
664640|NCT00833885|Non pharmaceutical measures|non pharmaceutical measures
664641|NCT00833898|depression|depression
664642|NCT00833898|stress|stress
664643|NCT00833898|caregiving|caregiving
664644|NCT00833898|anxiety|anxiety
664645|NCT00833898|psychoeducation intervention|psychoeducation intervention
664646|NCT00833898|psycho-oncology|psycho-oncology
664744|NCT00834535|Healthy Subjects|healthy subjects
664647|NCT00833911|Moderate to severe symptomatic osteoarthritis of the knee|moderate to severe symptomatic osteoarthritis of the knee
664648|NCT00833924|Low Profile|low profile
664649|NCT00833924|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
664650|NCT00833924|Endovascular|endovascular
664651|NCT00833937|Bioequivalence|bioequivalence
664652|NCT00833937|Healthy Subjects|healthy subjects
664653|NCT00833950|Tinnitus|tinnitus
664654|NCT00833950|Phase Out|phase out
664655|NCT00834002|AML in remission|aml in remission
664656|NCT00834015|spinal fusion|spinal fusion
664657|NCT00834015|pain|pain
664658|NCT00834015|disability|disability
664659|NCT00834015|muscle strength|muscle strength
664660|NCT00834015|mobility|mobility
664661|NCT00834015|quality of life|quality of life
664662|NCT00834015|lumbar|lumbar
664663|NCT00834015|isthmic or degenerative spondylolisthesis|isthmic or degenerative spondylolisthesis
664664|NCT00834028|hepatocellular carcinoma|hepatocellular carcinoma
664665|NCT00834028|vascular endothelial growth factor|vascular endothelial growth factor
664666|NCT00834028|angiopoietin|angiopoietin
664667|NCT00834028|cathepsin|cathepsin
664668|NCT00834041|aliskiren|aliskiren
664669|NCT00834041|pediatric|pediatric
664670|NCT00834041|hypertension|hypertension
664671|NCT00834041|pharmacokinetics (PK)|pharmacokinetics (pk)
664672|NCT00834041|pharmacodynamics (PD)|pharmacodynamics (pd)
664673|NCT00834041|plasma renin activity|plasma renin activity
664674|NCT00834041|mini-tablet formulation|mini-tablet formulation
664675|NCT00834067|Bioequivalence|bioequivalence
664676|NCT00834067|Healthy Subjects|healthy subjects
664677|NCT00834080|opioid dependence|opioid dependence
664678|NCT00834080|VIVITROL|vivitrol
664679|NCT00834080|opioid-related disorders|opioid-related disorders
664680|NCT00834093|Epstein-Barr Virus|epstein-barr virus
664681|NCT00834093|NPC|npc
664682|NCT00834093|EBV|ebv
664683|NCT00834093|immunotherapy|immunotherapy
664684|NCT00834106|HPV 6/11/16/18 Infection|hpv 6/11/16/18 infection
664685|NCT00834132|Bioequivalence|bioequivalence
664686|NCT00834132|Healthy Subjects|healthy subjects
664687|NCT00834145|Edema|edema
664688|NCT00834145|Right heart failure|right heart failure
664689|NCT00834145|Cor pulmonale|cor pulmonale
664690|NCT00834145|Pump|pump
664691|NCT00834145|Leg compression|leg compression
664692|NCT00834158|Hepatocellular Carcinoma|hepatocellular carcinoma
664693|NCT00834158|Hepatitis B|hepatitis b
664694|NCT00834158|Transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
664695|NCT00834158|Portal vein embolization (PVE)|portal vein embolization (pve)
664696|NCT00834158|Surgical resection|surgical resection
664697|NCT00834158|Disease-free survival|disease-free survival
664698|NCT00834158|Overall survival|overall survival
664699|NCT00834184|nikkomycin Z|nikkomycin z
664700|NCT00834184|evaluate safety, tolerance and pharmacokinetics of nikkomycin Z|evaluate safety, tolerance and pharmacokinetics of nikkomycin z
664701|NCT00834197|Bioequivalence|bioequivalence
664702|NCT00834197|Healthy Subjects|healthy subjects
664703|NCT00834223|refractory chronic forms of open angle glaucoma (OAG)|refractory chronic forms of open angle glaucoma (oag)
664704|NCT00834223|OAG|oag
664705|NCT00834223|glaucoma|glaucoma
664706|NCT00834236|gastric cancer|gastric cancer
664707|NCT00834236|proteomics|proteomics
664708|NCT00834236|gastric juice|gastric juice
664709|NCT00834249|Bioequivalence|bioequivalence
664710|NCT00834249|Healthy Subjects|healthy subjects
664711|NCT00834275|Bioequivalence|bioequivalence
664712|NCT00834275|Healthy Subjects|healthy subjects
664713|NCT00834288|Healthy subjects|healthy subjects
664714|NCT00834288|Pharmacokinetics|pharmacokinetics
664715|NCT00834288|Bioavailability|bioavailability
664716|NCT00834301|End Stage Renal Disease|end stage renal disease
664717|NCT00834301|Inflammation|inflammation
664718|NCT00834327|Restless Legs Syndrome|restless legs syndrome
664719|NCT00834340|Bioequivalence|bioequivalence
664720|NCT00834340|Healthy Subjects|healthy subjects
664721|NCT00834366|Healthy volunteers|healthy volunteers
664722|NCT00834379|Bioequivalence|bioequivalence
664723|NCT00834379|Healthy Subjects|healthy subjects
664724|NCT00834405|Bioequivalence|bioequivalence
664725|NCT00834405|Healthy Subjects|healthy subjects
664726|NCT00834418|Bioequivalence|bioequivalence
664727|NCT00834418|Healthy Subjects|healthy subjects
664728|NCT00834431|Bioequivalence|bioequivalence
664729|NCT00834431|Healthy Subjects|healthy subjects
664730|NCT00834444|Bioequivalence|bioequivalence
664731|NCT00834444|Healthy Subjects|healthy subjects
664732|NCT00834457|AIDS-related Kaposi's sarcoma|aids-related kaposi's sarcoma
664733|NCT00834457|antiretroviral therapy|antiretroviral therapy
664734|NCT00834483|Safety|safety
664735|NCT00834483|Efficacy|efficacy
664736|NCT00834483|Cost-savings|cost-savings
664737|NCT00834483|Cosmesis|cosmesis
664738|NCT00834483|Safety and efficacy of wound closure|safety and efficacy of wound closure
664739|NCT00834483|Cost-savings potential|cost-savings potential
664740|NCT00834483|Cosmesis of the wound/scar|cosmesis of the wound/scar
664741|NCT00834522|Bioequivalence|bioequivalence
664742|NCT00834522|Healthy Subjects|healthy subjects
664743|NCT00834535|Bioequivalence|bioequivalence
665194|NCT00835471|erlotinib|erlotinib
664745|NCT00834548|Magnetic resonance|magnetic resonance
664746|NCT00834548|whole body|whole body
664747|NCT00834548|angiography|angiography
664748|NCT00834548|hybrid protocol|hybrid protocol
664750|NCT00834561|Bioequivalence|bioequivalence
664751|NCT00834561|Healthy Subjects|healthy subjects
664752|NCT00834574|Bioequivalence|bioequivalence
664753|NCT00834574|Healthy Subjects|healthy subjects
664754|NCT00834587|Bioequivalence|bioequivalence
664755|NCT00834587|Healthy Subjects|healthy subjects
664756|NCT00834613|Bioequivalence|bioequivalence
664757|NCT00834613|Healthy Subjects|healthy subjects
664758|NCT00834626|Ileal Interposition|ileal interposition
664759|NCT00834626|Sleeve Gastrectomy|sleeve gastrectomy
664760|NCT00834626|Type-2 Diabetes|type-2 diabetes
664761|NCT00834639|Bioequivalence|bioequivalence
664762|NCT00834639|Healthy Subjects|healthy subjects
665107|NCT00829114|FDA|fda
664763|NCT00834652|Metabolic Diseases|metabolic diseases
664764|NCT00834652|Depressive Disorder, Major|depressive disorder, major
664765|NCT00834652|Depressive Disorder|depressive disorder
664766|NCT00834652|Glucose Metabolism Disorders|glucose metabolism disorders
664767|NCT00834652|Depression Recurrence|depression recurrence
664768|NCT00834678|male breast cancer|male breast cancer
664769|NCT00834678|recurrent breast cancer|recurrent breast cancer
664770|NCT00834678|stage IIIB breast cancer|stage iiib breast cancer
664771|NCT00834678|stage IIIC breast cancer|stage iiic breast cancer
664772|NCT00834678|stage IV breast cancer|stage iv breast cancer
664773|NCT00834678|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
664774|NCT00834678|HER2-negative breast cancer|her2-negative breast cancer
664899|NCT00828490|opioids|opioids
664775|NCT00834678|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
664776|NCT00834678|triple-negative breast cancer|triple-negative breast cancer
664777|NCT00834691|Inflammation|inflammation
664778|NCT00834691|Oxidative stress|oxidative stress
664779|NCT00834691|Estimated glomerular filtration rate|estimated glomerular filtration rate
664780|NCT00834704|PEGPH20|pegph20
664781|NCT00834704|PEGylated recombinant human hyaluronidase|pegylated recombinant human hyaluronidase
664782|NCT00834704|Metastatic or locally advanced solid tumor|metastatic or locally advanced solid tumor
664783|NCT00834717|Bioequivalence|bioequivalence
664784|NCT00834717|Healthy Subjects|healthy subjects
664785|NCT00834743|Bioequivalence|bioequivalence
664786|NCT00834743|Healthy Subjects|healthy subjects
664787|NCT00834756|Bioequivalence|bioequivalence
664788|NCT00834756|Healthy Subjects|healthy subjects
664790|NCT00834782|IOP|iop
664791|NCT00834795|Bioequivalence|bioequivalence
664792|NCT00834795|Healthy Subjects|healthy subjects
664793|NCT00834808|Healthy volunteers|healthy volunteers
752400|NCT01172873|D-cycloserine|d-cycloserine
752401|NCT01172873|CBT|cbt
664794|NCT00834821|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
664795|NCT00834821|ADHD, Predominantly Inattentive Type|adhd, predominantly inattentive type
664796|NCT00834821|Inattention|inattention
664797|NCT00834821|Psychosocial Intervention|psychosocial intervention
664798|NCT00834821|Behavioral Intervention|behavioral intervention
664799|NCT00834834|Suicidal and Self-Injurious Behavior|suicidal and self-injurious behavior
664800|NCT00834847|Bioequivalence|bioequivalence
664801|NCT00834847|Healthy Subjects|healthy subjects
664802|NCT00834860|chronic hepatitis C|chronic hepatitis c
664803|NCT00834860|sustained virological response|sustained virological response
664804|NCT00834860|peginterferon|peginterferon
664805|NCT00834860|ribavirin|ribavirin
664806|NCT00834860|neoplasm|neoplasm
664807|NCT00834873|Bioequivalence|bioequivalence
664808|NCT00834873|Healthy Subjects|healthy subjects
664809|NCT00834899|Sickle cell disease|sickle cell disease
664810|NCT00834899|Pain crisis|pain crisis
664811|NCT00834899|Acute pain episode|acute pain episode
664812|NCT00834899|Eptifibatide|eptifibatide
664813|NCT00834899|Antiplatelet therapy|antiplatelet therapy
664814|NCT00834899|Safety|safety
664815|NCT00834899|Treatment|treatment
664816|NCT00834912|Healthy Subjects|healthy subjects
664817|NCT00834925|atrial fibrillation with rapid ventricular response|atrial fibrillation with rapid ventricular response
664818|NCT00834938|diabetes mellitus, type 2|diabetes mellitus, type 2
664819|NCT00834938|Insulin resistance|insulin resistance
664820|NCT00834938|bariatric surgery|bariatric surgery
664821|NCT00834938|Glucagon-Like Peptide 1|glucagon-like peptide 1
664822|NCT00834938|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
664823|NCT00834938|insulin|insulin
664824|NCT00834938|glucagon|glucagon
664825|NCT00834938|ghrelin|ghrelin
664826|NCT00834938|adiponectin|adiponectin
664827|NCT00834938|Cytokines|cytokines
664828|NCT00834938|gastric bypass|gastric bypass
664829|NCT00834938|Obesity|obesity
664830|NCT00834951|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
664831|NCT00834951|Elderly patients|elderly patients
664832|NCT00834951|Low dose total body irradiation|low dose total body irradiation
664833|NCT00834951|RCHOP14|rchop14
664834|NCT00834964|Bioequivalence|bioequivalence
664835|NCT00834964|Healthy Subjects|healthy subjects
664836|NCT00834977|Bioequivalence|bioequivalence
664837|NCT00834977|Healthy Subjects|healthy subjects
664838|NCT00834990|Bioequivalence|bioequivalence
664839|NCT00834990|Healthy Subjects|healthy subjects
664840|NCT00835003|Neonatal admission|neonatal admission
664841|NCT00835003|Elective Caesarean Section|elective caesarean section
664842|NCT00835003|Timing|timing
664843|NCT00835003|Choice behavior|choice behavior
664844|NCT00835003|Intraoperative complications|intraoperative complications
664845|NCT00835003|Postoperative complications|postoperative complications
664846|NCT00835016|Early psychosocial stimulation, RCT, Depressed mother|early psychosocial stimulation, rct, depressed mother
664847|NCT00835029|oral|oral
664848|NCT00835029|candida|candida
664849|NCT00835029|denture|denture
664850|NCT00835029|clotrimazole|clotrimazole
664851|NCT00835029|slow releases|slow releases
664852|NCT00835042|Bioequivalence|bioequivalence
664853|NCT00835042|Healthy Subjects|healthy subjects
664854|NCT00835055|rectal cancer with neoadjuvant treatment|rectal cancer with neoadjuvant treatment
664855|NCT00835055|standardized clinical tests|standardized clinical tests
664856|NCT00835055|tumor markers on tumor tissue|tumor markers on tumor tissue
664857|NCT00835068|Hemophilia B|hemophilia b
664858|NCT00835068|observational|observational
664859|NCT00835068|post marketing study|post marketing study
664860|NCT00835081|Bioequivalence|bioequivalence
664861|NCT00835081|Healthy Subjects|healthy subjects
664862|NCT00835107|Bipolar Depression|bipolar depression
664863|NCT00835107|Sleep|sleep
664864|NCT00835107|Polysomnograph|polysomnograph
664865|NCT00835107|Slow Wave Sleep|slow wave sleep
664866|NCT00835107|Ziprasidone|ziprasidone
664867|NCT00835107|Antipsychotic|antipsychotic
664868|NCT00835107|Placebo|placebo
664869|NCT00835133|family|family
664870|NCT00835133|history|history
664871|NCT00835133|pancreas|pancreas
664872|NCT00835133|cancer|cancer
664873|NCT00835133|melanoma|melanoma
664874|NCT00835133|genetic|genetic
664875|NCT00835146|Bioequivalence|bioequivalence
664876|NCT00835146|Healthy Subjects|healthy subjects
664877|NCT00828360|Heart Failure|heart failure
664878|NCT00828360|CRT|crt
664879|NCT00828360|Dobutamine echocardiography|dobutamine echocardiography
664880|NCT00828386|Nasopharyngeal cancers|nasopharyngeal cancers
664881|NCT00828386|induction chemotherapy|induction chemotherapy
664882|NCT00828386|radiochemotherapy|radiochemotherapy
664883|NCT00828399|Radiotherapy|radiotherapy
664884|NCT00828399|Diarrhoea|diarrhoea
664885|NCT00828399|Glutamine|glutamine
664886|NCT00828399|Oxydative stress|oxydative stress
664887|NCT00828399|Calprotectin|calprotectin
664888|NCT00828399|Citrulline|citrulline
664889|NCT00828425|Diabetes Mellitus|diabetes mellitus
664890|NCT00828425|retinopathy|retinopathy
664891|NCT00828425|Management of diabetic patients with retinopathy|management of diabetic patients with retinopathy
664892|NCT00828451|newborn|newborn
664893|NCT00828451|necrotizing enterocolitis|necrotizing enterocolitis
664894|NCT00828451|genetics|genetics
664895|NCT00828451|growth factors|growth factors
664896|NCT00828451|metabolism|metabolism
664897|NCT00828464|Dermatosis, Dermatitis, Dry skin, Irritated skin|dermatosis, dermatitis, dry skin, irritated skin
664898|NCT00828490|Fraud and Abuse|fraud and abuse
664900|NCT00828503|Certi-CMV|certi-cmv
664901|NCT00828503|immunosuppressive switch (to Certican)|immunosuppressive switch (to certican)
664902|NCT00828503|renal transplant|renal transplant
664903|NCT00828516|lymphedema|lymphedema
664904|NCT00828516|male breast cancer|male breast cancer
664905|NCT00828516|stage IA breast cancer|stage ia breast cancer
664906|NCT00828516|stage IB breast cancer|stage ib breast cancer
664907|NCT00828516|stage II breast cancer|stage ii breast cancer
664908|NCT00828516|recurrent breast cancer|recurrent breast cancer
664909|NCT00828516|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
664910|NCT00828516|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
664911|NCT00828516|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
664912|NCT00828516|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
664913|NCT00828516|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
664914|NCT00828516|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
664915|NCT00828516|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
664916|NCT00828516|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
664917|NCT00828516|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
664918|NCT00828516|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
664919|NCT00828516|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
664920|NCT00828516|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
664921|NCT00828516|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
664922|NCT00828516|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
664923|NCT00828516|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
664924|NCT00828516|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
664925|NCT00828516|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
664926|NCT00828516|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
664927|NCT00828516|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
664928|NCT00828516|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
664929|NCT00828516|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
664930|NCT00828516|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
664931|NCT00828516|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
664932|NCT00828516|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
664933|NCT00828516|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
664934|NCT00828516|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
664935|NCT00828516|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
664936|NCT00828516|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
664937|NCT00828516|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
664938|NCT00828516|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
664939|NCT00828516|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
664940|NCT00828516|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
664941|NCT00828516|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
664942|NCT00828516|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
664943|NCT00828516|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
664944|NCT00828516|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
664945|NCT00828516|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
664946|NCT00828516|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
664947|NCT00828516|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
664948|NCT00828516|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
664949|NCT00828516|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
664950|NCT00828516|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
664951|NCT00828516|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
666400|NCT00844311|hCG|hcg
752402|NCT01172873|E/RP|e/rp
664952|NCT00828516|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
664953|NCT00828516|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
664954|NCT00828516|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
664955|NCT00828516|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
664956|NCT00828516|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
751809|NCT01170546|knee internal rotator|knee internal rotator
664957|NCT00828516|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
664958|NCT00828516|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
664959|NCT00828516|recurrent salivary gland cancer|recurrent salivary gland cancer
664960|NCT00828516|salivary gland acinic cell tumor|salivary gland acinic cell tumor
664961|NCT00828516|salivary gland adenocarcinoma|salivary gland adenocarcinoma
664962|NCT00828516|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
664963|NCT00828516|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
664964|NCT00828516|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
664965|NCT00828516|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
664966|NCT00828516|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
664967|NCT00828516|stage I salivary gland cancer|stage i salivary gland cancer
664968|NCT00828516|stage II salivary gland cancer|stage ii salivary gland cancer
664969|NCT00828516|tongue cancer|tongue cancer
664970|NCT00828529|TMC207-TiDP13-C110|tmc207-tidp13-c110
664971|NCT00828529|TMC207-C110|tmc207-c110
664972|NCT00828529|TMC207|tmc207
664973|NCT00828529|Drug-drug interaction|drug-drug interaction
664974|NCT00828529|Tuberculosis|tuberculosis
664975|NCT00828529|HIV|hiv
664976|NCT00828529|Kaletra|kaletra
664977|NCT00828529|Lopinavir|lopinavir
664978|NCT00828529|Ritonavir|ritonavir
664979|NCT00828529|Open-label|open-label
664980|NCT00828529|HIV Infections|hiv infections
664981|NCT00828542|Adverse Effects|adverse effects
664982|NCT00828542|Etonogestrel|etonogestrel
664983|NCT00828542|Postpartum period|postpartum period
664984|NCT00828542|Contraception|contraception
664985|NCT00828542|Hemostasis|hemostasis
664986|NCT00828542|Metabolism|metabolism
664987|NCT00828555|HPV vaccine|hpv vaccine
664988|NCT00828555|Tdap vaccine|tdap vaccine
664989|NCT00828568|Actinic Keratosis|actinic keratosis
665292|NCT00836212|lopinavir|lopinavir
664990|NCT00828594|Hepatocellular carcinoma|hepatocellular carcinoma
664991|NCT00828594|dose-finding study|dose-finding study
664992|NCT00828594|randomized trial|randomized trial
664993|NCT00828594|medical treatment|medical treatment
664994|NCT00828594|RAD001|rad001
664995|NCT00828594|sorafenib|sorafenib
664996|NCT00828594|Advanced hepatocellular cancer (HCC)|advanced hepatocellular cancer (hcc)
664997|NCT00828607|Contrast Enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
664998|NCT00828607|Liver tumors|liver tumors
664999|NCT00828607|Hepatocellular carcinoma|hepatocellular carcinoma
665000|NCT00828607|Hemangioma|hemangioma
665001|NCT00828607|Focal Nodular Hyperplasia|focal nodular hyperplasia
665002|NCT00828607|Hepatic metastases|hepatic metastases
665003|NCT00828633|stage I prostate cancer|stage i prostate cancer
665004|NCT00828633|stage II prostate cancer|stage ii prostate cancer
665005|NCT00828646|Healthy Subjects|healthy subjects
665006|NCT00828659|Abuse potential|abuse potential
665007|NCT00828672|assess activity|assess activity
665008|NCT00828672|bevacizumab|bevacizumab
665009|NCT00828672|capecitabine|capecitabine
665010|NCT00828672|radiation therapy|radiation therapy
665011|NCT00828672|oxaliplatin|oxaliplatin
665012|NCT00828672|pre-operative treatment|pre-operative treatment
665013|NCT00828672|TME (total mesorectal excision).|tme (total mesorectal excision).
665014|NCT00828685|Return to Work|return to work
665015|NCT00828685|CRPP|crpp
665016|NCT00828685|ORIF|orif
665017|NCT00828685|Distal Radius|distal radius
665018|NCT00828698|Death, sudden|death, sudden
665019|NCT00828698|All cause mortality|all cause mortality
665020|NCT00828711|Misoprostol vaginal insert|misoprostol vaginal insert
665021|NCT00828711|Induction of labor|induction of labor
665022|NCT00828711|Cervical ripening|cervical ripening
665023|NCT00828711|Rate of cesarean section|rate of cesarean section
665024|NCT00828750|eltrombopag|eltrombopag
665025|NCT00828750|thrombopoietin receptor agonist|thrombopoietin receptor agonist
665026|NCT00828750|ITP|itp
665027|NCT00828750|blood platelet|blood platelet
665028|NCT00828763|healthy volunteer|healthy volunteer
665029|NCT00828763|radiolabelled|radiolabelled
665030|NCT00828776|TTPa|ttpa
665031|NCT00828776|Anti-Xa|anti-xa
665032|NCT00828776|Adverse Reactions|adverse reactions
665033|NCT00828789|Hepatitis C|hepatitis c
665034|NCT00828789|HCV|hcv
665035|NCT00828789|HIV|hiv
665036|NCT00828789|AIDS|aids
665037|NCT00828789|Telaprevir|telaprevir
665038|NCT00828789|Efavirenz|efavirenz
665039|NCT00828789|Tenofovir disproxil fumarate|tenofovir disproxil fumarate
665040|NCT00828789|Healthy volunteer|healthy volunteer
665041|NCT00828789|VX-950-C134|vx-950-c134
665042|NCT00828789|VX-950-TiDP24-C134|vx-950-tidp24-c134
665043|NCT00828789|HIV Infections|hiv infections
665044|NCT00828802|Myelodysplastic Syndromes|myelodysplastic syndromes
665045|NCT00828802|MDS|mds
665046|NCT00828815|HIV-negative|hiv-negative
665047|NCT00828815|buprenorphine/nalaxone|buprenorphine/nalaxone
665048|NCT00828815|norbuprenorphine|norbuprenorphine
665049|NCT00828815|opioid-dependent|opioid-dependent
665050|NCT00828815|TMC125-TiDP2-C188|tmc125-tidp2-c188
665051|NCT00828815|TMC125-C188|tmc125-c188
665052|NCT00828815|TMC125|tmc125
665053|NCT00828815|HIV Infections|hiv infections
665054|NCT00828828|Influenza Vaccine|influenza vaccine
665055|NCT00828828|Sarcoidosis|sarcoidosis
665056|NCT00828828|Antibody|antibody
665057|NCT00828854|breast cancer|breast cancer
665058|NCT00828854|estrogen receptor postive|estrogen receptor postive
665059|NCT00828867|healthy subjects|healthy subjects
665060|NCT00828867|FTIH, single dose, food effect, healthy subjects, double-blind|ftih, single dose, food effect, healthy subjects, double-blind
665061|NCT00828893|drain under scanner|drain under scanner
665062|NCT00828906|Glaucoma|glaucoma
665063|NCT00828906|IOP|iop
665064|NCT00828906|DuoTrav|duotrav
665065|NCT00828919|VEGFR inhibitor|vegfr inhibitor
665066|NCT00828919|angi-angiogenic|angi-angiogenic
665067|NCT00828919|tyrosine kinase inhibitor|tyrosine kinase inhibitor
665068|NCT00828958|schizophrenia|schizophrenia
665069|NCT00828958|Risperidone|risperidone
665070|NCT00828958|Long acting injectable|long acting injectable
665071|NCT00828958|Intradeltoidal injection|intradeltoidal injection
665072|NCT00828971|Complicated skin and skin structure infections|complicated skin and skin structure infections
665073|NCT00828971|cSSSI|csssi
665074|NCT00828997|rheumatoid arthritis|rheumatoid arthritis
665075|NCT00828997|spondylarthropathy|spondylarthropathy
665188|NCT00835458|perforation|perforation
665076|NCT00828997|immunological response following vaccination with Prevenar|immunological response following vaccination with prevenar
665077|NCT00829010|Human Immunodeficiency Virus|human immunodeficiency virus
665078|NCT00829010|Booster vaccination|booster vaccination
665079|NCT00829010|Safety|safety
665080|NCT00829010|Primary vaccination|primary vaccination
665081|NCT00829010|Pneumococcal vaccine|pneumococcal vaccine
665082|NCT00829010|Immunogenicity|immunogenicity
665083|NCT00829010|Pneumococcal disease|pneumococcal disease
665084|NCT00829023|Positive aerobic or anaerobic cultures|positive aerobic or anaerobic cultures
665085|NCT00829036|Rehabilitation|rehabilitation
665086|NCT00829036|Sensory Aid|sensory aid
665087|NCT00829062|Type 1 diabetes|type 1 diabetes
665293|NCT00836212|efavirenz|efavirenz
665088|NCT00829062|Insulin pump|insulin pump
665089|NCT00829062|Glycemic variability|glycemic variability
665090|NCT00829088|Mass balance|mass balance
665091|NCT00829088|AZD2066|azd2066
665092|NCT00829088|Pain|pain
665093|NCT00829088|Pain conditions|pain conditions
665094|NCT00829101|unilateral cleft lip and palate|unilateral cleft lip and palate
665095|NCT00829101|primary palatal surgery|primary palatal surgery
665096|NCT00829101|articulation|articulation
665097|NCT00829101|phonology|phonology
665098|NCT00829101|one stage palatal repair|one stage palatal repair
665099|NCT00829101|two stage palatal repair|two stage palatal repair
665100|NCT00829114|AE|ae
665101|NCT00829114|AIDS|aids
665102|NCT00829114|ALT|alt
665103|NCT00829114|ART|art
665104|NCT00829114|AST|ast
665105|NCT00829114|DCF|dcf
665121|NCT00829114|Combined Oral Contraceptives|combined oral contraceptives
665122|NCT00829127|volunteers|volunteers
665123|NCT00835159|Postoperative Delirium|postoperative delirium
665124|NCT00835159|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
665125|NCT00835159|Rivastigmine|rivastigmine
665126|NCT00835159|Exelon|exelon
665127|NCT00835159|Memory impairment|memory impairment
665128|NCT00835159|Delirium|delirium
665129|NCT00835159|Cognitive function|cognitive function
665130|NCT00835172|Bioequivalence|bioequivalence
665131|NCT00835172|Healthy Subjects|healthy subjects
665132|NCT00835185|Antibodies, Monoclonal|antibodies, monoclonal
665133|NCT00835185|Colorectal Neoplasms|colorectal neoplasms
665134|NCT00835211|Bioequivalence|bioequivalence
665135|NCT00835211|Healthy Subjects|healthy subjects
665136|NCT00835224|Spinal Cord Injury|spinal cord injury
665137|NCT00835224|Orthostatic Hypotension|orthostatic hypotension
665138|NCT00835224|Blood Pressure|blood pressure
665139|NCT00835224|Midodrine Hydrochloride|midodrine hydrochloride
665140|NCT00835224|L-NAME|l-name
665141|NCT00835237|Boostrix®|boostrix®
665142|NCT00835237|adults|adults
665143|NCT00835250|Transvaginal cholecystectomy|transvaginal cholecystectomy
665144|NCT00835250|NOTES|notes
665145|NCT00835250|Minilaparoscopy|minilaparoscopy
665146|NCT00835250|Endoscopic surgery|endoscopic surgery
665147|NCT00835250|Cholecystectomy|cholecystectomy
665148|NCT00835250|Surgical translumenal endoscopic surgery|surgical translumenal endoscopic surgery
665149|NCT00835250|Transvaginal translumenal endoscopic surgery|transvaginal translumenal endoscopic surgery
665150|NCT00835263|Bioequivalence|bioequivalence
665151|NCT00835263|Healthy Subjects|healthy subjects
665152|NCT00835276|Bioequivalence|bioequivalence
665153|NCT00835276|Healthy Subjects|healthy subjects
665154|NCT00835289|Clinical Trials, Randomized|clinical trials, randomized
665155|NCT00835302|Cervical|cervical
665156|NCT00835302|Thoracic|thoracic
665157|NCT00835302|Manipulation|manipulation
665158|NCT00835302|Mobilization|mobilization
665159|NCT00835302|Clinical prediction rule|clinical prediction rule
665160|NCT00835302|Shoulder pain.|shoulder pain.
665161|NCT00835315|interdigital psoriasis (psoriasis alba)|interdigital psoriasis (psoriasis alba)
665162|NCT00835328|hyperinsulinism|hyperinsulinism
665163|NCT00835328|hypoglycemia|hypoglycemia
665164|NCT00835328|ATP- sensitive potassium channel (KATP)|atp- sensitive potassium channel (katp)
665165|NCT00835341|oral epithelial dysplasia|oral epithelial dysplasia
665166|NCT00835341|p16 methylation|p16 methylation
665167|NCT00835341|prognosis|prognosis
665168|NCT00835341|malignant transformation|malignant transformation
665169|NCT00835341|oral squamous cell carcinoma|oral squamous cell carcinoma
665170|NCT00835354|Bioequivalence|bioequivalence
665171|NCT00835354|Healthy Subjects|healthy subjects
665172|NCT00835367|Bioequivalence|bioequivalence
665173|NCT00835367|Healthy Subjects|healthy subjects
665174|NCT00835393|Bioequivalence|bioequivalence
665175|NCT00835393|Healthy Subjects|healthy subjects
665176|NCT00835406|Bioequivalence|bioequivalence
665177|NCT00835406|Healthy Subjects|healthy subjects
665178|NCT00835419|metastatic malignant melanoma with cyclin D1 positivity|metastatic malignant melanoma with cyclin d1 positivity
665179|NCT00835432|Lateral augmentation|lateral augmentation
665180|NCT00835432|GBR|gbr
665181|NCT00835432|BoneCeramic|boneceramic
665182|NCT00835432|collagen membrane|collagen membrane
665183|NCT00835432|histomorphometry|histomorphometry
665184|NCT00835432|morphometry|morphometry
665185|NCT00835432|reentry|reentry
665186|NCT00835432|biopsy|biopsy
665187|NCT00835458|gastric fistula|gastric fistula
665189|NCT00835458|endoscopy|endoscopy
665190|NCT00835458|closure|closure
665191|NCT00835458|endolumenal|endolumenal
665192|NCT00835471|Lung cancer|lung cancer
665193|NCT00835471|non-small-cell|non-small-cell
665195|NCT00835471|chemotherapy|chemotherapy
665196|NCT00835484|Bioequivalence|bioequivalence
665197|NCT00835484|Healthy Subjects|healthy subjects
665198|NCT00835822|Chronic Venous Insufficiency, Venocur Triplex®|chronic venous insufficiency, venocur triplex®
665199|NCT00835835|Multiple Sclerosis|multiple sclerosis
665200|NCT00835835|gait|gait
665201|NCT00835835|falls|falls
665202|NCT00835835|lokomat|lokomat
665203|NCT00835835|body-weight support treadmill training|body-weight support treadmill training
665204|NCT00835848|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
665205|NCT00835848|Primary PCI|primary pci
665206|NCT00835848|Postconditioning|postconditioning
665207|NCT00835861|Non Insulin Dependent Diabetes|non insulin dependent diabetes
665208|NCT00835861|Pregnancy|pregnancy
665209|NCT00835874|probiotic|probiotic
665210|NCT00835874|preterm|preterm
665211|NCT00835874|lactation|lactation
665212|NCT00835874|breast feeding|breast feeding
665213|NCT00835874|necrotizing enterocolitis|necrotizing enterocolitis
665214|NCT00835874|sepsis|sepsis
665215|NCT00835874|bacterial cultures|bacterial cultures
665216|NCT00835874|lactating mother|lactating mother
665217|NCT00835874|breast feeding of at least 50% of enteric feeding volume|breast feeding of at least 50% of enteric feeding volume
665218|NCT00835874|Infant, very low birth weight|infant, very low birth weight
665219|NCT00835900|smoking cessation|smoking cessation
665220|NCT00835900|varenicline|varenicline
665221|NCT00835900|smoking cessation treatment|smoking cessation treatment
665222|NCT00835913|Autonomic nervous system|autonomic nervous system
665223|NCT00835913|Sepsis shock|sepsis shock
665224|NCT00835913|severe sepsis|severe sepsis
665225|NCT00835913|sinusal change|sinusal change
665226|NCT00835913|Myocardiac fixing|myocardiac fixing
665227|NCT00835913|NTproBNP|ntprobnp
665228|NCT00835913|Patient in intensive care unit with sepsis shock or severe|patient in intensive care unit with sepsis shock or severe
665229|NCT00835913|Sepsis|sepsis
665230|NCT00835926|Influenza|influenza
665231|NCT00835926|Fluzone®|fluzone®
665232|NCT00835939|Achilles|achilles
665233|NCT00835939|Tendinopathy|tendinopathy
665234|NCT00835939|Sclerotherapy|sclerotherapy
665235|NCT00835939|Neovascularisation|neovascularisation
665236|NCT00835939|sports medicine|sports medicine
665237|NCT00835939|interventional radiology|interventional radiology
665238|NCT00835965|Laparoscopic|laparoscopic
665239|NCT00835965|Surgery|surgery
665240|NCT00835965|Postoperative|postoperative
665241|NCT00835965|Nausea|nausea
665242|NCT00835965|Vomiting|vomiting
665243|NCT00835965|Aprepitant|aprepitant
665244|NCT00835965|Dexamethasone|dexamethasone
665245|NCT00835965|Postoperative Nausea, Postoperative Vomiting|postoperative nausea, postoperative vomiting
665246|NCT00835978|axitinib or AG-013736 dose titration (increase) renal cell carcinoma|axitinib or ag-013736 dose titration (increase) renal cell carcinoma
665247|NCT00835978|kidney cancer|kidney cancer
665248|NCT00835991|Bioequivalence|bioequivalence
665249|NCT00835991|Healthy Subjects|healthy subjects
665250|NCT00836004|Bioequivalence|bioequivalence
665251|NCT00836004|Healthy Subjects|healthy subjects
665253|NCT00836043|alemtuzumab|alemtuzumab
665254|NCT00836056|Bioequivalence|bioequivalence
665255|NCT00836056|Healthy Subjects|healthy subjects
665256|NCT00836069|Generalized Anxiety Disorder|generalized anxiety disorder
665257|NCT00836082|Healthy volunteers|healthy volunteers
665258|NCT00836095|laryngeal mask, proseal|laryngeal mask, proseal
665259|NCT00836108|Lung Diseases, Obstructive|lung diseases, obstructive
665260|NCT00836108|Breathing Exercises|breathing exercises
665261|NCT00836108|Exercise Tolerance|exercise tolerance
665262|NCT00836108|Dyspnea|dyspnea
665263|NCT00836108|Arm Exercise|arm exercise
665264|NCT00836121|Teratoma|teratoma
665265|NCT00836121|Mediastinum|mediastinum
665266|NCT00836134|pain relief after umbilical hernia repair|pain relief after umbilical hernia repair
665267|NCT00836134|morphine consumption|morphine consumption
665268|NCT00836134|plasma bupivacaine levels|plasma bupivacaine levels
665269|NCT00836160|EGFR-TKI therapy|egfr-tki therapy
665270|NCT00836160|NSCLC|nsclc
665271|NCT00836160|Efficacy|efficacy
665272|NCT00836173|CARBOPLATIN|carboplatin
665273|NCT00836173|DEXAMETHASONE|dexamethasone
665274|NCT00836173|DIFFUSE LARGE B-CELL LYMPHOMA|diffuse large b-cell lymphoma
665275|NCT00836173|ETOPOSIDE|etoposide
665276|NCT00836173|GALLIUM NITRATE|gallium nitrate
665277|NCT00836173|IFOSFAMIDE|ifosfamide
665278|NCT00836173|PHASE II|phase ii
665279|NCT00836173|RELAPSED OR REFRACTORY|relapsed or refractory
665280|NCT00836173|RITUXIMAB|rituximab
665281|NCT00836199|smoking cessation|smoking cessation
665282|NCT00836199|NicVAX|nicvax
665283|NCT00836199|smoking vaccine|smoking vaccine
665284|NCT00836199|smoking abstinence|smoking abstinence
665285|NCT00836199|smoking|smoking
665286|NCT00836199|tobacco cessation|tobacco cessation
665287|NCT00836212|HIV|hiv
665288|NCT00836212|Adjusting Antiretroviral Therapy|adjusting antiretroviral therapy
665289|NCT00836212|Dosage using Therapeutic Drug Monitoring|dosage using therapeutic drug monitoring
665290|NCT00836212|Swiss HIV Cohort Study|swiss hiv cohort study
665291|NCT00836212|HIV Geneva|hiv geneva
665294|NCT00836212|Treatment Experienced|treatment experienced
665295|NCT00836225|diabetes|diabetes
665296|NCT00836225|SGLT2 inhibitor|sglt2 inhibitor
665297|NCT00836238|Prostate Cancer|prostate cancer
665298|NCT00836238|Neural Functioning Assessment|neural functioning assessment
665299|NCT00836238|Physical Assessment|physical assessment
665300|NCT00836238|Questionnaire|questionnaire
665301|NCT00836238|Objective Measures of Functional Status|objective measures of functional status
665302|NCT00836238|Physical Function|physical function
665303|NCT00836238|Symptom Assessment Interview|symptom assessment interview
665304|NCT00836238|Elderly|elderly
665305|NCT00836251|energy expenditure|energy expenditure
665306|NCT00836251|schizophrenia|schizophrenia
665307|NCT00836264|Morphine|morphine
665308|NCT00836264|Phenotype|phenotype
665309|NCT00836264|Genotype|genotype
665310|NCT00836264|Tonsillectomy|tonsillectomy
665311|NCT00836264|Adenoidectomy|adenoidectomy
665312|NCT00836264|Opioid Receptors|opioid receptors
665313|NCT00836264|Genome-Wide Association|genome-wide association
665314|NCT00836264|Pharmacokinetics|pharmacokinetics
665315|NCT00836277|Panitumumab|panitumumab
665316|NCT00836277|Irinotecan|irinotecan
665317|NCT00836277|Esophageal Adenocarcinoma|esophageal adenocarcinoma
665318|NCT00836277|Phase II|phase ii
665319|NCT00836290|risk reduction|risk reduction
665320|NCT00836290|HIV prevention|hiv prevention
665321|NCT00836290|HIV education|hiv education
665322|NCT00836290|HIV Seronegativity|hiv seronegativity
665323|NCT00836316|laparoscopic cholecystectomy|laparoscopic cholecystectomy
665324|NCT00836329|Neurologic|neurologic
665325|NCT00836329|Diabetes|diabetes
665326|NCT00836329|Cardiac Surgery|cardiac surgery
665327|NCT00836329|Stroke|stroke
665328|NCT00836342|Non-melanoma skin cancer|non-melanoma skin cancer
665329|NCT00836342|Basal cell carcinoma|basal cell carcinoma
665330|NCT00836342|Squamous cell carcinoma|squamous cell carcinoma
665331|NCT00836355|stroke|stroke
665332|NCT00836355|magnetic resonance imaging|magnetic resonance imaging
665333|NCT00836355|enoxaparin|enoxaparin
665334|NCT00836355|minocycline|minocycline
665335|NCT00836355|NIH stroke scale|nih stroke scale
665336|NCT00836355|modified Rankin scale|modified rankin scale
665337|NCT00836355|neuroprotection|neuroprotection
665338|NCT00836368|Asthma|asthma
665339|NCT00836368|Asthmatic|asthmatic
665340|NCT00836368|Allergy|allergy
665341|NCT00836368|Allergic|allergic
665342|NCT00836368|Gamma-tocopherol|gamma-tocopherol
665343|NCT00836368|Vitamin|vitamin
665344|NCT00836368|Vitamin E|vitamin e
665345|NCT00836381|Overactive bladder|overactive bladder
665346|NCT00836381|Antimuscarinics|antimuscarinics
665347|NCT00836381|Patient-reported goal achievement|patient-reported goal achievement
665348|NCT00836394|arthritis|arthritis
665349|NCT00836394|juvenile idiopathic arthritis|juvenile idiopathic arthritis
665350|NCT00836394|pediatric|pediatric
665351|NCT00836394|intervention|intervention
665352|NCT00836394|vibration therapy|vibration therapy
665353|NCT00836394|JIA|jia
665354|NCT00836407|pancreatic cancer|pancreatic cancer
665355|NCT00836407|vaccine|vaccine
665356|NCT00836407|immunotherapy|immunotherapy
665357|NCT00836407|antibody|antibody
665358|NCT00836407|CTLA-4|ctla-4
665359|NCT00836420|ammonia|ammonia
665360|NCT00836420|acute liver failure|acute liver failure
665361|NCT00836420|brain edema|brain edema
665362|NCT00836420|oxidative metabolism|oxidative metabolism
665363|NCT00836420|intracranial pressure|intracranial pressure
665364|NCT00836433|staff education|staff education
665365|NCT00836433|complexity science|complexity science
665366|NCT00836433|social constructivist theory|social constructivist theory
665368|NCT00836446|children|children
665369|NCT00836446|obesity|obesity
665370|NCT00836446|cardiovascular risk|cardiovascular risk
665371|NCT00836446|physical activity|physical activity
665372|NCT00836459|Humans|humans
665373|NCT00836459|Middle Aged|middle aged
665374|NCT00836459|Behavior Therapy|behavior therapy
665375|NCT00836459|Directive Counseling|directive counseling
665376|NCT00836459|Health Behavior|health behavior
665377|NCT00836459|Interview, Psychological|interview, psychological
665378|NCT00836459|Motivation|motivation
665379|NCT00836459|Exercise|exercise
665380|NCT00836459|Physical Fitness|physical fitness
665381|NCT00836459|Self Efficacy|self efficacy
665382|NCT00836459|Life Style|life style
665383|NCT00836459|Health Promotion|health promotion
665384|NCT00836459|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
665385|NCT00836459|Body Mass Index|body mass index
665386|NCT00836459|Monitoring, Ambulatory|monitoring, ambulatory
665387|NCT00836459|Walking|walking
665388|NCT00836472|Bioequivalence|bioequivalence
665389|NCT00836472|Healthy Subjects|healthy subjects
665390|NCT00836524|IUGR|iugr
665391|NCT00836524|Preeclampsia|preeclampsia
665392|NCT00836524|ultrasound|ultrasound
665393|NCT00836524|YKL-40|ykl-40
665394|NCT00836537|Bioequivalence|bioequivalence
665395|NCT00836537|Healthy Subjects|healthy subjects
665396|NCT00836550|HIV|hiv
665397|NCT00836550|HIV knowledge measure|hiv knowledge measure
665398|NCT00836550|Teen HIV testing|teen hiv testing
665399|NCT00836550|HIV Seronegativity|hiv seronegativity
665400|NCT00836563|Hemodialysis|hemodialysis
665401|NCT00836563|Arteriovenous Graft|arteriovenous graft
665402|NCT00836576|Bioequivalence|bioequivalence
665403|NCT00836576|Healthy Subjects|healthy subjects
665404|NCT00836589|Long-term safety and reliability of ICD leads|long-term safety and reliability of icd leads
665405|NCT00836641|preschool asthma|preschool asthma
665406|NCT00836641|sequential pneumococcal immunization|sequential pneumococcal immunization
665407|NCT00836641|immunogenicity|immunogenicity
665408|NCT00836641|safety|safety
665409|NCT00836654|EpCAM positive tumor|epcam positive tumor
665410|NCT00836654|malignant ascites|malignant ascites
665411|NCT00836654|intraperitoneal|intraperitoneal
665412|NCT00836667|Bioequivalence|bioequivalence
665413|NCT00836667|Healthy Subjects|healthy subjects
665414|NCT00836693|Erectile Dysfunction|erectile dysfunction
665415|NCT00836706|Bioequivalence|bioequivalence
665416|NCT00836706|Healthy Subjects|healthy subjects
665417|NCT00836719|Multiple sclerosis|multiple sclerosis
665418|NCT00836719|safety|safety
665419|NCT00836719|open label|open label
665420|NCT00836719|Polyphenon E|polyphenon e
665421|NCT00836719|EGCG|egcg
665422|NCT00836719|NAA|naa
665423|NCT00836719|N-acetyl-aspartate|n-acetyl-aspartate
665424|NCT00836719|MRI|mri
665425|NCT00836732|celle therapy|celle therapy
665426|NCT00836732|cell culture|cell culture
665427|NCT00836732|mesenchymal stem cells|mesenchymal stem cells
665428|NCT00836745|Advanced renal cell Cancer|advanced renal cell cancer
665429|NCT00836745|Non interventional study|non interventional study
665430|NCT00836745|Renal Cancer|renal cancer
665431|NCT00836745|Sutent|sutent
665432|NCT00836745|Metastatic|metastatic
665433|NCT00836745|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
665434|NCT00836771|Infant formula|infant formula
665435|NCT00836771|Probiotic microorganisms|probiotic microorganisms
665436|NCT00836771|prebiotic|prebiotic
665437|NCT00836784|Old tooth brush|old tooth brush
665438|NCT00836784|Plaque removal|plaque removal
665439|NCT00836797|Alveolar Bone Loss|alveolar bone loss
665440|NCT00836797|Alveolar ridge|alveolar ridge
665441|NCT00836797|Alveolar Process|alveolar process
665442|NCT00836810|Circadian variations of cytokines in PMR|circadian variations of cytokines in pmr
665443|NCT00836810|effect of TRT Prednisone in cytokines|effect of trt prednisone in cytokines
665444|NCT00836823|Patient-reported most bothersome symptom|patient-reported most bothersome symptom
665445|NCT00836823|Patient-reported symptom-specific goal achievement|patient-reported symptom-specific goal achievement
665446|NCT00836823|Medical treatment|medical treatment
665447|NCT00836836|Childhood epilepsy|childhood epilepsy
665448|NCT00836836|ketogenic diet|ketogenic diet
665449|NCT00836849|Bioequivalence|bioequivalence
665450|NCT00836849|Healthy Subjects|healthy subjects
665451|NCT00836862|Hemodialysis|hemodialysis
665452|NCT00836862|Vascular access|vascular access
666857|NCT00846092|NIR|nir
665453|NCT00836862|Arteriovenous fistula|arteriovenous fistula
665454|NCT00836875|Pediatrics voriconazole invasive fungal infection invasive aspergillosis immunocompromized|pediatrics voriconazole invasive fungal infection invasive aspergillosis immunocompromized
665455|NCT00836888|ONO-4538|ono-4538
665456|NCT00836888|MDX-1106|mdx-1106
665457|NCT00836888|solid tumors|solid tumors
665458|NCT00836901|Bioequivalence|bioequivalence
665459|NCT00836901|Healthy Subjects|healthy subjects
665460|NCT00836914|Allergic Rhinitis|allergic rhinitis
665461|NCT00836914|Allergy|allergy
665462|NCT00836914|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
665463|NCT00836940|Type 2 diabetes mellitus|type 2 diabetes mellitus
665464|NCT00836940|GRC 8200|grc 8200
665465|NCT00836953|Influenza|influenza
665466|NCT00836953|Fluzone®|fluzone®
665467|NCT00836953|Children|children
665468|NCT00836979|Urinary Incontinence|urinary incontinence
665469|NCT00836979|Incontinence|incontinence
665470|NCT00836979|bladder problems|bladder problems
665471|NCT00836979|bladder dysfunction|bladder dysfunction
665472|NCT00836992|anal cancer|anal cancer
665473|NCT00836992|colon cancer|colon cancer
665474|NCT00836992|rectal cancer|rectal cancer
665475|NCT00836992|esophageal cancer|esophageal cancer
665476|NCT00836992|extrahepatic bile duct cancer|extrahepatic bile duct cancer
665477|NCT00836992|gallbladder cancer|gallbladder cancer
665478|NCT00836992|gastric cancer|gastric cancer
665479|NCT00836992|adult primary liver cancer|adult primary liver cancer
665480|NCT00836992|pancreatic cancer|pancreatic cancer
665481|NCT00836992|small intestine cancer|small intestine cancer
665482|NCT00836992|non-small cell lung cancer|non-small cell lung cancer
665483|NCT00836992|small cell lung cancer|small cell lung cancer
665484|NCT00836992|head and neck cancer|head and neck cancer
665485|NCT00837005|dobutamine stress|dobutamine stress
665486|NCT00837005|inducible ischemia|inducible ischemia
665487|NCT00837005|CAD|cad
665488|NCT00837018|OSAS|osas
665489|NCT00837018|exercise|exercise
665490|NCT00837018|metabolic|metabolic
665491|NCT00837018|cardio-vascular|cardio-vascular
665492|NCT00837031|Pancreatic|pancreatic
665493|NCT00837031|Pancreatic Cancer|pancreatic cancer
665494|NCT00837031|Lenalidomide|lenalidomide
665495|NCT00837031|Revlimid|revlimid
665496|NCT00837031|Gemcitabine|gemcitabine
665497|NCT00837070|Zygapophyseal|zygapophyseal
665498|NCT00837070|joint|joint
665499|NCT00837070|cyst|cyst
665500|NCT00837070|Fluoroscopy|fluoroscopy
665501|NCT00837070|guided|guided
665502|NCT00837070|percutaneous|percutaneous
665503|NCT00837070|Lumbar|lumbar
665504|NCT00837083|hypercholesterolemia|hypercholesterolemia
665505|NCT00837083|cholesterol|cholesterol
665506|NCT00837083|LDL-cholesterol|ldl-cholesterol
665507|NCT00837083|rosuvastatin|rosuvastatin
665508|NCT00837083|Crestor|crestor
665509|NCT00837122|Diabetes|diabetes
665510|NCT00837122|Genetics|genetics
665511|NCT00837122|Type 2 Diabetes|type 2 diabetes
665512|NCT00837135|Pancreatic Cancer|pancreatic cancer
665513|NCT00837148|Sarcoma|sarcoma
665514|NCT00837148|Bone|bone
665515|NCT00837148|BAY 43-9006 (SORAFENIB)|bay 43-9006 (sorafenib)
665516|NCT00837148|DACARBAZINE|dacarbazine
665517|NCT00837148|08-068|08-068
665518|NCT00837161|High Intensity Focused Ultrasound Ablation|high intensity focused ultrasound ablation
665519|NCT00837161|Uterine Fibroids|uterine fibroids
665520|NCT00837161|Leiomyomata|leiomyomata
665521|NCT00837161|Non-Invasive Treatment of Uterine Fibroids|non-invasive treatment of uterine fibroids
665522|NCT00837161|MRI-Guided|mri-guided
665523|NCT00837161|Fibroids|fibroids
665524|NCT00837161|Uterine Leiomyomata|uterine leiomyomata
665525|NCT00837174|non-Hodgkin Lymphoma|non-hodgkin lymphoma
665526|NCT00837174|aggressive lymphoma|aggressive lymphoma
665527|NCT00837174|indolent lymphoma|indolent lymphoma
665528|NCT00837174|B cell lymphoma|b cell lymphoma
665529|NCT00837174|T cell lymphoma|t cell lymphoma
665530|NCT00837174|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
665531|NCT00837174|anaplastic large B cell lymphoma|anaplastic large b cell lymphoma
665532|NCT00837174|lymphoblastic lymphoma|lymphoblastic lymphoma
665533|NCT00837174|Burkitt's lymphoma|burkitt's lymphoma
665534|NCT00837174|transformed follicular center cell lymphoma|transformed follicular center cell lymphoma
665535|NCT00837174|transformed marginal zone lymphoma|transformed marginal zone lymphoma
665536|NCT00837174|transformed small lymphocytic lymphoma|transformed small lymphocytic lymphoma
665537|NCT00837174|grade 3 follicular center cell lymphoma|grade 3 follicular center cell lymphoma
665538|NCT00837174|blastic form marginal zone lymphoma|blastic form marginal zone lymphoma
665539|NCT00837174|transformed cutaneous T cell lymphoma|transformed cutaneous t cell lymphoma
665540|NCT00837174|mycosis fungoides stage IV|mycosis fungoides stage iv
665541|NCT00837174|angioimmunoblastic lymphadenopathy-like T-cell lymphoma|angioimmunoblastic lymphadenopathy-like t-cell lymphoma
665542|NCT00837174|nasal NK/T cell lymphoma|nasal nk/t cell lymphoma
665543|NCT00837174|peripheral T-cell lymphoma|peripheral t-cell lymphoma
665544|NCT00837174|small lymphocytic lymphoma|small lymphocytic lymphoma
665545|NCT00837174|lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
665546|NCT00837174|follicular center cell lymphoma grade 1|follicular center cell lymphoma grade 1
665547|NCT00837174|follicular center cell lymphoma grade 2|follicular center cell lymphoma grade 2
665548|NCT00837174|mantle cell lymphoma|mantle cell lymphoma
665549|NCT00837174|marginal zone lymphoma|marginal zone lymphoma
665550|NCT00837174|mycosis fungoides|mycosis fungoides
665551|NCT00837187|dexmedetomidine|dexmedetomidine
665552|NCT00837187|intranasal|intranasal
665553|NCT00837187|pharmacokinetics|pharmacokinetics
665554|NCT00837187|pharmacodynamics|pharmacodynamics
665555|NCT00837200|lymphoma|lymphoma
665556|NCT00837200|myeloma|myeloma
665557|NCT00837213|Acne|acne
665558|NCT00837239|HuaChanSu|huachansu
665559|NCT00837239|HCS|hcs
665560|NCT00837239|Gastrointestinal|gastrointestinal
665561|NCT00837239|Gastrointestinal Disease|gastrointestinal disease
665562|NCT00837239|Metastases|metastases
665563|NCT00837239|Cancer|cancer
665564|NCT00837239|Pancreatic cancer|pancreatic cancer
665565|NCT00837239|Placebo|placebo
665566|NCT00837239|Gemcitabine|gemcitabine
665567|NCT00837239|Gemcitabine Hydrocholoride|gemcitabine hydrocholoride
665568|NCT00837239|Gemzar|gemzar
665569|NCT00837239|Fudan UniversityCancer Hospital|fudan universitycancer hospital
665570|NCT00837252|Central Serous Chorioretinopathy|central serous chorioretinopathy
665571|NCT00837252|Finasteride|finasteride
665572|NCT00837252|Proscar|proscar
665573|NCT00837252|Retinal Eye Disease|retinal eye disease
665574|NCT00837265|Breast Cancer Supportive Care Neutropenia|breast cancer supportive care neutropenia
665575|NCT00837278|IVF|ivf
665576|NCT00837278|angiogenic factors|angiogenic factors
665577|NCT00837278|cytokines|cytokines
665578|NCT00837291|osteoarthritis|osteoarthritis
665579|NCT00837291|knee|knee
665580|NCT00837291|CF101|cf101
665581|NCT00837317|Phenols|phenols
665582|NCT00837317|Laser-Doppler|laser-doppler
665583|NCT00837317|Olive Oil|olive oil
665584|NCT00837317|Sunflower Oil|sunflower oil
665585|NCT00837317|Dimethylpolysiloxane|dimethylpolysiloxane
665586|NCT00837317|Postprandial|postprandial
665587|NCT00837317|Inflammation|inflammation
665588|NCT00837317|Oxidative Stress|oxidative stress
665589|NCT00837330|polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
665590|NCT00837330|choroidal neovascularization|choroidal neovascularization
665591|NCT00837330|ranibizumab|ranibizumab
665592|NCT00837330|Lucentis|lucentis
665593|NCT00837343|Bipolar disorder|bipolar disorder
665594|NCT00837369|Stress echocardiography|stress echocardiography
665595|NCT00837369|SPECT|spect
665596|NCT00837369|Myocardial perfusion imaging|myocardial perfusion imaging
665597|NCT00837395|premenstrual increase in asthma symptoms|premenstrual increase in asthma symptoms
665598|NCT00837408|Diabetes|diabetes
665599|NCT00837408|Genetics|genetics
665600|NCT00837408|Asians|asians
665601|NCT00837408|Type 2 Diabetes|type 2 diabetes
665602|NCT00837421|sepsis|sepsis
665603|NCT00837421|registry|registry
665604|NCT00837434|tumor necrosis factor (TNF) blockade|tumor necrosis factor (tnf) blockade
665605|NCT00837434|inflammatory autoimmune disorder|inflammatory autoimmune disorder
665606|NCT00837460|Hand|hand
665607|NCT00837460|Rehabilitation|rehabilitation
665608|NCT00837473|Bone Void Filler|bone void filler
665609|NCT00837473|Iliac Crest Bone Void Filler|iliac crest bone void filler
665610|NCT00837473|Back Surgery and Autograft Bone|back surgery and autograft bone
665611|NCT00837473|Autograft Bone|autograft bone
665612|NCT00837473|Allograft Bone|allograft bone
665613|NCT00837486|Treatment Resistant Depression|treatment resistant depression
665614|NCT00837486|Treatment Refractory Depression|treatment refractory depression
665615|NCT00837486|Deep Brain Stimulation|deep brain stimulation
665616|NCT00837486|Depression|depression
665618|NCT00837499|Breast Cancer|breast cancer
665619|NCT00837499|Risk Factors|risk factors
665620|NCT00837499|Mexican Women|mexican women
665621|NCT00837499|Mexican-American Women|mexican-american women
665622|NCT00837499|African-American Women|african-american women
665623|NCT00837499|Epidemiological|epidemiological
665624|NCT00837499|Questionnaire|questionnaire
665626|NCT00837499|Interview|interview
665627|NCT00837512|microneedle continuous subcutaneous insulin infusion|microneedle continuous subcutaneous insulin infusion
665628|NCT00837538|Spinal sagittal range of motion|spinal sagittal range of motion
665629|NCT00837538|Intersegmental range of motion|intersegmental range of motion
665630|NCT00837538|Spinal Mouse|spinal mouse
665631|NCT00837551|Non-steroid|non-steroid
665632|NCT00837551|Small molecule|small molecule
665633|NCT00837551|Topical cream|topical cream
665634|NCT00837551|Inflammatory disease|inflammatory disease
665635|NCT00837551|Skin|skin
665636|NCT00837564|chronic depression|chronic depression
665637|NCT00837564|CBASP|cbasp
665638|NCT00837564|Escitalopram|escitalopram
665639|NCT00837564|depression|depression
665640|NCT00837564|trauma|trauma
665641|NCT00837590|Vascular function|vascular function
665642|NCT00837590|Glucose tolerance|glucose tolerance
665643|NCT00837590|Obesity|obesity
665644|NCT00837590|Pre-diabetes|pre-diabetes
665645|NCT00837603|tga|tga
665646|NCT00837603|atrial switch|atrial switch
665647|NCT00837603|training|training
665648|NCT00837616|Turner Syndrome|turner syndrome
665649|NCT00837616|Hypogonadism|hypogonadism
665650|NCT00837616|GH|gh
665651|NCT00837616|Estrogen|estrogen
665652|NCT00837616|Estrogen Patches|estrogen patches
665653|NCT00837616|IGF-I|igf-i
665654|NCT00837616|Body Composition|body composition
665655|NCT00837616|Protein Metabolism|protein metabolism
665656|NCT00837616|Lipid Oxidation|lipid oxidation
665657|NCT00837616|Estradiol assay by LCMSMS|estradiol assay by lcmsms
665658|NCT00837616|Recombinant Cell Bioassay|recombinant cell bioassay
665659|NCT00837629|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
665660|NCT00837629|COPD|copd
665661|NCT00837629|Symbicort Turbuhaler|symbicort turbuhaler
665662|NCT00837642|Vascular function in offspring of ART|vascular function in offspring of art
665663|NCT00837655|Chronic kidney disease|chronic kidney disease
665664|NCT00837655|End-stage renal disease|end-stage renal disease
665665|NCT00837655|phosphate binder|phosphate binder
665666|NCT00837655|insulin resistance|insulin resistance
665667|NCT00837655|glucose intolerance|glucose intolerance
665668|NCT00837655|sevelamer|sevelamer
665669|NCT00837668|sarcoidosis|sarcoidosis
665670|NCT00837668|stromal gene expression|stromal gene expression
665671|NCT00837668|pulmonary sarcoidosis|pulmonary sarcoidosis
665672|NCT00837668|bronchoscopy|bronchoscopy
665673|NCT00837681|Bone Marrow Transplant|bone marrow transplant
665674|NCT00837681|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
665675|NCT00837694|BMI|bmi
665676|NCT00837694|obesity|obesity
665677|NCT00837694|sensitization|sensitization
665678|NCT00837694|food reinforcement|food reinforcement
665679|NCT00837694|snack food|snack food
665680|NCT00837694|Portion size of daily snacks|portion size of daily snacks
665681|NCT00837694|Weight status|weight status
665682|NCT00837707|aripiprazole|aripiprazole
665683|NCT00837707|Tardive Dyskinesia|tardive dyskinesia
665684|NCT00837720|hypertension|hypertension
665685|NCT00837720|blood pressure|blood pressure
665686|NCT00837720|Atacand®|atacand®
665687|NCT00837720|candesartan|candesartan
665688|NCT00837733|Endometrial biopsy|endometrial biopsy
665689|NCT00837733|IVF/ICSI|ivf/icsi
665690|NCT00837733|Pregnancy outcome|pregnancy outcome
665881|NCT00832247|Cirrhosis|cirrhosis
665691|NCT00837733|Recurrent implantation failure|recurrent implantation failure
665692|NCT00837759|Type I Diabetes|type i diabetes
665693|NCT00837759|Preserve Beta Cell Function|preserve beta cell function
665694|NCT00837759|Sitagliptin|sitagliptin
665695|NCT00837759|Lansoprazole|lansoprazole
665696|NCT00837759|GAD65 (Diamyd)|gad65 (diamyd)
665697|NCT00837759|Diabetes|diabetes
665698|NCT00837759|Type 1 Diabetes|type 1 diabetes
665699|NCT00837759|T1DM|t1dm
665700|NCT00837772|Alignment|alignment
665701|NCT00837811|Arthritis|arthritis
665702|NCT00837824|Fabry Disease patients with Severe Renal Disease|fabry disease patients with severe renal disease
665703|NCT00837837|pharmacokinetics|pharmacokinetics
665704|NCT00837837|children|children
665705|NCT00837837|adolescents|adolescents
665706|NCT00837837|antihistamine|antihistamine
665707|NCT00837850|total hip arthroplasty|total hip arthroplasty
665708|NCT00837850|Charnley stem|charnley stem
665709|NCT00837850|RSA|rsa
665710|NCT00837850|non-inflammatory arthritis|non-inflammatory arthritis
665711|NCT00837876|recurrent pancreatic cancer|recurrent pancreatic cancer
665712|NCT00837876|stage III pancreatic cancer|stage iii pancreatic cancer
665713|NCT00837876|stage IV pancreatic cancer|stage iv pancreatic cancer
665714|NCT00837876|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
665715|NCT00837889|cognition|cognition
665716|NCT00837889|decompensation|decompensation
665717|NCT00837889|heart failure|heart failure
665718|NCT00837889|recompensation|recompensation
665719|NCT00837902|Atenolol|atenolol
665720|NCT00837902|Exercise|exercise
665721|NCT00837902|Genotype|genotype
665722|NCT00837902|Healthy volunteers|healthy volunteers
665723|NCT00837915|Bioequivaelnce Loratadine 10mg /Pseudoephedrine Sulfate 240 mg Extended Release Tablets|bioequivaelnce loratadine 10mg /pseudoephedrine sulfate 240 mg extended release tablets
665724|NCT00837928|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
665725|NCT00837928|tumors metastatic to brain|tumors metastatic to brain
665726|NCT00837954|PTFE Graft|ptfe graft
665727|NCT00837954|Suture Hole Bleeding|suture hole bleeding
665728|NCT00837954|Hemostasis|hemostasis
665729|NCT00837967|Asthma|asthma
665730|NCT00837967|Symbicort Turbuhaler|symbicort turbuhaler
665731|NCT00837980|head and neck cancer|head and neck cancer
665732|NCT00837980|DW MRI|dw mri
665733|NCT00837980|PET|pet
665734|NCT00837980|DCE MRI|dce mri
665735|NCT00837980|functional imaging|functional imaging
665736|NCT00837980|IMRT|imrt
665737|NCT00837993|Advanced Stage Serous Carcinoma of the Ovary|advanced stage serous carcinoma of the ovary
665738|NCT00837993|serous ovarian carcinoma|serous ovarian carcinoma
665739|NCT00837993|Ovary|ovary
665740|NCT00837993|GOG Protocol 158|gog protocol 158
665741|NCT00837993|Survival Analysis|survival analysis
665742|NCT00837993|Pathology Slides|pathology slides
665743|NCT00837993|Two-tier Grading System|two-tier grading system
665744|NCT00837993|Ancillary Study|ancillary study
665745|NCT00838006|post-traumatic stress disorder|post-traumatic stress disorder
665746|NCT00838006|post-deployment|post-deployment
665747|NCT00838006|prediction|prediction
665748|NCT00838006|prevention|prevention
665749|NCT00838032|acute schizophrenic patients|acute schizophrenic patients
665750|NCT00838058|pharmacology formulation normal healthy volunteers food effect|pharmacology formulation normal healthy volunteers food effect
665751|NCT00838071|Hepatitis B|hepatitis b
665752|NCT00838071|HBV|hbv
665753|NCT00838071|Anti-hepatitis B antibodies|anti-hepatitis b antibodies
665754|NCT00838071|Immunoglobulins|immunoglobulins
665755|NCT00838071|liver transplantation|liver transplantation
665756|NCT00838071|Protective levels|protective levels
665758|NCT00838071|Intravenous|intravenous
665759|NCT00838097|CKD|ckd
665760|NCT00838097|Paediatric|paediatric
665761|NCT00838097|Darbepoetin Alfa|darbepoetin alfa
665762|NCT00838110|Alzheimer's Disease|alzheimer's disease
665763|NCT00838110|Dimebon|dimebon
665764|NCT00838110|Safety|safety
665765|NCT00838110|Tolerability|tolerability
665766|NCT00838136|Bioequivalence|bioequivalence
665767|NCT00838136|Healthy Subjects|healthy subjects
665768|NCT00838162|Human immunodeficiency virus type 1|human immunodeficiency virus type 1
665769|NCT00838162|HIV-1|hiv-1
665770|NCT00838162|HIV-1 treatment-naive|hiv-1 treatment-naive
665771|NCT00838162|TMC310911|tmc310911
665772|NCT00838162|Protease inhibitor|protease inhibitor
665773|NCT00838162|Ritonavir|ritonavir
665774|NCT00838162|Antiviral Activity|antiviral activity
665775|NCT00838162|HIV Infections|hiv infections
665776|NCT00838162|Treatment Naive|treatment naive
665777|NCT00838175|Peripheral Venous Catheterization|peripheral venous catheterization
665778|NCT00838188|Metabolic rate|metabolic rate
665779|NCT00838188|indirect calorimetry|indirect calorimetry
665780|NCT00838188|oral feeding|oral feeding
665781|NCT00838201|Androgen deprivation therapy for non-metastatic prostate cancer|androgen deprivation therapy for non-metastatic prostate cancer
665782|NCT00838227|Schizophrenia|schizophrenia
665783|NCT00838227|Cognition|cognition
665784|NCT00838227|Obesity|obesity
665785|NCT00838227|Sedation|sedation
665786|NCT00838240|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
665787|NCT00838240|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
665788|NCT00838240|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
665789|NCT00838240|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
665790|NCT00838240|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
665791|NCT00838240|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
665792|NCT00838240|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
665793|NCT00838240|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
665794|NCT00838240|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
665795|NCT00838240|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
665796|NCT00838240|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
665797|NCT00838240|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
665798|NCT00838240|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
665799|NCT00838240|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
665800|NCT00838240|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
665801|NCT00838240|secondary acute myeloid leukemia|secondary acute myeloid leukemia
665802|NCT00838253|Acute Heart Failure|acute heart failure
665803|NCT00838253|Inotropes|inotropes
665804|NCT00838253|Lusitropic agents|lusitropic agents
665805|NCT00838253|Istaroxime|istaroxime
665806|NCT00838253|Debio 0614|debio 0614
665807|NCT00838266|mouthrinse|mouthrinse
665808|NCT00838266|grape seed extract|grape seed extract
665810|NCT00838266|plaque index|plaque index
665811|NCT00838279|Bioequivalence|bioequivalence
665812|NCT00838279|Healthy Subjects|healthy subjects
665813|NCT00838292|food supplementation|food supplementation
665814|NCT00838292|HIV|hiv
665815|NCT00838292|malnutrition|malnutrition
665816|NCT00838305|MDMA|mdma
665817|NCT00838305|citalopram|citalopram
665818|NCT00838305|serotonin|serotonin
665819|NCT00838305|psychedelic|psychedelic
665820|NCT00831987|Fluzone®|fluzone®
665821|NCT00831987|Influenza|influenza
665822|NCT00831987|Adults|adults
665823|NCT00832013|Propofol|propofol
665824|NCT00832013|sedation|sedation
665825|NCT00832013|pediatric|pediatric
665826|NCT00832013|Induction of sedation|induction of sedation
665827|NCT00832026|sleep apnea|sleep apnea
665828|NCT00832026|snoring|snoring
665829|NCT00832026|sleep apnea treatment|sleep apnea treatment
665830|NCT00832026|TNI|tni
665831|NCT00832026|Trans nasal insuflation|trans nasal insuflation
665832|NCT00832026|Open CPAP|open cpap
665833|NCT00832039|sepsis|sepsis
665834|NCT00832039|adjunctive therapy|adjunctive therapy
665835|NCT00832039|sodium-selenite|sodium-selenite
665836|NCT00832039|procalcitonin|procalcitonin
665837|NCT00832052|elderly, multi-dose, safety, efficacy|elderly, multi-dose, safety, efficacy
665838|NCT00832065|Sleep Apnea Syndrome|sleep apnea syndrome
665839|NCT00832065|Sleep Apnea|sleep apnea
665840|NCT00832065|CPAP|cpap
665841|NCT00832065|Low testosterone|low testosterone
665842|NCT00832065|Sexual Dysfunction|sexual dysfunction
665843|NCT00832091|Venous Stasis Ulcers|venous stasis ulcers
665844|NCT00832091|venous insufficiency|venous insufficiency
665845|NCT00832091|leg ulcers|leg ulcers
665846|NCT00832091|Thymosin Beta 4|thymosin beta 4
665847|NCT00832091|Laminin-5|laminin-5
665848|NCT00832117|Lung Cancer (NSCLC)|lung cancer (nsclc)
665849|NCT00832143|neonatal illness|neonatal illness
665850|NCT00832143|qualified care seeking|qualified care seeking
665851|NCT00832143|Behaviour change|behaviour change
665852|NCT00832143|Urban slums|urban slums
665853|NCT00832143|India|india
665854|NCT00832143|Neonatal morbidity|neonatal morbidity
665855|NCT00832143|Care seeking for neonatal illnesses|care seeking for neonatal illnesses
665856|NCT00832143|Qualified medical care seeking|qualified medical care seeking
665857|NCT00832143|Integrated management of neonatal and childhood illnesses (IMNCI)|integrated management of neonatal and childhood illnesses (imnci)
665858|NCT00832156|Burns|burns
665859|NCT00832156|Cultured autologous keratinocytes|cultured autologous keratinocytes
665860|NCT00832156|Wound healing|wound healing
665861|NCT00832156|Wound closure|wound closure
665862|NCT00832156|Scar quality|scar quality
665863|NCT00832169|Pain|pain
665864|NCT00832195|running|running
665865|NCT00832195|injury|injury
665866|NCT00832195|pronation|pronation
665867|NCT00832195|footwear.|footwear.
665869|NCT00832221|Phase 1|phase 1
665870|NCT00832221|Depression|depression
665871|NCT00832221|SEROQUEL|seroquel
665872|NCT00832221|Positron Emission Tomography|positron emission tomography
665873|NCT00832221|Drug profile comparison|drug profile comparison
665874|NCT00832234|Morbus Waldenstrom|morbus waldenstrom
665875|NCT00832234|Waldenstroms Macroglobulinemia|waldenstroms macroglobulinemia
665876|NCT00832234|Therapy|therapy
665877|NCT00832234|Rituximab|rituximab
665878|NCT00832234|Dexamethasone|dexamethasone
665879|NCT00832234|Bortezomib|bortezomib
665880|NCT00832247|Hepatitis C|hepatitis c
665882|NCT00832247|Stem cell|stem cell
665883|NCT00832273|Expanded access to ELAD® in patients with liver failure|expanded access to elad® in patients with liver failure
665884|NCT00832286|genomic techniques,intestinal microbiome|genomic techniques,intestinal microbiome
665885|NCT00832312|Osteoarthritis|osteoarthritis
665886|NCT00832312|Knee|knee
665887|NCT00832312|Pain management|pain management
665888|NCT00832312|Ozone therapy|ozone therapy
665889|NCT00832312|Intraarticular injection|intraarticular injection
665890|NCT00832325|Childhood Survivor|childhood survivor
665891|NCT00832325|survivors|survivors
665892|NCT00832325|Young Adult Cancer Survivors|young adult cancer survivors
665893|NCT00832325|Childhood cancers|childhood cancers
665894|NCT00832325|09-001|09-001
665895|NCT00832338|Breast cancer|breast cancer
665896|NCT00832338|Tumors, Breast|tumors, breast
665897|NCT00832338|Cancer of the breast|cancer of the breast
665898|NCT00832351|Stroke|stroke
665899|NCT00832351|Brain infarction|brain infarction
665900|NCT00832351|Intracerebral hemorrhage|intracerebral hemorrhage
665901|NCT00832351|Early Mobilisation|early mobilisation
665902|NCT00832364|Psoriasis|psoriasis
665903|NCT00832364|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
665904|NCT00832403|atrophic rhinitis|atrophic rhinitis
665905|NCT00832403|implants|implants
665906|NCT00832403|Polytetrafluoroethylene|polytetrafluoroethylene
665907|NCT00832429|Sebaceous Gland Carcinoma of the Eyelid|sebaceous gland carcinoma of the eyelid
665908|NCT00832429|Eyelid Sebaceous Gland Carcinoma|eyelid sebaceous gland carcinoma
665909|NCT00832429|Cancer of the eyelid|cancer of the eyelid
665910|NCT00832429|Eye Cancer|eye cancer
665911|NCT00832429|Tumors of the Eye|tumors of the eye
665912|NCT00832429|Sentinel Lymph Node Localization and Biopsy|sentinel lymph node localization and biopsy
665913|NCT00832429|SLN|sln
665914|NCT00832429|Metastatic Disease|metastatic disease
665915|NCT00832429|Metastatic Cancer of the Eyelid|metastatic cancer of the eyelid
665916|NCT00832429|Lymphatic Mapping|lymphatic mapping
665917|NCT00832429|SLN Mapping/Biopsy|sln mapping/biopsy
665918|NCT00832429|SLN Biopsy Procedure|sln biopsy procedure
665919|NCT00832429|SLN Biopsy|sln biopsy
665920|NCT00832429|Lymph Nodes|lymph nodes
665921|NCT00832429|Tc99m-Sulfur Colloid|tc99m-sulfur colloid
665922|NCT00832429|Single Photon Emission Computed Tomography|single photon emission computed tomography
665923|NCT00832429|Computed Tomography|computed tomography
665924|NCT00832429|SPECT/CT|spect/ct
665925|NCT00832442|Beta blocker|beta blocker
665926|NCT00832442|Heart Failure|heart failure
665927|NCT00832442|Meta analysis|meta analysis
665928|NCT00832442|Individual patient data|individual patient data
665929|NCT00832468|insomnia|insomnia
665930|NCT00832468|ear acupressure|ear acupressure
665931|NCT00832481|Repaglinide|repaglinide
665932|NCT00832481|Metformin|metformin
665933|NCT00832507|PAH|pah
665934|NCT00832507|pulmonary hypertension|pulmonary hypertension
665935|NCT00832507|cicletanine|cicletanine
665936|NCT00832507|cicletanine HCL|cicletanine hcl
665937|NCT00832507|cardiovascular|cardiovascular
665938|NCT00832507|endothelin receptor antagonist|endothelin receptor antagonist
665939|NCT00832507|ERA|era
665940|NCT00832507|monotherapy|monotherapy
665941|NCT00832507|combination therapy|combination therapy
665942|NCT00832507|phosphodiesterase type-5 inhibitor|phosphodiesterase type-5 inhibitor
665943|NCT00832507|PDE5i|pde5i
665944|NCT00832507|parenteral prostanoid|parenteral prostanoid
665945|NCT00832507|PH|ph
665946|NCT00832507|pulmonary|pulmonary
665948|NCT00832520|weight loss|weight loss
665949|NCT00832520|Remeron|remeron
665950|NCT00832520|body weight|body weight
665951|NCT00832533|Vitamin D|vitamin d
665952|NCT00832533|Serum 25-Hydroxyvitamin D|serum 25-hydroxyvitamin d
665953|NCT00832533|UV exposure|uv exposure
665954|NCT00832533|Ultraviolet Light Exposure|ultraviolet light exposure
665955|NCT00832533|Skin Melanoma Advanced|skin melanoma advanced
665956|NCT00832559|CAVATAK|cavatak
665957|NCT00832559|Coxsackievirus A21|coxsackievirus a21
665958|NCT00832559|CVA21|cva21
665959|NCT00832559|Oncolytic virotherapy|oncolytic virotherapy
665960|NCT00832572|Coronary Artery Disease|coronary artery disease
665961|NCT00832572|Pain|pain
665962|NCT00832572|Peripheral Neuropathy|peripheral neuropathy
665963|NCT00832572|Polyneuropathy|polyneuropathy
665964|NCT00832585|Atopic|atopic
665965|NCT00832585|Dermatitis|dermatitis
665966|NCT00832585|chronic|chronic
665967|NCT00832585|skin|skin
665968|NCT00832598|18F-FACBC|18f-facbc
665969|NCT00832598|PET scan imaging|pet scan imaging
665970|NCT00832598|08-142|08-142
665971|NCT00832611|Lung Disease|lung disease
665972|NCT00832611|Chronic Airflow Obstruction|chronic airflow obstruction
665973|NCT00832611|Chronic Bronchitis|chronic bronchitis
665974|NCT00832611|Chronic Emphysema|chronic emphysema
665975|NCT00832637|Liver|liver
665976|NCT00832637|Gallbladder|gallbladder
665977|NCT00832637|Bile duct|bile duct
665978|NCT00832637|Gemzar|gemzar
665979|NCT00832637|Eloxatin|eloxatin
665980|NCT00832637|Tarceva|tarceva
665981|NCT00832637|erlotinib|erlotinib
665982|NCT00832637|Gem-ox|gem-ox
666264|NCT00843531|erlotinib|erlotinib
666265|NCT00843531|Tarceva|tarceva
665983|NCT00832650|Healthy; Fesoterodine; Solifenacin|healthy; fesoterodine; solifenacin
665984|NCT00838318|Colorectal CancerScreening|colorectal cancerscreening
665985|NCT00838318|CRC|crc
665986|NCT00838318|Hispanic|hispanic
665987|NCT00838318|CRC Patients|crc patients
665988|NCT00838318|First-Degree Relatives|first-degree relatives
665989|NCT00838318|FDRs|fdrs
665990|NCT00838318|Interviews|interviews
665991|NCT00838318|Colorectal cancer screening|colorectal cancer screening
665992|NCT00838318|CRCS|crcs
665993|NCT00838318|Key Informants|key informants
665994|NCT00838331|Blood Transfusions|blood transfusions
665995|NCT00838344|medication adherence|medication adherence
665996|NCT00838344|medication persistence|medication persistence
665997|NCT00838344|pharmacist interventions|pharmacist interventions
665998|NCT00838344|diabetes|diabetes
665999|NCT00838344|persistence|persistence
666000|NCT00838344|adherence|adherence
666001|NCT00838357|Mobilisation stem cells|mobilisation stem cells
666002|NCT00838357|G-CSF Mobilisation Regimen|g-csf mobilisation regimen
666003|NCT00838357|Lymphoma|lymphoma
666004|NCT00838357|Multiple Myeloma|multiple myeloma
666005|NCT00838370|Pharmacogenetics|pharmacogenetics
666006|NCT00838370|cost-benefit analysis|cost-benefit analysis
666007|NCT00838370|toxicity|toxicity
666008|NCT00838370|antineoplastic drugs|antineoplastic drugs
666009|NCT00838370|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
666561|NCT00844948|Depression|depression
666010|NCT00838383|multi-center, placebo-controlled, randomized study of sitaxsentan administered to subjects post-cross-clamp release and 12 hours post-CPB|multi-center, placebo-controlled, randomized study of sitaxsentan administered to subjects post-cross-clamp release and 12 hours post-cpb
666011|NCT00838435|Phenylketonuria|phenylketonuria
666013|NCT00838435|Kuvan|kuvan
666014|NCT00838435|Phenoptin|phenoptin
666015|NCT00838435|Biopten|biopten
666016|NCT00838435|Neurocognitive Function|neurocognitive function
666017|NCT00838435|Phenylalanine|phenylalanine
666018|NCT00838448|exercise|exercise
666019|NCT00838448|cannabis use|cannabis use
666020|NCT00838448|visual cues|visual cues
666021|NCT00838474|metabolic rate|metabolic rate
666022|NCT00838474|music|music
666023|NCT00838474|preterm infants|preterm infants
666024|NCT00838474|energy expenditure|energy expenditure
666025|NCT00838474|NIDCA|nidca
666026|NCT00838487|chondroitin|chondroitin
666027|NCT00838487|glucosamine|glucosamine
666028|NCT00838487|osteoarthritis|osteoarthritis
666029|NCT00838500|Venous insufficiency|venous insufficiency
666030|NCT00838500|Leg ulcer|leg ulcer
666031|NCT00838500|balneology|balneology
666032|NCT00838500|hydrotherapy|hydrotherapy
666033|NCT00838500|Modified Rutherford score|modified rutherford score
666034|NCT00838500|Euroquol EQ 5d scale|euroquol eq 5d scale
666035|NCT00838500|CIVIQ2 scale|civiq2 scale
666036|NCT00838500|Visual analogic Scale|visual analogic scale
666037|NCT00838500|SPA treatment|spa treatment
666038|NCT00838513|aHUS|ahus
666039|NCT00838526|Gastroesophageal|gastroesophageal
666040|NCT00838526|Reflux|reflux
666041|NCT00838526|Disease|disease
666042|NCT00838526|GERD|gerd
666043|NCT00838539|Neratinib in combination with Temsirolimus|neratinib in combination with temsirolimus
666044|NCT00838539|solid tumors|solid tumors
666045|NCT00838539|phase 1|phase 1
666046|NCT00838539|dose finding study|dose finding study
666047|NCT00838552|asthma inflammation bronchoscopy|asthma inflammation bronchoscopy
666048|NCT00838565|Safety and tolerability Pharmacokinetics Pharmacodynamics PF-04236921|safety and tolerability pharmacokinetics pharmacodynamics pf-04236921
666049|NCT00838578|KRN330|krn330
666050|NCT00838578|Colorectal Cancer|colorectal cancer
666051|NCT00838578|Antimetabolites|antimetabolites
666052|NCT00838578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
666053|NCT00838578|Digestive System Neoplasms|digestive system neoplasms
666054|NCT00838578|Immunologic Factors|immunologic factors
666055|NCT00838578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
666056|NCT00838578|Antineoplastic Agents|antineoplastic agents
666057|NCT00838578|Gastrointestinal Diseases|gastrointestinal diseases
666058|NCT00838578|Physiological Effects of Drugs|physiological effects of drugs
666059|NCT00838578|Colonic Diseases|colonic diseases
666060|NCT00838578|Irinotecan|irinotecan
666061|NCT00838578|Enzyme Inhibitors|enzyme inhibitors
666062|NCT00838578|Intestinal Diseases|intestinal diseases
666063|NCT00838578|Immunosuppressive Agents|immunosuppressive agents
666064|NCT00838578|Rectal Diseases|rectal diseases
666065|NCT00838578|Pharmacologic Actions|pharmacologic actions
666066|NCT00838578|Intestinal Neoplasms|intestinal neoplasms
666067|NCT00838578|Neoplasms by Site|neoplasms by site
666068|NCT00838578|Digestive System Diseases|digestive system diseases
666069|NCT00838578|Therapeutic Uses|therapeutic uses
666070|NCT00838578|Fluorouracil|fluorouracil
666071|NCT00838578|Neoplasms|neoplasms
666072|NCT00838578|Gastrointestinal Neoplasms|gastrointestinal neoplasms
666073|NCT00838578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
666074|NCT00838578|Colorectal Neoplasms|colorectal neoplasms
666075|NCT00838591|MN-221|mn-221
666076|NCT00838591|Asthma|asthma
666077|NCT00838591|Acute|acute
666078|NCT00838591|Exacerbation|exacerbation
666079|NCT00838617|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
666080|NCT00838617|Ultrasonography|ultrasonography
666081|NCT00838617|Atrophy|atrophy
666082|NCT00838630|Bioequivalence|bioequivalence
666083|NCT00838630|Healthy Subjects|healthy subjects
666084|NCT00838643|allogeneic transplantation|allogeneic transplantation
666085|NCT00838643|Invasive aspergillosis|invasive aspergillosis
666086|NCT00838656|ovarian carcinosarcoma|ovarian carcinosarcoma
666087|NCT00838656|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
666088|NCT00838656|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
666089|NCT00838656|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
666090|NCT00838656|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
666091|NCT00838656|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
666092|NCT00838656|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
666093|NCT00838656|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
666094|NCT00838656|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
666095|NCT00838656|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
666096|NCT00838656|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
666097|NCT00838656|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
666098|NCT00838656|stage IV fallopian tube cancer|stage iv fallopian tube cancer
666099|NCT00842985|Cannabis Abuse|cannabis abuse
666100|NCT00842985|Cannabis Dependence|cannabis dependence
666101|NCT00842985|Cannabis-Related Disorder|cannabis-related disorder
666102|NCT00842985|Marijuana Dependence|marijuana dependence
666103|NCT00842985|Marihuana Abuse|marihuana abuse
666104|NCT00842998|breast cancer|breast cancer
666105|NCT00842998|HER2|her2
666106|NCT00842998|Trastuzumab|trastuzumab
666107|NCT00842998|Lapatinib|lapatinib
666108|NCT00842998|HER2 gene-amplification|her2 gene-amplification
666109|NCT00843011|formulation|formulation
666110|NCT00843011|safety and tolerability|safety and tolerability
666111|NCT00843011|pharmacokinetics|pharmacokinetics
666112|NCT00843011|NK1 antagonist|nk1 antagonist
666113|NCT00843011|effect of food|effect of food
666114|NCT00843024|Migraine with or without aura|migraine with or without aura
666115|NCT00843024|Migraine efficacy|migraine efficacy
666116|NCT00843024|Migraine|migraine
666117|NCT00843024|Migraine headache|migraine headache
666118|NCT00843024|Adolescent migraine|adolescent migraine
666119|NCT00843024|TREXIMET|treximet
666120|NCT00843024|Sumatriptan succinate|sumatriptan succinate
666121|NCT00843024|Naproxen sodium|naproxen sodium
666122|NCT00843024|Migraine, acute|migraine, acute
666123|NCT00843037|PARAGANGLIOMA|paraganglioma
666124|NCT00843037|PHEOCHROMOCYTOMA|pheochromocytoma
666125|NCT00843037|SUNITINIB|sunitinib
666126|NCT00843037|PHASE II|phase ii
666127|NCT00843037|Metastatic or locally advanced malignant paraganglioma|metastatic or locally advanced malignant paraganglioma
666128|NCT00843037|Metastatic or locally advanced malignant pheochromocytoma|metastatic or locally advanced malignant pheochromocytoma
666129|NCT00843050|CKD inhibitor|ckd inhibitor
666130|NCT00843050|Mantle Cell Lymphoma|mantle cell lymphoma
666131|NCT00843063|pantoprazole|pantoprazole
666132|NCT00843063|famotidine|famotidine
666133|NCT00843063|aspirin|aspirin
666134|NCT00843063|dyspepsia|dyspepsia
666135|NCT00843063|gastrointestinal bleeding|gastrointestinal bleeding
666136|NCT00843063|peptic ulcer / erosion|peptic ulcer / erosion
666137|NCT00843089|coronary artery disease|coronary artery disease
666138|NCT00843089|CABG|cabg
666139|NCT00843102|atherosclerosis|atherosclerosis
666140|NCT00843102|pulmonary hypertension|pulmonary hypertension
666141|NCT00843115|Alzheimer's Disease, naturalistic study|alzheimer's disease, naturalistic study
666142|NCT00843141|ADHD|adhd
666143|NCT00843141|Executive functions|executive functions
666144|NCT00843141|Quality of life|quality of life
666145|NCT00843154|Natriuretic Peptide, Brain|natriuretic peptide, brain
666146|NCT00843154|Biological Markers|biological markers
666147|NCT00843154|Biomarkers|biomarkers
666148|NCT00843154|Cardiac Failure|cardiac failure
666149|NCT00843154|Congestive Heart Failure|congestive heart failure
666150|NCT00843154|Heart Decompensation|heart decompensation
666151|NCT00843154|Drug Therapy|drug therapy
666152|NCT00843167|mammography|mammography
666153|NCT00843167|biopsy|biopsy
666154|NCT00843167|ductal breast carcinoma in situ|ductal breast carcinoma in situ
666155|NCT00843167|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
666156|NCT00843180|Bone Marrow Transplant|bone marrow transplant
666157|NCT00843180|Massage|massage
666158|NCT00843180|Pediatric Oncology|pediatric oncology
666159|NCT00843180|children undergoing bone marrow transplantation|children undergoing bone marrow transplantation
666160|NCT00843193|Asthma|asthma
666161|NCT00843193|Asthma control questionnaire|asthma control questionnaire
666162|NCT00843219|Lung|lung
666163|NCT00843219|Lung Cancer|lung cancer
666164|NCT00843219|Non-small cell Lung Cancer|non-small cell lung cancer
666165|NCT00843219|NSCLC|nsclc
666166|NCT00843219|Motion Correction|motion correction
666167|NCT00843219|PET/CT Scan|pet/ct scan
666168|NCT00843219|PET|pet
666169|NCT00843219|Positron Emission Tomography|positron emission tomography
666170|NCT00843219|CT|ct
666171|NCT00843219|Computed Tomography|computed tomography
666172|NCT00843219|Amplitude Gating|amplitude gating
666173|NCT00843232|diabetes mellitus, type 2|diabetes mellitus, type 2
666174|NCT00843232|Insulin resistance|insulin resistance
666176|NCT00843232|Incretins|incretins
666177|NCT00843232|DPP-IV protein, human|dpp-iv protein, human
666178|NCT00843232|Glucagon-Like Peptide 1|glucagon-like peptide 1
666179|NCT00843232|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
666180|NCT00843232|insulin|insulin
666181|NCT00843232|glucagon|glucagon
666182|NCT00843232|ghrelin|ghrelin
666183|NCT00843245|Heart Failure|heart failure
666184|NCT00843245|Electric bioimpedance|electric bioimpedance
666185|NCT00843245|Body composition|body composition
666186|NCT00843245|Diagnosis|diagnosis
666187|NCT00843245|monitoring|monitoring
666188|NCT00843245|Prognosis|prognosis
666189|NCT00843245|Total body water|total body water
666190|NCT00843258|therapy|therapy
666191|NCT00843258|ultrasound|ultrasound
666192|NCT00843258|mild dysplasia|mild dysplasia
666193|NCT00843271|COPD MESA LUNG BIOMARKERS|copd mesa lung biomarkers
666194|NCT00843284|neuropathic, pain, pregabalin, Lyrica|neuropathic, pain, pregabalin, lyrica
666195|NCT00843297|Sudden Cardiac Arrest|sudden cardiac arrest
666196|NCT00843297|Hypothermia|hypothermia
666197|NCT00843297|Outcome, neurological|outcome, neurological
666198|NCT00843297|Coolgard|coolgard
666199|NCT00843297|ArcticSun|arcticsun
666200|NCT00843310|multiple myeloma|multiple myeloma
666201|NCT00843310|frontline treatment|frontline treatment
666202|NCT00843310|first-line treatment|first-line treatment
666203|NCT00843336|fertility monitoring|fertility monitoring
666204|NCT00843336|contraception|contraception
666205|NCT00843349|Phosphorus|phosphorus
666206|NCT00843349|Fibroblast Growth Factor-23|fibroblast growth factor-23
666207|NCT00843349|Kidney Disease|kidney disease
666208|NCT00843401|Low oxygen saturation|low oxygen saturation
666209|NCT00843401|Anticipated need for pulse oximetry monitoring|anticipated need for pulse oximetry monitoring
666210|NCT00843401|Arterial line in place as indicated per patient's clinical management needs|arterial line in place as indicated per patient's clinical management needs
666211|NCT00843401|Availability to analyze arterial blood saturation by Co-Oximeter or|availability to analyze arterial blood saturation by co-oximeter or
666212|NCT00843401|Blood Gas Analyzer|blood gas analyzer
666213|NCT00843414|Emphysema|emphysema
666214|NCT00843414|Sarcoidosis|sarcoidosis
666215|NCT00843414|Interstitial Pulmonary Fibrosis|interstitial pulmonary fibrosis
666216|NCT00843427|aphasia|aphasia
666217|NCT00843427|stroke|stroke
666218|NCT00843427|functional magnetic resonance imaging|functional magnetic resonance imaging
666219|NCT00843427|fMRI|fmri
666220|NCT00843427|language recovery after stroke|language recovery after stroke
666221|NCT00843427|constraint-induced aphasia therapy|constraint-induced aphasia therapy
666222|NCT00843427|CIAT|ciat
666223|NCT00843440|Antiangiogenic therapies|antiangiogenic therapies
666224|NCT00843440|Bevacuzimab|bevacuzimab
666225|NCT00843440|Hemorrhagic Hereditary Telangiectasia (HHT) with severe liver involvement|hemorrhagic hereditary telangiectasia (hht) with severe liver involvement
666226|NCT00843453|vitamin B12 deficiency|vitamin b12 deficiency
666227|NCT00843453|cyanocobalamin deficiency|cyanocobalamin deficiency
666228|NCT00843453|proton pump inhibitors|proton pump inhibitors
666229|NCT00843453|omeprazole|omeprazole
666230|NCT00843466|Hand dermatitis|hand dermatitis
666231|NCT00843479|diabetes mellitus, type 2|diabetes mellitus, type 2
666232|NCT00843479|Insulin resistance|insulin resistance
666234|NCT00843479|Incretins|incretins
666235|NCT00843479|DPP-IV protein, human|dpp-iv protein, human
666236|NCT00843479|Glucagon-Like Peptide 1|glucagon-like peptide 1
666355|NCT00844038|erythema multiform|erythema multiform
666237|NCT00843479|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
666238|NCT00843479|insulin|insulin
666239|NCT00843479|glucagon|glucagon
666240|NCT00843479|ghrelin|ghrelin
666241|NCT00843492|deep vein thrombosis|deep vein thrombosis
666242|NCT00843492|immobilization|immobilization
666243|NCT00843492|nadroparin|nadroparin
666244|NCT00843492|isolated lower-extremity injuries distal to the knee|isolated lower-extremity injuries distal to the knee
666245|NCT00843492|plaster cast|plaster cast
666246|NCT00843492|non-surgical leg injury|non-surgical leg injury
666247|NCT00843492|venous thromboembolism|venous thromboembolism
666248|NCT00843492|bleeding events|bleeding events
666249|NCT00843492|fondaparinux|fondaparinux
666250|NCT00843505|Smoking Cessation|smoking cessation
666251|NCT00843505|Motivational Interviewing|motivational interviewing
666252|NCT00843505|Quitline|quitline
666253|NCT00843505|Telemedicine|telemedicine
666254|NCT00843505|Stop Smoking Medication|stop smoking medication
666255|NCT00843518|Agitation and Aggression|agitation and aggression
666256|NCT00843531|neuroendocrine|neuroendocrine
666257|NCT00843531|islet cell|islet cell
666258|NCT00843531|carcinoid|carcinoid
666259|NCT00843531|pancreatic neuroendocrine|pancreatic neuroendocrine
666260|NCT00843531|paraganglioma|paraganglioma
666261|NCT00843531|pheochromocytoma|pheochromocytoma
666262|NCT00843531|RAD001|rad001
666263|NCT00843531|everolimus|everolimus
666266|NCT00843557|critical illness|critical illness
666267|NCT00843557|intensive care|intensive care
666268|NCT00843557|nosocomial infection|nosocomial infection
666269|NCT00843570|IVF|ivf
666270|NCT00843570|Frozen Embryo Replacement|frozen embryo replacement
666271|NCT00843583|prevalence|prevalence
666272|NCT00843583|obstructive sleep apnea|obstructive sleep apnea
666273|NCT00843583|resistant hypertension|resistant hypertension
666274|NCT00843596|cardiac surgery requiring ECC|cardiac surgery requiring ecc
666275|NCT00843609|diabetes mellitus, type 1|diabetes mellitus, type 1
666276|NCT00843609|hypoglycemia|hypoglycemia
666277|NCT00843609|continuous glucose monitoring|continuous glucose monitoring
666278|NCT00843609|HbA1c|hba1c
666279|NCT00843609|glycemic variability|glycemic variability
666280|NCT00843622|Smoking|smoking
666281|NCT00843622|Smoking cessation|smoking cessation
666282|NCT00843622|Smokeless tobacco|smokeless tobacco
666283|NCT00843622|Snus|snus
666284|NCT00843635|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
666285|NCT00843635|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
666286|NCT00843635|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
666287|NCT00843635|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
666288|NCT00843635|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
666382|NCT00844142|axial spondyloarthritis|axial spondyloarthritis
666289|NCT00843635|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
666290|NCT00843635|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
666291|NCT00843635|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
666292|NCT00843635|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
666293|NCT00843635|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
666294|NCT00843635|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
666295|NCT00843635|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
666296|NCT00843648|antibody immune profile|antibody immune profile
666297|NCT00843648|preterm|preterm
666298|NCT00843648|c-section|c-section
666299|NCT00843648|breastfeeding|breastfeeding
666300|NCT00843661|Treatment Experienced|treatment experienced
666301|NCT00843687|Schizophrenia|schizophrenia
666302|NCT00843687|Risperidone|risperidone
666303|NCT00843687|Long-acting injectable|long-acting injectable
666304|NCT00843687|Intramuscular injection|intramuscular injection
666305|NCT00843687|Pharmacokinetics|pharmacokinetics
666306|NCT00843713|HIV|hiv
666307|NCT00843713|endothelium|endothelium
666308|NCT00843713|inflammation|inflammation
666309|NCT00843713|Treatment Experienced|treatment experienced
666310|NCT00843726|stage I non-small cell lung cancer|stage i non-small cell lung cancer
666311|NCT00843726|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
666312|NCT00843739|Breathing|breathing
666313|NCT00843739|Cough|cough
666314|NCT00843739|Speech|speech
666315|NCT00843739|Swallow|swallow
666316|NCT00843739|Parkinson's disease|parkinson's disease
666317|NCT00843765|Stroke|stroke
666318|NCT00843765|Traditional Chinese Medicine|traditional chinese medicine
666320|NCT00843778|Rheumatoid Arthritis|rheumatoid arthritis
666321|NCT00843778|Moderate to Low Disease Activity|moderate to low disease activity
666322|NCT00843778|Certolizumab Pegol|certolizumab pegol
666323|NCT00843791|obesity|obesity
666324|NCT00843804|nosocomial infection|nosocomial infection
666325|NCT00843804|bloodstream infection|bloodstream infection
666326|NCT00843804|central venous catheter|central venous catheter
666327|NCT00843804|invasive Aspergillosis|invasive aspergillosis
666328|NCT00843804|Clostridium difficile associated disease|clostridium difficile associated disease
666329|NCT00843817|cystic fibrosis|cystic fibrosis
666330|NCT00843843|Circadian Rhythms|circadian rhythms
666331|NCT00843895|Laboratory based study|laboratory based study
666332|NCT00843895|antibiotic susceptibilty|antibiotic susceptibilty
666333|NCT00843895|invasive strains|invasive strains
666334|NCT00843908|Stress incontinence|stress incontinence
666335|NCT00843908|Surgical Treatments|surgical treatments
666336|NCT00843908|Minislings|minislings
666337|NCT00843921|Hyperammonemia|hyperammonemia
666338|NCT00843934|Carcinoma, Hepatocellular|carcinoma, hepatocellular
666339|NCT00843934|Trans arterial chemoembolization|trans arterial chemoembolization
666340|NCT00843934|Epirubicin|epirubicin
666341|NCT00843934|Cisplatin|cisplatin
666342|NCT00843973|Iliac Crest Bone Graft|iliac crest bone graft
666343|NCT00843973|Reamer Irrigator Aspirator|reamer irrigator aspirator
666344|NCT00843986|hyponatremia|hyponatremia
666345|NCT00843986|euvolemic hyponatremia|euvolemic hyponatremia
666346|NCT00843986|hypervolemic hyponatremia|hypervolemic hyponatremia
666347|NCT00843986|acute decompensated heart failure|acute decompensated heart failure
666348|NCT00843986|conivaptan|conivaptan
666349|NCT00843986|Vaprisol|vaprisol
666350|NCT00844025|Adverse drug reaction|adverse drug reaction
666351|NCT00844025|Inappropriate medication|inappropriate medication
666352|NCT00844025|Pharmacist|pharmacist
666353|NCT00844025|Pharmaceutical care|pharmaceutical care
666354|NCT00844038|Steven-Johnson syndrome|steven-johnson syndrome
666356|NCT00844038|autoimmune disease|autoimmune disease
666357|NCT00844051|Influenza|influenza
666358|NCT00844051|influenza vaccination|influenza vaccination
666359|NCT00844051|school-based vaccination|school-based vaccination
666360|NCT00844064|Pancreatic cancer|pancreatic cancer
666361|NCT00844064|Metastatic melanoma|metastatic melanoma
666362|NCT00844064|Advanced tumor|advanced tumor
666363|NCT00844064|Targeted therapy|targeted therapy
666364|NCT00844064|Antisense|antisense
666365|NCT00844064|Transforming Growth Factor beta 2|transforming growth factor beta 2
666366|NCT00844064|Dose escalation|dose escalation
666367|NCT00844077|Barrett's Intestinal Metaplasia|barrett's intestinal metaplasia
666368|NCT00844090|Apathy|apathy
666369|NCT00844090|Diabetes|diabetes
666370|NCT00844090|Self-care behaviors|self-care behaviors
666371|NCT00844103|Volunteer|volunteer
666372|NCT00844103|Safety|safety
666373|NCT00844103|Tolerability|tolerability
666374|NCT00844103|AZD8566|azd8566
666375|NCT00844116|COPD|copd
666376|NCT00844116|spirometry|spirometry
666377|NCT00844116|Telematic spirometry|telematic spirometry
666378|NCT00844129|neurofibromatosis type 1|neurofibromatosis type 1
666379|NCT00844129|spinal abnormalities|spinal abnormalities
666380|NCT00844129|scoliosis|scoliosis
666381|NCT00844142|ankylosing spondylitis|ankylosing spondylitis
666383|NCT00844142|magnetic resonance imaging|magnetic resonance imaging
666384|NCT00844142|etanercept|etanercept
666385|NCT00844142|sulfasalazine|sulfasalazine
666386|NCT00844155|Prevention or treatment of influenza in ventilated patients|prevention or treatment of influenza in ventilated patients
666387|NCT00844207|Bioavailability|bioavailability
666388|NCT00844220|Suspected coronary artery disease|suspected coronary artery disease
666389|NCT00844246|Developmental delays|developmental delays
666390|NCT00844246|Early intervention services|early intervention services
666391|NCT00844259|Down syndrome|down syndrome
666392|NCT00844259|Pragmatics|pragmatics
666393|NCT00844259|Language Development|language development
666394|NCT00844272|Opiate Dependence|opiate dependence
666395|NCT00844272|Chronic Hepatitis C|chronic hepatitis c
666396|NCT00844285|Certolizumab Pegol, Cimzia ®|certolizumab pegol, cimzia ®
666397|NCT00844285|Crohn's Disease|crohn's disease
666398|NCT00844298|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
666399|NCT00844298|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
666401|NCT00844311|human chorionic gonadotropin|human chorionic gonadotropin
666402|NCT00844324|Candesartan|candesartan
666403|NCT00844324|Bioequivalence|bioequivalence
666404|NCT00844337|antibiotic regimens|antibiotic regimens
666405|NCT00844337|sepsis|sepsis
666406|NCT00844337|young infants|young infants
666407|NCT00844337|Bangladeshi|bangladeshi
666408|NCT00844337|outpatient treatment|outpatient treatment
753271|NCT01176136|Time Management|time management
666409|NCT00844337|Suspected sepsis in young infants|suspected sepsis in young infants
666410|NCT00844350|Oxytocin|oxytocin
666411|NCT00844350|Letrozole|letrozole
666412|NCT00844350|Induction of ovulation|induction of ovulation
666413|NCT00844376|Cardiovascular Diseases|cardiovascular diseases
666414|NCT00844389|Open Angle Glaucoma|open angle glaucoma
666415|NCT00844389|Biophotomodulation|biophotomodulation
666416|NCT00844389|Near to Infrared light stimulation|near to infrared light stimulation
666417|NCT00844389|Neuroprotection|neuroprotection
666419|NCT00844402|Atherosclerosis|atherosclerosis
666420|NCT00844402|Statins|statins
666421|NCT00844402|Vascular function|vascular function
666422|NCT00844441|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
666423|NCT00844441|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
666424|NCT00844441|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
666425|NCT00844441|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
666426|NCT00844441|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
666427|NCT00844441|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
666428|NCT00844441|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
666429|NCT00844441|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
666430|NCT00844441|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
666431|NCT00844441|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
666432|NCT00844441|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
666433|NCT00844441|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
666434|NCT00844441|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
666435|NCT00844441|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
666436|NCT00844441|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
666437|NCT00844441|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
666532|NCT00844792|Vitamin D|vitamin d
666438|NCT00844441|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
666439|NCT00844441|adult acute basophilic leukemia|adult acute basophilic leukemia
666537|NCT00844831|Constipation|constipation
666440|NCT00844441|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
666441|NCT00844441|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
666442|NCT00844441|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
666443|NCT00844454|hepatocellular carcinoma|hepatocellular carcinoma
666445|NCT00844454|RF ablation|rf ablation
666446|NCT00844454|tumor ablation|tumor ablation
666447|NCT00844467|Risk factors|risk factors
666448|NCT00844467|Case fatality|case fatality
666449|NCT00844467|disease burden|disease burden
666450|NCT00844467|Resistance|resistance
666451|NCT00844467|Benefits of pneumococcal vaccination|benefits of pneumococcal vaccination
666452|NCT00844480|spinal cord injury|spinal cord injury
666453|NCT00844480|osteoporosis|osteoporosis
666454|NCT00844480|bone loss|bone loss
666455|NCT00844480|zoledronic acid|zoledronic acid
666456|NCT00844480|bisphosphonate|bisphosphonate
666457|NCT00844493|diarrhea|diarrhea
666458|NCT00844493|vaccine|vaccine
666459|NCT00844493|enterotoxigenic E coli|enterotoxigenic e coli
666460|NCT00844493|colonization factor antigen|colonization factor antigen
666461|NCT00844493|volunteer study|volunteer study
666462|NCT00844506|Ovarian cancer patients with recurrent disease|ovarian cancer patients with recurrent disease
666463|NCT00844519|Treatment Experienced|treatment experienced
666464|NCT00844519|CCR5 receptor|ccr5 receptor
666465|NCT00844519|maraviroc|maraviroc
666466|NCT00844532|Atherosclerosis|atherosclerosis
666467|NCT00844532|Peripheral artery disease|peripheral artery disease
666468|NCT00844532|Peripheral vascular disease|peripheral vascular disease
666469|NCT00844532|PAD|pad
666470|NCT00844532|Claudication|claudication
666471|NCT00844532|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
666472|NCT00844532|Stent|stent
666473|NCT00844532|PAOD|paod
666474|NCT00844532|PVD|pvd
666475|NCT00844545|aHUS|ahus
666476|NCT00844558|osteoarthritis|osteoarthritis
666477|NCT00844558|knee pain|knee pain
666478|NCT00844558|gait training|gait training
666479|NCT00844558|power training|power training
666480|NCT00844558|rehabilitation|rehabilitation
666481|NCT00844558|physical therapy|physical therapy
666482|NCT00844571|child abuse and neglect|child abuse and neglect
666483|NCT00844571|child maltreatment|child maltreatment
666484|NCT00844571|non accidental injury|non accidental injury
666485|NCT00844571|training|training
666486|NCT00844571|educational program|educational program
666487|NCT00844584|Atrial fibrillation|atrial fibrillation
666488|NCT00844584|radiofrequency|radiofrequency
666489|NCT00844584|totally thoracoscope|totally thoracoscope
666490|NCT00844584|epicardial|epicardial
666491|NCT00844623|primary liver cancer, hepatoma|primary liver cancer, hepatoma
666492|NCT00844636|Needlestick injuries|needlestick injuries
666493|NCT00844636|Glove perforations|glove perforations
666494|NCT00844636|Blunt Needles|blunt needles
666495|NCT00844636|Glove perforations of surgeons, assistants|glove perforations of surgeons, assistants
666496|NCT00844636|Needlestick injuries of same|needlestick injuries of same
666497|NCT00844662|Hyperphosphataemia|hyperphosphataemia
668865|NCT00838825|outcome|outcome
666498|NCT00844662|phosphate binder|phosphate binder
666499|NCT00844675|endoscopic mucosal resection|endoscopic mucosal resection
666500|NCT00844675|Proton Pump Inhibitor|proton pump inhibitor
666501|NCT00844675|gastrointestinal hemorrhage|gastrointestinal hemorrhage
666502|NCT00844675|rabeprazole|rabeprazole
666503|NCT00844688|Hepatocellular Carcinoma|hepatocellular carcinoma
666504|NCT00844688|Sorafenib|sorafenib
666505|NCT00844688|Gemcitabine|gemcitabine
666506|NCT00844701|nicotine|nicotine
666507|NCT00844701|addiction|addiction
666508|NCT00844701|fMRI|fmri
666509|NCT00844701|neuroimaging|neuroimaging
666510|NCT00844701|neurobiology|neurobiology
666511|NCT00844701|craving|craving
666512|NCT00844714|endothelial function|endothelial function
666513|NCT00844714|rheumatoid arthritis|rheumatoid arthritis
666514|NCT00844714|cardiovascular risk|cardiovascular risk
666515|NCT00844714|rituxan therapy|rituxan therapy
666516|NCT00844740|Familial hypophosphatemic rickets|familial hypophosphatemic rickets
666517|NCT00844740|Cinacalcet|cinacalcet
666518|NCT00844740|hyperparathyroidism|hyperparathyroidism
666519|NCT00844753|Autism|autism
666520|NCT00844753|PDD NOS|pdd nos
666521|NCT00844753|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
666522|NCT00844753|Parent Management Training|parent management training
666523|NCT00844766|Lactose intolerance|lactose intolerance
666524|NCT00844766|Lactose|lactose
666525|NCT00844766|Home-screening test|home-screening test
666526|NCT00844766|Validate|validate
666527|NCT00844779|Metabolic syndrome- hepatic steatosis- steatohepatitis - gene expression|metabolic syndrome- hepatic steatosis- steatohepatitis - gene expression
666528|NCT00844779|Non alcoholic fatty liver disease (NFALD)|non alcoholic fatty liver disease (nfald)
666529|NCT00844792|Male Urogenital Diseases|male urogenital diseases
666530|NCT00844792|Antioxidants|antioxidants
666531|NCT00844792|Vitamin E|vitamin e
666533|NCT00844792|Lycopene|lycopene
666534|NCT00844792|Selenium|selenium
666535|NCT00844818|smoking cessation|smoking cessation
666536|NCT00844818|parents|parents
666538|NCT00844831|small intestinal bacterial overgrowth|small intestinal bacterial overgrowth
666539|NCT00844831|stool bacteria|stool bacteria
666540|NCT00844844|aHUS|ahus
666541|NCT00844857|Bipolar I Depression|bipolar i depression
666542|NCT00844870|rehabilitation, reaching, stroke|rehabilitation, reaching, stroke
666543|NCT00844883|primary liver cancer|primary liver cancer
666544|NCT00844883|sorafenib|sorafenib
666545|NCT00844883|Nexavar|nexavar
666546|NCT00844883|doxorubicin|doxorubicin
666547|NCT00844883|drug eluting beads|drug eluting beads
666548|NCT00844883|transarterial chemoembolization|transarterial chemoembolization
666549|NCT00844896|Pathological stress & PTSD in preschool children & parents|pathological stress & ptsd in preschool children & parents
666550|NCT00844896|Child and parent resilience after burn trauma|child and parent resilience after burn trauma
666551|NCT00844909|CNTO 136|cnto 136
666552|NCT00844909|safety|safety
666553|NCT00844909|pharmacokinetics|pharmacokinetics
666554|NCT00844909|healthy Japanese|healthy japanese
666555|NCT00844909|healthy Caucasian|healthy caucasian
666556|NCT00844909|Phase I|phase i
666557|NCT00844909|antibody|antibody
666558|NCT00844909|male.|male.
666559|NCT00844935|Heart rate variability, mechanical ventilation, weaning,|heart rate variability, mechanical ventilation, weaning,
666560|NCT00844935|spontaneous breathing trial|spontaneous breathing trial
666564|NCT00844961|Internet treatment|internet treatment
666565|NCT00844961|Cognitive behavior therapy|cognitive behavior therapy
666566|NCT00844987|PDGF|pdgf
666567|NCT00844987|HGF|hgf
666568|NCT00844987|VEGF|vegf
666569|NCT00844987|ACS|acs
666570|NCT00844987|markers of myocardial injury|markers of myocardial injury
666571|NCT00844987|Vascular Endothelial Growth Factor|vascular endothelial growth factor
666572|NCT00844987|Hepatocyte Growth Factor|hepatocyte growth factor
666573|NCT00844987|Platelet Derived Growth Factor|platelet derived growth factor
666574|NCT00844987|Strategies in ACS|strategies in acs
666575|NCT00845013|HIV infection|hiv infection
666576|NCT00845013|pulmonary hypertension|pulmonary hypertension
666577|NCT00845013|endothelial function|endothelial function
666578|NCT00845013|antiretroviral medication|antiretroviral medication
666579|NCT00845013|Treatment Experienced|treatment experienced
666580|NCT00845039|Tumors|tumors
666581|NCT00845039|Antibodies, Monoclonal|antibodies, monoclonal
666582|NCT00845039|Colorectal Neoplasms|colorectal neoplasms
666583|NCT00845039|Metastatic K-RAS Wild-Type Carcinoma of the Colon or Rectum|metastatic k-ras wild-type carcinoma of the colon or rectum
666584|NCT00845052|Housestaff|housestaff
666585|NCT00845052|Patient Safety|patient safety
666586|NCT00845052|Patient Care|patient care
666587|NCT00845052|Focus of Study: To assess safety climate amongst housestaff|focus of study: to assess safety climate amongst housestaff
666588|NCT00845078|Breast|breast
666589|NCT00845078|Radiotherapy|radiotherapy
666590|NCT00845078|Esthetics|esthetics
666591|NCT00845078|Treatment Outcome|treatment outcome
666592|NCT00845078|Reconstructive Surgical Procedures|reconstructive surgical procedures
666593|NCT00845091|Parasympathetic activity|parasympathetic activity
666594|NCT00845091|Exercise|exercise
666595|NCT00845091|Education|education
666596|NCT00845091|Arrhythmias|arrhythmias
666597|NCT00845091|Defibrillators, Implantable|defibrillators, implantable
666598|NCT00845117|Aniridia,|aniridia,
666599|NCT00845117|Steven Johnsons Syndrome,|steven johnsons syndrome,
666600|NCT00845117|Ocular burns,|ocular burns,
666601|NCT00845117|Pterygium|pterygium
666602|NCT00845130|Diabetes|diabetes
666603|NCT00845130|MR imaging|mr imaging
666604|NCT00845130|Vitamin C|vitamin c
666605|NCT00845143|Non-small cell lung cancer|non-small cell lung cancer
666606|NCT00845143|surgery|surgery
666607|NCT00845143|lung function|lung function
666608|NCT00845156|Diabetes|diabetes
666609|NCT00845156|Insulin resistance|insulin resistance
666610|NCT00845156|healthy controls|healthy controls
666611|NCT00845156|anti oxidants|anti oxidants
666612|NCT00845169|Air Pollution|air pollution
666613|NCT00845169|Nitric Oxide|nitric oxide
666614|NCT00845169|Nitric Oxide Synthase|nitric oxide synthase
666615|NCT00845169|Diesel exhaust|diesel exhaust
666616|NCT00845169|endothelial dysfunction|endothelial dysfunction
666617|NCT00845182|Type 2 diabetes pathogenesis, thiazolidinediones|type 2 diabetes pathogenesis, thiazolidinediones
666618|NCT00845182|impaired glucose tolerance|impaired glucose tolerance
666619|NCT00845182|Incretins|incretins
666620|NCT00845182|Insulin secretion|insulin secretion
666621|NCT00845195|Rhinitis|rhinitis
666622|NCT00845195|Allergy|allergy
666623|NCT00845195|Nasal Spray|nasal spray
666624|NCT00845195|Antihistamine|antihistamine
666625|NCT00845195|Intranasal Corticosteroid|intranasal corticosteroid
666626|NCT00845208|Network Support|network support
666627|NCT00845208|AA|aa
666628|NCT00845208|Contingency Management|contingency management
666629|NCT00845234|behavioral intervention|behavioral intervention
666630|NCT00845234|implantable cardioverter defibrillator|implantable cardioverter defibrillator
666631|NCT00845234|psychosocial education|psychosocial education
666632|NCT00845234|anxiety|anxiety
666633|NCT00845234|depression|depression
666634|NCT00845247|Case Management|case management
666730|NCT00835796|Bioequivalence|bioequivalence
666635|NCT00845273|Subfoveal choroidal neovascularization secondary to age-related macular degeneration|subfoveal choroidal neovascularization secondary to age-related macular degeneration
666636|NCT00845286|exercise, myocardial dysfunction, endothelial dysfunction,|exercise, myocardial dysfunction, endothelial dysfunction,
666637|NCT00845286|polymorphism|polymorphism
666638|NCT00845299|glaucoma|glaucoma
666639|NCT00845299|ocular hypertension|ocular hypertension
666640|NCT00845312|Age|age
666641|NCT00845312|Mortality|mortality
666642|NCT00845325|Carpal tunnel release|carpal tunnel release
666643|NCT00845325|Rehabilitation|rehabilitation
666644|NCT00845325|Early motion|early motion
666645|NCT00845338|Darifenacin|darifenacin
666646|NCT00845338|Multiple Sclerosis|multiple sclerosis
666647|NCT00845338|Open Label Study|open label study
666648|NCT00845351|Cushing's|cushing's
666649|NCT00845364|Perhexiline|perhexiline
666650|NCT00845364|Coronary artery bypass|coronary artery bypass
666651|NCT00845364|Myocardial reperfusion injury|myocardial reperfusion injury
666652|NCT00845364|Cardiac output, low|cardiac output, low
666653|NCT00845364|Troponin|troponin
666654|NCT00845377|Depression|depression
666655|NCT00845377|Aging|aging
666656|NCT00845377|Psychological well-being|psychological well-being
666657|NCT00845377|Psychosocial intervention|psychosocial intervention
666658|NCT00845403|Hepatitis B carrier|hepatitis b carrier
666659|NCT00845416|TREC|trec
666661|NCT00845416|Primary Immunodeficiency|primary immunodeficiency
666662|NCT00845416|PID|pid
666663|NCT00845416|Navajo|navajo
666664|NCT00845416|SCID|scid
666665|NCT00845429|Influenza|influenza
666666|NCT00845429|Orthomyxoviruses|orthomyxoviruses
666667|NCT00845429|Split-virion inactivated influenza vaccine|split-virion inactivated influenza vaccine
666668|NCT00845429|cell-based vaccine|cell-based vaccine
666669|NCT00845429|Adults|adults
666670|NCT00845442|Bilateral vocal cord paralyses|bilateral vocal cord paralyses
666671|NCT00845442|Implanted laryngeal stimulator|implanted laryngeal stimulator
666672|NCT00845442|vocal cord opening|vocal cord opening
666673|NCT00845442|pulmonary function tests|pulmonary function tests
666674|NCT00845468|coronary flow reserve|coronary flow reserve
666675|NCT00845468|diabetes mellitus|diabetes mellitus
666676|NCT00845468|acute myocardial infarction|acute myocardial infarction
666677|NCT00845468|transthoracic echocardiography|transthoracic echocardiography
666678|NCT00845494|Medication history|medication history
666679|NCT00845494|medication errors|medication errors
666680|NCT00845494|Reduction of admission medication history errors|reduction of admission medication history errors
666681|NCT00835497|Bioequivalence|bioequivalence
666682|NCT00835497|Healthy Subjects|healthy subjects
666683|NCT00835510|Tinea pedis|tinea pedis
666684|NCT00835523|frozen-thawed embryo replacement|frozen-thawed embryo replacement
666685|NCT00835523|GnRH agonist|gnrh agonist
666686|NCT00835523|GnRH antagonist|gnrh antagonist
666687|NCT00835523|ovarian hyperstimulation|ovarian hyperstimulation
666688|NCT00835536|Bioequivalence|bioequivalence
666689|NCT00835536|Healthy Subjects|healthy subjects
666690|NCT00835549|Bioequivalence|bioequivalence
666691|NCT00835549|Healthy Subjects|healthy subjects
666692|NCT00835562|Shoulder fractures|shoulder fractures
666693|NCT00835562|Proximal humeral fractures|proximal humeral fractures
666694|NCT00835562|Randomised clinical trial|randomised clinical trial
666695|NCT00835562|elderly|elderly
666696|NCT00835562|Displaced four-part fractures of the proximal humerus|displaced four-part fractures of the proximal humerus
666697|NCT00835575|Bioequivalence|bioequivalence
666698|NCT00835575|Healthy Subjects|healthy subjects
666699|NCT00835588|Bioequivalence|bioequivalence
666700|NCT00835588|Healthy Subjects|healthy subjects
666701|NCT00835614|Bioequivalence|bioequivalence
666702|NCT00835614|Healthy Subjects|healthy subjects
666703|NCT00835627|Treatment|treatment
666704|NCT00835627|Cognitive Behavior Therapy|cognitive behavior therapy
666705|NCT00835627|pharmacotherapy|pharmacotherapy
666706|NCT00835627|psychogenic nonepileptic seizures|psychogenic nonepileptic seizures
666707|NCT00835627|pseudoseizures|pseudoseizures
666708|NCT00835627|dissociative seizures|dissociative seizures
666709|NCT00835627|conversion disorder|conversion disorder
666710|NCT00835640|Bioequivalence|bioequivalence
666711|NCT00835640|Healthy Subjects|healthy subjects
666712|NCT00835666|Bioequivalence|bioequivalence
666713|NCT00835666|Healthy Subjects|healthy subjects
666714|NCT00835692|Bioequivalence|bioequivalence
666715|NCT00835692|Healthy Subjects|healthy subjects
666716|NCT00835705|Bioequivalence|bioequivalence
666717|NCT00835705|Healthy Subjects|healthy subjects
666718|NCT00835731|induced abortion|induced abortion
666719|NCT00835731|misoprostol|misoprostol
666720|NCT00835731|cervical ripening|cervical ripening
666721|NCT00835731|second trimester abortion|second trimester abortion
666722|NCT00835731|Dilapan-S|dilapan-s
666723|NCT00835744|ovulation induction|ovulation induction
667024|NCT00846755|Thyroid|thyroid
666724|NCT00835744|clomiphene citrate|clomiphene citrate
666725|NCT00835744|gonadotropins|gonadotropins
666726|NCT00835770|relapsing|relapsing
666727|NCT00835770|multiple sclerosis|multiple sclerosis
666728|NCT00835770|remitting|remitting
666729|NCT00835770|oral|oral
666731|NCT00835796|Healthy Subjects|healthy subjects
666732|NCT00835809|Acute respiratory insufficiency respiratory|acute respiratory insufficiency respiratory
666733|NCT00835809|Biomarkers|biomarkers
666734|NCT00835809|Emergency|emergency
666735|NCT00835809|Intensive care unit|intensive care unit
666736|NCT00835809|Prospective|prospective
666737|NCT00835809|Patient hospitalize in emergency or in intensive care unit|patient hospitalize in emergency or in intensive care unit
666738|NCT00835809|for acute respiratory insufficiency|for acute respiratory insufficiency
666739|NCT00845507|weight gain|weight gain
666740|NCT00845546|Bioequivalence 10 mg Loratadine 240 mg Pseudoephedrine Sulfate Extended Release Tablets|bioequivalence 10 mg loratadine 240 mg pseudoephedrine sulfate extended release tablets
666741|NCT00845559|Childhood Obesity|childhood obesity
666742|NCT00845559|Insulin resistance|insulin resistance
666743|NCT00845559|Impaired Glucose Tolerance|impaired glucose tolerance
666744|NCT00845559|Cardiovascular Disease|cardiovascular disease
666745|NCT00845559|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
666746|NCT00845559|Continuous Glucose Monitoring (CGMS)|continuous glucose monitoring (cgms)
666747|NCT00845559|Exenatide|exenatide
666748|NCT00845559|Oral Glucose Tolerance Test|oral glucose tolerance test
666749|NCT00845572|Schizophrenia|schizophrenia
666750|NCT00845572|Schizoaffective|schizoaffective
666751|NCT00845572|Risperdal Consta|risperdal consta
666752|NCT00845572|Medication Adherence|medication adherence
666753|NCT00845572|Antipsychotic|antipsychotic
666754|NCT00845585|arterial reconstruction|arterial reconstruction
666755|NCT00845585|bypass|bypass
666756|NCT00845585|below knee|below knee
666757|NCT00845585|PZFE|pzfe
666758|NCT00845585|Ovine graft|ovine graft
666759|NCT00845585|Omniflow II|omniflow ii
666760|NCT00845585|graft patency|graft patency
666761|NCT00845598|Allergic Rhinitis|allergic rhinitis
666762|NCT00845611|peptide vaccine|peptide vaccine
666763|NCT00845611|URLC10|urlc10
666764|NCT00845624|oxygen saturation|oxygen saturation
666765|NCT00845624|retinopathy of prematurity|retinopathy of prematurity
666766|NCT00845624|long term outcomes|long term outcomes
666767|NCT00845624|hypoxia|hypoxia
666768|NCT00845624|hyperoxia|hyperoxia
666769|NCT00845637|eggplant|eggplant
666770|NCT00845637|dyslipidemia|dyslipidemia
666771|NCT00845637|postprandial lipemia|postprandial lipemia
666772|NCT00845650|Anthrax|anthrax
666773|NCT00845650|Human Anthrax Immune Globulin Intravenous|human anthrax immune globulin intravenous
666774|NCT00845650|Safety|safety
666775|NCT00845650|Pharmacokinetics|pharmacokinetics
666776|NCT00845663|certolizumab pegol|certolizumab pegol
666777|NCT00845663|Cimzia|cimzia
666778|NCT00845663|bioequivalence|bioequivalence
666779|NCT00845663|Comparison Bioequivalence Study|comparison bioequivalence study
666780|NCT00845676|Hepatitis C virus|hepatitis c virus
666781|NCT00845676|Acute hepatitis C infection|acute hepatitis c infection
666782|NCT00845676|HIV|hiv
666783|NCT00845676|HCV|hcv
666784|NCT00845689|liver surgery|liver surgery
666785|NCT00845702|Renal artery stenosis|renal artery stenosis
666786|NCT00845702|Contrast agent|contrast agent
666787|NCT00845702|MRA|mra
666788|NCT00845715|rotator cuff|rotator cuff
666789|NCT00845715|rehabilitation|rehabilitation
666790|NCT00845715|range of motion|range of motion
666791|NCT00845728|Indacaterol|indacaterol
666792|NCT00845728|Tiotropium|tiotropium
666793|NCT00845728|COPD|copd
666794|NCT00845754|Post-operative febrile morbidity|post-operative febrile morbidity
666795|NCT00845754|Post-operative pain management|post-operative pain management
666796|NCT00845767|Nitric Oxide|nitric oxide
666797|NCT00845767|Nitric Oxide Synthase|nitric oxide synthase
666798|NCT00845767|Air Pollution|air pollution
666799|NCT00845767|Endothelial Dysfunction|endothelial dysfunction
666800|NCT00845767|Diesel Exhaust|diesel exhaust
666801|NCT00845780|persistent atrial fibrillation|persistent atrial fibrillation
666802|NCT00845780|amiodarone|amiodarone
666803|NCT00845780|late recurrence atrial fibrillation|late recurrence atrial fibrillation
666804|NCT00845780|adverse events|adverse events
666805|NCT00845793|Type 2 diabetes|type 2 diabetes
666806|NCT00845793|Nutrition|nutrition
666807|NCT00845793|Lifestyle modifications|lifestyle modifications
666808|NCT00845806|Diacritics|diacritics
666809|NCT00845806|Neuronal Processing|neuronal processing
666810|NCT00845806|fMRI|fmri
666811|NCT00845806|Arabic|arabic
666812|NCT00845819|oral mucositis|oral mucositis
666813|NCT00845819|intensive chemotherapy|intensive chemotherapy
666814|NCT00845819|stem cell transplantation|stem cell transplantation
666815|NCT00845819|epidermal growth factor|epidermal growth factor
666816|NCT00845962|bupivacaine|bupivacaine
666817|NCT00845962|chloroprocaine|chloroprocaine
666818|NCT00845962|spinal|spinal
666819|NCT00845962|anesthesia|anesthesia
666820|NCT00845962|elective surgery|elective surgery
666821|NCT00845962|ambulatory surgery|ambulatory surgery
666822|NCT00845988|Bipolar disorder|bipolar disorder
666823|NCT00845988|metabolic complication|metabolic complication
666824|NCT00845988|Aripiprazole|aripiprazole
666825|NCT00845988|Weight gain|weight gain
666826|NCT00845988|Clinical Trial|clinical trial
666827|NCT00845988|Antipsychotic|antipsychotic
666828|NCT00845988|Metabolic syndrome|metabolic syndrome
666829|NCT00845988|Psychopharmacology|psychopharmacology
666830|NCT00845988|Open Label|open label
666831|NCT00846001|Resynchronization Therapy|resynchronization therapy
666832|NCT00846014|asthma|asthma
666833|NCT00846014|exacerbation|exacerbation
666834|NCT00846014|Helium|helium
666835|NCT00846014|MRI|mri
666836|NCT00846014|Lung imaging|lung imaging
666837|NCT00846040|Obesity|obesity
666838|NCT00846040|Weight Loss|weight loss
666839|NCT00846040|Carbohydrate|carbohydrate
666840|NCT00846040|Fat|fat
666841|NCT00846040|Macronutrient Balance|macronutrient balance
666842|NCT00846040|Healthy Volunteer|healthy volunteer
666843|NCT00846066|educational research,|educational research,
666844|NCT00846066|instructional methods,|instructional methods,
666845|NCT00846066|Hands on training,|hands on training,
666846|NCT00846066|Web based training,|web based training,
666847|NCT00846066|pediatric residents|pediatric residents
666848|NCT00846066|preventive oral health,|preventive oral health,
666849|NCT00846066|dental caries,|dental caries,
666850|NCT00846066|Instructional strategies in Preventive Oral health|instructional strategies in preventive oral health
666851|NCT00846066|Web-based training on Preventive Oral Health|web-based training on preventive oral health
666852|NCT00846066|Hands on Training on Preventive Oral Health|hands on training on preventive oral health
666853|NCT00846079|coronary artery disease|coronary artery disease
666854|NCT00846079|stress testing|stress testing
666855|NCT00846092|Diabetic Retinopathy|diabetic retinopathy
666856|NCT00846092|Diabetic Macular Edema|diabetic macular edema
666858|NCT00846092|Near-infrared Light Therapy|near-infrared light therapy
666859|NCT00846105|methicillin resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
666860|NCT00846105|MRSA|mrsa
666861|NCT00846105|cross-infection|cross-infection
666862|NCT00846105|staphylococcal infection|staphylococcal infection
666863|NCT00846105|infection control|infection control
666864|NCT00846118|Pitavastatin|pitavastatin
666865|NCT00846118|Hemodialysis|hemodialysis
666866|NCT00846118|Mortality|mortality
666867|NCT00846118|Cardiovascular disease|cardiovascular disease
666868|NCT00846131|Subjects with primary hepatocellular carcinoma, intended for liver transplantation.|subjects with primary hepatocellular carcinoma, intended for liver transplantation.
666869|NCT00846144|Glucose stimulated insulin secretion|glucose stimulated insulin secretion
666870|NCT00846144|copper|copper
666871|NCT00846144|cytokines|cytokines
666872|NCT00846144|diabetes|diabetes
666873|NCT00846144|Reduction in insulin secretion|reduction in insulin secretion
666874|NCT00846157|natural killer cell|natural killer cell
666875|NCT00846157|DLBCL (Diffuse Large B Cell Lymphoma)|dlbcl (diffuse large b cell lymphoma)
666876|NCT00846170|Irritable bowel syndrome probiotics|irritable bowel syndrome probiotics
666877|NCT00846183|local injury|local injury
666878|NCT00846183|implantation rate|implantation rate
666879|NCT00846183|endometrial receptivity|endometrial receptivity
666880|NCT00846183|IVF|ivf
666881|NCT00846209|prescription drug|prescription drug
666882|NCT00846209|warnings|warnings
666883|NCT00846209|health literacy|health literacy
666884|NCT00846209|enhanced language|enhanced language
666885|NCT00846235|Dermatitis|dermatitis
666886|NCT00846235|Atopic|atopic
666887|NCT00846235|Moisturising cream|moisturising cream
666888|NCT00846235|Skin|skin
666889|NCT00846248|diabetes|diabetes
666890|NCT00846248|insulin resistance|insulin resistance
666891|NCT00846248|chromium|chromium
666892|NCT00846248|healthy volunteers|healthy volunteers
666893|NCT00846261|infected|infected
666894|NCT00846261|Ilizarov|ilizarov
666895|NCT00846274|Healthy Male subjects|healthy male subjects
666896|NCT00846287|COPD|copd
666897|NCT00846287|aformoterol|aformoterol
666898|NCT00846287|Helium|helium
666899|NCT00846287|Hyperpolarized helium|hyperpolarized helium
666900|NCT00846287|Hyperpolarized Noble Gas|hyperpolarized noble gas
666901|NCT00846287|MRI|mri
666902|NCT00846300|Patient compliance|patient compliance
666903|NCT00846300|Hispanics|hispanics
666904|NCT00846300|Health Behavior|health behavior
666905|NCT00846300|Family Physicians|family physicians
666906|NCT00846300|Primary Healthcare|primary healthcare
666907|NCT00846313|Dietary intake|dietary intake
666908|NCT00846313|Dietary counseling|dietary counseling
666909|NCT00846313|Weight loss|weight loss
666910|NCT00846313|Body composition|body composition
666911|NCT00846313|Resting energy expenditure|resting energy expenditure
666912|NCT00846313|Quality of life|quality of life
666913|NCT00846326|allergic rhinitis|allergic rhinitis
666914|NCT00846326|rhinitis medicamentosa|rhinitis medicamentosa
666915|NCT00846326|imidazolines|imidazolines
666916|NCT00846326|corticosteroid|corticosteroid
666917|NCT00846339|Smoking cessation|smoking cessation
666918|NCT00846339|Bupropion|bupropion
666919|NCT00846352|Bone Marrow Transplantation|bone marrow transplantation
667023|NCT00846742|Hodgkin Lymphoma|hodgkin lymphoma
666920|NCT00846352|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
666921|NCT00846352|Bronchoscopy|bronchoscopy
666922|NCT00846365|Essential Hypertension|essential hypertension
666923|NCT00846365|Hypertensive|hypertensive
666924|NCT00846365|Blood Pressure, High|blood pressure, high
666925|NCT00846365|Vascular Disease|vascular disease
666926|NCT00846365|Cardiovascular Disease|cardiovascular disease
666927|NCT00846365|Drug Therapy|drug therapy
666928|NCT00846378|ST segment elevation myocardial infarction (STEMI)|st segment elevation myocardial infarction (stemi)
666929|NCT00846378|timed balloon inflations|timed balloon inflations
666930|NCT00846378|post conditioning|post conditioning
666931|NCT00846404|heart failure|heart failure
666932|NCT00846404|cardiomyopathy|cardiomyopathy
666933|NCT00846404|diastolic dysfunction|diastolic dysfunction
666934|NCT00846417|myocardial infarction|myocardial infarction
666935|NCT00846417|heart failure|heart failure
666936|NCT00846417|arrhythmia|arrhythmia
666937|NCT00846430|Neurofibromas|neurofibromas
666938|NCT00846430|Neurofibromatosis 1|neurofibromatosis 1
666939|NCT00846430|Celecoxib|celecoxib
666940|NCT00846430|Celebrex|celebrex
666941|NCT00846430|Peg-Interferon alpha-2b|peg-interferon alpha-2b
666942|NCT00846430|PEG-Intron|peg-intron
666943|NCT00846430|Temozolomide|temozolomide
666944|NCT00846430|Temodar|temodar
666945|NCT00846430|Vincristine Sulfate|vincristine sulfate
666946|NCT00846430|Oncovin|oncovin
666947|NCT00846443|non-small cell lung cancer|non-small cell lung cancer
666948|NCT00846456|Tumor setm cell|tumor setm cell
666949|NCT00846482|Colorectal cancer|colorectal cancer
666950|NCT00846482|Oxaliplatin|oxaliplatin
666951|NCT00846482|ERCC-1|ercc-1
666953|NCT00846495|Migraine prevention|migraine prevention
666954|NCT00846495|Prodrome|prodrome
666955|NCT00846495|Premonitory phase|premonitory phase
666956|NCT00846495|Preemptive therapy|preemptive therapy
666957|NCT00846508|cervical cancer|cervical cancer
666958|NCT00846508|Cisplatin|cisplatin
666959|NCT00846508|chemoradiation|chemoradiation
666960|NCT00846521|Pediatric Obesity|pediatric obesity
666961|NCT00846521|Insulin Resistance|insulin resistance
666962|NCT00846521|Glucose Tolerance|glucose tolerance
666963|NCT00846521|Adolescents|adolescents
666964|NCT00846521|Acarbose|acarbose
666965|NCT00846521|Continuous Glucose Monitoring (CGMS)|continuous glucose monitoring (cgms)
666966|NCT00846521|Endothelial Dysfunction|endothelial dysfunction
666967|NCT00846534|Oxidative stress markers|oxidative stress markers
666968|NCT00846534|Cardiac surgery|cardiac surgery
666969|NCT00846534|Atrial Fibrillation|atrial fibrillation
666971|NCT00846547|Autism Spectrum Disorders|autism spectrum disorders
666972|NCT00846547|irritability|irritability
666973|NCT00846547|aberrant behavior|aberrant behavior
666974|NCT00846573|Helium|helium
666975|NCT00846573|MRI|mri
666976|NCT00846573|Hyperpolarized Helium|hyperpolarized helium
666977|NCT00846573|Hyperpolarized Noble Gas|hyperpolarized noble gas
666978|NCT00846586|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
666979|NCT00846586|COPD|copd
666980|NCT00846586|indacaterol|indacaterol
666981|NCT00846586|tiotropium|tiotropium
666982|NCT00846586|bronchodilation|bronchodilation
666983|NCT00846599|brachial artery ultrasound|brachial artery ultrasound
666984|NCT00846599|brachial artery reactivity|brachial artery reactivity
666985|NCT00846599|HIV|hiv
666986|NCT00846599|human immunodeficiency virus|human immunodeficiency virus
666987|NCT00846599|cardiovascular risk|cardiovascular risk
666988|NCT00846599|omega three|omega three
666989|NCT00846599|saturated fat|saturated fat
666990|NCT00846599|sustiva|sustiva
666991|NCT00846599|atripla|atripla
666992|NCT00846599|kaletra|kaletra
666993|NCT00846599|treatment naive|treatment naive
666994|NCT00846612|refractory|refractory
666995|NCT00846612|avastin|avastin
666996|NCT00846612|doxil|doxil
666997|NCT00846612|relapsed|relapsed
666998|NCT00846612|ovarian cancer|ovarian cancer
666999|NCT00846612|platinum-resistant|platinum-resistant
667000|NCT00846625|Biomedical research|biomedical research
667001|NCT00846625|Macular Edema|macular edema
667002|NCT00846625|Uveitis|uveitis
667003|NCT00846625|Ranibizumab|ranibizumab
667004|NCT00846625|Steroids|steroids
667005|NCT00846638|Risk drinking|risk drinking
667006|NCT00846638|Women|women
667007|NCT00846638|Medical problems|medical problems
667008|NCT00846651|spinal anesthesia|spinal anesthesia
667009|NCT00846651|cesarean section|cesarean section
667010|NCT00846677|Healthy|healthy
667011|NCT00846677|Infants|infants
667012|NCT00846677|Vitamin D|vitamin d
667013|NCT00846690|topical anesthetics|topical anesthetics
667014|NCT00846690|topical anesthesia|topical anesthesia
667015|NCT00846690|20% benzocaine|20% benzocaine
667016|NCT00846690|TAC alternate gel|tac alternate gel
667017|NCT00846690|combination topical anesthetics|combination topical anesthetics
667018|NCT00846690|dental anesthesia|dental anesthesia
667019|NCT00846716|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
667020|NCT00846716|Diabetic Nephropathy|diabetic nephropathy
667021|NCT00846716|Diabetic Retinopathy|diabetic retinopathy
667022|NCT00846716|pioglitazone|pioglitazone
667025|NCT00846755|Pregnancy|pregnancy
667026|NCT00846833|Melanoma, Experimental|melanoma, experimental
667027|NCT00846859|alcohol dependence|alcohol dependence
667028|NCT00846859|nicotine dependence|nicotine dependence
667029|NCT00846859|alcohol abuse|alcohol abuse
667030|NCT00846859|varenicline|varenicline
667031|NCT00846859|Champix|champix
667032|NCT00846859|Chantix|chantix
667033|NCT00846859|smoking|smoking
667034|NCT00846859|drinking|drinking
667035|NCT00846859|snuffing|snuffing
667036|NCT00846859|diary|diary
667037|NCT00846859|phosphatidyl ethanol|phosphatidyl ethanol
667038|NCT00846859|PEth|peth
667039|NCT00846872|GHRP-3|ghrp-3
667040|NCT00846872|Insulin Resistance|insulin resistance
667041|NCT00846872|Markers of inflammation|markers of inflammation
667042|NCT00846872|Endothelial Dysfunction|endothelial dysfunction
667043|NCT00846872|Flow Mediated Dilation|flow mediated dilation
667044|NCT00846872|GH/IGF-1 axis|gh/igf-1 axis
667045|NCT00846872|Post menopausal|post menopausal
667046|NCT00846885|Bioequivalence|bioequivalence
667047|NCT00846885|Healthy Subjects|healthy subjects
667048|NCT00846898|blood sugar|blood sugar
667049|NCT00846898|cholesterol|cholesterol
667050|NCT00846898|cinnamon|cinnamon
667051|NCT00846898|HbA1c|hba1c
667052|NCT00846911|Acute Exacerbation of Chronic Bronchitis (AECB) patients|acute exacerbation of chronic bronchitis (aecb) patients
667053|NCT00846924|Stroke|stroke
667054|NCT00846924|Transient Ischemic Attack|transient ischemic attack
667055|NCT00846924|Atrial fibrillation|atrial fibrillation
667056|NCT00846924|Atrial flutter|atrial flutter
667057|NCT00846937|Cholesterol|cholesterol
667058|NCT00846937|Plant stanolester|plant stanolester
667059|NCT00846937|Beverage|beverage
667061|NCT00846937|Serum cholesterol level|serum cholesterol level
667062|NCT00846937|serum LDL-cholesterol level|serum ldl-cholesterol level
667063|NCT00846937|Intestinal cholesterol absorption efficiency|intestinal cholesterol absorption efficiency
667064|NCT00846950|H1-antagonist|h1-antagonist
667065|NCT00846950|Event Related Potentials|event related potentials
667066|NCT00846950|Memory|memory
667067|NCT00846950|Information processing|information processing
667068|NCT00846950|The effects of an H1 antagonist (dexchlorpheniramine) on human cognition|the effects of an h1 antagonist (dexchlorpheniramine) on human cognition
667069|NCT00846963|parenteral nutrition associated cholestasis in neonates|parenteral nutrition associated cholestasis in neonates
667070|NCT00846963|parenteral nutrition induced cholestasis in preterms|parenteral nutrition induced cholestasis in preterms
667071|NCT00846963|Bile duct obstruction|bile duct obstruction
667072|NCT00846963|biliary stasis|biliary stasis
667073|NCT00846976|Safety|safety
667074|NCT00846989|glaucoma,|glaucoma,
667075|NCT00846989|primary open-angle glaucoma (POAG),|primary open-angle glaucoma (poag),
667076|NCT00846989|ocular hypertension (OH),|ocular hypertension (oh),
667077|NCT00846989|intraocular pressure (IOP)|intraocular pressure (iop)
667078|NCT00847002|Flexitouch system|flexitouch system
667079|NCT00847002|FarrowWrap|farrowwrap
667080|NCT00847002|venous stasis ulcer|venous stasis ulcer
667081|NCT00847015|Bladder|bladder
667082|NCT00847015|Urinary|urinary
667083|NCT00847015|CISPLATIN|cisplatin
667084|NCT00847015|GEMCITABINE|gemcitabine
668547|NCT00851019|Dance|dance
667085|NCT00847015|SU011248 (Sunitinib Malate)|su011248 (sunitinib malate)
667086|NCT00847015|08-159|08-159
667087|NCT00847028|Newborn|newborn
667088|NCT00847028|Pain|pain
667089|NCT00847028|glucose solution|glucose solution
667090|NCT00847028|venipuncture|venipuncture
667091|NCT00847028|non-pharmacologic pain relief.|non-pharmacologic pain relief.
667092|NCT00847054|Solid Tumor|solid tumor
667093|NCT00847054|Endosialin|endosialin
667094|NCT00847080|Reactive hypoglycemia|reactive hypoglycemia
667095|NCT00847080|Sitagliptin|sitagliptin
667096|NCT00847080|Glucagon-Like Peptide 1|glucagon-like peptide 1
667097|NCT00847080|Incretins|incretins
667098|NCT00847080|Prediabetes|prediabetes
667099|NCT00847106|Dendritic Cells|dendritic cells
667100|NCT00847106|Regulatory T cells|regulatory t cells
667101|NCT00847106|CD25|cd25
667102|NCT00847106|Melanoma|melanoma
667103|NCT00847106|Immunotherapy|immunotherapy
667104|NCT00847106|Daclizumab|daclizumab
667105|NCT00847106|Stage IV Melanoma|stage iv melanoma
667106|NCT00847119|rectum|rectum
667107|NCT00847119|adenocarcinoma|adenocarcinoma
667108|NCT00847119|neoadjuvant|neoadjuvant
667109|NCT00847119|bevacizumab|bevacizumab
667110|NCT00847119|capecitabine|capecitabine
667111|NCT00847119|radiotherapy|radiotherapy
667112|NCT00847119|locally|locally
667113|NCT00847119|advanced|advanced
667114|NCT00847119|resectable|resectable
667115|NCT00847119|resectable locally advanced adenocarcinoma of the rectum|resectable locally advanced adenocarcinoma of the rectum
667116|NCT00847119|xeberecto|xeberecto
667117|NCT00847132|Collaborative Care|collaborative care
667118|NCT00847145|toddler|toddler
667119|NCT00847145|Meningococcal disease|meningococcal disease
667120|NCT00847145|prevention|prevention
667121|NCT00847145|vaccination|vaccination
667122|NCT00847158|POAG|poag
667123|NCT00847158|Combination glaucoma & cataract procedure|combination glaucoma & cataract procedure
667124|NCT00847158|trabecular micro-bypass stent|trabecular micro-bypass stent
667125|NCT00847158|iStent|istent
667126|NCT00847171|male breast cancer|male breast cancer
667127|NCT00847171|stage II breast cancer|stage ii breast cancer
667128|NCT00847171|stage IIIA breast cancer|stage iiia breast cancer
667129|NCT00847171|stage IIIB breast cancer|stage iiib breast cancer
667130|NCT00847171|stage IIIC breast cancer|stage iiic breast cancer
667614|NCT00841074|Pneumonia|pneumonia
667131|NCT00847171|stage IV breast cancer|stage iv breast cancer
667132|NCT00847171|HER2-positive breast cancer|her2-positive breast cancer
667133|NCT00847184|nasal intubation|nasal intubation
667134|NCT00847184|Aitraq|aitraq
667135|NCT00847184|difficult intubation|difficult intubation
667136|NCT00847210|Esophageal Reflux|esophageal reflux
667137|NCT00847210|Gastro-Esophageal Reflux|gastro-esophageal reflux
667138|NCT00847210|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
667139|NCT00847210|GERD|gerd
667140|NCT00847210|Regurgitation, Gastric|regurgitation, gastric
667141|NCT00847210|Heartburn|heartburn
667142|NCT00847210|Drug Therapy|drug therapy
667143|NCT00847210|Adolescent|adolescent
667144|NCT00847223|Mantle cell lymphoma|mantle cell lymphoma
667145|NCT00847223|Lymphoma|lymphoma
667146|NCT00847223|relapsed, refractory or progressive MCL|relapsed, refractory or progressive mcl
667147|NCT00847223|Mantle cell lymphoma (relapsed, refractory or progressive)|mantle cell lymphoma (relapsed, refractory or progressive)
667148|NCT00847236|Polymyalgia Rheumatica|polymyalgia rheumatica
667149|NCT00847236|Rheumatoid Arthritis|rheumatoid arthritis
667150|NCT00847236|Rheumatic Disease|rheumatic disease
667152|NCT00847249|safety|safety
667153|NCT00847249|tolerability|tolerability
667154|NCT00847249|healthy|healthy
667155|NCT00847249|inhalation|inhalation
667156|NCT00847249|Healthy males|healthy males
667157|NCT00847262|Hypertension|hypertension
667158|NCT00847262|Abdominal obesity|abdominal obesity
667159|NCT00847262|Diabetes|diabetes
667160|NCT00847262|Treatment|treatment
667161|NCT00847275|Elderly patients|elderly patients
667162|NCT00847275|renal insufficiency|renal insufficiency
667163|NCT00847275|gerontologic evaluation|gerontologic evaluation
667164|NCT00847288|Heart Failure|heart failure
667165|NCT00847288|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
667166|NCT00847288|Cardiac Resynchronization Therapy with Defibrillator (CRT D)|cardiac resynchronization therapy with defibrillator (crt d)
667167|NCT00847288|OptiVol®|optivol®
667168|NCT00847314|Hypogonadism|hypogonadism
667169|NCT00847314|Abdominal obesity|abdominal obesity
667170|NCT00847314|Physical exercise|physical exercise
667171|NCT00847314|Testosterone|testosterone
667172|NCT00847327|Type 1 Diabetes|type 1 diabetes
667173|NCT00847327|Parenting|parenting
667174|NCT00847327|Young Children|young children
667175|NCT00847340|Genital warts|genital warts
667176|NCT00847340|HPV typing|hpv typing
667177|NCT00847340|HPV infections|hpv infections
667178|NCT00847340|Condyloma Acuminata|condyloma acuminata
667179|NCT00847353|high frequency ECG|high frequency ecg
667180|NCT00847353|normal values|normal values
667181|NCT00847353|asymptomatic|asymptomatic
667182|NCT00847353|obese|obese
667183|NCT00847366|Perifosine|perifosine
667184|NCT00847379|Duchenne muscular dystrophy|duchenne muscular dystrophy
667185|NCT00847379|Becker muscular dystrophy|becker muscular dystrophy
667186|NCT00847379|Nonsense mutation|nonsense mutation
667187|NCT00847379|Premature stop codon|premature stop codon
667189|NCT00847379|BMD|bmd
667190|NCT00847379|Ataluren|ataluren
667191|NCT00847379|PTC124|ptc124
667192|NCT00847392|Urethral catheterization|urethral catheterization
667193|NCT00847392|Emergency Department|emergency department
667194|NCT00847392|Ultrasound|ultrasound
667195|NCT00847392|Urinary tract infection|urinary tract infection
667196|NCT00847392|Pediatric|pediatric
667197|NCT00847405|Bioequivalence|bioequivalence
667198|NCT00847405|Healthy Subjects|healthy subjects
667199|NCT00847418|pharmacokinetics|pharmacokinetics
667200|NCT00847418|ketamine|ketamine
667201|NCT00847418|Anesthetics, Dissociative|anesthetics, dissociative
667202|NCT00847431|Subthalamic Nucleus|subthalamic nucleus
667203|NCT00847431|Deep Brain Stimulation|deep brain stimulation
667204|NCT00847431|Depression|depression
667205|NCT00847431|Anxiety|anxiety
667206|NCT00847431|Parkinson's Disease|parkinson's disease
667207|NCT00847457|Exercise|exercise
667208|NCT00847457|Stretching|stretching
667209|NCT00847457|Adolescents|adolescents
667210|NCT00847470|Dental caries|dental caries
667211|NCT00847470|Assessments|assessments
667212|NCT00847470|dental materials|dental materials
667213|NCT00847483|glaucoma|glaucoma
667214|NCT00847483|ocular hypertension|ocular hypertension
667215|NCT00847483|latanoprost|latanoprost
667216|NCT00847483|travoprost|travoprost
667217|NCT00847483|bimatoprost|bimatoprost
667218|NCT00847496|Partial Thickness burn|partial thickness burn
667219|NCT00847496|Biological Dressing|biological dressing
667220|NCT00847509|lung cancer|lung cancer
667221|NCT00847509|head and neck cancer|head and neck cancer
667222|NCT00847509|radiotherapy|radiotherapy
667223|NCT00847509|chemoradiotherapy|chemoradiotherapy
667224|NCT00847509|radiation|radiation
667225|NCT00847509|chemoradiation|chemoradiation
667226|NCT00847509|FLT|flt
667227|NCT00847509|[F-18]FLT|[f-18]flt
667228|NCT00847509|FDG|fdg
667229|NCT00847509|[F-18]FDG|[f-18]fdg
667230|NCT00847522|melanoma|melanoma
667231|NCT00847522|skin cancer|skin cancer
667232|NCT00847522|lymph node|lymph node
667233|NCT00847522|sentinel lymph node|sentinel lymph node
667615|NCT00841074|Elderly|elderly
667234|NCT00847522|malignant melanoma|malignant melanoma
667235|NCT00847522|mapping|mapping
667236|NCT00847548|intimate partner violence|intimate partner violence
667237|NCT00847548|domestic violence|domestic violence
667238|NCT00847548|substance abuse|substance abuse
667239|NCT00847548|alcohol abuse|alcohol abuse
667240|NCT00847548|drug abuse|drug abuse
667241|NCT00847548|addiction|addiction
667242|NCT00847561|Anxiety|anxiety
667243|NCT00847574|Weight loss|weight loss
667244|NCT00847574|Weight maintenance|weight maintenance
667245|NCT00847574|Weight management|weight management
667246|NCT00847574|Cardiovascular disease risk|cardiovascular disease risk
667247|NCT00847574|Dietary Guidelines|dietary guidelines
667248|NCT00847574|Diet and exercise|diet and exercise
667249|NCT00847574|Prevention|prevention
667250|NCT00847587|Contraceptive|contraceptive
667251|NCT00847587|Implant|implant
667252|NCT00847587|Postpartum period|postpartum period
667253|NCT00847587|etonogestrel-releasing|etonogestrel-releasing
667254|NCT00847587|lactogenesis|lactogenesis
667255|NCT00847587|Breastfeeding|breastfeeding
667256|NCT00847600|Schizophrenia|schizophrenia
667257|NCT00847600|Neurosteroids|neurosteroids
667258|NCT00847600|Pregnenolone|pregnenolone
667259|NCT00847600|Augmentation|augmentation
667354|NCT00848029|Influenza vaccine|influenza vaccine
667355|NCT00848042|cancer|cancer
667260|NCT00847613|double-blind placebo-controlled investigational drug oral therapy safety and efficacy hand and feet x-rays|double-blind placebo-controlled investigational drug oral therapy safety and efficacy hand and feet x-rays
667261|NCT00847626|Hypertensive|hypertensive
667262|NCT00847626|Blood Pressure, High|blood pressure, high
667263|NCT00847626|Vascular Disease|vascular disease
667264|NCT00847626|Cardiovascular Disease|cardiovascular disease
667265|NCT00847626|Drug Therapy|drug therapy
667266|NCT00847639|Multiple Myeloma|multiple myeloma
667267|NCT00847639|lenalidomide|lenalidomide
667268|NCT00847639|Revlimid|revlimid
667269|NCT00847639|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
667270|NCT00847665|Pressure ulcers|pressure ulcers
667271|NCT00847665|Repositioning|repositioning
667272|NCT00847665|Prevention|prevention
667273|NCT00847665|Mechanical Ventilation|mechanical ventilation
667274|NCT00847665|Critical care|critical care
667275|NCT00847678|Cryptococcal Meningitis|cryptococcal meningitis
667276|NCT00847691|economic evaluation|economic evaluation
667277|NCT00847691|diagnostics|diagnostics
667279|NCT00847704|Stroke|stroke
667280|NCT00847704|Rehabilitation|rehabilitation
667281|NCT00847704|Robotics|robotics
667282|NCT00847717|Oral|oral
667283|NCT00847717|cancer|cancer
667284|NCT00847717|surgery|surgery
667285|NCT00847717|neck dissection|neck dissection
667286|NCT00847717|spinal accessory nerve|spinal accessory nerve
752403|NCT01172873|exposure response prevention|exposure response prevention
667287|NCT00847730|Ease of dressing application, dressing conformability and ease of dressing removal on diabetic foot ulcers using the ActiVAC therapy|ease of dressing application, dressing conformability and ease of dressing removal on diabetic foot ulcers using the activac therapy
667288|NCT00847743|oxidative stress|oxidative stress
667290|NCT00847743|ischemia-reperfusion|ischemia-reperfusion
667291|NCT00847756|Otitis media|otitis media
667292|NCT00847756|demography|demography
667293|NCT00847756|Streptococcus pneumoniae|streptococcus pneumoniae
667294|NCT00847756|Haemophilus influenzae|haemophilus influenzae
667295|NCT00847756|Moraxella catarrhalis|moraxella catarrhalis
667296|NCT00847756|rhinovirus|rhinovirus
667297|NCT00847756|children, 0-5 years of age|children, 0-5 years of age
667298|NCT00847756|diagnosed rAOM, COME or CSOM by an otorhinolaryngologist|diagnosed raom, come or csom by an otorhinolaryngologist
667299|NCT00847756|primary and secondary hospital Nijmegen, the Netherlands|primary and secondary hospital nijmegen, the netherlands
667300|NCT00847769|Ankle Sprain|ankle sprain
667301|NCT00847808|Esophageal Reflux|esophageal reflux
667302|NCT00847808|Gastro-Esophageal Reflux|gastro-esophageal reflux
667303|NCT00847808|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
667304|NCT00847808|GERD|gerd
667305|NCT00847808|Regurgitation, Gastric|regurgitation, gastric
667306|NCT00847808|Heartburn|heartburn
667307|NCT00847808|Drug Therapy|drug therapy
667308|NCT00847847|ALS|als
667309|NCT00847847|Motor neuron|motor neuron
667310|NCT00847847|Pathophysiology|pathophysiology
667311|NCT00847847|Neuromuscular junction|neuromuscular junction
667312|NCT00847847|Neuromuscular transmission|neuromuscular transmission
667313|NCT00847847|Microelectrodes|microelectrodes
667314|NCT00847860|cognition|cognition
667315|NCT00847873|intimate partner violence|intimate partner violence
667316|NCT00847873|domestic violence|domestic violence
667317|NCT00847873|alcohol abuse|alcohol abuse
667318|NCT00847873|alcohol dependence|alcohol dependence
667319|NCT00847873|drug abuse|drug abuse
667320|NCT00847873|drug dependence|drug dependence
667321|NCT00847873|addiction|addiction
667322|NCT00847899|hypertension|hypertension
667323|NCT00847899|impaired glucose tolerance|impaired glucose tolerance
667324|NCT00847899|s-EH enzyme inhibition|s-eh enzyme inhibition
667325|NCT00847899|pre-diabetes|pre-diabetes
667326|NCT00847912|NMSC|nmsc
668108|NCT00848549|Monotherapy|monotherapy
667327|NCT00847912|nonmelanoma skin cancer|nonmelanoma skin cancer
667328|NCT00847912|topical 5-FU 5% cream|topical 5-fu 5% cream
667329|NCT00847912|Neoplasms|neoplasms
667330|NCT00847912|Antineoplastic Agents|antineoplastic agents
667331|NCT00847912|Therapeutic Uses|therapeutic uses
667332|NCT00847912|Dermatologic Agents|dermatologic agents
667333|NCT00847912|Neoplasms by Site|neoplasms by site
667334|NCT00847912|carcinoma, basal cell|carcinoma, basal cell
667335|NCT00847912|carcinoma, squamous cell|carcinoma, squamous cell
667336|NCT00847938|neostigmine|neostigmine
667337|NCT00847938|neuromuscular blocking agent|neuromuscular blocking agent
667338|NCT00847938|train of four|train of four
667339|NCT00847938|anesthesia|anesthesia
667340|NCT00847951|renal|renal
667341|NCT00847951|neonates|neonates
667342|NCT00847964|Heart Failure|heart failure
667343|NCT00847977|Acute head trauma|acute head trauma
667344|NCT00847990|Down syndrome|down syndrome
667345|NCT00847990|aneuploidy|aneuploidy
667346|NCT00847990|chromosome abnormality|chromosome abnormality
667347|NCT00847990|amniocentesis|amniocentesis
667348|NCT00847990|chorionic villus sampling|chorionic villus sampling
667349|NCT00847990|Laboratory Developed Test (LDT)|laboratory developed test (ldt)
667350|NCT00848003|Probiotics|probiotics
667351|NCT00848003|BB-12|bb-12
667352|NCT00848003|Yogurt|yogurt
667353|NCT00848003|Antibiotics|antibiotics
667356|NCT00848042|head and neck|head and neck
667357|NCT00848042|laser|laser
667358|NCT00848042|ablation|ablation
667359|NCT00848068|lipid layer thickness|lipid layer thickness
667360|NCT00848081|Prostate|prostate
667361|NCT00848081|BPH|bph
667362|NCT00848081|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
667363|NCT00848081|BPH-LUTS|bph-luts
667364|NCT00848081|LUTS|luts
667365|NCT00848081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
667366|NCT00848081|tadalafil|tadalafil
667367|NCT00848081|alpha blockers|alpha blockers
667368|NCT00848094|hepatocellular carcinoma|hepatocellular carcinoma
667369|NCT00848094|radiation therapy|radiation therapy
667370|NCT00848094|3-dimensional conformal radiation therapy (3-DCRT)|3-dimensional conformal radiation therapy (3-dcrt)
667371|NCT00848094|intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
667372|NCT00848094|active breathing control|active breathing control
667373|NCT00848107|systemic sclerosis|systemic sclerosis
667374|NCT00848107|scleroderma|scleroderma
667375|NCT00848107|digital ulcers|digital ulcers
667376|NCT00848107|vasculopathy|vasculopathy
667377|NCT00848159|Osteoporosis|osteoporosis
667378|NCT00848159|kyphosis|kyphosis
667379|NCT00848159|photogrammetry|photogrammetry
667380|NCT00848172|Essential Tremor|essential tremor
667381|NCT00848172|Octanol|octanol
667382|NCT00848172|Octanoic Acid|octanoic acid
667383|NCT00848172|Ethanol|ethanol
667384|NCT00848172|Accelerometry|accelerometry
667385|NCT00848185|VEGF|vegf
667386|NCT00848185|Trigger|trigger
667387|NCT00848185|OHSS|ohss
667388|NCT00848198|Dry Eye Disease|dry eye disease
667389|NCT00848198|Dry Eye Syndrome|dry eye syndrome
667390|NCT00848198|Dry Eye|dry eye
667391|NCT00848211|HIV|hiv
667392|NCT00848211|vaccine|vaccine
667393|NCT00848211|lipopeptide|lipopeptide
667394|NCT00848211|Tat|tat
667395|NCT00848211|TUTI-16|tuti-16
667396|NCT00848211|THYMON|thymon
667397|NCT00848211|Treatment Naive|treatment naive
667398|NCT00848224|coronary heart disease|coronary heart disease
667399|NCT00848224|lipid lowering medication|lipid lowering medication
667400|NCT00848224|NCEP guidelines|ncep guidelines
667401|NCT00848237|Barrett's Esophagus|barrett's esophagus
667402|NCT00848237|Dysplasia|dysplasia
667403|NCT00848237|Intestinal Metaplasia|intestinal metaplasia
667404|NCT00848250|Cardiopulmonary Bypass|cardiopulmonary bypass
667405|NCT00848250|ACE inhibitor|ace inhibitor
667406|NCT00848250|Pediatrics|pediatrics
667407|NCT00848263|Fracture|fracture
667408|NCT00848263|Radius|radius
667409|NCT00848263|Surgery|surgery
667410|NCT00848263|Osteosynthesis|osteosynthesis
667411|NCT00848276|PCSK9|pcsk9
667412|NCT00848276|Lipoprotein metabolism|lipoprotein metabolism
667413|NCT00848276|testosterone|testosterone
667414|NCT00848276|estradiol|estradiol
667415|NCT00848289|Bladder cancer|bladder cancer
667416|NCT00848289|Genetic susceptibility|genetic susceptibility
667417|NCT00848289|Increased Risk|increased risk
667418|NCT00848302|peripheral vascular disease|peripheral vascular disease
667419|NCT00848302|endothelial dysfunction|endothelial dysfunction
667420|NCT00848302|intravascular ultrasound|intravascular ultrasound
667421|NCT00848302|L-Arginine|l-arginine
667422|NCT00848315|cognitive behavioral intervention|cognitive behavioral intervention
667423|NCT00848315|low literate/illiterate Hispanic patients|low literate/illiterate hispanic patients
667526|NCT00840788|skin adhesive|skin adhesive
667424|NCT00848328|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
667425|NCT00848328|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
667426|NCT00848328|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
667427|NCT00848328|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
667428|NCT00848354|enbrel|enbrel
667429|NCT00848354|moderate arthritis|moderate arthritis
667430|NCT00848354|severe arthritis|severe arthritis
667431|NCT00848354|rheumatoid arthritis|rheumatoid arthritis
667432|NCT00848380|Hypertension|hypertension
667433|NCT00848380|hyperlipidemia|hyperlipidemia
667434|NCT00848393|pediatric cardiac surgery|pediatric cardiac surgery
667435|NCT00848393|stress response|stress response
667436|NCT00848393|early extubation|early extubation
667437|NCT00848393|Dexmedetomidine|dexmedetomidine
667438|NCT00848393|TOF|tof
667439|NCT00848393|VSD|vsd
667440|NCT00848393|AVSD|avsd
667441|NCT00848406|bronchial|bronchial
667442|NCT00848406|COPD|copd
667443|NCT00848406|Asthma|asthma
667444|NCT00848406|sputum|sputum
667445|NCT00848406|biopsies|biopsies
667446|NCT00848419|Epidural|epidural
667447|NCT00848419|Analgesia|analgesia
667448|NCT00848419|Methadone|methadone
667449|NCT00848419|Morphine|morphine
667450|NCT00848419|Pharmacokinetic-pharmacodynamic|pharmacokinetic-pharmacodynamic
667451|NCT00848419|Experimental pain - analgesic response|experimental pain - analgesic response
667452|NCT00848432|Schizophrenia|schizophrenia
667453|NCT00848432|Risperidone|risperidone
667454|NCT00848432|Maintenance treatment|maintenance treatment
667455|NCT00848432|Relapse|relapse
667456|NCT00840502|malaria|malaria
667457|NCT00840502|ultrasound|ultrasound
667459|NCT00840502|Pregnant women (infected with malaria and without)|pregnant women (infected with malaria and without)
667460|NCT00840528|ozone|ozone
667461|NCT00840554|Fatigue|fatigue
667462|NCT00840554|Cancer-related fatigue|cancer-related fatigue
667463|NCT00840554|High grade glioma|high grade glioma
667464|NCT00840554|Quality of life|quality of life
667465|NCT00840554|Exercise|exercise
667466|NCT00840554|Physical Therapy|physical therapy
667467|NCT00840554|HGG|hgg
667468|NCT00840554|QOL|qol
667469|NCT00840567|Stem cells|stem cells
667470|NCT00840580|Cataract, Cornea, Vigamox, Cravit|cataract, cornea, vigamox, cravit
667471|NCT00840593|Acromioclavicular Joint|acromioclavicular joint
667472|NCT00840593|Dislocation|dislocation
667473|NCT00840593|Trials, Randomized Clinical|trials, randomized clinical
667474|NCT00840593|Surgical Procedures, Operative|surgical procedures, operative
667475|NCT00840606|Bioequivalence|bioequivalence
667476|NCT00840606|Healthy Subjects|healthy subjects
667477|NCT00840632|Bioequivalence|bioequivalence
667478|NCT00840632|Healthy Subjects|healthy subjects
667479|NCT00840645|YM178|ym178
667480|NCT00840645|Urinary Bladder, Overactive|urinary bladder, overactive
667481|NCT00840645|Mirabegron|mirabegron
667482|NCT00840658|HIV|hiv
667483|NCT00840658|Injection drug users|injection drug users
667484|NCT00840658|Female sex workers|female sex workers
667485|NCT00840658|STIs|stis
667486|NCT00840658|HIV Seronegativity|hiv seronegativity
667487|NCT00840671|Cerebrolysin|cerebrolysin
667488|NCT00840671|Alteplase|alteplase
667489|NCT00840671|Ischemic Stroke|ischemic stroke
667490|NCT00840671|Modified Rankin Scale|modified rankin scale
667491|NCT00840671|NIH Stroke Scale|nih stroke scale
667492|NCT00840671|Barthel Index|barthel index
667493|NCT00840671|Glasgow Outcome Score|glasgow outcome score
667494|NCT00840684|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
667495|NCT00840684|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
667496|NCT00840697|low back pain|low back pain
667497|NCT00840697|neck pain|neck pain
667498|NCT00840697|return to work|return to work
667499|NCT00840697|exercises|exercises
667500|NCT00840697|cognitive intervention|cognitive intervention
667501|NCT00840710|women in active labor|women in active labor
667502|NCT00840723|Healthy smokers|healthy smokers
667503|NCT00840723|Current cigarette smokers|current cigarette smokers
667504|NCT00840723|No lung disease|no lung disease
667505|NCT00840736|VBG|vbg
667506|NCT00840736|LAGB|lagb
667507|NCT00840736|long term results|long term results
667508|NCT00840736|Weight loss|weight loss
667509|NCT00840736|Complications|complications
667510|NCT00840736|Reoperations|reoperations
667511|NCT00840736|Conversion|conversion
667512|NCT00840749|STARS|stars
667513|NCT00840749|Early Stage Non Small Cell Lung Cancer|early stage non small cell lung cancer
667514|NCT00840749|NSCLC|nsclc
667515|NCT00840749|CyberKnife|cyberknife
667516|NCT00840749|Surgery|surgery
667517|NCT00840749|Accuray|accuray
667518|NCT00840762|HIV-1|hiv-1
667519|NCT00840762|HIV|hiv
667520|NCT00840762|HIV Genotypic testing|hiv genotypic testing
667521|NCT00840762|resistance|resistance
667522|NCT00840775|Stent|stent
667523|NCT00840775|interventional cardiology|interventional cardiology
667524|NCT00840775|catheterization|catheterization
667525|NCT00840775|symptomatic ischemic heart disease|symptomatic ischemic heart disease
667527|NCT00840788|tissue adhesive|tissue adhesive
667528|NCT00840788|mediolateral episiotomy|mediolateral episiotomy
667529|NCT00840788|perineal repair|perineal repair
667530|NCT00840788|labor and delivery|labor and delivery
667531|NCT00840788|repair|repair
667532|NCT00840814|lymphedema|lymphedema
667533|NCT00840814|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
667534|NCT00840814|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
667535|NCT00840814|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
667536|NCT00840814|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
667537|NCT00840814|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
667538|NCT00840814|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
667539|NCT00840814|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
667540|NCT00840814|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
667541|NCT00840814|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
667542|NCT00840814|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
667543|NCT00840814|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
667544|NCT00840814|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
667545|NCT00840814|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
667546|NCT00840814|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
667547|NCT00840814|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
667548|NCT00840814|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
667549|NCT00840814|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
667550|NCT00840814|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
667551|NCT00840814|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
667552|NCT00840814|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
667553|NCT00840814|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
667554|NCT00840814|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
667555|NCT00840814|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
667556|NCT00840814|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
667557|NCT00840814|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
667558|NCT00840814|stage I salivary gland cancer|stage i salivary gland cancer
667559|NCT00840814|stage II salivary gland cancer|stage ii salivary gland cancer
667560|NCT00840814|stage III salivary gland cancer|stage iii salivary gland cancer
667561|NCT00840827|stage (IPSS low and INT-1)|stage (ipss low and int-1)
667562|NCT00840827|RBC transfusion-dependent|rbc transfusion-dependent
667563|NCT00840827|non-del 5q MDS|non-del 5q mds
667564|NCT00840840|Bioequivalence|bioequivalence
667565|NCT00840840|Healthy Subjects|healthy subjects
669049|NCT00839436|ICL|icl
667566|NCT00840853|Stem cell transplant|stem cell transplant
667567|NCT00840853|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
667568|NCT00840853|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
667569|NCT00840853|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
667570|NCT00840853|Cytotoxic T lymphocytes|cytotoxic t lymphocytes
667571|NCT00840853|CTL|ctl
667572|NCT00840853|CD-19|cd-19
667573|NCT00840853|chimeric receptor|chimeric receptor
667574|NCT00840866|Bioequivalence|bioequivalence
667575|NCT00840866|Healthy Subjects|healthy subjects
667576|NCT00840879|Bioequivalence|bioequivalence
667577|NCT00840879|Healthy Subjects|healthy subjects
667578|NCT00840905|HPV|hpv
667579|NCT00840918|Cardiac surgery|cardiac surgery
667580|NCT00840918|Lidocaine|lidocaine
667581|NCT00840918|Quality of life|quality of life
667582|NCT00840931|Myeloid|myeloid
667583|NCT00840931|Monocytic|monocytic
667584|NCT00840931|Immunotherapy|immunotherapy
667585|NCT00840931|Vaccine|vaccine
667586|NCT00840931|MDS|mds
667587|NCT00840931|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
667588|NCT00840944|gonadotropin releasing hormone agonist|gonadotropin releasing hormone agonist
667589|NCT00840944|growth hormone|growth hormone
667590|NCT00840944|final height|final height
667591|NCT00840944|bone density|bone density
667592|NCT00840944|puberty|puberty
667593|NCT00840983|delayed cord clamping|delayed cord clamping
667594|NCT00840983|very low birthweight infant|very low birthweight infant
667595|NCT00840983|bronchopulmonary dysplasia|bronchopulmonary dysplasia
667596|NCT00840983|intraventricular hemorrhage|intraventricular hemorrhage
667597|NCT00840983|motor function|motor function
667598|NCT00840996|Spine Surgery|spine surgery
667599|NCT00840996|Intraocular pressure|intraocular pressure
667600|NCT00840996|Lidocaine|lidocaine
667601|NCT00840996|Epidural Anesthetic|epidural anesthetic
667602|NCT00841009|gastric bypass|gastric bypass
667603|NCT00841009|obesity|obesity
667604|NCT00841022|anxiety|anxiety
667605|NCT00841022|anaesthesia|anaesthesia
667606|NCT00841022|child|child
667608|NCT00841022|Elective surgery|elective surgery
667609|NCT00841035|Pancreatic|pancreatic
667610|NCT00841035|Cancer|cancer
667611|NCT00841035|Assay|assay
667612|NCT00841035|Biomarkers|biomarkers
667613|NCT00841048|Safety and tolerability|safety and tolerability
667616|NCT00841074|Chlorhexidine|chlorhexidine
667617|NCT00841074|Respiratory pathogens|respiratory pathogens
667618|NCT00841100|PKU|pku
667619|NCT00841100|Kuvan|kuvan
667620|NCT00841100|BH4|bh4
667621|NCT00841100|tetrahydrobiopterin|tetrahydrobiopterin
667622|NCT00841113|Prostate cancer|prostate cancer
667623|NCT00841113|Advanced|advanced
667624|NCT00841113|Metastatic|metastatic
667625|NCT00841126|Hyperphosphatemia|hyperphosphatemia
667626|NCT00841126|Phosphate binder|phosphate binder
667627|NCT00841139|perhexiline|perhexiline
667628|NCT00841139|idiopathic dilated cardiomyopathy|idiopathic dilated cardiomyopathy
667629|NCT00841139|magnetic resonance spectroscopy|magnetic resonance spectroscopy
667630|NCT00841139|cardiac energetics|cardiac energetics
667631|NCT00841152|Bone tumors|bone tumors
667632|NCT00841152|Surgery|surgery
667633|NCT00841152|Bone graft substitutes|bone graft substitutes
667634|NCT00841152|Bioactive glass|bioactive glass
667635|NCT00841152|Bioceramics|bioceramics
667636|NCT00841152|Bone autograft|bone autograft
667637|NCT00841152|Bone allograft|bone allograft
667638|NCT00841165|Carbon Monoxide Toxicity|carbon monoxide toxicity
667639|NCT00841165|Carbon|carbon
667640|NCT00841165|Monoxide|monoxide
667641|NCT00841165|Poisoning|poisoning
667642|NCT00841165|Toxicity|toxicity
667643|NCT00841165|Treatment|treatment
667647|NCT00841178|Randomised controlled trial|randomised controlled trial
667648|NCT00841178|Venous insufficiency|venous insufficiency
667649|NCT00841178|Varicose veins|varicose veins
667650|NCT00841178|Quality of Life|quality of life
667651|NCT00841178|Clinical effectiveness|clinical effectiveness
667652|NCT00841178|Cost effectiveness|cost effectiveness
667653|NCT00841191|Resistant to anti-EGFR|resistant to anti-egfr
667654|NCT00841191|Interleukin-6|interleukin-6
667655|NCT00841191|Neoplasms by Histologic Type|neoplasms by histologic type
667656|NCT00841191|Immunologic Factors|immunologic factors
667657|NCT00841191|Mol Physiological Effects of Drugs|mol physiological effects of drugs
667658|NCT00841191|KRAS protein, human|kras protein, human
667659|NCT00841191|CNTO 328|cnto 328
667660|NCT00841217|Drug treatment|drug treatment
667661|NCT00841230|Tinnitus|tinnitus
667662|NCT00841243|Hepatitis C|hepatitis c
667663|NCT00841243|Antiviral therapy|antiviral therapy
667664|NCT00841243|weight loss|weight loss
667665|NCT00841243|dietary support|dietary support
667666|NCT00841243|dietary advise|dietary advise
667667|NCT00841256|specific immunotherapy|specific immunotherapy
667669|NCT00841256|SLIT|slit
667670|NCT00841256|sublingual|sublingual
667671|NCT00841269|Bipolar Manic Depression|bipolar manic depression
667672|NCT00841282|Colorectal cancer screening|colorectal cancer screening
667673|NCT00841282|Optical colonoscopy|optical colonoscopy
753272|NCT01176149|Diabetes|diabetes
667674|NCT00841282|Water method|water method
667675|NCT00841282|Sedation|sedation
667676|NCT00841321|Ginkgo biloba|ginkgo biloba
667677|NCT00841321|Multiple Sclerosis|multiple sclerosis
667678|NCT00841321|Cognition|cognition
667679|NCT00841321|Neuropsychological Tests|neuropsychological tests
667680|NCT00841321|Neurobehavioral Manifestations|neurobehavioral manifestations
667681|NCT00841321|Quality of life|quality of life
667682|NCT00841321|Randomized Controlled Trials|randomized controlled trials
667683|NCT00841321|Placebos|placebos
667684|NCT00841321|Double-Blind Method|double-blind method
667685|NCT00841334|Adolescent|adolescent
667686|NCT00841334|Overweight|overweight
667687|NCT00841334|Obesity|obesity
667688|NCT00841334|Weight loss|weight loss
667689|NCT00841334|Nutrition|nutrition
667690|NCT00841334|Physical activity|physical activity
667691|NCT00841334|Community-based participatory research|community-based participatory research
667692|NCT00841334|School-based|school-based
667693|NCT00841334|Primary Care|primary care
667694|NCT00841334|Motivational interviewing|motivational interviewing
667695|NCT00841347|Obesity|obesity
667696|NCT00841347|Glucose metabolism disorders|glucose metabolism disorders
667697|NCT00841347|Appetite regulation|appetite regulation
667698|NCT00841347|Sleep|sleep
667699|NCT00841347|Adolescent|adolescent
667700|NCT00841347|Randomized controlled trials|randomized controlled trials
667701|NCT00841360|Social network|social network
667702|NCT00841360|Asymptomatic HIV|asymptomatic hiv
667703|NCT00841373|Retinal ischemia: Iris/Angle Neovascularization|retinal ischemia: iris/angle neovascularization
667704|NCT00841386|Cornea|cornea
667705|NCT00841386|Keratoconus|keratoconus
667706|NCT00841386|Ectasia|ectasia
667707|NCT00841386|Riboflavin|riboflavin
667708|NCT00841386|Collagen cross-linking|collagen cross-linking
667709|NCT00841399|Breast cancer|breast cancer
667710|NCT00841412|Usual Care Control Group|usual care control group
667711|NCT00841438|Angioplasty|angioplasty
667712|NCT00841438|Transluminal|transluminal
667713|NCT00841438|Percutaneous Coronary|percutaneous coronary
667714|NCT00841451|Atrial Fibrillation|atrial fibrillation
667715|NCT00841451|Persistent|persistent
667716|NCT00841451|Paroxysmal|paroxysmal
667717|NCT00841451|Pulmonary Vein isolation|pulmonary vein isolation
667718|NCT00841451|Omega three fatty acids|omega three fatty acids
667719|NCT00841451|Fish Oils|fish oils
668510|NCT00850941|Casodex|casodex
667720|NCT00841464|Parkinson's disease|parkinson's disease
667721|NCT00841464|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
667722|NCT00841477|druguser,HB vaccine adherence, HBV, HCV, HIV incidence|druguser,hb vaccine adherence, hbv, hcv, hiv incidence
667723|NCT00841490|Helicobacter pylori|helicobacter pylori
667724|NCT00841490|Oral Health|oral health
667725|NCT00841490|Intellectually & Developmentally Disabled|intellectually & developmentally disabled
667726|NCT00841503|functional food study|functional food study
667727|NCT00841516|Specific immunotherapy|specific immunotherapy
667728|NCT00841516|SIT|sit
667729|NCT00841516|SCIT|scit
667730|NCT00841516|recombinant|recombinant
667731|NCT00841516|Type 1 - Allergy|type 1 - allergy
667732|NCT00841529|left atrial appendage|left atrial appendage
667733|NCT00841529|LAA|laa
667734|NCT00841529|atrial fibrillation|atrial fibrillation
667735|NCT00841529|AF|af
667736|NCT00841542|Bioequivalence|bioequivalence
667737|NCT00841542|Healthy Subjects|healthy subjects
667738|NCT00841555|adult giant cell glioblastoma|adult giant cell glioblastoma
667739|NCT00841555|adult gliosarcoma|adult gliosarcoma
667740|NCT00841555|adult anaplastic astrocytoma|adult anaplastic astrocytoma
667741|NCT00841555|adult glioblastoma|adult glioblastoma
667742|NCT00841555|GBM/AA|gbm/aa
667743|NCT00841568|ADPKD|adpkd
667744|NCT00841568|Tolvaptan|tolvaptan
667846|NCT00842023|BNP|bnp
667745|NCT00841581|Age Related Macular Degeneration|age related macular degeneration
667746|NCT00841581|Pigment Epithelial Detachment|pigment epithelial detachment
667747|NCT00841581|Intravitreal Detachment|intravitreal detachment
667748|NCT00841581|Anti-VEGF|anti-vegf
667749|NCT00841594|healthy volunteers|healthy volunteers
667750|NCT00841607|whipple|whipple
667751|NCT00841607|pancreas|pancreas
667752|NCT00841607|reconstruction|reconstruction
667753|NCT00841607|leak|leak
667754|NCT00841607|fistula|fistula
667755|NCT00841620|Symptoms|symptoms
667756|NCT00841620|Postoperative pain|postoperative pain
667757|NCT00841620|Postoperative complications|postoperative complications
667758|NCT00841620|Milligan|milligan
667759|NCT00841620|Anopxy|anopxy
667760|NCT00841633|subarachnoid hemorrhage|subarachnoid hemorrhage
667761|NCT00841633|ischemia|ischemia
667762|NCT00841633|vasospasm|vasospasm
667763|NCT00841633|CT|ct
667764|NCT00841633|perfusion|perfusion
667765|NCT00841633|induced hypertension|induced hypertension
667766|NCT00841633|delayed cerebral ischemia|delayed cerebral ischemia
667767|NCT00841646|Influenza vaccine|influenza vaccine
667768|NCT00841659|Bioequivalence|bioequivalence
667769|NCT00841659|Healthy Subjects|healthy subjects
667770|NCT00841672|Hypertension|hypertension
667771|NCT00841672|systolic blood pressure|systolic blood pressure
667772|NCT00841672|cardiovascular disease|cardiovascular disease
667773|NCT00841672|aliskiren|aliskiren
667774|NCT00841672|amlodipine|amlodipine
667775|NCT00841698|Bioequivalence|bioequivalence
667776|NCT00841698|Healthy Subjects|healthy subjects
667777|NCT00841711|HIV|hiv
667778|NCT00841711|AIDS|aids
667780|NCT00841711|Intensive Case Management|intensive case management
667781|NCT00841711|Money Management|money management
667782|NCT00841711|Rapid Testing|rapid testing
667783|NCT00841711|Substance Abuse|substance abuse
667784|NCT00841711|Opioid Dependance|opioid dependance
667785|NCT00841711|Inmate Population|inmate population
667786|NCT00841724|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
667787|NCT00841724|Reduced-intensity conditioning|reduced-intensity conditioning
667788|NCT00841724|Reduced-toxicity conditioning|reduced-toxicity conditioning
667789|NCT00841724|Hematological malignancies|hematological malignancies
667790|NCT00841724|IV Busulfan|iv busulfan
667791|NCT00841737|Depressive Disorders;|depressive disorders;
667792|NCT00841737|Primary Health Care;|primary health care;
667793|NCT00841737|Nurses;|nurses;
667794|NCT00841737|Health education.|health education.
667795|NCT00841750|Chest Tubes|chest tubes
667796|NCT00841750|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
667797|NCT00841750|Lung Diseases, Interstitial|lung diseases, interstitial
667798|NCT00841750|Pulmonary Nodule, Solitary|pulmonary nodule, solitary
667799|NCT00841763|virus|virus
667800|NCT00841763|pandemic influenza|pandemic influenza
667801|NCT00841763|vaccine|vaccine
667802|NCT00841776|Acne Vulgaris|acne vulgaris
667803|NCT00841776|Acne|acne
667804|NCT00841789|Etanercept|etanercept
667805|NCT00841802|Chronic sinusitis|chronic sinusitis
667806|NCT00841802|Chronic rhinosinusitis|chronic rhinosinusitis
667807|NCT00841802|Nasal polyps|nasal polyps
667808|NCT00841815|Bioequivalence|bioequivalence
667809|NCT00841815|Healthy Subjects|healthy subjects
667810|NCT00841841|Analgesia|analgesia
667811|NCT00841841|molar third|molar third
667812|NCT00841841|acetaminophen|acetaminophen
667813|NCT00841841|dipyrone|dipyrone
667814|NCT00841854|Helicobacter pylori|helicobacter pylori
667815|NCT00841854|Bismuth|bismuth
667816|NCT00841854|Salvage treatment|salvage treatment
667817|NCT00841854|Metronidazole|metronidazole
667818|NCT00841867|Impaired Glucose Tolerance|impaired glucose tolerance
667819|NCT00841867|Diabetes|diabetes
667820|NCT00841893|Thermogenesis|thermogenesis
667821|NCT00841893|Meal-induced thermogenesis|meal-induced thermogenesis
667822|NCT00841893|Energy expenditure|energy expenditure
667823|NCT00841893|Fat oxidation|fat oxidation
667824|NCT00841893|Carbohydrate oxidation|carbohydrate oxidation
667825|NCT00841893|Bioactive ingredient|bioactive ingredient
667826|NCT00841893|Spice|spice
667827|NCT00841919|Diabetes|diabetes
667828|NCT00841919|Inpatient|inpatient
667829|NCT00841919|Insulin|insulin
667830|NCT00841919|Insulin pen|insulin pen
667831|NCT00841932|Fractional Flow Reserve|fractional flow reserve
667832|NCT00841932|Without anticoagulation|without anticoagulation
667833|NCT00841945|Diffuse B larg cell lymphoma|diffuse b larg cell lymphoma
667834|NCT00841945|Chemotherapy|chemotherapy
667835|NCT00841945|Radiotherapy|radiotherapy
667836|NCT00841984|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
667837|NCT00841984|neurological diseases|neurological diseases
667838|NCT00841984|metabolic|metabolic
667839|NCT00841984|inborn errors of metabolism|inborn errors of metabolism
667840|NCT00841984|Complex neurological diseases of unknown cause|complex neurological diseases of unknown cause
667841|NCT00842010|Diabetes|diabetes
667842|NCT00842010|Inpatient|inpatient
667843|NCT00842010|Hospital|hospital
667844|NCT00842010|Hyperglycemia|hyperglycemia
667845|NCT00842023|Natriuretic peptides|natriuretic peptides
667847|NCT00842023|Heart Failure|heart failure
667848|NCT00842023|Nitoglycerin|nitoglycerin
667849|NCT00842023|Biomarkers|biomarkers
667850|NCT00842036|Family Therapy|family therapy
667851|NCT00842036|Relationship Dysfunction|relationship dysfunction
667852|NCT00842036|Family Dysfunction|family dysfunction
667853|NCT00842036|Family Relations|family relations
667854|NCT00842036|Stimulant Dependence|stimulant dependence
667855|NCT00842036|Opiate Dependence|opiate dependence
667856|NCT00842036|Alcohol Dependence|alcohol dependence
667857|NCT00842036|Behavior Therapy|behavior therapy
667858|NCT00842036|Drug Treatment|drug treatment
667859|NCT00842036|Substance Abuse|substance abuse
667860|NCT00842036|Drug Addiction|drug addiction
667861|NCT00842049|Subarachnoid haemorrhage|subarachnoid haemorrhage
667862|NCT00842049|Aneurysm|aneurysm
667863|NCT00842049|Cerebrospinal fluid drainage|cerebrospinal fluid drainage
667864|NCT00842075|type 1 diabetes|type 1 diabetes
667865|NCT00842075|adolescents|adolescents
667866|NCT00842075|post prandial glucose|post prandial glucose
667867|NCT00842101|Intramedullary nails|intramedullary nails
667868|NCT00842101|Compartmental syndrome|compartmental syndrome
667869|NCT00842101|Fractures|fractures
667870|NCT00842114|Intermediate-high FLIPI score|intermediate-high flipi score
667871|NCT00842114|Follicular Lymphoma|follicular lymphoma
667872|NCT00842114|Progression free survival|progression free survival
667873|NCT00842127|Methylphenidate|methylphenidate
667874|NCT00842127|ADHD|adhd
667875|NCT00842127|Multidrug resistance(MDR)polymorphism|multidrug resistance(mdr)polymorphism
667876|NCT00842127|OROS methylphenidate|oros methylphenidate
667877|NCT00842140|Polycystic ovary syndrome|polycystic ovary syndrome
667878|NCT00842140|Oral Contraceptives, Hormonal|oral contraceptives, hormonal
667879|NCT00842140|Cardiovascular Disease|cardiovascular disease
667880|NCT00842140|Endothelium|endothelium
667881|NCT00842153|Psoriasis|psoriasis
667882|NCT00842153|Plaque Type Psoriasis|plaque type psoriasis
667883|NCT00842179|Perclose|perclose
667884|NCT00842205|hepatitis C|hepatitis c
667885|NCT00842205|NASH|nash
667886|NCT00842205|Hem Oxygenase|hem oxygenase
667887|NCT00842205|Gene polymorphism|gene polymorphism
667888|NCT00842218|Gait|gait
667889|NCT00842218|scoliosis|scoliosis
667890|NCT00842218|energy|energy
667891|NCT00842218|mechanics|mechanics
667892|NCT00842231|Corneal astigmatism|corneal astigmatism
667893|NCT00842231|post-cataract surgery|post-cataract surgery
667894|NCT00842231|visual performance|visual performance
667895|NCT00842231|Corneal astigmatism 0.5-0.75 Diopter|corneal astigmatism 0.5-0.75 diopter
667896|NCT00842257|panitumumab|panitumumab
667897|NCT00842257|cetuximab|cetuximab
667898|NCT00842257|KRAS wild-type|kras wild-type
667899|NCT00842270|severe asthma|severe asthma
667900|NCT00842270|corticosteroids dependent|corticosteroids dependent
667901|NCT00842270|asthma exacerbation|asthma exacerbation
667902|NCT00842270|weaning|weaning
667903|NCT00842270|tyrosine kinase inhibitor|tyrosine kinase inhibitor
667904|NCT00842270|severe persistent corticosteroid dependent asthma|severe persistent corticosteroid dependent asthma
667905|NCT00842283|dermatologic diseases|dermatologic diseases
667906|NCT00842296|GSV|gsv
667907|NCT00842296|RadioFrequency|radiofrequency
667908|NCT00842322|chronic kidney disease|chronic kidney disease
667909|NCT00842322|transplantation|transplantation
667910|NCT00842322|kidney function|kidney function
667911|NCT00842322|fluid intake|fluid intake
667912|NCT00842322|osmolarity|osmolarity
667913|NCT00842335|solid tumors|solid tumors
667914|NCT00842335|angiogenesis inhibitor|angiogenesis inhibitor
667915|NCT00842335|dose escalation|dose escalation
667916|NCT00842335|maximum tolerated dose|maximum tolerated dose
667917|NCT00842335|JI-101|ji-101
667918|NCT00842348|Lanreotide|lanreotide
667919|NCT00842348|Somatuline|somatuline
668511|NCT00850941|Flutamide|flutamide
667920|NCT00842348|Neuroendocrine tumour|neuroendocrine tumour
667921|NCT00842348|NET|net
667922|NCT00842387|gastroesophageal reflux disease|gastroesophageal reflux disease
667923|NCT00842387|reflux, heartburn|reflux, heartburn
667924|NCT00842387|regurgitation|regurgitation
667925|NCT00842387|acid control|acid control
667926|NCT00842387|PPI|ppi
667927|NCT00842387|antiacid|antiacid
667928|NCT00842387|primary care|primary care
667929|NCT00842387|esophagitis|esophagitis
667930|NCT00842400|Obesity|obesity
667931|NCT00842413|Prefrontal cortex|prefrontal cortex
667932|NCT00842413|visual consciousness|visual consciousness
667933|NCT00842413|focal lesions|focal lesions
667934|NCT00842413|action perception|action perception
667935|NCT00842426|Diabetes|diabetes
667936|NCT00842426|Cardiovascular disease|cardiovascular disease
667937|NCT00842426|Metabolic syndrome|metabolic syndrome
667938|NCT00842426|Cardiometabolic|cardiometabolic
667939|NCT00842439|aggression|aggression
667940|NCT00842439|Prevention and treatment of youth aggression|prevention and treatment of youth aggression
667941|NCT00842452|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
667942|NCT00842452|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
667943|NCT00842452|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
667944|NCT00842452|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
667945|NCT00842452|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
667946|NCT00842452|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
667947|NCT00842452|recurrent endometrial carcinoma|recurrent endometrial carcinoma
667948|NCT00842452|stage III endometrial carcinoma|stage iii endometrial carcinoma
667949|NCT00842452|stage IV endometrial carcinoma|stage iv endometrial carcinoma
667950|NCT00842452|recurrent uterine sarcoma|recurrent uterine sarcoma
667951|NCT00842452|stage III uterine sarcoma|stage iii uterine sarcoma
667952|NCT00842452|stage IV uterine sarcoma|stage iv uterine sarcoma
667953|NCT00842452|recurrent vaginal cancer|recurrent vaginal cancer
667954|NCT00842452|stage III vaginal cancer|stage iii vaginal cancer
667955|NCT00842452|stage IVA vaginal cancer|stage iva vaginal cancer
667956|NCT00842452|stage IVB vaginal cancer|stage ivb vaginal cancer
667957|NCT00842452|recurrent vulvar cancer|recurrent vulvar cancer
667958|NCT00842452|stage III vulvar cancer|stage iii vulvar cancer
667959|NCT00842452|stage IV vulvar cancer|stage iv vulvar cancer
667960|NCT00842452|recurrent cervical cancer|recurrent cervical cancer
667961|NCT00842452|stage III cervical cancer|stage iii cervical cancer
667962|NCT00842452|stage IVA cervical cancer|stage iva cervical cancer
667963|NCT00842452|stage IVB cervical cancer|stage ivb cervical cancer
667964|NCT00842452|fallopian tube cancer|fallopian tube cancer
667965|NCT00842452|ovarian sarcoma|ovarian sarcoma
667966|NCT00842452|ovarian stromal cancer|ovarian stromal cancer
667967|NCT00842465|Breast diseases,|breast diseases,
667968|NCT00842465|human mutation,|human mutation,
667969|NCT00842465|prolactin receptor;|prolactin receptor;
667970|NCT00842465|breast cancer|breast cancer
667971|NCT00842504|Anti-fungal|anti-fungal
667972|NCT00842504|Immunocompromised|immunocompromised
667973|NCT00842504|Pharmacokinetic|pharmacokinetic
667975|NCT00842504|Pharmacokinetics|pharmacokinetics
667976|NCT00842517|Cocaine Dependence|cocaine dependence
667977|NCT00842517|Cocaine Abuse|cocaine abuse
667978|NCT00842517|Substance Abuse|substance abuse
667979|NCT00842517|Contingency Management|contingency management
667980|NCT00842517|Drug Treatment|drug treatment
667981|NCT00842530|Dengue virus|dengue virus
667982|NCT00842530|Dengue fever|dengue fever
667983|NCT00842530|Dengue hemorrhagic fever|dengue hemorrhagic fever
667984|NCT00842530|Dengue diseases|dengue diseases
667985|NCT00842530|Dengue vaccine|dengue vaccine
667986|NCT00842543|Nutrition|nutrition
667987|NCT00842543|Oxidative Stress|oxidative stress
667988|NCT00842543|Insulin Resistance|insulin resistance
667989|NCT00842543|Whole Food Supplement|whole food supplement
667990|NCT00842543|Pediatric|pediatric
667991|NCT00842543|Retinoids|retinoids
667992|NCT00842543|Antioxidants|antioxidants
667993|NCT00842543|Dietary Supplements|dietary supplements
667994|NCT00842569|obesity|obesity
667995|NCT00842569|cognitive process|cognitive process
667996|NCT00842569|reward|reward
667997|NCT00842569|P300|p300
667998|NCT00842569|ERP|erp
667999|NCT00842569|Event-related potential during oddball paradigm|event-related potential during oddball paradigm
668000|NCT00842569|brain electrophysiological patterns|brain electrophysiological patterns
668001|NCT00842569|externalizing factor|externalizing factor
668002|NCT00842582|Ovarian cancer|ovarian cancer
668003|NCT00842582|chemotherapy|chemotherapy
668004|NCT00842582|azacitidine|azacitidine
668005|NCT00842595|relapsed aggressive B-cell lymphoma|relapsed aggressive b-cell lymphoma
668006|NCT00842595|Chemotherapy|chemotherapy
668007|NCT00842608|confusion|confusion
668008|NCT00842608|dementia|dementia
668009|NCT00842621|Sickle Cell Disease, Hemolytic Anemia|sickle cell disease, hemolytic anemia
668010|NCT00842621|Hemolysis|hemolysis
668012|NCT00842634|Treatment Experienced|treatment experienced
668013|NCT00842647|Sensitivity|sensitivity
668014|NCT00842647|specificity|specificity
668015|NCT00842647|positive rate|positive rate
668016|NCT00842647|negative rate|negative rate
668017|NCT00842660|Cervical cancer|cervical cancer
668018|NCT00842660|concurrent chemoradiotherapy|concurrent chemoradiotherapy
668019|NCT00842660|gemcitabine|gemcitabine
668020|NCT00842673|Dementia|dementia
668021|NCT00842673|Alzheimer Type Senile Dementia|alzheimer type senile dementia
668022|NCT00842673|Cognitive impairment|cognitive impairment
668023|NCT00842686|rectal cancer|rectal cancer
668024|NCT00842686|capecitabine|capecitabine
668025|NCT00842686|bevacizumab|bevacizumab
668026|NCT00842686|radiotherapy|radiotherapy
668027|NCT00842712|First-line treatment for subjects with advanced NSCLC,|first-line treatment for subjects with advanced nsclc,
668028|NCT00842712|integrin receptor antagonist, EGFR chimerized monoclonal antibody, chemotherapy|integrin receptor antagonist, egfr chimerized monoclonal antibody, chemotherapy
668029|NCT00842712|safety run-in + randomization part, MTD, PFS, Overall survival time, best overall response|safety run-in + randomization part, mtd, pfs, overall survival time, best overall response
668030|NCT00842738|Screening|screening
668031|NCT00842738|Cervical cancer|cervical cancer
668032|NCT00842738|Cervical dysplasia|cervical dysplasia
668033|NCT00842738|Adverse psychosocial effects|adverse psychosocial effects
668034|NCT00842738|Alternative treatment|alternative treatment
668035|NCT00842751|5α-reductase|5α-reductase
668036|NCT00842751|androgen|androgen
668334|NCT00850252|A-V shunt|a-v shunt
668037|NCT00842751|dihydrotestosterone (DHT)|dihydrotestosterone (dht)
668038|NCT00842751|drug delivery|drug delivery
668039|NCT00842751|oestradiol|oestradiol
668040|NCT00842764|eyelid fat pads|eyelid fat pads
668041|NCT00842777|Childhood obesity|childhood obesity
668042|NCT00842777|Quality of life|quality of life
668043|NCT00842777|Self-esteem|self-esteem
668044|NCT00842777|BMI|bmi
668045|NCT00842777|parental group treatment|parental group treatment
668046|NCT00842777|Body image|body image
668047|NCT00842790|Carcinoma, Renal Cell [C04.557.470.200.025.390]|carcinoma, renal cell [c04.557.470.200.025.390]
668048|NCT00842790|Angiogenesis Inhibitors [D27.505.954.248.025]|angiogenesis inhibitors [d27.505.954.248.025]
668049|NCT00842790|Tomography Scanners, X-Ray Computed [E07.913]|tomography scanners, x-ray computed [e07.913]
668050|NCT00842790|Magnetic Resonance Imaging [E01.370.350.825.500]|magnetic resonance imaging [e01.370.350.825.500]
668051|NCT00842790|Diffusion Magnetic Resonance Imaging [E01.370.350.825.500.150]|diffusion magnetic resonance imaging [e01.370.350.825.500.150]
668052|NCT00842790|Perfusion [E05.680]|perfusion [e05.680]
668053|NCT00842803|Liver|liver
668054|NCT00842803|transplant|transplant
668055|NCT00842803|albumin|albumin
668056|NCT00842803|outcome|outcome
668057|NCT00842803|Liver transplant recipients canadian transplant status 1 or 2|liver transplant recipients canadian transplant status 1 or 2
668058|NCT00842816|Dementia|dementia
668059|NCT00842816|Alzheimer Type Senile Dementia|alzheimer type senile dementia
668060|NCT00842816|Cognitive impairment|cognitive impairment
668061|NCT00842829|Breakthrough Cancer Pain|breakthrough cancer pain
668062|NCT00842842|surgical fixation devices|surgical fixation devices
668063|NCT00842842|postoperative pain|postoperative pain
668064|NCT00842842|ventral hernia|ventral hernia
668065|NCT00842842|fibrin tissue adhesive|fibrin tissue adhesive
668066|NCT00842842|laparoscopy|laparoscopy
668067|NCT00842842|quality of life|quality of life
668068|NCT00842842|fatigue|fatigue
668069|NCT00842855|GERD|gerd
668070|NCT00842855|PPI|ppi
668071|NCT00842855|partial responders|partial responders
668072|NCT00842868|atherosclerosis|atherosclerosis
668073|NCT00842868|contrast induced nephropathy|contrast induced nephropathy
668074|NCT00842868|renal impairment|renal impairment
668075|NCT00842868|catheterization|catheterization
668076|NCT00842881|Healingstone|healingstone
668077|NCT00842907|Brazil|brazil
668078|NCT00842907|isotretinoin|isotretinoin
668079|NCT00842907|photodamage|photodamage
668080|NCT00842907|photoaging|photoaging
668081|NCT00842920|amnestic MCI|amnestic mci
668082|NCT00842933|Septic shock|septic shock
668083|NCT00842933|Acute adrenal insufficiency|acute adrenal insufficiency
668084|NCT00842959|Improvement of adjustment accuracy of intraocular lenses and imaging quality|improvement of adjustment accuracy of intraocular lenses and imaging quality
668085|NCT00848458|Azelaic Acid|azelaic acid
668086|NCT00848458|Iontophoresis|iontophoresis
668087|NCT00848471|Indirect calorimeter|indirect calorimeter
668088|NCT00848471|Validation|validation
668089|NCT00848471|Energy expenditure|energy expenditure
668090|NCT00848471|Healthy volunteers|healthy volunteers
668091|NCT00848497|hormone replacement therapy|hormone replacement therapy
668092|NCT00848497|radical prostatectomy|radical prostatectomy
668093|NCT00848497|erectile dysfunctions|erectile dysfunctions
668094|NCT00848497|scheduled for removal of prostate gland|scheduled for removal of prostate gland
668095|NCT00848523|LBH859|lbh859
668096|NCT00848523|Panobinostat|panobinostat
668098|NCT00848523|Glioma|glioma
668099|NCT00848523|Glioblastoma|glioblastoma
668100|NCT00848523|Astrocytoma|astrocytoma
668101|NCT00848523|oligodendroglioma|oligodendroglioma
668102|NCT00848523|oligoastrocytoma|oligoastrocytoma
668103|NCT00848523|gliosarcoma|gliosarcoma
668104|NCT00848523|anaplastic|anaplastic
668105|NCT00848536|OAG|oag
668106|NCT00848536|OHT|oht
668107|NCT00848549|Epilepsy|epilepsy
668109|NCT00848562|sudden cardiac death|sudden cardiac death
668110|NCT00848588|agonal breathing|agonal breathing
668111|NCT00848588|cardiac arrest|cardiac arrest
668112|NCT00848588|9-1-1 call taker|9-1-1 call taker
668113|NCT00848588|survey|survey
668114|NCT00848601|SGI-1776|sgi-1776
668115|NCT00848601|PIM|pim
668116|NCT00848601|Hormone & Docetaxel refractory Prostate Cancer|hormone & docetaxel refractory prostate cancer
668117|NCT00848601|Refractory non-Hodgkin's Lymphoma|refractory non-hodgkin's lymphoma
668118|NCT00848627|Bladder cancer|bladder cancer
668119|NCT00848627|Smokers|smokers
668120|NCT00848627|Hematuria|hematuria
668121|NCT00848679|Pre-eclampsia|pre-eclampsia
668122|NCT00848679|Pregnancy|pregnancy
668123|NCT00848679|Uteroplacental blood flow|uteroplacental blood flow
668124|NCT00848679|Epidural|epidural
668125|NCT00848679|Anesthesia|anesthesia
668126|NCT00848692|Chronic Fatigue Syndrome|chronic fatigue syndrome
668127|NCT00848692|CFS|cfs
668128|NCT00848692|Myalgic Encephalomyelitis|myalgic encephalomyelitis
668129|NCT00848692|Rituximab|rituximab
668130|NCT00848692|B-lymphocyte depletion|b-lymphocyte depletion
668131|NCT00848692|B-cell depletion|b-cell depletion
668132|NCT00848705|type 1 diabetes, adolescent, self-management|type 1 diabetes, adolescent, self-management
668133|NCT00848718|Tumors, cancer|tumors, cancer
668134|NCT00848731|pulmonary hypertension|pulmonary hypertension
668135|NCT00848731|venous thromboembolism|venous thromboembolism
668136|NCT00848744|Acne|acne
668137|NCT00848757|Diabetes|diabetes
668138|NCT00848757|Lifestyle Intervention|lifestyle intervention
668139|NCT00848770|Stroke, Acute|stroke, acute
668140|NCT00848770|Systolic Pressure of Blood|systolic pressure of blood
668141|NCT00848783|gastric cancer|gastric cancer
668142|NCT00848783|gastroesophageal junction|gastroesophageal junction
668143|NCT00848783|stomach cancer|stomach cancer
668144|NCT00848783|intraperitoneal infusion|intraperitoneal infusion
668145|NCT00848783|capecitabine|capecitabine
668146|NCT00848783|irinotecan|irinotecan
668147|NCT00848783|cisplatin|cisplatin
668148|NCT00848783|floxuridine|floxuridine
668149|NCT00849459|recurrent breast cancer|recurrent breast cancer
668150|NCT00849459|stage IV breast cancer|stage iv breast cancer
668151|NCT00849472|Neoadjuvant Breast Cancer|neoadjuvant breast cancer
668152|NCT00849472|Pazopanib (GW786034)|pazopanib (gw786034)
668153|NCT00849472|NSABP Foundation, Inc.|nsabp foundation, inc.
668154|NCT00849472|cyclophosphamide|cyclophosphamide
668155|NCT00849472|Paclitaxel|paclitaxel
668156|NCT00849472|Doxorubicin|doxorubicin
668157|NCT00849485|Bioequivalence|bioequivalence
668158|NCT00849485|Healthy Subjects|healthy subjects
668159|NCT00849511|Migraine prevention|migraine prevention
668160|NCT00849511|Crossover|crossover
668161|NCT00849511|Melatonin|melatonin
668162|NCT00849537|Triamcinolon|triamcinolon
668163|NCT00849537|Cataract|cataract
668164|NCT00849537|Diabetic retinopathy|diabetic retinopathy
668165|NCT00849537|non-proliferative retinopathy|non-proliferative retinopathy
668166|NCT00849550|Advanced Solid Tumors|advanced solid tumors
668167|NCT00849550|Cancer|cancer
668168|NCT00849550|Capecitabine|capecitabine
668169|NCT00849550|XELOX|xelox
668170|NCT00849550|Neoplasms|neoplasms
668171|NCT00849550|Oxaliplatin|oxaliplatin
668172|NCT00849550|Bevacizumab|bevacizumab
668173|NCT00849550|RAD001|rad001
668174|NCT00849563|predictive genomics|predictive genomics
668175|NCT00849563|personalized medicine|personalized medicine
668176|NCT00849563|personal genomics|personal genomics
668177|NCT00849563|genetic knowledge|genetic knowledge
668178|NCT00849563|genetic attitudes|genetic attitudes
668179|NCT00849563|prevention|prevention
668180|NCT00849563|health outcomes|health outcomes
668181|NCT00849563|behavioral|behavioral
668182|NCT00849589|Screening|screening
668183|NCT00849589|Brief intervention|brief intervention
668184|NCT00849589|Underage drinking|underage drinking
668185|NCT00849628|Aged|aged
668186|NCT00849628|Polypharmacy|polypharmacy
668187|NCT00849628|Adverse effects|adverse effects
668188|NCT00849628|Nursing homes|nursing homes
668189|NCT00849641|decompensation|decompensation
668190|NCT00849641|septic shock|septic shock
668191|NCT00849641|tissue oxygenation|tissue oxygenation
668192|NCT00849641|near infrared spectroscopy|near infrared spectroscopy
668193|NCT00849654|PCI-32765|pci-32765
668194|NCT00849654|Lymphoma|lymphoma
668195|NCT00849654|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
668196|NCT00849654|Lymphoma, B-Cell|lymphoma, b-cell
668197|NCT00849654|Burkitt Lymphoma|burkitt lymphoma
668198|NCT00849654|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
668199|NCT00849654|Lymphoma, B-Cell, Diffuse|lymphoma, b-cell, diffuse
668200|NCT00849654|Lymphoma, Follicular|lymphoma, follicular
668201|NCT00849654|Lymphoma, Mantle Cell|lymphoma, mantle cell
668202|NCT00849654|Leukemia, Lymphoid|leukemia, lymphoid
668203|NCT00849654|Leukemia, B-Cell|leukemia, b-cell
668204|NCT00849654|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
668205|NCT00849654|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
668206|NCT00849667|ovarian cancer|ovarian cancer
668207|NCT00849667|relapsed ovarian cancer|relapsed ovarian cancer
668788|NCT00851799|ART|art
668208|NCT00849667|Platinum-sensitive Ovarian Cancer|platinum-sensitive ovarian cancer
668209|NCT00849680|HIV Seronegativity|hiv seronegativity
668210|NCT00849680|Preventive Vaccine|preventive vaccine
668211|NCT00849706|sleep deprivation|sleep deprivation
668212|NCT00849706|workload|workload
668213|NCT00849706|increased workload|increased workload
668214|NCT00849719|visual analog scale|visual analog scale
668215|NCT00849719|patient controlled analgesia|patient controlled analgesia
668216|NCT00849719|post operative pain|post operative pain
668217|NCT00849719|rescue drug|rescue drug
668218|NCT00849732|HIV Seronegativity|hiv seronegativity
668219|NCT00849732|Preventive Vaccine|preventive vaccine
668220|NCT00849745|severe autoimmune diseases|severe autoimmune diseases
668221|NCT00849745|allogeneic stem cell transplant|allogeneic stem cell transplant
668222|NCT00849758|breast cancer|breast cancer
668223|NCT00849758|elderly|elderly
668224|NCT00849758|biomarker|biomarker
668225|NCT00849771|Displaced Scapula Fracture|displaced scapula fracture
668226|NCT00849771|Scapula Fracture|scapula fracture
668227|NCT00849771|Extraarticular Scapula Fractures|extraarticular scapula fractures
668228|NCT00849771|Clavicle|clavicle
668229|NCT00849797|Bioequivalence|bioequivalence
668230|NCT00849797|Healthy Subjects|healthy subjects
668231|NCT00849810|Hypertension|hypertension
668232|NCT00849810|Beta-blockers|beta-blockers
668233|NCT00849810|Ambulatory blood pressure|ambulatory blood pressure
668234|NCT00849810|Basal metabolic rate|basal metabolic rate
668235|NCT00849810|Quality of life|quality of life
668236|NCT00849823|African American|african american
668237|NCT00849823|Men|men
668238|NCT00849823|Condoms|condoms
668239|NCT00849823|Randomization|randomization
668240|NCT00849823|Brief Intervention|brief intervention
668241|NCT00849823|HIV|hiv
668242|NCT00849823|HIV Seronegativity|hiv seronegativity
668243|NCT00849849|postgestational diabetes|postgestational diabetes
668244|NCT00849849|diabetes mellitus|diabetes mellitus
668245|NCT00849849|OGTT|ogtt
668246|NCT00849849|insulin sensitivity|insulin sensitivity
668247|NCT00849849|insulin secretion|insulin secretion
668248|NCT00849862|Bioequivalence|bioequivalence
668249|NCT00849862|Healthy Subjects|healthy subjects
668250|NCT00849875|ASCI|asci
668251|NCT00849875|Dacarbazine|dacarbazine
668252|NCT00849875|Cancer immunotherapeutic|cancer immunotherapeutic
668253|NCT00849875|MAGE-A3|mage-a3
668254|NCT00849875|Malignant melanoma|malignant melanoma
668255|NCT00849888|Thymus Transplantation|thymus transplantation
668256|NCT00849888|DiGeorge Anomaly|digeorge anomaly
668257|NCT00849888|Athymia|athymia
668258|NCT00849888|Low T cell numbers|low t cell numbers
668259|NCT00849888|Immunoreconstitution|immunoreconstitution
668260|NCT00849888|Immunodeficiency|immunodeficiency
669703|NCT00854516|3M|3m
668261|NCT00849927|shoulder instability|shoulder instability
668262|NCT00849927|labral lesions|labral lesions
668263|NCT00849927|arthroscopic labral repair|arthroscopic labral repair
668264|NCT00849927|SLAP|slap
668265|NCT00849927|triple labrum|triple labrum
668266|NCT00849927|circumferential labrum|circumferential labrum
668267|NCT00849927|Pan-labral lesion|pan-labral lesion
668268|NCT00849940|Spectroscopy|spectroscopy
668269|NCT00849940|Near infrared|near infrared
668271|NCT00849940|Hypoxemia|hypoxemia
668272|NCT00849940|Tissue oxygenation|tissue oxygenation
668273|NCT00849940|Pediatric|pediatric
668274|NCT00849966|Celebrex|celebrex
668275|NCT00849966|celecoxib|celecoxib
668276|NCT00849966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
668277|NCT00849966|Anti-Inflammatory Agents Non-Steroidal|anti-inflammatory agents non-steroidal
668278|NCT00849966|Adverse drug events|adverse drug events
668279|NCT00849966|quality of life|quality of life
668280|NCT00849966|Pain Postoperative|pain postoperative
668281|NCT00849966|Tonsillectomy|tonsillectomy
668282|NCT00849966|Adenotonsillectomy|adenotonsillectomy
668283|NCT00849966|Otologic Surgical Procedures|otologic surgical procedures
668284|NCT00849979|Colorectal|colorectal
668285|NCT00849979|Gastric|gastric
668286|NCT00849979|Gastrointestinal|gastrointestinal
668287|NCT00849979|GI|gi
668288|NCT00849979|Liver|liver
668289|NCT00849979|Pancreas|pancreas
668290|NCT00849979|Gastrointestinal Cancers|gastrointestinal cancers
668291|NCT00849979|Gastro-Intestinal Chemotherapy|gastro-intestinal chemotherapy
668292|NCT00849979|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
668293|NCT00849979|MDASI-GI|mdasi-gi
668294|NCT00849979|Medical Oncology|medical oncology
668397|NCT00850538|BML|bml
668295|NCT00849992|Actinic cheilitis|actinic cheilitis
668296|NCT00849992|Imiquimod 5%|imiquimod 5%
668297|NCT00849992|Photodynamic therapy|photodynamic therapy
668298|NCT00850005|neuropathic pain|neuropathic pain
668299|NCT00850005|resistant|resistant
668300|NCT00850005|neuroinflammation|neuroinflammation
668301|NCT00850005|neuroinflammatory markers|neuroinflammatory markers
668302|NCT00850005|Neuropathic pain that has not responded to standard therapy|neuropathic pain that has not responded to standard therapy
668303|NCT00850018|Sickle Cell Disease|sickle cell disease
668304|NCT00850018|Sickle Cell Anemia|sickle cell anemia
668305|NCT00850018|Hemoglobin SS|hemoglobin ss
668306|NCT00850018|Hemoglobin SB0|hemoglobin sb0
668307|NCT00850031|Presbyopia|presbyopia
668308|NCT00850031|Accommodation|accommodation
668309|NCT00850031|Near visual acuity|near visual acuity
668310|NCT00850031|LASIK|lasik
668311|NCT00850044|FIH|fih
668312|NCT00850044|SAD|sad
668313|NCT00850070|autism|autism
668314|NCT00850083|Fever|fever
668315|NCT00850083|Children|children
668316|NCT00850096|Phase 2 Study for novel insulin delivery of type 2 diabetes|phase 2 study for novel insulin delivery of type 2 diabetes
668317|NCT00850148|Anwar|anwar
668318|NCT00850148|Melles|melles
668319|NCT00850148|Keratoconus|keratoconus
668320|NCT00850161|Type 1 Diabetes|type 1 diabetes
668321|NCT00850161|Nasal Insulin|nasal insulin
668322|NCT00850161|Insulin Deficiency|insulin deficiency
668323|NCT00850161|Insulin-Dependent|insulin-dependent
668324|NCT00850174|Bioequivalence|bioequivalence
668325|NCT00850174|Healthy Subjects|healthy subjects
668326|NCT00850187|Knee cartilage diseases|knee cartilage diseases
668327|NCT00850200|Hodgkin Lymphoma, Proton Radiation|hodgkin lymphoma, proton radiation
668328|NCT00850226|test anxiety|test anxiety
668329|NCT00850239|diabetes|diabetes
668330|NCT00850239|DPP4 inhibitor|dpp4 inhibitor
668331|NCT00850239|dutogliptin|dutogliptin
668332|NCT00850252|Lifeline|lifeline
668333|NCT00850252|Tissue engineered blood vessel|tissue engineered blood vessel
668337|NCT00850265|Beclomethasone|beclomethasone
668338|NCT00850265|Extrafine formulation|extrafine formulation
668339|NCT00850265|Spacer|spacer
668340|NCT00850265|Moderate|moderate
668341|NCT00850265|Severe|severe
668342|NCT00850265|Stable|stable
668343|NCT00850278|Brain tumor|brain tumor
668344|NCT00850278|[18F]FLT|[18f]flt
668345|NCT00850278|[11C]MET|[11c]met
668346|NCT00850278|TEP-imaging|tep-imaging
668347|NCT00850278|tumor cell proliferation|tumor cell proliferation
668348|NCT00850291|Partial duodenopancreatectomy using electrosurgical vessel sealing device|partial duodenopancreatectomy using electrosurgical vessel sealing device
668349|NCT00850304|AML|aml
668350|NCT00850330|Drug interactions|drug interactions
668351|NCT00850330|Drug interaction software|drug interaction software
668352|NCT00850330|Older patients|older patients
668353|NCT00850330|Hospitalization|hospitalization
668354|NCT00850343|Rheumatoid Arthritis|rheumatoid arthritis
668355|NCT00850343|Certolizumab Pegol|certolizumab pegol
668356|NCT00850343|Cimzia|cimzia
668357|NCT00850356|Bariatric Surgery|bariatric surgery
668358|NCT00850356|Body Weight|body weight
668359|NCT00850356|Health care costs|health care costs
668360|NCT00850356|Obesity|obesity
668361|NCT00850356|Obesity Complications|obesity complications
668362|NCT00850356|Prolonged wait times|prolonged wait times
668363|NCT00850356|Quality of Life|quality of life
668364|NCT00850369|Pulmonary hypertension|pulmonary hypertension
668365|NCT00850369|Sickle cell disease|sickle cell disease
668366|NCT00850382|CBF AML|cbf aml
668367|NCT00850382|Dasatinib|dasatinib
668368|NCT00850382|Core Binding Factor (CBF)|core binding factor (cbf)
668369|NCT00850395|HIV-1|hiv-1
668370|NCT00850395|non-interventional|non-interventional
668371|NCT00850395|CCR-5 tropic virus|ccr-5 tropic virus
668372|NCT00850395|therapy experienced patients|therapy experienced patients
668373|NCT00850408|Stroke|stroke
668374|NCT00850408|rTMS|rtms
668375|NCT00850408|TMS|tms
668376|NCT00850408|Rehabilitation|rehabilitation
668377|NCT00850408|Upper Extremity|upper extremity
668378|NCT00850421|migraine headache|migraine headache
668379|NCT00850421|Botulinum Toxin Type A|botulinum toxin type a
668380|NCT00850421|BOTOX|botox
668381|NCT00850421|BTX-A|btx-a
668382|NCT00850447|Posttraumatic stress disorder|posttraumatic stress disorder
668383|NCT00850447|Cognition|cognition
668384|NCT00850447|Neuropsychological Tests|neuropsychological tests
668385|NCT00850473|PET|pet
668386|NCT00850473|CT|ct
668387|NCT00850473|Heart Attack|heart attack
668388|NCT00850473|Coronary Artery disease|coronary artery disease
668389|NCT00850473|Cardiac Catheterization|cardiac catheterization
668390|NCT00850486|women|women
668391|NCT00850486|ischemic heart disease|ischemic heart disease
668392|NCT00850486|high frequency ECG|high frequency ecg
668393|NCT00850486|exercise stress testing|exercise stress testing
668394|NCT00850486|signal processing|signal processing
668395|NCT00850486|ischemic heart disease in women|ischemic heart disease in women
668396|NCT00850538|Bone Marrow Lesion|bone marrow lesion
668398|NCT00850538|Arthroplasty|arthroplasty
668399|NCT00850538|Replacement|replacement
668400|NCT00850538|Knee|knee
668401|NCT00850538|Discarded tissue|discarded tissue
668402|NCT00850551|Early Intervention|early intervention
668403|NCT00850551|Pulmonary Exacerbation|pulmonary exacerbation
668404|NCT00850551|Cystic Fibrosis|cystic fibrosis
668405|NCT00850551|Lung Function|lung function
668406|NCT00850551|Spirometry|spirometry
668407|NCT00850551|Phillips Telemonitor|phillips telemonitor
668408|NCT00850551|Home Spirometry|home spirometry
668409|NCT00850551|PiKo-6|piko-6
668410|NCT00850551|Home Monitoring|home monitoring
668411|NCT00850564|growth hormone releasing hormone|growth hormone releasing hormone
668412|NCT00850603|Menomune® - A/C/Y/W-135|menomune® - a/c/y/w-135
668413|NCT00850603|Meningococcal Infections|meningococcal infections
668414|NCT00850603|Meningitis|meningitis
668415|NCT00850616|HIV|hiv
668416|NCT00850616|HIV Seronegativity|hiv seronegativity
668417|NCT00850616|Preventive Vaccine|preventive vaccine
668418|NCT00850629|weight regain|weight regain
668419|NCT00850629|endocrine counterregulation|endocrine counterregulation
668420|NCT00850642|Sputum cell counts|sputum cell counts
668421|NCT00850642|Neutrophils|neutrophils
668422|NCT00850642|Severe Asthma|severe asthma
668423|NCT00850642|ICS|ics
668424|NCT00850642|Inhaled corticosteroids|inhaled corticosteroids
668425|NCT00850668|Food Allergy|food allergy
668426|NCT00850668|Peanut Allergy|peanut allergy
668427|NCT00850681|Peplin|peplin
668428|NCT00850681|PEP005|pep005
668429|NCT00850694|Vitamin D deficiency|vitamin d deficiency
668430|NCT00850694|Obesity|obesity
668431|NCT00850694|Insulin resistance|insulin resistance
668432|NCT00850694|Glucose tolerance|glucose tolerance
668433|NCT00850707|AVF|avf
668434|NCT00850707|AVG|avg
668435|NCT00850707|TCC|tcc
668436|NCT00850707|inflammation|inflammation
668437|NCT00850707|monocite senescence|monocite senescence
668438|NCT00850720|Biological Response Modifiers|biological response modifiers
668439|NCT00850720|Bypass Surgery|bypass surgery
668440|NCT00850720|Cardiology|cardiology
668441|NCT00850720|Congenital Heart Disease|congenital heart disease
668442|NCT00850720|Endocrinology|endocrinology
668443|NCT00850720|Hormone Dysfunction|hormone dysfunction
668444|NCT00850720|Hormones|hormones
668445|NCT00850720|Neuroendocrinology|neuroendocrinology
668446|NCT00850720|Pediatric Surgery|pediatric surgery
668447|NCT00850746|QT interval|qt interval
668448|NCT00850746|Cardiac Repolarization|cardiac repolarization
668449|NCT00850746|Cardiac Conduction|cardiac conduction
668450|NCT00850746|Healthy Subjects|healthy subjects
668451|NCT00850746|YM443 (Z-338, acotiamide hydrochloride)|ym443 (z-338, acotiamide hydrochloride)
668452|NCT00850746|Evaluation of QT Interval|evaluation of qt interval
668453|NCT00850759|pedestrian safety|pedestrian safety
668454|NCT00850759|street-crossing ability|street-crossing ability
668455|NCT00850759|road-crossing|road-crossing
668456|NCT00850759|children|children
668457|NCT00850759|injury prevention|injury prevention
668458|NCT00850772|Enteral nutrition|enteral nutrition
668459|NCT00850772|Ovarian cancer|ovarian cancer
668460|NCT00850772|Peritoneal cancer|peritoneal cancer
668461|NCT00850772|Fallopian tube cancer|fallopian tube cancer
668462|NCT00850772|Malnutrition|malnutrition
668463|NCT00850772|Surgery|surgery
668464|NCT00850772|Gynecological Cancer|gynecological cancer
668465|NCT00850772|Suspected advanced epithelial ovarian cancer|suspected advanced epithelial ovarian cancer
668466|NCT00850798|Type 2 diabetes|type 2 diabetes
668467|NCT00850798|Elder patients|elder patients
668468|NCT00850798|Glycemic control|glycemic control
751810|NCT01170598|acute myeloid leukemia|acute myeloid leukemia
751811|NCT01170598|AML|aml
668469|NCT00850798|Men or women aged ≥80 years at time of randomization. There is no upper age limit.|men or women aged ≥80 years at time of randomization. there is no upper age limit.
668470|NCT00850798|Be able to walk by themselves|be able to walk by themselves
668471|NCT00850798|They had their first diagnosis of type 2 diabetes mellitus at age 30 years or older.|they had their first diagnosis of type 2 diabetes mellitus at age 30 years or older.
668472|NCT00850811|Peplin|peplin
668473|NCT00850811|PEP005|pep005
668474|NCT00850824|T2DM|t2dm
668475|NCT00850837|Microbicide|microbicide
668476|NCT00850837|HIV Seronegativity|hiv seronegativity
668477|NCT00850850|PACU|pacu
668478|NCT00850850|Physostigmine|physostigmine
668479|NCT00850850|Recovery|recovery
668480|NCT00850850|Postanesthesia Nursing|postanesthesia nursing
668481|NCT00850850|Wakefulness|wakefulness
668482|NCT00850850|General anesthesia|general anesthesia
668483|NCT00850850|General Anesthetics|general anesthetics
668484|NCT00850850|Postoperative Period|postoperative period
668485|NCT00850863|COPD|copd
668486|NCT00850863|Inflammation|inflammation
668487|NCT00850863|Smoking|smoking
668488|NCT00850863|Susceptibility|susceptibility
668489|NCT00850889|Aesthetic correction of nasolabial folds|aesthetic correction of nasolabial folds
668490|NCT00850902|ELBW|elbw
668491|NCT00850902|Humidity|humidity
668492|NCT00850902|BPD|bpd
668493|NCT00850915|tuberculosis|tuberculosis
668494|NCT00850915|community IPT|community ipt
668495|NCT00850915|isoniazid adverse events|isoniazid adverse events
668496|NCT00850915|tuberculosis incidence|tuberculosis incidence
668497|NCT00850928|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
668498|NCT00850928|MCI|mci
668499|NCT00850928|Mild Cognitive Impairment|mild cognitive impairment
668500|NCT00850928|Aβ40|aβ40
668501|NCT00850928|Aβ42|aβ42
668502|NCT00850928|Apolipoprotein E|apolipoprotein e
668503|NCT00850928|Inflammatory Markers|inflammatory markers
668504|NCT00850928|Apolipoprotein E Profile|apolipoprotein e profile
668505|NCT00850928|Serum Beta Amyloid Profile|serum beta amyloid profile
668506|NCT00850928|Inflammatory Markers Profile|inflammatory markers profile
668507|NCT00850941|Registry|registry
668508|NCT00850941|Research Database|research database
668509|NCT00850941|Prostate cancer|prostate cancer
668512|NCT00850941|Goserelin Acetate|goserelin acetate
668513|NCT00850941|Leuprolide Acetate|leuprolide acetate
668514|NCT00850941|Radiation|radiation
668515|NCT00850941|PSA|psa
668516|NCT00850941|Post-prostatectomy|post-prostatectomy
668517|NCT00850941|Radiation Therapy|radiation therapy
668518|NCT00850941|Prostate Specific Antigen|prostate specific antigen
668519|NCT00850941|Adenocarcinoma|adenocarcinoma
668520|NCT00850941|Radical Prostatectomy|radical prostatectomy
668521|NCT00850941|Bicalutamide|bicalutamide
668522|NCT00850941|Zoladex|zoladex
668523|NCT00850941|Lupron Depot|lupron depot
668524|NCT00850941|Tissue banking|tissue banking
668525|NCT00850941|Hormones|hormones
668526|NCT00850954|Lung Cancer|lung cancer
668527|NCT00850954|Cancer|cancer
668528|NCT00850954|Smoke|smoke
668529|NCT00850954|Mexican American|mexican american
668530|NCT00850954|Indoor Air Policy|indoor air policy
668531|NCT00850954|Secondhand smoke|secondhand smoke
668532|NCT00850954|SHS|shs
668533|NCT00850954|Smoking cessation programs|smoking cessation programs
668534|NCT00850954|Smokers|smokers
668535|NCT00850954|Tobacco|tobacco
668536|NCT00850954|Nicotine|nicotine
668537|NCT00850954|Chronic diseases|chronic diseases
668538|NCT00850954|Transtheoretical model of change|transtheoretical model of change
668539|NCT00850954|TTM|ttm
668540|NCT00850993|Hemolysis|hemolysis
668546|NCT00851019|Type 2 diabetes|type 2 diabetes
668548|NCT00851032|Advanced Cancer|advanced cancer
668549|NCT00851032|Initiative for Molecular Profiling in Advanced Cancer Therapy|initiative for molecular profiling in advanced cancer therapy
668550|NCT00851032|IMPACT|impact
668551|NCT00851032|Molecular Profile-Based Study|molecular profile-based study
668552|NCT00851032|Investigational Cancer Therapeutics Program|investigational cancer therapeutics program
668553|NCT00851032|Molecular profiling|molecular profiling
668554|NCT00851032|Phase I Therapies|phase i therapies
668555|NCT00851032|Tissue Bank|tissue bank
668556|NCT00851058|Behavioral research|behavioral research
668557|NCT00851058|Motivational counseling|motivational counseling
668558|NCT00851058|Group Counseling|group counseling
668559|NCT00851058|Motivational Interviewing|motivational interviewing
668560|NCT00851058|Vicarious Learning|vicarious learning
668561|NCT00851058|Risky alcohol use|risky alcohol use
668562|NCT00851058|Recidivism|recidivism
668563|NCT00851058|Motor Vehicles|motor vehicles
668564|NCT00851058|Crime|crime
668565|NCT00851071|Anxiety|anxiety
668566|NCT00851071|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
668567|NCT00851071|Defibrillators, Implantable|defibrillators, implantable
668568|NCT00851084|Angiogenesis|angiogenesis
668569|NCT00851084|Colon cancer|colon cancer
668570|NCT00851084|Rectal cancer|rectal cancer
668571|NCT00851084|Oxaliplatin|oxaliplatin
668572|NCT00851110|high dose|high dose
668573|NCT00851110|breast cancer|breast cancer
668574|NCT00851110|adjuvant|adjuvant
668575|NCT00851123|Stroke|stroke
668576|NCT00851123|arm paresis|arm paresis
668577|NCT00851123|mCIMT|mcimt
668578|NCT00851123|bimanual training|bimanual training
668579|NCT00851123|rehabilitation|rehabilitation
668580|NCT00851136|CRC|crc
668581|NCT00851136|Colon cancer|colon cancer
668582|NCT00851136|Avastin|avastin
668583|NCT00851136|APM4566g|apm4566g
668584|NCT00851149|aorta|aorta
668585|NCT00851149|disease|disease
668586|NCT00851149|abdominal|abdominal
668587|NCT00851149|surgery|surgery
668588|NCT00851149|Osteoarthritis, Hip|osteoarthritis, hip
668589|NCT00851149|replacement|replacement
668590|NCT00851149|blood|blood
668591|NCT00851149|autolog|autolog
668592|NCT00851149|transfusion|transfusion
668593|NCT00851149|cytokines|cytokines
668594|NCT00851162|Bone defect|bone defect
668595|NCT00851162|Benign bone lesions|benign bone lesions
668596|NCT00851162|Stem cells|stem cells
668597|NCT00851201|children|children
668598|NCT00851201|obesity|obesity
668599|NCT00851201|weight loss|weight loss
668600|NCT00851201|prevention|prevention
668601|NCT00851201|diabetes risk|diabetes risk
668602|NCT00851201|cardiometabolic|cardiometabolic
668666|NCT00851279|mapping|mapping
668603|NCT00851214|Non-invasive hemodynamic monitoring|non-invasive hemodynamic monitoring
668604|NCT00851214|Emergency Department patients|emergency department patients
668605|NCT00851214|trauma with an ISS>15|trauma with an iss>15
668606|NCT00851214|Non-invasive continuous hemodynamic monitoring|non-invasive continuous hemodynamic monitoring
668607|NCT00851227|Pharmacokinetics|pharmacokinetics
668608|NCT00851227|Protein Binding|protein binding
668609|NCT00851227|Conivaptan|conivaptan
668610|NCT00851227|Vaprisol|vaprisol
668611|NCT00851227|Liver Disease|liver disease
668612|NCT00851240|rheumatoid arthritis|rheumatoid arthritis
668613|NCT00851240|safety|safety
668614|NCT00851253|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
668615|NCT00851253|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
668616|NCT00851253|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
668617|NCT00851253|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
668618|NCT00851253|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
668619|NCT00851253|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
668620|NCT00851253|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
668621|NCT00851253|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
668622|NCT00851253|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
668623|NCT00851253|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
668624|NCT00851253|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
668625|NCT00851253|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
668626|NCT00851253|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
668627|NCT00851253|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
668628|NCT00851253|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
668629|NCT00851253|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
668630|NCT00851253|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
668631|NCT00851253|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
668632|NCT00851253|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
668633|NCT00851253|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
668634|NCT00851253|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
668635|NCT00851253|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
668636|NCT00851253|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
668637|NCT00851253|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
668638|NCT00851253|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
668639|NCT00851253|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
668640|NCT00851253|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
668641|NCT00851253|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
668642|NCT00851253|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
668643|NCT00851253|recurrent salivary gland cancer|recurrent salivary gland cancer
668644|NCT00851253|salivary gland acinic cell tumor|salivary gland acinic cell tumor
668645|NCT00851253|salivary gland adenocarcinoma|salivary gland adenocarcinoma
668646|NCT00851253|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
668647|NCT00851253|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
668648|NCT00851253|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
668649|NCT00851253|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
668650|NCT00851253|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
668651|NCT00851253|stage II salivary gland cancer|stage ii salivary gland cancer
668652|NCT00851253|stage III salivary gland cancer|stage iii salivary gland cancer
668653|NCT00851253|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
668654|NCT00851253|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
668655|NCT00851253|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
668656|NCT00851253|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
668657|NCT00851253|stage IV salivary gland cancer|stage iv salivary gland cancer
668658|NCT00851253|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
668659|NCT00851253|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
668660|NCT00851253|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
668661|NCT00851253|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
668662|NCT00851253|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
668664|NCT00851279|ventricular tachycardia|ventricular tachycardia
668665|NCT00851279|ablation|ablation
668667|NCT00851279|electrophysiology|electrophysiology
668668|NCT00851292|prostate cancer|prostate cancer
668669|NCT00851292|biopsy|biopsy
668670|NCT00851292|TRUS|trus
668671|NCT00851292|diagnosis|diagnosis
668672|NCT00851305|Stomach|stomach
668673|NCT00851305|endoscopy|endoscopy
668674|NCT00851305|neoplasms|neoplasms
668675|NCT00851318|Rheumatoid Arthritis|rheumatoid arthritis
668676|NCT00851318|Certolizumab Pegol|certolizumab pegol
668677|NCT00851318|Cimzia|cimzia
668678|NCT00851331|Benign childhood epilepsy|benign childhood epilepsy
668679|NCT00851344|Proof-of-Concept|proof-of-concept
668680|NCT00851344|Allergic Rhinitis|allergic rhinitis
668681|NCT00851357|Nicotine Replacement Therapy|nicotine replacement therapy
668682|NCT00851357|Nicotine Patch|nicotine patch
668683|NCT00851357|Smoking cessation|smoking cessation
668684|NCT00851357|Telephone|telephone
668685|NCT00851357|Tobacco cessation|tobacco cessation
668686|NCT00851357|Counseling|counseling
668687|NCT00851357|Nicotine|nicotine
668688|NCT00851357|Self-Help|self-help
668689|NCT00851357|Smoking abstinence|smoking abstinence
668690|NCT00851357|Tobacco Use Disorder|tobacco use disorder
668691|NCT00851370|COPD|copd
668692|NCT00851370|Exacerbation|exacerbation
668694|NCT00851383|Human Immunodeficiency Virus|human immunodeficiency virus
668695|NCT00851383|HIV Seronegativity|hiv seronegativity
668696|NCT00851383|Preventive Vaccine|preventive vaccine
668697|NCT00851396|Vitamin D deficiency|vitamin d deficiency
668698|NCT00851396|Insulin resistance|insulin resistance
668699|NCT00851396|Glucose- Insulin dynamics|glucose- insulin dynamics
668700|NCT00851396|Obese adolescents|obese adolescents
668701|NCT00851422|Ultrasound Dilution|ultrasound dilution
668702|NCT00851422|Cardiac Output|cardiac output
668703|NCT00851422|Validation of measured ultrasound dilution cardiac output|validation of measured ultrasound dilution cardiac output
668704|NCT00851435|Pneumonia|pneumonia
668705|NCT00851435|Nosocomial pneumonia|nosocomial pneumonia
668706|NCT00851435|Pseudomonas aeruginosa|pseudomonas aeruginosa
668707|NCT00851435|Monoclonal antibody|monoclonal antibody
668708|NCT00851435|Hospital-Acquired Pneumonia|hospital-acquired pneumonia
668709|NCT00851461|Spinobulbar muscular atrophy|spinobulbar muscular atrophy
668710|NCT00851461|Kennedy's disease|kennedy's disease
668711|NCT00851461|Goserelin|goserelin
668906|NCT00838968|p48|p48
668712|NCT00851461|Electrophysiologic study|electrophysiologic study
668713|NCT00851461|Inclusion body|inclusion body
668714|NCT00851474|COstatus(R)|costatus(r)
668715|NCT00851474|Ultrasound Dilution|ultrasound dilution
668716|NCT00851474|Cardiac Output|cardiac output
668717|NCT00851474|Blood Volumes|blood volumes
668718|NCT00851474|Comparison of COstatus(R) cardiac output with other methods|comparison of costatus(r) cardiac output with other methods
668719|NCT00851487|ARI|ari
668720|NCT00851487|LRTI|lrti
668721|NCT00851500|atherosclerosis|atherosclerosis
668722|NCT00851500|carotid artery disease|carotid artery disease
668723|NCT00851513|Pudendal neuralgia|pudendal neuralgia
668724|NCT00851513|pudendal nerve|pudendal nerve
668725|NCT00851513|Alcock's canal syndrome|alcock's canal syndrome
668726|NCT00851513|Canal syndrome|canal syndrome
668727|NCT00851513|neuropathic pain|neuropathic pain
668728|NCT00851513|infiltration|infiltration
668729|NCT00851513|randomized protocol|randomized protocol
668730|NCT00851513|pain scales|pain scales
668731|NCT00851526|Coronary bifurcation lesion|coronary bifurcation lesion
668732|NCT00851526|Drug-eluting stent|drug-eluting stent
668733|NCT00851539|HIV|hiv
668734|NCT00851539|Teenagers|teenagers
668735|NCT00851539|Adolescent|adolescent
668736|NCT00851539|HIV Testing|hiv testing
670248|NCT00856323|HIV|hiv
668737|NCT00851539|HIV Seronegativity|hiv seronegativity
668738|NCT00851552|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
668739|NCT00851552|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
668740|NCT00851552|anaplastic large cell lymphoma|anaplastic large cell lymphoma
668741|NCT00851578|AF|af
668742|NCT00851578|atrial fibrillation|atrial fibrillation
668743|NCT00851578|LAA occlusion|laa occlusion
668744|NCT00851591|fenugreek|fenugreek
668745|NCT00851591|galactogogue|galactogogue
668746|NCT00851591|breastmilk|breastmilk
668747|NCT00851591|Trigonella foenum-graecum|trigonella foenum-graecum
668748|NCT00851591|Bird's Foot|bird's foot
668749|NCT00851591|Greek Clover|greek clover
668750|NCT00851591|Greek Hay|greek hay
668751|NCT00851591|Hu Lu Ba|hu lu ba
668752|NCT00851591|Trigonella|trigonella
668753|NCT00851604|ProGRP|progrp
668754|NCT00851604|CgA|cga
668755|NCT00851604|NSE|nse
668756|NCT00851604|TUM2-PK|tum2-pk
668757|NCT00851604|Neuroendocrine Tumors|neuroendocrine tumors
668758|NCT00851617|Mechanical ventilator weaning|mechanical ventilator weaning
668759|NCT00851617|Respiratory Muscle Training|respiratory muscle training
668760|NCT00851617|Ventilator dependent|ventilator dependent
668761|NCT00851630|HIV|hiv
668762|NCT00851630|Tuberculosis|tuberculosis
668763|NCT00851630|Treatment Naive|treatment naive
668764|NCT00851669|depression|depression
668765|NCT00851669|alcohol dependence|alcohol dependence
668766|NCT00851669|women|women
668767|NCT00851669|psychotherapy|psychotherapy
668768|NCT00851669|men|men
668769|NCT00851682|Prostate Cancer|prostate cancer
668770|NCT00851682|Dynamic Contrast Enhanced MRI|dynamic contrast enhanced mri
668771|NCT00851682|Non-invasive Prostate Cancer Detection|non-invasive prostate cancer detection
668772|NCT00851695|Lung Function Decline|lung function decline
668773|NCT00851695|Lung Function|lung function
668774|NCT00851695|Allergy|allergy
668775|NCT00851695|COPD|copd
668776|NCT00851695|Vitamin D|vitamin d
668777|NCT00851708|kidney|kidney
668778|NCT00851708|deceased kidney transplant|deceased kidney transplant
668779|NCT00851708|oxidative stress|oxidative stress
668780|NCT00851708|renal function measurements|renal function measurements
668781|NCT00851721|Hemophilia A|hemophilia a
668782|NCT00851721|Factor VIII Inhibitor|factor viii inhibitor
668783|NCT00851721|Factor IX Inhibitor|factor ix inhibitor
668784|NCT00851721|Hemophilia B|hemophilia b
668785|NCT00851786|Herpes Zoster Vaccine|herpes zoster vaccine
668786|NCT00851786|Herpes Zoster Virus|herpes zoster virus
668787|NCT00851786|HIV|hiv
668789|NCT00851799|Antiretroviral therapy|antiretroviral therapy
668790|NCT00851799|Treatment naive|treatment naive
668791|NCT00851799|Highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
668792|NCT00851812|Exercise|exercise
668793|NCT00851812|Breast cancer|breast cancer
668794|NCT00851812|fatigue|fatigue
668795|NCT00851825|autonomic modulation|autonomic modulation
668796|NCT00851825|heart rate|heart rate
668797|NCT00851825|pressure support ventilation|pressure support ventilation
668798|NCT00851825|T-tube|t-tube
668799|NCT00851825|Mechanical ventilation|mechanical ventilation
668800|NCT00851838|Peritoneal dialysis|peritoneal dialysis
668801|NCT00851838|L-carnitine|l-carnitine
668802|NCT00851851|Surgical patients|surgical patients
668803|NCT00851864|anticoagulation|anticoagulation
668804|NCT00851864|pregnancy|pregnancy
668805|NCT00851877|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
668806|NCT00851877|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
668807|NCT00851877|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
668808|NCT00851877|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
668905|NCT00838968|interferon-alpha|interferon-alpha
668809|NCT00851877|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
668810|NCT00851877|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
668811|NCT00851877|tongue cancer|tongue cancer
668812|NCT00851929|sarcoidosis|sarcoidosis
668813|NCT00851929|pulmonary hypertension|pulmonary hypertension
668814|NCT00851929|dyspnea|dyspnea
668815|NCT00851929|sarcoidosis associated pulmonary hypertension|sarcoidosis associated pulmonary hypertension
668816|NCT00851942|Volunteer|volunteer
668817|NCT00851942|Hypoadrenalism|hypoadrenalism
668818|NCT00851942|Hypopituitarism|hypopituitarism
668819|NCT00851942|Healthy volunteers|healthy volunteers
668820|NCT00851968|hepatectomy|hepatectomy
668821|NCT00851968|Selective HepaticVascular Clamping|selective hepaticvascular clamping
668822|NCT00851981|Alcohol Liver Disease|alcohol liver disease
668823|NCT00851994|Patients having surgery|patients having surgery
668824|NCT00838669|Schizophrenia|schizophrenia
668825|NCT00838669|Mood disorders|mood disorders
668826|NCT00838669|Antipsychotic drugs|antipsychotic drugs
668827|NCT00838669|Extended release OROS paliperidone|extended release oros paliperidone
668828|NCT00838682|peptic ulcer bleeding|peptic ulcer bleeding
668829|NCT00838682|rabeprazole|rabeprazole
668830|NCT00838682|proton pump inhibitor|proton pump inhibitor
668831|NCT00838695|Hand vein sensitivity|hand vein sensitivity
668833|NCT00838695|nitroglycerin|nitroglycerin
668834|NCT00838721|Open Angle Glaucoma|open angle glaucoma
668835|NCT00838721|Ocular Hypertension|ocular hypertension
668836|NCT00838721|Laser Trabeculoplasty|laser trabeculoplasty
668837|NCT00838734|CORNEAL TOPOGRAPHY|corneal topography
668838|NCT00838734|KERATOPLASTY|keratoplasty
668839|NCT00838747|folate receptor|folate receptor
668840|NCT00838747|blood samples|blood samples
668841|NCT00838747|ovarian cancer|ovarian cancer
668842|NCT00838747|development of measure of folate receptor in blood samples|development of measure of folate receptor in blood samples
668843|NCT00838747|possible selection of patients for treatment with FR targeted agents|possible selection of patients for treatment with fr targeted agents
668844|NCT00838760|PEPI-TiDP23-C103|pepi-tidp23-c103
668845|NCT00838760|PEPI-C103|pepi-c103
668846|NCT00838760|PEPI|pepi
668847|NCT00838760|TMC558445|tmc558445
668848|NCT00838760|TMC310911|tmc310911
668849|NCT00838760|Darunavir, Healthy volunteers|darunavir, healthy volunteers
668850|NCT00838760|Pharmacokinetics|pharmacokinetics
668851|NCT00838760|HIV Infections|hiv infections
668852|NCT00838799|diabetic|diabetic
668853|NCT00838799|peripheral|peripheral
668854|NCT00838799|neuropathic|neuropathic
668855|NCT00838799|pain|pain
668856|NCT00838799|chronic|chronic
668857|NCT00838799|diabetes|diabetes
668858|NCT00838812|clindamycin|clindamycin
668859|NCT00838812|tretinoin|tretinoin
668860|NCT00838812|acne vulgaris|acne vulgaris
668861|NCT00838812|Acne vulgaris mild to moderate|acne vulgaris mild to moderate
668862|NCT00838825|diabetes|diabetes
668863|NCT00838825|chronic care management|chronic care management
668864|NCT00838825|resource utilization|resource utilization
668866|NCT00838825|glycohemoglobin|glycohemoglobin
668867|NCT00838825|hospitalization|hospitalization
668868|NCT00838838|Testosterone replacement therapy|testosterone replacement therapy
668869|NCT00838838|Hypogonadism|hypogonadism
668870|NCT00838838|Osteoporosis|osteoporosis
668871|NCT00838838|Immobilisation|immobilisation
668872|NCT00838838|Paraplegia|paraplegia
668873|NCT00838838|Testosterone|testosterone
668874|NCT00838851|endotoxin|endotoxin
668875|NCT00838851|CCRE|ccre
668876|NCT00838851|LPS|lps
668877|NCT00838864|variceal bleeding|variceal bleeding
668878|NCT00838864|antibiotic prophylaxis|antibiotic prophylaxis
668879|NCT00838864|ceftrioxone|ceftrioxone
668880|NCT00838877|Alzheimer's Disease|alzheimer's disease
668881|NCT00838877|PET|pet
668882|NCT00838877|Phase 1|phase 1
668883|NCT00838877|Positron Emission Tomography|positron emission tomography
668884|NCT00838903|diabetes|diabetes
668885|NCT00838916|diabetes|diabetes
668886|NCT00838929|brain metastases|brain metastases
668887|NCT00838929|radiation|radiation
668888|NCT00838929|vorinostat|vorinostat
668889|NCT00838929|lung cancer|lung cancer
668890|NCT00838929|breast cancer|breast cancer
668891|NCT00838942|Eyes disease and dementia.|eyes disease and dementia.
668892|NCT00838942|Cataract surgery in the patient with dementia.|cataract surgery in the patient with dementia.
668893|NCT00838942|Visual hallucinations|visual hallucinations
668894|NCT00838942|Visual acuity,|visual acuity,
668895|NCT00838942|Specific eye pathologies in Alzheimer's disease.|specific eye pathologies in alzheimer's disease.
668896|NCT00838942|Improvement of behaviour,|improvement of behaviour,
668897|NCT00838942|Improvement of autonomy|improvement of autonomy
668898|NCT00838942|Improvement of mood|improvement of mood
668899|NCT00838942|Cataract extraction in Alzheimer disease patient|cataract extraction in alzheimer disease patient
668900|NCT00838955|Hodgkin's lymphoma|hodgkin's lymphoma
668901|NCT00838955|relapsed Hodgkin's lymphoma|relapsed hodgkin's lymphoma
668902|NCT00838955|refractory Hodgkin's lymphoma|refractory hodgkin's lymphoma
668903|NCT00838955|Temsirolimus|temsirolimus
668904|NCT00838968|hepatocellular carcinoma|hepatocellular carcinoma
668907|NCT00838981|Treatment for addiction|treatment for addiction
668908|NCT00838981|Methadone given for opioid dependence|methadone given for opioid dependence
668909|NCT00838981|Cocaine|cocaine
668910|NCT00838981|Opiates|opiates
668911|NCT00838994|Insomnia|insomnia
668912|NCT00838994|Depression|depression
668913|NCT00838994|Electroacupuncture|electroacupuncture
668914|NCT00838994|Acupuncture|acupuncture
668915|NCT00838994|Randomized Clinical Trial|randomized clinical trial
668916|NCT00838994|Traditional Chinese Medicine|traditional chinese medicine
668917|NCT00839007|ADHF|adhf
668918|NCT00839007|AHF|ahf
668919|NCT00839007|HF|hf
668920|NCT00839020|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
668921|NCT00839020|Range of Motion|range of motion
668922|NCT00839020|Articular Arthroplasty, Replacement, Knee|articular arthroplasty, replacement, knee
668923|NCT00839033|Cough assisted device|cough assisted device
668924|NCT00839033|Neuromuscular disease|neuromuscular disease
668925|NCT00839033|Respiratory exacerbation|respiratory exacerbation
668926|NCT00839033|Invasive ventilation,|invasive ventilation,
668927|NCT00839033|Chest physiotherapy|chest physiotherapy
668928|NCT00839033|Congenital myopathies|congenital myopathies
668929|NCT00839046|Pediatric Asthma|pediatric asthma
668930|NCT00839046|Air Filters|air filters
668931|NCT00839046|Indoor Particulate Matter|indoor particulate matter
668932|NCT00839059|AML|aml
668933|NCT00839059|lenalidomide|lenalidomide
668934|NCT00839072|bioavailability|bioavailability
668935|NCT00839072|pharmacokinetics|pharmacokinetics
668936|NCT00839072|healthy|healthy
668937|NCT00839072|crossover|crossover
668938|NCT00839072|trazodone|trazodone
668939|NCT00839085|CABG|cabg
668940|NCT00839085|on pump|on pump
668941|NCT00839085|Grape seed extract|grape seed extract
668942|NCT00839085|Vit C|vit c
668943|NCT00839085|Oxidative stress|oxidative stress
668944|NCT00839098|power wheelchairs|power wheelchairs
668945|NCT00839098|assistive technology|assistive technology
668946|NCT00839098|rehabilitation|rehabilitation
668947|NCT00839111|Progression free survival|progression free survival
668948|NCT00839111|Toxicity|toxicity
668949|NCT00839111|Response rate|response rate
668950|NCT00839111|overall survival|overall survival
668951|NCT00839124|normal volunteer|normal volunteer
668952|NCT00839124|healthy control volunteer|healthy control volunteer
668953|NCT00839124|healthy subjects|healthy subjects
668954|NCT00839124|asthma|asthma
668955|NCT00839124|allergy|allergy
668956|NCT00839124|allergic asthma|allergic asthma
668957|NCT00839137|asthma|asthma
668958|NCT00839137|exercise therapy|exercise therapy
668959|NCT00839150|Diabetic retinopathy|diabetic retinopathy
668960|NCT00839150|Color vision|color vision
668961|NCT00839150|Contrast sensitivity|contrast sensitivity
668962|NCT00839150|Electroretinogram|electroretinogram
668963|NCT00839150|Flicker-induced vasodilatation|flicker-induced vasodilatation
668964|NCT00839150|Dynamic Vessel Analyzer|dynamic vessel analyzer
668965|NCT00839163|Embolism and Thrombosis|embolism and thrombosis
668966|NCT00839163|Pulmonary embolism|pulmonary embolism
668967|NCT00839163|Embolism|embolism
668968|NCT00839163|Thrombosis|thrombosis
668969|NCT00839176|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
668970|NCT00839176|Serdaxin|serdaxin
668971|NCT00839176|Rexahn|rexahn
668972|NCT00839189|CCRE|ccre
668973|NCT00839189|endotoxin|endotoxin
668974|NCT00839189|LPS|lps
668975|NCT00839189|asthma|asthma
668976|NCT00839189|allergies|allergies
668977|NCT00839189|allergic rhinitis|allergic rhinitis
668978|NCT00839202|factor VIII|factor viii
668979|NCT00839202|hemophilia A|hemophilia a
668980|NCT00839202|assay|assay
668981|NCT00839228|diastolic dysfunction|diastolic dysfunction
668982|NCT00839228|cardiac energetics|cardiac energetics
668983|NCT00839228|perhexiline|perhexiline
668984|NCT00839228|magnetic resonance spectroscopy|magnetic resonance spectroscopy
668985|NCT00839254|Streptococcus pneumoniae|streptococcus pneumoniae
668986|NCT00839254|acute otitis media|acute otitis media
668987|NCT00839254|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
668988|NCT00839254|nasopharyngeal carriage|nasopharyngeal carriage
668989|NCT00839254|Haemophilus influenzae|haemophilus influenzae
668990|NCT00839254|immunogenicity|immunogenicity
668991|NCT00839254|invasive disease|invasive disease
668992|NCT00839267|platelet|platelet
668993|NCT00839267|VASP|vasp
668994|NCT00839267|clopidogrel|clopidogrel
668995|NCT00839267|cardiogenic shock|cardiogenic shock
668996|NCT00839267|myocardial infarction|myocardial infarction
668997|NCT00839267|percutaneous coronary intervention|percutaneous coronary intervention
668998|NCT00839280|Dry skin|dry skin
668999|NCT00839280|Dexpanthenol|dexpanthenol
669000|NCT00839280|Moisturizing effect|moisturizing effect
669001|NCT00839293|Bioavailability|bioavailability
669002|NCT00839306|Gastroesophageal|gastroesophageal
669003|NCT00839306|Reflux|reflux
669004|NCT00839306|Disease|disease
669005|NCT00839306|GERD|gerd
669006|NCT00839319|hCG|hcg
669007|NCT00839319|testosterone|testosterone
669008|NCT00839319|Acyline|acyline
669009|NCT00839319|Intratesticular hormone|intratesticular hormone
669011|NCT00839332|metastatic cancer|metastatic cancer
669012|NCT00839332|advanced cancer|advanced cancer
669013|NCT00839332|Pancreatic cancer|pancreatic cancer
669014|NCT00839345|platelet|platelet
669015|NCT00839345|clopidogrel|clopidogrel
669016|NCT00839345|VerifyNow|verifynow
669017|NCT00839345|ticlopidine|ticlopidine
669018|NCT00839345|thrombosis|thrombosis
669019|NCT00839358|cirrhosis|cirrhosis
669020|NCT00839358|renal failure|renal failure
669021|NCT00839358|midodrine|midodrine
669022|NCT00839358|albumine|albumine
669023|NCT00839371|bispectral analysis|bispectral analysis
669024|NCT00839371|bronchoscopy|bronchoscopy
669025|NCT00839371|midazolam|midazolam
669026|NCT00839371|propofol|propofol
669027|NCT00839371|recovery|recovery
669028|NCT00839371|sedation|sedation
669029|NCT00839410|skin cancer|skin cancer
669030|NCT00839410|melanoma|melanoma
669031|NCT00839410|sentinel lymph node biopsy|sentinel lymph node biopsy
669032|NCT00839410|bio bank|bio bank
669033|NCT00839410|genetic polymorphism|genetic polymorphism
669034|NCT00839410|prospective cohort|prospective cohort
669035|NCT00839410|cohort|cohort
669036|NCT00839410|sentinel lymph nodes|sentinel lymph nodes
669037|NCT00839410|tissue samples|tissue samples
671396|NCT00860587|Antibiotic treatment|antibiotic treatment
671397|NCT00860600|Idiopathic Thrombocytopenic Purpura (ITP)|idiopathic thrombocytopenic purpura (itp)
671398|NCT00860600|Platelet Response|platelet response
669038|NCT00839423|Major depressive disorder|major depressive disorder
669039|NCT00839423|Placebo-controlled|placebo-controlled
669040|NCT00839423|Active reference|active reference
669041|NCT00839423|Multicenter study|multicenter study
669042|NCT00839423|Randomised study|randomised study
669043|NCT00839423|Acute treatment|acute treatment
669044|NCT00839436|Idiopathic CD4+ T-Lymphocytopenia|idiopathic cd4+ t-lymphocytopenia
669045|NCT00839436|Interleukin-7|interleukin-7
669046|NCT00839436|Clinical Trial|clinical trial
669047|NCT00839436|T-Lymphocytes|t-lymphocytes
669048|NCT00839436|Idiopathic CD4 Lymphocytopenia (ICL)|idiopathic cd4 lymphocytopenia (icl)
669050|NCT00839449|subarachnoid hemorrhage|subarachnoid hemorrhage
669051|NCT00839449|cerebral vasospasm|cerebral vasospasm
669052|NCT00839449|eicosapentaenoic acid|eicosapentaenoic acid
669053|NCT00839462|Thermal Erythema|thermal erythema
669054|NCT00839462|Dexpanthenol|dexpanthenol
669055|NCT00839462|Erythema|erythema
669056|NCT00839462|Efficacy|efficacy
669057|NCT00839475|colposcopy|colposcopy
669058|NCT00839475|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
669059|NCT00839475|cervical cancer|cervical cancer
669060|NCT00839475|cervical precancer|cervical precancer
669061|NCT00839488|pantoprazole|pantoprazole
669062|NCT00839488|famotidine|famotidine
669063|NCT00839488|stomach ulcer|stomach ulcer
669064|NCT00839488|digestive system surgical procedure|digestive system surgical procedure
669250|NCT00845871|deferasirox|deferasirox
669065|NCT00839514|Parkinson's disease|parkinson's disease
669066|NCT00839514|Trichloroethylene|trichloroethylene
669067|NCT00839527|diabetes|diabetes
669068|NCT00839540|candidemia|candidemia
669069|NCT00839540|echinocandin|echinocandin
669070|NCT00839540|micafungin|micafungin
669071|NCT00839540|caspofungin|caspofungin
669072|NCT00839566|Atrial Fibrillation|atrial fibrillation
669073|NCT00839566|Heart Failure|heart failure
669074|NCT00839579|slightly overweight|slightly overweight
669075|NCT00839579|males 35-45 years|males 35-45 years
669076|NCT00839592|Insomnia|insomnia
669077|NCT00839592|Acupuncture|acupuncture
669078|NCT00839592|Electroacupuncture|electroacupuncture
669079|NCT00839592|Randomized Clinical Trial|randomized clinical trial
669080|NCT00839592|Traditional Chinese Medicine|traditional chinese medicine
669081|NCT00839605|Thoracic surgery one lung ventilation|thoracic surgery one lung ventilation
669082|NCT00839605|airway reconstruction|airway reconstruction
669173|NCT00840125|ERLOTINIB|erlotinib
669083|NCT00839631|subjects with advanced solid tumors refractory to standard therapy or for whom no effective therapy is available.|subjects with advanced solid tumors refractory to standard therapy or for whom no effective therapy is available.
669084|NCT00839644|cystic fibrosis|cystic fibrosis
669085|NCT00839644|Chest Wall Oscillation|chest wall oscillation
669086|NCT00839644|drainage, postural|drainage, postural
669087|NCT00839644|Medication Adherence|medication adherence
669088|NCT00839644|patient dropouts|patient dropouts
669089|NCT00839657|Embolism|embolism
669090|NCT00839657|Thrombosis|thrombosis
669091|NCT00839670|1- Constraint induced therapy|1- constraint induced therapy
669092|NCT00839670|2- Stroke|2- stroke
669093|NCT00839670|3- Upper limb|3- upper limb
669094|NCT00839670|4- Rehabilitation|4- rehabilitation
669095|NCT00839670|5- Motor training|5- motor training
669096|NCT00839670|1- First time clinical ischemic or hemorrhagic stroke|1- first time clinical ischemic or hemorrhagic stroke
669097|NCT00839670|2- At least 10° of active wrist extension|2- at least 10° of active wrist extension
669098|NCT00839670|3- At least 10° of thumb abduction/ extension|3- at least 10° of thumb abduction/ extension
669099|NCT00839670|4- At least 10° of extension in at least 2 additional digits|4- at least 10° of extension in at least 2 additional digits
669100|NCT00839670|3- Adequate balance while wearing the restraint.|3- adequate balance while wearing the restraint.
669101|NCT00839696|Breast|breast
669102|NCT00839696|Estrogens|estrogens
669103|NCT00839696|Mammography|mammography
669104|NCT00839709|liver disease|liver disease
669105|NCT00839709|liver transplantation|liver transplantation
669106|NCT00839709|depletion immunosuppression|depletion immunosuppression
669107|NCT00839709|non-depletion immunosuppression|non-depletion immunosuppression
669108|NCT00839722|Uterine embolization|uterine embolization
669109|NCT00839722|leiomyomas|leiomyomas
669110|NCT00839722|fertility|fertility
669111|NCT00839722|myomectomies|myomectomies
669112|NCT00839735|COPD|copd
669113|NCT00839748|asthma|asthma
669114|NCT00839748|registry for future asthmatic studies|registry for future asthmatic studies
669115|NCT00839748|questionnaires|questionnaires
669116|NCT00839748|lung function tests|lung function tests
669117|NCT00839774|Peas|peas
669118|NCT00839774|Cardiovascular|cardiovascular
669119|NCT00839774|Diabetes|diabetes
669120|NCT00839774|Insulin|insulin
669121|NCT00839774|Insulin resistance|insulin resistance
669122|NCT00839774|Abdominal fat|abdominal fat
669123|NCT00839800|Asthma|asthma
669124|NCT00839800|Symbicort Turbuhaler|symbicort turbuhaler
669125|NCT00839813|Yoga|yoga
669126|NCT00839813|Posttraumatic Stress Disorder|posttraumatic stress disorder
669127|NCT00839813|PTSD|ptsd
669128|NCT00839813|women's health|women's health
669129|NCT00839826|Prevention of Thromboembolism after total hip replacement|prevention of thromboembolism after total hip replacement
669130|NCT00839839|infertility|infertility
669131|NCT00839839|egg freezing|egg freezing
669132|NCT00839839|fertility preservation|fertility preservation
669133|NCT00839865|Evidence-based evaluation|evidence-based evaluation
669134|NCT00839865|Multi-center randomized controlled clinical trials|multi-center randomized controlled clinical trials
669135|NCT00839865|Traditional Chinese Medicine|traditional chinese medicine
669136|NCT00839865|therapy|therapy
669137|NCT00839865|diabetic foot ulcer|diabetic foot ulcer
669138|NCT00839865|clinical trails|clinical trails
669139|NCT00839891|TQT, QTc|tqt, qtc
669140|NCT00839904|children|children
669141|NCT00839904|cancer|cancer
669142|NCT00839904|exercise|exercise
669143|NCT00839904|fitness|fitness
669144|NCT00839904|body composition|body composition
669145|NCT00839917|Measles|measles
669146|NCT00839917|Mumps|mumps
669147|NCT00839917|Rubella|rubella
669148|NCT00839917|Varicella|varicella
669149|NCT00839930|Bioequivalence|bioequivalence
669150|NCT00839930|Healthy Subjects|healthy subjects
669151|NCT00839943|ozone|ozone
669152|NCT00839943|clean air|clean air
669153|NCT00839969|overactive bladder syndrome|overactive bladder syndrome
669154|NCT00839969|voiding|voiding
669155|NCT00839969|pressure flow studies|pressure flow studies
669156|NCT00839969|urethral dilatation|urethral dilatation
669157|NCT00839995|To determine the efficacy of ROTEM on assessing coagulation profiles.|to determine the efficacy of rotem on assessing coagulation profiles.
669643|NCT00854256|glaucoma|glaucoma
669158|NCT00840008|peptic ulcer bleeding|peptic ulcer bleeding
669159|NCT00840008|upper GI hemorrhage|upper gi hemorrhage
669160|NCT00840008|adherence to guidelines|adherence to guidelines
669161|NCT00840008|knowledge transfer|knowledge transfer
669162|NCT00840047|Pediatric brain tumor|pediatric brain tumor
669163|NCT00840047|Pediatric solid tumor|pediatric solid tumor
669164|NCT00840047|Pediatric solid neoplasms|pediatric solid neoplasms
669165|NCT00840073|Bioequivalence|bioequivalence
669166|NCT00840073|Healthy Subjects|healthy subjects
669167|NCT00840099|Bioequivalence|bioequivalence
669168|NCT00840099|Healthy Subjects|healthy subjects
669169|NCT00840112|Long-chain 3-hydroxyacyl CoA dehydrogenase (LCHAD)|long-chain 3-hydroxyacyl coa dehydrogenase (lchad)
669170|NCT00840112|Mitochondrial trifunctional protein (TFP)|mitochondrial trifunctional protein (tfp)
669171|NCT00840112|LCHAD/TFP deficiency with peripheral neuropathy|lchad/tfp deficiency with peripheral neuropathy
669172|NCT00840125|NSCLC|nsclc
669174|NCT00840125|DOCETAXEL|docetaxel
669175|NCT00840125|first line treatment|first line treatment
669176|NCT00840125|Stage IIIB /IV|stage iiib /iv
669177|NCT00840125|not previously treated|not previously treated
669178|NCT00840125|ECOG PS 2 or age over 65|ecog ps 2 or age over 65
669179|NCT00840151|Substance Abuse|substance abuse
669180|NCT00840151|Contingency Management|contingency management
669181|NCT00840164|small-fiber sensory neuropathy|small-fiber sensory neuropathy
669182|NCT00840164|nerve pathology|nerve pathology
669183|NCT00840164|vasculature pathology|vasculature pathology
669184|NCT00840164|amputation|amputation
669185|NCT00840164|diabetic foot wound|diabetic foot wound
669186|NCT00840164|sensory neuropathy|sensory neuropathy
669187|NCT00840164|below knee amputation|below knee amputation
669188|NCT00840177|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
669189|NCT00840177|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
669190|NCT00840177|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
669191|NCT00840177|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
669192|NCT00840177|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
669193|NCT00840177|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
669194|NCT00840203|Bioequivalence|bioequivalence
669195|NCT00840203|Healthy Subjects|healthy subjects
669196|NCT00840216|Bioequivalence|bioequivalence
669197|NCT00840216|Healthy Subjects|healthy subjects
669198|NCT00840229|adhesive capsulitis|adhesive capsulitis
669199|NCT00840229|corticosteroids|corticosteroids
669200|NCT00840229|injection|injection
669201|NCT00840229|pain|pain
669202|NCT00840255|Chronic Insomnia lasting more than 1 month|chronic insomnia lasting more than 1 month
669203|NCT00840268|OSDI|osdi
669204|NCT00840268|corneal staining|corneal staining
669205|NCT00840268|Dry Eye|dry eye
669206|NCT00840268|Dry Eye Signs and Symptoms in Dry Eye Patients|dry eye signs and symptoms in dry eye patients
669207|NCT00840281|Bioequivalence|bioequivalence
669208|NCT00840281|Healthy Subjects|healthy subjects
669209|NCT00840294|Men with Elevated PSA|men with elevated psa
669210|NCT00840307|Obesity|obesity
669211|NCT00840307|Type 2 Diabetes|type 2 diabetes
669212|NCT00840307|Gastric Banding|gastric banding
669214|NCT00840320|tolerability|tolerability
669215|NCT00840346|Acute Myeloblastic Leukaemia (AML)|acute myeloblastic leukaemia (aml)
669216|NCT00840346|Panobinostat|panobinostat
670746|NCT00858325|PK|pk
669217|NCT00840359|Cutaneous leishmaniasis|cutaneous leishmaniasis
669218|NCT00840359|Photodynamic therapy|photodynamic therapy
669219|NCT00840372|Blunt needles|blunt needles
669220|NCT00840372|Semi-blunt needles|semi-blunt needles
669221|NCT00840372|Buttonhole cannulation method|buttonhole cannulation method
669222|NCT00840385|Peripheral T-cell lymphomas (PTCL)|peripheral t-cell lymphomas (ptcl)
669223|NCT00840385|Fludarabine|fludarabine
669224|NCT00840398|Bioequivalence|bioequivalence
669225|NCT00840398|Healthy Subjects|healthy subjects
669226|NCT00840411|Bioequivalence|bioequivalence
669227|NCT00840411|Healthy Subjects|healthy subjects
669228|NCT00840437|angina|angina
669229|NCT00840437|health related quality of life|health related quality of life
669230|NCT00840450|ovarian cancer|ovarian cancer
669231|NCT00840450|recurrent|recurrent
669232|NCT00840450|Gleevec|gleevec
669233|NCT00840450|Paclitaxel|paclitaxel
669234|NCT00840450|Taxane|taxane
669235|NCT00840450|mullerian|mullerian
669236|NCT00840463|Pulmonary Hypertension|pulmonary hypertension
669237|NCT00840463|Diastolic Heart Failure|diastolic heart failure
669238|NCT00840476|Bioequivalence|bioequivalence
669239|NCT00840476|Healthy Subjects|healthy subjects
669240|NCT00845845|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
669241|NCT00845845|Omega-3 fatty acids|omega-3 fatty acids
669243|NCT00845845|NASH|nash
669244|NCT00845858|Gastroparesis|gastroparesis
669245|NCT00845858|Diabetic Gastroparesis|diabetic gastroparesis
669246|NCT00845858|Diabetes|diabetes
669247|NCT00845858|Diabetes Mellitus|diabetes mellitus
669248|NCT00845858|Delayed Gastric Emptying|delayed gastric emptying
669249|NCT00845871|Exjade|exjade
669251|NCT00845871|palatability|palatability
669252|NCT00845871|tolerability|tolerability
669253|NCT00845871|food|food
669254|NCT00845871|iron overload|iron overload
669255|NCT00845871|Serum Iron overload due to transfusions|serum iron overload due to transfusions
669256|NCT00845884|Gastric|gastric
669257|NCT00845884|Cancer|cancer
669258|NCT00845884|Advanced|advanced
669259|NCT00845884|Docetaxel|docetaxel
669260|NCT00845884|Cisplatin|cisplatin
669261|NCT00845884|Capecitabine|capecitabine
669262|NCT00845884|Bevacizumab|bevacizumab
669263|NCT00845897|Diabetes mellitus|diabetes mellitus
669264|NCT00845897|plantar ulcers|plantar ulcers
669265|NCT00845897|peripheral neuropathy|peripheral neuropathy
669266|NCT00845923|Postherpetic neuralgia of at least 6 months|postherpetic neuralgia of at least 6 months
669267|NCT00845936|Atypical antipsychotics|atypical antipsychotics
669268|NCT00845936|Weight|weight
669269|NCT00845936|adolecsents|adolecsents
669270|NCT00845936|pediatric|pediatric
669271|NCT00845936|Metformin|metformin
669272|NCT00845949|chemokines synovium|chemokines synovium
669273|NCT00852007|prostate cancer|prostate cancer
669274|NCT00852007|dendritic cells|dendritic cells
669275|NCT00852007|MUC-1|muc-1
669276|NCT00852007|immune therapy|immune therapy
669277|NCT00852033|alcoholism|alcoholism
669278|NCT00852033|alcohol abuse|alcohol abuse
669279|NCT00852033|prevention|prevention
669280|NCT00852033|behavior modification|behavior modification
669281|NCT00852033|parent offspring interaction|parent offspring interaction
669282|NCT00852033|university student|university student
669283|NCT00852033|substance abuse related behavior|substance abuse related behavior
669284|NCT00852033|adolescence|adolescence
669285|NCT00852046|Mechanical ventilation|mechanical ventilation
669286|NCT00852059|ADHD|adhd
669287|NCT00852059|children|children
669288|NCT00852059|adolescents|adolescents
669289|NCT00852059|methylphenidate|methylphenidate
669290|NCT00852059|adherence|adherence
669291|NCT00852059|immediate release|immediate release
669292|NCT00852059|extended release|extended release
669293|NCT00852059|efficacy|efficacy
669294|NCT00852072|common bile duct stones|common bile duct stones
669295|NCT00852072|mechanical lithotripsy|mechanical lithotripsy
669296|NCT00852072|balloon sphincteroplasty|balloon sphincteroplasty
669297|NCT00852085|Counseling|counseling
669298|NCT00852085|Crime|crime
669299|NCT00852085|Adolescent|adolescent
669300|NCT00852098|Fundoplication|fundoplication
669301|NCT00852098|gastroesophageal reflux|gastroesophageal reflux
669302|NCT00852098|gastric vessels|gastric vessels
669303|NCT00852098|surgery|surgery
669304|NCT00852111|Fatigue|fatigue
669305|NCT00852111|Radiotherapy|radiotherapy
669306|NCT00852111|Cancer Therapy|cancer therapy
669307|NCT00852111|Cancer|cancer
669308|NCT00852124|Asthma|asthma
669309|NCT00852124|Probiotic|probiotic
669310|NCT00852124|VSL#3|vsl#3
669311|NCT00852137|Peplin|peplin
669312|NCT00852137|PEP005|pep005
669313|NCT00852137|Actinic Keratosis|actinic keratosis
669314|NCT00852150|gastritis|gastritis
669315|NCT00852150|duodenitis|duodenitis
669316|NCT00852150|inter-rater reliability|inter-rater reliability
669317|NCT00852150|intra-rater reliablity|intra-rater reliablity
669318|NCT00852150|gastroscopy|gastroscopy
669319|NCT00852150|duodenoscopy|duodenoscopy
669320|NCT00852163|conditioning, preparative|conditioning, preparative
669321|NCT00852163|clofarabine; transplant|clofarabine; transplant
669322|NCT00852163|Busulfan|busulfan
669323|NCT00852163|leukemia|leukemia
669324|NCT00852163|myelodysplastic syndrome|myelodysplastic syndrome
669325|NCT00852176|Coronary brachytherapy|coronary brachytherapy
669326|NCT00852176|Coronary restenosis|coronary restenosis
669327|NCT00852176|Coronary in stent restenosis|coronary in stent restenosis
669328|NCT00852189|Cancer|cancer
669329|NCT00852189|Phase 1|phase 1
669330|NCT00852189|EC0489|ec0489
669331|NCT00852189|EC20|ec20
669332|NCT00852189|Refractory|refractory
669333|NCT00852189|Metastatic|metastatic
669334|NCT00852189|Experimental|experimental
669335|NCT00852202|bipolar|bipolar
669336|NCT00852202|depression|depression
669337|NCT00852215|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
669338|NCT00852215|Paclitaxel-eluting stent|paclitaxel-eluting stent
669339|NCT00852215|Vision stent|vision stent
669340|NCT00852228|colorectal cancer|colorectal cancer
669341|NCT00852228|unresectable metastases|unresectable metastases
669342|NCT00852228|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
669343|NCT00852228|liver metastases|liver metastases
669344|NCT00852228|chronotherapy|chronotherapy
669345|NCT00852228|cetuximab|cetuximab
669346|NCT00852228|irinotecan|irinotecan
669347|NCT00852228|oxaliplatin|oxaliplatin
669348|NCT00852228|5-fluorouracil|5-fluorouracil
669349|NCT00852228|hepatic artery infusion|hepatic artery infusion
669350|NCT00852228|Unresectable hepatic lesions|unresectable hepatic lesions
669351|NCT00852228|1 to 3 prior chemotherapy regimens|1 to 3 prior chemotherapy regimens
669352|NCT00852254|Cardiac Index|cardiac index
669353|NCT00852254|Ultrasound Dilution|ultrasound dilution
669448|NCT00853619|clinical decision support|clinical decision support
669354|NCT00852254|Accuracy of ultrasound dilution cardiac index.|accuracy of ultrasound dilution cardiac index.
669355|NCT00852267|cholesterol|cholesterol
669356|NCT00852267|diet|diet
669357|NCT00852267|protein|protein
669358|NCT00852267|carbohydrate|carbohydrate
669359|NCT00852267|saturated fat|saturated fat
669360|NCT00852267|LDL subclass|ldl subclass
669361|NCT00852267|healthy volunteers|healthy volunteers
669362|NCT00852280|scars|scars
669363|NCT00852280|late effect of burn|late effect of burn
669364|NCT00852280|burn|burn
669365|NCT00852280|pulsed-dye laser|pulsed-dye laser
669366|NCT00852293|liver disease|liver disease
669367|NCT00852293|Chitinase 3 like-1 protein|chitinase 3 like-1 protein
669368|NCT00852306|oocyte freezing|oocyte freezing
669369|NCT00852306|vitrification|vitrification
669370|NCT00852306|slow freeze|slow freeze
669371|NCT00852306|fertility preservation|fertility preservation
669372|NCT00852319|Interpregnancy Care|interpregnancy care
669373|NCT00852319|Preconceptual Care|preconceptual care
669374|NCT00852319|Premature Birth|premature birth
669375|NCT00852319|Preterm Delivery|preterm delivery
669376|NCT00852332|male breast cancer|male breast cancer
669377|NCT00852332|stage IIIB breast cancer|stage iiib breast cancer
669378|NCT00852332|stage IIIC breast cancer|stage iiic breast cancer
669379|NCT00852332|stage IV breast cancer|stage iv breast cancer
669380|NCT00852332|recurrent breast cancer|recurrent breast cancer
669381|NCT00852332|stage IIIA breast cancer|stage iiia breast cancer
669382|NCT00852332|HER2-negative breast cancer|her2-negative breast cancer
669383|NCT00853268|Healthy Subjects|healthy subjects
669384|NCT00853268|Bioequivalence|bioequivalence
669385|NCT00853281|Forest malaria prevention|forest malaria prevention
669386|NCT00853281|Long-lasting insecticidal hammocks|long-lasting insecticidal hammocks
669387|NCT00853281|Cluster randomized trial|cluster randomized trial
669388|NCT00853281|Central Vietnam|central vietnam
669389|NCT00853294|Healthy Subjects|healthy subjects
669390|NCT00853294|Bioequivalence|bioequivalence
669391|NCT00853320|Healthy Subjects|healthy subjects
669392|NCT00853320|Bioequivalence|bioequivalence
669393|NCT00853333|Pain|pain
669394|NCT00853333|Propofol|propofol
669395|NCT00853333|Dexmedetomidine|dexmedetomidine
669396|NCT00853333|Midazolam|midazolam
669397|NCT00853333|Effects of sedation on pain perception.|effects of sedation on pain perception.
669398|NCT00853346|Depression|depression
669493|NCT00853710|Assay|assay
669399|NCT00853346|Parkinson's Disease|parkinson's disease
669400|NCT00853346|Major Depression|major depression
669401|NCT00853346|Cognitive Behavioral Therapy|cognitive behavioral therapy
669402|NCT00853385|oral DMARD|oral dmard
669403|NCT00853385|JAK inhibitor|jak inhibitor
669404|NCT00853385|clinical trial|clinical trial
669405|NCT00853398|Primary Osteoarthritis of the knee.|primary osteoarthritis of the knee.
669406|NCT00853411|Moderate to severe asthma|moderate to severe asthma
669407|NCT00853424|diabetic retinopathy|diabetic retinopathy
669408|NCT00853424|diabetic macular edema|diabetic macular edema
669409|NCT00853424|type 1 diabetes|type 1 diabetes
669410|NCT00853424|intensive medical therapy|intensive medical therapy
669411|NCT00853424|islet cell transplantation|islet cell transplantation
669412|NCT00853424|visual acuity|visual acuity
669413|NCT00853424|diabetic eye disease|diabetic eye disease
669414|NCT00853437|Comparison of CO by new method to clinician's estimate and implied CO from the measurement of arteriovenous oxygen content difference.|comparison of co by new method to clinician's estimate and implied co from the measurement of arteriovenous oxygen content difference.
669415|NCT00853450|Antiplatelet|antiplatelet
669416|NCT00853463|Pulmonary Embolism|pulmonary embolism
669417|NCT00853463|Deep Vein Thrombosis|deep vein thrombosis
669418|NCT00853463|Prophylaxis|prophylaxis
669419|NCT00853463|Venous thromboembolism|venous thromboembolism
669420|NCT00853463|Prevention|prevention
669421|NCT00853463|Medical patients|medical patients
669422|NCT00853489|Open tibia fractures|open tibia fractures
669423|NCT00853489|rhBMP-2|rhbmp-2
669424|NCT00853489|critical size defects|critical size defects
669425|NCT00853489|bone grafting|bone grafting
669426|NCT00853502|anorexia nervosa|anorexia nervosa
669427|NCT00853502|testosterone|testosterone
669428|NCT00853502|disordered eating|disordered eating
669429|NCT00853502|hypogonadism|hypogonadism
669430|NCT00853502|bone|bone
669431|NCT00853528|spinal cord metastases|spinal cord metastases
669432|NCT00853541|renal impairment|renal impairment
669433|NCT00853541|heart failure|heart failure
669434|NCT00853541|hyperphosphatemia|hyperphosphatemia
669435|NCT00853541|coronary artery calcification|coronary artery calcification
669436|NCT00853554|Healthy Subjects|healthy subjects
669437|NCT00853554|Bioequivalence|bioequivalence
669438|NCT00853567|Uterine Fibroids|uterine fibroids
669439|NCT00853580|Neurofibromatosis Type 1, Neurocognitive, Phase II|neurofibromatosis type 1, neurocognitive, phase ii
669440|NCT00853593|heart failure|heart failure
669441|NCT00853593|cardiac pacing|cardiac pacing
669442|NCT00853593|cardiac resynchronization therapy|cardiac resynchronization therapy
669443|NCT00853593|left ventricular lead|left ventricular lead
669444|NCT00853606|ED|ed
669445|NCT00853606|Erectile Dysfunction|erectile dysfunction
669446|NCT00853606|Dysfunction|dysfunction
669447|NCT00853606|Erectile|erectile
669449|NCT00853619|knowledge management|knowledge management
669450|NCT00853619|knowledge representation|knowledge representation
669451|NCT00853619|clinical guidelines|clinical guidelines
669452|NCT00853619|coronary artery disease|coronary artery disease
669453|NCT00853619|myocardial ischemia|myocardial ischemia
669454|NCT00853619|diabetes mellitus|diabetes mellitus
669455|NCT00853619|hypertension|hypertension
669456|NCT00853632|Mitral valve|mitral valve
669457|NCT00853632|pericardial bioprostheses|pericardial bioprostheses
669458|NCT00853632|PERIMOUNT|perimount
669459|NCT00853632|bovine pericardial leaflets|bovine pericardial leaflets
669460|NCT00853632|mitral valve replacement|mitral valve replacement
669461|NCT00853632|mitral valve regurgitation|mitral valve regurgitation
669462|NCT00853632|Heart valve disease|heart valve disease
669463|NCT00853658|Chronic Heart Failure|chronic heart failure
669464|NCT00853658|Cardiovascular death|cardiovascular death
669465|NCT00853658|CHF hospitalization|chf hospitalization
669466|NCT00853658|morbi-mortality trial|morbi-mortality trial
669467|NCT00853658|outcome study|outcome study
669468|NCT00853658|endpoint driven|endpoint driven
669469|NCT00853658|plasma renin activity|plasma renin activity
669470|NCT00853658|renin angiotensin aldosterone system|renin angiotensin aldosterone system
669471|NCT00853658|direct renin inhibitors|direct renin inhibitors
669472|NCT00853658|BNP|bnp
669473|NCT00853658|KCCQ|kccq
669474|NCT00853658|eGFR|egfr
669475|NCT00853658|(NYHA class II to IV) with elevated|(nyha class ii to iv) with elevated
669476|NCT00853658|BNP and reduced LVEF|bnp and reduced lvef
669477|NCT00853671|Coronary Artery Disease|coronary artery disease
669478|NCT00853671|Multidetector Computed Tomography|multidetector computed tomography
669479|NCT00853671|Myocardial Perfusion Imaging|myocardial perfusion imaging
669480|NCT00853684|Advanced Colorectal Cancer|advanced colorectal cancer
669481|NCT00853684|Oxaliplatin|oxaliplatin
669482|NCT00853684|Capecitabine|capecitabine
669483|NCT00853684|Endostar|endostar
669484|NCT00853684|efficacy|efficacy
669485|NCT00853697|Prostate|prostate
669486|NCT00853697|DUTASTERIDE|dutasteride
669487|NCT00853697|TESTOSTERONE|testosterone
669488|NCT00853697|09-008|09-008
669489|NCT00853697|Consortium Protocol LOI# c09-028|consortium protocol loi# c09-028
669490|NCT00853710|Prostate-Specific Antigen|prostate-specific antigen
669491|NCT00853710|Prostate Cancer|prostate cancer
669492|NCT00853710|Cancer|cancer
669494|NCT00853723|osteoporosis|osteoporosis
669495|NCT00853723|post-menopausal|post-menopausal
669496|NCT00853723|bone anabolic agents|bone anabolic agents
669497|NCT00853736|Healthy Subjects|healthy subjects
669498|NCT00853736|Bioequivalence|bioequivalence
669499|NCT00853749|Immune response|immune response
669500|NCT00853749|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
669501|NCT00853749|polysaccharide|polysaccharide
669502|NCT00853775|heart disease|heart disease
669503|NCT00853775|cardiovascular disease|cardiovascular disease
669504|NCT00853775|lipoproteins|lipoproteins
669505|NCT00853775|lipoprotein(a)|lipoprotein(a)
669506|NCT00853775|Lp(a)|lp(a)
669507|NCT00853775|apolipoprotein(a)|apolipoprotein(a)
669508|NCT00853775|apo(a)|apo(a)
669509|NCT00853775|fats|fats
669510|NCT00853775|proteins|proteins
669511|NCT00853775|metabolism|metabolism
669512|NCT00853788|systemic sclerosis|systemic sclerosis
669513|NCT00853788|biomarkers|biomarkers
669514|NCT00853788|microarray|microarray
669515|NCT00853801|Pre-Diabetes|pre-diabetes
669516|NCT00853801|Metabolic Syndrome|metabolic syndrome
669517|NCT00853801|Type 2 Diabetes|type 2 diabetes
669518|NCT00853801|Diabetes Prevention|diabetes prevention
669519|NCT00853801|Lifestyle Modification|lifestyle modification
669520|NCT00853801|Diet Therapy|diet therapy
669521|NCT00853801|Provider Education|provider education
669522|NCT00853814|adolescence|adolescence
669523|NCT00853814|obesity|obesity
669524|NCT00853814|physical activity|physical activity
669525|NCT00853814|built environment|built environment
669526|NCT00853814|neighborhood environment|neighborhood environment
669527|NCT00853814|children|children
669528|NCT00853814|youth|youth
669529|NCT00853814|increasing physical activity|increasing physical activity
669530|NCT00853814|changing dietary intake|changing dietary intake
669531|NCT00853814|reducing zBMI|reducing zbmi
669533|NCT00853827|coronary artery disease|coronary artery disease
669534|NCT00853827|coronary atherosclerosis|coronary atherosclerosis
669535|NCT00853827|coronary angiography|coronary angiography
669536|NCT00853827|IVUS|ivus
669537|NCT00853827|intravascular ultrasound|intravascular ultrasound
669538|NCT00853827|plasma renin activity|plasma renin activity
669539|NCT00853827|renin angiotensin aldosterone system,|renin angiotensin aldosterone system,
669540|NCT00853827|direct renin inhibitors|direct renin inhibitors
669541|NCT00853827|coronary atheroma|coronary atheroma
669542|NCT00853840|pharmacodynamics. maraviroc, vardenafil, blood pressure|pharmacodynamics. maraviroc, vardenafil, blood pressure
669543|NCT00853853|Hemorrhoidectomy|hemorrhoidectomy
669544|NCT00853853|Hemorrhoids|hemorrhoids
669545|NCT00853866|stroke|stroke
669546|NCT00853866|reboxetine|reboxetine
669547|NCT00853866|noradrenaline|noradrenaline
669548|NCT00853866|motor cortex|motor cortex
669549|NCT00853866|transcranial direct current stimulation|transcranial direct current stimulation
669550|NCT00853866|motor function|motor function
669551|NCT00853866|rehabilitation|rehabilitation
669552|NCT00853866|Jebsen Taylor test|jebsen taylor test
669553|NCT00853892|Healthy Subjects|healthy subjects
669554|NCT00853892|Bioequivalence|bioequivalence
669555|NCT00853905|open angle glaucoma (POAG)|open angle glaucoma (poag)
669556|NCT00853905|angle closure glaucoma (PACG)|angle closure glaucoma (pacg)
669557|NCT00853905|pigmentary glaucoma|pigmentary glaucoma
669558|NCT00853905|pseudoexfoliation glaucoma|pseudoexfoliation glaucoma
669559|NCT00853905|neovascular glaucoma|neovascular glaucoma
669560|NCT00853905|traumatic glaucoma|traumatic glaucoma
669561|NCT00853918|Physician survey|physician survey
669562|NCT00853918|Mail survey|mail survey
669563|NCT00853918|Response rate|response rate
669564|NCT00853931|KRAS wild type|kras wild type
669565|NCT00853931|metastatic colorectal cancer|metastatic colorectal cancer
669566|NCT00853931|KRAS wild type metastatic colorectal cancer with no prior exposure to EGFR inhibitors|kras wild type metastatic colorectal cancer with no prior exposure to egfr inhibitors
669567|NCT00853944|islet transplantation|islet transplantation
669568|NCT00853944|type 1 diabetes|type 1 diabetes
669569|NCT00853944|incretin|incretin
669570|NCT00853957|Hypertension|hypertension
669571|NCT00853957|African Americans|african americans
669572|NCT00853957|Aliskiren|aliskiren
669573|NCT00853957|Amlodipine|amlodipine
669574|NCT00853957|Systolic blood pressure|systolic blood pressure
669575|NCT00853957|Diastolic blood pressure|diastolic blood pressure
669576|NCT00853957|Stage II|stage ii
669577|NCT00853957|Combination|combination
669578|NCT00853970|Pain and Inflammation as a function of cataract surgery|pain and inflammation as a function of cataract surgery
669579|NCT00853983|Healthy Volunteers|healthy volunteers
669580|NCT00853983|ADME|adme
669581|NCT00854009|Healthy Subjects|healthy subjects
669582|NCT00854035|MK-0431/ONO-5435|mk-0431/ono-5435
669583|NCT00854035|Type 2 diabetes mellitus|type 2 diabetes mellitus
669584|NCT00854048|Pediatric|pediatric
669585|NCT00854048|Oxygen Saturation|oxygen saturation
669586|NCT00854048|Cardiopulmonary bypass|cardiopulmonary bypass
669587|NCT00854074|Post-operative Paralytic Ileus|post-operative paralytic ileus
669588|NCT00854074|Neuromodulation|neuromodulation
669589|NCT00854074|Neurostimulation|neurostimulation
669590|NCT00854074|Extended loss of functional bowel motility|extended loss of functional bowel motility
669591|NCT00854087|Hepatitis C Virus|hepatitis c virus
669592|NCT00854087|HCV|hcv
669593|NCT00854087|Herbal treatment|herbal treatment
669594|NCT00854087|Herbs|herbs
669595|NCT00854087|San Diego|san diego
669596|NCT00854087|Non responder|non responder
669597|NCT00854087|Relapser|relapser
669598|NCT00854087|Treatment failure|treatment failure
669599|NCT00854087|Antifibrotic|antifibrotic
669600|NCT00854087|Anti-fibrotic|anti-fibrotic
669601|NCT00854087|Fibrosis|fibrosis
669602|NCT00854087|Failure of previous Interferon based therapy|failure of previous interferon based therapy
669603|NCT00854087|Refuse Interferon based therapy|refuse interferon based therapy
669604|NCT00854087|Intolerance to Interferon|intolerance to interferon
751812|NCT01170598|chemotherapy|chemotherapy
669605|NCT00854087|Male or female 18-70 years of age|male or female 18-70 years of age
669606|NCT00854100|Adjunctive|adjunctive
669607|NCT00854100|Depression|depression
669608|NCT00854100|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
669609|NCT00854113|Diabetes Mellitus Type 2|diabetes mellitus type 2
669610|NCT00854126|NHL|nhl
669611|NCT00854126|Solid Tumors|solid tumors
669612|NCT00854126|Carcinogenic Tumors|carcinogenic tumors
669613|NCT00854139|Multiple myeloma|multiple myeloma
669614|NCT00854139|Renal failure|renal failure
669615|NCT00854139|Kidney transplant|kidney transplant
669616|NCT00854152|NHL|nhl
669617|NCT00854152|Tumors|tumors
669618|NCT00854152|Carcinogenic Tumors|carcinogenic tumors
669619|NCT00854165|lung transplantation|lung transplantation
669620|NCT00854165|respiratory failure|respiratory failure
669621|NCT00854165|ECMO|ecmo
669622|NCT00854165|Lung transplants in respiratory failure patients|lung transplants in respiratory failure patients
669623|NCT00854178|isoflurane|isoflurane
669624|NCT00854178|propofol|propofol
669625|NCT00854178|genotoxicity|genotoxicity
669626|NCT00854178|gene expression|gene expression
669627|NCT00854178|cytokines|cytokines
669628|NCT00854178|apoptosis|apoptosis
669629|NCT00854191|mechanical simulator|mechanical simulator
669630|NCT00854191|ERCP|ercp
669631|NCT00854191|training|training
669632|NCT00854204|Innovation-TiFP4-C101|innovation-tifp4-c101
669633|NCT00854204|Innovation-C101|innovation-c101
669634|NCT00854204|Innovation|innovation
669635|NCT00854204|TMC114/TMC41629|tmc114/tmc41629
669636|NCT00854204|controlled-release coformulations|controlled-release coformulations
669637|NCT00854204|immediate-release coformulation|immediate-release coformulation
669638|NCT00854204|Pharmacokinetics|pharmacokinetics
669639|NCT00854230|HIV|hiv
669640|NCT00854230|alcohol|alcohol
669641|NCT00854230|naltrexone|naltrexone
669642|NCT00854230|Treatment Experienced|treatment experienced
669644|NCT00854295|arthritis|arthritis
669645|NCT00854295|osteoarthritis|osteoarthritis
669646|NCT00854295|degenerative knee disease|degenerative knee disease
669647|NCT00854295|avascular necrosis|avascular necrosis
669648|NCT00854295|total knee replacement|total knee replacement
669649|NCT00854295|TKA|tka
669650|NCT00854308|Tarceva|tarceva
669651|NCT00854308|Lung Cancer|lung cancer
669652|NCT00854308|NSCLC|nsclc
669653|NCT00854321|rheumatoid arthritis|rheumatoid arthritis
669654|NCT00854321|rituximab|rituximab
669655|NCT00854321|therapy|therapy
669656|NCT00854334|Sleep|sleep
669657|NCT00854334|Overweight|overweight
669658|NCT00854334|Physical activity|physical activity
669659|NCT00854334|Appetite|appetite
669660|NCT00854334|NEAT|neat
669661|NCT00854347|hyperglycemia|hyperglycemia
669662|NCT00854347|diabetes|diabetes
669663|NCT00854347|intensive care|intensive care
669664|NCT00854347|prevalence|prevalence
669665|NCT00854360|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
669666|NCT00854360|Hayfever|hayfever
669667|NCT00854373|Infertility|infertility
669668|NCT00854373|Pregnancy|pregnancy
669669|NCT00854373|in vitro fertilization|in vitro fertilization
669670|NCT00854386|fluid management|fluid management
669671|NCT00854386|VATS|vats
669672|NCT00854386|ALI|ali
669673|NCT00854386|ARDS|ards
669674|NCT00854412|Obesity|obesity
669675|NCT00854412|Weight loss|weight loss
669676|NCT00854412|Very low-calorie diet|very low-calorie diet
669677|NCT00854412|Mannose-binding lectin|mannose-binding lectin
669678|NCT00854412|Insulin resistance|insulin resistance
669679|NCT00854438|anticholinergic drugs|anticholinergic drugs
669680|NCT00854438|adverse events|adverse events
669681|NCT00854438|elderly|elderly
669682|NCT00854438|clinical pharmacist|clinical pharmacist
669683|NCT00854438|Evaluate the clinical effects of reducing anticholinergic in elderly|evaluate the clinical effects of reducing anticholinergic in elderly
669684|NCT00854451|Helicobacter pylori|helicobacter pylori
669685|NCT00854451|CYP2C19 genotype|cyp2c19 genotype
669686|NCT00854451|intragastric pH|intragastric ph
669687|NCT00854451|dual therapy|dual therapy
669688|NCT00854451|antibiotic resistance|antibiotic resistance
669689|NCT00854464|Arsenic Methylation Capability|arsenic methylation capability
669690|NCT00854464|Arsenic Methylation Enzymes|arsenic methylation enzymes
669691|NCT00854464|Cigarette Metabolites|cigarette metabolites
669983|NCT00855725|Depression|depression
669692|NCT00854464|Cigarette Metabolic Enzymes|cigarette metabolic enzymes
669693|NCT00854464|DNA Repair Enzymes|dna repair enzymes
669694|NCT00854464|Inflammatory Factors|inflammatory factors
669695|NCT00854464|Urothelial Carcinoma|urothelial carcinoma
669696|NCT00854477|capecitabine|capecitabine
669697|NCT00854477|Post whipples|post whipples
669698|NCT00854477|pancreatico-duodenectomy|pancreatico-duodenectomy
669699|NCT00854477|pancreatic adenocarcinoma|pancreatic adenocarcinoma
669700|NCT00854477|pharmacokinetic|pharmacokinetic
669701|NCT00854503|Statins administration in diabetic dyslipidemia|statins administration in diabetic dyslipidemia
669702|NCT00854516|compression therapy|compression therapy
669704|NCT00854529|bevacizumab|bevacizumab
669705|NCT00854529|subconjunctival injection|subconjunctival injection
669706|NCT00854529|trabeculectomy|trabeculectomy
669707|NCT00854529|bleb|bleb
669708|NCT00854529|mitomycin c|mitomycin c
669709|NCT00854542|Telepsychiatry|telepsychiatry
669710|NCT00854542|Culturally Sensitive Collaborative Treatment|culturally sensitive collaborative treatment
669711|NCT00854542|Chinese Americans|chinese americans
669712|NCT00854542|Depression|depression
669713|NCT00854555|incomplete spinal cord injury|incomplete spinal cord injury
669714|NCT00854555|locomotor activity|locomotor activity
669715|NCT00854555|walking function|walking function
669716|NCT00854555|gait|gait
669717|NCT00854568|B-cell lymphoma|b-cell lymphoma
669718|NCT00854568|CHOP|chop
669719|NCT00854568|CEOP|ceop
669720|NCT00854568|Cardiotoxicity|cardiotoxicity
669721|NCT00854581|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
669722|NCT00854581|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
669723|NCT00854581|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
669724|NCT00854581|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
669725|NCT00854581|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
669726|NCT00854581|HTLV-1 infection|htlv-1 infection
669727|NCT00854594|Diabetes|diabetes
669728|NCT00854594|Telemedicine|telemedicine
669729|NCT00854594|Shared Medical Appointments|shared medical appointments
669730|NCT00854633|Pre-term infants|pre-term infants
669731|NCT00854633|Pre-term infants 750 to 1500 grams|pre-term infants 750 to 1500 grams
669732|NCT00854646|ON 01910.Na|on 01910.na
669733|NCT00854646|refractory|refractory
669734|NCT00854646|leukemia|leukemia
669735|NCT00854646|myelodysplastic|myelodysplastic
669736|NCT00854646|cell cycle|cell cycle
669737|NCT00854672|Sarcoidosis|sarcoidosis
669738|NCT00854672|muscle strength|muscle strength
669739|NCT00854672|exercise intolerance|exercise intolerance
669740|NCT00854672|QOL|qol
669835|NCT00855062|Treatment Naive|treatment naive
669836|NCT00855075|Sedation|sedation
669741|NCT00854698|THE LEFT VENTRICULAR REMODELING AFTER MECHANICAL AORTIC VALVE REPLACEMENT|the left ventricular remodeling after mechanical aortic valve replacement
669742|NCT00854698|exercise training|exercise training
669743|NCT00854711|ST elevated Myocardical infraction|st elevated myocardical infraction
669744|NCT00854737|bipolar disorder|bipolar disorder
669745|NCT00854737|bipolar depression|bipolar depression
669746|NCT00854737|bipolar mania|bipolar mania
669747|NCT00854737|manic depression|manic depression
669748|NCT00854737|depression|depression
669749|NCT00854737|mania|mania
669750|NCT00854737|hypomania|hypomania
669751|NCT00854750|Multiple Sclerosis, hx of unilateral ON, evidence of thermal sensitivity, and no evidence of an ocular motor syndrome|multiple sclerosis, hx of unilateral on, evidence of thermal sensitivity, and no evidence of an ocular motor syndrome
669752|NCT00854750|Multiple Sclerosis, no evidence of ON, and evidence of thermal sensitivity|multiple sclerosis, no evidence of on, and evidence of thermal sensitivity
669753|NCT00854750|Healthy age/gender matched controls|healthy age/gender matched controls
669754|NCT00854776|aspirin|aspirin
669755|NCT00854776|clopidogrel|clopidogrel
669756|NCT00854776|proton pump inhibitor|proton pump inhibitor
669757|NCT00854776|peptic ulcer|peptic ulcer
669758|NCT00854776|ulcer complications|ulcer complications
669759|NCT00854789|Breast cancer|breast cancer
669760|NCT00854802|Hepatitis|hepatitis
669761|NCT00854802|Hepatitis C|hepatitis c
669762|NCT00854815|Perforated appendicitis|perforated appendicitis
669763|NCT00854815|laparoscopic appendectomy|laparoscopic appendectomy
669764|NCT00854815|children|children
669765|NCT00854815|irrigation|irrigation
669766|NCT00854828|Symptomatic 40-80 y/o w/lumbar Cobb of 30 degrees|symptomatic 40-80 y/o w/lumbar cobb of 30 degrees
669767|NCT00854828|All Participants must be reasonable surgical candidate at enrollment|all participants must be reasonable surgical candidate at enrollment
669768|NCT00854841|CML|cml
669769|NCT00854841|suboptimal response|suboptimal response
669770|NCT00854841|dasatinib|dasatinib
669771|NCT00854841|imatinib|imatinib
669772|NCT00854854|NKCell|nkcell
669773|NCT00854854|FOLFOX-4|folfox-4
669774|NCT00854854|gastric cancer|gastric cancer
669775|NCT00854867|Solid tumour neoplastic meningitis|solid tumour neoplastic meningitis
669776|NCT00854867|STNM|stnm
669777|NCT00854867|leptomeningeal metastases|leptomeningeal metastases
669778|NCT00854867|DepoCyte|depocyte
669779|NCT00854867|WBRT|wbrt
669780|NCT00854867|Whole Brain Radiotherapy|whole brain radiotherapy
669781|NCT00854867|Liposomal cytarabine intrathecal|liposomal cytarabine intrathecal
669782|NCT00854867|Solid Tumour Neoplastic Meningitis with or without brain metastasis|solid tumour neoplastic meningitis with or without brain metastasis
669783|NCT00854880|Erosive Gastritis|erosive gastritis
669784|NCT00854893|stroke|stroke
669785|NCT00854893|aphasia|aphasia
669786|NCT00854893|aging|aging
669787|NCT00854893|language learning|language learning
669788|NCT00854906|dry eye|dry eye
669789|NCT00854906|keratometer|keratometer
669790|NCT00854906|fluorescein|fluorescein
669791|NCT00854919|obsessive-compulsive disorder|obsessive-compulsive disorder
669792|NCT00854919|augmentation treatment|augmentation treatment
669793|NCT00854919|SSRI-refractory|ssri-refractory
669794|NCT00854932|procalcitonin|procalcitonin
669795|NCT00854932|sepsis|sepsis
669796|NCT00854932|newborn|newborn
669797|NCT00854932|intervention study|intervention study
671275|NCT00859989|obesity|obesity
669798|NCT00854945|Myelodysplastic Syndrome|myelodysplastic syndrome
669799|NCT00854945|Refractory Cytopenia|refractory cytopenia
669800|NCT00854945|Refractory Anemia|refractory anemia
669801|NCT00854945|Dysplasia|dysplasia
669802|NCT00854945|Acute Myeloid Leukemia|acute myeloid leukemia
669803|NCT00854958|Oral|oral
669804|NCT00854958|Allergy|allergy
669805|NCT00854958|Syndrome|syndrome
669806|NCT00854958|Food|food
669807|NCT00854958|Pollen|pollen
669808|NCT00854971|NKCell|nkcell
669809|NCT00854971|FOLFOX-4|folfox-4
669810|NCT00854971|advanced or unresectable colorectal cancer|advanced or unresectable colorectal cancer
669811|NCT00854984|Depression|depression
669812|NCT00854984|diabetes|diabetes
669813|NCT00854984|Coronary heart disease|coronary heart disease
669814|NCT00854984|CBT|cbt
669815|NCT00854984|Cognitive behavioural therapy|cognitive behavioural therapy
669816|NCT00854997|Obstructive sleep apnea; myocardial infarction|obstructive sleep apnea; myocardial infarction
669817|NCT00855010|Pioglitazone|pioglitazone
669818|NCT00855010|prediabetes|prediabetes
669819|NCT00855010|diabetes|diabetes
669820|NCT00855010|obesity|obesity
669821|NCT00855010|Pancreatic fat|pancreatic fat
669822|NCT00855023|anterior cruciate ligament|anterior cruciate ligament
669823|NCT00855023|Knee Joint|knee joint
669824|NCT00855036|blunt renal injury|blunt renal injury
669825|NCT00855036|kidney laceration|kidney laceration
669826|NCT00855049|Pharmacokinetics|pharmacokinetics
669827|NCT00855049|Acetaminophen|acetaminophen
669828|NCT00855049|Intranasal|intranasal
669829|NCT00855049|Absorption|absorption
669830|NCT00855062|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
669831|NCT00855062|HIV associated cognitive impairment|hiv associated cognitive impairment
669832|NCT00855062|HIV dementia|hiv dementia
669833|NCT00855062|Uganda|uganda
669834|NCT00855062|Acquired immune deficiency syndrome (AIDS)|acquired immune deficiency syndrome (aids)
669837|NCT00855075|Analgesia|analgesia
669838|NCT00855075|Mechanical ventilation|mechanical ventilation
669839|NCT00855075|Cerebral State Monitor|cerebral state monitor
669840|NCT00855075|Cerebral State Index|cerebral state index
669841|NCT00855088|HIV seronegativity|hiv seronegativity
669842|NCT00855101|Pharmacokinetics and safety of voriconazole intravenous oral adults|pharmacokinetics and safety of voriconazole intravenous oral adults
669843|NCT00855114|stage II breast cancer|stage ii breast cancer
669844|NCT00855114|stage III breast cancer|stage iii breast cancer
669845|NCT00855114|stage IIIA breast cancer|stage iiia breast cancer
669846|NCT00855127|Biological Markers|biological markers
669847|NCT00855127|Renal Replacement Therapy|renal replacement therapy
669848|NCT00855127|Mortality|mortality
669849|NCT00855140|Insomnia|insomnia
669850|NCT00855140|Primary insomnia|primary insomnia
669851|NCT00855140|Insomnia disorder|insomnia disorder
669852|NCT00855140|Acupuncture|acupuncture
669853|NCT00855153|PTSD|ptsd
669854|NCT00855153|burns|burns
669855|NCT00855153|virtual reality exposure|virtual reality exposure
669856|NCT00855153|D-Cycloserine|d-cycloserine
669857|NCT00855153|Combat related psychological trauma in burned servicemembers|combat related psychological trauma in burned servicemembers
669858|NCT00855166|Dapagliflozin|dapagliflozin
669859|NCT00855166|Metformin|metformin
669860|NCT00855166|Type 2 diabetes|type 2 diabetes
669861|NCT00855166|body weight|body weight
669862|NCT00855192|anxiety|anxiety
669863|NCT00855192|depression|depression
669864|NCT00855192|pregnancy|pregnancy
669865|NCT00855192|antenatal|antenatal
669866|NCT00855192|prenatal|prenatal
669867|NCT00855192|mindfulness-based therapy|mindfulness-based therapy
669868|NCT00855192|interpersonal therapy|interpersonal therapy
669869|NCT00855192|support groups|support groups
669870|NCT00855205|pulmonary sarcoidosis|pulmonary sarcoidosis
669871|NCT00855218|Sorafenib|sorafenib
669872|NCT00855218|TACE|tace
669873|NCT00855218|DC bead|dc bead
669874|NCT00855218|Combination|combination
669875|NCT00855231|Acute coronary syndrome|acute coronary syndrome
669876|NCT00855231|Coronary artery disease|coronary artery disease
669877|NCT00855231|cardiac imaging|cardiac imaging
669878|NCT00855231|computed tomography|computed tomography
669879|NCT00855244|Bone marrow transplantation|bone marrow transplantation
669880|NCT00855257|Acid nicotinique|acid nicotinique
669984|NCT00855725|Neurology|neurology
669881|NCT00855257|FLOW MEDIATED DILATATION (FMD)|flow mediated dilatation (fmd)
669882|NCT00855257|HDL-C< 0.4 G/L|hdl-c< 0.4 g/l
669883|NCT00855270|PTSD|ptsd
669884|NCT00855309|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
669885|NCT00855309|renal toxicity|renal toxicity
669886|NCT00855309|infection|infection
669887|NCT00855309|neutropenia|neutropenia
669888|NCT00855322|Arthritis, Rheumatoid|arthritis, rheumatoid
669889|NCT00855322|Exercise|exercise
669890|NCT00855322|Biological Therapy|biological therapy
669891|NCT00855335|HIV-1|hiv-1
669892|NCT00855335|HIV|hiv
669893|NCT00855335|Pregnancy|pregnancy
669894|NCT00855335|Postpartum|postpartum
669895|NCT00855335|Human immunodeficiency virus|human immunodeficiency virus
669896|NCT00855335|PREZISTA|prezista
669897|NCT00855335|INTELENCE|intelence
669898|NCT00855335|NORVIR|norvir
669899|NCT00855335|TMC114|tmc114
669900|NCT00855335|TMC125|tmc125
669901|NCT00855335|darunavir|darunavir
669902|NCT00855335|ritonavir|ritonavir
669903|NCT00855335|etravirine|etravirine
669904|NCT00855335|rilpivirine|rilpivirine
669905|NCT00855335|TMC278|tmc278
669906|NCT00855335|Cobicistat|cobicistat
669907|NCT00855335|treatment experienced|treatment experienced
669908|NCT00855348|colorectal cancer|colorectal cancer
669909|NCT00855348|early detection|early detection
669910|NCT00855348|methylation, biomarker|methylation, biomarker
669911|NCT00855361|Gastroesophageal Reflux|gastroesophageal reflux
669912|NCT00855361|Erosive Gastroesophageal Reflux Disease|erosive gastroesophageal reflux disease
669913|NCT00855361|Ulcerative Gastroesophageal Reflux Disease|ulcerative gastroesophageal reflux disease
669914|NCT00855361|Endoscopy|endoscopy
669915|NCT00855361|Pediatrics|pediatrics
669916|NCT00855361|GERD|gerd
669917|NCT00855361|Rabeprazole, Rabeprazole sodium|rabeprazole, rabeprazole sodium
669918|NCT00855361|AcipHex|aciphex
669919|NCT00855387|Clinical outcome (complications), in-hospital costs|clinical outcome (complications), in-hospital costs
669920|NCT00855387|The influence and impact of postoperative complications on in-hospital costs|the influence and impact of postoperative complications on in-hospital costs
669921|NCT00855400|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
669922|NCT00855400|Bone marrow|bone marrow
669923|NCT00855400|Stem cells|stem cells
669924|NCT00855400|Autologous|autologous
669925|NCT00855400|Safety|safety
669926|NCT00855413|Acute HIV|acute hiv
669927|NCT00855413|HIV|hiv
669928|NCT00855413|Treatment Naive|treatment naive
669929|NCT00855413|Acute Infections|acute infections
669930|NCT00855439|Diabetes|diabetes
669931|NCT00855439|Neuropathy|neuropathy
669932|NCT00855439|Glucose|glucose
669933|NCT00855439|Control|control
669934|NCT00855439|Peripheral|peripheral
669935|NCT00855439|Autonomic|autonomic
669936|NCT00855452|GVL|gvl
669937|NCT00855452|rIL-2(LAK)|ril-2(lak)
669938|NCT00855452|GVHD|gvhd
669939|NCT00855452|MST|mst
669940|NCT00855452|alloCT|alloct
669941|NCT00855452|alloBMT|allobmt
669942|NCT00855465|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
669943|NCT00855465|PH|ph
669944|NCT00855465|soluble Guanylate Cyclase Stimulator|soluble guanylate cyclase stimulator
669945|NCT00855465|sGC|sgc
669946|NCT00855491|PCO|pco
669947|NCT00855491|POCO|poco
669948|NCT00855504|preeclampsia|preeclampsia
669949|NCT00855504|periodontitis|periodontitis
669950|NCT00855504|cytokines|cytokines
669951|NCT00855530|Depression|depression
669952|NCT00855569|allografting|allografting
669953|NCT00855582|Erectile Dysfunction|erectile dysfunction
669954|NCT00855582|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
669955|NCT00855595|Rosacea|rosacea
669956|NCT00855608|choroidal neovascularization|choroidal neovascularization
669957|NCT00855608|diabetic retinopathy|diabetic retinopathy
669958|NCT00855608|uveitis|uveitis
669959|NCT00855608|refractory cases of uveitis|refractory cases of uveitis
669960|NCT00855621|deep brain stimulation|deep brain stimulation
669961|NCT00855621|subthalamic nucleus|subthalamic nucleus
669962|NCT00855634|Pancreatic cancer|pancreatic cancer
669963|NCT00855634|metastasis|metastasis
669964|NCT00855634|venous infiltration|venous infiltration
669965|NCT00855634|Pancreatic cancer with minimal metastatic disease or venous infiltration|pancreatic cancer with minimal metastatic disease or venous infiltration
669966|NCT00855660|Bone Metabolism|bone metabolism
669967|NCT00855673|Claudication|claudication
669968|NCT00855673|Peripheral Arterial Disease|peripheral arterial disease
669969|NCT00855673|Intermittent Compression|intermittent compression
669970|NCT00855673|Mechanical Compression|mechanical compression
669971|NCT00855673|Flowmedic|flowmedic
669972|NCT00855686|Memantine|memantine
669973|NCT00855686|Cognition|cognition
669974|NCT00855686|Parkinson's Disease Dementia|parkinson's disease dementia
669975|NCT00855686|Dementia With Lewy Bodies|dementia with lewy bodies
669976|NCT00855699|Alcohol detoxification|alcohol detoxification
669977|NCT00855712|Heart Failure|heart failure
669978|NCT00855712|Transplant|transplant
669979|NCT00855712|Warm Perfusion|warm perfusion
669980|NCT00855712|Organ Care|organ care
669981|NCT00855712|Resting Mode|resting mode
669982|NCT00855725|Epilepsy|epilepsy
669986|NCT00855725|Healthy Controls|healthy controls
669987|NCT00855738|epilepsy antiepileptic biotherapy|epilepsy antiepileptic biotherapy
669988|NCT00848796|Heparin Leo|heparin leo
669989|NCT00848796|Hepalean|hepalean
669990|NCT00848796|CPB Cardiopuilmonary Bypass|cpb cardiopuilmonary bypass
669991|NCT00848796|CABG Coronary Artery Bypass Grafting|cabg coronary artery bypass grafting
669992|NCT00848796|Anticoagulation efficacy|anticoagulation efficacy
669993|NCT00848809|Acute kidney injury|acute kidney injury
669994|NCT00848809|Vancomycin therapy|vancomycin therapy
669995|NCT00848809|Slow-low efficiency daily dialysis|slow-low efficiency daily dialysis
669996|NCT00848809|Intermittent Hemodialysis|intermittent hemodialysis
669997|NCT00848809|Kidney|kidney
669998|NCT00848809|Vancomycin|vancomycin
669999|NCT00848809|Hemofiltration|hemofiltration
670000|NCT00848822|Pediatrics|pediatrics
670001|NCT00848822|Sleep|sleep
670002|NCT00848822|Glucose regulation|glucose regulation
670003|NCT00848822|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
670004|NCT00848835|defibrillator|defibrillator
670005|NCT00848848|Influenza|influenza
670007|NCT00848848|Vaccine|vaccine
670008|NCT00848848|Intradermal|intradermal
670009|NCT00848848|Adjuvant|adjuvant
670010|NCT00848861|propofol sedation|propofol sedation
670011|NCT00848861|colonoscopy|colonoscopy
670012|NCT00848861|recovery time|recovery time
670013|NCT00848861|recovery time after sedation for colonoscopy|recovery time after sedation for colonoscopy
670014|NCT00848887|Influenza|influenza
670015|NCT00848887|Flu|flu
670016|NCT00848887|Vaccine|vaccine
670017|NCT00848887|Adjuvant|adjuvant
670018|NCT00848913|strength deficit|strength deficit
670019|NCT00848913|physical function|physical function
670020|NCT00848926|Antigens, CD30|antigens, cd30
670021|NCT00848926|Antibody-Drug Conjugate|antibody-drug conjugate
670022|NCT00848926|Antibodies, Monoclonal|antibodies, monoclonal
670023|NCT00848926|Disease, Hodgkin|disease, hodgkin
670024|NCT00848926|Hematologic Diseases|hematologic diseases
670025|NCT00848926|Lymphoma|lymphoma
670026|NCT00848926|monomethylauristatin E|monomethylauristatin e
670027|NCT00848926|Drug Therapy|drug therapy
670028|NCT00848926|Immunotherapy|immunotherapy
670029|NCT00848939|systemic sclerosis|systemic sclerosis
670030|NCT00848939|scleroderma|scleroderma
670031|NCT00848939|pharmacokinetics|pharmacokinetics
670032|NCT00848939|treprostinil diethanolamine|treprostinil diethanolamine
670033|NCT00848965|fluticasone propionate|fluticasone propionate
670034|NCT00848965|Vienna Challenge Chamber|vienna challenge chamber
670035|NCT00848965|glucocorticosteroids|glucocorticosteroids
670036|NCT00848965|allergic rhinitis|allergic rhinitis
670037|NCT00848978|Functional capacity|functional capacity
670038|NCT00848978|Quality of life|quality of life
670039|NCT00848978|Depression|depression
670040|NCT00848978|Falls|falls
670041|NCT00848978|Body composition|body composition
670042|NCT00848978|Physical activity|physical activity
670043|NCT00848991|precedex|precedex
670044|NCT00848991|propofol|propofol
670045|NCT00849004|keloid|keloid
670046|NCT00849004|silicone sheet|silicone sheet
670047|NCT00849004|silicone gel|silicone gel
670048|NCT00849004|paper tape|paper tape
670049|NCT00849004|steri-strip|steri-strip
670050|NCT00849017|placebo|placebo
670051|NCT00849017|albiglutide|albiglutide
670052|NCT00849017|monotherapy|monotherapy
670053|NCT00849017|diabetes|diabetes
670054|NCT00849043|obstructive sleep apnea hypopnea|obstructive sleep apnea hypopnea
670055|NCT00849043|OSA|osa
670056|NCT00849043|OSAH|osah
670057|NCT00849056|diabetes|diabetes
670058|NCT00849069|Streptococcus pneumoniae|streptococcus pneumoniae
670059|NCT00849069|Vaccine|vaccine
670060|NCT00849069|Non-typable Haemophilus influenza|non-typable haemophilus influenza
670061|NCT00849069|Adults and Elderly Adults|adults and elderly adults
670062|NCT00849082|stage IIB prostate cancer|stage iib prostate cancer
670063|NCT00849082|stage IIA prostate cancer|stage iia prostate cancer
670064|NCT00849082|stage III prostate cancer|stage iii prostate cancer
670065|NCT00849082|stage IV prostate cancer|stage iv prostate cancer
670066|NCT00849095|Adult|adult
670067|NCT00849095|Asthma|asthma
670068|NCT00849095|Bronchodilator Agents|bronchodilator agents
670069|NCT00849095|Budesonide|budesonide
670070|NCT00849095|Double-Blind Method|double-blind method
670071|NCT00849095|Drug Therapy, Combination|drug therapy, combination
670072|NCT00849095|Ethanolamines|ethanolamines
670073|NCT00849095|Female|female
670074|NCT00849095|Forced Expiratory Volume|forced expiratory volume
670075|NCT00849095|Humans|humans
670076|NCT00849095|Male|male
670077|NCT00849095|Terbutaline|terbutaline
670078|NCT00849108|Myocardial Perfusion|myocardial perfusion
670079|NCT00849108|PET imaging|pet imaging
670080|NCT00849108|SPECT imaging|spect imaging
670081|NCT00849108|Coronary artery disease|coronary artery disease
670082|NCT00849108|Subjects that are male and nonpregnant female patients|subjects that are male and nonpregnant female patients
670083|NCT00849108|presenting with reversible ischemia as characterized by a|presenting with reversible ischemia as characterized by a
670084|NCT00849108|rest/stress SPECT imaging study using|rest/stress spect imaging study using
670085|NCT00849108|Technetium(99mTc)-labeled tracers|technetium(99mtc)-labeled tracers
670086|NCT00849121|Vaccine|vaccine
670087|NCT00849121|pTVG-HP|ptvg-hp
670088|NCT00849121|Prostate Cancer|prostate cancer
670089|NCT00849121|Castrate Resistant|castrate resistant
670090|NCT00849134|First-Time-in-Human|first-time-in-human
670091|NCT00849134|Tolerability|tolerability
670092|NCT00849134|Pharmacodynamics|pharmacodynamics
670093|NCT00849134|Safety|safety
670094|NCT00849134|Food Effect|food effect
670095|NCT00849134|Pharmacokinetics|pharmacokinetics
670096|NCT00849134|Healthy Volunteers|healthy volunteers
670097|NCT00849147|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
670098|NCT00849147|Acute Myelogenous Leukemia|acute myelogenous leukemia
670099|NCT00849147|Mantel-Cell Lymphoma|mantel-cell lymphoma
670100|NCT00849147|Hematopoietic Transplant|hematopoietic transplant
670101|NCT00849147|Haplo-Identical Transplant|haplo-identical transplant
670102|NCT00849147|Non-Myeloablative Transplant|non-myeloablative transplant
670103|NCT00849160|Treatment Experienced|treatment experienced
670104|NCT00849173|Endometriosis|endometriosis
670106|NCT00849173|Tubal Ligation|tubal ligation
670107|NCT00849173|Chronic Pelvic Pain|chronic pelvic pain
670108|NCT00849173|Quality of Life|quality of life
670109|NCT00849186|stage I renal cell cancer|stage i renal cell cancer
670110|NCT00849186|stage II renal cell cancer|stage ii renal cell cancer
670111|NCT00849186|stage III renal cell cancer|stage iii renal cell cancer
670112|NCT00849186|stage IV renal cell cancer|stage iv renal cell cancer
670113|NCT00849199|screening|screening
670114|NCT00849199|early detection|early detection
670115|NCT00849199|prevention|prevention
670116|NCT00849199|cancer|cancer
670117|NCT00849199|high risk|high risk
670118|NCT00849199|ovarian cancer|ovarian cancer
670119|NCT00849199|breast cancer|breast cancer
670120|NCT00849212|Seizures|seizures
670121|NCT00849212|epilepsy|epilepsy
670122|NCT00849264|hepatocellular carcinoma|hepatocellular carcinoma
670123|NCT00849264|portal vein tumor thrombus|portal vein tumor thrombus
670124|NCT00849264|surgical comprehensive treatment|surgical comprehensive treatment
670125|NCT00849277|Respiratory Tract Infections|respiratory tract infections
670126|NCT00849277|Influenza, Human|influenza, human
670127|NCT00849277|Probiotics|probiotics
670128|NCT00849303|stroke|stroke
670129|NCT00849303|rehabilitation|rehabilitation
670130|NCT00849303|gait|gait
670131|NCT00849303|timing|timing
670132|NCT00849303|transcranial magnetic stimulation|transcranial magnetic stimulation
670133|NCT00849329|lapatinib (GW572016), subject, pharmacokinetic, esomeprazole, proton-pump inhibitor, drug interaction, Phase 1|lapatinib (gw572016), subject, pharmacokinetic, esomeprazole, proton-pump inhibitor, drug interaction, phase 1
670134|NCT00849381|HPV|hpv
670135|NCT00849381|HPV vaccine|hpv vaccine
670136|NCT00849381|papillomavirus|papillomavirus
670137|NCT00849381|cervical cancer|cervical cancer
670138|NCT00849381|human papillomavirus|human papillomavirus
670139|NCT00849394|bevacizumab|bevacizumab
670140|NCT00849394|proteinuria|proteinuria
670141|NCT00849433|Inflammation|inflammation
670142|NCT00849433|epithelial|epithelial
670143|NCT00849433|integrity|integrity
670144|NCT00849433|ECIS|ecis
670145|NCT00855777|third molar extraction|third molar extraction
670146|NCT00855777|etoricoxib|etoricoxib
670147|NCT00855777|ibuprofen|ibuprofen
670148|NCT00855777|analgesic efficacy|analgesic efficacy
670149|NCT00855777|pain|pain
670150|NCT00855790|evaluate the effectiveness of one bite polypectomy with the RJ3 biopsy forcep versus the RJ4 biopsy forcep|evaluate the effectiveness of one bite polypectomy with the rj3 biopsy forcep versus the rj4 biopsy forcep
670151|NCT00855803|spinal cord metastases|spinal cord metastases
670152|NCT00855803|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
670153|NCT00855803|pain|pain
670338|NCT00856609|Weight Loss|weight loss
670154|NCT00855842|second trimester abortion|second trimester abortion
670155|NCT00855842|labor induction abortion|labor induction abortion
670156|NCT00855842|second trimester medical abortion|second trimester medical abortion
670157|NCT00855842|pregnancy|pregnancy
670158|NCT00855855|Diphtheria|diphtheria
670159|NCT00855855|Tetanus|tetanus
670160|NCT00855855|Pertussis|pertussis
670161|NCT00855855|Poliovirus types 1-3|poliovirus types 1-3
670162|NCT00855855|Haemophilus influenzae type b|haemophilus influenzae type b
670163|NCT00855855|Pentacel®|pentacel®
670164|NCT00855868|Amyloid imaging|amyloid imaging
670165|NCT00855868|Positron Emission Tomography|positron emission tomography
670166|NCT00855868|18F-AV-45|18f-av-45
670167|NCT00855868|florbetapir F 18|florbetapir f 18
670168|NCT00855868|Diagnostic imaging|diagnostic imaging
670169|NCT00855881|adjuvant chemotherapy for head and neck cancer|adjuvant chemotherapy for head and neck cancer
670170|NCT00855894|Tarceva|tarceva
670171|NCT00855894|NSCLC|nsclc
670172|NCT00855907|IBD|ibd
670173|NCT00855907|inflammatory bowel disease|inflammatory bowel disease
670174|NCT00855907|fatty liver|fatty liver
670175|NCT00855920|Metabolism, Inborn Errors|metabolism, inborn errors
670176|NCT00855920|Allopurinol|allopurinol
670177|NCT00855920|Metabolic Diseases|metabolic diseases
670178|NCT00855920|Genetic Diseases, Inborn|genetic diseases, inborn
670363|NCT00856791|Cisplatin|cisplatin
670179|NCT00855920|Musculoskeletal Diseases|musculoskeletal diseases
670180|NCT00855920|Joint Diseases|joint diseases
670181|NCT00855920|Arthritis|arthritis
670182|NCT00855920|Rheumatic Diseases|rheumatic diseases
670183|NCT00855920|Metabolic disorder|metabolic disorder
670184|NCT00855920|Purine-Pyrimidine Metabolism, Inborn Errors|purine-pyrimidine metabolism, inborn errors
670186|NCT00855920|Flare|flare
670187|NCT00855946|tumor response|tumor response
670188|NCT00855946|rectal adenocarcinoma|rectal adenocarcinoma
670189|NCT00855946|preoperative radiochemotherapy|preoperative radiochemotherapy
670190|NCT00855946|Proteomic analysis|proteomic analysis
670191|NCT00855946|MALDI-TOF-TOF|maldi-tof-tof
751813|NCT01170598|exercise|exercise
670192|NCT00855946|rectal adenocarcinoma, tumor response after preoperative radiochemotherapy|rectal adenocarcinoma, tumor response after preoperative radiochemotherapy
670193|NCT00855959|Asthma|asthma
670194|NCT00855959|Pulmicort Respules|pulmicort respules
670195|NCT00855985|Pancreatic anastomosis|pancreatic anastomosis
670196|NCT00855985|Whipple operation|whipple operation
670197|NCT00855998|Thymidine Kinase 1|thymidine kinase 1
670198|NCT00855998|BRCA1 and BRCA2 mutations|brca1 and brca2 mutations
670199|NCT00855998|hereditary breast/ovarian cancer|hereditary breast/ovarian cancer
670200|NCT00856050|estrogen receptor positive|estrogen receptor positive
670201|NCT00856050|progesterone receptor positive|progesterone receptor positive
670202|NCT00856050|letrozole|letrozole
670203|NCT00856063|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
670204|NCT00856063|Atomoxetine|atomoxetine
670205|NCT00856063|Electrodermal Response|electrodermal response
670206|NCT00856063|Impulsivity|impulsivity
670207|NCT00856063|Preschool Children|preschool children
670208|NCT00856076|Venous thromboembolism|venous thromboembolism
670209|NCT00856076|Intrauterine fetal death|intrauterine fetal death
670210|NCT00856076|Risk factor|risk factor
670211|NCT00856076|Thrombophilia|thrombophilia
670212|NCT00856076|Venous thromboembolism (in pregnancy)|venous thromboembolism (in pregnancy)
670213|NCT00856193|COPD|copd
670214|NCT00856193|Bronchodilator|bronchodilator
670215|NCT00856206|Metabolism, Inborn Errors|metabolism, inborn errors
670216|NCT00856206|Allopurinol|allopurinol
670217|NCT00856206|Metabolic Disease|metabolic disease
670218|NCT00856206|Genetic Diseases, Inborn|genetic diseases, inborn
670219|NCT00856206|Musculoskeletal Diseases|musculoskeletal diseases
670220|NCT00856206|Joint Diseases|joint diseases
670221|NCT00856206|Arthritis|arthritis
670222|NCT00856206|Rheumatic Diseases|rheumatic diseases
670223|NCT00856206|Metabolic disorder|metabolic disorder
670224|NCT00856206|Purine Pyrimidine Metabolism, Inborn Errors|purine pyrimidine metabolism, inborn errors
670225|NCT00856206|Gout|gout
670226|NCT00856206|Intercritical Gout|intercritical gout
670227|NCT00856219|Immune System|immune system
670228|NCT00856232|Headache|headache
670229|NCT00856232|Cephalgia|cephalgia
670230|NCT00856232|Migraine|migraine
670231|NCT00856245|non-Hodgkins|non-hodgkins
670232|NCT00856245|lymphoma|lymphoma
670233|NCT00856245|stem cell transplant|stem cell transplant
670234|NCT00856258|Multiple dose in healthy volunteers|multiple dose in healthy volunteers
670235|NCT00856284|Diabetes Mellitus|diabetes mellitus
670236|NCT00856284|Drug Therapy|drug therapy
670237|NCT00856284|Hyperinsulinism|hyperinsulinism
670238|NCT00856284|Hyperglycemia|hyperglycemia
670239|NCT00856284|Glucose Intolerance|glucose intolerance
670240|NCT00856297|Meningococcal|meningococcal
670241|NCT00856297|ACWY|acwy
670242|NCT00856297|Conjugate Vaccine|conjugate vaccine
670243|NCT00856297|Meningitis|meningitis
670244|NCT00856297|Adolescents|adolescents
670245|NCT00856297|Persistence|persistence
670246|NCT00856310|Healthy volunteers|healthy volunteers
670247|NCT00856323|Methamphetamine|methamphetamine
670249|NCT00856323|Post-exposure prophylaxis|post-exposure prophylaxis
670250|NCT00856323|HIV seronegativity|hiv seronegativity
670251|NCT00856349|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
670252|NCT00856349|Cardiac Resynchronization Therapy-Defibrillator (CRT-D)|cardiac resynchronization therapy-defibrillator (crt-d)
670253|NCT00856349|Lead Integrity Alert (LIA)|lead integrity alert (lia)
670254|NCT00856349|Therapy Programming Report (TPR)|therapy programming report (tpr)
670255|NCT00856362|Healthy Subjects|healthy subjects
670256|NCT00856375|colorectal cancer|colorectal cancer
670257|NCT00856375|Colorectal cancer, second line|colorectal cancer, second line
670258|NCT00856401|hypoparathyroidism|hypoparathyroidism
670259|NCT00856401|hypopara|hypopara
670260|NCT00856401|PTH|pth
670261|NCT00856401|parathyroid hormone|parathyroid hormone
670262|NCT00856401|CL-11-040|cl-11-040
670263|NCT00856401|CL1-11 Study|cl1-11 study
670264|NCT00856401|NPSP 558|npsp 558
670265|NCT00856401|RELAY|relay
670266|NCT00856401|RACE|race
670267|NCT00856401|REPLACE|replace
670268|NCT00856401|HEXT|hext
670269|NCT00856401|c10-007|c10-007
670270|NCT00856401|c10-008|c10-008
670271|NCT00856401|NPSP558|npsp558
670272|NCT00856401|Columbia study|columbia study
670273|NCT00856401|Columbia studies|columbia studies
670274|NCT00856401|HPTH|hpth
670275|NCT00856401|PTH1-84|pth1-84
670364|NCT00856791|Carboplatin|carboplatin
670276|NCT00856427|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
670277|NCT00856427|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
670278|NCT00856427|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
670279|NCT00856427|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
670280|NCT00856427|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
670281|NCT00856427|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
670283|NCT00856453|fatigue|fatigue
670284|NCT00856453|depression|depression
670285|NCT00856453|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
670286|NCT00856453|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
670287|NCT00856453|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
670288|NCT00856453|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
670289|NCT00856453|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
670290|NCT00856453|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
670291|NCT00856453|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
670292|NCT00856453|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
670293|NCT00856453|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
670294|NCT00856453|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
670295|NCT00856479|Infuse|infuse
670296|NCT00856479|cost analysis|cost analysis
670297|NCT00856479|Non union diaphyseal fracture|non union diaphyseal fracture
670298|NCT00856479|The efficacy of Infuse BMP 2 in Non union diaphyseal fractures. Also the cost analysis with the amount of time spent in hospital post op.|the efficacy of infuse bmp 2 in non union diaphyseal fractures. also the cost analysis with the amount of time spent in hospital post op.
670299|NCT00856492|inflammatory breast cancer|inflammatory breast cancer
670300|NCT00856492|stage II breast cancer|stage ii breast cancer
670301|NCT00856492|stage IIIA breast cancer|stage iiia breast cancer
670302|NCT00856492|stage IIIB breast cancer|stage iiib breast cancer
670303|NCT00856492|HER2-negative breast cancer|her2-negative breast cancer
670304|NCT00856492|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
670305|NCT00856492|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
670306|NCT00856492|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
670307|NCT00856492|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
670308|NCT00856492|stage IIIC breast cancer|stage iiic breast cancer
670309|NCT00856505|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
670310|NCT00856505|Drug Therapy, Combination|drug therapy, combination
670311|NCT00856505|Immunosuppression|immunosuppression
670312|NCT00856518|Multiple Sclerosis|multiple sclerosis
670313|NCT00856518|Parkinson's disease|parkinson's disease
670314|NCT00856518|Dysphagia|dysphagia
670315|NCT00856531|Möbius syndrome|möbius syndrome
670316|NCT00856531|Language|language
670317|NCT00856531|Speech, Language and Hearing Sciences|speech, language and hearing sciences
670318|NCT00856544|Arthritis|arthritis
670319|NCT00856544|Rheumatoid|rheumatoid
670320|NCT00856544|Antirheumatic Agents|antirheumatic agents
670321|NCT00856544|Clinical Trial|clinical trial
670322|NCT00856557|Patients with complex psychosocial needs|patients with complex psychosocial needs
670323|NCT00856570|YM178|ym178
670324|NCT00856570|Mirabegron|mirabegron
670326|NCT00856570|Phase I|phase i
670327|NCT00856570|Warfarin|warfarin
670328|NCT00856570|Pharmacokinetics|pharmacokinetics
670329|NCT00856596|Tinea pedis|tinea pedis
670330|NCT00856596|Fungus|fungus
670331|NCT00856596|Pruritus|pruritus
670332|NCT00856596|Dermatophyte|dermatophyte
670333|NCT00856596|Athlete's foot|athlete's foot
670334|NCT00856596|Dermatomycosis|dermatomycosis
670335|NCT00856596|Skin manifestation|skin manifestation
670336|NCT00856596|Infectious skin disease|infectious skin disease
670337|NCT00856596|Foot diseases|foot diseases
670339|NCT00856609|Byetta (Exenatide)|byetta (exenatide)
670340|NCT00856609|Energy Expenditure|energy expenditure
670341|NCT00856609|Obesity|obesity
670342|NCT00856609|Food Intake|food intake
670343|NCT00856622|open-angle glaucoma ocular hypertension glaucoma|open-angle glaucoma ocular hypertension glaucoma
670344|NCT00856661|Acute ischemic stroke|acute ischemic stroke
670345|NCT00856661|Angiography|angiography
670346|NCT00856661|Desmoteplase|desmoteplase
670347|NCT00856661|Thrombolytic|thrombolytic
670348|NCT00856674|IgA nephropathy|iga nephropathy
670349|NCT00856674|chemokine fusion protein|chemokine fusion protein
670350|NCT00856674|leukocyte population modulator|leukocyte population modulator
670351|NCT00856674|phase-1|phase-1
670352|NCT00856687|Asthma Allergen Challenge|asthma allergen challenge
670353|NCT00856700|GLP-1|glp-1
670354|NCT00856700|Endothelial Function|endothelial function
670355|NCT00856700|Metabolic Syndrome|metabolic syndrome
670356|NCT00856739|obesity|obesity
670357|NCT00856739|arthritis|arthritis
670358|NCT00856778|Male sling|male sling
670359|NCT00856778|stress urinary incontinence|stress urinary incontinence
670360|NCT00856778|urinary incontinence|urinary incontinence
670361|NCT00856791|Ovarian|ovarian
670362|NCT00856791|Cancer|cancer
670367|NCT00856804|Interferon resistance|interferon resistance
670368|NCT00856804|Immunomodulators|immunomodulators
670369|NCT00856830|Small cell lung cancer|small cell lung cancer
670370|NCT00856830|Chemonaive|chemonaive
670371|NCT00856830|Bendamustine|bendamustine
670372|NCT00856830|Irinotecan|irinotecan
670373|NCT00856830|Etoposide|etoposide
670374|NCT00856830|Carboplatin|carboplatin
670375|NCT00856843|colonoscopy|colonoscopy
670376|NCT00856843|bowel preparation|bowel preparation
670377|NCT00856856|Bioabsorbable|bioabsorbable
670378|NCT00856856|Coronary Stent|coronary stent
670379|NCT00856856|Everolimus|everolimus
670380|NCT00856856|drug eluting stents|drug eluting stents
670381|NCT00856856|stents|stents
670383|NCT00856856|coronary artery disease|coronary artery disease
670384|NCT00856856|total coronary occlusion|total coronary occlusion
670385|NCT00856856|coronary artery restenosis|coronary artery restenosis
670386|NCT00856856|stent thrombosis|stent thrombosis
670387|NCT00856856|vascular disease|vascular disease
670388|NCT00856856|myocardial ischemia|myocardial ischemia
670389|NCT00856856|coronary artery stenosis|coronary artery stenosis
670391|NCT00856856|CAOD|caod
670392|NCT00856895|Improved Life Quality|improved life quality
670393|NCT00856908|Type II Diabetes|type ii diabetes
670394|NCT00856921|Relationship between achalasia and AAAS gene|relationship between achalasia and aaas gene
670395|NCT00856934|Skin graft donor site healing|skin graft donor site healing
670396|NCT00856934|skin|skin
670397|NCT00856934|wound|wound
670398|NCT00856934|platelet concentrate|platelet concentrate
670399|NCT00856934|keratinocytes|keratinocytes
670400|NCT00856934|burns|burns
670401|NCT00856947|wheeze|wheeze
670402|NCT00856947|infections|infections
670403|NCT00856947|allergy|allergy
670404|NCT00856947|eczema|eczema
670405|NCT00856947|vitamin D|vitamin d
670406|NCT00856973|Hypnotic|hypnotic
670407|NCT00856973|Eszopiclone|eszopiclone
670408|NCT00856973|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
670409|NCT00856973|Insomnia|insomnia
670410|NCT00856973|Children|children
670411|NCT00856973|Adolescent|adolescent
670412|NCT00856973|Polysomnography|polysomnography
670413|NCT00856973|Actigraphy|actigraphy
670414|NCT00856999|Glabellar lines of moderate severity at maximum frown|glabellar lines of moderate severity at maximum frown
670415|NCT00857012|Primary early MCa|primary early mca
670416|NCT00857012|Arimidex|arimidex
670417|NCT00857025|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
670418|NCT00857025|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
670419|NCT00857025|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
670420|NCT00857025|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
670421|NCT00857038|COPD|copd
670422|NCT00857038|Inflammation|inflammation
670423|NCT00857038|Neutrophilic|neutrophilic
670424|NCT00857038|Myeloperoxidase|myeloperoxidase
670425|NCT00857038|Doxycycline|doxycycline
670426|NCT00857051|Stress|stress
670427|NCT00857064|Schizophrenia|schizophrenia
670428|NCT00857064|antipsychotics|antipsychotics
670429|NCT00857064|social functioning|social functioning
670430|NCT00857064|subjective well being|subjective well being
670431|NCT00857064|Patients suffering from Schizophrenia|patients suffering from schizophrenia
670432|NCT00857077|incidence of anaemia|incidence of anaemia
670433|NCT00857090|Urinary Calculi|urinary calculi
670434|NCT00857090|Urinary Stones|urinary stones
670435|NCT00857090|Urinary Tract Stones|urinary tract stones
670436|NCT00857090|Renal Calculi|renal calculi
670437|NCT00857090|Kidney Stones|kidney stones
670438|NCT00857090|Calculi|calculi
670439|NCT00857090|Urolithotomy|urolithotomy
670440|NCT00857090|Ureteroscopy|ureteroscopy
670441|NCT00857103|computer support|computer support
670442|NCT00857103|patient-provider communication|patient-provider communication
670443|NCT00857103|patient-centered care|patient-centered care
670444|NCT00857103|cancer|cancer
670445|NCT00857116|Deworming|deworming
670446|NCT00857116|Tuberculosis|tuberculosis
670447|NCT00857116|TB-score|tb-score
670448|NCT00857116|Albendazole|albendazole
670449|NCT00857116|Helminths|helminths
670450|NCT00857129|"normal birth"|"normal birth"
670451|NCT00857129|"birth outcome"|"birth outcome"
670452|NCT00857129|"low risk birth"|"low risk birth"
670453|NCT00857129|"low risk units"|"low risk units"
670454|NCT00857129|If type of birth care unit have effect on birth outcome|if type of birth care unit have effect on birth outcome
670455|NCT00857129|Apgar score|apgar score
670456|NCT00857129|breast feeding frequency|breast feeding frequency
670457|NCT00857129|patient satisfaction|patient satisfaction
670458|NCT00857155|Coronary Artery Disease|coronary artery disease
670459|NCT00857155|CABG|cabg
670460|NCT00857155|Clopidogrel|clopidogrel
670461|NCT00857155|Aspirin|aspirin
670462|NCT00857155|Point of Care devices|point of care devices
670463|NCT00857181|Liver Cirrhosis|liver cirrhosis
670464|NCT00857181|Infection|infection
670465|NCT00857181|Inflammation|inflammation
670466|NCT00857181|Cytokines|cytokines
670467|NCT00857194|Coronary Heart Disease|coronary heart disease
670468|NCT00857194|spinal cord injury|spinal cord injury
670469|NCT00857194|risk factor|risk factor
670470|NCT00857194|postprandial lipemia|postprandial lipemia
670471|NCT00857207|Cognitive Therapy|cognitive therapy
670472|NCT00857207|Outcomes Assessment|outcomes assessment
670473|NCT00857220|Hypnotic|hypnotic
670474|NCT00857220|Eszopiclone|eszopiclone
670475|NCT00857220|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
670476|NCT00857220|Insomnia|insomnia
670477|NCT00857220|Children|children
670478|NCT00857220|Adolescent|adolescent
670479|NCT00857233|Alzheimer's Disease|alzheimer's disease
670480|NCT00857246|stomach cancer|stomach cancer
670481|NCT00857246|biologics|biologics
670482|NCT00857246|antibody|antibody
670483|NCT00857246|chemotherapy|chemotherapy
670484|NCT00857246|chemoradiation|chemoradiation
670485|NCT00857246|adjuvant therapy|adjuvant therapy
670486|NCT00857246|neoadjuvant therapy|neoadjuvant therapy
670487|NCT00857246|epidermal growth factor receptor|epidermal growth factor receptor
670488|NCT00857246|combination therapy|combination therapy
670490|NCT00857259|macular degeneration|macular degeneration
670491|NCT00857259|Everolimus|everolimus
670492|NCT00857259|Lucentis|lucentis
670493|NCT00857259|Ranibizumab|ranibizumab
670494|NCT00857259|Choroidal Neo-Vascular (CNV) age-onset macular degeneration|choroidal neo-vascular (cnv) age-onset macular degeneration
670495|NCT00857259|Age-related Macular Degeneration (AMD)|age-related macular degeneration (amd)
670496|NCT00857272|colonoscopy|colonoscopy
670497|NCT00857272|bowel preparation|bowel preparation
670498|NCT00857298|HIV|hiv
670499|NCT00857298|Metabolic Syndrome|metabolic syndrome
670500|NCT00857298|Obesity|obesity
670501|NCT00857298|Treatment Experienced|treatment experienced
670502|NCT00857324|Refractory or relapsed patients|refractory or relapsed patients
670503|NCT00857324|dose-finding|dose-finding
670504|NCT00857324|Vorinostat|vorinostat
670505|NCT00857350|HIV|hiv
670506|NCT00857350|resistance|resistance
670507|NCT00857350|opioid dependence|opioid dependence
670508|NCT00857363|capsule|capsule
670509|NCT00857363|constipation|constipation
670510|NCT00857363|whole gut transit|whole gut transit
670511|NCT00857363|colonic transit|colonic transit
670512|NCT00857363|gastric emptying|gastric emptying
670513|NCT00857363|small bowel transit|small bowel transit
670514|NCT00857376|Heart disease risk factors|heart disease risk factors
670515|NCT00857376|Risk factor management|risk factor management
670516|NCT00857376|Pre-Diabetes|pre-diabetes
670517|NCT00857376|Hypertension|hypertension
670518|NCT00857376|obesity|obesity
670815|NCT00858572|STA-9090|sta-9090
670519|NCT00857376|glucose intolerance|glucose intolerance
670520|NCT00857376|high cholesterol|high cholesterol
670521|NCT00857376|abdominal obesity|abdominal obesity
670522|NCT00857376|enlarged waist|enlarged waist
670523|NCT00857389|Cancer|cancer
670524|NCT00857389|Blood And Marrow Transplantation|blood and marrow transplantation
670525|NCT00857389|Stem Cell|stem cell
670526|NCT00857389|Leukemia|leukemia
670527|NCT00857389|Lymphoma|lymphoma
670528|NCT00857389|Pediatrics|pediatrics
670529|NCT00857389|Bone marrow|bone marrow
670530|NCT00857389|Lymph node system|lymph node system
670531|NCT00857389|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
670532|NCT00857389|ASCT|asct
670533|NCT00857389|Busulfan|busulfan
670534|NCT00857389|Busulfex|busulfex
670535|NCT00857389|Myleran|myleran
670536|NCT00857389|Clofarabine|clofarabine
670537|NCT00857389|Clofarex|clofarex
670538|NCT00857389|Clolar|clolar
670539|NCT00857389|Thiotepa|thiotepa
670540|NCT00857389|Antithymocyte globulin|antithymocyte globulin
670541|NCT00857389|ATG|atg
670542|NCT00857389|Thymoglobulin|thymoglobulin
670543|NCT00857389|G-CSF|g-csf
670544|NCT00857389|Filgrastim|filgrastim
670545|NCT00857389|Neupogen|neupogen
670546|NCT00857389|Cyclophosphamide|cyclophosphamide
670547|NCT00857389|Cytoxan|cytoxan
670548|NCT00857389|Neosar|neosar
670549|NCT00857389|Mesna|mesna
670550|NCT00857389|Mesnex|mesnex
670551|NCT00857389|Tacrolimus|tacrolimus
670552|NCT00857389|Prograf|prograf
670553|NCT00857389|Methotrexate|methotrexate
670554|NCT00857402|Arginine|arginine
670555|NCT00857402|Nitric oxide|nitric oxide
670556|NCT00857402|Peanuts|peanuts
670557|NCT00857402|Sedimentation rate|sedimentation rate
670558|NCT00857415|florbetapir F 18 PET|florbetapir f 18 pet
670559|NCT00857415|amyloid imaging|amyloid imaging
670560|NCT00857415|Amyloid pathology in the brain|amyloid pathology in the brain
670561|NCT00857506|Cognitive outcome|cognitive outcome
670562|NCT00857506|18F-AV-45 PET scan|18f-av-45 pet scan
670563|NCT00857506|Amyloid PET scan|amyloid pet scan
670564|NCT00857506|Florbetapir F 18 amyloid PET scan|florbetapir f 18 amyloid pet scan
670565|NCT00857506|Normal cognition|normal cognition
670566|NCT00857506|Change in cognitive status in relation to brain amyloid on PET|change in cognitive status in relation to brain amyloid on pet
670567|NCT00857519|retinoblastoma|retinoblastoma
670568|NCT00857519|Intraarterial|intraarterial
670760|NCT00858351|Thermal|thermal
670569|NCT00857519|Chemotherapy|chemotherapy
670570|NCT00857519|Melphalan|melphalan
670571|NCT00857519|Carboplatin|carboplatin
670572|NCT00857532|amyloid burden|amyloid burden
670573|NCT00857532|Parkinson's disease|parkinson's disease
670574|NCT00857532|florbetapir PET|florbetapir pet
670575|NCT00857532|amyloid PET imaging|amyloid pet imaging
670576|NCT00857571|Dose Response Bioavailability Study|dose response bioavailability study
670577|NCT00857584|Bipolar disorder|bipolar disorder
670578|NCT00857584|Bipolar depression|bipolar depression
670579|NCT00857584|quetiapine|quetiapine
670580|NCT00857584|sertraline|sertraline
670581|NCT00857597|GERD|gerd
670582|NCT00857597|endoscopic|endoscopic
670583|NCT00857597|fundoplication|fundoplication
670584|NCT00857597|Proton Pump Inhibitors|proton pump inhibitors
670585|NCT00857597|heartburn|heartburn
670586|NCT00857597|anti-reflux surgery|anti-reflux surgery
670587|NCT00857610|Aged skin|aged skin
670588|NCT00857610|Photoaged skin|photoaged skin
670590|NCT00857610|Topical retinoids|topical retinoids
670591|NCT00857623|Pain|pain
670592|NCT00857623|Diabetic Neuropathy|diabetic neuropathy
670594|NCT00857623|Analgesia|analgesia
670595|NCT00857623|Efficacy|efficacy
670596|NCT00857636|Ethnic minority women|ethnic minority women
670597|NCT00857636|Cancer screening|cancer screening
670598|NCT00857636|Health literacy|health literacy
670599|NCT00857636|Behavioral intervention|behavioral intervention
670600|NCT00857636|Breast Cancer screening|breast cancer screening
670601|NCT00857636|Cervical Cancer screening|cervical cancer screening
670602|NCT00857649|Alzheimer's Disease|alzheimer's disease
670603|NCT00857662|US Multicenter|us multicenter
670604|NCT00857662|Randomized|randomized
670605|NCT00857662|Onyx|onyx
670606|NCT00857662|Brain Arteriovenous Malformation (BAVMs)|brain arteriovenous malformation (bavms)
670607|NCT00857675|HBV DNA suppression|hbv dna suppression
670608|NCT00857675|ALT normalisation|alt normalisation
670609|NCT00857675|Viral resistance|viral resistance
670610|NCT00857675|HBeAg seroconversion|hbeag seroconversion
670611|NCT00857688|aphtous|aphtous
670612|NCT00857688|bismuth|bismuth
670613|NCT00857688|procain|procain
670614|NCT00857688|neomycin|neomycin
670615|NCT00857688|Efficacy of the Association in Treatment of Aphtous|efficacy of the association in treatment of aphtous
670616|NCT00857701|total knee arthroplasty|total knee arthroplasty
670617|NCT00857701|Dynamic Splinting|dynamic splinting
670618|NCT00857701|Knee extension|knee extension
670619|NCT00857701|knee|knee
670620|NCT00857701|Reduced knee flexion after total knee arthroscopy|reduced knee flexion after total knee arthroscopy
670621|NCT00857714|DCIS|dcis
670622|NCT00857714|breast|breast
670623|NCT00857727|Dexmedetomidine|dexmedetomidine
670624|NCT00857727|Emergence Delirium|emergence delirium
670625|NCT00857727|Agitation|agitation
670626|NCT00857727|Pediatric|pediatric
670627|NCT00857727|Anesthesia|anesthesia
670628|NCT00857766|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
670629|NCT00857766|arterial stiffness|arterial stiffness
670630|NCT00857766|Computed Tomography|computed tomography
670631|NCT00857766|pulse wave velocity|pulse wave velocity
670632|NCT00857766|Pulse wave analysis|pulse wave analysis
670633|NCT00857779|allergen immunotherapy|allergen immunotherapy
670634|NCT00857779|allergy to grass pollen|allergy to grass pollen
670635|NCT00857792|Coronary Disease|coronary disease
670636|NCT00857792|Cardiac CT Imaging|cardiac ct imaging
670637|NCT00857792|Stress Testing|stress testing
670638|NCT00857792|Lexiscan (regadenoson)|lexiscan (regadenoson)
670639|NCT00857805|Transarterial chemoembolization|transarterial chemoembolization
670640|NCT00857805|Carcinoma, Hepatocellular|carcinoma, hepatocellular
670641|NCT00857805|Proton Beam Radiotherapy|proton beam radiotherapy
670642|NCT00857831|spinal cord injury|spinal cord injury
670643|NCT00857831|Vitamin D deficiency|vitamin d deficiency
670644|NCT00857831|Functional Electrical Stimulation|functional electrical stimulation
670645|NCT00857844|Chronic Nephrotoxicity|chronic nephrotoxicity
670646|NCT00857844|Kidney dysfunction post liver transplant|kidney dysfunction post liver transplant
670647|NCT00857844|Urinary biomarkers of chronic nephrotoxicity from CI|urinary biomarkers of chronic nephrotoxicity from ci
670648|NCT00857857|asthma|asthma
670649|NCT00857857|late phase response|late phase response
670650|NCT00857857|allergen|allergen
670651|NCT00857857|challenge|challenge
670652|NCT00857857|GW870086X|gw870086x
670653|NCT00857883|Obesity|obesity
670654|NCT00857883|Food Effect|food effect
670655|NCT00857883|Pharmacokinetics|pharmacokinetics
670656|NCT00857883|First-Time-In-Humans|first-time-in-humans
670657|NCT00857883|Pharmacodynamics|pharmacodynamics
670658|NCT00857883|Healthy Volunteers|healthy volunteers
670659|NCT00857896|Study of fesoterodine in pediatric overactive bladder patients|study of fesoterodine in pediatric overactive bladder patients
670660|NCT00857922|Neurological|neurological
670661|NCT00857922|Neurosurgical|neurosurgical
670662|NCT00857935|Pediculosis Capitis|pediculosis capitis
670663|NCT00857935|Head Lice|head lice
670664|NCT00857948|head lice|head lice
670665|NCT00857948|Pediculus humanus capitis|pediculus humanus capitis
670666|NCT00857948|ivermectin|ivermectin
670761|NCT00858351|Temperature|temperature
670667|NCT00857974|Physical Activity|physical activity
670668|NCT00857974|Renal Transplant Candidate|renal transplant candidate
670669|NCT00857974|Physical Function|physical function
670670|NCT00857974|Body Composition|body composition
670671|NCT00857987|IRA, Guaifenesin, Etaphedrine, Doxilamine|ira, guaifenesin, etaphedrine, doxilamine
670672|NCT00858000|markers|markers
670673|NCT00858000|expression analysis|expression analysis
670674|NCT00858013|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
670675|NCT00858013|Nateglinide|nateglinide
670676|NCT00858013|Pancreatic beta cell function|pancreatic beta cell function
670677|NCT00858026|weaning|weaning
670678|NCT00858026|breastfeeding|breastfeeding
670679|NCT00858026|infant formula|infant formula
670680|NCT00858026|fermented formula|fermented formula
670681|NCT00858052|breast implants|breast implants
670682|NCT00858052|saline|saline
672155|NCT00866073|AML|aml
670683|NCT00858065|Adolescent alcohol and other drug use|adolescent alcohol and other drug use
670684|NCT00858065|Choice|choice
670685|NCT00858065|Family-based|family-based
670686|NCT00858065|Prevention|prevention
670687|NCT00858078|Qualitative Research|qualitative research
670688|NCT00858078|Semi-Structured Telephone Interview|semi-structured telephone interview
670689|NCT00858078|BRCA 1/2|brca 1/2
670690|NCT00858078|Psychosocial/Behavioral Research|psychosocial/behavioral research
670691|NCT00858078|Hereditary Cancer Risk|hereditary cancer risk
670692|NCT00858078|BRCA|brca
670693|NCT00858078|BRCA1 Gene|brca1 gene
670694|NCT00858078|BRCA2 Gene|brca2 gene
670695|NCT00858117|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
670696|NCT00858117|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
670697|NCT00858117|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
670698|NCT00858117|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
670699|NCT00858117|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
670700|NCT00858130|Veinoplus|veinoplus
670701|NCT00858130|post thrombotic syndrome|post thrombotic syndrome
670702|NCT00858130|deep vein thrombosis|deep vein thrombosis
670703|NCT00858130|electrical muscle stimulator|electrical muscle stimulator
670704|NCT00858130|Venous stasis syndrome|venous stasis syndrome
670705|NCT00858130|venous insufficiency syndrome|venous insufficiency syndrome
670706|NCT00858130|Postphlebitic syndrome|postphlebitic syndrome
670707|NCT00858130|history of deep vein thrombosis|history of deep vein thrombosis
670708|NCT00858143|Open-label, national, prospective, observational, non-interventional, multi-center, post marketing surveillance study|open-label, national, prospective, observational, non-interventional, multi-center, post marketing surveillance study
670709|NCT00858156|Pharmacokinetics|pharmacokinetics
670710|NCT00858169|three-dimensional power Doppler ultrasonography|three-dimensional power doppler ultrasonography
670711|NCT00858169|wrist|wrist
670712|NCT00858169|knee|knee
670713|NCT00858169|rheumatoid arthritis|rheumatoid arthritis
670714|NCT00858182|L-Carnitine|l-carnitine
670715|NCT00858182|Xylitol|xylitol
670716|NCT00858182|Peritoneal Dialysis|peritoneal dialysis
670717|NCT00858195|Anti-inflammatory|anti-inflammatory
670718|NCT00858208|efficacy and safety of Macugen in routine clinical practice|efficacy and safety of macugen in routine clinical practice
670719|NCT00858221|obesity|obesity
670720|NCT00858221|genes|genes
670721|NCT00858221|polymorphisms|polymorphisms
670722|NCT00858221|weight loss|weight loss
670723|NCT00858221|haplotype|haplotype
670724|NCT00858221|diplotype|diplotype
670725|NCT00858247|vitamin D|vitamin d
670726|NCT00858247|Obesity|obesity
670727|NCT00858247|Insulin sensitivity|insulin sensitivity
670728|NCT00858247|Adolescent Obesity|adolescent obesity
670729|NCT00858260|Klotho|klotho
670730|NCT00858260|calcium|calcium
670731|NCT00858260|phosphate|phosphate
670732|NCT00858260|parathormone|parathormone
670733|NCT00858260|survival|survival
670734|NCT00858260|dialysis|dialysis
670735|NCT00858260|Adult patients undergoing maintenance dialysis since at leat three months|adult patients undergoing maintenance dialysis since at leat three months
670736|NCT00858273|Glutathione|glutathione
670737|NCT00858299|proteinuria|proteinuria
670738|NCT00858299|chronic kidney disease|chronic kidney disease
670739|NCT00858299|renin-angiotensin system|renin-angiotensin system
670740|NCT00858299|angiotensinogen|angiotensinogen
670741|NCT00858312|dairy foods|dairy foods
670742|NCT00858312|weight loss|weight loss
670743|NCT00858312|fat loss|fat loss
670744|NCT00858312|metabolic regulation|metabolic regulation
670745|NCT00858325|Cubicin|cubicin
670747|NCT00858325|China Registration|china registration
670748|NCT00858325|Pharmacokinetics|pharmacokinetics
670749|NCT00858338|stomach cancer|stomach cancer
670750|NCT00858338|gastroesophageal junction cancer|gastroesophageal junction cancer
670751|NCT00858338|GEJ cancer|gej cancer
670752|NCT00858338|intraperitoneal|intraperitoneal
670753|NCT00858338|adjuvant chemoradiation therapy|adjuvant chemoradiation therapy
670754|NCT00858338|resection of advanced stomach cancer|resection of advanced stomach cancer
670755|NCT00858338|locally advanced stomach cancer|locally advanced stomach cancer
670756|NCT00858351|Diabetes|diabetes
670757|NCT00858351|Neuropathy|neuropathy
670758|NCT00858351|Peripheral|peripheral
670759|NCT00858351|Painful|painful
670765|NCT00858364|darbepoetin alfa|darbepoetin alfa
670766|NCT00858364|non-small cell lung cancer|non-small cell lung cancer
670767|NCT00858364|Aranesp|aranesp
670768|NCT00858364|chemotherapy|chemotherapy
670769|NCT00858364|chemotherapy induce anemia|chemotherapy induce anemia
670770|NCT00858364|advanced lung cancer|advanced lung cancer
670771|NCT00858364|malignant pleural effusion|malignant pleural effusion
670772|NCT00858364|metastatic lung cancer|metastatic lung cancer
670773|NCT00858364|NSCLC|nsclc
670774|NCT00858364|anemia|anemia
670775|NCT00858364|lung cancer|lung cancer
670776|NCT00858364|pleural effusion|pleural effusion
670777|NCT00858364|Stage IIIB lung cancer|stage iiib lung cancer
670778|NCT00858364|Stage IV lung cancer|stage iv lung cancer
670779|NCT00858377|Amgen|amgen
670780|NCT00858377|Phase 1|phase 1
670781|NCT00858377|First in Human|first in human
670782|NCT00858377|Advanced Solid Tumors|advanced solid tumors
670783|NCT00858377|Clinical Trial|clinical trial
670784|NCT00858377|Aurora kinase inhibitor|aurora kinase inhibitor
670785|NCT00858377|Open-label|open-label
670786|NCT00858377|Oncology|oncology
670787|NCT00858403|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
670788|NCT00858429|advanced adult primary liver cancer|advanced adult primary liver cancer
670789|NCT00858429|liver metastases|liver metastases
670790|NCT00858429|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
670791|NCT00858442|Burn sequelae|burn sequelae
670792|NCT00858442|PRP|prp
670793|NCT00858442|Children|children
670794|NCT00858455|Healthy Volunteers|healthy volunteers
670795|NCT00858455|Drug interation, Pharmacokinetics|drug interation, pharmacokinetics
670796|NCT00858468|Influenza|influenza
670797|NCT00858468|Influenza vaccine|influenza vaccine
670798|NCT00858481|Pediculosis capitis|pediculosis capitis
670799|NCT00858481|Head Lice|head lice
670800|NCT00858494|upper respiratory tract infection|upper respiratory tract infection
670801|NCT00858494|children|children
670802|NCT00858494|homeopathic|homeopathic
670803|NCT00858520|COPD|copd
670804|NCT00858520|Lung cancer|lung cancer
670805|NCT00858520|genes|genes
670806|NCT00858520|DNA|dna
670807|NCT00858533|early intervention|early intervention
670808|NCT00858533|sickness absence|sickness absence
670809|NCT00858533|return to work|return to work
670810|NCT00858533|primary care|primary care
670811|NCT00858559|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
670812|NCT00858559|Remote monitoring|remote monitoring
670813|NCT00858559|Follow-up|follow-up
670814|NCT00858572|Synta|synta
670816|NCT00858572|AML|aml
670817|NCT00858572|CML|cml
670818|NCT00858572|MDS|mds
670819|NCT00858572|myeloproliferative disorder|myeloproliferative disorder
670820|NCT00858572|hematologic malignancy|hematologic malignancy
670821|NCT00858572|ganetespib|ganetespib
670822|NCT00858585|Bone metastasis, SNP concordance|bone metastasis, snp concordance
670823|NCT00858598|Total Knee Arthroplasty|total knee arthroplasty
670824|NCT00858598|Revision|revision
670825|NCT00858598|Tibial|tibial
670826|NCT00858598|Void|void
670827|NCT00858598|Bone Filler|bone filler
670828|NCT00858611|Influenza|influenza
670829|NCT00858611|Healthy|healthy
670830|NCT00858611|Immunity|immunity
670831|NCT00858611|Preventive|preventive
670832|NCT00858611|Flu|flu
670833|NCT00858611|Healthy Volunteer|healthy volunteer
670834|NCT00858611|HV|hv
670835|NCT00858624|Cough|cough
670836|NCT00858624|Cough reflex|cough reflex
670837|NCT00858624|NMDA receptor|nmda receptor
670838|NCT00858624|central sensitisation|central sensitisation
670839|NCT00858637|Chronic Kidney Disease|chronic kidney disease
670840|NCT00858637|Dialysis|dialysis
670841|NCT00858637|Dyslipidemia|dyslipidemia
670842|NCT00858637|Bile acid sequestrant|bile acid sequestrant
670843|NCT00858650|registry|registry
670844|NCT00858650|natural history|natural history
670845|NCT00858663|RAD001(Everolimus)|rad001(everolimus)
670846|NCT00858663|Cisplatin|cisplatin
670847|NCT00858663|08-138|08-138
670848|NCT00858676|acarbose|acarbose
670849|NCT00858676|diabetes mellitus|diabetes mellitus
670850|NCT00858676|impaired glucose tolerance|impaired glucose tolerance
670851|NCT00858676|coronary artery disease|coronary artery disease
670852|NCT00852345|multibacillary leprosy|multibacillary leprosy
670853|NCT00852345|leprosy|leprosy
670854|NCT00852345|clofazamine|clofazamine
670855|NCT00852358|mucopolysaccharidosis|mucopolysaccharidosis
670856|NCT00852358|Hurler-Scheie|hurler-scheie
670857|NCT00852358|Scheie|scheie
670858|NCT00852358|laronidase|laronidase
670859|NCT00852358|cognitive decline|cognitive decline
670860|NCT00852358|central nervous system|central nervous system
670861|NCT00852358|enzyme replacement therapy|enzyme replacement therapy
670862|NCT00852358|intrathecal|intrathecal
670863|NCT00852358|LA Biomed|la biomed
670864|NCT00852371|Malaria|malaria
670865|NCT00852371|Intermittent preventive treatment|intermittent preventive treatment
670866|NCT00852371|Efficacy|efficacy
670867|NCT00852371|Safety|safety
670868|NCT00852371|Tolerability|tolerability
670869|NCT00852371|Schoolchildren|schoolchildren
670870|NCT00852371|Uganda|uganda
670871|NCT00852384|Anesthesia induction|anesthesia induction
670872|NCT00852384|Obese patients|obese patients
670873|NCT00852384|Noninvasive ventilation|noninvasive ventilation
670874|NCT00852384|Alveolar recruitment|alveolar recruitment
670875|NCT00852410|Endoscopic sinus surgery|endoscopic sinus surgery
670876|NCT00852423|Malaria in pregnancy|malaria in pregnancy
670877|NCT00852423|Sub-saharan Africa|sub-saharan africa
670878|NCT00852423|Treatment|treatment
670879|NCT00852423|Artemisinin containing Therapy|artemisinin containing therapy
670880|NCT00852423|Efficacy|efficacy
670882|NCT00852436|neuropathic pain|neuropathic pain
670883|NCT00852436|orofacial pain|orofacial pain
670884|NCT00852436|clinical trials|clinical trials
670885|NCT00852436|pregabalin|pregabalin
670886|NCT00852436|randomized controlled trial|randomized controlled trial
670887|NCT00852449|Intraoperative fluid|intraoperative fluid
670888|NCT00852449|Monitoring|monitoring
670889|NCT00852449|Oesophageal Doppler|oesophageal doppler
670890|NCT00852449|Abdominal surgery|abdominal surgery
670891|NCT00852449|major abdominal surgery|major abdominal surgery
670892|NCT00852462|SAMI|sami
670893|NCT00852462|Symptom Assessment and Management Intervention Program|symptom assessment and management intervention program
670894|NCT00852475|MUFA|mufa
670895|NCT00852475|PUFA|pufa
670896|NCT00852475|MOVE! program|move! program
670897|NCT00852501|Non-functioning pituitary adenoma|non-functioning pituitary adenoma
670898|NCT00852501|RTPCR|rtpcr
670899|NCT00852501|Hormonal receptors|hormonal receptors
670900|NCT00852514|Bioimpedance|bioimpedance
670901|NCT00852514|ultrafiltration|ultrafiltration
670902|NCT00852514|blood pressure|blood pressure
670903|NCT00852514|pulse pressure|pulse pressure
670904|NCT00852527|Traumatic Brain Injury|traumatic brain injury
670905|NCT00852527|Screening|screening
670906|NCT00852527|Diagnosis|diagnosis
670907|NCT00852527|Rehabilitation Outcome|rehabilitation outcome
670908|NCT00852540|impetigo|impetigo
670909|NCT00852540|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
670910|NCT00852540|linezolid|linezolid
670911|NCT00852540|secondarily-infected traumatic lesion|secondarily-infected traumatic lesion
670912|NCT00852540|uncomplicated skin infection|uncomplicated skin infection
670913|NCT00852540|retapamulin|retapamulin
670914|NCT00852553|intestinal|intestinal
670915|NCT00852553|smooth|smooth
670916|NCT00852553|muscle|muscle
670917|NCT00852553|GI|gi
670918|NCT00852553|motility|motility
670919|NCT00852566|Chronic myeloid leukemia|chronic myeloid leukemia
670920|NCT00852566|tyrosine kinase inhibitor|tyrosine kinase inhibitor
670921|NCT00852566|stem cell|stem cell
670922|NCT00852566|Philadelphia chromosome|philadelphia chromosome
670923|NCT00852566|dasatinib|dasatinib
670925|NCT00852579|Smoker|smoker
670926|NCT00852579|Macrolide|macrolide
670927|NCT00852592|Bipolar Disorder Depression Midday Light Therapy|bipolar disorder depression midday light therapy
670928|NCT00852592|Bipolar Disorder Type I or II|bipolar disorder type i or ii
670929|NCT00852605|Acute Lung Injury after allogeneic transplantation|acute lung injury after allogeneic transplantation
670930|NCT00852618|HIV Integrase Inhibitors|hiv integrase inhibitors
670931|NCT00852618|HIV Nucleoside Reverse Transcriptase Inhibitors|hiv nucleoside reverse transcriptase inhibitors
670932|NCT00852618|Treatment Naive|treatment naive
670933|NCT00852618|Viral Load|viral load
670934|NCT00852631|Quetiapine efficacy in schizophrenia|quetiapine efficacy in schizophrenia
670935|NCT00852644|stage I non-small cell lung cancer|stage i non-small cell lung cancer
670936|NCT00852644|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
670937|NCT00852657|Rotator cuff tear|rotator cuff tear
670938|NCT00852657|surgical repair|surgical repair
670939|NCT00852657|Physiotherapy|physiotherapy
670940|NCT00852657|Treatment benefit|treatment benefit
670941|NCT00852657|Surgery|surgery
670942|NCT00852696|Overactive Bladder|overactive bladder
670943|NCT00852696|Incontinence|incontinence
670944|NCT00852696|Solifenacin|solifenacin
670945|NCT00852696|Women|women
670946|NCT00852696|Postoperative|postoperative
671035|NCT00853021|recurrent renal cell cancer|recurrent renal cell cancer
670947|NCT00852709|Myelodysplastic syndrome that has transformed to AML (AML/MDS)|myelodysplastic syndrome that has transformed to aml (aml/mds)
670948|NCT00852709|Treatment-related AML|treatment-related aml
670949|NCT00852709|AML evolving from myeloproliferative disorders (MPD)|aml evolving from myeloproliferative disorders (mpd)
670950|NCT00852709|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
670951|NCT00852709|Acute promyelocytic leukemia (APL) refractory to arsenic therapy or retinoic acid therapy|acute promyelocytic leukemia (apl) refractory to arsenic therapy or retinoic acid therapy
670952|NCT00852709|Relapsed and/or refractory acute leukemia with progressive disease since last therapy|relapsed and/or refractory acute leukemia with progressive disease since last therapy
670953|NCT00852709|Chronic myelogenous leukemia (CML) in accelerated phase or blast crisis refractory to imatinib|chronic myelogenous leukemia (cml) in accelerated phase or blast crisis refractory to imatinib
670954|NCT00852709|High-risk MPD including myelofibrosis, chronic myelomonocytic leukemia (CMML, and relapsed or refractory juvenile myelomonocytic leukemia (JMML).|high-risk mpd including myelofibrosis, chronic myelomonocytic leukemia (cmml, and relapsed or refractory juvenile myelomonocytic leukemia (jmml).
670955|NCT00852722|Multiple sclerosis|multiple sclerosis
670956|NCT00852722|Diet|diet
673131|NCT00871208|pruritus|pruritus
670957|NCT00852735|Cardiovascular diseases|cardiovascular diseases
670958|NCT00852735|Rapeseed oil|rapeseed oil
670959|NCT00852735|Micronutriments|micronutriments
670960|NCT00852735|HDL cholesterol|hdl cholesterol
670961|NCT00852735|Oxidative stress|oxidative stress
670962|NCT00852735|Tocopherols|tocopherols
670963|NCT00852735|Sterols|sterols
670964|NCT00852735|Prevention of cardiovascular diseases|prevention of cardiovascular diseases
670965|NCT00852748|headache|headache
670966|NCT00852761|Psoriasis|psoriasis
670967|NCT00852787|Digoxin like substances|digoxin like substances
670968|NCT00852787|digibind|digibind
670969|NCT00852787|digoxin immune fab|digoxin immune fab
670970|NCT00852787|end-stage-renal-disease|end-stage-renal-disease
670971|NCT00852787|marinobufagenin|marinobufagenin
670972|NCT00852800|spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
670973|NCT00852800|albumin|albumin
670974|NCT00852800|renal impairment|renal impairment
670975|NCT00852800|mortality|mortality
670976|NCT00852813|tolerance|tolerance
670977|NCT00852813|prebiotic|prebiotic
670978|NCT00852813|gastrointestinal effects|gastrointestinal effects
670979|NCT00852826|axillary seroma|axillary seroma
670980|NCT00852826|axillary lymphadenectomy|axillary lymphadenectomy
670981|NCT00852826|morbidity|morbidity
670982|NCT00852826|morbidity postlymphadenectomy|morbidity postlymphadenectomy
670983|NCT00852826|Lymphadenectomy|lymphadenectomy
670984|NCT00852839|Dry mouth|dry mouth
670985|NCT00852839|Sjogren's syndrome|sjogren's syndrome
670986|NCT00852839|Xerostomia|xerostomia
670987|NCT00852852|ESRA-C 2|esra-c 2
670988|NCT00852852|computerized assessment|computerized assessment
670989|NCT00852865|Inflammation|inflammation
670990|NCT00852865|Pain|pain
670991|NCT00852878|Recurrent Abdominal Pain|recurrent abdominal pain
670992|NCT00852878|Biofeedback|biofeedback
670993|NCT00852878|Heart Rate Variability|heart rate variability
670994|NCT00852891|weaning|weaning
670995|NCT00852891|echocardiogram|echocardiogram
670996|NCT00852891|diastolic dysfunction|diastolic dysfunction
670997|NCT00852891|Mechanical ventilation|mechanical ventilation
670998|NCT00852904|Childhood Growth and Development|childhood growth and development
670999|NCT00852904|Genetics|genetics
671000|NCT00852904|Children|children
671001|NCT00852904|Environment|environment
671002|NCT00852904|Longitudinal Study|longitudinal study
671003|NCT00852904|National Children's Study|national children's study
671004|NCT00852917|Pain due to Osteoarthritis of the Knee|pain due to osteoarthritis of the knee
671005|NCT00852930|lymphedema|lymphedema
671006|NCT00852930|quality of life|quality of life
671007|NCT00852930|breast cancer|breast cancer
671008|NCT00852930|symptoms|symptoms
671009|NCT00852930|lymphedema in breast cancer survivors|lymphedema in breast cancer survivors
671010|NCT00852943|Mast Cells|mast cells
671011|NCT00852943|Piebaldism|piebaldism
671012|NCT00852943|Anaphylaxis|anaphylaxis
671013|NCT00852943|Allergy|allergy
671014|NCT00852943|Genetics|genetics
671015|NCT00852956|Betahistine|betahistine
671016|NCT00852956|Olanzapine|olanzapine
671017|NCT00852956|Safety of co-administration of Betahistien and Olanzapine|safety of co-administration of betahistien and olanzapine
671018|NCT00852969|Chronic Kidney Disease|chronic kidney disease
671019|NCT00852969|Niacin|niacin
671020|NCT00852969|HDL|hdl
671021|NCT00852969|Endothelial Function|endothelial function
671022|NCT00852982|Exercise|exercise
671023|NCT00852982|Risk factors|risk factors
671024|NCT00852982|Primary health care|primary health care
671025|NCT00852995|Venous Leg Ulcer (VLU)|venous leg ulcer (vlu)
671026|NCT00852995|Venous Stasis Ulcer (VSU)|venous stasis ulcer (vsu)
671027|NCT00852995|VLU|vlu
671028|NCT00852995|VSU|vsu
671029|NCT00852995|Leg Ulcer|leg ulcer
671030|NCT00852995|Leg Wound|leg wound
671031|NCT00853008|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
671032|NCT00853008|High-Risk (HR)|high-risk (hr)
671033|NCT00853008|Philadelphia Chromosome-Negative|philadelphia chromosome-negative
671034|NCT00853021|clear cell renal cell carcinoma|clear cell renal cell carcinoma
671036|NCT00853021|stage IV renal cell cancer|stage iv renal cell cancer
671037|NCT00853034|gastrointestinal effects|gastrointestinal effects
671038|NCT00853034|prebiotic|prebiotic
671039|NCT00853060|energy expenditure|energy expenditure
671040|NCT00853060|mechanical ventilation|mechanical ventilation
671041|NCT00853060|weaning|weaning
671042|NCT00853060|pressure support ventilation|pressure support ventilation
671043|NCT00853060|T-tube|t-tube
671044|NCT00853073|failing blebs|failing blebs
671045|NCT00853073|failing express shunt|failing express shunt
671046|NCT00853073|avastin|avastin
671047|NCT00853073|bevacizumab|bevacizumab
671048|NCT00853073|glaucoma|glaucoma
671049|NCT00853073|prior trabeculectomy|prior trabeculectomy
671050|NCT00853073|Express shunt placed under a scleral flap|express shunt placed under a scleral flap
671051|NCT00853073|subsequent filtration failure|subsequent filtration failure
671052|NCT00853099|Ulcerative Colitis|ulcerative colitis
671053|NCT00853112|PAH pulmonary hypertension pulmonary arterial hypertension|pah pulmonary hypertension pulmonary arterial hypertension
671054|NCT00853125|clear cell renal cell carcinoma|clear cell renal cell carcinoma
671055|NCT00853125|stage IV renal cell cancer|stage iv renal cell cancer
671056|NCT00853138|cognitive-behavioral therapy|cognitive-behavioral therapy
671057|NCT00853138|chronic pain|chronic pain
671058|NCT00853138|randomized controlled trial|randomized controlled trial
671059|NCT00853138|pediatrics|pediatrics
671060|NCT00853164|prostate cancer|prostate cancer
671061|NCT00853164|aerobic exercise|aerobic exercise
671062|NCT00853164|resistance training|resistance training
671063|NCT00853177|Oocyte retrieval|oocyte retrieval
671064|NCT00853177|pain|pain
671065|NCT00853177|surgery|surgery
671066|NCT00853177|anaesthesiology|anaesthesiology
671067|NCT00853177|Assisted Reproductive Technologies|assisted reproductive technologies
671068|NCT00853190|Healthy Subjects|healthy subjects
671069|NCT00853203|Colorectal Cancer|colorectal cancer
671070|NCT00853203|Rectal Cancer|rectal cancer
671071|NCT00853203|Psychosocial|psychosocial
671072|NCT00853203|Expressive Disclosure|expressive disclosure
671073|NCT00853203|Questionnaires|questionnaires
671074|NCT00853203|Quality of life|quality of life
671075|NCT00853203|QOL|qol
671076|NCT00853203|Electronically Activated Recorder|electronically activated recorder
671077|NCT00853203|EAR|ear
671078|NCT00853216|Healthy Subjects|healthy subjects
671079|NCT00853216|Bioequivalence|bioequivalence
671080|NCT00853229|vulvodynia|vulvodynia
671081|NCT00853229|vulvar vestibulitis|vulvar vestibulitis
671082|NCT00853229|chronic vulvar pain|chronic vulvar pain
671083|NCT00853229|generalized vulvodynia|generalized vulvodynia
671084|NCT00853229|localized vulvodynia|localized vulvodynia
671085|NCT00853242|Chronic Kidney Disease|chronic kidney disease
671086|NCT00853242|Phosphate Binder|phosphate binder
671087|NCT00853242|Phosphate|phosphate
671088|NCT00853242|Hyperphosphatemia|hyperphosphatemia
671089|NCT00853255|Bird Flu|bird flu
671090|NCT00858689|Clinical Drug Trial|clinical drug trial
671091|NCT00858702|Essential hypertension|essential hypertension
671092|NCT00858702|Combination therapy|combination therapy
671093|NCT00858715|Clopidogrel|clopidogrel
671094|NCT00858715|Aspirin|aspirin
671095|NCT00858715|Antithrombotic therapy|antithrombotic therapy
671096|NCT00858715|Platelet function testing|platelet function testing
671097|NCT00858728|Natural killer cell cytotoxicity|natural killer cell cytotoxicity
671098|NCT00858728|Antibody response|antibody response
671099|NCT00858728|Tetanus toxoid vaccination|tetanus toxoid vaccination
671100|NCT00858728|Pneumovax II vaccination|pneumovax ii vaccination
671101|NCT00858728|Total serum immunoglobulins|total serum immunoglobulins
671492|NCT00860925|Clonidine|clonidine
671102|NCT00858728|IgG subclasses|igg subclasses
671103|NCT00858741|bone metastases from any histological subtype.|bone metastases from any histological subtype.
671104|NCT00858754|opioid induced constipation|opioid induced constipation
671105|NCT00858754|Cancer patients|cancer patients
671106|NCT00858754|methylnaltrexone|methylnaltrexone
671107|NCT00858767|vitamin K2|vitamin k2
671108|NCT00858767|absorption|absorption
671109|NCT00858767|efficacy|efficacy
671110|NCT00858793|AIDS|aids
671111|NCT00858793|HIV|hiv
671112|NCT00858793|Lymphoma|lymphoma
671113|NCT00858793|Stem Cell Transplantation|stem cell transplantation
671114|NCT00858793|gene-modified Stem Cells|gene-modified stem cells
671115|NCT00858793|treatment experienced|treatment experienced
671116|NCT00858819|Osteoporosis|osteoporosis
671117|NCT00858819|Fractures|fractures
671118|NCT00858819|Bone Mineral Density|bone mineral density
671119|NCT00858819|Quantitative Computed Tomography|quantitative computed tomography
671120|NCT00858845|Leg Weakness|leg weakness
671121|NCT00858845|Skeletal Myopathy|skeletal myopathy
671122|NCT00858845|Sympathetic Nerve Activity|sympathetic nerve activity
671123|NCT00858884|Systemic lupus erythematosus|systemic lupus erythematosus
671124|NCT00858884|Libman-Sacks endocarditis|libman-sacks endocarditis
671125|NCT00858884|Stroke|stroke
671126|NCT00858884|Transient ischemic attack|transient ischemic attack
671127|NCT00858884|Neuropsychiatric systemic lupus erythematosus|neuropsychiatric systemic lupus erythematosus
671128|NCT00858884|Transesophageal echocardiography|transesophageal echocardiography
671129|NCT00858884|Magnetic resonance imaging|magnetic resonance imaging
671130|NCT00858897|Glutathione|glutathione
671131|NCT00858910|Motor imagery|motor imagery
671132|NCT00858910|Motor skill|motor skill
671133|NCT00858910|Performance improvement|performance improvement
671134|NCT00858923|Extracorporeal Photophoresis|extracorporeal photophoresis
671135|NCT00858923|immuno-therapy|immuno-therapy
671136|NCT00858923|treatment naive|treatment naive
671137|NCT00858936|CABG(coronary artery bypass graft)|cabg(coronary artery bypass graft)
671138|NCT00858936|Ischemia|ischemia
671139|NCT00858936|Heart surgery|heart surgery
671140|NCT00858936|Heart damage|heart damage
671141|NCT00858949|Outpatient surgery|outpatient surgery
671142|NCT00858949|Postoperative nausea and vomiting|postoperative nausea and vomiting
671143|NCT00858949|Costs|costs
671144|NCT00858949|Observational|observational
671145|NCT00858962|HIV|hiv
671146|NCT00858962|Pharmacokinetics|pharmacokinetics
671147|NCT00858962|Pharmacodynamics|pharmacodynamics
671148|NCT00858962|Buprenorphine|buprenorphine
671149|NCT00858962|Raltegravir|raltegravir
673428|NCT00862602|diabetes|diabetes
671150|NCT00858962|HIV seronegativity|hiv seronegativity
671151|NCT00858962|Interaction|interaction
671152|NCT00858975|renal tumor|renal tumor
671153|NCT00858975|cryotherapy|cryotherapy
671154|NCT00858975|cytokine|cytokine
671155|NCT00859365|back pain|back pain
671156|NCT00859365|neck pain|neck pain
671157|NCT00859365|anxiety|anxiety
671158|NCT00859365|range of motion|range of motion
671159|NCT00859378|Hip|hip
671160|NCT00859378|Hip endoprosthesis|hip endoprosthesis
671161|NCT00859378|Hip fracture|hip fracture
671162|NCT00859378|Femoral fracture|femoral fracture
671163|NCT00859378|Bone cement|bone cement
671164|NCT00859378|Non-cemented|non-cemented
671165|NCT00859391|Celiac Disease|celiac disease
671166|NCT00859404|Mild to moderate persistent asthma|mild to moderate persistent asthma
671167|NCT00859417|correction of anterior prolapse|correction of anterior prolapse
671168|NCT00859417|prosthetic trans-obturator way kit|prosthetic trans-obturator way kit
671169|NCT00859417|randomized study|randomized study
671170|NCT00859430|Bioequivalence|bioequivalence
671171|NCT00859430|Healthy Subjects|healthy subjects
671172|NCT00859469|Mesothelioma|mesothelioma
671173|NCT00859482|natalizumab|natalizumab
671174|NCT00859482|multiple sclerosis|multiple sclerosis
671175|NCT00859508|dura repair following cranial surgery|dura repair following cranial surgery
671176|NCT00859521|Bioequivalence|bioequivalence
671177|NCT00859521|Healthy Subjects|healthy subjects
671178|NCT00859534|Solar Urticaria|solar urticaria
671179|NCT00859560|Breast cancer|breast cancer
671180|NCT00859560|post-menopausal women|post-menopausal women
671181|NCT00859560|Arimidex|arimidex
671182|NCT00859560|bone fracture|bone fracture
671183|NCT00859586|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
671184|NCT00859586|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
671185|NCT00859586|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
671186|NCT00859586|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
671187|NCT00859586|Acute Myelogenous Leukemia|acute myelogenous leukemia
671188|NCT00859586|AML|aml
671189|NCT00859586|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
671190|NCT00859586|ALL|all
671191|NCT00859586|Myelodysplastic Syndrome|myelodysplastic syndrome
671192|NCT00859586|MDS|mds
671193|NCT00859599|Monochromatic Phototherapy|monochromatic phototherapy
671194|NCT00859599|Diabetic Foot Ulcers|diabetic foot ulcers
671195|NCT00859599|Wound healing|wound healing
671196|NCT00859599|Bacterial colonisation|bacterial colonisation
671197|NCT00859625|colonoscopy|colonoscopy
671198|NCT00859625|adenoma detection rate|adenoma detection rate
671199|NCT00859651|breast cancer chemoprevention|breast cancer chemoprevention
671200|NCT00859651|vitamin D|vitamin d
671201|NCT00859651|breast density|breast density
671202|NCT00859677|HIV|hiv
671203|NCT00859677|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
671204|NCT00859677|HIV and Staphylococcus aureus infection|hiv and staphylococcus aureus infection
671205|NCT00859690|Obstructive Sleep Apnea|obstructive sleep apnea
671206|NCT00859690|Thrombosis|thrombosis
671207|NCT00859690|Adenosine Deaminase|adenosine deaminase
671208|NCT00859690|Sleep Disorder|sleep disorder
671209|NCT00859703|Aromatase inhibitor treatment|aromatase inhibitor treatment
671210|NCT00859703|osteoporosis|osteoporosis
671211|NCT00859703|breast cancer|breast cancer
671212|NCT00859703|bisphosphonates|bisphosphonates
671213|NCT00859716|Vaccination|vaccination
671214|NCT00859716|Diarrhea|diarrhea
671215|NCT00859716|Traveler's Diarrhea|traveler's diarrhea
671216|NCT00859716|Campylobacter jejuni|campylobacter jejuni
671217|NCT00859716|C. jejuni|c. jejuni
671218|NCT00859716|Campylobacter|campylobacter
671219|NCT00859716|Campy|campy
671220|NCT00859729|DNA|dna
671221|NCT00859729|Vaccine|vaccine
671222|NCT00859729|Electroporation|electroporation
671223|NCT00859729|xenogenic|xenogenic
671224|NCT00859729|PSA|psa
671225|NCT00859768|Cancer|cancer
671226|NCT00859781|Prostate|prostate
671227|NCT00859794|Epilepsy|epilepsy
671228|NCT00859794|fMRI|fmri
671229|NCT00859794|Electrophysiology|electrophysiology
671230|NCT00859794|Cortical Mapping|cortical mapping
671231|NCT00859794|Neurosurgery|neurosurgery
671232|NCT00859807|Amodiaquine suspension|amodiaquine suspension
671233|NCT00859807|Flavoquine tablets|flavoquine tablets
671234|NCT00859807|Bioequivalence study|bioequivalence study
671235|NCT00859833|adenosine|adenosine
671236|NCT00859833|regadenoson|regadenoson
671237|NCT00859833|adenosine receptor subtypes|adenosine receptor subtypes
671238|NCT00859846|Arterial line|arterial line
671239|NCT00859846|Ultrasound|ultrasound
671240|NCT00859846|Anesthesia|anesthesia
671241|NCT00859846|Pediatric|pediatric
671242|NCT00859872|acute psychotic agitation|acute psychotic agitation
671243|NCT00859872|schizophrenia|schizophrenia
671244|NCT00859872|risperidone oral solution|risperidone oral solution
671245|NCT00859872|clonazepam|clonazepam
671246|NCT00859872|haloperidol|haloperidol
671247|NCT00859885|patent foramen ovale|patent foramen ovale
671248|NCT00859885|ischemic stroke|ischemic stroke
671249|NCT00859885|transient ischemic attack|transient ischemic attack
673429|NCT00862602|walking|walking
671250|NCT00859885|secondary prevention|secondary prevention
671251|NCT00859885|medical treatment|medical treatment
671252|NCT00859885|percutaneous device closure|percutaneous device closure
671253|NCT00859898|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
671254|NCT00859898|Diabetes Mellitus|diabetes mellitus
671255|NCT00859898|Endocrine System Diseases|endocrine system diseases
671256|NCT00859898|Glucose Metabolism Disorders|glucose metabolism disorders
671257|NCT00859898|Metabolic Diseases|metabolic diseases
671258|NCT00859898|Metformin|metformin
671259|NCT00859898|Dapagliflozin|dapagliflozin
671260|NCT00859898|Hypoglycemic Agents|hypoglycemic agents
671261|NCT00859898|Pharmacologic Actions|pharmacologic actions
671262|NCT00859898|Physiological Effects of Drugs|physiological effects of drugs
671263|NCT00859911|micronutrients|micronutrients
671264|NCT00859950|Sleep Apnea|sleep apnea
671265|NCT00859950|Vascular Occlusion|vascular occlusion
671266|NCT00859950|Nocturnal Polysomnography|nocturnal polysomnography
671267|NCT00859950|Continuous Positive Airway Pressure|continuous positive airway pressure
671268|NCT00859963|Press fit tibial tray|press fit tibial tray
671269|NCT00859976|BoneMaster|bonemaster
671270|NCT00859976|Total Hip Replacement|total hip replacement
671271|NCT00859976|Bone Density|bone density
671272|NCT00859976|Patients suitable for Total Hip Replacement|patients suitable for total hip replacement
671273|NCT00859989|breast cancer|breast cancer
671274|NCT00859989|weight changes|weight changes
671276|NCT00860002|myomectomy|myomectomy
671277|NCT00860002|uterine artery occlusion|uterine artery occlusion
671278|NCT00860002|uterine vessel occlusion|uterine vessel occlusion
671279|NCT00860002|fibroids|fibroids
671280|NCT00860002|leiomyomas|leiomyomas
671281|NCT00860002|Surgical technique, patient suffering and outcomes|surgical technique, patient suffering and outcomes
671282|NCT00860028|Smoking cessation|smoking cessation
671284|NCT00860028|Tobacco|tobacco
671285|NCT00860028|Varenicline|varenicline
671286|NCT00860028|Alcohol|alcohol
671287|NCT00860041|pain|pain
671288|NCT00860041|neurotoxicity|neurotoxicity
671289|NCT00860041|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
671290|NCT00860041|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
671291|NCT00860054|phytosterols|phytosterols
671292|NCT00860054|cholesterol excretion|cholesterol excretion
671293|NCT00860054|cholesterol absorption|cholesterol absorption
671294|NCT00860054|diet|diet
671295|NCT00860054|mass spectrometry|mass spectrometry
671296|NCT00860054|deuterium|deuterium
671297|NCT00860067|influenza, FluMist, adults, vaccine|influenza, flumist, adults, vaccine
671298|NCT00860080|post-surgery adhesion formation|post-surgery adhesion formation
671299|NCT00860093|Kidney Calculi|kidney calculi
671300|NCT00860093|Urolithiasis|urolithiasis
671301|NCT00860093|Lithotripsy|lithotripsy
671302|NCT00860093|potassium compounds|potassium compounds
671303|NCT00860093|magnesium compounds|magnesium compounds
671305|NCT00860106|VKA treatment|vka treatment
671306|NCT00860106|VKA treatment cessation|vka treatment cessation
671307|NCT00860119|Bioequivalence, Pharmacokinetics, Alprazolam, Sublingual|bioequivalence, pharmacokinetics, alprazolam, sublingual
671308|NCT00860132|hip fracture elderly orthogeriatric|hip fracture elderly orthogeriatric
671309|NCT00860132|cost effectiveness of hip fracture patients|cost effectiveness of hip fracture patients
671310|NCT00860145|epilepsy|epilepsy
671311|NCT00860145|radiosurgery|radiosurgery
671312|NCT00860145|temporal lobectomy|temporal lobectomy
671313|NCT00860184|carotid artery|carotid artery
671314|NCT00860184|atherosclerosis|atherosclerosis
671315|NCT00860184|stroke|stroke
671316|NCT00860184|transient ischemic attack|transient ischemic attack
671317|NCT00860184|MRI|mri
671318|NCT00860184|software|software
671319|NCT00860184|risk|risk
671320|NCT00860197|Coffee|coffee
671321|NCT00860197|Elderly|elderly
671322|NCT00860197|Immune response|immune response
671323|NCT00860197|Inflammatory status|inflammatory status
671324|NCT00860223|Healthy Subjects|healthy subjects
671325|NCT00860236|CFS|cfs
671326|NCT00860236|Giardia|giardia
671327|NCT00860236|Fatigue|fatigue
671328|NCT00860236|Cognitive behavioural therapy|cognitive behavioural therapy
671329|NCT00860236|CBT|cbt
671330|NCT00860236|Chronic fatigue syndrome|chronic fatigue syndrome
671331|NCT00860249|education|education
671332|NCT00860249|preventive service|preventive service
671333|NCT00860249|screening|screening
671334|NCT00860249|Colorectal Cancer Screening|colorectal cancer screening
671335|NCT00860249|Prevention & Control|prevention & control
671336|NCT00860288|Type 2 Diabetes|type 2 diabetes
671337|NCT00860288|vildagliptin|vildagliptin
671338|NCT00860301|infantile colic|infantile colic
671339|NCT00860314|external electrical cardioversion|external electrical cardioversion
671340|NCT00860314|typical atrial flutter|typical atrial flutter
671341|NCT00860314|electrode position|electrode position
671342|NCT00860314|antero-lateral|antero-lateral
671343|NCT00860314|antero-posterior|antero-posterior
671344|NCT00860314|biphasic cardioversion|biphasic cardioversion
671345|NCT00860314|step-up protocol|step-up protocol
671346|NCT00860327|Pediatric Heart Disease|pediatric heart disease
671347|NCT00860327|Congenital Heart Disease|congenital heart disease
671348|NCT00860327|Congenital Heart Defects|congenital heart defects
671349|NCT00860327|Developmental Biology|developmental biology
671350|NCT00860327|Contractile Function|contractile function
671351|NCT00860340|Congestive Heart Failure|congestive heart failure
671352|NCT00860340|Hemodynamics|hemodynamics
671353|NCT00860340|Echocardiographs|echocardiographs
671354|NCT00860353|Healthy Volunteer|healthy volunteer
671355|NCT00860353|Single Ascending Dose|single ascending dose
671356|NCT00860353|Safety|safety
671357|NCT00860353|Tolerability|tolerability
671358|NCT00860353|AZD2551|azd2551
671359|NCT00860353|Healthy Volunteer Study|healthy volunteer study
671360|NCT00860366|Acute ischemic stroke|acute ischemic stroke
671361|NCT00860366|thrombolysis|thrombolysis
671362|NCT00860366|alteplase|alteplase
671363|NCT00860366|uric acid|uric acid
671364|NCT00860366|neuroprotection|neuroprotection
671365|NCT00860366|oxidative stress|oxidative stress
671366|NCT00860418|asthma|asthma
671367|NCT00860418|feedback|feedback
671368|NCT00860418|anti-inflammatory|anti-inflammatory
671369|NCT00860418|ED visits|ed visits
671370|NCT00860444|Primary Care|primary care
671371|NCT00860444|Diet|diet
671372|NCT00860444|Physical Activity|physical activity
671373|NCT00860457|Leukemia|leukemia
671374|NCT00860470|micronutrients|micronutrients
671375|NCT00860470|deficiency|deficiency
671376|NCT00860470|pregnancy|pregnancy
671377|NCT00860470|birth outcomes|birth outcomes
671378|NCT00860470|infant mortality|infant mortality
671379|NCT00860470|neonatal mortality|neonatal mortality
671380|NCT00860470|malnutrition|malnutrition
671381|NCT00860470|antenatal|antenatal
671382|NCT00860483|Comparison of experienced and novice laparoscopic surgeons|comparison of experienced and novice laparoscopic surgeons
671383|NCT00860496|Immunosuppression, JAK3 inhibitor, calcineurin inhibitors, tacrolimus, cyclosporine, pharmacokinetics, safety, tolerability|immunosuppression, jak3 inhibitor, calcineurin inhibitors, tacrolimus, cyclosporine, pharmacokinetics, safety, tolerability
671384|NCT00860509|phytosterols|phytosterols
671385|NCT00860509|cholesterol excretion|cholesterol excretion
671386|NCT00860509|cholesterol absorption|cholesterol absorption
671387|NCT00860509|diet|diet
671388|NCT00860509|mass spectrometry|mass spectrometry
671389|NCT00860509|deuterium|deuterium
671390|NCT00860522|relapsed leukemia|relapsed leukemia
671391|NCT00860522|refractory leukemia|refractory leukemia
671392|NCT00860561|Efficacy profile|efficacy profile
671393|NCT00860561|Safety profile|safety profile
671394|NCT00860561|Faslodex|faslodex
671395|NCT00860587|Antibiotic resistance|antibiotic resistance
671399|NCT00860600|PG2 Treatment|pg2 treatment
671400|NCT00860600|Quality of Life|quality of life
671401|NCT00860600|Fatigue|fatigue
671402|NCT00860600|WHO Bleeding score|who bleeding score
671403|NCT00860613|gestational diabetes|gestational diabetes
671404|NCT00860613|medical nutrition therapy program|medical nutrition therapy program
671405|NCT00860613|glucose monitoring|glucose monitoring
671406|NCT00860613|metabolic control|metabolic control
671407|NCT00860613|nutritional status|nutritional status
671408|NCT00860613|cost effectiveness|cost effectiveness
671410|NCT00860639|gemtuzumab ozogamycin|gemtuzumab ozogamycin
671411|NCT00860652|Oncology|oncology
671412|NCT00860652|Prostate Cancer|prostate cancer
671413|NCT00860652|Radiotherapy|radiotherapy
671414|NCT00860652|Radical Prostatectomy|radical prostatectomy
671415|NCT00860652|Prior Radical Prostatectomy (RP)|prior radical prostatectomy (rp)
671416|NCT00860652|Histological Confirmation of adenocarcinoma of the prostate|histological confirmation of adenocarcinoma of the prostate
671417|NCT00860652|Positive margins and/or extraprostatic extension (EPE)|positive margins and/or extraprostatic extension (epe)
671418|NCT00860665|colorectal cancer|colorectal cancer
671419|NCT00860665|prevention|prevention
671420|NCT00860665|colonoscopy|colonoscopy
671421|NCT00860665|screening|screening
671422|NCT00860665|quality assessment|quality assessment
671423|NCT00860665|colorectal cancer prevention|colorectal cancer prevention
671424|NCT00860691|Curative surgical resection|curative surgical resection
671425|NCT00860691|Laparoscopic technique|laparoscopic technique
671426|NCT00860704|goal directed fluid therapy|goal directed fluid therapy
671427|NCT00860704|lean patients|lean patients
671428|NCT00860704|obese patients|obese patients
671429|NCT00860704|crystalloids|crystalloids
671430|NCT00860704|Esophageal Doppler|esophageal doppler
671431|NCT00860704|tissue oxygenation|tissue oxygenation
671432|NCT00860704|Fluid management during surgery|fluid management during surgery
671433|NCT00860704|Fluid management|fluid management
671434|NCT00860717|Leprosy|leprosy
671435|NCT00860717|Ulcers|ulcers
671436|NCT00860717|Laser|laser
671437|NCT00860730|Aortic valve replacement|aortic valve replacement
671438|NCT00860730|Aortic stenosis|aortic stenosis
671439|NCT00860730|Biological valve|biological valve
671440|NCT00860730|Sutureless valve|sutureless valve
671441|NCT00860730|Stented valve|stented valve
671442|NCT00860730|Aortic Valve Disease|aortic valve disease
671443|NCT00860743|intermittent hypoxia|intermittent hypoxia
671444|NCT00860743|ventilatory long-term facilitation|ventilatory long-term facilitation
671445|NCT00860743|autonomic nervous system plasticity|autonomic nervous system plasticity
671447|NCT00860756|disturbance|disturbance
671448|NCT00860756|deployment|deployment
671449|NCT00860756|intervention|intervention
671450|NCT00860756|actigraph|actigraph
671454|NCT00860795|Echinacea|echinacea
671455|NCT00860795|prevention|prevention
671456|NCT00860795|immune modulation|immune modulation
671457|NCT00860808|tinnitus|tinnitus
671458|NCT00860821|Healthy subjects|healthy subjects
671460|NCT00860821|Effect|effect
671461|NCT00860821|Intranasally|intranasally
671462|NCT00860834|Consumer Participation|consumer participation
671463|NCT00860834|Telephone Coaching Program|telephone coaching program
671464|NCT00860847|Progression of Atherosclerosis|progression of atherosclerosis
671465|NCT00860847|Aged garlic extract|aged garlic extract
671466|NCT00860847|Biomarkers of inflammation|biomarkers of inflammation
671467|NCT00860847|Coronary Plaque Volume and coronary Stenosis|coronary plaque volume and coronary stenosis
671468|NCT00860847|Vascular function|vascular function
671469|NCT00860860|radioimmunotherapy|radioimmunotherapy
671470|NCT00860860|pretargeting|pretargeting
671471|NCT00860860|bispecific antibody|bispecific antibody
671472|NCT00860860|lutetium 177|lutetium 177
671473|NCT00860860|phase I clinical trial|phase i clinical trial
671474|NCT00860886|Mongolia|mongolia
671475|NCT00860886|Asia|asia
671476|NCT00860886|GROWTH FACTORS|growth factors
671477|NCT00860886|Hormones|hormones
671478|NCT00860886|Premenopausal|premenopausal
671479|NCT00860886|Breast Cancer|breast cancer
671480|NCT00860899|clonidine|clonidine
671481|NCT00860899|levobupivacaine|levobupivacaine
671482|NCT00860899|preoperative analgesia|preoperative analgesia
671483|NCT00860899|postoperative pain|postoperative pain
671484|NCT00860899|systemic inflammatory stress response|systemic inflammatory stress response
671485|NCT00860899|epidural analgesia|epidural analgesia
671486|NCT00860899|Anesthetics, Local|anesthetics, local
671487|NCT00860912|Veritas|veritas
671488|NCT00860912|Cystocele|cystocele
671489|NCT00860912|Prolapse|prolapse
671490|NCT00860925|Randomized Controlled Trial|randomized controlled trial
671491|NCT00860925|Blinded|blinded
671493|NCT00860925|acetyl-salicylic acid (ASA)|acetyl-salicylic acid (asa)
671494|NCT00860925|Perioperative vascular complications|perioperative vascular complications
671495|NCT00860925|Noncardiac surgery|noncardiac surgery
671496|NCT00860938|Inhaled corticosteroids|inhaled corticosteroids
671497|NCT00860938|COPD|copd
671498|NCT00860938|mannitol|mannitol
671499|NCT00860951|Normal|normal
671500|NCT00860964|estradiol valerate|estradiol valerate
671501|NCT00860964|Medroxyprogesterone|medroxyprogesterone
671502|NCT00860964|menopause|menopause
671503|NCT00860964|Lipid|lipid
671504|NCT00860964|Bone mineral density|bone mineral density
671505|NCT00860964|Body Composition|body composition
671506|NCT00860977|HIV|hiv
671507|NCT00860977|Herpes simplex virus type II|herpes simplex virus type ii
671508|NCT00860977|Genital herpes|genital herpes
671509|NCT00860977|Treatment Naive|treatment naive
671510|NCT00861003|schizophrenia|schizophrenia
671511|NCT00861003|adherence|adherence
671512|NCT00861016|Post marketing study|post marketing study
671513|NCT00861029|GW786034, pazopanib, moxifloxacin, ECG intervals and morphology, QTc, Holter monitor, pharmacokinetics, safety, cancer|gw786034, pazopanib, moxifloxacin, ecg intervals and morphology, qtc, holter monitor, pharmacokinetics, safety, cancer
671514|NCT00861042|Lacosamide, Vimpat®|lacosamide, vimpat®
671515|NCT00861068|Lacosamide, Vimpat®|lacosamide, vimpat®
671516|NCT00861081|Group Clinics|group clinics
671517|NCT00861081|Self Management|self management
671518|NCT00861094|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
671519|NCT00861094|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
671520|NCT00861094|stage IIA esophageal cancer|stage iia esophageal cancer
671521|NCT00861094|stage IIB esophageal cancer|stage iib esophageal cancer
671522|NCT00861094|stage IIIA esophageal cancer|stage iiia esophageal cancer
671523|NCT00861094|stage IIIB esophageal cancer|stage iiib esophageal cancer
671524|NCT00861094|stage IIIC esophageal cancer|stage iiic esophageal cancer
671525|NCT00861094|stage IV esophageal cancer|stage iv esophageal cancer
671921|NCT00865163|PCI|pci
671526|NCT00861107|Colorectal cancer|colorectal cancer
671527|NCT00861107|Breast Cancer|breast cancer
671528|NCT00861107|Melanoma|melanoma
671529|NCT00861107|GI cancer|gi cancer
671530|NCT00861107|Prostate cancer|prostate cancer
671531|NCT00861107|Kidney cancer|kidney cancer
671532|NCT00861107|Lung cancer|lung cancer
671533|NCT00861107|all types metastatic cancer where at least one tumor lesion is accessable for percutaneous cryoablation|all types metastatic cancer where at least one tumor lesion is accessable for percutaneous cryoablation
671534|NCT00861120|Ovarian cancer|ovarian cancer
671535|NCT00861120|KRAS wildtype|kras wildtype
671536|NCT00861120|Platinum resistant|platinum resistant
671537|NCT00861133|cardiac monitor|cardiac monitor
671538|NCT00861133|loop recorder|loop recorder
671539|NCT00861133|stroke|stroke
671540|NCT00861133|ECG|ecg
671541|NCT00861133|Implantable Loop Recorder|implantable loop recorder
671542|NCT00861133|cryptogenic|cryptogenic
671543|NCT00861133|ILR|ilr
671544|NCT00861146|nicotine dependence|nicotine dependence
671545|NCT00861146|tobacco dependence|tobacco dependence
671546|NCT00861146|smoking cessation|smoking cessation
671547|NCT00861146|alcoholism|alcoholism
671548|NCT00861146|self-efficacy|self-efficacy
671549|NCT00861146|relapse|relapse
671550|NCT00861159|RLIP76 Auto Antibodies|rlip76 auto antibodies
671551|NCT00861172|Multiple sclerosis|multiple sclerosis
671552|NCT00861172|Active plaque|active plaque
671553|NCT00861172|Multimodal analysis|multimodal analysis
671554|NCT00861172|3T MRI|3t mri
671555|NCT00861172|Weekly follow-up|weekly follow-up
671556|NCT00861172|Physiopathology|physiopathology
671557|NCT00861172|Physiopathology of active lesions formation in Multiple Sclerosis using multimodal MR sequences|physiopathology of active lesions formation in multiple sclerosis using multimodal mr sequences
671558|NCT00861185|bronchospasm|bronchospasm
671559|NCT00861185|exercise asthma|exercise asthma
671560|NCT00861185|inflammation|inflammation
671561|NCT00861185|KCa3.1|kca3.1
671562|NCT00861211|asthma|asthma
671563|NCT00861211|inflammation|inflammation
671564|NCT00861211|bronchoconstriction|bronchoconstriction
671565|NCT00861211|allergen challenge|allergen challenge
671566|NCT00861211|KCa3.1|kca3.1
671567|NCT00861237|Nux vomica|nux vomica
671568|NCT00861237|homeopathy|homeopathy
671569|NCT00861237|heart lung machine|heart lung machine
671570|NCT00861237|heart surgery|heart surgery
671571|NCT00861237|postoperatively studied|postoperatively studied
671572|NCT00861250|Bortezomib plus dexamethasone induction therapy|bortezomib plus dexamethasone induction therapy
671573|NCT00861250|Autologous stem cell transplantation|autologous stem cell transplantation
671574|NCT00861250|Molecular remission|molecular remission
671575|NCT00861276|Smoking Cessation|smoking cessation
671576|NCT00861276|Nicotine|nicotine
671577|NCT00861276|Administration and dosage|administration and dosage
671578|NCT00861276|Randomized Controlled Trial|randomized controlled trial
671579|NCT00861315|Pneumonia|pneumonia
671580|NCT00861315|Nebulization|nebulization
671581|NCT00861315|Amikacin|amikacin
671582|NCT00861328|Phase 1|phase 1
671583|NCT00861328|maximum tolerated dose|maximum tolerated dose
671584|NCT00861328|oxaliplatin|oxaliplatin
671585|NCT00861328|irinotecan|irinotecan
671586|NCT00861328|ON 01910.Na|on 01910.na
671587|NCT00861341|Pioglitazone|pioglitazone
671588|NCT00861341|Thiazolidinediones|thiazolidinediones
671589|NCT00861341|Platelet Function|platelet function
671590|NCT00861341|Platelet aggregation|platelet aggregation
671591|NCT00861341|Diabetic|diabetic
671592|NCT00861341|Aspirin.|aspirin.
671593|NCT00861354|atrial fibrillation|atrial fibrillation
671594|NCT00861354|home blood pressure monitoring|home blood pressure monitoring
671595|NCT00861367|aspirin|aspirin
671596|NCT00861367|blood loss|blood loss
671597|NCT00861367|transurethral surgery|transurethral surgery
671598|NCT00861380|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
671599|NCT00861380|Invasive disease|invasive disease
671600|NCT00861380|Respiratory tract infections|respiratory tract infections
671601|NCT00861380|Haemophilus influenzae|haemophilus influenzae
671602|NCT00861380|Streptococcus pneumoniae|streptococcus pneumoniae
671603|NCT00861380|Acute otitis media|acute otitis media
671604|NCT00861380|Pneumonia|pneumonia
671605|NCT00861406|Melanoma|melanoma
671606|NCT00861406|Stage II melanoma|stage ii melanoma
671607|NCT00861406|Pegylated Interferon-alfa 2b|pegylated interferon-alfa 2b
671608|NCT00861406|PEG Interferon alfa-2b|peg interferon alfa-2b
671609|NCT00861406|PEG Intron|peg intron
671610|NCT00861406|Melanoma Peptide Vaccine|melanoma peptide vaccine
671611|NCT00861406|GP100 Vaccine|gp100 vaccine
671612|NCT00861406|gp100|gp100
671613|NCT00861406|peptide vaccine|peptide vaccine
671614|NCT00861406|Leukapheresis|leukapheresis
671615|NCT00861406|Immune-cell response|immune-cell response
671616|NCT00861419|AMG 386|amg 386
671617|NCT00861419|AMG 706|amg 706
671618|NCT00861419|Bevacizumab|bevacizumab
671619|NCT00861419|Sorafenib|sorafenib
671620|NCT00861419|Angiogenesis Inhibitors|angiogenesis inhibitors
671621|NCT00861419|Combination Therapy|combination therapy
671622|NCT00861419|Peptibody|peptibody
671623|NCT00861419|Sunitinib|sunitinib
671624|NCT00861432|Life quality|life quality
671625|NCT00861432|questionnaire|questionnaire
671626|NCT00861432|tumor patients|tumor patients
671627|NCT00861445|Lacosamide, Vimpat®|lacosamide, vimpat®
671628|NCT00861471|hormone refractory prostate cancer|hormone refractory prostate cancer
671629|NCT00861471|tyrosine kinase inhibitor|tyrosine kinase inhibitor
671630|NCT00861471|Gleevec|gleevec
671632|NCT00861471|prostate specific antigen|prostate specific antigen
671633|NCT00861471|growth factor receptor inhibitor|growth factor receptor inhibitor
671634|NCT00861471|androgen independent|androgen independent
671635|NCT00861497|Open-label|open-label
671636|NCT00861497|Flexible-dose|flexible-dose
671637|NCT00861497|Extension|extension
671638|NCT00861497|Safety study|safety study
671639|NCT00861510|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
671640|NCT00861510|Prolymphocytic Lymphoma (PLL)|prolymphocytic lymphoma (pll)
671641|NCT00861510|Hairy Cell Leukemia (HCL)|hairy cell leukemia (hcl)
671642|NCT00861510|Mantle Cell Lymphoma|mantle cell lymphoma
671643|NCT00861510|MCL|mcl
671644|NCT00861510|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
671645|NCT00861510|CLL|cll
671646|NCT00861510|Multiple Myeloma|multiple myeloma
671647|NCT00861510|MM|mm
671648|NCT00861523|nausea|nausea
671649|NCT00861523|vomiting|vomiting
671650|NCT00861523|pregnancy|pregnancy
671651|NCT00861523|thiamine|thiamine
671653|NCT00861523|nausea and vomiting in pregnancy|nausea and vomiting in pregnancy
671654|NCT00861536|risk factors|risk factors
671655|NCT00861536|immunology|immunology
671656|NCT00861549|Bioavailability|bioavailability
671657|NCT00861549|Pharmacokinetics|pharmacokinetics
671658|NCT00861549|Safety Evaluation|safety evaluation
671659|NCT00861562|constipation|constipation
671660|NCT00861562|hemorrhoids|hemorrhoids
671661|NCT00861562|water smartweed|water smartweed
671662|NCT00861562|RCT|rct
671663|NCT00861575|Cardiovascular|cardiovascular
671664|NCT00861588|complementary & alternative medicine|complementary & alternative medicine
671665|NCT00861588|randomized control trial|randomized control trial
671666|NCT00861588|uroflowmetry|uroflowmetry
671667|NCT00861588|quality of life|quality of life
671668|NCT00861588|benign prostate hyperplasia|benign prostate hyperplasia
671669|NCT00861627|REOLYSIN|reolysin
671670|NCT00861627|reovirus|reovirus
671671|NCT00861627|non-small cell lung cancer|non-small cell lung cancer
671672|NCT00861627|carcinoma|carcinoma
671673|NCT00861627|oncolytics virus|oncolytics virus
671674|NCT00861627|chemotherapy|chemotherapy
671675|NCT00861627|paclitaxel|paclitaxel
671676|NCT00861627|carboplatin|carboplatin
671677|NCT00861640|rabeprazole|rabeprazole
671678|NCT00861640|omeprazole|omeprazole
671679|NCT00861640|upper gastrointestinal bleeding|upper gastrointestinal bleeding
671680|NCT00861653|Atherosclerosis|atherosclerosis
671681|NCT00861653|Subjects diagnosed with atherosclerosis|subjects diagnosed with atherosclerosis
671682|NCT00861666|Forgiveness|forgiveness
671683|NCT00861666|Writing|writing
671684|NCT00861666|PTSD|ptsd
671685|NCT00861666|OEF|oef
671686|NCT00861666|OIF|oif
671687|NCT00861666|Veterans|veterans
671688|NCT00861679|HSCT|hsct
671689|NCT00861679|ALL|all
671690|NCT00861679|GvHD|gvhd
671691|NCT00861692|Argatroban|argatroban
671692|NCT00861692|heparin induced thrombocytopenia (HIT)|heparin induced thrombocytopenia (hit)
671693|NCT00861692|direct thrombin inhibitor (DTI)|direct thrombin inhibitor (dti)
671694|NCT00861718|Phase 1|phase 1
671695|NCT00861718|Healthy Volunteer|healthy volunteer
671696|NCT00861731|chronic renal failure|chronic renal failure
671697|NCT00861731|proteinuria|proteinuria
671698|NCT00861731|apolipoprotein|apolipoprotein
671699|NCT00861731|c reactive protein|c reactive protein
671700|NCT00861744|Measles, Mumps, Rubella, Varicella Vaccine|measles, mumps, rubella, varicella vaccine
671701|NCT00861744|Children|children
671702|NCT00861744|Immunogenicity|immunogenicity
671703|NCT00861744|Safety|safety
671704|NCT00861744|Humans|humans
671705|NCT00861744|Combined Vaccine|combined vaccine
671706|NCT00861744|Vaccines|vaccines
671707|NCT00861770|Congestive Heart Failure|congestive heart failure
671708|NCT00861770|Ultrafiltration|ultrafiltration
671709|NCT00861770|Blood Volume Measurement|blood volume measurement
671710|NCT00861783|oxaliplatin|oxaliplatin
671711|NCT00861783|diaminocyclohexane oxalatoplatinum|diaminocyclohexane oxalatoplatinum
671712|NCT00861783|oxalatoplatin|oxalatoplatin
671713|NCT00861783|oxalatoplatinum|oxalatoplatinum
671714|NCT00861783|Eloxatin|eloxatin
671715|NCT00861809|single dose|single dose
671716|NCT00861809|gut motility|gut motility
671717|NCT00861809|Type I Diabetes Mellitus patients|type i diabetes mellitus patients
671718|NCT00861809|tolerability|tolerability
671719|NCT00861809|phase II|phase ii
671720|NCT00861809|13C octanoic acid breath test|13c octanoic acid breath test
671721|NCT00861809|pharmacodynamics|pharmacodynamics
671722|NCT00861809|gastric emtpying|gastric emtpying
671723|NCT00861809|pharmacokinetics|pharmacokinetics
671724|NCT00861822|Anemia|anemia
671725|NCT00861822|Cardiac surgery|cardiac surgery
671726|NCT00861822|RBC transfusion|rbc transfusion
671727|NCT00861822|Acute Kidney Injury|acute kidney injury
671922|NCT00865202|delirium|delirium
671728|NCT00861822|Cardiac surgery with cardiopulmonary bypass|cardiac surgery with cardiopulmonary bypass
671729|NCT00861861|Pitavastatin|pitavastatin
671730|NCT00861861|Atorvastatin|atorvastatin
671731|NCT00861861|CAD|cad
671732|NCT00861861|HDL-C|hdl-c
671733|NCT00861861|Adiponectin|adiponectin
671734|NCT00856115|stage I colon cancer|stage i colon cancer
671735|NCT00856115|stage II colon cancer|stage ii colon cancer
671736|NCT00856115|stage III colon cancer|stage iii colon cancer
671737|NCT00856115|stage IV colon cancer|stage iv colon cancer
671738|NCT00856115|stage I rectal cancer|stage i rectal cancer
671739|NCT00856115|stage II rectal cancer|stage ii rectal cancer
671740|NCT00856115|stage III rectal cancer|stage iii rectal cancer
671741|NCT00856115|stage IV rectal cancer|stage iv rectal cancer
671742|NCT00856141|IOP measurement|iop measurement
671743|NCT00856141|IOP fluctuation|iop fluctuation
673430|NCT00862602|exercise|exercise
671744|NCT00856141|in-vivo IOP measuring device|in-vivo iop measuring device
671745|NCT00856141|intraocular pressure measurement|intraocular pressure measurement
671746|NCT00856154|HIV-1|hiv-1
671747|NCT00856154|HLA-A2|hla-a2
671748|NCT00856154|Therapeutic|therapeutic
671749|NCT00856154|Vaccine|vaccine
671750|NCT00856154|treatment vaccine|treatment vaccine
671751|NCT00856154|treatment naive|treatment naive
671752|NCT00856167|temporomandibular dysfunction|temporomandibular dysfunction
671753|NCT00856167|TMD|tmd
671754|NCT00856167|TMJ|tmj
671755|NCT00856167|Traditional Chinese Medicine|traditional chinese medicine
671756|NCT00856167|TCM|tcm
671757|NCT00856180|avastin|avastin
671758|NCT00856180|bevacizumab|bevacizumab
671759|NCT00856180|cyclophosphamide|cyclophosphamide
671760|NCT00856180|cytoxan|cytoxan
671761|NCT00856180|mullerian malignancies|mullerian malignancies
671762|NCT00861887|Clostridium difficile|clostridium difficile
671763|NCT00861887|colitis|colitis
671764|NCT00861887|recurrence|recurrence
671765|NCT00861887|relapse|relapse
671766|NCT00861887|Vancomycin|vancomycin
671767|NCT00861926|Maintenance and Reliever Treatments|maintenance and reliever treatments
671768|NCT00861952|Diabetic peripheral neuropathies|diabetic peripheral neuropathies
671769|NCT00861952|Neuralgia|neuralgia
671770|NCT00861952|Complementary medicine|complementary medicine
671771|NCT00861952|Analgesia|analgesia
671772|NCT00861965|Leukemia|leukemia
671773|NCT00861965|Lymphoma|lymphoma
671774|NCT00861965|Multiple Myeloma|multiple myeloma
671775|NCT00861978|mild to moderate depression with atypical features according to DSM-IV|mild to moderate depression with atypical features according to dsm-iv
671776|NCT00861991|medical communication|medical communication
671777|NCT00861991|empathy|empathy
671778|NCT00861991|medical education|medical education
671779|NCT00861991|standardized patients|standardized patients
671780|NCT00861991|"enhancing patient satisfaction"|"enhancing patient satisfaction"
671781|NCT00862004|video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
671782|NCT00862004|systematic node dissection (SND)|systematic node dissection (snd)
671783|NCT00862004|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
671784|NCT00862017|Physiology|physiology
671785|NCT00862030|Palliative radiotherapy|palliative radiotherapy
671786|NCT00862030|Treatment planning|treatment planning
671787|NCT00862030|Non-small cell lung cancer|non-small cell lung cancer
671788|NCT00862043|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
671789|NCT00862043|Valvular Heart Disease|valvular heart disease
671790|NCT00862043|Phosphodiesterase-Inhibitors|phosphodiesterase-inhibitors
671791|NCT00862043|Sildenafil|sildenafil
671792|NCT00862043|Outcomes Research|outcomes research
671793|NCT00862056|asymptomatic|asymptomatic
671794|NCT00862056|coronary artery disease|coronary artery disease
671795|NCT00862108|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
671796|NCT00862108|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
671797|NCT00862108|SLC6A2 protein, human|slc6a2 protein, human
671798|NCT00862108|ADRA2A protein, human|adra2a protein, human
671799|NCT00862147|Child psychosocial Functioning|child psychosocial functioning
671800|NCT00862160|coronary artery bypass surgery|coronary artery bypass surgery
671801|NCT00862160|cardiopulmonary bypass|cardiopulmonary bypass
671802|NCT00862160|heart lung machine|heart lung machine
671803|NCT00862160|acute cerebrovascular event|acute cerebrovascular event
671804|NCT00862160|intracranial embolism|intracranial embolism
671805|NCT00862160|embolism, air|embolism, air
671806|NCT00862160|outcome assessment (health care)|outcome assessment (health care)
671807|NCT00862160|neuropsychological tests|neuropsychological tests
671808|NCT00862160|magnetic resonance imaging|magnetic resonance imaging
671809|NCT00862160|saccadic eye movement test|saccadic eye movement test
671810|NCT00862173|Gene-expression profile|gene-expression profile
671811|NCT00862173|Central nervous system metastasis|central nervous system metastasis
671812|NCT00862173|Non-small-cell lung cancer|non-small-cell lung cancer
671813|NCT00862186|Neoplasms|neoplasms
671814|NCT00862186|Fatigue|fatigue
671815|NCT00862186|Self Care|self care
671816|NCT00862212|anxiety|anxiety
671817|NCT00862212|social anxiety|social anxiety
671818|NCT00862212|social anxiety disorder|social anxiety disorder
671819|NCT00862212|coping behaviors|coping behaviors
671820|NCT00862212|alcohol abuse|alcohol abuse
671821|NCT00862225|rhinomanometry|rhinomanometry
671822|NCT00862225|mode of action|mode of action
671823|NCT00862225|grass pollen|grass pollen
671824|NCT00864721|Untreated NSCLC in patients > 70|untreated nsclc in patients > 70
671825|NCT00864734|Bioequivalence|bioequivalence
671826|NCT00864734|Metformin|metformin
671827|NCT00864734|Glyburide|glyburide
671828|NCT00864734|Healthy subjects|healthy subjects
671829|NCT00864747|Bioequivalence|bioequivalence
671830|NCT00864747|Propranolol|propranolol
671831|NCT00864747|Healthy subjects|healthy subjects
671832|NCT00864760|Bioequivalence|bioequivalence
671833|NCT00864760|Gabapentin|gabapentin
671834|NCT00864760|Healthy subjects|healthy subjects
671835|NCT00864786|Multiple dose safety and pharmacokinetics study|multiple dose safety and pharmacokinetics study
671836|NCT00864799|Abortion|abortion
671837|NCT00864799|Misoprostol|misoprostol
671838|NCT00864799|Mifepristone|mifepristone
671839|NCT00864799|Pregnancy|pregnancy
671840|NCT00864799|Fetus|fetus
671841|NCT00864825|Schizophrenia|schizophrenia
671842|NCT00864825|Allopurinol|allopurinol
671843|NCT00864825|Add-on-treatment|add-on-treatment
671844|NCT00864838|intraocular pressure|intraocular pressure
671845|NCT00864838|bevacizumab|bevacizumab
671846|NCT00864838|acetazolamide|acetazolamide
671847|NCT00864838|brimonidine|brimonidine
671848|NCT00864838|anterior chamber paracentesis|anterior chamber paracentesis
671849|NCT00864864|sunitinib|sunitinib
671850|NCT00864877|retrospective|retrospective
671851|NCT00864877|comparison|comparison
671852|NCT00864877|biodegradable|biodegradable
671853|NCT00864877|implant|implant
671854|NCT00864877|ankle fracture|ankle fracture
671855|NCT00864890|Bioequivalence|bioequivalence
671856|NCT00864890|Citalopram|citalopram
671857|NCT00864890|Healthy subjects|healthy subjects
671858|NCT00864903|enterovirus|enterovirus
671859|NCT00864903|aseptic meningitis|aseptic meningitis
671860|NCT00864903|real time PCR|real time pcr
671861|NCT00864903|diagnostics|diagnostics
671862|NCT00864916|Endothelial Function|endothelial function
671863|NCT00864916|Pentoxifylline|pentoxifylline
671864|NCT00864916|Antiretroviral Therapy|antiretroviral therapy
671865|NCT00864916|Inflammation|inflammation
671866|NCT00864929|Non-interventional study|non-interventional study
671867|NCT00864929|Vietnam|vietnam
671868|NCT00864929|inappropriate treatment|inappropriate treatment
671869|NCT00864929|nosocomial infection|nosocomial infection
671870|NCT00864942|CLL|cll
671871|NCT00864942|NHL|nhl
671872|NCT00864942|lymphoma|lymphoma
671873|NCT00864955|UV-A irradiation|uv-a irradiation
671874|NCT00864955|Cyclobutane-Pyrimidine Dimer|cyclobutane-pyrimidine dimer
671875|NCT00864955|Oxidative lesions|oxidative lesions
671876|NCT00864955|cutaneous phototype|cutaneous phototype
671877|NCT00864955|UV-B irradiation|uv-b irradiation
671878|NCT00864955|DNA damages|dna damages
671879|NCT00864968|Bioequivalence|bioequivalence
671880|NCT00864968|Nabumetone|nabumetone
671881|NCT00864968|Healthy subjects|healthy subjects
671882|NCT00864994|COPD|copd
671883|NCT00864994|Inflammation|inflammation
671884|NCT00864994|Smoking|smoking
672189|NCT00866138|relapsing|relapsing
671885|NCT00864994|Multiorgan pathology|multiorgan pathology
671886|NCT00864994|Extra pulmonary manifestations|extra pulmonary manifestations
671887|NCT00865007|Lipodystrophy|lipodystrophy
671888|NCT00865007|treatment experienced|treatment experienced
671889|NCT00865020|Hypertension|hypertension
671890|NCT00865020|ABPM|abpm
671891|NCT00865020|systolic blood pressure|systolic blood pressure
671892|NCT00865020|diastolic blood pressure|diastolic blood pressure
671893|NCT00865020|cardiovascular disease|cardiovascular disease
671894|NCT00865020|aliskiren|aliskiren
671895|NCT00865020|telmisartan|telmisartan
671896|NCT00865046|acupuncture|acupuncture
671897|NCT00865059|Bioequivalence|bioequivalence
671898|NCT00865059|Gabapentin|gabapentin
671899|NCT00865059|Healthy subjects|healthy subjects
671900|NCT00865072|Bioequivalence|bioequivalence
671901|NCT00865072|Metformin|metformin
671902|NCT00865072|Healthy subjects|healthy subjects
671903|NCT00865085|Bioequivalence|bioequivalence
671904|NCT00865085|Citalopram|citalopram
671905|NCT00865085|Healthy subjects|healthy subjects
671906|NCT00865098|Newly diagnosed locally advanced squamous cell carcinoma of the head and neck (SCCHN)|newly diagnosed locally advanced squamous cell carcinoma of the head and neck (scchn)
671907|NCT00865111|Bioequivalence|bioequivalence
671908|NCT00865111|Bupropion|bupropion
671909|NCT00865111|Healthy subjects|healthy subjects
671910|NCT00865137|Kidney Transplantation|kidney transplantation
671911|NCT00865137|Pharmacokinetics|pharmacokinetics
671912|NCT00865137|Tacrolimus modified release|tacrolimus modified release
671913|NCT00865137|FK506E|fk506e
671914|NCT00865150|Prematurity|prematurity
671915|NCT00865150|Neonatal screening|neonatal screening
671916|NCT00865150|Parenteral nutrition|parenteral nutrition
671917|NCT00865150|Amino acids|amino acids
671918|NCT00865150|Acylcarnitine|acylcarnitine
671919|NCT00865163|Percutaneous Coronary Intervention|percutaneous coronary intervention
671920|NCT00865163|anticoagulation|anticoagulation
671923|NCT00865202|surgery|surgery
671924|NCT00865202|operation|operation
671925|NCT00865202|geriatric|geriatric
671926|NCT00865202|complication|complication
671927|NCT00865215|Bioequivalence|bioequivalence
671928|NCT00865215|Propranolol|propranolol
671929|NCT00865215|Healthy subjects|healthy subjects
671930|NCT00865228|Hyperlipidemia|hyperlipidemia
671931|NCT00865228|Dyslipidemia|dyslipidemia
671932|NCT00865228|High Cholesterol|high cholesterol
671933|NCT00865228|Drug Therapy|drug therapy
671934|NCT00865241|Bioequivalence|bioequivalence
671935|NCT00865241|Metformin|metformin
671936|NCT00865241|Glyburide|glyburide
671937|NCT00865241|Healthy subjects|healthy subjects
671938|NCT00865254|Nicotine Dependence|nicotine dependence
671939|NCT00865254|Smoking|smoking
671940|NCT00865254|Smoking Cessation|smoking cessation
671941|NCT00865254|Contingency Management|contingency management
671942|NCT00865267|Vasoconstriction|vasoconstriction
671943|NCT00865267|Halobetasol|halobetasol
671944|NCT00865267|Healthy adult subjects|healthy adult subjects
671945|NCT00865280|CSSI|cssi
671946|NCT00865280|Abscess|abscess
671947|NCT00865280|Wound|wound
671948|NCT00865280|Cellulitis|cellulitis
671949|NCT00865280|Complicated Skin and Skin Structure Infections (cSSSI)|complicated skin and skin structure infections (csssi)
671950|NCT00865293|Obesity|obesity
671951|NCT00865293|expiratory flow limitation|expiratory flow limitation
671952|NCT00865293|EFL|efl
671953|NCT00865293|posture|posture
671954|NCT00865293|small airways obstruction|small airways obstruction
671955|NCT00865293|FOT|fot
671956|NCT00865306|Cognitive behavioral therapy|cognitive behavioral therapy
671957|NCT00865306|Anxiety|anxiety
671958|NCT00865306|Preschoolers|preschoolers
671959|NCT00865306|Young Children|young children
671960|NCT00865306|Parents|parents
671961|NCT00865306|At-risk|at-risk
671962|NCT00865306|Behavioral Inhibition|behavioral inhibition
671963|NCT00865319|Non Small Cell Lung Cancer|non small cell lung cancer
671964|NCT00865319|Spect CT Imaging|spect ct imaging
671965|NCT00865319|PET CT Imaging as Comparator|pet ct imaging as comparator
671966|NCT00865332|PET|pet
671967|NCT00865332|fMRI|fmri
671968|NCT00865332|D-Amphetamine|d-amphetamine
671969|NCT00865332|Cocaine Addiction|cocaine addiction
671970|NCT00865332|Methylphenidate|methylphenidate
671971|NCT00865345|blood sugar|blood sugar
671972|NCT00865345|glucose|glucose
671973|NCT00865345|sensor|sensor
671974|NCT00865358|yoga|yoga
671975|NCT00865358|complementary alternative medicine|complementary alternative medicine
671976|NCT00865358|low back pain|low back pain
671977|NCT00865358|minority health|minority health
671978|NCT00865358|health care disparities|health care disparities
671979|NCT00865358|community health centers|community health centers
671980|NCT00865371|Bioequivalence|bioequivalence
671981|NCT00865371|Bupropion|bupropion
671982|NCT00865371|Healthy subjects|healthy subjects
671983|NCT00865384|Bioequivalence|bioequivalence
671984|NCT00865384|Mirtazapine|mirtazapine
671985|NCT00865384|Healthy subjects|healthy subjects
671986|NCT00865410|Bioequivalence|bioequivalence
671987|NCT00865410|Bupropion|bupropion
671988|NCT00865410|Healthy subjects|healthy subjects
671989|NCT00865423|Bioequivalence|bioequivalence
671990|NCT00865423|Gabapentin|gabapentin
671991|NCT00865423|Healthy subjects|healthy subjects
671992|NCT00865436|Bioequivalence|bioequivalence
671993|NCT00865436|Metformin|metformin
671994|NCT00865436|Glyburide|glyburide
671995|NCT00865436|Healthy subjects|healthy subjects
671996|NCT00865449|spironolactone|spironolactone
671997|NCT00865449|peritoneal fibrosis|peritoneal fibrosis
671998|NCT00865449|peritoneal dialysis|peritoneal dialysis
671999|NCT00865462|Bioequivalence|bioequivalence
672000|NCT00865462|Bupropion|bupropion
672001|NCT00865462|Healthy subjects|healthy subjects
672002|NCT00865475|HIV infection|hiv infection
672003|NCT00865475|Treatment Experienced|treatment experienced
672004|NCT00865501|primary hypertension|primary hypertension
672005|NCT00865501|aldosterone|aldosterone
672006|NCT00865501|left ventricular hypertrophy|left ventricular hypertrophy
672007|NCT00865514|dichloroacetate|dichloroacetate
672008|NCT00865514|tyrosine|tyrosine
672009|NCT00865514|maleylacetoacetate|maleylacetoacetate
672010|NCT00865514|trichloroethylene|trichloroethylene
672011|NCT00865514|leucine|leucine
672012|NCT00865514|haplotype|haplotype
672013|NCT00865527|Colorectal cancer|colorectal cancer
672014|NCT00865527|Colon cancer|colon cancer
672015|NCT00865527|Adenomatous polyps|adenomatous polyps
672016|NCT00865527|Screening|screening
672017|NCT00865527|Fecal occult blood test|fecal occult blood test
672018|NCT00865527|Computed tomographic colonography|computed tomographic colonography
672019|NCT00865527|Colonoscopy|colonoscopy
672020|NCT00865540|cataract|cataract
672021|NCT00865540|pupillary dilation|pupillary dilation
672022|NCT00865540|anti-inflammatory|anti-inflammatory
672023|NCT00865540|therapeutic use|therapeutic use
672024|NCT00865553|tobacco use disorder|tobacco use disorder
672025|NCT00865566|HIV Seronegativity|hiv seronegativity
672026|NCT00865566|HIV Preventive Vaccine|hiv preventive vaccine
672027|NCT00865566|HIV Treatment Vaccine|hiv treatment vaccine
672028|NCT00865566|Adenovirus|adenovirus
672029|NCT00865579|MAO inhibitors|mao inhibitors
672030|NCT00865579|motor fluctuations|motor fluctuations
672031|NCT00865579|dyskinesia|dyskinesia
672032|NCT00865579|Parkinson's Disease|parkinson's disease
672033|NCT00865592|diabetes|diabetes
672034|NCT00865592|DPP4 inhibitor|dpp4 inhibitor
672035|NCT00865592|dutogliptin|dutogliptin
672036|NCT00865592|PHX1149|phx1149
672037|NCT00865605|bioequivalence|bioequivalence
672038|NCT00865605|Vasoconstriction|vasoconstriction
672039|NCT00865605|Halobetasol|halobetasol
672040|NCT00865605|Healthy subjects|healthy subjects
672041|NCT00865631|Bioequivalence|bioequivalence
672042|NCT00865631|Gabapentin|gabapentin
672043|NCT00865631|Healthy subjects|healthy subjects
672044|NCT00865644|imiquimod 5% cream|imiquimod 5% cream
672045|NCT00865657|Bioequivalence|bioequivalence
672046|NCT00865657|Alprazolam|alprazolam
672047|NCT00865657|Healthy subjects|healthy subjects
672048|NCT00865683|Gestational Diabetes|gestational diabetes
672049|NCT00865683|Pregnancy|pregnancy
672050|NCT00865683|Docosahexaenoic Acid|docosahexaenoic acid
672052|NCT00865683|Maternal-Fetal Exchange|maternal-fetal exchange
672053|NCT00865696|Bioequivalence|bioequivalence
672054|NCT00865696|Mirtazapine|mirtazapine
672055|NCT00865696|Healthy subjects|healthy subjects
672056|NCT00865709|Colorectal Cancer|colorectal cancer
672057|NCT00865709|Metastasis|metastasis
672058|NCT00865709|Stage IV|stage iv
672059|NCT00865709|Liver Metastasis|liver metastasis
672060|NCT00865722|Remote Postconditioning|remote postconditioning
672061|NCT00865722|Myocardial reperfusion Injury|myocardial reperfusion injury
672062|NCT00865722|Myocardial Infarction|myocardial infarction
672063|NCT00865722|Primary PCI|primary pci
672064|NCT00865748|Bioequivalence|bioequivalence
672065|NCT00865748|Metformin|metformin
672066|NCT00865748|Healthy subjects|healthy subjects
672067|NCT00865761|Bioequivalence|bioequivalence
672068|NCT00865761|Alprazolam|alprazolam
672069|NCT00865761|Healthy subjects|healthy subjects
672070|NCT00865774|Trauma|trauma
672071|NCT00865774|Alcohol|alcohol
672072|NCT00865774|Brief Intervention|brief intervention
672073|NCT00865813|Punch biopsy,|punch biopsy,
672074|NCT00865813|periocular|periocular
672075|NCT00865813|tumors.|tumors.
672076|NCT00865826|Pulmonary Tuberculosis|pulmonary tuberculosis
672077|NCT00865826|Myobacterium Infections|myobacterium infections
672078|NCT00865839|Bioequivalence|bioequivalence
672079|NCT00865839|Metformin|metformin
672080|NCT00865839|Healthy subjects|healthy subjects
672081|NCT00865852|Bioequivalence|bioequivalence
672082|NCT00865852|Metformin|metformin
672083|NCT00865852|Healthy subjects|healthy subjects
672084|NCT00865865|Knee|knee
672085|NCT00865865|Computer|computer
672086|NCT00865865|Gap|gap
672087|NCT00865865|Soft tissue|soft tissue
672088|NCT00865865|Balancing|balancing
672089|NCT00865865|Replacement|replacement
672090|NCT00865865|Arthroplasty|arthroplasty
672091|NCT00865878|Actinic Keratoses|actinic keratoses
672092|NCT00865878|Skin Neoplasms|skin neoplasms
672093|NCT00865878|Photodynamic Therapy|photodynamic therapy
672094|NCT00865878|Transplants|transplants
672095|NCT00865891|Bioequivalence|bioequivalence
672096|NCT00865891|Nifedipine|nifedipine
672097|NCT00865891|Healthy subjects|healthy subjects
672098|NCT00865904|∆F508|∆f508
672099|NCT00865904|F508del|f508del
672100|NCT00865904|Cystic Fibrosis Transmembrane Conductance Regulator|cystic fibrosis transmembrane conductance regulator
672101|NCT00865904|CFTR|cftr
672102|NCT00865904|Pancreatic diseases|pancreatic diseases
672103|NCT00865904|Lung diseases|lung diseases
672104|NCT00865904|Genetic disease, inborn|genetic disease, inborn
672105|NCT00865904|Infant, newborn, diseases|infant, newborn, diseases
672106|NCT00865917|POTS|pots
672107|NCT00865943|Bioequivalence|bioequivalence
672108|NCT00865943|Citalopram|citalopram
672109|NCT00865943|Healthy subjects|healthy subjects
672110|NCT00865956|disease management|disease management
672111|NCT00865956|substance use disorders|substance use disorders
672112|NCT00865956|behavioral incentives|behavioral incentives
672113|NCT00865969|Belinostat|belinostat
672114|NCT00865969|peripheral T-cell lymphoma|peripheral t-cell lymphoma
672115|NCT00865969|PXD101|pxd101
672116|NCT00865969|PTCL|ptcl
672117|NCT00865969|HDAC inhibitor|hdac inhibitor
672118|NCT00865969|histone deacetylase inhibitor|histone deacetylase inhibitor
672119|NCT00865982|adenocarcinoma of the stomach, gastro-esophageal junction or distal esophagus|adenocarcinoma of the stomach, gastro-esophageal junction or distal esophagus
672120|NCT00865982|gastric cancer|gastric cancer
672121|NCT00865982|esophageal cancer|esophageal cancer
672122|NCT00865982|gastro-esophageal junction|gastro-esophageal junction
672123|NCT00865982|docetaxel|docetaxel
672124|NCT00865982|capecitabine|capecitabine
672125|NCT00865982|cisplatin|cisplatin
672126|NCT00865982|perioperative chemotherapy|perioperative chemotherapy
672127|NCT00865995|pepsin|pepsin
672128|NCT00865995|aspiration|aspiration
672129|NCT00865995|GE reflux|ge reflux
672130|NCT00866008|IVF|ivf
672131|NCT00866008|In vitro implantation|in vitro implantation
672132|NCT00866008|Preimplantation genetic screening|preimplantation genetic screening
672133|NCT00866008|Aneuploidy|aneuploidy
672134|NCT00866021|HIV infection|hiv infection
672135|NCT00866021|HCV infection|hcv infection
672136|NCT00866021|treatment experienced|treatment experienced
672137|NCT00866034|Cetrotide|cetrotide
672138|NCT00866034|IVF|ivf
672139|NCT00866034|ICSI|icsi
672140|NCT00866034|Treatment protocol|treatment protocol
672141|NCT00866047|Antigens, CD30|antigens, cd30
672142|NCT00866047|Antibody-Drug Conjugate|antibody-drug conjugate
672143|NCT00866047|Antibodies, Monoclonal|antibodies, monoclonal
672144|NCT00866047|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
672145|NCT00866047|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
672146|NCT00866047|monomethyl auristatin E|monomethyl auristatin e
672147|NCT00866047|Drug Therapy|drug therapy
672148|NCT00866047|Immunotherapy|immunotherapy
672149|NCT00866047|Hematologic Diseases|hematologic diseases
672150|NCT00866047|Lymphoma|lymphoma
672151|NCT00866060|donepezil|donepezil
672152|NCT00866060|memantine|memantine
672153|NCT00866060|moderately severe Alzheimer's disease|moderately severe alzheimer's disease
672154|NCT00866060|severe Alzheimer's disease|severe alzheimer's disease
672156|NCT00866073|Acute myeloid leukemia|acute myeloid leukemia
672157|NCT00866073|Decitabine|decitabine
672158|NCT00866086|stage I non-small cell lung cancer|stage i non-small cell lung cancer
672159|NCT00866086|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
672160|NCT00866086|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
672161|NCT00866086|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
672162|NCT00866086|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
672163|NCT00866086|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
672164|NCT00866086|pulmonary carcinoid tumor|pulmonary carcinoid tumor
672165|NCT00866086|extensive stage small cell lung cancer|extensive stage small cell lung cancer
672166|NCT00866086|limited stage small cell lung cancer|limited stage small cell lung cancer
672167|NCT00866086|recurrent small cell lung cancer|recurrent small cell lung cancer
672168|NCT00866099|Dementia|dementia
672169|NCT00866099|primary care|primary care
672170|NCT00866099|early diagnosis|early diagnosis
672171|NCT00866099|psychosocial interventions|psychosocial interventions
672172|NCT00866099|cholinesterase inhibitors|cholinesterase inhibitors
672173|NCT00866112|Wheelchair use|wheelchair use
672174|NCT00866112|Spinal cord injury|spinal cord injury
672175|NCT00866112|Multiple sclerosis|multiple sclerosis
672176|NCT00866112|Muscular dystrophy|muscular dystrophy
672177|NCT00866112|Cerebral palsy|cerebral palsy
672178|NCT00866112|Spina bifida|spina bifida
672179|NCT00866112|Amputation|amputation
672180|NCT00866112|Arthritis|arthritis
672181|NCT00866112|Stroke|stroke
672182|NCT00866125|Polymyositis|polymyositis
672183|NCT00866125|Dermatomyositis|dermatomyositis
672184|NCT00866125|Grip force|grip force
672185|NCT00866125|Quality of life|quality of life
672186|NCT00866125|Activity performance|activity performance
672187|NCT00866138|multiple myeloma|multiple myeloma
672188|NCT00866138|t(4/14)|t(4/14)
672190|NCT00866138|refractory|refractory
672191|NCT00866151|genetic biomarker|genetic biomarker
672192|NCT00866151|biomarker|biomarker
672193|NCT00866151|molecular diagnostics|molecular diagnostics
672194|NCT00866151|genes|genes
672195|NCT00866151|genetics|genetics
672196|NCT00866151|overweight management|overweight management
672197|NCT00866151|weight management|weight management
672198|NCT00866151|weight reduction|weight reduction
672199|NCT00866151|SNPs|snps
672200|NCT00866151|single nucleotide polymorphisms|single nucleotide polymorphisms
672201|NCT00866164|back pain|back pain
672202|NCT00866164|intractable pain|intractable pain
672203|NCT00866164|implantable infusion pump|implantable infusion pump
672204|NCT00866164|morphine|morphine
672205|NCT00866190|Mycobacterium tuberculosis, SQ109|mycobacterium tuberculosis, sq109
672206|NCT00866242|Shigella|shigella
672207|NCT00866242|Vaccine|vaccine
672208|NCT00866242|Mucosal immunity|mucosal immunity
672209|NCT00866255|endotracheal tube|endotracheal tube
672210|NCT00866255|endotracheal pressure|endotracheal pressure
672211|NCT00866255|airway pressure|airway pressure
672212|NCT00866255|pressure drop|pressure drop
672213|NCT00866255|calculation|calculation
672214|NCT00866255|continuous calculation|continuous calculation
672215|NCT00866268|Blood loss|blood loss
672216|NCT00866268|Total knee arthroplasty|total knee arthroplasty
672217|NCT00866268|Adults|adults
672218|NCT00866268|Drain|drain
672219|NCT00866268|Drainage system|drainage system
672220|NCT00866281|Acute Myeloid Leukemia|acute myeloid leukemia
672221|NCT00866281|AML|aml
672222|NCT00866281|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
672223|NCT00866281|ALL|all
672224|NCT00866281|midostaurin|midostaurin
672225|NCT00866281|PKC412|pkc412
672226|NCT00866281|Pediatric relapsed or refractory FLT3 positive Acute Myeloid Leukemia|pediatric relapsed or refractory flt3 positive acute myeloid leukemia
672227|NCT00866281|Pediatric relapsed or refractory Mixed-lineage leukemia gene rearranged Acute Lymphoblastic leukemia|pediatric relapsed or refractory mixed-lineage leukemia gene rearranged acute lymphoblastic leukemia
672228|NCT00866294|Immediate-release formulation of paroxetine (paroxetine IR)|immediate-release formulation of paroxetine (paroxetine ir)
672229|NCT00866294|HAM-D (17 items)|ham-d (17 items)
672230|NCT00866294|Controlled-release formulation of paroxetine (paroxetine CR)|controlled-release formulation of paroxetine (paroxetine cr)
672231|NCT00866320|clear cell renal cell carcinoma|clear cell renal cell carcinoma
672232|NCT00866320|recurrent renal cell cancer|recurrent renal cell cancer
672233|NCT00866320|stage IV renal cell cancer|stage iv renal cell cancer
672234|NCT00866333|Hodgkin's Lymphoma|hodgkin's lymphoma
672235|NCT00866333|Relapsed Hodgkin's Lymphoma|relapsed hodgkin's lymphoma
672236|NCT00866333|Refractory Hodgkin's Lymphoma|refractory hodgkin's lymphoma
672237|NCT00866346|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
672238|NCT00866346|CML|cml
672239|NCT00866346|Allogeneic Hematopoietic Transplantation|allogeneic hematopoietic transplantation
672240|NCT00866346|Bone Marrow Transplant|bone marrow transplant
672241|NCT00866346|PR1-Specific Cytotoxic T-Lymphocyte Infusion|pr1-specific cytotoxic t-lymphocyte infusion
672242|NCT00866385|Healthy Volunteer|healthy volunteer
672243|NCT00866385|AZD8566|azd8566
672244|NCT00866385|Food Effect|food effect
672245|NCT00866385|Microtracer|microtracer
672246|NCT00866398|coronary heart disease|coronary heart disease
672247|NCT00866398|chd|chd
672248|NCT00866398|stent|stent
672249|NCT00866411|cranial electrotherapy stimulation|cranial electrotherapy stimulation
672250|NCT00866411|anxiety|anxiety
672251|NCT00866411|depression|depression
672252|NCT00866411|pain|pain
672253|NCT00866411|sleep disturbance|sleep disturbance
672254|NCT00866411|combat exposure|combat exposure
672255|NCT00866411|post traumatic stress|post traumatic stress
672256|NCT00866411|health status|health status
672257|NCT00866411|medication use|medication use
672258|NCT00866411|soldiers|soldiers
672259|NCT00866424|trigeminal neuralgia|trigeminal neuralgia
672260|NCT00866424|pain|pain
672261|NCT00866424|HBO|hbo
672262|NCT00866424|VAS|vas
672263|NCT00866424|MGPQ|mgpq
672264|NCT00866437|PMS|pms
672265|NCT00866437|Hormones|hormones
672266|NCT00866437|Skin tests|skin tests
672267|NCT00866437|Allergen Immunotherapy|allergen immunotherapy
672268|NCT00866463|Sildenafil, Pharmacokinetics, Healthy Volunteer|sildenafil, pharmacokinetics, healthy volunteer
672269|NCT00866476|Shigella|shigella
672270|NCT00866476|Vaccine|vaccine
672271|NCT00866476|Mucosal immunity|mucosal immunity
672272|NCT00866489|Experimental|experimental
672273|NCT00866502|Parkinson|parkinson
672274|NCT00866502|Safety|safety
672275|NCT00866502|PDGF|pdgf
672276|NCT00866502|Intracerebroventricular|intracerebroventricular
672277|NCT00866502|Infusion|infusion
672278|NCT00866502|Device|device
672279|NCT00866515|Healthy volunteer|healthy volunteer
672280|NCT00866515|pharmacodynamics|pharmacodynamics
672281|NCT00866515|Ketoconazole|ketoconazole
672282|NCT00866515|Drug Interaction|drug interaction
672283|NCT00866515|pharmacokinetcs|pharmacokinetcs
672284|NCT00866515|GW642444M|gw642444m
672285|NCT00866515|pharmacokinetics|pharmacokinetics
672286|NCT00866528|NSCLC|nsclc
673180|NCT00871403|GW786034|gw786034
672287|NCT00866528|non-small cell lung cancer|non-small cell lung cancer
672288|NCT00866528|GW786034|gw786034
672289|NCT00866528|pazopanib|pazopanib
672290|NCT00866528|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
672291|NCT00866528|Advanced Solid Tumor|advanced solid tumor
672292|NCT00866528|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
672293|NCT00866528|paclitaxel|paclitaxel
672294|NCT00866541|resistance|resistance
672295|NCT00866541|flow proportional pressure support|flow proportional pressure support
672296|NCT00866541|pressure support ventilation|pressure support ventilation
672297|NCT00866541|volunteers|volunteers
672298|NCT00866541|assistant breathing|assistant breathing
672299|NCT00866541|breathing comfort and objective breathing data|breathing comfort and objective breathing data
672300|NCT00866554|Prostate|prostate
672301|NCT00866554|Brachytherapy|brachytherapy
672302|NCT00866554|Cytoreduction|cytoreduction
672303|NCT00866554|Sexual function|sexual function
672304|NCT00866554|Toxicity|toxicity
672305|NCT00866567|prematurity|prematurity
672306|NCT00866567|VLBW|vlbw
672307|NCT00866567|sepsis|sepsis
672308|NCT00866567|innate immunity|innate immunity
672309|NCT00866580|Pandemic influenza|pandemic influenza
672310|NCT00866593|major depressive disorder(MDD)|major depressive disorder(mdd)
672311|NCT00866593|depression|depression
672312|NCT00866593|antidepressant|antidepressant
672313|NCT00866593|escitalpram oxalate|escitalpram oxalate
672314|NCT00866593|generic|generic
672315|NCT00866593|innovator|innovator
672316|NCT00866593|Lexapro|lexapro
672317|NCT00866593|efficacy|efficacy
672318|NCT00866593|safety|safety
672319|NCT00866593|multicenter|multicenter
672320|NCT00866593|double-blind|double-blind
672321|NCT00866593|randomized|randomized
672322|NCT00866593|chinese|chinese
672323|NCT00866593|HAMD|hamd
672324|NCT00866593|MADRS|madrs
672325|NCT00866593|HAMA|hama
672326|NCT00866593|VAS-PI|vas-pi
672328|NCT00866593|CGI|cgi
672329|NCT00866606|On-demand treatment|on-demand treatment
672330|NCT00866606|Hemostatic efficacy|hemostatic efficacy
672331|NCT00866606|Factor IX activity|factor ix activity
672332|NCT00866606|Factor IX recovery|factor ix recovery
672333|NCT00866606|Factor IX inhibitor|factor ix inhibitor
672334|NCT00866606|Chinese|chinese
672335|NCT00866632|Depression|depression
672336|NCT00866632|Anxiety|anxiety
672337|NCT00866632|Brain Injury|brain injury
672338|NCT00866632|Cognitive Therapy|cognitive therapy
672339|NCT00866632|Coping Skills|coping skills
672340|NCT00866645|Agitation|agitation
672341|NCT00866645|Schizophrenia|schizophrenia
672342|NCT00866645|Randomized|randomized
672343|NCT00866645|Blind|blind
672344|NCT00866645|Parallel|parallel
673431|NCT00862602|pedometer|pedometer
672345|NCT00866645|Intramuscular Haloperidol|intramuscular haloperidol
672346|NCT00866645|Controlled|controlled
672347|NCT00866645|Multicenter|multicenter
672348|NCT00866645|Clinical Trial|clinical trial
672349|NCT00866645|Efficacy|efficacy
672350|NCT00866645|Safety|safety
672351|NCT00866645|Intramuscular Levosulpiride|intramuscular levosulpiride
672352|NCT00866645|Chinese|chinese
672353|NCT00866645|PANSS-EC|panss-ec
672354|NCT00866645|ACES|aces
672355|NCT00866645|CGI|cgi
672356|NCT00866645|BPRS|bprs
672357|NCT00866645|PANSS|panss
672358|NCT00866645|RSESE|rsese
672359|NCT00866645|BAS|bas
672360|NCT00866658|hyperglycemia|hyperglycemia
672361|NCT00866658|GLP-1|glp-1
672362|NCT00866658|sulfonylurea|sulfonylurea
672363|NCT00866658|insulin|insulin
672364|NCT00866671|T-ALL|t-all
672365|NCT00866671|Safety|safety
672366|NCT00866671|Post Authorisation Safety Study|post authorisation safety study
672367|NCT00866671|T-LBL|t-lbl
672368|NCT00866671|Lymphoblastic Lymphoma|lymphoblastic lymphoma
672369|NCT00866671|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
672370|NCT00866684|renal transplant-patients with high-risk for skin cancer|renal transplant-patients with high-risk for skin cancer
672371|NCT00866697|fallopian tube cancer|fallopian tube cancer
672372|NCT00866697|pazopanib|pazopanib
672373|NCT00866697|anti-angiogenesis|anti-angiogenesis
672374|NCT00866697|ovarian cancer|ovarian cancer
672375|NCT00866697|primary peritoneal cancer|primary peritoneal cancer
672376|NCT00866697|tyrosine kinase inhibitors|tyrosine kinase inhibitors
672377|NCT00866697|gynecologic cancer|gynecologic cancer
672378|NCT00866723|Avastin|avastin
672379|NCT00866723|bevacizumab|bevacizumab
672380|NCT00866736|chronic myeloid leukemia|chronic myeloid leukemia
672381|NCT00866736|dasatinib|dasatinib
672382|NCT00866736|chronic phase myeloid leukemia|chronic phase myeloid leukemia
672383|NCT00866749|acute lymphoblastic leukemia|acute lymphoblastic leukemia
672384|NCT00866749|acute lymphoblastic lymphoma|acute lymphoblastic lymphoma
672385|NCT00866749|Leukemia|leukemia
672386|NCT00866749|ALL|all
672387|NCT00866749|6-Thioguanine|6-thioguanine
672388|NCT00866749|Cyclophosphamide|cyclophosphamide
672389|NCT00866749|Cytarabine|cytarabine
672390|NCT00866749|Daunorubicin|daunorubicin
672391|NCT00866749|Doxorubicin|doxorubicin
672392|NCT00866749|Methotrexate|methotrexate
672393|NCT00866749|PEG-L-Asparaginase|peg-l-asparaginase
672394|NCT00866749|Vincristine|vincristine
672395|NCT00866749|Intrathecal Methotrexate|intrathecal methotrexate
672396|NCT00866749|Mercaptopurine|mercaptopurine
672397|NCT00866762|Polycythaemia Vera|polycythaemia vera
672398|NCT00866762|Polycythemia Vera|polycythemia vera
672399|NCT00866762|Essential Thrombocythaemia|essential thrombocythaemia
672400|NCT00866762|Essential Thrombocythemia|essential thrombocythemia
672401|NCT00866762|HDAC-inhibitor|hdac-inhibitor
672402|NCT00866762|Haematology|haematology
672403|NCT00866762|Hematology|hematology
672404|NCT00866762|Haematological disorder|haematological disorder
672405|NCT00866762|Haematological disease|haematological disease
672406|NCT00866762|Hematological disorder|hematological disorder
672407|NCT00866762|Hematological disease|hematological disease
672408|NCT00866775|Seizure|seizure
672409|NCT00866775|Epilepsy|epilepsy
672410|NCT00866775|Anticonvulsant|anticonvulsant
672411|NCT00866775|Historical Control|historical control
672412|NCT00866775|Monotherapy|monotherapy
672413|NCT00866788|Xolair|xolair
672414|NCT00866788|CIU|ciu
672415|NCT00866801|coronary blood flow|coronary blood flow
672416|NCT00866801|coronary flow reserve|coronary flow reserve
672417|NCT00866801|cardiac sympathetic innervation|cardiac sympathetic innervation
672418|NCT00866801|general anesthesia|general anesthesia
672419|NCT00866801|thoracic epidural|thoracic epidural
672420|NCT00866801|autonomic dysfunction|autonomic dysfunction
672421|NCT00866801|autonomic neuropathy|autonomic neuropathy
672422|NCT00866814|hernia|hernia
672423|NCT00866814|open|open
672424|NCT00866827|Airway|airway
672425|NCT00866827|Hemangiomas|hemangiomas
672426|NCT00866827|Venous Malformations|venous malformations
672427|NCT00866827|Lymphatic Malformations|lymphatic malformations
672428|NCT00866840|stage III melanoma|stage iii melanoma
672429|NCT00866840|stage IV melanoma|stage iv melanoma
672430|NCT00866840|recurrent melanoma|recurrent melanoma
672431|NCT00866853|TMC435350|tmc435350
672432|NCT00866853|HCV|hcv
672433|NCT00866853|Hepatitis C|hepatitis c
672434|NCT00866853|TMC435|tmc435
672435|NCT00866853|protease inhibitor|protease inhibitor
672436|NCT00866853|CYP|cyp
672437|NCT00866853|Cooperstown 5+1 cocktail|cooperstown 5+1 cocktail
672438|NCT00866879|Sirolimus|sirolimus
672439|NCT00866879|Rapamune|rapamune
672440|NCT00866879|Immunosuppression|immunosuppression
672441|NCT00866879|Renal allograft function|renal allograft function
672442|NCT00866879|Lymphocytes function|lymphocytes function
672443|NCT00866905|Breast Cancer|breast cancer
672444|NCT00866905|Ixabepilone|ixabepilone
672445|NCT00866905|Ixempra|ixempra
672446|NCT00866905|Cyclophosphamide|cyclophosphamide
672447|NCT00866905|Cytoxan|cytoxan
672448|NCT00866905|Neoadjuvant Therapy|neoadjuvant therapy
672449|NCT00866944|Colorectal carcinoma|colorectal carcinoma
672450|NCT00866944|Liver metastases (only)|liver metastases (only)
672451|NCT00866944|R0 resection|r0 resection
672452|NCT00866944|R0 resection of liver metastases from colorectal cancer|r0 resection of liver metastases from colorectal cancer
672453|NCT00866970|Lung Cancer|lung cancer
672454|NCT00866970|Fatigue|fatigue
672455|NCT00866970|Cachexia|cachexia
672456|NCT00866983|Open label|open label
672457|NCT00866983|sildenafil|sildenafil
672459|NCT00866983|Brazil|brazil
672460|NCT00866996|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
672461|NCT00866996|Methylphenidate|methylphenidate
672462|NCT00866996|Atomoxetine|atomoxetine
672463|NCT00866996|Concerta|concerta
672464|NCT00867022|Inflammatory factors|inflammatory factors
672465|NCT00867022|Coagulation factors|coagulation factors
672466|NCT00867022|Sympathetic activity|sympathetic activity
672467|NCT00867048|highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
672468|NCT00867048|CD4 Count|cd4 count
672469|NCT00867048|Early Intervention|early intervention
672470|NCT00867048|HIV|hiv
672471|NCT00867048|HIV Infection|hiv infection
672472|NCT00867048|HIV Infections|hiv infections
672473|NCT00867048|treatment naive|treatment naive
672474|NCT00867061|Myelodysplastic|myelodysplastic
672475|NCT00867061|IPSS Intermediate 1|ipss intermediate 1
672476|NCT00867061|IPSS Intermediate 2|ipss intermediate 2
672477|NCT00867061|IPSS High risk|ipss high risk
672478|NCT00867087|Diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
672479|NCT00867087|inotuzumab ozogamicin|inotuzumab ozogamicin
672480|NCT00867087|autologous stem cell transplant|autologous stem cell transplant
672481|NCT00867113|Imatinib|imatinib
672482|NCT00867113|Protein Kinase Inhibitors|protein kinase inhibitors
672483|NCT00867113|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
672484|NCT00867113|Digestive System Diseases|digestive system diseases
672485|NCT00867113|Digestive System Neoplasms|digestive system neoplasms
672486|NCT00867113|Gastrointestinal Diseases|gastrointestinal diseases
672487|NCT00867113|Gastrointestinal Neoplasms|gastrointestinal neoplasms
672488|NCT00867113|Adjuvant|adjuvant
672489|NCT00867113|PERSIST|persist
672490|NCT00867113|PERSIS-5|persis-5
672491|NCT00867126|stage IV pancreatic cancer|stage iv pancreatic cancer
672492|NCT00867126|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
672493|NCT00867126|recurrent pancreatic cancer|recurrent pancreatic cancer
672494|NCT00867139|Influenza|influenza
672495|NCT00867139|Immunocompromised|immunocompromised
672496|NCT00867139|Antiviral|antiviral
672497|NCT00867152|ritonavir|ritonavir
672498|NCT00867152|GSK1349572|gsk1349572
672499|NCT00867152|integrase|integrase
672500|NCT00867152|lopinavir|lopinavir
672501|NCT00867152|darunavir|darunavir
672502|NCT00867152|etravirine|etravirine
672503|NCT00867165|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
672504|NCT00867165|nonfamilial hypercholesterolemia|nonfamilial hypercholesterolemia
672505|NCT00867204|ERCP|ercp
672506|NCT00867204|Study focus was to compare the performance of the ERCP short-wire device versus the Long-wire device.|study focus was to compare the performance of the ercp short-wire device versus the long-wire device.
672507|NCT00867230|Myelodysplastic Syndrome|myelodysplastic syndrome
672508|NCT00867230|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
672509|NCT00867230|Acute Myeloid Leukemia|acute myeloid leukemia
672510|NCT00867230|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
672511|NCT00867230|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
672512|NCT00867230|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
672513|NCT00867230|Agnogenic Myeloid Metaplasia|agnogenic myeloid metaplasia
672514|NCT00867230|FTS|fts
672515|NCT00867230|S-Trans, Trans-Farnesylthiosalicylic Acid|s-trans, trans-farnesylthiosalicylic acid
672516|NCT00859027|Non-metastatic|non-metastatic
672517|NCT00859040|recurrent intracranial meningioma(s)|recurrent intracranial meningioma(s)
672518|NCT00859040|progressive intracranial meningioma(s)|progressive intracranial meningioma(s)
672519|NCT00859079|diabetes mellitus type 2, GLP-1, insulin infusion|diabetes mellitus type 2, glp-1, insulin infusion
672520|NCT00859144|HIV Prevention|hiv prevention
672521|NCT00859144|Youth|youth
672522|NCT00859144|Adolescent|adolescent
672523|NCT00859144|Community Collaboration|community collaboration
672524|NCT00859144|Community Mentorship|community mentorship
672525|NCT00859144|Minority|minority
672526|NCT00859144|Urban|urban
672527|NCT00859144|Sexual Risk Behaviors|sexual risk behaviors
672528|NCT00859144|HIV seronegativity|hiv seronegativity
672529|NCT00859157|perioperative/postoperative complications|perioperative/postoperative complications
672530|NCT00859157|pain|pain
672531|NCT00859157|ductal breast carcinoma in situ|ductal breast carcinoma in situ
672532|NCT00859157|invasive ductal breast carcinoma|invasive ductal breast carcinoma
672533|NCT00859157|invasive lobular breast carcinoma|invasive lobular breast carcinoma
672534|NCT00859157|stage IA breast cancer|stage ia breast cancer
672535|NCT00859157|stage IB breast cancer|stage ib breast cancer
672536|NCT00859157|stage II breast cancer|stage ii breast cancer
672537|NCT00859157|stage IIIA breast cancer|stage iiia breast cancer
672538|NCT00859157|stage IIIB breast cancer|stage iiib breast cancer
672539|NCT00859170|kidney stones|kidney stones
672540|NCT00859170|ureter|ureter
672541|NCT00859170|laser lithotripsy|laser lithotripsy
672542|NCT00859183|in-stent restenosis|in-stent restenosis
672543|NCT00859183|stents|stents
672544|NCT00859183|sirolimus|sirolimus
672545|NCT00859196|Wound healing|wound healing
672546|NCT00859196|Cell proliferation|cell proliferation
672547|NCT00859196|Gene expression|gene expression
672548|NCT00859209|HVF|hvf
672549|NCT00859209|Premature infants|premature infants
672550|NCT00859209|ETCO2|etco2
672551|NCT00859222|LBH589|lbh589
672552|NCT00859222|bevacizumab|bevacizumab
672553|NCT00859222|Avastin|avastin
672554|NCT00859222|Panobinostat|panobinostat
753391|NCT01176461|stage IIIC melanoma|stage iiic melanoma
672555|NCT00859235|Percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
672556|NCT00859235|peristomal wound infection|peristomal wound infection
672557|NCT00859235|antibiotic mouth wash solution|antibiotic mouth wash solution
672558|NCT00859235|prophylaxis prior Percutaneous endoscopic gastrostomy (PEG)|prophylaxis prior percutaneous endoscopic gastrostomy (peg)
672559|NCT00859287|Reflux esophagitis|reflux esophagitis
672560|NCT00859287|Omepral®|omepral®
672561|NCT00859287|QOLRAD|qolrad
672562|NCT00859300|myocardial infarction|myocardial infarction
672563|NCT00859300|ventricular fibrillation|ventricular fibrillation
672564|NCT00859300|sudden death|sudden death
672565|NCT00859300|polymorphism|polymorphism
672567|NCT00867243|Hepatitis C virus|hepatitis c virus
672568|NCT00867243|HCV|hcv
672569|NCT00867243|Hepatitis C (and cirrhosis)|hepatitis c (and cirrhosis)
672570|NCT00867243|Liver cirrhosis not due to HCV infection|liver cirrhosis not due to hcv infection
672571|NCT00867269|Idiopathic Lymphocytopenia|idiopathic lymphocytopenia
672572|NCT00867269|Opportunistic Infection|opportunistic infection
672573|NCT00867269|Immunodeficiency Syndrome|immunodeficiency syndrome
672574|NCT00867269|Autoimmune Disease|autoimmune disease
672575|NCT00867269|CD4+ Lymphocytes|cd4+ lymphocytes
672576|NCT00867269|Idiopathic CD4 Lymphocytopenia|idiopathic cd4 lymphocytopenia
672577|NCT00867295|implantable catheters|implantable catheters
672578|NCT00867295|Indwelling Catheters|indwelling catheters
672579|NCT00867295|infection|infection
672580|NCT00867295|cefazolin sodium|cefazolin sodium
672581|NCT00867295|prophylactic|prophylactic
672582|NCT00867295|antibiotic|antibiotic
672583|NCT00867295|totally implantable venous access device|totally implantable venous access device
672584|NCT00867295|cancer patients|cancer patients
672585|NCT00867308|IPSS Int-2|ipss int-2
672586|NCT00867308|high risk myelodysplastic syndrome|high risk myelodysplastic syndrome
672587|NCT00867308|MDS)|mds)
672588|NCT00867308|5q31.1 deletions|5q31.1 deletions
672589|NCT00867321|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
672590|NCT00867321|advanced adult primary liver cancer|advanced adult primary liver cancer
672591|NCT00867321|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
672592|NCT00867321|recurrent adult primary liver cancer|recurrent adult primary liver cancer
672593|NCT00867334|colorectal neoplasm|colorectal neoplasm
672594|NCT00867334|colorectal cancer|colorectal cancer
672595|NCT00867334|imatinib mesylate|imatinib mesylate
672596|NCT00867334|Gleevec|gleevec
672597|NCT00867334|Physiological Effects of Drugs|physiological effects of drugs
672598|NCT00867334|panitumumab|panitumumab
672599|NCT00867334|Vectibix|vectibix
672600|NCT00867334|c-kit receptor|c-kit receptor
672601|NCT00867334|Receptor|receptor
672602|NCT00867334|Platelet-Derived Growth Factor alpha|platelet-derived growth factor alpha
672603|NCT00867347|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
672604|NCT00867347|stage II bladder cancer|stage ii bladder cancer
672605|NCT00867347|stage III bladder cancer|stage iii bladder cancer
672606|NCT00867373|Obesity|obesity
672607|NCT00867373|Weight perceptions|weight perceptions
672608|NCT00867412|NSCLC|nsclc
672609|NCT00867412|PET/CT|pet/ct
672610|NCT00867412|Surgery|surgery
672611|NCT00867412|FDG|fdg
672612|NCT00867412|staging|staging
672613|NCT00867425|Diabetes|diabetes
672614|NCT00867425|Internet|internet
672615|NCT00867425|Obesity|obesity
672616|NCT00867425|Obesity with high cardiovascular risks|obesity with high cardiovascular risks
672617|NCT00867438|ulcerative colitis|ulcerative colitis
672618|NCT00867438|Left-sided, mild to moderate ulcerative colitis|left-sided, mild to moderate ulcerative colitis
672619|NCT00867451|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
672620|NCT00867464|Vaccine Efficacy|vaccine efficacy
672621|NCT00867464|Long-Term Protection|long-term protection
672622|NCT00867464|Immune Response|immune response
672623|NCT00867464|Human Papillomavirus|human papillomavirus
672624|NCT00867464|HPV|hpv
672625|NCT00867464|Vaccine|vaccine
672626|NCT00867477|Cancer of esophagus|cancer of esophagus
672627|NCT00867477|Gastrointestine|gastrointestine
672628|NCT00867477|esophagus cancer|esophagus cancer
672629|NCT00867477|Positron emission tomography|positron emission tomography
672630|NCT00867477|PET scan|pet scan
672631|NCT00867477|Nitric oxide|nitric oxide
672632|NCT00867477|NO|no
672633|NCT00867477|NO Breathing Test|no breathing test
672634|NCT00867477|Respiratory symptoms questionnaire|respiratory symptoms questionnaire
672635|NCT00867490|Hypertension|hypertension
672636|NCT00867490|aliskiren|aliskiren
672637|NCT00867490|cardiovascular diseases|cardiovascular diseases
672638|NCT00867503|ovarian cancer|ovarian cancer
672639|NCT00867503|bendamustine|bendamustine
672640|NCT00867542|past IUGR|past iugr
751814|NCT01170598|quality of life|quality of life
672642|NCT00867542|oral findings in children with past IUGR|oral findings in children with past iugr
672643|NCT00867568|Relapsed Neuroblastoma|relapsed neuroblastoma
672644|NCT00867568|Refractory Neuroblastoma|refractory neuroblastoma
672645|NCT00867568|Relapsed Medulloblastoma|relapsed medulloblastoma
672646|NCT00867568|Refractory Medulloblastoma|refractory medulloblastoma
672647|NCT00869336|Tinea Pedis|tinea pedis
672648|NCT00869336|Athlete's Foot|athlete's foot
672649|NCT00869349|Rheumatoid Arthritis|rheumatoid arthritis
672650|NCT00869349|IFS|ifs
672651|NCT00869349|psychosocial|psychosocial
672652|NCT00869349|social support|social support
672653|NCT00869375|acute or critical limb ischemia with angiographic thrombus|acute or critical limb ischemia with angiographic thrombus
672654|NCT00869388|malignant|malignant
672655|NCT00869388|resistant|resistant
672656|NCT00869388|solid tumor|solid tumor
672657|NCT00869401|adult giant cell glioblastoma|adult giant cell glioblastoma
672658|NCT00869401|adult glioblastoma|adult glioblastoma
672659|NCT00869401|adult gliosarcoma|adult gliosarcoma
672660|NCT00869414|hypoglycemia|hypoglycemia
672661|NCT00869414|type 1 diabetes|type 1 diabetes
672662|NCT00869414|split dosing insulin glargine|split dosing insulin glargine
672663|NCT00869414|continuous glucose monitoring|continuous glucose monitoring
672664|NCT00869427|UVI|uvi
672665|NCT00869427|Spinal cord injury|spinal cord injury
672666|NCT00869427|Prevention|prevention
672667|NCT00869427|Vitamin C|vitamin c
672668|NCT00869440|CNS 7056|cns 7056
672669|NCT00869440|Procedural Sedation|procedural sedation
672670|NCT00869440|Sedation|sedation
672671|NCT00869440|Endoscopy|endoscopy
672672|NCT00869453|Gut hormone|gut hormone
672673|NCT00869453|hyperglycaemic clamp|hyperglycaemic clamp
672674|NCT00869453|glucose turnver|glucose turnver
672675|NCT00869466|weight changes|weight changes
672676|NCT00869466|stage IA breast cancer|stage ia breast cancer
672677|NCT00869466|stage IB breast cancer|stage ib breast cancer
672678|NCT00869466|stage II breast cancer|stage ii breast cancer
672679|NCT00869466|stage IIIA breast cancer|stage iiia breast cancer
672680|NCT00869466|stage IIIB breast cancer|stage iiib breast cancer
672681|NCT00869466|stage IIIC breast cancer|stage iiic breast cancer
672682|NCT00869479|Nephrogenic Systemic Fibrosis|nephrogenic systemic fibrosis
672683|NCT00869479|Screening|screening
672684|NCT00869492|Acne|acne
672685|NCT00869492|Nadifloxacin|nadifloxacin
672686|NCT00869492|benzoyl peroxide|benzoyl peroxide
672687|NCT00869505|To evaluate the effectiveness of memantine as an augmenting agent for standard intensive residential treatment of severe obsessive-compulsive disorder (OCD)|to evaluate the effectiveness of memantine as an augmenting agent for standard intensive residential treatment of severe obsessive-compulsive disorder (ocd)
672688|NCT00869518|Staphylococcus aureus|staphylococcus aureus
672689|NCT00869518|colonization|colonization
672690|NCT00869518|eradication|eradication
672691|NCT00869518|HIV|hiv
672692|NCT00869518|rifabutin|rifabutin
672693|NCT00869531|Obesity|obesity
672694|NCT00869531|wholegrain|wholegrain
672695|NCT00869531|wheat|wheat
672696|NCT00869531|cardiovascular disease|cardiovascular disease
672697|NCT00869544|HIV|hiv
672698|NCT00869544|smoker|smoker
672699|NCT00869544|emphysema|emphysema
672700|NCT00869544|antiretrovirals|antiretrovirals
672701|NCT00869544|COPD|copd
672702|NCT00869557|HIV|hiv
672703|NCT00869557|HIV-1|hiv-1
672704|NCT00869557|Antiretroviral Treatment-Naive|antiretroviral treatment-naive
672705|NCT00869557|treatment naive|treatment naive
672706|NCT00869570|adenocarcinoma of the rectum|adenocarcinoma of the rectum
672707|NCT00869570|stage II rectal cancer|stage ii rectal cancer
672708|NCT00869570|stage III rectal cancer|stage iii rectal cancer
672709|NCT00869583|Women|women
672710|NCT00869583|Physical Activity|physical activity
672711|NCT00869583|Hispanic|hispanic
672712|NCT00869583|Overweight|overweight
672713|NCT00869596|Sputum inflammatory biomarkers|sputum inflammatory biomarkers
672714|NCT00869609|Diabetes Prevention|diabetes prevention
672715|NCT00869609|CVD Risk Reduction|cvd risk reduction
672716|NCT00869609|Lifestyle Intervention|lifestyle intervention
672717|NCT00869622|osteoporosis|osteoporosis
672916|NCT00870350|pertactin|pertactin
672718|NCT00869622|bone mineral density|bone mineral density
672719|NCT00869622|fracture|fracture
672720|NCT00869622|antiepileptic drug|antiepileptic drug
672721|NCT00869622|seizure|seizure
672722|NCT00869622|Prevention of bone loss|prevention of bone loss
672723|NCT00869622|Prevention of osteoporosis|prevention of osteoporosis
672724|NCT00869622|Prevention of Fractures|prevention of fractures
672725|NCT00869635|Cholangiocarcinoma|cholangiocarcinoma
672726|NCT00869635|Photodynamic therapy|photodynamic therapy
672727|NCT00869635|S-1|s-1
672728|NCT00869648|Airway|airway
672729|NCT00869648|Anaesthesia|anaesthesia
672730|NCT00869648|Resuscitation|resuscitation
672731|NCT00869648|Ventilation|ventilation
672732|NCT00869674|GeneSearch|genesearch
672733|NCT00869674|Breast cancer|breast cancer
672734|NCT00869700|HIV|hiv
672735|NCT00869700|Malaria|malaria
672736|NCT00869700|Pharmacokinetics|pharmacokinetics
672737|NCT00869700|Treatment Experienced|treatment experienced
672738|NCT00869713|Hemorrhagic Fever|hemorrhagic fever
672739|NCT00869713|Viral Infections|viral infections
672741|NCT00869713|Arbovirus Infections|arbovirus infections
672742|NCT00869713|RVF|rvf
672743|NCT00869739|cancer survivor|cancer survivor
672744|NCT00869739|depression|depression
672745|NCT00869739|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
672746|NCT00869739|male erectile disorder|male erectile disorder
672747|NCT00869739|urinary complications|urinary complications
672748|NCT00869739|gastrointestinal complications|gastrointestinal complications
672749|NCT00869739|stage I prostate cancer|stage i prostate cancer
672750|NCT00869739|stage IIB prostate cancer|stage iib prostate cancer
672751|NCT00869739|stage IIA prostate cancer|stage iia prostate cancer
672752|NCT00869739|stage III prostate cancer|stage iii prostate cancer
672753|NCT00869752|combined type small cell lung cancer|combined type small cell lung cancer
672754|NCT00869752|fusiform type small cell lung cancer|fusiform type small cell lung cancer
672755|NCT00869752|polygonal type small cell lung cancer|polygonal type small cell lung cancer
672756|NCT00869752|lymphocyte-like type small cell lung cancer|lymphocyte-like type small cell lung cancer
672757|NCT00869752|extensive stage small cell lung cancer|extensive stage small cell lung cancer
672758|NCT00869765|Depression|depression
672759|NCT00869765|Treatment|treatment
672760|NCT00869765|Transcranial direct current stimulation|transcranial direct current stimulation
672761|NCT00869765|D-cycloserine|d-cycloserine
672762|NCT00869778|Chronic Hepatitis B|chronic hepatitis b
672763|NCT00869778|HBeAg positive|hbeag positive
672764|NCT00869778|Therapeutic HBV Vaccine|therapeutic hbv vaccine
672765|NCT00869778|HBV-specific Cytotoxic T Lymphocyte|hbv-specific cytotoxic t lymphocyte
672766|NCT00869791|Parkinson's|parkinson's
672767|NCT00869804|breast cancer|breast cancer
672768|NCT00869804|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
672769|NCT00869804|exercise|exercise
672770|NCT00869817|Alzheimer's disease|alzheimer's disease
672771|NCT00869817|antecedent biomarkers|antecedent biomarkers
672772|NCT00869817|Amyloid Precursor Protein (APP) mutation|amyloid precursor protein (app) mutation
673181|NCT00871403|pazopanib|pazopanib
672773|NCT00869817|presenilin I (PS1) mutation|presenilin i (ps1) mutation
672774|NCT00869817|presenilin 2 (PS2) mutation|presenilin 2 (ps2) mutation
672775|NCT00869817|Autosomal Dominant Alzheimer's Disease|autosomal dominant alzheimer's disease
672776|NCT00869830|Biofeedback|biofeedback
672777|NCT00869830|constipation|constipation
672778|NCT00869830|Parkinson's disease|parkinson's disease
672779|NCT00869843|Metastatic colorectal cancer|metastatic colorectal cancer
672780|NCT00869856|Treatment associated with CRI|treatment associated with cri
672781|NCT00869869|Heart Failure|heart failure
672782|NCT00869869|Sleep Disorders|sleep disorders
672783|NCT00869869|Melatonin|melatonin
672784|NCT00869869|Antioxidants|antioxidants
672785|NCT00869869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
672786|NCT00869869|Nervous System Diseases|nervous system diseases
672787|NCT00869869|Physiological Effects of Drugs|physiological effects of drugs
672788|NCT00869869|Vascular Diseases|vascular diseases
672789|NCT00869869|Central Nervous System Depressants|central nervous system depressants
672790|NCT00869869|Protective Agents|protective agents
672791|NCT00869869|Pharmacologic Actions|pharmacologic actions
672792|NCT00869869|Signs and Symptoms|signs and symptoms
672793|NCT00869869|Mental Disorders|mental disorders
672794|NCT00869869|Therapeutic Uses|therapeutic uses
672795|NCT00869869|Neurologic Manifestations|neurologic manifestations
672796|NCT00869869|Cardiovascular Diseases|cardiovascular diseases
672797|NCT00869869|Central Nervous System Agents|central nervous system agents
672798|NCT00869882|Spondylolisthesis|spondylolisthesis
672799|NCT00869882|degeneration|degeneration
672800|NCT00869882|spinal fusion|spinal fusion
672801|NCT00869895|Advanced solid tumors|advanced solid tumors
672802|NCT00869934|Insomnia|insomnia
672803|NCT00869934|Sleep disorders|sleep disorders
672804|NCT00869934|Treatment|treatment
672805|NCT00869934|Sleep disturbances|sleep disturbances
672806|NCT00869947|Unilateral below the knee amputation|unilateral below the knee amputation
672807|NCT00869960|Healthy Volunteers|healthy volunteers
672808|NCT00869973|aprepitant|aprepitant
672809|NCT00869973|delayed emesis|delayed emesis
672810|NCT00869973|cyclophosphamide plus anthracyclines|cyclophosphamide plus anthracyclines
672811|NCT00869973|breast cancer|breast cancer
672812|NCT00869973|antiemetic|antiemetic
672813|NCT00869999|rituximab|rituximab
672814|NCT00869999|everolimus|everolimus
672815|NCT00869999|DLBCL|dlbcl
672816|NCT00869999|mTOR|mtor
672817|NCT00870025|androgens|androgens
672819|NCT00870025|low response|low response
672820|NCT00870025|IVF|ivf
672821|NCT00870025|Ovarian response in women with previous low response|ovarian response in women with previous low response
672822|NCT00870038|PCI|pci
672823|NCT00870038|stent|stent
672824|NCT00870038|drug eluting stent|drug eluting stent
672825|NCT00870038|reendothelialization|reendothelialization
672826|NCT00870038|restenosis|restenosis
672827|NCT00870038|Percutaneous Coronary Angioplasty|percutaneous coronary angioplasty
672828|NCT00870051|Endurant|endurant
672829|NCT00870051|Stent Graft|stent graft
672830|NCT00870051|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
672831|NCT00870064|Surgical Procedures, Operative|surgical procedures, operative
672832|NCT00870064|Fractures, Open|fractures, open
672833|NCT00870064|Fracture Fixation|fracture fixation
672834|NCT00870077|Intrahepatic fat|intrahepatic fat
672836|NCT00870077|body fat|body fat
672837|NCT00870077|impaired glucose tolerance|impaired glucose tolerance
672838|NCT00870103|Cataract|cataract
672839|NCT00870116|SBRT|sbrt
672840|NCT00870116|non-operated|non-operated
672841|NCT00870116|non-metastatic|non-metastatic
672842|NCT00870116|non-small-cell lung cancer|non-small-cell lung cancer
672843|NCT00870116|conformational radiotherapy|conformational radiotherapy
672844|NCT00870116|non-operated non-metastatic non-small-cell lung cancer|non-operated non-metastatic non-small-cell lung cancer
672845|NCT00870129|brain tumor|brain tumor
672846|NCT00870129|radiation|radiation
672847|NCT00870129|MRI|mri
672848|NCT00870129|09-009|09-009
672849|NCT00870142|Bioequivalence|bioequivalence
672850|NCT00870142|amlodipine besylate|amlodipine besylate
672851|NCT00870142|amlodipine|amlodipine
672852|NCT00870142|Healthy subjects|healthy subjects
672853|NCT00870168|stage IV breast cancer|stage iv breast cancer
672854|NCT00870168|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
672855|NCT00870168|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
672856|NCT00870194|diabetes|diabetes
672857|NCT00870194|exenatide|exenatide
672858|NCT00870194|Byetta|byetta
672859|NCT00870194|sitagliptin|sitagliptin
672860|NCT00870194|Januvia|januvia
672861|NCT00870194|Amylin|amylin
672862|NCT00870194|Lilly|lilly
672863|NCT00870207|Feasibility of implementing TSSC in worksite environment|feasibility of implementing tssc in worksite environment
672864|NCT00870220|Turner's Syndrome|turner's syndrome
672865|NCT00870233|Gynecologic cancers|gynecologic cancers
672866|NCT00870233|Quality of Life|quality of life
672867|NCT00870233|08-155|08-155
672868|NCT00870233|Surgery|surgery
672869|NCT00870246|COPD|copd
672870|NCT00870246|pulmonary emphysema|pulmonary emphysema
672871|NCT00870259|Weight loss|weight loss
672872|NCT00870259|Weight maintenance|weight maintenance
672873|NCT00870272|Medical Abortion|medical abortion
672874|NCT00870272|Mifepristone|mifepristone
672875|NCT00870272|Misoprostol|misoprostol
672876|NCT00870272|Sublingual administration|sublingual administration
672877|NCT00870272|Buccal administration|buccal administration
672878|NCT00870285|Psoriasis|psoriasis
672879|NCT00870285|Biologic|biologic
672880|NCT00870285|Ustekinumab|ustekinumab
672881|NCT00870285|UVB-311nm narrowband|uvb-311nm narrowband
672882|NCT00870285|phototherapy|phototherapy
672883|NCT00870285|half-side comparison|half-side comparison
672884|NCT00870298|drug orders|drug orders
672885|NCT00870311|Lithium|lithium
672886|NCT00870311|Neuroprotection|neuroprotection
672887|NCT00870311|Neurotrophic|neurotrophic
672888|NCT00870311|bcl2|bcl2
672889|NCT00870311|gsk3|gsk3
672890|NCT00870311|pkc|pkc
672891|NCT00870311|MRI|mri
672892|NCT00870311|myoinositol|myoinositol
672893|NCT00870311|MRS|mrs
672894|NCT00870311|Alzheimers Disease|alzheimers disease
672895|NCT00870324|ICD|icd
672896|NCT00870324|Tachyarrhythmias|tachyarrhythmias
672897|NCT00870324|Atrial Fibrillation|atrial fibrillation
672898|NCT00870324|Patients who meets current ICD or CRT-D implant indications|patients who meets current icd or crt-d implant indications
672899|NCT00870337|recurrent endometrial carcinoma|recurrent endometrial carcinoma
672900|NCT00870337|stage IV endometrial carcinoma|stage iv endometrial carcinoma
672901|NCT00870337|endometrial adenocarcinoma|endometrial adenocarcinoma
672902|NCT00870350|immunogenicity|immunogenicity
672903|NCT00870350|safety|safety
672904|NCT00870350|tetanus|tetanus
672905|NCT00870350|diphtheria|diphtheria
672906|NCT00870350|acellular|acellular
672907|NCT00870350|pertussis|pertussis
672908|NCT00870350|vaccine|vaccine
672909|NCT00870350|booster|booster
672910|NCT00870350|adverse event|adverse event
672911|NCT00870350|adverse reaction|adverse reaction
672912|NCT00870350|DT1aP|dt1ap
672913|NCT00870350|DT5ap|dt5ap
672914|NCT00870350|FHA|fha
672915|NCT00870350|fimbriae|fimbriae
672917|NCT00870350|SMI|smi
672918|NCT00870350|Smittskyddsinstitutet|smittskyddsinstitutet
672919|NCT00870350|Immune response and safety profile to a Tdap booster|immune response and safety profile to a tdap booster
672920|NCT00870363|HIV|hiv
672921|NCT00870363|HIV positive|hiv positive
672922|NCT00870363|Gastrointestinal Associated Lymphoid Tissue (GALT)|gastrointestinal associated lymphoid tissue (galt)
672923|NCT00870363|GALT Immune Reconstruction|galt immune reconstruction
672924|NCT00870363|treatment naive|treatment naive
672925|NCT00870376|lower urinary tract symptoms|lower urinary tract symptoms
672926|NCT00870376|biomarkers|biomarkers
672927|NCT00870376|urodynamic studies|urodynamic studies
672928|NCT00870402|aldosterone|aldosterone
672929|NCT00870402|albuminuria|albuminuria
672930|NCT00870402|diastolic disfunction|diastolic disfunction
672931|NCT00870402|hyperkalemia|hyperkalemia
672932|NCT00870415|stage IA breast cancer|stage ia breast cancer
672933|NCT00870415|stage IB breast cancer|stage ib breast cancer
672934|NCT00870415|stage II breast cancer|stage ii breast cancer
672935|NCT00870415|stage IIIA breast cancer|stage iiia breast cancer
672936|NCT00870415|stage IIIC breast cancer|stage iiic breast cancer
672937|NCT00870415|ductal breast carcinoma|ductal breast carcinoma
672938|NCT00870415|invasive ductal breast carcinoma|invasive ductal breast carcinoma
672939|NCT00870428|Preeclampsia|preeclampsia
672940|NCT00870428|proteinuria|proteinuria
672941|NCT00870441|ASP2151|asp2151
672942|NCT00870441|Valacyclovir|valacyclovir
672943|NCT00870441|Healthy Volunteers|healthy volunteers
672944|NCT00870454|Diabetic neuropathies|diabetic neuropathies
672945|NCT00870454|Diabetic neuropathy, painful|diabetic neuropathy, painful
672946|NCT00870454|Carisbamate|carisbamate
672947|NCT00870454|Neurotherapeutic agents|neurotherapeutic agents
672948|NCT00870467|Rheumatoid Arthritis|rheumatoid arthritis
672949|NCT00870480|Bioequivalence|bioequivalence
672950|NCT00870480|finasteride|finasteride
672951|NCT00870480|Healthy subjects|healthy subjects
672952|NCT00870493|proteinuria|proteinuria
672953|NCT00870493|renal failure|renal failure
672954|NCT00870493|glomerulonephritis|glomerulonephritis
672955|NCT00870506|Randomized Controlled Trial|randomized controlled trial
672956|NCT00870506|Healthcare Disparities|healthcare disparities
672957|NCT00870519|Alzheimer disease|alzheimer disease
672958|NCT00870532|Phase I|phase i
672959|NCT00870532|Combination|combination
672960|NCT00870532|Anti-angiogenic|anti-angiogenic
672961|NCT00870532|Sorafenib|sorafenib
672962|NCT00870532|Metronomic oral vinorelbine|metronomic oral vinorelbine
672963|NCT00870545|spouses|spouses
672964|NCT00870545|social support|social support
672965|NCT00870545|reintegration|reintegration
672966|NCT00870545|families|families
672967|NCT00870545|military|military
672968|NCT00870545|post deployment|post deployment
672969|NCT00870545|OEF/OIF|oef/oif
672970|NCT00870558|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
672971|NCT00870558|advanced adult primary liver cancer|advanced adult primary liver cancer
672972|NCT00870558|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
672973|NCT00870558|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
672974|NCT00870571|Bioequivalence|bioequivalence
672975|NCT00870571|amlodipine besylate|amlodipine besylate
672976|NCT00870571|amlodipine|amlodipine
672977|NCT00870571|Healthy subjects|healthy subjects
672978|NCT00870584|Asthma; asthma management; asthma impairment ; Xolair ; omalizumab|asthma; asthma management; asthma impairment ; xolair ; omalizumab
672979|NCT00870597|Floaters|floaters
672980|NCT00870597|multifocal IOL|multifocal iol
672981|NCT00870597|visual complaints|visual complaints
672982|NCT00870597|vitrectomy|vitrectomy
672983|NCT00870610|jugular venous oxygen saturation|jugular venous oxygen saturation
672984|NCT00870610|hypothermia|hypothermia
672985|NCT00870636|Pan-Vascular Endothelial Growth Factor Blockade|pan-vascular endothelial growth factor blockade
672988|NCT00870636|Bevacizumab|bevacizumab
672989|NCT00870636|Avastin|avastin
672990|NCT00870649|Schistosomiasis vaccine|schistosomiasis vaccine
672991|NCT00870649|therapeutic vaccine|therapeutic vaccine
672992|NCT00870649|Bilhvax|bilhvax
672993|NCT00870675|Ventriculomegaly|ventriculomegaly
672994|NCT00870675|ultrasound|ultrasound
672995|NCT00870675|MRI|mri
672996|NCT00870675|fetus|fetus
672997|NCT00870688|valproate|valproate
672998|NCT00870688|epilepsy|epilepsy
672999|NCT00870688|compliance|compliance
673000|NCT00870688|sustained released minitablet|sustained released minitablet
673001|NCT00870688|Orfiril long|orfiril long
673002|NCT00870701|sarcoma|sarcoma
673003|NCT00870701|soft tissue|soft tissue
673004|NCT00870701|members|members
673005|NCT00870701|radiotherapy|radiotherapy
673006|NCT00870701|absence of radiotherapy|absence of radiotherapy
673007|NCT00870714|Prostate Cancer|prostate cancer
673008|NCT00870714|Neoadjuvant|neoadjuvant
673009|NCT00870727|PDD NOS|pdd nos
673010|NCT00870740|MS|ms
673011|NCT00870740|Multiple Sclerosis|multiple sclerosis
673012|NCT00870753|Eating disorders|eating disorders
673013|NCT00870753|yoga|yoga
673014|NCT00870753|body awareness|body awareness
673015|NCT00870753|depression|depression
673016|NCT00870753|anxiety|anxiety
673017|NCT00870779|Fluorescence|fluorescence
673018|NCT00870779|Brain Tumor|brain tumor
673019|NCT00870779|Malignant Glioma|malignant glioma
673020|NCT00870779|Pituitary Tumor|pituitary tumor
673021|NCT00870779|Skull Base Tumor|skull base tumor
673022|NCT00870779|Brain Lesions|brain lesions
673023|NCT00870779|Brain Metastases|brain metastases
673024|NCT00870779|Meningioma|meningioma
673025|NCT00870792|HIV|hiv
673026|NCT00870792|antiretroviral therapy|antiretroviral therapy
673027|NCT00870792|medication adherence|medication adherence
673432|NCT00862602|online|online
673028|NCT00870792|Treatment Experienced|treatment experienced
673029|NCT00870818|Teplizumab|teplizumab
673030|NCT00870818|Protege|protege
673031|NCT00870818|MGA031|mga031
673032|NCT00870818|Monoclonal antibody|monoclonal antibody
673033|NCT00870818|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
673034|NCT00870818|T1DM|t1dm
673035|NCT00870818|MacroGenics|macrogenics
673036|NCT00870831|diabetes|diabetes
673037|NCT00870844|Acute ischemic stroke|acute ischemic stroke
673038|NCT00870844|Erythropoietin|erythropoietin
673039|NCT00870844|Carbamylated|carbamylated
673040|NCT00870844|Neuroprotection|neuroprotection
673041|NCT00870857|Lungs|lungs
673042|NCT00870857|antiretrovirals|antiretrovirals
673043|NCT00870857|HIV|hiv
673044|NCT00870857|COPD|copd
673045|NCT00870870|Tumors|tumors
673046|NCT00870870|Antibodies, Monoclonal|antibodies, monoclonal
673047|NCT00870870|Stage IIIb Metastatic Non-Small Cell Lung Cancer|stage iiib metastatic non-small cell lung cancer
673048|NCT00870870|Stage IV Metastatic Non-Small Cell Lung Cancer|stage iv metastatic non-small cell lung cancer
673049|NCT00870896|capsaicin|capsaicin
673050|NCT00870896|COPD|copd
673051|NCT00870896|COPD with chronic bronchitis|copd with chronic bronchitis
673052|NCT00870935|Balloon catheter|balloon catheter
673053|NCT00870935|Cervical vacuum cup|cervical vacuum cup
673054|NCT00870935|Hysterosalpingography|hysterosalpingography
673055|NCT00870935|Infertility|infertility
673056|NCT00870935|Pain|pain
673057|NCT00870935|Fallopian Tube Patency Tests|fallopian tube patency tests
673058|NCT00870935|Female Infertility|female infertility
673059|NCT00870948|Open Label|open label
673060|NCT00870948|Healthy Volunteers|healthy volunteers
673061|NCT00870961|colon cancer|colon cancer
673062|NCT00870961|rectal cancer|rectal cancer
673063|NCT00870961|adenomatous polyp|adenomatous polyp
673064|NCT00870974|Parkinson|parkinson
673065|NCT00870974|Huntington's|huntington's
673066|NCT00870974|Fragile X|fragile x
673067|NCT00870974|Autistic Spectrum|autistic spectrum
673068|NCT00870974|Alzheimer's|alzheimer's
673069|NCT00870974|MCI|mci
673070|NCT00870987|Malaria|malaria
673071|NCT00870987|Vaccine|vaccine
673072|NCT00871000|Boostrix Polio|boostrix polio
673073|NCT00871000|dTpa-IPV|dtpa-ipv
673179|NCT00871390|Permanent/Persistent Atrial Fibrillation|permanent/persistent atrial fibrillation
673074|NCT00871013|This study is being done in an attempt to improve the remission rate and the survival time for participants with high-risk myeloma|this study is being done in an attempt to improve the remission rate and the survival time for participants with high-risk myeloma
673075|NCT00871026|CAD/CAM|cad/cam
673076|NCT00871026|orthodontics|orthodontics
673077|NCT00871026|fixed appliance|fixed appliance
673078|NCT00871026|tooth movement|tooth movement
673079|NCT00871026|Adverse Effects|adverse effects
673080|NCT00871026|Time Factors|time factors
673081|NCT00871026|Treatment Outcome|treatment outcome
673082|NCT00871039|Alcoholism|alcoholism
673083|NCT00871039|Mechanical ventilation|mechanical ventilation
673084|NCT00871052|Polymorphic light eruption|polymorphic light eruption
673085|NCT00871052|UV radiation|uv radiation
673086|NCT00871052|Vitamin D|vitamin d
673087|NCT00871052|Immune suppression|immune suppression
673088|NCT00871052|Prevention|prevention
673089|NCT00871065|Cerebral Vasospasm|cerebral vasospasm
673090|NCT00871065|Vasospasm|vasospasm
673091|NCT00871065|Subarachnoid Hemorrhage|subarachnoid hemorrhage
673092|NCT00871065|Sildenafil citrate|sildenafil citrate
673093|NCT00871065|Aneurysm|aneurysm
673094|NCT00871065|Intracranial aneurysm|intracranial aneurysm
673095|NCT00871091|CAD/CAM|cad/cam
673096|NCT00871091|orthodontics|orthodontics
673097|NCT00871091|fixed appliance|fixed appliance
673098|NCT00871091|tooth movement|tooth movement
673099|NCT00871104|Infective endocarditis|infective endocarditis
673100|NCT00871117|Co-administration|co-administration
673101|NCT00871117|Immunization|immunization
673102|NCT00871117|Preschool|preschool
673103|NCT00871117|Booster|booster
673104|NCT00871130|Thyroid gland|thyroid gland
673105|NCT00871130|bariatric surgery|bariatric surgery
673106|NCT00871130|weight loss|weight loss
673107|NCT00871130|thyroid hormones|thyroid hormones
673108|NCT00871130|adult|adult
673109|NCT00871130|morbid obesity|morbid obesity
673110|NCT00871130|cohort|cohort
673111|NCT00871143|CBT|cbt
673112|NCT00871143|BDD|bdd
673113|NCT00871156|Drug-Drug Interaction|drug-drug interaction
673114|NCT00871169|Irinotecan|irinotecan
673115|NCT00871169|Oxaliplatin|oxaliplatin
673116|NCT00871169|Cetuximab|cetuximab
673226|NCT00871533|Markers, Biological|markers, biological
673117|NCT00871169|Advanced or metastatic pancreatic cancer|advanced or metastatic pancreatic cancer
673118|NCT00871182|COPD|copd
673119|NCT00871182|obstructive lung diseases|obstructive lung diseases
673120|NCT00871182|Tiotropium|tiotropium
673121|NCT00871195|Rhesus D|rhesus d
673122|NCT00871195|RHD|rhd
673123|NCT00871195|genotype|genotype
673124|NCT00871195|phenotype|phenotype
673125|NCT00871195|neonatal|neonatal
673126|NCT00871195|noninvasive|noninvasive
673127|NCT00871195|fetal|fetal
673128|NCT00871195|MassARRAY|massarray
673129|NCT00871195|DNA|dna
673130|NCT00871208|Atopic Dermatitis|atopic dermatitis
673132|NCT00871208|quality of life|quality of life
673133|NCT00871234|HIV|hiv
673134|NCT00871234|Endothelial function|endothelial function
673135|NCT00871234|Etravirine|etravirine
673136|NCT00871247|Bioequivalence|bioequivalence
673137|NCT00871247|finasteride|finasteride
673138|NCT00871247|Healthy subjects|healthy subjects
673139|NCT00871260|Coronary Disease|coronary disease
673140|NCT00871260|Stress Testing|stress testing
673141|NCT00871260|Lexiscan (regadenoson)|lexiscan (regadenoson)
673142|NCT00871260|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
673143|NCT00871273|capecitabine|capecitabine
673144|NCT00871273|total gastrectomy|total gastrectomy
673145|NCT00871273|pharmacokinetic|pharmacokinetic
673146|NCT00871286|Chronic rhinosinusitis|chronic rhinosinusitis
673147|NCT00871286|Chronic sinusitis|chronic sinusitis
673149|NCT00871299|Treatment-resistant depression, meditation, mindfulness|treatment-resistant depression, meditation, mindfulness
673150|NCT00871312|diabetes|diabetes
673151|NCT00871312|diabetic|diabetic
673152|NCT00871312|wound|wound
673153|NCT00871312|ulcer|ulcer
673154|NCT00871312|lower extremity|lower extremity
673155|NCT00871312|foot|foot
673156|NCT00871312|oxygen|oxygen
673157|NCT00871312|hyperbaric|hyperbaric
673158|NCT00871312|topical wound oxygen|topical wound oxygen
673159|NCT00871325|Gastric emptying|gastric emptying
673160|NCT00871325|Small bowel transit|small bowel transit
673161|NCT00871325|Colonic transit|colonic transit
673162|NCT00871325|Whole gut transit|whole gut transit
673163|NCT00871325|Postoperative Ileus|postoperative ileus
673164|NCT00871338|combined|combined
673165|NCT00871338|Vaccines|vaccines
673166|NCT00871364|Bioequivalence|bioequivalence
673167|NCT00871364|venlafaxine|venlafaxine
673168|NCT00871364|Healthy subjects|healthy subjects
673169|NCT00871377|epilepsy|epilepsy
673170|NCT00871377|cardiac risk factors|cardiac risk factors
673171|NCT00871377|memory|memory
673172|NCT00871377|cognition|cognition
673173|NCT00871377|n-3 fatty acids|n-3 fatty acids
673174|NCT00871377|fish oil|fish oil
673175|NCT00871377|EPA|epa
673176|NCT00871377|DHA|dha
673177|NCT00871377|seizures|seizures
673178|NCT00871390|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
673182|NCT00871403|pemetrexed|pemetrexed
673183|NCT00871403|cisplatin|cisplatin
673184|NCT00871403|non-small cell lung cancer|non-small cell lung cancer
673185|NCT00871403|NSCLC|nsclc
673186|NCT00871429|skin toxicity|skin toxicity
673187|NCT00871429|cancer patients|cancer patients
673188|NCT00871429|adverse effects|adverse effects
673189|NCT00871442|PCEA|pcea
673190|NCT00871442|labor and delivery|labor and delivery
673191|NCT00871442|pain|pain
673192|NCT00871442|epidural|epidural
673193|NCT00871442|anesthesia|anesthesia
673194|NCT00871442|pregnant women|pregnant women
673195|NCT00871455|Spinal Cord Injury|spinal cord injury
673196|NCT00871455|Baclofen|baclofen
673197|NCT00871455|Growth Hormone, Pituitary|growth hormone, pituitary
673198|NCT00871455|Insulin-Like Growth Factor I|insulin-like growth factor i
673199|NCT00871507|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
673200|NCT00871520|Palliative Care|palliative care
673201|NCT00871520|Predictive Value of Tests|predictive value of tests
673202|NCT00871520|Prospective Studies|prospective studies
673203|NCT00871520|Survival Analysis|survival analysis
673204|NCT00871520|Survival prediction|survival prediction
673205|NCT00871533|Biochemical Marker|biochemical marker
673206|NCT00871533|Biochemical Markers|biochemical markers
673207|NCT00871533|Biologic Marker|biologic marker
673208|NCT00871533|Biologic Markers|biologic markers
673209|NCT00871533|Biomarkers|biomarkers
673210|NCT00871533|Clinical Marker|clinical marker
673211|NCT00871533|Clinical Markers|clinical markers
673212|NCT00871533|Immune Marker|immune marker
673213|NCT00871533|Immune Markers|immune markers
673214|NCT00871533|Immunologic Marker|immunologic marker
673215|NCT00871533|Immunologic Markers|immunologic markers
673216|NCT00871533|Laboratory Marker|laboratory marker
673217|NCT00871533|Laboratory Markers|laboratory markers
673218|NCT00871533|Marker, Biochemical|marker, biochemical
673219|NCT00871533|Marker, Biological|marker, biological
673220|NCT00871533|Marker, Clinical|marker, clinical
673221|NCT00871533|Marker, Immunologic|marker, immunologic
673222|NCT00871533|Marker, Laboratory|marker, laboratory
673223|NCT00871533|Marker, Serum|marker, serum
673224|NCT00871533|Marker, Surrogate|marker, surrogate
673225|NCT00871533|Markers, Biochemical|markers, biochemical
673227|NCT00871533|Markers, Clinical|markers, clinical
673228|NCT00871533|Markers, Immunologic|markers, immunologic
673229|NCT00871533|Markers, Laboratory|markers, laboratory
673230|NCT00871533|Markers, Serum|markers, serum
673231|NCT00871533|Markers, Surrogate|markers, surrogate
673232|NCT00871533|Markers, Viral|markers, viral
673233|NCT00871533|Serum Marker|serum marker
673234|NCT00871533|Serum Markers|serum markers
673235|NCT00871533|Surrogate End Point|surrogate end point
673236|NCT00871533|Surrogate End Points|surrogate end points
673237|NCT00871533|Surrogate Endpoint|surrogate endpoint
673243|NCT00871572|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
673245|NCT00871585|PSA|psa
673246|NCT00871585|advanced prostate cancer|advanced prostate cancer
673247|NCT00871598|plaque psoriasis|plaque psoriasis
673249|NCT00871598|safety|safety
673250|NCT00871598|pharmacokinetics|pharmacokinetics
673251|NCT00871611|Hereditary|hereditary
673252|NCT00871611|Anderson-Fabry|anderson-fabry
673253|NCT00871611|prevalence|prevalence
673254|NCT00871611|heart|heart
673255|NCT00871611|hypertrophy|hypertrophy
673256|NCT00871611|urine|urine
673257|NCT00871611|globotriaosylceramide|globotriaosylceramide
673258|NCT00871611|isoforms|isoforms
673259|NCT00871611|α - Galactosidase|α - galactosidase
673265|NCT00871650|Post Traumatic Stress Disorder|post traumatic stress disorder
673266|NCT00871650|PTSD|ptsd
673267|NCT00871650|Brain|brain
673268|NCT00871650|Imaging|imaging
673269|NCT00871650|PET|pet
673270|NCT00871650|Neural|neural
673271|NCT00871650|Sleep|sleep
673272|NCT00871650|REM Sleep|rem sleep
673273|NCT00871689|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
673274|NCT00871689|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
673275|NCT00871689|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
673276|NCT00871689|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
673277|NCT00871689|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
673278|NCT00871689|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
673400|NCT00862511|metal ion concentration|metal ion concentration
673279|NCT00871689|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
673280|NCT00871689|secondary acute myeloid leukemia|secondary acute myeloid leukemia
673281|NCT00871689|childhood acute myeloid leukemia with 11q23 (MLL) abnormalities|childhood acute myeloid leukemia with 11q23 (mll) abnormalities
673282|NCT00871689|childhood acute myeloid leukemia with inv(16)(p13;q22)|childhood acute myeloid leukemia with inv(16)(p13;q22)
673283|NCT00871689|childhood acute myeloid leukemia with t(15;17)(q22;q12)|childhood acute myeloid leukemia with t(15;17)(q22;q12)
673284|NCT00871689|childhood acute myeloid leukemia with t(16;16)(p13;q22)|childhood acute myeloid leukemia with t(16;16)(p13;q22)
673285|NCT00871689|childhood acute myeloid leukemia with t(8;21)(q22;q22)|childhood acute myeloid leukemia with t(8;21)(q22;q22)
673286|NCT00871702|Leukemia|leukemia
673287|NCT00871702|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
673288|NCT00871702|Hodgkin Disease|hodgkin disease
673289|NCT00871702|Myelodysplastic Syndromes|myelodysplastic syndromes
673290|NCT00871702|Multiple Myeloma|multiple myeloma
673291|NCT00871715|stroke|stroke
673292|NCT00871715|hemiparesis|hemiparesis
673293|NCT00871715|physical therapy|physical therapy
673294|NCT00871715|occupational therapy|occupational therapy
673295|NCT00871715|neurorehabilitation|neurorehabilitation
673296|NCT00871715|patient focused|patient focused
673297|NCT00871715|motor learning|motor learning
673298|NCT00871715|motor control|motor control
673299|NCT00871715|skill acquisition|skill acquisition
673300|NCT00871715|skill training|skill training
673301|NCT00871715|motor recovery|motor recovery
673302|NCT00871715|task oriented training|task oriented training
673303|NCT00871715|task specific training|task specific training
673304|NCT00871715|arm function|arm function
673305|NCT00871715|hand function|hand function
673306|NCT00871715|upper extremity|upper extremity
673307|NCT00871715|arm therapy|arm therapy
673308|NCT00871715|physical rehabilitation|physical rehabilitation
673309|NCT00871715|arm rehabilitation|arm rehabilitation
673310|NCT00871715|motor function|motor function
673311|NCT00871728|Onychomycosis, Toe|onychomycosis, toe
673312|NCT00871728|Itraconazole|itraconazole
673313|NCT00871728|Sporanox|sporanox
673314|NCT00871741|Combined vaccine|combined vaccine
673315|NCT00871741|Primary vaccination|primary vaccination
673316|NCT00871754|Bladder Cancer|bladder cancer
673317|NCT00871754|Cancer, bladder|cancer, bladder
673318|NCT00871754|Urinary Bladder Cancer|urinary bladder cancer
673319|NCT00871767|AZD5672|azd5672
673320|NCT00871767|relative bioavailability|relative bioavailability
673321|NCT00871767|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
673322|NCT00871780|TYSABRI naive|tysabri naive
673323|NCT00871780|Relapsing-remitting multiple sclerosis (RRMS)|relapsing-remitting multiple sclerosis (rrms)
673324|NCT00871806|Pharmacokinetics|pharmacokinetics
673325|NCT00871806|eletriptan|eletriptan
673326|NCT00871806|bioavailability|bioavailability
673327|NCT00871806|oral disintegrating tablet|oral disintegrating tablet
673328|NCT00871819|Spinal Cord Stimulation|spinal cord stimulation
673329|NCT00871832|hyperglycemia|hyperglycemia
673330|NCT00871832|HgA1c|hga1c
673331|NCT00871832|mortality|mortality
673332|NCT00862251|cardiovascular disorder|cardiovascular disorder
673333|NCT00862277|Menactra®|menactra®
673334|NCT00862277|Menomune®|menomune®
673335|NCT00862277|Meningitis|meningitis
673336|NCT00862277|Meningococcal Infections|meningococcal infections
673337|NCT00862290|sepsis|sepsis
673338|NCT00862290|microRNA|microrna
673339|NCT00862303|autologous cytokine induced killer cells|autologous cytokine induced killer cells
673340|NCT00862303|dendritic cell|dendritic cell
673341|NCT00862303|vaccine|vaccine
673342|NCT00862303|renal cell carcinoma|renal cell carcinoma
675725|NCT00877617|Neoadjuvant Investigational Therapy|neoadjuvant investigational therapy
675726|NCT00877617|Radical Prostatectomy|radical prostatectomy
675727|NCT00877682|Prostate Cancer|prostate cancer
675728|NCT00877682|Prostate Tumor|prostate tumor
675729|NCT00877682|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
675730|NCT00877682|PCA|pca
675731|NCT00877682|Regional Prostate Cryoablation|regional prostate cryoablation
673343|NCT00862316|Eligible for Unicompartmental Knee Arthritis|eligible for unicompartmental knee arthritis
673344|NCT00862329|Healthy subjects|healthy subjects
673345|NCT00862342|colorectal cancer|colorectal cancer
673346|NCT00862342|Bevacizumab|bevacizumab
673347|NCT00862355|Carcinoma|carcinoma
673348|NCT00862355|Ovary|ovary
673349|NCT00862355|Carcinoma Ovary|carcinoma ovary
673350|NCT00862368|Motivational Interviewing|motivational interviewing
673351|NCT00862368|Pediatric Asthma|pediatric asthma
673352|NCT00862368|Smoking Cessation|smoking cessation
673353|NCT00862368|Environmental Tobacco Smoke|environmental tobacco smoke
673354|NCT00862368|Second hand smoke|second hand smoke
673355|NCT00862368|Biomarker|biomarker
673356|NCT00862368|Asthma|asthma
673357|NCT00862368|Asthma Education|asthma education
673358|NCT00862368|Family Intervention|family intervention
673359|NCT00862368|Smoking|smoking
673360|NCT00862368|Nicotine Patch|nicotine patch
673361|NCT00862368|Parents|parents
673362|NCT00862368|Caregivers|caregivers
673363|NCT00862368|Child Wellness|child wellness
673364|NCT00862381|shock|shock
673365|NCT00862381|Tracheal Intubation|tracheal intubation
673366|NCT00862381|reanimation|reanimation
673367|NCT00862381|suprarenal insufficiency|suprarenal insufficiency
673368|NCT00862381|Etomidate|etomidate
673369|NCT00862381|Adrenocorticotropic Hormone|adrenocorticotropic hormone
673370|NCT00862381|hydrocortisone|hydrocortisone
673371|NCT00862407|Cardiopulmonary bypass|cardiopulmonary bypass
673372|NCT00862407|Non-pulsatile perfusion|non-pulsatile perfusion
673373|NCT00862407|Pulsatile perfusion|pulsatile perfusion
673374|NCT00862407|plasma proteins|plasma proteins
673375|NCT00862420|Platelet aggregation inhibitors|platelet aggregation inhibitors
673376|NCT00862420|Peripheral arterial disease (PAD)|peripheral arterial disease (pad)
673377|NCT00862433|Vitamin C|vitamin c
673378|NCT00862433|Antioxidant|antioxidant
673379|NCT00862433|Lipid Peroxidation|lipid peroxidation
673380|NCT00862433|Non-Insulin Requiring Diabetics|non-insulin requiring diabetics
673381|NCT00862433|Alpha-Tocopherol|alpha-tocopherol
673382|NCT00862433|Health Volunteer|health volunteer
673384|NCT00862433|Normal Weight|normal weight
673385|NCT00862433|Overweight|overweight
673386|NCT00862433|Type 2 Diabetes|type 2 diabetes
673387|NCT00862446|Parenteral nutrition associate liver disease|parenteral nutrition associate liver disease
673388|NCT00862446|TPN cholestasis|tpn cholestasis
673389|NCT00862446|TPN Associated Liver Disease|tpn associated liver disease
673390|NCT00862459|Contrast Agents|contrast agents
673391|NCT00862472|open-angle glaucoma|open-angle glaucoma
673392|NCT00862472|ocular hypertension|ocular hypertension
673393|NCT00862472|open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)|open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)
673394|NCT00862498|PTSD|ptsd
673395|NCT00862498|Written Disclosure|written disclosure
673396|NCT00862498|Written Emotional Disclosure|written emotional disclosure
673397|NCT00862498|Narrative Exposure|narrative exposure
673398|NCT00862498|Narrative Writing|narrative writing
673399|NCT00862498|Motor Vehicle Accident|motor vehicle accident
673401|NCT00862511|total knee arthroplasty|total knee arthroplasty
673402|NCT00862511|metal hypersensitivity|metal hypersensitivity
673403|NCT00862550|Head and Neck Cancer|head and neck cancer
673404|NCT00862550|HNC|hnc
673405|NCT00862550|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
673406|NCT00862550|Acupuncture|acupuncture
673407|NCT00862550|Radiation-Induced Xerostomia|radiation-induced xerostomia
673408|NCT00862550|Xerostomia|xerostomia
673409|NCT00862550|Dry Mouth|dry mouth
673410|NCT00862550|Radiation|radiation
673411|NCT00862563|Alcoholism|alcoholism
673412|NCT00862563|Alcohol Dependence|alcohol dependence
673413|NCT00862563|Alcohol Abuse|alcohol abuse
673414|NCT00862563|Substance Abuse|substance abuse
673415|NCT00862563|Alcoholic Intoxication|alcoholic intoxication
673416|NCT00862576|Burning Mouth Syndrome|burning mouth syndrome
673417|NCT00862576|Sleep|sleep
673418|NCT00862576|Neuropathic pain|neuropathic pain
673419|NCT00862576|Glossodynia|glossodynia
673420|NCT00862576|Chronic pain|chronic pain
673421|NCT00862576|Orofacial pain|orofacial pain
673422|NCT00862589|glucagon|glucagon
673423|NCT00862589|GLP-1|glp-1
673424|NCT00862589|hyperglycemia|hyperglycemia
673425|NCT00862602|GDM|gdm
673426|NCT00862602|gestational diabetes|gestational diabetes
673427|NCT00862602|pregnancy|pregnancy
673434|NCT00862615|Inflammation|inflammation
673435|NCT00862615|Muscle protein synthesis|muscle protein synthesis
673436|NCT00862615|Osteopenia|osteopenia
673437|NCT00862615|Sarcopenia|sarcopenia
673438|NCT00862641|regadenoson|regadenoson
673439|NCT00862641|CVT 3146|cvt 3146
673440|NCT00862641|asthma|asthma
673441|NCT00862641|coronary artery disease|coronary artery disease
673442|NCT00862641|pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
673443|NCT00862667|Pharmacokinetics|pharmacokinetics
673444|NCT00862680|Lung Colorectum|lung colorectum
673445|NCT00862680|Colorectal cancer|colorectal cancer
673446|NCT00862680|Lung Cancer|lung cancer
673447|NCT00862680|Liver Cancer|liver cancer
673448|NCT00862680|Non-small cell lung cancer|non-small cell lung cancer
673449|NCT00862680|NSCLC|nsclc
673450|NCT00862680|4D PET/CT Imaging|4d pet/ct imaging
673451|NCT00862680|Positron emission tomography/computed tomography|positron emission tomography/computed tomography
673452|NCT00862680|PET/CT scan|pet/ct scan
673453|NCT00862680|Breathing motion|breathing motion
673454|NCT00862693|Immunoglobulin A|immunoglobulin a
673455|NCT00862693|Antibodies|antibodies
673456|NCT00862693|treatment|treatment
673457|NCT00862706|Chronic HBV|chronic hbv
673458|NCT00862732|active suicidal ideation|active suicidal ideation
673459|NCT00862732|cognitive behavioural therapy|cognitive behavioural therapy
673460|NCT00862732|Sri Lanka|sri lanka
673461|NCT00862732|RCT|rct
673462|NCT00862758|juvenile idiopathic arthritis|juvenile idiopathic arthritis
673463|NCT00862784|Colorectal carcinoma|colorectal carcinoma
673464|NCT00862784|CRC|crc
673465|NCT00862784|Colon Cancer|colon cancer
673466|NCT00862797|endotracheal tube|endotracheal tube
673467|NCT00862797|swallowing|swallowing
673468|NCT00862797|aspiration|aspiration
673469|NCT00862797|cuff pressure|cuff pressure
673470|NCT00862797|pneumonia|pneumonia
673471|NCT00862810|Human papillomavirus|human papillomavirus
673472|NCT00862810|Cervical cancer|cervical cancer
673473|NCT00862810|Genital warts|genital warts
673474|NCT00862810|Vaccine|vaccine
673968|NCT00872066|Bone Cement|bone cement
673475|NCT00862810|Immunogenicity|immunogenicity
673476|NCT00862823|Healthy Volunteers|healthy volunteers
673477|NCT00862836|ZD6474|zd6474
673478|NCT00862836|Vandetanib|vandetanib
673479|NCT00862836|Zactima|zactima
673480|NCT00862836|Ovarian Cancer|ovarian cancer
673481|NCT00862836|Phase I|phase i
673482|NCT00862836|Phase II|phase ii
673483|NCT00862836|Randomized|randomized
673484|NCT00862836|Safety|safety
673485|NCT00862849|rHuPH20|rhuph20
673486|NCT00862849|Recombinant Human Hyaluronidase|recombinant human hyaluronidase
673487|NCT00862849|Insulin Lispro|insulin lispro
673488|NCT00862849|Regular Human Insulin|regular human insulin
673489|NCT00862862|infection|infection
673490|NCT00862862|staphylococcus aureus|staphylococcus aureus
673491|NCT00862862|vancomycin|vancomycin
673492|NCT00862862|pharmacodynammics|pharmacodynammics
673493|NCT00862875|Insulin initiation|insulin initiation
673494|NCT00862875|oral therapy failure|oral therapy failure
673495|NCT00862901|cancer|cancer
673496|NCT00862901|skin metastases|skin metastases
673497|NCT00862901|chest wall progression of breast cancer|chest wall progression of breast cancer
673498|NCT00862901|malignant melanoma|malignant melanoma
673499|NCT00862901|photodynamic therapy|photodynamic therapy
673500|NCT00862901|photophrin|photophrin
673501|NCT00862901|satellite and in-transit metastases of malignant melanoma|satellite and in-transit metastases of malignant melanoma
673502|NCT00862901|skin cancer|skin cancer
673503|NCT00862914|Skin|skin
673504|NCT00862914|MicroRNA|microrna
673505|NCT00862914|miRNA|mirna
673506|NCT00862914|Dicer|dicer
673507|NCT00862914|Malignant Melanoma|malignant melanoma
673508|NCT00862927|Smoking Cessation|smoking cessation
673509|NCT00862927|Cigarette Smoking|cigarette smoking
673510|NCT00862927|Tobacco Smoking|tobacco smoking
673511|NCT00862927|Cue Reactivity|cue reactivity
673512|NCT00862927|Virtual Reality|virtual reality
673513|NCT00862927|VR|vr
673514|NCT00862927|Contextual Cues|contextual cues
673515|NCT00862927|Explicit Smoking Cues|explicit smoking cues
673516|NCT00862927|Craving|craving
673517|NCT00862927|Physiological Arousal|physiological arousal
673518|NCT00862927|Nicotine Dependence|nicotine dependence
673519|NCT00862927|Breath Sample|breath sample
673520|NCT00862927|Saliva Test|saliva test
673521|NCT00862927|Questionnaire|questionnaire
673522|NCT00862940|Memantine|memantine
673523|NCT00862940|Neuroimaging|neuroimaging
673524|NCT00862940|MRI|mri
673525|NCT00862940|Brain atrophy|brain atrophy
673526|NCT00862953|low carbohydrate|low carbohydrate
673527|NCT00862953|high protein diet|high protein diet
673528|NCT00862979|Heart Transplantation|heart transplantation
673529|NCT00862979|Cardiac Transplantation|cardiac transplantation
673530|NCT00862979|CNI-sparing|cni-sparing
673531|NCT00862979|renal function|renal function
673532|NCT00862979|CNI|cni
673533|NCT00862979|Cyclosporine A|cyclosporine a
673534|NCT00862979|Everolimus|everolimus
673535|NCT00862979|enteric coated mycophenolic acid|enteric coated mycophenolic acid
673536|NCT00862992|schizophrenia|schizophrenia
673537|NCT00862992|antipsychotics|antipsychotics
673538|NCT00862992|dopamine D3/D2 antagonist|dopamine d3/d2 antagonist
673539|NCT00863018|Corneal endothelial cell|corneal endothelial cell
673540|NCT00863018|Specular microscopy|specular microscopy
673541|NCT00863018|Glaucoma implant surgery|glaucoma implant surgery
673542|NCT00863018|Ahmed glaucoma valve|ahmed glaucoma valve
673543|NCT00863018|Trabeculectomy|trabeculectomy
673544|NCT00863031|mental health|mental health
673545|NCT00863031|problem-solving therapy|problem-solving therapy
673546|NCT00863031|elderly|elderly
673547|NCT00863031|health-related quality of life|health-related quality of life
673548|NCT00863031|primary care|primary care
673549|NCT00863031|Chinese|chinese
673550|NCT00863044|off pump coronary bypass|off pump coronary bypass
673551|NCT00863044|high frequency ventilation|high frequency ventilation
673552|NCT00863044|cerebral oxygen saturation|cerebral oxygen saturation
673553|NCT00863044|vasopressors used|vasopressors used
673554|NCT00863044|right and left ventricular function|right and left ventricular function
673555|NCT00863044|arterial blood pressure|arterial blood pressure
673556|NCT00863044|heart rate|heart rate
673557|NCT00863057|HIV Infections|hiv infections
673558|NCT00863057|Neuropathy|neuropathy
673559|NCT00863057|Pain|pain
673560|NCT00863070|Bladder exstrophy|bladder exstrophy
673561|NCT00863070|Abnormal gait|abnormal gait
673562|NCT00863070|anatomy|anatomy
673563|NCT00863070|urinary bladder disease|urinary bladder disease
673564|NCT00863070|urogenital abnormalities|urogenital abnormalities
673565|NCT00863083|pediatric obesity|pediatric obesity
673566|NCT00863083|pediatric overweight|pediatric overweight
673567|NCT00863083|multi-family group weight management intervention|multi-family group weight management intervention
673568|NCT00863083|financial rewards|financial rewards
673569|NCT00863096|HPV|hpv
673570|NCT00863096|acceptability|acceptability
673571|NCT00863122|Lapatinib|lapatinib
673572|NCT00863122|Tykerb|tykerb
673573|NCT00863122|EGFR inhibitor|egfr inhibitor
673574|NCT00863122|ErbB2 inhibitor|erbb2 inhibitor
673575|NCT00863122|Pharmacokinetics|pharmacokinetics
673576|NCT00863135|obstructive sleep apnea|obstructive sleep apnea
673577|NCT00863135|refractory arterial hypertension|refractory arterial hypertension
673578|NCT00863135|continuous positive airways pressure|continuous positive airways pressure
673579|NCT00863148|MDS|mds
673580|NCT00863148|AML|aml
673581|NCT00863148|ALL|all
673582|NCT00863148|RIC|ric
673583|NCT00863148|clofarabine|clofarabine
673584|NCT00863148|allo-HSCT|allo-hsct
673585|NCT00863148|high-risk MDS/AML|high-risk mds/aml
673586|NCT00863161|Safety|safety
673587|NCT00863161|tolerability|tolerability
673588|NCT00863161|exposure|exposure
673589|NCT00863161|healthy|healthy
673590|NCT00863161|renally impaired subjects|renally impaired subjects
673591|NCT00863174|Multiple myeloma|multiple myeloma
673592|NCT00863174|Bio-equivalence|bio-equivalence
673593|NCT00863200|Depression|depression
673594|NCT00863200|Cancer|cancer
673595|NCT00863200|African Americans|african americans
673596|NCT00863200|Latinos|latinos
673597|NCT00863200|Hispanics|hispanics
673598|NCT00863200|Interactive voice response|interactive voice response
673599|NCT00863200|IVR|ivr
673600|NCT00863200|Behavioral Intervention|behavioral intervention
673601|NCT00863213|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
673602|NCT00863213|Atrial fibrillation|atrial fibrillation
673603|NCT00863213|Antiarrhythmic Drugs|antiarrhythmic drugs
673604|NCT00863226|Quality of Life issues in Parkinson's disease|quality of life issues in parkinson's disease
673605|NCT00863239|treatment naive|treatment naive
673606|NCT00863239|genotype 1|genotype 1
673607|NCT00863252|proteinuria|proteinuria
673608|NCT00863252|creatinine|creatinine
673609|NCT00863252|kidney survival|kidney survival
673610|NCT00863252|ESRD|esrd
673611|NCT00863265|Phytosterols|phytosterols
673612|NCT00863265|Ezetimibe|ezetimibe
673613|NCT00863265|Cholesterol Excretion|cholesterol excretion
673614|NCT00863265|Cholesterol Absorption|cholesterol absorption
673615|NCT00863265|Diet|diet
673616|NCT00863265|Mass Spectrometry|mass spectrometry
673617|NCT00863265|Deuterium|deuterium
673618|NCT00863291|Depression|depression
673619|NCT00863291|suicidality|suicidality
673620|NCT00863291|buprenorphine|buprenorphine
673621|NCT00863304|monoclonal antibody RN624 PF-04383119 nerve growth factor anti-nerve growth factor OA pain arthritis|monoclonal antibody rn624 pf-04383119 nerve growth factor anti-nerve growth factor oa pain arthritis
673622|NCT00863317|Bronchiolitis|bronchiolitis
673623|NCT00863317|montelukast|montelukast
673624|NCT00863317|leukotriene inhibitor|leukotriene inhibitor
673625|NCT00863330|stage IV melanoma|stage iv melanoma
673626|NCT00863330|recurrent melanoma|recurrent melanoma
673627|NCT00863343|Influenza infections|influenza infections
673628|NCT00863343|Orthomyxoviridae infections|orthomyxoviridae infections
673629|NCT00863356|Epistaxis|epistaxis
673630|NCT00863356|Chitosan|chitosan
673631|NCT00863356|Hemostatic|hemostatic
673632|NCT00863356|Nose bleed|nose bleed
673633|NCT00863356|Nasal bleeding|nasal bleeding
673634|NCT00863356|Nasal pack|nasal pack
673635|NCT00863356|Sealant|sealant
673636|NCT00863356|ChitoFlex®|chitoflex®
673638|NCT00863356|HemCon® ChitoFlex Surgical Dressing|hemcon® chitoflex surgical dressing
673639|NCT00863356|HemCon® Nasal Plugs|hemcon® nasal plugs
673640|NCT00863356|Biocompatible dressing|biocompatible dressing
673641|NCT00863369|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
673642|NCT00863369|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
673643|NCT00863369|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
673644|NCT00863369|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
673645|NCT00863369|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
673646|NCT00863369|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
673647|NCT00863369|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
673648|NCT00863369|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
673649|NCT00863369|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
673650|NCT00863369|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
673651|NCT00863382|atrial fibrillation|atrial fibrillation
673652|NCT00863395|pruritis|pruritis
673654|NCT00863395|CTCL|ctcl
673655|NCT00863408|Mosquito|mosquito
673656|NCT00863408|Human Landing Collection|human landing collection
673657|NCT00863408|Malaria|malaria
673658|NCT00863421|Sleep disordered breathing|sleep disordered breathing
673659|NCT00863421|Prevalence|prevalence
673660|NCT00863421|Chronic heart failure|chronic heart failure
673661|NCT00863421|Incidence|incidence
673662|NCT00863421|Sleep apnea|sleep apnea
673663|NCT00863421|Cheyne-Stokes-Breathing|cheyne-stokes-breathing
673664|NCT00863473|Proximal Humerus Fracture in elderly|proximal humerus fracture in elderly
673665|NCT00863499|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
673666|NCT00863499|Attention Deficit Disorder|attention deficit disorder
673667|NCT00863499|ADHD|adhd
673668|NCT00863499|ADD|add
673669|NCT00863499|iSPOT|ispot
673670|NCT00863512|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
673969|NCT00872079|warfarin|warfarin
673671|NCT00863512|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
673672|NCT00863512|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
673673|NCT00863512|adenocarcinoma of the lung|adenocarcinoma of the lung
673674|NCT00863512|adenosquamous cell lung cancer|adenosquamous cell lung cancer
673675|NCT00863512|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
673676|NCT00863512|large cell lung cancer|large cell lung cancer
673677|NCT00863512|squamous cell lung cancer|squamous cell lung cancer
673678|NCT00863538|Spinocerebellar degeneration|spinocerebellar degeneration
673679|NCT00863538|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
673680|NCT00863538|SCD|scd
673681|NCT00863564|Postprandial Period|postprandial period
673682|NCT00863564|Postprandial Lipaemia|postprandial lipaemia
673683|NCT00863564|Incretins|incretins
673684|NCT00863564|Subclinical Inflammation|subclinical inflammation
673685|NCT00863564|Obesity|obesity
673686|NCT00863564|Atherosclerosis|atherosclerosis
673687|NCT00863564|Triglyceride|triglyceride
673688|NCT00863564|Lipoproteins|lipoproteins
673689|NCT00863564|Postprandial inflammation|postprandial inflammation
673690|NCT00863577|Healthy volunteers|healthy volunteers
673691|NCT00863603|Supplemental oxygen|supplemental oxygen
673692|NCT00863603|Intimal hyperplasia|intimal hyperplasia
673693|NCT00863603|Graft patency|graft patency
673694|NCT00863616|COPD|copd
673695|NCT00863616|Mucus hypersecretion|mucus hypersecretion
673696|NCT00863616|HRQL|hrql
673697|NCT00863616|ESWT|eswt
673698|NCT00863616|HFCWO|hfcwo
673699|NCT00863629|myocardial infarction|myocardial infarction
673700|NCT00863629|oxidative stress|oxidative stress
673701|NCT00863629|stem cells|stem cells
673702|NCT00863629|glycemic control|glycemic control
673703|NCT00863642|Early cholecystectomy|early cholecystectomy
673704|NCT00863642|gallstone pancreatitis|gallstone pancreatitis
673705|NCT00863655|Breast Cancer|breast cancer
673706|NCT00863655|Estrogen Receptor positive|estrogen receptor positive
673707|NCT00863655|ER+|er+
673708|NCT00863655|exemestane|exemestane
673709|NCT00863655|mTOR|mtor
673710|NCT00863655|everolimus|everolimus
673711|NCT00863655|refractory|refractory
673712|NCT00863655|NSAI|nsai
673713|NCT00863668|Infection|infection
673714|NCT00863668|HIV 1|hiv 1
673715|NCT00863668|HIV|hiv
673716|NCT00863668|treatment naive|treatment naive
673717|NCT00863681|Pulmonary arterial hypertension|pulmonary arterial hypertension
673718|NCT00863681|PH|ph
673719|NCT00863681|Stimulator|stimulator
673720|NCT00863694|cystic fibrosis|cystic fibrosis
673721|NCT00863694|calprotectin|calprotectin
673722|NCT00863694|elastase|elastase
673723|NCT00863707|regadenoson|regadenoson
673724|NCT00863707|chronic kidney disease stage III|chronic kidney disease stage iii
673725|NCT00863707|chronic kidney disease stage IV|chronic kidney disease stage iv
673726|NCT00863707|renal impairment|renal impairment
673727|NCT00863707|coronary artery disease|coronary artery disease
673728|NCT00863746|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
673730|NCT00863759|intra-ocular lenses|intra-ocular lenses
673731|NCT00863759|comparative study|comparative study
673732|NCT00863759|Ocular aberrations|ocular aberrations
673733|NCT00863759|Contrast Sensitivity|contrast sensitivity
673734|NCT00863785|Acute Alcoholic Hepatitis|acute alcoholic hepatitis
673735|NCT00863785|Cirrhosis|cirrhosis
673736|NCT00863785|Alcohol|alcohol
673737|NCT00863785|Alcoholic Liver disease|alcoholic liver disease
673738|NCT00863798|Major Depressive Disorder|major depressive disorder
673739|NCT00863811|POAG|poag
673741|NCT00863811|Forskolin|forskolin
673742|NCT00863811|beta-blockers|beta-blockers
673743|NCT00863811|prostaglandins|prostaglandins
673744|NCT00863824|NNAL|nnal
673745|NCT00863824|Cotinine|cotinine
673746|NCT00863824|Second hand smoke|second hand smoke
673747|NCT00863824|NNAL is a known lung carcinogen. So, we are studying an agent that can potentially cause lung cancer.|nnal is a known lung carcinogen. so, we are studying an agent that can potentially cause lung cancer.
673748|NCT00863837|Acute variceal bleeding|acute variceal bleeding
673749|NCT00863837|banding ligation|banding ligation
673750|NCT00863837|vasoconstrictor|vasoconstrictor
675196|NCT00875693|AML|aml
673751|NCT00863837|proton pump inhibitor|proton pump inhibitor
673752|NCT00863863|Bioequivalence|bioequivalence
673753|NCT00863863|Griseofulvin|griseofulvin
673754|NCT00863863|Healthy subjects|healthy subjects
673755|NCT00863876|wavefront measurements of the entire eye|wavefront measurements of the entire eye
673756|NCT00863902|Bioequivalence|bioequivalence
673757|NCT00863902|Cetirizine|cetirizine
673758|NCT00863902|Healthy subjects|healthy subjects
673759|NCT00863915|Bioequivalence|bioequivalence
673760|NCT00863915|Ramipril|ramipril
673761|NCT00863915|Healthy subjects|healthy subjects
673762|NCT00863941|Bioequivalence|bioequivalence
673763|NCT00863941|Bupropion|bupropion
673764|NCT00863941|Healthy subjects|healthy subjects
673765|NCT00863967|physical examination|physical examination
673766|NCT00863967|diagnostic techniques and procedures|diagnostic techniques and procedures
673767|NCT00863967|diagnosis|diagnosis
673768|NCT00863967|immunologic tests|immunologic tests
673769|NCT00863967|diagnostic tests|diagnostic tests
673770|NCT00863967|causality|causality
673771|NCT00863967|genetic test|genetic test
673772|NCT00863967|biomarker|biomarker
673773|NCT00863980|angiotensin|angiotensin
673774|NCT00863980|receptor|receptor
673775|NCT00863980|vulnerable plaque|vulnerable plaque
673776|NCT00863980|coronary artery|coronary artery
673777|NCT00864019|Bioequivalence|bioequivalence
673778|NCT00864019|Sertraline|sertraline
673779|NCT00864019|Healthy subjects|healthy subjects
673780|NCT00864032|Soft tissue sarcoma of the extremity and body wall|soft tissue sarcoma of the extremity and body wall
673781|NCT00864058|Bioequivalence|bioequivalence
673782|NCT00864058|Gabapentin|gabapentin
673783|NCT00864058|Healthy subjects|healthy subjects
673784|NCT00864071|Bioequivalence|bioequivalence
673785|NCT00864071|Griseofulvin|griseofulvin
673786|NCT00864071|Healthy subjects|healthy subjects
673787|NCT00864097|Arthritis monoclonal antibody nerve growth factor (NGF) anti-NGF tanezumab PF-04383119 RN-624 OA|arthritis monoclonal antibody nerve growth factor (ngf) anti-ngf tanezumab pf-04383119 rn-624 oa
673788|NCT00864110|Non small cell lung cancer|non small cell lung cancer
673789|NCT00864110|SPECT CT imaging|spect ct imaging
673790|NCT00864110|Pharmacokinetic|pharmacokinetic
673791|NCT00864110|Radiation Dosimetry|radiation dosimetry
673792|NCT00864110|PET CT comparison|pet ct comparison
673793|NCT00864123|Obsessive-compulsive disorder|obsessive-compulsive disorder
673794|NCT00864149|Bioequivalence|bioequivalence
673795|NCT00864149|Carvedilol|carvedilol
673796|NCT00864149|Healthy subjects|healthy subjects
673797|NCT00864162|Bioequivalence|bioequivalence
673798|NCT00864162|Ramipril|ramipril
673799|NCT00864162|Healthy subjects|healthy subjects
673800|NCT00864188|skin health|skin health
673801|NCT00864188|probiotics|probiotics
673802|NCT00864188|dairy|dairy
673803|NCT00864188|oral|oral
673804|NCT00864214|bioidentical hormone|bioidentical hormone
673805|NCT00864214|menopause|menopause
673806|NCT00864214|estrogen|estrogen
673807|NCT00864214|progesterone|progesterone
673808|NCT00864227|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
673809|NCT00864227|Acute Myelogenous Leukemia|acute myelogenous leukemia
673810|NCT00864227|Mantel-Cell Lymphoma|mantel-cell lymphoma
673811|NCT00864227|Hematopoietic Transplant|hematopoietic transplant
673812|NCT00864227|Umbilical Cord Blood (UCB)|umbilical cord blood (ucb)
673813|NCT00864227|Non-Myeloablative Transplant|non-myeloablative transplant
673814|NCT00864240|Vasoconstriction|vasoconstriction
673815|NCT00864240|Clobetasol|clobetasol
673816|NCT00864240|Healthy adult females|healthy adult females
673817|NCT00864253|Melanoma|melanoma
673818|NCT00864253|Malignant|malignant
673819|NCT00864253|Abraxane|abraxane
673820|NCT00864253|ABI-007|abi-007
673821|NCT00864253|Dacarbazine|dacarbazine
673822|NCT00864253|Dtic-Dome|dtic-dome
673823|NCT00864266|Non small cell lung carcinoma|non small cell lung carcinoma
673824|NCT00864266|Chemotherapy|chemotherapy
673825|NCT00864266|Response prediction|response prediction
673826|NCT00864279|Bioequivalence|bioequivalence
673828|NCT00864279|Healthy subjects|healthy subjects
673829|NCT00864305|Bioequivalence|bioequivalence
673830|NCT00864305|Gabapentin|gabapentin
673831|NCT00864305|Healthy subjects|healthy subjects
673832|NCT00864318|refractory|refractory
673833|NCT00864318|germ cell tumors|germ cell tumors
673834|NCT00864318|relapse|relapse
673835|NCT00864318|bad prognosis|bad prognosis
673836|NCT00864318|Refractory germ cell tumors with relapse and bad prognosis|refractory germ cell tumors with relapse and bad prognosis
673837|NCT00864331|lung cancer|lung cancer
673838|NCT00864331|nonsmall cell lung cancer|nonsmall cell lung cancer
673839|NCT00864331|radiation therapy|radiation therapy
673840|NCT00864331|chemotherapy|chemotherapy
673841|NCT00864331|Locally advanced and metastatic nonsmall cell lung cancer|locally advanced and metastatic nonsmall cell lung cancer
673842|NCT00864344|Bioequivalence|bioequivalence
673843|NCT00864344|Sertralin|sertralin
673844|NCT00864344|Healthy subjectse|healthy subjectse
673845|NCT00864357|Bioequivalence|bioequivalence
673846|NCT00864357|Oxycodone|oxycodone
673847|NCT00864357|Ibuprofen|ibuprofen
673848|NCT00864357|Healthy subjects|healthy subjects
673849|NCT00864370|Psychiatry|psychiatry
673850|NCT00864370|Pregnancy|pregnancy
673851|NCT00864370|Bipolar Disorder|bipolar disorder
673852|NCT00864396|Laryngopharyngeal reflux|laryngopharyngeal reflux
673853|NCT00864396|Gastroesophageal reflux disease|gastroesophageal reflux disease
673854|NCT00864396|GERD|gerd
673855|NCT00864409|postoperative pain|postoperative pain
673856|NCT00864409|total hip arthroplasty|total hip arthroplasty
673857|NCT00864422|low back pain|low back pain
673858|NCT00864422|motor training|motor training
673859|NCT00864422|motor cortex|motor cortex
673860|NCT00864422|brain plasticity|brain plasticity
673861|NCT00864435|Bioequivalence|bioequivalence
673862|NCT00864435|Carvedilol|carvedilol
673863|NCT00864435|Healthy subjects|healthy subjects
673864|NCT00864448|Bioequivalence|bioequivalence
673865|NCT00864448|Ramipril|ramipril
673866|NCT00864448|Healthy subjects|healthy subjects
673867|NCT00864461|Down syndrome|down syndrome
673868|NCT00864461|Metabolic syndrome X|metabolic syndrome x
673869|NCT00864461|Insulin resistance|insulin resistance
673870|NCT00864500|Bio-Equivalence|bio-equivalence
673871|NCT00864500|Vasoconstriction|vasoconstriction
673872|NCT00864500|Clobetasol|clobetasol
673873|NCT00864500|Healthy adult females|healthy adult females
673874|NCT00864513|pancreas|pancreas
673875|NCT00864513|metastatic|metastatic
673876|NCT00864513|recurrent|recurrent
673877|NCT00864526|Bioequivalence|bioequivalence
673878|NCT00864526|Oxycodone|oxycodone
673879|NCT00864526|Ibuprofen|ibuprofen
673880|NCT00864526|Healthy subjects|healthy subjects
673881|NCT00864539|vitamin D fortification|vitamin d fortification
673882|NCT00864539|milk|milk
673883|NCT00864539|orange juice|orange juice
673884|NCT00864539|supplement|supplement
673885|NCT00864539|efficacy|efficacy
673886|NCT00864552|Hemophilia A|hemophilia a
673887|NCT00864552|Recombinant Factor VIII|recombinant factor viii
673888|NCT00864565|Bioequivalence|bioequivalence
673889|NCT00864565|Fentanyl|fentanyl
673890|NCT00864565|Healthy subjects|healthy subjects
673891|NCT00864578|POAG|poag
673892|NCT00864578|IOP|iop
673893|NCT00864578|Forskolin|forskolin
673894|NCT00864578|Food supplement|food supplement
673895|NCT00864591|SPECT Imaging|spect imaging
673896|NCT00864591|Stress adenosine CMR|stress adenosine cmr
673897|NCT00864604|Bioequivalence|bioequivalence
673898|NCT00864604|Nabumetone|nabumetone
673899|NCT00864604|Healthy subjects|healthy subjects
673900|NCT00864617|Bioequivalence|bioequivalence
673901|NCT00864617|Nifedipine|nifedipine
673902|NCT00864617|Healthy subjects|healthy subjects
673903|NCT00864643|Hyperlipidemia|hyperlipidemia
673904|NCT00864643|Drug Therapy|drug therapy
673905|NCT00864643|Dyslipidemia|dyslipidemia
673906|NCT00864656|adrenergic alpha-agonists|adrenergic alpha-agonists
673907|NCT00864656|phenylephrine|phenylephrine
673908|NCT00864656|drug effects|drug effects
673909|NCT00864656|diagnostic use|diagnostic use
673910|NCT00864669|Bioequivalence|bioequivalence
673911|NCT00864669|Metformin|metformin
673912|NCT00864669|Healthy subjects|healthy subjects
673913|NCT00864682|propofol|propofol
673914|NCT00864682|lidocaine|lidocaine
673915|NCT00864682|injection pain|injection pain
673916|NCT00864695|Anesthesia|anesthesia
673917|NCT00864695|Ethics|ethics
673918|NCT00864695|Trends|trends
673919|NCT00864695|Manpower|manpower
673920|NCT00864695|Perioperative care|perioperative care
673921|NCT00864708|Functional Electrical Stimulation|functional electrical stimulation
673922|NCT00871845|obesity|obesity
673923|NCT00871845|hepatitis C|hepatitis c
673924|NCT00871845|insulin resistance|insulin resistance
673925|NCT00871845|metabolic syndrome|metabolic syndrome
674020|NCT00872313|Psychology|psychology
673926|NCT00871858|stage II breast cancer|stage ii breast cancer
673927|NCT00871858|stage IIIA breast cancer|stage iiia breast cancer
673928|NCT00871858|stage IIIB breast cancer|stage iiib breast cancer
751815|NCT01170598|cancer-related fatigue|cancer-related fatigue
673929|NCT00871858|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
674122|NCT00872664|ROP|rop
673930|NCT00871858|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
673931|NCT00871884|Post Concussion Syndrome|post concussion syndrome
673932|NCT00871884|Cognitive Behavioral Therapy|cognitive behavioral therapy
673933|NCT00871884|Anxiety Sensitivity|anxiety sensitivity
673934|NCT00871884|Mild Head Injury|mild head injury
673935|NCT00871884|Psychotherapy|psychotherapy
673936|NCT00871884|Chronic Post Concussion Symptoms|chronic post concussion symptoms
673937|NCT00871897|Neuropsychology|neuropsychology
673938|NCT00871897|Cardiac Rehabilitation|cardiac rehabilitation
673939|NCT00871923|Non-small cell lung cancer|non-small cell lung cancer
673940|NCT00871923|NSCLC|nsclc
673941|NCT00871923|Brain Metastases|brain metastases
673942|NCT00871923|Brain Cancer|brain cancer
673943|NCT00871923|Lung Cancer|lung cancer
673944|NCT00871923|Tarceva|tarceva
673945|NCT00871923|Erlotinib Hydrochloride|erlotinib hydrochloride
673946|NCT00871923|OSI-774|osi-774
673947|NCT00871923|Radiation Therapy|radiation therapy
673948|NCT00871923|Whole Brain Radiation Therapy|whole brain radiation therapy
673949|NCT00871923|WBRT|wbrt
673950|NCT00871949|Safety tolerability pharmacokinetics PK first in human FIH|safety tolerability pharmacokinetics pk first in human fih
673951|NCT00871962|long-term oxygen therapy|long-term oxygen therapy
673952|NCT00871962|COPD patients on necessity of long-term oxygen therapy|copd patients on necessity of long-term oxygen therapy
673953|NCT00871975|LUTS|luts
673954|NCT00871975|OAB|oab
673955|NCT00872027|Critical Illness|critical illness
673956|NCT00872027|Intensive Care Unit|intensive care unit
673957|NCT00872027|Acute Respiratory Failure|acute respiratory failure
673958|NCT00872027|Prolonged Mechanical Ventilation|prolonged mechanical ventilation
673959|NCT00872040|Sexual function|sexual function
673960|NCT00872040|Pelvic floor disorders|pelvic floor disorders
673961|NCT00872040|Delivery mode|delivery mode
673962|NCT00872053|robot|robot
673963|NCT00872053|treadmill|treadmill
673964|NCT00872053|foot drop|foot drop
673965|NCT00872053|rehabilitation|rehabilitation
673966|NCT00872053|gait|gait
673967|NCT00872066|Hip|hip
673970|NCT00872079|pharmacokinetics|pharmacokinetics
673971|NCT00872079|pharmacodynamics|pharmacodynamics
673972|NCT00872092|small bowel|small bowel
673973|NCT00872092|bacterial overgrowth|bacterial overgrowth
673974|NCT00872105|clavicle|clavicle
673975|NCT00872105|fractures|fractures
673976|NCT00872105|distal|distal
673977|NCT00872118|alcohol consumption|alcohol consumption
673978|NCT00872118|social anxiety|social anxiety
673979|NCT00872118|brief intervention|brief intervention
673980|NCT00872118|motivational interviewing|motivational interviewing
673981|NCT00872118|cognitive behavioral|cognitive behavioral
673982|NCT00872131|Anxiety|anxiety
673983|NCT00872131|Social Phobia|social phobia
673984|NCT00872131|Generalized Social Anxiety Disorder|generalized social anxiety disorder
673985|NCT00872157|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
673986|NCT00872157|Prostate|prostate
673987|NCT00872157|High-Volume Osseous Metastases|high-volume osseous metastases
673988|NCT00872157|BMTP-11|bmtp-11
673989|NCT00872157|Prostate State Antigen|prostate state antigen
673990|NCT00872157|PSA|psa
673991|NCT00872170|Pulmonary Hypertension|pulmonary hypertension
673992|NCT00872183|Motor Learning|motor learning
673993|NCT00872183|Mirror Neurons|mirror neurons
673994|NCT00872183|Healthy Volunteer|healthy volunteer
673995|NCT00872183|HV|hv
673996|NCT00872235|Bioequivalence fixed-dose combination of quinapril 20 mg and hydrochlorothiazide 25 mg tablets|bioequivalence fixed-dose combination of quinapril 20 mg and hydrochlorothiazide 25 mg tablets
673997|NCT00872248|Restless leg syndrome|restless leg syndrome
673998|NCT00872248|Spinal anesthesia|spinal anesthesia
673999|NCT00872248|Epidural anesthesia|epidural anesthesia
674000|NCT00872248|Neuraxial block|neuraxial block
674001|NCT00872261|Clinical Trials as Topic|clinical trials as topic
674002|NCT00872261|Adolescent Psychology|adolescent psychology
674003|NCT00872261|Patient Acceptance of Health Care|patient acceptance of health care
674004|NCT00872261|HIV Risk Behaviors|hiv risk behaviors
674005|NCT00872261|Adolescents|adolescents
674006|NCT00872261|Clinical Trial Recruitment|clinical trial recruitment
674007|NCT00872261|Microbicide Acceptability|microbicide acceptability
674008|NCT00872261|Ethics|ethics
674009|NCT00872261|Mixed Methods|mixed methods
674010|NCT00872261|HIV|hiv
674011|NCT00872274|Bioequivalence|bioequivalence
674012|NCT00872287|minimally invasive surgery|minimally invasive surgery
674013|NCT00872287|scarless cholecystectomy|scarless cholecystectomy
674014|NCT00872287|new techniques in laparoscopy|new techniques in laparoscopy
674015|NCT00872287|invisible scar|invisible scar
674016|NCT00872287|single port access|single port access
674017|NCT00872287|abdominal pain|abdominal pain
674018|NCT00872287|shoulder pain|shoulder pain
674019|NCT00872313|Labor|labor
674021|NCT00872313|Postpartum Psychology|postpartum psychology
674022|NCT00872326|Diabetes Complications|diabetes complications
674023|NCT00872326|Lower limb ischemia|lower limb ischemia
674024|NCT00872326|Adult stem cells|adult stem cells
674025|NCT00872339|Transfusion-Dependent Thalassemia|transfusion-dependent thalassemia
674026|NCT00872339|Non-Transfusion-Dependent Thalassemia|non-transfusion-dependent thalassemia
674027|NCT00872352|Multiple Myeloma|multiple myeloma
674028|NCT00872352|Bortezomib|bortezomib
674029|NCT00872352|Peripheral Neuropathy|peripheral neuropathy
674030|NCT00872352|evaluation|evaluation
674031|NCT00872352|evaluation of electrophysiological changes related to the dose and time of bortezomib administration|evaluation of electrophysiological changes related to the dose and time of bortezomib administration
674032|NCT00872352|investigation of correlation between the incidence of BIPN and the subtype of myeloma|investigation of correlation between the incidence of bipn and the subtype of myeloma
674033|NCT00872365|Pregnancy|pregnancy
674034|NCT00872365|Exercise|exercise
674035|NCT00872365|Nutrition|nutrition
674036|NCT00872365|Micronutrients|micronutrients
674037|NCT00872365|non-transmissible chronic diseases|non-transmissible chronic diseases
674038|NCT00872365|Endothelium|endothelium
674039|NCT00872378|Morbid Obesity|morbid obesity
674040|NCT00872378|LAP Band|lap band
674041|NCT00872378|Adjustable Gastric Band|adjustable gastric band
674042|NCT00872378|Exenatide|exenatide
674043|NCT00872378|Byetta|byetta
674044|NCT00872378|Weight Loss|weight loss
674045|NCT00872378|Bariatric Surgery|bariatric surgery
674046|NCT00872404|CP-751,871|cp-751,871
674047|NCT00872404|squamous cell carcinoma|squamous cell carcinoma
674048|NCT00872404|recurrent or metastatic|recurrent or metastatic
674049|NCT00872404|after 1st line chemotherapy|after 1st line chemotherapy
674050|NCT00872417|HIV/AIDS|hiv/aids
674051|NCT00872417|antiretroviral therapy|antiretroviral therapy
674052|NCT00872417|immune reconstitution|immune reconstitution
674053|NCT00872430|constipation|constipation
674054|NCT00872430|RCT|rct
674055|NCT00872430|phytotherapy|phytotherapy
674056|NCT00872456|Diabetes Mellitus|diabetes mellitus
674057|NCT00872456|Cardiovascular Disease|cardiovascular disease
674058|NCT00872456|Haptoglobin|haptoglobin
674059|NCT00872469|Postpartum haemorrhage|postpartum haemorrhage
674060|NCT00872469|randomised controlled trial|randomised controlled trial
674061|NCT00872469|tranexamic acid|tranexamic acid
674062|NCT00872469|antifibrinolytic|antifibrinolytic
674360|NCT00873535|Champix|champix
674063|NCT00872482|non-small cell lung cancer|non-small cell lung cancer
674064|NCT00872482|NSCLC|nsclc
674065|NCT00872482|Brain metastases|brain metastases
674066|NCT00872482|nimotuzumab|nimotuzumab
674067|NCT00872482|TheraCIM|theracim
674068|NCT00872482|h-R3|h-r3
674069|NCT00872482|Radiation|radiation
674070|NCT00872495|Urothelial Cancer|urothelial cancer
674071|NCT00872495|Cancer|cancer
674072|NCT00872495|Bladder Neoplasms|bladder neoplasms
674073|NCT00872495|Urinary Bladder Cancer|urinary bladder cancer
674074|NCT00872521|Multiple Myeloma|multiple myeloma
674075|NCT00872521|transplant eligible|transplant eligible
674076|NCT00872521|doxorubicin|doxorubicin
674077|NCT00872521|dexamethasone|dexamethasone
674078|NCT00872521|bortezomib|bortezomib
674079|NCT00872521|bortezomib resistance|bortezomib resistance
674080|NCT00872521|PAD induction|pad induction
674081|NCT00872521|PIMMS Trial|pimms trial
674082|NCT00872534|To evaluate the acute gastrointestinal safety of PL-2100.|to evaluate the acute gastrointestinal safety of pl-2100.
674083|NCT00872547|Hip|hip
674084|NCT00872547|Resurfacing|resurfacing
674085|NCT00872547|Metal-on-Metal|metal-on-metal
674086|NCT00872547|Large Heads|large heads
674087|NCT00872547|XL Head|xl head
674088|NCT00872547|ASR - osteoarthritis (primary)|asr - osteoarthritis (primary)
674089|NCT00872573|Hip|hip
674090|NCT00872573|Cemented|cemented
674091|NCT00872599|Hypertension|hypertension
674092|NCT00872599|Phenotyping|phenotyping
674093|NCT00872599|High Salt intake|high salt intake
674094|NCT00872599|frequently sampled IV glucose tolerance test(FSIVGTT)|frequently sampled iv glucose tolerance test(fsivgtt)
674095|NCT00872599|fenofibrate|fenofibrate
674096|NCT00872599|epoxyeicosatrienoic acids|epoxyeicosatrienoic acids
674097|NCT00872599|hydroxyeicosatetraenoic acids|hydroxyeicosatetraenoic acids
674098|NCT00872599|dihydroxyeicosatrienoic acid|dihydroxyeicosatrienoic acid
674099|NCT00872599|PPAR Alpha Agonist|ppar alpha agonist
674100|NCT00872599|CYP Monooxygenase Activity|cyp monooxygenase activity
674101|NCT00872612|Sarcoidosis|sarcoidosis
674102|NCT00872612|Diagnosis|diagnosis
674103|NCT00872612|Non-caseating granulomas|non-caseating granulomas
674104|NCT00872612|BAL|bal
674105|NCT00872612|EUS-FNA|eus-fna
674106|NCT00872612|EBUS-TBNA|ebus-tbna
674107|NCT00872612|TBLB|tblb
674108|NCT00872625|stage IA breast cancer|stage ia breast cancer
674109|NCT00872625|stage IB breast cancer|stage ib breast cancer
674110|NCT00872625|stage II breast cancer|stage ii breast cancer
674111|NCT00872625|stage IIIA breast cancer|stage iiia breast cancer
674112|NCT00872625|stage IIIB breast cancer|stage iiib breast cancer
674113|NCT00872625|stage IIIC breast cancer|stage iiic breast cancer
674114|NCT00872625|recurrent breast cancer|recurrent breast cancer
674115|NCT00872638|wound edge eversion|wound edge eversion
674116|NCT00872638|cosmetic outcomes|cosmetic outcomes
674117|NCT00872638|surgical incisions|surgical incisions
674118|NCT00872651|Glaucoma|glaucoma
676532|NCT00880919|BPD|bpd
674119|NCT00872651|intraocular pressure|intraocular pressure
674120|NCT00872651|travoprost/timolol|travoprost/timolol
674121|NCT00872651|timolol|timolol
674123|NCT00872664|anti-oxidants|anti-oxidants
674124|NCT00872664|carotenoids|carotenoids
674125|NCT00872677|weight changes|weight changes
674126|NCT00872677|obesity|obesity
674127|NCT00872677|stage I breast cancer|stage i breast cancer
674128|NCT00872677|stage II breast cancer|stage ii breast cancer
674129|NCT00872677|stage IIIA breast cancer|stage iiia breast cancer
674130|NCT00872690|Multiple Trauma|multiple trauma
674131|NCT00872690|Blast Injuries|blast injuries
674132|NCT00872690|Brain Injuries|brain injuries
674133|NCT00872690|Rehabilitation, Vocational|rehabilitation, vocational
674134|NCT00872690|Consumer participation|consumer participation
674135|NCT00872703|CMV|cmv
674136|NCT00872703|Prenatal Diagnosis|prenatal diagnosis
674137|NCT00872703|Ultrasound|ultrasound
674138|NCT00872703|MRI|mri
674139|NCT00872716|specific phobia|specific phobia
674140|NCT00872716|simple phobia|simple phobia
674141|NCT00872716|anxiety disorder|anxiety disorder
674142|NCT00872729|cystinosis|cystinosis
674143|NCT00872729|cysteamine|cysteamine
674144|NCT00872729|inheritable disease|inheritable disease
674145|NCT00872729|orphan disease|orphan disease
674146|NCT00872729|CTNS protein, human|ctns protein, human
674147|NCT00872729|nephropathic cystinosis|nephropathic cystinosis
674272|NCT00873262|PreMenstrual Syndrome|premenstrual syndrome
674148|NCT00872742|Impulse Control Disorders|impulse control disorders
674149|NCT00872742|Behavior Therapy|behavior therapy
674150|NCT00872742|Acceptance|acceptance
674151|NCT00872742|Habit Reversal|habit reversal
674152|NCT00872781|Bioequivalence fixed dose combination of Quinapril HCl 20 mg and Hydrochlorothiazide 25 mg tablets|bioequivalence fixed dose combination of quinapril hcl 20 mg and hydrochlorothiazide 25 mg tablets
674154|NCT00872794|Conservative|conservative
674155|NCT00872794|Metal on Metal|metal on metal
674156|NCT00872794|Resurfacing|resurfacing
674157|NCT00872807|childhood|childhood
674158|NCT00872807|therapy|therapy
674159|NCT00872807|life style|life style
674160|NCT00872807|motor activity|motor activity
674161|NCT00872807|obesity|obesity
674162|NCT00872807|overweight|overweight
674361|NCT00873561|diabetes|diabetes
674163|NCT00872807|body mass index|body mass index
674164|NCT00872807|treatment|treatment
674165|NCT00872820|Social Anxiety|social anxiety
674166|NCT00872820|Social Anxiety Treatment|social anxiety treatment
674167|NCT00872820|Cognitive Therapy|cognitive therapy
674168|NCT00872820|Mindfulness|mindfulness
674169|NCT00872820|Social Phobia|social phobia
674170|NCT00872820|Social Phobia Treatment|social phobia treatment
674171|NCT00872833|Transfusion-Dependant Thalassemia|transfusion-dependant thalassemia
674172|NCT00872833|Pain|pain
674173|NCT00872833|Mild Pain|mild pain
674174|NCT00872846|Body weight|body weight
674175|NCT00872846|Signs and symptoms|signs and symptoms
674176|NCT00872846|Obesity|obesity
674177|NCT00872846|Metabolic disease|metabolic disease
674178|NCT00872846|Diabetes mellitus type 2|diabetes mellitus type 2
674179|NCT00872846|Diabetes mellitus|diabetes mellitus
674180|NCT00872846|Nutrition disorder|nutrition disorder
674181|NCT00872846|Endocrine system diseases|endocrine system diseases
674182|NCT00872846|Overweight|overweight
674183|NCT00872846|Overnutrition|overnutrition
674184|NCT00872846|Glucose metabolic disorder|glucose metabolic disorder
674185|NCT00872859|Breast Cancer|breast cancer
674186|NCT00872859|Cancer of Breast|cancer of breast
674187|NCT00872859|Reconstructive Surgery|reconstructive surgery
674188|NCT00872872|NVP|nvp
674189|NCT00872872|PMTCT|pmtct
674190|NCT00872872|pregnancy|pregnancy
674191|NCT00872872|resistance|resistance
674192|NCT00872885|analgesic|analgesic
674193|NCT00872885|bunionectomy|bunionectomy
674194|NCT00872885|surgery|surgery
674195|NCT00872885|post operative pain|post operative pain
674196|NCT00872885|single Hallux valgus repair|single hallux valgus repair
674197|NCT00872898|autism|autism
674198|NCT00872898|memantine|memantine
674199|NCT00872898|pediatric|pediatric
674200|NCT00872898|Forest Laboratories|forest laboratories
674201|NCT00872898|Autism in pediatric patients|autism in pediatric patients
674202|NCT00872911|Sarcopenia|sarcopenia
674203|NCT00872911|nutrition|nutrition
674204|NCT00872911|aging|aging
674205|NCT00872911|metabolism|metabolism
674206|NCT00872911|exercise|exercise
674207|NCT00872924|Bioequivalence|bioequivalence
674208|NCT00872950|LEMS|lems
674209|NCT00872950|CMS|cms
674210|NCT00872950|3,4 DIAMINOPYRIDINE|3,4 diaminopyridine
674211|NCT00872950|3,4 DAP|3,4 dap
674212|NCT00872963|malaria vaccine|malaria vaccine
674213|NCT00872963|RTS,S,|rts,s,
674214|NCT00872989|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
674215|NCT00872989|recurrent fallopian tube cancer|recurrent fallopian tube cancer
674216|NCT00872989|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
674311|NCT00873405|Sleeve gastrectomy|sleeve gastrectomy
674217|NCT00873002|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
674218|NCT00873002|advanced adult primary liver cancer|advanced adult primary liver cancer
674219|NCT00873002|recurrent adult primary liver cancer|recurrent adult primary liver cancer
674220|NCT00873002|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
674221|NCT00873015|Cerebral aneurysm|cerebral aneurysm
674222|NCT00873015|Subarachnoid hemorrhage|subarachnoid hemorrhage
674223|NCT00873015|Nitrite|nitrite
674224|NCT00873028|Physical therapy|physical therapy
674225|NCT00873028|Inspiratory muscles|inspiratory muscles
674226|NCT00873028|Exercise|exercise
674227|NCT00873041|Thalassemia|thalassemia
674228|NCT00873041|thalassemia intermedia|thalassemia intermedia
674229|NCT00873041|alpha-thalassemia|alpha-thalassemia
674230|NCT00873041|beta-thalassemia|beta-thalassemia
674231|NCT00873041|deferasirox|deferasirox
674232|NCT00873041|iron overload|iron overload
674233|NCT00873041|non-transfusion dependent|non-transfusion dependent
674234|NCT00873067|Atrial fibrillation|atrial fibrillation
674235|NCT00873067|Complex fractionated electrograms|complex fractionated electrograms
674236|NCT00873067|CFAE|cfae
674237|NCT00873080|reliability|reliability
674238|NCT00873080|photogrammetry|photogrammetry
674239|NCT00873119|Belinostat|belinostat
674240|NCT00873119|PXD101|pxd101
674241|NCT00873119|Carboplatin|carboplatin
674242|NCT00873119|Paclitaxel|paclitaxel
674243|NCT00873119|CUP|cup
674244|NCT00873119|Carcinoma of unknown primary|carcinoma of unknown primary
674245|NCT00873119|Occult primary|occult primary
674246|NCT00873145|Survival|survival
674247|NCT00873145|Function|function
674248|NCT00873145|Infection|infection
674249|NCT00873145|Revision|revision
674250|NCT00873145|Loosening|loosening
674251|NCT00873158|Adhesive Capsulitis|adhesive capsulitis
674252|NCT00873158|ROM|rom
674253|NCT00873158|Dynasplint|dynasplint
674254|NCT00873171|Osteopathic Manipulation|osteopathic manipulation
674255|NCT00873184|massage therapy in patients with brain tumors|massage therapy in patients with brain tumors
674256|NCT00873197|Co-administration of transdermal and intravenous granisetron|co-administration of transdermal and intravenous granisetron
674257|NCT00873197|Granisetron|granisetron
674258|NCT00873197|Healthy subjects|healthy subjects
674259|NCT00873197|Intravenous|intravenous
674260|NCT00873197|Pharmacokinetic profile|pharmacokinetic profile
674261|NCT00873197|Sancuso® patch|sancuso® patch
674262|NCT00873197|Transdermal|transdermal
674362|NCT00873561|type 1|type 1
674263|NCT00873197|Pharmacokinetics|pharmacokinetics
674264|NCT00873210|renal cell carcinoma|renal cell carcinoma
674265|NCT00873210|sunitinib malate|sunitinib malate
674266|NCT00873236|stage III renal cell cancer|stage iii renal cell cancer
674267|NCT00873236|stage IV renal cell cancer|stage iv renal cell cancer
674268|NCT00873249|Schizophrenia|schizophrenia
674269|NCT00873249|Therapeutic adherence|therapeutic adherence
674270|NCT00873249|Short message system|short message system
674271|NCT00873249|Mobile phone|mobile phone
674273|NCT00873262|Hormones|hormones
674274|NCT00873262|Skin tests|skin tests
674275|NCT00873262|Desensitization|desensitization
674276|NCT00873262|Allergen Immunotherapy|allergen immunotherapy
674277|NCT00873275|stage IV colon cancer|stage iv colon cancer
674278|NCT00873275|stage IV rectal cancer|stage iv rectal cancer
674279|NCT00873275|recurrent colon cancer|recurrent colon cancer
674280|NCT00873275|recurrent rectal cancer|recurrent rectal cancer
674281|NCT00873275|adenocarcinoma of the colon|adenocarcinoma of the colon
674282|NCT00873275|adenocarcinoma of the rectum|adenocarcinoma of the rectum
674283|NCT00873288|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
674284|NCT00873288|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
674285|NCT00873288|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
674286|NCT00873288|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
674287|NCT00873301|vulvodynia|vulvodynia
674288|NCT00873301|vestibulectomy|vestibulectomy
674289|NCT00873301|surgery|surgery
674290|NCT00873301|vestibulitis|vestibulitis
674291|NCT00873327|presumed sepsis|presumed sepsis
674292|NCT00873340|MS|ms
674293|NCT00873340|Multiple Sclerosis|multiple sclerosis
674294|NCT00873340|Betaferon|betaferon
674295|NCT00873340|Colombia|colombia
674296|NCT00873353|Metastatic Adenocarcinoma of the Pancreas|metastatic adenocarcinoma of the pancreas
674297|NCT00873366|stage I breast cancer|stage i breast cancer
674298|NCT00873366|stage II breast cancer|stage ii breast cancer
674299|NCT00873366|stage IIIA breast cancer|stage iiia breast cancer
674300|NCT00873366|stage IIIB breast cancer|stage iiib breast cancer
674301|NCT00873366|stage IIIC breast cancer|stage iiic breast cancer
674302|NCT00873392|Parkinson's disease|parkinson's disease
674303|NCT00873392|Motor fluctuation|motor fluctuation
674304|NCT00873392|Nicotine|nicotine
674305|NCT00873392|Drug treatment|drug treatment
674306|NCT00873392|neuroprotection|neuroprotection
674307|NCT00873405|Type 2 diabetes mellitus|type 2 diabetes mellitus
674308|NCT00873405|Metabolic control|metabolic control
674309|NCT00873405|Bariatric Surgery|bariatric surgery
674310|NCT00873405|Weight Loss|weight loss
674312|NCT00873405|BMI reduction|bmi reduction
674313|NCT00873405|Waist circumference reduction|waist circumference reduction
674314|NCT00873405|Percentage of excess BMI loss|percentage of excess bmi loss
674315|NCT00873405|Glucose homeostasis|glucose homeostasis
674316|NCT00873418|Heart Failure|heart failure
674317|NCT00873418|Intervention|intervention
674318|NCT00873418|Cognitive Behavior Therapy|cognitive behavior therapy
674319|NCT00873418|Quality of Life|quality of life
674320|NCT00873431|Prevention of pneumococcal infections|prevention of pneumococcal infections
674321|NCT00873444|Hip|hip
674322|NCT00873444|Cementless|cementless
674323|NCT00873444|Ceramic-on-Metal|ceramic-on-metal
674324|NCT00873444|Metal-on-Metal|metal-on-metal
674325|NCT00873457|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
674326|NCT00873457|Leukemia|leukemia
674327|NCT00873483|Pregnancy prevention|pregnancy prevention
674328|NCT00873483|female contraception|female contraception
674329|NCT00873483|patch|patch
674330|NCT00873496|Sjögren's Syndrome|sjögren's syndrome
674331|NCT00873496|hyposalivation|hyposalivation
674332|NCT00873496|mouth dryness|mouth dryness
674333|NCT00873496|complications|complications
674334|NCT00873509|Autism|autism
674335|NCT00873522|pneumonia|pneumonia
674336|NCT00873535|Nicotine|nicotine
674337|NCT00873535|Nicotine dependence|nicotine dependence
674338|NCT00873535|Smoking cessation|smoking cessation
674339|NCT00873535|Alcohol|alcohol
674340|NCT00873535|Alcohol dependence|alcohol dependence
674341|NCT00873535|Alcohol cessation|alcohol cessation
674342|NCT00873535|Treatment|treatment
674343|NCT00873535|Smoking|smoking
674344|NCT00873535|Cigarette|cigarette
674345|NCT00873535|Heavy drinkers|heavy drinkers
674346|NCT00873535|Social drinkers|social drinkers
674347|NCT00873535|Co-morbidity of alcohol and nicotine dependence|co-morbidity of alcohol and nicotine dependence
674348|NCT00873535|Nicotine receptor|nicotine receptor
674349|NCT00873535|Nicotinic receptor|nicotinic receptor
674350|NCT00873535|Nicotinic acetycholine receptor|nicotinic acetycholine receptor
674351|NCT00873535|Alpha-4-beta-2 nicotinic acetycholine receptor|alpha-4-beta-2 nicotinic acetycholine receptor
674352|NCT00873535|Cholinergic receptor|cholinergic receptor
674353|NCT00873535|Dopamine|dopamine
674354|NCT00873535|Craving|craving
674355|NCT00873535|Diary|diary
674356|NCT00873535|Cue induced|cue induced
674357|NCT00873535|Pharmacotherapy|pharmacotherapy
674358|NCT00873535|Varenicline|varenicline
674359|NCT00873535|Chantix|chantix
674363|NCT00873561|adult|adult
674364|NCT00873561|adolescent|adolescent
674365|NCT00873561|new onset|new onset
674366|NCT00873574|Familial myeloproliferative disorders|familial myeloproliferative disorders
674367|NCT00873574|JAK-STAT|jak-stat
674368|NCT00873574|V617|v617
674369|NCT00873574|JAK2|jak2
674370|NCT00873587|Thoracotomy|thoracotomy
674371|NCT00873587|Inspiration|inspiration
674372|NCT00873587|Expiration|expiration
674373|NCT00873587|Chest Tube|chest tube
674374|NCT00873587|pneumothorax|pneumothorax
674375|NCT00873587|Method of chest tube removal|method of chest tube removal
674376|NCT00873600|cognitive/functional effects|cognitive/functional effects
674377|NCT00873600|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
674378|NCT00873600|stage I breast cancer|stage i breast cancer
674379|NCT00873600|stage II breast cancer|stage ii breast cancer
674380|NCT00873600|stage IIIA breast cancer|stage iiia breast cancer
674381|NCT00873600|stage IIIB breast cancer|stage iiib breast cancer
674382|NCT00873600|stage IIIC breast cancer|stage iiic breast cancer
674383|NCT00873600|adenocarcinoma of the colon|adenocarcinoma of the colon
674384|NCT00873600|stage I colon cancer|stage i colon cancer
674385|NCT00873600|stage II colon cancer|stage ii colon cancer
674386|NCT00873600|stage III colon cancer|stage iii colon cancer
674387|NCT00873626|Urinary tract infection|urinary tract infection
674388|NCT00873626|treatment duration|treatment duration
674389|NCT00873626|acute pyelonephritis|acute pyelonephritis
674390|NCT00873626|good use of antibiotics|good use of antibiotics
674391|NCT00873652|Hepatitis B vaccine|hepatitis b vaccine
674392|NCT00873652|Booster dose|booster dose
674393|NCT00873652|Persistence|persistence
674394|NCT00873652|Immune response|immune response
674395|NCT00873652|Healthy children|healthy children
674396|NCT00873678|Molar tooth|molar tooth
674397|NCT00873678|AHI1 gene|ahi1 gene
674398|NCT00873678|CEP290 gene|cep290 gene
674399|NCT00873678|ciliopathies|ciliopathies
674400|NCT00873691|Patients indicated for an ICD/ CRT-D|patients indicated for an icd/ crt-d
674402|NCT00873717|long-term facilities|long-term facilities
674403|NCT00873717|nutritional status|nutritional status
674404|NCT00873730|Effect of etanercept in subjects with ankylosing spondylitis|effect of etanercept in subjects with ankylosing spondylitis
674405|NCT00873743|lower pain intensity with combination drug after cesarian section in first 48h postoperatively|lower pain intensity with combination drug after cesarian section in first 48h postoperatively
674406|NCT00873756|CRC|crc
674407|NCT00873756|Colon Cancer|colon cancer
674408|NCT00873756|Avastin|avastin
674409|NCT00873756|Apo2L/TRAIL|apo2l/trail
674410|NCT00873769|Staccato Loxapine|staccato loxapine
674411|NCT00873769|pharmacokinetics|pharmacokinetics
674412|NCT00873769|smokers|smokers
674413|NCT00873769|non-smokers|non-smokers
674414|NCT00873782|Limb Perfusion|limb perfusion
674415|NCT00873782|Gene Therapy|gene therapy
674416|NCT00873795|efficacy|efficacy
674417|NCT00873795|tolerability|tolerability
674519|NCT00874211|stage II multiple myeloma|stage ii multiple myeloma
674418|NCT00873795|combination of aripiprazole and SSRI(sertraline)|combination of aripiprazole and ssri(sertraline)
674419|NCT00873808|breast cancer|breast cancer
674420|NCT00873834|autism|autism
674421|NCT00873834|fluoxetine|fluoxetine
674422|NCT00873834|Comparative|comparative
674423|NCT00873834|double blind|double blind
674424|NCT00873834|placebo|placebo
674425|NCT00873834|controlled trial|controlled trial
674426|NCT00873834|anatomy-functional imaging|anatomy-functional imaging
674427|NCT00873834|children|children
674428|NCT00873834|DSM-IV-R criteria for autism and CARS score (of 30 or above)|dsm-iv-r criteria for autism and cars score (of 30 or above)
674429|NCT00873847|NICHD Neonatal Research Network|nichd neonatal research network
674430|NCT00873847|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
674431|NCT00873847|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
674432|NCT00873847|Prematurity|prematurity
674433|NCT00873847|Amplitude-integrated Electroencephalography (aEEG)|amplitude-integrated electroencephalography (aeeg)
674434|NCT00873860|CAT-354|cat-354
674435|NCT00873860|Tralokinumab|tralokinumab
674436|NCT00873860|Asthma|asthma
674437|NCT00873873|Asthma Progression|asthma progression
674438|NCT00873873|Airway Wall Thickness|airway wall thickness
674439|NCT00873873|Corticosteroid Resistance|corticosteroid resistance
674440|NCT00873873|Biomarkers|biomarkers
674441|NCT00873873|Pulmonary Physiology|pulmonary physiology
674442|NCT00873899|Heart Failure|heart failure
674443|NCT00873899|Implantable defibrillator|implantable defibrillator
674444|NCT00873899|Remote Monitoring|remote monitoring
674445|NCT00873912|influenza|influenza
674446|NCT00873912|FluMist|flumist
674447|NCT00873925|Type 1 Diabetes|type 1 diabetes
674448|NCT00873938|Artesunate-Amodiaquine|artesunate-amodiaquine
674449|NCT00873938|Compliance|compliance
674450|NCT00873938|Malaria|malaria
674451|NCT00873964|Metabolic Syndrome|metabolic syndrome
674452|NCT00873964|Obesity|obesity
674453|NCT00873964|Elderly|elderly
674454|NCT00873964|Insulin Resistance|insulin resistance
674455|NCT00873977|Adherence|adherence
674456|NCT00873977|Continuous Positive Airway Pressure|continuous positive airway pressure
674457|NCT00873990|fissure sealant|fissure sealant
674458|NCT00873990|self etch|self etch
674459|NCT00873990|total etch|total etch
674460|NCT00874003|alcohol dependence|alcohol dependence
674461|NCT00874003|anti-depressant|anti-depressant
674462|NCT00874003|5-HT|5-ht
674463|NCT00874003|NE|ne
674464|NCT00874016|intubation|intubation
674465|NCT00874016|Airtraq|airtraq
674466|NCT00874016|pediatric|pediatric
674467|NCT00874016|airway|airway
674468|NCT00874029|Uterine Fibroids|uterine fibroids
674469|NCT00874029|Myomas|myomas
674470|NCT00874042|dose escalation|dose escalation
674471|NCT00874042|safety|safety
674472|NCT00874042|tolerability|tolerability
674473|NCT00874042|tumor|tumor
674474|NCT00874042|PK|pk
674475|NCT00874055|social influence|social influence
674476|NCT00874055|friends|friends
674477|NCT00874055|eating behavior|eating behavior
674478|NCT00874055|childhood overweight|childhood overweight
674479|NCT00874068|term infants|term infants
674480|NCT00874068|preterm infants|preterm infants
674481|NCT00874068|bone strength|bone strength
674482|NCT00874068|Speed of sound (SOS)|speed of sound (sos)
674483|NCT00874068|Ultrasound|ultrasound
674484|NCT00874094|nasolabial folds|nasolabial folds
674485|NCT00874094|platelet rich plasma|platelet rich plasma
674486|NCT00874094|fibrin matrix|fibrin matrix
674487|NCT00874094|facial rhytids|facial rhytids
674488|NCT00874094|dermal filler|dermal filler
674489|NCT00874107|NSCLC|nsclc
674490|NCT00874107|Phase 2|phase 2
674491|NCT00874107|Randomized|randomized
674492|NCT00874107|Efficacy|efficacy
674493|NCT00874107|Safety|safety
674494|NCT00874107|Imprime PGG|imprime pgg
674495|NCT00874107|Bevacizumab|bevacizumab
674496|NCT00874172|Anemia|anemia
674497|NCT00874172|Sickle Cell|sickle cell
674498|NCT00874172|Analgesic|analgesic
674499|NCT00874172|Pain|pain
674500|NCT00874172|Emergency treatment|emergency treatment
674501|NCT00874172|Quality of life|quality of life
674502|NCT00874185|satisfaction|satisfaction
674503|NCT00874198|normal pressure hydrocephalus|normal pressure hydrocephalus
674504|NCT00874198|cerebrospinal fluid dynamic test|cerebrospinal fluid dynamic test
674505|NCT00874198|cerebrospinal fluid outflow resistance|cerebrospinal fluid outflow resistance
674506|NCT00874198|cerebrospinal compliance|cerebrospinal compliance
674507|NCT00874198|outcome|outcome
674508|NCT00874198|shunt surgery|shunt surgery
674509|NCT00874198|normal pressure hydrocephalus guidelines|normal pressure hydrocephalus guidelines
674510|NCT00874198|biomarkers|biomarkers
674511|NCT00874198|shunt surgery selection|shunt surgery selection
674512|NCT00874198|Outcome measures|outcome measures
674513|NCT00874198|Outcomes assessment|outcomes assessment
751816|NCT01170598|elderly|elderly
674514|NCT00874198|Outcome and process assessment|outcome and process assessment
674515|NCT00874211|bone metastases|bone metastases
674516|NCT00874211|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
674517|NCT00874211|refractory multiple myeloma|refractory multiple myeloma
674518|NCT00874211|stage I multiple myeloma|stage i multiple myeloma
674520|NCT00874211|stage III multiple myeloma|stage iii multiple myeloma
674521|NCT00874211|male breast cancer|male breast cancer
674522|NCT00874211|recurrent breast cancer|recurrent breast cancer
674523|NCT00874211|stage IA breast cancer|stage ia breast cancer
674524|NCT00874211|stage IB breast cancer|stage ib breast cancer
674525|NCT00874211|stage II breast cancer|stage ii breast cancer
674526|NCT00874211|stage IIIA breast cancer|stage iiia breast cancer
674527|NCT00874211|stage IIIB breast cancer|stage iiib breast cancer
674528|NCT00874211|stage IIIC breast cancer|stage iiic breast cancer
674529|NCT00874211|stage IV breast cancer|stage iv breast cancer
674530|NCT00874211|recurrent prostate cancer|recurrent prostate cancer
674531|NCT00874211|stage I prostate cancer|stage i prostate cancer
674532|NCT00874211|stage IIB prostate cancer|stage iib prostate cancer
674533|NCT00874211|stage IIA prostate cancer|stage iia prostate cancer
674534|NCT00874211|stage III prostate cancer|stage iii prostate cancer
674535|NCT00874211|stage IV prostate cancer|stage iv prostate cancer
674536|NCT00874211|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
674537|NCT00874211|stage I non-small cell lung cancer|stage i non-small cell lung cancer
674538|NCT00874211|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
674539|NCT00874211|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
674540|NCT00874211|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
674541|NCT00874211|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
674542|NCT00874211|extensive stage small cell lung cancer|extensive stage small cell lung cancer
674543|NCT00874211|limited stage small cell lung cancer|limited stage small cell lung cancer
674544|NCT00874211|recurrent small cell lung cancer|recurrent small cell lung cancer
674545|NCT00874224|Colorectal cancer liver metastasis|colorectal cancer liver metastasis
674546|NCT00874224|Benign liver disease|benign liver disease
674547|NCT00874237|Staccato loxapine|staccato loxapine
674549|NCT00874237|healthy volunteers|healthy volunteers
674550|NCT00874263|Probe-based imaging of GI pre-malignant or malignant lesions|probe-based imaging of gi pre-malignant or malignant lesions
674551|NCT00874276|DCA|dca
674552|NCT00874276|Dichloroacetate|dichloroacetate
674553|NCT00874276|Trichloroacetate|trichloroacetate
674554|NCT00874289|NGAL|ngal
674555|NCT00874289|Heart failure|heart failure
674556|NCT00874302|Uterine fibroids|uterine fibroids
674557|NCT00874315|recurrent or refractory neuroblastoma|recurrent or refractory neuroblastoma
674558|NCT00874328|Non small cell lung cancer|non small cell lung cancer
674559|NCT00874328|Irinotecan plus Cisplatin plus S-1|irinotecan plus cisplatin plus s-1
674560|NCT00874328|Phase I/II trial|phase i/ii trial
674561|NCT00874341|Fruit|fruit
674562|NCT00874341|Vegetables|vegetables
674563|NCT00874341|Intervention|intervention
674564|NCT00874341|Insulin resistance|insulin resistance
674565|NCT00874341|Cardiovascular disease risk|cardiovascular disease risk
674566|NCT00874341|Dose response|dose response
674567|NCT00874341|High risk of cardiovascular disease|high risk of cardiovascular disease
674568|NCT00874354|Myocardial Infarction|myocardial infarction
674569|NCT00874354|Heart Attack|heart attack
674570|NCT00874354|Infarct|infarct
674571|NCT00874354|Stem Cells|stem cells
674572|NCT00874354|Bone Marrow Derived Mononuclear Cells|bone marrow derived mononuclear cells
674573|NCT00874354|CHF|chf
674574|NCT00874354|Congestive Heart Failure|congestive heart failure
674575|NCT00874354|Stent|stent
674576|NCT00874354|PCI|pci
674577|NCT00874354|Percutaneous Coronary Intervention|percutaneous coronary intervention
674578|NCT00874367|NICHD Neonatal Research Network|nichd neonatal research network
674579|NCT00874367|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
674580|NCT00874367|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
674581|NCT00874367|Prematurity|prematurity
674582|NCT00874367|Early Onset Sepsis|early onset sepsis
674583|NCT00874380|Fiber|fiber
674584|NCT00874380|Dialysis|dialysis
674585|NCT00874380|Renal Replacement Therapy|renal replacement therapy
674586|NCT00874380|Food Frequency Questionnaire|food frequency questionnaire
674587|NCT00874380|FFQ|ffq
674588|NCT00874380|Dietary counseling|dietary counseling
674589|NCT00874393|NICHD Neonatal Research Network|nichd neonatal research network
674590|NCT00874393|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
674591|NCT00874393|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
674592|NCT00874393|Prematurity|prematurity
674593|NCT00874393|Blood Pressure Management|blood pressure management
674594|NCT00874393|Dopamine|dopamine
674595|NCT00874393|Hydrocortisone|hydrocortisone
674596|NCT00874406|colorectal cancer|colorectal cancer
674597|NCT00874406|liver metastasis|liver metastasis
674598|NCT00874406|neoadjuvant chemotherapy|neoadjuvant chemotherapy
674599|NCT00874419|EGFR mutation|egfr mutation
674600|NCT00874419|EGFR-TKI|egfr-tki
674601|NCT00874419|Chemotherapy|chemotherapy
674993|NCT00869063|contusion|contusion
674602|NCT00874432|cardiovascular disease|cardiovascular disease
674603|NCT00874432|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
674604|NCT00874432|chronic kidney disease|chronic kidney disease
674605|NCT00874432|cardiovascular disease in elderly patients with CKD|cardiovascular disease in elderly patients with ckd
674606|NCT00874458|ductal breast carcinoma in situ|ductal breast carcinoma in situ
674607|NCT00874510|sleep deprivation|sleep deprivation
674608|NCT00874510|fatigue|fatigue
674609|NCT00874523|raltegravir|raltegravir
674610|NCT00874523|atazanavir|atazanavir
674611|NCT00874523|HIV infections|hiv infections
674612|NCT00874523|pharmacokinetics|pharmacokinetics
674613|NCT00874523|antiretroviral agents|antiretroviral agents
674614|NCT00874523|treatment experienced|treatment experienced
674615|NCT00874536|ADHD|adhd
674616|NCT00874536|methylphenidate|methylphenidate
674617|NCT00874536|omega-3|omega-3
674618|NCT00874549|Meningococcal Vaccine|meningococcal vaccine
674619|NCT00874549|Menactra®|menactra®
674620|NCT00874549|Menomune®|menomune®
674621|NCT00874562|rapamycin|rapamycin
674622|NCT00874562|corticosteroid|corticosteroid
674624|NCT00874575|HMB|hmb
674625|NCT00874575|Vitamin D|vitamin d
674626|NCT00874575|Older Adults|older adults
674627|NCT00874601|acute ischemic stroke|acute ischemic stroke
674628|NCT00874601|blood pressure|blood pressure
674629|NCT00874601|valsartan|valsartan
674630|NCT00874601|death|death
674631|NCT00874601|dependancy|dependancy
674632|NCT00874614|radiotherapy|radiotherapy
674633|NCT00874614|MIBG|mibg
674634|NCT00874614|Azedra|azedra
674635|NCT00874614|neuroendocrine tumors|neuroendocrine tumors
674636|NCT00874614|Iobenguane I 131|iobenguane i 131
674637|NCT00874614|progenics|progenics
674638|NCT00874627|children > 5 years old|children > 5 years old
674639|NCT00874627|IgE-mediated|ige-mediated
674640|NCT00874627|cow milk allergy|cow milk allergy
674641|NCT00874627|IgE-mediated cow milk allergy persisting after 5 years|ige-mediated cow milk allergy persisting after 5 years
674642|NCT00874640|Drug utilization review|drug utilization review
674643|NCT00874666|garlic|garlic
674644|NCT00874666|allicin|allicin
674645|NCT00874666|allyl methyl sulfide|allyl methyl sulfide
674646|NCT00874666|healthy persons|healthy persons
674647|NCT00874692|tap water temperature|tap water temperature
674648|NCT00874692|social housing|social housing
674649|NCT00874692|scald reduction|scald reduction
674750|NCT00867867|Iron absorption|iron absorption
674650|NCT00874692|Temperature (degrees Celsius) of hot tap water at point of delivery.|temperature (degrees celsius) of hot tap water at point of delivery.
674651|NCT00874718|repetitive strain injury|repetitive strain injury
674652|NCT00874718|quality of life|quality of life
674653|NCT00874718|functional capacity|functional capacity
674654|NCT00874718|workers|workers
674655|NCT00874744|Diabetic macular edema|diabetic macular edema
674656|NCT00874744|intravitreal injection|intravitreal injection
674657|NCT00874744|Pharmacological treatment|pharmacological treatment
674658|NCT00867581|middle cerebral artery|middle cerebral artery
674659|NCT00867581|infarction|infarction
674660|NCT00867581|chronic stage|chronic stage
674661|NCT00867581|hippocampal volume|hippocampal volume
674662|NCT00867581|MRI|mri
674663|NCT00867581|MRS|mrs
674664|NCT00867581|neuropsychologic assessment|neuropsychologic assessment
674665|NCT00867607|Contact dermatitis|contact dermatitis
674666|NCT00867607|Eczema|eczema
674667|NCT00867633|urothelial carinoma|urothelial carinoma
674668|NCT00867633|aristolochic acid|aristolochic acid
674669|NCT00867633|DNA|dna
674670|NCT00867633|adduct|adduct
674671|NCT00867646|PT|pt
674672|NCT00867646|DVT|dvt
674673|NCT00867659|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
674674|NCT00867659|cetrotide acetate|cetrotide acetate
674675|NCT00867659|GnRH antagonist|gnrh antagonist
674676|NCT00867659|oocyte donors|oocyte donors
674677|NCT00867672|Acute Myeloid Leukemia|acute myeloid leukemia
674678|NCT00867672|Low-dose Decitabine|low-dose decitabine
674679|NCT00867672|Valproic acid|valproic acid
674680|NCT00867672|All-trans retinoic acid|all-trans retinoic acid
674681|NCT00867672|Older Patients|older patients
674682|NCT00867685|Healthy Volunteers|healthy volunteers
674683|NCT00867698|Hepatic encephalopathy|hepatic encephalopathy
674684|NCT00867698|Mild hepatic encephalopathy|mild hepatic encephalopathy
674685|NCT00867698|HE|he
674686|NCT00867698|MHE|mhe
674687|NCT00867698|Cognitive impairment|cognitive impairment
674688|NCT00867698|Cognitive dysfunction|cognitive dysfunction
674689|NCT00867698|Liver Disease|liver disease
674690|NCT00867698|Cirrhosis|cirrhosis
674691|NCT00867724|polyp|polyp
674692|NCT00867737|Asthma|asthma
674693|NCT00867737|Forced Oscillation|forced oscillation
674694|NCT00867737|Impulse Oscillometry|impulse oscillometry
674695|NCT00867737|Electrical-equivalent respiratory system model|electrical-equivalent respiratory system model
674696|NCT00867750|HCC|hcc
674697|NCT00867750|RE|re
674698|NCT00867750|Yttrium-90|yttrium-90
674699|NCT00867750|SIR-Spheres microspheres|sir-spheres microspheres
674700|NCT00867750|TACE|tace
674701|NCT00867750|Radioembolisation|radioembolisation
674702|NCT00867750|Transarterial Chemoembolisation|transarterial chemoembolisation
674704|NCT00867763|Tubal occlusion|tubal occlusion
674705|NCT00867763|Unexplained infertility|unexplained infertility
674706|NCT00867763|Low ovarian reserve|low ovarian reserve
674707|NCT00867763|Male factor infertility|male factor infertility
674708|NCT00867776|Depression|depression
674709|NCT00867776|African Americans|african americans
674710|NCT00867776|Exercise|exercise
674711|NCT00867776|Culturally tailored intervention|culturally tailored intervention
674712|NCT00867776|Health disparities|health disparities
674713|NCT00867789|abscess|abscess
674714|NCT00867789|outcomes|outcomes
674715|NCT00867789|antibiotics|antibiotics
674716|NCT00867789|incision and drainage|incision and drainage
674717|NCT00867789|skin abscess|skin abscess
674718|NCT00867802|MICAS|micas
674719|NCT00867802|MBSR|mbsr
674720|NCT00867815|Non-arteritic Anterior Ischemic Optic Neuropathy|non-arteritic anterior ischemic optic neuropathy
674721|NCT00867815|NAION|naion
674722|NCT00867815|PDE5 inhibitors|pde5 inhibitors
674723|NCT00867815|vardenafil|vardenafil
674724|NCT00867815|Levitra|levitra
674725|NCT00867815|sildenafil|sildenafil
674726|NCT00867815|Viagra|viagra
674727|NCT00867815|Tadalafil|tadalafil
674728|NCT00867815|Cialis|cialis
674729|NCT00867815|acute vision loss|acute vision loss
674730|NCT00867815|vision loss|vision loss
674731|NCT00867815|blurred vision|blurred vision
674732|NCT00867815|optic neuropathy|optic neuropathy
674733|NCT00867815|erectile dysfunction.|erectile dysfunction.
674734|NCT00867828|Decline of global cognitive function|decline of global cognitive function
674735|NCT00867828|Neuropsychological Test Battery (NTB)|neuropsychological test battery (ntb)
674736|NCT00867828|Early stage Alzheimer's disease|early stage alzheimer's disease
674737|NCT00867841|pneumonia, community-acquired|pneumonia, community-acquired
674738|NCT00867841|polymerase chain reaction|polymerase chain reaction
674739|NCT00867841|pneumococcus|pneumococcus
674740|NCT00867841|mycoplasma|mycoplasma
674741|NCT00867841|chlamydophila|chlamydophila
674742|NCT00867841|anti-bacterial agents|anti-bacterial agents
674743|NCT00867854|de-intensification|de-intensification
674744|NCT00867854|HAART|haart
674745|NCT00867854|monotherapy|monotherapy
674746|NCT00867854|persistent low-level viremia (LLV)|persistent low-level viremia (llv)
674747|NCT00867854|treatment experienced|treatment experienced
674748|NCT00867867|Iron deficiency anemia|iron deficiency anemia
674749|NCT00867867|Helicobacter pylori|helicobacter pylori
674751|NCT00867867|Iron fortification|iron fortification
674752|NCT00867867|ferrous sulphate|ferrous sulphate
674753|NCT00867867|ferrous fumarate|ferrous fumarate
674754|NCT00867880|To evaluate the Pharmacokinetic Profile of IVIb|to evaluate the pharmacokinetic profile of ivib
674755|NCT00867906|Cat allergy|cat allergy
674756|NCT00867906|Immunotherapy|immunotherapy
674757|NCT00867906|Cat-PAD|cat-pad
674758|NCT00867932|Paroxysmal Nocturnal Hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
674759|NCT00867958|Colon Anastomosis|colon anastomosis
674760|NCT00867958|Rectum Anastomosis|rectum anastomosis
674761|NCT00867958|Intestine|intestine
674762|NCT00867958|Colorectal Surgery|colorectal surgery
674763|NCT00867958|Colorectal Anastomosis|colorectal anastomosis
674764|NCT00867984|CRT, resynchronization,|crt, resynchronization,
674765|NCT00867997|Noncarious Cervical Lesions|noncarious cervical lesions
674766|NCT00867997|Hypersensitivity|hypersensitivity
674767|NCT00867997|Teeth|teeth
674768|NCT00867997|Dentistry|dentistry
674769|NCT00867997|Practice-based research network|practice-based research network
674770|NCT00868010|stroke|stroke
674771|NCT00868010|donepezil|donepezil
674772|NCT00868010|recovery|recovery
674773|NCT00868036|urticaria|urticaria
674774|NCT00868036|hives|hives
674775|NCT00868036|dermatitis|dermatitis
674776|NCT00868036|rash|rash
674777|NCT00868036|contact dermatitis|contact dermatitis
674778|NCT00868036|contact|contact
674779|NCT00868036|contact sensitization|contact sensitization
674780|NCT00868036|allergy|allergy
674781|NCT00868036|allergen|allergen
674782|NCT00868036|patch testing|patch testing
674783|NCT00868036|IgG|igg
674784|NCT00868036|delayed-hypersensitivity reaction|delayed-hypersensitivity reaction
674785|NCT00868036|hypersensitivity|hypersensitivity
674786|NCT00868049|chewing|chewing
674787|NCT00868049|deglutition|deglutition
674788|NCT00868049|orofacial motricity|orofacial motricity
674789|NCT00868049|obesity|obesity
674790|NCT00868062|The responses of patients to 1L infusions of Gelofusine (succinylated gelatine 40g/L) and Voluven (6% hydroxyethyl starch in 0.9% saline) intraoperatively.|the responses of patients to 1l infusions of gelofusine (succinylated gelatine 40g/l) and voluven (6% hydroxyethyl starch in 0.9% saline) intraoperatively.
674791|NCT00868075|Physiotherapy|physiotherapy
674792|NCT00868075|Rehabilitation|rehabilitation
674793|NCT00868075|Bronchiectasis|bronchiectasis
674794|NCT00868088|AC|ac
674795|NCT00868088|SCC|scc
674796|NCT00868088|SCC-is|scc-is
674797|NCT00868088|PDT|pdt
674798|NCT00868088|Mohs|mohs
674799|NCT00868101|ischemic|ischemic
674800|NCT00868101|preconditioning|preconditioning
674801|NCT00868101|congenital heart disease|congenital heart disease
674802|NCT00868114|Inoperable pancreatic cancer|inoperable pancreatic cancer
674994|NCT00869063|diclofenac|diclofenac
674803|NCT00868114|Dendritic Cell Vaccine|dendritic cell vaccine
674804|NCT00868114|Locally advanced or low volume metatstatic pancreatic cancer|locally advanced or low volume metatstatic pancreatic cancer
674805|NCT00868127|Hyperlipidemia|hyperlipidemia
674806|NCT00868127|Drug Therapy|drug therapy
674807|NCT00868127|Dyslipidemia|dyslipidemia
674808|NCT00868166|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
674809|NCT00868166|TRO19622|tro19622
674810|NCT00868166|Trophos|trophos
674811|NCT00868179|Thrombosis|thrombosis
674812|NCT00868179|total knee replacement|total knee replacement
674813|NCT00868205|oxidative stress|oxidative stress
674814|NCT00868205|Comet assay|comet assay
674815|NCT00868205|antioxidants|antioxidants
674816|NCT00868218|Influenza A|influenza a
674817|NCT00868218|pandemic|pandemic
674818|NCT00868218|vaccine|vaccine
674819|NCT00868218|immunogenicity|immunogenicity
674820|NCT00868218|Virus|virus
674821|NCT00868218|H5N1|h5n1
674822|NCT00868231|COPD|copd
674823|NCT00868231|Antimuscarinic|antimuscarinic
674824|NCT00868244|facial patterns|facial patterns
674825|NCT00868244|bruxism|bruxism
674826|NCT00868244|masticatory muscles|masticatory muscles
674827|NCT00868257|AIDS|aids
674828|NCT00868257|Adherence to Antiretroviral Therapy|adherence to antiretroviral therapy
674829|NCT00868257|Pediatric|pediatric
674830|NCT00868257|Resource Limited Setting|resource limited setting
674831|NCT00868257|Treatment experienced|treatment experienced
674832|NCT00868296|Safety|safety
674833|NCT00868309|Snake Bite|snake bite
674834|NCT00868309|Venom and antivenom kinetics|venom and antivenom kinetics
674835|NCT00868335|Cervical degenerative disc disease|cervical degenerative disc disease
674836|NCT00868335|Anterior cervical discectomy|anterior cervical discectomy
674837|NCT00868335|Cervical disc prosthesis|cervical disc prosthesis
674838|NCT00868335|Activ-C|activ-c
674839|NCT00868335|Mobility|mobility
674840|NCT00868335|Movement|movement
674841|NCT00868348|Total Knee Arthroplasty|total knee arthroplasty
674842|NCT00868361|Mass Balance|mass balance
674843|NCT00868361|Talampanel|talampanel
674844|NCT00868361|Pharmacokinetics|pharmacokinetics
674845|NCT00868361|Metabolism|metabolism
674846|NCT00868361|Metabolites|metabolites
674847|NCT00868361|Healthy Volunteers|healthy volunteers
674848|NCT00868387|weight reduction|weight reduction
674849|NCT00868387|low-carbohydrate|low-carbohydrate
674850|NCT00868387|body fat|body fat
674851|NCT00868387|telemedicine|telemedicine
674852|NCT00868387|cardiovascular risk markers|cardiovascular risk markers
674853|NCT00868400|Preoperative care|preoperative care
674854|NCT00868400|colorectal surgery|colorectal surgery
674855|NCT00868400|carbohydrate|carbohydrate
674856|NCT00868400|fasting|fasting
674857|NCT00868426|Healthy volunteer study|healthy volunteer study
674858|NCT00868439|HF|hf
674859|NCT00868439|Heart failure|heart failure
674860|NCT00868439|hyperkalemia|hyperkalemia
674861|NCT00868439|chronic kidney disease|chronic kidney disease
674862|NCT00868439|prevention of hyperkalemia in heart failure participants|prevention of hyperkalemia in heart failure participants
674863|NCT00868452|Bipolar I|bipolar i
674864|NCT00868452|Latuda|latuda
674865|NCT00868452|Lurasidone|lurasidone
674866|NCT00868478|humanized monoclonal antibody|humanized monoclonal antibody
674867|NCT00868491|head and neck cancer|head and neck cancer
674868|NCT00868491|inoperable|inoperable
674869|NCT00868491|induction chemotherapy|induction chemotherapy
674870|NCT00868491|concomitant radiochemotherapy|concomitant radiochemotherapy
674871|NCT00868491|biological agent|biological agent
674872|NCT00868491|efficacy|efficacy
674873|NCT00868491|toxicity|toxicity
674874|NCT00868504|GI tract|gi tract
674875|NCT00868504|Tumors|tumors
674876|NCT00868504|Temperatures|temperatures
674877|NCT00868517|Veterans|veterans
674878|NCT00868517|Operation Iraqi Freedom|operation iraqi freedom
674879|NCT00868517|Operation Enduring Freedom|operation enduring freedom
674880|NCT00868517|Combat Disorders|combat disorders
674881|NCT00868517|Acupuncture|acupuncture
674882|NCT00868517|Complementary Therapies|complementary therapies
674883|NCT00868530|On-demand treatment; Hemostatic Efficacy Assessments; Factor VIII recovery; Factor VIII Inhibitor; Chinese|on-demand treatment; hemostatic efficacy assessments; factor viii recovery; factor viii inhibitor; chinese
674884|NCT00868543|Gastric bypass|gastric bypass
674885|NCT00868543|obesity|obesity
674886|NCT00868543|superobese|superobese
674887|NCT00868556|fMRI scans|fmri scans
674888|NCT00868556|episodic migraine sufferers|episodic migraine sufferers
674889|NCT00868556|chronic migraine sufferers|chronic migraine sufferers
674890|NCT00868556|non migraine sufferers (controls)|non migraine sufferers (controls)
674891|NCT00868569|liver metastasis|liver metastasis
674892|NCT00868569|colorectal cancer|colorectal cancer
674893|NCT00868569|oxaliplatine|oxaliplatine
674894|NCT00868569|transartery chemotherapy|transartery chemotherapy
674895|NCT00868569|embolision|embolision
674896|NCT00868569|Unresectable Liver Metastasis of Colorectal Cancer|unresectable liver metastasis of colorectal cancer
751817|NCT01170598|physical fitness|physical fitness
751818|NCT01170598|muscular strength|muscular strength
674995|NCT00869063|patch|patch
674996|NCT00869063|acute pain|acute pain
674897|NCT00868582|Patients with proven or suspected cancer referred for NaF-18 PET to identify bone metastasis|patients with proven or suspected cancer referred for naf-18 pet to identify bone metastasis
674898|NCT00868608|Refractory Indolent NHL|refractory indolent nhl
674899|NCT00868608|lymphoma|lymphoma
674900|NCT00868673|Role of Fructose in overweight and obesity|role of fructose in overweight and obesity
674901|NCT00868673|Fructose and metabolic syndrome|fructose and metabolic syndrome
674902|NCT00868673|Low fructose diet study|low fructose diet study
675004|NCT00869115|Inotropes|inotropes
674903|NCT00868673|Effects of fructose in blood pressure and hypertension|effects of fructose in blood pressure and hypertension
674904|NCT00868673|Somatometry changes observed in fructose diets|somatometry changes observed in fructose diets
674905|NCT00868673|Fructose induced overweight and obesity|fructose induced overweight and obesity
674906|NCT00868673|Fructose induced metabolic syndrome|fructose induced metabolic syndrome
674907|NCT00868673|Fructose induced hyperuricemia|fructose induced hyperuricemia
674908|NCT00868699|Bipolar I, Depression|bipolar i, depression
674909|NCT00868712|coronary calcification|coronary calcification
674910|NCT00868712|vitamin K dependent proteins|vitamin k dependent proteins
674911|NCT00868712|warfarin|warfarin
674912|NCT00868725|oral cavity|oral cavity
674913|NCT00868725|carcinoma|carcinoma
674914|NCT00868725|thermal imaging|thermal imaging
674915|NCT00868738|Calcium|calcium
674916|NCT00868738|Vitamin D|vitamin d
674917|NCT00868738|Magnesium|magnesium
674918|NCT00868738|Zinc|zinc
674919|NCT00868751|Antibodies, Monoclonal|antibodies, monoclonal
674920|NCT00868751|Interleukin 6|interleukin 6
674921|NCT00868764|Effect of age|effect of age
674922|NCT00868764|Effect of body fat|effect of body fat
674923|NCT00868764|Granisetron|granisetron
674924|NCT00868764|Pharmacokinetic profile|pharmacokinetic profile
674925|NCT00868764|Sancuso® patch|sancuso® patch
674926|NCT00868764|Transdermal|transdermal
674927|NCT00868777|Implant site development|implant site development
674928|NCT00868777|Bone grafting|bone grafting
674929|NCT00868777|Dental implants|dental implants
674930|NCT00868803|prostate cancer|prostate cancer
674931|NCT00868816|oxaliplatine|oxaliplatine
674932|NCT00868816|colorectal cancer|colorectal cancer
674933|NCT00868816|chemotherapy|chemotherapy
674934|NCT00868829|Stent|stent
674935|NCT00868829|FireBird2|firebird2
674936|NCT00868829|Coronary Heart Disease|coronary heart disease
674937|NCT00868842|Penicillin|penicillin
674938|NCT00868842|Allergy|allergy
674939|NCT00868842|Prevention|prevention
674940|NCT00868842|Anaphylaxis|anaphylaxis
674941|NCT00868842|Clinically proven history of penicillin allergy|clinically proven history of penicillin allergy
674942|NCT00868842|preventing anaphylaxis|preventing anaphylaxis
674943|NCT00868855|Coronary Artery Disease|coronary artery disease
674944|NCT00868868|Pedometer|pedometer
674945|NCT00868868|Prostate|prostate
674947|NCT00868868|Hormonotherapy|hormonotherapy
674948|NCT00868868|Exercise|exercise
674949|NCT00868881|Hypertension|hypertension
674950|NCT00868881|Therapeutic diagnostic attitude|therapeutic diagnostic attitude
674951|NCT00868881|Blood pressure|blood pressure
674952|NCT00868946|Ribavirin|ribavirin
674953|NCT00868946|Hemorrhagic Fever with Renal Syndrome|hemorrhagic fever with renal syndrome
674954|NCT00868946|Dobrava Virus|dobrava virus
674955|NCT00868946|Puumala Virus|puumala virus
674956|NCT00868959|Bipolar|bipolar
674957|NCT00868959|Depression|depression
674958|NCT00868959|Lurasidone|lurasidone
674959|NCT00868959|Latuda|latuda
674960|NCT00868972|Renal Artery Obstruction|renal artery obstruction
674961|NCT00868972|renovascular hypertension|renovascular hypertension
674962|NCT00868972|stent|stent
674963|NCT00868972|Kidney Failure|kidney failure
674964|NCT00868972|embolic protection|embolic protection
674965|NCT00868998|Biliary Cancer|biliary cancer
674966|NCT00869011|Cancer|cancer
674967|NCT00869011|renal cell carcinoma|renal cell carcinoma
674968|NCT00869011|fatigue|fatigue
674969|NCT00869011|exercise|exercise
674970|NCT00869024|Heart failure|heart failure
674971|NCT00869024|Left ventricular assist device|left ventricular assist device
674972|NCT00869024|Stem cells|stem cells
674973|NCT00869037|Randomized controlled study|randomized controlled study
674974|NCT00869037|Total knee arthroplasty|total knee arthroplasty
674975|NCT00869037|Post operative pain|post operative pain
674976|NCT00869037|Continuous Femoral Nerve Block|continuous femoral nerve block
674977|NCT00869037|Posterior Capsular injection|posterior capsular injection
674978|NCT00869037|Periarticular injection|periarticular injection
674979|NCT00869050|Pancreatic cancer|pancreatic cancer
674980|NCT00869050|Neuroendocrine tumors|neuroendocrine tumors
674981|NCT00869050|Carcinoid tumors|carcinoid tumors
674982|NCT00869050|Pheochromocytomas|pheochromocytomas
674983|NCT00869050|Gastrinomas|gastrinomas
674984|NCT00869050|Zollinger-Ellison syndrome|zollinger-ellison syndrome
674985|NCT00869050|MEN Type I/II|men type i/ii
674986|NCT00869050|Somatostatinomas|somatostatinomas
674987|NCT00869050|VIPomas|vipomas
674988|NCT00869050|Merkel cell tumors|merkel cell tumors
674989|NCT00869050|medullary thyroid carcinoma|medullary thyroid carcinoma
674990|NCT00869063|wrist|wrist
674991|NCT00869063|sprain|sprain
674992|NCT00869063|strain|strain
674997|NCT00869063|acute pain due to mild to moderate wrist sprain, strain or contusion|acute pain due to mild to moderate wrist sprain, strain or contusion
674998|NCT00869076|Diabetes Mellitus|diabetes mellitus
674999|NCT00869076|Pharmacist|pharmacist
675000|NCT00869089|PN|pn
675001|NCT00869102|IGT|igt
675002|NCT00869102|IFG|ifg
675003|NCT00869115|Digoxin|digoxin
675005|NCT00869115|Lusitropic agents|lusitropic agents
675006|NCT00869115|Istaroxime|istaroxime
675007|NCT00869115|Debio 0614|debio 0614
675008|NCT00869128|melatonin|melatonin
675009|NCT00869128|insomnia|insomnia
675010|NCT00869128|diabetes|diabetes
675011|NCT00869128|sleep|sleep
675012|NCT00869141|Glaucoma tube shunt procedure|glaucoma tube shunt procedure
675013|NCT00869154|Mild TBI|mild tbi
675014|NCT00869154|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
675015|NCT00869154|Traumatic Brain Injury|traumatic brain injury
675016|NCT00869154|Injury, Brain, Traumatic|injury, brain, traumatic
675017|NCT00869154|Injuries, Acute Brain|injuries, acute brain
675018|NCT00869154|Brain Injuries, Traumatic|brain injuries, traumatic
675019|NCT00869154|Acute Brain Injuries|acute brain injuries
675020|NCT00869180|diclofenac|diclofenac
675021|NCT00869180|ankle sprain|ankle sprain
675022|NCT00869180|acute pain|acute pain
675023|NCT00869180|topical|topical
675024|NCT00869180|patch|patch
675025|NCT00869180|Acute Pain due to Mild to Moderate Ankle Sprain|acute pain due to mild to moderate ankle sprain
675026|NCT00869193|Blood pressure|blood pressure
675027|NCT00869193|Grape seed|grape seed
675028|NCT00869206|pain|pain
675029|NCT00869206|Prostate Adenocarcinoma|prostate adenocarcinoma
675030|NCT00869206|urinary complications|urinary complications
675031|NCT00869206|stage IV breast cancer|stage iv breast cancer
675032|NCT00869206|Recurrent Breast Carcinoma|recurrent breast carcinoma
675033|NCT00869206|stage IV prostate cancer|stage iv prostate cancer
675034|NCT00869206|recurrent prostate cancer|recurrent prostate cancer
675035|NCT00869206|Recurrent Prostate Carcinoma|recurrent prostate carcinoma
675036|NCT00869206|stage I multiple myeloma|stage i multiple myeloma
675037|NCT00869206|stage II multiple myeloma|stage ii multiple myeloma
675038|NCT00869206|Refractory Plasma Cell Myeloma|refractory plasma cell myeloma
675039|NCT00869206|bone metastases|bone metastases
675040|NCT00869219|Pain|pain
675041|NCT00869219|Pain after eyedrops|pain after eyedrops
675042|NCT00869232|Multiple Myeloma|multiple myeloma
675044|NCT00869245|Acute Coronary Syndrome|acute coronary syndrome
675045|NCT00869245|Chest pain|chest pain
675046|NCT00869245|Cardiac MRI|cardiac mri
675047|NCT00869245|CMR|cmr
675048|NCT00869245|Risk Stratification|risk stratification
675049|NCT00869245|Emergency Department|emergency department
675050|NCT00869258|Pancreatic cancer|pancreatic cancer
675051|NCT00869258|Gemcitabine|gemcitabine
675052|NCT00869258|Docetaxel|docetaxel
675053|NCT00869258|Capecitabine|capecitabine
675054|NCT00869271|liver metastasis|liver metastasis
675055|NCT00869271|colorectal cancer|colorectal cancer
675056|NCT00869284|High-dose chemotherapy|high-dose chemotherapy
675057|NCT00869284|aggressive NHL|aggressive nhl
675058|NCT00869284|high-risk|high-risk
675059|NCT00869284|PBSC|pbsc
675060|NCT00869310|aprepitant|aprepitant
675061|NCT00869310|delayed emesis|delayed emesis
675062|NCT00869310|cisplatin|cisplatin
675063|NCT00869310|antiemetic|antiemetic
675064|NCT00869323|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
675065|NCT00874757|Statins, anti-inflammatory|statins, anti-inflammatory
675066|NCT00874757|Healthy subjects study|healthy subjects study
675067|NCT00874770|Antivirals|antivirals
675068|NCT00874783|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
675069|NCT00874783|Familial Dysautonomia|familial dysautonomia
675070|NCT00874783|Parkinson's Disease|parkinson's disease
675071|NCT00874783|Alzheimer's Disease|alzheimer's disease
675072|NCT00874783|Age Related Macular Degeneration|age related macular degeneration
675073|NCT00874783|Retinitis Pigmentosa|retinitis pigmentosa
675074|NCT00874783|Huntington's Disease|huntington's disease
675075|NCT00874783|Machado - Joseph Disease|machado - joseph disease
675076|NCT00874783|SMA - Spinal Muscular Atrophy|sma - spinal muscular atrophy
675077|NCT00874783|Ataxia Telangiectasia|ataxia telangiectasia
675078|NCT00874796|apoptosis|apoptosis
675079|NCT00874796|liver inflammation|liver inflammation
675080|NCT00874796|hepatitis C|hepatitis c
675081|NCT00874809|insulin pump|insulin pump
675082|NCT00874809|DM Type 2|dm type 2
675083|NCT00874809|CGMS|cgms
675084|NCT00874809|basal rate|basal rate
675085|NCT00874835|Endothelial Keratoplasty|endothelial keratoplasty
675086|NCT00874835|EK|ek
675087|NCT00874835|Descemet Stripping Endothelial Keratoplasty|descemet stripping endothelial keratoplasty
675088|NCT00874835|Corneal Transplantation|corneal transplantation
675089|NCT00874835|Keratoplasty|keratoplasty
675090|NCT00874835|DSEK|dsek
675091|NCT00874835|DSAEK|dsaek
675092|NCT00874848|Imprime PGG|imprime pgg
675093|NCT00874848|NSCLC|nsclc
675094|NCT00874848|Cetuximab|cetuximab
675095|NCT00874861|cancer|cancer
675096|NCT00874861|brain|brain
675097|NCT00874861|tumor|tumor
675098|NCT00874861|vaccine|vaccine
675099|NCT00874874|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
675100|NCT00874874|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
675101|NCT00874874|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
675102|NCT00874874|adult angiosarcoma|adult angiosarcoma
675103|NCT00874913|blood flow|blood flow
675477|NCT00876772|Zyprexa|zyprexa
675104|NCT00874913|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
675105|NCT00874913|normal tension glaucoma|normal tension glaucoma
675106|NCT00874926|Octocog alfa|octocog alfa
675107|NCT00874926|Haemophilia A|haemophilia a
675108|NCT00874952|Metabolic syndrome|metabolic syndrome
675109|NCT00874952|Lipids|lipids
675110|NCT00874952|Waist Circumference|waist circumference
675111|NCT00874952|HDL|hdl
675112|NCT00874952|hypertension|hypertension
675113|NCT00874965|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
676623|NCT00881010|IVR|ivr
675114|NCT00874965|Electrostimulation|electrostimulation
675115|NCT00874965|Muscle function|muscle function
675116|NCT00874965|Exercise ventilation|exercise ventilation
675117|NCT00874965|Anabolism/catabolism pathway|anabolism/catabolism pathway
675118|NCT00874978|Lenalidomide|lenalidomide
675119|NCT00874978|myelodysplastic syndromes|myelodysplastic syndromes
675120|NCT00874991|Cardiac deformation|cardiac deformation
675121|NCT00874991|Cardiopulmonary bypass|cardiopulmonary bypass
675122|NCT00874991|TEE|tee
675123|NCT00874991|Cardiac Surgery|cardiac surgery
675124|NCT00874991|Left ventricular function|left ventricular function
675125|NCT00874991|Pulmonary Artery catheter|pulmonary artery catheter
675126|NCT00874991|Tissue Doppler|tissue doppler
675127|NCT00874991|Left ventricular function in cardiac surgery|left ventricular function in cardiac surgery
675128|NCT00875004|anemia|anemia
675129|NCT00875004|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
675130|NCT00875030|Bioequivalence study-artesunate sachets-arsuamoon tablet|bioequivalence study-artesunate sachets-arsuamoon tablet
675131|NCT00875043|ischemic optic neuropathy|ischemic optic neuropathy
675132|NCT00875043|cortical blindness|cortical blindness
675133|NCT00875069|Nosocomial infection|nosocomial infection
675134|NCT00875069|Catheterization|catheterization
675135|NCT00875069|Central Venous Ethanol|central venous ethanol
675136|NCT00875069|lock solution|lock solution
675137|NCT00875069|intensive care units|intensive care units
675138|NCT00875069|Renal replacement therapy in ICU|renal replacement therapy in icu
675139|NCT00875082|Asthma|asthma
675140|NCT00875082|Children|children
675141|NCT00875082|Remodelling|remodelling
675142|NCT00875082|Metalloproteinases|metalloproteinases
675143|NCT00875082|Montelukast|montelukast
675144|NCT00875420|hot flashes|hot flashes
675145|NCT00875420|hot flushes|hot flushes
675146|NCT00875420|vasomotor symptoms|vasomotor symptoms
675147|NCT00875420|postmenopausal|postmenopausal
675148|NCT00875472|social influences|social influences
675149|NCT00875472|food purchases|food purchases
675150|NCT00875472|childhood obesity|childhood obesity
675151|NCT00875472|amount of energy dense food and beverage items purchased|amount of energy dense food and beverage items purchased
675152|NCT00875472|amount of nutrient dense food and beverage items purchased|amount of nutrient dense food and beverage items purchased
675153|NCT00875485|Monovalent Hepatitis A|monovalent hepatitis a
675154|NCT00875485|hepatitis B vaccine|hepatitis b vaccine
675155|NCT00875485|Belgium and Czech Republic|belgium and czech republic
675156|NCT00875498|iTBS|itbs
675157|NCT00875498|Negative Symptoms|negative symptoms
675158|NCT00875511|peer rejection|peer rejection
675159|NCT00875511|obesity|obesity
675160|NCT00875511|amount of food chosen|amount of food chosen
675161|NCT00875511|amount of social time chosen|amount of social time chosen
675162|NCT00875524|Dengue virus|dengue virus
675163|NCT00875524|Dengue fever|dengue fever
675164|NCT00875524|Dengue hemorrhagic fever|dengue hemorrhagic fever
675165|NCT00875524|Dengue diseases|dengue diseases
675166|NCT00875524|Dengue vaccine|dengue vaccine
675167|NCT00875537|Burning mouth syndrome|burning mouth syndrome
675168|NCT00875537|neuropathy|neuropathy
675169|NCT00875537|inflammation|inflammation
675170|NCT00875537|tongue mucosa|tongue mucosa
675171|NCT00875537|tongue innervation|tongue innervation
675172|NCT00875537|dysgeusia|dysgeusia
675173|NCT00875550|Intubated and mechanically ventilated PICU subjects|intubated and mechanically ventilated picu subjects
675174|NCT00875576|social influences|social influences
675175|NCT00875576|meals|meals
675176|NCT00875576|obesity|obesity
675177|NCT00875576|amount of food consumed|amount of food consumed
675178|NCT00875589|Traumatic Brain Injury|traumatic brain injury
675179|NCT00875589|Eye movement recording|eye movement recording
675180|NCT00875602|All hospitalized patients in a general Med/ Surg unit|all hospitalized patients in a general med/ surg unit
675181|NCT00875615|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
675182|NCT00875615|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
675183|NCT00875615|advanced adult primary liver cancer|advanced adult primary liver cancer
751819|NCT01170598|Feasibility|feasibility
751820|NCT01170598|Efficacy|efficacy
675184|NCT00875628|Japanese Healthy volunteers HCV pharmacokinetics PF-00868554 filibuvir|japanese healthy volunteers hcv pharmacokinetics pf-00868554 filibuvir
675185|NCT00875654|Cell therapy|cell therapy
675186|NCT00875654|Stroke|stroke
675187|NCT00875654|Neuronal Plasticity|neuronal plasticity
675188|NCT00875654|Recovery|recovery
675189|NCT00875654|Mesenchymal Stem Cells|mesenchymal stem cells
675190|NCT00875654|Transplantation|transplantation
675191|NCT00875667|Mantle Cell Lymphoma|mantle cell lymphoma
675192|NCT00875667|Relapsed Mantle Cell Lymphoma|relapsed mantle cell lymphoma
675282|NCT00876005|Wound infection|wound infection
675193|NCT00875667|Refractory Mantle Cell Lymphoma|refractory mantle cell lymphoma
675194|NCT00875667|Lymphoma|lymphoma
675197|NCT00875693|leukemia|leukemia
675198|NCT00875693|MDS|mds
675199|NCT00875706|Nursing Homes|nursing homes
675200|NCT00875706|Implementation of innovative programs|implementation of innovative programs
675201|NCT00875706|Nursing staff|nursing staff
675202|NCT00875706|Nurses' aides|nurses' aides
675203|NCT00875706|Educational models|educational models
675204|NCT00875719|COPD patients with respiratory failure|copd patients with respiratory failure
675205|NCT00875732|Resynchronization|resynchronization
675206|NCT00875732|Device|device
675207|NCT00875732|Bradycardia|bradycardia
675208|NCT00875732|atrioventricular block|atrioventricular block
675209|NCT00875732|Cardiac Resynchronization|cardiac resynchronization
675210|NCT00875758|preterm infants|preterm infants
675211|NCT00875758|IVH|ivh
675212|NCT00875758|germinal matrix|germinal matrix
675213|NCT00875758|intraventricular hemorrhage|intraventricular hemorrhage
675214|NCT00875758|hydrocephalus|hydrocephalus
675215|NCT00875771|metastatic colorectal cancer|metastatic colorectal cancer
675216|NCT00875771|BEVACIZUMAB|bevacizumab
675217|NCT00875771|CAPECITABINE|capecitabine
675218|NCT00875771|IRINOTECAN|irinotecan
675219|NCT00875784|Sumatriptan exposure|sumatriptan exposure
675220|NCT00875797|enteral|enteral
675221|NCT00875797|parenteral|parenteral
675222|NCT00875797|glutamine|glutamine
675223|NCT00875797|intestinal permeability|intestinal permeability
675224|NCT00875797|infection|infection
675225|NCT00875823|PH|ph
675226|NCT00875823|Primary Hyperoxaluria|primary hyperoxaluria
675227|NCT00875823|Type I|type i
675228|NCT00875823|Type II|type ii
675229|NCT00875823|NonI-NonII|noni-nonii
675230|NCT00875823|Kidney stones|kidney stones
675231|NCT00875823|oxalate|oxalate
675232|NCT00875823|oxalosis|oxalosis
675233|NCT00875836|Marijuana|marijuana
675234|NCT00875836|Buspirone|buspirone
675235|NCT00875836|Contingency management|contingency management
675236|NCT00875836|Motivational enhancement therapy|motivational enhancement therapy
675237|NCT00875849|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
675238|NCT00875849|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
675239|NCT00875849|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
675240|NCT00875849|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
675241|NCT00875849|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
675242|NCT00875849|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
675243|NCT00875849|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
675244|NCT00875849|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
675245|NCT00875849|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
675246|NCT00875849|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
675247|NCT00875849|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
675248|NCT00875849|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
675249|NCT00875849|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
675250|NCT00875849|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
675251|NCT00875849|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
675252|NCT00875849|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
675253|NCT00875849|tongue cancer|tongue cancer
675254|NCT00875862|UCSD|ucsd
675255|NCT00875862|pain|pain
675256|NCT00875862|quality-of-life|quality-of-life
675257|NCT00875862|range-of-motion|range-of-motion
675258|NCT00875862|interscalene catheter|interscalene catheter
675259|NCT00875862|nerve block|nerve block
675260|NCT00875862|shoulder|shoulder
675261|NCT00875862|Shoulder Manipulation|shoulder manipulation
675262|NCT00875875|Diarrhea, travelers|diarrhea, travelers
675263|NCT00875875|Acute travelers' diarrhea|acute travelers' diarrhea
675264|NCT00875901|Lung Cancer|lung cancer
675265|NCT00875901|Stage I Non-Small Cell Lung Cancer|stage i non-small cell lung cancer
675266|NCT00875901|Proton Radiation|proton radiation
675267|NCT00875901|HypoIGRT|hypoigrt
675268|NCT00875914|AV-node reentry tachycardia|av-node reentry tachycardia
675269|NCT00875914|radiofrequency ablation|radiofrequency ablation
675270|NCT00875914|magnetic navigation system|magnetic navigation system
675271|NCT00875927|Halitosis|halitosis
675272|NCT00875953|squamous cell carcinoma|squamous cell carcinoma
675682|NCT00877448|UNIVERSAL|universal
675273|NCT00875953|head and neck cancer|head and neck cancer
675274|NCT00875953|neck dissection|neck dissection
675275|NCT00875979|MBC|mbc
675276|NCT00875979|Breast Cancer|breast cancer
675277|NCT00875979|HER2+|her2+
675278|NCT00875979|HER2+ breast cancer|her2+ breast cancer
675279|NCT00875979|HER2 positive breast cancer|her2 positive breast cancer
675280|NCT00875979|herceptin|herceptin
675281|NCT00875979|Trastuzumab emtansine|trastuzumab emtansine
675286|NCT00876018|healthy children|healthy children
675287|NCT00876031|pediatric soft tissue sarcoma|pediatric soft tissue sarcoma
675288|NCT00876031|rhabdomyosarcoma|rhabdomyosarcoma
675289|NCT00876031|extraosseous Ewing family tumours|extraosseous ewing family tumours
675290|NCT00876031|synovial sarcoma|synovial sarcoma
675291|NCT00876031|undifferentiated sarcoma|undifferentiated sarcoma
675292|NCT00876057|psychological well-being|psychological well-being
675293|NCT00876057|recovery|recovery
675294|NCT00876057|time in hospital|time in hospital
675295|NCT00876057|sick-leave|sick-leave
675296|NCT00876057|complications|complications
675297|NCT00876057|Sexual well-being|sexual well-being
675298|NCT00876070|Metastatic Breast Cancer|metastatic breast cancer
675299|NCT00876070|Breast Cancer|breast cancer
675300|NCT00876070|MBC|mbc
675301|NCT00876070|Abraxane|abraxane
675302|NCT00876070|Paclitaxel|paclitaxel
675303|NCT00876070|Taxol|taxol
675304|NCT00876070|Docetaxel|docetaxel
675305|NCT00876070|Taxotere|taxotere
675306|NCT00876083|Drug utilization review|drug utilization review
675307|NCT00876096|Diagnosis, Differential|diagnosis, differential
675308|NCT00876109|Metastatic Solid Tumors|metastatic solid tumors
675309|NCT00876109|PI3K|pi3k
675310|NCT00876109|PI3K Inhibitors|pi3k inhibitors
675311|NCT00876122|NHL|nhl
675312|NCT00876122|Metastatic Solid Tumors|metastatic solid tumors
675313|NCT00876122|PI3K Inhibitors|pi3k inhibitors
675314|NCT00876122|PI3K|pi3k
675315|NCT00876148|Incidence of hepatitis B after allografting|incidence of hepatitis b after allografting
675316|NCT00876148|Risk of hepatitis B reactivation|risk of hepatitis b reactivation
675317|NCT00876148|Lamivudine prophylaxis|lamivudine prophylaxis
675318|NCT00876161|Healthy Adults|healthy adults
675319|NCT00876174|Chronic hepatitis C|chronic hepatitis c
675320|NCT00876174|Genotype 1|genotype 1
675321|NCT00876187|randomized controlled trial|randomized controlled trial
675322|NCT00876187|monoclonal antibody|monoclonal antibody
675323|NCT00876187|nerve growth factor|nerve growth factor
675324|NCT00876187|naproxen|naproxen
675325|NCT00876200|Williams Beuren syndrome|williams beuren syndrome
675326|NCT00876200|Cardiovascular abnormalities|cardiovascular abnormalities
675327|NCT00876200|Cardiovascular structure|cardiovascular structure
675328|NCT00876213|Amylin|amylin
675329|NCT00876213|GLP-1|glp-1
675330|NCT00876213|gastric emptying|gastric emptying
675331|NCT00876213|appetite and food intake|appetite and food intake
675332|NCT00876226|Citalopram|citalopram
675333|NCT00876226|Pharmacokinetics|pharmacokinetics
675334|NCT00876226|Short Bowel Syndrome|short bowel syndrome
675335|NCT00876265|Facial wrinkles|facial wrinkles
675336|NCT00876265|Nasolabial fold|nasolabial fold
675337|NCT00876278|Cataract|cataract
675338|NCT00876278|Intraocular Lens (IOL)|intraocular lens (iol)
675339|NCT00876278|Mesotest II|mesotest ii
675340|NCT00876278|Evaluation of usability of Mesotest II for assessment of night driving capacity of pseudo-phakic patients|evaluation of usability of mesotest ii for assessment of night driving capacity of pseudo-phakic patients
675341|NCT00876304|PF-04802540 multiple dose safety study|pf-04802540 multiple dose safety study
675342|NCT00876317|Tenosynovitis|tenosynovitis
675343|NCT00876317|Bursitis|bursitis
675344|NCT00876330|Clinical Decision Support Systems|clinical decision support systems
675345|NCT00876330|Hyperlipidemia|hyperlipidemia
675346|NCT00876330|Hypertension|hypertension
675347|NCT00876356|Asthma|asthma
675348|NCT00876356|Conjugated Linoleic Acid (CLA)|conjugated linoleic acid (cla)
675349|NCT00876356|dietary supplement|dietary supplement
675354|NCT00876382|advanced renal cell carcinoma|advanced renal cell carcinoma
675355|NCT00876382|renal cancer|renal cancer
675356|NCT00876382|renal cell|renal cell
675357|NCT00876382|Sorafenib|sorafenib
675358|NCT00876382|Nexavar|nexavar
675359|NCT00876382|Bevacizumab|bevacizumab
675360|NCT00876382|Avastin|avastin
675361|NCT00876382|Sunitinib|sunitinib
675362|NCT00876382|Sutent|sutent
675363|NCT00876395|Breast Cancer|breast cancer
675364|NCT00876395|HER2+|her2+
675365|NCT00876395|mTOR|mtor
675366|NCT00876395|everolimus|everolimus
675367|NCT00876395|RAD001|rad001
675368|NCT00876395|first line|first line
675369|NCT00876395|metastatic|metastatic
675370|NCT00876395|locally advanced|locally advanced
675371|NCT00876408|RT-PCR molecular profiling assay|rt-pcr molecular profiling assay
675372|NCT00876408|Molecular Profiling-Real Time Polymerase Chain Reaction|molecular profiling-real time polymerase chain reaction
675373|NCT00876408|Unknown Primary|unknown primary
675374|NCT00876408|UPC|upc
675375|NCT00876408|CUP|cup
675376|NCT00876421|ONO-8539|ono-8539
675377|NCT00876421|Overactive bladder|overactive bladder
675378|NCT00876421|OAB|oab
675379|NCT00876434|Sirolimus|sirolimus
675683|NCT00877448|SAFETY|safety
675380|NCT00876434|Anterior Uveitis|anterior uveitis
675381|NCT00876434|Autoimmune Disease|autoimmune disease
675382|NCT00876434|Uveitis|uveitis
675384|NCT00876473|Acute Respiratory Failure|acute respiratory failure
675385|NCT00876499|Primary Brain Tumor|primary brain tumor
675386|NCT00876499|PBT|pbt
675387|NCT00876499|Brain Cancer|brain cancer
675388|NCT00876499|Primary glioma|primary glioma
675389|NCT00876499|Astrocytoma|astrocytoma
675390|NCT00876499|Oligodendroglioma|oligodendroglioma
675391|NCT00876499|Oligo-astrocytoma|oligo-astrocytoma
675392|NCT00876499|Ependymoma|ependymoma
675393|NCT00876499|Anaplastic astrocytoma|anaplastic astrocytoma
675394|NCT00876499|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
675395|NCT00876499|Anaplastic oligo-astrocytoma|anaplastic oligo-astrocytoma
675396|NCT00876499|Anaplastic ependymoma|anaplastic ependymoma
675397|NCT00876499|Fatigue|fatigue
675398|NCT00876499|Cytokines|cytokines
675399|NCT00876499|Questionnaires|questionnaires
675400|NCT00876499|Actigraphy|actigraphy
675401|NCT00876499|Sleep Disturbance|sleep disturbance
675402|NCT00876499|Radiation Therapy|radiation therapy
675403|NCT00876512|thienopyridine resistance|thienopyridine resistance
675404|NCT00876512|stable effort angina|stable effort angina
675405|NCT00876512|platelet activation|platelet activation
675406|NCT00876512|ADAMTS13|adamts13
675407|NCT00876512|von Willebrand Factor|von willebrand factor
675408|NCT00876525|Heart diseases.|heart diseases.
675409|NCT00876525|Aortic valve diseases.|aortic valve diseases.
675410|NCT00876525|Aortic valve insufficiency.|aortic valve insufficiency.
675411|NCT00876525|Aortic valve stenosis.|aortic valve stenosis.
675412|NCT00876538|Chemotherapy Induced Peripheral Neuropathy|chemotherapy induced peripheral neuropathy
675413|NCT00876538|TR019622|tr019622
675414|NCT00876538|Trophos|trophos
675415|NCT00876551|Negative-Pressure Wound Therapy|negative-pressure wound therapy
675416|NCT00876551|Endoscopic/endoluminal V.A.C. therapy|endoscopic/endoluminal v.a.c. therapy
675417|NCT00876551|Esophagectomy|esophagectomy
675418|NCT00876551|Anastomotic leakage|anastomotic leakage
675419|NCT00876551|Anastomosis, Surgical|anastomosis, surgical
675420|NCT00876564|Triage precision|triage precision
675517|NCT00876902|ischemic reperfusion injury|ischemic reperfusion injury
675421|NCT00876577|Acute Exacerbations of Chronic Bronchitis|acute exacerbations of chronic bronchitis
675422|NCT00876577|Avelox|avelox
675423|NCT00876577|Bronchitis|bronchitis
675424|NCT00876603|cervical spondylotic myelopathy|cervical spondylotic myelopathy
675425|NCT00876603|anterior decompression and fusion|anterior decompression and fusion
675426|NCT00876603|cervical laminoplasty|cervical laminoplasty
675427|NCT00876616|lupus nephritis;multi-target therapy; MMF; FK506|lupus nephritis;multi-target therapy; mmf; fk506
675428|NCT00876629|MR Elastography|mr elastography
675429|NCT00876629|kidney|kidney
675430|NCT00876629|fibrosis|fibrosis
675431|NCT00876642|Radiation dermatitis|radiation dermatitis
675432|NCT00876642|best supportive care|best supportive care
675433|NCT00876642|Aloe vera gel|aloe vera gel
675434|NCT00876642|phase III study was to assess the effectiveness of aloe vera and vitamin E.|phase iii study was to assess the effectiveness of aloe vera and vitamin e.
675435|NCT00876668|Peripheral Vascular diseases|peripheral vascular diseases
675436|NCT00876668|Microcirculation|microcirculation
675437|NCT00876668|fluorescence angiography|fluorescence angiography
675438|NCT00876681|Catheter|catheter
675439|NCT00876681|Ultrasound-guidance|ultrasound-guidance
675440|NCT00876681|Nerve Stimulation|nerve stimulation
675441|NCT00876681|Electrical stimulation|electrical stimulation
675442|NCT00876681|nerve block|nerve block
675443|NCT00876681|UCSD|ucsd
675444|NCT00876681|Orthopedic surgery|orthopedic surgery
675445|NCT00876681|Foot/ankle pain|foot/ankle pain
675446|NCT00876681|Foot/ankle numbness|foot/ankle numbness
675447|NCT00876681|Popliteal-Sciatic Catheters|popliteal-sciatic catheters
675448|NCT00876694|COPD, Chronic Obstructive Pulmonary Disease, Indacaterol, long acting β2-agonist|copd, chronic obstructive pulmonary disease, indacaterol, long acting β2-agonist
675449|NCT00876707|wavefront|wavefront
675450|NCT00876707|multifocal IOL|multifocal iol
675451|NCT00876707|modulation transfer function|modulation transfer function
675452|NCT00876707|intraocular lenses|intraocular lenses
675453|NCT00876707|wavefront data|wavefront data
675454|NCT00876707|Visual performance|visual performance
675455|NCT00876720|Tinnitus|tinnitus
675456|NCT00876720|chronic subjective tinnitus|chronic subjective tinnitus
675457|NCT00876720|transcranial magnetic stimulation|transcranial magnetic stimulation
675458|NCT00876720|sensation disorders|sensation disorders
675459|NCT00876720|hearing disorders|hearing disorders
675460|NCT00876746|Pain|pain
675461|NCT00876746|surgery|surgery
675462|NCT00876746|catheter|catheter
675463|NCT00876746|nerve block|nerve block
675464|NCT00876746|supraclavicular|supraclavicular
675465|NCT00876746|infraclavicular|infraclavicular
675466|NCT00876746|UCSD|ucsd
675467|NCT00876746|moderate-to-severe pain|moderate-to-severe pain
675468|NCT00876746|Supraclavicular catheter|supraclavicular catheter
675469|NCT00876746|Infraclavicular catheter|infraclavicular catheter
675470|NCT00876759|cerebral metastases|cerebral metastases
675471|NCT00876772|ALS|als
675472|NCT00876772|olanazapine|olanazapine
675473|NCT00876772|Loss of Apptetite|loss of apptetite
675474|NCT00876772|Appetite Loss|appetite loss
675475|NCT00876772|Malnutrition|malnutrition
675476|NCT00876772|Cachexia|cachexia
675478|NCT00876785|Rye bread satiety breakfast|rye bread satiety breakfast
675479|NCT00876798|Euvolemic Hyponatremia|euvolemic hyponatremia
675481|NCT00876798|Serum Sodium|serum sodium
675482|NCT00876811|raspberry|raspberry
675483|NCT00876811|fruit|fruit
675484|NCT00876811|antioxidants|antioxidants
675485|NCT00876811|polyphenols|polyphenols
675486|NCT00876811|oxidative stress|oxidative stress
675487|NCT00876811|dietary intervention|dietary intervention
675488|NCT00876824|Black Fever|black fever
675489|NCT00876824|Kala-Azar|kala-azar
675490|NCT00876824|Amphotericin B lipid emulsion|amphotericin b lipid emulsion
675491|NCT00876824|Liposomal Amphotericin B|liposomal amphotericin b
675492|NCT00876850|cSSI|cssi
675493|NCT00876850|Abscess|abscess
675494|NCT00876850|Would|would
675495|NCT00876850|Cellulitis|cellulitis
675496|NCT00876850|Complicated Skin and Skin Structure Infections (cSSSI)|complicated skin and skin structure infections (csssi)
675497|NCT00876863|Alzheimer's disease|alzheimer's disease
675498|NCT00876863|Dementia|dementia
675499|NCT00876863|Memory loss|memory loss
675500|NCT00876863|Cognitive impairment|cognitive impairment
675501|NCT00876863|Nerve growth factor|nerve growth factor
675502|NCT00876863|NGF|ngf
675503|NCT00876863|Neurotrophic factors|neurotrophic factors
675504|NCT00876863|Gene therapy|gene therapy
675505|NCT00876876|hypervolemic hyponatremia|hypervolemic hyponatremia
675506|NCT00876876|serum sodium|serum sodium
675507|NCT00876876|fluid overload|fluid overload
675508|NCT00876876|heartfailure|heartfailure
675509|NCT00876876|acute heart failure|acute heart failure
675510|NCT00876876|vasopressin antagonist|vasopressin antagonist
675511|NCT00876889|spinal cord injury|spinal cord injury
675512|NCT00876889|riluzole|riluzole
675513|NCT00876889|pharmacokinetics|pharmacokinetics
675514|NCT00876889|Acute Traumatic Spinal Cord Injury|acute traumatic spinal cord injury
675515|NCT00876902|liver transplantation|liver transplantation
675516|NCT00876902|cadaveric liver transplantation|cadaveric liver transplantation
675518|NCT00876902|primary non-function|primary non-function
675519|NCT00876902|delayed non-Function|delayed non-function
675520|NCT00876902|poor early graft function|poor early graft function
675521|NCT00876902|YSPSL|yspsl
675522|NCT00876902|recombinant PSGL-Ig|recombinant psgl-ig
675523|NCT00876915|prevention of VTE and PE in high risk cancer patients|prevention of vte and pe in high risk cancer patients
675524|NCT00876928|pre-diabetes|pre-diabetes
675525|NCT00876928|minorities|minorities
675526|NCT00876928|oral glucose tolerance test|oral glucose tolerance test
675527|NCT00876928|disposition index|disposition index
675528|NCT00876928|insulin secretion|insulin secretion
675529|NCT00876928|insulin sensitivity|insulin sensitivity
675530|NCT00876928|diabetes|diabetes
675531|NCT00876941|Drug|drug
675532|NCT00876941|Drug Use|drug use
675533|NCT00876941|Screening|screening
675534|NCT00876941|Brief Intervention|brief intervention
675535|NCT00876941|Primary Care|primary care
675536|NCT00876941|Utilization|utilization
675537|NCT00876967|anesthesiology|anesthesiology
675538|NCT00876967|randomized|randomized
675539|NCT00876967|laryngoscope|laryngoscope
675540|NCT00876967|intubation|intubation
675541|NCT00876967|laryngeal exposition|laryngeal exposition
675542|NCT00876967|laryngoscope blades|laryngoscope blades
675543|NCT00876967|plastic single use blade|plastic single use blade
675544|NCT00876967|metallic single use blade|metallic single use blade
675545|NCT00876967|metallic reusable blade|metallic reusable blade
675546|NCT00876967|success to intubation at first attempt|success to intubation at first attempt
675547|NCT00876967|Cormack and lehanne modify grade|cormack and lehanne modify grade
675548|NCT00876980|Obstructive sleep apnea|obstructive sleep apnea
675549|NCT00876980|Type II diabetes mellitus|type ii diabetes mellitus
675550|NCT00876980|Randomized controlled trial|randomized controlled trial
675551|NCT00877019|sonic brushes|sonic brushes
675552|NCT00877019|time effectiveness|time effectiveness
675553|NCT00877019|brush head design|brush head design
675554|NCT00877019|ADA-toothbrush|ada-toothbrush
675555|NCT00877019|professional brushing|professional brushing
675556|NCT00877019|time dependence|time dependence
675557|NCT00877019|efficacy|efficacy
675558|NCT00877019|toothbrush|toothbrush
675559|NCT00877032|Phase 1|phase 1
675560|NCT00877032|Dry Age Related Macular Degeneration|dry age related macular degeneration
675561|NCT00877032|RN6G|rn6g
675562|NCT00877045|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
675563|NCT00877045|GIST|gist
675564|NCT00877045|tyrosine kinase inhibitors|tyrosine kinase inhibitors
675565|NCT00877045|Imatinib|imatinib
675566|NCT00877045|Gleevec|gleevec
675567|NCT00877045|Suntinib|suntinib
675568|NCT00877045|Sutent|sutent
675569|NCT00877058|Frailty|frailty
675570|NCT00877058|health promotion|health promotion
675571|NCT00877058|prevention|prevention
675572|NCT00877058|self management|self management
675573|NCT00877058|intervention|intervention
675574|NCT00877084|exacerbation|exacerbation
675575|NCT00877084|COPD|copd
675576|NCT00877084|Resistance training|resistance training
675577|NCT00877084|Muscle force|muscle force
675578|NCT00877097|osteoporosis|osteoporosis
675579|NCT00877097|Bone mineral density|bone mineral density
675580|NCT00877097|clodronate|clodronate
675581|NCT00877097|HRT|hrt
675582|NCT00877097|postmenopausal|postmenopausal
675583|NCT00877110|BETA-D-GLUCAN|beta-d-glucan
675584|NCT00877110|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
675585|NCT00877110|MAB 131 I - 3F8|mab 131 i - 3f8
675586|NCT00877110|TOPOTECAN|topotecan
675587|NCT00877110|VINCRISTINE|vincristine
675588|NCT00877110|Neuroblastoma|neuroblastoma
675589|NCT00877110|09-011|09-011
675590|NCT00877123|fasting glucose|fasting glucose
675591|NCT00877123|obesity|obesity
675592|NCT00877123|arab women|arab women
675593|NCT00877123|interleukin|interleukin
675594|NCT00877123|diabetes|diabetes
675595|NCT00877123|impaired fasting glucose (IFG)|impaired fasting glucose (ifg)
675596|NCT00877136|Liver tumors|liver tumors
675597|NCT00877136|Liver cancer|liver cancer
675598|NCT00877136|Adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
675599|NCT00877136|HCC|hcc
675600|NCT00877136|Hepatoma|hepatoma
675601|NCT00877136|Neoplasms|neoplasms
675602|NCT00877149|Chronic HBV|chronic hbv
675603|NCT00877162|Cognitive and behavioural intervention|cognitive and behavioural intervention
675604|NCT00877162|trial|trial
675605|NCT00877162|group|group
675606|NCT00877162|Behavioral sleep problems|behavioral sleep problems
675607|NCT00877175|preterm infants|preterm infants
675608|NCT00877175|mydriasis|mydriasis
675609|NCT00877175|pupil dilation|pupil dilation
675610|NCT00877188|breast cancer|breast cancer
675611|NCT00877188|exercise|exercise
675612|NCT00877188|upper extremity function|upper extremity function
675613|NCT00877188|quality of life|quality of life
675614|NCT00877201|Accommodation|accommodation
675615|NCT00877201|visual display terminal (VDT)|visual display terminal (vdt)
675616|NCT00877201|antioxidant|antioxidant
675617|NCT00877214|Bendamustine|bendamustine
675618|NCT00877214|Rituximab|rituximab
675724|NCT00877617|HRLPC|hrlpc
675619|NCT00877214|Significance of maintenance therapy|significance of maintenance therapy
675620|NCT00877214|Efficacy and safety|efficacy and safety
675621|NCT00877227|CVA|cva
675622|NCT00877227|stroke|stroke
675623|NCT00877227|newborns|newborns
675624|NCT00877227|homocysteine|homocysteine
675625|NCT00877227|folinic acid|folinic acid
675626|NCT00877266|catheter|catheter
675627|NCT00877266|ultrasound guidance|ultrasound guidance
675628|NCT00877266|nerve stimulation|nerve stimulation
675629|NCT00877266|electrical stimulation|electrical stimulation
675630|NCT00877266|nerve block|nerve block
675631|NCT00877266|UCSD|ucsd
675632|NCT00877266|timed placement|timed placement
675633|NCT00877266|surgery|surgery
675634|NCT00877266|Catheter Placement Time|catheter placement time
675635|NCT00877279|Facial wrinkles|facial wrinkles
675636|NCT00877279|Nasolabial folds|nasolabial folds
675637|NCT00877292|Down Syndrome|down syndrome
675638|NCT00877292|trisomy 21|trisomy 21
675639|NCT00877292|prenatal testing|prenatal testing
675640|NCT00877292|pregnant women|pregnant women
675641|NCT00877305|Ischemic Preconditioning|ischemic preconditioning
675642|NCT00877305|Cognitive function|cognitive function
675643|NCT00877331|Drug Abuse|drug abuse
675644|NCT00877331|Drug Addiction|drug addiction
675645|NCT00877331|Drug Dependence|drug dependence
675646|NCT00877331|Drug Usage|drug usage
675647|NCT00877331|Drug Use Disorders|drug use disorders
675648|NCT00877331|Substance Abuse|substance abuse
675649|NCT00877331|Substance Addiction|substance addiction
675650|NCT00877331|Substance Dependence|substance dependence
675651|NCT00877331|Substance Use Disorders|substance use disorders
675652|NCT00877344|Pregnancy|pregnancy
675653|NCT00877344|IUC|iuc
675654|NCT00877344|abortion|abortion
675655|NCT00877344|contraception|contraception
675656|NCT00877357|Vaccine|vaccine
675657|NCT00877357|Prevention|prevention
675658|NCT00877357|Diphtheria|diphtheria
675659|NCT00877357|Tetanus|tetanus
675660|NCT00877357|Pertussis|pertussis
675661|NCT00877357|Hepatitis B|hepatitis b
675662|NCT00877357|Haemophilus influenzae type b|haemophilus influenzae type b
675663|NCT00877357|Lot Consistency|lot consistency
675664|NCT00877357|Long Term Immunogenicity|long term immunogenicity
675665|NCT00877357|Reactogenicity|reactogenicity
675666|NCT00877357|Healthy infants|healthy infants
675667|NCT00877370|ertapenem|ertapenem
675668|NCT00877370|continuous hemodialysis|continuous hemodialysis
675669|NCT00877370|pharmacokinetics|pharmacokinetics
675670|NCT00877383|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
675671|NCT00877383|COPD|copd
675672|NCT00877383|indacaterol|indacaterol
675673|NCT00877383|tiotropium|tiotropium
675674|NCT00877383|bronchodilation|bronchodilation
675675|NCT00877409|Acnase|acnase
675676|NCT00877409|Acne Vulgaris|acne vulgaris
675677|NCT00877409|Safety|safety
675678|NCT00877409|Efficacy|efficacy
675679|NCT00877422|vitamin deficiency|vitamin deficiency
675680|NCT00877448|INFLUENZA|influenza
675681|NCT00877448|VACCINE|vaccine
675685|NCT00877474|Solid tumors|solid tumors
675686|NCT00877474|PharmaMar USA|pharmamar usa
675687|NCT00877487|ADHD|adhd
675688|NCT00877500|HER2/neu-negative Breast Cancer|her2/neu-negative breast cancer
675689|NCT00877500|Residual Breast Cancer|residual breast cancer
675690|NCT00877500|Surgery|surgery
675691|NCT00877500|Neoadjuvant Systemic Therapy|neoadjuvant systemic therapy
675692|NCT00877500|NST|nst
675693|NCT00877500|Ixabepilone|ixabepilone
675694|NCT00877500|BMS-247550|bms-247550
675695|NCT00877500|Epothilone B analogue|epothilone b analogue
675696|NCT00877513|Smoking|smoking
675697|NCT00877513|Insulin resistance|insulin resistance
675698|NCT00877513|Metabolic syndrome|metabolic syndrome
675699|NCT00877513|Body fat distribution|body fat distribution
675700|NCT00877513|Cigarette smoking|cigarette smoking
675701|NCT00877539|Asthma Allergen Challenge|asthma allergen challenge
675702|NCT00877552|Schizophrenia|schizophrenia
675703|NCT00877552|brain development|brain development
675704|NCT00877552|MRI|mri
675705|NCT00877565|LVF|lvf
675706|NCT00877565|Left ventricular systolic function|left ventricular systolic function
675707|NCT00877578|elderly patient|elderly patient
675708|NCT00877578|malnutrition|malnutrition
675709|NCT00877578|new nutritional support|new nutritional support
675710|NCT00877578|micronutrients|micronutrients
675711|NCT00877578|elderly patient malnutrition|elderly patient malnutrition
675712|NCT00877591|Interaction of Buprenorphine with HIV and TB Medications|interaction of buprenorphine with hiv and tb medications
675713|NCT00877604|ALS|als
675714|NCT00877604|Therapy|therapy
675715|NCT00877604|Tauroursodeoxycholic acid|tauroursodeoxycholic acid
675716|NCT00877604|TUDCA|tudca
675717|NCT00877604|antioxidant|antioxidant
675718|NCT00877604|antiapoptotic drug|antiapoptotic drug
675719|NCT00877604|neuroprotective drug|neuroprotective drug
675720|NCT00877617|Quality of Life|quality of life
675721|NCT00877617|QOL|qol
675722|NCT00877617|Questionnaire|questionnaire
675723|NCT00877617|High Risk localized Prostate Cancer|high risk localized prostate cancer
675732|NCT00877682|Cryotherapy|cryotherapy
675733|NCT00877682|Cryoablation|cryoablation
675734|NCT00877682|Health Related Quality of Life|health related quality of life
675735|NCT00877682|HRQOL|hrqol
675736|NCT00877695|HIV|hiv
675737|NCT00877695|HIV Seronegativity|hiv seronegativity
675738|NCT00877695|prevention|prevention
675739|NCT00877695|Hispanic|hispanic
675740|NCT00877695|Latino|latino
675741|NCT00877695|MSM|msm
675742|NCT00877695|men|men
675743|NCT00877708|E. Coli|e. coli
675744|NCT00877708|isolates|isolates
675745|NCT00877721|Postural Control|postural control
675746|NCT00877721|Gait|gait
675747|NCT00877721|Falls|falls
675748|NCT00877721|Elderly|elderly
675749|NCT00877721|Old adults (65 years old and older) with low risk of falls|old adults (65 years old and older) with low risk of falls
675750|NCT00877734|alcohol dependence|alcohol dependence
675751|NCT00877734|baclofen|baclofen
675752|NCT00877734|pharmacotherapy|pharmacotherapy
675753|NCT00877734|women|women
675754|NCT00877747|PET|pet
675755|NCT00877760|Hepatitis B Entecavir pegylated interferon a-2a|hepatitis b entecavir pegylated interferon a-2a
675756|NCT00877773|Advanced cancer|advanced cancer
675757|NCT00877773|Advanced Cancer with genetic mutation|advanced cancer with genetic mutation
675758|NCT00877773|Phosphoinositides 3-kinase|phosphoinositides 3-kinase
675759|NCT00877773|PI3K|pi3k
675760|NCT00877773|PIK3 mutations|pik3 mutations
675761|NCT00877773|Temsirolimus|temsirolimus
675762|NCT00877773|CCI-779|cci-779
675763|NCT00877773|Torisel|torisel
675764|NCT00877773|mTOR inhibitor|mtor inhibitor
675765|NCT00877799|pain|pain
675766|NCT00877799|acute pain|acute pain
675767|NCT00877799|visceral pain|visceral pain
675768|NCT00877799|kappa agonist|kappa agonist
675769|NCT00877799|opioid analgesics|opioid analgesics
675770|NCT00877799|peripheral nervous system agents|peripheral nervous system agents
675771|NCT00877799|physiological effects of drugs|physiological effects of drugs
675772|NCT00877799|surgery|surgery
675773|NCT00877799|hysterectomy|hysterectomy
675774|NCT00877799|post-operative|post-operative
675775|NCT00877799|post-operative complications|post-operative complications
675776|NCT00877812|Vitamin B6|vitamin b6
675777|NCT00877812|Vitamin B6 deficiency|vitamin b6 deficiency
675778|NCT00877812|Amino acids|amino acids
675779|NCT00877812|pyridoxine|pyridoxine
675780|NCT00877825|Diet Therapy|diet therapy
675781|NCT00877838|Headache|headache
675782|NCT00877838|Migraine|migraine
675783|NCT00877838|Aura|aura
675784|NCT00877838|Acute|acute
675785|NCT00877838|Attack|attack
675786|NCT00877838|Clinical|clinical
675787|NCT00877838|Trial|trial
675788|NCT00877838|Intervention|intervention
675789|NCT00877838|Nitrogen Oxide|nitrogen oxide
675790|NCT00877838|NOS|nos
675791|NCT00877838|nNOS|nnos
675792|NCT00877838|Triptan|triptan
675793|NCT00877838|5HT|5ht
675794|NCT00877838|Serotonin|serotonin
675795|NCT00877851|Diet|diet
675796|NCT00877851|Physical activity|physical activity
675797|NCT00877851|Self management|self management
675798|NCT00877851|Goal setting|goal setting
675801|NCT00877864|printed materials|printed materials
675802|NCT00877877|HPV vaccine|hpv vaccine
675803|NCT00877877|cervical cancer|cervical cancer
675804|NCT00872209|swimmer's ear|swimmer's ear
675805|NCT00872209|ear drops|ear drops
675806|NCT00872209|ear foam|ear foam
675807|NCT00872209|otic foam|otic foam
675808|NCT00872209|ear infection|ear infection
675809|NCT00872209|ear pain|ear pain
675810|NCT00872209|ear inflammation|ear inflammation
675811|NCT00872222|Hip|hip
675812|NCT00872222|Cementless|cementless
675813|NCT00872222|Ceramic-on-Ceramic|ceramic-on-ceramic
675814|NCT00877890|diabetes|diabetes
675815|NCT00877890|exenatide once weekly|exenatide once weekly
675816|NCT00877890|Byetta|byetta
675817|NCT00877890|Amylin|amylin
675818|NCT00877890|Lilly|lilly
675819|NCT00877890|Bydureon|bydureon
675828|NCT00877955|bioequivalence|bioequivalence
675829|NCT00877955|pharmacokinetic|pharmacokinetic
675830|NCT00877955|alprazolam|alprazolam
675831|NCT00877955|sublingual|sublingual
675832|NCT00877968|Pea flour|pea flour
675833|NCT00877968|Glycemic response|glycemic response
675834|NCT00877968|Diabetes|diabetes
675835|NCT00877968|Sensory|sensory
675836|NCT00877968|Functional food|functional food
675837|NCT00877968|Diabetes control and prevention|diabetes control and prevention
675838|NCT00877981|hyperparathyroidism|hyperparathyroidism
675839|NCT00877981|surgery|surgery
675840|NCT00877981|minimal invasive|minimal invasive
675841|NCT00877981|videoassited|videoassited
675842|NCT00877994|Disordered Eating|disordered eating
675843|NCT00877994|Parenting|parenting
675844|NCT00877994|Mothers|mothers
675845|NCT00878007|Anaemia|anaemia
675846|NCT00878007|Malaria|malaria
675847|NCT00878007|Literacy|literacy
675848|NCT00878007|Kenya|kenya
675849|NCT00878046|Hip|hip
675850|NCT00878046|Cementless|cementless
675851|NCT00878046|Conservative|conservative
675852|NCT00878072|Herpes labialis|herpes labialis
675853|NCT00878072|cold sores|cold sores
675854|NCT00878072|herpes simplex type 1|herpes simplex type 1
675855|NCT00878085|Robot Therapy|robot therapy
675856|NCT00878085|Upper Limb|upper limb
675857|NCT00878085|Stroke|stroke
675858|NCT00878085|Rehabilitation|rehabilitation
675859|NCT00878085|fMRI|fmri
675860|NCT00878085|DTI|dti
675861|NCT00878098|DDT|ddt
675862|NCT00878098|Malaria|malaria
675863|NCT00878098|Pregnancy Outcome|pregnancy outcome
675864|NCT00878098|Spontaneous Abortion|spontaneous abortion
675865|NCT00878098|HIV|hiv
675866|NCT00878098|Pregnancy|pregnancy
675867|NCT00878111|NGR-hTNF|ngr-htnf
675868|NCT00878111|Solid tumours|solid tumours
675869|NCT00878111|High doses|high doses
675870|NCT00878124|Poor ovarian response|poor ovarian response
675871|NCT00878124|Chromosomal aberrations|chromosomal aberrations
675872|NCT00878124|poor pregnancy outcome|poor pregnancy outcome
675873|NCT00878124|Late maternal age|late maternal age
675874|NCT00878150|traumatic brain injury|traumatic brain injury
675875|NCT00878150|TBI|tbi
675876|NCT00878150|head injury|head injury
675877|NCT00878150|brain injury|brain injury
675878|NCT00878150|depression|depression
675879|NCT00878150|major depressive disorder|major depressive disorder
675880|NCT00878150|cognitive behavioral therapy|cognitive behavioral therapy
675881|NCT00878150|CBT|cbt
675882|NCT00878150|counseling|counseling
675883|NCT00878176|sacral neuromodulation therapy|sacral neuromodulation therapy
675884|NCT00878176|urinary retention|urinary retention
675885|NCT00878176|screening|screening
675886|NCT00878176|non obstructive urinary retention|non obstructive urinary retention
675887|NCT00878189|Phase 1 dose escalation study in advanced solid tumor malignancy and leukemia|phase 1 dose escalation study in advanced solid tumor malignancy and leukemia
675888|NCT00878215|Image Guided Liver Surgery|image guided liver surgery
675889|NCT00878397|malaria|malaria
675890|NCT00878397|long lasting insecticide nets|long lasting insecticide nets
675891|NCT00878397|anaemia|anaemia
675892|NCT00878397|schools|schools
675893|NCT00878423|HSP90|hsp90
675894|NCT00878423|Metastatic solid tumor including lymphoma which are|metastatic solid tumor including lymphoma which are
675895|NCT00878423|refractory to standard therapy|refractory to standard therapy
675896|NCT00878436|histone deacetylase inhibitor|histone deacetylase inhibitor
675897|NCT00878436|hormone therapy|hormone therapy
675898|NCT00878436|androgen-independent|androgen-independent
675899|NCT00878436|PSA|psa
675900|NCT00878436|androgen receptor|androgen receptor
675901|NCT00878475|Quantitative Capnometry|quantitative capnometry
675902|NCT00878475|N-Terminal Pro-Brain Natriuretic Peptide|n-terminal pro-brain natriuretic peptide
675903|NCT00878475|Acute Heart Failure|acute heart failure
675904|NCT00878475|Diagnostic Accuracy|diagnostic accuracy
675905|NCT00878501|Phase II|phase ii
675906|NCT00878501|Pain|pain
675907|NCT00878514|Alprazolam|alprazolam
675908|NCT00878514|Bioequivalence|bioequivalence
675909|NCT00878527|Heart Failure|heart failure
675910|NCT00878527|Partial Circulatory Assist|partial circulatory assist
675911|NCT00878527|NYHA Class IIIb|nyha class iiib
675912|NCT00878527|NYHA Class IV|nyha class iv
675913|NCT00878527|Ventricular Assist Device|ventricular assist device
675918|NCT00878540|Healthy males|healthy males
675919|NCT00878553|insomnia|insomnia
675920|NCT00878553|middle of the night|middle of the night
675921|NCT00878553|sleep maintenance|sleep maintenance
675922|NCT00878566|hypertension|hypertension
675923|NCT00878566|pharmacists|pharmacists
675924|NCT00878566|rural health|rural health
675925|NCT00878566|prescribing|prescribing
675926|NCT00878579|back pain|back pain
675927|NCT00878579|Spine|spine
675928|NCT00878579|Spinal|spinal
675929|NCT00878579|Lower back pain|lower back pain
675930|NCT00878579|Lumbar|lumbar
675931|NCT00878579|Lumbar Pain|lumbar pain
675932|NCT00878579|DDD|ddd
675933|NCT00878579|Degenerative Disc Disease|degenerative disc disease
675934|NCT00878592|Post liver transplant|post liver transplant
675935|NCT00878592|weight reduction classes|weight reduction classes
675936|NCT00878592|obesity|obesity
675937|NCT00878592|weight management|weight management
676134|NCT00879333|GI neoplasm|gi neoplasm
675938|NCT00878592|dietary and lifestyle modification|dietary and lifestyle modification
675939|NCT00878605|Diabetes|diabetes
675940|NCT00878605|Cyclo-Z|cyclo-z
675941|NCT00878618|Healthy volunteers|healthy volunteers
675942|NCT00878631|emergency medical services|emergency medical services
675943|NCT00878631|traumatic brain injury|traumatic brain injury
675944|NCT00878631|hypertonic saline with dextran|hypertonic saline with dextran
675945|NCT00878631|fluid resuscitation|fluid resuscitation
675946|NCT00878644|Cardiac Arrest|cardiac arrest
675947|NCT00878644|Cardiopulmonary Arrest|cardiopulmonary arrest
675948|NCT00878644|Pediatric Cardiac Arrest|pediatric cardiac arrest
675949|NCT00878644|VABS|vabs
675950|NCT00878644|Vineland Adaptive Behavior Survey|vineland adaptive behavior survey
675951|NCT00878644|POPC/PCPC|popc/pcpc
675952|NCT00878644|hypoxic-ichemic encephalopathy|hypoxic-ichemic encephalopathy
675953|NCT00878657|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
675954|NCT00878657|stage III pancreatic cancer|stage iii pancreatic cancer
675955|NCT00878709|HER-2/erbB-2 positive breast cancer|her-2/erbb-2 positive breast cancer
675956|NCT00878709|breast cancer|breast cancer
675957|NCT00878709|adjuvant therapy|adjuvant therapy
675958|NCT00878709|neratinib|neratinib
675959|NCT00878709|HKI-272|hki-272
675960|NCT00878722|Acute Myeloid Leukemia|acute myeloid leukemia
675961|NCT00878722|PXD101|pxd101
675962|NCT00878722|Belinostat|belinostat
675963|NCT00878722|Idarubicin|idarubicin
675964|NCT00878735|Meditation|meditation
675965|NCT00878735|Mindfulness|mindfulness
675966|NCT00878735|fMRI|fmri
675967|NCT00878735|cancer|cancer
675968|NCT00878735|stress|stress
675969|NCT00878735|anxiety|anxiety
675970|NCT00878735|depression|depression
675971|NCT00878735|attention|attention
675972|NCT00878735|Neuroscience|neuroscience
675973|NCT00878735|Neuroimaging|neuroimaging
675974|NCT00878735|Psychobiology|psychobiology
675975|NCT00878735|Healthy volunteers (regular meditators and non-meditators)|healthy volunteers (regular meditators and non-meditators)
675976|NCT00878761|Renal transplant|renal transplant
675977|NCT00878761|Interstitial fibrosis and tubular atrophy|interstitial fibrosis and tubular atrophy
675978|NCT00878761|Chronic allograft dysfunction|chronic allograft dysfunction
675979|NCT00878761|Chronic allograft nephropathy|chronic allograft nephropathy
675980|NCT00878761|kidney transplant|kidney transplant
675981|NCT00878774|Ragweed allergy|ragweed allergy
675982|NCT00878774|Immunotherapy|immunotherapy
675983|NCT00878774|Rhinoconjunctivitis|rhinoconjunctivitis
675984|NCT00878774|Toleromune Ragweed|toleromune ragweed
675985|NCT00878800|Phase I/II trial|phase i/ii trial
675986|NCT00878800|Solid tumors|solid tumors
675987|NCT00878800|Soft tissue sarcoma|soft tissue sarcoma
675988|NCT00878800|PXD101|pxd101
675989|NCT00878800|Doxorubicin|doxorubicin
675990|NCT00878813|Copeptin|copeptin
675991|NCT00878813|Vasopressin|vasopressin
675992|NCT00878813|Stroke|stroke
675993|NCT00878813|Transient ischemic attack|transient ischemic attack
675994|NCT00878813|Thrombolytic therapy|thrombolytic therapy
675995|NCT00878813|Prognosis|prognosis
675996|NCT00878813|Complications|complications
675997|NCT00878839|Cataract|cataract
675998|NCT00878839|Toric IOL|toric iol
675999|NCT00878839|Corneal Aberration|corneal aberration
676000|NCT00878839|Astigmatism|astigmatism
676001|NCT00878839|AcrySof|acrysof
676002|NCT00878865|Alprazolam|alprazolam
676003|NCT00878865|bioequivalence|bioequivalence
676004|NCT00878878|Pulmonary artery systolic pressure (PASP)|pulmonary artery systolic pressure (pasp)
676005|NCT00878878|Pulmonary Vascular Resistance (PVR)|pulmonary vascular resistance (pvr)
676006|NCT00878878|Right Heart Catheterization|right heart catheterization
676007|NCT00878878|Pulmonary hemodynamics|pulmonary hemodynamics
676008|NCT00878891|Microdialysis|microdialysis
676009|NCT00878891|realtime|realtime
676010|NCT00878891|glucose sensor|glucose sensor
676011|NCT00878891|coronary artery bypass|coronary artery bypass
676012|NCT00878904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
676013|NCT00878917|Equivalence Study|equivalence study
676014|NCT00878917|Eye Drops Solution|eye drops solution
676015|NCT00878917|Dorzolamide|dorzolamide
676016|NCT00878917|Open Angle Glaucoma|open angle glaucoma
676017|NCT00878917|Ocular Hypertension|ocular hypertension
676018|NCT00878930|Breast cancer|breast cancer
676019|NCT00878930|Fulvestrant|fulvestrant
676020|NCT00878930|Faslodex|faslodex
676021|NCT00878930|Acceptability|acceptability
676022|NCT00878930|Compliance|compliance
676023|NCT00878930|Efficacy|efficacy
676024|NCT00878943|Open label access|open label access
676025|NCT00878943|sildenafil|sildenafil
676026|NCT00878943|pulmonary arterial hypertension|pulmonary arterial hypertension
676027|NCT00878956|Cardiac surgery|cardiac surgery
676028|NCT00878956|Cardiopulmonary bypass|cardiopulmonary bypass
676029|NCT00878956|Oxidative stress|oxidative stress
676030|NCT00878956|Acute renal dysfunction|acute renal dysfunction
676031|NCT00878956|Sodium bicarbonate|sodium bicarbonate
676032|NCT00878969|Hemodialysis|hemodialysis
676033|NCT00878969|fibrinolysis|fibrinolysis
676034|NCT00878969|oxidative stress|oxidative stress
676035|NCT00878969|systemic inflammatory reaction|systemic inflammatory reaction
676036|NCT00878969|endothelial dysfunction|endothelial dysfunction
676037|NCT00878969|carotid intima media thickness (IMT|carotid intima media thickness (imt
676038|NCT00878969|angiotensin receptor blockade|angiotensin receptor blockade
676039|NCT00878969|angiotensin converting enzyme inhibition|angiotensin converting enzyme inhibition
676040|NCT00878995|stage IIB cervical cancer|stage iib cervical cancer
676041|NCT00878995|stage III cervical cancer|stage iii cervical cancer
676042|NCT00878995|recurrent cervical cancer|recurrent cervical cancer
676043|NCT00878995|cachexia|cachexia
676044|NCT00878995|advanced head/neck carcinoma|advanced head/neck carcinoma
676045|NCT00878995|recurrent head/neck carcinoma|recurrent head/neck carcinoma
676046|NCT00879008|Disease Exacerbation|disease exacerbation
676047|NCT00879008|Acute Exacerbations of Chronic Bronchitis|acute exacerbations of chronic bronchitis
676048|NCT00879008|AECB|aecb
676049|NCT00879008|Avelox|avelox
676050|NCT00879008|Bronchitis|bronchitis
676051|NCT00879021|The outcome is to prevent Central Neuropathic Pain|the outcome is to prevent central neuropathic pain
676052|NCT00879021|participants will have suffered spinal cord trauma|participants will have suffered spinal cord trauma
676053|NCT00879034|Hutchinson-Gilford Progeria Syndrome|hutchinson-gilford progeria syndrome
676054|NCT00879034|HGPS|hgps
676055|NCT00879034|Progeria|progeria
676056|NCT00879034|FTI|fti
676057|NCT00879034|Farnesyltransferase Inhibitor|farnesyltransferase inhibitor
676058|NCT00879034|Lonafarnib|lonafarnib
676059|NCT00879034|Zoledronic Acid|zoledronic acid
676060|NCT00879034|Pravastatin|pravastatin
676061|NCT00879047|HIV|hiv
676062|NCT00879047|Hepatitis C|hepatitis c
676063|NCT00879060|Fibrosis|fibrosis
676064|NCT00879060|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
676065|NCT00879060|MRI|mri
676066|NCT00879060|To evaluate the efficacy of spironolactone in decreasing myocardial fibrosis in Hypertrophic cardiomyopathy|to evaluate the efficacy of spironolactone in decreasing myocardial fibrosis in hypertrophic cardiomyopathy
676067|NCT00879073|Brain and Nervous System|brain and nervous system
676068|NCT00879086|Breast Cancer|breast cancer
676069|NCT00879086|Oncology|oncology
676070|NCT00879099|Interaction|interaction
676071|NCT00879099|healthy volunteers|healthy volunteers
676072|NCT00879099|Interaction study for healthy volunteers|interaction study for healthy volunteers
676073|NCT00879112|Hyperlipidemia|hyperlipidemia
676074|NCT00879125|Gastric by-pass on patients with T2DM|gastric by-pass on patients with t2dm
676075|NCT00879164|hot flashes|hot flashes
676076|NCT00879177|smoking|smoking
676077|NCT00879177|varenicline|varenicline
676078|NCT00879177|behavioral therapy|behavioral therapy
676079|NCT00879177|ABPM|abpm
676080|NCT00879177|hypertension|hypertension
676081|NCT00879203|Type 1 Diabetes Mellitis|type 1 diabetes mellitis
676082|NCT00879203|Youth|youth
676083|NCT00879203|Hypoglycemia|hypoglycemia
676084|NCT00879203|Hyperglycemia|hyperglycemia
676085|NCT00879203|Cognition|cognition
676086|NCT00879203|Memory|memory
676087|NCT00879203|Brain Growth & Development|brain growth & development
676088|NCT00879203|Magnetic Resonance Imaging|magnetic resonance imaging
676089|NCT00879216|Nocturia|nocturia
676090|NCT00879216|Hyptotension|hyptotension
676091|NCT00879216|Elderly|elderly
676092|NCT00879216|Males|males
676093|NCT00879229|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
676094|NCT00879229|Pulmonary Hypertension|pulmonary hypertension
676095|NCT00879229|PH|ph
676096|NCT00879229|IPF|ipf
676097|NCT00879229|Ambrisentan|ambrisentan
676098|NCT00879229|ERA|era
676099|NCT00879229|Endothelin Receptor Antagonist|endothelin receptor antagonist
676100|NCT00879229|Cardiovascular|cardiovascular
676101|NCT00879242|Thalassemia|thalassemia
676102|NCT00879242|cardiac MRI T2*|cardiac mri t2*
676103|NCT00879255|cognitive processing therapy|cognitive processing therapy
676104|NCT00879255|combat|combat
676105|NCT00879255|veterans|veterans
676106|NCT00879255|PTSD|ptsd
676107|NCT00879255|Telemental Health|telemental health
676108|NCT00879255|Videoteleconference|videoteleconference
676109|NCT00879255|outcome|outcome
676110|NCT00879255|Rural|rural
676112|NCT00879255|CPT|cpt
676113|NCT00879255|VTC|vtc
676114|NCT00879268|Liver Transplantation|liver transplantation
676115|NCT00879268|Organ Preservation|organ preservation
676116|NCT00879268|Liver Preservation|liver preservation
676117|NCT00879268|Machine Perfusion|machine perfusion
676118|NCT00879268|Vasosol|vasosol
676119|NCT00879268|Machine Preservation|machine preservation
676120|NCT00879281|COPD|copd
676121|NCT00879281|emphysema|emphysema
676122|NCT00879281|chronic bronchitis|chronic bronchitis
676123|NCT00879294|Perforated appendicitis|perforated appendicitis
676124|NCT00879294|Ruptured appendicitis|ruptured appendicitis
676125|NCT00879294|Acute appendicitis with perforation|acute appendicitis with perforation
676126|NCT00879320|ADHD|adhd
676127|NCT00879320|health|health
676128|NCT00879320|healthy lifestyle|healthy lifestyle
676129|NCT00879333|Gastric cancer,|gastric cancer,
676130|NCT00879333|advanced gastric cancer,|advanced gastric cancer,
676131|NCT00879333|stomach neoplasm,|stomach neoplasm,
676132|NCT00879333|stomach disease,|stomach disease,
676133|NCT00879333|adenocarcinoma of stomach,|adenocarcinoma of stomach,
676135|NCT00879346|Healthy Volunteers|healthy volunteers
676136|NCT00879346|ADME|adme
676137|NCT00879346|Healthy male volunteers|healthy male volunteers
676138|NCT00879372|Bipolar Disorder|bipolar disorder
676139|NCT00879372|cognitive impairment|cognitive impairment
676140|NCT00879372|depression|depression
676141|NCT00879385|KRAS wild-type|kras wild-type
676142|NCT00879385|Colon|colon
676143|NCT00879385|Cancer|cancer
676144|NCT00879385|colorectal|colorectal
676145|NCT00879385|metastatic colorectal|metastatic colorectal
676146|NCT00879385|advanced colorectal|advanced colorectal
676147|NCT00879424|vitamin D|vitamin d
676148|NCT00879424|atopic dermatitis|atopic dermatitis
676149|NCT00879424|eczema|eczema
676150|NCT00879424|winter|winter
676151|NCT00879437|brain tumor|brain tumor
676152|NCT00879437|bevacizumab|bevacizumab
676153|NCT00879437|valproic acid|valproic acid
676154|NCT00879437|radiation therapy|radiation therapy
676155|NCT00879450|Congenital muscular torticollis|congenital muscular torticollis
676156|NCT00879463|Blood transfusion in cardiac operations under CPB|blood transfusion in cardiac operations under cpb
676157|NCT00879463|Infrared spectrophotoscopy|infrared spectrophotoscopy
676158|NCT00879476|Bioequivalence ramipril fasting condition|bioequivalence ramipril fasting condition
676159|NCT00879489|Stage IV histologically proven breast cancer|stage iv histologically proven breast cancer
676160|NCT00879502|Fragile X Premutation|fragile x premutation
676161|NCT00879502|FMR1|fmr1
676162|NCT00879502|Premutation|premutation
676163|NCT00879502|Fragile X|fragile x
676164|NCT00879502|Brain Function|brain function
676165|NCT00879515|Fragile X Premutation|fragile x premutation
676166|NCT00879515|Fragile X Syndrome|fragile x syndrome
676167|NCT00879515|Down Syndrome|down syndrome
676168|NCT00879528|Hodgkin's Lymphoma|hodgkin's lymphoma
676169|NCT00879528|stem cell reinfusion|stem cell reinfusion
676170|NCT00879541|Hemophilia A|hemophilia a
676171|NCT00879554|Phase 1|phase 1
676172|NCT00879554|Solid Tumors|solid tumors
676173|NCT00879554|CVX-045|cvx-045
676174|NCT00879580|aneurysm|aneurysm
676175|NCT00879580|stent|stent
676176|NCT00879580|intracranial aneurysm|intracranial aneurysm
676177|NCT00879580|Ruptured Intracranial Aneurysm|ruptured intracranial aneurysm
676178|NCT00879606|Sepsis|sepsis
676179|NCT00879606|Acute Lung Injury|acute lung injury
676180|NCT00879606|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
676181|NCT00879606|ALI/ARDS|ali/ards
676182|NCT00879606|Lung Disease|lung disease
676183|NCT00879645|Renal Impairment|renal impairment
676184|NCT00879645|Renal Disease|renal disease
676185|NCT00879645|Sodium Sulfide|sodium sulfide
676186|NCT00879658|Multiple Sclerosis|multiple sclerosis
676187|NCT00879658|Relapsing-Remitting|relapsing-remitting
676188|NCT00879658|Demyelinating Autoimmune Diseases|demyelinating autoimmune diseases
676189|NCT00879671|lutein|lutein
676190|NCT00879671|nonexudative AMD|nonexudative amd
676191|NCT00879671|MPOD|mpod
676192|NCT00879671|Supplementary Concepts|supplementary concepts
676193|NCT00879684|Phase 1|phase 1
676194|NCT00879684|Tumors|tumors
676195|NCT00879684|CVX-060|cvx-060
676196|NCT00879697|peripheral arterial disease|peripheral arterial disease
676197|NCT00879697|exercise|exercise
676198|NCT00879697|resistance training|resistance training
676199|NCT00879697|cardiac rehabilitation|cardiac rehabilitation
676200|NCT00879710|Diabetes Mellitus|diabetes mellitus
676201|NCT00879710|Hypercholesterolemia|hypercholesterolemia
676202|NCT00879710|Simvastatin|simvastatin
676203|NCT00879710|Ezetimibe.|ezetimibe.
676204|NCT00879723|post-burn recovery|post-burn recovery
676205|NCT00879723|oxidative stress|oxidative stress
676206|NCT00879723|micronutrient protocol|micronutrient protocol
676207|NCT00879736|Doctor-patient communication|doctor-patient communication
676208|NCT00879736|Encounters|encounters
676209|NCT00879736|Patient education training|patient education training
676210|NCT00879762|smallpox, vaccine, IMVAMUNE®|smallpox, vaccine, imvamune®
676211|NCT00879775|Pain|pain
676212|NCT00879775|Cancer patients|cancer patients
676213|NCT00879775|Caffeine|caffeine
676214|NCT00879775|Adjuvant analgesics|adjuvant analgesics
676215|NCT00879775|Sedation|sedation
676217|NCT00879775|Quality of life|quality of life
676218|NCT00879775|Fatigue|fatigue
676219|NCT00879788|Ramipril fed condition|ramipril fed condition
676220|NCT00879801|prevention of diabetes|prevention of diabetes
676221|NCT00879801|susceptibility genes|susceptibility genes
676222|NCT00879801|type 2 diabetes|type 2 diabetes
676223|NCT00879801|insulin resistance|insulin resistance
676224|NCT00879801|beta-cell funtion|beta-cell funtion
676225|NCT00879840|Screening|screening
676226|NCT00879840|Modalities|modalities
676227|NCT00879840|Gynecological Cancers|gynecological cancers
676228|NCT00879853|PTSD|ptsd
676229|NCT00879853|Depression|depression
676230|NCT00879853|Anger|anger
676231|NCT00879853|Domestic Violence|domestic violence
676232|NCT00879853|Refugee|refugee
676233|NCT00879853|Asylum Seeker|asylum seeker
676234|NCT00879853|Community Therapist|community therapist
676235|NCT00879853|Paraprofessional Therapists|paraprofessional therapists
676236|NCT00879866|NSCLC|nsclc
676237|NCT00879866|immunocytokine|immunocytokine
676238|NCT00879866|radiation|radiation
676239|NCT00879866|interleukin-2|interleukin-2
676240|NCT00879866|immunotherapy|immunotherapy
676241|NCT00879866|maintenance therapy|maintenance therapy
676242|NCT00879879|precancerous condition|precancerous condition
676243|NCT00879892|xenon|xenon
676244|NCT00879892|hypothermia|hypothermia
676245|NCT00879892|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
676246|NCT00879905|Phase I|phase i
676247|NCT00879905|Adults|adults
676248|NCT00879905|HSP990|hsp990
676249|NCT00879905|Advanced Solid Tumors|advanced solid tumors
676250|NCT00879905|Hsp90 inhibitor|hsp90 inhibitor
676251|NCT00879905|Cancer|cancer
676252|NCT00879918|Cigarette Smoking in African Americans|cigarette smoking in african americans
676253|NCT00879944|Psoriasis|psoriasis
676254|NCT00879944|Obesity|obesity
676255|NCT00879944|BMI|bmi
676256|NCT00879944|Atopic Dermatitis|atopic dermatitis
676257|NCT00879957|Infant, Premature|infant, premature
676258|NCT00879957|Infant|infant
676259|NCT00879957|Central venous catheterization|central venous catheterization
676260|NCT00879957|Anticoagulants|anticoagulants
676261|NCT00879970|Cardiovascular Outcomes|cardiovascular outcomes
676262|NCT00879983|azithromycin, pharmacokinetics|azithromycin, pharmacokinetics
676263|NCT00879996|Opiate Addiction|opiate addiction
676264|NCT00879996|Narcotic Addiction|narcotic addiction
676265|NCT00879996|Drug Addiction|drug addiction
676266|NCT00879996|Pain|pain
676267|NCT00880022|compression|compression
676268|NCT00880022|Flexitouch|flexitouch
676269|NCT00880022|breast cancer|breast cancer
676270|NCT00880022|lymphedema|lymphedema
676271|NCT00880035|sedative drug|sedative drug
676272|NCT00880035|stress|stress
676273|NCT00880035|music|music
676274|NCT00880035|mechanical ventilation|mechanical ventilation
676275|NCT00880035|IL-6|il-6
676276|NCT00880035|cortisol|cortisol
676277|NCT00880035|prolactin|prolactin
676278|NCT00880035|CRP|crp
676279|NCT00880035|copeptin|copeptin
676280|NCT00880048|depression|depression
676281|NCT00880048|safety|safety
676282|NCT00880048|HAMD|hamd
676283|NCT00880048|QIDS-SR|qids-sr
676284|NCT00880048|NK-1 antagonist|nk-1 antagonist
676285|NCT00880048|efficacy|efficacy
676286|NCT00880048|orvepitant|orvepitant
676287|NCT00880048|placebo|placebo
676288|NCT00880048|MDD|mdd
676289|NCT00880048|video-rating|video-rating
676290|NCT00880061|Diffuse Infiltrating Pontine Glioma|diffuse infiltrating pontine glioma
676291|NCT00880061|Supratentorial High Grade Glioma|supratentorial high grade glioma
676292|NCT00880061|Convection-Enhanced Delivery|convection-enhanced delivery
676293|NCT00880061|Pediatric Brain Tumor|pediatric brain tumor
676294|NCT00880061|Brain Tumor|brain tumor
676295|NCT00880061|Glioma|glioma
676296|NCT00880074|Advanced Cancers|advanced cancers
676297|NCT00880074|FLT-PET|flt-pet
676298|NCT00880074|Positron Emission Tomography|positron emission tomography
676299|NCT00880074|PET|pet
676300|NCT00880074|[18F] fluorothymidine|[18f] fluorothymidine
676301|NCT00880074|[F-18]-fluoro-L-thymidine|[f-18]-fluoro-l-thymidine
676302|NCT00880074|FLT|flt
676303|NCT00880087|Cardiac Arrest|cardiac arrest
676304|NCT00880087|Cardiopulmonary Arrest|cardiopulmonary arrest
676305|NCT00880087|Pediatric Cardiac Arrest|pediatric cardiac arrest
676306|NCT00880087|VABS|vabs
676307|NCT00880087|Vineland Adaptive Behavior Scale|vineland adaptive behavior scale
676308|NCT00880087|POPC/PCPC|popc/pcpc
676309|NCT00880087|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
676310|NCT00880100|Steatorrhea|steatorrhea
676311|NCT00880100|Malabsorption of fat|malabsorption of fat
676312|NCT00880100|Pancreatic enzymes|pancreatic enzymes
676313|NCT00880100|Abdominal pain|abdominal pain
676314|NCT00880100|Greasy stools|greasy stools
676315|NCT00880113|CT-perfusion|ct-perfusion
676316|NCT00880113|CT-angiography|ct-angiography
676317|NCT00880126|Individualized Implementation|individualized implementation
751821|NCT01170598|Safety|safety
676318|NCT00880126|Community Development Teams|community development teams
676319|NCT00880139|Diabetes mellitus, type 1|diabetes mellitus, type 1
676320|NCT00880139|Inflammation|inflammation
676321|NCT00880139|Cytokines|cytokines
676322|NCT00880139|Vascular reactivity|vascular reactivity
676323|NCT00880152|stress|stress
676324|NCT00880152|mindfulness|mindfulness
676325|NCT00880152|trauma|trauma
676326|NCT00880165|Polysomnogram|polysomnogram
676327|NCT00880165|Continuous positive airway pressure|continuous positive airway pressure
676328|NCT00880178|Simvastatin|simvastatin
676329|NCT00880178|Niacin|niacin
676330|NCT00880178|Vascular Disease|vascular disease
676331|NCT00880178|Magnetic Resonance Imaging|magnetic resonance imaging
676332|NCT00880178|High Density Lipoprotein|high density lipoprotein
676333|NCT00880178|Oxidation|oxidation
676334|NCT00880178|Proteomics|proteomics
676335|NCT00880178|Stroke|stroke
676336|NCT00880178|Cerebrovascular Accident|cerebrovascular accident
676337|NCT00880191|nausea and vomiting|nausea and vomiting
676338|NCT00880191|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
676339|NCT00880204|Cluster Randomized Trial|cluster randomized trial
676340|NCT00880204|ESS-EMCH|ess-emch
676341|NCT00880204|Neonatal|neonatal
676342|NCT00880204|Maternal|maternal
676343|NCT00880204|Life threatening emergency event|life threatening emergency event
676344|NCT00880217|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
676345|NCT00880217|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
676346|NCT00880217|Adult ADHD|adult adhd
676347|NCT00880217|JNJ-31001074|jnj-31001074
676348|NCT00880230|Iliac Artery Stenting|iliac artery stenting
676349|NCT00880230|Peripheral Artery Disease|peripheral artery disease
676350|NCT00880243|Acute myeloid leukemia|acute myeloid leukemia
676351|NCT00880243|Priming|priming
676352|NCT00880243|GM-CSF|gm-csf
676353|NCT00880243|Timed-sequential chemotherapy|timed-sequential chemotherapy
676354|NCT00880243|Prognosis|prognosis
676355|NCT00880256|irritable bowel|irritable bowel
676356|NCT00880256|mindfulness|mindfulness
676357|NCT00880256|stress|stress
676358|NCT00880256|meditation|meditation
676359|NCT00880269|Acute myeloid leukemia|acute myeloid leukemia
676360|NCT00880269|AML|aml
676361|NCT00880269|relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
676362|NCT00880269|refractory AML|refractory aml
676363|NCT00880269|refractory de novo AML|refractory de novo aml
676364|NCT00880269|refractory secondary AML|refractory secondary aml
676365|NCT00880269|secondary AML|secondary aml
676366|NCT00880269|AML following myelodysplastic syndrome (MDS)|aml following myelodysplastic syndrome (mds)
676367|NCT00880269|AML following antecedent hematological disorder (AHD)|aml following antecedent hematological disorder (ahd)
676368|NCT00880269|AML resistant to therapy|aml resistant to therapy
676369|NCT00880308|Advanced tumors|advanced tumors
676370|NCT00880308|hedgehog|hedgehog
676371|NCT00880308|smoothened inhibitor|smoothened inhibitor
676372|NCT00880321|first time in human|first time in human
676373|NCT00880321|BRAF inhibitor|braf inhibitor
676374|NCT00880321|dose escalation|dose escalation
676375|NCT00880334|TCC|tcc
676376|NCT00880334|Zactima|zactima
676377|NCT00880334|docetaxel|docetaxel
676378|NCT00880334|ZD6474|zd6474
676379|NCT00880334|taxotere|taxotere
676380|NCT00880347|Alzheimer's disease|alzheimer's disease
676381|NCT00880347|Other dementia|other dementia
676382|NCT00880347|Vascular dementia|vascular dementia
676383|NCT00880347|Mixed dementia|mixed dementia
676384|NCT00880347|Parkinson's Disease dementia|parkinson's disease dementia
676385|NCT00880347|Lewy bodies dementia|lewy bodies dementia
676386|NCT00880347|Frontotemporal dementia|frontotemporal dementia
676387|NCT00880347|Blood signature|blood signature
676388|NCT00880347|Diagnosis|diagnosis
676389|NCT00880347|SpliceArray (tm)|splicearray (tm)
676390|NCT00880347|Alzheimer's Disease and other non-AD dementia|alzheimer's disease and other non-ad dementia
676391|NCT00880360|Epithelial Ovarian Cancer|epithelial ovarian cancer
676638|NCT00881101|Liposomal Paclitaxel|liposomal paclitaxel
676392|NCT00880360|FIGO (International Federation of Gynecology and Obstetrics )Stage III or Stage IV|figo (international federation of gynecology and obstetrics )stage iii or stage iv
676393|NCT00880360|Extraovarian Peritoneal Cancer|extraovarian peritoneal cancer
676394|NCT00880360|Fallopian Tube Carcinoma Failing|fallopian tube carcinoma failing
676395|NCT00880373|Sickle Cell Disease|sickle cell disease
676396|NCT00880373|Pain|pain
676397|NCT00880373|Ibuprofen|ibuprofen
676398|NCT00880373|Morphine|morphine
676399|NCT00880373|Diamorphine|diamorphine
676400|NCT00880373|Patient Controlled Analgesia|patient controlled analgesia
676401|NCT00880386|dyspnea|dyspnea
676402|NCT00880386|stage I non-small cell lung cancer|stage i non-small cell lung cancer
676403|NCT00880386|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
676404|NCT00880386|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
676405|NCT00880386|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
676406|NCT00880386|pulmonary complications|pulmonary complications
676407|NCT00880386|radiation fibrosis|radiation fibrosis
676408|NCT00880399|depression|depression
676409|NCT00880399|QIDS-SR|qids-sr
676410|NCT00880399|HAMD-17|hamd-17
676411|NCT00880399|orvepitant|orvepitant
676413|NCT00880399|neurokinin-1 antagonist|neurokinin-1 antagonist
676414|NCT00880399|double-blind|double-blind
676415|NCT00880399|Phase II|phase ii
676422|NCT00880412|Alzheimer's disease|alzheimer's disease
676423|NCT00880412|treatment|treatment
676424|NCT00880412|phase II|phase ii
676425|NCT00880412|study|study
676426|NCT00880412|cholinesterase inhibitor|cholinesterase inhibitor
676427|NCT00880451|Children and Adolescents|children and adolescents
676428|NCT00880451|Aging|aging
676429|NCT00880451|Brain Imaging|brain imaging
676430|NCT00880451|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
676431|NCT00880464|autologous vaccination|autologous vaccination
676432|NCT00880464|GM-CSF|gm-csf
676433|NCT00880464|adenoviral mediated gene transfer|adenoviral mediated gene transfer
676434|NCT00880464|Stage IV breast cancer|stage iv breast cancer
676435|NCT00880490|COPD|copd
677033|NCT00884091|Mixed meals|mixed meals
676436|NCT00880503|Multidrug Resistance Molecular Target Analysis|multidrug resistance molecular target analysis
676437|NCT00880529|rib fractures|rib fractures
676438|NCT00880529|ventilator|ventilator
676439|NCT00880529|ON-Q|on-q
676440|NCT00880529|analgesia|analgesia
676441|NCT00880542|localized osteosarcoma|localized osteosarcoma
676442|NCT00880542|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
676443|NCT00880542|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
676444|NCT00880555|Magnetic Resonance Imaging|magnetic resonance imaging
676445|NCT00880555|Alzheimer disease|alzheimer disease
676446|NCT00880555|Mild cognitive impairment|mild cognitive impairment
676447|NCT00880555|Continuous arterial spin labeling|continuous arterial spin labeling
676448|NCT00880555|Semantic memory|semantic memory
676449|NCT00880607|Pain|pain
676450|NCT00880607|Pediatric|pediatric
676451|NCT00880607|Spinal Fusion|spinal fusion
676452|NCT00880607|pain management|pain management
676453|NCT00880620|Parkinson's disease|parkinson's disease
676454|NCT00880633|EUS|eus
676455|NCT00880633|periampullary neoplasms|periampullary neoplasms
676456|NCT00880659|Influenza|influenza
676457|NCT00880659|secondary transmission|secondary transmission
676458|NCT00880659|handwashing|handwashing
676459|NCT00880672|prostate, dutasteride|prostate, dutasteride
676460|NCT00880672|vascular endothelial growth factor|vascular endothelial growth factor
676461|NCT00880672|hypoxia inducible factor|hypoxia inducible factor
676462|NCT00880685|Compulsive Stealing|compulsive stealing
676463|NCT00880685|Compulsive Shoplifting|compulsive shoplifting
676464|NCT00880698|Rotavirus|rotavirus
676465|NCT00880698|Rotavirus vaccine|rotavirus vaccine
676466|NCT00880711|Fiona|fiona
676467|NCT00880711|Faslodex|faslodex
676468|NCT00880711|Advanced Breast Cancer|advanced breast cancer
676469|NCT00880711|Real life data|real life data
676470|NCT00880711|Collect real life data in clinical practice across Austria|collect real life data in clinical practice across austria
676471|NCT00880724|COPD|copd
676472|NCT00880724|Emphysema|emphysema
676473|NCT00880724|Bronchoscopic Treatment|bronchoscopic treatment
676474|NCT00880724|Interventional Bronchoscopy|interventional bronchoscopy
676475|NCT00880750|End stage Renal disease|end stage renal disease
676476|NCT00880789|Cord Blood Transplant|cord blood transplant
676477|NCT00880789|cytomegalovirus|cytomegalovirus
676478|NCT00880789|CMV|cmv
676479|NCT00880789|Adenovirus|adenovirus
676480|NCT00880789|ADV|adv
676481|NCT00880802|Acute Coronary Syndromes|acute coronary syndromes
676482|NCT00880802|Non ST-Segment Elevation Myocardial Infarction|non st-segment elevation myocardial infarction
676483|NCT00880802|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
676484|NCT00880802|Unstable Angina|unstable angina
676485|NCT00880815|Leukemia|leukemia
676486|NCT00880815|Lymphoma|lymphoma
676487|NCT00880815|Lymphoid Malignancies|lymphoid malignancies
676488|NCT00880815|Non-myeloablative Allogeneic Conditioning|non-myeloablative allogeneic conditioning
676489|NCT00880815|Non-myeloablative Allogeneic Hematopoietic Transplantation|non-myeloablative allogeneic hematopoietic transplantation
676490|NCT00880815|Stem Cell Transplant|stem cell transplant
676491|NCT00880815|SCT|sct
676492|NCT00880815|Bendamustine HCI|bendamustine hci
676493|NCT00880815|Bendamustine|bendamustine
676494|NCT00880815|Bendamustine Hydrochloride|bendamustine hydrochloride
676495|NCT00880815|CEP-18083|cep-18083
676496|NCT00880815|SDX-105|sdx-105
676497|NCT00880815|Treanda|treanda
676498|NCT00880815|Fludarabine|fludarabine
676499|NCT00880815|Fludarabine Phosphate|fludarabine phosphate
676500|NCT00880815|Fludara|fludara
676501|NCT00880815|Rituximab|rituximab
676502|NCT00880815|Rituxan|rituxan
676503|NCT00880815|FBR|fbr
676504|NCT00880815|Graft-versus-host disease|graft-versus-host disease
676505|NCT00880815|GVHD|gvhd
676506|NCT00880828|Cervical Radiculopathy|cervical radiculopathy
676507|NCT00880828|Radicular Pain|radicular pain
676508|NCT00880828|Acute neck pain|acute neck pain
676509|NCT00880828|Cervicobrachial pain|cervicobrachial pain
676510|NCT00880828|Far-infrared ray|far-infrared ray
676511|NCT00880828|FIR|fir
676512|NCT00880828|Cervical collar|cervical collar
676513|NCT00880828|Cervical device|cervical device
676514|NCT00880828|FIR Device|fir device
676515|NCT00880841|healthy normals, phase 1|healthy normals, phase 1
676516|NCT00880841|phase 1a study for healthy normals|phase 1a study for healthy normals
676517|NCT00880854|bladder cancer|bladder cancer
676518|NCT00880854|BCG-resistant localized transitional cell of the bladder|bcg-resistant localized transitional cell of the bladder
676519|NCT00880867|Low Grade Recurrent B and T Cell Lymphoma|low grade recurrent b and t cell lymphoma
676520|NCT00880880|urinary incontinence|urinary incontinence
676521|NCT00880880|fecal incontinence|fecal incontinence
676522|NCT00880880|communication|communication
676523|NCT00880893|Dengue virus|dengue virus
676524|NCT00880893|Dengue fever|dengue fever
676525|NCT00880893|Dengue hemorrhagic fever|dengue hemorrhagic fever
676526|NCT00880893|Dengue diseases|dengue diseases
676527|NCT00880893|Sanofi Pasteur's CYD Dengue Vaccine|sanofi pasteur's cyd dengue vaccine
676528|NCT00880906|eosinophilic esophagitis|eosinophilic esophagitis
676529|NCT00880906|esophageal food impaction|esophageal food impaction
676530|NCT00880906|dysphagia|dysphagia
676531|NCT00880919|Borderline Personality Disorder|borderline personality disorder
676533|NCT00880919|Seroquel|seroquel
676534|NCT00880919|Seroquel XR|seroquel xr
676535|NCT00880919|quetiapine|quetiapine
676536|NCT00880919|quetiapine extended-release|quetiapine extended-release
676537|NCT00875095|sperm DNA integrity|sperm dna integrity
676538|NCT00875095|Toluidine blue staining|toluidine blue staining
676539|NCT00875121|Food reinforcement|food reinforcement
676540|NCT00875121|social reinforcers|social reinforcers
676541|NCT00875121|overweight|overweight
676542|NCT00875121|children|children
676543|NCT00875147|neoadjuvant chemotherapy|neoadjuvant chemotherapy
676544|NCT00875147|bevacizumab|bevacizumab
676545|NCT00875173|Selenium|selenium
676546|NCT00875173|Chagas disease|chagas disease
676547|NCT00875173|Chagasic cardiopathy|chagasic cardiopathy
676548|NCT00875186|bariatric surgery|bariatric surgery
676549|NCT00875186|co-morbidities|co-morbidities
676550|NCT00875186|aerobic physical exercise|aerobic physical exercise
676551|NCT00875199|Overweight|overweight
676553|NCT00875199|Contingency Management|contingency management
676554|NCT00875212|Calcium glycerophosphate|calcium glycerophosphate
676555|NCT00875212|Fluoride|fluoride
676556|NCT00875212|Dentifrice|dentifrice
676557|NCT00875212|Biofilm|biofilm
676558|NCT00875212|Dental caries|dental caries
676559|NCT00875225|Hypertension|hypertension
676560|NCT00875225|Adherence to medications|adherence to medications
676561|NCT00875238|cardiac toxicity|cardiac toxicity
676562|NCT00875238|cardiovascular complications|cardiovascular complications
676563|NCT00875238|stage I breast cancer|stage i breast cancer
676564|NCT00875238|stage II breast cancer|stage ii breast cancer
676565|NCT00875238|stage IIIA breast cancer|stage iiia breast cancer
676566|NCT00875238|stage IIIB breast cancer|stage iiib breast cancer
676567|NCT00875238|stage IIIC breast cancer|stage iiic breast cancer
676568|NCT00875251|body composition|body composition
676569|NCT00875251|preterm infant|preterm infant
676570|NCT00875251|anthropometry|anthropometry
676571|NCT00875264|CEP-11981|cep-11981
676572|NCT00875264|TIE-2|tie-2
676573|NCT00875264|VEGF-R|vegf-r
676574|NCT00875290|Diabetes Mellitus, Type I|diabetes mellitus, type i
676575|NCT00875290|Children|children
676576|NCT00875290|Insulin pump therapy|insulin pump therapy
676577|NCT00875290|Continuous glucose monitor|continuous glucose monitor
676578|NCT00875303|Parents' plans to discipline their children|parents' plans to discipline their children
676579|NCT00875316|Parkinson's disease|parkinson's disease
676580|NCT00875316|Phase I|phase i
676581|NCT00875329|Brain Injury|brain injury
676582|NCT00875342|Traumatic Event|traumatic event
676583|NCT00875342|Trauma Survivor|trauma survivor
676584|NCT00875342|Exposure Therapy|exposure therapy
676585|NCT00875342|PTSD DCS|ptsd dcs
676586|NCT00875342|Telemedicine|telemedicine
676587|NCT00875342|Telepsychiatry|telepsychiatry
676588|NCT00875342|Telemental health|telemental health
676589|NCT00875355|tumors metastatic to brain|tumors metastatic to brain
676590|NCT00875355|stage IV breast cancer|stage iv breast cancer
676591|NCT00875368|HIV-1|hiv-1
676592|NCT00875368|HAART|haart
676593|NCT00875368|CD4 cell|cd4 cell
676594|NCT00875368|Immunologic non-responders|immunologic non-responders
676595|NCT00875368|Immunology|immunology
676596|NCT00875368|treatment experienced|treatment experienced
676597|NCT00875381|Melanocytes|melanocytes
676598|NCT00880932|warfarin|warfarin
676599|NCT00880932|NSAID|nsaid
676600|NCT00880932|The condition is the concomitant prescription of|the condition is the concomitant prescription of
676601|NCT00880945|FBS|fbs
676602|NCT00880945|coin lesions|coin lesions
676603|NCT00880945|ENB|enb
676604|NCT00880945|ROSE|rose
676605|NCT00880971|Lung|lung
676606|NCT00880971|Carcinoma|carcinoma
676607|NCT00880971|radiotherapy|radiotherapy
676608|NCT00880971|Surgery|surgery
676609|NCT00880984|Colon Anastomosis|colon anastomosis
676610|NCT00880984|Rectum Anastomosis|rectum anastomosis
676611|NCT00880984|Intestine|intestine
676612|NCT00880984|Colorectal Surgery|colorectal surgery
676613|NCT00880984|Colorectal Anastomosis|colorectal anastomosis
676614|NCT00880997|Cocaine Dependence|cocaine dependence
676615|NCT00880997|Substance Related Disorders|substance related disorders
676616|NCT00881010|Breast Cancer|breast cancer
677119|NCT00884494|Obesity|obesity
676818|NCT00883207|Depression|depression
676617|NCT00881010|Pain Intervention|pain intervention
676618|NCT00881010|Underserved minority patients|underserved minority patients
676619|NCT00881010|African American|african american
676620|NCT00881010|Hispanic|hispanic
676621|NCT00881010|Automated Telephone System for measuring symptoms|automated telephone system for measuring symptoms
676622|NCT00881010|Interactive voice response|interactive voice response
676624|NCT00881036|Hepatitis B|hepatitis b
676625|NCT00881049|metastatic acral or mucosal melanoma with c-kit mutation or copy number increase|metastatic acral or mucosal melanoma with c-kit mutation or copy number increase
676626|NCT00881062|ABSORPTION|absorption
676627|NCT00881062|METABOLISM|metabolism
676628|NCT00881062|EXCRETION|excretion
676629|NCT00881075|Magnetic resonance imaging|magnetic resonance imaging
676630|NCT00881075|Heart diseases|heart diseases
676631|NCT00881075|myocardial infarction|myocardial infarction
676632|NCT00881075|contrast agents|contrast agents
676633|NCT00881075|manganese|manganese
676634|NCT00881088|Deep vein trombosis|deep vein trombosis
676635|NCT00881088|Profylaxis|profylaxis
676636|NCT00881088|Below knee plaster cast|below knee plaster cast
676637|NCT00881088|Ankle fracture|ankle fracture
676639|NCT00881101|Maximum tolerated dose|maximum tolerated dose
676640|NCT00881101|Dose limiting toxicity|dose limiting toxicity
676641|NCT00881114|Head and neck cancer|head and neck cancer
676642|NCT00881114|pharmacogenetics|pharmacogenetics
676643|NCT00881114|chemoradiotherapy|chemoradiotherapy
676644|NCT00881140|oral mifepristone|oral mifepristone
676645|NCT00881140|vaginal tablets|vaginal tablets
676646|NCT00881153|Antibiotic|antibiotic
676647|NCT00881166|MP-470|mp-470
676648|NCT00881166|Multi-targeted Tyrosine Kinase Inhibitor|multi-targeted tyrosine kinase inhibitor
676649|NCT00881166|Malignant disease|malignant disease
676650|NCT00881179|Antibiotic|antibiotic
676651|NCT00881192|CABG|cabg
676652|NCT00881192|coronary surgery|coronary surgery
676653|NCT00881192|intra-aortic balloon pump|intra-aortic balloon pump
676654|NCT00881192|CABG operation|cabg operation
676655|NCT00881205|Multiple Sclerosis|multiple sclerosis
676656|NCT00881205|Cognition|cognition
676657|NCT00881205|Rivastigmine|rivastigmine
676658|NCT00881205|Patch|patch
676659|NCT00881218|myocardial ischemia, perfusion imaging, cardiac MRI|myocardial ischemia, perfusion imaging, cardiac mri
676660|NCT00881257|Peripheral Vascular Disease|peripheral vascular disease
676661|NCT00881257|Peripheral Artery Disease|peripheral artery disease
676662|NCT00881257|Radiofrequency|radiofrequency
676663|NCT00882596|Contura|contura
676664|NCT00882596|Cancer|cancer
676665|NCT00882596|Accelerated|accelerated
676666|NCT00882596|Partial|partial
676667|NCT00882596|Breast|breast
676668|NCT00882596|Irradiation|irradiation
676669|NCT00882609|bone metastasis|bone metastasis
676670|NCT00882609|bone metastases|bone metastases
676671|NCT00882609|Sodium Fluoride|sodium fluoride
676672|NCT00882609|F18 Fluoride|f18 fluoride
676673|NCT00882609|bone scan|bone scan
676674|NCT00882622|Ischemic Preconditioning|ischemic preconditioning
676675|NCT00882622|Cardiac Surgery|cardiac surgery
676676|NCT00882635|STEMI|stemi
676677|NCT00882635|acute coronary syndromes|acute coronary syndromes
676678|NCT00882635|primary percutaneous coronary intervention|primary percutaneous coronary intervention
676679|NCT00882648|Drug dependence during pregnancy|drug dependence during pregnancy
676680|NCT00882661|Neck Pain|neck pain
676681|NCT00882661|Arm Pain|arm pain
676682|NCT00882700|Antibiotic|antibiotic
676683|NCT00882726|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
676684|NCT00882726|CNTO 3649|cnto 3649
676685|NCT00882726|safety|safety
676686|NCT00882726|Phase I|phase i
676687|NCT00882726|healthy adults|healthy adults
676688|NCT00882726|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
676689|NCT00882739|angiography|angiography
676690|NCT00882739|percutaneous coronary intervention|percutaneous coronary intervention
676691|NCT00882739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
676692|NCT00882739|Platelet Function Tests|platelet function tests
676693|NCT00882752|Ulcerative Colitis (UC)|ulcerative colitis (uc)
676694|NCT00882765|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
676695|NCT00882765|stage I pancreatic cancer|stage i pancreatic cancer
676696|NCT00882765|stage II pancreatic cancer|stage ii pancreatic cancer
676697|NCT00882765|stage III pancreatic cancer|stage iii pancreatic cancer
676698|NCT00882791|Skin Cancer|skin cancer
676699|NCT00882791|Basal Cell|basal cell
676700|NCT00882791|Mohs surgery|mohs surgery
676701|NCT00882804|hemin, heme oxygenase, humans, HO-1|hemin, heme oxygenase, humans, ho-1
676702|NCT00882817|ILD|ild
676703|NCT00882830|ICU|icu
676704|NCT00882830|myopathy|myopathy
676705|NCT00882830|neuropathy|neuropathy
676706|NCT00882830|EMS|ems
676707|NCT00882830|critical illness polyneuromyopathy|critical illness polyneuromyopathy
676708|NCT00882830|NIRS|nirs
676709|NCT00882830|muscle biopsy|muscle biopsy
676710|NCT00882830|microdialysis|microdialysis
676711|NCT00882830|CIPNM|cipnm
676712|NCT00882843|Vibrating plate|vibrating plate
676713|NCT00882843|Mechanical Stimulation|mechanical stimulation
676714|NCT00882843|Osteoporosis|osteoporosis
676715|NCT00882856|Clozapine|clozapine
676716|NCT00882856|Sinustachycardia|sinustachycardia
676717|NCT00882856|Heartrate variability|heartrate variability
676718|NCT00882856|Cardiomyopathy|cardiomyopathy
676719|NCT00882869|Advanced Hepatocellular carcinoma|advanced hepatocellular carcinoma
676720|NCT00882869|liver|liver
676721|NCT00882869|cancer|cancer
676722|NCT00882869|antisense|antisense
676723|NCT00882869|sorafenib|sorafenib
676724|NCT00882895|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
676725|NCT00882895|Transplantation, Autologous|transplantation, autologous
676726|NCT00882895|Transplantation, Homologous|transplantation, homologous
676727|NCT00882895|Total Lymphoid Irradiation|total lymphoid irradiation
676728|NCT00882895|Anti-thymocyte globulin|anti-thymocyte globulin
676729|NCT00882908|Hepatitis C|hepatitis c
676730|NCT00882908|TMC435|tmc435
676731|NCT00882908|Peginterferon alpha-2a|peginterferon alpha-2a
676732|NCT00882908|PegIFNalpha-2a|pegifnalpha-2a
676734|NCT00882908|Ribavirin|ribavirin
676735|NCT00882908|Placebo|placebo
676736|NCT00882921|Hunter syndrome|hunter syndrome
676737|NCT00882921|hunters syndrome|hunters syndrome
676738|NCT00882921|hunter's syndrome|hunter's syndrome
676739|NCT00882921|hunter disease|hunter disease
676740|NCT00882921|hunters disease|hunters disease
676741|NCT00882921|hunter's disease|hunter's disease
676742|NCT00882921|MPS II|mps ii
676743|NCT00882921|MPSII|mpsii
676744|NCT00882921|MPS2|mps2
676745|NCT00882921|MPS 2|mps 2
676746|NCT00882921|mucopolysaccharides|mucopolysaccharides
676747|NCT00882921|lysosomal storage disease|lysosomal storage disease
676748|NCT00882921|lysosomal storage disorder|lysosomal storage disorder
676749|NCT00882921|chronic ear infection|chronic ear infection
676750|NCT00882921|enlarged adenoids|enlarged adenoids
676751|NCT00882921|mps symptoms|mps symptoms
676752|NCT00882921|mps diagnosis|mps diagnosis
676753|NCT00882921|mps ii therapy|mps ii therapy
676754|NCT00882921|MPS II treatment|mps ii treatment
676755|NCT00882921|ert treatment|ert treatment
676756|NCT00882921|elaprase|elaprase
676757|NCT00882921|idursulfase|idursulfase
676758|NCT00882921|iduronate sulfatase|iduronate sulfatase
676759|NCT00882921|iduronate 2 sulfatase|iduronate 2 sulfatase
676760|NCT00882921|enzyme replacement therapy|enzyme replacement therapy
676761|NCT00882921|hunter syndrome treatment|hunter syndrome treatment
676762|NCT00882921|hunter's syndrome treatment|hunter's syndrome treatment
676763|NCT00882921|hunter syndrome therapy|hunter syndrome therapy
676764|NCT00882921|hunter's disease treatment|hunter's disease treatment
676765|NCT00882921|mps society|mps society
676766|NCT00882934|Placebo|placebo
676767|NCT00882934|Placebo Effect|placebo effect
676768|NCT00882934|Sexual Dysfunction|sexual dysfunction
676769|NCT00882934|Erectile Dysfunction|erectile dysfunction
676770|NCT00882934|Clinical Trial|clinical trial
676771|NCT00882947|Primary Pulmonary Hypertension (PPH)|primary pulmonary hypertension (pph)
676772|NCT00882960|pre-hospital|pre-hospital
676773|NCT00882960|intra-nasal fentanyl|intra-nasal fentanyl
676774|NCT00882960|patients requiring analgesia|patients requiring analgesia
676775|NCT00882986|insulin resistance|insulin resistance
676776|NCT00882999|Relapsing|relapsing
676777|NCT00882999|Remitting|remitting
676778|NCT00882999|Multiple Sclerosis|multiple sclerosis
676779|NCT00882999|Multiple|multiple
676780|NCT00882999|Sclerosis|sclerosis
676782|NCT00882999|LY2127399|ly2127399
676783|NCT00883012|Viral-confirmed|viral-confirmed
676784|NCT00883025|Friedman Classification|friedman classification
676785|NCT00883025|Apnea-Hypopnea Index|apnea-hypopnea index
676786|NCT00883025|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
676787|NCT00883038|insulin resistance|insulin resistance
676788|NCT00883038|vegetarian diet|vegetarian diet
676789|NCT00883051|COL-144|col-144
676790|NCT00883051|acute treatment|acute treatment
676791|NCT00883051|migraine|migraine
676792|NCT00883077|permeability|permeability
676793|NCT00883077|inflammatory bowel disease|inflammatory bowel disease
676794|NCT00883077|confocal laser endomicroscopy|confocal laser endomicroscopy
676795|NCT00883077|irritable bowel syndrome|irritable bowel syndrome
676796|NCT00883090|Factor XIII|factor xiii
676797|NCT00883103|female urethral catheterization|female urethral catheterization
676798|NCT00883103|Lidocaine|lidocaine
676799|NCT00883103|lubricant|lubricant
676800|NCT00883103|Q-tip test|q-tip test
676801|NCT00883103|Q tip test|q tip test
676802|NCT00883103|K-Y jelly|k-y jelly
676803|NCT00883103|pain perception|pain perception
676804|NCT00883103|straight catheterization|straight catheterization
676805|NCT00883129|Systemic Sclerosis|systemic sclerosis
676806|NCT00883129|Mycophenolate Mofetil|mycophenolate mofetil
676807|NCT00883129|Cyclophosphamide|cyclophosphamide
676808|NCT00883129|High Resolution Computerized Tomography|high resolution computerized tomography
676809|NCT00883129|Pulmonary Function|pulmonary function
676810|NCT00883129|Dyspnea|dyspnea
676811|NCT00883129|Health Related Quality of Life|health related quality of life
676812|NCT00883142|Lokomat|lokomat
676813|NCT00883142|Suspended walking|suspended walking
676814|NCT00883142|Body Weight Supported|body weight supported
676815|NCT00883142|Treadmill Training|treadmill training
676816|NCT00883155|Antidepressant|antidepressant
676817|NCT00883194|Experimental Pain Model|experimental pain model
676819|NCT00883207|family therapy|family therapy
676820|NCT00883207|dialogical processes|dialogical processes
676821|NCT00883207|Developing couple therapy for depression|developing couple therapy for depression
676822|NCT00883220|self management|self management
676823|NCT00883220|chronic condition|chronic condition
676824|NCT00883220|urinary catheter|urinary catheter
676825|NCT00883233|Acne|acne
676826|NCT00883246|PAD|pad
676827|NCT00883259|High-risk patients|high-risk patients
676828|NCT00883259|Metformin|metformin
676829|NCT00883259|PCOS|pcos
676830|NCT00883259|Pregnancy complications|pregnancy complications
676831|NCT00883259|Previous gestational DM|previous gestational dm
676832|NCT00883272|Menopause|menopause
676833|NCT00883272|Thrombophilia|thrombophilia
676834|NCT00883272|factor V Leiden|factor v leiden
676835|NCT00883272|Estrogen Replacement Therapy|estrogen replacement therapy
676836|NCT00883272|Hypercoagulability|hypercoagulability
676837|NCT00883272|Venous Thrombosis|venous thrombosis
676838|NCT00883298|temozolomide|temozolomide
676839|NCT00883298|bevacizumab|bevacizumab
676840|NCT00883298|Temodar|temodar
676841|NCT00883298|Avastin|avastin
676842|NCT00883298|glioblastoma multiforme|glioblastoma multiforme
676843|NCT00883298|gliosarcoma|gliosarcoma
676844|NCT00883298|glioma|glioma
676845|NCT00883298|GBM|gbm
676846|NCT00883298|brain tumor|brain tumor
676847|NCT00883311|Efficacy|efficacy
676848|NCT00883324|fFN|ffn
676849|NCT00883324|fetal fibronectin|fetal fibronectin
676850|NCT00883324|non-speculum|non-speculum
676851|NCT00883324|risk of preterm delivery|risk of preterm delivery
676852|NCT00883337|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
676853|NCT00883350|Body weight changes|body weight changes
676854|NCT00883350|Overweight|overweight
676855|NCT00883350|Obesity|obesity
676856|NCT00883363|precondition|precondition
676857|NCT00883363|ruptured abdominal aortic aneurysm|ruptured abdominal aortic aneurysm
676858|NCT00883363|myocardial infarction|myocardial infarction
676859|NCT00883376|Classification of Stanford for Snoring|classification of stanford for snoring
676860|NCT00883376|OSAS|osas
676861|NCT00883376|Apnea-Hipopnea Index|apnea-hipopnea index
676862|NCT00883389|patient safety|patient safety
676863|NCT00883389|chronic kidney disease|chronic kidney disease
676864|NCT00883389|med-alert|med-alert
676865|NCT00883402|Carotid stenosis|carotid stenosis
676866|NCT00883402|CEA|cea
676867|NCT00883402|CAS|cas
676868|NCT00883402|Stenting|stenting
676869|NCT00883415|metabolism|metabolism
676870|NCT00883415|myocardium|myocardium
676871|NCT00883415|chronic kidney disease|chronic kidney disease
676872|NCT00883428|low back pain|low back pain
676873|NCT00883428|pelvic pain|pelvic pain
676874|NCT00883428|pregnancy|pregnancy
676875|NCT00883441|IMPLEMENTATION RESEARCH|implementation research
676876|NCT00883441|AEDES|aedes
676877|NCT00883441|VECTOR CONTROL|vector control
676878|NCT00883454|hepatocellular carcinoma|hepatocellular carcinoma
676879|NCT00883454|liver tumor|liver tumor
676880|NCT00883454|cirrhosis|cirrhosis
676881|NCT00883454|liver resection|liver resection
676882|NCT00883454|tumor staging|tumor staging
676883|NCT00883454|liver disease staging|liver disease staging
676884|NCT00883467|Ischemic Preconditioning|ischemic preconditioning
676885|NCT00883467|functional MRI|functional mri
676886|NCT00883467|BOLD|bold
676887|NCT00883467|Reperfusion|reperfusion
676888|NCT00883480|NSCLC|nsclc
676889|NCT00883493|Acute bipolar depression|acute bipolar depression
676890|NCT00883493|Lithium carbonate|lithium carbonate
676891|NCT00883493|quetiapine fumarate|quetiapine fumarate
676892|NCT00883493|MADRS|madrs
676893|NCT00883532|Preterm infant|preterm infant
676894|NCT00883532|Respiratory distress syndrome|respiratory distress syndrome
676895|NCT00883532|chronic lung disease|chronic lung disease
676896|NCT00883532|budesonide|budesonide
676897|NCT00883532|surfactant|surfactant
676898|NCT00883545|Adherence to screening colonoscopy in women|adherence to screening colonoscopy in women
676899|NCT00883558|recombinant human hyaluronidase (rHuPH20)|recombinant human hyaluronidase (rhuph20)
676900|NCT00883558|Insulin lispro|insulin lispro
676901|NCT00883558|regular human insulin|regular human insulin
676902|NCT00883571|anal stenosis|anal stenosis
676903|NCT00883571|flaps|flaps
676904|NCT00883571|anoplasty|anoplasty
676905|NCT00883584|Proof of Concept|proof of concept
676906|NCT00883584|Inflammatory Markers|inflammatory markers
676907|NCT00883584|Lung Function|lung function
676908|NCT00883584|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
676909|NCT00883584|COPD|copd
676910|NCT00883610|QT Interval|qt interval
676911|NCT00883610|Dual Chamber Pacemaker|dual chamber pacemaker
676912|NCT00883610|Atrial Fibrillation|atrial fibrillation
676913|NCT00883623|AL-Amyloidosis|al-amyloidosis
676914|NCT00883623|Lenalidomide|lenalidomide
676915|NCT00883636|Podocyte Protein|podocyte protein
676916|NCT00883636|Podocyte Mutation|podocyte mutation
676917|NCT00883649|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
676918|NCT00883649|Dry Eyes|dry eyes
676919|NCT00883649|Post-menopausal|post-menopausal
676920|NCT00883675|Lung cancer|lung cancer
676921|NCT00883675|Adjuvant therapy|adjuvant therapy
676922|NCT00883688|Brain Tumor|brain tumor
676923|NCT00883688|Recurrent Ependymoma|recurrent ependymoma
676924|NCT00883688|Refractory Ependymoma|refractory ependymoma
676925|NCT00883688|Intracranial ependymoma|intracranial ependymoma
676926|NCT00883688|Ependymoblastoma|ependymoblastoma
676927|NCT00883688|Subependymoma|subependymoma
676928|NCT00883688|Myxopapillary|myxopapillary
676929|NCT00883688|Clear cell|clear cell
676930|NCT00883688|Anaplastic|anaplastic
676931|NCT00883688|Bevacizumab|bevacizumab
677135|NCT00884520|exploratory|exploratory
676933|NCT00883688|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
676934|NCT00883688|rhuMAb-VEGF|rhumab-vegf
676935|NCT00883688|Lapatinib|lapatinib
676936|NCT00883688|Tykerb|tykerb
676937|NCT00883688|GW572016|gw572016
676938|NCT00883701|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
676939|NCT00883701|exacerbations|exacerbations
676940|NCT00883701|perforin|perforin
676941|NCT00883701|granzymes|granzymes
676942|NCT00883714|Exercise|exercise
676943|NCT00883714|sport|sport
676944|NCT00883714|Allogeneic blood stem cell transplantation|allogeneic blood stem cell transplantation
676945|NCT00883714|Blood stem cell transplantation|blood stem cell transplantation
676946|NCT00883714|Fatigue|fatigue
676947|NCT00883714|Cancer|cancer
676948|NCT00883714|Physical performance|physical performance
676949|NCT00883714|Mood|mood
676950|NCT00883714|Complications|complications
676951|NCT00883727|mesenchymal stem cells|mesenchymal stem cells
676952|NCT00883727|myocardial infarction|myocardial infarction
676953|NCT00883740|Fibromyalgia sleep maintenance disturbance pregabalin|fibromyalgia sleep maintenance disturbance pregabalin
676954|NCT00883766|Polycystic Ovary Syndrome|polycystic ovary syndrome
676955|NCT00883766|GnRH Antagonist|gnrh antagonist
676956|NCT00883766|Long Agonist Protocol|long agonist protocol
676957|NCT00883766|OHSS|ohss
676958|NCT00883805|Metal Ion Concentration|metal ion concentration
676959|NCT00883805|Osteolysis|osteolysis
676960|NCT00883818|Overactive bladder|overactive bladder
676961|NCT00883818|Mycoplasma|mycoplasma
676962|NCT00883831|Acupuncture|acupuncture
676963|NCT00883831|Hemodialysis|hemodialysis
676964|NCT00883831|Symptom|symptom
676965|NCT00883831|end stage renal disease|end stage renal disease
676966|NCT00883831|chronic kidney disease|chronic kidney disease
676967|NCT00883831|supportive care|supportive care
676968|NCT00883844|Hepatitis B|hepatitis b
676969|NCT00883844|sustained response|sustained response
676970|NCT00883844|peginterferon|peginterferon
676971|NCT00883844|nucleos(t)ide analogues|nucleos(t)ide analogues
676972|NCT00883870|mesenchymal stem cells|mesenchymal stem cells
676973|NCT00883870|critical limb ischemia|critical limb ischemia
676974|NCT00883883|Antibiotic|antibiotic
676975|NCT00883896|Rheumatoid Arthritis|rheumatoid arthritis
676976|NCT00883896|ACR|acr
676977|NCT00883896|Methotrexate|methotrexate
676978|NCT00883896|Interleukin-22|interleukin-22
676979|NCT00883909|Prostate Cancer|prostate cancer
676980|NCT00883909|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
676981|NCT00883935|GSK1349572|gsk1349572
676982|NCT00883935|Atazanavir|atazanavir
676983|NCT00883935|Ritonavir|ritonavir
676984|NCT00883935|Reyataz|reyataz
676985|NCT00883935|Norvir|norvir
676986|NCT00883935|healthy|healthy
676987|NCT00883935|pharmacokinetic|pharmacokinetic
676988|NCT00883948|Acute Lung Injury|acute lung injury
676989|NCT00883948|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
676990|NCT00883948|Feeding|feeding
676991|NCT00883948|Critical Care|critical care
676992|NCT00883948|Ventilator|ventilator
676993|NCT00883961|High-dose chemotherapy|high-dose chemotherapy
676994|NCT00883961|Hematological neoplasties|hematological neoplasties
676995|NCT00883961|Fatigue|fatigue
676996|NCT00883961|Cancer|cancer
676997|NCT00883961|Exercise|exercise
676998|NCT00883961|Sport|sport
676999|NCT00883961|Hematologic neoplastic disorders|hematologic neoplastic disorders
677000|NCT00883974|preterm bith|preterm bith
677001|NCT00883974|neurodevelopment|neurodevelopment
677002|NCT00883974|sensitivity training|sensitivity training
677003|NCT00883974|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
677004|NCT00883974|Infant neurodevelopment following preterm birth|infant neurodevelopment following preterm birth
677005|NCT00884013|Pay for Quality|pay for quality
677006|NCT00884013|Provider|provider
677007|NCT00884013|Clinical Decision Support|clinical decision support
677008|NCT00884013|Quality Reporting|quality reporting
677009|NCT00884013|Quality Measurement|quality measurement
677010|NCT00884026|Cesarean delivery|cesarean delivery
677011|NCT00884026|hypotension|hypotension
677012|NCT00884026|Augmentation Index|augmentation index
677013|NCT00884026|Pulse Wave analysis|pulse wave analysis
677014|NCT00884026|spinal anesthesia|spinal anesthesia
677015|NCT00884026|Hypotension following spinal anesthesia for cesarean delivery|hypotension following spinal anesthesia for cesarean delivery
677016|NCT00884039|cornea|cornea
677017|NCT00884039|transplant|transplant
677018|NCT00884039|intraocular pressure|intraocular pressure
677019|NCT00884039|steroid response|steroid response
677020|NCT00884052|Neonatal seizures|neonatal seizures
677021|NCT00884065|Physiotherapy|physiotherapy
677022|NCT00884065|Manual therapy|manual therapy
677023|NCT00884065|Painful Shoulder|painful shoulder
677024|NCT00884065|Diacutaneous Fibrolysis|diacutaneous fibrolysis
677025|NCT00884078|Self harm in south asian women|self harm in south asian women
677026|NCT00884078|depression|depression
677027|NCT00884078|suicidal ideations|suicidal ideations
677028|NCT00884078|problem solving training|problem solving training
677030|NCT00884091|Glucagon-like peptide 1|glucagon-like peptide 1
677031|NCT00884091|Glucagon|glucagon
677032|NCT00884091|Insulin|insulin
677034|NCT00884091|Healthy Adults|healthy adults
677035|NCT00884104|Solifenacin|solifenacin
677036|NCT00884104|Tamsulosin|tamsulosin
677037|NCT00884104|OAB|oab
677038|NCT00884130|Laparoscopy|laparoscopy
677039|NCT00884130|Colorectal surgery|colorectal surgery
677040|NCT00884130|Quality of life|quality of life
677041|NCT00884130|economic analysis|economic analysis
677042|NCT00884130|Patients undergoing laparoscopic colorectal surgery|patients undergoing laparoscopic colorectal surgery
677043|NCT00884143|tamoxifen|tamoxifen
677044|NCT00884143|arimidex|arimidex
677045|NCT00884143|adjuvant hormonal therapies|adjuvant hormonal therapies
677046|NCT00884143|breast cancer|breast cancer
677047|NCT00884143|post-menopausal|post-menopausal
677048|NCT00884143|Adjuvant hormonal therapy in patients post menopausal with breast cancer|adjuvant hormonal therapy in patients post menopausal with breast cancer
677049|NCT00884182|Influenza|influenza
677050|NCT00884182|Orthomyxoviruses|orthomyxoviruses
677051|NCT00884182|Split Virion Pandemic Influenza Vaccine|split virion pandemic influenza vaccine
677052|NCT00884182|A/H5N1|a/h5n1
677053|NCT00884195|Obesity|obesity
677054|NCT00884234|Lateral Canthal Lines|lateral canthal lines
677055|NCT00884234|Crow's Feet|crow's feet
677056|NCT00884234|Facial Wrinkles|facial wrinkles
677057|NCT00884234|Lateral Canthal Area|lateral canthal area
677058|NCT00884247|GERD|gerd
677059|NCT00884247|Quality of life|quality of life
677060|NCT00884247|Structured treatment|structured treatment
677061|NCT00884260|Contraception|contraception
677062|NCT00884260|Intrauterine contraception system|intrauterine contraception system
677063|NCT00884286|Aplidin|aplidin
677064|NCT00884286|Aggressive Non Hodgkin Lymphoma|aggressive non hodgkin lymphoma
677065|NCT00884286|Leukemia-Lymphoma, Adult T-Cell and B-cell|leukemia-lymphoma, adult t-cell and b-cell
677066|NCT00884299|Lung function|lung function
677067|NCT00884299|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
677068|NCT00884299|Antioxidants|antioxidants
677069|NCT00884312|Multiple myeloma|multiple myeloma
677070|NCT00884312|proteasome|proteasome
677071|NCT00884312|Hematological|hematological
677072|NCT00884312|carfilzomib|carfilzomib
677073|NCT00884312|PR-171|pr-171
677074|NCT00884325|Itching|itching
677075|NCT00884325|Atopic Dermatitis|atopic dermatitis
677076|NCT00884338|Fatigue|fatigue
677077|NCT00884338|Cancer|cancer
677078|NCT00884338|Cognitive impairment|cognitive impairment
677079|NCT00884338|Exercise|exercise
677080|NCT00884338|Sport|sport
677081|NCT00884338|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
677082|NCT00884338|High-dose chemotherapy|high-dose chemotherapy
677083|NCT00884351|Epilepsy|epilepsy
677084|NCT00884351|MEG|meg
677085|NCT00884351|Seizures|seizures
677086|NCT00884364|Lymphoma|lymphoma
677087|NCT00884364|Leukemia|leukemia
677088|NCT00884364|Multiple myeloma|multiple myeloma
677089|NCT00884364|Hodgkin´s disease|hodgkin´s disease
677090|NCT00884364|Exercise|exercise
677091|NCT00884364|Sport|sport
677092|NCT00884364|Fatigue|fatigue
677093|NCT00884364|Hematological neoplastic diseases|hematological neoplastic diseases
677094|NCT00884390|Hemophilia A|hemophilia a
677095|NCT00884403|abortion|abortion
677096|NCT00884403|pregnancy dating|pregnancy dating
677097|NCT00884403|gestational age|gestational age
677098|NCT00884403|ultrasound|ultrasound
677099|NCT00884416|high grade glioma|high grade glioma
677100|NCT00884416|glioblastoma|glioblastoma
677101|NCT00884416|gliosarcoma|gliosarcoma
677102|NCT00884416|anaplastic astrocytoma|anaplastic astrocytoma
677103|NCT00884416|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
677104|NCT00884416|anaplastic oligodendroglioma|anaplastic oligodendroglioma
677105|NCT00884416|phase I|phase i
677106|NCT00884416|first line treatment|first line treatment
677107|NCT00884416|sorafenib|sorafenib
677108|NCT00884416|temozolomide|temozolomide
677109|NCT00884416|radiation therapy|radiation therapy
677110|NCT00884416|safety|safety
677111|NCT00884416|tolerability|tolerability
677112|NCT00884416|protein kinase inhibitors|protein kinase inhibitors
677113|NCT00884429|Chest physiotherapy|chest physiotherapy
677114|NCT00884442|Healthy|healthy
751822|NCT01170624|PhD|phd
677115|NCT00884442|Bioavailability|bioavailability
677116|NCT00884442|Nifedipine|nifedipine
677117|NCT00884455|tissue banking, research|tissue banking, research
677118|NCT00884468|Anxiety and depression in patients with psoriatic arthritis|anxiety and depression in patients with psoriatic arthritis
677120|NCT00884494|Insulin resistance|insulin resistance
677121|NCT00884494|Ghrelin|ghrelin
677122|NCT00884520|[F-18]VM4-037|[f-18]vm4-037
677123|NCT00884520|VM4-037|vm4-037
677124|NCT00884520|hypoxia|hypoxia
677125|NCT00884520|CA-IX|ca-ix
677126|NCT00884520|CAIX|caix
677127|NCT00884520|carbonic anhydrase IX|carbonic anhydrase ix
677128|NCT00884520|hypoxia marker|hypoxia marker
677129|NCT00884520|lung cancer|lung cancer
677130|NCT00884520|renal carcinoma|renal carcinoma
677131|NCT00884520|squamous cell carcinoma|squamous cell carcinoma
677132|NCT00884520|hepatic carcinoma|hepatic carcinoma
677133|NCT00884520|head and neck cancer|head and neck cancer
677134|NCT00884520|advanced stage lung cancer|advanced stage lung cancer
677136|NCT00884533|QTc|qtc
677137|NCT00884533|pharmacokinetics|pharmacokinetics
677138|NCT00884533|rosiglitazone XR|rosiglitazone xr
677139|NCT00884533|cardiac conduction|cardiac conduction
677140|NCT00884533|healthy volunteers|healthy volunteers
677141|NCT00884559|Leadership|leadership
677142|NCT00884559|Team building|team building
677143|NCT00884559|Resuscitation|resuscitation
677144|NCT00884598|adult tumors metastatic to brain|adult tumors metastatic to brain
677145|NCT00884598|extensive stage small cell lung cancer|extensive stage small cell lung cancer
677146|NCT00884598|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
677147|NCT00884624|Bowel Diseases|bowel diseases
677148|NCT00884637|HMP|hmp
677149|NCT00884637|CNV|cnv
677150|NCT00884637|AMD|amd
677151|NCT00884637|PHP|php
677152|NCT00884637|HPHP|hphp
677153|NCT00884637|foresee home|foresee home
677154|NCT00884650|Pain|pain
677155|NCT00884650|Pain management|pain management
677156|NCT00884650|Cerebral Palsy|cerebral palsy
677157|NCT00884676|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
677158|NCT00884689|Symbicort SMART|symbicort smart
677159|NCT00884689|Free Combination GCS/LABA treatment|free combination gcs/laba treatment
677160|NCT00884702|Sleep|sleep
677161|NCT00884702|14C-Leucine|14c-leucine
677162|NCT00884702|Cerebral Protein Synthesis|cerebral protein synthesis
677163|NCT00884702|Memory|memory
677164|NCT00884702|Positron Emission Tomography (PET)|positron emission tomography (pet)
677165|NCT00884702|HV|hv
677166|NCT00884702|Healthy Volunteer|healthy volunteer
677167|NCT00884728|Scabies|scabies
677168|NCT00884728|Impetigo|impetigo
677169|NCT00884728|Pyoderma|pyoderma
677170|NCT00884728|Streptococcal infections|streptococcal infections
677171|NCT00884767|neurotoxicity|neurotoxicity
677172|NCT00884767|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
677173|NCT00884767|recurrent colon cancer|recurrent colon cancer
677174|NCT00884767|stage I colon cancer|stage i colon cancer
677175|NCT00884767|stage II colon cancer|stage ii colon cancer
677176|NCT00884767|stage III colon cancer|stage iii colon cancer
677177|NCT00884767|stage IV colon cancer|stage iv colon cancer
677178|NCT00884767|recurrent rectal cancer|recurrent rectal cancer
677179|NCT00884767|stage I rectal cancer|stage i rectal cancer
677180|NCT00884767|stage II rectal cancer|stage ii rectal cancer
677181|NCT00884767|stage III rectal cancer|stage iii rectal cancer
677182|NCT00884767|stage IV rectal cancer|stage iv rectal cancer
677183|NCT00884780|Electronic Diary|electronic diary
677184|NCT00884780|Body Map|body map
677185|NCT00884780|Electronic Measure of Pediatric Pain|electronic measure of pediatric pain
677186|NCT00884793|HIV|hiv
677187|NCT00884793|persistence|persistence
677188|NCT00884793|reservoirs|reservoirs
677189|NCT00884793|residual replication|residual replication
677190|NCT00884793|gut|gut
677191|NCT00884793|gut-associated lymphoid tissue|gut-associated lymphoid tissue
677192|NCT00884793|treatment experienced|treatment experienced
677193|NCT00884806|Contact lenses|contact lenses
677194|NCT00884806|Disinfecting solutions|disinfecting solutions
677195|NCT00884819|polycystic ovary syndrome|polycystic ovary syndrome
677196|NCT00884819|hepatic adiposity|hepatic adiposity
677197|NCT00884819|diabetes|diabetes
677198|NCT00884819|hormones|hormones
677199|NCT00884819|cardiovascular disease|cardiovascular disease
677200|NCT00884832|fecal incontinence|fecal incontinence
677201|NCT00884832|stool leakage|stool leakage
677202|NCT00884832|incontinence|incontinence
677203|NCT00884832|FI|fi
677204|NCT00884832|Urge predominant fecal incontinence|urge predominant fecal incontinence
677205|NCT00884845|PM2734|pm2734
677206|NCT00884845|Tumors|tumors
677207|NCT00884845|PharmaMar|pharmamar
677208|NCT00884845|Erlotinib|erlotinib
677209|NCT00884845|Tarceva|tarceva
677210|NCT00884858|HIV-1|hiv-1
677211|NCT00884858|CD4|cd4
677212|NCT00884858|INR|inr
677213|NCT00884858|HIV-1 infection|hiv-1 infection
677214|NCT00884858|extreme immunological compromission|extreme immunological compromission
677215|NCT00884858|treatment experienced|treatment experienced
677216|NCT00884871|pelvic floor disorders|pelvic floor disorders
677217|NCT00884871|weight loss|weight loss
677218|NCT00884884|Alcohol dependence|alcohol dependence
677219|NCT00884884|alcohol abuse|alcohol abuse
677220|NCT00884884|topiramate|topiramate
677221|NCT00884884|aripiprazole|aripiprazole
677222|NCT00884897|Social Cognition|social cognition
677223|NCT00884897|Schizophrenia|schizophrenia
677224|NCT00884897|Oxytocin|oxytocin
677225|NCT00884910|laryngectomy|laryngectomy
677226|NCT00884910|Provox Vega|provox vega
677227|NCT00884910|voice prosthesis|voice prosthesis
677228|NCT00884936|Skin|skin
677229|NCT00884936|Aging|aging
677230|NCT00884936|Dermogenomics|dermogenomics
677231|NCT00884936|Genetic|genetic
677232|NCT00884936|Biomarker|biomarker
677233|NCT00884936|Dermatology|dermatology
677234|NCT00884949|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
677235|NCT00884949|MPS IV Type A|mps iv type a
677236|NCT00884949|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
677237|NCT00884949|MPS IVA|mps iva
679014|NCT00890721|Analgesia|analgesia
677238|NCT00884949|Morquio A Syndrome|morquio a syndrome
677239|NCT00884949|Lysosomal Storage Disorder|lysosomal storage disorder
677241|NCT00884949|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
677242|NCT00884949|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
677243|NCT00884949|galactose-6-sulfatase|galactose-6-sulfatase
677244|NCT00884949|GALNS|galns
677245|NCT00884949|enzyme replacement therapy|enzyme replacement therapy
677247|NCT00884962|emphysema|emphysema
677248|NCT00884962|aeris|aeris
677249|NCT00884962|PLVR|plvr
677250|NCT00884962|BLVR|blvr
677251|NCT00884962|germany|germany
677252|NCT00884962|treatment|treatment
677253|NCT00884962|device|device
677254|NCT00884962|breathing|breathing
677255|NCT00884975|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
677256|NCT00884975|exacerbations|exacerbations
677257|NCT00884975|quality of life|quality of life
677258|NCT00884975|emphysema|emphysema
677259|NCT00884988|ankle fracture|ankle fracture
677260|NCT00884988|edema|edema
677261|NCT00884988|surgical repair|surgical repair
677262|NCT00884988|homeopathy|homeopathy
677263|NCT00884988|lymphomyosot|lymphomyosot
677264|NCT00885014|Depressive disorder|depressive disorder
677265|NCT00885014|Behavior therapy|behavior therapy
677266|NCT00885014|Workplace|workplace
677267|NCT00885014|Subthreshold depression|subthreshold depression
677268|NCT00885040|Neurofeedback|neurofeedback
677269|NCT00885040|Tourette Syndrome|tourette syndrome
677270|NCT00885040|Healthy Volunteer|healthy volunteer
677271|NCT00885040|Movement Disorder|movement disorder
677272|NCT00885040|Brain Activity|brain activity
677273|NCT00885040|fMRI|fmri
677274|NCT00885040|HV|hv
677275|NCT00885053|Inflammation|inflammation
677276|NCT00885053|Fatty acids, Omega 3|fatty acids, omega 3
677277|NCT00885053|Leukotrienes|leukotrienes
677278|NCT00885053|Adiponectin|adiponectin
677279|NCT00885053|Adipose tissue|adipose tissue
677280|NCT00885053|RNA, Messenger|rna, messenger
677281|NCT00885066|stage III pancreatic cancer|stage iii pancreatic cancer
677282|NCT00885066|stage IV pancreatic cancer|stage iv pancreatic cancer
677283|NCT00885066|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
677284|NCT00885066|recurrent pancreatic cancer|recurrent pancreatic cancer
677285|NCT00885092|Contact lenses|contact lenses
677286|NCT00885092|Disinfecting solutions|disinfecting solutions
677287|NCT00878241|Colon Anastomosis|colon anastomosis
677288|NCT00878241|Rectum Anastomosis|rectum anastomosis
677289|NCT00878241|Intestine|intestine
677290|NCT00878241|Colorectal Surgery|colorectal surgery
677291|NCT00878241|Colorectal Anastomosis|colorectal anastomosis
677292|NCT00878254|Mantle Cell Lymphoma|mantle cell lymphoma
677293|NCT00878254|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
677294|NCT00878254|MCL|mcl
677295|NCT00878254|NHL|nhl
677296|NCT00878267|Cancer|cancer
677297|NCT00878267|Computer Program|computer program
677298|NCT00878267|Palliative Care|palliative care
677299|NCT00878267|Patient-Reported Outcomes|patient-reported outcomes
677300|NCT00878267|PRO|pro
677301|NCT00878267|Palliative and Hospice Care Practice|palliative and hospice care practice
677302|NCT00878267|Electronic Health Record|electronic health record
677303|NCT00878267|EHR|ehr
677304|NCT00878267|Interview|interview
677305|NCT00878293|analgesic|analgesic
677306|NCT00878293|diabetes mellitus|diabetes mellitus
677307|NCT00878293|chronic neuropathic pain|chronic neuropathic pain
677308|NCT00878293|painful polyneuropathy caused by diabetes mellitus type I or II|painful polyneuropathy caused by diabetes mellitus type i or ii
677309|NCT00878306|Treatment of drug dependency with HIV medications|treatment of drug dependency with hiv medications
677310|NCT00878306|HIV|hiv
677311|NCT00878319|Humeral|humeral
677312|NCT00878319|diaphyseal (mid-shaft)|diaphyseal (mid-shaft)
677313|NCT00878319|fracture|fracture
677314|NCT00878319|operative|operative
677315|NCT00878319|non-operative|non-operative
677316|NCT00878332|edentulous|edentulous
677317|NCT00878332|fixed dental rehabilitation|fixed dental rehabilitation
677318|NCT00878332|insufficient bone height|insufficient bone height
751823|NCT01170624|EGM|egm
677319|NCT00878332|Partially edentulous patients|partially edentulous patients
677320|NCT00878332|Patients interested in fixed non removable dental rehabilitation by dental implants.|patients interested in fixed non removable dental rehabilitation by dental implants.
677321|NCT00878332|The recipient bone with insufficient bone height for dental implant insertion.|the recipient bone with insufficient bone height for dental implant insertion.
677322|NCT00878332|Adult patients|adult patients
677323|NCT00878345|Pediatric sedation|pediatric sedation
677324|NCT00878345|Pentobarbital|pentobarbital
677325|NCT00878345|Dexmedetomidine|dexmedetomidine
677326|NCT00878345|Procedural sedation in children|procedural sedation in children
677327|NCT00878358|Osteoarthritis|osteoarthritis
677328|NCT00878358|Total knee replacement|total knee replacement
677329|NCT00878371|morphine|morphine
677330|NCT00878371|blood brain barrier|blood brain barrier
677331|NCT00878371|surgery induced peripheral inflammatory response|surgery induced peripheral inflammatory response
677332|NCT00878384|Atrial Fibrillation|atrial fibrillation
677333|NCT00878384|Heart Failure|heart failure
677334|NCT00878384|Heart Rate Control|heart rate control
677335|NCT00878384|Catheter Ablation|catheter ablation
677336|NCT00885105|Fluzone® vaccine|fluzone® vaccine
677337|NCT00885105|Influenza|influenza
677338|NCT00885131|Reward Processing|reward processing
677339|NCT00885131|Motor Cortex|motor cortex
677340|NCT00885131|HV|hv
677341|NCT00885131|Healthy Volunteer|healthy volunteer
677342|NCT00885144|Stunting|stunting
677343|NCT00885144|Growth failure|growth failure
677344|NCT00885144|Malnutrition|malnutrition
677345|NCT00885144|Lipid based nutrient supplement|lipid based nutrient supplement
677346|NCT00885144|LNS|lns
677347|NCT00885144|Prevention|prevention
677348|NCT00885144|Malawi|malawi
677349|NCT00885144|Sub-Saharan Africa|sub-saharan africa
677350|NCT00885144|Dietary supplementation|dietary supplementation
677351|NCT00885157|Poliomyelitis|poliomyelitis
677352|NCT00885157|intradermal|intradermal
677353|NCT00885183|breast cancer|breast cancer
677354|NCT00885183|chemotherapy|chemotherapy
677355|NCT00885183|adjuvant therapy|adjuvant therapy
677356|NCT00885183|acupuncture|acupuncture
677357|NCT00885183|fatigue|fatigue
677358|NCT00885183|Early stage breast cancer patients|early stage breast cancer patients
677359|NCT00885196|Psoriasis|psoriasis
677360|NCT00885196|plaque psoriasis|plaque psoriasis
677361|NCT00885196|inflammatory skin disease|inflammatory skin disease
677362|NCT00885196|scaly patches|scaly patches
677363|NCT00885196|AEB071|aeb071
677364|NCT00885209|Colonic Diseases|colonic diseases
677365|NCT00885222|Parkinson's disease|parkinson's disease
677366|NCT00885222|Major depressive disorder|major depressive disorder
677367|NCT00885222|Deep brain stimulation|deep brain stimulation
677368|NCT00885235|Bowel Diseases|bowel diseases
677369|NCT00885248|pancreatic cancer|pancreatic cancer
677370|NCT00885248|integrated PET-CT|integrated pet-ct
677371|NCT00885261|chronic pain and metabolic syndrome|chronic pain and metabolic syndrome
677372|NCT00885287|uncomplicated malaria|uncomplicated malaria
677373|NCT00885287|HIV/AIDS|hiv/aids
677374|NCT00885287|drug interactions|drug interactions
677375|NCT00885287|antimalarial drug efficacy|antimalarial drug efficacy
677376|NCT00885287|antiretrovirals|antiretrovirals
677377|NCT00885287|pharmacovigilance|pharmacovigilance
677378|NCT00885287|Tanzania|tanzania
677379|NCT00885313|NAFLD|nafld
677380|NCT00885313|NASH|nash
677381|NCT00885313|fibrosis|fibrosis
677382|NCT00885326|recurrent neuroblastoma|recurrent neuroblastoma
677383|NCT00885339|Colonic Diseases|colonic diseases
677384|NCT00885365|cystic fibrosis|cystic fibrosis
677385|NCT00885365|P. aeruginosa|p. aeruginosa
677386|NCT00885365|tobramycin|tobramycin
677387|NCT00885391|Atrial Fibrillation|atrial fibrillation
677388|NCT00885391|Cardioversion|cardioversion
677389|NCT00885391|Direct Current Cardioversion|direct current cardioversion
677390|NCT00885391|QT Interval|qt interval
677391|NCT00885404|chloride|chloride
677392|NCT00885404|acidosis|acidosis
677393|NCT00885417|Helicobacter pylori|helicobacter pylori
677394|NCT00885417|sequential therapy|sequential therapy
677395|NCT00885417|levofloxacin|levofloxacin
677396|NCT00885417|clarithromycin|clarithromycin
677397|NCT00885417|rescue|rescue
677398|NCT00885417|salvage|salvage
677399|NCT00885417|treatment failure|treatment failure
677400|NCT00885417|For those who fail from one standard eradication therapy for H. pylori infection|for those who fail from one standard eradication therapy for h. pylori infection
677401|NCT00885430|colonoscopy|colonoscopy
677402|NCT00885430|preparation|preparation
677403|NCT00885586|herpes zoster|herpes zoster
677404|NCT00885586|neuropathic pain|neuropathic pain
677405|NCT00885586|acupuncture|acupuncture
677406|NCT00885586|randomised controlled trial|randomised controlled trial
677407|NCT00885586|acute herpes zoster|acute herpes zoster
677408|NCT00885599|gingivitis|gingivitis
677409|NCT00885599|natural remedy|natural remedy
677410|NCT00885599|inflammation|inflammation
677411|NCT00885599|C-reactive protein|c-reactive protein
677412|NCT00885599|mouthwash|mouthwash
677413|NCT00885612|CHD-Risk|chd-risk
677414|NCT00885612|Breast Cancer|breast cancer
677415|NCT00885612|Aromatase Inhibitors|aromatase inhibitors
677416|NCT00885612|postmenopausal early breast cancer|postmenopausal early breast cancer
677417|NCT00885625|invasive pneumococcal disease|invasive pneumococcal disease
677418|NCT00885625|pneumococcal conjugated vaccine|pneumococcal conjugated vaccine
677420|NCT00885638|Insulin secretion|insulin secretion
677421|NCT00885638|Macronutrients|macronutrients
677423|NCT00885651|catecholamines|catecholamines
677424|NCT00885651|metoprolole|metoprolole
677425|NCT00885651|healthy subjects|healthy subjects
677426|NCT00885651|physiological stress|physiological stress
677427|NCT00885664|HIV|hiv
677428|NCT00885664|immune reconstitution|immune reconstitution
677429|NCT00885664|treatment naive|treatment naive
677430|NCT00885690|Schizophrenia|schizophrenia
677431|NCT00885690|Antipsychotic|antipsychotic
677432|NCT00885690|Cognition|cognition
677433|NCT00885703|CM|cm
677434|NCT00885703|HIV|hiv
677435|NCT00885703|Meningitis|meningitis
679540|NCT00892684|Cytokines|cytokines
677436|NCT00885729|Cartilage defect|cartilage defect
677437|NCT00885729|chondrocytes|chondrocytes
677438|NCT00885729|mesenchymal stem cells (MSC)|mesenchymal stem cells (msc)
677439|NCT00885729|femoral condyle|femoral condyle
677440|NCT00885729|knee|knee
677441|NCT00885742|Hereditary Factor XIII deficiency|hereditary factor xiii deficiency
677442|NCT00885742|Factor XIII|factor xiii
677443|NCT00885768|RAS(renal Artery Stenosis)|ras(renal artery stenosis)
677444|NCT00885768|Atherosclerosis|atherosclerosis
677445|NCT00885768|angiography|angiography
677446|NCT00885794|Clinically Significant Diabetic Macular Edema|clinically significant diabetic macular edema
677447|NCT00885794|Focal Laser|focal laser
677448|NCT00885794|GRID-Laser|grid-laser
677449|NCT00885794|Ranibizumab|ranibizumab
677450|NCT00885794|Lucentis|lucentis
677451|NCT00885794|Microperimetry|microperimetry
677452|NCT00885794|High-Definition OCT|high-definition oct
677453|NCT00885794|Randomized|randomized
677454|NCT00885794|Observer-Blinded|observer-blinded
677455|NCT00885794|Ineffective Treatment with Focal Laser or GRID-Laser|ineffective treatment with focal laser or grid-laser
677456|NCT00885807|ADHD|adhd
677457|NCT00885807|WFIRS|wfirs
677458|NCT00885807|WSR|wsr
677459|NCT00885820|Kidney Transplantation|kidney transplantation
677460|NCT00885820|Tacrolimus|tacrolimus
677461|NCT00885820|Immunosuppression|immunosuppression
677462|NCT00885820|Graft Survival|graft survival
677463|NCT00885833|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
677464|NCT00885833|HSCT|hsct
677465|NCT00885846|Qigong|qigong
677466|NCT00885846|Breathing management|breathing management
677467|NCT00885846|Glucose|glucose
677468|NCT00885885|Colorectal Cancer|colorectal cancer
677469|NCT00885885|Panitumumab|panitumumab
677470|NCT00885885|FOLFOX-4|folfox-4
677471|NCT00885885|FOLFIRI|folfiri
677472|NCT00885898|Respiratory Insufficiency|respiratory insufficiency
677473|NCT00885898|Respiratory Failure|respiratory failure
677474|NCT00885911|Intubating laryngeal airway|intubating laryngeal airway
677475|NCT00885911|pediatric|pediatric
677476|NCT00885911|observational study|observational study
677477|NCT00885924|postoperative Hemorrhage|postoperative hemorrhage
677478|NCT00885924|Hemorrhage|hemorrhage
677479|NCT00885924|Vasopressin|vasopressin
677480|NCT00885924|Blood Loss, Surgical|blood loss, surgical
677481|NCT00885937|Dexpanthenol|dexpanthenol
677482|NCT00885937|Safety,|safety,
677483|NCT00885937|New formulation|new formulation
677484|NCT00885937|Topical administration|topical administration
677485|NCT00885950|colorectal liver metastases|colorectal liver metastases
677486|NCT00885950|neoadjuvant chemotherapy|neoadjuvant chemotherapy
677487|NCT00885950|oxaliplatin|oxaliplatin
677488|NCT00885950|sinusoidal obstruction syndrome|sinusoidal obstruction syndrome
677489|NCT00885950|anticoagulants|anticoagulants
677490|NCT00885989|SLV338|slv338
677491|NCT00885989|phase I|phase i
677492|NCT00885989|healthy volunteers|healthy volunteers
677493|NCT00886002|Healthy volunteers|healthy volunteers
677494|NCT00886015|Trachoma|trachoma
677495|NCT00886015|trichiasis|trichiasis
677496|NCT00886015|bilamellar tarsal rotation procedure|bilamellar tarsal rotation procedure
677497|NCT00886028|Malignant pleural mesothelioma|malignant pleural mesothelioma
677498|NCT00886028|Liposomal doxorubicin|liposomal doxorubicin
677499|NCT00886028|Progression free survival|progression free survival
677500|NCT00886028|Patients who received LD 60mg/m2 plus cisplatin 80 mg/m2 every 4 weeks for 6 cycles|patients who received ld 60mg/m2 plus cisplatin 80 mg/m2 every 4 weeks for 6 cycles
677501|NCT00886028|Patients with epithelial, sarcomatoid or biphasic histological confirmed diagnosis of MPM|patients with epithelial, sarcomatoid or biphasic histological confirmed diagnosis of mpm
677502|NCT00886041|laparoscopy|laparoscopy
677503|NCT00886041|unexplained infertility|unexplained infertility
677504|NCT00886054|Transcranial Doppler|transcranial doppler
677505|NCT00886054|Transcranial color-coded duplex sonography|transcranial color-coded duplex sonography
677506|NCT00886054|Neurocritical patients|neurocritical patients
677507|NCT00886067|AZD1446|azd1446
677508|NCT00886067|PET examination|pet examination
677509|NCT00886080|Atrial fibrillation|atrial fibrillation
677510|NCT00886080|Health related Quality of Life|health related quality of life
677511|NCT00886080|Add-on surgery|add-on surgery
677512|NCT00886080|Ablation|ablation
677513|NCT00886080|Randomised controlled trial|randomised controlled trial
677514|NCT00886080|SF-36|sf-36
677515|NCT00886080|EuroQoL|euroqol
677516|NCT00886080|MFI-20|mfi-20
677517|NCT00886093|pharmacokinetics, single dose, crossover, fed vs fasted state|pharmacokinetics, single dose, crossover, fed vs fasted state
677518|NCT00886106|Capsaicin|capsaicin
677519|NCT00886106|Remifentanil|remifentanil
677520|NCT00886106|Hyperalgesia|hyperalgesia
677521|NCT00886132|Phase 2 Study|phase 2 study
677522|NCT00886132|Sunitinib|sunitinib
677523|NCT00886132|Recurrent|recurrent
677524|NCT00886132|Metastatic|metastatic
677525|NCT00886132|Adenoid Cystic Carcinoma|adenoid cystic carcinoma
677526|NCT00886132|Salivary Glands|salivary glands
677527|NCT00886132|Metastasis|metastasis
677528|NCT00886145|Spinal Cord Injuries|spinal cord injuries
677529|NCT00886145|Mechanical Stimulation|mechanical stimulation
677530|NCT00886145|Vibration Plate|vibration plate
677531|NCT00886158|Organ Transplants|organ transplants
677532|NCT00886171|social skills|social skills
677533|NCT00886171|physical activity|physical activity
677534|NCT00886171|peer relationships|peer relationships
677535|NCT00886171|childhood obesity|childhood obesity
677536|NCT00886171|changes in physical activity|changes in physical activity
677537|NCT00886171|changes in social involvement|changes in social involvement
677538|NCT00886184|Hypothermia|hypothermia
677539|NCT00886184|Cardiac arrest|cardiac arrest
677540|NCT00886184|Biomarkers|biomarkers
677541|NCT00886184|Pre hospital cardiac arrest|pre hospital cardiac arrest
677542|NCT00886197|reflux|reflux
677543|NCT00886197|GERD|gerd
677544|NCT00886210|drain|drain
677545|NCT00886210|laparoscopic cholecystectomy|laparoscopic cholecystectomy
677546|NCT00886210|pneumoperitonum|pneumoperitonum
677547|NCT00886223|vaginal vault prolapse repair|vaginal vault prolapse repair
677548|NCT00886223|robot-assisted laparoscopic sacropexy|robot-assisted laparoscopic sacropexy
677549|NCT00886223|robot-assisted laparoscopic sacrocolpopexy|robot-assisted laparoscopic sacrocolpopexy
677550|NCT00886223|robotic laparoscopic sacropexy|robotic laparoscopic sacropexy
677551|NCT00886236|Gastric Bypass|gastric bypass
677552|NCT00886236|Gabapentin|gabapentin
677553|NCT00886236|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
677554|NCT00886236|Analgesics, Opioids|analgesics, opioids
677555|NCT00886236|Sleep Apnea, Obstructive|sleep apnea, obstructive
677556|NCT00886236|Respiratory Depression|respiratory depression
677557|NCT00886236|Oximetry|oximetry
677558|NCT00886249|Vision|vision
677560|NCT00886249|Cataract|cataract
677561|NCT00886262|liver transplantation|liver transplantation
677562|NCT00886262|vasopressin|vasopressin
677563|NCT00886262|renal function|renal function
677564|NCT00886262|hypotension|hypotension
677565|NCT00886262|creatinine|creatinine
677566|NCT00886262|urine output|urine output
677567|NCT00886262|diuretics|diuretics
677568|NCT00886262|vasopressors|vasopressors
677569|NCT00886262|hemodynamic stability|hemodynamic stability
677570|NCT00886275|Postoperative sedation in intensive care|postoperative sedation in intensive care
677571|NCT00886301|overweight|overweight
677572|NCT00886301|obesity|obesity
677573|NCT00886301|steatohepatitis|steatohepatitis
677574|NCT00886301|ectopic fat|ectopic fat
677575|NCT00886314|children|children
677576|NCT00886314|surgery|surgery
677577|NCT00886314|anxiety|anxiety
677578|NCT00886327|Colonic capsule endoscopy|colonic capsule endoscopy
677579|NCT00886327|Crohn's disease|crohn's disease
677580|NCT00886327|Capsule endoscopy|capsule endoscopy
677581|NCT00886340|diabetes prevention, primary care|diabetes prevention, primary care
677582|NCT00886353|RAS|ras
677583|NCT00886353|ACE2|ace2
677584|NCT00886353|Cardiovascular|cardiovascular
677585|NCT00886353|Pulmonary|pulmonary
677586|NCT00886353|Angiotensin II|angiotensin ii
677587|NCT00886353|Angiotensin 1-7|angiotensin 1-7
677588|NCT00886366|Type II Diabetes|type ii diabetes
677589|NCT00886379|vitamin d|vitamin d
677590|NCT00886379|children|children
677591|NCT00886379|Mongolia|mongolia
677592|NCT00886392|Clinically Significant Macular Edema|clinically significant macular edema
677593|NCT00886392|Diabetic Macular Edema|diabetic macular edema
677594|NCT00886392|Optical Coherence Tomography|optical coherence tomography
677595|NCT00886392|Diabetic Retinopathy|diabetic retinopathy
677596|NCT00886392|Severity|severity
677597|NCT00886405|Nitroglycerin|nitroglycerin
677598|NCT00886405|Locally advanced non small-cell lung cancer|locally advanced non small-cell lung cancer
677599|NCT00886405|Vascular endothelial growth factor|vascular endothelial growth factor
677600|NCT00886405|Hypoxia Inducible Factor|hypoxia inducible factor
677601|NCT00886405|Clinical stage IIIA and/or IIIB (without pleural effusion)|clinical stage iiia and/or iiib (without pleural effusion)
677602|NCT00886431|IVF|ivf
677603|NCT00886431|embryo cryopreservation|embryo cryopreservation
677604|NCT00886431|vitrification|vitrification
677605|NCT00886431|slow cooling|slow cooling
677606|NCT00886431|slow freezing|slow freezing
677607|NCT00886431|surplus embryos|surplus embryos
677608|NCT00886431|Human Reproduction|human reproduction
677609|NCT00886457|Biopsy proven cancer, which is metastatic or unresectable|biopsy proven cancer, which is metastatic or unresectable
677610|NCT00886470|cytokines|cytokines
677611|NCT00886470|pain|pain
677612|NCT00886470|scarring|scarring
677613|NCT00886470|vascularity|vascularity
677614|NCT00886483|Neurofeedback|neurofeedback
677615|NCT00886496|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
677616|NCT00886496|fever, sweats, and hot flashes|fever, sweats, and hot flashes
677617|NCT00886496|neutropenia|neutropenia
677618|NCT00886496|infection|infection
677780|NCT00886925|Albumin|albumin
677619|NCT00886496|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
677620|NCT00886496|stage I and II childhood small noncleaved cell lymphoma|stage i and ii childhood small noncleaved cell lymphoma
677621|NCT00886496|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
677622|NCT00886496|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
677623|NCT00886496|stage III and IV childhood small noncleaved cell lymphoma|stage iii and iv childhood small noncleaved cell lymphoma
679847|NCT00894010|Epilepsy|epilepsy
677624|NCT00886496|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
677625|NCT00886496|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
677626|NCT00886496|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
677627|NCT00886496|stage I and II childhood lymphoblastic lymphoma|stage i and ii childhood lymphoblastic lymphoma
677628|NCT00886496|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
677629|NCT00886496|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
677630|NCT00886496|stage III and IV childhood lymphoblastic lymphoma|stage iii and iv childhood lymphoblastic lymphoma
677631|NCT00886496|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
677632|NCT00886496|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
677633|NCT00886496|childhood Burkitt lymphoma|childhood burkitt lymphoma
677634|NCT00886496|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
677635|NCT00886496|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
677636|NCT00886496|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
677637|NCT00886496|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
677638|NCT00886496|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
677639|NCT00886496|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
677640|NCT00886496|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
677641|NCT00886496|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
677642|NCT00886496|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
677643|NCT00886496|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
677644|NCT00886496|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
677645|NCT00886496|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
677646|NCT00886496|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
677647|NCT00886496|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
677648|NCT00886496|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
677649|NCT00886496|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
677650|NCT00886496|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
677651|NCT00886496|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
677652|NCT00886496|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
677653|NCT00886496|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
677654|NCT00886496|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
677655|NCT00886496|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
677656|NCT00886496|stage III and IV childhood large cell lymphoma|stage iii and iv childhood large cell lymphoma
677657|NCT00886496|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
677658|NCT00886496|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
677659|NCT00886509|Coronary Artery Disease|coronary artery disease
677660|NCT00886509|Stable|stable
677661|NCT00886509|Coronary Collaterals|coronary collaterals
677662|NCT00886509|Therapeutic Collateral Promotion (TCP)|therapeutic collateral promotion (tcp)
677663|NCT00886522|Anti-thymocyte globulin Fresenius|anti-thymocyte globulin fresenius
677664|NCT00886522|Busulfan|busulfan
677665|NCT00886522|Cord blood|cord blood
677666|NCT00886522|Cyclophosphamide|cyclophosphamide
677667|NCT00886522|Fludarabine|fludarabine
677668|NCT00886522|Human Leucocyte Antigen|human leucocyte antigen
677669|NCT00886522|Hematopoietic Stem Cell|hematopoietic stem cell
677670|NCT00886522|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
677671|NCT00886522|Graft-versus-Host-Disease|graft-versus-host-disease
677672|NCT00886522|Graft-versus-Host-Disease prophylaxis|graft-versus-host-disease prophylaxis
677673|NCT00886522|Intrabone infusion|intrabone infusion
677674|NCT00886522|Thiotepa|thiotepa
677675|NCT00886535|breast cancer|breast cancer
677676|NCT00886535|hot flashes|hot flashes
677677|NCT00886535|tamoxifen|tamoxifen
751824|NCT01170624|CRT-D|crt-d
677678|NCT00886561|HIV prevention, female sex workers|hiv prevention, female sex workers
677679|NCT00886561|HIV seronegativity|hiv seronegativity
677680|NCT00886574|Cilostazol versus Aspirin|cilostazol versus aspirin
677681|NCT00886574|Anti-PLT drug|anti-plt drug
677773|NCT00886899|coronary artery disease|coronary artery disease
677682|NCT00886574|Primary Prevention of Atherosclerotic Events|primary prevention of atherosclerotic events
677684|NCT00886574|Intima media thickness (IMT)|intima media thickness (imt)
677685|NCT00886587|eczema|eczema
677686|NCT00886626|Obesity|obesity
677781|NCT00886938|tinnitus|tinnitus
677687|NCT00886626|Impaired Glucose Tolerance|impaired glucose tolerance
677688|NCT00886626|Children|children
677689|NCT00886639|COPD III/IV|copd iii/iv
677690|NCT00886639|Oxygen Supply|oxygen supply
677691|NCT00886639|Six-Minute-Walking-Test|six-minute-walking-test
677692|NCT00886639|Oxygen Responder|oxygen responder
677693|NCT00886652|Scoliosis|scoliosis
677694|NCT00886652|Muscle Strength|muscle strength
677695|NCT00886652|Respiratory function tests|respiratory function tests
677696|NCT00886652|Exercise therapy|exercise therapy
677697|NCT00886665|Diabetic Neuropathy|diabetic neuropathy
680248|NCT00896285|chest tube|chest tube
677698|NCT00886665|Nerve Conduction Studies|nerve conduction studies
677699|NCT00886665|Clinical Trial|clinical trial
677700|NCT00886678|Non-Small Cell Lung Cancer|non-small cell lung cancer
677701|NCT00886678|pemetrexed|pemetrexed
677702|NCT00886678|radiation|radiation
677703|NCT00886691|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
677704|NCT00886691|recurrent fallopian tube cancer|recurrent fallopian tube cancer
677705|NCT00886691|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
677706|NCT00886704|Omega-3 fatty acids|omega-3 fatty acids
677707|NCT00886704|dietary supplementation|dietary supplementation
677708|NCT00886704|atherosclerosis|atherosclerosis
677709|NCT00886717|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
677710|NCT00886717|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
677711|NCT00886717|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
677712|NCT00886717|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
677713|NCT00886717|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
677714|NCT00886717|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
677715|NCT00886717|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
677716|NCT00886717|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
677717|NCT00886730|Depressive disorder|depressive disorder
677718|NCT00886730|Primary care|primary care
677719|NCT00886730|Internet|internet
677720|NCT00886730|Social support|social support
677721|NCT00886730|Feasibility|feasibility
677722|NCT00886756|Phase I|phase i
677723|NCT00886756|Japanese healthy volunteer|japanese healthy volunteer
677724|NCT00886756|AZD8529|azd8529
677725|NCT00886769|Flare|flare
677726|NCT00886769|arthritis|arthritis
677727|NCT00886769|IL-1beta antagonist|il-1beta antagonist
677728|NCT00886769|systemic juvenile idiopathic arthritis|systemic juvenile idiopathic arthritis
677729|NCT00886769|Juvenile Rheumatoid|juvenile rheumatoid
677730|NCT00886769|Systemic juvenile idiopathic arthritis with active flare|systemic juvenile idiopathic arthritis with active flare
677731|NCT00886782|Advanced and/or Metastatic solid cancers|advanced and/or metastatic solid cancers
677732|NCT00886795|hives|hives
677733|NCT00886795|rash|rash
677734|NCT00886795|pruritis|pruritis
677735|NCT00886808|DME, Diabetic Retinopathy, Diabetic Macular Edema|dme, diabetic retinopathy, diabetic macular edema
677736|NCT00886821|Phase 1 Type 2 diabetes CVX-096 diabetes mellitus|phase 1 type 2 diabetes cvx-096 diabetes mellitus
677737|NCT00886821|adult-onset diabetes mellitus|adult-onset diabetes mellitus
677738|NCT00886821|non-insulin dependent|non-insulin dependent
677739|NCT00886834|IUD insertion|iud insertion
677740|NCT00886834|Nulliparous women|nulliparous women
677741|NCT00886834|Contraception|contraception
677742|NCT00886834|Family Planning|family planning
677743|NCT00886834|IUD insertion in nulliparous women|iud insertion in nulliparous women
677744|NCT00886847|Lung|lung
677745|NCT00886847|Lymphadenopathy|lymphadenopathy
677746|NCT00886847|Enlarged hilar or/and mediastinal lymph adenopathy|enlarged hilar or/and mediastinal lymph adenopathy
677747|NCT00886847|Benign|benign
677748|NCT00886847|Malignant|malignant
677749|NCT00886847|Mediastinal lymph nodes|mediastinal lymph nodes
677750|NCT00886847|Hilar lymph nodes|hilar lymph nodes
677751|NCT00886847|Fine Needle Aspiration|fine needle aspiration
677752|NCT00886847|FNA|fna
677753|NCT00886847|Fine Needle Capillary Sampling|fine needle capillary sampling
677754|NCT00886847|FNC|fnc
677755|NCT00886847|Endobronchial Ultrasound-Guided Biopsy|endobronchial ultrasound-guided biopsy
677756|NCT00886847|EBUS|ebus
677757|NCT00886847|Tissue Sample|tissue sample
677758|NCT00886847|Suction|suction
677759|NCT00886860|Efficacy|efficacy
677760|NCT00886860|Cervical ripening/Labor induction|cervical ripening/labor induction
677761|NCT00886860|Titrated oral misoprostol/Conventional oral misoprostol|titrated oral misoprostol/conventional oral misoprostol
677762|NCT00886860|Term pregnancy|term pregnancy
677763|NCT00886873|Uterine fibroids|uterine fibroids
677764|NCT00886873|Mifepristone|mifepristone
677765|NCT00886873|Antiprogestins|antiprogestins
677766|NCT00886886|MDMA|mdma
677767|NCT00886886|norepinephrine|norepinephrine
677768|NCT00886886|Ecstasy|ecstasy
677769|NCT00886886|stimulant|stimulant
677771|NCT00886899|chronic total occlusion|chronic total occlusion
677772|NCT00886899|CAD|cad
677774|NCT00886899|interventional cardiology|interventional cardiology
677775|NCT00886899|revascularization|revascularization
677776|NCT00886899|recanalization|recanalization
677777|NCT00886912|mountain sickness|mountain sickness
677778|NCT00886925|Hepatic encephalopathy|hepatic encephalopathy
677779|NCT00886925|Cirrhosis|cirrhosis
677782|NCT00886964|HBV vaccine|hbv vaccine
677783|NCT00886964|HIV children|hiv children
677784|NCT00886964|immune recovery|immune recovery
677785|NCT00886964|HBV antibody|hbv antibody
677786|NCT00886964|Intradermal|intradermal
677787|NCT00886964|Intramuscular|intramuscular
677788|NCT00886964|antibody response after HBV vaccine|antibody response after hbv vaccine
677789|NCT00886964|treatment experienced|treatment experienced
677790|NCT00886977|ALS|als
677791|NCT00886990|single- and double-boosted PI|single- and double-boosted pi
677792|NCT00886990|second line regimen|second line regimen
677793|NCT00886990|NNRTI failure|nnrti failure
677794|NCT00886990|HIV-infected children|hiv-infected children
677795|NCT00886990|Compare virological efficacy and safety of single- or double-boosted PI regimens as second line therapy in children with NNRTI-based treatment failure|compare virological efficacy and safety of single- or double-boosted pi regimens as second line therapy in children with nnrti-based treatment failure
677796|NCT00886990|treatment experienced|treatment experienced
677797|NCT00887003|epidural|epidural
677798|NCT00887003|volume|volume
677799|NCT00887003|dose|dose
677800|NCT00887003|pain relief|pain relief
677801|NCT00887003|steroid|steroid
677802|NCT00887029|Topical prostaglandin analogue|topical prostaglandin analogue
677803|NCT00887029|glaucoma|glaucoma
677804|NCT00887029|POAG|poag
677805|NCT00887029|OHT|oht
677806|NCT00887029|OAG|oag
677807|NCT00887029|ocular hypertension|ocular hypertension
677808|NCT00887029|fixed combination protaglandin analogue therapy|fixed combination protaglandin analogue therapy
677809|NCT00887029|DuoTrav|duotrav
677810|NCT00887029|timolol|timolol
677811|NCT00887029|travoprost|travoprost
677812|NCT00887029|24 hour post dose|24 hour post dose
677813|NCT00887029|IOP|iop
677814|NCT00887029|dosing preference|dosing preference
677815|NCT00887042|Acute myeloid leukemia|acute myeloid leukemia
677816|NCT00887042|Cord blood transplantation|cord blood transplantation
677817|NCT00887042|Pediatric|pediatric
677818|NCT00887068|Leukemia|leukemia
677819|NCT00887068|Acute myelogenous leukemia|acute myelogenous leukemia
677820|NCT00887068|AML|aml
677821|NCT00887068|Myelodysplastic syndrome|myelodysplastic syndrome
677822|NCT00887068|MDS|mds
677823|NCT00887068|Remission|remission
677824|NCT00887068|Allogeneic stem cell transplant|allogeneic stem cell transplant
677825|NCT00887068|Allotx|allotx
677826|NCT00887068|Azacitidine|azacitidine
677827|NCT00887068|5-Azacitidine|5-azacitidine
677828|NCT00887068|5-aza|5-aza
677829|NCT00887068|Vidaza|vidaza
677830|NCT00887068|5-AZC|5-azc
677831|NCT00887068|AZA-CR|aza-cr
677832|NCT00887068|Ladakamycin|ladakamycin
677833|NCT00887068|NSC-102816|nsc-102816
677834|NCT00887081|antiviral treatment in hemoglobinopathies|antiviral treatment in hemoglobinopathies
677835|NCT00887081|management of chronic viral hepatitis C infection|management of chronic viral hepatitis c infection
677836|NCT00887081|antiviral treatment|antiviral treatment
677837|NCT00887094|Diabetes mellitus|diabetes mellitus
677838|NCT00887094|Exercise|exercise
677839|NCT00887094|Endurance|endurance
677840|NCT00887094|Resistance|resistance
677841|NCT00887094|Continuous glucose monitoring system|continuous glucose monitoring system
677842|NCT00887120|Second line treatment|second line treatment
677843|NCT00887120|therapeutic drug monitoring|therapeutic drug monitoring
677844|NCT00887120|Asia|asia
677845|NCT00887120|LPV|lpv
677846|NCT00887120|children|children
677847|NCT00887120|pharmacokinetic|pharmacokinetic
677848|NCT00887120|To study the pharmacokinetics of low-dose and standard dose, lopinavir/ritonavir in Protease inhibitor (PI)- naive HIV-1 infected Thai patients.|to study the pharmacokinetics of low-dose and standard dose, lopinavir/ritonavir in protease inhibitor (pi)- naive hiv-1 infected thai patients.
677849|NCT00887120|To study clinical and immunological efficacy after 48-weeks of lopinavir/ritonavir-based antiretroviral therapy in PI naive HIV-1 infected Thai patients.|to study clinical and immunological efficacy after 48-weeks of lopinavir/ritonavir-based antiretroviral therapy in pi naive hiv-1 infected thai patients.
677850|NCT00887146|adult anaplastic astrocytoma|adult anaplastic astrocytoma
677851|NCT00887146|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
677852|NCT00887146|adult mixed glioma|adult mixed glioma
677853|NCT00887172|Acute upper respiratory tract infections|acute upper respiratory tract infections
677854|NCT00887185|Surgical Simulation|surgical simulation
677855|NCT00887185|Surgical skills training|surgical skills training
677856|NCT00887185|Temporal bone surgery|temporal bone surgery
677857|NCT00887185|Computer simulation|computer simulation
677858|NCT00887198|Prostate cancer|prostate cancer
677859|NCT00887198|Abiraterone acetate|abiraterone acetate
677860|NCT00887198|CB7630|cb7630
677861|NCT00887198|CRPC|crpc
677862|NCT00887198|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
677863|NCT00887198|hormone refractory prostate cancer|hormone refractory prostate cancer
677864|NCT00887211|stent|stent
677865|NCT00887211|coronary artery disease|coronary artery disease
677866|NCT00887224|Major Depressive Disorder|major depressive disorder
677867|NCT00887237|Heart failure|heart failure
677868|NCT00887237|Cardiac resynchronization|cardiac resynchronization
677869|NCT00887237|Triple site ventricular pacing|triple site ventricular pacing
677870|NCT00887276|Ampicillin|ampicillin
677871|NCT00887276|Amoxicillin|amoxicillin
677872|NCT00887276|Moxifloxacin|moxifloxacin
677873|NCT00887276|Community-Acquired Pneumonia|community-acquired pneumonia
677874|NCT00887315|NSCLC|nsclc
677875|NCT00887315|Metastatic Stage IV NSCLC|metastatic stage iv nsclc
677876|NCT00887315|Limited Volume Stage IV Non-small Cell Lung Cancer|limited volume stage iv non-small cell lung cancer
677877|NCT00887328|ischemic stroke|ischemic stroke
677878|NCT00887328|ischemic penumbra|ischemic penumbra
680249|NCT00896285|cancer|cancer
677879|NCT00887328|magnetic resonance imaging|magnetic resonance imaging
677881|NCT00887328|diffusion imaging|diffusion imaging
677882|NCT00887328|DWI|dwi
677883|NCT00887328|perfusion imaging|perfusion imaging
677884|NCT00887328|PWI|pwi
677885|NCT00887328|thrombolysis|thrombolysis
677886|NCT00887328|alteplase|alteplase
677887|NCT00887328|tPA|tpa
677888|NCT00887328|EPITHET|epithet
677889|NCT00887354|Low bone mass|low bone mass
677890|NCT00887354|Recent pertrochanteric hip fracture|recent pertrochanteric hip fracture
677891|NCT00887367|Healthy volunteers|healthy volunteers
677892|NCT00887367|Substance dependence|substance dependence
677893|NCT00887367|Alcohol dependence|alcohol dependence
677894|NCT00887380|Breast Cancer|breast cancer
677895|NCT00887380|Timing of Radiotherapy|timing of radiotherapy
677896|NCT00887380|Local control|local control
677897|NCT00887393|morbid obesity|morbid obesity
677898|NCT00887393|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
677899|NCT00887393|bariatric surgery|bariatric surgery
677900|NCT00887393|low fat diet|low fat diet
677901|NCT00887393|low carbohydrate diet|low carbohydrate diet
677902|NCT00887406|first time in human study|first time in human study
677903|NCT00887406|COPD|copd
677904|NCT00887406|long-acting bronchodilator|long-acting bronchodilator
677905|NCT00887419|chronic back pain|chronic back pain
677906|NCT00887419|spinal cord stimulator implant|spinal cord stimulator implant
677907|NCT00887445|First in Man|first in man
677908|NCT00887445|SLV341|slv341
677909|NCT00887445|diabetes|diabetes
677910|NCT00887458|metastatic prostate cancer|metastatic prostate cancer
677911|NCT00887458|castration resistant prostate cancer|castration resistant prostate cancer
677912|NCT00887458|rising PSA|rising psa
677913|NCT00887471|Sleep-disordered breathing|sleep-disordered breathing
677914|NCT00887471|Obstructive sleep apnea|obstructive sleep apnea
677915|NCT00887471|Polysomnography|polysomnography
677916|NCT00887471|Tonsillectomy|tonsillectomy
677917|NCT00887471|Microdebrider assisted partial intracapsular tonsillectomy|microdebrider assisted partial intracapsular tonsillectomy
677918|NCT00887484|Acne|acne
677919|NCT00887484|Acne Vulgaris|acne vulgaris
677920|NCT00887510|Metabolic Syndrome|metabolic syndrome
677921|NCT00887510|High Blood Pressure|high blood pressure
677922|NCT00887510|Abdominal Obesity|abdominal obesity
677923|NCT00887510|Impaired Glucose Tolerance|impaired glucose tolerance
677924|NCT00887536|National Surgical Adjuvant Breast and Bowel Project (NSABP)|national surgical adjuvant breast and bowel project (nsabp)
677925|NCT00887536|Taxotere|taxotere
677926|NCT00887536|Docetaxel|docetaxel
677927|NCT00887536|Doxorubicin|doxorubicin
677928|NCT00887536|Cyclophosphamide|cyclophosphamide
677929|NCT00887536|Bevacizumab|bevacizumab
677930|NCT00887536|Breast Neoplasms|breast neoplasms
677931|NCT00887536|Adenocarcinoma|adenocarcinoma
677932|NCT00887536|Breast Diseases|breast diseases
677933|NCT00887536|Carcinoma|carcinoma
677934|NCT00887536|HER2 negative|her2 negative
677935|NCT00887536|Node negative|node negative
677936|NCT00887536|High risk node positive|high risk node positive
677937|NCT00887536|Adjuvant Therapy|adjuvant therapy
677938|NCT00887575|Breast Cancer|breast cancer
677939|NCT00887575|Triple-Negative|triple-negative
677940|NCT00887575|Paclitaxel|paclitaxel
677941|NCT00887575|Carboplatin|carboplatin
677942|NCT00887575|Sunitinib|sunitinib
677943|NCT00887575|Sutent|sutent
677944|NCT00887575|Neoadjuvant|neoadjuvant
677945|NCT00887588|Chronic heart failure|chronic heart failure
677946|NCT00887588|preserved ejection fraction|preserved ejection fraction
677947|NCT00887588|cardiovascular disease|cardiovascular disease
677948|NCT00887588|NT-proBNP|nt-probnp
677949|NCT00887588|biomarkers|biomarkers
677950|NCT00887588|Heart failure with preserved left-ventricular ejection|heart failure with preserved left-ventricular ejection
677951|NCT00887588|fraction|fraction
677952|NCT00887614|mindfulness|mindfulness
677953|NCT00887614|meditation|meditation
677954|NCT00887614|stress|stress
677955|NCT00887614|rumination|rumination
677956|NCT00887614|emotion regulation|emotion regulation
677957|NCT00887614|sleep quality|sleep quality
677958|NCT00887614|spirituality|spirituality
677959|NCT00887614|quality of life|quality of life
677960|NCT00887627|Pharmacokinetics|pharmacokinetics
677961|NCT00887627|Protein Binding|protein binding
677962|NCT00887627|Conivaptan|conivaptan
677964|NCT00887627|Kidney Diseases|kidney diseases
677965|NCT00887640|metastatic|metastatic
677966|NCT00887640|Temsirolimus|temsirolimus
677967|NCT00887640|prostate|prostate
677968|NCT00887640|cancer|cancer
677969|NCT00887679|Escitalopram|escitalopram
677970|NCT00887679|Anxiety Disorder|anxiety disorder
677971|NCT00887679|HIV and AIDS|hiv and aids
678069|NCT00888069|Vitamin D|vitamin d
677972|NCT00887679|treatment experienced|treatment experienced
677973|NCT00887705|COPD|copd
677974|NCT00887705|Pulmonary Rehabilitation|pulmonary rehabilitation
677975|NCT00887705|ADL-Training|adl-training
677976|NCT00887705|COPD Rehabilitation|copd rehabilitation
677977|NCT00887718|PET scan and Hodgkin's Lymphoma|pet scan and hodgkin's lymphoma
677978|NCT00887718|PET scan and Non Hodgkin's Lymphoma|pet scan and non hodgkin's lymphoma
677979|NCT00887718|PET scan|pet scan
677980|NCT00887731|closed loop oxygen controller|closed loop oxygen controller
677981|NCT00887731|premature infants|premature infants
677982|NCT00887731|oxygen exposure|oxygen exposure
677983|NCT00887744|Degenerative Lumbar Spinal Stenosis|degenerative lumbar spinal stenosis
677984|NCT00887744|Neurogenic Intermittent Claudication|neurogenic intermittent claudication
677985|NCT00887744|Interpinous Device|interpinous device
677986|NCT00887744|Percutaneous|percutaneous
677987|NCT00887770|QTcF|qtcf
677988|NCT00887770|Crossover|crossover
677989|NCT00887770|ICH E14|ich e14
677990|NCT00887770|QT/QTc prolongation|qt/qtc prolongation
677991|NCT00887770|Moxifloxacin|moxifloxacin
677992|NCT00887770|QT/QTc Interval|qt/qtc interval
677993|NCT00887783|Induction chemotherapy|induction chemotherapy
677994|NCT00887783|Non-small cell lung cancer|non-small cell lung cancer
677995|NCT00887783|Randomized phase II study|randomized phase ii study
677996|NCT00887783|Navelbine Oral (R)|navelbine oral (r)
677997|NCT00887783|3D-conformal radiotherapy|3d-conformal radiotherapy
677998|NCT00887783|Chemo-radiotherapy|chemo-radiotherapy
677999|NCT00887783|Local-regionally advanced non-small cell lung cancer|local-regionally advanced non-small cell lung cancer
678000|NCT00887809|Bevacizumab (avastin)|bevacizumab (avastin)
678001|NCT00887809|Gemcitabine|gemcitabine
678002|NCT00887809|Taxotere (docetaxel)|taxotere (docetaxel)
678003|NCT00887809|09-015|09-015
678004|NCT00887809|Soft tissue|soft tissue
678005|NCT00887835|PERPOS fusion|perpos fusion
678006|NCT00887848|Child|child
678007|NCT00887848|Robotic-assisted treadmill training|robotic-assisted treadmill training
678008|NCT00887848|Rehabilitation|rehabilitation
678009|NCT00887861|epilepsy|epilepsy
678010|NCT00887861|seizure|seizure
678011|NCT00887861|monotherapy trials|monotherapy trials
678012|NCT00887861|partial seizure|partial seizure
678013|NCT00887861|Partial seizures and undergoing evaluation for epilepsy surgery|partial seizures and undergoing evaluation for epilepsy surgery
678014|NCT00887887|liver surgery|liver surgery
678015|NCT00887887|gene polymorphisms|gene polymorphisms
678016|NCT00887887|innate immune response|innate immune response
678017|NCT00887887|infectious complications|infectious complications
678018|NCT00887887|post-resectional liver failure|post-resectional liver failure
678019|NCT00887887|mortality|mortality
678020|NCT00887900|lamellar keratoplasty|lamellar keratoplasty
678021|NCT00887900|keratoconus|keratoconus
678022|NCT00887900|penetrated keratoplasty|penetrated keratoplasty
678023|NCT00887900|Visual acuity|visual acuity
678024|NCT00887926|AML|aml
678025|NCT00887926|Leukemia|leukemia
678026|NCT00887926|Acute Myeloid Leukemia|acute myeloid leukemia
678027|NCT00887926|Antibodies, Monoclonal|antibodies, monoclonal
678028|NCT00887939|Physical Urticaria|physical urticaria
678029|NCT00887939|Pathogenesis|pathogenesis
678030|NCT00887939|Inflammasome|inflammasome
678031|NCT00887939|IL-1|il-1
678032|NCT00887939|Mast Cell|mast cell
678033|NCT00887939|Urticaria|urticaria
678034|NCT00887952|Deep caries lesion|deep caries lesion
678035|NCT00887952|dentine caries removal|dentine caries removal
678036|NCT00887952|dental restoration|dental restoration
678037|NCT00887952|stepwise excavation|stepwise excavation
678038|NCT00887965|Low Bone Mass|low bone mass
678039|NCT00887965|Low Bone Mineral Density|low bone mineral density
678040|NCT00887965|Osteoporosis|osteoporosis
678041|NCT00887965|Postmenopausal Osteoporosis|postmenopausal osteoporosis
678042|NCT00887965|Bone Biopsy|bone biopsy
678043|NCT00887965|Transiliac Crest Bone Histology|transiliac crest bone histology
678044|NCT00887965|Histomorphometry|histomorphometry
678045|NCT00887991|Randomised trial|randomised trial
678046|NCT00887991|breast pumps|breast pumps
678047|NCT00887991|efficacy|efficacy
678048|NCT00887991|preterm|preterm
678049|NCT00887991|Mothers of preterm infants who plan to express milk for their infants.|mothers of preterm infants who plan to express milk for their infants.
678050|NCT00888004|Parkinson's|parkinson's
678051|NCT00888004|L-dopa|l-dopa
678052|NCT00888004|dyskinesia|dyskinesia
678053|NCT00888017|bone density|bone density
678054|NCT00888017|proton pump inhibitors|proton pump inhibitors
678055|NCT00888017|premature infants|premature infants
678056|NCT00888030|p-cresol|p-cresol
678057|NCT00888030|indoxyl sulfate|indoxyl sulfate
678058|NCT00888030|chronic kidney disease|chronic kidney disease
678059|NCT00888030|outcome|outcome
678060|NCT00888043|solid tumors|solid tumors
678061|NCT00888043|avastin|avastin
678063|NCT00888043|combination therapy|combination therapy
678064|NCT00888043|bevacizumab|bevacizumab
678065|NCT00888069|Parathyroid Diseases|parathyroid diseases
678066|NCT00888069|Renal Insufficiency|renal insufficiency
678067|NCT00888069|Kidney Failure, Chronic|kidney failure, chronic
678068|NCT00888069|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
678070|NCT00888069|Hyperparathyroidism|hyperparathyroidism
678071|NCT00888069|Renal Insufficiency, Chronic|renal insufficiency, chronic
678072|NCT00888069|Kidney Diseases|kidney diseases
678073|NCT00888069|Kidney Failure|kidney failure
678074|NCT00881283|Cushing's disease|cushing's disease
678075|NCT00881296|Elder Patients|elder patients
678076|NCT00881296|Non-Small Cell Lung Cancer|non-small cell lung cancer
678077|NCT00881296|Previously Untreated|previously untreated
678078|NCT00881296|Advanced|advanced
678079|NCT00881335|geriatric|geriatric
678080|NCT00881335|pulmonary disease|pulmonary disease
678082|NCT00881335|sputum|sputum
678083|NCT00881335|physical therapy techniques|physical therapy techniques
678084|NCT00881361|stage II breast cancer|stage ii breast cancer
678085|NCT00881361|stage IIIA breast cancer|stage iiia breast cancer
678086|NCT00881361|stage IIIB breast cancer|stage iiib breast cancer
678087|NCT00881387|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
678088|NCT00881387|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
678089|NCT00881387|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
678090|NCT00881387|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
678091|NCT00881387|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
678092|NCT00881400|Antibiotic|antibiotic
678093|NCT00881413|Peptic ulcer bleeding|peptic ulcer bleeding
678094|NCT00881413|Proton pump inhibitor|proton pump inhibitor
678095|NCT00881413|Esomeprazole|esomeprazole
678096|NCT00881413|Pantoprazole|pantoprazole
678097|NCT00881413|Recurrent bleeding|recurrent bleeding
678098|NCT00881413|bleeding|bleeding
678099|NCT00881426|Antibiotic|antibiotic
678100|NCT00881439|Heart failure|heart failure
678101|NCT00881439|Renal Failure|renal failure
678102|NCT00881439|Cardiorenal Syndrome|cardiorenal syndrome
678103|NCT00881439|Renin inhibition|renin inhibition
678104|NCT00881439|Aliskiren|aliskiren
678105|NCT00881452|Autism|autism
678106|NCT00881465|Obsessive compulsive disorder|obsessive compulsive disorder
678107|NCT00881478|Obesity|obesity
678108|NCT00881478|Children|children
678109|NCT00881478|Dyslipidemia|dyslipidemia
678110|NCT00881478|Hypertension|hypertension
678111|NCT00881491|Regeneration (revascularization) of dental pulp|regeneration (revascularization) of dental pulp
678359|NCT00888082|goserelin acetate|goserelin acetate
678112|NCT00881491|Immature permanent tooth with a diagnosis of|immature permanent tooth with a diagnosis of
678113|NCT00881504|Biliary|biliary
678114|NCT00881504|Oxaliplatin|oxaliplatin
678115|NCT00881504|Bevacizumab|bevacizumab
678116|NCT00881517|human cytomegalovirus|human cytomegalovirus
678117|NCT00881517|immune globulin|immune globulin
678118|NCT00881517|congenital infection|congenital infection
678119|NCT00881517|prevention|prevention
678120|NCT00881517|pregnancy|pregnancy
678121|NCT00881543|Sitagliptin|sitagliptin
678122|NCT00881543|Diets|diets
678123|NCT00881543|Diabetes type 2|diabetes type 2
678124|NCT00881543|Näive patients|näive patients
678125|NCT00881556|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
678126|NCT00881556|AlloSCT|allosct
678127|NCT00881556|RDEB|rdeb
678128|NCT00881556|recessive dystrophic epidermolysis bullosa|recessive dystrophic epidermolysis bullosa
678129|NCT00881582|Hepatitis c|hepatitis c
678130|NCT00881582|Renal transplantation|renal transplantation
678131|NCT00881582|Pegylated interferon|pegylated interferon
678132|NCT00881595|Sarcomas|sarcomas
678133|NCT00881595|High-Risk Soft Tissue Sarcomas|high-risk soft tissue sarcomas
678134|NCT00881608|Menstruation|menstruation
678135|NCT00881621|Pancreas cancer|pancreas cancer
678136|NCT00881621|lapatinib|lapatinib
678137|NCT00881621|capecitabine|capecitabine
678138|NCT00881647|PTSD|ptsd
678139|NCT00881647|Insomnia Disorder|insomnia disorder
678140|NCT00881647|Insomnia|insomnia
678141|NCT00881647|CBT|cbt
678142|NCT00881660|Fetal Tracheal Occlusion|fetal tracheal occlusion
678143|NCT00881660|congenital diaphragmatic hernia|congenital diaphragmatic hernia
678144|NCT00881660|FETO plug-unplug|feto plug-unplug
678145|NCT00881660|Goldvalve balloon|goldvalve balloon
678146|NCT00881660|Severe Congenital Diaphragmatic Hernia|severe congenital diaphragmatic hernia
678147|NCT00881660|Extremely Severe Congenital Diaphragmatic Hernia|extremely severe congenital diaphragmatic hernia
678148|NCT00881660|Goldbal balloon|goldbal balloon
678150|NCT00881673|Conjunctivitis|conjunctivitis
678151|NCT00881686|Ischemic Preconditioning, Myocardial|ischemic preconditioning, myocardial
678152|NCT00881686|Adenosine|adenosine
678153|NCT00881699|HIV Information|hiv information
678154|NCT00881699|HIV Prevention|hiv prevention
678155|NCT00881699|Severe Mental Illness|severe mental illness
678156|NCT00881699|HIV seronegativity|hiv seronegativity
678162|NCT00881725|Radical Prostatectomy|radical prostatectomy
678163|NCT00881725|Neoadjuvant Intervention|neoadjuvant intervention
678164|NCT00881725|PTEN/AKT Pathway|pten/akt pathway
678165|NCT00881725|Tumour Expression|tumour expression
678166|NCT00881725|Ki67 Expression|ki67 expression
678167|NCT00881738|Antibiotic|antibiotic
678168|NCT00881751|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
678169|NCT00881751|advanced adult primary liver cancer|advanced adult primary liver cancer
678365|NCT00888095|Nucleus subthalamicus|nucleus subthalamicus
678170|NCT00881751|recurrent adult primary liver cancer|recurrent adult primary liver cancer
678171|NCT00881764|Anesthesia|anesthesia
678172|NCT00881764|New York|new york
678173|NCT00881764|Columbia|columbia
678174|NCT00881764|Children|children
678175|NCT00881764|Neurodevelopment|neurodevelopment
678176|NCT00881764|Child development|child development
678177|NCT00881764|Pediatric|pediatric
678178|NCT00881777|Heart Failure|heart failure
678179|NCT00881777|Cardiomyopathy|cardiomyopathy
678180|NCT00881777|Ventricular Dysfunction|ventricular dysfunction
678181|NCT00881777|Heart Disease|heart disease
678182|NCT00881803|Spinal Cord Injuries|spinal cord injuries
678183|NCT00881803|Ascorbic Acid|ascorbic acid
678184|NCT00881803|Vitamin C|vitamin c
678185|NCT00881803|Iron|iron
678186|NCT00881803|Dietary Supplements|dietary supplements
678187|NCT00881816|Liposomal Paclitaxel|liposomal paclitaxel
678188|NCT00881816|Capecitabine|capecitabine
678189|NCT00881816|Maximum tolerated dose|maximum tolerated dose
678190|NCT00881816|Dose limiting toxicity|dose limiting toxicity
678191|NCT00881829|Pulse Oximetry|pulse oximetry
678192|NCT00881829|Temperature|temperature
678193|NCT00881829|Respiratory Rate|respiratory rate
678194|NCT00881829|Respiratory Gases|respiratory gases
678195|NCT00881829|This study determine the measurement accuracy of the physiological parameters|this study determine the measurement accuracy of the physiological parameters
678196|NCT00881842|Influenza|influenza
678197|NCT00881842|Vaccine|vaccine
678198|NCT00881842|CHMP criteria|chmp criteria
678199|NCT00881855|Antibiotics|antibiotics
678200|NCT00881894|Rotigotine|rotigotine
678201|NCT00881894|Neupro®|neupro®
678202|NCT00881894|Transdermal Patch|transdermal patch
678203|NCT00881907|Regeneration (revascularization) of dental pulp|regeneration (revascularization) of dental pulp
678204|NCT00881907|Immature Permanent Tooth With a Diagnosis of Pulpal Necrosis|immature permanent tooth with a diagnosis of pulpal necrosis
678205|NCT00881920|Lymphocytic|lymphocytic
678206|NCT00881920|Leukemia|leukemia
678207|NCT00881920|B Cell|b cell
678208|NCT00881920|Non-Hodgkin|non-hodgkin
678209|NCT00881920|Multiple Myeloma|multiple myeloma
678210|NCT00881920|Lymphoma|lymphoma
678211|NCT00881933|Fludarabine, Cyclophosphamide, TBI, severe aplastic anemia,|fludarabine, cyclophosphamide, tbi, severe aplastic anemia,
678212|NCT00881933|cord blood transplantation, pediatric|cord blood transplantation, pediatric
678213|NCT00881946|chronic lymphocytic leukemia|chronic lymphocytic leukemia
678214|NCT00881946|aggressive lymphoma|aggressive lymphoma
678215|NCT00881946|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
678216|NCT00881946|Hodgkin's lymphoma|hodgkin's lymphoma
678217|NCT00881946|chronic myelogenous leukemia|chronic myelogenous leukemia
678218|NCT00881946|multiple myeloma|multiple myeloma
678219|NCT00881946|acute lymphoblastic leukemia|acute lymphoblastic leukemia
678220|NCT00881946|acute myeloid leukemia|acute myeloid leukemia
678221|NCT00881959|exposed Root Surface or Tooth|exposed root surface or tooth
678222|NCT00881959|Tooth Sensitivity Miller Class I|tooth sensitivity miller class i
678223|NCT00881959|Miller Class II|miller class ii
678224|NCT00881959|Gingival Margin|gingival margin
678225|NCT00881985|obstructive sleep apnea|obstructive sleep apnea
678226|NCT00881985|resistant hypertension|resistant hypertension
678227|NCT00881985|refractory hypertension|refractory hypertension
678228|NCT00881985|continuous positive airway pressure|continuous positive airway pressure
678229|NCT00881985|blood pressure control|blood pressure control
678230|NCT00881998|Evaluate early functional outcomes of two anterior approaches to total hip arthroplasty|evaluate early functional outcomes of two anterior approaches to total hip arthroplasty
678231|NCT00882011|T-lymphoblastic lymphoma|t-lymphoblastic lymphoma
678232|NCT00882011|Intensive chemo/radiotherapy|intensive chemo/radiotherapy
678233|NCT00882011|Intensive chemotherapy|intensive chemotherapy
678234|NCT00882011|Transplant|transplant
678235|NCT00882011|Adult patients|adult patients
678236|NCT00882024|Rheumatoid arthritis|rheumatoid arthritis
678241|NCT00882063|Multiple Myeloma|multiple myeloma
678242|NCT00882076|acute lymphoblastic leukemia|acute lymphoblastic leukemia
678243|NCT00882076|chronic lymphocytic leukemia|chronic lymphocytic leukemia
678244|NCT00882089|Contura|contura
678245|NCT00882089|Cancer|cancer
678250|NCT00882102|Acute Myelogenous Leukemia|acute myelogenous leukemia
678251|NCT00882102|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
678252|NCT00882102|AML|aml
678253|NCT00882102|MDS|mds
678254|NCT00882102|Leukemia|leukemia
678255|NCT00882102|Decitabine|decitabine
678256|NCT00882102|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
678257|NCT00882102|Dacogen|dacogen
678258|NCT00882102|Mylotarg|mylotarg
678259|NCT00882115|DEP|dep
678260|NCT00882115|Broccoli Sprout Extract|broccoli sprout extract
678261|NCT00882115|Allergies|allergies
678262|NCT00882128|Asthma seasonal respiratory symptoms|asthma seasonal respiratory symptoms
678263|NCT00882128|Asthmatic patients with increase of respiratory symptoms|asthmatic patients with increase of respiratory symptoms
678264|NCT00882141|Exercise|exercise
678265|NCT00882141|Obesity|obesity
678266|NCT00882141|Insulin Sensitivity|insulin sensitivity
678267|NCT00882154|Antibiotic|antibiotic
678268|NCT00882180|Liver|liver
678269|NCT00882180|Solid Tumors|solid tumors
678270|NCT00882180|Advanced Solid Tumors with Liver Involvement|advanced solid tumors with liver involvement
678271|NCT00882193|Chronic hepatitis C|chronic hepatitis c
678272|NCT00882193|Genotype 1|genotype 1
678273|NCT00882193|Nonresponder|nonresponder
678274|NCT00882193|Relapser|relapser
678275|NCT00882193|Betaine|betaine
678276|NCT00882193|Antiviral therapy|antiviral therapy
678277|NCT00882206|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
678278|NCT00882206|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
678279|NCT00882206|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
678280|NCT00882206|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
678281|NCT00882219|Drug eluting stent|drug eluting stent
678282|NCT00882219|Stents|stents
678283|NCT00882219|Angioplasty|angioplasty
678284|NCT00882219|Chronic coronary occlusion|chronic coronary occlusion
678285|NCT00882219|Stent thrombosis|stent thrombosis
678286|NCT00882219|Vascular disease|vascular disease
678287|NCT00882219|Myocardial ischemia|myocardial ischemia
678288|NCT00882219|Coronary artery stenosis|coronary artery stenosis
678289|NCT00882219|Coronary Disease|coronary disease
678290|NCT00882219|Coronary Artery Disease|coronary artery disease
678291|NCT00882219|Coronary Restenosis|coronary restenosis
678292|NCT00882232|prostate|prostate
678293|NCT00882232|cancer|cancer
678294|NCT00882232|cross-linked|cross-linked
678295|NCT00882232|hyaluronan|hyaluronan
678296|NCT00882232|gel|gel
678297|NCT00882232|Hylaform|hylaform
678298|NCT00882232|rectal|rectal
678299|NCT00882232|toxicity|toxicity
678300|NCT00882258|Uterine fibroids|uterine fibroids
678301|NCT00882271|Fibromyalgia|fibromyalgia
678302|NCT00882271|Acupuncture|acupuncture
678303|NCT00882271|Pain|pain
678304|NCT00882284|NICHD Neonatal Research Network|nichd neonatal research network
678305|NCT00882284|Blood Pressure Management|blood pressure management
678306|NCT00882297|Ultrasoundography|ultrasoundography
678307|NCT00882297|catheterization|catheterization
678308|NCT00882297|central venous subclavian vein methods|central venous subclavian vein methods
678309|NCT00882310|Pancreatic cancer|pancreatic cancer
678310|NCT00882310|Gemzar|gemzar
678311|NCT00882310|Taxotere|taxotere
678312|NCT00882310|Xeloda|xeloda
678313|NCT00882310|GTX|gtx
678314|NCT00882336|Cardiovascular risk management|cardiovascular risk management
678315|NCT00882336|Hyperlipidemia|hyperlipidemia
678316|NCT00882336|Hypertension|hypertension
678317|NCT00882336|Diabetes|diabetes
678318|NCT00882336|Obesity|obesity
678319|NCT00882375|Smoking Cessation|smoking cessation
678320|NCT00882388|celecoxib|celecoxib
678321|NCT00882388|platelet|platelet
678322|NCT00882388|thrombosis|thrombosis
678323|NCT00882388|Volunteers|volunteers
678324|NCT00882414|ferric carboxymaltose|ferric carboxymaltose
678325|NCT00882414|platelet|platelet
678326|NCT00882414|thrombocyte|thrombocyte
678327|NCT00882414|ferritin|ferritin
678328|NCT00882414|hemoglobin|hemoglobin
678329|NCT00882414|transferrin|transferrin
678330|NCT00882427|algorithm|algorithm
678331|NCT00882427|tight glycemic control|tight glycemic control
678332|NCT00882427|glucose control|glucose control
678333|NCT00882427|intensive care|intensive care
678334|NCT00882427|insulin|insulin
678335|NCT00882427|ICU|icu
678336|NCT00882453|Physical Activity|physical activity
678337|NCT00882453|Fatigue|fatigue
678338|NCT00882453|RRMS|rrms
678339|NCT00882453|CIS|cis
678340|NCT00882466|erythropoietin|erythropoietin
678341|NCT00882492|Cardiac|cardiac
678342|NCT00882492|Surgery|surgery
678343|NCT00882492|Glycemia|glycemia
678344|NCT00882518|Quetiapine Fumarate (SEROQUEL) Extended-Release (XR)|quetiapine fumarate (seroquel) extended-release (xr)
678345|NCT00882518|qualified PANSS assessment|qualified panss assessment
678346|NCT00882544|hydronephrosis|hydronephrosis
678347|NCT00882544|robotic pyeloplasty|robotic pyeloplasty
678348|NCT00882544|pediatric pyeloplasty|pediatric pyeloplasty
678349|NCT00882557|End-stage renal disease|end-stage renal disease
678350|NCT00882557|hemodialysis|hemodialysis
678351|NCT00882557|chronic renal failure|chronic renal failure
678357|NCT00888082|adjuvant chemotherapy|adjuvant chemotherapy
678358|NCT00888082|breast cancer|breast cancer
678360|NCT00888082|ovarian function|ovarian function
678361|NCT00888082|Chemotherapy|chemotherapy
678362|NCT00888082|Primary invasive breast cancer|primary invasive breast cancer
678363|NCT00888095|deep brain stimulation|deep brain stimulation
678364|NCT00888095|caudal Zona incerta|caudal zona incerta
683048|NCT00894816|Caries|caries
678366|NCT00888095|Parkinson's disease|parkinson's disease
678367|NCT00888095|randomized|randomized
678368|NCT00888095|blinded|blinded
678369|NCT00888095|Movement disorder|movement disorder
678370|NCT00888147|Tube feeding|tube feeding
678371|NCT00888147|Fiber|fiber
678372|NCT00888147|Constipation|constipation
678373|NCT00888186|Dyskinesias|dyskinesias
678374|NCT00888186|Duodenal levodopa infusion|duodenal levodopa infusion
678375|NCT00888186|Dose optimization|dose optimization
678376|NCT00888186|Pharmacokinetics|pharmacokinetics
678377|NCT00888186|Pharmacodynamics|pharmacodynamics
678378|NCT00888199|amputation|amputation
678379|NCT00888199|amputee|amputee
678380|NCT00888199|prosthetic|prosthetic
678381|NCT00888199|foot|foot
678382|NCT00888199|prosthesis|prosthesis
678383|NCT00888199|Tensegrity|tensegrity
678384|NCT00888199|Prosthetics|prosthetics
678385|NCT00888199|K3 Promoter|k3 promoter
678386|NCT00888225|Tennis elbow|tennis elbow
678387|NCT00888225|Epicondylitis|epicondylitis
678388|NCT00888225|Pain|pain
678389|NCT00888225|Muscle strength|muscle strength
678390|NCT00888225|Quality of life|quality of life
678391|NCT00888225|RCT|rct
678392|NCT00888225|Tendinitis|tendinitis
678393|NCT00888225|Chronic tennis elbow|chronic tennis elbow
678394|NCT00888251|Obesity|obesity
678395|NCT00888251|Meal replacement|meal replacement
678396|NCT00888251|Obesity treatment|obesity treatment
678397|NCT00888251|Weight management|weight management
678398|NCT00888264|Antipsychotics|antipsychotics
678399|NCT00888264|Bipolar Disorder|bipolar disorder
678400|NCT00888264|Depressive episodes|depressive episodes
678401|NCT00888264|Bipolar I or II Disorders|bipolar i or ii disorders
678402|NCT00888290|metabolic acidosis|metabolic acidosis
678403|NCT00888290|chronic kidney disease|chronic kidney disease
678404|NCT00888290|Estimated GFR 15-45|estimated gfr 15-45
678405|NCT00888316|iron overload|iron overload
678406|NCT00888329|Elective hysterectomy|elective hysterectomy
678407|NCT00888342|Pulmonary Disease|pulmonary disease
678408|NCT00888342|Chronic Obstructive|chronic obstructive
678409|NCT00888342|Hypercapnia|hypercapnia
678410|NCT00888342|Hypoxemia|hypoxemia
678411|NCT00888342|Arrhythmias, Cardiac|arrhythmias, cardiac
678412|NCT00888342|Polysomnography|polysomnography
678413|NCT00888342|Capnography|capnography
678414|NCT00888342|Electrocardiography, Holter|electrocardiography, holter
678415|NCT00888394|chiropody|chiropody
678416|NCT00888394|podiatry|podiatry
678417|NCT00888394|insoles|insoles
678418|NCT00888394|foot orthesis|foot orthesis
678419|NCT00888407|Asian American Health|asian american health
678420|NCT00888407|Cancer|cancer
678421|NCT00888407|Hepatitis|hepatitis
678422|NCT00888407|Hepatitis B|hepatitis b
678423|NCT00888407|Liver Cancer|liver cancer
678424|NCT00888420|Chronic Pain|chronic pain
678425|NCT00888563|Fatigue|fatigue
678426|NCT00888563|Depression|depression
678427|NCT00888563|Healthy Volunteer|healthy volunteer
678428|NCT00888563|HV|hv
678429|NCT00888589|MBI|mbi
678430|NCT00888589|Molecular Breast Imaging|molecular breast imaging
678431|NCT00888589|Breast|breast
678432|NCT00888589|Breast Cancer|breast cancer
678433|NCT00888589|Molecular Imaging|molecular imaging
678434|NCT00888628|Type I diabetes|type i diabetes
678435|NCT00888628|Islet after Kidney Transplant|islet after kidney transplant
678436|NCT00888628|Islet transplantation|islet transplantation
678437|NCT00888654|adenocarcinoma of the prostate|adenocarcinoma of the prostate
678438|NCT00888654|stage I prostate cancer|stage i prostate cancer
678439|NCT00888654|stage II prostate cancer|stage ii prostate cancer
678440|NCT00888667|ICD patients with PVCs and EGM recordings|icd patients with pvcs and egm recordings
678441|NCT00888680|Migraine|migraine
678442|NCT00888680|Headaches|headaches
678443|NCT00888680|Migraine headaches|migraine headaches
678444|NCT00888680|Head pain|head pain
678445|NCT00888732|Diabetes|diabetes
678446|NCT00888745|RA|ra
678447|NCT00888758|Stents|stents
678448|NCT00888771|Colorectal cancer|colorectal cancer
678449|NCT00888771|polyps|polyps
678450|NCT00888771|colonoscopy|colonoscopy
678451|NCT00888771|advanced imaging|advanced imaging
678452|NCT00888810|ovarian - cancer - relapse - topotecan - lapatinib|ovarian - cancer - relapse - topotecan - lapatinib
678453|NCT00888823|Fractionated stereotactic radiotherapy|fractionated stereotactic radiotherapy
678454|NCT00888823|Medically inoperable|medically inoperable
678455|NCT00888823|Image-guided radiotherapy|image-guided radiotherapy
678456|NCT00888836|bariatric surgery|bariatric surgery
678457|NCT00888836|GBP|gbp
678458|NCT00888836|BPD|bpd
678459|NCT00888836|type 2 diabetes|type 2 diabetes
678460|NCT00888849|Stapling|stapling
678461|NCT00888849|hand sutured anastamosis|hand sutured anastamosis
678462|NCT00888849|colorectal disease|colorectal disease
678463|NCT00888862|depression|depression
678464|NCT00888862|desvenlafaxine|desvenlafaxine
678465|NCT00888862|menopause|menopause
678466|NCT00888862|imaging|imaging
678467|NCT00888862|FMRI|fmri
678468|NCT00888875|i-gel|i-gel
678469|NCT00888875|Fastrach|fastrach
678470|NCT00888875|intubation|intubation
678471|NCT00888875|fiberoptic|fiberoptic
678472|NCT00888875|difficult airway|difficult airway
678473|NCT00888875|Patients undergoing elective surgery requiring tracheal intubation|patients undergoing elective surgery requiring tracheal intubation
678474|NCT00888875|Presenting at least one sign of difficult intubation|presenting at least one sign of difficult intubation
678475|NCT00888888|Acute appendicitis|acute appendicitis
678476|NCT00888888|Colonic diverticulitis|colonic diverticulitis
678477|NCT00888888|Colonic tumors|colonic tumors
678478|NCT00888888|Colonic resections|colonic resections
678479|NCT00888901|ITP|itp
678480|NCT00888901|eltrombopag|eltrombopag
678481|NCT00888901|platelet function|platelet function
678482|NCT00888901|thrombocytopenia|thrombocytopenia
678483|NCT00888901|Platelet function in patients with cAITP on eltrombopag|platelet function in patients with caitp on eltrombopag
678484|NCT00888914|Lateral Canthal Lines|lateral canthal lines
678485|NCT00888914|Crow's Feet|crow's feet
678486|NCT00888914|Facial Wrinkles|facial wrinkles
678487|NCT00888927|T-Cell Lymphoma|t-cell lymphoma
678488|NCT00888927|PTCL|ptcl
678489|NCT00888927|CTCL|ctcl
678490|NCT00888953|Falls|falls
678491|NCT00888953|Nursing Homes|nursing homes
678492|NCT00888953|Elderly|elderly
678493|NCT00888953|Prevention|prevention
678494|NCT00888953|Spain|spain
678495|NCT00888953|Cluster Randomized Clinical Trial|cluster randomized clinical trial
678496|NCT00888966|heart arrest|heart arrest
678497|NCT00888966|oxidative stress|oxidative stress
678498|NCT00888966|lactic acid|lactic acid
678499|NCT00888966|outcome|outcome
678500|NCT00888979|Smoking Cessation during Pregnancy|smoking cessation during pregnancy
678501|NCT00888979|Nicotrol Inhaler|nicotrol inhaler
678502|NCT00888992|Smoking|smoking
678503|NCT00888992|Cessation|cessation
678504|NCT00888992|Quitline|quitline
678505|NCT00888992|Counseling|counseling
678506|NCT00889005|Post-traumatic Stress Disorder|post-traumatic stress disorder
678507|NCT00889005|Acute Stress Disorder|acute stress disorder
678508|NCT00889005|Cognitive behavioral therapy|cognitive behavioral therapy
678509|NCT00889005|Secondary Prevention|secondary prevention
678510|NCT00889005|Anxiety disorders|anxiety disorders
678511|NCT00889005|Service Delivery|service delivery
678512|NCT00889018|intraocular retinoblastoma|intraocular retinoblastoma
678513|NCT00889018|chemotherapy|chemotherapy
678514|NCT00889031|CLL|cll
678515|NCT00889057|osteosarcoma|osteosarcoma
678516|NCT00889057|sorafenib|sorafenib
678517|NCT00889057|target therapy|target therapy
678518|NCT00889083|Sepsis|sepsis
678519|NCT00889083|Peritonitis|peritonitis
678520|NCT00889083|Mitochondria|mitochondria
678521|NCT00889083|Liver|liver
678522|NCT00889096|memory|memory
678523|NCT00889096|heart rate|heart rate
678524|NCT00889096|skin conductance|skin conductance
678525|NCT00889096|α-amylase|α-amylase
678526|NCT00889096|propranolol|propranolol
678527|NCT00889096|tolerability|tolerability
678528|NCT00889122|Obesity|obesity
678529|NCT00889122|Exergames|exergames
678530|NCT00889122|Videogames|videogames
678531|NCT00889122|Prevention|prevention
678532|NCT00889122|Family|family
678533|NCT00889122|Dance Dance Revolution|dance dance revolution
678534|NCT00889122|Pedometer|pedometer
678535|NCT00889148|hip|hip
678536|NCT00889148|arthroplasty|arthroplasty
678537|NCT00889148|postoperative pain|postoperative pain
678538|NCT00889148|gabapentin|gabapentin
678539|NCT00889161|Crohn's disease|crohn's disease
678540|NCT00889161|ulcerative colitis|ulcerative colitis
678541|NCT00889161|curcumin|curcumin
678542|NCT00889161|pediatric|pediatric
678543|NCT00889161|inflammatory bowel disease|inflammatory bowel disease
678544|NCT00889174|Genetic Disorders of the White Matter|genetic disorders of the white matter
678545|NCT00889174|Leukodystrophies|leukodystrophies
678546|NCT00889174|Myelin|myelin
678547|NCT00889174|White Matter Disorder|white matter disorder
678548|NCT00889174|Genetic Disorder|genetic disorder
678549|NCT00889187|radiation therapy|radiation therapy
678550|NCT00889187|capecitabine|capecitabine
678551|NCT00889213|pancreatectomy|pancreatectomy
678552|NCT00889213|fistula|fistula
678553|NCT00889213|fibrin glue|fibrin glue
678554|NCT00889213|falciform patch|falciform patch
678555|NCT00889213|surgery|surgery
678556|NCT00889213|complications|complications
678557|NCT00889226|pitavastatin|pitavastatin
678558|NCT00889226|PWV|pwv
678559|NCT00889226|ESPRIT|esprit
678560|NCT00889226|Pitavastatin and Atorvastatin|pitavastatin and atorvastatin
678561|NCT00889226|Adiponectin|adiponectin
678562|NCT00889226|fasting insulin|fasting insulin
678563|NCT00889226|hs-CRP|hs-crp
678564|NCT00889226|baPWV|bapwv
678565|NCT00889239|ceramic|ceramic
678566|NCT00889239|wear rate|wear rate
678567|NCT00889239|opposing enamel|opposing enamel
678568|NCT00889265|Alveolar Bone Augmentation|alveolar bone augmentation
680644|NCT00897234|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
680645|NCT00897234|stage I non-small cell lung cancer|stage i non-small cell lung cancer
680671|NCT00897299|HER-2|her-2
678569|NCT00889265|Implant Surgery|implant surgery
678570|NCT00889265|Guided Bone Regeneration (GBR)|guided bone regeneration (gbr)
678571|NCT00889265|Guided Tissue Regeneration (GTR)|guided tissue regeneration (gtr)
678572|NCT00889265|Bone Graft|bone graft
678573|NCT00889265|Periodontal Surgery|periodontal surgery
678574|NCT00889278|Lymphoma|lymphoma
683250|NCT00901693|pink eye|pink eye
678575|NCT00889278|Autologous Peripheral Blood Stem Cell Transplant|autologous peripheral blood stem cell transplant
678576|NCT00889278|APBSCT|apbsct
678577|NCT00889278|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
678578|NCT00889291|End stage renal disease|end stage renal disease
678579|NCT00889291|Bacteremia|bacteremia
678580|NCT00889291|HeRO Vascular Access Device|hero vascular access device
678581|NCT00889291|Access challenged|access challenged
678582|NCT00889291|Catheter dependent|catheter dependent
678583|NCT00889291|End stage renal disease requiring vascular access. See HeRO device instructions for use for appropriate patient population|end stage renal disease requiring vascular access. see hero device instructions for use for appropriate patient population
678584|NCT00889304|HTO, high tibial osteotomy, open wedge, medial arthritis|hto, high tibial osteotomy, open wedge, medial arthritis
678585|NCT00889343|Second-line therapy of metastatic colorectal cancer|second-line therapy of metastatic colorectal cancer
678586|NCT00889343|Sorafenib|sorafenib
678587|NCT00889343|Colorectal Neoplasms|colorectal neoplasms
678588|NCT00889343|palliative therapy|palliative therapy
678589|NCT00889343|after progression of firstline therapy with an Oxaliplatin- or Irinotecan based Fluoropyrimidine containing regimen ± bevacizumab|after progression of firstline therapy with an oxaliplatin- or irinotecan based fluoropyrimidine containing regimen ± bevacizumab
678590|NCT00889369|depression|depression
678591|NCT00889369|duloxetine|duloxetine
678592|NCT00889369|menopause|menopause
678593|NCT00889369|imaging|imaging
678594|NCT00889369|FMRI|fmri
678595|NCT00889369|Menopausal staging|menopausal staging
678596|NCT00889369|vasomotor symptoms|vasomotor symptoms
678597|NCT00889382|Ovarian Cancer|ovarian cancer
678598|NCT00889382|Ovarian|ovarian
678599|NCT00889382|Paclitaxel|paclitaxel
678600|NCT00889382|OSI-906|osi-906
678601|NCT00889382|IGF-1R|igf-1r
678602|NCT00889382|Solid Tumors|solid tumors
678603|NCT00889395|MISC|misc
678604|NCT00889395|caregivers|caregivers
678605|NCT00889395|children|children
678606|NCT00889395|psychosocial gains|psychosocial gains
678607|NCT00889395|cognitive benefits|cognitive benefits
678608|NCT00889408|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
678609|NCT00889408|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
678610|NCT00889408|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
678720|NCT00889772|high risk surgery|high risk surgery
678611|NCT00889408|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
678612|NCT00889408|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
678613|NCT00889408|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
678614|NCT00889408|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
678615|NCT00889408|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
678616|NCT00889408|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
678617|NCT00889408|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
678618|NCT00889408|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
678619|NCT00889408|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
678620|NCT00889408|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
678621|NCT00889408|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
678622|NCT00889408|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
678623|NCT00889408|secondary acute myeloid leukemia|secondary acute myeloid leukemia
678624|NCT00889408|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
678625|NCT00889408|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
678626|NCT00889408|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
678627|NCT00889408|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
678628|NCT00889408|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
678629|NCT00889408|Waldenström macroglobulinemia|waldenström macroglobulinemia
678630|NCT00889408|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
678631|NCT00889408|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
678632|NCT00889408|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
678633|NCT00889408|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
678634|NCT00889408|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
678635|NCT00889408|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
678636|NCT00889408|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
678637|NCT00889408|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
678638|NCT00889408|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
678735|NCT00889798|Germany|germany
678639|NCT00889408|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
678640|NCT00889408|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
678641|NCT00889408|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
678642|NCT00889408|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
678643|NCT00889408|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
678644|NCT00889408|splenic marginal zone lymphoma|splenic marginal zone lymphoma
678645|NCT00889408|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
678646|NCT00889408|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
678647|NCT00889408|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
678648|NCT00889408|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
678649|NCT00889408|childhood Burkitt lymphoma|childhood burkitt lymphoma
678650|NCT00889408|intraocular lymphoma|intraocular lymphoma
678651|NCT00889408|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
678652|NCT00889408|prolymphocytic leukemia|prolymphocytic leukemia
678653|NCT00889421|uveitis|uveitis
678654|NCT00889421|apremilast|apremilast
678655|NCT00889434|Cystic fibrosis|cystic fibrosis
678656|NCT00889434|splicing mutations|splicing mutations
678657|NCT00889434|molecular therapy|molecular therapy
678658|NCT00889434|EGCG|egcg
678659|NCT00889434|Tocotrienol|tocotrienol
678660|NCT00889434|Splicing-mutation-mediated Cystic Fibrosis|splicing-mutation-mediated cystic fibrosis
678661|NCT00889447|Chronic Obstructive Pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
678662|NCT00889460|rBet v 1|rbet v 1
678663|NCT00889460|Birch pollen allergy|birch pollen allergy
678664|NCT00889460|Sublingual Immunotherapy|sublingual immunotherapy
678665|NCT00889473|Celiac Disease|celiac disease
678666|NCT00889473|Gluten|gluten
678667|NCT00889486|gastroparesis|gastroparesis
678668|NCT00889486|diabetes mellitus|diabetes mellitus
678669|NCT00889486|delayed gastric emptying|delayed gastric emptying
678670|NCT00889525|Cabergoline|cabergoline
678671|NCT00889538|Autism|autism
678672|NCT00889538|Severe Behavior Disorder|severe behavior disorder
678673|NCT00889538|Glutathione|glutathione
678674|NCT00889538|Antioxidants|antioxidants
678675|NCT00889564|Vascular access for hemodialysis|vascular access for hemodialysis
678676|NCT00889564|Catheter dependent patients|catheter dependent patients
678677|NCT00889564|Access challenged patients|access challenged patients
678678|NCT00889564|Bacteremia|bacteremia
678679|NCT00889564|HeRO Vascular Access Device|hero vascular access device
678681|NCT00889590|Bisfosfonates|bisfosfonates
678682|NCT00889603|Aricept® Evess|aricept® evess
678683|NCT00889603|non-interventional study|non-interventional study
678684|NCT00889603|Alzheimer's Disease|alzheimer's disease
678685|NCT00889603|Vascular Dementia|vascular dementia
678686|NCT00889603|efficacy|efficacy
678687|NCT00889603|tolerability|tolerability
678688|NCT00889603|safety.|safety.
678689|NCT00889616|Malaria|malaria
678690|NCT00889616|Asexual Blood Stafe|asexual blood stafe
678691|NCT00889616|Plasmodium Falciparum|plasmodium falciparum
678692|NCT00889616|Immunogenicity|immunogenicity
678693|NCT00889616|Safety|safety
678694|NCT00889616|Vaccine|vaccine
678695|NCT00889629|kidney transplantation|kidney transplantation
678696|NCT00889629|kidney transplant recipients|kidney transplant recipients
678697|NCT00889655|efficacy of bowel cleansing|efficacy of bowel cleansing
678698|NCT00889655|patient tolerability|patient tolerability
678699|NCT00889655|Golytely|golytely
678700|NCT00889655|MiraLax|miralax
678701|NCT00889655|colonoscopy preparation|colonoscopy preparation
678702|NCT00889655|bowel preparation|bowel preparation
678703|NCT00889655|screening colonoscopy|screening colonoscopy
678704|NCT00889668|Glucose monitoring|glucose monitoring
678705|NCT00889668|GlucoTrack|glucotrack
678706|NCT00889668|Self glucose monitoring|self glucose monitoring
678707|NCT00889707|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
678708|NCT00889707|BPH|bph
678709|NCT00889707|Enlarged Prostate|enlarged prostate
678710|NCT00889720|smoking cessation|smoking cessation
678711|NCT00889720|varenicline|varenicline
678712|NCT00889720|elective surgery|elective surgery
678713|NCT00889720|wound infections|wound infections
678714|NCT00889720|post-operative complications|post-operative complications
678715|NCT00889759|Tuberculosis|tuberculosis
678716|NCT00889759|Outbreaks|outbreaks
678717|NCT00889772|Respiratory distress, adult|respiratory distress, adult
678718|NCT00889772|risk|risk
678719|NCT00889772|emergency room|emergency room
678721|NCT00889772|sepsis|sepsis
678722|NCT00889772|trauma|trauma
678723|NCT00889772|aspiration|aspiration
678724|NCT00889772|pneumonia|pneumonia
678725|NCT00889785|Adolescents|adolescents
678726|NCT00889785|Type 2 Diabetes|type 2 diabetes
678727|NCT00889785|Behavioral Research|behavioral research
678728|NCT00889798|Malignant lymphatic disease|malignant lymphatic disease
678729|NCT00889798|therapy-reality|therapy-reality
678730|NCT00889798|observation|observation
678731|NCT00889798|registry|registry
678732|NCT00889798|therapy sequences|therapy sequences
678733|NCT00889798|NHL|nhl
678734|NCT00889798|CLL|cll
678736|NCT00889798|lenalidomide|lenalidomide
678737|NCT00889798|alemtuzumab|alemtuzumab
678738|NCT00889798|rituximab|rituximab
678739|NCT00889798|bendamustin|bendamustin
678740|NCT00889798|thalidomide|thalidomide
678741|NCT00889798|bortezomib|bortezomib
678742|NCT00889798|ibritumomab-tiuxetan|ibritumomab-tiuxetan
678743|NCT00889798|G-CSF (Granulocyte-Colony Stimulating Factor)|g-csf (granulocyte-colony stimulating factor)
683649|NCT00903734|Cetuximab|cetuximab
678744|NCT00889798|chronic lymphocytic leukaemia|chronic lymphocytic leukaemia
678745|NCT00889798|follicular lymphoma|follicular lymphoma
678746|NCT00889798|gastric MALT lymphoma (Mucosa Associated Lymphoid Tissue)|gastric malt lymphoma (mucosa associated lymphoid tissue)
678845|NCT00890149|heavy drinking|heavy drinking
678747|NCT00889798|nongastric MALT lymphoma (Mucosa Associated Lymphoid Tissue)|nongastric malt lymphoma (mucosa associated lymphoid tissue)
678748|NCT00889798|nodal marginal zone lymphoma|nodal marginal zone lymphoma
678749|NCT00889798|splenic marginal zone lymphoma|splenic marginal zone lymphoma
678750|NCT00889798|mantle cell lymphoma|mantle cell lymphoma
678751|NCT00889798|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
678752|NCT00889811|OPCAB|opcab
678753|NCT00889811|RIPC|ripc
678754|NCT00889824|Chronic imbalance|chronic imbalance
678755|NCT00889824|vestibular disorders|vestibular disorders
678756|NCT00889824|balance prosthesis|balance prosthesis
678757|NCT00889837|Staccato Loxapine|staccato loxapine
678758|NCT00889837|COPD|copd
678759|NCT00889837|pulmonary safety|pulmonary safety
678760|NCT00889850|Healthy|healthy
678761|NCT00889850|Bioavailability|bioavailability
678762|NCT00889850|Bioequivalence|bioequivalence
678763|NCT00889850|Esomeprazole|esomeprazole
678764|NCT00889850|Bioavailability, Therapeutical Indication Not Studied|bioavailability, therapeutical indication not studied
678765|NCT00889863|Flare|flare
678766|NCT00889863|arthritis|arthritis
678767|NCT00889863|IL-1beta antagonist|il-1beta antagonist
678768|NCT00889863|systemic juvenile idiopathic arthritis|systemic juvenile idiopathic arthritis
678769|NCT00889863|Juvenile rheumatoid|juvenile rheumatoid
678770|NCT00889876|Obesity|obesity
678771|NCT00889876|Adolescents|adolescents
678772|NCT00889876|Nocturnal blood pressure reduction|nocturnal blood pressure reduction
678773|NCT00889876|Insulin metabolism|insulin metabolism
678774|NCT00889876|Cardiovascular structure and function|cardiovascular structure and function
678775|NCT00889876|Treatment|treatment
678776|NCT00889876|Exercise|exercise
678777|NCT00889876|Metformin|metformin
678778|NCT00889876|Insulin|insulin
678779|NCT00889876|Blood glucose|blood glucose
678780|NCT00889876|Impaired nocturnal blood pressure reduction|impaired nocturnal blood pressure reduction
678781|NCT00889889|Influenza|influenza
678782|NCT00889889|Phase II|phase ii
678783|NCT00889889|Placebo-controlled|placebo-controlled
678784|NCT00889902|Molecular Markers|molecular markers
678785|NCT00889902|Cervical Cancer|cervical cancer
678786|NCT00889902|Screening|screening
678787|NCT00889902|Makov|makov
678788|NCT00889915|ADHD|adhd
678789|NCT00889915|Methylphenidate|methylphenidate
678790|NCT00889915|Amphetamine|amphetamine
678791|NCT00889928|gallbladder disease|gallbladder disease
678792|NCT00889928|cholecystectomy|cholecystectomy
678793|NCT00889928|gallbladder disease indicated for cholecystectomy|gallbladder disease indicated for cholecystectomy
678794|NCT00889954|EBV+|ebv+
678795|NCT00889954|Her2|her2
678796|NCT00889954|TGFBeta|tgfbeta
678797|NCT00889954|EBV positive|ebv positive
678798|NCT00889954|HER 2 positive malignancy|her 2 positive malignancy
678799|NCT00889954|cytotoxic T lymphocytes|cytotoxic t lymphocytes
678800|NCT00889967|Pseudomonas aeruginosa|pseudomonas aeruginosa
678801|NCT00889967|antimicrobial|antimicrobial
678802|NCT00889967|inhalation|inhalation
678803|NCT00889967|ciprofloxacin|ciprofloxacin
678804|NCT00889967|Non-Cystic Fibrosis Bronchiectasis|non-cystic fibrosis bronchiectasis
678805|NCT00889993|Food intake|food intake
678806|NCT00889993|Gut hormones|gut hormones
678807|NCT00889993|Fiber|fiber
678808|NCT00889993|Visual analog scales|visual analog scales
678809|NCT00890006|Prostate cancer|prostate cancer
678810|NCT00890006|Magnetic resonance imaging|magnetic resonance imaging
678811|NCT00890032|adult giant cell glioblastoma|adult giant cell glioblastoma
678812|NCT00890032|adult glioblastoma|adult glioblastoma
678813|NCT00890032|adult gliosarcoma|adult gliosarcoma
678814|NCT00890032|adult astrocytoma|adult astrocytoma
678815|NCT00890032|recurrent adult brain tumor|recurrent adult brain tumor
678816|NCT00890045|Vascular access hemodialysis|vascular access hemodialysis
678817|NCT00890045|ePTFE graft|eptfe graft
678818|NCT00890045|Graft-eligible|graft-eligible
678819|NCT00890045|Long-term vascular access for hemodialysis|long-term vascular access for hemodialysis
678820|NCT00890058|Arthritis|arthritis
678821|NCT00890058|Synovitis|synovitis
678822|NCT00890058|Aromatase Inhibitor|aromatase inhibitor
678823|NCT00890058|Arthralgia Syndrome|arthralgia syndrome
678824|NCT00890071|Fluid responsiveness|fluid responsiveness
678825|NCT00890071|Ultrasound|ultrasound
678826|NCT00890071|Cardiac output|cardiac output
678827|NCT00890097|Geographic Atrophy|geographic atrophy
678829|NCT00890097|Age-Related Macular Degeneration|age-related macular degeneration
678830|NCT00890097|AMD|amd
678831|NCT00890110|Renal cell cancer|renal cell cancer
678832|NCT00890110|sunitinib|sunitinib
678833|NCT00890110|autologous vaccine|autologous vaccine
678834|NCT00890110|metastatic RCC|metastatic rcc
678835|NCT00890123|Omega 3 Fatty Acids|omega 3 fatty acids
678836|NCT00890123|Inflammation|inflammation
678837|NCT00890123|Hip Surgery|hip surgery
678838|NCT00890123|Inflammatory status|inflammatory status
678839|NCT00890123|Infectious complications|infectious complications
678840|NCT00890136|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
678841|NCT00890149|alcohol abuse|alcohol abuse
678842|NCT00890149|binge drinking|binge drinking
678843|NCT00890149|severe drinking|severe drinking
678844|NCT00890149|alcoholism|alcoholism
678846|NCT00890162|Omalizumab|omalizumab
678847|NCT00890162|Idiopathic Anaphylaxis|idiopathic anaphylaxis
678848|NCT00890162|Serum Tryptase|serum tryptase
678849|NCT00890162|Placebo-Controlled|placebo-controlled
678850|NCT00890162|Adult|adult
678851|NCT00890162|Anaphylaxis|anaphylaxis
678852|NCT00890162|Allergic Reaction|allergic reaction
678853|NCT00890175|Asthma, Staccato loxapine|asthma, staccato loxapine
678854|NCT00890188|THALIDOMIDE|thalidomide
678855|NCT00890188|UFUR|ufur
678856|NCT00890188|Colorectal cancer|colorectal cancer
678857|NCT00890188|Oxaliplatin|oxaliplatin
678858|NCT00890201|Pancreaticobiliary reflux|pancreaticobiliary reflux
678859|NCT00890201|Normal pancreaticobiliary junction|normal pancreaticobiliary junction
678860|NCT00890201|Gallstones|gallstones
678861|NCT00890201|Cholelithiasis|cholelithiasis
678862|NCT00890201|Cholecystectomy|cholecystectomy
678863|NCT00890214|Anticoagulation|anticoagulation
678864|NCT00890214|Prostacyclin|prostacyclin
678865|NCT00890214|Heparin|heparin
678866|NCT00890214|Renal Replacement Therapy|renal replacement therapy
678867|NCT00890214|Kidney failure acute|kidney failure acute
678868|NCT00890214|Platelet aggregation|platelet aggregation
678869|NCT00890227|scoliosis|scoliosis
678870|NCT00890227|kyphosis|kyphosis
678871|NCT00890227|Surgical treatment|surgical treatment
678872|NCT00890240|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
678873|NCT00890240|ADHD|adhd
678874|NCT00890240|JNJ-31001074|jnj-31001074
678875|NCT00890253|Renal impairment|renal impairment
678876|NCT00890253|Liver transplantation|liver transplantation
678877|NCT00890253|Chronic Renal Insufficiency|chronic renal insufficiency
678878|NCT00890266|keratoconus|keratoconus
678879|NCT00890266|collagen cross-linking|collagen cross-linking
678880|NCT00890266|riboflavin|riboflavin
678881|NCT00890266|UV light|uv light
678882|NCT00890279|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
678883|NCT00890279|Hypertension|hypertension
678884|NCT00890279|Angiotensin-II Receptor Blocker|angiotensin-ii receptor blocker
678885|NCT00890279|Calcium Channel Blocker|calcium channel blocker
678886|NCT00890279|Angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
678887|NCT00890279|Kidney Volume|kidney volume
678888|NCT00890279|eGFR|egfr
678889|NCT00890292|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
678890|NCT00890292|ADHD|adhd
678891|NCT00890292|JNJ-31001074|jnj-31001074
678892|NCT00890305|Metastatic colorectal cancer|metastatic colorectal cancer
678893|NCT00890305|FOLFOX chemotherapy|folfox chemotherapy
678894|NCT00890344|PeaPod|peapod
678895|NCT00890344|BIA|bia
678896|NCT00890344|Anthropometry|anthropometry
678897|NCT00890344|Body Composition|body composition
678898|NCT00890344|Fat Mass|fat mass
678899|NCT00890344|Total Body Water|total body water
678900|NCT00890344|Neonatology|neonatology
678901|NCT00890370|Cystic fibrosis|cystic fibrosis
678902|NCT00890370|Airway clearance|airway clearance
678903|NCT00890383|trauma resuscitation|trauma resuscitation
678904|NCT00890383|abdominal hypertension|abdominal hypertension
678905|NCT00890383|abdominal compartment syndrome|abdominal compartment syndrome
678906|NCT00890396|Sickle Cell Anemia|sickle cell anemia
678907|NCT00890396|Hydroxyurea|hydroxyurea
678908|NCT00890409|hypothermia|hypothermia
678909|NCT00890409|neonate|neonate
678910|NCT00890409|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
678911|NCT00890409|efficacy|efficacy
678912|NCT00890409|safety|safety
678913|NCT00890422|encephalitis|encephalitis
678914|NCT00890422|FSME|fsme
678915|NCT00890422|central european encephalitis|central european encephalitis
678916|NCT00890435|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
678917|NCT00890435|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
678918|NCT00890435|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
678919|NCT00890435|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
678920|NCT00890435|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
678921|NCT00890435|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
678922|NCT00890435|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
678923|NCT00890435|recurrent childhood ependymoma|recurrent childhood ependymoma
679344|NCT00891930|biomarker|biomarker
678924|NCT00890435|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
678925|NCT00890435|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
678926|NCT00890435|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
678927|NCT00890435|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
678928|NCT00890435|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
679013|NCT00890721|Postoperative pain|postoperative pain
678929|NCT00890435|childhood choroid plexus tumor|childhood choroid plexus tumor
678930|NCT00890435|childhood craniopharyngioma|childhood craniopharyngioma
678931|NCT00890435|childhood ependymoblastoma|childhood ependymoblastoma
678932|NCT00890435|childhood medulloepithelioma|childhood medulloepithelioma
678933|NCT00890435|childhood meningioma|childhood meningioma
678934|NCT00890435|childhood mixed glioma|childhood mixed glioma
678935|NCT00890435|childhood oligodendroglioma|childhood oligodendroglioma
678936|NCT00890435|adult astrocytic tumors|adult astrocytic tumors
678937|NCT00890435|adult brain stem glioma|adult brain stem glioma
678938|NCT00890435|adult choroid plexus tumor|adult choroid plexus tumor
678939|NCT00890435|adult craniopharyngioma|adult craniopharyngioma
678940|NCT00890435|adult ependymoblastoma|adult ependymoblastoma
678941|NCT00890435|adult medulloblastoma|adult medulloblastoma
678942|NCT00890435|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
678943|NCT00890435|adult ependymal tumors|adult ependymal tumors
678944|NCT00890435|adult meningeal tumor|adult meningeal tumor
678945|NCT00890435|adult mixed glioma|adult mixed glioma
678946|NCT00890435|adult oligodendroglial tumors|adult oligodendroglial tumors
678947|NCT00890435|adult pineal parenchymal tumor|adult pineal parenchymal tumor
678948|NCT00890435|recurrent adult brain tumor|recurrent adult brain tumor
678949|NCT00890435|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
678950|NCT00890435|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
678951|NCT00890435|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
678952|NCT00890435|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
678953|NCT00890435|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
678954|NCT00890435|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
678955|NCT00890435|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
678956|NCT00890435|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
678957|NCT00890435|secondary acute myeloid leukemia|secondary acute myeloid leukemia
678958|NCT00890435|acute undifferentiated leukemia|acute undifferentiated leukemia
678959|NCT00890435|mast cell leukemia|mast cell leukemia
678960|NCT00890435|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
678961|NCT00890435|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
678962|NCT00890435|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
678963|NCT00890435|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
678964|NCT00890435|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
678965|NCT00890435|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
678966|NCT00890435|refractory hairy cell leukemia|refractory hairy cell leukemia
678967|NCT00890435|prolymphocytic leukemia|prolymphocytic leukemia
678968|NCT00890448|Alanine Transaminase elevation|alanine transaminase elevation
678969|NCT00890448|Genetic Markers|genetic markers
678970|NCT00890448|DNA Markers|dna markers
678972|NCT00890461|ICD|icd
678973|NCT00890474|Breech presentation at 34 to 36 weeks of gestation|breech presentation at 34 to 36 weeks of gestation
678974|NCT00890526|Tinnitus Retraining Therapy (TRT)|tinnitus retraining therapy (trt)
678975|NCT00890565|Electrocardiogram|electrocardiogram
678976|NCT00890565|Effect on electrocardiogram|effect on electrocardiogram
678977|NCT00890565|Granisetron|granisetron
678978|NCT00890565|Moxifloxacin|moxifloxacin
678979|NCT00890565|Pharmacokinetic profile|pharmacokinetic profile
678980|NCT00890565|Sancuso® patch|sancuso® patch
678981|NCT00890565|Transdermal|transdermal
678982|NCT00890578|Histoacryl|histoacryl
678983|NCT00890578|closure of surgical incisions|closure of surgical incisions
678984|NCT00890591|hypertension|hypertension
678985|NCT00890591|angiotensin II type 1 receptor blocker|angiotensin ii type 1 receptor blocker
678986|NCT00890591|olmesartan|olmesartan
678987|NCT00890617|lung metastases|lung metastases
678988|NCT00890617|stage I non-small cell lung cancer|stage i non-small cell lung cancer
678989|NCT00890643|Stress disorders, post-traumatic|stress disorders, post-traumatic
678990|NCT00890643|Combat Disorders|combat disorders
678991|NCT00890643|prazosin|prazosin
678992|NCT00890643|cognition|cognition
678993|NCT00890643|neurophysiology|neurophysiology
678994|NCT00890656|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
678995|NCT00890656|ALL|all
678996|NCT00890656|Leukemia|leukemia
678997|NCT00890656|Hyper-CVAD|hyper-cvad
678999|NCT00890669|body load|body load
679000|NCT00890669|quality of life|quality of life
679001|NCT00890669|Parkinson's disease|parkinson's disease
679002|NCT00890669|Motor Symptoms|motor symptoms
679003|NCT00890682|Bunion|bunion
679004|NCT00890682|Bunionectomy|bunionectomy
679005|NCT00890682|Osteotomy|osteotomy
679006|NCT00890695|supplementary feeding|supplementary feeding
679007|NCT00890695|moderate malnutrition|moderate malnutrition
679008|NCT00890695|acute infection|acute infection
679009|NCT00890695|developing country|developing country
679010|NCT00890695|children|children
679011|NCT00890721|Hemorrhoid|hemorrhoid
679012|NCT00890721|Hemorrhoidectomy|hemorrhoidectomy
679015|NCT00890747|HIV Infections|hiv infections
679016|NCT00890747|treatment experienced|treatment experienced
679017|NCT00890760|Malaria|malaria
679018|NCT00890760|Vaccine|vaccine
679019|NCT00890799|transcatheter closure|transcatheter closure
679020|NCT00890799|ventricular septal defects|ventricular septal defects
679021|NCT00890812|Acute Ischemic Stroke|acute ischemic stroke
679022|NCT00890825|Non small cell lung cancer (NSCLC)|non small cell lung cancer (nsclc)
679023|NCT00890825|KRAS mutation|kras mutation
679024|NCT00890838|IVFO|ivfo
679025|NCT00890838|Inflammation|inflammation
679026|NCT00890838|Valvular surgery|valvular surgery
679027|NCT00890838|Inflammatory status|inflammatory status
679028|NCT00890838|Infectious complications|infectious complications
679029|NCT00890851|Radiofrequency|radiofrequency
679030|NCT00890851|Mini invasin surgery|mini invasin surgery
679031|NCT00890851|Outpatient treatment|outpatient treatment
679032|NCT00890851|Men health|men health
679033|NCT00890864|Breast screening|breast screening
679034|NCT00890864|Mammogram|mammogram
679035|NCT00890864|Routine screening programme|routine screening programme
679036|NCT00890877|asthma|asthma
679037|NCT00890877|treatment|treatment
679038|NCT00890877|placebo|placebo
679039|NCT00890877|efficacy|efficacy
679040|NCT00890877|safety|safety
679041|NCT00890903|NSCLC|nsclc
679042|NCT00890903|non small cell lung carcinoma|non small cell lung carcinoma
679043|NCT00890903|metastatic breast cancer|metastatic breast cancer
679044|NCT00890903|MBC|mbc
679045|NCT00890903|advanced breast cancer|advanced breast cancer
679046|NCT00890903|Navelbine|navelbine
679047|NCT00890903|Navelbine-ORAL|navelbine-oral
679048|NCT00890903|Vinorelbine|vinorelbine
679049|NCT00890903|Vinorelbine-ORAL|vinorelbine-oral
679050|NCT00890903|daily routine|daily routine
679051|NCT00890903|concomitant antiemetic therapy|concomitant antiemetic therapy
679052|NCT00890903|patient compliance|patient compliance
679053|NCT00890903|germany|germany
679054|NCT00890903|non-interventional study|non-interventional study
679055|NCT00890903|oral anti cancer therapy|oral anti cancer therapy
679056|NCT00890903|quality of life|quality of life
679057|NCT00890916|spinal cord injury|spinal cord injury
679058|NCT00890916|neuroprosthesis|neuroprosthesis
679059|NCT00890916|functional electrical stimulation|functional electrical stimulation
679060|NCT00890916|quadriplegia|quadriplegia
679061|NCT00890929|Acute myeloid leukemia|acute myeloid leukemia
679062|NCT00890929|Acute myeloblastic leukemia|acute myeloblastic leukemia
679063|NCT00890929|AML|aml
679064|NCT00890942|pruritus|pruritus
679065|NCT00890942|intrathecal morphine|intrathecal morphine
679066|NCT00890955|Solid tumors|solid tumors
679067|NCT00890968|hand dermatitis|hand dermatitis
679068|NCT00890968|hand eczema|hand eczema
679069|NCT00890968|triamcinolone acetonide|triamcinolone acetonide
679070|NCT00890994|MBI|mbi
679071|NCT00890994|Molecular Breast Imaging|molecular breast imaging
679072|NCT00890994|Breast Cancer|breast cancer
679073|NCT00890994|DCIS|dcis
679074|NCT00890994|Breast|breast
679075|NCT00890994|Calcifications|calcifications
679076|NCT00890994|Microcalcifications|microcalcifications
679077|NCT00891007|Measles|measles
679078|NCT00891007|Virus Disease|virus disease
679079|NCT00891007|Paediatric Diseases|paediatric diseases
679080|NCT00891007|Paramyoxyviridae|paramyoxyviridae
679081|NCT00891033|cancer|cancer
679082|NCT00885443|propofol|propofol
679083|NCT00885443|sevoflurane|sevoflurane
679084|NCT00885443|pediatric|pediatric
679085|NCT00885443|emergence delirium|emergence delirium
679086|NCT00885443|Induction of sedation|induction of sedation
679087|NCT00885456|stroke|stroke
679088|NCT00885456|secondary prevention|secondary prevention
679089|NCT00885456|vascular risk|vascular risk
679090|NCT00885456|behavioral change|behavioral change
679091|NCT00885456|exercise|exercise
679092|NCT00885456|lifestyle modification|lifestyle modification
679093|NCT00885469|known Barrett's Esophagus|known barrett's esophagus
679094|NCT00885469|Suspected Barrett's Esophagus|suspected barrett's esophagus
679095|NCT00885469|chronic GERD|chronic gerd
679096|NCT00885469|known Barrett's Esophagus or chronic GERD|known barrett's esophagus or chronic gerd
679097|NCT00885482|HIV/AIDS|hiv/aids
679098|NCT00885482|HAART|haart
679099|NCT00885482|Simplification|simplification
679100|NCT00885482|Atazanavir|atazanavir
679101|NCT00885482|Lamivudine|lamivudine
679102|NCT00885482|treatment experienced|treatment experienced
679103|NCT00885495|HIV|hiv
679104|NCT00885495|dyslipidemia|dyslipidemia
679105|NCT00885495|statins|statins
679106|NCT00885495|protease inhibitors|protease inhibitors
679107|NCT00885508|MDS|mds
679108|NCT00885508|AML|aml
679109|NCT00885508|deletion 5q|deletion 5q
679110|NCT00885508|Documented diagnosis of MDS, or CMML|documented diagnosis of mds, or cmml
679111|NCT00885508|with WBC < 13,000/mm3 that meets IPSS criteria for intermediate-2|with wbc < 13,000/mm3 that meets ipss criteria for intermediate-2
679112|NCT00885508|or high-risk disease, or AML with an associated del 5q[31]|or high-risk disease, or aml with an associated del 5q[31]
679113|NCT00885508|(the deleted chromosomal region must include 5q[31]),|(the deleted chromosomal region must include 5q[31]),
683650|NCT00903734|Bortezomib|bortezomib
679114|NCT00885508|with or without additional cytogenetic abnormalities|with or without additional cytogenetic abnormalities
679115|NCT00885534|skin cancer|skin cancer
679116|NCT00885534|CISPLATIN|cisplatin
679117|NCT00885534|TEMOZOLOMIDE|temozolomide
679118|NCT00885534|VINBLASTINE|vinblastine
679119|NCT00885534|09-017|09-017
679120|NCT00885560|ADHD|adhd
679121|NCT00885560|SNAP 25|snap 25
679122|NCT00885560|amphetamine|amphetamine
679123|NCT00885560|methylphenidate|methylphenidate
679124|NCT00885573|sleep apnea|sleep apnea
679125|NCT00885573|pharyngeal sensitivity|pharyngeal sensitivity
679126|NCT00885573|pharyngeal dilator reflex|pharyngeal dilator reflex
679127|NCT00885573|diagnosis algorithm|diagnosis algorithm
679128|NCT00885573|patients with suspected sleep apnea syndrome|patients with suspected sleep apnea syndrome
679129|NCT00891046|Flare|flare
679130|NCT00891046|arthritis|arthritis
679131|NCT00891046|IL-1beta antagonist|il-1beta antagonist
679132|NCT00891046|systemic juvenile idiopathic arthritis|systemic juvenile idiopathic arthritis
679133|NCT00891046|CHAQ|chaq
679134|NCT00891046|steroids|steroids
679135|NCT00891046|ACR pediatric response|acr pediatric response
679136|NCT00891046|Systemic juvenile idiopathic arthritis with active flare|systemic juvenile idiopathic arthritis with active flare
679137|NCT00891059|Cognitive Impairment|cognitive impairment
679138|NCT00891059|Diskus Inhaler|diskus inhaler
679139|NCT00891059|Nursing Home|nursing home
679140|NCT00891085|ventilation|ventilation
679141|NCT00891085|ards|ards
679142|NCT00891085|ali|ali
679143|NCT00891085|trauma|trauma
679144|NCT00891085|Trauma Patients with ISS > 25|trauma patients with iss > 25
679145|NCT00891111|Health Risk Assessment|health risk assessment
679146|NCT00891111|Incentives|incentives
679147|NCT00891111|Preventative Healthcare|preventative healthcare
679148|NCT00891111|Encouraging Health Risk Assessments|encouraging health risk assessments
679149|NCT00891124|Hypertension|hypertension
679150|NCT00891124|Type II DM|type ii dm
679151|NCT00891124|Hyperlipidemia|hyperlipidemia
679152|NCT00891124|Glycemia|glycemia
679153|NCT00891124|ADA 2008 guideline|ada 2008 guideline
679154|NCT00891124|Patient Consultation|patient consultation
679155|NCT00891137|adult acute myeloid leukemia 11q23 (MLL) abnormalities|adult acute myeloid leukemia 11q23 (mll) abnormalities
679156|NCT00891137|adult acute myeloid leukemia inv(16)(p13;q22)|adult acute myeloid leukemia inv(16)(p13;q22)
679157|NCT00891137|adult acute myeloid leukemia t(15;17)(q22;q12)|adult acute myeloid leukemia t(15;17)(q22;q12)
679158|NCT00891137|adult acute myeloid leukemia t(16;16)(p13;q22)|adult acute myeloid leukemia t(16;16)(p13;q22)
679159|NCT00891137|adult acute myeloid leukemia t(8;21)(q22;q22)|adult acute myeloid leukemia t(8;21)(q22;q22)
679160|NCT00891137|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
679161|NCT00891137|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
679162|NCT00891137|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
679163|NCT00891137|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
679164|NCT00891137|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
679165|NCT00891137|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
679166|NCT00891137|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
679167|NCT00891137|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
679168|NCT00891137|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
679169|NCT00891137|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
679170|NCT00891137|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
679171|NCT00891137|extranodal marginal zone B-cell lymphoma|extranodal marginal zone b-cell lymphoma
679172|NCT00891137|mucosa-associated lymphoid tissue|mucosa-associated lymphoid tissue
679173|NCT00891137|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
679174|NCT00891137|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
679175|NCT00891137|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
679176|NCT00891137|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
679177|NCT00891137|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
679178|NCT00891137|noncontiguous stage II adult immunoblastic|noncontiguous stage ii adult immunoblastic
679179|NCT00891137|contiguous stage II adult immunoblastic|contiguous stage ii adult immunoblastic
679180|NCT00891137|large cell lymphoma|large cell lymphoma
679181|NCT00891137|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
679182|NCT00891137|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
679183|NCT00891137|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
679184|NCT00891137|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
679185|NCT00891137|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
679186|NCT00891137|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
679187|NCT00891137|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
679188|NCT00891137|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
679189|NCT00891137|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
679190|NCT00891137|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
679191|NCT00891137|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
679192|NCT00891137|refractory multiple myeloma|refractory multiple myeloma
679193|NCT00891137|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
679194|NCT00891137|secondary acute myeloid leukemia|secondary acute myeloid leukemia
679195|NCT00891137|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
679266|NCT00891254|Complications|complications
679196|NCT00891137|splenic marginal zone lymphoma|splenic marginal zone lymphoma
679197|NCT00891137|stage I multiple myeloma|stage i multiple myeloma
679198|NCT00891137|stage II multiple myeloma|stage ii multiple myeloma
679199|NCT00891137|stage III multiple myeloma|stage iii multiple myeloma
679200|NCT00891137|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
679201|NCT00891137|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
679202|NCT00891137|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
679203|NCT00891137|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
679204|NCT00891137|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
679205|NCT00891137|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
679206|NCT00891137|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
679207|NCT00891137|refractory anemia with excess blasts|refractory anemia with excess blasts
679209|NCT00891137|prolymphocytic leukemia|prolymphocytic leukemia
679210|NCT00891137|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
679211|NCT00891137|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
679212|NCT00891137|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
679213|NCT00891137|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
679214|NCT00891137|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
679215|NCT00891137|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
679216|NCT00891137|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
679217|NCT00891137|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
679218|NCT00891137|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
679219|NCT00891137|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
679220|NCT00891137|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
679221|NCT00891137|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
679222|NCT00891137|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
679223|NCT00891137|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
679224|NCT00891137|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
679225|NCT00891137|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
679226|NCT00891137|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
679227|NCT00891137|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
679228|NCT00891137|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
679229|NCT00891137|stage I mantle cell lymphoma|stage i mantle cell lymphoma
679230|NCT00891137|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
679231|NCT00891137|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
679232|NCT00891137|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
679233|NCT00891137|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
679234|NCT00891137|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
679235|NCT00891137|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
679236|NCT00891137|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
679237|NCT00891137|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
679238|NCT00891137|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
679239|NCT00891137|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
679240|NCT00891137|Burkitt lymphoma|burkitt lymphoma
679241|NCT00891163|Topical anesthesia|topical anesthesia
679242|NCT00891163|Analgesia|analgesia
679243|NCT00891176|Conjugate vaccines|conjugate vaccines
679244|NCT00891176|Meningococcal serogroup C vaccine|meningococcal serogroup c vaccine
679245|NCT00891176|Antibody persistence|antibody persistence
679246|NCT00891176|Pneumococcal vaccine|pneumococcal vaccine
679247|NCT00891176|Haemophilus Influenzae type b vaccine|haemophilus influenzae type b vaccine
679248|NCT00891189|Circadian Rhythm|circadian rhythm
679249|NCT00891202|Gaucher,|gaucher,
679250|NCT00891202|beta-glucosidase,|beta-glucosidase,
679251|NCT00891202|acid ß-glucosidase,|acid ß-glucosidase,
679252|NCT00891202|glucocerebrosidase,|glucocerebrosidase,
679253|NCT00891202|glucosylceramide,|glucosylceramide,
679440|NCT00892307|Diagnostic Imaging|diagnostic imaging
679254|NCT00891202|D-glucosyl-N-acylsphingosine glucohydrolase,|d-glucosyl-n-acylsphingosine glucohydrolase,
679255|NCT00891202|substrate reduction therapy|substrate reduction therapy
679256|NCT00891228|Contraception|contraception
679257|NCT00891228|Male Contraception|male contraception
679258|NCT00891228|Suppression of Sperm Production|suppression of sperm production
679259|NCT00891241|Heart Failure, PET Imaging, Implantable Cardioverter-Defibrillator, Dosimetry|heart failure, pet imaging, implantable cardioverter-defibrillator, dosimetry
679260|NCT00891254|Incisional hernia|incisional hernia
679261|NCT00891254|Intraperitoneal mesh repair|intraperitoneal mesh repair
679262|NCT00891254|On-lay repair|on-lay repair
679263|NCT00891254|Prosthetic mesh|prosthetic mesh
679264|NCT00891254|First repair (no recurrent hernia will be included)|first repair (no recurrent hernia will be included)
679265|NCT00891254|Recurrence|recurrence
679267|NCT00891267|Inflammatory markers|inflammatory markers
679268|NCT00891267|Vascular protection|vascular protection
679269|NCT00891267|OM Effect|om effect
679270|NCT00891267|Metabolic syndrome|metabolic syndrome
679271|NCT00891267|Hypertension|hypertension
679272|NCT00891280|Inflammatory breast cancer|inflammatory breast cancer
679273|NCT00891280|Castleman's Disease|castleman's disease
679274|NCT00891280|Multiple Myeloma|multiple myeloma
679275|NCT00891280|Breast cancer|breast cancer
679276|NCT00891280|Solid tumors|solid tumors
679277|NCT00891280|CK2 inhibitor|ck2 inhibitor
679278|NCT00891293|omega-3-acid ethyl esters|omega-3-acid ethyl esters
679279|NCT00891293|Very high triglycerides|very high triglycerides
679281|NCT00891293|fenofibrate|fenofibrate
679282|NCT00891306|LPLD, Lipoprotein Lipase Deficiency|lpld, lipoprotein lipase deficiency
679283|NCT00891306|Chylomicronemia|chylomicronemia
679284|NCT00891306|Gene therapy|gene therapy
679286|NCT00891306|Lipoprotein Lipase|lipoprotein lipase
679287|NCT00891306|Alipogene tiparvovec|alipogene tiparvovec
679289|NCT00891319|hand|hand
679290|NCT00891319|stroke|stroke
679291|NCT00891319|hemiplegia|hemiplegia
679292|NCT00891319|electrical stimulation|electrical stimulation
679293|NCT00891319|recovery|recovery
679294|NCT00891345|hormone-refractory prostate cancer|hormone-refractory prostate cancer
679295|NCT00891345|Immunotherapy|immunotherapy
679296|NCT00891358|Adolescent Medicine Trials Network for HIV/AIDS Interventions|adolescent medicine trials network for hiv/aids interventions
679297|NCT00891358|Human Immunodeficiency Virus|human immunodeficiency virus
679298|NCT00891358|HIV seronegativity|hiv seronegativity
679299|NCT00891371|symptomatic treatment of patients with refractory diarrhea|symptomatic treatment of patients with refractory diarrhea
679300|NCT00891384|Multiple Myeloma|multiple myeloma
679301|NCT00891384|maintenance therapy|maintenance therapy
679302|NCT00891384|lenalidomide|lenalidomide
679303|NCT00891761|cisplatin|cisplatin
679304|NCT00891761|nausea|nausea
679305|NCT00891761|vomiting|vomiting
679306|NCT00891761|cancer|cancer
679307|NCT00891761|lung cancer|lung cancer
679308|NCT00891787|Probiotics|probiotics
679309|NCT00891787|Isoagglutinins|isoagglutinins
679310|NCT00891787|Anti-A|anti-a
679311|NCT00891787|Anti-B|anti-b
679312|NCT00891787|Hemolysis|hemolysis
679313|NCT00891787|Healthy Volunteer|healthy volunteer
679314|NCT00891787|HV|hv
679315|NCT00891800|Cancer|cancer
679316|NCT00891800|Breast|breast
679317|NCT00891800|Liver|liver
679318|NCT00891826|Bipolar disorders|bipolar disorders
679319|NCT00891826|Omega-3 fatty acids|omega-3 fatty acids
679320|NCT00891826|Heart rate|heart rate
679321|NCT00891865|lung transplant|lung transplant
679322|NCT00891865|BOS|bos
679323|NCT00891865|OB|ob
679324|NCT00891865|Respiratory Viral Infection (RVI)|respiratory viral infection (rvi)
679325|NCT00891865|Lung disease|lung disease
679326|NCT00891878|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
679327|NCT00891878|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
679328|NCT00891878|recurrent esophageal cancer|recurrent esophageal cancer
679329|NCT00891878|stage IV esophageal cancer|stage iv esophageal cancer
679330|NCT00891878|stage III esophageal cancer|stage iii esophageal cancer
679331|NCT00891891|spina bifida, psychosocial adjustment, adolescence, emerging adulthood|spina bifida, psychosocial adjustment, adolescence, emerging adulthood
679332|NCT00891904|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
679333|NCT00891904|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
679334|NCT00891904|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
679335|NCT00891904|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
679336|NCT00891904|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
679337|NCT00891904|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
679338|NCT00891917|Down syndrome|down syndrome
679339|NCT00891917|coenzyme Q10|coenzyme q10
679340|NCT00891917|language function|language function
679341|NCT00891917|behavior|behavior
679342|NCT00891930|wild-type KRAS|wild-type kras
679343|NCT00891930|panitumumab|panitumumab
679345|NCT00891930|mechanisms of acquired resistance|mechanisms of acquired resistance
679346|NCT00891930|metastatic colorectal cancer|metastatic colorectal cancer
679347|NCT00891943|Obesity|obesity
679348|NCT00891943|Overweight|overweight
679349|NCT00891943|Randomised controlled trial|randomised controlled trial
679350|NCT00891943|Primary Care|primary care
679351|NCT00891943|Weight|weight
679352|NCT00891943|Cardiovascular Risk|cardiovascular risk
679353|NCT00891943|Diabetes|diabetes
679354|NCT00891943|Quality of life|quality of life
679355|NCT00891956|Rett Syndrome|rett syndrome
679356|NCT00891969|stage I breast cancer|stage i breast cancer
679357|NCT00891969|stage II breast cancer|stage ii breast cancer
679358|NCT00891969|stage IIIA breast cancer|stage iiia breast cancer
679359|NCT00891982|Acne Vulgaris|acne vulgaris
679360|NCT00891995|Type 1 Diabetes|type 1 diabetes
679361|NCT00891995|Closed Loop Therapy|closed loop therapy
679362|NCT00891995|Continuous Glucose Monitor|continuous glucose monitor
679363|NCT00892008|pregabalin|pregabalin
679364|NCT00892008|neuropathic pain|neuropathic pain
679365|NCT00892008|safety|safety
679366|NCT00892047|Depression|depression
679367|NCT00892047|Aripiprazole|aripiprazole
679368|NCT00892047|Venlafaxine|venlafaxine
679369|NCT00892047|Partial Remission|partial remission
679370|NCT00892047|Augmentation strategy|augmentation strategy
679371|NCT00892047|Treatment resistance|treatment resistance
679372|NCT00892047|Elderly|elderly
679373|NCT00892047|Late-life|late-life
679374|NCT00892073|Craniopharyngioma surgery|craniopharyngioma surgery
679375|NCT00892073|Hypothalamic Obesity|hypothalamic obesity
679376|NCT00892073|Children|children
679377|NCT00892073|Combined Diazoxide and Metformin|combined diazoxide and metformin
679378|NCT00892086|geriatric syndrome|geriatric syndrome
679379|NCT00892086|immobility|immobility
679380|NCT00892099|end stage renal disease|end stage renal disease
679381|NCT00892099|hemodialysis|hemodialysis
679382|NCT00892112|Immunoglobulins, Intravenous|immunoglobulins, intravenous
679383|NCT00892112|Cardiomyopathies|cardiomyopathies
679384|NCT00892112|Parvo B19, Human|parvo b19, human
679385|NCT00892125|Schizophrenia|schizophrenia
679386|NCT00892125|Bipolar I disorder|bipolar i disorder
679387|NCT00892125|mood disorders|mood disorders
679388|NCT00892125|antipsychotic drugs|antipsychotic drugs
679389|NCT00892125|enzyme inducer|enzyme inducer
679390|NCT00892125|Paliperidone ER|paliperidone er
679391|NCT00892138|mindfulness training|mindfulness training
679392|NCT00892138|medical students|medical students
679393|NCT00892138|psychology students|psychology students
679394|NCT00892138|stress management|stress management
679395|NCT00892138|personal development|personal development
679396|NCT00892138|stress|stress
679397|NCT00892164|thyroid surgery|thyroid surgery
679398|NCT00892164|total thyroidectomy|total thyroidectomy
679399|NCT00892164|harmonic scalpel|harmonic scalpel
679400|NCT00892164|electrothermal bipolar vessel sealer|electrothermal bipolar vessel sealer
679401|NCT00892164|hemostatic device|hemostatic device
679402|NCT00892177|adult giant cell glioblastoma|adult giant cell glioblastoma
679403|NCT00892177|adult glioblastoma|adult glioblastoma
679404|NCT00892177|adult gliosarcoma|adult gliosarcoma
679405|NCT00892177|adult mixed glioma|adult mixed glioma
679406|NCT00892177|recurrent adult brain tumor|recurrent adult brain tumor
679407|NCT00892177|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
679408|NCT00892177|adult oligodendroglioma|adult oligodendroglioma
679409|NCT00892177|adult anaplastic astrocytoma|adult anaplastic astrocytoma
679411|NCT00892190|Dasatinib|dasatinib
679412|NCT00892190|all trans retinoic acid|all trans retinoic acid
679413|NCT00892190|relapsed AML|relapsed aml
679414|NCT00892190|refractory AML|refractory aml
679415|NCT00892190|Relapsed/Refractory Acute myelogenous leukemia|relapsed/refractory acute myelogenous leukemia
679541|NCT00892684|Eicosanoids|eicosanoids
679416|NCT00892190|Elderly subjects (age 65 or older) with acute myelogenous leukemia|elderly subjects (age 65 or older) with acute myelogenous leukemia
679417|NCT00892190|Myelodysplastic Syndrome|myelodysplastic syndrome
679419|NCT00892203|Migraine|migraine
679420|NCT00892203|Headache|headache
679421|NCT00892216|PONV|ponv
679422|NCT00892216|NUSS procedure|nuss procedure
679423|NCT00892216|Acupressure|acupressure
679424|NCT00892216|Pectus Excavatum|pectus excavatum
679425|NCT00892229|First trimester missed abortion|first trimester missed abortion
679426|NCT00892229|Misoprostol|misoprostol
679427|NCT00892229|buccal|buccal
679428|NCT00892229|vaginal|vaginal
679429|NCT00892229|cervical ripening|cervical ripening
679430|NCT00892229|first trimester|first trimester
679431|NCT00892229|missed abortion|missed abortion
679432|NCT00892242|Neoadjuvant zoledronic acid in resectable pancreas cancer|neoadjuvant zoledronic acid in resectable pancreas cancer
679433|NCT00892255|Liver cancer|liver cancer
679434|NCT00892255|Tumors|tumors
679435|NCT00892268|menopausal symptoms|menopausal symptoms
679436|NCT00892268|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
679437|NCT00892268|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
679438|NCT00892268|breast cancer|breast cancer
679439|NCT00892268|pain|pain
679836|NCT00893906|Africa|africa
679441|NCT00892307|Dual Source Multidetector Computed Tomography|dual source multidetector computed tomography
679442|NCT00892307|Computed Tomography|computed tomography
679444|NCT00892307|Single Photon Emission Computed Tomography|single photon emission computed tomography
679445|NCT00892307|SPECT|spect
679446|NCT00892307|Myocardial Perfusion|myocardial perfusion
679447|NCT00892307|Atherosclerosis|atherosclerosis
683651|NCT00903734|Dasatinib|dasatinib
679448|NCT00892320|Schizophrenia, mood stabilizers, antipsychotics|schizophrenia, mood stabilizers, antipsychotics
679449|NCT00892320|ER OROS paliperidone|er oros paliperidone
679450|NCT00892333|Repair of a large hernia with SurgiMend 3.0, a biologic mesh|repair of a large hernia with surgimend 3.0, a biologic mesh
679451|NCT00892346|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
679452|NCT00892346|maintenance|maintenance
679453|NCT00892359|pharmacokinetics|pharmacokinetics
679454|NCT00892359|renal replacement therapy|renal replacement therapy
679455|NCT00892359|hemofiltration|hemofiltration
679456|NCT00892359|anidulafungin|anidulafungin
679457|NCT00892372|body weight|body weight
679458|NCT00892372|glycohemoglobin|glycohemoglobin
679459|NCT00892385|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
679460|NCT00892398|Trabeculectomy|trabeculectomy
679461|NCT00892398|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
679462|NCT00892398|Wound Healing|wound healing
679463|NCT00892398|Angiogenesis Inhibitors|angiogenesis inhibitors
679464|NCT00892411|Neuroplasticity|neuroplasticity
679465|NCT00892411|Prognosis|prognosis
679466|NCT00892424|Liver metastasis|liver metastasis
679467|NCT00892424|sorafenib|sorafenib
679468|NCT00892424|Liver metastasis from cancer|liver metastasis from cancer
679469|NCT00892437|HIV|hiv
679470|NCT00892437|HIV-1|hiv-1
679471|NCT00892437|Antiretroviral Treatment-Naive|antiretroviral treatment-naive
679472|NCT00892450|Overactive bladder symptoms|overactive bladder symptoms
679473|NCT00892450|Parkinson's disease|parkinson's disease
679474|NCT00892450|darifenacin|darifenacin
679475|NCT00892450|oxybutynin|oxybutynin
679476|NCT00892450|cognition|cognition
679477|NCT00892463|Major Depressive Disorder|major depressive disorder
679478|NCT00892463|Seroquel XR|seroquel xr
679479|NCT00892463|Quetiapine|quetiapine
679480|NCT00892476|myopia|myopia
679481|NCT00892476|calcium supplementation|calcium supplementation
679482|NCT00892476|prematurity|prematurity
679483|NCT00892489|Schizophrenia, Mood disorders, Antipsychotics|schizophrenia, mood disorders, antipsychotics
679484|NCT00892489|ER OROS Paliperidone|er oros paliperidone
679485|NCT00892502|haematology|haematology
679486|NCT00892502|haematological|haematological
679487|NCT00892502|hematology|hematology
679488|NCT00892502|hematological|hematological
679489|NCT00892502|malignancy|malignancy
679490|NCT00892502|lymphoma|lymphoma
679491|NCT00892502|myeloma|myeloma
679492|NCT00892502|leukemia|leukemia
679493|NCT00892502|blood diseases|blood diseases
679494|NCT00892502|malignant|malignant
679495|NCT00892502|bismuth|bismuth
679496|NCT00892515|breast cancer|breast cancer
679497|NCT00892515|healthy, no evidence of disease|healthy, no evidence of disease
679498|NCT00892541|Schizophrenia|schizophrenia
679499|NCT00892541|Mood disorders|mood disorders
679500|NCT00892541|Antipsychotic drugs|antipsychotic drugs
679501|NCT00892541|Renal secretion|renal secretion
679502|NCT00892541|ER OROS paliperidone|er oros paliperidone
679503|NCT00892554|Phenylketonurias|phenylketonurias
679504|NCT00892554|Docosahexaenoic Acids|docosahexaenoic acids
679505|NCT00892554|Neuropsychological Tests|neuropsychological tests
679506|NCT00892554|Female|female
679507|NCT00892554|Adolescent|adolescent
679508|NCT00892554|Adult|adult
679509|NCT00892567|breast cancer|breast cancer
679510|NCT00892567|peptide vaccine|peptide vaccine
679511|NCT00892567|immunotherapy|immunotherapy
679512|NCT00892580|fragile X syndrome|fragile x syndrome
679513|NCT00892580|biomarkers|biomarkers
679514|NCT00892593|colon|colon
679515|NCT00892593|neoplasia|neoplasia
679516|NCT00892593|polyp|polyp
679517|NCT00892593|adenoma|adenoma
679518|NCT00892593|FIT|fit
679519|NCT00892593|cancer|cancer
679520|NCT00892606|Surgery, Orthopedic|surgery, orthopedic
679521|NCT00892606|Pain, Postoperative|pain, postoperative
679522|NCT00892619|Epiretinal Membrane|epiretinal membrane
679523|NCT00892619|Vitreomacular traction|vitreomacular traction
679524|NCT00892619|MVR blade|mvr blade
679525|NCT00892619|Tano brush|tano brush
679526|NCT00892619|ILM forceps|ilm forceps
679527|NCT00892619|surgical technique|surgical technique
679528|NCT00892632|Biliary Strictures|biliary strictures
679529|NCT00892632|Cholangiocarcinoma|cholangiocarcinoma
679530|NCT00892632|ERCP|ercp
679531|NCT00892658|Sorafenib|sorafenib
679532|NCT00892658|Hepatocellular carcinoma|hepatocellular carcinoma
679533|NCT00892671|Perceived effectiveness|perceived effectiveness
679534|NCT00892684|Randomized|randomized
679535|NCT00892684|Placebo controlled|placebo controlled
679536|NCT00892684|Double blind|double blind
679537|NCT00892684|Omega-3 fatty acids|omega-3 fatty acids
679538|NCT00892684|Pregnancy|pregnancy
679539|NCT00892684|Childhood allergy|childhood allergy
679542|NCT00892684|Polyunsaturated fatty acids|polyunsaturated fatty acids
679543|NCT00892697|hepatitis C|hepatitis c
679544|NCT00892697|FNA|fna
679545|NCT00892697|intrahepatic|intrahepatic
679546|NCT00892710|Non small cell lung cancer|non small cell lung cancer
679547|NCT00892710|NSCLC|nsclc
679548|NCT00892710|Pemetrexed|pemetrexed
679549|NCT00892710|Bevacizumab|bevacizumab
679550|NCT00892710|Avastin|avastin
679551|NCT00892710|Carboplatin|carboplatin
679552|NCT00892710|Stage IIIB/IV|stage iiib/iv
679553|NCT00892723|AZX100|azx100
679554|NCT00892723|Patient and Observer Scar Assessment Scale|patient and observer scar assessment scale
679555|NCT00892723|POSAS|posas
679556|NCT00892723|Visual Analog Scale|visual analog scale
679557|NCT00892723|VAS|vas
679558|NCT00892723|Keloid|keloid
679559|NCT00892723|Scarring|scarring
679560|NCT00892723|Scar reduction|scar reduction
679561|NCT00892723|Scar prevention|scar prevention
679562|NCT00892749|hyperphosphatemia|hyperphosphatemia
679563|NCT00892749|hemodialysis|hemodialysis
679564|NCT00892749|CKD|ckd
679565|NCT00892749|ASP1585|asp1585
679566|NCT00892762|Open Angle Glaucoma|open angle glaucoma
679567|NCT00892762|Ocular hypertension|ocular hypertension
679568|NCT00892762|OAG|oag
679569|NCT00892762|OH|oh
679570|NCT00892775|Working seed virus|working seed virus
679571|NCT00892775|Rubella|rubella
679572|NCT00892775|Mumps|mumps
679573|NCT00892775|Varicella|varicella
679574|NCT00892775|Combined measles-mumps-rubella-varicella vaccine|combined measles-mumps-rubella-varicella vaccine
679575|NCT00892775|Pediatric immunization|pediatric immunization
679576|NCT00892775|Measles|measles
679577|NCT00892788|Overweight|overweight
679578|NCT00892788|Obesity|obesity
679579|NCT00892788|Contingency Management|contingency management
679580|NCT00892801|tumors metastatic to brain|tumors metastatic to brain
679581|NCT00892801|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
679582|NCT00892801|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
679583|NCT00892827|Rituximab|rituximab
679584|NCT00892827|Mabthera|mabthera
679585|NCT00892827|FFP|ffp
679586|NCT00892827|Fresh Frozen Plasma|fresh frozen plasma
679587|NCT00892827|CLL|cll
679588|NCT00892827|Complement|complement
679589|NCT00892827|Response|response
679590|NCT00892827|Overall response rate of FFP+Rituximab combined therapy|overall response rate of ffp+rituximab combined therapy
679591|NCT00892827|Analysis of complement activation pathways prior to, during and|analysis of complement activation pathways prior to, during and
679592|NCT00892827|after the study treatment.|after the study treatment.
679593|NCT00892827|Time to disease progression|time to disease progression
679594|NCT00892827|Time to re-treatment (See Appendix I).|time to re-treatment (see appendix i).
679595|NCT00892827|Safety of the combination treatment of FFP and RTX.|safety of the combination treatment of ffp and rtx.
679596|NCT00892853|calcification|calcification
679597|NCT00892853|osteoporosis|osteoporosis
679598|NCT00892892|sympatholytic treatment|sympatholytic treatment
679599|NCT00892892|sympathetic nerve activity|sympathetic nerve activity
679600|NCT00892905|coagulation|coagulation
679601|NCT00892905|INR|inr
679602|NCT00892905|aPTT|aptt
679603|NCT00892905|point of care|point of care
679604|NCT00892905|laboratory|laboratory
679605|NCT00892905|CABG|cabg
679606|NCT00892905|surgery|surgery
679607|NCT00892918|pterygium|pterygium
679608|NCT00892918|gatifloxacin|gatifloxacin
679609|NCT00892918|moxifloxacin|moxifloxacin
679610|NCT00892918|corneal epithelial defect|corneal epithelial defect
679611|NCT00892931|Glioblastoma|glioblastoma
679612|NCT00892931|Brain Neoplasms|brain neoplasms
679613|NCT00892931|Recurrence|recurrence
679614|NCT00892944|Positron Emission Tomography|positron emission tomography
679615|NCT00892944|Phase 1|phase 1
679616|NCT00892944|Healthy volunteers|healthy volunteers
679617|NCT00892944|AZD2516|azd2516
679618|NCT00892957|Vascular Surgery|vascular surgery
679619|NCT00892957|Arterio-arterial bypasses|arterio-arterial bypasses
679620|NCT00892957|Arterio-venous (AV) shunts|arterio-venous (av) shunts
679621|NCT00892983|Obesity|obesity
679622|NCT00892983|Sleep|sleep
679623|NCT00892983|Physical activity|physical activity
679624|NCT00892983|Breast feeding|breast feeding
679625|NCT00892983|Depression|depression
679626|NCT00892996|Intrathecal morphine|intrathecal morphine
679627|NCT00892996|Cesarean section|cesarean section
679628|NCT00892996|Nausea and vomiting|nausea and vomiting
679629|NCT00892996|Prevention|prevention
679630|NCT00893009|Forced expiratory volume in one second|forced expiratory volume in one second
679631|NCT00893009|Inspiratory capacity|inspiratory capacity
679632|NCT00893009|endurance time|endurance time
679633|NCT00893009|residual volume|residual volume
679634|NCT00893035|Radiotherapy|radiotherapy
679635|NCT00893035|Late side effects|late side effects
679636|NCT00893035|Predictive assay|predictive assay
679637|NCT00893048|prednisone|prednisone
679638|NCT00893048|cellulitis|cellulitis
679639|NCT00893048|erysipelas|erysipelas
679640|NCT00893048|steroids|steroids
679642|NCT00893061|stage IA breast cancer|stage ia breast cancer
679643|NCT00893061|stage IB breast cancer|stage ib breast cancer
679644|NCT00893061|stage II breast cancer|stage ii breast cancer
679645|NCT00893061|stage IIIA breast cancer|stage iiia breast cancer
679646|NCT00893061|stage IIIB breast cancer|stage iiib breast cancer
679647|NCT00893061|stage IIIC breast cancer|stage iiic breast cancer
679648|NCT00893061|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
679649|NCT00893061|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
679650|NCT00893074|withdrawal|withdrawal
679651|NCT00893074|acute effects|acute effects
679652|NCT00893074|cognitive performance|cognitive performance
679653|NCT00893074|Marijuana Use|marijuana use
679654|NCT00893074|Marijuana Abstinence|marijuana abstinence
679655|NCT00893087|Ventilatory care, children, intensive care, asynchrony, triggering|ventilatory care, children, intensive care, asynchrony, triggering
679656|NCT00893087|Children needing ventilatory care|children needing ventilatory care
679657|NCT00893126|psoriasis|psoriasis
679658|NCT00893126|coronary arteriosclerosis|coronary arteriosclerosis
679659|NCT00893126|coronary events|coronary events
679660|NCT00893126|rheumatoid arthritis|rheumatoid arthritis
679661|NCT00893126|arthritis|arthritis
679662|NCT00893139|Dry Eye|dry eye
679663|NCT00893165|inflammation|inflammation
679664|NCT00893165|cardiovascular disease|cardiovascular disease
679665|NCT00893178|eNOS Polymorphism|enos polymorphism
679666|NCT00893178|TNF alpha polymorphism|tnf alpha polymorphism
679667|NCT00893178|pulmonary pressure|pulmonary pressure
679668|NCT00893178|polymorphism of vasoactive substances|polymorphism of vasoactive substances
679669|NCT00893230|atopic dermatitis|atopic dermatitis
679670|NCT00893230|chemokines|chemokines
679671|NCT00893230|probiotics|probiotics
679672|NCT00893256|schizophrenia|schizophrenia
679673|NCT00893256|risperidone|risperidone
679674|NCT00893256|citalopram|citalopram
679675|NCT00893256|secondary negative symptoms|secondary negative symptoms
679676|NCT00893269|marijuana|marijuana
679677|NCT00893269|cannabis|cannabis
679678|NCT00893269|dependence|dependence
679679|NCT00893269|withdrawal|withdrawal
679680|NCT00893282|renal|renal
679681|NCT00893282|calculi|calculi
679682|NCT00893282|kidney|kidney
679683|NCT00893282|stones|stones
679684|NCT00893295|colon cancer|colon cancer
679685|NCT00893295|rectal cancer|rectal cancer
679686|NCT00893334|Duchenne and Becker muscular dystrophy|duchenne and becker muscular dystrophy
679687|NCT00893334|muscular dystrophy|muscular dystrophy
679688|NCT00893347|Mild traumatic brain injury|mild traumatic brain injury
679689|NCT00893347|Concussion|concussion
679690|NCT00893347|Post-Concussion Syndrome|post-concussion syndrome
679691|NCT00893347|Cognitive-Behavioural Therapy|cognitive-behavioural therapy
679692|NCT00893360|Adult Stem cells|adult stem cells
679693|NCT00893360|Cardiosphere derived stem cells|cardiosphere derived stem cells
679694|NCT00893360|Myocardial infarction|myocardial infarction
679696|NCT00893373|sorafenib|sorafenib
679697|NCT00893386|Extraction|extraction
679698|NCT00893386|Removal|removal
679699|NCT00893386|Lead|lead
679700|NCT00893386|Heart Failure|heart failure
679701|NCT00893399|adult patients|adult patients
679702|NCT00893399|NPM1 mutation|npm1 mutation
679703|NCT00893412|HSG|hsg
679704|NCT00893412|analgesia|analgesia
679705|NCT00893412|tramadol|tramadol
679706|NCT00893412|metal cannula|metal cannula
679707|NCT00893412|balloon catheter|balloon catheter
679708|NCT00893425|CD95|cd95
679709|NCT00893425|ADMA|adma
679710|NCT00893425|proteinuria|proteinuria
679711|NCT00893425|diabetic nephropathy|diabetic nephropathy
679712|NCT00893425|CD95 and ADMA levels|cd95 and adma levels
679713|NCT00893438|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
679714|NCT00893438|Adolescence|adolescence
679715|NCT00893438|Cognitive behaviour therapy (CBT)|cognitive behaviour therapy (cbt)
679716|NCT00893438|Web-based|web-based
679717|NCT00893438|Internet|internet
679718|NCT00893438|Efficacy|efficacy
679719|NCT00893451|renal disease|renal disease
679720|NCT00893451|renal impairment|renal impairment
679721|NCT00893451|chronic kidney disease stage 3-4|chronic kidney disease stage 3-4
679722|NCT00893451|25(OH) vitamin D|25(oh) vitamin d
679723|NCT00893451|cholecalciferol|cholecalciferol
679724|NCT00893451|vitamin D deficiency|vitamin d deficiency
679725|NCT00893451|insulin resistance|insulin resistance
679726|NCT00893451|insulin-glucose clamp|insulin-glucose clamp
679727|NCT00893451|non-diabetic|non-diabetic
679728|NCT00893477|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
679729|NCT00893477|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
679730|NCT00893477|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
679731|NCT00893477|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
679732|NCT00893477|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
679733|NCT00893477|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
679734|NCT00893477|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
679735|NCT00893477|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
679736|NCT00893477|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
679837|NCT00893932|SIRS leptin outcome sepsis|sirs leptin outcome sepsis
679737|NCT00893516|non cutaneous peripheral t-cell lymphoma with nodal involvement|non cutaneous peripheral t-cell lymphoma with nodal involvement
679738|NCT00893529|overweight|overweight
679739|NCT00893529|children|children
679740|NCT00893529|intervention|intervention
679741|NCT00893529|sugar-sweetened beverages|sugar-sweetened beverages
679742|NCT00893555|Invasive fungal infection|invasive fungal infection
679743|NCT00893555|hematological malignancy|hematological malignancy
679744|NCT00893555|voriconazole|voriconazole
679745|NCT00893555|therapeutic drug monitoring|therapeutic drug monitoring
679746|NCT00893568|Post traumatic stress disorder PTSD|post traumatic stress disorder ptsd
679748|NCT00893581|adolescent|adolescent
679749|NCT00893581|bipolar|bipolar
679750|NCT00893594|migraine|migraine
679751|NCT00893594|migraine with aura|migraine with aura
679752|NCT00893594|headache|headache
679753|NCT00893620|iliac aneurysm|iliac aneurysm
679754|NCT00893620|endovascular repair|endovascular repair
679755|NCT00893633|neuromuscular diseases|neuromuscular diseases
679756|NCT00893633|critical illness|critical illness
679757|NCT00893633|mechanical ventilation|mechanical ventilation
679758|NCT00893633|phrenic nerve|phrenic nerve
679759|NCT00893633|nerve conduction studies|nerve conduction studies
679760|NCT00893646|abdominal obesity|abdominal obesity
679761|NCT00893646|weight reduction|weight reduction
679762|NCT00893646|diet|diet
679763|NCT00893646|exercise training|exercise training
679764|NCT00893646|lifestyle activity|lifestyle activity
679765|NCT00893646|health-related fitness|health-related fitness
679766|NCT00893646|walking|walking
679767|NCT00893646|actigraphy|actigraphy
679768|NCT00893646|lifestyle modification|lifestyle modification
679769|NCT00893646|sleep|sleep
679770|NCT00893646|sleep hygiene|sleep hygiene
679771|NCT00893646|alertness|alertness
679772|NCT00893646|daytime sleepiness|daytime sleepiness
679773|NCT00893646|metabolic syndrome|metabolic syndrome
679774|NCT00893646|counselling|counselling
679775|NCT00893646|health education|health education
679776|NCT00893646|truck drivers|truck drivers
679777|NCT00893646|bus drivers|bus drivers
679778|NCT00893646|randomized controlled trial|randomized controlled trial
679779|NCT00893659|Beta-glucan|beta-glucan
679780|NCT00893659|faecal microflora|faecal microflora
679781|NCT00893659|polypectomized|polypectomized
679782|NCT00893659|Precancerous Nonmalignant Condition|precancerous nonmalignant condition
679783|NCT00893672|Radiography, Thoracic|radiography, thoracic
679784|NCT00893672|Intensive Care Units|intensive care units
679785|NCT00893672|Ventilation, mechanical|ventilation, mechanical
679786|NCT00893672|Matched-Pair Analysis|matched-pair analysis
679787|NCT00893685|Telemedicine|telemedicine
679788|NCT00893711|infantile colic|infantile colic
679789|NCT00893711|lactobacillus|lactobacillus
679790|NCT00893711|gut microflora|gut microflora
679791|NCT00893711|FISH|fish
679792|NCT00893724|DME|dme
679793|NCT00893724|NAMD|namd
679794|NCT00893724|Oxidative damage|oxidative damage
679795|NCT00893724|Nutritional supplements/vitamins|nutritional supplements/vitamins
679796|NCT00893724|DNA repair|dna repair
679797|NCT00893724|NAMD/wet AMD|namd/wet amd
679798|NCT00893737|Migraine|migraine
679799|NCT00893737|Headache, Migraine|headache, migraine
679800|NCT00893750|Vulnerable Youths in Northern Uganda|vulnerable youths in northern uganda
679801|NCT00893750|Formerly Abducted Children|formerly abducted children
679802|NCT00893750|Reintegration and Reconciliation|reintegration and reconciliation
679803|NCT00893750|Trauma Treatment|trauma treatment
679804|NCT00893750|Narrative Exposure Therapy|narrative exposure therapy
679805|NCT00893750|Reconciliation|reconciliation
679806|NCT00893750|Revenge Feelings|revenge feelings
679807|NCT00893763|Nosocomial (Hospital-Acquired) Infections|nosocomial (hospital-acquired) infections
679808|NCT00893763|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
679809|NCT00893763|Mechanical ventilation|mechanical ventilation
679810|NCT00893763|Endotracheal intubation|endotracheal intubation
679811|NCT00893802|periodontal disease|periodontal disease
679812|NCT00893802|pregnancy|pregnancy
679813|NCT00893802|periodontal treatment|periodontal treatment
679814|NCT00893815|HIV|hiv
679815|NCT00893815|Neurocognitive function|neurocognitive function
679816|NCT00893841|bipolar|bipolar
679817|NCT00893841|bipolar depression|bipolar depression
679818|NCT00893841|bipolar disorder|bipolar disorder
679819|NCT00893841|depression|depression
679820|NCT00893841|quetiapine|quetiapine
679821|NCT00893841|pramipexole|pramipexole
679822|NCT00893841|Seroquel XR|seroquel xr
679823|NCT00893841|Mirapex|mirapex
679824|NCT00893867|acute ischemic stroke|acute ischemic stroke
679825|NCT00893867|neuroprotective agent|neuroprotective agent
679826|NCT00893880|Tinea Pedis|tinea pedis
679827|NCT00893880|Athletes Foot|athletes foot
679828|NCT00893880|Nitric Oxide|nitric oxide
679830|NCT00893893|Lipid metabolism|lipid metabolism
679831|NCT00893893|VLDL|vldl
679832|NCT00893906|influenza|influenza
679833|NCT00893906|influenza vaccine|influenza vaccine
679834|NCT00893906|vaccine effectiveness|vaccine effectiveness
679835|NCT00893906|cluster randomized|cluster randomized
679838|NCT00893971|Healthy Volunteers|healthy volunteers
679839|NCT00893984|Intolerance|intolerance
679840|NCT00893984|Beta blocker|beta blocker
679841|NCT00893997|myelodysplastic syndrome|myelodysplastic syndrome
679843|NCT00893997|PR1 Peptide Vaccine|pr1 peptide vaccine
679844|NCT00894010|Photosensitive epilepsy|photosensitive epilepsy
679845|NCT00894010|Photosensitivity|photosensitivity
679846|NCT00894010|Seizures|seizures
679848|NCT00894023|Patients with AMI|patients with ami
679849|NCT00894036|esbl children Switzerland|esbl children switzerland
679850|NCT00894036|Colonization|colonization
679851|NCT00894036|ESBL-producing gram-negative bacilli|esbl-producing gram-negative bacilli
679852|NCT00894036|Infection|infection
679853|NCT00894075|genetic metabolic disorder|genetic metabolic disorder
679854|NCT00894075|alkaline phosphatase|alkaline phosphatase
679855|NCT00894075|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
679856|NCT00894075|rickets|rickets
679857|NCT00894075|osteomalacia|osteomalacia
679858|NCT00894127|Lung Cancer|lung cancer
679859|NCT00894127|Porphyrin|porphyrin
679860|NCT00894127|Fluorescence|fluorescence
679861|NCT00894127|Diagnostic|diagnostic
679862|NCT00894127|Sputum Cytology|sputum cytology
679863|NCT00894127|Early Detection|early detection
679864|NCT00894140|Hip|hip
679865|NCT00894140|Cementless|cementless
679866|NCT00894140|Conservative|conservative
679867|NCT00894153|p53 gene|p53 gene
679868|NCT00894153|head and neck malignent tumors|head and neck malignent tumors
679869|NCT00894153|gene therapy|gene therapy
679870|NCT00894166|Smoking Cessation|smoking cessation
679871|NCT00894166|Chantix|chantix
679872|NCT00894166|varenicline|varenicline
679873|NCT00894166|Nicotine Replacement Therapy|nicotine replacement therapy
679874|NCT00894166|Nicotine Patches|nicotine patches
679875|NCT00894166|Zyban|zyban
679876|NCT00894166|bupropion|bupropion
679877|NCT00894166|Quit Smoking|quit smoking
679878|NCT00894179|coronary artery disease|coronary artery disease
679879|NCT00894179|stress echocardiography|stress echocardiography
679880|NCT00894179|regadenoson|regadenoson
679881|NCT00894179|atropine|atropine
679882|NCT00894179|coronary angiogram|coronary angiogram
679883|NCT00894192|This study tests functional ability of patients with refractive error or normal vision while using different types of eyeglasses.|this study tests functional ability of patients with refractive error or normal vision while using different types of eyeglasses.
679884|NCT00894205|neuropsychological function|neuropsychological function
679885|NCT00894205|cognitive function|cognitive function
679886|NCT00894205|exercise|exercise
679887|NCT00894205|older adult|older adult
679888|NCT00894244|None- Normal healthy upper arm skin will be used.|none- normal healthy upper arm skin will be used.
679889|NCT00894257|HCV infected pregnant women|hcv infected pregnant women
679890|NCT00894270|Diabetes|diabetes
679891|NCT00894270|Injection|injection
679892|NCT00894270|Needle|needle
679893|NCT00894283|DVT|dvt
679894|NCT00894283|PE|pe
679895|NCT00894283|MRV|mrv
679896|NCT00894283|bariatric surgery|bariatric surgery
679897|NCT00894296|MEG|meg
679898|NCT00894296|schizophrenia|schizophrenia
679899|NCT00894296|negative symptoms|negative symptoms
679900|NCT00888433|hypertension|hypertension
679901|NCT00888433|renal denervation|renal denervation
679902|NCT00888433|sympathetic nervous system|sympathetic nervous system
679903|NCT00888433|RDN|rdn
679904|NCT00888446|HIV|hiv
679905|NCT00888446|HIV seronegativity|hiv seronegativity
679906|NCT00888446|preventative vaccine|preventative vaccine
679907|NCT00888459|tobacco|tobacco
679908|NCT00888459|chew|chew
679909|NCT00888459|nrt|nrt
679910|NCT00888459|nicotine lozenges|nicotine lozenges
679911|NCT00888459|self-help|self-help
679912|NCT00888472|Extracorporeal leukocytapheresis|extracorporeal leukocytapheresis
679913|NCT00888498|Sprains and Strains|sprains and strains
679914|NCT00888498|Ankle|ankle
679915|NCT00888498|Manual Therapies|manual therapies
679916|NCT00888498|Outcome Studies|outcome studies
679917|NCT00888511|Lung cancer|lung cancer
679918|NCT00888511|Non-small cell lung cancer|non-small cell lung cancer
679919|NCT00888511|Tarceva|tarceva
679920|NCT00888511|Radiotherapy|radiotherapy
679921|NCT00888511|Local-regionally advanced non-small cell lung cancer|local-regionally advanced non-small cell lung cancer
679922|NCT00888524|head out water immersion,|head out water immersion,
679923|NCT00888524|high intensity exercise,|high intensity exercise,
679924|NCT00888524|evidence-based physiotherapy;|evidence-based physiotherapy;
679925|NCT00888524|aquatics;|aquatics;
679926|NCT00888524|hydrotherapy|hydrotherapy
679927|NCT00888524|aquatics therapy|aquatics therapy
679928|NCT00888524|exercise therapy|exercise therapy
679929|NCT00888537|Decision aid|decision aid
679930|NCT00888537|Heart attack|heart attack
679931|NCT00888537|myocardial infarction|myocardial infarction
679932|NCT00894322|diabetes|diabetes
679933|NCT00894322|exenatide once weekly|exenatide once weekly
679934|NCT00894322|Byetta|byetta
679935|NCT00894322|Amylin|amylin
679936|NCT00894322|Lilly|lilly
679937|NCT00894335|retroperitoneoscopic adrenalectomy|retroperitoneoscopic adrenalectomy
679938|NCT00894335|intraoperative arterial-alveolar Carbon dioxide Difference|intraoperative arterial-alveolar carbon dioxide difference
679939|NCT00894348|ERCP|ercp
679940|NCT00894348|Positive Biliary Brush Cytology|positive biliary brush cytology
679941|NCT00894361|knee arthritis|knee arthritis
679942|NCT00894361|total knee arthroplasty|total knee arthroplasty
679943|NCT00894361|total knee replacement|total knee replacement
679944|NCT00894361|mobile bearing design|mobile bearing design
684875|NCT00908557|ethic|ethic
679945|NCT00894361|all-polyethylene tibia|all-polyethylene tibia
679946|NCT00894374|Bio-equivalence, Healthy Volunteers|bio-equivalence, healthy volunteers
679947|NCT00894387|elevated BNP|elevated bnp
679948|NCT00894387|reduced LVEF|reduced lvef
679949|NCT00894387|Acute Heart Failure|acute heart failure
679950|NCT00894387|Cardiovascular death|cardiovascular death
679952|NCT00894387|hospitalization|hospitalization
679953|NCT00894387|morbi-mortality trial|morbi-mortality trial
679954|NCT00894387|outcome study|outcome study
679955|NCT00894387|endpoint driven|endpoint driven
679956|NCT00894387|plasma renin activity|plasma renin activity
679957|NCT00894387|renin angiotensin|renin angiotensin
679958|NCT00894387|aldosterone system|aldosterone system
679959|NCT00894387|direct renin inhibitors|direct renin inhibitors
679961|NCT00894387|KCCQ|kccq
679962|NCT00894387|eGFR|egfr
679963|NCT00894400|AF|af
679964|NCT00894400|catheter ablation|catheter ablation
679965|NCT00894400|fractionated electrogram|fractionated electrogram
679966|NCT00894400|complex fractionated atrial electrogram (CFAE)|complex fractionated atrial electrogram (cfae)
679967|NCT00894426|COPD|copd
679968|NCT00894426|Symptom|symptom
679969|NCT00894426|Morning activity|morning activity
679970|NCT00894426|Questionnaire|questionnaire
679971|NCT00894452|Methadone|methadone
679972|NCT00894452|CYP|cyp
679973|NCT00894452|OPRM1|oprm1
679974|NCT00894452|MDR1|mdr1
679975|NCT00894452|COMT|comt
679976|NCT00894452|Midazolam challenge|midazolam challenge
679977|NCT00894465|Midazolam|midazolam
679978|NCT00894465|VCUG|vcug
679979|NCT00894465|Anxiety|anxiety
679980|NCT00894478|MRI-Negative|mri-negative
679981|NCT00894478|Diffusion tensor imaging|diffusion tensor imaging
679982|NCT00894478|Localization-related epilepsy|localization-related epilepsy
679983|NCT00894478|Partial Epilepsy|partial epilepsy
679984|NCT00894478|Children|children
679985|NCT00894491|alternative medicine|alternative medicine
679986|NCT00894491|complementary medicine|complementary medicine
679987|NCT00894491|acupuncture|acupuncture
679988|NCT00894491|Chinese herbals|chinese herbals
679989|NCT00894504|Metastatic Breast Cancer|metastatic breast cancer
679990|NCT00894504|Triple Negative|triple negative
679991|NCT00894504|Panitumumab|panitumumab
679992|NCT00894504|Vectibix|vectibix
679993|NCT00894504|Gemcitabine|gemcitabine
679994|NCT00894504|Gemzar|gemzar
679995|NCT00894504|Carboplatin|carboplatin
679996|NCT00894543|Hot flashes|hot flashes
679997|NCT00894543|Menopause|menopause
679998|NCT00894543|Vasomotor symptoms|vasomotor symptoms
679999|NCT00894556|Treatment of acute migraine with or without aura in adults|treatment of acute migraine with or without aura in adults
680000|NCT00894569|carcinoma of unknown primary|carcinoma of unknown primary
680001|NCT00894569|cancer of unknown primary|cancer of unknown primary
680002|NCT00894569|CUP|cup
680003|NCT00894569|carboplatin|carboplatin
680004|NCT00894569|paclitaxel|paclitaxel
680005|NCT00894569|cetuximab|cetuximab
680006|NCT00894582|massive ventral hernia|massive ventral hernia
680007|NCT00894582|abdominal volume|abdominal volume
680008|NCT00894582|pulmonary function|pulmonary function
680009|NCT00894582|components separation|components separation
680010|NCT00894582|abdominal compartments syndrome|abdominal compartments syndrome
680011|NCT00894595|Incidence of ACL injury|incidence of acl injury
680012|NCT00894595|Risk factors for ACL injury|risk factors for acl injury
680013|NCT00894595|Prevention of ACL injury or any acute knee injury|prevention of acl injury or any acute knee injury
680014|NCT00894608|letrozole|letrozole
680015|NCT00894608|ovarian stimulation|ovarian stimulation
680016|NCT00894608|PCOS|pcos
680017|NCT00894608|IVF-ET|ivf-et
680018|NCT00894621|Shock|shock
680019|NCT00894621|Respiration, artificial|respiration, artificial
680020|NCT00894621|Norepinephrine|norepinephrine
680021|NCT00895375|Dermatology|dermatology
680022|NCT00895375|Skin|skin
680023|NCT00895375|Psoriasis|psoriasis
680024|NCT00895375|Sleep|sleep
680025|NCT00895375|Wake Forest|wake forest
680026|NCT00895375|Insomnia|insomnia
680027|NCT00895388|Urinary function|urinary function
680028|NCT00895388|Anal function|anal function
680029|NCT00895401|Nutritional supplement|nutritional supplement
680030|NCT00895401|Malnutrition|malnutrition
680031|NCT00895401|Hemodialysis|hemodialysis
680032|NCT00895401|Nepro with Carb Steady|nepro with carb steady
680033|NCT00895414|stage I breast cancer|stage i breast cancer
680034|NCT00895414|stage II breast cancer|stage ii breast cancer
680035|NCT00895414|stage IIIA breast cancer|stage iiia breast cancer
680036|NCT00895414|stage IIIB breast cancer|stage iiib breast cancer
680037|NCT00895414|stage IIIC breast cancer|stage iiic breast cancer
680038|NCT00895414|stage IV breast cancer|stage iv breast cancer
680039|NCT00895427|Coronary artery calcification|coronary artery calcification
680040|NCT00895440|Diabetes|diabetes
680041|NCT00895440|Diabetic neuropathy|diabetic neuropathy
680042|NCT00895440|neuropad|neuropad
680043|NCT00895440|Painless peripheral diabetic neuropathy|painless peripheral diabetic neuropathy
680044|NCT00895440|Painful peripheral diabetic neuropathy|painful peripheral diabetic neuropathy
680250|NCT00896285|cancer pain management|cancer pain management
680045|NCT00895440|Autonomic peripheral neuropathy|autonomic peripheral neuropathy
680046|NCT00895440|Charcot neuroarthropathy|charcot neuroarthropathy
680047|NCT00895453|recurrent vulvovaginal candidiasis|recurrent vulvovaginal candidiasis
680048|NCT00895453|itraconazole|itraconazole
680049|NCT00895453|classic homeopathy|classic homeopathy
680050|NCT00895466|prostatic diseases|prostatic diseases
680051|NCT00895466|neoplasms|neoplasms
680052|NCT00895466|prostatic neoplasms|prostatic neoplasms
680053|NCT00895466|hormones|hormones
680054|NCT00895466|androgen antagonists|androgen antagonists
680055|NCT00895466|vaccines|vaccines
680056|NCT00895466|peptide vaccines|peptide vaccines
680057|NCT00895466|adjuvants, immunological|adjuvants, immunological
680058|NCT00895479|End Stage Renal Disease|end stage renal disease
680060|NCT00895479|Hemodialysis|hemodialysis
680061|NCT00895479|Access Graft|access graft
680062|NCT00895492|diarrhea|diarrhea
680063|NCT00895492|rotavirus|rotavirus
680064|NCT00895492|genotype|genotype
680065|NCT00895492|VP4|vp4
680066|NCT00895492|VP7|vp7
680067|NCT00895505|DVT|dvt
680068|NCT00895505|Venous thromboembolism|venous thromboembolism
680069|NCT00895505|D-Dimer|d-dimer
680070|NCT00895505|thrombophilia|thrombophilia
680071|NCT00895505|secondary prophylaxis|secondary prophylaxis
680072|NCT00895505|secondary prophylaxis using oral anticoagulant treatment (OAT)|secondary prophylaxis using oral anticoagulant treatment (oat)
680073|NCT00895505|higher risk of recurrence in patients showing increased levels|higher risk of recurrence in patients showing increased levels
680074|NCT00895505|of D-Dimer after withdrawal of OAT|of d-dimer after withdrawal of oat
680075|NCT00895505|D-Dimer-based treatment|d-dimer-based treatment
680076|NCT00895518|PTSD|ptsd
680077|NCT00895531|Knee Replacement, Total|knee replacement, total
680078|NCT00895531|Morphine|morphine
680079|NCT00895557|varenicline|varenicline
680080|NCT00895557|cocaine|cocaine
680081|NCT00895557|brain imaging|brain imaging
680082|NCT00895570|sleep restriction|sleep restriction
680083|NCT00895570|glucose metabolism|glucose metabolism
680084|NCT00895570|modafinil|modafinil
680085|NCT00895570|euglycemic clamp|euglycemic clamp
680086|NCT00895570|insulin sensitivity|insulin sensitivity
680087|NCT00895570|insulin release|insulin release
680088|NCT00895583|renal transplant|renal transplant
680089|NCT00895583|immunosuppression|immunosuppression
680090|NCT00895583|sirolimus/rapamune|sirolimus/rapamune
680091|NCT00895583|planned transition|planned transition
680092|NCT00895596|Chronic hepatitis B|chronic hepatitis b
680093|NCT00895596|Lamivudine resistant|lamivudine resistant
680094|NCT00895596|YMDD mutant type|ymdd mutant type
680095|NCT00895609|Residual neuromuscular block|residual neuromuscular block
680096|NCT00895609|post-operative residual curarization|post-operative residual curarization
680097|NCT00895609|PORC|porc
680098|NCT00895609|sugammadex|sugammadex
680099|NCT00895609|neostigmine|neostigmine
680100|NCT00895609|Shallow neuromuscular block (TOF-ratio of 0.5)|shallow neuromuscular block (tof-ratio of 0.5)
680101|NCT00895622|adult grade I meningioma|adult grade i meningioma
680102|NCT00895622|adult grade II meningioma|adult grade ii meningioma
680103|NCT00895622|adult grade III meningioma|adult grade iii meningioma
680104|NCT00895622|adult anaplastic meningioma|adult anaplastic meningioma
680105|NCT00895622|adult papillary meningioma|adult papillary meningioma
680106|NCT00895622|recurrent adult brain tumor|recurrent adult brain tumor
680107|NCT00895635|Claudication|claudication
680108|NCT00895635|Peripheral Arterial Disease|peripheral arterial disease
680109|NCT00895635|Exercise Rehabilitation|exercise rehabilitation
680110|NCT00895635|Cardiovascular Function|cardiovascular function
680111|NCT00895648|Meso|meso
680112|NCT00895648|mesothelioma|mesothelioma
680113|NCT00895648|pleura|pleura
680114|NCT00895648|pleural|pleural
680115|NCT00895661|rituximab|rituximab
680116|NCT00895674|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
680117|NCT00895687|Metastatic Cancer|metastatic cancer
680118|NCT00895687|Bortezomib|bortezomib
680119|NCT00895687|Velcade|velcade
680120|NCT00895687|Erlotinib|erlotinib
680121|NCT00895687|Erlotinib Hydrochloride|erlotinib hydrochloride
680122|NCT00895687|Tarceva|tarceva
680123|NCT00895687|EGFR|egfr
680124|NCT00895687|EGFR mutations|egfr mutations
680126|NCT00895700|ICD concerns|icd concerns
680127|NCT00895700|Quality of life|quality of life
680128|NCT00895713|Hepatitis B|hepatitis b
680129|NCT00895713|HBV|hbv
680130|NCT00895713|Anti-hepatitis B antibodies|anti-hepatitis b antibodies
680131|NCT00895713|Immunoglobulins|immunoglobulins
680132|NCT00895713|liver transplantation|liver transplantation
680133|NCT00895713|Protective levels|protective levels
680135|NCT00895713|Intramuscular|intramuscular
680136|NCT00895726|cachexia|cachexia
680137|NCT00895726|neoplasms|neoplasms
680138|NCT00895739|aplastic anemia|aplastic anemia
680139|NCT00895765|Melamine|melamine
680140|NCT00895765|Calculus|calculus
680142|NCT00895765|Child|child
680143|NCT00895778|Neuromuscular blockade|neuromuscular blockade
680144|NCT00895778|post-operative pain|post-operative pain
680145|NCT00895778|post-operative pulmonary function|post-operative pulmonary function
680146|NCT00895791|coronary bifurcation|coronary bifurcation
680147|NCT00895791|stent implantation|stent implantation
680148|NCT00895791|PCI|pci
680149|NCT00895791|Optical Coherence Tomography|optical coherence tomography
680150|NCT00895804|MDMA|mdma
680151|NCT00895804|beta adrenergic|beta adrenergic
680152|NCT00895804|Ecstasy|ecstasy
680153|NCT00895817|Eosinophilic esophagitis|eosinophilic esophagitis
680154|NCT00895817|acid reflux|acid reflux
680155|NCT00895843|Third molar|third molar
680156|NCT00895856|Physiotherapy|physiotherapy
680157|NCT00895856|Aged|aged
680158|NCT00895856|Functionality|functionality
680159|NCT00895856|Physiotherapic assistance|physiotherapic assistance
680160|NCT00895856|Functional capacity|functional capacity
680161|NCT00895869|Screening|screening
680162|NCT00895869|Retinopathy|retinopathy
680163|NCT00895869|Prematurity|prematurity
680164|NCT00895869|Pain|pain
680165|NCT00895908|ADHD|adhd
680166|NCT00895908|Psychosocial Intervention|psychosocial intervention
680167|NCT00895908|Social Skills Training|social skills training
680168|NCT00895921|Insulin Resistance|insulin resistance
680169|NCT00895921|Antipsychotic Medications|antipsychotic medications
680170|NCT00895947|Prophylaxis|prophylaxis
680171|NCT00895947|Treatment|treatment
680172|NCT00895947|Symptoms|symptoms
680173|NCT00895947|Winter Colds and Flu|winter colds and flu
680174|NCT00895960|Brain|brain
680175|NCT00895960|CNS Disease|cns disease
680176|NCT00895960|CNS|cns
680177|NCT00895960|Intracranial Supratentorial GBM|intracranial supratentorial gbm
680178|NCT00895960|Gliosarcoma|gliosarcoma
680179|NCT00895960|GS|gs
680180|NCT00895960|Glioblastoma|glioblastoma
680181|NCT00895960|GBM|gbm
680182|NCT00895960|Dasatinib|dasatinib
680183|NCT00895960|Sprycel|sprycel
680184|NCT00895960|Temozolomide|temozolomide
680185|NCT00895960|TMZ|tmz
680186|NCT00895960|Temodar|temodar
680187|NCT00895960|Radiation Therapy|radiation therapy
680188|NCT00895960|Radiotherapy|radiotherapy
680189|NCT00895960|RT|rt
680190|NCT00895986|Diabetes|diabetes
680191|NCT00895986|Education|education
680192|NCT00896012|Kidney Transplant|kidney transplant
680193|NCT00896012|Immunosuppression drugs|immunosuppression drugs
680194|NCT00896012|Rapamune|rapamune
680195|NCT00896012|tacrolimus|tacrolimus
680196|NCT00896012|calcineurin inhibitor|calcineurin inhibitor
680197|NCT00896012|Kidney Biopsy, Needle|kidney biopsy, needle
680198|NCT00896025|Liver disease|liver disease
680199|NCT00896038|Alcohol Dependence|alcohol dependence
680200|NCT00896038|Alcohol Treatment|alcohol treatment
680201|NCT00896038|Alcoholics|alcoholics
680202|NCT00896038|Alcoholism|alcoholism
680203|NCT00896038|Posttraumatic Stress Disorder|posttraumatic stress disorder
680204|NCT00896038|PTSD|ptsd
680205|NCT00896051|HIV Infections|hiv infections
680206|NCT00896051|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
680207|NCT00896051|TMC125-TiDP2-C238|tmc125-tidp2-c238
680208|NCT00896051|TMC125-C238|tmc125-c238
680209|NCT00896051|Etravirine|etravirine
680210|NCT00896051|Intelence|intelence
680211|NCT00896051|HIV|hiv
680212|NCT00896051|HIV-1|hiv-1
680213|NCT00896051|Pharmacokinetics|pharmacokinetics
680214|NCT00896064|Pneumococcal vaccine|pneumococcal vaccine
680215|NCT00896064|Streptococcus pneumoniae|streptococcus pneumoniae
680216|NCT00896064|Young adults|young adults
680217|NCT00896077|healthy subjects|healthy subjects
680218|NCT00896129|Health Outcomes Research|health outcomes research
680219|NCT00896129|CML|cml
680220|NCT00896142|ischemic cardiomyopathy|ischemic cardiomyopathy
680221|NCT00896142|cardiac resynchronization therapy|cardiac resynchronization therapy
680222|NCT00896142|LV structure and function|lv structure and function
680223|NCT00896155|Breast cancer|breast cancer
680224|NCT00896155|Pulmonary fibrosis|pulmonary fibrosis
680225|NCT00896155|tamoxifen|tamoxifen
680226|NCT00896155|radiotherapy|radiotherapy
680227|NCT00896168|Arthritis, Rheumatoid|arthritis, rheumatoid
680228|NCT00896168|Infliximab|infliximab
680229|NCT00896168|Methotrexate|methotrexate
680230|NCT00896194|Overweight|overweight
680231|NCT00896194|Obesity|obesity
680232|NCT00896194|Self-Efficacy|self-efficacy
680233|NCT00896194|Treatment Adherence|treatment adherence
680234|NCT00896220|chronic critical illness|chronic critical illness
680235|NCT00896220|mechanical ventilation|mechanical ventilation
680236|NCT00896220|outcomes|outcomes
680237|NCT00896220|weakness|weakness
680238|NCT00896220|quality of life|quality of life
680239|NCT00896220|Critically Ill patients and their family caregiver|critically ill patients and their family caregiver
680240|NCT00896233|Staging of liver fibrosis prior to clinical trials for treatment of Hepatitis C Virus|staging of liver fibrosis prior to clinical trials for treatment of hepatitis c virus
680241|NCT00896259|Unilateral total hip arthroplasty|unilateral total hip arthroplasty
680242|NCT00896272|Klinefelter Syndrome|klinefelter syndrome
680243|NCT00896272|47,XXY|47,xxy
680245|NCT00896285|Pleural malignancy|pleural malignancy
680246|NCT00896285|pleural effusion|pleural effusion
680247|NCT00896285|pleurodesis|pleurodesis
680251|NCT00896298|Lipodystrophy|lipodystrophy
680252|NCT00896298|Insulin secretory response|insulin secretory response
680253|NCT00896324|Quality of life|quality of life
680254|NCT00896337|iliac artery stenosis|iliac artery stenosis
680255|NCT00896337|claudication|claudication
680256|NCT00896337|atherosclerotic iliac disease|atherosclerotic iliac disease
680257|NCT00896337|peripheral vascular disease|peripheral vascular disease
680258|NCT00896350|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
680259|NCT00896350|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
680260|NCT00896350|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
680261|NCT00896350|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
681213|NCT00891657|Adhesion|adhesion
680262|NCT00896350|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
680263|NCT00896350|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
680264|NCT00896350|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
680265|NCT00896350|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
680266|NCT00896350|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
680267|NCT00896350|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
680268|NCT00896350|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
680269|NCT00896350|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
680270|NCT00896350|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
680271|NCT00896350|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
680272|NCT00896350|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
680273|NCT00896350|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
680274|NCT00896350|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
680275|NCT00896350|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
680276|NCT00896350|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
680277|NCT00896350|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
680278|NCT00896350|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
680279|NCT00896350|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
680280|NCT00896350|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
680281|NCT00896350|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
680282|NCT00896350|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
680283|NCT00896350|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
680284|NCT00896350|tongue cancer|tongue cancer
680285|NCT00896363|anti-depressant|anti-depressant
680286|NCT00896363|Severe Depression|severe depression
680287|NCT00896363|Efficacy|efficacy
680288|NCT00896363|Major Depressive Disorder|major depressive disorder
680289|NCT00896363|Major Depressive Episode|major depressive episode
680290|NCT00896376|stage IV breast cancer|stage iv breast cancer
680291|NCT00896376|HER2-positive breast cancer|her2-positive breast cancer
680292|NCT00896389|hypertension|hypertension
680293|NCT00896389|hydrochlorothiazide|hydrochlorothiazide
680295|NCT00896389|salt sensitivity|salt sensitivity
680296|NCT00896389|Hydrochlorothiazide induced hyperglycemia|hydrochlorothiazide induced hyperglycemia
680297|NCT00896402|chloraprep|chloraprep
680298|NCT00896402|betadine|betadine
680299|NCT00896402|colonization|colonization
680300|NCT00896402|femoral catheter|femoral catheter
680301|NCT00896415|on two models of CT scanner acquire CT images of the abdomen pelvis and midthigh in 20 Postmenopausal female volunteers|on two models of ct scanner acquire ct images of the abdomen pelvis and midthigh in 20 postmenopausal female volunteers
680302|NCT00896428|Asthma|asthma
680303|NCT00896428|gallopamil|gallopamil
680304|NCT00896428|airway remodelling|airway remodelling
680305|NCT00896428|smooth muscle|smooth muscle
680306|NCT00896454|hypercalcemia|hypercalcemia
680307|NCT00896454|calcium|calcium
680308|NCT00896454|bisphosphonates|bisphosphonates
680309|NCT00896454|denosumab|denosumab
680310|NCT00896454|amgen|amgen
680311|NCT00896454|malignancy|malignancy
680312|NCT00896454|20070315|20070315
680313|NCT00896454|HMC|hmc
680314|NCT00896454|oncology|oncology
680315|NCT00896454|hematology|hematology
680316|NCT00896467|anxiety disorder|anxiety disorder
680317|NCT00896467|depression|depression
680318|NCT00896467|stage IV breast cancer|stage iv breast cancer
680319|NCT00896467|stage IV renal cell cancer|stage iv renal cell cancer
680320|NCT00896467|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
680321|NCT00896467|extensive stage small cell lung cancer|extensive stage small cell lung cancer
680322|NCT00896467|stage IV gastric cancer|stage iv gastric cancer
680323|NCT00896467|stage IV anal cancer|stage iv anal cancer
680324|NCT00896467|stage IV pancreatic cancer|stage iv pancreatic cancer
680325|NCT00896467|stage IV esophageal cancer|stage iv esophageal cancer
680326|NCT00896467|advanced adult primary liver cancer|advanced adult primary liver cancer
680327|NCT00896467|unresectable gallbladder cancer|unresectable gallbladder cancer
680328|NCT00896467|small intestine cancer|small intestine cancer
752570|NCT01167725|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
680329|NCT00896480|ASCI (Antigen-Specific Cancer Immunotherapeutic)|asci (antigen-specific cancer immunotherapeutic)
680330|NCT00896480|Cancer immunotherapeutic|cancer immunotherapeutic
680331|NCT00896480|Malignant melanoma|malignant melanoma
680332|NCT00896480|MAGE-A3|mage-a3
680333|NCT00896519|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
680334|NCT00896519|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
680335|NCT00896519|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
680336|NCT00896519|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
680337|NCT00896519|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
680338|NCT00896519|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
680339|NCT00896558|GSK1322322, repeat dose, healthy subjects, elderly, drug-drug interaction, probe, midazolam, double-blind|gsk1322322, repeat dose, healthy subjects, elderly, drug-drug interaction, probe, midazolam, double-blind
680340|NCT00896571|Fertility control|fertility control
680341|NCT00896571|Contraception|contraception
680342|NCT00896584|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
680343|NCT00896584|Hypoxemia|hypoxemia
680344|NCT00896584|Pre-flight evaluation|pre-flight evaluation
680345|NCT00896584|Hypobaria|hypobaria
680346|NCT00896584|COPD|copd
680347|NCT00896584|Pulseoximetry|pulseoximetry
680348|NCT00896584|Air travel|air travel
680349|NCT00896584|Exercise desaturation|exercise desaturation
680350|NCT00896610|Diabetes Mellitus|diabetes mellitus
680351|NCT00896610|Type 1 Diabetes|type 1 diabetes
680352|NCT00896610|Complications|complications
680353|NCT00896610|Anti Beta-Cell Autoantibodies|anti beta-cell autoantibodies
680354|NCT00896610|T-Lymphocyte Assays|t-lymphocyte assays
680355|NCT00896610|Type 2 Diabetes|type 2 diabetes
680356|NCT00896610|Autoimmune Diabetes|autoimmune diabetes
680357|NCT00896610|At Risk Diabetes|at risk diabetes
680358|NCT00896623|stage I breast cancer|stage i breast cancer
680359|NCT00896623|stage II breast cancer|stage ii breast cancer
680360|NCT00896636|breast cancer|breast cancer
680361|NCT00896636|healthy, no evidence of disease|healthy, no evidence of disease
680362|NCT00896649|breast cancer|breast cancer
680363|NCT00896662|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
680364|NCT00896662|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
680365|NCT00896662|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
680366|NCT00896662|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
680367|NCT00896662|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
680368|NCT00896662|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
680369|NCT00896662|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
680370|NCT00896662|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
680371|NCT00896662|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
680372|NCT00896662|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
680373|NCT00896662|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
680374|NCT00896662|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
680375|NCT00896662|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
680376|NCT00896662|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
680377|NCT00896662|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
680378|NCT00896662|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
680379|NCT00896662|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
680380|NCT00896662|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
680381|NCT00896662|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
680382|NCT00896662|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
680383|NCT00896662|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
680384|NCT00896662|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
680385|NCT00896662|splenic marginal zone lymphoma|splenic marginal zone lymphoma
680386|NCT00896662|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
680773|NCT00897754|stage III rectal cancer|stage iii rectal cancer
680387|NCT00896662|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
680388|NCT00896662|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
681199|NCT00891618|Bortezomib|bortezomib
680389|NCT00896662|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
680390|NCT00896662|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
680391|NCT00896675|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
680392|NCT00896675|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
680393|NCT00896675|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
680641|NCT00897208|stage IB breast cancer|stage ib breast cancer
680394|NCT00896675|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
680395|NCT00896675|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
680396|NCT00896675|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
680397|NCT00896675|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
680398|NCT00896675|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
680399|NCT00896675|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
680400|NCT00896675|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
680401|NCT00896675|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
680402|NCT00896675|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
680403|NCT00896675|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
680404|NCT00896675|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
680405|NCT00896675|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
680406|NCT00896675|stage IV salivary gland cancer|stage iv salivary gland cancer
680407|NCT00896675|recurrent salivary gland cancer|recurrent salivary gland cancer
680408|NCT00896688|cervical branch block|cervical branch block
680409|NCT00896688|fluoroscopic guidance|fluoroscopic guidance
680410|NCT00896688|ultrasound guidance|ultrasound guidance
680411|NCT00896701|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
680412|NCT00896701|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
680413|NCT00896701|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
680414|NCT00896701|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
680415|NCT00896701|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
680416|NCT00896701|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
680417|NCT00896701|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
680418|NCT00896727|stage IA breast cancer|stage ia breast cancer
680419|NCT00896727|stage IB breast cancer|stage ib breast cancer
680420|NCT00896727|stage II breast cancer|stage ii breast cancer
680421|NCT00896727|stage IIIA breast cancer|stage iiia breast cancer
680422|NCT00896740|Fanconi anemia|fanconi anemia
680423|NCT00896753|stage IV colon cancer|stage iv colon cancer
680424|NCT00896753|liver metastases|liver metastases
680425|NCT00896753|lung metastases|lung metastases
680426|NCT00896753|recurrent colon cancer|recurrent colon cancer
680427|NCT00896766|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
680428|NCT00896766|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
680429|NCT00896792|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
680430|NCT00896792|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
680431|NCT00896818|breast cancer|breast cancer
680432|NCT00896831|minimal hepatic encephalopathy|minimal hepatic encephalopathy
680433|NCT00896831|L-ornithine-L-aspartate|l-ornithine-l-aspartate
680434|NCT00896831|psychometric test|psychometric test
680435|NCT00896831|critical flicker frequency|critical flicker frequency
680436|NCT00896831|quality of life|quality of life
680437|NCT00896831|Treatment|treatment
680438|NCT00896831|Health-related quality of life|health-related quality of life
680439|NCT00896844|emotional disclosure|emotional disclosure
680440|NCT00896844|expressive writing|expressive writing
680441|NCT00896844|students|students
680442|NCT00896857|breast cancer|breast cancer
680443|NCT00896857|ductal breast carcinoma in situ|ductal breast carcinoma in situ
680444|NCT00896883|turbinate|turbinate
680445|NCT00896883|implant|implant
680446|NCT00896883|sinus surgery|sinus surgery
680447|NCT00896883|Turbinates|turbinates
680448|NCT00896896|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
680449|NCT00896896|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
680450|NCT00896896|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
680451|NCT00896896|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
680452|NCT00896896|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
680453|NCT00896896|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
680454|NCT00896896|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
680455|NCT00896896|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
680456|NCT00896896|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
680457|NCT00896896|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
680458|NCT00896896|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
680459|NCT00896896|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
680460|NCT00896896|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
680642|NCT00897208|stage II breast cancer|stage ii breast cancer
680461|NCT00896896|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
680462|NCT00896896|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
680463|NCT00896896|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
680464|NCT00896896|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
680465|NCT00896896|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
680466|NCT00896896|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
680467|NCT00896896|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
680468|NCT00896896|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
680469|NCT00896896|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
680470|NCT00896896|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
680471|NCT00896896|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
680472|NCT00896896|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
680473|NCT00896896|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
680474|NCT00896896|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
680475|NCT00896896|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
680476|NCT00896896|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
680477|NCT00896896|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
680478|NCT00896896|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
680479|NCT00896896|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
680480|NCT00896896|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
680481|NCT00896896|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
680482|NCT00896896|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
680483|NCT00896896|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
680484|NCT00896896|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
680485|NCT00896896|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
680486|NCT00896896|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
680487|NCT00896896|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
680488|NCT00896896|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
680489|NCT00896896|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
680490|NCT00896896|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
680491|NCT00896896|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
680492|NCT00896896|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
680493|NCT00896896|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
680494|NCT00896896|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
680495|NCT00896896|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
680496|NCT00896896|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
680497|NCT00896896|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
680498|NCT00896896|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
680499|NCT00896896|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
680500|NCT00896896|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
680501|NCT00896896|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
680502|NCT00896896|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
680503|NCT00896896|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
680504|NCT00896896|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
752859|NCT01174511|ATOPIC DERMATITIS|atopic dermatitis
680505|NCT00896896|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
680506|NCT00896896|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
680507|NCT00896896|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
680508|NCT00896896|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
680509|NCT00896896|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
681200|NCT00891618|Neuropathy|neuropathy
680510|NCT00896896|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
680511|NCT00896896|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
680512|NCT00896896|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
680513|NCT00896896|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
680643|NCT00897221|Friedreich's ataxia|friedreich's ataxia
680514|NCT00896896|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
680515|NCT00896896|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
680516|NCT00896896|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
680517|NCT00896896|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
680518|NCT00896896|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
681214|NCT00891657|Fibroid|fibroid
680519|NCT00896896|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
680520|NCT00896896|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
680521|NCT00896896|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
680522|NCT00896896|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
680523|NCT00896896|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
680524|NCT00896896|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
680525|NCT00896896|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
680526|NCT00896896|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
680527|NCT00896896|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
680528|NCT00896896|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
680529|NCT00896896|stage I salivary gland cancer|stage i salivary gland cancer
680530|NCT00896896|stage II salivary gland cancer|stage ii salivary gland cancer
680531|NCT00896896|stage III salivary gland cancer|stage iii salivary gland cancer
680532|NCT00896896|stage IV salivary gland cancer|stage iv salivary gland cancer
680533|NCT00896896|recurrent salivary gland cancer|recurrent salivary gland cancer
680534|NCT00896896|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
680535|NCT00896896|recurrent colon cancer|recurrent colon cancer
680536|NCT00896896|stage IV colon cancer|stage iv colon cancer
680537|NCT00896896|recurrent rectal cancer|recurrent rectal cancer
680538|NCT00896896|stage IV rectal cancer|stage iv rectal cancer
680539|NCT00896896|adenocarcinoma of the colon|adenocarcinoma of the colon
680540|NCT00896909|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
680541|NCT00896909|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
680542|NCT00896909|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
680543|NCT00896922|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
680544|NCT00896922|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
680545|NCT00896922|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
680546|NCT00896922|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
680547|NCT00896922|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
680548|NCT00896922|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
680549|NCT00896922|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
680550|NCT00896922|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
680551|NCT00896922|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
680552|NCT00896922|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
680553|NCT00896922|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
680554|NCT00896922|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
680556|NCT00896948|head and neck cancer|head and neck cancer
680557|NCT00896987|Epilepsy|epilepsy
680558|NCT00896987|lamotrigine|lamotrigine
680559|NCT00896987|cognitive function|cognitive function
680560|NCT00897026|stage II breast cancer|stage ii breast cancer
680561|NCT00897026|stage IIIA breast cancer|stage iiia breast cancer
680562|NCT00897039|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
680563|NCT00897039|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
680564|NCT00897039|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
680565|NCT00897039|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
680566|NCT00897039|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
680567|NCT00897039|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
680568|NCT00897039|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
680569|NCT00897039|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
680570|NCT00897039|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
680571|NCT00897039|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
680572|NCT00897039|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
680573|NCT00897039|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
680574|NCT00897039|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
680575|NCT00897039|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
680576|NCT00897039|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
680577|NCT00897039|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
680578|NCT00897039|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
680579|NCT00897039|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
680580|NCT00897039|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
680581|NCT00897039|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
680582|NCT00897039|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
680583|NCT00897039|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
680584|NCT00897039|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
680585|NCT00897039|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
680586|NCT00897039|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
680587|NCT00897039|recurrent fallopian tube cancer|recurrent fallopian tube cancer
680588|NCT00897039|stage IA fallopian tube cancer|stage ia fallopian tube cancer
680589|NCT00897039|stage IB fallopian tube cancer|stage ib fallopian tube cancer
680590|NCT00897039|stage IC fallopian tube cancer|stage ic fallopian tube cancer
680591|NCT00897039|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
680592|NCT00897039|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
680593|NCT00897039|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
680594|NCT00897039|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
680595|NCT00897039|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
680596|NCT00897039|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
680597|NCT00897052|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
680598|NCT00897052|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
680599|NCT00897052|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
680600|NCT00897052|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
680601|NCT00897052|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
680602|NCT00897052|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
680603|NCT00897052|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
680604|NCT00897052|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
680605|NCT00897052|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
680606|NCT00897052|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
680607|NCT00897052|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
680608|NCT00897052|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
680609|NCT00897065|stage IA breast cancer|stage ia breast cancer
680610|NCT00897065|stage IB breast cancer|stage ib breast cancer
680611|NCT00897065|stage II breast cancer|stage ii breast cancer
680612|NCT00897065|stage IIIA breast cancer|stage iiia breast cancer
680613|NCT00897065|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
680614|NCT00897065|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
680615|NCT00897078|cancer survivor|cancer survivor
680616|NCT00897078|healthy, no evidence of disease|healthy, no evidence of disease
680617|NCT00897078|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
680618|NCT00897078|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
680619|NCT00897091|stage II breast cancer|stage ii breast cancer
680620|NCT00897091|stage IIIA breast cancer|stage iiia breast cancer
680621|NCT00897117|stage I non-small cell lung cancer|stage i non-small cell lung cancer
680622|NCT00897117|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
680623|NCT00897130|low-risk (IPSS 0-INT1) MDS according to WHO classification|low-risk (ipss 0-int1) mds according to who classification
680624|NCT00897143|non-small cell lung cancer|non-small cell lung cancer
680625|NCT00897143|malignant pleural effusion|malignant pleural effusion
680626|NCT00897143|small cell lung cancer|small cell lung cancer
680627|NCT00897182|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
680628|NCT00897182|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
680629|NCT00897182|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
680630|NCT00897182|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
680631|NCT00897182|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
680632|NCT00897182|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
681201|NCT00891618|Peripheral Neuropathy|peripheral neuropathy
680633|NCT00897182|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
680634|NCT00897182|secondary acute myeloid leukemia|secondary acute myeloid leukemia
680635|NCT00897182|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
680636|NCT00897182|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
680637|NCT00897208|breast cancer|breast cancer
680638|NCT00897208|ductal breast carcinoma in situ|ductal breast carcinoma in situ
680639|NCT00897208|breast cancer in situ|breast cancer in situ
680640|NCT00897208|stage IA breast cancer|stage ia breast cancer
680646|NCT00897234|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
680647|NCT00897234|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
680648|NCT00897234|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
680649|NCT00897234|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
680650|NCT00897247|malignant mesothelioma|malignant mesothelioma
680651|NCT00897247|pulmonary complications|pulmonary complications
680652|NCT00897260|Unrelated Umbilical Cord Blood Transplant|unrelated umbilical cord blood transplant
680653|NCT00897260|Multiple cord blood|multiple cord blood
680654|NCT00897273|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
680655|NCT00897273|oropharyngeal cancer|oropharyngeal cancer
680656|NCT00897273|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
680658|NCT00897273|precancerous condition|precancerous condition
680659|NCT00897273|human papilloma virus infection|human papilloma virus infection
680660|NCT00897286|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
680661|NCT00897286|childhood choroid plexus tumor|childhood choroid plexus tumor
680662|NCT00897286|childhood medulloblastoma|childhood medulloblastoma
680663|NCT00897286|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
680664|NCT00897286|childhood infratentorial ependymoma|childhood infratentorial ependymoma
680665|NCT00897286|childhood supratentorial ependymoma|childhood supratentorial ependymoma
680666|NCT00897286|recurrent childhood ependymoma|recurrent childhood ependymoma
680667|NCT00897286|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
680668|NCT00897286|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
680670|NCT00897299|estrogen receptor|estrogen receptor
680672|NCT00897299|PgR|pgr
680673|NCT00897299|stage II breast cancer|stage ii breast cancer
680674|NCT00897299|stage IIIA breast cancer|stage iiia breast cancer
680675|NCT00897299|stage IIIB breast cancer|stage iiib breast cancer
680676|NCT00897312|stage IV melanoma|stage iv melanoma
680677|NCT00897312|hepatitis C infection|hepatitis c infection
680678|NCT00897312|melanoma (skin)|melanoma (skin)
680679|NCT00897312|precancerous/nonmalignant condition|precancerous/nonmalignant condition
680680|NCT00897338|stage IV breast cancer|stage iv breast cancer
680681|NCT00897351|recurrent prostate cancer|recurrent prostate cancer
680685|NCT00897403|colon cancer|colon cancer
680686|NCT00897403|health status unknown|health status unknown
680687|NCT00897416|breast cancer|breast cancer
680688|NCT00897416|stage I breast cancer|stage i breast cancer
680689|NCT00897416|stage II breast cancer|stage ii breast cancer
680690|NCT00897416|stage IIIA breast cancer|stage iiia breast cancer
680691|NCT00897416|stage IIIB breast cancer|stage iiib breast cancer
680692|NCT00897416|stage IIIC breast cancer|stage iiic breast cancer
680693|NCT00897416|stage IV breast cancer|stage iv breast cancer
680694|NCT00897429|stage IIA colon cancer|stage iia colon cancer
680695|NCT00897429|stage IIB colon cancer|stage iib colon cancer
680696|NCT00897429|stage IIC colon cancer|stage iic colon cancer
680697|NCT00897455|breast cancer|breast cancer
680698|NCT00897455|BRCA1 mutation carrier|brca1 mutation carrier
680699|NCT00897455|BRCA2 mutation carrier|brca2 mutation carrier
680700|NCT00897468|breast cancer|breast cancer
680701|NCT00897481|stage IV melanoma|stage iv melanoma
680702|NCT00897481|recurrent melanoma|recurrent melanoma
680703|NCT00897481|stage IA melanoma|stage ia melanoma
680704|NCT00897481|stage IB melanoma|stage ib melanoma
680705|NCT00897481|stage IIA melanoma|stage iia melanoma
680706|NCT00897481|stage IIB melanoma|stage iib melanoma
680707|NCT00897481|stage IIC melanoma|stage iic melanoma
680708|NCT00897481|stage IIIA melanoma|stage iiia melanoma
680709|NCT00897481|stage IIIB melanoma|stage iiib melanoma
680710|NCT00897481|stage IIIC melanoma|stage iiic melanoma
680711|NCT00897494|stage I pancreatic cancer|stage i pancreatic cancer
680712|NCT00897494|stage II pancreatic cancer|stage ii pancreatic cancer
680713|NCT00897494|stage III pancreatic cancer|stage iii pancreatic cancer
680714|NCT00897494|stage IV pancreatic cancer|stage iv pancreatic cancer
680715|NCT00897507|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
680716|NCT00897507|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
680717|NCT00897520|stage II melanoma|stage ii melanoma
680718|NCT00897520|stage III melanoma|stage iii melanoma
680719|NCT00897520|stage IV melanoma|stage iv melanoma
680720|NCT00897533|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
680721|NCT00897533|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
680722|NCT00897533|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
680723|NCT00897533|adenocarcinoma of the lung|adenocarcinoma of the lung
680724|NCT00897533|squamous cell lung cancer|squamous cell lung cancer
680725|NCT00897533|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
680726|NCT00897546|recurrent melanoma|recurrent melanoma
680727|NCT00897546|stage IV melanoma|stage iv melanoma
680728|NCT00897546|stage IA melanoma|stage ia melanoma
680729|NCT00897546|stage IB melanoma|stage ib melanoma
680730|NCT00897546|stage IIA melanoma|stage iia melanoma
680731|NCT00897546|stage IIB melanoma|stage iib melanoma
680732|NCT00897546|stage IIC melanoma|stage iic melanoma
680733|NCT00897546|stage IIIA melanoma|stage iiia melanoma
680734|NCT00897546|stage IIIB melanoma|stage iiib melanoma
680735|NCT00897546|stage IIIC melanoma|stage iiic melanoma
680736|NCT00897559|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
680737|NCT00897611|adult anaplastic astrocytoma|adult anaplastic astrocytoma
680738|NCT00897611|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
680739|NCT00897611|adult giant cell glioblastoma|adult giant cell glioblastoma
680740|NCT00897611|recurrent adult brain tumor|recurrent adult brain tumor
681215|NCT00891657|Myoma|myoma
680741|NCT00897611|adult glioblastoma|adult glioblastoma
680742|NCT00897611|adult gliosarcoma|adult gliosarcoma
680743|NCT00897624|metastatic intraocular melanoma|metastatic intraocular melanoma
680744|NCT00897624|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
680745|NCT00897624|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
680746|NCT00897650|lung cancer|lung cancer
680747|NCT00897663|adult giant cell glioblastoma|adult giant cell glioblastoma
680748|NCT00897663|adult gliosarcoma|adult gliosarcoma
680749|NCT00897663|adult glioblastoma|adult glioblastoma
680750|NCT00897676|Hyperinsulinism|hyperinsulinism
680751|NCT00897676|Hypoglycemia|hypoglycemia
680752|NCT00897676|KATP channel|katp channel
680753|NCT00897702|recurrent breast cancer|recurrent breast cancer
680754|NCT00897702|male breast cancer|male breast cancer
680755|NCT00897702|stage IV breast cancer|stage iv breast cancer
680757|NCT00897715|inflammation|inflammation
680758|NCT00897715|CVD|cvd
680759|NCT00897728|stage IA breast cancer|stage ia breast cancer
680760|NCT00897728|stage IB breast cancer|stage ib breast cancer
680761|NCT00897728|stage II breast cancer|stage ii breast cancer
680762|NCT00897728|stage IIIA breast cancer|stage iiia breast cancer
680763|NCT00897728|stage IIIB breast cancer|stage iiib breast cancer
680764|NCT00897728|stage IIIC breast cancer|stage iiic breast cancer
680765|NCT00897728|HER2-positive breast cancer|her2-positive breast cancer
680766|NCT00897728|triple-negative breast cancer|triple-negative breast cancer
680767|NCT00897728|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
680768|NCT00897741|recurrent pancreatic cancer|recurrent pancreatic cancer
680769|NCT00897741|stage IV pancreatic cancer|stage iv pancreatic cancer
680770|NCT00897754|adenocarcinoma of the colon|adenocarcinoma of the colon
680771|NCT00897754|adenocarcinoma of the rectum|adenocarcinoma of the rectum
680772|NCT00897754|recurrent rectal cancer|recurrent rectal cancer
680774|NCT00897754|stage IV rectal cancer|stage iv rectal cancer
680775|NCT00897754|recurrent colon cancer|recurrent colon cancer
680776|NCT00897754|stage III colon cancer|stage iii colon cancer
680777|NCT00897754|stage IV colon cancer|stage iv colon cancer
680778|NCT00897767|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
680779|NCT00897767|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
680780|NCT00897767|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
680781|NCT00897767|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
680782|NCT00897767|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
680783|NCT00897767|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
680784|NCT00897767|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
680785|NCT00897767|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
680786|NCT00897767|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
680787|NCT00897767|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
680788|NCT00897767|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
680789|NCT00897767|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
680790|NCT00897767|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
680791|NCT00897767|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
680792|NCT00897767|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
680793|NCT00897767|refractory hairy cell leukemia|refractory hairy cell leukemia
680794|NCT00897767|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
680795|NCT00897767|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
680796|NCT00897767|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
680797|NCT00897767|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
680798|NCT00897767|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
680799|NCT00897767|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
681203|NCT00891631|alcohol|alcohol
680800|NCT00897767|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
680801|NCT00897767|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
680802|NCT00897767|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
680803|NCT00897767|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
680804|NCT00897767|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
680805|NCT00897767|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
680806|NCT00897767|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
680807|NCT00897767|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
680808|NCT00897767|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
680809|NCT00897767|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
680810|NCT00897767|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
680811|NCT00897767|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
680812|NCT00897767|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
681216|NCT00891657|Leiomyoma|leiomyoma
680813|NCT00897767|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
680814|NCT00897767|secondary acute myeloid leukemia|secondary acute myeloid leukemia
680815|NCT00897767|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
680816|NCT00897767|acute undifferentiated leukemia|acute undifferentiated leukemia
680817|NCT00897767|mast cell leukemia|mast cell leukemia
680818|NCT00897767|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
680819|NCT00897767|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
680820|NCT00897767|prolymphocytic leukemia|prolymphocytic leukemia
680821|NCT00897767|untreated hairy cell leukemia|untreated hairy cell leukemia
680822|NCT00897780|Headache|headache
680823|NCT00897780|Pediatric|pediatric
680824|NCT00897780|Virtual Reality|virtual reality
680825|NCT00897780|Biofeedback|biofeedback
680826|NCT00897793|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
680827|NCT00897793|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
680828|NCT00897793|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
680829|NCT00897793|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
680830|NCT00897793|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
680831|NCT00897793|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
680832|NCT00897793|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
680833|NCT00897793|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
680834|NCT00897793|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
680835|NCT00897793|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
680836|NCT00897793|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
680837|NCT00897793|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
680838|NCT00897793|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
680839|NCT00897793|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
680840|NCT00897793|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
680841|NCT00897793|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
680842|NCT00897793|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
680843|NCT00897793|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
680844|NCT00897793|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
680845|NCT00897793|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
680846|NCT00897793|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
680847|NCT00897793|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
680848|NCT00897793|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
680849|NCT00897793|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
680850|NCT00897793|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
680851|NCT00897793|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
680852|NCT00897793|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
680853|NCT00897793|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
680854|NCT00897793|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
680855|NCT00897793|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
680856|NCT00897793|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
680857|NCT00897793|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
680858|NCT00897793|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
681204|NCT00891631|marijuana|marijuana
680859|NCT00897793|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
680860|NCT00897793|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
680861|NCT00897793|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
681208|NCT00891631|depression|depression
680862|NCT00897793|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
680863|NCT00897793|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
680864|NCT00897793|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
680865|NCT00897793|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
680866|NCT00897793|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
680867|NCT00897793|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
680868|NCT00897793|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
680869|NCT00897793|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
681210|NCT00891631|sexual risk behaviors|sexual risk behaviors
680870|NCT00897793|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
680871|NCT00897793|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
680872|NCT00897793|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
680873|NCT00897793|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
680874|NCT00897793|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
680875|NCT00897793|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
680876|NCT00897793|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
680877|NCT00897793|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
680878|NCT00897793|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
680879|NCT00897793|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
680880|NCT00897793|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
680881|NCT00897793|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
680882|NCT00897793|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
680883|NCT00897793|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
680884|NCT00897793|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
680885|NCT00897793|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
680886|NCT00897793|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
680887|NCT00897793|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
680888|NCT00897793|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
680889|NCT00897793|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
680890|NCT00897793|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
680891|NCT00897793|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
680892|NCT00897793|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
680893|NCT00897793|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
680894|NCT00897793|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
680895|NCT00897793|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
680896|NCT00897793|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
680897|NCT00897793|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
680898|NCT00897793|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
680899|NCT00897793|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
680900|NCT00897793|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
680901|NCT00897793|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
752860|NCT01174511|A-1 COOL CREAM|a-1 cool cream
680902|NCT00897793|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
680903|NCT00897793|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
680904|NCT00897793|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
680905|NCT00897793|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
680906|NCT00897793|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
680907|NCT00897793|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
680908|NCT00897793|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
680909|NCT00897793|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
680910|NCT00897793|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
680911|NCT00897793|recurrent salivary gland cancer|recurrent salivary gland cancer
680912|NCT00897793|salivary gland acinic cell tumor|salivary gland acinic cell tumor
680913|NCT00897793|salivary gland adenocarcinoma|salivary gland adenocarcinoma
680914|NCT00897793|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
680915|NCT00897793|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
680916|NCT00897793|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
680917|NCT00897793|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
680918|NCT00897793|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
680919|NCT00897793|stage I salivary gland cancer|stage i salivary gland cancer
680920|NCT00897793|stage II salivary gland cancer|stage ii salivary gland cancer
680921|NCT00897793|stage III salivary gland cancer|stage iii salivary gland cancer
680922|NCT00897793|stage IV salivary gland cancer|stage iv salivary gland cancer
680923|NCT00897793|limited stage small cell lung cancer|limited stage small cell lung cancer
680924|NCT00897793|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
680925|NCT00897793|recurrent small cell lung cancer|recurrent small cell lung cancer
680926|NCT00897793|stage I non-small cell lung cancer|stage i non-small cell lung cancer
680927|NCT00897793|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
680928|NCT00897793|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
680929|NCT00897793|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
680930|NCT00897793|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
680931|NCT00897793|extensive stage small cell lung cancer|extensive stage small cell lung cancer
680932|NCT00897793|male breast cancer|male breast cancer
680933|NCT00897793|recurrent breast cancer|recurrent breast cancer
680934|NCT00897793|stage I breast cancer|stage i breast cancer
680935|NCT00897793|stage II breast cancer|stage ii breast cancer
680936|NCT00897793|stage IIIA breast cancer|stage iiia breast cancer
680937|NCT00897793|stage IIIB breast cancer|stage iiib breast cancer
680938|NCT00897793|stage IIIC breast cancer|stage iiic breast cancer
680939|NCT00897793|stage IV breast cancer|stage iv breast cancer
680940|NCT00897793|recurrent colon cancer|recurrent colon cancer
680941|NCT00897793|stage I colon cancer|stage i colon cancer
680942|NCT00897793|stage II colon cancer|stage ii colon cancer
680943|NCT00897793|stage III colon cancer|stage iii colon cancer
680944|NCT00897793|stage IV colon cancer|stage iv colon cancer
680945|NCT00897793|recurrent rectal cancer|recurrent rectal cancer
680946|NCT00897793|stage I rectal cancer|stage i rectal cancer
680947|NCT00897793|stage II rectal cancer|stage ii rectal cancer
680948|NCT00897793|stage III rectal cancer|stage iii rectal cancer
680949|NCT00897793|stage IV rectal cancer|stage iv rectal cancer
680950|NCT00897793|recurrent prostate cancer|recurrent prostate cancer
680951|NCT00897793|stage I prostate cancer|stage i prostate cancer
680952|NCT00897793|stage II prostate cancer|stage ii prostate cancer
680953|NCT00897793|stage III prostate cancer|stage iii prostate cancer
680954|NCT00897793|stage IV prostate cancer|stage iv prostate cancer
680955|NCT00897806|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
680956|NCT00897806|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
680957|NCT00897806|peritoneal cavity cancer|peritoneal cavity cancer
680958|NCT00897819|recurrent colon cancer|recurrent colon cancer
680959|NCT00897819|recurrent rectal cancer|recurrent rectal cancer
680960|NCT00897819|stage III colon cancer|stage iii colon cancer
680961|NCT00897819|stage III rectal cancer|stage iii rectal cancer
680962|NCT00897819|stage IV colon cancer|stage iv colon cancer
680963|NCT00897819|stage IV rectal cancer|stage iv rectal cancer
680964|NCT00897819|adenocarcinoma of the colon|adenocarcinoma of the colon
680965|NCT00897819|adenocarcinoma of the rectum|adenocarcinoma of the rectum
680966|NCT00897832|pancreatic cancer|pancreatic cancer
680967|NCT00897845|stage II breast cancer|stage ii breast cancer
680968|NCT00897845|stage IIIA breast cancer|stage iiia breast cancer
680969|NCT00897845|stage IIIB breast cancer|stage iiib breast cancer
680970|NCT00897858|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
680971|NCT00897858|childhood choroid plexus tumor|childhood choroid plexus tumor
682605|NCT00900302|unresectable gallbladder cancer|unresectable gallbladder cancer
682606|NCT00900302|recurrent vulvar cancer|recurrent vulvar cancer
682607|NCT00900302|stage I vulvar cancer|stage i vulvar cancer
682608|NCT00900302|stage II vulvar cancer|stage ii vulvar cancer
682609|NCT00900302|stage III vulvar cancer|stage iii vulvar cancer
682610|NCT00900302|stage IV vulvar cancer|stage iv vulvar cancer
682611|NCT00900302|recurrent cervical cancer|recurrent cervical cancer
682612|NCT00900302|stage IA cervical cancer|stage ia cervical cancer
682613|NCT00900302|stage IB cervical cancer|stage ib cervical cancer
680972|NCT00897858|childhood grade I meningioma|childhood grade i meningioma
680973|NCT00897858|childhood grade II meningioma|childhood grade ii meningioma
680974|NCT00897858|childhood grade III meningioma|childhood grade iii meningioma
680975|NCT00897858|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
680976|NCT00897858|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
680977|NCT00897858|childhood infratentorial ependymoma|childhood infratentorial ependymoma
680978|NCT00897858|childhood supratentorial ependymoma|childhood supratentorial ependymoma
680979|NCT00897858|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
680980|NCT00897858|childhood craniopharyngioma|childhood craniopharyngioma
680981|NCT00897858|untreated childhood medulloblastoma|untreated childhood medulloblastoma
680982|NCT00897858|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
680983|NCT00897858|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
680984|NCT00897858|untreated childhood brain stem glioma|untreated childhood brain stem glioma
680985|NCT00897858|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
680986|NCT00897858|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
680987|NCT00897858|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
681211|NCT00891644|HIV|hiv
680988|NCT00897858|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
680989|NCT00897858|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
680990|NCT00897858|childhood central nervous system germinoma|childhood central nervous system germinoma
680991|NCT00897858|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
680992|NCT00897858|childhood central nervous system teratoma|childhood central nervous system teratoma
680993|NCT00897858|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
680994|NCT00897871|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
680995|NCT00897884|breast cancer|breast cancer
680996|NCT00897884|metformin|metformin
680997|NCT00897884|breast surgery|breast surgery
680998|NCT00897897|Uterine Leiomyomas|uterine leiomyomas
680999|NCT00897897|Fibroids|fibroids
681000|NCT00897897|HIFU|hifu
681001|NCT00897897|Ablation|ablation
681002|NCT00897897|High Intensity Focused Ultrasound|high intensity focused ultrasound
681003|NCT00897910|stage I multiple myeloma|stage i multiple myeloma
681004|NCT00897910|stage II multiple myeloma|stage ii multiple myeloma
681005|NCT00897910|stage III multiple myeloma|stage iii multiple myeloma
681006|NCT00897910|refractory multiple myeloma|refractory multiple myeloma
681007|NCT00897923|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
681008|NCT00897923|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
681009|NCT00897923|anaplastic large cell lymphoma|anaplastic large cell lymphoma
681010|NCT00897923|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
681011|NCT00897923|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
681012|NCT00897923|intraocular lymphoma|intraocular lymphoma
681013|NCT00897923|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
681014|NCT00897923|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
681015|NCT00897923|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
681016|NCT00897923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
681017|NCT00897923|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
681018|NCT00897923|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
681019|NCT00897923|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
681020|NCT00897923|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
681021|NCT00897923|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
681022|NCT00897923|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
681023|NCT00897923|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
682684|NCT00900432|recurrent colon cancer|recurrent colon cancer
682685|NCT00900432|stage I colon cancer|stage i colon cancer
682686|NCT00900432|stage II colon cancer|stage ii colon cancer
682687|NCT00900432|stage III colon cancer|stage iii colon cancer
682688|NCT00900432|stage IV colon cancer|stage iv colon cancer
681024|NCT00897923|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
681025|NCT00897923|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
681026|NCT00897923|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
681027|NCT00897923|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
681028|NCT00897923|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
681029|NCT00897923|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
681030|NCT00897923|small intestine lymphoma|small intestine lymphoma
681031|NCT00897923|splenic marginal zone lymphoma|splenic marginal zone lymphoma
681032|NCT00897923|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
681033|NCT00897923|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
681034|NCT00897923|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
681035|NCT00897923|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
681036|NCT00897923|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
681037|NCT00897923|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
681038|NCT00897923|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
681039|NCT00897923|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
681040|NCT00897923|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
681041|NCT00897923|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
681042|NCT00897923|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
681043|NCT00897923|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
681044|NCT00897923|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
752571|NCT01167725|stage III colon cancer|stage iii colon cancer
681045|NCT00897923|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
681046|NCT00897923|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
681047|NCT00897923|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
681048|NCT00897923|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
681049|NCT00897923|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
681212|NCT00891644|Care-seeking|care-seeking
681050|NCT00897923|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
681051|NCT00897923|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
681052|NCT00897923|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
681053|NCT00897923|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
681054|NCT00897923|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
681055|NCT00897923|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
681056|NCT00897923|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
681057|NCT00897923|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
681058|NCT00897923|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
681059|NCT00897923|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
681060|NCT00897923|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
681061|NCT00897923|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
681062|NCT00897923|Waldenström macroglobulinemia|waldenström macroglobulinemia
681063|NCT00897923|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
681064|NCT00897923|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
681065|NCT00897923|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
681066|NCT00897923|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
681067|NCT00897923|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
681068|NCT00897923|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
681069|NCT00897923|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
681070|NCT00897923|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
681071|NCT00897923|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
681072|NCT00897923|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
681073|NCT00897923|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
681074|NCT00897923|stage I mantle cell lymphoma|stage i mantle cell lymphoma
681075|NCT00897923|stage I marginal zone lymphoma|stage i marginal zone lymphoma
681076|NCT00897923|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
681077|NCT00897923|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
681078|NCT00897923|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
681079|NCT00897923|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
751840|NCT01170780|Transabdominal preperitoneal hernia repair|transabdominal preperitoneal hernia repair
681080|NCT00897923|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
681081|NCT00897923|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
681082|NCT00897923|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
681083|NCT00897923|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
681084|NCT00897923|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
681085|NCT00897923|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
681086|NCT00897923|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
681087|NCT00897923|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
681088|NCT00897923|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
681089|NCT00897923|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
681090|NCT00897923|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
681091|NCT00897923|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
681092|NCT00897923|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
681093|NCT00897923|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
681094|NCT00897923|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
681095|NCT00897923|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
681096|NCT00897923|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
681097|NCT00897923|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
681098|NCT00897923|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
681099|NCT00897923|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
681100|NCT00897923|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
681101|NCT00897923|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
681102|NCT00897923|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
681103|NCT00897923|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
681104|NCT00897923|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
681105|NCT00897923|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
681106|NCT00897923|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
681107|NCT00897923|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
681108|NCT00897936|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
681109|NCT00897936|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
681110|NCT00897936|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
681111|NCT00897936|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
681112|NCT00897936|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
681209|NCT00891631|suicidality|suicidality
681113|NCT00897936|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
681114|NCT00897936|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
681115|NCT00897936|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
681116|NCT00897962|stage IV breast cancer|stage iv breast cancer
681117|NCT00897975|statin associated myalgias|statin associated myalgias
681118|NCT00897975|hyperlipidemia|hyperlipidemia
681119|NCT00897975|red yeast rice|red yeast rice
681120|NCT00897975|phytosterols|phytosterols
681121|NCT00897975|therapeutic lifestyle changes|therapeutic lifestyle changes
681122|NCT00897975|compliance|compliance
681123|NCT00897988|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
681124|NCT00897988|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
681125|NCT00897988|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
681126|NCT00897988|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
681127|NCT00897988|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
681128|NCT00898014|stage IV breast cancer|stage iv breast cancer
681129|NCT00891397|CPRS|cprs
681130|NCT00891397|stellate ganglion block|stellate ganglion block
681131|NCT00891397|pregabalin|pregabalin
681132|NCT00891397|pain|pain
681133|NCT00891397|Type I|type i
681134|NCT00891423|Meropenem|meropenem
681135|NCT00891423|extended infusion|extended infusion
681136|NCT00891423|prolonged infusion|prolonged infusion
681137|NCT00891423|Time above MIC|time above mic
681138|NCT00891449|space flight simulation study|space flight simulation study
681139|NCT00891449|medical research study|medical research study
681140|NCT00891449|bed rest|bed rest
681141|NCT00891449|microgravity|microgravity
681142|NCT00891449|weightlessness|weightlessness
681143|NCT00891449|The effects of long duration microgravity on humans|the effects of long duration microgravity on humans
681144|NCT00891462|COPD|copd
681145|NCT00891462|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
681146|NCT00891462|Chronic Bronchitis|chronic bronchitis
681147|NCT00891462|Emphysema|emphysema
681148|NCT00891462|Airflow Obstruction, Chronic|airflow obstruction, chronic
681149|NCT00891462|Chronic Airflow Obstruction|chronic airflow obstruction
681150|NCT00891462|Chronic Obstructive Airway Disease|chronic obstructive airway disease
681151|NCT00891462|Chronic Obstructive Lung Disease|chronic obstructive lung disease
681152|NCT00891475|metastatic renal cell carcinoma|metastatic renal cell carcinoma
681153|NCT00891475|radiofrequency ablation|radiofrequency ablation
681154|NCT00891488|VO2 max|vo2 max
681155|NCT00891488|stress|stress
681156|NCT00891488|cortisol|cortisol
681157|NCT00891488|fitness|fitness
681158|NCT00891501|autologous bone marrow mesenchymal stem cells|autologous bone marrow mesenchymal stem cells
681159|NCT00891501|cartilage repair|cartilage repair
681160|NCT00891501|osteoarthritis|osteoarthritis
681161|NCT00891501|osteochondral defects|osteochondral defects
681162|NCT00891514|Exercise|exercise
681163|NCT00891514|Inflammation|inflammation
681164|NCT00891514|Insulin Sensitivity|insulin sensitivity
681165|NCT00891527|Pulmonary Vein Stenosis,|pulmonary vein stenosis,
681166|NCT00891527|Avastin and Gleevec,|avastin and gleevec,
681167|NCT00891527|Targeting VEGF and PDGF|targeting vegf and pdgf
681168|NCT00891553|bone mineral density|bone mineral density
681169|NCT00891553|calcium-sensing receptor antagonist|calcium-sensing receptor antagonist
681170|NCT00891553|ronacaleret|ronacaleret
681171|NCT00891553|postmenopausal osteoporosis|postmenopausal osteoporosis
681172|NCT00891566|medium to large tear|medium to large tear
681173|NCT00891566|rotator cuff tear|rotator cuff tear
681174|NCT00891566|arthroscopic repair|arthroscopic repair
681175|NCT00891566|repair integrity|repair integrity
681176|NCT00891566|immobilization|immobilization
681177|NCT00891579|NSCLC|nsclc
681178|NCT00891579|EGFR|egfr
681179|NCT00891579|Pemetrexed|pemetrexed
681180|NCT00891579|Gefitinib|gefitinib
681181|NCT00891579|without EGFR mutations|without egfr mutations
681182|NCT00891592|AML|aml
681183|NCT00891592|MDS|mds
681184|NCT00891592|ALL|all
681185|NCT00891592|NHL|nhl
681186|NCT00891592|Multiple Myeloma|multiple myeloma
681187|NCT00891592|Hodgkin's|hodgkin's
681188|NCT00891605|Paclitaxel|paclitaxel
681189|NCT00891605|Solid Tumors|solid tumors
681190|NCT00891618|Lymphoma|lymphoma
681191|NCT00891618|Myeloma|myeloma
681192|NCT00891618|Multiple Myeloma|multiple myeloma
681193|NCT00891618|MM|mm
681194|NCT00891618|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
681195|NCT00891618|NHL|nhl
681196|NCT00891618|Acupuncture|acupuncture
681197|NCT00891618|Treatment-induced Peripheral Neuropathy|treatment-induced peripheral neuropathy
681198|NCT00891618|Thalidomide|thalidomide
681217|NCT00891657|Myomectomy|myomectomy
681218|NCT00891670|CYP2C19 polymorphism|cyp2c19 polymorphism
681219|NCT00891670|platelet|platelet
681220|NCT00891670|Adjunctive cilostazol|adjunctive cilostazol
681221|NCT00891670|high maintenance dose clopidogrel|high maintenance dose clopidogrel
681222|NCT00891670|P2Y12 Reaction Unit|p2y12 reaction unit
681223|NCT00891683|Diabetic|diabetic
681224|NCT00891683|peripheral|peripheral
681225|NCT00891683|neuropathy|neuropathy
681226|NCT00891683|pain|pain
681227|NCT00891683|hyperalgesia|hyperalgesia
681228|NCT00891683|allodynia|allodynia
681229|NCT00891696|Sarcopenia|sarcopenia
681230|NCT00891696|Aging|aging
681231|NCT00891696|Metabolism|metabolism
681232|NCT00891696|Muscle|muscle
681233|NCT00891696|mTOR|mtor
681234|NCT00891696|Essential Amino Acids|essential amino acids
681235|NCT00891696|Exercise|exercise
681236|NCT00891696|Rapamycin|rapamycin
681237|NCT00891722|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
681238|NCT00891722|untreated childhood brain stem glioma|untreated childhood brain stem glioma
681239|NCT00891722|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
681240|NCT00891722|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
681241|NCT00891722|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
681242|NCT00891722|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
681243|NCT00891722|childhood oligodendroglioma|childhood oligodendroglioma
681244|NCT00891722|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
681245|NCT00891722|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
681246|NCT00891722|childhood mixed glioma|childhood mixed glioma
681247|NCT00891735|Lucentis|lucentis
681248|NCT00891735|AMD|amd
681249|NCT00891735|Age-related macular degeneration|age-related macular degeneration
681250|NCT00891735|Subfoveal neovascular age-related macular degeneration|subfoveal neovascular age-related macular degeneration
681251|NCT00891735|Wet AMD|wet amd
751841|NCT01170780|TAPP|tapp
681252|NCT00891735|Macular degeneration|macular degeneration
681253|NCT00891735|Ranibizumab|ranibizumab
681254|NCT00898027|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
681255|NCT00898040|stage I multiple myeloma|stage i multiple myeloma
681256|NCT00898040|stage II multiple myeloma|stage ii multiple myeloma
681257|NCT00898040|stage III multiple myeloma|stage iii multiple myeloma
681258|NCT00898040|refractory multiple myeloma|refractory multiple myeloma
681259|NCT00898066|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
681260|NCT00898066|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
681261|NCT00898066|primary systemic amyloidosis|primary systemic amyloidosis
681262|NCT00898066|stage I multiple myeloma|stage i multiple myeloma
681263|NCT00898066|stage II multiple myeloma|stage ii multiple myeloma
681264|NCT00898066|stage III multiple myeloma|stage iii multiple myeloma
681265|NCT00898092|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
681266|NCT00898092|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
681267|NCT00898092|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
681268|NCT00898092|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
681269|NCT00898092|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
681270|NCT00898092|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
681271|NCT00898092|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
681272|NCT00898092|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
681273|NCT00898092|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
681274|NCT00898092|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
681275|NCT00898092|adult acute basophilic leukemia|adult acute basophilic leukemia
681276|NCT00898092|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
681277|NCT00898118|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
681278|NCT00898118|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
681279|NCT00898118|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
681280|NCT00898118|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
681281|NCT00898131|breast cancer|breast cancer
681282|NCT00898144|cervical cancer|cervical cancer
681283|NCT00898144|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
681284|NCT00898144|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
681285|NCT00898144|cervical adenocarcinoma|cervical adenocarcinoma
681286|NCT00898144|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
681287|NCT00898157|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
681288|NCT00898157|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
681289|NCT00898157|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
681290|NCT00898157|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
681291|NCT00898157|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
681292|NCT00898157|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
681293|NCT00898170|myoma|myoma
681294|NCT00898170|hypertension|hypertension
681295|NCT00898170|erythropoetin|erythropoetin
681296|NCT00898170|blood pressure|blood pressure
681297|NCT00898170|erythropoetin level|erythropoetin level
681298|NCT00898183|stage III melanoma|stage iii melanoma
681299|NCT00898183|stage IV melanoma|stage iv melanoma
681300|NCT00898183|recurrent melanoma|recurrent melanoma
681301|NCT00898209|stage I non-small cell lung cancer|stage i non-small cell lung cancer
681302|NCT00898209|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
681303|NCT00898209|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
681304|NCT00898209|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
681305|NCT00898209|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
681306|NCT00898222|healthy volunteers|healthy volunteers
681307|NCT00898222|aspirin|aspirin
681308|NCT00898222|Normal healthy subjects|normal healthy subjects
681309|NCT00898235|primary systemic amyloidosis|primary systemic amyloidosis
681310|NCT00898261|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
681311|NCT00898274|prostate cancer|prostate cancer
681312|NCT00898274|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
681313|NCT00898287|Locally advanced or metastatic adenocarcinoma of pancreas|locally advanced or metastatic adenocarcinoma of pancreas
681314|NCT00898300|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
681315|NCT00898300|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
681316|NCT00898300|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
681317|NCT00898300|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
681318|NCT00898300|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
681319|NCT00898300|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
751842|NCT01170780|Dexamethasone|dexamethasone
681320|NCT00898300|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
681321|NCT00898300|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
681322|NCT00898300|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
681323|NCT00898300|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
681324|NCT00898300|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
681325|NCT00898300|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
681326|NCT00898300|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
681327|NCT00898300|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
681328|NCT00898300|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
681329|NCT00898300|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
681330|NCT00898300|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
681331|NCT00898300|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
681332|NCT00898300|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
681333|NCT00898300|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
681334|NCT00898300|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
681335|NCT00898300|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
681336|NCT00898300|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
681337|NCT00898300|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
681338|NCT00898300|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
681339|NCT00898300|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
681340|NCT00898300|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
681341|NCT00898300|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
681342|NCT00898300|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
681343|NCT00898300|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
681344|NCT00898300|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
752572|NCT01167725|stage IV colon cancer|stage iv colon cancer
681345|NCT00898300|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
681346|NCT00898300|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
681347|NCT00898300|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
681348|NCT00898300|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
681349|NCT00898300|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
681350|NCT00898300|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
681351|NCT00898300|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
681352|NCT00898300|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
681405|NCT00898352|stage III vulvar cancer|stage iii vulvar cancer
681353|NCT00898300|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
681354|NCT00898300|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
681355|NCT00898300|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
681356|NCT00898300|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
681357|NCT00898300|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
681358|NCT00898300|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
681359|NCT00898300|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
681360|NCT00898300|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
681361|NCT00898300|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
681362|NCT00898300|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
681363|NCT00898300|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
681364|NCT00898300|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
681365|NCT00898300|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
681366|NCT00898300|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
681367|NCT00898300|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
681368|NCT00898300|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
681369|NCT00898300|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
681370|NCT00898300|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
681371|NCT00898300|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
681372|NCT00898300|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
681373|NCT00898300|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
681374|NCT00898300|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
681375|NCT00898300|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
681376|NCT00898300|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
681377|NCT00898300|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
681378|NCT00898300|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
681379|NCT00898300|stage I salivary gland cancer|stage i salivary gland cancer
681380|NCT00898300|stage II salivary gland cancer|stage ii salivary gland cancer
681381|NCT00898300|stage III salivary gland cancer|stage iii salivary gland cancer
681382|NCT00898300|stage IV salivary gland cancer|stage iv salivary gland cancer
681383|NCT00898300|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
681384|NCT00898300|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
681385|NCT00898300|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
681386|NCT00898300|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
681387|NCT00898300|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
681388|NCT00898300|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
681389|NCT00898300|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
681390|NCT00898300|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
681391|NCT00898300|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
681392|NCT00898300|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
681393|NCT00898300|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
681394|NCT00898300|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
681395|NCT00898300|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
681396|NCT00898300|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
681397|NCT00898300|recurrent salivary gland cancer|recurrent salivary gland cancer
681398|NCT00898300|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
681399|NCT00898300|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
681400|NCT00898300|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
681401|NCT00898313|lung cancer|lung cancer
681402|NCT00898326|stage I prostate cancer|stage i prostate cancer
681403|NCT00898326|stage IIB prostate cancer|stage iib prostate cancer
681404|NCT00898326|stage IIA prostate cancer|stage iia prostate cancer
681406|NCT00898352|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
681407|NCT00898378|healthy, no evidence of disease|healthy, no evidence of disease
681408|NCT00898378|stage I colon cancer|stage i colon cancer
681409|NCT00898378|stage II colon cancer|stage ii colon cancer
681410|NCT00898378|stage III colon cancer|stage iii colon cancer
681411|NCT00898378|stage IV colon cancer|stage iv colon cancer
681412|NCT00898378|stage I rectal cancer|stage i rectal cancer
681413|NCT00898378|stage II rectal cancer|stage ii rectal cancer
681414|NCT00898378|stage III rectal cancer|stage iii rectal cancer
681415|NCT00898378|stage IV rectal cancer|stage iv rectal cancer
681416|NCT00898378|recurrent rectal cancer|recurrent rectal cancer
681417|NCT00898378|recurrent colon cancer|recurrent colon cancer
681418|NCT00898378|adenomatous polyp|adenomatous polyp
681419|NCT00898846|stage II colon cancer|stage ii colon cancer
681420|NCT00898846|stage II rectal cancer|stage ii rectal cancer
681421|NCT00898846|adenocarcinoma of the colon|adenocarcinoma of the colon
681422|NCT00898846|adenocarcinoma of the rectum|adenocarcinoma of the rectum
681423|NCT00898859|ADAM|adam
681424|NCT00898859|epithelial|epithelial
681425|NCT00898859|COPD|copd
681426|NCT00898872|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
681427|NCT00898872|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
681428|NCT00898872|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
681429|NCT00898872|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
681430|NCT00898872|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
681431|NCT00898872|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
681432|NCT00898872|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
681433|NCT00898872|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
681434|NCT00898872|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
681435|NCT00898872|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
681436|NCT00898872|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
681437|NCT00898872|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
681438|NCT00898872|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
681439|NCT00898872|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
681440|NCT00898872|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
681441|NCT00898872|splenic marginal zone lymphoma|splenic marginal zone lymphoma
681442|NCT00898872|Waldenström macroglobulinemia|waldenström macroglobulinemia
681443|NCT00898872|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
681444|NCT00898872|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
681445|NCT00898872|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
681446|NCT00898872|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
681447|NCT00898872|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
681448|NCT00898872|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
681449|NCT00898872|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
681450|NCT00898872|childhood Burkitt lymphoma|childhood burkitt lymphoma
681451|NCT00898872|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
681452|NCT00898885|oral manifestations|oral manifestations
681453|NCT00898885|bone marrow transplantation|bone marrow transplantation
681454|NCT00898885|adverse effects|adverse effects
681455|NCT00898898|stage IA breast cancer|stage ia breast cancer
681456|NCT00898898|stage IB breast cancer|stage ib breast cancer
681457|NCT00898898|stage II breast cancer|stage ii breast cancer
681458|NCT00898898|stage IIIA breast cancer|stage iiia breast cancer
681459|NCT00898898|HER2-positive breast cancer|her2-positive breast cancer
681460|NCT00898911|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
681461|NCT00898911|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
681462|NCT00898911|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
681463|NCT00898911|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
681464|NCT00898911|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
753392|NCT01176461|stage IV melanoma|stage iv melanoma
681465|NCT00898911|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
681466|NCT00898911|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
681467|NCT00898911|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
681468|NCT00898911|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
681469|NCT00898911|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
681470|NCT00898911|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
681471|NCT00898911|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
681472|NCT00898911|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
681620|NCT00899392|Duration in Endoscopy Suite|duration in endoscopy suite
681473|NCT00898911|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
681474|NCT00898911|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
681475|NCT00898911|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
681476|NCT00898911|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
681477|NCT00898911|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
681478|NCT00898911|recurrent salivary gland cancer|recurrent salivary gland cancer
681479|NCT00898911|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
681480|NCT00898911|stage IV salivary gland cancer|stage iv salivary gland cancer
681481|NCT00898924|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
681482|NCT00898924|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
681483|NCT00898937|breast cancer|breast cancer
681484|NCT00898950|diabetes|diabetes
681485|NCT00898950|aspirin|aspirin
681486|NCT00898950|oxidative stress|oxidative stress
681487|NCT00898950|insulin resistance|insulin resistance
681488|NCT00898950|endothelial function|endothelial function
681489|NCT00898950|inflammation|inflammation
681490|NCT00898950|photoplethysmography|photoplethysmography
681491|NCT00898950|dysglycaemia|dysglycaemia
681492|NCT00898963|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
681493|NCT00898963|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
681494|NCT00898963|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
681495|NCT00898963|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
681496|NCT00898963|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
751843|NCT01170780|Pain|pain
681497|NCT00898963|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
681499|NCT00898976|stage II breast cancer|stage ii breast cancer
681500|NCT00898976|stage IV breast cancer|stage iv breast cancer
681501|NCT00898976|stage IIIA breast cancer|stage iiia breast cancer
681502|NCT00898976|breast cancer in situ|breast cancer in situ
681503|NCT00898976|recurrent breast cancer|recurrent breast cancer
681504|NCT00898976|stage IIIB breast cancer|stage iiib breast cancer
681505|NCT00898976|inflammatory breast cancer|inflammatory breast cancer
681506|NCT00898976|stage IIIC breast cancer|stage iiic breast cancer
681507|NCT00899002|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
681508|NCT00899002|childhood liver cancer|childhood liver cancer
681509|NCT00899002|adult primary liver cancer|adult primary liver cancer
681510|NCT00899002|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
681511|NCT00899015|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
681512|NCT00899015|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
681513|NCT00899015|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
681514|NCT00899015|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
681515|NCT00899015|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
681516|NCT00899015|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
681517|NCT00899015|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
681518|NCT00899015|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
681519|NCT00899015|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
681520|NCT00899028|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
681521|NCT00899028|stage I non-small cell lung cancer|stage i non-small cell lung cancer
681522|NCT00899028|extensive stage small cell lung cancer|extensive stage small cell lung cancer
681523|NCT00899028|limited stage small cell lung cancer|limited stage small cell lung cancer
681524|NCT00899028|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
681525|NCT00899028|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
681526|NCT00899028|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
681527|NCT00899028|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
681528|NCT00899041|Prosthesis|prosthesis
681529|NCT00899080|stage I multiple myeloma|stage i multiple myeloma
681530|NCT00899080|stage II multiple myeloma|stage ii multiple myeloma
681531|NCT00899080|stage III multiple myeloma|stage iii multiple myeloma
681532|NCT00899119|Waldenström macroglobulinemia|waldenström macroglobulinemia
681533|NCT00899132|skin cancer|skin cancer
681534|NCT00899132|small intestine cancer|small intestine cancer
681535|NCT00899132|pancreatic cancer|pancreatic cancer
681536|NCT00899132|malignant testicular germ cell tumor|malignant testicular germ cell tumor
681537|NCT00899132|testicular teratoma|testicular teratoma
681538|NCT00899158|recurrent pancreatic cancer|recurrent pancreatic cancer
681539|NCT00899158|stage I pancreatic cancer|stage i pancreatic cancer
681540|NCT00899158|stage II pancreatic cancer|stage ii pancreatic cancer
681541|NCT00899158|stage III pancreatic cancer|stage iii pancreatic cancer
681542|NCT00899158|stage IV pancreatic cancer|stage iv pancreatic cancer
681543|NCT00899158|cachexia|cachexia
681544|NCT00899171|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
681545|NCT00899171|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
681546|NCT00899171|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
681547|NCT00899171|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
681548|NCT00899171|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
681549|NCT00899171|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
681550|NCT00899171|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
681551|NCT00899171|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
681552|NCT00899171|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
681553|NCT00899171|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
681554|NCT00899171|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
681555|NCT00899171|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
681556|NCT00899171|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
681557|NCT00899171|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
681558|NCT00899171|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
681559|NCT00899171|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
681560|NCT00899171|secondary acute myeloid leukemia|secondary acute myeloid leukemia
681561|NCT00899184|recurrent prostate cancer|recurrent prostate cancer
681562|NCT00899184|stage IV prostate cancer|stage iv prostate cancer
681563|NCT00899184|stage I prostate cancer|stage i prostate cancer
681564|NCT00899184|stage IIB prostate cancer|stage iib prostate cancer
681565|NCT00899184|stage IIA prostate cancer|stage iia prostate cancer
681566|NCT00899184|stage III prostate cancer|stage iii prostate cancer
681567|NCT00899197|stage I breast cancer|stage i breast cancer
681568|NCT00899197|stage II breast cancer|stage ii breast cancer
681569|NCT00899197|stage IIIA breast cancer|stage iiia breast cancer
681570|NCT00899197|stage IIIB breast cancer|stage iiib breast cancer
681571|NCT00899210|liver metastases|liver metastases
681572|NCT00899210|adenocarcinoma of the colon|adenocarcinoma of the colon
681573|NCT00899210|stage IV colon cancer|stage iv colon cancer
681574|NCT00899210|adenocarcinoma of the rectum|adenocarcinoma of the rectum
681575|NCT00899210|stage IV rectal cancer|stage iv rectal cancer
681576|NCT00899210|recurrent colon cancer|recurrent colon cancer
681577|NCT00899210|recurrent rectal cancer|recurrent rectal cancer
681578|NCT00899262|lung cancer|lung cancer
681579|NCT00899262|tobacco use disorder|tobacco use disorder
681580|NCT00899275|osteosarcoma|osteosarcoma
681581|NCT00899288|osteoporosis|osteoporosis
681582|NCT00899288|stage I breast cancer|stage i breast cancer
681583|NCT00899288|stage II breast cancer|stage ii breast cancer
681584|NCT00899288|stage IIIA breast cancer|stage iiia breast cancer
681585|NCT00899301|breast cancer|breast cancer
681586|NCT00899301|stage IA breast cancer|stage ia breast cancer
681587|NCT00899301|stage IB breast cancer|stage ib breast cancer
681588|NCT00899301|stage II breast cancer|stage ii breast cancer
681589|NCT00899301|stage IIIA breast cancer|stage iiia breast cancer
681590|NCT00899301|stage IIIB breast cancer|stage iiib breast cancer
681591|NCT00899301|stage IIIC breast cancer|stage iiic breast cancer
681592|NCT00899301|stage IV breast cancer|stage iv breast cancer
681593|NCT00899327|myelodysplastic syndromes|myelodysplastic syndromes
681594|NCT00899327|acute myeloid leukemia|acute myeloid leukemia
681595|NCT00899340|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
681596|NCT00899340|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
681597|NCT00899340|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
681598|NCT00899340|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
681599|NCT00899340|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
681600|NCT00899353|ES-CLL|es-cll
681601|NCT00899353|MGUS|mgus
681602|NCT00899353|SMM|smm
681603|NCT00899353|Early Stage - Chronic Lymphocytic Leukemia|early stage - chronic lymphocytic leukemia
681604|NCT00899366|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
681605|NCT00899366|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
681606|NCT00899366|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
681607|NCT00899366|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
681608|NCT00899366|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
681609|NCT00899366|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
681610|NCT00899366|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
681611|NCT00899366|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
681612|NCT00899392|consent|consent
681613|NCT00899392|Anxiety|anxiety
681614|NCT00899392|Satisfaction|satisfaction
681615|NCT00899392|Efficiency|efficiency
681616|NCT00899392|Questions|questions
681617|NCT00899392|Attainment of Informed Consent (Consent-20)|attainment of informed consent (consent-20)
681618|NCT00899392|Procedural State Anxiety (STAI)|procedural state anxiety (stai)
681619|NCT00899392|Subject Satisfaction (mGHAA-9)|subject satisfaction (mghaa-9)
684971|NCT00909116|rectocele|rectocele
681621|NCT00899392|Number of questions asked|number of questions asked
681622|NCT00899405|lung cancer|lung cancer
681623|NCT00899418|recurrent breast cancer|recurrent breast cancer
681624|NCT00899418|stage IV breast cancer|stage iv breast cancer
681625|NCT00899431|Nonmyeloablative Stem Cell Transplantation|nonmyeloablative stem cell transplantation
681626|NCT00899431|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
681627|NCT00899431|CLL|cll
681628|NCT00899431|Immunomanipulation|immunomanipulation
681629|NCT00899431|Fludarabine|fludarabine
681630|NCT00899431|Lenalidomide|lenalidomide
681631|NCT00899431|Rituximab|rituximab
681632|NCT00899431|Thymoglobulin|thymoglobulin
681633|NCT00899431|Stem Cell Transplantation|stem cell transplantation
681634|NCT00899457|squamous cell lung cancer|squamous cell lung cancer
681635|NCT00899457|non-small cell lung cancer|non-small cell lung cancer
681636|NCT00899457|small cell lung cancer|small cell lung cancer
681637|NCT00899457|healthy, no evidence of disease|healthy, no evidence of disease
681638|NCT00899496|stage IV bladder cancer|stage iv bladder cancer
681639|NCT00899496|stage IV colon cancer|stage iv colon cancer
681640|NCT00899496|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
681641|NCT00899496|stage IV pancreatic cancer|stage iv pancreatic cancer
681642|NCT00899496|stage IV rectal cancer|stage iv rectal cancer
681643|NCT00899496|stage IV renal cell cancer|stage iv renal cell cancer
681644|NCT00899496|stage IV melanoma|stage iv melanoma
681645|NCT00899496|stage III multiple myeloma|stage iii multiple myeloma
751844|NCT01170793|education, quality of life|education, quality of life
681646|NCT00899496|extensive stage small cell lung cancer|extensive stage small cell lung cancer
681647|NCT00899496|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
681648|NCT00899496|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
681649|NCT00899496|stage IV breast cancer|stage iv breast cancer
681650|NCT00899496|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
681651|NCT00899496|stage IV prostate cancer|stage iv prostate cancer
681652|NCT00899496|stage IV endometrial carcinoma|stage iv endometrial carcinoma
681653|NCT00899496|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
681654|NCT00899496|metastatic osteosarcoma|metastatic osteosarcoma
681655|NCT00899496|stage IV uterine sarcoma|stage iv uterine sarcoma
681656|NCT00899496|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
681657|NCT00899496|ovarian sarcoma|ovarian sarcoma
681658|NCT00899496|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
681659|NCT00899496|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
681660|NCT00899496|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
681661|NCT00899496|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
681662|NCT00899496|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
681663|NCT00899496|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
681664|NCT00899496|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
681665|NCT00899496|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
681666|NCT00899496|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
681667|NCT00899496|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
681668|NCT00899496|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
681669|NCT00899496|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
681670|NCT00899496|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
681671|NCT00899496|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
681672|NCT00899496|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
681673|NCT00899496|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
681674|NCT00899496|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
681675|NCT00899496|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
681676|NCT00899496|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
681677|NCT00899496|splenic marginal zone lymphoma|splenic marginal zone lymphoma
681678|NCT00899496|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
681679|NCT00899496|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
681680|NCT00899496|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
681681|NCT00899496|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
681682|NCT00899496|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
681683|NCT00899496|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
681684|NCT00899496|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
681685|NCT00899496|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
681686|NCT00899496|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
681687|NCT00899496|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
681688|NCT00899496|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
681689|NCT00899496|anaplastic large cell lymphoma|anaplastic large cell lymphoma
681690|NCT00899496|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
681691|NCT00899496|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
685365|NCT00902590|ureter|ureter
681692|NCT00899496|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
681693|NCT00899496|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
681694|NCT00899496|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
681695|NCT00899496|intraocular lymphoma|intraocular lymphoma
681696|NCT00899509|stage II breast cancer|stage ii breast cancer
681697|NCT00899509|stage IIIA breast cancer|stage iiia breast cancer
681698|NCT00899522|Fanconi anemia|fanconi anemia
681699|NCT00899522|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
681700|NCT00899522|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
681701|NCT00899535|adenocarcinoma of the lung|adenocarcinoma of the lung
681702|NCT00899535|large cell lung cancer|large cell lung cancer
681703|NCT00899535|squamous cell lung cancer|squamous cell lung cancer
681704|NCT00899535|stage I non-small cell lung cancer|stage i non-small cell lung cancer
681705|NCT00899535|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
681706|NCT00899548|stage IV breast cancer|stage iv breast cancer
681707|NCT00899548|recurrent breast cancer|recurrent breast cancer
681708|NCT00899561|Chronic rhinosinusitis|chronic rhinosinusitis
681709|NCT00899561|Computed tomography|computed tomography
681710|NCT00899561|Histology|histology
681711|NCT00899561|Middle turbinate|middle turbinate
681712|NCT00899561|Morphometry|morphometry
681713|NCT00899561|osteomyelitis|osteomyelitis
681714|NCT00899561|polyps|polyps
683655|NCT00903760|MDS|mds
681715|NCT00899574|toll-like receptor|toll-like receptor
681716|NCT00899574|toll-like receptor agonist|toll-like receptor agonist
681717|NCT00899574|recurrent breast cancer|recurrent breast cancer
681718|NCT00899574|breast cancer metastasized to skin and/or chestwall|breast cancer metastasized to skin and/or chestwall
681719|NCT00899574|immunomodulator|immunomodulator
681720|NCT00899600|chronic pain|chronic pain
681721|NCT00899600|back surgery|back surgery
681722|NCT00899600|opioid dependent|opioid dependent
681723|NCT00899600|NMDA receptor antagonism|nmda receptor antagonism
681724|NCT00899600|Ketamine|ketamine
681725|NCT00899600|Central sensitization|central sensitization
681726|NCT00899613|localized malignant mesothelioma|localized malignant mesothelioma
681727|NCT00899613|lung metastases|lung metastases
681728|NCT00899613|malignant pleural effusion|malignant pleural effusion
681729|NCT00899626|colon cancer|colon cancer
681730|NCT00899626|esophageal cancer|esophageal cancer
681731|NCT00899626|gastric cancer|gastric cancer
681732|NCT00899626|pancreatic cancer|pancreatic cancer
681733|NCT00899626|adenomatous polyp|adenomatous polyp
681734|NCT00899639|stage I breast cancer|stage i breast cancer
681735|NCT00899639|stage II breast cancer|stage ii breast cancer
681736|NCT00899639|stage IIIA breast cancer|stage iiia breast cancer
681737|NCT00899639|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
681738|NCT00899639|male breast cancer|male breast cancer
681739|NCT00899652|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
681740|NCT00899652|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
681741|NCT00899652|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
681742|NCT00899652|secondary acute myeloid leukemia|secondary acute myeloid leukemia
681743|NCT00899652|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
681744|NCT00899652|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
681745|NCT00899652|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
681746|NCT00899652|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
681747|NCT00899665|stage IV prostate cancer|stage iv prostate cancer
681748|NCT00899665|bone metastases|bone metastases
681749|NCT00899665|anemia|anemia
681750|NCT00899665|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
681751|NCT00899665|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
681752|NCT00899665|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
681753|NCT00899665|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
681754|NCT00899678|Certolizumab Pegol|certolizumab pegol
681755|NCT00899678|Cimzia ®|cimzia ®
681756|NCT00899678|Crohn's Disease|crohn's disease
681757|NCT00899691|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
681758|NCT00899704|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
681759|NCT00899704|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
681760|NCT00899704|tongue cancer|tongue cancer
681761|NCT00899717|Temporomandibular Joint Disorders (TMD)|temporomandibular joint disorders (tmd)
681762|NCT00899717|Orofacial pain|orofacial pain
681763|NCT00899717|Limited mouth opening|limited mouth opening
681764|NCT00899717|Craniomandibular dysfunction syndrome|craniomandibular dysfunction syndrome
681765|NCT00899717|Axiography|axiography
681766|NCT00899717|Gnatography|gnatography
681767|NCT00899717|Preferred chewing side|preferred chewing side
681768|NCT00899717|Occlusal adjustment|occlusal adjustment
681769|NCT00899717|Selective grinding|selective grinding
681770|NCT00899717|Handedness|handedness
681771|NCT00899717|Bruxism|bruxism
681772|NCT00899717|TMD|tmd
681773|NCT00899717|Costen's Syndrome|costen's syndrome
681774|NCT00899717|Myofascial pain|myofascial pain
681775|NCT00899717|TMD treatment|tmd treatment
681776|NCT00899717|Pain|pain
681777|NCT00899743|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
681778|NCT00899743|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
681779|NCT00899743|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
681780|NCT00899743|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
681781|NCT00899743|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
681782|NCT00899743|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
681783|NCT00899743|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
681784|NCT00899743|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
681785|NCT00899743|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
681786|NCT00899743|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
681787|NCT00899743|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
681788|NCT00899743|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
751845|NCT01170806|Intestinal lipase|intestinal lipase
681789|NCT00899743|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
681790|NCT00899743|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
681791|NCT00899756|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
681792|NCT00899756|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
681793|NCT00899756|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
681794|NCT00899756|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
681795|NCT00899769|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
681796|NCT00899769|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
681797|NCT00899769|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
681798|NCT00899769|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
681799|NCT00899769|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
681800|NCT00899769|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
681801|NCT00899769|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
681802|NCT00899769|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
681803|NCT00899769|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
681804|NCT00899769|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
681805|NCT00899769|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
681806|NCT00899769|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
681807|NCT00899769|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
681808|NCT00899769|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
681809|NCT00899769|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
681810|NCT00899769|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
681811|NCT00899769|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
681812|NCT00899769|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
681813|NCT00899769|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
681814|NCT00899769|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
681815|NCT00899769|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
681816|NCT00899769|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
681817|NCT00899769|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
681818|NCT00899769|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
681819|NCT00899769|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
681820|NCT00899769|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
681821|NCT00899769|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
681822|NCT00899769|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
681823|NCT00899769|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
681824|NCT00899769|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
681825|NCT00899769|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
681826|NCT00899769|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
681827|NCT00899769|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
681828|NCT00899769|recurrent salivary gland cancer|recurrent salivary gland cancer
681829|NCT00899769|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
681830|NCT00899769|stage I salivary gland cancer|stage i salivary gland cancer
681831|NCT00899769|stage II salivary gland cancer|stage ii salivary gland cancer
681832|NCT00899769|stage III salivary gland cancer|stage iii salivary gland cancer
681833|NCT00899769|stage IV salivary gland cancer|stage iv salivary gland cancer
681834|NCT00899795|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
681835|NCT00899795|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
681836|NCT00899795|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
681837|NCT00899795|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
681838|NCT00899795|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
681839|NCT00899795|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
681840|NCT00899795|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
681841|NCT00899795|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
681842|NCT00899795|secondary acute myeloid leukemia|secondary acute myeloid leukemia
751846|NCT01170806|Orlistat|orlistat
681843|NCT00899795|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
682589|NCT00900302|stage II anal cancer|stage ii anal cancer
681844|NCT00899795|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
681845|NCT00899795|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
681846|NCT00899808|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
681847|NCT00899808|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
681848|NCT00899808|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
681849|NCT00899821|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
681850|NCT00899821|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
681851|NCT00899821|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
681852|NCT00899821|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
681853|NCT00899821|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
681854|NCT00899821|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
681855|NCT00899821|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
681856|NCT00899821|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
681857|NCT00899821|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
681858|NCT00899821|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
681859|NCT00899821|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
681860|NCT00899821|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
681861|NCT00899821|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
681862|NCT00899821|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
681863|NCT00899821|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
681864|NCT00899821|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
681865|NCT00899821|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
681866|NCT00899821|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
681867|NCT00899821|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
681868|NCT00899821|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
681869|NCT00899821|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
681870|NCT00899821|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
681871|NCT00899821|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
681872|NCT00899821|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
681873|NCT00899821|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
681874|NCT00899821|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
681875|NCT00899821|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
681876|NCT00899821|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
681877|NCT00899821|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
681878|NCT00899821|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
681879|NCT00899821|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
681880|NCT00899821|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
681881|NCT00899821|recurrent salivary gland cancer|recurrent salivary gland cancer
682466|NCT00900211|adult epithelioid sarcoma|adult epithelioid sarcoma
681882|NCT00899821|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
681883|NCT00899821|stage I salivary gland cancer|stage i salivary gland cancer
681884|NCT00899821|stage II salivary gland cancer|stage ii salivary gland cancer
681885|NCT00899821|stage III salivary gland cancer|stage iii salivary gland cancer
681886|NCT00899821|stage IV salivary gland cancer|stage iv salivary gland cancer
681887|NCT00899834|adult brain stem glioma|adult brain stem glioma
681888|NCT00899834|childhood brain stem glioma|childhood brain stem glioma
681889|NCT00899860|recurrent renal cell cancer|recurrent renal cell cancer
681890|NCT00899860|stage I renal cell cancer|stage i renal cell cancer
681891|NCT00899860|stage II renal cell cancer|stage ii renal cell cancer
681892|NCT00899860|stage III renal cell cancer|stage iii renal cell cancer
681893|NCT00899860|stage IV renal cell cancer|stage iv renal cell cancer
681894|NCT00899873|chronic lymphocytic leukemia|chronic lymphocytic leukemia
681895|NCT00899899|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
681896|NCT00899899|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
681897|NCT00899899|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
681898|NCT00899899|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
681899|NCT00899912|stage IIB prostate cancer|stage iib prostate cancer
681900|NCT00899912|stage IIA prostate cancer|stage iia prostate cancer
681901|NCT00899912|adenocarcinoma of the prostate|adenocarcinoma of the prostate
681902|NCT00899951|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
681903|NCT00899951|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
681904|NCT00899951|acute undifferentiated leukemia|acute undifferentiated leukemia
681905|NCT00899951|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
681906|NCT00899951|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
681907|NCT00899951|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
681908|NCT00899951|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
681909|NCT00899951|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
681910|NCT00899951|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
681911|NCT00899951|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
681912|NCT00899951|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
681913|NCT00899951|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
681914|NCT00899951|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
681915|NCT00899951|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
681916|NCT00899951|mast cell leukemia|mast cell leukemia
681917|NCT00899951|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
681918|NCT00899951|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
681919|NCT00899951|prolymphocytic leukemia|prolymphocytic leukemia
681920|NCT00899951|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
681921|NCT00899951|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
681922|NCT00899951|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
681923|NCT00899951|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
681924|NCT00899951|refractory hairy cell leukemia|refractory hairy cell leukemia
681925|NCT00899951|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
681926|NCT00899951|secondary acute myeloid leukemia|secondary acute myeloid leukemia
681927|NCT00899951|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
681928|NCT00899951|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
681929|NCT00899951|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
681930|NCT00899951|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
681931|NCT00899951|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
681932|NCT00899951|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
681933|NCT00899951|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
681934|NCT00899951|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
681935|NCT00899951|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
681936|NCT00899951|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
681937|NCT00899951|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
681938|NCT00899951|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
681939|NCT00899951|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
681940|NCT00899951|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
681941|NCT00899951|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
681942|NCT00899951|anaplastic large cell lymphoma|anaplastic large cell lymphoma
681943|NCT00899951|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
681944|NCT00899951|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
681945|NCT00899951|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
681946|NCT00899951|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
681947|NCT00899951|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
682874|NCT00900991|Safety|safety
681948|NCT00899951|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
681949|NCT00899951|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
681950|NCT00899951|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
681951|NCT00899951|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
681952|NCT00899951|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
681953|NCT00899951|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
681954|NCT00899951|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
681955|NCT00899951|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
681956|NCT00899951|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
681957|NCT00899951|Waldenström macroglobulinemia|waldenström macroglobulinemia
681958|NCT00899951|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
681959|NCT00899951|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
681960|NCT00899951|splenic marginal zone lymphoma|splenic marginal zone lymphoma
681961|NCT00899951|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
751847|NCT01170806|fecal fat|fecal fat
684002|NCT00905034|ALL|all
681962|NCT00899951|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
681963|NCT00899951|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
681964|NCT00899951|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
681965|NCT00899951|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
681966|NCT00899951|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
681967|NCT00899951|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
681968|NCT00899951|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
681969|NCT00899951|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
681970|NCT00899951|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
681971|NCT00899951|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
681972|NCT00899951|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
681973|NCT00899951|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
681974|NCT00899951|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
681975|NCT00899951|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
681976|NCT00899951|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
681977|NCT00899951|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
681978|NCT00899951|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
681979|NCT00899951|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
681980|NCT00899951|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
681981|NCT00899951|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
681982|NCT00899951|stage I mantle cell lymphoma|stage i mantle cell lymphoma
681983|NCT00899951|stage I marginal zone lymphoma|stage i marginal zone lymphoma
681984|NCT00899951|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
681985|NCT00899951|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
681986|NCT00899951|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
681987|NCT00899951|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
681988|NCT00899951|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
681989|NCT00899951|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
683214|NCT00901550|MTX|mtx
681990|NCT00899951|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
681991|NCT00899951|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
681992|NCT00899951|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
681993|NCT00899951|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
681994|NCT00899951|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
681995|NCT00899951|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
681996|NCT00899951|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
681997|NCT00899951|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
681998|NCT00899951|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
681999|NCT00899951|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
682000|NCT00899951|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
682001|NCT00899951|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
682002|NCT00899951|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
682003|NCT00899951|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
682004|NCT00899951|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
682005|NCT00899951|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
682006|NCT00899951|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
682007|NCT00899951|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
682008|NCT00899951|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
682009|NCT00899951|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
682010|NCT00899951|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
682011|NCT00899951|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
682012|NCT00899951|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
682013|NCT00899951|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
682014|NCT00899951|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
682015|NCT00899951|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
682016|NCT00899951|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
682017|NCT00899951|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
682018|NCT00899951|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
682019|NCT00899951|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
682020|NCT00899951|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
682021|NCT00899951|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
682022|NCT00899951|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
682023|NCT00899951|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
682024|NCT00899951|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
682025|NCT00899951|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
682026|NCT00899951|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
682027|NCT00899951|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
682028|NCT00899951|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
682029|NCT00899951|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
682030|NCT00899951|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
682031|NCT00899951|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
682032|NCT00899951|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
682033|NCT00899951|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
682034|NCT00899951|intraocular lymphoma|intraocular lymphoma
682035|NCT00899951|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
682036|NCT00899951|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
682037|NCT00899951|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
682038|NCT00899951|chronic eosinophilic leukemia|chronic eosinophilic leukemia
682039|NCT00899951|chronic neutrophilic leukemia|chronic neutrophilic leukemia
682040|NCT00899951|primary myelofibrosis|primary myelofibrosis
682041|NCT00899951|essential thrombocythemia|essential thrombocythemia
682042|NCT00899951|polycythemia vera|polycythemia vera
682043|NCT00899951|extramedullary plasmacytoma|extramedullary plasmacytoma
682044|NCT00899951|isolated plasmacytoma of bone|isolated plasmacytoma of bone
682045|NCT00899951|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
682046|NCT00899951|stage I multiple myeloma|stage i multiple myeloma
682047|NCT00899951|stage II multiple myeloma|stage ii multiple myeloma
682048|NCT00899951|stage III multiple myeloma|stage iii multiple myeloma
682049|NCT00899951|primary systemic amyloidosis|primary systemic amyloidosis
682050|NCT00899951|refractory multiple myeloma|refractory multiple myeloma
682051|NCT00899951|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
682052|NCT00899951|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
682053|NCT00899951|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
682054|NCT00899951|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
682055|NCT00899951|pain|pain
682056|NCT00899977|refractory hypertension|refractory hypertension
682057|NCT00899977|hypertension|hypertension
682058|NCT00900003|stage I pancreatic cancer|stage i pancreatic cancer
682059|NCT00900003|stage II pancreatic cancer|stage ii pancreatic cancer
682060|NCT00900003|stage III pancreatic cancer|stage iii pancreatic cancer
682061|NCT00900003|stage IV pancreatic cancer|stage iv pancreatic cancer
682062|NCT00900016|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
682063|NCT00900016|recurrent pancreatic cancer|recurrent pancreatic cancer
682064|NCT00900016|stage I pancreatic cancer|stage i pancreatic cancer
682065|NCT00900016|stage II pancreatic cancer|stage ii pancreatic cancer
682066|NCT00900029|Venous Leg Ulcer|venous leg ulcer
682067|NCT00900029|Venous Stasis Ulcer|venous stasis ulcer
682068|NCT00900029|VLU|vlu
682069|NCT00900029|VSU|vsu
682070|NCT00900029|Leg Ulcer|leg ulcer
682071|NCT00900029|Leg Wound|leg wound
682072|NCT00900042|stage IV renal cell cancer|stage iv renal cell cancer
682073|NCT00900055|Fanconi anemia|fanconi anemia
682074|NCT00900055|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
682075|NCT00900055|chronic myeloproliferative disorders|chronic myeloproliferative disorders
682076|NCT00900055|myelodysplastic/myeloproliferative neoplasms|myelodysplastic/myeloproliferative neoplasms
682077|NCT00900068|nausea and vomiting|nausea and vomiting
682078|NCT00900068|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
682079|NCT00900068|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
682080|NCT00900068|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
682081|NCT00900068|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
682082|NCT00900068|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
682083|NCT00900068|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
682084|NCT00900068|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
682085|NCT00900068|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
682086|NCT00900068|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
682087|NCT00900068|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
682088|NCT00900068|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
682089|NCT00900068|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
682090|NCT00900068|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
682091|NCT00900068|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
682092|NCT00900068|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
751848|NCT01170806|obesity|obesity
682093|NCT00900068|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
682094|NCT00900068|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
682095|NCT00900068|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
682096|NCT00900068|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
682097|NCT00900068|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
682098|NCT00900068|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
682099|NCT00900068|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
682100|NCT00900068|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
682101|NCT00900068|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
682102|NCT00900068|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
682103|NCT00900068|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
682104|NCT00900068|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
682105|NCT00900068|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
682106|NCT00900068|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
682107|NCT00900068|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
682108|NCT00900068|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
682109|NCT00900068|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
682110|NCT00900068|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
682111|NCT00900068|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
682112|NCT00900068|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
682113|NCT00900068|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
682114|NCT00900068|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
682115|NCT00900068|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
682116|NCT00900068|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
682117|NCT00900068|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
682118|NCT00900068|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
682119|NCT00900068|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
682590|NCT00900302|stage IIIA anal cancer|stage iiia anal cancer
682120|NCT00900068|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
683392|NCT00902863|yoga|yoga
682121|NCT00900068|splenic marginal zone lymphoma|splenic marginal zone lymphoma
682122|NCT00900068|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
682123|NCT00900068|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
682124|NCT00900068|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
682125|NCT00900068|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
682126|NCT00900068|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
682127|NCT00900068|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
682128|NCT00900068|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
682129|NCT00900068|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
682130|NCT00900068|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
682131|NCT00900068|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
682132|NCT00900068|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
682133|NCT00900068|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
682134|NCT00900068|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
682135|NCT00900068|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
682136|NCT00900068|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
682137|NCT00900068|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
683688|NCT00903968|plerixafor|plerixafor
682138|NCT00900068|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
682139|NCT00900068|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
682140|NCT00900068|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
682141|NCT00900068|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
682142|NCT00900068|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
682143|NCT00900068|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
682144|NCT00900068|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
682145|NCT00900068|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
682146|NCT00900068|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
682147|NCT00900068|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
682148|NCT00900068|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
682149|NCT00900068|refractory hairy cell leukemia|refractory hairy cell leukemia
682150|NCT00900068|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
682151|NCT00900068|secondary acute myeloid leukemia|secondary acute myeloid leukemia
751849|NCT01170819|Cervical ripening|cervical ripening
682152|NCT00900068|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
682153|NCT00900068|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
682154|NCT00900068|chronic eosinophilic leukemia|chronic eosinophilic leukemia
682155|NCT00900068|primary myelofibrosis|primary myelofibrosis
682156|NCT00900068|chronic neutrophilic leukemia|chronic neutrophilic leukemia
682157|NCT00900068|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
682158|NCT00900068|disseminated neuroblastoma|disseminated neuroblastoma
682159|NCT00900068|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
682160|NCT00900068|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
682161|NCT00900068|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
682162|NCT00900068|recurrent neuroblastoma|recurrent neuroblastoma
682163|NCT00900068|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
682164|NCT00900068|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
682165|NCT00900068|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
682166|NCT00900068|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
682167|NCT00900068|stage I multiple myeloma|stage i multiple myeloma
682168|NCT00900068|stage II multiple myeloma|stage ii multiple myeloma
682169|NCT00900068|stage III multiple myeloma|stage iii multiple myeloma
682170|NCT00900068|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
682171|NCT00900068|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
682172|NCT00900068|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
682173|NCT00900068|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
682174|NCT00900068|stage IIIA breast cancer|stage iiia breast cancer
682175|NCT00900068|stage IIIB breast cancer|stage iiib breast cancer
682176|NCT00900068|stage IIIC breast cancer|stage iiic breast cancer
682177|NCT00900068|stage IV breast cancer|stage iv breast cancer
682178|NCT00900068|refractory multiple myeloma|refractory multiple myeloma
682179|NCT00900081|cervical squamous cell carcinoma|cervical squamous cell carcinoma
682180|NCT00900081|stage IA cervical cancer|stage ia cervical cancer
682181|NCT00900081|stage 0 cervical cancer|stage 0 cervical cancer
682182|NCT00900081|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
682183|NCT00900081|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
682184|NCT00900081|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
682185|NCT00900094|stage I breast cancer|stage i breast cancer
682186|NCT00900094|stage II breast cancer|stage ii breast cancer
682187|NCT00900094|stage IIIA breast cancer|stage iiia breast cancer
682188|NCT00900094|stage IIIB breast cancer|stage iiib breast cancer
682189|NCT00900094|stage IV breast cancer|stage iv breast cancer
682190|NCT00900094|adenocarcinoma of the colon|adenocarcinoma of the colon
682191|NCT00900094|stage I colon cancer|stage i colon cancer
682192|NCT00900094|stage II colon cancer|stage ii colon cancer
682193|NCT00900094|stage III colon cancer|stage iii colon cancer
682194|NCT00900094|stage IV colon cancer|stage iv colon cancer
682195|NCT00900094|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
682196|NCT00900094|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
682197|NCT00900094|stage I esophageal cancer|stage i esophageal cancer
682198|NCT00900094|stage II esophageal cancer|stage ii esophageal cancer
682199|NCT00900094|stage III esophageal cancer|stage iii esophageal cancer
682200|NCT00900094|stage IV esophageal cancer|stage iv esophageal cancer
682201|NCT00900094|stage I non-small cell lung cancer|stage i non-small cell lung cancer
682202|NCT00900094|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
682203|NCT00900094|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
682204|NCT00900094|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
682205|NCT00900094|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
682206|NCT00900094|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
682207|NCT00900094|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
682208|NCT00900094|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
682209|NCT00900094|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
682210|NCT00900094|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
682211|NCT00900094|advanced adult primary liver cancer|advanced adult primary liver cancer
682212|NCT00900094|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
685366|NCT00902590|bladder|bladder
682213|NCT00900094|stage II pancreatic cancer|stage ii pancreatic cancer
682214|NCT00900094|stage III pancreatic cancer|stage iii pancreatic cancer
682215|NCT00900094|extensive stage small cell lung cancer|extensive stage small cell lung cancer
682216|NCT00900094|stage IIIC breast cancer|stage iiic breast cancer
682217|NCT00900094|stage IV pancreatic cancer|stage iv pancreatic cancer
682218|NCT00900094|recurrent breast cancer|recurrent breast cancer
682219|NCT00900094|recurrent colon cancer|recurrent colon cancer
682220|NCT00900094|recurrent esophageal cancer|recurrent esophageal cancer
682221|NCT00900094|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
682222|NCT00900094|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
682223|NCT00900094|recurrent adult primary liver cancer|recurrent adult primary liver cancer
751850|NCT01170819|Induction of labor|induction of labor
682224|NCT00900094|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
682225|NCT00900094|recurrent small cell lung cancer|recurrent small cell lung cancer
682226|NCT00900120|aplastic anemia|aplastic anemia
682227|NCT00900120|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
682228|NCT00900120|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
682229|NCT00900120|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
682230|NCT00900120|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
682231|NCT00900120|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
682232|NCT00900120|acute undifferentiated leukemia|acute undifferentiated leukemia
682233|NCT00900120|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
682234|NCT00900120|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
682235|NCT00900120|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
682236|NCT00900120|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
682237|NCT00900120|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
682238|NCT00900120|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
682239|NCT00900120|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
682240|NCT00900120|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
682241|NCT00900120|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
682242|NCT00900120|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
682243|NCT00900120|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
682244|NCT00900120|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
682245|NCT00900120|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
682246|NCT00900120|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
682247|NCT00900120|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
682248|NCT00900120|mast cell leukemia|mast cell leukemia
753393|NCT01176474|stage IV melanoma|stage iv melanoma
682249|NCT00900120|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
682250|NCT00900120|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
682251|NCT00900120|prolymphocytic leukemia|prolymphocytic leukemia
682252|NCT00900120|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
682253|NCT00900120|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
682254|NCT00900120|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
682255|NCT00900120|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
682256|NCT00900120|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
682257|NCT00900120|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
682258|NCT00900120|refractory hairy cell leukemia|refractory hairy cell leukemia
682259|NCT00900120|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
682260|NCT00900120|secondary acute myeloid leukemia|secondary acute myeloid leukemia
682261|NCT00900120|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
682262|NCT00900120|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
682263|NCT00900120|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
682264|NCT00900120|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
682265|NCT00900120|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
682266|NCT00900120|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
682267|NCT00900120|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
682268|NCT00900120|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
682269|NCT00900120|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
682270|NCT00900120|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
683689|NCT00903994|Acute Pain|acute pain
682271|NCT00900120|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
682272|NCT00900120|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
682273|NCT00900120|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
682274|NCT00900120|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
682275|NCT00900120|untreated hairy cell leukemia|untreated hairy cell leukemia
682276|NCT00900120|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
685367|NCT00902590|09-025|09-025
682277|NCT00900120|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
682278|NCT00900120|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
682279|NCT00900120|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
682280|NCT00900120|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
682281|NCT00900120|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
682282|NCT00900120|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
682283|NCT00900120|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
682284|NCT00900120|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
682285|NCT00900120|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
682286|NCT00900120|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
682287|NCT00900120|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
682288|NCT00900120|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
682289|NCT00900120|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
682290|NCT00900120|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
682291|NCT00900120|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
682292|NCT00900120|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
682293|NCT00900120|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
682294|NCT00900120|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
682295|NCT00900120|anaplastic large cell lymphoma|anaplastic large cell lymphoma
682296|NCT00900120|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
682297|NCT00900120|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
682298|NCT00900120|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
682299|NCT00900120|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
682300|NCT00900120|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
682301|NCT00900120|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
682302|NCT00900120|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
682303|NCT00900120|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
682304|NCT00900120|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
682305|NCT00900120|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
682306|NCT00900120|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
682307|NCT00900120|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
682308|NCT00900120|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
682309|NCT00900120|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
682310|NCT00900120|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
682311|NCT00900120|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
682312|NCT00900120|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
682313|NCT00900120|splenic marginal zone lymphoma|splenic marginal zone lymphoma
682314|NCT00900120|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
682315|NCT00900120|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
682316|NCT00900120|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
682317|NCT00900120|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
682318|NCT00900120|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
682319|NCT00900120|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
682320|NCT00900120|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
682321|NCT00900120|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
682322|NCT00900120|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
682323|NCT00900120|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
682324|NCT00900120|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
682325|NCT00900120|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
682326|NCT00900120|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
682327|NCT00900120|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
682328|NCT00900120|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
682329|NCT00900120|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
682330|NCT00900120|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
682331|NCT00900120|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
682332|NCT00900120|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
682333|NCT00900120|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
682334|NCT00900120|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
682335|NCT00900120|stage I mantle cell lymphoma|stage i mantle cell lymphoma
682336|NCT00900120|stage I marginal zone lymphoma|stage i marginal zone lymphoma
682337|NCT00900120|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
682338|NCT00900120|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
682755|NCT00900601|Pelvic girdle pain|pelvic girdle pain
682339|NCT00900120|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
682340|NCT00900120|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
682341|NCT00900120|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
682342|NCT00900120|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
682343|NCT00900120|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
682344|NCT00900120|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
682345|NCT00900120|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
682346|NCT00900120|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
682347|NCT00900120|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
682348|NCT00900120|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
682349|NCT00900120|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
682350|NCT00900120|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
682351|NCT00900120|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
682352|NCT00900120|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
682353|NCT00900120|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
682354|NCT00900120|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
682355|NCT00900120|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
682356|NCT00900120|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
682357|NCT00900120|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
682358|NCT00900120|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
682359|NCT00900120|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
682360|NCT00900120|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
682361|NCT00900120|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
682362|NCT00900120|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
682363|NCT00900120|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
682364|NCT00900120|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
682365|NCT00900120|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
682366|NCT00900120|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
682367|NCT00900120|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
682368|NCT00900120|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
682369|NCT00900120|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
682370|NCT00900120|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
682371|NCT00900120|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
682372|NCT00900120|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
682373|NCT00900120|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
682374|NCT00900120|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
682375|NCT00900120|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
682376|NCT00900120|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
682377|NCT00900120|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
682378|NCT00900120|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
682379|NCT00900120|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
682380|NCT00900120|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
682381|NCT00900120|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
682382|NCT00900120|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
682383|NCT00900120|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
682384|NCT00900120|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
682385|NCT00900120|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
682386|NCT00900120|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
682387|NCT00900120|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
682388|NCT00900120|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
682389|NCT00900120|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
682390|NCT00900120|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
682391|NCT00900120|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
682595|NCT00900302|stage II bladder cancer|stage ii bladder cancer
682392|NCT00900120|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
682393|NCT00900120|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
682394|NCT00900120|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
682395|NCT00900120|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
682396|NCT00900120|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
682397|NCT00900120|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
682398|NCT00900120|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
683046|NCT00894816|Asthma|asthma
682399|NCT00900120|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
682400|NCT00900120|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
682401|NCT00900120|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
682402|NCT00900120|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
682403|NCT00900120|Burkitt lymphoma|burkitt lymphoma
682404|NCT00900120|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
682405|NCT00900120|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
682406|NCT00900120|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
682407|NCT00900120|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
682408|NCT00900120|intraocular lymphoma|intraocular lymphoma
682409|NCT00900120|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
682410|NCT00900120|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
682411|NCT00900120|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
682412|NCT00900120|chronic eosinophilic leukemia|chronic eosinophilic leukemia
682413|NCT00900120|chronic neutrophilic leukemia|chronic neutrophilic leukemia
682414|NCT00900120|primary myelofibrosis|primary myelofibrosis
682415|NCT00900120|essential thrombocythemia|essential thrombocythemia
682416|NCT00900120|polycythemia vera|polycythemia vera
682417|NCT00900120|extramedullary plasmacytoma|extramedullary plasmacytoma
682418|NCT00900120|isolated plasmacytoma of bone|isolated plasmacytoma of bone
682419|NCT00900120|stage I multiple myeloma|stage i multiple myeloma
682420|NCT00900120|stage II multiple myeloma|stage ii multiple myeloma
682421|NCT00900120|stage III multiple myeloma|stage iii multiple myeloma
682422|NCT00900120|primary systemic amyloidosis|primary systemic amyloidosis
682423|NCT00900120|refractory multiple myeloma|refractory multiple myeloma
682424|NCT00900120|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
682425|NCT00900120|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
682426|NCT00900120|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
682427|NCT00900120|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
682428|NCT00900120|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
682429|NCT00900120|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
682430|NCT00900120|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
682431|NCT00900120|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
682432|NCT00900133|stage I breast cancer|stage i breast cancer
682433|NCT00900133|stage II breast cancer|stage ii breast cancer
682434|NCT00900133|stage IIIA breast cancer|stage iiia breast cancer
682435|NCT00900133|stage IIIB breast cancer|stage iiib breast cancer
682436|NCT00900133|stage IIIC breast cancer|stage iiic breast cancer
682437|NCT00900146|type 2 diabetes|type 2 diabetes
682438|NCT00900146|canakinumab|canakinumab
682439|NCT00900159|Shift-work|shift-work
682440|NCT00900159|SWSD|swsd
682441|NCT00900159|eszopiclone|eszopiclone
682442|NCT00900159|MWT|mwt
682443|NCT00900159|shiftworkers|shiftworkers
682444|NCT00900172|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
682445|NCT00900172|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
682446|NCT00900172|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
682447|NCT00900172|adenocarcinoma of the lung|adenocarcinoma of the lung
682448|NCT00900172|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
682449|NCT00900185|recurrent prostate cancer|recurrent prostate cancer
682450|NCT00900185|stage I prostate cancer|stage i prostate cancer
682451|NCT00900185|stage IIB prostate cancer|stage iib prostate cancer
682452|NCT00900185|stage IIA prostate cancer|stage iia prostate cancer
682453|NCT00900185|stage III prostate cancer|stage iii prostate cancer
682454|NCT00900185|stage IV prostate cancer|stage iv prostate cancer
682455|NCT00900198|Tissue Collection|tissue collection
682456|NCT00900198|Biospecimen|biospecimen
682457|NCT00900198|Assay Development|assay development
682458|NCT00900198|Tissue Acquisition|tissue acquisition
682459|NCT00900198|Tissue Biopsies|tissue biopsies
682460|NCT00900211|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
682461|NCT00900211|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
682462|NCT00900211|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
682463|NCT00900211|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
682464|NCT00900211|adult synovial sarcoma|adult synovial sarcoma
682465|NCT00900211|adult angiosarcoma|adult angiosarcoma
683932|NCT00904774|prematurity|prematurity
682467|NCT00900211|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
682468|NCT00900211|adult leiomyosarcoma|adult leiomyosarcoma
682469|NCT00900211|adult liposarcoma|adult liposarcoma
682470|NCT00900211|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
682471|NCT00900211|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
682472|NCT00900211|adult malignant mesenchymoma|adult malignant mesenchymoma
682473|NCT00900211|adult fibrosarcoma|adult fibrosarcoma
682474|NCT00900211|adult neurofibrosarcoma|adult neurofibrosarcoma
682541|NCT00900302|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
682475|NCT00900224|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
682476|NCT00900224|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
682477|NCT00900224|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
682478|NCT00900224|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
682479|NCT00900224|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
682480|NCT00900224|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
682481|NCT00900224|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
684523|NCT00898768|HNPCC|hnpcc
682482|NCT00900224|secondary acute myeloid leukemia|secondary acute myeloid leukemia
682483|NCT00900237|Partial|partial
682484|NCT00900237|Epilepsy|epilepsy
682485|NCT00900237|Eslicarbazepine acetate|eslicarbazepine acetate
682486|NCT00900237|Pharmacokinetics|pharmacokinetics
682487|NCT00900237|Tolerability|tolerability
682488|NCT00900263|stage I multiple myeloma|stage i multiple myeloma
682489|NCT00900263|isolated plasmacytoma of bone|isolated plasmacytoma of bone
682490|NCT00900263|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
682491|NCT00900276|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
682492|NCT00900276|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
682493|NCT00900276|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
682494|NCT00900276|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
682495|NCT00900276|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
682496|NCT00900276|stage I renal cell cancer|stage i renal cell cancer
682497|NCT00900276|stage II renal cell cancer|stage ii renal cell cancer
682498|NCT00900276|recurrent renal cell cancer|recurrent renal cell cancer
682591|NCT00900302|stage IIIB anal cancer|stage iiib anal cancer
682499|NCT00900276|recurrent bladder cancer|recurrent bladder cancer
682500|NCT00900276|stage I bladder cancer|stage i bladder cancer
682501|NCT00900276|stage II bladder cancer|stage ii bladder cancer
682502|NCT00900276|stage III bladder cancer|stage iii bladder cancer
682503|NCT00900276|stage IV bladder cancer|stage iv bladder cancer
682504|NCT00900276|anterior urethral cancer|anterior urethral cancer
682505|NCT00900276|posterior urethral cancer|posterior urethral cancer
682506|NCT00900276|recurrent urethral cancer|recurrent urethral cancer
682507|NCT00900276|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
682508|NCT00900289|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
682509|NCT00900289|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
682510|NCT00900289|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
682511|NCT00900289|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
682512|NCT00900289|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
682513|NCT00900289|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
682514|NCT00900289|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
682515|NCT00900289|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
682516|NCT00900302|male breast cancer|male breast cancer
682517|NCT00900302|recurrent breast cancer|recurrent breast cancer
682518|NCT00900302|stage IA breast cancer|stage ia breast cancer
682519|NCT00900302|stage IB breast cancer|stage ib breast cancer
682520|NCT00900302|stage II breast cancer|stage ii breast cancer
682521|NCT00900302|stage IIIA breast cancer|stage iiia breast cancer
682522|NCT00900302|stage IIIB breast cancer|stage iiib breast cancer
682523|NCT00900302|stage IIIC breast cancer|stage iiic breast cancer
682524|NCT00900302|stage IV breast cancer|stage iv breast cancer
682525|NCT00900302|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
682526|NCT00900302|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
682527|NCT00900302|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
682528|NCT00900302|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
682529|NCT00900302|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
682530|NCT00900302|squamous cell carcinoma of the gallbladder|squamous cell carcinoma of the gallbladder
682531|NCT00900302|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
682532|NCT00900302|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
682533|NCT00900302|squamous cell lung cancer|squamous cell lung cancer
682534|NCT00900302|vaginal squamous cell carcinoma|vaginal squamous cell carcinoma
682535|NCT00900302|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
682536|NCT00900302|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
682537|NCT00900302|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
682538|NCT00900302|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
682539|NCT00900302|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
682540|NCT00900302|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
682754|NCT00900601|Sacroiliac instability|sacroiliac instability
682542|NCT00900302|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
682543|NCT00900302|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
682544|NCT00900302|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
682545|NCT00900302|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
682546|NCT00900302|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
682547|NCT00900302|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
682548|NCT00900302|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
682549|NCT00900302|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
682550|NCT00900302|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
682551|NCT00900302|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
682552|NCT00900302|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
682553|NCT00900302|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
682554|NCT00900302|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
682555|NCT00900302|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
682556|NCT00900302|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
682557|NCT00900302|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
682558|NCT00900302|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
682559|NCT00900302|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
682560|NCT00900302|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
682561|NCT00900302|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
682562|NCT00900302|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
682563|NCT00900302|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
682564|NCT00900302|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
682565|NCT00900302|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
682566|NCT00900302|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
682567|NCT00900302|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
682568|NCT00900302|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
682569|NCT00900302|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
682570|NCT00900302|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
682571|NCT00900302|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
682572|NCT00900302|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
682573|NCT00900302|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
682574|NCT00900302|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
682575|NCT00900302|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
682576|NCT00900302|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
682577|NCT00900302|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
682578|NCT00900302|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
682579|NCT00900302|stage I salivary gland cancer|stage i salivary gland cancer
682580|NCT00900302|stage II salivary gland cancer|stage ii salivary gland cancer
682581|NCT00900302|stage III salivary gland cancer|stage iii salivary gland cancer
682582|NCT00900302|stage IV salivary gland cancer|stage iv salivary gland cancer
682583|NCT00900302|recurrent salivary gland cancer|recurrent salivary gland cancer
682584|NCT00900302|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
682585|NCT00900302|cervical squamous cell carcinoma|cervical squamous cell carcinoma
682586|NCT00900302|penile squamous cell carcinoma|penile squamous cell carcinoma
682587|NCT00900302|recurrent anal cancer|recurrent anal cancer
682588|NCT00900302|stage I anal cancer|stage i anal cancer
682592|NCT00900302|stage IV anal cancer|stage iv anal cancer
682593|NCT00900302|recurrent bladder cancer|recurrent bladder cancer
682594|NCT00900302|stage I bladder cancer|stage i bladder cancer
682596|NCT00900302|stage III bladder cancer|stage iii bladder cancer
682597|NCT00900302|stage IV bladder cancer|stage iv bladder cancer
682598|NCT00900302|recurrent esophageal cancer|recurrent esophageal cancer
682599|NCT00900302|stage I esophageal cancer|stage i esophageal cancer
682600|NCT00900302|stage II esophageal cancer|stage ii esophageal cancer
682601|NCT00900302|stage III esophageal cancer|stage iii esophageal cancer
682602|NCT00900302|stage IV esophageal cancer|stage iv esophageal cancer
682603|NCT00900302|localized gallbladder cancer|localized gallbladder cancer
682604|NCT00900302|recurrent gallbladder cancer|recurrent gallbladder cancer
682614|NCT00900302|stage IIA cervical cancer|stage iia cervical cancer
682615|NCT00900302|stage IIB cervical cancer|stage iib cervical cancer
682616|NCT00900302|stage III cervical cancer|stage iii cervical cancer
682617|NCT00900302|stage IVA cervical cancer|stage iva cervical cancer
682618|NCT00900302|stage IVB cervical cancer|stage ivb cervical cancer
682619|NCT00900302|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
751851|NCT01170819|Prostaglandins|prostaglandins
682620|NCT00900302|stage I non-small cell lung cancer|stage i non-small cell lung cancer
682621|NCT00900302|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
682622|NCT00900302|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
682623|NCT00900302|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
682624|NCT00900302|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
682625|NCT00900302|recurrent skin cancer|recurrent skin cancer
682626|NCT00900302|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
682627|NCT00900302|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
682628|NCT00900302|recurrent penile cancer|recurrent penile cancer
682629|NCT00900302|stage I penile cancer|stage i penile cancer
682630|NCT00900302|stage II penile cancer|stage ii penile cancer
682631|NCT00900302|stage III penile cancer|stage iii penile cancer
682632|NCT00900302|stage IV penile cancer|stage iv penile cancer
682633|NCT00900302|recurrent melanoma|recurrent melanoma
682634|NCT00900302|stage IA melanoma|stage ia melanoma
682635|NCT00900302|stage IB melanoma|stage ib melanoma
682636|NCT00900302|stage IIA melanoma|stage iia melanoma
682637|NCT00900302|stage IIB melanoma|stage iib melanoma
682638|NCT00900302|stage IIC melanoma|stage iic melanoma
682639|NCT00900302|stage IIIA melanoma|stage iiia melanoma
682640|NCT00900302|stage IIIB melanoma|stage iiib melanoma
682641|NCT00900302|stage IIIC melanoma|stage iiic melanoma
682642|NCT00900302|stage IV melanoma|stage iv melanoma
682643|NCT00900328|adenocarcinoma of the lung|adenocarcinoma of the lung
682644|NCT00900328|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
682645|NCT00900328|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
682646|NCT00900328|stage I non-small cell lung cancer|stage i non-small cell lung cancer
682647|NCT00900328|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
682648|NCT00900328|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
682649|NCT00900328|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
682650|NCT00900328|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
682651|NCT00900341|adult soft tissue sarcoma|adult soft tissue sarcoma
682652|NCT00900341|childhood soft tissue sarcoma|childhood soft tissue sarcoma
682653|NCT00900354|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
682655|NCT00900380|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
682656|NCT00900380|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
682657|NCT00900380|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
682658|NCT00900380|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
682659|NCT00900380|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
682660|NCT00900380|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
682661|NCT00900380|secondary acute myeloid leukemia|secondary acute myeloid leukemia
682662|NCT00900380|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
682663|NCT00900380|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
682664|NCT00900380|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
682665|NCT00900380|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
682666|NCT00900380|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
682667|NCT00900380|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
682668|NCT00900380|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
682669|NCT00900380|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
682689|NCT00900445|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
682690|NCT00900445|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
682691|NCT00900458|preeclampsia|preeclampsia
682692|NCT00900458|low vs high plasma volume|low vs high plasma volume
682693|NCT00900471|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
682694|NCT00900471|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
682695|NCT00900484|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
682696|NCT00900484|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
682697|NCT00900484|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
682698|NCT00900484|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
682699|NCT00900484|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
682700|NCT00900484|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
682701|NCT00900484|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
682702|NCT00900484|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
682703|NCT00900484|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
682704|NCT00900484|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
682705|NCT00900484|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
682706|NCT00900484|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
682707|NCT00900484|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
682708|NCT00900484|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
682709|NCT00900484|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
682710|NCT00900484|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
682711|NCT00900484|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
682712|NCT00900484|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
682713|NCT00900484|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
682714|NCT00900484|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
682715|NCT00900484|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
682716|NCT00900484|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
682717|NCT00900484|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
682718|NCT00900484|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
682719|NCT00900484|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
682720|NCT00900484|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
682721|NCT00900484|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
682722|NCT00900484|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
682724|NCT00900497|Graft-vs-Host-Disease|graft-vs-host-disease
682725|NCT00900510|subcutaneous abscess|subcutaneous abscess
682726|NCT00900510|Incision and drainage|incision and drainage
682727|NCT00900510|Methicillin-resistant staphylococcus aureus|methicillin-resistant staphylococcus aureus
682728|NCT00900523|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
682729|NCT00900523|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
682730|NCT00900523|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
682731|NCT00900523|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
682732|NCT00900523|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
682733|NCT00900536|clear cell renal cell carcinoma|clear cell renal cell carcinoma
682734|NCT00900536|stage I renal cell cancer|stage i renal cell cancer
682735|NCT00900536|stage II renal cell cancer|stage ii renal cell cancer
682736|NCT00900536|stage III renal cell cancer|stage iii renal cell cancer
682737|NCT00900536|stage IV renal cell cancer|stage iv renal cell cancer
682738|NCT00900536|papillary renal cell carcinoma|papillary renal cell carcinoma
682739|NCT00900549|Heart failure|heart failure
682740|NCT00900549|Cardiac resynchronization therapy|cardiac resynchronization therapy
682742|NCT00900562|Zalypsis|zalypsis
682743|NCT00900562|Cancer|cancer
682744|NCT00900562|Endometrial|endometrial
682745|NCT00900562|Uterine Cervical|uterine cervical
682746|NCT00900562|PharmaMar|pharmamar
682747|NCT00900575|cervical cancer|cervical cancer
682748|NCT00900575|LEEP|leep
682749|NCT00900575|colposcopy|colposcopy
682750|NCT00900588|immunogenictiy|immunogenictiy
682751|NCT00900588|safety|safety
682752|NCT00900588|pandemic influenza A vaccine|pandemic influenza a vaccine
682753|NCT00900601|Sacroiliac pain|sacroiliac pain
682756|NCT00900601|Sacroiliac arthrodesis|sacroiliac arthrodesis
682757|NCT00900601|Arthrodesis|arthrodesis
682758|NCT00900601|Surgery|surgery
682759|NCT00900614|Hematologic malignancy|hematologic malignancy
682760|NCT00900614|Prostate carcinoma|prostate carcinoma
682761|NCT00900614|Hematologic cancer|hematologic cancer
682762|NCT00900614|Prostate cancer|prostate cancer
682763|NCT00900627|Cancer|cancer
682764|NCT00900627|Tumour|tumour
682765|NCT00900627|Breast cancer|breast cancer
682766|NCT00900627|Metastatic|metastatic
682767|NCT00900627|Secondary|secondary
682768|NCT00900653|urinary tract infections|urinary tract infections
682769|NCT00900653|postmenopause|postmenopause
682770|NCT00900653|lactobacillus|lactobacillus
682771|NCT00900653|estriol|estriol
682772|NCT00900666|Stiff knee gait|stiff knee gait
682773|NCT00900666|Gait analysis|gait analysis
682774|NCT00900666|Traumatic Brain Injury|traumatic brain injury
682775|NCT00900666|Acquired Brain Injury|acquired brain injury
682776|NCT00900679|transitional care planning|transitional care planning
682777|NCT00900679|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
682778|NCT00900679|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
682873|NCT00900991|Immunogenictiy|immunogenictiy
682779|NCT00900679|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
682780|NCT00900679|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
682781|NCT00900692|Excessive pronation|excessive pronation
682782|NCT00900692|CVA|cva
682783|NCT00900692|Forearm|forearm
682784|NCT00900692|Excessive pronation following CVA|excessive pronation following cva
682785|NCT00900731|COPD|copd
682786|NCT00900731|indacaterol|indacaterol
682787|NCT00900731|beta 2 agonist|beta 2 agonist
682788|NCT00900731|tiotropium|tiotropium
682790|NCT00900744|Breast Cancer|breast cancer
682791|NCT00900757|Primary Glioma|primary glioma
682792|NCT00900757|Palonosetron|palonosetron
682793|NCT00900757|Standard Radiotherapy|standard radiotherapy
682794|NCT00900757|Temozolomide|temozolomide
682795|NCT00900770|dementia|dementia
682796|NCT00900770|mild cognitive impairment|mild cognitive impairment
682797|NCT00900770|beta amyloid|beta amyloid
682798|NCT00900783|herpes zoster|herpes zoster
682799|NCT00900783|shingles|shingles
682800|NCT00900783|Phase II|phase ii
682801|NCT00900783|FV-100|fv-100
682802|NCT00900783|Inhibitex|inhibitex
682803|NCT00900796|Ankylosing spondylitis;predictive factors|ankylosing spondylitis;predictive factors
682804|NCT00900809|Acute Myeloid Leukemia|acute myeloid leukemia
682805|NCT00900809|Neukoplast™|neukoplast™
682806|NCT00900809|NK-92|nk-92
682807|NCT00900809|Refractory|refractory
682808|NCT00900809|Refractory or Relapsed Acute Myeloid Leukemia|refractory or relapsed acute myeloid leukemia
682809|NCT00900822|bone grafting|bone grafting
682810|NCT00900822|sinus elevation|sinus elevation
682811|NCT00900822|sinus augmentation|sinus augmentation
682812|NCT00900835|fatigue|fatigue
682813|NCT00900835|pain|pain
682814|NCT00900835|recurrent breast cancer|recurrent breast cancer
682815|NCT00900835|stage I breast cancer|stage i breast cancer
682816|NCT00900835|stage II breast cancer|stage ii breast cancer
682817|NCT00900835|stage IIIA breast cancer|stage iiia breast cancer
682818|NCT00900835|stage IIIB breast cancer|stage iiib breast cancer
682819|NCT00900835|stage IIIC breast cancer|stage iiic breast cancer
682820|NCT00900835|stage IV breast cancer|stage iv breast cancer
682821|NCT00900835|recurrent prostate cancer|recurrent prostate cancer
682822|NCT00900835|stage I prostate cancer|stage i prostate cancer
682823|NCT00900835|stage II prostate cancer|stage ii prostate cancer
682824|NCT00900835|stage III prostate cancer|stage iii prostate cancer
682825|NCT00900835|stage IV prostate cancer|stage iv prostate cancer
682826|NCT00900835|recurrent colon cancer|recurrent colon cancer
682827|NCT00900835|stage I colon cancer|stage i colon cancer
682828|NCT00900835|stage II colon cancer|stage ii colon cancer
682829|NCT00900835|stage III colon cancer|stage iii colon cancer
682830|NCT00900835|stage IV colon cancer|stage iv colon cancer
682831|NCT00900835|extensive stage small cell lung cancer|extensive stage small cell lung cancer
682832|NCT00900835|limited stage small cell lung cancer|limited stage small cell lung cancer
682833|NCT00900835|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
682834|NCT00900835|recurrent small cell lung cancer|recurrent small cell lung cancer
682835|NCT00900835|stage I non-small cell lung cancer|stage i non-small cell lung cancer
682836|NCT00900835|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
682837|NCT00900835|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
682838|NCT00900835|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
682839|NCT00900835|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
682840|NCT00900848|Posterior tibial artery bypass|posterior tibial artery bypass
682841|NCT00900848|Iliofemoral artery injury|iliofemoral artery injury
682842|NCT00900848|Shock|shock
682843|NCT00900848|Reconstruction|reconstruction
682844|NCT00900861|asthma control level|asthma control level
682845|NCT00900861|visual analogue scale|visual analogue scale
682846|NCT00900874|Formoterol|formoterol
682847|NCT00900874|Rapid bronchodilation|rapid bronchodilation
682848|NCT00900887|diabetic retinopathy|diabetic retinopathy
682849|NCT00900887|clinically significant macular edema|clinically significant macular edema
682850|NCT00900887|selective photocoagulation|selective photocoagulation
682851|NCT00900887|topic ketorolac|topic ketorolac
682852|NCT00900887|topic nepafenac|topic nepafenac
682853|NCT00900887|efficacy|efficacy
682854|NCT00900887|treatment|treatment
682855|NCT00900900|Cigarette Smokers|cigarette smokers
682856|NCT00900900|DHEA|dhea
682857|NCT00900900|dehydroepiandrosterone|dehydroepiandrosterone
682858|NCT00900900|pregnenolone|pregnenolone
682859|NCT00900900|Nicotine withdrawal symptoms|nicotine withdrawal symptoms
682860|NCT00900965|irritable bowel syndrome|irritable bowel syndrome
682861|NCT00900965|IBS|ibs
682862|NCT00900965|fMRI|fmri
682863|NCT00900965|acupuncture|acupuncture
682864|NCT00900965|functional|functional
682865|NCT00900965|brain|brain
682866|NCT00900978|Streptococcus pneumoniae|streptococcus pneumoniae
682867|NCT00900978|carriage|carriage
682868|NCT00900978|Resistance|resistance
682869|NCT00900978|Serotype|serotype
682870|NCT00900978|vaccination|vaccination
682871|NCT00900978|Colonization of S. pneumoniae|colonization of s. pneumoniae
682872|NCT00900991|Pandemic Influenza A Vaccine|pandemic influenza a vaccine
682875|NCT00901004|Minimal Change|minimal change
682876|NCT00901004|GERD|gerd
682877|NCT00901004|GERDQ|gerdq
682878|NCT00901030|platelet function|platelet function
682879|NCT00901030|perioperative complications|perioperative complications
682880|NCT00901030|thromboelastography|thromboelastography
682881|NCT00901030|coronary stents|coronary stents
682882|NCT00901030|non-cardiac surgery|non-cardiac surgery
682883|NCT00901056|ED|ed
682884|NCT00901056|Erectile Dysfunction|erectile dysfunction
682885|NCT00901056|Erectile dysfunction treated with PDE-5 inhibitors|erectile dysfunction treated with pde-5 inhibitors
682886|NCT00901082|chronic pain|chronic pain
682887|NCT00901082|anxiety|anxiety
682888|NCT00901082|intervention|intervention
682890|NCT00901082|relaxation|relaxation
682891|NCT00901108|open angle glaucoma|open angle glaucoma
682892|NCT00901108|trabectome|trabectome
682893|NCT00901108|trabeculectomy|trabeculectomy
682894|NCT00901108|cataract|cataract
682895|NCT00901121|maxillary sinus lift|maxillary sinus lift
682896|NCT00901121|Histomorphometric evaluation|histomorphometric evaluation
682897|NCT00901121|bone graft|bone graft
682898|NCT00901121|bone augmentation|bone augmentation
682899|NCT00901134|therapeutic hypothermia after cardiac arrest|therapeutic hypothermia after cardiac arrest
682900|NCT00901147|t-cell lymphoma|t-cell lymphoma
682901|NCT00901147|peripheral t-cell lymphoma|peripheral t-cell lymphoma
682902|NCT00901147|nk/t-cell lymphoma, nasal type|nk/t-cell lymphoma, nasal type
682903|NCT00901147|bortezomib|bortezomib
682904|NCT00901147|velcade|velcade
682905|NCT00901147|panobinostat|panobinostat
682906|NCT00901147|LBH589b|lbh589b
682907|NCT00901147|histone deacetylase inhibitor|histone deacetylase inhibitor
682908|NCT00901147|proteasome inhibitor|proteasome inhibitor
682909|NCT00901160|thromboelastography|thromboelastography
682910|NCT00901160|post-operative complications|post-operative complications
682911|NCT00901160|anti-platelet agents|anti-platelet agents
682912|NCT00901160|prospective|prospective
682913|NCT00901160|pilot|pilot
682914|NCT00901160|patients taking anti-platelet agents|patients taking anti-platelet agents
682915|NCT00901173|Case-Control Study|case-control study
682916|NCT00901173|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
682917|NCT00901173|Risk Factors|risk factors
682918|NCT00901186|Diabetic Macular Edema|diabetic macular edema
682919|NCT00901186|Ranibizumab|ranibizumab
682920|NCT00901186|Laser Treatment|laser treatment
682921|NCT00901186|Visual impairment|visual impairment
682922|NCT00901199|Thalassemia|thalassemia
682923|NCT00901199|Chelation|chelation
682924|NCT00901199|Iron Overload|iron overload
682925|NCT00901199|Thalassemia patients with Iron overload|thalassemia patients with iron overload
682926|NCT00901212|Heart Failure|heart failure
682927|NCT00901212|resynchronisation|resynchronisation
682928|NCT00901212|ICD|icd
682929|NCT00901225|NHL|nhl
682930|NCT00901238|retinoblastoma|retinoblastoma
682931|NCT00901238|intra-arterial chemotherapy|intra-arterial chemotherapy
682932|NCT00901238|chemosurgery|chemosurgery
682933|NCT00901238|melphalan|melphalan
682934|NCT00901238|topotecan|topotecan
682935|NCT00901251|OABSS|oabss
682936|NCT00901264|Chemosensitivity, chemotherapy, all cancers, personalized chemotherapy, personalized cancer treatment|chemosensitivity, chemotherapy, all cancers, personalized chemotherapy, personalized cancer treatment
682937|NCT00901264|Cancer Patients for whom chemotherapy is planned.|cancer patients for whom chemotherapy is planned.
682938|NCT00901277|Post MI|post mi
682939|NCT00901290|oral contraceptive|oral contraceptive
682940|NCT00901316|Skin and Soft Tissue Infections|skin and soft tissue infections
682941|NCT00901316|Abscesses|abscesses
682942|NCT00901316|Boils|boils
682943|NCT00901316|Clorox Baths|clorox baths
682944|NCT00901316|Colonization|colonization
682945|NCT00901316|Staph|staph
682946|NCT00901316|MRSA|mrsa
682947|NCT00901316|MSSA|mssa
682948|NCT00901316|Recurrent Infections|recurrent infections
682949|NCT00901316|Prevention CA-SA Infections|prevention ca-sa infections
682950|NCT00901316|Community-Acquired Staphylococcus in Children|community-acquired staphylococcus in children
682951|NCT00901329|TKA|tka
682952|NCT00901329|functional outcome|functional outcome
682953|NCT00901329|pain|pain
682954|NCT00901329|ROM|rom
682955|NCT00901329|gait|gait
682956|NCT00901342|Androgen independent prostate cancer (AIPC)|androgen independent prostate cancer (aipc)
682957|NCT00901342|CRPC|crpc
682958|NCT00901342|prostate cancer|prostate cancer
682959|NCT00901342|prostate|prostate
682960|NCT00901342|immune therapy|immune therapy
682961|NCT00901342|immunotherapy|immunotherapy
682962|NCT00901342|vaccine|vaccine
682963|NCT00901342|dendritic cells|dendritic cells
682964|NCT00901342|antigen-presenting cells|antigen-presenting cells
682965|NCT00901342|antigen presenting cells|antigen presenting cells
682966|NCT00901342|cancer vaccine|cancer vaccine
682967|NCT00901342|prostate specific antigen (PSA)|prostate specific antigen (psa)
682968|NCT00901342|prostatic adenocarcinoma|prostatic adenocarcinoma
682969|NCT00901355|Blood pressure|blood pressure
682970|NCT00901355|Arterial stiffness|arterial stiffness
682971|NCT00901355|Morbidity|morbidity
682972|NCT00901355|Mortality|mortality
682973|NCT00901355|Elderly|elderly
682974|NCT00901381|Ischemic stroke|ischemic stroke
682975|NCT00901381|Stem cells|stem cells
682976|NCT00901381|Colony-stimulating factors|colony-stimulating factors
682977|NCT00901381|Filgrastim|filgrastim
682978|NCT00901381|Randomized controlled trial|randomized controlled trial
682979|NCT00901394|Nitrous oxide|nitrous oxide
682980|NCT00901394|cobalamin|cobalamin
682981|NCT00901394|homocysteine|homocysteine
682984|NCT00901394|No specific diseases targeted|no specific diseases targeted
682985|NCT00901407|augmentation|augmentation
682986|NCT00901407|depression|depression
682987|NCT00901407|resistance|resistance
682988|NCT00901420|Prostate|prostate
682989|NCT00901420|Urodynamic Evaluation|urodynamic evaluation
682990|NCT00901420|Prostatectomy|prostatectomy
682991|NCT00901420|Salvage prostatectomy|salvage prostatectomy
682992|NCT00901420|Bladder compliance|bladder compliance
682993|NCT00901420|Radiation Therapy|radiation therapy
682994|NCT00901420|External beam radiation therapy|external beam radiation therapy
682995|NCT00901420|Quality-of-life|quality-of-life
682996|NCT00901433|Asthma|asthma
682997|NCT00901433|Wheeze Rate|wheeze rate
682998|NCT00901433|Respiratory Function Tests|respiratory function tests
682999|NCT00901459|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
683000|NCT00901459|Cigarette Smoker|cigarette smoker
683001|NCT00901459|Cigarette Dependence|cigarette dependence
683002|NCT00901459|To block cue-elicited craving in dependent cigarette smokers|to block cue-elicited craving in dependent cigarette smokers
683003|NCT00901472|Type 2 diabetes,|type 2 diabetes,
683004|NCT00901472|obstructive sleep apnea|obstructive sleep apnea
683005|NCT00894647|actinic keratosis|actinic keratosis
683006|NCT00894647|skin disease|skin disease
683007|NCT00894660|Bioequivalence, Healthy Volunteers|bioequivalence, healthy volunteers
683008|NCT00894673|heparin cardiac surgery|heparin cardiac surgery
683009|NCT00894699|procedural sedation|procedural sedation
683010|NCT00894712|Radiation Therapy|radiation therapy
683011|NCT00894725|left colon cancer|left colon cancer
683012|NCT00894738|pediatric|pediatric
683013|NCT00894738|mental illness|mental illness
683014|NCT00894738|antipsychotic|antipsychotic
683015|NCT00894738|cardiometabolic risk|cardiometabolic risk
683016|NCT00894738|Antipsychotic agents|antipsychotic agents
683017|NCT00894738|Mental disorders diagnosed in childhood|mental disorders diagnosed in childhood
683018|NCT00894751|dexmedetomidine and propofol for MRI|dexmedetomidine and propofol for mri
683019|NCT00894751|quality of care between two anesthetic agents for MRI|quality of care between two anesthetic agents for mri
683020|NCT00894764|Childhood|childhood
683021|NCT00894764|Pneumonia|pneumonia
683022|NCT00894764|Pneumococcal|pneumococcal
683023|NCT00894764|pneumococcus|pneumococcus
683024|NCT00894764|Carriage|carriage
683025|NCT00894777|Psoriasis|psoriasis
683026|NCT00894790|Treatment of the acute pain due to cervical|treatment of the acute pain due to cervical
683027|NCT00894790|sprain|sprain
683028|NCT00894790|Celecoxib|celecoxib
683029|NCT00894790|NSAID|nsaid
683030|NCT00894790|Diclofenac|diclofenac
683031|NCT00894803|acute ischemic stroke|acute ischemic stroke
683032|NCT00894803|stroke|stroke
683033|NCT00894803|rt-PA, thrombolytic|rt-pa, thrombolytic
683034|NCT00894803|t-PA|t-pa
683035|NCT00894803|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
683036|NCT00894803|Activase|activase
683037|NCT00894803|eptifibatide|eptifibatide
683038|NCT00894803|Integrilin|integrilin
683039|NCT00894803|fibrinolytic agents|fibrinolytic agents
683040|NCT00894803|clot dissolving|clot dissolving
683041|NCT00894803|blood clot|blood clot
683042|NCT00894816|Prevention|prevention
683043|NCT00894816|Probiotics|probiotics
683044|NCT00894816|Eczema|eczema
683045|NCT00894816|Allergy|allergy
683049|NCT00894816|Gut microbiota|gut microbiota
683050|NCT00894829|heparin cardiac surgery|heparin cardiac surgery
683051|NCT00894842|Schizophrenia|schizophrenia
683052|NCT00894842|Pregnenolone|pregnenolone
683053|NCT00894842|Neurocognition|neurocognition
683054|NCT00894855|skin cancer prevention|skin cancer prevention
683055|NCT00894855|SHADE|shade
683057|NCT00894868|Congestive Heart Failure|congestive heart failure
683058|NCT00894868|CHF, vildagliptin|chf, vildagliptin
683059|NCT00894868|metabolic disease|metabolic disease
683060|NCT00894868|cardiovascular disease|cardiovascular disease
683061|NCT00894868|T2DM|t2dm
683062|NCT00894881|colonoscopy|colonoscopy
683063|NCT00894881|Healthy individuals before colonoscopy|healthy individuals before colonoscopy
683064|NCT00894894|MP470|mp470
683065|NCT00894894|MP-470|mp-470
683066|NCT00894894|SuperGen|supergen
683067|NCT00894894|Tyrosine|tyrosine
683068|NCT00894894|Kinase|kinase
683069|NCT00894894|Inhibitor|inhibitor
683070|NCT00894894|Solid Malignancies|solid malignancies
683071|NCT00894894|Oncology|oncology
683072|NCT00894907|Severe pancreatitis|severe pancreatitis
683073|NCT00894907|acute pancreatitis|acute pancreatitis
683074|NCT00894907|haemodynamic monitoring|haemodynamic monitoring
683075|NCT00894907|PiCCO|picco
683076|NCT00894920|biotin|biotin
683077|NCT00894920|deficiency|deficiency
683078|NCT00894920|pregnancy|pregnancy
683933|NCT00904787|Leukemia|leukemia
683079|NCT00894920|lymphocyte propionyl-CoA carboxylase|lymphocyte propionyl-coa carboxylase
683080|NCT00894933|Prostate Cancer|prostate cancer
683081|NCT00894933|Radical Prostatectomy|radical prostatectomy
683082|NCT00894933|Vesico-Urethral Anastomosis|vesico-urethral anastomosis
683083|NCT00894946|recurrent IVF implantation failure|recurrent ivf implantation failure
683084|NCT00894959|heparin cardiac surgery|heparin cardiac surgery
683085|NCT00894985|heparin cardiac surgery|heparin cardiac surgery
683086|NCT00894998|heparin cardiac surgery|heparin cardiac surgery
683087|NCT00895011|Erectile Dysfunction|erectile dysfunction
683088|NCT00895011|E.D.|e.d.
683089|NCT00895024|Caregiver|caregiver
683090|NCT00895024|Questionnaire|questionnaire
683091|NCT00895024|Home Hospice Care|home hospice care
683092|NCT00895024|Family Evaluation of Hospice Care|family evaluation of hospice care
683093|NCT00895024|FEHC|fehc
683094|NCT00895024|The Texas Revised Inventory of Grief|the texas revised inventory of grief
683095|NCT00895024|TRIG|trig
683096|NCT00895024|Cross-ethnic differences|cross-ethnic differences
683097|NCT00895024|Parenteral Hydration|parenteral hydration
683098|NCT00895024|Grief|grief
683099|NCT00895063|Spasmodic Dysphonia|spasmodic dysphonia
683100|NCT00895063|Botulinum Toxin|botulinum toxin
683101|NCT00895063|Vocal Exercise|vocal exercise
683102|NCT00895089|liver abscess|liver abscess
683103|NCT00895089|moxifloxacin|moxifloxacin
683104|NCT00895089|ceftriaxone|ceftriaxone
683105|NCT00895089|treatment|treatment
683106|NCT00895102|Bioavailability (BA)|bioavailability (ba)
683107|NCT00895102|Single Ascending Dose (SAD)|single ascending dose (sad)
683108|NCT00895115|prostate cancer|prostate cancer
683109|NCT00895128|Advanced Cancer|advanced cancer
683110|NCT00895128|EGFR mutations|egfr mutations
683111|NCT00895128|Dasatinib|dasatinib
683112|NCT00895128|Sprycel|sprycel
683113|NCT00895128|Erlotinib|erlotinib
683114|NCT00895128|Erlotinib Hydrochloride|erlotinib hydrochloride
683115|NCT00895128|Tarceva|tarceva
683116|NCT00895141|Saturated fat|saturated fat
683117|NCT00895141|LDL size|ldl size
683118|NCT00895141|Large LDL|large ldl
683119|NCT00895141|Large HDL|large hdl
683120|NCT00895154|Sickle Cell Disease|sickle cell disease
683121|NCT00895154|Sickle Cell|sickle cell
683122|NCT00895154|Memory|memory
683123|NCT00895154|Learning|learning
683124|NCT00895154|Achievement|achievement
683125|NCT00895167|Heme Oxygenase|heme oxygenase
683126|NCT00895167|Genetic Polymorphism|genetic polymorphism
683127|NCT00895167|Healthy Subjects|healthy subjects
683128|NCT00895180|recurrent adult brain tumor|recurrent adult brain tumor
683129|NCT00895180|adult glioblastoma|adult glioblastoma
683130|NCT00895180|adult giant cell glioblastoma|adult giant cell glioblastoma
683131|NCT00895180|adult gliosarcoma|adult gliosarcoma
683132|NCT00895193|Niacin|niacin
683133|NCT00895193|Hypercholesterolemia|hypercholesterolemia
683134|NCT00895193|Flushing|flushing
683135|NCT00895219|Hyperventilation|hyperventilation
683136|NCT00895219|Dysfunctional breathing|dysfunctional breathing
683137|NCT00895219|Physiotherapy|physiotherapy
683138|NCT00895219|Musculoskeletal techniques|musculoskeletal techniques
683139|NCT00895258|Schizoaffective Disorder|schizoaffective disorder
683140|NCT00895258|Major Depressive Disorder|major depressive disorder
683141|NCT00895258|Supported Employment|supported employment
683142|NCT00895258|Work|work
683143|NCT00895258|Rehabilitation|rehabilitation
683144|NCT00895258|Severe Mental Illness|severe mental illness
683145|NCT00895258|Cognitive Training|cognitive training
683146|NCT00895258|Cognitive Rehabilitation|cognitive rehabilitation
683147|NCT00895258|Cognitive Remediation|cognitive remediation
683148|NCT00895271|Primary Immunodeficiency|primary immunodeficiency
683149|NCT00895271|Immunodysregulation|immunodysregulation
683150|NCT00895271|Skin Biopsy|skin biopsy
683151|NCT00895271|Induced Pluripotent Stem Cell (iPS)|induced pluripotent stem cell (ips)
683152|NCT00895271|Lymphocyte|lymphocyte
683153|NCT00895271|Common Variable Immunodeficiency|common variable immunodeficiency
683154|NCT00895271|Severe Combined Immunodeficiency|severe combined immunodeficiency
683155|NCT00895271|Healthy Volunteer|healthy volunteer
683156|NCT00895271|HV|hv
683157|NCT00895284|robotic|robotic
683158|NCT00895284|laparoscopic surgical procedures|laparoscopic surgical procedures
683159|NCT00895297|Relapsing after allogeneic transplantation|relapsing after allogeneic transplantation
683160|NCT00895297|Dasatinib|dasatinib
683161|NCT00895297|Sprycel|sprycel
683162|NCT00895297|Philadelphia Chromosomes|philadelphia chromosomes
683163|NCT00895310|PSA|psa
683164|NCT00895310|Ketoconazole|ketoconazole
683165|NCT00895310|Prostate Cancer|prostate cancer
683166|NCT00895310|Hormone Refractory|hormone refractory
683167|NCT00895310|Chemotherapy Regimen|chemotherapy regimen
683168|NCT00895323|stage I colon cancer|stage i colon cancer
683169|NCT00895323|stage II colon cancer|stage ii colon cancer
683170|NCT00895323|stage III colon cancer|stage iii colon cancer
683171|NCT00895323|stage IV colon cancer|stage iv colon cancer
683172|NCT00895323|stage I rectal cancer|stage i rectal cancer
683173|NCT00895323|stage II rectal cancer|stage ii rectal cancer
683174|NCT00895323|stage III rectal cancer|stage iii rectal cancer
683175|NCT00895323|stage IV rectal cancer|stage iv rectal cancer
683176|NCT00895323|recurrent colon cancer|recurrent colon cancer
683177|NCT00895323|recurrent rectal cancer|recurrent rectal cancer
683178|NCT00895336|Pediatric Ulcerative Colitis|pediatric ulcerative colitis
683179|NCT00895349|Positron Emission Tomography (PET)|positron emission tomography (pet)
683180|NCT00895349|Diagnostic Intervention|diagnostic intervention
683181|NCT00895349|Locally Advanced Cervical Cancer|locally advanced cervical cancer
683182|NCT00895362|Advanced Cancer|advanced cancer
683183|NCT00895362|EGFR mutation|egfr mutation
683184|NCT00895362|Erlotinib|erlotinib
683185|NCT00895362|Erlotinib Hydrochloride|erlotinib hydrochloride
683186|NCT00895362|Tarceva|tarceva
683187|NCT00895362|OSI-774|osi-774
683188|NCT00895362|Cetuximab|cetuximab
683189|NCT00895362|C225|c225
683190|NCT00895362|Erbitux|erbitux
683191|NCT00895362|IMC-C225|imc-c225
683192|NCT00901485|Respiratory insufficiency|respiratory insufficiency
683193|NCT00901485|Hypercapnia|hypercapnia
683194|NCT00901485|Hypoventilation|hypoventilation
683195|NCT00901485|Sleep|sleep
683196|NCT00901485|Polysomnography|polysomnography
683197|NCT00901485|Hypoxia|hypoxia
683198|NCT00901485|Titration|titration
683199|NCT00901485|Non Invasive Ventilation|non invasive ventilation
683200|NCT00901511|Whole lung lavage|whole lung lavage
683201|NCT00901511|Pulmonary surfactant|pulmonary surfactant
683202|NCT00901511|GM-CSF|gm-csf
683203|NCT00901511|Autoantibodies anti GM-CSF|autoantibodies anti gm-csf
683204|NCT00901524|HCV Genotype 1, 4|hcv genotype 1, 4
683205|NCT00901524|Virological response|virological response
683206|NCT00901524|Ribavirin|ribavirin
683207|NCT00901524|PegPegIFN- alpha 2a|pegpegifn- alpha 2a
683208|NCT00901524|Viral Hepatitis (HCV)|viral hepatitis (hcv)
683209|NCT00901537|Non-small Cell Lung Cancer|non-small cell lung cancer
683210|NCT00901537|Head and Neck Cancer|head and neck cancer
683211|NCT00901537|Azacitidine|azacitidine
683212|NCT00901537|Vidaza|vidaza
683213|NCT00901537|Cisplatin|cisplatin
683215|NCT00901550|anti-TNF|anti-tnf
683216|NCT00901550|Early RA|early ra
683217|NCT00901563|Gap Junctions|gap junctions
683218|NCT00901563|Rotigaptide|rotigaptide
683219|NCT00901563|Ischaemia reperfusion|ischaemia reperfusion
683220|NCT00901563|t-PA|t-pa
683221|NCT00901563|Fibrinolysis|fibrinolysis
683222|NCT00901563|Endothelial function|endothelial function
683223|NCT00901563|Venous occlusion plethysmography|venous occlusion plethysmography
683224|NCT00901576|Healthy volunteers|healthy volunteers
683225|NCT00901589|n-3 PUFAs|n-3 pufas
683226|NCT00901589|menopause|menopause
683227|NCT00901589|adipose tissue|adipose tissue
683228|NCT00901589|estrogens|estrogens
683229|NCT00901589|Incorporation of fishoil in pre- and postmenopausal women|incorporation of fishoil in pre- and postmenopausal women
683230|NCT00901589|Marine n-3 PUFAs influence on female hormones in blood|marine n-3 pufas influence on female hormones in blood
683231|NCT00901602|streptococcus pneumoniae|streptococcus pneumoniae
683232|NCT00901602|pneumococcus|pneumococcus
683233|NCT00901602|pneumonia|pneumonia
683234|NCT00901602|meningitis|meningitis
683235|NCT00901602|serotypes|serotypes
683236|NCT00901602|bacteremia|bacteremia
683237|NCT00901602|sepsis|sepsis
683238|NCT00901615|lymphoma|lymphoma
683239|NCT00901615|lenalidomide|lenalidomide
683240|NCT00901615|gela|gela
683241|NCT00901628|periarticular multimodal drug injection|periarticular multimodal drug injection
683242|NCT00901641|cognitive training|cognitive training
683243|NCT00901641|insomnia|insomnia
683244|NCT00901654|Vaccination|vaccination
683245|NCT00901654|Diarrhea|diarrhea
683246|NCT00901654|Traveler's Diarrhea|traveler's diarrhea
683247|NCT00901654|ETEC|etec
683248|NCT00901654|Enterotoxigenic E. coli|enterotoxigenic e. coli
683249|NCT00901680|Tissue Bank|tissue bank
683251|NCT00901693|eye infection|eye infection
683252|NCT00901693|conjunctivitis|conjunctivitis
683253|NCT00901706|Self-Neglect|self-neglect
683254|NCT00901706|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
683255|NCT00901706|Geriatric Syndromes|geriatric syndromes
683256|NCT00901706|Quality of Life|quality of life
683257|NCT00901706|Basic Activities of Daily Living|basic activities of daily living
683258|NCT00901706|Instrumental Activities of Daily Living|instrumental activities of daily living
683259|NCT00901719|Renin angiotensin system|renin angiotensin system
683260|NCT00901719|Apelin|apelin
683261|NCT00901719|Cardiac output|cardiac output
683262|NCT00901719|Vasodilatation|vasodilatation
683263|NCT00901732|Caphosol|caphosol
683264|NCT00901732|Oral Mucositis|oral mucositis
683265|NCT00901732|Eusa Pharma|eusa pharma
683266|NCT00901732|Moffitt Cancer Center|moffitt cancer center
683267|NCT00901745|Renin angiotensin system|renin angiotensin system
683268|NCT00901745|Apelin|apelin
683269|NCT00901745|Vasodilatation|vasodilatation
683270|NCT00901745|Heart disease|heart disease
683271|NCT00901745|Vascular biology|vascular biology
683272|NCT00901771|Sleep|sleep
683273|NCT00901771|Sleep Apnea, Obstructive|sleep apnea, obstructive
683275|NCT00901771|OSAH|osah
683276|NCT00901784|Topiramate fasting study|topiramate fasting study
683278|NCT00901797|ABDuction|abduction
683279|NCT00901797|ABR|abr
686674|NCT00918593|Metastases|metastases
683280|NCT00901797|Arthroscopic Bankart Repair|arthroscopic bankart repair
683281|NCT00901797|ACJ|acj
683282|NCT00901797|AcromioClavicular Joint|acromioclavicular joint
683283|NCT00901797|AD|ad
683284|NCT00901797|Anterior Drawer|anterior drawer
683285|NCT00901797|ARIC|aric
683286|NCT00901797|Arthroscopic Rotator Interval Closure|arthroscopic rotator interval closure
683287|NCT00901797|BL|bl
683288|NCT00901797|Bankart Lesion|bankart lesion
683289|NCT00901797|CHL|chl
683290|NCT00901797|CoracoHumeral Ligament|coracohumeral ligament
683291|NCT00901797|ER|er
683292|NCT00901797|External Rotation|external rotation
683293|NCT00901797|FF|ff
683294|NCT00901797|Forward Flexion|forward flexion
683295|NCT00901797|GHJ|ghj
683296|NCT00901797|GlenoHumeral Joint|glenohumeral joint
683297|NCT00901797|HSL|hsl
683298|NCT00901797|HillSacs Lesion|hillsacs lesion
683299|NCT00901797|IR|ir
683300|NCT00901797|Internal Rotation|internal rotation
683301|NCT00901797|ISP|isp
683302|NCT00901797|InfraSPinatus|infraspinatus
683303|NCT00901797|PD|pd
683304|NCT00901797|Posterior Drawer|posterior drawer
683305|NCT00901797|RI|ri
683306|NCT00901797|Rotator Interval|rotator interval
683307|NCT00901797|ROM|rom
683308|NCT00901797|Range Of Motion|range of motion
683309|NCT00901797|SGHL|sghl
683310|NCT00901797|Superior GlenoHumeral Ligament|superior glenohumeral ligament
683311|NCT00901797|SSC|ssc
683312|NCT00901797|SubSCapularis|subscapularis
683313|NCT00901797|SSP|ssp
683314|NCT00901797|SupraSPinatus|supraspinatus
683315|NCT00901810|Length Determination|length determination
683316|NCT00901810|Working Length|working length
683317|NCT00901810|Electronic Apex Locator|electronic apex locator
683318|NCT00901810|Root Canal Therapy|root canal therapy
683319|NCT00901810|Endodontics|endodontics
683320|NCT00902616|Type 2 diabetes|type 2 diabetes
683321|NCT00902616|Peripheral neuropathy|peripheral neuropathy
683322|NCT00902616|Microcirculation|microcirculation
683323|NCT00902629|Epiretinal Fibrosis|epiretinal fibrosis
683324|NCT00902629|Macular Pucker|macular pucker
683325|NCT00902642|Physical therapy,|physical therapy,
683326|NCT00902642|musculoskeletal pain,|musculoskeletal pain,
683327|NCT00902642|psychosocial factors,|psychosocial factors,
683328|NCT00902642|dissimilation,|dissimilation,
683329|NCT00902642|evidence based,|evidence based,
683330|NCT00902642|education|education
683331|NCT00902655|Nocturnal polyuria|nocturnal polyuria
683332|NCT00902655|Nocturnal bladder capacity|nocturnal bladder capacity
683333|NCT00902668|radiation toxicity|radiation toxicity
683334|NCT00902668|stage IA breast cancer|stage ia breast cancer
683335|NCT00902668|stage IB breast cancer|stage ib breast cancer
683336|NCT00902668|stage II breast cancer|stage ii breast cancer
683337|NCT00902668|breast cancer in situ|breast cancer in situ
683338|NCT00902681|Bioequivalence, Pharmacokinetics|bioequivalence, pharmacokinetics
683339|NCT00902694|Serious Mental Illness|serious mental illness
683340|NCT00902694|Weight Loss|weight loss
683341|NCT00902707|healthy nonsmokers|healthy nonsmokers
683342|NCT00902720|Ovarian|ovarian
683343|NCT00902720|Tissue|tissue
683344|NCT00902720|Cryopreservation|cryopreservation
683345|NCT00902733|pain|pain
683346|NCT00902733|fatigue|fatigue
683347|NCT00902733|nausea and vomiting|nausea and vomiting
683348|NCT00902733|recurrent pancreatic cancer|recurrent pancreatic cancer
683349|NCT00902733|stage I pancreatic cancer|stage i pancreatic cancer
683350|NCT00902733|stage II pancreatic cancer|stage ii pancreatic cancer
683351|NCT00902733|stage III pancreatic cancer|stage iii pancreatic cancer
683352|NCT00902733|stage IV pancreatic cancer|stage iv pancreatic cancer
683353|NCT00902759|Surgery|surgery
683354|NCT00902759|Chemotherapy|chemotherapy
683355|NCT00902759|Radiation Therapy|radiation therapy
683356|NCT00902759|Pancreatic cancer|pancreatic cancer
683357|NCT00902759|Fatigue|fatigue
683358|NCT00902772|Recreational CNS depressant|recreational cns depressant
683359|NCT00902772|Abuse liability|abuse liability
683360|NCT00902772|Abuse potential|abuse potential
683361|NCT00902772|Healthy Recreational CNS Depressant Users|healthy recreational cns depressant users
683362|NCT00902785|exploratory|exploratory
683363|NCT00902785|observational|observational
683364|NCT00902785|non-interventional study age-related macular degeneration (AMD) choroidal neovascularization (CNV)|non-interventional study age-related macular degeneration (amd) choroidal neovascularization (cnv)
683365|NCT00902798|Autism|autism
683366|NCT00902798|Autism Spectrum Disorders|autism spectrum disorders
683367|NCT00902798|Asperger's Syndrome|asperger's syndrome
683368|NCT00902798|Pervasive Developmental Disorder|pervasive developmental disorder
683369|NCT00902798|Cognition|cognition
683370|NCT00902798|Social Cognition|social cognition
683371|NCT00902798|Psychosocial Treatment|psychosocial treatment
683372|NCT00902798|Cognitive Enhancement Therapy|cognitive enhancement therapy
683373|NCT00902798|Enriched Supportive Therapy|enriched supportive therapy
683374|NCT00902798|Therapy|therapy
683375|NCT00902798|Psychotherapy|psychotherapy
683376|NCT00902811|uncomplicated falciparum malaria|uncomplicated falciparum malaria
683377|NCT00902811|artemisinin combination therapy|artemisinin combination therapy
683378|NCT00902824|HIV|hiv
683379|NCT00902837|randomised|randomised
683380|NCT00902837|double-blind|double-blind
683381|NCT00902837|double-dummy|double-dummy
683382|NCT00902837|parallel-group|parallel-group
683383|NCT00902837|non-inferiority|non-inferiority
683384|NCT00902837|pain locomotor function|pain locomotor function
683385|NCT00902837|improvement in symptoms of constipation|improvement in symptoms of constipation
683386|NCT00902837|moderate to severe pain due to osteoarthritis (OA)|moderate to severe pain due to osteoarthritis (oa)
683389|NCT00902837|Moderate to severe chronic nonmalignant OA|moderate to severe chronic nonmalignant oa
683390|NCT00902863|chronic pain|chronic pain
683391|NCT00902863|mindfulness|mindfulness
683393|NCT00902863|quality of life|quality of life
683394|NCT00902863|stress|stress
683396|NCT00902876|gingival recession|gingival recession
683397|NCT00902876|keratinized gingiva|keratinized gingiva
683398|NCT00902889|Globus pallidus|globus pallidus
683399|NCT00902889|Huntington's Disease|huntington's disease
683400|NCT00902889|Deep Brain Stimulation|deep brain stimulation
683401|NCT00902889|Movement Disorders|movement disorders
683402|NCT00902902|Hepatocellular carcinoma|hepatocellular carcinoma
683403|NCT00902915|multiple myeloma renal insufficiency|multiple myeloma renal insufficiency
683404|NCT00902928|Elective hip replacement surgery|elective hip replacement surgery
683405|NCT00902928|Factor Xa|factor xa
683406|NCT00902928|Venous Thromboembolism|venous thromboembolism
683407|NCT00902928|Thrombosis|thrombosis
683408|NCT00902928|Anticoagulants|anticoagulants
683409|NCT00902928|Prevention|prevention
683410|NCT00902928|YM150|ym150
683411|NCT00902941|Parkinson´s disease|parkinson´s disease
683412|NCT00902941|olfaction|olfaction
683413|NCT00902941|rasagiline|rasagiline
683414|NCT00902941|smell testing|smell testing
683415|NCT00902954|Disease free survival|disease free survival
683416|NCT00902954|Distant disease free survival|distant disease free survival
683417|NCT00902954|Toxicity|toxicity
683418|NCT00902954|Overall survival|overall survival
683419|NCT00902967|Postoperative pain|postoperative pain
683420|NCT00902967|atorvastatin|atorvastatin
683421|NCT00902967|analgesic|analgesic
683422|NCT00902967|antiinflammatory|antiinflammatory
683423|NCT00902980|Kidney transplantation|kidney transplantation
683424|NCT00902980|Tacrolimus|tacrolimus
683425|NCT00902980|Immunosuppression|immunosuppression
683426|NCT00902993|MAD|mad
683427|NCT00902993|NNR|nnr
683428|NCT00902993|to investigate safety and tolerability in a multiple ascending dose study in Healthy subjects|to investigate safety and tolerability in a multiple ascending dose study in healthy subjects
683429|NCT00902993|AZD1446|azd1446
683430|NCT00903006|Breast|breast
683431|NCT00903006|Hormone receptor-positive metastatic breast cancer|hormone receptor-positive metastatic breast cancer
683432|NCT00903006|Fulvestrant|fulvestrant
683433|NCT00903006|Faslodex|faslodex
683434|NCT00903006|MK-0646|mk-0646
683435|NCT00903006|Dasatinib|dasatinib
683436|NCT00903006|BMS-354825|bms-354825
683437|NCT00903006|Sprycel|sprycel
683438|NCT00903006|Adjuvant hormonal therapy|adjuvant hormonal therapy
683439|NCT00903019|Homebound|homebound
683440|NCT00903019|Older Adults|older adults
683441|NCT00903019|Disability|disability
683442|NCT00903019|Videoconferencing|videoconferencing
683443|NCT00903032|compliance/adherence|compliance/adherence
683444|NCT00903045|Overactive bladder|overactive bladder
683445|NCT00903045|Propiverin|propiverin
683446|NCT00903071|Hypertension|hypertension
683447|NCT00903071|Primary Care|primary care
683448|NCT00903071|Physician Learning|physician learning
683449|NCT00903084|Pharmacokinetics in Hair|pharmacokinetics in hair
683450|NCT00903084|Tenofovir|tenofovir
683451|NCT00903084|Pharmacokinetics|pharmacokinetics
683452|NCT00903084|Concentrations|concentrations
683453|NCT00903084|Hair|hair
683454|NCT00903136|Barrett esophagus|barrett esophagus
683455|NCT00903136|esophageal cancer|esophageal cancer
683456|NCT00903136|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
683457|NCT00903149|Premature babies|premature babies
683458|NCT00903149|Social interaction|social interaction
683459|NCT00903149|Psychoeducative intervention|psychoeducative intervention
683460|NCT00903149|Mother Infant Transaction Program|mother infant transaction program
683461|NCT00903149|Three years follow-up|three years follow-up
683462|NCT00903149|Late preterm|late preterm
683463|NCT00903149|Cognitive development|cognitive development
683464|NCT00903149|Social development|social development
683465|NCT00903149|Emotional development|emotional development
683466|NCT00903149|Motor development|motor development
683467|NCT00903149|Children born preterm and their parents|children born preterm and their parents
683468|NCT00903162|hormone-receptor positive|hormone-receptor positive
683469|NCT00903162|tamoxifen|tamoxifen
683470|NCT00903162|letrozole|letrozole
683471|NCT00903162|zoledronic acid|zoledronic acid
683472|NCT00903162|leuprolide|leuprolide
683473|NCT00903175|RAD001|rad001
683474|NCT00903175|everolimus|everolimus
683475|NCT00903175|sunitinib|sunitinib
683476|NCT00903175|renal cell carcinoma|renal cell carcinoma
683477|NCT00903175|kidney cancer|kidney cancer
683478|NCT00903175|metastatic renal cell cancer|metastatic renal cell cancer
683479|NCT00903175|advanced kidney cancer|advanced kidney cancer
683480|NCT00903188|Renal Transplantation|renal transplantation
683481|NCT00903188|graft function|graft function
683482|NCT00903188|cardiovascular events|cardiovascular events
683483|NCT00903188|malignancy|malignancy
683484|NCT00903188|cyclosporin|cyclosporin
683485|NCT00903188|steroids|steroids
683486|NCT00903188|mycophenolate|mycophenolate
683488|NCT00903188|renal biopsies|renal biopsies
683489|NCT00903188|pharmacokinetics|pharmacokinetics
683490|NCT00903201|cystic fibrosis|cystic fibrosis
683491|NCT00903214|stage I breast cancer|stage i breast cancer
683492|NCT00903214|stage II breast cancer|stage ii breast cancer
683493|NCT00903214|stage IIIA breast cancer|stage iiia breast cancer
683494|NCT00903227|Asthma|asthma
683495|NCT00903227|Allergic rhinitis|allergic rhinitis
683496|NCT00903227|fluticasone|fluticasone
683497|NCT00903227|methacholine|methacholine
683498|NCT00903266|Aphasia|aphasia
683499|NCT00903266|Speech Impairment|speech impairment
683500|NCT00903266|Stroke|stroke
683501|NCT00903266|Cerebrovascular Accident|cerebrovascular accident
683502|NCT00903266|Cerebral Infarction|cerebral infarction
683503|NCT00903266|Brain Ischemia|brain ischemia
683504|NCT00903266|Brain Infarction|brain infarction
683505|NCT00903266|Cerebrovascular Disorder|cerebrovascular disorder
683506|NCT00903279|MRSA colonization|mrsa colonization
683507|NCT00903279|Orthopedic Surgery|orthopedic surgery
683508|NCT00903279|Altabax|altabax
683509|NCT00903279|Placebo|placebo
683510|NCT00903292|EGFR|egfr
683511|NCT00903292|NSCLC|nsclc
683512|NCT00903292|EGFR mutation rate|egfr mutation rate
683513|NCT00903305|pain|pain
683514|NCT00903305|fatigue|fatigue
683515|NCT00903305|nausea and vomiting|nausea and vomiting
683516|NCT00903305|stage I breast cancer|stage i breast cancer
683517|NCT00903305|stage II breast cancer|stage ii breast cancer
683518|NCT00903305|stage IIIA breast cancer|stage iiia breast cancer
683519|NCT00903305|stage IIIB breast cancer|stage iiib breast cancer
683520|NCT00903305|stage IIIC breast cancer|stage iiic breast cancer
683521|NCT00903318|Endocrine|endocrine
683522|NCT00903318|Environmental Chemicals|environmental chemicals
683523|NCT00903318|Male:Female Birth Ratio|male:female birth ratio
683524|NCT00903318|Phthalate Exposure|phthalate exposure
683525|NCT00903318|Generational sex ratio trends|generational sex ratio trends
683526|NCT00903318|Mexican American|mexican american
683527|NCT00903318|Baytown|baytown
683528|NCT00903318|Rio Grande Valley|rio grande valley
683529|NCT00903318|Hidalgo County|hidalgo county
683530|NCT00903318|Texas|texas
683531|NCT00903331|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
683532|NCT00903331|MUSIC|music
683533|NCT00903357|Atopic dermatitis|atopic dermatitis
683534|NCT00903357|Montelukast|montelukast
683535|NCT00903370|Mitral Valve Regurgitation|mitral valve regurgitation
683536|NCT00903370|Mitral Valve Surgery|mitral valve surgery
683537|NCT00903370|Mitral Valve Disease|mitral valve disease
683538|NCT00903370|Ablation, Catheter|ablation, catheter
683539|NCT00903370|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
683540|NCT00903396|nausea and vomiting|nausea and vomiting
683541|NCT00903396|gastrointestinal carcinoid tumor|gastrointestinal carcinoid tumor
683542|NCT00903396|anal cancer|anal cancer
683543|NCT00903396|carcinoma of the appendix|carcinoma of the appendix
683544|NCT00903396|colon cancer|colon cancer
683545|NCT00903396|rectal cancer|rectal cancer
683546|NCT00903396|extrahepatic bile duct cancer|extrahepatic bile duct cancer
683547|NCT00903396|gallbladder cancer|gallbladder cancer
683548|NCT00903396|gastric cancer|gastric cancer
683549|NCT00903396|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
683550|NCT00903396|pancreatic cancer|pancreatic cancer
683551|NCT00903396|small intestine cancer|small intestine cancer
683552|NCT00903396|primary peritoneal cavity cancer|primary peritoneal cavity cancer
683553|NCT00903409|High triglycerides|high triglycerides
683554|NCT00903409|Lovaza|lovaza
683555|NCT00903409|simvastatin|simvastatin
683556|NCT00903409|omega-3-acid ethyl esters|omega-3-acid ethyl esters
683557|NCT00903422|de novo AML|de novo aml
683558|NCT00903422|sAML/MDS|saml/mds
683559|NCT00903422|Thrombopoietin|thrombopoietin
683560|NCT00903422|secondary Acute Myeloid Leukemia after MDS|secondary acute myeloid leukemia after mds
683562|NCT00903422|Eltrombopag|eltrombopag
683563|NCT00903422|Platelets|platelets
683564|NCT00903422|TPO-R agonist|tpo-r agonist
683565|NCT00903422|Advanced Myelodysplastic Syndrome|advanced myelodysplastic syndrome
683566|NCT00903422|Thrombocytopenia|thrombocytopenia
683567|NCT00903422|Thrombopoietin receptor agonist|thrombopoietin receptor agonist
683568|NCT00903435|Cystitis|cystitis
683569|NCT00903435|Urinary|urinary
683570|NCT00903435|Bladder|bladder
683571|NCT00903448|Normal Healthy Subject Population|normal healthy subject population
683572|NCT00903474|anxiety disorder|anxiety disorder
683573|NCT00903474|depression|depression
683574|NCT00903474|cognitive/functional effects|cognitive/functional effects
683575|NCT00903474|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
683576|NCT00903474|cancer survivor|cancer survivor
683577|NCT00903474|breast cancer|breast cancer
683578|NCT00903526|fungal susceptibility|fungal susceptibility
683579|NCT00903539|Peripherally Inserted Central Catheter|peripherally inserted central catheter
683580|NCT00903539|Central Venous Catheter|central venous catheter
683581|NCT00903539|Intravenous Catheter|intravenous catheter
683582|NCT00903539|StatLock|statlock
683583|NCT00903539|Patients indicated to have an intravenous catheter placed|patients indicated to have an intravenous catheter placed
683584|NCT00903565|genomic profiling|genomic profiling
683585|NCT00903565|gene expression|gene expression
683586|NCT00903565|ColoPrint|coloprint
683587|NCT00903565|adenocarcinoma colon|adenocarcinoma colon
683588|NCT00903565|recurrence risk assessment|recurrence risk assessment
683589|NCT00903565|prospective|prospective
683590|NCT00903578|FGF-23|fgf-23
683591|NCT00903578|vitamin D|vitamin d
683592|NCT00903578|phosphate|phosphate
683593|NCT00903578|allograft dysfunction|allograft dysfunction
683594|NCT00903578|mortality|mortality
683595|NCT00903591|Breast|breast
683596|NCT00903591|cancer|cancer
683597|NCT00903591|09-040|09-040
683598|NCT00903591|blood sample|blood sample
683599|NCT00903591|saliva sample|saliva sample
683600|NCT00903591|WECARE|wecare
683601|NCT00903591|GWA|gwa
683602|NCT00903604|Cardiac surgery|cardiac surgery
683603|NCT00903604|coronary artery bypass grafting|coronary artery bypass grafting
683604|NCT00903604|valve surgery|valve surgery
683605|NCT00903604|aortic root or ascending aortic aneurysm repair surgery|aortic root or ascending aortic aneurysm repair surgery
683606|NCT00903604|Acute kidney injury|acute kidney injury
683607|NCT00903617|lipids|lipids
683608|NCT00903617|HM74A|hm74a
683609|NCT00903630|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
683610|NCT00903630|fallopian tube cancer|fallopian tube cancer
683611|NCT00903630|peritoneal cavity cancer|peritoneal cavity cancer
683612|NCT00903643|Painful Bladder Syndrome|painful bladder syndrome
683613|NCT00903643|Urinary Bladder|urinary bladder
683614|NCT00903656|metastatic breast cancer|metastatic breast cancer
683615|NCT00903656|Her2|her2
683616|NCT00903656|Lapatinib|lapatinib
683617|NCT00903656|Caelyx|caelyx
683618|NCT00903656|cardiotoxic|cardiotoxic
683619|NCT00903669|Facial paralysis|facial paralysis
683620|NCT00903669|Muscle tonus|muscle tonus
683621|NCT00903669|Rehabilitation|rehabilitation
683622|NCT00903669|Myofunctional|myofunctional
683623|NCT00903669|Stomatognathic system|stomatognathic system
683624|NCT00903682|HIV|hiv
683625|NCT00903682|Intelence|intelence
683626|NCT00903682|etravirine|etravirine
683627|NCT00903682|ETR|etr
683628|NCT00903682|TMC125|tmc125
683629|NCT00903682|Sustiva|sustiva
683630|NCT00903682|efavirenz|efavirenz
683631|NCT00903682|EFV|efv
683632|NCT00903682|Non-nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
683633|NCT00903682|NNRTI|nnrti
683634|NCT00903682|treatment-naive|treatment-naive
683635|NCT00903695|Memory XL|memory xl
683636|NCT00903695|Mild Cognitive Impairment|mild cognitive impairment
683637|NCT00903695|cognitive status|cognitive status
683638|NCT00903708|Advanced Cancers|advanced cancers
683639|NCT00903708|LY2275796|ly2275796
683640|NCT00903708|Eukaryotic initiation factor 4E|eukaryotic initiation factor 4e
683641|NCT00903708|eIF-4E|eif-4e
683642|NCT00903734|Metastatic Cancer|metastatic cancer
683643|NCT00903734|Histology-independent|histology-independent
683644|NCT00903734|EGFR Mutation|egfr mutation
683645|NCT00903734|EGFR inhibitor-sensitive mutation|egfr inhibitor-sensitive mutation
683646|NCT00903734|Erlotinib Hydrochloride|erlotinib hydrochloride
683647|NCT00903734|Tarceva|tarceva
683648|NCT00903734|OSI-774|osi-774
683652|NCT00903747|Prucalopride|prucalopride
683653|NCT00903747|safety study|safety study
683654|NCT00903760|Myelodysplastic Syndrome|myelodysplastic syndrome
683656|NCT00903760|Leukemia|leukemia
683657|NCT00903760|Decitabine|decitabine
683658|NCT00903760|clofarabine|clofarabine
683659|NCT00903760|Dacogen®|dacogen®
683660|NCT00903760|Clolar®|clolar®
683661|NCT00903773|VX-950-TiDP24-C132|vx-950-tidp24-c132
683662|NCT00903773|VX-950-C132|vx-950-c132
683663|NCT00903773|VX-950|vx-950
683664|NCT00903773|HCV|hcv
683665|NCT00903786|Seizure|seizure
683666|NCT00903786|epilepsy|epilepsy
683667|NCT00903799|Drug-refractory gastroparesis|drug-refractory gastroparesis
683668|NCT00903799|diabetes mellitus induced gastroparesis|diabetes mellitus induced gastroparesis
683669|NCT00903799|Gastric electrical stimulation|gastric electrical stimulation
683670|NCT00903799|Long-term multicenter study|long-term multicenter study
683671|NCT00903825|femoral artery puncture|femoral artery puncture
683672|NCT00903825|local anesthesia|local anesthesia
683673|NCT00903825|ultrasound guided|ultrasound guided
683674|NCT00903838|Parkinson's disease|parkinson's disease
683675|NCT00903903|active synovitis|active synovitis
683676|NCT00903916|antipsychotic|antipsychotic
683677|NCT00903916|ghrelin|ghrelin
683678|NCT00903916|PYY|pyy
683679|NCT00903916|appetite|appetite
683680|NCT00903916|weight gain|weight gain
683681|NCT00903955|Mucus|mucus
683682|NCT00903955|COPD|copd
683683|NCT00903955|Chronic Bronchitis|chronic bronchitis
683684|NCT00903968|refractory|refractory
683685|NCT00903968|relapsed|relapsed
683686|NCT00903968|bortezomib|bortezomib
683687|NCT00903968|AMD3100|amd3100
683690|NCT00904007|Educational Technology|educational technology
683691|NCT00904007|Hypertension|hypertension
683692|NCT00904007|Education, Professional|education, professional
683693|NCT00904046|Uric acid|uric acid
683694|NCT00904046|Nephrolithiasis|nephrolithiasis
683695|NCT00904072|CDSS|cdss
683696|NCT00904072|prescribing error|prescribing error
683697|NCT00904072|prescribing errors influenced by CDSS|prescribing errors influenced by cdss
683698|NCT00904072|CPOE|cpoe
683700|NCT00904124|Dietary fiber|dietary fiber
683701|NCT00904124|guar gum|guar gum
683702|NCT00904124|alginate|alginate
683703|NCT00904124|cellulose|cellulose
683704|NCT00904124|food intake|food intake
683705|NCT00904124|eating behaviour|eating behaviour
683706|NCT00904137|Supracondylar fracture|supracondylar fracture
683707|NCT00904137|humerus|humerus
683708|NCT00904137|elbow|elbow
683709|NCT00904150|menstruation|menstruation
683710|NCT00904150|migraine|migraine
683711|NCT00904150|menstrual migraine|menstrual migraine
683712|NCT00904150|genetics|genetics
683713|NCT00904228|hypothermia|hypothermia
683714|NCT00904228|euthermia|euthermia
683715|NCT00904228|hyperthermia|hyperthermia
683716|NCT00904228|mortality|mortality
683717|NCT00904228|morbidity|morbidity
683718|NCT00904228|sepsis|sepsis
683719|NCT00904228|bronchopulmonary dysplasia|bronchopulmonary dysplasia
683720|NCT00904228|intraventricular hemorrhage|intraventricular hemorrhage
683721|NCT00904228|ventilator days|ventilator days
683722|NCT00904254|cerebrovascular disorders|cerebrovascular disorders
683723|NCT00904254|symptomatic carotid artery stenosis|symptomatic carotid artery stenosis
683724|NCT00904254|asymptomatic carotid artery stenosis|asymptomatic carotid artery stenosis
683725|NCT00904254|monoclonal antibody|monoclonal antibody
683726|NCT00904254|diagnostics|diagnostics
683727|NCT00904254|molecular target|molecular target
683728|NCT00904254|immunoglobulin Fab fragments|immunoglobulin fab fragments
683729|NCT00904254|physiological effects of drugs|physiological effects of drugs
683730|NCT00904254|Tc99m-pertechnetate|tc99m-pertechnetate
683731|NCT00904254|Fab-fragment of Anti-human CD4|fab-fragment of anti-human cd4
683732|NCT00904254|Antibodies, Monoclonal|antibodies, monoclonal
683733|NCT00904254|Antibodies|antibodies
683734|NCT00904293|warfarin|warfarin
683735|NCT00904293|CYP2C9|cyp2c9
683736|NCT00904293|VKOR|vkor
683737|NCT00904293|Coumadin|coumadin
683738|NCT00904293|pharmacogenetics|pharmacogenetics
683739|NCT00904293|pharmacogenomics|pharmacogenomics
683740|NCT00904293|anticoagulation|anticoagulation
683741|NCT00904293|genotype-guided therapy|genotype-guided therapy
683742|NCT00904306|binge eating|binge eating
683743|NCT00904306|chromium|chromium
683744|NCT00904306|mood|mood
683745|NCT00904306|glucose|glucose
683746|NCT00904306|appetite|appetite
683747|NCT00904319|osteoarthritis|osteoarthritis
683748|NCT00904319|knee pain|knee pain
683749|NCT00904319|power training|power training
683750|NCT00904319|rehabilitation|rehabilitation
683751|NCT00904332|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
683752|NCT00904332|Electroencephalogram (EEG)|electroencephalogram (eeg)
683753|NCT00904332|Motor Learning|motor learning
683754|NCT00904332|Health Volunteer|health volunteer
683756|NCT00904345|SCC Head and Neck Cancer|scc head and neck cancer
683757|NCT00904358|internal jugular vein|internal jugular vein
683758|NCT00904358|cross sectional area|cross sectional area
683759|NCT00904358|ultrasound|ultrasound
683760|NCT00904358|central venous pressure|central venous pressure
683761|NCT00904384|HIV+|hiv+
683762|NCT00904384|COPD|copd
683763|NCT00904384|emphysema|emphysema
683764|NCT00904410|adenocarcinoma|adenocarcinoma
683765|NCT00904410|breast|breast
683766|NCT00904436|Tetraplegia|tetraplegia
683767|NCT00904436|Breathing Patterns|breathing patterns
683768|NCT00904436|Dyspnea|dyspnea
683769|NCT00904488|Acute Decompensated Heart Failure|acute decompensated heart failure
683770|NCT00904488|Diuretics|diuretics
683771|NCT00904501|Limb ischemia|limb ischemia
683772|NCT00904501|Cell Therapy|cell therapy
683773|NCT00904514|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
683774|NCT00904514|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
683775|NCT00904514|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
683776|NCT00904514|Waldenström macroglobulinemia|waldenström macroglobulinemia
683777|NCT00904514|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
683778|NCT00904514|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
683779|NCT00904514|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
683780|NCT00904514|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
683781|NCT00904514|refractory hairy cell leukemia|refractory hairy cell leukemia
683782|NCT00904514|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
683783|NCT00904514|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
683784|NCT00904514|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
683785|NCT00904514|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
683934|NCT00904787|Hematologic neoplasms|hematologic neoplasms
683786|NCT00904514|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
683787|NCT00904514|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
683938|NCT00904813|Preoperative radiotherapy|preoperative radiotherapy
683788|NCT00904514|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
683789|NCT00904514|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
683790|NCT00904514|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
683791|NCT00904514|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
683792|NCT00904514|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
683793|NCT00904514|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
683794|NCT00904514|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
683795|NCT00904514|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
683796|NCT00904514|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
683797|NCT00904514|prolymphocytic leukemia|prolymphocytic leukemia
683798|NCT00904514|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
683799|NCT00904514|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
683800|NCT00904514|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
683801|NCT00904514|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
683802|NCT00904514|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
683803|NCT00904514|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
683804|NCT00904514|splenic marginal zone lymphoma|splenic marginal zone lymphoma
683805|NCT00904514|stage IV colon cancer|stage iv colon cancer
683806|NCT00904514|stage IV breast cancer|stage iv breast cancer
683807|NCT00904514|recurrent breast cancer|recurrent breast cancer
683808|NCT00904514|stage IV gastric cancer|stage iv gastric cancer
683809|NCT00904514|recurrent gastric cancer|recurrent gastric cancer
683810|NCT00904514|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
683811|NCT00904514|recurrent pancreatic cancer|recurrent pancreatic cancer
683812|NCT00904514|recurrent colon cancer|recurrent colon cancer
683813|NCT00904514|stage IV esophageal cancer|stage iv esophageal cancer
683814|NCT00904514|recurrent esophageal cancer|recurrent esophageal cancer
683815|NCT00904514|recurrent bladder cancer|recurrent bladder cancer
683816|NCT00904514|stage IV bladder cancer|stage iv bladder cancer
683817|NCT00904514|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
683818|NCT00904514|epithelial mesothelioma|epithelial mesothelioma
683819|NCT00904514|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
683820|NCT00904514|recurrent salivary gland cancer|recurrent salivary gland cancer
683821|NCT00904514|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
683822|NCT00904514|stage III cervical cancer|stage iii cervical cancer
683823|NCT00904514|recurrent cervical cancer|recurrent cervical cancer
683824|NCT00904514|stage IVB cervical cancer|stage ivb cervical cancer
683825|NCT00904514|stage IVA cervical cancer|stage iva cervical cancer
683826|NCT00904514|squamous cell lung cancer|squamous cell lung cancer
683827|NCT00904514|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
683828|NCT00904514|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
683829|NCT00904514|advanced malignant mesothelioma|advanced malignant mesothelioma
683830|NCT00904514|recurrent malignant mesothelioma|recurrent malignant mesothelioma
683831|NCT00904514|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
683832|NCT00904514|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
683833|NCT00904514|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
683834|NCT00904514|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
683835|NCT00904514|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
683836|NCT00904514|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
683837|NCT00904514|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
683838|NCT00904514|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
683839|NCT00904514|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
683840|NCT00904514|cervical squamous cell carcinoma|cervical squamous cell carcinoma
683841|NCT00904514|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
683842|NCT00904514|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
683843|NCT00904514|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
683844|NCT00904514|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
683845|NCT00904514|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
683846|NCT00904514|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
683847|NCT00904514|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
683848|NCT00904514|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
683849|NCT00904514|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
683935|NCT00904800|Phase I|phase i
683850|NCT00904514|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
683851|NCT00904514|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
683939|NCT00904813|Timing of Surgery|timing of surgery
683852|NCT00904514|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
683853|NCT00904514|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
683854|NCT00904514|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
683855|NCT00904514|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
683856|NCT00904514|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
683857|NCT00904514|fallopian tube cancer|fallopian tube cancer
683858|NCT00904514|primary peritoneal cavity cancer|primary peritoneal cavity cancer
683859|NCT00904514|ovarian carcinosarcoma|ovarian carcinosarcoma
683860|NCT00904514|Brenner tumor|brenner tumor
683861|NCT00904514|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
683862|NCT00904514|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
683863|NCT00904514|stage III salivary gland cancer|stage iii salivary gland cancer
683864|NCT00904514|stage IV salivary gland cancer|stage iv salivary gland cancer
683865|NCT00904514|stage II pancreatic cancer|stage ii pancreatic cancer
683866|NCT00904514|stage III pancreatic cancer|stage iii pancreatic cancer
683867|NCT00904514|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
683868|NCT00904514|stage IV pancreatic cancer|stage iv pancreatic cancer
683869|NCT00904514|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
683870|NCT00904514|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
683871|NCT00904514|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
683872|NCT00904514|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
683873|NCT00904514|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
683874|NCT00904514|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
683875|NCT00904527|Relaxation (Schultz)|relaxation (schultz)
683876|NCT00904527|Migraine|migraine
683877|NCT00904527|antipain center|antipain center
683878|NCT00904553|Brain|brain
683879|NCT00904553|metastases|metastases
683880|NCT00904566|microarray|microarray
683881|NCT00904566|gene expression profiling|gene expression profiling
683882|NCT00904566|MammaPrint|mammaprint
683883|NCT00904566|breast cancer|breast cancer
683884|NCT00904579|Organ Transplants|organ transplants
683885|NCT00904579|Immunosuppression|immunosuppression
683886|NCT00904579|Cancer|cancer
683887|NCT00904579|End Stage Renal Disease|end stage renal disease
683888|NCT00904579|ESRD|esrd
683889|NCT00904579|Cancer Risk|cancer risk
683890|NCT00904592|diabetic retinopathy|diabetic retinopathy
683891|NCT00904592|traditional chinese medicine|traditional chinese medicine
683892|NCT00904618|Suburethral slings|suburethral slings
683893|NCT00904618|Urethra|urethra
683894|NCT00904618|Urinary incontinence|urinary incontinence
683895|NCT00904618|Urinary stress incontinence|urinary stress incontinence
683897|NCT00904644|antiretroviral treatment|antiretroviral treatment
683898|NCT00904644|Swiss HIV Cohort Study|swiss hiv cohort study
683899|NCT00904644|drug resistance|drug resistance
683900|NCT00904644|integrase inhibitor|integrase inhibitor
683901|NCT00904644|Treatment|treatment
683902|NCT00904657|pharmacokinetic/pharmacodynamic modeling|pharmacokinetic/pharmacodynamic modeling
683903|NCT00904657|biomarkers (growth factors) as a possible tool of drug effect|biomarkers (growth factors) as a possible tool of drug effect
683904|NCT00904670|Hyperactivity Attention Deficit Disorder|hyperactivity attention deficit disorder
683906|NCT00904670|Pediatric Patients|pediatric patients
683907|NCT00904670|Quillivant|quillivant
683908|NCT00904670|methylphenidate|methylphenidate
683909|NCT00904696|Irritable bowel syndrome|irritable bowel syndrome
683910|NCT00904696|probiotics|probiotics
683911|NCT00904722|Follicular lymphoma|follicular lymphoma
683912|NCT00904722|Immunotherapy|immunotherapy
683913|NCT00904722|CT-011|ct-011
683914|NCT00904722|Monoclonal Antibody CT-011|monoclonal antibody ct-011
683915|NCT00904722|Rituximab|rituximab
683916|NCT00904722|Rituxan|rituxan
683917|NCT00904735|adult grade I meningioma|adult grade i meningioma
683918|NCT00904735|adult grade II meningioma|adult grade ii meningioma
683919|NCT00904735|adult anaplastic meningioma|adult anaplastic meningioma
683920|NCT00904735|adult papillary meningioma|adult papillary meningioma
683921|NCT00904735|recurrent adult brain tumor|recurrent adult brain tumor
683922|NCT00904748|Sildenafil|sildenafil
683923|NCT00904748|Bio-equivalence|bio-equivalence
683924|NCT00904761|diabetes mellitus|diabetes mellitus
683925|NCT00904761|autonomic neuropathy|autonomic neuropathy
683926|NCT00904761|exercise training|exercise training
683927|NCT00904761|exercise capacity|exercise capacity
683928|NCT00904761|heart rate variability|heart rate variability
683929|NCT00904774|bronchopulmonary dysplasia|bronchopulmonary dysplasia
683930|NCT00904774|neonates|neonates
683931|NCT00904774|lung development|lung development
683936|NCT00904800|Healthy volunteers|healthy volunteers
683937|NCT00904813|Rectal cancer|rectal cancer
683942|NCT00904826|Devic's disease|devic's disease
683943|NCT00904826|Neuromyelitis optica|neuromyelitis optica
683945|NCT00904826|Aquaporin-4 antibody|aquaporin-4 antibody
683946|NCT00904826|Eculizumab|eculizumab
683947|NCT00904826|Complement|complement
683948|NCT00904865|Single port access|single port access
683949|NCT00904865|Laparoscopy|laparoscopy
683950|NCT00904865|cholecystectomy|cholecystectomy
683951|NCT00904865|cholangiography|cholangiography
683952|NCT00904865|cosmesis|cosmesis
683953|NCT00904878|pregnant IBD patients|pregnant ibd patients
683954|NCT00904891|Adolescents|adolescents
683955|NCT00904891|Prevention|prevention
683956|NCT00904891|Bibliotherapy|bibliotherapy
683957|NCT00904917|African American Mothers|african american mothers
683958|NCT00904917|Children|children
683959|NCT00904917|African American Families|african american families
683960|NCT00904917|Parental Depression|parental depression
683961|NCT00904917|Preventive Intervention|preventive intervention
683962|NCT00904930|Tooth mobility assessment|tooth mobility assessment
683963|NCT00904930|Splinting|splinting
683964|NCT00904930|Splint Rigidity|splint rigidity
683965|NCT00904943|Bioequivalence|bioequivalence
683966|NCT00904943|Healthy Subjects|healthy subjects
683967|NCT00904956|Latent Tuberculosis Infection|latent tuberculosis infection
683968|NCT00904956|High Resolution Scanners|high resolution scanners
683969|NCT00904956|Dynamic Hypothesis of Latent Tuberculosis Infection|dynamic hypothesis of latent tuberculosis infection
683970|NCT00904969|Urinary Incontinence, Stress|urinary incontinence, stress
683971|NCT00904969|Intrinsic sphincter deficiency|intrinsic sphincter deficiency
683972|NCT00904969|Secondary|secondary
683973|NCT00904969|TUR|tur
683974|NCT00904969|TURP|turp
683975|NCT00904969|Radical prostatectomy|radical prostatectomy
683976|NCT00904969|Open prostatectomy|open prostatectomy
683977|NCT00904969|Post-suprapubic prostatectomy|post-suprapubic prostatectomy
683978|NCT00904982|warfarin|warfarin
683979|NCT00904982|coumadin|coumadin
683980|NCT00904982|adherence|adherence
683981|NCT00904982|mechanical heart valves|mechanical heart valves
683982|NCT00904995|Leukemia|leukemia
683983|NCT00904995|Cancer of the blood|cancer of the blood
683984|NCT00904995|Cancer of the bone marrow|cancer of the bone marrow
683985|NCT00904995|Hematologic malignancy|hematologic malignancy
683986|NCT00904995|Invasive fungal infection|invasive fungal infection
683987|NCT00904995|Voriconazole|voriconazole
683988|NCT00904995|Vfend|vfend
683989|NCT00904995|antifungal prophylaxis|antifungal prophylaxis
683990|NCT00905008|drug-eluting stent|drug-eluting stent
683991|NCT00905008|bare-metal stent|bare-metal stent
683992|NCT00905008|long-term safety|long-term safety
683993|NCT00905008|mortality|mortality
683994|NCT00905008|stent thrombosis|stent thrombosis
683995|NCT00905008|Angioplasty|angioplasty
683996|NCT00905008|Transluminal|transluminal
683997|NCT00905008|Percutaneous Coronary|percutaneous coronary
683998|NCT00905021|Breast Cancer|breast cancer
683999|NCT00905021|Metastatic|metastatic
684000|NCT00905021|Hormone Receptor Positive|hormone receptor positive
684001|NCT00905034|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
684003|NCT00905034|Leukemia|leukemia
684004|NCT00905034|Methotrexate|methotrexate
684005|NCT00905034|Vincristine|vincristine
684006|NCT00905034|PEG-l-asparaginase|peg-l-asparaginase
684007|NCT00905034|PEG asparaginase|peg asparaginase
684008|NCT00905034|Pegaspargase|pegaspargase
684009|NCT00905034|Oncaspar|oncaspar
684010|NCT00905034|Polyethylene Glycol Conjugated Lasparaginase-H|polyethylene glycol conjugated lasparaginase-h
684011|NCT00905034|Dexamethasone|dexamethasone
684012|NCT00905034|Decadron|decadron
684013|NCT00905034|Rituximab|rituximab
684014|NCT00905034|Rituxan|rituxan
684015|NCT00905047|colo-rectal cancer|colo-rectal cancer
684016|NCT00905047|advanced|advanced
684017|NCT00905047|metastatic|metastatic
684018|NCT00905047|locally advanced or metastatic colo-rectal cancer|locally advanced or metastatic colo-rectal cancer
684019|NCT00905060|Newly Diagnosed Glioblastoma Multiforme, vaccine|newly diagnosed glioblastoma multiforme, vaccine
684020|NCT00905073|type 1 diabetes mellitus|type 1 diabetes mellitus
684021|NCT00905073|cyclosporin|cyclosporin
684022|NCT00905073|methotrexate|methotrexate
684023|NCT00905073|renal function|renal function
684024|NCT00905086|cognitive/functional effects|cognitive/functional effects
684025|NCT00905086|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
684026|NCT00905086|stage I breast cancer|stage i breast cancer
684027|NCT00905086|stage II breast cancer|stage ii breast cancer
684028|NCT00905086|stage IIIA breast cancer|stage iiia breast cancer
684029|NCT00905086|stage IIIB breast cancer|stage iiib breast cancer
684030|NCT00905086|stage IIIC breast cancer|stage iiic breast cancer
684031|NCT00905086|stage I colon cancer|stage i colon cancer
684032|NCT00905086|stage II colon cancer|stage ii colon cancer
684033|NCT00905086|stage III colon cancer|stage iii colon cancer
684034|NCT00905086|stage I rectal cancer|stage i rectal cancer
684035|NCT00905086|stage II rectal cancer|stage ii rectal cancer
684036|NCT00905086|stage III rectal cancer|stage iii rectal cancer
684037|NCT00905086|stage I non-small cell lung cancer|stage i non-small cell lung cancer
684038|NCT00905086|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
684039|NCT00905086|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
684040|NCT00905086|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
684041|NCT00905086|stage I prostate cancer|stage i prostate cancer
684042|NCT00905086|stage II prostate cancer|stage ii prostate cancer
684043|NCT00905086|stage III prostate cancer|stage iii prostate cancer
684044|NCT00905086|extensive stage small cell lung cancer|extensive stage small cell lung cancer
684045|NCT00905086|limited stage small cell lung cancer|limited stage small cell lung cancer
684046|NCT00905112|Pregnancy|pregnancy
684047|NCT00905112|Pain|pain
684048|NCT00905112|Musculoskeletal manipulations|musculoskeletal manipulations
684049|NCT00905112|Exercise|exercise
684050|NCT00905125|influenza, trivalent, vaccine, pregnant women|influenza, trivalent, vaccine, pregnant women
684051|NCT00905138|Safety|safety
684052|NCT00905138|Tolerability|tolerability
684053|NCT00905138|Pharmacokinetics|pharmacokinetics
684054|NCT00905151|HIV positive|hiv positive
684055|NCT00905151|AIDS|aids
684056|NCT00905151|antiretroviral|antiretroviral
684057|NCT00905151|Kidney disease|kidney disease
684058|NCT00905151|Antiretroviral Therapy|antiretroviral therapy
684059|NCT00898417|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
684060|NCT00898417|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
684061|NCT00898417|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
684062|NCT00898417|adenocarcinoma of the lung|adenocarcinoma of the lung
684063|NCT00898417|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
684064|NCT00898430|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
684065|NCT00898430|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
684066|NCT00898430|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
684067|NCT00898430|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
684068|NCT00898430|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
684069|NCT00898430|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
684070|NCT00898430|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
684071|NCT00898430|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
684072|NCT00898430|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
684073|NCT00898430|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
684074|NCT00898430|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
684075|NCT00898430|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
684076|NCT00898430|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
684077|NCT00898430|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
684078|NCT00898430|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
684079|NCT00898430|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
684080|NCT00898430|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
684081|NCT00898430|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
684082|NCT00898430|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
684083|NCT00898430|stage III salivary gland cancer|stage iii salivary gland cancer
684084|NCT00898430|stage IV salivary gland cancer|stage iv salivary gland cancer
684085|NCT00898456|adult acute myeloid leukemia|adult acute myeloid leukemia
684086|NCT00898456|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
684087|NCT00898456|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
684088|NCT00898456|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
684089|NCT00898456|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
684090|NCT00898456|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
684091|NCT00898456|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
684092|NCT00898456|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
684093|NCT00898456|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
684094|NCT00898456|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
684095|NCT00898456|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
684096|NCT00898456|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
684097|NCT00898456|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
684098|NCT00898456|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
684099|NCT00898456|adult acute basophilic leukemia|adult acute basophilic leukemia
684100|NCT00898456|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
684101|NCT00898469|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
684709|NCT00908011|Ezetimibe|ezetimibe
684102|NCT00898482|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
685014|NCT00909285|Alzheimer|alzheimer
684103|NCT00898482|recurrent pancreatic cancer|recurrent pancreatic cancer
684104|NCT00898482|stage I pancreatic cancer|stage i pancreatic cancer
684105|NCT00898482|stage II pancreatic cancer|stage ii pancreatic cancer
684106|NCT00898482|stage III pancreatic cancer|stage iii pancreatic cancer
684107|NCT00898482|stage IV pancreatic cancer|stage iv pancreatic cancer
684108|NCT00898495|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
684109|NCT00898495|stage II esophageal cancer|stage ii esophageal cancer
684110|NCT00898495|stage III esophageal cancer|stage iii esophageal cancer
684111|NCT00898495|stage IV esophageal cancer|stage iv esophageal cancer
684112|NCT00898495|stage I esophageal cancer|stage i esophageal cancer
684113|NCT00898508|invasive ductal breast carcinoma|invasive ductal breast carcinoma
684114|NCT00898508|invasive lobular breast carcinoma|invasive lobular breast carcinoma
684115|NCT00898508|ductal breast carcinoma in situ|ductal breast carcinoma in situ
684116|NCT00898508|lobular breast carcinoma in situ|lobular breast carcinoma in situ
684117|NCT00898508|stage I breast cancer|stage i breast cancer
684118|NCT00898508|stage II breast cancer|stage ii breast cancer
684119|NCT00898508|stage IIIA breast cancer|stage iiia breast cancer
684120|NCT00898508|stage IIIB breast cancer|stage iiib breast cancer
684121|NCT00898508|stage IIIC breast cancer|stage iiic breast cancer
684122|NCT00898508|stage IV breast cancer|stage iv breast cancer
684123|NCT00898534|Pediatrics|pediatrics
684124|NCT00898534|Hemoglobin A1c|hemoglobin a1c
684125|NCT00898534|Point of Care testing|point of care testing
684126|NCT00898547|advanced malignant mesothelioma|advanced malignant mesothelioma
684127|NCT00898547|recurrent malignant mesothelioma|recurrent malignant mesothelioma
684128|NCT00898547|epithelial mesothelioma|epithelial mesothelioma
684129|NCT00898547|sarcomatous mesothelioma|sarcomatous mesothelioma
684130|NCT00898560|Partial|partial
684131|NCT00898560|Epilepsy|epilepsy
684132|NCT00898560|Eslicarbazepine acetate|eslicarbazepine acetate
684133|NCT00898560|Combined oral contraceptive|combined oral contraceptive
684134|NCT00898560|Pharmacokinetics|pharmacokinetics
684135|NCT00898560|Tolerability|tolerability
684136|NCT00898573|breast cancer|breast cancer
684137|NCT00898612|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
684138|NCT00898612|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
684139|NCT00898612|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
684140|NCT00898612|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
753394|NCT01176474|stage IIIC melanoma|stage iiic melanoma
684141|NCT00898612|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
684142|NCT00898612|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
684143|NCT00898612|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
684144|NCT00898612|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
684145|NCT00898612|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
684146|NCT00898612|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
684147|NCT00898612|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
684499|NCT00898755|extraocular retinoblastoma|extraocular retinoblastoma
684148|NCT00898612|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
684149|NCT00898612|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
684150|NCT00898612|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
684151|NCT00898612|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
684152|NCT00898612|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
684153|NCT00898612|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
684154|NCT00898612|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
684155|NCT00898612|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
684156|NCT00898612|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
684157|NCT00898612|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
684158|NCT00898612|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
684159|NCT00898612|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
684160|NCT00898612|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
684161|NCT00898612|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
684162|NCT00898612|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
684163|NCT00898612|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
684164|NCT00898612|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
684165|NCT00898612|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
684166|NCT00898612|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
684167|NCT00898612|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
684168|NCT00898612|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
684169|NCT00898612|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
684170|NCT00898612|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
684171|NCT00898612|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
751852|NCT01170819|Mechanical methods|mechanical methods
684172|NCT00898612|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
684173|NCT00898612|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
684625|NCT00907543|Radiotherapy|radiotherapy
684174|NCT00898612|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
684175|NCT00898612|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
684176|NCT00898612|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
684177|NCT00898612|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
684178|NCT00898612|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
684179|NCT00898612|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
684180|NCT00898612|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
684181|NCT00898612|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
684182|NCT00898612|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
684183|NCT00898612|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
684184|NCT00898612|splenic marginal zone lymphoma|splenic marginal zone lymphoma
684185|NCT00898612|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
684186|NCT00898612|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
684187|NCT00898612|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
684188|NCT00898612|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
684189|NCT00898612|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
684190|NCT00898612|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
684191|NCT00898612|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
684192|NCT00898612|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
684193|NCT00898612|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
684194|NCT00898612|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
684195|NCT00898612|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
684196|NCT00898612|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
684197|NCT00898612|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
684198|NCT00898612|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
684199|NCT00898612|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
684200|NCT00898612|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
684201|NCT00898612|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
684202|NCT00898612|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
684203|NCT00898612|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
684204|NCT00898612|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
684205|NCT00898612|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
684206|NCT00898612|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
684207|NCT00898612|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
684208|NCT00898612|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
684209|NCT00898612|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
684210|NCT00898612|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
684211|NCT00898612|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
684212|NCT00898612|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
684213|NCT00898612|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
684214|NCT00898612|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
684215|NCT00898612|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
684216|NCT00898612|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
684217|NCT00898612|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
684218|NCT00898612|refractory hairy cell leukemia|refractory hairy cell leukemia
684219|NCT00898612|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
684220|NCT00898612|secondary acute myeloid leukemia|secondary acute myeloid leukemia
684221|NCT00898612|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
684222|NCT00898612|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
684223|NCT00898612|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
684224|NCT00898612|chronic eosinophilic leukemia|chronic eosinophilic leukemia
684225|NCT00898612|primary myelofibrosis|primary myelofibrosis
684226|NCT00898612|chronic neutrophilic leukemia|chronic neutrophilic leukemia
684227|NCT00898612|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
684228|NCT00898612|disseminated neuroblastoma|disseminated neuroblastoma
684229|NCT00898612|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
751853|NCT01170819|Balloon catheter|balloon catheter
684230|NCT00898612|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
684231|NCT00898612|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
684232|NCT00898612|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
684233|NCT00898612|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
684234|NCT00898612|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
684235|NCT00898612|recurrent neuroblastoma|recurrent neuroblastoma
684236|NCT00898612|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
684237|NCT00898612|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
684238|NCT00898612|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
684239|NCT00898612|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
684240|NCT00898612|stage I multiple myeloma|stage i multiple myeloma
684241|NCT00898612|stage II multiple myeloma|stage ii multiple myeloma
684242|NCT00898612|stage III multiple myeloma|stage iii multiple myeloma
684243|NCT00898612|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
684244|NCT00898612|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
684245|NCT00898612|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
684246|NCT00898612|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
684247|NCT00898612|stage IIIA breast cancer|stage iiia breast cancer
684248|NCT00898612|stage IIIB breast cancer|stage iiib breast cancer
684249|NCT00898612|stage IIIC breast cancer|stage iiic breast cancer
684250|NCT00898612|stage IV breast cancer|stage iv breast cancer
684251|NCT00898612|refractory multiple myeloma|refractory multiple myeloma
684252|NCT00898638|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
684253|NCT00898638|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
684254|NCT00898638|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
684255|NCT00898638|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
684256|NCT00898638|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
684257|NCT00898638|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
684258|NCT00898638|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
684259|NCT00898638|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
684260|NCT00898638|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
684261|NCT00898638|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
684262|NCT00898638|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
684263|NCT00898638|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
684264|NCT00898638|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
684265|NCT00898638|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
684266|NCT00898638|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
684267|NCT00898638|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
684268|NCT00898638|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
684269|NCT00898638|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
684270|NCT00898638|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
684271|NCT00898638|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
684272|NCT00898638|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
684273|NCT00898638|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
684274|NCT00898638|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
684275|NCT00898638|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
684276|NCT00898638|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
684277|NCT00898638|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
684278|NCT00898638|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
684279|NCT00898638|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
684280|NCT00898638|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
684281|NCT00898638|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
684282|NCT00898638|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
684283|NCT00898638|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
684284|NCT00898638|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
684285|NCT00898638|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
684286|NCT00898638|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
684287|NCT00898638|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
684288|NCT00898638|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
684289|NCT00898638|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
684290|NCT00898638|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
684291|NCT00898638|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
684292|NCT00898638|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
684626|NCT00907569|Small cell lung cancer|small cell lung cancer
684293|NCT00898638|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
684294|NCT00898638|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
684295|NCT00898638|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
684296|NCT00898638|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
684297|NCT00898638|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
684298|NCT00898638|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
684299|NCT00898638|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
684300|NCT00898638|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
684301|NCT00898638|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
684302|NCT00898638|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
684303|NCT00898638|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
684384|NCT00898690|stage IV breast cancer|stage iv breast cancer
684304|NCT00898638|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
684305|NCT00898638|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
684306|NCT00898638|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
684307|NCT00898638|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
684308|NCT00898638|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
684309|NCT00898638|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
684310|NCT00898638|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
684311|NCT00898638|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
684312|NCT00898638|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
753600|NCT01176825|high risk behaviors|high risk behaviors
684313|NCT00898638|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
684314|NCT00898638|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
684315|NCT00898638|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
684316|NCT00898638|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
684317|NCT00898638|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
684318|NCT00898638|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
684319|NCT00898638|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
684320|NCT00898638|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
684321|NCT00898638|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
684322|NCT00898638|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
684585|NCT00905333|Atacand®|atacand®
684323|NCT00898638|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
684324|NCT00898638|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
684325|NCT00898638|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
684326|NCT00898638|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
684327|NCT00898638|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
684328|NCT00898638|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
684329|NCT00898638|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
684330|NCT00898638|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
684331|NCT00898638|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
684332|NCT00898638|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
684333|NCT00898638|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
684334|NCT00898638|stage I salivary gland cancer|stage i salivary gland cancer
686703|NCT00918697|PRK|prk
684335|NCT00898638|stage II salivary gland cancer|stage ii salivary gland cancer
684336|NCT00898638|stage III salivary gland cancer|stage iii salivary gland cancer
684337|NCT00898638|stage IV salivary gland cancer|stage iv salivary gland cancer
684338|NCT00898638|recurrent salivary gland cancer|recurrent salivary gland cancer
684339|NCT00898638|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
684340|NCT00898664|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
684341|NCT00898664|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
684459|NCT00898755|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
684342|NCT00898664|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
684343|NCT00898664|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
684344|NCT00898664|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
684345|NCT00898664|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
684346|NCT00898664|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
684347|NCT00898664|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
684348|NCT00898664|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
684349|NCT00898664|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
684350|NCT00898664|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
684351|NCT00898664|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
684352|NCT00898664|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
684353|NCT00898664|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
684354|NCT00898664|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
684355|NCT00898664|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
684356|NCT00898664|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
684357|NCT00898664|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
684358|NCT00898664|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
685818|NCT00914576|Retina|retina
684359|NCT00898664|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
684360|NCT00898664|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
684361|NCT00898664|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
684362|NCT00898664|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
684363|NCT00898664|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
684364|NCT00898664|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
684365|NCT00898664|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
684366|NCT00898664|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
684367|NCT00898664|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
684368|NCT00898664|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
684369|NCT00898664|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
684370|NCT00898664|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
684371|NCT00898664|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
684372|NCT00898664|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
684586|NCT00905333|Splendil®|splendil®
684373|NCT00898664|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
684374|NCT00898664|stage I salivary gland cancer|stage i salivary gland cancer
684375|NCT00898664|stage II salivary gland cancer|stage ii salivary gland cancer
684376|NCT00898664|stage III salivary gland cancer|stage iii salivary gland cancer
684377|NCT00898664|stage IV salivary gland cancer|stage iv salivary gland cancer
684378|NCT00898664|recurrent salivary gland cancer|recurrent salivary gland cancer
684379|NCT00898690|stage I breast cancer|stage i breast cancer
684380|NCT00898690|stage II breast cancer|stage ii breast cancer
684381|NCT00898690|stage IIIA breast cancer|stage iiia breast cancer
684382|NCT00898690|stage IIIB breast cancer|stage iiib breast cancer
684383|NCT00898690|stage IIIC breast cancer|stage iiic breast cancer
684385|NCT00898690|recurrent breast cancer|recurrent breast cancer
684386|NCT00898703|breast cancer|breast cancer
684387|NCT00898742|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
684388|NCT00898742|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
684389|NCT00898742|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
751854|NCT01170845|Esophagectomy|esophagectomy
684390|NCT00898742|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
684391|NCT00898742|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
684392|NCT00898742|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
684393|NCT00898742|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
684394|NCT00898742|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
684395|NCT00898742|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
684396|NCT00898742|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
684397|NCT00898742|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
684624|NCT00907543|Clinical Trial|clinical trial
684398|NCT00898742|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
684399|NCT00898742|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
684400|NCT00898742|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
684401|NCT00898742|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
684402|NCT00898742|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
684403|NCT00898742|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
684404|NCT00898742|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
684405|NCT00898742|recurrent salivary gland cancer|recurrent salivary gland cancer
684406|NCT00898742|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
684407|NCT00898742|stage IV salivary gland cancer|stage iv salivary gland cancer
684408|NCT00898755|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
684409|NCT00898755|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
684410|NCT00898755|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
684411|NCT00898755|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
684412|NCT00898755|childhood choroid plexus tumor|childhood choroid plexus tumor
684413|NCT00898755|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
684414|NCT00898755|childhood craniopharyngioma|childhood craniopharyngioma
684415|NCT00898755|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
684416|NCT00898755|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
684417|NCT00898755|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
684418|NCT00898755|childhood infratentorial ependymoma|childhood infratentorial ependymoma
684419|NCT00898755|childhood teratoma|childhood teratoma
684420|NCT00898755|childhood grade I meningioma|childhood grade i meningioma
684421|NCT00898755|childhood grade II meningioma|childhood grade ii meningioma
684422|NCT00898755|childhood grade III meningioma|childhood grade iii meningioma
684423|NCT00898755|childhood supratentorial ependymoma|childhood supratentorial ependymoma
684424|NCT00898755|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
684425|NCT00898755|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
684426|NCT00898755|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
684427|NCT00898755|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
684428|NCT00898755|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
684429|NCT00898755|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
684430|NCT00898755|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
684431|NCT00898755|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
684432|NCT00898755|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
684433|NCT00898755|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
684434|NCT00898755|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
684435|NCT00898755|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
684436|NCT00898755|recurrent childhood ependymoma|recurrent childhood ependymoma
684437|NCT00898755|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
684438|NCT00898755|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
684439|NCT00898755|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
684440|NCT00898755|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
684441|NCT00898755|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
684442|NCT00898755|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
684443|NCT00898755|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
684444|NCT00898755|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
684445|NCT00898755|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
684446|NCT00898755|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
684447|NCT00898755|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
684448|NCT00898755|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
684449|NCT00898755|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
684450|NCT00898755|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
684451|NCT00898755|stage I childhood liver cancer|stage i childhood liver cancer
684452|NCT00898755|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
684710|NCT00908011|Statin|statin
684453|NCT00898755|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
684454|NCT00898755|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
684455|NCT00898755|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
684456|NCT00898755|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
684457|NCT00898755|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
684458|NCT00898755|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
684460|NCT00898755|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
684461|NCT00898755|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
684462|NCT00898755|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
684463|NCT00898755|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
684464|NCT00898755|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
684465|NCT00898755|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
684466|NCT00898755|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
684467|NCT00898755|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
684468|NCT00898755|untreated childhood brain stem glioma|untreated childhood brain stem glioma
684469|NCT00898755|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
684470|NCT00898755|untreated childhood medulloblastoma|untreated childhood medulloblastoma
684471|NCT00898755|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
684472|NCT00898755|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
684473|NCT00898755|childhood hepatoblastoma|childhood hepatoblastoma
684474|NCT00898755|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
752573|NCT01167738|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
684475|NCT00898755|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
684476|NCT00898755|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
684477|NCT00898755|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
684478|NCT00898755|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
684479|NCT00898755|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
684480|NCT00898755|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
684481|NCT00898755|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
684482|NCT00898755|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
684483|NCT00898755|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
684484|NCT00898755|childhood Burkitt lymphoma|childhood burkitt lymphoma
684485|NCT00898755|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
684486|NCT00898755|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
684487|NCT00898755|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
684488|NCT00898755|disseminated neuroblastoma|disseminated neuroblastoma
684489|NCT00898755|localized resectable neuroblastoma|localized resectable neuroblastoma
684490|NCT00898755|localized unresectable neuroblastoma|localized unresectable neuroblastoma
684491|NCT00898755|recurrent neuroblastoma|recurrent neuroblastoma
684492|NCT00898755|regional neuroblastoma|regional neuroblastoma
684493|NCT00898755|stage 4S neuroblastoma|stage 4s neuroblastoma
684494|NCT00898755|childhood germ cell tumor|childhood germ cell tumor
684495|NCT00898755|recurrent childhood liver cancer|recurrent childhood liver cancer
684496|NCT00898755|localized osteosarcoma|localized osteosarcoma
684497|NCT00898755|metastatic osteosarcoma|metastatic osteosarcoma
684498|NCT00898755|recurrent osteosarcoma|recurrent osteosarcoma
684500|NCT00898755|intraocular retinoblastoma|intraocular retinoblastoma
684501|NCT00898755|recurrent retinoblastoma|recurrent retinoblastoma
684502|NCT00898755|stage I Wilms tumor|stage i wilms tumor
684503|NCT00898755|stage II Wilms tumor|stage ii wilms tumor
684504|NCT00898755|stage III Wilms tumor|stage iii wilms tumor
684505|NCT00898755|stage IV Wilms tumor|stage iv wilms tumor
684506|NCT00898755|stage II childhood liver cancer|stage ii childhood liver cancer
684507|NCT00898755|stage III childhood liver cancer|stage iii childhood liver cancer
684508|NCT00898755|stage IV childhood liver cancer|stage iv childhood liver cancer
684509|NCT00898755|unusual cancers of childhood|unusual cancers of childhood
684510|NCT00898755|stage V Wilms tumor|stage v wilms tumor
684511|NCT00898755|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
684512|NCT00898755|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
684513|NCT00898755|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
684514|NCT00898755|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
684515|NCT00898755|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
684516|NCT00898755|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
684517|NCT00898755|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
684518|NCT00898755|childhood central nervous system germinoma|childhood central nervous system germinoma
686675|NCT00918593|Cutaneous|cutaneous
684519|NCT00898755|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
684520|NCT00898755|childhood central nervous system teratoma|childhood central nervous system teratoma
684521|NCT00898755|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
684522|NCT00898768|Lynch syndrome|lynch syndrome
684524|NCT00898768|Capsule endoscopy|capsule endoscopy
684525|NCT00898768|Small bowel cancer|small bowel cancer
684526|NCT00898768|Double balloon endoscopy|double balloon endoscopy
684527|NCT00898781|male breast cancer|male breast cancer
684528|NCT00898781|stage IV breast cancer|stage iv breast cancer
684529|NCT00898781|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
684530|NCT00898781|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
684531|NCT00898781|stage IV pancreatic cancer|stage iv pancreatic cancer
684532|NCT00898781|stage IV colon cancer|stage iv colon cancer
684533|NCT00898781|ovarian sarcoma|ovarian sarcoma
684534|NCT00898794|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
684535|NCT00898794|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
684536|NCT00898807|neuropsychiatric symptoms|neuropsychiatric symptoms
684537|NCT00898807|aggression|aggression
684538|NCT00898807|mood lability|mood lability
684539|NCT00898820|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
684540|NCT00898820|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
684541|NCT00898820|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
684542|NCT00898833|recurrent prostate cancer|recurrent prostate cancer
684543|NCT00898833|stage III prostate cancer|stage iii prostate cancer
684544|NCT00898833|stage IV prostate cancer|stage iv prostate cancer
684545|NCT00898833|adenocarcinoma of the prostate|adenocarcinoma of the prostate
684546|NCT00905164|Bioequivalence|bioequivalence
684547|NCT00905164|Healthy Subjects|healthy subjects
684548|NCT00905177|Atrial Fibrillation|atrial fibrillation
684549|NCT00905177|deep vein thrombosis|deep vein thrombosis
684550|NCT00905177|anticoagulation|anticoagulation
684551|NCT00905177|warfarin|warfarin
684552|NCT00905177|coumadin|coumadin
684553|NCT00905203|Postmenopausal women|postmenopausal women
684554|NCT00905203|Diabetes|diabetes
684555|NCT00905203|Skin microcirculation|skin microcirculation
684556|NCT00905203|Exercise capacity|exercise capacity
684557|NCT00905203|Skeletal muscle oxygenation|skeletal muscle oxygenation
684558|NCT00905203|Dose-response relationship|dose-response relationship
684559|NCT00905203|postmenopausal diabetic women|postmenopausal diabetic women
684560|NCT00905216|heparin|heparin
684561|NCT00905229|hip fracture|hip fracture
684562|NCT00905229|warfarin|warfarin
684563|NCT00905229|vitamin k|vitamin k
684564|NCT00905229|Phytonadione|phytonadione
684565|NCT00905229|INR level|inr level
684566|NCT00905242|Kidney Transplantation|kidney transplantation
684567|NCT00905242|Gastrointestinal Agents|gastrointestinal agents
684568|NCT00905255|hyperglycemia|hyperglycemia
684569|NCT00905255|GLP-1|glp-1
684570|NCT00905268|FRDA|frda
684571|NCT00905268|idebenone|idebenone
684572|NCT00905268|FRDA disease|frda disease
684573|NCT00905281|Metastatic breast cancer|metastatic breast cancer
684574|NCT00905281|Supportive care|supportive care
684575|NCT00905281|Third or fourth line of chemotherapy|third or fourth line of chemotherapy
684576|NCT00905281|Quality of life|quality of life
684577|NCT00905281|Treatment preferences|treatment preferences
684578|NCT00905307|Schizophrenia|schizophrenia
684579|NCT00905307|Relapsed|relapsed
684580|NCT00905320|Hernia repair|hernia repair
684581|NCT00905333|pharmacokinetics|pharmacokinetics
684582|NCT00905333|candesartan|candesartan
684583|NCT00905333|felodipine|felodipine
684584|NCT00905333|test formulations|test formulations
684587|NCT00905333|healthy volunteers|healthy volunteers
684588|NCT00905333|blood samples|blood samples
684589|NCT00905333|after meal intake interaction|after meal intake interaction
684590|NCT00905333|Kinetic interaction amongst test formulations of Candesartan and Felodipine and the brands Atacand® and Splendil® in healthy volunteers after a fasting period.|kinetic interaction amongst test formulations of candesartan and felodipine and the brands atacand® and splendil® in healthy volunteers after a fasting period.
684591|NCT00905346|Bioequivalence|bioequivalence
684592|NCT00905346|Healthy Subjects|healthy subjects
684593|NCT00905385|nontypeable Haemophilus influenzae, NTHi|nontypeable haemophilus influenzae, nthi
684594|NCT00905398|Leukemia|leukemia
684595|NCT00905398|Lymphoblastic|lymphoblastic
684597|NCT00905398|Philadelphia|philadelphia
684598|NCT00905398|BCR-ABL|bcr-abl
684599|NCT00905398|Nilotinib|nilotinib
684600|NCT00905398|Treatment|treatment
684601|NCT00905411|Overweight|overweight
684602|NCT00905411|blood pressure|blood pressure
684603|NCT00905411|DASH diet|dash diet
684604|NCT00905411|Pacific|pacific
684605|NCT00905411|children|children
684606|NCT00905437|perioperative|perioperative
684607|NCT00905437|pregabalin|pregabalin
684608|NCT00905437|total hip replacement|total hip replacement
684609|NCT00905437|post-operative pain|post-operative pain
684610|NCT00905450|Surgery|surgery
684611|NCT00905463|Lung transplant candidates|lung transplant candidates
684804|NCT00908336|Carcinoma, Non-Small Cell|carcinoma, non-small cell
684612|NCT00905463|Health-related quality of life|health-related quality of life
684613|NCT00905463|patient reported outcome|patient reported outcome
684614|NCT00905463|Prognosis|prognosis
684615|NCT00905476|NPPV|nppv
684616|NCT00905476|Prognosis|prognosis
684617|NCT00905476|Health-related quality of life|health-related quality of life
684618|NCT00905476|Patient reported outcomes|patient reported outcomes
684619|NCT00907543|esophageal carcinoma|esophageal carcinoma
684620|NCT00907543|chemotherapy|chemotherapy
684621|NCT00907543|radiation|radiation
684622|NCT00907543|surgery|surgery
684623|NCT00907543|randomized clinical trial|randomized clinical trial
684627|NCT00907569|radiotherapy dose escalation|radiotherapy dose escalation
684628|NCT00907582|PCR negative|pcr negative
684629|NCT00907595|Huntington's chorea|huntington's chorea
684630|NCT00907595|Huntington's Disease|huntington's disease
684631|NCT00907595|Parkinson's Disease|parkinson's disease
684632|NCT00907595|Parkinsonism|parkinsonism
684633|NCT00907595|Dementia|dementia
684634|NCT00907595|Dementia with Lewy Bodies|dementia with lewy bodies
684635|NCT00907595|Actigraphy|actigraphy
684636|NCT00907595|Circadian dysregulation|circadian dysregulation
684637|NCT00907595|Sleep Disorders|sleep disorders
684638|NCT00907595|Circadian rhythm|circadian rhythm
684639|NCT00907621|Infant Colic|infant colic
684640|NCT00907621|Acupuncture|acupuncture
684641|NCT00907621|General Practice|general practice
684642|NCT00907634|cervix|cervix
684643|NCT00907634|cervical|cervical
684644|NCT00907634|radiation|radiation
684645|NCT00907660|Obesity|obesity
684646|NCT00907660|Weight loss|weight loss
684647|NCT00907660|Meal replacements|meal replacements
684648|NCT00907660|Health services research|health services research
684649|NCT00907686|Transfusion Transmitted Cytomegalovirus (TT-CMV)|transfusion transmitted cytomegalovirus (tt-cmv)
684650|NCT00907686|Low birthweight infants (LBWIs)|low birthweight infants (lbwis)
684651|NCT00907686|Leukoreduction and filter failure|leukoreduction and filter failure
684652|NCT00907686|CMV Seronegative blood products|cmv seronegative blood products
684653|NCT00907699|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
684654|NCT00907699|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
684655|NCT00907699|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
684656|NCT00907712|amputation|amputation
684657|NCT00907712|vascular|vascular
684658|NCT00907712|below knee|below knee
684659|NCT00907712|above knee|above knee
684660|NCT00907712|cardiovascular|cardiovascular
684661|NCT00907712|echo|echo
684662|NCT00907712|cardiovascular assessment|cardiovascular assessment
684663|NCT00907725|medical abortion|medical abortion
684664|NCT00907725|serum BhCG follow-up|serum bhcg follow-up
684665|NCT00907725|ultrasonographic follow-up|ultrasonographic follow-up
684666|NCT00907725|follow-up methods|follow-up methods
684667|NCT00907777|Haemophilus influenzae|haemophilus influenzae
684668|NCT00907777|Streptococcus pneumoniae|streptococcus pneumoniae
684669|NCT00907777|safety|safety
684670|NCT00907777|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
684671|NCT00907777|immunogenicity|immunogenicity
684672|NCT00907790|Irritable Bowel Syndrome|irritable bowel syndrome
684673|NCT00907790|Cognitive Therapy|cognitive therapy
684674|NCT00907790|Abdominal Pain|abdominal pain
684675|NCT00907790|Quality of Life|quality of life
684676|NCT00907803|Orthopoxvirus|orthopoxvirus
684677|NCT00907803|Smallpox|smallpox
684678|NCT00907803|This is a safety study only|this is a safety study only
684679|NCT00907803|ST-246 is being studied for treatment of Orthopoxviruses|st-246 is being studied for treatment of orthopoxviruses
684779|NCT00908232|dexamethasone|dexamethasone
684680|NCT00907816|this study does not look at patient conditions|this study does not look at patient conditions
684681|NCT00907829|stroke|stroke
684682|NCT00907829|fingertip force|fingertip force
684683|NCT00907829|muscle coordination|muscle coordination
684684|NCT00907842|stoma|stoma
684685|NCT00907855|Ischemic Heart Disease|ischemic heart disease
684686|NCT00907855|Duke Activity Status Index|duke activity status index
684687|NCT00907855|Stress Myocardial Perfusion Imaging|stress myocardial perfusion imaging
684688|NCT00907868|ductal breast carcinoma in situ|ductal breast carcinoma in situ
684689|NCT00907894|Chronic hepatitis B,|chronic hepatitis b,
684690|NCT00907894|telbivudine,|telbivudine,
684691|NCT00907894|pharmacokinetics,|pharmacokinetics,
684692|NCT00907894|safety,|safety,
684693|NCT00907894|tolerability,|tolerability,
684694|NCT00907894|pediatric|pediatric
684695|NCT00907907|Bioequivalence|bioequivalence
684696|NCT00907907|Subjects|subjects
684697|NCT00907946|Renal stones|renal stones
684698|NCT00907972|Parkinson's Disease|parkinson's disease
684699|NCT00907972|Parkinson Disease|parkinson disease
684701|NCT00907972|Movement Disorder|movement disorder
687092|NCT00920075|Fosamax|fosamax
684702|NCT00907985|Healthy Volunteer|healthy volunteer
684703|NCT00907985|Resting motor threshold (rMT)|resting motor threshold (rmt)
684704|NCT00907985|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
684705|NCT00907998|Coronary heart disease|coronary heart disease
684706|NCT00907998|APL180|apl180
684707|NCT00908011|Hypercholesterolemia|hypercholesterolemia
684711|NCT00908011|Apolipoprotein B100/Apolipoprotein A1 ratio|apolipoprotein b100/apolipoprotein a1 ratio
684712|NCT00908037|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
684713|NCT00908037|ITP|itp
684714|NCT00908037|pharmacokinetics|pharmacokinetics
684715|NCT00908037|chronic ITP|chronic itp
684716|NCT00908037|eltrombopag|eltrombopag
684717|NCT00908037|thrombocytopenia|thrombocytopenia
684718|NCT00908037|pharmacodynamics|pharmacodynamics
684719|NCT00908037|pediatrics|pediatrics
684720|NCT00908050|bruxism, botulinum toxin, sleep study|bruxism, botulinum toxin, sleep study
684721|NCT00908063|TBI|tbi
684722|NCT00908063|Traumatic Brain Injury|traumatic brain injury
684723|NCT00908076|constipation|constipation
684724|NCT00908076|Parkinson's disease|parkinson's disease
684725|NCT00908089|rheumatoid arthritis|rheumatoid arthritis
684726|NCT00908089|methotrexate|methotrexate
684727|NCT00908089|sulfasalazine|sulfasalazine
684728|NCT00908089|hydroxychloroquine|hydroxychloroquine
684729|NCT00908089|infliximab|infliximab
684730|NCT00908102|low back pain|low back pain
684731|NCT00908102|recurrent|recurrent
684732|NCT00908102|subacute|subacute
684733|NCT00908102|secondary prevention|secondary prevention
684734|NCT00908102|primary care|primary care
684735|NCT00908102|occupational health|occupational health
684736|NCT00908102|back book|back book
684737|NCT00908102|rehabilitation|rehabilitation
684738|NCT00908128|Bioequivalence|bioequivalence
684739|NCT00908128|Healthy Subjects|healthy subjects
684740|NCT00908141|adenocarcinoma of the prostate|adenocarcinoma of the prostate
684741|NCT00908141|recurrent prostate cancer|recurrent prostate cancer
684742|NCT00908154|sodium channel blocker|sodium channel blocker
684743|NCT00908154|bipolar disorder|bipolar disorder
684744|NCT00908154|repeat dose|repeat dose
684745|NCT00908167|sorafenib|sorafenib
684746|NCT00908167|cytarabine|cytarabine
684747|NCT00908167|clofarabine|clofarabine
684748|NCT00908167|acute myeloid leukemia|acute myeloid leukemia
684749|NCT00908167|acute promyelocytic leukemia|acute promyelocytic leukemia
684750|NCT00908167|acute lymphoblastic leukemia|acute lymphoblastic leukemia
684751|NCT00908180|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
684752|NCT00908193|Treatment of abdominal ruptured|treatment of abdominal ruptured
684753|NCT00908193|Digestive system disease|digestive system disease
684754|NCT00908193|Coelioscopy|coelioscopy
684755|NCT00908193|Assistance robotics|assistance robotics
684756|NCT00908193|Medical device|medical device
684757|NCT00908193|DA VINCI Robot|da vinci robot
684758|NCT00908193|Pain patient|pain patient
684759|NCT00908193|Morphine consumption|morphine consumption
684760|NCT00908193|Comparative Randomized study|comparative randomized study
684761|NCT00908193|patient over 18 years|patient over 18 years
684762|NCT00908193|with ruptured abdominal|with ruptured abdominal
684763|NCT00908193|with an indication of treatment of ruptured|with an indication of treatment of ruptured
684764|NCT00908206|Alcoholism|alcoholism
684765|NCT00908206|Craving|craving
684766|NCT00908206|Dependence|dependence
684767|NCT00908206|Alcohol|alcohol
684768|NCT00908219|malignant ascites|malignant ascites
684769|NCT00908219|bevacizumab|bevacizumab
684770|NCT00908219|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
684771|NCT00908219|paracentesis|paracentesis
684772|NCT00908232|multiple myeloma|multiple myeloma
684773|NCT00908232|bortezomib|bortezomib
684774|NCT00908232|hematology|hematology
684775|NCT00908232|bone marrow cancer|bone marrow cancer
684776|NCT00908232|immunoglobulin|immunoglobulin
684777|NCT00908232|refractory|refractory
684778|NCT00908232|progression|progression
684780|NCT00908232|lenalidomide|lenalidomide
684781|NCT00908232|cyclophosphamide|cyclophosphamide
684782|NCT00908245|Preconditioning|preconditioning
684783|NCT00908245|Hepatectomy|hepatectomy
684784|NCT00908245|Clamping|clamping
684785|NCT00908284|AIDS|aids
684786|NCT00908284|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
684787|NCT00908284|Human Immunodeficiency Virus|human immunodeficiency virus
684788|NCT00908284|Exercise Physiology|exercise physiology
684789|NCT00908284|Endothelial Dysfunction|endothelial dysfunction
684790|NCT00908297|Cardiovascular disease|cardiovascular disease
684791|NCT00908297|End stage renal disease|end stage renal disease
684792|NCT00908297|Atherosclerosis|atherosclerosis
684793|NCT00908297|Oxidative stress|oxidative stress
684794|NCT00908297|Antioxidants|antioxidants
684795|NCT00908310|CKD - Chronic Kidney Disease|ckd - chronic kidney disease
684796|NCT00908310|GBCA - Gadolinium-based contrast agent|gbca - gadolinium-based contrast agent
684797|NCT00908310|GFR - Glomerular Filtration Rate|gfr - glomerular filtration rate
684798|NCT00908310|MRI - Magnetic Resonance Imaging|mri - magnetic resonance imaging
684799|NCT00908310|NSF - Nephrogenic Systemic Fibrosis|nsf - nephrogenic systemic fibrosis
684800|NCT00908310|Known or suspected CKD with an eGFR greater than or equal to 30mL & less than 60 mL/min/1.73m2 as measured within 30 days prior to the OMNISCAN.|known or suspected ckd with an egfr greater than or equal to 30ml & less than 60 ml/min/1.73m2 as measured within 30 days prior to the omniscan.
684801|NCT00908323|HIV Seronegativity|hiv seronegativity
684802|NCT00908323|HIV Preventive Vaccine|hiv preventive vaccine
684803|NCT00908336|Adenocarcinoma|adenocarcinoma
684805|NCT00908336|Lung Neoplasms|lung neoplasms
684806|NCT00908336|Docetaxel|docetaxel
684807|NCT00908336|Erlotinib|erlotinib
684808|NCT00908336|Chemotherapy|chemotherapy
684809|NCT00908362|Dendritic cells|dendritic cells
684810|NCT00908362|Airway|airway
684811|NCT00908362|Smoker|smoker
684812|NCT00908362|COPD|copd
684813|NCT00908375|Pregabalin|pregabalin
684814|NCT00908375|Radicular pain|radicular pain
684815|NCT00908375|Failed back surgery|failed back surgery
684816|NCT00908375|Of greater than 3 months duration|of greater than 3 months duration
684817|NCT00908388|Acute, Complicated Type B Dissection|acute, complicated type b dissection
684818|NCT00908401|breastmilk|breastmilk
684819|NCT00908401|oral sucrose|oral sucrose
684820|NCT00908401|analgesia|analgesia
684821|NCT00908401|preterm neonates|preterm neonates
684822|NCT00908401|Neonates|neonates
684823|NCT00908414|PEPI-TiDP23-C104|pepi-tidp23-c104
684824|NCT00908414|PEPI-C104|pepi-c104
684825|NCT00908414|PEPI|pepi
684826|NCT00908414|TMC589337|tmc589337
684827|NCT00908414|TMC589354|tmc589354
684828|NCT00908414|TMC310911|tmc310911
684829|NCT00908414|Healthy Volunteers|healthy volunteers
684830|NCT00908427|benign prostatic hyperplasia|benign prostatic hyperplasia
684831|NCT00908427|KTP laser|ktp laser
684832|NCT00908427|transurethral resection of prostate|transurethral resection of prostate
684833|NCT00908427|urinary bladder neck obstruction|urinary bladder neck obstruction
684834|NCT00908440|Decision Aid|decision aid
684835|NCT00908440|Posttraumatic Stress Disorder|posttraumatic stress disorder
684836|NCT00908440|evidence-based treatments|evidence-based treatments
684837|NCT00908453|NPC-06|npc-06
684838|NCT00908453|fosphenytoin|fosphenytoin
684839|NCT00908453|phenytoin|phenytoin
684840|NCT00908453|pharmacokinetics|pharmacokinetics
684841|NCT00908453|safety|safety
684842|NCT00908466|Non-infectious|non-infectious
684843|NCT00908466|Uveitis|uveitis
684844|NCT00908466|Panuveitis|panuveitis
684845|NCT00908479|Exercise|exercise
684846|NCT00908479|Rehabilitation|rehabilitation
684847|NCT00908479|leg function|leg function
684848|NCT00908479|in patient|in patient
684849|NCT00908479|RCT|rct
684850|NCT00908492|Randomized control trial|randomized control trial
684851|NCT00908492|Dementia caregivers|dementia caregivers
684852|NCT00908492|Occupational Therapy|occupational therapy
684853|NCT00908492|Caregivers|caregivers
684854|NCT00908505|Cystic fibrosis|cystic fibrosis
684855|NCT00908505|physiotherapy|physiotherapy
684856|NCT00908505|pulmonary function test|pulmonary function test
684857|NCT00908518|Cognitive dysfunction|cognitive dysfunction
684858|NCT00908518|Cardiac morbidity|cardiac morbidity
684859|NCT00908518|anesthesia|anesthesia
684860|NCT00908531|Breast neoplasms|breast neoplasms
684861|NCT00908531|Randomised trial|randomised trial
684862|NCT00908531|Aromatase Inhibitors|aromatase inhibitors
684863|NCT00908531|Preoperative care|preoperative care
684864|NCT00908531|Age 60 or older|age 60 or older
684865|NCT00908531|Hormone receptor positive tumor|hormone receptor positive tumor
684866|NCT00908531|Tumor lager than 2 cm|tumor lager than 2 cm
684867|NCT00908531|No distant metastasis|no distant metastasis
684868|NCT00908544|HIV-infection|hiv-infection
684869|NCT00908544|Primary HIV-infection|primary hiv-infection
684870|NCT00908544|Proviral DNA|proviral dna
684871|NCT00908544|Eradication|eradication
684872|NCT00908544|Multi drug class HAART|multi drug class haart
684873|NCT00908557|Lexicosyntactic readability improvement|lexicosyntactic readability improvement
684874|NCT00908557|phase II/III trials|phase ii/iii trials
684876|NCT00908557|Informed consent|informed consent
684877|NCT00908570|estrogen|estrogen
684878|NCT00908570|estriol|estriol
684879|NCT00908570|cream|cream
684880|NCT00908570|vagina|vagina
684881|NCT00908570|infection prevention|infection prevention
684882|NCT00908583|Alloantibody|alloantibody
684883|NCT00908583|Desensitization|desensitization
684884|NCT00908583|Kidney Transplantation|kidney transplantation
684885|NCT00908583|Nephrology|nephrology
684886|NCT00908583|Plasma Cells|plasma cells
684887|NCT00908583|Translational Research/Science|translational research/science
684888|NCT00908596|Nephrogenic Systemic Fibrosis (NSF)|nephrogenic systemic fibrosis (nsf)
684889|NCT00908596|Primovist / Eovist|primovist / eovist
684890|NCT00908609|Breast Cancer Diagnosis|breast cancer diagnosis
684891|NCT00908609|Optical Imaging|optical imaging
684892|NCT00908609|Ultrasound Imaging|ultrasound imaging
684893|NCT00908609|Monitoring Neoadjuvant Chemotherapy Response|monitoring neoadjuvant chemotherapy response
752861|NCT01174524|Quality of life|quality of life
684894|NCT00908622|Percutaneous implantation of autologous myoblasts|percutaneous implantation of autologous myoblasts
684895|NCT00908635|sepsis|sepsis
684896|NCT00908635|organ failure|organ failure
684897|NCT00908648|screening colonoscopy|screening colonoscopy
684898|NCT00908648|narrow band imaging|narrow band imaging
684899|NCT00908661|Parastomal, hernia|parastomal, hernia
684900|NCT00908700|Atrial fibrillation|atrial fibrillation
684901|NCT00908700|Stroke|stroke
684902|NCT00908700|left atrial appendage|left atrial appendage
684903|NCT00908700|Re-exploration for bleeding|re-exploration for bleeding
684904|NCT00908713|Severe CAP|severe cap
684905|NCT00908713|Adjuvant therapy|adjuvant therapy
684906|NCT00908713|Glucocorticoids|glucocorticoids
684907|NCT00908713|CAP Fine V with C-reactive protein >= 15 mg/100 mL|cap fine v with c-reactive protein >= 15 mg/100 ml
684908|NCT00908739|stage I renal cell cancer|stage i renal cell cancer
684909|NCT00908739|stage III renal cell cancer|stage iii renal cell cancer
684910|NCT00908739|recurrent renal cell cancer|recurrent renal cell cancer
684911|NCT00908739|clear cell renal cell carcinoma|clear cell renal cell carcinoma
684912|NCT00908739|childhood renal cell carcinoma|childhood renal cell carcinoma
684913|NCT00908752|HCC|hcc
684914|NCT00908765|Exercise Training COPD|exercise training copd
684915|NCT00908778|Diabetic Retinopathy|diabetic retinopathy
684916|NCT00908791|Conjugated Linoleic Acid|conjugated linoleic acid
684917|NCT00908791|Proof of Principle|proof of principle
684918|NCT00908791|Lipogenic Pathway|lipogenic pathway
684919|NCT00908791|Clarinol|clarinol
684920|NCT00908804|acute appendicitis|acute appendicitis
684921|NCT00908817|postoperative sore throat|postoperative sore throat
684922|NCT00908817|tracheal intubation|tracheal intubation
684923|NCT00908817|lubrication|lubrication
684924|NCT00908817|triamcinolone|triamcinolone
684925|NCT00908843|Contrast nephropathy|contrast nephropathy
684926|NCT00908843|Renal failure|renal failure
684927|NCT00908856|stroke cell therapy repair autologous|stroke cell therapy repair autologous
684928|NCT00908869|advanced neoplasm|advanced neoplasm
684929|NCT00908869|adult advanced neoplasm|adult advanced neoplasm
684930|NCT00908882|Nursing Care|nursing care
684931|NCT00908882|Veterans|veterans
684932|NCT00908895|Radius fractures|radius fractures
684933|NCT00908895|Radio-radial fixator|radio-radial fixator
684934|NCT00908895|Percutaneous pinning|percutaneous pinning
684935|NCT00908895|Grip strength|grip strength
684936|NCT00908908|Advanced Solid Tumors|advanced solid tumors
684937|NCT00908908|Failure of Multiple Prior Chemotherapy Regimens|failure of multiple prior chemotherapy regimens
684938|NCT00908934|Relative Bioavailability|relative bioavailability
684939|NCT00908934|AZD9056|azd9056
684940|NCT00908947|SFA|sfa
684941|NCT00908947|Stent|stent
684942|NCT00908947|Popliteal|popliteal
684943|NCT00908947|infrainguinal|infrainguinal
684944|NCT00908947|LifeStent|lifestent
684945|NCT00908947|Peripheral|peripheral
684946|NCT00908947|Arterial|arterial
684947|NCT00908960|enoxaparin|enoxaparin
684948|NCT00908973|Obesity|obesity
684949|NCT00908973|Gastric bypass|gastric bypass
684950|NCT00908973|Gut hormone|gut hormone
684951|NCT00908973|Intestinal transit time|intestinal transit time
684952|NCT00908986|Lupus Membranous Nephritis|lupus membranous nephritis
684953|NCT00908999|anosognosia fMRI amnestic MCI Alzheimer|anosognosia fmri amnestic mci alzheimer
684954|NCT00908999|anosognosia in AD and MCI|anosognosia in ad and mci
684955|NCT00909012|phenylketonuria|phenylketonuria
684956|NCT00909012|docosahexaenoic acid|docosahexaenoic acid
684957|NCT00909012|visually evoked potential|visually evoked potential
684958|NCT00909012|choice-reaction time|choice-reaction time
684959|NCT00909051|Diabetes Mellitus|diabetes mellitus
684960|NCT00909077|ITP-Rituximab-dexamethasone|itp-rituximab-dexamethasone
684961|NCT00909090|macular pigment|macular pigment
684962|NCT00909090|glare disability|glare disability
684963|NCT00909090|lutein|lutein
684964|NCT00909090|photostress|photostress
684965|NCT00909103|Endoscopic Ultrasound Elastography|endoscopic ultrasound elastography
684966|NCT00909103|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
684967|NCT00909103|Chronic Pancreatitis|chronic pancreatitis
684968|NCT00909116|ODS|ods
684969|NCT00909116|chronic constipation|chronic constipation
684970|NCT00909116|internal rectal prolapse|internal rectal prolapse
684972|NCT00909116|Stapled Transanal Rectal Resection|stapled transanal rectal resection
684973|NCT00909116|Contour Transtar|contour transtar
684974|NCT00909116|STARR|starr
684975|NCT00909129|HIV-1|hiv-1
684976|NCT00909129|Chronic hepatitis C|chronic hepatitis c
684977|NCT00909129|Immune activation|immune activation
684978|NCT00909129|HCV kinetics|hcv kinetics
684979|NCT00909129|IP-10|ip-10
684980|NCT00909142|Breast cancer|breast cancer
684981|NCT00909142|Prostate cancer|prostate cancer
684982|NCT00909142|Multiple myeloma|multiple myeloma
684983|NCT00909155|Major Depressive Disorder|major depressive disorder
684984|NCT00909168|Induction chemotherapy|induction chemotherapy
684985|NCT00909168|Fludarabine|fludarabine
684986|NCT00909168|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
684987|NCT00909194|Juvenile Primary Fibromyalgia|juvenile primary fibromyalgia
684988|NCT00909194|Adolescents|adolescents
684989|NCT00909194|Psychiatry|psychiatry
752862|NCT01174524|Menopause|menopause
684990|NCT00909207|Advanced Cancers|advanced cancers
684991|NCT00909207|Hematologic Disorders|hematologic disorders
684992|NCT00909207|Solid Tumors|solid tumors
684993|NCT00909207|Cognitive Interview|cognitive interview
684994|NCT00909207|Patient-Reported Outcomes|patient-reported outcomes
684995|NCT00909207|PRO|pro
684996|NCT00909207|Common Terminology Criteria for Adverse Events|common terminology criteria for adverse events
684997|NCT00909207|CTCAE|ctcae
684998|NCT00909207|PRO-CTCAE|pro-ctcae
684999|NCT00909207|Cancer Symptoms|cancer symptoms
685000|NCT00909207|Interview|interview
685001|NCT00909220|Major Depressive Disorder|major depressive disorder
685002|NCT00909233|Erectile dysfunction,|erectile dysfunction,
685003|NCT00909233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
685004|NCT00909259|Sleep Disordered Breathing|sleep disordered breathing
685005|NCT00909259|Periodic Breathing|periodic breathing
685006|NCT00909259|Cheyne-Stokes Respiration|cheyne-stokes respiration
685007|NCT00909259|Sleep Apnea|sleep apnea
685008|NCT00909272|ultrasound|ultrasound
685009|NCT00909272|diagnostic|diagnostic
685010|NCT00909272|lumbar|lumbar
685011|NCT00909272|median branch|median branch
685012|NCT00909272|block|block
685013|NCT00909272|Lumbar facet joint pain|lumbar facet joint pain
685016|NCT00909285|cognitive training|cognitive training
685017|NCT00909298|Left ventricular assist devices|left ventricular assist devices
685018|NCT00909298|Cardiac Disease|cardiac disease
685019|NCT00909298|Heart Failure|heart failure
685020|NCT00909298|Anticoagulant for Left Ventricular Assist Devices|anticoagulant for left ventricular assist devices
685021|NCT00909311|Food effect|food effect
685022|NCT00909324|Post LASIK dry eye|post lasik dry eye
685023|NCT00909324|Pre LASIK dry eye|pre lasik dry eye
685024|NCT00909324|Hypromellose|hypromellose
685025|NCT00909350|Barrett's esophagus|barrett's esophagus
685026|NCT00909350|BE|be
685027|NCT00909350|esophageal adenocarcinoma|esophageal adenocarcinoma
685028|NCT00909350|Micro-RNA|micro-rna
685029|NCT00909350|miR expression|mir expression
685030|NCT00909376|Pregnancy|pregnancy
685031|NCT00909376|Ultrasonography|ultrasonography
685032|NCT00909376|outcome|outcome
685033|NCT00909376|adverse|adverse
685034|NCT00909415|patients with anorectal malformation|patients with anorectal malformation
685035|NCT00909428|Bladder|bladder
685036|NCT00909428|Urinary Urgency|urinary urgency
685037|NCT00909428|Solifenacin|solifenacin
685038|NCT00909428|Vesicare(R)|vesicare(r)
685039|NCT00909441|Breast Cancer|breast cancer
685040|NCT00909441|Node Positive Breast Cancer|node positive breast cancer
685041|NCT00909441|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
685042|NCT00909441|Breast Surgery|breast surgery
685043|NCT00909441|Axillary Lymph Node Dissection|axillary lymph node dissection
685044|NCT00909441|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
685045|NCT00909454|Vitamin D deficiency|vitamin d deficiency
685046|NCT00909454|Adolescents|adolescents
685047|NCT00909454|African Americans|african americans
685048|NCT00909454|Overweight|overweight
685049|NCT00909454|Obesity|obesity
685050|NCT00909493|Improvement of patient care as measured by self-rated health and improve physician satisfaction with chronic pain management|improvement of patient care as measured by self-rated health and improve physician satisfaction with chronic pain management
685051|NCT00909532|Fibrosis|fibrosis
685052|NCT00909532|Pancreatic Diseases|pancreatic diseases
685053|NCT00909532|Lung Diseases|lung diseases
685054|NCT00909532|Respiratory Tract Diseases|respiratory tract diseases
685055|NCT00909532|Genetic Diseases, Inborn|genetic diseases, inborn
685056|NCT00909532|Infant, Newborn, Diseases|infant, newborn, diseases
685057|NCT00909532|Pathologic Processes|pathologic processes
685058|NCT00909545|Early Parkinson disease|early parkinson disease
685059|NCT00909558|metastatic malignancies|metastatic malignancies
685060|NCT00909558|tumor markers|tumor markers
685061|NCT00909558|chemotherapy|chemotherapy
685062|NCT00909558|cancer|cancer
685063|NCT00909558|breast cancer|breast cancer
685064|NCT00909558|glioma|glioma
685065|NCT00909558|hepatocellular cancer|hepatocellular cancer
685066|NCT00909558|squamous cell lung cancer|squamous cell lung cancer
685067|NCT00909558|pancreatic cancer|pancreatic cancer
685068|NCT00909558|colon cancer|colon cancer
685069|NCT00909558|prostate cancer|prostate cancer
685070|NCT00909571|FK506E|fk506e
685071|NCT00909571|MR4|mr4
685072|NCT00909571|Prograf|prograf
685073|NCT00909571|Tacrolimus|tacrolimus
685074|NCT00909571|Living Liver Transplantation|living liver transplantation
685075|NCT00909584|Hematology|hematology
685076|NCT00909584|Neutropenia|neutropenia
685077|NCT00909584|SCN|scn
685078|NCT00909584|Severe Chronic Neutropenia|severe chronic neutropenia
685079|NCT00909584|Idiopathic|idiopathic
685080|NCT00909584|Telintra|telintra
685081|NCT00909584|ezatiostat hydrochloride|ezatiostat hydrochloride
685082|NCT00909584|ezatiostat|ezatiostat
685083|NCT00909584|TLK199|tlk199
685084|NCT00909584|Glutathione|glutathione
685085|NCT00909584|Glutathione analog|glutathione analog
685086|NCT00909584|Glutathione Transferase|glutathione transferase
685087|NCT00909584|Glutathione Transferase inhibitor|glutathione transferase inhibitor
685088|NCT00909584|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
685089|NCT00909584|GSTp1-1 inhibitor|gstp1-1 inhibitor
685090|NCT00909584|Apoptosis|apoptosis
685091|NCT00909584|Differentiation|differentiation
685092|NCT00909584|Enzyme inhibitor|enzyme inhibitor
685093|NCT00909610|Bioequivalence|bioequivalence
685094|NCT00909610|Healthy Subjects|healthy subjects
685095|NCT00909636|multiple ascending doses (MAD)|multiple ascending doses (mad)
685096|NCT00909649|fibrin glue|fibrin glue
685098|NCT00909649|mastectomy|mastectomy
685099|NCT00909662|cognitive/functional effects|cognitive/functional effects
685193|NCT00910013|Femoral block|femoral block
685100|NCT00909662|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
685101|NCT00909662|fatigue|fatigue
685102|NCT00909662|stage I breast cancer|stage i breast cancer
685103|NCT00909662|stage II breast cancer|stage ii breast cancer
685104|NCT00909662|stage IIIA breast cancer|stage iiia breast cancer
685105|NCT00909662|stage IIIB breast cancer|stage iiib breast cancer
685106|NCT00909662|stage IIIC breast cancer|stage iiic breast cancer
685107|NCT00909688|Healthy Subjects|healthy subjects
685108|NCT00909701|Dietary supplement|dietary supplement
685109|NCT00909701|healthy volunteers|healthy volunteers
685110|NCT00909701|Anaesthesia for surgery|anaesthesia for surgery
685111|NCT00909714|stroke|stroke
685112|NCT00909714|non-invasive cortical stimulation|non-invasive cortical stimulation
685113|NCT00909714|motor recovery|motor recovery
685114|NCT00909714|cortical plasticity|cortical plasticity
685115|NCT00909714|TDCS|tdcs
685116|NCT00909727|Fibrosis|fibrosis
685117|NCT00909727|Pancreatic Diseases|pancreatic diseases
685118|NCT00909727|Digestive System Diseases|digestive system diseases
685119|NCT00909727|Lung Diseases|lung diseases
685120|NCT00909727|Respiratory Tract Diseases|respiratory tract diseases
685121|NCT00909727|Genetic Diseases, Inborn|genetic diseases, inborn
685122|NCT00909727|Infant, Newborn, Diseases|infant, newborn, diseases
685123|NCT00909727|Pathologic Processes|pathologic processes
685124|NCT00909740|Solid Tumor|solid tumor
685125|NCT00909740|Cancer|cancer
685126|NCT00909753|Bioequivalence|bioequivalence
685127|NCT00909753|Healthy Subjects|healthy subjects
685128|NCT00909779|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
685129|NCT00909779|respiratory|respiratory
685130|NCT00909779|long-acting beta agonist (LABA)|long-acting beta agonist (laba)
685131|NCT00909805|dermabond glue|dermabond glue
685132|NCT00909805|suture|suture
685133|NCT00909805|children|children
685134|NCT00909831|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
685135|NCT00909857|Primary Dysmenorrhea|primary dysmenorrhea
685136|NCT00909857|Oral Contraception|oral contraception
685137|NCT00909870|Venous leg ulcer|venous leg ulcer
685138|NCT00909870|randomized trial|randomized trial
685139|NCT00909870|clinical trial|clinical trial
685140|NCT00909870|Dermagraft|dermagraft
685141|NCT00909870|compression therapy|compression therapy
685142|NCT00909870|surgical debridement|surgical debridement
685143|NCT00909870|venous stasis|venous stasis
685144|NCT00909870|chronic ulcer|chronic ulcer
685145|NCT00909870|chronic wound|chronic wound
685146|NCT00909870|fibroblasts|fibroblasts
685147|NCT00909883|Idiopathic Parkinson's disease|idiopathic parkinson's disease
685148|NCT00909883|Foot (Tiptoe) dystonia|foot (tiptoe) dystonia
685149|NCT00909883|Botulinum Toxin|botulinum toxin
685150|NCT00909883|Muscles : Flexor digitorum longus/ Flexor digitorum brevis/ quadratus plantae|muscles : flexor digitorum longus/ flexor digitorum brevis/ quadratus plantae
685151|NCT00909896|endometrial|endometrial
685152|NCT00909896|pain|pain
685153|NCT00909909|ductal breast carcinoma in situ|ductal breast carcinoma in situ
685154|NCT00909909|invasive ductal breast carcinoma|invasive ductal breast carcinoma
685155|NCT00909909|invasive lobular breast carcinoma|invasive lobular breast carcinoma
685156|NCT00909909|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
685157|NCT00909909|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
685158|NCT00909909|papillary ductal breast carcinoma|papillary ductal breast carcinoma
685159|NCT00909909|tubular ductal breast carcinoma|tubular ductal breast carcinoma
685160|NCT00909909|stage I breast cancer|stage i breast cancer
685161|NCT00909909|stage II breast cancer|stage ii breast cancer
685162|NCT00909909|stage IIIA breast cancer|stage iiia breast cancer
685163|NCT00909922|Amputation|amputation
685164|NCT00909922|Amputees|amputees
685165|NCT00909922|Artificial Limbs|artificial limbs
685166|NCT00909922|Leg Length Inequality|leg length inequality
685167|NCT00909922|Lower Extremity|lower extremity
685168|NCT00909922|Pelvis|pelvis
685169|NCT00909922|Posture|posture
685170|NCT00909922|Prostheses|prostheses
685171|NCT00909922|Range of Motion|range of motion
685172|NCT00909922|Trunk Muscles|trunk muscles
685173|NCT00909935|To determine pharmacokinetics of dexmedetomidine in children|to determine pharmacokinetics of dexmedetomidine in children
685174|NCT00909948|Related stem cell transplant,|related stem cell transplant,
685175|NCT00909948|TBI,|tbi,
685176|NCT00909948|Mismatched stem cell transplant|mismatched stem cell transplant
685177|NCT00909948|Fludarabine|fludarabine
685178|NCT00909948|Non-myeloablative|non-myeloablative
685179|NCT00909948|Lymphoma|lymphoma
685180|NCT00909948|Multiple myeloma|multiple myeloma
685181|NCT00909961|Osteoporosis|osteoporosis
685182|NCT00909961|Bone Mineral Density|bone mineral density
685183|NCT00909961|Biomarkers|biomarkers
685184|NCT00909974|multiple micronutrients|multiple micronutrients
685185|NCT00909974|energy deficiency|energy deficiency
685186|NCT00909987|rectum|rectum
685187|NCT00909987|intermediate risk cancer rectum|intermediate risk cancer rectum
685188|NCT00909987|neoadjuvant|neoadjuvant
685189|NCT00910000|carboplatin|carboplatin
685190|NCT00910000|gemcitabine|gemcitabine
685191|NCT00910000|vorinostat|vorinostat
685194|NCT00910013|Ropivacaïne|ropivacaïne
685195|NCT00910013|intra-articular ropivacaïne|intra-articular ropivacaïne
685196|NCT00910013|post-operative analgesia|post-operative analgesia
685197|NCT00910026|EBC and mechanical ventilation|ebc and mechanical ventilation
685198|NCT00910026|low tidal volume ventilation|low tidal volume ventilation
685199|NCT00910026|high tidal volume ventilation|high tidal volume ventilation
685200|NCT00910026|inflammatory and oxidative stress EBC biomarkers|inflammatory and oxidative stress ebc biomarkers
685201|NCT00910026|Ventilator induced lung injury|ventilator induced lung injury
685202|NCT00910039|cognitive/functional effects|cognitive/functional effects
685707|NCT00914108|EEG|eeg
685203|NCT00910039|tumors metastatic to brain|tumors metastatic to brain
685204|NCT00910039|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
685205|NCT00910052|randomised|randomised
685206|NCT00910052|controlled|controlled
685207|NCT00910052|double blinded|double blinded
685209|NCT00901862|Migraine|migraine
685210|NCT00901862|therapy|therapy
685211|NCT00901862|magnetic therapy|magnetic therapy
685212|NCT00901862|prophylaxis|prophylaxis
685213|NCT00901862|prevention|prevention
685214|NCT00901875|Buprenorphine|buprenorphine
685215|NCT00901875|Naloxone|naloxone
685216|NCT00901875|Suboxone|suboxone
685217|NCT00901888|Renin Angiotensin System|renin angiotensin system
685218|NCT00901901|Sorafenib (Nexavar)|sorafenib (nexavar)
685219|NCT00901901|Erlotinib (Tarceva)|erlotinib (tarceva)
685220|NCT00901901|First Line|first line
685221|NCT00901901|HCC|hcc
685222|NCT00901914|Hypersensitivity|hypersensitivity
685223|NCT00901914|Allergy|allergy
752574|NCT01167738|stage IV pancreatic cancer|stage iv pancreatic cancer
685224|NCT00901914|Birch, allergy, Sublingual Immunotherapy|birch, allergy, sublingual immunotherapy
685225|NCT00901927|Lymphoma|lymphoma
685226|NCT00901927|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
685227|NCT00901927|Untreated High Risk Follicular Lymphoma|untreated high risk follicular lymphoma
685228|NCT00901927|Bendamustine hydrochloride|bendamustine hydrochloride
685229|NCT00901927|Bendamustine HCI|bendamustine hci
685230|NCT00901927|Bendamustine|bendamustine
685231|NCT00901927|CEP-18083|cep-18083
685232|NCT00901927|SDX-105|sdx-105
685233|NCT00901927|Treanda|treanda
685234|NCT00901927|Mitoxantrone|mitoxantrone
685235|NCT00901927|Novantrone|novantrone
685236|NCT00901927|Rituximab|rituximab
685237|NCT00901927|Rituxan|rituxan
685238|NCT00901953|migraine|migraine
685239|NCT00901953|migrainous vertigo|migrainous vertigo
685240|NCT00901953|vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
685241|NCT00901953|vestibular function test|vestibular function test
685242|NCT00901953|vestibular disorders|vestibular disorders
685243|NCT00901966|Melanoma|melanoma
685244|NCT00901966|Sun Exposure History|sun exposure history
685245|NCT00901966|Sun Exposure|sun exposure
685246|NCT00901979|Type 2 Diabetes|type 2 diabetes
685247|NCT00901992|type 2 diabetes|type 2 diabetes
685248|NCT00901992|education|education
685249|NCT00901992|self-management|self-management
685250|NCT00901992|insulin therapy|insulin therapy
685251|NCT00902005|Endothelial dysfunction|endothelial dysfunction
685252|NCT00902005|Bone and cartilage markers|bone and cartilage markers
685253|NCT00902005|Inflammatory disease activity|inflammatory disease activity
685254|NCT00902005|Rheumatoid arthritis|rheumatoid arthritis
685255|NCT00902005|Psoriatic arthritis|psoriatic arthritis
685256|NCT00902005|Ankylosing Spondylitis|ankylosing spondylitis
685257|NCT00902018|ITP|itp
685258|NCT00902031|Docusate|docusate
685259|NCT00902031|Constipation|constipation
685260|NCT00902031|Colace|colace
685261|NCT00902031|Palliative Care|palliative care
685262|NCT00902031|Sennoside|sennoside
685263|NCT00902031|Senokot|senokot
685264|NCT00902031|Terminally Ill|terminally ill
685265|NCT00902031|Stool|stool
685266|NCT00902031|Randomized Trial|randomized trial
685267|NCT00902044|Refractory Sarcoma|refractory sarcoma
685268|NCT00902044|Metastatic Sarcoma|metastatic sarcoma
685269|NCT00902044|Sarcoma|sarcoma
685270|NCT00902044|HER2-positive|her2-positive
685271|NCT00902044|Gene Therapy|gene therapy
685272|NCT00902044|HER2-specific T cells|her2-specific t cells
685273|NCT00902083|p53 gene|p53 gene
685274|NCT00902083|Oral and Maxillofacial|oral and maxillofacial
685275|NCT00902083|gene therapy|gene therapy
685276|NCT00902083|malignant tumors|malignant tumors
685277|NCT00902096|cord blood|cord blood
685278|NCT00902096|IgE|ige
685279|NCT00902096|prenatal|prenatal
685280|NCT00902096|predictor|predictor
685281|NCT00902109|visual field|visual field
685282|NCT00902109|perimetry|perimetry
685283|NCT00902109|progression|progression
685284|NCT00902109|POAG|poag
685285|NCT00902109|glaucoma|glaucoma
685286|NCT00902122|p53 gene|p53 gene
685287|NCT00902122|thyroid|thyroid
685288|NCT00902122|gene therapy|gene therapy
685289|NCT00902122|malignant tumors|malignant tumors
685290|NCT00902135|Multiple Sclerosis|multiple sclerosis
685291|NCT00902135|Interferon beta-1b|interferon beta-1b
685292|NCT00902148|Surgery|surgery
685293|NCT00902148|Colectomy|colectomy
685294|NCT00902148|Proctocolectomy|proctocolectomy
685295|NCT00902148|Adhesions|adhesions
685296|NCT00902174|Pulmonary arterial hypertension|pulmonary arterial hypertension
685297|NCT00902174|Imatinib|imatinib
685298|NCT00902174|6MWD|6mwd
685299|NCT00902174|Borg scale|borg scale
685300|NCT00902174|Pulmonary hypertension|pulmonary hypertension
685301|NCT00902187|Bioequivalence|bioequivalence
685302|NCT00902200|Glaucoma|glaucoma
685303|NCT00902200|Intraocular pressure|intraocular pressure
685304|NCT00902226|Social Anxiety Disorder|social anxiety disorder
685306|NCT00902226|Antidepressant|antidepressant
685307|NCT00902226|Anxiolytic|anxiolytic
685308|NCT00902278|influenzavirus A|influenzavirus a
685309|NCT00902278|influenzavirus B|influenzavirus b
685310|NCT00902278|human influenza|human influenza
685311|NCT00902278|T lymphocytes|t lymphocytes
685312|NCT00902278|influenza vaccines|influenza vaccines
685313|NCT00902291|Clinical Trial, Phase II|clinical trial, phase ii
685314|NCT00902291|Combination Drug Therapy|combination drug therapy
685315|NCT00902291|Gemcitabine|gemcitabine
685316|NCT00902291|AGS-1C4D4|ags-1c4d4
685317|NCT00902291|Pancreatic Cancer|pancreatic cancer
685318|NCT00902304|Hypertension|hypertension
685319|NCT00902304|valsartan|valsartan
685320|NCT00902330|depression|depression
685321|NCT00902330|anxiety disorder|anxiety disorder
685322|NCT00902330|fatigue|fatigue
685323|NCT00902330|pain|pain
685324|NCT00902330|sleep disorders|sleep disorders
685325|NCT00902330|stage IA breast cancer|stage ia breast cancer
685326|NCT00902330|stage IB breast cancer|stage ib breast cancer
685327|NCT00902330|stage II breast cancer|stage ii breast cancer
685328|NCT00902330|stage IIIA breast cancer|stage iiia breast cancer
685329|NCT00902343|Liver|liver
685330|NCT00902343|Cancer|cancer
685331|NCT00902343|Primary|primary
685332|NCT00902343|Metastatic|metastatic
685333|NCT00902343|transfusions|transfusions
685334|NCT00902343|08-158|08-158
685335|NCT00902356|Amgen|amgen
685336|NCT00902356|Phase 1|phase 1
685337|NCT00902356|First in Human|first in human
685338|NCT00902356|Postmenopausal|postmenopausal
685339|NCT00902369|AK106-001616|ak106-001616
685340|NCT00902382|Infertility|infertility
685341|NCT00902382|Ovulation stimulation|ovulation stimulation
685342|NCT00902382|Pregnancy|pregnancy
685343|NCT00902395|Preschool children|preschool children
685344|NCT00902421|Overactive bladder|overactive bladder
685345|NCT00902421|SSRI|ssri
685346|NCT00902421|Antimuscarinics|antimuscarinics
685347|NCT00902434|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
685348|NCT00902447|Human Blood Cell Disorders|human blood cell disorders
685349|NCT00902447|lymphoid, myeloid and erythroid proliferative disease|lymphoid, myeloid and erythroid proliferative disease
685350|NCT00902460|drug interactions CYP3A4 CYP3A5 midazolam anti-rheumatic agents|drug interactions cyp3a4 cyp3a5 midazolam anti-rheumatic agents
685351|NCT00902473|Topiramate fed study|topiramate fed study
685352|NCT00902486|Rheumatoid arthritis|rheumatoid arthritis
685353|NCT00902499|functional magnetic resonance imaging|functional magnetic resonance imaging
685354|NCT00902525|two sequential doses of 90Y-Ibritumomab Tiuxetan|two sequential doses of 90y-ibritumomab tiuxetan
685355|NCT00902538|Add on treatment|add on treatment
685356|NCT00902538|essential hypertension|essential hypertension
685357|NCT00902551|DNA cytometry|dna cytometry
685358|NCT00902551|Cytology|cytology
685359|NCT00902551|Diagnosis accuracy|diagnosis accuracy
685360|NCT00902564|Generalized Anxiety Disorder|generalized anxiety disorder
685362|NCT00902564|Antidepressant|antidepressant
685363|NCT00902564|Anxiolytic|anxiolytic
685364|NCT00902590|renal pelvis|renal pelvis
685368|NCT00902590|Renal Pelvis, Ureter, Bladder Cancer|renal pelvis, ureter, bladder cancer
685369|NCT00902603|pulmonary arterial hypertension|pulmonary arterial hypertension
685370|NCT00902603|Ventavis®|ventavis®
685371|NCT00902603|iloprost|iloprost
685372|NCT00910065|Acute Coronary Syndrome|acute coronary syndrome
685373|NCT00910065|ACS|acs
685374|NCT00910065|Aspirin|aspirin
685375|NCT00910078|Total kappa and lambda ratio|total kappa and lambda ratio
685376|NCT00910078|Stem cell transplantation|stem cell transplantation
685377|NCT00910078|Serum immunofixation|serum immunofixation
685378|NCT00910091|Endometrial cancer|endometrial cancer
685379|NCT00910091|Antitumour efficacy in women with advanced endometrial cancer|antitumour efficacy in women with advanced endometrial cancer
685380|NCT00910104|PNALD|pnald
685381|NCT00910104|Omegaven|omegaven
685382|NCT00910104|Parenteral Nutrition Associated Liver Disease|parenteral nutrition associated liver disease
685383|NCT00910104|Cholestasis|cholestasis
685384|NCT00910104|Short Bowel Syndrome|short bowel syndrome
685385|NCT00910117|HNSCC|hnscc
685386|NCT00910117|induction chemotherapy|induction chemotherapy
685387|NCT00910117|nimotuzumab|nimotuzumab
685388|NCT00910130|Retinol Binding Protein 4|retinol binding protein 4
685389|NCT00910130|Insulin Resistance|insulin resistance
685390|NCT00910130|Diabetes|diabetes
685391|NCT00910130|End Stage Renal Disease|end stage renal disease
685392|NCT00910130|Dialysis|dialysis
685393|NCT00910130|Nutrition|nutrition
685394|NCT00910143|Rectal cancer|rectal cancer
685395|NCT00910143|Colorectal Surgery|colorectal surgery
685396|NCT00910143|Surgery|surgery
685397|NCT00910143|Local neoplasm recurrence|local neoplasm recurrence
685398|NCT00910143|survival|survival
685399|NCT00910143|Follow-up Study|follow-up study
685400|NCT00910169|Anorexia nervosa|anorexia nervosa
685401|NCT00910169|treatment|treatment
685402|NCT00910169|inpatient|inpatient
685403|NCT00910169|efficacy|efficacy
685404|NCT00910169|outcome|outcome
685405|NCT00910182|Splenic rupture|splenic rupture
685406|NCT00910182|abdominal injuries|abdominal injuries
685407|NCT00910182|Surgery|surgery
685408|NCT00910182|Angiography|angiography
685409|NCT00910182|Embolisation|embolisation
685806|NCT00914537|HPV|hpv
685410|NCT00910182|Computed tomography|computed tomography
685411|NCT00910182|Classification|classification
685412|NCT00910195|Obstructive sleep apnea|obstructive sleep apnea
685413|NCT00910195|CPAP|cpap
685414|NCT00910195|Bi-Level|bi-level
685415|NCT00910208|Pain|pain
685416|NCT00910208|Analgesia|analgesia
685417|NCT00910208|Analgesia, Patient-controlled|analgesia, patient-controlled
685418|NCT00910208|Emergency Medicine|emergency medicine
685419|NCT00910221|Cardiac surgery|cardiac surgery
685420|NCT00910221|Cardiopulmonary bypass|cardiopulmonary bypass
685421|NCT00910221|Oxidative stress|oxidative stress
685422|NCT00910221|Acute renal dysfunction|acute renal dysfunction
685423|NCT00910221|Atorvastatin|atorvastatin
685424|NCT00910234|Periventricular leukomalacia (PVL)|periventricular leukomalacia (pvl)
685425|NCT00910234|Erythropoietin (EPO)|erythropoietin (epo)
685426|NCT00910234|Retinopathy of prematurity (ROP)|retinopathy of prematurity (rop)
685427|NCT00910234|Hypoxia-ischemia|hypoxia-ischemia
685428|NCT00910247|Seizures|seizures
685429|NCT00910247|Epilepsy|epilepsy
685430|NCT00910247|Anticonvulsant|anticonvulsant
685431|NCT00910247|Monotherapy|monotherapy
685432|NCT00910247|Epilepsy with simple or complete partial onset seizures|epilepsy with simple or complete partial onset seizures
685433|NCT00910260|vitamin D level under phototherapy|vitamin d level under phototherapy
685434|NCT00910273|IMT evaluation in AS patients treated with etanercept|imt evaluation in as patients treated with etanercept
685435|NCT00910286|Pressure support ventilation|pressure support ventilation
685436|NCT00910286|cycling off criteria|cycling off criteria
685437|NCT00910286|expiratory trigger|expiratory trigger
685438|NCT00910286|patient-ventilator interaction|patient-ventilator interaction
685439|NCT00910286|patient comfort|patient comfort
685440|NCT00910299|Clopidogrel|clopidogrel
685441|NCT00910299|VerifyNow|verifynow
685442|NCT00910299|PRU Measurements|pru measurements
685443|NCT00910299|Drug Eluting Stents (DES)|drug eluting stents (des)
685444|NCT00910299|Heart Disease|heart disease
685445|NCT00910299|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
685446|NCT00910299|P2Y12|p2y12
685447|NCT00910299|Platelets|platelets
685448|NCT00910299|Platelet Reactivity|platelet reactivity
685449|NCT00910325|Female|female
685450|NCT00910325|Cholelithiasis|cholelithiasis
685451|NCT00910325|Natural Orifice Surgery|natural orifice surgery
685452|NCT00910325|Laparoscopic- Assisted|laparoscopic- assisted
685453|NCT00910325|Transvaginal|transvaginal
685454|NCT00910338|Pelvic Floor Muscle Training|pelvic floor muscle training
685455|NCT00910338|Extracorporeal Biofeedback|extracorporeal biofeedback
685456|NCT00910351|Cystic Fibrosis|cystic fibrosis
685457|NCT00910351|Pharmacokinetics|pharmacokinetics
685458|NCT00910351|Pediatrics|pediatrics
685459|NCT00910351|Inhalation|inhalation
685460|NCT00910351|Sputum|sputum
685461|NCT00910364|Lower extremity DVT|lower extremity dvt
685462|NCT00910364|Clot|clot
685463|NCT00910364|leg clot|leg clot
685464|NCT00910364|Deep vein thrombosis|deep vein thrombosis
685466|NCT00910364|Warfarin|warfarin
685467|NCT00910377|breastfeeding|breastfeeding
685468|NCT00910377|exclusive breastfeeding|exclusive breastfeeding
685469|NCT00910377|lactation counseling|lactation counseling
685470|NCT00910377|teenagers|teenagers
685471|NCT00910377|complementary food|complementary food
685472|NCT00910377|adolescent|adolescent
685473|NCT00910377|caregivers|caregivers
685474|NCT00910390|IVF|ivf
685475|NCT00910390|embryo cryopreservation|embryo cryopreservation
685476|NCT00910390|vitrification|vitrification
685477|NCT00910390|Human Embryo|human embryo
685478|NCT00910390|Embryonic development|embryonic development
685479|NCT00910390|Pregnancy rate|pregnancy rate
685480|NCT00912990|Pediatric|pediatric
685481|NCT00913003|Lidocaine|lidocaine
685482|NCT00913003|Mastectomy|mastectomy
685483|NCT00913003|Pain|pain
685484|NCT00913016|hormonal therapy(letrozole)|hormonal therapy(letrozole)
685485|NCT00913016|postmenopausal breast cancer|postmenopausal breast cancer
685486|NCT00913016|quality of life|quality of life
685487|NCT00913029|primary open angle glaucoma (POAG)|primary open angle glaucoma (poag)
685488|NCT00913029|OAG|oag
685489|NCT00913029|glaucoma|glaucoma
685490|NCT00913042|Febrile neutropenia|febrile neutropenia
685491|NCT00913042|Blood culture|blood culture
685492|NCT00913042|Bacteremia|bacteremia
685493|NCT00913042|Bacterial DNA testing|bacterial dna testing
685494|NCT00913055|S-LAR|s-lar
685495|NCT00913055|Octreotide|octreotide
685496|NCT00913055|Implant|implant
686171|NCT00906035|PAD|pad
685497|NCT00913068|radical prostatectomy|radical prostatectomy
685498|NCT00913081|Skin|skin
685499|NCT00913081|pharmacology|pharmacology
685500|NCT00913081|metabolism|metabolism
685501|NCT00913081|lipid|lipid
685502|NCT00913094|Hypertension|hypertension
685503|NCT00913107|Trigeminal Neuralgia|trigeminal neuralgia
685504|NCT00913107|Lamotrigine|lamotrigine
685505|NCT00913107|Carbamazepine|carbamazepine
685506|NCT00913107|Lamictal®|lamictal®
685507|NCT00913107|Tegretol®|tegretol®
685508|NCT00913120|YM150|ym150
685509|NCT00913120|FXa inhibitor|fxa inhibitor
685510|NCT00913120|Thrombosis|thrombosis
685511|NCT00913120|Anticoagulant|anticoagulant
685512|NCT00913120|Venous thromboembolism|venous thromboembolism
685513|NCT00913120|Arthroplasty, replacement, hip|arthroplasty, replacement, hip
685514|NCT00913133|Anticoagulation|anticoagulation
685515|NCT00913133|Prophylaxis|prophylaxis
685516|NCT00913133|Desirudin|desirudin
685517|NCT00913133|Direct thrombin inhibitor|direct thrombin inhibitor
685518|NCT00913133|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
685519|NCT00913146|Management of fever|management of fever
685520|NCT00913146|Malaria|malaria
685521|NCT00913146|Malaria rapid diagnostic test|malaria rapid diagnostic test
685522|NCT00913146|Clinical trial|clinical trial
685523|NCT00913159|Renal stones|renal stones
685524|NCT00913159|lithotripsy|lithotripsy
685525|NCT00913159|stone free rate|stone free rate
685526|NCT00913172|TB|tb
685527|NCT00913172|cost|cost
685528|NCT00913172|HEWs|hews
685529|NCT00913172|Cost-effectiveness|cost-effectiveness
685530|NCT00913172|treatment success rate|treatment success rate
685531|NCT00913185|Acne|acne
685532|NCT00913198|Pancreas|pancreas
685533|NCT00913198|Advanced adenocarcinoma|advanced adenocarcinoma
685534|NCT00913198|CP-4126|cp-4126
685535|NCT00913224|Anti-inflammatory|anti-inflammatory
685536|NCT00913237|Antidepressant|antidepressant
685537|NCT00913250|Multiple Sclerosis|multiple sclerosis
685538|NCT00913250|Interferon beta-1a|interferon beta-1a
685539|NCT00913263|Prostate cancer|prostate cancer
685540|NCT00913289|Liver Cirrhosis|liver cirrhosis
685541|NCT00913302|Ankylosing Spondylitis|ankylosing spondylitis
685542|NCT00913302|Education|education
685543|NCT00913302|Physical fitness|physical fitness
685544|NCT00913315|prostatitis|prostatitis
685545|NCT00913315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
685546|NCT00913315|tolterodine|tolterodine
685547|NCT00913328|Asthma|asthma
685548|NCT00913328|Airway responsiveness|airway responsiveness
685549|NCT00913328|Dose-response plateau|dose-response plateau
685550|NCT00913328|Montelukast|montelukast
685551|NCT00913328|Add-on to inhaled corticosteroids|add-on to inhaled corticosteroids
685552|NCT00913354|infertility|infertility
685553|NCT00913354|ivf|ivf
685554|NCT00913354|acupuncture|acupuncture
685555|NCT00913367|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
685556|NCT00913406|Effect of lutein fortification growth healthy term infants|effect of lutein fortification growth healthy term infants
685557|NCT00913419|Antidepressant|antidepressant
685558|NCT00913432|rheumatoid arthritis|rheumatoid arthritis
685559|NCT00913432|methotrexate|methotrexate
685560|NCT00913432|DMARD|dmard
685561|NCT00913432|c-kit inhibitor|c-kit inhibitor
685562|NCT00913445|Appendicitis|appendicitis
685563|NCT00913445|appendicectomy|appendicectomy
685564|NCT00913445|stitches|stitches
685565|NCT00913445|wound healing|wound healing
685566|NCT00913445|cosmetic results|cosmetic results
685567|NCT00913471|Spinal cord injury|spinal cord injury
685568|NCT00913471|SCI|sci
685569|NCT00913471|Neuropathic pain|neuropathic pain
685570|NCT00913471|Pain|pain
685571|NCT00913484|Disulfiram|disulfiram
685572|NCT00913484|Buprenorphine|buprenorphine
685573|NCT00913484|Cocaine dependence|cocaine dependence
685574|NCT00913484|Opioid dependence|opioid dependence
685575|NCT00913484|Dopamine-Beta-Hydroxylase|dopamine-beta-hydroxylase
685576|NCT00913497|Type 1 diabetes mellitus in children|type 1 diabetes mellitus in children
685577|NCT00913497|insulin glulisine|insulin glulisine
685578|NCT00913497|insulin aspart|insulin aspart
685579|NCT00913497|post prandial|post prandial
685580|NCT00913523|tampons|tampons
685581|NCT00913523|Glycerol Monolaurate|glycerol monolaurate
685582|NCT00913523|vaginal microflora|vaginal microflora
685583|NCT00913523|microbes|microbes
685584|NCT00913523|Vaginal Tampon|vaginal tampon
685585|NCT00913536|Bladder Cancer|bladder cancer
685586|NCT00913536|Cone Beam CT|cone beam ct
685587|NCT00913536|On-line image guidance|on-line image guidance
685588|NCT00913536|Radiation therapy in bladder cancer patients|radiation therapy in bladder cancer patients
685589|NCT00913549|Antihistamine|antihistamine
685590|NCT00913562|Ocular Physiology|ocular physiology
685591|NCT00913562|Regional Blood Flow|regional blood flow
685592|NCT00913575|neuromuscular training|neuromuscular training
685593|NCT00913575|preoperative exercise|preoperative exercise
685594|NCT00913575|physiotherapy|physiotherapy
685595|NCT00913575|total knee replacement|total knee replacement
685596|NCT00913575|knee osteoarthritis|knee osteoarthritis
685597|NCT00913601|Idiopathic Fecal Incontinence|idiopathic fecal incontinence
686676|NCT00918593|Ulcerating|ulcerating
685598|NCT00913601|Fecal Incontinence|fecal incontinence
685599|NCT00913601|Sacral Nerve Stimulation|sacral nerve stimulation
685600|NCT00913601|Sacral Nerve Neuromodulation|sacral nerve neuromodulation
685601|NCT00913614|insomnia pediatric safety|insomnia pediatric safety
685602|NCT00913627|Extended-release, ibuprofen|extended-release, ibuprofen
685603|NCT00913640|Prospective Memory Performance|prospective memory performance
685604|NCT00913640|Prospective Memory Outcome|prospective memory outcome
685605|NCT00913640|Parkinson's Disease|parkinson's disease
685606|NCT00913653|Heart failure|heart failure
685607|NCT00913653|LCZ696|lcz696
685608|NCT00913666|Multiple Sclerosis|multiple sclerosis
685609|NCT00913679|osteonecrosis|osteonecrosis
685807|NCT00914537|Cytology|cytology
685610|NCT00913679|femoral neck fracture|femoral neck fracture
685611|NCT00913679|implant fixation|implant fixation
685612|NCT00913679|implant failure|implant failure
685613|NCT00913679|periprosthetic bone mineral density|periprosthetic bone mineral density
685614|NCT00913679|gait function|gait function
685615|NCT00913679|gait analysis|gait analysis
685616|NCT00913679|patient recovery|patient recovery
685617|NCT00913692|Glutamine|glutamine
685618|NCT00913692|Herpes Labialis|herpes labialis
685619|NCT00913692|Herpes Simplex Virus|herpes simplex virus
685620|NCT00913692|Cold Sore|cold sore
685621|NCT00913705|NATCH|natch
685622|NCT00913705|LUNG|lung
685623|NCT00913705|OPERABLE NSCLC|operable nsclc
685624|NCT00913705|SURGERY PLUS ADJUVANT THERAPY|surgery plus adjuvant therapy
685625|NCT00913705|SURGERY PLUS NEOADJUVANT THERAPY|surgery plus neoadjuvant therapy
685626|NCT00913731|Psychotic symptom assessments|psychotic symptom assessments
752575|NCT01167751|Myocardial infarction|myocardial infarction
685627|NCT00913731|Observational assessments of patients with acute psychotic symptoms|observational assessments of patients with acute psychotic symptoms
685629|NCT00913757|Hepatocellular Carcinoma|hepatocellular carcinoma
685630|NCT00913757|Liver Cancer|liver cancer
685631|NCT00913757|Chronic Liver Disease|chronic liver disease
685632|NCT00913757|Genome Wide Association Study|genome wide association study
685633|NCT00913757|Gene Expression Profiling|gene expression profiling
685634|NCT00913770|opioid dependence|opioid dependence
685635|NCT00913770|buprenorphine|buprenorphine
685636|NCT00913770|brief intervention|brief intervention
685637|NCT00913783|Antidepressant|antidepressant
685638|NCT00913796|Renal transplantation|renal transplantation
685639|NCT00913796|Metabolic acidosis|metabolic acidosis
685640|NCT00913796|Physical capacity|physical capacity
685641|NCT00913796|Bone histology|bone histology
685642|NCT00913796|Bone histomorphometry|bone histomorphometry
685643|NCT00913796|Parathyroid function|parathyroid function
685644|NCT00913796|Calcium and phosphate metabolism|calcium and phosphate metabolism
685645|NCT00913809|Antidepressant|antidepressant
685646|NCT00913822|Antidepressant|antidepressant
685647|NCT00913835|Liposomal Doxorubicin|liposomal doxorubicin
685648|NCT00913835|IMC-3G3|imc-3g3
685649|NCT00913835|3G3|3g3
685650|NCT00913835|Platinum resistant|platinum resistant
685651|NCT00913835|Platinum refractory|platinum refractory
685652|NCT00913835|Ovary|ovary
685653|NCT00913835|Neoplasm|neoplasm
685654|NCT00913835|PDGFr|pdgfr
685655|NCT00913848|Treatment of Epilepsy and Bipolar Disorder|treatment of epilepsy and bipolar disorder
685656|NCT00913861|endoscopy|endoscopy
685657|NCT00913861|comfort|comfort
685658|NCT00913861|non-pharmacological|non-pharmacological
685659|NCT00913887|Anti-Inflammatory|anti-inflammatory
685660|NCT00913900|Arterial Occlusive Diseases|arterial occlusive diseases
685661|NCT00913900|Vascular Disease|vascular disease
685662|NCT00913913|Renal Cell Carcinoma|renal cell carcinoma
685663|NCT00913926|Climacteric symptoms|climacteric symptoms
685664|NCT00913939|Prostate Cancer|prostate cancer
685762|NCT00914368|Clopidogrel|clopidogrel
685665|NCT00913939|HDR Brachytherapy|hdr brachytherapy
685666|NCT00913939|Prostate Brachytherapy|prostate brachytherapy
685667|NCT00913952|Antidepressant|antidepressant
685668|NCT00913978|Normothermia|normothermia
685669|NCT00913978|Abdominal Surgery|abdominal surgery
685670|NCT00913978|Bair Paws|bair paws
685671|NCT00913991|Nitric Oxide|nitric oxide
685672|NCT00914004|Antidepressant|antidepressant
685673|NCT00914017|Breast Cancer|breast cancer
685674|NCT00914017|Breast Cancer Prevention|breast cancer prevention
685675|NCT00914017|Mammographic Density|mammographic density
685676|NCT00914017|Breast Density|breast density
685677|NCT00914017|Breast Cancer Biomarkers|breast cancer biomarkers
685678|NCT00914030|Visual perception|visual perception
685679|NCT00914030|Local/global processing|local/global processing
685680|NCT00914030|Attention|attention
685681|NCT00914030|Visual priming|visual priming
685682|NCT00914030|Collinearity|collinearity
685683|NCT00914030|Grouping|grouping
685685|NCT00914043|HER2-negative breast cancer|her2-negative breast cancer
685686|NCT00914043|stage II breast cancer|stage ii breast cancer
685687|NCT00914043|stage IIIA breast cancer|stage iiia breast cancer
685688|NCT00914043|stage IIIB breast cancer|stage iiib breast cancer
685689|NCT00914082|Self hypnosis|self hypnosis
685690|NCT00914082|Hypnosis|hypnosis
685691|NCT00914082|mental training|mental training
686677|NCT00918593|Palliative|palliative
685692|NCT00914082|antenatal training|antenatal training
685693|NCT00914082|pregnancy|pregnancy
685694|NCT00914082|pain control|pain control
685695|NCT00914082|Childbirth|childbirth
685696|NCT00914082|Analgesia|analgesia
685697|NCT00914095|Parkinson's disease|parkinson's disease
685698|NCT00914095|Freezing of Gait|freezing of gait
685699|NCT00914095|Methylphenidate|methylphenidate
685700|NCT00914095|Dopamine transporter inhibitor|dopamine transporter inhibitor
685701|NCT00914095|Noradrenaline|noradrenaline
685702|NCT00914108|Preterm Infants|preterm infants
685703|NCT00914108|Developmental Care|developmental care
685704|NCT00914108|NIDCAP|nidcap
685705|NCT00914108|Intrauterine Growth Restriction|intrauterine growth restriction
685706|NCT00914108|APIB|apib
685708|NCT00914108|Neurobehavior|neurobehavior
685709|NCT00914134|Parkinson's disease|parkinson's disease
685710|NCT00914134|Autonomic nervous system|autonomic nervous system
685711|NCT00914134|Levodopa infusion|levodopa infusion
685712|NCT00914147|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
685713|NCT00914160|Anti-inflammatory|anti-inflammatory
685714|NCT00914186|Atopic Dermatitis|atopic dermatitis
685715|NCT00914186|Pruritus|pruritus
685716|NCT00914199|PCI|pci
685717|NCT00914199|Bifurcation lesion|bifurcation lesion
685718|NCT00914225|Human immunodeficiency virus|human immunodeficiency virus
685719|NCT00914225|malaria|malaria
685720|NCT00914225|plasmodium falciparum|plasmodium falciparum
685721|NCT00914225|diarrhea|diarrhea
685722|NCT00914225|helminth|helminth
685723|NCT00914225|HIV|hiv
685724|NCT00914225|Treatment naive|treatment naive
685725|NCT00914238|Randomized clinical trial|randomized clinical trial
685726|NCT00914238|first episode psychosis of schizophrenia and schizotypal disorder|first episode psychosis of schizophrenia and schizotypal disorder
685727|NCT00914238|rehabilitation|rehabilitation
685728|NCT00914238|psychosocial|psychosocial
685729|NCT00914238|health service research|health service research
685730|NCT00914238|schizotypal Disorder|schizotypal disorder
685731|NCT00914251|endothelial|endothelial
685732|NCT00914251|metabolic syndrome|metabolic syndrome
685733|NCT00914251|hesperidin|hesperidin
685734|NCT00914264|chronic obstructive airway disease|chronic obstructive airway disease
685735|NCT00914264|obstructive sleep apnea|obstructive sleep apnea
685736|NCT00914264|continuous positive airway pressure|continuous positive airway pressure
685737|NCT00914277|Rho-kinase inhibitor|rho-kinase inhibitor
685738|NCT00914277|male impotence|male impotence
685739|NCT00914303|Safety|safety
685740|NCT00914303|tolerability|tolerability
685741|NCT00914303|healthy|healthy
685742|NCT00914303|Healthy volunteer study|healthy volunteer study
685743|NCT00914316|Lower leg claudication|lower leg claudication
685744|NCT00914316|Poor circulation of the leg muscles|poor circulation of the leg muscles
685745|NCT00914316|Cramping or discomfort in the lower legs|cramping or discomfort in the lower legs
685746|NCT00914316|Lower leg pain|lower leg pain
685747|NCT00914316|PAD (Peripheral arterial disease)|pad (peripheral arterial disease)
685748|NCT00914329|stress provoked|stress provoked
685749|NCT00914329|healthy volunteers|healthy volunteers
685750|NCT00914329|gelsemium|gelsemium
685751|NCT00914329|homeopathy|homeopathy
685752|NCT00914342|Gerd|gerd
685753|NCT00914342|GerdQ questionnaire|gerdq questionnaire
685754|NCT00914342|work productivity|work productivity
685755|NCT00914342|Greece|greece
685756|NCT00914355|Hepatocellular Carcinoma|hepatocellular carcinoma
685757|NCT00914355|Stereotactic Body Radiation|stereotactic body radiation
685758|NCT00914355|Unresectable liver cancer|unresectable liver cancer
685759|NCT00914355|Patients with Hepatocellular Carcinoma|patients with hepatocellular carcinoma
685760|NCT00914368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
685761|NCT00914368|Aspirin|aspirin
685763|NCT00914368|Pathologic Processes|pathologic processes
685764|NCT00914368|Disease|disease
685765|NCT00914368|Therapeutic Uses|therapeutic uses
685766|NCT00914368|Syndrome|syndrome
685767|NCT00914368|Hematologic Agents|hematologic agents
685768|NCT00914368|Cardiovascular Diseases|cardiovascular diseases
685769|NCT00914368|Pharmacologic Actions|pharmacologic actions
685770|NCT00914381|Community reinforcement approach|community reinforcement approach
685771|NCT00914381|Contingency management|contingency management
685772|NCT00914381|12-step facilitation counseling|12-step facilitation counseling
685773|NCT00914381|Cocaine dependence|cocaine dependence
685774|NCT00914381|Women|women
685775|NCT00914394|L-NG-Monomethyl Arginine|l-ng-monomethyl arginine
685776|NCT00914394|Optic Nerve Head Blood Flow|optic nerve head blood flow
685777|NCT00914394|Intraocular Pressure|intraocular pressure
685778|NCT00914394|Regional Blood Flow|regional blood flow
685779|NCT00914394|Ocular Physiology|ocular physiology
685780|NCT00914394|Optic Disk|optic disk
685781|NCT00914407|Ocular physiology|ocular physiology
685782|NCT00914420|OCT|oct
685783|NCT00914420|Reendothelialisation|reendothelialisation
685784|NCT00914420|Intrepide|intrepide
685785|NCT00914420|Trapidil|trapidil
685786|NCT00914420|Taxus|taxus
685787|NCT00914433|COPD|copd
685788|NCT00914446|Steatohepatitis|steatohepatitis
685789|NCT00914459|hemophilia A|hemophilia a
686761|NCT00918879|HbA1c|hba1c
685790|NCT00914472|Preventing the thrombi formation|preventing the thrombi formation
685791|NCT00914498|Xylocaine|xylocaine
685792|NCT00914498|Casarean section|casarean section
685793|NCT00914498|Post operative pain|post operative pain
685794|NCT00914498|Scar quality|scar quality
685795|NCT00914511|Semen|semen
685796|NCT00914511|Sperm|sperm
685797|NCT00914511|Avanafil|avanafil
685798|NCT00914511|Pharmacokinetics|pharmacokinetics
685799|NCT00914511|Elderly|elderly
685800|NCT00914524|Chronic Glomerulonephritis|chronic glomerulonephritis
685801|NCT00914524|Diabetic Nephropathy|diabetic nephropathy
685802|NCT00914524|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
685803|NCT00914524|Urinary Protein|urinary protein
685804|NCT00914537|Anal Cancer|anal cancer
685805|NCT00914537|AIN|ain
685809|NCT00914537|HIV Positive|hiv positive
685810|NCT00914550|Pneumonia|pneumonia
685811|NCT00914550|Lung Infiltrates|lung infiltrates
685812|NCT00914550|Antibiotic discontinuation|antibiotic discontinuation
685813|NCT00914550|De-escalation therapy|de-escalation therapy
685814|NCT00914563|Burned shock|burned shock
685815|NCT00914563|Volume resuscitative patterns|volume resuscitative patterns
685816|NCT00914563|Non-invasive hemodynamic monitoring|non-invasive hemodynamic monitoring
685817|NCT00914576|Endotoxin, Escherichia Coli|endotoxin, escherichia coli
685819|NCT00914576|Regional Blood Flow|regional blood flow
685820|NCT00914615|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
685821|NCT00914615|Liver Metastasis from colorectal cancer|liver metastasis from colorectal cancer
685822|NCT00914615|Patients with Liver Metastasis|patients with liver metastasis
685823|NCT00914628|high risk acute leukemia|high risk acute leukemia
685824|NCT00914628|HSV-TK|hsv-tk
685825|NCT00914628|Haploidentical HCT|haploidentical hct
685826|NCT00914628|GvHD|gvhd
685827|NCT00914628|GvL|gvl
685828|NCT00914628|Immunoreconstitution|immunoreconstitution
685829|NCT00914641|formulation; sustained release; modified release; extended release|formulation; sustained release; modified release; extended release
685830|NCT00914654|Asthma|asthma
685831|NCT00914654|Doping|doping
685832|NCT00914654|Formoterol|formoterol
685833|NCT00914654|Urinary concentrations|urinary concentrations
685834|NCT00914654|Beta-agonists|beta-agonists
685835|NCT00914667|Overactive Bladder Urgency Frequency|overactive bladder urgency frequency
685836|NCT00914693|Fertility control|fertility control
685837|NCT00914693|Contraception|contraception
685838|NCT00914706|Diabetes|diabetes
685839|NCT00914719|sexual risk behavior among adolescents|sexual risk behavior among adolescents
685840|NCT00914719|alcohol and drug use among adolescents|alcohol and drug use among adolescents
685841|NCT00914732|IMVAMUNE®, smallpox, vaccine|imvamune®, smallpox, vaccine
685842|NCT00914758|multiple sclerosis|multiple sclerosis
685843|NCT00914758|cognition|cognition
685844|NCT00914758|cognitive functioning|cognitive functioning
685845|NCT00914758|Campath|campath
685846|NCT00914758|Rebif|rebif
685847|NCT00914758|alemtuzumab|alemtuzumab
685848|NCT00914758|interferon|interferon
685849|NCT00914771|Pandemic Influenza|pandemic influenza
685850|NCT00914771|H5N1|h5n1
685851|NCT00914771|Adults and Elderly|adults and elderly
685852|NCT00914771|antigen dose|antigen dose
685853|NCT00914784|TRALI|trali
685854|NCT00914784|Transfusion|transfusion
685855|NCT00914784|dyspnea|dyspnea
685856|NCT00914784|pulmonary infiltrates|pulmonary infiltrates
685857|NCT00914797|Asthma|asthma
685858|NCT00914797|Doping|doping
685859|NCT00914797|Beta agonist|beta agonist
685860|NCT00914797|Terbutaline|terbutaline
685861|NCT00914797|Pharmacokinetics|pharmacokinetics
686046|NCT00905580|thyroidectomy|thyroidectomy
685862|NCT00914810|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
685863|NCT00914810|Vitamin D|vitamin d
685864|NCT00914810|Cholecalciferol|cholecalciferol
685865|NCT00914810|Skeletal muscle|skeletal muscle
685866|NCT00914836|shoulder|shoulder
685867|NCT00914836|subacromion|subacromion
685868|NCT00914836|corticosteroid|corticosteroid
685869|NCT00914836|bursitis|bursitis
685870|NCT00914836|tendinitis|tendinitis
685871|NCT00914836|calcific tendonitis|calcific tendonitis
685872|NCT00914836|subacromial bursitis|subacromial bursitis
685873|NCT00914836|rotator cuff tendinitis|rotator cuff tendinitis
685874|NCT00914862|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
685875|NCT00914862|Drug Therapy|drug therapy
685876|NCT00914875|kidney function tests|kidney function tests
685877|NCT00914875|anti-inflammatory agents, non-steroidal|anti-inflammatory agents, non-steroidal
685878|NCT00914875|laparoscopic cholecystectomy|laparoscopic cholecystectomy
685879|NCT00914875|adult|adult
685880|NCT00914888|children|children
685881|NCT00914888|pediatry|pediatry
685882|NCT00914888|pneumonia|pneumonia
685883|NCT00914888|intra-abdominal|intra-abdominal
685884|NCT00914888|infection|infection
685885|NCT00914901|Asthma|asthma
685886|NCT00914901|Doping|doping
685887|NCT00914901|Salmeterol|salmeterol
685888|NCT00914901|Beta-agonist|beta-agonist
685889|NCT00914901|Urine concentrations|urine concentrations
685890|NCT00914927|Thrombocytopenia|thrombocytopenia
685891|NCT00914927|chronic liver disease|chronic liver disease
685892|NCT00914940|graft versus host disease|graft versus host disease
685893|NCT00914940|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
685894|NCT00914940|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
685895|NCT00914940|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
685896|NCT00914940|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
685897|NCT00914940|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
685898|NCT00914940|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
685899|NCT00914940|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
685993|NCT00915278|PF-04605412|pf-04605412
685900|NCT00914940|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
685901|NCT00914940|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
685902|NCT00914940|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
685903|NCT00914940|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
685904|NCT00914940|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
685905|NCT00914940|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
685906|NCT00914940|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
685907|NCT00914940|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
685908|NCT00914940|refractory anemia with excess blasts|refractory anemia with excess blasts
685909|NCT00914940|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
685910|NCT00914940|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
685911|NCT00914953|social isolation|social isolation
685912|NCT00914953|cooperative behavior|cooperative behavior
685913|NCT00914953|depression|depression
685914|NCT00914953|loneliness|loneliness
685915|NCT00914953|happiness|happiness
685917|NCT00914979|Angiosculpt|angiosculpt
685918|NCT00914979|Bifurcation Lesion|bifurcation lesion
685919|NCT00914979|Side branch|side branch
685920|NCT00914979|IVUS|ivus
685921|NCT00914992|optic disk|optic disk
685922|NCT00914992|regional blood flow|regional blood flow
685923|NCT00914992|autoregulation|autoregulation
685924|NCT00915005|Locally-advanced non-small-cell lung carcinoma|locally-advanced non-small-cell lung carcinoma
685925|NCT00915005|NSCLC|nsclc
685926|NCT00915005|Lung Cancer|lung cancer
685927|NCT00915005|Image-Guided Adaptive Conformal Photon|image-guided adaptive conformal photon
685928|NCT00915005|Proton Therapy|proton therapy
685929|NCT00915005|Chemotherapy|chemotherapy
685930|NCT00915005|Treatment Related Pneumonitis|treatment related pneumonitis
685931|NCT00915018|ErbB-2 positive advanced breast cancer|erbb-2 positive advanced breast cancer
685932|NCT00915031|Robotic prostatectomy|robotic prostatectomy
685933|NCT00915031|Hypothermia|hypothermia
685934|NCT00915031|Potency|potency
685935|NCT00915044|IBD|ibd
685936|NCT00915070|BQ-123|bq-123
685937|NCT00915070|Optic Nerve Head Blood Flow|optic nerve head blood flow
685938|NCT00915070|Intraocular Pressure|intraocular pressure
685939|NCT00915070|Regional Blood Flow|regional blood flow
685940|NCT00915070|Ocular Physiology|ocular physiology
685941|NCT00915070|Optic Disk|optic disk
685942|NCT00915096|Follicular Lymphoma|follicular lymphoma
685943|NCT00915096|PET|pet
685944|NCT00915096|GELA|gela
685945|NCT00915109|amputees|amputees
685946|NCT00915109|lower limb|lower limb
685947|NCT00915122|IMRT treatment for Prostate cancer patients|imrt treatment for prostate cancer patients
685948|NCT00915122|Radiation treatment for prostate cancer|radiation treatment for prostate cancer
685949|NCT00915122|cancer of the prostate|cancer of the prostate
685950|NCT00915122|Patients with high risk adenocarcinoma of the prostate|patients with high risk adenocarcinoma of the prostate
685951|NCT00915135|Insomnia|insomnia
685952|NCT00915135|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
685953|NCT00915135|Drug Therapy|drug therapy
685954|NCT00915148|Prolonged labor|prolonged labor
685955|NCT00915148|Ultrasound|ultrasound
685956|NCT00915148|Caeserian section|caeserian section
685957|NCT00915161|ventilation|ventilation
685958|NCT00915161|oxygenation|oxygenation
685959|NCT00915174|drug-drug interaction study|drug-drug interaction study
685960|NCT00915187|Vaccination, influenza prevention|vaccination, influenza prevention
685961|NCT00915200|Diabetic Nephropathies|diabetic nephropathies
685962|NCT00915200|Proteinuria|proteinuria
685963|NCT00915200|Renal Insufficiency, Chronic|renal insufficiency, chronic
685964|NCT00915200|Monocytes|monocytes
685965|NCT00915200|Oxidative stress|oxidative stress
685966|NCT00915200|Inflammation|inflammation
685967|NCT00915200|Antioxidants|antioxidants
685968|NCT00915200|Glutathione|glutathione
685969|NCT00915200|Silymarin|silymarin
685970|NCT00915200|Acetylcysteine|acetylcysteine
685971|NCT00915200|Dietary Supplements|dietary supplements
685972|NCT00915200|Complementary Therapies|complementary therapies
685974|NCT00915213|Prostate Biopsy|prostate biopsy
685975|NCT00915226|Optic disk|optic disk
685976|NCT00915226|Regional blood flow|regional blood flow
685977|NCT00915226|Autoregulation|autoregulation
685978|NCT00915239|volunteers|volunteers
686762|NCT00918879|Incretins|incretins
685979|NCT00915252|Acute Myeloid Leukemia|acute myeloid leukemia
685980|NCT00915252|azacitidine|azacitidine
685981|NCT00915252|elderly|elderly
685982|NCT00915252|demethylating agent|demethylating agent
685983|NCT00915252|flt3|flt3
685984|NCT00915252|AML|aml
685985|NCT00915265|Epidural analgesia|epidural analgesia
685986|NCT00915265|Continuous preperitoneal analgesia|continuous preperitoneal analgesia
685987|NCT00915265|Surgery|surgery
685988|NCT00915265|Open colorectal surgery|open colorectal surgery
685989|NCT00915265|Fast-track surgery|fast-track surgery
685990|NCT00915265|ERAS|eras
685991|NCT00915278|Neoplasms|neoplasms
685992|NCT00915278|monoclonal antibody|monoclonal antibody
685994|NCT00915278|advanced metastatic solid tumors|advanced metastatic solid tumors
685995|NCT00915291|medical education|medical education
685996|NCT00915291|clinical decisionmaking|clinical decisionmaking
685997|NCT00915291|pharmaceutical marketing|pharmaceutical marketing
685998|NCT00915304|Clinical Decision Support System|clinical decision support system
685999|NCT00915304|Automatic reminder|automatic reminder
686000|NCT00915304|Primary care|primary care
686001|NCT00915304|Evidence-Based Medicine|evidence-based medicine
686002|NCT00915330|Transbronchial needle aspiration|transbronchial needle aspiration
686003|NCT00915330|Bronchoscopy|bronchoscopy
686004|NCT00915330|Rapid on-site cytopathologic evaluation|rapid on-site cytopathologic evaluation
686005|NCT00915330|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
686006|NCT00915330|Hilar Lymphadenopathy|hilar lymphadenopathy
686007|NCT00915343|Adrenal insufficiency|adrenal insufficiency
686008|NCT00915343|Primary adrenal insufficiency|primary adrenal insufficiency
686009|NCT00915343|Addison's disease|addison's disease
686010|NCT00915343|Hydrocortisone|hydrocortisone
686011|NCT00915343|Modified release|modified release
686012|NCT00915356|AZD1305|azd1305
686013|NCT00915356|intravenous cardioversion of Atrial Fibrillation|intravenous cardioversion of atrial fibrillation
686014|NCT00915408|Multiple Myeloma|multiple myeloma
686015|NCT00915408|Cyclophosphamide|cyclophosphamide
686016|NCT00915408|Dexamethasone|dexamethasone
686017|NCT00915408|Lenalidomide|lenalidomide
686018|NCT00915421|cardiac arrest|cardiac arrest
686019|NCT00915421|therapeutic hypothermia|therapeutic hypothermia
686020|NCT00915421|Postresuscitative disease|postresuscitative disease
686021|NCT00915434|Healthy volunteer|healthy volunteer
686022|NCT00915434|Phase I|phase i
686023|NCT00915434|Non-childbearing potential|non-childbearing potential
686024|NCT00915434|JNJ-31001074|jnj-31001074
686025|NCT00915434|Food|food
686026|NCT00915434|Pharmacokinetics|pharmacokinetics
686027|NCT00915447|Cat Allergic Rhinitis|cat allergic rhinitis
686028|NCT00915460|Multiple Sclerosis|multiple sclerosis
686029|NCT00915460|Avonex|avonex
686030|NCT00915460|Interferon beta-1a|interferon beta-1a
686031|NCT00915460|patients at high risk to develop multiple sclerosis|patients at high risk to develop multiple sclerosis
686032|NCT00905502|Obesity|obesity
686033|NCT00905502|fluid management|fluid management
686034|NCT00905502|postoperative complications|postoperative complications
686035|NCT00905502|bariatric surgery|bariatric surgery
686036|NCT00905502|hemostasis|hemostasis
686037|NCT00905515|Kidney Transplantation|kidney transplantation
686038|NCT00905515|Immunosuppressive Agents|immunosuppressive agents
686039|NCT00905528|type 2 diabetes mellitus|type 2 diabetes mellitus
686040|NCT00905528|endothelial function|endothelial function
686041|NCT00905528|renal hemodynamics|renal hemodynamics
686042|NCT00905554|sedation|sedation
686043|NCT00905554|warm water|warm water
686044|NCT00905567|Bioequivalence|bioequivalence
686045|NCT00905567|Healthy Subjects|healthy subjects
686047|NCT00905580|pain, postoperative|pain, postoperative
686048|NCT00905580|pregabalin|pregabalin
686049|NCT00905593|chronic myeloid leukemia,|chronic myeloid leukemia,
686050|NCT00905593|blast crisis,|blast crisis,
686051|NCT00905593|accelerated phase,|accelerated phase,
686052|NCT00905593|nilotinib,|nilotinib,
686053|NCT00905593|imatinib,|imatinib,
686054|NCT00905593|resistant,|resistant,
686055|NCT00905593|intolerant,|intolerant,
686056|NCT00905593|chronic phase|chronic phase
686057|NCT00905606|Bioequivalence|bioequivalence
686058|NCT00905606|Healthy Subjects|healthy subjects
686059|NCT00905645|Breast Augmentation|breast augmentation
686060|NCT00905645|Breast Reconstruction|breast reconstruction
686061|NCT00905645|Breast Revision|breast revision
688476|NCT00924339|FH|fh
686062|NCT00905645|Silicone breast implants|silicone breast implants
686063|NCT00905658|stage IVA cervical cancer|stage iva cervical cancer
686064|NCT00905658|stage IVB cervical cancer|stage ivb cervical cancer
686065|NCT00905658|fallopian tube cancer|fallopian tube cancer
686066|NCT00905658|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
686067|NCT00905658|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
686068|NCT00905658|ovarian sarcoma|ovarian sarcoma
686069|NCT00905658|ovarian stromal cancer|ovarian stromal cancer
686070|NCT00905658|stage IV endometrial carcinoma|stage iv endometrial carcinoma
686071|NCT00905658|stage IV uterine sarcoma|stage iv uterine sarcoma
686072|NCT00905658|stage IVA vaginal cancer|stage iva vaginal cancer
686073|NCT00905658|stage IVB vaginal cancer|stage ivb vaginal cancer
686854|NCT00919217|Women|women
686074|NCT00905658|stage IV vulvar cancer|stage iv vulvar cancer
686075|NCT00905671|Lipid Core Plaque|lipid core plaque
686076|NCT00905671|LCP|lcp
686077|NCT00905671|Bifurcation|bifurcation
686078|NCT00905671|Stenosis|stenosis
686079|NCT00905671|Lesion|lesion
686080|NCT00905671|Angioplasty|angioplasty
686081|NCT00905684|Compliance|compliance
686082|NCT00905684|Hormonal Contraception|hormonal contraception
686083|NCT00905697|Living donor lung transplantation|living donor lung transplantation
686084|NCT00905697|Health-related quality of life|health-related quality of life
686085|NCT00905697|Prognosis|prognosis
686086|NCT00905697|Patient reported outcome|patient reported outcome
686087|NCT00905710|colorectal adenomas|colorectal adenomas
686381|NCT00906984|TheraSphere|therasphere
686088|NCT00905710|colorectal cancer|colorectal cancer
686089|NCT00905710|Lynch syndrome|lynch syndrome
686090|NCT00905710|chromoendoscopy|chromoendoscopy
686091|NCT00905723|climacterium|climacterium
686092|NCT00905723|sexual life|sexual life
686093|NCT00905723|isoflavone|isoflavone
686094|NCT00905723|estrogen|estrogen
686095|NCT00905723|McCoy's sexual questionnaire|mccoy's sexual questionnaire
686096|NCT00905723|Kupperman index|kupperman index
686097|NCT00905736|tendon|tendon
686098|NCT00905736|healing|healing
686099|NCT00905736|microcurrent|microcurrent
686100|NCT00905736|chronic tennis elbow|chronic tennis elbow
686101|NCT00905762|pharmacokinetics|pharmacokinetics
686102|NCT00905775|Isoflurane;|isoflurane;
686103|NCT00905775|Propofol|propofol
686104|NCT00905775|Renal functions tests|renal functions tests
686105|NCT00905775|Cardiovascular tests|cardiovascular tests
686106|NCT00905775|revascularization surgery of the myocardium|revascularization surgery of the myocardium
686107|NCT00905775|extracorporeal circulation|extracorporeal circulation
686108|NCT00905788|Embryo transfer|embryo transfer
686109|NCT00905788|IVF/ICSI|ivf/icsi
686110|NCT00905788|Embryo expulsion|embryo expulsion
686111|NCT00905801|Non small cell lung cancer|non small cell lung cancer
686112|NCT00905801|NSCLC|nsclc
686113|NCT00905801|CTP|ctp
686114|NCT00905801|Perfusion|perfusion
686115|NCT00905801|Imaging|imaging
686116|NCT00905814|Bioequivalence|bioequivalence
686117|NCT00905827|suicide|suicide
686118|NCT00905827|assessment|assessment
686119|NCT00905827|management|management
686120|NCT00905827|Provider Training|provider training
686121|NCT00905827|health services|health services
686122|NCT00905853|Ventricular Tachycardia|ventricular tachycardia
686123|NCT00905853|Catheter Ablation|catheter ablation
686124|NCT00905853|ICD therapy|icd therapy
686125|NCT00905853|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
686126|NCT00905853|Ischemic Heart Disease|ischemic heart disease
686127|NCT00905866|Quality of life|quality of life
686128|NCT00905866|Hyperparathyroidism|hyperparathyroidism
686129|NCT00905879|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
686130|NCT00905879|Observational study|observational study
686131|NCT00905879|Gadobutrol|gadobutrol
686132|NCT00905892|overfeeding|overfeeding
686133|NCT00905892|stable isotopes|stable isotopes
686134|NCT00905892|lipoprotein metabolism|lipoprotein metabolism
686135|NCT00905892|lipid oxidation|lipid oxidation
686136|NCT00905892|fat distribution|fat distribution
686137|NCT00905892|gene expression|gene expression
686138|NCT00905892|endotoxemia|endotoxemia
686139|NCT00905892|mass spectrometry/gas chromatography|mass spectrometry/gas chromatography
686140|NCT00905905|myocardial infarction|myocardial infarction
686141|NCT00905905|systemic inflammatory activity|systemic inflammatory activity
686142|NCT00905905|endothelial function|endothelial function
686143|NCT00905918|colon cancer|colon cancer
686144|NCT00905918|rectal cancer|rectal cancer
686247|NCT00906399|PEGylated|pegylated
686145|NCT00905931|Aneurysmal subarachnoid hemorrhage (aSAH)|aneurysmal subarachnoid hemorrhage (asah)
686146|NCT00905931|Cerebral vasospasm|cerebral vasospasm
686147|NCT00905931|impaired cerebral autoregulation|impaired cerebral autoregulation
686148|NCT00905931|transient hyperaemic response test|transient hyperaemic response test
686149|NCT00905931|delayed ischaemic neurological deficits|delayed ischaemic neurological deficits
686150|NCT00905944|Left ventricular failure|left ventricular failure
686151|NCT00905944|chronic heart failure|chronic heart failure
686152|NCT00905944|Pacemaker|pacemaker
686153|NCT00905944|Resynchronisation therapy|resynchronisation therapy
686154|NCT00905944|Exercise|exercise
686155|NCT00905944|Endurance exercise|endurance exercise
686156|NCT00905957|transversus abdominis plane block|transversus abdominis plane block
686157|NCT00905957|relief|relief
686158|NCT00905983|Carcinoma, Non-Small-Cell|carcinoma, non-small-cell
686159|NCT00905983|Elderly patients|elderly patients
686160|NCT00905983|Docetaxel|docetaxel
686161|NCT00905983|Gemcitabine|gemcitabine
686162|NCT00906022|Below the Knee|below the knee
686163|NCT00906022|Infrapopliteal arteries|infrapopliteal arteries
686164|NCT00906022|nitinol|nitinol
686165|NCT00906022|limb ischemia|limb ischemia
686166|NCT00906022|claudication|claudication
686167|NCT00906022|self-expanding stent|self-expanding stent
686168|NCT00906022|duplex|duplex
686169|NCT00906022|angiography|angiography
686170|NCT00906035|Peripheral Arterial Disease|peripheral arterial disease
686172|NCT00906035|Claudication|claudication
686173|NCT00906035|Peripheral Vascular Disease|peripheral vascular disease
686174|NCT00906061|Carcinoma, Small Cell|carcinoma, small cell
686175|NCT00906061|Lung Neoplasms|lung neoplasms
686176|NCT00906061|Docetaxel|docetaxel
686177|NCT00906061|Gemcitabine|gemcitabine
686178|NCT00906061|ECOG 2|ecog 2
686179|NCT00906074|Surgical Wound Infection|surgical wound infection
686180|NCT00906074|Surgical Site Infection|surgical site infection
686181|NCT00906074|Abdominal Surgery|abdominal surgery
686182|NCT00906087|Myocilin gene|myocilin gene
686183|NCT00906087|Glaucoma|glaucoma
686184|NCT00906087|dorzolamide and timolol combination eyedrop|dorzolamide and timolol combination eyedrop
686383|NCT00906997|Screening|screening
686185|NCT00906100|Biventricular ICD|biventricular icd
686186|NCT00906100|AV delay|av delay
686187|NCT00906113|Retinoblastoma|retinoblastoma
686188|NCT00906126|oral misoprostol|oral misoprostol
686189|NCT00906126|labor augmentation|labor augmentation
686190|NCT00906126|arrest of dilation|arrest of dilation
686191|NCT00906126|nulliparous|nulliparous
686192|NCT00906139|Propofol|propofol
686193|NCT00906139|Midazolam|midazolam
686194|NCT00906139|Cirrhosis|cirrhosis
686195|NCT00906139|Gastrointestinal endoscopy|gastrointestinal endoscopy
686196|NCT00906139|Complications|complications
686197|NCT00906139|Sedation|sedation
686198|NCT00906152|quality of sleep|quality of sleep
686199|NCT00906152|low back pain|low back pain
686200|NCT00906152|disability|disability
686201|NCT00906152|catastrophizing|catastrophizing
686202|NCT00906152|depression|depression
686203|NCT00906178|HIV prevention|hiv prevention
686204|NCT00906178|technology|technology
686205|NCT00906178|adolescent|adolescent
686206|NCT00906178|developing countries|developing countries
686207|NCT00906204|Renal transplantation|renal transplantation
686208|NCT00906204|Kidney transplantation|kidney transplantation
686209|NCT00906217|colonoscopy|colonoscopy
686210|NCT00906217|preparation|preparation
686211|NCT00906217|safety|safety
686212|NCT00906217|elderly|elderly
686213|NCT00906256|Hepatitis C|hepatitis c
686214|NCT00906256|Pharmacokinetics|pharmacokinetics
686215|NCT00906256|AZD7295|azd7295
686216|NCT00906256|Healthy volunteers|healthy volunteers
686217|NCT00906269|impotence|impotence
686218|NCT00906269|prostatic neoplasms|prostatic neoplasms
686219|NCT00906269|hyperbaric oxygenation|hyperbaric oxygenation
686220|NCT00906269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
686221|NCT00906282|neoadjuvant NSCLC|neoadjuvant nsclc
686222|NCT00906282|NSCLC|nsclc
686223|NCT00906282|pemetrexed|pemetrexed
686224|NCT00906295|Hemoglobin|hemoglobin
686225|NCT00906295|Ambulation|ambulation
686226|NCT00906321|Web-Based Decision Support|web-based decision support
686227|NCT00906321|Breast Cancer Risk|breast cancer risk
686228|NCT00906334|Myelodysplastic Syndrome|myelodysplastic syndrome
686229|NCT00906334|Trisomy 8|trisomy 8
686230|NCT00906334|Intermediate-2 Risk Group|intermediate-2 risk group
686231|NCT00906334|High-Risk Group|high-risk group
686232|NCT00906334|azacitidine|azacitidine
686233|NCT00906334|azacytidine|azacytidine
686234|NCT00906334|Vidaza|vidaza
686235|NCT00906334|decitabine|decitabine
686236|NCT00906334|Dacogen|dacogen
686237|NCT00906347|Labor augmentation|labor augmentation
686238|NCT00906347|Oral misoprostol|oral misoprostol
686239|NCT00906373|Hepatocellular Carcinoma|hepatocellular carcinoma
686240|NCT00906373|Liver Neoplasms|liver neoplasms
686241|NCT00906373|Antibodies, Monoclonal|antibodies, monoclonal
686242|NCT00906386|Varenicline|varenicline
686243|NCT00906399|interferon|interferon
686244|NCT00906399|injectable|injectable
686245|NCT00906399|MS|ms
686246|NCT00906399|SC|sc
686248|NCT00906399|Interferon beta-1a|interferon beta-1a
686249|NCT00906399|relapsing|relapsing
686250|NCT00906399|PEG|peg
686251|NCT00906399|multiple sclerosis|multiple sclerosis
686252|NCT00906399|subcutaneous|subcutaneous
686253|NCT00906412|Essential Tremor|essential tremor
686254|NCT00906425|Dental Implant|dental implant
686255|NCT00906451|myocardial infarction|myocardial infarction
686256|NCT00906451|inflammation|inflammation
686257|NCT00906451|endothelial dysfunction|endothelial dysfunction
686258|NCT00906490|Glucose Monitoring|glucose monitoring
686259|NCT00906490|Accurate Blood Glucose Monitoring in critical care setting|accurate blood glucose monitoring in critical care setting
686260|NCT00906503|pulmonary nodule|pulmonary nodule
686261|NCT00906516|Recurrent Glioblastoma multiforme (GBM)|recurrent glioblastoma multiforme (gbm)
686262|NCT00906516|Recurrent Brain Tumor|recurrent brain tumor
686263|NCT00906516|Recurrent Brain Disease|recurrent brain disease
686265|NCT00906516|Avastin|avastin
686266|NCT00906516|Bevacizumab|bevacizumab
686267|NCT00906529|Type 2 Diabetes|type 2 diabetes
686268|NCT00906529|Inpatient|inpatient
686269|NCT00906529|Length of Stay|length of stay
686270|NCT00906529|Blood Glucose Control|blood glucose control
686271|NCT00906542|acute stroke|acute stroke
686272|NCT00906542|ischemic stroke|ischemic stroke
686273|NCT00906542|pneumonia|pneumonia
686274|NCT00906542|chest infection|chest infection
686275|NCT00906542|brain lesion|brain lesion
686932|NCT00919451|Ciclosporin|ciclosporin
686276|NCT00906542|lesion topology|lesion topology
686277|NCT00906542|dysphagia|dysphagia
686278|NCT00906542|sympathetic activation|sympathetic activation
686279|NCT00906542|immunosuppression|immunosuppression
686280|NCT00906568|Cystic fibrosis|cystic fibrosis
686281|NCT00906568|Sensitization to Aspergillus|sensitization to aspergillus
686282|NCT00906568|Bronchial allergen challenge|bronchial allergen challenge
686283|NCT00906568|Induced Sputum|induced sputum
686284|NCT00906568|Bronchial inflammation|bronchial inflammation
686285|NCT00906568|Small airways disease (SAD)|small airways disease (sad)
686286|NCT00906581|Depression|depression
686287|NCT00906607|Urinary Incontinence|urinary incontinence
686382|NCT00906997|Colorectal cancer|colorectal cancer
686288|NCT00906620|Data on student's healthy and at-risk lifestyles and their relation with health measured by well-being, depression and suicidality|data on student's healthy and at-risk lifestyles and their relation with health measured by well-being, depression and suicidality
686289|NCT00906633|antifungal therapies|antifungal therapies
686290|NCT00906646|cardiac|cardiac
686291|NCT00906646|surgery|surgery
686292|NCT00906646|metabolic|metabolic
686293|NCT00906646|supplements|supplements
686294|NCT00906646|antioxidant|antioxidant
686295|NCT00906659|center point thickness|center point thickness
686296|NCT00906659|diabetic retinopathy|diabetic retinopathy
686297|NCT00906659|diabetic macular edema|diabetic macular edema
686298|NCT00906659|macular volume|macular volume
686299|NCT00906659|visual capacity|visual capacity
686300|NCT00906659|visual function|visual function
686301|NCT00906672|Dermal substitute Integra®|dermal substitute integra®
686302|NCT00906672|Flap|flap
686303|NCT00906672|graft|graft
686304|NCT00906672|traumatic wound|traumatic wound
686305|NCT00906672|medico economic costs|medico economic costs
686306|NCT00906672|esthetical and functional scar results|esthetical and functional scar results
686307|NCT00906685|CRVO|crvo
686308|NCT00906685|anti-VEGF|anti-vegf
686309|NCT00906685|Macular edema|macular edema
686310|NCT00906711|Aging|aging
686311|NCT00906711|Postural Balance|postural balance
686312|NCT00906737|Multiple Sclerosis|multiple sclerosis
686313|NCT00906737|Gait|gait
686314|NCT00906737|foot-drop|foot-drop
686315|NCT00906737|Ankle-Bot|ankle-bot
686316|NCT00906737|Physical Therapy|physical therapy
686317|NCT00906737|Gait Abnormalities|gait abnormalities
686318|NCT00906750|FLuMIST|flumist
686319|NCT00906750|Inactivated influenza vaccine|inactivated influenza vaccine
686320|NCT00906750|Study of FluMist versus inactivated influenza vaccine in children with cancer|study of flumist versus inactivated influenza vaccine in children with cancer
686321|NCT00906763|Parkinson's disease|parkinson's disease
686322|NCT00906763|Neurodegenerative Disorders|neurodegenerative disorders
686323|NCT00906763|Biogenic amines|biogenic amines
686324|NCT00906763|Chocolate|chocolate
686325|NCT00906763|Cocoa|cocoa
686326|NCT00906789|Lung Cancer|lung cancer
686327|NCT00906789|Chest Radiograph|chest radiograph
686328|NCT00906789|Computer-aided Detection|computer-aided detection
686329|NCT00906789|Image processing|image processing
686330|NCT00906802|pancreaticoduodenectomy|pancreaticoduodenectomy
686331|NCT00906802|reconstruction|reconstruction
686332|NCT00906828|Levodopa/carbidopa infusion|levodopa/carbidopa infusion
686333|NCT00906828|entacapone|entacapone
686334|NCT00906828|tolcapone|tolcapone
686335|NCT00906828|efficacy|efficacy
686336|NCT00906828|pharmacokinetic|pharmacokinetic
686337|NCT00906828|pharmacodynamics|pharmacodynamics
686338|NCT00906841|Disseminated diffuse large B-cell lymphoma|disseminated diffuse large b-cell lymphoma
686339|NCT00906841|first line treatment|first line treatment
686340|NCT00906841|R CHOP|r chop
686341|NCT00906841|90Y-DOTA-hLL2|90y-dota-hll2
686342|NCT00906841|Patients older than 60 years|patients older than 60 years
686644|NCT00918411|YM060|ym060
686343|NCT00906854|urinary incontinence|urinary incontinence
686344|NCT00906854|physical exercise|physical exercise
686345|NCT00906867|Vocal cord dysfunction|vocal cord dysfunction
686346|NCT00906867|Laryngoscopy|laryngoscopy
686347|NCT00906867|Methacholine challenge|methacholine challenge
686348|NCT00906867|Pulmonary function testing|pulmonary function testing
686349|NCT00906880|Human African Trypanosomiasis|human african trypanosomiasis
686350|NCT00906880|HAT|hat
686351|NCT00906880|sleeping sickness|sleeping sickness
686352|NCT00906880|combination treatment|combination treatment
686353|NCT00906880|nifurtimox|nifurtimox
686354|NCT00906880|eflornithine|eflornithine
686355|NCT00906880|Human African Trypanosomiasis in the meningo-encephalitic phase (stage 2 HAT)|human african trypanosomiasis in the meningo-encephalitic phase (stage 2 hat)
686356|NCT00906893|[18F]-FMISO uptake|[18f]-fmiso uptake
686357|NCT00906893|Glioblastoma|glioblastoma
686358|NCT00906893|Hypoxia|hypoxia
686359|NCT00906893|tumours|tumours
686360|NCT00906919|self-efficacy|self-efficacy
686361|NCT00906919|health behavior|health behavior
686362|NCT00906919|patient education|patient education
686363|NCT00906919|health education|health education
686364|NCT00906932|Fiberoptic intubation|fiberoptic intubation
686365|NCT00906932|direct laryngoscopy|direct laryngoscopy
686366|NCT00906932|Trachview|trachview
686472|NCT00907296|Tibial Diaphyseal Fracture|tibial diaphyseal fracture
686473|NCT00907309|alcohol abuse|alcohol abuse
686367|NCT00906932|Comparison of a fiberoptic intubating videoscope to direct laryngoscopy.|comparison of a fiberoptic intubating videoscope to direct laryngoscopy.
686368|NCT00906945|stem cell mobilization|stem cell mobilization
686369|NCT00906945|chemosensitization|chemosensitization
686370|NCT00906945|CXCR4|cxcr4
686371|NCT00906945|SDF-1|sdf-1
686372|NCT00906945|CXCL-12|cxcl-12
686373|NCT00906971|Physical Therapy|physical therapy
686374|NCT00906971|Chronic Functional Constipation|chronic functional constipation
686375|NCT00906971|Children|children
686376|NCT00906984|Hepatocellular carcinoma|hepatocellular carcinoma
686377|NCT00906984|Liver cancer|liver cancer
686378|NCT00906984|Primary liver cancer|primary liver cancer
686379|NCT00906984|Unresectable liver cancer|unresectable liver cancer
686380|NCT00906984|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
686385|NCT00906997|Fecal occult blood test|fecal occult blood test
686386|NCT00906997|Colonoscopy|colonoscopy
686387|NCT00906997|Colorectal neoplasm|colorectal neoplasm
686388|NCT00906997|Randomized clinical trial|randomized clinical trial
686389|NCT00907010|Ageing|ageing
686390|NCT00907010|Sarcopenia|sarcopenia
686391|NCT00907010|Muscular contraction|muscular contraction
686392|NCT00907023|solid organ transplant|solid organ transplant
686393|NCT00907023|hospital discharge|hospital discharge
686394|NCT00907036|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
686395|NCT00907049|quality of sleep|quality of sleep
686396|NCT00907049|neck pain|neck pain
686397|NCT00907049|disability|disability
686398|NCT00907049|catastrophizing|catastrophizing
686399|NCT00907049|depression|depression
686400|NCT00907062|vitiligo|vitiligo
686401|NCT00907062|leucoderma|leucoderma
686402|NCT00907075|diabetes|diabetes
686403|NCT00907075|nutrition|nutrition
686404|NCT00907075|diet|diet
686405|NCT00907075|foods|foods
686406|NCT00907088|Iron depletion|iron depletion
686407|NCT00907088|Children|children
686408|NCT00907088|Educational intervention|educational intervention
686409|NCT00907088|Office-based|office-based
686410|NCT00907114|proliferative diabetic retinopathy|proliferative diabetic retinopathy
686411|NCT00907114|macular edema|macular edema
686412|NCT00907114|panphotocoagulation|panphotocoagulation
686413|NCT00907114|topic ketorolac|topic ketorolac
686414|NCT00907114|efficacy|efficacy
686415|NCT00907114|treatment|treatment
686416|NCT00907127|Metabolic|metabolic
686417|NCT00907127|Syndrome|syndrome
686419|NCT00907140|Cervical Cancer|cervical cancer
686420|NCT00907140|Positron Emission Tomography|positron emission tomography
686421|NCT00907140|Fluorodeoxyglucose|fluorodeoxyglucose
686422|NCT00907153|Polycystic Ovary Syndrome|polycystic ovary syndrome
686423|NCT00907153|Vitamin D|vitamin d
686424|NCT00907153|Insulin resistance|insulin resistance
686425|NCT00907153|Inflammation|inflammation
686426|NCT00907166|Cornerstone Pharmaceuticals, Inc.|cornerstone pharmaceuticals, inc.
686427|NCT00907166|CPI-613|cpi-613
686428|NCT00907166|Altered Energy Metabolism Directed Compound|altered energy metabolism directed compound
686429|NCT00907166|Phase I|phase i
686430|NCT00907166|Phase II|phase ii
686431|NCT00907166|Cancer|cancer
686432|NCT00907166|Carcinoma of the Pancreas|carcinoma of the pancreas
686433|NCT00907166|Pancreatic Cancer|pancreatic cancer
686434|NCT00907166|Pancreatic Carcinoma|pancreatic carcinoma
686435|NCT00907192|Cancer|cancer
686436|NCT00907192|Opioid analgesic prescriptions|opioid analgesic prescriptions
686437|NCT00907192|Narcotic pain drugs|narcotic pain drugs
686438|NCT00907192|Self-report|self-report
686439|NCT00907192|Questionnaire|questionnaire
686440|NCT00907192|Interview|interview
686441|NCT00907192|Actual use|actual use
686442|NCT00907192|Doctor-prescribed use|doctor-prescribed use
686443|NCT00907192|Frequency of deviation|frequency of deviation
686444|NCT00907205|Advanced Solid Tumors|advanced solid tumors
686445|NCT00907205|Metastatic Solid Tumors|metastatic solid tumors
686446|NCT00907205|PI3K|pi3k
686447|NCT00907205|PI3K Inhibitors|pi3k inhibitors
686448|NCT00907205|PI3 Kinase Inhibitors|pi3 kinase inhibitors
686449|NCT00907205|mTORC inhibitor|mtorc inhibitor
686450|NCT00907205|mTORC1 inhibitor|mtorc1 inhibitor
686451|NCT00907205|mTORC2 inhibitor|mtorc2 inhibitor
686452|NCT00907205|vascular targeted|vascular targeted
686453|NCT00907205|conjugate|conjugate
686455|NCT00907218|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
686456|NCT00907218|ADHD medication|adhd medication
686457|NCT00907218|Chantix|chantix
686458|NCT00907218|varenicline|varenicline
686459|NCT00907218|smoking|smoking
686460|NCT00907218|smoking cessation|smoking cessation
686461|NCT00907218|quit smoking|quit smoking
686462|NCT00907257|acne|acne
686463|NCT00907257|irritation|irritation
686464|NCT00907257|objective sensory methods|objective sensory methods
686465|NCT00907283|NBIA|nbia
686466|NCT00907283|Iron overload AND brain|iron overload and brain
686467|NCT00907283|Iron chelation AND neurodegeneration|iron chelation and neurodegeneration
686468|NCT00907283|Brain iron Overload|brain iron overload
686469|NCT00907283|Neurodegeneration|neurodegeneration
686470|NCT00907283|Brain iron Accumulation|brain iron accumulation
686471|NCT00907296|Fracture Healing|fracture healing
686474|NCT00907309|marijuana abuse|marijuana abuse
686475|NCT00907309|drug abuse|drug abuse
686476|NCT00907309|tobacco use|tobacco use
686477|NCT00907309|tobacco dependence|tobacco dependence
686478|NCT00907322|oral, single ascending doses; CYP2D6 metabolizer status; healthy subjects; safety, tolerability, pharmacokinetics|oral, single ascending doses; cyp2d6 metabolizer status; healthy subjects; safety, tolerability, pharmacokinetics
686479|NCT00907335|acne|acne
686480|NCT00907335|irritation|irritation
686481|NCT00907335|objective sensory methods|objective sensory methods
686483|NCT00907348|Non Hodgkin Lymphoma|non hodgkin lymphoma
686484|NCT00907348|Follicular Lymphoma|follicular lymphoma
686487|NCT00907361|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
686488|NCT00907361|MRI|mri
686489|NCT00907361|Magnetic Resonance Imaging|magnetic resonance imaging
686490|NCT00907374|Microalbuminuria|microalbuminuria
686491|NCT00907374|Carotid intima media thickness|carotid intima media thickness
686492|NCT00907374|Endothelial dysfunction|endothelial dysfunction
686493|NCT00907374|Renin angiotensin system|renin angiotensin system
686494|NCT00907374|Diabetic nephropathy|diabetic nephropathy
686495|NCT00907387|Lateral Canthal Lines|lateral canthal lines
686496|NCT00907387|Crow's Feet|crow's feet
686497|NCT00907387|Facial Wrinkles|facial wrinkles
686498|NCT00907400|Phase 1|phase 1
686499|NCT00907400|Healthy Volunteer|healthy volunteer
686500|NCT00907400|Healthy Volunteer Study|healthy volunteer study
686501|NCT00907413|cancer|cancer
686502|NCT00907413|bile duct|bile duct
686503|NCT00907426|eyelashes|eyelashes
686504|NCT00907439|Diastole, physiopathology|diastole, physiopathology
686505|NCT00907439|coronary artery disease|coronary artery disease
686506|NCT00907439|volatile anesthetic|volatile anesthetic
686507|NCT00907439|sevoflurane|sevoflurane
686508|NCT00907452|Pharmacogenomics|pharmacogenomics
686509|NCT00907452|prediction response|prediction response
686510|NCT00907452|prediction adverse event|prediction adverse event
686511|NCT00907478|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
686512|NCT00907478|Idiopathic Thrombocytopenia Purpura|idiopathic thrombocytopenia purpura
686513|NCT00907478|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
686514|NCT00907478|Immune Thrombocytopenia|immune thrombocytopenia
686515|NCT00907478|ITP|itp
686516|NCT00907491|Cough|cough
686517|NCT00907491|Wheeze Rate|wheeze rate
686518|NCT00907491|Respiratory Function Tests|respiratory function tests
686519|NCT00915486|Diabetic|diabetic
686520|NCT00915486|ulcer|ulcer
686521|NCT00915486|topical|topical
686522|NCT00915486|PDGF|pdgf
686523|NCT00915486|GSoC|gsoc
686524|NCT00915512|Schizophrenia|schizophrenia
686525|NCT00915512|Paliperidone|paliperidone
686526|NCT00915512|Invega|invega
686527|NCT00915538|Asthma|asthma
686528|NCT00915538|Formoterol|formoterol
686529|NCT00915538|LABA|laba
686530|NCT00915538|Symbicort|symbicort
686531|NCT00915538|Aerochamber|aerochamber
686532|NCT00915551|Peplin|peplin
686533|NCT00915551|Actinic keratosis|actinic keratosis
686534|NCT00915551|PEP005|pep005
686535|NCT00915564|Hepatitis C|hepatitis c
686536|NCT00915564|HCV|hcv
686537|NCT00915564|Hepatitis C Virus|hepatitis c virus
686538|NCT00915564|HCV negative|hcv negative
686539|NCT00915564|Protease inhibitor|protease inhibitor
686540|NCT00915564|Methadone|methadone
686541|NCT00915564|TMC435|tmc435
686542|NCT00915577|Multiple Sclerosis|multiple sclerosis
687467|NCT00911144|Safety|safety
686543|NCT00915577|interferon beta-1a|interferon beta-1a
686544|NCT00915577|Avonex|avonex
686545|NCT00915577|liquid Avonex|liquid avonex
686546|NCT00915603|Metastatic Breast Cancer|metastatic breast cancer
686547|NCT00915603|Paclitaxel|paclitaxel
686548|NCT00915603|Bevacizumab|bevacizumab
686549|NCT00915603|Everolimus|everolimus
686550|NCT00915642|Obesity|obesity
686551|NCT00915642|Weight loss rate|weight loss rate
686552|NCT00915642|Sleep|sleep
686553|NCT00915642|Vigil|vigil
686554|NCT00915642|Metabolism|metabolism
686555|NCT00915642|Actigraphy|actigraphy
686556|NCT00915642|Normal|normal
686557|NCT00915655|HIV Infections|hiv infections
688953|NCT00916370|stents|stents
686558|NCT00915655|TMC114-TiDP29-C230|tmc114-tidp29-c230
686559|NCT00915655|TMC114-C230|tmc114-c230
686560|NCT00915655|TMC114|tmc114
686561|NCT00915655|HIV-1|hiv-1
686562|NCT00915655|Darunavir|darunavir
686563|NCT00915655|Ritonavir|ritonavir
686564|NCT00915655|NRTI|nrti
686565|NCT00915655|Treatment Naive|treatment naive
686566|NCT00915668|Healthy women|healthy women
686567|NCT00915668|Non-childbearing potential|non-childbearing potential
686568|NCT00915668|Drug-drug interaction|drug-drug interaction
686569|NCT00915668|Oral contraceptive|oral contraceptive
686570|NCT00915668|OC|oc
686571|NCT00915668|Ovral-L|ovral-l
686572|NCT00915668|ethinyl estradiol|ethinyl estradiol
686573|NCT00915668|EE|ee
686574|NCT00915668|levonorgestrel|levonorgestrel
686575|NCT00915668|JNJ-31001074|jnj-31001074
686576|NCT00915681|amatoxin|amatoxin
686577|NCT00915681|amanita|amanita
686578|NCT00915681|mushroom poisoning|mushroom poisoning
686579|NCT00915681|hepatic failure|hepatic failure
686580|NCT00915681|milk thistle|milk thistle
686581|NCT00915681|Silibinin|silibinin
686582|NCT00915681|Legalon|legalon
686583|NCT00915694|adult giant cell glioblastoma|adult giant cell glioblastoma
686584|NCT00915694|adult gliosarcoma|adult gliosarcoma
686585|NCT00915694|adult glioblastoma|adult glioblastoma
686586|NCT00915707|obesity|obesity
686587|NCT00915707|diabetes, risk|diabetes, risk
686588|NCT00915707|obesity, diabetes risk related to sleep|obesity, diabetes risk related to sleep
686589|NCT00915720|Atrial Fibrillation|atrial fibrillation
686590|NCT00915720|Surgical Ablation|surgical ablation
686591|NCT00915720|Implanted loop recorder|implanted loop recorder
686863|NCT00919282|gemcitabine|gemcitabine
686592|NCT00915720|Atrial Fibrillation Ablation|atrial fibrillation ablation
686593|NCT00915733|acute myocardial infarction|acute myocardial infarction
686594|NCT00915733|inhibition of platelet aggregation|inhibition of platelet aggregation
686595|NCT00915733|triple antiplatelet therapy|triple antiplatelet therapy
686596|NCT00915733|high maintenance-dose clopidogrel.|high maintenance-dose clopidogrel.
686597|NCT00915733|CYP2C19 polymorphism|cyp2c19 polymorphism
686598|NCT00915733|High posttreatment platelet reactivity|high posttreatment platelet reactivity
686599|NCT00915733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
686600|NCT00915733|CYP2C19, human|cyp2c19, human
686601|NCT00915746|Phase I|phase i
686602|NCT00915746|ketoconazole|ketoconazole
686603|NCT00915746|CYP3A4 inhibitor|cyp3a4 inhibitor
686604|NCT00915746|drug interaction|drug interaction
686605|NCT00915746|metabolism|metabolism
686606|NCT00915746|Healthly Volunteer|healthly volunteer
686607|NCT00915746|JNJ-31001074|jnj-31001074
686608|NCT00915759|ProKera|prokera
686609|NCT00915759|Amniotic membrane|amniotic membrane
686610|NCT00915759|Photorefractive Keratectomy|photorefractive keratectomy
686611|NCT00915759|PRK|prk
686612|NCT00915759|time to re-epithelialization|time to re-epithelialization
686613|NCT00918294|CRT|crt
686614|NCT00918294|heart failure|heart failure
686615|NCT00918294|optimization|optimization
686616|NCT00918294|Timing cycle optimization methods|timing cycle optimization methods
686617|NCT00918307|Tobacco Dependence|tobacco dependence
686618|NCT00918307|HIV infection|hiv infection
686619|NCT00918307|varenicline|varenicline
686620|NCT00918320|Temozolomide|temozolomide
686621|NCT00918320|Topotecan|topotecan
686622|NCT00918320|paediatric solid tumours|paediatric solid tumours
686623|NCT00918320|Miscellaneous other solid tumours|miscellaneous other solid tumours
686624|NCT00918346|Ocular hypertension|ocular hypertension
686625|NCT00918372|MSCTA|mscta
686626|NCT00918372|Marathon runners|marathon runners
686627|NCT00918385|hormone resistant prostate cancer|hormone resistant prostate cancer
686628|NCT00918385|castration resistant prostate cancer|castration resistant prostate cancer
686629|NCT00918385|hormone refractory prostate cancer|hormone refractory prostate cancer
686630|NCT00918385|metastatic prostate cancer|metastatic prostate cancer
686631|NCT00918385|hormonal therapy|hormonal therapy
686632|NCT00918385|antiandrogen therapy|antiandrogen therapy
686633|NCT00918385|androgen receptor|androgen receptor
686634|NCT00918385|nilutamide|nilutamide
686635|NCT00918385|dasatinib|dasatinib
686636|NCT00918385|genomics|genomics
686637|NCT00918385|genomic signature|genomic signature
686638|NCT00918385|genomic predictor|genomic predictor
686639|NCT00918385|genomic analysis|genomic analysis
686640|NCT00918385|genomic expression profile|genomic expression profile
686641|NCT00918411|diarrhea|diarrhea
686642|NCT00918411|IBS|ibs
686643|NCT00918411|Colonic diseases|colonic diseases
686645|NCT00918437|uvulopalatoplasty|uvulopalatoplasty
686646|NCT00918437|postoperative pain|postoperative pain
686647|NCT00918437|quality of life|quality of life
686648|NCT00918463|lymphoma|lymphoma
686649|NCT00918463|diffuse|diffuse
686650|NCT00918463|refractory|refractory
686651|NCT00918489|soft tissue sarcoma|soft tissue sarcoma
686652|NCT00918489|metastatic|metastatic
686653|NCT00918489|vorinostat|vorinostat
686654|NCT00918515|Sedation|sedation
686655|NCT00918515|Anaesthesia|anaesthesia
686656|NCT00918515|Safety|safety
686657|NCT00918515|tolerability|tolerability
686658|NCT00918515|pharmacokinetics|pharmacokinetics
686659|NCT00918515|pharmacodynamics|pharmacodynamics
686660|NCT00918515|healthy male volunteers|healthy male volunteers
686661|NCT00918528|Urethral stricture|urethral stricture
686662|NCT00918528|Mitomycin C|mitomycin c
686663|NCT00918528|Internal Urethrotomy|internal urethrotomy
686664|NCT00918541|atherosclerotic disease|atherosclerotic disease
686665|NCT00918541|progression|progression
686666|NCT00918541|natural progression of atherosclerotic disease|natural progression of atherosclerotic disease
686667|NCT00918541|natural history of atherosclerosis at the level of the carotid artery as evaluated by MRI|natural history of atherosclerosis at the level of the carotid artery as evaluated by mri
686668|NCT00918554|Sarcoid-associated uveitis|sarcoid-associated uveitis
686669|NCT00918554|Macular oedema|macular oedema
686670|NCT00918554|Methotrexate|methotrexate
686671|NCT00918554|Conventional corticosteroids sparing agent.|conventional corticosteroids sparing agent.
686672|NCT00918567|ADHD|adhd
686673|NCT00918567|impact of atomoxetine with and and without behavior therapy at school and home|impact of atomoxetine with and and without behavior therapy at school and home
686678|NCT00918593|ulcerating metastases|ulcerating metastases
686679|NCT00918619|randomized,|randomized,
686680|NCT00918619|controlled,|controlled,
686681|NCT00918619|haemostatic agents,|haemostatic agents,
686682|NCT00918619|Sangustop,|sangustop,
686683|NCT00918619|Tachosil,|tachosil,
686684|NCT00918619|liver resection,|liver resection,
686685|NCT00918619|haemostasis|haemostasis
686686|NCT00918632|food-effect pharmacokinetics AG-013736 food fasting|food-effect pharmacokinetics ag-013736 food fasting
686687|NCT00918645|stage IV prostate cancer|stage iv prostate cancer
686688|NCT00918645|recurrent prostate cancer|recurrent prostate cancer
686689|NCT00918645|bone metastases|bone metastases
686690|NCT00918658|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
686691|NCT00918658|chronic myelogenous leukemia|chronic myelogenous leukemia
686692|NCT00918658|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
686693|NCT00918658|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
686694|NCT00918658|adult acute myeloid leukemia|adult acute myeloid leukemia
686695|NCT00918658|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
686696|NCT00918658|multiple myeloma|multiple myeloma
686697|NCT00918671|Headache|headache
686698|NCT00918671|Medication overuse|medication overuse
686699|NCT00918671|chronic|chronic
686700|NCT00918671|relapse|relapse
686701|NCT00918684|Depression|depression
686702|NCT00918697|photorefractive keratectomy|photorefractive keratectomy
686704|NCT00918697|alcohol-assisted debridement|alcohol-assisted debridement
686705|NCT00918697|mechanical debridement|mechanical debridement
686706|NCT00918697|confocal scan|confocal scan
686707|NCT00918697|confocal microscopy|confocal microscopy
686708|NCT00918710|Squamous cell carcinoma of Oropharynx|squamous cell carcinoma of oropharynx
686709|NCT00918710|Human papillomavirus.|human papillomavirus.
686710|NCT00918710|Biological prognostic markers.|biological prognostic markers.
686711|NCT00918736|Ankle joint|ankle joint
686712|NCT00918736|Balance|balance
686713|NCT00918736|Hyaluronic acid|hyaluronic acid
686714|NCT00918736|Osteoarthritis|osteoarthritis
686715|NCT00918762|perioperative/postoperative complications|perioperative/postoperative complications
686716|NCT00918762|precancerous condition|precancerous condition
686717|NCT00918762|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
686718|NCT00918762|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
686719|NCT00918762|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
686720|NCT00918762|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
686721|NCT00918762|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
686722|NCT00918762|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
686723|NCT00918762|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
686724|NCT00918762|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
686725|NCT00918762|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
686726|NCT00918762|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
686727|NCT00918762|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
686728|NCT00918762|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
686729|NCT00918762|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
686730|NCT00918762|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
686731|NCT00918762|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
686732|NCT00918762|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
686733|NCT00918762|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
686734|NCT00918762|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
686735|NCT00918762|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
686736|NCT00918762|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
686737|NCT00918762|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
686738|NCT00918775|Renal Cell Carcinoma|renal cell carcinoma
686739|NCT00918775|RCC|rcc
686740|NCT00918775|Kidney|kidney
686741|NCT00918775|Metastasectomy|metastasectomy
686742|NCT00918775|Surgery|surgery
686743|NCT00918775|Tumor Removal|tumor removal
686744|NCT00918788|breast cancer|breast cancer
686745|NCT00918801|T1DM|t1dm
686746|NCT00918801|MRI|mri
686747|NCT00918827|adenocarcinoma of the colon|adenocarcinoma of the colon
686748|NCT00918827|stage III colon cancer|stage iii colon cancer
686749|NCT00918840|HIV|hiv
686750|NCT00918840|Vaccine|vaccine
686751|NCT00918840|Immune Therapy|immune therapy
686752|NCT00918840|DermaVir|dermavir
686753|NCT00918840|Treatment experienced|treatment experienced
686754|NCT00918853|pancreas|pancreas
686755|NCT00918853|adenocarcinoma|adenocarcinoma
686756|NCT00918866|Phase 4|phase 4
686757|NCT00918866|DEFINITY®|definity®
686758|NCT00918866|hemodynamics|hemodynamics
686759|NCT00918866|pulmonary artery pressure|pulmonary artery pressure
686760|NCT00918879|DPP-4 inhibitors|dpp-4 inhibitors
686763|NCT00918892|breast cancer|breast cancer
686764|NCT00918892|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
686765|NCT00918892|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
686766|NCT00918892|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
686767|NCT00918892|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
686768|NCT00918892|triple-negative breast cancer|triple-negative breast cancer
686769|NCT00918892|HER2-negative breast cancer|her2-negative breast cancer
686770|NCT00918892|HER2-positive breast cancer|her2-positive breast cancer
686771|NCT00918905|pervasive healthcare|pervasive healthcare
686772|NCT00918905|telecare|telecare
686773|NCT00918905|telemedicine|telemedicine
686774|NCT00918905|COPD|copd
686775|NCT00918918|Alcohol Consumption|alcohol consumption
686776|NCT00918918|High Density Lipoprotein (HDL)|high density lipoprotein (hdl)
686777|NCT00918918|lipopolysaccharides (LPS)|lipopolysaccharides (lps)
686778|NCT00918918|Apolipoproteins|apolipoproteins
686779|NCT00918918|Inflammation|inflammation
686780|NCT00918931|Leukemia|leukemia
686781|NCT00918931|Systemic Mastocytosis|systemic mastocytosis
686782|NCT00918931|SM|sm
686783|NCT00918931|Obatoclax mesylate|obatoclax mesylate
686784|NCT00918931|GX15-070MS|gx15-070ms
686785|NCT00918944|clinical decision support tool|clinical decision support tool
686786|NCT00918944|electronic health record|electronic health record
686787|NCT00918944|control tool|control tool
686788|NCT00918944|spirometry|spirometry
686789|NCT00918944|quality of life survey|quality of life survey
686790|NCT00918944|provider survey|provider survey
686791|NCT00918957|Tobramycin Inhalation Powder|tobramycin inhalation powder
686792|NCT00918957|Cystic fibrosis|cystic fibrosis
686793|NCT00918957|Lung diseases|lung diseases
686794|NCT00918957|Anti-Bacterial Agents|anti-bacterial agents
686795|NCT00918957|Treatment of infections with P. aeruginosa in cystic fibrosis subjects|treatment of infections with p. aeruginosa in cystic fibrosis subjects
686796|NCT00918970|autonomous nervous system|autonomous nervous system
686797|NCT00918970|brain death|brain death
686798|NCT00918970|organs transplantation|organs transplantation
686799|NCT00918983|Benign prostatic hyperplasia|benign prostatic hyperplasia
686801|NCT00918983|Enlarged prostate|enlarged prostate
686802|NCT00918996|Cesarean Section|cesarean section
686803|NCT00918996|Bladder Flap|bladder flap
686804|NCT00918996|Operating time|operating time
686805|NCT00919009|TACE|tace
686806|NCT00919009|Sorafenib|sorafenib
686807|NCT00919022|Inoperable Prostate Cancer|inoperable prostate cancer
686808|NCT00919022|Erectile Dysfunction|erectile dysfunction
686809|NCT00919035|prostate cancer|prostate cancer
686810|NCT00919035|androgen-independent prostate cancer (AIPC) Prostate Cancer|androgen-independent prostate cancer (aipc) prostate cancer
686811|NCT00919061|GALL BLADDER|gall bladder
686812|NCT00919061|BILE DUCTS|bile ducts
686813|NCT00919061|BAY 43-9006|bay 43-9006
686814|NCT00919061|SORAFENIB|sorafenib
686815|NCT00919061|CISPLATIN|cisplatin
686816|NCT00919061|GEMCITABINE|gemcitabine
686817|NCT00919061|09-029|09-029
686818|NCT00919074|Patients undergoing endoscopic retrograde cholangiopancreatography for the first time|patients undergoing endoscopic retrograde cholangiopancreatography for the first time
686819|NCT00919074|Particular focus on patients who meet predefined criteria for a difficult bile duct cannulation|particular focus on patients who meet predefined criteria for a difficult bile duct cannulation
686820|NCT00919100|pediatric|pediatric
686821|NCT00919100|venipuncture|venipuncture
686822|NCT00919100|pain|pain
686823|NCT00919100|vibration|vibration
686824|NCT00919100|vapocoolant|vapocoolant
686825|NCT00919113|Bladder Pain|bladder pain
686826|NCT00919113|GAG replacement therapy|gag replacement therapy
686827|NCT00919113|IC/PBS|ic/pbs
686828|NCT00919126|Xenon in Anaesthesia|xenon in anaesthesia
686829|NCT00919139|multiple myeloma|multiple myeloma
686830|NCT00919139|Waldenström macroglobulinemia|waldenström macroglobulinemia
686831|NCT00919139|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
686832|NCT00919139|primary systemic amyloidosis|primary systemic amyloidosis
686833|NCT00919152|stress ulcer prophylaxis|stress ulcer prophylaxis
686834|NCT00919152|intensive care|intensive care
686835|NCT00919152|Critically ill|critically ill
686836|NCT00919152|proton pump inhibitors|proton pump inhibitors
686837|NCT00919152|pharmacoeconomics|pharmacoeconomics
686838|NCT00919165|carotid stenting|carotid stenting
686839|NCT00919165|cognitive function|cognitive function
686840|NCT00919165|pre and post stent|pre and post stent
686841|NCT00919165|severe carotid artery stenosis|severe carotid artery stenosis
686842|NCT00919178|Dengue virus|dengue virus
686843|NCT00919178|Vaccine|vaccine
686844|NCT00919178|DEN4|den4
686845|NCT00919178|Dengue|dengue
686846|NCT00919191|acne|acne
686847|NCT00919191|irritation|irritation
686848|NCT00919191|objective sensory methods|objective sensory methods
686849|NCT00919204|AG-013736, axitinib, pharmacokinetics, healthy, Chinese|ag-013736, axitinib, pharmacokinetics, healthy, chinese
686850|NCT00919217|Multiple Sclerosis|multiple sclerosis
686851|NCT00919217|MS|ms
686852|NCT00919217|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
686853|NCT00919217|RR-MS|rr-ms
686855|NCT00919230|Hip fracture|hip fracture
686856|NCT00919230|iron therapy|iron therapy
686857|NCT00919230|anaemia|anaemia
686858|NCT00919243|prednisone|prednisone
686859|NCT00919243|allopurinol|allopurinol
686860|NCT00919243|heart failure|heart failure
686861|NCT00919243|hyperuricemia|hyperuricemia
686862|NCT00919282|pancreatic cancer|pancreatic cancer
686865|NCT00919295|Fibromyalgia syndrome|fibromyalgia syndrome
686866|NCT00919295|mirtazapine|mirtazapine
686867|NCT00919295|randomized controlled trial|randomized controlled trial
686868|NCT00919295|pilot study|pilot study
686869|NCT00919308|Simulation|simulation
686870|NCT00919308|Invasive procedures|invasive procedures
686871|NCT00919321|CLL|cll
686872|NCT00919321|PPV|ppv
686873|NCT00919321|PCV|pcv
686874|NCT00919334|Myopia progression|myopia progression
686875|NCT00919334|Myopia control|myopia control
686876|NCT00919334|Simultaneous vision|simultaneous vision
686877|NCT00919334|Myopic defocus|myopic defocus
686878|NCT00919347|Cardiovascular Autonomic Neuropathy|cardiovascular autonomic neuropathy
686879|NCT00919347|Diabetic Autonomic Neuropathy|diabetic autonomic neuropathy
686880|NCT00919347|Autonomic Dysfunction|autonomic dysfunction
688430|NCT00924183|MDE|mde
686881|NCT00919373|Catheter Ablation|catheter ablation
686882|NCT00919373|Defibrillators, Implantable|defibrillators, implantable
686883|NCT00919386|Ureteric Measurement|ureteric measurement
686884|NCT00919399|breast cancer|breast cancer
686885|NCT00919399|locally advanced|locally advanced
686886|NCT00919399|Menopausal patient|menopausal patient
686887|NCT00919399|aromasin|aromasin
686888|NCT00919399|tamoxifen|tamoxifen
686889|NCT00919399|efficacy|efficacy
686890|NCT00919412|Non Invasive Biomarkers Preterm Delivery|non invasive biomarkers preterm delivery
686891|NCT00919425|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
686892|NCT00919425|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
686893|NCT00919425|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
686894|NCT00919425|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
686895|NCT00919425|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
686896|NCT00919425|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
686897|NCT00919425|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
686898|NCT00919425|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
686899|NCT00919425|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
686900|NCT00919425|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
686901|NCT00919425|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
686902|NCT00919425|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
686903|NCT00919425|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
686904|NCT00919425|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
686905|NCT00919425|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
686906|NCT00919425|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
687564|NCT00911482|FFA|ffa
686907|NCT00919425|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
686908|NCT00919425|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
686909|NCT00919425|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
686910|NCT00919425|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
686911|NCT00919425|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
686912|NCT00919425|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
686913|NCT00919425|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
686914|NCT00919425|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
686915|NCT00919425|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
686916|NCT00919425|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
686917|NCT00919425|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
686918|NCT00919425|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
686919|NCT00919425|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
686920|NCT00919425|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
686921|NCT00919425|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
686922|NCT00919425|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
686923|NCT00919425|secondary acute myeloid leukemia|secondary acute myeloid leukemia
686924|NCT00919425|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
686925|NCT00919425|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
686926|NCT00919425|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
686927|NCT00919425|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
686928|NCT00919425|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
686929|NCT00919451|Leprosy|leprosy
686930|NCT00919451|Type 1 Reaction|type 1 reaction
686931|NCT00919451|Prednisolone|prednisolone
686933|NCT00919464|Compartment pressure|compartment pressure
686934|NCT00919464|compartment syndrome|compartment syndrome
686935|NCT00919464|femur fracture|femur fracture
686936|NCT00919477|Prostate cancer|prostate cancer
686937|NCT00919477|Casodex|casodex
686938|NCT00919477|Monotherapy|monotherapy
686939|NCT00919490|Healthy Volunteers|healthy volunteers
686940|NCT00919503|nonmalignant diseases|nonmalignant diseases
686941|NCT00919503|nonmalignant inherited disorders|nonmalignant inherited disorders
686942|NCT00919503|primary immunodeficiency diseases|primary immunodeficiency diseases
686943|NCT00919503|primary immune deficiency disorders|primary immune deficiency disorders
686944|NCT00919503|chronic granulomatous|chronic granulomatous
686945|NCT00919503|disease|disease
686946|NCT00919503|IPEX syndrome|ipex syndrome
686947|NCT00919503|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
686948|NCT00919503|Wiskott Aldrich Syndrome|wiskott aldrich syndrome
686949|NCT00919503|bone marrow failure syndromes|bone marrow failure syndromes
686950|NCT00919503|Shwachman Diamond Syndrome|shwachman diamond syndrome
686951|NCT00919503|Dyskeratosis Congenita|dyskeratosis congenita
686952|NCT00919503|Diamond Blackfan Anemia|diamond blackfan anemia
686953|NCT00919503|inborn errors of metabolism|inborn errors of metabolism
686954|NCT00919503|metabolic diseases|metabolic diseases
686955|NCT00919503|hemoglobinopathies|hemoglobinopathies
686956|NCT00919503|sickle cell disease|sickle cell disease
686957|NCT00919503|thalassemia|thalassemia
686958|NCT00919503|reduced intensity transplantation|reduced intensity transplantation
686959|NCT00919503|hematopoietic cell transplantation|hematopoietic cell transplantation
686960|NCT00919503|bone marrow transplantation|bone marrow transplantation
686961|NCT00919503|umbilical cord blood transplantation|umbilical cord blood transplantation
686962|NCT00919516|Bone marrow transplantation|bone marrow transplantation
686963|NCT00919516|Ischemia|ischemia
686964|NCT00919516|Neoangiogenesis|neoangiogenesis
686965|NCT00919516|Peripheral arterial disease|peripheral arterial disease
686966|NCT00919516|Stem cell therapy|stem cell therapy
686967|NCT00919542|Leprosy|leprosy
686968|NCT00919542|ENL|enl
686969|NCT00919542|Erythema Nodosum Leprosum|erythema nodosum leprosum
686970|NCT00919542|Prednisolone|prednisolone
686971|NCT00919542|Ciclosporin|ciclosporin
686972|NCT00919555|ALS Treatment|als treatment
686973|NCT00919555|Tretinoin|tretinoin
686974|NCT00919555|Pioglitazone HCL|pioglitazone hcl
686975|NCT00919555|Actos|actos
686976|NCT00919555|Tau levels|tau levels
686977|NCT00919555|ALS|als
686978|NCT00919581|Spinal cord injury|spinal cord injury
686979|NCT00919594|Interpersonal Psychotherapy|interpersonal psychotherapy
686980|NCT00919594|Depression|depression
686981|NCT00919594|Mothers|mothers
686982|NCT00919607|quetiapine fumarate(SEROQUEL) extended-release(XR) China PK Study|quetiapine fumarate(seroquel) extended-release(xr) china pk study
686983|NCT00919607|pharmacokinetics parameters|pharmacokinetics parameters
686984|NCT00919620|Psychotic disorders|psychotic disorders
686985|NCT00919620|Psychoses|psychoses
686986|NCT00919633|hepatitis C|hepatitis c
686987|NCT00919633|HCV|hcv
686988|NCT00919633|genotype|genotype
686989|NCT00919633|sustained virological response|sustained virological response
686990|NCT00919633|rapid virological response|rapid virological response
686991|NCT00919633|interferon|interferon
686992|NCT00919659|parenteral nutrition|parenteral nutrition
686993|NCT00919659|cancer cachexia|cancer cachexia
686994|NCT00919659|pancreatic cancer|pancreatic cancer
686995|NCT00919672|Irritable bowel syndrome|irritable bowel syndrome
686996|NCT00919672|Sacral nerve stimulation|sacral nerve stimulation
686997|NCT00919672|Motility|motility
686998|NCT00919672|Pain perception|pain perception
686999|NCT00919672|GSRS-IBS|gsrs-ibs
687000|NCT00919672|IBS-IS|ibs-is
687001|NCT00919698|Hypnotics and Sedatives|hypnotics and sedatives
687002|NCT00919698|Respiration, Artificial|respiration, artificial
687003|NCT00919698|Ventilators, Mechanical|ventilators, mechanical
687004|NCT00919698|Critical care|critical care
687005|NCT00919698|Intensive care|intensive care
687006|NCT00919711|Menopausal Osteoporosis|menopausal osteoporosis
687007|NCT00919724|AIDS|aids
687008|NCT00919724|Endothelial Function|endothelial function
687009|NCT00919724|Inflammation|inflammation
687010|NCT00919724|Immune Activation|immune activation
687011|NCT00919724|treatment naive|treatment naive
687012|NCT00919737|NPC-08|npc-08
687013|NCT00919737|carmustine|carmustine
687014|NCT00919737|nitrosourea|nitrosourea
687015|NCT00919737|safety|safety
687016|NCT00919763|Atopic Dermatitis|atopic dermatitis
687017|NCT00919776|Leprosy|leprosy
687018|NCT00919776|ENL|enl
687019|NCT00919776|Erythema Nodosum Leprosum|erythema nodosum leprosum
687020|NCT00919776|Prednisolone|prednisolone
687021|NCT00919776|Ciclosporin|ciclosporin
687022|NCT00919802|Interstitial cystitis (IC)|interstitial cystitis (ic)
687023|NCT00919802|Oxytocin|oxytocin
687024|NCT00919802|Bladder|bladder
687025|NCT00919802|Void|void
687026|NCT00919815|Leprosy|leprosy
687027|NCT00919815|Type 1 Reactions|type 1 reactions
687028|NCT00919815|Prednisolone|prednisolone
687029|NCT00919815|Ciclosporin|ciclosporin
687030|NCT00919841|postpartum|postpartum
687031|NCT00919841|involution|involution
687032|NCT00919841|three-dimension sonography|three-dimension sonography
687033|NCT00919841|size of the uterus|size of the uterus
687034|NCT00919854|Human immunodeficiency virus 1|human immunodeficiency virus 1
687035|NCT00919854|HIV-1|hiv-1
687036|NCT00919854|Darunavir|darunavir
687037|NCT00919854|Ritonavir|ritonavir
687038|NCT00919854|Norvir|norvir
687039|NCT00919867|Normal, healthy volunteers (for this Phase 1 study)|normal, healthy volunteers (for this phase 1 study)
687040|NCT00919893|chronic prostatitis symptom index|chronic prostatitis symptom index
687042|NCT00919893|inflammatory|inflammatory
687043|NCT00919893|CP-CPPS|cp-cpps
687044|NCT00919893|Cernilton|cernilton
687045|NCT00919893|pelvic pain|pelvic pain
687046|NCT00919893|symptoms|symptoms
687047|NCT00919906|haptic|haptic
687048|NCT00919906|rehabilitation|rehabilitation
687049|NCT00919906|fine-motor skill|fine-motor skill
687050|NCT00919906|handwriting|handwriting
687051|NCT00919919|menopause|menopause
687052|NCT00919919|Endometrial Thickness|endometrial thickness
687053|NCT00919919|progesterone|progesterone
687054|NCT00919932|Depression|depression
687055|NCT00919932|CBT|cbt
687056|NCT00919932|Texting|texting
687057|NCT00919932|SMS|sms
687058|NCT00919945|Neonates|neonates
687059|NCT00919945|Congenital Heart Disease|congenital heart disease
687060|NCT00919945|Postoperative Feeding|postoperative feeding
687061|NCT00919945|Splanchnic Blood Flow|splanchnic blood flow
687062|NCT00919958|Peripheral Artery Disease|peripheral artery disease
687063|NCT00919958|Peripheral Vascular Disease|peripheral vascular disease
687064|NCT00919958|Critical limb ischemia|critical limb ischemia
687065|NCT00919971|Bi spectral Index|bi spectral index
687066|NCT00919971|Sedation depth monitoring|sedation depth monitoring
687067|NCT00919971|Out of hospital ventilated patients|out of hospital ventilated patients
687068|NCT00919984|OVARIAN NEOPLASMS|ovarian neoplasms
687069|NCT00919984|ADJUVANT CHEMOTHERAPY|adjuvant chemotherapy
687070|NCT00919984|INTRAPERITONEAL CHEMOTHERAPY|intraperitoneal chemotherapy
687071|NCT00919997|human papilloma virus infection|human papilloma virus infection
687072|NCT00919997|HIV infection|hiv infection
687073|NCT00919997|HIV Infections|hiv infections
687074|NCT00920010|non-small cell lung cancer|non-small cell lung cancer
687075|NCT00920010|small cell lung cancer|small cell lung cancer
687076|NCT00920023|SPIO MRI|spio mri
687077|NCT00920023|Feridex|feridex
687078|NCT00920036|PTSD|ptsd
687079|NCT00920036|Combat|combat
687080|NCT00920036|Biofeedback|biofeedback
687081|NCT00920036|Psychophysiology|psychophysiology
687082|NCT00920049|Driving|driving
687083|NCT00920049|Injury|injury
687084|NCT00920049|Prevention|prevention
687085|NCT00920049|Intervention|intervention
687086|NCT00920049|Parents|parents
687087|NCT00920062|recirculation|recirculation
687088|NCT00920062|ultrasound dilution|ultrasound dilution
687089|NCT00920062|venovenous extracorporeal membrane oxygenation|venovenous extracorporeal membrane oxygenation
687090|NCT00920075|Juvenile Osteoporosis|juvenile osteoporosis
687662|NCT00911859|Melphalan|melphalan
687091|NCT00920075|Bone Mineral Density|bone mineral density
687093|NCT00920075|Dual Energy X-Ray Absorptiometry|dual energy x-ray absorptiometry
687094|NCT00920075|Fracture|fracture
687095|NCT00920088|probes|probes
687096|NCT00920088|NNRTI|nnrti
687097|NCT00920088|drug interaction|drug interaction
687098|NCT00920088|protease inhitibor|protease inhitibor
687099|NCT00920101|atherosclerotic plaques|atherosclerotic plaques
687100|NCT00920101|hypercholesterolemia|hypercholesterolemia
687101|NCT00920101|HMG-CoA reductase inhibitor|hmg-coa reductase inhibitor
687102|NCT00920101|statin|statin
687103|NCT00920101|lipid-lowering therapy|lipid-lowering therapy
687104|NCT00920127|AKL1|akl1
687105|NCT00920127|COPD|copd
687106|NCT00920140|Oncology, GSK1120212, MEK inhibitor, hematological malignancies, AML|oncology, gsk1120212, mek inhibitor, hematological malignancies, aml
687107|NCT00920140|CMML|cmml
687108|NCT00920140|MDS|mds
687109|NCT00920153|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
687110|NCT00920153|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
687111|NCT00920153|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
687112|NCT00920153|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
687113|NCT00920166|Infant formula|infant formula
687114|NCT00920166|Alpha-lactalbumin|alpha-lactalbumin
687115|NCT00920166|Symbiotic|symbiotic
687116|NCT00920166|Allergy|allergy
687117|NCT00920166|Gastrointestinal tolerance|gastrointestinal tolerance
687118|NCT00920166|Bacterial colonization|bacterial colonization
687119|NCT00920166|Faecal IgA analysis|faecal iga analysis
687120|NCT00920179|dry eye, in vivo confocal microscopy, inflammation, acinar unit density, lacrimal gland|dry eye, in vivo confocal microscopy, inflammation, acinar unit density, lacrimal gland
687121|NCT00920192|c-MET|c-met
687122|NCT00920192|VEGFR2|vegfr2
687123|NCT00920192|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
687124|NCT00920205|MPC-3100|mpc-3100
687125|NCT00920205|HSP90 inhibitor|hsp90 inhibitor
687126|NCT00920205|oral drug|oral drug
687127|NCT00920205|cancer|cancer
687128|NCT00920218|Vaccine|vaccine
687129|NCT00920218|Immunogenicity|immunogenicity
687130|NCT00920218|Stem cell transplantation|stem cell transplantation
687131|NCT00920218|Safety|safety
687132|NCT00920218|Herpes Zoster|herpes zoster
687133|NCT00920244|Resuscitation|resuscitation
687134|NCT00920244|Cardiac arrest|cardiac arrest
687135|NCT00920244|State-transitions|state-transitions
687136|NCT00920244|Markov|markov
687138|NCT00920257|breast cancer|breast cancer
687139|NCT00920257|oncology|oncology
687140|NCT00920257|solid tumors|solid tumors
687141|NCT00920257|AKT inhibitor|akt inhibitor
687142|NCT00920257|endometrial cancer|endometrial cancer
687143|NCT00920257|first time in human|first time in human
687144|NCT00920257|GSK2141795|gsk2141795
687145|NCT00920270|Hospital-Acquired Pneumonia|hospital-acquired pneumonia
687146|NCT00920270|Gram Negative Bacteria|gram negative bacteria
687147|NCT00920283|Stents|stents
687148|NCT00920283|Bare Metal Stents|bare metal stents
687149|NCT00920283|PCI|pci
687150|NCT00920283|Coronary Artery Disease|coronary artery disease
687151|NCT00920283|Coronary Artery Stenosis|coronary artery stenosis
687152|NCT00920283|Stent Thrombosis|stent thrombosis
688737|NCT00925301|AT1001|at1001
687153|NCT00920283|Vascular Disease|vascular disease
687154|NCT00920283|Myocardial Ischemia|myocardial ischemia
687155|NCT00920296|drug interaction|drug interaction
687156|NCT00920296|integrase inhibitor|integrase inhibitor
687157|NCT00920309|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
687158|NCT00920309|rapamycin|rapamycin
687159|NCT00920309|ADPKD|adpkd
687160|NCT00920322|Depression|depression
687161|NCT00920322|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
687162|NCT00920335|Adult intracranial ependymoma|adult intracranial ependymoma
687163|NCT00920348|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
687164|NCT00920348|COPD|copd
687165|NCT00920348|Cohort study|cohort study
687166|NCT00920348|prospective longitudinal study|prospective longitudinal study
687167|NCT00920348|tissue bank|tissue bank
687168|NCT00920374|Influenza|influenza
687169|NCT00920387|Anxiety|anxiety
687170|NCT00920387|quality of life|quality of life
687171|NCT00920387|psychotherapy|psychotherapy
687172|NCT00920387|potentially fatal illness|potentially fatal illness
687173|NCT00920387|lysergic acid diethylamide|lysergic acid diethylamide
687174|NCT00920426|HIV|hiv
687175|NCT00920426|naive|naive
687176|NCT00920426|Phase II|phase ii
687177|NCT00920426|integrase inhibitor|integrase inhibitor
687178|NCT00920426|GSK1265744|gsk1265744
687179|NCT00920426|newly diagnosed|newly diagnosed
687180|NCT00920426|pharmacokinetics|pharmacokinetics
687181|NCT00920426|AIDS|aids
687182|NCT00920426|integrase|integrase
687183|NCT00920426|HIV Infections|hiv infections
687184|NCT00920426|Treatment naive|treatment naive
687185|NCT00920439|Poliomyelitis Vaccines|poliomyelitis vaccines
687186|NCT00920439|IPV|ipv
687187|NCT00920452|implantable cardioverter defibrillator (ICD)|implantable cardioverter defibrillator (icd)
687468|NCT00911144|Pneumococcal vaccine|pneumococcal vaccine
687188|NCT00920452|defibrillation leads, cardiac resynchronization therapy (CRT)|defibrillation leads, cardiac resynchronization therapy (crt)
687189|NCT00920478|Rheumatoid arthritis|rheumatoid arthritis
687190|NCT00920478|Musculoskeletal Ultrasound|musculoskeletal ultrasound
687191|NCT00920478|Synovitis|synovitis
687192|NCT00920478|DMARD|dmard
687193|NCT00920478|Etanercept|etanercept
687194|NCT00920478|Biomarkers|biomarkers
687195|NCT00920478|Undifferentiated Inflammatory Polyarthritis|undifferentiated inflammatory polyarthritis
687196|NCT00920491|Chief complaint|chief complaint
687197|NCT00920491|non-specific symptoms|non-specific symptoms
752863|NCT01174524|Contraception|contraception
689665|NCT00926861|AMD|amd
687198|NCT00920491|general weakness / general deterioration|general weakness / general deterioration
687199|NCT00920491|risk assessment in ED patients with non-specific symptoms|risk assessment in ed patients with non-specific symptoms
687200|NCT00920504|Mesh: patient education as topic|mesh: patient education as topic
687201|NCT00920504|Mesh: neoplasms|mesh: neoplasms
687202|NCT00920504|Mesh: medication therapy management|mesh: medication therapy management
687203|NCT00920504|pain self management|pain self management
687204|NCT00920504|symptom management|symptom management
687205|NCT00920504|education of patients with pain from neoplasm metastases|education of patients with pain from neoplasm metastases
687206|NCT00920530|Screening|screening
687207|NCT00920530|real time PCR|real time pcr
687208|NCT00920530|Streptococcus agalactiae|streptococcus agalactiae
687209|NCT00920530|Pregnant women|pregnant women
687210|NCT00920569|cardiac output|cardiac output
687211|NCT00920569|recirculation|recirculation
687212|NCT00920569|oxygenator blood volume|oxygenator blood volume
687213|NCT00920569|venoarterial extracorporeal membrane oxygenation|venoarterial extracorporeal membrane oxygenation
687214|NCT00920569|venovenous extracorporeal membrane oxygenation|venovenous extracorporeal membrane oxygenation
687215|NCT00920582|Teplizumab|teplizumab
687216|NCT00920582|Protege|protege
687217|NCT00920582|Protege Encore|protege encore
687218|NCT00920582|MGA031|mga031
687219|NCT00920582|Monoclonal antibody|monoclonal antibody
687220|NCT00920582|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
687221|NCT00920582|T1DM|t1dm
687222|NCT00920582|MacroGenics|macrogenics
687223|NCT00920582|Recent Onset Diabetes|recent onset diabetes
687224|NCT00920582|hOKT3γ1 (Ala-Ala)|hokt3γ1 (ala-ala)
687225|NCT00920582|Encore|encore
687226|NCT00920595|Cancer|cancer
687227|NCT00920608|AZD9056|azd9056
687228|NCT00920608|Pharmacokinetics|pharmacokinetics
687229|NCT00920608|interaction|interaction
687230|NCT00920608|Methotrexate|methotrexate
687231|NCT00920608|Rheumatoid Arthritis|rheumatoid arthritis
687234|NCT00920621|Randomized Control Trial|randomized control trial
687235|NCT00920647|hunters syndrome|hunters syndrome
687236|NCT00920647|hunter's syndrome|hunter's syndrome
687237|NCT00920647|hunter disease|hunter disease
687238|NCT00920647|hunters disease|hunters disease
687239|NCT00920647|hunter's disease|hunter's disease
687240|NCT00920647|Mucopolysaccharidosis(MPS) II|mucopolysaccharidosis(mps) ii
687241|NCT00920647|Mucopolysaccharidosis(MPS)2|mucopolysaccharidosis(mps)2
687242|NCT00920647|Mucopolysaccharidosis (MPS) 2|mucopolysaccharidosis (mps) 2
687243|NCT00920647|Mucopolysaccharidosis (mps) ii|mucopolysaccharidosis (mps) ii
687244|NCT00920647|mucopolysaccharides|mucopolysaccharides
687245|NCT00920647|lysosomal storage disease|lysosomal storage disease
687246|NCT00920647|lysosomal storage disorder|lysosomal storage disorder
687247|NCT00920647|chronic ear infection|chronic ear infection
687248|NCT00920647|enlarged adenoids|enlarged adenoids
687249|NCT00920647|mps symptoms|mps symptoms
687250|NCT00920647|mps diagnosis|mps diagnosis
687251|NCT00920647|ert treatment|ert treatment
687252|NCT00920647|elaprase|elaprase
687253|NCT00920647|idursulfase|idursulfase
687254|NCT00920647|iduronate sulfatase|iduronate sulfatase
687255|NCT00920647|iduronate 2 sulfatase|iduronate 2 sulfatase
687256|NCT00920647|enzyme replacement therapy|enzyme replacement therapy
687257|NCT00920647|hunter syndrome treatment|hunter syndrome treatment
687258|NCT00920647|hunter's syndrome treatment|hunter's syndrome treatment
687259|NCT00920647|hunter syndrome therapy|hunter syndrome therapy
687260|NCT00920647|hunter's disease treatment|hunter's disease treatment
687261|NCT00920647|mps society|mps society
687262|NCT00920673|child|child
687263|NCT00920686|Migraine|migraine
687264|NCT00920686|aura|aura
687265|NCT00920712|chronic atrophic gastritis|chronic atrophic gastritis
687266|NCT00920712|Traditional Chinese Medicine|traditional chinese medicine
687267|NCT00920725|DKA|dka
687268|NCT00920738|metabolic syndrome|metabolic syndrome
687269|NCT00920738|cancer survivor|cancer survivor
687270|NCT00920738|childhood soft tissue sarcoma|childhood soft tissue sarcoma
687271|NCT00920738|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
687390|NCT00910819|Palliative Treatment|palliative treatment
687272|NCT00920738|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
687273|NCT00920738|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
687274|NCT00920738|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
687275|NCT00920738|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
687469|NCT00911144|Immunogenicity|immunogenicity
687663|NCT00911859|Prednisone|prednisone
687276|NCT00920738|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
687277|NCT00920738|chronic lymphocytic leukemia|chronic lymphocytic leukemia
687278|NCT00920738|childhood brain stem glioma|childhood brain stem glioma
687279|NCT00920738|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
687280|NCT00920738|childhood cerebral astrocytoma/malignant glioma|childhood cerebral astrocytoma/malignant glioma
687281|NCT00920738|childhood choroid plexus tumor|childhood choroid plexus tumor
687282|NCT00920738|childhood craniopharyngioma|childhood craniopharyngioma
752864|NCT01174537|NDV|ndv
687283|NCT00920738|childhood embryonal tumor|childhood embryonal tumor
687284|NCT00920738|childhood ependymoma|childhood ependymoma
687285|NCT00920738|childhood oligodendroglioma|childhood oligodendroglioma
687286|NCT00920738|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
687287|NCT00920738|childhood mixed glioma|childhood mixed glioma
687288|NCT00920738|childhood subependymal giant cell astrocytoma|childhood subependymal giant cell astrocytoma
687289|NCT00920738|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
687290|NCT00920751|water infusion|water infusion
687291|NCT00920751|air insufflation|air insufflation
687292|NCT00920751|colonoscopy|colonoscopy
687293|NCT00920751|colorectal cancer screening|colorectal cancer screening
687294|NCT00920764|CKD Stages 3&4|ckd stages 3&4
687295|NCT00920764|Endothelin antagonist|endothelin antagonist
687296|NCT00920764|Proteinuria|proteinuria
687297|NCT00920777|CBT|cbt
687298|NCT00920777|Fukuda criteria|fukuda criteria
687299|NCT00920777|Mental functioning|mental functioning
687300|NCT00920777|Physical functioning|physical functioning
687301|NCT00910494|Rectal neoplasm C04.588.274.476.411.307.790|rectal neoplasm c04.588.274.476.411.307.790
687302|NCT00910494|Intraoperative Radiotherapy|intraoperative radiotherapy
687303|NCT00910507|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
687304|NCT00910507|Exercise|exercise
687305|NCT00910507|Counseling|counseling
687306|NCT00910507|Behavior|behavior
687307|NCT00910533|Lyme neuroborreliosis|lyme neuroborreliosis
687308|NCT00910546|Lung Cancer|lung cancer
687309|NCT00910546|Stereotactic radiotherapy|stereotactic radiotherapy
687310|NCT00910546|Image guidance|image guidance
687311|NCT00910546|breathing adaption|breathing adaption
687312|NCT00910546|tumor motion|tumor motion
687313|NCT00910546|implanted marker|implanted marker
687314|NCT00910559|Autism Spectrum Disorder|autism spectrum disorder
687315|NCT00910559|Autism|autism
687316|NCT00910559|Asperger Syndrome|asperger syndrome
687317|NCT00910559|Pervasive Developmental Disorders- Not Otherwise Specified|pervasive developmental disorders- not otherwise specified
687318|NCT00910572|Yttrium-90|yttrium-90
687320|NCT00910572|Radioembolization|radioembolization
687321|NCT00910572|Hepatoma|hepatoma
687322|NCT00910572|BCLC classification|bclc classification
687323|NCT00910572|Hepatic loco-regional treatments|hepatic loco-regional treatments
687324|NCT00910572|Yttrium|yttrium
687325|NCT00910572|Microspheres|microspheres
687326|NCT00910585|childhood|childhood
687327|NCT00910585|asthma|asthma
687328|NCT00910598|clinically isolated syndrome|clinically isolated syndrome
687329|NCT00910598|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
687330|NCT00910598|glatiramer acetate|glatiramer acetate
687331|NCT00910598|Optical Coherence Tomography|optical coherence tomography
687332|NCT00910611|pediatric|pediatric
687333|NCT00910611|immunization|immunization
687334|NCT00910611|pain|pain
687335|NCT00910611|analgesia|analgesia
687336|NCT00910611|Immunization pain|immunization pain
687337|NCT00910637|Pregnancy prevention|pregnancy prevention
687338|NCT00910637|Female contraception|female contraception
687339|NCT00910637|Patch|patch
687340|NCT00910650|Adoptive transfer therapy|adoptive transfer therapy
687341|NCT00910650|Dendritic cell vaccines|dendritic cell vaccines
687342|NCT00910663|Bioequivalence|bioequivalence
687343|NCT00910663|Healthy Subjects|healthy subjects
687344|NCT00910676|EGF-R inhibitors|egf-r inhibitors
687345|NCT00910689|Migraine Headache|migraine headache
687346|NCT00910689|Preventive Therapy|preventive therapy
687347|NCT00910689|Beta Blocker Medication|beta blocker medication
687348|NCT00910689|Behavior Therapy|behavior therapy
687349|NCT00910689|Clinical Trial|clinical trial
687350|NCT00910702|retinal detachment, vitreous body substitute|retinal detachment, vitreous body substitute
687351|NCT00910715|erythema migrans|erythema migrans
687352|NCT00910715|Lyme borreliosis|lyme borreliosis
687353|NCT00910715|doxycycline treatment|doxycycline treatment
687354|NCT00910715|outcome|outcome
687355|NCT00910715|subjective symptoms|subjective symptoms
687356|NCT00910728|Primary Myelofibrosis (PMF)|primary myelofibrosis (pmf)
687357|NCT00910728|Post-Polycythaemia Vera/Essential Thrombocythaemia Myelofibrosis (Post-PV/ET MF)|post-polycythaemia vera/essential thrombocythaemia myelofibrosis (post-pv/et mf)
687358|NCT00910728|Myeloproliferative diseases|myeloproliferative diseases
687359|NCT00910728|Phase I|phase i
687360|NCT00910728|Phase II|phase ii
687361|NCT00910728|Bone marrow|bone marrow
687362|NCT00910741|pancreatic cancer|pancreatic cancer
687363|NCT00910741|Gemcitabine|gemcitabine
687364|NCT00910754|Prostate neoplasms|prostate neoplasms
687470|NCT00911144|Pneumococcal disease|pneumococcal disease
687365|NCT00910754|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
687366|NCT00910754|Abiraterone acetate|abiraterone acetate
687367|NCT00910754|CB7630|cb7630
687368|NCT00910793|Asthma|asthma
687369|NCT00910793|Formoterol|formoterol
687370|NCT00910793|Beclomethasone Dipropionate|beclomethasone dipropionate
687371|NCT00910793|Computational Fluid Dynamics|computational fluid dynamics
687372|NCT00910793|Functional Imaging|functional imaging
687373|NCT00910793|Central and Peripheral Airways|central and peripheral airways
687374|NCT00910806|TMC207-TiDP13-C117|tmc207-tidp13-c117
687375|NCT00910806|TMC207-C110|tmc207-c110
687376|NCT00910806|TMC207|tmc207
687377|NCT00910806|drug-drug interaction|drug-drug interaction
687378|NCT00910806|Tuberculosis|tuberculosis
687379|NCT00910806|HIV|hiv
687380|NCT00910806|nevirapine|nevirapine
687381|NCT00910806|open-label|open-label
687382|NCT00910806|Pharmacokinetics|pharmacokinetics
687383|NCT00910819|Colorectal Cancer|colorectal cancer
687384|NCT00910819|Advanced Colorectal Cancer|advanced colorectal cancer
687385|NCT00910819|Epidemiology|epidemiology
687386|NCT00910819|Health Services Research|health services research
687387|NCT00910819|Germany|germany
687388|NCT00910819|Registry|registry
687389|NCT00910819|Palliative Care|palliative care
687391|NCT00910819|Adjuvant Drug Therapy|adjuvant drug therapy
687392|NCT00910819|Nutrition Assessment|nutrition assessment
687393|NCT00910819|Physical Activity|physical activity
687394|NCT00910832|Dyschesia treatment|dyschesia treatment
687395|NCT00910832|Rehabilitation|rehabilitation
687396|NCT00910832|Dyschesia|dyschesia
687397|NCT00910871|Tuberculosis|tuberculosis
687398|NCT00910871|TMC207-TiDP13-C209|tmc207-tidp13-c209
687399|NCT00910871|TMC207-C209|tmc207-c209
687400|NCT00910871|TMC207|tmc207
687401|NCT00910871|TB|tb
687402|NCT00910871|MDR-TB|mdr-tb
687403|NCT00910884|stage I breast cancer|stage i breast cancer
687404|NCT00910884|stage II breast cancer|stage ii breast cancer
687405|NCT00910884|stage IIIA breast cancer|stage iiia breast cancer
687406|NCT00910884|male breast cancer|male breast cancer
687407|NCT00910897|Newly Diagnosed|newly diagnosed
687408|NCT00910897|multiple myeloma|multiple myeloma
687409|NCT00910897|induction|induction
687410|NCT00910897|Thalidomide|thalidomide
687411|NCT00910923|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
687412|NCT00910936|HIV|hiv
687413|NCT00910936|Exercise|exercise
687414|NCT00910936|Inflammation|inflammation
687415|NCT00910936|Quality of life|quality of life
687416|NCT00910936|Lipodystrophia|lipodystrophia
687417|NCT00910949|persistent pain|persistent pain
687814|NCT00912600|Death|death
687418|NCT00910949|neuropathic pain|neuropathic pain
687419|NCT00910949|Thoracotomy|thoracotomy
687420|NCT00910949|Chronic Pain|chronic pain
687421|NCT00910962|NSTEMI, acute coronary syndrome, p38 MAPK inhibitor, GW856553, percutaneous coronary intervention|nstemi, acute coronary syndrome, p38 mapk inhibitor, gw856553, percutaneous coronary intervention
687422|NCT00910975|Hepatitis C virus|hepatitis c virus
687423|NCT00910975|Real-time PCR|real-time pcr
687424|NCT00910975|Treatment|treatment
687425|NCT00910988|healthy|healthy
687426|NCT00910988|sedentary|sedentary
687427|NCT00910988|men|men
687428|NCT00910988|acute effects of antipsychotic|acute effects of antipsychotic
687429|NCT00910988|blood sugar|blood sugar
687430|NCT00910988|insulin sensitivity|insulin sensitivity
687431|NCT00911001|Arthroplasty|arthroplasty
687432|NCT00911001|Antithrombotic prophylaxis treatment|antithrombotic prophylaxis treatment
687433|NCT00911001|Replacement|replacement
687434|NCT00911001|Knee|knee
687435|NCT00911027|Prostate|prostate
687436|NCT00911027|Cancer|cancer
687437|NCT00911027|Biopsy|biopsy
687438|NCT00911027|Guided|guided
687439|NCT00911027|Contrast|contrast
687440|NCT00911027|Enhanced|enhanced
687441|NCT00911027|SonoVue|sonovue
687442|NCT00911027|Suspicion of prostate cancer|suspicion of prostate cancer
687443|NCT00911053|melatonin|melatonin
687444|NCT00911053|sleep|sleep
687445|NCT00911053|blindness|blindness
687446|NCT00911053|blind individuals|blind individuals
687447|NCT00911079|Stage III, IV cervical cancer|stage iii, iv cervical cancer
687448|NCT00911079|Rising prostate specific antigen (PSA) after local therapy|rising prostate specific antigen (psa) after local therapy
687449|NCT00911092|Oesophageal cancer|oesophageal cancer
687450|NCT00911092|exclusive concomitant radiochemotherapy|exclusive concomitant radiochemotherapy
687451|NCT00911105|Multiple Myeloma|multiple myeloma
687452|NCT00911105|Non-interventional study|non-interventional study
687453|NCT00911105|Lenalidomide|lenalidomide
687454|NCT00911105|Dexamethasone|dexamethasone
687455|NCT00911105|Observational|observational
687456|NCT00911105|Time to progression|time to progression
687457|NCT00911105|Clinical routine|clinical routine
687458|NCT00911105|Germany|germany
687459|NCT00911105|Plasmacytoma|plasmacytoma
687460|NCT00911118|prostate|prostate
687461|NCT00911118|radiation|radiation
687462|NCT00911118|09-035|09-035
687463|NCT00911131|Small grade esophageal varices|small grade esophageal varices
687464|NCT00911131|capsule endoscopy|capsule endoscopy
687465|NCT00911131|PillCam ESO|pillcam eso
687466|NCT00911131|abdominal binder|abdominal binder
687471|NCT00911144|Booster vaccination|booster vaccination
687472|NCT00911157|Pulmonary thromboembolism|pulmonary thromboembolism
687473|NCT00911157|contrast-enhanced MDCT|contrast-enhanced mdct
687474|NCT00911157|Deep Vein Thrombosis|deep vein thrombosis
687475|NCT00911157|Fondaparinux sodium|fondaparinux sodium
687476|NCT00911170|adenocarcinoma of the colon or rectum|adenocarcinoma of the colon or rectum
687477|NCT00911170|febrile neutropenia|febrile neutropenia
687478|NCT00911170|Bevacizumab|bevacizumab
687479|NCT00911170|Avastin|avastin
752865|NCT01174537|Metastatic|metastatic
687480|NCT00911170|5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX)|5-fluorouracil, oxaliplatin, leucovorin (folfox)
687481|NCT00911170|5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)|5-fluorouracil, irinotecan, leucovorin (folfiri)
687482|NCT00911183|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
687483|NCT00911183|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
687484|NCT00911183|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
687485|NCT00911183|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
687486|NCT00911196|Prognosis|prognosis
687488|NCT00911196|Expression analysis|expression analysis
687489|NCT00911196|Hepatocellular carcinoma|hepatocellular carcinoma
687490|NCT00911209|Heart Disease|heart disease
687491|NCT00911209|Obesity|obesity
687492|NCT00911222|antiemetic therapy|antiemetic therapy
687493|NCT00911222|emesis|emesis
687494|NCT00911222|vomiting|vomiting
687495|NCT00911222|nausea|nausea
687496|NCT00911222|moderately and highly emetogenic chemotherapy|moderately and highly emetogenic chemotherapy
687497|NCT00911222|cisplatin|cisplatin
687498|NCT00911222|carboplatin|carboplatin
687499|NCT00911222|oxaliplatin|oxaliplatin
687500|NCT00911222|anthracycline|anthracycline
687501|NCT00911222|cyclophosphamid|cyclophosphamid
687502|NCT00911235|The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects|the effect of fluconazole on pharmacokinetics of fesoterodine in healthy subjects
687503|NCT00911248|Angiogenesis|angiogenesis
687504|NCT00911248|Neurofibromatosis|neurofibromatosis
687505|NCT00911248|Post-transcriptional control|post-transcriptional control
687506|NCT00911248|PTC299|ptc299
687507|NCT00911248|VEGF|vegf
687508|NCT00911261|Cancer Pain|cancer pain
687509|NCT00911261|Neuropathic Pain|neuropathic pain
687510|NCT00911261|Extended Release|extended release
687511|NCT00911261|Long-Acting Opioid|long-acting opioid
687512|NCT00911261|Oxymorphone|oxymorphone
687513|NCT00911274|Bioequivalence|bioequivalence
687514|NCT00911274|Healthy Subjects|healthy subjects
687515|NCT00911287|Chronic pain|chronic pain
687516|NCT00911287|Extended Release|extended release
687517|NCT00911287|Long-Acting Opioid|long-acting opioid
687518|NCT00911287|Opioid|opioid
687519|NCT00911287|Opioid-Naive|opioid-naive
687520|NCT00911287|Oxymorphone|oxymorphone
687521|NCT00911300|Cardioversion, Electric|cardioversion, electric
687522|NCT00911300|Pathological Conditions, Sings and Symptoms|pathological conditions, sings and symptoms
687523|NCT00911300|Cardiovascular Diseases|cardiovascular diseases
687524|NCT00911300|Heart Diseases|heart diseases
687525|NCT00911300|Atrial Fibrillation|atrial fibrillation
687526|NCT00911300|Arrhythmias, Cardiac|arrhythmias, cardiac
687527|NCT00911300|Pathologic Processes|pathologic processes
687528|NCT00911300|Anticoagulants|anticoagulants
687529|NCT00911313|Polycystic ovary syndrome|polycystic ovary syndrome
687530|NCT00911313|clomiphene resistance|clomiphene resistance
687531|NCT00911313|letrozole|letrozole
687532|NCT00911326|HNSCC|hnscc
687533|NCT00911352|Cryotherapy|cryotherapy
687534|NCT00911352|Hand toxicity|hand toxicity
687535|NCT00911352|Nail toxicity|nail toxicity
687536|NCT00911352|Infection control|infection control
687537|NCT00911365|voluntary participants|voluntary participants
687538|NCT00911365|75 years old or less|75 years old or less
687539|NCT00911378|weaning|weaning
687540|NCT00911378|mechanical ventilation|mechanical ventilation
687541|NCT00911391|Doppler|doppler
687542|NCT00911391|Colectomy|colectomy
687543|NCT00911391|ERAS|eras
687544|NCT00911391|Fluid|fluid
687545|NCT00911391|Perioperative Care|perioperative care
687546|NCT00911404|Gestational diabetes|gestational diabetes
687547|NCT00911404|Carbohydrate|carbohydrate
687548|NCT00911404|Diet|diet
687549|NCT00911404|Insulin|insulin
687550|NCT00911417|peripheral arterial disease|peripheral arterial disease
687551|NCT00911417|peripheral vascular disease|peripheral vascular disease
687552|NCT00911430|Staphylococcus Aureus (S. Areus)|staphylococcus aureus (s. areus)
687553|NCT00911430|Recurrent Staphylococcal Infection|recurrent staphylococcal infection
687554|NCT00911430|Atopic Dermatitis|atopic dermatitis
687555|NCT00911430|Immunodeficiency|immunodeficiency
687556|NCT00911430|Community Associated Staphylococcal Infection|community associated staphylococcal infection
687557|NCT00911430|Staphylococcal Infection|staphylococcal infection
687558|NCT00911430|Invasive Staphylococcal Infection|invasive staphylococcal infection
687559|NCT00911430|Staph Infection|staph infection
687560|NCT00911469|Knee osteoarthritis|knee osteoarthritis
687561|NCT00911469|fibroblast growth factor 18|fibroblast growth factor 18
687562|NCT00911482|Type 2 Diabetes|type 2 diabetes
687563|NCT00911482|Dyslipidemia|dyslipidemia
687565|NCT00911482|Triglycerides|triglycerides
687566|NCT00911482|Tracers|tracers
687567|NCT00911495|Sickle Cell Disease|sickle cell disease
687568|NCT00911508|Atrial Fibrillation|atrial fibrillation
687569|NCT00911508|Left Atrial Ablation|left atrial ablation
687570|NCT00911508|Pulmonary Vein Isolation|pulmonary vein isolation
687571|NCT00911508|Catheter Ablation|catheter ablation
687572|NCT00911508|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
687573|NCT00911521|human papillomavirus|human papillomavirus
687574|NCT00911521|vaccine|vaccine
687575|NCT00911521|lupus|lupus
687576|NCT00911534|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
687577|NCT00911534|GERD|gerd
687578|NCT00911547|chronic asthma|chronic asthma
687579|NCT00911560|BETA-D-GLUCAN|beta-d-glucan
687580|NCT00911560|OPT-821|opt-821
687581|NCT00911560|GD2-KLH|gd2-klh
687582|NCT00911560|GD3-KLH|gd3-klh
687583|NCT00911560|QS 21|qs 21
687584|NCT00911560|Vaccine|vaccine
687585|NCT00911560|05-075|05-075
687586|NCT00911573|pediatry|pediatry
687587|NCT00911573|children|children
687588|NCT00911573|skin|skin
687589|NCT00911573|bacteria|bacteria
687590|NCT00911573|MRSA|mrsa
687591|NCT00911599|Individuals undergoing unilateral total hip replacement.|individuals undergoing unilateral total hip replacement.
687592|NCT00911612|bile acid|bile acid
687593|NCT00911612|malabsorption|malabsorption
687594|NCT00911612|permeability|permeability
687595|NCT00911612|diarrhea|diarrhea
687597|NCT00911612|stool|stool
687598|NCT00911625|glargine|glargine
687599|NCT00911625|glulisine|glulisine
687600|NCT00911625|type 2 diabetes|type 2 diabetes
687601|NCT00911625|renal insufficiency|renal insufficiency
687602|NCT00911638|Patient decision aids|patient decision aids
687603|NCT00911638|Patient preferences|patient preferences
687604|NCT00911638|Osteoarthritis|osteoarthritis
687605|NCT00911638|Joint replacement|joint replacement
687606|NCT00911638|Waiting times|waiting times
687607|NCT00911651|COPD|copd
687608|NCT00911651|salbutamol|salbutamol
687609|NCT00911651|ipratropium bromide|ipratropium bromide
687708|NCT00912106|HA|ha
687610|NCT00911651|computational fluid dynamics|computational fluid dynamics
687611|NCT00911651|functional imaging|functional imaging
687612|NCT00911651|central and peripheral airways|central and peripheral airways
687613|NCT00911664|Vitamin D|vitamin d
687614|NCT00911664|HIV-Infected children|hiv-infected children
687615|NCT00911664|CD4 count|cd4 count
687616|NCT00911677|Delirium (MeSH Unique ID D003693)|delirium (mesh unique id d003693)
687617|NCT00911677|Cognition Disorders (MeSH Unique ID D003072)|cognition disorders (mesh unique id d003072)
687618|NCT00911677|Postoperative Complications (MeSH Unique ID D011183)|postoperative complications (mesh unique id d011183)
687619|NCT00911677|Apolipoproteins E (MeSH Unique ID D001057)|apolipoproteins e (mesh unique id d001057)
687620|NCT00911690|Dementia|dementia
687621|NCT00911690|Alzheimers Disease|alzheimers disease
687622|NCT00911690|Cognitive Disorders|cognitive disorders
687623|NCT00911690|Tissue Banking|tissue banking
687624|NCT00911716|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
689225|NCT00917332|VAS|vas
687625|NCT00911716|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
687626|NCT00911716|HER2-negative breast cancer|her2-negative breast cancer
687627|NCT00911716|stage IA breast cancer|stage ia breast cancer
687628|NCT00911716|stage IB breast cancer|stage ib breast cancer
687629|NCT00911716|stage II breast cancer|stage ii breast cancer
687630|NCT00911716|stage IIIA breast cancer|stage iiia breast cancer
687631|NCT00911716|male breast cancer|male breast cancer
687632|NCT00911729|paraganglioma|paraganglioma
687633|NCT00911729|pheochromocytoma|pheochromocytoma
687634|NCT00911755|Laryngoscopy|laryngoscopy
687635|NCT00911755|Glidescope|glidescope
687636|NCT00911768|Xerostomia|xerostomia
687637|NCT00911768|Panax ginseng(Korean Red Ginseng)|panax ginseng(korean red ginseng)
687638|NCT00911768|Visual Analogue Scale|visual analogue scale
687639|NCT00911768|Salivary Flow Rates|salivary flow rates
687640|NCT00911781|Infantile hemangioma|infantile hemangioma
687641|NCT00911794|Dyspnea|dyspnea
687642|NCT00911794|Written Disclosure Therapy|written disclosure therapy
687643|NCT00911794|COPD|copd
687644|NCT00911794|Pulmonary Fibrosis|pulmonary fibrosis
687645|NCT00911794|Chronic Lung Diseases|chronic lung diseases
687646|NCT00911794|Pulmonary Rehabilitation|pulmonary rehabilitation
687647|NCT00911807|Clinical Trial, Phase II|clinical trial, phase ii
687648|NCT00911807|Randomized Controlled Trial|randomized controlled trial
687649|NCT00911807|Multicenter Study|multicenter study
687650|NCT00911807|Cerebrolysin|cerebrolysin
687651|NCT00911807|Donepezil|donepezil
687652|NCT00911833|Trust|trust
687653|NCT00911846|opioid dependence substitution buprenorphine methadone|opioid dependence substitution buprenorphine methadone
687654|NCT00911846|"substitution"|"substitution"
687655|NCT00911859|Multiple Myeloma|multiple myeloma
687656|NCT00911859|CNTO328|cnto328
687657|NCT00911859|Interleukin-6 (IL-6)|interleukin-6 (il-6)
687658|NCT00911859|Monoclonal antibody|monoclonal antibody
687659|NCT00911859|Anti-IL-6 monoclonal antibody|anti-il-6 monoclonal antibody
687660|NCT00911859|Bortezomib|bortezomib
687661|NCT00911859|Velcade|velcade
687664|NCT00911872|wrinkles|wrinkles
687665|NCT00911872|dermal filler|dermal filler
687666|NCT00911872|collagen|collagen
687667|NCT00911872|soft tissue augmentation|soft tissue augmentation
687668|NCT00911872|aesthetic|aesthetic
687669|NCT00911885|Weight|weight
687670|NCT00911885|Diet|diet
687671|NCT00911885|Lipids|lipids
687672|NCT00911898|Her2 amplified solid tumors|her2 amplified solid tumors
687673|NCT00911898|Breast Cancer|breast cancer
687674|NCT00911898|Her3/ErbB3|her3/erbb3
687675|NCT00911898|Bispecific Antibody|bispecific antibody
687676|NCT00911911|Breast cancer|breast cancer
687677|NCT00911911|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
687678|NCT00911911|Proteomic|proteomic
687679|NCT00911911|Histological response|histological response
687680|NCT00911924|primary open angle glaucoma (POAG)|primary open angle glaucoma (poag)
687682|NCT00911924|glaucoma|glaucoma
687683|NCT00911937|incontinence OAB urgency nocturia|incontinence oab urgency nocturia
687684|NCT00911963|VX-222|vx-222
687685|NCT00911976|Coronary artery bypass|coronary artery bypass
687686|NCT00911976|Stents|stents
687687|NCT00911976|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
687688|NCT00911976|Coronary Restenosis|coronary restenosis
687689|NCT00911976|Everolimus|everolimus
687690|NCT00911976|Saphenous vein grafts|saphenous vein grafts
687691|NCT00911989|Obesity|obesity
687692|NCT00911989|Weight Loss|weight loss
687693|NCT00912041|Brain computer interface|brain computer interface
687694|NCT00912041|Assistive device|assistive device
687695|NCT00912041|Environmental control|environmental control
687696|NCT00912041|Communication device|communication device
687697|NCT00912041|quadriplegia|quadriplegia
687698|NCT00912041|tetraplegia|tetraplegia
687699|NCT00912054|OAG|oag
687700|NCT00912054|OH|oh
687701|NCT00912080|genomic signature|genomic signature
687702|NCT00912080|lymph nodes|lymph nodes
687703|NCT00912080|no metastases|no metastases
687704|NCT00912093|HAE|hae
687705|NCT00912093|Type I HAE|type i hae
687706|NCT00912093|Type II HAE|type ii hae
687707|NCT00912106|osteoarthritis|osteoarthritis
687709|NCT00912106|synovial fluid|synovial fluid
687710|NCT00912106|lubrication|lubrication
687711|NCT00912119|craniofacial surgery|craniofacial surgery
687712|NCT00912119|pharmacokinetics|pharmacokinetics
687713|NCT00912119|cranial vault abnormalities|cranial vault abnormalities
687714|NCT00912119|homologous blood products|homologous blood products
687715|NCT00912119|wide scalp dissections|wide scalp dissections
687716|NCT00912119|transfusion requirements|transfusion requirements
687717|NCT00912132|Fetal Growth|fetal growth
687718|NCT00912132|Pregnancy|pregnancy
687719|NCT00912158|CPE|cpe
687720|NCT00912158|CPAP|cpap
687721|NCT00912158|BiPAP|bipap
687722|NCT00912158|non invasive mechanical ventilation|non invasive mechanical ventilation
687723|NCT00912171|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
687724|NCT00912171|snoring|snoring
687725|NCT00912171|adenotonsillar hypertrophy|adenotonsillar hypertrophy
687726|NCT00912171|polysomnography|polysomnography
687727|NCT00912171|intranasal steroids|intranasal steroids
687728|NCT00912171|Anti-leukotrienes|anti-leukotrienes
687729|NCT00912184|Kidney failure, acute|kidney failure, acute
687730|NCT00912184|Shock|shock
687731|NCT00912184|Toxins, biological|toxins, biological
687732|NCT00912184|Hemofiltration|hemofiltration
687733|NCT00912184|High cut off/super high flux membranes|high cut off/super high flux membranes
687734|NCT00912223|Follicular Non-Hodgkin's Lymphoma|follicular non-hodgkin's lymphoma
687735|NCT00912223|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
687736|NCT00912223|Non-Myeloablative Transplant (NST)|non-myeloablative transplant (nst)
687737|NCT00912236|Obesity|obesity
687738|NCT00912236|HDL|hdl
687739|NCT00912236|HDL functionality|hdl functionality
687740|NCT00912249|Horticulture Therapy|horticulture therapy
687741|NCT00912249|Psychiatric Rehabilitation|psychiatric rehabilitation
687742|NCT00912249|Nature-assisted psychotherapy|nature-assisted psychotherapy
687743|NCT00912249|Day Care|day care
687744|NCT00912262|Analgesics|analgesics
687745|NCT00912262|Capsaicin|capsaicin
687746|NCT00912288|Alzheimer disease moderate-to-severe memantine safety and efficacy|alzheimer disease moderate-to-severe memantine safety and efficacy
687747|NCT00912301|chenodeoxycholate, IBS, transit, colon, constipation|chenodeoxycholate, ibs, transit, colon, constipation
687748|NCT00912314|OAB|oab
687749|NCT00912314|overactive bladder|overactive bladder
687750|NCT00912314|ptns|ptns
687751|NCT00912314|posterior tibial nerve stimulation|posterior tibial nerve stimulation
687752|NCT00912314|percutaneous tibial nerve stimulation|percutaneous tibial nerve stimulation
687753|NCT00912327|Colorectal|colorectal
687754|NCT00912327|KRAS mutation|kras mutation
687755|NCT00912327|Stage IV|stage iv
687756|NCT00912327|Imprime PGG|imprime pgg
687757|NCT00912327|Cetuximab|cetuximab
687758|NCT00912327|Immunotherapy|immunotherapy
687759|NCT00912340|Breast Cancer|breast cancer
687760|NCT00912353|Phase I|phase i
687761|NCT00912353|Japanese healthy volunteer|japanese healthy volunteer
687762|NCT00912353|AZD7268|azd7268
687763|NCT00912366|VATS|vats
687764|NCT00912366|Lung cancer|lung cancer
687765|NCT00912366|NSCLC|nsclc
687766|NCT00912405|Patients diagnosed with Chronic Sinusitis undergoing functional endoscopic surgery (FESS)|patients diagnosed with chronic sinusitis undergoing functional endoscopic surgery (fess)
687767|NCT00912418|melanoma|melanoma
687768|NCT00912418|vaccine|vaccine
687769|NCT00912418|IL2 low dose|il2 low dose
687770|NCT00912431|Healthy Volunteers|healthy volunteers
687771|NCT00912444|Breast Neoplasms|breast neoplasms
687772|NCT00912444|Neoadjuvant|neoadjuvant
687773|NCT00912444|Chemotherapy|chemotherapy
687774|NCT00912444|Docetaxel|docetaxel
687775|NCT00912444|Cyclophosphamide|cyclophosphamide
687776|NCT00912444|Anthracycline|anthracycline
687777|NCT00912457|sleep apnea|sleep apnea
687778|NCT00912457|donepezil|donepezil
687779|NCT00912457|pharmacological|pharmacological
687780|NCT00912457|cholinergic|cholinergic
687781|NCT00912470|genetic vascular risc factors|genetic vascular risc factors
687782|NCT00912470|ocular blood flow|ocular blood flow
687783|NCT00912470|progressive glaucoma|progressive glaucoma
687785|NCT00912496|Influenza, H5N1, vaccine, avian influenza|influenza, h5n1, vaccine, avian influenza
687786|NCT00912509|infectious keratitis|infectious keratitis
687787|NCT00912509|cross linking|cross linking
687788|NCT00912509|corneal ulcer|corneal ulcer
687789|NCT00912509|corneal infection|corneal infection
687790|NCT00912509|collagen cross linking|collagen cross linking
687792|NCT00912522|TMS|tms
687793|NCT00912522|cognition|cognition
687794|NCT00912522|Motivation|motivation
687795|NCT00912522|Perception|perception
687796|NCT00912522|Decision making|decision making
687797|NCT00912535|Primary Anxiety Disorders|primary anxiety disorders
687798|NCT00912535|Mood Disorders with Comorbid Anxiety Symptoms|mood disorders with comorbid anxiety symptoms
687799|NCT00912548|premenopause|premenopause
687800|NCT00912548|ovarian function suppression|ovarian function suppression
687801|NCT00912548|tamoxifen|tamoxifen
687802|NCT00912561|chronic brain ischaemia|chronic brain ischaemia
687803|NCT00912561|stroke prevention|stroke prevention
687804|NCT00912561|exercise|exercise
687805|NCT00912561|physical training|physical training
688005|NCT00921050|NEUROPSI|neuropsi
687806|NCT00912561|Chronic, extra- or intracranial stenoses of brain supplying arteries|chronic, extra- or intracranial stenoses of brain supplying arteries
687807|NCT00912574|Melanoma|melanoma
687808|NCT00912574|adjuvant|adjuvant
687809|NCT00912574|dendritic cells|dendritic cells
687810|NCT00912574|vaccine|vaccine
687811|NCT00912600|Intensive Care Units|intensive care units
687812|NCT00912600|Triage|triage
687813|NCT00912600|Aged, 80 and over|aged, 80 and over
687815|NCT00912600|Activities of Daily Living|activities of daily living
687816|NCT00912600|Health Services Research|health services research
687817|NCT00912600|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
687818|NCT00912613|Critical illness|critical illness
687819|NCT00912613|ICU Diaries|icu diaries
687820|NCT00912613|Post Traumatic Stress Disorder|post traumatic stress disorder
687821|NCT00912613|Incidence|incidence
687822|NCT00912626|siblings|siblings
687823|NCT00912626|family|family
687824|NCT00912626|child behavior|child behavior
687825|NCT00912626|critical illness|critical illness
687826|NCT00912626|social support|social support
687827|NCT00912639|recurrent breast cancer|recurrent breast cancer
687828|NCT00912639|Genexol-PM|genexol-pm
687829|NCT00912652|obesity|obesity
687830|NCT00912652|rural health|rural health
687831|NCT00912652|exercise|exercise
687832|NCT00912665|Optic Nerve Head Blood Flow|optic nerve head blood flow
687833|NCT00912665|Intraocular Pressure|intraocular pressure
687834|NCT00912665|Regional Blood Flow|regional blood flow
687835|NCT00912665|Ocular Physiology|ocular physiology
687836|NCT00912665|Optic Disk|optic disk
687837|NCT00912678|Kidney transplantation|kidney transplantation
687838|NCT00912678|Old for old kidney transplantation|old for old kidney transplantation
687839|NCT00912678|European senior program|european senior program
687840|NCT00912678|Calcineurin inhibitor free immunosuppression|calcineurin inhibitor free immunosuppression
687841|NCT00912691|Autism|autism
687842|NCT00912704|Hemodialysis patients|hemodialysis patients
687843|NCT00912704|Kidney|kidney
687844|NCT00912704|Physician attitudes|physician attitudes
687845|NCT00912704|Family wishes|family wishes
687846|NCT00912704|30 numbers require maximum|30 numbers require maximum
687847|NCT00912730|melanoma|melanoma
687848|NCT00912730|imaging|imaging
687849|NCT00912730|sentinel node|sentinel node
687850|NCT00912730|biopsy|biopsy
687851|NCT00912743|Colorectal cancer|colorectal cancer
687852|NCT00912743|Olaparib|olaparib
687853|NCT00912743|MSI status|msi status
687854|NCT00912743|Stage IV|stage iv
687855|NCT00912743|Measurable Colorectal Cancer|measurable colorectal cancer
687856|NCT00912743|Stratified by MSI Status|stratified by msi status
687857|NCT00912756|endovascular therapy|endovascular therapy
687858|NCT00912756|restenosis|restenosis
687859|NCT00912756|cilostazol|cilostazol
687860|NCT00912756|femoropopliteal artery lesions|femoropopliteal artery lesions
687956|NCT00920920|Cervical Cancer|cervical cancer
687861|NCT00912756|Chronic arteriosclerosis obliterans afflicting the femoropopliteal artery area|chronic arteriosclerosis obliterans afflicting the femoropopliteal artery area
687862|NCT00912769|Total knee replacement|total knee replacement
687863|NCT00912769|Subvastus|subvastus
687864|NCT00912769|Midvastus|midvastus
687865|NCT00912769|Isokinetic|isokinetic
687866|NCT00912769|Quadriceps|quadriceps
687868|NCT00912782|Vitamin D|vitamin d
687869|NCT00912782|Arteriovenous Fistulae|arteriovenous fistulae
687870|NCT00912782|Dialysis Vascular Access|dialysis vascular access
687871|NCT00912795|Smoking Cessation|smoking cessation
687872|NCT00912795|technology|technology
687873|NCT00912795|developing countries|developing countries
687874|NCT00912808|parkinsons disease|parkinsons disease
687876|NCT00912821|Renal Replacement Therapy|renal replacement therapy
687877|NCT00912821|Peritoneal dialysis|peritoneal dialysis
687878|NCT00912834|hematuria|hematuria
687879|NCT00912834|urinary tract infection|urinary tract infection
687880|NCT00912847|HBV carriers|hbv carriers
687881|NCT00912860|multiple sclerosis|multiple sclerosis
687882|NCT00912860|interferon beta-1a|interferon beta-1a
687883|NCT00912860|avonex|avonex
687884|NCT00912873|pain|pain
687885|NCT00912873|catheter|catheter
687886|NCT00912873|nerve block|nerve block
687887|NCT00912873|UCSD|ucsd
687888|NCT00912873|range of motion|range of motion
687889|NCT00912873|hip surgery|hip surgery
687890|NCT00912873|psoas compartment|psoas compartment
687891|NCT00912886|alzheimer|alzheimer
687892|NCT00912886|memory|memory
687893|NCT00912886|neurosteroids|neurosteroids
687894|NCT00912899|Refractory Multiple Myeloma|refractory multiple myeloma
687895|NCT00912899|CB3304|cb3304
687896|NCT00912899|Noscapine HCl|noscapine hcl
687897|NCT00912899|Multiple Myeloma|multiple myeloma
687898|NCT00912912|Genitourinary|genitourinary
687899|NCT00912912|Testis|testis
687900|NCT00912912|Refractory Germ Cell Tumors|refractory germ cell tumors
687901|NCT00912912|Advanced germ cell tumors|advanced germ cell tumors
687902|NCT00912912|GCTs|gcts
687903|NCT00912912|Sunitinib Malate|sunitinib malate
687904|NCT00912912|Sutent|sutent
687905|NCT00912912|SU011248|su011248
687906|NCT00912938|metastatic breast cancer|metastatic breast cancer
687907|NCT00912938|bone remodeling markers|bone remodeling markers
687908|NCT00912938|zoledronic acid|zoledronic acid
687909|NCT00912964|Overactive Bladder|overactive bladder
687910|NCT00912964|Frequency|frequency
687911|NCT00912964|Micturition|micturition
687912|NCT00912964|Urgency|urgency
687913|NCT00912964|Urinary incontinence|urinary incontinence
687914|NCT00912964|Urinary urgency incontinence|urinary urgency incontinence
687917|NCT00912977|Parkinsons disease|parkinsons disease
687918|NCT00912977|dyskinesia|dyskinesia
687919|NCT00912977|measurement|measurement
687920|NCT00920816|Axitinib in First & Second Line Treatment of Patients With Metastatic Renal Cell Cancer|axitinib in first & second line treatment of patients with metastatic renal cell cancer
687921|NCT00920829|Alcohol Dependence|alcohol dependence
687922|NCT00920829|Alcoholism|alcoholism
687923|NCT00920829|Naltrexone|naltrexone
687924|NCT00920829|Substance Abuse|substance abuse
687925|NCT00920829|Genetics|genetics
687926|NCT00920842|metabolic syndrome|metabolic syndrome
687927|NCT00920842|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
687928|NCT00920842|cardiovascular complications|cardiovascular complications
687929|NCT00920842|cancer survivor|cancer survivor
687930|NCT00920842|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
687931|NCT00920842|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
687932|NCT00920842|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
687933|NCT00920842|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
687934|NCT00920842|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
687935|NCT00920842|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
687936|NCT00920842|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
687937|NCT00920842|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
687938|NCT00920868|Phase I|phase i
687939|NCT00920868|Solid Tumor|solid tumor
687940|NCT00920868|Colorectal|colorectal
687941|NCT00920868|Dasatinib|dasatinib
687942|NCT00920868|Sprycel|sprycel
687943|NCT00920868|Bevacizumab|bevacizumab
687944|NCT00920868|Avastin|avastin
687945|NCT00920868|Oxaliplatin|oxaliplatin
687946|NCT00920868|Eloxatin|eloxatin
687947|NCT00920868|Capecitabine|capecitabine
687948|NCT00920868|Xeloda|xeloda
687949|NCT00920868|Duke|duke
687950|NCT00920868|Any Solid Tumor (Phase I)|any solid tumor (phase i)
687951|NCT00920868|Metastatic Colorectal Cancer (Expanded Cohort)|metastatic colorectal cancer (expanded cohort)
687952|NCT00920881|Continuous glucose monitoring|continuous glucose monitoring
687953|NCT00920881|Accuracy|accuracy
687954|NCT00920881|Continuous glucose-error grid analysis|continuous glucose-error grid analysis
687955|NCT00920920|3D-4D MRI-based Brachytherapy|3d-4d mri-based brachytherapy
687957|NCT00920920|Multicenter Clinical Study|multicenter clinical study
687958|NCT00920920|Locally advanced cervical cancer|locally advanced cervical cancer
687959|NCT00920933|Ozone challenge|ozone challenge
687960|NCT00920933|airway neutrophilia|airway neutrophilia
687961|NCT00920933|induced sputum|induced sputum
687962|NCT00920933|Healthy volunteers|healthy volunteers
687963|NCT00920946|Huntington|huntington
687964|NCT00920946|Dimebon|dimebon
687965|NCT00920946|HD|hd
687966|NCT00920946|Huntingtin|huntingtin
687967|NCT00920972|Bone marrow|bone marrow
687968|NCT00920972|Transplant|transplant
687969|NCT00920972|Transplantation|transplantation
687970|NCT00920972|Hematopoietic|hematopoietic
687971|NCT00920972|Umbilical cord|umbilical cord
687972|NCT00920972|Related|related
687973|NCT00920972|Unrelated|unrelated
687974|NCT00920972|Reduced|reduced
687975|NCT00920972|Non-myeloablative|non-myeloablative
687976|NCT00920972|Nonmyeloablative|nonmyeloablative
687977|NCT00920972|Non-malignant|non-malignant
687978|NCT00920972|Nonmalignant|nonmalignant
687979|NCT00920985|Pregnancy prevention|pregnancy prevention
687980|NCT00920985|Female contraception|female contraception
687981|NCT00920985|Patch|patch
687982|NCT00920998|Z-338|z-338
687983|NCT00920998|YM443|ym443
687984|NCT00920998|healthy volunteers|healthy volunteers
687985|NCT00921011|hypertension|hypertension
687986|NCT00921011|diabetes|diabetes
687987|NCT00921011|smoking|smoking
687988|NCT00921011|hyperlipidemia|hyperlipidemia
687989|NCT00921011|atherosclerosis risk|atherosclerosis risk
687990|NCT00921024|Complicated Urinary Tract Infection|complicated urinary tract infection
687991|NCT00921024|Pyelonephritis|pyelonephritis
687992|NCT00921024|Antimicrobial|antimicrobial
687993|NCT00921024|Cephalosporin|cephalosporin
687994|NCT00921024|Intravenous|intravenous
687995|NCT00921037|Neurofibromatosis Type 1|neurofibromatosis type 1
687996|NCT00921037|Morbus Recklinghausen|morbus recklinghausen
687997|NCT00921037|cutaneous neurofibromas|cutaneous neurofibromas
687998|NCT00921037|Erbium-YAG-Laser|erbium-yag-laser
687999|NCT00921037|Vaporisation|vaporisation
688000|NCT00921037|Thermal Necrosis|thermal necrosis
688001|NCT00921050|subclinical hypothyroidism|subclinical hypothyroidism
688002|NCT00921050|elderly|elderly
688003|NCT00921050|mild cognitive impairment|mild cognitive impairment
688004|NCT00921050|neuropsychological test|neuropsychological test
688006|NCT00921089|Atherosclerosis|atherosclerosis
688007|NCT00921089|Cardiovascular disease|cardiovascular disease
688008|NCT00921089|Hemodialysis|hemodialysis
688009|NCT00921089|Inflammation|inflammation
688010|NCT00921089|Vascular calcification|vascular calcification
688011|NCT00921102|Atropine|atropine
688012|NCT00921102|Morphine|morphine
688013|NCT00921102|Analgesics, Opioid|analgesics, opioid
688015|NCT00921115|hormone receptor positive|hormone receptor positive
688016|NCT00921115|invasive breast cancer|invasive breast cancer
688017|NCT00921115|endocrine therapy|endocrine therapy
688018|NCT00921115|Anastrazole|anastrazole
688019|NCT00921115|Fulvestrant|fulvestrant
688020|NCT00921115|breast tumors|breast tumors
688021|NCT00921115|postmenopausal|postmenopausal
688022|NCT00921128|Muscimol|muscimol
688023|NCT00921128|Convection-Enhanced Delivery|convection-enhanced delivery
688024|NCT00921128|Parkinson's Disease|parkinson's disease
688025|NCT00921128|Deep Brain Stimulation|deep brain stimulation
688026|NCT00921128|Parkinson Disease|parkinson disease
688027|NCT00921128|PD|pd
688028|NCT00923000|Herb Drug|herb drug
688029|NCT00923000|volunteers|volunteers
688030|NCT00923013|Hairy Cell Leukemia|hairy cell leukemia
688031|NCT00923013|Cladribine|cladribine
688032|NCT00923013|Rituximab|rituximab
688033|NCT00923013|Minimal Residual Disease|minimal residual disease
688034|NCT00923013|Leukemia|leukemia
688035|NCT00923026|Gene Therapy|gene therapy
688036|NCT00923026|Follow-Up|follow-up
688037|NCT00923026|Delayed Toxicity|delayed toxicity
688038|NCT00923026|Adenocarcinoma|adenocarcinoma
688039|NCT00923026|Melanoma|melanoma
688040|NCT00923026|Neuroendocrine Tumors|neuroendocrine tumors
688041|NCT00923026|Carcinoma|carcinoma
688042|NCT00923039|The early origin of cardiovascular disease|the early origin of cardiovascular disease
688043|NCT00923052|Cancer Stem Cells|cancer stem cells
688044|NCT00923052|Biomarkers|biomarkers
688045|NCT00923052|Surgery|surgery
688046|NCT00923052|Solid Organ Cancers|solid organ cancers
688047|NCT00923052|Natural History|natural history
688048|NCT00923052|Cancer|cancer
688049|NCT00923052|Solid Organ Cancer|solid organ cancer
688050|NCT00923052|Liver Cancer|liver cancer
688051|NCT00923052|Colorectal Cancer|colorectal cancer
688052|NCT00923052|Breast Cancer|breast cancer
688053|NCT00923052|Gastric Cancer|gastric cancer
688054|NCT00923052|Pancreatic Ductal Cancer|pancreatic ductal cancer
688055|NCT00923065|Cancer|cancer
688056|NCT00923065|Oncology|oncology
688057|NCT00923065|Standard Care|standard care
688058|NCT00923078|schizophrenia|schizophrenia
688059|NCT00923078|cognitive remediation|cognitive remediation
688060|NCT00923078|rehabilitation|rehabilitation
688061|NCT00923078|evoked potentials|evoked potentials
688062|NCT00923078|neuropsychology|neuropsychology
688063|NCT00923091|triple combination|triple combination
688064|NCT00923091|parallel group|parallel group
688065|NCT00923091|dual combination|dual combination
688066|NCT00923104|Radiation|radiation
688067|NCT00923104|Blister|blister
688068|NCT00923104|Healthy Volunteer|healthy volunteer
688069|NCT00923104|Samples|samples
688070|NCT00923104|Prostate Cancer|prostate cancer
688071|NCT00923104|Breast Cancer|breast cancer
688072|NCT00923104|HV|hv
688073|NCT00923117|Glioblastoma|glioblastoma
688074|NCT00923117|Chemotherapy|chemotherapy
688075|NCT00923117|Anti-Angiogenesis|anti-angiogenesis
688076|NCT00923117|Radiation|radiation
688077|NCT00923117|Brain Tumor|brain tumor
688078|NCT00923117|Malignant Glioma|malignant glioma
688079|NCT00923117|Glioblastoma Multiforme|glioblastoma multiforme
688080|NCT00923130|Renal Cell Carcinoma|renal cell carcinoma
688081|NCT00923130|Bevacizumab|bevacizumab
688082|NCT00923130|Ixabepilone|ixabepilone
688083|NCT00923130|Phase II|phase ii
688084|NCT00923156|Heart failure|heart failure
688085|NCT00923156|Systolic|systolic
688086|NCT00923156|Aliskiren|aliskiren
688087|NCT00923156|Ramipril|ramipril
688088|NCT00923156|Angiotensin II|angiotensin ii
688089|NCT00923156|Ang II|ang ii
688090|NCT00923156|Plasma Renin Activity|plasma renin activity
688091|NCT00923156|PRA|pra
688092|NCT00923156|Plasma Renin Concentration|plasma renin concentration
688093|NCT00923156|PR,|pr,
688094|NCT00923156|brain natriuretic peptide|brain natriuretic peptide
688095|NCT00923156|BNP|bnp
688096|NCT00923156|urinary aldosterone|urinary aldosterone
688097|NCT00923156|Escape|escape
688098|NCT00923156|Pharmacokinetic|pharmacokinetic
688099|NCT00923156|PK|pk
688100|NCT00923169|Renal Cell|renal cell
688101|NCT00923169|Melanoma|melanoma
688102|NCT00923169|Monoclonal Antibodies|monoclonal antibodies
688103|NCT00923169|Phase I|phase i
688104|NCT00923169|TGF-B|tgf-b
688105|NCT00923182|Relapsed or Refractory Chronic Lymphocytic Leukemia,|relapsed or refractory chronic lymphocytic leukemia,
688106|NCT00923182|CLL|cll
688107|NCT00923195|Metastatic Melanoma|metastatic melanoma
688108|NCT00923195|Tumor Regression|tumor regression
688109|NCT00923195|Safety|safety
688110|NCT00923195|Immunotherapy|immunotherapy
688111|NCT00923221|Blood|blood
688112|NCT00923221|Prostate Cancer|prostate cancer
688113|NCT00923221|Genotyping|genotyping
688114|NCT00923234|monosomy 5|monosomy 5
688115|NCT00923234|del5q|del5q
688116|NCT00923234|lenalidomide|lenalidomide
688117|NCT00923234|azacitidine|azacitidine
688118|NCT00923247|Vandetanib|vandetanib
688119|NCT00923247|Bortezomib|bortezomib
688120|NCT00923247|Medullary Thyroid|medullary thyroid
688121|NCT00923247|Proteasome Inhibitor|proteasome inhibitor
688124|NCT00923247|Thyroid Cancer|thyroid cancer
688125|NCT00923247|Medullary Thyroid Cancer|medullary thyroid cancer
688126|NCT00923260|Omentectomy|omentectomy
688127|NCT00923260|metabolic syndrome|metabolic syndrome
688128|NCT00923260|acute phase reactants|acute phase reactants
688129|NCT00923273|Pemetrexed|pemetrexed
688130|NCT00923273|Sirolimus|sirolimus
688131|NCT00923273|Non-Small Cell Lung Cancer|non-small cell lung cancer
688132|NCT00923273|Phase I/II|phase i/ii
688133|NCT00923273|mTOR Inhibitor|mtor inhibitor
688134|NCT00923273|NSCLC|nsclc
688135|NCT00923273|Lung Cancer|lung cancer
688136|NCT00923299|stage IV pancreatic cancer|stage iv pancreatic cancer
688137|NCT00923299|recurrent pancreatic cancer|recurrent pancreatic cancer
688138|NCT00923299|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
688139|NCT00923325|Biomarker Analysis|biomarker analysis
688140|NCT00923325|Sarcomas|sarcomas
688141|NCT00923325|Ewing's Sarcoma|ewing's sarcoma
688142|NCT00923325|Osteosarcoma|osteosarcoma
688143|NCT00923325|Rhabdomyosarcoma|rhabdomyosarcoma
688144|NCT00923325|Synovial Sarcoma|synovial sarcoma
688145|NCT00923325|Other Sarcoma|other sarcoma
688146|NCT00923338|fistula|fistula
688147|NCT00923338|vesico-vaginal fistula|vesico-vaginal fistula
688148|NCT00923351|Vaccine|vaccine
688149|NCT00923351|Immunotherapy|immunotherapy
688150|NCT00923351|Cancer|cancer
688151|NCT00923351|Chemotherapy|chemotherapy
688152|NCT00923351|Ewings Sarcoma|ewings sarcoma
688153|NCT00923351|Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine|tumor lysate/klh pulsed dendritic cell vaccine
688154|NCT00923351|Neuroblastoma|neuroblastoma
688155|NCT00923351|Autologous Lymphocyte Infusion|autologous lymphocyte infusion
688156|NCT00923351|Ewing's Sarcoma|ewing's sarcoma
688157|NCT00923351|Rhabdomyosarcoma|rhabdomyosarcoma
688158|NCT00923364|GATA2|gata2
688159|NCT00923364|Transplant|transplant
688160|NCT00923364|Immunodeficiency|immunodeficiency
688161|NCT00923364|Myelodysplasia|myelodysplasia
688162|NCT00923364|MonoMAC|monomac
688163|NCT00923377|Breast Cancer|breast cancer
688164|NCT00923377|Breast Cancer Prevention|breast cancer prevention
688165|NCT00923377|High Risk|high risk
688166|NCT00923377|Breast Stem Cells|breast stem cells
688471|NCT00924326|Lymphoma|lymphoma
688167|NCT00923377|Mammographic Density|mammographic density
688168|NCT00923377|Breast Cancer Risk|breast cancer risk
688169|NCT00923390|Renal Cancer|renal cancer
688170|NCT00923390|Immunotherapy|immunotherapy
688171|NCT00923390|Clinical Response|clinical response
688172|NCT00923390|Toxicity|toxicity
688173|NCT00923390|Gene Therapy|gene therapy
688174|NCT00923390|Kidney Cancer|kidney cancer
688175|NCT00923403|plant sterols|plant sterols
688176|NCT00923403|diet|diet
688177|NCT00923403|soymilk|soymilk
688178|NCT00923403|cholesterol|cholesterol
752866|NCT01174537|Refractory|refractory
688179|NCT00923416|Intra-Prostate Markers|intra-prostate markers
688180|NCT00923416|Transrectal Ultrasound|transrectal ultrasound
688181|NCT00923416|Prostate Cancer Patients|prostate cancer patients
688182|NCT00923429|Manual therapy|manual therapy
688183|NCT00923429|Low back pain|low back pain
688184|NCT00923429|Pain|pain
688185|NCT00923429|Return to work|return to work
688186|NCT00923442|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
688187|NCT00923442|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
688188|NCT00923442|Pediatric Blood Disorders|pediatric blood disorders
688189|NCT00923442|Hodgkins and non-Hodgkins lymphoma|hodgkins and non-hodgkins lymphoma
688191|NCT00923468|Pharmacokinetics|pharmacokinetics
688192|NCT00923468|Phase I Trials|phase i trials
688193|NCT00923468|Children|children
688194|NCT00923468|Relaspsed Solid Tumors|relaspsed solid tumors
688195|NCT00923468|Relapsed Leukemia|relapsed leukemia
688196|NCT00923468|Relapsed Brain Tumors|relapsed brain tumors
688197|NCT00923481|Multi-Kinase Inhibitor|multi-kinase inhibitor
688198|NCT00923481|Neoplasms|neoplasms
688199|NCT00923481|Advanced Cancer|advanced cancer
688200|NCT00923481|Kidney Cancer|kidney cancer
688201|NCT00923481|Liver Cancer|liver cancer
688202|NCT00923481|Pheochromocytoma|pheochromocytoma
688203|NCT00923481|Non-Small Cell Lung Cancer|non-small cell lung cancer
688204|NCT00923481|Colorectal Cancer|colorectal cancer
688205|NCT00923481|Head and Neck Cancer|head and neck cancer
688206|NCT00923494|Anesthesia|anesthesia
688207|NCT00923507|Gene Expression|gene expression
688208|NCT00923507|Prognosis|prognosis
688209|NCT00923507|Watch and Wait|watch and wait
688210|NCT00923507|Molecular Genetics|molecular genetics
688211|NCT00923507|Biologic Markers|biologic markers
688212|NCT00923507|Leukemia|leukemia
688213|NCT00923507|Lymphoma|lymphoma
688214|NCT00923520|Solid Tumors|solid tumors
688215|NCT00923520|Phase I|phase i
688216|NCT00923520|Lymphoma|lymphoma
688217|NCT00923520|Dimethane Sulfonate (DMS612, NSC 281612)|dimethane sulfonate (dms612, nsc 281612)
688218|NCT00923520|Cancer|cancer
688219|NCT00923520|Solid Tumor|solid tumor
688220|NCT00923520|Renal Cell Cancer|renal cell cancer
688221|NCT00923520|Kidney Cancer|kidney cancer
688222|NCT00923520|Breast Cancer|breast cancer
688223|NCT00923520|Colon Cancer|colon cancer
688224|NCT00923520|Lung Disease|lung disease
688225|NCT00923520|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
688226|NCT00923520|NHL|nhl
688227|NCT00923533|Fimasartan|fimasartan
688228|NCT00923533|Drug interaction|drug interaction
688229|NCT00923572|Oral contraceptive|oral contraceptive
688230|NCT00923598|TKA|tka
688231|NCT00923598|Bilateral|bilateral
688232|NCT00923598|Cleveland Clinic|cleveland clinic
688233|NCT00923598|UCSD|ucsd
688234|NCT00923598|Catheter|catheter
688235|NCT00923598|Nerve block|nerve block
688236|NCT00923598|Postoperative pain|postoperative pain
688237|NCT00923598|Femoral Catheter|femoral catheter
688238|NCT00923598|Bilateral Total Knee Arthroplasty|bilateral total knee arthroplasty
688239|NCT00923598|Bilateral Femoral Catheter|bilateral femoral catheter
688240|NCT00923611|Hypertension|hypertension
688241|NCT00923611|Fimasartan|fimasartan
688242|NCT00923624|electronic medical record|electronic medical record
688243|NCT00923624|antiretroviral medication adherence|antiretroviral medication adherence
688244|NCT00923637|Non small cell lung cancer|non small cell lung cancer
688245|NCT00923637|video assisted thoracic surgery|video assisted thoracic surgery
688246|NCT00923637|Adjuvant chemotherapy|adjuvant chemotherapy
688247|NCT00923637|Pemetrexed|pemetrexed
688248|NCT00923637|Oxaliplatin|oxaliplatin
688249|NCT00923650|Informed Consent|informed consent
688250|NCT00923650|Pediatric Phase I Clinical Trials|pediatric phase i clinical trials
688251|NCT00923650|Assent|assent
688252|NCT00923650|Questionnaires|questionnaires
688253|NCT00923650|Osteosarcoma|osteosarcoma
688254|NCT00923650|Ewing's Sarcoma|ewing's sarcoma
688255|NCT00923650|Neuroblastoma|neuroblastoma
688256|NCT00923650|Brain Tumors|brain tumors
688257|NCT00923650|Leukemia|leukemia
688258|NCT00923663|MALT lymphoma|malt lymphoma
688259|NCT00923663|Advanced or Helicobacter pylori-refractory MALT lymphoma|advanced or helicobacter pylori-refractory malt lymphoma
688260|NCT00923676|Hyperlipidemia|hyperlipidemia
688261|NCT00923676|LDL-cholesterol|ldl-cholesterol
688262|NCT00923676|HDL-cholesterol|hdl-cholesterol
688263|NCT00923676|triglycerides|triglycerides
688264|NCT00923676|IIEF|iief
688265|NCT00923676|FSFI|fsfi
688266|NCT00923676|Male and female sexual dysfunctions|male and female sexual dysfunctions
688472|NCT00924339|soy protein|soy protein
688267|NCT00923715|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
688268|NCT00923715|Exenatide|exenatide
688269|NCT00923715|Pramlintide|pramlintide
688270|NCT00923728|AVN - 944|avn - 944
688271|NCT00923728|Phase I|phase i
688272|NCT00923728|Adult Solid Tumors|adult solid tumors
688273|NCT00923728|Cancer|cancer
688274|NCT00923728|Solid Tumor|solid tumor
688275|NCT00923741|Lung Cancer|lung cancer
688276|NCT00923741|Immunity|immunity
688277|NCT00923741|Clinical Response|clinical response
688278|NCT00923741|Cytokines|cytokines
688279|NCT00923741|Elispot Assay|elispot assay
688280|NCT00923741|Non-Small Cell Lung Cancer|non-small cell lung cancer
688281|NCT00923741|NSCLC|nsclc
688282|NCT00923780|Tissue Acquisition|tissue acquisition
688283|NCT00923780|Gene Expression|gene expression
688284|NCT00923780|Class Predictor Model|class predictor model
688285|NCT00923780|Endocrine Tumor|endocrine tumor
688286|NCT00923793|skull defects|skull defects
688287|NCT00923793|Hydroxylapatite implant|hydroxylapatite implant
688288|NCT00923793|Titanium implant|titanium implant
688289|NCT00923793|calotte defects without the possibility to be covered with the missing own bone|calotte defects without the possibility to be covered with the missing own bone
688290|NCT00923806|Metastatic Cancer|metastatic cancer
688291|NCT00923806|Tumor Regression|tumor regression
688292|NCT00923806|Safety|safety
688293|NCT00923806|Immunotherapy|immunotherapy
688294|NCT00923819|Adolescents|adolescents
688295|NCT00923819|Gastric Bypass|gastric bypass
688296|NCT00923819|Quality of Life|quality of life
688297|NCT00923819|Mental Health|mental health
688298|NCT00923819|Lifestyle|lifestyle
688299|NCT00923832|Fungal Infections|fungal infections
688300|NCT00923832|PCR Assays|pcr assays
688301|NCT00923832|Cell Wall Derived Biomarkers|cell wall derived biomarkers
688302|NCT00923832|EORTC/MSG Definitions|eortc/msg definitions
688303|NCT00923832|Molecular Assays|molecular assays
688304|NCT00923832|Lung Fungal Infection|lung fungal infection
688305|NCT00923832|Invasive Pulmonary Fungal Infection|invasive pulmonary fungal infection
688306|NCT00923832|Invasive Pulmonary Aspegillosis|invasive pulmonary aspegillosis
688307|NCT00923832|Invasive Pulmonary Zycomycosis|invasive pulmonary zycomycosis
688308|NCT00923845|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
688309|NCT00923845|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
688310|NCT00923845|Th2 Cells|th2 cells
688311|NCT00923845|Sirolimus|sirolimus
688312|NCT00923845|Pentostatin|pentostatin
688313|NCT00923845|Kidney Cancer|kidney cancer
688314|NCT00923845|Renal Cell Carcinoma|renal cell carcinoma
688315|NCT00923845|Metastatic Renal Cell Cancer|metastatic renal cell cancer
688316|NCT00923858|Rotator Cuff|rotator cuff
688317|NCT00923858|Ultrasound|ultrasound
688318|NCT00923858|Pain|pain
688319|NCT00923858|Tear Progression|tear progression
688320|NCT00923871|CBCT|cbct
688321|NCT00923871|Breast Cancer|breast cancer
688322|NCT00923884|NSCLC|nsclc
688326|NCT00923884|Non-Small Cell Lung Cancer|non-small cell lung cancer
688327|NCT00923884|Small Cell Lung Cancer|small cell lung cancer
688328|NCT00923897|Hepatocellular Carcinoma|hepatocellular carcinoma
688329|NCT00923897|Hepatic Metastasis|hepatic metastasis
688330|NCT00923897|Palliative Radiation Therapy|palliative radiation therapy
688331|NCT00923897|Locally advanced HCC and Hepatic Metastasis|locally advanced hcc and hepatic metastasis
688332|NCT00923910|WT1 Peptide Dendritic Cell Vaccine|wt1 peptide dendritic cell vaccine
688333|NCT00923910|Hematologic Malignancies|hematologic malignancies
688334|NCT00923910|Relapse After Allogeneic Stem Cell Transplantation|relapse after allogeneic stem cell transplantation
688335|NCT00923910|Donor Lymphocyte Infusions|donor lymphocyte infusions
688336|NCT00923910|WT1-Positive|wt1-positive
688337|NCT00923910|Dendritic Cell Vaccine|dendritic cell vaccine
688338|NCT00923910|Tumor Immunotherapy|tumor immunotherapy
688339|NCT00923910|Allogeneic Adoptive Immunotherapy|allogeneic adoptive immunotherapy
688340|NCT00923910|Hodgkins Lymphoma|hodgkins lymphoma
688341|NCT00923910|Leukemia|leukemia
688342|NCT00923910|Acute Myelogenous Leukemia|acute myelogenous leukemia
688344|NCT00923910|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
688345|NCT00923910|ALL|all
688346|NCT00923910|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
688347|NCT00923910|CML|cml
688348|NCT00923910|Myelodysplasia Syndrome|myelodysplasia syndrome
688349|NCT00923910|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
688350|NCT00923923|stress reactivity|stress reactivity
688351|NCT00923923|PTSD|ptsd
688352|NCT00923923|alcohol dependence|alcohol dependence
688353|NCT00923923|drinking|drinking
688354|NCT00923923|craving|craving
688355|NCT00923936|Kaposi's Sarcoma|kaposi's sarcoma
688356|NCT00923936|HIV|hiv
688357|NCT00923936|Doxil|doxil
688358|NCT00923936|VEGF|vegf
688359|NCT00923936|Bevacizumab|bevacizumab
688360|NCT00923949|NSCLC Stage Ia-IIb|nsclc stage ia-iib
688361|NCT00923949|Resectable NSCLC|resectable nsclc
688362|NCT00923949|Non-Small Cell Lung Cancer|non-small cell lung cancer
688363|NCT00923949|NSCLC|nsclc
688364|NCT00923962|Basic science|basic science
688365|NCT00923962|Type 2 Diabetes mellitus|type 2 diabetes mellitus
688366|NCT00923962|Glucagon like peptid-1|glucagon like peptid-1
688367|NCT00923962|Coronary Bloodflow|coronary bloodflow
688368|NCT00923962|Metabolite uptake|metabolite uptake
688369|NCT00923988|Secondhand smoke|secondhand smoke
688370|NCT00923988|passive smoking|passive smoking
688371|NCT00923988|platelet function|platelet function
688372|NCT00923988|endothelial function|endothelial function
688373|NCT00924001|Clinical Response|clinical response
688374|NCT00924001|Immunotherapy|immunotherapy
688375|NCT00924001|Cancer|cancer
688376|NCT00924001|Cytokines|cytokines
688377|NCT00924001|Adoptive Cell Therapy|adoptive cell therapy
688378|NCT00924001|Melanoma|melanoma
688379|NCT00924001|Metastatic Melanoma|metastatic melanoma
688380|NCT00924014|heart failure|heart failure
688381|NCT00924027|Radiation|radiation
688382|NCT00924027|Cancer|cancer
688383|NCT00924027|HDR|hdr
688384|NCT00924027|Brachytherapy|brachytherapy
688385|NCT00924027|Training|training
688386|NCT00924040|BL22 in HCL after Immunotoxin|bl22 in hcl after immunotoxin
688387|NCT00924040|Hairy Cell Leukemia|hairy cell leukemia
688388|NCT00924040|Leukemia|leukemia
688389|NCT00924053|Diabetes Mellitus Type 2|diabetes mellitus type 2
688390|NCT00924066|Ixabepilone|ixabepilone
688391|NCT00924066|BMS-247550|bms-247550
688392|NCT00924066|Ixempra|ixempra
688393|NCT00924066|Cervical Cancer|cervical cancer
688394|NCT00924066|Epothilone|epothilone
688395|NCT00924079|Analysis of plasma concentration of nalbuphine|analysis of plasma concentration of nalbuphine
688396|NCT00924092|Immunotherapy|immunotherapy
688397|NCT00924092|Lung Cancer|lung cancer
688398|NCT00924092|Colorectal Cancer|colorectal cancer
688399|NCT00924092|Head and Neck Cancer|head and neck cancer
688400|NCT00924092|Prostate|prostate
688401|NCT00924092|Breast Cancer|breast cancer
688402|NCT00924118|Acute myocardial infarction|acute myocardial infarction
688403|NCT00924118|Reperfusion injury|reperfusion injury
688404|NCT00924118|Nitric oxide|nitric oxide
688405|NCT00924131|Late Effects|late effects
688406|NCT00924131|Radiation|radiation
688407|NCT00924131|Chemotherapy|chemotherapy
688408|NCT00924131|Hodgkin's Disease|hodgkin's disease
688409|NCT00924131|Lymphoma|lymphoma
688410|NCT00924131|Hodgkin Disease|hodgkin disease
688411|NCT00924170|Immunotoxin|immunotoxin
688412|NCT00924170|CD25|cd25
688413|NCT00924170|Immunogenicity|immunogenicity
688414|NCT00924170|Neutralization|neutralization
688415|NCT00924170|Neutralizing Antibodies|neutralizing antibodies
688416|NCT00924170|Adult T-Cell Leukemia|adult t-cell leukemia
688417|NCT00924170|Leukemia|leukemia
688418|NCT00924170|ATL|atl
688419|NCT00924183|Depression|depression
688420|NCT00924183|Symptom scales|symptom scales
688421|NCT00924183|Symptom measures|symptom measures
688422|NCT00924183|Vancouver Semi-Structured Interview for Depression|vancouver semi-structured interview for depression
688423|NCT00924183|V-SID|v-sid
688424|NCT00924183|VSID|vsid
688425|NCT00924183|treatment-as-usual|treatment-as-usual
688426|NCT00924183|treatment as usual|treatment as usual
688427|NCT00924183|open-label|open-label
688428|NCT00924183|open label|open label
688429|NCT00924183|Major Depressive Episode|major depressive episode
688431|NCT00924196|Plexiform Neurofibroma|plexiform neurofibroma
688432|NCT00924196|Optic Pathway Tumor|optic pathway tumor
688433|NCT00924196|Neurofibroma|neurofibroma
688434|NCT00924196|Malignant Peripheral Nerve Sheath Tumor|malignant peripheral nerve sheath tumor
688435|NCT00924196|Volumetric MRI|volumetric mri
688436|NCT00924196|Neurofibromatosis Type 1|neurofibromatosis type 1
688437|NCT00924196|NF1|nf1
688438|NCT00924196|Optic Glioma|optic glioma
688439|NCT00924209|Neoadjuvant|neoadjuvant
688440|NCT00924209|Stage IIIA (N2)|stage iiia (n2)
688441|NCT00924209|Cisplatin|cisplatin
688442|NCT00924209|Gemcitabine|gemcitabine
688443|NCT00924209|Bevacizumab|bevacizumab
688444|NCT00924209|Non-Small Cell Lung Cancer|non-small cell lung cancer
688445|NCT00924209|NSCLC|nsclc
688446|NCT00924248|Liver MRI|liver mri
688447|NCT00924261|hip|hip
688448|NCT00924261|gait|gait
688449|NCT00924261|walking|walking
688450|NCT00924261|falls|falls
688451|NCT00924261|stretching|stretching
688452|NCT00924261|Flexibility|flexibility
688453|NCT00924261|Aged|aged
688454|NCT00924287|Metastatic Cancer|metastatic cancer
688455|NCT00924287|Tumor Regression|tumor regression
688456|NCT00924287|Immunotherapy|immunotherapy
688457|NCT00924287|Safety|safety
688458|NCT00924287|Cancer|cancer
688459|NCT00924300|feasibility of MEG in pediatric populations|feasibility of meg in pediatric populations
688460|NCT00924313|Prostate Cancer|prostate cancer
688461|NCT00924313|MRI|mri
688462|NCT00924313|C-11 Acetate|c-11 acetate
688463|NCT00924313|PET|pet
688464|NCT00924326|B Cell Malignancies|b cell malignancies
688465|NCT00924326|T Cell Persistence|t cell persistence
688466|NCT00924326|Immunotherapy|immunotherapy
688467|NCT00924326|Cell Transfer|cell transfer
688468|NCT00924326|Leukemia|leukemia
688469|NCT00924326|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
688470|NCT00924326|CLL|cll
688473|NCT00924339|familial hypercholesterolaemia|familial hypercholesterolaemia
688474|NCT00924339|children and adolescents|children and adolescents
688475|NCT00924339|isoflavones|isoflavones
688477|NCT00924352|Metastatic Breast Cancer|metastatic breast cancer
688478|NCT00924365|Children|children
688479|NCT00924365|AIDS|aids
688480|NCT00924365|Toxicity|toxicity
688481|NCT00924365|Development|development
688482|NCT00924365|Puberty|puberty
688483|NCT00924365|HIV|hiv
688484|NCT00924365|Pediatrics|pediatrics
688485|NCT00924365|HIV Infections|hiv infections
688486|NCT00924391|cholesterol|cholesterol
688487|NCT00924391|plant sterols|plant sterols
688488|NCT00924391|cholesterol absorption|cholesterol absorption
688489|NCT00924404|Xylitol|xylitol
688490|NCT00924404|sinusitis|sinusitis
688491|NCT00924404|Comparing efficacy of twice daily xylitol nasal rinse with saline rinse presently current standard, comparing outcomes like quality of life and exacerbations|comparing efficacy of twice daily xylitol nasal rinse with saline rinse presently current standard, comparing outcomes like quality of life and exacerbations
688492|NCT00924417|Pain associated with peripheral intravenous line placement|pain associated with peripheral intravenous line placement
688493|NCT00924430|Interaction SLV337 and simvastatin|interaction slv337 and simvastatin
688494|NCT00924430|Type 2 diabetes mellitus|type 2 diabetes mellitus
688495|NCT00924443|acute myelogenous leukemia|acute myelogenous leukemia
688496|NCT00924443|acute myeloid leukemia|acute myeloid leukemia
688497|NCT00924443|clolar|clolar
688498|NCT00924443|evoltra|evoltra
688499|NCT00924443|clofarabine|clofarabine
688500|NCT00924443|untreated acute leukemia|untreated acute leukemia
688501|NCT00924443|adult acute leukemia|adult acute leukemia
688502|NCT00924456|Transcendental Meditation|transcendental meditation
688503|NCT00924456|blood pressure|blood pressure
688504|NCT00924456|psychological distress|psychological distress
688505|NCT00924456|high psychological distress|high psychological distress
688506|NCT00924469|Prostate cancer|prostate cancer
688507|NCT00924469|Abiraterone acetate|abiraterone acetate
688508|NCT00924469|Leuprolide acetate|leuprolide acetate
688509|NCT00924469|Prednisone|prednisone
688510|NCT00924469|CB7630|cb7630
688511|NCT00924469|Testosterone|testosterone
688512|NCT00924482|cardiac output|cardiac output
688513|NCT00924482|ECOM|ecom
688514|NCT00924482|Endotracheal Cardiac Output Monitor|endotracheal cardiac output monitor
688515|NCT00924482|Perioperative medical care|perioperative medical care
688516|NCT00924495|low back pain|low back pain
688517|NCT00924495|motor control|motor control
688518|NCT00924495|cortical regulation|cortical regulation
688519|NCT00924495|transcranial magnetic stimulation|transcranial magnetic stimulation
688520|NCT00924508|eczema|eczema
688718|NCT00925275|Radiation|radiation
688521|NCT00924508|at least 3 patches of eczema|at least 3 patches of eczema
688522|NCT00924521|grains|grains
688523|NCT00924521|fiber|fiber
688524|NCT00924521|metabolic syndrome|metabolic syndrome
688525|NCT00924521|insulin|insulin
688526|NCT00924534|type 2 diabetes|type 2 diabetes
688527|NCT00924534|interventional|interventional
688528|NCT00924534|placebo|placebo
688533|NCT00924547|Cystic Fibrosis|cystic fibrosis
688534|NCT00924547|Docosahexanoic Acid|docosahexanoic acid
688535|NCT00924547|DHA|dha
688536|NCT00924547|isoprostanes|isoprostanes
688537|NCT00924547|fatty acid|fatty acid
688538|NCT00924560|Adolescents|adolescents
688539|NCT00924560|Bone Mineral Density|bone mineral density
688540|NCT00924560|Oral Contraceptive|oral contraceptive
688541|NCT00924573|Glimepiride|glimepiride
688542|NCT00924573|Metformin|metformin
688543|NCT00924573|Combination Drug Therapy|combination drug therapy
688544|NCT00924599|Recurring Gestational Diabetes|recurring gestational diabetes
688545|NCT00924599|Prevention|prevention
688546|NCT00924612|Primary hypogonadism|primary hypogonadism
688547|NCT00924612|Secondary hypogonadism|secondary hypogonadism
688548|NCT00924638|atrial fibrillation|atrial fibrillation
688549|NCT00924638|cryptogenic stroke|cryptogenic stroke
688550|NCT00924638|continuous monitoring|continuous monitoring
688551|NCT00924638|implantable loop recorder|implantable loop recorder
688552|NCT00924638|insertable cardiac monitor|insertable cardiac monitor
688553|NCT00924651|fatigue|fatigue
688554|NCT00924651|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
688555|NCT00924664|low back pain monoclonal antibody nerve growth factor|low back pain monoclonal antibody nerve growth factor
688556|NCT00924677|genicular nerve|genicular nerve
688557|NCT00924677|osteoarthritis|osteoarthritis
688558|NCT00924677|knee|knee
688559|NCT00924677|neurotomy|neurotomy
688560|NCT00924690|Colon|colon
688561|NCT00924690|Cancer|cancer
688562|NCT00924690|Screening|screening
688563|NCT00924690|Prevention|prevention
688564|NCT00924690|Information|information
688565|NCT00924742|The PK of Tapimycin|the pk of tapimycin
688566|NCT00924742|volunteer|volunteer
688567|NCT00924755|Surgical mesh|surgical mesh
688568|NCT00924768|Otherwise healthy current cigarette smokers|otherwise healthy current cigarette smokers
688569|NCT00924768|current cigarette smokers|current cigarette smokers
688570|NCT00924781|Anemia associated with chronic kidney disease (CKD)|anemia associated with chronic kidney disease (ckd)
688571|NCT00924781|Hemodialysis|hemodialysis
688572|NCT00924807|Prostate Cancer|prostate cancer
688573|NCT00924807|Combined Androgen Blockade|combined androgen blockade
688574|NCT00924807|Radiotherapy|radiotherapy
688575|NCT00924807|Sorafenib|sorafenib
688576|NCT00924820|Neoplastic Meningitis|neoplastic meningitis
688577|NCT00924820|NM|nm
688578|NCT00924820|Advanced Cancers|advanced cancers
688579|NCT00924820|Brain Cancer|brain cancer
688580|NCT00924820|Advanced Cancer|advanced cancer
688581|NCT00924820|Brain Diseases|brain diseases
688582|NCT00924820|Central Nervous System Disorders|central nervous system disorders
688583|NCT00924820|CNS|cns
688584|NCT00924820|Bevacizumab|bevacizumab
688585|NCT00924820|Avastin|avastin
688586|NCT00924820|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
688587|NCT00924820|rhuMAb-VEGF|rhumab-vegf
688588|NCT00924820|Spinal Cord|spinal cord
688589|NCT00924820|meninges|meninges
688590|NCT00924820|cerebrospinal fluid|cerebrospinal fluid
688591|NCT00924820|CSF|csf
688592|NCT00924833|hypoxia|hypoxia
688593|NCT00924833|autonomic nervous system|autonomic nervous system
688594|NCT00924833|blood pressure|blood pressure
688595|NCT00924833|heart rate|heart rate
688596|NCT00924833|exercise|exercise
688597|NCT00924833|heart failure|heart failure
688598|NCT00924833|receptors, adrenergic, beta.|receptors, adrenergic, beta.
688599|NCT00924846|high frequency oscillatory ventilation|high frequency oscillatory ventilation
688600|NCT00924846|respiratory failure|respiratory failure
688601|NCT00924846|children|children
688602|NCT00924846|inhaled nitric oxide|inhaled nitric oxide
688603|NCT00924859|cerebral venous thrombosis|cerebral venous thrombosis
688604|NCT00924859|stroke|stroke
688605|NCT00924859|coagulation|coagulation
688606|NCT00924872|stroke|stroke
688607|NCT00924872|power wheelchair skills|power wheelchair skills
688608|NCT00924872|training|training
688609|NCT00924872|safety|safety
688610|NCT00924885|Reproductive Medicine|reproductive medicine
688611|NCT00924885|Fertilization in Vitro|fertilization in vitro
688612|NCT00924885|Oocyte retrieval|oocyte retrieval
688613|NCT00924885|Local anaesthesia|local anaesthesia
688614|NCT00924885|Aspiration needle|aspiration needle
688615|NCT00924898|Acute HIV|acute hiv
688616|NCT00924898|HIV|hiv
688617|NCT00924898|Acute Infections|acute infections
688618|NCT00924898|Acute Infection|acute infection
688619|NCT00924911|GSK1322322, relative bioavailability, single dose, food effect, H2 blocker, healthy subjects, open label, PIB, tablet|gsk1322322, relative bioavailability, single dose, food effect, h2 blocker, healthy subjects, open label, pib, tablet
688620|NCT00924924|health promotion|health promotion
688621|NCT00924924|prevention|prevention
688622|NCT00924924|worksite wellness|worksite wellness
688623|NCT00924924|behavior change|behavior change
688624|NCT00924924|healthy volunteers|healthy volunteers
688625|NCT00924937|Cardiovascular events|cardiovascular events
688626|NCT00924937|Blood pressure|blood pressure
688627|NCT00924937|Incidence of Cancer|incidence of cancer
688628|NCT00924937|Cognitive decline|cognitive decline
688629|NCT00924937|Mediterranean Diet|mediterranean diet
688630|NCT00924937|Secondary Prevention|secondary prevention
688631|NCT00924937|Low fat diet|low fat diet
688632|NCT00924950|Psoriasis|psoriasis
688633|NCT00924950|Plaque psoriasis, with bilateral symmetrical lesions.|plaque psoriasis, with bilateral symmetrical lesions.
688634|NCT00924950|A diagnosis of stable plaque-type psoriasis vulgaris|a diagnosis of stable plaque-type psoriasis vulgaris
688635|NCT00924950|with at least one pair of symmetric lesions on either|with at least one pair of symmetric lesions on either
688636|NCT00924950|the trunk, arms, or legs that would serve as target lesions.|the trunk, arms, or legs that would serve as target lesions.
690216|NCT00921505|Humans|humans
688637|NCT00924963|Pain of venipuncture or IV insertion|pain of venipuncture or iv insertion
688638|NCT00924989|ACC|acc
688639|NCT00924989|Adrenocortical carcinoma|adrenocortical carcinoma
688640|NCT00924989|OSI-906|osi-906
689005|NCT00916526|Chronic cough|chronic cough
688641|NCT00924989|Insulin-like growth factor-1 receptor (IGF-1R)|insulin-like growth factor-1 receptor (igf-1r)
688642|NCT00924989|GALACCTIC|galacctic
688643|NCT00925054|PKU|pku
688644|NCT00925054|PEG PAL|peg pal
688645|NCT00925054|BioMarin|biomarin
688646|NCT00925067|Inguinal hernia|inguinal hernia
688647|NCT00925067|Laparoscopic repair|laparoscopic repair
688648|NCT00925067|Prostheses|prostheses
688649|NCT00925067|Male fertility|male fertility
688650|NCT00925093|vancomycin|vancomycin
688651|NCT00925093|teicoplanin|teicoplanin
688652|NCT00925093|linezolid|linezolid
688653|NCT00925093|intravenous|intravenous
688654|NCT00925093|cerebrospinal fluid|cerebrospinal fluid
688655|NCT00925093|CSF|csf
688656|NCT00925093|pharmacokinetics|pharmacokinetics
688657|NCT00925093|penetration|penetration
688658|NCT00925093|blood-brain barrier|blood-brain barrier
688659|NCT00925093|Pharmacokinetics of three antibiotics in relation to cerebrospinal fluid|pharmacokinetics of three antibiotics in relation to cerebrospinal fluid
688660|NCT00925106|Bioavailability, pharmacokinetics, celecoxib|bioavailability, pharmacokinetics, celecoxib
688661|NCT00925119|Diabetes|diabetes
688662|NCT00925119|Atenolol|atenolol
688663|NCT00925119|Genetic|genetic
688664|NCT00925132|Metastatic|metastatic
688665|NCT00925132|Melanoma|melanoma
688666|NCT00925132|Epigenetic|epigenetic
688667|NCT00925132|Temozolomide|temozolomide
688668|NCT00925132|Decitabine|decitabine
688669|NCT00925132|Panobinostat|panobinostat
688670|NCT00925132|LBH589|lbh589
688671|NCT00925158|Rhytidoplasty|rhytidoplasty
688672|NCT00925158|Video-Assisted Surgery|video-assisted surgery
688673|NCT00925158|Surgical instruments|surgical instruments
688674|NCT00925158|Dissection|dissection
688675|NCT00925158|Innovative therapies|innovative therapies
688676|NCT00925158|Face|face
688677|NCT00925158|Aging|aging
688678|NCT00925158|Premature aging|premature aging
688679|NCT00925158|Rejuvenation|rejuvenation
688680|NCT00925171|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
688681|NCT00925171|Pulmonary rehabilitation|pulmonary rehabilitation
688682|NCT00925171|Chronic Respiratory Questionnaire|chronic respiratory questionnaire
688683|NCT00925184|questionnaire, medical education, medical students.|questionnaire, medical education, medical students.
688684|NCT00925197|anticoagulation|anticoagulation
688685|NCT00925197|fluindione|fluindione
688686|NCT00925197|patient self-testing|patient self-testing
688687|NCT00925197|coaguchek|coaguchek
688688|NCT00925197|inratio|inratio
688689|NCT00925197|Post operative antivitamin K therapy|post operative antivitamin k therapy
688690|NCT00925210|Endobronchial ultrasound|endobronchial ultrasound
688691|NCT00925210|Electromagnetic Navigation Bronchoscopy|electromagnetic navigation bronchoscopy
688692|NCT00925210|Bronchoscopy|bronchoscopy
688693|NCT00925210|Ultrasonography|ultrasonography
688694|NCT00925223|IBS|ibs
688695|NCT00925223|BDNf|bdnf
688696|NCT00925223|visceral hypersensitivity|visceral hypersensitivity
688697|NCT00925236|MYH9 gene|myh9 gene
688698|NCT00925236|macrothrombocytopenia|macrothrombocytopenia
688699|NCT00925236|leukocyte inclusions|leukocyte inclusions
688700|NCT00925236|cataracts deafness|cataracts deafness
688701|NCT00925236|nephritis|nephritis
688702|NCT00925236|MYH9 Related Disorders|myh9 related disorders
688703|NCT00925249|rheumatoid arthritis|rheumatoid arthritis
688704|NCT00925249|RA|ra
688705|NCT00925249|TB|tb
688706|NCT00925249|tuberculosis|tuberculosis
688707|NCT00925249|anti-TNF therapy|anti-tnf therapy
688708|NCT00925249|biologic therapy|biologic therapy
688709|NCT00925249|quantiferon|quantiferon
688710|NCT00925249|IGRA|igra
688711|NCT00925249|Newly diagnosed rheumatoid arthritis (RA) in the Tricare system|newly diagnosed rheumatoid arthritis (ra) in the tricare system
688712|NCT00925262|mental health|mental health
688713|NCT00925262|randomized controlled trial|randomized controlled trial
688714|NCT00925262|torture|torture
688715|NCT00925275|Solid tumors|solid tumors
688716|NCT00925275|Refractory|refractory
688717|NCT00925275|Relapsed|relapsed
688719|NCT00925275|Dosimetry|dosimetry
688720|NCT00925275|Radiopharmaceutical|radiopharmaceutical
688721|NCT00925275|Biodistribution|biodistribution
688722|NCT00925275|Pharmacokinetics|pharmacokinetics
688723|NCT00925275|Cancer|cancer
688724|NCT00925275|Phase I|phase i
688725|NCT00925288|Female sex worker|female sex worker
688726|NCT00925288|Peru|peru
688727|NCT00925288|Cervical infection|cervical infection
688728|NCT00925288|Cervical abnormality|cervical abnormality
688729|NCT00925288|Serum antibody|serum antibody
688730|NCT00925288|Vaccine acceptance|vaccine acceptance
688731|NCT00925288|Alternative schedule|alternative schedule
688732|NCT00925288|Viral infections|viral infections
688733|NCT00925288|Human papillomavirus vaccine|human papillomavirus vaccine
688734|NCT00925288|Human papillomavirus (HPV)|human papillomavirus (hpv)
688735|NCT00925288|non inferiority|non inferiority
688736|NCT00925301|AmicusTherapeutics|amicustherapeutics
688738|NCT00925301|Migalastat|migalastat
688739|NCT00925301|Pharmacokinetics|pharmacokinetics
688740|NCT00925301|Substrate|substrate
688741|NCT00925314|Stage III Melanoma|stage iii melanoma
688742|NCT00925314|Melanoma|melanoma
688743|NCT00925314|TLI|tli
688744|NCT00925314|Transgenic Lymphocyte Immunization|transgenic lymphocyte immunization
688745|NCT00925314|CB-10-01-02|cb-10-01-02
688746|NCT00925340|Alcohol|alcohol
688747|NCT00925340|Substance Abuse|substance abuse
688748|NCT00925340|Adolescent|adolescent
688749|NCT00925340|Family functioning|family functioning
688750|NCT00925353|lidocaine|lidocaine
688751|NCT00925353|pre-medication|pre-medication
688752|NCT00925353|mammography|mammography
688753|NCT00925353|pain|pain
688754|NCT00925353|safety|safety
688755|NCT00925366|Shoulder|shoulder
688756|NCT00925366|MRI|mri
688757|NCT00925366|MR arthrography|mr arthrography
688758|NCT00925366|CT arthrography|ct arthrography
688759|NCT00925366|Rotator cuff tear|rotator cuff tear
688760|NCT00925366|Arthroscopy|arthroscopy
688761|NCT00925392|doripenem|doripenem
688762|NCT00925392|epithelial lining fluid|epithelial lining fluid
688763|NCT00925392|alveolar macrophages|alveolar macrophages
688764|NCT00925392|pharmacokinetics|pharmacokinetics
688765|NCT00925392|Healthy adult subjects|healthy adult subjects
688766|NCT00925405|Breast Cancer|breast cancer
688767|NCT00925405|Hodgkin's lymphoma|hodgkin's lymphoma
688768|NCT00925405|Mantle-field Irradiation|mantle-field irradiation
688769|NCT00925405|Mammogram|mammogram
688770|NCT00925405|Magnetic resonance imaging|magnetic resonance imaging
688771|NCT00925405|MRI Breast Cancer Screening|mri breast cancer screening
688772|NCT00925418|Neoplasm|neoplasm
688773|NCT00925418|breast Neoplasm|breast neoplasm
688774|NCT00925418|docetaxel|docetaxel
688775|NCT00925418|Glove|glove
688776|NCT00925444|Absorbable implants|absorbable implants
688777|NCT00925444|Humans|humans
688778|NCT00925444|Alginates|alginates
688779|NCT00925444|Pneumonectomy/methods|pneumonectomy/methods
688780|NCT00925444|Pneumonectomy/instrumentation|pneumonectomy/instrumentation
688781|NCT00925444|Surgical Stapling|surgical stapling
688782|NCT00925444|Thoracic surgery|thoracic surgery
688783|NCT00925444|Tissue Adhesives|tissue adhesives
688784|NCT00925444|Prospective studies|prospective studies
688785|NCT00925457|Serious ventricular arrhythmia|serious ventricular arrhythmia
688786|NCT00925457|Sudden cardiac death|sudden cardiac death
688787|NCT00925457|Domperidone|domperidone
688788|NCT00925457|Case-control study|case-control study
688789|NCT00925457|Saskatchewan residents|saskatchewan residents
688790|NCT00925457|Observational Study|observational study
688791|NCT00925470|Target organs impairment|target organs impairment
688792|NCT00925470|High blood pressure|high blood pressure
688793|NCT00925470|Evaluation of target organs impairment on patients suffering from high blood pressure without known cardiovascular or renal disease|evaluation of target organs impairment on patients suffering from high blood pressure without known cardiovascular or renal disease
688794|NCT00925483|left ventricular mass|left ventricular mass
688795|NCT00925483|cardiac MRI|cardiac mri
688796|NCT00925483|long dialysis|long dialysis
688797|NCT00925483|daily dialysis|daily dialysis
688798|NCT00925496|Omarthrosis shoulder joint|omarthrosis shoulder joint
688799|NCT00925509|upper digestive tract cancer|upper digestive tract cancer
688800|NCT00925509|implants|implants
688801|NCT00925509|implants insertion|implants insertion
688802|NCT00925509|radio-surgical guidance|radio-surgical guidance
688803|NCT00925509|accuracy of implants insertion|accuracy of implants insertion
688804|NCT00925509|cranial/facial radiotherapy or brachytherapy and/or microvascular fibula transfer.|cranial/facial radiotherapy or brachytherapy and/or microvascular fibula transfer.
688805|NCT00925509|Bone volume sufficient to support an implant|bone volume sufficient to support an implant
688806|NCT00925535|Pharmacokinetics HIV Tuberculosis Lersivirine UK-453|pharmacokinetics hiv tuberculosis lersivirine uk-453
688807|NCT00925535|061 Rifabutin|061 rifabutin
688808|NCT00925535|HIV Infections|hiv infections
688809|NCT00925548|Phase III trial|phase iii trial
688810|NCT00925548|randomized|randomized
688811|NCT00925548|cancer vaccine|cancer vaccine
688812|NCT00925548|MUC1|muc1
688813|NCT00925548|BLP25|blp25
688814|NCT00925548|advanced breast cancer|advanced breast cancer
689305|NCT00917709|IBVM|ibvm
688815|NCT00925548|postmenopausal breast cancer|postmenopausal breast cancer
688816|NCT00925548|immunotherapy of breast cancer|immunotherapy of breast cancer
688817|NCT00925548|Inoperable locally advanced, recurrent, or metastatic endocrine-sensitive Breast Cancer|inoperable locally advanced, recurrent, or metastatic endocrine-sensitive breast cancer
688818|NCT00925561|Coronary Artery Calcification|coronary artery calcification
688820|NCT00925574|Healthy Volunteers|healthy volunteers
688821|NCT00925574|Psoriasis|psoriasis
688823|NCT00925587|Anemia|anemia
688824|NCT00925587|correction|correction
688825|NCT00925587|darbepoetin alfa|darbepoetin alfa
688826|NCT00925600|Lens Opacification|lens opacification
688827|NCT00925600|Bone Loss|bone loss
688828|NCT00925600|Androgen Deprivation Therapy|androgen deprivation therapy
688829|NCT00925600|Non-metastatic prostate cancer|non-metastatic prostate cancer
752576|NCT01167751|Bone marrow stem cells|bone marrow stem cells
688830|NCT00925613|Exchanging double lumen tube with laryngeal mask Proseal|exchanging double lumen tube with laryngeal mask proseal
688831|NCT00925613|Exchange double lumen tube with tracheal tube|exchange double lumen tube with tracheal tube
688832|NCT00925613|Exchange double lumen tube before emergence decrease cough|exchange double lumen tube before emergence decrease cough
688833|NCT00925613|thoracoscopy and postoperative respiratory complications|thoracoscopy and postoperative respiratory complications
688834|NCT00925613|thoracostomy and postoperative respiratory complications|thoracostomy and postoperative respiratory complications
688835|NCT00925613|postoperative cough|postoperative cough
688836|NCT00925613|postoperative respiratory complications|postoperative respiratory complications
688837|NCT00925613|laryngeal mask and postoperative respiratory complications|laryngeal mask and postoperative respiratory complications
688838|NCT00915811|Myelodysplastic Syndromes|myelodysplastic syndromes
688839|NCT00915811|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
688840|NCT00915811|Haematopoietic stem cell transplantation|haematopoietic stem cell transplantation
688841|NCT00915811|Fludarabine|fludarabine
688842|NCT00915811|Busulphan|busulphan
688843|NCT00915811|Thymoglobuline|thymoglobuline
688844|NCT00915824|Drug therapy|drug therapy
688845|NCT00915824|Prescribing|prescribing
688846|NCT00915824|Appropriateness|appropriateness
688847|NCT00915824|Randomized controlled trial|randomized controlled trial
688848|NCT00915824|STOPP/START criteria|stopp/start criteria
688849|NCT00915824|Appropriateness of prescribing in older patients|appropriateness of prescribing in older patients
688850|NCT00915824|Prescription Drugs|prescription drugs
688851|NCT00915837|DME|dme
688852|NCT00915863|pancreaticoduodenectomy|pancreaticoduodenectomy
688853|NCT00915863|pancreatic fistula|pancreatic fistula
688854|NCT00915863|reconstruction|reconstruction
688855|NCT00915863|isolated Roux-en-Y|isolated roux-en-y
688856|NCT00915876|chronic kidney disease|chronic kidney disease
688857|NCT00915876|Vitamin D|vitamin d
688858|NCT00915889|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
688859|NCT00915889|stage IA cervical cancer|stage ia cervical cancer
688860|NCT00915889|stage IB cervical cancer|stage ib cervical cancer
688861|NCT00915889|stage IIA cervical cancer|stage iia cervical cancer
688862|NCT00915889|stage IIB cervical cancer|stage iib cervical cancer
688863|NCT00915889|stage III cervical cancer|stage iii cervical cancer
688864|NCT00915889|cancer survivor|cancer survivor
688865|NCT00915915|Female contraception|female contraception
688866|NCT00915915|Ovulation inhibition|ovulation inhibition
688867|NCT00915954|Acromegaly|acromegaly
688868|NCT00915954|Type 2 diabetes mellitus|type 2 diabetes mellitus
688869|NCT00915954|recombinant human IGF1|recombinant human igf1
688870|NCT00915954|oral glucose tolerance test|oral glucose tolerance test
688871|NCT00915967|Infection|infection
688872|NCT00915967|Vancomycin|vancomycin
688873|NCT00915967|Neurosurgery|neurosurgery
688874|NCT00915967|Stimulator|stimulator
688875|NCT00915967|Pump|pump
688876|NCT00915967|Deep Brain Stimulation|deep brain stimulation
688877|NCT00915967|Intrathecal Pump|intrathecal pump
688878|NCT00915980|Meal-test|meal-test
688879|NCT00915980|reduced OGTT|reduced ogtt
688880|NCT00915980|gastric bypass surgery and glucose metabolism|gastric bypass surgery and glucose metabolism
688881|NCT00915980|Glucose metabolism before and after gastric bypass|glucose metabolism before and after gastric bypass
688882|NCT00915980|Different OGTT|different ogtt
688883|NCT00915980|New meal- test|new meal- test
688884|NCT00915993|stage IV renal cell cancer|stage iv renal cell cancer
688885|NCT00915993|recurrent renal cell cancer|recurrent renal cell cancer
688886|NCT00916006|Peplin|peplin
688887|NCT00916006|Actinic keratosis|actinic keratosis
688888|NCT00916006|PEP005|pep005
688889|NCT00916019|gene expression|gene expression
688890|NCT00916019|skeletal muscle|skeletal muscle
688891|NCT00916019|Healthy men|healthy men
688892|NCT00916058|Multiple Myeloma|multiple myeloma
688893|NCT00916058|Autologous Stem Cell Transplant|autologous stem cell transplant
688894|NCT00916058|ASCT|asct
688896|NCT00916071|Bulimia Nervosa|bulimia nervosa
688897|NCT00916071|Eating Disorder NOS|eating disorder nos
688898|NCT00916071|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
688899|NCT00916071|ADHD|adhd
688900|NCT00916110|healthy subjects|healthy subjects
688901|NCT00916123|castrate-resistant prostate cancer|castrate-resistant prostate cancer
688902|NCT00916123|CRPC|crpc
688903|NCT00916136|Pre-operative Traction|pre-operative traction
688904|NCT00916136|Traction|traction
688905|NCT00916136|Proximal Femur Fracture|proximal femur fracture
688906|NCT00916136|Femoral Fractures|femoral fractures
688907|NCT00916136|Femoral Fracture|femoral fracture
688908|NCT00916136|Skeletal Traction|skeletal traction
688909|NCT00916136|Cutaneous Traction|cutaneous traction
688915|NCT00916149|Levetiracetam|levetiracetam
688916|NCT00916162|aromatase inhibitor|aromatase inhibitor
688917|NCT00916175|hyperglycemia|hyperglycemia
688918|NCT00916175|overweight|overweight
688919|NCT00916175|functional food|functional food
688920|NCT00916175|aloe vera|aloe vera
688921|NCT00916175|cnidoscolus chayamansa|cnidoscolus chayamansa
688922|NCT00916188|Black Tea|black tea
688923|NCT00916188|Oxidative Stress|oxidative stress
688924|NCT00916188|Blood Lipids|blood lipids
688925|NCT00916188|Insulin Sensitivity|insulin sensitivity
688926|NCT00916201|schizophrenia|schizophrenia
688927|NCT00916227|Low or Intermediate-1 Risk Myelodysplastic Syndrome|low or intermediate-1 risk myelodysplastic syndrome
688928|NCT00916240|Adolescents|adolescents
688929|NCT00916240|African American|african american
688930|NCT00916253|Sleep|sleep
688931|NCT00916253|real driving|real driving
688932|NCT00916253|simulated driving|simulated driving
688933|NCT00916253|MWT|mwt
688934|NCT00916266|Seizure frequency|seizure frequency
688935|NCT00916266|Hippocampal volume|hippocampal volume
688936|NCT00916266|Adverse effects|adverse effects
688937|NCT00916279|Bare Metal In-Stent Restenosis|bare metal in-stent restenosis
688938|NCT00916279|Paclitaxel Coated Balloon Catheter|paclitaxel coated balloon catheter
688939|NCT00916279|Drug Coated Balloon|drug coated balloon
688940|NCT00916279|Coronary Artery Disease|coronary artery disease
688941|NCT00916292|Diabetes|diabetes
688942|NCT00916292|dermal ulcers|dermal ulcers
688943|NCT00916305|deafness noise tinnitus hearingloss|deafness noise tinnitus hearingloss
688944|NCT00916331|total knee replacement arthroplasty|total knee replacement arthroplasty
688945|NCT00916331|subcutaneous indwelling|subcutaneous indwelling
688946|NCT00916331|blood loss|blood loss
688947|NCT00916331|complications|complications
688948|NCT00916331|functional status|functional status
688949|NCT00916357|recombinant human hyaluronidase PH20 (rHuPH20)|recombinant human hyaluronidase ph20 (rhuph20)
688950|NCT00916357|Insulin lispro|insulin lispro
688951|NCT00916357|Regular human insulin|regular human insulin
688952|NCT00916370|drug eluting stents|drug eluting stents
688954|NCT00916370|Angioplasty|angioplasty
688955|NCT00916370|myocardial ischemia|myocardial ischemia
688956|NCT00916370|coronary artery stenosis|coronary artery stenosis
688957|NCT00916370|Coronary Disease|coronary disease
688958|NCT00916370|Coronary Artery Disease|coronary artery disease
688959|NCT00916370|Coronary Restenosis|coronary restenosis
688960|NCT00916370|Long lesion|long lesion
688961|NCT00916383|Skin Irritation|skin irritation
688962|NCT00916383|Donepezil Transdermal Patch System|donepezil transdermal patch system
688963|NCT00916383|Elderly|elderly
688964|NCT00916383|Alzheimer's subjects|alzheimer's subjects
688965|NCT00916383|Skin Irritation in elderly Alzheimer's subjects|skin irritation in elderly alzheimer's subjects
688966|NCT00916409|Glioblastoma Multiforme|glioblastoma multiforme
688967|NCT00916409|Glioblastoma|glioblastoma
688968|NCT00916409|GBM|gbm
688969|NCT00916409|Brain tumor|brain tumor
688970|NCT00916409|Treatment|treatment
688971|NCT00916409|Minimal toxicity|minimal toxicity
688972|NCT00916409|Newly Diagnosed|newly diagnosed
688973|NCT00916409|TTFields|ttfields
688974|NCT00916409|Tumor Treating Fields|tumor treating fields
688975|NCT00916409|NovoCure|novocure
688976|NCT00916422|Immunotherapy|immunotherapy
688977|NCT00916422|Allergoid|allergoid
688978|NCT00916422|Depigmented|depigmented
688979|NCT00916422|Polymerized|polymerized
688980|NCT00916422|Allergen-extract|allergen-extract
688981|NCT00916422|Rhinoconjunctivitis|rhinoconjunctivitis
688982|NCT00916435|Arrhythmia|arrhythmia
688983|NCT00916435|Cardiac Arrest|cardiac arrest
688984|NCT00916435|Cardiomyopathy|cardiomyopathy
688985|NCT00916435|Heart Failure|heart failure
688986|NCT00916448|Endotoxin|endotoxin
688987|NCT00916448|Bilirubin|bilirubin
688988|NCT00916448|Inflammation|inflammation
688989|NCT00916448|Sepsis|sepsis
688990|NCT00916448|Multi organ dysfunction syndrome|multi organ dysfunction syndrome
688991|NCT00916448|Oxidative Stress|oxidative stress
688992|NCT00916448|Heme oxygenase|heme oxygenase
688993|NCT00916461|First episode psychosis|first episode psychosis
688994|NCT00916461|Schizophrenia|schizophrenia
688995|NCT00916461|Minocycline|minocycline
688996|NCT00916461|neuroprotection|neuroprotection
688997|NCT00916461|First episode non affective psychosis|first episode non affective psychosis
688998|NCT00916461|With in first five years of illness|with in first five years of illness
688999|NCT00916500|CERVICAL CANCER, CONCURRENT CHEMORADIATION, CISPLATIN|cervical cancer, concurrent chemoradiation, cisplatin
689000|NCT00916513|Diabetes|diabetes
689001|NCT00916513|Treatment Satisfaction|treatment satisfaction
689002|NCT00916513|Quality of Life|quality of life
689003|NCT00916513|HbA1c levels and goals|hba1c levels and goals
689004|NCT00916513|Healthcare resources consumption|healthcare resources consumption
689306|NCT00917709|DATSCAN|datscan
689006|NCT00916526|Inhaled corticosteroid treatment|inhaled corticosteroid treatment
689007|NCT00916526|Bronchial provocation test with mannitol|bronchial provocation test with mannitol
689008|NCT00916526|Methacholine|methacholine
689009|NCT00916552|Erythropoietin|erythropoietin
689010|NCT00916552|Epo|epo
689011|NCT00916552|depression|depression
689012|NCT00916552|bipolar disorder|bipolar disorder
689013|NCT00916552|cognition|cognition
689014|NCT00916552|cognitive function|cognitive function
689015|NCT00916552|antidepressant|antidepressant
689016|NCT00916565|optimize nutritional content of infant formula|optimize nutritional content of infant formula
689017|NCT00916565|Infant|infant
689018|NCT00916578|Advanced Inflammatory Breast Cancer|advanced inflammatory breast cancer
689019|NCT00916578|Non-Inflammatory Breast Cancer|non-inflammatory breast cancer
689020|NCT00916578|Capecitabine|capecitabine
689021|NCT00916578|Xeloda|xeloda
689022|NCT00916578|Concomitant Radiation|concomitant radiation
689023|NCT00916578|Radiation Therapy|radiation therapy
689024|NCT00916578|Radiotherapy|radiotherapy
689025|NCT00916578|Women|women
689026|NCT00916591|gastroesophageal reflux|gastroesophageal reflux
689027|NCT00916591|respiratory aspiration|respiratory aspiration
689028|NCT00916604|AZD1656|azd1656
689029|NCT00916604|Safety|safety
689030|NCT00916604|Pharmacokinetics|pharmacokinetics
689031|NCT00916604|Pharmacodynamic|pharmacodynamic
689032|NCT00916604|Multiple ascending doses|multiple ascending doses
689033|NCT00916604|Japanese|japanese
689034|NCT00916604|T2DM|t2dm
689035|NCT00916617|open-label|open-label
689036|NCT00916617|safety|safety
689037|NCT00916617|antibody|antibody
689038|NCT00916630|recurrent|recurrent
689039|NCT00916630|alimta|alimta
689040|NCT00916630|pemetrexed|pemetrexed
689041|NCT00916630|CNS lymphoma|cns lymphoma
689042|NCT00916630|Primary CNS lymphoma|primary cns lymphoma
689043|NCT00916630|Metastatic lymphoma to brain|metastatic lymphoma to brain
689044|NCT00916643|Hypercholesterolemia|hypercholesterolemia
689045|NCT00916643|FH|fh
689046|NCT00916643|LDL-C|ldl-c
689047|NCT00916643|CHD|chd
689048|NCT00916656|Congenital fibrinogen deficiency|congenital fibrinogen deficiency
689049|NCT00916669|SCLC|sclc
689050|NCT00916669|enoxaparin sodium|enoxaparin sodium
689051|NCT00916669|cisplatin|cisplatin
689052|NCT00916669|etoposide|etoposide
689053|NCT00916695|Stents|stents
689054|NCT00916695|Angioplasty|angioplasty
689055|NCT00916695|Coronary Artery Disease|coronary artery disease
689056|NCT00916695|Bifurcation Coronary Lesions|bifurcation coronary lesions
689057|NCT00916708|endometrial cancer|endometrial cancer
689058|NCT00916708|follow up|follow up
689059|NCT00916708|relapse|relapse
689060|NCT00916721|Smoking cessation|smoking cessation
689061|NCT00916721|propranolol|propranolol
689062|NCT00916721|memory reconsolidation blockade|memory reconsolidation blockade
689063|NCT00916721|craving|craving
689064|NCT00916734|McKenzie|mckenzie
689065|NCT00916734|thrust manipulation|thrust manipulation
689066|NCT00916734|clinical prediction rule|clinical prediction rule
689067|NCT00916747|Progeria|progeria
689068|NCT00916760|allergic, rhinoconjunctivitis, Immunotherapy|allergic, rhinoconjunctivitis, immunotherapy
689069|NCT00916773|Obstructive sleep apnea|obstructive sleep apnea
689070|NCT00916773|Airway inflammation|airway inflammation
689071|NCT00916773|Exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
689072|NCT00916773|Continuous positive airway pressure|continuous positive airway pressure
689073|NCT00916786|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
689074|NCT00916786|pharmacogenetics|pharmacogenetics
689075|NCT00916786|molecular genetics|molecular genetics
689076|NCT00916786|medication response|medication response
689077|NCT00916799|telehealth|telehealth
689078|NCT00916799|oximetry|oximetry
689079|NCT00916799|copd|copd
689080|NCT00916812|Difficult intubation|difficult intubation
689081|NCT00916812|Hyomental distance|hyomental distance
689082|NCT00916812|Obstetric|obstetric
689083|NCT00916812|Mallampati classification|mallampati classification
689084|NCT00916812|Thyromental distance|thyromental distance
689085|NCT00916812|Sternomental distance|sternomental distance
689086|NCT00916825|breast cancer|breast cancer
689087|NCT00916825|quality of life|quality of life
689088|NCT00916825|children of somatically ill parents|children of somatically ill parents
689089|NCT00916825|psychological adaptation|psychological adaptation
689090|NCT00916838|Type 1 Diabetes Mellitis|type 1 diabetes mellitis
689091|NCT00916838|MRI|mri
689092|NCT00916851|attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
689093|NCT00916851|autism spectrum disorders|autism spectrum disorders
689094|NCT00916851|normally developing children and adolescents|normally developing children and adolescents
689095|NCT00916851|cognitive functions|cognitive functions
689096|NCT00916851|emotion/behaviors|emotion/behaviors
689097|NCT00916851|brain imaging|brain imaging
689098|NCT00916851|genotypes|genotypes
689099|NCT00916877|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
689100|NCT00916877|Her-2-positive met breast cancer|her-2-positive met breast cancer
689101|NCT00916890|Opioid pharmacogenetics|opioid pharmacogenetics
689607|NCT00926588|Telecare|telecare
689102|NCT00916890|Opioid pharmacokinetic|opioid pharmacokinetic
689103|NCT00916890|Long-term opioid treatment|long-term opioid treatment
689104|NCT00916890|Cancer pain|cancer pain
689105|NCT00916903|Talus|talus
689106|NCT00916903|Neuroserpin|neuroserpin
689107|NCT00916903|mental retardation|mental retardation
689108|NCT00916903|epilepsy|epilepsy
689109|NCT00916903|FENIB|fenib
689110|NCT00916903|XLMR|xlmr
689111|NCT00916916|Acromegaly|acromegaly
689113|NCT00916942|Tolerability study|tolerability study
689114|NCT00916955|22q11.2 deletion syndrome|22q11.2 deletion syndrome
689115|NCT00916955|velo-cardio-facial syndrome|velo-cardio-facial syndrome
689116|NCT00916955|congenital anomalies|congenital anomalies
689117|NCT00916955|mental illness|mental illness
689118|NCT00916955|congenital heart disease|congenital heart disease
689119|NCT00916968|Gender specific|gender specific
689120|NCT00916968|cruciate retaining|cruciate retaining
689121|NCT00916968|total knee arthroplasty|total knee arthroplasty
689122|NCT00916968|Bilateral Osteoarthritis of the knee joint|bilateral osteoarthritis of the knee joint
689123|NCT00916981|pseudarthrosis|pseudarthrosis
689124|NCT00916981|Treatment|treatment
689125|NCT00916981|osteoblast grafting|osteoblast grafting
689126|NCT00916981|cell therapy|cell therapy
689127|NCT00916981|nonunion|nonunion
689128|NCT00916994|Rotator Cuff Tear|rotator cuff tear
689129|NCT00917007|ABO incompatibility|abo incompatibility
689130|NCT00917007|hemolysis|hemolysis
689131|NCT00917007|jaundice|jaundice
689132|NCT00917007|hyperbilirubinemia|hyperbilirubinemia
689133|NCT00917007|newborn|newborn
689134|NCT00917020|Randomized|randomized
689135|NCT00917020|Double-Blind|double-blind
689136|NCT00917020|Multi-Center|multi-center
689137|NCT00917020|Phase II|phase ii
689138|NCT00917020|Nasal Carbon Dioxide|nasal carbon dioxide
689139|NCT00917020|Carbon Dioxide|carbon dioxide
689140|NCT00917020|Efficacy|efficacy
689141|NCT00917020|Safety|safety
689142|NCT00917020|Total Nasal Symptom Score|total nasal symptom score
689143|NCT00917046|All-cause heart failure patients|all-cause heart failure patients
689144|NCT00917046|coronary artery disease etiology|coronary artery disease etiology
689145|NCT00917046|dilated cardiomyopathy etiology|dilated cardiomyopathy etiology
689146|NCT00917059|Major Depressive Disorder|major depressive disorder
689147|NCT00917059|SSRI|ssri
689148|NCT00917059|EEG|eeg
689149|NCT00917072|Clinical Handoff|clinical handoff
689150|NCT00917072|Medical Education|medical education
689151|NCT00917072|Simulation|simulation
689152|NCT00917072|Residency and Internship|residency and internship
689153|NCT00917085|Preterm infant|preterm infant
689154|NCT00917085|Skin-to-skin contact|skin-to-skin contact
689155|NCT00917085|kangaroo care|kangaroo care
689156|NCT00917085|temperature|temperature
689157|NCT00917085|behavioral state|behavioral state
689158|NCT00917098|Behavior Therapy|behavior therapy
689159|NCT00917098|Supportive Counseling|supportive counseling
689160|NCT00917098|Child|child
689161|NCT00917098|Adolescent|adolescent
689162|NCT00917098|Hair Pulling|hair pulling
689163|NCT00917098|CBT|cbt
689164|NCT00917111|Randomized|randomized
689165|NCT00917111|Double-Blind|double-blind
689166|NCT00917111|Multi-Center|multi-center
689167|NCT00917111|Placebo-Controlled|placebo-controlled
689168|NCT00917111|Phase II|phase ii
689169|NCT00917111|Nasal Carbon Dioxide|nasal carbon dioxide
689170|NCT00917111|Carbon Dioxide|carbon dioxide
689171|NCT00917111|Efficacy|efficacy
689172|NCT00917111|Safety|safety
689173|NCT00917111|Total Nasal Symptom Score|total nasal symptom score
689174|NCT00917124|cerebral oximetry|cerebral oximetry
689175|NCT00917124|NIRS|nirs
689176|NCT00917124|INVOS|invos
689177|NCT00917137|Lung cancer|lung cancer
689178|NCT00917137|Lung nodule|lung nodule
689179|NCT00917137|Transbronchial needle aspiration|transbronchial needle aspiration
689180|NCT00917137|Transbronchial lung biopsy|transbronchial lung biopsy
689181|NCT00917137|Bronchoscopy|bronchoscopy
689182|NCT00917150|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
689183|NCT00917150|COPD|copd
689184|NCT00917150|emphysema|emphysema
689185|NCT00917163|coronary artery disease|coronary artery disease
689186|NCT00917163|restenosis|restenosis
689187|NCT00917163|stent thrombosis|stent thrombosis
689188|NCT00917163|coronary stents|coronary stents
689189|NCT00917163|angioplasty|angioplasty
689190|NCT00917163|drug eluting stents|drug eluting stents
689191|NCT00917189|VCFS|vcfs
689192|NCT00917189|Chromosome 22q Deletion Syndrome|chromosome 22q deletion syndrome
689193|NCT00917189|Learning Disorders|learning disorders
689194|NCT00917215|Asthma|asthma
689195|NCT00917215|Acupuncture|acupuncture
689196|NCT00917215|Pulmonary function|pulmonary function
689197|NCT00917215|Quality of life|quality of life
689198|NCT00917241|Graves' disease|graves' disease
689199|NCT00917241|dexamethasone|dexamethasone
689200|NCT00917241|relapse|relapse
689201|NCT00917241|methimazole|methimazole
689202|NCT00917254|YM150|ym150
689203|NCT00917254|Thrombosis|thrombosis
689204|NCT00917254|VTE|vte
689205|NCT00917254|Knee Replacement|knee replacement
689901|NCT00927862|genotyping|genotyping
689206|NCT00917254|Anticoagulant|anticoagulant
689207|NCT00917254|FXa inhibitor|fxa inhibitor
689208|NCT00917267|diabetes|diabetes
689209|NCT00917267|exenatide|exenatide
689210|NCT00917267|once weekly|once weekly
689211|NCT00917267|Byetta|byetta
689212|NCT00917267|Amylin|amylin
689213|NCT00917267|Lilly|lilly
689214|NCT00917280|Parkinson's Disease|parkinson's disease
689215|NCT00917293|Tardive Dyskinesia|tardive dyskinesia
689216|NCT00917293|Schizophrenia|schizophrenia
689217|NCT00917293|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
689218|NCT00917306|Peplin|peplin
689219|NCT00917306|Actinic keratosis|actinic keratosis
689220|NCT00917306|PEP005|pep005
689221|NCT00917332|pain|pain
689222|NCT00917332|childbirth|childbirth
689223|NCT00917332|relaxation|relaxation
689224|NCT00917332|guided imagery|guided imagery
689226|NCT00917332|epidural|epidural
689227|NCT00917345|ARC|arc
689228|NCT00917345|PRA|pra
689229|NCT00917345|primary aldosteronism|primary aldosteronism
689230|NCT00917345|captopril test|captopril test
689231|NCT00917345|aldosterone-renin ratio|aldosterone-renin ratio
689232|NCT00917345|Primary aldosteronism (PA) than PRA and establish thresholds for the diagnosis using ARC.|primary aldosteronism (pa) than pra and establish thresholds for the diagnosis using arc.
689233|NCT00917358|Hepatitis C|hepatitis c
689234|NCT00917358|Dialysis|dialysis
689235|NCT00917358|Interferon|interferon
689236|NCT00917371|adults with attention-deficit hyperactivity disorder|adults with attention-deficit hyperactivity disorder
689237|NCT00917371|atomoxetine|atomoxetine
689238|NCT00917371|neuropsychological functioning|neuropsychological functioning
689239|NCT00917371|brain imaging studies|brain imaging studies
689240|NCT00917384|IMC-1121B|imc-1121b
689241|NCT00917384|Monoclonal antibody (MAb)|monoclonal antibody (mab)
689242|NCT00917384|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
689243|NCT00917384|Human vascular endothelial growth factor receptor-2 (VEGFR-2)|human vascular endothelial growth factor receptor-2 (vegfr-2)
689244|NCT00917384|Platinum resistant|platinum resistant
689245|NCT00917384|platinum refractory|platinum refractory
689246|NCT00917384|Gastric|gastric
689247|NCT00917384|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
689248|NCT00917384|metastatic|metastatic
689249|NCT00917384|Angiogenesis|angiogenesis
689250|NCT00917397|Traumatized refugee|traumatized refugee
689251|NCT00917397|treatment|treatment
689252|NCT00917397|antidepressants|antidepressants
689253|NCT00917397|psychotherapy|psychotherapy
689254|NCT00917397|PTSD in traumatized refugees|ptsd in traumatized refugees
689255|NCT00917423|Anorexia Nervosa|anorexia nervosa
689256|NCT00917423|Exercise|exercise
689257|NCT00917423|Physical Activity|physical activity
689258|NCT00917449|Metabolic Syndrome|metabolic syndrome
689259|NCT00917449|Impaired glucose tolerance|impaired glucose tolerance
689260|NCT00917449|Type 2 diabetes mellitus|type 2 diabetes mellitus
689261|NCT00917449|Endothelial dysfunction|endothelial dysfunction
689262|NCT00917449|L-arginine|l-arginine
689263|NCT00917449|Insulin resistance|insulin resistance
689264|NCT00917462|ESOPHAGUS|esophagus
752867|NCT01174537|Cancer|cancer
689265|NCT00917462|BAY 43-9006 (SORAFENIB)|bay 43-9006 (sorafenib)
689266|NCT00917462|09-016|09-016
689267|NCT00917462|Nexavar®.|nexavar®.
689268|NCT00917475|preterm infants|preterm infants
689269|NCT00917488|Allergen extract Standardization|allergen extract standardization
689270|NCT00917501|Mania|mania
689271|NCT00917501|Adolescents at risk for Mania|adolescents at risk for mania
689272|NCT00917514|Dosing Tool|dosing tool
689273|NCT00917514|Compliance|compliance
689274|NCT00917514|User Friendly|user friendly
689275|NCT00917514|Crohn's Disease|crohn's disease
689276|NCT00917514|Ulcerative Colitis|ulcerative colitis
689277|NCT00917527|Subjects with family history of coronary heart disease|subjects with family history of coronary heart disease
689278|NCT00917553|diabetic retinopathy|diabetic retinopathy
689279|NCT00917553|diabetes|diabetes
689280|NCT00917553|diabetic eye studies|diabetic eye studies
689281|NCT00917566|Airtraq|airtraq
689282|NCT00917566|Pediatric|pediatric
689283|NCT00917579|Bioequivalence, pharmacokinetics, atorvastatin|bioequivalence, pharmacokinetics, atorvastatin
689284|NCT00917592|Diverticulitis|diverticulitis
689285|NCT00917618|osteoarthritis|osteoarthritis
689286|NCT00917618|knee|knee
689287|NCT00917618|exercise|exercise
689288|NCT00917618|cycling|cycling
689289|NCT00917631|Co-bedding|co-bedding
689290|NCT00917631|Procedural pain|procedural pain
689291|NCT00917631|Twin|twin
689292|NCT00917631|Comfort|comfort
689293|NCT00917631|RCT|rct
689294|NCT00917644|Bioqeuivalence, Pharmacokinetics, Atorvastatin|bioqeuivalence, pharmacokinetics, atorvastatin
689295|NCT00917657|photorefractive keratectomy|photorefractive keratectomy
689296|NCT00917657|hyperopia|hyperopia
689297|NCT00917657|radial keratotomy|radial keratotomy
689298|NCT00917657|refractive surgery|refractive surgery
689299|NCT00917670|trabecular meshwork|trabecular meshwork
689300|NCT00917670|electron microscopy|electron microscopy
689301|NCT00917709|dementia with Lewy bodies|dementia with lewy bodies
689302|NCT00917709|imaging|imaging
689303|NCT00917709|acetylcholine|acetylcholine
689304|NCT00917709|dopamine|dopamine
689307|NCT00917722|Parkinson's Disease|parkinson's disease
689308|NCT00917722|STN DBS|stn dbs
689309|NCT00917722|Deep Brain Stimulation|deep brain stimulation
689310|NCT00917735|Green tea|green tea
689311|NCT00917735|Breast cancer|breast cancer
689312|NCT00917735|Prevention|prevention
689313|NCT00917735|COMT genotype|comt genotype
689314|NCT00917735|EGCG (Epigallocatechin gallate)|egcg (epigallocatechin gallate)
689315|NCT00917735|Mammographic density|mammographic density
689316|NCT00917735|Reproductive hormones|reproductive hormones
689317|NCT00917735|IGF axis proteins|igf axis proteins
689318|NCT00917735|Oxidative stress|oxidative stress
689319|NCT00917761|Hepatitis B, chronic|hepatitis b, chronic
689320|NCT00917761|Peginterferon alfa-2a|peginterferon alfa-2a
689321|NCT00917761|Entecavir|entecavir
689322|NCT00917774|gender specific knee|gender specific knee
689323|NCT00917774|osteoarthritis|osteoarthritis
689324|NCT00917774|total knee arthroplasty|total knee arthroplasty
689325|NCT00917787|Asthma|asthma
689326|NCT00917800|angiography|angiography
689327|NCT00917800|exercise testing|exercise testing
689328|NCT00917800|high frequency ECG|high frequency ecg
689329|NCT00917800|coronary artery disease|coronary artery disease
689330|NCT00917813|HIV|hiv
689331|NCT00917813|monoclonal antibody|monoclonal antibody
689332|NCT00917813|KD-247|kd-247
689333|NCT00917813|treatment naive|treatment naive
689334|NCT00917839|neuroprotection|neuroprotection
689335|NCT00917839|multiple sclerosis|multiple sclerosis
689336|NCT00917839|brain atrophy|brain atrophy
689337|NCT00917839|mr-spectroscopy|mr-spectroscopy
689338|NCT00917852|aorta|aorta
689339|NCT00917852|trauma|trauma
689340|NCT00917852|transection|transection
689341|NCT00917878|Milk|milk
689342|NCT00917878|Postprandial hyperlipidemia|postprandial hyperlipidemia
689343|NCT00917878|Postprandial inflammation|postprandial inflammation
689344|NCT00917878|Overweight|overweight
689345|NCT00917891|HIV Infections|hiv infections
689346|NCT00917891|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
689347|NCT00917891|Healthy|healthy
689348|NCT00917891|HIV seronegativity|hiv seronegativity
689349|NCT00917904|HIV Infections|hiv infections
689350|NCT00917904|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
689351|NCT00917904|Healthy|healthy
689352|NCT00917904|HIV seronegativity|hiv seronegativity
689353|NCT00917917|Metabolic syndrome|metabolic syndrome
689354|NCT00917917|exercise training|exercise training
689355|NCT00917917|abdominal fat mass|abdominal fat mass
689356|NCT00917917|endothelial function|endothelial function
689357|NCT00917917|diastolic function|diastolic function
689358|NCT00917930|exercise training|exercise training
689359|NCT00917930|functional recovery|functional recovery
689360|NCT00917930|heart diseases|heart diseases
689361|NCT00917930|altered glucose metabolism early after an acute cardiac event|altered glucose metabolism early after an acute cardiac event
689362|NCT00917930|non diabetes CAD patients|non diabetes cad patients
689363|NCT00917930|glycometabolic state|glycometabolic state
689364|NCT00917943|smoking|smoking
689365|NCT00917943|pregnancy|pregnancy
689366|NCT00917943|counseling|counseling
689367|NCT00917943|prevention|prevention
689368|NCT00917943|tailored intervention|tailored intervention
689369|NCT00917943|postpartum|postpartum
689370|NCT00917943|women|women
689371|NCT00917943|cessation|cessation
689372|NCT00917956|Lithium|lithium
689373|NCT00917956|IBM|ibm
689374|NCT00917956|InclusionIBM|inclusionibm
689375|NCT00917956|Myositis|myositis
689376|NCT00917995|parastomal hernia|parastomal hernia
689377|NCT00917995|prophylactic mesh|prophylactic mesh
689378|NCT00917995|colostomy|colostomy
689379|NCT00917995|hernia|hernia
689380|NCT00918008|URINARY BLADDER|urinary bladder
689381|NCT00918008|Bladder|bladder
689382|NCT00918008|Blood sample|blood sample
689383|NCT00918008|Lymph Nodes|lymph nodes
689384|NCT00918034|BPH|bph
689385|NCT00918034|LUTS|luts
689386|NCT00918034|talaporfin sodium|talaporfin sodium
689387|NCT00918073|HIV infected smokers|hiv infected smokers
689388|NCT00918073|HIV|hiv
689389|NCT00918086|Vitamin D|vitamin d
689390|NCT00918086|Tuberculosis|tuberculosis
689391|NCT00918099|Mesh|mesh
689392|NCT00918099|vaginal prolapse|vaginal prolapse
689393|NCT00918099|Recurrence rate|recurrence rate
689394|NCT00918112|Parkinson's Disease|parkinson's disease
689395|NCT00918190|Postoperative nausea and vomiting|postoperative nausea and vomiting
689396|NCT00918190|Pediatric|pediatric
689397|NCT00918190|Strabismus|strabismus
689398|NCT00918190|Late onset postoperative nausea and vomiting|late onset postoperative nausea and vomiting
689399|NCT00918203|Lung neoplasms|lung neoplasms
689400|NCT00918203|IMC-3G3|imc-3g3
689401|NCT00918203|carboplatin|carboplatin
689402|NCT00918203|paclitaxel|paclitaxel
689403|NCT00918203|PDGFr|pdgfr
689404|NCT00918216|breast cancer|breast cancer
689405|NCT00918229|Prostate|prostate
689406|NCT00918229|cancer|cancer
689407|NCT00918229|radiation|radiation
689408|NCT00918229|biodegradable implantable balloon|biodegradable implantable balloon
689409|NCT00918229|intrarectal balloon|intrarectal balloon
689410|NCT00918242|Coronary Heart Disease|coronary heart disease
689411|NCT00918242|computed tomography|computed tomography
689412|NCT00918242|prevalence of coronary artery disease|prevalence of coronary artery disease
689413|NCT00918255|Hidradenitis Suppurativa|hidradenitis suppurativa
689414|NCT00918255|Adalimumab|adalimumab
689415|NCT00918255|Nodule|nodule
689416|NCT00918255|Abscess|abscess
689417|NCT00918255|Fistula|fistula
689517|NCT00926237|Tinnitus|tinnitus
689418|NCT00918255|Physicians Global Assessment|physicians global assessment
689419|NCT00918255|Hurley Stage|hurley stage
689420|NCT00918255|Sartorius Scale|sartorius scale
689421|NCT00918268|Influenza vaccine|influenza vaccine
689422|NCT00925639|phytoestrogen|phytoestrogen
689423|NCT00925639|coagulation|coagulation
689424|NCT00925639|menopause|menopause
689425|NCT00925639|ddimer|ddimer
689426|NCT00925639|antithrombin|antithrombin
689427|NCT00925639|hypercoagulation|hypercoagulation
689429|NCT00925652|bevacizumab|bevacizumab
689430|NCT00925652|cyclophosphamide|cyclophosphamide
689431|NCT00925652|methotrexate|methotrexate
689432|NCT00925652|exercise intervention|exercise intervention
689433|NCT00925652|diet intervention|diet intervention
689434|NCT00925665|Intubation|intubation
689435|NCT00925665|Glidescope|glidescope
689436|NCT00925665|Macintosh|macintosh
689437|NCT00925665|Abscess|abscess
689438|NCT00925665|Difficult intubations in patients with odontogenic abscesses|difficult intubations in patients with odontogenic abscesses
689439|NCT00925717|ADA recommendation|ada recommendation
689440|NCT00925730|Atopic dermatitis|atopic dermatitis
689441|NCT00925730|AD|ad
689442|NCT00925730|pimecrolimus|pimecrolimus
689443|NCT00925730|blood|blood
689444|NCT00925730|absorption|absorption
689445|NCT00925730|systemic|systemic
689446|NCT00925743|Phase 1|phase 1
689447|NCT00925743|XRP6258|xrp6258
689448|NCT00925743|cisplatin|cisplatin
689449|NCT00925743|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
689450|NCT00925756|HIV|hiv
689451|NCT00925756|low CD4 recovery|low cd4 recovery
689937|NCT00928005|Prediabetes|prediabetes
689452|NCT00925756|Low CD4 recovery despite HIV control|low cd4 recovery despite hiv control
689453|NCT00925756|Treatment experienced|treatment experienced
689454|NCT00925782|autologous stem cell transplantation|autologous stem cell transplantation
689455|NCT00925795|HIV|hiv
689456|NCT00925795|atherosclerosis|atherosclerosis
689457|NCT00925795|extra virgin olive oil|extra virgin olive oil
689458|NCT00925795|Alternative therapies|alternative therapies
689459|NCT00925795|Treatment experienced+|treatment experienced+
689460|NCT00925808|Unsuspected Venous Thromboembolism|unsuspected venous thromboembolism
689461|NCT00925808|VTE|vte
689462|NCT00925808|Routine Computed Tomography|routine computed tomography
689463|NCT00925808|CT Scans|ct scans
689464|NCT00925821|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
689465|NCT00925821|Lenalidomide|lenalidomide
689466|NCT00925821|IMiD|imid
689467|NCT00925834|Coronary angiography|coronary angiography
689468|NCT00925834|Placebo effect|placebo effect
689469|NCT00925834|Suggestion|suggestion
689470|NCT00925847|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
689472|NCT00925847|Survival|survival
689473|NCT00925873|Fludarabine|fludarabine
689474|NCT00925873|AML|aml
689475|NCT00925873|elderly patients|elderly patients
689476|NCT00925886|Astigmatism|astigmatism
689477|NCT00925886|Cataract|cataract
689478|NCT00925899|Melatonin|melatonin
689479|NCT00925899|Palliative care|palliative care
689480|NCT00925899|Advanced cancer|advanced cancer
689481|NCT00925899|Symptoms|symptoms
689482|NCT00925899|Quality of life|quality of life
689483|NCT00925899|Randomized controlled trial|randomized controlled trial
689484|NCT00925912|Hemorrhoidectomy|hemorrhoidectomy
689485|NCT00925912|perianal block|perianal block
689486|NCT00925912|local anesthesia|local anesthesia
689487|NCT00925912|spinal anesthesia|spinal anesthesia
689488|NCT00925925|Low birth weight|low birth weight
689489|NCT00925925|small for gestational age|small for gestational age
689490|NCT00925925|B-cell function|b-cell function
689491|NCT00925925|epigenetics|epigenetics
689492|NCT00925925|B1a|b1a
689493|NCT00925925|B1b|b1b
689494|NCT00925925|CD19|cd19
689495|NCT00925925|CD5|cd5
689496|NCT00925938|Hysteroscopy|hysteroscopy
689497|NCT00925938|Cervical priming|cervical priming
689498|NCT00925938|Cervical dilatation|cervical dilatation
689499|NCT00925938|Misoprostol|misoprostol
689500|NCT00925938|Endoscopy, uterine|endoscopy, uterine
689501|NCT00925951|Persistent Non-specific Low Back Pain|persistent non-specific low back pain
689502|NCT00925951|wet cupping|wet cupping
689503|NCT00925951|cupping|cupping
689504|NCT00925951|Numerical Rating Scale|numerical rating scale
689505|NCT00926172|Magnetic resonance angiography|magnetic resonance angiography
689506|NCT00926172|Intracranial aneurysm|intracranial aneurysm
689507|NCT00926172|cerebral aneurysm|cerebral aneurysm
689508|NCT00926172|unruptured aneurysm|unruptured aneurysm
689509|NCT00926172|Epidemiology|epidemiology
689510|NCT00926172|Magnetic Resonance Imaging|magnetic resonance imaging
689511|NCT00926185|Dry Eye|dry eye
689512|NCT00926185|ophthalmic delivery|ophthalmic delivery
689513|NCT00926198|Upper airway infections|upper airway infections
689514|NCT00926198|pharyngotonsillitis|pharyngotonsillitis
689515|NCT00926198|GABHS|gabhs
689516|NCT00926224|Adult patients with chronic liver disease scheduled for a liver biopsy and a BMI superior or equal to 28 kg/m²|adult patients with chronic liver disease scheduled for a liver biopsy and a bmi superior or equal to 28 kg/m²
689518|NCT00926237|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
689519|NCT00926237|TMS|tms
689520|NCT00926237|rTMS|rtms
689521|NCT00926250|Sarcopenia|sarcopenia
689522|NCT00926263|Pharmacokinetics|pharmacokinetics
689523|NCT00926263|Pharmacodynamics|pharmacodynamics
689524|NCT00926263|QTc interval prolongation|qtc interval prolongation
689525|NCT00926276|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
752577|NCT01167751|AC133|ac133
689526|NCT00926276|Bronchopulmonary Dysplasia (BPD)|bronchopulmonary dysplasia (bpd)
689527|NCT00926276|Fundoplication|fundoplication
689528|NCT00926302|The bioequivalence of Levetiracetam vs. Keppra|the bioequivalence of levetiracetam vs. keppra
689529|NCT00926302|volunteer|volunteer
689530|NCT00926315|Breast Neoplasms|breast neoplasms
689531|NCT00926315|Calcitriol|calcitriol
689532|NCT00926315|Postmenopausal|postmenopausal
689533|NCT00926315|Cell Proliferation|cell proliferation
689534|NCT00926315|Gene Expression Profiling|gene expression profiling
689535|NCT00926328|Gingivitis and Plaque|gingivitis and plaque
689536|NCT00926341|Metabolic syndrome|metabolic syndrome
689537|NCT00926341|inflammatory markers|inflammatory markers
689538|NCT00926341|Thiazolidinediones|thiazolidinediones
689539|NCT00926341|Angiotensin receptor blockers|angiotensin receptor blockers
689540|NCT00926367|Acne|acne
689541|NCT00926380|osteoporosis|osteoporosis
689542|NCT00926380|postmenopausal|postmenopausal
689543|NCT00926380|denosumab|denosumab
689544|NCT00926380|teriparatide|teriparatide
689545|NCT00926380|Forteo®|forteo®
689546|NCT00926380|DXA|dxa
689547|NCT00926380|Bone Mineral Density|bone mineral density
689548|NCT00926380|pQCT|pqct
689549|NCT00926393|inpatient|inpatient
689550|NCT00926393|bipolar depression|bipolar depression
689551|NCT00926393|quetiapine|quetiapine
689552|NCT00926393|Seroquel IR|seroquel ir
689553|NCT00926393|Seroquel XR|seroquel xr
689554|NCT00926393|safety|safety
689555|NCT00926393|tolerability|tolerability
689556|NCT00926406|Environmental lead exposure, maintenance hemodialysis; blood lead levels, EDTA chelating agents, malnutrition, anemia, inflammation, mortality.|environmental lead exposure, maintenance hemodialysis; blood lead levels, edta chelating agents, malnutrition, anemia, inflammation, mortality.
689557|NCT00926406|To determine whether lead chelation therapy improves the anemia, malnutrition, inflammation, morbidity or mortality in hemodialysis patients.|to determine whether lead chelation therapy improves the anemia, malnutrition, inflammation, morbidity or mortality in hemodialysis patients.
689558|NCT00926419|Varicella|varicella
689559|NCT00926419|Hepatitis A|hepatitis a
689560|NCT00926419|Vaccine|vaccine
689561|NCT00926419|Injector|injector
689562|NCT00926419|Fractional dose|fractional dose
689563|NCT00926419|Intradermal|intradermal
689564|NCT00926419|Children|children
689566|NCT00926432|Spine disorders|spine disorders
689567|NCT00926432|equilibrium|equilibrium
689568|NCT00926445|Pain behavior|pain behavior
689569|NCT00926458|stress echocardiography|stress echocardiography
689570|NCT00926458|coronary angiography|coronary angiography
689571|NCT00926458|coronary artery disease|coronary artery disease
689572|NCT00926471|Autism|autism
689573|NCT00926471|Anxiety|anxiety
689574|NCT00926471|Autism Spectrum Disorders with Comorbid Anxiety|autism spectrum disorders with comorbid anxiety
689575|NCT00926484|Dentin hypersensitivity|dentin hypersensitivity
689576|NCT00926484|Tooth Mousse|tooth mousse
689577|NCT00926484|fluoride varnish|fluoride varnish
689578|NCT00926497|antibiotic therapy|antibiotic therapy
689579|NCT00926497|early-onset sepsis|early-onset sepsis
689580|NCT00926497|interventions study|interventions study
689581|NCT00926497|procalcitonin|procalcitonin
689582|NCT00926497|term and near-term neonates|term and near-term neonates
689583|NCT00926523|Pulmonary Hypertension|pulmonary hypertension
689584|NCT00926523|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
689585|NCT00926523|Interstitial Lung Disease|interstitial lung disease
689586|NCT00926523|MIF|mif
689587|NCT00926549|spectral domain-OCT|spectral domain-oct
689588|NCT00926549|macular thickness|macular thickness
689589|NCT00926549|myopia|myopia
689590|NCT00926549|hypermetropia|hypermetropia
689591|NCT00926549|normal|normal
689592|NCT00926562|Contrast Induced Nephropathy|contrast induced nephropathy
689593|NCT00926562|CIN|cin
689594|NCT00926562|Cardiac Catheterization|cardiac catheterization
689595|NCT00926575|BDP|bdp
689596|NCT00926575|orBec|orbec
689597|NCT00926575|GVHD|gvhd
689598|NCT00926575|beclomethasone dipropionate|beclomethasone dipropionate
689599|NCT00926575|bone marrow transplant|bone marrow transplant
689600|NCT00926575|hematopoietic cell transplant|hematopoietic cell transplant
689601|NCT00926575|HCT|hct
689602|NCT00926575|stem cell transplant|stem cell transplant
689603|NCT00926575|marrow transplant|marrow transplant
689604|NCT00926575|SCT|sct
689605|NCT00926575|beclomethasone 17,21-dipropionate|beclomethasone 17,21-dipropionate
689606|NCT00926588|Pain|pain
689608|NCT00926588|Collaborative care|collaborative care
689609|NCT00926614|GT1|gt1
689610|NCT00926614|HCV|hcv
689611|NCT00926614|non responder|non responder
689612|NCT00926614|relapser|relapser
689613|NCT00926627|endothelin receptor antagonist|endothelin receptor antagonist
689615|NCT00926640|Solid Tumors|solid tumors
689616|NCT00926640|Histone deacetylase inhibitors|histone deacetylase inhibitors
689617|NCT00926640|EP &amp; Belinostat|ep &amp; belinostat
689618|NCT00926640|Phase I|phase i
689619|NCT00926640|SCLC|sclc
689620|NCT00926640|Small Cell Lung Cancer|small cell lung cancer
689621|NCT00926653|Geriatric Depression|geriatric depression
689622|NCT00926666|Ageing|ageing
689623|NCT00926666|Pain|pain
689624|NCT00926666|Pharmacology|pharmacology
689625|NCT00926666|Imaging|imaging
689626|NCT00926666|Anaesthesiology|anaesthesiology
689627|NCT00926666|Musculoskeletal disease|musculoskeletal disease
689628|NCT00926692|B-cells|b-cells
689629|NCT00926692|CD5+|cd5+
689630|NCT00926692|B1 Cells|b1 cells
689631|NCT00926692|Healthy Controls|healthy controls
689632|NCT00926705|Dexmedetomidine|dexmedetomidine
689633|NCT00926705|Fentanyl|fentanyl
689634|NCT00926705|Pain|pain
689635|NCT00926705|Pediatrics|pediatrics
689636|NCT00926718|BIS monitor|bis monitor
689637|NCT00926718|rocuronium|rocuronium
689638|NCT00926718|The effect of the neuromuscular blocking drug rocuronium on the response of the Composite Variability Index to laryngoscopy|the effect of the neuromuscular blocking drug rocuronium on the response of the composite variability index to laryngoscopy
689639|NCT00926731|Acute Myeloid Leukaemia (AML)|acute myeloid leukaemia (aml)
689640|NCT00926744|physical activity|physical activity
689641|NCT00926744|nutrition|nutrition
689642|NCT00926744|cardiovascular diseases|cardiovascular diseases
689643|NCT00926744|musculo-skeletal problems|musculo-skeletal problems
689644|NCT00926757|lymphoma|lymphoma
689645|NCT00926757|CD20|cd20
690339|NCT00921986|genetics|genetics
689646|NCT00926757|Hepatitis B virus|hepatitis b virus
689647|NCT00926757|reactivation|reactivation
689648|NCT00926757|Rituximab|rituximab
689649|NCT00926783|paroxysmal|paroxysmal
689650|NCT00926783|persistent|persistent
689651|NCT00926783|targeted|targeted
689652|NCT00926783|generalized|generalized
689653|NCT00926783|CFAE|cfae
689654|NCT00926796|gonorrhea, gonococcal infections, Neisseria gonorrhoeae|gonorrhea, gonococcal infections, neisseria gonorrhoeae
689655|NCT00926809|endoscopic mucosal resection|endoscopic mucosal resection
689656|NCT00926809|iatrogenic|iatrogenic
689657|NCT00926848|coronary heart disease|coronary heart disease
689658|NCT00926848|cardiac rehabilitation|cardiac rehabilitation
689659|NCT00926848|lifestyle change|lifestyle change
689660|NCT00926848|coronary artery bypass graft|coronary artery bypass graft
689661|NCT00926848|social support|social support
689662|NCT00926848|social cognitive learning theory|social cognitive learning theory
689663|NCT00926861|age-related macular degeneration|age-related macular degeneration
689664|NCT00926861|detachment of the posterior hyaloid|detachment of the posterior hyaloid
689666|NCT00926874|ischaemic stroke|ischaemic stroke
689667|NCT00926874|acute coronary syndrome|acute coronary syndrome
689668|NCT00926874|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
689669|NCT00926874|brachial endothelial function|brachial endothelial function
689670|NCT00926874|blood pressure|blood pressure
689671|NCT00926874|aortic stiffness|aortic stiffness
689672|NCT00926900|Alcoholism|alcoholism
689673|NCT00926900|D-cycloserine|d-cycloserine
689674|NCT00926900|extinction|extinction
689675|NCT00926900|cue-exposure|cue-exposure
689676|NCT00926913|Macular Degeneration|macular degeneration
689677|NCT00926926|Healthy volunteer|healthy volunteer
689678|NCT00926939|Cigarette|cigarette
689679|NCT00926939|Nicotine|nicotine
689680|NCT00926939|Smoking|smoking
689681|NCT00926939|Contingency Management|contingency management
689682|NCT00926939|Voucher reinforcement|voucher reinforcement
689683|NCT00926939|Smoking Abstinence|smoking abstinence
689684|NCT00926939|Internet-based treatment|internet-based treatment
689685|NCT00926952|Actinic keratoses|actinic keratoses
689686|NCT00926952|actinic keratosis|actinic keratosis
689687|NCT00926952|methylamonolevulinate|methylamonolevulinate
689688|NCT00926952|photodynamic therapy|photodynamic therapy
689689|NCT00926952|without occlusion|without occlusion
689690|NCT00926952|short incubation|short incubation
689691|NCT00926965|tardive dyskinesia|tardive dyskinesia
689692|NCT00926965|neurocognitive function|neurocognitive function
689693|NCT00926978|Thyroid|thyroid
689694|NCT00926978|I-124|i-124
689695|NCT00927004|mechanical hyperalgesia|mechanical hyperalgesia
689696|NCT00927004|cold hyperalgesia|cold hyperalgesia
689697|NCT00927004|chronic pain|chronic pain
689698|NCT00927017|Healthy volunteers|healthy volunteers
689699|NCT00927030|Autism|autism
689700|NCT00927030|children|children
689701|NCT00927030|sleep|sleep
689702|NCT00927030|insomnia|insomnia
689703|NCT00927069|Adalimumab|adalimumab
689704|NCT00927095|PMDD|pmdd
689705|NCT00927095|Oral contraceptives|oral contraceptives
689706|NCT00927095|steroid hormones|steroid hormones
689707|NCT00927095|neurosteroids|neurosteroids
689708|NCT00927108|Adult Progenitor Stem cells|adult progenitor stem cells
689709|NCT00927108|Alzheimer's disease|alzheimer's disease
689710|NCT00927108|Parkinson's disease|parkinson's disease
689711|NCT00927108|Multiple sclerosis|multiple sclerosis
689808|NCT00927524|diabetes|diabetes
690205|NCT00921492|Cortisol|cortisol
689712|NCT00927134|Chronic Granulomatous Disease in children (=or< 18 years)|chronic granulomatous disease in children (=or< 18 years)
689713|NCT00927147|head and neck cancer|head and neck cancer
689714|NCT00927147|boron neutron capture therapy|boron neutron capture therapy
689715|NCT00927147|cetuximab|cetuximab
689716|NCT00927147|epidermal growth factor receptor|epidermal growth factor receptor
689717|NCT00927147|safety|safety
689718|NCT00927147|efficacy|efficacy
689719|NCT00927147|survival|survival
689720|NCT00927160|Mobile Acute Care of the Elderly Unit|mobile acute care of the elderly unit
689721|NCT00927160|Geriatric Models of Care|geriatric models of care
689722|NCT00927173|TMS|tms
689723|NCT00927173|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
689724|NCT00927173|MDD|mdd
689725|NCT00927173|Major Depressive Disorder|major depressive disorder
689726|NCT00927186|osteoporosis|osteoporosis
689727|NCT00927186|teriparatide|teriparatide
689728|NCT00927186|zoledronic acid|zoledronic acid
689729|NCT00927186|histomorphometry|histomorphometry
689730|NCT00927186|bone biopsy|bone biopsy
689731|NCT00927186|postmenopausal|postmenopausal
689732|NCT00927199|High-Oleic Canola Oil|high-oleic canola oil
689733|NCT00927199|Flaxseed Oil|flaxseed oil
689734|NCT00927199|Monounsaturated Fatty Acids|monounsaturated fatty acids
689735|NCT00927199|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
689736|NCT00927199|Alpha Linolenic Acid|alpha linolenic acid
689737|NCT00927199|Cardiovascular|cardiovascular
689738|NCT00927199|Hypercholesterolemia|hypercholesterolemia
689739|NCT00927199|Lipids|lipids
689740|NCT00927199|Inflammation|inflammation
689741|NCT00927199|Metabolism|metabolism
689742|NCT00927238|Single Level|single level
689743|NCT00927238|Lumbar Disc Disease|lumbar disc disease
689744|NCT00927238|DDD|ddd
689745|NCT00927251|heart failure|heart failure
689746|NCT00927251|cardiac pacing|cardiac pacing
689747|NCT00927251|cardiac resynchronization therapy|cardiac resynchronization therapy
689748|NCT00927251|left ventricular lead|left ventricular lead
689749|NCT00927264|tobacco smoke exposure smoking|tobacco smoke exposure smoking
689750|NCT00927290|hepatitis C; insulin resistance; glitazones; pioglitazone; steatosis; viral kinetics; antiviral response|hepatitis c; insulin resistance; glitazones; pioglitazone; steatosis; viral kinetics; antiviral response
689751|NCT00927303|retinal thickness|retinal thickness
689752|NCT00927303|threshold algorithm|threshold algorithm
689753|NCT00927303|optical coherence tomography|optical coherence tomography
689754|NCT00927316|Report of Urinary Tract Infection episode|report of urinary tract infection episode
689755|NCT00927329|Dermatophagoides|dermatophagoides
689756|NCT00927329|farinae|farinae
689757|NCT00927329|allergen|allergen
689758|NCT00927329|dust|dust
689759|NCT00927329|allergic|allergic
689760|NCT00927329|mite|mite
689761|NCT00927329|allergy|allergy
689762|NCT00927342|Air leak|air leak
689763|NCT00927342|Thoracic Surgery|thoracic surgery
689764|NCT00927342|Sealants|sealants
689765|NCT00927355|pioglitazone|pioglitazone
689766|NCT00927355|human bone marrow stem cells|human bone marrow stem cells
689767|NCT00927355|adipocytes|adipocytes
689768|NCT00927355|osteoblasts|osteoblasts
689769|NCT00927355|bone mineral density|bone mineral density
689770|NCT00927355|adiponectin|adiponectin
689771|NCT00927355|leptin|leptin
689772|NCT00927355|CTX|ctx
689773|NCT00927355|P1NP|p1np
689774|NCT00927355|Osteocalcin|osteocalcin
689775|NCT00927368|TKA|tka
689776|NCT00927368|total knee replacement|total knee replacement
689777|NCT00927394|Hypertension, Type II Diabetes, Aliskiren, Valsartan,|hypertension, type ii diabetes, aliskiren, valsartan,
689778|NCT00927394|Systolic blood pressure, Diastolic blood pressure,|systolic blood pressure, diastolic blood pressure,
689779|NCT00927394|Stage II, Combination|stage ii, combination
689780|NCT00927407|Head Lice|head lice
689781|NCT00927420|Bipolar disorder|bipolar disorder
689782|NCT00927420|adherence|adherence
689783|NCT00927420|treatment|treatment
689784|NCT00927420|real life practice|real life practice
689785|NCT00927433|Fatigue|fatigue
689786|NCT00927433|Cancer|cancer
689787|NCT00927433|Radiation therapy|radiation therapy
689788|NCT00927433|Chemotherapy|chemotherapy
689789|NCT00927433|Hormones|hormones
689790|NCT00927433|Surgery|surgery
689791|NCT00927433|Breast cancer|breast cancer
689792|NCT00927446|esophageal cancer|esophageal cancer
689793|NCT00927446|head and neck cancer|head and neck cancer
689794|NCT00927446|narrow band imaging|narrow band imaging
689795|NCT00927446|endoscopy|endoscopy
689796|NCT00927446|screening|screening
689797|NCT00927459|cholesterol|cholesterol
689798|NCT00927459|coronary artery disease|coronary artery disease
689799|NCT00927472|Head Lice|head lice
689800|NCT00927485|Familial Adenomatous Polyposis (FAP)|familial adenomatous polyposis (fap)
689801|NCT00927485|Curcumin|curcumin
689802|NCT00927485|Colorectal polyps|colorectal polyps
689803|NCT00927485|Duodenal polyps|duodenal polyps
689804|NCT00927498|Acute myeloid Leukemia|acute myeloid leukemia
689805|NCT00927498|patient aged 50 to 70 years|patient aged 50 to 70 years
689806|NCT00927511|metastatic hormone-responsive breast cancer menopausal women|metastatic hormone-responsive breast cancer menopausal women
689807|NCT00927524|Insulin analogs|insulin analogs
689809|NCT00927537|Hypertension|hypertension
689810|NCT00927550|resistant depression|resistant depression
689811|NCT00927550|lithium|lithium
689812|NCT00927550|RCT|rct
689813|NCT00927550|lithium therapy|lithium therapy
689814|NCT00927550|standard therapy|standard therapy
689815|NCT00927563|Gambling|gambling
691436|NCT00935948|RCT|rct
689816|NCT00927563|Addiction|addiction
689817|NCT00927576|cognitive training|cognitive training
689818|NCT00927576|neuroplasticity|neuroplasticity
689819|NCT00927576|cognitive impairment|cognitive impairment
689820|NCT00927576|recovery of function|recovery of function
689821|NCT00927576|memory|memory
689822|NCT00927576|attention|attention
689823|NCT00927589|HER2+ Metastatic Cancer|her2+ metastatic cancer
689824|NCT00927589|HER2+ Locally Advanced Inoperable Cancer|her2+ locally advanced inoperable cancer
689825|NCT00927589|HER2+ Solid Malignancy|her2+ solid malignancy
689826|NCT00927602|renal failure|renal failure
689827|NCT00927602|medical patient|medical patient
689828|NCT00927602|venous thromboembolism|venous thromboembolism
689829|NCT00927602|prophylaxis|prophylaxis
689830|NCT00927602|fondaparinux|fondaparinux
689831|NCT00927615|myocardial infarction|myocardial infarction
689832|NCT00927615|glycoprotein IIb/IIIa|glycoprotein iib/iiia
689833|NCT00927615|percutaneous coronary intervention|percutaneous coronary intervention
689834|NCT00927615|thrombus aspiration|thrombus aspiration
689835|NCT00927615|myocardial perfusion|myocardial perfusion
689836|NCT00927628|vitrectomy|vitrectomy
689837|NCT00927628|macular hole|macular hole
689838|NCT00927628|ILM peeling|ilm peeling
689839|NCT00927641|Ankle Sprain|ankle sprain
689840|NCT00927654|Iloprost|iloprost
689841|NCT00927654|pulmonary hypertension|pulmonary hypertension
689842|NCT00927654|cardio pulmonary morbidity|cardio pulmonary morbidity
689843|NCT00927654|high risk cardiac surgical patients|high risk cardiac surgical patients
689844|NCT00927667|Hemophilia A|hemophilia a
689845|NCT00927667|Joint Status|joint status
689846|NCT00927667|Bleeds|bleeds
689847|NCT00927667|Magnetic Resonce Imaging|magnetic resonce imaging
689848|NCT00927680|Colorectal Cancer|colorectal cancer
689849|NCT00927680|Familial Colorectal Cancer|familial colorectal cancer
689850|NCT00927680|Genetics|genetics
689851|NCT00927680|Hispanics|hispanics
689852|NCT00927693|Atherosclerosis|atherosclerosis
689853|NCT00927693|Coronary Artery Disease|coronary artery disease
689854|NCT00927693|Cardiac Risk Factors|cardiac risk factors
689855|NCT00927693|Coronary Calcium Scan|coronary calcium scan
689856|NCT00927693|Prevention|prevention
689857|NCT00927706|Assistive Technology|assistive technology
689858|NCT00927706|Mobility Limitation|mobility limitation
689859|NCT00927706|Physical Disability|physical disability
689860|NCT00927706|Caregiver|caregiver
689861|NCT00927706|Participation|participation
689862|NCT00927719|Smallpox|smallpox
689863|NCT00927719|Smallpox Vaccine|smallpox vaccine
689864|NCT00927719|Vaccinia virus|vaccinia virus
689865|NCT00927719|Military|military
689866|NCT00927732|Brugada|brugada
689867|NCT00927732|hydroquinidine|hydroquinidine
689868|NCT00927732|ventricular arrhythmia|ventricular arrhythmia
689869|NCT00927732|patients with Brugada syndrome, high cardiac arrhythmic risk and implanted with an implantable cardioverter defibrillator|patients with brugada syndrome, high cardiac arrhythmic risk and implanted with an implantable cardioverter defibrillator
689870|NCT00927745|Respiration Artificial|respiration artificial
689871|NCT00927745|Positive-Pressure Respiration|positive-pressure respiration
689872|NCT00927745|Critical Care|critical care
689873|NCT00927745|Intensive Care Units|intensive care units
689874|NCT00927771|melanosis|melanosis
689875|NCT00927771|melasma|melasma
689876|NCT00927771|azelaic acid|azelaic acid
689877|NCT00927771|hydroquinone|hydroquinone
689878|NCT00927784|Mesenchymal Precursor Cells|mesenchymal precursor cells
689879|NCT00927784|Left Ventricular Assist Device|left ventricular assist device
689880|NCT00927784|LVAD|lvad
689881|NCT00927784|Congestive Heart Failure|congestive heart failure
689882|NCT00927784|Stem Cells|stem cells
689883|NCT00927797|immunochemotherapy|immunochemotherapy
689884|NCT00927797|Pentostatin|pentostatin
689885|NCT00927797|Cyclophosphamide|cyclophosphamide
689886|NCT00927797|Rituximab|rituximab
689887|NCT00927797|Maintenance|maintenance
689888|NCT00927797|indolent B-NHL|indolent b-nhl
689889|NCT00927797|B-CLL|b-cll
689890|NCT00927797|B-NHL|b-nhl
689891|NCT00927810|Gout|gout
689892|NCT00927810|Gouty arthritis|gouty arthritis
689893|NCT00927810|Gout flares|gout flares
689894|NCT00927810|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
689895|NCT00927849|anal hypertonia|anal hypertonia
689896|NCT00927849|sphincterotomy|sphincterotomy
689897|NCT00927849|incontinence|incontinence
689898|NCT00927849|manometry|manometry
689899|NCT00927862|warfarin metabolism|warfarin metabolism
689900|NCT00927862|CYP2C9|cyp2c9
689902|NCT00927862|VKORC1|vkorc1
689903|NCT00927862|anticoagulation|anticoagulation
689904|NCT00927862|atrial fibrillation|atrial fibrillation
689905|NCT00927862|deep vein thrombosis|deep vein thrombosis
689906|NCT00927862|pulmonary embolism|pulmonary embolism
690008|NCT00928265|stent-assisted coiling|stent-assisted coiling
689907|NCT00927862|Patients initiating warfarin for thromboembolic conditions|patients initiating warfarin for thromboembolic conditions
689908|NCT00927901|QAB149|qab149
689909|NCT00927901|asthma|asthma
689910|NCT00927901|indacaterol salts (acetate, maleate, and xinafoate)|indacaterol salts (acetate, maleate, and xinafoate)
752578|NCT01167764|hemoptysis|hemoptysis
689911|NCT00927901|orally inhaled indacaterol salts|orally inhaled indacaterol salts
689912|NCT00927901|persistent asthma|persistent asthma
689913|NCT00927940|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
689914|NCT00927940|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
689915|NCT00927940|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
689916|NCT00927940|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
689917|NCT00927940|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
689918|NCT00927940|STENT THROMBOSIS|stent thrombosis
689919|NCT00927940|RESTENOTIC LESION|restenotic lesion
689920|NCT00927940|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
689921|NCT00927953|West Nile virus|west nile virus
689922|NCT00927953|WNV|wnv
689923|NCT00927953|Encephalitis|encephalitis
689924|NCT00927953|Meningitis|meningitis
689925|NCT00927953|Acute Flaccid Paralysis|acute flaccid paralysis
689926|NCT00927953|Monoclonal Antibody|monoclonal antibody
689927|NCT00927953|WNND|wnnd
689928|NCT00927953|West Nile Fever|west nile fever
689929|NCT00927953|WNF|wnf
689930|NCT00927966|RAD001|rad001
689931|NCT00927966|CP-751,871|cp-751,871
689932|NCT00927966|advanced sarcoma|advanced sarcoma
689933|NCT00927966|advanced malignant solid tumor|advanced malignant solid tumor
689934|NCT00928005|Weight loss diet|weight loss diet
689935|NCT00928005|Exercise training|exercise training
689936|NCT00928005|Type 2 diabetes|type 2 diabetes
689938|NCT00928005|Cardiovascular health|cardiovascular health
689939|NCT00928018|allogeneic stem cell transplant|allogeneic stem cell transplant
689940|NCT00928018|reduced intensity conditioning|reduced intensity conditioning
689941|NCT00928018|graft versus host disease|graft versus host disease
689942|NCT00928018|GVHD|gvhd
689943|NCT00928018|RIC transplantation|ric transplantation
689944|NCT00928057|Pen Needle|pen needle
689945|NCT00928057|Diabetes|diabetes
689946|NCT00928057|Insulin|insulin
689947|NCT00928057|Glycemic|glycemic
689948|NCT00928057|Pain|pain
689949|NCT00928057|Fructosamine|fructosamine
689950|NCT00928057|Leakage|leakage
689951|NCT00928057|Hypoglycemia|hypoglycemia
689952|NCT00928057|Hyperglycemia|hyperglycemia
689953|NCT00928070|Urgency Urinary Incontinence OAB|urgency urinary incontinence oab
689954|NCT00928083|Phase I|phase i
689955|NCT00928083|Safety and tolerability|safety and tolerability
689956|NCT00928083|Pharmacokinetic|pharmacokinetic
689957|NCT00928083|synthetic peroxide|synthetic peroxide
689958|NCT00928083|trioxolane|trioxolane
689959|NCT00928083|treatment of erythrocytic stages of malaria|treatment of erythrocytic stages of malaria
689960|NCT00928096|Lymphoma|lymphoma
689961|NCT00928096|Radiotherapy|radiotherapy
689962|NCT00928096|Positron-Emission Tomography|positron-emission tomography
689963|NCT00928096|CT scan|ct scan
689964|NCT00928109|eating disorders|eating disorders
689965|NCT00928109|couples therapy|couples therapy
689966|NCT00928161|Reflux Disease|reflux disease
689967|NCT00928161|Acid-reflux|acid-reflux
689968|NCT00928161|Head and Neck Cancer|head and neck cancer
689969|NCT00928161|HNC|hnc
689970|NCT00928161|Radiation Therapy|radiation therapy
689971|NCT00928161|Mucositis|mucositis
689972|NCT00928161|Radiation-induced xerostomia|radiation-induced xerostomia
689973|NCT00928161|RIX|rix
689974|NCT00928161|Dry Mouth|dry mouth
689975|NCT00928161|Heartburn|heartburn
689976|NCT00928161|Dexlansoprazole|dexlansoprazole
689977|NCT00928161|Prevacid|prevacid
689978|NCT00928161|Prevacid Solu-Tab|prevacid solu-tab
689979|NCT00928161|GERD|gerd
689980|NCT00928174|Androgen insensitive prostate cancer|androgen insensitive prostate cancer
689981|NCT00928187|HIV|hiv
689982|NCT00928187|Second line treatment|second line treatment
689983|NCT00928187|WHO recommendations|who recommendations
689984|NCT00928187|Africa|africa
689985|NCT00928187|Treatment strategies|treatment strategies
689986|NCT00928187|treatment experienced|treatment experienced
689987|NCT00928200|Relapsed|relapsed
689988|NCT00928200|Allergy|allergy
689989|NCT00928200|Erwinia|erwinia
689990|NCT00928200|Acute|acute
689991|NCT00928200|Lymphoblastic|lymphoblastic
689992|NCT00928200|Leukemia|leukemia
689993|NCT00928213|Preeclampsia|preeclampsia
689994|NCT00928213|IUGR|iugr
689995|NCT00928213|GH|gh
689996|NCT00928213|PP13|pp13
689997|NCT00928213|Doppler|doppler
689998|NCT00928213|placenta|placenta
689999|NCT00928213|PTD|ptd
690000|NCT00928213|Preterm delivery|preterm delivery
690001|NCT00928239|vaginal vault prolapse|vaginal vault prolapse
690002|NCT00928239|laparoscopic sacropexy|laparoscopic sacropexy
690003|NCT00928252|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
690004|NCT00928252|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
690005|NCT00928265|intracranial|intracranial
690006|NCT00928265|stenting|stenting
690007|NCT00928265|endovascular treatment|endovascular treatment
690009|NCT00928265|cerebrovascular disease|cerebrovascular disease
690010|NCT00928291|procalcitonin|procalcitonin
690011|NCT00928291|neutropenia|neutropenia
690012|NCT00928291|febrile neutropenia|febrile neutropenia
690013|NCT00928291|antibiotic therapy|antibiotic therapy
752579|NCT01167764|recurrence|recurrence
690014|NCT00928291|neutropenic patients|neutropenic patients
690015|NCT00928304|Amyloid beta-protein|amyloid beta-protein
690016|NCT00928304|Down Syndrome|down syndrome
690017|NCT00928330|TDM-1|tdm-1
690018|NCT00928330|HER2|her2
690019|NCT00928330|HER2+|her2+
690020|NCT00928330|HER2+ Breast Cancer|her2+ breast cancer
690021|NCT00928330|HER-2|her-2
690022|NCT00928330|MBC|mbc
690023|NCT00928330|Trastuzumab emtansine|trastuzumab emtansine
690024|NCT00928343|Safety|safety
690025|NCT00928343|Tolerability|tolerability
690026|NCT00928343|Pharmacokinetics|pharmacokinetics
690027|NCT00928356|Coronary Artery Disease|coronary artery disease
690028|NCT00928356|Robotic Coronary Artery Bypass Surgery|robotic coronary artery bypass surgery
690029|NCT00928356|Percutaneous Coronary Intervention|percutaneous coronary intervention
690030|NCT00928356|Hybrid Coronary Revascularization|hybrid coronary revascularization
690031|NCT00928382|Spinal Cord|spinal cord
690032|NCT00928382|Healthy Volunteer|healthy volunteer
690033|NCT00928382|Metastasis|metastasis
690034|NCT00928382|Samples|samples
690035|NCT00928382|Spinal Cord Vertebrae|spinal cord vertebrae
690036|NCT00928382|Cancer|cancer
690037|NCT00928382|HV|hv
690038|NCT00928395|Urgent PC|urgent pc
690039|NCT00928395|Overactive Bladder|overactive bladder
690040|NCT00928395|SUmiT Trial|sumit trial
690041|NCT00928395|Overactive Urinary Bladder|overactive urinary bladder
690042|NCT00928421|Varicose Veins|varicose veins
690043|NCT00928447|rHuPH20|rhuph20
690044|NCT00928447|Recombinant Human hyaluronidase|recombinant human hyaluronidase
690045|NCT00928460|Electrocardiogram|electrocardiogram
690046|NCT00928460|Electrocardiography|electrocardiography
690047|NCT00928460|Perioperative care|perioperative care
690048|NCT00928460|Preoperative care|preoperative care
690049|NCT00928460|Preanesthesia Evaluation|preanesthesia evaluation
690050|NCT00928460|Acute Coronary Syndrome|acute coronary syndrome
690051|NCT00928460|Postoperative Myocardial Infarction|postoperative myocardial infarction
690052|NCT00928460|Myocardial ischaemia|myocardial ischaemia
690053|NCT00928460|Postoperative Cardiac Death|postoperative cardiac death
690054|NCT00928460|Intraoperative complications|intraoperative complications
690055|NCT00928460|Postoperative complications|postoperative complications
690056|NCT00928460|Cost-effectiveness analysis|cost-effectiveness analysis
690057|NCT00928499|urge/frequency|urge/frequency
690058|NCT00928499|urge incontinence|urge incontinence
690060|NCT00928499|after success Interstim planning IPG placement|after success interstim planning ipg placement
690061|NCT00928512|Rheumatoid Arthritis, RA, ACR, inflammatory joints|rheumatoid arthritis, ra, acr, inflammatory joints
690062|NCT00928525|PDGFr alpha|pdgfr alpha
690063|NCT00928525|PDGFr beta|pdgfr beta
690064|NCT00928525|KIT|kit
690065|NCT00928538|Female Contraception|female contraception
690066|NCT00928538|Home Visits|home visits
690067|NCT00928538|CONTRACEPTIVE AGENTS|contraceptive agents
690068|NCT00928538|CONTRACEPTIVE DEVICES|contraceptive devices
690069|NCT00928564|Pelvic floor muscle spasm|pelvic floor muscle spasm
690070|NCT00928564|Pelvic pain|pelvic pain
690071|NCT00928564|physical therapy|physical therapy
690072|NCT00928564|pudendal block|pudendal block
690073|NCT00928577|Smallpox|smallpox
690074|NCT00928577|Smallpox Vaccine|smallpox vaccine
690075|NCT00928577|Vaccinia virus|vaccinia virus
690076|NCT00928577|Military|military
690077|NCT00928590|open-angle glaucoma|open-angle glaucoma
690078|NCT00928590|ocular hypertension|ocular hypertension
690079|NCT00928590|pseudoexfoliation|pseudoexfoliation
690080|NCT00928590|pigment dispersion|pigment dispersion
690081|NCT00928603|prostate cancer|prostate cancer
690082|NCT00928603|therapy|therapy
690083|NCT00928616|hyperlipidemia|hyperlipidemia
690084|NCT00928616|plant sterols|plant sterols
690085|NCT00928616|monocytes|monocytes
690086|NCT00928629|Peripheral Arterial Disease|peripheral arterial disease
690087|NCT00928629|Cardiovascular Disease|cardiovascular disease
690088|NCT00928629|Vascular Disease|vascular disease
690089|NCT00928642|ovarian|ovarian
690090|NCT00928642|cancer|cancer
690091|NCT00928642|peritoneal|peritoneal
690092|NCT00928642|endometrioid|endometrioid
690093|NCT00928642|mucinous|mucinous
690094|NCT00928642|serous|serous
690095|NCT00928642|clear cell|clear cell
690096|NCT00928655|apnea|apnea
690097|NCT00928655|sleep|sleep
690098|NCT00928655|altitude|altitude
690099|NCT00928655|hypoxia|hypoxia
690100|NCT00928655|treatment|treatment
690101|NCT00928655|CPAP|cpap
690102|NCT00910403|Presbyopia|presbyopia
690103|NCT00910403|LASIK|lasik
690104|NCT00910403|Hyperopes|hyperopes
690105|NCT00910416|Anesthesia|anesthesia
690106|NCT00910416|Monitoring, Intraoperative|monitoring, intraoperative
690107|NCT00910416|Electroencephalography/*drug effects|electroencephalography/*drug effects
690108|NCT00910429|Chronic thromboembolic Hypertension|chronic thromboembolic hypertension
690109|NCT00910429|PH|ph
690110|NCT00910429|soluble Guanylate Cyclase Stimulator|soluble guanylate cyclase stimulator
690111|NCT00910429|sGC|sgc
690112|NCT00910455|Phase 1|phase 1
690113|NCT00910455|Safety|safety
690114|NCT00910455|Tolerability|tolerability
690115|NCT00910455|Pharmacokinetics|pharmacokinetics
690116|NCT00910481|Coronary Artery Disease|coronary artery disease
690117|NCT00910481|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
690118|NCT00910481|Intraaortic Balloon Pumping|intraaortic balloon pumping
690119|NCT00910481|Left Ventricular Dysfunction|left ventricular dysfunction
690120|NCT00910481|High Risk|high risk
690121|NCT00921141|Implantable central venous access ports, cancer|implantable central venous access ports, cancer
690122|NCT00921154|therapeutic equivalency|therapeutic equivalency
690123|NCT00921154|pharmacokinetics|pharmacokinetics
690124|NCT00921154|fasting|fasting
690125|NCT00921154|Healthy Volunteers|healthy volunteers
690126|NCT00921167|Glioblastoma|glioblastoma
690127|NCT00921167|Astrocytoma|astrocytoma
690128|NCT00921167|Chemotherapy|chemotherapy
690129|NCT00921180|Hepatitis B, chronic|hepatitis b, chronic
690130|NCT00921180|Peginterferon alfa-2a|peginterferon alfa-2a
690131|NCT00921180|Entecavir|entecavir
690132|NCT00921193|Prostate|prostate
690133|NCT00921193|fiducials|fiducials
690134|NCT00921193|radiation Therapy|radiation therapy
690135|NCT00921193|Tracking|tracking
690136|NCT00921193|Localization|localization
690137|NCT00921206|influenza|influenza
690138|NCT00921206|influenza vaccine|influenza vaccine
690139|NCT00921206|universal influenza vaccine|universal influenza vaccine
690140|NCT00921206|Matrix 2e protein|matrix 2e protein
690141|NCT00921206|M2e|m2e
690142|NCT00921206|Immune response|immune response
690143|NCT00921219|therapeutic equivalency|therapeutic equivalency
690144|NCT00921219|pharmacokinetics|pharmacokinetics
690145|NCT00921219|food|food
690146|NCT00921219|Healthy volunteers|healthy volunteers
690147|NCT00921232|Life-ending patient|life-ending patient
690148|NCT00921232|caregiver|caregiver
690149|NCT00921245|Overactive Bladder|overactive bladder
690150|NCT00921258|latent prostate cancer|latent prostate cancer
690151|NCT00921258|Patient with latent prostate cancer|patient with latent prostate cancer
690152|NCT00921258|PSA ≤ 10 ng/ml|psa ≤ 10 ng/ml
690153|NCT00921258|Clinical stage T1c or T2a|clinical stage t1c or t2a
690154|NCT00921258|Patient who accept just be control|patient who accept just be control
690155|NCT00921271|Compartment syndrome|compartment syndrome
690156|NCT00921297|Alzheimer's Disease|alzheimer's disease
690157|NCT00921297|vision impairment|vision impairment
690159|NCT00921297|quality of life|quality of life
690160|NCT00921297|retinal nerve fiber layer|retinal nerve fiber layer
690161|NCT00921310|Temsirolimus and pemetrexed for recurrent or refractory NSCLC|temsirolimus and pemetrexed for recurrent or refractory nsclc
690162|NCT00921323|Obesity|obesity
690163|NCT00921323|Physical activity|physical activity
690164|NCT00921323|pedometers|pedometers
690165|NCT00921323|children|children
690166|NCT00921336|subjects with advanced Solid tumor who have not responded to standard therapy or for whom no standard therapy is available|subjects with advanced solid tumor who have not responded to standard therapy or for whom no standard therapy is available
690167|NCT00921349|Prophylaxis|prophylaxis
690168|NCT00921349|ligation|ligation
690169|NCT00921349|beta blockers|beta blockers
690170|NCT00921349|First bleeding rate|first bleeding rate
690171|NCT00921362|Schizophrenia|schizophrenia
690172|NCT00921388|Smoking Cessation|smoking cessation
690173|NCT00921388|Exercise|exercise
690174|NCT00921388|Postmenopausal women|postmenopausal women
690175|NCT00921388|CHANTIX|chantix
690176|NCT00921388|varenicline|varenicline
690177|NCT00921414|Mantle cell lymphoma|mantle cell lymphoma
690178|NCT00921414|R DHAP|r dhap
690179|NCT00921414|ASCT|asct
690180|NCT00921414|Rituximab Maintenance|rituximab maintenance
690181|NCT00921427|Hemianopia|hemianopia
690182|NCT00921427|Rehabilitation|rehabilitation
690183|NCT00921427|Transcranial direct current stimulation|transcranial direct current stimulation
690184|NCT00921427|Visual field|visual field
690185|NCT00921440|coronary artery|coronary artery
690186|NCT00921440|stenosis|stenosis
690187|NCT00921453|Internet|internet
690188|NCT00921453|Information supply|information supply
690189|NCT00921453|Tailoring|tailoring
690190|NCT00921453|Patient empowerment|patient empowerment
690191|NCT00921453|Headaches|headaches
690192|NCT00921453|Meta-search|meta-search
690193|NCT00921453|Consumer Health Information|consumer health information
690194|NCT00921453|Information Services|information services
690195|NCT00921453|Information Storage and Retrieval|information storage and retrieval
690196|NCT00921453|Information Systems|information systems
690197|NCT00921466|Evaluate the clinical content of the e-SSRS-IVR|evaluate the clinical content of the e-ssrs-ivr
690198|NCT00921479|third molar|third molar
690199|NCT00921479|quality of life|quality of life
690200|NCT00921479|postoperative swelling|postoperative swelling
690201|NCT00921479|postoperative pain|postoperative pain
690202|NCT00921479|Surgical Procedures, Operative|surgical procedures, operative
690203|NCT00921479|Postoperative Period|postoperative period
690204|NCT00921492|Luteinizing hormone|luteinizing hormone
690209|NCT00921492|Heart rate variability|heart rate variability
690210|NCT00921492|Psychological distress and quality of life|psychological distress and quality of life
690211|NCT00921505|Acetaminophen|acetaminophen
690212|NCT00921505|Ibuprofen|ibuprofen
690213|NCT00921505|Platelets|platelets
690214|NCT00921505|Leukocytes|leukocytes
690215|NCT00921505|Oxygen species|oxygen species
690217|NCT00921505|Blood Platelets|blood platelets
690218|NCT00921505|Reactive Oxygen Species|reactive oxygen species
690219|NCT00921505|Platelet Activation|platelet activation
690220|NCT00921518|Cardiac surgery|cardiac surgery
690221|NCT00921518|Sodium bicarbonate|sodium bicarbonate
690222|NCT00921518|Acute kidney injury|acute kidney injury
690223|NCT00921518|Saline|saline
690224|NCT00921531|Hepatocellular carcinoma|hepatocellular carcinoma
690225|NCT00921531|thalidomide|thalidomide
690226|NCT00921531|TACE|tace
690227|NCT00921531|Child-Pugh Class A or B|child-pugh class a or b
690229|NCT00921544|sucrose|sucrose
690230|NCT00921544|pain|pain
690231|NCT00921557|Bone mineral density|bone mineral density
690232|NCT00921570|TWEAK|tweak
690233|NCT00921570|FMD|fmd
690234|NCT00921570|PTX3|ptx3
690235|NCT00921570|Valsartan|valsartan
690236|NCT00921570|Amlodipine|amlodipine
690237|NCT00921570|Renin Angiotensin System|renin angiotensin system
690238|NCT00921583|survival rate|survival rate
690239|NCT00921583|success rate|success rate
690240|NCT00921596|Surgical Procedures, Cardiac|surgical procedures, cardiac
690241|NCT00921596|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
690242|NCT00921596|Thoracoscopes|thoracoscopes
690243|NCT00921596|Cardiopulmonary Bypass|cardiopulmonary bypass
690244|NCT00921609|Acromegaly|acromegaly
690245|NCT00921609|OGTT|ogtt
690246|NCT00921609|post-op|post-op
690247|NCT00921622|Blood pressure|blood pressure
690248|NCT00921622|Vitamin C|vitamin c
690249|NCT00921622|Vitamin D|vitamin d
690250|NCT00921635|Haemoglobin|haemoglobin
690251|NCT00921648|EEG|eeg
690252|NCT00921648|general paresis|general paresis
690253|NCT00921648|MRI|mri
690254|NCT00921648|neurosyphilis|neurosyphilis
690255|NCT00921661|oxaliplatin|oxaliplatin
690256|NCT00921661|5-FU|5-fu
690257|NCT00921661|Folinic Acid|folinic acid
690258|NCT00921674|therapeutic equivalency|therapeutic equivalency
690259|NCT00921674|pharmacokinetics|pharmacokinetics
690260|NCT00921674|food|food
690261|NCT00921674|Healthy Volunteers|healthy volunteers
690262|NCT00921700|Paracetamol|paracetamol
690263|NCT00921700|Acetaminophen|acetaminophen
690264|NCT00921700|Ibuprofen|ibuprofen
690266|NCT00921700|Postoperative pain|postoperative pain
690267|NCT00921700|third molar|third molar
690268|NCT00921713|Early cancer care|early cancer care
690269|NCT00921726|Drug Interaction|drug interaction
690270|NCT00921739|Non small cell lung cancer|non small cell lung cancer
690271|NCT00921739|Small cell lung cancer|small cell lung cancer
690272|NCT00921739|Thymoma unresectable|thymoma unresectable
690273|NCT00921739|Thymic carcinoma unresectable|thymic carcinoma unresectable
690274|NCT00921752|Lipid therapy|lipid therapy
690275|NCT00921752|high CV risk|high cv risk
690276|NCT00921752|lipid goal attainment|lipid goal attainment
690277|NCT00921752|High cardiovascular risk patients|high cardiovascular risk patients
690278|NCT00921765|Pain|pain
690279|NCT00921765|Naloxone|naloxone
690280|NCT00921765|Ketamine|ketamine
690281|NCT00921765|Third Molar|third molar
690282|NCT00921765|Surgery|surgery
690283|NCT00921778|Laparoscopic supracervical hysterectomy|laparoscopic supracervical hysterectomy
690284|NCT00921778|Vaginal bleeding|vaginal bleeding
690285|NCT00921778|Patient satisfaction|patient satisfaction
690286|NCT00921778|vaginal bleeding after laparoscopic hysterectomy|vaginal bleeding after laparoscopic hysterectomy
690287|NCT00921791|Hypertension|hypertension
690288|NCT00921791|Blood pressure|blood pressure
690289|NCT00921791|Home Blood Pressure Monitoring|home blood pressure monitoring
690290|NCT00921791|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
690291|NCT00921791|Pharmaceutical care|pharmaceutical care
690292|NCT00921804|Schizophrenia|schizophrenia
690293|NCT00921804|Hallucinations|hallucinations
690294|NCT00921804|Paranoia|paranoia
690295|NCT00921804|Inpatient schizophrenia clinical trial|inpatient schizophrenia clinical trial
690296|NCT00921817|healthy children|healthy children
690297|NCT00921830|ibuprofen|ibuprofen
690298|NCT00921830|healthy volunteers|healthy volunteers
690299|NCT00921830|bioavailability|bioavailability
690300|NCT00921830|pharmacokinetics|pharmacokinetics
690301|NCT00921830|suppository|suppository
690302|NCT00921843|Pediatric patients undergoing surgery|pediatric patients undergoing surgery
690303|NCT00921856|Acetylcholine|acetylcholine
690304|NCT00921869|Cancer|cancer
690305|NCT00921869|Gastrointestinal Cancer|gastrointestinal cancer
690306|NCT00921882|Type 2 diabetes|type 2 diabetes
690512|NCT00922727|Cytokines|cytokines
690307|NCT00921882|Post-partum screening|post-partum screening
690308|NCT00921895|Pink Eye,|pink eye,
690309|NCT00921895|Viral conjunctivitis|viral conjunctivitis
690310|NCT00921895|Adenoviral conjunctivitis|adenoviral conjunctivitis
690311|NCT00921895|Keratoconjunctivitis|keratoconjunctivitis
690312|NCT00921908|total hip arthroplasty|total hip arthroplasty
690313|NCT00921934|Herpes|herpes
690314|NCT00921934|Shingles|shingles
690315|NCT00921934|virus disease|virus disease
690316|NCT00921934|vitamin C|vitamin c
690317|NCT00921934|ascorbic acid|ascorbic acid
690318|NCT00921934|antioxidant|antioxidant
690319|NCT00921934|oxidative stress|oxidative stress
690320|NCT00921947|influenza vaccine|influenza vaccine
690321|NCT00921947|M2e|m2e
690322|NCT00921947|Universal influenza vaccine|universal influenza vaccine
690323|NCT00921960|Left ventricular dysfunction|left ventricular dysfunction
690324|NCT00921960|Left ventricular systolic dysfunction|left ventricular systolic dysfunction
690325|NCT00921960|Left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
690326|NCT00921960|Myocardial Infarction|myocardial infarction
690327|NCT00921960|Hypertension|hypertension
690328|NCT00921960|Diabetes|diabetes
690329|NCT00921960|Obesity|obesity
690330|NCT00921960|Dyslipidaemia|dyslipidaemia
690331|NCT00921960|Heart Failure|heart failure
690332|NCT00921960|Prevention|prevention
690333|NCT00921960|Screening|screening
690334|NCT00921960|Cardiovascular Risk Factors|cardiovascular risk factors
690335|NCT00921960|Echocardiography|echocardiography
690336|NCT00921960|Natriuretic Peptides|natriuretic peptides
690337|NCT00921973|influenza|influenza
690338|NCT00921973|universal influenza vaccine|universal influenza vaccine
690340|NCT00921986|biorepository|biorepository
690341|NCT00921986|cardiac death|cardiac death
690342|NCT00921986|atrial fibrillation|atrial fibrillation
690343|NCT00921986|ventricular fibrillation|ventricular fibrillation
690344|NCT00921986|ventricular tachycardia|ventricular tachycardia
690345|NCT00921986|supraventricular tachycardias|supraventricular tachycardias
690346|NCT00921986|premature ventricular complexes|premature ventricular complexes
690347|NCT00921986|premature atrial complexes|premature atrial complexes
690348|NCT00921986|atrioventricular and intraventricular blocks|atrioventricular and intraventricular blocks
690349|NCT00921986|sinus node dysfunction|sinus node dysfunction
690350|NCT00921986|syncope|syncope
690351|NCT00921986|vasovagal reactivity|vasovagal reactivity
690352|NCT00921986|postural orthostatic tachycardia syndrome|postural orthostatic tachycardia syndrome
690353|NCT00921999|Chickenpox|chickenpox
690354|NCT00921999|Shingles|shingles
690355|NCT00921999|Varicella|varicella
690356|NCT00921999|Zoster|zoster
690357|NCT00921999|Vaccine|vaccine
690358|NCT00922012|Electromagnetic Stimulation Therapy|electromagnetic stimulation therapy
690359|NCT00922012|Chronic Prostatitis|chronic prostatitis
690360|NCT00922012|Chronic Pelvic Pain Syndrome|chronic pelvic pain syndrome
690361|NCT00922025|NSCLC|nsclc
690362|NCT00922025|Male|male
690363|NCT00922025|Smoking Pattern|smoking pattern
690364|NCT00922025|Efficacy|efficacy
690365|NCT00922051|COPD|copd
690366|NCT00922051|FEV1|fev1
690367|NCT00922051|beta endorphin|beta endorphin
690368|NCT00922051|TENS|tens
690369|NCT00922051|acupuncture|acupuncture
690370|NCT00922090|Schizophrenia|schizophrenia
690371|NCT00922090|Seroquel XR|seroquel xr
690372|NCT00922090|CGI-CB|cgi-cb
690373|NCT00922090|SWN-K|swn-k
690374|NCT00922103|Colitis, Ulcerative|colitis, ulcerative
690375|NCT00922103|Ileo Neo Rectal Anastomosis|ileo neo rectal anastomosis
690376|NCT00922103|Ileal Pouch Anal Anastomosis|ileal pouch anal anastomosis
690377|NCT00922103|Quality of Life|quality of life
690378|NCT00922103|functional results|functional results
690379|NCT00922103|reconstructive surgery|reconstructive surgery
690380|NCT00922103|surgery|surgery
690381|NCT00922129|Sirolimus|sirolimus
690382|NCT00922129|Calcineurin inhibitor|calcineurin inhibitor
690383|NCT00922129|prostate cancer|prostate cancer
690384|NCT00922155|endobronchial ultrasound|endobronchial ultrasound
690385|NCT00922155|guide sheath|guide sheath
690386|NCT00922155|peripheral pulmonary lesions|peripheral pulmonary lesions
690387|NCT00922168|Sleep|sleep
690388|NCT00922168|apnea|apnea
690389|NCT00922168|obstructive|obstructive
690390|NCT00922168|central|central
690391|NCT00922181|malignancy|malignancy
690392|NCT00922181|liver|liver
690393|NCT00922181|microwave|microwave
690394|NCT00922181|surgery|surgery
690395|NCT00922194|Type 2 diabetes|type 2 diabetes
690396|NCT00922194|Obesity|obesity
690397|NCT00922194|Extended Release Metformin|extended release metformin
690398|NCT00922220|low back pain|low back pain
690399|NCT00922220|spinal manipulation|spinal manipulation
690400|NCT00922220|central sensitization|central sensitization
690401|NCT00922220|manual therapy|manual therapy
690402|NCT00922233|Contraception|contraception
690403|NCT00922246|overuse injuries|overuse injuries
690404|NCT00922246|conscript|conscript
690405|NCT00922246|prevention|prevention
690407|NCT00922259|Influenza|influenza
690408|NCT00922259|Vaccine|vaccine
690409|NCT00922259|Prevention|prevention
690410|NCT00922272|Schizophrenia|schizophrenia
690411|NCT00922285|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
690412|NCT00922285|health status unknown|health status unknown
690413|NCT00922311|Proteinuria|proteinuria
690414|NCT00922324|Healthy volunteers|healthy volunteers
690415|NCT00922337|distal embolization|distal embolization
690416|NCT00922337|thrombotic lesions|thrombotic lesions
690417|NCT00922337|AMI|ami
690418|NCT00922337|ACS|acs
690419|NCT00922337|SVG|svg
690420|NCT00922350|asthma|asthma
690421|NCT00922350|heliox|heliox
690422|NCT00922350|bronchodilators|bronchodilators
690423|NCT00922350|posture|posture
690424|NCT00922363|safety|safety
690425|NCT00922363|vaccine|vaccine
690426|NCT00922363|tuberculosis|tuberculosis
690427|NCT00922363|CAF01|caf01
690428|NCT00922363|Ag85B-ESAT-6|ag85b-esat-6
690429|NCT00922363|prevention|prevention
690430|NCT00922376|Diabetes|diabetes
690431|NCT00922376|self- management|self- management
690432|NCT00922376|glycemic control|glycemic control
690433|NCT00922376|telehealth|telehealth
690434|NCT00922376|mhealth|mhealth
690435|NCT00922389|Diabetes Complications|diabetes complications
690436|NCT00922389|Lower limb ischemia|lower limb ischemia
690437|NCT00922389|Adult stem cells|adult stem cells
690438|NCT00922389|peripheral blood stem cells|peripheral blood stem cells
690439|NCT00922402|Acute|acute
690440|NCT00922402|heart failure|heart failure
690441|NCT00922402|hyperglycemia|hyperglycemia
690442|NCT00922402|Acute heart failure with high levels of glycemia|acute heart failure with high levels of glycemia
690443|NCT00922415|Crohn's disease|crohn's disease
690444|NCT00922415|calprotectin|calprotectin
690445|NCT00922428|rheumatism|rheumatism
690446|NCT00922428|arthralgia|arthralgia
690447|NCT00922428|myalgia|myalgia
690448|NCT00922428|lumbago|lumbago
690449|NCT00922428|homoeopathy|homoeopathy
690450|NCT00922428|injection|injection
690451|NCT00922428|PASCOE-Agil HOM Injektopas|pascoe-agil hom injektopas
690452|NCT00922428|efficacy|efficacy
690453|NCT00922428|tolerability|tolerability
690454|NCT00922428|acceptance|acceptance
690455|NCT00922428|safety|safety
690456|NCT00922441|Fimasartan|fimasartan
690457|NCT00922441|Essential Hypertension|essential hypertension
690458|NCT00922441|24hour ABPM|24hour abpm
690459|NCT00922441|Population PK|population pk
690460|NCT00922454|patients will be matched based on AAA neck length and neck and iliac angulation|patients will be matched based on aaa neck length and neck and iliac angulation
690461|NCT00922480|Hypertension|hypertension
690462|NCT00922480|Losartan|losartan
690463|NCT00922493|weaning|weaning
690464|NCT00922493|inspiratory muscle training|inspiratory muscle training
690465|NCT00922493|maximum inspiratory pressure (MIP)|maximum inspiratory pressure (mip)
690466|NCT00922493|index of Tobin (IT)|index of tobin (it)
690467|NCT00922493|intubated|intubated
690468|NCT00922493|intensive care unit|intensive care unit
690469|NCT00922493|elderly|elderly
690470|NCT00922506|Overactive bladder|overactive bladder
690471|NCT00922506|Benign prostate hyperplasia|benign prostate hyperplasia
690472|NCT00922506|Doxazosin|doxazosin
690473|NCT00922506|Tolterodine|tolterodine
690474|NCT00922519|Positron Emission Tomography|positron emission tomography
690475|NCT00922519|Sodium 18F-Fluoride|sodium 18f-fluoride
690476|NCT00922519|99mTc-MDP|99mtc-mdp
690477|NCT00922519|Bone Scan|bone scan
690478|NCT00922532|Hypoxic Respiratory Failure (HRF), Pulmonary Hypertension|hypoxic respiratory failure (hrf), pulmonary hypertension
690479|NCT00922545|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
690480|NCT00922545|Quality of life|quality of life
690481|NCT00922545|Primary health care|primary health care
690482|NCT00922558|tetra-axiametric posturography|tetra-axiametric posturography
690483|NCT00922558|postural control|postural control
690484|NCT00922558|tetrax|tetrax
690485|NCT00922558|children|children
690486|NCT00922571|Cataract|cataract
690487|NCT00922571|Femtosecond laser|femtosecond laser
690488|NCT00922584|non-small cell lung cancer|non-small cell lung cancer
690489|NCT00922584|Sorafenib|sorafenib
690490|NCT00922584|targeted therapy|targeted therapy
690491|NCT00922597|Continuous infusion|continuous infusion
690492|NCT00922597|Surgery|surgery
690493|NCT00922597|Severe haemophilia A|severe haemophilia a
690494|NCT00922623|Nasolabial folds|nasolabial folds
690495|NCT00922662|coronary artery disease|coronary artery disease
690496|NCT00922662|chest pain|chest pain
690497|NCT00922662|CCTA|ccta
690498|NCT00922675|ST-elevation myocardial infarction|st-elevation myocardial infarction
690499|NCT00922688|Dipeptide Alanyl-Glutamine|dipeptide alanyl-glutamine
690500|NCT00922688|Insulin sensitivity|insulin sensitivity
690501|NCT00922688|Intracellular signaling|intracellular signaling
690502|NCT00922688|Antioxidant/oxidant parameters|antioxidant/oxidant parameters
690503|NCT00922688|Lipolysis|lipolysis
690504|NCT00922688|Inflammatory response in the liver|inflammatory response in the liver
690505|NCT00922701|Peritoneal dialysis|peritoneal dialysis
690506|NCT00922701|L-carnitine|l-carnitine
690507|NCT00922714|Glutamine|glutamine
690508|NCT00922714|ICU patients|icu patients
690509|NCT00922714|Critically ill|critically ill
690510|NCT00922714|Nutrition|nutrition
690511|NCT00922727|L. reuteri|l. reuteri
690513|NCT00922727|Toll like receptors|toll like receptors
690514|NCT00922727|Healthy Adults|healthy adults
690515|NCT00922727|Probiotics|probiotics
690517|NCT00922740|Pharmacokinetics|pharmacokinetics
690518|NCT00922740|Pharmacodynamics|pharmacodynamics
690519|NCT00922740|Water-loading|water-loading
690520|NCT00922740|Elderly|elderly
690521|NCT00922740|Males|males
690522|NCT00922753|Preoxygenation|preoxygenation
690523|NCT00922753|Inspiratory|inspiratory
690524|NCT00922753|Support|support
690525|NCT00922753|Healthy|healthy
690526|NCT00922753|EndtidalO2|endtidalo2
690527|NCT00922766|dalteparin non-ST segment elevated acute coronary syndromes|dalteparin non-st segment elevated acute coronary syndromes
690528|NCT00922805|Pediatrics, short bowel syndrome, soluble fiber|pediatrics, short bowel syndrome, soluble fiber
690529|NCT00922818|Perineal|perineal
690530|NCT00922818|Prostatectomy|prostatectomy
690531|NCT00922818|Nerve|nerve
690532|NCT00922818|Anatomic|anatomic
690533|NCT00922818|Surgery|surgery
690534|NCT00922818|Neoplasms, Prostatic|neoplasms, prostatic
690535|NCT00922818|Prostate Cancer|prostate cancer
690536|NCT00922818|Prostate Neoplasms|prostate neoplasms
690537|NCT00922818|Prostatic Cancer|prostatic cancer
690538|NCT00922818|Prostate|prostate
690539|NCT00922818|Cancer|cancer
690540|NCT00922818|Recurrent|recurrent
690541|NCT00922831|Cognition, Affective MS symptoms|cognition, affective ms symptoms
690542|NCT00922844|hypotension|hypotension
690543|NCT00922844|low blood pressure|low blood pressure
690544|NCT00922844|vasopressor need|vasopressor need
690545|NCT00922857|Respiratory Insufficiency|respiratory insufficiency
690546|NCT00922857|Muscular Atrophy|muscular atrophy
690547|NCT00922857|Respiratory rehabilitation|respiratory rehabilitation
690548|NCT00922883|Promacta|promacta
690549|NCT00922883|SAA|saa
690550|NCT00922883|Aplastic Anemia|aplastic anemia
690551|NCT00922883|Thrombocytopenia|thrombocytopenia
690552|NCT00922896|Gemcitabine|gemcitabine
690553|NCT00922896|Cisplatin|cisplatin
690554|NCT00922896|Erlotinib|erlotinib
690555|NCT00922948|Radiofrequency ablation|radiofrequency ablation
690556|NCT00922948|Cryosurgery|cryosurgery
690557|NCT00922948|Renal cancers|renal cancers
690558|NCT00922961|brachytherapy, late cutaneous toxicity|brachytherapy, late cutaneous toxicity
690559|NCT00922974|spinal bone metastases|spinal bone metastases
690560|NCT00922974|pain|pain
690561|NCT00922987|lyrica pregabalin epilepsy partial seizures|lyrica pregabalin epilepsy partial seizures
690562|NCT00928707|Polycythemia Vera|polycythemia vera
690563|NCT00928707|GIVINOSTAT|givinostat
690564|NCT00928707|ITF2357|itf2357
690565|NCT00928720|fibromyalgia|fibromyalgia
690566|NCT00928720|pain|pain
690567|NCT00928720|sleep disturbance|sleep disturbance
690568|NCT00928720|fatigue|fatigue
690569|NCT00928720|depression|depression
690570|NCT00928720|functional magnetic resonance imaging|functional magnetic resonance imaging
690571|NCT00928733|Permeability|permeability
690572|NCT00928733|tight junctions|tight junctions
690573|NCT00928733|cytokines|cytokines
690574|NCT00928733|inflammatory bowel diseases|inflammatory bowel diseases
690575|NCT00928733|The effect of alcohol on the intestinal permeability may have major consequences on health.|the effect of alcohol on the intestinal permeability may have major consequences on health.
690576|NCT00928733|It's generally accepted that an increased intestinal permeability in alcoholic subjects lead|it's generally accepted that an increased intestinal permeability in alcoholic subjects lead
690577|NCT00928733|to translocation of bacterial endotoxins from the gut lumen into the portal vein and then to the liver.|to translocation of bacterial endotoxins from the gut lumen into the portal vein and then to the liver.
690578|NCT00928733|In the liver, endotoxins trigger the immune system and activate the resident macrophages, Kupffer cells.|in the liver, endotoxins trigger the immune system and activate the resident macrophages, kupffer cells.
690579|NCT00928733|Activation of Kupffer cells leads to production of chemokines (IL-8) and|activation of kupffer cells leads to production of chemokines (il-8) and
690580|NCT00928733|proinflammatory cytokines (IL-1, TNFα),resulting in hepatocytes damage, inflammation, fibrosis and finally cirrhosis.|proinflammatory cytokines (il-1, tnfα),resulting in hepatocytes damage, inflammation, fibrosis and finally cirrhosis.
690581|NCT00928759|Obesity|obesity
690582|NCT00928759|Polycystic Ovary Syndrome|polycystic ovary syndrome
690583|NCT00928772|Cranial Electro Stimulation|cranial electro stimulation
690584|NCT00928772|First Eye Cataract Surgery|first eye cataract surgery
690585|NCT00928772|Preoperative sedation|preoperative sedation
690586|NCT00928772|Perioperative sedation|perioperative sedation
690587|NCT00928785|Tetanus Vaccine|tetanus vaccine
690588|NCT00928785|Tdap-IPV vaccine|tdap-ipv vaccine
690589|NCT00928811|Simulect|simulect
690590|NCT00928811|de novo kidney transplant subjects|de novo kidney transplant subjects
690591|NCT00928811|calcineurin inhibitors|calcineurin inhibitors
690592|NCT00928811|Prograf|prograf
690593|NCT00928850|Prostate|prostate
690594|NCT00928850|Radical Prostatectomy|radical prostatectomy
690595|NCT00928850|urethral irrigation|urethral irrigation
690596|NCT00928850|fascial suturing|fascial suturing
690597|NCT00928850|09-051|09-051
690598|NCT00928863|haemorrhagia postpartum|haemorrhagia postpartum
690599|NCT00928863|implementation guidelines|implementation guidelines
690600|NCT00928863|maternal morbidity|maternal morbidity
690601|NCT00928863|management of obstetrics and trauma|management of obstetrics and trauma
690602|NCT00928876|anakinra|anakinra
690603|NCT00928876|Diabetes mellitus, type 2|diabetes mellitus, type 2
690604|NCT00928876|Insulin resistance|insulin resistance
690605|NCT00928876|Interleukin-1beta|interleukin-1beta
690606|NCT00928889|diabetes mellitus, type 2|diabetes mellitus, type 2
690607|NCT00928889|nateglinide|nateglinide
690608|NCT00928889|acarbose|acarbose
690609|NCT00928889|hyperglycemia|hyperglycemia
690610|NCT00928889|dyslipidemias|dyslipidemias
690611|NCT00928889|C-reactive protein|c-reactive protein
690612|NCT00928902|melanoma|melanoma
690613|NCT00928902|vaccine|vaccine
690614|NCT00928902|peptides|peptides
690615|NCT00928902|adjuvant|adjuvant
690616|NCT00928902|immunogenicity|immunogenicity
690617|NCT00928902|stage IIB, stage III or resected stage IV|stage iib, stage iii or resected stage iv
690618|NCT00928915|Intracranial Hemorrhages|intracranial hemorrhages
690619|NCT00928915|Vitamin-K antagonist|vitamin-k antagonist
690620|NCT00928915|Hemostatic treatment|hemostatic treatment
690621|NCT00928915|Prothrombin complex|prothrombin complex
690622|NCT00928915|Fresh frozen plasma|fresh frozen plasma
690623|NCT00928915|Intracranial Hemorrhages related to vitamin-K antagonist|intracranial hemorrhages related to vitamin-k antagonist
690624|NCT00928928|Lipid peroxidation|lipid peroxidation
690625|NCT00928928|Protein peroxidation|protein peroxidation
690626|NCT00928928|DNA peroxidation|dna peroxidation
690627|NCT00928928|RNA peroxidation|rna peroxidation
690628|NCT00928928|Cytokines|cytokines
690629|NCT00928928|hsCRP|hscrp
690630|NCT00928928|Oxidative stress markers|oxidative stress markers
690631|NCT00928928|Open surgery|open surgery
690632|NCT00928928|Laparoscopic surgery|laparoscopic surgery
690633|NCT00928941|PTSD|ptsd
690634|NCT00928941|rehabilitation|rehabilitation
690635|NCT00928954|gabapentin|gabapentin
690636|NCT00928954|memantine|memantine
690637|NCT00928954|nystagmus|nystagmus
690638|NCT00928954|Drug treatment|drug treatment
690639|NCT00928967|Multiple Sclerosis|multiple sclerosis
690640|NCT00928967|Quality of life|quality of life
690641|NCT00928980|Recurrent Major Depressive Disorder|recurrent major depressive disorder
690642|NCT00928980|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
690643|NCT00928980|Cost-effectiveness|cost-effectiveness
690644|NCT00928980|Antidepressant medication|antidepressant medication
690645|NCT00928980|Randomized Controlled Trial|randomized controlled trial
690646|NCT00928993|actigraphy|actigraphy
690647|NCT00928993|polysomnography|polysomnography
690648|NCT00928993|pediatrics|pediatrics
690649|NCT00928993|sleep|sleep
690650|NCT00928993|To validate Actigraphy against polysomnography|to validate actigraphy against polysomnography
690651|NCT00929331|Influenza|influenza
690652|NCT00929331|Fluviral®|fluviral®
690653|NCT00929344|Alcohol|alcohol
690654|NCT00929344|Alcohol treatment|alcohol treatment
690655|NCT00929344|Alcoholism|alcoholism
690656|NCT00929344|Alcohol Abuse|alcohol abuse
690657|NCT00929344|Alcohol Dependence|alcohol dependence
690658|NCT00929370|Schizophrenia|schizophrenia
690659|NCT00929370|GSK1018921|gsk1018921
690660|NCT00929370|GlyT-1 inhibitor|glyt-1 inhibitor
690661|NCT00929370|Healthy Volunteers|healthy volunteers
690663|NCT00929370|Patient|patient
690664|NCT00929370|Midazolam|midazolam
690665|NCT00929383|Intracranial Atherosclerosis|intracranial atherosclerosis
690666|NCT00929383|Stenosis|stenosis
690667|NCT00929383|ICAD|icad
690668|NCT00929383|atherosclerotic lesions|atherosclerotic lesions
690669|NCT00929383|stenting|stenting
690670|NCT00929396|Tuberculosis|tuberculosis
690671|NCT00929396|Vaccine|vaccine
690672|NCT00929396|Ag85B|ag85b
690673|NCT00929396|ESAT-6|esat-6
690674|NCT00929396|IC31|ic31
690675|NCT00929409|Postpartum anemia, iron-deficiency|postpartum anemia, iron-deficiency
690676|NCT00929422|spinal cord injury|spinal cord injury
690678|NCT00929422|cerebral function|cerebral function
690679|NCT00929422|cortical reorganization|cortical reorganization
690680|NCT00929435|MRSA|mrsa
690681|NCT00929435|Contact isolation|contact isolation
690682|NCT00929435|Incidence|incidence
690683|NCT00929448|Traumatic brain injury|traumatic brain injury
690684|NCT00929461|omega-3 fatty acids|omega-3 fatty acids
690685|NCT00929461|lactate|lactate
690686|NCT00929461|surgery|surgery
690687|NCT00929461|gastric cancer|gastric cancer
690688|NCT00929461|address the effect of postoperative administration of omega-3 fatty acids on cellular hypoperfusion associated with major gastric surgery.|address the effect of postoperative administration of omega-3 fatty acids on cellular hypoperfusion associated with major gastric surgery.
690689|NCT00929487|contact lens wear|contact lens wear
690690|NCT00929487|contact lens solution|contact lens solution
690691|NCT00929487|corneal staining|corneal staining
690692|NCT00929526|HPV vaccine|hpv vaccine
690693|NCT00929526|cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
690694|NCT00929526|including new onset of autoimmune disease [NOAD])|including new onset of autoimmune disease [noad])
690695|NCT00929526|new onset of chronic disease (NOCD)|new onset of chronic disease (nocd)
690696|NCT00929526|medically significant condition (MSC)|medically significant condition (msc)
690697|NCT00929539|Diabetes|diabetes
690698|NCT00929552|Blood pressure|blood pressure
690699|NCT00929552|Insulin sensitivity|insulin sensitivity
690700|NCT00929552|Blood lipid profile|blood lipid profile
690701|NCT00929565|hemoptysis|hemoptysis
690703|NCT00929578|T-lymphocytes|t-lymphocytes
690704|NCT00929578|Fluphenazine|fluphenazine
690705|NCT00929591|stage II breast cancer|stage ii breast cancer
690706|NCT00929591|stage IIIA breast cancer|stage iiia breast cancer
690707|NCT00929604|HIV|hiv
690708|NCT00929604|AIDS|aids
690709|NCT00929604|Zambia|zambia
690710|NCT00929604|viral load|viral load
752581|NCT01167777|GC|gc
690711|NCT00929604|antiretroviral therapy|antiretroviral therapy
690712|NCT00929604|cluster randomization|cluster randomization
690713|NCT00929604|ART monitoring|art monitoring
690714|NCT00929604|treatment failure|treatment failure
690715|NCT00929604|randomized clinical trial|randomized clinical trial
690716|NCT00929604|treatment naive|treatment naive
690717|NCT00929617|breast cancer|breast cancer
690718|NCT00929617|physical activity|physical activity
690719|NCT00929617|exercise|exercise
690720|NCT00929617|quality of life|quality of life
690721|NCT00929617|doubly labeled water|doubly labeled water
690722|NCT00929630|fibrin glue|fibrin glue
690723|NCT00929630|transsphincteric anal fistulas|transsphincteric anal fistulas
690724|NCT00929630|seton|seton
690725|NCT00929630|incontinence|incontinence
690726|NCT00929630|prospective randomised trial|prospective randomised trial
690727|NCT00929643|health care costs|health care costs
690728|NCT00929643|Intra-Abdominal Infection|intra-abdominal infection
690729|NCT00929656|Rehabilitation|rehabilitation
690730|NCT00929656|Neurophysiology|neurophysiology
690731|NCT00929656|Upper Extremity|upper extremity
690732|NCT00929669|pituitary tumor|pituitary tumor
690733|NCT00929669|endocrine|endocrine
690734|NCT00929682|Labor|labor
690735|NCT00929682|Epidural analgesia|epidural analgesia
690736|NCT00929682|Local anesthetics|local anesthetics
690737|NCT00929682|Levobupivacaine|levobupivacaine
690738|NCT00929682|Opiates|opiates
690739|NCT00929682|Patient-controlled|patient-controlled
690740|NCT00929682|Active spontaneous labor requiring epidural analgesia|active spontaneous labor requiring epidural analgesia
690741|NCT00929708|COPD|copd
690742|NCT00929708|Efficacy|efficacy
690743|NCT00929708|Safety|safety
690744|NCT00929708|Inhalation|inhalation
690745|NCT00929721|CAP|cap
690746|NCT00929734|Inflammation|inflammation
690747|NCT00929734|Atherosclerosis|atherosclerosis
690748|NCT00929734|Hydroxymethylglutaryl-coenzyme A Reductase Inhibitors|hydroxymethylglutaryl-coenzyme a reductase inhibitors
690749|NCT00929747|Cataract|cataract
690750|NCT00929747|Toric|toric
690751|NCT00929747|IOL|iol
690752|NCT00929747|AcrySof, LRI|acrysof, lri
690753|NCT00929760|Chronic Kidney disease|chronic kidney disease
690754|NCT00929760|Nephrologists|nephrologists
690755|NCT00929760|Primary Care|primary care
690756|NCT00929760|Death|death
690757|NCT00929760|Renal Replacement Therapy|renal replacement therapy
690758|NCT00929760|Specialised renal care|specialised renal care
690759|NCT00929786|Plasma levels isoniazid rifampicin pyrazinamide|plasma levels isoniazid rifampicin pyrazinamide
690760|NCT00929812|obesity|obesity
690761|NCT00929812|food intake|food intake
690762|NCT00929812|glucagon|glucagon
690763|NCT00929812|ghrelin|ghrelin
690764|NCT00929812|glucose|glucose
690765|NCT00929812|insulin|insulin
690766|NCT00929825|Salivary stimulation|salivary stimulation
690767|NCT00929825|Transplantation of hematopoietic stem cells|transplantation of hematopoietic stem cells
690768|NCT00929825|Hyperboloid|hyperboloid
690769|NCT00929825|Transcutaneous Electrical Stimulation|transcutaneous electrical stimulation
690770|NCT00929838|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
690771|NCT00929838|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
690772|NCT00929838|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
690773|NCT00929838|African Americans|african americans
690774|NCT00929838|Blacks|blacks
690775|NCT00929838|Randomized Controlled Trial|randomized controlled trial
690776|NCT00929838|Controlled Clinical Trial|controlled clinical trial
690777|NCT00929838|Behavioral Research|behavioral research
690778|NCT00929838|Behavioral Medicine|behavioral medicine
690779|NCT00929890|Obesity|obesity
690780|NCT00929890|Exercise|exercise
690781|NCT00929890|Diet|diet
690782|NCT00929890|Lifestyle|lifestyle
690783|NCT00929890|Vascular reactivity|vascular reactivity
690784|NCT00929890|Body composition|body composition
690785|NCT00929890|Lipids|lipids
690786|NCT00929890|Glucose|glucose
690787|NCT00929890|Insulin resistance|insulin resistance
690788|NCT00929916|colonoscopy|colonoscopy
690789|NCT00929916|MoviPrep|moviprep
690790|NCT00929929|Aging|aging
690791|NCT00929929|Functionality|functionality
690792|NCT00929929|Sarcopenia|sarcopenia
690793|NCT00929929|Leucine|leucine
690794|NCT00929929|Progressive resistance exercise|progressive resistance exercise
690795|NCT00929942|lung transplantation|lung transplantation
690796|NCT00929942|bronchial stenosis|bronchial stenosis
690797|NCT00929942|biodegradable stent|biodegradable stent
690798|NCT00929955|Anti inflammatory|anti inflammatory
690799|NCT00929955|Schizophrenia|schizophrenia
690800|NCT00929955|Simvastatin|simvastatin
690801|NCT00929955|ondansetron|ondansetron
690802|NCT00929968|Allergic rhinitis,|allergic rhinitis,
690803|NCT00929968|atopic patients,|atopic patients,
691393|NCT00935779|Peritoneum|peritoneum
690804|NCT00929968|seasonal allergy,|seasonal allergy,
690805|NCT00929968|ragweed allergy|ragweed allergy
690806|NCT00929981|Contact Dermatitis|contact dermatitis
690807|NCT00929981|Allergic Dermatitis|allergic dermatitis
690808|NCT00929994|cardiac rehab|cardiac rehab
690809|NCT00930007|Luteinizing hormone|luteinizing hormone
690810|NCT00930007|Puberty|puberty
690811|NCT00930020|ischemic stroke recovery|ischemic stroke recovery
690812|NCT00930020|minocycline|minocycline
690813|NCT00930020|neuroprotection|neuroprotection
690814|NCT00930020|acute stroke|acute stroke
690815|NCT00930033|Nephrectomy,|nephrectomy,
690816|NCT00930033|metastatic renal cell carcinoma,|metastatic renal cell carcinoma,
690817|NCT00930033|sunitinib|sunitinib
690818|NCT00930046|ropivacaine|ropivacaine
690819|NCT00930046|pediatric|pediatric
690820|NCT00930046|children|children
690821|NCT00930046|continuous|continuous
690822|NCT00930046|wound|wound
690823|NCT00930046|catheter|catheter
690824|NCT00930046|infusion|infusion
690825|NCT00930046|pyeloplasty|pyeloplasty
690826|NCT00930059|Alzheimer's disease|alzheimer's disease
690827|NCT00930059|PF-04447943|pf-04447943
690828|NCT00930059|efficacy|efficacy
690829|NCT00930059|safety|safety
690830|NCT00930059|plasma concentrations|plasma concentrations
690831|NCT00930085|sepsis|sepsis
690832|NCT00930085|septic shock|septic shock
690930|NCT00930462|hood|hood
690833|NCT00930098|acute lymphoblastic leukemia|acute lymphoblastic leukemia
690834|NCT00930098|clolar|clolar
690835|NCT00930098|evoltra|evoltra
690836|NCT00930098|clofarabine|clofarabine
690837|NCT00930098|refractory/relapsed acute leukemia|refractory/relapsed acute leukemia
690838|NCT00930098|pediatric acute leukemia|pediatric acute leukemia
690839|NCT00930111|inpatient|inpatient
690840|NCT00930111|hospitalists|hospitalists
690841|NCT00930111|residency|residency
690842|NCT00930111|job satisfaction|job satisfaction
690843|NCT00930111|burnout, professional|burnout, professional
690844|NCT00930111|professional practice|professional practice
690845|NCT00930111|medical education|medical education
690846|NCT00930124|cleft lip and palate|cleft lip and palate
690847|NCT00930124|distraction osteogenesis|distraction osteogenesis
690848|NCT00930124|conventional orthognathic surgery|conventional orthognathic surgery
690849|NCT00930124|stability|stability
690850|NCT00930124|morbidity|morbidity
690851|NCT00930124|soft tissue changes|soft tissue changes
690852|NCT00930124|psychological adjustment|psychological adjustment
690853|NCT00930124|speech changes|speech changes
690854|NCT00930124|velopharyngeal function|velopharyngeal function
690855|NCT00930137|Cardiovascular disease|cardiovascular disease
690856|NCT00930137|Trans fatty acids|trans fatty acids
690857|NCT00930137|Ruminant|ruminant
690858|NCT00930137|Blood lipids|blood lipids
690859|NCT00930137|Lipoproteins|lipoproteins
690860|NCT00930137|Women|women
690861|NCT00930150|Schizoaffective Disorder|schizoaffective disorder
690862|NCT00930163|Adult Asthma|adult asthma
690863|NCT00930189|age related macular degeneration|age related macular degeneration
690864|NCT00930202|Traumatic Brain Injury|traumatic brain injury
690865|NCT00930202|Conivaptan|conivaptan
690866|NCT00930202|Vaprisol|vaprisol
690867|NCT00930202|Sodium|sodium
690868|NCT00930215|Healthy volunteer|healthy volunteer
690869|NCT00930215|Japanese males|japanese males
690870|NCT00930215|homo-EM|homo-em
690871|NCT00930215|Bioequivalence study|bioequivalence study
690872|NCT00930228|Luteinizing hormone|luteinizing hormone
690873|NCT00930228|Testosterone|testosterone
690874|NCT00930241|Lung Transplantation|lung transplantation
690875|NCT00930241|Tacrolimus|tacrolimus
690876|NCT00930241|Deterioration of graft function|deterioration of graft function
690877|NCT00930254|pediatric nursing|pediatric nursing
690878|NCT00930254|peripheral catheterization|peripheral catheterization
690879|NCT00930254|ultrasonics|ultrasonics
690880|NCT00930254|intravenous infusions|intravenous infusions
690881|NCT00930267|fever|fever
690882|NCT00930267|children|children
690883|NCT00930267|cancer|cancer
690884|NCT00930267|leukemia|leukemia
690885|NCT00930267|stem cell transplantation|stem cell transplantation
690886|NCT00930267|infections in pediatric cancer patients presenting with fever during or following chemotherapy.|infections in pediatric cancer patients presenting with fever during or following chemotherapy.
690887|NCT00930280|stroke|stroke
690888|NCT00930280|brain attack|brain attack
690889|NCT00930280|hemorrhagic stroke|hemorrhagic stroke
690890|NCT00930280|risk factors|risk factors
690891|NCT00930293|Interpersonal Psychotherapy|interpersonal psychotherapy
690892|NCT00930306|Chronic Pain|chronic pain
690893|NCT00930306|AZD2066|azd2066
690894|NCT00930332|sleep disorders|sleep disorders
690895|NCT00930332|nausea and vomiting|nausea and vomiting
690896|NCT00930332|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
690897|NCT00930332|pain|pain
690898|NCT00930345|Renal cell carcinoma|renal cell carcinoma
690899|NCT00930345|Antiangiogenics|antiangiogenics
690900|NCT00930345|Biomarkers|biomarkers
690901|NCT00930345|Imagery|imagery
690902|NCT00930358|Sedation|sedation
690903|NCT00930358|Colonoscopy|colonoscopy
690904|NCT00930358|General anesthesia|general anesthesia
690905|NCT00930371|fatty liver|fatty liver
690906|NCT00930371|insulin resistance|insulin resistance
690908|NCT00930371|inflammation|inflammation
690909|NCT00930371|oxidative stress|oxidative stress
690910|NCT00930384|psoriasis|psoriasis
690911|NCT00930384|fatty liver|fatty liver
690912|NCT00930384|metabolic syndrome|metabolic syndrome
690913|NCT00930397|Pre-eclampsia|pre-eclampsia
690914|NCT00930397|UTERO-placental unit vascularization|utero-placental unit vascularization
690915|NCT00930397|Hypertension, pregnancy- induced|hypertension, pregnancy- induced
690916|NCT00930397|IUGR|iugr
690917|NCT00930397|Screening|screening
690918|NCT00930397|3D Doppler Ultrasound|3d doppler ultrasound
690919|NCT00930410|pancreas neoplasms|pancreas neoplasms
690920|NCT00930410|bile duct diseases|bile duct diseases
690921|NCT00930410|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
690922|NCT00930410|ERCP|ercp
690923|NCT00930436|chronic kidney disease|chronic kidney disease
690924|NCT00930449|Pediatrics|pediatrics
690925|NCT00930449|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
690926|NCT00930449|Learning Disorder|learning disorder
690927|NCT00930449|Computerized Working Memory Training Program|computerized working memory training program
690928|NCT00930462|colonoscopy|colonoscopy
690929|NCT00930462|cap|cap
690931|NCT00930462|cecal intubation time|cecal intubation time
690932|NCT00930462|polyp detection rate|polyp detection rate
690933|NCT00930462|performance|performance
690934|NCT00930488|Moxifloxacin|moxifloxacin
690936|NCT00930488|Avelox|avelox
690937|NCT00930488|Sinusitis|sinusitis
690938|NCT00930488|Acute bacterial sinusitis, ABS|acute bacterial sinusitis, abs
690939|NCT00930501|chemotherapy|chemotherapy
690940|NCT00930501|cancer|cancer
690941|NCT00930501|AMH|amh
690942|NCT00930501|gonadotoxicity|gonadotoxicity
690943|NCT00930501|ovarian reserve|ovarian reserve
690944|NCT00930501|patients exposed to chemotherapy|patients exposed to chemotherapy
690945|NCT00930553|Multiple Sclerosis|multiple sclerosis
690946|NCT00930566|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
690947|NCT00930566|Extracorporeal Photopheresis|extracorporeal photopheresis
690948|NCT00930592|Psoriasis|psoriasis
690949|NCT00930592|Metabolic Syndrome|metabolic syndrome
690950|NCT00930592|Cardiovascular Risk|cardiovascular risk
690951|NCT00930618|Prolonged pregnancy|prolonged pregnancy
690952|NCT00930618|Nulliparity|nulliparity
690953|NCT00930618|Cervical ripening|cervical ripening
690954|NCT00930618|Induced labor|induced labor
690955|NCT00930618|Cesarean section|cesarean section
690956|NCT00930631|CAD|cad
690957|NCT00930631|Pharmacokinetics|pharmacokinetics
690958|NCT00930631|BMS747158|bms747158
690959|NCT00930644|short bowel syndrome|short bowel syndrome
690960|NCT00930644|parenteral nutrition|parenteral nutrition
690961|NCT00930644|PN|pn
690962|NCT00930644|HPN|hpn
690963|NCT00930644|TPN|tpn
690964|NCT00930644|SBS|sbs
690965|NCT00930657|Panic Disorder|panic disorder
690966|NCT00930657|Separation Anxiety|separation anxiety
690967|NCT00930657|Familial|familial
690968|NCT00930657|Risk|risk
690969|NCT00930657|Respiratory Physiology|respiratory physiology
690970|NCT00930670|ranitidine|ranitidine
690971|NCT00930670|pantoprazole|pantoprazole
690972|NCT00930670|esomeprazole|esomeprazole
690973|NCT00930670|omeprazole|omeprazole
690974|NCT00930670|atorvastatin|atorvastatin
690975|NCT00930670|rosuvastatin|rosuvastatin
690976|NCT00930670|statin|statin
690977|NCT00930670|clopidogrel resistance|clopidogrel resistance
690978|NCT00930670|antiplatelet therapy|antiplatelet therapy
690979|NCT00930670|coronary artery disease|coronary artery disease
690980|NCT00930670|percutaneous coronary intervention|percutaneous coronary intervention
690981|NCT00930670|stent|stent
690982|NCT00930670|clopidogrel|clopidogrel
690983|NCT00930670|proton pump inhibitors|proton pump inhibitors
690984|NCT00930670|drug interactions|drug interactions
690985|NCT00930670|drug resistance|drug resistance
690986|NCT00930670|genetic polymorphism|genetic polymorphism
690987|NCT00930696|endometriosis|endometriosis
690988|NCT00930696|abdominal lavage|abdominal lavage
690989|NCT00930696|bowel perforation|bowel perforation
690990|NCT00930696|discoid resection|discoid resection
690991|NCT00930696|laparoscopy|laparoscopy
690992|NCT00930709|Botulinum Toxin Type A|botulinum toxin type a
690993|NCT00930709|Exercise|exercise
690994|NCT00930709|Randomized Controlled Trial|randomized controlled trial
690995|NCT00930709|Muscle Stretching Exercises|muscle stretching exercises
690996|NCT00930709|Strength Training|strength training
690997|NCT00930709|Treatment Outcome|treatment outcome
690998|NCT00930722|Quinapril non-interventional/observational study safety|quinapril non-interventional/observational study safety
690999|NCT00930761|breast feeding|breast feeding
691000|NCT00930761|music therapy|music therapy
691001|NCT00930761|maternal welfare|maternal welfare
691002|NCT00930761|infant, newborn|infant, newborn
691003|NCT00930774|traumatic brain injury|traumatic brain injury
691004|NCT00930774|rehabilitation|rehabilitation
691005|NCT00930774|auditory processing disorder|auditory processing disorder
691006|NCT00930787|hernia repair, surgical mesh, co-morbidities|hernia repair, surgical mesh, co-morbidities
691007|NCT00930800|Exercise capacity|exercise capacity
691008|NCT00930800|Physical activity|physical activity
691009|NCT00930800|Quality of life|quality of life
691010|NCT00930813|Drug coated balloon|drug coated balloon
691011|NCT00930813|SFA disease|sfa disease
691012|NCT00930813|Femoropopliteal disease|femoropopliteal disease
691013|NCT00930813|Angioplasty|angioplasty
691014|NCT00930813|PAD|pad
691015|NCT00930813|Paclitaxel|paclitaxel
691016|NCT00930813|Tubulin modulators|tubulin modulators
691017|NCT00930813|Antineoplastic Agents|antineoplastic agents
691018|NCT00930813|Mitosis Modulators|mitosis modulators
691019|NCT00930813|Balloon angioplasty|balloon angioplasty
691020|NCT00930813|Local drug delivery|local drug delivery
691021|NCT00930813|Restenosis|restenosis
691022|NCT00930813|Drug-coated balloon|drug-coated balloon
691023|NCT00930826|The effect of bronchial asthma on school performance|the effect of bronchial asthma on school performance
691024|NCT00930839|Niacin|niacin
691025|NCT00930839|Prostaglandin D2|prostaglandin d2
691026|NCT00930839|Flushing|flushing
691027|NCT00930839|Nicotinic acid stimulated release of prostaglandin D2|nicotinic acid stimulated release of prostaglandin d2
691028|NCT00930852|Migraine|migraine
691029|NCT00930852|Children|children
691030|NCT00930852|Primary headache disorders|primary headache disorders
691031|NCT00930852|Appetite|appetite
691033|NCT00930852|Feeding Behavior|feeding behavior
691034|NCT00930878|registry|registry
691035|NCT00930878|drug eluting coronary stent system|drug eluting coronary stent system
691036|NCT00930878|observational|observational
691037|NCT00930878|prospective|prospective
691038|NCT00930878|open-label|open-label
691039|NCT00930891|Extensive-Disease Small-Cell Lung Cancer|extensive-disease small-cell lung cancer
691040|NCT00930917|delivery room, polyethylene cap, preterm infant, temperature|delivery room, polyethylene cap, preterm infant, temperature
691041|NCT00930930|triple-negative breast cancer|triple-negative breast cancer
691042|NCT00930930|stage II breast cancer|stage ii breast cancer
691043|NCT00930930|stage IIIA breast cancer|stage iiia breast cancer
691044|NCT00930930|stage IIIB breast cancer|stage iiib breast cancer
691045|NCT00930930|stage IIIC breast cancer|stage iiic breast cancer
693339|NCT00935129|OmniPod|omnipod
691046|NCT00930930|male breast cancer|male breast cancer
691047|NCT00930943|opioid tolerant|opioid tolerant
691048|NCT00930943|chronic pain|chronic pain
691049|NCT00930956|Diabetes|diabetes
691050|NCT00930956|Obesity|obesity
691051|NCT00930956|Hyperglycemia|hyperglycemia
691052|NCT00930956|Dietary Fiber|dietary fiber
691053|NCT00930956|Wheat|wheat
691054|NCT00930956|Grain|grain
691055|NCT00930969|Cardiac Ischemia|cardiac ischemia
691056|NCT00930969|ST segment elevated Myocardial Infarction (STEMI)|st segment elevated myocardial infarction (stemi)
691057|NCT00930969|Non-ST Segment elevated Myocardial Infarction (NSTEMI)|non-st segment elevated myocardial infarction (nstemi)
691058|NCT00930969|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
691059|NCT00930969|Cardiac Electrogram (EGM)|cardiac electrogram (egm)
691060|NCT00930969|Coronary Artery Disease (CAD)|coronary artery disease (cad)
691061|NCT00930982|Ciprofloxacin|ciprofloxacin
691062|NCT00930982|Airway infection|airway infection
691063|NCT00930982|Bronchiectasis|bronchiectasis
691064|NCT00931008|Locally Advanced or Metastatic Non-Small Cell Lung Cancer|locally advanced or metastatic non-small cell lung cancer
691065|NCT00931034|South Beach Diet™|south beach diet™
691066|NCT00931034|overweight|overweight
691067|NCT00931034|obesity|obesity
691068|NCT00931034|satiety|satiety
691069|NCT00931034|weight loss|weight loss
691070|NCT00931034|diabetes|diabetes
691071|NCT00931060|Ammonia|ammonia
691072|NCT00931060|Citric acid cycle|citric acid cycle
691073|NCT00931060|Branched Chain Amino Acids|branched chain amino acids
691074|NCT00931073|Drug Interactions|drug interactions
691075|NCT00931073|pharmacokinetics|pharmacokinetics
691076|NCT00931073|CYP2D6|cyp2d6
691077|NCT00931073|CYP2C19|cyp2c19
691078|NCT00931073|ketoconazole|ketoconazole
691079|NCT00931073|omeprazole|omeprazole
691080|NCT00931086|Rheumatoid Arthritis|rheumatoid arthritis
691081|NCT00931086|RA|ra
691082|NCT00931099|pregnancy|pregnancy
691083|NCT00931099|sleep disordered breathing|sleep disordered breathing
691084|NCT00931099|obstructive sleep apnea|obstructive sleep apnea
691085|NCT00931112|Peripheral Arterial Disease|peripheral arterial disease
691086|NCT00931112|Walking ability|walking ability
691087|NCT00931112|Quality of life|quality of life
691088|NCT00931112|Exercise training|exercise training
691089|NCT00931125|Severe proliferative diabetic retinopathy|severe proliferative diabetic retinopathy
691090|NCT00931138|Acute Myeloid Leukemia in adults|acute myeloid leukemia in adults
691091|NCT00931138|Newly-diagnosed untreated AML|newly-diagnosed untreated aml
691092|NCT00931138|Patient aged 50 to 70 years|patient aged 50 to 70 years
691093|NCT00931164|phase I/II study|phase i/ii study
691094|NCT00931164|effects of sodium oxybate|effects of sodium oxybate
691191|NCT00931619|Epilepsy|epilepsy
691095|NCT00931164|cohort of 6 children and young adults|cohort of 6 children and young adults
691096|NCT00931164|AHC|ahc
691097|NCT00931216|PMTCT|pmtct
691594|NCT00936663|Sitagliptin|sitagliptin
691098|NCT00931216|Vertical transmission of HIV|vertical transmission of hiv
691099|NCT00931216|Pregnant women|pregnant women
691100|NCT00931216|Infant HIV testing|infant hiv testing
691101|NCT00931216|Kenya|kenya
691102|NCT00931216|AIDS|aids
752582|NCT01167777|NG|ng
691103|NCT00931229|hepatitis B reactivation|hepatitis b reactivation
691104|NCT00931242|eczema|eczema
691105|NCT00931242|dermatitis|dermatitis
691106|NCT00931242|TNF blockade|tnf blockade
691107|NCT00931242|PDE4 inhibitor|pde4 inhibitor
691108|NCT00931242|T cell inhibitor|t cell inhibitor
691109|NCT00931255|kidney transplant|kidney transplant
691110|NCT00931255|tacrolimus|tacrolimus
691111|NCT00931255|sirolimus|sirolimus
691112|NCT00931255|delayed graft function|delayed graft function
691113|NCT00931255|Graft survival|graft survival
691114|NCT00931255|Acute rejection|acute rejection
691115|NCT00931255|Chronic allograft nephropathy|chronic allograft nephropathy
691116|NCT00931268|Lipoatrophy|lipoatrophy
691117|NCT00931268|Buttock treatment|buttock treatment
691118|NCT00931281|Multiple Ascending Doses|multiple ascending doses
691119|NCT00931320|Ratio improvement|ratio improvement
691120|NCT00931320|LDL-C|ldl-c
691121|NCT00931320|HDL-C|hdl-c
691122|NCT00931320|Ratio of Low Density Lipoprotein Cholesterol to High Density Lipoprotein Cholesterol Improvement|ratio of low density lipoprotein cholesterol to high density lipoprotein cholesterol improvement
691123|NCT00931320|High Density Lipoprotein Cholesterol|high density lipoprotein cholesterol
691124|NCT00931333|Vertebroplasty|vertebroplasty
691125|NCT00931333|spine|spine
691126|NCT00931333|vertebra height|vertebra height
691127|NCT00931333|adverse events|adverse events
691128|NCT00931333|calcium phosphate bone cement|calcium phosphate bone cement
691129|NCT00931346|HIV|hiv
691130|NCT00931346|Human Immunodeficiency Virus|human immunodeficiency virus
691131|NCT00931359|axillary|axillary
691132|NCT00931359|hyperhidrosis|hyperhidrosis
691133|NCT00931359|primary focal|primary focal
691134|NCT00931372|Insulin release|insulin release
691135|NCT00931372|Diabetes mellitus type 2|diabetes mellitus type 2
691136|NCT00931372|GLP-1 agonist|glp-1 agonist
691137|NCT00931411|Atopic Dermatitis|atopic dermatitis
691138|NCT00931411|Vitamin B3|vitamin b3
691139|NCT00931424|Primary Chronic Venous Insufficiency|primary chronic venous insufficiency
691140|NCT00931424|surgery|surgery
691141|NCT00931424|reconstruction|reconstruction
691142|NCT00931424|valve|valve
691143|NCT00931437|vitamin K|vitamin k
691144|NCT00931437|Bio-availability|bio-availability
691145|NCT00931450|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
691146|NCT00931450|HER2-negative breast cancer|her2-negative breast cancer
691147|NCT00931450|stage IA breast cancer|stage ia breast cancer
691148|NCT00931450|stage IB breast cancer|stage ib breast cancer
691149|NCT00931450|stage II breast cancer|stage ii breast cancer
691150|NCT00931450|stage IIIA breast cancer|stage iiia breast cancer
691151|NCT00931450|stage IIIB breast cancer|stage iiib breast cancer
691152|NCT00931463|second line therapy|second line therapy
691153|NCT00931463|combination antiretroviral therapy|combination antiretroviral therapy
691154|NCT00931463|first-line failure|first-line failure
691155|NCT00931463|AIDS|aids
691156|NCT00931463|treatment experienced|treatment experienced
691157|NCT00931489|Age Related Macular Degeneration|age related macular degeneration
691158|NCT00931489|Lucentis|lucentis
691159|NCT00931489|Ranibizumab|ranibizumab
691160|NCT00931489|Antibodies|antibodies
691161|NCT00931489|Retinal and RPE Autoimmunity|retinal and rpe autoimmunity
691162|NCT00931502|Stent thrombosis|stent thrombosis
691163|NCT00931502|Acute Coronary Syndrome|acute coronary syndrome
691164|NCT00931502|ACS|acs
691165|NCT00931502|Stenting|stenting
691166|NCT00931502|Interventional Cardiology|interventional cardiology
691167|NCT00931502|Cardiology|cardiology
691168|NCT00931502|Cardiovascular Research|cardiovascular research
691169|NCT00931502|Registry|registry
691170|NCT00931515|DDD|ddd
691171|NCT00931528|sexual dysfunction|sexual dysfunction
691172|NCT00931528|stage IIB prostate cancer|stage iib prostate cancer
691173|NCT00931528|stage IIA prostate cancer|stage iia prostate cancer
691174|NCT00931528|adenocarcinoma of the prostate|adenocarcinoma of the prostate
691175|NCT00931541|Safety|safety
691176|NCT00931541|Tolerability|tolerability
691177|NCT00931541|Healthy|healthy
691178|NCT00931580|Vitamin D|vitamin d
691179|NCT00931580|Adolescent|adolescent
691180|NCT00931580|African American|african american
691181|NCT00931580|White|white
691182|NCT00931593|Transient lower esophageal sphincter relaxation|transient lower esophageal sphincter relaxation
691183|NCT00931593|high resolution manometry|high resolution manometry
691184|NCT00931593|dentsleeve probe|dentsleeve probe
691185|NCT00931593|healthy volunteers|healthy volunteers
691186|NCT00931606|anemia|anemia
691187|NCT00931606|metastatic|metastatic
691188|NCT00931606|breast|breast
691189|NCT00931606|cancer|cancer
691190|NCT00931619|Fluorine-18 Fluorodeoxyglucose|fluorine-18 fluorodeoxyglucose
691192|NCT00931619|Epileptic Focus|epileptic focus
691193|NCT00931619|Temporal Lobe Epilepsy|temporal lobe epilepsy
691194|NCT00931619|Depression|depression
691595|NCT00936676|parkinson's|parkinson's
691195|NCT00931619|Major Depressive Disorder|major depressive disorder
691196|NCT00931619|Healthy Volunteer|healthy volunteer
691198|NCT00931632|Bronchopulmonary Dysplasia, BPD|bronchopulmonary dysplasia, bpd
691199|NCT00931645|Chronic lymphocytic leukemia,|chronic lymphocytic leukemia,
691200|NCT00931645|autologous stem cell transplantation|autologous stem cell transplantation
691201|NCT00931671|Physical fitness|physical fitness
691202|NCT00931671|Cerebral circulation|cerebral circulation
691203|NCT00931671|Walking|walking
691204|NCT00931697|Mefloquine|mefloquine
691205|NCT00931697|Malaria|malaria
691206|NCT00931697|(+) Mefloquine|(+) mefloquine
691207|NCT00931697|Pharmacokinetics|pharmacokinetics
691208|NCT00931710|Hypertension|hypertension
691209|NCT00931710|combination therapy|combination therapy
691210|NCT00931710|valsartan|valsartan
691211|NCT00931710|cardiovascular diseases|cardiovascular diseases
691212|NCT00931723|Acute Mania|acute mania
691213|NCT00931723|Mania, Adults|mania, adults
691214|NCT00931723|Seroquel|seroquel
691215|NCT00931723|Acute Mania in Adult Patients|acute mania in adult patients
691216|NCT00931736|Tuberculosis|tuberculosis
691217|NCT00931749|ultrasound therapy|ultrasound therapy
691218|NCT00931749|knee cartilage thickness|knee cartilage thickness
691219|NCT00931749|knee cartilage volume|knee cartilage volume
691220|NCT00931749|mild knee osteoarthritis|mild knee osteoarthritis
691221|NCT00931749|moderate knee osteoarthritis|moderate knee osteoarthritis
691222|NCT00931762|Bone marrow|bone marrow
691223|NCT00931762|Myelofibrosis|myelofibrosis
691224|NCT00931762|JAK2mutation|jak2mutation
691225|NCT00931762|Post-Polycythemia Vera|post-polycythemia vera
691226|NCT00931762|Post-Essential Thrombocytopenia|post-essential thrombocytopenia
691227|NCT00931775|Major depressive disorder, citalopram, pindolol, HDRS|major depressive disorder, citalopram, pindolol, hdrs
691228|NCT00931788|Management of hypertension and cholesterol|management of hypertension and cholesterol
691229|NCT00931788|stroke|stroke
691230|NCT00931788|TIA|tia
691231|NCT00931801|AIDS|aids
691232|NCT00931801|HIV|hiv
691233|NCT00931801|Atazanavir|atazanavir
691234|NCT00931801|Raltegravir|raltegravir
691236|NCT00931801|protease inhibitors|protease inhibitors
691237|NCT00931814|Depression|depression
691238|NCT00931814|physical function|physical function
691239|NCT00931814|Quality of life|quality of life
691240|NCT00931827|Contraception|contraception
691241|NCT00931840|EZN-2208 (PEG-SN38)|ezn-2208 (peg-sn38)
691242|NCT00925977|treatment satisfaction|treatment satisfaction
691243|NCT00925977|insulin Glargine|insulin glargine
691244|NCT00925977|insulin Apidra|insulin apidra
691245|NCT00925977|NPH insulin|nph insulin
691246|NCT00925990|HCV|hcv
691247|NCT00925990|interferon-naive|interferon-naive
691248|NCT00926003|HIV|hiv
691249|NCT00926003|Children|children
691250|NCT00926003|Africa|africa
691251|NCT00926003|Neuropsychology|neuropsychology
691252|NCT00926003|cognitive rehabilitation|cognitive rehabilitation
691253|NCT00926003|computers|computers
691254|NCT00926016|Hepatitis C|hepatitis c
691255|NCT00926042|Healthy|healthy
691256|NCT00926042|volunteer|volunteer
691257|NCT00926042|Healthy controls|healthy controls
691258|NCT00926042|Normal controls|normal controls
691259|NCT00926055|high risk patients in atherosclerosis|high risk patients in atherosclerosis
691260|NCT00926068|Diabetes Mellitus|diabetes mellitus
691261|NCT00926068|Foot Ulcer|foot ulcer
691262|NCT00926068|DFU|dfu
691263|NCT00926068|Wound healing|wound healing
691264|NCT00926081|Peripheral Artery Disease|peripheral artery disease
691265|NCT00926081|Quality of Life|quality of life
691266|NCT00926081|Outcome|outcome
691267|NCT00926081|Endothelial Progenitor Cells|endothelial progenitor cells
691268|NCT00926081|Microcirculation|microcirculation
691269|NCT00926120|Chronic Hepatitis C|chronic hepatitis c
691270|NCT00926146|Hepatitis B and C|hepatitis b and c
691271|NCT00926146|HIV|hiv
691272|NCT00926146|nurse case management|nurse case management
691273|NCT00926146|HIV seronegativity|hiv seronegativity
691274|NCT00926159|Cardiomyopathies|cardiomyopathies
691275|NCT00931866|diclofenac|diclofenac
691276|NCT00931866|acute pain|acute pain
691277|NCT00931866|topical|topical
691278|NCT00931866|patch|patch
691279|NCT00931866|Acute Pain due to Mild to Moderate Soft Tissue Injury|acute pain due to mild to moderate soft tissue injury
691280|NCT00931892|celiac disease|celiac disease
691281|NCT00931892|gluten challenge|gluten challenge
691282|NCT00931905|This study included workers exposed to lead.|this study included workers exposed to lead.
691283|NCT00931944|ALS|als
691284|NCT00931944|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
691285|NCT00931944|Lou Gehrig|lou gehrig
691286|NCT00931944|Lou Gehrig's|lou gehrig's
691287|NCT00931944|Lou Gehrig's disease|lou gehrig's disease
691288|NCT00931944|Motor Neuron Disease|motor neuron disease
691289|NCT00931944|Nervous System Diseases|nervous system diseases
691290|NCT00931944|KNS-760704|kns-760704
691291|NCT00931944|RTPB|rtpb
691292|NCT00931957|Etanercept|etanercept
691293|NCT00931957|Behcet's syndrome|behcet's syndrome
691294|NCT00931957|Behcet's Disease|behcet's disease
691295|NCT00931957|Ocular Lesions|ocular lesions
691297|NCT00931957|Retinal Vasculitis|retinal vasculitis
691298|NCT00931970|Hemodialysis|hemodialysis
691299|NCT00931970|Peritoneal dialysis|peritoneal dialysis
691300|NCT00931970|Mortality|mortality
691301|NCT00931970|Prospective cohort|prospective cohort
691302|NCT00931970|Clinical study|clinical study
691303|NCT00931983|Incomplete spinal cord injuries|incomplete spinal cord injuries
691304|NCT00931983|Walking|walking
691305|NCT00931983|Treadmill|treadmill
691306|NCT00931983|Training|training
691307|NCT00931996|schizophrenia|schizophrenia
691308|NCT00931996|antipsychotic|antipsychotic
691309|NCT00931996|risperidone|risperidone
691310|NCT00932009|Human papillomavirus infection|human papillomavirus infection
691311|NCT00932009|Tanzanian men|tanzanian men
691312|NCT00932009|Prevalence|prevalence
691313|NCT00932035|breast cancer|breast cancer
691314|NCT00932035|axillary mapping|axillary mapping
691315|NCT00932035|lymphedema|lymphedema
691316|NCT00932048|Diabetes Mellitus|diabetes mellitus
691317|NCT00932048|Statins|statins
691318|NCT00932048|PET|pet
691319|NCT00932061|Fibromyalgia|fibromyalgia
691320|NCT00932061|Healthy controls|healthy controls
691321|NCT00932061|Acupuncture|acupuncture
691322|NCT00932061|Sham Acupuncture|sham acupuncture
691323|NCT00932061|fMRI|fmri
691616|NCT00936741|Ectopic|ectopic
691324|NCT00932061|Biological marker|biological marker
691325|NCT00932074|Atopic Dermatitis|atopic dermatitis
691326|NCT00932087|Platelet function|platelet function
691327|NCT00932087|diabetes|diabetes
691328|NCT00932087|metabolic syndrome|metabolic syndrome
691329|NCT00932100|ACS|acs
691330|NCT00932100|Acute Coronary Syndrome|acute coronary syndrome
691331|NCT00932100|Catheterization|catheterization
691332|NCT00932113|tumor necrosis factor (TNF) inhibitor|tumor necrosis factor (tnf) inhibitor
691333|NCT00932113|tumor necrosis factor (TNF) blockade|tumor necrosis factor (tnf) blockade
691334|NCT00932113|Methotrexate|methotrexate
691335|NCT00932113|treatment|treatment
691336|NCT00932113|mechanism|mechanism
691337|NCT00932113|psoriasis|psoriasis
691338|NCT00932126|Phase 1 dose escalation dose finding pharmacokinetic and pharmacodynamic study|phase 1 dose escalation dose finding pharmacokinetic and pharmacodynamic study
691339|NCT00932139|Hypertension|hypertension
691340|NCT00932139|blood pressure|blood pressure
691341|NCT00932139|arrhythmias|arrhythmias
691342|NCT00932139|mild to moderate hypertension (145-199/90-110)|mild to moderate hypertension (145-199/90-110)
691343|NCT00932152|advanced non-small cell lung cancer|advanced non-small cell lung cancer
691344|NCT00932152|postmenopausal|postmenopausal
691345|NCT00932152|bevacizumab|bevacizumab
691346|NCT00932152|fulvestrant|fulvestrant
691347|NCT00932152|anastrozole|anastrozole
691348|NCT00932178|Anxiety|anxiety
691349|NCT00932178|Worry|worry
691350|NCT00932178|nervousness|nervousness
691351|NCT00932178|Older Adult|older adult
691352|NCT00932191|Cataract|cataract
691353|NCT00932191|Corneal endothelial cell loss|corneal endothelial cell loss
691354|NCT00932191|Ultrasound power|ultrasound power
691355|NCT00932191|Corneal endothelium|corneal endothelium
691356|NCT00935623|Malaria, Plasmodium vivax|malaria, plasmodium vivax
691357|NCT00935636|Intubation|intubation
691358|NCT00935649|Toenail Fungus|toenail fungus
691359|NCT00935649|PinPointe|pinpointe
691360|NCT00935649|FootLaser|footlaser
691361|NCT00935649|Onychomycosis|onychomycosis
691362|NCT00935649|Fungal nails|fungal nails
691363|NCT00935662|First time in man|first time in man
691364|NCT00935662|Safety study|safety study
691365|NCT00935662|AZD8329|azd8329
691366|NCT00935675|Patients with head and neck squamous cell carcinomas|patients with head and neck squamous cell carcinomas
691367|NCT00935675|head and neck squamous cell carcinomas|head and neck squamous cell carcinomas
691368|NCT00935688|malaria|malaria
691369|NCT00935688|rapid diagnostic tests|rapid diagnostic tests
691370|NCT00935688|afghanistan|afghanistan
691371|NCT00935688|Non-specific fever|non-specific fever
691372|NCT00935701|Autism Spectrum Disorder|autism spectrum disorder
691373|NCT00935701|Acupressure|acupressure
691374|NCT00935701|Acupuncture|acupuncture
691375|NCT00935714|Arm|arm
691376|NCT00935714|Lymphedema|lymphedema
691377|NCT00935714|Breast Cancer|breast cancer
691378|NCT00935714|Exercise|exercise
691379|NCT00935714|Breast Cancer related Lymphedema|breast cancer related lymphedema
691380|NCT00935727|renal transplant|renal transplant
691381|NCT00935727|ultrasound|ultrasound
691382|NCT00935727|elastography|elastography
691383|NCT00935740|thromboembolic disease|thromboembolic disease
691384|NCT00935740|thromboplastin|thromboplastin
691385|NCT00935740|hypercoagulability|hypercoagulability
691386|NCT00935740|congestive heart failure|congestive heart failure
691387|NCT00935753|Lesch-Nyhan Disease|lesch-nyhan disease
691388|NCT00935753|self-mutilating behavior|self-mutilating behavior
691389|NCT00935766|Latinos Using Cardio Health Actions to Reduce Risk|latinos using cardio health actions to reduce risk
691390|NCT00935766|Omega three Fatty Acids|omega three fatty acids
691391|NCT00935766|Vascular Function and Inflammation|vascular function and inflammation
691392|NCT00935779|Stomach Neoplasms|stomach neoplasms
691394|NCT00935792|hematopoietic cancer|hematopoietic cancer
691395|NCT00935792|lymphoid cancer|lymphoid cancer
691396|NCT00935805|Diabetes Mellitus|diabetes mellitus
691397|NCT00935805|Arterial Hypertension|arterial hypertension
691398|NCT00935805|Treatment|treatment
691399|NCT00935805|Primary Care|primary care
691400|NCT00935818|smoking|smoking
691401|NCT00935818|nicotine|nicotine
691402|NCT00935818|tobacco|tobacco
691403|NCT00935818|dependence|dependence
691404|NCT00935818|cessation|cessation
691405|NCT00935818|abstinence|abstinence
691406|NCT00935831|Tolerability|tolerability
691407|NCT00935831|Safety|safety
691408|NCT00935831|Pharmacokinetics|pharmacokinetics
691409|NCT00935831|Pharmacodynamics|pharmacodynamics
691410|NCT00935844|Advanced solid tumors|advanced solid tumors
691411|NCT00935844|Lymphoma|lymphoma
691412|NCT00935857|Balloon Enteroscopy|balloon enteroscopy
691413|NCT00935857|Looping|looping
691414|NCT00935883|Age Related macular Degeneration|age related macular degeneration
691415|NCT00935883|Macular Degeneration|macular degeneration
691416|NCT00935883|Drusen|drusen
691417|NCT00935883|Geographic atrophy|geographic atrophy
691418|NCT00935883|Eculizumab|eculizumab
691419|NCT00935883|Soliris|soliris
691420|NCT00935896|Ventilator-associated lung injury|ventilator-associated lung injury
691421|NCT00935896|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
691422|NCT00935896|Interleukin-8|interleukin-8
691423|NCT00935896|Mechanical ventilation|mechanical ventilation
691424|NCT00935896|Low tidal volume ventilation|low tidal volume ventilation
691425|NCT00935896|Normal lungs|normal lungs
691426|NCT00935909|IV cannulation|iv cannulation
691427|NCT00935922|Flaxseed|flaxseed
691428|NCT00935922|Weight loss|weight loss
691429|NCT00935922|Heart health|heart health
691430|NCT00935922|Diabetes|diabetes
691431|NCT00935935|Treatment experienced|treatment experienced
691432|NCT00935948|hemorrhoids|hemorrhoids
691433|NCT00935948|hemorrhoidal disease|hemorrhoidal disease
691434|NCT00935948|water smartweed|water smartweed
691435|NCT00935948|hamamelis|hamamelis
691437|NCT00935961|CISPLATIN|cisplatin
691438|NCT00935961|RAD001|rad001
691439|NCT00935961|TAXOTERE (DOCETAXEL)|taxotere (docetaxel)
691440|NCT00935961|09-028|09-028
691441|NCT00935961|Squamous Cell Carcinoma|squamous cell carcinoma
691442|NCT00935961|Local-Regional Advanced Head and Neck|local-regional advanced head and neck
691443|NCT00935987|Primary Myelofibrosis|primary myelofibrosis
691444|NCT00935987|Post-Polycythemia Vera|post-polycythemia vera
691445|NCT00935987|Post-Essential Thrombocythemia|post-essential thrombocythemia
691446|NCT00935987|CYT387|cyt387
691447|NCT00936000|alcohol abuse|alcohol abuse
691448|NCT00936000|alveolar capillary permeability|alveolar capillary permeability
691449|NCT00936013|novel influenza A(H1N1)|novel influenza a(h1n1)
691450|NCT00936013|chinese medicinal herbs|chinese medicinal herbs
691451|NCT00936052|glioblastomas|glioblastomas
691452|NCT00936052|GBM|gbm
691453|NCT00936052|gliosarcoma|gliosarcoma
691454|NCT00936052|blastoma|blastoma
691455|NCT00936052|sarcoma|sarcoma
691456|NCT00936065|Etanercept|etanercept
691457|NCT00936065|Acitretin|acitretin
691458|NCT00936065|Psoriasis|psoriasis
691459|NCT00936078|kidney transplantation|kidney transplantation
691460|NCT00936078|cohort study|cohort study
691461|NCT00936078|qualitative research|qualitative research
691462|NCT00936078|health services research|health services research
691463|NCT00936078|hypertension|hypertension
691464|NCT00936091|intestinal parasitic infections|intestinal parasitic infections
691465|NCT00936091|malnutrition|malnutrition
691466|NCT00936091|Anemia|anemia
691467|NCT00936104|pancreas|pancreas
691468|NCT00936104|cancer|cancer
691469|NCT00936104|stem cell|stem cell
691470|NCT00936117|Cancer of the Blood|cancer of the blood
691471|NCT00936117|Cancer of Bone Marrow|cancer of bone marrow
691472|NCT00936117|Acute Leukemia|acute leukemia
691473|NCT00936117|AML|aml
691474|NCT00936117|Fungal infection|fungal infection
691475|NCT00936117|Prophylaxis|prophylaxis
691476|NCT00936117|Posaconazole|posaconazole
691477|NCT00936117|SCH 56592|sch 56592
691478|NCT00936117|Noxafil|noxafil
691479|NCT00936117|Chemotherapy|chemotherapy
691480|NCT00936130|Roux-en-Y gastric bypass surgery|roux-en-y gastric bypass surgery
691481|NCT00936130|Sleeve gastrectomy (SGx) surgery|sleeve gastrectomy (sgx) surgery
691482|NCT00936130|Gastric banding (GBx) surgery|gastric banding (gbx) surgery
691483|NCT00936130|Low calorie diet program|low calorie diet program
691484|NCT00936143|Spondylitis, Ankylosing|spondylitis, ankylosing
691485|NCT00936143|infliximab|infliximab
691486|NCT00936143|Antibodies, Monoclonal|antibodies, monoclonal
691487|NCT00936169|Patients with at least one complex lesion suitable for implantation of a drug-eluting stent|patients with at least one complex lesion suitable for implantation of a drug-eluting stent
691488|NCT00936195|HIV|hiv
691489|NCT00936195|pregnancy|pregnancy
691490|NCT00936195|breastfeeding|breastfeeding
691491|NCT00936195|PMTCT|pmtct
691492|NCT00936195|ARV treatment|arv treatment
691493|NCT00936195|treatment naive|treatment naive
691494|NCT00936221|BRAF mutation positive|braf mutation positive
691495|NCT00936221|advanced melanoma|advanced melanoma
691496|NCT00936221|Advanced cutaneous melanoma|advanced cutaneous melanoma
691497|NCT00936221|Unknown primary melanoma|unknown primary melanoma
691498|NCT00936234|CAD|cad
691499|NCT00936234|diabetes|diabetes
691500|NCT00936234|SDF-1|sdf-1
691501|NCT00936234|endothelial function|endothelial function
691502|NCT00936260|osteoporosis|osteoporosis
691503|NCT00936260|postmenopausal|postmenopausal
691504|NCT00936260|alendronate|alendronate
691505|NCT00936273|Sleep apnea syndrome|sleep apnea syndrome
691506|NCT00936273|SAS|sas
691507|NCT00936273|double loop gain|double loop gain
691508|NCT00936273|DLI|dli
691509|NCT00936273|double loop index|double loop index
691510|NCT00936273|periodic breathing|periodic breathing
691511|NCT00936273|polysomnography|polysomnography
691512|NCT00936286|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
691513|NCT00936286|Respiratory Muscle Training|respiratory muscle training
691514|NCT00936286|Normocapnic Hyperpnea|normocapnic hyperpnea
691515|NCT00936286|SpiroTiger|spirotiger
691516|NCT00936286|Polysomnography|polysomnography
691517|NCT00936299|Adolescents|adolescents
691518|NCT00936299|Substance Use Disorder|substance use disorder
691519|NCT00936299|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
691520|NCT00936299|Cognitive Behavioral Therapy|cognitive behavioral therapy
691521|NCT00936325|SCLS|scls
691522|NCT00936325|Systemic Capillary Leak Syndrome|systemic capillary leak syndrome
691523|NCT00936338|anterior disc displacement without reduction of temporomandibular disorders|anterior disc displacement without reduction of temporomandibular disorders
691524|NCT00936351|schizophrenia|schizophrenia
691525|NCT00936351|intervention studies|intervention studies
691526|NCT00936351|mindfulness meditation|mindfulness meditation
691527|NCT00936351|vocational rehabilitation|vocational rehabilitation
691528|NCT00936351|schizoaffective disorder|schizoaffective disorder
691529|NCT00936351|psychotic disorders|psychotic disorders
691530|NCT00936390|adenocarcinoma of the prostate|adenocarcinoma of the prostate
691531|NCT00936390|stage IIB prostate cancer|stage iib prostate cancer
691532|NCT00936390|stage IIA prostate cancer|stage iia prostate cancer
691533|NCT00936416|Glomerular Filtration Rate|glomerular filtration rate
691534|NCT00936416|Renal Blood Flow|renal blood flow
691535|NCT00936416|MRI|mri
691536|NCT00936416|Inulin|inulin
691537|NCT00936416|Para-Aminohippuric Acid|para-aminohippuric acid
691538|NCT00936429|Dengue fever|dengue fever
691539|NCT00936429|Dengue hemorrhagic fever|dengue hemorrhagic fever
691540|NCT00936429|Dengue shock syndrome|dengue shock syndrome
691541|NCT00936429|Vaccine|vaccine
691542|NCT00936429|Hawaii Biotech|hawaii biotech
691543|NCT00936442|Compliance|compliance
691544|NCT00936442|Early Breast Cancer|early breast cancer
691545|NCT00936455|telemedicine|telemedicine
691546|NCT00936455|telephone|telephone
691547|NCT00936455|outcomes|outcomes
691548|NCT00936468|Elderly influenza vaccine|elderly influenza vaccine
691549|NCT00936481|OSA|osa
691550|NCT00936494|obstructive sleep apnea|obstructive sleep apnea
691551|NCT00936494|sleep related breathing disorder|sleep related breathing disorder
691552|NCT00936494|snoring|snoring
691553|NCT00936494|disturbed sleeping|disturbed sleeping
691554|NCT00936494|open mouth breathing|open mouth breathing
691555|NCT00936494|upper airway resistance syndrome|upper airway resistance syndrome
691556|NCT00936507|energy density|energy density
691557|NCT00936507|portion size|portion size
691558|NCT00936507|child feeding|child feeding
691559|NCT00936520|Diabetic Macular Edema|diabetic macular edema
691560|NCT00936520|DME|dme
691561|NCT00936520|Pars Plana Vitrectomy|pars plana vitrectomy
691562|NCT00936520|Ocular Inflammation|ocular inflammation
691563|NCT00936559|rotator cuff tear repair|rotator cuff tear repair
691564|NCT00936559|open surgical technique|open surgical technique
691565|NCT00936559|safety|safety
691566|NCT00936572|Probiotics|probiotics
691567|NCT00936572|La1|la1
691568|NCT00936572|BB536|bb536
691569|NCT00936572|Colorectal surgery|colorectal surgery
691570|NCT00936572|Intestinal immunity|intestinal immunity
691571|NCT00936572|Dendritic cells|dendritic cells
691572|NCT00936572|Lymphocyte|lymphocyte
691573|NCT00936572|Microbiota|microbiota
691574|NCT00936585|Crohn's Disease|crohn's disease
691575|NCT00936585|Infusion|infusion
691576|NCT00936585|Anti IL-17 Monoclonal Antibody|anti il-17 monoclonal antibody
691577|NCT00936585|Placebo|placebo
691578|NCT00936585|Crohn Disease|crohn disease
691579|NCT00936585|Inflammatory Bowel Disease|inflammatory bowel disease
691580|NCT00936598|Sleep|sleep
691581|NCT00936598|Endometrial Neoplasms|endometrial neoplasms
691582|NCT00936598|Pain|pain
691583|NCT00936611|LBH589|lbh589
691584|NCT00936611|WM|wm
691585|NCT00936611|panobinostat|panobinostat
691586|NCT00936611|relapsed|relapsed
691587|NCT00936611|waldenstrom|waldenstrom
691588|NCT00936611|macroglobulinemia|macroglobulinemia
691589|NCT00936624|Persistent asthma|persistent asthma
691590|NCT00936650|Hyperparathyroidism, Primary|hyperparathyroidism, primary
691591|NCT00936650|cinacalcet|cinacalcet
691592|NCT00936663|Diabetes|diabetes
691593|NCT00936663|Kidney Transplant|kidney transplant
691596|NCT00936676|long-term effects|long-term effects
691597|NCT00936676|adagio|adagio
691598|NCT00936676|rasagiline|rasagiline
691599|NCT00936676|delayed start|delayed start
691600|NCT00936689|Hepatocellular carcinoma;|hepatocellular carcinoma;
691601|NCT00936689|Chemoembolization;|chemoembolization;
691602|NCT00936689|DC-Beads.|dc-beads.
691603|NCT00936702|Newly Diagnosed Carcinoma of Unknown Primary Origin|newly diagnosed carcinoma of unknown primary origin
691604|NCT00936702|Squamous Cell Carcinoma of Unknown Primary Origin|squamous cell carcinoma of unknown primary origin
691605|NCT00936702|Undifferentiated Carcinoma of Unknown Primary|undifferentiated carcinoma of unknown primary
691606|NCT00936702|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
691607|NCT00936715|prevention of chronic hepatitis B recurrence|prevention of chronic hepatitis b recurrence
691608|NCT00936715|post orthotopic liver transplant|post orthotopic liver transplant
691609|NCT00936715|prevention of chronic hepatitis B recurrence in patients who have undergone orthotopic liver transplant|prevention of chronic hepatitis b recurrence in patients who have undergone orthotopic liver transplant
691610|NCT00936741|Cushing's Disease|cushing's disease
691611|NCT00936741|Cushing's Syndrome|cushing's syndrome
691612|NCT00936741|Cushings|cushings
691613|NCT00936741|Pituitary|pituitary
691614|NCT00936741|ACTH|acth
691615|NCT00936741|Adrenocorticotropic hormone|adrenocorticotropic hormone
691617|NCT00936741|Adrenal adenoma|adrenal adenoma
691618|NCT00936741|Adrenal carcinoma|adrenal carcinoma
691619|NCT00936741|Adrenal autonomy|adrenal autonomy
691620|NCT00936741|Cortisol|cortisol
691621|NCT00936741|Hypercortisolemia|hypercortisolemia
691622|NCT00936741|Cushingoid|cushingoid
691623|NCT00936741|Moon facies|moon facies
691624|NCT00936741|Dorsocervical fat|dorsocervical fat
691625|NCT00936741|Plethora|plethora
691626|NCT00936741|Hirsutism|hirsutism
691627|NCT00936741|Violaceous striae|violaceous striae
691628|NCT00936741|Hormone|hormone
691629|NCT00936741|Contraceptive|contraceptive
691630|NCT00936741|Endocrine|endocrine
691631|NCT00936741|Cushing Syndrome|cushing syndrome
691632|NCT00936741|Ectopic ACTH Secretion|ectopic acth secretion
691633|NCT00936754|Glycemic index|glycemic index
691634|NCT00936754|Reduction of glycemic index of ingested foods|reduction of glycemic index of ingested foods
691635|NCT00936767|falciparum malaria|falciparum malaria
691636|NCT00936767|artemisone|artemisone
691637|NCT00936767|artesunate|artesunate
691638|NCT00936767|resistance|resistance
691639|NCT00936780|Coronary Artery Disease|coronary artery disease
691640|NCT00936780|Restenosis|restenosis
691641|NCT00936780|Stent thrombosis|stent thrombosis
691642|NCT00936780|Coronary stents|coronary stents
691643|NCT00936780|Angioplasty|angioplasty
691644|NCT00936780|Drug Eluting Stents (DES)|drug eluting stents (des)
691645|NCT00936793|Drug Interaction|drug interaction
691646|NCT00936793|Asthma|asthma
691647|NCT00936793|HIV|hiv
691648|NCT00936793|Beclomethasone|beclomethasone
691649|NCT00936793|Protease Inhibitors|protease inhibitors
691650|NCT00936793|HV|hv
691651|NCT00936793|Healthy Volunteer|healthy volunteer
691652|NCT00936793|HIV Infections|hiv infections
691653|NCT00936806|Intracranial tumor patients|intracranial tumor patients
691654|NCT00936819|Stent|stent
691655|NCT00936819|endothelial progenitor cells|endothelial progenitor cells
691656|NCT00936819|nitric oxide|nitric oxide
691657|NCT00936819|myocardial infarction|myocardial infarction
691658|NCT00936819|MRI|mri
691659|NCT00936832|stage IV rectal cancer|stage iv rectal cancer
691660|NCT00936832|adenocarcinoma of the rectum|adenocarcinoma of the rectum
691661|NCT00936832|liver metastases|liver metastases
691662|NCT00936832|lung metastases|lung metastases
691663|NCT00936858|radioiodine refractory thyroid cancer|radioiodine refractory thyroid cancer
691664|NCT00936858|RAD001|rad001
691665|NCT00936871|lersivirine QT QTc ECG HIV NNRTI|lersivirine qt qtc ecg hiv nnrti
691666|NCT00936884|Opioid Induced Constipation|opioid induced constipation
691667|NCT00936910|central line fungal infections|central line fungal infections
691668|NCT00936910|antifungal lock therapy|antifungal lock therapy
691669|NCT00936910|Ambisome lock therapy|ambisome lock therapy
691670|NCT00936923|CAPD|capd
691671|NCT00936923|Diuretics|diuretics
691672|NCT00936923|Residual Renal Function|residual renal function
691673|NCT00936923|furosemide|furosemide
691674|NCT00936936|Testis|testis
691675|NCT00936936|Relapsed Testicular Cancer|relapsed testicular cancer
691676|NCT00936936|Bevacizumab|bevacizumab
691677|NCT00936936|Avastin|avastin
691678|NCT00936936|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
691679|NCT00936936|rhuMAb-VEGF|rhumab-vegf
691680|NCT00936936|Carboplatin|carboplatin
691681|NCT00936936|Paraplatin|paraplatin
691682|NCT00936936|Docetaxel|docetaxel
691683|NCT00936936|Taxotere|taxotere
691684|NCT00936936|Etoposide|etoposide
691685|NCT00936936|VePesid|vepesid
691686|NCT00936936|Gemcitabine|gemcitabine
691687|NCT00936936|Gemcitabine Hydrochloride|gemcitabine hydrochloride
691688|NCT00936936|Gemzar|gemzar
691689|NCT00936936|Ifosfamide|ifosfamide
691690|NCT00936936|Ifex|ifex
691691|NCT00936936|Melphalan|melphalan
691692|NCT00936936|Alkeran|alkeran
691693|NCT00936949|total hip arthroplasty|total hip arthroplasty
691694|NCT00936949|posterolateral|posterolateral
691695|NCT00936949|modified lateral|modified lateral
691696|NCT00936962|Meningococcal C vaccine|meningococcal c vaccine
691697|NCT00936962|Meningitis study|meningitis study
691698|NCT00936962|Canadian vaccine schedule|canadian vaccine schedule
691699|NCT00936962|Prevention of Meningococcal C disease|prevention of meningococcal c disease
691700|NCT00936988|Hyperparathyroidism, Primary|hyperparathyroidism, primary
691701|NCT00936988|cinacalcet|cinacalcet
691702|NCT00937001|myopathy|myopathy
691703|NCT00937001|respiratory failure|respiratory failure
691704|NCT00937001|cognitive impairment|cognitive impairment
691705|NCT00937001|delirium|delirium
691706|NCT00937014|infant formula|infant formula
691707|NCT00937014|growth|growth
691708|NCT00937014|weight|weight
691709|NCT00937027|Antifolate|antifolate
691710|NCT00937027|Psoriasis|psoriasis
691711|NCT00937027|Antiinflammatory drug|antiinflammatory drug
691712|NCT00937027|Autoimmune disease|autoimmune disease
691713|NCT00937027|Treatment|treatment
691714|NCT00937040|Osmotic Release Oral System (OROS®) Extended Release Methylphenidate HCl|osmotic release oral system (oros®) extended release methylphenidate hcl
691715|NCT00937040|CONCERTA® (OROS MPH)|concerta® (oros mph)
691716|NCT00937053|Neutropenia|neutropenia
691717|NCT00937053|Transfusions|transfusions
691718|NCT00937053|Hemoglobin|hemoglobin
691719|NCT00937053|Bone marrow transplant|bone marrow transplant
691720|NCT00937053|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
691721|NCT00937066|Cost-effectiveness analysis|cost-effectiveness analysis
691722|NCT00937066|Symbicort|symbicort
691723|NCT00937079|Glucagon-like peptide-1 receptor targeting|glucagon-like peptide-1 receptor targeting
691724|NCT00937079|Insulinoma imaging|insulinoma imaging
691725|NCT00937079|Exendin-4|exendin-4
691726|NCT00937079|molecular imaging|molecular imaging
691727|NCT00937092|Heart Failure|heart failure
691728|NCT00937092|Dopamine|dopamine
691729|NCT00937092|Furosemide|furosemide
691730|NCT00937092|Worsening Renal Function|worsening renal function
691731|NCT00937092|Hypokalemia|hypokalemia
691732|NCT00937092|Outcomes|outcomes
691733|NCT00937092|Prognosis|prognosis
691734|NCT00937118|laparotomy|laparotomy
691735|NCT00937118|duodenal injury|duodenal injury
691736|NCT00937118|pancreatic injury|pancreatic injury
691737|NCT00937118|trauma|trauma
691738|NCT00937144|endothelial function|endothelial function
691739|NCT00937144|endothelial progenitor stem cells|endothelial progenitor stem cells
691740|NCT00937157|Inflammation|inflammation
691741|NCT00937157|Multiple Sclerosis|multiple sclerosis
691742|NCT00937157|Glatiramer Acetate|glatiramer acetate
691743|NCT00937157|Gd enhancing lesions|gd enhancing lesions
691744|NCT00937157|1.5T protocol|1.5t protocol
691745|NCT00937157|3T protocol|3t protocol
691746|NCT00937157|Magnetization transfer imaging (MTI)|magnetization transfer imaging (mti)
691747|NCT00937157|Lesion activity analysis|lesion activity analysis
691748|NCT00937157|Copaxone|copaxone
691749|NCT00937170|Total Knee Replacement|total knee replacement
691750|NCT00937170|Gender Specific Design|gender specific design
691751|NCT00937183|Waldenström macroglobulinemia|waldenström macroglobulinemia
691752|NCT00937183|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
691753|NCT00937183|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
691754|NCT00937183|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
691755|NCT00937183|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
691756|NCT00937183|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
691757|NCT00937183|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
691758|NCT00937183|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
691759|NCT00937183|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
691760|NCT00937183|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
691761|NCT00937183|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
691762|NCT00937183|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
691763|NCT00937183|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
691764|NCT00937183|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
691765|NCT00937183|stage I marginal zone lymphoma|stage i marginal zone lymphoma
691766|NCT00937183|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
691767|NCT00937183|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
691768|NCT00937183|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
691769|NCT00937183|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
691770|NCT00937183|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
691771|NCT00937183|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
691772|NCT00937183|stage I mantle cell lymphoma|stage i mantle cell lymphoma
691773|NCT00937183|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
691774|NCT00937183|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
691775|NCT00937183|stage I multiple myeloma|stage i multiple myeloma
691776|NCT00937183|stage II multiple myeloma|stage ii multiple myeloma
691777|NCT00937183|stage III multiple myeloma|stage iii multiple myeloma
691941|NCT00937716|schizophrenia|schizophrenia
691778|NCT00937183|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
691779|NCT00937183|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
691780|NCT00937183|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
691781|NCT00937183|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
691782|NCT00937222|diabetes|diabetes
691783|NCT00937222|cholesterol|cholesterol
691784|NCT00937222|peanuts|peanuts
691785|NCT00937222|peanut butter|peanut butter
691786|NCT00937222|dietary intervention|dietary intervention
691787|NCT00937222|HDL cholesterol|hdl cholesterol
691788|NCT00937235|Smoking Cessation|smoking cessation
691789|NCT00937235|Anxiety|anxiety
691790|NCT00937235|Behavior Therapy|behavior therapy
691791|NCT00937235|Varenicline|varenicline
691792|NCT00937248|Cone Beam CT in rectal cancer patients|cone beam ct in rectal cancer patients
691793|NCT00937248|Immobilizing rectal cancer patients|immobilizing rectal cancer patients
691794|NCT00937248|Image guided radiotherapy in rectal cancer patients|image guided radiotherapy in rectal cancer patients
691795|NCT00937274|ETEC EPEC diarrhoea|etec epec diarrhoea
691796|NCT00937274|phage therapy|phage therapy
691799|NCT00937287|African American|african american
691800|NCT00937287|Rural|rural
691801|NCT00937339|cerebrovascular accident|cerebrovascular accident
691802|NCT00937339|bone|bone
691803|NCT00937339|muscle|muscle
691804|NCT00937339|vibration|vibration
691805|NCT00937352|Mild to moderate Alzheimer's disease|mild to moderate alzheimer's disease
691806|NCT00937365|Pregnancy|pregnancy
691807|NCT00937365|Pain|pain
691808|NCT00937365|Low back pain|low back pain
691809|NCT00937365|Pubic symphysis pain|pubic symphysis pain
691810|NCT00937365|CAM|cam
691811|NCT00937365|Complementary & Alternative Medicine|complementary & alternative medicine
691812|NCT00937365|Exercise|exercise
691813|NCT00937365|Chiropractic|chiropractic
691814|NCT00937365|Spinal manipulation|spinal manipulation
691815|NCT00937365|Adjustments|adjustments
691816|NCT00937365|Neuroemotional technique|neuroemotional technique
691817|NCT00937365|Mind body|mind body
691818|NCT00937365|Mind body therapy|mind body therapy
691820|NCT00937365|Maternal Fetal relationship|maternal fetal relationship
691821|NCT00937365|Intrauterine attachment|intrauterine attachment
691822|NCT00937365|Heart rate variability|heart rate variability
691823|NCT00937365|VAS|vas
691824|NCT00937365|Visual analog scale|visual analog scale
691825|NCT00937365|Roland Morris Disability Index|roland morris disability index
691826|NCT00937391|MRI agents|mri agents
691827|NCT00937391|Magnevist|magnevist
691828|NCT00937404|IPV|ipv
691829|NCT00937417|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
691830|NCT00937417|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
691831|NCT00937417|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
691832|NCT00937417|stage IV breast cancer|stage iv breast cancer
691833|NCT00937417|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
691834|NCT00937417|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
691835|NCT00937417|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
691836|NCT00937417|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
691837|NCT00937417|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
691838|NCT00937417|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
691839|NCT00937417|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
691840|NCT00937417|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
691841|NCT00937417|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
691842|NCT00937417|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
691843|NCT00937417|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
691844|NCT00937417|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
691845|NCT00937417|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
691846|NCT00937417|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
691847|NCT00937417|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
691848|NCT00937417|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
691849|NCT00937417|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
691850|NCT00937417|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
691851|NCT00937417|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
691852|NCT00937417|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
691853|NCT00937417|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
691854|NCT00937417|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
691855|NCT00937417|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
691942|NCT00937716|treatment response|treatment response
691940|NCT00937690|imaging|imaging
692143|NCT00938184|tolerance|tolerance
691856|NCT00937417|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
691857|NCT00937417|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
691858|NCT00937417|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
691859|NCT00937417|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
752583|NCT01167777|chlamydia|chlamydia
691860|NCT00937417|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
691861|NCT00937417|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
691862|NCT00937417|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
691863|NCT00937417|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
691864|NCT00937417|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
691865|NCT00937417|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
691866|NCT00937417|recurrent salivary gland cancer|recurrent salivary gland cancer
691867|NCT00937417|stage IV salivary gland cancer|stage iv salivary gland cancer
691868|NCT00937417|anaplastic thyroid cancer|anaplastic thyroid cancer
693721|NCT00942084|Acyclovir|acyclovir
691869|NCT00937417|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
691870|NCT00937417|insular thyroid cancer|insular thyroid cancer
691871|NCT00937417|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
691872|NCT00937417|recurrent thyroid cancer|recurrent thyroid cancer
691873|NCT00937417|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
691874|NCT00937417|recurrent prostate cancer|recurrent prostate cancer
691875|NCT00937417|hormone-resistant prostate cancer|hormone-resistant prostate cancer
691876|NCT00937417|recurrent breast cancer|recurrent breast cancer
691877|NCT00937417|stage IV prostate cancer|stage iv prostate cancer
691878|NCT00937417|male breast cancer|male breast cancer
691879|NCT00937430|Pelvic organ prolapse|pelvic organ prolapse
691880|NCT00937430|Bowel preparation|bowel preparation
691881|NCT00937443|Physical Activity|physical activity
691882|NCT00937443|Cardiac Heart Failure|cardiac heart failure
691883|NCT00937443|Exercise Regimen|exercise regimen
691884|NCT00937443|Cardioreparative Factors|cardioreparative factors
691885|NCT00937456|Esophagus|esophagus
691886|NCT00937456|Cancer|cancer
691887|NCT00937456|Surgery|surgery
691888|NCT00937456|Laparoscopy|laparoscopy
691889|NCT00937456|Randomized trial|randomized trial
691890|NCT00937456|Esophageal cancer deemed to be resectable|esophageal cancer deemed to be resectable
691891|NCT00937469|Social skills training for children with ADHD|social skills training for children with adhd
691892|NCT00937469|Children with ADHD|children with adhd
691893|NCT00937508|smoking|smoking
691894|NCT00937508|quitting|quitting
691895|NCT00937508|varenicline|varenicline
691896|NCT00937508|preoperative|preoperative
691897|NCT00937508|long term abstinence|long term abstinence
691898|NCT00937521|Immunogenicity|immunogenicity
691899|NCT00937521|Meningitis|meningitis
691900|NCT00937521|Antibody|antibody
691901|NCT00937521|Infants|infants
691902|NCT00937534|Fimasartan|fimasartan
691903|NCT00937534|healthy elderly and young male volunteer|healthy elderly and young male volunteer
691904|NCT00937534|pharmacokinetic|pharmacokinetic
691905|NCT00937547|cervical cancer|cervical cancer
691906|NCT00937547|Human Papillomavirus Infection|human papillomavirus infection
691907|NCT00937573|stents|stents
691908|NCT00937573|mortality|mortality
691909|NCT00937573|revascularization|revascularization
691910|NCT00937573|stent thrombosis|stent thrombosis
691911|NCT00937573|Drug-Eluting Stents|drug-eluting stents
691912|NCT00937586|Metastatic Prostate Cancer|metastatic prostate cancer
691913|NCT00937586|Prostate Cancer Risk Assessment|prostate cancer risk assessment
691914|NCT00937599|obese|obese
691915|NCT00937599|brazil nuts|brazil nuts
691916|NCT00937599|oxidative stress|oxidative stress
691917|NCT00937599|microcirculatory|microcirculatory
691918|NCT00937599|metabolic profile|metabolic profile
691919|NCT00937612|Head and Neck Neoplasms|head and neck neoplasms
691920|NCT00937612|Chemotherapy|chemotherapy
691921|NCT00937612|Radiotherapy, Adjuvant|radiotherapy, adjuvant
691922|NCT00937612|Surgery|surgery
691923|NCT00937638|Metabolic syndrome|metabolic syndrome
691924|NCT00937638|Lean Beef|lean beef
691925|NCT00937638|CVD|cvd
691926|NCT00937651|Fimasartan|fimasartan
691927|NCT00937651|Essential Hypertension|essential hypertension
691928|NCT00937664|Phase I|phase i
691929|NCT00937664|cancer|cancer
691930|NCT00937664|solid tumors|solid tumors
691931|NCT00937664|advanced solid malignancies|advanced solid malignancies
691932|NCT00937664|dose escalation|dose escalation
691933|NCT00937664|combination treatment|combination treatment
691934|NCT00937664|CHK inhibitor|chk inhibitor
691935|NCT00937664|Japanese|japanese
691936|NCT00937677|Tysabri|tysabri
691937|NCT00937677|VWMTR|vwmtr
691938|NCT00937690|melanoma|melanoma
691939|NCT00937690|cutaneous|cutaneous
691944|NCT00937716|functional magnetic resonance|functional magnetic resonance
691945|NCT00937716|functional magnetic spectroscopy|functional magnetic spectroscopy
691946|NCT00937729|uncompliant patients with virological failure|uncompliant patients with virological failure
691947|NCT00937729|Treatment experienced|treatment experienced
691948|NCT00937742|cardiovascular disease|cardiovascular disease
693440|NCT00935545|CNS|cns
691949|NCT00937742|Lycopene|lycopene
691951|NCT00937755|schizophrenia|schizophrenia
691952|NCT00937755|antipsychotics|antipsychotics
691953|NCT00937755|glucose homeostasis|glucose homeostasis
691954|NCT00937755|metabolic disturbance|metabolic disturbance
691955|NCT00937781|stage III melanoma|stage iii melanoma
691956|NCT00937781|recurrent melanoma|recurrent melanoma
691957|NCT00937807|hemodynamic stability|hemodynamic stability
691958|NCT00937807|xenon|xenon
691959|NCT00937807|carotid surgery|carotid surgery
691960|NCT00937807|general anesthesia|general anesthesia
691961|NCT00937820|YM150|ym150
691962|NCT00937820|Bleeding|bleeding
691963|NCT00937820|VTE|vte
691964|NCT00937820|FXa inhibitor|fxa inhibitor
691965|NCT00937820|Venous thromboembolism|venous thromboembolism
691966|NCT00937833|prostate cancer|prostate cancer
691967|NCT00937833|prostatectomy|prostatectomy
691968|NCT00937833|incontinence|incontinence
691969|NCT00937846|Cognitive impairment|cognitive impairment
691970|NCT00937846|Schizophrenia|schizophrenia
691971|NCT00937846|Alzheimer's Disease|alzheimer's disease
691973|NCT00937885|Reminiscence|reminiscence
691974|NCT00937885|Nursing home staff|nursing home staff
691975|NCT00937885|Nursing home residents|nursing home residents
691976|NCT00937885|Elderly|elderly
691977|NCT00937898|lean beef|lean beef
691978|NCT00937898|cholesterol|cholesterol
691979|NCT00937898|lipids|lipids
691980|NCT00937898|diet intervention|diet intervention
691981|NCT00937911|YM150|ym150
691982|NCT00937911|Bleeding|bleeding
691983|NCT00937911|Anticoagulant|anticoagulant
691984|NCT00937911|Venous thromboembolism|venous thromboembolism
691985|NCT00937911|FXa inhibitor|fxa inhibitor
691987|NCT00937924|ERCP|ercp
691988|NCT00937924|Sedation Level|sedation level
691989|NCT00937924|Adverse Symptoms|adverse symptoms
691990|NCT00937924|Recovery time|recovery time
691991|NCT00937950|HPV|hpv
691992|NCT00937950|Papillomavirus|papillomavirus
691993|NCT00937950|Human papillomavirus|human papillomavirus
691994|NCT00937950|Cervical cancer|cervical cancer
691995|NCT00937950|HPV vaccine|hpv vaccine
691996|NCT00937963|cholesterol|cholesterol
691997|NCT00937963|cardiovascular|cardiovascular
691998|NCT00937963|CVD|cvd
691999|NCT00937963|Triglycerides|triglycerides
692000|NCT00937963|Heart|heart
692001|NCT00937976|Hemodialysis and peritoneal dialysis|hemodialysis and peritoneal dialysis
692002|NCT00937989|ductal breast carcinoma in situ|ductal breast carcinoma in situ
692003|NCT00937989|lobular breast carcinoma in situ|lobular breast carcinoma in situ
692004|NCT00937989|male breast cancer|male breast cancer
692005|NCT00937989|stage I breast cancer|stage i breast cancer
692006|NCT00937989|stage II breast cancer|stage ii breast cancer
692007|NCT00937989|stage IIIA breast cancer|stage iiia breast cancer
692008|NCT00937989|stage IIIB breast cancer|stage iiib breast cancer
692009|NCT00937989|stage IIIC breast cancer|stage iiic breast cancer
692010|NCT00938015|postmarketing surveillance|postmarketing surveillance
692011|NCT00938015|Enbrel|enbrel
692012|NCT00938015|psoriatic arthritis|psoriatic arthritis
692013|NCT00938028|microbiome|microbiome
692014|NCT00938028|metabolome|metabolome
692015|NCT00938028|stool|stool
692016|NCT00938028|fecal samples|fecal samples
692017|NCT00938028|handling|handling
692018|NCT00938028|toddler|toddler
692019|NCT00938054|Outcome|outcome
692020|NCT00938054|Autism|autism
692021|NCT00938054|Pervasive Developmental Disorder|pervasive developmental disorder
692022|NCT00938067|Injuries, Trauma|injuries, trauma
692023|NCT00929006|hyperandrogenemia|hyperandrogenemia
692024|NCT00929006|pubertal|pubertal
692025|NCT00929006|polycystic ovary syndrome|polycystic ovary syndrome
692026|NCT00929019|uveal melanoma|uveal melanoma
692027|NCT00929019|chromosome 3|chromosome 3
692028|NCT00929019|high risk|high risk
692029|NCT00929019|immunotherapy|immunotherapy
692030|NCT00929019|adjuvant|adjuvant
692031|NCT00929019|high risk genetic profile|high risk genetic profile
692032|NCT00929019|loss of chromosome 3|loss of chromosome 3
692033|NCT00929032|Liver Transplantation|liver transplantation
692034|NCT00929032|Immunosystem of the Liver|immunosystem of the liver
692035|NCT00929032|Marginal and Non-marginal grafts|marginal and non-marginal grafts
692036|NCT00929045|Growth Hormone replacement|growth hormone replacement
692037|NCT00929045|subject 8 to 21|subject 8 to 21
692038|NCT00929045|moderate to severe traumatic brain injury|moderate to severe traumatic brain injury
692039|NCT00929045|growth hormone deficient|growth hormone deficient
692040|NCT00929071|wrinkles|wrinkles
692041|NCT00929071|dermal filler|dermal filler
692042|NCT00929071|collagen|collagen
692043|NCT00929071|soft tissue augmentation|soft tissue augmentation
692044|NCT00929071|lidocaine|lidocaine
692046|NCT00929084|Race Disparities|race disparities
692047|NCT00929084|Breast Cancer|breast cancer
692048|NCT00929084|Quality of Life|quality of life
692049|NCT00929084|Treatment Adherence|treatment adherence
692050|NCT00929097|Colorectal Neoplasms, (Hereditary Nonpolyposis)|colorectal neoplasms, (hereditary nonpolyposis)
692051|NCT00929097|Guideline|guideline
692052|NCT00929097|Health Plan Implementation|health plan implementation
752584|NCT01167777|gonorrhoeae|gonorrhoeae
692053|NCT00929097|Decision Support Techniques|decision support techniques
692054|NCT00929097|Risk assessment|risk assessment
692055|NCT00929097|Familial colorectal cancer risk|familial colorectal cancer risk
692056|NCT00929097|Risk assessment tool|risk assessment tool
692057|NCT00929110|COPD|copd
692058|NCT00929110|NVA237|nva237
692059|NCT00929110|glycopyrronium bromide|glycopyrronium bromide
692060|NCT00929123|manual therapy|manual therapy
692061|NCT00929123|carpal tunnel syndrome|carpal tunnel syndrome
692062|NCT00929123|central sensitization|central sensitization
692063|NCT00929136|Endotoxin|endotoxin
692064|NCT00929136|Insulin resistance|insulin resistance
692065|NCT00929136|Lipolysis|lipolysis
692066|NCT00929136|Proteolysis|proteolysis
692067|NCT00929136|Intracellular Insulin Signaling|intracellular insulin signaling
692068|NCT00929136|Regional effects of inflammation/endotoxin|regional effects of inflammation/endotoxin
692069|NCT00929162|ovarian|ovarian
692070|NCT00929162|cancer|cancer
692071|NCT00929162|chemotherapy|chemotherapy
692072|NCT00929162|sensitive|sensitive
692073|NCT00929162|ZD4054|zd4054
692074|NCT00929175|Hypertension|hypertension
692075|NCT00929175|Resistant Hypertension|resistant hypertension
692076|NCT00929175|Sleep apnea syndrome|sleep apnea syndrome
692077|NCT00929175|Treatment|treatment
692078|NCT00929188|Moderate to severe chronic, cancer-related pain related to an active cancer|moderate to severe chronic, cancer-related pain related to an active cancer
692079|NCT00929188|Cancer-related pain|cancer-related pain
692080|NCT00929188|Moderate to severe chronic pain|moderate to severe chronic pain
692081|NCT00929188|JNJ-42160443|jnj-42160443
692082|NCT00929214|Breast Cancer|breast cancer
692083|NCT00929214|Metastasized|metastasized
692084|NCT00929214|Limited bone-only metastasis|limited bone-only metastasis
692085|NCT00929214|Local Therapy|local therapy
692086|NCT00929214|Radiation|radiation
692087|NCT00929214|Radiation Therapy|radiation therapy
692089|NCT00929214|Surgery|surgery
692090|NCT00929214|Standard Therapy|standard therapy
692091|NCT00929214|Chemotherapy|chemotherapy
692092|NCT00929214|Endocrine Therapy|endocrine therapy
692093|NCT00929227|Atherosclerosis|atherosclerosis
692094|NCT00929227|Myocardial Ischemia|myocardial ischemia
692095|NCT00929227|Diagnostic Testing|diagnostic testing
692220|NCT00938938|risk communication|risk communication
692096|NCT00929227|Cardiac Commuted Tomography|cardiac commuted tomography
692097|NCT00929227|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
692098|NCT00929227|Coronary Artery Disease|coronary artery disease
692099|NCT00929253|Opioid Dependence|opioid dependence
692100|NCT00929253|Opiates|opiates
692101|NCT00929253|Hydrocodone|hydrocodone
692102|NCT00929253|Oxycodone|oxycodone
692103|NCT00929253|Oxycontin|oxycontin
692104|NCT00929253|Narcotic Abuse|narcotic abuse
692105|NCT00929266|peripheral stem cells (PSC) donors|peripheral stem cells (psc) donors
692106|NCT00929266|cultured red blood cells|cultured red blood cells
692107|NCT00929266|In vivo half life|in vivo half life
692108|NCT00929279|Acute coronary syndrome|acute coronary syndrome
692109|NCT00929279|Abciximab|abciximab
692110|NCT00929279|Bolus|bolus
692111|NCT00929279|Infusion|infusion
692112|NCT00929279|platelet inhibition|platelet inhibition
692113|NCT00929279|Non ST segment elevation acute coronary syndrome|non st segment elevation acute coronary syndrome
692114|NCT00929292|Infant formula|infant formula
692115|NCT00929292|Alpha-lactalbumin|alpha-lactalbumin
692116|NCT00929292|Protein composition|protein composition
692117|NCT00929292|Colic|colic
692118|NCT00929292|Probiotics|probiotics
692119|NCT00929305|chronic pain|chronic pain
692120|NCT00929305|neck|neck
692121|NCT00929305|shoulder|shoulder
692122|NCT00929305|musculoskeletal origin|musculoskeletal origin
692123|NCT00938106|Intra-uterine Brachytherapy|intra-uterine brachytherapy
692124|NCT00938106|cervix cancer|cervix cancer
692125|NCT00938106|Patients suitable for intra-uterine brachytherapy for invasive carcinoma of the cervix.|patients suitable for intra-uterine brachytherapy for invasive carcinoma of the cervix.
692126|NCT00938119|Cardiovascular disease|cardiovascular disease
692127|NCT00938119|Diabetes|diabetes
692128|NCT00938132|fimasartan|fimasartan
692129|NCT00938132|drug interaction|drug interaction
692130|NCT00938145|recurrent bladder cancer|recurrent bladder cancer
692131|NCT00938145|stage II bladder cancer|stage ii bladder cancer
692132|NCT00938145|stage III bladder cancer|stage iii bladder cancer
692133|NCT00938145|stage IV bladder cancer|stage iv bladder cancer
692134|NCT00938158|albiglutide|albiglutide
692135|NCT00938158|hemodialysis|hemodialysis
692136|NCT00938158|pharmacokinetics|pharmacokinetics
692137|NCT00938158|renal|renal
692138|NCT00938171|Cytokine|cytokine
692139|NCT00938171|Anesthesia|anesthesia
692140|NCT00938171|Local anesthesia|local anesthesia
692142|NCT00938171|breast cancer|breast cancer
692144|NCT00938184|single dose|single dose
692145|NCT00938184|paroxetine|paroxetine
692146|NCT00938184|controlled-release tablet|controlled-release tablet
692147|NCT00938184|safety|safety
692148|NCT00938184|pharmacokinetics|pharmacokinetics
692149|NCT00938184|Japanese healthy male subjects|japanese healthy male subjects
692150|NCT00938197|Fimasartan|fimasartan
692151|NCT00938197|Drug interaction|drug interaction
692152|NCT00938210|Colonic surgery|colonic surgery
692153|NCT00938210|Postoperative care|postoperative care
692154|NCT00938210|Fatigue|fatigue
692155|NCT00938210|Physical function|physical function
692156|NCT00938210|Quality of life|quality of life
692157|NCT00938223|melanoma|melanoma
692158|NCT00938223|peptide|peptide
692159|NCT00938223|vaccine|vaccine
692160|NCT00938223|adjuvant|adjuvant
692161|NCT00938223|advanced|advanced
692162|NCT00938236|lung transplant|lung transplant
692163|NCT00938236|lung transplant recipient|lung transplant recipient
692164|NCT00938236|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
694406|NCT00932906|Retention|retention
692165|NCT00938236|bronchiolitis obliterans|bronchiolitis obliterans
692166|NCT00938236|single lung transplant|single lung transplant
692167|NCT00938236|double lung transplant|double lung transplant
692168|NCT00938236|heart-lung transplant|heart-lung transplant
692169|NCT00938236|Aerosol|aerosol
692170|NCT00938249|Moderately Elevated Serum Triglyceride|moderately elevated serum triglyceride
692171|NCT00938288|Antithrombin|antithrombin
692172|NCT00938288|Thrombosis|thrombosis
692173|NCT00938288|Pharmacokinetics|pharmacokinetics
692174|NCT00938288|Hereditary Antithrombin Deficiency|hereditary antithrombin deficiency
692175|NCT00938288|Congenital Antithrombin Deficiency|congenital antithrombin deficiency
692176|NCT00938301|healthy volunteer, first in human, safety and tolerability|healthy volunteer, first in human, safety and tolerability
692177|NCT00938327|Gastroenteritis|gastroenteritis
692178|NCT00938340|Cardiovascular Disease|cardiovascular disease
752868|NCT01174537|Progression-free|progression-free
692179|NCT00938353|Moderate croup (Westley score 3-8)|moderate croup (westley score 3-8)
692180|NCT00938379|mosquito|mosquito
692181|NCT00938379|repellent|repellent
692182|NCT00938379|vector control|vector control
692183|NCT00938379|malaria|malaria
692184|NCT00938392|influenza infection|influenza infection
692185|NCT00938392|GSK Bio's influenza vaccine GSK2186877A|gsk bio's influenza vaccine gsk2186877a
692186|NCT00938405|type 1 diabetes mellitus|type 1 diabetes mellitus
692187|NCT00938405|colesevelam|colesevelam
692188|NCT00938405|LDL|ldl
692189|NCT00938405|cholesterol|cholesterol
692190|NCT00938405|A1c|a1c
692191|NCT00938405|target range glucose values|target range glucose values
692192|NCT00938431|Lacosamide|lacosamide
692193|NCT00938431|Vimpat|vimpat
692194|NCT00938431|Children|children
692195|NCT00938431|Epilepsy|epilepsy
692196|NCT00938431|Seizures|seizures
692197|NCT00938431|Anti-epileptic|anti-epileptic
692198|NCT00938847|left ventricular dysfunction|left ventricular dysfunction
692199|NCT00938847|myocardial infarction|myocardial infarction
692200|NCT00938847|left ventricular dysfunction (LVDF) after acute myocardial infarction|left ventricular dysfunction (lvdf) after acute myocardial infarction
692201|NCT00938860|Hepatitis C|hepatitis c
692202|NCT00938860|liver transplantation|liver transplantation
692203|NCT00938860|anti-viral therapy|anti-viral therapy
692204|NCT00938873|MBCT|mbct
692205|NCT00938873|identity|identity
692206|NCT00938873|depression|depression
692207|NCT00938873|recurrent|recurrent
692208|NCT00938873|homework|homework
692209|NCT00938899|TMC435350-TiDP16-C101|tmc435350-tidp16-c101
692210|NCT00938899|TMC435350-C101|tmc435350-c101
692211|NCT00938899|TMC435350|tmc435350
692212|NCT00938899|HCV|hcv
692213|NCT00938912|Lacosamide (VIMPAT)|lacosamide (vimpat)
692214|NCT00938925|aggressive debridement|aggressive debridement
692215|NCT00938925|nail lacquer|nail lacquer
692216|NCT00938925|onychomycosis|onychomycosis
692217|NCT00938925|podiatry|podiatry
692218|NCT00938925|chiropody|chiropody
692219|NCT00938925|podiatry care|podiatry care
692221|NCT00938938|medical reporting|medical reporting
692222|NCT00938938|Mass media|mass media
692223|NCT00938951|Dry Eye|dry eye
692224|NCT00938951|Visual Performance|visual performance
692225|NCT00938964|Cognition|cognition
692226|NCT00938977|Obesity Hypoventilation syndrome|obesity hypoventilation syndrome
692227|NCT00938977|cytokines|cytokines
692228|NCT00938977|Adipokines|adipokines
692229|NCT00938977|continuous positive airway pressure|continuous positive airway pressure
692230|NCT00938977|bilevel support ventilation|bilevel support ventilation
692231|NCT00938977|Response to continuous positive airway pressure|response to continuous positive airway pressure
692232|NCT00939016|Dietary Assessment|dietary assessment
692233|NCT00939016|24-hour dietary recall|24-hour dietary recall
692234|NCT00939016|Dietary Restraint|dietary restraint
692235|NCT00939016|Social Desirability|social desirability
692236|NCT00939016|Portion estimation|portion estimation
692237|NCT00939016|Underreporting|underreporting
692238|NCT00939029|tobacco use|tobacco use
692239|NCT00939029|smokeless tobacco|smokeless tobacco
692240|NCT00939029|chewing tobacco|chewing tobacco
692334|NCT00939432|taboo|taboo
692242|NCT00939029|nicotine replacement|nicotine replacement
692243|NCT00939029|tobacco dependence|tobacco dependence
692244|NCT00939029|tobacco cessation|tobacco cessation
692245|NCT00939029|tobacco abstinence|tobacco abstinence
692246|NCT00939068|Chronic hepatitis B, Telbivudine, Intrauterine transmission|chronic hepatitis b, telbivudine, intrauterine transmission
692247|NCT00939081|Obesity|obesity
692248|NCT00939081|Women's health|women's health
692249|NCT00939081|Minority health|minority health
692250|NCT00939081|Obesity prevention|obesity prevention
692251|NCT00939094|Pain, Mechanical Hypersensitivity|pain, mechanical hypersensitivity
692252|NCT00939094|Allodynia|allodynia
692253|NCT00939094|Efficacy|efficacy
692254|NCT00939094|analgesia|analgesia
692255|NCT00939094|Neuropathic|neuropathic
692256|NCT00939107|low back pain|low back pain
692257|NCT00939107|Intervertebral disc|intervertebral disc
692258|NCT00939107|McKenzie|mckenzie
692259|NCT00939107|Physical Therapy|physical therapy
692260|NCT00939107|Spinal manipulation|spinal manipulation
692261|NCT00939107|Chiropractics|chiropractics
692262|NCT00939107|Patient education|patient education
694407|NCT00932906|Retrieval|retrieval
692263|NCT00939107|Exercise therapy|exercise therapy
692264|NCT00939107|Random allocation|random allocation
692265|NCT00939120|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
692266|NCT00939120|dutasteride|dutasteride
692267|NCT00939120|tolterodine ER|tolterodine er
692268|NCT00939133|acne|acne
692269|NCT00939133|tretinoin|tretinoin
692270|NCT00939133|isotretinoin|isotretinoin
692271|NCT00939133|recurrence|recurrence
692272|NCT00939133|Retin A micro|retin a micro
692273|NCT00939146|self management|self management
692274|NCT00939146|quality of life|quality of life
692275|NCT00939146|end of life|end of life
692276|NCT00939159|Low or Intermediate-1 Risk Myelodysplastic Syndrome|low or intermediate-1 risk myelodysplastic syndrome
692277|NCT00939159|MDS|mds
692278|NCT00939159|Cancer|cancer
692279|NCT00939159|LBH589|lbh589
752869|NCT01174537|survival|survival
692280|NCT00939172|Advanced Refractory Solid Malignancies|advanced refractory solid malignancies
692281|NCT00939172|Solid tumor|solid tumor
692282|NCT00939172|Lymphoma|lymphoma
692283|NCT00939172|TTP607|ttp607
692284|NCT00939185|Compliance and Safety Study in Children with Upper and Lower Respiratory Tract Infections|compliance and safety study in children with upper and lower respiratory tract infections
692285|NCT00939198|Hookworm|hookworm
692286|NCT00939198|Allergy|allergy
692287|NCT00939198|Vaccine|vaccine
692288|NCT00939198|Skin Test|skin test
692289|NCT00939198|Immediate-type hypersensitivity to Na-ASP-2 hookworm antigen|immediate-type hypersensitivity to na-asp-2 hookworm antigen
692290|NCT00939211|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
692291|NCT00939211|efficacy|efficacy
692292|NCT00939211|safety|safety
692293|NCT00939211|inhalation|inhalation
692294|NCT00939211|long-acting muscarinic receptor antagonist (LAMA)|long-acting muscarinic receptor antagonist (lama)
692295|NCT00939224|Near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
692296|NCT00939224|Regional oxygen saturation|regional oxygen saturation
692297|NCT00939224|Pediatrics|pediatrics
692298|NCT00939224|Cardiac catheterization|cardiac catheterization
692299|NCT00939224|Congenital heart disease|congenital heart disease
692300|NCT00939237|Coronary heart disease|coronary heart disease
692301|NCT00939237|Carotid intima-media thickness|carotid intima-media thickness
692302|NCT00939237|Biomarkers|biomarkers
692303|NCT00939250|Diabetes|diabetes
692304|NCT00939250|Depression|depression
692305|NCT00939250|Disease Self Management|disease self management
692306|NCT00939250|Measurement Based Care|measurement based care
692307|NCT00939263|deglutition disorders|deglutition disorders
692308|NCT00939263|esophageal diseases|esophageal diseases
692309|NCT00939263|eosinophilia|eosinophilia
692310|NCT00939276|cataract surgery|cataract surgery
692311|NCT00939276|macular edema|macular edema
692312|NCT00939276|prevention|prevention
692313|NCT00939289|Continuous glucose monitoring|continuous glucose monitoring
692314|NCT00939315|Glioma, diagnosis|glioma, diagnosis
692315|NCT00939315|Imaging|imaging
692316|NCT00939315|Positron emission tomography|positron emission tomography
692317|NCT00939315|Magnetic resonance imaging|magnetic resonance imaging
692318|NCT00939315|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
692319|NCT00939328|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
692320|NCT00939328|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
692321|NCT00939341|Symbicort SMART|symbicort smart
692322|NCT00939354|Asthma in subjects over the age of 65|asthma in subjects over the age of 65
692323|NCT00939380|hematopoietic stem cell transplant|hematopoietic stem cell transplant
692324|NCT00939380|bone marrow transplant|bone marrow transplant
692325|NCT00939380|children|children
692326|NCT00939380|parents|parents
692327|NCT00939380|counseling|counseling
692328|NCT00939380|depression|depression
692329|NCT00939419|Tuberculosis care|tuberculosis care
692330|NCT00939419|community tuberculosis care|community tuberculosis care
692331|NCT00939419|Health facility based tuberculosis care|health facility based tuberculosis care
692332|NCT00939432|incontinence|incontinence
692333|NCT00939432|urinary|urinary
692336|NCT00939432|embarrassment|embarrassment
692337|NCT00939432|treatment|treatment
692338|NCT00939432|depression|depression
692339|NCT00939432|cancer|cancer
692340|NCT00939510|adenocarcinoma of the prostate|adenocarcinoma of the prostate
692341|NCT00939510|hormone-resistant prostate cancer|hormone-resistant prostate cancer
692342|NCT00939510|recurrent prostate cancer|recurrent prostate cancer
692343|NCT00939510|stage IV prostate cancer|stage iv prostate cancer
692344|NCT00939523|recurrent nonfunctioning adenoma|recurrent nonfunctioning adenoma
692345|NCT00939523|prolactinomas|prolactinomas
692346|NCT00939523|resistant pituitary tumors|resistant pituitary tumors
692347|NCT00939523|aggressive pituitary tumors|aggressive pituitary tumors
692348|NCT00939523|malignant pituitary adenomas|malignant pituitary adenomas
692349|NCT00939549|High dose cyclophosphamide|high dose cyclophosphamide
692350|NCT00939562|Bioequivalence|bioequivalence
692351|NCT00939575|preeclampsia, metabolomics, blood, urine|preeclampsia, metabolomics, blood, urine
692352|NCT00939588|Aliskiren,|aliskiren,
692353|NCT00939588|hypertension,|hypertension,
692354|NCT00939588|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
692355|NCT00939601|Obstructive Sleep Apnea|obstructive sleep apnea
692356|NCT00939601|OSA|osa
692357|NCT00939601|Adherence|adherence
692358|NCT00939601|CPAP|cpap
692359|NCT00939601|Cognition|cognition
692360|NCT00939640|Diet|diet
692361|NCT00939640|Sodium|sodium
692362|NCT00939640|Hypertension|hypertension
692363|NCT00939640|Potassium|potassium
692364|NCT00939640|Antioxidants|antioxidants
692365|NCT00939640|congestive heart failure|congestive heart failure
692366|NCT00939640|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
692367|NCT00939640|Heart failure with preserved systolic function|heart failure with preserved systolic function
692368|NCT00939653|relapsed|relapsed
692369|NCT00939653|relapse|relapse
692370|NCT00939653|refractory|refractory
692371|NCT00939653|AML|aml
692372|NCT00939653|Acute myelogenous leukemia|acute myelogenous leukemia
692373|NCT00939653|Relapsed AML|relapsed aml
692374|NCT00939666|Rectal cancer|rectal cancer
692375|NCT00939666|Chemoradiation|chemoradiation
692376|NCT00939666|Response|response
692377|NCT00939666|Wait-and-see policy|wait-and-see policy
692378|NCT00939666|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
692379|NCT00939679|obesity|obesity
692380|NCT00939679|bariatric surgery|bariatric surgery
692381|NCT00939679|energy expenditure|energy expenditure
692382|NCT00939679|incretins|incretins
692383|NCT00939679|appetite regulation|appetite regulation
692384|NCT00939679|body composition|body composition
692385|NCT00939679|GLP-1|glp-1
692386|NCT00939718|depression;vitamin B12;randomized control trial|depression;vitamin b12;randomized control trial
692387|NCT00939731|bioavailability, capsule, tablet, healthy volunteer|bioavailability, capsule, tablet, healthy volunteer
692388|NCT00939744|contractile activity|contractile activity
692389|NCT00939744|eicosanoids|eicosanoids
692390|NCT00939744|pregnant women|pregnant women
692391|NCT00939744|obstetrics complications|obstetrics complications
692392|NCT00939757|Healthy volunteer subjects|healthy volunteer subjects
692393|NCT00939757|pharmacokinetics|pharmacokinetics
692394|NCT00939757|YM178|ym178
692395|NCT00939757|mirabegron|mirabegron
692396|NCT00939757|food|food
692397|NCT00939770|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
692398|NCT00939770|recurrent neuroblastoma|recurrent neuroblastoma
692399|NCT00939770|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
692400|NCT00939770|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
692401|NCT00939770|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
692402|NCT00939770|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
692403|NCT00939770|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
692404|NCT00939770|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
692405|NCT00939770|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
692406|NCT00939770|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
692407|NCT00939770|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
692408|NCT00939770|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
692409|NCT00939770|recurrent childhood glioblastoma|recurrent childhood glioblastoma
692410|NCT00939770|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
692411|NCT00939770|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
692412|NCT00939770|recurrent childhood oligoastrocytoma|recurrent childhood oligoastrocytoma
692413|NCT00939770|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
692414|NCT00939770|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
692415|NCT00939770|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
692416|NCT00939770|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
692417|NCT00939770|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
692418|NCT00939770|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
692714|NCT00940927|Nebulizer|nebulizer
692419|NCT00939770|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
692420|NCT00939770|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
753601|NCT01176825|medication adherence|medication adherence
692421|NCT00939770|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
692422|NCT00939770|recurrent childhood ependymoma|recurrent childhood ependymoma
692423|NCT00939770|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
692424|NCT00939770|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
692425|NCT00939770|childhood choroid plexus tumor|childhood choroid plexus tumor
692426|NCT00939770|childhood craniopharyngioma|childhood craniopharyngioma
692427|NCT00939770|childhood ependymoblastoma|childhood ependymoblastoma
692428|NCT00939770|childhood medulloepithelioma|childhood medulloepithelioma
692429|NCT00939770|childhood grade I meningioma|childhood grade i meningioma
692430|NCT00939770|childhood grade II meningioma|childhood grade ii meningioma
692431|NCT00939770|childhood grade III meningioma|childhood grade iii meningioma
692432|NCT00939770|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
692433|NCT00939770|recurrent childhood spinal cord neoplasm|recurrent childhood spinal cord neoplasm
692434|NCT00939770|childhood infratentorial ependymoma|childhood infratentorial ependymoma
692435|NCT00939770|childhood supratentorial ependymoma|childhood supratentorial ependymoma
692436|NCT00939770|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
692437|NCT00939770|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
692438|NCT00939770|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
692439|NCT00939770|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
692440|NCT00939770|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
752870|NCT01174537|recurrent|recurrent
692441|NCT00939848|Disease-Free Survival|disease-free survival
692442|NCT00939861|colorectal endometriosis, laparoscopy, laparotomy|colorectal endometriosis, laparoscopy, laparotomy
692443|NCT00939861|gynecologic and digestive symptoms|gynecologic and digestive symptoms
692444|NCT00939861|quality of life (SF-36 questionnaire)|quality of life (sf-36 questionnaire)
692445|NCT00939861|morbidity|morbidity
692446|NCT00939861|fertility|fertility
692447|NCT00939874|HIV+|hiv+
692448|NCT00939874|Raltegravir|raltegravir
692449|NCT00939874|Tenofovir|tenofovir
692450|NCT00939874|osteopenia|osteopenia
692451|NCT00939874|osteoporosis|osteoporosis
692452|NCT00939874|bone markers|bone markers
692453|NCT00939874|treatment experienced|treatment experienced
692454|NCT00939900|avascular necrosis of femoral head|avascular necrosis of femoral head
692455|NCT00939900|bisphosphonate|bisphosphonate
692456|NCT00939900|collapse|collapse
692457|NCT00939913|contrast nephropathy|contrast nephropathy
692458|NCT00939913|intravenous n-acetlycysteine|intravenous n-acetlycysteine
692459|NCT00939952|ertapenem|ertapenem
692460|NCT00939952|CAPD|capd
692461|NCT00939952|dialysis|dialysis
692462|NCT00939965|localized unresectable neuroblastoma|localized unresectable neuroblastoma
692463|NCT00939965|recurrent neuroblastoma|recurrent neuroblastoma
692464|NCT00939965|stage 4S neuroblastoma|stage 4s neuroblastoma
692466|NCT00940004|dendritic cell vaccination|dendritic cell vaccination
692467|NCT00940004|melanoma|melanoma
692468|NCT00940004|toll like receptor ligands|toll like receptor ligands
692469|NCT00940004|vaccines|vaccines
692470|NCT00940017|PK|pk
692471|NCT00940017|fungal infection|fungal infection
692472|NCT00940030|Mechanical Bowel Preparation (MBP)|mechanical bowel preparation (mbp)
692473|NCT00940030|enema|enema
692474|NCT00940043|bedside test|bedside test
692475|NCT00940043|interleukins|interleukins
692476|NCT00940043|inflammation|inflammation
692477|NCT00940043|vaginal secretions|vaginal secretions
692478|NCT00940056|Atrial fibrillation|atrial fibrillation
692479|NCT00940056|Ablation|ablation
692480|NCT00940056|Thoracoscopy|thoracoscopy
692481|NCT00940056|Atrial function|atrial function
692482|NCT00940069|TS|ts
692483|NCT00940069|polymorphism|polymorphism
692484|NCT00940069|lung cancer|lung cancer
692485|NCT00940069|adenocarcinoma|adenocarcinoma
692486|NCT00940069|pemetrexed|pemetrexed
692487|NCT00940082|Diabetes;|diabetes;
692488|NCT00940082|Echocardiography;|echocardiography;
692489|NCT00940082|High-sensitive C-reactive protein;|high-sensitive c-reactive protein;
692490|NCT00940082|homocysteine;|homocysteine;
692491|NCT00940082|TNF-α|tnf-α
692492|NCT00940095|Aneurysmal|aneurysmal
692493|NCT00940095|Subarachnoid|subarachnoid
692494|NCT00940095|Hemorrhage|hemorrhage
692495|NCT00940095|vasospasm|vasospasm
692496|NCT00940095|clazosentan|clazosentan
692497|NCT00940095|PIVLAZ|pivlaz
692498|NCT00940095|Actelion|actelion
692499|NCT00940095|surgical clipping|surgical clipping
692500|NCT00940121|Healthy volunteer subjects|healthy volunteer subjects
692501|NCT00940121|pharmacokinetics|pharmacokinetics
692502|NCT00940121|YM178|ym178
692503|NCT00940121|mirabegron|mirabegron
692504|NCT00940121|IV infusion|iv infusion
692505|NCT00940121|oral administration|oral administration
692506|NCT00940134|obesity|obesity
692507|NCT00940134|energy expenditure|energy expenditure
692508|NCT00940134|incretins|incretins
692509|NCT00940134|appetite regulation|appetite regulation
692510|NCT00940134|GLP-1|glp-1
692511|NCT00940134|PYY|pyy
692512|NCT00940134|ad libitum energy intake|ad libitum energy intake
692513|NCT00940160|Asthma|asthma
692514|NCT00940173|xenotransplantation|xenotransplantation
692515|NCT00940173|type I diabetes|type i diabetes
692516|NCT00940173|porcine islets|porcine islets
692517|NCT00940199|Breast cancer, sentinel lymph node mapping, biopsy|breast cancer, sentinel lymph node mapping, biopsy
692518|NCT00940212|Safety|safety
692519|NCT00940212|tolerability|tolerability
692520|NCT00940212|healthy|healthy
692521|NCT00940212|pharmacokinetics|pharmacokinetics
692522|NCT00940225|Breast Cancer|breast cancer
692523|NCT00940225|Melanoma|melanoma
692524|NCT00940225|Stomach or Gastroesophageal Junction Carcinoma|stomach or gastroesophageal junction carcinoma
692525|NCT00940225|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
692526|NCT00940225|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
692527|NCT00940225|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
692528|NCT00940225|Ovarian Cancer|ovarian cancer
692529|NCT00940225|Pancreatic Cancer|pancreatic cancer
692530|NCT00940225|Prostate Cancer|prostate cancer
692531|NCT00940251|Ayurvedic formulation|ayurvedic formulation
692532|NCT00940251|type 2 diabetes mellitus|type 2 diabetes mellitus
692533|NCT00940251|secondary failure to oral hypoglycemic agents|secondary failure to oral hypoglycemic agents
692534|NCT00940251|antidiabetic|antidiabetic
692535|NCT00940264|symptomatic cholecystolithiasis|symptomatic cholecystolithiasis
692536|NCT00940277|women couples counseling groups support intervention marriage|women couples counseling groups support intervention marriage
692537|NCT00940290|practice guideline as topic|practice guideline as topic
692538|NCT00940290|decision making|decision making
692539|NCT00940290|evidence based medicine|evidence based medicine
692540|NCT00940316|recurrent colon cancer|recurrent colon cancer
692541|NCT00940316|stage IV colon cancer|stage iv colon cancer
692542|NCT00940316|recurrent rectal cancer|recurrent rectal cancer
692543|NCT00940316|stage IV rectal cancer|stage iv rectal cancer
692544|NCT00940329|Drug interactions|drug interactions
692545|NCT00940329|Pharmacodynamic interactions|pharmacodynamic interactions
692546|NCT00940329|Pharmacokinetic interactions|pharmacokinetic interactions
692547|NCT00940329|Formoterol|formoterol
692548|NCT00940329|Healthy subjects|healthy subjects
692549|NCT00940329|Phase I study|phase i study
692550|NCT00940329|Roflumilast|roflumilast
692551|NCT00940342|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
692552|NCT00940342|Rituximab|rituximab
692553|NCT00940342|Leukemia|leukemia
692554|NCT00940342|Sargramostim|sargramostim
692556|NCT00940355|COPD|copd
692557|NCT00940355|Health Status|health status
692558|NCT00940355|Intervention|intervention
692559|NCT00940355|Secondary prevention|secondary prevention
692560|NCT00940355|patient-tailored treatment|patient-tailored treatment
692561|NCT00940368|Nausea|nausea
692562|NCT00940368|Vomiting|vomiting
692563|NCT00940368|Chemotherapy|chemotherapy
692564|NCT00940381|Advanced Malignancies|advanced malignancies
692565|NCT00940381|Sirolimus|sirolimus
692566|NCT00940381|Rapamune|rapamune
692567|NCT00940381|Cetuximab|cetuximab
692568|NCT00940381|C225|c225
692569|NCT00940381|Erbitux|erbitux
692570|NCT00940381|IMC-225|imc-225
692571|NCT00940394|mutual support group|mutual support group
692572|NCT00940394|psychoeducation group|psychoeducation group
692573|NCT00940394|family caregivers|family caregivers
692574|NCT00940394|schizophrenia|schizophrenia
692575|NCT00940407|dry AMD|dry amd
692576|NCT00940407|light treatment|light treatment
692577|NCT00940407|ARMD|armd
692578|NCT00940407|photobiomodulation|photobiomodulation
692579|NCT00940407|macular|macular
692580|NCT00940407|eye disease|eye disease
692581|NCT00940407|ageing eye disease|ageing eye disease
692582|NCT00940433|Minimally invasive|minimally invasive
692583|NCT00940433|Inguinal hernia|inguinal hernia
692584|NCT00940433|Pro-peritoneal repair|pro-peritoneal repair
692585|NCT00940446|Insorb staples|insorb staples
692586|NCT00940446|Metal Staples|metal staples
692587|NCT00940459|contact lenses|contact lenses
692588|NCT00940459|conjunctival staining|conjunctival staining
692589|NCT00940459|contact lens wear|contact lens wear
692590|NCT00940472|type 2 diabetes|type 2 diabetes
692591|NCT00940472|monotherapy|monotherapy
692592|NCT00940472|antidiabetics|antidiabetics
692593|NCT00940472|metformin|metformin
692594|NCT00940498|Phase 1|phase 1
692595|NCT00940498|Dose Finding|dose finding
692596|NCT00940498|Solid Tumors|solid tumors
692597|NCT00940498|Tumors|tumors
692598|NCT00940498|PF-05212384|pf-05212384
692599|NCT00940511|All conditions faced by disabled Medicaid recipients|all conditions faced by disabled medicaid recipients
692600|NCT00940524|Leukemia|leukemia
692601|NCT00940524|ALL|all
692602|NCT00940524|ALLOPURINOL|allopurinol
692603|NCT00940524|CARMUSTINE (BCNU)|carmustine (bcnu)
692604|NCT00940524|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
692605|NCT00940524|CYTARABINE (ARA-C)|cytarabine (ara-c)
692606|NCT00940524|DACTINOMYCIN|dactinomycin
692607|NCT00940524|DASATINIB|dasatinib
692608|NCT00940524|DEXAMETHASONE|dexamethasone
692609|NCT00940524|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
692610|NCT00940524|ETOPOSIDE (VP-16)|etoposide (vp-16)
692611|NCT00940524|MERCAPTOPURINE|mercaptopurine
692612|NCT00940524|METHOTREXATE|methotrexate
692613|NCT00940524|MITOXANTRONE|mitoxantrone
692614|NCT00940524|PEGASPERGASE|pegaspergase
692615|NCT00940524|VINCRISTINE|vincristine
692616|NCT00940537|Obese|obese
692617|NCT00940537|MRS|mrs
692618|NCT00940537|hepatic triglyceride content|hepatic triglyceride content
692619|NCT00940537|MR spectroscopy|mr spectroscopy
692620|NCT00940563|GIST|gist
692621|NCT00940563|imatinib|imatinib
692622|NCT00940563|advanced GIST|advanced gist
692623|NCT00940576|mare's milk, Crohn's disease, ulcerative colitis, clinical|mare's milk, crohn's disease, ulcerative colitis, clinical
692624|NCT00940589|Alzheimer's Disease|alzheimer's disease
692625|NCT00940589|Acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
692626|NCT00940589|cognitive function|cognitive function
692627|NCT00940589|Circadin|circadin
692628|NCT00940589|Sleep disturbances|sleep disturbances
692629|NCT00940602|TELESTO|telesto
692630|NCT00940602|MDS Study|mds study
692631|NCT00940602|Myelodysplastic Syndromes|myelodysplastic syndromes
692632|NCT00940602|Myelodysplastic Syndromes (low-int-1 risk)|myelodysplastic syndromes (low-int-1 risk)
692633|NCT00940615|traumatic brain injury|traumatic brain injury
692634|NCT00940615|aerobic exercise|aerobic exercise
692635|NCT00940615|Diffusion Tensor Imaging|diffusion tensor imaging
692636|NCT00940615|Neuropsychology|neuropsychology
692637|NCT00940615|Rehabilitation|rehabilitation
692638|NCT00940641|Healthy Volunteer|healthy volunteer
692640|NCT00940654|Antipyretic|antipyretic
692641|NCT00940654|Infection|infection
692642|NCT00940654|Mortality|mortality
692643|NCT00940654|Cooling|cooling
752871|NCT01174550|chest pain|chest pain
692644|NCT00940654|Non steroid anti inflammatory drugs|non steroid anti inflammatory drugs
692645|NCT00940654|Acetaminophen|acetaminophen
692646|NCT00940654|Steroid|steroid
692647|NCT00940654|ICU|icu
692648|NCT00940654|Intensive care|intensive care
692649|NCT00940654|Critically ill|critically ill
692650|NCT00940667|Amlodipine|amlodipine
692651|NCT00940667|Losartan|losartan
692652|NCT00940667|hypertension|hypertension
692653|NCT00940680|Amlodipine|amlodipine
692654|NCT00940680|Losartan|losartan
692655|NCT00940680|hypertension|hypertension
692656|NCT00940693|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
692657|NCT00940693|Duloxetine|duloxetine
692658|NCT00940693|Adult|adult
692659|NCT00940693|ADDH|addh
692660|NCT00940693|ADHD|adhd
692661|NCT00940706|Cerebral Palsy|cerebral palsy
692662|NCT00940706|Activity monitoring|activity monitoring
692663|NCT00940706|Treadmill|treadmill
692664|NCT00940706|Group training|group training
692665|NCT00940706|Physical active life style|physical active life style
692666|NCT00940719|Multiple Sclerosis|multiple sclerosis
692667|NCT00940719|Regulatory T cell function|regulatory t cell function
692668|NCT00940719|Vitamin D|vitamin d
692669|NCT00940719|Vitamin D3|vitamin d3
692670|NCT00940719|25-hydroxyvitamin D|25-hydroxyvitamin d
692671|NCT00940732|Help-seeking|help-seeking
692672|NCT00940732|Mental Health|mental health
692673|NCT00940732|Athletes|athletes
692674|NCT00940745|HICH|hich
692675|NCT00940745|Suction drainages|suction drainages
692676|NCT00940745|TTAC|ttac
692677|NCT00940771|HIV|hiv
692678|NCT00940771|Lipids|lipids
692679|NCT00940771|Atazanavir|atazanavir
692680|NCT00940771|Pediatric|pediatric
692681|NCT00940771|treatment experienced|treatment experienced
692682|NCT00940797|diabetes|diabetes
692683|NCT00940797|Type 2|type 2
692684|NCT00940797|monotherapy|monotherapy
692685|NCT00940797|antidiabetics|antidiabetics
692686|NCT00940797|metformin|metformin
692687|NCT00940823|Glaucoma Drainage Device|glaucoma drainage device
692688|NCT00940823|Aqueous Shunt Implant|aqueous shunt implant
692689|NCT00940823|Ahmed Valve|ahmed valve
692690|NCT00940823|Baerveldt Tube|baerveldt tube
692691|NCT00940823|Refractory Glaucoma|refractory glaucoma
692692|NCT00940836|Anti-cold|anti-cold
692693|NCT00940836|Cold preparation|cold preparation
692694|NCT00940836|RCT|rct
692695|NCT00940862|psoriasis|psoriasis
692696|NCT00940862|vascular inflammation|vascular inflammation
692697|NCT00940862|coronary atherosclerosis|coronary atherosclerosis
692698|NCT00940888|ICD|icd
692699|NCT00940888|CRTD|crtd
692700|NCT00940888|Heart Failure|heart failure
692701|NCT00940888|DF4|df4
692702|NCT00940901|priapism|priapism
692703|NCT00940901|sickle cell disease|sickle cell disease
692704|NCT00940901|sildenafil|sildenafil
692705|NCT00940901|phosphodiesterase type 5 inhibitor|phosphodiesterase type 5 inhibitor
692706|NCT00940914|Parkinson's disease|parkinson's disease
692707|NCT00940914|pain|pain
692708|NCT00940914|dopamine transporters imaging|dopamine transporters imaging
692709|NCT00940927|Albuterol|albuterol
692710|NCT00940927|Forced expiratory volume in one second|forced expiratory volume in one second
692711|NCT00940927|Dose at fifty percent of maximum effect|dose at fifty percent of maximum effect
692712|NCT00940927|Maximum effective dose|maximum effective dose
692713|NCT00940927|Metered dose inhaler|metered dose inhaler
692716|NCT00940966|low carbohydrate diet|low carbohydrate diet
692717|NCT00940966|Metabolic syndrome|metabolic syndrome
692718|NCT00940979|Integuseal microbial sealant|integuseal microbial sealant
692719|NCT00940979|Infection prophylaxis|infection prophylaxis
692720|NCT00940979|Postoperative wound infection|postoperative wound infection
692721|NCT00940979|Arterial bypass surgery|arterial bypass surgery
692722|NCT00941018|Resolvins|resolvins
692723|NCT00941018|RvE1|rve1
692724|NCT00941018|Healthy volunteers|healthy volunteers
692725|NCT00941031|Moderate to severe chronic plaque-type psoriasis|moderate to severe chronic plaque-type psoriasis
692726|NCT00941031|AIN457|ain457
692727|NCT00941031|dermatology|dermatology
692728|NCT00941044|non-invasive ventilation|non-invasive ventilation
692729|NCT00941044|diaphragm|diaphragm
692730|NCT00941044|electrical activity|electrical activity
692731|NCT00941044|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
692732|NCT00941044|volunteers|volunteers
692733|NCT00941083|Simplification from protease inhibitors to raltegravir|simplification from protease inhibitors to raltegravir
692734|NCT00941083|Treatment Experienced|treatment experienced
692735|NCT00941083|HIV-1 Infections|hiv-1 infections
692736|NCT00941096|Glaucoma|glaucoma
692737|NCT00941096|Ocular Hypertension|ocular hypertension
692738|NCT00941096|Lumigan|lumigan
692739|NCT00941096|Ganfort|ganfort
692740|NCT00941109|MDS|mds
692741|NCT00941122|MRSA, VRE|mrsa, vre
692742|NCT00941174|(13C5) Calcium Leucovorin|(13c5) calcium leucovorin
692743|NCT00941174|Folate absorption across the large intestine|folate absorption across the large intestine
692744|NCT00941174|Folate Bioavailability|folate bioavailability
692745|NCT00941187|pulmonary embolism|pulmonary embolism
692746|NCT00941187|pulmonary capillary blood volume|pulmonary capillary blood volume
692747|NCT00941187|double diffusion NO/CO method|double diffusion no/co method
692748|NCT00941213|fractures of vertebral bodies Th10-L2|fractures of vertebral bodies th10-l2
692749|NCT00941213|(AO A1 with kyphosis, A2.3, B or C-type)|(ao a1 with kyphosis, a2.3, b or c-type)
692750|NCT00941226|Cerebral Palsy|cerebral palsy
692751|NCT00941226|Caregivers|caregivers
692752|NCT00941226|Quality of Life|quality of life
692753|NCT00941239|Metformin ER|metformin er
692754|NCT00941239|Pharmacokinetics|pharmacokinetics
692755|NCT00941239|Tolerability|tolerability
692756|NCT00941239|Healthy volunteers|healthy volunteers
692757|NCT00941265|treatment of anomia|treatment of anomia
692758|NCT00941265|levodopa|levodopa
692759|NCT00941265|"patient with aphasia hospitalised at the Service de neurorehabilitation with presence of anomia"|"patient with aphasia hospitalised at the service de neurorehabilitation with presence of anomia"
692760|NCT00941291|idiopathic macular hole|idiopathic macular hole
692761|NCT00941291|cataract|cataract
692762|NCT00941291|edema|edema
692763|NCT00941291|Reopening|reopening
692764|NCT00933127|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
692765|NCT00933127|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
692766|NCT00933127|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
692767|NCT00933127|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
692768|NCT00933127|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
692769|NCT00933127|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
692770|NCT00933127|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
692771|NCT00933127|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
692772|NCT00933127|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
692773|NCT00933127|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
692774|NCT00933127|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
692775|NCT00933127|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
692776|NCT00933140|HIV|hiv
692777|NCT00933140|women|women
692778|NCT00933140|anal cytology|anal cytology
692779|NCT00933153|Elderly|elderly
692780|NCT00933153|Malnutrition|malnutrition
692781|NCT00933153|Oral Nutrition Supplement|oral nutrition supplement
692782|NCT00933153|Meals on Wheels|meals on wheels
692783|NCT00933179|Prevention of pregnancy|prevention of pregnancy
692784|NCT00933231|Tacrolimus|tacrolimus
692785|NCT00933231|Kidney Transplantation|kidney transplantation
692786|NCT00933231|Advagraf|advagraf
692787|NCT00933231|Immunosuppression|immunosuppression
692788|NCT00933231|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
692789|NCT00933244|Vitamin D|vitamin d
692790|NCT00933244|Cholecalciferol|cholecalciferol
692791|NCT00933244|Parathyroid Hormone|parathyroid hormone
692792|NCT00933244|Calcium Absorption|calcium absorption
692793|NCT00933244|Bone Mineral Density|bone mineral density
692794|NCT00933244|Muscle Function|muscle function
692795|NCT00933270|Superficial Femoral Artery or SFA|superficial femoral artery or sfa
692796|NCT00933283|Healthy participants|healthy participants
692797|NCT00933283|Pharmacokinetics|pharmacokinetics
692798|NCT00933283|Pharmacodynamic|pharmacodynamic
692799|NCT00933283|Potential interaction|potential interaction
692800|NCT00933283|VX-950-TiDP24-C135|vx-950-tidp24-c135
692801|NCT00933283|VX-950|vx-950
692802|NCT00933283|Methadone|methadone
692804|NCT00933283|Steady-state|steady-state
692805|NCT00933296|Schnitzler syndrome|schnitzler syndrome
692806|NCT00933296|Waldentsröm's disease|waldentsröm's disease
692807|NCT00933296|anakinra|anakinra
692808|NCT00933309|Breast|breast
692809|NCT00933309|Obese|obese
692810|NCT00933309|Obesity Treatment|obesity treatment
692811|NCT00933309|Exemestane|exemestane
692812|NCT00933309|Aromasin|aromasin
692813|NCT00933309|Metformin and Rosiglitazone|metformin and rosiglitazone
692814|NCT00933309|Avandamet|avandamet
692815|NCT00933309|Postmenopausal|postmenopausal
692816|NCT00933309|Hormone-sensitive|hormone-sensitive
692817|NCT00933309|Hormone-receptive-positive breast cancer|hormone-receptive-positive breast cancer
692818|NCT00933322|ruminant|ruminant
692819|NCT00933322|industrial|industrial
692820|NCT00933322|endothelial function|endothelial function
692821|NCT00933322|flow-mediated dilation|flow-mediated dilation
692822|NCT00933322|blood lipids|blood lipids
692823|NCT00933322|nutrition|nutrition
692824|NCT00933322|trans fatty acids|trans fatty acids
692825|NCT00933322|coronary disease|coronary disease
692826|NCT00933322|endothelial function of the brachial artery|endothelial function of the brachial artery
692827|NCT00933322|inflammation|inflammation
692828|NCT00933322|insulin resistancy|insulin resistancy
692829|NCT00933322|coagulation|coagulation
692830|NCT00933348|ulcer|ulcer
692831|NCT00933348|venous|venous
692832|NCT00933348|pressure|pressure
692833|NCT00933348|wound|wound
692834|NCT00933348|treatment|treatment
692835|NCT00933361|Adult|adult
692836|NCT00933374|bladder cancer|bladder cancer
692837|NCT00933374|RAD001|rad001
692838|NCT00933374|Paclitaxel|paclitaxel
692839|NCT00933387|oral squamous cell carcinoma|oral squamous cell carcinoma
692840|NCT00933387|neoadjuvant bio-chemotherapy|neoadjuvant bio-chemotherapy
692841|NCT00933387|concurrent bio-radiotherapy|concurrent bio-radiotherapy
692842|NCT00933387|biomarker|biomarker
692843|NCT00933400|Computed Tomography|computed tomography
692844|NCT00933400|CTA|cta
692845|NCT00933400|Cardiac CT|cardiac ct
692846|NCT00933400|CT|ct
692847|NCT00933400|Cardiac CTA|cardiac cta
692848|NCT00933400|Chest Pain|chest pain
692849|NCT00933400|Heart Attack|heart attack
692850|NCT00933400|Emergency Department|emergency department
692851|NCT00933400|Myocardial Infarction|myocardial infarction
692852|NCT00933400|Cost Effectiveness|cost effectiveness
692853|NCT00933400|Acute Coronary Event|acute coronary event
692854|NCT00933400|Heart Imaging|heart imaging
692855|NCT00933426|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
692856|NCT00933426|CRPC|crpc
692857|NCT00933426|Prostate|prostate
692858|NCT00933426|Lenalidomide|lenalidomide
692859|NCT00933426|Revlimid|revlimid
692860|NCT00933426|CC-5103|cc-5103
692861|NCT00933426|Paclitaxel|paclitaxel
692862|NCT00933426|Taxol|taxol
692863|NCT00933426|Taxanes|taxanes
692864|NCT00933439|Depression|depression
692865|NCT00933439|Major Depressive Disorder|major depressive disorder
692866|NCT00933439|Cognitive Function|cognitive function
692867|NCT00933439|Psychosocial Function|psychosocial function
692868|NCT00933452|duloxetine|duloxetine
692869|NCT00933452|pharmacokinetics|pharmacokinetics
692870|NCT00933452|antidepressant|antidepressant
692871|NCT00933452|antidepressive agents|antidepressive agents
692872|NCT00933452|depression|depression
692873|NCT00933452|psychotropic drugs|psychotropic drugs
692874|NCT00933452|safety|safety
692875|NCT00933452|Chinese|chinese
692876|NCT00933452|HAN|han
692877|NCT00933452|BDNF|bdnf
692878|NCT00933465|Fecal incontinence|fecal incontinence
692879|NCT00933478|Patulous Eustachian Tube Dysfunction|patulous eustachian tube dysfunction
692880|NCT00933491|healthy|healthy
692881|NCT00933517|breast cancer, neoadjuvant therapies, chemotherapy, targeted therapy|breast cancer, neoadjuvant therapies, chemotherapy, targeted therapy
692882|NCT00933543|Acne Vulgaris|acne vulgaris
692883|NCT00933543|Moderate to severe|moderate to severe
692884|NCT00933556|infection|infection
692885|NCT00933556|probiotics|probiotics
692886|NCT00933582|Osteoarthritis, Knee|osteoarthritis, knee
692887|NCT00933582|Knee Pain|knee pain
692888|NCT00933582|Pain Measurement|pain measurement
692889|NCT00933582|Naproxen|naproxen
692890|NCT00933582|Placebo|placebo
692891|NCT00933582|Treatment Outcome|treatment outcome
692892|NCT00933595|HIV|hiv
692893|NCT00933595|Lung|lung
692894|NCT00933608|subjective memory complaints|subjective memory complaints
692895|NCT00933608|cognitively healthy|cognitively healthy
692896|NCT00933608|family history|family history
692897|NCT00933608|AD|ad
692898|NCT00933634|atrial fibrillation|atrial fibrillation
692899|NCT00933634|electrical cardioversion|electrical cardioversion
692900|NCT00933634|pharmacological cardioversion|pharmacological cardioversion
692901|NCT00933647|Camellia sinensis|camellia sinensis
692902|NCT00933647|Ilex paraguariensis|ilex paraguariensis
692903|NCT00933647|Green tea|green tea
692904|NCT00933647|Yerba mate tea|yerba mate tea
692905|NCT00933647|Maté|maté
692906|NCT00933647|Dyslipidemia|dyslipidemia
692907|NCT00933647|Inflammation|inflammation
692912|NCT00933673|NK/T cell lymphoma|nk/t cell lymphoma
692913|NCT00933673|DICE|dice
692914|NCT00933673|L-asparaginase|l-asparaginase
692915|NCT00933725|menopausal syndrome|menopausal syndrome
692916|NCT00933725|TCM intervention|tcm intervention
692917|NCT00933738|Patients needing OAT (Oral Anticoagulation Therapy)|patients needing oat (oral anticoagulation therapy)
692918|NCT00933751|central venous oxygen saturation|central venous oxygen saturation
692919|NCT00933751|oxygen transport|oxygen transport
692920|NCT00933751|physiologic monitoring|physiologic monitoring
692921|NCT00933751|tissue oxygenation|tissue oxygenation
692922|NCT00933751|Patients before high risk abdominal surgery|patients before high risk abdominal surgery
692923|NCT00933790|TB|tb
692924|NCT00933790|HIV|hiv
692925|NCT00933790|ARR|arr
692926|NCT00933790|Short course chemotherapy|short course chemotherapy
692927|NCT00933790|Drug resistance|drug resistance
692928|NCT00933816|sorafenib|sorafenib
692929|NCT00933816|intraarterial infusion chemotherapy|intraarterial infusion chemotherapy
692930|NCT00933816|Low dose FP|low dose fp
692931|NCT00933816|cisplatin|cisplatin
692932|NCT00933816|fluorouracil|fluorouracil
692933|NCT00933829|absorbable sutures|absorbable sutures
692934|NCT00933829|non-absorbable sutures|non-absorbable sutures
692935|NCT00933829|wound management|wound management
692936|NCT00933855|Training Workshop|training workshop
692937|NCT00933855|Communication|communication
692938|NCT00933855|Questionnaires|questionnaires
692939|NCT00933855|Multiple Diseases|multiple diseases
692940|NCT00933868|A stroke that occurred three months to four years ago|a stroke that occurred three months to four years ago
692941|NCT00933881|GDM|gdm
692942|NCT00933894|VX-950-TiDP24-C133|vx-950-tidp24-c133
692943|NCT00933894|VX-950-C133|vx-950-c133
692944|NCT00933894|VX950|vx950
692946|NCT00933894|telaprevir|telaprevir
692947|NCT00933894|escitalopram|escitalopram
692948|NCT00933920|Aliskiren,|aliskiren,
692949|NCT00933920|hypertension,|hypertension,
692950|NCT00933920|renin-angiotensin-aldosterone system,|renin-angiotensin-aldosterone system,
692951|NCT00933920|pharmacokinetics,|pharmacokinetics,
692952|NCT00933920|pharmacodynamics|pharmacodynamics
692953|NCT00933959|Sleep problems|sleep problems
692954|NCT00933959|Awareness training program|awareness training program
692955|NCT00933959|Mind body bridging|mind body bridging
692956|NCT00933998|DPN|dpn
692957|NCT00934011|C-reactive protein|c-reactive protein
692958|NCT00934011|procalcitonin|procalcitonin
692959|NCT00934011|sepsis|sepsis
692960|NCT00934011|antibiotic therapy|antibiotic therapy
692961|NCT00934024|nicotine dependence|nicotine dependence
692962|NCT00934024|tobacco|tobacco
692963|NCT00934024|smoking|smoking
692964|NCT00934037|Coronary Artery Disease|coronary artery disease
692965|NCT00934037|Computed Tomography|computed tomography
692966|NCT00934037|Myoperfusion|myoperfusion
692967|NCT00934037|Angiography|angiography
692968|NCT00934037|SPECT|spect
692969|NCT00934115|To define the incidence, categories of infections by organ systems, etiologic agents and risk|to define the incidence, categories of infections by organ systems, etiologic agents and risk
692970|NCT00934128|Advanced Cancer|advanced cancer
692971|NCT00934128|Persistent Dyspnea|persistent dyspnea
692972|NCT00934128|Shortness of breath|shortness of breath
692973|NCT00934128|Specialized breathing devices|specialized breathing devices
692974|NCT00934128|Bilevel positive airway pressure device|bilevel positive airway pressure device
692975|NCT00934128|BIPAP|bipap
692976|NCT00934128|High flow oxygen delivery device|high flow oxygen delivery device
692977|NCT00934128|VapoTherm|vapotherm
692978|NCT00934128|Edmonton Symptom Assessment Scale|edmonton symptom assessment scale
692979|NCT00934128|ESAS|esas
692980|NCT00934141|Organizational change|organizational change
692981|NCT00934141|process improvement|process improvement
692982|NCT00934141|addiction treatment|addiction treatment
692983|NCT00934141|cost effectiveness study|cost effectiveness study
692984|NCT00934154|multiple myeloma|multiple myeloma
692985|NCT00934154|thalidomide|thalidomide
692986|NCT00934154|melphalan|melphalan
692987|NCT00934154|prednisolone|prednisolone
692988|NCT00934154|newly diagnosed|newly diagnosed
692989|NCT00934154|elderly|elderly
692990|NCT00934154|not eligible for transplantation|not eligible for transplantation
692991|NCT00934180|Bioequivalence|bioequivalence
692992|NCT00934206|Exercise|exercise
692993|NCT00934206|healthy subjects|healthy subjects
692994|NCT00934219|hypertriglyceridemia|hypertriglyceridemia
692995|NCT00934219|triglycerides|triglycerides
692996|NCT00934219|familial hypertriglyceridemia|familial hypertriglyceridemia
692997|NCT00934232|cancer|cancer
692998|NCT00934232|myeloma|myeloma
692999|NCT00934245|Influenza|influenza
693000|NCT00934245|India|india
693001|NCT00934245|Children|children
693002|NCT00934245|Trivalent Influenza Vaccine (TIV)|trivalent influenza vaccine (tiv)
693003|NCT00934245|Inactivated poliovirus vaccine (IPV)|inactivated poliovirus vaccine (ipv)
693004|NCT00934245|Direct vaccine effectiveness|direct vaccine effectiveness
693005|NCT00934245|Indirect vaccine effectiveness|indirect vaccine effectiveness
693006|NCT00934258|genes|genes
693007|NCT00934258|rosuvastatin|rosuvastatin
693008|NCT00934258|fenofibrate|fenofibrate
693009|NCT00934258|Cardiovascular (CV) diseases|cardiovascular (cv) diseases
693010|NCT00934258|dyslipidemia|dyslipidemia
693011|NCT00934258|metabolic syndrome|metabolic syndrome
693012|NCT00934258|identify genetic determinants of the wide range of interindividual variability in phenotypic and clinical response to the lipid-lowering drug classes|identify genetic determinants of the wide range of interindividual variability in phenotypic and clinical response to the lipid-lowering drug classes
693013|NCT00934258|identify genetic susceptibility to drug-related side effects.|identify genetic susceptibility to drug-related side effects.
693014|NCT00934271|acromegaly|acromegaly
693015|NCT00934271|irradiation|irradiation
693016|NCT00934271|remission|remission
693017|NCT00934271|pituitary function|pituitary function
693018|NCT00934284|sciatic neuropathy|sciatic neuropathy
694505|NCT00938743|ADHD|adhd
693019|NCT00934284|physical therapy|physical therapy
693020|NCT00934284|spinal injections|spinal injections
693021|NCT00934297|MRI visible breast lesions that are occult under ultrasound|mri visible breast lesions that are occult under ultrasound
693022|NCT00934310|Patient Safety|patient safety
693023|NCT00934310|Team work|team work
693024|NCT00934310|Communication|communication
693025|NCT00934310|Ambulatory surgical patients|ambulatory surgical patients
693026|NCT00934323|volunteer|volunteer
693027|NCT00934349|Comoro Island|comoro island
693028|NCT00934349|vit B1 intake|vit b1 intake
693029|NCT00934349|Thiamine status|thiamine status
693030|NCT00934349|Genetic factor|genetic factor
693031|NCT00934375|Mild Cognitive Impairment|mild cognitive impairment
693032|NCT00934388|Sportsmans groin, Gilmores groin|sportsmans groin, gilmores groin
693033|NCT00934401|FLT|flt
693034|NCT00934401|fluorolabeled thymidine|fluorolabeled thymidine
693035|NCT00934401|breast cancer|breast cancer
693036|NCT00934401|Positron-Emission Mammography|positron-emission mammography
693037|NCT00934427|Raynaud's|raynaud's
693038|NCT00934427|scleroderma|scleroderma
693039|NCT00934427|nitroglycerin|nitroglycerin
693040|NCT00934427|MQX-503|mqx-503
693041|NCT00934427|treatment|treatment
693042|NCT00934440|kidney cancer|kidney cancer
693043|NCT00934440|renal cell|renal cell
693044|NCT00934453|Healthy adult volunteers|healthy adult volunteers
693045|NCT00934453|Lactobacillus rhamnosus GG|lactobacillus rhamnosus gg
693046|NCT00934453|probiotic|probiotic
693047|NCT00934453|dietary supplement|dietary supplement
693048|NCT00934453|safety|safety
693049|NCT00934453|Safety Assessment|safety assessment
693050|NCT00934479|Chronic Constipation|chronic constipation
693051|NCT00934479|Constipation Predominant Irritable Bowel Syndrome|constipation predominant irritable bowel syndrome
693052|NCT00934479|Intestinal Microecology|intestinal microecology
693053|NCT00934492|Malnutrition|malnutrition
693054|NCT00934492|Wasting|wasting
693055|NCT00934492|Kwashiorkor|kwashiorkor
693056|NCT00934492|Immune deficiency|immune deficiency
693057|NCT00934492|Infection|infection
693058|NCT00934492|Prophylaxis|prophylaxis
693059|NCT00934492|Mortality|mortality
693060|NCT00934492|Kenya|kenya
693061|NCT00934505|Positron-Emission Tomography|positron-emission tomography
693062|NCT00934505|PET Scan|pet scan
693063|NCT00934505|FDG|fdg
693064|NCT00934505|oesophageal cancer|oesophageal cancer
693065|NCT00934505|chemo-Radiation Oncology|chemo-radiation oncology
693066|NCT00934505|SUV|suv
693067|NCT00934518|Squamous cell carcinoma, Head and Neck cancer|squamous cell carcinoma, head and neck cancer
693068|NCT00934531|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
693069|NCT00934531|Falls|falls
693070|NCT00934531|donepezil|donepezil
693071|NCT00934531|gait variability|gait variability
693072|NCT00934544|Myelofibrosis|myelofibrosis
693073|NCT00934544|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
693074|NCT00934544|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
693075|NCT00934570|Obesity|obesity
693076|NCT00934570|Metformin|metformin
693077|NCT00934570|Physical activity|physical activity
693078|NCT00934570|Cardiovascular health|cardiovascular health
693079|NCT00934583|Bulimia Nervosa|bulimia nervosa
693080|NCT00934583|Binge Eating|binge eating
693081|NCT00934583|Binge-Eating Disorder|binge-eating disorder
693082|NCT00934596|Cardiac de-airing|cardiac de-airing
693083|NCT00934596|CO2 insufflation|co2 insufflation
693084|NCT00934596|Air emboli|air emboli
693085|NCT00934596|Trans cranial doppler|trans cranial doppler
693086|NCT00934596|Intraoperative echocardiography|intraoperative echocardiography
693087|NCT00934609|Exercise|exercise
693088|NCT00934609|heart failure|heart failure
693089|NCT00934609|dilated cardiomyopathy|dilated cardiomyopathy
693090|NCT00934609|Endurance training|endurance training
693091|NCT00934622|AcrySof|acrysof
693092|NCT00934622|ReSTOR|restor
693093|NCT00934622|Aspheric IOL|aspheric iol
693094|NCT00934622|Cataract|cataract
693095|NCT00934635|D2-receptor occupancy|d2-receptor occupancy
693096|NCT00934635|Antipsychotic drugs|antipsychotic drugs
693097|NCT00934635|Paliperidone ER, Oral risperidone|paliperidone er, oral risperidone
693098|NCT00934635|Dopamine|dopamine
693099|NCT00934635|Fallypride|fallypride
693100|NCT00934635|Plasma concentration|plasma concentration
693101|NCT00934635|Therapeutic window, Healthy controls|therapeutic window, healthy controls
693102|NCT00934661|hip resurfacing|hip resurfacing
693103|NCT00934661|hip arthroplasty|hip arthroplasty
693104|NCT00934674|Healthy Subjects|healthy subjects
693105|NCT00934687|depression|depression
693106|NCT00934687|depressive|depressive
693107|NCT00934687|botulinum|botulinum
693108|NCT00934687|botox|botox
693109|NCT00934700|perinatal asphyxia|perinatal asphyxia
693110|NCT00934700|encephalopathy|encephalopathy
693111|NCT00934700|neuroprotection|neuroprotection
693112|NCT00934713|montelukast, very young children, lung function tests|montelukast, very young children, lung function tests
693113|NCT00934726|Quality of Life|quality of life
693114|NCT00934726|Patient satisfaction|patient satisfaction
693115|NCT00934726|Schizophrenia|schizophrenia
693419|NCT00935441|telemedicine|telemedicine
693116|NCT00934726|Investigate quality of life in schizophrenia|investigate quality of life in schizophrenia
693117|NCT00934739|High-Risk Oral Cavity Cancer,|high-risk oral cavity cancer,
693118|NCT00934739|Anti-Angiogenesis|anti-angiogenesis
693119|NCT00934752|de novo stenotic lesions|de novo stenotic lesions
693120|NCT00934765|overweight, obesity, male, fertility|overweight, obesity, male, fertility
693121|NCT00934778|Confocal microscopy|confocal microscopy
693122|NCT00934778|Endocytoscopy|endocytoscopy
693123|NCT00934778|Diffuse lung disease|diffuse lung disease
693124|NCT00934778|Minimally invasive|minimally invasive
693125|NCT00934778|Lung cancer and dysplasia|lung cancer and dysplasia
693126|NCT00934791|Kidney Transplant|kidney transplant
693127|NCT00934791|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
693128|NCT00934791|Polycystic liver disease|polycystic liver disease
693129|NCT00934804|refractive surgery|refractive surgery
693130|NCT00934817|Volunteer|volunteer
693131|NCT00934830|Antibiotic|antibiotic
693132|NCT00934830|Ultrasound|ultrasound
693133|NCT00934830|Efficacy|efficacy
693134|NCT00934830|Treatment|treatment
693135|NCT00934843|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
693136|NCT00934843|System Inflammatory Response|system inflammatory response
693137|NCT00934843|Low Cardiac Output Syndrome (LCOS) in Neonates|low cardiac output syndrome (lcos) in neonates
693138|NCT00934843|Methylprednisolone|methylprednisolone
693139|NCT00934843|Cardiopulmonary Bypass (CPB) in Neonates|cardiopulmonary bypass (cpb) in neonates
693140|NCT00934843|Glucocorticoid Use in Neonatal Cardiac Surgery|glucocorticoid use in neonatal cardiac surgery
693141|NCT00934843|Steroid|steroid
693142|NCT00934882|Colorectal cancer|colorectal cancer
693143|NCT00934882|Targeted therapy|targeted therapy
693144|NCT00934882|Multi-kinase inhibitor|multi-kinase inhibitor
693145|NCT00934882|FOLFOX|folfox
693146|NCT00934882|FOLFIRI|folfiri
693147|NCT00934895|stage IIIA breast cancer|stage iiia breast cancer
693148|NCT00934895|stage IIIB breast cancer|stage iiib breast cancer
693149|NCT00934895|stage IIIC breast cancer|stage iiic breast cancer
693150|NCT00934895|stage IV breast cancer|stage iv breast cancer
693151|NCT00934895|HER2-negative breast cancer|her2-negative breast cancer
693152|NCT00934895|recurrent breast cancer|recurrent breast cancer
693153|NCT00934908|Zyprexa®|zyprexa®
693154|NCT00934908|Green Tea|green tea
693156|NCT00934921|Bioequivalence|bioequivalence
693157|NCT00934934|Candida|candida
693158|NCT00934934|ventilator associated pneumonia|ventilator associated pneumonia
693159|NCT00934934|respiratory tract infection|respiratory tract infection
693160|NCT00934934|antifungal|antifungal
693161|NCT00934934|biomarker|biomarker
693162|NCT00934947|Burns|burns
693163|NCT00934947|Pain|pain
693164|NCT00934960|vision|vision
693165|NCT00934960|Intraocular lenses|intraocular lenses
693166|NCT00934973|irritable bowel syndrome|irritable bowel syndrome
693167|NCT00934973|treatment|treatment
693168|NCT00934986|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
693169|NCT00934986|NK Cells|nk cells
693170|NCT00935025|Phase I|phase i
693171|NCT00935025|Japanese healthy volunteer|japanese healthy volunteer
693172|NCT00935025|AZD1305|azd1305
693173|NCT00935025|Japanese and Caucasian|japanese and caucasian
693174|NCT00935051|type 1 diabetes|type 1 diabetes
693175|NCT00935051|type 2 diabetes|type 2 diabetes
693176|NCT00935051|Diabetic foot ulcer|diabetic foot ulcer
693177|NCT00935064|Diabetes|diabetes
693178|NCT00935077|Hypertension|hypertension
693179|NCT00935077|Pharmacist Physician Collaborative Management of Hypertension|pharmacist physician collaborative management of hypertension
693180|NCT00935090|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
693181|NCT00935090|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
693182|NCT00935090|acute undifferentiated leukemia|acute undifferentiated leukemia
693183|NCT00935090|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
693184|NCT00935090|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
693185|NCT00935090|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
693186|NCT00935090|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
693187|NCT00935090|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
693309|NCT00935090|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
693188|NCT00935090|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
752585|NCT01167790|Precancerous lesions of the oral mucosa|precancerous lesions of the oral mucosa
693189|NCT00935090|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
693190|NCT00935090|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
693191|NCT00935090|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
693192|NCT00935090|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
693193|NCT00935090|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
693194|NCT00935090|mast cell leukemia|mast cell leukemia
693195|NCT00935090|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
693196|NCT00935090|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
693197|NCT00935090|prolymphocytic leukemia|prolymphocytic leukemia
693198|NCT00935090|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
693199|NCT00935090|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
693200|NCT00935090|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
693201|NCT00935090|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
693202|NCT00935090|refractory hairy cell leukemia|refractory hairy cell leukemia
693203|NCT00935090|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
693204|NCT00935090|secondary acute myeloid leukemia|secondary acute myeloid leukemia
693205|NCT00935090|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
693206|NCT00935090|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
693207|NCT00935090|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
693208|NCT00935090|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
693209|NCT00935090|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
693210|NCT00935090|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
693211|NCT00935090|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
693212|NCT00935090|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
693213|NCT00935090|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
693214|NCT00935090|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
693215|NCT00935090|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
693216|NCT00935090|untreated hairy cell leukemia|untreated hairy cell leukemia
693217|NCT00935090|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
693218|NCT00935090|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
693219|NCT00935090|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
693220|NCT00935090|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
693221|NCT00935090|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
693222|NCT00935090|anaplastic large cell lymphoma|anaplastic large cell lymphoma
693223|NCT00935090|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
693224|NCT00935090|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
693225|NCT00935090|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
693226|NCT00935090|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
693227|NCT00935090|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
693228|NCT00935090|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
693229|NCT00935090|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
693230|NCT00935090|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
693231|NCT00935090|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
693232|NCT00935090|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
693233|NCT00935090|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
693234|NCT00935090|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
693235|NCT00935090|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
693236|NCT00935090|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
693237|NCT00935090|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
693238|NCT00935090|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
693239|NCT00935090|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
693240|NCT00935090|splenic marginal zone lymphoma|splenic marginal zone lymphoma
693241|NCT00935090|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
693242|NCT00935090|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
693243|NCT00935090|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
693244|NCT00935090|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
693245|NCT00935090|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
693246|NCT00935090|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
693247|NCT00935090|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
693248|NCT00935090|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
693399|NCT00935376|Mindfulness Meditation|mindfulness meditation
693249|NCT00935090|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
693250|NCT00935090|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
693401|NCT00935402|Energy balance|energy balance
693251|NCT00935090|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
693252|NCT00935090|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
693253|NCT00935090|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
693254|NCT00935090|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
693255|NCT00935090|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
693256|NCT00935090|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
693257|NCT00935090|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
693258|NCT00935090|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
693259|NCT00935090|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
693260|NCT00935090|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
693517|NCT00941512|Colposcopy|colposcopy
693261|NCT00935090|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
693262|NCT00935090|stage I mantle cell lymphoma|stage i mantle cell lymphoma
693263|NCT00935090|stage I marginal zone lymphoma|stage i marginal zone lymphoma
693264|NCT00935090|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
693265|NCT00935090|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
693266|NCT00935090|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
693267|NCT00935090|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
693268|NCT00935090|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
693269|NCT00935090|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
693270|NCT00935090|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
693271|NCT00935090|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
693272|NCT00935090|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
693273|NCT00935090|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
693274|NCT00935090|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
693275|NCT00935090|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
693276|NCT00935090|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
693277|NCT00935090|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
693278|NCT00935090|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
693386|NCT00935337|Mind body bridging|mind body bridging
693279|NCT00935090|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
693280|NCT00935090|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
693281|NCT00935090|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
693282|NCT00935090|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
693283|NCT00935090|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
693284|NCT00935090|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
693285|NCT00935090|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
693286|NCT00935090|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
693287|NCT00935090|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
693288|NCT00935090|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
693289|NCT00935090|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
693290|NCT00935090|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
693291|NCT00935090|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
693292|NCT00935090|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
693293|NCT00935090|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
693294|NCT00935090|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
693295|NCT00935090|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
693296|NCT00935090|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
693297|NCT00935090|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
693298|NCT00935090|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
693299|NCT00935090|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
693300|NCT00935090|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
693301|NCT00935090|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
693302|NCT00935090|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
693303|NCT00935090|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
693304|NCT00935090|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
693305|NCT00935090|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
693306|NCT00935090|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
693307|NCT00935090|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
693308|NCT00935090|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
693310|NCT00935090|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
693402|NCT00935402|Weight management|weight management
693311|NCT00935090|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
693312|NCT00935090|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
693313|NCT00935090|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
693314|NCT00935090|intraocular lymphoma|intraocular lymphoma
693315|NCT00935090|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
693316|NCT00935090|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
693317|NCT00935090|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
693318|NCT00935090|chronic eosinophilic leukemia|chronic eosinophilic leukemia
693319|NCT00935090|chronic neutrophilic leukemia|chronic neutrophilic leukemia
693320|NCT00935090|primary myelofibrosis|primary myelofibrosis
693321|NCT00935090|essential thrombocythemia|essential thrombocythemia
693322|NCT00935090|polycythemia vera|polycythemia vera
693323|NCT00935090|extramedullary plasmacytoma|extramedullary plasmacytoma
693324|NCT00935090|isolated plasmacytoma of bone|isolated plasmacytoma of bone
693325|NCT00935090|stage I multiple myeloma|stage i multiple myeloma
693326|NCT00935090|stage II multiple myeloma|stage ii multiple myeloma
693327|NCT00935090|stage III multiple myeloma|stage iii multiple myeloma
693328|NCT00935090|primary systemic amyloidosis|primary systemic amyloidosis
693329|NCT00935090|refractory multiple myeloma|refractory multiple myeloma
693330|NCT00935090|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
693331|NCT00935090|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
693332|NCT00935090|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
693333|NCT00935090|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
693334|NCT00935103|Addiction|addiction
693335|NCT00935103|Psychoeducation|psychoeducation
693336|NCT00935103|Risk reduction behaviour|risk reduction behaviour
693337|NCT00935103|Drop in center (DIC)|drop in center (dic)
693338|NCT00935129|Treatment satisfaction|treatment satisfaction
693340|NCT00935129|Insulin pump|insulin pump
693341|NCT00935129|diabetes|diabetes
693342|NCT00935142|stage IV cancer with no treatment options|stage iv cancer with no treatment options
693343|NCT00935142|non-curative|non-curative
693344|NCT00935155|exercise therapy|exercise therapy
693345|NCT00935155|Knee arthroplasty|knee arthroplasty
693346|NCT00935155|Acupuncture Analgesia|acupuncture analgesia
693347|NCT00935155|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
693348|NCT00935155|rehabilitation|rehabilitation
693349|NCT00935168|Intensive Care|intensive care
693350|NCT00935168|Fluid Resuscitation|fluid resuscitation
693351|NCT00935168|Saline|saline
693352|NCT00935168|Hydroxy-ethyl starch|hydroxy-ethyl starch
693353|NCT00935181|COPD|copd
693354|NCT00935181|diaphragm|diaphragm
693355|NCT00935181|muscle|muscle
693356|NCT00935181|stretching|stretching
693357|NCT00935181|exercises|exercises
693358|NCT00935181|dyspnea|dyspnea
693359|NCT00935181|respiratory muscle stretching|respiratory muscle stretching
693360|NCT00935181|pulmonary rehabilitation|pulmonary rehabilitation
693361|NCT00935181|exercise training|exercise training
693362|NCT00935181|improved exercise capacity, dyspnea, quality of life|improved exercise capacity, dyspnea, quality of life
693363|NCT00935194|Novel Influenza A(H1N1)|novel influenza a(h1n1)
693364|NCT00935194|Oseltamivir|oseltamivir
693365|NCT00935194|Chinese Medicinal Herbs|chinese medicinal herbs
693366|NCT00935207|Pain|pain
693367|NCT00935207|Pediatric Pain|pediatric pain
693368|NCT00935207|Pain Diary|pain diary
693369|NCT00935207|Pediatric Pain Measurement|pediatric pain measurement
693370|NCT00935207|Pain Measurement|pain measurement
693371|NCT00935233|ductal breast carcinoma in situ|ductal breast carcinoma in situ
693372|NCT00935246|Genomic devices|genomic devices
693373|NCT00935246|Prediction of Escitalopram Response|prediction of escitalopram response
693374|NCT00935246|Depressed Patients|depressed patients
693375|NCT00935259|Hypercholesterolemia, Dyslipidemia, simvastatin, Zocor|hypercholesterolemia, dyslipidemia, simvastatin, zocor
693376|NCT00935285|Ventilator-associated pneumonia (VAP)|ventilator-associated pneumonia (vap)
693377|NCT00935285|Intensive care unit (ICU)|intensive care unit (icu)
693378|NCT00935285|Toll-like receptors|toll-like receptors
693379|NCT00935298|Renal Transplantation|renal transplantation
693380|NCT00935298|Tacrolimus|tacrolimus
693381|NCT00935298|CYP3A5|cyp3a5
693382|NCT00935298|Genotyping|genotyping
693383|NCT00935324|allo-SCT, GvHD, CK18-F|allo-sct, gvhd, ck18-f
693384|NCT00935337|Sleep problems|sleep problems
693385|NCT00935337|Awareness training program|awareness training program
693387|NCT00935350|viscous|viscous
693388|NCT00935350|fibre|fibre
693389|NCT00935350|polysaccharide|polysaccharide
693390|NCT00935350|blood glucose|blood glucose
693391|NCT00935350|postprandial|postprandial
693392|NCT00935363|glyburide|glyburide
693393|NCT00935363|pharmacokinetics|pharmacokinetics
693394|NCT00935363|pharmacodynamics|pharmacodynamics
693395|NCT00935363|drug interaction|drug interaction
693396|NCT00935363|Healthy Volunteers|healthy volunteers
693397|NCT00935376|Sleep Management|sleep management
693398|NCT00935376|Awareness Training Programs|awareness training programs
693400|NCT00935376|Mind Body Bridging|mind body bridging
693404|NCT00935402|Energy expenditure|energy expenditure
693405|NCT00935415|asthma|asthma
693406|NCT00935415|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
693407|NCT00935415|montelukast|montelukast
693408|NCT00935415|clinical protection|clinical protection
693409|NCT00935415|children|children
693410|NCT00935415|time effect|time effect
693411|NCT00935428|Equestrian injury|equestrian injury
693412|NCT00935428|Horse injury|horse injury
693413|NCT00935428|Trauma|trauma
693414|NCT00935428|Horse|horse
693415|NCT00935428|Equestrian|equestrian
693416|NCT00935441|Diabetes mellitus|diabetes mellitus
693417|NCT00935441|chronic care|chronic care
693418|NCT00935441|case management|case management
693420|NCT00935454|hepatocyte matrix implantation|hepatocyte matrix implantation
693421|NCT00935454|endstage liver disease|endstage liver disease
693422|NCT00935454|liver cirrhosis|liver cirrhosis
693423|NCT00935454|impaired liver parenchyma|impaired liver parenchyma
693424|NCT00935454|improvement of liver function|improvement of liver function
693426|NCT00935480|INTEGRASE INHIBITOR|integrase inhibitor
693427|NCT00935480|Inhibitor on the lymphoid reservoir|inhibitor on the lymphoid reservoir
693428|NCT00935480|Residual HIV replication|residual hiv replication
693429|NCT00935480|treatment experienced|treatment experienced
693430|NCT00935493|guanfacine|guanfacine
693431|NCT00935493|aging|aging
693432|NCT00935493|cognitive aging|cognitive aging
693433|NCT00935493|prefrontal cognitive function|prefrontal cognitive function
695780|NCT00953654|Generalized Anxiety Disorder|generalized anxiety disorder
695781|NCT00953654|Exercise Training|exercise training
695782|NCT00953654|Strength Training|strength training
695783|NCT00953654|Mental Health|mental health
695785|NCT00953693|Hepatic disorders|hepatic disorders
693434|NCT00935493|executive function|executive function
693435|NCT00935493|prefrontal cortex|prefrontal cortex
693436|NCT00935519|total hip arthroplasty, ceramic, survival|total hip arthroplasty, ceramic, survival
693437|NCT00935532|diabetes; exenatide once weekly; Byetta; glargine; Lantus; Amylin; Lilly|diabetes; exenatide once weekly; byetta; glargine; lantus; amylin; lilly
693438|NCT00935545|Brain Tumors|brain tumors
693439|NCT00935545|High Grade|high grade
693441|NCT00935558|dendritic cell|dendritic cell
693442|NCT00935558|cancer vaccine|cancer vaccine
693443|NCT00935558|breast cancer|breast cancer
693444|NCT00935558|aromatase inhibitor|aromatase inhibitor
693445|NCT00935558|Zadaxin|zadaxin
693446|NCT00935584|Communication|communication
693447|NCT00935584|Doctor-patient relations|doctor-patient relations
693448|NCT00935584|medical informatics|medical informatics
693449|NCT00935584|patient-centered care|patient-centered care
693450|NCT00935584|medical records systems, computerized|medical records systems, computerized
693451|NCT00935597|Relapsed Non-Hodgkin's Lymphoma|relapsed non-hodgkin's lymphoma
693452|NCT00935597|Hodgkin's Disease|hodgkin's disease
693453|NCT00935597|Multiple Myeloma|multiple myeloma
693454|NCT00935597|Chronic Lymphocytic Lymphoma|chronic lymphocytic lymphoma
693455|NCT00935597|Relapsed Non-Hodgkin's lymphoma (excluding follicular lymphoma and marginal zone lymphoma)|relapsed non-hodgkin's lymphoma (excluding follicular lymphoma and marginal zone lymphoma)
693456|NCT00935610|Elderly persons|elderly persons
693457|NCT00935610|Muscle function and strength|muscle function and strength
693458|NCT00935610|Body composition|body composition
693459|NCT00935610|Inflammatory cytokine levels|inflammatory cytokine levels
693460|NCT00935610|Cognitive functions|cognitive functions
693461|NCT00935610|Cysteine-rich whey protein isolate|cysteine-rich whey protein isolate
693462|NCT00935610|Immunocal|immunocal
693463|NCT00935610|Resistance training|resistance training
693464|NCT00935610|Improved muscle function|improved muscle function
693465|NCT00935610|Improved quality of life|improved quality of life
693466|NCT00935610|Aging processes|aging processes
693467|NCT00935610|Quality of life|quality of life
693468|NCT00941317|onychomycosis|onychomycosis
693469|NCT00941317|micro-drilling|micro-drilling
693470|NCT00941330|Breast, Male|breast, male
693471|NCT00941330|Breast, Female|breast, female
693472|NCT00941356|MRSA nasal colonisation|mrsa nasal colonisation
693473|NCT00941356|Probiotics|probiotics
693474|NCT00941382|sibutramine|sibutramine
693475|NCT00941382|metformin|metformin
693476|NCT00941382|obesity|obesity
693477|NCT00941395|Cancer Prevention|cancer prevention
693478|NCT00941395|College students|college students
693479|NCT00941395|Prevention intervention|prevention intervention
693480|NCT00941395|Smoking|smoking
693481|NCT00941395|Tobacco|tobacco
693482|NCT00941395|Internet-based|internet-based
693483|NCT00941395|Cognitive Behavioral Therapy|cognitive behavioral therapy
693484|NCT00941395|Nicotine lozenges|nicotine lozenges
693485|NCT00941434|RUTF|rutf
693486|NCT00941434|SAM|sam
693487|NCT00941434|Nutributter|nutributter
693488|NCT00941447|Type 2 Diabetes|type 2 diabetes
693489|NCT00941447|Obesity|obesity
693490|NCT00941447|Self-Regulation|self-regulation
693491|NCT00941447|Self-Efficacy|self-efficacy
693492|NCT00941460|progressive or recurrent glioblastoma|progressive or recurrent glioblastoma
693493|NCT00941460|temozolomide|temozolomide
693494|NCT00941460|dose intensification|dose intensification
694192|NCT00943969|absorption|absorption
693495|NCT00941460|comparison of two dosing regimens|comparison of two dosing regimens
693496|NCT00941473|Epidural Injection|epidural injection
693497|NCT00941473|Bone Density|bone density
693498|NCT00941499|Advanced Cancers|advanced cancers
693499|NCT00941499|Liver|liver
693500|NCT00941499|Oxaliplatin|oxaliplatin
693504|NCT00941499|Anit-VEGF monoclonal antibody|anit-vegf monoclonal antibody
693505|NCT00941499|rhuMAb-VEGF|rhumab-vegf
693506|NCT00941499|5-fluorouracil|5-fluorouracil
693507|NCT00941499|5-FU|5-fu
693508|NCT00941499|Adrucil|adrucil
693509|NCT00941499|Efudex|efudex
693510|NCT00941499|Leucovorin|leucovorin
693511|NCT00941499|Citrovorum|citrovorum
693512|NCT00941499|Wellcovorin|wellcovorin
693513|NCT00941499|Cetuximab|cetuximab
693514|NCT00941499|C225|c225
693515|NCT00941499|Erbitux|erbitux
693516|NCT00941499|IMC-C225|imc-c225
693518|NCT00941525|Central corneal thickness|central corneal thickness
693519|NCT00941525|24hour fluctuation of intraocular pressure|24hour fluctuation of intraocular pressure
693520|NCT00941525|Open angle glaucoma|open angle glaucoma
693521|NCT00941525|Ocular hypertension|ocular hypertension
693522|NCT00941538|nasopharyngeal cancer|nasopharyngeal cancer
693523|NCT00941538|screening|screening
693524|NCT00941538|biomarker|biomarker
693525|NCT00941538|early detection|early detection
693526|NCT00941538|epidemiological survey|epidemiological survey
693527|NCT00941551|Thyroid lobectomy,|thyroid lobectomy,
693528|NCT00941551|prophylactic levothyroxine treatment,|prophylactic levothyroxine treatment,
693529|NCT00941551|recurrent nodular goiter,|recurrent nodular goiter,
693530|NCT00941551|iodine deficiency,|iodine deficiency,
693531|NCT00941551|long-term follow-up,|long-term follow-up,
693532|NCT00941551|completion thyroidectomy|completion thyroidectomy
693533|NCT00941577|Hypersensitivity|hypersensitivity
693534|NCT00941577|Lung Diseases, Obstructive|lung diseases, obstructive
693535|NCT00941577|Immune System Diseases|immune system diseases
693536|NCT00941577|Respiratory Tract Diseases|respiratory tract diseases
693537|NCT00941577|Bronchial Diseases|bronchial diseases
693538|NCT00941577|Lung Diseases|lung diseases
693539|NCT00941577|Hypersensitivity, Immediate|hypersensitivity, immediate
693540|NCT00941577|Asthma|asthma
693541|NCT00941577|Respiratory Hypersensitivity|respiratory hypersensitivity
693542|NCT00941590|tick borne encephalitis|tick borne encephalitis
693543|NCT00941590|clinical outcome|clinical outcome
693544|NCT00941590|postencephalitic symptoms|postencephalitic symptoms
693545|NCT00941616|Von Willebrand Disease|von willebrand disease
693546|NCT00941629|PTSD|ptsd
693547|NCT00941629|Telemedicine|telemedicine
693548|NCT00941629|Clinical Trial|clinical trial
693549|NCT00941629|Psychotherapy|psychotherapy
693550|NCT00941759|Breast|breast
693551|NCT00941759|Blood and tissue collection|blood and tissue collection
693552|NCT00941759|Epidemiologic|epidemiologic
693553|NCT00941759|Questionnaire|questionnaire
693554|NCT00941759|TBCRC (Translational Breast Cancer Research Consortium)|tbcrc (translational breast cancer research consortium)
693555|NCT00941759|09-056|09-056
693556|NCT00941772|Nasogastric tube verification with ultrasonography|nasogastric tube verification with ultrasonography
693557|NCT00941772|ultrasonography|ultrasonography
693558|NCT00941785|Malaria|malaria
693559|NCT00941785|Intermittent Preventive Treatment|intermittent preventive treatment
693560|NCT00941785|IPTc|iptc
693561|NCT00941785|sIPTc|siptc
693562|NCT00941785|Burkina Faso|burkina faso
693563|NCT00941798|Asthma|asthma
693564|NCT00941798|LABA|laba
693565|NCT00941798|Safety|safety
693566|NCT00941824|pharmacokinetic|pharmacokinetic
693567|NCT00941824|mycophénolate acid|mycophénolate acid
693568|NCT00941824|kidney transplantation|kidney transplantation
693569|NCT00941837|Palm olein|palm olein
693570|NCT00941837|homocsyteine|homocsyteine
693571|NCT00941837|Cholesterol|cholesterol
693572|NCT00941837|lipoproteins|lipoproteins
693573|NCT00941837|Interleukins|interleukins
693574|NCT00941837|CRP|crp
693575|NCT00941837|Blood Pressure|blood pressure
693576|NCT00941837|Total homocystein|total homocystein
693577|NCT00941837|Serum lipid profile|serum lipid profile
693578|NCT00941837|Serum apolipoproteins|serum apolipoproteins
693579|NCT00941837|Inflammatory markers|inflammatory markers
693580|NCT00941850|Cardiac resynchronizton therapy|cardiac resynchronizton therapy
693581|NCT00941850|CRT|crt
693582|NCT00941850|Heart failure|heart failure
693583|NCT00941850|Dyssynchrony|dyssynchrony
693584|NCT00941850|Echocardiography|echocardiography
693585|NCT00941850|Pacemakers|pacemakers
693586|NCT00941850|Nonresponders|nonresponders
693587|NCT00941863|Sorafenib|sorafenib
693588|NCT00941863|Advanced Solid Tumors|advanced solid tumors
693589|NCT00941863|Maximum tolerated dose|maximum tolerated dose
693590|NCT00941863|Carboplatin and paclitaxel chemotherapy combination|carboplatin and paclitaxel chemotherapy combination
693591|NCT00941876|AE|ae
693592|NCT00941876|adverse event|adverse event
693593|NCT00941876|AIDS|aids
693594|NCT00941876|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
693595|NCT00941876|ALT (SGPT)|alt (sgpt)
693596|NCT00941876|alanine aminotransferase|alanine aminotransferase
693597|NCT00941876|ART|art
694297|NCT00932334|donation|donation
693598|NCT00941876|antiretroviral therapy|antiretroviral therapy
693599|NCT00941876|AST (SGOT)|ast (sgot)
693600|NCT00941876|aspartate aminotransferase|aspartate aminotransferase
693601|NCT00941876|DCF|dcf
693602|NCT00941876|data collection forms|data collection forms
693603|NCT00941876|DMC|dmc
693604|NCT00941876|Data Monitoring Committee|data monitoring committee
693606|NCT00941876|(U.S.) Food and Drug Administration|(u.s.) food and drug administration
693607|NCT00941876|GCP|gcp
693608|NCT00941876|Good Clinical Practice guidelines|good clinical practice guidelines
693609|NCT00941876|HB sAg|hb sag
693610|NCT00941876|Hepatitis B surface antigen|hepatitis b surface antigen
693611|NCT00941876|ICH|ich
693612|NCT00941876|International Conference of Harmonisation|international conference of harmonisation
693613|NCT00941876|IND|ind
693614|NCT00941876|Investigational New Drug Application|investigational new drug application
693615|NCT00941876|IRB|irb
693616|NCT00941876|Institutional Review Board|institutional review board
693617|NCT00941876|IU|iu
693618|NCT00941876|International units|international units
693619|NCT00941876|mg|mg
693620|NCT00941876|milligram(s)|milligram(s)
693621|NCT00941876|mm3|mm3
693622|NCT00941876|cubic millimeter(s)|cubic millimeter(s)
693623|NCT00941876|PCR|pcr
693624|NCT00941876|polymerase chain reaction|polymerase chain reaction
693625|NCT00941876|SAE|sae
693626|NCT00941876|serious adverse event|serious adverse event
693627|NCT00941876|µg|µg
693628|NCT00941876|microgram|microgram
693629|NCT00941876|ULN|uln
693630|NCT00941876|upper limit of the normal range|upper limit of the normal range
693631|NCT00941876|WB|wb
693632|NCT00941876|Western Blot|western blot
693633|NCT00941876|To inform the Ministry of Health strategy for integrating FP and HIV/AIDS Care and Treatment Services in Tanzania|to inform the ministry of health strategy for integrating fp and hiv/aids care and treatment services in tanzania
693634|NCT00941876|HIV seronegativity|hiv seronegativity
693635|NCT00941889|HIV|hiv
693636|NCT00941889|HPV|hpv
693637|NCT00941889|Anal condylomata|anal condylomata
693638|NCT00941889|Vaccine|vaccine
693639|NCT00941889|HIV positive patients|hiv positive patients
693640|NCT00941889|Anal condylomata or anal warts|anal condylomata or anal warts
693641|NCT00941902|human asialoglycoprotein receptor (ASGPR)|human asialoglycoprotein receptor (asgpr)
693642|NCT00941902|hepatocytes|hepatocytes
693643|NCT00941902|bariatric surgery|bariatric surgery
693644|NCT00941915|CaP|cap
693645|NCT00941915|SBRT|sbrt
693646|NCT00941915|Prostate|prostate
693647|NCT00941915|ExacTrac|exactrac
693648|NCT00941915|Calypso|calypso
693649|NCT00941915|IMRT|imrt
693650|NCT00941915|Radiation|radiation
693651|NCT00941915|Cancer of Prostate|cancer of prostate
693652|NCT00941915|Prostatic Neoplasms|prostatic neoplasms
693653|NCT00941928|Blood And Marrow Transplantation|blood and marrow transplantation
693654|NCT00941928|Relapsed Acute Lymphoblastic Leukemia|relapsed acute lymphoblastic leukemia
693655|NCT00941928|ALL|all
693656|NCT00941928|Leukemia|leukemia
693657|NCT00941928|Pediatrics|pediatrics
693658|NCT00941928|Haploidentical NK cells|haploidentical nk cells
693659|NCT00941928|Cyclophosphamide|cyclophosphamide
693660|NCT00941928|Cytoxan|cytoxan
693661|NCT00941928|Neosar|neosar
693662|NCT00941928|Epratuzumab|epratuzumab
693663|NCT00941928|Fludarabine|fludarabine
693664|NCT00941928|Fludarabine Phosphate|fludarabine phosphate
693665|NCT00941928|Fludara|fludara
693666|NCT00941928|Interleukin-2|interleukin-2
693667|NCT00941928|IL-2|il-2
693668|NCT00941928|Proleukin|proleukin
693669|NCT00941928|Low-dose interleukin|low-dose interleukin
693670|NCT00941928|Mesna|mesna
693671|NCT00941928|Mesnex|mesnex
693672|NCT00941928|Natural Killer Cells|natural killer cells
693673|NCT00941928|NK Cells Transplant|nk cells transplant
693674|NCT00941941|Inguinal|inguinal
693675|NCT00941941|Hernia|hernia
693676|NCT00941941|Hernia-repair|hernia-repair
693677|NCT00941941|Non-mesh|non-mesh
693678|NCT00941941|Mesh|mesh
693679|NCT00941941|Desarda|desarda
693680|NCT00941941|Lichtenstein|lichtenstein
693681|NCT00941954|Physical activity|physical activity
693682|NCT00941954|Diabetes|diabetes
693683|NCT00941954|Prevention|prevention
693684|NCT00941954|Pedometer|pedometer
693685|NCT00941954|Walking|walking
693686|NCT00941954|Structured education|structured education
693687|NCT00941954|Randomized|randomized
693688|NCT00941954|Risk score|risk score
693689|NCT00941954|Impaired glucose regulation|impaired glucose regulation
693690|NCT00941967|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
693691|NCT00941967|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
693692|NCT00941967|recurrent adult primary liver cancer|recurrent adult primary liver cancer
693693|NCT00941967|advanced adult primary liver cancer|advanced adult primary liver cancer
693694|NCT00941980|biologics|biologics
693695|NCT00941980|fusion rates|fusion rates
693696|NCT00941980|PLIF|plif
693697|NCT00941980|lumbar fusion|lumbar fusion
693698|NCT00942006|Lyme neuroborreliosis|lyme neuroborreliosis
693699|NCT00942006|Lyme borreliosis|lyme borreliosis
695194|NCT00950118|Genes|genes
694390|NCT00932750|Diet|diet
693700|NCT00942006|erythema migrans|erythema migrans
693701|NCT00942006|doxycycline treatment|doxycycline treatment
693702|NCT00942006|ceftriaxone treatment|ceftriaxone treatment
693703|NCT00942006|outcome|outcome
693704|NCT00942006|subjective symptoms|subjective symptoms
693705|NCT00942019|BMI|bmi
693706|NCT00942019|obesity|obesity
693707|NCT00942019|CO|co
693708|NCT00942019|tobacco smoking|tobacco smoking
693710|NCT00942045|cervical spine|cervical spine
693711|NCT00942045|ACDF|acdf
693712|NCT00942045|biologics|biologics
693713|NCT00942045|fusion rates|fusion rates
693714|NCT00942058|biological markers|biological markers
693715|NCT00942058|CA9 protein|ca9 protein
693716|NCT00942058|metastatic conventional renal cell cancer|metastatic conventional renal cell cancer
693717|NCT00942058|kidney cancer|kidney cancer
693718|NCT00942071|Influenza|influenza
693719|NCT00942071|Vaccine|vaccine
693720|NCT00942084|HSV|hsv
693722|NCT00942084|Pharmacokinetics|pharmacokinetics
693724|NCT00942084|Premature|premature
693725|NCT00942084|Sepsis|sepsis
693726|NCT00942097|Homeopathy|homeopathy
693727|NCT00942097|overweight|overweight
693728|NCT00942097|obesity|obesity
693729|NCT00942097|mental disorder|mental disorder
693730|NCT00942097|pregnancy|pregnancy
693731|NCT00942097|Overweight pregnant women with suspicious mental disorder|overweight pregnant women with suspicious mental disorder
696081|NCT00944931|Cognitive Enhancement|cognitive enhancement
696082|NCT00944931|Prefrontal Cortex|prefrontal cortex
696083|NCT00944931|Healthy Volunteer|healthy volunteer
693732|NCT00942110|Postprandial glucose, lipid metabolism|postprandial glucose, lipid metabolism
693733|NCT00942110|humoral factors|humoral factors
693735|NCT00942136|GSK1349572|gsk1349572
693736|NCT00942136|omeprazole|omeprazole
693737|NCT00942136|Prilosec|prilosec
693738|NCT00942136|supratherapeutic dose|supratherapeutic dose
693739|NCT00942136|pharmacokinetics|pharmacokinetics
693740|NCT00942136|drug interaction|drug interaction
693741|NCT00942136|HIV Infections|hiv infections
693742|NCT00942149|Infants|infants
693743|NCT00942149|Daptomycin|daptomycin
693744|NCT00942162|PREDICT|predict
693745|NCT00942162|ASCI|asci
693746|NCT00942162|Tumor antigen|tumor antigen
693747|NCT00942162|Melanoma|melanoma
693748|NCT00942162|Immunotherapeutic|immunotherapeutic
693749|NCT00942175|Pharmacology|pharmacology
693750|NCT00942175|Stomach Ulcer|stomach ulcer
693751|NCT00942175|Esophagitis, Peptic|esophagitis, peptic
693752|NCT00942175|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
693753|NCT00942175|Platelet function|platelet function
693754|NCT00942175|PPI|ppi
693755|NCT00942175|clopidogrel|clopidogrel
693756|NCT00942175|Pharmacokinetics and Pharmacodynamics|pharmacokinetics and pharmacodynamics
693757|NCT00942188|Diabetes|diabetes
693758|NCT00942188|Type 2 Diabetes|type 2 diabetes
693759|NCT00942201|Asthma|asthma
693760|NCT00942201|Dexamethasone|dexamethasone
693761|NCT00942201|Emergency Department|emergency department
693762|NCT00942214|Multiple sclerosis|multiple sclerosis
693763|NCT00942214|natalizumab|natalizumab
693764|NCT00942214|pharmacogenomics|pharmacogenomics
693765|NCT00942227|Sciatica|sciatica
693766|NCT00942227|Radiculopathy|radiculopathy
693767|NCT00942227|Physical therapy modalities|physical therapy modalities
693768|NCT00942227|Rehabilitation|rehabilitation
693769|NCT00942253|RLS|rls
693770|NCT00942253|Muscle|muscle
693771|NCT00942253|Dialysis|dialysis
693772|NCT00942253|exercise|exercise
693773|NCT00942253|dopamine agonist|dopamine agonist
693774|NCT00942253|Sleep|sleep
693775|NCT00942292|Hepatic|hepatic
693776|NCT00942292|colorectal|colorectal
693777|NCT00942292|metastases|metastases
693778|NCT00942292|TPN|tpn
693779|NCT00942292|Fish oil|fish oil
693780|NCT00942305|Allogeneic stem cell transplant|allogeneic stem cell transplant
693781|NCT00942305|CMV seropositive (R+)|cmv seropositive (r+)
693782|NCT00942305|transplant|transplant
693783|NCT00942305|Allogeneic stem cell transplant recipients who were CMV seropositive (R+) at the time of transplant will be eligible for enrollment|allogeneic stem cell transplant recipients who were cmv seropositive (r+) at the time of transplant will be eligible for enrollment
693784|NCT00942318|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
693785|NCT00942318|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
693786|NCT00942318|Insulin external pump|insulin external pump
693787|NCT00942318|Multiple daily injections|multiple daily injections
693788|NCT00942318|Basal-bolus regimen|basal-bolus regimen
693789|NCT00942318|Education|education
693790|NCT00942344|Amlodipine|amlodipine
693791|NCT00942344|Losartan|losartan
693792|NCT00942344|Hypertension|hypertension
693793|NCT00942370|mechanography|mechanography
693794|NCT00942370|electromyography|electromyography
693795|NCT00942370|effort cough|effort cough
693796|NCT00942383|liver tumor|liver tumor
693797|NCT00942383|liver tumors|liver tumors
693798|NCT00942383|liver cancer|liver cancer
693799|NCT00942383|hepatocellular carcinoma|hepatocellular carcinoma
693800|NCT00942383|metastatic colorectal cancer|metastatic colorectal cancer
693801|NCT00942383|metastatic cancer to the liver|metastatic cancer to the liver
693802|NCT00942383|metastatic cancer|metastatic cancer
693803|NCT00942383|metastatic neuroendocrine cancer|metastatic neuroendocrine cancer
693804|NCT00942383|liver|liver
693805|NCT00942383|liver surgery|liver surgery
693806|NCT00942383|radiofrequency ablation|radiofrequency ablation
693807|NCT00942383|microwave ablation|microwave ablation
693808|NCT00942396|Mammography|mammography
693809|NCT00942422|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
693810|NCT00942422|smoldering multiple myeloma|smoldering multiple myeloma
693811|NCT00942435|YM150|ym150
693814|NCT00942435|FXa inhibitor|fxa inhibitor
693815|NCT00942435|Deep Vein Thrombosis|deep vein thrombosis
693816|NCT00942435|Venous thromboembolism|venous thromboembolism
693817|NCT00942461|a-defensins|a-defensins
693818|NCT00942461|TLRs|tlrs
693819|NCT00942461|Inflammatory Cytokines|inflammatory cytokines
693820|NCT00942461|CRP|crp
693821|NCT00942461|No metastases|no metastases
693822|NCT00942461|No other obvious inflammation|no other obvious inflammation
693823|NCT00942461|No chronic diseases|no chronic diseases
751855|NCT01170845|Postoperative respiratory complications|postoperative respiratory complications
751856|NCT01170845|neutrophil elastase inhibitor|neutrophil elastase inhibitor
693824|NCT00942474|The focus of the study is to assess the ability of the nerve access tool to facilitate nerve lead placement|the focus of the study is to assess the ability of the nerve access tool to facilitate nerve lead placement
693825|NCT00942487|arterial hypertension|arterial hypertension
693826|NCT00942500|Post-conditioning|post-conditioning
693827|NCT00942500|ST-elevation myocardial infarction|st-elevation myocardial infarction
693828|NCT00942500|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
693829|NCT00942513|substrate absorption|substrate absorption
693830|NCT00942513|substrate oxidation|substrate oxidation
693831|NCT00942513|glucose regulation|glucose regulation
693832|NCT00942513|whey protein|whey protein
693833|NCT00942513|soy protein|soy protein
693834|NCT00942513|sucrose|sucrose
693835|NCT00942513|fructose|fructose
693836|NCT00942513|lactose|lactose
693837|NCT00942526|esophageal cancer|esophageal cancer
693838|NCT00942526|anastomotic leakage|anastomotic leakage
693839|NCT00942526|Prevention of anastomotic leakage after esophageal surgery|prevention of anastomotic leakage after esophageal surgery
693840|NCT00942539|Neonates|neonates
693841|NCT00942565|Open gynecological surgery|open gynecological surgery
693842|NCT00942578|Dual Antiangiogenic Combination Therapy for mCRPC|dual antiangiogenic combination therapy for mcrpc
693843|NCT00942578|Efficacy and Toxicity Profile|efficacy and toxicity profile
693844|NCT00942578|Single Stage Phase 2 With Early Stopping, Run In Phase For Toxicity|single stage phase 2 with early stopping, run in phase for toxicity
693845|NCT00942578|Correlative Measurements|correlative measurements
693846|NCT00942578|Overall Survival Assessment|overall survival assessment
693847|NCT00942578|Metastatic Prostate Cancer|metastatic prostate cancer
693848|NCT00942578|Prostate Cancer|prostate cancer
693849|NCT00942591|multiple sclerosis|multiple sclerosis
693850|NCT00942591|interferon beta|interferon beta
693851|NCT00942591|atorvastatin|atorvastatin
693852|NCT00942604|Peplin|peplin
693853|NCT00942604|Actinic keratosis|actinic keratosis
693854|NCT00942604|PEP005|pep005
693855|NCT00942617|platelet aggregation|platelet aggregation
693856|NCT00942617|granule secretion|granule secretion
693857|NCT00942617|thromboxane production|thromboxane production
693858|NCT00942617|cyclooxygenase-1|cyclooxygenase-1
693859|NCT00942617|ATP release|atp release
693860|NCT00942617|aspirin resistance|aspirin resistance
693861|NCT00942617|platelet activation|platelet activation
693862|NCT00942617|flow cytometry|flow cytometry
693863|NCT00942617|Platelet aggregation in healthy volunteers|platelet aggregation in healthy volunteers
693864|NCT00942630|percutaneous|percutaneous
693865|NCT00942630|transhepatic|transhepatic
693866|NCT00942630|biliary|biliary
693867|NCT00942630|drainage|drainage
693868|NCT00942630|cholangioscopy|cholangioscopy
693869|NCT00942656|trans fatty acids|trans fatty acids
693870|NCT00942656|ruminant|ruminant
693871|NCT00942656|cardiovascular disease|cardiovascular disease
693872|NCT00942669|Sleep Apnea Syndrome|sleep apnea syndrome
693873|NCT00942669|SAS|sas
693874|NCT00942669|SleepStrip OTC|sleepstrip otc
693875|NCT00942682|sorafenib|sorafenib
693876|NCT00942682|RAD001|rad001
693877|NCT00942695|pistachio|pistachio
693878|NCT00942695|nuts|nuts
693879|NCT00942695|energy value|energy value
693880|NCT00942695|cardiovascular disease|cardiovascular disease
693881|NCT00942695|phytonutrient|phytonutrient
693882|NCT00942695|gene expression|gene expression
693883|NCT00942695|energy value of pistachio nuts|energy value of pistachio nuts
693884|NCT00942708|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
693885|NCT00942708|Pulmonary Hypertension|pulmonary hypertension
693886|NCT00942721|Web-based Intervention|web-based intervention
693887|NCT00942721|CBT Treatment|cbt treatment
693888|NCT00942734|Head and Neck|head and neck
693889|NCT00942734|Squamous Cell Carcinoma|squamous cell carcinoma
693890|NCT00942734|RAD001|rad001
693891|NCT00942734|Erlotinib|erlotinib
693892|NCT00942734|Everolimus|everolimus
693893|NCT00942734|OSI-774|osi-774
693894|NCT00942734|Tarceva|tarceva
693895|NCT00942747|temsirolimus, primary CNS lymphoma, PCNSL, salvage treatment|temsirolimus, primary cns lymphoma, pcnsl, salvage treatment
693896|NCT00942773|Healthy volunteer|healthy volunteer
693897|NCT00942786|natriuretic peptides|natriuretic peptides
693898|NCT00942786|emergency non-cardiac surgery|emergency non-cardiac surgery
693899|NCT00942799|Genz-644282|genz-644282
693900|NCT00942799|Topoisomerase I inhibitors|topoisomerase i inhibitors
693901|NCT00942799|Top1|top1
693902|NCT00942799|solid tumors|solid tumors
693903|NCT00942799|dose-escalation|dose-escalation
693904|NCT00942799|pharmacokinetic (PK)|pharmacokinetic (pk)
693905|NCT00942799|MTD (Maximum Tolerated Dose)|mtd (maximum tolerated dose)
693906|NCT00942799|oncology|oncology
693907|NCT00942799|cancer|cancer
693910|NCT00942812|Diarrhea Pack|diarrhea pack
693911|NCT00942812|Social Marketing|social marketing
693912|NCT00942825|NSCL|nscl
693913|NCT00942825|non-squamous non small cell lung cancer|non-squamous non small cell lung cancer
693914|NCT00942825|Lung Cancer|lung cancer
693915|NCT00942825|Lung|lung
693916|NCT00942825|non-squamous|non-squamous
693917|NCT00942825|metastatic|metastatic
693918|NCT00942825|pleural effusion|pleural effusion
693919|NCT00942825|Stage IIIb|stage iiib
693920|NCT00942825|Stage IV|stage iv
693921|NCT00942825|NSCLC|nsclc
693922|NCT00942838|Recurrent Ovarian Carcinoma|recurrent ovarian carcinoma
693923|NCT00942838|Cancer|cancer
693924|NCT00942851|Dystonia|dystonia
693925|NCT00942851|Blepharospasm|blepharospasm
693926|NCT00942851|Botulinum Toxin|botulinum toxin
693927|NCT00942851|Treatment|treatment
693928|NCT00942851|Clinical Trial|clinical trial
693929|NCT00942851|Focal Dystonia|focal dystonia
693930|NCT00942877|VEGF|vegf
693931|NCT00942877|Antiangiogenesis|antiangiogenesis
693932|NCT00942877|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
693933|NCT00942877|Advanced Cancer|advanced cancer
693934|NCT00942877|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
693935|NCT00942877|Sarcoma|sarcoma
693936|NCT00942890|Case Management|case management
693937|NCT00942890|Amputation|amputation
693938|NCT00942890|Muscle strength|muscle strength
693939|NCT00942890|phantom limb pain|phantom limb pain
693940|NCT00942903|HME|hme
693941|NCT00942903|Provox|provox
693942|NCT00942903|voice prosthesis|voice prosthesis
693943|NCT00942903|laryngectomy|laryngectomy
693944|NCT00942916|Make sure the difference of the serum inflammatory marker between the two groups|make sure the difference of the serum inflammatory marker between the two groups
693945|NCT00942929|anorexia nervosa|anorexia nervosa
693946|NCT00942929|adolescents|adolescents
693947|NCT00942929|lung function tests|lung function tests
693948|NCT00942929|refeeding|refeeding
693949|NCT00942981|PET Study|pet study
693950|NCT00942981|(18F) Fallypride|(18f) fallypride
693951|NCT00942981|(11C)NNC-112|(11c)nnc-112
693952|NCT00942981|Schizoaffective Disorder|schizoaffective disorder
693953|NCT00942981|Schizophrenia|schizophrenia
693954|NCT00942981|Healthy Volunteer|healthy volunteer
693955|NCT00942981|HV|hv
693956|NCT00942994|Hypertension|hypertension
693957|NCT00942994|Aliskiren|aliskiren
693958|NCT00942994|Amlodipine|amlodipine
693959|NCT00942994|HCTZ|hctz
693960|NCT00942994|Systolic blood pressure|systolic blood pressure
693961|NCT00942994|Diastolic blood pressure|diastolic blood pressure
693962|NCT00942994|Stage II|stage ii
693963|NCT00942994|Combination|combination
693964|NCT00943020|Dietary supplement|dietary supplement
693965|NCT00943020|Carbohydrate loading|carbohydrate loading
693966|NCT00943020|Healthy volunteers|healthy volunteers
693967|NCT00943020|Anaesthesia|anaesthesia
693968|NCT00943020|Surgery|surgery
693969|NCT00943020|Glutamine|glutamine
693970|NCT00943033|MBCT|mbct
693971|NCT00943033|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
693972|NCT00943033|Mindfulness|mindfulness
693973|NCT00943033|Meditation|meditation
693974|NCT00943033|Relapse Prevention|relapse prevention
693975|NCT00943033|Recurrent Depression|recurrent depression
693976|NCT00943033|Depression|depression
693977|NCT00943033|Major Depressive Disorder|major depressive disorder
693978|NCT00943046|leads|leads
693979|NCT00943046|pacemaker|pacemaker
693980|NCT00943046|efficacy|efficacy
693981|NCT00943046|safety|safety
693982|NCT00943059|Mitochondrial function|mitochondrial function
693983|NCT00943059|Diabetes|diabetes
693984|NCT00943059|Cardiomyopathy|cardiomyopathy
693985|NCT00943059|insulin resistance|insulin resistance
693986|NCT00943059|lipid lowering|lipid lowering
693987|NCT00943059|triglycerides|triglycerides
693988|NCT00943059|Acipimox|acipimox
693989|NCT00943072|Macular edema|macular edema
693990|NCT00943072|Retinal vein occlusion|retinal vein occlusion
693991|NCT00943072|CRVO|crvo
693992|NCT00943072|VEGF Trap-Eye|vegf trap-eye
693993|NCT00943072|best-corrected visual acuity|best-corrected visual acuity
693994|NCT00943072|Regeneron|regeneron
693995|NCT00943072|COPERNICUS|copernicus
693996|NCT00943085|Early Signs of Bipolar Disorder|early signs of bipolar disorder
693997|NCT00943085|High Risk Youth|high risk youth
693998|NCT00943085|Adolescence|adolescence
693999|NCT00943085|Childhood|childhood
694000|NCT00943111|Gaucher disease,|gaucher disease,
694001|NCT00943111|Genz-112638,|genz-112638,
694002|NCT00943111|beta-glucosidase,|beta-glucosidase,
694003|NCT00943111|acid ß-glucosidase,|acid ß-glucosidase,
694004|NCT00943111|glucocerebrosidase,|glucocerebrosidase,
694005|NCT00943111|glucosylceramide,|glucosylceramide,
694006|NCT00943111|D-glucosyl-N-acylsphingosine glucohydrolase,|d-glucosyl-n-acylsphingosine glucohydrolase,
694007|NCT00943111|substrate reduction therapy|substrate reduction therapy
694008|NCT00943150|Abdominoplasty|abdominoplasty
694009|NCT00943150|PlasmaBlade|plasmablade
694010|NCT00943150|Electrosurgery|electrosurgery
694011|NCT00943150|PEAK Surgical|peak surgical
694012|NCT00943150|Medtronic Advanced Energy|medtronic advanced energy
694014|NCT00943163|cyclorotation|cyclorotation
694015|NCT00943163|pupil|pupil
694016|NCT00943163|laser refractive surgery|laser refractive surgery
694017|NCT00943176|Fatigue|fatigue
694018|NCT00943189|Fetal anomalies scan at the time of NT study|fetal anomalies scan at the time of nt study
694019|NCT00943202|H1N1, influenza A viruses, TIV, vaccine, infants, children|h1n1, influenza a viruses, tiv, vaccine, infants, children
751857|NCT01170897|PEGPH20|pegph20
694020|NCT00943215|CALERIE II Follow-up|calerie ii follow-up
694021|NCT00943228|Renal transplantation|renal transplantation
694022|NCT00943228|Adequate exposure|adequate exposure
694023|NCT00943228|Acute rejection|acute rejection
694024|NCT00943228|mycophenolate mofetil|mycophenolate mofetil
694025|NCT00943228|immunosuppression|immunosuppression
694026|NCT00943241|Breast|breast
694027|NCT00943241|Breast Cancer|breast cancer
694028|NCT00943241|MBI|mbi
694029|NCT00943241|Molecular Breast Imaging|molecular breast imaging
694030|NCT00943241|Molecular Imaging|molecular imaging
694031|NCT00943254|Metabolic Cardiovascular Syndrome|metabolic cardiovascular syndrome
694032|NCT00943267|Activated Protein C|activated protein c
694033|NCT00943267|Lipopolysaccharides|lipopolysaccharides
694034|NCT00943267|Inflammation, Pulmonary|inflammation, pulmonary
694035|NCT00943280|probability of patient participation in each of the Groups 1, 2 and 3.|probability of patient participation in each of the groups 1, 2 and 3.
694036|NCT00943280|Identification of factors predicting poor participation in screening for Barrett's esophagus.|identification of factors predicting poor participation in screening for barrett's esophagus.
694037|NCT00943293|GVHD|gvhd
694038|NCT00943306|Homozygous|homozygous
694039|NCT00943306|Familial|familial
694040|NCT00943306|Hypercholesterolemia|hypercholesterolemia
694041|NCT00943306|MTP|mtp
694042|NCT00943306|Apheresis|apheresis
694043|NCT00943306|lomitapide|lomitapide
694044|NCT00943306|Homozygous Familial Hypercholesterolemia (HoFH)|homozygous familial hypercholesterolemia (hofh)
694045|NCT00943319|Cancers of the blood|cancers of the blood
694046|NCT00943332|Orthopedic Procedures|orthopedic procedures
694047|NCT00943332|Fracture Fixation, Internal|fracture fixation, internal
694048|NCT00943332|Fracture Fixation, External|fracture fixation, external
694049|NCT00943332|femur fracture|femur fracture
694050|NCT00943332|pediatrics|pediatrics
694051|NCT00943345|GI|gi
694052|NCT00943345|gastrointestinal|gastrointestinal
694053|NCT00943345|permeability|permeability
694054|NCT00943345|indometacin|indometacin
694055|NCT00943345|indomethacin|indomethacin
694056|NCT00943345|coeliac|coeliac
694057|NCT00943358|influenza|influenza
694058|NCT00943358|immunogenicity|immunogenicity
694059|NCT00943358|vaccine|vaccine
694060|NCT00943410|HER2-positive breast cancer|her2-positive breast cancer
694061|NCT00943410|inflammatory breast cancer|inflammatory breast cancer
694062|NCT00943410|recurrent breast cancer|recurrent breast cancer
694063|NCT00943410|stage IIIA breast cancer|stage iiia breast cancer
694064|NCT00943410|stage IIIB breast cancer|stage iiib breast cancer
694065|NCT00943410|stage IIIC breast cancer|stage iiic breast cancer
694066|NCT00943410|stage IV breast cancer|stage iv breast cancer
694067|NCT00943423|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
694068|NCT00943423|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
694069|NCT00943436|Exercise|exercise
694070|NCT00943436|Sedentary|sedentary
694071|NCT00943436|Energy Expenditure|energy expenditure
694072|NCT00943436|Energy Balance|energy balance
694073|NCT00943436|Macronutrient Intake|macronutrient intake
694074|NCT00943436|Energy and Macronutrient intake|energy and macronutrient intake
694075|NCT00943436|Exercise and Energy Balance|exercise and energy balance
694076|NCT00943449|Hepatocellular Carcinoma|hepatocellular carcinoma
694077|NCT00943449|Sorafenib|sorafenib
694078|NCT00943449|HDAC|hdac
694079|NCT00943449|4SC-201|4sc-201
694080|NCT00943449|Phase II|phase ii
694081|NCT00943449|Resminostat|resminostat
694082|NCT00943475|DPNB, pain, hemodynamics effects, circumcision|dpnb, pain, hemodynamics effects, circumcision
694083|NCT00943488|influenza A viruses, H1N1, elderly|influenza a viruses, h1n1, elderly
694084|NCT00943514|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
694085|NCT00943514|Variant Cystic Fibrosis|variant cystic fibrosis
694086|NCT00943514|Bronchopulmonary Mycosis|bronchopulmonary mycosis
694087|NCT00943514|Airway Infection Susceptibility|airway infection susceptibility
694088|NCT00943514|Chronic Respiratory Infection|chronic respiratory infection
694089|NCT00943514|Bronchiectasis|bronchiectasis
694090|NCT00943527|Breast|breast
694091|NCT00943527|Menstrual Cycle|menstrual cycle
694092|NCT00943527|Breast Cancer|breast cancer
694093|NCT00943527|Hormone|hormone
694094|NCT00943527|MBI|mbi
694095|NCT00943527|Molecular Breast Imaging|molecular breast imaging
694096|NCT00943527|Breast Imaging|breast imaging
694097|NCT00943540|pharmacokinetics|pharmacokinetics
694098|NCT00943540|single dose|single dose
694099|NCT00943540|raltegravir|raltegravir
694100|NCT00943540|Treatment experienced|treatment experienced
694101|NCT00943553|AML|aml
694102|NCT00943566|Pain|pain
694103|NCT00943566|Cancer|cancer
694104|NCT00943566|Morphine|morphine
694105|NCT00943579|autism|autism
694106|NCT00943579|autistic disorder|autistic disorder
694107|NCT00943579|tetrahydrobiopterin|tetrahydrobiopterin
694108|NCT00943579|sapropterin|sapropterin
694115|NCT00943605|Electrosurgery|electrosurgery
694116|NCT00943605|PEAK Surgical|peak surgical
694117|NCT00943605|Medtronic Advanced Energy|medtronic advanced energy
694118|NCT00943605|Medtronic|medtronic
694119|NCT00943618|Smoking Cessation|smoking cessation
694120|NCT00943618|Nicotine Withdrawal|nicotine withdrawal
694121|NCT00943618|Smoking Reduction|smoking reduction
694122|NCT00943618|Varenicline|varenicline
694123|NCT00943618|Chantix|chantix
694124|NCT00943618|Bupropion|bupropion
694125|NCT00943618|Zyban|zyban
694126|NCT00943631|H1N1, influenza A viruses, vaccine, elderly|h1n1, influenza a viruses, vaccine, elderly
694128|NCT00943644|Breast|breast
694129|NCT00943644|Breast Cancer|breast cancer
694130|NCT00943670|MBC|mbc
694131|NCT00943670|TDM1|tdm1
694132|NCT00943670|Armed Herceptin|armed herceptin
694133|NCT00943670|Herceptin|herceptin
694134|NCT00943670|Trastuzumab emtansine|trastuzumab emtansine
694135|NCT00943709|hyperglycemia|hyperglycemia
694136|NCT00943709|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
694137|NCT00943709|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
694138|NCT00943709|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
694139|NCT00943709|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
694140|NCT00943709|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
694141|NCT00943709|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
694142|NCT00943709|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
694143|NCT00943709|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
694144|NCT00943709|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
694145|NCT00943735|Overactive Bladder Incontinence Adherence Behavioral interventions|overactive bladder incontinence adherence behavioral interventions
694146|NCT00943761|hepatitis C|hepatitis c
694147|NCT00943774|Physiology|physiology
694148|NCT00943774|Phenotype|phenotype
694149|NCT00943774|Genetics|genetics
694150|NCT00943774|Genomics|genomics
694151|NCT00943774|Stress|stress
694152|NCT00943774|Baroreflex|baroreflex
694153|NCT00943774|Blood Pressure|blood pressure
694154|NCT00943774|Arterial stiffness|arterial stiffness
694155|NCT00943800|Appropriate candidate for transplantation|appropriate candidate for transplantation
694156|NCT00943800|An HLA-identical related or unrelated donor cannot be identified within an appropriate time frame.|an hla-identical related or unrelated donor cannot be identified within an appropriate time frame.
694157|NCT00943813|communication|communication
694158|NCT00943813|survey|survey
694159|NCT00943813|video|video
694160|NCT00943813|09-043|09-043
694161|NCT00943839|stage IV renal cell cancer|stage iv renal cell cancer
694162|NCT00943865|metabolic syndrome|metabolic syndrome
694163|NCT00943865|lifestyle|lifestyle
694164|NCT00943865|exercise|exercise
694165|NCT00943865|endothelial dysfunction|endothelial dysfunction
694166|NCT00943865|insulin sensitivity|insulin sensitivity
694167|NCT00943865|lipids|lipids
694168|NCT00943878|H1N1, influenza A viruses, vaccine, elderly, TIV|h1n1, influenza a viruses, vaccine, elderly, tiv
694169|NCT00943904|urinary leakage associated with urinary urgency|urinary leakage associated with urinary urgency
694170|NCT00943904|unable to fully empty bladder|unable to fully empty bladder
694171|NCT00943904|Comparison: Motor&Sensory Response to Interstim Stimulation|comparison: motor&sensory response to interstim stimulation
694172|NCT00943943|acute myelogenous leukemia|acute myelogenous leukemia
694173|NCT00943943|AML|aml
694174|NCT00943943|Leukemia|leukemia
694175|NCT00943943|myeloid leukemias|myeloid leukemias
694176|NCT00943943|mutated fms-like tyrosine kinase receptor-3|mutated fms-like tyrosine kinase receptor-3
694177|NCT00943943|FLT3 Mutations|flt3 mutations
694178|NCT00943943|G-CSF|g-csf
694179|NCT00943943|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
694180|NCT00943943|Filgrastim|filgrastim
694181|NCT00943943|Neupogen|neupogen
694182|NCT00943943|Plerixafor|plerixafor
694183|NCT00943943|Mobozil|mobozil
694184|NCT00943943|Sorafenib|sorafenib
694185|NCT00943943|BAY 43-9006|bay 43-9006
694186|NCT00943956|stage III prostate cancer|stage iii prostate cancer
694187|NCT00943956|stage IV prostate cancer|stage iv prostate cancer
694188|NCT00943969|obesity|obesity
694189|NCT00943969|gastric bypass|gastric bypass
694190|NCT00943969|morphine|morphine
694191|NCT00943969|pharmacokinetic|pharmacokinetic
694193|NCT00943982|Cystoid Macular Edema|cystoid macular edema
694194|NCT00943982|Intermediate Uveitis|intermediate uveitis
694195|NCT00943982|Uveitis|uveitis
694196|NCT00943982|OCT|oct
694197|NCT00943982|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
694198|NCT00943995|End Stage Kidney Disease|end stage kidney disease
694199|NCT00943995|Kidney Failure|kidney failure
694200|NCT00943995|Short stature|short stature
694201|NCT00943995|Growth Hormone therapy|growth hormone therapy
694202|NCT00944008|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
694203|NCT00944008|Depocyte®|depocyte®
694204|NCT00944008|Neuromeningeal relapse|neuromeningeal relapse
694506|NCT00938743|adults|adults
694205|NCT00944008|Between 16 and 30 years old|between 16 and 30 years old
694206|NCT00944008|Standard risk|standard risk
694207|NCT00944021|Early Bactericidal Activity|early bactericidal activity
694208|NCT00944021|EBA|eba
694209|NCT00944021|Pulmonary Tuberculosis|pulmonary tuberculosis
694210|NCT00944021|PA-824|pa-824
694211|NCT00944021|pretomanid|pretomanid
694212|NCT00944034|Meningococcal meningitis|meningococcal meningitis
694213|NCT00944034|prevention|prevention
694214|NCT00944034|vaccination|vaccination
694215|NCT00944034|toddler|toddler
694216|NCT00944047|invasive breast cancer|invasive breast cancer
694217|NCT00944047|HER2|her2
694218|NCT00944047|primary breast cancer|primary breast cancer
694219|NCT00944047|neo-adjuvant therapy|neo-adjuvant therapy
694220|NCT00944047|Trastuzumab|trastuzumab
694221|NCT00944047|Nab-paclitaxel|nab-paclitaxel
694222|NCT00944073|H1N1, influenza A viruses, vaccine, infants, children|h1n1, influenza a viruses, vaccine, infants, children
694223|NCT00944086|Recruitment|recruitment
694224|NCT00944086|Oxygen Concentration|oxygen concentration
694225|NCT00944086|pneumoperitoneum|pneumoperitoneum
694226|NCT00944086|laparoscopy|laparoscopy
694227|NCT00944099|intervention studies|intervention studies
694228|NCT00944099|feeding behavior|feeding behavior
694229|NCT00944099|eating frequency|eating frequency
694230|NCT00944099|weight loss|weight loss
694231|NCT00944099|dietary intake|dietary intake
694232|NCT00944112|Intensive care|intensive care
694233|NCT00944112|Blood Transfusion|blood transfusion
694234|NCT00944112|Anemia|anemia
694235|NCT00944138|Obesity|obesity
694236|NCT00944138|meditation|meditation
694237|NCT00944138|chronic kidney disease|chronic kidney disease
694238|NCT00944151|pain|pain
694239|NCT00944151|UCSD|ucsd
694240|NCT00944151|catheter|catheter
694241|NCT00944151|nerve block|nerve block
694242|NCT00944151|hernia|hernia
694243|NCT00944151|post-surgery pain|post-surgery pain
694244|NCT00944151|abdominal pain|abdominal pain
694245|NCT00944151|pelvic pain|pelvic pain
694246|NCT00944151|Transversus abdominal plane|transversus abdominal plane
694247|NCT00944151|Hernia Repair|hernia repair
694248|NCT00944151|Transversus Abdominal Plane Block|transversus abdominal plane block
694249|NCT00944190|pain|pain
694250|NCT00944190|fatigue|fatigue
694251|NCT00944190|depression|depression
694252|NCT00944190|cognitive difficulties|cognitive difficulties
694253|NCT00944190|self-management|self-management
694254|NCT00944203|jellyfish|jellyfish
694255|NCT00944203|jellyfish venom|jellyfish venom
694256|NCT00944203|jellyfish dermatitis|jellyfish dermatitis
694257|NCT00944203|jellyfish stings|jellyfish stings
694258|NCT00944203|Ipomea pes-caprae|ipomea pes-caprae
694259|NCT00944216|keratosis pilaris|keratosis pilaris
694260|NCT00944229|Heart Failure|heart failure
694261|NCT00944229|omega 3|omega 3
694262|NCT00944229|lovaza|lovaza
694263|NCT00944229|VO2 max|vo2 max
694264|NCT00932204|obsessive-compulsive disorder|obsessive-compulsive disorder
694265|NCT00932204|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
694266|NCT00932204|right dorsolateral prefrontal cortex|right dorsolateral prefrontal cortex
694267|NCT00932204|supplementary motor area (SMA)|supplementary motor area (sma)
694268|NCT00932243|bacteremia|bacteremia
694269|NCT00932243|sepsis|sepsis
694270|NCT00932243|Toll-Like-Receptors (TLRs)|toll-like-receptors (tlrs)
694271|NCT00932256|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
694272|NCT00932269|Diphtheria|diphtheria
694273|NCT00932269|Tetanus|tetanus
694274|NCT00932269|Pertussis|pertussis
694275|NCT00932269|Polio|polio
694276|NCT00932269|Haemophilus influenzae type B|haemophilus influenzae type b
694277|NCT00932269|Hib|hib
694278|NCT00932269|Measles|measles
694279|NCT00932269|Mumps|mumps
694280|NCT00932269|Rubella|rubella
694281|NCT00932269|Hepatitis B|hepatitis b
694282|NCT00932269|Vaccine|vaccine
694283|NCT00932269|Vaccination|vaccination
694284|NCT00932269|Immunity|immunity
694285|NCT00932269|Vaccination program|vaccination program
694286|NCT00932269|Sweden|sweden
694287|NCT00932269|ELISA|elisa
694288|NCT00932282|Peanut|peanut
694289|NCT00932282|Allergy|allergy
694290|NCT00932282|Hypersensitivity|hypersensitivity
694291|NCT00932295|tobacco|tobacco
694292|NCT00932295|cigarette|cigarette
694293|NCT00932295|nicotine|nicotine
694294|NCT00932321|Contraception|contraception
694295|NCT00932334|kidney|kidney
694296|NCT00932334|transplant|transplant
694298|NCT00932347|Camellia sinensis|camellia sinensis
694299|NCT00932347|volatile sulfur compounds|volatile sulfur compounds
694300|NCT00932360|Fibromyalgia|fibromyalgia
694301|NCT00932360|Transcutaneous Electrical Nerve Stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
694302|NCT00932373|HER2-positive breast cancer|her2-positive breast cancer
694303|NCT00932373|MBC|mbc
694304|NCT00932373|Trastuzumab emtansine|trastuzumab emtansine
694305|NCT00932373|Herceptin|herceptin
694306|NCT00932373|T-DM1|t-dm1
694307|NCT00932386|Lower extremity surgery with tourniquet use|lower extremity surgery with tourniquet use
694404|NCT00932893|Lung Neoplasms ALK gene crizotinib|lung neoplasms alk gene crizotinib
694308|NCT00932412|Younger Patients with Newly-Diagnosed Acute Myeloid Leukemia (AML).|younger patients with newly-diagnosed acute myeloid leukemia (aml).
694309|NCT00932425|Stroke|stroke
694310|NCT00932425|Cryptogenic|cryptogenic
694311|NCT00932425|Cardioembolic|cardioembolic
694312|NCT00932425|Atrial Fibrillation|atrial fibrillation
694313|NCT00932438|colon cancer|colon cancer
694314|NCT00932438|liver metastases|liver metastases
694315|NCT00932451|Lung Neoplasms ALK gene Crizotinib|lung neoplasms alk gene crizotinib
694316|NCT00932503|Vicryl plus|vicryl plus
694317|NCT00932503|wound infection|wound infection
694318|NCT00932503|coated suture material|coated suture material
694319|NCT00932503|open abdominal surgery|open abdominal surgery
694320|NCT00932503|transverse laparotomy|transverse laparotomy
694321|NCT00932516|South Beach Diet™|south beach diet™
694322|NCT00932516|overweight|overweight
694323|NCT00932516|obesity|obesity
694324|NCT00932516|satiety|satiety
694325|NCT00932516|weight loss|weight loss
694326|NCT00932529|Antipsychotic drugs|antipsychotic drugs
694327|NCT00932529|Treatment effectiveness|treatment effectiveness
694328|NCT00932529|Randomized controlled trial|randomized controlled trial
694329|NCT00932542|Hemorrhoidectomy|hemorrhoidectomy
694330|NCT00932555|Octocog alfa|octocog alfa
694331|NCT00932555|Hemophilia A|hemophilia a
694332|NCT00932581|Parkinson's Disease|parkinson's disease
694333|NCT00932581|Movement Disorders|movement disorders
694334|NCT00932581|Unified Parkinson's Disease Rating Scale|unified parkinson's disease rating scale
694335|NCT00932581|Short Parkinson's Evaluation Scale|short parkinson's evaluation scale
694336|NCT00932581|Scales for Outcomes in Parkinson's Disease|scales for outcomes in parkinson's disease
694337|NCT00932581|Motor Evaluation|motor evaluation
694338|NCT00932581|Schwab and England activities of daily living|schwab and england activities of daily living
694339|NCT00932581|Bradykinesia|bradykinesia
694340|NCT00932581|psychometrics|psychometrics
694341|NCT00932581|order effects|order effects
694342|NCT00932581|hoehn yahr aging|hoehn yahr aging
694343|NCT00932581|assessments|assessments
694344|NCT00932594|Create the New Serial Treatment of TMD|create the new serial treatment of tmd
694345|NCT00932594|Promote the Classification of Biodynamics in the TMD|promote the classification of biodynamics in the tmd
694346|NCT00932594|Evaluate the Effect of Adjusting TMJ Treatment|evaluate the effect of adjusting tmj treatment
694347|NCT00932594|Establish the New Standard of the TMJ Treatment|establish the new standard of the tmj treatment
694348|NCT00932594|Invent New Device to Measure Pressure without Trauma|invent new device to measure pressure without trauma
694349|NCT00932607|seasonal|seasonal
694350|NCT00932607|rhinitis|rhinitis
694351|NCT00932607|rhinoconjunctivitis|rhinoconjunctivitis
694352|NCT00932607|birch pollen|birch pollen
694353|NCT00932607|immunotherapy|immunotherapy
694354|NCT00932607|sublingual|sublingual
694355|NCT00932620|hypercholesterolemia|hypercholesterolemia
694356|NCT00932620|statins|statins
694357|NCT00932620|simvastatin|simvastatin
694358|NCT00932620|ezetimibe|ezetimibe
694359|NCT00932620|LDL particles|ldl particles
694360|NCT00932633|neonatal brain injury|neonatal brain injury
694361|NCT00932633|congenital heart disease|congenital heart disease
694362|NCT00932633|magnetic resonance imaging|magnetic resonance imaging
694363|NCT00932633|cardiopulmonary bypass|cardiopulmonary bypass
694364|NCT00932633|neurodevelopmental outcome|neurodevelopmental outcome
694365|NCT00932659|End-Stage Renal Disease|end-stage renal disease
694366|NCT00932659|Hemodialysis|hemodialysis
694367|NCT00932659|Cardiac Arrhythmias|cardiac arrhythmias
694368|NCT00932672|Prostate Cancer|prostate cancer
694369|NCT00932672|Atkins|atkins
694370|NCT00932685|pediatric emergence agitation and pain|pediatric emergence agitation and pain
694371|NCT00932698|Relapsed multiple myeloma|relapsed multiple myeloma
694372|NCT00932698|Refractory multiple myeloma|refractory multiple myeloma
694373|NCT00932698|IXAZOMIB Proteasome inhibitor|ixazomib proteasome inhibitor
694374|NCT00932711|COPD|copd
694375|NCT00932724|Metastatic|metastatic
694376|NCT00932724|Colorectal|colorectal
694377|NCT00932724|Cancer|cancer
694378|NCT00932724|refractory|refractory
694379|NCT00932724|Phase II|phase ii
694380|NCT00932724|randomised|randomised
694381|NCT00932724|double-blind|double-blind
694382|NCT00932724|controlled|controlled
694383|NCT00932724|multicenter|multicenter
694384|NCT00932724|CY-503|cy-503
694385|NCT00932724|Cytavis|cytavis
694386|NCT00932750|Body composition|body composition
694387|NCT00932750|Weight loss|weight loss
694388|NCT00932750|Weight management|weight management
694389|NCT00932750|Beverages|beverages
694391|NCT00932802|Non-Interventional|non-interventional
694392|NCT00932802|Observational|observational
694393|NCT00932802|NIS|nis
694394|NCT00932802|Moxifloxacin|moxifloxacin
694395|NCT00932802|MXF|mxf
694396|NCT00932802|Avelox|avelox
694397|NCT00932802|AECB|aecb
694398|NCT00932828|Peanut allergy|peanut allergy
694399|NCT00932854|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
694400|NCT00932854|EBUS|ebus
694401|NCT00932854|Bronchoscopy|bronchoscopy
694402|NCT00932854|Sarcoidosis|sarcoidosis
694403|NCT00932867|Arterial Hypertension|arterial hypertension
694405|NCT00932906|Education|education
694408|NCT00932906|Self training|self training
694409|NCT00932919|Agoraphobia|agoraphobia
694410|NCT00932919|Cognitive therapy|cognitive therapy
694411|NCT00932919|Thought field therapy|thought field therapy
694412|NCT00932919|Psychotherapy research|psychotherapy research
694413|NCT00932958|Myocardial Infarction|myocardial infarction
694414|NCT00932997|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
694416|NCT00932997|stage II breast cancer|stage ii breast cancer
694417|NCT00932997|stage IIIA breast cancer|stage iiia breast cancer
694418|NCT00932997|cancer survivor|cancer survivor
694419|NCT00933010|metabolic syndrome|metabolic syndrome
694420|NCT00933010|lipids|lipids
694421|NCT00933010|waist circumference|waist circumference
694422|NCT00933010|HDL|hdl
694423|NCT00933010|hypertension|hypertension
694424|NCT00933036|Osteoporosis|osteoporosis
694425|NCT00933036|VCF|vcf
694426|NCT00933036|PVA|pva
694427|NCT00933036|Vertebroplasty|vertebroplasty
694428|NCT00933036|Kyphoplasty|kyphoplasty
694429|NCT00933036|Vertebral fracture|vertebral fracture
694430|NCT00933036|Pathologic fracture|pathologic fracture
694431|NCT00933036|Vertebral augmentation|vertebral augmentation
694432|NCT00933049|Efficacy|efficacy
694433|NCT00933049|children|children
694434|NCT00933049|pneumonia|pneumonia
694435|NCT00933049|cotrimoxazole|cotrimoxazole
694436|NCT00933049|amoxicillin|amoxicillin
694437|NCT00933088|adolescent coping strategies|adolescent coping strategies
694438|NCT00933088|stress response|stress response
694439|NCT00933088|breast cancer|breast cancer
694440|NCT00933114|DCE MRI|dce mri
694441|NCT00933114|PET|pet
694442|NCT00933114|Perfusion|perfusion
694443|NCT00933114|Permeability|permeability
694444|NCT00933114|Cancer of the head and neck|cancer of the head and neck
694445|NCT00933114|Head, Neck neoplasms|head, neck neoplasms
694446|NCT00938444|Patients with moderate to severe RA|patients with moderate to severe ra
694447|NCT00938457|protocol specific|protocol specific
694448|NCT00938470|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
694449|NCT00938470|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
694450|NCT00938470|stage IIIA gastric cancer|stage iiia gastric cancer
694451|NCT00938470|stage IIIB gastric cancer|stage iiib gastric cancer
694452|NCT00938470|stage IIIC gastric cancer|stage iiic gastric cancer
694453|NCT00938470|stage IIIA esophageal cancer|stage iiia esophageal cancer
694454|NCT00938470|stage IIIB esophageal cancer|stage iiib esophageal cancer
694455|NCT00938470|stage IIIC esophageal cancer|stage iiic esophageal cancer
694456|NCT00938483|infant formula|infant formula
694457|NCT00938483|cow's milk allergy|cow's milk allergy
694458|NCT00938509|IBUPROFEN|ibuprofen
694459|NCT00938509|CHILDREN|children
694460|NCT00938509|FEVER|fever
694461|NCT00938522|Cilostazol loading|cilostazol loading
694462|NCT00938522|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
694463|NCT00938535|Obesity|obesity
694464|NCT00938535|Women's health|women's health
694465|NCT00938535|Minority health|minority health
694466|NCT00938535|Obesity prevention|obesity prevention
694467|NCT00938548|mastectomy|mastectomy
694468|NCT00938548|pain, postoperative|pain, postoperative
694469|NCT00938548|pregabalin|pregabalin
694470|NCT00938561|Chronic Kidney Disease|chronic kidney disease
694471|NCT00938561|Glomerular Filtration Rate|glomerular filtration rate
694472|NCT00938561|Kidney function|kidney function
694473|NCT00938561|Markers|markers
694474|NCT00938587|Rheumatoid Arthritis Glucocorticoids Prednisone|rheumatoid arthritis glucocorticoids prednisone
694475|NCT00938600|pharmacokinetics|pharmacokinetics
694476|NCT00938600|safety|safety
694477|NCT00938613|SAR|sar
694478|NCT00938626|refractory multiple myeloma|refractory multiple myeloma
694479|NCT00938626|stage I multiple myeloma|stage i multiple myeloma
694480|NCT00938626|stage II multiple myeloma|stage ii multiple myeloma
694481|NCT00938626|stage III multiple myeloma|stage iii multiple myeloma
694482|NCT00938652|triple negative breast cancer|triple negative breast cancer
694483|NCT00938652|metastatic breast cancer|metastatic breast cancer
694484|NCT00938652|Triple negative metastatic breast cancer|triple negative metastatic breast cancer
694485|NCT00938665|Alzheimer|alzheimer
694486|NCT00938665|Memory disorder|memory disorder
694487|NCT00938665|dementia|dementia
694488|NCT00938665|cognitive behavioral decline|cognitive behavioral decline
694489|NCT00938665|vascular dementia|vascular dementia
694490|NCT00938665|front temporal dementia|front temporal dementia
694491|NCT00938678|Healthy volunteers|healthy volunteers
694492|NCT00938691|Scar|scar
694493|NCT00938691|Appearance|appearance
694494|NCT00938691|Spread|spread
694495|NCT00938717|IBS|ibs
694496|NCT00938730|Nonvalvular Atrial Fibrillation (NVAF)|nonvalvular atrial fibrillation (nvaf)
694497|NCT00938730|Factor Xa Inhibitor|factor xa inhibitor
694498|NCT00938730|Stroke|stroke
694499|NCT00938730|Thromboembolism|thromboembolism
694500|NCT00938730|Transient Ischemic attack|transient ischemic attack
694501|NCT00938730|Anticoagulants|anticoagulants
694502|NCT00938730|Prevention|prevention
694503|NCT00938730|YM150|ym150
694504|NCT00938730|Warfarin|warfarin
694507|NCT00938743|driving performance|driving performance
694508|NCT00938743|atomoxetine|atomoxetine
694509|NCT00938756|leptomeningeal metastases|leptomeningeal metastases
694510|NCT00938756|male breast cancer|male breast cancer
694511|NCT00938756|stage IV breast cancer|stage iv breast cancer
694512|NCT00938756|tumors metastatic to brain|tumors metastatic to brain
694514|NCT00938769|cancer|cancer
694515|NCT00938769|caregiver|caregiver
694516|NCT00938769|symptom|symptom
694517|NCT00938769|self management|self management
694518|NCT00938795|liver disease|liver disease
694519|NCT00938795|uncertainty|uncertainty
694520|NCT00938795|self management|self management
694521|NCT00938808|Osteoarthritis|osteoarthritis
694522|NCT00938808|Obesity|obesity
694523|NCT00938808|Weight loss|weight loss
694524|NCT00938808|Dietary instruction|dietary instruction
694525|NCT00938808|Formula diet|formula diet
694526|NCT00938808|Attention|attention
694527|NCT00944268|Passiflora, Crataegus and Salix|passiflora, crataegus and salix
694528|NCT00944268|Mild and Moderate anxiety|mild and moderate anxiety
694529|NCT00944268|Tablet|tablet
694530|NCT00944268|To evaluate the efficacy and tolerability of the combination|to evaluate the efficacy and tolerability of the combination
694531|NCT00944281|point-of-use fortification|point-of-use fortification
694532|NCT00944281|zinc supplement|zinc supplement
694533|NCT00944281|lipid-based nutrient supplement|lipid-based nutrient supplement
694534|NCT00944281|zinc deficiency|zinc deficiency
694535|NCT00944281|micronutrient deficiency|micronutrient deficiency
694536|NCT00944281|anemia|anemia
694537|NCT00944294|Coronary artery disease|coronary artery disease
694538|NCT00944294|Angina|angina
694539|NCT00944294|Anginal symptoms|anginal symptoms
694540|NCT00944294|Ischemic heart disease|ischemic heart disease
694541|NCT00944294|Ischemia|ischemia
694542|NCT00944294|Single photon emission computed tomography|single photon emission computed tomography
694543|NCT00944294|Pharmacologic stress|pharmacologic stress
694544|NCT00944294|Myocardial perfusion imaging|myocardial perfusion imaging
694545|NCT00944294|typical or atypical anginal symptoms|typical or atypical anginal symptoms
694546|NCT00944294|Suspected coronary artery disease|suspected coronary artery disease
694547|NCT00944294|known coronary artery disease|known coronary artery disease
694548|NCT00944307|HIV|hiv
694549|NCT00944307|antiretroviral|antiretroviral
694550|NCT00944307|drug interaction|drug interaction
694551|NCT00944307|human immunodeficiency virus|human immunodeficiency virus
694552|NCT00944333|second generation DES|second generation des
694553|NCT00944333|clopidogrel|clopidogrel
694554|NCT00944333|dual platelet therapy|dual platelet therapy
694555|NCT00944333|patients with documented silent ischemia|patients with documented silent ischemia
694556|NCT00944333|unstable angina pectoris (Braunwald Classification)|unstable angina pectoris (braunwald classification)
694557|NCT00944333|Diagnosis of angina pectoris (CCS)|diagnosis of angina pectoris (ccs)
694558|NCT00944359|zinc supplementation|zinc supplementation
694559|NCT00944359|diarrhea management|diarrhea management
694560|NCT00944359|zinc deficiency|zinc deficiency
694561|NCT00944359|malaria|malaria
694562|NCT00944372|Tumor|tumor
694563|NCT00944372|somatostatin receptor|somatostatin receptor
694564|NCT00944398|Zinc fortification|zinc fortification
694565|NCT00944398|Plasma zinc concentration|plasma zinc concentration
694566|NCT00944398|Assessment of zinc status|assessment of zinc status
694567|NCT00944424|Vitamin D in patients with metastatic breast cancer|vitamin d in patients with metastatic breast cancer
694568|NCT00944437|Ventilation, Mechanical|ventilation, mechanical
694569|NCT00944437|Positive-Pressure Respiration|positive-pressure respiration
694570|NCT00944437|Continuous Positive Airway Pressure|continuous positive airway pressure
694571|NCT00944463|advanced pancreatic cancer|advanced pancreatic cancer
694572|NCT00944463|gemcitabine|gemcitabine
694573|NCT00944463|simvastatin|simvastatin
694574|NCT00944463|placebo|placebo
694575|NCT00944476|Sarcoma|sarcoma
694576|NCT00944476|soft tissue|soft tissue
694577|NCT00944476|MRI|mri
694578|NCT00944476|Questionnaire|questionnaire
694579|NCT00944476|09-078|09-078
694580|NCT00944489|Hypertension|hypertension
694581|NCT00944489|Health-Related Quality of Life Adherence to the antihypertension treatment|health-related quality of life adherence to the antihypertension treatment
694582|NCT00944489|Ambulatory Patients|ambulatory patients
694583|NCT00944489|MINICHAL score|minichal score
694584|NCT00944489|Treatment Adherence Scale (MMAS)|treatment adherence scale (mmas)
694585|NCT00944489|Quality of life|quality of life
694586|NCT00944489|Adherence to treatment|adherence to treatment
694587|NCT00944502|Neuralgy|neuralgy
694588|NCT00944502|Dexamethasone|dexamethasone
694589|NCT00944502|Complex Vitamins|complex vitamins
694590|NCT00944502|Injection|injection
694591|NCT00944502|Symptoms of neuralgy of various origins|symptoms of neuralgy of various origins
694592|NCT00944515|sinusitis|sinusitis
694593|NCT00944515|azithromycin|azithromycin
694594|NCT00944528|Cancer of Breast|cancer of breast
694595|NCT00944528|Cancer of the Breast|cancer of the breast
694596|NCT00944528|Neoplasms, Breast|neoplasms, breast
694597|NCT00944528|Single dose radiation|single dose radiation
694598|NCT00944528|Radiotherapy|radiotherapy
694599|NCT00944528|Preoperative|preoperative
694601|NCT00944541|immune restoration|immune restoration
694602|NCT00944541|treatment intensification|treatment intensification
694604|NCT00944554|Smoking Cessation|smoking cessation
694605|NCT00944554|Substance Abuse|substance abuse
694606|NCT00944567|Primary Mediastinal B-Cell Lymphoma|primary mediastinal b-cell lymphoma
694607|NCT00944567|Positron emission tomography|positron emission tomography
694608|NCT00948324|ype 2 diabetes mellitus, continuous subcutaneous insulin infusion,|ype 2 diabetes mellitus, continuous subcutaneous insulin infusion,
694609|NCT00948324|α-lipoic acid ,rosiglitazone ,metformin，therapy|α-lipoic acid ,rosiglitazone ,metformin，therapy
694610|NCT00948350|cervical instability|cervical instability
694611|NCT00948350|awake intubation|awake intubation
694612|NCT00948350|laryngeal anesthesia|laryngeal anesthesia
694613|NCT00948363|Kiwi fruits|kiwi fruits
694614|NCT00948363|Blood pressure|blood pressure
694615|NCT00948363|Endothelial function|endothelial function
694616|NCT00948363|Antioxidant capacity|antioxidant capacity
694617|NCT00948376|Natural history|natural history
694618|NCT00948376|IFT80|ift80
694619|NCT00948376|short ribs|short ribs
694620|NCT00948376|multivisceral involvement|multivisceral involvement
694621|NCT00948402|PED/PEA-15 protein|ped/pea-15 protein
694622|NCT00948402|PCOS|pcos
694623|NCT00948402|IR|ir
694624|NCT00948402|metformin|metformin
694625|NCT00948402|OCP|ocp
694626|NCT00948402|Oral Contraceptive|oral contraceptive
694627|NCT00948415|Obesity|obesity
694628|NCT00948415|Weight loss|weight loss
694629|NCT00948415|Internet|internet
694630|NCT00948428|actinic keratoses|actinic keratoses
694631|NCT00948428|imiquimod|imiquimod
694632|NCT00948428|therapeutic equivalence|therapeutic equivalence
694633|NCT00948428|bioequivalence|bioequivalence
694634|NCT00948441|intestinal insufficiency|intestinal insufficiency
694635|NCT00948441|central venous catheter|central venous catheter
694636|NCT00948441|Catheter-Related Infections|catheter-related infections
694637|NCT00948441|pediatrics|pediatrics
694638|NCT00948441|ethanol|ethanol
694639|NCT00948454|smoking|smoking
694640|NCT00948467|Advanced nonhematologic malignancies|advanced nonhematologic malignancies
694641|NCT00948467|Advanced metastatic melanoma|advanced metastatic melanoma
694642|NCT00948467|BRAF gene|braf gene
694643|NCT00948480|autologous tumor cell vaccine|autologous tumor cell vaccine
694644|NCT00948480|metastatic melanoma|metastatic melanoma
694645|NCT00948480|sargramostim (GM-CSF)|sargramostim (gm-csf)
694646|NCT00948493|diabetes|diabetes
694647|NCT00948493|insulin therapy|insulin therapy
694648|NCT00948519|Rhinosinusitis, sinusitis, chronic, nasal polyps, phototherapy, laser,laser therapy, antibiotic, safety laser, ICG, indocyanine green|rhinosinusitis, sinusitis, chronic, nasal polyps, phototherapy, laser,laser therapy, antibiotic, safety laser, icg, indocyanine green
694649|NCT00948519|Chronic Rhinosinusitis with or without nasal polyposis|chronic rhinosinusitis with or without nasal polyposis
694650|NCT00948532|degenerative disc disease|degenerative disc disease
694651|NCT00948532|lumbar spine|lumbar spine
694652|NCT00948532|XLIF|xlif
694653|NCT00948532|Degenerative conditions|degenerative conditions
694654|NCT00948545|Autonomic nervous system|autonomic nervous system
694655|NCT00948545|Bariatric surgery|bariatric surgery
694656|NCT00948545|Observational study for individuals having bariatric surgery|observational study for individuals having bariatric surgery
694657|NCT00948558|citrate anticoagulation|citrate anticoagulation
694658|NCT00948558|pharmacokinetic|pharmacokinetic
694659|NCT00948558|critically ill|critically ill
694660|NCT00948558|acute kidney failure|acute kidney failure
694661|NCT00948571|Vital capacity, FEV1, airway resistance|vital capacity, fev1, airway resistance
694662|NCT00948571|perioperative changes in lung function|perioperative changes in lung function
694663|NCT00948584|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
694664|NCT00948584|Insulin dose titration system|insulin dose titration system
694665|NCT00948597|propofol|propofol
694666|NCT00948597|elective surgical procedure|elective surgical procedure
694667|NCT00948597|Obese subjects|obese subjects
694668|NCT00948610|Rheumatoid Arthritis|rheumatoid arthritis
694669|NCT00948623|COPD|copd
694670|NCT00948623|physical activity|physical activity
694671|NCT00948623|pulmonary rehabilitation|pulmonary rehabilitation
694672|NCT00948623|counseling|counseling
694673|NCT00948649|Varenicline, Working memory|varenicline, working memory
694674|NCT00948662|Safety|safety
694675|NCT00948662|tolerability|tolerability
694676|NCT00948662|ascending single doses|ascending single doses
694677|NCT00948662|healthy subjects|healthy subjects
694678|NCT00948675|Advanced Non-Small Cell Lung Cancer of Nonsquamous Histology|advanced non-small cell lung cancer of nonsquamous histology
694679|NCT00948675|Advanced Lung Cancer|advanced lung cancer
694680|NCT00948675|Non-Small Cell Lung Cancer|non-small cell lung cancer
694681|NCT00948675|Lung Cancer|lung cancer
694682|NCT00948688|Zolinza|zolinza
694683|NCT00948701|Breast cancer|breast cancer
694684|NCT00948701|Exercise|exercise
694685|NCT00948701|Physical activity|physical activity
694686|NCT00948701|Community volunteers|community volunteers
694687|NCT00948701|Peer mentors|peer mentors
694688|NCT00948701|Peer coaches|peer coaches
694689|NCT00948701|Social support|social support
694690|NCT00948740|vitamin D|vitamin d
694691|NCT00948753|Graft-versus-host disease|graft-versus-host disease
694694|NCT00948753|non-myeloablative allogeneic stem-cell transplantation|non-myeloablative allogeneic stem-cell transplantation
694695|NCT00948753|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
694696|NCT00948766|Alzheimer's disease|alzheimer's disease
694697|NCT00948766|dementia|dementia
694698|NCT00948766|Alzheimer's type|alzheimer's type
694699|NCT00948779|Patient education|patient education
694700|NCT00948779|Antibiotic|antibiotic
694701|NCT00948779|Child|child
694702|NCT00948779|Respiratory tract infection|respiratory tract infection
694703|NCT00948779|Patient satisfaction|patient satisfaction
694704|NCT00948779|Parental knowledge|parental knowledge
694705|NCT00948779|Adherence|adherence
694706|NCT00948792|platelets|platelets
694707|NCT00948792|transfusion|transfusion
694708|NCT00948792|thrombocytopenia|thrombocytopenia
694709|NCT00948805|corpus luteum rescue|corpus luteum rescue
694710|NCT00948805|Gonadotropin Releasing Hormone (GnRH agonist)|gonadotropin releasing hormone (gnrh agonist)
694711|NCT00948805|human Chorionic Gonadotropin (hCG)|human chorionic gonadotropin (hcg)
694712|NCT00948805|infertility|infertility
694713|NCT00948805|pregnancy rate|pregnancy rate
694714|NCT00948818|Irritable Bowel Syndrome|irritable bowel syndrome
694715|NCT00948818|Constipation|constipation
694716|NCT00948818|Linaclotide|linaclotide
694717|NCT00948831|biologics|biologics
694718|NCT00948831|fusion rates|fusion rates
694719|NCT00948831|lumbar fusion|lumbar fusion
694720|NCT00948831|ALIF|alif
694721|NCT00948844|falls|falls
694722|NCT00948844|Missteps|missteps
694723|NCT00948857|DHEA|dhea
694725|NCT00948857|Pregnancy|pregnancy
694726|NCT00948857|Ovarian Failure|ovarian failure
694727|NCT00948857|Otherwise Unexplained infertility|otherwise unexplained infertility
694728|NCT00948857|Ovarian aging|ovarian aging
694729|NCT00948870|alternative medicine|alternative medicine
694730|NCT00948883|organ transplant|organ transplant
694731|NCT00948883|cancer|cancer
694732|NCT00948883|biobank|biobank
694733|NCT00948883|immunosuppressive drugs|immunosuppressive drugs
694734|NCT00948883|lymphoma|lymphoma
694735|NCT00948896|Chemoprevention|chemoprevention
694736|NCT00948896|Uganda|uganda
694737|NCT00948896|Malaria|malaria
694738|NCT00948896|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
694739|NCT00948896|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
694740|NCT00948896|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
694741|NCT00948922|multiple myeloma|multiple myeloma
694742|NCT00948922|myeloma|myeloma
694743|NCT00948922|myeloma proteins|myeloma proteins
694744|NCT00948922|autologous|autologous
694745|NCT00948922|allogeneic|allogeneic
694746|NCT00948935|Biliary Cancer|biliary cancer
694747|NCT00948935|Cholangiocarcinoma|cholangiocarcinoma
694748|NCT00948935|Panitumumab|panitumumab
694749|NCT00948961|NYESO1|nyeso1
694750|NCT00948961|cancer vaccine|cancer vaccine
694751|NCT00948961|immunotherapy|immunotherapy
694752|NCT00948961|breast cancer|breast cancer
694753|NCT00948961|ovarian cancer|ovarian cancer
694754|NCT00948961|non-small cell lung cancer|non-small cell lung cancer
694755|NCT00948961|myeloma|myeloma
694756|NCT00948961|sarcoma|sarcoma
694757|NCT00948961|melanoma|melanoma
694758|NCT00948961|Resiquimod|resiquimod
694759|NCT00948961|Poly-ICLC|poly-iclc
694760|NCT00948961|Hiltonol|hiltonol
694761|NCT00948961|esophageal cancer|esophageal cancer
694762|NCT00948961|bladder cancer|bladder cancer
694763|NCT00948961|chondrosarcoma|chondrosarcoma
694764|NCT00948961|adenocarcinoma|adenocarcinoma
694765|NCT00948974|social anxiety|social anxiety
694766|NCT00948974|treatment|treatment
694767|NCT00948974|Cognitive Behavioral Therapy|cognitive behavioral therapy
694768|NCT00948974|Acceptance and Commitment Therapy|acceptance and commitment therapy
694769|NCT00948974|Cognitive Therapy|cognitive therapy
694770|NCT00948987|aspirin resistance|aspirin resistance
694771|NCT00948987|cardiovascular risk|cardiovascular risk
694772|NCT00948987|prostaglandins|prostaglandins
694773|NCT00948987|platelet inhibition|platelet inhibition
694774|NCT00949013|stage IA breast cancer|stage ia breast cancer
694775|NCT00949013|stage IB breast cancer|stage ib breast cancer
694776|NCT00949013|stage II breast cancer|stage ii breast cancer
694777|NCT00949013|stage IIIA breast cancer|stage iiia breast cancer
694778|NCT00949013|stage IIIB breast cancer|stage iiib breast cancer
694779|NCT00949013|stage IIIC breast cancer|stage iiic breast cancer
694780|NCT00949026|Brain Cancer|brain cancer
694781|NCT00949026|Brain Neoplasms, Malignant|brain neoplasms, malignant
694782|NCT00949052|cancer survivor|cancer survivor
694783|NCT00949052|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
694784|NCT00949052|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
694785|NCT00949052|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
694786|NCT00949052|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
694787|NCT00949052|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
694788|NCT00949052|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
694789|NCT00949052|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
695891|NCT00954317|epidural|epidural
694790|NCT00949052|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
694791|NCT00949052|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
694792|NCT00949052|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
694793|NCT00949052|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
694794|NCT00949052|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
694795|NCT00949052|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
694796|NCT00949052|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
694797|NCT00949052|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
694798|NCT00949052|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
694799|NCT00949052|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
694800|NCT00949052|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
694801|NCT00949052|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
694802|NCT00949052|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
694803|NCT00949052|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
694804|NCT00949052|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
694805|NCT00949052|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
694806|NCT00949052|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
694807|NCT00949052|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
694808|NCT00949052|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
694809|NCT00949052|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
694810|NCT00949052|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
694811|NCT00949052|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
694812|NCT00949052|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
694813|NCT00949052|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
694814|NCT00949052|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
694815|NCT00949052|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
694816|NCT00949052|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
694817|NCT00949052|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
694818|NCT00949052|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
694819|NCT00949052|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
694820|NCT00949052|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
694821|NCT00949052|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
694822|NCT00949052|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
694823|NCT00949052|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
694824|NCT00949052|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
694825|NCT00949052|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
694826|NCT00949052|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
694827|NCT00949052|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
694828|NCT00949052|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
694829|NCT00949052|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
694830|NCT00949052|splenic marginal zone lymphoma|splenic marginal zone lymphoma
694831|NCT00949052|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
694832|NCT00949052|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
694833|NCT00949052|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
694834|NCT00949052|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
694835|NCT00949052|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
694836|NCT00949052|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
694837|NCT00949052|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
694838|NCT00949052|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
694839|NCT00949052|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
694840|NCT00949052|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
694841|NCT00949052|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
694842|NCT00949052|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
694843|NCT00949052|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
694910|NCT00949104|neonate|neonate
694911|NCT00949104|preterm|preterm
694844|NCT00949052|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
694845|NCT00949052|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
694846|NCT00949052|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
694847|NCT00949052|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
694993|NCT00949260|pregnancy induced hypertension|pregnancy induced hypertension
694848|NCT00949052|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
695187|NCT00950105|Semapimod|semapimod
695990|NCT00954837|repeat FNA|repeat fna
752872|NCT01174550|coronary artery disease|coronary artery disease
694849|NCT00949052|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
694850|NCT00949052|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
694851|NCT00949052|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
694852|NCT00949052|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
694853|NCT00949052|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
694854|NCT00949052|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
694855|NCT00949052|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
694856|NCT00949052|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
694857|NCT00949052|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
694858|NCT00949052|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
694859|NCT00949052|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
694860|NCT00949052|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
694861|NCT00949052|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
694862|NCT00949052|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
694863|NCT00949052|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
694864|NCT00949052|refractory hairy cell leukemia|refractory hairy cell leukemia
694865|NCT00949052|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
694866|NCT00949052|secondary acute myeloid leukemia|secondary acute myeloid leukemia
694867|NCT00949052|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
694868|NCT00949052|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
694869|NCT00949052|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
694870|NCT00949052|chronic eosinophilic leukemia|chronic eosinophilic leukemia
694871|NCT00949052|primary myelofibrosis|primary myelofibrosis
694872|NCT00949052|chronic neutrophilic leukemia|chronic neutrophilic leukemia
694873|NCT00949052|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
694874|NCT00949052|disseminated neuroblastoma|disseminated neuroblastoma
694875|NCT00949052|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
694876|NCT00949052|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
694877|NCT00949052|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
694878|NCT00949052|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
694879|NCT00949052|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
694880|NCT00949052|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
694881|NCT00949052|recurrent neuroblastoma|recurrent neuroblastoma
694882|NCT00949052|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
694883|NCT00949052|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
694884|NCT00949052|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
694885|NCT00949052|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
694886|NCT00949052|stage I multiple myeloma|stage i multiple myeloma
694887|NCT00949052|stage II multiple myeloma|stage ii multiple myeloma
694888|NCT00949052|stage III multiple myeloma|stage iii multiple myeloma
694889|NCT00949052|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
694890|NCT00949052|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
694891|NCT00949052|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
694892|NCT00949052|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
694893|NCT00949052|stage IIIA breast cancer|stage iiia breast cancer
694894|NCT00949052|stage IIIB breast cancer|stage iiib breast cancer
694895|NCT00949052|stage IIIC breast cancer|stage iiic breast cancer
694896|NCT00949052|stage IV breast cancer|stage iv breast cancer
694897|NCT00949052|refractory multiple myeloma|refractory multiple myeloma
694898|NCT00949065|complex regional pain syndrome|complex regional pain syndrome
694899|NCT00949065|sympathetic reflex dystrophy|sympathetic reflex dystrophy
694900|NCT00949065|intravenous immunoglobulins|intravenous immunoglobulins
694901|NCT00949065|autoimmune disease|autoimmune disease
694902|NCT00949078|peanut|peanut
694903|NCT00949078|allergy|allergy
694904|NCT00949091|Diabetes Mellitus, Non Insulin Dependent|diabetes mellitus, non insulin dependent
694905|NCT00949091|Diabetes Mellitus, Type II|diabetes mellitus, type ii
694906|NCT00949091|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
694907|NCT00949091|Drug Therapy|drug therapy
694908|NCT00949104|Sucrose|sucrose
694909|NCT00949104|pain|pain
694912|NCT00949104|orogastric tube|orogastric tube
694913|NCT00949117|malnutrition|malnutrition
694914|NCT00949117|weight changes|weight changes
694915|NCT00949117|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
694916|NCT00949117|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
694917|NCT00949117|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
694994|NCT00949260|pregnancy|pregnancy
694918|NCT00949117|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
752873|NCT01174550|CAD|cad
694996|NCT00949260|noninvasive monitoring|noninvasive monitoring
694919|NCT00949117|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
694920|NCT00949117|untreated childhood acute myeloid leukemia|untreated childhood acute myeloid leukemia
694921|NCT00949117|other myeloid malignancies|other myeloid malignancies
694922|NCT00949117|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
694923|NCT00949117|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
694924|NCT00949117|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
694925|NCT00949117|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
694926|NCT00949117|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
694927|NCT00949117|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
694928|NCT00949117|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
694929|NCT00949117|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
694930|NCT00949117|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
694931|NCT00949117|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
694932|NCT00949117|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
694933|NCT00949117|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
694934|NCT00949117|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
694935|NCT00949117|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
694936|NCT00949117|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
694937|NCT00949117|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
694938|NCT00949117|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
694939|NCT00949117|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
694940|NCT00949117|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
694941|NCT00949117|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
694942|NCT00949117|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
694943|NCT00949117|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
694944|NCT00949117|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
694945|NCT00949117|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
694946|NCT00949117|childhood Burkitt lymphoma|childhood burkitt lymphoma
694947|NCT00949117|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
694948|NCT00949117|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
694949|NCT00949117|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
694950|NCT00949117|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
694951|NCT00949117|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
694952|NCT00949117|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
694953|NCT00949117|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
694954|NCT00949117|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
694955|NCT00949117|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
694956|NCT00949117|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
694957|NCT00949143|wheelchair user|wheelchair user
694958|NCT00949156|Craniopharyngiomas|craniopharyngiomas
694959|NCT00949156|Classification|classification
694960|NCT00949156|Membranous structure|membranous structure
694961|NCT00949156|Pituitary stalk|pituitary stalk
694963|NCT00949156|panhypopituitarism|panhypopituitarism
694964|NCT00949169|Atherosclerosis|atherosclerosis
694965|NCT00949169|Carotid IMT|carotid imt
694966|NCT00949169|Multidetector CT|multidetector ct
694967|NCT00949169|Type 2 diabetes|type 2 diabetes
694968|NCT00949182|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
694969|NCT00949182|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
694970|NCT00949195|COPD|copd
694971|NCT00949195|healthy patients|healthy patients
694972|NCT00949195|PAP|pap
694973|NCT00949195|CPX|cpx
694974|NCT00949195|SSE|sse
694975|NCT00949195|hsCRP|hscrp
694976|NCT00949195|FMD|fmd
694977|NCT00949208|Healthy people|healthy people
694978|NCT00949221|Type 1 diabetes|type 1 diabetes
694979|NCT00949221|Paediatric|paediatric
694980|NCT00949221|Real Time Continuous Glucose Monitoring|real time continuous glucose monitoring
694981|NCT00949221|Glycemic control|glycemic control
694982|NCT00949221|Therapeutic education|therapeutic education
694983|NCT00949234|post exposure prophylaxis|post exposure prophylaxis
694984|NCT00949234|biomedical prevention|biomedical prevention
694985|NCT00949234|HIV seronegativity|hiv seronegativity
694986|NCT00949247|stage I breast cancer|stage i breast cancer
694987|NCT00949247|stage II breast cancer|stage ii breast cancer
694988|NCT00949247|stage IIIA breast cancer|stage iiia breast cancer
694989|NCT00949247|stage IIIB breast cancer|stage iiib breast cancer
694990|NCT00949247|stage IIIC breast cancer|stage iiic breast cancer
694991|NCT00949247|HER2-positive breast cancer|her2-positive breast cancer
694992|NCT00949260|PIH|pih
694995|NCT00949260|bioimpedance|bioimpedance
695484|NCT00951028|Adherence|adherence
694997|NCT00949260|Cardiac Output|cardiac output
694998|NCT00949260|Blood Pressure|blood pressure
694999|NCT00949273|cylindrical abdominoperineal resection|cylindrical abdominoperineal resection
695000|NCT00949273|rectal cancer|rectal cancer
695001|NCT00949273|acellular dermal matrix|acellular dermal matrix
695002|NCT00949273|pelvic reconstruction|pelvic reconstruction
695003|NCT00949273|circumferential resection margin|circumferential resection margin
695004|NCT00949273|overall survival|overall survival
695005|NCT00949286|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
695006|NCT00949312|stage II colon cancer|stage ii colon cancer
695007|NCT00949325|osteosarcoma|osteosarcoma
695008|NCT00949325|soft tissue sarcoma|soft tissue sarcoma
695009|NCT00949325|rhabdomyosarcoma|rhabdomyosarcoma
695010|NCT00949325|leiomyosarcoma|leiomyosarcoma
695011|NCT00949325|Ewing's sarcoma|ewing's sarcoma
695012|NCT00949325|chondrosarcoma|chondrosarcoma
695013|NCT00949325|liposarcoma|liposarcoma
695014|NCT00949325|malignant fibrous histiocytoma|malignant fibrous histiocytoma
695015|NCT00949325|malignant peripheral nerve sheath tumor|malignant peripheral nerve sheath tumor
695016|NCT00949325|pleiomorphic sarcoma|pleiomorphic sarcoma
695017|NCT00949325|spindle cell sarcoma|spindle cell sarcoma
695018|NCT00949325|synovial sarcoma|synovial sarcoma
695019|NCT00949325|cancer stem cell|cancer stem cell
695020|NCT00949338|stage I prostate cancer|stage i prostate cancer
695021|NCT00949338|stage IIB prostate cancer|stage iib prostate cancer
695022|NCT00949338|stage IIA prostate cancer|stage iia prostate cancer
695023|NCT00949338|stage III prostate cancer|stage iii prostate cancer
695024|NCT00949338|stage IV prostate cancer|stage iv prostate cancer
695025|NCT00949338|recurrent prostate cancer|recurrent prostate cancer
695026|NCT00949351|ACEI, ARB, DN, aliskiren, proteinuria|acei, arb, dn, aliskiren, proteinuria
695027|NCT00949364|Myeloproliferative Neoplasms|myeloproliferative neoplasms
695028|NCT00949364|Pomalidomide|pomalidomide
695029|NCT00949364|Fibrotic Stage|fibrotic stage
695030|NCT00949364|Patients with Myeloproliferative Neoplasms in Fibrotic Stage|patients with myeloproliferative neoplasms in fibrotic stage
695031|NCT00949377|Constipation|constipation
695033|NCT00949390|Advanced Cancer|advanced cancer
695034|NCT00949390|Advanced Malignancy|advanced malignancy
695035|NCT00949390|Complementary and Alternative Medicine|complementary and alternative medicine
695037|NCT00949390|Investigational Cancer Therapeutics|investigational cancer therapeutics
695038|NCT00949390|Phase I Clinical Trials|phase i clinical trials
695039|NCT00949403|Non-Alcoholic Fatty Liver disease|non-alcoholic fatty liver disease
695040|NCT00949416|genetic|genetic
695041|NCT00949429|postoperative pain|postoperative pain
695042|NCT00949429|cardiac surgery|cardiac surgery
695043|NCT00949429|risk factors|risk factors
695044|NCT00949455|stage IV bladder cancer|stage iv bladder cancer
695045|NCT00949455|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
695046|NCT00949468|Keratitis|keratitis
695047|NCT00949481|postpartum|postpartum
695048|NCT00949481|family planning|family planning
695049|NCT00949481|job aid|job aid
695050|NCT00949481|immunization|immunization
695051|NCT00949481|pregnancy test|pregnancy test
695052|NCT00949494|knee osteoarthritis, synvisc, hyaluronan, dGEMRIC,cartilage|knee osteoarthritis, synvisc, hyaluronan, dgemric,cartilage
695053|NCT00949520|patients|patients
695054|NCT00949520|functional evaluation|functional evaluation
695055|NCT00949520|known coronary artery lesion|known coronary artery lesion
695056|NCT00949572|mucosal immunity|mucosal immunity
695057|NCT00949572|immunization|immunization
695058|NCT00949572|sublingual|sublingual
695059|NCT00949585|randomized, controlled feeding study;|randomized, controlled feeding study;
695060|NCT00949585|crossover design|crossover design
695061|NCT00949585|potassium intake|potassium intake
695062|NCT00949598|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
695063|NCT00949598|stage IA breast cancer|stage ia breast cancer
695064|NCT00949598|stage IB breast cancer|stage ib breast cancer
695065|NCT00949598|stage II breast cancer|stage ii breast cancer
696691|NCT00947050|CAD|cad
695066|NCT00949598|stage IIIA breast cancer|stage iiia breast cancer
695067|NCT00949611|Decision Aid|decision aid
695068|NCT00949611|Shared Decision Making|shared decision making
695069|NCT00949611|Shared Medical Decision Making|shared medical decision making
695070|NCT00949624|PDGFr Inhibition;|pdgfr inhibition;
695071|NCT00949624|VEGFr inhibition;|vegfr inhibition;
695072|NCT00949624|targeted therapy|targeted therapy
695073|NCT00949637|obesity prevention|obesity prevention
695074|NCT00949637|girl scouts|girl scouts
695075|NCT00949637|physical activity|physical activity
695076|NCT00949637|family meals|family meals
695077|NCT00949637|fruits and vegetables|fruits and vegetables
695078|NCT00949637|health promotion|health promotion
695079|NCT00949663|Diabetes|diabetes
695080|NCT00949663|Blood Sugar|blood sugar
695081|NCT00949663|Xenin-25|xenin-25
695082|NCT00949663|GIP|gip
695083|NCT00949663|Insulin|insulin
695084|NCT00949689|adolescence|adolescence
695085|NCT00949689|insomnia|insomnia
695086|NCT00949689|depression|depression
695087|NCT00949689|sleep problems|sleep problems
695088|NCT00949689|cognitive therapy|cognitive therapy
695089|NCT00949715|Pacemaker|pacemaker
695090|NCT00949715|Implantable Pulse Generator (IPG)|implantable pulse generator (ipg)
695091|NCT00949715|AV Conduction Disturbance|av conduction disturbance
695092|NCT00949715|Selective Site Pacing|selective site pacing
695093|NCT00949728|Pterygium|pterygium
695094|NCT00949728|Autologous Transplantation|autologous transplantation
695095|NCT00949728|Conjunctiva|conjunctiva
695096|NCT00949728|Fibrin Tissue Adhesive|fibrin tissue adhesive
695097|NCT00949728|Recurrence|recurrence
695098|NCT00949754|honeybee venom|honeybee venom
695099|NCT00949754|osteoarthritis|osteoarthritis
695100|NCT00949754|pain|pain
695101|NCT00949754|knees|knees
695102|NCT00949780|ABR|abr
695103|NCT00949780|Chloral Hydrate|chloral hydrate
695104|NCT00949780|Sedation|sedation
695105|NCT00949780|Children|children
695106|NCT00949793|Pathology|pathology
695107|NCT00949793|Microscopy, Confocal|microscopy, confocal
695108|NCT00949793|Microscopy, Fluorescence|microscopy, fluorescence
695109|NCT00949793|Intraoperative Procedures|intraoperative procedures
695110|NCT00949806|Botulinum toxin|botulinum toxin
695111|NCT00949819|Prostate Cancer|prostate cancer
695112|NCT00949819|Low risk|low risk
695113|NCT00949819|Gleason 6|gleason 6
695114|NCT00949819|Active surveillance|active surveillance
695115|NCT00949832|rickets|rickets
695116|NCT00949832|calcium|calcium
695117|NCT00949832|vitamin D|vitamin d
695118|NCT00949832|nutrition|nutrition
695119|NCT00949832|child|child
695120|NCT00949845|Effect of Inflammatory challenge on depressed mood|effect of inflammatory challenge on depressed mood
695121|NCT00949845|Effect of inflammatory challenge on social pain|effect of inflammatory challenge on social pain
695122|NCT00949858|Sleep Disorders|sleep disorders
695123|NCT00949858|Obstructive Sleep Apnea|obstructive sleep apnea
695124|NCT00949858|Restless Leg Syndrome|restless leg syndrome
695125|NCT00949858|Insomnia|insomnia
695126|NCT00949858|Actigraphy|actigraphy
695127|NCT00949871|stage I breast cancer|stage i breast cancer
695128|NCT00949871|stage II breast cancer|stage ii breast cancer
695129|NCT00949871|stage IIIA breast cancer|stage iiia breast cancer
695130|NCT00949871|stage IIIB breast cancer|stage iiib breast cancer
695131|NCT00949871|stage IIIC breast cancer|stage iiic breast cancer
695132|NCT00949871|stage IV breast cancer|stage iv breast cancer
695133|NCT00949871|cancer survivor|cancer survivor
695134|NCT00949897|Adult Acquired Flatfoot|adult acquired flatfoot
695135|NCT00949897|Biofoam Porous Metal Implant|biofoam porous metal implant
695136|NCT00949897|Allograft Bone Wedge|allograft bone wedge
695137|NCT00949923|Postmenopausal women|postmenopausal women
695138|NCT00949923|Suspicious for breast ca|suspicious for breast ca
695139|NCT00949936|Spine surgery|spine surgery
695140|NCT00949962|stage I prostate cancer|stage i prostate cancer
695141|NCT00949962|stage IIB prostate cancer|stage iib prostate cancer
695142|NCT00949962|stage IIA prostate cancer|stage iia prostate cancer
695143|NCT00949962|stage III prostate cancer|stage iii prostate cancer
695144|NCT00949975|Chronic|chronic
695145|NCT00949975|Obstructive|obstructive
695146|NCT00949975|Pulmonary|pulmonary
695147|NCT00949975|Lung|lung
695148|NCT00949975|Respiratory disease|respiratory disease
695149|NCT00949975|Efficacy|efficacy
695150|NCT00949975|Safety and tolerability|safety and tolerability
695151|NCT00949975|Placebo-controlled|placebo-controlled
695152|NCT00949975|Pharmacokinetics|pharmacokinetics
695153|NCT00949975|COPD|copd
695154|NCT00949988|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
695155|NCT00949988|CLL|cll
695156|NCT00949988|Dasatinib|dasatinib
695157|NCT00949988|Rituximab|rituximab
695158|NCT00949988|Relapsed|relapsed
695159|NCT00949988|Refractory|refractory
695160|NCT00950001|Brain tumors|brain tumors
695161|NCT00950001|Metastatic brain disease|metastatic brain disease
695162|NCT00950001|Post-surgical|post-surgical
695163|NCT00950001|Stereotactic radiosurgery|stereotactic radiosurgery
695164|NCT00950001|SRS|srs
695165|NCT00950001|Whole brain radiotherapy|whole brain radiotherapy
695166|NCT00950001|MRI|mri
695167|NCT00950001|Magnetic Resonance Imaging|magnetic resonance imaging
695168|NCT00950001|Outpatient radiation procedure|outpatient radiation procedure
695169|NCT00950014|Numeracy|numeracy
695170|NCT00950040|At-risk drinking|at-risk drinking
695171|NCT00950040|Type 2 diabetes|type 2 diabetes
695172|NCT00950040|Treatment adherence|treatment adherence
695173|NCT00950040|At-risk drinking among Type 2 diabetic patients|at-risk drinking among type 2 diabetic patients
695174|NCT00950079|sodium bicarbonate|sodium bicarbonate
695175|NCT00950079|diabetes mellitus|diabetes mellitus
695176|NCT00950079|coronary angiography or intervention|coronary angiography or intervention
695177|NCT00950092|AF|af
695178|NCT00950092|atrial fibrillation|atrial fibrillation
695179|NCT00950092|ablation|ablation
695180|NCT00950092|surgical ablation|surgical ablation
695181|NCT00950092|afib|afib
695182|NCT00950092|coagulation|coagulation
695183|NCT00950092|RF|rf
695184|NCT00950092|epicardial|epicardial
695185|NCT00950092|Arrhythmias|arrhythmias
695186|NCT00950105|CPSI2364|cpsi2364
695188|NCT00950105|Anti TNF alpha|anti tnf alpha
695189|NCT00950105|Crohn's Disease|crohn's disease
695190|NCT00950105|Safety|safety
695191|NCT00950105|Tolerability|tolerability
695192|NCT00950105|Pharmacokinetics|pharmacokinetics
695193|NCT00950118|Congenital Diaphragmatic Hernia (CDH)|congenital diaphragmatic hernia (cdh)
695195|NCT00950118|Genetic|genetic
695196|NCT00950118|chromosome|chromosome
695197|NCT00950118|chromosome microarray|chromosome microarray
695198|NCT00950118|microarray|microarray
695199|NCT00950144|pain|pain
695200|NCT00950144|depression|depression
695201|NCT00950144|fatigue|fatigue
695202|NCT00950144|stage III colon cancer|stage iii colon cancer
695203|NCT00950144|stage IV colon cancer|stage iv colon cancer
695204|NCT00950144|recurrent colon cancer|recurrent colon cancer
695205|NCT00950144|stage III rectal cancer|stage iii rectal cancer
695206|NCT00950144|stage IV rectal cancer|stage iv rectal cancer
695207|NCT00950144|recurrent rectal cancer|recurrent rectal cancer
695208|NCT00950144|stage III pancreatic cancer|stage iii pancreatic cancer
695209|NCT00950144|stage IV pancreatic cancer|stage iv pancreatic cancer
695210|NCT00950144|recurrent pancreatic cancer|recurrent pancreatic cancer
695211|NCT00950144|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
695212|NCT00950144|advanced adult primary liver cancer|advanced adult primary liver cancer
695213|NCT00950144|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
695214|NCT00950144|recurrent adult primary liver cancer|recurrent adult primary liver cancer
695215|NCT00950170|ReFacto AF|refacto af
695216|NCT00950170|factor VIII|factor viii
695217|NCT00950170|inhibitors|inhibitors
695218|NCT00950170|antibodies|antibodies
695219|NCT00950183|cryotherapy|cryotherapy
695220|NCT00950183|postoperative pain|postoperative pain
695221|NCT00950183|Iceman|iceman
695222|NCT00950183|primary first metatarsal osteotomy (PMO)|primary first metatarsal osteotomy (pmo)
695223|NCT00950183|lateral ankle ligament reconstruction (LAR)|lateral ankle ligament reconstruction (lar)
695224|NCT00950209|type 2 diabetic patients in the fed state|type 2 diabetic patients in the fed state
695225|NCT00950222|Intensive care unit|intensive care unit
695226|NCT00950222|Ventilator associated pneumonia|ventilator associated pneumonia
695227|NCT00950222|Gram negative bacilli infection|gram negative bacilli infection
695228|NCT00950222|Empirical antibiotic therapy|empirical antibiotic therapy
695229|NCT00950222|Pharmacokinetic / pharmacodynamic|pharmacokinetic / pharmacodynamic
695230|NCT00950222|Imipenem|imipenem
695231|NCT00950222|Amikacin|amikacin
695232|NCT00950222|Gram negative bacilli|gram negative bacilli
695233|NCT00950235|obese|obese
695234|NCT00950235|pregnant|pregnant
695235|NCT00950235|large for gestational age|large for gestational age
695236|NCT00950235|large for gestational age baby|large for gestational age baby
695237|NCT00950248|Idebenone|idebenone
695238|NCT00950248|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
695239|NCT00950248|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
695240|NCT00950248|Mitochondrial Enhancer|mitochondrial enhancer
695241|NCT00950248|Multiple Sclerosis|multiple sclerosis
695243|NCT00950248|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
695244|NCT00950261|Cervical neoplasms|cervical neoplasms
695245|NCT00950261|Cisplatin|cisplatin
695246|NCT00950261|Concurrent Chemoradiation|concurrent chemoradiation
695247|NCT00950274|Cell therapy|cell therapy
695248|NCT00950274|Bone marrow|bone marrow
695249|NCT00950274|CD133|cd133
695250|NCT00950274|Bypass surgery|bypass surgery
695251|NCT00950274|Stem cells|stem cells
695252|NCT00950274|Myocardial infarction|myocardial infarction
695253|NCT00950274|Myocardial ischemia|myocardial ischemia
695254|NCT00950287|apnea-bradycardias|apnea-bradycardias
695255|NCT00950287|preterm infants|preterm infants
695256|NCT00950313|Diabetes|diabetes
695257|NCT00950313|Screening|screening
695258|NCT00950313|Risk|risk
695259|NCT00950313|Self assessment|self assessment
695260|NCT00950326|osteoarthritis|osteoarthritis
695261|NCT00950326|hydrotherapy|hydrotherapy
695262|NCT00950326|affusion|affusion
695263|NCT00950326|conventional physiotherapy|conventional physiotherapy
695264|NCT00950326|comparison|comparison
695265|NCT00950339|GI bleeding|gi bleeding
695266|NCT00950339|clopidogrel|clopidogrel
695267|NCT00950339|aspirin|aspirin
695268|NCT00950339|prevention|prevention
695269|NCT00950339|angiography|angiography
695270|NCT00950352|methamphetamine|methamphetamine
695271|NCT00950352|Citicoline|citicoline
695272|NCT00950352|CDP-Choline|cdp-choline
695273|NCT00950352|Neuroimaging|neuroimaging
695275|NCT00950352|Brain|brain
695276|NCT00950352|MRS|mrs
695277|NCT00950352|DTI|dti
695278|NCT00950365|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
695474|NCT00951015|tenofovir|tenofovir
695279|NCT00950365|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
695280|NCT00950365|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
695281|NCT00950365|progressive or recurrent stage III or stage IV non-small cell lung cancer|progressive or recurrent stage iii or stage iv non-small cell lung cancer
695282|NCT00950378|edema|edema
695283|NCT00950378|blood supply|blood supply
695284|NCT00950378|lower legs|lower legs
695285|NCT00950378|venous stasis|venous stasis
695286|NCT00950391|peripheral nerve injury|peripheral nerve injury
695287|NCT00950391|peripheral nerve surgery|peripheral nerve surgery
695288|NCT00950391|nerve repair|nerve repair
695289|NCT00950391|nerve graft|nerve graft
695290|NCT00950404|Bioavailability Pharmacokinetic Formulation|bioavailability pharmacokinetic formulation
695291|NCT00950417|nimotuzumab esophageal chemo-radiotherapy|nimotuzumab esophageal chemo-radiotherapy
695292|NCT00950430|Imaging|imaging
695293|NCT00950430|PET|pet
695294|NCT00950430|PiB|pib
695295|NCT00950430|FDG|fdg
695296|NCT00950430|MCI|mci
695297|NCT00950430|Dementia|dementia
695298|NCT00950430|Alzheimer's Disease|alzheimer's disease
695299|NCT00950430|Brain Amyloid|brain amyloid
695300|NCT00950443|Upper airway obstruction|upper airway obstruction
695301|NCT00950443|child|child
695302|NCT00950443|acoustic reflection method|acoustic reflection method
695303|NCT00950443|endoscopy|endoscopy
695304|NCT00950443|work of breathing|work of breathing
695305|NCT00950443|sleep study|sleep study
695306|NCT00950443|CT scan|ct scan
695307|NCT00950469|high sensitive troponin T; cardiac necrosis; early detection; myoglobin; h-FABP|high sensitive troponin t; cardiac necrosis; early detection; myoglobin; h-fabp
695308|NCT00950469|early identification and risk stratification of patients with suspicious acute coronary syndrome|early identification and risk stratification of patients with suspicious acute coronary syndrome
695309|NCT00950482|Menopause|menopause
695310|NCT00950482|Acupuncture|acupuncture
695311|NCT00950482|Hotflash|hotflash
695312|NCT00950495|Parallel design|parallel design
695313|NCT00950495|Oral appliance|oral appliance
695314|NCT00950495|Mandibular advancement device|mandibular advancement device
695315|NCT00950495|Continuous positive airway pressure|continuous positive airway pressure
695316|NCT00950495|Placebo|placebo
695317|NCT00950495|Therapy|therapy
695318|NCT00950495|Side-effects|side-effects
695319|NCT00950495|Compliance|compliance
695320|NCT00950521|Stroke|stroke
695321|NCT00950521|Stem Cell|stem cell
695322|NCT00950521|Cell Therapy|cell therapy
695323|NCT00950521|CD34 Stem cell|cd34 stem cell
695324|NCT00950521|Peripheral blood Stem cell|peripheral blood stem cell
695325|NCT00950547|Blood Transfusion|blood transfusion
695326|NCT00950547|Cell Saver|cell saver
695327|NCT00950547|Cardiac Surgery|cardiac surgery
695328|NCT00950547|Evaluate the efficacy of cell salvage CardioPAT routinely used in cardiac surgery in reducing blood transfusions.|evaluate the efficacy of cell salvage cardiopat routinely used in cardiac surgery in reducing blood transfusions.
695329|NCT00950573|cardiovascular disease|cardiovascular disease
695330|NCT00950573|endstage renal disease|endstage renal disease
695331|NCT00950586|Drug interaction|drug interaction
695332|NCT00950586|Saftey|saftey
695333|NCT00950586|Pharmacokinetics|pharmacokinetics
695334|NCT00950586|Cognition|cognition
695335|NCT00950612|Tuberculosis vaccine|tuberculosis vaccine
695336|NCT00950625|intraperitoneal analgesia|intraperitoneal analgesia
695337|NCT00950625|laparoscopic cholecystectomy|laparoscopic cholecystectomy
695338|NCT00950625|lignocaine|lignocaine
695339|NCT00950625|bupevacaine|bupevacaine
695340|NCT00950638|AMD|amd
695341|NCT00950664|cervical dystonia|cervical dystonia
695342|NCT00950664|botulinum toxin|botulinum toxin
695343|NCT00950677|Diabetes|diabetes
695344|NCT00950677|pramlintide|pramlintide
695345|NCT00950677|Symlin|symlin
695346|NCT00950677|exenatide|exenatide
695347|NCT00950677|byetta|byetta
695348|NCT00950677|glucagon|glucagon
695349|NCT00950677|gastric emptying|gastric emptying
695350|NCT00950690|observational safety study|observational safety study
695351|NCT00950703|Assessing the perceptions of Canadian Primary care physicians towards global Cardiovascular risk assessment.|assessing the perceptions of canadian primary care physicians towards global cardiovascular risk assessment.
695352|NCT00950716|type II diabetes|type ii diabetes
695353|NCT00950716|peer support|peer support
695354|NCT00950716|empowerment|empowerment
695355|NCT00950729|car driving simulator|car driving simulator
695356|NCT00950729|orthopedic leg immobilisation|orthopedic leg immobilisation
695357|NCT00950729|braking time|braking time
695358|NCT00950729|braking force|braking force
695359|NCT00950768|Myeloma|myeloma
695360|NCT00950768|Melphalan|melphalan
695361|NCT00950768|Autologous transplantation|autologous transplantation
695362|NCT00941642|Nonalcoholic Fatty Liver Disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
695363|NCT00941642|Lovaza|lovaza
695364|NCT00941642|Steatosis|steatosis
695365|NCT00941642|Non-Alcoholic steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
695366|NCT00941655|Gastric Carcinoma|gastric carcinoma
695367|NCT00941655|Chemotherapy|chemotherapy
695368|NCT00941655|Liver Tumors|liver tumors
695369|NCT00941655|Peritoneal Tumors|peritoneal tumors
695370|NCT00941655|Metastatic Gastric Cancer|metastatic gastric cancer
695371|NCT00941655|Stomach Cancer|stomach cancer
695372|NCT00941655|Gastric Cancer|gastric cancer
695373|NCT00941681|omecamtiv mecarbil|omecamtiv mecarbil
695374|NCT00941694|asthma|asthma
695375|NCT00941694|aged|aged
695376|NCT00941694|self care|self care
695377|NCT00941707|Rheumatoid Arthritis|rheumatoid arthritis
695378|NCT00941707|JNJ-38518168|jnj-38518168
695379|NCT00941720|stage I multiple myeloma|stage i multiple myeloma
695380|NCT00941720|stage II multiple myeloma|stage ii multiple myeloma
695585|NCT00952692|dHER2 ASCI|dher2 asci
695381|NCT00941720|stage III multiple myeloma|stage iii multiple myeloma
695383|NCT00941733|CLI|cli
695384|NCT00941733|PTA|pta
695385|NCT00950781|Menopause|menopause
695386|NCT00950781|Cortisol|cortisol
695387|NCT00950781|ACTH|acth
695388|NCT00950794|Long acting beta2-agonist|long acting beta2-agonist
695389|NCT00950807|Dose ranging|dose ranging
695390|NCT00950807|Chronic Bronchitis|chronic bronchitis
695391|NCT00950807|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
695392|NCT00950807|cross-over|cross-over
695393|NCT00950807|COPD|copd
695394|NCT00950807|Emphysema|emphysema
695395|NCT00950807|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
695396|NCT00950807|anticholinergic|anticholinergic
695397|NCT00950820|Open-label|open-label
695398|NCT00950820|Phase-II-Study|phase-ii-study
695399|NCT00950820|Randomized|randomized
695400|NCT00950820|Metastatic|metastatic
695401|NCT00950820|Colorectal|colorectal
695402|NCT00950820|Cancer|cancer
695403|NCT00950820|Panitumumab|panitumumab
695404|NCT00950820|Vectibix®|vectibix®
695405|NCT00950820|second-line-treatment|second-line-treatment
695406|NCT00950820|KRAS|kras
695407|NCT00950833|Catch-up vaccination|catch-up vaccination
695408|NCT00950833|Pneumococcal vaccine|pneumococcal vaccine
695409|NCT00950833|Immune memory|immune memory
695410|NCT00950833|Nasopharyngeal carriage|nasopharyngeal carriage
695411|NCT00950833|Immunogenicity|immunogenicity
695412|NCT00950833|Pneumococcal disease|pneumococcal disease
695413|NCT00950833|Safety|safety
695414|NCT00950846|Congenital Pediatric Disorders|congenital pediatric disorders
695415|NCT00950846|Umbilical Cord Blood Transplant|umbilical cord blood transplant
695416|NCT00950846|Congenital Abnormalities|congenital abnormalities
695417|NCT00950846|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
695418|NCT00950846|Busulfan|busulfan
695419|NCT00950846|Cytoxan|cytoxan
695420|NCT00950846|Cyclophosphamide|cyclophosphamide
695421|NCT00950846|Fludarabine|fludarabine
695422|NCT00950859|treatment experienced|treatment experienced
695423|NCT00950859|HIV Infection|hiv infection
695424|NCT00950859|raltegravir resistance|raltegravir resistance
695425|NCT00950859|GSK1349572|gsk1349572
695426|NCT00950859|optimized background regimen|optimized background regimen
695427|NCT00950859|integrase inhibitor|integrase inhibitor
695428|NCT00950885|sleep|sleep
695429|NCT00950885|alertness|alertness
695430|NCT00950885|performance|performance
695431|NCT00950885|vigilance|vigilance
695432|NCT00950885|circadian|circadian
695433|NCT00950898|coffee|coffee
695434|NCT00950898|caffeine|caffeine
695435|NCT00950898|glucose metabolism|glucose metabolism
695436|NCT00950898|insulin sensitivity|insulin sensitivity
695437|NCT00950898|diabetes|diabetes
695438|NCT00950911|Bone metastases|bone metastases
695439|NCT00950911|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
695440|NCT00950911|Multiple myeloma|multiple myeloma
695441|NCT00950911|Denosumab|denosumab
695442|NCT00950911|Breast cancer|breast cancer
695443|NCT00950911|20050103|20050103
695444|NCT00950911|20050136|20050136
695445|NCT00950911|20050244|20050244
695446|NCT00950911|Advanced cancer|advanced cancer
695447|NCT00950911|Tumor|tumor
695448|NCT00950911|Prostate cancer|prostate cancer
695449|NCT00950911|Zoledronic acid|zoledronic acid
695450|NCT00950924|Hyperopia|hyperopia
695451|NCT00950924|Refractive Error|refractive error
695452|NCT00950924|Ocular Biometrics|ocular biometrics
695453|NCT00950924|Axial Length|axial length
695454|NCT00950924|Contact Lenses|contact lenses
695455|NCT00950924|Bifocal Contact Lenses|bifocal contact lenses
695456|NCT00950950|Amgen|amgen
695457|NCT00950950|Postmenopausal|postmenopausal
695458|NCT00950950|Bone Density|bone density
695459|NCT00950963|Diabetes, Nurse phone intervention, lipid control|diabetes, nurse phone intervention, lipid control
695460|NCT00950989|Autoimmune Diseases|autoimmune diseases
695461|NCT00950989|Musculoskeletal Diseases|musculoskeletal diseases
695462|NCT00950989|Joint Diseases|joint diseases
695463|NCT00950989|Arthritis|arthritis
695464|NCT00950989|Connective Tissue Diseases|connective tissue diseases
695465|NCT00950989|Arthritis, Rheumatoid|arthritis, rheumatoid
695466|NCT00950989|Rheumatic Diseases|rheumatic diseases
695467|NCT00951002|anal fistula|anal fistula
695468|NCT00951002|acellular dermal matrix|acellular dermal matrix
695469|NCT00951002|treatment|treatment
695470|NCT00951002|postoperative complications|postoperative complications
695471|NCT00951002|recurrence|recurrence
695472|NCT00951015|GSK1349572|gsk1349572
695473|NCT00951015|emtricitabine|emtricitabine
695475|NCT00951015|efavirenz|efavirenz
695476|NCT00951015|abacavir|abacavir
695477|NCT00951015|antiretroviral therapy naive|antiretroviral therapy naive
695478|NCT00951015|dose selection|dose selection
695479|NCT00951015|HIV-1 Infection|hiv-1 infection
695480|NCT00951015|integrase inhibitor|integrase inhibitor
695481|NCT00951015|HIV infection|hiv infection
695482|NCT00951015|once daily|once daily
695483|NCT00951015|lamivudine|lamivudine
695485|NCT00951041|influenza infection|influenza infection
695486|NCT00951041|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
695487|NCT00951054|breast cancer|breast cancer
695488|NCT00951054|triple negative|triple negative
695489|NCT00951054|ER-negative|er-negative
695490|NCT00951054|PR-negative|pr-negative
695491|NCT00951054|HER2-negative|her2-negative
695492|NCT00951054|ER-, PR-, HER2- (Triple Negative) breast cancer|er-, pr-, her2- (triple negative) breast cancer
695493|NCT00951067|Lymphedema|lymphedema
695494|NCT00951067|Breast Cancer|breast cancer
695495|NCT00951067|Upper Extremity|upper extremity
695496|NCT00951067|Arm|arm
695497|NCT00951080|ulcer|ulcer
695498|NCT00951080|venous|venous
695499|NCT00951080|diabetic|diabetic
695500|NCT00951080|wounds and injuries|wounds and injuries
695501|NCT00951093|GERD|gerd
695502|NCT00951093|Gastric bypass|gastric bypass
695503|NCT00951106|Peru|peru
695504|NCT00951106|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
695505|NCT00951106|Drug resistance|drug resistance
695506|NCT00952380|VTE|vte
695507|NCT00952393|receptors nicotinic|receptors nicotinic
695508|NCT00952406|Pelvic Floor Disorders|pelvic floor disorders
695509|NCT00952406|Sexual Function|sexual function
695510|NCT00952406|Incontinence|incontinence
695511|NCT00952406|Pelvic Organ Prolapse|pelvic organ prolapse
695512|NCT00952419|Influenza|influenza
695513|NCT00952419|Pandemic Flu|pandemic flu
695514|NCT00952419|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
695515|NCT00952419|Children|children
695516|NCT00952432|Carpal Tunnel Syndrome|carpal tunnel syndrome
695517|NCT00952432|Multiple Excitability Test|multiple excitability test
695518|NCT00952432|Nerve Conduction Study|nerve conduction study
695519|NCT00952432|QtracW|qtracw
695520|NCT00952432|carbamazepine|carbamazepine
695521|NCT00952432|Acupuncture|acupuncture
695522|NCT00952458|Safety|safety
695523|NCT00952458|Midazolam and propofol sedation|midazolam and propofol sedation
695524|NCT00952458|ERCP|ercp
695525|NCT00952458|Bispectral Index monitoring|bispectral index monitoring
695526|NCT00952471|Asthma|asthma
695527|NCT00952471|Children|children
695528|NCT00952471|CPOE|cpoe
695529|NCT00952471|Decision Support|decision support
695530|NCT00952471|Framing|framing
695531|NCT00952471|Heuristic|heuristic
695532|NCT00952471|Order Sets|order sets
695533|NCT00952484|Hypophosphatasia|hypophosphatasia
695534|NCT00952484|HPP|hpp
695535|NCT00952484|Bone Disease|bone disease
695536|NCT00952484|Soft Bones|soft bones
695537|NCT00952484|Low Alkaline Phosphatase|low alkaline phosphatase
695538|NCT00952484|genetic metabolic disorder|genetic metabolic disorder
695539|NCT00952484|alkaline phosphatase|alkaline phosphatase
695540|NCT00952484|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
695541|NCT00952484|rickets|rickets
695542|NCT00952484|osteomalacia|osteomalacia
695543|NCT00952497|Gastric Cancer|gastric cancer
695544|NCT00952497|Gastro-Esophageal Cancer|gastro-esophageal cancer
695545|NCT00952497|GE-Junction|ge-junction
695546|NCT00952497|Advanced Gastric Cancer|advanced gastric cancer
695547|NCT00952510|Range of motion, articular|range of motion, articular
695548|NCT00952510|Cervical spine|cervical spine
695549|NCT00952523|acne|acne
695550|NCT00952523|irritation|irritation
695551|NCT00952523|objective sensory methods|objective sensory methods
695552|NCT00952536|Randomised controlled trial|randomised controlled trial
695553|NCT00952536|Double blind fully masked|double blind fully masked
695554|NCT00952536|Dietary supplement|dietary supplement
695555|NCT00952562|vitamin d|vitamin d
695556|NCT00952562|calcium|calcium
695557|NCT00952562|blood pressure|blood pressure
695558|NCT00952575|Prevention of foeto-maternal allo-immunisation|prevention of foeto-maternal allo-immunisation
695559|NCT00952588|Acute Myeloid Leukaemia,|acute myeloid leukaemia,
695560|NCT00952588|AML|aml
695561|NCT00952601|Tourette|tourette
695562|NCT00952601|Atkins|atkins
695563|NCT00952601|Ketosis|ketosis
695564|NCT00952601|Tic|tic
695565|NCT00952614|retinal vein occlusion|retinal vein occlusion
695566|NCT00952614|sustained drug delivery implant|sustained drug delivery implant
695567|NCT00952614|steroid|steroid
695568|NCT00952614|macular edema|macular edema
695569|NCT00952627|Cardiac fibrosis|cardiac fibrosis
695570|NCT00952627|Diastolic dysfunction|diastolic dysfunction
695571|NCT00952627|Hypertension|hypertension
695572|NCT00952640|vitamin A|vitamin a
695573|NCT00952640|post-partum|post-partum
695574|NCT00952640|infant|infant
695575|NCT00952640|acute phase response|acute phase response
695576|NCT00952653|depression|depression
695577|NCT00952666|Prostate Cancer|prostate cancer
695578|NCT00952666|Transrectal Ultrasound Imaging of Prostate|transrectal ultrasound imaging of prostate
695579|NCT00952666|Neurovascular Bundles|neurovascular bundles
695580|NCT00952666|Robot Assisted Laparoscopic Radical Prostatectomy|robot assisted laparoscopic radical prostatectomy
695581|NCT00952679|The investigators evaluated the new method by comparing lymph nodes defined by CT and traditional ways.|the investigators evaluated the new method by comparing lymph nodes defined by ct and traditional ways.
695582|NCT00952692|breast cancer|breast cancer
695583|NCT00952692|HER2|her2
695584|NCT00952692|Lapatinib|lapatinib
695586|NCT00952692|overexpressing HER2|overexpressing her2
695587|NCT00952692|refractory to trastuzumab|refractory to trastuzumab
695588|NCT00952744|acute myocardial infarction|acute myocardial infarction
695589|NCT00952744|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
695590|NCT00952744|STEMI|stemi
695591|NCT00952744|non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
695592|NCT00952744|NSTEMI|nstemi
695593|NCT00952744|unstable angina|unstable angina
695594|NCT00952744|unstable angina pectoris|unstable angina pectoris
695595|NCT00952744|UA|ua
695596|NCT00952744|UAP|uap
695597|NCT00952757|APS-related hyperprolactinaemia|aps-related hyperprolactinaemia
695598|NCT00952757|Quetiapine|quetiapine
695599|NCT00952757|Schizophrenia|schizophrenia
695600|NCT00952757|Bipolar|bipolar
695601|NCT00952770|Coronary artery disease|coronary artery disease
695602|NCT00952770|Coronary intervention|coronary intervention
695603|NCT00952770|intima-media thickness|intima-media thickness
695604|NCT00952783|Peplin|peplin
695605|NCT00952783|Actinic keratosis|actinic keratosis
695606|NCT00952783|PEP005|pep005
695607|NCT00952796|intra-abdominal infection|intra-abdominal infection
695608|NCT00952796|moxifloxacin|moxifloxacin
695609|NCT00952796|ampicillin/sulbactam|ampicillin/sulbactam
695610|NCT00952835|Asthma|asthma
695611|NCT00952835|rhinitis|rhinitis
695612|NCT00952835|EIB|eib
695613|NCT00952835|Exhaled Nitric oxide|exhaled nitric oxide
695614|NCT00952835|lung function|lung function
695615|NCT00952835|vitamin d|vitamin d
695616|NCT00952848|pain|pain
695617|NCT00952848|neurotoxicity|neurotoxicity
695618|NCT00952848|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
695619|NCT00952848|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
695620|NCT00952848|peripheral neuropathy|peripheral neuropathy
695621|NCT00952861|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
695622|NCT00952861|Infection|infection
695623|NCT00952861|Antibiotics|antibiotics
695624|NCT00952874|anal cancer|anal cancer
695625|NCT00952874|Molecular biology|molecular biology
695626|NCT00952874|HIV status|hiv status
695627|NCT00952874|HPV infection|hpv infection
695628|NCT00952874|Microsatellite instability|microsatellite instability
695629|NCT00952874|Biopsy proven Squamous Cell carcinoma of the Anus|biopsy proven squamous cell carcinoma of the anus
695630|NCT00952874|Squamous Cell carcinoma of the Anus|squamous cell carcinoma of the anus
695631|NCT00952900|TMJMD|tmjmd
695632|NCT00952900|Acute Pain|acute pain
695633|NCT00952900|RDC/TMD|rdc/tmd
695634|NCT00952900|Community Treatment Clinics|community treatment clinics
695635|NCT00952900|RCT|rct
695636|NCT00952900|Evidence-Based Outcomes|evidence-based outcomes
695637|NCT00952900|Short- and long-term follow-up|short- and long-term follow-up
695638|NCT00952900|Biopsychosocial|biopsychosocial
695639|NCT00952900|Assessment and Treatment|assessment and treatment
695640|NCT00952900|Ability to read and write English|ability to read and write english
695641|NCT00952900|6 months' or less duration of TMD|6 months' or less duration of tmd
695642|NCT00952900|No other pain-related conditions|no other pain-related conditions
695643|NCT00952926|Watchful Waiting|watchful waiting
695644|NCT00952926|Rectal cancer|rectal cancer
695645|NCT00952926|Observation|observation
695646|NCT00952926|Avoid operation|avoid operation
695647|NCT00952939|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
695648|NCT00952939|iris melanoma|iris melanoma
695649|NCT00952939|intraocular melanoma|intraocular melanoma
695650|NCT00952939|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
695651|NCT00952965|BP|bp
695652|NCT00952978|Ilaprazole|ilaprazole
695653|NCT00952978|Proton pump inhibitor|proton pump inhibitor
695654|NCT00952978|Duodenal ulcer|duodenal ulcer
695655|NCT00952978|Acid suppression|acid suppression
695656|NCT00952978|Randomized trial|randomized trial
695657|NCT00953004|dietary fiber|dietary fiber
695658|NCT00953004|obesity|obesity
695659|NCT00953004|apparent energy digestibility|apparent energy digestibility
695660|NCT00953017|Efficacy of bowel cleansing|efficacy of bowel cleansing
695661|NCT00953017|Patient tolerability|patient tolerability
695662|NCT00953017|Amitiza|amitiza
695663|NCT00953017|Dulcolax|dulcolax
695664|NCT00953017|Miralax|miralax
695665|NCT00953017|Colonoscopy preparation|colonoscopy preparation
695666|NCT00953017|Bowel preparation|bowel preparation
695667|NCT00953017|Screening colonoscopy|screening colonoscopy
695668|NCT00953043|lubiprostone|lubiprostone
695669|NCT00953043|colon|colon
695670|NCT00953043|motility|motility
695671|NCT00953043|sensation|sensation
695672|NCT00953095|Autism Spectrum Disorder|autism spectrum disorder
695673|NCT00953095|treatment|treatment
695674|NCT00953095|joint attention|joint attention
695675|NCT00953095|communication|communication
695676|NCT00953095|language|language
695677|NCT00953121|irinotecan|irinotecan
695678|NCT00953121|carboplatin|carboplatin
695679|NCT00953121|bevacizumab|bevacizumab
695680|NCT00953121|Avastin|avastin
695681|NCT00953134|periconceptional|periconceptional
695682|NCT00953134|iron|iron
695683|NCT00953134|folic acid|folic acid
695684|NCT00953134|supplementation|supplementation
695685|NCT00953160|Cellulite|cellulite
695686|NCT00953160|Adipose tissue|adipose tissue
695687|NCT00953160|Circumference|circumference
695688|NCT00953160|Reduction|reduction
695690|NCT00953160|Abdomen|abdomen
695691|NCT00953160|Flank|flank
695692|NCT00953186|Diabetes|diabetes
695693|NCT00953186|Foot ulcer|foot ulcer
695694|NCT00953186|Neuropathy|neuropathy
695695|NCT00953186|Ischemia|ischemia
695696|NCT00953199|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
695697|NCT00953199|ERCP|ercp
695698|NCT00953199|pancreatitis|pancreatitis
695699|NCT00953199|lidocaine|lidocaine
695700|NCT00953199|post-ERCP pancreatitis|post-ercp pancreatitis
695701|NCT00953212|atrial fibrillation|atrial fibrillation
695702|NCT00953212|cardiac surgery|cardiac surgery
695703|NCT00953212|open heart surgery|open heart surgery
695704|NCT00953225|prostate cancer|prostate cancer
695705|NCT00953225|vitamin D|vitamin d
695706|NCT00953251|high sensitive troponin T; non-STEMI; early detection.|high sensitive troponin t; non-stemi; early detection.
695707|NCT00953251|To detect non-STEMI in a cohort of patients with acute coronary syndrome|to detect non-stemi in a cohort of patients with acute coronary syndrome
695708|NCT00953277|Nerve Repair|nerve repair
695709|NCT00953277|Erectile Function|erectile function
695710|NCT00953277|Prostate Cancer|prostate cancer
695711|NCT00953277|Robot Assisted Laparoscopic Prostatectomy|robot assisted laparoscopic prostatectomy
695712|NCT00953277|Continence|continence
695713|NCT00953290|Cellulite|cellulite
695714|NCT00953290|Adipose tissue|adipose tissue
695715|NCT00953290|Circumference|circumference
695716|NCT00953290|Reduction|reduction
695717|NCT00953290|Thigh|thigh
695718|NCT00953303|heart failure|heart failure
695719|NCT00953303|prednisone|prednisone
695720|NCT00953303|cardiovascular mortality|cardiovascular mortality
695721|NCT00953303|renal function|renal function
695722|NCT00953342|AEROBIC EXERCISE|aerobic exercise
695723|NCT00953342|ASTHMA CONTROL|asthma control
695724|NCT00953342|ASTHMA QUALITY OF LIFE|asthma quality of life
695725|NCT00953342|INFLAMMATION|inflammation
695726|NCT00953342|TREATMENT|treatment
695727|NCT00953368|remote ischemic preconditioning|remote ischemic preconditioning
695728|NCT00953368|cognitive function|cognitive function
695729|NCT00953368|off-pump coronary artery bypass graft|off-pump coronary artery bypass graft
695730|NCT00953381|Ilaprazole|ilaprazole
695731|NCT00953381|Proton pump inhibitor|proton pump inhibitor
695732|NCT00953381|Duodenal ulcer|duodenal ulcer
695733|NCT00953381|Acid suppression|acid suppression
695734|NCT00953381|Randomized trial|randomized trial
695735|NCT00953394|octreotide LAR|octreotide lar
695736|NCT00953394|neuroendocrine carcinoma|neuroendocrine carcinoma
695737|NCT00953394|metronomic 5fluorouracil|metronomic 5fluorouracil
695738|NCT00953420|nasopharyngeal carcinoma|nasopharyngeal carcinoma
695739|NCT00953420|Carboplatin|carboplatin
695740|NCT00953420|Docetaxel|docetaxel
695741|NCT00953420|Epstein-Barr Virus|epstein-barr virus
695742|NCT00953420|T Lymphocytes|t lymphocytes
695743|NCT00953420|EBV-CTLs|ebv-ctls
695744|NCT00953433|Intratracheal|intratracheal
695745|NCT00953446|metastatic renal cell carcinoma|metastatic renal cell carcinoma
695746|NCT00953446|ASL MRI|asl mri
695747|NCT00953446|sunitinib|sunitinib
695748|NCT00953446|AMG386|amg386
695749|NCT00953459|extensive stage small cell lung cancer|extensive stage small cell lung cancer
695750|NCT00953459|recurrent small cell lung cancer|recurrent small cell lung cancer
695751|NCT00953472|hypertension treatment|hypertension treatment
695752|NCT00953485|Sjogren's Syndrome|sjogren's syndrome
695753|NCT00953485|Mesenchymal Stem Cells|mesenchymal stem cells
695754|NCT00953485|Transplantation|transplantation
695755|NCT00953498|diabetes|diabetes
695756|NCT00953498|glitazones|glitazones
695758|NCT00953511|esophagus|esophagus
695759|NCT00953511|chemoradiation|chemoradiation
695760|NCT00953511|excision repair cross-complementing gene|excision repair cross-complementing gene
695761|NCT00953511|polymorphism|polymorphism
695762|NCT00953511|response prediction|response prediction
695763|NCT00953524|Influenza|influenza
695764|NCT00953524|Pandemic Flu|pandemic flu
695765|NCT00953524|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
695766|NCT00953524|Adult|adult
695767|NCT00953537|stage IV breast cancer|stage iv breast cancer
695768|NCT00953563|Venous Leg Ulcers|venous leg ulcers
695769|NCT00953576|castration resistant prostate cancer|castration resistant prostate cancer
695770|NCT00953576|KHAD|khad
695771|NCT00953589|treatment naive|treatment naive
695772|NCT00953615|PSC|psc
695773|NCT00953615|Thalidomide|thalidomide
695774|NCT00953628|endometrium|endometrium
695775|NCT00953628|histology|histology
695776|NCT00953628|pregnancy|pregnancy
695777|NCT00953641|Vaginal Misoprostol|vaginal misoprostol
695778|NCT00953641|Cervical ripening|cervical ripening
695779|NCT00953641|Endometrial biopsy|endometrial biopsy
695877|NCT00954226|HN cancer|hn cancer
695784|NCT00953693|Induced pluripotent stem cells|induced pluripotent stem cells
695786|NCT00953693|Eye disorders|eye disorders
695787|NCT00953693|Blood groups|blood groups
695788|NCT00953706|Fibrosis|fibrosis
695789|NCT00953706|Pancreatic Diseases|pancreatic diseases
695790|NCT00953706|Digestive System Diseases|digestive system diseases
695791|NCT00953706|Lung Diseases|lung diseases
695792|NCT00953706|Respiratory Tract Diseases|respiratory tract diseases
695793|NCT00953706|Genetic Diseases, Inborn|genetic diseases, inborn
695794|NCT00953706|Infant, Newborn, Diseases|infant, newborn, diseases
695795|NCT00953706|Pathologic Processes|pathologic processes
695796|NCT00953719|Hip arthroplasty|hip arthroplasty
695797|NCT00953719|Acetabular cup|acetabular cup
695798|NCT00953719|Ceramic-on-polyethylene|ceramic-on-polyethylene
695799|NCT00953732|Peplin|peplin
695800|NCT00953732|Actinic keratosis|actinic keratosis
695801|NCT00953732|PEP005|pep005
695802|NCT00953745|Depression|depression
695803|NCT00953745|Neuroimaging|neuroimaging
695804|NCT00953745|Aripiprazole|aripiprazole
695805|NCT00953745|Mood disorder|mood disorder
695806|NCT00953745|PET Scan|pet scan
695807|NCT00953745|fMRI|fmri
695808|NCT00953758|Chronic Myeloid Leukemia Myelofibrosis Myelodysplastic Syndrome Acute myeloid Leukemia Hedgehog inhibitor|chronic myeloid leukemia myelofibrosis myelodysplastic syndrome acute myeloid leukemia hedgehog inhibitor
695809|NCT00953771|TTP|ttp
695810|NCT00953771|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
695811|NCT00953784|surgery|surgery
695812|NCT00953784|wound infections|wound infections
695813|NCT00953784|colorectal|colorectal
695814|NCT00953797|Resistant Hypertension|resistant hypertension
695815|NCT00953797|Endothelial dysfunction|endothelial dysfunction
695816|NCT00953797|Enhanced External Counterpulsation|enhanced external counterpulsation
695817|NCT00953810|heart failure|heart failure
695818|NCT00953810|education|education
695819|NCT00953810|non-pharmacological management|non-pharmacological management
695820|NCT00953810|prognosis|prognosis
695821|NCT00953823|Thiamin supplementation|thiamin supplementation
695822|NCT00953823|Thiamin deficiency|thiamin deficiency
695823|NCT00953823|Heart failure|heart failure
695824|NCT00953823|Heart function|heart function
695825|NCT00953823|Vitamin B1 supplementation|vitamin b1 supplementation
695826|NCT00953836|kinetics|kinetics
695827|NCT00953836|alkylresorcinol metabolites|alkylresorcinol metabolites
695828|NCT00953836|rye fiber|rye fiber
695829|NCT00953849|Calcitriol|calcitriol
695830|NCT00953849|Celecoxib|celecoxib
695831|NCT00953849|Immunotherapy|immunotherapy
695832|NCT00953862|ADHD|adhd
695833|NCT00953862|Substance Use Disorder|substance use disorder
695834|NCT00953862|Residential Treatment Facility|residential treatment facility
695835|NCT00953888|Healthy volunteer|healthy volunteer
695836|NCT00953888|Single ascending dose|single ascending dose
695837|NCT00953888|Safety|safety
695838|NCT00953888|Tolerability|tolerability
695839|NCT00953888|Healthy volunteer study|healthy volunteer study
695840|NCT00953914|pyridostigmine|pyridostigmine
695841|NCT00953914|autonomic modulation|autonomic modulation
695842|NCT00953914|diabetes mellitus|diabetes mellitus
695843|NCT00953914|heart rate variability|heart rate variability
695844|NCT00953979|ankylosing spondylitis|ankylosing spondylitis
695845|NCT00953979|treatment|treatment
695846|NCT00953979|Sulfasalazine|sulfasalazine
695847|NCT00953979|kunxian capsule|kunxian capsule
695853|NCT00954005|relapsed indolent lymphoma|relapsed indolent lymphoma
695854|NCT00954005|gemcitabine|gemcitabine
695855|NCT00954005|oxaliplatin|oxaliplatin
695856|NCT00954005|rituximab|rituximab
695857|NCT00954044|randomized clinical trial|randomized clinical trial
695858|NCT00954044|prostate cancer|prostate cancer
695859|NCT00954044|partnered exercise|partnered exercise
695860|NCT00954057|TED|ted
695861|NCT00954070|gastroesophageal reflux disease|gastroesophageal reflux disease
695862|NCT00954109|Insulin Resistance|insulin resistance
695863|NCT00954109|Type 2 Diabetes|type 2 diabetes
695864|NCT00954122|Acute schizophrenia|acute schizophrenia
695865|NCT00954135|neoadjuvant therapy, sorafenib, letrozolo, cyclophosphamide|neoadjuvant therapy, sorafenib, letrozolo, cyclophosphamide
695866|NCT00954148|cancer|cancer
695867|NCT00954148|colorectal|colorectal
695868|NCT00954148|head/neck|head/neck
695869|NCT00954148|lung|lung
695870|NCT00954148|PET/CT|pet/ct
695871|NCT00954161|First aid|first aid
695872|NCT00954161|Helping behaviour|helping behaviour
695873|NCT00954161|Health education|health education
695874|NCT00954161|Myocardial infarction|myocardial infarction
695875|NCT00954161|Emergencies|emergencies
695876|NCT00954226|Head & Neck squamous cell carcinoma|head & neck squamous cell carcinoma
695878|NCT00954226|Surgery|surgery
695879|NCT00954226|Erlotinib|erlotinib
695880|NCT00954226|Biomarkers|biomarkers
695881|NCT00954226|Phosphorylation of AKT|phosphorylation of akt
695882|NCT00954265|pregnancy occurence|pregnancy occurence
695883|NCT00954265|OHSS|ohss
695981|NCT00954798|Influenza|influenza
695884|NCT00954278|non small cell lung cancer|non small cell lung cancer
695885|NCT00954278|phase 1|phase 1
695886|NCT00954278|sorafenib|sorafenib
695887|NCT00954278|intrapatient dose escalation|intrapatient dose escalation
695888|NCT00954291|antinauseant and antiemetic|antinauseant and antiemetic
695889|NCT00954304|Pgp inhibitor|pgp inhibitor
695890|NCT00954304|P-glycoprotein inhibitor|p-glycoprotein inhibitor
695892|NCT00954317|labour analgesia|labour analgesia
752874|NCT01174576|coffee|coffee
695893|NCT00954330|rct, intervention, surgery, lateral ligament injury of the ankle|rct, intervention, surgery, lateral ligament injury of the ankle
695894|NCT00954330|REturn to pre-injury level|return to pre-injury level
695895|NCT00954343|Foot Ulcers|foot ulcers
695896|NCT00954343|Extracorporeal Shockwave|extracorporeal shockwave
695897|NCT00954343|Chronic wound|chronic wound
695898|NCT00954356|Pain following 3rd molar/wisdom tooth extraction|pain following 3rd molar/wisdom tooth extraction
695899|NCT00954369|Alzheimer's disease|alzheimer's disease
695900|NCT00954369|AD|ad
695901|NCT00954369|W372|w372
695902|NCT00954369|W372000|w372000
695903|NCT00954369|[F-18]W372|[f-18]w372
695904|NCT00954369|exploratory|exploratory
695905|NCT00954369|imaging|imaging
695906|NCT00954382|Down syndrome|down syndrome
695907|NCT00954382|IQ|iq
695908|NCT00954382|mental age|mental age
695909|NCT00954382|neuropsychological function|neuropsychological function
695910|NCT00954395|vitamin K antagonists, D-dimer,|vitamin k antagonists, d-dimer,
695911|NCT00954395|deep vein thrombosis, pulmonary embolism,|deep vein thrombosis, pulmonary embolism,
695912|NCT00954460|VPRIV|vpriv
695913|NCT00954460|Enzyme Replacement Therapy|enzyme replacement therapy
695914|NCT00954460|Gaucher disease|gaucher disease
695915|NCT00954460|glucocerebrosidase|glucocerebrosidase
695916|NCT00954460|beta-glucocerebrosidase|beta-glucocerebrosidase
695917|NCT00954460|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
695918|NCT00954460|glucosylceramidase|glucosylceramidase
695919|NCT00954460|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
695920|NCT00954460|gene activation|gene activation
695921|NCT00954460|human|human
695922|NCT00954499|tactile stimulation|tactile stimulation
695923|NCT00954499|pain|pain
695924|NCT00954499|immunization|immunization
695925|NCT00954499|infant|infant
695926|NCT00954512|Antibodies, neoplasm|antibodies, neoplasm
695927|NCT00954525|Pancreatic Cancer|pancreatic cancer
695928|NCT00954564|arthralgia|arthralgia
695929|NCT00954564|stage I breast cancer|stage i breast cancer
695930|NCT00954564|stage II breast cancer|stage ii breast cancer
695931|NCT00954564|stage IIIA breast cancer|stage iiia breast cancer
695932|NCT00954577|obesity|obesity
695933|NCT00954577|diabetes|diabetes
695934|NCT00954577|exercise|exercise
695935|NCT00954577|education|education
695936|NCT00954577|child|child
695937|NCT00954603|delirium rating scale|delirium rating scale
695938|NCT00954603|clinical global improvement|clinical global improvement
695939|NCT00954603|extrapyramidal side effect|extrapyramidal side effect
695940|NCT00954616|Inappropriate Medications Associated|inappropriate medications associated
695941|NCT00954616|Alzheimer's disease|alzheimer's disease
695942|NCT00954629|Osteoarthritis|osteoarthritis
695943|NCT00954629|Pain|pain
695944|NCT00954629|Knee|knee
695945|NCT00954642|Solid Tumor|solid tumor
695946|NCT00954642|Locally Advanced Solid Tumor|locally advanced solid tumor
695947|NCT00954642|Avastin|avastin
695948|NCT00954655|gastrointestinal stromal tumor|gastrointestinal stromal tumor
695949|NCT00954668|Non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
695950|NCT00954668|angiography|angiography
695951|NCT00954668|percutaneous coronary intervention|percutaneous coronary intervention
695952|NCT00954668|timing|timing
695953|NCT00954681|Cannabis|cannabis
695954|NCT00954681|quetiapine|quetiapine
695955|NCT00954707|Atherosclerosis|atherosclerosis
695956|NCT00954720|AML|aml
695957|NCT00954720|ALL|all
695958|NCT00954720|MDS|mds
695959|NCT00954720|iron overload|iron overload
695960|NCT00954733|Hysteroscopic surgery|hysteroscopic surgery
695961|NCT00954733|Hypoventilation|hypoventilation
695962|NCT00954733|Co2|co2
695963|NCT00954733|Transcutaneous Co2 Monitor|transcutaneous co2 monitor
695964|NCT00954746|Advanced Dupuytren's Disease|advanced dupuytren's disease
695965|NCT00954746|Muscular Diseases|muscular diseases
695966|NCT00954746|Musculoskeletal Diseases|musculoskeletal diseases
695967|NCT00954746|Contracture Joint Diseases|contracture joint diseases
695968|NCT00954746|Connective Tissue Diseases|connective tissue diseases
695969|NCT00954746|Dupuytren's Contracture|dupuytren's contracture
695970|NCT00954759|Infantile colic|infantile colic
695971|NCT00954759|Chiropractic|chiropractic
695972|NCT00954759|Manipulation|manipulation
695973|NCT00954759|Randomized controlled trial|randomized controlled trial
695974|NCT00954772|Staged versus Simultaneous Bilateral DBS|staged versus simultaneous bilateral dbs
695975|NCT00954785|ankle|ankle
695976|NCT00954785|ligament|ligament
695977|NCT00954785|sprain|sprain
695978|NCT00954785|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
695979|NCT00954785|treatment|treatment
695980|NCT00954785|Acute ankle ligament sprain|acute ankle ligament sprain
695982|NCT00954798|Pandemic Flu|pandemic flu
695983|NCT00954798|Swine-origin Influenza|swine-origin influenza
695984|NCT00954798|Inactivated split-virion vaccine|inactivated split-virion vaccine
695985|NCT00954798|Adjuvant|adjuvant
695986|NCT00954798|Adult|adult
695987|NCT00954811|pregnancy|pregnancy
695988|NCT00954837|Thyroid cancer|thyroid cancer
695989|NCT00954837|thyroid FNA|thyroid fna
695991|NCT00954837|thyroid screening|thyroid screening
695992|NCT00954837|thyroid ultrasonography|thyroid ultrasonography
695993|NCT00954837|FNA screening|fna screening
695994|NCT00954902|Spice|spice
695995|NCT00954902|responses to stress|responses to stress
695996|NCT00954902|Inflammatory|inflammatory
695997|NCT00954915|chronic plaque psoriasis|chronic plaque psoriasis
695998|NCT00954915|psoriatic arthritis|psoriatic arthritis
695999|NCT00944580|MAGE-A1|mage-a1
696000|NCT00944580|MAGE-A3|mage-a3
696001|NCT00944580|NY-ESO-1|ny-eso-1
696002|NCT00944580|antigen|antigen
696003|NCT00944580|vaccine|vaccine
696004|NCT00944580|dendritic cells|dendritic cells
696005|NCT00944580|immunohistochemistry|immunohistochemistry
696006|NCT00944580|immunology|immunology
696007|NCT00944658|Ankylosing spondylitis|ankylosing spondylitis
696008|NCT00944658|Imaging|imaging
696009|NCT00944684|Chronic hepatitis C|chronic hepatitis c
696010|NCT00944684|Antiviral treatment|antiviral treatment
696011|NCT00944684|Ribavirin|ribavirin
696012|NCT00944684|Sustained virological response|sustained virological response
696013|NCT00944684|Hemolytic anemia|hemolytic anemia
696014|NCT00944684|Erythropoetin|erythropoetin
696015|NCT00944710|Amblyopia|amblyopia
696016|NCT00944710|atropine|atropine
696017|NCT00944710|Plano lens|plano lens
696018|NCT00944723|zinc fortification|zinc fortification
696019|NCT00944723|zinc supplementation|zinc supplementation
696020|NCT00944723|plasma zinc concentration|plasma zinc concentration
696021|NCT00944736|Crohn's Disease|crohn's disease
696022|NCT00944736|Pediatric|pediatric
696023|NCT00944736|VSL#3|vsl#3
696024|NCT00944736|Permeability|permeability
696025|NCT00944736|Probiotic|probiotic
696026|NCT00944736|Zonulin|zonulin
696027|NCT00944749|H- ATG|h- atg
696028|NCT00944749|Anti -Thymocyte Globulin|anti -thymocyte globulin
696029|NCT00944749|Lymphocyte Immune Globulin|lymphocyte immune globulin
696030|NCT00944749|Aplastic Anemia|aplastic anemia
696031|NCT00944762|Stroke|stroke
696032|NCT00944775|Exercise|exercise
696033|NCT00944775|Dialysis|dialysis
696034|NCT00944775|Non-invasive cardiac measures|non-invasive cardiac measures
696035|NCT00944775|Exercise trained patients|exercise trained patients
696036|NCT00944775|Controls|controls
696037|NCT00944788|physical activity|physical activity
696038|NCT00944788|aging|aging
696039|NCT00944788|inpatients|inpatients
696040|NCT00944788|quality of life|quality of life
696041|NCT00944788|depression|depression
696042|NCT00944801|glioblastoma|glioblastoma
696043|NCT00944801|first-line|first-line
696044|NCT00944801|clinical trial|clinical trial
696045|NCT00944801|PEG-liposomal doxorubicin|peg-liposomal doxorubicin
696046|NCT00944801|temozolomide|temozolomide
696047|NCT00944801|radiotherapy|radiotherapy
696048|NCT00944801|phase 1|phase 1
696049|NCT00944801|phase 2|phase 2
696050|NCT00944814|Lipid-based nutrient supplement|lipid-based nutrient supplement
696051|NCT00944814|Prevention of malnutrition|prevention of malnutrition
696052|NCT00944814|Prevention of micronutrient deficiencies|prevention of micronutrient deficiencies
696053|NCT00944814|Zinc|zinc
696054|NCT00944827|Green Tea Extract|green tea extract
696055|NCT00944827|Catechins|catechins
696056|NCT00944827|Statin|statin
696057|NCT00944827|atorvastatin|atorvastatin
696058|NCT00944827|body composition|body composition
696059|NCT00944827|visceral fat|visceral fat
696060|NCT00944827|steatosis|steatosis
696061|NCT00944827|oxidative stress|oxidative stress
696062|NCT00944827|quality of life|quality of life
696063|NCT00944827|OGTT|ogtt
696064|NCT00944827|OGIS|ogis
696065|NCT00944827|ISI matsuda|isi matsuda
696066|NCT00944840|Intermittent Preventive Treatment|intermittent preventive treatment
696067|NCT00944840|Home based management of malaria|home based management of malaria
696068|NCT00944853|zinc supplement|zinc supplement
696069|NCT00944853|prevention|prevention
696070|NCT00944853|zinc deficiency|zinc deficiency
696071|NCT00944853|plasma zinc concentration|plasma zinc concentration
696072|NCT00944879|HIV|hiv
696073|NCT00944879|vaccine|vaccine
696074|NCT00944879|prevention|prevention
696075|NCT00944879|HPV|hpv
696076|NCT00944879|adolescents|adolescents
696077|NCT00944918|Breast Cancer|breast cancer
696078|NCT00944931|Cerebral Cortex|cerebral cortex
696079|NCT00944931|Cognition|cognition
696080|NCT00944931|Motor Cortex|motor cortex
696172|NCT00945165|Exercise|exercise
696084|NCT00944944|CORPUS UTERI,|corpus uteri,
696085|NCT00944944|ENDOMETRIUM|endometrium
696086|NCT00944944|FALLOPIAN TUBE|fallopian tube
696087|NCT00944944|OVARY|ovary
696088|NCT00944944|VAGINA|vagina
696089|NCT00944944|Lymphedema|lymphedema
696090|NCT00944944|Questionnaire|questionnaire
696091|NCT00944944|Quality of Life|quality of life
696092|NCT00944944|09-077|09-077
696093|NCT00944944|Fallopian Tubes|fallopian tubes
696094|NCT00944957|Raltegravir|raltegravir
696095|NCT00944957|efavirenz|efavirenz
696096|NCT00944957|anxiety|anxiety
696097|NCT00944957|depression|depression
696098|NCT00944957|sleep quality|sleep quality
696099|NCT00944957|HIV|hiv
696100|NCT00944957|NNRTI|nnrti
696104|NCT00944957|treatment experienced|treatment experienced
696105|NCT00944970|Coronary artery disease|coronary artery disease
696106|NCT00944970|Angina|angina
696107|NCT00944970|Anginal symptoms|anginal symptoms
696108|NCT00944970|Ischemic heart disease|ischemic heart disease
696109|NCT00944970|Ischemia|ischemia
696110|NCT00944970|Single photon emission computed tomography|single photon emission computed tomography
696111|NCT00944970|Pharmacologic stress|pharmacologic stress
696112|NCT00944970|Myocardial perfusion imaging|myocardial perfusion imaging
696113|NCT00944970|Suspected coronary artery disease|suspected coronary artery disease
696114|NCT00944970|known coronary artery disease|known coronary artery disease
696115|NCT00944970|typical or atypical anginal symptoms|typical or atypical anginal symptoms
696116|NCT00944983|Hypertension|hypertension
696117|NCT00944983|Hypotension|hypotension
696118|NCT00944983|Clinical Validation|clinical validation
696119|NCT00944983|Blood Pressure Accuracy|blood pressure accuracy
696120|NCT00944983|ISO 81600 Standard|iso 81600 standard
696121|NCT00944983|British Hypertension Society|british hypertension society
696122|NCT00944983|European Society of Hypertension|european society of hypertension
696123|NCT00944983|International Protocol|international protocol
696124|NCT00944996|PACAP (Pituitary Adenylate Cyclase Activating Polypeptide)|pacap (pituitary adenylate cyclase activating polypeptide)
696125|NCT00944996|Major Depression|major depression
696126|NCT00944996|Receptors|receptors
696127|NCT00944996|Gene polymorphism|gene polymorphism
696128|NCT00944996|PACAP signaling system|pacap signaling system
696129|NCT00944996|Etiology of major depression|etiology of major depression
696130|NCT00944996|Mechanism of antidepressants action|mechanism of antidepressants action
696131|NCT00944996|PACAP receptors gene polymorphism|pacap receptors gene polymorphism
696132|NCT00944996|Pathogenesis of major depression|pathogenesis of major depression
696133|NCT00944996|Responsiveness to the antidepressant drugs|responsiveness to the antidepressant drugs
696134|NCT00945022|General Surgery|general surgery
696135|NCT00945061|ductal breast carcinoma in situ|ductal breast carcinoma in situ
696136|NCT00945061|recurrent breast cancer|recurrent breast cancer
696137|NCT00945061|invasive ductal breast carcinoma|invasive ductal breast carcinoma
696138|NCT00945061|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
696139|NCT00945061|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
696140|NCT00945061|papillary ductal breast carcinoma|papillary ductal breast carcinoma
696141|NCT00945061|tubular ductal breast carcinoma|tubular ductal breast carcinoma
696142|NCT00945061|male breast cancer|male breast cancer
696143|NCT00945074|Acupuncture|acupuncture
696144|NCT00945074|Moxibustion|moxibustion
696145|NCT00945074|Traditional Chinese Medicine|traditional chinese medicine
696146|NCT00945074|Complementary Medicine|complementary medicine
696147|NCT00945074|Irritable Bowel Syndrome|irritable bowel syndrome
696148|NCT00945074|IBS|ibs
696149|NCT00945087|bacteriophage|bacteriophage
696150|NCT00945087|bacteriophage preparation|bacteriophage preparation
696151|NCT00945087|bacterial infection|bacterial infection
696152|NCT00945087|antibiotic-resistant infection|antibiotic-resistant infection
696153|NCT00945087|multidrug-resistant bacteria|multidrug-resistant bacteria
696154|NCT00945087|MRSA|mrsa
696155|NCT00945100|Amblyopia|amblyopia
696156|NCT00945100|patching|patching
696157|NCT00945100|occlusion|occlusion
696158|NCT00945113|pilot|pilot
696159|NCT00945113|stammer|stammer
696160|NCT00945113|stutter|stutter
696161|NCT00945113|children|children
696162|NCT00945113|randomised controlled trial|randomised controlled trial
696163|NCT00945113|RCT|rct
696164|NCT00945113|Speech and Language Therapy|speech and language therapy
696165|NCT00945113|Stuttering|stuttering
696166|NCT00945126|Allogeneic stem cell transplantation in pediatric patients|allogeneic stem cell transplantation in pediatric patients
696167|NCT00945126|CD3/CD19 depleted stem cells|cd3/cd19 depleted stem cells
696168|NCT00945126|malignant and non-malignant high risk diseases|malignant and non-malignant high risk diseases
696171|NCT00945165|Continuous Glucose Monitoring System|continuous glucose monitoring system
696173|NCT00945178|Safety|safety
696174|NCT00945178|Tolerability|tolerability
696175|NCT00945178|Healthy|healthy
696176|NCT00945178|Pharmacokinetics|pharmacokinetics
696177|NCT00945191|ovarian|ovarian
696178|NCT00945191|cancer|cancer
696179|NCT00945191|metastatic|metastatic
696180|NCT00945191|locally|locally
696181|NCT00945191|advanced|advanced
696182|NCT00945191|chemotherapy|chemotherapy
696183|NCT00945191|neoplasm|neoplasm
696184|NCT00945204|type 2 diabetes|type 2 diabetes
696185|NCT00945204|intermediate care|intermediate care
696186|NCT00945204|primary care|primary care
696187|NCT00945204|randomised controlled trial|randomised controlled trial
696188|NCT00945217|Atherogenic dyslipidemia|atherogenic dyslipidemia
696189|NCT00945217|Non-HDL-C|non-hdl-c
696190|NCT00945217|Postmenopausal women|postmenopausal women
696191|NCT00945217|SAH gene family|sah gene family
696192|NCT00945230|Neurosurgical outcome|neurosurgical outcome
696193|NCT00945230|Actigraphy|actigraphy
696194|NCT00945230|Treatment Response Measurement|treatment response measurement
696195|NCT00945243|SCDD|scdd
696196|NCT00945256|metabolism|metabolism
696197|NCT00945256|exercise|exercise
696198|NCT00945256|sodium nitroprusside|sodium nitroprusside
696199|NCT00945282|IDX12899|idx12899
696200|NCT00945282|adaptive|adaptive
696201|NCT00945282|monotherapy|monotherapy
696202|NCT00945282|pharmacokinetics|pharmacokinetics
696203|NCT00945282|Treatment-naive|treatment-naive
696204|NCT00945282|HIV-1|hiv-1
696205|NCT00945282|GSK2248761|gsk2248761
696206|NCT00945282|NNRTI|nnrti
696207|NCT00945282|HIV Infections|hiv infections
696208|NCT00945282|treatment naive|treatment naive
696209|NCT00945295|Cerebrovascular Accident/Rehabilitation|cerebrovascular accident/rehabilitation
696210|NCT00945295|Muscle Spasticity|muscle spasticity
696211|NCT00945295|Botulinum Neurotoxin Type A|botulinum neurotoxin type a
696212|NCT00945295|Post-stroke focal upper limb spasticity|post-stroke focal upper limb spasticity
696213|NCT00945308|Primary PCI|primary pci
696214|NCT00945308|Acute myocardial infarction|acute myocardial infarction
696215|NCT00945308|Myocardial blush|myocardial blush
696216|NCT00945308|Primary coronary intervention in acute myocardial infarction|primary coronary intervention in acute myocardial infarction
696217|NCT00945308|focusing on the effect of the study drug on the immediate TIMI|focusing on the effect of the study drug on the immediate timi
696218|NCT00945308|flow at the infarct related artery and on the myocardial|flow at the infarct related artery and on the myocardial
696219|NCT00945308|perfusion evaluated by the TIMI myocardial perfusion grade or|perfusion evaluated by the timi myocardial perfusion grade or
696220|NCT00945308|blush|blush
696221|NCT00945334|Constipation predominant Irritable Bowel Syndrome|constipation predominant irritable bowel syndrome
696222|NCT00945347|Cystic fibrosis|cystic fibrosis
696223|NCT00945347|miglustat|miglustat
696224|NCT00945347|nasal instillation|nasal instillation
696225|NCT00945347|nasal potential difference|nasal potential difference
696226|NCT00945360|Leiomyoma|leiomyoma
696227|NCT00945360|perimenopause|perimenopause
696228|NCT00945360|aromatase inhibitor|aromatase inhibitor
696229|NCT00945373|rosacea|rosacea
696230|NCT00945373|telangiectasias|telangiectasias
696231|NCT00945373|topical treatment|topical treatment
696232|NCT00945373|pulsed dye laser|pulsed dye laser
696233|NCT00945386|children|children
696234|NCT00945386|critically ill|critically ill
696235|NCT00945386|furosemide|furosemide
696236|NCT00945386|acoustic emission|acoustic emission
696237|NCT00945412|microdebrider tonsillotomy|microdebrider tonsillotomy
696238|NCT00945412|Post-tonsillectomy hemorrhage|post-tonsillectomy hemorrhage
696239|NCT00945425|Phase I|phase i
696240|NCT00945425|Volunteer|volunteer
696241|NCT00945438|Influenza|influenza
696242|NCT00945438|Influenza virus vaccine|influenza virus vaccine
696243|NCT00945438|Split virion|split virion
696244|NCT00945438|Intradermal|intradermal
696245|NCT00945451|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
696246|NCT00945451|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
696247|NCT00945451|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
696248|NCT00945490|Benign prostatic hyperplasia|benign prostatic hyperplasia
696249|NCT00945490|BPH|bph
696250|NCT00945490|Enlarged prostate|enlarged prostate
696251|NCT00945503|Glycine Tranporter|glycine tranporter
696252|NCT00945503|MRI|mri
696253|NCT00945503|PET|pet
696254|NCT00945516|Metal stent|metal stent
696255|NCT00945516|Bile duct stricture|bile duct stricture
696256|NCT00945516|Stent migration|stent migration
696257|NCT00945516|Feasibility|feasibility
696258|NCT00945516|Safety|safety
696259|NCT00945516|Removability|removability
696260|NCT00945529|Fontan|fontan
696261|NCT00945542|Trauma|trauma
696262|NCT00945542|Coagulopathy|coagulopathy
696263|NCT00945542|Transfusion|transfusion
696264|NCT00945542|Plasma|plasma
696265|NCT00945542|Massive Transfusion|massive transfusion
696266|NCT00945555|Antibacterials|antibacterials
696267|NCT00945555|Classification of antibacterial agent|classification of antibacterial agent
696268|NCT00945555|Febrile neutropenia|febrile neutropenia
696269|NCT00945555|Turkey|turkey
696270|NCT00945568|QOL|qol
696271|NCT00945568|liver|liver
696272|NCT00945581|Healthy Elderly volunteers|healthy elderly volunteers
696273|NCT00945594|flexible cystoscopy|flexible cystoscopy
696274|NCT00945594|rigid cystoscopy|rigid cystoscopy
696276|NCT00945594|outcome assessment|outcome assessment
696277|NCT00945594|pain measurement|pain measurement
696278|NCT00945607|Complementary Medicine|complementary medicine
696279|NCT00945607|Alternative Medicine|alternative medicine
696280|NCT00945607|Breast Cancer|breast cancer
696281|NCT00945620|Trans-abdominis block|trans-abdominis block
696282|NCT00945620|post-cesarean|post-cesarean
696283|NCT00945633|Obesity|obesity
696284|NCT00945633|unhealthy weight gain|unhealthy weight gain
696285|NCT00945672|Alzheimer's disease amyloid imaging antibody|alzheimer's disease amyloid imaging antibody
696286|NCT00945685|Skin Aging|skin aging
696287|NCT00945685|Skin Wrinkling|skin wrinkling
696288|NCT00945698|Stunting|stunting
696289|NCT00945698|Growth failure|growth failure
696290|NCT00945698|Malnutrition|malnutrition
696291|NCT00945698|Lipid based nutrient supplement|lipid based nutrient supplement
696292|NCT00945698|LNS|lns
696293|NCT00945698|Prevention|prevention
696294|NCT00945698|Malawi|malawi
696295|NCT00945698|Sub-Saharan Africa|sub-saharan africa
696296|NCT00945698|Dietary supplementation|dietary supplementation
696297|NCT00945698|Efficacy|efficacy
696298|NCT00945711|dual diagnosis|dual diagnosis
696299|NCT00945737|hypercholesterolemia|hypercholesterolemia
696300|NCT00945737|cholesterol|cholesterol
696301|NCT00945737|soy|soy
696302|NCT00945763|Dental Pain|dental pain
696303|NCT00945776|OSA|osa
696304|NCT00945776|CPAP|cpap
696305|NCT00945789|Asphyxia neonatorum|asphyxia neonatorum
696306|NCT00945789|Infants|infants
696307|NCT00945789|EEG|eeg
696308|NCT00945789|Brain MRI|brain mri
696309|NCT00945789|Nitric oxide|nitric oxide
696310|NCT00945815|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
696311|NCT00945815|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
696312|NCT00945815|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
696313|NCT00945815|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
696314|NCT00945841|influenza vaccine|influenza vaccine
696315|NCT00945841|vaccine|vaccine
696316|NCT00945854|wholegrain cereals|wholegrain cereals
696317|NCT00945854|glycemic index|glycemic index
696318|NCT00945854|metabolic syndrome|metabolic syndrome
696319|NCT00945854|insulin sensitivity|insulin sensitivity
696320|NCT00945867|flecainide|flecainide
696321|NCT00945867|pharmacogenetics|pharmacogenetics
696322|NCT00945880|HCV|hcv
696323|NCT00945880|Hepatitis C|hepatitis c
696324|NCT00945880|Hepatitis|hepatitis
696325|NCT00945906|Hereditary Factor XIII deficiency|hereditary factor xiii deficiency
696326|NCT00945906|Factor XIII|factor xiii
696327|NCT00945919|Oral morphine|oral morphine
696328|NCT00945919|oxycodone|oxycodone
696329|NCT00945919|OPANA|opana
696330|NCT00945919|Oxymorphone|oxymorphone
696331|NCT00945919|pain|pain
696332|NCT00945919|nociceptive|nociceptive
696333|NCT00945919|neuropathic|neuropathic
696334|NCT00945919|rotation|rotation
696335|NCT00945919|titration|titration
696336|NCT00945919|mixed origin non-cancer pain|mixed origin non-cancer pain
696337|NCT00945932|asthma|asthma
696338|NCT00945932|GW870086X|gw870086x
696339|NCT00945932|Efficacy|efficacy
696340|NCT00945932|FEV1|fev1
696341|NCT00945932|repeat-dose|repeat-dose
696342|NCT00945945|Osteoarthritis, Knee|osteoarthritis, knee
696343|NCT00945945|Pain|pain
696344|NCT00945958|Glaucoma|glaucoma
696345|NCT00945958|Ocular hypertension|ocular hypertension
696346|NCT00945971|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
696347|NCT00945971|Catecholamine|catecholamine
696348|NCT00945971|Children|children
696349|NCT00945971|Physical Activity|physical activity
696350|NCT00945984|Localized renal cell carcinoma|localized renal cell carcinoma
696351|NCT00945997|misoprostol|misoprostol
696352|NCT00945997|mifepristone|mifepristone
696353|NCT00945997|medical abortion|medical abortion
696354|NCT00945997|randomised controlled trial|randomised controlled trial
696355|NCT00946010|Hepatitis B|hepatitis b
696356|NCT00946010|Hepatitis C|hepatitis c
696357|NCT00946010|genotype|genotype
696358|NCT00946010|DNA level|dna level
696359|NCT00946010|RNA level|rna level
696360|NCT00946010|Taiwan|taiwan
696361|NCT00946023|lymphoma|lymphoma
696362|NCT00946023|non hodgkin lymphoma|non hodgkin lymphoma
696363|NCT00946023|allogeneic|allogeneic
696364|NCT00946023|bone marrow transplantation|bone marrow transplantation
696365|NCT00946023|nonmyeloablative|nonmyeloablative
696366|NCT00946023|cyclophosphamide|cyclophosphamide
696367|NCT00946023|rituximab|rituximab
696368|NCT00946049|Checking clinical antibacterial effect of Vicryl Plus compared to conventional Vicryl in intraoral surgery|checking clinical antibacterial effect of vicryl plus compared to conventional vicryl in intraoral surgery
696369|NCT00946049|Bacteria|bacteria
696370|NCT00946062|low vision|low vision
696371|NCT00946062|ophthalmology|ophthalmology
696372|NCT00946062|randomised controlled trial|randomised controlled trial
696373|NCT00946062|mobility|mobility
696374|NCT00946062|orientation|orientation
696375|NCT00946062|cane|cane
696376|NCT00946062|aged|aged
696377|NCT00946101|randomized, double-blind, placebo-controlled|randomized, double-blind, placebo-controlled
696378|NCT00946127|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
696379|NCT00946127|Communicating Hydrocephalus|communicating hydrocephalus
696380|NCT00946127|Gait disorder|gait disorder
696381|NCT00946127|Cognition|cognition
696382|NCT00946127|Shunt|shunt
696383|NCT00946127|Endoscopic Third Ventriculostomy.|endoscopic third ventriculostomy.
696384|NCT00946140|Ovary|ovary
696385|NCT00946140|MRI|mri
696386|NCT00946140|08-132|08-132
696387|NCT00946153|Carcinoma|carcinoma
696388|NCT00946153|Hepatocellular|hepatocellular
696389|NCT00946166|pneumonia|pneumonia
696390|NCT00946166|statins|statins
696391|NCT00946166|cytokines|cytokines
696392|NCT00946179|Influenza|influenza
696393|NCT00946179|Influenza virus vaccine|influenza virus vaccine
696394|NCT00946179|Split virion|split virion
696395|NCT00946192|Amenorrhea|amenorrhea
696396|NCT00946192|Adolescent|adolescent
696397|NCT00946192|Endurance|endurance
696398|NCT00946192|Athletes|athletes
696399|NCT00946192|Females|females
696401|NCT00946192|Osteoporosis|osteoporosis
696402|NCT00946192|Estrogen|estrogen
696403|NCT00946205|rectal prolapse|rectal prolapse
696404|NCT00946205|laparoscopic rectopexy|laparoscopic rectopexy
696405|NCT00946205|obstructed defecation|obstructed defecation
696406|NCT00946231|Heart Failure|heart failure
696408|NCT00946231|B-type natriuretic peptide|b-type natriuretic peptide
696409|NCT00946231|home testing|home testing
696410|NCT00946244|Early intervention|early intervention
696411|NCT00946244|Mother-child interaction|mother-child interaction
696412|NCT00946244|Neurodevelopment|neurodevelopment
696413|NCT00946244|Parenting|parenting
696414|NCT00946244|Prematurity|prematurity
696415|NCT00946244|Preschool age|preschool age
696416|NCT00946257|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
696418|NCT00946270|Pomalidomide|pomalidomide
696419|NCT00946270|polycythemia vera|polycythemia vera
696420|NCT00946270|essential thrombocythemia myelofibrosis|essential thrombocythemia myelofibrosis
696421|NCT00946283|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
696422|NCT00946283|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
696423|NCT00946283|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
696424|NCT00946283|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
696425|NCT00946283|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
696426|NCT00946283|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
696427|NCT00946283|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
696428|NCT00946283|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
696429|NCT00946283|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
696430|NCT00946283|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
696431|NCT00946283|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
696432|NCT00946283|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
696433|NCT00946283|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
696434|NCT00946283|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
696435|NCT00946283|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
696436|NCT00946283|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
696437|NCT00946283|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
696438|NCT00946283|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
696439|NCT00946283|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
696440|NCT00946283|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
696441|NCT00946283|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
696442|NCT00946283|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
696443|NCT00946283|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
696444|NCT00946283|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
696445|NCT00946283|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
696446|NCT00946283|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
696447|NCT00946283|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
696448|NCT00946283|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
696449|NCT00946283|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
696450|NCT00946283|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
696451|NCT00946283|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
696452|NCT00946283|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
696453|NCT00946283|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
696454|NCT00946283|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
696455|NCT00946283|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
696456|NCT00946283|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
696457|NCT00946283|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
752586|NCT01167790|Fluorescence visualization|fluorescence visualization
696458|NCT00946283|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
696459|NCT00946283|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
696460|NCT00946283|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
696461|NCT00946283|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
696462|NCT00946283|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
696463|NCT00946283|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
696464|NCT00946283|splenic marginal zone lymphoma|splenic marginal zone lymphoma
696465|NCT00946283|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
696534|NCT00946374|Immunochemotherapy|immunochemotherapy
696466|NCT00946283|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
696467|NCT00946283|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
696468|NCT00946283|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
696469|NCT00946283|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
696543|NCT00946374|Sibling donor|sibling donor
696470|NCT00946283|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
696471|NCT00946283|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
696472|NCT00946283|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
696473|NCT00946283|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
696474|NCT00946283|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
696475|NCT00946283|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
696476|NCT00946283|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
696477|NCT00946283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
696478|NCT00946283|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
696479|NCT00946283|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
696480|NCT00946283|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
696481|NCT00946283|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
696482|NCT00946283|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
696483|NCT00946283|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
696484|NCT00946283|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
696485|NCT00946283|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
696486|NCT00946283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
696487|NCT00946283|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
696488|NCT00946283|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
696489|NCT00946283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
696490|NCT00946283|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
696491|NCT00946283|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
696492|NCT00946283|refractory hairy cell leukemia|refractory hairy cell leukemia
696493|NCT00946283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
696494|NCT00946283|secondary acute myeloid leukemia|secondary acute myeloid leukemia
696495|NCT00946283|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
696496|NCT00946283|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
696497|NCT00946283|chronic eosinophilic leukemia|chronic eosinophilic leukemia
696498|NCT00946283|primary myelofibrosis|primary myelofibrosis
696499|NCT00946283|chronic neutrophilic leukemia|chronic neutrophilic leukemia
696500|NCT00946283|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
696501|NCT00946283|disseminated neuroblastoma|disseminated neuroblastoma
696502|NCT00946283|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
696503|NCT00946283|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
696504|NCT00946283|recurrent neuroblastoma|recurrent neuroblastoma
696505|NCT00946283|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
696506|NCT00946283|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
696507|NCT00946283|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
696508|NCT00946283|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
696509|NCT00946283|stage II multiple myeloma|stage ii multiple myeloma
696510|NCT00946283|stage III multiple myeloma|stage iii multiple myeloma
696511|NCT00946283|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
696512|NCT00946283|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
696513|NCT00946283|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
696514|NCT00946283|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
696515|NCT00946283|stage IIIA breast cancer|stage iiia breast cancer
696516|NCT00946283|stage IIIB breast cancer|stage iiib breast cancer
696517|NCT00946283|stage IIIC breast cancer|stage iiic breast cancer
696518|NCT00946283|stage IV breast cancer|stage iv breast cancer
696519|NCT00946283|refractory multiple myeloma|refractory multiple myeloma
696520|NCT00946296|Graves Disease|graves disease
696521|NCT00946322|post-traumatic stress disorder|post-traumatic stress disorder
696522|NCT00946322|alcohol-related disorders|alcohol-related disorders
696523|NCT00946322|substance use disorders|substance use disorders
696524|NCT00946322|couple therapy|couple therapy
696525|NCT00946348|Dronabinol|dronabinol
696526|NCT00946348|Schizophrenia|schizophrenia
696527|NCT00946348|Dual Diagnosis|dual diagnosis
696528|NCT00946348|Substance Abuse|substance abuse
696529|NCT00946348|Cannabis Use Disorder|cannabis use disorder
696530|NCT00946374|Mantle-Cell-Lymphoma|mantle-cell-lymphoma
696531|NCT00946374|MCL|mcl
696532|NCT00946374|Non Hodgkin´s Lymphoma|non hodgkin´s lymphoma
696533|NCT00946374|NHL|nhl
696535|NCT00946374|R-CHOP|r-chop
696536|NCT00946374|CHOP|chop
696537|NCT00946374|High-dose chemotherapy|high-dose chemotherapy
696538|NCT00946374|BEAM|beam
696539|NCT00946374|HD-BEAM|hd-beam
696540|NCT00946374|Autologous stem cell transplantation|autologous stem cell transplantation
752875|NCT01174576|appetite|appetite
696541|NCT00946374|Reduced conditioning regimen|reduced conditioning regimen
696542|NCT00946374|Unrelated donor|unrelated donor
696544|NCT00946374|Total Body Irradiation|total body irradiation
696546|NCT00946374|Allogenic stem cell transplantation|allogenic stem cell transplantation
696547|NCT00946374|ABSCT|absct
696548|NCT00946374|ASCT|asct
696549|NCT00946374|Fludarabine+TBI|fludarabine+tbi
696550|NCT00946387|Antiemetic|antiemetic
696551|NCT00946400|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
696552|NCT00946400|HIT|hit
696553|NCT00946400|4Ts|4ts
696554|NCT00946400|Chong scale|chong scale
696555|NCT00946400|interobserver variability|interobserver variability
696556|NCT00946413|CBT, Depressed and suicidal adolescents|cbt, depressed and suicidal adolescents
696557|NCT00946439|training exercise gait|training exercise gait
696558|NCT00946452|Control|control
696559|NCT00946452|Satisfaction|satisfaction
696560|NCT00946478|atopic dermatitis|atopic dermatitis
696561|NCT00946478|elidel|elidel
696562|NCT00946478|pimecrolimus|pimecrolimus
696563|NCT00946478|CASM981|casm981
696564|NCT00946478|immunity|immunity
696565|NCT00946478|cathelicidin|cathelicidin
696566|NCT00946478|antimicrobial peptide|antimicrobial peptide
696567|NCT00946478|eczema|eczema
696568|NCT00946491|Typical Antipsychotic|typical antipsychotic
696569|NCT00946543|stage IIB prostate cancer|stage iib prostate cancer
696570|NCT00946543|stage IIA prostate cancer|stage iia prostate cancer
696571|NCT00946543|stage III prostate cancer|stage iii prostate cancer
696572|NCT00946543|stage IV prostate cancer|stage iv prostate cancer
696573|NCT00946556|herpes simplex virus type 2|herpes simplex virus type 2
696574|NCT00946556|HIV|hiv
696575|NCT00946556|genital immunology|genital immunology
696576|NCT00946556|CD4+ T cell|cd4+ t cell
696577|NCT00946556|valacyclovir|valacyclovir
696578|NCT00946556|HIV seronegativity|hiv seronegativity
696579|NCT00946569|Asthma|asthma
696580|NCT00946569|Persistent asthma|persistent asthma
696581|NCT00946569|Adults with persistent asthma|adults with persistent asthma
696582|NCT00946569|Chronic asthma|chronic asthma
696583|NCT00946569|JNJ-39758979|jnj-39758979
696584|NCT00946569|Placebo|placebo
696585|NCT00946582|parenting management program|parenting management program
696586|NCT00946582|ADHD|adhd
696587|NCT00946595|Undetectable|undetectable
696588|NCT00946595|HIV infections|hiv infections
696589|NCT00946595|Monotherapy|monotherapy
696590|NCT00946595|Lopinavir/ritonavir|lopinavir/ritonavir
696591|NCT00946595|Protease inhibitor|protease inhibitor
696592|NCT00946595|Treatment experienced|treatment experienced
696593|NCT00946608|Antihistamine|antihistamine
696594|NCT00946647|Myelodysplastic Syndromes|myelodysplastic syndromes
696595|NCT00946647|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
696596|NCT00946647|Acute Myeloid Leukemia|acute myeloid leukemia
696597|NCT00946647|hypomethylating therapy|hypomethylating therapy
696598|NCT00946647|deacetylase inhibitor|deacetylase inhibitor
696599|NCT00946647|MDS|mds
696600|NCT00946647|CMML|cmml
696601|NCT00946647|AML|aml
696602|NCT00946660|Contingency Management|contingency management
696603|NCT00946660|Drug Self-Administration|drug self-administration
696604|NCT00946725|Angina (Chest Pain)|angina (chest pain)
696605|NCT00946725|Hypertension|hypertension
696606|NCT00946738|Raynaud's phenomenon|raynaud's phenomenon
696607|NCT00946738|biofeedback|biofeedback
696608|NCT00946738|deep oscillation|deep oscillation
696609|NCT00946738|systemic sclerosis|systemic sclerosis
696610|NCT00946738|physiotherapy|physiotherapy
696611|NCT00946751|Anticonvulsant|anticonvulsant
696612|NCT00946764|Antidepressant|antidepressant
696613|NCT00946777|Dry Eye Signs|dry eye signs
696614|NCT00946777|barrier function|barrier function
696615|NCT00946790|Immunosuppressant and Antirheumatic|immunosuppressant and antirheumatic
696616|NCT00946803|Pain|pain
696617|NCT00946803|Fatigue|fatigue
696618|NCT00946803|Sleep|sleep
696619|NCT00946803|Cancer|cancer
696720|NCT00947193|Factor IX|factor ix
696620|NCT00946803|Complementary therapies|complementary therapies
696621|NCT00946842|Healthy|healthy
696622|NCT00946842|Bioavailability|bioavailability
696623|NCT00946842|Relative bioavailability|relative bioavailability
696624|NCT00946842|TMC207|tmc207
696625|NCT00946842|Fed condition|fed condition
696626|NCT00946842|Fasted condition|fasted condition
696627|NCT00946855|soccer|soccer
696628|NCT00946855|laboratory|laboratory
696629|NCT00946855|reference|reference
696630|NCT00946855|exercise|exercise
696631|NCT00946855|variability|variability
696632|NCT00946855|season|season
696633|NCT00946855|elite athletes|elite athletes
696634|NCT00946855|Define reference blood parameters in elite athletes|define reference blood parameters in elite athletes
696635|NCT00946868|intermittent claudication|intermittent claudication
696636|NCT00946868|metabolic syndrome|metabolic syndrome
696637|NCT00946881|Prostatic disease|prostatic disease
696638|NCT00946881|genital neoplasm, male|genital neoplasm, male
696639|NCT00946881|Urogenital neoplasm|urogenital neoplasm
696640|NCT00946881|Genital disease|genital disease
696641|NCT00946881|male|male
696642|NCT00946881|Male urogenital disease|male urogenital disease
696643|NCT00946881|Neoplasms|neoplasms
696644|NCT00946881|Neoplasm by site|neoplasm by site
696645|NCT00946881|prostatic neoplasm|prostatic neoplasm
696646|NCT00946881|Carcinoma|carcinoma
696647|NCT00946894|Total thyroidectomy|total thyroidectomy
696648|NCT00946894|Subtotal thyroidectomy|subtotal thyroidectomy
696649|NCT00946894|Dunhill operation|dunhill operation
696650|NCT00946894|Recurrent nodular goiter|recurrent nodular goiter
696651|NCT00946894|Completion thyroidectomy|completion thyroidectomy
696652|NCT00946894|Recurrent laryngeal nerve palsy|recurrent laryngeal nerve palsy
696781|NCT00947453|montelukast|montelukast
696653|NCT00946894|Hypoparathyroidism following thyroidectomy|hypoparathyroidism following thyroidectomy
696654|NCT00946894|Recurrent goiter|recurrent goiter
696655|NCT00946907|acute pericarditis|acute pericarditis
696656|NCT00946907|treatment|treatment
696657|NCT00946907|recurrence|recurrence
696658|NCT00946933|acid-base balance|acid-base balance
696659|NCT00946933|ventilatory control|ventilatory control
696660|NCT00946933|dyspnea|dyspnea
696661|NCT00946933|exercise|exercise
696662|NCT00946933|modified rebreathing procedure|modified rebreathing procedure
696663|NCT00946933|Normal|normal
696664|NCT00946933|older|older
696665|NCT00946946|Randomized|randomized
696666|NCT00946946|Crohn's Disease|crohn's disease
696667|NCT00946946|Prevention|prevention
696668|NCT00946946|Azathioprine|azathioprine
696669|NCT00946946|mesalazine|mesalazine
696670|NCT00946946|mesalamine|mesalamine
696671|NCT00946946|TPMT|tpmt
696672|NCT00946959|cardiac surgery|cardiac surgery
696673|NCT00946959|angioplasty|angioplasty
696674|NCT00946959|cognitive decline|cognitive decline
696675|NCT00946972|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
696676|NCT00946985|Schizophrenia|schizophrenia
696677|NCT00946985|Risperidone|risperidone
696678|NCT00946985|Risperdal|risperdal
696679|NCT00946985|Paliperidone Palmitate|paliperidone palmitate
696680|NCT00946985|Invega Sustenna|invega sustenna
696681|NCT00946998|Chronic Kidney Disease|chronic kidney disease
696682|NCT00946998|Depression|depression
696683|NCT00946998|Antidepressants|antidepressants
696684|NCT00946998|randomized controlled trial|randomized controlled trial
696685|NCT00946998|treatment|treatment
696686|NCT00946998|Sertraline|sertraline
696687|NCT00947011|Healthy volunteers|healthy volunteers
696688|NCT00947011|GLP-1|glp-1
696689|NCT00947011|Januvia|januvia
696690|NCT00947011|Sitagliptin|sitagliptin
696692|NCT00947050|prompt physical exercise|prompt physical exercise
696693|NCT00947050|collateral function|collateral function
696694|NCT00947063|Antihistamine|antihistamine
696695|NCT00947076|Antidepressant|antidepressant
696696|NCT00947089|ORC (oxidized regenerated cellulose)|orc (oxidized regenerated cellulose)
696697|NCT00947089|SSI (Surgical site infections)|ssi (surgical site infections)
696698|NCT00947102|pancreatic tubular adenocarcinoma|pancreatic tubular adenocarcinoma
696699|NCT00947102|gemcitabine|gemcitabine
696700|NCT00947102|gene expression|gene expression
696701|NCT00947102|immunological status|immunological status
696702|NCT00947102|serological status|serological status
696703|NCT00947102|pancreatic tubular adenocarcinoma adjuvant setting|pancreatic tubular adenocarcinoma adjuvant setting
696704|NCT00947115|Cervical cancer|cervical cancer
696705|NCT00947115|HPV vaccine|hpv vaccine
696706|NCT00947128|Antiemetic|antiemetic
696707|NCT00947141|Optimising treatment of cytomegalovirus infection|optimising treatment of cytomegalovirus infection
696708|NCT00947154|trichotillomania|trichotillomania
696709|NCT00947154|aripiprazole|aripiprazole
696710|NCT00947154|treatment|treatment
696711|NCT00947180|Biofeedback|biofeedback
696712|NCT00947180|Pelvic floor|pelvic floor
696713|NCT00947180|Levator ani syndrome|levator ani syndrome
696714|NCT00947180|Chronic proctalgia|chronic proctalgia
696715|NCT00947180|Electrogalvanic stimulation|electrogalvanic stimulation
696716|NCT00947180|Massage|massage
696717|NCT00947193|Hemophilia A|hemophilia a
696718|NCT00947193|Hemophilia B|hemophilia b
696719|NCT00947193|Factor VIII|factor viii
696721|NCT00947193|FVIII|fviii
696722|NCT00947193|FIX|fix
696723|NCT00947193|Nonsense mutation|nonsense mutation
696724|NCT00947193|Premature stop codon|premature stop codon
696725|NCT00947193|HA|ha
696726|NCT00947193|HB|hb
696727|NCT00947193|PTC124|ptc124
696728|NCT00947193|Ataluren|ataluren
696729|NCT00947206|Chinese Americans|chinese americans
696730|NCT00947206|lay health worker outreach|lay health worker outreach
696731|NCT00947206|colorectal cancer screening|colorectal cancer screening
696732|NCT00947219|Androgenetic Alopecia|androgenetic alopecia
696733|NCT00947219|Hair Loss|hair loss
696734|NCT00947219|Male Pattern Baldness|male pattern baldness
696735|NCT00947232|major depressive disorder|major depressive disorder
696736|NCT00947232|physical activity|physical activity
696737|NCT00947232|aging with physical disability|aging with physical disability
696738|NCT00947232|motivational interviewing|motivational interviewing
696739|NCT00947258|Muscle Strength|muscle strength
696740|NCT00947258|Torque|torque
696741|NCT00947258|Muscle Stretching Exercises|muscle stretching exercises
696742|NCT00947258|Range of Motion|range of motion
696743|NCT00947271|STD|std
696744|NCT00947271|STI|sti
696745|NCT00947271|Sexual Behavior|sexual behavior
698890|NCT00963833|MS|ms
696747|NCT00947271|HIV seronegativity|hiv seronegativity
696748|NCT00947297|Urea Cycle Disorder|urea cycle disorder
696749|NCT00947297|UCD|ucd
696750|NCT00947297|hyperammonemia|hyperammonemia
696751|NCT00947297|Buphenyl|buphenyl
696752|NCT00947297|Sodium Phenylbutyrate|sodium phenylbutyrate
696753|NCT00947310|Inappropriate therapy|inappropriate therapy
696754|NCT00947310|ICD therapy|icd therapy
696755|NCT00947310|Primary prevention|primary prevention
696756|NCT00947323|simvastatin|simvastatin
696757|NCT00947323|endothelial dysfunction|endothelial dysfunction
696758|NCT00947323|erectile dysfunction|erectile dysfunction
696759|NCT00947375|schizophrenia|schizophrenia
696760|NCT00947375|lamictal TM|lamictal tm
696761|NCT00947375|haloperidol decanoate|haloperidol decanoate
696762|NCT00947388|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
696763|NCT00947388|Bendamustine|bendamustine
696764|NCT00947388|Alemtuzumab|alemtuzumab
696765|NCT00947388|Phase I|phase i
696766|NCT00947388|CLL|cll
696767|NCT00947401|Surgery, elective|surgery, elective
696768|NCT00947401|Fluids|fluids
696769|NCT00947401|Post Anesthesia Care Unit|post anesthesia care unit
696770|NCT00947401|PACU|pacu
696771|NCT00947401|Fluid management|fluid management
696772|NCT00947414|cellulite; shockwave; microcirculation; skin|cellulite; shockwave; microcirculation; skin
696773|NCT00947427|type 1 diabetes|type 1 diabetes
696774|NCT00947427|newly diagnosed T1D|newly diagnosed t1d
696775|NCT00947427|T1D|t1d
696776|NCT00947427|canakinumab|canakinumab
696777|NCT00947427|anti IL-1|anti il-1
696778|NCT00947440|Phase 1|phase 1
696779|NCT00947440|Bioavailability|bioavailability
696780|NCT00947453|asthma|asthma
696782|NCT00947466|Buprenorphine transdermal patch (BTDS)|buprenorphine transdermal patch (btds)
696783|NCT00947466|Moderate to severe mouth pain|moderate to severe mouth pain
696784|NCT00947466|Chemotherapy induced mucositis|chemotherapy induced mucositis
696785|NCT00947466|Pharmacokinetic|pharmacokinetic
696786|NCT00947479|obstructive sleep apnea|obstructive sleep apnea
696787|NCT00947479|pulse-wave velocity,|pulse-wave velocity,
696788|NCT00947479|acute kidney injury|acute kidney injury
696789|NCT00947479|biomarkers of acute kidney injury|biomarkers of acute kidney injury
696790|NCT00947492|Rheumatoid Arthritis patients|rheumatoid arthritis patients
696791|NCT00947492|treated with new immunosuppressive drugs : Orencia* (abatacept) and RoActemra* (tocilizumab).|treated with new immunosuppressive drugs : orencia* (abatacept) and roactemra* (tocilizumab).
696792|NCT00947505|Androgenetic alopecia|androgenetic alopecia
696793|NCT00947505|Hair loss|hair loss
696794|NCT00947505|Male Pattern baldness|male pattern baldness
696795|NCT00947518|chlorhexidine|chlorhexidine
696796|NCT00947518|preterm|preterm
696797|NCT00947518|newborn|newborn
696798|NCT00947518|skin condition|skin condition
696799|NCT00947518|temperature|temperature
696800|NCT00947518|skin flora|skin flora
696801|NCT00947544|Urea Cycle Disorder|urea cycle disorder
696803|NCT00947544|GT4P|gt4p
696804|NCT00947544|Buphenyl|buphenyl
696805|NCT00947544|hyperammonemia|hyperammonemia
696806|NCT00947544|sodium phenylbutyrate|sodium phenylbutyrate
696807|NCT00947570|Cognitive Behavioral Therapy|cognitive behavioral therapy
696808|NCT00947570|Functional Brain Imaging|functional brain imaging
696809|NCT00947570|Psychotherapy|psychotherapy
696810|NCT00947570|Treatment|treatment
696811|NCT00947570|Brain Imaging|brain imaging
696812|NCT00947583|fusion rates|fusion rates
696813|NCT00947583|TLIF|tlif
696814|NCT00947583|Osteocel Plus|osteocel plus
696815|NCT00947583|biologics|biologics
696816|NCT00947583|lumbar fusion|lumbar fusion
696817|NCT00947596|Atropine|atropine
696818|NCT00947596|Aerosol|aerosol
696819|NCT00947596|Inhaler|inhaler
696820|NCT00947596|Dry Powder|dry powder
696821|NCT00947609|Latent tuberculosis|latent tuberculosis
696822|NCT00947609|HIV|hiv
696823|NCT00947609|Children|children
697220|NCT00956332|amputation|amputation
696824|NCT00947609|Interferon gamma release assays|interferon gamma release assays
696825|NCT00947609|Thailand|thailand
696826|NCT00947609|QuantiFERON TB Gold In-tube|quantiferon tb gold in-tube
696827|NCT00947609|T-Spot.TB|t-spot.tb
696828|NCT00947622|Fibromyalgia|fibromyalgia
696829|NCT00947622|Neuromodulation|neuromodulation
696830|NCT00947622|Transcranial Direct Current Stimulation|transcranial direct current stimulation
696831|NCT00947622|Occipital|occipital
696832|NCT00947635|Type 1 diabetes|type 1 diabetes
696833|NCT00947635|Transplants|transplants
696834|NCT00947635|Immunosuppression|immunosuppression
696835|NCT00947635|Hyperlipidemia|hyperlipidemia
696836|NCT00947635|Nutrition Therapy|nutrition therapy
696837|NCT00947648|acute myelogenous leukemia|acute myelogenous leukemia
696838|NCT00947648|AML|aml
696839|NCT00947648|myelodysplastic syndrome|myelodysplastic syndrome
696840|NCT00947648|MDS|mds
696841|NCT00947648|Neutropenia|neutropenia
696842|NCT00947648|raw fruits and vegetables|raw fruits and vegetables
696843|NCT00947661|glaucoma latanoprost|glaucoma latanoprost
696844|NCT00947674|Cellsorba EX|cellsorba ex
696845|NCT00947687|influenza|influenza
696846|NCT00947687|healthy subject|healthy subject
696847|NCT00947687|virus inoculation|virus inoculation
696848|NCT00947687|symptom scores|symptom scores
696849|NCT00947687|viral shedding|viral shedding
696850|NCT00947687|bioaerosol output|bioaerosol output
696851|NCT00947700|Infants|infants
696852|NCT00947700|Risk markers|risk markers
696854|NCT00947700|Parent child interaction|parent child interaction
696855|NCT00947700|Promoting First Relations|promoting first relations
696856|NCT00947700|Social Communication|social communication
696857|NCT00947713|Human chorionic gonadotropin|human chorionic gonadotropin
696858|NCT00947713|Clomiphene citrate|clomiphene citrate
696859|NCT00947713|chronic anovulation|chronic anovulation
696860|NCT00947713|Polycystic Ovary Syndrome|polycystic ovary syndrome
696861|NCT00947713|Follicolugenesis|follicolugenesis
696862|NCT00947739|CZ|cz
696863|NCT00947739|Stehlin|stehlin
696864|NCT00947739|Lymphomas|lymphomas
696865|NCT00947752|Multiple Sclerosis|multiple sclerosis
696866|NCT00947752|Relapsing Remitting Multiple Sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
696867|NCT00947752|Glatiramer Acetate (GA)|glatiramer acetate (ga)
696868|NCT00947765|Tennis Elbow|tennis elbow
696869|NCT00947765|Epicondylitis, Lateral Humeral|epicondylitis, lateral humeral
696870|NCT00947791|Bipolar Disorder|bipolar disorder
696871|NCT00947791|Depression|depression
696872|NCT00947791|Treatment-Resistant|treatment-resistant
696873|NCT00947791|ketamine|ketamine
696874|NCT00947791|antidepressant|antidepressant
696875|NCT00947791|glutamate|glutamate
696876|NCT00947804|Acute Coronary Artery Syndrome Risk Stratification Score|acute coronary artery syndrome risk stratification score
696877|NCT00947830|CML|cml
696878|NCT00947830|intracellular imatinib level|intracellular imatinib level
696879|NCT00947830|OCT-1|oct-1
696880|NCT00947843|CHD|chd
696881|NCT00947843|CHD equivalents|chd equivalents
696882|NCT00947856|Antibodies, Monoclonal|antibodies, monoclonal
696883|NCT00947856|Antibody-Drug Conjugate|antibody-drug conjugate
696884|NCT00947856|Antigens, CD30|antigens, cd30
696885|NCT00947856|Drug Therapy|drug therapy
696886|NCT00947856|Hematologic Diseases|hematologic diseases
696887|NCT00947856|Immunotherapy|immunotherapy
696888|NCT00947856|Monomethylauristatin E|monomethylauristatin e
696889|NCT00947895|ACTH|acth
696890|NCT00947895|Acthar gel|acthar gel
696891|NCT00947895|adrenocorticotropin|adrenocorticotropin
696892|NCT00947895|methylprednisolone|methylprednisolone
696893|NCT00947895|solumedrol|solumedrol
696894|NCT00947895|MS|ms
696895|NCT00947895|multiple|multiple
696896|NCT00947895|sclerosis|sclerosis
696897|NCT00947895|relapse|relapse
696898|NCT00947895|exacerbation|exacerbation
696899|NCT00947895|sub-responsive|sub-responsive
696900|NCT00947895|IV|iv
696901|NCT00947908|Hymenoptera venom allergy|hymenoptera venom allergy
696902|NCT00947908|Dendritic cells (DC)|dendritic cells (dc)
696903|NCT00947921|Functional MItral regurgitation|functional mitral regurgitation
696904|NCT00947934|Alzheimer disease,hypothalamus,Deep Brain Stimulation|alzheimer disease,hypothalamus,deep brain stimulation
696905|NCT00947947|condom use|condom use
696906|NCT00947947|HIV prevention|hiv prevention
696907|NCT00947947|African American|african american
696908|NCT00947947|Behavioral intervention|behavioral intervention
696909|NCT00947947|HIV Seronegativity|hiv seronegativity
696910|NCT00947960|Adult Polyglucosan Body Disease (APBD)|adult polyglucosan body disease (apbd)
696911|NCT00947960|Glycogen Brancher Enzyme (GBE1) Deficiency|glycogen brancher enzyme (gbe1) deficiency
696912|NCT00947973|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
696913|NCT00947973|ADHD|adhd
696914|NCT00947973|School Based|school based
696915|NCT00947973|Intervention|intervention
696916|NCT00947973|Psychosocial|psychosocial
696917|NCT00947973|Academic Intervention|academic intervention
696918|NCT00947973|Behavioral|behavioral
696919|NCT00948012|Sickle Cell Anemia|sickle cell anemia
696920|NCT00948012|Pulmonary Hypertension|pulmonary hypertension
696921|NCT00948012|Exercise echocardiography|exercise echocardiography
696922|NCT00948012|Echocardiography|echocardiography
696923|NCT00948025|Peripheral Nerve Repair|peripheral nerve repair
696924|NCT00948025|Conduit|conduit
696925|NCT00948025|AVANCE|avance
696926|NCT00948025|Neuroma Resection|neuroma resection
696927|NCT00948025|Nerve Gap Repair|nerve gap repair
696928|NCT00948025|Digital Nerve Repair|digital nerve repair
696929|NCT00948038|Inflammation|inflammation
696930|NCT00948038|Oxidative stress|oxidative stress
696931|NCT00948064|Leukemia|leukemia
696932|NCT00948064|Acute Myelogenous Leukemia|acute myelogenous leukemia
696933|NCT00948064|AML|aml
696934|NCT00948064|Myelodysplastic Syndrome|myelodysplastic syndrome
696935|NCT00948064|MDS|mds
696936|NCT00948064|Vorinostat|vorinostat
696937|NCT00948064|SAHA|saha
696938|NCT00948064|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
696939|NCT00948064|MSK-390|msk-390
696940|NCT00948064|Zolinza|zolinza
696941|NCT00948064|Azacitidine|azacitidine
696942|NCT00948064|5-Azacitidine|5-azacitidine
696943|NCT00948064|5-Aza|5-aza
696944|NCT00948064|Vidaza|vidaza
696945|NCT00948064|5-AZC|5-azc
696946|NCT00948064|AZA-CR|aza-cr
696947|NCT00948064|Ladakamycin|ladakamycin
696948|NCT00948064|NSC-102816|nsc-102816
696949|NCT00948077|tuberculosis|tuberculosis
696950|NCT00948077|pharmacokinetic|pharmacokinetic
696951|NCT00948077|first-line drugs|first-line drugs
696952|NCT00948090|Hodgkin Lymphoma|hodgkin lymphoma
696953|NCT00948090|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
696954|NCT00948090|Bone marrow transplant|bone marrow transplant
696955|NCT00948090|stem cell transplant|stem cell transplant
696956|NCT00948090|busulfan|busulfan
696957|NCT00948090|cyclophosphamide|cyclophosphamide
696958|NCT00948090|etoposide|etoposide
696959|NCT00948103|Nitrous Oxide|nitrous oxide
696960|NCT00948103|Administration, Intravesical Drug|administration, intravesical drug
696961|NCT00948103|Botulinum toxin|botulinum toxin
696962|NCT00948116|Diabetes mellitus|diabetes mellitus
696963|NCT00948116|Renal Impairment|renal impairment
696964|NCT00948116|Acute Kidney Injury|acute kidney injury
696965|NCT00948116|Coronary revascularisation|coronary revascularisation
696966|NCT00948116|eGFR <60ml/min|egfr <60ml/min
696967|NCT00948129|Smoking Cessation|smoking cessation
696968|NCT00948129|Low-Income|low-income
696969|NCT00948129|Cigarette smoking|cigarette smoking
696970|NCT00948129|Uninsured and underinsured|uninsured and underinsured
696971|NCT00948129|NRT|nrt
696972|NCT00948129|Nicoderm CQ|nicoderm cq
696973|NCT00948129|Habits|habits
696974|NCT00948142|Acute Bacterial Skin and Skin Struction Infections; Bacterial Skin Diseases; Staphylococcal Skin Infections; MRSA|acute bacterial skin and skin struction infections; bacterial skin diseases; staphylococcal skin infections; mrsa
696975|NCT00948155|smoking|smoking
696976|NCT00948155|nicotine|nicotine
696977|NCT00948155|varenicline|varenicline
696978|NCT00948168|T2DM|t2dm
696979|NCT00948168|exenatide|exenatide
696980|NCT00948168|HbA1c|hba1c
696981|NCT00948168|weight|weight
696982|NCT00948168|waist circumference|waist circumference
696983|NCT00948168|insulin sensitivity|insulin sensitivity
696984|NCT00948168|beta-cell function|beta-cell function
696985|NCT00948181|Epinephrine, Norepinephrine, normetanephrine|epinephrine, norepinephrine, normetanephrine
696986|NCT00948181|Catecholamine concentrations during surgery|catecholamine concentrations during surgery
696987|NCT00948194|Extended Donor Criteria|extended donor criteria
696988|NCT00948207|Metastatic Cancer|metastatic cancer
696989|NCT00948207|Recurrent Cancer|recurrent cancer
696990|NCT00948207|Distributed Hematological Cancer|distributed hematological cancer
696991|NCT00948207|Advanced Cancer|advanced cancer
696992|NCT00948207|Terminal Cancer|terminal cancer
696993|NCT00948207|Stage III Cancer|stage iii cancer
696994|NCT00948207|Stage IV Cancer|stage iv cancer
696995|NCT00948220|HCV|hcv
696996|NCT00948220|hepatitis C virus|hepatitis c virus
696997|NCT00948220|CHC|chc
696998|NCT00948220|chronic hepatitis c|chronic hepatitis c
696999|NCT00948220|interferon|interferon
697000|NCT00948220|ribavirin|ribavirin
697001|NCT00948220|DEXA|dexa
697002|NCT00948220|BMD|bmd
697003|NCT00948220|bone mineral density|bone mineral density
697004|NCT00948220|osteoporosis|osteoporosis
697005|NCT00948220|osteopenia|osteopenia
697006|NCT00948220|osteodystrophy|osteodystrophy
697007|NCT00948220|osteodensitometry|osteodensitometry
697008|NCT00948220|Bone Density|bone density
697009|NCT00948220|Hepatitis, Viral, Human|hepatitis, viral, human
697010|NCT00948220|Anti-Infective Agents|anti-infective agents
697011|NCT00948220|peginterferon alfa-2a|peginterferon alfa-2a
697012|NCT00948233|Tobacco|tobacco
697013|NCT00948233|Smoking Cessation|smoking cessation
697014|NCT00948233|Prevention|prevention
697015|NCT00948233|Smokeless tobacco|smokeless tobacco
697016|NCT00948233|Habit|habit
697017|NCT00948259|safety|safety
697018|NCT00948259|GSK inhibitor|gsk inhibitor
697019|NCT00948259|Alzheimer|alzheimer
697020|NCT00948272|Rabies|rabies
697021|NCT00948272|Rabies virus|rabies virus
697022|NCT00948272|Purified Vero Rabies Vaccine|purified vero rabies vaccine
697023|NCT00948272|Serum Free|serum free
697024|NCT00948285|breast cancer|breast cancer
697025|NCT00948285|magnetic resonance imaging|magnetic resonance imaging
697026|NCT00948298|cardiovascular disease|cardiovascular disease
697027|NCT00948298|vitamin D|vitamin d
697028|NCT00948298|african american|african american
697029|NCT00948298|low vitamin D levels|low vitamin d levels
697030|NCT00954928|hand|hand
697031|NCT00954928|wrist|wrist
697032|NCT00954928|anticoagulation|anticoagulation
697033|NCT00954928|surgery|surgery
697034|NCT00954928|patients on anticoagulant medication|patients on anticoagulant medication
697035|NCT00954941|Hematologic Disorder|hematologic disorder
697036|NCT00954941|Acute myelogenous leukemia|acute myelogenous leukemia
697037|NCT00954941|AML|aml
697038|NCT00954941|High-risk myelodysplastic syndrome|high-risk myelodysplastic syndrome
697039|NCT00954941|HR-MDS|hr-mds
697040|NCT00954941|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
697041|NCT00954941|CML|cml
697042|NCT00954941|Ondansetron|ondansetron
697043|NCT00954941|Zofran|zofran
697044|NCT00954941|Aprepitant|aprepitant
697045|NCT00954941|Emend|emend
697046|NCT00954941|L 754030|l 754030
697047|NCT00954941|MK 869|mk 869
697048|NCT00954941|Emesis|emesis
697049|NCT00954941|Nausea|nausea
697050|NCT00954941|Vomiting|vomiting
697051|NCT00954954|Arthroplasty|arthroplasty
697054|NCT00954954|Range of Motion|range of motion
697055|NCT00954967|Diabetes Mellitus|diabetes mellitus
697056|NCT00954967|Smoking Cessation|smoking cessation
697057|NCT00954967|Primary Health Care|primary health care
697058|NCT00954967|Motivational Interview|motivational interview
697059|NCT00954980|Varicose Veins|varicose veins
697060|NCT00954980|Superficial Thrombophlebitis|superficial thrombophlebitis
697061|NCT00954980|Deep Vein Thrombosis|deep vein thrombosis
697062|NCT00954980|Ulceration|ulceration
697063|NCT00954980|leg pain|leg pain
697064|NCT00954980|leg swelling|leg swelling
697065|NCT00954993|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
697066|NCT00954993|Vaniprevir|vaniprevir
697067|NCT00954993|MK-7009|mk-7009
697068|NCT00955006|HIV Seronegativity|hiv seronegativity
697069|NCT00955006|HIV Preventive Vaccine|hiv preventive vaccine
697070|NCT00955019|Barrett's|barrett's
697071|NCT00955019|Esophagus|esophagus
697072|NCT00955019|Reflux|reflux
697073|NCT00955019|dysplasia|dysplasia
697074|NCT00955019|adenocarcinoma|adenocarcinoma
697075|NCT00955032|Parkinson's disease|parkinson's disease
697076|NCT00955032|Apathy|apathy
697077|NCT00955032|rTMS|rtms
697078|NCT00955032|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
697079|NCT00955032|Depression|depression
697080|NCT00955045|long-term tolerability and safety|long-term tolerability and safety
697081|NCT00955045|istradefylline treatment|istradefylline treatment
697082|NCT00955045|levodopa/carbidopa|levodopa/carbidopa
697083|NCT00955058|PSA|psa
697084|NCT00955058|PCO|pco
697085|NCT00955058|PCOS|pcos
697086|NCT00955071|exercise|exercise
697087|NCT00955071|physical activity|physical activity
697088|NCT00955071|diet|diet
697089|NCT00955071|metabolic risk|metabolic risk
697090|NCT00955071|visceral fat|visceral fat
697091|NCT00955071|Insulin Resistance|insulin resistance
697092|NCT00955097|Definity|definity
697093|NCT00955097|liver tumors|liver tumors
697094|NCT00955097|intra operative contrast|intra operative contrast
697095|NCT00955097|liver cancer|liver cancer
697096|NCT00955097|hepatic tumors|hepatic tumors
697097|NCT00955097|identify liver tumors|identify liver tumors
697098|NCT00955097|surgery liver tumors|surgery liver tumors
697099|NCT00955097|Patients with known hepatic tumors|patients with known hepatic tumors
697100|NCT00955110|Opioid|opioid
697101|NCT00955110|Recreational|recreational
697102|NCT00955110|Oxymorphone|oxymorphone
697103|NCT00955110|Oxycodone|oxycodone
697104|NCT00955110|Extended Release|extended release
697105|NCT00955110|Healthy NonDependent Recreational Opioid Users|healthy nondependent recreational opioid users
697106|NCT00955123|Inflammation|inflammation
697107|NCT00955123|Urea synthesis|urea synthesis
697108|NCT00955123|Catabolism|catabolism
697109|NCT00955123|Nitrogen balance|nitrogen balance
697110|NCT00955136|ST elevated myocardial infarction|st elevated myocardial infarction
697111|NCT00955136|Acute coronary syndrome|acute coronary syndrome
697112|NCT00955136|MRX 801|mrx 801
697113|NCT00955136|Echocardiography|echocardiography
697114|NCT00955149|Primary sclerosing cholangitis|primary sclerosing cholangitis
697115|NCT00955149|Trisomy 7|trisomy 7
697116|NCT00955149|Cholangiocarcinoma|cholangiocarcinoma
697117|NCT00955149|Chemoprevention|chemoprevention
697118|NCT00955149|Erlotinib|erlotinib
697119|NCT00955162|Substance Abuse, Intravenous|substance abuse, intravenous
697120|NCT00955162|Buprenorphine|buprenorphine
697121|NCT00955175|stage I non-small cell lung cancer|stage i non-small cell lung cancer
697122|NCT00955175|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
697123|NCT00955175|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
697124|NCT00955175|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
697125|NCT00955188|colon cancer|colon cancer
697126|NCT00955188|rectal cancer|rectal cancer
697127|NCT00955201|diabetes mellitus|diabetes mellitus
697128|NCT00955201|diabetic neuropathies|diabetic neuropathies
697129|NCT00955201|Aerobic Exercise|aerobic exercise
697130|NCT00955201|Exercise Therapy|exercise therapy
697131|NCT00955201|electromyography|electromyography
697132|NCT00955201|United States Veterans|united states veterans
697133|NCT00955214|TAXUS Liberté|taxus liberté
697134|NCT00955214|Small coronary artery disease|small coronary artery disease
697135|NCT00955214|Paclitaxel-eluting stent|paclitaxel-eluting stent
697136|NCT00955227|Omega-3 Fatty acid|omega-3 fatty acid
697137|NCT00955227|ALA (alpha linolenic acid)|ala (alpha linolenic acid)
697138|NCT00955227|Ezetimibe|ezetimibe
697139|NCT00955227|Flaxseed oil capsules|flaxseed oil capsules
697140|NCT00955240|stage II anal cancer|stage ii anal cancer
697141|NCT00955240|stage IIIA anal cancer|stage iiia anal cancer
697142|NCT00955240|stage IIIB anal cancer|stage iiib anal cancer
697143|NCT00955240|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
697144|NCT00955253|Neglect|neglect
697145|NCT00955253|Attention|attention
697146|NCT00955253|Vigilance|vigilance
697147|NCT00955253|Stroke|stroke
697148|NCT00955253|Hemineglect|hemineglect
697149|NCT00955253|Unilateral Neglect|unilateral neglect
697150|NCT00955253|Spatial Neglect|spatial neglect
697245|NCT00956436|Hepatocellular Carcinoma|hepatocellular carcinoma
697151|NCT00956059|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
697152|NCT00956059|prednisone|prednisone
697153|NCT00956059|mycophenolate mofetil|mycophenolate mofetil
697154|NCT00956059|FK506|fk506
697155|NCT00956072|gastrointestinal stromal tumor|gastrointestinal stromal tumor
697156|NCT00956085|OCD|ocd
697157|NCT00956111|Novel Influenza A/H1N1 Vaccine|novel influenza a/h1n1 vaccine
697158|NCT00956111|Immunogenictiy|immunogenictiy
697159|NCT00956111|Safety|safety
697160|NCT00956137|spinal anesthesia|spinal anesthesia
697161|NCT00956137|ultrasound|ultrasound
697162|NCT00956137|palpation|palpation
697163|NCT00956137|knee|knee
697164|NCT00956137|hip|hip
697165|NCT00956137|surgery|surgery
697166|NCT00956137|intervertebral space|intervertebral space
697167|NCT00956150|Chronic Multisymptom Complex|chronic multisymptom complex
697168|NCT00956150|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
697169|NCT00956150|Gulf War Syndrome|gulf war syndrome
697170|NCT00956150|Chronic Multisymptom Illness Complex|chronic multisymptom illness complex
697171|NCT00956176|Cidofovir|cidofovir
697172|NCT00956176|Vistide|vistide
697173|NCT00956176|Adenovirus|adenovirus
697174|NCT00956176|BK virus infections|bk virus infections
697175|NCT00956176|HSCT|hsct
697176|NCT00956176|Hemorrhagic Cystitis|hemorrhagic cystitis
697177|NCT00956176|Foley catheter|foley catheter
697178|NCT00956176|Viral infection|viral infection
697179|NCT00956176|Bladder instillation|bladder instillation
697180|NCT00956176|Intravesical|intravesical
697181|NCT00956176|Transurethral catheter|transurethral catheter
697182|NCT00956176|Transplantation|transplantation
697183|NCT00956189|Antipsychotic Agents|antipsychotic agents
697184|NCT00956189|Metabolic Syndrome X|metabolic syndrome x
697185|NCT00956189|Identification|identification
697186|NCT00956189|Prediction|prediction
697187|NCT00956202|Influenza|influenza
697188|NCT00956202|Pandemic Flu|pandemic flu
697189|NCT00956202|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
697190|NCT00956202|Inactivated split-virion vaccine|inactivated split-virion vaccine
697191|NCT00956202|Adjuvant|adjuvant
697192|NCT00956215|post operative|post operative
697193|NCT00956215|obese|obese
697194|NCT00956241|rectal cancer|rectal cancer
697195|NCT00956241|colonic pouch|colonic pouch
697196|NCT00956241|side-to-end anastomosis|side-to-end anastomosis
697197|NCT00956241|preoperative radiotherapy|preoperative radiotherapy
697198|NCT00956254|mucositis|mucositis
697199|NCT00956254|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
697200|NCT00956254|pain|pain
697201|NCT00956267|Polycystic ovary syndrome|polycystic ovary syndrome
697202|NCT00956267|clomiphene resistance|clomiphene resistance
697203|NCT00956267|letrozole|letrozole
697204|NCT00956267|Laparoscopic ovarian diathermy|laparoscopic ovarian diathermy
697205|NCT00956280|The frequency and type of KRAS mutation in a sample of the Brazilian population with advanced NSCLC|the frequency and type of kras mutation in a sample of the brazilian population with advanced nsclc
697206|NCT00956280|KRAS mutation in population with advanced NSCLC|kras mutation in population with advanced nsclc
697207|NCT00956306|Udenafil,DA-8159,hepatic impairment,healthy volunteers|udenafil,da-8159,hepatic impairment,healthy volunteers
697208|NCT00956319|Insomnia|insomnia
697209|NCT00956319|Zolpidem|zolpidem
697210|NCT00956319|Estazolam|estazolam
697211|NCT00956332|Peripheral arterial disease (PAD)|peripheral arterial disease (pad)
697212|NCT00956332|Peripheral vascular disease (PVD)|peripheral vascular disease (pvd)
697213|NCT00956332|Critical limb ischemia (CLI)|critical limb ischemia (cli)
697214|NCT00956332|Cell therapy|cell therapy
697215|NCT00956332|Gene therapy|gene therapy
697216|NCT00956332|Endothelial cells|endothelial cells
697217|NCT00956332|Smooth muscle cells|smooth muscle cells
697218|NCT00956332|Angiogenesis|angiogenesis
697219|NCT00956332|Arteriogenesis|arteriogenesis
697221|NCT00956332|diabetic foot|diabetic foot
697222|NCT00956358|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
697223|NCT00956371|ONO-7746|ono-7746
697224|NCT00956371|Healthy adult subjects|healthy adult subjects
697225|NCT00956384|Breast reconstruction|breast reconstruction
697226|NCT00956384|Early stage|early stage
697227|NCT00956384|Skin-saving mastectomy|skin-saving mastectomy
697228|NCT00956384|Prophylactic mastectomy|prophylactic mastectomy
697229|NCT00956384|Acellular dermal matrix|acellular dermal matrix
697230|NCT00956384|BRCA Mutation Carriers|brca mutation carriers
697231|NCT00956397|Functional Dyspepsia|functional dyspepsia
697232|NCT00956397|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
697233|NCT00956397|chronic abdominal discomfort|chronic abdominal discomfort
697234|NCT00956410|Active immunization|active immunization
697235|NCT00956410|Alzheimer disease|alzheimer disease
697236|NCT00956410|Antibody|antibody
697237|NCT00956410|Central Nervous System Diseases|central nervous system diseases
697238|NCT00956410|Neurodegenerative diseases|neurodegenerative diseases
697239|NCT00956410|Vaccine|vaccine
697240|NCT00956423|obstructive sleep apnea|obstructive sleep apnea
697241|NCT00956423|exercise training|exercise training
697242|NCT00956423|aerobic exercise|aerobic exercise
697243|NCT00956423|resistance exercise|resistance exercise
697244|NCT00956436|Liver Cancer|liver cancer
697254|NCT00956449|seasonal influenza|seasonal influenza
697255|NCT00956449|influenza vaccine antigen|influenza vaccine antigen
697256|NCT00956449|immunogenicity|immunogenicity
697257|NCT00956449|safety|safety
697258|NCT00956449|tolerability|tolerability
697259|NCT00956449|antibody response|antibody response
697260|NCT00956449|intra muscular|intra muscular
697261|NCT00956449|elderly|elderly
697262|NCT00956449|non-elderly|non-elderly
697263|NCT00956462|intraocular pressure|intraocular pressure
697264|NCT00956462|Ahmed valve|ahmed valve
697265|NCT00956462|NSAIDS|nsaids
697266|NCT00956462|steroids|steroids
697267|NCT00956475|anxiety disorder|anxiety disorder
697268|NCT00956475|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
697269|NCT00956475|fatigue|fatigue
697270|NCT00956475|pain|pain
697271|NCT00956475|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
697272|NCT00956475|cancer survivor|cancer survivor
697273|NCT00956475|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
697274|NCT00956475|acute undifferentiated leukemia|acute undifferentiated leukemia
697275|NCT00956475|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
697276|NCT00956475|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
697277|NCT00956475|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
697278|NCT00956475|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
697279|NCT00956475|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
697280|NCT00956475|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
697281|NCT00956475|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
697282|NCT00956475|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
697283|NCT00956475|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
697284|NCT00956475|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
697285|NCT00956475|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
697286|NCT00956475|mast cell leukemia|mast cell leukemia
697287|NCT00956475|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
697288|NCT00956475|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
697289|NCT00956475|prolymphocytic leukemia|prolymphocytic leukemia
697290|NCT00956475|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
697291|NCT00956475|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
697292|NCT00956475|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
697293|NCT00956475|refractory hairy cell leukemia|refractory hairy cell leukemia
697294|NCT00956475|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
697295|NCT00956475|secondary acute myeloid leukemia|secondary acute myeloid leukemia
697296|NCT00956475|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
697297|NCT00956475|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
697298|NCT00956475|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
697299|NCT00956475|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
697300|NCT00956475|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
697301|NCT00956475|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
697302|NCT00956475|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
697967|NCT00958529|inulin|inulin
697303|NCT00956475|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
697304|NCT00956475|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
697305|NCT00956475|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
697306|NCT00956475|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
697307|NCT00956475|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
697308|NCT00956475|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
697309|NCT00956475|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
697310|NCT00956475|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
697311|NCT00956475|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
697312|NCT00956475|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
697313|NCT00956475|stage I mantle cell lymphoma|stage i mantle cell lymphoma
697314|NCT00956475|stage I marginal zone lymphoma|stage i marginal zone lymphoma
697315|NCT00956475|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
697316|NCT00956475|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
697317|NCT00956475|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
697318|NCT00956475|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
697319|NCT00956475|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
697465|NCT00956735|Pistachios|pistachios
697320|NCT00956475|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
752876|NCT01174576|energy intake|energy intake
697321|NCT00956475|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
697322|NCT00956475|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
697323|NCT00956475|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
697472|NCT00956774|infertility evaluation|infertility evaluation
697324|NCT00956475|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
697325|NCT00956475|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
697326|NCT00956475|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
697327|NCT00956475|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
697328|NCT00956475|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
697329|NCT00956475|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
697330|NCT00956475|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
697331|NCT00956475|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
697332|NCT00956475|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
697333|NCT00956475|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
697334|NCT00956475|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
697335|NCT00956475|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
697336|NCT00956475|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
697337|NCT00956475|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
697338|NCT00956475|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
697339|NCT00956475|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
697340|NCT00956475|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
697341|NCT00956475|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
697342|NCT00956475|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
697343|NCT00956475|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
697344|NCT00956475|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
697345|NCT00956475|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
697346|NCT00956475|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
697347|NCT00956475|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
697348|NCT00956475|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
697349|NCT00956475|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
697350|NCT00956475|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
697351|NCT00956475|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
697352|NCT00956475|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
697353|NCT00956475|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
697354|NCT00956475|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
697355|NCT00956475|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
697356|NCT00956475|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
697357|NCT00956475|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
697358|NCT00956475|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
697359|NCT00956475|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
697360|NCT00956475|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
697361|NCT00956475|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
697362|NCT00956475|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
697363|NCT00956475|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
697364|NCT00956475|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
697365|NCT00956475|anaplastic large cell lymphoma|anaplastic large cell lymphoma
697366|NCT00956475|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
697367|NCT00956475|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
697368|NCT00956475|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
697369|NCT00956475|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
697370|NCT00956475|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
697371|NCT00956475|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
697372|NCT00956475|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
697373|NCT00956475|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
697374|NCT00956475|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
697375|NCT00956475|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
697376|NCT00956475|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
697377|NCT00956475|splenic marginal zone lymphoma|splenic marginal zone lymphoma
697378|NCT00956475|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
697379|NCT00956475|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
697380|NCT00956475|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
697463|NCT00956735|Type II Diabetes|type ii diabetes
697381|NCT00956475|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
697382|NCT00956475|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
697383|NCT00956475|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
697384|NCT00956475|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
697385|NCT00956475|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
697565|NCT00957320|ALL|all
697386|NCT00956475|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
697387|NCT00956475|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
697388|NCT00956475|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
697389|NCT00956475|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
697390|NCT00956475|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
697391|NCT00956475|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
697392|NCT00956475|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
697393|NCT00956475|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
697394|NCT00956475|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
697395|NCT00956475|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
697396|NCT00956475|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
697397|NCT00956475|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
697398|NCT00956475|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
697399|NCT00956475|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
697400|NCT00956475|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
697401|NCT00956475|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
697402|NCT00956475|intraocular lymphoma|intraocular lymphoma
697403|NCT00956475|primary central nervous system lymphoma|primary central nervous system lymphoma
697404|NCT00956475|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
697405|NCT00956475|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
697406|NCT00956475|small intestine lymphoma|small intestine lymphoma
697407|NCT00956488|Exercise for Amyotrophic lateral sclerosis|exercise for amyotrophic lateral sclerosis
697408|NCT00956501|fall|fall
697409|NCT00956501|balance|balance
697410|NCT00956514|depression|depression
697411|NCT00956514|major depressive disorder|major depressive disorder
697412|NCT00956514|transcranial magnetic stimulation|transcranial magnetic stimulation
697413|NCT00956514|TMS|tms
697414|NCT00956514|EEG|eeg
697415|NCT00956514|electroencephalography|electroencephalography
697416|NCT00956514|Major Depression,|major depression,
697417|NCT00956527|Adolescent|adolescent
697418|NCT00956527|Substance Use|substance use
697419|NCT00956527|Early Intervention|early intervention
697420|NCT00956527|Martial Arts|martial arts
697421|NCT00956527|Karate|karate
697422|NCT00956540|Tracheostomy|tracheostomy
697423|NCT00956540|decannulation|decannulation
697424|NCT00956540|weaning|weaning
697425|NCT00956540|Tracheostomy Weaning|tracheostomy weaning
697426|NCT00956553|HPV|hpv
697427|NCT00956553|Human Papilloma Virus|human papilloma virus
697428|NCT00956553|Cervical cancer vaccine|cervical cancer vaccine
697429|NCT00956579|autism|autism
697430|NCT00956579|autistic|autistic
697431|NCT00956579|sensory|sensory
697432|NCT00956579|MEG|meg
697433|NCT00956579|connectivity|connectivity
697434|NCT00956579|brain|brain
697435|NCT00956579|MRI|mri
697436|NCT00956579|language|language
697437|NCT00956579|developmental|developmental
697438|NCT00956579|neurodevelopmental|neurodevelopmental
697439|NCT00956579|aspergers|aspergers
697440|NCT00956579|asperger's|asperger's
697441|NCT00956579|dyslexia|dyslexia
697442|NCT00956579|coherence|coherence
697443|NCT00956592|Video laryngoscopy|video laryngoscopy
697444|NCT00956592|Intubation success|intubation success
697445|NCT00956592|Difficult airway|difficult airway
697446|NCT00956592|CMAC laryngoscope|cmac laryngoscope
697447|NCT00956605|EEG-biofeedback|eeg-biofeedback
697448|NCT00956605|neurofeedback|neurofeedback
697449|NCT00956605|computer attention training systems|computer attention training systems
697450|NCT00956605|ADHD|adhd
697451|NCT00956605|ADD|add
697452|NCT00956605|child|child
697453|NCT00956605|children|children
697454|NCT00956631|Spinal Stenosis|spinal stenosis
697455|NCT00956631|Lumbar Spinal Stenosis|lumbar spinal stenosis
697456|NCT00956657|Randomised Controlled Trial|randomised controlled trial
697457|NCT00956657|Adherence|adherence
697458|NCT00956657|Patient Participation|patient participation
697459|NCT00956683|infraclavicular nerve block ultrasound dual endpoint stimulation|infraclavicular nerve block ultrasound dual endpoint stimulation
697460|NCT00956696|Epilepsy|epilepsy
697461|NCT00956696|mental retardation|mental retardation
697462|NCT00956735|Cardiovascular Disease|cardiovascular disease
697466|NCT00956735|Cardiovascular disease risk factors in adults with Type II diabetes|cardiovascular disease risk factors in adults with type ii diabetes
697467|NCT00956748|chronic suppurative otitis media with persistent otorrhea|chronic suppurative otitis media with persistent otorrhea
697468|NCT00956761|Influenza vaccine|influenza vaccine
697469|NCT00956774|HSG|hsg
697470|NCT00956774|Cannula|cannula
697471|NCT00956774|HSG procedure|hsg procedure
697473|NCT00956787|Myelodysplastic Syndrome|myelodysplastic syndrome
697474|NCT00956813|menopausal symptoms|menopausal symptoms
697475|NCT00956813|hot flashes|hot flashes
697476|NCT00956813|breast cancer|breast cancer
697477|NCT00956813|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
697478|NCT00956826|electrode vacuum delivery|electrode vacuum delivery
697479|NCT00956839|Tropical calcific pancreatitis|tropical calcific pancreatitis
697480|NCT00956839|Tropical chronic pancreatitis|tropical chronic pancreatitis
697481|NCT00956839|Chronic pancreatitis|chronic pancreatitis
697482|NCT00956839|Vitamin D|vitamin d
697483|NCT00956839|Vitamin D deficiency|vitamin d deficiency
697484|NCT00956839|Cholecalciferol|cholecalciferol
697485|NCT00956839|Intramuscular vitamin D3|intramuscular vitamin d3
697486|NCT00956865|Glaucoma|glaucoma
697487|NCT00956865|Intervention|intervention
697488|NCT00956865|Follow up|follow up
697490|NCT00956878|Pain|pain
697491|NCT00956878|SNP|snp
697492|NCT00956891|short-term effects|short-term effects
697493|NCT00956891|long-term follow-up|long-term follow-up
697494|NCT00956891|liver failure patients|liver failure patients
697495|NCT00956891|autologous MSCs transplantation|autologous mscs transplantation
697496|NCT00956904|Prostate Cancer|prostate cancer
697497|NCT00956904|Prostatectomy|prostatectomy
697498|NCT00956904|Transrectal Ultrasound|transrectal ultrasound
697499|NCT00956904|Tandem RALP|tandem ralp
697500|NCT00956930|advanced adult primary liver cancer|advanced adult primary liver cancer
697501|NCT00956930|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
697502|NCT00956930|recurrent adult primary liver cancer|recurrent adult primary liver cancer
697503|NCT00956930|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
697504|NCT00956943|nicotine dependence|nicotine dependence
697505|NCT00956943|nicotine replacement therapy|nicotine replacement therapy
697506|NCT00956943|transdermal nicotine|transdermal nicotine
697507|NCT00956943|nicotine metabolism|nicotine metabolism
697508|NCT00956943|high dose|high dose
697509|NCT00956956|An investigator and subject blinded (sponsor open)|an investigator and subject blinded (sponsor open)
697510|NCT00956956|multiple dose|multiple dose
697511|NCT00956956|dose escalation design with PF 04455242 and matching placebo.|dose escalation design with pf 04455242 and matching placebo.
697512|NCT00956969|headaches|headaches
697513|NCT00956969|stress management|stress management
697514|NCT00956969|assertiveness training|assertiveness training
697515|NCT00956969|relaxation training|relaxation training
697516|NCT00956969|emotional expression|emotional expression
697517|NCT00956982|Hepatitis C Virus Pegylated Interferon Ribavirin Older|hepatitis c virus pegylated interferon ribavirin older
697518|NCT00957021|Knee|knee
697519|NCT00957047|refractory|refractory
697520|NCT00957047|partial|partial
697521|NCT00957047|epilepsy|epilepsy
697522|NCT00957073|Heart Failure|heart failure
697523|NCT00957073|Diastolic dysfunction|diastolic dysfunction
697524|NCT00957086|Phase III Adjuvant Concurrent Chemo-RT +/- nimotuzumab|phase iii adjuvant concurrent chemo-rt +/- nimotuzumab
697525|NCT00957112|anxiety disorder|anxiety disorder
697526|NCT00957112|depression|depression
697527|NCT00957112|fatigue|fatigue
697528|NCT00957112|stage IA breast cancer|stage ia breast cancer
697529|NCT00957112|stage IB breast cancer|stage ib breast cancer
697530|NCT00957112|stage II breast cancer|stage ii breast cancer
697531|NCT00957112|stage IIIA breast cancer|stage iiia breast cancer
697532|NCT00957125|Localized primary breast cancer|localized primary breast cancer
697533|NCT00957125|Inflammatory breast cancer|inflammatory breast cancer
697534|NCT00957151|chronic pancreatitis|chronic pancreatitis
697535|NCT00957151|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
698902|NCT00963859|Bladder|bladder
697536|NCT00957151|enzyme therapy|enzyme therapy
697537|NCT00957151|patients with chronic pancreatitis and exocrine pancreatic insufficiency|patients with chronic pancreatitis and exocrine pancreatic insufficiency
697538|NCT00957151|taking enzyme replacement therapy|taking enzyme replacement therapy
697539|NCT00957164|Chronic pain|chronic pain
697540|NCT00957164|PTSD|ptsd
697541|NCT00957190|Ocular Hypertension|ocular hypertension
697542|NCT00957190|Open Angle Glaucoma|open angle glaucoma
697543|NCT00957203|Parkinson's disease|parkinson's disease
697544|NCT00957203|levodopa|levodopa
697545|NCT00957203|end of dose wearing off|end of dose wearing off
697546|NCT00957203|OFF time|off time
697547|NCT00957216|adult onset ataxia|adult onset ataxia
697548|NCT00957242|IPF|ipf
697549|NCT00957242|Warfarin|warfarin
697550|NCT00957255|rotator cuff tear|rotator cuff tear
697551|NCT00957255|rotator cuff repair|rotator cuff repair
697552|NCT00957268|Type 2 diabetes mellitus|type 2 diabetes mellitus
697553|NCT00957268|Non-insulin dependent diabetes mellitus|non-insulin dependent diabetes mellitus
697554|NCT00957268|Drug therapy|drug therapy
697555|NCT00957268|Pediatrics|pediatrics
697556|NCT00957281|Asthma|asthma
697557|NCT00957281|Systemic inflammation|systemic inflammation
697558|NCT00957281|Oxidative stress|oxidative stress
697559|NCT00957281|Cardiovascular morbidity|cardiovascular morbidity
697560|NCT00957281|Airway inflammation|airway inflammation
697561|NCT00957320|leukemia|leukemia
697562|NCT00957320|cancer|cancer
697563|NCT00957320|oncology|oncology
697564|NCT00957320|sirolimus|sirolimus
697567|NCT00957333|bladder dysfunction|bladder dysfunction
697568|NCT00957333|bladder mucosa|bladder mucosa
697569|NCT00957333|mechanisms|mechanisms
697570|NCT00957346|Pregnancy termination|pregnancy termination
697571|NCT00957346|abortion|abortion
697572|NCT00957346|medical abortion|medical abortion
697573|NCT00957346|2nd trimester|2nd trimester
697574|NCT00957346|mifepristone|mifepristone
697575|NCT00957346|misoprostol|misoprostol
697576|NCT00957359|Cancer|cancer
697577|NCT00957359|Anxiety|anxiety
697578|NCT00957359|Depression|depression
697579|NCT00957359|Hallucinogens|hallucinogens
697580|NCT00957372|epilepsy|epilepsy
697581|NCT00957385|Leukemia|leukemia
697582|NCT00957385|Remission|remission
697583|NCT00957398|Irritable Bowel Syndrome|irritable bowel syndrome
697584|NCT00957398|Irritable Bowel Syndrome subgroups|irritable bowel syndrome subgroups
697585|NCT00957398|Motility|motility
697586|NCT00957411|stage IB cervical cancer|stage ib cervical cancer
697587|NCT00957411|stage IIA cervical cancer|stage iia cervical cancer
697588|NCT00957411|stage IIB cervical cancer|stage iib cervical cancer
697589|NCT00957411|stage III cervical cancer|stage iii cervical cancer
697590|NCT00957411|cervical adenocarcinoma|cervical adenocarcinoma
697591|NCT00957411|cervical squamous cell carcinoma|cervical squamous cell carcinoma
697592|NCT00957424|tobacco use disorder|tobacco use disorder
697593|NCT00957424|bladder cancer|bladder cancer
697594|NCT00957424|cervical cancer|cervical cancer
697595|NCT00957424|esophageal cancer|esophageal cancer
697596|NCT00957424|gastric cancer|gastric cancer
697597|NCT00957424|renal cell carcinoma|renal cell carcinoma
697598|NCT00957424|adult primary liver cancer|adult primary liver cancer
697599|NCT00957424|non-small cell lung cancer|non-small cell lung cancer
697600|NCT00957424|small cell lung cancer|small cell lung cancer
697601|NCT00957424|pancreatic cancer|pancreatic cancer
697602|NCT00957424|hypopharyngeal cancer|hypopharyngeal cancer
697603|NCT00957424|laryngeal cancer|laryngeal cancer
697604|NCT00957424|lip and oral cavity cancer|lip and oral cavity cancer
697605|NCT00957424|nasopharyngeal cancer|nasopharyngeal cancer
697606|NCT00957424|oropharyngeal cancer|oropharyngeal cancer
697607|NCT00957424|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
697608|NCT00957424|adult acute myeloid leukemia|adult acute myeloid leukemia
697609|NCT00957437|Phase 1|phase 1
697610|NCT00957437|healthy volunteer|healthy volunteer
697611|NCT00957437|male|male
697612|NCT00957437|pharmacokinetics|pharmacokinetics
697613|NCT00957437|AZD1305|azd1305
697614|NCT00957450|cervix cancer|cervix cancer
697615|NCT00957450|intra-pelvic organ motion|intra-pelvic organ motion
697616|NCT00957450|cervical cancer and CBCT|cervical cancer and cbct
697617|NCT00957463|endothelial function|endothelial function
697618|NCT00957476|Pregnancy|pregnancy
697619|NCT00957476|Metabolic Diseases|metabolic diseases
697620|NCT00957476|Obesity|obesity
697621|NCT00957476|Fetal adiposity|fetal adiposity
697622|NCT00957476|Omega-3|omega-3
697623|NCT00957476|Inflammation|inflammation
697624|NCT00957476|Insulin Resistance|insulin resistance
697625|NCT00957489|Orthodontic treatment of Class II division 1 malocclusion|orthodontic treatment of class ii division 1 malocclusion
697626|NCT00957528|Low Normal Testosterone|low normal testosterone
697627|NCT00957528|Male|male
697628|NCT00957528|Aging|aging
697629|NCT00957541|NYHA Class III or IV|nyha class iii or iv
697864|NCT00958204|light therapy|light therapy
697630|NCT00957541|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
697631|NCT00957541|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
697632|NCT00957580|MEK Inhibitor|mek inhibitor
697633|NCT00957580|Pimasertib|pimasertib
697634|NCT00957580|Acute Myeloid Leukemia|acute myeloid leukemia
697635|NCT00957580|Hematological Malignancies|hematological malignancies
697636|NCT00957580|Elderly Patients|elderly patients
697637|NCT00957580|Phase II|phase ii
697638|NCT00957593|Induction of labor in term pregnancies|induction of labor in term pregnancies
697639|NCT00957593|Term pregnancy|term pregnancy
697640|NCT00957593|Cesarean delivery|cesarean delivery
697641|NCT00957606|Prostate cancer|prostate cancer
697642|NCT00957606|androgen deprivation therapy|androgen deprivation therapy
697643|NCT00957606|osteoporosis|osteoporosis
697644|NCT00957619|pentoxyfilline|pentoxyfilline
697645|NCT00957619|liver regeneration|liver regeneration
697646|NCT00957619|major liver resection|major liver resection
697647|NCT00957619|reduction of the I/R injury|reduction of the i/r injury
697648|NCT00957645|Central post-stroke pain|central post-stroke pain
697649|NCT00957645|post-stroke pain|post-stroke pain
697650|NCT00957645|shoulder pain|shoulder pain
697651|NCT00957658|Osteoarthritis|osteoarthritis
697652|NCT00957671|TBI|tbi
697653|NCT00957671|Traumatic Brain injury|traumatic brain injury
697654|NCT00957671|Growth hormone deficiency|growth hormone deficiency
697655|NCT00957671|Anterior pituitary hormone|anterior pituitary hormone
697656|NCT00957684|refractory|refractory
697657|NCT00957684|partial|partial
697658|NCT00957684|epilepsy|epilepsy
697659|NCT00957697|Central Neuropathic Pain|central neuropathic pain
697660|NCT00957697|Central Post-Stroke Pain|central post-stroke pain
697661|NCT00957697|Stroke|stroke
697663|NCT00957710|progressive aphasia|progressive aphasia
697664|NCT00957710|semantic dementia|semantic dementia
697665|NCT00957710|neuroimaging|neuroimaging
697666|NCT00957710|treatment|treatment
697667|NCT00957710|errorless learning|errorless learning
697668|NCT00957736|graft versus host disease|graft versus host disease
697669|NCT00957736|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
697670|NCT00957736|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
697671|NCT00957736|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
697672|NCT00957736|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
697673|NCT00957736|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
697674|NCT00957736|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
697675|NCT00957736|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
697676|NCT00957736|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
697677|NCT00957736|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
697678|NCT00957736|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
697679|NCT00957736|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
697680|NCT00957736|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
697681|NCT00957736|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
697682|NCT00957736|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
697683|NCT00957736|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
697684|NCT00957736|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
697685|NCT00957736|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
697686|NCT00957736|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
697687|NCT00957736|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
697688|NCT00957736|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
697689|NCT00957736|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
697690|NCT00957736|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
697691|NCT00957736|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
697692|NCT00957736|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
697693|NCT00957736|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
697694|NCT00957736|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
697695|NCT00957736|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
697696|NCT00957736|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
697697|NCT00957736|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
697698|NCT00957736|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
697699|NCT00957736|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
697700|NCT00957736|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
697701|NCT00957736|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
697702|NCT00957736|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
697703|NCT00957736|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
697704|NCT00957736|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
697705|NCT00957736|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
697706|NCT00957736|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
697707|NCT00957736|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
697708|NCT00957736|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
697709|NCT00957736|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
697710|NCT00957736|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
697711|NCT00957736|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
697712|NCT00957736|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
697713|NCT00957736|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
697714|NCT00957736|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
697715|NCT00957736|splenic marginal zone lymphoma|splenic marginal zone lymphoma
697716|NCT00957736|noncontiguous (NC) stage II adult Burkitt lymphoma|noncontiguous (nc) stage ii adult burkitt lymphoma
697717|NCT00957736|NC stage II adult diffuse large cell lymphoma|nc stage ii adult diffuse large cell lymphoma
697718|NCT00957736|NC stage II adult diffuse mixed cell lymphoma|nc stage ii adult diffuse mixed cell lymphoma
697719|NCT00957736|NC stage II adult diffuse small cleaved cell lymphoma|nc stage ii adult diffuse small cleaved cell lymphoma
752877|NCT01174576|inflammation|inflammation
697720|NCT00957736|NC stage II adult immunoblastic large cell lymphoma|nc stage ii adult immunoblastic large cell lymphoma
697721|NCT00957736|NC stage II adult lymphoblastic lymphoma|nc stage ii adult lymphoblastic lymphoma
697722|NCT00957736|NC stage II grade 1 follicular lymphoma|nc stage ii grade 1 follicular lymphoma
697723|NCT00957736|NC stage II grade 2 follicular lymphoma|nc stage ii grade 2 follicular lymphoma
697724|NCT00957736|NC stage II grade 3 follicular lymphoma|nc stage ii grade 3 follicular lymphoma
697725|NCT00957736|NC stage II mantle cell lymphoma|nc stage ii mantle cell lymphoma
697726|NCT00957736|NC stage II marginal zone lymphoma|nc stage ii marginal zone lymphoma
697727|NCT00957736|NC stage II small lymphocytic lymphoma|nc stage ii small lymphocytic lymphoma
697728|NCT00957736|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
697729|NCT00957736|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
697730|NCT00957736|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
697731|NCT00957736|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
697732|NCT00957736|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
697733|NCT00957736|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
697734|NCT00957736|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
697735|NCT00957736|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
697736|NCT00957736|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
697737|NCT00957736|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
697738|NCT00957736|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
697739|NCT00957736|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
697740|NCT00957736|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
697741|NCT00957736|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
697742|NCT00957736|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
697743|NCT00957736|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
697744|NCT00957736|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
697745|NCT00957736|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
697746|NCT00957736|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
697747|NCT00957736|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
697748|NCT00957736|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
697749|NCT00957736|refractory hairy cell leukemia|refractory hairy cell leukemia
697750|NCT00957736|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
697751|NCT00957736|secondary acute myeloid leukemia|secondary acute myeloid leukemia
697752|NCT00957736|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
697753|NCT00957736|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
697754|NCT00957736|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
697755|NCT00957736|chronic eosinophilic leukemia|chronic eosinophilic leukemia
697756|NCT00957736|primary myelofibrosis|primary myelofibrosis
697757|NCT00957736|chronic neutrophilic leukemia|chronic neutrophilic leukemia
697758|NCT00957736|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
697759|NCT00957736|disseminated neuroblastoma|disseminated neuroblastoma
697760|NCT00957736|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
697761|NCT00957736|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
697762|NCT00957736|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
697763|NCT00957736|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
697764|NCT00957736|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
697765|NCT00957736|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
697766|NCT00957736|recurrent neuroblastoma|recurrent neuroblastoma
697767|NCT00957736|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
697768|NCT00957736|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
697769|NCT00957736|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
697770|NCT00957736|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
697771|NCT00957736|stage I multiple myeloma|stage i multiple myeloma
697772|NCT00957736|stage II multiple myeloma|stage ii multiple myeloma
697773|NCT00957736|stage III multiple myeloma|stage iii multiple myeloma
697774|NCT00957736|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
697775|NCT00957736|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
697776|NCT00957736|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
697777|NCT00957736|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
697778|NCT00957736|stage IIIA breast cancer|stage iiia breast cancer
697779|NCT00957736|stage IIIB breast cancer|stage iiib breast cancer
697780|NCT00957736|stage IIIC breast cancer|stage iiic breast cancer
697781|NCT00957736|stage IV breast cancer|stage iv breast cancer
697782|NCT00957736|refractory multiple myeloma|refractory multiple myeloma
697783|NCT00957762|Body Composition|body composition
697784|NCT00957762|Glucose Tolerance|glucose tolerance
699968|NCT00967343|TH9402|th9402
697785|NCT00957762|Insulin Sensitivity|insulin sensitivity
697786|NCT00957762|Metabolic Syndrome|metabolic syndrome
697787|NCT00957775|Substance Abuse Treatment|substance abuse treatment
697788|NCT00957775|Adolescents|adolescents
697789|NCT00957775|Substance-Related Disorders|substance-related disorders
697790|NCT00957775|Alcohol-Related Disorders|alcohol-related disorders
697791|NCT00957775|Marijuana Abuse|marijuana abuse
697792|NCT00957788|tinnitus|tinnitus
697793|NCT00957788|acouphenes|acouphenes
697794|NCT00957788|ear|ear
697795|NCT00957788|ringing|ringing
697796|NCT00957788|buzzing|buzzing
697797|NCT00957788|roaring|roaring
697798|NCT00957788|hissing|hissing
697799|NCT00957788|clicking|clicking
697800|NCT00957801|Sarcopenia|sarcopenia
697801|NCT00957801|Aging muscle|aging muscle
697804|NCT00957801|Muscle metabolism|muscle metabolism
697805|NCT00957814|nutritional education|nutritional education
697806|NCT00957814|diet adherence|diet adherence
697807|NCT00957814|nutritional knowledge|nutritional knowledge
697808|NCT00957814|life quality|life quality
697809|NCT00957814|nutritional status|nutritional status
697810|NCT00957814|impact of nutritional orientations by a systematic education program applied to outpatients with HF, in comparison to patients in a conventional treatment.|impact of nutritional orientations by a systematic education program applied to outpatients with hf, in comparison to patients in a conventional treatment.
697811|NCT00957840|Omaya reservoirs|omaya reservoirs
697812|NCT00957840|cerebral oxygenation|cerebral oxygenation
697813|NCT00957840|VP shunt|vp shunt
697814|NCT00957840|IVH|ivh
697815|NCT00957840|post hemorrhagic ventricular dilation (PVHD)|post hemorrhagic ventricular dilation (pvhd)
697816|NCT00957853|Head and Neck Cancer|head and neck cancer
697817|NCT00957853|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
697818|NCT00957853|HNSCC|hnscc
697819|NCT00957853|Cetuximab|cetuximab
697820|NCT00957853|IMC-A12|imc-a12
697821|NCT00957853|Tumor|tumor
697822|NCT00957853|Biomarkers|biomarkers
697823|NCT00957853|Phospho-AKT|phospho-akt
697824|NCT00957853|Surgical resection|surgical resection
697825|NCT00957866|The number of cases in the database thus far (4,477) is clearly sufficient to achieve meaningful results|the number of cases in the database thus far (4,477) is clearly sufficient to achieve meaningful results
697826|NCT00957879|Vitamin D|vitamin d
697827|NCT00957879|FGF23|fgf23
697828|NCT00957879|FGF-23|fgf-23
697829|NCT00957879|Phosphate|phosphate
697830|NCT00957892|Healthy Infants|healthy infants
697831|NCT00957892|Satiation|satiation
697832|NCT00957892|Satiety|satiety
697833|NCT00957892|Intake Regulation|intake regulation
697834|NCT00957892|Infant Feeding|infant feeding
697835|NCT00957892|Infant Formula Feeding|infant formula feeding
697836|NCT00957918|levodopa-induced dyskinesia|levodopa-induced dyskinesia
697837|NCT00957918|Parkinson's disease|parkinson's disease
697838|NCT00957918|parkinsonian|parkinsonian
697839|NCT00957918|levodopa-induced dyskinesias in Parkinson's disease|levodopa-induced dyskinesias in parkinson's disease
697840|NCT00957944|Rotigotine|rotigotine
697841|NCT00957944|Neupro®|neupro®
697842|NCT00957970|Stress shielding|stress shielding
697843|NCT00957970|Bone mineral density|bone mineral density
697844|NCT00957970|stemless femoral component|stemless femoral component
697845|NCT00957996|influenza|influenza
697846|NCT00957996|hospitalized|hospitalized
697847|NCT00957996|flu|flu
697848|NCT00957996|antiviral|antiviral
697849|NCT00958048|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
697850|NCT00958048|hypoventilation|hypoventilation
697851|NCT00958061|CVD|cvd
697852|NCT00958100|raltegravir switch toxicity|raltegravir switch toxicity
697853|NCT00958100|treatment experienced|treatment experienced
697854|NCT00958139|Lyme disease|lyme disease
697855|NCT00958139|tick|tick
697856|NCT00958152|VX-950|vx-950
697857|NCT00958152|VX-222|vx-222
697858|NCT00958152|STAT-C|stat-c
697859|NCT00958165|Treatment of PAF using EAS-AC|treatment of paf using eas-ac
697860|NCT00958204|Depression|depression
697861|NCT00958204|rating scales|rating scales
697862|NCT00958204|RCT|rct
697863|NCT00958204|combination treatment|combination treatment
697865|NCT00958204|negative ion therapy|negative ion therapy
697866|NCT00958204|fluoxetine|fluoxetine
697867|NCT00958204|antidepressants|antidepressants
697868|NCT00958217|Depressive symptoms|depressive symptoms
697869|NCT00958217|Substance-related disorders|substance-related disorders
697870|NCT00958217|Posttraumatic stress disorders|posttraumatic stress disorders
697871|NCT00958217|Psychotherapy|psychotherapy
697872|NCT00958230|endarterectomy|endarterectomy
697873|NCT00958230|dCell|dcell
697874|NCT00958230|Tissue Regenix Ltd|tissue regenix ltd
697875|NCT00958230|TRL|trl
697876|NCT00958230|Vascular Patch|vascular patch
697877|NCT00958230|Treatment|treatment
697878|NCT00958256|Mantle Cell Lymphoma|mantle cell lymphoma
697879|NCT00958256|Lymphoma|lymphoma
697880|NCT00958256|Bortezomib|bortezomib
697881|NCT00958256|Velcade|velcade
697882|NCT00958256|Rituximab|rituximab
697883|NCT00958256|Rituxan|rituxan
697884|NCT00958256|Cyclophosphamide|cyclophosphamide
697885|NCT00958256|Cytoxan|cytoxan
697886|NCT00958256|Neosar|neosar
697887|NCT00958256|Mesna|mesna
697888|NCT00958256|Mesnex|mesnex
697889|NCT00958256|G-CSF|g-csf
697890|NCT00958256|Filgrastim|filgrastim
697891|NCT00958256|Neupogen|neupogen
697892|NCT00958269|diabetes|diabetes
697893|NCT00958269|DPP4 inhibitor|dpp4 inhibitor
697894|NCT00958269|dutogliptin|dutogliptin
697895|NCT00958269|PHX1149|phx1149
697896|NCT00958282|cocaine|cocaine
697897|NCT00958282|treatment|treatment
697898|NCT00958282|lisdexamfetamine|lisdexamfetamine
697899|NCT00958282|dependence|dependence
697900|NCT00958282|addiction|addiction
697901|NCT00958282|crack|crack
697902|NCT00958295|urinary tract infection|urinary tract infection
697903|NCT00958295|cystitis|cystitis
697904|NCT00958308|Probiotic|probiotic
698002|NCT00951236|Trigger Thumb|trigger thumb
697905|NCT00958308|Antibiotic-Associated Diarrhea (AAD) Prevention|antibiotic-associated diarrhea (aad) prevention
697906|NCT00958308|Clostridium Difficile-Associated Diarrhea (CDAD)Prevention|clostridium difficile-associated diarrhea (cdad)prevention
697907|NCT00958321|adenocarcinoma of the lung|adenocarcinoma of the lung
697908|NCT00958321|large cell lung cancer|large cell lung cancer
697909|NCT00958321|squamous cell lung cancer|squamous cell lung cancer
697910|NCT00958321|malignant pleural effusion|malignant pleural effusion
697911|NCT00958321|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
697912|NCT00958321|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
697913|NCT00958321|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
697914|NCT00958321|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
697915|NCT00958321|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
697916|NCT00958321|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
697917|NCT00958334|Uterine fibroids|uterine fibroids
697918|NCT00958360|vision, low|vision, low
697919|NCT00958373|Scoliosis|scoliosis
697920|NCT00958373|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
697921|NCT00958373|spine curve|spine curve
697922|NCT00958373|pediatric|pediatric
697923|NCT00958373|mental health|mental health
697924|NCT00958373|screening|screening
697925|NCT00958386|colorectal cancer|colorectal cancer
697926|NCT00958386|Panitumumab|panitumumab
697927|NCT00958386|irinotecan|irinotecan
697928|NCT00958399|satiety|satiety
697929|NCT00958399|fiber|fiber
697930|NCT00958399|food intake|food intake
697931|NCT00958399|gut hormones|gut hormones
697932|NCT00958399|visual analog scales|visual analog scales
697933|NCT00958399|microflora|microflora
697934|NCT00958412|Endometriosis|endometriosis
697935|NCT00958412|Pelvic pain|pelvic pain
697936|NCT00958412|Oral progesterone blocker|oral progesterone blocker
697937|NCT00958438|Intercritical Gout|intercritical gout
697938|NCT00958438|Metabolism, Inborn Errors|metabolism, inborn errors
697939|NCT00958438|Allopurinol|allopurinol
697940|NCT00958438|Metabolic Diseases|metabolic diseases
697941|NCT00958438|Genetic Diseases, Inborn|genetic diseases, inborn
697942|NCT00958438|Musculoskeletal Diseases|musculoskeletal diseases
697943|NCT00958438|Joint Diseases|joint diseases
697944|NCT00958438|Arthritis|arthritis
697945|NCT00958438|Rheumatic Diseases|rheumatic diseases
697946|NCT00958438|Metabolic disorder|metabolic disorder
697947|NCT00958438|Purine-Pyrimidine Metabolism, Inborn Errors|purine-pyrimidine metabolism, inborn errors
697948|NCT00958438|Gout|gout
697949|NCT00958451|Calcium|calcium
697950|NCT00958451|Vitamin D deficiency|vitamin d deficiency
697951|NCT00958451|Chronic Kidney disease|chronic kidney disease
697952|NCT00958464|MRI|mri
697953|NCT00958464|Perthes'disease|perthes'disease
697954|NCT00958464|hip|hip
697955|NCT00958464|cartilage|cartilage
697956|NCT00958477|Safety|safety
697957|NCT00958477|tolerability|tolerability
697958|NCT00958477|pharmacokinetics|pharmacokinetics
697959|NCT00958477|pharmacodynamics of EMD 525797|pharmacodynamics of emd 525797
697960|NCT00958477|prostate cancer patients|prostate cancer patients
697961|NCT00958503|safety|safety
697962|NCT00958503|biomarker|biomarker
697963|NCT00958503|thiamphenicol|thiamphenicol
697964|NCT00958503|EAAT2|eaat2
697965|NCT00958516|volunteers|volunteers
697966|NCT00958529|fiber|fiber
697968|NCT00958529|gastrointestinal tolerance|gastrointestinal tolerance
697969|NCT00958542|cerebral palsy|cerebral palsy
697970|NCT00958542|scoliosis|scoliosis
697971|NCT00958542|children|children
697972|NCT00945828|pediatric cancer, neurocognitive outcomes for pediatric cancer|pediatric cancer, neurocognitive outcomes for pediatric cancer
697973|NCT00945828|acute lymphoblastic leukemia|acute lymphoblastic leukemia
697974|NCT00945828|central nervous system tumors|central nervous system tumors
697975|NCT00945828|lymphoma|lymphoma
697976|NCT00951119|type 2 diabetes|type 2 diabetes
697977|NCT00951119|hypertension|hypertension
697978|NCT00951119|treatment|treatment
697979|NCT00951119|non-medical|non-medical
697980|NCT00951132|Inflammation|inflammation
697981|NCT00951132|Atherosclerosis|atherosclerosis
697982|NCT00951132|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
697983|NCT00951158|Conjugated Linoleic Acid|conjugated linoleic acid
697984|NCT00951158|Clarinol|clarinol
697985|NCT00951158|S14 Expression|s14 expression
697986|NCT00951184|depression|depression
697987|NCT00951184|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
697988|NCT00951197|dementia|dementia
697989|NCT00951197|Alzheimer's Disease|alzheimer's disease
697990|NCT00951197|diagnostic|diagnostic
697991|NCT00951197|biomarkers|biomarkers
697992|NCT00951197|neuroimaging|neuroimaging
697993|NCT00951197|PET|pet
697994|NCT00951197|MRI|mri
697995|NCT00951197|mild cognitive impairment|mild cognitive impairment
697996|NCT00951210|Peripheral Artery Disease|peripheral artery disease
697997|NCT00951210|Peripheral Vascular Disease|peripheral vascular disease
697998|NCT00951210|Critical limb ischemia|critical limb ischemia
697999|NCT00951210|PAD|pad
698000|NCT00951210|CLI|cli
698001|NCT00951236|Trigger Finger|trigger finger
698004|NCT00951249|HIV infections|hiv infections
698005|NCT00951249|HIV Seronegativity|hiv seronegativity
698006|NCT00951262|life review|life review
698007|NCT00951262|quality of life|quality of life
698008|NCT00951262|advanced cancer patients|advanced cancer patients
698010|NCT00951288|Retinal Function|retinal function
698011|NCT00951288|Neuroprotection|neuroprotection
698012|NCT00951314|Genetic Polymorphisms|genetic polymorphisms
698013|NCT00951314|Metabotropic Glutamate Receptors|metabotropic glutamate receptors
698014|NCT00951314|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
698015|NCT00951314|Cocaine Dependence|cocaine dependence
698016|NCT00951314|Cue-Induced Craving|cue-induced craving
698017|NCT00951314|Drug Abuse|drug abuse
698018|NCT00951327|Primary sclerosing cholangitis|primary sclerosing cholangitis
698019|NCT00951340|CBT|cbt
698020|NCT00951340|Emotional-Focused Therapy|emotional-focused therapy
698021|NCT00951340|Interpersonal Therapy|interpersonal therapy
698022|NCT00951353|Transplantation|transplantation
698023|NCT00951353|Kidney Failure|kidney failure
698024|NCT00951353|End Stage Renal Disease|end stage renal disease
698025|NCT00951353|Pediatric|pediatric
698026|NCT00951366|premature birth|premature birth
698027|NCT00951366|neonatal respiratory distress|neonatal respiratory distress
698028|NCT00951366|chronic lung disease|chronic lung disease
698029|NCT00951366|epidemiologicfactors|epidemiologicfactors
698030|NCT00951366|genetic factors|genetic factors
698031|NCT00951392|Insulin sensitivity|insulin sensitivity
698032|NCT00951392|aging|aging
698033|NCT00951392|lipid metabolism|lipid metabolism
698034|NCT00951392|hyperinsulinemic clamp|hyperinsulinemic clamp
698035|NCT00951392|gene expression|gene expression
698036|NCT00951392|sirtuins|sirtuins
698037|NCT00951418|clozapine|clozapine
698038|NCT00951418|schizophrenia|schizophrenia
698039|NCT00951418|cognition|cognition
698040|NCT00951418|t-wave morphology|t-wave morphology
698041|NCT00951431|Functional dyspepsia|functional dyspepsia
698042|NCT00951431|PPI|ppi
698043|NCT00951431|postprandial fullness|postprandial fullness
698044|NCT00951431|delayed gastric emptying|delayed gastric emptying
698045|NCT00951444|adenosquamous cell lung cancer|adenosquamous cell lung cancer
698046|NCT00951444|squamous cell lung cancer|squamous cell lung cancer
698047|NCT00951444|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
698048|NCT00951444|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
698049|NCT00951444|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
698050|NCT00951457|CLL|cll
698051|NCT00951457|pretreated|pretreated
698052|NCT00951457|immune therapy|immune therapy
698053|NCT00951457|dose escalation|dose escalation
698054|NCT00951457|maintenance therapy|maintenance therapy
698055|NCT00951457|Bendamustine|bendamustine
698056|NCT00951457|Alemtuzumab|alemtuzumab
698057|NCT00951470|Head and neck lymphedema|head and neck lymphedema
698058|NCT00951470|Complete Decongestive Therapy|complete decongestive therapy
698059|NCT00951470|CDT|cdt
698060|NCT00951470|Oral cavity cancer|oral cavity cancer
698061|NCT00951470|Oropharyngeal cancer|oropharyngeal cancer
698062|NCT00951483|Cardiovascular Biomarkers|cardiovascular biomarkers
698063|NCT00951483|Depression|depression
698064|NCT00951483|Quetiapine|quetiapine
699061|NCT00964457|cetuximab|cetuximab
698065|NCT00951509|Electric power wheelchair driving|electric power wheelchair driving
698066|NCT00951509|rehabilitation|rehabilitation
698067|NCT00951509|driving assessments|driving assessments
698068|NCT00951522|Cystic Fibrosis|cystic fibrosis
698069|NCT00951522|CF|cf
698070|NCT00951522|Mucociliary Clearance|mucociliary clearance
698071|NCT00951522|Epithelial Sodium Channel Inhibitor|epithelial sodium channel inhibitor
698072|NCT00951522|ENaC Inhibitor|enac inhibitor
698073|NCT00951522|Airway Hydration|airway hydration
698074|NCT00951522|Amiloride|amiloride
698075|NCT00951535|stage I prostate cancer|stage i prostate cancer
698076|NCT00951535|stage IIB prostate cancer|stage iib prostate cancer
698077|NCT00951535|stage IIA prostate cancer|stage iia prostate cancer
698078|NCT00951535|stage III prostate cancer|stage iii prostate cancer
698079|NCT00951548|Probiotics|probiotics
698080|NCT00951548|VSL#3|vsl#3
698081|NCT00951548|Double-blind|double-blind
698082|NCT00951548|Placebo controlled|placebo controlled
698083|NCT00951561|Dysmenorrhea|dysmenorrhea
698084|NCT00951574|thromboembolism|thromboembolism
698085|NCT00951574|cancer|cancer
698086|NCT00951574|chemotherapy|chemotherapy
698087|NCT00951574|low-molecular-weight-heparin|low-molecular-weight-heparin
698088|NCT00951574|nadroparin|nadroparin
698089|NCT00951587|Colonic Diseases|colonic diseases
698090|NCT00951600|Oxcarbazepine oral suspension fasting study|oxcarbazepine oral suspension fasting study
698091|NCT00951613|small cell lung cancer|small cell lung cancer
698092|NCT00951613|carcinoma, lung|carcinoma, lung
698093|NCT00951613|Sensitive-relapsed or refractory-relapsed small cell lung cancer|sensitive-relapsed or refractory-relapsed small cell lung cancer
698094|NCT00951626|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
698095|NCT00951626|therapy-related toxicity|therapy-related toxicity
698096|NCT00951626|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
698097|NCT00951626|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
698098|NCT00951626|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
698099|NCT00951626|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
698100|NCT00951626|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
698101|NCT00951626|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
698102|NCT00951626|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
698103|NCT00951626|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
698104|NCT00951626|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
698105|NCT00951626|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
698106|NCT00951626|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
698107|NCT00951626|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
698108|NCT00951626|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
698109|NCT00951626|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
698110|NCT00951626|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
698111|NCT00951626|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
698112|NCT00951626|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
698113|NCT00951626|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
698114|NCT00951626|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
698115|NCT00951626|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
698116|NCT00951626|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
698117|NCT00951626|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
698118|NCT00951626|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
698119|NCT00951626|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
698120|NCT00951626|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
698121|NCT00951626|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
698122|NCT00951626|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
698123|NCT00951626|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
698124|NCT00951626|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
698125|NCT00951626|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
698126|NCT00951626|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
698127|NCT00951626|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
698128|NCT00951626|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
698129|NCT00951626|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
698130|NCT00951626|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
698131|NCT00951626|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
698132|NCT00951626|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
698133|NCT00951626|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
698134|NCT00951626|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
698135|NCT00951626|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
698136|NCT00951626|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
698137|NCT00951626|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
698138|NCT00951626|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
698139|NCT00951626|splenic marginal zone lymphoma|splenic marginal zone lymphoma
698140|NCT00951626|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
698141|NCT00951626|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
698142|NCT00951626|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
698143|NCT00951626|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
698144|NCT00951626|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
698145|NCT00951626|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
698146|NCT00951626|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
751858|NCT01170897|PEGylated Recombinant Human Hyaluronidase|pegylated recombinant human hyaluronidase
698147|NCT00951626|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
698148|NCT00951626|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
698149|NCT00951626|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
698150|NCT00951626|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
698151|NCT00951626|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
698152|NCT00951626|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
698153|NCT00951626|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
698154|NCT00951626|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
698155|NCT00951626|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
698156|NCT00951626|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
698157|NCT00951626|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
698158|NCT00951626|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
698159|NCT00951626|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
698160|NCT00951626|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
698161|NCT00951626|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
698162|NCT00951626|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
698163|NCT00951626|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
698164|NCT00951626|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
698165|NCT00951626|refractory hairy cell leukemia|refractory hairy cell leukemia
698166|NCT00951626|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
698167|NCT00951626|secondary acute myeloid leukemia|secondary acute myeloid leukemia
698168|NCT00951626|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
698169|NCT00951626|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
698170|NCT00951626|chronic eosinophilic leukemia|chronic eosinophilic leukemia
698171|NCT00951626|primary myelofibrosis|primary myelofibrosis
698172|NCT00951626|chronic neutrophilic leukemia|chronic neutrophilic leukemia
698173|NCT00951626|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
698174|NCT00951626|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
698175|NCT00951626|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
698176|NCT00951626|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
698177|NCT00951626|refractory multiple myeloma|refractory multiple myeloma
698178|NCT00951639|Cassia|cassia
698179|NCT00951639|Cinnamon|cinnamon
698180|NCT00951639|Blood Glucose|blood glucose
698181|NCT00951639|Endurance exercise|endurance exercise
698182|NCT00951639|Acute exercise|acute exercise
698183|NCT00951639|Overweight|overweight
698184|NCT00951639|Obesity|obesity
698185|NCT00951639|Women|women
698186|NCT00951652|CBT|cbt
698187|NCT00951652|GAD|gad
698188|NCT00951652|Interpersonal Therapy|interpersonal therapy
698189|NCT00951652|Emotion-Focused Therapy|emotion-focused therapy
698190|NCT00951665|Trastuzumab DM1 (T-DM1)|trastuzumab dm1 (t-dm1)
698191|NCT00951665|Trastuzumab emtansine|trastuzumab emtansine
698192|NCT00951665|Armed Herceptin|armed herceptin
698193|NCT00951665|HER2|her2
698194|NCT00951665|HER2+|her2+
698195|NCT00951665|HER2 Positive Breast Cancer|her2 positive breast cancer
698196|NCT00951678|ultrasound|ultrasound
698197|NCT00951678|femoral vein|femoral vein
698198|NCT00951678|internal jugular vein|internal jugular vein
698199|NCT00951691|Elderly|elderly
698200|NCT00951691|Acute Medical Rehabilitation|acute medical rehabilitation
698201|NCT00951704|Open-chest|open-chest
698202|NCT00951704|CPR|cpr
698203|NCT00951704|Tissue Perfusion|tissue perfusion
698204|NCT00951704|invasive arterial pressure|invasive arterial pressure
698205|NCT00951704|exhaled carbon dioxide|exhaled carbon dioxide
698206|NCT00951704|Quality of life|quality of life
698207|NCT00951704|Quality of chest compressions|quality of chest compressions
698208|NCT00951704|Epidemiology of sudden cardiac arrest(OHCA)|epidemiology of sudden cardiac arrest(ohca)
698209|NCT00951717|Postpartum Depressive Symptoms|postpartum depressive symptoms
698210|NCT00951717|Physical Symptoms|physical symptoms
698211|NCT00951717|Emotional Symptoms|emotional symptoms
698212|NCT00951717|Infant Colic|infant colic
698213|NCT00951717|Social Support|social support
698214|NCT00951717|Breastfeeding|breastfeeding
698215|NCT00951730|Down Syndrome|down syndrome
698216|NCT00951730|Adult|adult
698217|NCT00951730|Children|children
698218|NCT00951730|Sleep apnea|sleep apnea
698219|NCT00951730|Sleep hypopnea|sleep hypopnea
698220|NCT00951730|Polysomnography|polysomnography
698221|NCT00951743|AIDS|aids
698223|NCT00951743|mDAPTA|mdapta
698224|NCT00951756|Dietary fat|dietary fat
698225|NCT00951756|Microbiome composition|microbiome composition
698226|NCT00951756|Controlled feeding experiment|controlled feeding experiment
698227|NCT00951782|COPD|copd
698228|NCT00951795|HIV|hiv
698229|NCT00951795|AIDS|aids
698230|NCT00951795|CD4|cd4
698231|NCT00951808|Anemia, Sickle Cell|anemia, sickle cell
698232|NCT00951808|Acute Chest Syndrome|acute chest syndrome
698233|NCT00951808|Secretory phospholipase A2(sPLA2)|secretory phospholipase a2(spla2)
698234|NCT00951821|Suicidal Ideation|suicidal ideation
698235|NCT00951821|Suicide Attempts|suicide attempts
698236|NCT00951834|Alzheimer´s Disease|alzheimer´s disease
698237|NCT00951834|Epigallocatechin-Gallate|epigallocatechin-gallate
698238|NCT00951834|Neuroprotection|neuroprotection
698239|NCT00951834|ADAS-COG|adas-cog
698240|NCT00951834|early stage of Alzheimer's Disease|early stage of alzheimer's disease
698241|NCT00951847|Oxcarbazepine oral suspension fed study|oxcarbazepine oral suspension fed study
698242|NCT00951860|Fullterm Birth|fullterm birth
698243|NCT00951860|Neonate|neonate
698244|NCT00951860|Prematurity|prematurity
698245|NCT00951860|Neurodevelopment|neurodevelopment
698246|NCT00951860|Autonomic Nervous System activity|autonomic nervous system activity
698247|NCT00951886|Ataxia Teleangiectasia|ataxia teleangiectasia
698248|NCT00951886|Spirometry|spirometry
698995|NCT00964106|midazolam|midazolam
698249|NCT00951886|Respiratory rare diseases|respiratory rare diseases
698250|NCT00951899|Incretins|incretins
698251|NCT00951899|colesevelam|colesevelam
698252|NCT00951899|hepatobiliary circulation|hepatobiliary circulation
698253|NCT00951912|genistein|genistein
698254|NCT00951912|daidzein|daidzein
698255|NCT00951912|impaired glucose regulation|impaired glucose regulation
698256|NCT00951912|glucose metabolism|glucose metabolism
698257|NCT00951912|lipids metabolism|lipids metabolism
698258|NCT00951912|inflammation|inflammation
698259|NCT00951912|women|women
698260|NCT00951925|Any patient undergoing diagnostic bone marrow biopsies|any patient undergoing diagnostic bone marrow biopsies
698261|NCT00951925|Any patient undergoing bone marrow harvesting for autologous bone marrow transplantation.|any patient undergoing bone marrow harvesting for autologous bone marrow transplantation.
698262|NCT00951938|Trinity Evolution|trinity evolution
698263|NCT00951938|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
698264|NCT00951938|Allograft|allograft
698265|NCT00951977|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
698266|NCT00951977|Transplantation|transplantation
698267|NCT00951977|Living Kidney Donation|living kidney donation
698268|NCT00951977|Kidney Transplant|kidney transplant
698269|NCT00952003|Avastin|avastin
698270|NCT00952003|Campto|campto
698271|NCT00952003|Oxaliplatin|oxaliplatin
698272|NCT00952003|Taxotere|taxotere
698273|NCT00952016|colorectal cancer|colorectal cancer
698274|NCT00952016|MSH2|msh2
698275|NCT00952016|metastatic|metastatic
698276|NCT00952029|stage IV colon cancer|stage iv colon cancer
698277|NCT00952029|stage IV rectal cancer|stage iv rectal cancer
698278|NCT00952042|Tendinopathy, Achilles, Eccentric training, Heavy slow resistance training|tendinopathy, achilles, eccentric training, heavy slow resistance training
698279|NCT00952055|neopterin|neopterin
698280|NCT00952055|macrophage|macrophage
698281|NCT00952055|inflammation|inflammation
698282|NCT00952068|Back Pain|back pain
698283|NCT00952081|Hypertension|hypertension
698284|NCT00952081|Neurosurgery|neurosurgery
698285|NCT00952081|bloodpressure control|bloodpressure control
698286|NCT00952081|brain tumor resection|brain tumor resection
698287|NCT00952081|epilepsy focus resection|epilepsy focus resection
698288|NCT00952094|Healthy volunteer|healthy volunteer
698289|NCT00952107|breast cancer|breast cancer
698290|NCT00952107|breast reconstructive surgery|breast reconstructive surgery
698291|NCT00952107|flap assessment|flap assessment
698292|NCT00952120|Wound healing|wound healing
698293|NCT00952120|Negative pressure wound therapy|negative pressure wound therapy
698294|NCT00952120|Skin graft|skin graft
698295|NCT00952133|PONV|ponv
698296|NCT00952133|Outpatient surgery|outpatient surgery
698297|NCT00952133|Laparoscopic abdominal surgery|laparoscopic abdominal surgery
698298|NCT00952133|Laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
698299|NCT00952146|NOTES|notes
698300|NCT00952146|Transgastric|transgastric
698301|NCT00952146|Appendectomy|appendectomy
698302|NCT00952146|Safety|safety
698303|NCT00952146|Feasibility|feasibility
698304|NCT00952159|tramadol|tramadol
698305|NCT00952159|CYP2D6|cyp2d6
698306|NCT00952159|O-demethyl-tramadol|o-demethyl-tramadol
698307|NCT00952159|poor metabolizer|poor metabolizer
698308|NCT00952159|genotyping|genotyping
698309|NCT00952159|phenotyping|phenotyping
698310|NCT00952172|Stair stepping training|stair stepping training
698311|NCT00952172|OSAS|osas
698312|NCT00952172|cardiopulmonary fitness|cardiopulmonary fitness
698313|NCT00952172|sleep disturbance|sleep disturbance
698314|NCT00952172|Actigraphy|actigraphy
698315|NCT00952185|viral infection|viral infection
698316|NCT00952185|aplastic anemia|aplastic anemia
698317|NCT00952185|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
698318|NCT00952185|acute undifferentiated leukemia|acute undifferentiated leukemia
698319|NCT00952185|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
698320|NCT00952185|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
698321|NCT00952185|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
698322|NCT00952185|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
698323|NCT00952185|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
698324|NCT00952185|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
698325|NCT00952185|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
698326|NCT00952185|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
698546|NCT00958841|Pituitary NETs|pituitary nets
698327|NCT00952185|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
698328|NCT00952185|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
698329|NCT00952185|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
698330|NCT00952185|mast cell leukemia|mast cell leukemia
698331|NCT00952185|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
698332|NCT00952185|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
698333|NCT00952185|prolymphocytic leukemia|prolymphocytic leukemia
698334|NCT00952185|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
698335|NCT00952185|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
698336|NCT00952185|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
698337|NCT00952185|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
698338|NCT00952185|refractory hairy cell leukemia|refractory hairy cell leukemia
698339|NCT00952185|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
698340|NCT00952185|secondary acute myeloid leukemia|secondary acute myeloid leukemia
698341|NCT00952185|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
698342|NCT00952185|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
698343|NCT00952185|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
698344|NCT00952185|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
698345|NCT00952185|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
698346|NCT00952185|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
698347|NCT00952185|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
698348|NCT00952185|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
698349|NCT00952185|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
698350|NCT00952185|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
698351|NCT00952185|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
698352|NCT00952185|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
698353|NCT00952185|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
698354|NCT00952185|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
698355|NCT00952185|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
698356|NCT00952185|anaplastic large cell lymphoma|anaplastic large cell lymphoma
698357|NCT00952185|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
698358|NCT00952185|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
698359|NCT00952185|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
698360|NCT00952185|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
698361|NCT00952185|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
698362|NCT00952185|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
698363|NCT00952185|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
698364|NCT00952185|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
698365|NCT00952185|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
698366|NCT00952185|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
698367|NCT00952185|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
698368|NCT00952185|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
698369|NCT00952185|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
698370|NCT00952185|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
698371|NCT00952185|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
698372|NCT00952185|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
698373|NCT00952185|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
698374|NCT00952185|splenic marginal zone lymphoma|splenic marginal zone lymphoma
698375|NCT00952185|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
698376|NCT00952185|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
698377|NCT00952185|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
698378|NCT00952185|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
698379|NCT00952185|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
698380|NCT00952185|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
698381|NCT00952185|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
698382|NCT00952185|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
698383|NCT00952185|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
698384|NCT00952185|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
698385|NCT00952185|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
698386|NCT00952185|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
698387|NCT00952185|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
698388|NCT00952185|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
698389|NCT00952185|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
698390|NCT00952185|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
698391|NCT00952185|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
698392|NCT00952185|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
698393|NCT00952185|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
698394|NCT00952185|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
698395|NCT00952185|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
698396|NCT00952185|stage I mantle cell lymphoma|stage i mantle cell lymphoma
698397|NCT00952185|stage I marginal zone lymphoma|stage i marginal zone lymphoma
698398|NCT00952185|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
698399|NCT00952185|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
698400|NCT00952185|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
698401|NCT00952185|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
698402|NCT00952185|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
698403|NCT00952185|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
698404|NCT00952185|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
698405|NCT00952185|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
698406|NCT00952185|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
698407|NCT00952185|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
698408|NCT00952185|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
698409|NCT00952185|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
698410|NCT00952185|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
698411|NCT00952185|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
698412|NCT00952185|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
698413|NCT00952185|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
698414|NCT00952185|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
698415|NCT00952185|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
698416|NCT00952185|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
698417|NCT00952185|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
698418|NCT00952185|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
698419|NCT00952185|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
698420|NCT00952185|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
698421|NCT00952185|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
698422|NCT00952185|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
698423|NCT00952185|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
698424|NCT00952185|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
698425|NCT00952185|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
698426|NCT00952185|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
698427|NCT00952185|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
698428|NCT00952185|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
698429|NCT00952185|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
698430|NCT00952185|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
698431|NCT00952185|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
698432|NCT00952185|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
698433|NCT00952185|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
698434|NCT00952185|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
698435|NCT00952185|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
698520|NCT00958685|enteral feeding|enteral feeding
698436|NCT00952185|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
698437|NCT00952185|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
698438|NCT00952185|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
698439|NCT00952185|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
698440|NCT00952185|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
698441|NCT00952185|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
698442|NCT00952185|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
698443|NCT00952185|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
698444|NCT00952185|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
698445|NCT00952185|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
698446|NCT00952185|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
698447|NCT00952185|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
698448|NCT00952185|intraocular lymphoma|intraocular lymphoma
698449|NCT00952185|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
698450|NCT00952185|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
698547|NCT00958841|EAS Tumors|eas tumors
698451|NCT00952185|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
698452|NCT00952185|chronic eosinophilic leukemia|chronic eosinophilic leukemia
698453|NCT00952185|chronic neutrophilic leukemia|chronic neutrophilic leukemia
698454|NCT00952185|primary myelofibrosis|primary myelofibrosis
698455|NCT00952185|essential thrombocythemia|essential thrombocythemia
698456|NCT00952185|polycythemia vera|polycythemia vera
698457|NCT00952185|extramedullary plasmacytoma|extramedullary plasmacytoma
698458|NCT00952185|isolated plasmacytoma of bone|isolated plasmacytoma of bone
698459|NCT00952185|stage I multiple myeloma|stage i multiple myeloma
698460|NCT00952185|stage II multiple myeloma|stage ii multiple myeloma
698461|NCT00952185|stage III multiple myeloma|stage iii multiple myeloma
698462|NCT00952185|primary systemic amyloidosis|primary systemic amyloidosis
698463|NCT00952185|refractory multiple myeloma|refractory multiple myeloma
698464|NCT00952185|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
698465|NCT00952185|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
698466|NCT00952185|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
698467|NCT00952185|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
698468|NCT00952211|stroke|stroke
698469|NCT00952211|obstructive sleep apnea|obstructive sleep apnea
698470|NCT00952211|fatigue|fatigue
698471|NCT00952211|quality of life|quality of life
698472|NCT00952224|myocardial salvage|myocardial salvage
698473|NCT00952224|cardiovascular magnetic resonance|cardiovascular magnetic resonance
698474|NCT00952224|magnetic resonance imaging|magnetic resonance imaging
698475|NCT00952224|myocardial infarction|myocardial infarction
698476|NCT00952224|prognosis|prognosis
698477|NCT00952237|Autologous Peripheral Blood Stem Cell Transplant|autologous peripheral blood stem cell transplant
698478|NCT00952237|IL-2|il-2
698479|NCT00952237|GM-CSF|gm-csf
698480|NCT00952250|quality improvement|quality improvement
698481|NCT00952263|Hepatitis C|hepatitis c
698482|NCT00952263|Phase I|phase i
698483|NCT00952263|Infusion|infusion
698484|NCT00952263|Pharmacokinetics|pharmacokinetics
698485|NCT00952263|MBL-HCV1|mbl-hcv1
698486|NCT00952263|Monoclonal antibody|monoclonal antibody
698487|NCT00952263|Safety Assessment|safety assessment
698488|NCT00952276|Influenza Pandemic Flu Swine-origin A/H1N1 Influenza Adults|influenza pandemic flu swine-origin a/h1n1 influenza adults
698489|NCT00952289|Myelofibrosis|myelofibrosis
698490|NCT00952289|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
698491|NCT00952289|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
698492|NCT00952302|Hypoxia|hypoxia
698493|NCT00952302|Iron|iron
698494|NCT00952302|Hypoxia-Inducible Factor 1|hypoxia-inducible factor 1
698495|NCT00952302|Chronic mountain sickness|chronic mountain sickness
698496|NCT00952315|kidney stones|kidney stones
698497|NCT00952315|intracorporeal lithotriptors|intracorporeal lithotriptors
698498|NCT00952315|kidney stone removal|kidney stone removal
698499|NCT00952328|breastfeeding outcomes|breastfeeding outcomes
698500|NCT00952328|breastfeeding self-efficacy|breastfeeding self-efficacy
698501|NCT00952328|infant weight loss|infant weight loss
698502|NCT00952341|CINV|cinv
698503|NCT00952354|Down syndrome|down syndrome
698505|NCT00952354|language development|language development
698506|NCT00952354|language assessment|language assessment
698507|NCT00958607|Caregivers|caregivers
698508|NCT00958607|Stroke|stroke
698509|NCT00958607|Social support|social support
698510|NCT00958607|Phase specific care|phase specific care
698511|NCT00958620|Chronic Achilles Tendinopathy|chronic achilles tendinopathy
698512|NCT00958633|Bipolar I disorder|bipolar i disorder
698513|NCT00958633|Depression|depression
698514|NCT00958633|Antidepressant|antidepressant
698515|NCT00958646|OMT|omt
698516|NCT00958646|biomarker|biomarker
698517|NCT00958646|Manipulation, osteopathic|manipulation, osteopathic
698518|NCT00958685|ginger extract|ginger extract
698519|NCT00958685|ARDS|ards
698521|NCT00958685|mechanical ventilation|mechanical ventilation
698522|NCT00958685|ICU|icu
698523|NCT00958724|HKI-272|hki-272
698524|NCT00958724|Vinorelbine|vinorelbine
698525|NCT00958724|Combination|combination
698526|NCT00958724|Solid Tumor|solid tumor
698527|NCT00958737|stage III colon cancer|stage iii colon cancer
698528|NCT00958737|adenocarcinoma of the colon|adenocarcinoma of the colon
698529|NCT00958750|Androgenetic alopecia|androgenetic alopecia
698530|NCT00958750|female pattern hair loss|female pattern hair loss
698531|NCT00958763|HCV|hcv
698532|NCT00958763|Alcohol|alcohol
698533|NCT00958763|Methadone Maintained|methadone maintained
698534|NCT00958776|Influenza|influenza
698535|NCT00958776|Hospitalized|hospitalized
698536|NCT00958776|Antiviral|antiviral
698537|NCT00958776|Flu|flu
698538|NCT00958802|tissue engineering|tissue engineering
698539|NCT00958815|vascular imaging|vascular imaging
698540|NCT00958815|diabetes|diabetes
698541|NCT00958815|rupture prone plaques|rupture prone plaques
698542|NCT00958815|HIV|hiv
698543|NCT00958815|treatment experienced|treatment experienced
698544|NCT00958841|Rare tumors of neuroendocrine origin|rare tumors of neuroendocrine origin
698545|NCT00958841|NETs of the pancreatic|nets of the pancreatic
698548|NCT00958841|Nelson's Syndrome|nelson's syndrome
698549|NCT00958841|Pancreatic neoplasm|pancreatic neoplasm
698550|NCT00958841|pituitary neoplasm|pituitary neoplasm
698551|NCT00958841|Nelson Syndrome|nelson syndrome
698552|NCT00958841|ectopic ACTH syndrome|ectopic acth syndrome
698553|NCT00958841|pasireotide LAR|pasireotide lar
698554|NCT00958841|PNETs|pnets
698555|NCT00958841|PiNETS|pinets
698556|NCT00958854|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
698557|NCT00958867|Resistance exercise training|resistance exercise training
698558|NCT00958867|aerobic exercise training|aerobic exercise training
698559|NCT00958893|Uterine fibroids|uterine fibroids
698560|NCT00962728|heart rate|heart rate
698561|NCT00962728|tachycardia|tachycardia
698562|NCT00962728|orthostatic intolerance|orthostatic intolerance
698563|NCT00962754|recording fluid balance|recording fluid balance
698564|NCT00962754|reliability|reliability
698565|NCT00962754|utility|utility
698566|NCT00962754|sick neonate|sick neonate
698567|NCT00962754|fluid balance|fluid balance
698568|NCT00962754|inpatient|inpatient
698569|NCT00962754|sick|sick
698570|NCT00962767|Oncology comparison study|oncology comparison study
698571|NCT00962780|vaccine|vaccine
698572|NCT00962780|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
698573|NCT00962780|23-valent pneumococcal polysaccharide vaccine|23-valent pneumococcal polysaccharide vaccine
698574|NCT00962780|human immunodeficiency virus|human immunodeficiency virus
698575|NCT00962793|latent tuberculosis prevalence of health care workers|latent tuberculosis prevalence of health care workers
698576|NCT00962806|Pediatric obesity|pediatric obesity
698577|NCT00962806|Insulin resistance|insulin resistance
698578|NCT00962806|Diabetes|diabetes
698579|NCT00962806|Mitochondria|mitochondria
698580|NCT00962819|Mumps|mumps
698581|NCT00962819|Immunity|immunity
698582|NCT00962819|Vaccine|vaccine
698583|NCT00962819|Mumps antibodies|mumps antibodies
698584|NCT00962819|Mumps immunity|mumps immunity
698585|NCT00962832|rhuMAb IFNalpha|rhumab ifnalpha
698586|NCT00962832|SLE|sle
698587|NCT00962845|stage III melanoma|stage iii melanoma
698588|NCT00962845|stage IV melanoma|stage iv melanoma
698589|NCT00962884|Orthostatic hypotension|orthostatic hypotension
698590|NCT00962884|Breathing|breathing
698591|NCT00962884|Blood pressure|blood pressure
698592|NCT00962884|standing|standing
698593|NCT00962897|atherosclerosis|atherosclerosis
698594|NCT00962897|covered stent|covered stent
698595|NCT00962897|percutaneous intervention|percutaneous intervention
698596|NCT00962897|stent|stent
698597|NCT00962897|angioplasty|angioplasty
698598|NCT00962910|Femoral Fractures|femoral fractures
698599|NCT00962910|Critical Pathway|critical pathway
698600|NCT00962910|Cluster Randomized Controlled Trial|cluster randomized controlled trial
698601|NCT00962910|Safety|safety
698602|NCT00962910|Efficiency|efficiency
698603|NCT00962923|Systemic sclerosis|systemic sclerosis
698604|NCT00962923|Mesenchymal Stem Cells|mesenchymal stem cells
698605|NCT00962923|Transplantation|transplantation
698606|NCT00962936|Chronic Hepatitis C|chronic hepatitis c
698607|NCT00962936|HCV Genotype I infection|hcv genotype i infection
698608|NCT00962936|Liver disease|liver disease
698609|NCT00962949|POTS|pots
698610|NCT00962949|Orthostatic intolerance|orthostatic intolerance
698611|NCT00962962|Abnormal fasting glucose|abnormal fasting glucose
698612|NCT00962988|Cerebrovascular disease|cerebrovascular disease
698613|NCT00962988|stroke|stroke
698614|NCT00962988|Transient Ischemic Attack|transient ischemic attack
698615|NCT00962988|smoking cessation|smoking cessation
698616|NCT00962988|Pharmacotherapy|pharmacotherapy
698617|NCT00963001|Hypertension, Pulmonary|hypertension, pulmonary
698618|NCT00963001|Treprostinil|treprostinil
698619|NCT00963001|Pharmacokinetics|pharmacokinetics
698620|NCT00963001|Treprostinil Diethanolamine|treprostinil diethanolamine
698621|NCT00963001|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
698622|NCT00963027|Hypertension, Pulmonary|hypertension, pulmonary
698623|NCT00963027|Treprostinil|treprostinil
698624|NCT00963027|Pharmacokinetics|pharmacokinetics
698625|NCT00963027|Treprostinil Diethanolamine|treprostinil diethanolamine
698626|NCT00963027|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
698627|NCT00963027|Esomeprazole|esomeprazole
698628|NCT00963040|intranasal oxytocin|intranasal oxytocin
698629|NCT00963040|acute headache treatment|acute headache treatment
698630|NCT00963040|chronic daily headache|chronic daily headache
698631|NCT00963053|dysmenorrhoea|dysmenorrhoea
698632|NCT00963053|dysmenorrhea|dysmenorrhea
698633|NCT00963053|pain|pain
698634|NCT00963053|pre-emptive|pre-emptive
698635|NCT00963066|NAVA|nava
698636|NCT00963066|Acute Lung Injury|acute lung injury
698637|NCT00963066|Pressure Support Ventilation|pressure support ventilation
698638|NCT00963066|Intubation|intubation
698639|NCT00963066|Tracheostomy|tracheostomy
698640|NCT00963066|Mechanical ventilation|mechanical ventilation
698641|NCT00963079|IVF|ivf
698642|NCT00963079|in vitro fertilization|in vitro fertilization
698643|NCT00963079|blastocyst transfer|blastocyst transfer
698644|NCT00963079|endometrial receptivity|endometrial receptivity
698645|NCT00963079|embryo cryopreservation|embryo cryopreservation
698646|NCT00963092|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
698647|NCT00963092|recurrent gastric cancer|recurrent gastric cancer
698648|NCT00963092|stage IV gastric cancer|stage iv gastric cancer
698649|NCT00963092|adenocarcinoma of the stomach|adenocarcinoma of the stomach
698650|NCT00963092|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
698651|NCT00963092|recurrent esophageal cancer|recurrent esophageal cancer
698652|NCT00963092|stage I esophageal cancer|stage i esophageal cancer
698653|NCT00963092|stage II esophageal cancer|stage ii esophageal cancer
698654|NCT00963092|stage III esophageal cancer|stage iii esophageal cancer
698655|NCT00963092|stage IV esophageal cancer|stage iv esophageal cancer
698656|NCT00963092|stage IA gastric cancer|stage ia gastric cancer
698657|NCT00963092|stage IB gastric cancer|stage ib gastric cancer
698658|NCT00963092|stage IIA gastric cancer|stage iia gastric cancer
698659|NCT00963092|stage IIB gastric cancer|stage iib gastric cancer
698660|NCT00963092|stage IIIA gastric cancer|stage iiia gastric cancer
698661|NCT00963092|stage IIIB gastric cancer|stage iiib gastric cancer
698662|NCT00963092|stage IIIC gastric cancer|stage iiic gastric cancer
698663|NCT00963118|Angelica keiskei|angelica keiskei
698664|NCT00963118|Glycine max|glycine max
698665|NCT00963118|metabolic syndrome|metabolic syndrome
698666|NCT00963131|Central serous chorioretinopathy,antioxidants|central serous chorioretinopathy,antioxidants
698667|NCT00963144|Gerd Questionnaire|gerd questionnaire
698668|NCT00963157|H1N1, influenza A viruses, vaccine, elderly|h1n1, influenza a viruses, vaccine, elderly
698669|NCT00963183|Safety|safety
698670|NCT00963183|Tolerability|tolerability
698671|NCT00963183|Healthy|healthy
698672|NCT00963183|Inhalation|inhalation
698673|NCT00963209|endocrine sensitive|endocrine sensitive
698674|NCT00963209|breast cancer|breast cancer
698675|NCT00963209|tamoxifen|tamoxifen
698676|NCT00963209|genotyping|genotyping
698677|NCT00963209|phenotyping|phenotyping
698678|NCT00963209|Pharmacokinetics|pharmacokinetics
698679|NCT00963209|Endoxifen|endoxifen
698680|NCT00963222|Atherosclerosis|atherosclerosis
698681|NCT00963222|Coronary Artery Disease|coronary artery disease
698682|NCT00963222|Vitamin A|vitamin a
698683|NCT00963222|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
698684|NCT00963222|Th1 Cells|th1 cells
698685|NCT00963222|Th2 Cells|th2 cells
698686|NCT00963235|vaccine|vaccine
698687|NCT00963235|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
698688|NCT00963235|human immunodeficiency virus|human immunodeficiency virus
698689|NCT00963248|EBV|ebv
698690|NCT00963248|PTLD|ptld
698691|NCT00963248|RTx|rtx
698692|NCT00963248|pediatric|pediatric
698693|NCT00963261|melanoma|melanoma
698694|NCT00963261|interferon-a|interferon-a
698695|NCT00963261|quality of life|quality of life
698696|NCT00963261|psychological distress|psychological distress
698697|NCT00963261|depressive symptoms|depressive symptoms
698698|NCT00963261|side effects|side effects
698699|NCT00963274|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
698700|NCT00963274|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
698701|NCT00963274|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
698702|NCT00963274|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
698703|NCT00963274|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
698704|NCT00963274|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
698705|NCT00963274|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
698706|NCT00963274|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
698707|NCT00963274|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
698708|NCT00963274|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
698709|NCT00963274|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
698959|NCT00964002|recurrent prostate cancer|recurrent prostate cancer
698710|NCT00963274|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
698711|NCT00963274|anaplastic large cell lymphoma|anaplastic large cell lymphoma
698712|NCT00963274|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
698713|NCT00963274|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
698714|NCT00963274|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
698715|NCT00963274|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
698716|NCT00963274|peripheral T-cell lymphoma|peripheral t-cell lymphoma
698717|NCT00963287|alternative medicine|alternative medicine
698718|NCT00963287|traditional Chinese medicine|traditional chinese medicine
698719|NCT00963300|adenocarcinoma of the prostate|adenocarcinoma of the prostate
698720|NCT00963300|stage I prostate cancer|stage i prostate cancer
698721|NCT00963300|stage IIB prostate cancer|stage iib prostate cancer
698722|NCT00963300|stage IIA prostate cancer|stage iia prostate cancer
698723|NCT00963300|stage III prostate cancer|stage iii prostate cancer
698724|NCT00963300|stage IV prostate cancer|stage iv prostate cancer
698725|NCT00963313|Axial psoriatic arthritis|axial psoriatic arthritis
698726|NCT00963313|Adalimumab|adalimumab
698727|NCT00963313|Humira|humira
698728|NCT00963313|anti-TNF|anti-tnf
698800|NCT00963482|Outcome|outcome
698729|NCT00963326|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
698730|NCT00963326|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
698731|NCT00963326|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
698732|NCT00963326|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
698733|NCT00963326|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
698734|NCT00963326|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
698996|NCT00964106|inhibitor|inhibitor
698735|NCT00963326|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
698736|NCT00963326|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
698737|NCT00963326|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
698738|NCT00963326|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
698739|NCT00963326|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
698740|NCT00963326|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
698741|NCT00963326|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
698742|NCT00963326|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
698743|NCT00963326|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
698744|NCT00963326|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
698745|NCT00963326|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
698746|NCT00963326|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
698747|NCT00963326|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
698748|NCT00963326|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
698749|NCT00963326|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
698750|NCT00963326|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
698751|NCT00963326|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
698752|NCT00963326|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
698753|NCT00963326|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
698754|NCT00963326|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
698755|NCT00963326|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
698756|NCT00963326|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
698757|NCT00963326|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
698758|NCT00963326|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
698759|NCT00963326|tongue cancer|tongue cancer
698760|NCT00963339|AMD|amd
698761|NCT00963352|Colon cancer|colon cancer
698762|NCT00963352|Open surgery resection|open surgery resection
698763|NCT00963352|Laparoscopic surgery resection|laparoscopic surgery resection
698764|NCT00963352|Morbidity|morbidity
698765|NCT00963352|Mortality|mortality
698766|NCT00963352|Metastases|metastases
698767|NCT00963352|Oncology|oncology
698768|NCT00963352|Freedom of malignant disease recurrence|freedom of malignant disease recurrence
698769|NCT00963352|Safety of intervention open and laparoscopic|safety of intervention open and laparoscopic
698770|NCT00963352|Examination of adverse markers|examination of adverse markers
698771|NCT00963352|Development of metastases in lungs and other organs|development of metastases in lungs and other organs
698772|NCT00963365|Phase 1|phase 1
698773|NCT00963365|Healthy volunteers|healthy volunteers
698774|NCT00963391|Health Production|health production
698775|NCT00963391|Government Policy; Regulation; Public Health|government policy; regulation; public health
698776|NCT00963391|Government Policy; Provision and Effects of Welfare Programs|government policy; provision and effects of welfare programs
698777|NCT00963391|Gastrointestinal diseases|gastrointestinal diseases
698778|NCT00963391|Respiratory Tract Infections|respiratory tract infections
698779|NCT00963391|Diarrhea|diarrhea
698780|NCT00963391|Ethanol|ethanol
698781|NCT00963391|Child, Preschool|child, preschool
698782|NCT00963391|Handwashing|handwashing
698783|NCT00963404|Image-guided Radiotherapy|image-guided radiotherapy
698784|NCT00963404|Fiducial marker|fiducial marker
698785|NCT00963404|Adverse effects|adverse effects
698786|NCT00963417|osteoporosis|osteoporosis
698787|NCT00963417|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
698788|NCT00963417|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
698789|NCT00963417|stage IA breast cancer|stage ia breast cancer
698790|NCT00963417|stage IB breast cancer|stage ib breast cancer
698791|NCT00963417|stage II breast cancer|stage ii breast cancer
698792|NCT00963417|stage IIIA breast cancer|stage iiia breast cancer
698793|NCT00963430|H1N1, influenza A viruses, pregnant women|h1n1, influenza a viruses, pregnant women
698794|NCT00963443|Aspirin Complex|aspirin complex
698795|NCT00963443|Acetylsalicylic Acid|acetylsalicylic acid
698796|NCT00963443|Pseudoephedrine|pseudoephedrine
698797|NCT00963443|Common Cold|common cold
698798|NCT00963482|Smoking|smoking
698799|NCT00963482|Alcohol|alcohol
698801|NCT00963482|Harm reduction|harm reduction
698802|NCT00963482|Alcohol drinking|alcohol drinking
698803|NCT00963482|Treatment outcome|treatment outcome
698804|NCT00963482|Treatment effectiveness|treatment effectiveness
698805|NCT00963495|clioquinol|clioquinol
698806|NCT00963495|relapsed and refractory hematologic malignancy|relapsed and refractory hematologic malignancy
698807|NCT00963495|ALL|all
698808|NCT00963495|HD|hd
698809|NCT00963495|CLL|cll
698810|NCT00963495|High risk myelodysplasia (MDS) with an IPSS score >2.5|high risk myelodysplasia (mds) with an ipss score >2.5
698811|NCT00963495|CML blast crisis|cml blast crisis
698812|NCT00963495|Relapsed or refractory acute myeloid leukemia (AML)|relapsed or refractory acute myeloid leukemia (aml)
698813|NCT00963508|Head Lice|head lice
698814|NCT00963521|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
698815|NCT00963521|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
698816|NCT00963521|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
698817|NCT00963521|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
698818|NCT00963521|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
698819|NCT00963521|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
698820|NCT00963521|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
698821|NCT00963534|Mantle cell lymphoma|mantle cell lymphoma
698822|NCT00963534|Lenalidomide|lenalidomide
698823|NCT00963534|Bendamustine|bendamustine
698824|NCT00963534|Rituximab|rituximab
698825|NCT00963534|Nordic Lymphoma Group|nordic lymphoma group
698826|NCT00963534|MTD for lenalidomide|mtd for lenalidomide
698827|NCT00963534|Untreated patients|untreated patients
698828|NCT00963534|Patients with mantle cell lymphoma, age over 65 years|patients with mantle cell lymphoma, age over 65 years
698829|NCT00963547|Documented to be HER2+|documented to be her2+
698830|NCT00963560|ReSTOR +3|restor +3
698831|NCT00963612|Microvascular Invasion|microvascular invasion
698832|NCT00963612|Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI)|blood-oxygen-level dependent magnetic resonance imaging (bold mri)
698833|NCT00963625|Blastocyst transfer|blastocyst transfer
698834|NCT00963625|endometrial receptivity|endometrial receptivity
698835|NCT00963625|IVF|ivf
698836|NCT00963625|in vitro fertilization|in vitro fertilization
698837|NCT00963625|embryo cryopreservation|embryo cryopreservation
698838|NCT00963651|Pulmonary nodule, solitary|pulmonary nodule, solitary
698839|NCT00963651|Multiple pulmonary nodules|multiple pulmonary nodules
698840|NCT00963664|melanoma|melanoma
698841|NCT00963664|malignant melanoma|malignant melanoma
698842|NCT00963664|interferon|interferon
698843|NCT00963664|interferon alfa-2b|interferon alfa-2b
698844|NCT00963664|Intron-A|intron-a
698845|NCT00963664|Intron A|intron a
698846|NCT00963664|Intron|intron
698847|NCT00963664|lovastatin|lovastatin
698848|NCT00963664|mevinolin|mevinolin
698849|NCT00963664|Mevacor|mevacor
698850|NCT00963664|statin|statin
698851|NCT00963664|HRI|hri
698852|NCT00963677|Shikani optical stylet(SOS)|shikani optical stylet(sos)
698853|NCT00963677|difficult airways|difficult airways
698854|NCT00963677|intubation|intubation
698855|NCT00963716|endobronchial biopsy|endobronchial biopsy
698856|NCT00963716|bronchoscopy|bronchoscopy
698857|NCT00963716|interventional pulmonology|interventional pulmonology
698858|NCT00963729|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
698859|NCT00963729|recurrent breast cancer|recurrent breast cancer
698860|NCT00963729|stage II breast cancer|stage ii breast cancer
698861|NCT00963729|stage IIIA breast cancer|stage iiia breast cancer
698862|NCT00963729|stage IIIB breast cancer|stage iiib breast cancer
698863|NCT00963729|stage IIIC breast cancer|stage iiic breast cancer
698864|NCT00963742|cataract surgery|cataract surgery
698865|NCT00963742|IOL|iol
698866|NCT00963742|Intraocular lens|intraocular lens
698867|NCT00963755|Imaging|imaging
698868|NCT00963755|Positron emission tomography|positron emission tomography
698869|NCT00963755|F-18-FCH|f-18-fch
698870|NCT00963755|Magnetic resonance imaging|magnetic resonance imaging
698871|NCT00963755|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
698872|NCT00963768|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
698873|NCT00963768|JNJ-28431754|jnj-28431754
698874|NCT00963768|Canagliflozin|canagliflozin
752878|NCT01174576|cortisol|cortisol
698875|NCT00963768|Sodium Glucose Co-transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
698876|NCT00963768|Pharmacokinetics|pharmacokinetics
698877|NCT00963768|Pharmacodynamics|pharmacodynamics
698878|NCT00963781|Coronary Artery Disease|coronary artery disease
698879|NCT00963781|Drug-Eluting Stents|drug-eluting stents
698880|NCT00963781|Coronary Thrombosis|coronary thrombosis
698881|NCT00963781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
698882|NCT00963781|Coronary Restenosis|coronary restenosis
698883|NCT00963794|Rectal cancer|rectal cancer
698884|NCT00963794|Population screening|population screening
698885|NCT00963794|Early detection|early detection
698886|NCT00963820|Relapsed multiple myeloma|relapsed multiple myeloma
698887|NCT00963820|Refractory multiple myeloma|refractory multiple myeloma
698888|NCT00963820|Drug therapy|drug therapy
698889|NCT00963833|Multiple Sclerosis|multiple sclerosis
698891|NCT00963833|Non-interventional|non-interventional
698892|NCT00963846|schizophrenia|schizophrenia
698893|NCT00963846|cognition|cognition
698894|NCT00963846|functioning|functioning
698895|NCT00963859|Robotic-assisted laparoscopic surgery|robotic-assisted laparoscopic surgery
698896|NCT00963859|Extended pelvic lymph node dissection|extended pelvic lymph node dissection
698897|NCT00963859|RA-PLND|ra-plnd
698898|NCT00963859|Second-look open lymph node dissection|second-look open lymph node dissection
698899|NCT00963859|O-PLND|o-plnd
698900|NCT00963859|Radical Cystectomy|radical cystectomy
698901|NCT00963859|Urinary diversion|urinary diversion
698903|NCT00963898|Intravenous sedation|intravenous sedation
698904|NCT00963898|Target controlled infusion|target controlled infusion
698905|NCT00963898|Bispectral index|bispectral index
698906|NCT00963898|Dental treatment|dental treatment
698907|NCT00963898|Mental Retardation|mental retardation
698908|NCT00963898|Deep sedation|deep sedation
698909|NCT00963911|colon cancer|colon cancer
698910|NCT00963911|rectal cancer|rectal cancer
698911|NCT00963911|non-small cell lung cancer|non-small cell lung cancer
698912|NCT00963911|small cell lung cancer|small cell lung cancer
698913|NCT00963911|hypopharyngeal squamous cell carcinoma|hypopharyngeal squamous cell carcinoma
698914|NCT00963911|laryngeal squamous cell carcinoma|laryngeal squamous cell carcinoma
698915|NCT00963911|laryngeal verrucous carcinoma|laryngeal verrucous carcinoma
698916|NCT00963911|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
698917|NCT00963911|oral cavity verrucous carcinoma|oral cavity verrucous carcinoma
698918|NCT00963911|nasopharyngeal squamous cell carcinoma|nasopharyngeal squamous cell carcinoma
698919|NCT00963911|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
698920|NCT00963911|paranasal sinus and nasal cavity squamous cell carcinoma|paranasal sinus and nasal cavity squamous cell carcinoma
698921|NCT00963911|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
698922|NCT00963911|prostate cancer|prostate cancer
698923|NCT00963911|breast cancer|breast cancer
698924|NCT00963911|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
698925|NCT00963924|Cognitive Impairment|cognitive impairment
698926|NCT00963924|Neuroplasticity|neuroplasticity
698927|NCT00963924|D-cycloserine|d-cycloserine
698928|NCT00963924|NMDA|nmda
698929|NCT00963924|Anti-Bacterial Agents|anti-bacterial agents
698930|NCT00963924|Mental Disorders|mental disorders
698931|NCT00963924|Psychotic Disorders|psychotic disorders
698932|NCT00963924|Antitubercular Agents|antitubercular agents
698933|NCT00963924|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
698934|NCT00963924|Schizoaffective Disorder|schizoaffective disorder
698935|NCT00963937|adolescent|adolescent
698936|NCT00963937|sumatriptan|sumatriptan
698937|NCT00963937|children|children
698938|NCT00963937|migraine|migraine
698939|NCT00963950|cholecystectomy|cholecystectomy
698940|NCT00963963|sexual health|sexual health
698941|NCT00963963|adolescent health|adolescent health
698942|NCT00963963|parent education|parent education
698943|NCT00963963|HIV Seronegativity|hiv seronegativity
698944|NCT00963963|treatment experienced|treatment experienced
698945|NCT00963976|Stroke|stroke
698946|NCT00963976|Hypertension|hypertension
698947|NCT00963976|Cerebral Blood Flow|cerebral blood flow
698948|NCT00963976|CT Perfusion|ct perfusion
698949|NCT00963989|Acute stroke|acute stroke
698950|NCT00963989|Large cerebral vessel occlusion|large cerebral vessel occlusion
698951|NCT00963989|Core infarct volume|core infarct volume
698952|NCT00963989|Penumbra System|penumbra system
698953|NCT00963989|Revascularization|revascularization
698954|NCT00963989|Intracerebral hemorrhage|intracerebral hemorrhage
698955|NCT00963989|mRS|mrs
698956|NCT00963989|NIHSS|nihss
698957|NCT00963989|Procedural serious adverse events|procedural serious adverse events
698958|NCT00963989|All cause mortality|all cause mortality
698960|NCT00964002|stage IV prostate cancer|stage iv prostate cancer
698961|NCT00964015|colloid fluid|colloid fluid
698962|NCT00964015|crystalloid fluid|crystalloid fluid
698963|NCT00964015|surgery|surgery
698964|NCT00964015|coronary artery bypass grafting|coronary artery bypass grafting
698965|NCT00964015|renal function|renal function
698966|NCT00964015|Patients undergoing coronary artery bypass surgery|patients undergoing coronary artery bypass surgery
698967|NCT00964028|Combined vaccine|combined vaccine
698968|NCT00964041|Cognitive Impairment|cognitive impairment
698969|NCT00964041|Neuroplasticity|neuroplasticity
698970|NCT00964041|D-cycloserine|d-cycloserine
698971|NCT00964041|N-methyl-D-aspartate (NMDA)|n-methyl-d-aspartate (nmda)
698972|NCT00964041|Anti-Bacterial Agents|anti-bacterial agents
698973|NCT00964041|Mental Disorders|mental disorders
698974|NCT00964041|Psychotic Disorders|psychotic disorders
698975|NCT00964041|Antitubercular Agents|antitubercular agents
698976|NCT00964041|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
698977|NCT00964041|Schizoaffective Disorder|schizoaffective disorder
698978|NCT00964054|adolescents|adolescents
698979|NCT00964054|exercise|exercise
698980|NCT00964054|depression|depression
698981|NCT00964054|dose response|dose response
698982|NCT00964054|pilot study|pilot study
698983|NCT00964067|rehabilitation outcome|rehabilitation outcome
698984|NCT00964067|cardiac patients|cardiac patients
698985|NCT00964067|exercise intensity|exercise intensity
698986|NCT00964093|premature|premature
698987|NCT00964093|infection|infection
698988|NCT00964093|central line|central line
698989|NCT00964093|very low birth weight|very low birth weight
698990|NCT00964093|silver alginate|silver alginate
698991|NCT00964093|Algidex|algidex
698992|NCT00964093|neonatal|neonatal
698993|NCT00964093|NICU|nicu
698994|NCT00964106|inducer|inducer
698997|NCT00964106|rosiglitazone|rosiglitazone
698998|NCT00964106|dextromethorphan|dextromethorphan
698999|NCT00964106|caffeine|caffeine
699000|NCT00964106|cocktail|cocktail
699001|NCT00964106|pioglitazone|pioglitazone
699002|NCT00964106|omeprazole|omeprazole
699003|NCT00964106|CYP|cyp
699004|NCT00964106|rosuvastatin|rosuvastatin
699005|NCT00964106|probe drug|probe drug
699006|NCT00964106|drug interaction|drug interaction
699007|NCT00964106|flurbiprofen|flurbiprofen
699008|NCT00964132|Non-Small Cell Lung Cancer|non-small cell lung cancer
699009|NCT00964132|NSCLC|nsclc
699010|NCT00964132|Rexinoid|rexinoid
699011|NCT00964132|NRX194204|nrx194204
699012|NCT00964132|Lung Cancer|lung cancer
699013|NCT00964132|RXR|rxr
699014|NCT00964145|Nulliparous women|nulliparous women
699015|NCT00964145|ultrasound|ultrasound
699016|NCT00964158|influenza infection|influenza infection
699017|NCT00964158|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
699018|NCT00964171|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
699019|NCT00964171|recurrent pancreatic cancer|recurrent pancreatic cancer
699020|NCT00964171|stage IV pancreatic cancer|stage iv pancreatic cancer
699021|NCT00964184|Maturity onset diabetes of the young 3 protein, human|maturity onset diabetes of the young 3 protein, human
699022|NCT00964197|FemmeJock|femmejock
699023|NCT00964197|Pelvic Organ Prolapse|pelvic organ prolapse
699024|NCT00964210|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
699025|NCT00964210|Inflammatory Bowel Disease|inflammatory bowel disease
699026|NCT00964210|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
699027|NCT00964210|Chronic Renal Disease|chronic renal disease
699028|NCT00964210|Solid Organ Transplant|solid organ transplant
699029|NCT00964223|Acne vulgaris|acne vulgaris
699030|NCT00964236|sapropterin|sapropterin
699031|NCT00964236|Kuvan|kuvan
699032|NCT00964236|cognition|cognition
699033|NCT00964236|brain|brain
699034|NCT00964262|diabetes|diabetes
699035|NCT00964262|exenatide|exenatide
699036|NCT00964262|SR exenatide|sr exenatide
699037|NCT00964262|Peptron|peptron
699038|NCT00964275|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
699039|NCT00964275|thromboembolism|thromboembolism
699040|NCT00964288|electrical hyperalgesia|electrical hyperalgesia
699041|NCT00964288|threshold tracking|threshold tracking
699042|NCT00964288|pain|pain
699043|NCT00964301|Asthma|asthma
699044|NCT00964301|Low-income|low-income
699045|NCT00964301|Quality of life|quality of life
699046|NCT00964301|Children|children
699047|NCT00964314|advanced cancer|advanced cancer
699048|NCT00964314|TCM five elements music therapy|tcm five elements music therapy
699049|NCT00964314|quality of life (QOL)|quality of life (qol)
699050|NCT00964327|TMC114-C201|tmc114-c201
699051|NCT00964327|TMC114|tmc114
699052|NCT00964327|HIV|hiv
699053|NCT00964327|darunavir|darunavir
699054|NCT00964353|coumadine|coumadine
699055|NCT00964353|genotype|genotype
699056|NCT00964353|genes|genes
699057|NCT00964353|Warfarin|warfarin
699058|NCT00964379|Intra versus extraperitoneal colostomy|intra versus extraperitoneal colostomy
699059|NCT00964444|Labor and delivery|labor and delivery
699060|NCT00964444|Vaginal delivery|vaginal delivery
699062|NCT00964457|rectum cancer|rectum cancer
699063|NCT00964457|radiation|radiation
699065|NCT00964470|Burn, donor site, skin graft, dressing, AWBAT™-D, XEROFORM™, GLUCAN II™|burn, donor site, skin graft, dressing, awbat™-d, xeroform™, glucan ii™
699066|NCT00964483|Hypertension|hypertension
699067|NCT00964496|vascular malformation|vascular malformation
699068|NCT00964496|gastrointestinal bleeding|gastrointestinal bleeding
699069|NCT00964496|thalidomide|thalidomide
699070|NCT00964522|Quality of life|quality of life
699071|NCT00964522|Breast Cancer|breast cancer
699072|NCT00964522|Nursing Care|nursing care
699073|NCT00964522|Education|education
699074|NCT00964522|Chemotherapy|chemotherapy
699075|NCT00964548|vasospasm|vasospasm
699076|NCT00964548|subarachnoid hemorrhage|subarachnoid hemorrhage
699077|NCT00964548|neurocritical care|neurocritical care
699078|NCT00964548|dantrolene|dantrolene
699079|NCT00964548|vasorelaxation|vasorelaxation
699080|NCT00964587|diabetes self management education|diabetes self management education
699081|NCT00964587|problem-solving training|problem-solving training
699082|NCT00964587|health behavior change|health behavior change
699083|NCT00964587|health literacy|health literacy
699084|NCT00964600|transversus abdominis block|transversus abdominis block
699085|NCT00964600|postoperative pain|postoperative pain
699086|NCT00964600|cesarean|cesarean
699087|NCT00964613|Pars Plana|pars plana
699088|NCT00964613|Surgical Capsulotomy|surgical capsulotomy
699089|NCT00964613|Posterior capsule opacification|posterior capsule opacification
699090|NCT00964613|visual outcome|visual outcome
699091|NCT00964613|Complications|complications
699092|NCT00964626|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
699093|NCT00964626|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
699094|NCT00964626|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
699095|NCT00964626|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
699814|NCT00966693|Decadron|decadron
699096|NCT00964626|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
699097|NCT00964626|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
699098|NCT00964626|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
699099|NCT00964626|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
699100|NCT00964626|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
699101|NCT00964626|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
699102|NCT00964639|Pain|pain
699103|NCT00964639|Postoperative|postoperative
699104|NCT00964639|Local infiltration analgesia|local infiltration analgesia
699105|NCT00964639|Cerebral palsy|cerebral palsy
699106|NCT00964639|r-FLACC|r-flacc
699107|NCT00964652|treadmill|treadmill
699108|NCT00964652|body load|body load
699109|NCT00964652|Parkinson's disease|parkinson's disease
699110|NCT00964652|gait|gait
699111|NCT00964665|Hepatitis B,|hepatitis b,
699112|NCT00964665|Chronic,|chronic,
699113|NCT00964665|Hepatitis B e Antigens positive|hepatitis b e antigens positive
699114|NCT00964691|malaria|malaria
699115|NCT00964691|IPTp|iptp
699116|NCT00964691|Fansidar|fansidar
699117|NCT00964691|Intermittent Preventive Treatment in pregnancy|intermittent preventive treatment in pregnancy
699118|NCT00964691|pregnancy|pregnancy
699119|NCT00964691|prophylaxis|prophylaxis
699120|NCT00964691|Chloroquine|chloroquine
699121|NCT00964691|Anemia|anemia
699122|NCT00964691|Prevention|prevention
699123|NCT00964691|Placental malaria|placental malaria
699124|NCT00964691|Solomon Islands|solomon islands
699125|NCT00964691|Low birth weight|low birth weight
699126|NCT00964717|back pain|back pain
699127|NCT00964717|neck pain|neck pain
699128|NCT00964717|anxiety|anxiety
699129|NCT00964717|range of motion|range of motion
699130|NCT00964730|Thorough QT Study|thorough qt study
699131|NCT00964730|Talampanel|talampanel
699132|NCT00964730|Cardiac Repolarizatiom|cardiac repolarizatiom
699133|NCT00964730|Healthy Volunteers|healthy volunteers
699134|NCT00964743|Neurologic Oncology|neurologic oncology
699135|NCT00964743|Neoplastic Meningitis from solid tumors|neoplastic meningitis from solid tumors
699136|NCT00964743|Brain and Nervous System|brain and nervous system
699137|NCT00964743|Breast Cancer|breast cancer
699138|NCT00964756|ovarian cancer|ovarian cancer
699139|NCT00964756|Recurrent ovarian cancer and other gynecologic cancers|recurrent ovarian cancer and other gynecologic cancers
699140|NCT00964769|Pneumococcal Vaccine|pneumococcal vaccine
699141|NCT00964769|Aged|aged
699142|NCT00964782|Fontan|fontan
699143|NCT00964782|sildenafil|sildenafil
699144|NCT00964782|exercise capacity|exercise capacity
699145|NCT00964782|Patients with Fontan Circulation|patients with fontan circulation
699146|NCT00964795|Eyes|eyes
699147|NCT00964795|Neovascular|neovascular
699148|NCT00964795|Macular Degeneration|macular degeneration
699149|NCT00964795|Retina|retina
699151|NCT00964795|VEGF Trap-Eye|vegf trap-eye
699152|NCT00964795|Best Corrected Visual Acuity|best corrected visual acuity
699153|NCT00964808|Hip fractures|hip fractures
699154|NCT00964808|Treatment Outcome|treatment outcome
699155|NCT00964808|Painkiller|painkiller
699156|NCT00964821|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
699157|NCT00964821|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
699158|NCT00964821|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
699159|NCT00964821|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
699160|NCT00964821|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
699161|NCT00964821|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
699162|NCT00964821|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
699163|NCT00964821|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
699164|NCT00964821|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
699165|NCT00964821|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
699166|NCT00964821|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
699167|NCT00964821|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
699168|NCT00964821|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
699169|NCT00964821|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
699170|NCT00964821|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
699171|NCT00964821|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
699172|NCT00964821|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
699173|NCT00964821|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
700200|NCT00968240|Brain|brain
699174|NCT00964821|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
699175|NCT00964821|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
699176|NCT00964821|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
699177|NCT00964821|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
699178|NCT00964821|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
699179|NCT00964821|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
699180|NCT00964821|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
700004|NCT00967434|infarction|infarction
699181|NCT00964821|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
699182|NCT00964821|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
699183|NCT00964821|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
699184|NCT00964821|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
699185|NCT00964821|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
699186|NCT00964821|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
699187|NCT00964821|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
699188|NCT00964821|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
699189|NCT00964821|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
699190|NCT00964821|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
699191|NCT00964821|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
699192|NCT00964821|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
699193|NCT00964821|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
699194|NCT00964821|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
699195|NCT00964821|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
699196|NCT00964821|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
699197|NCT00964821|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
699198|NCT00964821|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
699199|NCT00964821|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
699200|NCT00964821|splenic marginal zone lymphoma|splenic marginal zone lymphoma
699201|NCT00964821|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
699202|NCT00964821|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
699203|NCT00964821|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
699204|NCT00964821|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
699205|NCT00964821|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
699206|NCT00964821|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
699207|NCT00964821|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
699208|NCT00964821|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
699209|NCT00964821|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
699210|NCT00964821|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
699211|NCT00964821|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
699212|NCT00964821|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
699213|NCT00964821|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
699214|NCT00964821|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
699215|NCT00964821|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
699216|NCT00964821|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
699217|NCT00964821|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
699218|NCT00964821|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
699219|NCT00964821|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
699220|NCT00964821|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
752879|NCT01174576|glucose|glucose
699221|NCT00964821|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
699222|NCT00964821|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
699223|NCT00964821|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
699224|NCT00964821|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
699225|NCT00964821|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
699226|NCT00964821|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
699227|NCT00964821|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
699228|NCT00964821|refractory hairy cell leukemia|refractory hairy cell leukemia
699229|NCT00964821|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
699230|NCT00964821|secondary acute myeloid leukemia|secondary acute myeloid leukemia
699231|NCT00964821|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
699232|NCT00964821|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
699327|NCT00965276|Chemoresistance|chemoresistance
699233|NCT00964821|chronic eosinophilic leukemia|chronic eosinophilic leukemia
699234|NCT00964821|primary myelofibrosis|primary myelofibrosis
699235|NCT00964821|chronic neutrophilic leukemia|chronic neutrophilic leukemia
699236|NCT00964821|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
699237|NCT00964821|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
699238|NCT00964821|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
699239|NCT00964821|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
699240|NCT00964821|stage I multiple myeloma|stage i multiple myeloma
699241|NCT00964821|stage II multiple myeloma|stage ii multiple myeloma
699242|NCT00964821|stage III multiple myeloma|stage iii multiple myeloma
699243|NCT00964821|refractory multiple myeloma|refractory multiple myeloma
699244|NCT00964821|aplastic anemia|aplastic anemia
699245|NCT00964847|hypertension|hypertension
699246|NCT00964847|cardiovascular disease|cardiovascular disease
699248|NCT00964873|Synta|synta
699249|NCT00964873|STA-9090|sta-9090
699250|NCT00964873|ganetespib|ganetespib
699251|NCT00964873|Hematologic Cancers|hematologic cancers
699252|NCT00964873|Acute Myeloid Leukemia|acute myeloid leukemia
699253|NCT00964873|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
699254|NCT00964873|Blast-phase Chronic Myelogenous Leukemia|blast-phase chronic myelogenous leukemia
699256|NCT00964873|ALL|all
699257|NCT00964873|CML|cml
699258|NCT00964873|HSP90 Inhibitor|hsp90 inhibitor
699259|NCT00964886|chronic pain|chronic pain
699260|NCT00964886|back pain|back pain
699261|NCT00964886|antidepressants|antidepressants
699262|NCT00964938|Hemodynamic response|hemodynamic response
699263|NCT00964938|Cardiac resynchronization therapy|cardiac resynchronization therapy
699264|NCT00964951|H1N1, influenza A viruses, vaccine, elderly|h1n1, influenza a viruses, vaccine, elderly
699265|NCT00964977|pN1|pn1
699266|NCT00964977|head and neck cancer|head and neck cancer
699267|NCT00964977|radiation|radiation
699268|NCT00964977|prognosis|prognosis
699269|NCT00964977|comprehensive cohort design|comprehensive cohort design
699270|NCT00964990|Moderate to severe chronic peripheral neuropathic pain|moderate to severe chronic peripheral neuropathic pain
699271|NCT00964990|Postherpetic neuralgia|postherpetic neuralgia
699272|NCT00964990|Post-traumatic neuralgia|post-traumatic neuralgia
699273|NCT00964990|Moderate to severe chronic pain|moderate to severe chronic pain
699274|NCT00964990|JNJ-42160443|jnj-42160443
699275|NCT00965016|Extracorporeal membrane oxygenation，induced hypothermia|extracorporeal membrane oxygenation，induced hypothermia
699276|NCT00965029|COPD|copd
699277|NCT00965029|Spirometry|spirometry
699278|NCT00965029|Weaning|weaning
699279|NCT00965042|Ceftobiprole|ceftobiprole
699280|NCT00965042|ZEVTERA|zevtera
699281|NCT00965042|ZEFTERA|zeftera
699282|NCT00965042|Intestinal Microflora|intestinal microflora
699283|NCT00965068|Autism|autism
699284|NCT00965068|Autism Spectrum Disorder|autism spectrum disorder
699285|NCT00965068|Cholesterol|cholesterol
699286|NCT00965068|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
699287|NCT00965068|ASD|asd
699288|NCT00965068|Pervasive Developmental Disorder|pervasive developmental disorder
699289|NCT00965068|PPD-NOS|ppd-nos
699290|NCT00965120|Ischaemia reperfusion|ischaemia reperfusion
699291|NCT00965120|Bradykinin|bradykinin
699292|NCT00965120|Platelet activation|platelet activation
699293|NCT00965120|Endothelial function|endothelial function
699294|NCT00965146|Osteoarthritis, traumatic arthritis, avascular necrosis|osteoarthritis, traumatic arthritis, avascular necrosis
699295|NCT00965172|Cancer|cancer
699296|NCT00965172|Mucositis|mucositis
699297|NCT00965172|Chemotherapy|chemotherapy
699298|NCT00965172|Caphosol|caphosol
699299|NCT00965172|Calcium phosphate|calcium phosphate
699300|NCT00965172|Sodium Bicarbonate|sodium bicarbonate
699301|NCT00965172|Baking Soda Solution|baking soda solution
699302|NCT00965172|Multi-cycle chemotherapy|multi-cycle chemotherapy
699303|NCT00965185|Cardiovascular Disease|cardiovascular disease
699304|NCT00965185|HIV|hiv
699305|NCT00965185|Atherosclerosis|atherosclerosis
699306|NCT00965185|Inflammation|inflammation
699307|NCT00965185|Statins|statins
699308|NCT00965185|treatment experienced|treatment experienced
699309|NCT00965198|Catheters, Indwelling|catheters, indwelling
699310|NCT00965198|Biofilms|biofilms
699311|NCT00965211|Tourette's, OCD, dTMS, YGTSS, YBOCS, supplementary motor cortex|tourette's, ocd, dtms, ygtss, ybocs, supplementary motor cortex
699312|NCT00965211|Tourette's syndrome and Obsessive compulsive disorder|tourette's syndrome and obsessive compulsive disorder
699313|NCT00965224|AML (acute myeloid leukemia)|aml (acute myeloid leukemia)
699314|NCT00965224|CML (chronic myeloid leukemia)|cml (chronic myeloid leukemia)
699315|NCT00965224|MM (multiple myeloma)|mm (multiple myeloma)
699316|NCT00965250|Thymic Malignancies|thymic malignancies
699317|NCT00965250|IMC-A12|imc-a12
699318|NCT00965250|Insulin-Like Growth Factor|insulin-like growth factor
699319|NCT00965263|Cocaine|cocaine
699320|NCT00965263|immunotherapy|immunotherapy
699321|NCT00965263|vaccination|vaccination
699322|NCT00965263|antibody|antibody
699323|NCT00965263|addiction|addiction
699324|NCT00965263|dependence|dependence
699325|NCT00965276|Adjuvant Therapy|adjuvant therapy
699326|NCT00965276|Paclitaxel|paclitaxel
699328|NCT00965276|Serine/Threonine Kinase|serine/threonine kinase
699329|NCT00965276|Cell Survival|cell survival
699330|NCT00965276|Breast Cancer|breast cancer
699331|NCT00965289|Aggressive large B-cell lymphoma (DLBCL)|aggressive large b-cell lymphoma (dlbcl)
699332|NCT00965289|Intensive chemotherapy|intensive chemotherapy
699333|NCT00965289|Rituximab|rituximab
699334|NCT00965289|ASCT|asct
699335|NCT00965302|Obesity|obesity
699336|NCT00965302|Diabetes mellitus, Type 2|diabetes mellitus, type 2
699337|NCT00965302|Sleeve gastrectomy|sleeve gastrectomy
699338|NCT00965302|Metabolic surgery|metabolic surgery
699339|NCT00955266|Separation|separation
699340|NCT00955266|Cardiopulmonary bypass|cardiopulmonary bypass
699341|NCT00955266|Calcium chloride|calcium chloride
699342|NCT00955279|Ustekinumab|ustekinumab
699343|NCT00955279|CNTO 1275|cnto 1275
699344|NCT00955279|Stelara|stelara
699345|NCT00955279|Golimumab|golimumab
699346|NCT00955279|CNTO 148|cnto 148
699347|NCT00955279|Simponi|simponi
699348|NCT00955279|Sarcoidosis|sarcoidosis
699349|NCT00955279|Sarcoid|sarcoid
699350|NCT00955279|Pulmonary Sarcoidosis|pulmonary sarcoidosis
699351|NCT00955279|Skin Sarcoidosis|skin sarcoidosis
699352|NCT00955292|Solid Tumors|solid tumors
699353|NCT00955292|Lymphoma|lymphoma
699354|NCT00955292|G-Quadruplex|g-quadruplex
699355|NCT00955305|Non-Small Cell Lung Cancer|non-small cell lung cancer
699356|NCT00955305|cixutumumab|cixutumumab
699357|NCT00955344|colorectal cancer screening|colorectal cancer screening
699358|NCT00955344|American Board of Internal Medicine Maintenance of Certification program|american board of internal medicine maintenance of certification program
699359|NCT00955344|Currently enrolled in or plan to enroll in the American Board of Internal Medicine Maintenance of Certification program|currently enrolled in or plan to enroll in the american board of internal medicine maintenance of certification program
699360|NCT00955357|Epilepsy Treatment|epilepsy treatment
699361|NCT00955357|Anti-epileptic drugs|anti-epileptic drugs
699362|NCT00955357|Seizures|seizures
699363|NCT00955357|Vimpat|vimpat
699364|NCT00955370|Uncertainty|uncertainty
699365|NCT00955370|Undiagnosed|undiagnosed
699366|NCT00955370|Rare Diseases|rare diseases
699367|NCT00955370|Parents|parents
699368|NCT00955370|Multiple Abnormalities|multiple abnormalities
699369|NCT00955383|Japanese|japanese
699370|NCT00955396|sodium channel blocker|sodium channel blocker
699371|NCT00955396|ambulatory blood pressure|ambulatory blood pressure
699372|NCT00955422|Diagnosis|diagnosis
699373|NCT00955422|Alzheimer's Disease|alzheimer's disease
699374|NCT00955422|Memory Disorder|memory disorder
699375|NCT00955422|Dementia|dementia
699376|NCT00955422|Alzheimer Disease|alzheimer disease
699377|NCT00955422|Memory Loss|memory loss
699378|NCT00955435|adenocarcinoma of the prostate|adenocarcinoma of the prostate
699379|NCT00955435|stage I prostate cancer|stage i prostate cancer
699380|NCT00955435|stage IIB prostate cancer|stage iib prostate cancer
699381|NCT00955435|stage IIA prostate cancer|stage iia prostate cancer
699382|NCT00955435|stage III prostate cancer|stage iii prostate cancer
699383|NCT00955448|Anterior pelvic organ prolapse|anterior pelvic organ prolapse
699384|NCT00955448|Surgical repair|surgical repair
699385|NCT00955448|Pelvic floor surgery|pelvic floor surgery
699386|NCT00955448|Randomized clinical trial|randomized clinical trial
699387|NCT00955487|Premature Newborns|premature newborns
699388|NCT00955487|Inhaled Nitric Oxide|inhaled nitric oxide
699389|NCT00955500|Hepatic encephalopathy|hepatic encephalopathy
699390|NCT00955500|Cirrhosis|cirrhosis
699391|NCT00955500|Proteins of the diet|proteins of the diet
699392|NCT00955500|Branched-chain amino acids|branched-chain amino acids
699393|NCT00955513|Ankle sprain|ankle sprain
699394|NCT00955513|soft tissue injury|soft tissue injury
699395|NCT00955526|Parkinson's disease|parkinson's disease
699396|NCT00955526|levodopa|levodopa
699397|NCT00955526|end of dose wearing off|end of dose wearing off
699398|NCT00955526|OFF time|off time
699399|NCT00955539|Heart Failure|heart failure
699400|NCT00955539|Cardiac resynchronization therapy|cardiac resynchronization therapy
699401|NCT00955539|Optimization|optimization
699402|NCT00955539|Viability|viability
699403|NCT00955539|Mechanical dyssynchrony|mechanical dyssynchrony
699404|NCT00955552|osteoarthritis (OA)|osteoarthritis (oa)
699406|NCT00955591|human papilloma virus infection|human papilloma virus infection
699407|NCT00955591|anal cancer|anal cancer
699408|NCT00955591|HIV infection|hiv infection
699409|NCT00955604|Parkinson's Disease|parkinson's disease
699410|NCT00955604|Serotonin Toxicity|serotonin toxicity
699411|NCT00955604|Rasagiline|rasagiline
699412|NCT00955604|Antidepressants|antidepressants
699413|NCT00955604|Chart Review|chart review
699414|NCT00955604|Retrospective|retrospective
699415|NCT00955617|Dotarem|dotarem
699416|NCT00955617|Gadovist|gadovist
699417|NCT00955617|Peripheral arterial disease|peripheral arterial disease
699419|NCT00955630|Histoplasmosis|histoplasmosis
699420|NCT00955630|Lucentis|lucentis
699421|NCT00955630|Ranibizumab|ranibizumab
699422|NCT00955630|OHS|ohs
699423|NCT00955643|periodontitis|periodontitis
699424|NCT00955643|hyperbaric oxygen therapy|hyperbaric oxygen therapy
699425|NCT00955656|Characteristics of medical practices|characteristics of medical practices
699426|NCT00955656|Practitioners providing care to children with asthma|practitioners providing care to children with asthma
699427|NCT00955656|Medically underserved and impoverished Arkansas Delta region|medically underserved and impoverished arkansas delta region
699428|NCT00955656|Characteristics of medical practices and practitioners|characteristics of medical practices and practitioners
699429|NCT00955656|Disadvantaged populations|disadvantaged populations
699430|NCT00955669|mesenchymal stem cells|mesenchymal stem cells
699431|NCT00955669|mononuclear cells|mononuclear cells
700005|NCT00967434|ischemia|ischemia
699432|NCT00955682|Meningococcal vaccine GSK134612|meningococcal vaccine gsk134612
699433|NCT00955695|adenocarcinoma of the lung|adenocarcinoma of the lung
699434|NCT00955695|adenosquamous cell lung cancer|adenosquamous cell lung cancer
699435|NCT00955695|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
699436|NCT00955695|large cell lung cancer|large cell lung cancer
699437|NCT00955695|squamous cell lung cancer|squamous cell lung cancer
699438|NCT00955695|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
699439|NCT00955695|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
699440|NCT00955721|Cholangiocarcinoma|cholangiocarcinoma
699441|NCT00955721|Biliary Tract Cancer|biliary tract cancer
699442|NCT00955721|Gallbladder Cancer|gallbladder cancer
699443|NCT00955734|wrist|wrist
699444|NCT00955734|fracture|fracture
699445|NCT00955734|motion|motion
699446|NCT00955734|surgery|surgery
699447|NCT00955760|Healthy subjects|healthy subjects
699448|NCT00955773|GSK1120212, everolimus, solid tumors, pancreatic cancer, non-small lung cancer, KRAS-mutant|gsk1120212, everolimus, solid tumors, pancreatic cancer, non-small lung cancer, kras-mutant
699449|NCT00955773|cancer|cancer
699450|NCT00955786|Solid Tumors|solid tumors
699451|NCT00955786|Lymphoma|lymphoma
699452|NCT00955786|G-Quadruplex|g-quadruplex
699453|NCT00955799|Subjective, Tinnitus|subjective, tinnitus
699454|NCT00955812|OPB-31121|opb-31121
699455|NCT00955812|Advanced Solid Tumor|advanced solid tumor
699456|NCT00955812|STAT3|stat3
699457|NCT00955812|IL-6-induced STAT3 phosphorylation|il-6-induced stat3 phosphorylation
699458|NCT00955825|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
699459|NCT00955864|Cervix|cervix
699460|NCT00955864|Colposcope|colposcope
699461|NCT00955864|Polarized Light|polarized light
699462|NCT00955864|Cervix Structure|cervix structure
699463|NCT00955864|Collagen|collagen
699464|NCT00955864|HV|hv
699465|NCT00955864|Healthy Volunteer|healthy volunteer
699466|NCT00955864|Healthy Women|healthy women
699467|NCT00955877|extended-release epidural morphine|extended-release epidural morphine
699468|NCT00955877|DepoDur|depodur
699469|NCT00955877|Spastic Cerebral Palsy|spastic cerebral palsy
699470|NCT00955890|cardioprotection|cardioprotection
699471|NCT00955890|anthracycline chemotherapy|anthracycline chemotherapy
699472|NCT00955890|breast cancer|breast cancer
699473|NCT00955903|glucose|glucose
699474|NCT00955903|insulin|insulin
699475|NCT00955903|lipids|lipids
699476|NCT00955903|C-reactive protein|c-reactive protein
699477|NCT00955903|adiponectin|adiponectin
699478|NCT00955903|leptin|leptin
699479|NCT00955903|TNF alpha|tnf alpha
699480|NCT00955903|IL-6|il-6
699481|NCT00955903|Quality of Life|quality of life
699482|NCT00955903|functional status|functional status
699483|NCT00955916|relapsed|relapsed
699484|NCT00955916|refractory|refractory
699485|NCT00955916|acute|acute
699486|NCT00955916|myeloid|myeloid
699487|NCT00955916|AML|aml
699488|NCT00955916|CML|cml
699489|NCT00955916|blast crisis|blast crisis
699490|NCT00955929|Penis|penis
699491|NCT00955929|PLACEBO|placebo
699492|NCT00955929|SILDENAFIL CITRATE|sildenafil citrate
699493|NCT00955929|TRIMIX|trimix
699494|NCT00955929|Bimix|bimix
699495|NCT00955929|Viagra|viagra
699496|NCT00955929|09-005|09-005
699497|NCT00955929|Erectile Dysfunction following Bilateral Nerve-Sparing|erectile dysfunction following bilateral nerve-sparing
699498|NCT00955942|radiation toxicity|radiation toxicity
699499|NCT00955942|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
699500|NCT00955942|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
699501|NCT00955942|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
699502|NCT00955942|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
699503|NCT00955955|Depression|depression
699504|NCT00955955|Medical food|medical food
699505|NCT00955968|HIV Infection|hiv infection
699506|NCT00955968|HAART|haart
699507|NCT00955968|Maternal Health|maternal health
699508|NCT00956007|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
699509|NCT00956007|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
699510|NCT00956007|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
699511|NCT00956007|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
699512|NCT00956007|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
699513|NCT00956007|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
699514|NCT00956007|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
699608|NCT00965536|Seroquel|seroquel
699515|NCT00956007|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
699516|NCT00956007|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
699517|NCT00956007|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
699518|NCT00956007|tongue cancer|tongue cancer
699519|NCT00956020|platelet rich plasma|platelet rich plasma
699520|NCT00956020|fibrin matrix|fibrin matrix
699521|NCT00956020|dermal filler|dermal filler
699522|NCT00956033|Cancer|cancer
700006|NCT00967434|surgery|surgery
699523|NCT00956033|Peripheral Neuropathy|peripheral neuropathy
699524|NCT00956033|Bortezomib|bortezomib
699525|NCT00956046|Influenza|influenza
699526|NCT00956046|Pandemic Flu|pandemic flu
699527|NCT00956046|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
699528|NCT00956046|Swine-origin Influenza Virus|swine-origin influenza virus
699529|NCT00956046|Infants|infants
699530|NCT00965315|CV (cardiovascular)|cv (cardiovascular)
699531|NCT00965315|MI (myocardial infarction)|mi (myocardial infarction)
699532|NCT00965315|fenofibrate|fenofibrate
699533|NCT00965315|rosuvastatin|rosuvastatin
699534|NCT00965315|this trial is to test the hypothesis that the addition of fenofibrate on rosuvastatin would provide a further reduction in the time|this trial is to test the hypothesis that the addition of fenofibrate on rosuvastatin would provide a further reduction in the time
699535|NCT00965328|anticoagulation|anticoagulation
699536|NCT00965328|hemofiltration|hemofiltration
699537|NCT00965328|acute kidney injury|acute kidney injury
699538|NCT00965328|heparin|heparin
699539|NCT00965328|hemostasis|hemostasis
699540|NCT00965328|nadroparin|nadroparin
699541|NCT00965328|anti-Xa|anti-xa
699542|NCT00965328|endogenous thrombin potential|endogenous thrombin potential
699543|NCT00965341|Cancer|cancer
699544|NCT00965341|Fatigue|fatigue
699545|NCT00965341|Testosterone Replacement Therapy|testosterone replacement therapy
699546|NCT00965341|Depo-Testosterone|depo-testosterone
699547|NCT00965341|Testosterone cypionate|testosterone cypionate
699548|NCT00965341|Testosterone enanthate|testosterone enanthate
699549|NCT00965341|Hypogonadic|hypogonadic
699550|NCT00965341|Functional Assessment of Cancer Therapy-Fatigue subscale|functional assessment of cancer therapy-fatigue subscale
699551|NCT00965341|FACIT-F|facit-f
699552|NCT00965354|severe|severe
699553|NCT00965354|acute|acute
699554|NCT00965354|influenza|influenza
699555|NCT00965354|consortium|consortium
699556|NCT00965354|swine|swine
699557|NCT00965354|flu|flu
699558|NCT00965354|influenza A|influenza a
699559|NCT00965354|H1N1|h1n1
699560|NCT00965354|hospital|hospital
699561|NCT00965354|admission|admission
699562|NCT00965367|POV tonsillectomy adenoidectomy acupuncture acupressure child|pov tonsillectomy adenoidectomy acupuncture acupressure child
699563|NCT00965367|Effectiveness of acupuncture on|effectiveness of acupuncture on
699564|NCT00965380|Trinity Evolution|trinity evolution
699565|NCT00965380|Symptomatic lumbar degenerative disc disease|symptomatic lumbar degenerative disc disease
699566|NCT00965380|Posterior lumbar interbody fusion|posterior lumbar interbody fusion
699567|NCT00965380|Transforaminal lumbar interbody fusion|transforaminal lumbar interbody fusion
699568|NCT00965393|Ischaemia reperfusion|ischaemia reperfusion
699569|NCT00965393|Platelet activation|platelet activation
699570|NCT00965393|Endothelial function|endothelial function
699571|NCT00965393|Remote ischaemic preconditioning|remote ischaemic preconditioning
699572|NCT00965393|Bradykinin|bradykinin
699573|NCT00965406|acute coronary syndrome|acute coronary syndrome
699574|NCT00965406|glucose insulin potassium|glucose insulin potassium
699575|NCT00965445|isoprostanes|isoprostanes
699576|NCT00965445|mass spectrometry|mass spectrometry
699577|NCT00965458|New-onset Type 1 Diabetes Mellitus|new-onset type 1 diabetes mellitus
699578|NCT00965458|New-onset T1DM|new-onset t1dm
699579|NCT00965458|New-onset T1D|new-onset t1d
699580|NCT00965458|Alefacept|alefacept
699581|NCT00965458|Amevive®|amevive®
699582|NCT00965471|percutaneous coronary artery intervention|percutaneous coronary artery intervention
699583|NCT00965471|coronary artery bypass graft|coronary artery bypass graft
699584|NCT00965471|acute coronary syndrome|acute coronary syndrome
699585|NCT00965484|Genotropin Medical device Patient reported outcome|genotropin medical device patient reported outcome
699586|NCT00965497|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
699588|NCT00965497|Multiple Sclerosis|multiple sclerosis
699589|NCT00965497|MS|ms
699590|NCT00965497|Major Depression|major depression
699591|NCT00965497|Depression|depression
699592|NCT00965497|Major Depressive Disorder|major depressive disorder
699593|NCT00965497|antidepressants|antidepressants
699594|NCT00965497|Escitalopram|escitalopram
699595|NCT00965497|Lexapro|lexapro
699596|NCT00965510|diabetes|diabetes
699597|NCT00965523|Cancer|cancer
699598|NCT00965523|breast cancer|breast cancer
699599|NCT00965523|neoplasm|neoplasm
699600|NCT00965523|E7389|e7389
699601|NCT00965523|Eribulin|eribulin
699602|NCT00965536|Schizophrenia|schizophrenia
699603|NCT00965536|Bipolar Disorder|bipolar disorder
699604|NCT00965536|Manic Disorder|manic disorder
699605|NCT00965536|Register study|register study
699606|NCT00965536|Quetiapine|quetiapine
699607|NCT00965536|Quetiapine Prolong|quetiapine prolong
699609|NCT00965536|Seroquel Prolong|seroquel prolong
699610|NCT00965536|Seroquel XR|seroquel xr
699611|NCT00965536|In-patient|in-patient
699612|NCT00965562|Premenstrual syndrome|premenstrual syndrome
699613|NCT00965562|PMS|pms
699614|NCT00965562|calcium|calcium
699615|NCT00965575|epilepsy|epilepsy
699616|NCT00965575|sleep|sleep
699617|NCT00965575|seizures|seizures
699618|NCT00965575|cognition|cognition
699619|NCT00965588|Alzheimer's disease|alzheimer's disease
699620|NCT00965588|amyloid beta|amyloid beta
699622|NCT00965601|Fibromyalgia|fibromyalgia
699623|NCT00965614|diagnose cardiac arrhythmia and CAD.|diagnose cardiac arrhythmia and cad.
699624|NCT00965614|we'll try to establish the specific model to detect and diagnose cardiac arrhythmia and CAD.|we'll try to establish the specific model to detect and diagnose cardiac arrhythmia and cad.
699625|NCT00965640|male pattern baldness|male pattern baldness
699626|NCT00965640|androgenetic alopecia|androgenetic alopecia
699627|NCT00965640|hair loss|hair loss
699628|NCT00965874|Rapid Atrial Fibrillation|rapid atrial fibrillation
699629|NCT00965874|Magnesium Sulfate|magnesium sulfate
699630|NCT00965874|Cardiac arrhythmia|cardiac arrhythmia
699631|NCT00965900|Cirrhosis|cirrhosis
699632|NCT00965900|Esophagus Disorders|esophagus disorders
699633|NCT00965900|Varicose Veins|varicose veins
699634|NCT00965926|Overactive Bladder|overactive bladder
699635|NCT00965926|Urinary incontinence|urinary incontinence
699636|NCT00965926|YM178|ym178
699637|NCT00965926|mirabegron|mirabegron
699638|NCT00965965|health behavior|health behavior
699639|NCT00965965|randomized controlled trials|randomized controlled trials
699640|NCT00965965|self-efficacy|self-efficacy
699641|NCT00965965|patient education|patient education
699642|NCT00965965|comprehension|comprehension
699643|NCT00965965|mass screening|mass screening
699644|NCT00965965|prevention and control|prevention and control
699645|NCT00965978|ONO-5920|ono-5920
699646|NCT00965978|YM529|ym529
699647|NCT00965978|Minodronic Acid|minodronic acid
699648|NCT00965978|Food Effect|food effect
699649|NCT00965991|Gestational diabetes|gestational diabetes
699650|NCT00965991|Metformin|metformin
699651|NCT00965991|Glyburide|glyburide
699652|NCT00965991|oral agents|oral agents
699653|NCT00966004|Urge incontinence|urge incontinence
699654|NCT00966004|YM178|ym178
699655|NCT00966004|Overactive Bladder|overactive bladder
699656|NCT00966004|Urgency|urgency
699657|NCT00966004|Urinary incontinence|urinary incontinence
699658|NCT00966004|mirabegron|mirabegron
699659|NCT00966004|Micturition|micturition
699660|NCT00966017|PET Scan|pet scan
699661|NCT00966056|Nasal adhesions|nasal adhesions
699662|NCT00966056|Nasal synechiae|nasal synechiae
699663|NCT00966056|Mitomycin|mitomycin
699664|NCT00966056|Mitomycin c|mitomycin c
699665|NCT00966056|Teflon|teflon
699666|NCT00966056|Splints|splints
699667|NCT00966056|Septal splints|septal splints
699668|NCT00966069|Respiratory tract infections|respiratory tract infections
699669|NCT00966069|Viral infections|viral infections
699670|NCT00966069|Pediatrics|pediatrics
699671|NCT00966069|Specimen collection|specimen collection
699672|NCT00966082|Cirrhosis|cirrhosis
699673|NCT00966082|Esophagus Disorders|esophagus disorders
699674|NCT00966082|Varicose Veins|varicose veins
699675|NCT00966095|prostate cancer|prostate cancer
699676|NCT00966121|Cirrhosis|cirrhosis
699677|NCT00966121|Esophagus Disorders|esophagus disorders
699678|NCT00966121|Varicose Veins|varicose veins
699679|NCT00966134|mountain medicine|mountain medicine
699680|NCT00966134|ghrelin|ghrelin
699681|NCT00966134|growth hormone|growth hormone
699682|NCT00966134|hypoxia|hypoxia
699683|NCT00966134|physiology of hormonal adaptation to high altitude|physiology of hormonal adaptation to high altitude
699876|NCT00967044|NHL|nhl
699684|NCT00966160|treatment naive|treatment naive
699685|NCT00966186|ProSeal Laryngeal Mask Airway|proseal laryngeal mask airway
699686|NCT00966186|Rotational technique|rotational technique
699687|NCT00966186|Success rate|success rate
699688|NCT00966186|Postoperative complications|postoperative complications
699689|NCT00966199|blood pressure|blood pressure
699690|NCT00966199|aging|aging
699691|NCT00966199|cerebrovascular circulation|cerebrovascular circulation
699692|NCT00966199|hypertension|hypertension
699693|NCT00966238|influenza|influenza
699694|NCT00966238|vaccine|vaccine
699695|NCT00966251|Primary Hepatocellular Carcinoma|primary hepatocellular carcinoma
699696|NCT00966264|randomized controlled trial|randomized controlled trial
699697|NCT00966264|menorrhagia|menorrhagia
699698|NCT00966264|LNG-IUS|lng-ius
699699|NCT00966264|hysterectomy|hysterectomy
699700|NCT00966277|Pancreas|pancreas
699701|NCT00966277|Primary venous thromboembolism|primary venous thromboembolism
699702|NCT00966277|VTE|vte
699703|NCT00966277|Chemotherapy|chemotherapy
699704|NCT00966277|Deep venous thrombosis|deep venous thrombosis
699705|NCT00966277|Pulmonary embolism|pulmonary embolism
699706|NCT00966277|Dalteparin|dalteparin
699707|NCT00966277|Fragmin|fragmin
699708|NCT00966277|Thromboprophylaxis|thromboprophylaxis
699709|NCT00966290|anticoagulants|anticoagulants
699710|NCT00966290|management|management
699711|NCT00966290|anticoagulation clinics|anticoagulation clinics
699712|NCT00966290|randomized comparison|randomized comparison
699713|NCT00966303|rehabilitation|rehabilitation
699714|NCT00966303|dyspnea|dyspnea
699715|NCT00966303|strength|strength
699716|NCT00966316|Acute Ischemic Stroke；clinical pathway;TCM；|acute ischemic stroke；clinical pathway;tcm；
699717|NCT00966329|Switching|switching
699718|NCT00966329|Maraviroc|maraviroc
699719|NCT00966329|Virological efficacy|virological efficacy
699720|NCT00966329|Lipid profile|lipid profile
699722|NCT00966342|vaccine|vaccine
699723|NCT00966342|influenza|influenza
699724|NCT00966342|influenza vaccine|influenza vaccine
699725|NCT00966342|pandemic preparedness|pandemic preparedness
699726|NCT00966355|Cirrhosis, Esophagus Disorders, Varicose Veins|cirrhosis, esophagus disorders, varicose veins
699727|NCT00966381|breastfeeding|breastfeeding
699728|NCT00966381|bone mineral density|bone mineral density
699729|NCT00966381|exercise|exercise
699730|NCT00966381|diet|diet
699731|NCT00966394|ADHD, saliva, caries|adhd, saliva, caries
699732|NCT00966407|Metabolic Syndrome|metabolic syndrome
699733|NCT00966407|Obesity|obesity
699734|NCT00966407|Genetic risk markers|genetic risk markers
699735|NCT00966407|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
699736|NCT00966407|Young adults|young adults
699737|NCT00966407|Fitness testing|fitness testing
699738|NCT00966433|Proseal™ LMA|proseal™ lma
699739|NCT00966433|children|children
699740|NCT00966433|ventilation|ventilation
699741|NCT00966433|general anesthesia|general anesthesia
699742|NCT00966433|Children under general anesthesia for outpatient surgery|children under general anesthesia for outpatient surgery
699743|NCT00966446|MRSA; household; infection; colonization|mrsa; household; infection; colonization
699744|NCT00966459|COPD|copd
699745|NCT00966472|Rosuvastatin|rosuvastatin
699746|NCT00966472|Erlotinib|erlotinib
699747|NCT00966472|Squamous Cell Carcinoma|squamous cell carcinoma
699748|NCT00966472|Nom-Small Cell Lung Cancer|nom-small cell lung cancer
699749|NCT00966485|ASA resistance|asa resistance
699750|NCT00966485|coronary stenting|coronary stenting
699751|NCT00966485|platelet function|platelet function
699752|NCT00966485|laboratory ASA resistance|laboratory asa resistance
699753|NCT00966485|MACE|mace
699754|NCT00966485|Positive SPECT|positive spect
699755|NCT00966498|malignancy|malignancy
699756|NCT00966498|solid tumor|solid tumor
699757|NCT00966498|recurrent|recurrent
699758|NCT00966498|high risk|high risk
699759|NCT00966511|lung cancer|lung cancer
699760|NCT00966511|lung resection|lung resection
699761|NCT00966511|lobectomy|lobectomy
699762|NCT00966511|pneumonectomy|pneumonectomy
699763|NCT00966511|lung function|lung function
699764|NCT00966511|perfusion|perfusion
699765|NCT00966524|Endotracheal intubation|endotracheal intubation
699766|NCT00966537|to study the clinical application of 3D/4D ultrasound for fetal scanning|to study the clinical application of 3d/4d ultrasound for fetal scanning
699767|NCT00966537|to study the clinical application of 3D/4D ultrasound for pelvic scanning;|to study the clinical application of 3d/4d ultrasound for pelvic scanning;
701422|NCT00973232|fed|fed
752587|NCT01167803|Bariatric surgery|bariatric surgery
699768|NCT00966537|to demonstrate how to optimally display the different organs.|to demonstrate how to optimally display the different organs.
699769|NCT00966537|to correlate our findings with other diagnostic tools like MRI, CT;|to correlate our findings with other diagnostic tools like mri, ct;
699770|NCT00966537|to correlate our findings with clinical outcome.|to correlate our findings with clinical outcome.
699771|NCT00966550|Tomato|tomato
699772|NCT00966550|Nutrition|nutrition
699773|NCT00966563|Mangafodipir|mangafodipir
699774|NCT00966563|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
699775|NCT00966563|Myocardial infarction|myocardial infarction
699776|NCT00966563|Troponin|troponin
699777|NCT00966563|CK-MB|ck-mb
699877|NCT00967044|LBH589|lbh589
699778|NCT00966563|Magnetic Resonance Imaging|magnetic resonance imaging
699779|NCT00966576|Glaucoma|glaucoma
699780|NCT00966576|IOP|iop
699781|NCT00966576|AZARGA|azarga
699782|NCT00966589|groin pain|groin pain
699783|NCT00966589|sportsman hernia|sportsman hernia
699784|NCT00966589|osteitis pubis|osteitis pubis
699785|NCT00966589|laparoscopic surgery|laparoscopic surgery
699786|NCT00966615|malnutrition|malnutrition
699787|NCT00966615|fluid status|fluid status
699788|NCT00966615|survival|survival
699789|NCT00966628|pediatric|pediatric
699790|NCT00966628|dengue|dengue
699791|NCT00966628|hypertonic sodium lactate|hypertonic sodium lactate
699792|NCT00966628|fluid resuscitation|fluid resuscitation
699793|NCT00966628|Ringer's lactate|ringer's lactate
699794|NCT00966654|CABG|cabg
699795|NCT00966654|Cardiac Surgical Patient|cardiac surgical patient
699796|NCT00966667|cancer survivor|cancer survivor
699797|NCT00966667|stage I colon cancer|stage i colon cancer
699798|NCT00966667|stage II colon cancer|stage ii colon cancer
699799|NCT00966667|stage III colon cancer|stage iii colon cancer
699800|NCT00966667|stage I rectal cancer|stage i rectal cancer
699801|NCT00966667|stage II rectal cancer|stage ii rectal cancer
699802|NCT00966667|stage III rectal cancer|stage iii rectal cancer
699803|NCT00966680|general anesthesia|general anesthesia
699804|NCT00966680|spinal anesthesia|spinal anesthesia
699805|NCT00966680|emergency cesarean delivery|emergency cesarean delivery
699806|NCT00966693|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
699807|NCT00966693|RRMM|rrmm
699808|NCT00966693|Lenalidomide|lenalidomide
699809|NCT00966693|Revlimid|revlimid
699810|NCT00966693|CC-5013|cc-5013
699811|NCT00966693|Thalidomide|thalidomide
699812|NCT00966693|Thalomid|thalomid
699813|NCT00966693|Dexamethasone|dexamethasone
699815|NCT00966706|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
699816|NCT00966706|stage III pancreatic cancer|stage iii pancreatic cancer
699817|NCT00966706|stage IV pancreatic cancer|stage iv pancreatic cancer
699818|NCT00966719|Jaundice|jaundice
699819|NCT00966719|Breastfeeding|breastfeeding
699820|NCT00966719|Infants|infants
699821|NCT00966745|surgical field condition|surgical field condition
699822|NCT00966771|contraception|contraception
699823|NCT00966771|emergency contraception|emergency contraception
699824|NCT00966771|pregnancy prevention after unprotected intercourse|pregnancy prevention after unprotected intercourse
699825|NCT00966810|chronic myelocytic leukemia|chronic myelocytic leukemia
699826|NCT00966810|allogeneic stem cell transplantation|allogeneic stem cell transplantation
699827|NCT00966810|T cell depletion|t cell depletion
699828|NCT00966810|donor lymphocyte infusion|donor lymphocyte infusion
699829|NCT00966810|GvHD|gvhd
699830|NCT00966810|transplant related mortality|transplant related mortality
699831|NCT00966823|Diaphragm|diaphragm
699832|NCT00966823|Trachea|trachea
699833|NCT00966823|Lung development|lung development
699834|NCT00966823|Lung growth|lung growth
699835|NCT00966823|Tracheal occlusion|tracheal occlusion
699836|NCT00966823|ECMO|ecmo
699837|NCT00966823|Neonatal death|neonatal death
699838|NCT00966836|Heart Transplantation|heart transplantation
699839|NCT00966836|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
699840|NCT00966836|Cytomegalovirus Infection|cytomegalovirus infection
699841|NCT00966836|Everolimus|everolimus
699842|NCT00966836|Valganciclovir|valganciclovir
699843|NCT00966836|Mycophenolate|mycophenolate
699844|NCT00966849|Randomized Controlled Trial|randomized controlled trial
699845|NCT00966849|Financial Support|financial support
699846|NCT00966849|Poverty|poverty
699847|NCT00966849|Child, Orphaned|child, orphaned
699848|NCT00966849|HIV|hiv
699849|NCT00966875|rheumatoid arthritis|rheumatoid arthritis
699850|NCT00966875|RA|ra
699851|NCT00966888|stage II breast cancer|stage ii breast cancer
699852|NCT00966927|quality of life|quality of life
699853|NCT00966927|functional independence|functional independence
699854|NCT00966927|spina bifid|spina bifid
699855|NCT00966940|Glaucoma|glaucoma
699856|NCT00966940|IOP|iop
699857|NCT00966940|Travoprost|travoprost
699858|NCT00966966|Alzheimer Disease|alzheimer disease
699859|NCT00966979|Osteoarthritis, Post-traumatic arthritis|osteoarthritis, post-traumatic arthritis
699860|NCT00966992|Uterine Cervical Cancer|uterine cervical cancer
699861|NCT00966992|Cancer of Cervix|cancer of cervix
699862|NCT00966992|Cervix Cancer|cervix cancer
699863|NCT00967005|N acetyl cysteine|n acetyl cysteine
699864|NCT00967005|Pathological gambling|pathological gambling
699865|NCT00967005|Nicotine dependence|nicotine dependence
699866|NCT00967018|Safety parameters|safety parameters
699867|NCT00967018|ECG, blood and urine samples|ecg, blood and urine samples
699868|NCT00967018|general health state|general health state
699869|NCT00967031|HER2-positive breast cancer|her2-positive breast cancer
699870|NCT00967031|male breast cancer|male breast cancer
699871|NCT00967031|stage IV breast cancer|stage iv breast cancer
699872|NCT00967031|tumors metastatic to brain|tumors metastatic to brain
699873|NCT00967044|Relapsed or Refractory Lymphoma|relapsed or refractory lymphoma
699874|NCT00967044|Hodgkin's lymphoma|hodgkin's lymphoma
699875|NCT00967044|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
699878|NCT00967044|Panobinostat|panobinostat
699879|NCT00967044|RAD001|rad001
699880|NCT00967044|Everolimus|everolimus
699881|NCT00967057|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
752880|NCT01174576|randomized controlled trial|randomized controlled trial
699882|NCT00967057|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
699883|NCT00967083|Quality of Life|quality of life
699884|NCT00967083|Questionnaires|questionnaires
699885|NCT00967083|Interviews|interviews
699886|NCT00967083|family members|family members
699887|NCT00967083|care givers|care givers
699888|NCT00967083|09-104|09-104
699889|NCT00967096|rifaximin|rifaximin
699890|NCT00967096|acute graft versus host disease|acute graft versus host disease
699891|NCT00967096|bone marrow transplant|bone marrow transplant
699892|NCT00967096|non-malignancy requiring BMT|non-malignancy requiring bmt
699893|NCT00967109|Anemia|anemia
699894|NCT00967109|Tissue oxygenation|tissue oxygenation
699895|NCT00967109|Spine surgery|spine surgery
699896|NCT00967122|adjustment, hunger|adjustment, hunger
699897|NCT00967122|Hunger/satiety changes before and after gastric band adjustment|hunger/satiety changes before and after gastric band adjustment
699898|NCT00967135|Thoracotomy|thoracotomy
699899|NCT00967135|Neuropathic pain|neuropathic pain
699900|NCT00967161|knee replacement motion analysis|knee replacement motion analysis
700100|NCT00967863|stage IV prostate cancer|stage iv prostate cancer
699901|NCT00967200|adult anaplastic astrocytoma|adult anaplastic astrocytoma
699902|NCT00967200|adult diffuse astrocytoma|adult diffuse astrocytoma
699903|NCT00967200|adult glioblastoma|adult glioblastoma
699904|NCT00967200|adult giant cell glioblastoma|adult giant cell glioblastoma
699905|NCT00967200|adult gliosarcoma|adult gliosarcoma
699906|NCT00967200|adult pilocytic astrocytoma|adult pilocytic astrocytoma
699907|NCT00967200|adult pineal gland astrocytoma|adult pineal gland astrocytoma
699908|NCT00967200|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
700210|NCT00968253|Everolimus|everolimus
699909|NCT00967200|adult brain stem glioma|adult brain stem glioma
699910|NCT00967200|adult choroid plexus tumor|adult choroid plexus tumor
699911|NCT00967200|adult craniopharyngioma|adult craniopharyngioma
699912|NCT00967200|adult ependymoblastoma|adult ependymoblastoma
699913|NCT00967200|adult medulloblastoma|adult medulloblastoma
699914|NCT00967200|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
699915|NCT00967200|adult anaplastic ependymoma|adult anaplastic ependymoma
699916|NCT00967200|adult ependymoma|adult ependymoma
699917|NCT00967200|adult myxopapillary ependymoma|adult myxopapillary ependymoma
699918|NCT00967200|adult subependymoma|adult subependymoma
699919|NCT00967200|meningeal melanocytoma|meningeal melanocytoma
699920|NCT00967200|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
699921|NCT00967200|adult grade I meningioma|adult grade i meningioma
699922|NCT00967200|adult grade II meningioma|adult grade ii meningioma
699923|NCT00967200|adult anaplastic meningioma|adult anaplastic meningioma
699924|NCT00967200|adult papillary meningioma|adult papillary meningioma
699925|NCT00967200|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
699926|NCT00967200|adult oligodendroglioma|adult oligodendroglioma
699927|NCT00967200|adult pineoblastoma|adult pineoblastoma
699928|NCT00967200|adult pineocytoma|adult pineocytoma
699929|NCT00967200|adult mixed glioma|adult mixed glioma
699930|NCT00967200|recurrent adult brain tumor|recurrent adult brain tumor
699931|NCT00967226|hemangioma|hemangioma
699932|NCT00967239|ductal breast carcinoma in situ|ductal breast carcinoma in situ
699933|NCT00967239|invasive ductal breast carcinoma|invasive ductal breast carcinoma
699934|NCT00967239|invasive lobular breast carcinoma|invasive lobular breast carcinoma
699935|NCT00967239|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
699937|NCT00967252|inflammation|inflammation
699938|NCT00967252|infection|infection
699939|NCT00967252|statins|statins
699940|NCT00967265|Introduction seminar|introduction seminar
699941|NCT00967265|Psychoeducation|psychoeducation
699942|NCT00967265|Waiting list|waiting list
699943|NCT00967265|Patient participation|patient participation
699944|NCT00967265|Mental disorders|mental disorders
699945|NCT00967278|OPCAB|opcab
699946|NCT00967278|pulmonary artery catheter|pulmonary artery catheter
699947|NCT00967278|esophageal doppler|esophageal doppler
699948|NCT00967278|hemodynamics|hemodynamics
699949|NCT00967291|acinar cell adenocarcinoma of the pancreas|acinar cell adenocarcinoma of the pancreas
699950|NCT00967291|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
699951|NCT00967291|stage IV pancreatic cancer|stage iv pancreatic cancer
699952|NCT00967291|recurrent pancreatic cancer|recurrent pancreatic cancer
699953|NCT00967304|Unprovoked Venous thromboembolism|unprovoked venous thromboembolism
699954|NCT00967304|Clinical decision rule|clinical decision rule
699955|NCT00967304|Anticoagulants|anticoagulants
699956|NCT00967304|Recurrence|recurrence
699957|NCT00967304|Prognostic|prognostic
699958|NCT00967304|Risk stratification|risk stratification
699959|NCT00967317|Auris-Sedina|auris-sedina
699960|NCT00967317|Otitis|otitis
699961|NCT00967317|Efficacy|efficacy
699962|NCT00967317|Tolerability|tolerability
699963|NCT00967343|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
699964|NCT00967343|Graft-versus-host disease|graft-versus-host disease
699965|NCT00967343|Immune reconstitution|immune reconstitution
699966|NCT00967343|Alloreactive T-cells|alloreactive t-cells
699967|NCT00967343|Photodepletion|photodepletion
699969|NCT00967343|Transplant related mortality|transplant related mortality
699970|NCT00967343|Hematologic malignancy|hematologic malignancy
699971|NCT00967356|Healthy volunteers|healthy volunteers
699972|NCT00967369|Lymphoma|lymphoma
699973|NCT00967369|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
699974|NCT00967369|Cancer|cancer
699975|NCT00967369|Bortezomib|bortezomib
699976|NCT00967369|Velcade|velcade
699977|NCT00967369|Chemotherapy|chemotherapy
699978|NCT00967369|ICE|ice
699979|NCT00967369|Ifosfamide|ifosfamide
699980|NCT00967369|Ifex|ifex
699981|NCT00967369|Mesna|mesna
699982|NCT00967369|Mesnex|mesnex
699983|NCT00967369|Carboplatin|carboplatin
699984|NCT00967369|Paraplatin|paraplatin
699985|NCT00967369|Etoposide|etoposide
699986|NCT00967369|VePesid|vepesid
699987|NCT00967369|BICE|bice
699988|NCT00967369|Pegfilgrastim|pegfilgrastim
699989|NCT00967369|Neulasta|neulasta
699990|NCT00967382|Pregnancy|pregnancy
699991|NCT00967382|Thrombophilia|thrombophilia
699992|NCT00967382|High-risk pregnancy|high-risk pregnancy
699993|NCT00967382|LMWH prophylaxis|lmwh prophylaxis
699994|NCT00967382|Placenta mediated pregnancy complications|placenta mediated pregnancy complications
699995|NCT00967408|Stroke|stroke
699996|NCT00967408|Antidepressive Agents,Second-Generation|antidepressive agents,second-generation
699997|NCT00967408|Treatment Outcome|treatment outcome
699998|NCT00967408|Rehabilitation|rehabilitation
699999|NCT00967421|Driving|driving
700000|NCT00967421|DUI|dui
700001|NCT00967421|Driving simulation|driving simulation
700002|NCT00967421|Drugs|drugs
700003|NCT00967421|Ethanol|ethanol
700007|NCT00967434|perioperative|perioperative
700009|NCT00967460|Childhood obesity|childhood obesity
700010|NCT00967460|Children|children
700011|NCT00967460|Inactivity|inactivity
700012|NCT00967460|Physical activity|physical activity
700013|NCT00967460|Motor skills|motor skills
700014|NCT00967460|Motor fitness|motor fitness
700015|NCT00967460|Quality of life|quality of life
700016|NCT00967460|Nutrition|nutrition
700017|NCT00967460|Family|family
700018|NCT00967473|Astigmatism|astigmatism
700019|NCT00967473|cataract|cataract
700020|NCT00967473|corneal astigmatism|corneal astigmatism
700021|NCT00967473|IOL|iol
700022|NCT00967473|AcrySof|acrysof
700023|NCT00967499|PONV|ponv
700024|NCT00967499|rescue|rescue
700025|NCT00967512|Oligonucleotides, Antisense|oligonucleotides, antisense
700026|NCT00967512|Tumor Suppressor Protein p53|tumor suppressor protein p53
700027|NCT00967512|idarubicin|idarubicin
700028|NCT00967512|cytarabine|cytarabine
700029|NCT00967525|AML|aml
700030|NCT00967525|ALL|all
700031|NCT00967525|leukemia|leukemia
700032|NCT00967525|CML|cml
700033|NCT00967525|Myelodysplastic Syndrome|myelodysplastic syndrome
700034|NCT00967525|malignancies|malignancies
700035|NCT00967525|Undifferentiated leukemia|undifferentiated leukemia
700036|NCT00967525|High risk malignancies|high risk malignancies
700037|NCT00967538|psoriasis|psoriasis
700038|NCT00967538|etanercept|etanercept
700039|NCT00967538|efficacy|efficacy
700040|NCT00967538|response|response
700041|NCT00967538|anti-TNF alpha|anti-tnf alpha
700042|NCT00967538|treatment efficacy|treatment efficacy
700043|NCT00967551|Diarrhea|diarrhea
700044|NCT00967551|Pneumonia|pneumonia
700045|NCT00967551|Upper respiratory infections|upper respiratory infections
700046|NCT00967551|Acute gastroenteritis|acute gastroenteritis
700047|NCT00967564|Myelodysplastic Syndrome|myelodysplastic syndrome
700048|NCT00967564|Quality of Life|quality of life
700049|NCT00967564|Anemia|anemia
700050|NCT00967564|Epoetin alfa|epoetin alfa
700051|NCT00967564|Eprex|eprex
700052|NCT00967603|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
700053|NCT00967603|stage IV pancreatic cancer|stage iv pancreatic cancer
700054|NCT00967616|metastatic|metastatic
700055|NCT00967616|colon|colon
700056|NCT00967616|rectum|rectum
700057|NCT00967616|combination|combination
700058|NCT00967616|chemotherapy|chemotherapy
700059|NCT00967629|Diabetic nephropathy|diabetic nephropathy
700060|NCT00967629|CKD progression|ckd progression
700061|NCT00967629|AGEs|ages
752588|NCT01167803|Anesthesia|anesthesia
700062|NCT00967629|oxidative stress|oxidative stress
700063|NCT00967629|dietary AGEs|dietary ages
700064|NCT00967642|Patients with Diabetes Mellitus Submitted to Percutaneous Coronary Intervention with Stent|patients with diabetes mellitus submitted to percutaneous coronary intervention with stent
700065|NCT00967655|adenocarcinoma of the rectum|adenocarcinoma of the rectum
700066|NCT00967655|stage I rectal cancer|stage i rectal cancer
700067|NCT00967655|stage II rectal cancer|stage ii rectal cancer
700068|NCT00967655|stage III rectal cancer|stage iii rectal cancer
700069|NCT00967668|Counseling|counseling
700070|NCT00967668|Veterans|veterans
700071|NCT00967668|Weight loss|weight loss
700072|NCT00967668|Physical activity|physical activity
700073|NCT00967668|Diet|diet
700074|NCT00967694|Glaucoma|glaucoma
700075|NCT00967694|Nitrous oxide|nitrous oxide
700076|NCT00967759|common cold|common cold
700077|NCT00967759|treatment|treatment
700078|NCT00967759|inflammatory symptoms of superior air passages affection|inflammatory symptoms of superior air passages affection
700079|NCT00967772|Pharmacokinetics|pharmacokinetics
700080|NCT00967772|Safety|safety
700081|NCT00967772|tolerability|tolerability
700082|NCT00967785|WHIM|whim
700083|NCT00967785|Mozobil (TM)|mozobil (tm)
700084|NCT00967785|Neutrophil Disorder|neutrophil disorder
700085|NCT00967785|Plerixafor|plerixafor
700086|NCT00967798|cystic fibrosis|cystic fibrosis
700087|NCT00967798|diabetes|diabetes
700088|NCT00967798|inflammation|inflammation
700089|NCT00967798|oxidative stress|oxidative stress
700090|NCT00967798|redox balance|redox balance
700091|NCT00967798|lung disease|lung disease
700092|NCT00967824|breast cancer|breast cancer
700093|NCT00967837|Diabetes with complications|diabetes with complications
700094|NCT00967837|Wound healing|wound healing
700095|NCT00967850|High Myopia|high myopia
700096|NCT00967850|Bevacizumab|bevacizumab
700097|NCT00967850|Photodynamic therapy|photodynamic therapy
700098|NCT00967863|adenocarcinoma of the prostate|adenocarcinoma of the prostate
700099|NCT00967863|stage III prostate cancer|stage iii prostate cancer
700101|NCT00967876|Men or women of any ethnic group scheduled to undergo conventional coronary angiography for suspected coronary artery stent stenosis|men or women of any ethnic group scheduled to undergo conventional coronary angiography for suspected coronary artery stent stenosis
700102|NCT00967889|stage III prostate cancer|stage iii prostate cancer
700103|NCT00967889|stage IV prostate cancer|stage iv prostate cancer
700104|NCT00967889|recurrent prostate cancer|recurrent prostate cancer
700105|NCT00967902|intracoronary stent|intracoronary stent
700106|NCT00967902|drug eluting stent|drug eluting stent
700107|NCT00967902|sirolimus|sirolimus
700108|NCT00967902|endothelial progenitor cells|endothelial progenitor cells
700109|NCT00967915|Ankyloglossia|ankyloglossia
700110|NCT00967915|Tongue tie|tongue tie
700111|NCT00967915|Frenotomy|frenotomy
700112|NCT00967915|Frenulectomy|frenulectomy
700113|NCT00967915|Breast feeding|breast feeding
700114|NCT00967915|HATLFF|hatlff
700115|NCT00967915|IBFAT|ibfat
700116|NCT00967928|Stage IV or Recurrent Cervical cancer|stage iv or recurrent cervical cancer
700117|NCT00967941|Vascular Surgery|vascular surgery
700118|NCT00967954|stage IIB prostate cancer|stage iib prostate cancer
700119|NCT00967954|stage IIA prostate cancer|stage iia prostate cancer
700120|NCT00967954|stage III prostate cancer|stage iii prostate cancer
700121|NCT00967954|stage IV prostate cancer|stage iv prostate cancer
700122|NCT00967967|control|control
700123|NCT00967967|symptoms|symptoms
700124|NCT00967980|pain|pain
700125|NCT00967980|Hip Resurfacing|hip resurfacing
700126|NCT00967980|catheter|catheter
700127|NCT00967980|nerve block|nerve block
700128|NCT00967980|UCSD|ucsd
700129|NCT00967980|hip surgery|hip surgery
700130|NCT00967980|psoas|psoas
700131|NCT00967980|femoral|femoral
700132|NCT00967980|ambulation|ambulation
700133|NCT00967980|hip flexion|hip flexion
700134|NCT00967980|infusion|infusion
700135|NCT00967993|hyperphosphatemia|hyperphosphatemia
700136|NCT00967993|end-stage renal disease|end-stage renal disease
700137|NCT00967993|ESRD|esrd
700138|NCT00967993|hemodialysis|hemodialysis
700139|NCT00967993|diabetes|diabetes
700140|NCT00967993|dialysis|dialysis
700141|NCT00968006|diabetes|diabetes
700142|NCT00968006|endothelium|endothelium
700143|NCT00968006|stem cells|stem cells
700144|NCT00968032|PFO|pfo
700145|NCT00968032|Patent Foramen Ovale|patent foramen ovale
700146|NCT00968045|Fibrinogen|fibrinogen
700147|NCT00968045|Postoperative bleeding|postoperative bleeding
700148|NCT00968045|Transfusions|transfusions
700149|NCT00968045|CABG|cabg
700150|NCT00968058|Leak Pressure|leak pressure
700151|NCT00968058|Intubation, Endotracheal|intubation, endotracheal
700152|NCT00968058|Pediatric|pediatric
700153|NCT00968058|Temporal Variation|temporal variation
700154|NCT00968071|Leukemia|leukemia
700155|NCT00968071|AML|aml
700156|NCT00968071|MDS|mds
700157|NCT00968071|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
700158|NCT00968071|Decitabine|decitabine
700159|NCT00968071|5-aza-2 deoxycytidine|5-aza-2 deoxycytidine
700160|NCT00968071|Dacogen|dacogen
700161|NCT00968071|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
700162|NCT00968071|Mylotarg|mylotarg
700163|NCT00968084|Diagnostic Work Up|diagnostic work up
700164|NCT00968084|Normal Volunteers|normal volunteers
700165|NCT00968084|HV|hv
700166|NCT00968084|Inflammatory Disease|inflammatory disease
700167|NCT00968084|Autoimmune Disease|autoimmune disease
700168|NCT00968084|Immunologic Disease|immunologic disease
700169|NCT00968084|Healthy Volunteer|healthy volunteer
700170|NCT00968097|Alzheimer' disease|alzheimer' disease
700171|NCT00968097|SPECT imaging|spect imaging
700172|NCT00968110|Milk Allergy|milk allergy
700173|NCT00968136|refractory infantile spasms|refractory infantile spasms
700174|NCT00968162|Bone Marrow Transplant|bone marrow transplant
700175|NCT00968162|Sickle Cell Disease|sickle cell disease
700176|NCT00968175|Ultrasound guided celiac plexus neurolysis|ultrasound guided celiac plexus neurolysis
700177|NCT00968175|CPN|cpn
700178|NCT00968175|Pancreatic Cancer|pancreatic cancer
700179|NCT00968175|Pain Management|pain management
700180|NCT00968188|HIV Risk|hiv risk
700181|NCT00968188|Internet Intervention|internet intervention
700182|NCT00968188|Homosexuality, Male|homosexuality, male
700183|NCT00968188|HIV Seronegativity|hiv seronegativity
700184|NCT00968214|stage IA breast cancer|stage ia breast cancer
700185|NCT00968214|stage IB breast cancer|stage ib breast cancer
700186|NCT00968214|stage II breast cancer|stage ii breast cancer
700187|NCT00968214|stage IIIA breast cancer|stage iiia breast cancer
700188|NCT00968214|stage IIIB breast cancer|stage iiib breast cancer
700189|NCT00968214|stage IIIC breast cancer|stage iiic breast cancer
700190|NCT00968214|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
700191|NCT00968214|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
700192|NCT00968227|subarachnoid hemorrhage|subarachnoid hemorrhage
700193|NCT00968227|vasospasm|vasospasm
700194|NCT00968227|transfusion|transfusion
700195|NCT00968227|cerebral oxygen delivery|cerebral oxygen delivery
700196|NCT00968227|hemoglobin|hemoglobin
700197|NCT00968240|GBM|gbm
700198|NCT00968240|AA|aa
700199|NCT00968240|AO|ao
700201|NCT00968240|Tumors|tumors
700202|NCT00968240|Malignant|malignant
700203|NCT00968240|Glioblastoma|glioblastoma
700204|NCT00968240|Multiforme|multiforme
700205|NCT00968240|Anaplastic|anaplastic
700206|NCT00968240|Astrocytoma|astrocytoma
700207|NCT00968253|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
700208|NCT00968253|ALL|all
700209|NCT00968253|Hyper-CVAD|hyper-cvad
700211|NCT00968253|6-mercaptopurine|6-mercaptopurine
700212|NCT00968253|Citrovorum|citrovorum
700213|NCT00968253|Cyclophosphamide|cyclophosphamide
700214|NCT00968253|Cytarabine|cytarabine
700215|NCT00968253|Dexamethasone|dexamethasone
700216|NCT00968253|Doxorubicin|doxorubicin
700218|NCT00968253|Methotrexate|methotrexate
700219|NCT00968253|MESNA|mesna
700220|NCT00968253|Pegfilgrastim|pegfilgrastim
700221|NCT00968253|Prednisone|prednisone
700222|NCT00968253|RAD001|rad001
700223|NCT00968253|Solumedrol|solumedrol
700224|NCT00968253|Vincristine Sulfate|vincristine sulfate
700225|NCT00968266|Adherence|adherence
700226|NCT00968266|Compliance|compliance
700227|NCT00968266|Rheumatoid Arthritis|rheumatoid arthritis
700228|NCT00968266|Intervention|intervention
700229|NCT00968266|Beliefs about medication|beliefs about medication
700230|NCT00968266|Motivational Interviewing|motivational interviewing
700231|NCT00968266|Medication adherence|medication adherence
700232|NCT00968266|Patient compliance|patient compliance
700233|NCT00968266|Intervention studies|intervention studies
700234|NCT00968279|Patients with atrial fibrillation|patients with atrial fibrillation
700235|NCT00968292|K3 Promoter prosthetic foot Tensegrity Prosthetics Jerome Rifkin|k3 promoter prosthetic foot tensegrity prosthetics jerome rifkin
700236|NCT00968305|African American children with stable asthma|african american children with stable asthma
700237|NCT00968305|Asthma severity|asthma severity
700238|NCT00968305|Interleukin 13 from PHA stimulated PBMC|interleukin 13 from pha stimulated pbmc
700239|NCT00968305|Lung function (FEV1%)|lung function (fev1%)
700240|NCT00968305|Total serum IgE|total serum ige
700241|NCT00968305|Pediatrics|pediatrics
700242|NCT00968318|Tissue expander|tissue expander
700243|NCT00968318|seroma|seroma
700244|NCT00968318|extrusion|extrusion
700245|NCT00968318|lymphatics|lymphatics
700246|NCT00968318|deep fascia|deep fascia
700247|NCT00968318|Rate of seroma formation after excision of strip of deep fascia|rate of seroma formation after excision of strip of deep fascia
700248|NCT00968331|relapsed and refractory DLBCL|relapsed and refractory dlbcl
700249|NCT00960232|vitamin D|vitamin d
700250|NCT00960232|blood pressure|blood pressure
700251|NCT00960232|lipids|lipids
700252|NCT00960232|infection|infection
700253|NCT00960232|depression|depression
700254|NCT00960258|Solid Tumors|solid tumors
700255|NCT00960271|Non-small cell lung cancer|non-small cell lung cancer
700256|NCT00960271|mediastinal lymph node|mediastinal lymph node
700257|NCT00960271|resectable|resectable
700258|NCT00960271|EBUS|ebus
700259|NCT00960271|stage IIIA|stage iiia
700260|NCT00960271|significant mediastinal lymph node at thoracic CT Scan|significant mediastinal lymph node at thoracic ct scan
700261|NCT00960284|stage IB pancreatic cancer|stage ib pancreatic cancer
700262|NCT00960284|stage II pancreatic cancer|stage ii pancreatic cancer
700263|NCT00960284|stage III pancreatic cancer|stage iii pancreatic cancer
700264|NCT00960284|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
700265|NCT00960297|Non-Small Cell Lung Cancer|non-small cell lung cancer
700266|NCT00960297|NSCLC|nsclc
700267|NCT00960297|Preoperative chemotherapy|preoperative chemotherapy
700268|NCT00960297|Bevacizumab|bevacizumab
700269|NCT00960297|Avastin|avastin
700270|NCT00960310|Treatment|treatment
700271|NCT00960323|pharmacokinetics|pharmacokinetics
700272|NCT00960336|HER2-negative breast cancer|her2-negative breast cancer
700273|NCT00960336|recurrent breast cancer|recurrent breast cancer
700274|NCT00960336|stage IV breast cancer|stage iv breast cancer
700275|NCT00960336|invasive ductal breast carcinoma|invasive ductal breast carcinoma
700276|NCT00960336|invasive lobular breast carcinoma|invasive lobular breast carcinoma
700277|NCT00960349|Gastric cancer|gastric cancer
700278|NCT00960349|Japanese|japanese
700280|NCT00960349|Safety and tolerability|safety and tolerability
700281|NCT00960349|Cediranib in combination with cisplatin plus a fluoropyrimidine|cediranib in combination with cisplatin plus a fluoropyrimidine
700282|NCT00960349|Cediranib|cediranib
700283|NCT00960349|Capecitabine|capecitabine
700285|NCT00960349|Cisplatin|cisplatin
700286|NCT00960349|Untreated locally advanced or metastatic unresectable gastric cancer (GC)|untreated locally advanced or metastatic unresectable gastric cancer (gc)
700287|NCT00960375|smoking cessation|smoking cessation
700288|NCT00960375|serious mental illness|serious mental illness
700289|NCT00960401|coronary calcium scoring|coronary calcium scoring
700290|NCT00960401|breast cancer patients|breast cancer patients
700291|NCT00960401|radiation treatment|radiation treatment
700292|NCT00960414|obesity|obesity
700293|NCT00960414|randomized controlled trial|randomized controlled trial
700294|NCT00960414|weight loss|weight loss
700295|NCT00960414|metabolic syndrome|metabolic syndrome
700296|NCT00960427|adenocarcinoma of the rectum|adenocarcinoma of the rectum
700297|NCT00960427|stage II rectal cancer|stage ii rectal cancer
700298|NCT00960427|stage III rectal cancer|stage iii rectal cancer
700299|NCT00960440|randomized double-blind placebo-controlled investigational drug oral therapy safety and efficacy|randomized double-blind placebo-controlled investigational drug oral therapy safety and efficacy
700300|NCT00960466|Stress, Psychological|stress, psychological
700301|NCT00960466|Neoplasms/psychology|neoplasms/psychology
700302|NCT00960466|Psychology|psychology
700303|NCT00960492|Astrocytic tumor|astrocytic tumor
700304|NCT00960492|Glioblastoma with oligodendroglial components|glioblastoma with oligodendroglial components
700305|NCT00960505|Diet|diet
700306|NCT00960505|Coronary heart disease|coronary heart disease
700307|NCT00960505|Obesity|obesity
700308|NCT00960505|Weight loss|weight loss
700309|NCT00960505|Weight maintenance|weight maintenance
700310|NCT00960518|HBV-related unresectable HCC|hbv-related unresectable hcc
700311|NCT00960518|TACE|tace
700312|NCT00960518|adefovir|adefovir
700313|NCT00960518|recurrence rate|recurrence rate
700314|NCT00960544|Capecitabine|capecitabine
700315|NCT00960544|Xeloda|xeloda
700316|NCT00960544|Gene expression|gene expression
700317|NCT00960544|Pharmacokinetic testing|pharmacokinetic testing
700318|NCT00960544|PK sampling|pk sampling
700319|NCT00960544|DNA analysis|dna analysis
700320|NCT00960557|hepatic tumor burden|hepatic tumor burden
700321|NCT00960557|liver cancer|liver cancer
700322|NCT00960557|liver carcinoma|liver carcinoma
700323|NCT00960557|carcinoma|carcinoma
700324|NCT00960557|hepatic cancer|hepatic cancer
700325|NCT00960557|hepatic carcinoma|hepatic carcinoma
700326|NCT00960557|VDA|vda
700327|NCT00960557|Vascular Disrupting Agent|vascular disrupting agent
700328|NCT00960570|healthy|healthy
700329|NCT00960570|adult|adult
700330|NCT00960570|efavirenz|efavirenz
700331|NCT00960570|fenofibric acid|fenofibric acid
700332|NCT00960570|blood levels|blood levels
700333|NCT00960583|Chronic low back pain|chronic low back pain
700334|NCT00960583|Multidisciplinary rehabilitation|multidisciplinary rehabilitation
700335|NCT00960583|Exercise|exercise
700336|NCT00960583|Cost-effectiveness|cost-effectiveness
700337|NCT00960596|educational intervention|educational intervention
700338|NCT00960596|asthma|asthma
700339|NCT00960596|Environmental Tobacco Smoke(ETS)|environmental tobacco smoke(ets)
700340|NCT00960596|children|children
700341|NCT00960609|Communicating veins|communicating veins
700342|NCT00960609|hepatic venous anastomosis|hepatic venous anastomosis
700343|NCT00960609|intra-operative ultrasonography|intra-operative ultrasonography
700344|NCT00960609|hepatic resection|hepatic resection
700345|NCT00960609|hepatic neoplasm|hepatic neoplasm
700346|NCT00960609|Primary and metastatic liver tumors|primary and metastatic liver tumors
700347|NCT00960622|treatment experienced|treatment experienced
700348|NCT00960635|new-onset|new-onset
700349|NCT00960648|Everolimus|everolimus
700350|NCT00960648|Sirolimus|sirolimus
700351|NCT00960648|Drug eluting stent|drug eluting stent
700352|NCT00960661|diabetes|diabetes
700353|NCT00960661|exenatide|exenatide
700354|NCT00960661|Byetta|byetta
700355|NCT00960661|insulin lispro|insulin lispro
700356|NCT00960661|Humalog|humalog
700357|NCT00960661|insulin glargine|insulin glargine
700358|NCT00960661|Lantus|lantus
700359|NCT00960661|Amylin|amylin
700360|NCT00960661|Lilly|lilly
700361|NCT00960687|healthy|healthy
700362|NCT00960687|pharmacokinetics|pharmacokinetics
700363|NCT00960687|therapeutic equivalency|therapeutic equivalency
700364|NCT00960700|MFlex|mflex
700365|NCT00960700|Multifocal|multifocal
700366|NCT00960700|630F|630f
700367|NCT00960713|observational cohort|observational cohort
700368|NCT00960713|rituximab|rituximab
700369|NCT00960713|off-label use|off-label use
700370|NCT00960713|auto-immunity|auto-immunity
700371|NCT00960713|cytopenia|cytopenia
700372|NCT00960726|Leukemia|leukemia
700373|NCT00960726|NOV-002|nov-002
700374|NCT00960726|Myelodysplastic Syndrome|myelodysplastic syndrome
700375|NCT00960726|MDS|mds
700376|NCT00960739|disseminated neuroblastoma|disseminated neuroblastoma
700377|NCT00960739|localized unresectable neuroblastoma|localized unresectable neuroblastoma
700378|NCT00960739|recurrent neuroblastoma|recurrent neuroblastoma
700379|NCT00960739|stage 4S neuroblastoma|stage 4s neuroblastoma
700380|NCT00960752|gp100 peptide|gp100 peptide
700381|NCT00960752|MAGE-3 peptide|mage-3 peptide
700382|NCT00960752|R848|r848
700383|NCT00960752|Resiquimod|resiquimod
700384|NCT00960752|Toll Like Receptor|toll like receptor
700385|NCT00960752|TLR|tlr
700386|NCT00960752|T-cells|t-cells
700387|NCT00960752|Tumor|tumor
700388|NCT00960752|Metastatic|metastatic
700389|NCT00960752|Lesions|lesions
700390|NCT00960752|Injection Site|injection site
700391|NCT00960765|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
700392|NCT00960765|Gastric Bypass|gastric bypass
700393|NCT00960765|Gastric Banding|gastric banding
700394|NCT00960765|Endotoxin|endotoxin
700395|NCT00960778|gender|gender
700396|NCT00960778|nicotine dependence|nicotine dependence
700397|NCT00960778|nicotine replacement therapy|nicotine replacement therapy
700398|NCT00960778|extinction|extinction
700399|NCT00960778|denicotinized cigarettes|denicotinized cigarettes
700400|NCT00960791|Type II diabetes mellitus|type ii diabetes mellitus
700401|NCT00960791|absorption|absorption
700402|NCT00960791|distribution|distribution
700403|NCT00960791|metabolism|metabolism
700404|NCT00960791|excretion|excretion
700405|NCT00960791|14C-labelled|14c-labelled
700406|NCT00960804|OA|oa
700605|NCT00961805|Fibromyalgia|fibromyalgia
700407|NCT00960817|Normal coronary artery with slow blood flow|normal coronary artery with slow blood flow
700408|NCT00960843|Morbid Obesity|morbid obesity
700409|NCT00960843|Gastric Banding|gastric banding
700410|NCT00960843|Bariatric Banding|bariatric banding
700411|NCT00960843|Swedish Adjustable Gastric Band|swedish adjustable gastric band
700412|NCT00960856|pharmacokinetics|pharmacokinetics
700413|NCT00960869|PA32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.|pa32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.
700414|NCT00960882|Pharmacokinetics|pharmacokinetics
700415|NCT00960882|Diabetes|diabetes
700416|NCT00960882|gastric tolerability|gastric tolerability
700417|NCT00960895|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
700418|NCT00960895|Pulmonary hypertension|pulmonary hypertension
700419|NCT00960908|Zotarolimus|zotarolimus
700420|NCT00960908|Drug eluting stent|drug eluting stent
700421|NCT00960908|Endeavor Resolute|endeavor resolute
700422|NCT00960921|Pulmonary artery pressure|pulmonary artery pressure
700423|NCT00960921|Hypoxia|hypoxia
700424|NCT00960921|Iron|iron
700425|NCT00960921|Hypoxia-inducible factor|hypoxia-inducible factor
700426|NCT00960921|High altitude|high altitude
700427|NCT00960934|Osteoporosis|osteoporosis
700428|NCT00960934|Postmenopausal|postmenopausal
700429|NCT00960934|MK-5442|mk-5442
700430|NCT00960960|MBC|mbc
700431|NCT00960960|PI3K|pi3k
700432|NCT00960960|Avastin|avastin
700433|NCT00960960|Herceptin|herceptin
700434|NCT00960973|vitamin K|vitamin k
700435|NCT00960973|beta cell|beta cell
700436|NCT00960973|glucose metabolism|glucose metabolism
700437|NCT00960973|insulin resistance|insulin resistance
700438|NCT00960999|stage I non-small cell lung cancer|stage i non-small cell lung cancer
700439|NCT00960999|squamous cell lung cancer|squamous cell lung cancer
700440|NCT00960999|adenocarcinoma of the lung|adenocarcinoma of the lung
700441|NCT00960999|large cell lung cancer|large cell lung cancer
700442|NCT00961012|Randomized control trial|randomized control trial
700443|NCT00961012|pressure mapping|pressure mapping
700444|NCT00961012|High Fowler's position|high fowler's position
700445|NCT00961012|bed|bed
700446|NCT00961012|ventilation|ventilation
700447|NCT00961012|slow vital capacity|slow vital capacity
700448|NCT00961012|older adult population|older adult population
700449|NCT00961012|65 years and older|65 years and older
700450|NCT00961038|Ciprofloxacin|ciprofloxacin
700451|NCT00961038|Inhalation|inhalation
700452|NCT00961038|Pharmacokinetics|pharmacokinetics
700453|NCT00961038|Safety|safety
700454|NCT00961038|Tolerability|tolerability
700455|NCT00961038|COPD|copd
700456|NCT00961051|adapted contact lens wearers|adapted contact lens wearers
700457|NCT00961064|Promacta|promacta
700458|NCT00961064|Thrombocytopenia|thrombocytopenia
700459|NCT00961064|Myelodysplastic Syndrome|myelodysplastic syndrome
700460|NCT00961064|MDS|mds
700461|NCT00961077|elderly|elderly
700462|NCT00961077|S-1|s-1
700463|NCT00961077|Oxaliplatin|oxaliplatin
700464|NCT00961077|relapsed or metastatic gastric cancer|relapsed or metastatic gastric cancer
700465|NCT00961090|Brain tumor|brain tumor
700466|NCT00961090|glioma|glioma
700467|NCT00961090|surgical resection|surgical resection
700468|NCT00961090|ALA|ala
700469|NCT00961090|ultraviolet light|ultraviolet light
700470|NCT00961103|spinal muscular atrophy|spinal muscular atrophy
700471|NCT00961103|motor development|motor development
700472|NCT00961103|orthoses|orthoses
700473|NCT00961116|healthy|healthy
700474|NCT00961116|pharmacokinetics|pharmacokinetics
700475|NCT00961116|therapeutic equivalency|therapeutic equivalency
700476|NCT00961116|fasting|fasting
700477|NCT00961116|procetofen|procetofen
700478|NCT00961116|fenofibric acid|fenofibric acid
700479|NCT00961129|colorectal cancer|colorectal cancer
700480|NCT00961129|needs|needs
700481|NCT00961129|survivors|survivors
700482|NCT00961129|any stage|any stage
700483|NCT00961142|Haploidentical Transplantation|haploidentical transplantation
700484|NCT00961142|CD3/CD19 Depletion|cd3/cd19 depletion
700485|NCT00961142|AML|aml
700486|NCT00961142|ALL|all
700487|NCT00961142|Reduced Intensity Conditioning|reduced intensity conditioning
700488|NCT00961155|asthma|asthma
700489|NCT00961155|children|children
700490|NCT00961155|EBC|ebc
700491|NCT00961155|exposure to tabacco|exposure to tabacco
700492|NCT00961155|antiasthma treatment|antiasthma treatment
700493|NCT00961168|Mechanical Ventilation|mechanical ventilation
700494|NCT00961181|paclitaxel|paclitaxel
700495|NCT00961181|in-stent restenosis|in-stent restenosis
700496|NCT00961181|BMS-ISR|bms-isr
700497|NCT00961181|DES-ISR|des-isr
700498|NCT00961181|drug eluting balloon|drug eluting balloon
700499|NCT00961194|Ketamine|ketamine
700500|NCT00961194|pain|pain
701272|NCT00972634|depression|depression
700501|NCT00961194|neuropathic pain|neuropathic pain
700502|NCT00961194|chronic|chronic
700503|NCT00961233|eosinophilic esophagitis|eosinophilic esophagitis
700504|NCT00961246|web based intervention|web based intervention
700505|NCT00961246|individually-tailored|individually-tailored
700506|NCT00961246|Chinese-American children|chinese-american children
700507|NCT00961246|compared the changes in physical activity level|compared the changes in physical activity level
700508|NCT00961246|changes in dietary intake|changes in dietary intake
700509|NCT00961246|changes in coping strategy used|changes in coping strategy used
700510|NCT00961246|changes in BMI|changes in bmi
700511|NCT00961259|healthy|healthy
700512|NCT00961259|pharmacokinetics|pharmacokinetics
700513|NCT00961259|therapeutic equivalency|therapeutic equivalency
700514|NCT00961259|fenofibric acid|fenofibric acid
700515|NCT00961272|Pre-menopausal|pre-menopausal
700516|NCT00961272|Pharmacokinetics|pharmacokinetics
700517|NCT00961272|Raltegravir|raltegravir
700518|NCT00961272|Women|women
700519|NCT00961272|HIV-infected|hiv-infected
700520|NCT00961285|pharmacogenomics|pharmacogenomics
700521|NCT00961285|genotyping|genotyping
700522|NCT00961298|IBS|ibs
700523|NCT00961298|Irritable Bowel Syndrome|irritable bowel syndrome
700524|NCT00961298|GAD|gad
700525|NCT00961298|Generalized Anxiety Disorder|generalized anxiety disorder
700526|NCT00961311|Balloon|balloon
700527|NCT00961311|Angioplasty|angioplasty
700528|NCT00961311|Coronary Artery|coronary artery
700529|NCT00961311|PCI|pci
700530|NCT00961311|PTCA|ptca
700531|NCT00961311|Heart Disease|heart disease
700532|NCT00961311|Myocardial Ischemia|myocardial ischemia
700533|NCT00961337|school children|school children
700534|NCT00961337|influenza vaccination|influenza vaccination
700535|NCT00961337|vaccine effectiveness|vaccine effectiveness
700536|NCT00961337|influenza attack rate|influenza attack rate
700537|NCT00961337|absenteeism|absenteeism
700538|NCT00961337|Influenza vaccine|influenza vaccine
700539|NCT00961350|PA32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.|pa32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.
700540|NCT00961376|melanoma|melanoma
700541|NCT00961376|unresectable stage III or IV melanoma|unresectable stage iii or iv melanoma
700542|NCT00961389|delirium|delirium
700543|NCT00961389|critical care|critical care
700544|NCT00961389|risk factors|risk factors
700545|NCT00961389|prediction|prediction
700546|NCT00961389|inflammation|inflammation
700547|NCT00961402|Exercise|exercise
700548|NCT00961402|PostParum Depression|postparum depression
700549|NCT00961428|Anorexia Nervosa|anorexia nervosa
700550|NCT00961428|Eating Disorders|eating disorders
700551|NCT00961428|Exercise|exercise
700552|NCT00961428|Physical Activity|physical activity
700553|NCT00961441|Levetiracetam|levetiracetam
700554|NCT00961441|Epilepsy|epilepsy
700555|NCT00961441|Children|children
700556|NCT00961441|Adults|adults
702093|NCT00974883|GCA|gca
700557|NCT00961454|Major depressive disorder, anxiety disorders, treatments, photobiomodulation, near infra-red phototherapy, cerebral blood flow|major depressive disorder, anxiety disorders, treatments, photobiomodulation, near infra-red phototherapy, cerebral blood flow
700558|NCT00961467|Relapsed/ refractory Multiple Myeloma|relapsed/ refractory multiple myeloma
700559|NCT00961506|cholecystectomy|cholecystectomy
700560|NCT00961506|gallbladder|gallbladder
700561|NCT00961506|laparoscopy|laparoscopy
700562|NCT00961506|laparoendoscopic|laparoendoscopic
700563|NCT00961532|intracerebral hemorrhage|intracerebral hemorrhage
700564|NCT00961532|platelets|platelets
700565|NCT00961558|varicocelectomy|varicocelectomy
700566|NCT00961558|male infertility|male infertility
700567|NCT00961558|clinical varicoceles|clinical varicoceles
700568|NCT00961558|randomized control trial|randomized control trial
700569|NCT00961571|colorectal cancer|colorectal cancer
700570|NCT00961571|sunitinib|sunitinib
700571|NCT00961571|capecitabine|capecitabine
700572|NCT00961597|Meniscus|meniscus
700573|NCT00961597|Avascular region|avascular region
700574|NCT00961597|Platelet rich plasma|platelet rich plasma
700575|NCT00961610|internet support|internet support
700576|NCT00961610|cancer|cancer
700577|NCT00961610|rehabilitation|rehabilitation
700578|NCT00961649|Open-Angle Glaucoma|open-angle glaucoma
700579|NCT00961649|Ocular Hypertension|ocular hypertension
700580|NCT00961649|Brinzolamide|brinzolamide
700581|NCT00961649|Brimonidine|brimonidine
700582|NCT00961649|Intraocular Pressure|intraocular pressure
700583|NCT00961675|otitis|otitis
700584|NCT00961675|acute|acute
700585|NCT00961675|externa|externa
700586|NCT00961675|ear|ear
700587|NCT00961688|PCOS|pcos
700588|NCT00961688|polycystic ovary syndrome|polycystic ovary syndrome
700589|NCT00961688|Polycystic ovarian syndrome|polycystic ovarian syndrome
700590|NCT00961688|infertility|infertility
700591|NCT00961688|ovulation|ovulation
700592|NCT00961714|VCF|vcf
700593|NCT00961727|Bedside Pews|bedside pews
700594|NCT00961727|Credit Valley Hospital|credit valley hospital
700595|NCT00961727|The Bedside Paediatric Early Warning System|the bedside paediatric early warning system
700596|NCT00961727|clinically deteriorating|clinically deteriorating
700597|NCT00961740|Childhood Obesity|childhood obesity
700598|NCT00961740|CBT|cbt
700599|NCT00961740|Family|family
700600|NCT00961740|Lifestyle change|lifestyle change
700601|NCT00961753|PDA|pda
700602|NCT00961753|Ibuprofen|ibuprofen
700603|NCT00961753|Preterm|preterm
700604|NCT00961753|Neonate|neonate
700608|NCT00961805|Randomized controlled study|randomized controlled study
700609|NCT00961805|Exercise|exercise
700610|NCT00961818|Voice|voice
700611|NCT00961818|Voice Quality|voice quality
700612|NCT00961818|Voice Training|voice training
700613|NCT00961818|Evaluation|evaluation
700614|NCT00961831|Neoplasm|neoplasm
700615|NCT00961831|PET/CT diagnosis|pet/ct diagnosis
700616|NCT00961831|PET tracer|pet tracer
700617|NCT00961870|bone|bone
700618|NCT00961870|motor neuron excitability|motor neuron excitability
700619|NCT00961870|forearm vibration|forearm vibration
700620|NCT00961870|Mechanical Loading|mechanical loading
700621|NCT00961883|HIV|hiv
700622|NCT00961883|Vaccine|vaccine
700623|NCT00961883|HIV Seronegativity|hiv seronegativity
700624|NCT00961883|Preventive Vaccine|preventive vaccine
700625|NCT00961896|Basal Cell Carcinoma|basal cell carcinoma
700626|NCT00961896|Gorlin Syndrome,|gorlin syndrome,
700627|NCT00961896|Gorlin-Goltz Syndrome,|gorlin-goltz syndrome,
700628|NCT00961896|Basal Cell Nevus Syndrome,|basal cell nevus syndrome,
700629|NCT00961896|Nevoid Basal Cell Carcinoma Syndrome,|nevoid basal cell carcinoma syndrome,
700630|NCT00961896|Basal Cell Carcinoma Nevus Syndrome|basal cell carcinoma nevus syndrome
700631|NCT00961922|childhood brain tumour survivors|childhood brain tumour survivors
700632|NCT00961935|bipolar disorder|bipolar disorder
700633|NCT00961935|child bipolar disorder|child bipolar disorder
700634|NCT00961935|adolescent bipolar disorder|adolescent bipolar disorder
700635|NCT00961935|pediatric bipolar disorder|pediatric bipolar disorder
700636|NCT00961935|fMRI|fmri
700637|NCT00961935|MRI|mri
700638|NCT00961935|EEG|eeg
700639|NCT00961935|neurocognitive tasks|neurocognitive tasks
700640|NCT00961948|Indigo carmine dye spraying|indigo carmine dye spraying
700641|NCT00961948|Narrow band imaging (NBI)|narrow band imaging (nbi)
700642|NCT00961948|Confocal Microscopy|confocal microscopy
700643|NCT00961961|Bipolar Disorder|bipolar disorder
700644|NCT00961961|Manic Depression|manic depression
700645|NCT00961961|Major Depressive Episode|major depressive episode
700646|NCT00961961|Mania|mania
700647|NCT00961961|Hypomania|hypomania
700648|NCT00961961|Long Term Treatment|long term treatment
700649|NCT00961974|type 1 diabetes|type 1 diabetes
700650|NCT00961974|hemoglobin A1c|hemoglobin a1c
700651|NCT00961974|family|family
700652|NCT00961974|involvement|involvement
700653|NCT00961974|responsibility|responsibility
700654|NCT00961974|conflict|conflict
700655|NCT00961974|quality of life|quality of life
700656|NCT00961974|children|children
700657|NCT00961987|Maternity care|maternity care
700658|NCT00961987|Interprofessional collaboration|interprofessional collaboration
700659|NCT00961987|Continuity of Care|continuity of care
700660|NCT00961987|Integration|integration
700661|NCT00962000|Hemodialysis|hemodialysis
700662|NCT00962000|Dialysis, Renal|dialysis, renal
700663|NCT00962026|Interleukin 1|interleukin 1
700664|NCT00962026|Type 1 diabetes mellitus|type 1 diabetes mellitus
700665|NCT00962026|Rilonacept|rilonacept
700666|NCT00962026|Arcalyst|arcalyst
700667|NCT00962039|Abdominal Pain|abdominal pain
700668|NCT00962039|Anxiety|anxiety
700669|NCT00962078|COPD|copd
700670|NCT00962078|Pre-Lung-Transplantation|pre-lung-transplantation
700671|NCT00962078|Intervall versus continuous training|intervall versus continuous training
700672|NCT00962078|6 MWD|6 mwd
700673|NCT00962091|Area under the plasma concentration versus time curve (AUC)|area under the plasma concentration versus time curve (auc)
700674|NCT00962091|Maximum plasma concentration (Cmax)|maximum plasma concentration (cmax)
751859|NCT01170897|Metastatic or Locally Advanced Solid Tumors|metastatic or locally advanced solid tumors
751860|NCT01170910|Chronic renal failure|chronic renal failure
700675|NCT00962091|Area under the plasma concentration versus time curve zero to the time of the last quantifiable concentration (AUC0-tlast)|area under the plasma concentration versus time curve zero to the time of the last quantifiable concentration (auc0-tlast)
700676|NCT00962091|Confidence intervals (CI)|confidence intervals (ci)
700677|NCT00962091|Time of first observed maximum plasma concentration (Tmax)|time of first observed maximum plasma concentration (tmax)
700678|NCT00962104|ADHD|adhd
700679|NCT00962117|Food Reinforcement|food reinforcement
700680|NCT00962117|Energy Intake|energy intake
700681|NCT00962117|Obesity|obesity
700682|NCT00962117|Dopamine|dopamine
700683|NCT00962130|tissue perfusion|tissue perfusion
700684|NCT00962130|reconstructive surgery|reconstructive surgery
700685|NCT00962130|continuous glucose monitoring|continuous glucose monitoring
700686|NCT00962143|Acute Achilles Tendon Tear|acute achilles tendon tear
700687|NCT00962143|Acute Achilles Tendon Repair|acute achilles tendon repair
700688|NCT00962156|Sepsis|sepsis
700689|NCT00962156|Shock|shock
700690|NCT00962156|Fluid therapy|fluid therapy
700691|NCT00962156|Plasma expanders|plasma expanders
700692|NCT00962169|Guideline adherence|guideline adherence
700693|NCT00962169|Implementation|implementation
700694|NCT00962169|Physical therapy|physical therapy
700695|NCT00962169|Low back pain|low back pain
700696|NCT00962169|Health plan implementation|health plan implementation
700697|NCT00962182|celiac disease|celiac disease
700698|NCT00962182|transglutaminase antibody|transglutaminase antibody
700699|NCT00962195|health|health
700700|NCT00962195|blood pressure|blood pressure
700701|NCT00962195|liver enzymes|liver enzymes
700702|NCT00962195|insulin resistance|insulin resistance
700703|NCT00962208|children|children
700704|NCT00962208|corneal reshaping|corneal reshaping
700705|NCT00962208|myopia|myopia
700706|NCT00962208|myopia control|myopia control
700707|NCT00962208|orthokeratology|orthokeratology
700708|NCT00962221|LDL lipoprotein subclasses in subclinical hypothyroidism|ldl lipoprotein subclasses in subclinical hypothyroidism
700709|NCT00962234|Lipogenesis|lipogenesis
700710|NCT00962234|Lipolysis|lipolysis
700711|NCT00962234|Phospholipids|phospholipids
700712|NCT00962234|Body Composition|body composition
700713|NCT00962234|Nutritional Status|nutritional status
700714|NCT00962234|Lipid Metabolism|lipid metabolism
700715|NCT00962247|physical activity|physical activity
700716|NCT00962247|relative reinforcing value|relative reinforcing value
700717|NCT00962247|sedentary behavior|sedentary behavior
700718|NCT00962247|obesity|obesity
700719|NCT00962260|glucocerebrosidase|glucocerebrosidase
700720|NCT00962260|enzyme replacement therapy|enzyme replacement therapy
700721|NCT00962260|Gaucher disease|gaucher disease
700722|NCT00962260|plant cell culture|plant cell culture
700723|NCT00962260|splenomegaly|splenomegaly
700724|NCT00962260|hepatomegaly|hepatomegaly
700725|NCT00962260|anemia|anemia
700726|NCT00962260|thrombocytopenia|thrombocytopenia
700727|NCT00962273|health personnel|health personnel
700728|NCT00962273|communicable diseases|communicable diseases
700729|NCT00962273|stress, psychological|stress, psychological
700730|NCT00962273|resilience, psychological|resilience, psychological
700731|NCT00962273|disaster planning|disaster planning
700732|NCT00962273|education|education
700733|NCT00962273|online|online
700734|NCT00962286|Furosemide|furosemide
700735|NCT00962286|obesity|obesity
700736|NCT00962299|Child|child
700737|NCT00962299|Wheezing|wheezing
700738|NCT00962299|Dyspnea|dyspnea
700739|NCT00962299|Inhaled corticosteroids|inhaled corticosteroids
700740|NCT00962312|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
700741|NCT00962312|recurrent pancreatic cancer|recurrent pancreatic cancer
700742|NCT00962312|stage IV pancreatic cancer|stage iv pancreatic cancer
700743|NCT00962325|Physical activity|physical activity
700744|NCT00962325|Obesity|obesity
700745|NCT00962325|Bariatric surgery|bariatric surgery
700746|NCT00962325|Weight Loss|weight loss
700747|NCT00962338|convalescence|convalescence
700748|NCT00962338|pain|pain
700749|NCT00962338|nausea|nausea
700750|NCT00962338|vomiting|vomiting
700751|NCT00962338|sexual dysfunction|sexual dysfunction
700752|NCT00962351|total hip replacement|total hip replacement
700753|NCT00962351|primary cementless total hip arthroplasty|primary cementless total hip arthroplasty
700754|NCT00962351|metal ion|metal ion
700755|NCT00962351|metal-on-metal|metal-on-metal
700756|NCT00962377|molecular expression testing|molecular expression testing
700757|NCT00962377|right ventricular endomyocardial biopsy|right ventricular endomyocardial biopsy
700758|NCT00962403|post traumatic stress disorder|post traumatic stress disorder
700759|NCT00962403|yoga|yoga
700760|NCT00962403|meditation|meditation
700761|NCT00962403|military|military
700762|NCT00962403|veteran|veteran
700763|NCT00962403|trauma|trauma
700764|NCT00962403|stress|stress
700765|NCT00962403|depression|depression
700766|NCT00962403|anxiety|anxiety
700767|NCT00962403|insomnia|insomnia
700768|NCT00962403|autonomic|autonomic
700769|NCT00962416|Drug eluting stent|drug eluting stent
700770|NCT00962416|Biolimus|biolimus
700771|NCT00962416|Biodegradable stent|biodegradable stent
751861|NCT01170910|Transplantation|transplantation
700772|NCT00962416|ST-elevation myocardial infarction|st-elevation myocardial infarction
700773|NCT00962416|Coronary artery disease|coronary artery disease
700774|NCT00962429|neuropathy, lipoic acid|neuropathy, lipoic acid
700775|NCT00962442|alcoholic hepatitis|alcoholic hepatitis
700776|NCT00962442|N-Acetylcysteine|n-acetylcysteine
700777|NCT00962442|enteral nutrition|enteral nutrition
700778|NCT00962442|oxidative stress|oxidative stress
700779|NCT00962442|severe acute alcoholic hepatitis|severe acute alcoholic hepatitis
700780|NCT00962455|Spirometry|spirometry
700781|NCT00962455|Family Practice|family practice
700782|NCT00962455|Randomized Controlled Trial|randomized controlled trial
700783|NCT00962455|Feedback|feedback
700784|NCT00962455|Intervention Studies|intervention studies
700785|NCT00962468|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
700786|NCT00962468|Critical Pathway|critical pathway
700787|NCT00962468|Cluster Randomized Controlled Trial|cluster randomized controlled trial
700788|NCT00962468|Safety|safety
700789|NCT00962468|Efficiency|efficiency
700790|NCT00962507|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
700791|NCT00962507|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
700792|NCT00962507|anaplastic large cell lymphoma|anaplastic large cell lymphoma
700793|NCT00962507|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
700794|NCT00962507|splenic marginal zone lymphoma|splenic marginal zone lymphoma
700795|NCT00962507|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
700796|NCT00962507|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
700797|NCT00962507|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
700886|NCT00968396|Stem Cell Transplant|stem cell transplant
700798|NCT00962507|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
700799|NCT00962507|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
700800|NCT00962507|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
700801|NCT00962507|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
700802|NCT00962507|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
700803|NCT00962507|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
700804|NCT00962507|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
700805|NCT00962507|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
700806|NCT00962507|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
700807|NCT00962507|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
700808|NCT00962507|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
700809|NCT00962507|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
700810|NCT00962507|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
700811|NCT00962507|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
700812|NCT00962507|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
700813|NCT00962507|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
700814|NCT00962507|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
700815|NCT00962507|refractory multiple myeloma|refractory multiple myeloma
700816|NCT00962520|pancreatic cancer|pancreatic cancer
700817|NCT00962520|resectable|resectable
700818|NCT00962520|Tarceva|tarceva
700819|NCT00962533|Chronic Hepatitis B|chronic hepatitis b
700820|NCT00962546|cerebral aneurysm|cerebral aneurysm
700821|NCT00962546|subarachnoid hemorrhage|subarachnoid hemorrhage
700822|NCT00962546|cerebral vasospasm|cerebral vasospasm
700823|NCT00962546|computed tomographic perfusion|computed tomographic perfusion
700824|NCT00962546|computed tomographic angiography|computed tomographic angiography
700825|NCT00962572|Outcomes|outcomes
700826|NCT00962572|Cancer|cancer
700827|NCT00962572|Radiotherapy|radiotherapy
700828|NCT00962572|Socio-economic|socio-economic
700829|NCT00962598|Adolescents|adolescents
700830|NCT00962598|Major Depressive Disorder|major depressive disorder
700831|NCT00962598|Proton Magnetic Resonance Spectroscopy|proton magnetic resonance spectroscopy
700832|NCT00962598|Immune System Activation|immune system activation
700833|NCT00962598|Omega-3 Fatty Acids|omega-3 fatty acids
700834|NCT00962611|Solid tumors|solid tumors
700835|NCT00962611|Advanced cancer|advanced cancer
700836|NCT00962624|Meningococcal|meningococcal
700837|NCT00962624|Vaccine|vaccine
700838|NCT00962624|Meningitis|meningitis
700839|NCT00962637|Secondary Hypogonadism|secondary hypogonadism
700840|NCT00962650|abdominal adhesions|abdominal adhesions
700841|NCT00962650|diagnostic peritoneoscopy|diagnostic peritoneoscopy
700842|NCT00962650|Natural Orifice Transluminal Endoscopic Surgery|natural orifice transluminal endoscopic surgery
700843|NCT00962650|NOTES|notes
700844|NCT00962676|suspicious of tuberculosis|suspicious of tuberculosis
700845|NCT00962676|immunocompromised patients|immunocompromised patients
700846|NCT00962689|chronic rhinosinusitis|chronic rhinosinusitis
700847|NCT00962689|biofilm|biofilm
700848|NCT00962689|sinus tissue|sinus tissue
700849|NCT00962689|nasal secretions|nasal secretions
700850|NCT00962689|proteomics|proteomics
700851|NCT00962689|diagnosis|diagnosis
700852|NCT00962689|decreased antibiotics|decreased antibiotics
700853|NCT00962689|Develop a test to identify patients with sinusitis subtypes|develop a test to identify patients with sinusitis subtypes
700855|NCT00962702|Left Atrial Appendage|left atrial appendage
700856|NCT00962702|Surgical|surgical
700857|NCT00962702|Open chest|open chest
700858|NCT00962715|Leukemia|leukemia
700860|NCT00962715|Influenza Vaccine Trivalent Inactivated|influenza vaccine trivalent inactivated
700861|NCT00962715|TIV|tiv
700862|NCT00962715|Flu|flu
700863|NCT00962715|Pegasys|pegasys
700864|NCT00962715|Pegylated interferon|pegylated interferon
700865|NCT00962715|Roferon|roferon
700866|NCT00962715|Interferon|interferon
700867|NCT00968357|SCV-07|scv-07
700868|NCT00968357|relapsers|relapsers
700869|NCT00968357|Hepatitis C|hepatitis c
700870|NCT00968370|Severe and very severe pneumonia|severe and very severe pneumonia
700871|NCT00968370|severe malnutrition|severe malnutrition
700872|NCT00968370|children|children
700873|NCT00968370|day-care management|day-care management
700874|NCT00968370|hospital management|hospital management
700875|NCT00968383|Acute Coronary Syndrome|acute coronary syndrome
701273|NCT00972634|cachexia|cachexia
700876|NCT00968383|Myocardial infarction|myocardial infarction
700877|NCT00968383|Infarct Related Artery|infarct related artery
700878|NCT00968383|Percutaneous Coronary Intervention|percutaneous coronary intervention
700879|NCT00968383|Medical treatment|medical treatment
700880|NCT00968383|Tissue Viability|tissue viability
700881|NCT00968383|Magnetic Resonance|magnetic resonance
700882|NCT00968396|Myeloma|myeloma
700883|NCT00968396|Ex-Vivo Depletion of Myeloma Cells|ex-vivo depletion of myeloma cells
700884|NCT00968396|Peripheral Blood Progenitor Cell Grafts|peripheral blood progenitor cell grafts
700885|NCT00968396|PBPC|pbpc
700887|NCT00968396|Bone marrow stem cells|bone marrow stem cells
700888|NCT00968396|Melphalan|melphalan
700889|NCT00968396|Alkeran|alkeran
700890|NCT00968396|Apheresis|apheresis
700891|NCT00968409|Breast Cancer|breast cancer
700892|NCT00968409|Hormone Receptor|hormone receptor
700893|NCT00968422|Pharmacology|pharmacology
700894|NCT00968422|Drug Safety|drug safety
700895|NCT00968422|Phase 1 Clinical Trials|phase 1 clinical trials
700896|NCT00968422|Pharmacokinetics|pharmacokinetics
700897|NCT00968435|bevacizumab|bevacizumab
700898|NCT00968435|cisplatin|cisplatin
700899|NCT00968435|cetuximab|cetuximab
700900|NCT00968435|radiation therapy|radiation therapy
700901|NCT00968435|Phase II|phase ii
700902|NCT00968435|09-083|09-083
700903|NCT00968448|respiratory muscle|respiratory muscle
700904|NCT00968448|breathing pattern|breathing pattern
700905|NCT00968448|exercise performance|exercise performance
700906|NCT00968461|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
700907|NCT00968461|CLL|cll
700908|NCT00968461|PEITC|peitc
700909|NCT00968461|Phenethyl Isothiocyanate|phenethyl isothiocyanate
700910|NCT00968461|Fludarabine|fludarabine
700911|NCT00968487|Lyophilized Plasma|lyophilized plasma
700912|NCT00968487|Fresh Frozen Plasma|fresh frozen plasma
700913|NCT00968487|Hemorrhage|hemorrhage
700914|NCT00968487|Coagulopathy|coagulopathy
700915|NCT00968487|Autologous|autologous
700916|NCT00968487|HemCon|hemcon
700917|NCT00968487|Plasmapheresis|plasmapheresis
700918|NCT00968487|Freeze Drying|freeze drying
700919|NCT00968487|Transfusion|transfusion
700920|NCT00968487|Resuscitation|resuscitation
700921|NCT00968487|Safety of Lyophilized Plasma in Normal, Healthy Volunteers|safety of lyophilized plasma in normal, healthy volunteers
700922|NCT00968500|Grief|grief
700923|NCT00968500|bereavement|bereavement
700924|NCT00968500|questionnaires|questionnaires
700925|NCT00968500|09-107|09-107
700926|NCT00968513|Smoking Cessation, Inpatient Psychiatry, Stages of Change|smoking cessation, inpatient psychiatry, stages of change
700927|NCT00968526|influenza infection|influenza infection
700928|NCT00968526|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
700929|NCT00968539|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
700930|NCT00968539|influenza infection|influenza infection
700931|NCT00968552|Any Gastrointestinal problem that would require an endoscopically placed stent|any gastrointestinal problem that would require an endoscopically placed stent
700932|NCT00968565|Heart Defects, Congenital|heart defects, congenital
700933|NCT00968565|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
700934|NCT00968565|Citric Acid|citric acid
700935|NCT00968565|Heparin|heparin
700936|NCT00968565|Respiratory Insufficiency|respiratory insufficiency
700937|NCT00968578|Knee arthroplasty|knee arthroplasty
700938|NCT00968578|Methylprednisolone|methylprednisolone
700939|NCT00968578|Post-operative pain|post-operative pain
700940|NCT00968591|Hepatic insufficiency|hepatic insufficiency
700941|NCT00968591|liver disease|liver disease
700942|NCT00968591|cirrhosis|cirrhosis
700943|NCT00968591|pharmacokinetics|pharmacokinetics
700944|NCT00968604|Pancreatic Cancer|pancreatic cancer
700945|NCT00968604|Pancreas|pancreas
700946|NCT00968604|Liver|liver
700947|NCT00968604|Liver Tumor Biopsy|liver tumor biopsy
700948|NCT00968604|BikDD Nanoparticle|bikdd nanoparticle
700949|NCT00968604|C-VISA BikDD|c-visa bikdd
700950|NCT00968617|Anemia|anemia
700951|NCT00968643|spinal cord compression|spinal cord compression
700952|NCT00968643|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
700953|NCT00968656|Breast cancer|breast cancer
700954|NCT00968656|Head and Neck Cancer|head and neck cancer
700955|NCT00968656|Diffuse Large B-cell lymphoma|diffuse large b-cell lymphoma
700956|NCT00968656|Cellular proliferation|cellular proliferation
700957|NCT00968682|cardiac toxicity|cardiac toxicity
700958|NCT00968682|HER2-positive breast cancer|her2-positive breast cancer
700959|NCT00968682|stage IA breast cancer|stage ia breast cancer
700960|NCT00968682|stage IB breast cancer|stage ib breast cancer
700961|NCT00968682|stage II breast cancer|stage ii breast cancer
700962|NCT00968682|stage IIIA breast cancer|stage iiia breast cancer
700963|NCT00968682|stage IIIB breast cancer|stage iiib breast cancer
700964|NCT00968682|stage IIIC breast cancer|stage iiic breast cancer
700965|NCT00971165|Hypertension|hypertension
700966|NCT00971165|Chlorthalidone|chlorthalidone
700968|NCT00971165|Losartan|losartan
700969|NCT00971165|treatment|treatment
700970|NCT00971178|Analgesia|analgesia
700971|NCT00971178|Dental pain|dental pain
700972|NCT00971178|Dexmedetomidine|dexmedetomidine
700973|NCT00971178|Pain|pain
700974|NCT00971178|Peripheral effects|peripheral effects
700975|NCT00971191|Stage I - III surgical resection molecular change brief pre-operative exposure|stage i - iii surgical resection molecular change brief pre-operative exposure
700976|NCT00971204|atrial fibrillation|atrial fibrillation
700977|NCT00971204|PAF|paf
700978|NCT00971217|Internet based Cognitive-Behavioural Intervention|internet based cognitive-behavioural intervention
700979|NCT00971217|Exercise Intervention|exercise intervention
700980|NCT00971217|Depression|depression
700981|NCT00971217|Perceived Social Support|perceived social support
700982|NCT00971217|Physical Self-Concept|physical self-concept
700983|NCT00971230|HIV|hiv
700984|NCT00971230|Human Immunodeficiency Virus|human immunodeficiency virus
700985|NCT00971243|Insulin resistance|insulin resistance
700986|NCT00971256|Bladder|bladder
700987|NCT00971256|Cancer|cancer
700988|NCT00971256|Cytology|cytology
700989|NCT00971295|eslicarbazepine acetate|eslicarbazepine acetate
700990|NCT00971295|zebinix|zebinix
700991|NCT00971295|metformin|metformin
700992|NCT00971321|influenza infection|influenza infection
700993|NCT00971321|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
700994|NCT00971334|Down Syndrome|down syndrome
700995|NCT00971334|Aneuploidy|aneuploidy
700996|NCT00971334|Amniocentesis|amniocentesis
700997|NCT00971334|CVS|cvs
700998|NCT00971347|obesity|obesity
700999|NCT00971347|overweight|overweight
701000|NCT00971347|weight loss|weight loss
701001|NCT00971347|randomized controlled trial|randomized controlled trial
701002|NCT00971347|chewing gum|chewing gum
701003|NCT00971360|conversion|conversion
701004|NCT00971360|cytokine|cytokine
701005|NCT00971360|inflammation|inflammation
701006|NCT00971373|antimicrobial|antimicrobial
701007|NCT00971373|epidemiology|epidemiology
701008|NCT00971373|bacteriology|bacteriology
701009|NCT00971373|CFU|cfu
701010|NCT00971386|Heart Failure|heart failure
701011|NCT00971425|influenza infection|influenza infection
701012|NCT00971425|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
701013|NCT00971438|appendicitis|appendicitis
701014|NCT00971438|diagnosis|diagnosis
701015|NCT00971438|diagnostic imaging|diagnostic imaging
701016|NCT00971438|clinical scoring system|clinical scoring system
701017|NCT00971451|Anterior cruciate ligament|anterior cruciate ligament
701018|NCT00971451|ACL|acl
701019|NCT00971464|AMD|amd
701020|NCT00971464|EV|ev
701021|NCT00971464|CCTV|cctv
701022|NCT00971464|Reading|reading
701023|NCT00971464|vision|vision
701024|NCT00971477|Teledermatology|teledermatology
701025|NCT00971477|Telemedicine|telemedicine
701026|NCT00971477|Psoriasis|psoriasis
701027|NCT00971490|COPD|copd
701028|NCT00971490|FEV1|fev1
701029|NCT00971490|beta endorphin|beta endorphin
701030|NCT00971490|SGRQ|sgrq
701031|NCT00971490|Acu-TENS|acu-tens
701032|NCT00971503|Diabetes type 1|diabetes type 1
701033|NCT00971503|Adult Stem cells|adult stem cells
701034|NCT00971503|Local injection|local injection
701035|NCT00971503|Catheter delivery|catheter delivery
701036|NCT00971503|Bone marrow|bone marrow
701037|NCT00971516|diabetes|diabetes
701038|NCT00971516|implants|implants
701039|NCT00971516|cytokines|cytokines
701040|NCT00971529|Smoking cessation|smoking cessation
701041|NCT00971529|tea filter|tea filter
701042|NCT00971542|Pandemic influenza|pandemic influenza
701043|NCT00971542|Vaccine|vaccine
701044|NCT00971555|Transient Hypothyroxinemia|transient hypothyroxinemia
701045|NCT00971555|Late Preterm Infants|late preterm infants
701046|NCT00971555|Total T4|total t4
701047|NCT00971555|TSH|tsh
701048|NCT00971555|Illness severity|illness severity
701049|NCT00971555|NICU|nicu
701050|NCT00971568|Interstitial cystitis|interstitial cystitis
701051|NCT00971568|Painful bladder syndrome|painful bladder syndrome
701052|NCT00971594|weight loss|weight loss
701053|NCT00971594|glucose metabolism|glucose metabolism
701054|NCT00971607|Acute myocardial infarction|acute myocardial infarction
701055|NCT00971607|Postconditioning|postconditioning
701056|NCT00971607|Sevoflurane|sevoflurane
701057|NCT00971620|Cutaneous Leiomyomas|cutaneous leiomyomas
701058|NCT00971620|Skin Pain|skin pain
701059|NCT00971620|Botox Therapy|botox therapy
701060|NCT00971620|Hereditary Leiomyomatosis|hereditary leiomyomatosis
701061|NCT00971620|Renal Cell Cancer|renal cell cancer
701062|NCT00971620|Cutaneous Leiomyoma|cutaneous leiomyoma
701063|NCT00971646|overactive bladder|overactive bladder
701064|NCT00971646|self-consciousness|self-consciousness
701065|NCT00971646|perceptual urge sensation|perceptual urge sensation
701066|NCT00971659|type 2 diabetes|type 2 diabetes
701067|NCT00971672|Infants|infants
701068|NCT00971672|Iron Deficiency|iron deficiency
701069|NCT00971672|Anemia|anemia
701070|NCT00971672|Healthy infants that attend the pediatric community clinics|healthy infants that attend the pediatric community clinics
701071|NCT00971698|Splenectomy|splenectomy
701072|NCT00971698|Thrombocytosis|thrombocytosis
701073|NCT00971698|Infections|infections
701074|NCT00971698|Spleen|spleen
701075|NCT00971698|Sickle Cell Thalassemia|sickle cell thalassemia
701076|NCT00971711|IBS|ibs
701077|NCT00971711|irritable bowel syndrome|irritable bowel syndrome
701078|NCT00971711|abdominal pain|abdominal pain
701079|NCT00971711|urgency|urgency
701080|NCT00971711|bloating|bloating
701081|NCT00971711|diarrhea|diarrhea
701082|NCT00971724|Prednisolone|prednisolone
701083|NCT00971724|Glucocorticoids|glucocorticoids
701084|NCT00971737|stage IV breast cancer|stage iv breast cancer
701085|NCT00971737|male breast cancer|male breast cancer
701086|NCT00971750|ultrasonography|ultrasonography
701087|NCT00971750|gallbladder|gallbladder
701088|NCT00971750|cholelithiasis|cholelithiasis
701089|NCT00971750|laparoscopic|laparoscopic
701090|NCT00971750|gastric bypass|gastric bypass
701091|NCT00971750|obesity|obesity
701092|NCT00971750|bariatric surgery|bariatric surgery
701093|NCT00971763|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
701094|NCT00971763|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
701095|NCT00971763|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
701096|NCT00971763|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
701097|NCT00971763|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
701098|NCT00971776|Patient receiving AB5000 ventricle potentially recoverable|patient receiving ab5000 ventricle potentially recoverable
701099|NCT00971789|Sirolimus|sirolimus
701100|NCT00971789|Cowden Syndrome|cowden syndrome
701101|NCT00971789|PTEN Mutation|pten mutation
701102|NCT00971789|Hamartoma Syndrome|hamartoma syndrome
701103|NCT00971815|HPA-axis|hpa-axis
701104|NCT00971815|fetal programming|fetal programming
701105|NCT00971828|Myositis|myositis
701106|NCT00971828|polymyositis|polymyositis
701107|NCT00971828|dermatomyositis|dermatomyositis
701108|NCT00971854|Dystonia|dystonia
701109|NCT00971880|Blood transfusions|blood transfusions
701110|NCT00971880|Adverse events|adverse events
701111|NCT00971880|Hepatitis C|hepatitis c
701112|NCT00971880|HIV|hiv
701113|NCT00971893|Acute Exacerbation of Bronchial Asthma Acute Asthma|acute exacerbation of bronchial asthma acute asthma
701114|NCT00971906|Pandemic influenza|pandemic influenza
701115|NCT00971906|Vaccine|vaccine
701116|NCT00971919|pain|pain
701117|NCT00971919|perioperative/postoperative complications|perioperative/postoperative complications
701118|NCT00971919|breast cancer in situ|breast cancer in situ
701119|NCT00971919|stage IA breast cancer|stage ia breast cancer
701120|NCT00971919|stage IB breast cancer|stage ib breast cancer
701121|NCT00971919|stage II breast cancer|stage ii breast cancer
701122|NCT00971919|stage IIIA breast cancer|stage iiia breast cancer
701123|NCT00971919|stage IIIB breast cancer|stage iiib breast cancer
701124|NCT00971919|stage IIIC breast cancer|stage iiic breast cancer
701125|NCT00971932|Recurrent and/or metastatic|recurrent and/or metastatic
701126|NCT00971932|SCCHN|scchn
701127|NCT00971958|HIV prevention|hiv prevention
701128|NCT00971958|infant, neonatal, male circumcision|infant, neonatal, male circumcision
701129|NCT00971971|Hypotension|hypotension
701130|NCT00971971|Acute renal failure|acute renal failure
701131|NCT00971971|acute kidney injury|acute kidney injury
701132|NCT00971971|dialysis|dialysis
701134|NCT00972010|Breast|breast
701135|NCT00972010|Cancer|cancer
701136|NCT00972010|Lumpectomies|lumpectomies
701137|NCT00972010|PlasmaBlade|plasmablade
701138|NCT00972010|Breast conservation therapy|breast conservation therapy
701139|NCT00972023|triple-negative breast cancer|triple-negative breast cancer
701140|NCT00972023|stage I breast cancer|stage i breast cancer
701141|NCT00972023|stage II breast cancer|stage ii breast cancer
701142|NCT00972023|stage IIIA breast cancer|stage iiia breast cancer
701143|NCT00972023|stage IIIB breast cancer|stage iiib breast cancer
701144|NCT00972023|stage IIIC breast cancer|stage iiic breast cancer
701145|NCT00972036|COLON|colon
701146|NCT00972036|LIVER|liver
701147|NCT00972036|RECTUM|rectum
701148|NCT00972036|SIR-Spheres|sir-spheres
703560|NCT00980018|CML|cml
701149|NCT00972036|09-030|09-030
701150|NCT00972049|safety|safety
701151|NCT00972049|tolerability|tolerability
701152|NCT00972049|AZD2516|azd2516
701153|NCT00972049|pain|pain
701154|NCT00972049|Japanese|japanese
701155|NCT00972062|Subcutaneous injections|subcutaneous injections
701156|NCT00972062|Skin abnormalities|skin abnormalities
701157|NCT00972075|totally blind subjects|totally blind subjects
701158|NCT00972088|inflammation of the small bowel|inflammation of the small bowel
701159|NCT00972101|Blood And Marrow Transplantation|blood and marrow transplantation
701160|NCT00972101|Leukemia|leukemia
701161|NCT00972101|Lymphoma|lymphoma
701162|NCT00972101|Pediatrics|pediatrics
701163|NCT00972101|Etoposide|etoposide
701164|NCT00972101|Expanded Cord Blood T Cells|expanded cord blood t cells
701165|NCT00972101|Filgrastim|filgrastim
701166|NCT00972101|Fludarabine|fludarabine
701167|NCT00972101|Melphalan|melphalan
701168|NCT00972101|Mycophenolate Mofetil|mycophenolate mofetil
701169|NCT00972101|Rituximab|rituximab
701170|NCT00972101|Tacrolimus|tacrolimus
701171|NCT00972101|Thiotepa|thiotepa
701172|NCT00972101|Thymoglobulin|thymoglobulin
701173|NCT00972101|Total Body Irradiation|total body irradiation
701174|NCT00972140|Patients with stable COPD|patients with stable copd
701274|NCT00972634|pain|pain
701175|NCT00972153|Decrease in CFU density at surgery site|decrease in cfu density at surgery site
701176|NCT00972153|Decrease in airborne particulate at surgery site|decrease in airborne particulate at surgery site
701177|NCT00972179|healthy volunteers|healthy volunteers
701178|NCT00972192|HIV testing|hiv testing
701179|NCT00972192|HIV risk behavior|hiv risk behavior
701180|NCT00972192|access to care|access to care
701181|NCT00972205|Pgp|pgp
701182|NCT00972205|Solid Tumors|solid tumors
701183|NCT00972205|Drug Resistance|drug resistance
701184|NCT00972205|Sestamibi|sestamibi
701185|NCT00972205|Cancer|cancer
701187|NCT00972218|Spondyloarthritis|spondyloarthritis
701188|NCT00972218|Ankylosing Spondylitis|ankylosing spondylitis
701189|NCT00972218|Crohn's disease|crohn's disease
701190|NCT00972218|adalimumab|adalimumab
701191|NCT00972218|treatment|treatment
701192|NCT00972231|Thalassemia Major|thalassemia major
701193|NCT00972231|Thalassemia Intermedia|thalassemia intermedia
701194|NCT00972231|Sickle Cell Anemia|sickle cell anemia
701195|NCT00972231|Sickle Cell Thalassemia|sickle cell thalassemia
701196|NCT00972231|Iron Overload|iron overload
701197|NCT00972231|Growth Velocity|growth velocity
701198|NCT00972244|Type 2 diabetes mellitus|type 2 diabetes mellitus
701199|NCT00972244|Japanese|japanese
701200|NCT00972244|phase 2|phase 2
701201|NCT00972244|efficacy|efficacy
701202|NCT00972244|safety|safety
701203|NCT00972244|dapagliflozin|dapagliflozin
701204|NCT00972257|24-hour IOP control|24-hour iop control
701205|NCT00972257|primary open-angle glaucoma|primary open-angle glaucoma
701206|NCT00972257|brimonidine/timolol|brimonidine/timolol
701207|NCT00972257|dorzolamide/timolol|dorzolamide/timolol
701208|NCT00972270|Arterial Occlusive Disease|arterial occlusive disease
701209|NCT00972270|Heart Diseases|heart diseases
701210|NCT00972270|Myocardial Ischemia|myocardial ischemia
701211|NCT00972270|Vascular Disease|vascular disease
701212|NCT00972270|Arteriosclerosis|arteriosclerosis
701213|NCT00972270|Ischemia|ischemia
701214|NCT00972309|Epotope-Enhanced TARP Peptide|epotope-enhanced tarp peptide
701215|NCT00972309|Prostate Cancer|prostate cancer
701216|NCT00972309|TARP Peptide-Pulsed Dendritic Cells|tarp peptide-pulsed dendritic cells
701217|NCT00972309|PSADT|psadt
701218|NCT00972309|HLA-A*0201|hla-a*0201
701219|NCT00972335|Avastin|avastin
701220|NCT00972335|RAD001|rad001
701221|NCT00972335|Meningioma|meningioma
701222|NCT00972335|Bevacizumab|bevacizumab
701223|NCT00972335|Everolimus|everolimus
701224|NCT00972335|Brain|brain
701225|NCT00972348|HIV|hiv
701226|NCT00972348|Personal Health Record|personal health record
701227|NCT00972348|Laboratory values: CD4 cells and HIV Viral load|laboratory values: cd4 cells and hiv viral load
701228|NCT00972348|Medication Reconciliation|medication reconciliation
701229|NCT00972361|Adenoidectomy|adenoidectomy
701230|NCT00972361|Tonsillectomy|tonsillectomy
701231|NCT00972361|Ventilation Tubes|ventilation tubes
701232|NCT00972361|Preoperational screening|preoperational screening
701233|NCT00972361|Coagulation Profile|coagulation profile
701234|NCT00972361|Lupus anticoagulant|lupus anticoagulant
701235|NCT00972387|carbohydrate-protein|carbohydrate-protein
701236|NCT00972387|endurance exercise|endurance exercise
701237|NCT00972387|supplement|supplement
701238|NCT00972400|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
701239|NCT00972400|fatigue|fatigue
701240|NCT00972400|cancer survivor|cancer survivor
701241|NCT00972400|breast cancer|breast cancer
701242|NCT00972413|breast cancer|breast cancer
701243|NCT00972413|cone beam computed tomography|cone beam computed tomography
701244|NCT00972439|Oral Contraceptives|oral contraceptives
701245|NCT00972439|Breast Tissue|breast tissue
701246|NCT00972452|Type II Diabetes|type ii diabetes
701247|NCT00972452|Insulin Resistance|insulin resistance
701248|NCT00972452|Exercise|exercise
701249|NCT00972452|Continuous Glucose Monitoring|continuous glucose monitoring
701250|NCT00972465|nimotuzumab colorectal cancer chemotherapy|nimotuzumab colorectal cancer chemotherapy
701251|NCT00972504|Proof of concept|proof of concept
701252|NCT00972517|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
701253|NCT00972517|influenza infection|influenza infection
701254|NCT00972530|rheumatoid arthritis|rheumatoid arthritis
701255|NCT00972530|treatment|treatment
701256|NCT00972543|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
701257|NCT00972543|palms and/or soles|palms and/or soles
701258|NCT00972543|with or without pustules|with or without pustules
701259|NCT00972556|Mineral Trioxide Aggregate|mineral trioxide aggregate
701260|NCT00972556|Formocresol|formocresol
701261|NCT00972556|pulpotomy|pulpotomy
701262|NCT00972556|primary molar|primary molar
701263|NCT00972556|treatment outcome|treatment outcome
701264|NCT00972569|BNP with or without PDE-V in heart failure|bnp with or without pde-v in heart failure
701265|NCT00972582|leucine intake|leucine intake
701266|NCT00972582|tolerable upper limit|tolerable upper limit
701267|NCT00972582|adults|adults
701268|NCT00972582|amino acid supplements|amino acid supplements
701269|NCT00972582|Excessive Leucine Intake|excessive leucine intake
701270|NCT00972608|congenital heart disease|congenital heart disease
701271|NCT00972608|surgical planning|surgical planning
701275|NCT00972634|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
701276|NCT00972647|fracture|fracture
701277|NCT00972647|fixation|fixation
701278|NCT00972647|fluoroscopy|fluoroscopy
701279|NCT00972647|laser|laser
701280|NCT00972647|radiation|radiation
701281|NCT00972660|Mesenchymal stem cell|mesenchymal stem cell
701282|NCT00972660|Efficacy|efficacy
701283|NCT00972660|Safety|safety
701284|NCT00972686|solid tumors|solid tumors
701286|NCT00972686|Phosphoinositide 3-kinase inhibitor|phosphoinositide 3-kinase inhibitor
701287|NCT00972699|Human Immunodeficiency Virus|human immunodeficiency virus
701288|NCT00972699|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
701289|NCT00972699|Tuberculosis|tuberculosis
701290|NCT00972699|Women|women
701291|NCT00972699|Pregnancy|pregnancy
701292|NCT00972699|Vertical Transmission of Human Immunodeficiency Virus|vertical transmission of human immunodeficiency virus
701293|NCT00972699|South Africa|south africa
701294|NCT00972699|Low Birth Weight|low birth weight
701295|NCT00972712|Multiple Myeloma|multiple myeloma
701296|NCT00972725|Chloroquine|chloroquine
701297|NCT00972725|Human Immunodeficiency Virus|human immunodeficiency virus
701298|NCT00972751|stage II rectal cancer|stage ii rectal cancer
701299|NCT00972751|stage III rectal cancer|stage iii rectal cancer
701300|NCT00972751|adenocarcinoma of the rectum|adenocarcinoma of the rectum
701301|NCT00972764|Laryngomalacia|laryngomalacia
701302|NCT00972764|Factors Associated or Predisposing|factors associated or predisposing
701303|NCT00972790|brain tumor|brain tumor
701304|NCT00972790|un-ruptured aneurysm|un-ruptured aneurysm
701305|NCT00972790|arteriovenous malformation|arteriovenous malformation
701306|NCT00972790|epileptic focus|epileptic focus
701307|NCT00972790|supratentorial|supratentorial
701308|NCT00972803|gingivitis|gingivitis
701309|NCT00972803|dental plaque|dental plaque
701310|NCT00972803|mouthrinse|mouthrinse
701311|NCT00972816|Swine Flu|swine flu
701313|NCT00972816|Vaccine|vaccine
701314|NCT00972816|Children|children
701315|NCT00972816|Adjuvant|adjuvant
701316|NCT00972829|Hypercholesterolemia|hypercholesterolemia
701317|NCT00972842|PTCL|ptcl
701318|NCT00972842|Peripheral T-Cell Non-Hodgkin's Lymphoma|peripheral t-cell non-hodgkin's lymphoma
701319|NCT00972842|Vorinostat|vorinostat
701320|NCT00972842|Lenalidomid|lenalidomid
701321|NCT00972855|Bioequivalence|bioequivalence
701322|NCT00972868|Unidirectional mask|unidirectional mask
701323|NCT00972868|NPPV|nppv
701324|NCT00972868|COPD|copd
701325|NCT00972868|respiratory physiology|respiratory physiology
701326|NCT00972881|adenocarcinoma of the rectum|adenocarcinoma of the rectum
701327|NCT00972881|Locally advanced rectal cancer|locally advanced rectal cancer
701328|NCT00972894|Group B streptococcus|group b streptococcus
701329|NCT00972894|Polymerase chain reaction|polymerase chain reaction
701330|NCT00972894|PCR|pcr
701331|NCT00972894|Intrapartum screening|intrapartum screening
701332|NCT00972894|Risk factors|risk factors
701333|NCT00972894|arly onset Group B streptococcus infection|arly onset group b streptococcus infection
701334|NCT00972907|anal fissure|anal fissure
701335|NCT00972907|pain|pain
701336|NCT00972907|nifedipine|nifedipine
701337|NCT00972920|Transversus abdominis plane|transversus abdominis plane
701338|NCT00972920|Acute pain service|acute pain service
701339|NCT00972920|Ultrasound|ultrasound
701340|NCT00972933|Immunogenicity Analysis|immunogenicity analysis
701341|NCT00972933|Biomarker Analysis|biomarker analysis
701342|NCT00972933|experimental|experimental
701343|NCT00972946|MRI|mri
701344|NCT00972946|SPIO|spio
701345|NCT00972959|multiple myeloma|multiple myeloma
701346|NCT00972959|1-3 Prior Lines of Therapy|1-3 prior lines of therapy
701347|NCT00972959|bortezomib (Velcade)|bortezomib (velcade)
701348|NCT00972959|zoledronic acid (Zometa)|zoledronic acid (zometa)
701349|NCT00972959|Dexamethasone|dexamethasone
701350|NCT00972959|bone mineral density|bone mineral density
701351|NCT00972959|bone pain|bone pain
701352|NCT00972959|bone metabolism|bone metabolism
701353|NCT00972959|osteolytic lesions|osteolytic lesions
701354|NCT00972959|DEXA-scans|dexa-scans
701355|NCT00972959|X-ray radiography|x-ray radiography
701356|NCT00972972|fruit polyphenols|fruit polyphenols
701357|NCT00972972|phytochemicals|phytochemicals
701358|NCT00972972|neurocognition|neurocognition
701359|NCT00972972|neuropsychology|neuropsychology
701360|NCT00972972|psychopharmacology|psychopharmacology
701361|NCT00972972|gene expression|gene expression
701362|NCT00972972|biochemistry|biochemistry
701363|NCT00972985|Healthy Control subjects|healthy control subjects
701364|NCT00972998|anal sphincter pressure|anal sphincter pressure
701365|NCT00972998|phenyephrine|phenyephrine
701366|NCT00973011|GA|ga
701367|NCT00973024|JNJ-42160443|jnj-42160443
701368|NCT00973024|Low back pain-related pain|low back pain-related pain
701369|NCT00973024|moderate to severe, chronic pain|moderate to severe, chronic pain
701370|NCT00973037|Breast neoplasms|breast neoplasms
701371|NCT00973037|Tamoxifen|tamoxifen
701372|NCT00973037|Genotype|genotype
701373|NCT00973037|CYP2D6|cyp2d6
701374|NCT00973050|Bioequivalence|bioequivalence
701375|NCT00973063|bacteremia|bacteremia
701376|NCT00973063|blood culture|blood culture
701377|NCT00973063|contamination|contamination
701378|NCT00973076|Phase I, cancer|phase i, cancer
701379|NCT00973076|solid tumors|solid tumors
701380|NCT00973076|advanced solid malignancies|advanced solid malignancies
701381|NCT00973076|dose escalation|dose escalation
701382|NCT00973076|mTOR Kinase Inhibitor|mtor kinase inhibitor
701383|NCT00973076|Japanese|japanese
701384|NCT00973089|Primary tooth|primary tooth
701385|NCT00973089|Caries, Dental|caries, dental
701386|NCT00973089|Alternative treatment|alternative treatment
701387|NCT00973141|Moderate to severe, osteoarthritis-related pain|moderate to severe, osteoarthritis-related pain
701388|NCT00973141|Osteoarthritis-related pain|osteoarthritis-related pain
701389|NCT00973141|Moderate to severe chronic pain|moderate to severe chronic pain
701390|NCT00973141|JNJ-42160443|jnj-42160443
701391|NCT00973154|Pneumonia|pneumonia
701392|NCT00973154|Corticosteroids|corticosteroids
701393|NCT00973154|clinical stability|clinical stability
701394|NCT00973167|Fracture rate|fracture rate
701395|NCT00973167|Fracture risks|fracture risks
701396|NCT00973180|Prescription medication understanding among diabetic and hypertension patients.|prescription medication understanding among diabetic and hypertension patients.
701397|NCT00973180|Prescription medication use among diabetic and hypertension patients.|prescription medication use among diabetic and hypertension patients.
701398|NCT00973180|Hemoglobin A1c changes among diabetic patients.|hemoglobin a1c changes among diabetic patients.
701399|NCT00973180|Blood pressure changes among hypertension patients.|blood pressure changes among hypertension patients.
701400|NCT00973193|rectum|rectum
701401|NCT00973193|colorectal|colorectal
701402|NCT00973193|cancer|cancer
701403|NCT00973193|adenocarcinoma|adenocarcinoma
701404|NCT00973193|anti-EGFR|anti-egfr
701405|NCT00973193|monoclonal antibodies|monoclonal antibodies
701406|NCT00973193|neoadjuvant therapy|neoadjuvant therapy
701407|NCT00973193|preoperative radiotherapy|preoperative radiotherapy
701408|NCT00973206|cardiovascular morbidity|cardiovascular morbidity
701409|NCT00973206|mortality community study|mortality community study
701410|NCT00973219|HBsAg loss|hbsag loss
701411|NCT00973219|HBsAg seroconversion|hbsag seroconversion
701412|NCT00973219|chronic hepatitis B|chronic hepatitis b
701413|NCT00973219|low viral load|low viral load
701414|NCT00973219|inactive carrier hepatitis B|inactive carrier hepatitis b
701415|NCT00973232|Tramadol|tramadol
701416|NCT00973232|Acetaminophen|acetaminophen
701417|NCT00973232|combination|combination
701418|NCT00973232|pharmacokinetics|pharmacokinetics
701419|NCT00973232|bioavailability|bioavailability
701420|NCT00973232|Zaldiar|zaldiar
701421|NCT00973232|Ultracet|ultracet
701423|NCT00973232|fasted|fasted
701424|NCT00973232|single-dose|single-dose
701425|NCT00973232|multiple-dose|multiple-dose
701426|NCT00973232|healthy|healthy
701427|NCT00973232|volunteers|volunteers
701428|NCT00973232|Healthy volunteers|healthy volunteers
701429|NCT00973245|BAY59-7939|bay59-7939
701430|NCT00973245|Rivaroxaban|rivaroxaban
701431|NCT00973245|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
701432|NCT00973245|Japanese Patients|japanese patients
701433|NCT00973245|Phase II|phase ii
701434|NCT00973271|hypertriglyceridemia|hypertriglyceridemia
701435|NCT00973284|Prevention of acute gastroenteritis due to infection with and experimental Norwalk Virus|prevention of acute gastroenteritis due to infection with and experimental norwalk virus
701436|NCT00973297|Falls|falls
701437|NCT00973310|Non-small-cell lung cancer|non-small-cell lung cancer
701438|NCT00973310|Radiation therapy|radiation therapy
701439|NCT00973310|Epidermal growth factor receptor|epidermal growth factor receptor
701440|NCT00973310|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
701441|NCT00973323|BAY59-7939|bay59-7939
701442|NCT00973323|Rivaroxaban|rivaroxaban
701443|NCT00973323|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
701444|NCT00973323|Japanese Patients|japanese patients
701445|NCT00973323|Phase II|phase ii
701446|NCT00973336|postoperative follow-up|postoperative follow-up
701447|NCT00973349|Swine Flu|swine flu
701448|NCT00973349|Flu|flu
701449|NCT00973349|Vaccine|vaccine
701450|NCT00973349|Adults|adults
701451|NCT00973349|Elderly|elderly
701452|NCT00973349|Non-Elderly|non-elderly
701453|NCT00973349|Adjuvant|adjuvant
701454|NCT00973362|Cervix Cancer|cervix cancer
701455|NCT00973362|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
701456|NCT00973362|Human Papillomavirus Virus (HPV)|human papillomavirus virus (hpv)
701457|NCT00973362|APTIMA HPV Assay|aptima hpv assay
701458|NCT00973362|FDA-Approved HPV DNA Test|fda-approved hpv dna test
701459|NCT00973362|TIGRIS DTS (direct tube sampling) System|tigris dts (direct tube sampling) system
701460|NCT00973362|Clinical Sensitivity (%)|clinical sensitivity (%)
701461|NCT00973362|Clinical Specificity (%)|clinical specificity (%)
701462|NCT00973362|Positive Predictive Value [PPV] (%)|positive predictive value [ppv] (%)
701463|NCT00973362|Negative Predictive Value [NPV] (%)|negative predictive value [npv] (%)
701464|NCT00973362|Atypical Squamous Cells Undetermined Significance (ASC-US)|atypical squamous cells undetermined significance (asc-us)
701465|NCT00973362|Relative Risk|relative risk
701466|NCT00973375|Drug-eluting stent|drug-eluting stent
701467|NCT00973375|coronary restenosis|coronary restenosis
701468|NCT00973375|coronary thrombosis|coronary thrombosis
701469|NCT00973388|VX-950-TiDP24-C136|vx-950-tidp24-c136
701470|NCT00973388|VX-950-C136|vx-950-c136
701471|NCT00973388|VX-950|vx-950
701472|NCT00973388|HEPATITIS|hepatitis
701473|NCT00973388|Telaprevir|telaprevir
701474|NCT00973388|Moxifloxacin|moxifloxacin
701475|NCT00973388|ECG|ecg
701476|NCT00973388|QT|qt
701477|NCT00973388|QTc|qtc
701478|NCT00973414|Combined epidural spinal anesthesia|combined epidural spinal anesthesia
701479|NCT00973414|Fluid therapy|fluid therapy
701480|NCT00973427|NSCLC|nsclc
701481|NCT00973440|geriatric assessment|geriatric assessment
701482|NCT00973453|non-seasonal allergy|non-seasonal allergy
701483|NCT00973453|house dust mite|house dust mite
701484|NCT00973453|immunotherapy|immunotherapy
701485|NCT00973453|dose tolerability|dose tolerability
701486|NCT00973466|HIV-infection|hiv-infection
701487|NCT00973466|Neisseria gonorrhea|neisseria gonorrhea
701488|NCT00973466|Chlamydia trachomatis|chlamydia trachomatis
701489|NCT00973466|Herpes simplex virus|herpes simplex virus
701490|NCT00973466|prevalence|prevalence
701491|NCT00973479|Arthritis, Rheumatoid|arthritis, rheumatoid
701492|NCT00973479|Active rheumatoid arthritis|active rheumatoid arthritis
701493|NCT00973479|Golimumab|golimumab
701494|NCT00973479|CNTO148|cnto148
701495|NCT00973479|Anti-TNFalpha monoclonal antibody|anti-tnfalpha monoclonal antibody
701496|NCT00973479|Methotrexate|methotrexate
701497|NCT00973479|Intravenous|intravenous
701498|NCT00973492|type 1 diabetes|type 1 diabetes
701499|NCT00973492|functional insulinotherapy|functional insulinotherapy
701500|NCT00973505|Breast neoplasms|breast neoplasms
701501|NCT00973505|Aromatase inhibitors|aromatase inhibitors
701502|NCT00973505|Genetic polymorphisms|genetic polymorphisms
701503|NCT00973505|Arthralgia|arthralgia
701504|NCT00973505|Arthritis|arthritis
701505|NCT00973518|Alzheimer's Disease|alzheimer's disease
701506|NCT00973518|AD|ad
701507|NCT00973518|Healthy Control|healthy control
701508|NCT00973531|Sleep Disordered Breathing|sleep disordered breathing
701509|NCT00973531|Sleep Apnea|sleep apnea
701510|NCT00973531|Hypertension|hypertension
701511|NCT00973531|Continuous Positive Airway Pressure|continuous positive airway pressure
701512|NCT00973544|breast reconstruction complications|breast reconstruction complications
701513|NCT00973544|drains|drains
701514|NCT00973544|silicone implant|silicone implant
701515|NCT00973557|bevacizumab|bevacizumab
701516|NCT00973570|tobacco cessation|tobacco cessation
701517|NCT00973570|evaluation|evaluation
701518|NCT00973570|epidémiology|epidémiology
701519|NCT00973570|adolescent|adolescent
701520|NCT00973570|apprentices|apprentices
701521|NCT00973583|vitamin D|vitamin d
701522|NCT00973583|infection|infection
701523|NCT00973583|Vitamin D for the prevention of respiratory tract infections|vitamin d for the prevention of respiratory tract infections
701524|NCT00973609|metastatic colorectal cancer|metastatic colorectal cancer
701525|NCT00973609|Bevacizumab|bevacizumab
701526|NCT00973609|Avastin®|avastin®
701527|NCT00973609|phase 3|phase 3
701528|NCT00973609|maintenance treatment|maintenance treatment
701529|NCT00973609|treatment pause|treatment pause
701530|NCT00973609|drug holiday|drug holiday
701531|NCT00973609|stage IV|stage iv
701532|NCT00973622|Tobacco cessation|tobacco cessation
701533|NCT00973622|Tobacco dependence|tobacco dependence
701534|NCT00973622|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
703145|NCT00970580|Stage IIIB|stage iiib
701535|NCT00973622|Nicotine Dependence|nicotine dependence
701536|NCT00973622|Delayed Discounting|delayed discounting
703967|NCT00981565|CTS|cts
701537|NCT00973635|education|education
701538|NCT00973635|web-based intervention|web-based intervention
701539|NCT00973635|patient care|patient care
701540|NCT00973648|Tinnitus|tinnitus
701541|NCT00973648|Ringing in ears|ringing in ears
701542|NCT00973648|Functional connectivity MRI|functional connectivity mri
701543|NCT00973648|Voluntary control of tinnitus|voluntary control of tinnitus
701544|NCT00958906|Infliximab|infliximab
701545|NCT00958906|Uveitis|uveitis
701546|NCT00958906|Macular Edema|macular edema
701547|NCT00958906|Intraocular Inflammation|intraocular inflammation
701548|NCT00958919|breathlessness intensity|breathlessness intensity
701549|NCT00958919|breathlessness unpleasantness|breathlessness unpleasantness
701550|NCT00958919|endorphins|endorphins
701551|NCT00958919|resistive breathing loads|resistive breathing loads
701552|NCT00958945|Postoperative Hematocrit|postoperative hematocrit
701553|NCT00958945|Postoperative Hemoglobin|postoperative hemoglobin
701554|NCT00958958|Acute Coronary Syndrome|acute coronary syndrome
701555|NCT00958958|randomized cluster trial|randomized cluster trial
701556|NCT00958958|quality improvement|quality improvement
701557|NCT00958971|Breast cancer|breast cancer
701558|NCT00958971|HER2 negative|her2 negative
701559|NCT00958971|FGFR1|fgfr1
701560|NCT00958984|pediatric|pediatric
701561|NCT00958984|solid organ transplant|solid organ transplant
701562|NCT00958984|hemoglobin|hemoglobin
701563|NCT00958997|diabetes|diabetes
701564|NCT00958997|islet|islet
701565|NCT00958997|pancreas|pancreas
701566|NCT00958997|beta cell mass|beta cell mass
701567|NCT00958997|PET imaging|pet imaging
701568|NCT00958997|FPDTBZ|fpdtbz
701569|NCT00958997|arginine stimulus test|arginine stimulus test
701570|NCT00959010|Omega 3|omega 3
701571|NCT00959010|Cystic Fibrosis|cystic fibrosis
701572|NCT00959010|Inflammatory markers|inflammatory markers
701573|NCT00959023|stage I prostate cancer|stage i prostate cancer
701574|NCT00959023|stage IIB prostate cancer|stage iib prostate cancer
701575|NCT00959023|stage IIA prostate cancer|stage iia prostate cancer
701576|NCT00959023|stage III prostate cancer|stage iii prostate cancer
701577|NCT00959023|stage IV prostate cancer|stage iv prostate cancer
701578|NCT00959023|recurrent prostate cancer|recurrent prostate cancer
701579|NCT00959062|Pilot Study|pilot study
701580|NCT00959062|Randomized Controlled Trial|randomized controlled trial
701581|NCT00959062|Critically Ill|critically ill
701582|NCT00959062|Child|child
701583|NCT00959062|Pediatric|pediatric
701584|NCT00959062|Clonidine|clonidine
701585|NCT00959062|Sedation|sedation
701586|NCT00959075|Thiamin supplementation|thiamin supplementation
701587|NCT00959075|Thiamin deficiency|thiamin deficiency
701588|NCT00959075|Heart failure|heart failure
701589|NCT00959075|Improve heart function|improve heart function
701590|NCT00959075|Vitamin B1 supplementation|vitamin b1 supplementation
701591|NCT00959114|Celiac Disease|celiac disease
701592|NCT00959114|Coeliac Disease|coeliac disease
701593|NCT00959114|Celiac Sprue|celiac sprue
701594|NCT00959114|Keliakia|keliakia
701595|NCT00959127|Colorectal Adenocarcinoma|colorectal adenocarcinoma
701596|NCT00959127|Colon Cancer|colon cancer
701597|NCT00959127|Rectal Cancer|rectal cancer
701598|NCT00959140|Allo PBSC|allo pbsc
701599|NCT00959140|HSCT|hsct
701600|NCT00959140|Bone Marrow Transplant|bone marrow transplant
701601|NCT00959140|Allogeneic Bone Marrow Transplant|allogeneic bone marrow transplant
701602|NCT00959140|Matched Related Donor Transplant|matched related donor transplant
701603|NCT00959140|MRD HSCT|mrd hsct
701604|NCT00959153|Fragmenting of kidney stones|fragmenting of kidney stones
701605|NCT00959153|extracorporeal shockwave lithotripsy|extracorporeal shockwave lithotripsy
701606|NCT00959166|Acute hepatitis C|acute hepatitis c
701608|NCT00959166|Neurocognitive function|neurocognitive function
701609|NCT00959166|Neuroinflammation|neuroinflammation
701610|NCT00959179|CHF|chf
701611|NCT00959218|Dronabinol|dronabinol
701612|NCT00959218|(-)trans-delta9-tetrahydrocannabinol|(-)trans-delta9-tetrahydrocannabinol
701613|NCT00959218|central neuropathic pain|central neuropathic pain
701614|NCT00959218|multiple sclerosis|multiple sclerosis
701615|NCT00959218|analgesic|analgesic
701616|NCT00959218|Central neuropathic pain related to multiple sclerosis|central neuropathic pain related to multiple sclerosis
701617|NCT00959231|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
701618|NCT00959244|ductal breast carcinoma in situ|ductal breast carcinoma in situ
701619|NCT00959244|stage I breast cancer|stage i breast cancer
701620|NCT00959244|stage II breast cancer|stage ii breast cancer
701621|NCT00959244|stage IIIA breast cancer|stage iiia breast cancer
701622|NCT00959244|stage IIIB breast cancer|stage iiib breast cancer
701623|NCT00959244|stage IIIC breast cancer|stage iiic breast cancer
701624|NCT00959244|stage IV breast cancer|stage iv breast cancer
701625|NCT00959257|Asthma|asthma
701626|NCT00959257|Inhaled corticosteroids|inhaled corticosteroids
701627|NCT00959257|Cardiovascular morbidities|cardiovascular morbidities
701628|NCT00959257|Systemic inflammation|systemic inflammation
701726|NCT00959647|Hedgehog pathway inhibitor|hedgehog pathway inhibitor
751862|NCT01170910|Marginal kidney graft|marginal kidney graft
701629|NCT00959283|acute myeloid leukemia/transient myeloproliferative disorder|acute myeloid leukemia/transient myeloproliferative disorder
701630|NCT00959296|Registry|registry
701631|NCT00959296|Pain|pain
701632|NCT00959296|Chronic Pain|chronic pain
701633|NCT00959296|Back Pain|back pain
701634|NCT00959296|Intractable Spasticity|intractable spasticity
701635|NCT00959296|Parkinson's Disease|parkinson's disease
701636|NCT00959296|Essential Tremor|essential tremor
701637|NCT00959296|Dystonia|dystonia
701638|NCT00959296|Implantable Pumps|implantable pumps
701639|NCT00959296|Incontinence|incontinence
701640|NCT00959309|pediatrics|pediatrics
701641|NCT00959309|media|media
701642|NCT00959309|MUPS|mups
701643|NCT00959322|Capsulotomy|capsulotomy
701644|NCT00959335|treatment|treatment
701645|NCT00959348|Asthma|asthma
701646|NCT00959348|Diabetes|diabetes
701647|NCT00959348|Impaired glucose tolerance|impaired glucose tolerance
701648|NCT00959348|Insulin resistance|insulin resistance
701649|NCT00959361|patient compliance|patient compliance
701650|NCT00959361|guidelines adherence|guidelines adherence
701651|NCT00959361|advance directive adherence|advance directive adherence
701652|NCT00959361|treatment refusal|treatment refusal
701653|NCT00959361|directly observed therapy|directly observed therapy
701654|NCT00959361|anti-retroviral agents|anti-retroviral agents
701655|NCT00959361|HIV seropositivity|hiv seropositivity
701656|NCT00959361|HIV infections|hiv infections
701657|NCT00959361|HIV|hiv
701658|NCT00959361|pharmaceutical services|pharmaceutical services
701659|NCT00959361|HIV-positives patients|hiv-positives patients
701660|NCT00959361|treatment experienced|treatment experienced
701661|NCT00959374|Abdominoplasty|abdominoplasty
701662|NCT00959374|Reduction Mammaplasty|reduction mammaplasty
701663|NCT00959374|Mastopexy|mastopexy
701664|NCT00959387|head and neck cancer|head and neck cancer
701665|NCT00959387|induction chemotherapy|induction chemotherapy
701666|NCT00959400|Fentanyl Transdermal|fentanyl transdermal
701667|NCT00959400|Pain|pain
701668|NCT00959400|Cancer|cancer
701669|NCT00959426|- Mutliple Ascending Dose Study in Overweight Subjects - Body Weight - Signs and Symptoms|- mutliple ascending dose study in overweight subjects - body weight - signs and symptoms
701670|NCT00959452|Hypochondria|hypochondria
701671|NCT00959452|Cognitive behavioural therapy|cognitive behavioural therapy
701672|NCT00959452|Long term follow-up|long term follow-up
701673|NCT00959452|Psychosomatics|psychosomatics
701674|NCT00959452|Psychotherapy|psychotherapy
701675|NCT00959478|Carbon Monoxide (CO)|carbon monoxide (co)
701676|NCT00959478|Carbon Monoxide Poisoning|carbon monoxide poisoning
701677|NCT00959478|Carbon Monoxide Alarm/Detector|carbon monoxide alarm/detector
701678|NCT00959478|Precaution Adoption Process Model (PAPM)|precaution adoption process model (papm)
701679|NCT00959478|Injury Prevention|injury prevention
701680|NCT00959478|Emergency Department|emergency department
701681|NCT00959491|Colonoscopy|colonoscopy
701682|NCT00959491|Occult Blood|occult blood
701683|NCT00959491|Fecal|fecal
701684|NCT00959517|Placebo controlled|placebo controlled
701685|NCT00959517|Efficacy|efficacy
701686|NCT00959517|Artemisinin-based combination therapy|artemisinin-based combination therapy
701687|NCT00959517|Primaquine|primaquine
701688|NCT00959517|Gametocytes|gametocytes
701689|NCT00959530|complete dentures|complete dentures
701690|NCT00959530|patient satisfaction|patient satisfaction
701691|NCT00959530|treatment cost|treatment cost
701692|NCT00959556|recurrent breast cancer|recurrent breast cancer
701693|NCT00959556|stage IA breast cancer|stage ia breast cancer
701694|NCT00959556|stage IB breast cancer|stage ib breast cancer
701695|NCT00959556|stage II breast cancer|stage ii breast cancer
701696|NCT00959556|stage IIIA breast cancer|stage iiia breast cancer
701697|NCT00959556|stage IIIB breast cancer|stage iiib breast cancer
701698|NCT00959556|stage IIIC breast cancer|stage iiic breast cancer
701699|NCT00959556|stage IV breast cancer|stage iv breast cancer
701700|NCT00959569|esmolol|esmolol
701701|NCT00959569|cardiac surgery|cardiac surgery
701702|NCT00959569|cardiac anesthesia|cardiac anesthesia
701703|NCT00959569|mortality|mortality
701704|NCT00959569|beta blockers|beta blockers
701705|NCT00959569|beta-blockers|beta-blockers
701706|NCT00959569|cardiac protection|cardiac protection
701707|NCT00959582|Relapsed ovarian cancer|relapsed ovarian cancer
701708|NCT00959595|Diabetes mellitus|diabetes mellitus
701709|NCT00959595|neuropathy|neuropathy
701710|NCT00959595|foot|foot
701711|NCT00959595|sensibility|sensibility
701712|NCT00959595|brain plasticity|brain plasticity
701713|NCT00959608|Weight Management in adults|weight management in adults
701714|NCT00959608|Reducing Health Disparities|reducing health disparities
701715|NCT00959621|Habitual abortion|habitual abortion
701716|NCT00959621|recurrent abortion|recurrent abortion
701717|NCT00959621|hereditary and acquired|hereditary and acquired
701718|NCT00959621|thrombophilia|thrombophilia
701719|NCT00959621|preeclampsia|preeclampsia
701720|NCT00959621|premature birth|premature birth
701721|NCT00959621|miscarriage|miscarriage
701722|NCT00959621|stillbirth|stillbirth
701723|NCT00959621|LMWH (low molecular weigh heparin)|lmwh (low molecular weigh heparin)
701724|NCT00959621|ASA|asa
701725|NCT00959621|aspirin|aspirin
701727|NCT00959660|Diastolic heart failure|diastolic heart failure
701728|NCT00959660|Heart Failure|heart failure
701729|NCT00959660|Elderly|elderly
701730|NCT00959660|Obesity|obesity
701731|NCT00959686|Bendamustine refractory or relapsed T-cell lymphoma.|bendamustine refractory or relapsed t-cell lymphoma.
701732|NCT00959699|coinfection|coinfection
701733|NCT00959699|protease inhibitor|protease inhibitor
701734|NCT00959699|HIV|hiv
701735|NCT00959725|Infliximab|infliximab
701736|NCT00959725|Diabetes|diabetes
701737|NCT00959725|Macular Edema|macular edema
701738|NCT00959738|loop ileostomy|loop ileostomy
701739|NCT00959738|quality of life|quality of life
701740|NCT00959738|morbidity|morbidity
701741|NCT00959738|Rectal Neoplasms|rectal neoplasms
701742|NCT00959751|migraine|migraine
701743|NCT00959790|Health|health
701744|NCT00959790|Obesity|obesity
701745|NCT00959790|Oxidative stress|oxidative stress
701746|NCT00959790|Challenge concept|challenge concept
701747|NCT00959790|Vegetables|vegetables
701748|NCT00959803|Phase 1|phase 1
701749|NCT00959803|Pharmacokinetics|pharmacokinetics
701750|NCT00959803|Healthy Young Adult|healthy young adult
701751|NCT00959803|Japanese|japanese
701752|NCT00959803|Healthy Elderly|healthy elderly
701753|NCT00959803|Alzheimer disease|alzheimer disease
701754|NCT00959816|Volunteers|volunteers
701755|NCT00959829|Communication|communication
701756|NCT00959829|Complementary Therapies|complementary therapies
701757|NCT00959829|Intensive Care|intensive care
701758|NCT00959829|Ethics|ethics
701759|NCT00959842|hypertriglyceridemia|hypertriglyceridemia
701760|NCT00959842|Omega-3 Fatty Acids|omega-3 fatty acids
701761|NCT00959842|Lipoprotein|lipoprotein
701762|NCT00959842|Statin|statin
701763|NCT00959842|Lovaza|lovaza
701764|NCT00959855|COPD|copd
701765|NCT00959855|Pulmonary Rehabilitation|pulmonary rehabilitation
701766|NCT00959855|Inflammation|inflammation
701767|NCT00959855|Oxidative Stress|oxidative stress
701768|NCT00959855|Steps|steps
701769|NCT00959855|Free Living Activities|free living activities
701770|NCT00959855|Exacerbation|exacerbation
701771|NCT00959868|Bladder cancer|bladder cancer
701871|NCT00965705|overweight|overweight
701772|NCT00959868|Superficial bladder cancer (Ta or T1)|superficial bladder cancer (ta or t1)
701773|NCT00959868|Muscle invasive bladder cancer (T2)|muscle invasive bladder cancer (t2)
701774|NCT00959868|Transurethral resection|transurethral resection
701775|NCT00959868|Radical cystectomy|radical cystectomy
701776|NCT00959868|OGX-427|ogx-427
701777|NCT00959868|Antisense oligonucleotide|antisense oligonucleotide
701778|NCT00959868|Heat shock protein 27|heat shock protein 27
701779|NCT00959868|superficial bladder tumour (Ta or T1) or CIS prior to a transurethral resection|superficial bladder tumour (ta or t1) or cis prior to a transurethral resection
701780|NCT00959868|Muscle invasive (T2) bladder cancer prior to radical cystectomy|muscle invasive (t2) bladder cancer prior to radical cystectomy
701781|NCT00959881|Alzheimer Disease|alzheimer disease
701782|NCT00959894|HIV|hiv
701783|NCT00959894|Infection|infection
701784|NCT00959894|Treatment Naive|treatment naive
701785|NCT00959894|Adults|adults
701786|NCT00959894|Once|once
701787|NCT00959894|Daily|daily
701788|NCT00959894|Etravirine|etravirine
701789|NCT00959894|HIV-1 Infection|hiv-1 infection
701790|NCT00959907|Muscular activity|muscular activity
701791|NCT00959907|wrinkles in frontal area|wrinkles in frontal area
701792|NCT00959907|action halos|action halos
701793|NCT00959920|Indwelling bladder catheter|indwelling bladder catheter
701794|NCT00959920|Intermittent straight catheterization|intermittent straight catheterization
701795|NCT00959920|Labor and Delivery|labor and delivery
701796|NCT00959920|Time to delivery during labor|time to delivery during labor
701797|NCT00959946|Phase 1/2|phase 1/2
701798|NCT00959946|2-part study|2-part study
701799|NCT00959946|bosutinib and capecitabine|bosutinib and capecitabine
701800|NCT00959959|CRPC|crpc
701801|NCT00959959|HRPC|hrpc
701802|NCT00959959|TOK-001|tok-001
701803|NCT00959959|ARMOR|armor
701804|NCT00959959|ARMOR1|armor1
701805|NCT00959972|Varenicline|varenicline
701806|NCT00959972|transdermal nicotine patch|transdermal nicotine patch
701807|NCT00959972|cardiovascular disease|cardiovascular disease
701808|NCT00959972|prevention|prevention
701809|NCT00959972|coronary heart disease|coronary heart disease
701810|NCT00959972|Smoking cessation|smoking cessation
701811|NCT00959985|compression sleeve|compression sleeve
701812|NCT00959985|compression bandage|compression bandage
701813|NCT00959998|Persistent Cancer-Related Fatigue|persistent cancer-related fatigue
701814|NCT00960011|Inguinal hernia|inguinal hernia
701815|NCT00960011|mesh|mesh
701816|NCT00960011|progrip|progrip
701817|NCT00960024|Vocational rehabilitation|vocational rehabilitation
701818|NCT00960024|Severe mental illness|severe mental illness
701819|NCT00960024|Psychosis|psychosis
701820|NCT00960024|Mental Health|mental health
701821|NCT00960037|Vitamin D3|vitamin d3
701822|NCT00960037|obesity|obesity
701823|NCT00960037|cholecalciferol|cholecalciferol
701824|NCT00960076|T2DM|t2dm
701825|NCT00960076|Metformin|metformin
701826|NCT00960076|A1c|a1c
701827|NCT00960089|Toenail|toenail
701828|NCT00960089|Fungus|fungus
702149|NCT00975104|Aging|aging
701829|NCT00960089|Onychomycosis|onychomycosis
701830|NCT00960089|Dermatophyte|dermatophyte
701831|NCT00960102|cochlear implantation|cochlear implantation
701832|NCT00960115|NSCLC|nsclc
701833|NCT00960115|Stage III|stage iii
701834|NCT00960115|EMD531444|emd531444
701835|NCT00960115|L-BLP25|l-blp25
701836|NCT00960115|Cyclophosphamide|cyclophosphamide
701837|NCT00960115|Immunotherapy|immunotherapy
701838|NCT00960115|Tecemotide|tecemotide
701839|NCT00960154|Lumpectomy|lumpectomy
701840|NCT00960154|PlasmaBlade|plasmablade
701841|NCT00960154|Electrosurgery|electrosurgery
701842|NCT00960154|PEAK Surgical|peak surgical
701843|NCT00960154|Medtronic Advanced Energy|medtronic advanced energy
701844|NCT00960154|Medtronic|medtronic
701845|NCT00960167|HCC|hcc
701846|NCT00960167|radiotherapy|radiotherapy
701847|NCT00960167|dose escalation|dose escalation
701848|NCT00960167|Toxicity|toxicity
701849|NCT00960167|Local control|local control
701850|NCT00960193|blood levels over time|blood levels over time
701851|NCT00960193|colchicine|colchicine
701852|NCT00960193|seville orange juice|seville orange juice
701853|NCT00960193|pharmacokinetics|pharmacokinetics
701854|NCT00965666|Fanconi Anemia|fanconi anemia
701855|NCT00965666|Hemic and Lymphatic Diseases|hemic and lymphatic diseases
701856|NCT00965666|Anti-Rheumatic Agents|anti-rheumatic agents
701857|NCT00965666|Anemia, Hypoplastic, Congenital|anemia, hypoplastic, congenital
701858|NCT00965666|DNA Repair-Deficiency Disorders|dna repair-deficiency disorders
701859|NCT00965666|Congenital, Hereditary, and|congenital, hereditary, and
702767|NCT00968812|Metformin|metformin
701860|NCT00965666|Neonatal Diseases and Abnormalities|neonatal diseases and abnormalities
701861|NCT00965679|Cardiac CT|cardiac ct
701862|NCT00965679|Iodinated Radiocontrast|iodinated radiocontrast
701863|NCT00965679|Ionizing Radiation|ionizing radiation
701864|NCT00965679|Aortic Valve Stenosis|aortic valve stenosis
701865|NCT00965679|Percutaneous Aortic Valve Replacement|percutaneous aortic valve replacement
701866|NCT00965679|Heart Valve|heart valve
701867|NCT00965705|Binge Eating Disorder|binge eating disorder
701868|NCT00965705|overeating|overeating
701869|NCT00965705|binge eating|binge eating
701870|NCT00965705|women|women
701872|NCT00965705|compulsive overeating|compulsive overeating
701873|NCT00965718|advanced pancreatic cancer|advanced pancreatic cancer
701874|NCT00965731|Lung Neoplasms|lung neoplasms
701875|NCT00965731|Crizotinib|crizotinib
701876|NCT00965744|Ligasure vessel sealing system|ligasure vessel sealing system
701877|NCT00965744|Azygoportal Disconnection|azygoportal disconnection
701878|NCT00965744|Splenectomy|splenectomy
701879|NCT00965744|Portal hypertension|portal hypertension
701880|NCT00965770|abortion|abortion
701881|NCT00965770|intrauterine device|intrauterine device
701882|NCT00965770|cost-effectiveness|cost-effectiveness
701883|NCT00965783|Sleep, Apnea, OSA, obese, middle-aged|sleep, apnea, osa, obese, middle-aged
701884|NCT00965796|Intravenous lidocaine|intravenous lidocaine
701885|NCT00965796|postoperative analgesia|postoperative analgesia
701886|NCT00965822|URTI|urti
701887|NCT00965822|Natural Health Products|natural health products
701888|NCT00965835|PET Scan|pet scan
701889|NCT00965848|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
701890|NCT00965848|Intra-abdominal Infections|intra-abdominal infections
701891|NCT00965848|Urinary tract Infections|urinary tract infections
701892|NCT00965848|Doripenem|doripenem
701893|NCT00965848|Doribax|doribax
701894|NCT00965861|Tissue Registry|tissue registry
701895|NCT00965861|Tissue Collection|tissue collection
701896|NCT00965861|Unknown Primary|unknown primary
701897|NCT00965861|Breast|breast
701898|NCT00965861|Lung|lung
701899|NCT00965861|Gastrointestinal|gastrointestinal
701900|NCT00965861|Bone Marrow Transplant|bone marrow transplant
701901|NCT00965861|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
701902|NCT00965861|Central Nervous System|central nervous system
701903|NCT00965861|Head and Neck|head and neck
701904|NCT00965861|Melanoma|melanoma
701905|NCT00965861|Myelodysplastic syndrome|myelodysplastic syndrome
701906|NCT00965861|Multiple Myeloma|multiple myeloma
701907|NCT00965861|Lymphoma|lymphoma
701908|NCT00965861|Gynecologic|gynecologic
701909|NCT00965861|Genitourinary|genitourinary
701910|NCT00965861|Refractory Malignancy|refractory malignancy
701911|NCT00973661|Overweight|overweight
701912|NCT00973661|Diagnosis|diagnosis
701913|NCT00973661|Counseling|counseling
701914|NCT00973661|Medical Records Systems, Computerized|medical records systems, computerized
701915|NCT00973687|pediatric|pediatric
701916|NCT00973687|dexamethasone|dexamethasone
701917|NCT00973687|management|management
701918|NCT00973687|corticosteroids|corticosteroids
701919|NCT00973687|asthma|asthma
701920|NCT00973700|Swine Flu|swine flu
701921|NCT00973700|Flu|flu
701922|NCT00973700|Vaccine|vaccine
701923|NCT00973700|Adjuvant|adjuvant
701924|NCT00973713|Advanced cholangiocarcinoma|advanced cholangiocarcinoma
701925|NCT00973739|NF-2|nf-2
701926|NCT00973739|NF-2 related tumors|nf-2 related tumors
701927|NCT00973739|Schwannoma, Acoustic, Bilateral|schwannoma, acoustic, bilateral
701928|NCT00973739|schwannomas|schwannomas
701929|NCT00973739|Neurilemmoma of other cranial and peripheral nerves|neurilemmoma of other cranial and peripheral nerves
701930|NCT00973739|NF2 related benign intracranial tumors including|nf2 related benign intracranial tumors including
701931|NCT00973739|NF2 related meningiomas|nf2 related meningiomas
701932|NCT00973739|NF2 related ependymomas|nf2 related ependymomas
701933|NCT00973739|NF2 related spinal neurofibromas|nf2 related spinal neurofibromas
701934|NCT00973739|NF2 related gliomas|nf2 related gliomas
701935|NCT00973752|ALL|all
701936|NCT00973765|abcess|abcess
701937|NCT00973765|MRSA|mrsa
701938|NCT00973765|cellulitis|cellulitis
701939|NCT00973765|antibiotics|antibiotics
701940|NCT00973765|uncomplicated abscesses|uncomplicated abscesses
701941|NCT00973778|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
701942|NCT00973778|Capecitabine|capecitabine
701943|NCT00973778|Resectable Rectal Carcinoma|resectable rectal carcinoma
701944|NCT00973791|Spinal anesthesia|spinal anesthesia
701945|NCT00973791|Fluid therapy|fluid therapy
701946|NCT00973804|Reduced Intensity Conditioning|reduced intensity conditioning
701947|NCT00973804|Umbilical Cord Blood Transplant|umbilical cord blood transplant
701948|NCT00973804|Targeted Immune Depletion|targeted immune depletion
701949|NCT00973804|Leukemia|leukemia
701950|NCT00973804|Lymphoma|lymphoma
701951|NCT00973804|Multiple Myeloma|multiple myeloma
701952|NCT00973804|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
701953|NCT00973804|Hodgkins Lymphoma|hodgkins lymphoma
701954|NCT00973817|Hepatitis|hepatitis
701955|NCT00973817|AOCH|aoch
701956|NCT00973830|Changes in HbA1c|changes in hba1c
701957|NCT00973869|colon cancer|colon cancer
701958|NCT00973869|rectal cancer|rectal cancer
701959|NCT00973882|Hormone resistant prostate cancer|hormone resistant prostate cancer
701960|NCT00973882|Neuro-endocrine marker|neuro-endocrine marker
701961|NCT00973882|Carboplatin-Etoposide combination|carboplatin-etoposide combination
701962|NCT00973882|Neuro-endocrine differentiation|neuro-endocrine differentiation
701963|NCT00973895|Influenza|influenza
701964|NCT00973895|Healthy|healthy
701965|NCT00973895|Immunity|immunity
701966|NCT00973895|Preventive|preventive
701967|NCT00973895|Pandemic|pandemic
702193|NCT00975312|fluocinolone acetonide|fluocinolone acetonide
701968|NCT00973908|Clostridium difficile associated diarrhoea|clostridium difficile associated diarrhoea
701969|NCT00973908|antibiotic associated diarrhoea|antibiotic associated diarrhoea
701970|NCT00973921|Stent|stent
701971|NCT00973921|under-expansion|under-expansion
701972|NCT00973921|StentOp|stentop
701973|NCT00973921|StentOptimizer|stentoptimizer
701974|NCT00973921|IVUS|ivus
701975|NCT00973921|IC-PRO|ic-pro
701976|NCT00973921|image enhancement|image enhancement
701977|NCT00973947|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
701978|NCT00973947|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
701979|NCT00973947|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
701980|NCT00973947|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
701981|NCT00973947|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
701982|NCT00973947|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
701983|NCT00973947|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
701984|NCT00973947|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
701985|NCT00973947|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
701986|NCT00973947|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
701987|NCT00973947|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
701988|NCT00973947|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
701989|NCT00973947|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
701990|NCT00973947|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
701991|NCT00973947|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
701992|NCT00973947|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
701993|NCT00973947|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
701994|NCT00973947|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
701995|NCT00973947|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
701996|NCT00973947|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
701997|NCT00973947|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
701998|NCT00973947|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
701999|NCT00973947|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
702000|NCT00973947|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
751863|NCT01170910|Pulsatile perfusion machine|pulsatile perfusion machine
702001|NCT00973947|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
702002|NCT00973947|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
702003|NCT00973947|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
702151|NCT00975104|Sedentary|sedentary
702004|NCT00973947|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
702005|NCT00973947|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
702006|NCT00973947|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
702007|NCT00973947|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
702008|NCT00973947|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
702009|NCT00973947|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
702010|NCT00973947|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
702011|NCT00973947|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
702012|NCT00973947|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
702013|NCT00973947|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
702014|NCT00973947|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
702015|NCT00973947|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
702016|NCT00973947|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
702017|NCT00973947|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
702018|NCT00973947|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
702019|NCT00973947|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
702768|NCT00968812|Glimepiride|glimepiride
702020|NCT00973947|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
702021|NCT00973947|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
702022|NCT00973947|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
702023|NCT00973947|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
702024|NCT00973947|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
702025|NCT00973947|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
702026|NCT00973947|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
702027|NCT00973947|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
702028|NCT00973947|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
702029|NCT00973947|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
702030|NCT00973947|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
702031|NCT00973947|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
702032|NCT00973947|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
702033|NCT00973947|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
702034|NCT00973947|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
702035|NCT00973947|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
702036|NCT00973947|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
702037|NCT00973947|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
702038|NCT00973947|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
702039|NCT00973947|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
702040|NCT00973947|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
702041|NCT00973947|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
752404|NCT01172886|Metabolic Syndrome obesity visceral adiposity breast cancer|metabolic syndrome obesity visceral adiposity breast cancer
702042|NCT00973947|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
702043|NCT00973947|stage I salivary gland cancer|stage i salivary gland cancer
702044|NCT00973947|stage II salivary gland cancer|stage ii salivary gland cancer
702045|NCT00973947|stage III salivary gland cancer|stage iii salivary gland cancer
702046|NCT00973947|stage IV salivary gland cancer|stage iv salivary gland cancer
702047|NCT00973947|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
702048|NCT00973947|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
702049|NCT00973947|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
751864|NCT01170923|non small cell lung cancer|non small cell lung cancer
702050|NCT00973947|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
702051|NCT00973947|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
702052|NCT00973947|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
702053|NCT00973947|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
702054|NCT00973947|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
702055|NCT00973947|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
702056|NCT00973947|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
702057|NCT00973947|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
702058|NCT00973947|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
702059|NCT00973947|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
702060|NCT00973947|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
702061|NCT00973947|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
702062|NCT00973947|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
702063|NCT00973947|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
702064|NCT00973947|recurrent salivary gland cancer|recurrent salivary gland cancer
702065|NCT00973973|Pelvic Pain|pelvic pain
702066|NCT00973973|NBI-56418|nbi-56418
702067|NCT00973973|Endometriosis|endometriosis
702068|NCT00973986|atorvastatin|atorvastatin
702069|NCT00973986|genetic polymorphisms|genetic polymorphisms
702070|NCT00973986|coronary heart disease|coronary heart disease
702071|NCT00973986|pharmacokinetics|pharmacokinetics
702073|NCT00973999|Botulinum Toxin|botulinum toxin
702074|NCT00973999|Saliva|saliva
702075|NCT00973999|Tracheostomy tube|tracheostomy tube
702076|NCT00974818|Bladder|bladder
702077|NCT00974818|Mitomycin C|mitomycin c
702078|NCT00974818|MMC|mmc
702079|NCT00974818|TheracysR Bacillus Calmette-Guerin|theracysr bacillus calmette-guerin
702080|NCT00974818|BCG|bcg
702081|NCT00974818|intravesical|intravesical
702082|NCT00974818|09-118|09-118
702083|NCT00974844|posterior assisted levitation|posterior assisted levitation
702084|NCT00974844|Pars Plana|pars plana
702085|NCT00974844|Dropped nucleus|dropped nucleus
702086|NCT00974844|cataract|cataract
702087|NCT00974844|complication of|complication of
702088|NCT00974844|surgery|surgery
702089|NCT00974857|Hemodialysis|hemodialysis
702090|NCT00974857|Left Ventricular Hypertrophy|left ventricular hypertrophy
702091|NCT00974857|Body Composition Monitor|body composition monitor
702092|NCT00974883|ultrasound|ultrasound
702094|NCT00974883|temporal arteritis|temporal arteritis
702095|NCT00974883|biopsy|biopsy
702096|NCT00974896|Advanced Solid Tumors|advanced solid tumors
702097|NCT00974896|AMG 479|amg 479
702098|NCT00974896|Amgen|amgen
702099|NCT00974896|Oncology|oncology
702100|NCT00974896|Phase 1b|phase 1b
702101|NCT00974909|Fecal incontinence|fecal incontinence
702102|NCT00974922|Vitamin D|vitamin d
702103|NCT00974922|Hypertension|hypertension
702104|NCT00974935|Staphylococcal enterotoxin B, vaccine, Staphylococcus aureus, toxic shock syndrome|staphylococcal enterotoxin b, vaccine, staphylococcus aureus, toxic shock syndrome
702105|NCT00974948|Pancreatic cancer|pancreatic cancer
702106|NCT00974948|Therapy|therapy
702107|NCT00974948|Neurolysis|neurolysis
702108|NCT00974961|Levobupivacaine|levobupivacaine
702109|NCT00974961|HRV|hrv
702110|NCT00974961|Spinal Anesthesia|spinal anesthesia
702111|NCT00974961|Responses of ANS to these two drugs|responses of ans to these two drugs
702112|NCT00974974|Parkinson's Disease|parkinson's disease
702113|NCT00974987|adult giant cell glioblastoma|adult giant cell glioblastoma
702114|NCT00974987|adult glioblastoma|adult glioblastoma
702115|NCT00974987|adult gliosarcoma|adult gliosarcoma
702116|NCT00975000|Intervention|intervention
702117|NCT00975000|Cinacalcet|cinacalcet
702118|NCT00975000|Sensipar|sensipar
702119|NCT00975000|Mimpara|mimpara
702120|NCT00975000|hyperparathyroidism|hyperparathyroidism
702121|NCT00975000|calcium|calcium
702122|NCT00975000|osteodystrophy|osteodystrophy
702123|NCT00975000|hypercalcemia|hypercalcemia
702124|NCT00975000|renal|renal
702125|NCT00975000|transplant|transplant
702126|NCT00975000|acute rejection|acute rejection
702127|NCT00975000|kidney transplant failure|kidney transplant failure
702128|NCT00975000|hypophosphatemia|hypophosphatemia
702129|NCT00975013|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
702130|NCT00975013|Morbid Obesity|morbid obesity
702131|NCT00975013|Bone Mineral Density|bone mineral density
702132|NCT00975026|Massage|massage
702133|NCT00975026|Chair Massage|chair massage
702134|NCT00975026|Pain|pain
702135|NCT00975026|Discomfort|discomfort
702136|NCT00975026|Stretching|stretching
702137|NCT00975026|Stretching Exercises|stretching exercises
702138|NCT00975026|Sonographer|sonographer
702139|NCT00975026|Cardiac Sonographer|cardiac sonographer
702140|NCT00975039|Inoperable|inoperable
702141|NCT00975039|Inoperable Cholangiocarcinoma|inoperable cholangiocarcinoma
702142|NCT00975039|Non-resectable|non-resectable
702143|NCT00975039|Non-resectable Cholangiocarcinoma|non-resectable cholangiocarcinoma
702144|NCT00975039|Carcinoma|carcinoma
702145|NCT00975065|Galvus|galvus
702146|NCT00975078|dexamethasone-suppression-test|dexamethasone-suppression-test
702147|NCT00975078|high dose glucocorticoid treatment|high dose glucocorticoid treatment
702148|NCT00975078|Population at Risk|population at risk
702152|NCT00975104|Immobilization|immobilization
702153|NCT00975104|Atrophy|atrophy
702154|NCT00975104|Muscle Wasting|muscle wasting
702155|NCT00975104|Physical Activity|physical activity
702156|NCT00975117|Dietary supplement|dietary supplement
702157|NCT00975117|male infertility|male infertility
702158|NCT00975117|spermatogenesis|spermatogenesis
702159|NCT00975143|isotretinoin|isotretinoin
702160|NCT00975143|dermatology|dermatology
702161|NCT00975143|skin|skin
702162|NCT00975182|PI3K|pi3k
702163|NCT00975182|NSCLC|nsclc
702164|NCT00975182|Tarceva|tarceva
702165|NCT00975208|Osteogenesis [G07.700.320.500.325.377.625.100.729]|osteogenesis [g07.700.320.500.325.377.625.100.729]
702166|NCT00975208|Tooth Eruption [G10.549.235.726]|tooth eruption [g10.549.235.726]
702167|NCT00975221|Primary hyperparathyroidism|primary hyperparathyroidism
702168|NCT00975221|Parathyroidectomy|parathyroidectomy
702169|NCT00975221|Hypercalcemia|hypercalcemia
702170|NCT00975234|Intra-lesion injection of autologous myoblasts|intra-lesion injection of autologous myoblasts
702171|NCT00975247|Quality Improvement|quality improvement
702172|NCT00975247|Colonoscopy|colonoscopy
702173|NCT00975247|Screening|screening
702174|NCT00975247|Colon Cancer|colon cancer
702175|NCT00975247|Polyp detection rates|polyp detection rates
702176|NCT00975247|Colonoscopy completion rates|colonoscopy completion rates
702177|NCT00975247|Scope Withdrawal time|scope withdrawal time
702178|NCT00975247|Reduce costs through improving bowel prep quality|reduce costs through improving bowel prep quality
702179|NCT00975273|Asthma|asthma
702180|NCT00975273|Dyspnea|dyspnea
702181|NCT00975273|Paroxysmal|paroxysmal
702182|NCT00975273|Pulmonary|pulmonary
702183|NCT00975273|Respiratory hypersensitivity|respiratory hypersensitivity
702184|NCT00975273|Airway inflammation|airway inflammation
702185|NCT00975273|Airway obstruction|airway obstruction
702186|NCT00975273|Wheezing|wheezing
702187|NCT00975299|Neoplasm|neoplasm
702188|NCT00975299|PET/CT diagnosis|pet/ct diagnosis
702189|NCT00975299|PET tracer|pet tracer
702190|NCT00975312|lentigo|lentigo
702191|NCT00975312|hydroquinone|hydroquinone
702192|NCT00975312|tretinoin|tretinoin
702194|NCT00975325|Bioequivalency|bioequivalency
702195|NCT00975338|health care transition, young adults, rehabilitation|health care transition, young adults, rehabilitation
702196|NCT00975351|folates|folates
702197|NCT00975351|5-methyltetrahydrofolic acid|5-methyltetrahydrofolic acid
702198|NCT00975351|pharmacokinetics|pharmacokinetics
702199|NCT00975351|bioavailability|bioavailability
702200|NCT00975351|biotransformation|biotransformation
702201|NCT00975364|Folate|folate
702202|NCT00975364|Methylenetetrahydrofolate reductase|methylenetetrahydrofolate reductase
702203|NCT00975364|Speciation|speciation
702204|NCT00975364|Nutrient status|nutrient status
702205|NCT00975364|Bioavailability|bioavailability
702206|NCT00975364|Polymorphism, single nucleotide|polymorphism, single nucleotide
702207|NCT00975377|hair removal|hair removal
702208|NCT00975377|hair clipping|hair clipping
702209|NCT00975377|surgical site infection|surgical site infection
702210|NCT00975377|incisional infection|incisional infection
702211|NCT00975377|wound infection|wound infection
702212|NCT00975390|Glycogen|glycogen
702213|NCT00975390|Carbohydrate|carbohydrate
702214|NCT00975390|Protein|protein
702215|NCT00975390|Caffeine|caffeine
702216|NCT00975390|Post exercise muscle glycogen synthesis|post exercise muscle glycogen synthesis
702217|NCT00975390|Sports nutrition|sports nutrition
702218|NCT00975403|mild COPD|mild copd
702219|NCT00975403|dyspnea|dyspnea
702220|NCT00975403|exercise|exercise
702221|NCT00975403|respiratory mechanics|respiratory mechanics
702222|NCT00975403|COPD|copd
702223|NCT00975416|Drug Dependence|drug dependence
702224|NCT00975416|Cognitive Behavior|cognitive behavior
702225|NCT00975416|Oxytocin|oxytocin
702226|NCT00975416|Cocaine|cocaine
702227|NCT00975416|Heroin|heroin
702228|NCT00975416|fMRI|fmri
702229|NCT00975429|Prostatic Disease|prostatic disease
702230|NCT00975429|Genital neoplasm, male|genital neoplasm, male
702231|NCT00975429|Urogenital neoplasm|urogenital neoplasm
702232|NCT00975429|Genital disease,male|genital disease,male
702233|NCT00975429|Male urogenital disease|male urogenital disease
702234|NCT00975429|Neoplasms|neoplasms
702235|NCT00975429|Neoplasm by site|neoplasm by site
702236|NCT00975429|Prostatic neoplasm|prostatic neoplasm
702237|NCT00975429|Carcinoma|carcinoma
702238|NCT00975442|Elbow|elbow
702239|NCT00975442|Tendinitis|tendinitis
702240|NCT00975442|Sports Medicine|sports medicine
702241|NCT00975442|Athletic injuries|athletic injuries
702242|NCT00975468|pressure-controlled|pressure-controlled
702243|NCT00975468|volume-controlled|volume-controlled
702245|NCT00975468|ventilation|ventilation
702246|NCT00975468|lung injury|lung injury
702247|NCT00975468|thoracotomy|thoracotomy
702248|NCT00975481|oral single-dose 6-way crossover recreational drug users abuse potential pharmacodynamics safety|oral single-dose 6-way crossover recreational drug users abuse potential pharmacodynamics safety
702249|NCT00975494|pde5-inhibition|pde5-inhibition
702250|NCT00975494|sildenafil|sildenafil
702251|NCT00975494|LV diastolic function|lv diastolic function
702252|NCT00975494|heart failure patients|heart failure patients
702253|NCT00975520|Neurotropic|neurotropic
702254|NCT00975520|Melanoma|melanoma
702255|NCT00975520|Observation|observation
702256|NCT00975520|Radiation Therapy|radiation therapy
702257|NCT00975520|Relapse|relapse
702258|NCT00975533|type 2 diabetes mellitus|type 2 diabetes mellitus
702259|NCT00975533|obesity|obesity
702260|NCT00975546|fertility|fertility
702261|NCT00975546|HIV discordant|hiv discordant
702262|NCT00975546|HIV|hiv
702263|NCT00975546|Infertility in HIV-discordant couples|infertility in hiv-discordant couples
702264|NCT00975546|HIV seronegativity|hiv seronegativity
702265|NCT00975572|Flu|flu
702266|NCT00975572|adjuvanted H1N1 vaccine|adjuvanted h1n1 vaccine
702267|NCT00975572|non-adjuvanted H1N1 vaccine|non-adjuvanted h1n1 vaccine
702268|NCT00975572|Immunogenictiy|immunogenictiy
702269|NCT00975572|Safety|safety
702270|NCT00975611|schizophrenia|schizophrenia
702271|NCT00975611|schizoaffective disorder|schizoaffective disorder
702272|NCT00975611|paliperidone ER|paliperidone er
702273|NCT00975611|risperidone Consta|risperidone consta
702274|NCT00975611|prolactin|prolactin
702275|NCT00975611|hyperprolactinemia|hyperprolactinemia
702276|NCT00975650|Primary Hypogonadism|primary hypogonadism
702277|NCT00975650|Secondary Hypogonadism|secondary hypogonadism
702278|NCT00975663|Lung transplantation|lung transplantation
702279|NCT00975663|heart-lung transplantation|heart-lung transplantation
702280|NCT00975663|therapeutic drug monitoring|therapeutic drug monitoring
702281|NCT00975663|tacrolimus|tacrolimus
702282|NCT00975663|mycophenolate|mycophenolate
702283|NCT00975663|immunosuppressant|immunosuppressant
702284|NCT00975663|pharmacokinetics|pharmacokinetics
702285|NCT00975676|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
702286|NCT00975676|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
702287|NCT00975676|stage IA breast cancer|stage ia breast cancer
702288|NCT00975676|stage IB breast cancer|stage ib breast cancer
702289|NCT00975676|stage II breast cancer|stage ii breast cancer
702290|NCT00975676|stage IIIA breast cancer|stage iiia breast cancer
702291|NCT00975689|Niemann-Pick Disease, Type C|niemann-pick disease, type c
702292|NCT00975689|Biomarkers|biomarkers
702293|NCT00975689|N-Acetyl Cysteine|n-acetyl cysteine
702294|NCT00975689|Oxidized Cholesterol|oxidized cholesterol
702295|NCT00975689|Neurodegeneration|neurodegeneration
702297|NCT00975702|Remote ischemic preconditioning|remote ischemic preconditioning
702298|NCT00975702|deceased organ donors|deceased organ donors
702299|NCT00975702|ischemia reperfusion injury|ischemia reperfusion injury
702300|NCT00975702|Delayed graft function|delayed graft function
702301|NCT00975702|Clinical outcomes in kidney transplant recipients|clinical outcomes in kidney transplant recipients
702302|NCT00975702|Clinical outcomes in liver transplant recipients|clinical outcomes in liver transplant recipients
702303|NCT00975702|Clinical outcomes in pancreas transplant recipients|clinical outcomes in pancreas transplant recipients
702304|NCT00975715|Seizures|seizures
702305|NCT00975715|oxcarbazepine|oxcarbazepine
702306|NCT00975715|child|child
702307|NCT00975728|Anti-oxidant|anti-oxidant
702308|NCT00975728|Açai|açai
702309|NCT00975728|Food supplement|food supplement
702310|NCT00975728|Sun protection|sun protection
702311|NCT00975728|Skin erythema prevention|skin erythema prevention
702312|NCT00975728|Anti-oxidant efficacy|anti-oxidant efficacy
702313|NCT00975728|Anti-age efficacy|anti-age efficacy
702314|NCT00975728|Skin photo-induced damage protection|skin photo-induced damage protection
702315|NCT00975741|Asthma|asthma
702316|NCT00975741|Mometasone furoate|mometasone furoate
702317|NCT00975741|Inhalation devices|inhalation devices
702318|NCT00975741|Forced expiratory volume|forced expiratory volume
702319|NCT00975754|Inhalation|inhalation
702320|NCT00975754|lung deposition|lung deposition
702321|NCT00975780|Pneumonia|pneumonia
702322|NCT00975780|Lower respiratory tract infection|lower respiratory tract infection
702323|NCT00975780|Lower respiratory tract infection other than pneumonia|lower respiratory tract infection other than pneumonia
702324|NCT00975793|Sepsis|sepsis
702325|NCT00975793|Severe sepsis|severe sepsis
702326|NCT00975793|Septic shock|septic shock
702327|NCT00975832|The independent effect of PCOS and obesity on adipose expression and plasma levels of adipocytokines|the independent effect of pcos and obesity on adipose expression and plasma levels of adipocytokines
702328|NCT00975845|ACL|acl
702329|NCT00975845|Anterior Cruciate Ligament|anterior cruciate ligament
702330|NCT00975845|Torn tendon|torn tendon
702331|NCT00975845|ACL Repair|acl repair
702332|NCT00975845|ACL reconstruction|acl reconstruction
751865|NCT01170923|FDG PET|fdg pet
702333|NCT00975858|Symptomatic Coronary Artery Disease Patients|symptomatic coronary artery disease patients
702334|NCT00975871|Livedo vasculitis|livedo vasculitis
702335|NCT00975871|Genetic pleomorphism|genetic pleomorphism
702336|NCT00975884|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
702337|NCT00975884|influenza infection|influenza infection
702338|NCT00975884|Influenza vaccine|influenza vaccine
702339|NCT00975897|adenocarcinoma of the colon|adenocarcinoma of the colon
702340|NCT00975897|recurrent colon cancer|recurrent colon cancer
702341|NCT00975897|stage III colon cancer|stage iii colon cancer
702342|NCT00975897|stage IV colon cancer|stage iv colon cancer
702343|NCT00975897|adenocarcinoma of the rectum|adenocarcinoma of the rectum
702344|NCT00975897|recurrent rectal cancer|recurrent rectal cancer
702345|NCT00975897|stage III rectal cancer|stage iii rectal cancer
702346|NCT00975897|stage IV rectal cancer|stage iv rectal cancer
702347|NCT00975910|Supratentorial Craniotomy|supratentorial craniotomy
702348|NCT00975923|Quality Improvement|quality improvement
702349|NCT00975923|Critical Care|critical care
702350|NCT00975923|Collaboratives|collaboratives
702351|NCT00975923|Patient Safety|patient safety
702352|NCT00975923|Tool Kit|tool kit
702353|NCT00975936|Microdose|microdose
702354|NCT00975936|Drug-Drug Interaction|drug-drug interaction
702355|NCT00975936|Ketoconazole|ketoconazole
702356|NCT00975936|Phase 0|phase 0
702357|NCT00975949|fluconazole prophylaxis|fluconazole prophylaxis
702358|NCT00975949|fungal colonization|fungal colonization
702359|NCT00975949|fungal infection|fungal infection
702360|NCT00975949|preterm infants|preterm infants
702361|NCT00975949|long term outcomes|long term outcomes
702362|NCT00975949|quality of life|quality of life
702363|NCT00975962|Stroke|stroke
702364|NCT00975962|Neuroprotection|neuroprotection
702365|NCT00975962|remote preconditioning|remote preconditioning
702366|NCT00975962|Salvage index (%): Difference in infarct growth (PWI-DWI)|salvage index (%): difference in infarct growth (pwi-dwi)
702367|NCT00975975|Paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
702870|NCT00969241|saliva|saliva
702368|NCT00975975|severe aplastic anemia|severe aplastic anemia
702369|NCT00975975|Mantle cell|mantle cell
702370|NCT00975988|PMS (post-marketing surveillance)|pms (post-marketing surveillance)
702371|NCT00975988|TYKERB® tablets|tykerb® tablets
702372|NCT00976001|Follow-up after stroke|follow-up after stroke
702373|NCT00976027|Influenza|influenza
702374|NCT00976027|Respiratory Tract Infections|respiratory tract infections
702375|NCT00976027|Influenza-like illness|influenza-like illness
702376|NCT00976027|Elderly|elderly
702377|NCT00976027|Fluzone®|fluzone®
702378|NCT00976027|Efficacy|efficacy
702379|NCT00976040|HIV-1|hiv-1
702380|NCT00976040|Africa|africa
702381|NCT00976040|Botswana|botswana
702382|NCT00976040|Highly active antiretroviral therapy|highly active antiretroviral therapy
702383|NCT00976040|treatment naive|treatment naive
702384|NCT00976053|Myocardial perfusion imaging|myocardial perfusion imaging
702385|NCT00976053|Single photon emission computed tomography|single photon emission computed tomography
702386|NCT00976053|Positron emission tomography|positron emission tomography
702387|NCT00976066|Obesity|obesity
702388|NCT00976066|Naltrexone|naltrexone
702389|NCT00976066|Carfentanil|carfentanil
702390|NCT00976066|Receptor Occupancy|receptor occupancy
702391|NCT00976066|mu-opioid Receptor|mu-opioid receptor
702392|NCT00976066|PET (Positron Emission Tomography)|pet (positron emission tomography)
702393|NCT00976066|BOLD-fMRI|bold-fmri
702394|NCT00976079|Tibial femoral knee osteoarthritis|tibial femoral knee osteoarthritis
702395|NCT00976079|Osteoarthritis|osteoarthritis
702396|NCT00976092|myocardial infarction|myocardial infarction
702397|NCT00976092|clopidogrel|clopidogrel
702398|NCT00976092|prasugrel|prasugrel
702399|NCT00976092|bivalirudin|bivalirudin
702400|NCT00976092|primary PCI|primary pci
702401|NCT00976105|Pharmacokinetics|pharmacokinetics
702402|NCT00976105|Pharmacodynamics|pharmacodynamics
702403|NCT00976105|Safety and tolerability|safety and tolerability
702404|NCT00976105|Repeat dose|repeat dose
702405|NCT00976105|Personality traits|personality traits
702406|NCT00976105|Fat mass|fat mass
702407|NCT00976105|Healthy volunteers|healthy volunteers
702408|NCT00976118|Dementia of Alzheimer's type|dementia of alzheimer's type
702409|NCT00976118|mild to moderate Alzheimer's Disease|mild to moderate alzheimer's disease
702410|NCT00976131|Breast Cancer|breast cancer
702411|NCT00976131|Early Stage Breast Cancer|early stage breast cancer
702412|NCT00976131|Complementary and Alternative Medicine|complementary and alternative medicine
702413|NCT00976131|CAM|cam
702414|NCT00976144|safety|safety
702415|NCT00976144|LAMA|lama
702416|NCT00976144|pharmacodynamics|pharmacodynamics
702417|NCT00976144|tolerability|tolerability
702418|NCT00976144|Muscarinic receptor antagonist,|muscarinic receptor antagonist,
702419|NCT00976144|anticholinergic,|anticholinergic,
702420|NCT00976144|beta-2 agonist|beta-2 agonist
702421|NCT00976144|healthy Japanese subjects|healthy japanese subjects
702422|NCT00976144|LABA|laba
702423|NCT00976144|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
702424|NCT00976144|pharmacokinetics|pharmacokinetics
702425|NCT00976157|STREM-1|strem-1
702426|NCT00976157|BAL|bal
702427|NCT00976157|VAP|vap
702428|NCT00976170|Advanced or metastatic HCC|advanced or metastatic hcc
702429|NCT00976183|ovarian cancer|ovarian cancer
702430|NCT00976183|gynecologic oncology|gynecologic oncology
702432|NCT00976183|treatment|treatment
702433|NCT00976196|Aspirin|aspirin
702434|NCT00976196|Blood platelets|blood platelets
702435|NCT00976196|proteomics|proteomics
702436|NCT00976196|Platelet reactivity|platelet reactivity
702437|NCT00976235|Macular Degeneration|macular degeneration
702438|NCT00976235|Visual Impairment|visual impairment
702439|NCT00976235|Quality of Life|quality of life
702440|NCT00976235|Telescope Prosthesis|telescope prosthesis
702441|NCT00976248|everolimus|everolimus
702442|NCT00976248|RAD001|rad001
702443|NCT00976248|WM|wm
702444|NCT00976261|type 2 diabetes|type 2 diabetes
702445|NCT00976261|single dose|single dose
702446|NCT00976261|3-O-methylglucose|3-o-methylglucose
702447|NCT00976261|healthy volunteer|healthy volunteer
702448|NCT00976261|repeat dose|repeat dose
702449|NCT00976274|Korean red ginseng|korean red ginseng
702450|NCT00976274|metabolic syndrome|metabolic syndrome
702451|NCT00976274|blood pressure|blood pressure
702452|NCT00976274|arterial stiffness|arterial stiffness
702453|NCT00976274|inflammation|inflammation
702454|NCT00976274|oxidative stress|oxidative stress
702455|NCT00976287|Stem cells|stem cells
702456|NCT00976287|Liver cirrhosis|liver cirrhosis
702457|NCT00976287|Radiology|radiology
702458|NCT00976287|Interventional|interventional
702459|NCT00976287|Transplantation|transplantation
702460|NCT00976300|SLE|sle
702461|NCT00976300|lupus nephritis|lupus nephritis
702462|NCT00976300|cyclosporine A|cyclosporine a
702463|NCT00976300|cyclophosphamide|cyclophosphamide
702464|NCT00976300|active proliferative lupus nephritis (class III or IV according to WHO)|active proliferative lupus nephritis (class iii or iv according to who)
702465|NCT00976313|thoracic epidural analgesia|thoracic epidural analgesia
702466|NCT00976313|urinary micturition|urinary micturition
702467|NCT00976313|thoracotomy|thoracotomy
702468|NCT00976339|Breast cancer|breast cancer
702469|NCT00976339|Vitamin D|vitamin d
702470|NCT00976339|Premenopausal|premenopausal
702471|NCT00976352|Gene Therapy|gene therapy
702472|NCT00976352|Pompe Disease|pompe disease
702473|NCT00976352|Glycogen Storage Disease|glycogen storage disease
702474|NCT00976365|Breast Cancer|breast cancer
702475|NCT00976378|stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
702476|NCT00976378|L-oligonucleotide aptamer|l-oligonucleotide aptamer
702477|NCT00976378|Spiegelmer|spiegelmer
702478|NCT00976391|open-label|open-label
702479|NCT00976391|albiglutide|albiglutide
702480|NCT00976391|insulin glargine|insulin glargine
702481|NCT00976391|preprandial insulin|preprandial insulin
702482|NCT00976404|HIV-1 infection|hiv-1 infection
702483|NCT00976404|Treatment intensification|treatment intensification
702484|NCT00976404|Immunomodulation|immunomodulation
702485|NCT00976404|HIV-rAd5 vaccine|hiv-rad5 vaccine
702486|NCT00976430|Autologous Stem Cells.|autologous stem cells.
702487|NCT00976443|Obesity|obesity
702488|NCT00976443|Gastric Emptying|gastric emptying
702489|NCT00976443|Satiation|satiation
702490|NCT00976443|Endosonography|endosonography
702491|NCT00976443|Endoscopy|endoscopy
702492|NCT00976443|Feeding Behavior|feeding behavior
702493|NCT00976456|lung cancer|lung cancer
702494|NCT00976456|NSCLC|nsclc
702495|NCT00976456|elderly|elderly
702496|NCT00976456|non-squamous|non-squamous
702497|NCT00976456|Elderly patients at least 65 years old|elderly patients at least 65 years old
702498|NCT00976456|first line therapy|first line therapy
702499|NCT00976456|non-squamous non-small cell lung cancer stage IIIb or IV|non-squamous non-small cell lung cancer stage iiib or iv
702500|NCT00976482|Cardiovascular|cardiovascular
702501|NCT00976482|Pacemaker|pacemaker
702502|NCT00976482|Mortality|mortality
702503|NCT00976482|Physiologic pacing|physiologic pacing
702504|NCT00976508|advanced solid tumors cancer refractory cancer figitumumab pegvisomant|advanced solid tumors cancer refractory cancer figitumumab pegvisomant
702505|NCT00976534|Analgesic effect|analgesic effect
702506|NCT00976534|Peripheral Neuropathic pain|peripheral neuropathic pain
702507|NCT00976534|Posttraumatic Neuralgia (PTN)|posttraumatic neuralgia (ptn)
702508|NCT00976534|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
702509|NCT00976547|tinnitus|tinnitus
702510|NCT00976547|depression|depression
702511|NCT00976547|audiometry|audiometry
702512|NCT00976547|measurement|measurement
702513|NCT00976560|Lack of interest and energy|lack of interest and energy
702514|NCT00976560|Psychomotor retardation|psychomotor retardation
702515|NCT00976560|Cytokines|cytokines
702516|NCT00976560|Major Depressive disorder|major depressive disorder
702517|NCT00976573|Stage IV Skin Melanoma|stage iv skin melanoma
702518|NCT00976573|recurrent melanoma|recurrent melanoma
702519|NCT00976586|Incontinentia pigmenti|incontinentia pigmenti
702520|NCT00976586|recombination|recombination
702521|NCT00976586|IKBKG|ikbkg
702522|NCT00976586|IKBKGP|ikbkgp
702523|NCT00976612|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
702524|NCT00976612|pharmacokinetics|pharmacokinetics
702525|NCT00976612|nilotinib|nilotinib
702526|NCT00976625|diastolic function|diastolic function
702527|NCT00976625|aortic regurgitation|aortic regurgitation
702528|NCT00976625|aortic valve replacement|aortic valve replacement
702529|NCT00976625|left ventricular hypertrophy|left ventricular hypertrophy
702530|NCT00976625|myocardial structure|myocardial structure
702531|NCT00976625|LV remodeling|lv remodeling
702532|NCT00976625|Muscular regression|muscular regression
702533|NCT00976625|LV fibrous tissue|lv fibrous tissue
702534|NCT00976638|Antimicrobial Resistant Bacteria|antimicrobial resistant bacteria
702535|NCT00976638|Hospital acquired infections|hospital acquired infections
702536|NCT00976638|Colonization|colonization
702537|NCT00976638|Bacteremia|bacteremia
702538|NCT00976638|MRSA|mrsa
702540|NCT00976638|ESBL|esbl
702541|NCT00976638|Intensive Care|intensive care
702542|NCT00976638|ICU|icu
702543|NCT00976651|infertility|infertility
702544|NCT00976651|ICSI|icsi
702545|NCT00976651|hCG|hcg
702546|NCT00976651|infertility treatment|infertility treatment
702547|NCT00976690|Crohn's Disease|crohn's disease
702548|NCT00976690|Ileocolic resection|ileocolic resection
702549|NCT00976690|Endoscopic recurrence|endoscopic recurrence
702550|NCT00976690|Ileocolic or colon resection (>50cm)|ileocolic or colon resection (>50cm)
702551|NCT00976703|cervical foley catheter|cervical foley catheter
702552|NCT00976716|posttraumatic pain|posttraumatic pain
702553|NCT00976729|monocyte chemoattractant protein-1 (MCP-1)|monocyte chemoattractant protein-1 (mcp-1)
702554|NCT00976729|L-oligonucleotide aptamer|l-oligonucleotide aptamer
702555|NCT00976729|Spiegelmer|spiegelmer
702556|NCT00976742|plasma lipoprotein lipids|plasma lipoprotein lipids
702557|NCT00976742|body composition|body composition
702558|NCT00976742|glucose tolerance|glucose tolerance
702559|NCT00976742|inflammation markers|inflammation markers
702560|NCT00976742|insulin sensitivity|insulin sensitivity
702561|NCT00976742|coagulation markers|coagulation markers
702562|NCT00976755|adenocarcinoma of the prostate|adenocarcinoma of the prostate
702563|NCT00976755|hormone-resistant prostate cancer|hormone-resistant prostate cancer
702564|NCT00976755|stage III prostate cancer|stage iii prostate cancer
702565|NCT00976755|stage IV prostate cancer|stage iv prostate cancer
702566|NCT00976768|Advanced gastric cancer|advanced gastric cancer
702567|NCT00976768|FOLFIRI|folfiri
702568|NCT00976794|BD I|bd i
702569|NCT00976807|critical care|critical care
702570|NCT00976807|intensive care|intensive care
702571|NCT00976807|weakness|weakness
702572|NCT00976807|myopathy|myopathy
702573|NCT00976807|paresis|paresis
702574|NCT00976807|rehabilitation|rehabilitation
702575|NCT00976820|influenza infection|influenza infection
702576|NCT00976820|Influenza Vaccines|influenza vaccines
702676|NCT00977223|Aprepitant|aprepitant
702577|NCT00976820|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
702578|NCT00976820|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
702579|NCT00976833|Acute Respiratory Failure|acute respiratory failure
702580|NCT00976833|Early ICU Mobility|early icu mobility
702581|NCT00976833|Early Physical Therapy|early physical therapy
702582|NCT00976833|Critical Care|critical care
702583|NCT00976833|Intensive Care|intensive care
702585|NCT00976846|hemodialysis|hemodialysis
702586|NCT00976846|on line|on line
702587|NCT00976846|postdilution|postdilution
702588|NCT00976846|high-flux dialyzer|high-flux dialyzer
702589|NCT00976846|hemodiafiltration|hemodiafiltration
702590|NCT00976859|childhood sexual abuse|childhood sexual abuse
702591|NCT00976859|CSA|csa
702592|NCT00976859|posttraumatic stress disorder|posttraumatic stress disorder
702593|NCT00976859|PTSD, feeling of being polluted|ptsd, feeling of being polluted
702594|NCT00976859|mental pollution, mental contamination|mental pollution, mental contamination
702595|NCT00976859|feeling of being contaminated|feeling of being contaminated
702596|NCT00976859|sexual assault|sexual assault
702597|NCT00976859|disgust, shame|disgust, shame
702598|NCT00976872|omega 3|omega 3
702599|NCT00976872|inflammation|inflammation
702600|NCT00976872|augmentation index|augmentation index
702601|NCT00976872|endothelial function|endothelial function
702602|NCT00976898|proton beam radiation|proton beam radiation
702603|NCT00976924|blood glucose|blood glucose
702604|NCT00976963|UTI|uti
702605|NCT00976976|Resected advanced gastric cancer stage IIIB and IV|resected advanced gastric cancer stage iiib and iv
702606|NCT00977002|noninvasive ventilation|noninvasive ventilation
702607|NCT00977002|extubation|extubation
702608|NCT00977002|Respiratory failure|respiratory failure
702609|NCT00977002|reintubation|reintubation
702610|NCT00977028|Tumescent|tumescent
702611|NCT00977028|Local Anesthesia|local anesthesia
702612|NCT00977028|Lidocaine|lidocaine
702613|NCT00977028|Dosage Maximum|dosage maximum
702614|NCT00977028|Subcutaneous infiltration|subcutaneous infiltration
702615|NCT00977028|maximum Safe mg per kg dosage of lidocaine|maximum safe mg per kg dosage of lidocaine
702616|NCT00977028|Tumescent Local Anesthesia|tumescent local anesthesia
702617|NCT00977041|Neurofeedback|neurofeedback
702618|NCT00977054|Hepatitis C|hepatitis c
702619|NCT00977054|Peginterferon alfa-2a|peginterferon alfa-2a
702620|NCT00977054|Ribavirin|ribavirin
702621|NCT00977054|Plasmapheresis|plasmapheresis
702622|NCT00977054|Genotype 1|genotype 1
702623|NCT00977067|GDC0152|gdc0152
702624|NCT00977067|IAP|iap
702625|NCT00977067|IAP Antagonist|iap antagonist
702626|NCT00977080|Zemplar|zemplar
702627|NCT00977080|paricalcitol|paricalcitol
702628|NCT00977080|IMPACT SHPT|impact shpt
702629|NCT00977080|Hemodialysis|hemodialysis
702630|NCT00977080|Chronic Kidney Disease Stage 5|chronic kidney disease stage 5
702631|NCT00977093|Coronary artery disease|coronary artery disease
702632|NCT00977093|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
702633|NCT00977093|single photon emission computed tomography|single photon emission computed tomography
702634|NCT00977093|invasive coronary angiography|invasive coronary angiography
702635|NCT00977119|breast cancer|breast cancer
702636|NCT00977119|capecitabine|capecitabine
702637|NCT00977132|Myelodysplastic Syndromes|myelodysplastic syndromes
702638|NCT00977132|Valproic acid|valproic acid
702639|NCT00977132|Lenalidomide|lenalidomide
702640|NCT00977145|melanoma|melanoma
702641|NCT00977145|peptide vaccine|peptide vaccine
702642|NCT00977145|interferon gamma|interferon gamma
702643|NCT00977145|immunotherapy|immunotherapy
702644|NCT00977158|Cystic Fibrosis|cystic fibrosis
702645|NCT00977158|Microbiota|microbiota
702646|NCT00977158|upper respiratory tract|upper respiratory tract
702647|NCT00977158|16S rRNA sequence analysis|16s rrna sequence analysis
702648|NCT00977158|Staphylococcus aureus|staphylococcus aureus
702649|NCT00977158|Pseudomonas aeruginosa|pseudomonas aeruginosa
702650|NCT00977158|Burkholderia cepacia|burkholderia cepacia
702651|NCT00977158|Haemophilus influenzae|haemophilus influenzae
702652|NCT00977158|Streptococcus pneumoniae|streptococcus pneumoniae
702653|NCT00977171|chronic fatigue syndrome|chronic fatigue syndrome
702654|NCT00977171|CFS|cfs
702655|NCT00977171|neurally mediated hypotension|neurally mediated hypotension
702656|NCT00977171|NMH|nmh
702657|NCT00977171|neurogenic orthostatic hypotension|neurogenic orthostatic hypotension
702658|NCT00977171|NOH|noh
702659|NCT00977171|orthostatic hypotension|orthostatic hypotension
702660|NCT00977171|droxidopa|droxidopa
702661|NCT00977184|Parkinson's Disease|parkinson's disease
702662|NCT00977184|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
702663|NCT00977184|Treatment Study|treatment study
702664|NCT00977184|PD|pd
702665|NCT00977184|Parkinson Disease|parkinson disease
702666|NCT00977210|Phase 1|phase 1
702667|NCT00977210|oxi4503|oxi4503
702668|NCT00977210|oxigene|oxigene
702669|NCT00977210|cruk|cruk
702670|NCT00977210|solid tumors|solid tumors
702671|NCT00977210|VDA|vda
702672|NCT00977210|vascular disrupting agent|vascular disrupting agent
702673|NCT00977223|Aldosterone|aldosterone
702674|NCT00977223|Substance P|substance p
702675|NCT00977223|Cortisol|cortisol
702677|NCT00977223|Adrenal glands|adrenal glands
702678|NCT00977236|children|children
702679|NCT00977236|corneal reshaping|corneal reshaping
702680|NCT00977236|myopia|myopia
702681|NCT00977236|myopia control|myopia control
702682|NCT00977236|orthokeratology|orthokeratology
702683|NCT00977249|long term nicotine gum use|long term nicotine gum use
702684|NCT00977249|varenicline|varenicline
702685|NCT00977249|adverse effects|adverse effects
702686|NCT00977262|fatty acids|fatty acids
702687|NCT00977262|peripheral blood mononuclear cells|peripheral blood mononuclear cells
702688|NCT00977262|inflammation|inflammation
702689|NCT00977262|nutrigenomics|nutrigenomics
702690|NCT00977275|early stage invasive breast cancer|early stage invasive breast cancer
702691|NCT00977275|Partial breast irradiation|partial breast irradiation
702692|NCT00977275|interstitial implant|interstitial implant
702693|NCT00977301|HIV infection|hiv infection
702694|NCT00977301|interaction|interaction
702695|NCT00977301|pharmacokinetics|pharmacokinetics
702696|NCT00977314|Unilateral Hearing Loss|unilateral hearing loss
702697|NCT00968708|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
702698|NCT00968708|Diabetes Mellitus|diabetes mellitus
702699|NCT00968708|cardiovascular outcomes|cardiovascular outcomes
702700|NCT00968708|heart attack|heart attack
702701|NCT00968708|stroke|stroke
702702|NCT00968708|dipeptidyl-peptidase IV inhibitors|dipeptidyl-peptidase iv inhibitors
702703|NCT00968708|metabolic disorders|metabolic disorders
702704|NCT00968708|metabolic diseases|metabolic diseases
702705|NCT00968708|glucose metabolism disorders|glucose metabolism disorders
702706|NCT00968721|Inflammatory bowel disease|inflammatory bowel disease
702707|NCT00968721|Crohn's disease|crohn's disease
702708|NCT00968721|Ulcerative colitis|ulcerative colitis
702709|NCT00968721|medication adherence|medication adherence
702710|NCT00968721|Decisional influences|decisional influences
702711|NCT00968734|Vitamin D|vitamin d
702712|NCT00968734|colecalciferol|colecalciferol
702713|NCT00968734|absorption by Vitamin D|absorption by vitamin d
702714|NCT00968747|Fasting|fasting
702715|NCT00968747|Fast|fast
702716|NCT00968747|healthy|healthy
702717|NCT00968747|diet|diet
702718|NCT00968747|study|study
702719|NCT00968747|manipulation|manipulation
702720|NCT00968747|dietary|dietary
702721|NCT00968747|FGF21|fgf21
702722|NCT00968747|Fibroblast growth factor|fibroblast growth factor
702723|NCT00968747|PTRF|ptrf
702724|NCT00968747|Polymerase 1 and transcript release factor|polymerase 1 and transcript release factor
702725|NCT00968747|adipose|adipose
702727|NCT00968747|blood|blood
702728|NCT00968747|inpatient|inpatient
702729|NCT00968747|outpatient|outpatient
702730|NCT00968747|NAFLD|nafld
702731|NCT00968747|metabolism|metabolism
702732|NCT00968760|CD19+ lymphoid malignancies|cd19+ lymphoid malignancies
702733|NCT00968760|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
702734|NCT00968760|NHL|nhl
702735|NCT00968760|small lymphocytic lymphoma|small lymphocytic lymphoma
702737|NCT00968760|follicular lymphoma|follicular lymphoma
702738|NCT00968760|mantle cell lymphoma|mantle cell lymphoma
702739|NCT00968760|gene cell transfer|gene cell transfer
702740|NCT00968760|CD19-specific T cells|cd19-specific t cells
702741|NCT00968760|Stem Cell Transplant|stem cell transplant
702742|NCT00968760|T Cell Infusion|t cell infusion
702743|NCT00968760|Chemotherapy|chemotherapy
702744|NCT00968760|Leukapheresis|leukapheresis
702745|NCT00968760|BCNU|bcnu
702746|NCT00968760|carmustine|carmustine
702747|NCT00968760|Cytarabine|cytarabine
702748|NCT00968760|Etoposide|etoposide
702749|NCT00968760|Interleukin-2|interleukin-2
702750|NCT00968760|Proleukin|proleukin
702751|NCT00968760|Melphalan|melphalan
702752|NCT00968760|Rituximab|rituximab
702753|NCT00968760|T cell therapy|t cell therapy
702754|NCT00968773|inguinal hernia|inguinal hernia
702755|NCT00968773|mesh|mesh
702756|NCT00968773|hernia repair device|hernia repair device
702757|NCT00968786|hypertension|hypertension
702758|NCT00968786|type 2 diabetes|type 2 diabetes
702759|NCT00968786|home monitoring|home monitoring
702760|NCT00968799|Ovarian Neoplasms|ovarian neoplasms
702761|NCT00968799|Recurrence|recurrence
702762|NCT00968799|Hyperthermia, Induced|hyperthermia, induced
702763|NCT00968799|Peritoneal Neoplasms|peritoneal neoplasms
702764|NCT00968799|recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
702765|NCT00968799|recurrent fallopian tube carcinoma|recurrent fallopian tube carcinoma
702766|NCT00968812|Diabetes|diabetes
702769|NCT00968812|Hemoglobin A1c|hemoglobin a1c
702770|NCT00968812|Type 2 diabetes mellitus|type 2 diabetes mellitus
702771|NCT00968812|Canagliflozin|canagliflozin
702772|NCT00968825|Lateral Canthal Lines|lateral canthal lines
702773|NCT00968825|Crow's Feet|crow's feet
702774|NCT00968825|Facial Wrinkles|facial wrinkles
702775|NCT00968838|White Blood Cell Transfusion|white blood cell transfusion
702776|NCT00968838|Radiated Cells|radiated cells
702777|NCT00968838|Unradiated Cells|unradiated cells
702778|NCT00968838|Leukocyte Transfusions|leukocyte transfusions
702779|NCT00968838|Life-threatening Infections|life-threatening infections
702780|NCT00968851|Schizophrenia|schizophrenia
702781|NCT00968851|Central nervous System Diseases|central nervous system diseases
702782|NCT00968851|Cognition|cognition
702783|NCT00968864|T cell depleted|t cell depleted
702784|NCT00968864|Matched unrelated donors|matched unrelated donors
702785|NCT00968864|Haplocompatible donors|haplocompatible donors
702786|NCT00968877|Renal Insufficiency|renal insufficiency
702787|NCT00968877|Cholecalciferol|cholecalciferol
702788|NCT00968877|Kidney Disease|kidney disease
702789|NCT00968877|Kidney Failure|kidney failure
702790|NCT00968877|Vitamin D|vitamin d
702791|NCT00968877|Vitamin D Deficiency|vitamin d deficiency
702792|NCT00968877|Vitamin D3|vitamin d3
702793|NCT00968890|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
702794|NCT00968890|Influenza infection|influenza infection
702795|NCT00968903|Hip arthroplasty|hip arthroplasty
702796|NCT00968903|Methylprednisolone|methylprednisolone
702797|NCT00968903|Post-operative pain|post-operative pain
702798|NCT00968929|pulmonary embolism|pulmonary embolism
702799|NCT00968929|thrombolysis|thrombolysis
702800|NCT00968929|massive|massive
702801|NCT00968929|submassive|submassive
702802|NCT00968929|recombinant streptokinase|recombinant streptokinase
702803|NCT00968929|urokinase|urokinase
702804|NCT00968942|Lateral Canthal Lines|lateral canthal lines
702805|NCT00968942|Crow's Feet|crow's feet
702806|NCT00968942|Facial Wrinkles|facial wrinkles
702807|NCT00968955|Postoperative acute pain|postoperative acute pain
702808|NCT00968955|Total hip arthroplasty|total hip arthroplasty
702809|NCT00968955|Local infiltration analgesia|local infiltration analgesia
702810|NCT00968981|Hedgehog|hedgehog
702811|NCT00968981|BCC|bcc
702812|NCT00968981|basal cell carcinoma|basal cell carcinoma
702813|NCT00968994|Wound Healing|wound healing
702814|NCT00968994|Wound Infection|wound infection
702815|NCT00969020|Length of stay|length of stay
702816|NCT00969020|Timed up and go|timed up and go
702817|NCT00969046|Colon cancer|colon cancer
702818|NCT00969046|MTD|mtd
702819|NCT00969046|DLT|dlt
702820|NCT00969046|EPO906|epo906
702821|NCT00969046|patupilone|patupilone
702822|NCT00969059|peripheral nerve injury|peripheral nerve injury
702823|NCT00969059|p38 kinase inhibitor|p38 kinase inhibitor
702824|NCT00969059|neuropathic pain|neuropathic pain
702825|NCT00969072|GI198745|gi198745
702826|NCT00969072|Long term extension study|long term extension study
702827|NCT00969072|BPH|bph
702828|NCT00969085|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
702829|NCT00969085|Skin|skin
702830|NCT00969085|Mycosis fungoides|mycosis fungoides
702831|NCT00969085|MF|mf
702832|NCT00969085|Sézary syndrome|sézary syndrome
702833|NCT00969085|SS|ss
702834|NCT00969085|Curcumin|curcumin
702835|NCT00969085|Turmeric|turmeric
702836|NCT00969098|Histologically proven of Malignant pleural mesothelioma;|histologically proven of malignant pleural mesothelioma;
702837|NCT00969098|Patients not candidate to radical surgery;|patients not candidate to radical surgery;
702838|NCT00969098|Candidate to first-line pemetrexed-based chemotherapy;|candidate to first-line pemetrexed-based chemotherapy;
702839|NCT00969111|Proton Radiation, Prostate Cancer|proton radiation, prostate cancer
702840|NCT00969124|colonoscopy|colonoscopy
702841|NCT00969124|polyps|polyps
702842|NCT00969124|adenomas|adenomas
702843|NCT00969124|miss rates|miss rates
702844|NCT00969137|smoking, nicotine, cigarettes|smoking, nicotine, cigarettes
702845|NCT00969150|Major Depressive Disorder|major depressive disorder
702846|NCT00969150|Depression|depression
702847|NCT00969163|Biomarkers of Skin Androgenization|biomarkers of skin androgenization
702848|NCT00969176|pain|pain
702849|NCT00969176|fever|fever
702850|NCT00969176|neonate|neonate
702851|NCT00969176|preterm|preterm
702852|NCT00969176|term|term
702853|NCT00969176|newborn|newborn
702854|NCT00969189|anesthesia|anesthesia
702855|NCT00969189|child|child
702856|NCT00969189|infant|infant
702857|NCT00969189|laryngeal mask|laryngeal mask
702858|NCT00969202|Prostate Cancer|prostate cancer
702859|NCT00969202|Cancer of the Prostate|cancer of the prostate
702860|NCT00969202|Prostate Tumor|prostate tumor
702861|NCT00969202|Novalis Tx|novalis tx
702862|NCT00969202|Novalis|novalis
702863|NCT00969202|Stereotactic Radiosurgery|stereotactic radiosurgery
702864|NCT00969202|Radiosurgery|radiosurgery
702865|NCT00969202|Radiation|radiation
702866|NCT00969215|burn scar|burn scar
702867|NCT00969215|fractional carbon dioxide laser|fractional carbon dioxide laser
702868|NCT00969215|scar revision|scar revision
702869|NCT00969228|Gastroenteritis|gastroenteritis
702871|NCT00969241|free-radicals|free-radicals
702872|NCT00969241|periodontitis|periodontitis
702873|NCT00969254|Pílulas de Lussen|pílulas de lussen
702874|NCT00969254|Efficacy|efficacy
702875|NCT00969254|Safety|safety
702876|NCT00969254|Dysuria|dysuria
702877|NCT00969254|Symptomatic control|symptomatic control
702878|NCT00969267|ear acupuncture|ear acupuncture
702879|NCT00969267|obese|obese
702880|NCT00969267|obese women|obese women
702881|NCT00969267|women|women
702882|NCT00969280|Acupuncture|acupuncture
702883|NCT00969280|Dry eye syndrome|dry eye syndrome
702884|NCT00969280|Ocular Surface Disease Index|ocular surface disease index
702885|NCT00969280|Schirmer test|schirmer test
702886|NCT00969280|Tear film Break-up time|tear film break-up time
702887|NCT00969293|Macular Edema|macular edema
702888|NCT00969293|Occlusive retinal vascular disease|occlusive retinal vascular disease
702889|NCT00969293|Central Retinal Vein Occlusion|central retinal vein occlusion
702890|NCT00969293|CRVO|crvo
702891|NCT00969319|Octocog alfa|octocog alfa
702892|NCT00969319|Hemophilia A|hemophilia a
702893|NCT00969332|liver|liver
702894|NCT00969332|Parenteral Nutrition|parenteral nutrition
702895|NCT00969332|fish oil|fish oil
702896|NCT00969332|Omegaven|omegaven
702897|NCT00969332|children|children
702898|NCT00969345|Healthy Elderly Subjects|healthy elderly subjects
702899|NCT00969345|Respiratory Yoga Exercises|respiratory yoga exercises
702900|NCT00969345|Heart Rate Variability|heart rate variability
702901|NCT00969345|Baroreflex|baroreflex
702902|NCT00969345|Quality of Life|quality of life
702903|NCT00969371|posterior chamber intraocular lens|posterior chamber intraocular lens
702904|NCT00969371|PCIOL|pciol
702905|NCT00969371|IOL|iol
702906|NCT00969384|Physical health|physical health
702907|NCT00969384|Mental illness|mental illness
702908|NCT00969384|prevention|prevention
702909|NCT00969384|Waist circumference|waist circumference
702910|NCT00969397|Birthmark|birthmark
702911|NCT00969397|PWS|pws
702912|NCT00969410|Neoplasms|neoplasms
702913|NCT00969410|Neoplasm metastasis|neoplasm metastasis
702914|NCT00969410|Liver neoplasms|liver neoplasms
702915|NCT00969410|Neoplastic processes|neoplastic processes
702916|NCT00969410|Pathologic processes|pathologic processes
702917|NCT00969410|Digestive system neoplasms|digestive system neoplasms
702918|NCT00969410|Neoplasms by site|neoplasms by site
704590|NCT00983723|PFO|pfo
702919|NCT00969410|Digestive system diseases|digestive system diseases
702920|NCT00969410|Liver diseases|liver diseases
702921|NCT00969423|persistent pain|persistent pain
702922|NCT00969423|neuropathic pain|neuropathic pain
702923|NCT00969423|Chronic Pain|chronic pain
702924|NCT00969423|VATS|vats
702925|NCT00969423|Primary spontaneous pneumothorax patients|primary spontaneous pneumothorax patients
702926|NCT00969436|Mumps|mumps
702927|NCT00969436|Immunogenicity|immunogenicity
702928|NCT00969436|Vaccines|vaccines
702929|NCT00969436|Safety|safety
702930|NCT00969436|Rubella|rubella
702931|NCT00969436|Combined Vaccine|combined vaccine
702932|NCT00969436|Varicella Vaccine|varicella vaccine
702933|NCT00969436|Children|children
702934|NCT00969436|Measles|measles
702935|NCT00969436|Humans|humans
702936|NCT00969449|Naproxen Sodium|naproxen sodium
702937|NCT00969462|Doxorubicin|doxorubicin
702938|NCT00969462|pharmacokinetics|pharmacokinetics
702939|NCT00969462|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
702940|NCT00969462|response|response
702941|NCT00969462|association between response to chemotherapy|association between response to chemotherapy
702942|NCT00969462|myelosuppression degree|myelosuppression degree
702943|NCT00969462|doxorubicin pharmacokinetics|doxorubicin pharmacokinetics
702944|NCT00969475|scar revision|scar revision
702945|NCT00969475|intraoperative|intraoperative
702946|NCT00969475|fractional carbon dioxide laser|fractional carbon dioxide laser
702947|NCT00969488|matern diet|matern diet
702948|NCT00969488|obese|obese
702949|NCT00969488|postpartum|postpartum
702950|NCT00969488|body weight change|body weight change
702951|NCT00969488|Women with overweight|women with overweight
702952|NCT00969514|Robotic cystectomy|robotic cystectomy
702953|NCT00969514|Bladder|bladder
702954|NCT00969527|Oncoxin|oncoxin
702955|NCT00969527|Viusid|viusid
702956|NCT00969527|dietary supplements|dietary supplements
702957|NCT00969527|rheumatoid arthritis|rheumatoid arthritis
702958|NCT00969540|Back Pain|back pain
702959|NCT00969540|Sleep|sleep
702960|NCT00969566|Diabetes|diabetes
702961|NCT00969566|Sitagliptin|sitagliptin
702962|NCT00969566|C-peptide|c-peptide
702963|NCT00969566|Glucagon|glucagon
702964|NCT00969579|Cancer|cancer
702965|NCT00969579|Psychosocial Stress|psychosocial stress
702966|NCT00969579|Parenting|parenting
702967|NCT00969592|diabetes|diabetes
702968|NCT00969605|weaning|weaning
702969|NCT00969605|adaptive support ventilation|adaptive support ventilation
702970|NCT00969605|COPD|copd
702971|NCT00969618|ADHD|adhd
702972|NCT00969631|Polycystic ovary syndrome|polycystic ovary syndrome
702973|NCT00969631|clomiphene resistance|clomiphene resistance
702974|NCT00969631|metformin|metformin
702975|NCT00969631|laparoscopic ovarian diathermy|laparoscopic ovarian diathermy
702976|NCT00969657|rectal cancer stage I-III|rectal cancer stage i-iii
702977|NCT00969657|concurrent chemoradiotherapie|concurrent chemoradiotherapie
702978|NCT00969657|response prediction|response prediction
702979|NCT00969696|ability to learn, working memory|ability to learn, working memory
702980|NCT00969709|Depression|depression
702981|NCT00969709|Major Depressive Disorder|major depressive disorder
702982|NCT00969722|Neuroblastoma|neuroblastoma
702984|NCT00969722|Primary refractory|primary refractory
702985|NCT00969735|Atrial fibrillation|atrial fibrillation
702986|NCT00969735|Catheter ablation|catheter ablation
702987|NCT00969735|Cryoenergy|cryoenergy
702988|NCT00969735|Implantable loop recorder|implantable loop recorder
702989|NCT00969735|Pulmonary vein|pulmonary vein
702990|NCT00969774|Face|face
702991|NCT00969774|Cephalometry|cephalometry
702992|NCT00969774|Anthropometry|anthropometry
702993|NCT00969774|Photography|photography
702994|NCT00969774|Diagnosis|diagnosis
702995|NCT00969774|Adult|adult
702996|NCT00969774|Morphology|morphology
702997|NCT00969774|Comparative Study|comparative study
702998|NCT00969800|Common cold|common cold
702999|NCT00969800|Influenza|influenza
703000|NCT00969800|Pneumonia|pneumonia
703001|NCT00969813|Hepatic impairment|hepatic impairment
703002|NCT00969826|GCPGC|gcpgc
703003|NCT00969826|Pharmacokinetics|pharmacokinetics
703004|NCT00969826|Pharmacodynamics|pharmacodynamics
703005|NCT00969839|Fracture|fracture
703006|NCT00969839|Humerus|humerus
703007|NCT00969839|Intramedullary|intramedullary
703008|NCT00969839|Fixation|fixation
703009|NCT00969852|Sertraline|sertraline
703010|NCT00969852|PET|pet
703011|NCT00969852|Serotonin receptor occupancy|serotonin receptor occupancy
703012|NCT00969852|PK-PD Model|pk-pd model
703013|NCT00969865|Atherosclerosis|atherosclerosis
703014|NCT00969878|Cocaine Vaccine, TA-CD 09|cocaine vaccine, ta-cd 09
703015|NCT00969930|COMT|comt
703016|NCT00969930|ApoE|apoe
703017|NCT00969930|BDNF|bdnf
703018|NCT00969930|executive function|executive function
703019|NCT00969930|bipolar|bipolar
703020|NCT00969930|cognition|cognition
703021|NCT00969930|Cognitive deficits and Bipolar disease type I|cognitive deficits and bipolar disease type i
703022|NCT00969943|HPA axis|hpa axis
703023|NCT00969956|Diabetes, Complication, Cardio-vascular disease|diabetes, complication, cardio-vascular disease
703024|NCT00969969|First MTP Joint|first mtp joint
703025|NCT00969969|Hallux Rigidus|hallux rigidus
703026|NCT00969969|Hallux Limitus|hallux limitus
703027|NCT00969969|Cartilage Replacement|cartilage replacement
703028|NCT00969969|Osteoarthritis|osteoarthritis
703029|NCT00969969|First MTP Joint Osteoarthritis|first mtp joint osteoarthritis
703030|NCT00969969|Big Toe Pain|big toe pain
703031|NCT00969982|Pregnancy termination|pregnancy termination
703032|NCT00969982|abortion|abortion
703033|NCT00969982|medical abortion|medical abortion
703034|NCT00969982|2nd trimester|2nd trimester
703035|NCT00969982|mifepristone|mifepristone
703036|NCT00969982|misoprostol|misoprostol
703037|NCT00969995|inflammation|inflammation
703038|NCT00969995|migraine|migraine
703039|NCT00969995|headache|headache
703040|NCT00970008|Osteoarthritis|osteoarthritis
703041|NCT00970008|Knee|knee
703042|NCT00970034|Atrial fibrillation, apoptosis, oligonucleotide microarray|atrial fibrillation, apoptosis, oligonucleotide microarray
703043|NCT00970047|pregnant|pregnant
703044|NCT00970047|fetal sex determination|fetal sex determination
703144|NCT00970580|Taxol|taxol
703045|NCT00970047|gender determination|gender determination
703046|NCT00970047|noninvasive test|noninvasive test
703047|NCT00970047|fetal DNA|fetal dna
703048|NCT00970060|neuropathy|neuropathy
703049|NCT00970060|diabetes|diabetes
703050|NCT00970073|calcineurin inhibitor delay|calcineurin inhibitor delay
703051|NCT00970073|Kidney|kidney
703052|NCT00970086|measure of postoperative pain|measure of postoperative pain
703053|NCT00970086|children undergoing groin surgery|children undergoing groin surgery
703054|NCT00970112|pain|pain
703055|NCT00970112|pain assessment|pain assessment
703056|NCT00970125|advance care planning|advance care planning
703057|NCT00970125|cancer|cancer
703058|NCT00970138|Progress free survival|progress free survival
703059|NCT00970138|Toxicity|toxicity
703060|NCT00970138|Response rate|response rate
703061|NCT00970138|Overall survival|overall survival
703062|NCT00970138|Quality of live|quality of live
703063|NCT00970151|Fetal Inflammation|fetal inflammation
703064|NCT00970151|Birth Outcome|birth outcome
703065|NCT00970151|Pregnancy|pregnancy
703066|NCT00970177|Pandemic influenza vaccine|pandemic influenza vaccine
703067|NCT00970190|sinusitis|sinusitis
703068|NCT00970203|Vaccine|vaccine
703069|NCT00970203|Androgen Ablation|androgen ablation
703070|NCT00970203|PSA Progression|psa progression
703071|NCT00970216|HBV DNA non-detectability|hbv dna non-detectability
703072|NCT00970255|Breastfeeding difficulties|breastfeeding difficulties
703073|NCT00970255|lingual frenulum|lingual frenulum
703074|NCT00970255|labial frenulum|labial frenulum
703075|NCT00970255|frenotomy|frenotomy
703076|NCT00970268|COPD|copd
703077|NCT00970268|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
703078|NCT00970268|Chronic Bronchitis|chronic bronchitis
703079|NCT00970268|Emphysema|emphysema
703080|NCT00970268|Airflow Obstruction, Chronic|airflow obstruction, chronic
703081|NCT00970268|Chronic Airflow Obstruction|chronic airflow obstruction
703082|NCT00970268|Chronic Obstructive Airway Disease|chronic obstructive airway disease
703083|NCT00970268|Chronic Obstructive Lung Disease|chronic obstructive lung disease
703084|NCT00970294|diabetes|diabetes
703085|NCT00970320|Anal Incontinence|anal incontinence
703386|NCT00979290|efficiency|efficiency
703086|NCT00970320|urinary incontinence|urinary incontinence
703087|NCT00970320|primiparas|primiparas
703088|NCT00970320|prevalence|prevalence
703089|NCT00970320|pelvic floor exercise treatment|pelvic floor exercise treatment
703090|NCT00970320|Quality of Life (QoL)|quality of life (qol)
703091|NCT00970333|Alzheimer disease|alzheimer disease
703092|NCT00970333|Parkinson disease|parkinson disease
703093|NCT00970333|Multiple Sclerosis|multiple sclerosis
703094|NCT00970346|Digestive System Diseases|digestive system diseases
703095|NCT00970346|Genetic Diseases|genetic diseases
703096|NCT00970346|Inborn|inborn
703097|NCT00970346|Respiratory Tract Diseases|respiratory tract diseases
703098|NCT00970346|Cystic Fibrosis|cystic fibrosis
703099|NCT00970346|Lung Disease|lung disease
703100|NCT00970346|Pancreatic Diseases|pancreatic diseases
703101|NCT00970359|thyroid|thyroid
703102|NCT00970359|metastases|metastases
703103|NCT00970359|AZD6244|azd6244
703104|NCT00970359|09-048|09-048
703105|NCT00970372|Coercion|coercion
703106|NCT00970398|Infant formula|infant formula
703107|NCT00970398|Bovine milk Osteopontin|bovine milk osteopontin
703108|NCT00970398|growth|growth
703109|NCT00970398|health|health
703110|NCT00970398|immune functions|immune functions
703111|NCT00970450|Paracetamol|paracetamol
703112|NCT00970450|Tropisetron|tropisetron
703113|NCT00970450|Central analgesic effect|central analgesic effect
703114|NCT00970450|Area of allodynia|area of allodynia
703115|NCT00970450|Secondary hyperalgesia|secondary hyperalgesia
703116|NCT00970463|The GH-system and cardiac function|the gh-system and cardiac function
703117|NCT00970489|atrial fibrillation|atrial fibrillation
703118|NCT00970489|fish oil|fish oil
703119|NCT00970502|celecoxib|celecoxib
703120|NCT00970502|erlotinib|erlotinib
703121|NCT00970502|epidermal growth factor receptor|epidermal growth factor receptor
703122|NCT00970502|intensity-modulated radiotherapy|intensity-modulated radiotherapy
703123|NCT00970502|cyclooxygenase-2|cyclooxygenase-2
703124|NCT00970502|reirradiation|reirradiation
703125|NCT00970515|Laparoscopy|laparoscopy
703126|NCT00970515|Incisional hernia|incisional hernia
703127|NCT00970515|Umbilical hernia|umbilical hernia
703128|NCT00970515|Mesh repair|mesh repair
703129|NCT00970515|Postoperative complications|postoperative complications
703130|NCT00970528|Oral Hypoglycemic Agent|oral hypoglycemic agent
703131|NCT00970541|Cinnamon|cinnamon
703132|NCT00970541|PCOS|pcos
703133|NCT00970541|low blood sugar|low blood sugar
703134|NCT00970541|Insulin|insulin
703135|NCT00970541|Glucose|glucose
703136|NCT00970554|Amblyopia|amblyopia
703137|NCT00970554|Telescopic magnification|telescopic magnification
703138|NCT00970554|Patching|patching
703139|NCT00970567|therapy after positive ketone bodies in the blood|therapy after positive ketone bodies in the blood
703140|NCT00970567|timepoint of diagnosis|timepoint of diagnosis
703141|NCT00970567|timepoint of metabolic normalisation|timepoint of metabolic normalisation
703142|NCT00970580|BIIB022|biib022
703143|NCT00970580|Stage IV|stage iv
703146|NCT00970580|Carboplatin|carboplatin
703147|NCT00970580|Paclitaxel|paclitaxel
703148|NCT00970580|Non Small Cell Lung Cancer|non small cell lung cancer
703149|NCT00970580|Treatment Naive|treatment naive
703150|NCT00970580|Anti IGF1R|anti igf1r
703151|NCT00970580|NSCLC|nsclc
703152|NCT00970580|Open Label|open label
703153|NCT00970580|IGF1R|igf1r
703154|NCT00970580|Paraplatin|paraplatin
703155|NCT00970580|Cytotoxic|cytotoxic
703156|NCT00970580|Mitotic Inhibitor|mitotic inhibitor
703157|NCT00970580|Taxane|taxane
703158|NCT00970580|Alkylating agent|alkylating agent
703159|NCT00970606|ARDS|ards
703160|NCT00970606|H1N1|h1n1
703161|NCT00970606|Influenza|influenza
703162|NCT00970606|Statin|statin
703163|NCT00970645|Non small cell lung cancer|non small cell lung cancer
703164|NCT00970645|mediastinum|mediastinum
703165|NCT00970645|endobronchial ultrasound fine needle aspiration|endobronchial ultrasound fine needle aspiration
703166|NCT00970645|endoscopic ultrasound|endoscopic ultrasound
703167|NCT00970645|mediastinoscopy|mediastinoscopy
703168|NCT00970645|surgical or minimally invasive evaluation of mediastinum|surgical or minimally invasive evaluation of mediastinum
703169|NCT00970645|NSCLC|nsclc
703170|NCT00970658|Plaster|plaster
703171|NCT00970658|injuries|injuries
703172|NCT00970658|regions miofasciais articulated|regions miofasciais articulated
703173|NCT00970658|Reducing signs, symptoms|reducing signs, symptoms
703174|NCT00970671|scar|scar
703175|NCT00970671|laser therapy|laser therapy
703176|NCT00970671|lasers, pulsed dye|lasers, pulsed dye
703372|NCT00977600|HPN-100|hpn-100
703177|NCT00970684|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
703178|NCT00970684|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
703179|NCT00970684|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
703180|NCT00970684|adenocarcinoma of the lung|adenocarcinoma of the lung
703181|NCT00970684|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
703182|NCT00970684|large cell lung cancer|large cell lung cancer
703183|NCT00970697|MARTORELL'S ULCER|martorell's ulcer
703184|NCT00970697|hydrogel|hydrogel
703185|NCT00970697|Hypertensive leg ulcer|hypertensive leg ulcer
703186|NCT00970723|Diabetic retinopathy|diabetic retinopathy
703187|NCT00970723|Macula edema|macula edema
703188|NCT00970723|Sleep apnea|sleep apnea
703189|NCT00970723|High blood pressure|high blood pressure
703190|NCT00970736|Motor cortex|motor cortex
703191|NCT00970736|Motor control|motor control
703192|NCT00970736|Neuroplasticity|neuroplasticity
703193|NCT00970736|Aging|aging
703194|NCT00970736|Swallowing|swallowing
703195|NCT00970749|chlamydia|chlamydia
703196|NCT00970749|healthy women|healthy women
703197|NCT00970749|history of endocervical chlamydia|history of endocervical chlamydia
703198|NCT00970749|no history of endocervical chlamydia|no history of endocervical chlamydia
703199|NCT00970775|Phase I|phase i
703200|NCT00970775|Japanese healthy volunteer|japanese healthy volunteer
703201|NCT00970775|AZD2423|azd2423
703202|NCT00970801|Atypical mycobacteria|atypical mycobacteria
703203|NCT00970814|Alcoholism|alcoholism
703204|NCT00970814|Alcohol Drinking|alcohol drinking
703205|NCT00970814|Alcoholic Intoxication|alcoholic intoxication
703206|NCT00970814|Alcohol Abuse|alcohol abuse
703207|NCT00970827|Coronary artery disease|coronary artery disease
703208|NCT00970827|PCI|pci
703209|NCT00970827|Postconditioning|postconditioning
703210|NCT00970827|Elective or urgent PCI|elective or urgent pci
703211|NCT00970840|Acceptability|acceptability
703212|NCT00970840|Supplements|supplements
703213|NCT00970840|Home-fortification|home-fortification
703214|NCT00970853|Evaluate developmental outcomes|evaluate developmental outcomes
703215|NCT00970853|Evaluate child cognitive, academic, and behavioral outcomes|evaluate child cognitive, academic, and behavioral outcomes
703216|NCT00970866|multiple micronutrients|multiple micronutrients
703217|NCT00970866|home fortification|home fortification
703218|NCT00970866|complementary foods|complementary foods
703219|NCT00970866|infant feeding|infant feeding
752405|NCT01172899|Bariatric Surgery|bariatric surgery
703220|NCT00970866|lipid-based nutrient supplements|lipid-based nutrient supplements
703221|NCT00970879|malaria|malaria
703222|NCT00970879|pregnancy|pregnancy
703223|NCT00970879|HIV|hiv
703224|NCT00970879|prevention|prevention
703225|NCT00970879|cotrimoxazole|cotrimoxazole
703226|NCT00970879|mefloquine|mefloquine
703227|NCT00970892|Anticoagulation|anticoagulation
703228|NCT00970892|warfarin|warfarin
703229|NCT00970892|VKORC1|vkorc1
703230|NCT00970892|CYP2C9|cyp2c9
705721|NCT00986323|TLA|tla
703231|NCT00970892|thromboembolism|thromboembolism
703232|NCT00970892|pharmacogenetics|pharmacogenetics
703233|NCT00970905|Radiation|radiation
703234|NCT00970905|Nausea|nausea
703235|NCT00970905|Vomiting|vomiting
703236|NCT00970905|Ondansetron|ondansetron
703237|NCT00970905|Aprepitant|aprepitant
703238|NCT00970918|Cardiovascular disease|cardiovascular disease
703239|NCT00970918|Carotid Intima Media Thickness|carotid intima media thickness
703240|NCT00970931|hypertension|hypertension
703241|NCT00970931|diuretics|diuretics
703242|NCT00970944|Traumatic Brain Injury|traumatic brain injury
703243|NCT00970944|Rehabilitation|rehabilitation
703244|NCT00970944|Disorders of Consciousness|disorders of consciousness
703245|NCT00970944|Functional Outcome|functional outcome
703246|NCT00970944|Amantadine Hydrochloride|amantadine hydrochloride
703247|NCT00970957|Macular edema|macular edema
703248|NCT00970957|Retinal Vein Occlusion|retinal vein occlusion
703249|NCT00970957|Bevacizumab|bevacizumab
703250|NCT00970970|Vascular endothelial growth factor|vascular endothelial growth factor
703251|NCT00970970|von Hippel Lindau disease|von hippel lindau disease
703252|NCT00970970|molecular imaging|molecular imaging
703253|NCT00970970|biomarker|biomarker
703254|NCT00970996|Melanoma|melanoma
703255|NCT00970996|Abraxane|abraxane
703256|NCT00970996|Nab-paclitaxel|nab-paclitaxel
703257|NCT00970996|Paclitaxel (protein-bound)|paclitaxel (protein-bound)
703258|NCT00970996|ABI-007|abi-007
703259|NCT00970996|Cisplatin|cisplatin
703260|NCT00970996|Platinol-AQ|platinol-aq
703261|NCT00970996|Platinol|platinol
703262|NCT00970996|CDDP|cddp
703263|NCT00970996|Interleukin 2|interleukin 2
703264|NCT00970996|IL-2|il-2
703265|NCT00970996|Proleukin|proleukin
703266|NCT00970996|Intron A|intron a
703267|NCT00970996|Interferon alpha 2b|interferon alpha 2b
703268|NCT00970996|Interferon alfa-2b|interferon alfa-2b
703269|NCT00970996|Temodar|temodar
703270|NCT00970996|Temozolomide|temozolomide
703271|NCT00971009|Symptom management|symptom management
703272|NCT00971009|Interactive Health Communication Application|interactive health communication application
703273|NCT00971009|Patient-provider communication|patient-provider communication
703274|NCT00971009|Health care costs|health care costs
703275|NCT00971022|Low-income populations|low-income populations
703276|NCT00971022|Chronic health condition|chronic health condition
703277|NCT00971022|Prescription medication|prescription medication
703278|NCT00971022|Prescription drugs|prescription drugs
703279|NCT00971022|Discount generic prescription programs|discount generic prescription programs
703280|NCT00971022|Survey|survey
703281|NCT00971022|Awareness|awareness
703282|NCT00971022|Focus Group|focus group
703283|NCT00971022|Houston|houston
703284|NCT00971035|MILR1444A|milr1444a
703285|NCT00971048|pressure ulcers|pressure ulcers
703286|NCT00971048|PU|pu
703287|NCT00971048|diabetic foot ulcers|diabetic foot ulcers
703288|NCT00971048|DFU|dfu
703289|NCT00971048|Bates-Jensen Wound Assessment|bates-jensen wound assessment
703290|NCT00971061|Ahmed valve|ahmed valve
703291|NCT00971061|single-plate Molteno implant|single-plate molteno implant
703292|NCT00971061|refractory glaucoma|refractory glaucoma
703293|NCT00971061|surgical treatment|surgical treatment
703294|NCT00971074|Arthralgia|arthralgia
703295|NCT00971074|Viscosupplementation|viscosupplementation
703296|NCT00971074|Knee|knee
703297|NCT00971074|Menisci, Tibial|menisci, tibial
703298|NCT00971074|Surgery, Outpatient|surgery, outpatient
703299|NCT00971087|Breast cancer|breast cancer
703300|NCT00971087|breast cancer screening|breast cancer screening
703301|NCT00971100|Pandemic influenza|pandemic influenza
703302|NCT00971100|Vaccine|vaccine
703303|NCT00971126|hepatocellular carcinoma|hepatocellular carcinoma
703304|NCT00971139|Online patient-provider communication|online patient-provider communication
703305|NCT00971139|Organizational change|organizational change
703306|NCT00971139|Symptom management|symptom management
703307|NCT00971152|IVF|ivf
703308|NCT00971152|dose comparison of gonadotrophins|dose comparison of gonadotrophins
703309|NCT00971152|poor responder to ovarian stimulation|poor responder to ovarian stimulation
703310|NCT00977327|Glioma|glioma
703311|NCT00977327|Intraoperative MR|intraoperative mr
703312|NCT00977327|Intraoperative Ultrasound|intraoperative ultrasound
703313|NCT00977327|resection|resection
703314|NCT00977327|Intraoperative navigation|intraoperative navigation
703315|NCT00977327|Extent of resection|extent of resection
703316|NCT00977340|Chronic nightmare sufferers|chronic nightmare sufferers
703317|NCT00977340|nightmares|nightmares
703318|NCT00977340|Imagery Rehearsal Therapy IRT|imagery rehearsal therapy irt
703319|NCT00977340|sleep disturbance|sleep disturbance
703320|NCT00977340|treatment of nightmares|treatment of nightmares
703321|NCT00977340|confrontation|confrontation
703322|NCT00977340|People who suffer of chronic nightmares|people who suffer of chronic nightmares
703323|NCT00977353|Major depressive disorder|major depressive disorder
703324|NCT00977353|Depression|depression
703325|NCT00977353|Sarcosine|sarcosine
703326|NCT00977353|N-methylglycine|n-methylglycine
703327|NCT00977353|NMDA|nmda
703328|NCT00977392|human papilloma virus infection|human papilloma virus infection
703329|NCT00977392|health status unknown|health status unknown
703330|NCT00977405|Wound infection|wound infection
703331|NCT00977405|Gentamicin|gentamicin
703332|NCT00977405|Contaminated wounds|contaminated wounds
703333|NCT00977418|Healthy Aging|healthy aging
703334|NCT00977418|Exercise|exercise
703335|NCT00977418|Cognition|cognition
703336|NCT00977418|Cognitive Training|cognitive training
703337|NCT00977418|Keeping healthy seniors as mentally efficient as possible|keeping healthy seniors as mentally efficient as possible
703338|NCT00977444|knee|knee
703339|NCT00977444|osteoarthritis|osteoarthritis
703340|NCT00977457|stage I prostate cancer|stage i prostate cancer
703341|NCT00977457|stage II prostate cancer|stage ii prostate cancer
703342|NCT00977457|stage III prostate cancer|stage iii prostate cancer
703445|NCT00979550|laser|laser
703343|NCT00977457|stage IV prostate cancer|stage iv prostate cancer
703344|NCT00977470|NSCLC|nsclc
703345|NCT00977470|HCQ|hcq
703346|NCT00977470|erlotinib|erlotinib
703347|NCT00977470|Tarceva|tarceva
703348|NCT00977496|hemodialysis|hemodialysis
703349|NCT00977496|microbiota|microbiota
703350|NCT00977496|Staphylococcus aureus|staphylococcus aureus
703351|NCT00977509|genes|genes
703352|NCT00977509|mutation|mutation
703353|NCT00977509|non-small cell lung cancer|non-small cell lung cancer
703354|NCT00977509|cancer cells|cancer cells
703355|NCT00977522|schizophrenia negative symptoms adjunctive|schizophrenia negative symptoms adjunctive
703356|NCT00977548|MDS|mds
703357|NCT00977548|blood diseases|blood diseases
703358|NCT00977548|bone marrow|bone marrow
703359|NCT00977548|hematopoietic|hematopoietic
703360|NCT00977548|leukemia|leukemia
703361|NCT00977561|Small Cell Lung Cancer|small cell lung cancer
703362|NCT00977561|Extensive stage disease|extensive stage disease
703363|NCT00977561|SCLC|sclc
703364|NCT00977561|IGF-1R inhibitor|igf-1r inhibitor
703365|NCT00977587|irritable bowel syndrome|irritable bowel syndrome
703366|NCT00977587|faecal serine proteases|faecal serine proteases
703367|NCT00977600|Ammonul|ammonul
703368|NCT00977600|Sodium phenylacetate|sodium phenylacetate
703369|NCT00977600|sodium benzoate|sodium benzoate
703370|NCT00977600|Buphenyl|buphenyl
703371|NCT00977600|sodium phenylbutyrate|sodium phenylbutyrate
703373|NCT00977600|GT4P|gt4p
703374|NCT00977600|Glyceryl tri-(4-phenylbutyrate)|glyceryl tri-(4-phenylbutyrate)
703375|NCT00977600|Healthy Volunteers|healthy volunteers
703376|NCT00977613|Treated Stage 2 and Stage 3 colorectal cancer|treated stage 2 and stage 3 colorectal cancer
703377|NCT00977626|Safety|safety
703378|NCT00977626|Tolerability|tolerability
703379|NCT00977626|Healthy|healthy
703380|NCT00977626|Pharmacokinetics|pharmacokinetics
703381|NCT00977626|Healthy volunteers|healthy volunteers
703382|NCT00977652|fecal incontinence|fecal incontinence
703383|NCT00979264|Quality Improvement|quality improvement
703384|NCT00979290|Fix-dose combination anti-TB drug|fix-dose combination anti-tb drug
703385|NCT00979290|adverse effect|adverse effect
703388|NCT00979303|Electrophysiology|electrophysiology
703389|NCT00979303|Ablation|ablation
703390|NCT00979303|Radiation|radiation
703391|NCT00979303|Devices|devices
703392|NCT00979303|SVT|svt
703393|NCT00979329|sunitinib|sunitinib
703394|NCT00979329|sorafenib|sorafenib
703395|NCT00979329|fatigue|fatigue
703396|NCT00979329|depression|depression
703397|NCT00979329|quality of life|quality of life
703398|NCT00979329|metastatic RCC|metastatic rcc
703399|NCT00979329|colorectal cancer|colorectal cancer
703400|NCT00979329|GIST|gist
703401|NCT00979342|morcellator|morcellator
703402|NCT00979342|hysteroscope|hysteroscope
703403|NCT00979342|myomectomy|myomectomy
703404|NCT00979342|polypectomy|polypectomy
703405|NCT00979342|uterine fibroids|uterine fibroids
703406|NCT00979342|uterine polyps|uterine polyps
703407|NCT00979342|local anesthetic|local anesthetic
703408|NCT00979342|cervical block|cervical block
703409|NCT00979342|pain management|pain management
703410|NCT00979355|Whole body|whole body
703411|NCT00979355|SPECT|spect
703412|NCT00979381|sunitinib|sunitinib
703413|NCT00979381|sorafenib|sorafenib
703414|NCT00979381|immune response|immune response
703415|NCT00979394|Diabetes Care at GPs in Austria|diabetes care at gps in austria
703416|NCT00979394|Characteristic of diabetes patients at GPs in Austria|characteristic of diabetes patients at gps in austria
703417|NCT00979407|influenza infection|influenza infection
703418|NCT00979407|GSK Biologicals' influenza vaccine GSK2340272A and GSK2340274A|gsk biologicals' influenza vaccine gsk2340272a and gsk2340274a
703419|NCT00979420|treatment experienced|treatment experienced
703420|NCT00979433|Extubation failure|extubation failure
752406|NCT01172899|Adolescent|adolescent
703421|NCT00979433|Continuous positive airway pressure|continuous positive airway pressure
703422|NCT00979433|Bubble CPAP|bubble cpap
703423|NCT00979446|Interactive phone-based intervention with written materials|interactive phone-based intervention with written materials
703424|NCT00979446|Older adults|older adults
703425|NCT00979446|Physical activity|physical activity
703426|NCT00979446|Cognitive stimulation|cognitive stimulation
703427|NCT00979446|Social engagement|social engagement
703428|NCT00979472|Solifenacin|solifenacin
703429|NCT00979472|Overactive bladder|overactive bladder
703430|NCT00979472|Micturition|micturition
703431|NCT00979472|Urinary urgency|urinary urgency
703432|NCT00979472|Vesicare|vesicare
703433|NCT00979485|Pediatric IBD|pediatric ibd
703434|NCT00979485|Microparticles|microparticles
703435|NCT00979511|osteoporosis|osteoporosis
703436|NCT00979511|calcium|calcium
703437|NCT00979511|weight-bearing exercise|weight-bearing exercise
703438|NCT00979511|bone mass|bone mass
703439|NCT00979511|prepubertal girls|prepubertal girls
703440|NCT00979524|Depressive symptoms|depressive symptoms
703441|NCT00979524|Mental health services|mental health services
703442|NCT00979524|Adolescents|adolescents
703443|NCT00979524|Young adults|young adults
703444|NCT00979524|African-American|african-american
703446|NCT00979550|pediatric|pediatric
703447|NCT00979550|skin pigmentation|skin pigmentation
703448|NCT00979563|HM30181AK|hm30181ak
703449|NCT00979563|Irinotecan tablet|irinotecan tablet
703450|NCT00979563|MTD|mtd
703451|NCT00979563|DLT|dlt
703452|NCT00979589|stroke|stroke
703453|NCT00979589|transient ischemic attack|transient ischemic attack
703454|NCT00979589|acute treatment|acute treatment
703581|NCT00980109|Long Term|long term
703455|NCT00979589|acute non-disabling cerebrovascular event|acute non-disabling cerebrovascular event
703456|NCT00979589|clopidogrel|clopidogrel
703457|NCT00979589|clopidogrel combined with ASA|clopidogrel combined with asa
703458|NCT00979589|recurrence of stroke and other vascular events|recurrence of stroke and other vascular events
703459|NCT00979602|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
703460|NCT00979602|Influenza Vaccines|influenza vaccines
703461|NCT00979602|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
703462|NCT00979602|influenza infection|influenza infection
703463|NCT00979615|vasomotor rhinitis|vasomotor rhinitis
703464|NCT00979615|chronic non-allergic rhinitis|chronic non-allergic rhinitis
703465|NCT00979615|VMR|vmr
703466|NCT00979628|Type 2 Diabetes|type 2 diabetes
703467|NCT00979628|Inpatient Hyperglycemia|inpatient hyperglycemia
703468|NCT00979641|breast cancer|breast cancer
703469|NCT00979641|metastatic|metastatic
703470|NCT00979641|chemotherapy|chemotherapy
703471|NCT00979641|bevacizumab|bevacizumab
703472|NCT00979641|docetaxel|docetaxel
703473|NCT00979641|Phase II|phase ii
703474|NCT00979641|first line chemotherapy|first line chemotherapy
703475|NCT00979641|metastatic breast cancer patients|metastatic breast cancer patients
703476|NCT00979654|Sifalimumab|sifalimumab
703477|NCT00979654|MEDI-545|medi-545
703478|NCT00979667|Upper respiratory tract infection|upper respiratory tract infection
703479|NCT00979667|Influenza A|influenza a
703480|NCT00979667|Human Swine Influenza|human swine influenza
703481|NCT00979680|sphincter preservation|sphincter preservation
703482|NCT00979680|neoadjuvant therapy|neoadjuvant therapy
703483|NCT00979693|anxiety|anxiety
703484|NCT00979693|stage IV melanoma|stage iv melanoma
703485|NCT00979693|depression|depression
703486|NCT00979693|spirituality|spirituality
703487|NCT00979693|pain|pain
703488|NCT00979719|Randomized Controlled Trial|randomized controlled trial
703489|NCT00979719|evidence- and theory-based behavioral intervention|evidence- and theory-based behavioral intervention
703490|NCT00979719|expert system|expert system
703491|NCT00979719|stages of change|stages of change
703492|NCT00979719|motivational interviewing|motivational interviewing
703493|NCT00979719|tailoring|tailoring
703494|NCT00979719|Self Care|self care
703495|NCT00979719|Rehabilitation|rehabilitation
703496|NCT00979719|Expert Systems|expert systems
703497|NCT00979732|high blood pressure|high blood pressure
703498|NCT00979732|dietary supplements|dietary supplements
703499|NCT00979732|nutrition|nutrition
703500|NCT00979745|Erythropoietic Protoporphyria|erythropoietic protoporphyria
703501|NCT00979745|EPP|epp
703502|NCT00979745|Afamelanotide|afamelanotide
703503|NCT00979771|GSK706769|gsk706769
703504|NCT00979771|Enbrel|enbrel
703505|NCT00979771|Rheumatoid Arthritis|rheumatoid arthritis
703506|NCT00979784|obesity|obesity
703507|NCT00979784|primary care|primary care
703508|NCT00979797|Community IMCI|community imci
703509|NCT00979797|C-IMCI|c-imci
703510|NCT00979797|CHW|chw
703511|NCT00979797|Children|children
703512|NCT00979797|Evaluation|evaluation
703513|NCT00979797|Behaviour|behaviour
703514|NCT00979797|Counselling|counselling
703515|NCT00979797|Under 5 mortality|under 5 mortality
703516|NCT00979797|Under 5 Nutrition|under 5 nutrition
703517|NCT00979810|PET scan|pet scan
703518|NCT00979810|CT scan|ct scan
703519|NCT00979810|09-060|09-060
703520|NCT00979810|CNS|cns
703521|NCT00979836|venous|venous
703522|NCT00979836|ulcer|ulcer
703523|NCT00979836|phlebotonic|phlebotonic
703524|NCT00979836|calcium dobesilate|calcium dobesilate
703525|NCT00979836|clinical trial|clinical trial
703526|NCT00979849|safety|safety
703527|NCT00979849|tolerability|tolerability
703528|NCT00979849|healthy|healthy
703529|NCT00979849|inhalation|inhalation
703530|NCT00979875|insulin|insulin
703531|NCT00979875|recombinant human hyaluronidase|recombinant human hyaluronidase
703532|NCT00979875|Healthy volunteers|healthy volunteers
703533|NCT00979888|dyspnea|dyspnea
703534|NCT00979888|depression|depression
703535|NCT00979888|fatigue|fatigue
703536|NCT00979888|anxiety disorder|anxiety disorder
703537|NCT00979888|small cell lung cancer|small cell lung cancer
703538|NCT00979888|non-small cell lung cancer|non-small cell lung cancer
703539|NCT00979914|osteoarthritis|osteoarthritis
703540|NCT00979914|patient education|patient education
703541|NCT00979914|function|function
703542|NCT00979914|physio therapy|physio therapy
703543|NCT00979927|Antisense|antisense
703544|NCT00979927|miR-122 antagonist|mir-122 antagonist
703545|NCT00979927|safety in healthy Volunteers|safety in healthy volunteers
703546|NCT00979927|Hepatitis C|hepatitis c
703547|NCT00979940|atorvastatin|atorvastatin
703548|NCT00979940|clopidogrel|clopidogrel
703549|NCT00979940|percutaneous intervention|percutaneous intervention
703550|NCT00979940|periprocedural myonecrosis|periprocedural myonecrosis
703551|NCT00979953|delta opioid receptor agonist|delta opioid receptor agonist
703552|NCT00979953|osteoarthritis|osteoarthritis
703553|NCT00979953|pain|pain
703554|NCT00979966|Locally advanced or metastatic non-clear cell renal cell cancer (ncc-RCC)|locally advanced or metastatic non-clear cell renal cell cancer (ncc-rcc)
703555|NCT00979979|Hepatitis C|hepatitis c
703556|NCT00979979|Genotype|genotype
703557|NCT00979979|Realtime PCR|realtime pcr
703558|NCT00980005|GSK Biologicals influenza vaccine GSK1557482A|gsk biologicals influenza vaccine gsk1557482a
703559|NCT00980005|influenza infection|influenza infection
703561|NCT00980018|Leukemia|leukemia
703562|NCT00980018|Tasigna|tasigna
703563|NCT00980018|nilotinib|nilotinib
703564|NCT00980018|AMN107|amn107
703565|NCT00980018|CML-CP|cml-cp
703566|NCT00980018|Chronic Phase|chronic phase
703567|NCT00980031|Aldosterone Blockade|aldosterone blockade
703568|NCT00980031|Aldosterone Receptor Blockers|aldosterone receptor blockers
703569|NCT00980031|cardiac chamber size|cardiac chamber size
703570|NCT00980031|wall thickness|wall thickness
703571|NCT00980031|left ventricular ejection fraction|left ventricular ejection fraction
703572|NCT00980031|left atrial volumes|left atrial volumes
703573|NCT00980031|diastolic function|diastolic function
703574|NCT00980070|lumbar puncture positioning device|lumbar puncture positioning device
703575|NCT00980083|GLP-1|glp-1
703576|NCT00980083|exendin(9-39)|exendin(9-39)
703577|NCT00980083|gastric emptying|gastric emptying
703578|NCT00980083|incretin|incretin
703579|NCT00980083|human|human
703580|NCT00980109|Influenza Prophylaxis|influenza prophylaxis
703582|NCT00980109|Oral Oseltamivir|oral oseltamivir
703583|NCT00980109|Inhaled Zanamivir|inhaled zanamivir
703584|NCT00980122|Advanced cancer patients dying in hospital receive aggressive cancer-specific therapy and supportive measures.|advanced cancer patients dying in hospital receive aggressive cancer-specific therapy and supportive measures.
703585|NCT00980135|Sinecort|sinecort
703586|NCT00980135|Hydrocortison|hydrocortison
703587|NCT00980135|Mild atopic dermatitis|mild atopic dermatitis
703588|NCT00980135|Efficacy, safety|efficacy, safety
703687|NCT00980395|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
703589|NCT00980148|Chlamydia trachomatis, Chlamydia, Doxycycline, Azithromycin|chlamydia trachomatis, chlamydia, doxycycline, azithromycin
703590|NCT00980161|Hepatitis C|hepatitis c
703591|NCT00980161|Peginterferon|peginterferon
703592|NCT00980161|Ribavirin|ribavirin
703593|NCT00980161|MicroRNA|microrna
703596|NCT00980174|denosumab|denosumab
703598|NCT00980174|lumbar spine|lumbar spine
703599|NCT00980174|ADAMO|adamo
703600|NCT00980174|The ADAMO Trial|the adamo trial
703601|NCT00980174|male osteoporosis|male osteoporosis
703602|NCT00980174|osteoporosis in men|osteoporosis in men
703603|NCT00980174|males with low bone mineral density|males with low bone mineral density
703604|NCT00980187|blood tests|blood tests
703605|NCT00980187|cardiac function|cardiac function
703606|NCT00980187|endothelial function|endothelial function
703607|NCT00980187|arterial function|arterial function
703608|NCT00980200|GW642444|gw642444
703609|NCT00980200|once daily dosing|once daily dosing
703610|NCT00980200|asthma|asthma
703611|NCT00980200|efficacy|efficacy
703612|NCT00980200|safety|safety
703613|NCT00980200|FEV1|fev1
703614|NCT00980213|renal cell cancer|renal cell cancer
703615|NCT00980213|sunitinib|sunitinib
703616|NCT00980213|costs|costs
703617|NCT00980213|quality of life|quality of life
703618|NCT00980239|Solid Tumors|solid tumors
703619|NCT00980239|Liver|liver
703620|NCT00980239|hepatic arterial infusion|hepatic arterial infusion
703621|NCT00980239|HAI|hai
703622|NCT00980239|Bevacizumab|bevacizumab
703623|NCT00980239|Avastin|avastin
703624|NCT00980239|Cetuximab|cetuximab
703625|NCT00980239|Erbitux|erbitux
703626|NCT00980239|Irinotecan|irinotecan
703627|NCT00980239|Camptosar|camptosar
703628|NCT00980239|Oxaliplatin|oxaliplatin
703629|NCT00980239|Eloxatin|eloxatin
703630|NCT00980252|Schizophrenia|schizophrenia
703631|NCT00980252|Cognitive Behavioral Therapy|cognitive behavioral therapy
703632|NCT00980252|Compliance|compliance
703633|NCT00980252|Medication Adherence|medication adherence
703634|NCT00980252|Psychotic Disorders|psychotic disorders
703635|NCT00980252|Mental Disorders|mental disorders
703636|NCT00980252|Outcomes|outcomes
703637|NCT00980252|Psychoeducation|psychoeducation
703638|NCT00980252|Adherence Attitudes|adherence attitudes
703639|NCT00980252|Intervention|intervention
703640|NCT00980252|Nonadherence|nonadherence
703641|NCT00980252|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
703642|NCT00980278|sinus lift|sinus lift
703643|NCT00980278|tooth extraction|tooth extraction
703644|NCT00980278|dental implant|dental implant
703645|NCT00980304|Diffuse large B cell lymphomas|diffuse large b cell lymphomas
703646|NCT00980317|Renal tumor|renal tumor
703647|NCT00980317|Restored kidney|restored kidney
703648|NCT00980317|Renal transplantation|renal transplantation
703649|NCT00980317|Third party|third party
703650|NCT00980330|Hepatitis C|hepatitis c
703651|NCT00980330|Peginterferon alpha-2a|peginterferon alpha-2a
703652|NCT00980330|PegIFNalpha-2a|pegifnalpha-2a
703654|NCT00980330|Ribavirin|ribavirin
703655|NCT00980330|Placebo|placebo
703656|NCT00980330|TMC435-TIDP16-C206|tmc435-tidp16-c206
703657|NCT00980330|TMC435-C206|tmc435-c206
703658|NCT00980330|TMC435|tmc435
703659|NCT00980330|HCV|hcv
703660|NCT00980356|Diabetes Kidney transplantation|diabetes kidney transplantation
703661|NCT00980356|New onset diabetes mellitus after transplantation|new onset diabetes mellitus after transplantation
703662|NCT00980369|Lateral internal sphincterotomy|lateral internal sphincterotomy
703663|NCT00980369|Anal fissure|anal fissure
703664|NCT00980369|Surgical technique|surgical technique
703665|NCT00980369|Incision|incision
703666|NCT00980369|Wound healing|wound healing
703667|NCT00980382|Stomach Neoplasms|stomach neoplasms
703668|NCT00980382|phase I/II|phase i/ii
703669|NCT00980382|Combination chemotherapy|combination chemotherapy
703670|NCT00980382|S-1|s-1
703671|NCT00980382|Docetaxel|docetaxel
703672|NCT00980395|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
703673|NCT00980395|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
703674|NCT00980395|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
703675|NCT00980395|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
703676|NCT00980395|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
703677|NCT00980395|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
703678|NCT00980395|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
703679|NCT00980395|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
703680|NCT00980395|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
703681|NCT00980395|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
703682|NCT00980395|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
703683|NCT00980395|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
703684|NCT00980395|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
703685|NCT00980395|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
703686|NCT00980395|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
703688|NCT00980395|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
703689|NCT00980395|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
703690|NCT00980395|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
703691|NCT00980395|extranodal marginal zone BCL mucosa assoc lymphoid tissue|extranodal marginal zone bcl mucosa assoc lymphoid tissue
703692|NCT00980395|nodal marginal zone B Cell lymphoma|nodal marginal zone b cell lymphoma
703693|NCT00980395|splenic marginal zone lymphoma|splenic marginal zone lymphoma
703694|NCT00980421|iron|iron
703695|NCT00980421|iron toxicity markers|iron toxicity markers
703696|NCT00980421|oxidative stress markers|oxidative stress markers
703697|NCT00980421|iron supplementation|iron supplementation
703698|NCT00980421|NTBI|ntbi
703699|NCT00980421|iron over load|iron over load
703700|NCT00980421|interleukin levels|interleukin levels
703701|NCT00980421|iron status|iron status
703702|NCT00980421|acut phase reactants|acut phase reactants
703703|NCT00980421|preschool children|preschool children
703704|NCT00980434|vertebral fracture|vertebral fracture
703705|NCT00980434|spinal cord injury|spinal cord injury
703706|NCT00980447|H5N1|h5n1
703707|NCT00980447|Vaccine|vaccine
703708|NCT00980447|Influenza H5N1|influenza h5n1
703709|NCT00980447|Avian influenza H5N1|avian influenza h5n1
703710|NCT00980447|Pandemic|pandemic
703711|NCT00980473|Primary Angle Closure Disease|primary angle closure disease
703712|NCT00980486|Antibiotic Concentration|antibiotic concentration
703713|NCT00980486|Tissue|tissue
703714|NCT00980486|Obesity|obesity
703715|NCT00980486|Cesarean|cesarean
703716|NCT00980512|behavior problems|behavior problems
703717|NCT00980512|parent training|parent training
703718|NCT00980512|foster care|foster care
703719|NCT00980525|healthy|healthy
703720|NCT00980538|TMC125-TiDP35-C239|tmc125-tidp35-c239
703721|NCT00980538|TMC125-C239|tmc125-c239
703722|NCT00980538|TMC125|tmc125
703723|NCT00980538|HIV|hiv
703724|NCT00980538|Etravirine|etravirine
703725|NCT00980538|Intelence|intelence
703726|NCT00980538|IntelenceTM|intelencetm
703727|NCT00980590|supine emergency intubations|supine emergency intubations
706177|NCT00988117|PDD|pdd
703728|NCT00980590|emergency intubations|emergency intubations
703729|NCT00980603|gastric cancer|gastric cancer
703730|NCT00980603|metastatic|metastatic
703731|NCT00980603|docetaxel|docetaxel
703732|NCT00980603|cisplatin|cisplatin
703733|NCT00980603|S-1|s-1
703734|NCT00980616|Arthroplasty, hip|arthroplasty, hip
703735|NCT00980616|blood losses|blood losses
703736|NCT00980616|pain|pain
703737|NCT00980616|local analgesia|local analgesia
703738|NCT00980616|epinephrine|epinephrine
703739|NCT00980616|Primary total hip arthroplasty|primary total hip arthroplasty
703740|NCT00980642|surgery|surgery
703741|NCT00980642|thermometer|thermometer
703742|NCT00980642|non-invasive|non-invasive
703743|NCT00980642|interoperative core temperature|interoperative core temperature
703744|NCT00980642|anesthesia|anesthesia
703745|NCT00980681|Renal disease|renal disease
703746|NCT00980681|Contrast agent|contrast agent
703747|NCT00980681|MRA|mra
703748|NCT00980694|ubiquinol|ubiquinol
703749|NCT00980694|coenzyme Q10|coenzyme q10
703750|NCT00980694|Huntington disease|huntington disease
703751|NCT00980707|versican|versican
703752|NCT00980707|hyaluronan|hyaluronan
703753|NCT00980707|sputum|sputum
703754|NCT00980733|Micronutrients|micronutrients
703755|NCT00980733|zinc|zinc
703756|NCT00980733|iron|iron
703757|NCT00980733|iodine|iodine
703758|NCT00980733|fortification|fortification
703759|NCT00980733|school children|school children
703760|NCT00980746|pain diabetes neuropathy|pain diabetes neuropathy
703761|NCT00980759|Extended-field Irradiation (EFI)|extended-field irradiation (efi)
703762|NCT00980759|Cervical cancer|cervical cancer
703763|NCT00980759|Hypoxia|hypoxia
703764|NCT00980759|Carbonic anhydrase 9 (CA9)|carbonic anhydrase 9 (ca9)
703765|NCT00980759|locally advanced uterine cervical cancer|locally advanced uterine cervical cancer
703766|NCT00980785|Alzheimer's Disease|alzheimer's disease
703767|NCT00980785|Hypertension|hypertension
703768|NCT00980798|Osteoarthritis|osteoarthritis
703769|NCT00980798|Strong pain killer|strong pain killer
703770|NCT00980798|Strong opioid|strong opioid
703771|NCT00980798|Low starting dose|low starting dose
703772|NCT00980798|Fewer side effects|fewer side effects
703773|NCT00980798|Physical functioning|physical functioning
703774|NCT00980798|Pain control|pain control
703775|NCT00980798|Quality of life|quality of life
703776|NCT00980798|Sleep quality|sleep quality
703777|NCT00980824|cognitive behaviour therapy|cognitive behaviour therapy
703778|NCT00980824|self harm|self harm
703779|NCT00980824|personality disorder|personality disorder
703780|NCT00980824|complex comorbidity|complex comorbidity
703781|NCT00980824|mental health|mental health
703782|NCT00980850|Flu vaccine|flu vaccine
703783|NCT00980850|H1N1 swine flu virus|h1n1 swine flu virus
703784|NCT00980850|Immunogenicity|immunogenicity
703785|NCT00980850|Reactogenicity|reactogenicity
703786|NCT00980889|bile duct obstruction|bile duct obstruction
703787|NCT00980889|jaundice|jaundice
703788|NCT00980889|metal stent|metal stent
703969|NCT00981578|bone cancer|bone cancer
703789|NCT00980915|Acute Lung Injury|acute lung injury
703790|NCT00980915|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
703791|NCT00980915|Respiratory Distress|respiratory distress
703792|NCT00980915|pneumonia|pneumonia
703793|NCT00980915|sepsis|sepsis
703794|NCT00980915|aspiration|aspiration
703795|NCT00980915|pancreatitis|pancreatitis
703796|NCT00980941|starch|starch
703797|NCT00980941|carbohydrates|carbohydrates
703798|NCT00980941|blood glucose|blood glucose
703799|NCT00980941|food intake|food intake
703800|NCT00980941|satiety|satiety
703801|NCT00980941|appetite|appetite
703802|NCT00980954|cervical adenocarcinoma|cervical adenocarcinoma
703803|NCT00980954|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
703804|NCT00980954|cervical squamous cell carcinoma|cervical squamous cell carcinoma
703805|NCT00980954|stage IA cervical cancer|stage ia cervical cancer
703806|NCT00980954|stage IB cervical cancer|stage ib cervical cancer
703807|NCT00980954|stage IIA cervical cancer|stage iia cervical cancer
703808|NCT00980967|Lung transplantation|lung transplantation
703809|NCT00980967|Chronic lung rejection|chronic lung rejection
703810|NCT00980967|Obliterative bronchiolitis|obliterative bronchiolitis
703811|NCT00980967|Predictive factors|predictive factors
703812|NCT00980980|MRSA infection|mrsa infection
703813|NCT00980993|Prostate|prostate
703814|NCT00980993|Motion|motion
703815|NCT00980993|Respiration|respiration
703816|NCT00981006|ischemic cardiomyopathy (ICM)|ischemic cardiomyopathy (icm)
703817|NCT00981019|survival rates|survival rates
703818|NCT00981019|risk communication|risk communication
703819|NCT00981019|screening counselling|screening counselling
703820|NCT00981019|screening recommendation|screening recommendation
703821|NCT00981019|understanding of medical risk|understanding of medical risk
703822|NCT00981032|Aspirin|aspirin
703823|NCT00981032|Behavior|behavior
703824|NCT00981032|Cardiovascular Disease|cardiovascular disease
703825|NCT00981045|IDA|ida
703826|NCT00981058|Squamous|squamous
703827|NCT00981058|Non Small Cell Lung Cancer|non small cell lung cancer
703828|NCT00981058|First line treatment|first line treatment
703829|NCT00981058|Monoclonal|monoclonal
703830|NCT00981058|Antibodies|antibodies
703831|NCT00981058|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
703832|NCT00981071|Tuberculosis|tuberculosis
703833|NCT00981071|QuantiFERON|quantiferon
703834|NCT00981071|Outbreak|outbreak
703835|NCT00981071|Conversion|conversion
703836|NCT00981097|HIV infection|hiv infection
703837|NCT00981097|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
703838|NCT00981097|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
703839|NCT00981097|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
703840|NCT00981097|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
703841|NCT00981097|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
704024|NCT00981786|brimonidine/timolol|brimonidine/timolol
703842|NCT00981097|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
703843|NCT00981097|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
703844|NCT00981097|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
703845|NCT00981097|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
703846|NCT00981097|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
703847|NCT00981097|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
703848|NCT00981097|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
703849|NCT00981097|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
703850|NCT00981097|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
703851|NCT00981097|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
703852|NCT00981097|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
703853|NCT00981097|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
703854|NCT00981097|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
703855|NCT00981097|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
703856|NCT00981097|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
703857|NCT00981110|Surgical site infections (SSI)|surgical site infections (ssi)
703858|NCT00981110|Advanced antimicrobial dressing and clean surgery|advanced antimicrobial dressing and clean surgery
703859|NCT00981110|Hydrofibre dressing|hydrofibre dressing
703860|NCT00981136|Appendicitis|appendicitis
703861|NCT00981136|Appendectomy|appendectomy
703862|NCT00981136|Children|children
703863|NCT00981136|Laparoscopic|laparoscopic
703865|NCT00981175|Japanese Encephalitis|japanese encephalitis
703866|NCT00981175|Japanese Encephalitis Vaccines|japanese encephalitis vaccines
703867|NCT00981175|Adult|adult
703868|NCT00981201|Smoking|smoking
703869|NCT00981201|Cancer Prevention|cancer prevention
703870|NCT00981201|Celecoxib|celecoxib
703871|NCT00981201|Celebrex|celebrex
703872|NCT00981201|Placebo|placebo
703873|NCT00981214|Cystic fibrosis|cystic fibrosis
703968|NCT00981565|medianus impingement|medianus impingement
703874|NCT00981214|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
703875|NCT00981214|Zenpep-1009|zenpep-1009
703876|NCT00981227|pain herpetic neuralgia|pain herpetic neuralgia
703877|NCT00981253|Stress Management Training|stress management training
703878|NCT00981253|Cardiac Rehabilitation|cardiac rehabilitation
703879|NCT00981253|Stress|stress
703880|NCT00981253|Depression|depression
703881|NCT00981266|Augmentation|augmentation
703882|NCT00981266|Augmentation Revision|augmentation revision
703883|NCT00981279|Health Profile|health profile
703884|NCT00981279|AIDS|aids
703885|NCT00981279|Health Promotion|health promotion
703887|NCT00981279|treatment experienced|treatment experienced
703888|NCT00981292|Epigallocatechin Gallate|epigallocatechin gallate
703889|NCT00981292|cerebral blood flow|cerebral blood flow
703890|NCT00981292|Near Infrared spectroscopy|near infrared spectroscopy
703891|NCT00981292|Electroencephalography|electroencephalography
703892|NCT00981292|cognitive function|cognitive function
703893|NCT00981292|mood|mood
703894|NCT00981292|cerebro-electrical activity|cerebro-electrical activity
703895|NCT00981305|dyspareunia|dyspareunia
703896|NCT00981305|breast cancer|breast cancer
703897|NCT00981305|sexual dysfunction|sexual dysfunction
703898|NCT00981305|vaginal lubricant|vaginal lubricant
703899|NCT00981318|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
703900|NCT00981318|HIV|hiv
703901|NCT00981318|AIDS|aids
703902|NCT00981318|treatment experienced|treatment experienced
703903|NCT00981331|Subtalar joint|subtalar joint
703904|NCT00981331|Musculoskeletal Manipulations|musculoskeletal manipulations
703905|NCT00981331|Manipulation, Chiropractic|manipulation, chiropractic
703906|NCT00981331|Ankle sprain|ankle sprain
703907|NCT00981331|Inversion sprain|inversion sprain
703908|NCT00981331|Range of motion, Articular|range of motion, articular
703909|NCT00981331|Quaternion|quaternion
703910|NCT00981331|Eigen analysis|eigen analysis
703911|NCT00981344|wheelchair|wheelchair
703912|NCT00981344|mobility disability|mobility disability
703913|NCT00981344|evidence based practice|evidence based practice
703914|NCT00981344|self help devices|self help devices
703915|NCT00981344|Veterans prescribed mobility aids|veterans prescribed mobility aids
703916|NCT00981357|Cross-over evaluate the efficacy of PF-04457845 in relieving pain due to osteoarthritis OA knee osteoarthritis of knee pain due to osteoarthritis|cross-over evaluate the efficacy of pf-04457845 in relieving pain due to osteoarthritis oa knee osteoarthritis of knee pain due to osteoarthritis
703917|NCT00981370|Sickle Cell Disease|sickle cell disease
703918|NCT00981370|Sickle Cell Anemia|sickle cell anemia
703919|NCT00981370|Iron Overload|iron overload
703920|NCT00981370|Chelation Therapy|chelation therapy
703921|NCT00981370|Iron overload from blood transfusions|iron overload from blood transfusions
703922|NCT00981370|Heart rate variability|heart rate variability
703923|NCT00981370|Autonomic dysfunction|autonomic dysfunction
703924|NCT00981383|Fatty Acids, Omega-3|fatty acids, omega-3
703925|NCT00981396|smoking|smoking
703926|NCT00981396|EFT (Emotional Freedom Techniques)|eft (emotional freedom techniques)
703927|NCT00981396|CBT (cognitive behavior therapy)|cbt (cognitive behavior therapy)
703928|NCT00981396|cravings|cravings
703929|NCT00981396|trauma|trauma
703930|NCT00981409|Fondaparinux sodium|fondaparinux sodium
703931|NCT00981409|contrast-enhanced MDCT|contrast-enhanced mdct
703932|NCT00981409|Deep Vein Thrombosis|deep vein thrombosis
703933|NCT00981409|Pulmonary thromboembolism|pulmonary thromboembolism
703934|NCT00981422|glaucoma|glaucoma
703935|NCT00981422|immunology|immunology
703936|NCT00981422|immunophenotype|immunophenotype
703937|NCT00981435|Glaucoma|glaucoma
703938|NCT00981435|Trabeculoplasty|trabeculoplasty
703939|NCT00981435|Selective laser trabeculoplasty|selective laser trabeculoplasty
703940|NCT00981435|Intraocular pressure|intraocular pressure
703941|NCT00981448|zinc|zinc
703942|NCT00981448|diabetes|diabetes
703943|NCT00981448|genetics|genetics
703944|NCT00981461|Andregenetic Alopecia|andregenetic alopecia
703945|NCT00981461|Hair Loss|hair loss
703946|NCT00981461|Female Pattern Baldness|female pattern baldness
703947|NCT00981474|cardiac surgery; brain injury; cerebral autoregulation|cardiac surgery; brain injury; cerebral autoregulation
703948|NCT00981500|obesity|obesity
703949|NCT00981500|gastric bypass|gastric bypass
703950|NCT00981500|gastric banding|gastric banding
703951|NCT00981500|weight loss|weight loss
703952|NCT00981500|insulin sensitivity|insulin sensitivity
703953|NCT00981500|sleeve gastrectomy|sleeve gastrectomy
704361|NCT00982176|brain MRI|brain mri
703954|NCT00981500|fibroblast growth factor 21|fibroblast growth factor 21
703955|NCT00981500|fibroblast growth factor 19|fibroblast growth factor 19
703956|NCT00981526|Schizophrenia|schizophrenia
703957|NCT00981526|Cognition|cognition
703958|NCT00981526|Metabolism|metabolism
703959|NCT00981526|Antipsychotics|antipsychotics
703960|NCT00981526|Psychopathology|psychopathology
703961|NCT00981539|The focus of this study is to determine whether it is beneficial to administer enemas before surgery|the focus of this study is to determine whether it is beneficial to administer enemas before surgery
703962|NCT00981552|Cervix Cancer|cervix cancer
703963|NCT00981552|IMRT|imrt
703964|NCT00981552|Organ Motion|organ motion
703965|NCT00981552|Target Definition|target definition
703966|NCT00981565|Carpal tunnel syndrome|carpal tunnel syndrome
703970|NCT00981578|pain palliation|pain palliation
703971|NCT00981578|metastasis|metastasis
703972|NCT00981578|breast cancer|breast cancer
703973|NCT00981578|lung cancer|lung cancer
703974|NCT00981578|prostate cancer|prostate cancer
703975|NCT00981578|cancer related pain|cancer related pain
703976|NCT00981578|tumors|tumors
703977|NCT00981591|Iloprost|iloprost
703978|NCT00981591|Nitric oxide|nitric oxide
703979|NCT00981591|Mechanical ventilator|mechanical ventilator
703980|NCT00981604|SILS|sils
703981|NCT00981604|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
703982|NCT00981604|Children|children
703983|NCT00981630|Japanese Encephalitis|japanese encephalitis
703984|NCT00981630|ChimeriVax™-JE Vaccine|chimerivax™-je vaccine
703985|NCT00981630|Adult|adult
703986|NCT00981643|Meditation|meditation
703987|NCT00981643|Multiple Sclerosis|multiple sclerosis
703988|NCT00981643|Peripheral Neuropathy|peripheral neuropathy
703989|NCT00981656|stage I bladder cancer|stage i bladder cancer
703990|NCT00981656|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
703991|NCT00981669|brazilian pentavalent rotavirus vaccine|brazilian pentavalent rotavirus vaccine
703992|NCT00981669|safety|safety
703993|NCT00981669|tolerability|tolerability
703994|NCT00981669|immunogenicity|immunogenicity
703995|NCT00981682|decrease in the number of nocturic episodes for patients with nocturia|decrease in the number of nocturic episodes for patients with nocturia
703996|NCT00981695|HIV|hiv
703997|NCT00981695|Vaccine|vaccine
703998|NCT00981695|MVA|mva
703999|NCT00981695|PMTCT|pmtct
704000|NCT00981695|HIV preventive vaccine|hiv preventive vaccine
704001|NCT00981695|HIV seronegativity|hiv seronegativity
704002|NCT00981708|Amyloidosis|amyloidosis
704003|NCT00981708|lenalidomide|lenalidomide
704004|NCT00981708|newly diagnosed|newly diagnosed
704005|NCT00981708|relapsed|relapsed
704006|NCT00981708|primary systemic AL amyloidosis|primary systemic al amyloidosis
704007|NCT00981721|Phase I|phase i
704008|NCT00981721|Advanced solid malignancies|advanced solid malignancies
704009|NCT00981721|Advanced solid tumour|advanced solid tumour
704010|NCT00981721|Advanced cancer|advanced cancer
704011|NCT00981721|Cediranib (RECENTIN™, AZD2171)|cediranib (recentin™, azd2171)
704012|NCT00981721|China|china
704013|NCT00981721|PK|pk
704014|NCT00981721|pharmacokinetics|pharmacokinetics
704015|NCT00981734|Aging|aging
704016|NCT00981734|functionality|functionality
704017|NCT00981734|life style|life style
704018|NCT00981734|To have more than sixty years|to have more than sixty years
704019|NCT00981773|HIV switch|hiv switch
704020|NCT00981773|HIV|hiv
704021|NCT00981773|treatment experienced|treatment experienced
704022|NCT00981786|24-hour IOP control|24-hour iop control
704023|NCT00981786|brinzolamide/timolol|brinzolamide/timolol
704025|NCT00981786|travoprost|travoprost
704026|NCT00981799|Relapse|relapse
704027|NCT00981799|T cell|t cell
704028|NCT00981799|Lymphoblastic|lymphoblastic
704029|NCT00981799|Leukemia|leukemia
704030|NCT00981799|Lymphoma|lymphoma
704031|NCT00981799|Nelarabine|nelarabine
704032|NCT00981799|TACL|tacl
704033|NCT00981799|NECTAR|nectar
704034|NCT00981812|PET|pet
704035|NCT00981812|PEM|pem
704036|NCT00981812|Positron Emission Mammography|positron emission mammography
704037|NCT00981812|Breast Biopsy|breast biopsy
704038|NCT00981851|intervention study|intervention study
704039|NCT00981851|interaction|interaction
704040|NCT00981851|COPD|copd
704041|NCT00981864|radiation therapy in breast cancer|radiation therapy in breast cancer
704042|NCT00981864|concurrent radiation|concurrent radiation
704043|NCT00981864|Breast cancer patients|breast cancer patients
704044|NCT00981877|acute diarrhea|acute diarrhea
704045|NCT00981877|rotavirus|rotavirus
704046|NCT00981877|probiotic|probiotic
704047|NCT00981877|children|children
704048|NCT00981890|Brain Metastases|brain metastases
704049|NCT00981890|Stereotactic radiosurgery|stereotactic radiosurgery
704050|NCT00981890|Sunitinib|sunitinib
704051|NCT00981890|Patients with Brain Metastases|patients with brain metastases
704052|NCT00981903|VTE in cancer patients|vte in cancer patients
704053|NCT00974012|Bioequivalence|bioequivalence
704054|NCT00974038|Bulimia Nervosa, EDNOS, Adolescents|bulimia nervosa, ednos, adolescents
704055|NCT00974051|Children|children
704056|NCT00974051|Exercise|exercise
704057|NCT00974051|Hypoglycemia|hypoglycemia
704058|NCT00974064|COPD|copd
704059|NCT00974064|Lung disease|lung disease
704060|NCT00974064|Chronic bronchitis|chronic bronchitis
704061|NCT00974064|Emphysema|emphysema
704062|NCT00974064|Smoking|smoking
704063|NCT00974064|Smoking cessation|smoking cessation
704064|NCT00974064|Quit smoking|quit smoking
704065|NCT00974064|Healthy smoker|healthy smoker
704066|NCT00974064|Smoker|smoker
704067|NCT00974064|Non-smoker|non-smoker
704068|NCT00974077|recurrent depression,|recurrent depression,
704069|NCT00974077|mindfulness training|mindfulness training
704070|NCT00974077|attention|attention
704071|NCT00974077|Evoked EEG potentials|evoked eeg potentials
704072|NCT00974077|Relapse prevention in recurrent depression|relapse prevention in recurrent depression
704073|NCT00974090|insulin resistance|insulin resistance
704074|NCT00974103|low back pain|low back pain
704075|NCT00974103|pelvic pain|pelvic pain
704076|NCT00974103|pelvic girdle pain|pelvic girdle pain
704077|NCT00974103|post partum|post partum
704078|NCT00974142|COPD|copd
704079|NCT00974142|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
704080|NCT00974142|Cyclosporine|cyclosporine
704081|NCT00974142|Oral Immunotherapy|oral immunotherapy
704082|NCT00974142|Advanced stage|advanced stage
704083|NCT00974155|Major|major
704084|NCT00974155|Depression|depression
704085|NCT00974155|Disorder|disorder
704086|NCT00974168|pain|pain
704087|NCT00974168|radiation toxicity|radiation toxicity
704088|NCT00974168|spinal cord compression|spinal cord compression
704089|NCT00974168|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
704090|NCT00974194|Cholecystolithiasis|cholecystolithiasis
704091|NCT00974194|Cholecystectomy|cholecystectomy
704092|NCT00974194|Laparoscopic surgery|laparoscopic surgery
704093|NCT00974194|Single port|single port
704094|NCT00974220|inhaled fentanyl|inhaled fentanyl
704095|NCT00974220|dyspnea|dyspnea
704096|NCT00974220|exercise|exercise
704097|NCT00974220|COPD|copd
704098|NCT00974233|CLL|cll
704099|NCT00974233|SLL|sll
704100|NCT00974246|COPD|copd
704101|NCT00974246|Depression|depression
704102|NCT00974246|Nursing Home|nursing home
704103|NCT00974259|Hypoxia|hypoxia
704104|NCT00974259|Ischemia|ischemia
705743|NCT00986401|Adults|adults
704105|NCT00974259|Intracranial hypertension|intracranial hypertension
704106|NCT00974259|Neurocritical care|neurocritical care
704107|NCT00974285|AIDS|aids
704108|NCT00974285|complementary therapies|complementary therapies
704109|NCT00974311|MDV3100|mdv3100
704110|NCT00974311|Prostate Cancer|prostate cancer
704111|NCT00974311|Castration-resistant|castration-resistant
704112|NCT00974324|peripheral T cell lymphoma|peripheral t cell lymphoma
704113|NCT00974324|chemotherapy|chemotherapy
704114|NCT00974324|anti-angiogeneses|anti-angiogeneses
704115|NCT00974337|Adrenal insufficiency|adrenal insufficiency
704116|NCT00974337|cortisol|cortisol
704117|NCT00974337|preterm|preterm
704118|NCT00974337|shock|shock
704119|NCT00974337|neonate|neonate
704120|NCT00974350|Post-operative pain|post-operative pain
704121|NCT00974350|hernia surgery|hernia surgery
704122|NCT00974350|opioid|opioid
704123|NCT00974363|meningococcal vaccine GSK 134612|meningococcal vaccine gsk 134612
704124|NCT00974376|Cannabis Treatment|cannabis treatment
704125|NCT00974376|Cannabis Use|cannabis use
704126|NCT00974376|Cannabis Dependence|cannabis dependence
704127|NCT00974376|Executive Functioning|executive functioning
704128|NCT00974376|Cognitive Deficits|cognitive deficits
704129|NCT00974389|stage III colon cancer|stage iii colon cancer
704130|NCT00974389|stage III rectal cancer|stage iii rectal cancer
704131|NCT00974389|stage IV colon cancer|stage iv colon cancer
704132|NCT00974389|stage IV rectal cancer|stage iv rectal cancer
704133|NCT00974389|recurrent colon cancer|recurrent colon cancer
704134|NCT00974389|recurrent rectal cancer|recurrent rectal cancer
704135|NCT00974402|Active duty|active duty
704136|NCT00974402|Afghanistan|afghanistan
704138|NCT00974402|Anxiety|anxiety
704139|NCT00974402|Avoidance|avoidance
704140|NCT00974402|BAMC|bamc
704141|NCT00974402|Brooke Army Medical Center|brooke army medical center
704142|NCT00974402|Cognitive Behavioral Therapy|cognitive behavioral therapy
704143|NCT00974402|Combat|combat
704144|NCT00974402|Combat Disorder|combat disorder
704145|NCT00974402|Coping|coping
704146|NCT00974402|Counseling|counseling
704147|NCT00974402|Counselor|counselor
704148|NCT00974402|Deployment|deployment
704149|NCT00974402|Depression|depression
704150|NCT00974402|Exposure|exposure
704151|NCT00974402|Fear|fear
704152|NCT00974402|Feeling alone|feeling alone
704153|NCT00974402|Flashbacks|flashbacks
704154|NCT00974402|Guard|guard
704155|NCT00974402|Guilt|guilt
704156|NCT00974402|Hospitalization|hospitalization
704157|NCT00974402|Iraq|iraq
704158|NCT00974402|Mental Health|mental health
704159|NCT00974402|Military|military
704160|NCT00974402|Military member|military member
704161|NCT00974402|Military personnel|military personnel
704162|NCT00974402|Neuroses|neuroses
704163|NCT00974402|Nightmares|nightmares
704164|NCT00974402|OEF|oef
704165|NCT00974402|OIF|oif
704166|NCT00974402|Prolonged Exposure Therapy|prolonged exposure therapy
704167|NCT00974402|Psychiatric|psychiatric
704168|NCT00974402|Psychiatric medication|psychiatric medication
704169|NCT00974402|Psychological distress|psychological distress
704170|NCT00974402|Psychotherapy|psychotherapy
704171|NCT00974402|Reserve|reserve
704172|NCT00974402|Retired|retired
704173|NCT00974402|Sadness|sadness
704174|NCT00974402|Separated|separated
704175|NCT00974402|Sleeplessness|sleeplessness
704176|NCT00974402|Soldier|soldier
704177|NCT00974402|Stress|stress
704178|NCT00974402|Stress disorder|stress disorder
704179|NCT00974402|Stress management|stress management
704180|NCT00974402|STRONG STAR|strong star
704181|NCT00974402|Suicidal|suicidal
704182|NCT00974402|Suicide|suicide
704183|NCT00974402|Therapy|therapy
704185|NCT00974402|Traumatic Event|traumatic event
704186|NCT00974402|Trouble Sleeping|trouble sleeping
704187|NCT00974402|Veteran|veteran
704188|NCT00974402|Veterans|veterans
704189|NCT00974402|War|war
704190|NCT00974402|WHMC|whmc
704191|NCT00974402|Wilford Hall Medical Center|wilford hall medical center
704192|NCT00974402|PTSD|ptsd
704193|NCT00974402|Posttraumatic Stress Disorders|posttraumatic stress disorders
704194|NCT00974415|BMI classification-overweight|bmi classification-overweight
704195|NCT00974428|Osteoarthritis|osteoarthritis
704196|NCT00974428|Disease of joints|disease of joints
704197|NCT00974428|Wobenzym® N|wobenzym® n
704198|NCT00974428|WOMAC pain score|womac pain score
704199|NCT00974428|Subject reported pain (VAS)|subject reported pain (vas)
704200|NCT00974441|Bioequivalence|bioequivalence
704201|NCT00974454|AIDS|aids
704202|NCT00974454|complementary therapies|complementary therapies
704203|NCT00974454|treatment experienced|treatment experienced
704204|NCT00974480|Skin|skin
704205|NCT00974480|Aging|aging
704206|NCT00974480|Rejuva-a|rejuva-a
704207|NCT00974480|Redermic|redermic
704208|NCT00974493|oral|oral
704209|NCT00974493|intravenous|intravenous
704210|NCT00974493|antibiotics|antibiotics
704211|NCT00974493|bone|bone
704212|NCT00974493|joint|joint
704213|NCT00974493|infection|infection
752407|NCT01172912|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
704214|NCT00974506|geriatric patients living in residential community (shared flats), multiple disease-conditions|geriatric patients living in residential community (shared flats), multiple disease-conditions
704215|NCT00974519|ADIS|adis
704216|NCT00974519|complementary therapies|complementary therapies
704217|NCT00974532|balance|balance
704218|NCT00974532|chronic kidney disease|chronic kidney disease
704219|NCT00974532|calcium|calcium
704220|NCT00974532|phosphorus|phosphorus
704221|NCT00974558|dyspnea|dyspnea
704222|NCT00974558|fan|fan
704223|NCT00974584|NSCLC|nsclc
704224|NCT00974584|PI3K|pi3k
704225|NCT00974584|Avastin|avastin
704226|NCT00974597|burn|burn
704227|NCT00974597|donor site|donor site
704228|NCT00974597|treatment of burns|treatment of burns
704229|NCT00974597|Treatment of Donor Sites|treatment of donor sites
704230|NCT00974610|stage IV melanoma|stage iv melanoma
704231|NCT00974610|recurrent melanoma|recurrent melanoma
704232|NCT00974610|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
704233|NCT00974610|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
704234|NCT00974610|extensive stage small cell lung cancer|extensive stage small cell lung cancer
704235|NCT00974610|recurrent small cell lung cancer|recurrent small cell lung cancer
704236|NCT00974610|stage IV breast cancer|stage iv breast cancer
704237|NCT00974610|recurrent breast cancer|recurrent breast cancer
704238|NCT00974610|male breast cancer|male breast cancer
704239|NCT00974610|stage III pancreatic cancer|stage iii pancreatic cancer
704240|NCT00974610|stage IV pancreatic cancer|stage iv pancreatic cancer
704241|NCT00974610|recurrent pancreatic cancer|recurrent pancreatic cancer
704242|NCT00974610|stage IV colon cancer|stage iv colon cancer
704243|NCT00974610|recurrent colon cancer|recurrent colon cancer
704244|NCT00974610|stage IV rectal cancer|stage iv rectal cancer
704245|NCT00974610|recurrent rectal cancer|recurrent rectal cancer
704246|NCT00974623|Bone growth substitute|bone growth substitute
704247|NCT00974623|Autograft|autograft
704248|NCT00974623|Allograft|allograft
704249|NCT00974623|Spine fusion|spine fusion
704250|NCT00974636|Kidney Disease|kidney disease
704251|NCT00974636|Albuminuria|albuminuria
704252|NCT00974636|Glomerular filtration rate|glomerular filtration rate
704253|NCT00974636|Volume status|volume status
704254|NCT00974636|Bioimpedance analysis|bioimpedance analysis
704255|NCT00974649|drop-out|drop-out
704256|NCT00974649|predictors of treatment continuation/discontinuation|predictors of treatment continuation/discontinuation
704257|NCT00974649|IVF/ICSI|ivf/icsi
704258|NCT00974649|infertility|infertility
704259|NCT00974649|counseling|counseling
704260|NCT00974649|psychology|psychology
704261|NCT00974649|Assisted Reproduction|assisted reproduction
704262|NCT00974649|Counselling|counselling
704263|NCT00974662|Non-Small Cell Lung Cancer|non-small cell lung cancer
704264|NCT00974662|Lung Cancer|lung cancer
704265|NCT00974662|NSCLC|nsclc
704266|NCT00974675|Asthma|asthma
704267|NCT00974675|CAT-354|cat-354
704268|NCT00974675|Tralokinumab|tralokinumab
704269|NCT00974688|Congenital|congenital
704270|NCT00974688|physical activity participation|physical activity participation
704271|NCT00974688|Moderate-to-vigorous physical activity|moderate-to-vigorous physical activity
704272|NCT00974701|symptoms of acute overt upper gastrointestinal hemorrhage|symptoms of acute overt upper gastrointestinal hemorrhage
704273|NCT00974714|chronic hypertension in pregnancy|chronic hypertension in pregnancy
704274|NCT00974727|Childhood overweight|childhood overweight
704275|NCT00974727|Gardening|gardening
704276|NCT00974727|Summer weight gain|summer weight gain
704277|NCT00974740|type 1 diabetes|type 1 diabetes
704278|NCT00974753|epiretinal membrane|epiretinal membrane
704279|NCT00974766|bronchial asthma|bronchial asthma
704280|NCT00974766|allergic bronchopulmonary aspergillosis|allergic bronchopulmonary aspergillosis
704281|NCT00974779|kidney failure chronic|kidney failure chronic
704282|NCT00974779|renal dialysis|renal dialysis
704283|NCT00974779|inflammation|inflammation
704284|NCT00974779|monocytes|monocytes
704285|NCT00974779|end stage renal disease on regular thrice weekly hemodialysis|end stage renal disease on regular thrice weekly hemodialysis
704286|NCT00974792|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
704287|NCT00974792|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
704288|NCT00974805|COPD|copd
704289|NCT00974805|Emphysema|emphysema
704290|NCT00974805|Bronchitis|bronchitis
704291|NCT00981916|determination of depth to epidural space using ultrasound|determination of depth to epidural space using ultrasound
704292|NCT00981929|CYP2D6|cyp2d6
704293|NCT00981929|CYP2C9|cyp2c9
704294|NCT00981929|CYP2C19|cyp2c19
704295|NCT00981929|CYP1A2|cyp1a2
704296|NCT00981942|Nephrogenic systemic fibrosis|nephrogenic systemic fibrosis
704297|NCT00981942|Imatinib mesylate|imatinib mesylate
704298|NCT00981942|Glivec|glivec
704299|NCT00981942|Gleevec|gleevec
704300|NCT00981955|Caffeine|caffeine
704301|NCT00981955|Ltheanine|ltheanine
704302|NCT00981955|Near Infrared Spectroscopy|near infrared spectroscopy
704303|NCT00981955|Cerebral Blood Flow|cerebral blood flow
704304|NCT00981955|Cognitive Function|cognitive function
704305|NCT00981955|Mood|mood
704306|NCT00981981|humans|humans
704307|NCT00981981|randomized clinical trial|randomized clinical trial
704308|NCT00981981|dietary fiber|dietary fiber
704309|NCT00981981|nutrition|nutrition
704310|NCT00981981|beta-glucan|beta-glucan
704311|NCT00981981|oats|oats
704312|NCT00981981|LDL cholesterol|ldl cholesterol
704313|NCT00981981|coronary heart disease|coronary heart disease
704314|NCT00981994|respiratory infection|respiratory infection
704315|NCT00981994|antimicrobial drugs|antimicrobial drugs
704316|NCT00981994|decision support|decision support
704317|NCT00981994|Adult patients|adult patients
704318|NCT00982007|IDA|ida
704319|NCT00982020|safety|safety
704320|NCT00982020|schizophrenia|schizophrenia
704321|NCT00982020|bipolar I (manic or mixed)|bipolar i (manic or mixed)
704322|NCT00982020|adolescents|adolescents
704323|NCT00982020|weight management|weight management
704324|NCT00982033|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
704325|NCT00982033|Elderly|elderly
704326|NCT00982046|contact lenses|contact lenses
704327|NCT00982046|disinfection solutions|disinfection solutions
704328|NCT00982046|contact lens care|contact lens care
704329|NCT00982059|Colorectal cancer screening|colorectal cancer screening
704330|NCT00982059|Cancer survivor|cancer survivor
704331|NCT00982059|Radiation therapy|radiation therapy
704431|NCT00983060|chronic hepatitis C|chronic hepatitis c
704332|NCT00982072|nephrotic minimal change tacrolimus prednisolone|nephrotic minimal change tacrolimus prednisolone
704333|NCT00982085|Asthma|asthma
704334|NCT00982085|Allergic rhinitis|allergic rhinitis
704335|NCT00982085|Military|military
704336|NCT00982098|Prostatectomy|prostatectomy
704337|NCT00982098|Prostatic cancer|prostatic cancer
704338|NCT00982098|Urinary incontinence|urinary incontinence
704339|NCT00982098|Exercise|exercise
704340|NCT00982098|Electric stimulation therapy|electric stimulation therapy
704341|NCT00982098|Counseling|counseling
704342|NCT00982111|Nonsquamous|nonsquamous
704343|NCT00982111|Non Small Cell Lung Cancer|non small cell lung cancer
704344|NCT00982111|First line treatment|first line treatment
704345|NCT00982111|Monoclonal|monoclonal
704346|NCT00982111|Antibodies|antibodies
704347|NCT00982111|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
704348|NCT00982124|Osteogenesis Imperfecta|osteogenesis imperfecta
704349|NCT00982124|Infants with moderate to severe Osteogenesis Imperfecta|infants with moderate to severe osteogenesis imperfecta
704350|NCT00982137|Japanese Encephalitis|japanese encephalitis
704351|NCT00982137|Yellow Fever|yellow fever
704352|NCT00982137|ChimeriVax™-JE|chimerivax™-je
704353|NCT00982137|STAMARIL®|stamaril®
704354|NCT00982137|Adult|adult
704355|NCT00982150|Talampanel|talampanel
704356|NCT00982150|Open-Label Study|open-label study
704357|NCT00982150|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
704358|NCT00982176|Anatomo-functional determinants|anatomo-functional determinants
704359|NCT00982176|cognitive impairment|cognitive impairment
704360|NCT00982176|coronary syndrome|coronary syndrome
704362|NCT00982176|cerebral perfusion scintigraphy|cerebral perfusion scintigraphy
704363|NCT00982189|treatment experienced|treatment experienced
704364|NCT00982202|PPAR-gamma|ppar-gamma
704365|NCT00982202|inflammation|inflammation
704366|NCT00982215|Paracetamol|paracetamol
704367|NCT00982215|per-oral mucosa PMB|per-oral mucosa pmb
704368|NCT00982215|No disease, healthy volunteers|no disease, healthy volunteers
704369|NCT00982241|OAB|oab
704370|NCT00982241|urine|urine
704371|NCT00982241|osmolality|osmolality
704372|NCT00982241|urge|urge
704373|NCT00982241|fluid intake|fluid intake
704374|NCT00982241|PPIUS|ppius
704375|NCT00982241|urge score|urge score
704376|NCT00982241|bladder|bladder
704377|NCT00982878|treatment experienced|treatment experienced
704378|NCT00982891|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
704379|NCT00982891|palliation|palliation
704381|NCT00982904|neglected disease|neglected disease
704383|NCT00982904|new drug|new drug
704384|NCT00982904|oral drug|oral drug
704385|NCT00982904|parasite|parasite
704386|NCT00982917|playground|playground
704387|NCT00982917|injury prevention|injury prevention
704388|NCT00982930|Tobramycin Inhalation Powder|tobramycin inhalation powder
704389|NCT00982930|Cystic fibrosis|cystic fibrosis
704390|NCT00982930|Lung diseases|lung diseases
704391|NCT00982930|Anti-Bacterial Agents|anti-bacterial agents
704392|NCT00982969|tuberculosis|tuberculosis
704393|NCT00982969|pneumonia|pneumonia
704394|NCT00982969|QuantiFERON-TB Gold in-tube|quantiferon-tb gold in-tube
704395|NCT00982969|Tuberculin skin test|tuberculin skin test
704396|NCT00982982|Schizophrenia|schizophrenia
704397|NCT00982982|Mental Disorders|mental disorders
704398|NCT00982982|Psychotic Disorders|psychotic disorders
704399|NCT00982982|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
704400|NCT00982982|Cannabis|cannabis
704401|NCT00983008|Signs and Symptoms|signs and symptoms
704402|NCT00983008|Fatigue|fatigue
704403|NCT00983008|Sleep Deprivation|sleep deprivation
704404|NCT00983008|Internship and Residency|internship and residency
704405|NCT00983008|Depression|depression
704406|NCT00983008|Medical Errors|medical errors
704407|NCT00983008|Burnout, Professional|burnout, professional
704408|NCT00983008|Burnout|burnout
704409|NCT00983008|Actigraphy|actigraphy
704410|NCT00983008|Personnel Staffing and Scheduling|personnel staffing and scheduling
704411|NCT00983008|Workload|workload
704412|NCT00983008|Humans|humans
704413|NCT00983008|Adult|adult
704414|NCT00983008|Male|male
704415|NCT00983008|Female|female
704416|NCT00983008|Intensive Care Units|intensive care units
704417|NCT00983008|Prospective Studies|prospective studies
704418|NCT00983008|Work Schedule Tolerance|work schedule tolerance
704419|NCT00983008|Disorders of Excessive Somnolence|disorders of excessive somnolence
704420|NCT00983008|Guideline Adherence|guideline adherence
704421|NCT00983008|Internal Medicine Education|internal medicine education
704422|NCT00983034|nephrotic syndrome|nephrotic syndrome
704423|NCT00983034|Helicobacter pylori infection|helicobacter pylori infection
704424|NCT00983034|proteinuria|proteinuria
704425|NCT00983034|membranous nephropathy|membranous nephropathy
704426|NCT00983047|Nimotuzumab|nimotuzumab
704427|NCT00983047|NSCLC|nsclc
704428|NCT00983047|Docetaxel|docetaxel
704429|NCT00983060|NIM811|nim811
704430|NCT00983060|chronic hepatitis|chronic hepatitis
705459|NCT00978900|PYY|pyy
704432|NCT00983060|chronic hepatitis C genotype-1|chronic hepatitis c genotype-1
704433|NCT00983060|HCV|hcv
704434|NCT00983060|HCV-1|hcv-1
704435|NCT00983060|relapser|relapser
704436|NCT00983073|Osteoarthritis|osteoarthritis
704437|NCT00983073|Pain|pain
704438|NCT00983073|Assessment|assessment
704439|NCT00983073|Tapentadol|tapentadol
704440|NCT00983073|Centrally acting analgesic|centrally acting analgesic
704441|NCT00983073|Chronic pain due to osteoarthritis|chronic pain due to osteoarthritis
704442|NCT00983086|Flavanones and vascular function|flavanones and vascular function
704443|NCT00983112|Gonarthrosis|gonarthrosis
704444|NCT00983112|Knee prosthesis insertion|knee prosthesis insertion
704445|NCT00983112|Bleeding|bleeding
704446|NCT00983112|Undergoing a total knee prothesis surgery|undergoing a total knee prothesis surgery
704447|NCT00983112|knee prothesis surgery|knee prothesis surgery
704448|NCT00983112|Knee arthrosis|knee arthrosis
704449|NCT00983112|Thrombosis|thrombosis
704450|NCT00983125|Labour|labour
704451|NCT00983125|Epidural analgesia|epidural analgesia
704452|NCT00983125|Clonidine|clonidine
704453|NCT00983125|Levobupivacaine|levobupivacaine
704454|NCT00983125|Opiates|opiates
704455|NCT00983125|Patient-controlled|patient-controlled
704456|NCT00983125|Active spontaneous labour requiring epidural analgesia|active spontaneous labour requiring epidural analgesia
704457|NCT00983164|antiviral therapy|antiviral therapy
704458|NCT00983164|antioxidant therapy|antioxidant therapy
704459|NCT00983164|hepatitis C virus|hepatitis c virus
704460|NCT00983164|oxidative stress|oxidative stress
704461|NCT00983164|vitamin E|vitamin e
704462|NCT00983190|HeartMate II|heartmate ii
704463|NCT00983190|BeneMACS|benemacs
704464|NCT00983190|LVAD|lvad
704465|NCT00983190|Thoratec Corporation|thoratec corporation
704466|NCT00983203|Dry eye|dry eye
704467|NCT00983203|artificial tears|artificial tears
704468|NCT00983216|blood levels over time;|blood levels over time;
704469|NCT00983216|pharmacokinetics;|pharmacokinetics;
704470|NCT00983216|healthy adult;|healthy adult;
704471|NCT00983216|cytochrome p450|cytochrome p450
704472|NCT00983229|difficult airway|difficult airway
704473|NCT00983229|fibreoptic intubation|fibreoptic intubation
704474|NCT00983229|supraglottic airways|supraglottic airways
704475|NCT00983229|laryngeal mask airway|laryngeal mask airway
704476|NCT00983268|periampullary adenocarcinoma|periampullary adenocarcinoma
704477|NCT00983268|stage I pancreatic cancer|stage i pancreatic cancer
704478|NCT00983268|stage II pancreatic cancer|stage ii pancreatic cancer
704479|NCT00983268|stage III pancreatic cancer|stage iii pancreatic cancer
704480|NCT00983281|Combat casualty care|combat casualty care
704481|NCT00983281|Hextend|hextend
704482|NCT00983281|Colloid|colloid
704483|NCT00983294|blood levels over time;|blood levels over time;
704484|NCT00983294|colchicine;|colchicine;
704485|NCT00983294|azithromycin;|azithromycin;
704486|NCT00983294|healthy|healthy
704487|NCT00983307|Radiation|radiation
704488|NCT00983307|Erlotinib|erlotinib
704489|NCT00983307|Tarceva|tarceva
704490|NCT00983320|Fibromyalgia|fibromyalgia
704491|NCT00983320|pain|pain
704492|NCT00983320|quetiapine|quetiapine
704493|NCT00983320|randomized placebo controlled trial|randomized placebo controlled trial
704494|NCT00983333|Health communication|health communication
704495|NCT00983333|Health literacy|health literacy
704496|NCT00983333|Patient|patient
704497|NCT00983333|Health Care Professional|health care professional
704498|NCT00983333|Satisfaction|satisfaction
704499|NCT00983346|cancer|cancer
704500|NCT00983346|myeloma|myeloma
704501|NCT00983346|multiple myeloma|multiple myeloma
704502|NCT00983346|smoldering myeloma|smoldering myeloma
704503|NCT00983359|tumors metastatic to brain|tumors metastatic to brain
704504|NCT00983359|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
704505|NCT00983372|healthy; adult; volunteer; colchicine; diltiazem; blood levels over time|healthy; adult; volunteer; colchicine; diltiazem; blood levels over time
704506|NCT00983385|low back pain|low back pain
704507|NCT00983385|pain|pain
704508|NCT00983385|assessment|assessment
704509|NCT00983385|tapentadol|tapentadol
704510|NCT00983385|centrally acting analgesic|centrally acting analgesic
704511|NCT00983411|non-invasive intermittent positive-pressure ventilation|non-invasive intermittent positive-pressure ventilation
704512|NCT00983411|work of breathing|work of breathing
704513|NCT00983411|Pulse transit time|pulse transit time
704514|NCT00983424|Breast Cancer|breast cancer
704515|NCT00983463|Nonalcoholic fatty liver disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
704516|NCT00983463|Nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
704517|NCT00983463|Obesity|obesity
704518|NCT00983463|Lipidomics|lipidomics
704519|NCT00983463|Proteomics|proteomics
704520|NCT00983476|Randomized controlled trial|randomized controlled trial
704521|NCT00983476|Obesity|obesity
704522|NCT00983476|Comparative Effectiveness|comparative effectiveness
704523|NCT00983476|Clinical practice guidelines|clinical practice guidelines
704524|NCT00983476|Medical Informatics Computing|medical informatics computing
704525|NCT00983476|Services, Mental Health|services, mental health
704526|NCT00983476|Self-care|self-care
704527|NCT00983476|Psychotic disorders|psychotic disorders
704528|NCT00983476|Mental Health Care|mental health care
704529|NCT00983476|Veterans|veterans
704530|NCT00983489|breast feeding|breast feeding
704531|NCT00983489|counselling|counselling
704532|NCT00983489|video demonstration|video demonstration
704533|NCT00983502|Idiopathic Chronic Fatigue|idiopathic chronic fatigue
704534|NCT00983502|Chronic Fatigue Syndrome|chronic fatigue syndrome
704535|NCT00983502|Myalgic encephalomyelitis|myalgic encephalomyelitis
704536|NCT00983528|cancer|cancer
704537|NCT00983528|lymphoblastic|lymphoblastic
704538|NCT00983528|leukemia|leukemia
704539|NCT00983541|intra or extrahepatic cholangiocarcinoma|intra or extrahepatic cholangiocarcinoma
704540|NCT00983541|liver cancer|liver cancer
704541|NCT00983541|liver|liver
704543|NCT00983541|EHCC|ehcc
704544|NCT00983554|testosterone|testosterone
704545|NCT00983554|insulin|insulin
704546|NCT00983554|obesity|obesity
704547|NCT00983554|aromatase|aromatase
704548|NCT00983554|5 alpha reductase|5 alpha reductase
704549|NCT00983593|Mind Body Bridging|mind body bridging
704550|NCT00983593|Domestic Violence Offender Treatment|domestic violence offender treatment
704551|NCT00983593|Batterer Treatment|batterer treatment
704552|NCT00983619|Cancer|cancer
704553|NCT00983632|vagus nerve stimulation|vagus nerve stimulation
704554|NCT00983632|heart rate|heart rate
704555|NCT00983632|systolic arterial pressure|systolic arterial pressure
704556|NCT00983645|Kidney Transplantation|kidney transplantation
704557|NCT00983645|Immunosuppression|immunosuppression
704558|NCT00983658|Anti-OX40L|anti-ox40l
704559|NCT00983658|Mild Allergic Asthma|mild allergic asthma
704560|NCT00983658|Allergies|allergies
704561|NCT00983658|Allergic Asthma|allergic asthma
704562|NCT00983658|Adult Asthma|adult asthma
704563|NCT00983671|Asthma|asthma
704564|NCT00983671|cystic fibrosis|cystic fibrosis
704565|NCT00983671|chronic lung disease|chronic lung disease
704566|NCT00983671|bronchopulmonary dysplasia|bronchopulmonary dysplasia
704567|NCT00983671|pneumonia|pneumonia
704568|NCT00983684|Neoplasms by Site|neoplasms by site
704569|NCT00983684|Breast Neoplasms|breast neoplasms
704570|NCT00983684|Breast Diseases|breast diseases
704571|NCT00983684|Breast Cancer|breast cancer
704572|NCT00983684|Cancer of Breast|cancer of breast
704573|NCT00983684|Cancer of the Breast|cancer of the breast
704574|NCT00983684|Carcinoma|carcinoma
704575|NCT00983697|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
704778|NCT00984087|mood disorders|mood disorders
704576|NCT00983697|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
704577|NCT00983697|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
704578|NCT00983697|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
704579|NCT00983697|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
704580|NCT00983697|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
704581|NCT00983697|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
704582|NCT00983697|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
704583|NCT00983697|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
704584|NCT00983697|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
704585|NCT00983697|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
704586|NCT00983697|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
704587|NCT00983697|tongue cancer|tongue cancer
704588|NCT00983710|prostate neoplasms|prostate neoplasms
704589|NCT00983723|Patient Foramen Ovale|patient foramen ovale
704591|NCT00983723|Stroke|stroke
704592|NCT00983723|Ischemic Brain Injury|ischemic brain injury
704593|NCT00983723|Neurovascular Disease|neurovascular disease
704594|NCT00983749|External Counterpulsation|external counterpulsation
704595|NCT00983749|Counterpulsation, Diastolic|counterpulsation, diastolic
704596|NCT00983749|Ultrasonography, Doppler, Transcranial|ultrasonography, doppler, transcranial
704597|NCT00983749|Blood Flow Velocity|blood flow velocity
704598|NCT00983749|Neurologic Deficit|neurologic deficit
704599|NCT00983762|Knee osteoarthritis|knee osteoarthritis
704600|NCT00983762|Leg strength|leg strength
704601|NCT00983762|Functional outcomes|functional outcomes
704602|NCT00983762|Minimally Invasive Surgery Mini-Incision (MIS) TKA|minimally invasive surgery mini-incision (mis) tka
704603|NCT00983762|Unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
704604|NCT00983762|Standard Para-patellar surgery TKA|standard para-patellar surgery tka
704605|NCT00983762|gait|gait
704606|NCT00983762|knee arthroplasty|knee arthroplasty
704607|NCT00983775|Pharmacokinetic profile|pharmacokinetic profile
704608|NCT00983775|Pharmacodynamic profile|pharmacodynamic profile
704609|NCT00983775|insulin|insulin
704610|NCT00983775|jet injector|jet injector
704611|NCT00983788|CPT II|cpt ii
704612|NCT00983788|VLCAD|vlcad
704613|NCT00983814|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
704614|NCT00983814|ADHD|adhd
704615|NCT00983814|Adult ADHD|adult adhd
704616|NCT00983814|Adult Attention Deficit Hyperactivity Disorder|adult attention deficit hyperactivity disorder
704617|NCT00983840|diet|diet
704618|NCT00983840|African-American families|african-american families
704619|NCT00983840|web-based|web-based
704620|NCT00983853|VX-950|vx-950
704621|NCT00983853|INCIVEK|incivek
704622|NCT00983853|INCIVO|incivo
704623|NCT00983879|Infantile globoid cell leukodystrophy|infantile globoid cell leukodystrophy
704625|NCT00983879|Krabbe disease|krabbe disease
704626|NCT00983879|Natural History Study|natural history study
704627|NCT00983892|Cancer|cancer
704628|NCT00983892|caregiver|caregiver
704629|NCT00983892|pain|pain
704630|NCT00983892|symptom|symptom
704631|NCT00983892|information technology|information technology
704632|NCT00983892|palliative care|palliative care
704633|NCT00983905|healthy;|healthy;
704634|NCT00983905|adult;|adult;
704635|NCT00983905|blood levels over time|blood levels over time
704636|NCT00983931|healthy|healthy
704637|NCT00983931|adult|adult
704638|NCT00983931|colchicine|colchicine
704639|NCT00983931|cyclosporine|cyclosporine
704640|NCT00983931|blood levels over time|blood levels over time
704641|NCT00983944|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
704642|NCT00983944|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
704643|NCT00983944|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
704644|NCT00983944|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
704645|NCT00983944|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
704646|NCT00983944|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
704647|NCT00983944|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
704785|NCT00984139|persistence|persistence
704648|NCT00983944|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
704649|NCT00983944|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
704650|NCT00983944|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
704651|NCT00983970|Adolescents|adolescents
704652|NCT00983970|Obesity|obesity
704653|NCT00983970|Exercise|exercise
704654|NCT00983970|Music|music
704655|NCT00983970|Virtual Reality|virtual reality
704656|NCT00983983|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
704657|NCT00983983|ALS|als
704658|NCT00983983|Motor Neuron Disease|motor neuron disease
704659|NCT00983983|MND|mnd
704660|NCT00983983|Fat|fat
704661|NCT00983983|Lipid|lipid
704662|NCT00983983|Cholesterol|cholesterol
704663|NCT00983983|Omega-3 fatty acid|omega-3 fatty acid
704668|NCT00983983|Adults with Amyotrophic Lateral Sclerosis (ALS)|adults with amyotrophic lateral sclerosis (als)
704669|NCT00984009|healthy|healthy
704670|NCT00984009|pharmacokinetics|pharmacokinetics
704671|NCT00984009|grapefruit juice|grapefruit juice
704672|NCT00984009|furanocoumarins|furanocoumarins
704673|NCT00984009|cytochrome p450 3A4|cytochrome p450 3a4
704674|NCT00984022|abscess|abscess
704675|NCT00984022|MRSA|mrsa
704676|NCT00984022|Aquacel dressing|aquacel dressing
704677|NCT00984022|Iodoform dressing|iodoform dressing
704678|NCT00984048|Colorectal cancer|colorectal cancer
704679|NCT00984048|FOLFOX|folfox
704680|NCT00984048|FOLFIRI|folfiri
704681|NCT00984048|Avastin|avastin
704682|NCT00984048|Metastases|metastases
704683|NCT00984048|Liver|liver
704684|NCT00984048|Colon cancer|colon cancer
704685|NCT00984048|Biomarkers|biomarkers
704686|NCT00984048|Resistance|resistance
704687|NCT00984048|Biobanking|biobanking
704688|NCT00984048|Colorectal cancer with unresectable metastases to the liver|colorectal cancer with unresectable metastases to the liver
704689|NCT00984061|healthy|healthy
704690|NCT00984061|pharmacokinetics|pharmacokinetics
704691|NCT00984061|drug-drug interaction|drug-drug interaction
704692|NCT00984074|stage III salivary gland cancer|stage iii salivary gland cancer
704693|NCT00984074|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
704694|NCT00984074|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
704695|NCT00984074|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
704696|NCT00984074|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
704697|NCT00984074|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
704698|NCT00984074|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
704699|NCT00984074|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
704700|NCT00984074|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
704701|NCT00984074|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
704702|NCT00984074|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
704703|NCT00984074|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
704704|NCT00984074|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
705059|NCT00985179|stages of change|stages of change
704705|NCT00984074|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
704706|NCT00984074|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
704707|NCT00984074|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
704708|NCT00984074|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
704709|NCT00984074|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
704710|NCT00984074|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
704711|NCT00984074|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
704712|NCT00984074|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
704713|NCT00984074|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
704714|NCT00984074|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
704715|NCT00984074|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
704716|NCT00984074|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
704717|NCT00984074|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
704718|NCT00984074|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
704719|NCT00984074|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
704720|NCT00984074|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
704721|NCT00984074|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
704722|NCT00984074|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
704723|NCT00984074|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
704724|NCT00984074|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
704784|NCT00984113|Kidney dysfunction|kidney dysfunction
704725|NCT00984074|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
704726|NCT00984074|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
704727|NCT00984074|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
704728|NCT00984074|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
704729|NCT00984074|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
704730|NCT00984074|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
704731|NCT00984074|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
704732|NCT00984074|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
704733|NCT00984074|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
704734|NCT00984074|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
704735|NCT00984074|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
704736|NCT00984074|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
704737|NCT00984074|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
704738|NCT00984074|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
704739|NCT00984074|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
704740|NCT00984074|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
704741|NCT00984074|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
704742|NCT00984074|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
704743|NCT00984074|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
704744|NCT00984074|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
704745|NCT00984074|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
704746|NCT00984074|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
752589|NCT01167829|Experimental|experimental
704747|NCT00984074|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
704748|NCT00984074|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
704749|NCT00984074|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
704750|NCT00984074|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
704751|NCT00984074|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
704752|NCT00984074|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
704753|NCT00984074|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
704754|NCT00984074|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
704755|NCT00984074|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
704756|NCT00984074|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
704757|NCT00984074|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
704758|NCT00984074|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
704759|NCT00984074|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
704760|NCT00984074|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
704761|NCT00984074|recurrent salivary gland cancer|recurrent salivary gland cancer
704762|NCT00984074|salivary gland acinic cell tumor|salivary gland acinic cell tumor
704763|NCT00984074|salivary gland adenocarcinoma|salivary gland adenocarcinoma
704764|NCT00984074|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
704765|NCT00984074|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
704766|NCT00984074|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
704767|NCT00984074|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
704768|NCT00984074|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
704769|NCT00984074|stage I salivary gland cancer|stage i salivary gland cancer
704770|NCT00984074|stage II salivary gland cancer|stage ii salivary gland cancer
704771|NCT00984074|tongue cancer|tongue cancer
704772|NCT00984087|depression|depression
704773|NCT00984087|TMS|tms
704774|NCT00984087|adolescent|adolescent
704775|NCT00984087|transcranial magnetic stimulation|transcranial magnetic stimulation
704776|NCT00984087|MDD|mdd
704777|NCT00984087|Major depression|major depression
704779|NCT00984100|Cholelithiasis|cholelithiasis
704780|NCT00984100|Biliary dyskinesia|biliary dyskinesia
704781|NCT00984113|Elinogrel|elinogrel
704782|NCT00984113|Renal impairment|renal impairment
704783|NCT00984113|Healthy|healthy
704786|NCT00984139|HBV|hbv
704787|NCT00984139|Long-term|long-term
704788|NCT00984139|Engerix™-B Kinder|engerix™-b kinder
704789|NCT00984139|Hepatitis B|hepatitis b
704790|NCT00984139|adolescent|adolescent
704791|NCT00984152|HIV|hiv
704792|NCT00984152|Raltegravir|raltegravir
704793|NCT00984152|Women|women
704794|NCT00984152|Viral Suppression|viral suppression
704795|NCT00984152|Viral Reservoir|viral reservoir
704796|NCT00984152|Immune Parameters|immune parameters
704797|NCT00984152|Gut|gut
704798|NCT00984152|Genital Tract|genital tract
704799|NCT00984165|Allotransplant|allotransplant
704800|NCT00984165|Relapse|relapse
704801|NCT00984165|Radiation|radiation
704802|NCT00984165|Donor Lymphocyte Infusion|donor lymphocyte infusion
704906|NCT00984503|RN1001|rn1001
704803|NCT00984165|Hematologic Malignancies|hematologic malignancies
704804|NCT00984165|Multiple Myeloma|multiple myeloma
704805|NCT00984165|Hodgkin Lymphoma|hodgkin lymphoma
704806|NCT00984165|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
704807|NCT00984165|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
704808|NCT00984178|Reperfusion|reperfusion
704809|NCT00984178|acute myocardial infarction|acute myocardial infarction
704810|NCT00984178|stem cell therapy|stem cell therapy
704811|NCT00984178|GCSF|gcsf
704812|NCT00984178|bone marrow mononuclear cells|bone marrow mononuclear cells
704813|NCT00984178|magnetic resonance|magnetic resonance
704814|NCT00984191|Papillary thyroid cancer|papillary thyroid cancer
704815|NCT00984191|99mTechnetium MIBI SPECT CT|99mtechnetium mibi spect ct
704816|NCT00984191|preoperative|preoperative
704817|NCT00984191|cervical lymphadenopathy|cervical lymphadenopathy
704818|NCT00984191|cervical metastasis|cervical metastasis
704819|NCT00984204|cavo-tricuspid dependent|cavo-tricuspid dependent
704820|NCT00984217|panitumumab|panitumumab
704821|NCT00984217|salivary gland malignancies|salivary gland malignancies
704822|NCT00984217|radiotherapy|radiotherapy
704823|NCT00984230|Infant Formula|infant formula
704824|NCT00984230|Gut|gut
704825|NCT00984243|lung cancer|lung cancer
704826|NCT00984256|Malaria|malaria
704827|NCT00984256|Prophylaxis|prophylaxis
704828|NCT00984256|Atovaquone|atovaquone
704829|NCT00984256|Malarone|malarone
704830|NCT00984256|Challenge|challenge
704831|NCT00984282|RAI-Refractory|rai-refractory
704832|NCT00984282|Differentiated|differentiated
704833|NCT00984282|Follicular|follicular
704834|NCT00984282|Papillary|papillary
704835|NCT00984282|Hurthle|hurthle
704836|NCT00984308|sleep apnea|sleep apnea
704837|NCT00984308|hypertension|hypertension
704838|NCT00984308|brain ischemia|brain ischemia
704839|NCT00984321|Geriatric|geriatric
704840|NCT00984321|Elderly|elderly
704841|NCT00984321|Counseling|counseling
704842|NCT00984321|Depression|depression
704843|NCT00984321|Anxiety|anxiety
704844|NCT00984321|Intervention|intervention
704845|NCT00984321|Psychoeducational|psychoeducational
704846|NCT00984321|09-116|09-116
704847|NCT00984334|pain|pain
704848|NCT00984334|opioid|opioid
704849|NCT00984334|constipation|constipation
704850|NCT00984334|Subjects taking opioids for chronic non-cancer pain, who|subjects taking opioids for chronic non-cancer pain, who
705261|NCT00978302|TGF beta 3|tgf beta 3
704851|NCT00984334|experience symptoms of opioid induced constipation|experience symptoms of opioid induced constipation
704852|NCT00984347|nipple stimulation|nipple stimulation
704853|NCT00984347|Oxytocin|oxytocin
704854|NCT00984347|induction of labor|induction of labor
704855|NCT00984347|term pregnancies|term pregnancies
704856|NCT00984347|grandmultipara|grandmultipara
704857|NCT00984347|VBAC|vbac
704858|NCT00984347|PROM|prom
704859|NCT00984347|comparison of two methods for induction of labor|comparison of two methods for induction of labor
704860|NCT00984360|Meth|meth
704861|NCT00984360|Methamphetamine Addiction|methamphetamine addiction
704862|NCT00984360|Methamphetamine Treatment|methamphetamine treatment
704863|NCT00984360|Naltrexone|naltrexone
704864|NCT00984360|Vivitrol|vivitrol
704865|NCT00984360|A118G|a118g
704866|NCT00984360|OPRM1|oprm1
704867|NCT00984373|Schizophrenia epidemiology|schizophrenia epidemiology
704868|NCT00984373|Schizophrenic patients' social and health characteristics|schizophrenic patients' social and health characteristics
704869|NCT00984386|Cicatrix|cicatrix
704870|NCT00984386|Scar|scar
704871|NCT00984386|Wound-healing|wound-healing
704872|NCT00984386|Zesteem|zesteem
704873|NCT00984386|17β-Estradiol|17β-estradiol
704874|NCT00984386|RN1002|rn1002
704875|NCT00984399|vaginitis|vaginitis
704876|NCT00984399|Postmenopausal|postmenopausal
704877|NCT00984399|17-β estradiol|17-β estradiol
704878|NCT00984399|09-110|09-110
704879|NCT00984451|Antibody Treatment|antibody treatment
704880|NCT00984451|Immune Therapy|immune therapy
704881|NCT00984451|Infectious Diseases|infectious diseases
704882|NCT00984451|IVIG|ivig
704883|NCT00984451|Plasma Apheresis|plasma apheresis
704884|NCT00984451|Influenza A|influenza a
704885|NCT00984451|Swine Flu|swine flu
704886|NCT00984464|metastatic|metastatic
704887|NCT00984464|melanoma|melanoma
704888|NCT00984464|REOLYSIN|reolysin
704997|NCT00984893|Treatment|treatment
704889|NCT00984464|chemotherapy|chemotherapy
704890|NCT00984464|carboplatin|carboplatin
704891|NCT00984464|paclitaxel|paclitaxel
704892|NCT00984477|Healthy volunteer|healthy volunteer
704893|NCT00984477|healthy subjects|healthy subjects
704894|NCT00984477|AZD5122|azd5122
704895|NCT00984477|single oral dose|single oral dose
704896|NCT00984477|phase 1|phase 1
704897|NCT00984477|Healthy volunteer phase 1 study|healthy volunteer phase 1 study
704898|NCT00984490|stage I breast cancer|stage i breast cancer
704899|NCT00984490|stage II breast cancer|stage ii breast cancer
704900|NCT00984503|Cicatrix|cicatrix
704901|NCT00984503|Scar|scar
704902|NCT00984503|Wound healing|wound healing
704903|NCT00984503|Avotermin|avotermin
704904|NCT00984503|TGF beta 3|tgf beta 3
704905|NCT00984503|Juvista|juvista
704909|NCT00984516|Wound-healing|wound-healing
704910|NCT00984516|Juvidex|juvidex
704911|NCT00984516|Mannose-6-phosphate|mannose-6-phosphate
704913|NCT00984516|RN1004|rn1004
704914|NCT00984529|Chronic heart failure|chronic heart failure
704915|NCT00984529|candesartan cilexetil|candesartan cilexetil
704916|NCT00984529|clinical signs|clinical signs
704917|NCT00984529|symptoms|symptoms
704918|NCT00984542|recurrent small cell lung cancer|recurrent small cell lung cancer
704919|NCT00984555|Biomarkers|biomarkers
704920|NCT00984555|Semen Exposure|semen exposure
704921|NCT00984581|Cicatrix|cicatrix
704922|NCT00984581|Scar|scar
704923|NCT00984581|Wound healing|wound healing
704924|NCT00984581|Avotermin|avotermin
704925|NCT00984581|TGF beta 3|tgf beta 3
704926|NCT00984581|Juvista|juvista
704927|NCT00984581|RN1001|rn1001
704928|NCT00984594|allograft|allograft
704929|NCT00984594|knee injury|knee injury
704930|NCT00984594|cartilage injury|cartilage injury
704931|NCT00984607|Laparoscopic Gastric Band|laparoscopic gastric band
704932|NCT00984607|LAP BAND system|lap band system
704933|NCT00984633|Neuromuscular Blocking Agents|neuromuscular blocking agents
704934|NCT00984646|Cicatrix|cicatrix
704935|NCT00984646|Scar|scar
704936|NCT00984646|Wound-healing|wound-healing
704937|NCT00984646|Prevascar|prevascar
704938|NCT00984646|Interleukin-10 (IL-10)|interleukin-10 (il-10)
704939|NCT00984646|Ilodecakin|ilodecakin
704940|NCT00984646|RN1003|rn1003
704941|NCT00984659|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
704942|NCT00984659|Dyspnea|dyspnea
704943|NCT00984672|Lumbar Degenerative Disease|lumbar degenerative disease
704944|NCT00984672|Bone Morphogenetic Protein|bone morphogenetic protein
704945|NCT00984672|TLIF|tlif
704946|NCT00984698|Posttraumatic Stress Disorder|posttraumatic stress disorder
704947|NCT00984698|Depression|depression
704948|NCT00984698|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
704949|NCT00984698|Insomnia|insomnia
704950|NCT00984698|Psychotherapy, Group|psychotherapy, group
704951|NCT00984698|Cognitive Behavioral Therapy|cognitive behavioral therapy
704952|NCT00984698|Randomized Controlled Trial|randomized controlled trial
704953|NCT00984698|Veterans|veterans
704954|NCT00984698|Social Rhythms|social rhythms
704955|NCT00984724|Smoking|smoking
704956|NCT00984724|Motivation and Problem Solving|motivation and problem solving
704957|NCT00984724|MAPS|maps
704958|NCT00984724|Low Income Smokers|low income smokers
704959|NCT00984724|HCHD community clinics|hchd community clinics
704960|NCT00984724|Telephone-based counseling|telephone-based counseling
704961|NCT00984763|Malaria|malaria
704962|NCT00984763|Vaccine|vaccine
704963|NCT00984776|coronary artery|coronary artery
704964|NCT00984776|MRI|mri
704965|NCT00984776|vessel wall imaging|vessel wall imaging
704966|NCT00984789|Transdermal Patch|transdermal patch
704967|NCT00984789|Bleeding|bleeding
704968|NCT00984789|Pregnancy|pregnancy
704969|NCT00984815|NSAID|nsaid
704970|NCT00984815|Chronic Pain|chronic pain
704971|NCT00984815|Osteoarthritis|osteoarthritis
704972|NCT00984815|Rheumatoid Arthritis|rheumatoid arthritis
704973|NCT00984828|multiple myeloma|multiple myeloma
704974|NCT00984828|autologous stem cell transplantation|autologous stem cell transplantation
704975|NCT00984828|velcade|velcade
704976|NCT00984841|Diabetes Mellitus targeted mailing|diabetes mellitus targeted mailing
704977|NCT00984854|Cicatrix|cicatrix
704978|NCT00984854|Scar|scar
704979|NCT00984854|Wound-healing|wound-healing
704980|NCT00984854|Re-epithelialisation|re-epithelialisation
704981|NCT00984854|RN1004|rn1004
704982|NCT00984854|Mannose-6-phosphate|mannose-6-phosphate
704983|NCT00984854|M6P|m6p
704984|NCT00984854|Juvidex|juvidex
704985|NCT00984867|Dapagliflozin DPP IV inhibitor add on study|dapagliflozin dpp iv inhibitor add on study
704986|NCT00984867|Inadequate control|inadequate control
704987|NCT00984880|Sedation|sedation
704988|NCT00984880|anaesthesia|anaesthesia
704989|NCT00984880|Safety|safety
704990|NCT00984880|Tolerability|tolerability
704991|NCT00984880|Pharmacokinetics|pharmacokinetics
704992|NCT00984880|Pharmacodynamics|pharmacodynamics
704993|NCT00984893|Osteoporosis|osteoporosis
704994|NCT00984893|Bone Mineral density|bone mineral density
704995|NCT00984893|fragility fractures|fragility fractures
704996|NCT00984893|zoledronic acid.|zoledronic acid.
704998|NCT00984919|recurrent prostate cancer|recurrent prostate cancer
704999|NCT00984919|stage I prostate cancer|stage i prostate cancer
705000|NCT00984919|stage II prostate cancer|stage ii prostate cancer
705001|NCT00984919|stage III prostate cancer|stage iii prostate cancer
705002|NCT00984919|stage IV prostate cancer|stage iv prostate cancer
705003|NCT00984932|systemic sclerosis|systemic sclerosis
705004|NCT00984932|pulmonary hypertension|pulmonary hypertension
705005|NCT00984932|rosuvastatin|rosuvastatin
705006|NCT00984945|pandemic vaccine|pandemic vaccine
705007|NCT00984945|influenza|influenza
705008|NCT00984945|H5N1|h5n1
705009|NCT00984945|Virus Like Particle (VLP)|virus like particle (vlp)
705010|NCT00984971|Microbicides|microbicides
705012|NCT00984971|HIV seronegativity|hiv seronegativity
705013|NCT00984997|Superior Sulcus Tumor|superior sulcus tumor
705014|NCT00984997|Lung Cancer|lung cancer
705015|NCT00984997|Non-Small Cell|non-small cell
705016|NCT00984997|Multimodality Treatment|multimodality treatment
705017|NCT00984997|Surgery|surgery
705018|NCT00984997|Segmentectomy|segmentectomy
705019|NCT00984997|Lobectomy|lobectomy
705020|NCT00984997|Cisplatin|cisplatin
705021|NCT00984997|CDDP|cddp
705022|NCT00984997|Etoposide|etoposide
705023|NCT00984997|VP-16|vp-16
705024|NCT00984997|VePesid|vepesid
705025|NCT00984997|Radiation Therapy|radiation therapy
705026|NCT00984997|Radiotherapy|radiotherapy
705027|NCT00984997|Chest Irradiation|chest irradiation
705028|NCT00984997|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
705029|NCT00984997|PCI|pci
705030|NCT00985010|hepatic encephalopathy|hepatic encephalopathy
705031|NCT00985010|hepatitis C|hepatitis c
705032|NCT00985010|manganese|manganese
705033|NCT00985010|mortality|mortality
705034|NCT00985010|prognosis.|prognosis.
705035|NCT00985023|Unstable|unstable
705036|NCT00985023|Lisfranc|lisfranc
705037|NCT00985023|fracture|fracture
705038|NCT00985023|dislocation|dislocation
705039|NCT00985023|midfoot|midfoot
705040|NCT00985036|glioma|glioma
705041|NCT00985036|meningioma|meningioma
705042|NCT00985036|VEGF|vegf
705043|NCT00985062|Folic Acid|folic acid
705044|NCT00985062|Homocysteine|homocysteine
705045|NCT00985062|Ovarian response|ovarian response
705046|NCT00985062|In Vitro Fertilization|in vitro fertilization
705047|NCT00985075|Allergic rhinitis|allergic rhinitis
705048|NCT00985075|Allergic conjunctivitis|allergic conjunctivitis
705049|NCT00985088|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
705050|NCT00985088|influenza infection|influenza infection
751866|NCT01170936|Urticarial vasculitis|urticarial vasculitis
705051|NCT00985088|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
705052|NCT00985114|Type II Diabetes|type ii diabetes
705053|NCT00985114|Obesity|obesity
705054|NCT00985127|Hyperuricemia|hyperuricemia
705055|NCT00985127|Gout|gout
705056|NCT00985179|Randomized Controlled Trial|randomized controlled trial
705057|NCT00985179|evidence- and theory-based behavioral intervention|evidence- and theory-based behavioral intervention
705058|NCT00985179|expert system|expert system
705060|NCT00985179|motivational interviewing|motivational interviewing
705061|NCT00985179|tailoring|tailoring
705062|NCT00985179|Self Care|self care
705063|NCT00985179|Expert Systems|expert systems
705064|NCT00985192|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
705065|NCT00985192|adenocarcinoma of the stomach|adenocarcinoma of the stomach
705066|NCT00985192|recurrent esophageal cancer|recurrent esophageal cancer
705067|NCT00985192|stage III esophageal cancer|stage iii esophageal cancer
705068|NCT00985192|stage IV esophageal cancer|stage iv esophageal cancer
705069|NCT00985192|recurrent gastric cancer|recurrent gastric cancer
705070|NCT00985192|stage III gastric cancer|stage iii gastric cancer
705071|NCT00985192|stage IV gastric cancer|stage iv gastric cancer
705072|NCT00985205|Randomized Clinical Trial|randomized clinical trial
705073|NCT00985205|Glutamine|glutamine
705074|NCT00985205|Themal Burn Injuries|themal burn injuries
705075|NCT00985205|Nutrition|nutrition
705076|NCT00985205|Outcome Assessment|outcome assessment
705077|NCT00985205|Critical Care|critical care
705078|NCT00985205|Total Body Surface Area|total body surface area
705079|NCT00985218|infertility|infertility
705080|NCT00985218|embryo development|embryo development
705081|NCT00985244|COPD|copd
705082|NCT00985244|COPD exacerbation|copd exacerbation
705083|NCT00985244|macrolide|macrolide
705084|NCT00985244|diseae progression|diseae progression
705085|NCT00985244|bacterial colonisation|bacterial colonisation
705086|NCT00985283|prevention|prevention
705087|NCT00985283|older adults|older adults
705088|NCT00985283|function|function
705089|NCT00985283|participation|participation
705090|NCT00985283|life satisfaction|life satisfaction
705091|NCT00985283|self-rated health|self-rated health
705092|NCT00985296|Allergic rhinitis|allergic rhinitis
705093|NCT00985296|Allergic conjunctivitis|allergic conjunctivitis
705094|NCT00985309|unsatisfactory|unsatisfactory
705095|NCT00985309|Pap smear|pap smear
705096|NCT00985322|Hemodialysis|hemodialysis
705097|NCT00977678|open access gastroscopy|open access gastroscopy
705405|NCT00978744|Clinical Health Record|clinical health record
705098|NCT00977691|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
705099|NCT00977691|Anemia, Sickle Cell|anemia, sickle cell
705100|NCT00977691|Graft-Versus-Host Disease|graft-versus-host disease
705101|NCT00977691|Sirolimus (Rapamune )|sirolimus (rapamune )
705102|NCT00977691|Alemtuzumab (Campath )|alemtuzumab (campath )
705103|NCT00977691|Thalassemia|thalassemia
705104|NCT00977691|Sickle Cell Disease|sickle cell disease
705105|NCT00977704|Correction of peri-oral wrinkles|correction of peri-oral wrinkles
705106|NCT00977717|oxaliplatin|oxaliplatin
705107|NCT00977717|neuropathy|neuropathy
705108|NCT00977717|SNPs|snps
705109|NCT00977730|Hepatitis|hepatitis
705110|NCT00977730|Fatty Liver|fatty liver
705111|NCT00977730|Non Alcoholic Steatohepatitis|non alcoholic steatohepatitis
705112|NCT00977730|Protandim|protandim
705115|NCT00977756|Integrase Inhibitors|integrase inhibitors
705116|NCT00977756|Entry Inhibitors|entry inhibitors
705117|NCT00977756|Treatment Experienced|treatment experienced
705118|NCT00977769|cesarean delivery|cesarean delivery
705119|NCT00977769|blood pressure|blood pressure
705120|NCT00977769|cardiac output|cardiac output
705121|NCT00977795|Brain Neoplasms|brain neoplasms
705122|NCT00977795|5-ALA|5-ala
705123|NCT00977795|Aminolevulinic acid|aminolevulinic acid
705124|NCT00977795|Fluorescence|fluorescence
705125|NCT00977795|Gliomas|gliomas
705126|NCT00977795|Glioblastoma|glioblastoma
705127|NCT00977795|Surgery|surgery
705128|NCT00977808|Artificial pancreas|artificial pancreas
705129|NCT00977808|Closed-Loop control|closed-loop control
705130|NCT00977834|Geriatric Assessment|geriatric assessment
705131|NCT00977847|Family History|family history
705132|NCT00977847|Electronic Health Record|electronic health record
705133|NCT00977860|Prostate|prostate
705134|NCT00977860|Stereotactic|stereotactic
705135|NCT00977860|Radiosurgery|radiosurgery
705136|NCT00977899|Plasmodium Falciparum|plasmodium falciparum
705137|NCT00977899|Alum Adsorbed|alum adsorbed
705138|NCT00977899|Ookinete Surface Protein|ookinete surface protein
705139|NCT00977899|Malaria Vaccine|malaria vaccine
705140|NCT00977899|Healthy Volunteer|healthy volunteer
705141|NCT00977899|HV|hv
705142|NCT00977912|B. lactis|b. lactis
705143|NCT00977912|Preterm|preterm
705144|NCT00977912|Necrotizing Enterocolitis (NEC)|necrotizing enterocolitis (nec)
705145|NCT00977925|Hemostasis|hemostasis
705146|NCT00977938|Acute Coronary Syndrome|acute coronary syndrome
705147|NCT00977938|Adverse event|adverse event
705148|NCT00977938|Antiplatelet therapy|antiplatelet therapy
705149|NCT00977938|Sirolimus|sirolimus
705150|NCT00977938|Everolimus|everolimus
705151|NCT00977938|Paclitaxel|paclitaxel
705152|NCT00977938|Zotarolimus|zotarolimus
705153|NCT00977938|Bare Metal Stent|bare metal stent
705154|NCT00977938|Drug Eluting Stent|drug eluting stent
705155|NCT00977938|Clinical Events Committee|clinical events committee
705156|NCT00977938|Dual antiplatelet therapy|dual antiplatelet therapy
705157|NCT00977938|Harvard Clinical Research Institute|harvard clinical research institute
705262|NCT00978302|Juvista|juvista
705263|NCT00978302|RN1001|rn1001
705158|NCT00977938|Major Adverse Cardiac and Cerebral Event|major adverse cardiac and cerebral event
705159|NCT00977938|Major Bleeding|major bleeding
705160|NCT00977938|Myocardial infarction|myocardial infarction
705161|NCT00977938|Myocardial ischemia|myocardial ischemia
705162|NCT00977938|Percutaneous coronary intervention|percutaneous coronary intervention
705163|NCT00977938|Stent placement|stent placement
705164|NCT00977938|Stent Thrombosis|stent thrombosis
705165|NCT00977938|Thienopyridine|thienopyridine
705166|NCT00977938|Clopidogrel|clopidogrel
705167|NCT00977938|Prasugrel|prasugrel
705168|NCT00977951|Cicatrix|cicatrix
705170|NCT00977951|Avotermin|avotermin
705171|NCT00977951|Juvista|juvista
705172|NCT00977951|RN1001|rn1001
705173|NCT00977951|TGF beta 3|tgf beta 3
705174|NCT00977964|Infant|infant
705175|NCT00977977|Nephrotic Syndrome|nephrotic syndrome
705176|NCT00977977|Renal Disease|renal disease
705177|NCT00977977|Autoimmune Diseases|autoimmune diseases
705178|NCT00977977|Clinical Trial|clinical trial
705179|NCT00977977|Proteinuria|proteinuria
705180|NCT00977990|Skin Swab|skin swab
705181|NCT00977990|Self-Sample|self-sample
705182|NCT00978003|Vasti Medialis|vasti medialis
705183|NCT00978003|Knee|knee
705184|NCT00978003|MR Imaging|mr imaging
705185|NCT00978003|Vasti Lateralis|vasti lateralis
705186|NCT00978003|HV|hv
705187|NCT00978003|Healthy Volunteer|healthy volunteer
705188|NCT00978016|GERD|gerd
705189|NCT00978029|immunotherapy|immunotherapy
705190|NCT00978068|Pediatric HIV|pediatric hiv
705191|NCT00978068|Malaria|malaria
705192|NCT00978068|Uganda|uganda
705193|NCT00978068|Nevirapine|nevirapine
705194|NCT00978068|Zidovudine|zidovudine
705195|NCT00978068|Lamivudine|lamivudine
705196|NCT00978068|Lopinavir/ritonavir|lopinavir/ritonavir
705197|NCT00978068|Stavudine|stavudine
705198|NCT00978068|Efavirenz|efavirenz
705199|NCT00978068|HIV|hiv
705200|NCT00978081|precancerous condition|precancerous condition
705201|NCT00978081|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
705202|NCT00978081|stage 0 laryngeal cancer|stage 0 laryngeal cancer
705203|NCT00978081|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
705204|NCT00978081|stage 0 nasopharyngeal cancer|stage 0 nasopharyngeal cancer
705205|NCT00978081|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
705206|NCT00978081|stage 0 paranasal sinus and nasal cavity cancer|stage 0 paranasal sinus and nasal cavity cancer
705207|NCT00978107|Hepatic tumors|hepatic tumors
705208|NCT00978107|Metastatic colorectal cancer|metastatic colorectal cancer
705209|NCT00978120|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
705210|NCT00978120|Vaccine|vaccine
705211|NCT00978133|Colectomy|colectomy
705212|NCT00978133|Closure|closure
705213|NCT00978133|Wound|wound
705214|NCT00978133|Dermabond|dermabond
705215|NCT00978133|Propen|propen
705216|NCT00978159|esomeprazole|esomeprazole
705217|NCT00978159|famotidine|famotidine
705220|NCT00978185|nausea and vomiting|nausea and vomiting
705221|NCT00978185|anxiety disorder|anxiety disorder
705222|NCT00978185|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
705223|NCT00978198|Pharmacokinetics|pharmacokinetics
705224|NCT00978198|Safety and tolerability|safety and tolerability
705225|NCT00978198|Plasma concentration|plasma concentration
705226|NCT00978198|ASP1517|asp1517
705227|NCT00978198|FG-4592|fg-4592
705228|NCT00978211|DOTATOC|dotatoc
705229|NCT00978211|somatostatin|somatostatin
705230|NCT00978211|radiopeptide|radiopeptide
705231|NCT00978211|Yttrium|yttrium
705232|NCT00978211|Lutetium|lutetium
705233|NCT00978211|neuroendocrine|neuroendocrine
705234|NCT00978211|cancer|cancer
705235|NCT00978224|dietary supplement|dietary supplement
705236|NCT00978224|hemodialysis|hemodialysis
705237|NCT00978224|Chronic Inflammatory Syndrome|chronic inflammatory syndrome
705238|NCT00978224|Viusid|viusid
705239|NCT00978237|HIV - Lipoatrophy|hiv - lipoatrophy
705240|NCT00978237|treatment experienced|treatment experienced
705241|NCT00978250|DNA Methylation|dna methylation
705242|NCT00978250|Advanced Cancer|advanced cancer
705243|NCT00978250|Methyltransferase Inhibitor|methyltransferase inhibitor
705244|NCT00978250|Epigenetics|epigenetics
705245|NCT00978250|Gene Re-Expression|gene re-expression
705246|NCT00978250|Breast Cancer|breast cancer
705247|NCT00978250|Head and Neck Cancer|head and neck cancer
705248|NCT00978250|Lung Cancer|lung cancer
705249|NCT00978250|Non-Small Cell Lung Cancer|non-small cell lung cancer
705250|NCT00978250|Bladder Cancer|bladder cancer
705251|NCT00978276|Receptors|receptors
705252|NCT00978276|Immunohistochemistry|immunohistochemistry
705253|NCT00978276|Breast|breast
705254|NCT00978276|Over expression of Hormone receptors in carcinoma of the breast sues|over expression of hormone receptors in carcinoma of the breast sues
705255|NCT00978289|obesity|obesity
705256|NCT00978289|gastric bypass surgery|gastric bypass surgery
705257|NCT00978302|Cicatrix|cicatrix
705258|NCT00978302|Scar|scar
705259|NCT00978302|Wound healing|wound healing
705260|NCT00978302|Avotermin|avotermin
705264|NCT00978328|Pain conditions|pain conditions
705265|NCT00978328|Oxycodone immediate release|oxycodone immediate release
705266|NCT00978328|Percocet®, Tylox®|percocet®, tylox®
705267|NCT00978328|Roxicodone®|roxicodone®
705268|NCT00978328|Registry|registry
705269|NCT00978328|Side effects|side effects
705270|NCT00978328|Observational|observational
705271|NCT00978328|Pain management|pain management
705272|NCT00978341|Clinical Trial Methodology study Neuropathic pain in Spinal cord injury patients Pain endpoints Crossover design|clinical trial methodology study neuropathic pain in spinal cord injury patients pain endpoints crossover design
705273|NCT00978354|acute kidney injury|acute kidney injury
705274|NCT00978354|acute renal failure|acute renal failure
705275|NCT00978354|loop diuretic|loop diuretic
705276|NCT00978354|critical illness|critical illness
705277|NCT00978354|sepsis|sepsis
705278|NCT00978354|renal replacement therapy|renal replacement therapy
705279|NCT00978354|dialysis|dialysis
705280|NCT00978354|renal recovery|renal recovery
705281|NCT00978354|survival|survival
705282|NCT00978367|Cicatrix|cicatrix
705283|NCT00978367|Scar|scar
705284|NCT00978367|Avotermin|avotermin
705285|NCT00978367|Juvista|juvista
705286|NCT00978367|RN1001|rn1001
705287|NCT00978367|TGF beta 3|tgf beta 3
705288|NCT00978406|Dietary Assessment Methods|dietary assessment methods
705289|NCT00978406|Measurement of Diet|measurement of diet
705290|NCT00978406|24-Hour Diet Recall|24-hour diet recall
705291|NCT00978406|Validation|validation
705292|NCT00978406|Feeding Study|feeding study
705293|NCT00978419|Statins|statins
705294|NCT00978419|Burns|burns
705295|NCT00978419|Sedatives|sedatives
705296|NCT00978419|Neurocognitive|neurocognitive
705297|NCT00978419|Septic|septic
705298|NCT00978419|Mortality|mortality
705299|NCT00978419|C Reactive Protein|c reactive protein
705300|NCT00978419|Septic shock|septic shock
705301|NCT00978419|Sedation|sedation
705302|NCT00978419|Neurocognitive function|neurocognitive function
705304|NCT00978432|DLBCL|dlbcl
705305|NCT00978432|recurrent|recurrent
705306|NCT00978432|refractory|refractory
705307|NCT00978432|de novo|de novo
705308|NCT00978445|Systemic embolic events|systemic embolic events
705509|NCT00979134|FGFR|fgfr
705309|NCT00978445|Thromboembolic Complications with Atrial Fibrillation|thromboembolic complications with atrial fibrillation
705310|NCT00978445|Prophylaxis with Atrial Fibrillation|prophylaxis with atrial fibrillation
705311|NCT00978445|Mechanical Cardiac Valve Replacement|mechanical cardiac valve replacement
705312|NCT00978458|neurotoxicity|neurotoxicity
705313|NCT00978458|adult diffuse astrocytoma|adult diffuse astrocytoma
705314|NCT00978458|adult oligodendroglioma|adult oligodendroglioma
705315|NCT00978458|recurrent adult brain tumor|recurrent adult brain tumor
705316|NCT00978458|adult mixed glioma|adult mixed glioma
705317|NCT00978471|Conventional chemotherapy|conventional chemotherapy
705318|NCT00978471|cytapheresis|cytapheresis
705319|NCT00978471|Peripheral stem cell autograft|peripheral stem cell autograft
705320|NCT00978471|Surgical resection|surgical resection
705321|NCT00978471|Thiotepa|thiotepa
705325|NCT00978484|Virtual Reality|virtual reality
705326|NCT00978484|Computer Therapy|computer therapy
705327|NCT00978484|Exposure Therapy|exposure therapy
705328|NCT00978484|Prolonged Exposure|prolonged exposure
705329|NCT00978484|Military Medicine|military medicine
705330|NCT00978484|Combat|combat
705331|NCT00978484|Iraq|iraq
705332|NCT00978484|Afghanistan|afghanistan
705333|NCT00978484|Air Force Personnel|air force personnel
705334|NCT00978484|Armed Forces Personnel|armed forces personnel
705335|NCT00978484|Army Personnel|army personnel
705336|NCT00978484|Coast Guard|coast guard
705337|NCT00978484|psychology|psychology
705338|NCT00978484|military psychiatry|military psychiatry
705339|NCT00978484|combat disorders|combat disorders
705340|NCT00978484|combat neurosis|combat neurosis
705341|NCT00978484|Marines|marines
705342|NCT00978484|Military|military
705343|NCT00978484|Navy Personnel|navy personnel
705344|NCT00978484|Sailors|sailors
705345|NCT00978484|Soldiers|soldiers
705346|NCT00978510|Tuberculosis|tuberculosis
705347|NCT00978510|Disease transmission|disease transmission
705348|NCT00978510|Exposure to biological agents|exposure to biological agents
705349|NCT00978510|Health personnel|health personnel
705350|NCT00978536|Multiple sclerosis|multiple sclerosis
705351|NCT00978536|cognitive deterioration|cognitive deterioration
705352|NCT00978536|biomarkers|biomarkers
705353|NCT00978536|cerebrospinal fluid|cerebrospinal fluid
705354|NCT00978536|Alzheimer disease|alzheimer disease
705355|NCT00978549|pain|pain
705356|NCT00978549|nausea and vomiting|nausea and vomiting
705357|NCT00978549|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
705358|NCT00978549|adenocarcinoma of the stomach|adenocarcinoma of the stomach
705359|NCT00978549|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
705360|NCT00978549|recurrent gastric cancer|recurrent gastric cancer
707778|NCT00998790|TUR|tur
705361|NCT00978549|stage IIIA gastric cancer|stage iiia gastric cancer
705362|NCT00978549|stage IIIB gastric cancer|stage iiib gastric cancer
705363|NCT00978549|stage IIIC gastric cancer|stage iiic gastric cancer
705364|NCT00978549|stage IV gastric cancer|stage iv gastric cancer
705365|NCT00978549|recurrent esophageal cancer|recurrent esophageal cancer
705366|NCT00978549|stage IIIA esophageal cancer|stage iiia esophageal cancer
705367|NCT00978549|stage IIIB esophageal cancer|stage iiib esophageal cancer
705368|NCT00978549|stage IIIC esophageal cancer|stage iiic esophageal cancer
705369|NCT00978549|stage IV esophageal cancer|stage iv esophageal cancer
705370|NCT00978575|Iron treatment|iron treatment
705371|NCT00978575|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
705372|NCT00978601|post-operative analgesia|post-operative analgesia
705373|NCT00978601|early discharge,|early discharge,
705374|NCT00978601|fast recovery,|fast recovery,
705375|NCT00978601|minimally invasive myomectomy,|minimally invasive myomectomy,
705376|NCT00978601|laparoscopy,|laparoscopy,
705377|NCT00978601|laparoscopically assisted myomectomy|laparoscopically assisted myomectomy
705378|NCT00978601|patient discharge|patient discharge
705379|NCT00978601|Anesthesia Recovery Period|anesthesia recovery period
705380|NCT00978640|Sirt1 activity|sirt1 activity
705381|NCT00978653|allopurinol|allopurinol
705382|NCT00978653|chronic kidney disease|chronic kidney disease
705383|NCT00978653|endothelial dysfunction|endothelial dysfunction
705384|NCT00978653|hyperuricemia|hyperuricemia
705385|NCT00978653|uric acid|uric acid
705386|NCT00978653|vascular endothelium|vascular endothelium
705387|NCT00978653|xanthine oxidase inhibitor|xanthine oxidase inhibitor
705388|NCT00978679|Children|children
705389|NCT00978679|Peripheral refraction|peripheral refraction
705390|NCT00978679|Aberration|aberration
705391|NCT00978679|Eyeball length|eyeball length
705392|NCT00978679|Myopic control|myopic control
705393|NCT00978679|Myopia|myopia
705394|NCT00978679|Corneal reshaping|corneal reshaping
705395|NCT00978679|Orthokeratology|orthokeratology
705396|NCT00978692|Myopia|myopia
705397|NCT00978692|Astigmatism|astigmatism
705398|NCT00978692|Orthokeratology|orthokeratology
705399|NCT00978692|Corneal thickness|corneal thickness
705400|NCT00978692|Corneal curvatures|corneal curvatures
705401|NCT00978692|Corneal biomechanics|corneal biomechanics
705402|NCT00978705|Keratinocyte Cell|keratinocyte cell
705403|NCT00978705|severe burn wound|severe burn wound
705404|NCT00978718|prostate cancer|prostate cancer
705406|NCT00978744|Computerized Decision Support|computerized decision support
705407|NCT00978744|Patient Safety|patient safety
705408|NCT00978744|Resource Utilization|resource utilization
705409|NCT00978757|hepatectomy|hepatectomy
705410|NCT00978757|IL 6|il 6
705411|NCT00978757|organ failure|organ failure
705412|NCT00978757|ketamine|ketamine
705413|NCT00978757|Pringle|pringle
705414|NCT00978770|stage II breast cancer|stage ii breast cancer
705789|NCT00986583|myalgias|myalgias
705415|NCT00978770|stage IIIA breast cancer|stage iiia breast cancer
705416|NCT00978770|stage IIIB breast cancer|stage iiib breast cancer
705417|NCT00978770|stage IIIC breast cancer|stage iiic breast cancer
705418|NCT00978783|Phonation|phonation
705419|NCT00978783|Tracheostomy|tracheostomy
705420|NCT00978783|phonation valve|phonation valve
705421|NCT00978783|positive end expiratory pressure|positive end expiratory pressure
705422|NCT00978796|Diabetes Mellitus|diabetes mellitus
705423|NCT00978796|Type 1 diabetes|type 1 diabetes
705424|NCT00978796|glucose variability|glucose variability
705425|NCT00978809|BPPV|bppv
705426|NCT00978809|postural stability|postural stability
705427|NCT00978809|Epley|epley
705428|NCT00978809|Semont|semont
705429|NCT00978822|Subarachnoid hemorrhage|subarachnoid hemorrhage
705430|NCT00978822|Hypertension|hypertension
705431|NCT00978822|brain Aneurysm|brain aneurysm
705432|NCT00978822|intracerebral hemorrhage|intracerebral hemorrhage
705433|NCT00978822|antihypertensive|antihypertensive
705434|NCT00978822|calcium channel blockers|calcium channel blockers
705435|NCT00978822|infusion|infusion
705436|NCT00978822|neurocritical care|neurocritical care
705437|NCT00978835|Diabetes|diabetes
705438|NCT00978835|Hypertension|hypertension
705439|NCT00978835|Physical Activity|physical activity
705440|NCT00978835|Diet|diet
705441|NCT00978835|Medication Adherence|medication adherence
705442|NCT00978848|trichomonas|trichomonas
705443|NCT00978848|chlamydia|chlamydia
705444|NCT00978848|gonorrhea|gonorrhea
705445|NCT00978848|emergency contraception|emergency contraception
705446|NCT00978848|emergency contraception use|emergency contraception use
705447|NCT00978874|recurrent cervical cancer|recurrent cervical cancer
705448|NCT00978874|stage IB cervical cancer|stage ib cervical cancer
705449|NCT00978874|stage IIA cervical cancer|stage iia cervical cancer
705450|NCT00978874|stage IIB cervical cancer|stage iib cervical cancer
705451|NCT00978874|stage III cervical cancer|stage iii cervical cancer
705452|NCT00978874|stage IVA cervical cancer|stage iva cervical cancer
705453|NCT00978874|stage IVB cervical cancer|stage ivb cervical cancer
705454|NCT00978887|Facial cream|facial cream
705455|NCT00978887|natural product|natural product
705456|NCT00978887|facial wrinkles|facial wrinkles
705457|NCT00978900|satiety peptides|satiety peptides
705458|NCT00978900|GLP-1|glp-1
705460|NCT00978900|ghrelin|ghrelin
705461|NCT00978900|appetite profile|appetite profile
705462|NCT00978900|Sweetening Agents|sweetening agents
705463|NCT00978913|dendritic cell|dendritic cell
705464|NCT00978913|cancervaccine|cancervaccine
705465|NCT00978913|breast cancer|breast cancer
705466|NCT00978913|malignant melanoma|malignant melanoma
705467|NCT00978913|Cyclophosphamide|cyclophosphamide
705468|NCT00978926|Anti-Vascular Endothelial growth factor|anti-vascular endothelial growth factor
705469|NCT00978965|kidney transplantation|kidney transplantation
705470|NCT00978965|immunosuppression|immunosuppression
705471|NCT00978965|single nucleotide polymorphism|single nucleotide polymorphism
705472|NCT00978965|IMPDH|impdh
705473|NCT00978991|Benign prostate hyperplasia|benign prostate hyperplasia
705474|NCT00978991|Erectile dysfunction|erectile dysfunction
705475|NCT00979004|Photosensitivity|photosensitivity
705476|NCT00979004|Epilepsy|epilepsy
705477|NCT00979004|Seizures|seizures
705478|NCT00979017|malignant glioma|malignant glioma
705479|NCT00979017|glioblastoma multiforme|glioblastoma multiforme
705480|NCT00979017|gliosarcoma|gliosarcoma
705481|NCT00979017|Avastin|avastin
705482|NCT00979017|bevacizumab|bevacizumab
705483|NCT00979017|Temodar|temodar
705484|NCT00979017|temozolomide|temozolomide
705485|NCT00979017|Irinotecan|irinotecan
705486|NCT00979017|CPT-11|cpt-11
705487|NCT00979017|Pro00019065|pro00019065
705488|NCT00979017|Vredenburgh|vredenburgh
705489|NCT00979017|Duke|duke
705490|NCT00979043|knee osteoarthritis|knee osteoarthritis
705491|NCT00979043|weight-loss|weight-loss
705492|NCT00979043|exercise|exercise
705493|NCT00979043|obesity|obesity
705494|NCT00979043|physical function|physical function
705495|NCT00979043|total mortality|total mortality
705496|NCT00979056|Traveller's diarrhoea|traveller's diarrhoea
705497|NCT00979056|Prevention|prevention
705498|NCT00979095|multiple hernia|multiple hernia
705499|NCT00979108|Radiculopathy|radiculopathy
705500|NCT00979108|Neck pain|neck pain
705501|NCT00979108|Physical therapy modalities|physical therapy modalities
705502|NCT00979108|Rehabilitation|rehabilitation
705503|NCT00979121|ALI|ali
705504|NCT00979121|Sepsis|sepsis
705505|NCT00979121|statin|statin
705506|NCT00979134|Cancer|cancer
705507|NCT00979134|Tumour|tumour
705508|NCT00979134|Advanced Solid Malignancies|advanced solid malignancies
705510|NCT00979134|Squamous NSCLC|squamous nsclc
705511|NCT00979134|Gastric adenocarcinoma|gastric adenocarcinoma
705512|NCT00979147|knee arthritis|knee arthritis
705513|NCT00979147|total knee arthroplasty|total knee arthroplasty
705514|NCT00979147|total knee replacement|total knee replacement
705515|NCT00979147|metal backed tibial component|metal backed tibial component
705516|NCT00979147|all-polyethylene tibia|all-polyethylene tibia
705517|NCT00979147|modular polished tibial baseplate|modular polished tibial baseplate
705518|NCT00979173|malignant glioma|malignant glioma
705519|NCT00979173|glioblastoma multiforme|glioblastoma multiforme
705520|NCT00979173|gliosarcoma|gliosarcoma
705521|NCT00979173|anaplastic astrocytoma|anaplastic astrocytoma
705522|NCT00979173|anaplastic oligodendroglioma|anaplastic oligodendroglioma
705523|NCT00979173|anaplastic mixed glioma|anaplastic mixed glioma
705524|NCT00979173|Pro00018751|pro00018751
705526|NCT00979173|Ambit|ambit
705527|NCT00979173|AC480|ac480
705528|NCT00979186|transgastric cholecystectomy|transgastric cholecystectomy
705529|NCT00979199|IHD|ihd
705530|NCT00979199|CAD|cad
705531|NCT00979199|Non invasive imaging|non invasive imaging
705532|NCT00979199|SPECT|spect
705533|NCT00979199|PET|pet
705534|NCT00979199|CMR|cmr
705535|NCT00979199|Echocardiography|echocardiography
705536|NCT00979212|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
705537|NCT00979212|adenocarcinoma of the lung|adenocarcinoma of the lung
705538|NCT00979212|adenosquamous cell lung cancer|adenosquamous cell lung cancer
705539|NCT00979212|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
705540|NCT00979212|large cell lung cancer|large cell lung cancer
705541|NCT00979212|squamous cell lung cancer|squamous cell lung cancer
705542|NCT00979225|health information technology|health information technology
705543|NCT00979225|clinical decision support|clinical decision support
705544|NCT00979225|medication management|medication management
705545|NCT00979225|medication adherence|medication adherence
705546|NCT00979238|Hemophilia B|hemophilia b
705547|NCT00979238|Factor IX Gene|factor ix gene
705548|NCT00979238|Factor IX Protein|factor ix protein
705549|NCT00979238|Vector|vector
705550|NCT00979251|Influenza|influenza
705551|NCT00979251|Immunocompromised|immunocompromised
705552|NCT00979251|HIV|hiv
705553|NCT00979251|History of transplant|history of transplant
705554|NCT00985348|Levetiracetam|levetiracetam
705555|NCT00985348|Healthy volunteers|healthy volunteers
705556|NCT00985348|Healthy Subjects|healthy subjects
705557|NCT00985387|Solifenacin|solifenacin
705558|NCT00985387|Overactive bladder|overactive bladder
705559|NCT00985387|persistency of the treatment|persistency of the treatment
705560|NCT00985387|Vesicare|vesicare
705561|NCT00985400|recurrent colon cancer|recurrent colon cancer
705562|NCT00985400|stage IV colon cancer|stage iv colon cancer
705563|NCT00985400|Gastrointestinal|gastrointestinal
705564|NCT00985400|Exercise|exercise
705565|NCT00985400|Relaxation|relaxation
705566|NCT00985400|Meditation|meditation
705567|NCT00985413|Cockayne Syndrome|cockayne syndrome
705568|NCT00985413|pediatrics|pediatrics
705569|NCT00985413|growth|growth
705570|NCT00985413|hearing|hearing
705571|NCT00985413|Ageing|ageing
705572|NCT00985426|chronic kidney disease|chronic kidney disease
705573|NCT00985426|kidney failure|kidney failure
705574|NCT00985426|kidney failure,chronic|kidney failure,chronic
705575|NCT00985426|chronic kidney failure|chronic kidney failure
705576|NCT00985426|hepatitis B virus (HBV) vaccine|hepatitis b virus (hbv) vaccine
705577|NCT00985426|hepatitis B vaccine|hepatitis b vaccine
705578|NCT00985426|hepatitis B|hepatitis b
705579|NCT00985426|hepatitis|hepatitis
705580|NCT00985426|HBV|hbv
705581|NCT00985426|prevention and control|prevention and control
705582|NCT00985426|dialysis|dialysis
705583|NCT00985452|Medication|medication
705584|NCT00985452|Adherence|adherence
705585|NCT00985452|Hypertension|hypertension
705586|NCT00985465|Booster vaccination|booster vaccination
705587|NCT00985465|Pneumococcal vaccine|pneumococcal vaccine
705588|NCT00985465|Catch-up vaccination|catch-up vaccination
705589|NCT00985465|Pneumococcal disease|pneumococcal disease
705590|NCT00985465|Safety|safety
705591|NCT00985465|Immunogenicity|immunogenicity
705592|NCT00985478|First in Man|first in man
705593|NCT00985478|SLV342|slv342
705594|NCT00985478|Atherosclerosis|atherosclerosis
705595|NCT00985491|obesity|obesity
705596|NCT00985504|Major Depressive Disorder|major depressive disorder
705597|NCT00985504|Apathy|apathy
705598|NCT00985504|Duloxetine Hydrochloride|duloxetine hydrochloride
705599|NCT00985504|SSRI|ssri
705600|NCT00985504|Escitalopram|escitalopram
705601|NCT00985517|Parkinson's disease|parkinson's disease
705602|NCT00985517|Movement Disorders|movement disorders
705603|NCT00985517|Gene Therapy|gene therapy
705604|NCT00985517|Neurotrophic Factors|neurotrophic factors
705605|NCT00985517|GDNF|gdnf
705606|NCT00985517|Neurturin|neurturin
705607|NCT00985517|DBS|dbs
705608|NCT00985517|Dopamine|dopamine
705609|NCT00985543|HIV|hiv
705610|NCT00985543|ART|art
705611|NCT00985543|HAART|haart
705612|NCT00985543|Pharmacokinetics|pharmacokinetics
705613|NCT00985543|Lopinavir/ritonavir|lopinavir/ritonavir
705614|NCT00985543|Lower dose selection|lower dose selection
705615|NCT00985556|recurrent gastric cancer|recurrent gastric cancer
705616|NCT00985556|adenocarcinoma of the stomach|adenocarcinoma of the stomach
705617|NCT00985556|stage IIIA gastric cancer|stage iiia gastric cancer
705618|NCT00985556|stage IIIB gastric cancer|stage iiib gastric cancer
705619|NCT00985556|stage IIIC gastric cancer|stage iiic gastric cancer
705620|NCT00985556|stage IV gastric cancer|stage iv gastric cancer
705621|NCT00985569|Constipation|constipation
705622|NCT00985569|Nursing Home|nursing home
705623|NCT00985569|Quality Indicator|quality indicator
705624|NCT00985582|Influenza A Virus (H1N1)|influenza a virus (h1n1)
705626|NCT00985595|substance abuse|substance abuse
705627|NCT00985608|H pylori|h pylori
705628|NCT00985608|eradication therapy|eradication therapy
705629|NCT00985621|monoclonal antibody|monoclonal antibody
705630|NCT00985621|RN624|rn624
705631|NCT00985621|PF-04383119|pf-04383119
705632|NCT00985621|nerve growth factor|nerve growth factor
705634|NCT00985621|pain|pain
705635|NCT00985621|arthritis|arthritis
705636|NCT00985634|off pump bypass OPCAB|off pump bypass opcab
705637|NCT00985634|OPCAB|opcab
705638|NCT00985647|HIV|hiv
705639|NCT00985647|HAART|haart
705640|NCT00985647|ART|art
705641|NCT00985647|Pharmacokinetic|pharmacokinetic
705642|NCT00985647|Healthy volunteers|healthy volunteers
705643|NCT00985647|3TC|3tc
705644|NCT00985647|Lamivudine|lamivudine
705645|NCT00985673|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
705646|NCT00985673|influenza infection|influenza infection
705647|NCT00985673|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
705648|NCT00986102|Carbapenem|carbapenem
705649|NCT00986102|Doripenem|doripenem
705650|NCT00986102|Doribax|doribax
753602|NCT01176825|psychosocial functioning|psychosocial functioning
705651|NCT00986102|Nosocomial pneumonia, Intra-abdominal infections|nosocomial pneumonia, intra-abdominal infections
705652|NCT00986102|Urinary tract infection|urinary tract infection
705653|NCT00986115|epilepsy|epilepsy
705654|NCT00986115|memory|memory
705655|NCT00986115|cognition|cognition
705656|NCT00986115|memantine|memantine
705657|NCT00986128|Topiramate|topiramate
705658|NCT00986128|Lithium|lithium
705659|NCT00986128|Bipolar disorder|bipolar disorder
705660|NCT00986154|Recurrent Thrombosis|recurrent thrombosis
705661|NCT00986154|Recurrent Pulmonary Embolism|recurrent pulmonary embolism
705662|NCT00986154|Symptomatic Deep Vein Thrombosis|symptomatic deep vein thrombosis
705663|NCT00986154|Symptomatic Pulmonary Embolism|symptomatic pulmonary embolism
705664|NCT00986154|Venous Thromboembolism (VTE)|venous thromboembolism (vte)
705665|NCT00986167|Psychosis|psychosis
705666|NCT00986167|Aggression|aggression
705667|NCT00986167|Acute|acute
705668|NCT00986167|Quetiapine XR|quetiapine xr
705669|NCT00986180|Acute Low Back Pain|acute low back pain
705670|NCT00986180|Low Back Pain With Leg Pain Below The Knee|low back pain with leg pain below the knee
705671|NCT00986180|Radiculopathy, Oxycodone|radiculopathy, oxycodone
705672|NCT00986180|Tapentadol|tapentadol
705673|NCT00986180|NUCYNTA|nucynta
705674|NCT00986193|Aortic Valve Stenosis|aortic valve stenosis
705675|NCT00986193|Stent Valve|stent valve
705676|NCT00986193|Biological Aortic Valve Prosthesis|biological aortic valve prosthesis
705677|NCT00986206|ovarian epithelial cancer|ovarian epithelial cancer
705678|NCT00986206|BRCA1 mutation carrier|brca1 mutation carrier
705679|NCT00986206|BRCA2 mutation carrier|brca2 mutation carrier
705680|NCT00986206|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
705681|NCT00986206|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
705682|NCT00986206|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
705683|NCT00986206|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
705684|NCT00986206|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
705685|NCT00986206|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
705686|NCT00986206|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
705687|NCT00986206|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
705688|NCT00986206|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
705689|NCT00986206|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
705690|NCT00986219|Asthma|asthma
705691|NCT00986219|Language|language
705692|NCT00986219|Symptoms,|symptoms,
705693|NCT00986219|Limitation of Daily activities|limitation of daily activities
705694|NCT00986219|Patients|patients
705695|NCT00986219|Physicians|physicians
705696|NCT00986219|Greece|greece
705697|NCT00986245|Parkinson disease|parkinson disease
705698|NCT00986245|Ropinirole|ropinirole
705699|NCT00986258|pain assessment|pain assessment
705700|NCT00986258|tapentadol|tapentadol
705701|NCT00986258|centrally acting analgesic|centrally acting analgesic
705702|NCT00986271|severe sepsis, intensive care units|severe sepsis, intensive care units
705703|NCT00986284|Non Small Cell Lung Cancer|non small cell lung cancer
705704|NCT00986284|Gefitinib|gefitinib
705705|NCT00986284|Neoadjuvant Therapy|neoadjuvant therapy
705706|NCT00986297|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
705904|NCT00987155|paraplegia|paraplegia
705707|NCT00986297|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
705708|NCT00986297|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
705709|NCT00986297|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
705710|NCT00986297|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
705711|NCT00986297|adenocarcinoma of the lung|adenocarcinoma of the lung
705712|NCT00986297|adenosquamous cell lung cancer|adenosquamous cell lung cancer
705713|NCT00986297|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
705714|NCT00986297|large cell lung cancer|large cell lung cancer
705715|NCT00986297|squamous cell lung cancer|squamous cell lung cancer
705716|NCT00986310|fluoxetine|fluoxetine
705717|NCT00986310|epilepsy|epilepsy
705718|NCT00986310|Prozac|prozac
705720|NCT00986323|Temperature controlled Laminar Airflow|temperature controlled laminar airflow
705722|NCT00986323|Perennial allergy|perennial allergy
705723|NCT00986323|Quality of life|quality of life
705724|NCT00986323|Environmental control|environmental control
705725|NCT00986336|topiramate|topiramate
705726|NCT00986336|risperidone, bipolar disorder|risperidone, bipolar disorder
705727|NCT00986349|Diabetes|diabetes
705728|NCT00986349|Weight Loss|weight loss
705729|NCT00986349|GI Dynamics|gi dynamics
705730|NCT00986349|EndoBarrier|endobarrier
705731|NCT00986362|Safety in pediatrics|safety in pediatrics
705732|NCT00986375|Randomized Controlled Trial|randomized controlled trial
705733|NCT00986375|evidence- and theory-based behavioral intervention|evidence- and theory-based behavioral intervention
705734|NCT00986375|expert system|expert system
705735|NCT00986375|stages of change|stages of change
705736|NCT00986375|motivational interviewing|motivational interviewing
705737|NCT00986375|tailoring|tailoring
705738|NCT00986375|Self Care|self care
705739|NCT00986375|Rehabilitation|rehabilitation
705740|NCT00986375|Expert Systems|expert systems
705741|NCT00986375|Behavior|behavior
705742|NCT00986375|Motivation|motivation
705744|NCT00986414|Parkinson Disease|parkinson disease
705745|NCT00986414|L-dopa|l-dopa
705746|NCT00986414|Levodopa|levodopa
705747|NCT00986414|dyskinesia|dyskinesia
705748|NCT00986453|Breast Reduction|breast reduction
705749|NCT00986453|PlasmaBlade|plasmablade
705750|NCT00986453|Electrosurgery|electrosurgery
705751|NCT00986453|PEAK Surgical|peak surgical
705752|NCT00986453|Medtronic Advanced Energy|medtronic advanced energy
705753|NCT00986453|Medtronic|medtronic
705754|NCT00986466|exercise|exercise
705755|NCT00986466|falls|falls
705756|NCT00986466|physical functioning|physical functioning
705757|NCT00986466|vitamin D|vitamin d
705758|NCT00986466|mobility function|mobility function
705759|NCT00986466|neuromuscular functioning¨|neuromuscular functioning¨
705760|NCT00986466|quality of life|quality of life
705761|NCT00986466|number of fallers|number of fallers
705762|NCT00986466|fall-related injuries including bone fractures|fall-related injuries including bone fractures
705763|NCT00986466|bone mass|bone mass
705764|NCT00986479|Patients|patients
705765|NCT00986492|Sleep deprivation|sleep deprivation
705766|NCT00986492|Food intake|food intake
705767|NCT00986492|Motor activity|motor activity
705768|NCT00986492|Normal, healthy subjects|normal, healthy subjects
705769|NCT00986505|lidocaine|lidocaine
705770|NCT00986505|fibromyalgia|fibromyalgia
705771|NCT00986505|intravenous lidocaine|intravenous lidocaine
705772|NCT00986505|manifestations|manifestations
705773|NCT00986518|Advanced Colorectal Cancer|advanced colorectal cancer
705774|NCT00986518|Hepatic and/or lung metastasis|hepatic and/or lung metastasis
705775|NCT00986518|Adaptive autologous cell immunotherapy|adaptive autologous cell immunotherapy
705776|NCT00986518|T- regulatory lymphocyte depletion|t- regulatory lymphocyte depletion
705777|NCT00986518|Neo-adjuvant reduced intensity chemotherapeutic conditioning|neo-adjuvant reduced intensity chemotherapeutic conditioning
705778|NCT00986531|schizophrenia|schizophrenia
705779|NCT00986531|early phase trials|early phase trials
705780|NCT00986544|Laparoscopy|laparoscopy
705781|NCT00986544|cholecystectomy|cholecystectomy
705782|NCT00986544|drainage|drainage
705783|NCT00986557|cytomegalovirus infection|cytomegalovirus infection
705784|NCT00986557|graft versus host disease|graft versus host disease
705785|NCT00986570|Botulinum Toxin A|botulinum toxin a
705786|NCT00986570|Wrinkles|wrinkles
705787|NCT00986583|Succinylcholine|succinylcholine
705788|NCT00986583|Statins|statins
705790|NCT00986583|statins with succinylcholine and pain|statins with succinylcholine and pain
705791|NCT00986596|vitamin D|vitamin d
705792|NCT00986596|skeletal muscle|skeletal muscle
705793|NCT00986596|vitamin D receptor|vitamin d receptor
705794|NCT00986635|Activated partial thromboplastin time|activated partial thromboplastin time
705795|NCT00986635|Thrombin clotting Time|thrombin clotting time
705796|NCT00986635|Anti-Xa-activity|anti-xa-activity
705797|NCT00986635|Factor X-activity|factor x-activity
705798|NCT00986635|Factor XIII-activity|factor xiii-activity
705799|NCT00986635|Antithrombin (based on factor II)|antithrombin (based on factor ii)
705800|NCT00986635|Antithrombin (based on factor X<9|antithrombin (based on factor x<9
705801|NCT00986648|acute liver failure|acute liver failure
705802|NCT00986648|hepatic encephalopathy|hepatic encephalopathy
705803|NCT00986648|acetaminophen toxicity|acetaminophen toxicity
705804|NCT00986674|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
705805|NCT00986674|Carboplatin|carboplatin
705806|NCT00986674|Paclitaxel|paclitaxel
705807|NCT00986674|Cetuximab|cetuximab
705808|NCT00986674|IMC-A12|imc-a12
705809|NCT00986687|Oocyte cryopreservation|oocyte cryopreservation
705810|NCT00986687|vitrification|vitrification
705811|NCT00986739|Chronic pathologies|chronic pathologies
705812|NCT00986739|elderly|elderly
705813|NCT00986739|atmospheric pollution|atmospheric pollution
705814|NCT00986739|unplanned hospitalization|unplanned hospitalization
705815|NCT00986739|case-crossover|case-crossover
705816|NCT00986752|stent|stent
705817|NCT00986752|atherectomy|atherectomy
705818|NCT00986752|paclitaxel-eluting balloon|paclitaxel-eluting balloon
705819|NCT00986765|Fetal growth restriction|fetal growth restriction
705820|NCT00986765|Abruptio placentae|abruptio placentae
705821|NCT00986765|Perinatal death|perinatal death
705822|NCT00986791|risk reduction|risk reduction
705823|NCT00986817|Refractory ascites|refractory ascites
705824|NCT00986817|Cirrhosis Terlipressin|cirrhosis terlipressin
705825|NCT00986817|Paracentesis|paracentesis
705826|NCT00986830|Rhinosinusitis|rhinosinusitis
705827|NCT00986830|Balloon catheters|balloon catheters
705828|NCT00986830|Office treatment|office treatment
705829|NCT00986830|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
705830|NCT00986830|Respiratory Tract Infections|respiratory tract infections
705831|NCT00986830|Respiratory Tract Diseases|respiratory tract diseases
705832|NCT00986830|FinESS Sinus Treatment|finess sinus treatment
705833|NCT00986830|endoscopic sinus surgery|endoscopic sinus surgery
705834|NCT00986843|HM30181A|hm30181a
705835|NCT00986843|Irinotecan|irinotecan
705836|NCT00986843|MTD|mtd
705837|NCT00986843|DLT|dlt
705838|NCT00986869|Safety|safety
705839|NCT00986869|Bronchoscopy|bronchoscopy
705840|NCT00986869|Pulmonary|pulmonary
705841|NCT00986869|Hypertension|hypertension
705842|NCT00986882|Postoperative pain|postoperative pain
705843|NCT00986895|HPN-100|hpn-100
705844|NCT00986895|GT4P|gt4p
705845|NCT00986895|Glyceryl tri-(4-phenylbutyrate)|glyceryl tri-(4-phenylbutyrate)
705846|NCT00986921|Length of time for procedure to be completed|length of time for procedure to be completed
705847|NCT00986921|Need for additional dilation|need for additional dilation
705848|NCT00986921|Subject satisfaction with procedure|subject satisfaction with procedure
705849|NCT00986960|multiple sclerosis|multiple sclerosis
705850|NCT00986960|relapsing remitting|relapsing remitting
705851|NCT00986960|RRMS|rrms
705852|NCT00986973|PKU|pku
705854|NCT00986973|KUVAN|kuvan
705855|NCT00986973|PET scan|pet scan
705856|NCT00986973|Neurodevelopment|neurodevelopment
705857|NCT00986986|Human immunodeficiency virus|human immunodeficiency virus
705858|NCT00986986|Low high density lipoprotein|low high density lipoprotein
705859|NCT00986986|Endothelial function|endothelial function
705860|NCT00986986|Flow-mediated vasodilation|flow-mediated vasodilation
705861|NCT00986999|HIV infected|hiv infected
705862|NCT00986999|treatment experienced|treatment experienced
705863|NCT00987025|hypertension|hypertension
705864|NCT00987025|telehealth|telehealth
705865|NCT00987025|nurse monitor|nurse monitor
705866|NCT00987025|nutrition center|nutrition center
705867|NCT00987038|drug interaction CYP3A4 glucocorticoids midazolam|drug interaction cyp3a4 glucocorticoids midazolam
705868|NCT00987051|sentinel node procedure|sentinel node procedure
705869|NCT00987051|radiocolloid|radiocolloid
705870|NCT00987051|patent blue|patent blue
705871|NCT00987064|Protexo|protexo
705872|NCT00987064|Asthma|asthma
705873|NCT00987064|Temperature controlled Laminar Airflow|temperature controlled laminar airflow
705874|NCT00987064|Perennial allergy|perennial allergy
705875|NCT00987064|Quality of life|quality of life
705876|NCT00987064|MiniAQLQ|miniaqlq
705877|NCT00987064|FeNO|feno
705878|NCT00987064|FEV1|fev1
705879|NCT00987064|PEF|pef
705880|NCT00987077|CSC|csc
705881|NCT00987077|SRT|srt
705882|NCT00987090|subjects developing symptoms of Alzheimer Disease|subjects developing symptoms of alzheimer disease
705883|NCT00987103|renal transplantation|renal transplantation
705884|NCT00987103|tacrolimus|tacrolimus
705885|NCT00987103|pharmacokinetics|pharmacokinetics
705886|NCT00987103|rectal|rectal
705887|NCT00987103|sublingual|sublingual
705888|NCT00987103|rectal administration|rectal administration
705889|NCT00987103|sublingual administration|sublingual administration
705890|NCT00987116|Myasthenia gravis|myasthenia gravis
705891|NCT00987116|Steroids side effects|steroids side effects
705892|NCT00987116|Comparison of strategies for tapering steroids|comparison of strategies for tapering steroids
705893|NCT00987116|Generalized MG corresponding to grade III, IV or V of MGFA|generalized mg corresponding to grade iii, iv or v of mgfa
705894|NCT00987129|DHA|dha
705895|NCT00987129|EPA|epa
705896|NCT00987129|AMD|amd
705897|NCT00987129|drusen|drusen
705898|NCT00987129|omega-3 fatty acids|omega-3 fatty acids
705899|NCT00987129|omega6:omega3 ratio|omega6:omega3 ratio
705900|NCT00987155|Functional electrical stimulation cycling|functional electrical stimulation cycling
705901|NCT00987155|arm crank|arm crank
705902|NCT00987155|wheelchair|wheelchair
705903|NCT00987155|ergometry|ergometry
705905|NCT00987155|spinal cord injury|spinal cord injury
705906|NCT00987155|exercise testing|exercise testing
705907|NCT00987168|Congenital Hyperinsulinism|congenital hyperinsulinism
705908|NCT00987168|Hypoglycemia,|hypoglycemia,
705909|NCT00987168|Sandostatine subcutaneous in 3 daily injections|sandostatine subcutaneous in 3 daily injections
705910|NCT00987168|Intramuscular injection of Sandostatine® LP per month|intramuscular injection of sandostatine® lp per month
705911|NCT00987181|Pulse wave velocity|pulse wave velocity
705912|NCT00987181|Non contact|non contact
705913|NCT00987181|Non-invasive|non-invasive
705914|NCT00987181|Photoplethysmography|photoplethysmography
705915|NCT00987181|Doppler flow velocimetry|doppler flow velocimetry
705916|NCT00987194|HIV|hiv
705917|NCT00987194|rapid testing|rapid testing
705918|NCT00987194|HIV seronegativity|hiv seronegativity
705919|NCT00987207|Postconditioning|postconditioning
705920|NCT00987207|cyclosporine A|cyclosporine a
705921|NCT00987207|myocardial ischemia|myocardial ischemia
705922|NCT00987207|cardiac surgery|cardiac surgery
705923|NCT00987207|aortic valvulopathy|aortic valvulopathy
705924|NCT00987220|CSF Biomarkers Acetylcholine|csf biomarkers acetylcholine
705925|NCT00987246|Actinic Keratosis|actinic keratosis
705926|NCT00987246|AK|ak
705927|NCT00987246|NMSC|nmsc
705928|NCT00987246|Combination|combination
705929|NCT00987259|Myocardial infarction|myocardial infarction
705930|NCT00987259|Myocardial oedema|myocardial oedema
705931|NCT00987259|Magnetic resonance|magnetic resonance
705932|NCT00987272|Allergies|allergies
705933|NCT00987272|Ocular|ocular
705934|NCT00987285|RE AIM model|re aim model
705935|NCT00987285|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
705936|NCT00987285|Interactive voice recognition|interactive voice recognition
705937|NCT00987285|Computer Assisted Self Management|computer assisted self management
705938|NCT00987298|Abdominal Fat|abdominal fat
705939|NCT00987298|Visceral Fat|visceral fat
705940|NCT00987298|Subcutaneous Fat|subcutaneous fat
705941|NCT00987298|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
705942|NCT00987298|DXA|dxa
705943|NCT00987298|Computed Tomography|computed tomography
705944|NCT00987298|CT|ct
705945|NCT00987298|Body Mass Index|body mass index
705946|NCT00987298|Body composition|body composition
705947|NCT00987298|Percent fat|percent fat
705948|NCT00987298|Waist circumference|waist circumference
705949|NCT00987298|Hip circumference|hip circumference
705950|NCT00987311|Probiotics|probiotics
705951|NCT00987311|intestinal immune system|intestinal immune system
705952|NCT00987311|human|human
705953|NCT00987311|healthy subjects|healthy subjects
705954|NCT00987311|dairy drink|dairy drink
705955|NCT00987311|Healthy adults|healthy adults
705956|NCT00987337|Hepatitis C Polymerase Inhibitor PF-00868554 Filibuvir|hepatitis c polymerase inhibitor pf-00868554 filibuvir
705957|NCT00987350|Jet Injector|jet injector
705958|NCT00987350|Vaccine|vaccine
705959|NCT00987350|Influenza|influenza
705960|NCT00987363|critical limb ischemia (CLI)|critical limb ischemia (cli)
705961|NCT00987363|diabetic foot|diabetic foot
705962|NCT00987363|bone marrow derived mononuclear cells|bone marrow derived mononuclear cells
705963|NCT00987363|cell therapy|cell therapy
705964|NCT00987389|Vasculitis|vasculitis
705965|NCT00987389|Granulomatosis with Polyangiitis|granulomatosis with polyangiitis
705966|NCT00987389|Microscopic Polyangiitis|microscopic polyangiitis
705967|NCT00987389|Wegener's|wegener's
705968|NCT00987389|ANCA-Associated Vasculitis|anca-associated vasculitis
705970|NCT00987389|MPA|mpa
705971|NCT00987389|Treatment|treatment
705972|NCT00987389|Plasma exchange|plasma exchange
705973|NCT00987389|Glucocorticoids|glucocorticoids
705974|NCT00987389|ANCA-Positive|anca-positive
705975|NCT00987402|Surgery|surgery
705976|NCT00987402|hand scrubbing|hand scrubbing
705977|NCT00987402|post-operative infection|post-operative infection
705978|NCT00987402|surgical site infection|surgical site infection
705979|NCT00987402|surgical hand preparation|surgical hand preparation
705980|NCT00987402|plain soap and water|plain soap and water
705981|NCT00987402|alcohol-based hand rub|alcohol-based hand rub
705982|NCT00987402|Cost of surgical hand preparation agent|cost of surgical hand preparation agent
705983|NCT00987402|Side effects of use of hand preparation agent|side effects of use of hand preparation agent
705984|NCT00987428|ERCP|ercp
705985|NCT00987428|EUS|eus
705986|NCT00987428|Pancreatitis biliary|pancreatitis biliary
705987|NCT00987428|Severe|severe
705988|NCT00987428|Interventional endoscopy|interventional endoscopy
705989|NCT00987428|Choledocolithiasis|choledocolithiasis
705990|NCT00987441|Neurobehavior|neurobehavior
705991|NCT00987441|Epidural analgesia|epidural analgesia
705992|NCT00987441|Local anesthetic|local anesthetic
705993|NCT00987441|Opioid|opioid
705994|NCT00987467|Atopic|atopic
705995|NCT00987467|Keratoconjunctivitis|keratoconjunctivitis
705996|NCT00987467|Restasis|restasis
705997|NCT00987467|Cyclosporine|cyclosporine
705998|NCT00987480|Stem Cell Transplantation|stem cell transplantation
705999|NCT00987480|Anemia|anemia
706000|NCT00987480|Busulfan|busulfan
706001|NCT00987480|Cyclophosphamide|cyclophosphamide
706002|NCT00987480|Fludarabine|fludarabine
706003|NCT00987480|08-031|08-031
706004|NCT00987493|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
706005|NCT00987493|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
706006|NCT00987506|drug eluting stents|drug eluting stents
706007|NCT00987506|Stents|stents
706008|NCT00987506|Angioplasty|angioplasty
706009|NCT00987506|Chronic coronary occlusion|chronic coronary occlusion
706010|NCT00987506|Stent thrombosis|stent thrombosis
706011|NCT00987506|Vascular disease|vascular disease
706012|NCT00987506|Myocardial ischemia|myocardial ischemia
706013|NCT00987506|Coronary artery stenosis|coronary artery stenosis
706014|NCT00987506|Coronary Disease|coronary disease
706015|NCT00987506|Coronary Artery Disease|coronary artery disease
706016|NCT00987506|Coronary Restenosis|coronary restenosis
706017|NCT00987519|acute bronchiolitis|acute bronchiolitis
706018|NCT00987519|acute gastroenteritis|acute gastroenteritis
706019|NCT00987519|febrile convulsion|febrile convulsion
706020|NCT00987519|viral agents|viral agents
706021|NCT00987519|molecular methods|molecular methods
706022|NCT00987532|preschool|preschool
706023|NCT00987532|participatory intervention|participatory intervention
706024|NCT00987532|cluster-randomization|cluster-randomization
706025|NCT00987532|children|children
706026|NCT00987532|obesity prevention|obesity prevention
706027|NCT00987545|Keloids|keloids
706028|NCT00987545|recurrence|recurrence
706029|NCT00987558|Eslicarbazepine acetate|eslicarbazepine acetate
706030|NCT00987558|simvastatin|simvastatin
706031|NCT00987571|carpal tunnel syndrome|carpal tunnel syndrome
706032|NCT00987571|median nerve|median nerve
706033|NCT00987571|ultrasound|ultrasound
706034|NCT00987571|electrodiagnosis|electrodiagnosis
706035|NCT00987571|Normal subjects|normal subjects
706036|NCT00987597|Smoking|smoking
706037|NCT00987597|nicotine replacement|nicotine replacement
706038|NCT00987597|psychological behaviour|psychological behaviour
706039|NCT00987597|Smoking > 5 cigarettes per day|smoking > 5 cigarettes per day
706040|NCT00987597|Hospitalisation for acute coronary syndrome|hospitalisation for acute coronary syndrome
706041|NCT00987610|Percutaneous coronary intervention|percutaneous coronary intervention
706042|NCT00987610|chronic total occlusion|chronic total occlusion
706043|NCT00987610|guidewire|guidewire
706044|NCT00987610|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
706045|NCT00987610|Angioplasty|angioplasty
706046|NCT00987610|Percutaneous Coronary|percutaneous coronary
706047|NCT00987636|Ewing Sarcoma|ewing sarcoma
706048|NCT00987636|localized|localized
706049|NCT00987636|disseminated|disseminated
706050|NCT00987636|metastases|metastases
706051|NCT00987636|bone|bone
706052|NCT00987636|soft tissue|soft tissue
706053|NCT00987649|pelvic mass|pelvic mass
706054|NCT00987649|ovarian cancer|ovarian cancer
706055|NCT00987649|adnexal mass|adnexal mass
706056|NCT00987649|CA125|ca125
706057|NCT00987649|HE4|he4
706058|NCT00987662|irbesartan|irbesartan
706059|NCT00987662|amlodipine|amlodipine
706060|NCT00987662|obesity|obesity
706061|NCT00987662|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
706062|NCT00987662|new onset diabetes|new onset diabetes
706063|NCT00987675|stage I prostate cancer|stage i prostate cancer
706064|NCT00987675|stage IIB prostate cancer|stage iib prostate cancer
706065|NCT00987675|stage IIA prostate cancer|stage iia prostate cancer
706066|NCT00987675|stage III prostate cancer|stage iii prostate cancer
706067|NCT00987688|trauma|trauma
706068|NCT00987688|Brain injury|brain injury
706069|NCT00987688|Pre-hospital|pre-hospital
706070|NCT00987688|cooling|cooling
706071|NCT00987701|Neurobehavior|neurobehavior
706072|NCT00987701|Development|development
706073|NCT00987701|Fluid management|fluid management
706074|NCT00987701|Neuraxial anesthesia|neuraxial anesthesia
706075|NCT00987714|Organ Donors|organ donors
706076|NCT00987714|Recipients|recipients
706077|NCT00987740|hypercapnic respiratory failure, COPD|hypercapnic respiratory failure, copd
706078|NCT00987753|L-377202, prostate cancer, PSA|l-377202, prostate cancer, psa
706079|NCT00987766|advanced adult primary liver cancer|advanced adult primary liver cancer
706080|NCT00987766|stage III pancreatic cancer|stage iii pancreatic cancer
706081|NCT00987766|stage IV pancreatic cancer|stage iv pancreatic cancer
706082|NCT00987766|periampullary adenocarcinoma|periampullary adenocarcinoma
706083|NCT00987766|small intestine adenocarcinoma|small intestine adenocarcinoma
706084|NCT00987766|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
706085|NCT00987766|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
706086|NCT00987766|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
706087|NCT00987766|unresectable gallbladder cancer|unresectable gallbladder cancer
706088|NCT00987779|Bioequivalence study|bioequivalence study
706089|NCT00987779|Food effect study|food effect study
706090|NCT00987779|Pharmacokinetics|pharmacokinetics
706091|NCT00987779|Gabapentin|gabapentin
706092|NCT00987792|Community Acquired Pneumonia|community acquired pneumonia
706093|NCT00987805|Functional dyspepsia|functional dyspepsia
706094|NCT00987805|Banhasasim-tang|banhasasim-tang
706095|NCT00987805|Gastrointestinal Symptom score|gastrointestinal symptom score
706096|NCT00987805|Visual Analogue Scale|visual analogue scale
706097|NCT00987805|Functional Dyspepsia-related Quality of Life|functional dyspepsia-related quality of life
706098|NCT00987805|Electrogastrography|electrogastrography
706099|NCT00987818|Biomarkers|biomarkers
706100|NCT00987818|Antibiotic therapy|antibiotic therapy
706101|NCT00987831|SLE|sle
706102|NCT00987831|lupus|lupus
706103|NCT00987831|biomarkers|biomarkers
706104|NCT00987831|depomedrol|depomedrol
706105|NCT00987831|flare|flare
706106|NCT00987831|disease activity|disease activity
706107|NCT00987857|esophageal cancer|esophageal cancer
706108|NCT00987857|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
706109|NCT00987857|Barrett esophagus|barrett esophagus
706110|NCT00987870|Stable plaque Psoriasis|stable plaque psoriasis
706111|NCT00987870|inflammatory skin|inflammatory skin
706112|NCT00987870|with or without arthritis|with or without arthritis
706113|NCT00987883|Nutritional Support|nutritional support
706114|NCT00987896|colonoscopy|colonoscopy
706115|NCT00987896|polypectomy|polypectomy
706116|NCT00987896|NOTES|notes
706117|NCT00987909|Cat|cat
706118|NCT00987909|Allergy|allergy
706119|NCT00987909|Immunotherapy|immunotherapy
706120|NCT00987909|Sublingual|sublingual
706121|NCT00987909|Exposure chamber|exposure chamber
706122|NCT00987909|Safety|safety
706123|NCT00987909|Rhinoconjunctivitis|rhinoconjunctivitis
706124|NCT00987922|Stroke|stroke
706125|NCT00987922|Acute|acute
706126|NCT00987922|Infarction|infarction
706127|NCT00987922|Ischemic|ischemic
706128|NCT00987922|Thrombolysis|thrombolysis
706129|NCT00987922|Mild|mild
706130|NCT00987922|Hypothermia|hypothermia
706131|NCT00987948|HIV|hiv
706132|NCT00987948|dementia|dementia
706133|NCT00987948|High HIV DNA within CD14+ PBMCs|high hiv dna within cd14+ pbmcs
707793|NCT00998842|ECG|ecg
706134|NCT00987948|treatment experienced|treatment experienced
706135|NCT00987961|opioid dependence|opioid dependence
706136|NCT00987961|suboxone|suboxone
706137|NCT00987961|HIV risk behavior|hiv risk behavior
706138|NCT00987974|ischemia reperfusion injury|ischemia reperfusion injury
706139|NCT00987974|endothelial dysfunction|endothelial dysfunction
706140|NCT00987974|statins|statins
706141|NCT00987974|rosuvastatin|rosuvastatin
706142|NCT00987974|atorvastatin|atorvastatin
706143|NCT00987974|placebo|placebo
706144|NCT00987974|ecto-5'-nucleotidase|ecto-5'-nucleotidase
706145|NCT00987974|flow mediated dilation|flow mediated dilation
706146|NCT00987987|hematological malignancy|hematological malignancy
706147|NCT00987987|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
706148|NCT00987987|donor lymphocyte infusion|donor lymphocyte infusion
706149|NCT00987987|antitumor immunotherapy|antitumor immunotherapy
706150|NCT00987987|graft-versus-tumor effect|graft-versus-tumor effect
706151|NCT00987987|regulatory T cells|regulatory t cells
706152|NCT00987987|adult|adult
706153|NCT00988000|outpatients|outpatients
706154|NCT00988013|total marrow irradiation|total marrow irradiation
706155|NCT00988013|intensity modulated radiation|intensity modulated radiation
706156|NCT00988013|leukemia|leukemia
706157|NCT00988013|hematologic diseases|hematologic diseases
706158|NCT00988039|Human Immunodeficiency virus|human immunodeficiency virus
706159|NCT00988039|second line therapy|second line therapy
706160|NCT00988039|raltegravir|raltegravir
706161|NCT00988039|aluvia|aluvia
706162|NCT00988039|monotherapy|monotherapy
706163|NCT00988039|integrase inhibitor|integrase inhibitor
706164|NCT00988039|protease inhibitor|protease inhibitor
706165|NCT00988039|Randomized Controlled Trial|randomized controlled trial
706166|NCT00988052|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
706167|NCT00988078|metformin|metformin
706168|NCT00988078|Hyperandrogenism|hyperandrogenism
706169|NCT00988078|Metabolic Syndrome X|metabolic syndrome x
706170|NCT00988078|adolescents|adolescents
706171|NCT00988078|melatonin|melatonin
706172|NCT00988078|Polycystic Ovary Syndrome|polycystic ovary syndrome
706173|NCT00988078|Insulin Resistance|insulin resistance
706174|NCT00988078|Menstrual Cycle|menstrual cycle
706175|NCT00988104|Behavior Therapy|behavior therapy
706176|NCT00988104|Randomized Controlled Trial|randomized controlled trial
706178|NCT00988117|Parkinson's Disease with Dementia|parkinson's disease with dementia
706179|NCT00988117|rivastigmine|rivastigmine
706180|NCT00988117|rivastigmine patch|rivastigmine patch
706181|NCT00988117|open label|open label
706182|NCT00988117|Parkinson's Disease|parkinson's disease
706183|NCT00988117|Parkinsons Disease|parkinsons disease
706184|NCT00988117|memory|memory
706185|NCT00988117|Exelon|exelon
706186|NCT00988117|Exelon Patch|exelon patch
706187|NCT00988130|sexual dysfunction|sexual dysfunction
706188|NCT00988130|stage I prostate cancer|stage i prostate cancer
706189|NCT00988130|stage IIB prostate cancer|stage iib prostate cancer
706190|NCT00988130|stage IIA prostate cancer|stage iia prostate cancer
706191|NCT00988130|stage III prostate cancer|stage iii prostate cancer
706192|NCT00988143|Influenza|influenza
706193|NCT00988143|Trivalent Influenza Virus Vaccine|trivalent influenza virus vaccine
706194|NCT00988143|Quadrivalent Influenza Virus Vaccine|quadrivalent influenza virus vaccine
706195|NCT00988156|Epilepsy|epilepsy
706196|NCT00988156|Partial|partial
706197|NCT00988156|Refractory|refractory
706198|NCT00988156|Children|children
706199|NCT00988156|Adolescents|adolescents
706200|NCT00988156|Adjunctive|adjunctive
706201|NCT00988156|Randomised|randomised
706202|NCT00988156|Double-blind|double-blind
706203|NCT00988156|Placebo-controlled|placebo-controlled
706204|NCT00988156|Parallel-group|parallel-group
706205|NCT00988169|AT-101|at-101
706206|NCT00988169|erlotinib|erlotinib
706207|NCT00988169|Unresectable Stage IIIB|unresectable stage iiib
706208|NCT00988169|09-026|09-026
706209|NCT00988182|Whey protein|whey protein
706210|NCT00988182|Hydrolysate whey protein|hydrolysate whey protein
706211|NCT00988182|Blood glucose|blood glucose
706212|NCT00988182|Insulin|insulin
706213|NCT00988195|Neoplasm|neoplasm
706214|NCT00988195|Hepatocellular Carcinoma|hepatocellular carcinoma
706215|NCT00988208|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
706216|NCT00988208|Revlimid|revlimid
706217|NCT00988208|Lenalidomide|lenalidomide
706218|NCT00988234|Lumbar plexus block|lumbar plexus block
706219|NCT00988234|sciatic nerve block|sciatic nerve block
706220|NCT00988234|position|position
706221|NCT00988234|ultrasound guidance|ultrasound guidance
706222|NCT00988234|elective lower limb surgery|elective lower limb surgery
706223|NCT00988247|Rhinitis, Allergic, Perennial|rhinitis, allergic, perennial
706224|NCT00988247|BDP-HFA|bdp-hfa
706225|NCT00988247|Hay fever|hay fever
706226|NCT00988247|Allergic rhinitis|allergic rhinitis
706227|NCT00988273|Crohn's disease|crohn's disease
706228|NCT00988273|Ulcerative colitis|ulcerative colitis
706229|NCT00988273|dysplasia|dysplasia
706230|NCT00988299|older|older
706231|NCT00988299|NEAT|neat
706232|NCT00988299|exercise|exercise
706233|NCT00988299|RMR|rmr
706234|NCT00988299|energy expenditure|energy expenditure
706235|NCT00988312|dendritic cells (DC)|dendritic cells (dc)
706236|NCT00988312|idiotype (Id)|idiotype (id)
706237|NCT00988312|immunotherapy|immunotherapy
706238|NCT00988338|Trinity Evolution|trinity evolution
706239|NCT00988338|Arthrodesis|arthrodesis
706240|NCT00988338|Foot Fusion|foot fusion
706241|NCT00988338|Ankle Fusion|ankle fusion
706242|NCT00988338|Allograft|allograft
706243|NCT00988351|sleep apnea|sleep apnea
706244|NCT00988351|positive airway pressure|positive airway pressure
706245|NCT00988351|portable monitoring|portable monitoring
706246|NCT00988351|auto positive airway pressure|auto positive airway pressure
706247|NCT00988364|Metabolic Syndrome|metabolic syndrome
706248|NCT00988364|LDL subfraction L5|ldl subfraction l5
706439|NCT00982865|Cancer|cancer
706249|NCT00988364|The reduction of LDL Chol in patients with Metabolic Syndrome|the reduction of ldl chol in patients with metabolic syndrome
706250|NCT00988364|The prevalence of L5 in patients with Metabolic Syndrome|the prevalence of l5 in patients with metabolic syndrome
706251|NCT00988364|The reduction of L5 subfraction in patients with Metabolic Syndrome|the reduction of l5 subfraction in patients with metabolic syndrome
706252|NCT00988377|whey protein|whey protein
706253|NCT00988377|subjective appetite|subjective appetite
706254|NCT00988377|shor-term food intake|shor-term food intake
706255|NCT00988377|blood glucose|blood glucose
706256|NCT00988390|mothers living with HIV|mothers living with hiv
706257|NCT00988390|family intervention|family intervention
706258|NCT00988390|family functioning|family functioning
706259|NCT00988390|conflict|conflict
706260|NCT00988390|Mental health|mental health
706261|NCT00988390|and physical health|and physical health
706262|NCT00988390|Family relationships (functioning and conflict)|family relationships (functioning and conflict)
706263|NCT00988416|IPMN|ipmn
706264|NCT00988429|Refractory|refractory
706265|NCT00988429|partial|partial
706266|NCT00988429|epilepsy|epilepsy
706267|NCT00988429|efficacy|efficacy
706268|NCT00988429|eslicarbazepine|eslicarbazepine
706269|NCT00988429|safety|safety
706270|NCT00988442|Adherence|adherence
706271|NCT00988442|Treatment|treatment
706272|NCT00988442|Adherence Intervention|adherence intervention
706273|NCT00988442|Telephone Intervention|telephone intervention
706274|NCT00988442|treatment experienced|treatment experienced
706275|NCT00988455|basal cell carcinoma|basal cell carcinoma
706276|NCT00988455|photodynamic therapy|photodynamic therapy
706277|NCT00988455|photo chemotherapy|photo chemotherapy
706278|NCT00988455|basal cell epithelioma|basal cell epithelioma
706279|NCT00988468|Knee Osteoarthritis|knee osteoarthritis
706280|NCT00988468|Manual Therapy|manual therapy
706281|NCT00988468|Therapeutic Exercise|therapeutic exercise
706282|NCT00988468|Ultrasound|ultrasound
706283|NCT00988468|Effusion|effusion
706284|NCT00988481|Bulimia Nervosa|bulimia nervosa
706285|NCT00988481|Topiramate|topiramate
706286|NCT00988481|Augmentation|augmentation
706287|NCT00988520|Neuromuscular Blocking Agents|neuromuscular blocking agents
706288|NCT00988533|Head Lice|head lice
706289|NCT00988533|Pediculus|pediculus
706290|NCT00988546|Disability Evaluation|disability evaluation
706291|NCT00988546|Joint Diseases|joint diseases
706292|NCT00988546|Joint Disability|joint disability
706293|NCT00988559|high grade cervical dysplasia|high grade cervical dysplasia
706294|NCT00988559|treatment vaccine|treatment vaccine
706295|NCT00988559|therapeutic|therapeutic
706296|NCT00988559|HPV|hpv
706297|NCT00988559|DNA vaccine|dna vaccine
706298|NCT00988559|gene therapy|gene therapy
706299|NCT00988559|gene gun|gene gun
706300|NCT00988559|pre-cancerous|pre-cancerous
706301|NCT00988572|Wrist fractures|wrist fractures
706302|NCT00988572|Vestibular asymmetry|vestibular asymmetry
706303|NCT00988572|Vestibular rehabilitation|vestibular rehabilitation
706304|NCT00988572|Fall-related wrist fractures|fall-related wrist fractures
706305|NCT00988572|Patients 50 years or older|patients 50 years or older
706306|NCT00988585|Heart Disease Risk Reduction|heart disease risk reduction
706307|NCT00988598|phase 1 Alzheimer's disease donepezil|phase 1 alzheimer's disease donepezil
706308|NCT00988611|Reproductive aging|reproductive aging
706309|NCT00982254|Type 2 Diabetes|type 2 diabetes
706310|NCT00982254|Oral Insulin|oral insulin
706311|NCT00982254|Pharmacokinetics|pharmacokinetics
706312|NCT00982254|Pharmacodynamics|pharmacodynamics
706313|NCT00982267|cancer|cancer
706314|NCT00982280|Osteoarthritis|osteoarthritis
706315|NCT00982280|pain assessment|pain assessment
706316|NCT00982280|tapentadol|tapentadol
706317|NCT00982280|centrally acting analgesic|centrally acting analgesic
706318|NCT00982306|alcohol|alcohol
706319|NCT00982306|brief interventions|brief interventions
706320|NCT00982306|counseling|counseling
706321|NCT00982306|harmful/hazardous alcohol drinkers|harmful/hazardous alcohol drinkers
706322|NCT00982319|Broccoli Sprout Extract|broccoli sprout extract
706323|NCT00982319|Breast Cancer|breast cancer
706324|NCT00982332|polymyalgia rheumatica|polymyalgia rheumatica
706325|NCT00982345|Depression|depression
706326|NCT00982345|Anxiety|anxiety
706327|NCT00982345|Seroquel|seroquel
706328|NCT00982345|Quetiapine|quetiapine
706329|NCT00982345|fMRI|fmri
706330|NCT00982345|pictures|pictures
706331|NCT00982371|type 2 diabetes mellitus|type 2 diabetes mellitus
706332|NCT00982371|osteoporosis|osteoporosis
706333|NCT00982371|bone quality|bone quality
706334|NCT00982371|magnetic resonance imaging|magnetic resonance imaging
706335|NCT00982371|fracture|fracture
706336|NCT00982371|postmenopausal women >65 years old|postmenopausal women >65 years old
706337|NCT00982384|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
706338|NCT00982384|Disease management|disease management
706339|NCT00982384|Pulmonary rehabilitation|pulmonary rehabilitation
706340|NCT00982384|Quality of life|quality of life
706341|NCT00982410|pain|pain
706342|NCT00982410|alcohol|alcohol
706343|NCT00982410|illicit drugs|illicit drugs
706344|NCT00982410|pain management|pain management
706345|NCT00982423|heart failure|heart failure
706346|NCT00982423|heart failure with and without kidney dysfunction|heart failure with and without kidney dysfunction
706347|NCT00982436|Combined Modality Therapy|combined modality therapy
706348|NCT00982436|Neoadjuvant Therapy|neoadjuvant therapy
706349|NCT00982436|Head and neck neoplasms|head and neck neoplasms
706350|NCT00982449|EBV+ malignancies|ebv+ malignancies
706351|NCT00982449|KSHV+ malignancies|kshv+ malignancies
706352|NCT00982449|HIV-associated lymphomas|hiv-associated lymphomas
706353|NCT00982449|Hodgkin Lymphoma|hodgkin lymphoma
706354|NCT00982449|nonHodgkin Lymphoma or|nonhodgkin lymphoma or
706355|NCT00982449|nonHodgkins Lymphoproliferative Disease|nonhodgkins lymphoproliferative disease
706356|NCT00982449|Primary Effusion Lymphoma|primary effusion lymphoma
706357|NCT00982449|Kaposi's Sarcoma|kaposi's sarcoma
706358|NCT00982449|Gastric Cancer|gastric cancer
706359|NCT00982449|Nasopharyngeal Cancer|nasopharyngeal cancer
706360|NCT00982462|cognition|cognition
706361|NCT00982462|vision|vision
706362|NCT00982462|immunology|immunology
706363|NCT00982462|DHA|dha
706364|NCT00982462|ARA|ara
706365|NCT00982462|infant|infant
706366|NCT00982462|nutrition|nutrition
706367|NCT00982475|pulmonary vein isolation|pulmonary vein isolation
706368|NCT00982475|robotic navigation|robotic navigation
706369|NCT00982475|atrial fibrillation|atrial fibrillation
706370|NCT00982501|(BMI 25-29,9 kg/m2)|(bmi 25-29,9 kg/m2)
706371|NCT00982514|Asparaginase|asparaginase
706372|NCT00982514|thrombosis|thrombosis
706373|NCT00982514|ALL|all
706374|NCT00982514|central line|central line
706375|NCT00982527|cardiopulmonary bypass|cardiopulmonary bypass
706376|NCT00982527|pediatric cardiac surgery|pediatric cardiac surgery
706377|NCT00982527|acute renal failure|acute renal failure
706378|NCT00982527|renal biomarkers|renal biomarkers
706379|NCT00982527|fenoldopam|fenoldopam
706380|NCT00982527|Focus on optimization of perfusion during pediatric CPB|focus on optimization of perfusion during pediatric cpb
706381|NCT00982540|empiric antifungal therapy|empiric antifungal therapy
706382|NCT00982540|preemptive antifungal therapy|preemptive antifungal therapy
706383|NCT00982540|febrile neutropenia|febrile neutropenia
706384|NCT00982540|risk stratification|risk stratification
706385|NCT00982540|invasive fungal infection|invasive fungal infection
706386|NCT00982553|Healthy Volunteers|healthy volunteers
706387|NCT00982579|HIV preventive vaccine|hiv preventive vaccine
706388|NCT00982631|temsirolimus (Torisel®)|temsirolimus (torisel®)
706389|NCT00982631|pegylated liposomal doxorubicin (PLD, Doxil®/ Caelyx®)|pegylated liposomal doxorubicin (pld, doxil®/ caelyx®)
706485|NCT00988871|CICC (centrally inserted central venous catheter|cicc (centrally inserted central venous catheter
706390|NCT00982657|Phase Ib Phase II Advanced solid tumor Clear cell renal cancer Sunitinib plus / minus CVX-060|phase ib phase ii advanced solid tumor clear cell renal cancer sunitinib plus / minus cvx-060
706391|NCT00982670|Metabolic syndrome|metabolic syndrome
706392|NCT00982670|Systemic lupus erythematosus|systemic lupus erythematosus
706393|NCT00982683|Surgery|surgery
706394|NCT00982683|Moon phases|moon phases
706395|NCT00982683|hemorrhage|hemorrhage
706396|NCT00982696|head and neck cancer|head and neck cancer
706397|NCT00982696|opioid growth factor|opioid growth factor
706398|NCT00982722|primary hyperparathyroidism|primary hyperparathyroidism
706399|NCT00982722|postoperative vitamin D supplementation|postoperative vitamin d supplementation
706400|NCT00982748|Fatigue|fatigue
706401|NCT00982748|Chemotherapy|chemotherapy
706402|NCT00982748|Yoga|yoga
706408|NCT00982748|Fatigue-associated symptoms in chemotherapy patients|fatigue-associated symptoms in chemotherapy patients
706409|NCT00982748|Quality of life in chemotherapy patients|quality of life in chemotherapy patients
706410|NCT00982761|occupational drivers|occupational drivers
706411|NCT00982761|health status|health status
706412|NCT00982774|PKDL|pkdl
706413|NCT00982787|Epilepsy|epilepsy
706414|NCT00982787|Seizures|seizures
706415|NCT00982787|Passiflora|passiflora
706416|NCT00982800|gabapentin|gabapentin
706417|NCT00982800|opioid consumption|opioid consumption
706418|NCT00982800|analgesic|analgesic
706419|NCT00982800|anxiety|anxiety
706420|NCT00982800|quality of life|quality of life
706421|NCT00982813|Periodontal disease|periodontal disease
706422|NCT00982813|Per-term delivery|per-term delivery
706423|NCT00982813|Sulcular bleeding index|sulcular bleeding index
706424|NCT00982813|Bacteriological gingival presence|bacteriological gingival presence
706425|NCT00982813|Cytokines|cytokines
706426|NCT00982813|Active periodontal disease with sulcular bleeding index|active periodontal disease with sulcular bleeding index
753706|NCT01177202|HAC1, H1N1|hac1, h1n1
706427|NCT00982813|Bacteriological sampling in periodontal pocketing|bacteriological sampling in periodontal pocketing
706428|NCT00982813|Cytokines in the periodontal pocketing|cytokines in the periodontal pocketing
706429|NCT00982826|Phase 1|phase 1
706430|NCT00982826|Single and Multiple Ascending Dose|single and multiple ascending dose
706431|NCT00982826|Food Effect|food effect
706432|NCT00982852|Angioplasty|angioplasty
706433|NCT00982852|Coronary Vessels|coronary vessels
706434|NCT00982852|Heart Disease|heart disease
706435|NCT00982852|Cardiology|cardiology
706436|NCT00982852|Atherosclerosis|atherosclerosis
706437|NCT00982852|Catheterization|catheterization
708853|NCT00992680|Walk|walk
706438|NCT00982865|MEK inhibitor|mek inhibitor
706440|NCT00982865|Solid tumors|solid tumors
706441|NCT00988624|bioavailability pharmacokinetics Alzheimer's Disease Huntington Disease|bioavailability pharmacokinetics alzheimer's disease huntington disease
706442|NCT00988650|Metabolic syndrome|metabolic syndrome
706443|NCT00988650|Mediterranean diet|mediterranean diet
706444|NCT00988650|Blood lipids|blood lipids
706445|NCT00988650|Coronary heart disease|coronary heart disease
706446|NCT00988650|Apolipoprotein|apolipoprotein
706447|NCT00988663|electroconvulsive therapy|electroconvulsive therapy
706448|NCT00988663|memantine|memantine
706449|NCT00988663|cognitive function|cognitive function
706450|NCT00988663|memory|memory
706451|NCT00988689|starch|starch
706452|NCT00988689|carbohydrates|carbohydrates
706453|NCT00988689|blood glucose|blood glucose
706454|NCT00988689|food intake|food intake
706455|NCT00988689|satiety|satiety
706456|NCT00988689|appetite|appetite
706457|NCT00988702|Dan Tian Breathing|dan tian breathing
706458|NCT00988702|Physiological measurement|physiological measurement
706459|NCT00988702|progressive muscle relaxation|progressive muscle relaxation
706460|NCT00988702|Monitoring, Physiologic|monitoring, physiologic
706461|NCT00988741|Unresectable|unresectable
706462|NCT00988741|Hepatocellular|hepatocellular
706463|NCT00988741|Carcinoma|carcinoma
706464|NCT00988754|Obesity|obesity
706465|NCT00988754|childhood and adolescence|childhood and adolescence
706466|NCT00988754|school and family-based lifestyle intervention|school and family-based lifestyle intervention
706467|NCT00988754|cardiovascular risk|cardiovascular risk
706468|NCT00988754|Obesity and associated cardiovascular risk in childhood and adolescence,|obesity and associated cardiovascular risk in childhood and adolescence,
706469|NCT00988754|health behaviour|health behaviour
706470|NCT00988767|Hepatitis B|hepatitis b
706471|NCT00988767|DNA vaccine|dna vaccine
706472|NCT00988767|immunotherapy|immunotherapy
706473|NCT00988780|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
706474|NCT00988780|CCR5 antagonist|ccr5 antagonist
706475|NCT00988780|Maraviroc|maraviroc
706476|NCT00988780|HIV|hiv
706477|NCT00988780|treatment naive|treatment naive
706478|NCT00988806|Advanced heart failure|advanced heart failure
706479|NCT00988806|Levosimendan|levosimendan
706480|NCT00988806|Intermittent long-term infusions|intermittent long-term infusions
706481|NCT00988845|dietary supplement|dietary supplement
706482|NCT00988845|indole 3 carbinol|indole 3 carbinol
706483|NCT00988845|estrogen|estrogen
706484|NCT00988871|PICC (peripherally inserted central venous catheter)|picc (peripherally inserted central venous catheter)
706486|NCT00988871|CVP (central venous pressure)|cvp (central venous pressure)
706487|NCT00988871|LT (liver transplantation)|lt (liver transplantation)
706488|NCT00988871|agreement|agreement
706489|NCT00988910|Combined Oral Contraceptives|combined oral contraceptives
706490|NCT00988910|COC|coc
706491|NCT00988936|[F-18]RGD-K5|[f-18]rgd-k5
706492|NCT00988936|RGD-K5|rgd-k5
706493|NCT00988936|K5-101|k5-101
706494|NCT00988936|Avastin|avastin
706495|NCT00988936|angiogenesis|angiogenesis
706496|NCT00988936|anti-angiogenesis|anti-angiogenesis
706497|NCT00988936|chemotherapy|chemotherapy
706498|NCT00988936|breast cancer|breast cancer
706499|NCT00988936|colon cancer|colon cancer
706500|NCT00988936|rectal cancer|rectal cancer
706501|NCT00988936|lung cancer|lung cancer
706502|NCT00988936|non-squamous|non-squamous
706503|NCT00988936|non small cell|non small cell
706504|NCT00988949|Proof of mechanism study|proof of mechanism study
706505|NCT00994058|Preterm Labor|preterm labor
706506|NCT00994058|Uterine Inhibitor|uterine inhibitor
706507|NCT00994058|Electro-Inhibition|electro-inhibition
706508|NCT00994071|Brain Tumor|brain tumor
706509|NCT00994071|CNC Tumor|cnc tumor
706510|NCT00994071|Pediatric|pediatric
706511|NCT00994071|PARP Inhibitor|parp inhibitor
706512|NCT00994071|Oral Chemotherapy|oral chemotherapy
706513|NCT00994084|Obesity|obesity
706514|NCT00994084|Minority children|minority children
706515|NCT00994084|Community intervention program|community intervention program
706516|NCT00994084|Lifestyle changes|lifestyle changes
706517|NCT00994084|Physical activities|physical activities
706518|NCT00994084|Nutrition lessons|nutrition lessons
706519|NCT00994084|Behavior modification|behavior modification
706520|NCT00994097|NGR-hTNF|ngr-htnf
706521|NCT00994097|Randomized controlled trial|randomized controlled trial
706522|NCT00994097|Gemcitabine|gemcitabine
706523|NCT00994097|Cisplatin|cisplatin
706524|NCT00994097|Pemetrexed|pemetrexed
706525|NCT00994097|Carcinoma, non-small cell lung|carcinoma, non-small cell lung
706526|NCT00994110|PANCREAS|pancreas
706527|NCT00994110|Pasireotide|pasireotide
706528|NCT00994110|SOM230|som230
706529|NCT00994110|saline placebo|saline placebo
706530|NCT00994110|09-039|09-039
706531|NCT00994123|Non-Small Cell Lung Cancer|non-small cell lung cancer
706532|NCT00994123|NSCLC|nsclc
706533|NCT00994123|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
706534|NCT00994123|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
706535|NCT00994123|Lung Cancer|lung cancer
706536|NCT00994123|Erlotinib|erlotinib
706537|NCT00994123|Tarceva|tarceva
706538|NCT00994123|MM-121|mm-121
706539|NCT00994123|ErbB3|erbb3
706540|NCT00994123|Her3|her3
706541|NCT00994123|Epidermal Growth Factor Receptor|epidermal growth factor receptor
706542|NCT00994123|anti-ErbB3 human monoclonal antibody|anti-erbb3 human monoclonal antibody
706543|NCT00994123|ErbB3 antagonist|erbb3 antagonist
706544|NCT00994136|Catheters, indwelling|catheters, indwelling
706545|NCT00994136|Catheterization, Central Venous|catheterization, central venous
706546|NCT00994136|Withdrawal occlusion|withdrawal occlusion
706547|NCT00994136|Heparin lock|heparin lock
706548|NCT00994149|Infants of Diabetic Mothers|infants of diabetic mothers
706549|NCT00994149|Hypoglycemia|hypoglycemia
706550|NCT00994149|Diazoxide|diazoxide
706551|NCT00994149|Large for Gestation Infants|large for gestation infants
706552|NCT00994162|NPWT|npwt
706553|NCT00994162|Gauze-based filler|gauze-based filler
706554|NCT00994162|Acute or Chronic Wounds|acute or chronic wounds
706555|NCT00994162|Efficacy|efficacy
706556|NCT00994175|Pioglitazone|pioglitazone
706557|NCT00994175|Severe, Refractory Asthma|severe, refractory asthma
706558|NCT00994175|Peroxisome Proliferator-Activated Receptor Gamma|peroxisome proliferator-activated receptor gamma
706559|NCT00994175|Airflow Obstruction|airflow obstruction
706560|NCT00994175|Airway Inflammation|airway inflammation
706561|NCT00994175|Asthma|asthma
706562|NCT00994188|Renal tumor|renal tumor
706563|NCT00994188|Ureteral tumor|ureteral tumor
706564|NCT00994188|Ureteral stricture|ureteral stricture
706565|NCT00994188|Restored kidney|restored kidney
706566|NCT00994188|Renal transplantation|renal transplantation
706567|NCT00994188|Family members|family members
706568|NCT00994227|electron microscopy|electron microscopy
706569|NCT00994227|internal limiting membrane|internal limiting membrane
706570|NCT00994227|macular disease|macular disease
706571|NCT00994227|optical coherence tomography|optical coherence tomography
706572|NCT00994266|Type 2 diabetes|type 2 diabetes
706573|NCT00994266|Diamel|diamel
706574|NCT00994266|Dietary supplement|dietary supplement
706575|NCT00994279|fatigue|fatigue
706576|NCT00994279|depression|depression
706577|NCT00994279|sleep disorders|sleep disorders
706578|NCT00994279|stage IA breast cancer|stage ia breast cancer
706579|NCT00994279|stage IB breast cancer|stage ib breast cancer
706580|NCT00994279|stage II breast cancer|stage ii breast cancer
706581|NCT00994279|stage IIIA breast cancer|stage iiia breast cancer
706582|NCT00994279|stage IIIB breast cancer|stage iiib breast cancer
706583|NCT00994279|stage IIIC breast cancer|stage iiic breast cancer
706584|NCT00994279|recurrent breast cancer|recurrent breast cancer
706585|NCT00994292|Factor Xa|factor xa
706586|NCT00994292|Anticoagulant|anticoagulant
706587|NCT00994292|YM150|ym150
706588|NCT00994292|Acute Coronary Syndrome|acute coronary syndrome
706589|NCT00994305|kidney transplantation|kidney transplantation
706590|NCT00994305|oxidative stress|oxidative stress
706591|NCT00994305|acetylcysteine|acetylcysteine
706592|NCT00994305|graft rejection|graft rejection
706593|NCT00994318|Ferinject Iron Deficiency Anaemia Chronic Kidney Disease|ferinject iron deficiency anaemia chronic kidney disease
706594|NCT00994331|Percutaneous Coronary Intervention|percutaneous coronary intervention
706595|NCT00994331|Magnetic Navigation|magnetic navigation
706596|NCT00994331|Computed Tomography|computed tomography
706597|NCT00994344|Darunavir|darunavir
706598|NCT00994344|Lopinavir|lopinavir
706599|NCT00994344|Monotherapy|monotherapy
706698|NCT00994825|survival|survival
706600|NCT00994344|Antiretroviral simplification strategy|antiretroviral simplification strategy
706601|NCT00994344|HIV|hiv
706602|NCT00994344|Treatment experienced|treatment experienced
706603|NCT00994357|Real-time Continuous Glucose Monitoring|real-time continuous glucose monitoring
706604|NCT00994357|Macrosomia|macrosomia
706605|NCT00994370|Pro-angiogenic markers|pro-angiogenic markers
706606|NCT00994370|SIRT|sirt
706607|NCT00994370|hepatic metastases|hepatic metastases
706608|NCT00994409|Stroke|stroke
706609|NCT00994422|PEDICULUS HUMANUS CAPITIS|pediculus humanus capitis
706610|NCT00994422|Head Lice|head lice
706611|NCT00994435|obesity|obesity
706612|NCT00994448|Adolescents|adolescents
706613|NCT00994448|Methamphetamine abuse|methamphetamine abuse
706614|NCT00994448|Bupropion|bupropion
706615|NCT00994448|Addiction|addiction
706616|NCT00994448|Pharmacotherapy|pharmacotherapy
706617|NCT00994448|Cognitive Behavioral Therapy|cognitive behavioral therapy
706618|NCT00994448|Contingency Management|contingency management
706619|NCT00994448|Teens|teens
706620|NCT00994461|Endoscopy|endoscopy
706621|NCT00994474|Laser surgery|laser surgery
706622|NCT00994474|Profilometry|profilometry
706623|NCT00994474|Fitzpatrick wrinkle score|fitzpatrick wrinkle score
706624|NCT00994474|Patient Benefit Index|patient benefit index
706625|NCT00994474|Patient satisfaction|patient satisfaction
706626|NCT00994487|Childhood Obesity|childhood obesity
706627|NCT00994487|Breastfeeding|breastfeeding
706628|NCT00994487|Bottle Feeding|bottle feeding
706629|NCT00994487|Dietary Intake|dietary intake
706630|NCT00994487|Preload|preload
706631|NCT00994487|Compensation|compensation
706632|NCT00994487|Parental Feeding Style|parental feeding style
706633|NCT00994513|Antioxidant|antioxidant
706634|NCT00994513|Obesity|obesity
706635|NCT00994526|Colorectal cancer|colorectal cancer
706636|NCT00994526|Processed meat|processed meat
706637|NCT00994526|Calcium|calcium
706638|NCT00994526|Vitamin E|vitamin e
706639|NCT00994526|Preventive strategies|preventive strategies
706640|NCT00994565|Physical activity|physical activity
706641|NCT00994565|health behaviour|health behaviour
706642|NCT00994565|lifestyle|lifestyle
706643|NCT00994565|productivity|productivity
706644|NCT00994565|outcomes|outcomes
706645|NCT00994578|Advanced cancer|advanced cancer
706646|NCT00994591|Nicotine|nicotine
706647|NCT00994591|Cotinine|cotinine
706648|NCT00994591|CYP2A6|cyp2a6
706649|NCT00994643|NHL|nhl
706650|NCT00994643|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
706651|NCT00994643|Lymphoma|lymphoma
706652|NCT00994656|invasive procedures|invasive procedures
706653|NCT00994656|hypovolemia|hypovolemia
706654|NCT00994682|Additional relevant MeSH terms:|additional relevant mesh terms:
706655|NCT00994682|Hypoglycemic Agents|hypoglycemic agents
706656|NCT00994682|Physiological Effects of Drugs|physiological effects of drugs
706657|NCT00994682|Pharmacologic Actions|pharmacologic actions
706658|NCT00994682|Pioglitazone|pioglitazone
706659|NCT00994695|Trivalent meningococcal polysaccharide vaccine|trivalent meningococcal polysaccharide vaccine
706660|NCT00994695|Children|children
706661|NCT00994695|Safety|safety
706662|NCT00994695|Immunogenicity|immunogenicity
706663|NCT00994695|To assess Safety of trivalent meningococcal polysaccharide vaccine in children|to assess safety of trivalent meningococcal polysaccharide vaccine in children
706664|NCT00994695|To assess the immunogenicity of the trivalent polysaccharide vaccine in children|to assess the immunogenicity of the trivalent polysaccharide vaccine in children
706665|NCT00994721|Pancreatic Cancer|pancreatic cancer
706666|NCT00994747|infancy|infancy
706667|NCT00994747|nutrition|nutrition
706668|NCT00994747|protein hydrolysate formula|protein hydrolysate formula
706669|NCT00994747|flavor preferences|flavor preferences
706670|NCT00994747|food preferences|food preferences
706671|NCT00994747|growth|growth
706672|NCT00994747|emotional development|emotional development
706673|NCT00994747|mother-infant interaction|mother-infant interaction
706674|NCT00994747|infant temperament|infant temperament
706675|NCT00994747|feeding patterning|feeding patterning
706676|NCT00994747|taste receptor and obesity genotype|taste receptor and obesity genotype
706677|NCT00994747|sensitive period|sensitive period
706678|NCT00994760|intranasal fentanyl spray|intranasal fentanyl spray
706679|NCT00994773|Hepatitis B|hepatitis b
706680|NCT00994773|simvastatin|simvastatin
706681|NCT00994773|HBV DNA|hbv dna
706682|NCT00994786|treatment-resistant|treatment-resistant
706683|NCT00994786|refractory|refractory
706684|NCT00994786|obsessive compulsive disorder|obsessive compulsive disorder
706685|NCT00994786|Lyrica|lyrica
706686|NCT00994786|pregabalin|pregabalin
706687|NCT00994786|Serotonin Reuptake Inhibitor-Refractory Obsessive-Compulsive Disorder|serotonin reuptake inhibitor-refractory obsessive-compulsive disorder
706688|NCT00994812|Polycystic ovary syndrome|polycystic ovary syndrome
706689|NCT00994812|PCOS|pcos
706690|NCT00994812|Metformin|metformin
706691|NCT00994812|Miscarriage|miscarriage
706692|NCT00994812|Infertility|infertility
706693|NCT00994812|Complications of pregnancy|complications of pregnancy
706694|NCT00994825|levosimendan|levosimendan
706695|NCT00994825|cardiac surgery|cardiac surgery
706696|NCT00994825|cardiac anesthesia|cardiac anesthesia
706697|NCT00994825|mortality|mortality
706699|NCT00994825|inotropic drugs|inotropic drugs
706700|NCT00994890|Double-blind safety|double-blind safety
706701|NCT00994903|Statin|statin
706702|NCT00994903|Colon|colon
706703|NCT00994903|Colorectal|colorectal
706704|NCT00994903|Intestinal Neoplasms|intestinal neoplasms
706705|NCT00994903|ERAS|eras
706706|NCT00994903|Perioperative Care|perioperative care
706707|NCT00994916|Lambert-Eaton myasthenic syndrome|lambert-eaton myasthenic syndrome
706708|NCT00994916|3,4 diaminopyridine|3,4 diaminopyridine
706709|NCT00994929|biologic effects|biologic effects
706710|NCT00994929|von Willebrand disease|von willebrand disease
706711|NCT00994929|hemophilia|hemophilia
706712|NCT00994929|interleukin-11|interleukin-11
706713|NCT00994929|DDAVp|ddavp
706715|NCT00994955|laser|laser
706716|NCT00994955|diabetic macular edema|diabetic macular edema
706717|NCT00994955|diabetes|diabetes
706718|NCT00994955|Clinically significant diabetic macular edema|clinically significant diabetic macular edema
706719|NCT00994968|stage II breast cancer|stage ii breast cancer
706720|NCT00994968|stage III breast cancer|stage iii breast cancer
706721|NCT00994981|magnesium and reperfusion injury|magnesium and reperfusion injury
706722|NCT00994994|pediatric cardiac surgery|pediatric cardiac surgery
706723|NCT00994994|bleeding|bleeding
706724|NCT00994994|tranexamic acid|tranexamic acid
706725|NCT00994994|fibrinolysis|fibrinolysis
706726|NCT00994994|blood loss in pediatric cardiac surgery|blood loss in pediatric cardiac surgery
706727|NCT00995007|Brain Tumor|brain tumor
706728|NCT00995007|Chemotherapy|chemotherapy
706729|NCT00995007|Antiangiogenesis|antiangiogenesis
706730|NCT00995007|Radiation|radiation
706731|NCT00995007|Progression|progression
706732|NCT00995007|Glioma|glioma
706733|NCT00995007|Glioblastoma Multiforme|glioblastoma multiforme
706734|NCT00995020|Cone biopsy|cone biopsy
706735|NCT00995020|Conization|conization
706736|NCT00995020|Loop electrosurgical excisional procedures|loop electrosurgical excisional procedures
706737|NCT00995020|Large Loop Excision of Transformation Zone|large loop excision of transformation zone
706738|NCT00995020|Needle Excision of Transformation Zone|needle excision of transformation zone
706739|NCT00995020|Straight Wire Excision of Transformation Zone|straight wire excision of transformation zone
706740|NCT00995020|Electrosurgery|electrosurgery
706741|NCT00995033|Smoking cessation|smoking cessation
706742|NCT00995033|Smoking lapse behavior|smoking lapse behavior
706743|NCT00995033|Smoking Relapse behavior|smoking relapse behavior
706744|NCT00995033|Varenicline|varenicline
706745|NCT00995033|Nicotine conjugate vaccine|nicotine conjugate vaccine
706746|NCT00995033|Medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
706747|NCT00995046|Hemophilia A|hemophilia a
706748|NCT00995046|prophylaxis|prophylaxis
706749|NCT00995046|thrombin generation test (TGT)|thrombin generation test (tgt)
706750|NCT00995059|stage I multiple myeloma|stage i multiple myeloma
706751|NCT00995059|stage II multiple myeloma|stage ii multiple myeloma
706752|NCT00995059|stage III multiple myeloma|stage iii multiple myeloma
706753|NCT00995072|sexual dysfunction|sexual dysfunction
706754|NCT00995072|female|female
706755|NCT00995072|hypertension|hypertension
706756|NCT00995072|high blood pressure|high blood pressure
706757|NCT00995072|beta blockers|beta blockers
706758|NCT00995072|metoprolol|metoprolol
706759|NCT00995072|nebivolol|nebivolol
706760|NCT00995072|Bystolic|bystolic
706761|NCT00995072|Toprol XL|toprol xl
706762|NCT00995085|ADHD|adhd
706763|NCT00995085|ADD|add
706764|NCT00995085|TOVA|tova
706765|NCT00995085|METADOXINE|metadoxine
706766|NCT00995098|Acute severe pancreatitis|acute severe pancreatitis
706767|NCT00995098|nutritional support|nutritional support
706768|NCT00995098|enteral nutrition|enteral nutrition
706769|NCT00995098|parenteral nutrition|parenteral nutrition
706770|NCT00995124|ovicide|ovicide
706771|NCT00995124|head lice infestation|head lice infestation
706772|NCT00995137|Relapsed or refractory B-Lineage ALL|relapsed or refractory b-lineage all
706773|NCT00995150|contraception|contraception
706774|NCT00995150|intrauterine|intrauterine
706775|NCT00995150|long-term|long-term
706776|NCT00995150|reversible|reversible
706777|NCT00995163|outcomes study|outcomes study
706778|NCT00995163|hemodialysis|hemodialysis
706779|NCT00995163|CKD-MBD|ckd-mbd
706780|NCT00995176|Prevention|prevention
706781|NCT00995176|HIV|hiv
706782|NCT00995176|HIV seronegativity|hiv seronegativity
706783|NCT00995189|contact lens wear|contact lens wear
706784|NCT00995189|multi-purpose solution|multi-purpose solution
706785|NCT00995189|corneal staining|corneal staining
706786|NCT00995202|stage II colon cancer|stage ii colon cancer
706787|NCT00995202|stage II rectal cancer|stage ii rectal cancer
706788|NCT00995202|stage III colon cancer|stage iii colon cancer
706789|NCT00995202|stage III rectal cancer|stage iii rectal cancer
706790|NCT00995202|adenocarcinoma of the colon|adenocarcinoma of the colon
706791|NCT00995202|adenocarcinoma of the rectum|adenocarcinoma of the rectum
706792|NCT00995215|spinal cord injury|spinal cord injury
706793|NCT00995215|SCI|sci
706794|NCT00995215|paralysis|paralysis
706795|NCT00995215|cough|cough
706796|NCT00995215|cervical spinal cord injury|cervical spinal cord injury
707538|NCT00997854|Feeding|feeding
706797|NCT00995215|thoracic spinal cord injury|thoracic spinal cord injury
706798|NCT00995228|overhydration|overhydration
706799|NCT00995228|fluid restriction|fluid restriction
706800|NCT00995228|post-anesthesia care unit|post-anesthesia care unit
706801|NCT00995241|Raltegravir|raltegravir
706802|NCT00995241|intracellular concentration|intracellular concentration
706803|NCT00995241|plasmatic concentration|plasmatic concentration
706804|NCT00995241|HIV|hiv
706805|NCT00995241|Treatment experienced|treatment experienced
706806|NCT00995254|secondhand smoke|secondhand smoke
706807|NCT00995254|children|children
706808|NCT00995254|Chinese|chinese
706809|NCT00995254|respiratory symptoms|respiratory symptoms
706810|NCT00995254|household smoking policy|household smoking policy
706811|NCT00995254|Respiratory illnesses among children|respiratory illnesses among children
706812|NCT00995267|childhood obesity|childhood obesity
706813|NCT00995267|nutrition|nutrition
706814|NCT00995267|exercise|exercise
706815|NCT00995267|Alfred Adler|alfred adler
706816|NCT00995267|schoolchildren|schoolchildren
706817|NCT00995267|intervention study|intervention study
706818|NCT00995267|community-based trial|community-based trial
706819|NCT00995267|parent-child interaction|parent-child interaction
706820|NCT00995267|nutritional behaviors|nutritional behaviors
706821|NCT00995280|follicle flushing|follicle flushing
706822|NCT00995280|oocyte retrieval|oocyte retrieval
706823|NCT00995280|needle|needle
706824|NCT00995306|Active comparator|active comparator
706825|NCT00995306|Active civamide cream, 0.075%|active civamide cream, 0.075%
706826|NCT00995306|Active civamide cream, 0.01%|active civamide cream, 0.01%
706827|NCT00995319|mouth|mouth
706828|NCT00995319|Mucositis|mucositis
706829|NCT00995319|Dysphagia|dysphagia
706830|NCT00995319|malnutrition|malnutrition
706831|NCT00995319|Xerostomia|xerostomia
706832|NCT00995319|saliva|saliva
706833|NCT00995319|tooth injuries|tooth injuries
706834|NCT00995332|Acute myelogenous leukemia|acute myelogenous leukemia
706835|NCT00995332|all-trans retinoic acid|all-trans retinoic acid
706836|NCT00995332|valproic acid|valproic acid
706837|NCT00995332|cytarabine|cytarabine
706838|NCT00995332|Disease stabilization|disease stabilization
706839|NCT00995332|survival|survival
706840|NCT00995332|toxicity|toxicity
706841|NCT00995345|Type 2 Diabetes|type 2 diabetes
706842|NCT00995345|Metformin|metformin
706843|NCT00995358|Epitope peptide|epitope peptide
706844|NCT00995358|CTL|ctl
706845|NCT00995358|Esophageal cancer|esophageal cancer
706846|NCT00995358|Vaccination|vaccination
706847|NCT00995371|Spinal Stenosis|spinal stenosis
706848|NCT00995371|Lumbar Spinal Stenosis|lumbar spinal stenosis
706849|NCT00995371|Laminotomy|laminotomy
706850|NCT00995371|Laminectomy|laminectomy
706851|NCT00995371|Spine Surgery|spine surgery
706852|NCT00995397|Insect bites|insect bites
706853|NCT00995397|Dexchlorpheniramine|dexchlorpheniramine
706854|NCT00995397|Lotion|lotion
706855|NCT00995397|Cream|cream
706856|NCT00995410|Subjects Who are at Risk for Developing Aspirin-ASA|subjects who are at risk for developing aspirin-asa
706857|NCT00995410|Subject must have a pre-existing condition for which aspirin is already indicated|subject must have a pre-existing condition for which aspirin is already indicated
706858|NCT00995410|Gastric Ulcers|gastric ulcers
706859|NCT00995423|Coronary Artery Disease|coronary artery disease
706860|NCT00995423|stent|stent
706861|NCT00995436|Extractions|extractions
706862|NCT00995436|Anchorage supplementation|anchorage supplementation
706863|NCT00995449|Rheumatoid Arthritis|rheumatoid arthritis
706864|NCT00995449|Biologics-Inadequate|biologics-inadequate
706865|NCT00995449|KB003|kb003
706866|NCT00995449|GM-CSF|gm-csf
706867|NCT00995488|Urothelial Cancer|urothelial cancer
706868|NCT00995488|ABI-007|abi-007
706869|NCT00995488|Bladder Cancer|bladder cancer
706870|NCT00995488|front-line|front-line
706871|NCT00995501|steroid administration|steroid administration
706872|NCT00995501|tight glucose control|tight glucose control
706873|NCT00995501|light anesthesiReducing inflammatory response to surgical stress|light anesthesireducing inflammatory response to surgical stress
706874|NCT00995501|a|a
706875|NCT00995514|acute coronary syndrome|acute coronary syndrome
706876|NCT00995514|cardiovascular death|cardiovascular death
706877|NCT00995514|non-fatal MI|non-fatal mi
706878|NCT00995514|non-fatal stroke|non-fatal stroke
706879|NCT00995514|genetic testing|genetic testing
706880|NCT00995514|CYP2C19|cyp2c19
706881|NCT00995514|clopidogrel|clopidogrel
706882|NCT00995514|prasugrel|prasugrel
706883|NCT00995514|antiplatelet therapy|antiplatelet therapy
706884|NCT00995514|genotyping|genotyping
706885|NCT00995514|bleeding|bleeding
706886|NCT00995527|Post Swine Flu Blood Samples|post swine flu blood samples
706887|NCT00995527|Biologic Sample Collection|biologic sample collection
706888|NCT00995527|Laboratory Research Samples|laboratory research samples
706889|NCT00995527|H1N1 Vaccine Samples|h1n1 vaccine samples
706890|NCT00995527|HV|hv
706891|NCT00995527|Healthy Volunteer|healthy volunteer
706892|NCT00995540|T1DM|t1dm
706893|NCT00995540|Regeneration|regeneration
706894|NCT00995540|Islet|islet
706895|NCT00995540|Beta cell|beta cell
706896|NCT00995540|INGAP Peptide|ingap peptide
706897|NCT00995579|Physical Activity|physical activity
706898|NCT00995579|Energy Expenditure|energy expenditure
706899|NCT00995592|nutrition|nutrition
706900|NCT00995592|child weight|child weight
706901|NCT00995592|undernourishment|undernourishment
706902|NCT00995592|mentor mother|mentor mother
706903|NCT00995592|South Africa|south africa
706904|NCT00995618|Gout|gout
706905|NCT00995618|Hyperuricemia|hyperuricemia
706906|NCT00995631|liposuction|liposuction
706907|NCT00995631|adipose tissue|adipose tissue
706908|NCT00995631|dietary fatty acids|dietary fatty acids
706909|NCT00995631|triglyceride storage|triglyceride storage
706910|NCT00995631|Normal healthy aging|normal healthy aging
706911|NCT00995644|smoking|smoking
706912|NCT00995644|smoking cessation|smoking cessation
706913|NCT00995644|tobacco use cessation|tobacco use cessation
706914|NCT00995644|tobacco use disorder|tobacco use disorder
706915|NCT00995670|hyperglycemia|hyperglycemia
706916|NCT00995670|statin|statin
706917|NCT00995670|blood vessels|blood vessels
706918|NCT00995670|ischemic preconditioning|ischemic preconditioning
706919|NCT00995670|Anesthesia, inhalational|anesthesia, inhalational
706920|NCT00995670|endothelium|endothelium
706921|NCT00995670|5% dextrose|5% dextrose
706922|NCT00995683|intracranial hypertension|intracranial hypertension
706923|NCT00995683|neurological outcome|neurological outcome
706924|NCT00995683|osmotherapy|osmotherapy
751867|NCT01170936|anti-IL1ß therapy|anti-il1ß therapy
706925|NCT00995696|Interactive Voice Response (IVR)|interactive voice response (ivr)
706926|NCT00995696|Antidepressant|antidepressant
706927|NCT00995709|Behçet's disease,|behçet's disease,
706928|NCT00995709|intermediate uveitis|intermediate uveitis
706929|NCT00995709|panuveitis|panuveitis
706930|NCT00995709|posterior uveitis|posterior uveitis
706931|NCT00995709|uveitis|uveitis
706932|NCT00995722|Ocular myasthenia gravis|ocular myasthenia gravis
706933|NCT00995722|Prednisone|prednisone
706934|NCT00995722|Steroids|steroids
706935|NCT00995735|NOTES|notes
706936|NCT00995735|Natural Orifice Translumenal Endoscopic surgery|natural orifice translumenal endoscopic surgery
706937|NCT00995735|Cholecystectomy|cholecystectomy
706938|NCT00995735|Appendectomy|appendectomy
706939|NCT00995735|Endoscopy|endoscopy
706940|NCT00995735|Laparoscopy|laparoscopy
706941|NCT00995735|Minimally invasive surgery|minimally invasive surgery
706942|NCT00995735|clinical trials|clinical trials
706943|NCT00995761|biweekly|biweekly
706944|NCT00995761|docetaxel|docetaxel
706945|NCT00995761|cisplatin|cisplatin
706946|NCT00995761|non-small cell lung cancer|non-small cell lung cancer
706947|NCT00995774|stroke|stroke
706948|NCT00995774|function|function
706949|NCT00995774|arm|arm
706950|NCT00995774|hand|hand
706951|NCT00995774|robotic|robotic
706952|NCT00995774|therapy|therapy
706953|NCT00995774|motor|motor
706954|NCT00995774|movement|movement
706955|NCT00995774|treatment|treatment
706956|NCT00995787|Type II diabetes mellitus|type ii diabetes mellitus
706957|NCT00995787|metformin|metformin
706958|NCT00995787|sulfonylurea|sulfonylurea
706959|NCT00995800|Asthma|asthma
706960|NCT00995813|Intestinal failure|intestinal failure
706961|NCT00995813|Rotavirus vaccine|rotavirus vaccine
706962|NCT00995813|Infants|infants
706963|NCT00995839|terlipressin|terlipressin
706964|NCT00995839|vasopressin|vasopressin
706965|NCT00995839|sepsis|sepsis
706966|NCT00995839|septic shock|septic shock
706967|NCT00995839|norepinephrine|norepinephrine
706968|NCT00995852|Endoscopic lung volume reduction|endoscopic lung volume reduction
706969|NCT00995852|emphysema|emphysema
706970|NCT00995852|COPD|copd
706971|NCT00995852|Patients with bilateral heterogeneous pulmonary emphysema|patients with bilateral heterogeneous pulmonary emphysema
706972|NCT00995865|Prevention of yellow fever virus infection|prevention of yellow fever virus infection
706973|NCT00995878|Uterine fibroids|uterine fibroids
706974|NCT00995878|Fibroids|fibroids
706975|NCT00995878|Uterine leiomyomas|uterine leiomyomas
706976|NCT00995878|UAE|uae
706977|NCT00995878|UFE|ufe
706978|NCT00995878|Magnetic resonance guided focused ultrasound|magnetic resonance guided focused ultrasound
706979|NCT00995878|MRgFUS|mrgfus
706980|NCT00995878|Pelvic pain|pelvic pain
706981|NCT00995891|Laboratory Research Specimens|laboratory research specimens
706982|NCT00995891|Biologic Samples|biologic samples
706983|NCT00995891|Sample Collection|sample collection
706984|NCT00995891|Tissue Procurement|tissue procurement
706985|NCT00995891|HV|hv
706986|NCT00995891|Healthy Volunteer|healthy volunteer
706987|NCT00995904|asthmatic children|asthmatic children
706988|NCT00995917|acupuncture|acupuncture
706989|NCT00995917|menstrual pain|menstrual pain
706990|NCT00995917|dysmenorrhea|dysmenorrhea
706991|NCT00995917|menstrual cramps|menstrual cramps
706992|NCT00995917|vitamin K1|vitamin k1
706993|NCT00995930|Atherosclerosis,|atherosclerosis,
706994|NCT00995930|Type 2 Diabetes Mellitus, T2DM,|type 2 diabetes mellitus, t2dm,
706995|NCT00995930|Cardiovascular Diseases, ACZ885, impaired glucose tolerance, IGT, Canakinumab|cardiovascular diseases, acz885, impaired glucose tolerance, igt, canakinumab
706996|NCT00995956|Albumin|albumin
706997|NCT00995956|Mycophenolic acid|mycophenolic acid
706998|NCT00995956|IMPDH|impdh
706999|NCT00995956|Free fraction|free fraction
707000|NCT00995969|Mild to moderate psoriasis vulgaris|mild to moderate psoriasis vulgaris
707001|NCT00995982|Influenza|influenza
707002|NCT00995982|Healthy|healthy
707003|NCT00995982|Immunity|immunity
707004|NCT00995982|Preventive|preventive
707005|NCT00995982|Flu|flu
707006|NCT00995982|HV|hv
707007|NCT00995982|Healthy Volunteer|healthy volunteer
707008|NCT00996021|GSK1349572|gsk1349572
707009|NCT00996021|moxifloxacin|moxifloxacin
707010|NCT00996021|Avelox|avelox
707011|NCT00996021|QTc|qtc
707012|NCT00996034|Nicotine, SPECT, vaccine, receptor|nicotine, spect, vaccine, receptor
707013|NCT00996047|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
707014|NCT00996047|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
707015|NCT00996047|acute undifferentiated leukemia|acute undifferentiated leukemia
707016|NCT00996047|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
707017|NCT00996047|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
707018|NCT00996047|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
707019|NCT00996047|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
751868|NCT01170949|urticaria|urticaria
707020|NCT00996047|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
707021|NCT00996047|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
707022|NCT00996047|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
707023|NCT00996047|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
707024|NCT00996047|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
707025|NCT00996047|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
707026|NCT00996047|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
707027|NCT00996047|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
707028|NCT00996047|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
707029|NCT00996047|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
707030|NCT00996047|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
707031|NCT00996047|mast cell leukemia|mast cell leukemia
707032|NCT00996047|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
707033|NCT00996047|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
707034|NCT00996047|prolymphocytic leukemia|prolymphocytic leukemia
707035|NCT00996047|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
707036|NCT00996047|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
707037|NCT00996047|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
707038|NCT00996047|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
707039|NCT00996047|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
707040|NCT00996047|refractory hairy cell leukemia|refractory hairy cell leukemia
707041|NCT00996047|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
707042|NCT00996047|secondary acute myeloid leukemia|secondary acute myeloid leukemia
707043|NCT00996047|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
707044|NCT00996047|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
707045|NCT00996047|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
707046|NCT00996047|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
707047|NCT00996047|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
707048|NCT00996047|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
707049|NCT00996047|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
707050|NCT00996047|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
707051|NCT00996047|untreated hairy cell leukemia|untreated hairy cell leukemia
707052|NCT00996047|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
707053|NCT00996047|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
707054|NCT00996047|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
707055|NCT00996047|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
707158|NCT00996346|20091334|20091334
707056|NCT00996047|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
707057|NCT00996047|myelodysplastic/myeloproliferative neoplasms|myelodysplastic/myeloproliferative neoplasms
707058|NCT00996060|Lung Cancer|lung cancer
707059|NCT00996060|Advanced Lung Cancer|advanced lung cancer
707060|NCT00996060|Unresectable Lung cancer|unresectable lung cancer
707061|NCT00996060|Previously treated lung cancer|previously treated lung cancer
707062|NCT00996073|Degenerative disc disease|degenerative disc disease
707063|NCT00996073|Spondylolisthesis|spondylolisthesis
707064|NCT00996073|Spinal stenosis|spinal stenosis
707065|NCT00996073|Stem cells|stem cells
707066|NCT00996073|Adult Stem Cells|adult stem cells
707067|NCT00996073|Spinal Fusion|spinal fusion
707068|NCT00996073|Lumbar Spinal Fusion|lumbar spinal fusion
707069|NCT00996073|TLIF|tlif
707070|NCT00996073|PLIF|plif
707071|NCT00996073|Mesoblast|mesoblast
707539|NCT00997854|Intolerance|intolerance
707072|NCT00996099|continuous glucose monitoring|continuous glucose monitoring
707073|NCT00996099|intensive insulin therapy|intensive insulin therapy
707074|NCT00996099|critically ill|critically ill
707075|NCT00996099|cardiac surgery|cardiac surgery
707076|NCT00996099|hyperglycemia of critically ill|hyperglycemia of critically ill
707077|NCT00996112|primary health care|primary health care
707078|NCT00996125|Immunogenicity|immunogenicity
707079|NCT00996125|Safety|safety
707080|NCT00996125|Human papillomavirus|human papillomavirus
707081|NCT00996125|China|china
707082|NCT00996125|HPV vaccine|hpv vaccine
707083|NCT00996138|Influenza A|influenza a
707084|NCT00996138|H1N1 subtype|h1n1 subtype
707085|NCT00996138|Adult|adult
707086|NCT00996138|Vaccine|vaccine
707087|NCT00996138|Adjuvant|adjuvant
707088|NCT00996138|Swine-Origin Influenza A H1N1 Virus|swine-origin influenza a h1n1 virus
707089|NCT00996151|Hypergonadism|hypergonadism
707090|NCT00996151|Testosterone Transfer|testosterone transfer
707091|NCT00996177|Pain|pain
707092|NCT00996177|Patient-controlled analgesia|patient-controlled analgesia
707093|NCT00996177|Postoperative pain|postoperative pain
707094|NCT00996177|Transdermal fentanyl|transdermal fentanyl
707095|NCT00996177|Surgical pain|surgical pain
707096|NCT00996177|Opioid analgesics|opioid analgesics
707097|NCT00996190|transthoracic bioreactance|transthoracic bioreactance
707098|NCT00996190|noninvasive monitoring|noninvasive monitoring
707099|NCT00996190|vasopressor|vasopressor
707100|NCT00996190|blood pressure|blood pressure
707101|NCT00996216|Peginterferon|peginterferon
707102|NCT00996216|Platelets|platelets
707103|NCT00996216|Ribavirin|ribavirin
707104|NCT00996216|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
707105|NCT00996216|Thrombocytopenia|thrombocytopenia
707106|NCT00996216|Hepatitis C|hepatitis c
707107|NCT00996216|Thrombopoietin|thrombopoietin
707109|NCT00996229|elderly|elderly
707110|NCT00996229|cognition|cognition
707111|NCT00996229|prevention|prevention
707112|NCT00996229|cognitive decline|cognitive decline
707113|NCT00996229|Lifestyle|lifestyle
707114|NCT00996242|Schizophrenia|schizophrenia
707115|NCT00996242|L-lysine|l-lysine
707116|NCT00996242|PANSS|panss
707117|NCT00996268|hypertriglyceridemia|hypertriglyceridemia
707118|NCT00996268|GSK2212836|gsk2212836
707119|NCT00996268|relative bioavailability|relative bioavailability
707120|NCT00996281|Hypertensive|hypertensive
707121|NCT00996281|Blood Pressure, High|blood pressure, high
707122|NCT00996281|Cardiovascular disease|cardiovascular disease
707123|NCT00996281|Vascular Disease|vascular disease
707124|NCT00996281|Drug Therapy|drug therapy
707125|NCT00996307|Swine Flu|swine flu
707126|NCT00996307|Flu|flu
707127|NCT00996307|Vaccine|vaccine
707128|NCT00996307|Children|children
707129|NCT00996307|Adjuvant|adjuvant
707130|NCT00996307|A/H1N1 2009 Influenza|a/h1n1 2009 influenza
707131|NCT00996320|Internship and Residency|internship and residency
707132|NCT00996320|Medical Errors|medical errors
707133|NCT00996320|Burnout, Professional|burnout, professional
707134|NCT00996320|Burnout|burnout
707135|NCT00996320|Depression|depression
707136|NCT00996320|Actigraphy|actigraphy
707137|NCT00996320|Personnel Staffing and Scheduling|personnel staffing and scheduling
707138|NCT00996320|Sleep Deprivation|sleep deprivation
707139|NCT00996320|Workload|workload
707140|NCT00996320|Humans|humans
707142|NCT00996320|Male|male
707143|NCT00996320|Female|female
707144|NCT00996320|Intensive Care Units|intensive care units
707145|NCT00996320|Prospective Studies|prospective studies
707146|NCT00996320|Crossover Studies|crossover studies
707147|NCT00996320|Work Schedule Tolerance|work schedule tolerance
707148|NCT00996320|Disorders of Excessive Somnolence|disorders of excessive somnolence
707149|NCT00996320|Guideline Adherence|guideline adherence
707150|NCT00996320|Internal Medicine Education|internal medicine education
707151|NCT00996333|Stage IVB|stage ivb
707152|NCT00996346|INST 0909|inst 0909
707153|NCT00996346|Irinotecan|irinotecan
707154|NCT00996346|Temsirolimus|temsirolimus
707155|NCT00996346|refractory sarcomas|refractory sarcomas
707156|NCT00996346|3066K1|3066k1
707157|NCT00996346|3066K1-1208|3066k1-1208
707159|NCT00996359|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
707160|NCT00996359|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
707161|NCT00996359|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
707162|NCT00996359|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
707163|NCT00996359|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
707164|NCT00996359|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
707165|NCT00996359|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
707166|NCT00996359|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
707167|NCT00996359|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
707168|NCT00996359|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
707169|NCT00996359|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
707170|NCT00996359|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
707171|NCT00996359|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
707172|NCT00996359|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
707173|NCT00996359|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
707174|NCT00996359|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
707175|NCT00996359|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
707176|NCT00996359|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
707177|NCT00996359|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
707178|NCT00996359|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
707179|NCT00996359|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
707180|NCT00996359|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
707181|NCT00996359|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
707182|NCT00996359|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
707183|NCT00996359|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
707184|NCT00996359|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
707185|NCT00996359|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
707186|NCT00996359|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
707187|NCT00996359|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
707188|NCT00996359|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
707189|NCT00996359|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
707370|NCT00996567|Malignant mesothelioma|malignant mesothelioma
707190|NCT00996359|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
707191|NCT00996359|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
707192|NCT00996359|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
707193|NCT00996359|peripheral T-cell lymphoma|peripheral t-cell lymphoma
707194|NCT00996359|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
707195|NCT00996359|anaplastic large cell lymphoma|anaplastic large cell lymphoma
707196|NCT00996359|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
707197|NCT00996359|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
707198|NCT00996359|splenic marginal zone lymphoma|splenic marginal zone lymphoma
707199|NCT00996359|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
707200|NCT00996359|refractory multiple myeloma|refractory multiple myeloma
707201|NCT00996359|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
707202|NCT00996359|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
707203|NCT00996359|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
707204|NCT00996359|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
707205|NCT00996359|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
707206|NCT00996359|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
707207|NCT00996359|Burkitt lymphoma|burkitt lymphoma
707208|NCT00996359|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
707209|NCT00996359|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
707210|NCT00996359|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
707211|NCT00996359|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
707212|NCT00996359|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
707213|NCT00996359|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
707214|NCT00996359|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
707215|NCT00996385|Pleural Mesothelioma|pleural mesothelioma
707216|NCT00996385|Peritoneal Mesothelioma|peritoneal mesothelioma
707217|NCT00996398|Cryotherapy|cryotherapy
707218|NCT00996398|Joint Position Sense|joint position sense
707219|NCT00996398|Proprioception|proprioception
707220|NCT00996398|Pre Cooling|pre cooling
707221|NCT00996398|Knee Injury|knee injury
707222|NCT00996398|Physical Therapy Modalities|physical therapy modalities
707622|NCT00998140|asystole|asystole
707223|NCT00996398|Physical Therapy Techniques|physical therapy techniques
707224|NCT00996398|Weightbearing|weightbearing
707225|NCT00996398|NonWeightbearing|nonweightbearing
707226|NCT00996398|Randomised Control Trial|randomised control trial
707227|NCT00996411|Healthy volunteers are being studied to evaluate the subject-rated, behavioral, and abuse liability effects of salvinorin A|healthy volunteers are being studied to evaluate the subject-rated, behavioral, and abuse liability effects of salvinorin a
707228|NCT00996437|vitreous|vitreous
707229|NCT00996437|hemorrhage|hemorrhage
707230|NCT00996437|proliferative|proliferative
707231|NCT00996437|diabetic|diabetic
707232|NCT00996437|retinopathy|retinopathy
707233|NCT00996437|intravitreal|intravitreal
707234|NCT00996437|ranibizumab|ranibizumab
707235|NCT00996437|Lucentis|lucentis
707236|NCT00996437|saline|saline
707237|NCT00996437|vitrectomy|vitrectomy
707238|NCT00996450|brain tumour|brain tumour
707239|NCT00996476|Hepatitis C|hepatitis c
707240|NCT00996476|Hepatitis C virus|hepatitis c virus
707241|NCT00996476|Interferon Alfa-2a|interferon alfa-2a
707242|NCT00996476|Ribavirin|ribavirin
707243|NCT00996476|Viral RNA|viral rna
707244|NCT00996515|Advanced Solid Tumor Malignancies|advanced solid tumor malignancies
707245|NCT00996515|Erlotinib|erlotinib
707246|NCT00996515|Vidaza|vidaza
707247|NCT00996515|Tarceva|tarceva
707248|NCT00996515|5-azacytidine|5-azacytidine
707249|NCT00996528|fetal alcohol syndrome|fetal alcohol syndrome
707250|NCT00996528|alcohol abuse|alcohol abuse
707252|NCT00996528|malnutrition|malnutrition
707253|NCT00996528|children|children
707254|NCT00996528|mentor mother|mentor mother
708959|NCT00993031|HIV|hiv
707255|NCT00996528|behavioral intervention|behavioral intervention
707256|NCT00996528|South Africa|south africa
707257|NCT00996528|Maternal alcohol use|maternal alcohol use
707258|NCT00996528|HIV-related transmission behaviors|hiv-related transmission behaviors
707259|NCT00996528|low birth weight babies and low-weight children|low birth weight babies and low-weight children
707260|NCT00996528|HIV Seronegativity|hiv seronegativity
707261|NCT00996541|Runaway youth|runaway youth
707262|NCT00996541|Homeless youth|homeless youth
707263|NCT00996541|Family intervention|family intervention
707264|NCT00996541|Family functioning|family functioning
707265|NCT00996541|HIV risk behavior|hiv risk behavior
707266|NCT00996541|HIV Seronegativity|hiv seronegativity
707267|NCT00985686|e-mental health|e-mental health
707268|NCT00985686|Adolescent mental health|adolescent mental health
707269|NCT00985686|Spirituality|spirituality
707270|NCT00985699|non-Hodgkin lymphoma|non-hodgkin lymphoma
707271|NCT00985699|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
707668|NCT00998322|pancreatic|pancreatic
707272|NCT00985699|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
707273|NCT00985699|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
707274|NCT00985725|Major Depressive Disorder|major depressive disorder
707275|NCT00985738|Prostate Cancer|prostate cancer
707276|NCT00985738|Early Stage Prostate Cancer|early stage prostate cancer
707277|NCT00985751|immunogenicity|immunogenicity
707278|NCT00985751|toddlers|toddlers
707279|NCT00985751|Pneumococcal vaccine|pneumococcal vaccine
707280|NCT00985751|Haemophilus influenzae|haemophilus influenzae
707281|NCT00985751|safety|safety
707282|NCT00985751|Streptococcus pneumoniae|streptococcus pneumoniae
707283|NCT00985751|Streptococcus Pneumoniae Vaccines|streptococcus pneumoniae vaccines
707284|NCT00985777|pancreas|pancreas
707285|NCT00985777|resectable|resectable
707286|NCT00985777|pancreatic tumor|pancreatic tumor
707287|NCT00985777|pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
707288|NCT00985777|intraductal papillary mucinous neoplasm of the pancreas|intraductal papillary mucinous neoplasm of the pancreas
707289|NCT00985777|mucinous cystic neoplasm|mucinous cystic neoplasm
707290|NCT00985777|pancreatic exocrine neoplasia|pancreatic exocrine neoplasia
707291|NCT00985790|vaccine|vaccine
707292|NCT00985790|Influenza|influenza
707293|NCT00985803|Systemic Lupus Erythematosus|systemic lupus erythematosus
707294|NCT00985803|Activity Physical|activity physical
707295|NCT00985803|Activity Disease,trials randomized|activity disease,trials randomized
707296|NCT00985816|Preterm|preterm
707297|NCT00985816|newborns|newborns
707298|NCT00985816|Gastric|gastric
707299|NCT00985816|Motility|motility
707300|NCT00985816|Mucosal|mucosal
707301|NCT00985816|immunity|immunity
707302|NCT00985829|basal cell carcinoma|basal cell carcinoma
707303|NCT00985829|photodynamic therapy|photodynamic therapy
707304|NCT00985829|photo chemotherapy|photo chemotherapy
707305|NCT00985829|basal cell epithelioma|basal cell epithelioma
707306|NCT00985842|Artificial limbs|artificial limbs
707307|NCT00985842|Gait|gait
707308|NCT00985842|Oximetry|oximetry
707309|NCT00985842|Prosthesis|prosthesis
707310|NCT00985842|Rehabilitation|rehabilitation
707311|NCT00985868|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
707312|NCT00985881|Artificial limbs|artificial limbs
707313|NCT00985881|Gait|gait
707314|NCT00985881|Posture|posture
707315|NCT00985881|Prosthesis|prosthesis
707316|NCT00985881|Vibration|vibration
707317|NCT00985894|Teledermatology|teledermatology
707318|NCT00985894|Telemedicine|telemedicine
707319|NCT00985894|Atopic Dermatitis|atopic dermatitis
707320|NCT00985907|myeloma|myeloma
707321|NCT00985907|DMV|dmv
707322|NCT00985920|blood loss|blood loss
707323|NCT00985920|postoperative|postoperative
707324|NCT00985933|Healthy normal volunteers|healthy normal volunteers
707325|NCT00985959|Multiple myeloma|multiple myeloma
707326|NCT00985959|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
707327|NCT00985959|HSCT|hsct
707328|NCT00985959|Melphalan|melphalan
707329|NCT00985959|Prednisolone|prednisolone
707330|NCT00985959|Bortezomib|bortezomib
707331|NCT00985959|JNJ-26866138|jnj-26866138
707332|NCT00985972|PHYSICAL ACTIVITY|physical activity
707333|NCT00985972|SCHOOL|school
707334|NCT00985972|NUTRITION|nutrition
707335|NCT00985972|EDUCATION|education
707336|NCT00985972|OVERWEIGHT|overweight
707337|NCT00985985|smoking cessation|smoking cessation
707338|NCT00985985|nicotine lozenge|nicotine lozenge
707339|NCT00985985|nicotine replacement therapy|nicotine replacement therapy
707340|NCT00985998|nimotuzumab|nimotuzumab
707341|NCT00985998|non-small cell lung cancer|non-small cell lung cancer
707342|NCT00985998|chemotherapy|chemotherapy
707343|NCT00986011|obesity|obesity
707344|NCT00986011|weight changes|weight changes
707345|NCT00986011|healthy, no evidence of disease|healthy, no evidence of disease
707346|NCT00986024|Exercise therapy|exercise therapy
707347|NCT00986037|Adverse events|adverse events
707348|NCT00986037|Pharmacokinetics|pharmacokinetics
707349|NCT00986050|STEMI|stemi
707350|NCT00986050|DES|des
707351|NCT00986050|BMS|bms
707352|NCT00986050|abciximab|abciximab
707353|NCT00986063|Nevirapine induced rash|nevirapine induced rash
707354|NCT00986063|Hepatitis|hepatitis
707355|NCT00986063|Pharmacogenomics|pharmacogenomics
707356|NCT00986063|AIDS|aids
707357|NCT00986063|HIV|hiv
707359|NCT00986076|Pediatric Cataract Surgery|pediatric cataract surgery
707360|NCT00986076|Low-Molecular weight Heparin|low-molecular weight heparin
707361|NCT00986076|Intraocular infusion|intraocular infusion
707362|NCT00986076|Anti-inflammatory effect|anti-inflammatory effect
707363|NCT00986089|post-placental|post-placental
707364|NCT00986089|IUD|iud
707365|NCT00986089|Copper IUD|copper iud
707366|NCT00986089|cesarean section|cesarean section
707367|NCT00986089|immediate post-partum|immediate post-partum
707368|NCT00986089|continuation|continuation
707369|NCT00996554|Hand-sutured colo-colonic and ileo-colonic anastomoses in elective surgery|hand-sutured colo-colonic and ileo-colonic anastomoses in elective surgery
707371|NCT00996580|Contraception|contraception
707372|NCT00996580|Oral contraceptives|oral contraceptives
707373|NCT00996593|Tositumomab|tositumomab
707374|NCT00996593|radioimmunotherapy|radioimmunotherapy
707375|NCT00996593|rituximab|rituximab
707376|NCT00996593|anti-B1|anti-b1
707377|NCT00996593|I 131|i 131
707378|NCT00996593|Bexxar|bexxar
707379|NCT00996593|iodine|iodine
707380|NCT00996593|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
707381|NCT00996632|breast cancer|breast cancer
707382|NCT00996632|ultrasonic knife|ultrasonic knife
707383|NCT00996632|volume drainage|volume drainage
707384|NCT00996645|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
707385|NCT00996645|Coronary Artery Disease|coronary artery disease
707386|NCT00996645|Primary Health Care|primary health care
707387|NCT00996645|Feedback, Psychological|feedback, psychological
707388|NCT00996645|Quality Assurance, Health Care|quality assurance, health care
707389|NCT00996671|focal adhesion kinase inhibitor|focal adhesion kinase inhibitor
707390|NCT00996671|healthy volunteers|healthy volunteers
707391|NCT00996671|first time in human|first time in human
707392|NCT00996684|Wet age related macular degeneration (AMD)|wet age related macular degeneration (amd)
707393|NCT00996684|Wet AMD|wet amd
707394|NCT00996684|Vitreomacular adhesion (VMA)|vitreomacular adhesion (vma)
707395|NCT00996684|Vitreomacular traction (VMT)|vitreomacular traction (vmt)
707396|NCT00996684|Neovascular age related macular degeneration|neovascular age related macular degeneration
707397|NCT00996697|COPD (chronic obstructive pulmonary disease)|copd (chronic obstructive pulmonary disease)
707398|NCT00996710|Genome-wide|genome-wide
707399|NCT00996710|09-068|09-068
707400|NCT00996736|Fungal Infections|fungal infections
707401|NCT00996736|Eye Disease|eye disease
707402|NCT00996736|Fungal Keratitis|fungal keratitis
707403|NCT00996736|Visual Acuity|visual acuity
707404|NCT00996762|bioequivalence, lapatinib, GW572016|bioequivalence, lapatinib, gw572016
707405|NCT00996775|Alcohol Consumption|alcohol consumption
707406|NCT00996788|Patients suffering of dyspepsia due to chronic gastritis|patients suffering of dyspepsia due to chronic gastritis
707407|NCT00996814|Bioethics|bioethics
707408|NCT00996827|Melanoma|melanoma
707409|NCT00996827|Skin cancer|skin cancer
707410|NCT00996827|Vitamin D|vitamin d
707411|NCT00996827|Vitamin D receptor|vitamin d receptor
707412|NCT00996827|Sunlight|sunlight
707413|NCT00996827|Cytokine|cytokine
707414|NCT00996840|dilmapimod|dilmapimod
707415|NCT00996840|p38|p38
707416|NCT00996840|SB-681323|sb-681323
707417|NCT00996840|Acute Lung Injury (ALI)|acute lung injury (ali)
708599|NCT00991627|Narcotics|narcotics
707418|NCT00996840|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
707419|NCT00996853|safety|safety
707420|NCT00996853|Influenza|influenza
707421|NCT00996853|vaccine|vaccine
707422|NCT00996853|reactogenicity|reactogenicity
707423|NCT00996853|swine flu|swine flu
707424|NCT00996879|Human Volunteers|human volunteers
707425|NCT00997425|wandering|wandering
707426|NCT00997425|subjective exit barriers|subjective exit barriers
707427|NCT00997451|Medically unexplained chronic fatigue|medically unexplained chronic fatigue
707428|NCT00997451|Chronic fatigue syndrome|chronic fatigue syndrome
707429|NCT00997451|Cognitive-behavior therapy|cognitive-behavior therapy
707430|NCT00997451|Self-management|self-management
707431|NCT00997451|Primary care|primary care
707432|NCT00997451|Nurses|nurses
707433|NCT00997451|Economic analysis|economic analysis
707434|NCT00997451|Cost effectiveness|cost effectiveness
707540|NCT00997854|Preterm|preterm
707435|NCT00997451|One year follow-up|one year follow-up
707436|NCT00997477|aerolizer|aerolizer
707437|NCT00997477|formoterol|formoterol
707438|NCT00997477|budesonide|budesonide
707439|NCT00997477|asthma|asthma
707440|NCT00997490|depression|depression
707441|NCT00997490|HAMD 21|hamd 21
707442|NCT00997490|anxiety|anxiety
707443|NCT00997490|HAMA|hama
707444|NCT00997490|Hypericum|hypericum
707445|NCT00997490|Valerian|valerian
707446|NCT00997490|Passionflower|passionflower
707447|NCT00997490|F32.0|f32.0
707448|NCT00997490|F33.0|f33.0
707449|NCT00997516|Laparoscopy|laparoscopy
707450|NCT00997516|Appendicitis|appendicitis
707451|NCT00997516|Single-incision laparoscopic surgery|single-incision laparoscopic surgery
707452|NCT00997516|SILS|sils
707453|NCT00997529|Stem cell transplant|stem cell transplant
707454|NCT00997529|Non-myeloablative|non-myeloablative
707455|NCT00997529|Metastatic Solid Tumor|metastatic solid tumor
707456|NCT00997529|Donor Leukocyte Infusion|donor leukocyte infusion
707457|NCT00997555|inhalation|inhalation
707458|NCT00997555|bronchoscopy|bronchoscopy
707459|NCT00997555|burn|burn
707460|NCT00997555|pneumonia|pneumonia
707461|NCT00997568|transesophageal|transesophageal
707462|NCT00997568|transducer|transducer
707463|NCT00997568|TEE|tee
707464|NCT00997581|Gout|gout
707465|NCT00997594|adrenal gland|adrenal gland
707466|NCT00997607|Vaccine|vaccine
707467|NCT00997620|Hay Fever|hay fever
707468|NCT00997620|Daytime somnolence|daytime somnolence
707469|NCT00997620|Cognition|cognition
707470|NCT00997633|Intraperitoneal volume|intraperitoneal volume
707471|NCT00997633|peritoneal carcinomatosis|peritoneal carcinomatosis
707769|NCT00998751|GIST|gist
707472|NCT00997633|cytoreductive surgery|cytoreductive surgery
707473|NCT00997633|SPECT|spect
707474|NCT00997633|intraperitoneal chemotherapy|intraperitoneal chemotherapy
707475|NCT00997646|Performance|performance
707476|NCT00997646|hospitalist|hospitalist
707477|NCT00997646|ward|ward
707478|NCT00997646|hospitalization|hospitalization
707479|NCT00997659|chromium picolinate|chromium picolinate
707480|NCT00997659|insulin resistance|insulin resistance
707481|NCT00997659|obesity|obesity
707482|NCT00997672|MSA|msa
707483|NCT00997672|Lithium|lithium
707484|NCT00997672|Lithium carbonate|lithium carbonate
707485|NCT00997672|MSA-P|msa-p
707486|NCT00997672|MSA-C|msa-c
707487|NCT00997685|XELOX|xelox
707488|NCT00997685|potentially resectable liver metastasis from CRC|potentially resectable liver metastasis from crc
707489|NCT00997698|Intracranial aneurysm|intracranial aneurysm
707490|NCT00997698|Magnetic resonance angiography|magnetic resonance angiography
707491|NCT00997698|Epidemiology|epidemiology
707492|NCT00997711|Diabetes|diabetes
707493|NCT00997711|death|death
707494|NCT00997711|MI|mi
707495|NCT00997711|TVR|tvr
707496|NCT00997724|assisted-VATS (video-assisted thoracoscopic surgery)|assisted-vats (video-assisted thoracoscopic surgery)
707497|NCT00997724|sleeve lobectomy|sleeve lobectomy
707498|NCT00997724|bronchoplasty|bronchoplasty
707499|NCT00997737|incentive spirometry|incentive spirometry
707500|NCT00997737|diaphragm mobility|diaphragm mobility
707501|NCT00997737|ultrasound|ultrasound
707502|NCT00997737|diaphragmatic breathing|diaphragmatic breathing
707503|NCT00997750|ACS|acs
707504|NCT00997750|Acute Coronary Syndrome|acute coronary syndrome
707505|NCT00997750|NSAID|nsaid
707506|NCT00997750|Lornoxicam|lornoxicam
707507|NCT00997750|Xefocam|xefocam
707508|NCT00997763|stenting, XIENCE V, CYPHER|stenting, xience v, cypher
707509|NCT00997776|Hip Fracture|hip fracture
707510|NCT00997776|Exercise|exercise
707511|NCT00997776|Rehabilitation|rehabilitation
707512|NCT00997776|Functional Performance|functional performance
707513|NCT00997789|Rebamipide|rebamipide
707514|NCT00997789|Bioequivalence|bioequivalence
707515|NCT00997789|ABCB1 genetic polymorphisms|abcb1 genetic polymorphisms
707516|NCT00997802|Computed Tomographic Colonography|computed tomographic colonography
707517|NCT00997802|Colonic Polyps|colonic polyps
707518|NCT00997802|Colonic Neoplasms|colonic neoplasms
707519|NCT00997802|Computer Aided Diagnosis|computer aided diagnosis
707520|NCT00997815|Recalcitrant|recalcitrant
707521|NCT00997815|Alopecia totalis|alopecia totalis
707522|NCT00997815|Alopecia universalis|alopecia universalis
707523|NCT00997815|Botulinum toxin A|botulinum toxin a
707524|NCT00997828|Coronary Artery Disease|coronary artery disease
707525|NCT00997828|stent|stent
707526|NCT00997828|coronary artery bypass graft surgery|coronary artery bypass graft surgery
707527|NCT00997828|multivessel coronary artery disease|multivessel coronary artery disease
707528|NCT00997841|POC|poc
707529|NCT00997841|ROTEM|rotem
707530|NCT00997841|Multiplate|multiplate
707531|NCT00997841|bleeding tendency|bleeding tendency
707532|NCT00997841|coagulation management|coagulation management
707533|NCT00997841|amount of transfused red blood cell concentrates,|amount of transfused red blood cell concentrates,
707534|NCT00997841|FFP|ffp
707535|NCT00997841|platelet concentrates|platelet concentrates
707536|NCT00997841|rate of rethoracotomy|rate of rethoracotomy
707537|NCT00997841|ventilation time|ventilation time
707549|NCT00997867|Interscalene|interscalene
707550|NCT00997867|UCSD|ucsd
707551|NCT00997867|Moderate-to-severe pain|moderate-to-severe pain
707552|NCT00997867|Perineural Catheter|perineural catheter
707553|NCT00997867|Orthopedic Surgery|orthopedic surgery
707554|NCT00997880|rosuvastatin|rosuvastatin
707555|NCT00997893|menopause|menopause
707556|NCT00997893|hot flashes|hot flashes
707557|NCT00997893|soy|soy
707558|NCT00997893|estrogen|estrogen
707559|NCT00997893|anxiety|anxiety
707560|NCT00997906|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
707561|NCT00997906|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
707562|NCT00997906|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
707563|NCT00997906|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
707564|NCT00997932|levonorgestrel releasing intrauterine device|levonorgestrel releasing intrauterine device
707565|NCT00997932|levonorgestrel releasing intrauterine contraception|levonorgestrel releasing intrauterine contraception
707566|NCT00997932|unintended pregnancy prevention|unintended pregnancy prevention
707567|NCT00997932|postpartum contraception|postpartum contraception
707568|NCT00997945|Phase I, advanced solid malignancies, advance solid tumour|phase i, advanced solid malignancies, advance solid tumour
707569|NCT00997945|advanced cancer|advanced cancer
707570|NCT00997945|ZD4054 (Zibotentan)|zd4054 (zibotentan)
707571|NCT00997945|china|china
707572|NCT00997945|PK|pk
707573|NCT00997945|pharmacokinetics|pharmacokinetics
707574|NCT00997971|Hydrolysed rice protein formula|hydrolysed rice protein formula
707575|NCT00997971|Cow's milk protein allergy|cow's milk protein allergy
707576|NCT00997971|Infant formula|infant formula
707577|NCT00997971|Gastrointestinal tolerance|gastrointestinal tolerance
707578|NCT00997984|ADHD|adhd
707579|NCT00997997|Skin Diseases, Bacterial|skin diseases, bacterial
707580|NCT00997997|Product Surveillance|product surveillance
707581|NCT00997997|Postmarketing|postmarketing
707582|NCT00998010|adult giant cell glioblastoma|adult giant cell glioblastoma
707583|NCT00998010|adult glioblastoma|adult glioblastoma
707584|NCT00998010|adult gliosarcoma|adult gliosarcoma
707585|NCT00998023|Angiogram|angiogram
707586|NCT00998023|Catheter Angiogram|catheter angiogram
707587|NCT00998036|TNBC|tnbc
707588|NCT00998062|Dyslipaemia|dyslipaemia
707589|NCT00998062|atherosclerosis risk|atherosclerosis risk
707590|NCT00998062|increased hsCRP|increased hscrp
707591|NCT00998062|inflammatory and oxidative status in the Spanish population|inflammatory and oxidative status in the spanish population
707592|NCT00998075|Bioequivalence|bioequivalence
707593|NCT00998075|ASA|asa
707594|NCT00998075|Esomeprazole|esomeprazole
707595|NCT00998075|peptic ulcer disease|peptic ulcer disease
707596|NCT00998075|primary cardiovascular protection|primary cardiovascular protection
707597|NCT00998075|healthy volunteers|healthy volunteers
707598|NCT00998088|Blood management|blood management
707599|NCT00998088|Orthopedic surgery|orthopedic surgery
707600|NCT00998088|elective|elective
707601|NCT00998088|randomized study|randomized study
707602|NCT00998088|adults|adults
707603|NCT00998088|hip replacement|hip replacement
707604|NCT00998088|knee replacement|knee replacement
707605|NCT00998101|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
707606|NCT00998101|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
707607|NCT00998101|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
707608|NCT00998114|Early Cardiac Diastolic Dysfunction|early cardiac diastolic dysfunction
707609|NCT00998114|Aerobic Exercise|aerobic exercise
707610|NCT00998114|Weight Reduction|weight reduction
707611|NCT00998127|Dual Anti-Platelet Therapy|dual anti-platelet therapy
707612|NCT00998127|Non-adherence|non-adherence
707613|NCT00998127|MACE|mace
707614|NCT00998127|NACE|nace
707615|NCT00998140|resuscitation|resuscitation
707616|NCT00998140|sudden death|sudden death
707617|NCT00998140|cardiopulmonary resuscitation|cardiopulmonary resuscitation
707618|NCT00998140|emergency medical services|emergency medical services
707619|NCT00998140|termination of resuscitation|termination of resuscitation
707620|NCT00998140|ventricular fibrillation|ventricular fibrillation
707621|NCT00998140|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
707623|NCT00998140|medical futility|medical futility
707624|NCT00998140|withdrawing treatment|withdrawing treatment
707625|NCT00998140|transportation of patients|transportation of patients
707626|NCT00998140|health expenditures|health expenditures
707627|NCT00998140|healthcare costs|healthcare costs
707628|NCT00998153|substance use|substance use
707629|NCT00998153|PTSD|ptsd
707630|NCT00998153|risky behaviors|risky behaviors
707631|NCT00998153|revictimization|revictimization
707632|NCT00998166|NSCLC|nsclc
707633|NCT00998179|TENS|tens
707634|NCT00998179|acupuncture|acupuncture
707635|NCT00998179|FEV1|fev1
707636|NCT00998179|Normal Healthy subjects|normal healthy subjects
707637|NCT00998192|carcinoma|carcinoma
707638|NCT00998192|squamous cell|squamous cell
707639|NCT00998192|lung|lung
707640|NCT00998192|REOLYSIN|reolysin
707641|NCT00998192|chemotherapy|chemotherapy
707644|NCT00998192|Carcinoma, Squamous Cell of the Lung|carcinoma, squamous cell of the lung
707645|NCT00998218|Sudden Cardiac Death|sudden cardiac death
707646|NCT00998218|Arrythmias|arrythmias
707647|NCT00998218|Triggered activity|triggered activity
707648|NCT00998218|left ventricular dysfunction|left ventricular dysfunction
707649|NCT00998244|low carbohydrate|low carbohydrate
707650|NCT00998244|low fat|low fat
707651|NCT00998244|diet|diet
707652|NCT00998244|overweight|overweight
707653|NCT00998244|GERD|gerd
707654|NCT00998244|gastroesophageal reflux disease|gastroesophageal reflux disease
707655|NCT00998244|acid reflux|acid reflux
707656|NCT00998244|heartburn|heartburn
707657|NCT00998257|Contraception|contraception
707658|NCT00998257|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
707659|NCT00998257|PMDD|pmdd
707660|NCT00998257|Acne|acne
707661|NCT00998270|MM|mm
707662|NCT00998309|skin infection|skin infection
707663|NCT00998309|soft tissue infection|soft tissue infection
707664|NCT00998309|sexually-transmitted infection|sexually-transmitted infection
707665|NCT00998309|infection oral|infection oral
707666|NCT00998309|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
707667|NCT00998322|metastatic|metastatic
707669|NCT00998322|adenocarcinoma|adenocarcinoma
707670|NCT00998322|REOLYSIN|reolysin
707671|NCT00998322|chemotherapy|chemotherapy
707672|NCT00998322|gemcitabine|gemcitabine
707673|NCT00998335|Type 2 diabetes mellitus|type 2 diabetes mellitus
707674|NCT00998335|Insulin therapy|insulin therapy
707675|NCT00998335|Detemir (Levemir)|detemir (levemir)
707676|NCT00998335|Aspart (Novolog)|aspart (novolog)
707677|NCT00998335|Hepatic steatosis|hepatic steatosis
707678|NCT00998348|parenting|parenting
707679|NCT00998348|diet|diet
707680|NCT00998348|physical activity|physical activity
707681|NCT00998348|family|family
707682|NCT00998348|home|home
707683|NCT00998348|child|child
707684|NCT00998361|Sarcoma|sarcoma
707685|NCT00998361|allogeneic|allogeneic
707686|NCT00998361|Hemopoietic stem cell transplant|hemopoietic stem cell transplant
707687|NCT00998400|Cognitive-behavioral treatment|cognitive-behavioral treatment
707688|NCT00998400|Well-being therapy|well-being therapy
707689|NCT00998400|Depression|depression
707690|NCT00998400|Demoralization|demoralization
707691|NCT00998400|Acute coronary syndrome|acute coronary syndrome
707692|NCT00998413|asthma|asthma
707693|NCT00998413|overweight|overweight
707694|NCT00998413|obesity|obesity
707695|NCT00998413|children|children
707696|NCT00998426|hepatitis B immune globulin|hepatitis b immune globulin
707697|NCT00998426|HBIG|hbig
707698|NCT00998426|HepaGam B|hepagam b
707699|NCT00998426|orthotopic liver transplant|orthotopic liver transplant
707700|NCT00998439|in stent restenosis|in stent restenosis
707701|NCT00998439|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
707702|NCT00998439|pepcad|pepcad
707703|NCT00998439|drug eluting balloon|drug eluting balloon
707704|NCT00998452|Weight|weight
707705|NCT00998452|Diet|diet
707706|NCT00998452|Physical Activity|physical activity
707707|NCT00998452|Veterans|veterans
707708|NCT00998452|MOVE! Program|move! program
707709|NCT00998465|Obesity|obesity
707710|NCT00998465|Hypertension|hypertension
707711|NCT00998465|Salt sensitivity|salt sensitivity
707712|NCT00998465|Laparoscopic gastric bypass|laparoscopic gastric bypass
707713|NCT00998465|Bariatric surgery|bariatric surgery
707714|NCT00998504|impaired fat oxidation|impaired fat oxidation
707715|NCT00998504|fat accumulation|fat accumulation
707716|NCT00998504|mitochondrial dysfunction|mitochondrial dysfunction
707717|NCT00998504|mitochondrial biogenesis|mitochondrial biogenesis
707718|NCT00998517|Malnutrition|malnutrition
707719|NCT00998517|Supplemental Food|supplemental food
707720|NCT00998517|CSB++|csb++
707721|NCT00998517|Supplementary Plumpy|supplementary plumpy
707722|NCT00998530|Trichomonas vaginalis|trichomonas vaginalis
707723|NCT00998530|trichomoniasis|trichomoniasis
707724|NCT00998530|MLST|mlst
707725|NCT00998530|Multilocus sequence typing|multilocus sequence typing
707726|NCT00998543|Smallpox Vaccinia Virus Smallpox Vaccine Variola Virus|smallpox vaccinia virus smallpox vaccine variola virus
707727|NCT00998556|Peripartum cardiomyopathy|peripartum cardiomyopathy
707728|NCT00998556|Bromocriptine|bromocriptine
707729|NCT00998582|Cardiovascular Disease|cardiovascular disease
707730|NCT00998582|HIV Infection|hiv infection
707731|NCT00998582|Abacavir|abacavir
707732|NCT00998582|Artery Elasticity|artery elasticity
707733|NCT00998582|Treatment experienced|treatment experienced
707734|NCT00998595|Diabetes, Gestational|diabetes, gestational
707735|NCT00998595|Postpartum Period|postpartum period
707736|NCT00998595|Reproductive Health Services|reproductive health services
707737|NCT00998595|Health Promotion|health promotion
707738|NCT00998595|Health Personnel|health personnel
707739|NCT00998621|Hepatitis C, Chronic|hepatitis c, chronic
707740|NCT00998621|HIV Infection|hiv infection
707741|NCT00998621|Medication Adherence|medication adherence
707742|NCT00998621|Questionnaire Design|questionnaire design
707743|NCT00998621|Treatment experienced|treatment experienced
707744|NCT00998634|SCA2|sca2
707746|NCT00998647|modified ultrafiltration|modified ultrafiltration
707747|NCT00998647|cardiac surgery|cardiac surgery
707748|NCT00998647|ROTEM|rotem
707749|NCT00998647|Multiple Electrode Aggregometry|multiple electrode aggregometry
707750|NCT00998660|Parkinson's disease|parkinson's disease
707751|NCT00998660|Essential Tremor|essential tremor
707752|NCT00998660|Dystonia (where indication is approved)|dystonia (where indication is approved)
707753|NCT00998660|Deep brain stimulation|deep brain stimulation
707754|NCT00998660|Activa RC|activa rc
707755|NCT00998673|Silica gel fiber|silica gel fiber
707756|NCT00998673|Chronic venous leg ulcers|chronic venous leg ulcers
707757|NCT00998673|Venous ulcer|venous ulcer
707758|NCT00998673|Stasis ulcer|stasis ulcer
707759|NCT00998673|Varicose ulcer|varicose ulcer
707760|NCT00998686|diabetes|diabetes
707761|NCT00998686|DPP4 inhibitor|dpp4 inhibitor
707762|NCT00998686|dutogliptin|dutogliptin
707763|NCT00998699|Diabetes|diabetes
707764|NCT00998699|Type 1|type 1
707765|NCT00998712|gestational diabetes mellitus|gestational diabetes mellitus
707766|NCT00998712|pregnancy|pregnancy
707767|NCT00998712|cardiovascular disease risk|cardiovascular disease risk
707768|NCT00998751|cKIT inhibitor|ckit inhibitor
707770|NCT00998764|antibody|antibody
707771|NCT00998764|immunotherapy|immunotherapy
707772|NCT00998777|tubing program|tubing program
707773|NCT00998777|shoulder strengthening|shoulder strengthening
707774|NCT00998777|injury prevention|injury prevention
707775|NCT00998790|Urinary Incontinence, Stress|urinary incontinence, stress
707776|NCT00998790|Intrinsic sphincter deficiency|intrinsic sphincter deficiency
707777|NCT00998790|Secondary|secondary
707779|NCT00998790|TURP|turp
707780|NCT00998790|Radical prostatectomy|radical prostatectomy
707781|NCT00998790|Open prostatectomy|open prostatectomy
707782|NCT00998790|Post-suprapubic prostatectomy|post-suprapubic prostatectomy
707783|NCT00998803|Influenza virus|influenza virus
707784|NCT00998816|thoracotomy|thoracotomy
707785|NCT00998816|chronic|chronic
707786|NCT00998816|pain|pain
707787|NCT00998816|pregabalin|pregabalin
707788|NCT00998816|Lyrica|lyrica
707789|NCT00998829|psoriasis|psoriasis
707790|NCT00998829|psoriatic arthritis|psoriatic arthritis
707791|NCT00998829|epidemiology|epidemiology
707792|NCT00998829|prevalence|prevalence
707794|NCT00998842|EKG|ekg
707795|NCT00998842|healthy subjects|healthy subjects
707796|NCT00998842|electrocardiography, ambulatory|electrocardiography, ambulatory
707797|NCT00998855|Exercise in obesity|exercise in obesity
707798|NCT00998868|Rotator Cuff|rotator cuff
707799|NCT00998868|Tendinopathy|tendinopathy
707800|NCT00998868|ultrasonography|ultrasonography
707801|NCT00998881|insulin resistance|insulin resistance
707802|NCT00998894|BIS|bis
707803|NCT00998894|MAC|mac
707804|NCT00998894|MAP|map
707805|NCT00998907|Open Abdominal Surgery|open abdominal surgery
707806|NCT00998907|Fascial Closure|fascial closure
707807|NCT00998920|Healthy volunteers|healthy volunteers
707808|NCT00998933|Testosterone replacement therapy|testosterone replacement therapy
707809|NCT00998946|Relapsed|relapsed
707810|NCT00998946|Refractory|refractory
707811|NCT00998946|Non-Hodgkin's|non-hodgkin's
707812|NCT00998959|Depression|depression
707813|NCT00998959|Major Depression|major depression
707814|NCT00998972|kidney graft,|kidney graft,
707815|NCT00998972|delayed graft function|delayed graft function
707816|NCT00998972|N-acetylcysteine|n-acetylcysteine
707817|NCT00998998|iron deficiency anemia|iron deficiency anemia
707818|NCT00998998|infant behavior|infant behavior
707819|NCT00998998|infant development|infant development
707820|NCT00999011|critical care|critical care
707821|NCT00999011|inflammatory biomarkers|inflammatory biomarkers
707822|NCT00999011|cytokines|cytokines
707823|NCT00999011|mechanical ventilation|mechanical ventilation
707824|NCT00999011|activity|activity
707825|NCT00999011|mobility therapy|mobility therapy
707826|NCT00999011|More than 48 hours of mechanical ventilation|more than 48 hours of mechanical ventilation
707827|NCT00999050|type two diabetes|type two diabetes
707828|NCT00999050|gastric bypass surgery|gastric bypass surgery
707829|NCT00999050|overweight or moderately obese|overweight or moderately obese
707830|NCT00999063|GerdQ|gerdq
707831|NCT00999089|Coronary disease|coronary disease
707832|NCT00999089|Coronary artery bypass grafting|coronary artery bypass grafting
707833|NCT00999089|Cardiopulmonary bypass|cardiopulmonary bypass
707834|NCT00999089|Extracorporeal circulation|extracorporeal circulation
707835|NCT00999089|Cardioplegia|cardioplegia
707836|NCT00999089|Off pump|off pump
707837|NCT00999102|hypertension|hypertension
707838|NCT00999102|beta blockers|beta blockers
707839|NCT00999102|Metoprolol|metoprolol
707840|NCT00999102|blood pressure, high|blood pressure, high
707841|NCT00999102|antihypertensive agents|antihypertensive agents
707842|NCT00999102|vascular resistance|vascular resistance
707843|NCT00999102|adrenergic beta-receptor blockaders|adrenergic beta-receptor blockaders
707844|NCT00999102|beta-Adrenergic blockers|beta-adrenergic blockers
707845|NCT00999102|beta-Adrenergic Blocking Agents|beta-adrenergic blocking agents
707846|NCT00999102|beta-Adrenergic Receptor Blockaders|beta-adrenergic receptor blockaders
707847|NCT00999102|beta-Blockers, Adrenergic|beta-blockers, adrenergic
707848|NCT00999102|Bystolic|bystolic
707849|NCT00999102|Nebivolol|nebivolol
707850|NCT00999102|Nebivololum|nebivololum
707851|NCT00999102|Nebivololum [Latin]|nebivololum [latin]
707852|NCT00999102|R65,824|r65,824
707853|NCT00999102|Beloc- Zok|beloc- zok
707854|NCT00999102|H 93/26 succinate|h 93/26 succinate
707855|NCT00999102|Metoprolol succinate|metoprolol succinate
707856|NCT00999102|Seloken ZOC|seloken zoc
707857|NCT00999102|Selozok|selozok
707858|NCT00999102|Spesicor Dos|spesicor dos
707859|NCT00999102|Toprol XL|toprol xl
707860|NCT00999102|Toprol-XL|toprol-xl
707861|NCT00999102|UNII-TH25PD4CCB|unii-th25pd4ccb
709464|NCT01002066|RDT|rdt
707862|NCT00999115|Rectovaginal Fistula|rectovaginal fistula
707863|NCT00999115|Crohn Disease|crohn disease
707864|NCT00999115|Allogenic|allogenic
707865|NCT00999115|Adipose-Derived Stem Cells|adipose-derived stem cells
707866|NCT00999128|PI3K inhibitor|pi3k inhibitor
707867|NCT00999128|PI3 kinase|pi3 kinase
707868|NCT00999128|PI3 kinase inhibitor|pi3 kinase inhibitor
707869|NCT00999154|Energy Expenditure|energy expenditure
707870|NCT00999154|Dietary Intake|dietary intake
707871|NCT00999154|Physical Activity|physical activity
707872|NCT00999154|Body Weight Regulation|body weight regulation
707873|NCT00999154|Sedentary|sedentary
707875|NCT00999154|Healthy Volunteer|healthy volunteer
707876|NCT00999167|Cirrhosis|cirrhosis
707877|NCT00999167|Episodic Hepatic Encephalopathy|episodic hepatic encephalopathy
707878|NCT00999167|HE|he
707879|NCT00999167|HPN-100|hpn-100
707880|NCT00999167|GT4P|gt4p
707881|NCT00999167|glycerol phenylbutyrate|glycerol phenylbutyrate
707882|NCT00999180|Botulinum Toxin|botulinum toxin
707883|NCT00999180|Rehabilitation|rehabilitation
707884|NCT00999180|Stroke|stroke
707885|NCT00999193|Shoulder|shoulder
707886|NCT00999193|Fracture|fracture
707887|NCT00999193|Locking Plate|locking plate
707888|NCT00999193|Hemiarthroplasty|hemiarthroplasty
707889|NCT00999193|Conservative|conservative
707890|NCT00999193|Comminuted Proximal Humerus Fracture|comminuted proximal humerus fracture
707891|NCT00999206|Influenza|influenza
707892|NCT00999206|Vaccine|vaccine
707893|NCT00999206|CHMP criteria|chmp criteria
707894|NCT00999219|FK199B|fk199b
707895|NCT00999219|Zolpidem|zolpidem
707896|NCT00999232|erythromycin|erythromycin
707897|NCT00999232|prokinetics|prokinetics
707898|NCT00999232|nasojejunal tubes|nasojejunal tubes
707899|NCT00999232|Bengmark feeding tube|bengmark feeding tube
707900|NCT00999232|post-pyloric feeding|post-pyloric feeding
707901|NCT00999232|pancreatitis|pancreatitis
707902|NCT00999232|Non-critically ill patients having pancreatitis who require jejunal enteral nutrition|non-critically ill patients having pancreatitis who require jejunal enteral nutrition
707903|NCT00999258|glomerular filtration rate|glomerular filtration rate
707904|NCT00999258|chronic allograft nephropathy|chronic allograft nephropathy
707905|NCT00999258|Kidney transplantation|kidney transplantation
707906|NCT00999258|African American|african american
707907|NCT00999271|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
707908|NCT00999271|gastric emptying|gastric emptying
707909|NCT00999271|appetite|appetite
707910|NCT00999271|energy intake|energy intake
707911|NCT00999271|lipid metabolism|lipid metabolism
707912|NCT00999284|ZK200775 is tested for its effects on vision on healthy probands.|zk200775 is tested for its effects on vision on healthy probands.
707913|NCT00999297|thermogenesis|thermogenesis
707914|NCT00999297|respiratory quotient|respiratory quotient
707915|NCT00999297|fat oxidation|fat oxidation
707916|NCT00999310|Klinefelter syndrome|klinefelter syndrome
707917|NCT00999310|Neuropsychology|neuropsychology
707918|NCT00999310|Neuroradiology|neuroradiology
707919|NCT00999310|Genetics|genetics
707920|NCT00999336|Betrixaban|betrixaban
707921|NCT00999336|Renal impairment|renal impairment
707922|NCT00999336|Healthy|healthy
707923|NCT00999336|Kidney dysfunction|kidney dysfunction
707924|NCT00999349|iron overload condition|iron overload condition
707925|NCT00999349|regular desferrioxamine administration|regular desferrioxamine administration
707926|NCT00999349|receiving continuous blood transfusions|receiving continuous blood transfusions
707927|NCT00999362|calcineurin activity|calcineurin activity
707928|NCT00999362|real-time PCR|real-time pcr
707929|NCT00999362|Gene expression of calcineurin|gene expression of calcineurin
707930|NCT00999362|T-lymphocytes|t-lymphocytes
707931|NCT00999362|interferon-gamma|interferon-gamma
707932|NCT00999362|Pharmacodynamics|pharmacodynamics
707933|NCT00999362|Pharmacokinetics|pharmacokinetics
707934|NCT00999362|tacrolimus|tacrolimus
707935|NCT00999362|western blot|western blot
707936|NCT00999362|Hoechst|hoechst
707937|NCT00999375|Type 1 Diabetes|type 1 diabetes
707938|NCT00999375|Diet|diet
707939|NCT00999375|Behavioral Intervention|behavioral intervention
707940|NCT00999375|Children|children
707941|NCT00999375|Adolescents|adolescents
707942|NCT00999388|Lifestyle|lifestyle
707943|NCT00999388|Environment|environment
707944|NCT00999388|Neurodegenerative Diseases|neurodegenerative diseases
707945|NCT00999388|Elderly|elderly
707946|NCT00999388|Public Health|public health
707947|NCT00999388|PD|pd
707948|NCT00999388|Parkinson Disease|parkinson disease
707949|NCT00999414|MM|mm
707950|NCT00999427|Povidone-iodine|povidone-iodine
707951|NCT00999427|prostate cancer|prostate cancer
707952|NCT00999427|biopsy|biopsy
707953|NCT00999427|transrectal ultrasound|transrectal ultrasound
707954|NCT00999427|urinary tract infection|urinary tract infection
707955|NCT00999427|fever|fever
707956|NCT00999427|sepsis|sepsis
707957|NCT00999427|antisepsis|antisepsis
707958|NCT00999427|prevention|prevention
707959|NCT00999427|complications|complications
707960|NCT00999440|Chronic Pain|chronic pain
707961|NCT00999440|Methadone|methadone
707962|NCT00999440|Perceived Sleep|perceived sleep
707963|NCT00999440|QTc|qtc
707964|NCT00999453|LDL-cholesterol|ldl-cholesterol
751869|NCT01170975|Advanced solid tumors|advanced solid tumors
707965|NCT00999453|Prevalent peritoneal dialysis patients with hypercholesterolemia|prevalent peritoneal dialysis patients with hypercholesterolemia
707966|NCT00999492|Tecnis Multifocal|tecnis multifocal
707967|NCT00999492|Patients scheduled for cataract or lens replacement surgery with implantation of multifocal intraocular lenses|patients scheduled for cataract or lens replacement surgery with implantation of multifocal intraocular lenses
707968|NCT00999505|Schizophrenia|schizophrenia
707969|NCT00999505|Amantadine|amantadine
707970|NCT00999505|Residual symptoms|residual symptoms
707971|NCT00999518|Randomized double blind placebo-controlled parallel-group dose-range finding interstitial cystitis efficacy pain urinary symptoms safety|randomized double blind placebo-controlled parallel-group dose-range finding interstitial cystitis efficacy pain urinary symptoms safety
707972|NCT00999531|Cystic Fibrosis|cystic fibrosis
707973|NCT00999531|CF|cf
707974|NCT00999531|Mucociliary Clearance|mucociliary clearance
707975|NCT00999531|Epithelial Sodium Channel Inhibitor|epithelial sodium channel inhibitor
707976|NCT00999531|ENaC Inhibitor|enac inhibitor
707977|NCT00999531|Airway Hydration|airway hydration
707978|NCT00999531|Amiloride|amiloride
707979|NCT00999544|opioid|opioid
707980|NCT00999544|oxycodone|oxycodone
707981|NCT00999544|NK1 antagonist|nk1 antagonist
707982|NCT00999544|aprepitant|aprepitant
707983|NCT00999544|intranasal|intranasal
707984|NCT00999544|abuse|abuse
707985|NCT00999557|breast cancer|breast cancer
707986|NCT00999557|male breast cancer|male breast cancer
707987|NCT00999557|alopecia|alopecia
707988|NCT00999570|outcome|outcome
707989|NCT00999570|quality of life|quality of life
707990|NCT00999570|total knee arthroplasty|total knee arthroplasty
707991|NCT00999570|clinical outcome scores post total knee arthroplasty|clinical outcome scores post total knee arthroplasty
707992|NCT00999570|quality of life scores post total knee arthroplasty|quality of life scores post total knee arthroplasty
707993|NCT00999583|Cardiac arrest|cardiac arrest
707994|NCT00999583|erythropoietin|erythropoietin
707995|NCT00999583|post-anoxic encephalopathy|post-anoxic encephalopathy
707996|NCT00999583|neuroprotective drugs|neuroprotective drugs
707997|NCT00999596|Breast Cancer|breast cancer
707998|NCT00999596|Digital Mammography|digital mammography
707999|NCT00999609|Adeno-associated virus|adeno-associated virus
708000|NCT00999609|AAV|aav
708001|NCT00999609|Leber congenital amaurosis|leber congenital amaurosis
708002|NCT00999609|RPE65|rpe65
708003|NCT00999609|Gene therapy|gene therapy
708004|NCT00999609|Gene transfer|gene transfer
708005|NCT00999622|infection|infection
708006|NCT00999622|adult anaplastic astrocytoma|adult anaplastic astrocytoma
708007|NCT00999622|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
708008|NCT00999622|adult giant cell glioblastoma|adult giant cell glioblastoma
708009|NCT00999622|adult gliosarcoma|adult gliosarcoma
708010|NCT00999622|adult oligodendroglioma|adult oligodendroglioma
708011|NCT00999622|adult glioblastoma|adult glioblastoma
708012|NCT00999622|adult diffuse astrocytoma|adult diffuse astrocytoma
708013|NCT00999622|adult pilocytic astrocytoma|adult pilocytic astrocytoma
708014|NCT00999622|adult pineal gland astrocytoma|adult pineal gland astrocytoma
708015|NCT00999622|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
708016|NCT00999635|Insoles|insoles
708017|NCT00999635|Prevention of Ulceration|prevention of ulceration
708018|NCT00999635|Diabetic Foot|diabetic foot
708019|NCT00999635|Neuropathic|neuropathic
708020|NCT00999648|Tinnitus|tinnitus
708021|NCT00999648|Myofascial Trigger Points|myofascial trigger points
708698|NCT00991978|VEGF|vegf
708022|NCT00999648|Myofascial Pain Syndrome|myofascial pain syndrome
708023|NCT00999648|Controlled Clinical Trial|controlled clinical trial
708024|NCT00999674|Exercise|exercise
708025|NCT00999687|Nail psoriasis|nail psoriasis
708026|NCT00999687|Indigo naturalis|indigo naturalis
708027|NCT00999700|Locally advanced HNSCC|locally advanced hnscc
708028|NCT00999700|Chemo-radiation|chemo-radiation
708029|NCT00999700|Induction chemotherapy|induction chemotherapy
708030|NCT00999700|Stage III/IV|stage iii/iv
708031|NCT00999700|Unresectable disease|unresectable disease
708032|NCT00999713|Acute Lung Injury|acute lung injury
708033|NCT00999713|Cancer|cancer
708034|NCT00999713|Pediatrics|pediatrics
708035|NCT00999739|pneumococcal vaccines|pneumococcal vaccines
708036|NCT00999739|HIV|hiv
708037|NCT00999739|antibody response|antibody response
708038|NCT00999739|antibody affinity|antibody affinity
708039|NCT00999739|Antibody formation|antibody formation
708040|NCT00999739|Phagocytosis|phagocytosis
708041|NCT00999752|Hypertension|hypertension
708042|NCT00999752|African Americans|african americans
708043|NCT00999752|Arterial Stiffness|arterial stiffness
708044|NCT00999752|Vascular Resistance|vascular resistance
708045|NCT00999765|Bipolar Disorder|bipolar disorder
708046|NCT00999765|Bipolar Depression|bipolar depression
708047|NCT00999765|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
708048|NCT00999765|MBCT|mbct
708049|NCT00999765|Maintenance|maintenance
708050|NCT00999765|Euthymic|euthymic
708051|NCT00999765|Efficacy|efficacy
708052|NCT00999765|Feasibility|feasibility
708053|NCT00999778|Autism|autism
708054|NCT00999778|Social and Communication Deficits in Autism|social and communication deficits in autism
753078|NCT01175382|Male Urogenital Diseases|male urogenital diseases
708055|NCT00999778|Parent and Caregiver interventions with children with Autism|parent and caregiver interventions with children with autism
708056|NCT00999778|Autism Spectrum Disorder|autism spectrum disorder
708057|NCT00999778|ASD|asd
708058|NCT00999804|Locally Advanced Breast Cancer Neoadjuvant Endocrine|locally advanced breast cancer neoadjuvant endocrine
708059|NCT00999817|Drug-Drug interaction Study CYP2D6 inhibition Healthy Subjects|drug-drug interaction study cyp2d6 inhibition healthy subjects
708060|NCT00999843|Sorafenib|sorafenib
708061|NCT00999843|Three-dimensional conformal radiation therapy|three-dimensional conformal radiation therapy
708062|NCT00999843|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
708063|NCT00999843|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
708064|NCT00999856|medical device,|medical device,
708065|NCT00999856|sub-conjunctival insert|sub-conjunctival insert
708066|NCT00999856|photometer|photometer
708067|NCT00999856|fluorescence|fluorescence
708068|NCT00999856|subconjunctival interstitial fluid glucose|subconjunctival interstitial fluid glucose
708069|NCT00999856|non-invasive measurement|non-invasive measurement
708070|NCT00999869|Newly diagnosed|newly diagnosed
708071|NCT00999869|Alopecia areata|alopecia areata
708072|NCT00999869|Botulinum toxin A|botulinum toxin a
708073|NCT00999869|Corticosteroid|corticosteroid
708074|NCT00999869|Intralesional injection|intralesional injection
708075|NCT00999882|mTor Kinase Inhibitor|mtor kinase inhibitor
708076|NCT00999882|Phase I/II|phase i/ii
708077|NCT00999882|Dose escalation|dose escalation
708078|NCT00999882|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
708079|NCT00999882|Asia|asia
708080|NCT00999882|HCC|hcc
708081|NCT00999882|Safety and pharmacokinetics|safety and pharmacokinetics
708082|NCT00999895|Schizophrenia|schizophrenia
708083|NCT00999895|Switch of antipsychotic treatment|switch of antipsychotic treatment
708084|NCT00999895|Outcome evaluation|outcome evaluation
708085|NCT00999895|monotherapy|monotherapy
708086|NCT00999895|Greece|greece
708087|NCT00988962|pain|pain
708088|NCT00988962|opioids|opioids
708089|NCT00988988|Multiple Sclerosis|multiple sclerosis
708090|NCT00988988|AGEE|agee
708091|NCT00988988|histamine response|histamine response
708092|NCT00989001|Atrial Fibrillation|atrial fibrillation
708093|NCT00989001|RSD1235|rsd1235
708094|NCT00989001|Vernakalant|vernakalant
708095|NCT00989001|conversion|conversion
708096|NCT00989014|Erythematotelangiectatic|erythematotelangiectatic
708097|NCT00989014|Rosacea|rosacea
708098|NCT00989027|Uterine contraction|uterine contraction
708099|NCT00989027|Dose-response|dose-response
708100|NCT00989027|Oxytocin pre-treatment|oxytocin pre-treatment
708101|NCT00989040|NPZ|npz
708102|NCT00989040|Pain|pain
708103|NCT00989053|depression|depression
708104|NCT00989053|anxiety|anxiety
708105|NCT00989053|stress|stress
708106|NCT00989053|antidepressant therapy|antidepressant therapy
708107|NCT00989053|SSRI|ssri
708108|NCT00989053|infertility|infertility
708109|NCT00989053|in vitro fertilization (IVF)|in vitro fertilization (ivf)
708110|NCT00989053|immunological factors|immunological factors
708111|NCT00989053|depressive and anxiety symptoms in women undergoing IVF treatment|depressive and anxiety symptoms in women undergoing ivf treatment
708112|NCT00989066|Xience V|xience v
708113|NCT00989066|stent|stent
708114|NCT00989066|coronary disease|coronary disease
708115|NCT00989079|Single Ascending Dose Study in healthy subjects|single ascending dose study in healthy subjects
708699|NCT00991978|Screening|screening
708116|NCT00989092|anemia of cancer|anemia of cancer
708117|NCT00989092|darbepoetin alfa|darbepoetin alfa
708118|NCT00989092|Aranesp|aranesp
708119|NCT00989105|stage I prostate cancer|stage i prostate cancer
708120|NCT00989105|stage IIB prostate cancer|stage iib prostate cancer
708121|NCT00989105|stage IIA prostate cancer|stage iia prostate cancer
708122|NCT00989105|stage III prostate cancer|stage iii prostate cancer
708123|NCT00989105|stage IV prostate cancer|stage iv prostate cancer
708124|NCT00989105|recurrent prostate cancer|recurrent prostate cancer
708125|NCT00989131|Ovarian Cancer|ovarian cancer
708126|NCT00989144|HIV seronegative|hiv seronegative
708127|NCT00989144|acute infection|acute infection
708128|NCT00989157|Gastric Bypass|gastric bypass
708129|NCT00989157|Duloxetine|duloxetine
708130|NCT00989157|Cymbalta|cymbalta
708131|NCT00989157|Pharmacokinetics|pharmacokinetics
708132|NCT00989183|Ovaries|ovaries
708133|NCT00989183|Reproductive Age|reproductive age
708134|NCT00989183|Oophorectomy|oophorectomy
708135|NCT00989209|facial paralysis|facial paralysis
708136|NCT00989209|asymmetry|asymmetry
708728|NCT00992121|cancer|cancer
708137|NCT00989209|myofunctional therapy|myofunctional therapy
708138|NCT00989209|botulinum toxin|botulinum toxin
708139|NCT00989209|facial evaluation|facial evaluation
708140|NCT00989222|Distal radius fractures|distal radius fractures
708141|NCT00989222|Fractures of the distal radius|fractures of the distal radius
708142|NCT00989222|Volar plate|volar plate
708143|NCT00989222|External fixation|external fixation
708145|NCT00989248|Ergospirometry|ergospirometry
708146|NCT00989248|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
708147|NCT00989248|Exercises|exercises
708148|NCT00989248|Immersion|immersion
710532|NCT01005147|upper GI bleeding|upper gi bleeding
710533|NCT01005147|blood transfusion|blood transfusion
710534|NCT01005147|GI bleeding|gi bleeding
710535|NCT01005160|Mellitus, type 2|mellitus, type 2
710536|NCT01005160|pharmacokinetic evaluation|pharmacokinetic evaluation
710537|NCT01005160|drug interaction between CKD-501 and metformin|drug interaction between ckd-501 and metformin
708150|NCT00989261|AC220|ac220
708151|NCT00989261|acute|acute
708152|NCT00989261|FLT3|flt3
708153|NCT00989261|inhibitor|inhibitor
708154|NCT00989261|kinase|kinase
708155|NCT00989261|leukemia|leukemia
708156|NCT00989261|leukaemia|leukaemia
708157|NCT00989261|myeloid|myeloid
708158|NCT00989261|relapsed|relapsed
708159|NCT00989261|refractory|refractory
708160|NCT00989274|Influenza|influenza
708161|NCT00989274|Vaccination|vaccination
708162|NCT00989274|Immunology|immunology
708163|NCT00989274|Immunogenicity|immunogenicity
708164|NCT00989274|Reactogenicity|reactogenicity
708165|NCT00989274|Safety|safety
708166|NCT00989274|Influenza vaccine|influenza vaccine
708167|NCT00989274|Immune response|immune response
708168|NCT00989274|Adverse effects|adverse effects
708169|NCT00989287|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
708170|NCT00989287|influenza infection|influenza infection
708171|NCT00989300|Drug-Drug interaction|drug-drug interaction
708172|NCT00989300|Clopidogrel|clopidogrel
708173|NCT00989300|Rabeprazol|rabeprazol
708174|NCT00989300|Omeprazol|omeprazol
708175|NCT00989300|Pharmacodynamic Study|pharmacodynamic study
708176|NCT00989313|Peplin|peplin
708177|NCT00989313|Actinic keratosis|actinic keratosis
708178|NCT00989313|PEP005|pep005
708179|NCT00989326|Remote monitoring|remote monitoring
708180|NCT00989326|Pacemaker|pacemaker
708181|NCT00989326|Follow up|follow up
708182|NCT00989326|Follow-up studies|follow-up studies
708183|NCT00989339|lipid emulsion|lipid emulsion
708184|NCT00989339|endothelial function|endothelial function
708185|NCT00989339|inflammatory markers|inflammatory markers
708186|NCT00989339|oxidative stress|oxidative stress
708187|NCT00989339|insulin sensitivity|insulin sensitivity
708188|NCT00989339|carbohydrate metabolism|carbohydrate metabolism
708189|NCT00989352|PCNSL|pcnsl
708190|NCT00989352|Lymphoma|lymphoma
708191|NCT00989352|Methotrexate|methotrexate
708192|NCT00989352|Lomustine|lomustine
708193|NCT00989352|Procarbazine|procarbazine
708194|NCT00989352|Rituximab|rituximab
708195|NCT00989352|Elderly|elderly
708196|NCT00989352|Chemotherapy|chemotherapy
708197|NCT00989365|Aerobic Exercise|aerobic exercise
708198|NCT00989365|Exercise|exercise
708199|NCT00989378|sleep|sleep
708200|NCT00989378|insulin|insulin
708201|NCT00989378|diabetes|diabetes
708202|NCT00989378|determine association between sleep characteristics and diabetes risk|determine association between sleep characteristics and diabetes risk
708203|NCT00989391|Phase 1 multiple dose safety toleration pharmacokinetic|phase 1 multiple dose safety toleration pharmacokinetic
708204|NCT00989404|pk|pk
708205|NCT00989404|healthy subjects|healthy subjects
708206|NCT00989404|influenza virus|influenza virus
708207|NCT00989404|Safety|safety
708208|NCT00989404|pandemic|pandemic
708209|NCT00989417|Remote monitoring|remote monitoring
708210|NCT00989417|Defibrillators, Implantable|defibrillators, implantable
708211|NCT00989417|Home monitoring|home monitoring
708212|NCT00989417|Shock|shock
709615|NCT01002599|Boussignac|boussignac
708213|NCT00989417|Implantable cardioverter-defibrillator Therapy|implantable cardioverter-defibrillator therapy
708214|NCT00989430|stroke|stroke
708215|NCT00989430|CVA|cva
708216|NCT00989430|cerebrovascular accident|cerebrovascular accident
708217|NCT00989430|rehabilitation|rehabilitation
708218|NCT00989443|Cervix Intraepithelial Neoplasia grades 2 and 3|cervix intraepithelial neoplasia grades 2 and 3
708219|NCT00989456|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
708220|NCT00989456|Heart failure|heart failure
708221|NCT00989456|Stroke|stroke
708222|NCT00989456|quality of life|quality of life
708223|NCT00989456|self management education|self management education
708224|NCT00989456|physical exercise|physical exercise
708225|NCT00989456|primary health care|primary health care
708226|NCT00989495|AIS|ais
708227|NCT00989508|Perhexiline|perhexiline
708228|NCT00989508|Aortic Valve Stenosis|aortic valve stenosis
708229|NCT00989508|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
708230|NCT00989508|Myocardial Reperfusion Injury|myocardial reperfusion injury
708231|NCT00989508|Cardiac Output, Low|cardiac output, low
708232|NCT00989508|Troponin|troponin
708233|NCT00989521|Asthma|asthma
708234|NCT00989521|bronchial diseases|bronchial diseases
708235|NCT00989521|lung diseases|lung diseases
708236|NCT00989521|bronchitis|bronchitis
708237|NCT00989521|respiratory tract diseases|respiratory tract diseases
708238|NCT00989534|shift work|shift work
708239|NCT00989534|diabetes|diabetes
708240|NCT00989534|Affects of shift work and sleep loss on health|affects of shift work and sleep loss on health
708241|NCT00989586|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
709851|NCT01003509|double|double
708242|NCT00989586|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
708489|NCT00990509|Placebo-controlled|placebo-controlled
708243|NCT00989586|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
708244|NCT00989586|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
708245|NCT00989586|MALT lymphoma|malt lymphoma
708246|NCT00989586|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
708247|NCT00989586|splenic marginal zone lymphoma|splenic marginal zone lymphoma
708248|NCT00989586|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
708249|NCT00989586|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
708250|NCT00989599|phlebitis|phlebitis
708251|NCT00989599|Chamomilla recutita|chamomilla recutita
708252|NCT00989599|Catheterization peripheral|catheterization peripheral
708253|NCT00989612|influenza infection|influenza infection
708254|NCT00989612|GSK Biologicals' influenza vaccine GSK2340272A|gsk biologicals' influenza vaccine gsk2340272a
708255|NCT00989625|migraine|migraine
708256|NCT00989625|single dose|single dose
708257|NCT00989625|healthy volunteer|healthy volunteer
708258|NCT00989625|adolescence|adolescence
708259|NCT00989625|pharmacokinetics|pharmacokinetics
708260|NCT00989664|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
708261|NCT00989664|radioimmunotherapy|radioimmunotherapy
708262|NCT00989664|NHL|nhl
708263|NCT00989664|Bexxar|bexxar
708264|NCT00989664|lymphoma|lymphoma
708265|NCT00989664|Tositumomab|tositumomab
708266|NCT00989690|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
708267|NCT00989690|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
708268|NCT00989690|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
708269|NCT00989703|Safety|safety
708270|NCT00989703|Tolerability|tolerability
708271|NCT00989703|Pharmacokinetics|pharmacokinetics
708272|NCT00989729|Endovascular Aortic Repair|endovascular aortic repair
708273|NCT00989729|Methylprednisolone|methylprednisolone
708274|NCT00989729|Systemic inflammatory response syndrome|systemic inflammatory response syndrome
708275|NCT00989742|lymphangioleiomatosis|lymphangioleiomatosis
708276|NCT00989742|LAM|lam
708277|NCT00989742|tuberous sclerosis|tuberous sclerosis
708278|NCT00989742|doxycycline|doxycycline
708279|NCT00989742|matrix metalloproteinases|matrix metalloproteinases
708280|NCT00989742|MMP|mmp
708281|NCT00989755|Tobacco dependence treatment in primary health care setting|tobacco dependence treatment in primary health care setting
708282|NCT00989755|Fax to Quit|fax to quit
708283|NCT00989755|Fax to Quit plus Enhanced Academic Detailing|fax to quit plus enhanced academic detailing
708284|NCT00989755|Fax referral|fax referral
708285|NCT00989755|Quitline|quitline
708286|NCT00989768|Botulinum toxin type A|botulinum toxin type a
708287|NCT00989768|field effects|field effects
708288|NCT00989768|dose-equivalence|dose-equivalence
708289|NCT00989768|anhydrotic action halos|anhydrotic action halos
708290|NCT00989781|PCOS, Androgens, ovary, polycystic|pcos, androgens, ovary, polycystic
708291|NCT00989794|cartilage|cartilage
708292|NCT00989794|implantation|implantation
708293|NCT00989794|chondrocyte|chondrocyte
708294|NCT00989794|condyle|condyle
708295|NCT00989807|CF|cf
708296|NCT00989807|Cystic fibrosis|cystic fibrosis
708297|NCT00989807|Pseudomonas aeruginosa|pseudomonas aeruginosa
708298|NCT00989807|EAP|eap
708299|NCT00989807|Expanded access|expanded access
708300|NCT00989807|AZLI|azli
708301|NCT00989807|Aztreonam lysine|aztreonam lysine
708302|NCT00989820|osteoradionecrosis|osteoradionecrosis
708303|NCT00989820|mandible|mandible
708304|NCT00989820|radiotherapy|radiotherapy
708305|NCT00989820|hyperbaric oxygen therapy|hyperbaric oxygen therapy
708306|NCT00989833|Exercise induced asthma|exercise induced asthma
708307|NCT00989833|Mild intermittent asthma|mild intermittent asthma
708308|NCT00989833|Exercise induced bronchoconstriction|exercise induced bronchoconstriction
708309|NCT00989846|biomarker|biomarker
708310|NCT00989846|lung disease|lung disease
708311|NCT00989859|monitoring|monitoring
708312|NCT00989872|Macrolides|macrolides
708313|NCT00989872|Antibiotics|antibiotics
708314|NCT00989872|Safety|safety
708315|NCT00989872|Tolerability|tolerability
708316|NCT00989872|Pharmacokinetics|pharmacokinetics
708317|NCT00989872|Phase I|phase i
708318|NCT00989872|MRSA/SSTI|mrsa/ssti
708319|NCT00989885|Evaluation|evaluation
708320|NCT00989885|Obstructive sleep apnea|obstructive sleep apnea
708321|NCT00989885|Polysomnography|polysomnography
708322|NCT00989898|T1D, closed-loop systems, overnight hypoglycaemia|t1d, closed-loop systems, overnight hypoglycaemia
708323|NCT00989911|Single ventricle congenital heart disease|single ventricle congenital heart disease
708324|NCT00989924|Diabetes mellitus|diabetes mellitus
708325|NCT00989924|Coronary heart disease|coronary heart disease
708326|NCT00989924|Magnetocardiography|magnetocardiography
708327|NCT00989937|oxytocin|oxytocin
708328|NCT00989950|daytrana|daytrana
708329|NCT00989950|sleep latency|sleep latency
708330|NCT00989950|adhd rating scales|adhd rating scales
708331|NCT00989950|ADHD|adhd
708332|NCT00989963|PAH|pah
708333|NCT00989976|Sleep|sleep
708334|NCT00989976|Diabetes Risk|diabetes risk
708335|NCT00989989|DME|dme
708336|NCT00989989|Diabetic|diabetic
708337|NCT00989989|macula|macula
708338|NCT00989989|edema|edema
708339|NCT00989989|ranibizumab|ranibizumab
708340|NCT00989989|REVEAL|reveal
708341|NCT00990015|Safety; tolerability; pharmacokinetics/pharmacodynamics|safety; tolerability; pharmacokinetics/pharmacodynamics
708342|NCT00990028|moderate head injury|moderate head injury
708343|NCT00990028|rosuvastatin|rosuvastatin
708344|NCT00990028|statin|statin
708345|NCT00990028|amnesia|amnesia
708346|NCT00990028|orientation|orientation
708347|NCT00990041|periodontitis|periodontitis
708348|NCT00990041|find cytokines in blood of periodontal patients|find cytokines in blood of periodontal patients
708349|NCT00990054|Cytarabine,|cytarabine,
708350|NCT00990054|Daunorubicin,|daunorubicin,
708351|NCT00990054|De Novo,|de novo,
708352|NCT00990054|Acute Myeloid Leukemia,|acute myeloid leukemia,
708353|NCT00990054|AML|aml
708354|NCT00990067|MDMA|mdma
708355|NCT00990067|serotonin|serotonin
708356|NCT00990067|norepinephrine|norepinephrine
708357|NCT00990067|Ecstasy|ecstasy
708358|NCT00990067|stimulant|stimulant
708359|NCT00990106|posttraumatic stress disorder|posttraumatic stress disorder
708360|NCT00990106|PTSD|ptsd
708361|NCT00990106|nightmares|nightmares
708362|NCT00990106|prazosin|prazosin
708363|NCT00990106|sleep disturbance|sleep disturbance
708364|NCT00990106|combat trauma|combat trauma
708365|NCT00990119|high flow therapy|high flow therapy
708366|NCT00990119|high flow nasal cannula|high flow nasal cannula
708490|NCT00990509|Phase II|phase ii
708367|NCT00990119|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
708368|NCT00990119|respiratory insufficiency|respiratory insufficiency
708369|NCT00990132|COPD|copd
708370|NCT00990132|Respiratory failure|respiratory failure
708371|NCT00990132|Non-invasive ventilation|non-invasive ventilation
708372|NCT00990132|Home mechanical ventilation|home mechanical ventilation
708373|NCT00990158|Vitamin K1 (phytonadione)|vitamin k1 (phytonadione)
708374|NCT00990158|Randomized controlled trial|randomized controlled trial
708375|NCT00990158|Warfarin|warfarin
708376|NCT00990158|Coagulopathy|coagulopathy
708377|NCT00990158|Time in therapeutic range|time in therapeutic range
708378|NCT00990158|Bleeding|bleeding
708379|NCT00990158|Thrombosis|thrombosis
708380|NCT00990158|VKORC1 and CYP2C9 genotypes|vkorc1 and cyp2c9 genotypes
708381|NCT00990158|Time INR in therapeutic range|time inr in therapeutic range
708382|NCT00990171|peritoneal Dialysis|peritoneal dialysis
708383|NCT00990171|wasting and malnutrition|wasting and malnutrition
708384|NCT00990171|nutrition status|nutrition status
708385|NCT00990171|bioelectrical impedance analysis|bioelectrical impedance analysis
708386|NCT00990171|body composition|body composition
708387|NCT00990184|Impaired Fasting Glucose|impaired fasting glucose
708388|NCT00990184|PreDiabetes|prediabetes
708389|NCT00990197|Pilot study|pilot study
708390|NCT00990197|Randomized clinical trial|randomized clinical trial
708391|NCT00990197|Smoking cessation|smoking cessation
708392|NCT00990197|Acute coronary syndrome|acute coronary syndrome
708393|NCT00990197|Transdermal nicotine patch|transdermal nicotine patch
708394|NCT00990223|Eplerenone Aldosterone and Plasma Renin Activity responses Pharmacodynamics|eplerenone aldosterone and plasma renin activity responses pharmacodynamics
708395|NCT00990236|deep vein thrombosis|deep vein thrombosis
708396|NCT00990236|superficial venous thrombosis|superficial venous thrombosis
708397|NCT00990236|pulmonary embolus|pulmonary embolus
708398|NCT00990249|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
708399|NCT00990249|ALL|all
708400|NCT00990249|Acute lymphoblastic lymphoma|acute lymphoblastic lymphoma
708401|NCT00990249|acute biphenotypic leukemia|acute biphenotypic leukemia
708402|NCT00990249|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
708403|NCT00990249|HCT|hct
708404|NCT00990249|Stem Cell Transplant|stem cell transplant
708405|NCT00990249|Treatment-related mortality|treatment-related mortality
708406|NCT00990249|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
708407|NCT00990249|TKI|tki
708408|NCT00990249|Busulfan|busulfan
708409|NCT00990249|Busulfex|busulfex
708410|NCT00990249|Myleran|myleran
708411|NCT00990249|Clofarabine|clofarabine
708412|NCT00990249|Clolar|clolar
708413|NCT00990249|Clofarex|clofarex
708414|NCT00990249|Gleevec|gleevec
708415|NCT00990249|Imatinib Mesylate|imatinib mesylate
708416|NCT00990262|acute chest pain|acute chest pain
708417|NCT00990262|emergency department|emergency department
708418|NCT00990262|cardiac computed tomography|cardiac computed tomography
708419|NCT00990288|To decrease blood loss during knee surgery|to decrease blood loss during knee surgery
708420|NCT00990301|Healthy Subjects|healthy subjects
708421|NCT00990301|Bioequivalence|bioequivalence
708422|NCT00990327|Coronary artery disease|coronary artery disease
708423|NCT00990327|Myocardial Perfusion Imaging|myocardial perfusion imaging
708424|NCT00990353|Spatial neglect|spatial neglect
708425|NCT00990353|hemineglect|hemineglect
708426|NCT00990353|stroke|stroke
708427|NCT00990353|cognition|cognition
708428|NCT00990353|prism adaptation|prism adaptation
708429|NCT00990353|Hierarchical linear modeling|hierarchical linear modeling
708430|NCT00990353|growth curve modeling|growth curve modeling
708431|NCT00990366|antireflux valve|antireflux valve
708432|NCT00990366|biliary obstruction|biliary obstruction
708433|NCT00990366|cholangitis|cholangitis
708434|NCT00990366|biliary stent|biliary stent
708436|NCT00990379|brain diseases|brain diseases
708437|NCT00990379|spinal fluid|spinal fluid
708438|NCT00990379|HIV positive|hiv positive
708439|NCT00990392|Blood stream infections|blood stream infections
708440|NCT00990392|Catheter related infections|catheter related infections
708441|NCT00990392|Central venous catheter related infections|central venous catheter related infections
708442|NCT00990392|Line sepsis|line sepsis
708443|NCT00990392|Topical antibiotics|topical antibiotics
708444|NCT00990392|Bacitracin|bacitracin
708445|NCT00990392|Polymixin|polymixin
708446|NCT00990392|Gramicidin|gramicidin
708447|NCT00990392|Polysporin Triple Therapy|polysporin triple therapy
708448|NCT00990392|Intensive care unit|intensive care unit
708449|NCT00990405|Rome III criteria|rome iii criteria
708450|NCT00990418|Postoperative pain|postoperative pain
708451|NCT00990418|E-TRANS System, fentanyl HCl System|e-trans system, fentanyl hcl system
708452|NCT00990418|E-TRANSS (fentanyl HCl) System|e-transs (fentanyl hcl) system
708453|NCT00990418|Acute postoperative pain|acute postoperative pain
708454|NCT00990431|skin aging|skin aging
708455|NCT00990431|laser surgery|laser surgery
708456|NCT00990431|fractional photothermolysis|fractional photothermolysis
708457|NCT00990431|comparative study|comparative study
708458|NCT00990431|Ablative fractional treatment of peri-orbital rhytides|ablative fractional treatment of peri-orbital rhytides
708459|NCT00990444|blood glucose|blood glucose
708460|NCT00990444|blood insulin|blood insulin
708461|NCT00990444|dextran|dextran
708462|NCT00990444|diabetes|diabetes
708463|NCT00990444|hyperglycemia|hyperglycemia
708464|NCT00990444|hypoglycemia|hypoglycemia
708465|NCT00990444|oral delivery|oral delivery
708466|NCT00990444|portal delivery|portal delivery
708467|NCT00990457|Exercise|exercise
708468|NCT00990457|Weight loss diet|weight loss diet
708469|NCT00990457|Obesity|obesity
708470|NCT00990457|Overweight|overweight
708471|NCT00990457|Abdominal obesity|abdominal obesity
708472|NCT00990457|Cardiovascular function|cardiovascular function
708473|NCT00990457|Body composition|body composition
708474|NCT00990470|Transplantation|transplantation
708475|NCT00990470|Liver|liver
708476|NCT00990470|Endoscopy|endoscopy
708477|NCT00990470|Colonoscopy|colonoscopy
708478|NCT00990470|Gastroscopy|gastroscopy
708479|NCT00990496|Glioblastoma multiforme|glioblastoma multiforme
708480|NCT00990496|GBM|gbm
708481|NCT00990496|Cytomegalovirus|cytomegalovirus
708482|NCT00990496|CMV|cmv
708483|NCT00990496|Cytotoxic T lymphocyte|cytotoxic t lymphocyte
708484|NCT00990496|CTL|ctl
708485|NCT00990509|Primary ICH|primary ich
708486|NCT00990509|Albumin|albumin
708487|NCT00990509|MRI|mri
708488|NCT00990509|Neuroimaging outcome|neuroimaging outcome
708491|NCT00990509|Blinded|blinded
708492|NCT00990509|Safety|safety
708493|NCT00990509|Acute ICH|acute ich
708494|NCT00990509|ICH|ich
708495|NCT00990509|Primary acute (< 48 hours) supratentorial ICH|primary acute (< 48 hours) supratentorial ich
708496|NCT00990522|sharp debridment|sharp debridment
708497|NCT00990522|patients with full thickness wounds of greater than 30 days duration|patients with full thickness wounds of greater than 30 days duration
708498|NCT00990535|neuroendocrine tumors|neuroendocrine tumors
708499|NCT00990535|octreotide|octreotide
708500|NCT00990535|somatostatin analogues|somatostatin analogues
708501|NCT00990548|Cardiac Caregivers|cardiac caregivers
708502|NCT00990548|Cardiac Patient Clinical Outcomes|cardiac patient clinical outcomes
708503|NCT00990548|Prevention of CVD|prevention of cvd
708504|NCT00990587|relapsed and refractory hematologic malignancy|relapsed and refractory hematologic malignancy
708505|NCT00990587|ALL (acute lymphoid leukemia)|all (acute lymphoid leukemia)
708506|NCT00990587|CLL (chronic lymphoid leukemia)|cll (chronic lymphoid leukemia)
708507|NCT00990587|High risk myelodysplasia (MDS) with an IPSS (International Prognostic Scoring System) score >2.5|high risk myelodysplasia (mds) with an ipss (international prognostic scoring system) score >2.5
708508|NCT00990587|CML (chronic myelogenous leukemia) blast crisis|cml (chronic myelogenous leukemia) blast crisis
708509|NCT00990587|Relapsed or refractory acute myeloid leukemia (AML)|relapsed or refractory acute myeloid leukemia (aml)
708510|NCT00990600|adherence|adherence
708511|NCT00990600|Qol|qol
708512|NCT00990600|virologic efficacy|virologic efficacy
708513|NCT00990600|immunologic efficacy|immunologic efficacy
708514|NCT00990600|patients' preference|patients' preference
708515|NCT00990600|once-daily|once-daily
708516|NCT00990600|HAART|haart
708517|NCT00990600|treatment experienced|treatment experienced
708518|NCT00990613|percutaneous transcutaneous dimebon transdermal pharmacokinetics|percutaneous transcutaneous dimebon transdermal pharmacokinetics
708519|NCT00990626|Seroquel XR|seroquel xr
708520|NCT00990626|schizophrenia relapse prevention|schizophrenia relapse prevention
708521|NCT00990639|hepatic fibrosis|hepatic fibrosis
708522|NCT00990639|angiotensin II blocking agents|angiotensin ii blocking agents
708523|NCT00990639|alcoholic liver disease|alcoholic liver disease
708524|NCT00990652|brain tumor|brain tumor
708526|NCT00990665|Heart Failure|heart failure
708527|NCT00990665|LV Leads|lv leads
708528|NCT00990678|HIV-1|hiv-1
708529|NCT00990678|humans|humans
708530|NCT00990678|vitamin D|vitamin d
708531|NCT00990678|1-hydroxy-vitamin D|1-hydroxy-vitamin d
708532|NCT00990678|Rocaltrol|rocaltrol
708533|NCT00990678|calcium|calcium
708534|NCT00990678|complementary therapies|complementary therapies
708535|NCT00990691|Rett syndrome|rett syndrome
708536|NCT00990704|Secondary hyperparathyroidism|secondary hyperparathyroidism
708537|NCT00990704|Hemodialysis|hemodialysis
708538|NCT00990704|paricalcitol|paricalcitol
708539|NCT00990704|maxacalcitol|maxacalcitol
708540|NCT00990717|natural killer cells|natural killer cells
708541|NCT00990717|leukemia|leukemia
708542|NCT00990717|lymphoma|lymphoma
708543|NCT00990717|myeloma|myeloma
708544|NCT00990717|Hodgkin's disease|hodgkin's disease
708545|NCT00990717|cell therapy|cell therapy
708546|NCT00990730|rheumatoid arthritis|rheumatoid arthritis
708547|NCT00990730|endothelial dysfunction|endothelial dysfunction
708548|NCT00990730|lipoproteins|lipoproteins
708549|NCT00990730|inflammation|inflammation
708550|NCT00990730|oxidative stress|oxidative stress
708551|NCT00990730|arterial stiffness|arterial stiffness
708552|NCT00990743|Ocular hypertension|ocular hypertension
708553|NCT00990743|Glaucoma|glaucoma
708554|NCT00990743|Beta-blocker|beta-blocker
708555|NCT00990769|Emergence delirium|emergence delirium
708556|NCT00990769|Bispectral Index|bispectral index
708557|NCT00990769|Depth of anesthesia|depth of anesthesia
708558|NCT00990795|open heart surgery|open heart surgery
708559|NCT00990795|cyclosporine|cyclosporine
708560|NCT00990795|myocardial protection|myocardial protection
708561|NCT00990834|Statin|statin
708562|NCT00990834|Myopathy|myopathy
708563|NCT00990834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
708564|NCT00990834|Atrogin-1|atrogin-1
708565|NCT00990860|Combination of TACE With Sorafenib|combination of tace with sorafenib
708566|NCT00990873|stage I non-small cell lung cancer|stage i non-small cell lung cancer
708567|NCT00990886|Oxybutynin|oxybutynin
708568|NCT00990886|Ditropan|ditropan
708569|NCT00990886|Menopause Treatment|menopause treatment
708570|NCT00990886|Vasomotor symptoms|vasomotor symptoms
708571|NCT00990886|Hot Flashes|hot flashes
708572|NCT00990886|Non-hormonal therapy for Vasomotor symptoms|non-hormonal therapy for vasomotor symptoms
708573|NCT00990899|hypertension|hypertension
708574|NCT00990899|obstructive sleep apnea|obstructive sleep apnea
708575|NCT00990899|pediatrics|pediatrics
708576|NCT00991588|PCL|pcl
708577|NCT00991588|Posterolateral|posterolateral
708578|NCT00991601|liver|liver
708579|NCT00991601|pancreas|pancreas
708580|NCT00991601|cancer|cancer
708581|NCT00991601|tumor|tumor
708582|NCT00991601|FNAC|fnac
708583|NCT00991627|Ephedrine|ephedrine
708584|NCT00991627|Adrenergic Agents|adrenergic agents
708585|NCT00991627|Central Nervous System Stimulants|central nervous system stimulants
708586|NCT00991627|Sympathomimetics|sympathomimetics
708587|NCT00991627|Vasoconstrictor Agents|vasoconstrictor agents
708588|NCT00991627|Bupivacaine|bupivacaine
708589|NCT00991627|Anesthetics, Local|anesthetics, local
708590|NCT00991627|Atropine|atropine
708591|NCT00991627|Adjuvants, Anesthesia|adjuvants, anesthesia
708592|NCT00991627|Anti-Arrhythmia Agents|anti-arrhythmia agents
708593|NCT00991627|Bronchodilator Agents|bronchodilator agents
708594|NCT00991627|Muscarinic Antagonists|muscarinic antagonists
708595|NCT00991627|Mydriatics|mydriatics
708596|NCT00991627|Parasympatholytics|parasympatholytics
708597|NCT00991627|Morphine|morphine
708598|NCT00991627|Analgesics, Opioid|analgesics, opioid
708600|NCT00991627|Ringer's Lactate|ringer's lactate
708601|NCT00991627|Isotonic Solutions|isotonic solutions
708602|NCT00991627|Hypotension|hypotension
708603|NCT00991627|Blood pressure|blood pressure
708604|NCT00991627|Signs and Symptoms|signs and symptoms
708605|NCT00991627|Pregnancy|pregnancy
708606|NCT00991627|Anesthesia, Obstetrical|anesthesia, obstetrical
708607|NCT00991627|Inferior Vena Cava|inferior vena cava
708608|NCT00991653|Weight|weight
708609|NCT00991653|Breast|breast
708610|NCT00991653|Cancer|cancer
708611|NCT00991666|AMD|amd
708612|NCT00991666|rigidity|rigidity
708613|NCT00991666|pulsatile ocular blood flow|pulsatile ocular blood flow
708614|NCT00991666|Physiology of the eye|physiology of the eye
708615|NCT00991679|Dry eye syndrome|dry eye syndrome
708616|NCT00991679|CXCL9 chemokine|cxcl9 chemokine
708617|NCT00991679|CXCL10 chemokine|cxcl10 chemokine
708618|NCT00991679|CXCL11 chemokine|cxcl11 chemokine
708619|NCT00991679|CXCR3 receptor|cxcr3 receptor
708620|NCT00991692|Pediatric CI Therapy|pediatric ci therapy
708621|NCT00991692|ACQUIREc Therapy|acquirec therapy
708622|NCT00991692|Dosage|dosage
708623|NCT00991692|Occupational Therapy|occupational therapy
708624|NCT00991692|Physical Therapy|physical therapy
708625|NCT00991692|Cerebral Palsy|cerebral palsy
708626|NCT00991692|Hemiparesis|hemiparesis
708627|NCT00991705|Fimasartan, Atorvastatin|fimasartan, atorvastatin
708628|NCT00991718|GDC0449|gdc0449
708629|NCT00991731|Physical Activity|physical activity
708630|NCT00991731|Faith based|faith based
708631|NCT00991731|Non faith based|non faith based
753707|NCT01177215|Algorithm|algorithm
708632|NCT00991731|African American|african american
708633|NCT00991731|Female|female
708634|NCT00991731|Pedometers|pedometers
708635|NCT00991744|Leukemia|leukemia
708636|NCT00991744|Central nervous system|central nervous system
708637|NCT00991744|Neurotoxicity|neurotoxicity
708638|NCT00991744|Liposomal cytarabine|liposomal cytarabine
708639|NCT00991744|Children|children
708640|NCT00991744|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
708641|NCT00991744|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
708642|NCT00991744|Intrathecal|intrathecal
708643|NCT00991744|Efficacy|efficacy
708644|NCT00991744|Safety|safety
708645|NCT00991757|RWJ-333369|rwj-333369
708646|NCT00991757|Anticonvulsants|anticonvulsants
708647|NCT00991757|Antiepileptic drugs|antiepileptic drugs
708648|NCT00991757|Epilepsy, Focal|epilepsy, focal
708649|NCT00991757|Seizure Disorder|seizure disorder
708650|NCT00991770|Discomfort|discomfort
708752|NCT00992225|Metastatic|metastatic
708651|NCT00991770|Port-a-Catheters|port-a-catheters
708652|NCT00991770|Complementary and Alternative Medicine|complementary and alternative medicine
708653|NCT00991770|Massage|massage
708654|NCT00991783|Fimasartan|fimasartan
708655|NCT00991783|Drug interaction|drug interaction
708656|NCT00991809|opioid induced hyperalgesia|opioid induced hyperalgesia
708657|NCT00991822|open angle glaucoma|open angle glaucoma
708658|NCT00991822|timolol|timolol
708659|NCT00991822|dorzolamide|dorzolamide
708660|NCT00991848|Lidocaine;|lidocaine;
708661|NCT00991848|Fibromyalgia|fibromyalgia
708662|NCT00991848|signs|signs
708663|NCT00991848|symptoms|symptoms
708664|NCT00991861|Actinic Keratosis|actinic keratosis
708665|NCT00991861|AK|ak
708666|NCT00991861|NMSC|nmsc
708667|NCT00991874|Nitric oxide|nitric oxide
708668|NCT00991874|Asthma|asthma
708669|NCT00991874|Longitudinal studies|longitudinal studies
708670|NCT00991874|Child|child
708671|NCT00991887|OTA 13C1|ota 13c1
708672|NCT00991887|OTA 13C2|ota 13c2
708673|NCT00991887|OTA 13C3|ota 13c3
708674|NCT00991887|OTA 21B1|ota 21b1
708675|NCT00991887|OTA 21B2|ota 21b2
708676|NCT00991887|OTA 21B3|ota 21b3
708677|NCT00991887|OTA 21C1|ota 21c1
708678|NCT00991887|OTA 21C2|ota 21c2
708679|NCT00991887|OTA 21C3|ota 21c3
708680|NCT00991887|Distal humerus intraarticular fractures with or without proximal radius/ulna fractures - open or closed|distal humerus intraarticular fractures with or without proximal radius/ulna fractures - open or closed
708681|NCT00991887|Fracture-dislocations of the elbow (ulno-humeral dislocation associated with proximal ulna and/or radius fractures) - open or closed|fracture-dislocations of the elbow (ulno-humeral dislocation associated with proximal ulna and/or radius fractures) - open or closed
708682|NCT00991913|Delirium|delirium
708683|NCT00991913|Postoperative|postoperative
708684|NCT00991913|Non-cardiovascular surgery|non-cardiovascular surgery
708685|NCT00991913|Post-anaesthesia care unit|post-anaesthesia care unit
708686|NCT00991926|obesity|obesity
708687|NCT00991926|GH/IGF-1 axis|gh/igf-1 axis
708688|NCT00991926|postprandial NEFA|postprandial nefa
708689|NCT00991939|Immune thrombocytopenic purpura|immune thrombocytopenic purpura
708690|NCT00991939|ITP|itp
708691|NCT00991939|Dexamethasone|dexamethasone
708692|NCT00991939|Prednisone|prednisone
708693|NCT00991965|Alveolar Ridge Augmentation|alveolar ridge augmentation
708694|NCT00991965|Dental Implantation, Endosseous|dental implantation, endosseous
708695|NCT00991965|Osseointegration|osseointegration
708696|NCT00991965|Bone Morphogenetic Proteins|bone morphogenetic proteins
708697|NCT00991978|breast cancer|breast cancer
708700|NCT00991991|stage I melanoma|stage i melanoma
708701|NCT00991991|stage II melanoma|stage ii melanoma
708702|NCT00991991|stage III melanoma|stage iii melanoma
708703|NCT00992004|Osteoarthritis, Knee|osteoarthritis, knee
708704|NCT00992004|Osteoarthritis|osteoarthritis
708705|NCT00992004|Joint Diseases|joint diseases
708706|NCT00992004|Arthritis|arthritis
708707|NCT00992004|Rheumatic Diseases|rheumatic diseases
708708|NCT00992017|Vaccine|vaccine
708709|NCT00992017|Pregnant|pregnant
708710|NCT00992017|Perinatal|perinatal
708711|NCT00992043|creatine supplementation|creatine supplementation
708712|NCT00992043|exercise training|exercise training
708713|NCT00992069|ARV|arv
708714|NCT00992069|Pharmacokinetics|pharmacokinetics
708715|NCT00992069|TMC207|tmc207
708716|NCT00992069|Efavirenz|efavirenz
708717|NCT00992082|Postoperative pain|postoperative pain
708718|NCT00992082|Local Infiltration Analgesia|local infiltration analgesia
708719|NCT00992082|Knee arthroplasty|knee arthroplasty
708720|NCT00992108|Bruxism|bruxism
708721|NCT00992108|Myofascial pain|myofascial pain
708722|NCT00992108|EMG|emg
708723|NCT00992108|Ultrasound|ultrasound
708724|NCT00992108|Masticatory myofascial face pain from bruxism and clenching|masticatory myofascial face pain from bruxism and clenching
708725|NCT00992121|pazopanib|pazopanib
708726|NCT00992121|Renal Cell Carcinoma|renal cell carcinoma
708727|NCT00992121|Kidney|kidney
708730|NCT00992134|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
708731|NCT00992134|Bendamustine|bendamustine
708732|NCT00992134|Cytarabine|cytarabine
708733|NCT00992134|Rituximab|rituximab
708734|NCT00992134|Treatment|treatment
708735|NCT00992134|Combination chemotherapy|combination chemotherapy
708736|NCT00992160|Polysomnography (PSG)|polysomnography (psg)
708737|NCT00992160|Adults|adults
708738|NCT00992160|Primary Insomnia|primary insomnia
708739|NCT00992173|Neuroblastoma|neuroblastoma
708740|NCT00992173|MIBG|mibg
708741|NCT00992173|Iobenguane|iobenguane
708742|NCT00992186|Prostate cancer|prostate cancer
708743|NCT00992186|Infusion|infusion
708744|NCT00992186|Carlumab|carlumab
708745|NCT00992186|CNTO 888|cnto 888
708746|NCT00992199|intraperitoneal chemotherapy|intraperitoneal chemotherapy
708747|NCT00992199|cisplatin|cisplatin
708748|NCT00992199|fluorouracil|fluorouracil
708749|NCT00992199|advanced gastric cancer|advanced gastric cancer
708750|NCT00992212|Pandemic influenza|pandemic influenza
708751|NCT00992212|vaccine|vaccine
708753|NCT00992251|prostate cancer|prostate cancer
708754|NCT00992264|Cigarette Smoking|cigarette smoking
708755|NCT00992264|Health Behavior|health behavior
708756|NCT00992264|Intervention Studies|intervention studies
708757|NCT00992264|Personal Communication|personal communication
708758|NCT00992290|cirrhosis|cirrhosis
708759|NCT00992290|hepatic encephalopathy|hepatic encephalopathy
708760|NCT00992290|complications|complications
708761|NCT00992290|probiotic|probiotic
708762|NCT00992290|lactobacillus GG|lactobacillus gg
708763|NCT00992303|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
708764|NCT00992316|Inflammatory pain|inflammatory pain
708765|NCT00992329|ciprofloxacin|ciprofloxacin
708766|NCT00992329|pharmacokinetics|pharmacokinetics
708767|NCT00992329|formulation|formulation
708768|NCT00992355|Cataract|cataract
708769|NCT00992355|Phacoemulsification|phacoemulsification
708770|NCT00992355|Treatment duration|treatment duration
708771|NCT00992368|Quality-Adjusted Life Years:A measurement index|quality-adjusted life years:a measurement index
708772|NCT00992368|Cost-Benefit Analysis:A method of comparing costs|cost-benefit analysis:a method of comparing costs
708773|NCT00992368|Mammaplasty|mammaplasty
708774|NCT00992368|QALY|qaly
708775|NCT00992368|Health-related quality of life|health-related quality of life
708776|NCT00992368|Cost-effectiveness|cost-effectiveness
708777|NCT00992368|Breast|breast
708778|NCT00992381|GI Pain|gi pain
708779|NCT00992381|healthy participants|healthy participants
708780|NCT00992381|Safety|safety
708781|NCT00992381|bioavailability|bioavailability
708782|NCT00992394|Plaque psoriasis - etanercept - response maintenance|plaque psoriasis - etanercept - response maintenance
708783|NCT00992407|Schizophrenia|schizophrenia
708784|NCT00992407|Risperidone|risperidone
708785|NCT00992407|Risperdal|risperdal
708786|NCT00992420|thienopyridine|thienopyridine
708787|NCT00992420|platelets|platelets
708788|NCT00992420|CYP2C19|cyp2c19
708789|NCT00992420|clopidogrel|clopidogrel
708790|NCT00992420|platelet function tests|platelet function tests
708791|NCT00992420|platelet|platelet
708792|NCT00992420|genes|genes
708793|NCT00992420|cytochrome P450|cytochrome p450
708794|NCT00992420|single nucleotide polymorphisms|single nucleotide polymorphisms
708795|NCT00992420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
708796|NCT00992433|influenza, H1N1, vaccine, human immunodeficiency virus|influenza, h1n1, vaccine, human immunodeficiency virus
708797|NCT00992446|Autologous stem cell transplant|autologous stem cell transplant
708799|NCT00992446|maintenance therapy|maintenance therapy
708800|NCT00992459|Urea Cycle Disorder (UCD)|urea cycle disorder (ucd)
708801|NCT00992459|UCD|ucd
708802|NCT00992459|hyperammonemia|hyperammonemia
708803|NCT00992459|Buphenyl (NaPBA)|buphenyl (napba)
708804|NCT00992459|glycerol phenylbutyrate (GPB)|glycerol phenylbutyrate (gpb)
708805|NCT00992459|Sodium Phenylbutyrate (NaPBA)|sodium phenylbutyrate (napba)
708806|NCT00992498|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
708807|NCT00992498|outpatients|outpatients
708808|NCT00992498|rehabilitation|rehabilitation
708809|NCT00992498|comorbidities|comorbidities
708810|NCT00992498|patient-centered outcome|patient-centered outcome
708811|NCT00992511|influenza infection|influenza infection
708812|NCT00992511|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
708813|NCT00992524|Misoprostol|misoprostol
708814|NCT00992524|Labor, Obstetric|labor, obstetric
708815|NCT00992524|Labor, Induced|labor, induced
708816|NCT00992550|hookah|hookah
708817|NCT00992550|cigarette|cigarette
708818|NCT00992550|smoking|smoking
708819|NCT00992563|wet age-related macular degeneration, exudative|wet age-related macular degeneration, exudative
708820|NCT00992576|Confirmatory|confirmatory
708821|NCT00992576|Constipation|constipation
708822|NCT00992576|Pain|pain
708823|NCT00992576|Hydromorphone|hydromorphone
708824|NCT00992576|Naloxone|naloxone
708825|NCT00992589|Gastroesophageal Reflux|gastroesophageal reflux
708826|NCT00992589|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
708828|NCT00992589|Proton Pump Inhibitor|proton pump inhibitor
708830|NCT00992589|Regurgitation|regurgitation
708831|NCT00992589|Infants|infants
708832|NCT00992589|AcipHex, PARIET|aciphex, pariet
708833|NCT00992589|ALFENCE|alfence
708834|NCT00992628|GlideScope Video Laryngoscope|glidescope video laryngoscope
708835|NCT00992628|Macintosh Direct Laryngoscope|macintosh direct laryngoscope
708836|NCT00992628|Intubation|intubation
708837|NCT00992628|Applied Forces|applied forces
708838|NCT00992628|Elective surgery where endotracheal intubation required|elective surgery where endotracheal intubation required
708839|NCT00992641|Systems biology|systems biology
708840|NCT00992641|Nutrition|nutrition
708841|NCT00992641|Nordic diet|nordic diet
708842|NCT00992641|Dietary recommendations|dietary recommendations
708843|NCT00992641|Metabolic syndrome|metabolic syndrome
708844|NCT00992641|Features of metabolic syndrome|features of metabolic syndrome
708845|NCT00992654|Open Label Access Program|open label access program
708846|NCT00992654|Treatment experienced|treatment experienced
708847|NCT00992667|apocynin|apocynin
708848|NCT00992667|asthma|asthma
708849|NCT00992680|Lung Disease|lung disease
708850|NCT00992680|Chronic Airflow Obstruction|chronic airflow obstruction
708851|NCT00992680|Chronic Bronchitis|chronic bronchitis
708852|NCT00992680|Pulmonary Emphysema|pulmonary emphysema
708854|NCT00992693|Crimean-Congo Hemorrhagic Fever|crimean-congo hemorrhagic fever
708855|NCT00992693|Lassa Fever|lassa fever
708856|NCT00992693|CCHF|cchf
708857|NCT00992693|LF|lf
708858|NCT00992693|Viral Hemorrhagic Fever|viral hemorrhagic fever
708859|NCT00992693|VHF|vhf
708860|NCT00992693|Ribavirin|ribavirin
708861|NCT00992706|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
708862|NCT00992706|stage IV breast cancer|stage iv breast cancer
708863|NCT00992706|male breast cancer|male breast cancer
709312|NCT00994032|vertebroplasty|vertebroplasty
708864|NCT00992719|H1N1, influenza A viruses, vaccine, pregnant women|h1n1, influenza a viruses, vaccine, pregnant women
708865|NCT00992745|prostate cancer|prostate cancer
708866|NCT00992745|imaging|imaging
708867|NCT00992745|metastases|metastases
708868|NCT00992745|PSMA|psma
708869|NCT00992745|ProstaScint®|prostascint®
708870|NCT00992758|bone marrow|bone marrow
708871|NCT00992758|Radioimmunotherapy|radioimmunotherapy
708872|NCT00992758|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
708873|NCT00992758|Bexxar|bexxar
708874|NCT00992758|anti-B1 antibody|anti-b1 antibody
708875|NCT00992758|tositumomab and iodine I-131 tositumomab|tositumomab and iodine i-131 tositumomab
708877|NCT00992758|tositumomab|tositumomab
708878|NCT00992784|Influenza Vaccines|influenza vaccines
708879|NCT00992784|GSK Bio's influenza vaccine GSK2186877A|gsk bio's influenza vaccine gsk2186877a
708880|NCT00992784|influenza infection|influenza infection
708881|NCT00992797|Insulin resistance|insulin resistance
708882|NCT00992797|Insulin secretory dysfunction|insulin secretory dysfunction
708883|NCT00992797|Inflammation|inflammation
708884|NCT00992797|Vascular stiffness|vascular stiffness
708885|NCT00992810|upper limb|upper limb
708886|NCT00992810|hand|hand
708887|NCT00992810|arm|arm
708888|NCT00992810|surgery|surgery
708889|NCT00992810|supraclavicular nerve block|supraclavicular nerve block
708890|NCT00992810|brachial plexus nerve block|brachial plexus nerve block
708891|NCT00992810|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
708892|NCT00992823|Iron|iron
708893|NCT00992823|anemia|anemia
708894|NCT00992823|supplementation|supplementation
708895|NCT00992823|preschoolers|preschoolers
708896|NCT00992823|prevalence|prevalence
708897|NCT00992823|preschoolers children from public day care centers|preschoolers children from public day care centers
708898|NCT00992836|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
708899|NCT00992836|Vaccine|vaccine
708900|NCT00992836|Children|children
708901|NCT00992836|Adolescents|adolescents
708902|NCT00992836|HIV-Infected|hiv-infected
708903|NCT00992836|Perinatal HIV Infection|perinatal hiv infection
708904|NCT00992836|Treatment experienced|treatment experienced
708905|NCT00992849|Corneal neovascularization|corneal neovascularization
708906|NCT00992849|bevacizumab|bevacizumab
708907|NCT00992875|Healthy but stressed individuals|healthy but stressed individuals
708908|NCT00992888|Alcoholic Hepatitis|alcoholic hepatitis
708909|NCT00992888|Alcohol|alcohol
708910|NCT00992888|Endotoxin|endotoxin
708911|NCT00992888|LPS|lps
708912|NCT00992888|Liver dialysis|liver dialysis
708913|NCT00992888|Innate immunity|innate immunity
708914|NCT00992888|Toll Like receptors|toll like receptors
708915|NCT00992901|gastric bypass surgery|gastric bypass surgery
708916|NCT00992901|glucose tolerance|glucose tolerance
708917|NCT00992901|Insulin response to meal ingestion|insulin response to meal ingestion
708918|NCT00992901|Gut hormone and neural response to meal ingestion|gut hormone and neural response to meal ingestion
708919|NCT00992914|Hot flushes (vasomotor symptoms)|hot flushes (vasomotor symptoms)
708920|NCT00992927|Injections, Intra-Articular|injections, intra-articular
708921|NCT00992927|Range of Motion, Articular|range of motion, articular
708922|NCT00992927|Pain|pain
708923|NCT00992940|awake craniotomy|awake craniotomy
708924|NCT00992940|patient-controlled sedation analgesia|patient-controlled sedation analgesia
708925|NCT00992940|anesthetist-controlled sedation analgesia|anesthetist-controlled sedation analgesia
709026|NCT00993356|Acromegaly|acromegaly
708926|NCT00992940|remifentanil-propofol|remifentanil-propofol
708927|NCT00992940|tumour surgery|tumour surgery
708928|NCT00992953|Virtual Reality|virtual reality
708929|NCT00992953|Post Traumatic Stress Disorder|post traumatic stress disorder
708930|NCT00992953|Combat|combat
708931|NCT00992953|Military|military
708932|NCT00992953|Major Depressive Disorder|major depressive disorder
708933|NCT00992953|Anxiety|anxiety
708934|NCT00992953|Virtual Reality Exposure with Stimulus Control|virtual reality exposure with stimulus control
708935|NCT00992953|Treatment as Usual|treatment as usual
708936|NCT00992966|to acquire database of pneumonia cases in children|to acquire database of pneumonia cases in children
708937|NCT00992979|Addiction|addiction
708938|NCT00992979|Anxiety|anxiety
708939|NCT00992979|Withdrawal|withdrawal
708940|NCT00992979|Psychoactive Drugs|psychoactive drugs
708941|NCT00992979|Therapeutic Massage|therapeutic massage
708942|NCT00992992|Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP)|cyclophosphamide, doxorubicin, vincristine, and prednisone (chop)
708943|NCT00992992|Tositumomab|tositumomab
708944|NCT00992992|Tositumomab and Iodine I-131 tostumomab|tositumomab and iodine i-131 tostumomab
708945|NCT00992992|Bexxar|bexxar
708946|NCT00992992|Iodine-131 Anti-B1 Antibody|iodine-131 anti-b1 antibody
708947|NCT00992992|Mantle Cell|mantle cell
708948|NCT00992992|radioimmunotherapy|radioimmunotherapy
708949|NCT00993005|Hypertrophic scars|hypertrophic scars
708950|NCT00993005|Keloids|keloids
708951|NCT00993005|Asian Gotu Kola|asian gotu kola
708952|NCT00993005|Asian Pennywort|asian pennywort
708953|NCT00993018|Diabetic Neuropathy|diabetic neuropathy
708954|NCT00993018|Diabetic painful neuropathy|diabetic painful neuropathy
708955|NCT00993018|JNJ-42160443|jnj-42160443
708956|NCT00993018|Neuropathic pain|neuropathic pain
708957|NCT00993018|Pain|pain
708958|NCT00993018|Pharmacokinetics|pharmacokinetics
708960|NCT00993031|Placental Malaria|placental malaria
708961|NCT00993031|Pregnancy|pregnancy
708962|NCT00993031|Uganda|uganda
708963|NCT00993031|Protease inhibitors|protease inhibitors
708964|NCT00993031|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
708965|NCT00993031|Treatment experienced|treatment experienced
708966|NCT00993057|Euglycemia|euglycemia
708967|NCT00993057|craniotomy|craniotomy
708968|NCT00993057|neurosurgery|neurosurgery
708969|NCT00993057|hypoglycemia|hypoglycemia
708970|NCT00993057|insulin|insulin
708971|NCT00993070|capsaicin|capsaicin
708972|NCT00993070|placebo|placebo
708973|NCT00993070|trial|trial
708974|NCT00993070|diabetic polyneuropathy|diabetic polyneuropathy
708975|NCT00993070|neuropathic pain|neuropathic pain
708976|NCT00993083|Influenza|influenza
708977|NCT00993083|Vaccine|vaccine
708978|NCT00993109|Nifedipine GITS/OROS (Adalat®)|nifedipine gits/oros (adalat®)
708979|NCT00993109|Valsartan (Diovan®)|valsartan (diovan®)
708980|NCT00993109|Hypertension|hypertension
708981|NCT00993122|pre treatment|pre treatment
708982|NCT00993122|therapy compliance|therapy compliance
708983|NCT00993122|SVR|svr
708984|NCT00993122|sustained virological response|sustained virological response
708985|NCT00993122|TH1 TH2 ratio|th1 th2 ratio
708986|NCT00993135|renal toxicity|renal toxicity
708987|NCT00993135|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
708988|NCT00993135|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
708989|NCT00993148|Treatment naive|treatment naive
708990|NCT00993161|Neuromuscular disorders|neuromuscular disorders
708991|NCT00993161|Evaluation|evaluation
708992|NCT00993161|Strength|strength
708993|NCT00993161|Upper limb|upper limb
708994|NCT00993200|Warfarin|warfarin
708995|NCT00993200|Pharmacogenetic|pharmacogenetic
708996|NCT00993213|fat mass|fat mass
708997|NCT00993213|body composition|body composition
708998|NCT00993226|Postoperative pain|postoperative pain
708999|NCT00993226|Local anaesthesia|local anaesthesia
709000|NCT00993226|Postoperative pain after open abdominal hysterectomy surgery|postoperative pain after open abdominal hysterectomy surgery
709001|NCT00993252|head injury|head injury
709002|NCT00993252|radiography|radiography
709003|NCT00993252|clinical impact|clinical impact
709004|NCT00993252|dissemination|dissemination
709005|NCT00993265|Trichotillomania|trichotillomania
709006|NCT00993265|Hair pulling|hair pulling
709007|NCT00993265|glutamate|glutamate
709008|NCT00993265|N-Acetylcysteine|n-acetylcysteine
709009|NCT00993265|Children|children
709010|NCT00993291|Parkinson's Disease|parkinson's disease
709011|NCT00993291|DBS|dbs
709012|NCT00993291|Frequency|frequency
709013|NCT00993291|Deep brain stimulation|deep brain stimulation
709014|NCT00993317|CDP870|cdp870
709015|NCT00993317|Korea|korea
709016|NCT00993317|CIMZIA|cimzia
709017|NCT00993330|macular pigment|macular pigment
709018|NCT00993330|to measure macular pigment in the retina|to measure macular pigment in the retina
709019|NCT00993343|GVHD|gvhd
709020|NCT00993343|tacrolimus|tacrolimus
709021|NCT00993343|sirolimus|sirolimus
709022|NCT00993343|cyclosporine|cyclosporine
709023|NCT00993343|allogeneic|allogeneic
709024|NCT00993343|stem cell transplantation|stem cell transplantation
709025|NCT00993343|Relapse-free survival|relapse-free survival
709027|NCT00993356|Macroadenomas|macroadenomas
709028|NCT00993356|Lanreotide|lanreotide
709029|NCT00993356|Transsphenoidal neurosurgery|transsphenoidal neurosurgery
709030|NCT00993356|Preoperative|preoperative
709031|NCT00993369|Prediction of neuro developmental delay|prediction of neuro developmental delay
709032|NCT00993395|addiction|addiction
709033|NCT00993395|peer mentor|peer mentor
709034|NCT00993395|adherence|adherence
709035|NCT00993434|Child|child
709036|NCT00993447|Dengue|dengue
709037|NCT00993447|Dengue hemorrhagic fever|dengue hemorrhagic fever
709038|NCT00993447|Dengue virus|dengue virus
709039|NCT00993447|Dengue fever|dengue fever
709040|NCT00993447|Sanofi pasteur's CYD Dengue vaccine|sanofi pasteur's cyd dengue vaccine
709041|NCT00993460|Obesity|obesity
709042|NCT00993460|Insulin sensitivity|insulin sensitivity
709043|NCT00993460|Inflammation|inflammation
709044|NCT00993486|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
709045|NCT00993486|Graft-versus-host disease|graft-versus-host disease
709046|NCT00993486|Immune reconstitution|immune reconstitution
709047|NCT00993486|Alloreactive T-cells|alloreactive t-cells
709048|NCT00993486|Photodepletion|photodepletion
709049|NCT00993486|TH9402|th9402
709050|NCT00993486|Transplant related mortality|transplant related mortality
709051|NCT00993486|Hematologic malignancy|hematologic malignancy
709052|NCT00993512|photochemical internalisation|photochemical internalisation
709053|NCT00993512|photosensitiser|photosensitiser
709054|NCT00993512|cutaneous tumour|cutaneous tumour
709055|NCT00993512|sub-cutaneous tumour|sub-cutaneous tumour
709056|NCT00993512|dose escalation|dose escalation
709057|NCT00993525|diabetic retinopathy|diabetic retinopathy
709058|NCT00993525|ranibizumab|ranibizumab
709059|NCT00993525|new vessels|new vessels
709060|NCT00993525|intravitreal injection|intravitreal injection
709061|NCT00993525|Persistent retina new vessels|persistent retina new vessels
709062|NCT00993538|Leukaemia|leukaemia
709063|NCT00993538|Blood and marrow cells culture|blood and marrow cells culture
709064|NCT00993538|Cell growth|cell growth
709065|NCT00993538|Cell differentiation|cell differentiation
709066|NCT00993551|cleft palate|cleft palate
709067|NCT00993551|paediatric|paediatric
709068|NCT00993551|pediatric|pediatric
709069|NCT00993551|surgery|surgery
709070|NCT00993551|speech|speech
709071|NCT00993551|velopharyngeal|velopharyngeal
709072|NCT00993564|Therapeutic hypothermia|therapeutic hypothermia
709073|NCT00993564|Head cooling|head cooling
709074|NCT00993564|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
709075|NCT00993564|Newborn|newborn
709076|NCT00993577|Stretching|stretching
709077|NCT00993577|Pain|pain
709078|NCT00993590|Persistent asthma|persistent asthma
709079|NCT00993590|Asthma related emergency room visits|asthma related emergency room visits
709080|NCT00993590|Asthma control, adolescents|asthma control, adolescents
709081|NCT00993590|Adherence, asthma control medications|adherence, asthma control medications
709082|NCT00993603|Lifestyle|lifestyle
709083|NCT00993603|Diabetes Mellitus|diabetes mellitus
709084|NCT00993603|prevention/onset delay.|prevention/onset delay.
709085|NCT00993629|PTSD|ptsd
709086|NCT00993629|Depression|depression
709087|NCT00993629|Neurosteroids|neurosteroids
709088|NCT00993642|estrogen receptor positive tamoxifen resistant breast cancer|estrogen receptor positive tamoxifen resistant breast cancer
709089|NCT00993655|peritoneal cavity cancer|peritoneal cavity cancer
709090|NCT00993655|fallopian tube cancer|fallopian tube cancer
709091|NCT00993655|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
709092|NCT00993655|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
709093|NCT00993655|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
709094|NCT00993655|malignant pleural effusion|malignant pleural effusion
709095|NCT00993655|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
709311|NCT00994019|young adults|young adults
709096|NCT00993655|ovarian clear cell tumor with proliferating activity|ovarian clear cell tumor with proliferating activity
709097|NCT00993668|influenza|influenza
709098|NCT00993668|vaccine|vaccine
709099|NCT00993668|pneumococcal vaccine|pneumococcal vaccine
709100|NCT00993668|certolizumab pegol|certolizumab pegol
709101|NCT00993668|Cimzia|cimzia
709102|NCT00993681|Prevention of Travelers' Diarrhea|prevention of travelers' diarrhea
709103|NCT00993694|methemoglobinemia|methemoglobinemia
709104|NCT00993694|aplastic anemia|aplastic anemia
709105|NCT00993694|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
709106|NCT00993694|acute undifferentiated leukemia|acute undifferentiated leukemia
709107|NCT00993694|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
709313|NCT00994032|disability evaluation|disability evaluation
709108|NCT00993694|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
709109|NCT00993694|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
709110|NCT00993694|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
709111|NCT00993694|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
709112|NCT00993694|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
709113|NCT00993694|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
709342|NCT01000038|Wii-Fit|wii-fit
709114|NCT00993694|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
709115|NCT00993694|mast cell leukemia|mast cell leukemia
709116|NCT00993694|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
709117|NCT00993694|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
709118|NCT00993694|prolymphocytic leukemia|prolymphocytic leukemia
709119|NCT00993694|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
709120|NCT00993694|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
709121|NCT00993694|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
709122|NCT00993694|refractory hairy cell leukemia|refractory hairy cell leukemia
709123|NCT00993694|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
709124|NCT00993694|secondary acute myeloid leukemia|secondary acute myeloid leukemia
709125|NCT00993694|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
709126|NCT00993694|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
709127|NCT00993694|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
709128|NCT00993694|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
709129|NCT00993694|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
709130|NCT00993694|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
709131|NCT00993694|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
709132|NCT00993694|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
709133|NCT00993694|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
709134|NCT00993694|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
709135|NCT00993694|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
709136|NCT00993694|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
709137|NCT00993694|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
709138|NCT00993694|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
709139|NCT00993694|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
709140|NCT00993694|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
709141|NCT00993694|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
709142|NCT00993694|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
709143|NCT00993694|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
709144|NCT00993694|anaplastic large cell lymphoma|anaplastic large cell lymphoma
709145|NCT00993694|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
709146|NCT00993694|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
709147|NCT00993694|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
709148|NCT00993694|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
709149|NCT00993694|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
709150|NCT00993694|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
709151|NCT00993694|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
709152|NCT00993694|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
709153|NCT00993694|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
709154|NCT00993694|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
709155|NCT00993694|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
709156|NCT00993694|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
709157|NCT00993694|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
709158|NCT00993694|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
709159|NCT00993694|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
709160|NCT00993694|splenic marginal zone lymphoma|splenic marginal zone lymphoma
709513|NCT01002261|PET/CT|pet/ct
709161|NCT00993694|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
709162|NCT00993694|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
709163|NCT00993694|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
709164|NCT00993694|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
709165|NCT00993694|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
709166|NCT00993694|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
709167|NCT00993694|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
709168|NCT00993694|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
709169|NCT00993694|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
709170|NCT00993694|stage I mantle cell lymphoma|stage i mantle cell lymphoma
709171|NCT00993694|stage I marginal zone lymphoma|stage i marginal zone lymphoma
709172|NCT00993694|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
709173|NCT00993694|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
753079|NCT01175382|Urinary Bladder, overactive|urinary bladder, overactive
711601|NCT01013922|COPD-6|copd-6
709174|NCT00993694|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
709175|NCT00993694|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
709176|NCT00993694|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
709343|NCT01000038|Assisted living|assisted living
709177|NCT00993694|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
709178|NCT00993694|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
709179|NCT00993694|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
709180|NCT00993694|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
709181|NCT00993694|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
709182|NCT00993694|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
709183|NCT00993694|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
709184|NCT00993694|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
709185|NCT00993694|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
709186|NCT00993694|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
709187|NCT00993694|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
709188|NCT00993694|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
709362|NCT01000090|Acromegaly|acromegaly
709189|NCT00993694|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
709190|NCT00993694|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
709191|NCT00993694|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
709192|NCT00993694|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
709193|NCT00993694|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
709194|NCT00993694|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
709195|NCT00993694|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
709196|NCT00993694|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
709197|NCT00993694|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
709198|NCT00993694|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
709199|NCT00993694|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
709200|NCT00993694|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
709201|NCT00993694|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
709202|NCT00993694|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
709203|NCT00993694|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
709204|NCT00993694|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
709205|NCT00993694|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
709206|NCT00993694|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
709207|NCT00993694|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
709208|NCT00993694|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
709209|NCT00993694|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
709210|NCT00993694|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
709211|NCT00993694|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
709212|NCT00993694|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
709213|NCT00993694|Burkitt lymphoma|burkitt lymphoma
709214|NCT00993694|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
709215|NCT00993694|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
709216|NCT00993694|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
709217|NCT00993694|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
709218|NCT00993694|intraocular lymphoma|intraocular lymphoma
709219|NCT00993694|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
709220|NCT00993694|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
709221|NCT00993694|chronic eosinophilic leukemia|chronic eosinophilic leukemia
709222|NCT00993694|chronic neutrophilic leukemia|chronic neutrophilic leukemia
709223|NCT00993694|primary myelofibrosis|primary myelofibrosis
709224|NCT00993694|essential thrombocythemia|essential thrombocythemia
709225|NCT00993694|polycythemia vera|polycythemia vera
709226|NCT00993694|extramedullary plasmacytoma|extramedullary plasmacytoma
709227|NCT00993694|isolated plasmacytoma of bone|isolated plasmacytoma of bone
709228|NCT00993694|stage I multiple myeloma|stage i multiple myeloma
709229|NCT00993694|stage II multiple myeloma|stage ii multiple myeloma
709230|NCT00993694|stage III multiple myeloma|stage iii multiple myeloma
709231|NCT00993694|primary systemic amyloidosis|primary systemic amyloidosis
709232|NCT00993694|refractory multiple myeloma|refractory multiple myeloma
709233|NCT00993694|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
709234|NCT00993694|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
709235|NCT00993694|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
751870|NCT01170988|patients scheduled for bypass grafting|patients scheduled for bypass grafting
709236|NCT00993694|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
709237|NCT00993694|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
709238|NCT00993694|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
710910|NCT01006694|Vietnam|vietnam
709239|NCT00993694|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
709240|NCT00993694|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
709241|NCT00993694|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
709242|NCT00993694|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
709243|NCT00993694|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
709244|NCT00993707|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
709245|NCT00993720|patients with type 1 diabetes mellitus|patients with type 1 diabetes mellitus
709247|NCT00993733|cost|cost
709248|NCT00993733|dialysis solution|dialysis solution
709249|NCT00993733|acute renal failure|acute renal failure
709250|NCT00993733|intensive care unit|intensive care unit
709251|NCT00993746|Ultrasound guided infraclavicular brachial plexus block|ultrasound guided infraclavicular brachial plexus block
709252|NCT00993746|Bupivacaine|bupivacaine
709253|NCT00993746|Bupivacaine plus lidocaine|bupivacaine plus lidocaine
709254|NCT00993746|End stage renal disease|end stage renal disease
709255|NCT00993746|Arteriovenous fistula|arteriovenous fistula
709256|NCT00993759|common cold|common cold
709257|NCT00993759|rhinovirus|rhinovirus
709258|NCT00993759|prevention|prevention
709658|NCT01002794|Arthroscopy|arthroscopy
709259|NCT00993798|Post operative pain|post operative pain
709260|NCT00993798|Local anaesthesia|local anaesthesia
709261|NCT00993798|Postoperative pain after arthroscopic shoulder surgery|postoperative pain after arthroscopic shoulder surgery
709262|NCT00993811|male circumcision|male circumcision
709264|NCT00993811|Africa|africa
709265|NCT00993811|HIV Seronegativity|hiv seronegativity
709266|NCT00993837|endoscopic thyroidectomy|endoscopic thyroidectomy
709267|NCT00993837|thyroid carcinoma|thyroid carcinoma
709268|NCT00993850|Bipolar disorder|bipolar disorder
709269|NCT00993850|Insomnia|insomnia
709270|NCT00993850|Sleep disturbance|sleep disturbance
709271|NCT00993850|Cognitive behavioral therapy|cognitive behavioral therapy
709272|NCT00993863|delta opioid agonist|delta opioid agonist
709273|NCT00993863|dental pain|dental pain
709274|NCT00993876|Depression|depression
709275|NCT00993876|CREB|creb
709276|NCT00993876|cognitive performance|cognitive performance
709277|NCT00993876|psychotherapy|psychotherapy
709278|NCT00993876|SSRI|ssri
709279|NCT00993876|SNRI|snri
709281|NCT00993902|Double IUI|double iui
709282|NCT00993902|Intrauterine insemination|intrauterine insemination
709283|NCT00993902|Unexplained infertility|unexplained infertility
709284|NCT00993915|Coronary Artery Disease|coronary artery disease
709285|NCT00993915|Hyperlipidemia|hyperlipidemia
709286|NCT00993915|Atorvastatin|atorvastatin
709287|NCT00993928|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
709288|NCT00993928|fatigue|fatigue
709289|NCT00993928|sleep disorders|sleep disorders
709290|NCT00993928|cancer survivor|cancer survivor
709291|NCT00993941|BMSC|bmsc
709292|NCT00993941|Stem cells|stem cells
709293|NCT00993941|Liver cirrhosis|liver cirrhosis
709294|NCT00993941|Transplantation|transplantation
709295|NCT00993954|Nurse Treatment|nurse treatment
709296|NCT00993954|Pulled Elbow|pulled elbow
709297|NCT00993967|FRDA|frda
709298|NCT00993967|idebenone|idebenone
709299|NCT00993967|FRDA disease|frda disease
709300|NCT00993980|qigong|qigong
709301|NCT00993980|traditional chinese medicine|traditional chinese medicine
709302|NCT00993980|exercise therapy|exercise therapy
709303|NCT00993980|low back pain|low back pain
709304|NCT00993993|cleft palate|cleft palate
709305|NCT00994006|Magnesium|magnesium
709306|NCT00994006|nutrition|nutrition
709307|NCT00994006|platelets|platelets
709308|NCT00994006|aggregation|aggregation
709309|NCT00994019|HPV|hpv
709310|NCT00994019|oral cancer|oral cancer
709314|NCT00994032|outcome assessment|outcome assessment
709315|NCT00994032|pain measurement|pain measurement
709316|NCT00994045|Thoraco-Abdominal Aneurysm (TAAA)|thoraco-abdominal aneurysm (taaa)
709317|NCT00994045|Coagulopathy|coagulopathy
709318|NCT00994045|Fresh Frozen Plasma|fresh frozen plasma
709319|NCT00994045|Fibrinogen Concentrate|fibrinogen concentrate
709320|NCT00999908|COPD|copd
709321|NCT00999908|indacaterol|indacaterol
709322|NCT00999908|tiotropium|tiotropium
709323|NCT00999921|Fibrocystic Breast Disease|fibrocystic breast disease
709324|NCT00999921|Fibroadenoma|fibroadenoma
709325|NCT00999921|Mastalgia|mastalgia
709326|NCT00999947|genetics|genetics
709327|NCT00999947|mutation screening|mutation screening
709328|NCT00999947|phenotype-genotype analysis|phenotype-genotype analysis
709329|NCT00999947|desmosomal genes|desmosomal genes
709330|NCT00999960|Laparoscopy|laparoscopy
709331|NCT00999960|Prostate|prostate
709332|NCT00999960|Cancer|cancer
709333|NCT00999960|Learning|learning
709334|NCT00999960|Simulation|simulation
709335|NCT00999960|Simulator|simulator
709336|NCT00999999|Craniotomy outcome|craniotomy outcome
709337|NCT00999999|CSF leakage|csf leakage
709338|NCT00999999|Dural sealant|dural sealant
709339|NCT01000025|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
709340|NCT01000025|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
709341|NCT01000025|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
709344|NCT01000038|Alzheimer's dementia|alzheimer's dementia
709345|NCT01000051|Transplant Thrombocytopenia|transplant thrombocytopenia
709346|NCT01000051|Hematopoietic cell transplantation|hematopoietic cell transplantation
709347|NCT01000051|HCT|hct
709348|NCT01000051|Low platelet count|low platelet count
709349|NCT01000051|Bleeding|bleeding
709350|NCT01000051|Blood clot|blood clot
709351|NCT01000051|Stem Cell Transplant|stem cell transplant
709352|NCT01000051|Blood And Marrow Transplantation|blood and marrow transplantation
709353|NCT01000051|Eltrombopag|eltrombopag
709354|NCT01000051|Promacta|promacta
709355|NCT01000064|Traumatic Brain Injury|traumatic brain injury
709356|NCT01000064|Attention Deficit|attention deficit
709357|NCT01000064|TBI|tbi
709358|NCT01000077|Regenerative Medicine|regenerative medicine
709359|NCT01000077|Tissue Collection|tissue collection
709360|NCT01000077|Cell Culture Systems|cell culture systems
709361|NCT01000077|Routine Surgery|routine surgery
709363|NCT01000090|Somatostatin analogues|somatostatin analogues
709364|NCT01000090|Treatment|treatment
709365|NCT01000103|Stroke|stroke
709366|NCT01000103|Visuospatial neglect|visuospatial neglect
709367|NCT01000103|Visuospatial extinction|visuospatial extinction
709368|NCT01000103|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
709369|NCT01000103|Non-invasive brain stimulation|non-invasive brain stimulation
709370|NCT01000103|Neuromodulation|neuromodulation
709371|NCT01000103|Brain parietal cortex|brain parietal cortex
709372|NCT01000103|Neurological sequels|neurological sequels
709373|NCT01000103|Cognitive rehabilitation|cognitive rehabilitation
709374|NCT01000116|Tapp|tapp
709375|NCT01000116|Early pain|early pain
709376|NCT01000116|well-being|well-being
709377|NCT01000116|Seroma|seroma
709378|NCT01000116|Haematoma|haematoma
709379|NCT01000116|Fibrin glue|fibrin glue
709380|NCT01000116|tacks|tacks
709381|NCT01000129|Radiotherapy|radiotherapy
709382|NCT01000129|Bladder cancer|bladder cancer
709383|NCT01000129|Adaptive planning|adaptive planning
709384|NCT01000142|Osteopathic|osteopathic
709385|NCT01000142|Manipulation|manipulation
709386|NCT01000142|Preventative|preventative
709387|NCT01000142|Elderly|elderly
709388|NCT01000142|Nursing Home|nursing home
709389|NCT01000142|Prevention: General Health Status|prevention: general health status
709390|NCT01000155|fetal hemoglobin|fetal hemoglobin
709391|NCT01000155|vorinostat|vorinostat
709392|NCT01000155|HDAC inhibitor|hdac inhibitor
709393|NCT01000155|SAHA|saha
709394|NCT01000168|Brain Injury|brain injury
709395|NCT01000168|Rehabilitation|rehabilitation
709396|NCT01000168|Treadmill therapy|treadmill therapy
709397|NCT01000194|postprandial|postprandial
709398|NCT01000194|gene expression profiles|gene expression profiles
709399|NCT01000194|microarray|microarray
709400|NCT01000207|Influenza A|influenza a
709401|NCT01000207|H1N1 subtype|h1n1 subtype
709402|NCT01000207|Children/adolescent|children/adolescent
709403|NCT01000207|Vaccine|vaccine
709404|NCT01000207|Adjuvant|adjuvant
709405|NCT01000233|PATOLOGIC CALCIFICATION|patologic calcification
709406|NCT01000233|AORTIC VALVE STENOSIS|aortic valve stenosis
709407|NCT01000233|INOSITOL HEXAPHOSPHATE|inositol hexaphosphate
709408|NCT01001845|hemodialysis|hemodialysis
709409|NCT01001845|oxidative stress|oxidative stress
709410|NCT01001845|plasma malondialdehyde|plasma malondialdehyde
709411|NCT01001845|Glutathion peroxidase|glutathion peroxidase
709412|NCT01001858|OSA|osa
709413|NCT01001858|CPAP compliance|cpap compliance
709414|NCT01001858|nurse domiciliary led|nurse domiciliary led
709415|NCT01001858|sleep disease|sleep disease
709416|NCT01001871|Iron deficiency anemia|iron deficiency anemia
709417|NCT01001871|Sprinkles®|sprinkles®
709418|NCT01001871|micronutrients|micronutrients
709419|NCT01001871|malaria incidence|malaria incidence
709420|NCT01001871|iron supplement|iron supplement
709421|NCT01001884|caregiver, psychoeducational, colon|caregiver, psychoeducational, colon
709422|NCT01001897|IUD insertion|iud insertion
709423|NCT01001897|nulliparous women|nulliparous women
709424|NCT01001897|contraception|contraception
709425|NCT01001936|PHASE 1 SKI-606 Solid tumor|phase 1 ski-606 solid tumor
709426|NCT01001962|Hypertension in type II diabetes|hypertension in type ii diabetes
709427|NCT01001962|Cardiovascular morbidity and mortality|cardiovascular morbidity and mortality
709428|NCT01001975|Sunscreens|sunscreens
709429|NCT01001988|Encephalitis|encephalitis
709430|NCT01001988|Japanese Encephalitis|japanese encephalitis
709431|NCT01001988|Japanese Encephalitis Chimeric Virus Vaccine|japanese encephalitis chimeric virus vaccine
709432|NCT01001988|Toddlers|toddlers
709433|NCT01002014|Breast Cancer|breast cancer
709434|NCT01002014|Skin Sparing Mastectomy|skin sparing mastectomy
711899|NCT01015092|HAART|haart
709435|NCT01002014|Breast Cancer Prophylaxis|breast cancer prophylaxis
709436|NCT01002014|Nipple Sparing Mastectomy|nipple sparing mastectomy
709437|NCT01002014|Nipple Areolar Complex|nipple areolar complex
709438|NCT01002014|Mastectomy|mastectomy
709439|NCT01002014|Breast Reconstruction|breast reconstruction
709440|NCT01002014|Local recurrence following nipple sparing mastectomy|local recurrence following nipple sparing mastectomy
709441|NCT01002014|Cosmetic outcomes following nipple sparing mastectomy|cosmetic outcomes following nipple sparing mastectomy
709442|NCT01002014|Complications following nipple sparing mastectomy|complications following nipple sparing mastectomy
709443|NCT01002027|Postnatal Depression|postnatal depression
709444|NCT01002027|CBT-Counselling|cbt-counselling
709445|NCT01002027|Primary care|primary care
709447|NCT01002040|vaccine,|vaccine,
709448|NCT01002040|H1N1|h1n1
709449|NCT01002040|influenza|influenza
709450|NCT01002040|H1N1 Influenza vaccine|h1n1 influenza vaccine
709451|NCT01002040|Arepanrix|arepanrix
709452|NCT01002040|Pandemic|pandemic
709453|NCT01002040|H1N1 2009 Influenza|h1n1 2009 influenza
709454|NCT01002040|HIV preventive vaccine|hiv preventive vaccine
709455|NCT01002053|diabetes|diabetes
709456|NCT01002053|neuropathy|neuropathy
709457|NCT01002053|ankle block|ankle block
709458|NCT01002053|regional anesthesia|regional anesthesia
709459|NCT01002053|ultrasound|ultrasound
709460|NCT01002053|nerve localization|nerve localization
709765|NCT01003197|Validation|validation
709461|NCT01002053|Nerve localization in patients undergoing foot surgery and having ankle block|nerve localization in patients undergoing foot surgery and having ankle block
709462|NCT01002066|Fever|fever
709463|NCT01002066|Malaria|malaria
709465|NCT01002066|IMCI|imci
709466|NCT01002066|Children<5 years of age|children<5 years of age
709467|NCT01002066|ACT|act
709468|NCT01002092|Osteosarcoma|osteosarcoma
709469|NCT01002092|Endostar|endostar
709470|NCT01002092|Chemotherapy|chemotherapy
709471|NCT01002105|Baclofen|baclofen
709472|NCT01002105|Alcohol|alcohol
709473|NCT01002105|Baclofen as add-on to standard treatment of alcohol|baclofen as add-on to standard treatment of alcohol
709474|NCT01002118|heart rate variability|heart rate variability
709475|NCT01002118|Dialysis|dialysis
709476|NCT01002131|Digital Volume Tomography|digital volume tomography
709477|NCT01002131|Cone Beam CT|cone beam ct
709478|NCT01002131|impacted and supernumerary teeth|impacted and supernumerary teeth
709479|NCT01002131|dental and maxillofacial radiology|dental and maxillofacial radiology
709480|NCT01002157|Coronary Artery Calcification|coronary artery calcification
709481|NCT01002157|Vitamin K|vitamin k
709482|NCT01002157|Trial|trial
709483|NCT01002157|Treatment|treatment
709484|NCT01002170|Tuberculosis|tuberculosis
709485|NCT01002170|Cycloserine|cycloserine
709486|NCT01002170|Pharmacokinetics|pharmacokinetics
709487|NCT01002183|Malaria|malaria
709488|NCT01002183|Plasmodium falciparum|plasmodium falciparum
709489|NCT01002183|acute uncomplicated|acute uncomplicated
709490|NCT01002196|Selective Mutism|selective mutism
709491|NCT01002196|Intervention|intervention
709492|NCT01002209|Diabetes|diabetes
709493|NCT01002209|Vascular Surgery|vascular surgery
709494|NCT01002209|Hyperbaric oxygen|hyperbaric oxygen
709495|NCT01002209|Surgical complications|surgical complications
709496|NCT01002209|Wound complication|wound complication
709497|NCT01002209|Randomized|randomized
709498|NCT01002209|Controlled|controlled
709499|NCT01002222|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
709500|NCT01002222|MCS-2|mcs-2
709501|NCT01002222|Multi-Carotenoids|multi-carotenoids
709502|NCT01002222|Lower Urinary Tract Symptoms|lower urinary tract symptoms
709503|NCT01002222|International prostate symptom score|international prostate symptom score
709504|NCT01002235|Diabetic|diabetic
709505|NCT01002235|Neuropathy|neuropathy
709506|NCT01002235|peripheral|peripheral
709507|NCT01002235|diabetes|diabetes
709508|NCT01002248|Multiple Myeloma|multiple myeloma
709509|NCT01002248|Relapsed multiple myeloma|relapsed multiple myeloma
709510|NCT01002248|Refractory multiple myeloma|refractory multiple myeloma
709511|NCT01002248|Relapsed refractory multiple myeloma|relapsed refractory multiple myeloma
709512|NCT01002261|Galactose|galactose
709514|NCT01002261|Liver physiology|liver physiology
709515|NCT01002261|Liver pathophysiology|liver pathophysiology
709516|NCT01002274|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
709517|NCT01002274|BPH|bph
709518|NCT01002274|MCS-2|mcs-2
709519|NCT01002274|Multi-Carotenoids|multi-carotenoids
709520|NCT01002274|Lower Urinary Tract Symptoms|lower urinary tract symptoms
709521|NCT01002274|International prostate symptom score|international prostate symptom score
709522|NCT01002300|Social Cognition|social cognition
709523|NCT01002300|Oxytocin|oxytocin
709524|NCT01002326|Pediatric|pediatric
709525|NCT01002326|Body Dysmorphic Disorder|body dysmorphic disorder
709526|NCT01002326|BDD|bdd
709527|NCT01002326|CBT|cbt
709528|NCT01002326|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
709529|NCT01002352|obesity|obesity
709530|NCT01002352|bariatric|bariatric
709531|NCT01002352|BOLD|bold
709532|NCT01002352|weightloss|weightloss
709533|NCT01002352|database|database
709534|NCT01002352|data registry|data registry
709535|NCT01002391|breast hypertrophy|breast hypertrophy
709536|NCT01002391|mammaplasty|mammaplasty
709537|NCT01002391|bandages|bandages
709538|NCT01002391|surgical site infection|surgical site infection
709539|NCT01002391|skin colonization|skin colonization
709540|NCT01002404|ERCP|ercp
709541|NCT01002404|deep biliary cannulation|deep biliary cannulation
709542|NCT01002404|guide wire cannulation|guide wire cannulation
709543|NCT01002404|post-ERCP pancreatitis|post-ercp pancreatitis
709544|NCT01002404|Success of deep biliary cannulation|success of deep biliary cannulation
709545|NCT01002404|Rate of post-ERCP pancreatitis|rate of post-ercp pancreatitis
709546|NCT01002404|Time used to deep biliary cannulation|time used to deep biliary cannulation
709547|NCT01002417|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
709548|NCT01002417|Multi-carotenoids|multi-carotenoids
709549|NCT01002417|MCS-2|mcs-2
709550|NCT01002417|Lower Urinary Tract Symptoms|lower urinary tract symptoms
709551|NCT01002417|International prostate symptom scores|international prostate symptom scores
709552|NCT01002430|Myocardial ischemia|myocardial ischemia
709553|NCT01002430|Refractory angina pectoris|refractory angina pectoris
709554|NCT01002430|Vascular endothelial growth factor|vascular endothelial growth factor
709555|NCT01002430|Gene therapy|gene therapy
709556|NCT01002430|Perfusion|perfusion
709557|NCT01002443|Helicobacter pylori|helicobacter pylori
709558|NCT01002443|glandular atrophy|glandular atrophy
709559|NCT01002443|intestinal metaplasia|intestinal metaplasia
709560|NCT01002443|subtotal gastrectomy|subtotal gastrectomy
709561|NCT01002443|gastric cancer|gastric cancer
709562|NCT01002443|Precancerous lesion of gastric cancer|precancerous lesion of gastric cancer
709563|NCT01002456|Adrenergic beta-Antagonists|adrenergic beta-antagonists
709564|NCT01002456|Guideline Adherence|guideline adherence
709565|NCT01002456|Drug Prescriptions|drug prescriptions
709566|NCT01002456|target dose|target dose
709567|NCT01002469|isotope ratio measurement|isotope ratio measurement
709568|NCT01002469|urea cycle|urea cycle
709569|NCT01002469|13C acetate|13c acetate
709570|NCT01002469|Healthy adults|healthy adults
709571|NCT01002482|Hyperglycemia|hyperglycemia
709572|NCT01002482|Hypoglycemia|hypoglycemia
709573|NCT01002482|Intensive Care Unit|intensive care unit
709574|NCT01002482|Glucose Control|glucose control
709575|NCT01002482|Insulin|insulin
709576|NCT01002482|Computer Protocol|computer protocol
709577|NCT01002482|Metabolic Disorders|metabolic disorders
709578|NCT01002495|myocardial|myocardial
709579|NCT01002495|ischemia|ischemia
709580|NCT01002495|coronary disease|coronary disease
709581|NCT01002495|angina|angina
709582|NCT01002508|influenza vaccine scleroderma immunogenicity safety|influenza vaccine scleroderma immunogenicity safety
709583|NCT01002521|Diabetes|diabetes
709584|NCT01002521|vascular|vascular
709585|NCT01002521|haptoglobin|haptoglobin
709586|NCT01002521|tumor|tumor
709587|NCT01002521|necrosis|necrosis
709588|NCT01002521|factor|factor
709589|NCT01002521|alpha|alpha
709590|NCT01002521|traps|traps
709591|NCT01002521|impaired|impaired
709592|NCT01002521|wound|wound
709593|NCT01002521|healing|healing
709594|NCT01002521|Impaired wound healing in patients with diabetes mellitus|impaired wound healing in patients with diabetes mellitus
709595|NCT01002534|Cystic Fibrosis|cystic fibrosis
709596|NCT01002534|Vardenafil|vardenafil
709597|NCT01002534|Nasal instillation|nasal instillation
709598|NCT01002534|Nasal Potential difference|nasal potential difference
709599|NCT01002547|steatohepatitis|steatohepatitis
709600|NCT01002547|type 2 diabetes|type 2 diabetes
709601|NCT01002547|fatty liver|fatty liver
709602|NCT01002560|Melanoma|melanoma
709603|NCT01002560|Novel Prognostic Markers|novel prognostic markers
709604|NCT01002573|Pediatric|pediatric
709605|NCT01002573|Fever|fever
709606|NCT01002586|Alzheimer's dementia|alzheimer's dementia
709607|NCT01002586|Wii-Fit|wii-fit
709608|NCT01002586|Walking|walking
709609|NCT01002586|Falls|falls
709610|NCT01002599|bariatric surgery|bariatric surgery
709611|NCT01002599|morbidly obese|morbidly obese
709612|NCT01002599|BMI >35|bmi >35
709613|NCT01002599|CPAP|cpap
709614|NCT01002599|Venturi|venturi
709616|NCT01002599|Ventilation|ventilation
709617|NCT01002599|Pulmonary function|pulmonary function
709618|NCT01002599|Morbidly Obese Patients undergoing bariatric surgery|morbidly obese patients undergoing bariatric surgery
709619|NCT01002612|Nutritional status|nutritional status
709620|NCT01002612|Thai HIV-infected children|thai hiv-infected children
709621|NCT01002625|Double-Blind Randomized Placebo-Controlled 2-Way Crossover Polysomnographic Endpoints|double-blind randomized placebo-controlled 2-way crossover polysomnographic endpoints
709622|NCT01002651|gastrointestinal health|gastrointestinal health
709623|NCT01002651|healthy subjects|healthy subjects
709624|NCT01002664|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
709625|NCT01002664|Multi-carotenoids|multi-carotenoids
709626|NCT01002664|MCS-2|mcs-2
709627|NCT01002664|Lower Urinary Tract Symptoms|lower urinary tract symptoms
753528|NCT01173692|Symptoms|symptoms
709628|NCT01002664|International prostate symptom scores|international prostate symptom scores
709629|NCT01002677|brain injury|brain injury
709630|NCT01002677|traumatic brain injury|traumatic brain injury
709631|NCT01002677|training|training
709632|NCT01002677|teaching|teaching
709633|NCT01002677|curriculum|curriculum
709634|NCT01002690|Asthma|asthma
709635|NCT01002690|Allergen challenge|allergen challenge
709636|NCT01002690|Airway responsiveness|airway responsiveness
709637|NCT01002690|Prostaglandins|prostaglandins
709638|NCT01002690|Eicosanoids|eicosanoids
709639|NCT01002703|Lenalidomide|lenalidomide
709640|NCT01002703|Bendamustine|bendamustine
709641|NCT01002703|Multiple Myeloma|multiple myeloma
709642|NCT01002703|Myeloma|myeloma
709643|NCT01002703|Revlimid|revlimid
709644|NCT01002703|Phase I/II|phase i/ii
709645|NCT01002703|refractory Myeloma|refractory myeloma
709646|NCT01002703|relapsed Myeloma|relapsed myeloma
709647|NCT01002716|rheumatoid influenza vaccine cell immunity|rheumatoid influenza vaccine cell immunity
709648|NCT01002729|Oseltamivir Pharmacokinetics Obesity|oseltamivir pharmacokinetics obesity
709649|NCT01002729|Oseltamivir Pharmacokinetics in Obesity|oseltamivir pharmacokinetics in obesity
709650|NCT01002742|GVHD|gvhd
709651|NCT01002755|Leukemia|leukemia
709652|NCT01002755|CLL|cll
709653|NCT01002755|SLL|sll
709654|NCT01002755|Lenalidomide|lenalidomide
709655|NCT01002755|Ofatumumab|ofatumumab
709656|NCT01002781|Tocilizumab Still|tocilizumab still
709657|NCT01002794|Degenerative meniscal tear|degenerative meniscal tear
709659|NCT01002794|Exercise therapy|exercise therapy
709660|NCT01002820|Epileptic Seizures|epileptic seizures
709661|NCT01002820|Seizure Disorder|seizure disorder
709662|NCT01002820|Seizures|seizures
709663|NCT01002820|Convulsions|convulsions
709664|NCT01002820|Anticonvulsant|anticonvulsant
709665|NCT01002820|Anticonvulsive|anticonvulsive
709666|NCT01002820|Antiepileptic|antiepileptic
709667|NCT01002820|Ganaxolone|ganaxolone
709668|NCT01002833|Plasmodium falciparum|plasmodium falciparum
709669|NCT01002833|Malaria|malaria
709670|NCT01002846|Efficacy|efficacy
709671|NCT01002846|Acupuncture|acupuncture
709672|NCT01002846|Hypertension|hypertension
709673|NCT01002859|Coronary artery bypass graft surgery (CABG)|coronary artery bypass graft surgery (cabg)
709674|NCT01002859|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
709675|NCT01002859|Cyclosporine|cyclosporine
709676|NCT01002859|ischaemia reperfusion|ischaemia reperfusion
709677|NCT01002872|FGF23|fgf23
709678|NCT01002872|CKD|ckd
709679|NCT01002872|Fosrenol|fosrenol
709680|NCT01002872|Hyperphosphatemia|hyperphosphatemia
709681|NCT01002885|Infertility|infertility
709682|NCT01002885|FSH Receptor Polymorphisms|fsh receptor polymorphisms
709683|NCT01002898|HIV-1 RNA|hiv-1 rna
709684|NCT01002898|Treatment experienced|treatment experienced
709685|NCT01002911|Device procedure|device procedure
709686|NCT01002911|pacemaker|pacemaker
709687|NCT01002911|ICD|icd
709688|NCT01002911|antibiotics|antibiotics
709689|NCT01002924|Cancer|cancer
709690|NCT01002924|Adenocarcinoma|adenocarcinoma
709691|NCT01002924|Phase II|phase ii
709692|NCT01002924|Lung|lung
709693|NCT01002924|Non-small cell lung cancer|non-small cell lung cancer
709694|NCT01002924|NSCLC|nsclc
709695|NCT01002924|extension|extension
709696|NCT01002924|EC145|ec145
709697|NCT01002924|Prior exposure to EC145|prior exposure to ec145
709698|NCT01002937|Biomarkers|biomarkers
709699|NCT01002937|Prognosis response to treatment|prognosis response to treatment
709700|NCT01002937|Renal cancer|renal cancer
709701|NCT01002989|ankle brachial index|ankle brachial index
709702|NCT01002989|WatchBP Office|watchbp office
709703|NCT01002989|oscillometric measurement|oscillometric measurement
709704|NCT01003002|Parkinson's disease|parkinson's disease
709705|NCT01003002|Dyskinesia|dyskinesia
709706|NCT01003002|Movement Disorders|movement disorders
709707|NCT01003015|HCC|hcc
709708|NCT01003015|Safety|safety
709709|NCT01003015|BAY73-4506|bay73-4506
709710|NCT01003028|Total intravenous anesthesia|total intravenous anesthesia
709711|NCT01003028|Maximum plasma concentration of remifentanil|maximum plasma concentration of remifentanil
709712|NCT01003041|healthy normal infants|healthy normal infants
709713|NCT01003054|Leukemia|leukemia
709714|NCT01003054|CML|cml
709715|NCT01003054|Busulfan|busulfan
709716|NCT01003054|Busulfex|busulfex
709717|NCT01003054|Myleran|myleran
709718|NCT01003054|Cyclophosphamide|cyclophosphamide
709719|NCT01003054|Cytoxan|cytoxan
709720|NCT01003054|Neosar|neosar
709721|NCT01003054|Imatinib Mesylate|imatinib mesylate
709722|NCT01003054|Gleevec|gleevec
709723|NCT01003054|Autologous Stem Cell Transplantation|autologous stem cell transplantation
709724|NCT01003054|Stem Cell Transplant|stem cell transplant
709725|NCT01003080|The evaluation of hemostasis during total knee arthroplasty using the aquamantys device.|the evaluation of hemostasis during total knee arthroplasty using the aquamantys device.
709726|NCT01003093|Tuberculosis|tuberculosis
709727|NCT01003093|Vaccine|vaccine
709728|NCT01003093|Ag85B|ag85b
709729|NCT01003093|ESAT-6|esat-6
709730|NCT01003093|IC31|ic31
709731|NCT01003106|RVO|rvo
709732|NCT01003106|BRVO|brvo
709733|NCT01003106|CRVO|crvo
709734|NCT01003106|Vein occlusion|vein occlusion
709735|NCT01003119|Alcohol addiction|alcohol addiction
709736|NCT01003119|Alcohol treatment|alcohol treatment
709737|NCT01003119|Alcohol recovery|alcohol recovery
709738|NCT01003119|Post residential treatment DSM-IV diagnosis of alcohol dependence|post residential treatment dsm-iv diagnosis of alcohol dependence
709739|NCT01003132|Psychosis|psychosis
709740|NCT01003132|Distress|distress
709741|NCT01003132|Mindfulness|mindfulness
709742|NCT01003132|Acceptance|acceptance
709746|NCT01003145|Immunogenicity|immunogenicity
709747|NCT01003158|Cancer|cancer
709748|NCT01003158|tumour|tumour
709749|NCT01003158|metastatic|metastatic
709750|NCT01003158|breast cancer|breast cancer
709751|NCT01003171|Pharmacokinetics|pharmacokinetics
709752|NCT01003171|PK|pk
709753|NCT01003171|MCS|mcs
709754|NCT01003171|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
709755|NCT01003171|Multi-Carotenoids|multi-carotenoids
709756|NCT01003171|Healthy subjects|healthy subjects
709757|NCT01003184|diabetes|diabetes
709758|NCT01003184|exenatide once weekly|exenatide once weekly
709759|NCT01003184|Byetta|byetta
709760|NCT01003184|insulin detemir|insulin detemir
709761|NCT01003184|Levemir|levemir
709762|NCT01003184|Amylin|amylin
709763|NCT01003184|Lilly|lilly
709764|NCT01003197|Development|development
709766|NCT01003197|Prediction Score|prediction score
709767|NCT01003197|Complication|complication
709768|NCT01003197|Liver resection|liver resection
709769|NCT01003197|develop and validate a score to predict serious complications following liver resection using pre-operative risk factors.|develop and validate a score to predict serious complications following liver resection using pre-operative risk factors.
709770|NCT01003210|otitis media|otitis media
709771|NCT01003210|children|children
709772|NCT01003210|homeopathy|homeopathy
709773|NCT01003223|phosphorus|phosphorus
709774|NCT01003223|dialysis|dialysis
709775|NCT01003223|PhosLo|phoslo
709776|NCT01003223|CKD stage V|ckd stage v
709777|NCT01003236|Diabetic nephropathy|diabetic nephropathy
709778|NCT01003236|Type II Diabetes|type ii diabetes
709779|NCT01003236|Milk Thistle extract|milk thistle extract
709780|NCT01003236|Silymarin|silymarin
709781|NCT01003249|over distention of bladder|over distention of bladder
709782|NCT01003249|Dysfunctional voiding|dysfunctional voiding
709783|NCT01003249|dysfunctional elimination syndrome|dysfunctional elimination syndrome
709784|NCT01003262|Observation Unit|observation unit
709785|NCT01003262|Emergency Department|emergency department
709786|NCT01003275|Chronic kidney disease|chronic kidney disease
709787|NCT01003275|Vitamin D|vitamin d
709788|NCT01003275|Paricalcitol|paricalcitol
709789|NCT01003275|Placebo|placebo
709790|NCT01003275|Kidney|kidney
709791|NCT01003275|Renal|renal
709792|NCT01003275|Oxidative Stress|oxidative stress
709793|NCT01003275|Immune cell function|immune cell function
709794|NCT01003275|Glucose|glucose
709795|NCT01003275|Glucose tolerance|glucose tolerance
709796|NCT01003288|H1N1 pandemic vaccine immunogenicity safety|h1n1 pandemic vaccine immunogenicity safety
709797|NCT01003288|Health employees|health employees
709798|NCT01003301|cat allergy|cat allergy
709799|NCT01003314|Vaccine|vaccine
709800|NCT01003314|Safety|safety
709801|NCT01003314|Immunogenicity|immunogenicity
709802|NCT01003314|Protection|protection
709803|NCT01003314|Sporozoite challenge|sporozoite challenge
709804|NCT01003327|laryngeal mask, leak pressure|laryngeal mask, leak pressure
709805|NCT01003327|leak pressure|leak pressure
709806|NCT01003340|asthma|asthma
709807|NCT01003340|children|children
709808|NCT01003340|community health workers|community health workers
709809|NCT01003340|home intervention|home intervention
709810|NCT01003353|Stroke|stroke
709811|NCT01003353|Strength training|strength training
709812|NCT01003353|exercise therapy|exercise therapy
709813|NCT01003366|safety during central venous catheterization|safety during central venous catheterization
709814|NCT01003379|cognitive dysfunction|cognitive dysfunction
709815|NCT01003379|schizophrenia|schizophrenia
709816|NCT01003379|Phase 2|phase 2
709817|NCT01003392|Coronary artery disease|coronary artery disease
709818|NCT01003392|Coffee|coffee
709819|NCT01003392|Heart system|heart system
709820|NCT01003405|Overactive bladder|overactive bladder
709821|NCT01003405|Frequency|frequency
709822|NCT01003405|Micturition|micturition
709823|NCT01003405|Urgency|urgency
709824|NCT01003405|Urge urinary incontinence|urge urinary incontinence
709825|NCT01003405|OAB|oab
709826|NCT01003418|GSK2340272A|gsk2340272a
709827|NCT01003418|H1N1 pandemic influenza|h1n1 pandemic influenza
709828|NCT01003444|Muscle biopsy Malonyl CoA Biomarker assay|muscle biopsy malonyl coa biomarker assay
709829|NCT01003470|cerebral infarction|cerebral infarction
709830|NCT01003470|Paralysis|paralysis
709831|NCT01003470|acupuncture|acupuncture
709832|NCT01003470|rehabilitation|rehabilitation
709833|NCT01003470|trial|trial
709834|NCT01003483|metformin|metformin
709835|NCT01003483|orlistat|orlistat
709836|NCT01003483|pcos|pcos
709837|NCT01003483|obese|obese
709838|NCT01003496|Cocaine|cocaine
709839|NCT01003496|crack|crack
709840|NCT01003496|heroin|heroin
709841|NCT01003496|non-prescribed opioids|non-prescribed opioids
709842|NCT01003496|contingency management|contingency management
709843|NCT01003496|community reinforcement approach|community reinforcement approach
709844|NCT01003496|facilitated therapeutic alliance|facilitated therapeutic alliance
709845|NCT01003496|chronic disease treatment models|chronic disease treatment models
709846|NCT01003509|inguinal|inguinal
709847|NCT01003509|hernia|hernia
709848|NCT01003509|new|new
709849|NCT01003509|repair|repair
709850|NCT01003509|modified shouldice|modified shouldice
709852|NCT01003522|Bronchial stents|bronchial stents
709853|NCT01003522|Airway obstruction|airway obstruction
709854|NCT01003522|Non-small cell lung cancer|non-small cell lung cancer
709855|NCT01003535|Parkinson´s disease|parkinson´s disease
709856|NCT01003535|Acetylcholine receptors|acetylcholine receptors
709857|NCT01003548|Embryo culture|embryo culture
709858|NCT01003548|IVF|ivf
709859|NCT01003548|Microfluidics|microfluidics
709860|NCT01003548|infertility|infertility
709861|NCT01003561|ultrasonographic exam on upper and lower extremities|ultrasonographic exam on upper and lower extremities
709862|NCT01003574|cardiovascular health outcomes in cancer survivors|cardiovascular health outcomes in cancer survivors
709863|NCT01003587|India|india
709864|NCT01003587|evidence-based policy|evidence-based policy
709865|NCT01003587|knowledge translation|knowledge translation
709866|NCT01003587|disease control priorities|disease control priorities
709867|NCT01003587|decision-makers|decision-makers
709868|NCT01003587|health spending|health spending
709869|NCT01003587|health services delivery|health services delivery
709870|NCT01003587|maternal and child health|maternal and child health
709871|NCT01003587|policy making|policy making
709872|NCT01003587|delivery of health care|delivery of health care
709873|NCT01003600|Survivorship|survivorship
709874|NCT01003600|Quality of Life|quality of life
709875|NCT01003600|Questionnaire|questionnaire
709876|NCT01003600|09-133|09-133
709877|NCT01003613|Tranilast|tranilast
709878|NCT01003613|fibrin glue|fibrin glue
709879|NCT01003613|primary pterygium|primary pterygium
709880|NCT01003613|conjunctival autograft|conjunctival autograft
709881|NCT01003626|Advanced cutaneous melanoma|advanced cutaneous melanoma
709882|NCT01003626|Tumor Pressure|tumor pressure
709883|NCT01003626|Tumor IFP|tumor ifp
709884|NCT01003626|Interstitial Fluid Pressure|interstitial fluid pressure
709886|NCT01003626|Transducer-tipped catheter Mikro-Tip SPC-320|transducer-tipped catheter mikro-tip spc-320
709887|NCT01003626|Transducer Millar|transducer millar
709888|NCT01003626|Power Lab 8/30 amplifier|power lab 8/30 amplifier
709889|NCT01003639|papilledema|papilledema
709890|NCT01003639|vision loss|vision loss
709891|NCT01003639|headache|headache
709892|NCT01003639|obesity|obesity
709893|NCT01003639|women|women
709894|NCT01003639|diplopia|diplopia
709895|NCT01003639|tinnitus|tinnitus
709896|NCT01003652|goiter|goiter
709897|NCT01003678|Myelodysplastic syndrome|myelodysplastic syndrome
709898|NCT01003678|Clofarabine|clofarabine
709899|NCT01003678|low-dose oral clofarabine|low-dose oral clofarabine
709900|NCT01003678|intermediate risk Myelodysplastic syndrome|intermediate risk myelodysplastic syndrome
709901|NCT01003678|high risk Myelodysplastic syndrome|high risk myelodysplastic syndrome
709902|NCT01003691|Phase 1b Advanced Dry Age-Related Macular Degeneration RN6G|phase 1b advanced dry age-related macular degeneration rn6g
709903|NCT01003730|Intraoperative protective ventilation strategies|intraoperative protective ventilation strategies
709904|NCT01003756|Preoperative|preoperative
709905|NCT01003756|Exercise|exercise
709906|NCT01003756|Joint Replacement|joint replacement
709907|NCT01003756|Hip|hip
709908|NCT01003756|Knee|knee
709909|NCT01003782|cholangitis|cholangitis
709910|NCT01003782|antibiotic|antibiotic
709911|NCT01003782|bacteriobilia|bacteriobilia
709912|NCT01003782|bile|bile
709913|NCT01003782|ERCP|ercp
709914|NCT01003834|substance use|substance use
709915|NCT01003834|drug use|drug use
709916|NCT01003834|drug abuse|drug abuse
709917|NCT01003847|Insulin resistance|insulin resistance
709918|NCT01003860|postoperative analgesia|postoperative analgesia
709919|NCT01003873|morbid obesity|morbid obesity
709920|NCT01003873|bariatric surgery|bariatric surgery
709921|NCT01003873|lifestyle intervention|lifestyle intervention
709922|NCT01003873|endocannabinoids system|endocannabinoids system
709923|NCT01003886|post marketing surveillance Filipino benign prostatic hyperplasia BPH Doxazosin GITS|post marketing surveillance filipino benign prostatic hyperplasia bph doxazosin gits
709924|NCT01003912|Lysosomal Storage Diseases|lysosomal storage diseases
709925|NCT01003912|Inborn Errors of Metabolism|inborn errors of metabolism
709926|NCT01003912|Krabbe|krabbe
753708|NCT01177215|Treatment Protocol|treatment protocol
709927|NCT01003912|Infantile metachromatic leukodystrophy disease|infantile metachromatic leukodystrophy disease
709928|NCT01003912|MLD|mld
709929|NCT01003912|Tay Sachs|tay sachs
709930|NCT01003912|Sandhoff|sandhoff
709931|NCT01003912|GM2 gangliosidoses|gm2 gangliosidoses
709932|NCT01003912|Pelizaeus-Merzbacher disease|pelizaeus-merzbacher disease
709933|NCT01003912|PMD|pmd
709934|NCT01003925|Knee pain, osteoarthritis, non-surgical treatment, age 65+|knee pain, osteoarthritis, non-surgical treatment, age 65+
709935|NCT01003938|chemotherapy|chemotherapy
709936|NCT01003938|combination therapy|combination therapy
709937|NCT01003938|targeted therapy|targeted therapy
709938|NCT01003938|second-line|second-line
709939|NCT01003951|Lymphedema|lymphedema
709940|NCT01003951|Acupuncture|acupuncture
709941|NCT01003951|09-136|09-136
709942|NCT01003964|NON-SMALL CELL LUNG CANCER|non-small cell lung cancer
709943|NCT01003964|excision repair cross-complementing 1|excision repair cross-complementing 1
709944|NCT01003964|Gemcitabine and cisplatin|gemcitabine and cisplatin
709945|NCT01003964|Irinotecan and cisplatin|irinotecan and cisplatin
709946|NCT01003964|Pemetrexed|pemetrexed
709947|NCT01003964|Docetaxel|docetaxel
709948|NCT01003964|advanced NSCLC|advanced nsclc
709949|NCT01003990|Treatment experienced|treatment experienced
709950|NCT01004016|Spinocerebellar degeneration|spinocerebellar degeneration
709951|NCT01004016|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
709952|NCT01004016|SCD|scd
709953|NCT01004029|17P|17p
709954|NCT01004029|hydroxyprogesterone caproate|hydroxyprogesterone caproate
709955|NCT01004029|preterm birth|preterm birth
709956|NCT01004029|progesterone|progesterone
709957|NCT01004029|women with a singleton pregnancy aged 18 years or older with a history of a previous singleton spontaneous preterm delivery|women with a singleton pregnancy aged 18 years or older with a history of a previous singleton spontaneous preterm delivery
709958|NCT01004042|Depression|depression
709959|NCT01004042|Botulinum toxin|botulinum toxin
709960|NCT01004042|Glabella|glabella
709961|NCT01004042|Quality of life|quality of life
709962|NCT01004042|Self-steem|self-steem
709963|NCT01004055|Wound|wound
709964|NCT01004055|Skin lesion|skin lesion
709965|NCT01004055|Antimicrobial|antimicrobial
709966|NCT01004055|Bioelectric|bioelectric
709967|NCT01004068|Clomiphene|clomiphene
709968|NCT01004068|Diet|diet
709969|NCT01004068|Exercise|exercise
709970|NCT01004068|Infertility|infertility
709971|NCT01004068|PCOS|pcos
709972|NCT01004068|Physical activity|physical activity
709973|NCT01004068|Treatment|treatment
709974|NCT01004081|Cancer of Breast|cancer of breast
709975|NCT01004081|Cancer of the Breast|cancer of the breast
709976|NCT01004094|children|children
709977|NCT01004094|video games|video games
709978|NCT01004094|internet|internet
709979|NCT01004094|parents|parents
709980|NCT01004094|fruit|fruit
709981|NCT01004094|vegetable|vegetable
709982|NCT01004094|implementation intention|implementation intention
709983|NCT01004094|goal setting|goal setting
709984|NCT01004094|fruit and vegetable consumption|fruit and vegetable consumption
709985|NCT01004094|obesity prevention|obesity prevention
709986|NCT01004094|cancer prevention|cancer prevention
709987|NCT01004133|Age 80 or older|age 80 or older
709988|NCT01004133|No chronic disease|no chronic disease
709989|NCT01004146|incentive spirometry|incentive spirometry
709990|NCT01004146|bariatric surgery|bariatric surgery
709991|NCT01004146|obesity|obesity
709992|NCT01004159|Colorectal cancer|colorectal cancer
709993|NCT01004159|KRAS wild type tumors|kras wild type tumors
709994|NCT01004172|carboplatin|carboplatin
709995|NCT01004172|bevacizumab|bevacizumab
709996|NCT01004198|Trauma|trauma
709997|NCT01004198|Hemorrhage|hemorrhage
709998|NCT01004198|Hemorrhagic shock|hemorrhagic shock
709999|NCT01004198|Lactic acidosis|lactic acidosis
710000|NCT01004198|Oxygen carriers|oxygen carriers
710001|NCT01004198|Oxygen therapeutics|oxygen therapeutics
710002|NCT01004198|Hemoglobin solutions|hemoglobin solutions
710003|NCT01004198|Hemoglobin substitutes|hemoglobin substitutes
710004|NCT01004198|Red cell substitutes|red cell substitutes
710005|NCT01004198|PEG-hemoglobin|peg-hemoglobin
710006|NCT01004211|bladder cancer|bladder cancer
710007|NCT01004211|recurrence|recurrence
710008|NCT01004224|advanced solid tumors|advanced solid tumors
710009|NCT01004224|lung cancer|lung cancer
710010|NCT01004224|bladder cancer|bladder cancer
710011|NCT01004224|BGJ398|bgj398
710012|NCT01004224|FGFR|fgfr
710013|NCT01004224|kinase inhibitor|kinase inhibitor
710014|NCT01004224|advanced solid malignancies|advanced solid malignancies
710015|NCT01004237|insulin resistance|insulin resistance
710016|NCT01004237|hypertensive|hypertensive
710017|NCT01004237|hypercholesterolemic patients|hypercholesterolemic patients
710308|NCT00997295|Women|women
710018|NCT01004263|acute migraine with or without aura in adolescents|acute migraine with or without aura in adolescents
710019|NCT01004276|primary health care|primary health care
710020|NCT01004276|delivery of health care|delivery of health care
710021|NCT01004276|smoking cessation|smoking cessation
710022|NCT01004276|chronic disease|chronic disease
710023|NCT01004276|disease management|disease management
710024|NCT01004276|pilot projects|pilot projects
710025|NCT00990925|Obesity|obesity
710026|NCT00990925|Schizophrenia|schizophrenia
710027|NCT00990925|Schizoaffective disorder|schizoaffective disorder
710028|NCT00990925|weight loss|weight loss
710029|NCT00990977|breast cancer|breast cancer
710030|NCT00990977|supportive care|supportive care
710031|NCT00990977|post-treatment|post-treatment
710032|NCT00990977|intervention|intervention
710033|NCT00990977|MBSR|mbsr
710034|NCT00990977|mindfulness|mindfulness
710035|NCT00990977|anxiety|anxiety
710036|NCT00990977|depression|depression
710037|NCT00990977|lifestyle|lifestyle
710038|NCT00990977|diet|diet
710039|NCT00990977|alcohol consumption|alcohol consumption
710040|NCT00990977|smoking|smoking
710041|NCT00990977|exercise|exercise
710042|NCT00990977|spirituality|spirituality
710043|NCT00990977|existential well-being|existential well-being
710044|NCT00990977|physical symptoms|physical symptoms
710045|NCT00990977|women|women
710138|NCT00991302|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
710046|NCT00990990|Safety tolerability pharmacokinetics (PK) pharmacodynamics whole blood activity (WBA) PNU-100480 linezolid pyrazinamide multiple dose|safety tolerability pharmacokinetics (pk) pharmacodynamics whole blood activity (wba) pnu-100480 linezolid pyrazinamide multiple dose
710047|NCT00991003|Colon Capsule Endoscopy|colon capsule endoscopy
710048|NCT00991003|Colorectal Cancer|colorectal cancer
710049|NCT00991003|Colonoscopy|colonoscopy
710050|NCT00991029|Transient Ischemic Attack|transient ischemic attack
710051|NCT00991029|TIA|tia
710052|NCT00991029|minor stroke|minor stroke
710053|NCT00991042|Cytokines|cytokines
710054|NCT00991042|Low back pain|low back pain
710055|NCT00991042|Intervertebral disk displacement|intervertebral disk displacement
710056|NCT00991042|Interleukins|interleukins
710057|NCT00991042|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
710058|NCT00991068|Pain|pain
710059|NCT00991068|Mild to moderate Carpal Tunnel Syndrome|mild to moderate carpal tunnel syndrome
710060|NCT00991081|pharmacogenetics|pharmacogenetics
710061|NCT00991081|genetic counseling|genetic counseling
710062|NCT00991081|genetic feedback|genetic feedback
710063|NCT00991081|nicotine replacement|nicotine replacement
710064|NCT00991081|bupropion|bupropion
710065|NCT00991081|smoking cessation|smoking cessation
710066|NCT00991081|primary care|primary care
710067|NCT00991081|telehealth|telehealth
710068|NCT00991081|motivational interviewing|motivational interviewing
710069|NCT00991094|Proton Therapy|proton therapy
710070|NCT00991094|Proton Therapy Treatment Plan|proton therapy treatment plan
710071|NCT00991094|Proton Dose Distributions|proton dose distributions
710072|NCT00991094|Side Effects|side effects
710073|NCT00991094|Symptoms|symptoms
710074|NCT00991094|Normal Tissue Toxicity|normal tissue toxicity
710075|NCT00991094|Dose Response Relationship|dose response relationship
710076|NCT00991107|phase I|phase i
710077|NCT00991107|safety|safety
710078|NCT00991107|tolerance|tolerance
710079|NCT00991107|insulin resistance|insulin resistance
710080|NCT00991107|obese|obese
710081|NCT00991146|CAPS|caps
710082|NCT00991146|FCAS|fcas
710083|NCT00991146|MWS|mws
710084|NCT00991146|NOMID|nomid
710085|NCT00991146|cryopyrin-associated periodic syndromes|cryopyrin-associated periodic syndromes
710086|NCT00991146|Familial Cold Autoinflammatory Syndrome|familial cold autoinflammatory syndrome
710087|NCT00991146|Muckle-Wells Syndrome|muckle-wells syndrome
710088|NCT00991146|Neonatal Onset Multisystem Inflammatory Disease|neonatal onset multisystem inflammatory disease
710089|NCT00991146|canakinumab|canakinumab
710090|NCT00991146|ACZ885|acz885
710091|NCT00991146|children|children
710092|NCT00991146|systemic autoinflammatory disease|systemic autoinflammatory disease
710093|NCT00991146|NALP-3|nalp-3
710094|NCT00991146|human monoclonal anti-human interleukin-1beta (IL-1beta)antibody|human monoclonal anti-human interleukin-1beta (il-1beta)antibody
710095|NCT00991146|autosomal dominant|autosomal dominant
710096|NCT00991146|familial autoinflammatory syndrome|familial autoinflammatory syndrome
710097|NCT00991159|Endocrinology; Hypercholesterolemia; Hyperlipidemia; Lipid Metabolism Disorders RN316 PF-04950615|endocrinology; hypercholesterolemia; hyperlipidemia; lipid metabolism disorders rn316 pf-04950615
710098|NCT00991172|sciatica|sciatica
710099|NCT00991172|sciatic pain|sciatic pain
710100|NCT00991172|pain|pain
710101|NCT00991172|back pain|back pain
710102|NCT00991185|Infections in Children|infections in children
710103|NCT00991198|Topically dissolved oxygen|topically dissolved oxygen
710104|NCT00991198|inflammatory cutaneous disease|inflammatory cutaneous disease
710105|NCT00991198|rosacea|rosacea
710106|NCT00991198|acne vulgaris|acne vulgaris
710107|NCT00991198|atopic dermatitis|atopic dermatitis
710108|NCT00991198|seborrheic dermatitis|seborrheic dermatitis
710109|NCT00991198|photodamage|photodamage
710110|NCT00991211|Comparison|comparison
710111|NCT00991211|Bendamustine + Rituximab|bendamustine + rituximab
710112|NCT00991211|CHOP + Rituximab|chop + rituximab
710113|NCT00991211|Progression free survival|progression free survival
710114|NCT00991211|Overall survival|overall survival
710115|NCT00991211|Toxicity|toxicity
710116|NCT00991211|Safety|safety
710117|NCT00991224|HIV|hiv
710118|NCT00991224|HIV therapeutic vaccine|hiv therapeutic vaccine
710119|NCT00991237|NRS|nrs
710120|NCT00991237|GPE|gpe
710121|NCT00991237|pain reduction|pain reduction
710122|NCT00991237|quality of life|quality of life
710123|NCT00991250|Malignant melanoma|malignant melanoma
710124|NCT00991263|stage II breast cancer|stage ii breast cancer
710125|NCT00991263|stage IIIA breast cancer|stage iiia breast cancer
710126|NCT00991276|restless legs syndrome RLS polysomnography PSG sleep disturbance patient reported outcome|restless legs syndrome rls polysomnography psg sleep disturbance patient reported outcome
753931|NCT01178307|MDASI-GIST|mdasi-gist
710127|NCT00991289|Hepatitis C genotype 1|hepatitis c genotype 1
710128|NCT00991289|HCV treatment naive|hcv treatment naive
710129|NCT00991289|HCV/HIV coinfection|hcv/hiv coinfection
710130|NCT00991289|Antiretroviral|antiretroviral
710131|NCT00991289|Ribavirin|ribavirin
710132|NCT00991289|Pegylated Interferon alfa|pegylated interferon alfa
710133|NCT00991289|Nitazoxanide|nitazoxanide
710134|NCT00991302|Adherence|adherence
710135|NCT00991302|Behavioral Intervention|behavioral intervention
710136|NCT00991302|Antiretroviral Therapy|antiretroviral therapy
710137|NCT00991302|ART|art
710140|NCT00991302|Treatment experienced|treatment experienced
710141|NCT00991315|prostate cancer|prostate cancer
710142|NCT00991328|PD|pd
710143|NCT00991328|POCD|pocd
710144|NCT00991328|Post-op Delirium (PD)|post-op delirium (pd)
710145|NCT00991328|Post-op Cognitive Dysfunction (POCD)|post-op cognitive dysfunction (pocd)
710146|NCT00991341|Cardiac surgery|cardiac surgery
710147|NCT00991341|Red blood cell|red blood cell
710148|NCT00991341|Transfusion|transfusion
710149|NCT00991354|HIV Seronegativity|hiv seronegativity
710150|NCT00991354|HIV Preventive Vaccine|hiv preventive vaccine
710151|NCT00991367|Post-surgical scars|post-surgical scars
710152|NCT00991367|Asian Gotu Kola|asian gotu kola
710153|NCT00991367|Asian Pennywort|asian pennywort
710154|NCT00991393|Maxillary Sinus Augmentation|maxillary sinus augmentation
710155|NCT00991393|Dental Implantation|dental implantation
710156|NCT00991393|Osseointegration|osseointegration
710157|NCT00991393|Bone Morphogenetic Proteins|bone morphogenetic proteins
710158|NCT00991406|Electric Stimulation|electric stimulation
710159|NCT00991406|Hemiplegia|hemiplegia
710160|NCT00991406|walking|walking
710161|NCT00991419|PET|pet
710162|NCT00991419|Alzheimer's disease|alzheimer's disease
710163|NCT00991419|diagnostic|diagnostic
710164|NCT00991432|Alveolar Ridge Augmentation|alveolar ridge augmentation
710165|NCT00991432|Dental Implantation, Endosseous|dental implantation, endosseous
710166|NCT00991432|Osseointegration|osseointegration
710167|NCT00991432|Space Maintenance|space maintenance
710168|NCT00991432|Bone Morphogenetic Proteins|bone morphogenetic proteins
710169|NCT00991445|Unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
710170|NCT00991445|Surgical exposure|surgical exposure
710171|NCT00991445|Minimal invasive surgery|minimal invasive surgery
710172|NCT00991445|Local Infiltration Analgesia|local infiltration analgesia
710173|NCT00991445|Knee Arthroplasty|knee arthroplasty
710174|NCT00991471|Emergency Department Wait Times|emergency department wait times
710175|NCT00991471|Physician Nurse at Triage|physician nurse at triage
710176|NCT00991471|Overcrowding|overcrowding
710177|NCT00991471|CostEffectiveness|costeffectiveness
710178|NCT00991484|ventral|ventral
710179|NCT00991484|inguinal|inguinal
710180|NCT00991484|hernia|hernia
710181|NCT00991484|inheritance|inheritance
710182|NCT00991484|genetics|genetics
710183|NCT00991497|varicose veins|varicose veins
710184|NCT00991497|foam sclerotherapy|foam sclerotherapy
710185|NCT00991497|compression bandaging|compression bandaging
710186|NCT00991497|duration|duration
710187|NCT00991510|renal transplantation|renal transplantation
710188|NCT00991510|mycophenolate mofetil|mycophenolate mofetil
710189|NCT00991510|pharmacokinetics|pharmacokinetics
710190|NCT00991510|immunosuppression|immunosuppression
710191|NCT00991523|resistance|resistance
710192|NCT00991523|exercise|exercise
710193|NCT00991523|protein|protein
710194|NCT00991523|recovery|recovery
710195|NCT00991549|overweight|overweight
710196|NCT00991549|obesity|obesity
710197|NCT00991549|glucose intolerance|glucose intolerance
710198|NCT00991549|pre-diabetes|pre-diabetes
710199|NCT00991562|relapsed or relapsed/refractory multiple myeloma|relapsed or relapsed/refractory multiple myeloma
710200|NCT00991575|Diabetes mellitus, type1|diabetes mellitus, type1
710201|NCT00991575|cardiovascular disease|cardiovascular disease
710202|NCT00991575|diabetes complications|diabetes complications
710203|NCT00991575|Glycation end products, advanced|glycation end products, advanced
710204|NCT00996892|GDC0941|gdc0941
710205|NCT00996892|GDC0973|gdc0973
710206|NCT00996892|MEK|mek
710207|NCT00996892|MEK Inhibitor|mek inhibitor
710208|NCT00996892|PI3K|pi3k
710209|NCT00996892|PI3K Inhibitor|pi3k inhibitor
710210|NCT00996892|PI3 Kinase|pi3 kinase
710211|NCT00996892|PI3 Kinase Inhibitor|pi3 kinase inhibitor
710212|NCT00996905|Epidural Analgesia|epidural analgesia
710213|NCT00996905|Ultrasound|ultrasound
710214|NCT00996905|Training, Inservice|training, inservice
710215|NCT00996918|antibody|antibody
710216|NCT00996931|autistic spectrum disorder|autistic spectrum disorder
710217|NCT00996931|lenalidomide|lenalidomide
710218|NCT00996944|ropinirole|ropinirole
710219|NCT00996944|haemodialysis|haemodialysis
710220|NCT00996944|restless legs syndrome|restless legs syndrome
710221|NCT00996970|HIV|hiv
710222|NCT00996970|H1N1|h1n1
710223|NCT00996970|Influenza|influenza
710224|NCT00996970|Vaccination|vaccination
710225|NCT00996970|Seroresponse|seroresponse
710226|NCT00996970|Immunogenicity|immunogenicity
710227|NCT00996970|Vaccine|vaccine
710228|NCT00996996|Radioimmunotherapy|radioimmunotherapy
751871|NCT01171027|Cholecystectomy|cholecystectomy
710229|NCT00996996|Anti-B1 Antibody and Iodine-131 Anti-B1 Antibody|anti-b1 antibody and iodine-131 anti-b1 antibody
710230|NCT00996996|Tositumomab and Iodine I 131 Tositumomab|tositumomab and iodine i 131 tositumomab
710231|NCT00996996|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
710232|NCT00996996|Bexxar|bexxar
710233|NCT00997009|EGFR|egfr
710234|NCT00997009|chemotherapy|chemotherapy
710235|NCT00997022|HCC|hcc
710236|NCT00997022|High-risk Hepatocellular Cancer|high-risk hepatocellular cancer
710237|NCT00997035|Fungal Infections|fungal infections
710238|NCT00997035|Eye Disease|eye disease
710239|NCT00997035|Fungal Keratitis|fungal keratitis
710240|NCT00997035|Visual Acuity|visual acuity
710241|NCT00997074|pain after abortion|pain after abortion
710242|NCT00997074|abortion|abortion
710243|NCT00997087|OCD|ocd
710244|NCT00997100|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
710245|NCT00997100|ABR-215757|abr-215757
710246|NCT00997100|Change in Biomarkers|change in biomarkers
710247|NCT00997113|propofol|propofol
710248|NCT00997113|alfentanil|alfentanil
710249|NCT00997113|procedural sedation|procedural sedation
710250|NCT00997113|stress biomarkers|stress biomarkers
710251|NCT00997113|Deep procedural sedation in the ED|deep procedural sedation in the ed
710252|NCT00997126|propofol|propofol
710253|NCT00997126|alfentanil|alfentanil
710254|NCT00997126|nitrous oxide|nitrous oxide
710346|NCT01004315|Frequency|frequency
710255|NCT00997126|moderate procedural sedation|moderate procedural sedation
710256|NCT00997126|Moderate Procedural Sedation in the Emergency Department|moderate procedural sedation in the emergency department
710257|NCT00997139|healthcare|healthcare
710258|NCT00997139|staphylococcus aureus|staphylococcus aureus
710260|NCT00997152|Diabetes|diabetes
710261|NCT00997165|fatty liver|fatty liver
710262|NCT00997165|adipose tissue|adipose tissue
710263|NCT00997178|Diabetes|diabetes
710264|NCT00997178|Diabetes Mellitus|diabetes mellitus
710265|NCT00997178|Periodontal Disease|periodontal disease
710266|NCT00997178|Periodontitis|periodontitis
710267|NCT00997178|Glycosylated Hemoglobin|glycosylated hemoglobin
710268|NCT00997178|HbA1c|hba1c
710269|NCT00997191|Bevacizumab|bevacizumab
710270|NCT00997191|Diabetes|diabetes
710271|NCT00997191|Intravitreal|intravitreal
710272|NCT00997191|Macular edema|macular edema
710273|NCT00997191|triamcinolone|triamcinolone
710274|NCT00997191|VEGF|vegf
710275|NCT00997204|HAE|hae
710276|NCT00997204|Type I HAE|type i hae
710277|NCT00997204|Type II HAE|type ii hae
710278|NCT00997217|RIPC|ripc
710279|NCT00997217|cardiac surgery|cardiac surgery
710280|NCT00997217|ischemic preconditioning|ischemic preconditioning
710281|NCT00997217|cardiac surgical procedures|cardiac surgical procedures
710282|NCT00997230|EGFR mutation ,newly diagnosed NSCLC, locally advanced or metastatic NSCLC|egfr mutation ,newly diagnosed nsclc, locally advanced or metastatic nsclc
710283|NCT00997243|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
710284|NCT00997243|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
710285|NCT00997243|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
710286|NCT00997243|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
710287|NCT00997243|refractory anemia with excess blasts|refractory anemia with excess blasts
710288|NCT00997243|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
710289|NCT00997243|refractory anemia|refractory anemia
710290|NCT00997243|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
710291|NCT00997256|sleep-EEG|sleep-eeg
710292|NCT00997256|sleep architecture|sleep architecture
710293|NCT00997256|sleep duration|sleep duration
710294|NCT00997256|sleep continuity|sleep continuity
710295|NCT00997256|REM-sleep|rem-sleep
710296|NCT00997256|vigilance|vigilance
710297|NCT00997256|well-being|well-being
710298|NCT00997256|Healthy volunteers|healthy volunteers
710299|NCT00997269|CoQ-10|coq-10
710300|NCT00997269|statin|statin
710301|NCT00997269|muscle pain|muscle pain
710302|NCT00997269|cardiovascular|cardiovascular
710303|NCT00997295|low flow gas|low flow gas
710304|NCT00997295|Heat and moisture exchanger|heat and moisture exchanger
710305|NCT00997295|Humidity|humidity
710306|NCT00997295|Temperature|temperature
710307|NCT00997295|Core temperature|core temperature
710309|NCT00997308|AZD1446|azd1446
710431|NCT01004731|cetuximab|cetuximab
710310|NCT00997308|to investigate safety and tolerability in Healthy subjects during 4 weeks of administration|to investigate safety and tolerability in healthy subjects during 4 weeks of administration
710311|NCT00997321|ketamine|ketamine
710312|NCT00997321|propofol|propofol
710313|NCT00997321|procedural sedation|procedural sedation
710314|NCT00997321|moderate procedural sedation in the ED|moderate procedural sedation in the ed
710315|NCT00997334|erlotinib|erlotinib
710316|NCT00997334|EGFR mutation|egfr mutation
710317|NCT00997334|NSCLC|nsclc
710318|NCT00997360|Phase 1|phase 1
710319|NCT00997360|Maximum tolerated dose|maximum tolerated dose
710320|NCT00997360|Solid tumors|solid tumors
710321|NCT00997373|Endometrial Cancer|endometrial cancer
710322|NCT00997373|Endometrial Carcinoma|endometrial carcinoma
751872|NCT01171027|NOTES|notes
710323|NCT00997373|Aromatase Inhibitor|aromatase inhibitor
710324|NCT00997373|Letrozole|letrozole
710325|NCT00997373|Femara|femara
710326|NCT00997386|Hematologic malignancies|hematologic malignancies
710327|NCT00997386|lymphoma, leukemia, MDS (myelodysplastic syndrome)|lymphoma, leukemia, mds (myelodysplastic syndrome)
710328|NCT00997386|reduced-intensity preparative regimen|reduced-intensity preparative regimen
710329|NCT00997386|allogeneic peripheral blood stem cell transplant|allogeneic peripheral blood stem cell transplant
710330|NCT00997386|myelofibrosis or other myeloproliferative syndromes|myelofibrosis or other myeloproliferative syndromes
710331|NCT00997399|Ph I|ph i
710332|NCT00997399|panobinostat (DACi)|panobinostat (daci)
710334|NCT00997399|solid tumors|solid tumors
710335|NCT00997399|varying renal function|varying renal function
710336|NCT00997399|advanced|advanced
710337|NCT01004289|Acute myocardial infarction|acute myocardial infarction
710338|NCT01004289|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
710339|NCT01004289|Postconditioning|postconditioning
710340|NCT01004302|Obsessive-compulsive disorder|obsessive-compulsive disorder
710341|NCT01004302|Radiosurgery|radiosurgery
710342|NCT01004302|Psychosurgery|psychosurgery
710343|NCT01004302|Treatment outcome|treatment outcome
710344|NCT01004302|Randomized Controlled Trials|randomized controlled trials
710345|NCT01004315|Overactive bladder|overactive bladder
710347|NCT01004315|Micturition|micturition
710348|NCT01004315|Urgency|urgency
710349|NCT01004315|Urge urinary incontinence|urge urinary incontinence
710350|NCT01004315|OAB|oab
710351|NCT01004328|patient safety|patient safety
710352|NCT01004328|care transitions|care transitions
710353|NCT01004328|therapeutic monitoring|therapeutic monitoring
710354|NCT01004328|skilled nursing facilities|skilled nursing facilities
710355|NCT01004328|Adverse outcomes after discharge from a SNF to home|adverse outcomes after discharge from a snf to home
710356|NCT01004341|pediatric obesity|pediatric obesity
710357|NCT01004341|parenting style|parenting style
710358|NCT01004341|feeding style|feeding style
710359|NCT01004341|behavioral skills|behavioral skills
710360|NCT01004341|parenting skills|parenting skills
710361|NCT01004341|family meals|family meals
710362|NCT01004354|Psychiatric illnesses|psychiatric illnesses
710363|NCT01004354|Vitamin D deficiency|vitamin d deficiency
710364|NCT01004354|Obesity|obesity
710365|NCT01004367|Promoting healthy lifestyles in adolescents in Ecuador to prevent overweight|promoting healthy lifestyles in adolescents in ecuador to prevent overweight
710366|NCT01004380|Epithelial Ovarian Cancer|epithelial ovarian cancer
710367|NCT01004380|Ovarian Cancer|ovarian cancer
710368|NCT01004393|Methylnaltrexone|methylnaltrexone
710369|NCT01004393|Constipation|constipation
710370|NCT01004393|Narcotic Antagonists|narcotic antagonists
710371|NCT01004393|Analgesics, Opioid|analgesics, opioid
710372|NCT01004393|Neoplasms|neoplasms
710373|NCT01004406|plaque|plaque
710374|NCT01004406|LDL|ldl
710375|NCT01004406|statin|statin
710376|NCT01004406|endothelial|endothelial
710377|NCT01004406|apheresis|apheresis
710378|NCT01004406|acute coronary syndrome|acute coronary syndrome
710379|NCT01004419|non small cell lung cancer|non small cell lung cancer
710380|NCT01004419|vandetanib|vandetanib
710381|NCT01004419|ZD6474|zd6474
710382|NCT01004419|fulvestrant|fulvestrant
710383|NCT01004419|faslodex|faslodex
710384|NCT01004419|phase 1|phase 1
710385|NCT01004432|humira, remicade|humira, remicade
710386|NCT01004432|rheumatoid arthritis|rheumatoid arthritis
710387|NCT01004432|enbrel failure|enbrel failure
710388|NCT01004432|humira failure|humira failure
710389|NCT01004432|arthritis|arthritis
710390|NCT01004432|enbrel|enbrel
710391|NCT01004445|Pneumonia|pneumonia
710392|NCT01004445|Adjunctive treatment|adjunctive treatment
710393|NCT01004445|Gram-negative bacteria|gram-negative bacteria
710394|NCT01004458|fibromyalgia|fibromyalgia
710395|NCT01004458|cognitive behavioral therapy|cognitive behavioral therapy
710396|NCT01004458|women|women
710397|NCT01004458|pain|pain
710398|NCT01004458|stress|stress
710399|NCT01004458|type A behavior|type a behavior
710400|NCT01004471|Nasal dilator strip|nasal dilator strip
710401|NCT01004471|Sleep disordered breathing|sleep disordered breathing
710402|NCT01004484|non-patients|non-patients
710403|NCT01004484|non-diarrhea functional bowel symptoms|non-diarrhea functional bowel symptoms
710404|NCT01004497|Acute lymphoblastic leukemia, adult, dasatinib|acute lymphoblastic leukemia, adult, dasatinib
710405|NCT01004510|malignant pleural effusion|malignant pleural effusion
710406|NCT01004510|non small cell lung cancer|non small cell lung cancer
710407|NCT01004523|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
710408|NCT01004523|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
710409|NCT01004523|childhood mixed glioma|childhood mixed glioma
710410|NCT01004523|adult mixed glioma|adult mixed glioma
710411|NCT01004523|adult diffuse astrocytoma|adult diffuse astrocytoma
710412|NCT01004523|childhood oligodendroglioma|childhood oligodendroglioma
710413|NCT01004523|adult oligodendroglioma|adult oligodendroglioma
710414|NCT01004549|Patients who have previously undergone bilateral intraocular lens implantation|patients who have previously undergone bilateral intraocular lens implantation
710415|NCT01004562|breast cancer|breast cancer
710416|NCT01004575|stents|stents
710417|NCT01004575|bare metal stents|bare metal stents
710418|NCT01004588|elderly|elderly
710419|NCT01004588|sarcopenia|sarcopenia
710420|NCT01004588|protein drink|protein drink
710421|NCT01004588|resistance training|resistance training
710422|NCT01004601|pretreated failure advanced stage IIIb/IV NSCLC|pretreated failure advanced stage iiib/iv nsclc
710423|NCT01004705|cardiovascular|cardiovascular
710424|NCT01004705|fixed|fixed
710425|NCT01004705|dose|dose
710426|NCT01004705|combination|combination
710427|NCT01004705|pill|pill
710428|NCT01004705|LDL|ldl
710429|NCT01004705|cholesterol|cholesterol
710430|NCT01004731|EGFr|egfr
710435|NCT01004744|Postmenopausal women|postmenopausal women
710436|NCT01004744|ER+|er+
710437|NCT01004744|Estrogen positive|estrogen positive
710438|NCT01004744|PR+|pr+
710439|NCT01004744|Progesterone positive|progesterone positive
710440|NCT01004757|diastolic function|diastolic function
710441|NCT01004757|postmeal glucose|postmeal glucose
710442|NCT01004757|insulin resistance|insulin resistance
710443|NCT01004757|low carb diet|low carb diet
710444|NCT01004757|type 2 diabetes|type 2 diabetes
710531|NCT01005147|tranexamic acid|tranexamic acid
710445|NCT01004770|CECT - Contrast-enhanced computed tomography|cect - contrast-enhanced computed tomography
710446|NCT01004770|HCG - Human Chorionic Gonadotropin|hcg - human chorionic gonadotropin
710447|NCT01004770|HU - Hounsfield Units|hu - hounsfield units
710448|NCT01004770|Patient Safety|patient safety
710449|NCT01004770|Tolerance|tolerance
710450|NCT01004770|Pharmacokinetic|pharmacokinetic
710451|NCT01004783|stage I Wilms tumor|stage i wilms tumor
710452|NCT01004783|stage II Wilms tumor|stage ii wilms tumor
710453|NCT01004783|epithelial predominant Wilms tumor|epithelial predominant wilms tumor
710454|NCT01004796|breast cancer|breast cancer
710455|NCT01004809|Dutasteride|dutasteride
710456|NCT01004822|Treatment Non-Randomized Single Group Assignment Safety Study Neoplasms Carcinoma Cancer Malignancy|treatment non-randomized single group assignment safety study neoplasms carcinoma cancer malignancy
710457|NCT01004835|migraine|migraine
710458|NCT01004848|Pre-diabetes|pre-diabetes
710459|NCT01004848|pre-diabetic state|pre-diabetic state
710460|NCT01004848|community-based participatory research|community-based participatory research
710461|NCT01004848|overweight|overweight
710462|NCT01004848|weight loss intervention, peer-led lifestyle education|weight loss intervention, peer-led lifestyle education
710464|NCT01004874|malignant glioma|malignant glioma
710465|NCT01004874|glioblastoma multiforme|glioblastoma multiforme
710466|NCT01004874|gliosarcoma|gliosarcoma
710467|NCT01004874|Avastin|avastin
710468|NCT01004874|bevacizumab|bevacizumab
710469|NCT01004874|Topotecan|topotecan
710470|NCT01004874|Hycamtin|hycamtin
710471|NCT01004874|Temozolomide|temozolomide
710472|NCT01004874|Temodar|temodar
710473|NCT01004874|Pro00019960|pro00019960
710474|NCT01004874|Vredenburgh|vredenburgh
710475|NCT01004874|Duke|duke
710476|NCT01004887|adult anaplastic astrocytoma|adult anaplastic astrocytoma
710477|NCT01004887|adult giant cell glioblastoma|adult giant cell glioblastoma
710478|NCT01004887|adult gliosarcoma|adult gliosarcoma
710479|NCT01004887|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
710480|NCT01004887|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
710481|NCT01004900|Glaucoma, Angle Closure|glaucoma, angle closure
710482|NCT01004900|Selective laser trabeculoplasty|selective laser trabeculoplasty
710483|NCT01004900|Primary Angle Closure Disease|primary angle closure disease
710484|NCT01004913|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
710485|NCT01004913|Vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
710486|NCT01004913|Sacculo-colic reflex|sacculo-colic reflex
710487|NCT01004926|Unilateral trans-tibial amputees|unilateral trans-tibial amputees
710488|NCT01004939|prophylaxis|prophylaxis
710489|NCT01004939|venous thromboembolism|venous thromboembolism
710490|NCT01004939|postpartum|postpartum
710491|NCT01004939|fondaparinux|fondaparinux
710492|NCT01004939|pregnancy|pregnancy
710493|NCT01004952|Skin|skin
710494|NCT01004952|Sunscreen|sunscreen
710495|NCT01004952|UVR Protection|uvr protection
710496|NCT01004952|09-137|09-137
710497|NCT01004965|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
710692|NCT01005745|lymphodepletion|lymphodepletion
710498|NCT01004965|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
710499|NCT01004965|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
710500|NCT01004965|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
710501|NCT01004965|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
752590|NCT01167829|Acyline plus 27 oral testosterone pills|acyline plus 27 oral testosterone pills
710502|NCT01004965|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
710503|NCT01004965|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
710504|NCT01005004|PMD|pmd
710505|NCT01005004|stem cells|stem cells
710506|NCT01005004|Pelizaeus-Merzbacher Disease|pelizaeus-merzbacher disease
710507|NCT01005004|human stem cells|human stem cells
710508|NCT01005004|central nervous system stem cells|central nervous system stem cells
710509|NCT01005017|Radiofrequent ablation|radiofrequent ablation
712938|NCT01010932|MRA|mra
710510|NCT01005017|Percutaneous radiofrequent therapy|percutaneous radiofrequent therapy
710511|NCT01005030|Parkinson Disease|parkinson disease
710512|NCT01005030|blood|blood
710513|NCT01005030|plasma|plasma
710514|NCT01005030|metabolomics|metabolomics
710515|NCT01005030|spectroscopy|spectroscopy
710516|NCT01005030|oxidative stress.|oxidative stress.
710517|NCT01005043|non-resectable osteosarcoma|non-resectable osteosarcoma
710518|NCT01005043|heavy ion radiotherapy|heavy ion radiotherapy
710519|NCT01005043|particle therapy|particle therapy
710520|NCT01005043|safety|safety
710521|NCT01005043|toxicity|toxicity
710522|NCT01005043|survival|survival
710523|NCT01005043|radiotherapy|radiotherapy
710524|NCT01005069|diabetes mellitus|diabetes mellitus
710525|NCT01005069|DLBS-32|dlbs-32
710526|NCT01005069|fasting plasma glucose|fasting plasma glucose
710527|NCT01005069|insulin resistance|insulin resistance
710528|NCT01005082|Low salt diet, idiopathic hypercalciuria, calcium stone formers|low salt diet, idiopathic hypercalciuria, calcium stone formers
710529|NCT01005082|Calcium stone formers with idiopathic hypercalciuria|calcium stone formers with idiopathic hypercalciuria
710530|NCT01005108|Hot Flashes for Breast Cancer Patients|hot flashes for breast cancer patients
710538|NCT01005173|Acetaminophen|acetaminophen
710539|NCT01005173|APAP|apap
710540|NCT01005199|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
710541|NCT01005199|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
710542|NCT01005212|EVAR|evar
710543|NCT01005212|Ultrasounds|ultrasounds
710544|NCT01005212|AAA|aaa
710545|NCT01005212|endoleaks after endovascular repair of AAA|endoleaks after endovascular repair of aaa
710546|NCT01005225|Solid tumor|solid tumor
710547|NCT01005225|prostate cancer|prostate cancer
710548|NCT01005225|colon cancer|colon cancer
710549|NCT01005251|GERD treatment|gerd treatment
710550|NCT01005251|Acid and non-acid Reflux|acid and non-acid reflux
710551|NCT01005251|Heartburn|heartburn
710552|NCT01005251|Regurgitation|regurgitation
710553|NCT01005251|Add-on treatment to PPI|add-on treatment to ppi
710554|NCT01005264|diabetic foot|diabetic foot
710555|NCT01005264|neuropathic plantar ulcer|neuropathic plantar ulcer
710556|NCT01005264|ulcer healing|ulcer healing
710557|NCT01005264|non-removable total contact cast|non-removable total contact cast
710558|NCT01005264|removable cast walker|removable cast walker
710559|NCT01005277|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
710560|NCT01005277|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
710561|NCT01005277|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
710562|NCT01005277|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
710563|NCT01005277|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
710564|NCT01005277|secondary acute myeloid leukemia|secondary acute myeloid leukemia
710565|NCT01005277|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
710566|NCT01005277|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
710567|NCT01005277|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
710568|NCT01005290|cardiovascular|cardiovascular
710569|NCT01005290|fixed|fixed
710570|NCT01005290|dose|dose
710571|NCT01005290|combination|combination
710572|NCT01005290|pill|pill
710573|NCT01005290|hypertension|hypertension
710574|NCT01005303|Heart Failure|heart failure
710575|NCT01005303|Micronutrients|micronutrients
710576|NCT01005303|Vitamin D|vitamin d
710577|NCT01005303|Inflammation|inflammation
710578|NCT01005303|Oxidative Stress|oxidative stress
710579|NCT01005303|Quality of Life|quality of life
710580|NCT01005303|Physical Functioning|physical functioning
710581|NCT01005316|cohort study|cohort study
710582|NCT01005316|allo-antibodies|allo-antibodies
710583|NCT01005316|allosensitization|allosensitization
710584|NCT01005342|gene expression|gene expression
710585|NCT01005342|oats|oats
710587|NCT01005342|sugar beet fiber|sugar beet fiber
710588|NCT01005342|glucose|glucose
710589|NCT01005342|insulin|insulin
710590|NCT01005342|triglyceride|triglyceride
710591|NCT01005342|decreased postprandial glucose|decreased postprandial glucose
710592|NCT01005342|decreased postprandial insulin|decreased postprandial insulin
710593|NCT01005342|glycemic index|glycemic index
710594|NCT01005355|Solid tumor|solid tumor
710595|NCT01005355|recombinant human IgG1|recombinant human igg1
710596|NCT01005355|MAB|mab
710597|NCT01005355|monoclonal antibody|monoclonal antibody
710598|NCT01005355|VEGFR 2|vegfr 2
710599|NCT01005355|human vascular endothelial growth factor receptor 2|human vascular endothelial growth factor receptor 2
710600|NCT01005368|chronic lymphocytic leukemia|chronic lymphocytic leukemia
710601|NCT01005381|Calcium|calcium
710602|NCT01005381|Vitamin D|vitamin d
710603|NCT01005381|Particle Size|particle size
710604|NCT01005381|Adolescents|adolescents
710605|NCT01005381|Bone|bone
710606|NCT01005381|Osteoporosis|osteoporosis
710615|NCT01005420|Insulin Sensitivity|insulin sensitivity
710616|NCT01005420|Pre-diabetes|pre-diabetes
710617|NCT01005420|Diabetes|diabetes
710618|NCT01005420|Blueberries|blueberries
710619|NCT01005420|Anthocyanins|anthocyanins
710620|NCT01005433|dexmedetomidine|dexmedetomidine
710621|NCT01005433|stress response|stress response
710622|NCT01005433|cesarean delivery|cesarean delivery
710623|NCT01005459|labor pain|labor pain
710624|NCT01005459|combined spinal epidural labor analgesia|combined spinal epidural labor analgesia
710625|NCT01005459|CSE analgesia|cse analgesia
710626|NCT01005459|labor analgesia|labor analgesia
710627|NCT01005472|stage III melanoma|stage iii melanoma
710628|NCT01005472|stage IV melanoma|stage iv melanoma
710629|NCT01005472|recurrent melanoma|recurrent melanoma
710630|NCT01005472|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
710631|NCT01005472|extraocular extension melanoma|extraocular extension melanoma
710632|NCT01005472|iris melanoma|iris melanoma
710633|NCT01005472|metastatic intraocular melanoma|metastatic intraocular melanoma
710634|NCT01005472|recurrent intraocular melanoma|recurrent intraocular melanoma
710635|NCT01005485|Myocardial Infarction (MI)|myocardial infarction (mi)
710636|NCT01005485|Circulating Endothelial Cells (CEC)|circulating endothelial cells (cec)
710637|NCT01005485|Control Group A: (Vascular Surgery)|control group a: (vascular surgery)
710638|NCT01005485|Control Group B: (Healthy controls)|control group b: (healthy controls)
710639|NCT01005498|Low carbohydrate diet. Dietary treatment of diabetes mellitus.|low carbohydrate diet. dietary treatment of diabetes mellitus.
710640|NCT01005498|Diabetes mellitus type 2 and dietary treatment.|diabetes mellitus type 2 and dietary treatment.
710641|NCT01005511|Bruxism|bruxism
710642|NCT01005524|brain computer interface|brain computer interface
710643|NCT01005524|P3Speller|p3speller
710644|NCT01005524|P300|p300
710645|NCT01005524|Event Related potential|event related potential
710646|NCT01005524|tetraplegia|tetraplegia
710647|NCT01005524|Guillain barre syndrome|guillain barre syndrome
710648|NCT01005524|Feasibility|feasibility
710649|NCT01005524|Speed of spelling|speed of spelling
710650|NCT01005524|Accuracy|accuracy
710651|NCT01005537|stage IV melanoma|stage iv melanoma
710652|NCT01005550|Unilateral spinal anaesthesia|unilateral spinal anaesthesia
710653|NCT01005550|Hypobaric anaesthesia|hypobaric anaesthesia
710654|NCT01005550|Ropivacaine|ropivacaine
710655|NCT01005550|Traumatic hip surgery|traumatic hip surgery
710656|NCT01005576|Thalassemia|thalassemia
710657|NCT01005576|Alemtuzumab|alemtuzumab
710658|NCT01005576|Hematopoietic cell transplant|hematopoietic cell transplant
710659|NCT01005576|non-myeloablative|non-myeloablative
710660|NCT01005589|Neonatal sepsis|neonatal sepsis
710661|NCT01005589|Necrotizing enterocolitis|necrotizing enterocolitis
710662|NCT01005589|CD64 antigen|cd64 antigen
710663|NCT01005589|Receptors, IgG|receptors, igg
710664|NCT01005602|Digoxin|digoxin
710665|NCT01005602|Pharmacokinetics|pharmacokinetics
710666|NCT01005602|Dosing|dosing
710667|NCT01005602|Heart Failure|heart failure
710668|NCT01005628|Bortezomib postmarketing surveillance|bortezomib postmarketing surveillance
710669|NCT01005628|Korea bortezomib PMS|korea bortezomib pms
710670|NCT01005641|advanced breast cancer|advanced breast cancer
710671|NCT01005641|hormone-responsive|hormone-responsive
710672|NCT01005641|metastatic breast cancer|metastatic breast cancer
710673|NCT01005654|Gene Expression|gene expression
710674|NCT01005654|Epigenetic (methylation)|epigenetic (methylation)
710675|NCT01005654|Tissues Histological Evaluations|tissues histological evaluations
710676|NCT01005654|Establishment of Tumor Cell Lines|establishment of tumor cell lines
710677|NCT01005654|Metabolite and Protein Expression|metabolite and protein expression
710678|NCT01005654|Adrenal Cancer|adrenal cancer
710679|NCT01005654|Endocrine Tumor|endocrine tumor
710680|NCT01005654|Thyroid Cancer|thyroid cancer
710681|NCT01005667|Nulliparous women in spontaneous labor|nulliparous women in spontaneous labor
710682|NCT01005693|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
710683|NCT01005732|hypertrophic|hypertrophic
710684|NCT01005732|scar|scar
710685|NCT01005732|burn|burn
710686|NCT01005732|cicatrix|cicatrix
710687|NCT01005732|pressure|pressure
710688|NCT01005732|garment|garment
710689|NCT01005745|skin|skin
710690|NCT01005745|adoptive cell therapy|adoptive cell therapy
710691|NCT01005745|tumor-infiltrating lymphocytes (TIL)|tumor-infiltrating lymphocytes (til)
710693|NCT01005758|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
710694|NCT01005758|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
710695|NCT01005758|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
710696|NCT01005758|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
710697|NCT01005758|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
710698|NCT01005771|Secondarily infected traumatic lesions|secondarily infected traumatic lesions
710699|NCT01005784|GnRH antagonists|gnrh antagonists
710700|NCT01005797|Renal Cancer|renal cancer
710701|NCT01005797|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
710702|NCT01005797|Solid Tumor|solid tumor
710703|NCT01005797|Soft tissue sarcoma|soft tissue sarcoma
710704|NCT01005797|Sorafenib|sorafenib
710705|NCT01005797|Panobinostat|panobinostat
710706|NCT01005836|Cognitive behavioral therapy|cognitive behavioral therapy
710707|NCT01005836|Anxiety treatment|anxiety treatment
710708|NCT01005836|Depression treatment|depression treatment
710709|NCT01005836|Child treatment|child treatment
710710|NCT01005836|Usual care|usual care
710711|NCT01005849|Probiotics|probiotics
710712|NCT01005849|Traveler's diarrhea|traveler's diarrhea
710713|NCT01005849|Prevention|prevention
710714|NCT01005862|Alzheimer's disease antibody leucine ABeta|alzheimer's disease antibody leucine abeta
710715|NCT01005875|Hepatocellular carcinoma|hepatocellular carcinoma
710717|NCT01005875|Liver Cancer|liver cancer
710718|NCT01005875|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
710719|NCT01005888|Hereditary angioedema|hereditary angioedema
710720|NCT01005888|HAE|hae
710721|NCT01005888|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
710722|NCT01005888|C1INH-nf|c1inh-nf
710723|NCT01005901|COPD|copd
710724|NCT01005901|NVA|nva
710725|NCT01005901|FEV1|fev1
710726|NCT01005914|adults|adults
710727|NCT01005914|Philadelphia chromosome precursor ALL,|philadelphia chromosome precursor all,
710728|NCT01005914|T-cell ALL|t-cell all
710729|NCT01005914|untreated ALL|untreated all
710730|NCT01005927|Calcium|calcium
710731|NCT01005927|Bone and Bones|bone and bones
710732|NCT01005927|Girls|girls
710733|NCT01005927|Bone Mineralization|bone mineralization
710734|NCT01005927|Fiber|fiber
710735|NCT01005927|Fructooligosaccharide|fructooligosaccharide
710736|NCT01005927|Female|female
710737|NCT01005927|Healthy|healthy
710738|NCT01005927|Adolescents|adolescents
710739|NCT01005940|Sleep Apnea Syndromes|sleep apnea syndromes
710740|NCT01005940|Insulin Resistance|insulin resistance
710741|NCT01005940|Mandibular advancement device|mandibular advancement device
710742|NCT01005953|Autism|autism
710743|NCT01005953|Behavioral Observations|behavioral observations
710744|NCT01005953|Electronic diaries|electronic diaries
710745|NCT01005953|Professionals treating children 3-10 with lower functioning autism|professionals treating children 3-10 with lower functioning autism
710746|NCT01005966|remineralization|remineralization
710747|NCT01005966|enamel|enamel
710748|NCT01005966|in situ|in situ
710749|NCT01005966|fluoride|fluoride
710750|NCT01005966|caries|caries
710751|NCT01005979|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
710752|NCT01005979|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
710753|NCT01005979|Lymphoma, Small Lymphocytic|lymphoma, small lymphocytic
710754|NCT01005979|Lymphoma|lymphoma
710755|NCT01005979|Leukemia|leukemia
710756|NCT01005992|Scars secondary to injuries to tissues caused by contact with physical (heat, electricity) o chemical agent.|scars secondary to injuries to tissues caused by contact with physical (heat, electricity) o chemical agent.
710757|NCT01006005|HIV|hiv
710758|NCT01006005|Treatment experienced|treatment experienced
710759|NCT01006018|Prediabetic State|prediabetic state
710760|NCT01006031|Liver cirrhosis|liver cirrhosis
710761|NCT01006031|Hepatitis C virus|hepatitis c virus
710762|NCT01006031|HIV infection|hiv infection
710763|NCT01006031|Pegylated interferon alfa-2a|pegylated interferon alfa-2a
710764|NCT01006031|Ribavirin|ribavirin
710765|NCT01006031|Treatment experienced|treatment experienced
710766|NCT01006044|Glioblastoma multiforme, vaccine, dendritic cells, glioma|glioblastoma multiforme, vaccine, dendritic cells, glioma
710767|NCT01006070|multiple myeloma|multiple myeloma
710768|NCT01006070|spinal disease|spinal disease
710769|NCT01006083|Aspirin|aspirin
710770|NCT01006083|Plavix|plavix
710771|NCT01006083|antiplatelet therapy|antiplatelet therapy
710772|NCT01006083|Hemorrhage|hemorrhage
710773|NCT01006083|ischemic events|ischemic events
710774|NCT01006096|Psoriasis|psoriasis
710775|NCT01006096|double-blind|double-blind
710776|NCT01006096|randomized|randomized
710777|NCT01006096|placebo-controlled|placebo-controlled
710778|NCT01006096|erlotinib|erlotinib
710779|NCT01006096|efficacy|efficacy
710780|NCT01006109|MEG|meg
710781|NCT01006109|Repetitive TMS (rTMS)|repetitive tms (rtms)
710782|NCT01006109|Decision-Making|decision-making
710783|NCT01006109|Healthy Volunteers|healthy volunteers
710784|NCT01006109|HV|hv
710785|NCT01006109|Healthy Volunteer|healthy volunteer
710786|NCT01006122|Randomized|randomized
710787|NCT01006122|double-blind|double-blind
710788|NCT01006122|placebo-controlled|placebo-controlled
710908|NCT01006694|depression|depression
710789|NCT01006122|crossover study of PF-03654746 in Excessive Daytime Sleepiness associated with Narcolepsy|crossover study of pf-03654746 in excessive daytime sleepiness associated with narcolepsy
710790|NCT01006148|Metopic Craniosynostosis|metopic craniosynostosis
710791|NCT01006187|Analgesics|analgesics
710792|NCT01006187|Influenza|influenza
710793|NCT01006187|Vapocoolant|vapocoolant
710794|NCT01006187|vaccination|vaccination
710795|NCT01006187|pain|pain
710796|NCT01006200|granulation tissue|granulation tissue
710797|NCT01006200|benign|benign
710798|NCT01006200|tracheal stenosis|tracheal stenosis
710799|NCT01006200|ultraflex|ultraflex
710800|NCT01006200|COPD|copd
710801|NCT01006213|Motivational Intervention|motivational intervention
710802|NCT01006239|Cancer|cancer
710803|NCT01006252|metastatic|metastatic
710804|NCT01006252|second-line|second-line
710805|NCT01006278|biomarker|biomarker
710806|NCT01006278|knee arthroscopy|knee arthroscopy
710807|NCT01006278|pain|pain
710808|NCT01006304|JNJ-39439335|jnj-39439335
710809|NCT01006304|Placebo|placebo
710810|NCT01006304|Pain|pain
710811|NCT01006304|Pain Measurements|pain measurements
710812|NCT01006304|Adults|adults
710813|NCT01006304|Men|men
710814|NCT01006317|Maternal health services|maternal health services
710815|NCT01006317|utilization|utilization
710816|NCT01006317|education|education
710817|NCT01006317|randomized controlled trial|randomized controlled trial
710818|NCT01006317|cost|cost
711007|NCT01007058|Interferon|interferon
710819|NCT01006317|clinical skills|clinical skills
710820|NCT01006317|rural China|rural china
710821|NCT01006356|Hydromorphone hydrochloride Oral Osmotic System|hydromorphone hydrochloride oral osmotic system
710822|NCT01006356|Jurnista|jurnista
710823|NCT01006369|stage IV colon cancer|stage iv colon cancer
710824|NCT01006369|stage IV rectal cancer|stage iv rectal cancer
710825|NCT01006369|recurrent colon cancer|recurrent colon cancer
710826|NCT01006369|recurrent rectal cancer|recurrent rectal cancer
710827|NCT01006395|Prostate Cancer|prostate cancer
710828|NCT01006395|Androgen deprivation|androgen deprivation
710829|NCT01006395|Bone Health|bone health
710830|NCT01006395|Insulin resistance|insulin resistance
710831|NCT01006395|Men with nonmetastatic prostate cancer receiving androgen deprivation|men with nonmetastatic prostate cancer receiving androgen deprivation
710832|NCT01006408|Neuropathy|neuropathy
710833|NCT01006421|phototherapy|phototherapy
710834|NCT01006421|Gingko biloba|gingko biloba
710835|NCT01006421|repigmentation|repigmentation
710836|NCT01006434|Stroke|stroke
710837|NCT01006434|Thrombolysis|thrombolysis
710838|NCT01006447|tai chi|tai chi
710839|NCT01006447|exercise|exercise
710840|NCT01006447|older adults|older adults
710841|NCT01006447|exercise persistence|exercise persistence
710842|NCT01006460|Quality of life and subjective well-being in middle aged women|quality of life and subjective well-being in middle aged women
710843|NCT01006473|Chagas Disease|chagas disease
710844|NCT01006473|Chagas Cardiomyopathy|chagas cardiomyopathy
710845|NCT01006473|Exercise Movement Techniques|exercise movement techniques
710846|NCT01006486|Oral anticoagulants|oral anticoagulants
710847|NCT01006486|Warfarin|warfarin
710848|NCT01006486|Anticoagulation clinic|anticoagulation clinic
710849|NCT01006486|Thrombosis|thrombosis
710850|NCT01006486|Hemorrhage|hemorrhage
710851|NCT01006499|neonatal sepsis|neonatal sepsis
710852|NCT01006499|pentoxyfilline|pentoxyfilline
710853|NCT01006499|pentaglobin|pentaglobin
710854|NCT01006499|biomarker|biomarker
710855|NCT01006499|To reduce mortality in neonatal sepsis|to reduce mortality in neonatal sepsis
710856|NCT01006538|Wet Age-related Macular Degeneration|wet age-related macular degeneration
710857|NCT01006538|Predominantly classic|predominantly classic
710858|NCT01006538|Minimally classic|minimally classic
710859|NCT01006538|Occult with no classic|occult with no classic
710860|NCT01006538|Retinal Angiomatous Proliferation (RAP) lesions|retinal angiomatous proliferation (rap) lesions
710861|NCT01006551|Schizophrenia Spectrum Disorders|schizophrenia spectrum disorders
710862|NCT01006564|Magnetic Resonance Imaging|magnetic resonance imaging
710863|NCT01006564|Prostate Cancer|prostate cancer
710864|NCT01006564|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
710865|NCT01006564|Radiotherapy planning|radiotherapy planning
710866|NCT01006577|rectal cancer|rectal cancer
710867|NCT01006577|side-to-end anastomosis|side-to-end anastomosis
710868|NCT01006577|colon J pouch|colon j pouch
710869|NCT01006577|fecal incontinence|fecal incontinence
710870|NCT01006577|anorectal function|anorectal function
710871|NCT01006577|Are there differences between side-to-end anastomosis and colon J pouch in|are there differences between side-to-end anastomosis and colon j pouch in
710872|NCT01006577|bowel function (fecal incontinence, frequency of bowel movements, rectal urgency, incomplete evacuation)|bowel function (fecal incontinence, frequency of bowel movements, rectal urgency, incomplete evacuation)
710873|NCT01006577|quality of life|quality of life
710874|NCT01006577|postoperative complications|postoperative complications
710875|NCT01006577|operation time/ institutional costs|operation time/ institutional costs
710876|NCT01006590|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
710877|NCT01006590|Saxagliptin|saxagliptin
710878|NCT01006590|Randomised|randomised
710879|NCT01006590|Double-blind|double-blind
710880|NCT01006603|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
710881|NCT01006603|elderly patients|elderly patients
710882|NCT01006603|saxagliptin|saxagliptin
710883|NCT01006603|randomised|randomised
710884|NCT01006603|double-blind|double-blind
710885|NCT01006629|Efficacy of palivizumab|efficacy of palivizumab
710886|NCT01006629|Respiratory syncytial virus (RSV) infection|respiratory syncytial virus (rsv) infection
710887|NCT01006629|Prevention of severe RSV infection|prevention of severe rsv infection
710888|NCT01006629|Preterm infants|preterm infants
710889|NCT01006629|Infants with bronchopulmonary dysplasia|infants with bronchopulmonary dysplasia
751873|NCT01171027|Transvaginal|transvaginal
710890|NCT01006629|Infants with hemodynamically significant congenital heart disease|infants with hemodynamically significant congenital heart disease
710892|NCT01006655|preschool children|preschool children
710893|NCT01006655|bronchial hyperresponsiveness|bronchial hyperresponsiveness
710894|NCT01006655|beclometasone dipropionate - HFA|beclometasone dipropionate - hfa
710895|NCT01006655|Qvar|qvar
710896|NCT01006655|Adenosine Challenge test|adenosine challenge test
710897|NCT01006668|Neonates|neonates
710898|NCT01006668|Intensive care|intensive care
710899|NCT01006668|Endotracheal intubation|endotracheal intubation
710900|NCT01006668|Neonates in intensive care|neonates in intensive care
710901|NCT01006681|rheumatoid|rheumatoid
710902|NCT01006681|SLE|sle
711003|NCT01007058|BCG|bcg
710903|NCT01006681|Psoriatic arthritis|psoriatic arthritis
710904|NCT01006681|Ankylosing|ankylosing
710905|NCT01006681|Influenza H1N1|influenza h1n1
710906|NCT01006681|Vaccine|vaccine
710907|NCT01006681|Vaccination against H1N1 in rheumatic diseases|vaccination against h1n1 in rheumatic diseases
710909|NCT01006694|collaborative care|collaborative care
710911|NCT01006694|behavioral activation|behavioral activation
710912|NCT01006720|Residual neuromuscular block|residual neuromuscular block
710913|NCT01006720|post-operative residual curarization|post-operative residual curarization
710914|NCT01006720|PORC|porc
710915|NCT01006720|sugammadex|sugammadex
710916|NCT01006720|neostigmine|neostigmine
710917|NCT01006733|pharmacogenetics|pharmacogenetics
710918|NCT01006733|arthroplasty|arthroplasty
710919|NCT01006733|VKORC1|vkorc1
710920|NCT01006733|thromboembolism|thromboembolism
710921|NCT01006733|warfarin|warfarin
710922|NCT01006746|Remote monitoring|remote monitoring
710923|NCT01006746|Defibrillators|defibrillators
710924|NCT01006746|Survey|survey
710925|NCT01006746|Indication for ICD (primary and secondary prevention)|indication for icd (primary and secondary prevention)
710926|NCT01006759|Leprosy|leprosy
710927|NCT01006759|Disability Evaluation|disability evaluation
710928|NCT01006759|Quality of Life|quality of life
710929|NCT01006759|Sensation|sensation
710930|NCT01006772|Stroke|stroke
710931|NCT01006772|Ankle Foot Orthosis|ankle foot orthosis
710932|NCT01006772|Walking Speed|walking speed
710933|NCT01006772|Gait|gait
710934|NCT01006772|Rehabilitation|rehabilitation
710935|NCT01006772|Hemiplegia|hemiplegia
710936|NCT01006785|Breast Cancer|breast cancer
710937|NCT01006785|DLBS 1425|dlbs 1425
710938|NCT01006785|Cancer|cancer
710939|NCT01006785|Advanced/Metastatic (Stage IIIB/IV) Breast Cancer|advanced/metastatic (stage iiib/iv) breast cancer
710940|NCT01006798|Virus Diseases|virus diseases
710941|NCT01006798|Respiratory Tract Diseases|respiratory tract diseases
710942|NCT01006798|Vaccine|vaccine
710943|NCT01006811|West syndrome|west syndrome
710944|NCT01006811|Hypsarrhythmia|hypsarrhythmia
710945|NCT01006824|Capsule endoscopy|capsule endoscopy
710946|NCT01006824|gastrointestinal hemorrhage|gastrointestinal hemorrhage
710947|NCT01006837|trauma patients|trauma patients
710948|NCT01006837|severe injury|severe injury
710949|NCT01006837|ISS ≥9|iss ≥9
710950|NCT01006850|Acute pain hydromorphone emergency department|acute pain hydromorphone emergency department
710951|NCT01006863|Ephedrine|ephedrine
710952|NCT01006863|phenylephrine|phenylephrine
710953|NCT01006863|hypotension|hypotension
710954|NCT01006863|propofol|propofol
710955|NCT01006863|anesthesia|anesthesia
710956|NCT01006863|cardiac valve surgery|cardiac valve surgery
710957|NCT01006876|coumadin|coumadin
710958|NCT01006876|peri-procedural thromboembolism|peri-procedural thromboembolism
710959|NCT01006876|RFCA|rfca
710960|NCT01006876|high risk atrial fibrillation|high risk atrial fibrillation
710961|NCT01006902|Elderly|elderly
710962|NCT01006902|Function|function
710963|NCT01006902|Oncologic therapy|oncologic therapy
710964|NCT01006902|Functional change with chemotherapy|functional change with chemotherapy
710965|NCT01006915|Diabetic sensorimotor polyneuropathy|diabetic sensorimotor polyneuropathy
710966|NCT01006928|Subjective health feeling|subjective health feeling
710967|NCT01006928|NICU|nicu
710968|NCT01006928|team support|team support
710969|NCT01006941|Multiple sclerosis|multiple sclerosis
710970|NCT01006941|safety|safety
710971|NCT01006941|MRI|mri
710972|NCT01006941|immunological|immunological
710973|NCT01006941|Helminths|helminths
710974|NCT01006941|Trichuris suis|trichuris suis
710975|NCT01006954|Poor responder|poor responder
710976|NCT01006954|Flare up|flare up
710977|NCT01006954|Micro dose GnRH agonist flare up|micro dose gnrh agonist flare up
710978|NCT01006954|IVF/ICSI|ivf/icsi
710979|NCT01006967|balance|balance
710980|NCT01006967|gait|gait
710981|NCT01006967|physical therapy|physical therapy
710982|NCT01006967|ActiveStep|activestep
752591|NCT01167829|taken 3x/day|taken 3x/day
710983|NCT01007006|Telepharmacy Robotic Medicine Delivery Unit|telepharmacy robotic medicine delivery unit
710984|NCT01007006|Brain Injuries|brain injuries
710985|NCT01007006|Stress Disorders|stress disorders
710986|NCT01007006|Combat disorders|combat disorders
710987|NCT01007006|Polytrauma|polytrauma
710988|NCT01007006|Adherence|adherence
710989|NCT01007019|Safety, tolerability and PK/PD|safety, tolerability and pk/pd
710990|NCT01007032|anti-IGF-IR|anti-igf-ir
710991|NCT01007032|monoclonal|monoclonal
710992|NCT01007032|solid tumor|solid tumor
710993|NCT01007032|insulin-like growth factor|insulin-like growth factor
710994|NCT01007045|deep vein thrombosis|deep vein thrombosis
710995|NCT01007045|venous thromboembolic disorders|venous thromboembolic disorders
710996|NCT01007045|diagnostic ultrasound|diagnostic ultrasound
710997|NCT01007058|Urinary Bladder|urinary bladder
710998|NCT01007058|Non-muscle-invasive transitional cell carcinoma|non-muscle-invasive transitional cell carcinoma
710999|NCT01007058|Intact bladder|intact bladder
711000|NCT01007058|Intravesical Bladder Cancer Therapy|intravesical bladder cancer therapy
711001|NCT01007058|Tumor Recurrence|tumor recurrence
711002|NCT01007058|Surrogate markers of response|surrogate markers of response
711004|NCT01007058|Bacillus Calmette Guérin|bacillus calmette guérin
711005|NCT01007058|Interferon-alfa-2b|interferon-alfa-2b
711006|NCT01007058|IFN-alfa-2b|ifn-alfa-2b
711019|NCT01007123|A3309|a3309
711020|NCT01007136|tDCS|tdcs
711021|NCT01007136|stroke|stroke
711022|NCT01007136|functional MRI|functional mri
711023|NCT01007136|TMS|tms
711024|NCT01007149|Severe asthma,|severe asthma,
711025|NCT01007149|non-atopic,|non-atopic,
711026|NCT01007149|omalizumab|omalizumab
711027|NCT01007175|TNF inhibitor|tnf inhibitor
711028|NCT01007175|Multiple ascending dose study|multiple ascending dose study
711029|NCT01007188|almond|almond
711030|NCT01007188|nuts|nuts
711031|NCT01007188|energy value|energy value
711032|NCT01007188|cardiovascular disease|cardiovascular disease
711033|NCT01007188|phytonutrient|phytonutrient
711034|NCT01007188|gene expression|gene expression
711035|NCT01007188|energy value of almonds|energy value of almonds
711036|NCT01007188|energy|energy
711037|NCT01000246|mammacarcinoma|mammacarcinoma
711038|NCT01000246|breastcancer|breastcancer
711039|NCT01000246|chemotherapy|chemotherapy
711040|NCT01000246|heart failure|heart failure
711041|NCT01000246|influenza virus vaccine|influenza virus vaccine
711042|NCT01000311|MenACWY conjugate vaccine in infants|menacwy conjugate vaccine in infants
711043|NCT01000311|Meningococcal vaccine in infants|meningococcal vaccine in infants
711044|NCT01000311|MenACWY|menacwy
711045|NCT01000324|Hepatitis A|hepatitis a
711046|NCT01000324|Hepatitis B|hepatitis b
711047|NCT01000337|Liver Apoptosis|liver apoptosis
711048|NCT01000350|orthostatic intolerance|orthostatic intolerance
711049|NCT01000350|exercise capacity|exercise capacity
711050|NCT01000350|tachycardia|tachycardia
711051|NCT01000350|POTS|pots
711052|NCT01000376|Cancer|cancer
711053|NCT01000376|solid tumors|solid tumors
711054|NCT01000402|Bipolar Disorder|bipolar disorder
711055|NCT01000402|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
711056|NCT01000402|Genetics|genetics
711057|NCT01000402|Environmental Factors|environmental factors
711058|NCT01000402|Family Factors|family factors
711059|NCT01000415|Stage Ib2-early IIb of cervical cancer|stage ib2-early iib of cervical cancer
711060|NCT01000415|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
711061|NCT01000415|Cisplatin plus gemcitabine|cisplatin plus gemcitabine
711062|NCT01000415|Radical hysterectomy with pelvic lymphadenectomy|radical hysterectomy with pelvic lymphadenectomy
711063|NCT01000415|Quality of life|quality of life
711064|NCT01000415|Stage Ib2-IIb of cervical cancer patients|stage ib2-iib of cervical cancer patients
711065|NCT01000428|NSCLC|nsclc
711066|NCT01000428|Tarceva|tarceva
711067|NCT01000428|Positron emission technology|positron emission technology
711068|NCT01000428|FLT|flt
711069|NCT01000428|FDG|fdg
711070|NCT01000441|Rheumatoid arthritis with inadequate response to 1 anti-TNF|rheumatoid arthritis with inadequate response to 1 anti-tnf
711071|NCT01000467|PK assessment for healthy male volunteer|pk assessment for healthy male volunteer
711072|NCT01000467|Healthy male subjects aged 20 to 40 years|healthy male subjects aged 20 to 40 years
711086|NCT01000506|Dose-ranging|dose-ranging
711087|NCT01000506|Safety|safety
711088|NCT01000506|Pharmacodynamics|pharmacodynamics
711089|NCT01000506|eosinophils|eosinophils
711090|NCT01000506|SB-240563|sb-240563
711091|NCT01000506|Efficacy|efficacy
711092|NCT01000506|Severe refractory asthma|severe refractory asthma
711093|NCT01000506|mepolizumab|mepolizumab
711094|NCT01000506|Placebo|placebo
711095|NCT01000519|Diabetes mellitus|diabetes mellitus
711096|NCT01000519|Randomized control trial|randomized control trial
711097|NCT01000519|Exercise|exercise
711098|NCT01000519|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
711099|NCT01000532|steroid, leads, threshold, pacemaker|steroid, leads, threshold, pacemaker
711100|NCT01000545|Diabetes Mellitus|diabetes mellitus
711101|NCT01000545|Chronic Kidney Disease|chronic kidney disease
711102|NCT01000545|Glycosaminoglycans|glycosaminoglycans
711103|NCT01000545|Sulodexide|sulodexide
711104|NCT01000545|Macroalbuminuria|macroalbuminuria
711105|NCT01000545|Safety and Efficacy|safety and efficacy
711106|NCT01000558|non-Hodgkin lymphoma|non-hodgkin lymphoma
711107|NCT01000571|H1N1 pandemic flu|h1n1 pandemic flu
711108|NCT01000584|vaccine|vaccine
711109|NCT01000584|H1N1|h1n1
711110|NCT01000584|influenza|influenza
754169|NCT01176604|Radioactive|radioactive
711111|NCT01000584|H1N1 influenza vaccine|h1n1 influenza vaccine
711112|NCT01000584|influenza vaccine|influenza vaccine
711113|NCT01000584|seasonal Influenza|seasonal influenza
711114|NCT01000597|pharmacokinetics|pharmacokinetics
711115|NCT01000597|serum cortisol|serum cortisol
711116|NCT01000597|pharmacodynamics|pharmacodynamics
711117|NCT01000597|fluticasone furoate|fluticasone furoate
711118|NCT01000597|healthy Caucasian, Japanese, Korean and Chinese subjects|healthy caucasian, japanese, korean and chinese subjects
711119|NCT01000636|Renal transplant patients|renal transplant patients
711120|NCT01000636|Actinic Keratoses|actinic keratoses
711121|NCT01000636|Metvix PDT|metvix pdt
711122|NCT01000636|Field cancerisation|field cancerisation
711123|NCT01000636|Gene expression|gene expression
711124|NCT01000649|V1a agonist|v1a agonist
711125|NCT01000662|whole breast radiotherapy|whole breast radiotherapy
711126|NCT01000662|tumor bed boost|tumor bed boost
711127|NCT01000675|aneurysm|aneurysm
711128|NCT01000675|coils|coils
711129|NCT01000701|Inflammation|inflammation
711130|NCT01000701|ACS|acs
711131|NCT01000701|Prevention|prevention
711132|NCT01000701|Education|education
711133|NCT01000701|Clinical management|clinical management
711134|NCT01000727|Atherosclerosis|atherosclerosis
711135|NCT01000727|Heart disease|heart disease
711136|NCT01000727|Cardiovascular disease|cardiovascular disease
711137|NCT01000727|Lp-PLA2 inhibitor|lp-pla2 inhibitor
711138|NCT01000727|The TIMI Study Group|the timi study group
711139|NCT01000727|Coronary Heart Disease (CHD)|coronary heart disease (chd)
711140|NCT01000727|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
711141|NCT01000740|EAP|eap
711142|NCT01000740|Long term survival (3 years)|long term survival (3 years)
711143|NCT01000740|Gefitinib|gefitinib
711144|NCT01000740|efficacy|efficacy
711145|NCT01000753|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
711146|NCT01000753|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
711147|NCT01000753|grade 1 follicular lymphoma|grade 1 follicular lymphoma
711148|NCT01000753|grade 2 follicular lymphoma|grade 2 follicular lymphoma
711149|NCT01000753|grade 3 follicular lymphoma|grade 3 follicular lymphoma
711150|NCT01000753|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
711151|NCT01000753|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
711152|NCT01000753|mantle cell lymphoma|mantle cell lymphoma
711153|NCT01000753|marginal zone lymphoma|marginal zone lymphoma
711154|NCT01000753|small lymphocytic lymphoma|small lymphocytic lymphoma
711155|NCT01000753|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
711156|NCT01000753|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
711157|NCT01000753|cutaneous T-cell non-Hodgkin lymphoma|cutaneous t-cell non-hodgkin lymphoma
711158|NCT01000753|lymphoproliferative disorder|lymphoproliferative disorder
711159|NCT01000779|Non Cirrhotic Portal Hypertension, secondary prophylaxis|non cirrhotic portal hypertension, secondary prophylaxis
711160|NCT01000818|Treatment experienced|treatment experienced
711161|NCT01000831|vaccine|vaccine
711162|NCT01000831|influenza|influenza
711163|NCT01000831|H1N1 influenza vaccine|h1n1 influenza vaccine
711164|NCT01000831|influenza vaccine|influenza vaccine
711165|NCT01000831|Arepanrix|arepanrix
711166|NCT01000844|Hemophilia|hemophilia
711167|NCT01000844|Joint|joint
711168|NCT01000844|Cartilage|cartilage
711169|NCT01000844|Damage|damage
711170|NCT01000844|Prophylaxis|prophylaxis
711171|NCT01000844|Factor VIII|factor viii
711172|NCT01000844|FVIII|fviii
711173|NCT01000844|Disease|disease
711174|NCT01000844|Arthropathy|arthropathy
711175|NCT01000857|controlled-release tablet|controlled-release tablet
711176|NCT01000857|repeat dose|repeat dose
711177|NCT01000857|immediate-release tablet|immediate-release tablet
711178|NCT01000857|paroxetine|paroxetine
711179|NCT01000857|safety|safety
711180|NCT01000857|crossover|crossover
711181|NCT01000857|pharmacokinetics|pharmacokinetics
711182|NCT01000857|steady-state|steady-state
711183|NCT01000857|Japanese healthy male volunteers|japanese healthy male volunteers
711184|NCT01000857|tolerance|tolerance
711185|NCT01000883|stage IIIA breast cancer|stage iiia breast cancer
711186|NCT01000883|stage IIIB breast cancer|stage iiib breast cancer
711187|NCT01000883|stage IIIC breast cancer|stage iiic breast cancer
711188|NCT01000883|stage IV breast cancer|stage iv breast cancer
711189|NCT01000883|recurrent breast cancer|recurrent breast cancer
711190|NCT01000896|Phase I|phase i
711191|NCT01000896|cancer|cancer
711192|NCT01000896|solid tumors|solid tumors
711193|NCT01000896|advanced solid malignancies|advanced solid malignancies
711194|NCT01000896|NSCLC|nsclc
711195|NCT01000896|epithelial ovarian cancer|epithelial ovarian cancer
711196|NCT01000896|dose escalation|dose escalation
711197|NCT01000896|combination treatment|combination treatment
711198|NCT01000896|src inhibitor|src inhibitor
711199|NCT01000896|Japanese|japanese
711200|NCT01000922|Mealtime Insulin|mealtime insulin
711201|NCT01000922|Rapid acting insulin|rapid acting insulin
711202|NCT01000922|Ultra fast VIAject|ultra fast viaject
711203|NCT01000922|prandial insulin|prandial insulin
711204|NCT01000935|Rotator Cuff Decompression Repair|rotator cuff decompression repair
711205|NCT01000948|Prostate cancer|prostate cancer
711206|NCT01000948|Castration resistant|castration resistant
711207|NCT01000948|Chemotherapy resistant|chemotherapy resistant
711208|NCT01000948|Endothelial receptor A inhibitor|endothelial receptor a inhibitor
711210|NCT01000961|cystinosis|cystinosis
711211|NCT01000961|cysteamine|cysteamine
711212|NCT01000961|inheritable disease|inheritable disease
711213|NCT01000961|orphan disease|orphan disease
711214|NCT01000961|CTNS protein, human|ctns protein, human
711215|NCT01000961|metabolic disease|metabolic disease
711216|NCT01000961|nephropathic cystinosis|nephropathic cystinosis
711217|NCT01000974|booster vaccination|booster vaccination
711218|NCT01000974|Gram-negative bacterial infections|gram-negative bacterial infections
711219|NCT01000974|immunogenicity|immunogenicity
711220|NCT01000974|vaccines, conjugate|vaccines, conjugate
711221|NCT01000974|primary vaccination course|primary vaccination course
711222|NCT01000974|Haemophilus influenzae type b|haemophilus influenzae type b
711223|NCT01000974|safety|safety
711224|NCT01000974|infants, children|infants, children
711225|NCT01000987|alcohol|alcohol
711226|NCT01000987|reactivity|reactivity
711227|NCT01000987|smoking cessation medications|smoking cessation medications
711228|NCT01001026|vaccine|vaccine
711229|NCT01001026|H1N1|h1n1
711230|NCT01001026|influenza|influenza
711231|NCT01001026|H1N1 influenza vaccine|h1n1 influenza vaccine
711232|NCT01001026|pandemic|pandemic
711233|NCT01001039|chronic sinusitis|chronic sinusitis
711234|NCT01001039|facial pain|facial pain
711235|NCT01001052|Healthy|healthy
711236|NCT01001052|bioavailability|bioavailability
711237|NCT01001078|supraglottic airway devices|supraglottic airway devices
711238|NCT01001078|I-Gel|i-gel
711239|NCT01001078|Supreme Laryngeal mask airway|supreme laryngeal mask airway
711240|NCT01001078|Airway leak pressure|airway leak pressure
711241|NCT01001078|peak airway pressure|peak airway pressure
711242|NCT01001091|Conjunctivitis|conjunctivitis
711243|NCT01001091|conjunctival inflammation|conjunctival inflammation
711244|NCT01001091|ocular allergies|ocular allergies
711245|NCT01001104|Metabolic Diseases|metabolic diseases
711246|NCT01001104|Glucose Metabolism Disorders|glucose metabolism disorders
711247|NCT01001104|Diabetes|diabetes
711248|NCT01001104|GLP-1|glp-1
711249|NCT01001104|Lilly|lilly
711250|NCT01001117|Cataract|cataract
711251|NCT01001117|Capsulotomy|capsulotomy
711252|NCT01001117|Capsulorrhexis|capsulorrhexis
711253|NCT01001117|Phacoemulsification|phacoemulsification
711254|NCT01001130|avamys|avamys
711255|NCT01001130|Allergic Rhinitis|allergic rhinitis
711256|NCT01001130|post marketing surveillance|post marketing surveillance
711257|NCT01001130|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
711258|NCT01001130|Perennial Allergic Rhinitis (PAR)|perennial allergic rhinitis (par)
711259|NCT01001156|Aged|aged
711260|NCT01001156|Breathing Muscles|breathing muscles
711261|NCT01001156|Strength Muscles|strength muscles
711262|NCT01001156|Institution of long Permanence for elderly|institution of long permanence for elderly
711263|NCT01001169|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
711264|NCT01001169|influenza infection|influenza infection
711265|NCT01001182|observational|observational
711266|NCT01001182|non-interventional|non-interventional
711267|NCT01001182|prospective|prospective
711268|NCT01001208|Etanercept|etanercept
711269|NCT01001208|Methotrexate|methotrexate
711270|NCT01001208|Psoriasis|psoriasis
711271|NCT01001247|TMC278-TiDP6-C154|tmc278-tidp6-c154
711272|NCT01001247|TMC278-C154|tmc278-c154
711273|NCT01001247|TMC278|tmc278
711274|NCT01001247|Healthy volunteers|healthy volunteers
711275|NCT01001247|omeprazole|omeprazole
711276|NCT01001247|proton pump inhibitor|proton pump inhibitor
711277|NCT01001247|HIV|hiv
711278|NCT01001260|Prostaglandins|prostaglandins
711279|NCT01001260|vascular injury|vascular injury
711280|NCT01001273|Pancreas Transplantation|pancreas transplantation
711281|NCT01001273|Kidney Transplantation|kidney transplantation
711282|NCT01001273|Organ Transplantation|organ transplantation
711283|NCT01001273|Pancreas and Simultaneous Pancreas/Kidney Transplant Recipients|pancreas and simultaneous pancreas/kidney transplant recipients
711284|NCT01001286|dropout youth in low income communities in Amman, Jordan|dropout youth in low income communities in amman, jordan
711285|NCT01001312|Heart Failure|heart failure
711286|NCT01001312|Therapeutics|therapeutics
711287|NCT01001312|Blood volume|blood volume
711288|NCT01001325|influenza|influenza
711289|NCT01001325|vaccine|vaccine
711290|NCT01001325|observer blind|observer blind
711291|NCT01001351|Chronic Kidney Disease|chronic kidney disease
711292|NCT01001351|Arteriovenous Grafts (AVG)|arteriovenous grafts (avg)
711293|NCT01001351|Hemodialysis|hemodialysis
711294|NCT01001351|Vascular Access|vascular access
711295|NCT01001351|Dialysis|dialysis
711296|NCT01001351|Graft|graft
711297|NCT01001351|Access|access
711298|NCT01001351|vonapanitase|vonapanitase
711299|NCT01001351|kidney|kidney
711300|NCT01001351|renal|renal
711303|NCT01001377|Colon Cancer|colon cancer
711304|NCT01001377|Colorectal Cancer|colorectal cancer
711305|NCT01001377|Rectal Cancer|rectal cancer
711306|NCT01001377|Cetuximab|cetuximab
711307|NCT01001377|Erbitux|erbitux
711308|NCT01001377|Metastatic|metastatic
711309|NCT01001390|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
711310|NCT01001429|sedation for vitreoretinal surgery|sedation for vitreoretinal surgery
711311|NCT01001442|Multiple myeloma|multiple myeloma
711312|NCT01001442|Relapsed|relapsed
711313|NCT01001442|Refractory|refractory
711314|NCT01001455|BP|bp
711315|NCT01001468|Psoriasis|psoriasis
711316|NCT01001481|Treatment review|treatment review
711317|NCT01001481|Schizophrenia|schizophrenia
711318|NCT01001481|Observational|observational
711319|NCT01001481|Prospective studies|prospective studies
711320|NCT01001481|Australia|australia
711321|NCT01001494|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
711322|NCT01001494|antimuscarinic|antimuscarinic
711323|NCT01001494|COPD|copd
711324|NCT01001507|Family planning|family planning
711325|NCT01001507|HIV|hiv
711326|NCT01001507|Integrated services|integrated services
711327|NCT01001507|Unintended pregnancy|unintended pregnancy
711328|NCT01001507|Kenya|kenya
711329|NCT01001520|Genetics|genetics
711330|NCT01001520|Nicotine|nicotine
711331|NCT01001520|Cognition|cognition
711332|NCT01001520|fMRI|fmri
711333|NCT01001533|Electrical Cardiometry|electrical cardiometry
711334|NCT01001533|Dexmedetomidine|dexmedetomidine
711335|NCT01001533|ICON|icon
711336|NCT01001533|bio-impedance|bio-impedance
711337|NCT01001533|cardiac monitor|cardiac monitor
711338|NCT01001546|Veterans|veterans
711339|NCT01001546|Smoking cessation|smoking cessation
711340|NCT01001546|Operation Enduring Freedom|operation enduring freedom
711341|NCT01001546|Operation Iraqi Freedom|operation iraqi freedom
711342|NCT01001559|Depression|depression
711343|NCT01001559|Combination therapy|combination therapy
711344|NCT01001559|antidepressant|antidepressant
711345|NCT01001559|Deplin|deplin
711346|NCT01001559|folate|folate
711347|NCT01001559|methylfolate|methylfolate
711348|NCT01001572|Blood pressure|blood pressure
711349|NCT01001572|hypertension|hypertension
711350|NCT01001572|Exforge|exforge
711351|NCT01001572|valsartan/amlodipine|valsartan/amlodipine
711352|NCT01001585|mitochondrial disease|mitochondrial disease
711353|NCT01001585|sevoflurane|sevoflurane
711354|NCT01001585|mitochondrial disease and sevoflurane sensitivity|mitochondrial disease and sevoflurane sensitivity
711355|NCT01001611|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
711356|NCT01001611|glitazone|glitazone
711357|NCT01001611|Type II Diabetes|type ii diabetes
711358|NCT01001611|Hypolipidemic|hypolipidemic
711359|NCT01001611|oral hypoglycemic agent|oral hypoglycemic agent
711360|NCT01001624|Cosmetic|cosmetic
711361|NCT01001624|Facial cream|facial cream
711362|NCT01001624|Melasma|melasma
711363|NCT01001624|Melanil|melanil
711364|NCT01001637|curcumin|curcumin
711365|NCT01001637|alzheimer's|alzheimer's
711366|NCT01001637|longVida|longvida
711367|NCT01001637|dementia|dementia
711368|NCT01001650|Malaria Vaccine|malaria vaccine
711369|NCT01001650|Plasmodium falciparum|plasmodium falciparum
711370|NCT01001663|CAG|cag
711371|NCT01001676|renal failure|renal failure
711372|NCT01001676|Restenosis|restenosis
711373|NCT01001676|Dialysis access|dialysis access
711374|NCT01001676|Paclitaxel|paclitaxel
711375|NCT01001676|Angioplasty|angioplasty
711376|NCT01001676|Intimal hyperplasia|intimal hyperplasia
711377|NCT01001689|Pregnancy|pregnancy
711378|NCT01001689|Preventive health care|preventive health care
711379|NCT01001689|Fitness|fitness
711380|NCT01001689|Nutrition|nutrition
711381|NCT01001689|Obesity|obesity
711382|NCT01001689|Diabetes|diabetes
711383|NCT01001689|Weight gain|weight gain
711384|NCT01001702|Open Label|open label
711385|NCT01001702|Aripiprazole|aripiprazole
711386|NCT01001728|Breast Cancer|breast cancer
711387|NCT01001728|Radiotherapy|radiotherapy
711388|NCT01001728|Prone position|prone position
711389|NCT01001741|HIV|hiv
711390|NCT01001741|Antiretrovirals|antiretrovirals
711391|NCT01001741|Adherence|adherence
711392|NCT01001741|Text messaging|text messaging
711393|NCT01001741|Antiretroviral adherence|antiretroviral adherence
711394|NCT01001741|Treatment experienced|treatment experienced
711395|NCT01001754|Hepatitis C|hepatitis c
711396|NCT01001754|Hepatitis C, Chronic|hepatitis c, chronic
711397|NCT01001754|PEGylated recombinant interleukin 29|pegylated recombinant interleukin 29
711398|NCT01001754|PEG-interferon lambda|peg-interferon lambda
711399|NCT01001754|Interleukin 29|interleukin 29
711400|NCT01001754|Virus|virus
711401|NCT01001754|Infection|infection
711402|NCT01001754|Liver Diseases|liver diseases
711403|NCT01001767|Omega-3 Fatty Acids|omega-3 fatty acids
711404|NCT01001767|HIV|hiv
711405|NCT01001767|Heart Disease|heart disease
711406|NCT01001767|Treatment experienced|treatment experienced
711407|NCT01001780|Graft versus Host Disease|graft versus host disease
711408|NCT01001780|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
711412|NCT01007201|Immunogenicity|immunogenicity
711413|NCT01007214|Prostate cancer|prostate cancer
711414|NCT01007214|Prostatectomy|prostatectomy
711415|NCT01007240|head and neck carcinoma|head and neck carcinoma
711416|NCT01007240|obturators|obturators
711417|NCT01007240|maxillectomy|maxillectomy
711418|NCT01007240|soft liner|soft liner
711419|NCT01007240|nano particles|nano particles
711420|NCT01007240|antibacterial properties|antibacterial properties
711421|NCT01007240|patients post maxillectomy|patients post maxillectomy
711422|NCT01007266|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
711423|NCT01007266|Adolescents|adolescents
711424|NCT01007266|Pediatric|pediatric
711425|NCT01007266|Patient Partner|patient partner
711427|NCT01007266|Obesity|obesity
711428|NCT01007266|Type 2 Diabetes|type 2 diabetes
711429|NCT01007279|Percutaneous angioplasty|percutaneous angioplasty
711430|NCT01007279|Myocardial Infarction|myocardial infarction
711431|NCT01007292|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
711432|NCT01007292|relapsed|relapsed
711433|NCT01007292|CD20-Positive|cd20-positive
711434|NCT01007292|YM155|ym155
711435|NCT01007331|Infants|infants
711436|NCT01007331|Atopic Dermatitis|atopic dermatitis
711437|NCT01007331|SCORAD|scorad
711439|NCT01007331|Eosinophil Cation Protein|eosinophil cation protein
711440|NCT01007331|Calprotectin|calprotectin
711441|NCT01007331|Intestinal microflora|intestinal microflora
711442|NCT01007344|flaxseed|flaxseed
711443|NCT01007344|hypercholesterolemia|hypercholesterolemia
711444|NCT01007344|children|children
711445|NCT01007370|tracheal intubation|tracheal intubation
711446|NCT01007370|supraglottic airway devices|supraglottic airway devices
711447|NCT01007383|Safety and tolerability of LEO 27847|safety and tolerability of leo 27847
711448|NCT01007396|Interferon-gamma release assay|interferon-gamma release assay
711449|NCT01007409|To assess food effect on the pharmacokinetics of fimasartan in healthy male volunteers|to assess food effect on the pharmacokinetics of fimasartan in healthy male volunteers
711450|NCT01007422|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
711451|NCT01007422|pain|pain
711452|NCT01007448|CTCL|ctcl
711453|NCT01007448|bexarotene|bexarotene
711454|NCT01007448|Targretin|targretin
711455|NCT01007448|Refractory Cutaneous T-cell Lymphoma|refractory cutaneous t-cell lymphoma
711456|NCT01007448|cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
711457|NCT01007448|MF|mf
711458|NCT01007448|Mycoses fungoides|mycoses fungoides
711459|NCT01007461|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
711460|NCT01007461|STEMI|stemi
711461|NCT01007461|Acute ST-Segment Elevation Myocardial Infraction (STEMI)|acute st-segment elevation myocardial infraction (stemi)
711462|NCT01007487|Plastic wound protector|plastic wound protector
711463|NCT01007487|Plastic wound retractor|plastic wound retractor
711464|NCT01007487|Bacterial translocation|bacterial translocation
711465|NCT01007487|Surgical site infection|surgical site infection
711466|NCT01007487|Abdominal surgery|abdominal surgery
711467|NCT01007487|Wound infection|wound infection
711468|NCT01007500|Postoperative nausea and vomiting after video-assisted thoracoscopic surgery|postoperative nausea and vomiting after video-assisted thoracoscopic surgery
711469|NCT01007513|Prematurity|prematurity
711470|NCT01007513|Inflammation|inflammation
711471|NCT01007513|Transvaginal ultrasound|transvaginal ultrasound
711472|NCT01007513|Vaginal secretion|vaginal secretion
711473|NCT01007513|Inflammatory process|inflammatory process
711474|NCT01007513|Neonatal morbidity|neonatal morbidity
711475|NCT01007526|Extranodal Lymphoma|extranodal lymphoma
711476|NCT01007526|Natural killer cell|natural killer cell
711477|NCT01007526|T cell|t cell
711478|NCT01007526|Radiotherapy|radiotherapy
711479|NCT01007526|Chemotherapy|chemotherapy
711480|NCT01013389|actifuse|actifuse
711481|NCT01013389|INFUSE|infuse
711482|NCT01013389|InductOs|inductos
711483|NCT01013389|DDD|ddd
711484|NCT01013389|degenerative disk disease|degenerative disk disease
711485|NCT01013389|PLIF|plif
711486|NCT01013389|PITF|pitf
711487|NCT01013389|PLF|plf
711488|NCT01013389|poterolateral lumber fusion|poterolateral lumber fusion
711489|NCT01013389|Bone substitute|bone substitute
711490|NCT01013389|bone graft|bone graft
711491|NCT01013389|synthetic bone substitute|synthetic bone substitute
711492|NCT01013402|Hypoglycemia|hypoglycemia
711493|NCT01013402|Home Blood Glucose Monitoring|home blood glucose monitoring
711494|NCT01013402|Subjects are being investigated for the integrity of|subjects are being investigated for the integrity of
711495|NCT01013402|pituitary-adrenal functions by insulin hypoglycemia test.|pituitary-adrenal functions by insulin hypoglycemia test.
711496|NCT01013415|HIV-1|hiv-1
711497|NCT01013428|Traumatic Rupture of Tendon|traumatic rupture of tendon
711498|NCT01013441|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
711499|NCT01013454|varenicline percutaneous transcutaneous topical transdermal transdermal delivery system patch|varenicline percutaneous transcutaneous topical transdermal transdermal delivery system patch
711500|NCT01013467|blood pressure|blood pressure
711501|NCT01013467|control|control
711502|NCT01013467|adherence|adherence
711503|NCT01013467|behaviour|behaviour
711504|NCT01013480|Fragile X Syndrome|fragile x syndrome
711505|NCT01013493|breastfeeding|breastfeeding
711507|NCT01013493|nearsightedness|nearsightedness
711508|NCT01013493|children|children
711509|NCT01013506|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
711510|NCT01013506|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
711511|NCT01013506|stage IV breast cancer|stage iv breast cancer
711512|NCT01013506|recurrent breast cancer|recurrent breast cancer
711513|NCT01013532|Ischemic Stroke|ischemic stroke
711514|NCT01013532|Intracranial Hemorrhage|intracranial hemorrhage
711515|NCT01013532|Cilostazol|cilostazol
711516|NCT01013532|Probucol|probucol
711517|NCT01013545|joint engagement|joint engagement
711518|NCT01013545|augmentative communication (AAC)|augmentative communication (aac)
711519|NCT01013545|enhanced milieu training|enhanced milieu training
711520|NCT01013545|autism spectrum disorder|autism spectrum disorder
711521|NCT01013545|language|language
711522|NCT01013558|fetal pain|fetal pain
711523|NCT01013558|intrauterine|intrauterine
711524|NCT01013558|needling|needling
711525|NCT01013584|vitamin D|vitamin d
711526|NCT01013597|thyroid|thyroid
711527|NCT01013597|medullary|medullary
711528|NCT01013597|differentiated|differentiated
711529|NCT01013597|radioiodine-resistant|radioiodine-resistant
711530|NCT01013597|LBH589|lbh589
711531|NCT01013597|panobinostat|panobinostat
711532|NCT01013610|Healthy Elderly Volunteers|healthy elderly volunteers
711533|NCT01013623|melanoma|melanoma
711534|NCT01013623|stage IV|stage iv
711535|NCT01013623|resectable|resectable
711536|NCT01013623|surgery|surgery
711537|NCT01013623|medical therapy|medical therapy
711538|NCT01013662|septic shock|septic shock
711539|NCT01013662|glycemic control|glycemic control
711540|NCT01013662|icu|icu
711541|NCT01013662|lipid metabolism|lipid metabolism
711542|NCT01013662|septic patients|septic patients
711543|NCT01013675|influenza|influenza
711544|NCT01013675|active-controlled|active-controlled
711545|NCT01013675|Phase 2|phase 2
711546|NCT01013688|Radiofrequency ablation|radiofrequency ablation
711547|NCT01013688|Maze|maze
711548|NCT01013688|Atrial fibrillation|atrial fibrillation
711549|NCT01013701|nasal polyps|nasal polyps
711550|NCT01013701|nasal steroid|nasal steroid
711551|NCT01013701|fluticasone furoate|fluticasone furoate
711552|NCT01013714|Sudden cardiac death|sudden cardiac death
711553|NCT01013714|Ventricular tachycardia|ventricular tachycardia
711554|NCT01013714|Ventricular fibrillation|ventricular fibrillation
711555|NCT01013714|Cardiomyopathy|cardiomyopathy
711556|NCT01013714|Internal cardiac defibrillator shocks|internal cardiac defibrillator shocks
711557|NCT01013714|Internal cardiac defibrillator therapies|internal cardiac defibrillator therapies
711558|NCT01013727|Volunteers|volunteers
711559|NCT01013727|healthy subjects|healthy subjects
711560|NCT01013740|Neoplasms, Breast|neoplasms, breast
711561|NCT01013766|GSK1362885|gsk1362885
711562|NCT01013766|Pharmacodynamics|pharmacodynamics
711563|NCT01013766|Safety|safety
711564|NCT01013766|Pharmacokinetics|pharmacokinetics
711565|NCT01013766|T2DM|t2dm
711566|NCT01013766|Tolerability|tolerability
711567|NCT01013779|Merkel Cell Cancer|merkel cell cancer
711568|NCT01013779|PET scanning|pet scanning
711569|NCT01013792|Diabetic|diabetic
711570|NCT01013792|Foot|foot
711571|NCT01013792|Ulcer|ulcer
711572|NCT01013792|Neuropathic|neuropathic
711573|NCT01013792|Tegaderm Matrix Dressing|tegaderm matrix dressing
711574|NCT01013792|DFU|dfu
711575|NCT01013792|Wound Care|wound care
711576|NCT01013792|PHI|phi
711577|NCT01013805|Rectal Cancer|rectal cancer
711578|NCT01013805|Chemotherapy|chemotherapy
711579|NCT01013805|Radiotherapy|radiotherapy
711580|NCT01013844|skin self-examination|skin self-examination
711581|NCT01013844|SSE|sse
711582|NCT01013844|melanoma|melanoma
711583|NCT01013870|mild traumatic brain injury|mild traumatic brain injury
711584|NCT01013870|post-concussion syndrome|post-concussion syndrome
711585|NCT01013870|acute stress disorder|acute stress disorder
711586|NCT01013870|post-traumatic stress disorder|post-traumatic stress disorder
711587|NCT01013870|atorvastatin|atorvastatin
711588|NCT01013883|systolic dysfunction|systolic dysfunction
711589|NCT01013883|diastolic dysfunction|diastolic dysfunction
711590|NCT01013883|mortality|mortality
711591|NCT01013883|treatment|treatment
711592|NCT01013883|heart rate|heart rate
711593|NCT01013909|Bifonazole|bifonazole
711594|NCT01013909|Terbinafine|terbinafine
711595|NCT01013909|Reduced treatment duration|reduced treatment duration
711596|NCT01013909|Efficacy|efficacy
711597|NCT01013909|Safety|safety
711598|NCT01013909|Athlete's foot|athlete's foot
711599|NCT01013909|Moderate severity|moderate severity
711600|NCT01013922|COPD|copd
711602|NCT01013922|Spirometry|spirometry
711603|NCT01013922|VC|vc
711604|NCT01013922|FEV|fev
711605|NCT01013922|FEV1|fev1
711606|NCT01013935|HIV treatment|hiv treatment
711607|NCT01013935|ART adherence|art adherence
711608|NCT01013935|Using new technology to improve adherence|using new technology to improve adherence
711609|NCT01013935|CARE+|care+
711610|NCT01013935|HIV-1 viral loads|hiv-1 viral loads
711611|NCT01013948|Spirometry|spirometry
711614|NCT01013948|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
711615|NCT01013948|Emphysema|emphysema
711616|NCT01013948|Chronic Bronchitis|chronic bronchitis
711617|NCT01013961|chronic lymphocytic leukemia|chronic lymphocytic leukemia
711618|NCT01013961|small lymphocytic lymphoma|small lymphocytic lymphoma
711619|NCT01013961|CLL|cll
711620|NCT01013961|elderly|elderly
711621|NCT01013961|low dose rituximab|low dose rituximab
711622|NCT01013961|alemtuzumab|alemtuzumab
711623|NCT01013961|monoclonal antibodies|monoclonal antibodies
711624|NCT01013987|HIV-1|hiv-1
711625|NCT01013987|triple class failure|triple class failure
711626|NCT01013987|Maraviroc|maraviroc
711627|NCT01013987|Raltegravir|raltegravir
711628|NCT01013987|Darunavir/ritonavir|darunavir/ritonavir
711629|NCT01013987|Maraviroc with raltegravir and darunavir/ritonavir|maraviroc with raltegravir and darunavir/ritonavir
711630|NCT01014026|Mass Screening|mass screening
711631|NCT01014026|Polymerase Chain Reaction|polymerase chain reaction
711632|NCT01014026|Vaginal Smears|vaginal smears
711633|NCT01014065|sunitinib|sunitinib
711634|NCT01014065|cardiac MRI|cardiac mri
711635|NCT01014065|maximal exercise testing|maximal exercise testing
711636|NCT01014065|biomarkers|biomarkers
711637|NCT01014065|pharmacokinetics|pharmacokinetics
711638|NCT01014091|influenza infection|influenza infection
711639|NCT01014091|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
711640|NCT01014104|Ovarian hyper stimulation syndrome|ovarian hyper stimulation syndrome
711641|NCT01014104|Methylprednisolone|methylprednisolone
711642|NCT01014104|IVF|ivf
711643|NCT01014130|Non Small Cell Lung Cancer|non small cell lung cancer
711644|NCT01014130|Hypofractionated|hypofractionated
711645|NCT01014130|Stereotactic Radiotherapy|stereotactic radiotherapy
711646|NCT01014156|pulmonary embolism|pulmonary embolism
711647|NCT01014156|vasoconstriction|vasoconstriction
711648|NCT01014156|right ventricular dysfunction|right ventricular dysfunction
711649|NCT01014156|epoprostenol|epoprostenol
711650|NCT01014156|acute pulmonary embolism with right ventricular dysfunction|acute pulmonary embolism with right ventricular dysfunction
711651|NCT01014169|Health education|health education
711652|NCT01014169|Sudden Infant Death|sudden infant death
711653|NCT01014169|Breast Feeding|breast feeding
711654|NCT01014169|Infant Equipment|infant equipment
711655|NCT01014182|Early PCI|early pci
711656|NCT01014182|Myocardial Infarction|myocardial infarction
711657|NCT01014182|Thrombolysis|thrombolysis
711658|NCT01014182|Optimal revascularization therapy in STEMI patients|optimal revascularization therapy in stemi patients
711659|NCT01014195|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
711660|NCT01014195|Neurocognitive function|neurocognitive function
711661|NCT01014195|ADHD|adhd
711662|NCT01014195|brain imaging|brain imaging
711663|NCT01014195|genetic polymorphisms|genetic polymorphisms
711664|NCT01014195|Psychopathology and neurocognitive Impairment in Leukemia Survivors|psychopathology and neurocognitive impairment in leukemia survivors
711665|NCT01014208|The All Ireland Cooperative Oncology Research Group|the all ireland cooperative oncology research group
711666|NCT01014208|GELTAMO|geltamo
711667|NCT01014208|National Cancer Research Institute Lymphoma Clinical Studies Group|national cancer research institute lymphoma clinical studies group
711668|NCT01014208|Genmab|genmab
711669|NCT01014208|ofatumumab|ofatumumab
711670|NCT01014208|Japan Clinical Oncology Group|japan clinical oncology group
711671|NCT01014208|Oncology|oncology
711672|NCT01014208|Polish Lymphoma Research Group|polish lymphoma research group
711673|NCT01014208|Salvage chemotherapy|salvage chemotherapy
711674|NCT01014208|refractory|refractory
711675|NCT01014208|HOVON|hovon
711676|NCT01014208|DVD|dvd
711677|NCT01014208|relapsed|relapsed
711678|NCT01014208|safety|safety
711679|NCT01014208|efficacy|efficacy
711680|NCT01014208|DHAP|dhap
711681|NCT01014208|rituximab|rituximab
711682|NCT01014208|Autologous Stem Cell Transplant|autologous stem cell transplant
711683|NCT01014208|Dutch-Belgian Cooperative Trial Group for Hematology-Oncology|dutch-belgian cooperative trial group for hematology-oncology
711684|NCT01014208|Grupo Espanol de Linfomas|grupo espanol de linfomas
711685|NCT01014208|Nordic Lymphoma Group|nordic lymphoma group
711686|NCT01014221|acupuncture|acupuncture
711687|NCT01014221|carpal tunnel syndrome|carpal tunnel syndrome
711688|NCT01014221|CTS|cts
711689|NCT01014221|steroid|steroid
711690|NCT01014221|global symptom score (GSS)|global symptom score (gss)
711691|NCT01014234|Immunosuppressive Agents|immunosuppressive agents
711692|NCT01014234|Immune system regulation|immune system regulation
711693|NCT01014234|Regulatory T cells|regulatory t cells
711694|NCT01014234|Rapamycin|rapamycin
711695|NCT01014234|Tolerance|tolerance
711696|NCT01014247|Moxifloxacin|moxifloxacin
711794|NCT01014702|Capsulorrhexis|capsulorrhexis
711697|NCT01014260|Inflammatory markers of cardiovascular disease|inflammatory markers of cardiovascular disease
711698|NCT01014273|Acute Coronary Syndrome|acute coronary syndrome
711699|NCT01014273|PCI|pci
711700|NCT01014273|Percutaneous Coronary Intervention|percutaneous coronary intervention
711701|NCT01014273|Radial Access|radial access
711702|NCT01014299|Intubation|intubation
711703|NCT01014299|Hypoxemia|hypoxemia
711704|NCT01014299|Mechanical ventilation|mechanical ventilation
711705|NCT01014299|Recruitment maneuver|recruitment maneuver
711706|NCT01014299|Acute lung injury|acute lung injury
711707|NCT01014299|Bacterial translocation|bacterial translocation
711708|NCT01014299|Hypoxemic ICU patients requiring invasive mechanical ventilation|hypoxemic icu patients requiring invasive mechanical ventilation
711709|NCT01014312|Depression|depression
711710|NCT01014351|Metastatic Melanoma|metastatic melanoma
711711|NCT01014351|Everolimus|everolimus
711712|NCT01014351|Paclitaxel|paclitaxel
711713|NCT01014351|Carboplatin|carboplatin
711714|NCT01014364|Acute lung injury|acute lung injury
711715|NCT01014364|Acute respiratory distress syndrome|acute respiratory distress syndrome
711716|NCT01014364|corticosteroids|corticosteroids
711717|NCT01014364|inflammation|inflammation
711718|NCT01014390|benign biliary strictures secondary to chronic pancreatitis/post abdominal surgery/post liver transplant|benign biliary strictures secondary to chronic pancreatitis/post abdominal surgery/post liver transplant
711719|NCT01014403|venous thromboembolism|venous thromboembolism
711720|NCT01014403|enoxaparin|enoxaparin
711721|NCT01014403|traumatic brain injury|traumatic brain injury
711722|NCT01014403|Venous thromboembolism prophylaxis after traumatic brain injury|venous thromboembolism prophylaxis after traumatic brain injury
711723|NCT01014416|Healthy Korean male|healthy korean male
711724|NCT01014429|Phase I dose escalation study|phase i dose escalation study
711725|NCT01014429|Advanced or metastatic solid tumors|advanced or metastatic solid tumors
711726|NCT01014429|PLK 1 inhibitor|plk 1 inhibitor
711727|NCT01014429|Adult patients|adult patients
711728|NCT01014455|surgery|surgery
711729|NCT01014468|ranibizumab|ranibizumab
711730|NCT01014468|bevacizumab|bevacizumab
711731|NCT01014468|AMD|amd
711732|NCT01014468|Complications|complications
711733|NCT01014468|Visual acuity|visual acuity
711734|NCT01014468|OCt|oct
711735|NCT01014468|Age Macular Degeneration|age macular degeneration
711736|NCT01014481|HIV|hiv
711737|NCT01014481|tuberculosis|tuberculosis
711738|NCT01014481|antiretroviral treatment|antiretroviral treatment
711739|NCT01014481|timing|timing
711740|NCT01014520|Lumbar|lumbar
711741|NCT01014520|Diskectomy|diskectomy
711742|NCT01014520|Laminectomy|laminectomy
711743|NCT01014533|Alcoholism|alcoholism
711744|NCT01014533|Alcohol dependence|alcohol dependence
711745|NCT01014533|Insomnia|insomnia
711746|NCT01014533|Dim light melatonin onset|dim light melatonin onset
711747|NCT01014533|Gabapentin|gabapentin
711748|NCT01014559|Constipation|constipation
711749|NCT01014559|Oxycodone|oxycodone
711750|NCT01014559|Oxycodone hydrochloride|oxycodone hydrochloride
711751|NCT01014559|Naloxone hydrochloride|naloxone hydrochloride
711752|NCT01014559|Naloxone|naloxone
711753|NCT01014572|Clinical Trials, Phase II|clinical trials, phase ii
711754|NCT01014572|Exercise|exercise
711755|NCT01014572|Exercise Tolerance|exercise tolerance
711756|NCT01014572|Aging|aging
711757|NCT01014585|Milnacipran|milnacipran
711758|NCT01014585|Pain|pain
711759|NCT01014585|Durability of Effect|durability of effect
711760|NCT01014585|Loss of Therapeutic Response|loss of therapeutic response
711761|NCT01014585|Fatigue|fatigue
711762|NCT01014585|Forest Research Institute|forest research institute
711763|NCT01014585|Savella ®|savella ®
711764|NCT01014611|Heart failure|heart failure
711765|NCT01014611|Skeletal muscle|skeletal muscle
711766|NCT01014611|Calcium|calcium
711767|NCT01014611|Ryanodine receptor|ryanodine receptor
711768|NCT01014611|Mitochondria|mitochondria
711769|NCT01014611|Exercise training|exercise training
711770|NCT01014611|Muscle biopsy|muscle biopsy
711771|NCT01014611|Healthy volunteers|healthy volunteers
711772|NCT01014624|thienopyridine|thienopyridine
711773|NCT01014624|pharmacologic action|pharmacologic action
711774|NCT01014624|prasugrel|prasugrel
711775|NCT01014624|clopidogrel|clopidogrel
711776|NCT01014637|Dermatomycoses|dermatomycoses
711777|NCT01014637|Infection|infection
711778|NCT01014637|Mycoses|mycoses
711779|NCT01014637|Nail diseases|nail diseases
711780|NCT01014637|Ski diseases|ski diseases
711910|NCT01015170|smoking cessation|smoking cessation
711781|NCT01014637|Skin diseases/infectious|skin diseases/infectious
711782|NCT01014650|glycine site partial agonist|glycine site partial agonist
711783|NCT01014650|normal volunteers|normal volunteers
711784|NCT01014650|safety in normal volunteers|safety in normal volunteers
711785|NCT01014663|Parkinson's disease|parkinson's disease
711786|NCT01014663|exercise|exercise
711787|NCT01014663|training program|training program
711788|NCT01014663|rehabilitation|rehabilitation
711789|NCT01014663|boxing|boxing
711790|NCT01014676|Costs and Cost Analysis|costs and cost analysis
711791|NCT01014689|acne vulgaris|acne vulgaris
711792|NCT01014702|Cataract|cataract
711793|NCT01014702|Capsulotomy|capsulotomy
711795|NCT01014702|lens fragmentation|lens fragmentation
711796|NCT01014702|phacoemulsification|phacoemulsification
711797|NCT01014715|Breast Cancer|breast cancer
711798|NCT01014741|Atrial Fibrillation|atrial fibrillation
711799|NCT01014741|Catheter Ablation|catheter ablation
711800|NCT01014741|Complex Fractionate Electrograms|complex fractionate electrograms
711801|NCT01014767|Choroid Plexus Tumors|choroid plexus tumors
711802|NCT01014767|Brain Tumor|brain tumor
711803|NCT01014767|Chemotherapy|chemotherapy
711807|NCT01014767|Cyclophosphamide|cyclophosphamide
711808|NCT01014767|Methotrexate|methotrexate
711809|NCT01014767|Doxorubicin|doxorubicin
711810|NCT01014767|Cisplatin|cisplatin
711811|NCT01014767|Dactinomycin|dactinomycin
711812|NCT01014767|temozolomide|temozolomide
711813|NCT01014767|irinotecan|irinotecan
711814|NCT01014767|Pediatrics|pediatrics
711815|NCT01014780|dry eye|dry eye
711816|NCT01014780|tear film|tear film
711817|NCT01014780|thickness|thickness
711818|NCT01014780|artificial tears|artificial tears
711819|NCT01014793|Acromegaly resistant|acromegaly resistant
711820|NCT01014793|combined-treatment|combined-treatment
711821|NCT01014793|dopamine agonist|dopamine agonist
711822|NCT01014819|Dermacorder|dermacorder
711823|NCT01014819|Electric field|electric field
711824|NCT01014819|basal cell carcinoma|basal cell carcinoma
711825|NCT01014819|Gorlin Syndrome|gorlin syndrome
711826|NCT01014832|Diabetes, insulin.|diabetes, insulin.
711827|NCT01014845|hepatitis E|hepatitis e
711828|NCT01014845|vaccine|vaccine
711829|NCT01014845|efficacy|efficacy
711830|NCT01014858|Parkinson's disease|parkinson's disease
711831|NCT01014858|mild dementia|mild dementia
711832|NCT01014858|donepezil|donepezil
711833|NCT01014858|NIHR HTA|nihr hta
711834|NCT01014871|Forehead Wrinkles Toxin|forehead wrinkles toxin
711835|NCT01014897|stroke|stroke
711836|NCT01014897|recovery|recovery
711837|NCT01014897|tDCS|tdcs
711838|NCT01014897|direct current|direct current
711839|NCT01014897|electric stimulation|electric stimulation
711840|NCT01014910|Bronchiolitis|bronchiolitis
711841|NCT01014910|Hypoxia|hypoxia
711842|NCT01014910|Pulse|pulse
711843|NCT01014910|Oximetry|oximetry
711844|NCT01014910|Hospitalized|hospitalized
711845|NCT01014923|motor vehicle|motor vehicle
711846|NCT01014923|accidents, traffic|accidents, traffic
711847|NCT01014923|prevention and control|prevention and control
711848|NCT01014936|Phase 1|phase 1
711849|NCT01014936|advanced solid tumors|advanced solid tumors
711850|NCT01014936|refractory to standard therapy|refractory to standard therapy
711851|NCT01014962|Pharmacokinetic|pharmacokinetic
711852|NCT01014962|tolerability|tolerability
711853|NCT01014962|multiple escalating doses|multiple escalating doses
711854|NCT01014975|stroke|stroke
711855|NCT01014975|plasmin|plasmin
711856|NCT01014975|thrombus|thrombus
711857|NCT01014975|ischemic|ischemic
711858|NCT01014975|middle cerebral artery|middle cerebral artery
711859|NCT01014975|thrombolysis|thrombolysis
711860|NCT01014975|intra-arterial|intra-arterial
711861|NCT01014975|fibrin|fibrin
711862|NCT01014988|pandemic|pandemic
711863|NCT01014988|seasonal influenza|seasonal influenza
711864|NCT01014988|Influenza B virus|influenza b virus
711865|NCT01014988|H1N1|h1n1
711866|NCT01014988|zanamivir|zanamivir
711867|NCT01014988|Influenza A virus, H1N1 Subtype|influenza a virus, h1n1 subtype
711868|NCT01014988|Relenza|relenza
711869|NCT01014988|influenza|influenza
711870|NCT01014988|neuraminidase inhibitor|neuraminidase inhibitor
711871|NCT01015001|refractory schizophrenia|refractory schizophrenia
711872|NCT01015001|rTMS|rtms
711873|NCT01015001|auditory hallucinations|auditory hallucinations
711874|NCT01015014|Gram negative|gram negative
711875|NCT01015014|bacteria|bacteria
711876|NCT01015014|infection|infection
711877|NCT01015040|solifenacin succinate|solifenacin succinate
711878|NCT01015040|VESIcare|vesicare
711879|NCT01015040|Healthy Volunteers|healthy volunteers
711880|NCT01015053|postoperative pain|postoperative pain
711881|NCT01015053|pediatric|pediatric
711882|NCT01015053|umbilical hernia|umbilical hernia
711883|NCT01015053|ropivacaine|ropivacaine
711884|NCT01015053|rectus sheath block|rectus sheath block
711885|NCT01015053|regional block|regional block
711886|NCT01015053|ultrasound-guided regional block|ultrasound-guided regional block
711887|NCT01015053|local infiltration|local infiltration
711888|NCT01015053|ambulatory surgery|ambulatory surgery
711889|NCT01015066|drug dependence|drug dependence
711890|NCT01015066|substance abuse|substance abuse
711891|NCT01015066|substance use disorders|substance use disorders
711892|NCT01015066|buprenorphine|buprenorphine
711893|NCT01015066|naltrexone|naltrexone
711894|NCT01015066|adolescents|adolescents
711895|NCT01015079|Pap smear screening|pap smear screening
711897|NCT01015092|Cardiovascular|cardiovascular
711898|NCT01015092|Coronary hear disease|coronary hear disease
711900|NCT01015092|antiretroviral|antiretroviral
711901|NCT01015105|patients with hip fracture|patients with hip fracture
711902|NCT01015144|atorvastatin|atorvastatin
711903|NCT01015144|dilated cardiomyopathy|dilated cardiomyopathy
711904|NCT01015144|heart failure|heart failure
711905|NCT01015144|inflammation|inflammation
711906|NCT01015157|Gastric bypass|gastric bypass
711907|NCT01015157|staple line reinforcement|staple line reinforcement
711908|NCT01015157|outcomes|outcomes
711909|NCT01015157|per and postoperative blood loss|per and postoperative blood loss
711911|NCT01015170|nicotine addiction|nicotine addiction
711912|NCT01015170|Zyban|zyban
711913|NCT01015170|bupropion hydrochloride|bupropion hydrochloride
711915|NCT01015183|Bone Marrow Transplantation|bone marrow transplantation
711916|NCT01015183|BMT|bmt
711917|NCT01015183|HSCT|hsct
711918|NCT01015196|acute myeloid leukemia in first complete remission|acute myeloid leukemia in first complete remission
711919|NCT01015209|Dry eye syndromes|dry eye syndromes
711920|NCT01015222|Advanced Malignancies|advanced malignancies
711921|NCT01015222|Metastatic cancer|metastatic cancer
711922|NCT01015222|Bevacizumab|bevacizumab
711923|NCT01015222|Avastin|avastin
711924|NCT01015222|Dasatinib|dasatinib
711925|NCT01015222|Sprycel|sprycel
711926|NCT01015222|Paclitaxel|paclitaxel
711927|NCT01015222|Taxol|taxol
711928|NCT01015235|Ketorolac / therapeutic use|ketorolac / therapeutic use
711929|NCT01015235|Analgesics. Non-narcotic / therapeutic use|analgesics. non-narcotic / therapeutic use
711930|NCT01015235|Arthroplasty, replacement hip|arthroplasty, replacement hip
711931|NCT01015235|Arthroplasty, replacement knee|arthroplasty, replacement knee
711932|NCT01015235|Pain measurement / drug effect|pain measurement / drug effect
711933|NCT01015235|Pain postoperative / drug therapy|pain postoperative / drug therapy
711934|NCT01015248|CD 20 positive|cd 20 positive
711935|NCT01015261|ALL|all
711936|NCT01015261|BMT|bmt
711937|NCT01015261|Chemotherapy|chemotherapy
711938|NCT01015261|Allogenic|allogenic
711939|NCT01015287|Acute Coronary Syndromes|acute coronary syndromes
711940|NCT01015287|Heart Disease|heart disease
711941|NCT01015287|Percutaneous Coronary Intervention|percutaneous coronary intervention
711942|NCT01015287|P2Y12|p2y12
711943|NCT01015287|NSTEMI|nstemi
711944|NCT01015300|Hemangioblastoma|hemangioblastoma
711945|NCT01015300|Von Hippel Lindau|von hippel lindau
711946|NCT01015300|VHL|vhl
711947|NCT01015300|lesion|lesion
711948|NCT01015300|EGFR|egfr
711949|NCT01015313|sodium, hypertension, volume overload|sodium, hypertension, volume overload
711950|NCT01015326|EGFRI|egfri
711951|NCT01015326|HRQL|hrql
711952|NCT01015326|Quality of Life|quality of life
711953|NCT01015326|Development of a standardized HRQL instrument for anti-EGFR therapy induced|development of a standardized hrql instrument for anti-egfr therapy induced
711954|NCT01015352|Myelodysplastic Syndromes|myelodysplastic syndromes
711955|NCT01015365|Chronic infected hip arthroplasty|chronic infected hip arthroplasty
711956|NCT01015365|Fast-track|fast-track
711957|NCT01015365|One-stage cementless revision|one-stage cementless revision
711958|NCT01015378|Recurrent sigmoid diverticulitis|recurrent sigmoid diverticulitis
711959|NCT01015378|diverticulitis|diverticulitis
711960|NCT01015378|Colon|colon
711961|NCT01015378|sigmoid|sigmoid
711962|NCT01015378|recurrence|recurrence
711963|NCT01015391|T2|t2
711964|NCT01015391|AZA|aza
711965|NCT01015391|remission|remission
711966|NCT01015391|Crohn's disease|crohn's disease
711967|NCT01015404|Trafermin|trafermin
711968|NCT01015404|Periodontitis|periodontitis
711969|NCT01015417|Acute lithiasic cholecystitis|acute lithiasic cholecystitis
711970|NCT01015417|Cholecystectomy|cholecystectomy
711971|NCT01015417|Postoperative antibiotherapy|postoperative antibiotherapy
711972|NCT01015417|Surgical site infection|surgical site infection
711973|NCT01015417|Remote surgical site infection|remote surgical site infection
711974|NCT01015443|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
711975|NCT01015443|Tecemotide|tecemotide
711976|NCT01015443|L-BLP25|l-blp25
711977|NCT01015443|Cyclophosphamide|cyclophosphamide
711978|NCT01015443|placebo controlled|placebo controlled
711979|NCT01015443|Non-Small Cell Lung Cancer|non-small cell lung cancer
711980|NCT01015456|lupus nephritis|lupus nephritis
711981|NCT01015456|mycophenolate sodium|mycophenolate sodium
711982|NCT01015456|cyclophosphamide|cyclophosphamide
711983|NCT01015469|bariatric|bariatric
711984|NCT01015469|surgery|surgery
711985|NCT01015469|obesity|obesity
711986|NCT01015469|Roux-en-Y|roux-en-y
711987|NCT01015469|gastric|gastric
711988|NCT01015469|medical device|medical device
711989|NCT01015469|bypass|bypass
711990|NCT01015469|adiposity|adiposity
711991|NCT01015469|GaBP-Ring|gabp-ring
711992|NCT01015469|BMI|bmi
711993|NCT01015469|banded|banded
711994|NCT01015469|laparoscopic|laparoscopic
711995|NCT01015482|Sunburn|sunburn
711996|NCT01015482|Remifentanil|remifentanil
711997|NCT01015482|Hyperalgesia|hyperalgesia
711998|NCT01015495|angioid streaks|angioid streaks
711999|NCT01015495|CNV|cnv
712000|NCT01015495|intra vitreal ranibizumab|intra vitreal ranibizumab
712001|NCT01015508|Weight loss and maintenance|weight loss and maintenance
712002|NCT01015508|body composition|body composition
712003|NCT01015508|energy expenditure|energy expenditure
712004|NCT01015508|adipogenic capacity|adipogenic capacity
712005|NCT01015508|physical activity|physical activity
712006|NCT01015521|breast cancer|breast cancer
712007|NCT01015534|Brain metastases|brain metastases
712008|NCT01015534|Temozolomide|temozolomide
712009|NCT01015534|Whole-brain radiotherapy|whole-brain radiotherapy
712010|NCT01015534|Phase II trial|phase ii trial
712011|NCT01015547|juvenile idiopathic arthritis|juvenile idiopathic arthritis
712012|NCT01015547|polyarthritis|polyarthritis
712013|NCT01015547|combination therapy|combination therapy
712014|NCT01015547|biologic agents|biologic agents
712015|NCT01015547|TNF antagonists|tnf antagonists
712017|NCT01015560|bone metastases|bone metastases
712018|NCT01015560|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
712019|NCT01015586|Alcohol|alcohol
712020|NCT01015586|Bipolar Disorder|bipolar disorder
712021|NCT01015586|Manic depression|manic depression
712022|NCT01015586|Addiction|addiction
712023|NCT01015586|Alcoholism|alcoholism
712024|NCT01015586|Cognitive impairment|cognitive impairment
712025|NCT01015586|Executive function|executive function
712026|NCT01015586|Anxiety|anxiety
712027|NCT01015586|Depression|depression
712028|NCT01015586|Mania|mania
712029|NCT01015586|Affective disorder|affective disorder
712030|NCT01015586|Psychosis|psychosis
712031|NCT01015586|Carbohydrate deficient transferrin|carbohydrate deficient transferrin
712032|NCT01015586|Gammaglutamyltransferase|gammaglutamyltransferase
712033|NCT01015586|California Verbal Learning Test|california verbal learning test
712034|NCT01015586|Wisconsin Card Sort Test|wisconsin card sort test
712035|NCT01015586|Stroop Color and Word Test|stroop color and word test
712036|NCT01015586|Alcohol Stroop Test|alcohol stroop test
712037|NCT01015586|Emotion Stroop Test|emotion stroop test
712038|NCT01015586|Point Scoring Reaction Time Test|point scoring reaction time test
712039|NCT01015586|Rey Osterrieth Complex Figure Test|rey osterrieth complex figure test
712040|NCT01015586|Trail Making Test|trail making test
712041|NCT01015586|Montgomery Asberg Depression Rating Scale|montgomery asberg depression rating scale
712042|NCT01015586|Young Mania Rating Scale|young mania rating scale
712043|NCT01015586|Timeline Follow Back|timeline follow back
712044|NCT01015599|Obesity prevention|obesity prevention
712045|NCT01015599|after-school|after-school
712046|NCT01015599|physical activity|physical activity
712047|NCT01015599|fruit|fruit
712048|NCT01015599|vegetable|vegetable
712049|NCT01015599|children|children
712050|NCT01015612|Aortic Valve Stenosis|aortic valve stenosis
712051|NCT01015612|Aortic Valve Insufficiency|aortic valve insufficiency
712052|NCT01015625|breast cancer|breast cancer
712053|NCT01015625|ABCSG|abcsg
712054|NCT01015625|POSYTIVE|posytive
712055|NCT01015625|growth factor|growth factor
712056|NCT01015625|median survival|median survival
712057|NCT01015625|surgery on demand|surgery on demand
712058|NCT01015625|surgical therapy|surgical therapy
712059|NCT01015625|blood specimen|blood specimen
712060|NCT01015625|tissue specimen|tissue specimen
712061|NCT01015625|VEGF|vegf
712063|NCT01015625|circulating tumor cells|circulating tumor cells
712064|NCT01015625|stem cells|stem cells
712065|NCT01015638|Healthy volunteers|healthy volunteers
712066|NCT01015651|nociception, intraoperative, baroreflex|nociception, intraoperative, baroreflex
712067|NCT01015690|unexplained infertility|unexplained infertility
712068|NCT01015690|hCG|hcg
712069|NCT01015690|early pregnancy loss|early pregnancy loss
712070|NCT01015703|Vaccine, hypertension|vaccine, hypertension
712071|NCT01015716|Weight loss|weight loss
712072|NCT01015716|Physical activity|physical activity
712073|NCT01015716|Cognitive Behavioral Training|cognitive behavioral training
712074|NCT01015729|Bioequivalence|bioequivalence
712075|NCT01015729|ASA|asa
712076|NCT01015729|Esomeprazole|esomeprazole
712077|NCT01015729|peptic ulcer disease|peptic ulcer disease
712078|NCT01015729|pH measurements|ph measurements
712079|NCT01015742|AML|aml
712080|NCT01015742|ALL|all
712081|NCT01015742|CML|cml
712082|NCT01015755|thirst palliation and intensive care unit|thirst palliation and intensive care unit
712083|NCT01015755|thirst intensity and distress|thirst intensity and distress
712084|NCT01015755|predictors of thirst|predictors of thirst
712085|NCT01015768|corneal staining|corneal staining
712086|NCT01015768|barrier function|barrier function
712087|NCT01015768|contact lenses|contact lenses
712088|NCT01015768|contact lens care solutions|contact lens care solutions
712089|NCT01015768|contact lens material and care solution bioincompatibility|contact lens material and care solution bioincompatibility
712090|NCT01015781|Tinnitus|tinnitus
712091|NCT01015781|Counseling|counseling
712092|NCT01015781|Education|education
712093|NCT01015781|Rehabilitation of hearing impaired|rehabilitation of hearing impaired
712094|NCT01015781|Triage|triage
712095|NCT01015781|Evaluation studies|evaluation studies
712245|NCT01016028|bortezomib|bortezomib
712096|NCT01015781|Quality of health care|quality of health care
712097|NCT01015807|postoperative|postoperative
712098|NCT01015807|hyperalgesia|hyperalgesia
712099|NCT01015807|pain|pain
712100|NCT01015807|transversus abdominis plane block|transversus abdominis plane block
712101|NCT01015807|TAP block|tap block
712102|NCT01015807|cesarean section|cesarean section
712103|NCT01015820|Pancreatic Cancer|pancreatic cancer
712104|NCT01015820|Duodenum|duodenum
712105|NCT01015820|Spectroscopy|spectroscopy
712106|NCT01015820|Fiberoptic probe|fiberoptic probe
712107|NCT01015820|4D-ELF|4d-elf
712108|NCT01015846|Core|core
712109|NCT01015846|Redcord|redcord
712110|NCT01015846|RUSI|rusi
712111|NCT01015846|low back|low back
712112|NCT01004627|fistula|fistula
712113|NCT01004627|ultrasound|ultrasound
712114|NCT01004627|angioaccess|angioaccess
712267|NCT01016067|MASTERGRAFT|mastergraft
712115|NCT01004627|preoperative vein mapping|preoperative vein mapping
712116|NCT01004627|Haemodialysis|haemodialysis
712117|NCT01004627|Angioaccess surgery|angioaccess surgery
712118|NCT01004640|chronic myelogenous leukemia|chronic myelogenous leukemia
712119|NCT01004666|Breast cancer|breast cancer
712120|NCT01004666|Scintimammography|scintimammography
712122|NCT01004666|High-risk|high-risk
712123|NCT01015859|AV conduction|av conduction
712124|NCT01015859|Atrial fibrillation|atrial fibrillation
712125|NCT01015872|sleep apnea syndrome|sleep apnea syndrome
712126|NCT01015872|CPAP|cpap
712127|NCT01015872|prostanoids|prostanoids
712128|NCT01015898|basal cell carcinoma|basal cell carcinoma
712129|NCT01015898|photodynamic therapy|photodynamic therapy
712130|NCT01015898|photo chemotherapy|photo chemotherapy
712131|NCT01015898|basal cell epithelioma|basal cell epithelioma
712132|NCT01015911|Antibodies, Monoclonal|antibodies, monoclonal
712133|NCT01015911|Antibody-Drug Conjugate|antibody-drug conjugate
712134|NCT01015911|Antigens, CD70|antigens, cd70
712135|NCT01015911|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
712136|NCT01015911|Carcinoma, Renal Cell|carcinoma, renal cell
712137|NCT01015911|Immunotherapy|immunotherapy
712138|NCT01015911|Drug Therapy|drug therapy
712139|NCT01015911|monomethylauristatin F|monomethylauristatin f
712140|NCT01015924|clavicle|clavicle
712141|NCT01015924|TEN|ten
712142|NCT01015924|Plate osteosynthesis|plate osteosynthesis
712143|NCT01015924|displaced|displaced
712144|NCT01015924|ESIN|esin
712145|NCT01015924|displaced midshaft clavicular fractures|displaced midshaft clavicular fractures
712146|NCT01015937|diabetes|diabetes
712147|NCT01015937|nephropathy|nephropathy
712148|NCT01015937|turmeric|turmeric
712149|NCT01015937|serum IL8|serum il8
712150|NCT01015937|serum TGFb|serum tgfb
712151|NCT01015937|serumINF|seruminf
712152|NCT01015937|urinary IL8|urinary il8
712153|NCT01015937|urine TGFb|urine tgfb
712154|NCT01015963|recurrent breast cancer|recurrent breast cancer
712155|NCT01015963|stage IIIA breast cancer|stage iiia breast cancer
712156|NCT01015963|stage IIIB breast cancer|stage iiib breast cancer
712157|NCT01015963|stage IIIC breast cancer|stage iiic breast cancer
712158|NCT01015963|stage IV breast cancer|stage iv breast cancer
712159|NCT01015963|extensive stage small cell lung cancer|extensive stage small cell lung cancer
712160|NCT01015963|recurrent small cell lung cancer|recurrent small cell lung cancer
712161|NCT01015963|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
712162|NCT01015963|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
712163|NCT01015963|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
712164|NCT01015963|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
712165|NCT01015963|stage IV bladder cancer|stage iv bladder cancer
712166|NCT01015963|recurrent bladder cancer|recurrent bladder cancer
712167|NCT01015963|stage III bladder cancer|stage iii bladder cancer
712168|NCT01015963|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
712169|NCT01015963|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
712170|NCT01015963|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
712171|NCT01015963|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
712172|NCT01015963|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
712173|NCT01015963|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
712174|NCT01015963|pulmonary carcinoid tumor|pulmonary carcinoid tumor
712175|NCT01015963|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
712176|NCT01015963|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
712177|NCT01015963|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
712178|NCT01015963|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
712179|NCT01015963|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
712180|NCT01015963|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
712181|NCT01015963|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
712246|NCT01016041|drug-eluting stent|drug-eluting stent
712450|NCT01018069|Acute|acute
712182|NCT01015963|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
712183|NCT01015963|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
712184|NCT01015963|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
712185|NCT01015963|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
712186|NCT01015963|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
752592|NCT01173263|breathing machine|breathing machine
712187|NCT01015963|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
712188|NCT01015963|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
714598|NCT01010217|Filgrastim|filgrastim
714599|NCT01010217|Neupogen|neupogen
714600|NCT01010230|Childhood cancer survivors|childhood cancer survivors
714601|NCT01010243|multiple myeloma|multiple myeloma
714602|NCT01010243|anti-inflammatory|anti-inflammatory
714603|NCT01010243|relapsed|relapsed
714604|NCT01010243|refractory|refractory
714605|NCT01010243|progressive|progressive
714610|NCT01010308|infantile hemangioma|infantile hemangioma
712189|NCT01015963|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
712190|NCT01015963|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
712191|NCT01015963|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
712192|NCT01015963|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
712193|NCT01015963|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
712194|NCT01015963|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
712195|NCT01015963|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
712196|NCT01015963|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
712197|NCT01015963|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
712198|NCT01015963|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
712199|NCT01015963|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
712200|NCT01015963|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
712201|NCT01015963|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
712202|NCT01015963|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
712203|NCT01015963|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
712204|NCT01015963|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
712205|NCT01015963|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
712206|NCT01015963|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
712207|NCT01015963|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
712208|NCT01015963|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
712209|NCT01015963|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
712210|NCT01015963|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
712211|NCT01015963|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
712212|NCT01015963|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
712213|NCT01015963|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
712214|NCT01015963|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
712215|NCT01015963|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
712216|NCT01015963|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
712217|NCT01015963|recurrent salivary gland cancer|recurrent salivary gland cancer
712218|NCT01015963|stage III salivary gland cancer|stage iii salivary gland cancer
712219|NCT01015963|stage IV salivary gland cancer|stage iv salivary gland cancer
712220|NCT01015963|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
712221|NCT01015963|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
712222|NCT01015963|tongue cancer|tongue cancer
712223|NCT01015976|Gastric Bypass|gastric bypass
712224|NCT01015976|Sertraline|sertraline
712225|NCT01015976|Pharmacokinetics|pharmacokinetics
712226|NCT01015989|HIV treatment|hiv treatment
712227|NCT01015989|ART adherence|art adherence
712228|NCT01015989|Using new technology to improve adherence|using new technology to improve adherence
712229|NCT01015989|CARE+|care+
712230|NCT01015989|HIV-1 viral loads|hiv-1 viral loads
712231|NCT01016028|Cancer|cancer
712232|NCT01016028|Colorectum Cancer|colorectum cancer
712233|NCT01016028|Colorectal disease|colorectal disease
712234|NCT01016028|neuropathic symptom tool|neuropathic symptom tool
712235|NCT01016028|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
712236|NCT01016028|CIPN|cipn
712237|NCT01016028|Pain|pain
754170|NCT01176604|TheraSphere|therasphere
714700|NCT01010711|q10|q10
712238|NCT01016028|Quantitative Sensory Testing|quantitative sensory testing
712239|NCT01016028|QST|qst
712240|NCT01016028|symptom measurement tools|symptom measurement tools
712241|NCT01016028|platinum agents|platinum agents
712242|NCT01016028|cisplatin|cisplatin
712243|NCT01016028|oxaliplatin|oxaliplatin
712244|NCT01016028|taxanes|taxanes
712247|NCT01016041|stable angina|stable angina
712248|NCT01016041|ACS|acs
712249|NCT01016041|MACE|mace
712250|NCT01016041|safety|safety
712251|NCT01016041|stent thrombosis|stent thrombosis
712252|NCT01016054|Clinical Trial, Phase1|clinical trial, phase1
712253|NCT01016054|Combination Drug Therapy|combination drug therapy
712254|NCT01016054|pharmacokinetics|pharmacokinetics
712255|NCT01016054|safety|safety
712256|NCT01016054|Ovarian|ovarian
712257|NCT01016067|Tibia|tibia
712258|NCT01016067|Tibial|tibial
712259|NCT01016067|Fracture|fracture
712260|NCT01016067|Nonunion|nonunion
712261|NCT01016067|delayed|delayed
712262|NCT01016067|healing|healing
712263|NCT01016067|iliac|iliac
712264|NCT01016067|crest|crest
712265|NCT01016067|autograft|autograft
712266|NCT01016067|INFUSE|infuse
712274|NCT01016080|skin pigment|skin pigment
712275|NCT01016093|Thalassemia|thalassemia
712277|NCT01016093|HSCT|hsct
712278|NCT01016106|eczema|eczema
712279|NCT01016106|atopic dermatitis|atopic dermatitis
712280|NCT01016106|dry skin|dry skin
712281|NCT01016106|ichthyosis vulgaris|ichthyosis vulgaris
712282|NCT01016145|Schizophrenia|schizophrenia
712283|NCT01016145|predictors of response|predictors of response
712284|NCT01016145|antipsychotics|antipsychotics
712285|NCT01016145|18-45 years old|18-45 years old
712286|NCT01016145|non-refractory|non-refractory
712287|NCT01016158|Umbilical cord serum|umbilical cord serum
712288|NCT01016158|Recurrent corneal erosion|recurrent corneal erosion
712289|NCT01016184|Quality of life|quality of life
712290|NCT01016197|Soft tissue mallet finger|soft tissue mallet finger
712291|NCT01016210|pregnancy|pregnancy
712292|NCT01016210|IVF|ivf
712293|NCT01017315|baby talcum|baby talcum
712294|NCT01017315|pruritus|pruritus
712295|NCT01017315|cast|cast
712296|NCT01017328|infants and children undergoing surgery with general anesthesia|infants and children undergoing surgery with general anesthesia
712297|NCT01017341|hip fracture|hip fracture
712298|NCT01017341|back support|back support
712299|NCT01017354|vitamin D|vitamin d
712300|NCT01017354|function|function
712301|NCT01017354|falls|falls
712302|NCT01017354|25-hydroxyvitamin D|25-hydroxyvitamin d
712303|NCT01017354|disability|disability
712304|NCT01017367|RA|ra
712305|NCT01017367|inflammatory joint disease|inflammatory joint disease
712306|NCT01017380|preemptive analgesia|preemptive analgesia
712307|NCT01017380|cruciate ligament|cruciate ligament
712308|NCT01017393|preemptive epidural ketamine|preemptive epidural ketamine
712309|NCT01017393|prevention of chronic post-thoracotomy pain|prevention of chronic post-thoracotomy pain
712310|NCT01017406|plantar fasciitis|plantar fasciitis
712311|NCT01017406|heel cushion|heel cushion
712312|NCT01017406|treatment|treatment
712313|NCT01017419|hearing aids|hearing aids
712314|NCT01017419|counseling|counseling
712315|NCT01017445|osteoarthritis, exercise|osteoarthritis, exercise
712316|NCT01017458|Healthy Adults|healthy adults
712317|NCT01017471|carpal tunnel syndrome|carpal tunnel syndrome
712318|NCT01017471|surgery|surgery
712319|NCT01017471|PSU retractor|psu retractor
712320|NCT01017471|carpal tunnel syndrome who failed to conservative treatment|carpal tunnel syndrome who failed to conservative treatment
712321|NCT01017484|blood pressure|blood pressure
712322|NCT01017484|DASH diet|dash diet
712323|NCT01017484|hypertension|hypertension
712324|NCT01017497|Brain Metastases|brain metastases
712325|NCT01017523|diabetes|diabetes
712326|NCT01017523|relationship|relationship
712327|NCT01017523|social support|social support
712328|NCT01017523|telemedicine|telemedicine
712329|NCT01017536|HIV|hiv
712330|NCT01017536|Tuberculosis|tuberculosis
712331|NCT01017536|Vaccine|vaccine
712332|NCT01017549|Stage I|stage i
712333|NCT01017549|Stage II|stage ii
712334|NCT01017549|Breast|breast
712335|NCT01017549|Cancer|cancer
712336|NCT01017562|To clarify the 18F-fluoride uptake patterns associated with aseptic or septic loosening|to clarify the 18f-fluoride uptake patterns associated with aseptic or septic loosening
712337|NCT01017588|lumbar support|lumbar support
712338|NCT01017588|rubber tapper|rubber tapper
712339|NCT01017601|extensive stage small cell lung cancer|extensive stage small cell lung cancer
712340|NCT01017614|Inflammatory Bowel Disease|inflammatory bowel disease
712341|NCT01017614|Iron deficiency|iron deficiency
712342|NCT01017614|Iron deficiency anaemia|iron deficiency anaemia
712343|NCT01017614|Anaemia|anaemia
712344|NCT01017627|ESRD|esrd
712345|NCT01017627|Anemia|anemia
712346|NCT01017627|Hospitalizations|hospitalizations
712347|NCT01017627|Mortality|mortality
712348|NCT01017653|Panitumumab|panitumumab
712349|NCT01017653|Vectibix|vectibix
712350|NCT01017653|Irinotecan|irinotecan
712351|NCT01017653|CPT-11|cpt-11
712352|NCT01017653|Camptosar|camptosar
712449|NCT01018056|tics|tics
712353|NCT01017653|Malignant glioma|malignant glioma
712354|NCT01017653|Glioblastoma multiforme|glioblastoma multiforme
712355|NCT01017653|Gliosarcoma|gliosarcoma
712356|NCT01017653|Duke|duke
712357|NCT01017653|Vredenburgh|vredenburgh
712358|NCT01017653|Pro00015447|pro00015447
712359|NCT01017666|Healthy Volunteer|healthy volunteer
712360|NCT01017718|Diabetes mellitus type I|diabetes mellitus type i
712361|NCT01017718|nerve conduction velocity|nerve conduction velocity
712362|NCT01017718|Young score|young score
712363|NCT01017718|long term vascular complications|long term vascular complications
712364|NCT01017731|Advanced Solid tumor|advanced solid tumor
712365|NCT01017731|Antibodies, Monoclonal|antibodies, monoclonal
712366|NCT01017731|QTc|qtc
712367|NCT01017731|Metastatic|metastatic
712368|NCT01017731|Malignant|malignant
712369|NCT01017744|Anesthetic Conserving Device|anesthetic conserving device
712370|NCT01017744|Anaconda®|anaconda®
712371|NCT01017744|Sevoflurane|sevoflurane
712372|NCT01017744|Remifentanil|remifentanil
712373|NCT01017744|Sedation|sedation
712374|NCT01017744|Pressure support ventilation|pressure support ventilation
712375|NCT01017744|Work of breathing|work of breathing
712376|NCT01017744|Intrinsic positive end expiratory pressure|intrinsic positive end expiratory pressure
712377|NCT01017744|Ventilatory dead space|ventilatory dead space
712378|NCT01017744|Intensive care|intensive care
712379|NCT01017744|Weaning of mechanical ventilation|weaning of mechanical ventilation
712380|NCT01017744|Ventilated ICU patients in PSV|ventilated icu patients in psv
712381|NCT01017744|No more in acute state|no more in acute state
712382|NCT01017744|No respiratory distress|no respiratory distress
712383|NCT01017744|Sedated by intravenous remifentanil|sedated by intravenous remifentanil
712507|NCT01018420|healthy|healthy
712384|NCT01017744|In light sedation as define by a Richmond Agitation Sedation Scale (RASS) of - 1 to - 2.|in light sedation as define by a richmond agitation sedation scale (rass) of - 1 to - 2.
712385|NCT01017757|Interstitial lung disease|interstitial lung disease
712386|NCT01017757|Immunosuppressive therapy|immunosuppressive therapy
712387|NCT01017757|Renal transplant|renal transplant
712388|NCT01017770|Uncomplicated malaria|uncomplicated malaria
712389|NCT01017796|Contrast induced nephropathy|contrast induced nephropathy
712390|NCT01017809|ovarian|ovarian
712391|NCT01017809|chemotherapy|chemotherapy
712392|NCT01017809|nausea|nausea
712393|NCT01017822|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
712394|NCT01017822|stage III pancreatic cancer|stage iii pancreatic cancer
712395|NCT01017835|statins|statins
712396|NCT01017835|isolated hypertension|isolated hypertension
712397|NCT01017835|atherosclerosis|atherosclerosis
712398|NCT01017835|lipid profile|lipid profile
712399|NCT01017848|diabetes|diabetes
712400|NCT01017848|urine pH|urine ph
712401|NCT01017848|insulin resistance|insulin resistance
712402|NCT01017848|metabolic syndrome|metabolic syndrome
712403|NCT01017848|development of diabetes|development of diabetes
712404|NCT01017861|Temporal summation|temporal summation
712405|NCT01017861|Venipuncture pain|venipuncture pain
712406|NCT01017887|laparoscopy|laparoscopy
712407|NCT01017887|airseal|airseal
712408|NCT01017887|carbon dioxide|carbon dioxide
712409|NCT01017887|insufflation|insufflation
712410|NCT01017887|pneumoperitoneum|pneumoperitoneum
712411|NCT01017900|surgery|surgery
712412|NCT01017900|manual rupture|manual rupture
712413|NCT01017900|dorsal carpal ganglion|dorsal carpal ganglion
712414|NCT01017913|rehabilitation|rehabilitation
712415|NCT01017913|electrotherapy|electrotherapy
712416|NCT01017913|back pain|back pain
712417|NCT01017926|Triazolam bioequivalence|triazolam bioequivalence
712418|NCT01017939|Prostate neoplasms|prostate neoplasms
712419|NCT01017939|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
712420|NCT01017939|Metastatic castration refractory prostate cancer|metastatic castration refractory prostate cancer
712421|NCT01017939|Prostate cancer|prostate cancer
712422|NCT01017939|Abiraterone acetate|abiraterone acetate
712423|NCT01017939|CB7630|cb7630
712424|NCT01017952|Safety|safety
712425|NCT01017952|COPD|copd
712426|NCT01017952|FEV1|fev1
712427|NCT01017952|Efficacy|efficacy
712428|NCT01017965|Type 1 diabetes|type 1 diabetes
712429|NCT01017991|infants|infants
712430|NCT01017991|formula|formula
712431|NCT01017991|probiotic|probiotic
712432|NCT01017991|crying|crying
712433|NCT01018004|stage IB melanoma|stage ib melanoma
712434|NCT01018004|stage II melanoma|stage ii melanoma
712435|NCT01018030|uncomplicated acute rhinosinusitis|uncomplicated acute rhinosinusitis
712436|NCT01018030|fluticasone furoate|fluticasone furoate
712437|NCT01018030|sinusitis|sinusitis
712438|NCT01018043|Cancer Anemia Survey|cancer anemia survey
712439|NCT01018043|Chulalongkorn hospital|chulalongkorn hospital
712440|NCT01018056|Tourette syndrome|tourette syndrome
712441|NCT01018056|glutamatergic therapy|glutamatergic therapy
712442|NCT01018056|D-serine|d-serine
712443|NCT01018056|riluzole|riluzole
712444|NCT01018056|glutamate|glutamate
712445|NCT01018056|glutamate agonist|glutamate agonist
712446|NCT01018056|glutamate antagonist|glutamate antagonist
712447|NCT01018056|Tourette syndrome treatment study|tourette syndrome treatment study
712448|NCT01018056|OCD|ocd
712451|NCT01018069|myeloid|myeloid
712452|NCT01018069|leukemia|leukemia
712453|NCT01018069|antisense|antisense
712454|NCT01018069|chemotherapy|chemotherapy
712455|NCT01018069|idarubicin|idarubicin
712456|NCT01018069|cytarabine|cytarabine
712457|NCT01018069|Patients with AML, except those with APL (acute promyelocytic leukemia), failing a single standard dose cytarabine based frontline induction regimen.|patients with aml, except those with apl (acute promyelocytic leukemia), failing a single standard dose cytarabine based frontline induction regimen.
712458|NCT01018121|Behavioral Treatment|behavioral treatment
712459|NCT01018121|Preschool Children|preschool children
712460|NCT01018121|Obesity Treatment|obesity treatment
712461|NCT01018134|Psoriasis|psoriasis
712462|NCT01018134|Topical corticosteroids|topical corticosteroids
712463|NCT01018134|Plaque psoriasis|plaque psoriasis
712464|NCT01018147|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
712465|NCT01018147|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
712466|NCT01018147|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
712467|NCT01018147|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
712468|NCT01018147|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
712469|NCT01018147|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
712470|NCT01018160|Rabeprazole sodium|rabeprazole sodium
712471|NCT01018160|Gastroesophageal Reflux|gastroesophageal reflux
712472|NCT01018160|GERD|gerd
712473|NCT01018160|Observational|observational
712474|NCT01018199|C-reactive protein|c-reactive protein
712475|NCT01018199|procalcitonin|procalcitonin
712476|NCT01018199|community-acquired pneumonia|community-acquired pneumonia
712477|NCT01018199|antibiotic therapy|antibiotic therapy
712478|NCT01018212|Cutaneous Groves|cutaneous groves
712479|NCT01018264|Overactive bladder|overactive bladder
712480|NCT01018264|Urinary incontinence|urinary incontinence
712481|NCT01018264|Urinary frequency|urinary frequency
712482|NCT01018264|Parkinson's disease|parkinson's disease
712483|NCT01018303|cystic fibrosis|cystic fibrosis
712484|NCT01018303|vitamins|vitamins
712485|NCT01018303|antioxidants|antioxidants
712486|NCT01018303|anthropometric measurements|anthropometric measurements
712487|NCT01018303|pulmonary function|pulmonary function
712488|NCT01018316|preoxygenation|preoxygenation
712489|NCT01018316|UMOX|umox
712490|NCT01018329|Adult Brain Tumor|adult brain tumor
712491|NCT01018355|Patent foramen ovale|patent foramen ovale
712492|NCT01018355|PFO|pfo
712493|NCT01018355|Stroke|stroke
712494|NCT01018355|TIA|tia
712495|NCT01018355|Percutaneus closure|percutaneus closure
712496|NCT01018355|Intervention|intervention
712497|NCT01018381|HCC|hcc
712498|NCT01018381|HBV|hbv
712499|NCT01018381|MGN-3|mgn-3
712500|NCT01018381|BioBran|biobran
712501|NCT01018381|Alternative Therapy|alternative therapy
712502|NCT01018394|tobacco dependence|tobacco dependence
712503|NCT01018394|tobacco reduction|tobacco reduction
712504|NCT01018394|chewing tobacco|chewing tobacco
712505|NCT01018394|snuff|snuff
712506|NCT01018394|moist snuff|moist snuff
712508|NCT01018433|self-injury|self-injury
712509|NCT01018433|non-suicidal self-injury|non-suicidal self-injury
712510|NCT01018433|deliberate self-harm|deliberate self-harm
712511|NCT01018433|self-mutilation|self-mutilation
712512|NCT01018446|Hematopoietic stem cell transplantation with busulfan based conditioning|hematopoietic stem cell transplantation with busulfan based conditioning
712513|NCT01018459|malaria, vaccine, Burkina Faso|malaria, vaccine, burkina faso
712514|NCT01018472|cyanotic heart disease|cyanotic heart disease
712515|NCT01018472|congenital heart disease|congenital heart disease
712516|NCT01018472|intestinal microbiota|intestinal microbiota
712517|NCT01018472|probiotics|probiotics
712518|NCT01018498|Irritable Bowel Syndrome|irritable bowel syndrome
712519|NCT01018498|Children|children
712520|NCT01018511|EC905|ec905
712521|NCT01018511|Solifenacin succinate|solifenacin succinate
712522|NCT01018511|Tamsulosin hydrochloride OCAS|tamsulosin hydrochloride ocas
712523|NCT01018511|Treatment|treatment
712524|NCT01018511|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
712525|NCT01018511|Vesomni|vesomni
712526|NCT01018511|Lower Urinary Tract Symptoms|lower urinary tract symptoms
712527|NCT01018524|position of the mesh|position of the mesh
712528|NCT01018524|recurrence rate|recurrence rate
712529|NCT01018524|surgical procedure|surgical procedure
712530|NCT01018524|long time outcome|long time outcome
712531|NCT01018537|Multiple Sclerosis|multiple sclerosis
712532|NCT01018537|NARCOMS|narcoms
712533|NCT01018537|Global Patient Registry|global patient registry
712534|NCT01018563|Extension study|extension study
712535|NCT01018563|Epithelial ovarian cancer|epithelial ovarian cancer
712536|NCT01018576|delayed cord clamping|delayed cord clamping
712537|NCT01018576|premature infants|premature infants
712538|NCT01018576|hypothermia|hypothermia
712539|NCT01018576|anemia|anemia
712540|NCT01018576|intraventricular hemorrhage|intraventricular hemorrhage
712541|NCT01018576|Anemia in premature infants|anemia in premature infants
712542|NCT01018589|Post surgical scars|post surgical scars
712543|NCT01018589|Epidermic burn|epidermic burn
712544|NCT01018589|Cicatrix cream|cicatrix cream
712545|NCT01018615|chronic hepatitis C|chronic hepatitis c
712546|NCT01018615|silymarin|silymarin
712547|NCT01018615|green tea catechins|green tea catechins
712548|NCT01018615|green tea extract|green tea extract
712549|NCT01018615|pharmacokinetics|pharmacokinetics
712550|NCT01018615|antioxidant activity|antioxidant activity
712551|NCT01018641|Staphylococcus aureus|staphylococcus aureus
712552|NCT01018641|Vaccine|vaccine
712553|NCT01018654|Substance Abuse|substance abuse
712554|NCT01018654|Substance Addiction|substance addiction
712555|NCT01018667|Heart Failure|heart failure
712556|NCT01018667|clinical trial|clinical trial
712557|NCT01018667|biventricular pacing|biventricular pacing
712558|NCT01018667|cardiac device|cardiac device
712559|NCT01018693|Seasonal allergic rhinitis,|seasonal allergic rhinitis,
712560|NCT01018693|late phase response,|late phase response,
712561|NCT01018693|alutard avanz,|alutard avanz,
712562|NCT01018693|immunotherapy,|immunotherapy,
712563|NCT01018693|visual analogue scale,|visual analogue scale,
712564|NCT01018693|mini rhinitis quality of life,|mini rhinitis quality of life,
712565|NCT01018693|immune modulation|immune modulation
712566|NCT01018706|Primary pci|primary pci
712568|NCT01018706|Medical Hystory|medical hystory
712569|NCT01018706|Antiplatelet therapy|antiplatelet therapy
712570|NCT01018706|Compliance|compliance
712571|NCT01018719|breast cancer radiotherapy cardiotoxicity multidetector CT|breast cancer radiotherapy cardiotoxicity multidetector ct
712572|NCT01018719|Radiotherapy|radiotherapy
712573|NCT01018732|Meningococcal|meningococcal
712574|NCT01018732|ACWY|acwy
712575|NCT01018732|Conjugate Vaccine|conjugate vaccine
712576|NCT01018732|Meningitis|meningitis
712577|NCT01018732|Adolescents|adolescents
712578|NCT01018732|Persistence|persistence
712579|NCT01018758|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
712580|NCT01018758|Quality of life|quality of life
712581|NCT01018758|Chemotherapy toxicity|chemotherapy toxicity
712582|NCT01018758|aggressive Non Hodgkin's Lymphomas treated with moderately emetogenic chemotherapy|aggressive non hodgkin's lymphomas treated with moderately emetogenic chemotherapy
712583|NCT01018771|actifuse|actifuse
712584|NCT01018771|INFUSE|infuse
712585|NCT01018771|InductOs|inductos
712586|NCT01018771|DDD|ddd
712587|NCT01018771|Degenerative disc disease|degenerative disc disease
712588|NCT01018771|PLF|plf
712589|NCT01018771|posterolateral lumbar fusion|posterolateral lumbar fusion
712590|NCT01018771|bone substitute|bone substitute
712591|NCT01018771|bone graft|bone graft
712592|NCT01018771|synthetic bone substitute|synthetic bone substitute
712593|NCT01018771|spinal surgery|spinal surgery
712594|NCT01018784|Cancer|cancer
712595|NCT01018784|Mesothelin-positive|mesothelin-positive
712596|NCT01018797|INTRASTROMAL CORNEAL RING|intrastromal corneal ring
712597|NCT01018797|ASTIGMATISM|astigmatism
712598|NCT01018797|POSTKERATOPLASTY|postkeratoplasty
712599|NCT01018797|EYES|eyes
712600|NCT01018797|To evaluate the clinical outcomes of ICRS implantation to correct high-degree astigmatism on eyes with prior penetrating keratoplasty (PK)|to evaluate the clinical outcomes of icrs implantation to correct high-degree astigmatism on eyes with prior penetrating keratoplasty (pk)
712601|NCT01018810|Psoriasis|psoriasis
712602|NCT01018836|tumors metastatic to brain|tumors metastatic to brain
712603|NCT01018836|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
712604|NCT01018849|Vitamin D|vitamin d
712605|NCT01018849|Cardiac Catheterization|cardiac catheterization
712606|NCT01018849|Cardiovascular event|cardiovascular event
712607|NCT01018849|Cardiovascular Disease|cardiovascular disease
712608|NCT01018888|Cornea|cornea
712609|NCT01018888|Transplantation, Cornea|transplantation, cornea
712610|NCT01018888|Keratoplasty|keratoplasty
712611|NCT01018888|Grafting, Corneal|grafting, corneal
712612|NCT01018914|Prograf|prograf
712613|NCT01018914|Advagraf|advagraf
712614|NCT01018914|Myfortic|myfortic
712615|NCT01018927|Cardiac MR (CMR)|cardiac mr (cmr)
712616|NCT01018927|Early Myocardial Infiltration|early myocardial infiltration
712617|NCT01018927|Amyloid|amyloid
712618|NCT01018927|Light Chain Deposition Disease|light chain deposition disease
712619|NCT01018927|Multiple Myeloma|multiple myeloma
712620|NCT01018992|PTSD|ptsd
712621|NCT01018992|Anxiety Disorder|anxiety disorder
712622|NCT01018992|Corticotropin releasing factor|corticotropin releasing factor
712623|NCT01018992|Women|women
712624|NCT01019005|post-operative analgesia|post-operative analgesia
712625|NCT01019005|opioid|opioid
712626|NCT01019005|catheter|catheter
712627|NCT01019005|tibial nerve block|tibial nerve block
712628|NCT01019018|subtenon block|subtenon block
712629|NCT01019044|HIV|hiv
712630|NCT01019044|Viral reservoirs|viral reservoirs
712631|NCT01019044|Viral load|viral load
712632|NCT01019057|DDD|ddd
712633|NCT01019057|decompression|decompression
712634|NCT01019057|spinous process plate|spinous process plate
712635|NCT01019083|Cholera|cholera
712636|NCT01019083|Typhoid|typhoid
712637|NCT01019083|Oral Vaccine|oral vaccine
712638|NCT01019083|Immune response|immune response
712639|NCT01019083|Vaccine Evaluation|vaccine evaluation
712640|NCT01019083|Nutrition|nutrition
712641|NCT01019083|Child Health|child health
712642|NCT01019096|iron|iron
712643|NCT01019096|pregnancy|pregnancy
712644|NCT01019096|heme iron|heme iron
712645|NCT01019096|non-heme iron|non-heme iron
712646|NCT01019096|stable isotopes|stable isotopes
712647|NCT01019096|women/adolescents|women/adolescents
712648|NCT01019109|scoliosis|scoliosis
712649|NCT01019122|cerebral palsy|cerebral palsy
712650|NCT01019122|DEXA scan|dexa scan
712651|NCT01019122|bone density|bone density
712652|NCT01019135|Women|women
712653|NCT01019135|Cardiac Care Facilities|cardiac care facilities
712654|NCT01019135|Patient satisfaction|patient satisfaction
712655|NCT01019135|Patient participation|patient participation
712656|NCT01019135|Patient compliance|patient compliance
712657|NCT01019135|Randomized Control Trial|randomized control trial
712658|NCT01019135|Coronary artery bypass|coronary artery bypass
712659|NCT01019135|Angioplasty, transluminal, percutaneous coronary|angioplasty, transluminal, percutaneous coronary
712660|NCT01019161|Acute Myeloid Leukaemia (AML)|acute myeloid leukaemia (aml)
712661|NCT01019161|AML|aml
712662|NCT01019161|AZD1152|azd1152
712663|NCT01019161|Pharmacokinetics|pharmacokinetics
712664|NCT01019200|psoriasis|psoriasis
712665|NCT01019200|heart disease|heart disease
712666|NCT01019200|cardiovascular disease|cardiovascular disease
712667|NCT01019200|hyperlipidemia|hyperlipidemia
712668|NCT01019213|His-pacing|his-pacing
712669|NCT01019226|myocardium|myocardium
712670|NCT01019226|Magnetic resonance imaging|magnetic resonance imaging
712671|NCT01019239|Non-faeculant|non-faeculant
712672|NCT01019239|Perforated|perforated
712673|NCT01019239|Diverticulitis|diverticulitis
712674|NCT01019252|Adolescent|adolescent
712675|NCT01019252|ADHD|adhd
712676|NCT01019265|Norspan patch|norspan patch
712677|NCT01019265|Buprenorphine transdermal patch (BTDS)|buprenorphine transdermal patch (btds)
712678|NCT01019265|efficacy|efficacy
712679|NCT01019265|buprenorphine|buprenorphine
712680|NCT01019291|Indoor pollutants|indoor pollutants
712681|NCT01019317|Acute Myelogenous Leukemia|acute myelogenous leukemia
712682|NCT01019317|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
712683|NCT01019317|Chronic myeloid leukemia|chronic myeloid leukemia
712684|NCT01019317|CML|cml
712685|NCT01019317|Blast crisis|blast crisis
712686|NCT01019317|Cytarabine|cytarabine
712687|NCT01019317|Ara-C|ara-c
712688|NCT01019317|Cytosar|cytosar
712689|NCT01019317|DepoCyt|depocyt
712690|NCT01019317|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
712691|NCT01019317|Arabinosine Hydrochloride|arabinosine hydrochloride
712692|NCT01019317|Fludarabine|fludarabine
712693|NCT01019317|Fludarabine Phosphate|fludarabine phosphate
712694|NCT01019317|Fludara|fludara
712695|NCT01019317|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
712696|NCT01019317|Mylotarg|mylotarg
712697|NCT01019330|radial vs femoral|radial vs femoral
712698|NCT01019330|radial artery cardiac catheterization|radial artery cardiac catheterization
712699|NCT01019343|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
712700|NCT01019343|Magnetoencephalogram|magnetoencephalogram
712701|NCT01019343|Electroencephalogram (EEG)|electroencephalogram (eeg)
712702|NCT01019343|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
712703|NCT01019343|Motor Deficit|motor deficit
712704|NCT01019343|Dystonia|dystonia
712705|NCT01019343|Movement Disorder|movement disorder
712706|NCT01019343|Parkinson Disease|parkinson disease
712707|NCT01019343|PD|pd
712708|NCT01019343|Tourette Syndrome|tourette syndrome
712709|NCT01019343|TS|ts
712710|NCT01019343|Tic Disorder|tic disorder
712711|NCT01019356|PCOS|pcos
712712|NCT01019369|Contraception|contraception
712713|NCT01019369|Medroxyprogesterone 17-acetate|medroxyprogesterone 17-acetate
712714|NCT01019369|Self administration|self administration
712715|NCT01019382|pancreatic|pancreatic
712716|NCT01019382|carcinoma|carcinoma
712717|NCT01019382|cancer|cancer
712718|NCT01019382|fish|fish
712719|NCT01019382|alternative|alternative
712720|NCT01019395|Gram Positive Infection|gram positive infection
712721|NCT01019395|Concurrent Antibiotic Treatment|concurrent antibiotic treatment
712722|NCT01019408|Clinical Trial|clinical trial
712723|NCT01019408|Chloroquine|chloroquine
712724|NCT01019408|Refugees|refugees
712725|NCT01019408|Afghanistan|afghanistan
712726|NCT01019408|Pakistan|pakistan
712727|NCT01019421|Cognition|cognition
712728|NCT01019434|adult glioblastoma|adult glioblastoma
712729|NCT01019447|Surgical site infection|surgical site infection
712730|NCT01019447|Antimicrobial triclosan-coated polyglactin 910 suture|antimicrobial triclosan-coated polyglactin 910 suture
712731|NCT01019447|Length of hospital stay|length of hospital stay
712732|NCT01019447|SSI|ssi
712733|NCT01019460|Small intestine|small intestine
712734|NCT01019460|Magnetic resonance imaging|magnetic resonance imaging
712735|NCT01019460|Computed tomography scanning|computed tomography scanning
712736|NCT01019460|Capsule endoscopy|capsule endoscopy
712737|NCT01019473|Huntington's disease|huntington's disease
712738|NCT01019473|Chorea|chorea
712739|NCT01019473|Dyskinesia|dyskinesia
712740|NCT01019486|Myocardial blood flow|myocardial blood flow
712741|NCT01019486|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
712742|NCT01019486|Myocardial perfusion imaging|myocardial perfusion imaging
712743|NCT01019486|Coronary artery flow reserve|coronary artery flow reserve
712744|NCT01019486|Regadenoson|regadenoson
712745|NCT01019499|human|human
712746|NCT01019499|intervention|intervention
712747|NCT01019499|blood pressure|blood pressure
712748|NCT01019499|cardiovascular risk factors|cardiovascular risk factors
712749|NCT01019499|polyphenols|polyphenols
712750|NCT01019499|bioavailability|bioavailability
712751|NCT01019525|respiration|respiration
712752|NCT01019525|respiratory disorders|respiratory disorders
712753|NCT01019525|Otolaryngology|otolaryngology
712754|NCT01019525|Otorhinolaryngology|otorhinolaryngology
712755|NCT01019525|Posture|posture
712756|NCT01019538|Oxygen|oxygen
712757|NCT01019538|Hypoxemia|hypoxemia
712758|NCT01019538|Air travel|air travel
712759|NCT01019551|Controlled viremia|controlled viremia
712760|NCT01019551|Viral reservoirs|viral reservoirs
712761|NCT01019551|Virus eradication|virus eradication
712762|NCT01019551|Therapeutic intensification|therapeutic intensification
712763|NCT01019551|Immunointervention|immunointervention
712764|NCT01019603|Acne|acne
712855|NCT01007760|Oxidative stress|oxidative stress
712765|NCT01019629|Fabry, Fabry Disease, Alpha-galactosidase A deficiency, GLA gene, mutations|fabry, fabry disease, alpha-galactosidase a deficiency, gla gene, mutations
712766|NCT01019642|vitamin D|vitamin d
712767|NCT01019642|diabetes|diabetes
712768|NCT01019642|C-reactive protein|c-reactive protein
712769|NCT01019642|insulin resistance|insulin resistance
712770|NCT01019655|thrombophilia|thrombophilia
712771|NCT01019655|pregnancy|pregnancy
712772|NCT01019655|heparin|heparin
712773|NCT01019668|chorioretinopathy|chorioretinopathy
712774|NCT01019668|photodynamic therapy|photodynamic therapy
712775|NCT01019668|reduced fluence|reduced fluence
712776|NCT01019668|reduced dose|reduced dose
712777|NCT01019681|Cord blood injection in peripheral vascular disease|cord blood injection in peripheral vascular disease
712778|NCT01019707|crystal meth|crystal meth
712779|NCT01019707|methamphetamine|methamphetamine
712780|NCT01019707|substance abuse|substance abuse
712781|NCT01019733|Hypoxia|hypoxia
712782|NCT01019733|Ischemia|ischemia
712783|NCT01019733|Brain|brain
712784|NCT01019733|Children|children
712785|NCT01019733|Cerebral Palsy|cerebral palsy
712786|NCT01019746|Hypnosis with propofol|hypnosis with propofol
712787|NCT01019759|Atrial fibrillation|atrial fibrillation
712788|NCT01019759|cardiac surgery|cardiac surgery
712789|NCT01019759|ablation|ablation
712790|NCT01019759|pulmonary veins|pulmonary veins
712791|NCT01019785|Pregnancy rate (pos test, live fetus at 12 weeks, baby home)|pregnancy rate (pos test, live fetus at 12 weeks, baby home)
712792|NCT01019785|Pregnancy complication (Pregnancy hypertension, SGA, diab)|pregnancy complication (pregnancy hypertension, sga, diab)
712793|NCT01019785|Thrombin generation|thrombin generation
712794|NCT01019798|non small cell lung cancer|non small cell lung cancer
712795|NCT01019798|sunitinib|sunitinib
712796|NCT01019798|docetaxel|docetaxel
712797|NCT01019811|Cross-finger flap|cross-finger flap
712798|NCT01019811|finger injuries|finger injuries
712799|NCT01019811|fingertip reconstruction|fingertip reconstruction
712800|NCT01019811|proper digital artery|proper digital artery
712801|NCT01019811|proper digital nerve.|proper digital nerve.
712802|NCT01007552|Biliary Duct Cancer|biliary duct cancer
712803|NCT01007552|Cancer of the Gallbladder|cancer of the gallbladder
712804|NCT01007552|Adenocarcinoma of the Gall Bladder|adenocarcinoma of the gall bladder
712805|NCT01007552|Adenocarcinoma of the Biliary Ducts|adenocarcinoma of the biliary ducts
712806|NCT01007552|Cholangiocarcinoma|cholangiocarcinoma
712807|NCT01007552|Extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
712808|NCT01007565|periarticular injection|periarticular injection
712809|NCT01007578|Paclitaxel|paclitaxel
712810|NCT01007578|Paclitaxel-coated balloon catheters|paclitaxel-coated balloon catheters
712811|NCT01007578|Peripheral arterial occlusive disease (PAOD)|peripheral arterial occlusive disease (paod)
712812|NCT01007578|Plasma levels|plasma levels
712813|NCT01007578|Femoral artery|femoral artery
712814|NCT01007578|Popliteal artery|popliteal artery
712815|NCT01007578|Peripheral arterial disease (PAD) including stenotic or occluded femoro-popliteal arteries due to atherosclerosis|peripheral arterial disease (pad) including stenotic or occluded femoro-popliteal arteries due to atherosclerosis
712816|NCT01007604|claudication|claudication
712817|NCT01007604|pneumatic compression device|pneumatic compression device
712818|NCT01007617|Children|children
712819|NCT01007617|Cancer|cancer
712820|NCT01007617|Mucositis|mucositis
712821|NCT01007617|Laser|laser
712822|NCT01007617|Prevention|prevention
712823|NCT01007617|Chemotherapy|chemotherapy
712824|NCT01007617|Children with malignancies receiving chemotherapy and/or radiotherapy inducing severe mucositis|children with malignancies receiving chemotherapy and/or radiotherapy inducing severe mucositis
712825|NCT01007630|Parkinson's|parkinson's
712826|NCT01007630|Parkinsons|parkinsons
712827|NCT01007630|Parkinson|parkinson
712828|NCT01007630|Parkinson's Disease|parkinson's disease
712829|NCT01007630|PD|pd
712830|NCT01007630|Rasagiline|rasagiline
712831|NCT01007630|Azilect|azilect
712832|NCT01007630|Olfactory|olfactory
712833|NCT01007630|Sense of Smell|sense of smell
712834|NCT01007630|UPSIT|upsit
712835|NCT01007643|anterior knee pain|anterior knee pain
712836|NCT01007643|adolescents|adolescents
712837|NCT01007643|female|female
712838|NCT01007643|interactive video games|interactive video games
712839|NCT01007643|patellofemoral syndrome|patellofemoral syndrome
712840|NCT01007643|treatment|treatment
712841|NCT01007643|compliance|compliance
712842|NCT01007643|home exercises|home exercises
712843|NCT01007656|healthy adult subjects|healthy adult subjects
712844|NCT01007656|safety evaluation|safety evaluation
712845|NCT01007656|GD Antrodia camphorata|gd antrodia camphorata
712846|NCT01007669|Physical activity|physical activity
712847|NCT01007682|intrusive memories|intrusive memories
712848|NCT01007695|breast cancer|breast cancer
712849|NCT01007734|Quality of life|quality of life
712850|NCT01007734|COPD patients|copd patients
712851|NCT01007734|Evaluation According to Gender the Determining Independent Factors of Quality of Life Related to Respiratory Status of Patient With Moderate to Severe COPD|evaluation according to gender the determining independent factors of quality of life related to respiratory status of patient with moderate to severe copd
712852|NCT01007747|Geranium oil|geranium oil
712853|NCT01007747|Neuropathy|neuropathy
712854|NCT01007760|Tobacco smoke|tobacco smoke
712856|NCT01007760|Endothelial Function|endothelial function
712857|NCT01007760|Atherosclerosis|atherosclerosis
712858|NCT01007760|Arterial Stiffness|arterial stiffness
712859|NCT01007760|Microvascular Function|microvascular function
712860|NCT01007773|Dexmedetomidine|dexmedetomidine
712861|NCT01007773|Intracranial Pressure|intracranial pressure
712862|NCT01007773|Traumatic Brain Injury|traumatic brain injury
712863|NCT01007786|Pediatric Hydrocephalus|pediatric hydrocephalus
712864|NCT01007786|Ultrasound Guided Surgery|ultrasound guided surgery
712865|NCT01007838|Progressive Resistance Training/Exercise|progressive resistance training/exercise
712866|NCT01007838|Muscle wasting|muscle wasting
712867|NCT01007838|Chronic Kidney Disease|chronic kidney disease
712868|NCT01007851|GnRH agonist|gnrh agonist
712869|NCT01007851|GnRH antagonist|gnrh antagonist
712870|NCT01007851|IVF|ivf
712871|NCT01007851|ICSI|icsi
712872|NCT01007851|assisted reproduction|assisted reproduction
712873|NCT01007851|luteal phase|luteal phase
712874|NCT01007864|Parkinson|parkinson
712875|NCT01007864|piribedil|piribedil
712876|NCT01007864|vigilance|vigilance
712877|NCT01007864|dopamine agonist|dopamine agonist
712878|NCT01007864|cognition|cognition
712879|NCT01007877|sleepiness|sleepiness
712880|NCT01007877|driving|driving
712881|NCT01007890|ChemoFX|chemofx
712882|NCT01007890|Operable|operable
712883|NCT01007890|Breast|breast
712884|NCT01007890|Cancer|cancer
712885|NCT01007890|Measurable|measurable
712886|NCT01007890|Disease|disease
712887|NCT01007929|ADME|adme
712888|NCT01007929|safety|safety
712889|NCT01007929|oral solution|oral solution
712890|NCT01007942|Metastatic breast cancer|metastatic breast cancer
712891|NCT01007942|locally advanced breast cancer|locally advanced breast cancer
712892|NCT01007942|HER2/neu positive breast cancer|her2/neu positive breast cancer
712893|NCT01007942|HER2/neu over-expressing|her2/neu over-expressing
712894|NCT01007942|progressive-free survival (PFS)|progressive-free survival (pfs)
712895|NCT01007942|over survival (OS)|over survival (os)
712896|NCT01007942|bolero|bolero
712897|NCT01007942|bolero 3|bolero 3
712898|NCT01007942|Breast cancer|breast cancer
712899|NCT01007942|everolimus|everolimus
712900|NCT01007942|HER+|her+
712901|NCT01007942|vinorelbine|vinorelbine
712902|NCT01007942|herceptin|herceptin
712903|NCT01007942|trastuzumab|trastuzumab
712904|NCT01007942|RAD001|rad001
712905|NCT01007968|solid tumors|solid tumors
712906|NCT01007968|hepatic function|hepatic function
712907|NCT01007968|advanced|advanced
712908|NCT01007968|panobinostat|panobinostat
712909|NCT01007994|Nocturnal hypertension|nocturnal hypertension
712910|NCT01007994|Pediatric|pediatric
712911|NCT01007994|Renal Transplant|renal transplant
712912|NCT01007994|Pulse Wave Velocity|pulse wave velocity
712913|NCT01007994|Echocardiogram|echocardiogram
712914|NCT01007994|Pediatric Renal Transplant Recipient|pediatric renal transplant recipient
712915|NCT01008007|Viusid|viusid
712916|NCT01008007|Dietary supplements|dietary supplements
712917|NCT01008007|Acute fever|acute fever
712918|NCT01008007|Viral etiology|viral etiology
712919|NCT01008020|tea catechin extracts|tea catechin extracts
712920|NCT01008020|influenza infection|influenza infection
712921|NCT01008020|prophylaxis|prophylaxis
712922|NCT01008020|supplements|supplements
712923|NCT01008020|adults over 20 years old|adults over 20 years old
712924|NCT01008020|both men and women|both men and women
712925|NCT01008046|Polycystic ovary syndrome|polycystic ovary syndrome
712926|NCT01008046|clomiphene resistance|clomiphene resistance
712927|NCT01008046|metformin|metformin
712928|NCT01008046|N-acetyl cysteine|n-acetyl cysteine
712929|NCT01010893|pandemic|pandemic
712930|NCT01010893|prevention|prevention
712931|NCT01010893|influenza|influenza
712932|NCT01010893|infection|infection
712933|NCT01010893|influenza vaccine|influenza vaccine
712934|NCT01010893|vaccine|vaccine
712935|NCT01010893|influenza in humans|influenza in humans
712936|NCT01010932|carotid or vertebral artery disease|carotid or vertebral artery disease
712937|NCT01010932|Contrast agent|contrast agent
712939|NCT01010945|Advanced Pancreatic Cancer|advanced pancreatic cancer
712940|NCT01010945|erlotinib|erlotinib
712941|NCT01010945|gemcitabine|gemcitabine
712942|NCT01010945|nab-paclitaxel|nab-paclitaxel
712943|NCT01010945|Adenocarcinoma|adenocarcinoma
712944|NCT01010945|Phase 1b|phase 1b
712945|NCT01010971|Mountain Cedar|mountain cedar
712946|NCT01010984|metastatic melanoma|metastatic melanoma
712947|NCT01010984|stage IV melanoma|stage iv melanoma
712948|NCT01010984|metastatic melanoma to the liver|metastatic melanoma to the liver
712949|NCT01010997|AMD, CNV|amd, cnv
712950|NCT01011010|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
712951|NCT01011010|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
712952|NCT01011010|recurrent adult primary liver cancer|recurrent adult primary liver cancer
712953|NCT01011023|Bowel anastomosis|bowel anastomosis
712954|NCT01011023|nasogastric tube|nasogastric tube
712955|NCT01011023|children|children
712956|NCT01011036|healthy study subjects, no disease|healthy study subjects, no disease
712957|NCT01011049|Influenza|influenza
712958|NCT01011049|Fluzone Vaccine|fluzone vaccine
712959|NCT01011049|Intradermal Injections|intradermal injections
712960|NCT01011049|Adults|adults
712961|NCT01011062|Adipose tissue|adipose tissue
712962|NCT01011062|Adipokines|adipokines
712963|NCT01011075|Lung cancer,|lung cancer,
712964|NCT01011075|Non-small cell lung cancer|non-small cell lung cancer
712965|NCT01011075|NSCLC|nsclc
712966|NCT01011075|Metastatic|metastatic
712967|NCT01011075|Gleevec|gleevec
712968|NCT01011075|elderly|elderly
712969|NCT01011088|Paternity|paternity
712970|NCT01011088|Psychology|psychology
712971|NCT01011088|Risk factor|risk factor
712972|NCT01011101|Saccadic Eye Movements|saccadic eye movements
712973|NCT01011101|Schizophrenia|schizophrenia
712974|NCT01011101|Healthy Volunteer|healthy volunteer
712975|NCT01011101|HV|hv
712976|NCT01011114|hypophosphatemia|hypophosphatemia
712977|NCT01011114|hyperparathyroidism|hyperparathyroidism
712978|NCT01011114|renal transplant|renal transplant
712979|NCT01011127|Statins|statins
712980|NCT01011127|Insulin resistance|insulin resistance
712981|NCT01011140|Parenteral Hydration|parenteral hydration
712982|NCT01011140|Latin American Association for Palliative Care|latin american association for palliative care
712983|NCT01011140|ALCP|alcp
712984|NCT01011140|Spanish Society for Palliative Care|spanish society for palliative care
712985|NCT01011140|SECPAL|secpal
712986|NCT01011140|Online survey|online survey
712987|NCT01011140|Palliative care|palliative care
712988|NCT01011140|Physicians' attitudes|physicians' attitudes
712989|NCT01011140|End of life|end of life
712990|NCT01011140|Latin America|latin america
712991|NCT01011140|Spain|spain
712992|NCT01011166|Chronic Hepatitis C|chronic hepatitis c
712993|NCT01011166|HepC|hepc
712994|NCT01011166|Hep C|hep c
712995|NCT01011179|Teens Taking Charge|teens taking charge
712996|NCT01011179|Managing Arthritis Online|managing arthritis online
712997|NCT01011179|juvenile idiopathic arthritis|juvenile idiopathic arthritis
712998|NCT01011179|internet|internet
712999|NCT01011179|self-management|self-management
713000|NCT01011192|Intravenous anesthesia|intravenous anesthesia
713001|NCT01011192|propofol|propofol
713002|NCT01011192|pharmacokinetic model|pharmacokinetic model
713003|NCT01011192|Monitoring|monitoring
713004|NCT01011192|bispectral index.|bispectral index.
713005|NCT01011205|Advagraf|advagraf
713006|NCT01011205|Liver|liver
713007|NCT01011205|Transplant|transplant
713008|NCT01011205|Immunosuppression|immunosuppression
713009|NCT01011218|quality of life|quality of life
713010|NCT01011231|Gamma Knife radiosurgery|gamma knife radiosurgery
713011|NCT01011231|recurrent glioma|recurrent glioma
713012|NCT01011231|MRI|mri
713013|NCT01011231|Spectroscopy|spectroscopy
713014|NCT01011231|Recurrent grade IV glioma (glioblastoma), with two additional exploratory arms for patients with recurrent grade II and grade III gliomas|recurrent grade iv glioma (glioblastoma), with two additional exploratory arms for patients with recurrent grade ii and grade iii gliomas
713015|NCT01011257|CAD|cad
713016|NCT01011270|Back pain|back pain
713017|NCT01011270|postural balance|postural balance
713018|NCT01011270|RDM|rdm
713019|NCT01011270|industrial operators|industrial operators
713020|NCT01011283|MDS|mds
713021|NCT01011283|Myelodysplastic Syndromes|myelodysplastic syndromes
713022|NCT01011309|Leishmaniasis|leishmaniasis
713023|NCT01011309|vaccine|vaccine
713024|NCT01011309|immunotherapy|immunotherapy
713025|NCT01011335|Staphylococcus aureus|staphylococcus aureus
713026|NCT01011335|Skin and soft tissue infection|skin and soft tissue infection
713027|NCT01011335|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
713028|NCT01011335|Recombinant alpha-toxoid (rAT)|recombinant alpha-toxoid (rat)
713029|NCT01011335|Recombinant LukS subunit of Panton-Valentine Leukocidin (rLukS-PV)|recombinant luks subunit of panton-valentine leukocidin (rluks-pv)
713030|NCT01011348|Gulf War Illness|gulf war illness
713031|NCT01011348|Coenzyme Q10|coenzyme q10
713032|NCT01011348|Quality of Life|quality of life
713033|NCT01011348|Fatigue|fatigue
713034|NCT01011348|oxidative stress|oxidative stress
713035|NCT01011374|Retinal vein occlusion|retinal vein occlusion
713036|NCT01011374|Ranibizumab|ranibizumab
713037|NCT01011374|Lucentis|lucentis
713038|NCT01011374|Depression|depression
713039|NCT01011387|Diabetic foot ulcers|diabetic foot ulcers
713040|NCT01011400|clitoris|clitoris
713043|NCT01011413|Efavirenz|efavirenz
713044|NCT01011413|Dose reduction|dose reduction
713045|NCT01011426|laxative|laxative
713046|NCT01011426|postoperative care|postoperative care
713047|NCT01011426|ob-Gyn population|ob-gyn population
713048|NCT01011426|post-operative patients|post-operative patients
713049|NCT01011426|obstetrical and gynecological surgery|obstetrical and gynecological surgery
713050|NCT01011439|B3 and C malignant thymoma|b3 and c malignant thymoma
713051|NCT01011452|Acute Asthma Exacerbation|acute asthma exacerbation
713052|NCT01011452|Montelukast|montelukast
713053|NCT01011452|Management of acute asthma exacerbation|management of acute asthma exacerbation
713054|NCT01011465|Stress|stress
713055|NCT01011465|Oxytocin|oxytocin
713056|NCT01011465|Social Support|social support
713057|NCT01011465|Resilience|resilience
713058|NCT01011478|adenomatous polyp|adenomatous polyp
713059|NCT01011478|stage I colon cancer|stage i colon cancer
713060|NCT01011478|stage II colon cancer|stage ii colon cancer
713061|NCT01011478|adenocarcinoma of the colon|adenocarcinoma of the colon
713062|NCT01011491|Obesity|obesity
713063|NCT01011491|Weight loss|weight loss
713064|NCT01011491|meal replacements|meal replacements
713065|NCT01011491|inflammation|inflammation
713066|NCT01011491|oxidative stress|oxidative stress
713067|NCT01011491|visceral fat|visceral fat
713068|NCT01011517|muscadine grapes|muscadine grapes
713069|NCT01011517|endothelial function|endothelial function
713070|NCT01011530|Melanoma|melanoma
713071|NCT01011543|pulmonary tuberculosis|pulmonary tuberculosis
713072|NCT01011543|negative sputum exam|negative sputum exam
713073|NCT01011543|induced sputum|induced sputum
713074|NCT01011543|endoscopy|endoscopy
713075|NCT01011556|Age Related Osteoporosis|age related osteoporosis
713076|NCT01011556|Senile Osteoporosis|senile osteoporosis
713077|NCT01011569|difference|difference
713078|NCT01011582|To evaluate biomarkers that cause critical illness in patients with novel H1N1 influenza and with seasonal influenza.|to evaluate biomarkers that cause critical illness in patients with novel h1n1 influenza and with seasonal influenza.
713079|NCT01011595|lung cancer|lung cancer
713080|NCT01011595|mediastinoscopy|mediastinoscopy
713081|NCT01011595|mediastinal lymph nodes|mediastinal lymph nodes
713082|NCT01011595|staging|staging
713083|NCT01011595|EBUS|ebus
713084|NCT01011595|EUS|eus
713085|NCT01011595|Endobronchial Ultrasound|endobronchial ultrasound
713086|NCT01011595|Endoscopic Ultrasound|endoscopic ultrasound
713087|NCT01011621|Prednisolone acetate|prednisolone acetate
713088|NCT01011621|Betamethasone valerate|betamethasone valerate
713089|NCT01011634|abortion|abortion
713090|NCT01011634|uterine aspiration|uterine aspiration
713091|NCT01011634|pain control|pain control
713092|NCT01011660|hypertension|hypertension
713093|NCT01011660|cardiovascular risk factors|cardiovascular risk factors
713094|NCT01011660|drugs intervention|drugs intervention
713095|NCT01011660|lipid-lowering therapy|lipid-lowering therapy
713096|NCT01011660|50-79 years of age|50-79 years of age
713097|NCT01011660|sign|sign
713098|NCT01011660|the informed|the informed
713099|NCT01011660|consent|consent
713100|NCT01011660|forms|forms
713101|NCT01011673|headache|headache
713102|NCT01011673|tension-type headache|tension-type headache
713103|NCT01011699|nicotinamide|nicotinamide
713104|NCT01011699|sevelamer hydrochloride|sevelamer hydrochloride
713105|NCT01011699|phosphatemia|phosphatemia
713106|NCT01011699|cinacalcet|cinacalcet
713107|NCT01011699|dyslipidemia|dyslipidemia
713108|NCT01011699|vascular calcification|vascular calcification
713109|NCT01011699|bone mass loss|bone mass loss
713110|NCT01011712|Genetics|genetics
713111|NCT01011712|Virus|virus
713112|NCT01011712|Defense|defense
713113|NCT01011712|Immune Defects|immune defects
713114|NCT01011712|Respiratory Viruses|respiratory viruses
713115|NCT01011712|Herpesvirus|herpesvirus
713116|NCT01011712|Cytomegalovirus|cytomegalovirus
713117|NCT01011712|Human Papillomavirus|human papillomavirus
713118|NCT01011712|Adenovirus|adenovirus
713119|NCT01011751|Drug Therapy|drug therapy
713120|NCT01011764|social networks|social networks
713121|NCT01011764|friendships|friendships
713122|NCT01011764|autism spectrum disorder|autism spectrum disorder
713123|NCT01011777|bladder exstrophy epispadias complex|bladder exstrophy epispadias complex
713124|NCT01011777|urinary incontinence|urinary incontinence
713125|NCT01011777|muscle derive cell therapy|muscle derive cell therapy
713126|NCT01011777|stem cells|stem cells
713127|NCT01011790|Healing Rhythms™|healing rhythms™
713128|NCT01011790|Meditation|meditation
713129|NCT01011790|Biofeedback|biofeedback
713130|NCT01011790|Stress|stress
713131|NCT01011803|Deglutition|deglutition
713132|NCT01011803|Phonation|phonation
713133|NCT01011816|intervertebral disk|intervertebral disk
713134|NCT01011829|methamphetamine|methamphetamine
713135|NCT01011829|crystal meth|crystal meth
713136|NCT01011829|addiction|addiction
713137|NCT01011829|los angeles|los angeles
713138|NCT01011829|medication|medication
713139|NCT01011829|meth|meth
713140|NCT01011881|pleuritis|pleuritis
713141|NCT01011881|empyema|empyema
713142|NCT01011881|procalcitonin|procalcitonin
713143|NCT01011894|Lenalidomide|lenalidomide
713144|NCT01011894|CLL|cll
713145|NCT01011894|09-045|09-045
713146|NCT01011920|newly diagnosed primary central nervous system lymphoma|newly diagnosed primary central nervous system lymphoma
713147|NCT01011972|Dose escalation|dose escalation
713148|NCT01011972|XMT-1107|xmt-1107
713149|NCT01011972|1107|1107
713150|NCT01011972|Tumor|tumor
713151|NCT01011972|Phase 1|phase 1
713152|NCT01011972|Fumagillol|fumagillol
713153|NCT01011972|PHF|phf
713154|NCT01011972|Fleximer|fleximer
713155|NCT01011972|cancer|cancer
713156|NCT01011972|maximum tolerated dose|maximum tolerated dose
713157|NCT01011972|MTD|mtd
713158|NCT01011985|end stage renal disease|end stage renal disease
713159|NCT01011985|inflammation|inflammation
713160|NCT01011985|vascular access|vascular access
713161|NCT01011985|hemodialysis|hemodialysis
713163|NCT01011998|Chronic Myelogenous leukemia|chronic myelogenous leukemia
713164|NCT01011998|INST 0901|inst 0901
713165|NCT01011998|imatinib|imatinib
713166|NCT01011998|valproic acid|valproic acid
713167|NCT01011998|Gleevec|gleevec
713168|NCT01012011|Carcinoma, Hepatocellular|carcinoma, hepatocellular
713169|NCT01012011|Carcinoma, Renal Cell|carcinoma, renal cell
713170|NCT01012050|Asthma|asthma
713171|NCT01012050|status asthmatics|status asthmatics
713172|NCT01012063|iron|iron
713173|NCT01012063|erythropoietin|erythropoietin
713174|NCT01012063|hemoglobin|hemoglobin
713175|NCT01012063|Total knee replacement arthroplasty|total knee replacement arthroplasty
713176|NCT01012076|maternal synchrony|maternal synchrony
713177|NCT01012076|parent-child|parent-child
713178|NCT01012076|parent child play|parent child play
713179|NCT01012076|social communication|social communication
713180|NCT01012089|Hemodialysis|hemodialysis
713181|NCT01012089|Peritoneal dialysis|peritoneal dialysis
713182|NCT01012089|Daptomycin|daptomycin
713183|NCT01012089|Pharmacokinetics|pharmacokinetics
713184|NCT01012102|EMD 640744|emd 640744
713185|NCT01012102|Montanide|montanide
713186|NCT01012102|Advanced solid tumours|advanced solid tumours
713187|NCT01012115|Histones|histones
713188|NCT01012115|organ failure|organ failure
713189|NCT01012115|sepsis|sepsis
713190|NCT01012128|Temporal Artery Thermometer|temporal artery thermometer
713191|NCT01012128|Temperature|temperature
713192|NCT01012128|Preterm Infants|preterm infants
713193|NCT01012167|Schizophrenia, oxytocin, galantamine|schizophrenia, oxytocin, galantamine
713194|NCT01012180|Bipolar Disorder|bipolar disorder
713195|NCT01012180|Adaptation|adaptation
713196|NCT01012180|Parents|parents
713197|NCT01012180|Risk|risk
713198|NCT01012180|Coping|coping
713199|NCT01012180|Survey|survey
713200|NCT01012193|adjunctive cilostazol|adjunctive cilostazol
713201|NCT01012193|high-MD clopidogrel|high-md clopidogrel
713202|NCT01012193|CYP 2C19 polymorphism|cyp 2c19 polymorphism
713203|NCT01012193|high risk patients|high risk patients
713204|NCT01012206|Children|children
713205|NCT01012206|Overweight|overweight
713206|NCT01012206|Obesity|obesity
713207|NCT01012206|Food habits|food habits
713208|NCT01012206|Dietary assessment|dietary assessment
713209|NCT01012206|Physical activity|physical activity
713210|NCT01012232|total knee arthroplasty|total knee arthroplasty
713211|NCT01012232|postoperative pain|postoperative pain
713212|NCT01012245|Xchange|xchange
713213|NCT01012245|Xalatan|xalatan
713214|NCT01012245|Xalacom|xalacom
713215|NCT01012245|Betablocker|betablocker
713216|NCT01012245|observational|observational
713217|NCT01012245|longterm|longterm
713218|NCT01012258|antitumor activity|antitumor activity
713219|NCT01012258|safety|safety
713220|NCT01012258|cetuximab in combination with radiotherapy|cetuximab in combination with radiotherapy
713221|NCT01012258|locally advanced squamous cell head & neck carcinoma|locally advanced squamous cell head & neck carcinoma
713222|NCT01012271|Wrist abnormalities|wrist abnormalities
713223|NCT01012284|Moderate Hepatic Impairment|moderate hepatic impairment
713224|NCT01012284|Tuberculosis|tuberculosis
713225|NCT01012284|TMC207|tmc207
713226|NCT01012284|Mycobacterial adenosine triphosphate (ATP)-synthase|mycobacterial adenosine triphosphate (atp)-synthase
713227|NCT01012310|pharmacokinetics safety tolerability multiple dosing|pharmacokinetics safety tolerability multiple dosing
713228|NCT01012323|PID|pid
713229|NCT01012336|efficacy and safety of Aprepitant/Ramosetron/Dexamethasone in ovary cancer patients with taxol and carboplatin|efficacy and safety of aprepitant/ramosetron/dexamethasone in ovary cancer patients with taxol and carboplatin
713230|NCT01012362|Solid tumor malignancy|solid tumor malignancy
713231|NCT01012362|breast cancer|breast cancer
713232|NCT01012362|lung cancer|lung cancer
713233|NCT01012362|colon cancer|colon cancer
713234|NCT01012362|pancreatic cancer|pancreatic cancer
713235|NCT01012362|head and neck cancer|head and neck cancer
713236|NCT01012362|kidney cancer|kidney cancer
713237|NCT01012362|sarcoma|sarcoma
713238|NCT01012362|hepatocellular cancer|hepatocellular cancer
713239|NCT01012375|Adult ADHD|adult adhd
713240|NCT01012388|Moderate to severe wrinkles and folds such as nasolabial folds|moderate to severe wrinkles and folds such as nasolabial folds
713241|NCT01012401|Lung cancer|lung cancer
713242|NCT01012401|Quality of life|quality of life
713529|NCT01020019|Marinol|marinol
713243|NCT01012401|Communication with physician|communication with physician
713244|NCT01012414|Vitamin D|vitamin d
713245|NCT01012414|Coronary Artery Disease (CAD)|coronary artery disease (cad)
713246|NCT01012414|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
713247|NCT01012427|Kidney|kidney
713248|NCT01012427|Cryoablation|cryoablation
713249|NCT01012427|09-108|09-108
713250|NCT01012453|Hand eczema|hand eczema
713251|NCT01012453|Hand dermatitis|hand dermatitis
713252|NCT01012453|Occupational skin disease|occupational skin disease
713253|NCT01012453|skindisease in health care workers|skindisease in health care workers
713254|NCT01012453|occupational hand dermatitis|occupational hand dermatitis
713255|NCT01012453|occupational hand eczema|occupational hand eczema
713256|NCT01012466|pregnancy|pregnancy
713257|NCT01012466|birth|birth
713260|NCT01012466|catastrophizing|catastrophizing
713261|NCT01012479|Blood Pressure|blood pressure
713262|NCT01012479|Blood Pressure, High|blood pressure, high
713263|NCT01012479|Drug Therapy|drug therapy
713264|NCT01012492|cancer|cancer
713265|NCT01012492|leukemia|leukemia
713266|NCT01012492|transplant|transplant
713267|NCT01012492|bone marrow|bone marrow
713268|NCT01012518|percutaneous tracheostomy|percutaneous tracheostomy
713269|NCT01012518|paratracheal insertion|paratracheal insertion
713270|NCT01012518|tracheal injury|tracheal injury
713271|NCT01012518|transtracheal needle|transtracheal needle
713272|NCT01012518|ventilatory parameters|ventilatory parameters
713273|NCT01012544|clopidogrel|clopidogrel
713274|NCT01012544|pharmacokinetics|pharmacokinetics
713275|NCT01012544|platelet function tests|platelet function tests
713276|NCT01012544|platelet reactivity|platelet reactivity
713277|NCT01012557|H1N1v|h1n1v
713278|NCT01012557|vaccine|vaccine
713279|NCT01012557|pregnant|pregnant
713280|NCT01012557|women|women
713281|NCT01012557|Assess whether the adjuvanted vaccine offers a meaningful benefit in pregnant women in terms of immune response over the non-adjuvanted vaccine.|assess whether the adjuvanted vaccine offers a meaningful benefit in pregnant women in terms of immune response over the non-adjuvanted vaccine.
713282|NCT01012557|Assess the persistence of immune response over a 15 month time period after one single vaccination of the pregnant mother.|assess the persistence of immune response over a 15 month time period after one single vaccination of the pregnant mother.
713283|NCT01012557|Assess whether the immune response to H1N1 in pregnant women is different from that of non-pregnant women of similar age.|assess whether the immune response to h1n1 in pregnant women is different from that of non-pregnant women of similar age.
713284|NCT01012557|Gain insight on safety of the Novartis egg-based MF59 adjuvanted H1N1 vaccine Focetria in pregnant women and their babies.|gain insight on safety of the novartis egg-based mf59 adjuvanted h1n1 vaccine focetria in pregnant women and their babies.
713285|NCT01012557|Assess the maternally transferred specific antibodies against H1N1v in the newborn|assess the maternally transferred specific antibodies against h1n1v in the newborn
713286|NCT01012557|Passive immunity transferred to the infant.|passive immunity transferred to the infant.
713287|NCT01012583|Optical coherence tomography|optical coherence tomography
713288|NCT01012583|Drug eluting stent|drug eluting stent
713289|NCT01012583|Biodegradable polymer|biodegradable polymer
713290|NCT01012583|Intimal|intimal
713291|NCT01012583|Coverage|coverage
713292|NCT01012583|assess intimal hyperplasia of drug eluting stent with biodegradable polymer|assess intimal hyperplasia of drug eluting stent with biodegradable polymer
713293|NCT01012596|Natural Family Planning Methods|natural family planning methods
713294|NCT01012596|Ovulation Detection|ovulation detection
713295|NCT01012596|Cervix Mucus|cervix mucus
713296|NCT01012596|Intention|intention
713297|NCT01012596|Behavior|behavior
713298|NCT01012596|Birth Control|birth control
713299|NCT01012596|Contraception|contraception
713300|NCT01012596|Pregnancy|pregnancy
713301|NCT01012596|Fertility|fertility
713302|NCT01012609|high-grade astrocytomas|high-grade astrocytomas
713303|NCT01012609|newly diagnosed diffuse pontine tumors|newly diagnosed diffuse pontine tumors
713304|NCT01012609|External beam radiation therapy|external beam radiation therapy
713305|NCT01012609|cetuximab|cetuximab
713306|NCT01012609|irinotecan|irinotecan
713307|NCT01012609|POETIC|poetic
713308|NCT01012622|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
713309|NCT01012622|Methylphenidate Hydrochloride|methylphenidate hydrochloride
713310|NCT01012635|spinal cord injury|spinal cord injury
713311|NCT01012635|chronic pain|chronic pain
713312|NCT01012661|Moderate to severe wrinkles and folds such as nasolabial folds|moderate to severe wrinkles and folds such as nasolabial folds
713313|NCT01012674|carotid or vertebral artery disease|carotid or vertebral artery disease
713314|NCT01012674|Contrast agent|contrast agent
713316|NCT01012713|Psoriasis|psoriasis
713317|NCT01012713|Excimer|excimer
713318|NCT01012713|Laser|laser
713319|NCT01012713|Clobex|clobex
713320|NCT01012713|Vectical|vectical
713422|NCT01013220|absenteeism|absenteeism
713321|NCT01012713|clobetasol spray|clobetasol spray
713322|NCT01012713|calcitriol|calcitriol
713323|NCT01012713|Generalized plaque type psoriasis|generalized plaque type psoriasis
713324|NCT01012739|asthma|asthma
713325|NCT01012739|QAB149|qab149
713326|NCT01012739|indacaterol|indacaterol
713327|NCT01012739|pulmonary function|pulmonary function
713328|NCT01012765|COPD|copd
713329|NCT01012765|indacaterol|indacaterol
713330|NCT01012765|QAB149|qab149
713331|NCT01012765|inspiratory capacity|inspiratory capacity
713332|NCT01012778|Performance impairment|performance impairment
713333|NCT01012778|Yoga|yoga
713334|NCT01012778|Meditation|meditation
713335|NCT01012778|Peer mediated|peer mediated
713336|NCT01012791|Zumba exercise|zumba exercise
713337|NCT01012791|ApoE|apoe
713338|NCT01012804|stage IV colon cancer|stage iv colon cancer
713339|NCT01012804|recurrent colon cancer|recurrent colon cancer
713340|NCT01012830|Schizophrenia|schizophrenia
713341|NCT01012830|Cognitive Disorders|cognitive disorders
713342|NCT01012830|Dementia|dementia
713343|NCT01012830|Huperzine A|huperzine a
713344|NCT01012830|HupA|hupa
713345|NCT01012843|Perianal|perianal
713346|NCT01012843|Abscess|abscess
713347|NCT01012843|Fistulae in ano|fistulae in ano
713350|NCT01012856|depressive episode|depressive episode
713351|NCT01012856|psychotherapy|psychotherapy
713352|NCT01012856|cognitive therapy|cognitive therapy
713353|NCT01012856|emotional processing|emotional processing
713354|NCT01012856|RCT|rct
713355|NCT01012856|exposure|exposure
713356|NCT01012856|dual process model|dual process model
713357|NCT01012856|Implicit Association Test|implicit association test
713358|NCT01012856|mechanism of change|mechanism of change
713359|NCT01012869|Coronary chronic total occlusions|coronary chronic total occlusions
713360|NCT01012921|GBR|gbr
713361|NCT01012921|GTR|gtr
713362|NCT01012921|Dental Implant surgery|dental implant surgery
713363|NCT01012947|MMSE|mmse
713364|NCT01012947|activity|activity
713365|NCT01012960|methylnaltrexone|methylnaltrexone
713366|NCT01012960|upper esophageal sphincter|upper esophageal sphincter
713367|NCT01012960|lower esophageal sphincter|lower esophageal sphincter
713368|NCT01012960|high resolution solid state manometry|high resolution solid state manometry
713369|NCT01012960|opioid induced pharyngeal and esophageal dysfunction|opioid induced pharyngeal and esophageal dysfunction
713370|NCT01012973|Macular Edema|macular edema
713371|NCT01012973|Central Retinal Vein Occlusion|central retinal vein occlusion
713372|NCT01012973|CRVO|crvo
713373|NCT01012973|VEGF Trap-Eye|vegf trap-eye
713374|NCT01012973|best-corrected visual acuity|best-corrected visual acuity
713375|NCT01012999|acute pain, intranasal, sufentanil,|acute pain, intranasal, sufentanil,
713376|NCT01012999|Acute pain control with an intranasal opiate|acute pain control with an intranasal opiate
713377|NCT01013012|highly susceptible patients following spine surgery|highly susceptible patients following spine surgery
713378|NCT01013025|prostate cancer|prostate cancer
713379|NCT01013025|implant retrieval|implant retrieval
713380|NCT01013038|myocardial infarction|myocardial infarction
713381|NCT01013038|percutaneous coronary intervention|percutaneous coronary intervention
713382|NCT01013038|thrombus aspiration|thrombus aspiration
713383|NCT01013051|obesity|obesity
713384|NCT01013051|gastric bypass|gastric bypass
713385|NCT01013051|metformin|metformin
713386|NCT01013051|pharmacokinetics|pharmacokinetics
713387|NCT01013051|absorption|absorption
713388|NCT01013064|Erythropoietin|erythropoietin
713389|NCT01013064|Long acting|long acting
713390|NCT01013064|EPO|epo
713391|NCT01013077|functional vision|functional vision
713392|NCT01013077|contrast sensitivity|contrast sensitivity
713393|NCT01013077|aberrometry|aberrometry
713394|NCT01013077|reading ability|reading ability
713395|NCT01013090|Epidural anesthesia|epidural anesthesia
713396|NCT01013090|Spinal anesthesia|spinal anesthesia
713397|NCT01013090|Combined spinal-epidural anesthesia|combined spinal-epidural anesthesia
713398|NCT01013090|Fluid therapy|fluid therapy
713399|NCT01013090|Crystalloid|crystalloid
713400|NCT01013090|Colloid|colloid
713401|NCT01013129|hereditary prostate cancer|hereditary prostate cancer
713402|NCT01013129|prostate cancer|prostate cancer
713403|NCT01013142|COPD|copd
713404|NCT01013168|OncoSorb|oncosorb
713405|NCT01013168|immune apheresis|immune apheresis
713406|NCT01013168|sTNF-R1|stnf-r1
713407|NCT01013168|sTNF-R2|stnf-r2
713408|NCT01013168|sIL-2R|sil-2r
713409|NCT01013168|TNF|tnf
713410|NCT01013181|Immune Thrombopenia|immune thrombopenia
713411|NCT01013181|Thrombocytopenia|thrombocytopenia
713412|NCT01013181|romiplostim|romiplostim
713413|NCT01013181|compassionate program|compassionate program
713414|NCT01013194|Liver cirrhosis|liver cirrhosis
713415|NCT01013194|Fetal stem cells|fetal stem cells
713416|NCT01013194|Stem cell transplantation|stem cell transplantation
713417|NCT01013194|Liver transplant candidate|liver transplant candidate
713418|NCT01013207|CPAP compliance|cpap compliance
713419|NCT01013220|depression|depression
713420|NCT01013220|depression care management|depression care management
713421|NCT01013220|financing|financing
713423|NCT01013220|presenteeism|presenteeism
751874|NCT01171027|Transgastric|transgastric
713424|NCT01013220|employer decisions to purchase health care benefits|employer decisions to purchase health care benefits
713425|NCT01013233|cognitive dysfunction chemotherapy|cognitive dysfunction chemotherapy
713426|NCT01013246|Video games|video games
713427|NCT01013246|Energy balance|energy balance
713428|NCT01013246|Metabolism|metabolism
713429|NCT01013246|Appetite control|appetite control
713430|NCT01013259|E.coli|e.coli
713431|NCT01013259|Mutaflor|mutaflor
713530|NCT01020019|Lofexidine|lofexidine
713432|NCT01013259|grass pollen|grass pollen
713433|NCT01013259|rhinoconjunctivitis|rhinoconjunctivitis
713434|NCT01013259|rhinoconjunctivitis caused by grass pollen|rhinoconjunctivitis caused by grass pollen
713435|NCT01013272|entecavir|entecavir
713436|NCT01013272|lamivudine|lamivudine
713437|NCT01013272|sequential therapy|sequential therapy
713438|NCT01013285|adult giant cell glioblastoma|adult giant cell glioblastoma
713439|NCT01013285|adult gliosarcoma|adult gliosarcoma
713440|NCT01013285|adult glioblastoma|adult glioblastoma
713441|NCT01013298|percutaneous tracheostomy|percutaneous tracheostomy
713442|NCT01013298|paratracheal insertion|paratracheal insertion
713443|NCT01013298|tracheal injury|tracheal injury
713444|NCT01013298|transtracheal needle|transtracheal needle
713445|NCT01013298|ventilatory parameters|ventilatory parameters
713446|NCT01013311|Implantable Cardioverter-Defibrillator (ICD)- pre-existing|implantable cardioverter-defibrillator (icd)- pre-existing
713447|NCT01013324|endometrial cancer|endometrial cancer
713448|NCT01013324|endometrial carcinoma|endometrial carcinoma
713449|NCT01013324|carcinoma of the endometrium|carcinoma of the endometrium
713450|NCT01013324|cancer of the endometrium|cancer of the endometrium
713451|NCT01013350|Multiple Sclerosis|multiple sclerosis
713452|NCT01013350|Cladribine|cladribine
713453|NCT01013350|PREMIERE|premiere
713454|NCT01013350|Observational study|observational study
713455|NCT01013363|abortion|abortion
713456|NCT01013363|first trimester|first trimester
713457|NCT01013363|suction aspiration|suction aspiration
713458|NCT01013363|vacuum aspiration|vacuum aspiration
713459|NCT01013363|music|music
713460|NCT01013363|anesthesia|anesthesia
713461|NCT01013363|analgesia|analgesia
713462|NCT01013363|anxiolytic|anxiolytic
713463|NCT01013363|pain|pain
713464|NCT01013363|anxiety|anxiety
713465|NCT01013363|blood pressure|blood pressure
713466|NCT01013363|heart rate|heart rate
713467|NCT01013363|satisfaction|satisfaction
713468|NCT01019824|nerve compression|nerve compression
713469|NCT01019824|compression radiculopathy|compression radiculopathy
713470|NCT01019824|post-traumatic/post-surgical lumbar radiculopathy|post-traumatic/post-surgical lumbar radiculopathy
713471|NCT01019837|Vaccine|vaccine
713472|NCT01019850|disseminated neuroblastoma|disseminated neuroblastoma
713473|NCT01019850|localized unresectable neuroblastoma|localized unresectable neuroblastoma
713474|NCT01019850|recurrent neuroblastoma|recurrent neuroblastoma
713475|NCT01019850|regional neuroblastoma|regional neuroblastoma
713476|NCT01019876|Bone marrow Failure|bone marrow failure
713477|NCT01019876|Fanconi|fanconi
713478|NCT01019876|SCID|scid
713479|NCT01019889|upper respiratory tract infections|upper respiratory tract infections
713480|NCT01019889|herbal medicine|herbal medicine
713481|NCT01019902|iron|iron
713482|NCT01019902|pregnancy|pregnancy
713483|NCT01019902|adolescents|adolescents
713484|NCT01019902|auditory brainstem responses|auditory brainstem responses
713485|NCT01019902|anemia|anemia
713486|NCT01019902|neonate|neonate
713488|NCT01019915|heart failure|heart failure
713489|NCT01019915|left bundle branch block|left bundle branch block
713490|NCT01019915|skeletal muscle|skeletal muscle
713491|NCT01019915|cytokines|cytokines
713492|NCT01019915|VO2|vo2
713493|NCT01019915|pgc1alpha|pgc1alpha
713494|NCT01019928|GERD|gerd
713495|NCT01019928|patient|patient
713496|NCT01019928|esophagus|esophagus
713497|NCT01019928|pain|pain
713498|NCT01019941|Docetaxel|docetaxel
713499|NCT01019941|CKD-810|ckd-810
713500|NCT01019941|Taxotere inj.|taxotere inj.
713501|NCT01019941|Advanced Solid cancer|advanced solid cancer
713502|NCT01019941|Pharmacokinetic evaluation|pharmacokinetic evaluation
713503|NCT01019954|Adults with premalignant head and neck tumors and adults who have Carcinoma in situ of the head and neck in whom standard therapy is not indicated|adults with premalignant head and neck tumors and adults who have carcinoma in situ of the head and neck in whom standard therapy is not indicated
713504|NCT01019967|Children and Adolescents|children and adolescents
713505|NCT01019967|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
713506|NCT01019967|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
713507|NCT01019967|Autism|autism
713508|NCT01019967|OCD|ocd
713509|NCT01019967|Obsessive Compulsive Disorder|obsessive compulsive disorder
713510|NCT01019980|Antipyretics|antipyretics
713511|NCT01019980|fever|fever
713512|NCT01019980|diclofenac|diclofenac
713513|NCT01019980|acetaminophen|acetaminophen
713514|NCT01019980|children|children
713515|NCT01019980|acute upper respiratory tract infections|acute upper respiratory tract infections
713516|NCT01019993|Thoracotomy|thoracotomy
713517|NCT01019993|one lung ventilation|one lung ventilation
713518|NCT01019993|HFPPV|hfppv
713519|NCT01019993|right ventricular function.|right ventricular function.
713520|NCT01020006|PCI-27483|pci-27483
713521|NCT01020006|Factor VIIa|factor viia
713522|NCT01020006|Gemcitabine|gemcitabine
713523|NCT01020006|4 months life expectancy|4 months life expectancy
713524|NCT01020006|Pharmacyclics|pharmacyclics
713525|NCT01020006|Locally Advanced|locally advanced
713526|NCT01020006|Metastatic disease|metastatic disease
713527|NCT01020019|Cannabis Dependence|cannabis dependence
713528|NCT01020019|Marijuana Dependence|marijuana dependence
713531|NCT01020032|Music therapy|music therapy
713532|NCT01020032|Pain|pain
713533|NCT01020032|Anxiety|anxiety
713534|NCT01020032|Depression|depression
713535|NCT01020032|Controlled randomized trial|controlled randomized trial
713536|NCT01020045|HIV|hiv
713537|NCT01020045|Osteopenia|osteopenia
713538|NCT01020045|Osteoporosis|osteoporosis
713539|NCT01020071|iridotomy|iridotomy
713540|NCT01020071|iridoplasty|iridoplasty
713541|NCT01020071|angle closure glaucoma|angle closure glaucoma
713542|NCT01020084|Saliva|saliva
713543|NCT01020084|Mastication|mastication
713544|NCT01020084|Communication|communication
713545|NCT01020097|Stage 1 squamous cell carcinoma of the larynx|stage 1 squamous cell carcinoma of the larynx
713546|NCT01020110|perfusion chamber|perfusion chamber
713547|NCT01020110|thrombus D-Dimer|thrombus d-dimer
713549|NCT01020123|Type II Diabetes Mellitus|type ii diabetes mellitus
713550|NCT01020123|metformin|metformin
713551|NCT01020123|glipizide|glipizide
713552|NCT01020136|Bioequivalence Pharmacokinetics|bioequivalence pharmacokinetics
713553|NCT01020149|Nerve transsection|nerve transsection
713554|NCT01021384|Depression,|depression,
713555|NCT01021384|Early Intervention,|early intervention,
713556|NCT01021384|Behavior Disorder,|behavior disorder,
713557|NCT01021384|Parenting Skills,|parenting skills,
713558|NCT01021384|Children with Special Health Care Needs,|children with special health care needs,
713559|NCT01021384|Developmental Disabilities,|developmental disabilities,
713560|NCT01021384|Family Support Programs|family support programs
713561|NCT01021397|Respiratory Tract Infection|respiratory tract infection
713562|NCT01021410|acetaminophen|acetaminophen
713563|NCT01021410|paracetamol|paracetamol
713564|NCT01021410|protein adduct|protein adduct
713565|NCT01021410|healthy volunteer|healthy volunteer
713566|NCT01021410|acetaminophen-protein adduct formation|acetaminophen-protein adduct formation
713567|NCT01021423|Mantle Cell Lymphoma|mantle cell lymphoma
713568|NCT01021423|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
713570|NCT01021423|Revlimid|revlimid
713571|NCT01021423|Lenalidomide|lenalidomide
713572|NCT01021436|Pneumonia|pneumonia
713573|NCT01021436|Gram-negative bacteria|gram-negative bacteria
713574|NCT01021449|schizophrenia, BDNF, DNA methylation, histone modification|schizophrenia, bdnf, dna methylation, histone modification
713575|NCT01021475|Functional Dyspepsia, Visceral Manipulation|functional dyspepsia, visceral manipulation
713576|NCT01021488|Thrombosis|thrombosis
713577|NCT01021488|Vein|vein
713578|NCT01021488|Statin|statin
713579|NCT01021488|Prevention|prevention
713580|NCT01021501|nifedipine controlled release tablets|nifedipine controlled release tablets
713581|NCT01021501|hypertensive|hypertensive
713582|NCT01021501|chronic maintenance hemodialysis|chronic maintenance hemodialysis
713583|NCT01021501|Pharmacokinetics|pharmacokinetics
713584|NCT01021514|sRAGE|srage
713585|NCT01021514|SUV|suv
713586|NCT01021514|TBR|tbr
713587|NCT01021514|FDG PET CT|fdg pet ct
713588|NCT01021514|Type 2 DM|type 2 dm
713589|NCT01021540|Nephritis,Nephropathy|nephritis,nephropathy
713590|NCT01021553|Proof of Concept|proof of concept
713591|NCT01021553|Double Blind|double blind
713592|NCT01021566|Opiate addiction|opiate addiction
713593|NCT01021566|Withdrawal symptoms|withdrawal symptoms
713594|NCT01021566|hemoperfusion|hemoperfusion
713595|NCT01021566|hemodialysis|hemodialysis
713596|NCT01021566|methadone|methadone
713597|NCT01021579|Polycystic ovary syndrome|polycystic ovary syndrome
713598|NCT01021579|Metformin|metformin
713599|NCT01021579|Simvastatin|simvastatin
713600|NCT01021592|Velcade|velcade
713601|NCT01021592|QoL|qol
713602|NCT01021592|Proteasome inhibitor|proteasome inhibitor
713603|NCT01021592|Bortezomib|bortezomib
713604|NCT01021592|EORTC QLQ C30|eortc qlq c30
713605|NCT01021592|EQ 5D|eq 5d
713606|NCT01021631|Cardiac surgery|cardiac surgery
713607|NCT01021631|Strategies of transfusion|strategies of transfusion
713608|NCT01021631|Red blood cells|red blood cells
713609|NCT01021631|Liberal|liberal
713610|NCT01021631|Restrictive|restrictive
713611|NCT01021631|Anemia|anemia
713612|NCT01021644|APOE|apoe
713613|NCT01021644|Apolipoprotein E|apolipoprotein e
713614|NCT01021644|Cognition Disorders|cognition disorders
713615|NCT01021644|Neurocognition|neurocognition
713616|NCT01021657|Glaucoma|glaucoma
713617|NCT01021657|Tenon's Capsule|tenon's capsule
713618|NCT01021657|Lipid profile|lipid profile
713619|NCT01021657|Assessment of lipid profile in Tenon's capsule in patients with Glaucoma|assessment of lipid profile in tenon's capsule in patients with glaucoma
713620|NCT01021670|Dapoxetine hydrochloride|dapoxetine hydrochloride
713621|NCT01021670|Priligy|priligy
713622|NCT01021670|Premature ejaculation|premature ejaculation
713623|NCT01021670|Non-dapoxetine hydrochloride treatment(s)|non-dapoxetine hydrochloride treatment(s)
713624|NCT01021683|Hematological neoplasms|hematological neoplasms
713625|NCT01021683|Neutropenia|neutropenia
713626|NCT01021683|Fever|fever
713627|NCT01021683|Itraconazole|itraconazole
713628|NCT01021683|Sporanox|sporanox
713629|NCT01021683|Antifungal prophylaxis|antifungal prophylaxis
713630|NCT01021683|Defeverscence|defeverscence
713631|NCT01021696|Dementia|dementia
713632|NCT01021696|Nursing home|nursing home
713633|NCT01021696|Pain treatment|pain treatment
713634|NCT01021696|Pain assessment|pain assessment
713635|NCT01021696|Agitation|agitation
713636|NCT01021709|depression|depression
713637|NCT01021709|direct current stimulation|direct current stimulation
713638|NCT01021709|extracephalic electrode|extracephalic electrode
713639|NCT01021722|sphincter|sphincter
713640|NCT01021722|obstetric tears|obstetric tears
713641|NCT01021722|long-term follow-up|long-term follow-up
713642|NCT01021735|Rheumatoid|rheumatoid
713643|NCT01021735|Outcome|outcome
713644|NCT01021735|Cost effectiveness|cost effectiveness
713645|NCT01021735|Safety|safety
713646|NCT01021787|Sun Protection|sun protection
713647|NCT01021800|Pancreatic tubular adenocarcinoma adjuvant setting|pancreatic tubular adenocarcinoma adjuvant setting
713648|NCT01021826|knee replacement|knee replacement
713649|NCT01021826|hip replacement|hip replacement
713650|NCT01021826|hyperglycemia|hyperglycemia
713651|NCT01021826|diabetes|diabetes
713652|NCT01021826|osteoarthritis|osteoarthritis
713653|NCT01021839|renal dialysis|renal dialysis
713654|NCT01021839|bioprosthesis|bioprosthesis
713655|NCT01021839|arteriovenous shunt|arteriovenous shunt
713656|NCT01021839|surgical|surgical
713657|NCT01021865|GLP-1|glp-1
713658|NCT01021865|Myocardial contrast echocardiography|myocardial contrast echocardiography
713659|NCT01021865|Myocardial perfusion|myocardial perfusion
713660|NCT01021878|Peritoneal dialysis|peritoneal dialysis
713661|NCT01021878|Renal replacement therapy|renal replacement therapy
713662|NCT01021878|Dialysis solutions|dialysis solutions
713663|NCT01021878|Icodextrin|icodextrin
713664|NCT01021891|Technosphere® Insulin Inhalation Powder|technosphere® insulin inhalation powder
713665|NCT01021904|Primary prevention|primary prevention
713666|NCT01021904|HPV Vaccination|hpv vaccination
713667|NCT01021904|HPV Infection|hpv infection
713668|NCT01021904|Cervical Cancer|cervical cancer
713669|NCT01021904|HPV Related Diseases|hpv related diseases
713670|NCT01021917|Obesity|obesity
713671|NCT01021917|Weight Loss|weight loss
713672|NCT01021917|Meal Replacements|meal replacements
713673|NCT01021930|Optical coherence tomography|optical coherence tomography
713674|NCT01021930|Drug eluting stent|drug eluting stent
713675|NCT01021930|Coronary heart disease|coronary heart disease
713676|NCT01021930|Diabetes mellitus|diabetes mellitus
713677|NCT01021943|calcineurin inhibitors|calcineurin inhibitors
713678|NCT01021943|fibrosis|fibrosis
713679|NCT01021943|spironolactone|spironolactone
713680|NCT01021943|Focus of the study is to assess if aldosterone blockade has an effect on interstitial fibrosis amongst kidney transplant recipients|focus of the study is to assess if aldosterone blockade has an effect on interstitial fibrosis amongst kidney transplant recipients
713681|NCT01021956|Macular Degeneration|macular degeneration
713682|NCT01021956|Age Related Macular Degeneration|age related macular degeneration
713683|NCT01021956|Choroidal Neovascularization|choroidal neovascularization
713686|NCT01021956|WST11|wst11
713687|NCT01021956|Stakel|stakel
713688|NCT01021956|Photodynamic therapy|photodynamic therapy
713689|NCT01021956|Vascular Targeted Photodynamic therapy|vascular targeted photodynamic therapy
713690|NCT01021956|VTP|vtp
713691|NCT01021982|Pupillometer|pupillometer
713692|NCT01021982|Retinitis Pigmentosa|retinitis pigmentosa
713693|NCT01021982|Glaucoma|glaucoma
713694|NCT01021982|Objective perimetry|objective perimetry
713695|NCT01021995|Safety of Echinacea in comparison to placebo|safety of echinacea in comparison to placebo
713696|NCT01022008|Exorbitism|exorbitism
713697|NCT01022008|Upper respiratory airways|upper respiratory airways
713698|NCT01022008|Osteodistraction|osteodistraction
713699|NCT01022008|Polysomnography|polysomnography
713700|NCT01022021|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
713701|NCT01022021|autologous stem cell transplant|autologous stem cell transplant
713702|NCT01022034|Rectal prolapse|rectal prolapse
713703|NCT01022034|mesh|mesh
713704|NCT01022034|recurrence|recurrence
713705|NCT01022060|Dietary supplement|dietary supplement
713706|NCT01022060|Renalof|renalof
713707|NCT01022060|Recurrent calcic urolithiasis|recurrent calcic urolithiasis
713708|NCT01022060|Renal calculi|renal calculi
713709|NCT01022073|Deep Brain Stimulation|deep brain stimulation
713710|NCT01022073|Subthalamic Nucleus|subthalamic nucleus
713711|NCT01022073|Globus Pallidus|globus pallidus
713712|NCT01022073|Parkinson Disease|parkinson disease
713713|NCT01022086|Breast Cancer|breast cancer
713714|NCT01022086|Cardiotoxicity|cardiotoxicity
713715|NCT01022086|Trastuzumab|trastuzumab
713716|NCT01022086|Cardiac MRI|cardiac mri
713717|NCT01022099|Total Knee Arthroplasty|total knee arthroplasty
713718|NCT01022099|Navigation|navigation
713719|NCT01022112|TA-7284|ta-7284
716133|NCT01021189|AZD1446|azd1446
713720|NCT01022112|JNJ-28431754|jnj-28431754
713721|NCT01022112|Canagliflozin|canagliflozin
713722|NCT01022112|Type 2 diabetes mellitus|type 2 diabetes mellitus
713723|NCT01022112|Sodium Glucose Co-transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
713724|NCT01022125|TMC435-TiDP16-C121|tmc435-tidp16-c121
713725|NCT01022125|TMC435-C121|tmc435-c121
713726|NCT01022125|TMC435|tmc435
713727|NCT01022125|TMC435350|tmc435350
713728|NCT01022125|Protease inhibitor|protease inhibitor
713729|NCT01022125|HCV|hcv
713730|NCT01022125|Hepatitis C|hepatitis c
713731|NCT01022138|HER2-negative breast cancer|her2-negative breast cancer
713732|NCT01022138|stage IV breast cancer|stage iv breast cancer
713733|NCT01022138|recurrent breast cancer|recurrent breast cancer
713734|NCT01022151|Aminophylline|aminophylline
713735|NCT01022151|sevoflurane|sevoflurane
713736|NCT01022151|anaesthesia|anaesthesia
713737|NCT01022151|recovery|recovery
713738|NCT01022151|cognitive function|cognitive function
713739|NCT01022151|entropy|entropy
713740|NCT01022164|fibrin glue|fibrin glue
713741|NCT01022164|vitrectomy|vitrectomy
713742|NCT01022164|safety and efficacy of fibrin glue|safety and efficacy of fibrin glue
713743|NCT01022190|Arthroplasty|arthroplasty
713744|NCT01022190|Hip|hip
713745|NCT01022190|Cemented|cemented
713746|NCT01022190|Heterotopic ossification|heterotopic ossification
713747|NCT01022190|Selective Cyclooxygenase-2 Inhibitors|selective cyclooxygenase-2 inhibitors
713748|NCT01022190|Arthroplasty, Replacement|arthroplasty, replacement
713749|NCT01022190|Hip Prosthesis|hip prosthesis
713750|NCT01022190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
713751|NCT01022203|Couples Therapy|couples therapy
713752|NCT01022203|PTSD|ptsd
713753|NCT01022216|Wound|wound
713754|NCT01022216|Skin lesion|skin lesion
713755|NCT01022216|Antimicrobial|antimicrobial
713756|NCT01022216|Bioelectric|bioelectric
713757|NCT01022216|Diabetic foot|diabetic foot
713758|NCT01022216|Pressure Ulcer|pressure ulcer
713759|NCT01022229|Attention Deficit Disorder|attention deficit disorder
713760|NCT01022229|Pediatrics|pediatrics
713761|NCT01022229|Attention|attention
713762|NCT01022229|Impulsivity|impulsivity
713763|NCT01022229|Complementary Therapies|complementary therapies
713764|NCT01022242|Surgical Adhesions|surgical adhesions
713765|NCT01022242|Post-surgical adhesions|post-surgical adhesions
713766|NCT01022242|Flexor tendon|flexor tendon
713767|NCT01022255|autologous vaccine|autologous vaccine
713768|NCT01022255|follicular lymphoma|follicular lymphoma
713769|NCT01022255|magnICON|magnicon
713770|NCT01022255|plant-made vaccines|plant-made vaccines
713771|NCT01022255|immune response|immune response
713772|NCT01022281|Exfoliation|exfoliation
713773|NCT01022281|Scanning Laser Polarimetry|scanning laser polarimetry
713774|NCT01022281|Corneal Thickness|corneal thickness
713775|NCT01022294|children|children
713776|NCT01022294|analgesia|analgesia
713777|NCT01022294|dental treatment|dental treatment
713778|NCT01022294|inhalation|inhalation
713779|NCT01022307|behavioral data acquisition|behavioral data acquisition
713780|NCT01022307|MRI|mri
713781|NCT01022320|OSA|osa
713782|NCT01022320|Blood pressure|blood pressure
713783|NCT01022320|Lateral Pharyngoplasty|lateral pharyngoplasty
713784|NCT01022333|BRCA1|brca1
713785|NCT01022333|breast cancer|breast cancer
713786|NCT01022333|3,3'-di-indolylmethane|3,3'-di-indolylmethane
713787|NCT01022333|dietary intervention|dietary intervention
713788|NCT01022333|estrogen metabolites|estrogen metabolites
713789|NCT01022333|mRNA expression|mrna expression
713790|NCT01022333|BRCA1 protein|brca1 protein
713791|NCT01022333|Estrogen|estrogen
713792|NCT01022346|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
713793|NCT01022346|RO5217790|ro5217790
713794|NCT01022359|haemodialysis|haemodialysis
713795|NCT01022359|vascular access|vascular access
713796|NCT01022359|central venous catheter|central venous catheter
713797|NCT01022398|Vitamin D3|vitamin d3
713798|NCT01022398|HMG-CoA reductase inhibitors (statin)-related myalgias|hmg-coa reductase inhibitors (statin)-related myalgias
713799|NCT01022411|brown rice|brown rice
713800|NCT01022411|white rice|white rice
713801|NCT01022411|diabetes risk|diabetes risk
713802|NCT01022424|ADPKD|adpkd
713803|NCT01022424|Tolvaptan|tolvaptan
713804|NCT01022424|OPC-41061|opc-41061
713805|NCT01022450|rhabdomyolysis|rhabdomyolysis
713806|NCT01022450|myopathy|myopathy
713807|NCT01022450|acute renal failure|acute renal failure
713808|NCT01022450|neuroleptic malignant syndrome|neuroleptic malignant syndrome
713809|NCT01022450|Pharmaceutical Preparations|pharmaceutical preparations
713810|NCT01022450|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
713811|NCT01022450|fibrates|fibrates
713812|NCT01022450|creatine kinase|creatine kinase
713813|NCT01022476|Pharmacokinetics|pharmacokinetics
713814|NCT01022476|Raltegravir|raltegravir
713815|NCT01022476|Immunosuppressive Agents|immunosuppressive agents
713816|NCT01022476|Severe hepatic insufficiency|severe hepatic insufficiency
713817|NCT01022476|Liver Transplantation|liver transplantation
713818|NCT01022476|Additional Keywords|additional keywords
713819|NCT01022476|HIV Infection|hiv infection
713820|NCT01022476|Hepatocarcinoma|hepatocarcinoma
713821|NCT01022476|Hepatitis C|hepatitis c
713822|NCT01022476|Hepatitis B|hepatitis b
713823|NCT01022489|Schizophrenia, auditory hallucinations, TMS|schizophrenia, auditory hallucinations, tms
713824|NCT01022502|psoriasis, indigo naturalis|psoriasis, indigo naturalis
713825|NCT01022515|pheochromocytoma|pheochromocytoma
713826|NCT01022515|paraganglioma|paraganglioma
713827|NCT01022515|hypertension|hypertension
713929|NCT01022970|Eosinophilic esophagitis|eosinophilic esophagitis
713930|NCT01022996|Hodgkin's Lymphoma|hodgkin's lymphoma
713828|NCT01022528|Elective total abdominal hysterectomy (with or without salpingo-oophorectomy or minor bladder repair) or myomectomy|elective total abdominal hysterectomy (with or without salpingo-oophorectomy or minor bladder repair) or myomectomy
713829|NCT01022528|through a lower transverse or low midline incision under general anesthesia|through a lower transverse or low midline incision under general anesthesia
713830|NCT01022580|nitric oxide|nitric oxide
713831|NCT01022580|surfactant|surfactant
713832|NCT01022580|bronchopulmonary dysplasia|bronchopulmonary dysplasia
713833|NCT01022580|BPD|bpd
713834|NCT01022580|prematurity|prematurity
713835|NCT01022580|neonates|neonates
713836|NCT01022580|iNO|ino
713837|NCT01022580|pulmonary outcome|pulmonary outcome
713838|NCT01022580|neurodevelopmental outcome|neurodevelopmental outcome
713839|NCT01022580|Infasurf|infasurf
713840|NCT01022580|lung function|lung function
713841|NCT01022580|Surfactant Dysfunction|surfactant dysfunction
713842|NCT01022619|Sleep apnea|sleep apnea
713843|NCT01022619|high risk pregnancy|high risk pregnancy
713844|NCT01022619|fetal outcome|fetal outcome
713845|NCT01022619|cord blood|cord blood
713846|NCT01022632|Depression|depression
713847|NCT01022645|Intrauterine device|intrauterine device
713848|NCT01022645|Gestational diabetes|gestational diabetes
713849|NCT01022645|Postpartum contraception|postpartum contraception
713850|NCT01022645|Postpartum birth control|postpartum birth control
713851|NCT01022658|Insulin Therapy|insulin therapy
713852|NCT01022658|Vago-sympathetic activity|vago-sympathetic activity
713853|NCT01022658|arterial stiffness|arterial stiffness
713854|NCT01022658|endothelial function|endothelial function
713855|NCT01022671|Belotecan|belotecan
713856|NCT01022671|Camtobell inj|camtobell inj
713857|NCT01022671|NSCLC|nsclc
713858|NCT01022684|atherosclerosis|atherosclerosis
713859|NCT01022684|vascular inflammation|vascular inflammation
713860|NCT01022684|LpPLA2|lppla2
713861|NCT01022684|hsCRP|hscrp
713862|NCT01022684|MCP-1|mcp-1
713863|NCT01022684|18FDG-PET|18fdg-pet
713864|NCT01022710|hearing loss|hearing loss
713865|NCT01022710|otoacoustic emissions|otoacoustic emissions
713866|NCT01022723|Circulating tumor cells|circulating tumor cells
713867|NCT01022723|metastasis|metastasis
713868|NCT01022723|cancer|cancer
713869|NCT01022723|cell isolation|cell isolation
713870|NCT01022723|mircofludics|mircofludics
713871|NCT01022723|cell detection|cell detection
713872|NCT01022736|gabapentin|gabapentin
713873|NCT01022736|pharmacokinetics|pharmacokinetics
713874|NCT01022736|visual analogue pain scale|visual analogue pain scale
713875|NCT01022736|cardiopulmonary bypass|cardiopulmonary bypass
713876|NCT01022749|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
713877|NCT01022749|immunosuppressed or non-immunosuppressed|immunosuppressed or non-immunosuppressed
713878|NCT01022749|influenza vaccine|influenza vaccine
713879|NCT01022749|antibody titers|antibody titers
713880|NCT01022749|seroprotective titers|seroprotective titers
713881|NCT01022749|vaccine-associated adverse events|vaccine-associated adverse events
713882|NCT01022775|Degenerative rotator cuff disease|degenerative rotator cuff disease
713883|NCT01022775|Impingement syndrome|impingement syndrome
713884|NCT01022775|Dynamic humeral centering|dynamic humeral centering
713885|NCT01022775|Randomized clinical trial|randomized clinical trial
713886|NCT01022827|stiff shoulder|stiff shoulder
713887|NCT01022827|massage|massage
713888|NCT01022827|muscle stiffness|muscle stiffness
713889|NCT01022866|falls|falls
713890|NCT01022866|older adults|older adults
713891|NCT01022879|Pain scale of pain|pain scale of pain
713892|NCT01022892|Endovascular|endovascular
713893|NCT01022892|Abdominal|abdominal
713894|NCT01022892|Aortic|aortic
713895|NCT01022892|Aneurysm|aneurysm
713896|NCT01022892|Repair|repair
713897|NCT01022892|Surveillance|surveillance
713898|NCT01022892|EVAR|evar
713899|NCT01022892|CT|ct
713900|NCT01022892|Scan|scan
713901|NCT01022892|Endoleaks|endoleaks
713902|NCT01022892|Contrast|contrast
713903|NCT01022892|Enhanced|enhanced
713904|NCT01022892|Ultrasound|ultrasound
713905|NCT01022892|Definity|definity
713906|NCT01022892|AAA|aaa
713907|NCT01022892|imaging|imaging
713908|NCT01022892|No Endoleaks|no endoleaks
713909|NCT01022905|HIV infection|hiv infection
713910|NCT01022905|transplant|transplant
713911|NCT01022905|rheumatic disease|rheumatic disease
713912|NCT01022905|cancer|cancer
713913|NCT01022905|children|children
713914|NCT01022918|unresectable glioblastoma|unresectable glioblastoma
713915|NCT01022931|Influenza A H1N1|influenza a h1n1
713916|NCT01022931|Children|children
713917|NCT01022931|Epidemiology|epidemiology
713918|NCT01022931|Treatment|treatment
713919|NCT01022931|Oseltamivir|oseltamivir
713920|NCT01022931|Genetics|genetics
713921|NCT01022944|Serous otitis media|serous otitis media
713922|NCT01022944|Biofilm|biofilm
713923|NCT01022944|Adenoidectomy|adenoidectomy
713924|NCT01022944|Chronic otitis media|chronic otitis media
713925|NCT01022957|extra renal damages|extra renal damages
713926|NCT01022970|Esophagitis|esophagitis
713927|NCT01022970|Digestive System Diseases|digestive system diseases
713928|NCT01022970|Esophageal disorder|esophageal disorder
713931|NCT01022996|Hodgkin Lymphoma|hodgkin lymphoma
713932|NCT01022996|Hodgkin's Disease|hodgkin's disease
713933|NCT01022996|Hodgkin Disease|hodgkin disease
713934|NCT01022996|Lymphoma|lymphoma
713935|NCT01022996|Lymphoproliferative Disorders|lymphoproliferative disorders
713936|NCT01022996|Neoplasms by Histological type|neoplasms by histological type
713937|NCT01022996|Lymphatic Diseases|lymphatic diseases
713938|NCT01022996|Hemic and Lymphatic Diseases|hemic and lymphatic diseases
713939|NCT01022996|Recurrent Lymphoma|recurrent lymphoma
713940|NCT01022996|Refractory Lymphoma|refractory lymphoma
713941|NCT01022996|Relapsed Lymphoma|relapsed lymphoma
713942|NCT01022996|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
713943|NCT01022996|Classical Hodgkin's Disease|classical hodgkin's disease
714041|NCT01023373|Renal artery stenosis (RAS)|renal artery stenosis (ras)
713944|NCT01022996|Nodular sclerosing Hodgkin Lymphoma|nodular sclerosing hodgkin lymphoma
713945|NCT01022996|Mixed-cellularity Hodgkin Lymphoma|mixed-cellularity hodgkin lymphoma
713946|NCT01022996|Lymphocyte-rich Hodgkin Lymphoma|lymphocyte-rich hodgkin lymphoma
713947|NCT01022996|Lymphocyte depleted Hodgkin Lymphoma|lymphocyte depleted hodgkin lymphoma
713948|NCT01023009|Occlusion|occlusion
713949|NCT01023009|vitrectomy|vitrectomy
713950|NCT01023009|small gauge vitrectomy|small gauge vitrectomy
713951|NCT01023009|Postoperative occlusion|postoperative occlusion
713952|NCT01023022|CareLink|carelink
713953|NCT01023022|Remote Monitoring|remote monitoring
713954|NCT01023022|Cardiac Pacemaker, Artificial|cardiac pacemaker, artificial
713955|NCT01023022|Implantable Cardioverter-Defibrillators|implantable cardioverter-defibrillators
713956|NCT01023048|preimplantation diagnosis|preimplantation diagnosis
713957|NCT01023074|MS|ms
713958|NCT01023074|CAP|cap
713959|NCT01023100|taste study open label investigational drug oral therapy|taste study open label investigational drug oral therapy
713960|NCT01023113|Diabetic retinopathy|diabetic retinopathy
713961|NCT01023113|laser|laser
713962|NCT01023113|field loss|field loss
713963|NCT01023113|macular edema|macular edema
713964|NCT01023113|Visual field loss|visual field loss
713965|NCT01023126|Obesity|obesity
713966|NCT01023126|Exercise|exercise
713967|NCT01023126|Psychotherapy|psychotherapy
713968|NCT01023139|Adolescent|adolescent
713969|NCT01023139|Obesity|obesity
713970|NCT01023139|Pharmacotherapy|pharmacotherapy
713971|NCT01023139|Sibutramine|sibutramine
713972|NCT01023165|Diabetes Mellitus|diabetes mellitus
713973|NCT01023165|Metabolic Integrity|metabolic integrity
713974|NCT01023165|Intravenous Bolus Insulin|intravenous bolus insulin
713975|NCT01023191|Dialysis|dialysis
713976|NCT01023191|Peritoneal|peritoneal
713977|NCT01023191|Catheter|catheter
713978|NCT01023191|Surgery|surgery
713979|NCT01023217|Chronic hepatitis B|chronic hepatitis b
713980|NCT01023217|lamivudine|lamivudine
713981|NCT01023217|adefovir|adefovir
713982|NCT01023217|entecavir|entecavir
713983|NCT01023230|DV-601|dv-601
713984|NCT01023230|hepatitis B|hepatitis b
713985|NCT01023230|entecavir|entecavir
713986|NCT01023230|therapeutic vaccine|therapeutic vaccine
713987|NCT01023243|foot exam|foot exam
713988|NCT01023243|health services|health services
713989|NCT01023243|practice improvement|practice improvement
713990|NCT01023243|quality|quality
713991|NCT01023243|preventive services|preventive services
713992|NCT01023243|Natural Language Processing|natural language processing
713993|NCT01023256|Rheumatoid arthritis|rheumatoid arthritis
713994|NCT01023256|GM-CSF|gm-csf
713995|NCT01023256|MOR103|mor103
714246|NCT01008306|overweight and obesity|overweight and obesity
713996|NCT01023269|Neurogenic overactive bladder|neurogenic overactive bladder
713997|NCT01023269|Urinary incontinence due to incomplete spinal cord injury|urinary incontinence due to incomplete spinal cord injury
713998|NCT01023269|Neuromodulation|neuromodulation
713999|NCT01023269|Neuromodulation for treatment of neurogenic overactive bladder|neuromodulation for treatment of neurogenic overactive bladder
714000|NCT01023269|Patients with Urge urinary incontinence and detrusor overactivity|patients with urge urinary incontinence and detrusor overactivity
714001|NCT01023282|Parkinson's disease|parkinson's disease
714002|NCT01023282|Levodopa|levodopa
714003|NCT01023282|Dyskinesia|dyskinesia
714004|NCT01023282|ACR325|acr325
714005|NCT01023295|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
714006|NCT01023295|PCV|pcv
714007|NCT01023295|Polypoid|polypoid
714008|NCT01023295|oxigene|oxigene
714009|NCT01023295|VDA|vda
714010|NCT01023295|vascular disrupting agent|vascular disrupting agent
714011|NCT01023295|combretastatin|combretastatin
714012|NCT01023295|fosbretabulin|fosbretabulin
714013|NCT01023308|Myeloma|myeloma
714015|NCT01023308|Bortezomib|bortezomib
714016|NCT01023308|Combination|combination
714017|NCT01023308|Panobinostat|panobinostat
714018|NCT01023308|LBH589D|lbh589d
714019|NCT01023308|relapsed|relapsed
714020|NCT01023308|Velcade®|velcade®
714021|NCT01023321|Safety|safety
714022|NCT01023321|Tolerability|tolerability
714023|NCT01023321|Pharmacokinetics|pharmacokinetics
714024|NCT01023334|Topical analgesia|topical analgesia
714025|NCT01023334|FlACC Pain Scale|flacc pain scale
714026|NCT01023334|intracameral lignocaine|intracameral lignocaine
714027|NCT01023334|Anesthetics|anesthetics
714028|NCT01023334|Physiological Effects of Drugs|physiological effects of drugs
714029|NCT01023334|Lidocaine|lidocaine
714030|NCT01023347|NSCLC|nsclc
714031|NCT01023373|Angioplasty|angioplasty
714032|NCT01023373|Atherosclerotic reno vascular disease (ARVD)|atherosclerotic reno vascular disease (arvd)
714033|NCT01023373|Cardio- and cerebro- vascular comorbidity|cardio- and cerebro- vascular comorbidity
714034|NCT01023373|End stage renal disease (ERSD)|end stage renal disease (ersd)
714035|NCT01023373|kidney diseases|kidney diseases
714036|NCT01023373|High blood pressure|high blood pressure
714037|NCT01023373|Hypertension|hypertension
714038|NCT01023373|Ischemic nephropathy|ischemic nephropathy
714039|NCT01023373|Percutaneous transluminal renal artery stenting (PTRS)|percutaneous transluminal renal artery stenting (ptrs)
714040|NCT01023373|Randomized controlled trials|randomized controlled trials
714042|NCT01023373|Renal insufficiency|renal insufficiency
714043|NCT01023373|Vascular diseases|vascular diseases
714044|NCT01023386|YM155|ym155
714045|NCT01023386|Mass-balance|mass-balance
714046|NCT01023386|Phase I|phase i
714047|NCT01023386|Pharmacokinetics|pharmacokinetics
714048|NCT01023412|Immunonutrition|immunonutrition
714049|NCT01023412|cancer|cancer
714050|NCT01023412|GI cancer surgery|gi cancer surgery
714051|NCT01023425|naive group|naive group
714052|NCT01023425|switching group|switching group
714053|NCT01023425|treatment response|treatment response
714054|NCT01023425|Efficacy|efficacy
714055|NCT01023425|Adverse event|adverse event
714056|NCT01023451|Pulmonary hypertension|pulmonary hypertension
714057|NCT01023451|Sickle cell disease|sickle cell disease
714058|NCT01023451|Pediatric patients|pediatric patients
714059|NCT01023451|Brain Natriuretic Peptide levels|brain natriuretic peptide levels
714060|NCT01023464|tear film break-up time|tear film break-up time
714061|NCT01023477|Carcinoma, Intraductal, Noninfiltrating|carcinoma, intraductal, noninfiltrating
714062|NCT01023477|Ductal Carcinoma In Situ|ductal carcinoma in situ
714063|NCT01023477|DCIS|dcis
714064|NCT01023477|Carcinoma, Intraductal|carcinoma, intraductal
714065|NCT01023477|Breast Cancer|breast cancer
714066|NCT01023477|Breast Tumors|breast tumors
714067|NCT01023477|chloroquine|chloroquine
714068|NCT01023477|autophagy|autophagy
714069|NCT01023477|Autophagic Cell Death|autophagic cell death
714070|NCT01023477|Autophagocytosis|autophagocytosis
714071|NCT01023477|Programmed Cell Death, Type II|programmed cell death, type ii
714072|NCT01023477|Autophagy, Cellular|autophagy, cellular
714073|NCT01023477|Autophagic Programmed Cell Death|autophagic programmed cell death
714074|NCT01023490|back pain|back pain
714075|NCT01023490|hypovitaminosis D|hypovitaminosis d
714076|NCT01023503|Statins|statins
714077|NCT01023503|Dyslipidemia|dyslipidemia
714078|NCT01023503|Spain|spain
714079|NCT01023503|Rosuvastatin|rosuvastatin
714080|NCT01023503|Naive|naive
714081|NCT01023503|Switching|switching
714082|NCT01023503|New statins prescriptions in Spain (naive patients and switching)|new statins prescriptions in spain (naive patients and switching)
714083|NCT01023516|Chronic|chronic
714084|NCT01023516|obstructive|obstructive
714085|NCT01023516|pulmonary|pulmonary
714086|NCT01023516|lung|lung
714087|NCT01023516|respiratory disease|respiratory disease
714088|NCT01023516|efficacy|efficacy
714089|NCT01023516|placebo-controlled|placebo-controlled
714090|NCT01023516|COPD|copd
714091|NCT01023516|FEV1|fev1
714092|NCT01023516|St Georges Respiratory Questionnaire|st georges respiratory questionnaire
714093|NCT01023529|Prostatic Neoplasms|prostatic neoplasms
714094|NCT01023529|Rectal Neoplasms|rectal neoplasms
714095|NCT01023529|Palliative treatment|palliative treatment
714096|NCT01023529|Radiotherapy|radiotherapy
714097|NCT01023529|Quality of life|quality of life
714098|NCT01023542|renal impairment|renal impairment
714099|NCT01023542|MELD>25|meld>25
714100|NCT01023542|Liver transplantation|liver transplantation
714101|NCT01023542|CNI-free|cni-free
714102|NCT01023542|Bottom-Up|bottom-up
714103|NCT01023542|Everolimus|everolimus
714104|NCT01023555|Bacteremia|bacteremia
714105|NCT01023555|Blood Cultures|blood cultures
714106|NCT01023555|Sepsis|sepsis
714107|NCT01023568|intubation|intubation
714108|NCT01023568|pediatric|pediatric
714109|NCT01023568|videolaryngoscope devices|videolaryngoscope devices
714110|NCT01023581|Type 2 Diabetes mellitus|type 2 diabetes mellitus
714111|NCT01023581|Non-insulin dependent diabetes mellitus|non-insulin dependent diabetes mellitus
714112|NCT01023581|Drug Therapy|drug therapy
714113|NCT01023581|Hypoglycemia,|hypoglycemia,
714114|NCT01023581|Hyperglycemia|hyperglycemia
716521|NCT01028976|obesity|obesity
714115|NCT01023594|Pancreatic fistula|pancreatic fistula
714116|NCT01023594|Pancreatic leakage|pancreatic leakage
714117|NCT01023594|Pancreatoduodenectomy|pancreatoduodenectomy
714118|NCT01023594|Pancreatic stent|pancreatic stent
714119|NCT01023607|optical coherence tomography|optical coherence tomography
714120|NCT01023607|intravascular ultrasound|intravascular ultrasound
714121|NCT01023607|Coronary artery disease|coronary artery disease
714122|NCT01023607|Hyperlipidemia|hyperlipidemia
714124|NCT01023620|Lipodystrophy|lipodystrophy
714125|NCT01023620|Lipoatrophy|lipoatrophy
714126|NCT01023620|Lipohypertrophy|lipohypertrophy
714127|NCT01023620|Human Immunodeficiency Virus|human immunodeficiency virus
714128|NCT01023633|to investigate the efficacy and feasibility of this novel treatment strategy in Chinese mCRC patients|to investigate the efficacy and feasibility of this novel treatment strategy in chinese mcrc patients
714129|NCT01023633|Primary Endpoint:DDC|primary endpoint:ddc
714130|NCT01023633|Secondary Endpoint:OS, RR,DCR, PFS,safety|secondary endpoint:os, rr,dcr, pfs,safety
714131|NCT01023646|Glycemic Index|glycemic index
714132|NCT01023646|Glycemic Load|glycemic load
714133|NCT01023646|Glucose|glucose
714134|NCT01023646|Insulin|insulin
714135|NCT01023646|Lipoproteins|lipoproteins
714136|NCT01023646|Free fatty acids|free fatty acids
714137|NCT01023659|Smoking cessation|smoking cessation
714138|NCT01023659|Bupropion|bupropion
714139|NCT01023659|Varenicline|varenicline
714140|NCT01023659|Population-level|population-level
714141|NCT01023659|Mass distribution|mass distribution
714142|NCT01023659|Drug Therapy|drug therapy
714143|NCT01023672|Dementia with Lewy Bodies|dementia with lewy bodies
714144|NCT01023672|hypersomnolence|hypersomnolence
714145|NCT01023672|cognition|cognition
714146|NCT01023672|neuropsychiatric morbidity|neuropsychiatric morbidity
714147|NCT01023672|quality of life|quality of life
714148|NCT01023685|Active immunization|active immunization
714149|NCT01023685|Alzheimer disease|alzheimer disease
714150|NCT01023685|Antibody|antibody
714151|NCT01023685|Central Nervous System diseases|central nervous system diseases
714152|NCT01023685|Neurodegenerative diseases|neurodegenerative diseases
714153|NCT01023685|Vaccine|vaccine
714154|NCT01023698|Diabetic retinopathy|diabetic retinopathy
714155|NCT01023698|Diabetic macular edema|diabetic macular edema
714156|NCT01023698|Panretinal photocoagulation|panretinal photocoagulation
714157|NCT01023711|Influenza|influenza
714158|NCT01023737|Malignant Solid Tumor|malignant solid tumor
714159|NCT01023737|Solid Tumor|solid tumor
714160|NCT01023737|Hydroxychloroquine|hydroxychloroquine
714161|NCT01023737|Vorinostat|vorinostat
714162|NCT01023750|hypertriglyceridemia|hypertriglyceridemia
714163|NCT01023750|Triglycerides|triglycerides
714164|NCT01023750|HDL|hdl
714165|NCT01023750|Insulin resistance|insulin resistance
714166|NCT01023763|Nursing homes|nursing homes
714167|NCT01023763|Intravenous|intravenous
714168|NCT01023763|Treatment|treatment
714169|NCT01023763|Patient trajectory|patient trajectory
714170|NCT01023763|Hospital admissions|hospital admissions
714171|NCT01023776|Swine Flu|swine flu
714172|NCT01023776|H1N1|h1n1
714173|NCT01023789|Drug eluting stent|drug eluting stent
714174|NCT01023789|Stents|stents
714175|NCT01023789|Angioplasty|angioplasty
714176|NCT01023789|Bioabsorbable|bioabsorbable
714177|NCT01023789|Bioresorbable|bioresorbable
714178|NCT01023789|Scaffold|scaffold
714179|NCT01023802|neoadjuvant therapy|neoadjuvant therapy
714180|NCT01023802|chemotherapy|chemotherapy
714181|NCT01023802|hormone therapy|hormone therapy
714182|NCT01023802|breast cancer|breast cancer
714183|NCT01023802|MBI|mbi
714184|NCT01023802|Molecular Breast Imaging|molecular breast imaging
714185|NCT01023815|Immunosuppression|immunosuppression
714186|NCT01023815|renal transplantation|renal transplantation
714187|NCT01023815|once-a-day regimen|once-a-day regimen
714188|NCT01023815|steroid withdrawal|steroid withdrawal
714189|NCT01023815|drug minimization|drug minimization
714190|NCT01023815|immunosuppression for prevention of acute rejections|immunosuppression for prevention of acute rejections
714191|NCT01023828|K-RAS ONCOGENE MUTATION|k-ras oncogene mutation
714192|NCT01023828|NON-SMALL CELL LUNG CANCER|non-small cell lung cancer
714193|NCT01023828|WOOD SMOKE|wood smoke
714194|NCT01023854|Paravertebral block|paravertebral block
714195|NCT01023854|loco regional anesthesia|loco regional anesthesia
714196|NCT01023854|renal surgery|renal surgery
714197|NCT01023854|PCA morphine|pca morphine
714198|NCT01008085|STEMI|stemi
714199|NCT01008085|self-expandable|self-expandable
714200|NCT01008085|balloon-expandable|balloon-expandable
714201|NCT01008098|Posttraumatic Stress Disorder|posttraumatic stress disorder
714202|NCT01008098|Escitalopram|escitalopram
714203|NCT01008098|Magnetic Resonance Imaging|magnetic resonance imaging
714204|NCT01008098|BDNF|bdnf
714205|NCT01008111|regeneration|regeneration
714206|NCT01008111|tissue survival|tissue survival
714207|NCT01008111|biological processes|biological processes
714208|NCT01008111|connective tissue|connective tissue
714209|NCT01008111|tissue|tissue
714315|NCT01008423|Ulcer|ulcer
714210|NCT01008124|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
714211|NCT01008124|BPPV|bppv
714212|NCT01008124|PC|pc
714213|NCT01008124|BPPN|bppn
714214|NCT01008124|Vertigo|vertigo
714215|NCT01008150|breast cancer|breast cancer
714216|NCT01008150|neoadjuvant|neoadjuvant
714217|NCT01008150|neratinib|neratinib
714218|NCT01008150|paclitaxel|paclitaxel
714219|NCT01008150|trastuzumab|trastuzumab
714220|NCT01008150|doxorubicin|doxorubicin
714221|NCT01008150|cyclophosphamide|cyclophosphamide
714222|NCT01008163|diabetes|diabetes
714223|NCT01008176|Hypertension|hypertension
714224|NCT01008176|Sleep|sleep
714225|NCT01008176|Blood Pressure|blood pressure
714226|NCT01008176|Inflammatory Markers|inflammatory markers
714227|NCT01008215|INR Control|inr control
714228|NCT01008215|Warfarin dosing|warfarin dosing
714229|NCT01008215|Family physicians|family physicians
714230|NCT01008215|Cluster randomization|cluster randomization
714231|NCT01008228|spontaneous|spontaneous
714232|NCT01008228|primary|primary
714233|NCT01008228|first episode|first episode
714234|NCT01008241|Hospice|hospice
714235|NCT01008241|End of Life|end of life
714236|NCT01008241|Knowledge|knowledge
714237|NCT01008241|Attitudes|attitudes
714238|NCT01008241|Opinions|opinions
714239|NCT01008241|Advanced Care Planning|advanced care planning
714240|NCT01008241|Death and Dying|death and dying
714241|NCT01008241|Communication|communication
714242|NCT01008241|Knowledge and Attitudes of South Florida Residents on Hospice Care|knowledge and attitudes of south florida residents on hospice care
714243|NCT01008306|Cardiorespiratory fitness|cardiorespiratory fitness
714244|NCT01008306|physical activity|physical activity
714245|NCT01008306|hypertension|hypertension
714247|NCT01008306|metabolic syndrome|metabolic syndrome
714248|NCT01008306|Body composition|body composition
714249|NCT01008319|Anovulation|anovulation
714250|NCT01008319|Ovulation induction|ovulation induction
714251|NCT01008332|House Dust Mite Allergy|house dust mite allergy
714252|NCT01008332|Immunotherapy|immunotherapy
714253|NCT01008332|Rhinoconjunctivitis|rhinoconjunctivitis
714254|NCT01008332|Toleromune HDM|toleromune hdm
714255|NCT01008371|Obesity|obesity
714256|NCT01008371|Cholecystokinin|cholecystokinin
714257|NCT01008371|Oxytocin|oxytocin
714258|NCT01008371|Satiety|satiety
714259|NCT01008371|Gastric emptying|gastric emptying
714260|NCT01008371|Anxiety|anxiety
714261|NCT01008371|Depression|depression
714262|NCT01008371|Panic Disorder|panic disorder
714263|NCT01008397|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
714264|NCT01008410|Proctitis|proctitis
714265|NCT01008410|Proctosigmoiditis|proctosigmoiditis
714266|NCT01008410|Ulcerative|ulcerative
714267|NCT01008410|Salix|salix
714268|NCT01008410|Budesonide foam|budesonide foam
714269|NCT01008410|Budesonide|budesonide
714270|NCT01008410|Rectal|rectal
714271|NCT01008410|Gastrointestinal|gastrointestinal
714272|NCT01008410|Colitis|colitis
714273|NCT01008410|UC|uc
714274|NCT01008410|UP|up
714275|NCT01008410|UPS|ups
714276|NCT01008410|Additional relevant MeSH terms:|additional relevant mesh terms:
714277|NCT01008410|Proctocolitis|proctocolitis
714278|NCT01008410|Ulcer|ulcer
714279|NCT01008410|Colitis, Ulcerative|colitis, ulcerative
714280|NCT01008410|Gastroenteritis|gastroenteritis
714281|NCT01008410|Gastrointestinal Diseases|gastrointestinal diseases
714282|NCT01008410|Digestive System Diseases|digestive system diseases
714283|NCT01008410|Rectal Diseases|rectal diseases
714284|NCT01008410|Intestinal Diseases|intestinal diseases
714285|NCT01008410|Colonic Diseases|colonic diseases
714286|NCT01008410|Sigmoid Diseases|sigmoid diseases
714287|NCT01008410|Pathologic Processes|pathologic processes
714288|NCT01008410|Inflammatory Bowel Diseases|inflammatory bowel diseases
714289|NCT01008410|Bronchodilator Agents|bronchodilator agents
714290|NCT01008410|Autonomic Agents|autonomic agents
714291|NCT01008410|Peripheral Nervous System Agents|peripheral nervous system agents
714292|NCT01008410|Physiological Effects of Drugs|physiological effects of drugs
714293|NCT01008410|Pharmacologic Actions|pharmacologic actions
714294|NCT01008410|Anti-Asthmatic Agents|anti-asthmatic agents
714295|NCT01008410|Respiratory System Agents|respiratory system agents
714296|NCT01008410|Therapeutic Uses|therapeutic uses
714297|NCT01008410|Glucocorticoids|glucocorticoids
714298|NCT01008410|Hormones|hormones
714299|NCT01008410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
714300|NCT01008410|Anti-Inflammatory Agents|anti-inflammatory agents
714301|NCT01008423|Proctitis|proctitis
714302|NCT01008423|Proctosigmoiditis|proctosigmoiditis
714303|NCT01008423|Ulcerative|ulcerative
714304|NCT01008423|Salix|salix
714305|NCT01008423|Budesonide foam|budesonide foam
714306|NCT01008423|Budesonide|budesonide
714307|NCT01008423|Rectal|rectal
714308|NCT01008423|Gastrointestinal|gastrointestinal
714309|NCT01008423|Colitis|colitis
714310|NCT01008423|UC|uc
714311|NCT01008423|UP|up
714312|NCT01008423|UPS|ups
714313|NCT01008423|Additional relevant MeSH terms:|additional relevant mesh terms:
714314|NCT01008423|Proctocolitis|proctocolitis
714316|NCT01008423|Colitis, Ulcerative|colitis, ulcerative
714317|NCT01008423|Gastroenteritis|gastroenteritis
714318|NCT01008423|Gastrointestinal Diseases|gastrointestinal diseases
714319|NCT01008423|Digestive System Diseases|digestive system diseases
714320|NCT01008423|Rectal Diseases|rectal diseases
714321|NCT01008423|Intestinal Diseases|intestinal diseases
714322|NCT01008423|Colonic Diseases|colonic diseases
714323|NCT01008423|Sigmoid Diseases|sigmoid diseases
714324|NCT01008423|Pathologic Processes|pathologic processes
714325|NCT01008423|Inflammatory Bowel Diseases|inflammatory bowel diseases
714326|NCT01008423|Bronchodilator Agents|bronchodilator agents
714327|NCT01008423|Autonomic Agents|autonomic agents
714328|NCT01008423|Peripheral Nervous System Agents|peripheral nervous system agents
714329|NCT01008423|Physiological Effects of Drugs|physiological effects of drugs
714330|NCT01008423|Pharmacologic Actions|pharmacologic actions
714331|NCT01008423|Anti-Asthmatic Agents|anti-asthmatic agents
714332|NCT01008423|Respiratory System Agents|respiratory system agents
714333|NCT01008423|Therapeutic Uses|therapeutic uses
714334|NCT01008423|Glucocorticoids|glucocorticoids
714335|NCT01008423|Hormones|hormones
714336|NCT01008423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
714337|NCT01008423|Anti-Inflammatory Agents|anti-inflammatory agents
714338|NCT01008436|Ability of topical drug to reduce acute and overall bleeding as well as blood transfusions|ability of topical drug to reduce acute and overall bleeding as well as blood transfusions
714339|NCT01008449|Staples|staples
714340|NCT01008449|Sutures|sutures
714341|NCT01008449|Cesarean Delivery|cesarean delivery
714342|NCT01008449|Wound|wound
714343|NCT01008449|Skin Closure|skin closure
714344|NCT01008449|Wound infection|wound infection
714345|NCT01008449|Wound disruption|wound disruption
714346|NCT01008475|EMD 525797|emd 525797
714347|NCT01008475|Cetuximab|cetuximab
714348|NCT01008475|Irinotecan|irinotecan
714349|NCT01008475|metastatic colorectal cancer|metastatic colorectal cancer
714350|NCT01008488|colonic diverticulitis|colonic diverticulitis
714351|NCT01008488|diverticular disease|diverticular disease
714352|NCT01008488|antibiotic therapy|antibiotic therapy
714353|NCT01008501|hydatidiform moles|hydatidiform moles
714354|NCT01008501|complete hydatidiform moles|complete hydatidiform moles
714355|NCT01008501|partial hydatidiform moles|partial hydatidiform moles
714356|NCT01008501|Molar pregnancy|molar pregnancy
714357|NCT01008501|NLRP7|nlrp7
714358|NCT01008501|pregnancy wastage|pregnancy wastage
714359|NCT01008501|imprinting|imprinting
714360|NCT01008501|sporadic hydatidiform moles|sporadic hydatidiform moles
714361|NCT01008501|recurrent hydatidiform moles|recurrent hydatidiform moles
714362|NCT01008514|ductal breast carcinoma in situ|ductal breast carcinoma in situ
714363|NCT01008514|stage IA breast cancer|stage ia breast cancer
714364|NCT01008514|stage IB breast cancer|stage ib breast cancer
714365|NCT01008514|stage II breast cancer|stage ii breast cancer
714366|NCT01008527|skin|skin
714367|NCT01008527|cutaneous|cutaneous
714368|NCT01008527|immunotherapy|immunotherapy
714369|NCT01008527|immunology|immunology
714370|NCT01008527|dose escalation|dose escalation
714371|NCT01008540|cytomegalovirus|cytomegalovirus
714372|NCT01008540|resistance|resistance
714373|NCT01008540|transplantation|transplantation
714374|NCT01008540|Patient coming to an French transplantation center for solid organ or bone marrow transplant, with information and signed consent|patient coming to an french transplantation center for solid organ or bone marrow transplant, with information and signed consent
714375|NCT01008553|Postherpetic Neuralgia|postherpetic neuralgia
714376|NCT01008553|Complex Regional Pain Syndromes (CRPS)|complex regional pain syndromes (crps)
714377|NCT01008553|Postoperative Pain|postoperative pain
714378|NCT01008553|Fentanyl|fentanyl
714379|NCT01008553|Patch, transdermal|patch, transdermal
714380|NCT01008553|Opioid analgesics|opioid analgesics
714381|NCT01008579|Patient Reported Outcome Measures|patient reported outcome measures
714382|NCT01008579|falls|falls
714383|NCT01008579|older adults|older adults
714384|NCT01008592|dermatographism, levocetirizine (Xyzal)|dermatographism, levocetirizine (xyzal)
714385|NCT01008592|chronic idiopathic urticaria, dermatographism|chronic idiopathic urticaria, dermatographism
714386|NCT01008605|Erectile Dysfunction|erectile dysfunction
714387|NCT01008618|Chronic pain|chronic pain
714388|NCT01008618|Osteoarthritis|osteoarthritis
714389|NCT01008618|Low back pain|low back pain
714390|NCT01008618|Fentanyl|fentanyl
714391|NCT01008618|JNS020QD|jns020qd
714392|NCT01008618|Patch, transdermal|patch, transdermal
714393|NCT01008618|Opioid analgesics|opioid analgesics
714394|NCT01008631|renal failure|renal failure
714395|NCT01008631|sodium Thiosulfate|sodium thiosulfate
714396|NCT01008631|pharmakokinetic|pharmakokinetic
714397|NCT01009476|Dementia|dementia
714398|NCT01009476|Galantamine|galantamine
714399|NCT01009476|Cholinesterase inhibitors|cholinesterase inhibitors
714400|NCT01009476|Nootropic agents|nootropic agents
714401|NCT01009476|Alzheimer|alzheimer
714402|NCT01009476|Vascular dementia|vascular dementia
714403|NCT01009476|Cognitive symptoms|cognitive symptoms
714404|NCT01009476|Behavioural symptoms|behavioural symptoms
714405|NCT01009476|Care giving times|care giving times
714406|NCT01009515|metastatic|metastatic
714407|NCT01009515|melanoma|melanoma
714408|NCT01009515|skin cancer|skin cancer
714409|NCT01009515|paclitaxel|paclitaxel
714410|NCT01009515|carboplatin|carboplatin
714411|NCT01009515|temozolomide|temozolomide
714412|NCT01009528|Quality of care|quality of care
714413|NCT01009528|General Practice|general practice
714414|NCT01009528|Electronic Feedback System|electronic feedback system
714415|NCT01009541|pregabalin pharmacokinetics bioavailability bioequivalence|pregabalin pharmacokinetics bioavailability bioequivalence
714416|NCT01009554|Mouthwashes|mouthwashes
714417|NCT01009567|OHSS|ohss
714418|NCT01009593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
714419|NCT01009593|Antineoplastic Agents|antineoplastic agents
714420|NCT01009593|Growth Substances|growth substances
714421|NCT01009593|Physiological Effects of Drugs|physiological effects of drugs
714422|NCT01009593|Enzyme Inhibitors|enzyme inhibitors
714423|NCT01009593|Angiogenesis Inhibitors|angiogenesis inhibitors
714424|NCT01009593|Inhibitors, Angiogenesis|inhibitors, angiogenesis
714425|NCT01009593|Protein Kinase Inhibitors|protein kinase inhibitors
714426|NCT01009593|Pharmacologic Actions|pharmacologic actions
714427|NCT01009593|Growth Inhibitors|growth inhibitors
714428|NCT01009593|Angiogenesis Modulating Agents|angiogenesis modulating agents
714429|NCT01009593|Sorafenib|sorafenib
714430|NCT01009606|Out-of-hospital|out-of-hospital
714431|NCT01009606|Emergency|emergency
714432|NCT01009606|Cardiac arrest|cardiac arrest
714433|NCT01009606|Post-traumatic stress disorder|post-traumatic stress disorder
714434|NCT01009619|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
714530|NCT01009957|Everolimus|everolimus
714435|NCT01009619|Acute allograft Rejection|acute allograft rejection
714436|NCT01009619|Lymphocytic bronchiolitis|lymphocytic bronchiolitis
714437|NCT01009619|Respiratory infection|respiratory infection
714438|NCT01009619|Survival|survival
714439|NCT01009619|Mortality|mortality
714440|NCT01009619|Pulmonary function|pulmonary function
714441|NCT01009619|FEV1|fev1
714442|NCT01009619|Broncho-alveolar lavage|broncho-alveolar lavage
714443|NCT01009619|Neutrophils|neutrophils
714444|NCT01009619|Interleukin|interleukin
714445|NCT01009619|Culture|culture
714446|NCT01009619|Azithromycin|azithromycin
714447|NCT01009645|education|education
714448|NCT01009645|vaccination|vaccination
714449|NCT01009645|preventive service|preventive service
714450|NCT01009645|Prevention & Control|prevention & control
714451|NCT01009658|Gastrointestinal motility|gastrointestinal motility
714452|NCT01009658|Gastroesophageal reflux|gastroesophageal reflux
714453|NCT01009658|Gastric emptying|gastric emptying
714454|NCT01009658|Sodium glutamate|sodium glutamate
714455|NCT01009658|Lower esophageal sphincter|lower esophageal sphincter
714456|NCT01009671|knee osteoarthritis|knee osteoarthritis
714457|NCT01009684|Contraception|contraception
714458|NCT01009684|Estradiol valerate|estradiol valerate
714459|NCT01009723|Preterm delivery|preterm delivery
714460|NCT01009723|preterm labor|preterm labor
714461|NCT01009723|maternal-fetal care|maternal-fetal care
714462|NCT01009723|maternal serum screening biomarkers|maternal serum screening biomarkers
714463|NCT01009723|alphafetoprotein|alphafetoprotein
714464|NCT01009723|AFP|afp
714465|NCT01009723|human chorionic gonadotropin|human chorionic gonadotropin
714466|NCT01009723|hCG|hcg
714467|NCT01009723|unconjugated estriol|unconjugated estriol
714468|NCT01009723|Inhibin A|inhibin a
714469|NCT01009723|pregnancy associated plasma protein|pregnancy associated plasma protein
714470|NCT01009723|PAPP-A|papp-a
714471|NCT01009723|maternal screening|maternal screening
714472|NCT01009736|stage I prostate cancer|stage i prostate cancer
714473|NCT01009736|stage IIB prostate cancer|stage iib prostate cancer
714474|NCT01009736|stage IIA prostate cancer|stage iia prostate cancer
714475|NCT01009736|stage III prostate cancer|stage iii prostate cancer
714476|NCT01009736|stage IV prostate cancer|stage iv prostate cancer
714477|NCT01009749|HAART|haart
714478|NCT01009749|HIV|hiv
714479|NCT01009749|Adherence|adherence
714480|NCT01009762|VACCINE|vaccine
714481|NCT01009762|THERAPY|therapy
714482|NCT01009762|CELLULAR IMMUNITY|cellular immunity
714483|NCT01009762|IMMUNITY|immunity
714484|NCT01009775|Melanoma, Stage III|melanoma, stage iii
714485|NCT01009775|Melanoma, Stage IV|melanoma, stage iv
714486|NCT01009775|YM 155|ym 155
714487|NCT01009775|Metastatic Melanoma|metastatic melanoma
714488|NCT01009788|ABT-888|abt-888
714489|NCT01009788|temozolomide|temozolomide
714490|NCT01009788|TMZ|tmz
714491|NCT01009801|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
714492|NCT01009801|recurrent adult primary liver cancer|recurrent adult primary liver cancer
714493|NCT01009801|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
714494|NCT01009814|HIV, HIV attachment inhibitor, attachment inhibitor|hiv, hiv attachment inhibitor, attachment inhibitor
714495|NCT01009827|Medication adherence|medication adherence
714496|NCT01009827|Substance use|substance use
714497|NCT01009827|Sexual risk behaviors|sexual risk behaviors
714498|NCT01009840|Multiple Myeloma|multiple myeloma
714499|NCT01009840|Bone marrow transplant|bone marrow transplant
714500|NCT01009840|Stem cell transplant|stem cell transplant
714501|NCT01009840|Busulfan|busulfan
714502|NCT01009840|Bortezomib|bortezomib
714503|NCT01009866|Malignant brain tumor|malignant brain tumor
714505|NCT01009866|recurrent brain tumor|recurrent brain tumor
714506|NCT01009866|Supratentorial malignant brain tumor|supratentorial malignant brain tumor
714508|NCT01009866|ependymomas|ependymomas
714509|NCT01009866|Residual, progressive, or recurrent supratentorial malignant brain tumor based on imaging studies with measurable|residual, progressive, or recurrent supratentorial malignant brain tumor based on imaging studies with measurable
714510|NCT01009866|disease (>0.5cm).|disease (>0.5cm).
714511|NCT01009879|rheumatoid arthritis|rheumatoid arthritis
714512|NCT01009879|B lymphocytes|b lymphocytes
714513|NCT01009918|cardiac toxicity|cardiac toxicity
714514|NCT01009918|HER2-positive breast cancer|her2-positive breast cancer
714515|NCT01009918|recurrent breast cancer|recurrent breast cancer
714516|NCT01009918|stage IA breast cancer|stage ia breast cancer
714517|NCT01009918|stage IB breast cancer|stage ib breast cancer
714518|NCT01009918|stage II breast cancer|stage ii breast cancer
714519|NCT01009918|stage IIIA breast cancer|stage iiia breast cancer
714520|NCT01009918|stage IIIB breast cancer|stage iiib breast cancer
714521|NCT01009918|stage IIIC breast cancer|stage iiic breast cancer
714522|NCT01009918|male breast cancer|male breast cancer
714523|NCT01009931|Acute Myelogenous Leukemia|acute myelogenous leukemia
714524|NCT01009931|Relapsed AML|relapsed aml
714525|NCT01009931|Refractory AML|refractory aml
714526|NCT01009944|High blood pressure|high blood pressure
714527|NCT01009957|ADPKD|adpkd
714528|NCT01009957|CKD|ckd
714529|NCT01009957|Renal disease progression|renal disease progression
714531|NCT01009970|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
714532|NCT01009983|triple-negative breast cancer|triple-negative breast cancer
714533|NCT01009996|Coronary bifurcation lesions|coronary bifurcation lesions
714534|NCT01010009|resveratrol|resveratrol
714535|NCT01010009|cerebral blood flow|cerebral blood flow
714536|NCT01010009|NIRS|nirs
714537|NCT01010009|cognitive performance|cognitive performance
714538|NCT01010022|hypovolemia|hypovolemia
714539|NCT01010022|surgical blood loss|surgical blood loss
714540|NCT01010022|orthopedic procedures|orthopedic procedures
714541|NCT01010022|Treatment of reduced circulating blood volume (hypovolemia) including massive hemorrhage|treatment of reduced circulating blood volume (hypovolemia) including massive hemorrhage
714542|NCT01010035|type 2 diabetes mellitus|type 2 diabetes mellitus
714543|NCT01010035|dyslipidemia|dyslipidemia
714544|NCT01010035|kinetics|kinetics
714545|NCT01010048|ESWL|eswl
714546|NCT01010048|urinary calculus|urinary calculus
714547|NCT01010048|drugs treat|drugs treat
714548|NCT01010074|retina, Parkinson's disease, ganglion cell, pupillary|retina, parkinson's disease, ganglion cell, pupillary
714549|NCT01010087|patients admitted to ICU|patients admitted to icu
714550|NCT01010100|Metabolic Disease|metabolic disease
714551|NCT01010100|IGT Impaired Glucose Tolerance|igt impaired glucose tolerance
714552|NCT01010113|infants|infants
714553|NCT01010113|prebiotics|prebiotics
714554|NCT01010113|probiotics|probiotics
714555|NCT01010113|safety|safety
714556|NCT01010165|acute arthritis|acute arthritis
714557|NCT01010165|bacteria|bacteria
714558|NCT01010165|crystal arthritis|crystal arthritis
714559|NCT01010165|proteomic|proteomic
714560|NCT01010165|SELDI-TOF|seldi-tof
714561|NCT01010178|COPD|copd
714562|NCT01010178|Macrolid|macrolid
714563|NCT01010178|reversibility|reversibility
714564|NCT01010178|Theophylline|theophylline
714565|NCT01010178|Corticosteroids|corticosteroids
714566|NCT01010178|symptoms PFT|symptoms pft
714567|NCT01010191|irritable bowel syndrome|irritable bowel syndrome
714568|NCT01010191|no organic digestive disease|no organic digestive disease
714569|NCT01010204|Varenicline|varenicline
714570|NCT01010204|Chantix|chantix
714571|NCT01010204|Smoking|smoking
714572|NCT01010204|Bipolar Disorder|bipolar disorder
714573|NCT01010217|Hematologic Neoplasms|hematologic neoplasms
714574|NCT01010217|Blood Disorders|blood disorders
714575|NCT01010217|Blood Cancer|blood cancer
714576|NCT01010217|Transplantation, Blood And Marrow|transplantation, blood and marrow
714577|NCT01010217|Acute myelogenous leukemia|acute myelogenous leukemia
714578|NCT01010217|Myelodysplastic syndrome|myelodysplastic syndrome
714579|NCT01010217|Acute lymphocytic leukemia|acute lymphocytic leukemia
714580|NCT01010217|Aplastic anemia|aplastic anemia
714581|NCT01010217|Chronic myelogenous leukemia|chronic myelogenous leukemia
714582|NCT01010217|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
714583|NCT01010217|Myeloproliferative disease|myeloproliferative disease
714584|NCT01010217|Hodgkin's disease|hodgkin's disease
714585|NCT01010217|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
714586|NCT01010217|Multiple myeloma|multiple myeloma
714587|NCT01010217|Cyclophosphamide|cyclophosphamide
714588|NCT01010217|Fludarabine|fludarabine
714589|NCT01010217|Melphalan|melphalan
714590|NCT01010217|Mesna|mesna
714591|NCT01010217|Rituximab|rituximab
714592|NCT01010217|Tacrolimus|tacrolimus
714593|NCT01010217|Prograf|prograf
714594|NCT01010217|Mycofenolate mofetil|mycofenolate mofetil
714595|NCT01010217|MMF|mmf
714596|NCT01010217|CellCept|cellcept
714597|NCT01010217|G-CSF|g-csf
714609|NCT01010295|NHL of the ocular adnexae|nhl of the ocular adnexae
714611|NCT01010308|nadolol|nadolol
714612|NCT01010321|skin lesion suspect as BCC or SCC or others|skin lesion suspect as bcc or scc or others
714613|NCT01010334|INST 0813|inst 0813
714614|NCT01010334|Standard of Care|standard of care
714615|NCT01010347|fractures|fractures
714616|NCT01010347|casting|casting
714617|NCT01010347|splinting|splinting
714618|NCT01010347|pediatrics|pediatrics
714619|NCT01010360|celiac ganglia|celiac ganglia
752593|NCT01173263|mechanical ventilator|mechanical ventilator
714620|NCT01010373|Primary Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) induced AML.|primary acute myeloid leukemia (aml) and myelodysplastic syndrome (mds) induced aml.
714621|NCT01010386|Pregnancy|pregnancy
714622|NCT01010386|Infertility|infertility
714623|NCT01010386|Physiologic Oxygen Tension|physiologic oxygen tension
714624|NCT01010386|Atmospheric Oxygen Tension|atmospheric oxygen tension
714625|NCT01010399|HIV|hiv
714626|NCT01010399|triglycerides|triglycerides
714627|NCT01010399|fosamprenavir|fosamprenavir
714628|NCT01010412|Ultrasound|ultrasound
714629|NCT01010412|Nerve blocks|nerve blocks
714630|NCT01010412|Upper extremity|upper extremity
714631|NCT01010438|sleep studies|sleep studies
714632|NCT01010438|sleep apnea|sleep apnea
714633|NCT01010438|OSA|osa
714634|NCT01010438|Referred for sleep studies by a medical professional|referred for sleep studies by a medical professional
714635|NCT01010451|pulpotomy|pulpotomy
714636|NCT01010451|pulpectomy|pulpectomy
714637|NCT01010451|primary teeth|primary teeth
714638|NCT01010451|dental care for children|dental care for children
714639|NCT01010464|Adhesions|adhesions
714640|NCT01010464|Open abdomen|open abdomen
714642|NCT01010477|smoking cessation|smoking cessation
714643|NCT01010477|schizophrenia|schizophrenia
714644|NCT01010477|nicotine nasal spray|nicotine nasal spray
714645|NCT01010477|behavioral counseling|behavioral counseling
714646|NCT01010490|PACHYMETRY|pachymetry
714647|NCT01010490|CELL LOSS|cell loss
714649|NCT01010490|EFFICACY|efficacy
714650|NCT01010490|PHACOEMULSIFICATION|phacoemulsification
714651|NCT01010490|Intraoperative complications|intraoperative complications
714652|NCT01010490|CLOCK TIME|clock time
714653|NCT01010490|FLUID USED|fluid used
714654|NCT01010490|CORNEAL THICKNESS|corneal thickness
714655|NCT01010490|ENDOTHELIUM CELL LOSS|endothelium cell loss
714656|NCT01010529|Occupational Therapy|occupational therapy
714657|NCT01010529|Parkinson's Disease|parkinson's disease
714658|NCT01010529|Feasibility|feasibility
714659|NCT01010529|Effectiveness|effectiveness
714660|NCT01010529|RCT|rct
714661|NCT01010529|Activities of daily living|activities of daily living
714662|NCT01010529|Participation|participation
714663|NCT01010529|Caregiver's Burden|caregiver's burden
714664|NCT01010542|Single dose psoriasis study|single dose psoriasis study
714665|NCT01010568|CLL|cll
714666|NCT01010568|SLL|sll
714667|NCT01010568|Bendamustine|bendamustine
714668|NCT01010568|Ofatumumab|ofatumumab
714669|NCT01010581|Rheumatoid Arthritis|rheumatoid arthritis
714670|NCT01010581|SC12267|sc12267
714671|NCT01010581|4SC-101|4sc-101
714672|NCT01010581|Methotrexate|methotrexate
714673|NCT01010581|Phase II|phase ii
714674|NCT01010620|screening|screening
714675|NCT01010620|research participation|research participation
714676|NCT01010620|substance abuse|substance abuse
714677|NCT01010620|Schizophrenia|schizophrenia
714678|NCT01010620|nicotine|nicotine
714679|NCT01010620|Healthy|healthy
714680|NCT01010620|cigarettes|cigarettes
714681|NCT01010620|smoking|smoking
714682|NCT01010620|marijuana|marijuana
714683|NCT01010620|cocaine|cocaine
714684|NCT01010646|hepatitis C|hepatitis c
714685|NCT01010646|viral kinetics|viral kinetics
714686|NCT01010646|antiviral response|antiviral response
714687|NCT01010646|Genotype 1 or 4|genotype 1 or 4
714688|NCT01010659|Dacryocystorhinostomy|dacryocystorhinostomy
714689|NCT01010685|Natural Orifice Transluminal Endoscopic Surgery (NOTES)|natural orifice transluminal endoscopic surgery (notes)
714690|NCT01010685|Transgastric surgery|transgastric surgery
714691|NCT01010685|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
714692|NCT01010698|cimetidine|cimetidine
714693|NCT01010698|acyclovir|acyclovir
714793|NCT01016444|albuterol|albuterol
714694|NCT01010698|pharmacokinetics|pharmacokinetics
714695|NCT01010698|excipient|excipient
714696|NCT01010698|formulation|formulation
714697|NCT01010711|migraine|migraine
714698|NCT01010711|children|children
714699|NCT01010711|dietary supplement|dietary supplement
714701|NCT01010711|prevention|prevention
714702|NCT01010737|Multimeric|multimeric
714703|NCT01010737|Vaccine|vaccine
714704|NCT01010737|Influenza|influenza
714705|NCT01010737|elderly|elderly
714706|NCT01010737|phase 1/2|phase 1/2
714707|NCT01010737|safety|safety
714708|NCT01010737|efficacy|efficacy
714709|NCT01010737|tolerability|tolerability
714710|NCT01010737|reactogenicity|reactogenicity
714711|NCT01010737|Montanide|montanide
714712|NCT01010737|hemagglutinin inhibition|hemagglutinin inhibition
714713|NCT01010737|HAI|hai
714714|NCT01010737|TIV|tiv
714715|NCT01010750|ADHD|adhd
714716|NCT01010776|Schizophrenia|schizophrenia
714717|NCT01010776|Paliperidone|paliperidone
714718|NCT01010802|Neuroprotection|neuroprotection
714719|NCT01010802|Parkinson Disease|parkinson disease
714720|NCT01010802|Erythropoietin|erythropoietin
714721|NCT01010815|ulcerative colitis|ulcerative colitis
714722|NCT01010815|gut microbiome|gut microbiome
714723|NCT01010815|metagenomics|metagenomics
714724|NCT01010841|Metabolic syndrome|metabolic syndrome
714725|NCT01010841|Serum lipid|serum lipid
714726|NCT01010841|Dietary intervention|dietary intervention
714727|NCT01010841|Lifestyle modification|lifestyle modification
714728|NCT01010841|Glycemic load|glycemic load
714729|NCT01010841|Phytochemical|phytochemical
714730|NCT01010841|Hops|hops
714731|NCT01010841|Acacia|acacia
714732|NCT01010841|Mediterranean diet|mediterranean diet
714733|NCT01010841|Kinase modulator|kinase modulator
714734|NCT01010854|breast cancer|breast cancer
714735|NCT01010854|advanced|advanced
714736|NCT01010854|local|local
714737|NCT01010867|Probiotics|probiotics
714862|NCT01016743|parkinson|parkinson
714738|NCT01010867|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
714739|NCT01010867|Pediatrics|pediatrics
714740|NCT01010880|Multiple Myeloma|multiple myeloma
714741|NCT01010880|CXCR4|cxcr4
714742|NCT01010880|Stem Cells|stem cells
714743|NCT01010880|Mobilization|mobilization
714744|NCT01010880|Transplantation|transplantation
714745|NCT01010880|Chemotherapy|chemotherapy
714746|NCT01016223|Eosinophilic esophagitis|eosinophilic esophagitis
714747|NCT01016223|Beclomethasone|beclomethasone
714748|NCT01016223|Ultrasensitive CRP|ultrasensitive crp
714749|NCT01016249|Bronchiolitis, Viral|bronchiolitis, viral
714750|NCT01016249|An acute inflammation of the upper RESPIRATORY TRACT|an acute inflammation of the upper respiratory tract
714751|NCT01016262|Ulcerative proctitis|ulcerative proctitis
714752|NCT01016262|Proctocolitis|proctocolitis
714753|NCT01016262|Inflammatory Bowel Disease|inflammatory bowel disease
714754|NCT01016262|Gastrointestinal Diseases|gastrointestinal diseases
714755|NCT01016262|Colonic Diseases|colonic diseases
714756|NCT01016262|Mesalamine|mesalamine
714757|NCT01016262|5-ASA|5-asa
714758|NCT01016275|To obtain the first iliac long-term results for a patient cohort treated with nitinol stents only|to obtain the first iliac long-term results for a patient cohort treated with nitinol stents only
714759|NCT01016288|EUS-FNA|eus-fna
714760|NCT01016288|22 Gauge Needle|22 gauge needle
714761|NCT01016288|25 Gauge Needle|25 gauge needle
714762|NCT01016327|Phase I study|phase i study
714763|NCT01016327|Advanced Solid Tumors|advanced solid tumors
714764|NCT01016327|Cdc7 kinase inhibitor|cdc7 kinase inhibitor
714765|NCT01016340|Male Oligoasthenospermia|male oligoasthenospermia
714766|NCT01016340|MCS|mcs
714767|NCT01016353|ABThera|abthera
714768|NCT01016353|Barker's Vacuum Packing Technique|barker's vacuum packing technique
714769|NCT01016366|Friedreich's Ataxia|friedreich's ataxia
714770|NCT01016366|FRDA|frda
714771|NCT01016366|Neurodegenerative|neurodegenerative
714772|NCT01016366|Erythropoietin|erythropoietin
714773|NCT01016366|Carbamylated|carbamylated
714774|NCT01016366|Neuroprotection|neuroprotection
714775|NCT01016366|Frataxin|frataxin
714776|NCT01016379|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
714777|NCT01016379|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
714778|NCT01016392|Observational post-authorization safety study on Kuvan®.|observational post-authorization safety study on kuvan®.
714779|NCT01016405|Dry eye|dry eye
714780|NCT01016405|incidence and severity|incidence and severity
714781|NCT01016405|cataract surgery|cataract surgery
714782|NCT01016418|NASH|nash
714783|NCT01016418|fatty liver disease|fatty liver disease
714784|NCT01016418|colostrum|colostrum
714785|NCT01016431|cardiac pacing|cardiac pacing
714786|NCT01016431|heart failure|heart failure
714787|NCT01016431|oxygen consumption|oxygen consumption
714788|NCT01016431|ventricular dysfunction|ventricular dysfunction
714789|NCT01016431|left, exercise tolerance|left, exercise tolerance
714790|NCT01016431|chronotropic incompetence|chronotropic incompetence
714791|NCT01016431|pacemaker programming|pacemaker programming
714792|NCT01016444|asthma|asthma
714794|NCT01016444|B2AR receptors|b2ar receptors
714795|NCT01016444|Acute asthma responsive and unresponsive to albuterol|acute asthma responsive and unresponsive to albuterol
714796|NCT01016457|Diabetes Mellitus|diabetes mellitus
714797|NCT01016483|MEK inhibitor|mek inhibitor
714798|NCT01016483|cancer|cancer
714799|NCT01016483|pancreatic Adenocarcinoma|pancreatic adenocarcinoma
714800|NCT01016483|metastatic|metastatic
714801|NCT01016483|chemo-naive|chemo-naive
714802|NCT01016483|phase II|phase ii
714803|NCT01016496|Cerebral Palsy|cerebral palsy
714804|NCT01016496|Mirror neurons|mirror neurons
714805|NCT01016496|hemiplegia|hemiplegia
714806|NCT01016496|action observation therapy|action observation therapy
714807|NCT01016496|children affected by hemiplegia as a consequence of Cerebral Palsy|children affected by hemiplegia as a consequence of cerebral palsy
714808|NCT01016509|restenosis|restenosis
714809|NCT01016509|insulin|insulin
714810|NCT01016509|hyperglycemia|hyperglycemia
717199|NCT01032408|HIV-1|hiv-1
714811|NCT01016522|ALS|als
714812|NCT01016522|Ketogenic Diet|ketogenic diet
714813|NCT01016535|Family Health Program|family health program
714814|NCT01016535|Hygiene|hygiene
714815|NCT01016535|Child Health|child health
714816|NCT01016548|Lymphoma|lymphoma
714817|NCT01016548|Multiple myeloma|multiple myeloma
714818|NCT01016548|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
714819|NCT01016548|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
714820|NCT01016548|Influenza Vaccines|influenza vaccines
714821|NCT01016548|Bone Marrow Transplantation|bone marrow transplantation
714822|NCT01016587|symptoms|symptoms
714823|NCT01016587|dyspnea|dyspnea
714824|NCT01016587|pain|pain
714825|NCT01016587|fatigue|fatigue
714826|NCT01016587|anxiety|anxiety
714827|NCT01016587|depression|depression
714828|NCT01016587|sleeplessness|sleeplessness
714829|NCT01016587|genetic markers|genetic markers
714830|NCT01016587|immune markers|immune markers
714831|NCT01016587|COPD|copd
714832|NCT01016587|Quality of Life|quality of life
714833|NCT01016613|chronic kidney disease|chronic kidney disease
714834|NCT01016613|glomerulonephritis|glomerulonephritis
714835|NCT01016613|proteinuria|proteinuria
714836|NCT01016613|nephrotic syndrome|nephrotic syndrome
714837|NCT01016613|nephropathy|nephropathy
714838|NCT01016613|biobank|biobank
714839|NCT01016626|Pharmacokinetics|pharmacokinetics
714840|NCT01016626|Healthy volunteers|healthy volunteers
714841|NCT01016626|Mycophenolate Mofetil|mycophenolate mofetil
714842|NCT01016639|Stomach cancer|stomach cancer
714843|NCT01016639|Gall bladder cancer|gall bladder cancer
714844|NCT01016639|Bile ductus cancer|bile ductus cancer
714845|NCT01016639|Pancreas cancer|pancreas cancer
714846|NCT01016639|Colorectal cancer|colorectal cancer
714847|NCT01016639|Chemo radiotherapy|chemo radiotherapy
714848|NCT01016639|Phase I-II|phase i-ii
714849|NCT01016639|Oxaliplatin|oxaliplatin
714850|NCT01016639|Capecitabine|capecitabine
714851|NCT01016639|Response|response
714852|NCT01016665|Breast cancer|breast cancer
714853|NCT01016665|Short Term|short term
714854|NCT01016665|Homontherapy|homontherapy
714855|NCT01016665|aromatase inhibitor|aromatase inhibitor
714856|NCT01016665|Short term hormonetherapy in breast cancer|short term hormonetherapy in breast cancer
714857|NCT01016717|clopidogrel|clopidogrel
714858|NCT01016717|platelet function|platelet function
714859|NCT01016717|omeprazole|omeprazole
714860|NCT01016717|pantoprazole|pantoprazole
714861|NCT01016717|coronary disease|coronary disease
714863|NCT01016743|rTMS|rtms
714864|NCT01016756|PHACE syndrome|phace syndrome
714865|NCT01016756|Hemangioma|hemangioma
714866|NCT01016756|Coarctation of aorta|coarctation of aorta
714867|NCT01016756|Dandy Walker|dandy walker
714868|NCT01016756|Brain malformation|brain malformation
714869|NCT01016756|Eye anomaly|eye anomaly
714870|NCT01016756|Sternal malformation|sternal malformation
714871|NCT01016756|Genetic analysis|genetic analysis
714872|NCT01016756|Cerebral artery anomaly|cerebral artery anomaly
714873|NCT01016769|Paclitaxel|paclitaxel
714874|NCT01016769|Carboplatin|carboplatin
714875|NCT01016769|Temsirolimus|temsirolimus
714876|NCT01016769|Head and Neck|head and neck
714877|NCT01016769|recurrent and/or metastatic|recurrent and/or metastatic
714878|NCT01016769|09-131|09-131
714879|NCT01016782|Inflammatory Rosacea|inflammatory rosacea
714880|NCT01016782|Rosacea|rosacea
714881|NCT01016795|SCF|scf
714882|NCT01016795|Priming|priming
714883|NCT01016795|Mobilization|mobilization
714884|NCT01016795|Lymphoma|lymphoma
714885|NCT01016795|Clinical Trial|clinical trial
714886|NCT01016808|Bunionectomy|bunionectomy
714887|NCT01016808|Opioids|opioids
714888|NCT01016821|Oxycodone|oxycodone
714889|NCT01016821|Labour pain|labour pain
714890|NCT01016821|Pregnancy|pregnancy
714891|NCT01016821|Pregnant women|pregnant women
714892|NCT01016834|migraine|migraine
714893|NCT01016834|treatment satisfaction|treatment satisfaction
714894|NCT01016860|OSI-906, irinotecan, colorectal cancer|osi-906, irinotecan, colorectal cancer
714895|NCT01016873|Oraya|oraya
714896|NCT01016873|Oraya Therapeutics, Inc.|oraya therapeutics, inc.
714897|NCT01016873|low voltage stereotactic radiotherapy|low voltage stereotactic radiotherapy
714898|NCT01016873|radiotherapy|radiotherapy
714899|NCT01016873|IRay|iray
714900|NCT01016873|Ranibizumab|ranibizumab
714901|NCT01016873|Lucentis|lucentis
714902|NCT01016873|AMD|amd
714903|NCT01016873|Macular Degeneration|macular degeneration
714904|NCT01016873|xray|xray
714905|NCT01016873|radiation|radiation
714906|NCT01016873|x ray|x ray
714907|NCT01016873|external beam radiation|external beam radiation
714908|NCT01016873|radiosurgery|radiosurgery
714909|NCT01016886|trastuzumab|trastuzumab
714910|NCT01016886|cardiac MRI|cardiac mri
714911|NCT01016886|beta-blocker|beta-blocker
714912|NCT01016886|biomarkers|biomarkers
714913|NCT01016886|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
714914|NCT01016886|cardiotoxicity|cardiotoxicity
714915|NCT01016886|HER2 positive|her2 positive
714916|NCT01016899|Electronic|electronic
714917|NCT01016899|Brachytherapy|brachytherapy
714918|NCT01016899|Nonmelanoma|nonmelanoma
714920|NCT01016925|femoral perineural catheter|femoral perineural catheter
714921|NCT01016925|tunnelization|tunnelization
714922|NCT01016925|complication|complication
714923|NCT01016925|colonization|colonization
714924|NCT01016925|infection|infection
714925|NCT01016951|Phase I|phase i
714926|NCT01016951|Safety study|safety study
714927|NCT01016951|AZD9164|azd9164
714928|NCT01016964|Androgenetic Alopecia|androgenetic alopecia
714929|NCT01016964|Hair Loss|hair loss
714930|NCT01016964|Female Pattern Baldness|female pattern baldness
714931|NCT01016990|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
714932|NCT01016990|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
715024|NCT01024075|Chronic Rhinosinusitis|chronic rhinosinusitis
714933|NCT01016990|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
714934|NCT01016990|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
714935|NCT01016990|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
714936|NCT01016990|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
714937|NCT01016990|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
714938|NCT01016990|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
714939|NCT01016990|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
714940|NCT01016990|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
714941|NCT01016990|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
714942|NCT01016990|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
714943|NCT01016990|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
715135|NCT01024959|PCA3|pca3
714944|NCT01016990|peripheral T-cell lymphoma|peripheral t-cell lymphoma
714945|NCT01016990|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
714946|NCT01016990|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
714947|NCT01016990|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
714948|NCT01016990|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
714949|NCT01016990|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
714950|NCT01016990|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
714951|NCT01016990|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
714952|NCT01016990|Waldenström macroglobulinemia|waldenström macroglobulinemia
714953|NCT01017003|healthy|healthy
714954|NCT01017003|pharmacokinetics|pharmacokinetics
714955|NCT01017042|healthy|healthy
714956|NCT01017042|blood levels|blood levels
714957|NCT01017068|GLAUCOMA|glaucoma
714958|NCT01017081|physiotherapy|physiotherapy
714959|NCT01017081|children|children
714960|NCT01017081|clinical trial|clinical trial
714961|NCT01017094|Pin-site infection|pin-site infection
714962|NCT01017094|silversulfadiazine|silversulfadiazine
714963|NCT01017094|open fracture|open fracture
714964|NCT01017094|open tibial fracture underwent external fixator|open tibial fracture underwent external fixator
714965|NCT01017107|acute pancreatitis|acute pancreatitis
714966|NCT01017107|treatment|treatment
714967|NCT01017107|organ failure|organ failure
714968|NCT01017107|activated protein c|activated protein c
714969|NCT01017120|Acne|acne
714970|NCT01017146|Ance|ance
714971|NCT01017159|Polyradiculoneuropathy, Chronic Inflammatory Demyelinating|polyradiculoneuropathy, chronic inflammatory demyelinating
714972|NCT01017159|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
714973|NCT01017211|Pain|pain
714974|NCT01017211|Electromyography|electromyography
714975|NCT01017211|Acupuncture|acupuncture
714976|NCT01017211|Randomized controlled trial|randomized controlled trial
714977|NCT01017211|Rehabilitation|rehabilitation
714978|NCT01017237|Dexmedetomidine sedation|dexmedetomidine sedation
714979|NCT01017237|Oral surgery sedation|oral surgery sedation
714980|NCT01017237|Dexmedetomidine amnesia|dexmedetomidine amnesia
714981|NCT01017250|Recurrent|recurrent
714982|NCT01017263|ADHD|adhd
714983|NCT01017263|Glucose Intolerance|glucose intolerance
714984|NCT01017263|Obesity|obesity
714986|NCT01017276|Hyperphosphatemia|hyperphosphatemia
714987|NCT01017276|Peritoneal dialysis|peritoneal dialysis
714988|NCT01017276|CKD|ckd
714989|NCT01017276|ASP1585|asp1585
714990|NCT01023867|Alzheimer's disease|alzheimer's disease
714991|NCT01023867|Mixed Dementia|mixed dementia
714992|NCT01023867|Donepezil|donepezil
714993|NCT01023867|Efficacy|efficacy
714994|NCT01023867|Adverse Event|adverse event
714995|NCT01023906|Taste|taste
714996|NCT01023906|general Labeled Magnitude Scale|general labeled magnitude scale
714997|NCT01023906|Aging|aging
714998|NCT01023906|Chronic Disease Risk|chronic disease risk
714999|NCT01023906|Smell|smell
715000|NCT01023919|Optical coherence tomography|optical coherence tomography
715001|NCT01023919|Drug eluting stent|drug eluting stent
715002|NCT01023919|Coronary Artery Disease|coronary artery disease
715003|NCT01023919|Diabetes Mellitus|diabetes mellitus
715004|NCT01023945|ASP1941|asp1941
715005|NCT01023945|Diabetes mellitus|diabetes mellitus
715006|NCT01023945|Blood glucose|blood glucose
715007|NCT01023984|RECTAL NEOPLASMS|rectal neoplasms
715008|NCT01023997|corneal thickness|corneal thickness
715009|NCT01023997|exfoliation|exfoliation
715010|NCT01024023|Early Walking Aid|early walking aid
715011|NCT01024023|Amputee|amputee
715012|NCT01024023|Trans-tibial|trans-tibial
715013|NCT01024023|Quality of life|quality of life
715014|NCT01024036|Multicentric Castleman's Disease|multicentric castleman's disease
715015|NCT01024036|MCD|mcd
715016|NCT01024036|CNTO 328|cnto 328
715017|NCT01024036|Best Supportive Care|best supportive care
715018|NCT01024036|Tumor|tumor
715019|NCT01024036|Symptomatic response|symptomatic response
715020|NCT01024036|Pharmacokinetics|pharmacokinetics
715021|NCT01024036|Interleukin-6|interleukin-6
715022|NCT01024036|IL6|il6
715023|NCT01024049|heart failure blood left ventricular dysfunction|heart failure blood left ventricular dysfunction
715025|NCT01024075|Endoscopic sinus surgery|endoscopic sinus surgery
715026|NCT01024075|Sinufoam|sinufoam
715027|NCT01024075|Dexamethasone|dexamethasone
715028|NCT01024075|For patients with Chronic Rhinosinusitis without nasal polyps|for patients with chronic rhinosinusitis without nasal polyps
715029|NCT01024075|Focus: Define the postoperative sinonasal mucosal healing status of 2 Sinufoam mixtures|focus: define the postoperative sinonasal mucosal healing status of 2 sinufoam mixtures
715030|NCT01024088|Guillain Barré syndrome|guillain barré syndrome
715031|NCT01024088|Swallowing disorders|swallowing disorders
715032|NCT01024088|Respiratory failure|respiratory failure
715033|NCT01024114|MBI|mbi
715034|NCT01024114|Molecular Breast Imaging|molecular breast imaging
715035|NCT01024114|Breast Cancer|breast cancer
715036|NCT01024114|Positive Molecular Breast Imaging scan.|positive molecular breast imaging scan.
715815|NCT01009281|IL 17|il 17
715037|NCT01024140|Posttraumatic Stress Disorder|posttraumatic stress disorder
715038|NCT01024140|Escitalopram|escitalopram
715039|NCT01024140|Efficacy|efficacy
715040|NCT01024153|active video games|active video games
715041|NCT01024153|children|children
715042|NCT01024153|physical activity|physical activity
715043|NCT01024166|Cancer|cancer
715044|NCT01024166|Patient-Reported Outcomes Computer System|patient-reported outcomes computer system
715045|NCT01024166|PRO|pro
715046|NCT01024166|Palliative Care|palliative care
715047|NCT01024166|Symptoms|symptoms
715048|NCT01024166|Questionnaire|questionnaire
715049|NCT01024166|Patients|patients
715050|NCT01024166|Caregivers|caregivers
715051|NCT01024166|Palliative Care Physicians|palliative care physicians
715052|NCT01024166|Palliative Care Nurses|palliative care nurses
715053|NCT01024179|Optical Coherence Tomography|optical coherence tomography
715054|NCT01024179|Coronary artery disease|coronary artery disease
715055|NCT01024179|Chronic total occlusion|chronic total occlusion
715056|NCT01024543|Angiotensin II|angiotensin ii
715057|NCT01024556|HIV, HAART|hiv, haart
715058|NCT01024569|Severe Mental Illness|severe mental illness
715059|NCT01024569|Recovery|recovery
715060|NCT01024569|Psychiatric Disability|psychiatric disability
715061|NCT01024569|Wellness|wellness
715062|NCT01024569|Peer Service|peer service
715063|NCT01024569|WRAP|wrap
715064|NCT01024582|breast cancer|breast cancer
715065|NCT01024582|invasive breast cancer|invasive breast cancer
715066|NCT01024582|adenocarcinoma of the breast|adenocarcinoma of the breast
715067|NCT01024595|HIV|hiv
715068|NCT01024595|Tat protein|tat protein
715069|NCT01024621|gastric intestinal metaplasia|gastric intestinal metaplasia
715070|NCT01024621|Confocal laser endomicroscopy|confocal laser endomicroscopy
715071|NCT01024634|Arterial stiffness|arterial stiffness
715072|NCT01024634|Endothelial function|endothelial function
715073|NCT01024634|Autonomic function|autonomic function
715074|NCT01024634|Inflammation|inflammation
715075|NCT01024660|Patients with Mild to Moderate Alzheimer's Disease|patients with mild to moderate alzheimer's disease
715076|NCT01024673|H1N1|h1n1
715077|NCT01024712|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
715078|NCT01024712|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
715079|NCT01024712|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
715080|NCT01024712|adenocarcinoma of the lung|adenocarcinoma of the lung
715081|NCT01024712|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
715082|NCT01024712|large cell lung cancer|large cell lung cancer
715083|NCT01024725|A(H1N1)v influenza|a(h1n1)v influenza
715084|NCT01024725|vaccination|vaccination
715085|NCT01024725|pandemic|pandemic
715086|NCT01024764|HIV|hiv
715087|NCT01024764|Tat protein|tat protein
715088|NCT01024764|Preventive vaccine|preventive vaccine
715089|NCT01024777|cholecalciferol|cholecalciferol
715090|NCT01024777|multiple sclerosis|multiple sclerosis
715091|NCT01024777|vitamin D|vitamin d
715092|NCT01024777|D3|d3
715093|NCT01024803|Retina implant, Subretinal|retina implant, subretinal
715094|NCT01024803|Legal blindness|legal blindness
715095|NCT01024803|Genetic Diseases, Inborn|genetic diseases, inborn
715096|NCT01024803|Eye Diseases|eye diseases
715097|NCT01024803|Retinitis Pigmentosa|retinitis pigmentosa
715098|NCT01024803|Retinitis|retinitis
715099|NCT01024803|Retinal Degeneration|retinal degeneration
715100|NCT01024803|Eye Diseases, Hereditary|eye diseases, hereditary
715101|NCT01024803|Retinal Diseases|retinal diseases
715102|NCT01024816|Metabolic Syndrome|metabolic syndrome
715103|NCT01024816|Restorative Yoga|restorative yoga
715104|NCT01024816|Stretching|stretching
715105|NCT01024816|Visceral adiposity|visceral adiposity
715106|NCT01024816|Randomized controlled trial|randomized controlled trial
715107|NCT01024829|Non small cell lung cancer|non small cell lung cancer
715108|NCT01024829|Inoperable|inoperable
715109|NCT01024829|HX4|hx4
715110|NCT01024868|Transversus Abdominis Plane Block|transversus abdominis plane block
715111|NCT01024881|catheterization success rate|catheterization success rate
715112|NCT01024894|interleukin-7|interleukin-7
715113|NCT01024894|immune-based therapies|immune-based therapies
715114|NCT01024894|hepatitis C|hepatitis c
715115|NCT01024894|chronic hepatitis|chronic hepatitis
715116|NCT01024894|resistance to Peg-interferon and ribavirin bitherapy|resistance to peg-interferon and ribavirin bitherapy
715117|NCT01024894|immune specific responses to HCV|immune specific responses to hcv
715118|NCT01024894|taiwan|taiwan
715119|NCT01024894|phase 1/2a|phase 1/2a
715120|NCT01024894|viral disease|viral disease
715121|NCT01024894|liver disease|liver disease
715122|NCT01024933|Hypertension|hypertension
715123|NCT01024933|High Blood Pressure|high blood pressure
715124|NCT01024946|mesothelioma|mesothelioma
715125|NCT01024946|pleural|pleural
715126|NCT01024946|RAD001|rad001
715127|NCT01024946|Everolimus|everolimus
715128|NCT01024946|09-142|09-142
715129|NCT01024946|thoracic|thoracic
715130|NCT01024946|lung|lung
715131|NCT01024946|epithelioid|epithelioid
715132|NCT01024946|sarcomatoid|sarcomatoid
715133|NCT01024959|Prostate Cancer|prostate cancer
715134|NCT01024959|Prostate Biopsy|prostate biopsy
715136|NCT01024985|optic neuritis|optic neuritis
715137|NCT01024985|longitudinally extensive transverse myelitis|longitudinally extensive transverse myelitis
715138|NCT01024985|retinal nerve fiber layer|retinal nerve fiber layer
715139|NCT01024985|macular thickness|macular thickness
715140|NCT01024998|Age-Related Macular Degeneration|age-related macular degeneration
715141|NCT01024998|AMD|amd
715142|NCT01024998|Wet AMD|wet amd
715143|NCT01024998|Neovascular AMD|neovascular amd
715144|NCT01024998|Ocular|ocular
715145|NCT01024998|Ocular gene therapy|ocular gene therapy
715146|NCT01024998|Subretinal neovascularization|subretinal neovascularization
715147|NCT01025011|retinal hemoglobin concentration|retinal hemoglobin concentration
715148|NCT01025011|non-invasive hemoglobin measurement|non-invasive hemoglobin measurement
715149|NCT01025024|SNP|snp
715150|NCT01025024|single-nucleotide polymorphism|single-nucleotide polymorphism
715151|NCT01025024|glaucoma|glaucoma
715152|NCT01025024|primary open angle glaucoma|primary open angle glaucoma
715153|NCT01025037|Rotator Cuff Tear, Large, Massive, Rotator, Cuff. Tear|rotator cuff tear, large, massive, rotator, cuff. tear
715154|NCT01025050|Presbyopia|presbyopia
715155|NCT01025050|Intrastromal|intrastromal
715156|NCT01025050|Femtosecond Laser|femtosecond laser
715157|NCT01025050|minimal-invasive|minimal-invasive
715158|NCT01025050|INTRACOR|intracor
715159|NCT01025050|Enhance Near Visual Acuity|enhance near visual acuity
715160|NCT01025063|Spectral OCT|spectral oct
715161|NCT01025063|Choroidal Neovascularization|choroidal neovascularization
715162|NCT01025063|Lucentis|lucentis
715163|NCT01025063|Visudyne|visudyne
715164|NCT01025063|PDT|pdt
715165|NCT01025063|anti-VEGF|anti-vegf
715166|NCT01025076|Enlarged gastric pouch and stoma|enlarged gastric pouch and stoma
715167|NCT01025076|Post bariatric surgery|post bariatric surgery
715168|NCT01025089|Cetuximab|cetuximab
715169|NCT01025089|Cisplatin|cisplatin
715170|NCT01025089|Cyclophosphamide|cyclophosphamide
715171|NCT01025089|09-038|09-038
715172|NCT01025115|Dietary supplement|dietary supplement
715173|NCT01025115|Diamel|diamel
715174|NCT01025115|Metabolic Syndrome|metabolic syndrome
715175|NCT01025141|MINISCREW|miniscrew
715176|NCT01025141|space extraction closure|space extraction closure
715177|NCT01025141|anchorage|anchorage
715178|NCT01025141|Orthodontic Treatment|orthodontic treatment
715179|NCT01025141|Extraction of 2 Maxillary Premolar|extraction of 2 maxillary premolar
715180|NCT01025141|closing of extraction space|closing of extraction space
715181|NCT01025141|patient aged from 12 to 50 years old|patient aged from 12 to 50 years old
715182|NCT01025154|Leukemia|leukemia
715183|NCT01025154|AML|aml
715184|NCT01025154|chemotherapy-naïve|chemotherapy-naïve
715185|NCT01025154|Clofarabine|clofarabine
715186|NCT01025154|Clofarex|clofarex
715187|NCT01025154|Clolar|clolar
715188|NCT01025154|Idarubicin|idarubicin
715189|NCT01025154|Idamycin|idamycin
715190|NCT01025154|Cytarabine|cytarabine
715191|NCT01025154|Ara-C|ara-c
715192|NCT01025154|Cytosar|cytosar
715193|NCT01025154|DepoCyt|depocyt
715194|NCT01025154|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
715195|NCT01025167|cancer|cancer
715196|NCT01025167|enteral nutrition|enteral nutrition
715197|NCT01025167|omega-3-fatty acids|omega-3-fatty acids
715198|NCT01025180|safety|safety
715199|NCT01025180|Procalcitonin|procalcitonin
715201|NCT01025180|SOFA|sofa
715202|NCT01025180|Sepsis|sepsis
715203|NCT01025180|Antibiotic|antibiotic
715204|NCT01025180|Strategy|strategy
715205|NCT01025180|SIRS|sirs
715206|NCT01025180|severe sepsis without obvious infection|severe sepsis without obvious infection
715207|NCT01025193|belimumab|belimumab
715208|NCT01025193|Benlysta|benlysta
715209|NCT01025193|LymphoStat B|lymphostat b
715210|NCT01025193|BLyS specific inhibitors|blys specific inhibitors
715211|NCT01025206|Multiple Myeloma|multiple myeloma
715212|NCT01025206|monoclonal antibody|monoclonal antibody
715213|NCT01025206|safety|safety
715214|NCT01025206|pharmacokinetic|pharmacokinetic
753709|NCT01177215|Thoracic Drainage Device|thoracic drainage device
715215|NCT01025219|Diagnosis of dependence on cocaine according to DSM-IV-TR criteria|diagnosis of dependence on cocaine according to dsm-iv-tr criteria
715216|NCT01025232|Antibodies, Monoclonal|antibodies, monoclonal
715217|NCT01025232|Immunologic Factors|immunologic factors
715218|NCT01025232|Eye Diseases|eye diseases
715219|NCT01025232|Retinal Degeneration|retinal degeneration
715220|NCT01025232|Macular Degeneration|macular degeneration
715221|NCT01025232|Pharmacologic Actions|pharmacologic actions
715222|NCT01025232|Retinal Diseases|retinal diseases
715223|NCT01025245|Remifentanil induced postoperative hyperalgesia|remifentanil induced postoperative hyperalgesia
715224|NCT01025258|Cystic Fibrosis|cystic fibrosis
715225|NCT01025258|Medication Adherence|medication adherence
715226|NCT01025258|Multidisciplinary Team|multidisciplinary team
715227|NCT01025258|Clinical Outcomes|clinical outcomes
715228|NCT01025271|meningitis|meningitis
715229|NCT01025297|interleukin-7|interleukin-7
715230|NCT01025297|immune-based therapies|immune-based therapies
715231|NCT01025297|hepatitis C|hepatitis c
715232|NCT01025297|chronic hepatitis|chronic hepatitis
715233|NCT01025297|resistance to Peg-interferon and ribavirin bi-therapy|resistance to peg-interferon and ribavirin bi-therapy
715234|NCT01025297|immune specific responses to HCV|immune specific responses to hcv
715235|NCT01025297|phase 1/2a|phase 1/2a
715236|NCT01025297|viral disease|viral disease
715237|NCT01025297|liver disease|liver disease
715238|NCT01025310|eye movements|eye movements
715239|NCT01025310|saccades|saccades
715240|NCT01025310|visual|visual
715241|NCT01025310|stress|stress
715242|NCT01025310|search coil|search coil
715243|NCT01025310|environment|environment
715244|NCT01025310|Saccadic eye movements|saccadic eye movements
715245|NCT01025310|Urban environment|urban environment
715246|NCT01025323|Pre hypertension|pre hypertension
715247|NCT01025323|Lifestyle modification|lifestyle modification
715248|NCT01025323|DASH diet|dash diet
715249|NCT01025336|Antibody persistence|antibody persistence
715250|NCT01025349|bevacizumab|bevacizumab
715251|NCT01025349|metastatic breast cancer|metastatic breast cancer
715252|NCT01025349|docetaxel|docetaxel
715253|NCT01025375|overweight|overweight
715254|NCT01025388|Hypercholesterolemia|hypercholesterolemia
715255|NCT01025388|The study is focusing on the undertreatment of hypercholesterolemia|the study is focusing on the undertreatment of hypercholesterolemia
715256|NCT01025401|epilepsy|epilepsy
715257|NCT01025401|seizures|seizures
715258|NCT01025401|movement|movement
715259|NCT01025414|pancreatic fistula|pancreatic fistula
715260|NCT01025427|HIV|hiv
715261|NCT01025427|HIV persistence|hiv persistence
715262|NCT01025427|HIV reservoirs|hiv reservoirs
715263|NCT01025453|thyroid|thyroid
715264|NCT01025453|follicular cell|follicular cell
715265|NCT01025453|papillary cell|papillary cell
715266|NCT01025453|Hurthle cell|hurthle cell
715267|NCT01025453|BAY 43-9006|bay 43-9006
715268|NCT01025453|Temsirolimus|temsirolimus
715269|NCT01025453|Sorafenib|sorafenib
715270|NCT01025453|09-148|09-148
715271|NCT01025479|Osteoporosis|osteoporosis
715272|NCT01025479|Prostate cancer|prostate cancer
715273|NCT01025479|LHRH agonist and/or anti-androgen agent|lhrh agonist and/or anti-androgen agent
715274|NCT01025479|Korean prostate cancer|korean prostate cancer
715275|NCT01025492|high density lipoprotein|high density lipoprotein
715276|NCT01025492|arterial compliance|arterial compliance
715277|NCT01025492|brachial artery flow-mediated dilatation|brachial artery flow-mediated dilatation
715278|NCT01025505|Untreated Ph+ ALL unfit for intense therapy and allo SCT|untreated ph+ all unfit for intense therapy and allo sct
715279|NCT01025518|Head and Neck Neoplasms|head and neck neoplasms
715280|NCT01025518|Resistance training|resistance training
715281|NCT01025518|Muscle mass|muscle mass
715282|NCT01025518|Functional capacity|functional capacity
715283|NCT01025531|Hepatitis C|hepatitis c
715284|NCT01025544|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
715285|NCT01025544|Vaccine|vaccine
715286|NCT01025544|Booster|booster
715287|NCT01025557|Food intake|food intake
715288|NCT01025557|Blood glucose|blood glucose
715289|NCT01025557|Milk|milk
715290|NCT01025570|pancreas|pancreas
715291|NCT01025570|pancreatic|pancreatic
715292|NCT01025570|bosutinib|bosutinib
715293|NCT01025570|SKI-606|ski-606
715294|NCT01025570|gemcitabine|gemcitabine
715295|NCT01025570|gemzar|gemzar
715296|NCT01025570|Patients with resected pancreatic cancer|patients with resected pancreatic cancer
715297|NCT01025583|acute gastroenteritis|acute gastroenteritis
715298|NCT01025583|intestinal infection|intestinal infection
715299|NCT01025583|intestinal fluid secretion|intestinal fluid secretion
715300|NCT01025583|intestinal microflora|intestinal microflora
715301|NCT01025583|treatment of childhood acute diarrhea|treatment of childhood acute diarrhea
715302|NCT01025596|interleukin-7|interleukin-7
715303|NCT01025596|immune-based therapies|immune-based therapies
715304|NCT01025596|hepatitis C|hepatitis c
715305|NCT01025596|chronic hepatitis|chronic hepatitis
715306|NCT01025596|resistance to Peg-interferon and ribavirin bi-therapy|resistance to peg-interferon and ribavirin bi-therapy
715307|NCT01025596|immune specific responses to HCV|immune specific responses to hcv
715308|NCT01025596|phase 1|phase 1
716991|NCT01030536|NHL|nhl
715309|NCT01025596|viral disease|viral disease
715310|NCT01025596|liver disease|liver disease
715311|NCT01025609|spinal cord injury|spinal cord injury
715312|NCT01025609|cardiovascular disease|cardiovascular disease
715313|NCT01025609|dietary patterns|dietary patterns
715314|NCT01025622|Stem Cells|stem cells
715315|NCT01025622|Liver Cirrhosis|liver cirrhosis
715316|NCT01025622|Cell Therapy|cell therapy
715317|NCT01025635|rosacea|rosacea
715318|NCT01025635|papulopustular|papulopustular
715319|NCT01025635|azelaic acid|azelaic acid
715320|NCT01025635|foam|foam
715321|NCT01025648|Mild to Moderate Asthma|mild to moderate asthma
715322|NCT01025648|Dyspnea|dyspnea
715323|NCT01025648|Wheezing|wheezing
715324|NCT01025648|Status Asthmaticus|status asthmaticus
715325|NCT01025661|chiropractic|chiropractic
715326|NCT01025661|hip osteoarthritis|hip osteoarthritis
715327|NCT01025661|hip arthroplasty|hip arthroplasty
715328|NCT01025661|pain|pain
715329|NCT01025661|activities of daily living.|activities of daily living.
715330|NCT01025674|School health program|school health program
715331|NCT01025674|Positive health behavior|positive health behavior
715332|NCT01025674|School-wide climate|school-wide climate
715333|NCT01025674|Mental health|mental health
715334|NCT01025674|Self-esteem|self-esteem
715335|NCT01025674|Social support|social support
715336|NCT01025674|Exercise|exercise
715337|NCT01025674|Nutrition|nutrition
715338|NCT01025674|Parent involvement|parent involvement
715339|NCT01025674|Community involvement|community involvement
715340|NCT01025687|girls|girls
715341|NCT01025687|obesity|obesity
715342|NCT01025687|television viewing|television viewing
715343|NCT01025687|puberty|puberty
715344|NCT01025700|Efficacy|efficacy
715345|NCT01025700|Marijuana|marijuana
715346|NCT01025700|Reduction|reduction
715347|NCT01025700|Craving|craving
715348|NCT01025713|Cystic Fibrosis|cystic fibrosis
715349|NCT01025713|CF|cf
715350|NCT01025713|Mucociliary Clearance|mucociliary clearance
715351|NCT01025713|Epithelial Sodium Channel Inhibitor|epithelial sodium channel inhibitor
715352|NCT01025713|ENaC Inhibitor|enac inhibitor
715353|NCT01025713|Airway Hydration|airway hydration
715354|NCT01025713|Amiloride|amiloride
715355|NCT01025739|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
715356|NCT01025739|EsophyX|esophyx
715357|NCT01025752|chronic pain|chronic pain
715358|NCT01025752|cognitive behavior therapy|cognitive behavior therapy
715359|NCT01025752|low back pain|low back pain
715360|NCT01025778|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
715361|NCT01025778|Graft versus host disease|graft versus host disease
715362|NCT01025778|Donor lymphocyte infusion|donor lymphocyte infusion
715363|NCT01025778|Graft versus leukemia effect|graft versus leukemia effect
715364|NCT01025778|Immunological recovery|immunological recovery
715365|NCT01025778|Bridge to transplant approach|bridge to transplant approach
715366|NCT01025778|Therapy resistant leukemia|therapy resistant leukemia
715367|NCT01025778|Hematological malignancy|hematological malignancy
715368|NCT01025804|Interfant-06|interfant-06
715369|NCT01025804|Infant ALL|infant all
715370|NCT01025804|Asparaginase|asparaginase
715371|NCT01025804|Pharmacokinetics of asparaginase|pharmacokinetics of asparaginase
715372|NCT01025804|Antibody formation|antibody formation
715373|NCT01025817|Kidney transplant|kidney transplant
715374|NCT01025817|renal transplant|renal transplant
715375|NCT01025817|immunosuppression|immunosuppression
715376|NCT01025817|mycophenolate mofetil|mycophenolate mofetil
715377|NCT01025817|tacrolimus|tacrolimus
715378|NCT01025817|everolimus|everolimus
715379|NCT01025830|HIV;Bioequivalence;Triomune|hiv;bioequivalence;triomune
715380|NCT01025856|liver fat|liver fat
715476|NCT01026402|advanced solid malignancies|advanced solid malignancies
715381|NCT01025856|postprandial lipids metabolism|postprandial lipids metabolism
715382|NCT01025856|diet|diet
715383|NCT01025856|exercise|exercise
715384|NCT01025856|type 2 diabetes|type 2 diabetes
715385|NCT01025882|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
715386|NCT01025882|stage I pancreatic cancer|stage i pancreatic cancer
715387|NCT01025882|stage II pancreatic cancer|stage ii pancreatic cancer
715388|NCT01025882|stage III pancreatic cancer|stage iii pancreatic cancer
715389|NCT01025895|arthroscopic surgical procedure|arthroscopic surgical procedure
715390|NCT01025908|psychotherapy|psychotherapy
715391|NCT01025908|panic disorder|panic disorder
715392|NCT01025908|anxiety|anxiety
715393|NCT01025908|behavior|behavior
715394|NCT01025908|cognition|cognition
715395|NCT01025921|Tracheobronchitis|tracheobronchitis
715396|NCT01025921|pneumonia|pneumonia
715397|NCT01025921|inhaled antibiotics|inhaled antibiotics
715398|NCT01025921|colistin|colistin
715399|NCT01025921|Ventilator associated tracheobronchitis|ventilator associated tracheobronchitis
715400|NCT01025921|Ventilator associated pneumonia|ventilator associated pneumonia
715401|NCT01025947|Atrial fibrillation|atrial fibrillation
715402|NCT01025947|Cryptogenic stroke|cryptogenic stroke
715403|NCT01025947|Implantable loop recorder|implantable loop recorder
715404|NCT01025960|colonoscopy|colonoscopy
715405|NCT01025960|adenoma detection|adenoma detection
715406|NCT01025960|polyps|polyps
715407|NCT01025999|RYGB|rygb
715408|NCT01025999|Gastrostomy tube|gastrostomy tube
715409|NCT01025999|DM|dm
715410|NCT01025999|Gastric Bypass|gastric bypass
715411|NCT01026012|Regadenoson|regadenoson
715412|NCT01026012|85% predicted heart rate|85% predicted heart rate
715413|NCT01026012|Myocardial perfusion stress testing|myocardial perfusion stress testing
715414|NCT01026025|lobectomy|lobectomy
715415|NCT01026025|segmentectomy|segmentectomy
715416|NCT01026025|pulmonary resection|pulmonary resection
715417|NCT01026038|Pneumococcal vaccine 13-valent|pneumococcal vaccine 13-valent
715418|NCT01026051|Cancer Vaccine, Immunotherapy, Melanoma|cancer vaccine, immunotherapy, melanoma
715419|NCT01026064|Macrolides|macrolides
715420|NCT01026064|Inflammation|inflammation
715421|NCT01026064|Azithromycin|azithromycin
715422|NCT01026064|Cantharidin induced skin blister model|cantharidin induced skin blister model
715423|NCT01026077|Savella pregnant|savella pregnant
715424|NCT01026077|savella pregnancy|savella pregnancy
715425|NCT01026077|fibromyalgia pregnant|fibromyalgia pregnant
715426|NCT01026077|fibromyalgia pregnancy|fibromyalgia pregnancy
715427|NCT01026077|pregnancy registry savella|pregnancy registry savella
715816|NCT01009281|anti IL-17|anti il-17
715428|NCT01026103|gastric bypass|gastric bypass
715429|NCT01026103|Gastric bypass surgery|gastric bypass surgery
715430|NCT01026155|Obese patients (BMI > 30 kg / m²)|obese patients (bmi > 30 kg / m²)
715431|NCT01026194|insulin resistance|insulin resistance
715432|NCT01026207|Diagnostic test|diagnostic test
715433|NCT01026207|polysomnography|polysomnography
715434|NCT01026207|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
715435|NCT01026207|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
715436|NCT01026233|Antibodies, Monoclonal|antibodies, monoclonal
715437|NCT01026233|Antibody-Drug Conjugate|antibody-drug conjugate
715438|NCT01026233|Antigens, CD30|antigens, cd30
715439|NCT01026233|Disease, Hodgkin|disease, hodgkin
715440|NCT01026233|Drug Therapy|drug therapy
715441|NCT01026233|Hematologic Diseases|hematologic diseases
715442|NCT01026233|Immunotherapy|immunotherapy
715443|NCT01026233|Lymphoma|lymphoma
715444|NCT01026233|monomethylauristatin E|monomethylauristatin e
715445|NCT01026233|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
715446|NCT01026246|Ghana, malaria, vaccine, Plasmodium falciparum|ghana, malaria, vaccine, plasmodium falciparum
715447|NCT01026259|Surgical site infection|surgical site infection
715448|NCT01026259|wound healing|wound healing
715449|NCT01026259|tissue oxygen|tissue oxygen
715450|NCT01026259|angiogenesis|angiogenesis
715451|NCT01026259|flow cytometry|flow cytometry
715452|NCT01026259|immunohistochemistry|immunohistochemistry
715453|NCT01026272|Endocannabinoid|endocannabinoid
715454|NCT01026272|Fish Oil|fish oil
715455|NCT01026272|Multiple Sclerosis|multiple sclerosis
715456|NCT01026272|Monocyte Migration|monocyte migration
715457|NCT01026285|Risperdal Consta|risperdal consta
715458|NCT01026298|asthma|asthma
715459|NCT01026298|obstructive sleep apnea|obstructive sleep apnea
715460|NCT01026298|severe asthma|severe asthma
715461|NCT01026298|OSA|osa
715462|NCT01026311|Coenzyme q10|coenzyme q10
715463|NCT01026311|statins|statins
715464|NCT01026311|myalgias|myalgias
715465|NCT01026311|anaerobic threshold|anaerobic threshold
715466|NCT01026311|athletic performance|athletic performance
715467|NCT01026337|recurrent renal cell cancer|recurrent renal cell cancer
715468|NCT01026350|modulating immune response to flu antigen|modulating immune response to flu antigen
715469|NCT01026363|Vitamin D|vitamin d
715470|NCT01026363|Chronic Kidney Disease|chronic kidney disease
715471|NCT01026376|Myelodysplastic Syndromes|myelodysplastic syndromes
715472|NCT01026376|Decitabine|decitabine
715473|NCT01026389|MRA-Contrast agent comparison in peripheral disease|mra-contrast agent comparison in peripheral disease
715474|NCT01026402|Phase I|phase i
715475|NCT01026402|cancer|cancer
715477|NCT01026402|dose escalation|dose escalation
715478|NCT01026402|AZD2014|azd2014
715479|NCT01026402|mTor kinase inhibitor|mtor kinase inhibitor
715480|NCT01026402|safety|safety
715481|NCT01026402|pharmacokinetics|pharmacokinetics
715482|NCT01026415|Antibody-Drug Conjugate|antibody-drug conjugate
715483|NCT01026415|Antigens, CD30|antigens, cd30
715484|NCT01026415|Disease, Hodgkin|disease, hodgkin
715485|NCT01026415|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
715486|NCT01026415|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
715487|NCT01026415|monomethyl auristatin E|monomethyl auristatin e
715488|NCT01026415|Drug Therapy|drug therapy
715489|NCT01026415|Immunotherapy|immunotherapy
715490|NCT01026415|Hematologic Diseases|hematologic diseases
715491|NCT01026415|Lymphoma|lymphoma
715492|NCT01026415|Antibodies, Monoclonal|antibodies, monoclonal
715493|NCT01026428|safinamide|safinamide
715494|NCT01026428|levodopa|levodopa
715495|NCT01026428|drug -drug interaction|drug -drug interaction
715496|NCT01026428|pharmacokinetics|pharmacokinetics
715497|NCT01026428|Patients diagnosed with idiopathic Parkinson's disease, levodopa-responsive, treated with a stable dose of levodopa/carbidopa|patients diagnosed with idiopathic parkinson's disease, levodopa-responsive, treated with a stable dose of levodopa/carbidopa
715498|NCT01026441|Aesthetic|aesthetic
715500|NCT01026454|HIV|hiv
715501|NCT01026480|Ileal Pouch Anal Anastomosis|ileal pouch anal anastomosis
715502|NCT01026480|IPAA|ipaa
715503|NCT01026480|Pull through|pull through
715504|NCT01026480|IBD|ibd
715505|NCT01026480|Ulcerative colitis|ulcerative colitis
715506|NCT01026480|Familial adenomatous polyposis|familial adenomatous polyposis
715507|NCT01026480|FAP|fap
715508|NCT01026480|Hereditary nonpolyposis colorectal cancer|hereditary nonpolyposis colorectal cancer
715509|NCT01026480|HNPCC|hnpcc
715510|NCT01026493|adult giant cell glioblastoma|adult giant cell glioblastoma
715511|NCT01026493|adult glioblastoma|adult glioblastoma
715512|NCT01026493|adult gliosarcoma|adult gliosarcoma
715513|NCT01026493|recurrent adult brain tumor|recurrent adult brain tumor
715514|NCT01026493|adult anaplastic astrocytoma|adult anaplastic astrocytoma
715515|NCT01026493|adult anaplastic ependymoma|adult anaplastic ependymoma
715516|NCT01026493|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
715517|NCT01026493|adult brain stem glioma|adult brain stem glioma
715518|NCT01026493|adult mixed glioma|adult mixed glioma
715519|NCT01026493|adult pineal gland astrocytoma|adult pineal gland astrocytoma
715520|NCT01026506|c9,t11-CLA|c9,t11-cla
715521|NCT01026506|allergic bronchial asthma|allergic bronchial asthma
716663|NCT01029561|Adipokines|adipokines
715522|NCT01026506|children and adolescents|children and adolescents
715523|NCT01026545|safety|safety
715524|NCT01026545|tolerability|tolerability
715525|NCT01026545|pharmacokinetics|pharmacokinetics
715526|NCT01026545|multiple-dose|multiple-dose
715527|NCT01026545|macrolide|macrolide
715528|NCT01026558|Obesity, Ceftobiprole|obesity, ceftobiprole
715529|NCT01026558|Skin Infections|skin infections
715530|NCT01026558|Staphylococcal Skin Infections|staphylococcal skin infections
715531|NCT01026558|Bacterial Skin Infections|bacterial skin infections
715532|NCT01026558|Streptococcal Infection|streptococcal infection
715533|NCT01026571|Bicuspid aortic valve|bicuspid aortic valve
715534|NCT01026610|Chronic hepatitis B|chronic hepatitis b
715535|NCT01026610|LB80380|lb80380
715536|NCT01026610|treatment-naive|treatment-naive
715537|NCT01026610|entecavir|entecavir
715538|NCT01026636|Staphylococcal Skin Infections|staphylococcal skin infections
715539|NCT01026636|Skin Infections|skin infections
715540|NCT01026636|Streptococcal Infections|streptococcal infections
715541|NCT01026649|hematoma formation|hematoma formation
715542|NCT01026649|success rate|success rate
715543|NCT01026662|Aesthetic dermatology|aesthetic dermatology
715544|NCT01026688|Pragmatic randomized controlled trial|pragmatic randomized controlled trial
715545|NCT01026688|Cardiovascular risk reduction|cardiovascular risk reduction
715546|NCT01026688|Knowledge translation|knowledge translation
715547|NCT01026688|Clinical practice guidelines|clinical practice guidelines
715548|NCT01026701|Osteoblst effect|osteoblst effect
715549|NCT01026701|Velcade|velcade
715550|NCT01026701|Proteasome inhibitor|proteasome inhibitor
715551|NCT01026701|Bortezomib|bortezomib
715552|NCT01026701|Multjple Myeloma|multjple myeloma
715553|NCT01026727|HIV Infections|hiv infections
715554|NCT01026727|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
715555|NCT01026727|Virus Diseases|virus diseases
715556|NCT01026727|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
715557|NCT01026727|RNA Virus Infections|rna virus infections
715558|NCT01026727|Slow Virus Diseases|slow virus diseases
715559|NCT01026727|Immune System Diseases|immune system diseases
715560|NCT01026727|Sexually Transmitted Diseases|sexually transmitted diseases
715561|NCT01026727|Lentivirus Infections|lentivirus infections
715562|NCT01026727|Infection|infection
715563|NCT01026727|Retroviridae Infections|retroviridae infections
715564|NCT01026727|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
715565|NCT01026727|HIV|hiv
715566|NCT01026727|treatment experienced|treatment experienced
715567|NCT01026727|bevirimat|bevirimat
715568|NCT01026740|Staphylococcal Skin Infections|staphylococcal skin infections
715569|NCT01026740|Streptococcal Infections|streptococcal infections
715570|NCT01026753|colorectal cancer|colorectal cancer
715571|NCT01026753|screening|screening
715572|NCT01026753|fecal occult blood test|fecal occult blood test
715573|NCT01026753|randomized control trial|randomized control trial
715574|NCT01026753|primary care oncology|primary care oncology
715575|NCT01026753|web site|web site
715576|NCT01026753|provincial health contact center|provincial health contact center
715577|NCT01026766|Hypothermia|hypothermia
715578|NCT01026766|Obesity|obesity
715579|NCT01026766|Heat and moisture exchanger|heat and moisture exchanger
715580|NCT01026766|Warming blanket|warming blanket
715581|NCT01026766|Warming fluids|warming fluids
715582|NCT01026766|Gynecological surgery|gynecological surgery
715583|NCT01026766|Intravenous anesthesia|intravenous anesthesia
715584|NCT01026766|Obese patients|obese patients
715585|NCT01026766|Non obese patients|non obese patients
715586|NCT01026779|rotavirus|rotavirus
715587|NCT01026779|gastroenteritis|gastroenteritis
715588|NCT01026779|vaccine|vaccine
715589|NCT01026779|case-control study|case-control study
715590|NCT01026779|serotype|serotype
715591|NCT01026805|morcellator|morcellator
715592|NCT01026805|hysteroscope|hysteroscope
715593|NCT01026805|myomectomy|myomectomy
715594|NCT01026805|polypectomy|polypectomy
715595|NCT01026805|uterine fibroids|uterine fibroids
715596|NCT01026818|Erectile Dysfunction|erectile dysfunction
715597|NCT01026818|Radical Prostatectomy|radical prostatectomy
715598|NCT01026844|erlotinib|erlotinib
715599|NCT01026844|tarceva|tarceva
715600|NCT01026844|hydroxychloroquine|hydroxychloroquine
715601|NCT01026844|NSCLC|nsclc
715602|NCT01026883|hematocrit|hematocrit
715603|NCT01026883|layered resonant piezoelectric sensors|layered resonant piezoelectric sensors
715604|NCT01026896|Mental practice|mental practice
715605|NCT01026896|motor imagery|motor imagery
715606|NCT01026896|stroke|stroke
715607|NCT01026896|hemiplegia|hemiplegia
715608|NCT01026896|motor recovery|motor recovery
715609|NCT01026896|neuroplasticity|neuroplasticity
715610|NCT01026922|antroduodenal manometry|antroduodenal manometry
715611|NCT01026922|gastric dysmotility|gastric dysmotility
715612|NCT01026922|intestinal dysmotility|intestinal dysmotility
715613|NCT01026935|open mesh repair|open mesh repair
715614|NCT01026935|sutured|sutured
715615|NCT01026935|non-sutured|non-sutured
715616|NCT01026935|pro-grip|pro-grip
715617|NCT01026935|postoperative pain|postoperative pain
715618|NCT01026948|Induction of labour|induction of labour
716760|NCT01029912|Stroke|stroke
715619|NCT01026948|Intraprtum fetal monitoring|intraprtum fetal monitoring
715620|NCT01026961|Safety|safety
715621|NCT01026961|heart rate|heart rate
715622|NCT01026961|systolic and diastolic blood pressure|systolic and diastolic blood pressure
715623|NCT01026961|arrhythmias|arrhythmias
715624|NCT01026974|Children|children
715625|NCT01026974|Pre-school|pre-school
715626|NCT01026974|Meningococcal disease|meningococcal disease
715627|NCT01026974|Prevention|prevention
715628|NCT01026974|Vaccination|vaccination
715629|NCT01027000|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
715630|NCT01027000|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
715631|NCT01027000|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
715632|NCT01027000|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
715633|NCT01027000|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
715634|NCT01027000|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
715635|NCT01027000|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
715636|NCT01027000|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
715637|NCT01027000|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
715638|NCT01027000|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
715639|NCT01027000|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
715640|NCT01027000|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
715641|NCT01008644|carbon dioxide|carbon dioxide
715642|NCT01008644|ventilation|ventilation
715643|NCT01008644|gender|gender
715644|NCT01008644|osmolality|osmolality
715645|NCT01008644|menstruation cycle|menstruation cycle
715646|NCT01008657|Radiofrequency-Extranodular-Multipolar ablation|radiofrequency-extranodular-multipolar ablation
715647|NCT01008657|Recurrence|recurrence
715648|NCT01008670|Cardiac resynchronization therapy|cardiac resynchronization therapy
715649|NCT01008683|Stem cell and and heart transplant patients who will receive pandemic H1N1 influenza vaccinations|stem cell and and heart transplant patients who will receive pandemic h1n1 influenza vaccinations
715650|NCT01008696|Reflux esophagitis|reflux esophagitis
715651|NCT01008696|Rabeprazole|rabeprazole
715652|NCT01008696|Lansoprazole|lansoprazole
715653|NCT01008722|Atrial Fibrillation|atrial fibrillation
715654|NCT01008722|Ablation|ablation
715655|NCT01008748|Smoking|smoking
715656|NCT01008748|Latinos|latinos
715657|NCT01008748|Mexican American|mexican american
715658|NCT01008748|Spanish-speaking smokers|spanish-speaking smokers
715659|NCT01008748|Ecological momentary assessment|ecological momentary assessment
715660|NCT01008748|Nicotine patch|nicotine patch
715661|NCT01008748|Smoking cessation counseling|smoking cessation counseling
715662|NCT01008748|Questionnaire|questionnaire
715664|NCT01008761|Pre-school child|pre-school child
715665|NCT01008761|Wheezy episode|wheezy episode
715666|NCT01008787|Cancer Prevention|cancer prevention
715667|NCT01008787|Focus Group|focus group
715668|NCT01008787|Interview|interview
715669|NCT01008787|Physical Activity|physical activity
715670|NCT01008787|African American women|african american women
715671|NCT01008787|Exercise|exercise
715672|NCT01008787|Exercise habits|exercise habits
715673|NCT01008787|Health behavior|health behavior
715674|NCT01008800|Autism Spectrum Disorder|autism spectrum disorder
715675|NCT01008800|language|language
715676|NCT01008800|social|social
715677|NCT01008800|toddlers|toddlers
715678|NCT01008813|HIV infection|hiv infection
715679|NCT01008813|adjuvanted and non-adjuvanted A(H1N1)v influenza vaccine|adjuvanted and non-adjuvanted a(h1n1)v influenza vaccine
715680|NCT01008813|immunogenicity|immunogenicity
715681|NCT01008813|safety|safety
715682|NCT01008826|sulforaphane|sulforaphane
715683|NCT01008826|pharmacokinetics|pharmacokinetics
715684|NCT01008839|study sarcopenia, which muscle becomes weaker with age|study sarcopenia, which muscle becomes weaker with age
715685|NCT01008852|rheumatoid arthritis|rheumatoid arthritis
715686|NCT01008852|seropositive|seropositive
715687|NCT01008852|methotrexate|methotrexate
715688|NCT01008891|arthritis|arthritis
715689|NCT01008891|ankle pain|ankle pain
715690|NCT01008891|foot pain|foot pain
715691|NCT01008891|hindfoot fracture|hindfoot fracture
715692|NCT01008891|ankle fracture|ankle fracture
715795|NCT01009216|Drug Safety|drug safety
715693|NCT01008891|rheumatoid arthritis|rheumatoid arthritis
715694|NCT01008891|arthrosis|arthrosis
715695|NCT01008891|Foot/Hindfoot Fusion|foot/hindfoot fusion
715696|NCT01008904|cancer survivor|cancer survivor
715697|NCT01008904|hot flashes|hot flashes
715698|NCT01008904|breast cancer|breast cancer
715699|NCT01008904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
715700|NCT01008917|Hepatocellular carcinoma|hepatocellular carcinoma
715701|NCT01008917|HCC|hcc
715702|NCT01008917|Liver cancer|liver cancer
715703|NCT01008917|Hepatoma|hepatoma
715704|NCT01008930|Peripheral Tumors|peripheral tumors
715705|NCT01008930|Arm|arm
715706|NCT01008930|Leg|leg
715707|NCT01008930|Head|head
715708|NCT01008930|Neck|neck
715709|NCT01008930|HR PET Imaging System|hr pet imaging system
715710|NCT01008930|High-Resolution PET|high-resolution pet
715711|NCT01008930|PET/CT|pet/ct
716761|NCT01029912|Hemiplegia|hemiplegia
715712|NCT01008930|PEMFlex Solo II|pemflex solo ii
715713|NCT01008930|positron emission tomography/computed tomography (PET/CT)|positron emission tomography/computed tomography (pet/ct)
715714|NCT01008956|Influenza|influenza
715715|NCT01008956|H1N1|h1n1
715716|NCT01008956|Pandemic|pandemic
715717|NCT01008956|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
715718|NCT01008969|Prostate|prostate
715719|NCT01008969|SPECT/CT|spect/ct
715720|NCT01008982|Belimumab,Sjögren's Syndrome.|belimumab,sjögren's syndrome.
715721|NCT01008982|Have a diagnosis of primary SS according to the updated American European Consensus Group Criteria|have a diagnosis of primary ss according to the updated american european consensus group criteria
715722|NCT01008995|psoriasis|psoriasis
715723|NCT01008995|asian patients|asian patients
715724|NCT01008995|Chinese|chinese
715725|NCT01008995|ustekinumab|ustekinumab
715726|NCT01008995|CNTO 1275|cnto 1275
715727|NCT01008995|Stelara|stelara
715728|NCT01009008|cancer|cancer
715729|NCT01009008|breast cancer|breast cancer
715730|NCT01009008|mastectomy|mastectomy
715731|NCT01009008|breast reconstruction|breast reconstruction
715732|NCT01009008|reconstruction|reconstruction
715733|NCT01009008|tissue expansion|tissue expansion
715734|NCT01009008|two-stage breast reconstruction|two-stage breast reconstruction
715735|NCT01009008|tissue expander|tissue expander
715736|NCT01009008|AeroForm|aeroform
715737|NCT01009008|AirXpander|airxpander
715738|NCT01009021|pain|pain
715739|NCT01009021|retinal photocoagulation|retinal photocoagulation
715740|NCT01009021|potassium diclofenac|potassium diclofenac
715741|NCT01009047|Schizophrenia|schizophrenia
715742|NCT01009047|Paliperidone|paliperidone
715743|NCT01009047|Aripiprazole|aripiprazole
715744|NCT01009060|H3 Antagonist|h3 antagonist
715745|NCT01009060|Schizophrenia|schizophrenia
715746|NCT01009060|double blind|double blind
715747|NCT01009060|Histamine|histamine
715748|NCT01009060|randomised|randomised
715749|NCT01009060|placebo controlled|placebo controlled
715750|NCT01009060|Cognition|cognition
715751|NCT01009086|Arthritis, Psoriatic|arthritis, psoriatic
715752|NCT01009086|Ustekinumab|ustekinumab
715753|NCT01009086|CNTO 1275|cnto 1275
715754|NCT01009086|Stelara|stelara
715755|NCT01009086|Psoriasis|psoriasis
715756|NCT01009099|pulmonary disease|pulmonary disease
715757|NCT01009099|COPD|copd
715758|NCT01009112|Sleep|sleep
715759|NCT01009112|Sleep Disorder|sleep disorder
715760|NCT01009112|Veterans|veterans
715761|NCT01009112|Active Duty|active duty
715762|NCT01009112|OEF|oef
715763|NCT01009112|OIF|oif
715764|NCT01009112|PTSD|ptsd
715765|NCT01009125|questionnaires|questionnaires
715766|NCT01009125|health care surveys/methods|health care surveys/methods
715767|NCT01009125|motivation|motivation
715768|NCT01009125|living donors|living donors
715769|NCT01009125|living kidney donation|living kidney donation
715770|NCT01009138|Subthreshold Depression|subthreshold depression
715771|NCT01009138|Diabetes-related Distress|diabetes-related distress
715772|NCT01009138|Minor Depression|minor depression
715773|NCT01009138|Light affective Disorder|light affective disorder
715774|NCT01009138|Subclinical depressive Symptoms|subclinical depressive symptoms
715775|NCT01009138|Diabetes mellitus|diabetes mellitus
715776|NCT01009138|Late Complications|late complications
715777|NCT01009138|Markers of Inflammation|markers of inflammation
715778|NCT01009151|telemonitoring|telemonitoring
715779|NCT01009151|internet|internet
715780|NCT01009151|home monitoring system|home monitoring system
715781|NCT01009151|heart failure|heart failure
715782|NCT01009151|self management plan|self management plan
715783|NCT01009151|web portal|web portal
715784|NCT01009177|Melanoma|melanoma
715785|NCT01009177|Metastatic|metastatic
715786|NCT01009177|DTIC|dtic
715787|NCT01009177|Bosentan|bosentan
715788|NCT01009190|Dose finding PARPi Chemotherapy|dose finding parpi chemotherapy
715789|NCT01009203|squamous cell carcinoma|squamous cell carcinoma
715790|NCT01009203|head|head
715791|NCT01009203|neck|neck
715792|NCT01009203|aerodigestive|aerodigestive
715793|NCT01009216|Pharmacokinetics|pharmacokinetics
715794|NCT01009216|Pharmacology|pharmacology
715796|NCT01009216|Phase 1 Clinical Trials|phase 1 clinical trials
715797|NCT01009242|CDP6038|cdp6038
715798|NCT01009255|Alzheimer's disease|alzheimer's disease
715799|NCT01009255|placebo controlled|placebo controlled
715800|NCT01009255|randomised|randomised
715801|NCT01009255|Histamine|histamine
715802|NCT01009255|H3 Antagonist|h3 antagonist
715803|NCT01009255|double blind|double blind
715804|NCT01009255|Cognition|cognition
715805|NCT01009281|Crohn's Disease|crohn's disease
715806|NCT01009281|Crohns|crohns
715807|NCT01009281|Bowel disease|bowel disease
715808|NCT01009281|digestive disorders|digestive disorders
715809|NCT01009281|auto immune|auto immune
715810|NCT01009281|diarrhea|diarrhea
715811|NCT01009281|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
715812|NCT01009281|gastrointestinal diseases|gastrointestinal diseases
715813|NCT01009281|digestive system diseases|digestive system diseases
715814|NCT01009281|Antibody|antibody
715817|NCT01009281|monoclonal antibody|monoclonal antibody
715818|NCT01009281|Crohn's Disease (Chron's, CD)|crohn's disease (chron's, cd)
715819|NCT01009294|Duchenne muscular dystrophy|duchenne muscular dystrophy
715820|NCT01009294|Becker muscular dystrophy|becker muscular dystrophy
715821|NCT01009294|Nonsense mutation|nonsense mutation
715822|NCT01009294|Premature stop codon|premature stop codon
715823|NCT01009294|DMD|dmd
715824|NCT01009294|BMD|bmd
715825|NCT01009294|Ataluren|ataluren
715826|NCT01009294|PTC124|ptc124
715827|NCT01009307|adult anaplastic astrocytoma|adult anaplastic astrocytoma
715828|NCT01009307|adult diffuse astrocytoma|adult diffuse astrocytoma
715829|NCT01009307|adult pilocytic astrocytoma|adult pilocytic astrocytoma
715830|NCT01009307|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
715831|NCT01009307|adult anaplastic ependymoma|adult anaplastic ependymoma
715832|NCT01009307|adult ependymoma|adult ependymoma
715833|NCT01009307|adult myxopapillary ependymoma|adult myxopapillary ependymoma
715834|NCT01009307|adult subependymoma|adult subependymoma
715835|NCT01009307|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
715836|NCT01009307|adult oligodendroglioma|adult oligodendroglioma
715837|NCT01009307|adult brain stem glioma|adult brain stem glioma
715838|NCT01009307|adult giant cell glioblastoma|adult giant cell glioblastoma
715839|NCT01009307|adult glioblastoma|adult glioblastoma
715840|NCT01009307|recurrent adult brain tumor|recurrent adult brain tumor
715841|NCT01009307|adult gliosarcoma|adult gliosarcoma
715842|NCT01009307|adult mixed glioma|adult mixed glioma
715843|NCT01009307|adult pineal gland astrocytoma|adult pineal gland astrocytoma
715844|NCT01009307|adult ependymoblastoma|adult ependymoblastoma
715845|NCT01009307|adult medulloblastoma|adult medulloblastoma
716076|NCT01020942|pretreatment|pretreatment
715846|NCT01009307|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
715847|NCT01009307|adult pineoblastoma|adult pineoblastoma
715848|NCT01009307|adult pineocytoma|adult pineocytoma
715849|NCT01009320|Pacemaker|pacemaker
715850|NCT01009320|Magnets|magnets
715851|NCT01009320|Drape|drape
715852|NCT01009320|Ferrite|ferrite
715853|NCT01009320|Magnetic field|magnetic field
715854|NCT01009320|Pacemaker interference|pacemaker interference
715855|NCT01009333|urgency frequency|urgency frequency
715856|NCT01009333|urinary urge incontinence|urinary urge incontinence
715857|NCT01009333|InterStim Therapy|interstim therapy
715858|NCT01009359|Alzheimers disease|alzheimers disease
715859|NCT01009359|Diagnostic imaging|diagnostic imaging
715860|NCT01009359|PET/CT diagnosis|pet/ct diagnosis
715861|NCT01009359|PET tracer|pet tracer
715862|NCT01009372|surgeon's physiology|surgeon's physiology
715863|NCT01009372|stress response|stress response
715864|NCT01009372|break scheme|break scheme
715865|NCT01009385|cervical|cervical
715866|NCT01009385|epidural|epidural
715867|NCT01009385|epidural pressure|epidural pressure
715868|NCT01009385|monitoring|monitoring
715869|NCT01009398|Anesthesia and Analgesia|anesthesia and analgesia
715870|NCT01009398|Regional anesthesia|regional anesthesia
715871|NCT01009398|Thoracic Paravertebral block|thoracic paravertebral block
715872|NCT01009398|Catheter location|catheter location
715873|NCT01009437|HER2-negative breast cancer|her2-negative breast cancer
715874|NCT01009437|HER2-positive breast cancer|her2-positive breast cancer
715875|NCT01009437|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
715876|NCT01009437|triple-negative breast cancer|triple-negative breast cancer
715877|NCT01009437|stage I breast cancer|stage i breast cancer
715878|NCT01009437|stage II breast cancer|stage ii breast cancer
715879|NCT01009437|stage IIIA breast cancer|stage iiia breast cancer
715880|NCT01009437|stage IIIB breast cancer|stage iiib breast cancer
715881|NCT01009437|stage IIIC breast cancer|stage iiic breast cancer
715882|NCT01009437|stage IV breast cancer|stage iv breast cancer
715883|NCT01009437|ductal breast carcinoma in situ|ductal breast carcinoma in situ
715884|NCT01009450|cirrhotic liver, gall bladder stone|cirrhotic liver, gall bladder stone
715885|NCT01009463|COPD|copd
715886|NCT01009463|Safety|safety
715887|NCT01009463|FEV1|fev1
715888|NCT01009463|Efficacy|efficacy
715889|NCT01020162|Chronic pelvic pain|chronic pelvic pain
715890|NCT01020162|ilioinguinal nerve entrapment|ilioinguinal nerve entrapment
715891|NCT01020162|randomized study|randomized study
715892|NCT01020162|Chronic pelvic pain in women|chronic pelvic pain in women
715893|NCT01020175|allogeneic transplantation|allogeneic transplantation
715894|NCT01020175|Leukemia|leukemia
715895|NCT01020175|GvHD|gvhd
715897|NCT01020201|Anesthesia, General|anesthesia, general
715898|NCT01020201|Elective Gynecological Operation|elective gynecological operation
715899|NCT01020201|Chinese female patient|chinese female patient
715900|NCT01020201|Adult|adult
715901|NCT01020227|Postoperative Care|postoperative care
715902|NCT01020227|Quality of Life|quality of life
715903|NCT01020227|Integrative Medicine|integrative medicine
715904|NCT01020227|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
715905|NCT01020240|Immediate puerperium|immediate puerperium
715906|NCT01020240|physiotherapy in postpartum|physiotherapy in postpartum
715907|NCT01020240|cesarean complications|cesarean complications
716762|NCT01029912|Footdrop|footdrop
715908|NCT01020253|bisphosphonate, vitamin D3|bisphosphonate, vitamin d3
715909|NCT01020253|Total Hip arthroplasty|total hip arthroplasty
715910|NCT01020266|brain protection|brain protection
715911|NCT01020266|cardiac surgery|cardiac surgery
715912|NCT01020266|heart valve replacement|heart valve replacement
715913|NCT01020266|electroacupuncture|electroacupuncture
715914|NCT01020266|pretreatment|pretreatment
715915|NCT01020266|preconditioning|preconditioning
715916|NCT01020266|Thoracic Surgery|thoracic surgery
715917|NCT01020279|muscle pain|muscle pain
715918|NCT01020279|model|model
715919|NCT01020292|Adult subjects with a diagnosis of Grade IV Glioma|adult subjects with a diagnosis of grade iv glioma
715920|NCT01020318|Traumatic Brain Injury|traumatic brain injury
715921|NCT01020318|TBI|tbi
715922|NCT01020318|Brain Injuries|brain injuries
715923|NCT01020331|ALS|als
715924|NCT01020357|preterm infants|preterm infants
715925|NCT01020357|very low birthweight|very low birthweight
715926|NCT01020357|apnea of prematurity|apnea of prematurity
715927|NCT01020357|methylxanthines|methylxanthines
715928|NCT01020357|sleep disturbance|sleep disturbance
715929|NCT01020357|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
715930|NCT01020357|polysomnography|polysomnography
715931|NCT01020357|sleep disruption|sleep disruption
715932|NCT01020370|Patients with RRMS who are participating in the CARE MS I and CARE MS II|patients with rrms who are participating in the care ms i and care ms ii
715933|NCT01020396|Bioequivalence|bioequivalence
715934|NCT01020396|Metronidazole|metronidazole
715935|NCT01020396|Vaginosis|vaginosis
715936|NCT01020409|cardiac surgery|cardiac surgery
715937|NCT01020409|cardiopulmonary bypass|cardiopulmonary bypass
715938|NCT01020409|acute lung injury|acute lung injury
715939|NCT01020409|acute respiratory distress syndrome|acute respiratory distress syndrome
715940|NCT01020409|acute kidney injury|acute kidney injury
715941|NCT01020409|atrial fibrillation|atrial fibrillation
715942|NCT01020409|postoperative psychosis|postoperative psychosis
715943|NCT01020409|myocardial infarct|myocardial infarct
715944|NCT01020409|sepsis|sepsis
715945|NCT01020422|breast hypertrophy|breast hypertrophy
715946|NCT01020422|mammaplasty|mammaplasty
715947|NCT01020422|sexuality|sexuality
715948|NCT01020422|depression|depression
715949|NCT01020435|Hypertension|hypertension
715950|NCT01020448|Locally advanced or metastatic Prostate Cancer|locally advanced or metastatic prostate cancer
715951|NCT01020474|juvenile primary fibromyalgia syndrome|juvenile primary fibromyalgia syndrome
715952|NCT01020474|pediatric fibromyalgia|pediatric fibromyalgia
715953|NCT01020474|pregabalin|pregabalin
715954|NCT01020474|and Lyrica|and lyrica
716130|NCT01021176|smell|smell
715955|NCT01020487|Reduction of parathyroid hormone levels in pediatric patients with Chronic Kidney Disease Stage 3 and 4|reduction of parathyroid hormone levels in pediatric patients with chronic kidney disease stage 3 and 4
715956|NCT01020539|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
715957|NCT01020539|Targeted Immune Therapy|targeted immune therapy
715958|NCT01020539|Acute Myelogenous Leukemia|acute myelogenous leukemia
715959|NCT01020539|Myelodysplastic Syndrome|myelodysplastic syndrome
715960|NCT01020539|Juvenile Myelomonocytic Leukemia|juvenile myelomonocytic leukemia
715961|NCT01020539|AML|aml
715962|NCT01020539|MDS|mds
715963|NCT01020539|JMML|jmml
715964|NCT01020552|APHIA II|aphia ii
715965|NCT01020552|AIDS, Population, and Health Integrated Assistance project|aids, population, and health integrated assistance project
715966|NCT01020552|DCF|dcf
715967|NCT01020552|data collection forms|data collection forms
715968|NCT01020552|FDA|fda
715969|NCT01020552|Federal Drug Administration|federal drug administration
715970|NCT01020552|FP|fp
715971|NCT01020552|family planning|family planning
715972|NCT01020552|IRB|irb
715973|NCT01020552|Institutional Review Board|institutional review board
715974|NCT01020552|PAC|pac
715975|NCT01020552|postabortion care|postabortion care
715976|NCT01020552|To document the ESD PAC svc pkg including the provision of services, client satisfaction with those services and provider attitudes towards PAC services|to document the esd pac svc pkg including the provision of services, client satisfaction with those services and provider attitudes towards pac services
715977|NCT01020552|To examine any differences in implementation of the ESD PAC services package for youth and adult clients|to examine any differences in implementation of the esd pac services package for youth and adult clients
715978|NCT01020552|To assess the usefulness of five Youth-Friendly PAC Job Aids developed by ESD|to assess the usefulness of five youth-friendly pac job aids developed by esd
715979|NCT01020591|knee osteoarthritis|knee osteoarthritis
715980|NCT01020591|manual therapy|manual therapy
715981|NCT01020591|osteopathy|osteopathy
715982|NCT01020604|BMI|bmi
715983|NCT01020604|Prostate cancer|prostate cancer
715984|NCT01020604|Recurrence|recurrence
715985|NCT01020630|adenocarcinoma of stomach|adenocarcinoma of stomach
715986|NCT01020630|adenocarcinoma of lower oesophagus|adenocarcinoma of lower oesophagus
715987|NCT01020630|sunitinib|sunitinib
715988|NCT01020630|FOLFIRI|folfiri
715989|NCT01020656|anticoagulant agents|anticoagulant agents
715990|NCT01020656|antiplatelet agents|antiplatelet agents
715991|NCT01020656|vitreoretinal surgery|vitreoretinal surgery
715992|NCT01020656|Patients suffered from retinal detachment|patients suffered from retinal detachment
715993|NCT01020669|fMRI|fmri
715994|NCT01020669|Prenatal Drug Exposure|prenatal drug exposure
715995|NCT01020669|Decision Making|decision making
715996|NCT01020669|Working Memory|working memory
715997|NCT01020669|Vulnerability|vulnerability
715998|NCT01020682|apathy|apathy
715999|NCT01020682|parkinson|parkinson
716000|NCT01020682|agonist dopaminergic|agonist dopaminergic
716001|NCT01020695|PTSD|ptsd
716002|NCT01020695|EEG|eeg
716003|NCT01020695|QEEG|qeeg
716004|NCT01020695|LORETA|loreta
716005|NCT01020708|colitis|colitis
716006|NCT01020708|inflammatory bowel disease|inflammatory bowel disease
716007|NCT01020708|ulcerative colitis|ulcerative colitis
716008|NCT01020708|rectal administration|rectal administration
716009|NCT01020708|enema|enema
716010|NCT01020708|mesalamine|mesalamine
716011|NCT01020721|CYP1B1 gene|cyp1b1 gene
716012|NCT01020734|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
716013|NCT01020734|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
716014|NCT01020734|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
716015|NCT01020734|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
716016|NCT01020734|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
716017|NCT01020734|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
716018|NCT01020734|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
716019|NCT01020734|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
716020|NCT01020734|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
716021|NCT01020734|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
716022|NCT01020734|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
716023|NCT01020734|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
716024|NCT01020734|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
716025|NCT01020734|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
716026|NCT01020734|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
716027|NCT01020734|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
716028|NCT01020734|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
716029|NCT01020734|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
716030|NCT01020734|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
716031|NCT01020734|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
716131|NCT01021189|safety|safety
716032|NCT01020734|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
716033|NCT01020734|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
716034|NCT01020734|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
716035|NCT01020734|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
716036|NCT01020760|Macular hole|macular hole
718487|NCT01030874|falls|falls
716037|NCT01020760|Vitrectomy|vitrectomy
716038|NCT01020760|Prone posturing|prone posturing
716039|NCT01020773|extubation,Respiration, Artificial|extubation,respiration, artificial
716040|NCT01020786|Non-squamous|non-squamous
716041|NCT01020799|Depression|depression
716042|NCT01020825|Complex perianal fistula|complex perianal fistula
716043|NCT01020825|Adipose-derived adult stem cells|adipose-derived adult stem cells
716044|NCT01020825|Fibrin glue|fibrin glue
716045|NCT01020838|Florbetaben|florbetaben
716046|NCT01020838|Amyloid beta-protein|amyloid beta-protein
716047|NCT01020838|Alzheimer's disease|alzheimer's disease
716048|NCT01020851|hypertension|hypertension
716049|NCT01020851|stroke|stroke
716050|NCT01020851|cholesterol|cholesterol
716051|NCT01020851|adherence|adherence
716052|NCT01020864|Platinum-resistent head and neck cancer|platinum-resistent head and neck cancer
716053|NCT01020864|Cetuximab|cetuximab
716054|NCT01020864|Carboplatin|carboplatin
716055|NCT01020864|Navelbine|navelbine
716056|NCT01020864|Phase II trial|phase ii trial
716057|NCT01020864|Combination chemotherapy|combination chemotherapy
716058|NCT01020877|Bioequivalence|bioequivalence
716059|NCT01020877|Healthy Subjects|healthy subjects
716060|NCT01020877|Healthy, Normal Subjects|healthy, normal subjects
716061|NCT01020890|GERD diagnosis|gerd diagnosis
716062|NCT01020890|GERD-Q|gerd-q
716063|NCT01020890|GERD patients' characteristics|gerd patients' characteristics
716064|NCT01020890|GERD|gerd
716065|NCT01020916|Induced hypothermia|induced hypothermia
716066|NCT01020916|Mild induced hypothermia|mild induced hypothermia
716067|NCT01020916|Therapeutic hypothermia|therapeutic hypothermia
716068|NCT01020916|Cardiac arrest|cardiac arrest
716069|NCT01020916|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
716070|NCT01020916|Mortality|mortality
716071|NCT01020916|Neurological function|neurological function
716072|NCT01020916|Randomised clinical trial|randomised clinical trial
716073|NCT01020942|ischemia|ischemia
716074|NCT01020942|myocardial infarction|myocardial infarction
716075|NCT01020942|prognosis|prognosis
716077|NCT01020942|electroacupuncture|electroacupuncture
716078|NCT01020942|stents|stents
716079|NCT01020942|troponin|troponin
716080|NCT01020942|percutaneous coronary intervention|percutaneous coronary intervention
716081|NCT01020955|GH and IGF-I|gh and igf-i
716082|NCT01020955|growth hormone deficiency and IGT or diabetes|growth hormone deficiency and igt or diabetes
716083|NCT01020968|Ischemic Dilated Cardiomyopathy|ischemic dilated cardiomyopathy
716084|NCT01020968|Non-Ischemic Dilated Cardiomyopathy|non-ischemic dilated cardiomyopathy
716085|NCT01020968|ixmyelocel-T|ixmyelocel-t
716086|NCT01020981|OEF/OIF|oef/oif
716087|NCT01020981|Peer Group|peer group
716088|NCT01020981|Veterans|veterans
716089|NCT01020994|Superficial infected eczema|superficial infected eczema
716090|NCT01020994|Superinfected eczema|superinfected eczema
716091|NCT01021020|bioequivalence|bioequivalence
716092|NCT01021020|fasting|fasting
716094|NCT01021020|healthy|healthy
716095|NCT01021033|Ischemia|ischemia
716096|NCT01021033|Hemorrhage|hemorrhage
716097|NCT01021033|Rehabilitation|rehabilitation
716098|NCT01021033|Stroke|stroke
716099|NCT01021046|deep anterior lamellar keratoplasty|deep anterior lamellar keratoplasty
716100|NCT01021046|rejection|rejection
716101|NCT01021046|high risk patients|high risk patients
716102|NCT01021046|acellular corneal tissue|acellular corneal tissue
716103|NCT01021059|Biological Effects of rhIL-15|biological effects of rhil-15
716104|NCT01021059|Estimate Antitumor Activity|estimate antitumor activity
716105|NCT01021059|rhIL-15 Pharmacokinetics|rhil-15 pharmacokinetics
716106|NCT01021059|Dose and Safety Determination of IL-15|dose and safety determination of il-15
716107|NCT01021059|Kidney Cancer|kidney cancer
716108|NCT01021059|Melanoma|melanoma
716109|NCT01021059|Renal Cell Cancer|renal cell cancer
716110|NCT01021085|Assisted Reproductive Technology|assisted reproductive technology
716111|NCT01021085|circulating cell free fetal DNA|circulating cell free fetal dna
716112|NCT01021085|First trimester|first trimester
716113|NCT01021098|influenza|influenza
716114|NCT01021098|illness|illness
716115|NCT01021098|active-duty|active-duty
716116|NCT01021098|virus|virus
716118|NCT01021098|military|military
716119|NCT01021098|Influenza-like-illnesses|influenza-like-illnesses
716120|NCT01021124|tuberculosis|tuberculosis
716121|NCT01021124|bone marrow transplant|bone marrow transplant
716122|NCT01021124|diagnosis|diagnosis
716123|NCT01021137|vestibular function tests|vestibular function tests
716124|NCT01021137|postural balance|postural balance
716125|NCT01021137|neuroimaging|neuroimaging
716126|NCT01021176|Food Intake|food intake
716127|NCT01021176|Hunger|hunger
716128|NCT01021176|Lidocaine|lidocaine
716129|NCT01021176|Nose|nose
716132|NCT01021189|tolerability|tolerability
716134|NCT01021189|AD|ad
716135|NCT01021189|Japanese|japanese
716136|NCT01021202|tracheostomy|tracheostomy
716137|NCT01021202|tracheotomy|tracheotomy
716138|NCT01021202|dilational|dilational
716139|NCT01021202|dilatative|dilatative
716140|NCT01021202|critical care|critical care
718581|NCT01031225|Synta|synta
716141|NCT01021202|intensive care|intensive care
716142|NCT01021202|COPD|copd
716143|NCT01021202|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
716144|NCT01021202|lung disease|lung disease
716145|NCT01021202|pneumonia|pneumonia
716146|NCT01021202|prospective study|prospective study
716147|NCT01021202|questionnaire|questionnaire
716148|NCT01021202|quality of life|quality of life
716149|NCT01021202|outcome|outcome
716150|NCT01021202|mortality|mortality
716151|NCT01021215|Cancer Prevention|cancer prevention
716152|NCT01021215|Smoking-related lung disease|smoking-related lung disease
716153|NCT01021215|Smoking|smoking
716154|NCT01021215|Celecoxib|celecoxib
716155|NCT01021215|Celebrex|celebrex
716156|NCT01021215|Zileuton|zileuton
716157|NCT01021215|Zyflo CR|zyflo cr
716158|NCT01021215|Prevention|prevention
716159|NCT01021228|Liver resection|liver resection
716160|NCT01021228|Continuous volatile anesthesia|continuous volatile anesthesia
716161|NCT01021228|Continuous intravenous anesthesia|continuous intravenous anesthesia
716162|NCT01021228|Preconditioning volatile anesthesia|preconditioning volatile anesthesia
716257|NCT01027273|Community Based|community based
716258|NCT01027299|cardiac failure|cardiac failure
716736|NCT01029873|targeted|targeted
716163|NCT01021228|Comparing three groups of anesthesia during the liver surgery according to their benefit on liver and outcome.|comparing three groups of anesthesia during the liver surgery according to their benefit on liver and outcome.
716164|NCT01021267|sexual dysfunctions|sexual dysfunctions
716165|NCT01021267|benign prostatic hyperplasia|benign prostatic hyperplasia
716166|NCT01021267|saw palmetto|saw palmetto
716167|NCT01021280|Bartter syndrome,|bartter syndrome,
716168|NCT01021280|parathyroid hormone,|parathyroid hormone,
716169|NCT01021280|calcium sensing receptor,|calcium sensing receptor,
716170|NCT01021280|ROMK channel|romk channel
716171|NCT01021280|Barttin gene|barttin gene
716172|NCT01021280|PTH response to hypo- and hypercalcemia|pth response to hypo- and hypercalcemia
716173|NCT01021293|Poliorix|poliorix
716174|NCT01021293|IPV|ipv
716175|NCT01021319|ischemic stroke|ischemic stroke
716176|NCT01021319|thrombolysis|thrombolysis
716177|NCT01021319|magnetic resonance imaging|magnetic resonance imaging
716178|NCT01021319|diffusion weighted imaging|diffusion weighted imaging
716179|NCT01021319|fluid attenuated inversion recovery|fluid attenuated inversion recovery
716180|NCT01021319|time window|time window
716181|NCT01021332|Lower Urinary Tract Symptoms|lower urinary tract symptoms
716182|NCT01021332|Treatment|treatment
716183|NCT01021332|Solifenacin succinate|solifenacin succinate
716184|NCT01021332|Tamsulosin hydrochloride OCAS|tamsulosin hydrochloride ocas
716185|NCT01021332|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
716186|NCT01021332|EC905|ec905
716187|NCT01021332|Vesomni|vesomni
716188|NCT01021371|HRQOL|hrqol
716189|NCT01021371|Rehabilitation|rehabilitation
716190|NCT01021371|Cancer Patients|cancer patients
716191|NCT01021371|General Practice|general practice
716192|NCT01027026|Cost analysis|cost analysis
716193|NCT01027026|Safety|safety
716194|NCT01027026|Length of stay|length of stay
716195|NCT01027026|Randomized controlled trials|randomized controlled trials
716196|NCT01027026|Early discharge|early discharge
716197|NCT01027039|primary open angle glaucoma|primary open angle glaucoma
716198|NCT01027039|pigmentary glaucoma|pigmentary glaucoma
716199|NCT01027039|exfoliative glaucoma|exfoliative glaucoma
716200|NCT01027039|angle closure glaucoma|angle closure glaucoma
716201|NCT01027039|low tension glaucoma|low tension glaucoma
716203|NCT01027052|Spice|spice
716204|NCT01027065|interleukin-7|interleukin-7
716205|NCT01027065|immune-based therapies|immune-based therapies
716206|NCT01027065|hepatitis B|hepatitis b
716207|NCT01027065|HBe negative|hbe negative
716208|NCT01027065|HBV vaccination|hbv vaccination
716209|NCT01027065|entecavir|entecavir
716210|NCT01027065|tenofovir|tenofovir
716211|NCT01027065|chronic hepatitis|chronic hepatitis
716212|NCT01027065|immune specific responses to HBV|immune specific responses to hbv
716213|NCT01027065|phase 1/2a|phase 1/2a
716214|NCT01027065|viral disease|viral disease
716215|NCT01027065|liver disease|liver disease
716216|NCT01027091|hypocalcemia|hypocalcemia
716217|NCT01027091|total thyroidectomy|total thyroidectomy
716218|NCT01027104|injury prevention|injury prevention
716219|NCT01027104|firearms|firearms
716220|NCT01027104|training|training
716221|NCT01027104|counseling|counseling
716222|NCT01027104|medical education|medical education
716223|NCT01027104|safety|safety
716224|NCT01027104|anticipatory guidance|anticipatory guidance
716225|NCT01027104|Firearm injury prevention anticipatory guidance|firearm injury prevention anticipatory guidance
716226|NCT01027117|Bioavailability|bioavailability
716227|NCT01027117|Revatio|revatio
716228|NCT01027117|Healthy Volunteers|healthy volunteers
716229|NCT01027143|Asthma|asthma
716230|NCT01027143|Obesity|obesity
716231|NCT01027143|Pharmacogenetics|pharmacogenetics
716232|NCT01027143|Nutrigenetics|nutrigenetics
716233|NCT01027156|Public Health|public health
716234|NCT01027156|Biochemistry|biochemistry
716235|NCT01027156|Ecological|ecological
716236|NCT01027169|Hepatic impairment|hepatic impairment
716237|NCT01027169|Liver diseases|liver diseases
716238|NCT01027169|Pharmacokinetics|pharmacokinetics
716239|NCT01027169|To Investigate Pharmacokinetics of Safinamide in Subjects With Mild and Moderate Hepatic Impairment as Compared to Healthy Subjects With Normal Hepatic Function|to investigate pharmacokinetics of safinamide in subjects with mild and moderate hepatic impairment as compared to healthy subjects with normal hepatic function
716240|NCT01027182|HIV|hiv
716241|NCT01027221|Low Dose Radiation|low dose radiation
716242|NCT01027221|pancreatic cancer|pancreatic cancer
716243|NCT01027221|Immunostimulation|immunostimulation
716244|NCT01027234|Healthy volunteers|healthy volunteers
716245|NCT01027247|Primary Glaucoma|primary glaucoma
716246|NCT01027273|Stroke|stroke
716247|NCT01027273|Ischemic Stroke|ischemic stroke
716248|NCT01027273|Transient Ischemic Attack|transient ischemic attack
753808|NCT01177761|exercise|exercise
716249|NCT01027273|Stroke Recurrence Prevention|stroke recurrence prevention
716250|NCT01027273|Cerebrovascular Disorders|cerebrovascular disorders
716251|NCT01027273|Brain Ischemia|brain ischemia
716252|NCT01027273|Brain Infraction|brain infraction
716253|NCT01027273|Brain Diseases|brain diseases
716254|NCT01027273|Cerebral Infraction|cerebral infraction
716255|NCT01027273|Self-management|self-management
716256|NCT01027273|Peer-led|peer-led
716259|NCT01027299|thoracic surgery|thoracic surgery
716260|NCT01027299|cardiac pacing, artificial|cardiac pacing, artificial
716261|NCT01027312|Glaucoma|glaucoma
716262|NCT01027312|quality of life|quality of life
716263|NCT01027312|daily living activities|daily living activities
716264|NCT01027312|visual fields|visual fields
716265|NCT01027312|contrast sensitivity|contrast sensitivity
716266|NCT01027325|Resistant Starch|resistant starch
716267|NCT01027325|Amylose|amylose
716268|NCT01027325|Amylopectin|amylopectin
716269|NCT01027325|LDL subclasses|ldl subclasses
716270|NCT01027325|Dietary carbohydrate|dietary carbohydrate
716271|NCT01027325|Postprandial insulinemia|postprandial insulinemia
716272|NCT01027351|Children|children
716273|NCT01027351|Pre-school|pre-school
716274|NCT01027351|Meningococcal disease|meningococcal disease
716275|NCT01027351|Prevention|prevention
716276|NCT01027351|Vaccination|vaccination
716277|NCT01027832|tracheobronchitis|tracheobronchitis
716278|NCT01027845|Pneumococcal disease|pneumococcal disease
716279|NCT01027845|Immunogenicity|immunogenicity
716280|NCT01027845|Booster vaccination|booster vaccination
716281|NCT01027845|Pneumococcal vaccine|pneumococcal vaccine
716282|NCT01027845|Primary vaccination|primary vaccination
716283|NCT01027845|Safety|safety
716284|NCT01027858|exercise|exercise
716285|NCT01027858|aerobic exercise training|aerobic exercise training
716286|NCT01027858|vascular cognitive impairment|vascular cognitive impairment
716287|NCT01027858|Mild Sub-cortical Ischaemic Vascular Cognitive Impairment (SIVCI)|mild sub-cortical ischaemic vascular cognitive impairment (sivci)
716288|NCT01027884|Idebenone|idebenone
716289|NCT01027884|Duchenne Muscular Dystrophy (DMD)|duchenne muscular dystrophy (dmd)
716290|NCT01027884|Respiratory function|respiratory function
716291|NCT01027884|Ambulatory and non-ambulatory patients|ambulatory and non-ambulatory patients
716292|NCT01027884|Subjects not using glucocorticoids|subjects not using glucocorticoids
716293|NCT01027897|Pharmacokinetics|pharmacokinetics
716294|NCT01027897|Pharmacodynamics|pharmacodynamics
716295|NCT01027897|Doripenem|doripenem
716296|NCT01027897|Trauma|trauma
716297|NCT01027897|sepsis|sepsis
716298|NCT01027897|Trauma patients with sepsis|trauma patients with sepsis
716299|NCT01027910|PCI-24781|pci-24781
716300|NCT01027910|doxorubicin|doxorubicin
716301|NCT01027936|Healthy Volunteers|healthy volunteers
716302|NCT01027962|Early Onset Psychosis|early onset psychosis
716303|NCT01027962|Laptop Computer|laptop computer
716304|NCT01027962|Brain Training|brain training
716305|NCT01027975|laparoscopy|laparoscopy
716306|NCT01027975|fundoplication|fundoplication
716307|NCT01027975|Nissen|nissen
716308|NCT01027975|Thal|thal
716309|NCT01027975|children|children
716310|NCT01027975|operative treatment of gastro-oesophageal reflux disease in children|operative treatment of gastro-oesophageal reflux disease in children
716311|NCT01027988|Retinal Microvascularisation|retinal microvascularisation
716312|NCT01027988|Fundus|fundus
716313|NCT01027988|mfERGs|mfergs
716314|NCT01027988|CHF|chf
716315|NCT01027988|Cardiovascular Disease|cardiovascular disease
716316|NCT01027988|Coronarography|coronarography
716317|NCT01027988|Macrovascularisation|macrovascularisation
716318|NCT01027988|The objectives are to assess if if any retinal vascular disorder in arterioles and venules can be predictive for cardiovascular morbidity and mortality|the objectives are to assess if if any retinal vascular disorder in arterioles and venules can be predictive for cardiovascular morbidity and mortality
716319|NCT01028027|Blepharokeratoconjunctivitis|blepharokeratoconjunctivitis
716320|NCT01028040|Phase I|phase i
716321|NCT01028040|AZD3043|azd3043
716322|NCT01028040|Japanese healthy volunteer|japanese healthy volunteer
716444|NCT01028651|Remodulin|remodulin
716323|NCT01028053|Mild Cognitive Impairment|mild cognitive impairment
716324|NCT01028053|Positron Emission Tomography|positron emission tomography
716325|NCT01028053|National Institute of Neurological and Communicative Disorders and Stroke|national institute of neurological and communicative disorders and stroke
718776|NCT01031836|phase 2|phase 2
716326|NCT01028053|Alzheimer's Disease and Related Disorders Association|alzheimer's disease and related disorders association
716327|NCT01028053|Assess Prognostic Usefulness of Flutemetamol Injection for Identifying Subjects who will Convert to Clinically Probable Alzheimer's Disease|assess prognostic usefulness of flutemetamol injection for identifying subjects who will convert to clinically probable alzheimer's disease
716328|NCT01028066|nutritional intervention|nutritional intervention
716329|NCT01028066|nutritional counseling|nutritional counseling
716330|NCT01028066|feeding behavior|feeding behavior
716331|NCT01028066|food consumption|food consumption
716332|NCT01028066|angioplasty|angioplasty
716333|NCT01028079|Back Pain|back pain
716334|NCT01028079|Acute low back pain|acute low back pain
716335|NCT01028105|Preoperative screening|preoperative screening
716336|NCT01028105|MRSA|mrsa
716337|NCT01028105|Incidence|incidence
716338|NCT01028105|Postoperative infection|postoperative infection
716339|NCT01028105|Preoperative MRSA Screening Incidence|preoperative mrsa screening incidence
716340|NCT01028105|Postoperative MRSA Infection Rate|postoperative mrsa infection rate
716341|NCT01028118|domestic and sexual violence|domestic and sexual violence
716342|NCT01028118|menopause|menopause
716343|NCT01028118|professional improvement|professional improvement
716344|NCT01028118|social support network|social support network
716345|NCT01028131|cigarette smoking|cigarette smoking
716346|NCT01028131|pregnancy|pregnancy
716347|NCT01028131|intervention|intervention
716348|NCT01028131|efficacy|efficacy
716349|NCT01028131|Motivational Interviewing|motivational interviewing
716350|NCT01028131|Contingency Management|contingency management
716351|NCT01028144|Exercise|exercise
716352|NCT01028144|Physical Activity|physical activity
716353|NCT01028144|Adolescent|adolescent
716354|NCT01028144|Minority Health|minority health
716355|NCT01028157|HIV|hiv
716356|NCT01028157|risk reduction|risk reduction
716357|NCT01028157|behavioral intervention|behavioral intervention
716358|NCT01028170|Congestive Heart Failure|congestive heart failure
716359|NCT01028170|Renal Insufficiency|renal insufficiency
716360|NCT01028170|Cardio-renal Syndrome|cardio-renal syndrome
716361|NCT01028183|therapeutics|therapeutics
716362|NCT01028183|safety|safety
716363|NCT01028183|maternal|maternal
716364|NCT01028183|neonatal|neonatal
716365|NCT01028196|schizophrenia|schizophrenia
716366|NCT01028196|schizoaffective disorder|schizoaffective disorder
716367|NCT01028196|recurrent depression|recurrent depression
716368|NCT01028196|Bipolar disorders|bipolar disorders
716369|NCT01028222|Melanoma|melanoma
716370|NCT01028222|AMN107|amn107
716371|NCT01028222|c-Kit|c-kit
716372|NCT01028222|c-Kit mutated metastatic and/or inoperable melanoma|c-kit mutated metastatic and/or inoperable melanoma
716373|NCT01028235|Eosinophilic Esophagitis|eosinophilic esophagitis
716374|NCT01028248|Central Retinal Vein Occlusion|central retinal vein occlusion
716375|NCT01028248|Retinal Vein Occlusive disease|retinal vein occlusive disease
716376|NCT01028261|Obese|obese
716377|NCT01028261|Obesity|obesity
716378|NCT01028261|Overweight|overweight
716379|NCT01028274|Hypercholesterolemia|hypercholesterolemia
716380|NCT01028274|Hypertriglyceridemia|hypertriglyceridemia
716381|NCT01028274|Fish Oil|fish oil
716382|NCT01028274|Red Yeast Rice|red yeast rice
716383|NCT01028287|Diabetic Nephropathy|diabetic nephropathy
716384|NCT01028287|Nephrotic syndrome|nephrotic syndrome
716385|NCT01028300|DDD|ddd
716386|NCT01028313|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
716387|NCT01028313|GVHD|gvhd
716388|NCT01028313|LBH589|lbh589
716389|NCT01028313|Panobinostat|panobinostat
716390|NCT01028326|Pneumococcal pneumonia vaccine|pneumococcal pneumonia vaccine
716391|NCT01028339|traumatic brain injury|traumatic brain injury
716392|NCT01028339|PtiO2|ptio2
716393|NCT01028339|Cerebral microdialysis|cerebral microdialysis
716394|NCT01028339|Osmotherapy|osmotherapy
716395|NCT01028339|hypertonic saline|hypertonic saline
716396|NCT01028339|mannitol|mannitol
716397|NCT01028365|Fertility|fertility
716398|NCT01028365|Trying to Conceive|trying to conceive
716399|NCT01028365|Trying to Get Pregnant|trying to get pregnant
716400|NCT01028365|Pregnancy|pregnancy
716401|NCT01028417|subcentimetre nodules|subcentimetre nodules
716402|NCT01028430|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
716403|NCT01028456|Seizures|seizures
716404|NCT01028456|Light Therapy|light therapy
716405|NCT01028482|severity of depression measured by MADRS and CGI|severity of depression measured by madrs and cgi
716406|NCT01028508|Depression|depression
716407|NCT01028508|ECT|ect
716408|NCT01028508|electroconvulsive therapy|electroconvulsive therapy
716409|NCT01028508|mood disorders|mood disorders
716410|NCT01028508|continuation ECT|continuation ect
716411|NCT01028508|continuation pharmacotherapy|continuation pharmacotherapy
716412|NCT01028508|geriatric|geriatric
716413|NCT01028508|elderly|elderly
716414|NCT01028508|lithium|lithium
716415|NCT01028508|venlafaxine|venlafaxine
716416|NCT01028521|First time in man, safety study, Cm3.1-AC100|first time in man, safety study, cm3.1-ac100
716417|NCT01028521|Male volunteer aged 18 to 50 years at Screening|male volunteer aged 18 to 50 years at screening
716418|NCT01028534|Continuous positive pressure ventilation|continuous positive pressure ventilation
716419|NCT01028534|Blood pressure|blood pressure
716420|NCT01028534|Oxygen desaturation index|oxygen desaturation index
716421|NCT01028534|Endothelial dysfunction|endothelial dysfunction
716422|NCT01028534|Patient reported measurement|patient reported measurement
716423|NCT01028547|PONV|ponv
716424|NCT01028560|Wheezing|wheezing
716425|NCT01028560|Asthma|asthma
716426|NCT01028560|Allergy|allergy
716427|NCT01028560|Immunotherapy|immunotherapy
716428|NCT01028573|bowel preparation|bowel preparation
716429|NCT01028573|colonoscopy|colonoscopy
716430|NCT01028599|Heart transplantation|heart transplantation
716431|NCT01028599|Exercise capacity|exercise capacity
753809|NCT01177761|fractures|fractures
716432|NCT01028599|Endothelial function|endothelial function
716433|NCT01028625|Heart failure|heart failure
716434|NCT01028625|Depression|depression
716435|NCT01028625|Self Care|self care
716436|NCT01028625|Cognitive behavior therapy|cognitive behavior therapy
716437|NCT01028638|VEGF imaging|vegf imaging
716438|NCT01028638|everolimus|everolimus
716439|NCT01028638|renal cell carcinoma|renal cell carcinoma
716440|NCT01028638|PET|pet
716441|NCT01028638|bevacizumab|bevacizumab
716442|NCT01028651|PAH|pah
716443|NCT01028651|Pulmonary Hypertension|pulmonary hypertension
716445|NCT01028651|Treprostinil|treprostinil
716446|NCT01028651|Quality of Life|quality of life
716447|NCT01028664|Glaucoma and ocular hypertension patients|glaucoma and ocular hypertension patients
716448|NCT01028677|oxytocin|oxytocin
716449|NCT01028677|social cognition|social cognition
716450|NCT01028677|social skill|social skill
716451|NCT01028677|social functioning|social functioning
716452|NCT01028677|paranoia|paranoia
716453|NCT01028677|psychotic symptoms|psychotic symptoms
716454|NCT01028677|schizophrenia|schizophrenia
716455|NCT01028677|social deficits|social deficits
716456|NCT01028677|intranasal administration|intranasal administration
716457|NCT01028690|Helicobacter pylori|helicobacter pylori
716458|NCT01028690|Eradication therapy|eradication therapy
716459|NCT01028690|Lactobacillus reuteri|lactobacillus reuteri
716460|NCT01028690|Dyspeptic symptoms|dyspeptic symptoms
716461|NCT01028703|Chronic kidney disease|chronic kidney disease
716462|NCT01028703|left ventricular dysfunction|left ventricular dysfunction
716463|NCT01028703|diastolic dysfunction|diastolic dysfunction
716464|NCT01028703|hypertension|hypertension
716465|NCT01028742|Traumatic brain injury|traumatic brain injury
716466|NCT01028742|Hypopituitarism|hypopituitarism
716467|NCT01028742|Incidence|incidence
716468|NCT01028755|Maximum Tolerated Dose|maximum tolerated dose
716469|NCT01028768|Renal impairment|renal impairment
716470|NCT01028768|Renal impairment study|renal impairment study
716471|NCT01028794|stroke|stroke
716472|NCT01028794|bone marrow|bone marrow
716473|NCT01028794|mononuclear cell|mononuclear cell
716474|NCT01028794|angiogenesis|angiogenesis
716475|NCT01028794|neurogenesis|neurogenesis
716476|NCT01028807|Early feeding|early feeding
716477|NCT01028807|Bowel anastomosis|bowel anastomosis
716478|NCT01028807|Children|children
716479|NCT01028820|autism|autism
716480|NCT01028820|asperger's|asperger's
716481|NCT01028820|repetitive|repetitive
716482|NCT01028820|restricted|restricted
716483|NCT01028820|compulsions|compulsions
716484|NCT01028833|power wheelchairs|power wheelchairs
716485|NCT01028833|power mobility|power mobility
716486|NCT01028833|young children|young children
716487|NCT01028846|Type 2 Diabetes|type 2 diabetes
716488|NCT01028859|Tubulin polymerization inhibitor|tubulin polymerization inhibitor
716489|NCT01028859|CKD-516|ckd-516
716490|NCT01028859|Phase I|phase i
716491|NCT01028859|Vascular disrupting agent|vascular disrupting agent
716492|NCT01028859|DCE MRI|dce mri
716493|NCT01028872|higher-order aberrations, contrast sensitivity|higher-order aberrations, contrast sensitivity
716495|NCT01028898|proteomics|proteomics
716496|NCT01028898|fluorescent quantitation polymerase chain reaction|fluorescent quantitation polymerase chain reaction
716497|NCT01028898|Western blot|western blot
716498|NCT01028898|immunohistochemistry staining (IHC)|immunohistochemistry staining (ihc)
716499|NCT01028898|ATP content|atp content
716500|NCT01028898|micRNA|micrna
716501|NCT01028911|Phase 1 Alzheimer's disease Safety Tolerability Pharmacokinetics|phase 1 alzheimer's disease safety tolerability pharmacokinetics
716502|NCT01028924|Thorough QTc-Study|thorough qtc-study
716503|NCT01028924|Short Bowel Syndrome|short bowel syndrome
716504|NCT01028924|Cardiac safety|cardiac safety
716505|NCT01028937|Hyperopia correction|hyperopia correction
716506|NCT01028937|Laser vision correction|laser vision correction
716507|NCT01028937|Optimal keratoplasty|optimal keratoplasty
716508|NCT01028950|YM150|ym150
716509|NCT01028950|Bleeding|bleeding
716510|NCT01028950|VTE|vte
716511|NCT01028950|FXa inhibitor|fxa inhibitor
716512|NCT01028950|Deep Vein Thrombosis|deep vein thrombosis
716513|NCT01028950|Venous thromboembolism|venous thromboembolism
716514|NCT01028976|randomized controlled trial|randomized controlled trial
716515|NCT01028976|primary prevention|primary prevention
716516|NCT01028976|Vitamin C|vitamin c
716517|NCT01028976|Antioxidants|antioxidants
716518|NCT01028976|C-reactive protein|c-reactive protein
716519|NCT01028976|inflammation|inflammation
716520|NCT01028976|anti-inflammatory agents|anti-inflammatory agents
716522|NCT01028989|Polycystic Ovary Syndrome|polycystic ovary syndrome
716523|NCT01028989|Insulin|insulin
716524|NCT01028989|Diet|diet
716525|NCT01028989|Glycemic Load|glycemic load
716526|NCT01029002|Vitamin D|vitamin d
716528|NCT01029002|proteinuria|proteinuria
716529|NCT01029015|OAB|oab
716530|NCT01029015|Insomnia|insomnia
716531|NCT01029015|Bladder function|bladder function
716532|NCT01029015|cystometry|cystometry
716533|NCT01029015|polysomnography|polysomnography
716534|NCT01029041|fibromyalgia, exercise, strength, stretch|fibromyalgia, exercise, strength, stretch
716535|NCT01029054|Multiple Myeloma|multiple myeloma
716536|NCT01029067|schizophrenia|schizophrenia
716537|NCT01029067|delusion|delusion
716538|NCT01029067|paranoia|paranoia
716539|NCT01029067|psychosis|psychosis
716540|NCT01029080|Brain, blood flow|brain, blood flow
716541|NCT01029080|Measurement techniques, flow velocity waveform analysis|measurement techniques, flow velocity waveform analysis
716542|NCT01029080|Monitoring, intensive care|monitoring, intensive care
716543|NCT01029080|Sepsis|sepsis
716544|NCT01029080|transcranial doppler ultrasound (TCD)|transcranial doppler ultrasound (tcd)
716545|NCT01029080|Cerebrovascular autoregulation|cerebrovascular autoregulation
716546|NCT01029080|sepsis-associated delir|sepsis-associated delir
716547|NCT01029093|extremity with immobilisation|extremity with immobilisation
716548|NCT01029093|brain platicity|brain platicity
716549|NCT01029093|deprivation|deprivation
716550|NCT01029093|MRI|mri
716551|NCT01029106|SUI|sui
716552|NCT01029106|Stress Urinary Incontinence|stress urinary incontinence
716553|NCT01029106|Patients with Stress Urinary Incontinence|patients with stress urinary incontinence
716554|NCT01029119|blood pressure|blood pressure
716555|NCT01029132|Alzheimer's disease|alzheimer's disease
716556|NCT01029132|Galantamine|galantamine
716557|NCT01029132|Treatment response|treatment response
716558|NCT01029132|Efficacy|efficacy
716559|NCT01029132|Adverse Event|adverse event
716560|NCT01029145|Bipolar disorder|bipolar disorder
716561|NCT01029145|New occured episode: manic depressive or mixed|new occured episode: manic depressive or mixed
716562|NCT01029158|Healthy volunteers|healthy volunteers
716563|NCT01029158|Comparison of two formulations|comparison of two formulations
716564|NCT01029158|Improvement of scar appearance|improvement of scar appearance
716565|NCT01029171|falls|falls
716566|NCT01029171|balance training|balance training
716567|NCT01029171|strength training|strength training
716568|NCT01029184|weaning|weaning
716569|NCT01029184|cereals|cereals
716570|NCT01029184|allergy|allergy
716571|NCT01029184|atopy|atopy
716572|NCT01029184|open allergenic test|open allergenic test
716573|NCT01029210|osteoporosis|osteoporosis
716574|NCT01029210|temporomandibular disorders|temporomandibular disorders
716575|NCT01029210|resonance magnetic|resonance magnetic
716576|NCT01029236|obesity|obesity
716577|NCT01029236|metabolism|metabolism
716578|NCT01029236|weight loss|weight loss
716579|NCT01029236|energy expenditure|energy expenditure
716580|NCT01029236|thermogenesis|thermogenesis
716581|NCT01029236|Metabolism-Boosting Beverages effect on REE|metabolism-boosting beverages effect on ree
716582|NCT01029236|Metabolism-Boosting Beverages effect on appetite|metabolism-boosting beverages effect on appetite
716583|NCT01029262|Myelodysplastic Syndromes|myelodysplastic syndromes
716585|NCT01029262|transfusion dependent anemia|transfusion dependent anemia
716586|NCT01029262|Erythropoiesis stimulating agents|erythropoiesis stimulating agents
716587|NCT01029262|non-del 5q|non-del 5q
716588|NCT01029275|Acromegaly|acromegaly
716589|NCT01029275|pituitary adenoma|pituitary adenoma
716590|NCT01029275|octreotide|octreotide
716591|NCT01029275|transsphenoïdal surgery|transsphenoïdal surgery
716592|NCT01029275|GH|gh
716593|NCT01029275|IGF-1|igf-1
716594|NCT01029288|Diabetes|diabetes
716595|NCT01029288|Decision aid|decision aid
716596|NCT01029288|Cardiovascular risk|cardiovascular risk
716597|NCT01029288|Patient education|patient education
716598|NCT01029301|Skin aging|skin aging
716599|NCT01029301|Skin Wrinkling|skin wrinkling
716600|NCT01029314|Thermometry|thermometry
716601|NCT01029340|Hemophilia A|hemophilia a
716602|NCT01029340|Factor VIII|factor viii
716603|NCT01029340|Prophylaxis|prophylaxis
716604|NCT01029353|NICHD Neonatal Research Network|nichd neonatal research network
716605|NCT01029353|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
716606|NCT01029353|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
716607|NCT01029353|Prematurity|prematurity
716608|NCT01029353|Laparotomy|laparotomy
716609|NCT01029353|Drainage|drainage
716610|NCT01029353|Isolated intestinal perforation|isolated intestinal perforation
716611|NCT01029353|Focal intestinal perforation|focal intestinal perforation
716612|NCT01029379|propofol|propofol
716613|NCT01029379|depth of anesthesia|depth of anesthesia
716614|NCT01029379|pharmacogenetics|pharmacogenetics
716615|NCT01029379|Depth of anesthesia in correlation to plasma concentrations of propofol|depth of anesthesia in correlation to plasma concentrations of propofol
716616|NCT01029392|Diabetes|diabetes
716617|NCT01029392|Type I|type i
719078|NCT01039974|Phase I|phase i
716618|NCT01029392|Newly Diagnosis Type I Diabetes Mellitus|newly diagnosis type i diabetes mellitus
716619|NCT01029405|Topical|topical
716620|NCT01029405|Plaque type psoriasis|plaque type psoriasis
716621|NCT01029418|HCC|hcc
716622|NCT01029418|hepatocellular carcinoma|hepatocellular carcinoma
716623|NCT01029418|liver cancer|liver cancer
716624|NCT01029431|intubating laryngeal airway|intubating laryngeal airway
716625|NCT01029431|pediatric|pediatric
716626|NCT01029444|Diabetes|diabetes
716627|NCT01029444|Pulsatile intravenous insulin|pulsatile intravenous insulin
716628|NCT01029444|Oral carbohydrate loading|oral carbohydrate loading
716629|NCT01029444|Respiratory Quotients|respiratory quotients
716630|NCT01029444|Hypoglycemia|hypoglycemia
716631|NCT01029444|Hyperglycemia|hyperglycemia
716632|NCT01029444|Diabetes Mellitus, with complications|diabetes mellitus, with complications
716633|NCT01029470|Luveris|luveris
716634|NCT01029470|hyporesponse|hyporesponse
716635|NCT01029470|pituitary downregulation|pituitary downregulation
716636|NCT01029470|IVF|ivf
716637|NCT01029470|Infertility women|infertility women
716638|NCT01029483|Obesity|obesity
716639|NCT01029483|Weight loss|weight loss
716640|NCT01029483|low carbohydrate diets|low carbohydrate diets
716641|NCT01029483|high complex carbohydrate diets|high complex carbohydrate diets
716642|NCT01029483|Healthy adults|healthy adults
716643|NCT01029483|Body composition|body composition
716644|NCT01029483|Energy Expenditure|energy expenditure
716645|NCT01029496|umbilical CORD CLAMPING|umbilical cord clamping
716646|NCT01029496|Neonatal anemia|neonatal anemia
716647|NCT01029496|Omphalitis|omphalitis
716648|NCT01029509|Advanced Leukemia|advanced leukemia
716649|NCT01029509|Acute myeloid leukemia|acute myeloid leukemia
716650|NCT01029509|ALL|all
716651|NCT01029509|Chronic myeloid leukemia blast crisis|chronic myeloid leukemia blast crisis
716652|NCT01029509|CMS|cms
716653|NCT01029509|Acute lymphocytic leukemia|acute lymphocytic leukemia
716654|NCT01029509|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
716655|NCT01029509|Myelodysplastic syndromes|myelodysplastic syndromes
716656|NCT01029509|MDS|mds
716657|NCT01029509|OPB 31121|opb 31121
716658|NCT01029522|Dyslipidemia|dyslipidemia
716659|NCT01029548|HIV|hiv
716660|NCT01029548|Therapeutic Vaccine|therapeutic vaccine
716661|NCT01029561|Metabolic syndrome|metabolic syndrome
716662|NCT01029561|Insulin Resistance|insulin resistance
716664|NCT01029561|Proinflammatory markers|proinflammatory markers
716665|NCT01029561|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
716666|NCT01029561|Continuous Positive Airway Pressure|continuous positive airway pressure
716667|NCT01029561|Obesity|obesity
716668|NCT01029561|Bariatric surgery|bariatric surgery
716669|NCT01029574|Rotator cuff lesions|rotator cuff lesions
716670|NCT01029574|Platelet rich plasma|platelet rich plasma
716671|NCT01029574|Arthroscopic repair|arthroscopic repair
716672|NCT01029587|CAPS|caps
716673|NCT01029587|Kidney transplant|kidney transplant
716674|NCT01029587|Renal transplant|renal transplant
716675|NCT01029587|Catastrophic Antiphospholipid Antibody Syndrome|catastrophic antiphospholipid antibody syndrome
716676|NCT01029600|Randomized study capsulotomy vs distention with steroid|randomized study capsulotomy vs distention with steroid
716677|NCT01029639|Pulsatile intravenous insulin|pulsatile intravenous insulin
716678|NCT01029639|Oral carbohydrate loading|oral carbohydrate loading
716679|NCT01029639|Respiratory Quotients|respiratory quotients
716680|NCT01029639|Hypoglycemia|hypoglycemia
716681|NCT01029639|Diabetes Mellitus, with complications|diabetes mellitus, with complications
716682|NCT01029652|frequent flares|frequent flares
716683|NCT01029652|gout|gout
716684|NCT01029652|anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
716685|NCT01029665|Hernia, Diaphragmatic|hernia, diaphragmatic
716686|NCT01029665|Asthma|asthma
716687|NCT01029665|Feeding and Eating Disorders of Childhood|feeding and eating disorders of childhood
716688|NCT01029665|Growth & Development|growth & development
716689|NCT01029678|Locally advanced lung cancer|locally advanced lung cancer
716690|NCT01029678|Elderly patients|elderly patients
716691|NCT01029678|NSCLC|nsclc
716692|NCT01029691|Sleep disordered breathing|sleep disordered breathing
716693|NCT01029691|Preeclampsia|preeclampsia
716694|NCT01029691|Positive Airway Pressure|positive airway pressure
716695|NCT01029704|Diabetes Mellitus Type 2|diabetes mellitus type 2
716696|NCT01029717|Central Venous Catheters|central venous catheters
716697|NCT01029717|blood stream infection|blood stream infection
716698|NCT01029717|children, intensive care|children, intensive care
716699|NCT01029717|Heparin bonded|heparin bonded
716700|NCT01029717|antibiotic coated|antibiotic coated
716701|NCT01029717|Children in Paediatric Intensive Care Unit|children in paediatric intensive care unit
716702|NCT01029730|Low grade lymphoma|low grade lymphoma
716703|NCT01029730|Previously untreated lymphoma|previously untreated lymphoma
716704|NCT01029730|Lymphoma first line|lymphoma first line
716705|NCT01029730|bendamustine|bendamustine
716706|NCT01029730|Treanda|treanda
716707|NCT01029730|bortezomib|bortezomib
716708|NCT01029730|Velcade|velcade
716709|NCT01029730|rituximab|rituximab
716710|NCT01029730|Rituxan|rituxan
716711|NCT01029743|TKR (Total Knee Replacement)|tkr (total knee replacement)
716712|NCT01029743|THR (Total Hip Replacement)|thr (total hip replacement)
716713|NCT01029743|VTE (Venous Thromboembolism)|vte (venous thromboembolism)
716714|NCT01029743|LMWH (Low Molecular Weight Heparin)|lmwh (low molecular weight heparin)
716715|NCT01029743|VKA (Vitamin K antagonist)|vka (vitamin k antagonist)
716716|NCT01029756|Pentax Airway Scope AWS S100|pentax airway scope aws s100
716717|NCT01029756|Pentax AWS|pentax aws
716718|NCT01029756|Macintosh|macintosh
716719|NCT01029756|Laryngoscope|laryngoscope
716720|NCT01029756|Video Laryngoscope|video laryngoscope
716721|NCT01029782|Cellulitis|cellulitis
716722|NCT01029782|Emergency Department|emergency department
716723|NCT01029782|Cefazolin|cefazolin
716724|NCT01029782|Probenecid|probenecid
716725|NCT01029782|Cephalexin|cephalexin
716726|NCT01029808|carriers of hemophilia|carriers of hemophilia
716727|NCT01029821|Low-Molecular-Weight-Heparin|low-molecular-weight-heparin
716728|NCT01029821|Open Reduction and Internal Fixation|open reduction and internal fixation
716729|NCT01029821|Thromboprophylaxis|thromboprophylaxis
716730|NCT01029834|BMI >85%for age and gender|bmi >85%for age and gender
716731|NCT01029847|Patients with axial spondyloarthritis|patients with axial spondyloarthritis
716732|NCT01029860|Hypertension|hypertension
716733|NCT01029860|Ambulatory measurement|ambulatory measurement
716734|NCT01029873|cancer|cancer
716735|NCT01029873|immunotherapy|immunotherapy
716737|NCT01029873|metastatic|metastatic
716738|NCT01029873|interleukin-2|interleukin-2
716739|NCT01029873|IL-2|il-2
716740|NCT01029873|Cisplatin|cisplatin
716741|NCT01029873|antitumor|antitumor
716742|NCT01029873|melanoma|melanoma
716743|NCT01029873|TCR|tcr
716744|NCT01029873|T-cell receptor|t-cell receptor
716745|NCT01029873|p53|p53
716746|NCT01029873|p53 gene|p53 gene
716747|NCT01029873|p53 tumor suppressor protein|p53 tumor suppressor protein
716748|NCT01029886|diabetes|diabetes
716749|NCT01029886|exenatide once weekly|exenatide once weekly
716750|NCT01029886|Byetta|byetta
716751|NCT01029886|liraglutide|liraglutide
716752|NCT01029886|Victoza|victoza
716753|NCT01029886|Amylin|amylin
716754|NCT01029886|Lilly|lilly
716755|NCT01029899|Colonoscopy|colonoscopy
716756|NCT01029899|Force|force
716757|NCT01029899|Monitor|monitor
716758|NCT01029899|Endoscopist|endoscopist
716759|NCT01029899|Trainee|trainee
716763|NCT01029912|Electrical Stimulation|electrical stimulation
716764|NCT01029912|Motor Relearning|motor relearning
716765|NCT01029912|Neuroplasticity|neuroplasticity
716766|NCT01029925|metastatic breast cancer|metastatic breast cancer
716767|NCT01029925|lung cancer|lung cancer
716768|NCT01029925|Previously treated metastatic breast cancer|previously treated metastatic breast cancer
716769|NCT01029925|stage IIIb lung cancer|stage iiib lung cancer
716770|NCT01029925|stage IV lung cancer|stage iv lung cancer
716771|NCT01029938|Intracranial aneurysms;|intracranial aneurysms;
716772|NCT01029938|Covered stent;|covered stent;
716773|NCT01029938|Coil embolization|coil embolization
716774|NCT01029951|Chiropractic; osteopathic physicians; manipulation; neck pain; adverse effects; randomized clinical trial|chiropractic; osteopathic physicians; manipulation; neck pain; adverse effects; randomized clinical trial
716775|NCT01029951|Subacute non-specific neck pain|subacute non-specific neck pain
716776|NCT01029964|Childhood obesity|childhood obesity
716777|NCT01029964|Age-dependent|age-dependent
716778|NCT01029964|Long-term treatment|long-term treatment
716779|NCT01029964|BMI SDS|bmi sds
716780|NCT01029964|Dropouts|dropouts
716781|NCT01029990|participation|participation
716782|NCT01029990|mass screening|mass screening
716783|NCT01029990|cervical neoplasia|cervical neoplasia
716784|NCT01029990|health economics|health economics
716785|NCT01029990|cost-benefit|cost-benefit
716786|NCT01030003|Sleep-Disordered Breathing|sleep-disordered breathing
716787|NCT01030003|Snoring|snoring
716788|NCT01030003|Pregnancy|pregnancy
716789|NCT01030003|Fetal Growth Retardation|fetal growth retardation
716790|NCT01030003|Pre-Eclampsia|pre-eclampsia
716791|NCT01030016|resistance exercise|resistance exercise
716792|NCT01030016|beta-blockers|beta-blockers
716793|NCT01030016|blood pressure|blood pressure
716794|NCT01030029|auricular acupuncture|auricular acupuncture
716795|NCT01030029|postoperative pain|postoperative pain
716796|NCT01030029|opioid consumption|opioid consumption
716797|NCT01030029|laparoscopic surgery|laparoscopic surgery
716798|NCT01030029|ACUPUNCTURE THERAPY (IM) + EAR, EXTERNAL (IM)|acupuncture therapy (im) + ear, external (im)
716799|NCT01030042|metastatic|metastatic
716800|NCT01030042|colorectal cancer|colorectal cancer
716801|NCT01030042|two sequences therapy|two sequences therapy
716802|NCT01030055|Neoplasms|neoplasms
716803|NCT01030055|Cancer|cancer
716804|NCT01030055|Tumors|tumors
716805|NCT01030055|Administration, oral|administration, oral
716806|NCT01030055|Capsules|capsules
716807|NCT01030055|CHIR258|chir258
716808|NCT01030055|CHIR-258|chir-258
716809|NCT01030055|CHIR 258|chir 258
716810|NCT01030055|TKI258|tki258
716811|NCT01030055|TKI-258|tki-258
716812|NCT01030055|TKI 258|tki 258
716813|NCT01030055|Bioavailability|bioavailability
716814|NCT01030055|Food|food
716815|NCT01030068|Smoking Cessation|smoking cessation
716816|NCT01030068|Yoga|yoga
716817|NCT01030068|Wellness|wellness
716818|NCT01030068|Feasibility|feasibility
716819|NCT01030068|Smoking Cessation Therapy|smoking cessation therapy
716820|NCT01030081|24 hour blood pressure|24 hour blood pressure
716821|NCT01030081|morning blood pressure surge|morning blood pressure surge
716822|NCT01030081|amlodipine|amlodipine
716823|NCT01030081|nifedipine GITS|nifedipine gits
716824|NCT01030094|Topiramate|topiramate
716825|NCT01030094|Carbamazepine|carbamazepine
716826|NCT01030094|Valproic acid|valproic acid
716827|NCT01030094|Epilepsy|epilepsy
716828|NCT01030094|Bone mineral density|bone mineral density
716829|NCT01030094|Monotherapy|monotherapy
716830|NCT01030107|sleep|sleep
716831|NCT01030107|obesity|obesity
716832|NCT01030107|children|children
716833|NCT01030107|eating behaviors|eating behaviors
716834|NCT01030107|activity|activity
716835|NCT01030107|leptin|leptin
716836|NCT01030107|ghrelin|ghrelin
716837|NCT01030120|chronic idiopathic urticaria|chronic idiopathic urticaria
716838|NCT01030120|etanercept|etanercept
716839|NCT01030133|pain|pain
716840|NCT01030159|Cancer Anemia Survey|cancer anemia survey
716841|NCT01030159|Thai National Cancer Institute|thai national cancer institute
716842|NCT01030185|ascites|ascites
716843|NCT01030185|liver cirrhosis|liver cirrhosis
716844|NCT01030211|Dengue|dengue
716845|NCT01030211|Platelet transfusion|platelet transfusion
716846|NCT01030211|Bleeding|bleeding
716847|NCT01030211|Prevention|prevention
716848|NCT01030224|Healthy volunteer|healthy volunteer
716849|NCT01030224|First time in human|first time in human
716850|NCT01030237|Dry eye|dry eye
716851|NCT01030237|artificial tears|artificial tears
716852|NCT01030250|Breast Cancer|breast cancer
716853|NCT01030250|Adjuvant Chemotherapy|adjuvant chemotherapy
716854|NCT01030289|food cravings|food cravings
716855|NCT01030302|Bortezomib retreatment|bortezomib retreatment
716856|NCT01030302|Velcade|velcade
716857|NCT01030302|Proteasome inhibitor|proteasome inhibitor
716858|NCT01030302|Bortezomib|bortezomib
716859|NCT01030315|Erythropoietin|erythropoietin
716860|NCT01030315|Long-acting|long-acting
716861|NCT01030315|EPO|epo
716862|NCT01024205|clear cell renal cell carcinoma|clear cell renal cell carcinoma
716863|NCT01024205|stage IV renal cell cancer|stage iv renal cell cancer
716864|NCT01024257|beta-irradiation;conjunctival autograft;pterygium;recurrence; clinical trial|beta-irradiation;conjunctival autograft;pterygium;recurrence; clinical trial
716865|NCT01024270|endometrial pathology of uterus|endometrial pathology of uterus
716866|NCT01024270|operative hysteroscopy|operative hysteroscopy
716867|NCT01024270|efficacy of misoprostol per different routes|efficacy of misoprostol per different routes
716868|NCT01024283|Heat Shock Protein 90 Inhibitor (HSP90)|heat shock protein 90 inhibitor (hsp90)
716869|NCT01024283|Pharmacodynamic|pharmacodynamic
716870|NCT01024283|Blood|blood
716871|NCT01024283|Biopsy|biopsy
716872|NCT01024283|Solid malignancies|solid malignancies
716873|NCT01024309|total hip arthroplasty|total hip arthroplasty
716874|NCT01024322|Diagnosis of keratoconus, post-LASIK ectasia, FFKC, or pellucid marginal degeneration|diagnosis of keratoconus, post-lasik ectasia, ffkc, or pellucid marginal degeneration
716875|NCT01024335|opioid dependence|opioid dependence
716876|NCT01024335|naltrexone|naltrexone
716877|NCT01024335|vivitrol|vivitrol
716878|NCT01024335|dronabinol|dronabinol
716879|NCT01024335|marinol|marinol
716880|NCT01024348|Surgery, knee arthroscopy|surgery, knee arthroscopy
716881|NCT01024348|Pain, postoperative|pain, postoperative
716882|NCT01024348|tramadol, extended release|tramadol, extended release
716883|NCT01024361|Preterm infants|preterm infants
716884|NCT01024361|Nasal CPAP|nasal cpap
716885|NCT01024361|Delivery room|delivery room
716886|NCT01024361|Newborn|newborn
716887|NCT01024387|AMG 479|amg 479
716888|NCT01024400|Influenza|influenza
716889|NCT01024400|Vaccine|vaccine
716890|NCT01024400|Pregnancy|pregnancy
716891|NCT01024413|Thoracic Neoplasms|thoracic neoplasms
716892|NCT01024413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
716893|NCT01024413|Protein Kinase Inhibitors|protein kinase inhibitors
716894|NCT01024413|Respiratory Tract Diseases|respiratory tract diseases
716895|NCT01024413|Lung Neoplasms|lung neoplasms
716896|NCT01024413|Erlotinib|erlotinib
716897|NCT01024413|Gefitinib|gefitinib
716898|NCT01024413|Epidermal growth factor receptor genes|epidermal growth factor receptor genes
716899|NCT01024426|Uganda|uganda
716900|NCT01024426|malaria|malaria
716901|NCT01024426|enhanced health facility-based care|enhanced health facility-based care
716902|NCT01024426|febrile illnesses|febrile illnesses
716903|NCT01024426|health services|health services
716904|NCT01024452|anticoagulation|anticoagulation
716905|NCT01024452|warfarin|warfarin
716906|NCT01024452|computer systems|computer systems
716907|NCT01024452|international normalized ratio|international normalized ratio
716908|NCT01024452|nomograms|nomograms
716909|NCT01024465|obesity|obesity
716910|NCT01024465|intragastric balloon|intragastric balloon
716911|NCT01024478|Coronary Artery|coronary artery
716912|NCT01024478|Magnetic Resonance Angiography|magnetic resonance angiography
716913|NCT01024478|Coronary Artery disease|coronary artery disease
716914|NCT01024478|Multicenter Trial|multicenter trial
716915|NCT01024478|Cardiac MRI|cardiac mri
716916|NCT01024491|premature ejaculation|premature ejaculation
716917|NCT01024491|paroxetine|paroxetine
716918|NCT01024491|daily treatment|daily treatment
716919|NCT01024504|Cancer|cancer
716920|NCT01024504|Colorectal cancer|colorectal cancer
716921|NCT01024504|Elderly|elderly
716922|NCT01024504|Chemotherapy|chemotherapy
716923|NCT01024504|Capecitabine|capecitabine
716924|NCT01024504|Oxaliplatin|oxaliplatin
716925|NCT01024504|Bevacizumab|bevacizumab
716926|NCT01024517|Safety|safety
716927|NCT01024517|Tolerability|tolerability
716928|NCT01024517|Pharmacokinetics|pharmacokinetics
716929|NCT01024530|hepatocellular carcinoma|hepatocellular carcinoma
716930|NCT01024530|HCC|hcc
716931|NCT01024530|NK|nk
716932|NCT01024530|immune killer cells|immune killer cells
716933|NCT01030341|Diabetes|diabetes
716934|NCT01030341|Gastroparesis|gastroparesis
716935|NCT01030354|Satiety|satiety
716936|NCT01030354|Meal Replacements|meal replacements
716937|NCT01030354|High Protein|high protein
716938|NCT01030354|Standard Protein|standard protein
716939|NCT01030367|Coronary artery disease|coronary artery disease
716940|NCT01030380|Facial toning|facial toning
716941|NCT01030380|Facial lift|facial lift
716942|NCT01030380|Improve facial complexion|improve facial complexion
716943|NCT01030380|Improve facial tone|improve facial tone
716944|NCT01030380|Improve radiance of the face|improve radiance of the face
716945|NCT01030380|Reduce signs of facial aging|reduce signs of facial aging
716946|NCT01030380|firming, lift, tone face|firming, lift, tone face
716947|NCT01030393|hCG|hcg
716948|NCT01030393|pregnancy|pregnancy
716949|NCT01030393|implantation|implantation
716950|NCT01030393|ICSI|icsi
716951|NCT01030393|IVF|ivf
716952|NCT01030406|Abuse Liability|abuse liability
716953|NCT01030406|Abuse Prevention|abuse prevention
716954|NCT01030406|Abuse Resistance|abuse resistance
716955|NCT01030406|Abuse Deterrence|abuse deterrence
716956|NCT01030419|Aging|aging
716957|NCT01030419|Quality of Life|quality of life
716958|NCT01030419|Functional fitness|functional fitness
716959|NCT01030445|non-invasive cardiac output monitor|non-invasive cardiac output monitor
716960|NCT01030445|electrical velocimetry|electrical velocimetry
716961|NCT01030445|Aesculon|aesculon
716964|NCT01030445|normal reference|normal reference
716965|NCT01030458|Blood pressure|blood pressure
716966|NCT01030458|Hypertension|hypertension
716967|NCT01030458|Blacks|blacks
716968|NCT01030458|Africa|africa
716969|NCT01030458|Blood pressure control|blood pressure control
716970|NCT01030458|Side-effects|side-effects
716971|NCT01030471|adolescents|adolescents
716972|NCT01030471|depression|depression
716973|NCT01030471|adherence|adherence
716974|NCT01030471|family functioning|family functioning
716975|NCT01030471|intervention|intervention
716976|NCT01030484|NAFLD|nafld
716977|NCT01030484|NASH|nash
716978|NCT01030484|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
716979|NCT01030484|fatty liver disease|fatty liver disease
716980|NCT01030497|Cancer|cancer
716981|NCT01030497|Cervical Lymph Node Metastases|cervical lymph node metastases
716982|NCT01030497|High-Resolution PET Imaging System|high-resolution pet imaging system
716983|NCT01030497|Upper Aerodigestive Tract|upper aerodigestive tract
716984|NCT01030497|Head|head
716985|NCT01030497|Neck|neck
716986|NCT01030497|HR PET Imaging System|hr pet imaging system
716987|NCT01030497|High-Resolution PET|high-resolution pet
716988|NCT01030497|PET/CT|pet/ct
716989|NCT01030497|PEMFlex Solo II|pemflex solo ii
716990|NCT01030497|positron emission tomography/computed tomography (PET/CT)|positron emission tomography/computed tomography (pet/ct)
716992|NCT01030536|CLL|cll
716993|NCT01030549|cardiovascular magnetic resonance|cardiovascular magnetic resonance
716994|NCT01030549|ventricular volumes|ventricular volumes
716995|NCT01030549|ventricular function|ventricular function
716996|NCT01030549|Healthy normal individuals from 20 to 80 years of age|healthy normal individuals from 20 to 80 years of age
716997|NCT01030562|adolescent, vaccine, human papillomavirus, HPV|adolescent, vaccine, human papillomavirus, hpv
716998|NCT01030575|NICHD Neonatal Research Network|nichd neonatal research network
716999|NCT01030575|Pharmacokinetics|pharmacokinetics
717000|NCT01030575|Inositol|inositol
717001|NCT01030575|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
717002|NCT01030575|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
717003|NCT01030575|Prematurity|prematurity
717004|NCT01030601|Diabetic|diabetic
717005|NCT01030601|Macular Edema|macular edema
717006|NCT01030601|Pseudophakic|pseudophakic
717007|NCT01030601|Dexamethasone|dexamethasone
717008|NCT01030601|Intravitreal|intravitreal
717009|NCT01030601|Cataract surgery|cataract surgery
717010|NCT01030614|Laparoscopic cholecystectomy,postoperative symptoms|laparoscopic cholecystectomy,postoperative symptoms
717011|NCT01030627|Eclampsia|eclampsia
717012|NCT01030627|Preeclampsia|preeclampsia
717013|NCT01030627|Magnesium sulfate|magnesium sulfate
717014|NCT01030640|intraepidermal nerve fiber density|intraepidermal nerve fiber density
717016|NCT01030640|tanezumab|tanezumab
717017|NCT01030640|subcutaneous|subcutaneous
717018|NCT01030640|healthy volunteers|healthy volunteers
717019|NCT01030653|Voriconazole|voriconazole
717020|NCT01030653|Pharmacokinetics|pharmacokinetics
717021|NCT01030653|Obese|obese
717022|NCT01030653|Healthy Volunteer|healthy volunteer
717023|NCT01030666|periodontal regeneration|periodontal regeneration
717024|NCT01030666|radiographic bone fill|radiographic bone fill
717025|NCT01030666|infrabony defects|infrabony defects
717026|NCT01030666|randomized placebo-controlled clinical trial|randomized placebo-controlled clinical trial
717027|NCT01030666|guided tissue regeneration, periodontal|guided tissue regeneration, periodontal
717028|NCT01031901|Tuberous Sclerosis|tuberous sclerosis
717029|NCT01031901|Neurofibromatoses|neurofibromatoses
717030|NCT01031901|Angiofibroma|angiofibroma
717031|NCT01031901|Neurofibroma|neurofibroma
717032|NCT01031901|Sirolimus|sirolimus
717033|NCT01031914|Paced Breathing|paced breathing
717034|NCT01031914|OSA|osa
717035|NCT01031914|sleep/wake detection|sleep/wake detection
717036|NCT01031927|obsessive compulsive disorder|obsessive compulsive disorder
717037|NCT01031927|sarcosine|sarcosine
717038|NCT01031927|glycine transporter I|glycine transporter i
717039|NCT01031927|NMDA receptor|nmda receptor
717040|NCT01031953|nausea and vomiting|nausea and vomiting
717041|NCT01031953|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
717042|NCT01031966|ESRD|esrd
717043|NCT01031979|PTSD|ptsd
717044|NCT01031979|Prolonged Exposure|prolonged exposure
717045|NCT01031979|extinction|extinction
717046|NCT01031979|habituation|habituation
717047|NCT01031979|psychophysiology|psychophysiology
717048|NCT01031992|Hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
717049|NCT01031992|Rendu-Osler-Weber syndrome|rendu-osler-weber syndrome
717050|NCT01031992|Epistaxis|epistaxis
717051|NCT01031992|Nosebleeds|nosebleeds
717052|NCT01031992|Anemia|anemia
717053|NCT01031992|Tranexamic acid|tranexamic acid
717054|NCT01031992|Antifibrinolytics|antifibrinolytics
717055|NCT01032018|Acute coronary syndrome|acute coronary syndrome
717056|NCT01032018|Depression|depression
717057|NCT01032018|Satisfaction with care|satisfaction with care
717058|NCT01032031|Green tea|green tea
717059|NCT01032031|Vitamin C|vitamin c
717060|NCT01032031|Ultraviolet radiation|ultraviolet radiation
717061|NCT01032031|Inflammation|inflammation
717062|NCT01032031|Photoageing|photoageing
717063|NCT01032044|Barrett's esophagus|barrett's esophagus
717064|NCT01032044|EsoGastroDuodenoscopy|esogastroduodenoscopy
717065|NCT01032044|Barrett's carcinoma|barrett's carcinoma
717066|NCT01032044|adenocarcinoma|adenocarcinoma
717067|NCT01032044|Cellvizio|cellvizio
717068|NCT01032044|endomicroscopy|endomicroscopy
717069|NCT01032044|probe-based Confocal Laser Endomicroscopy|probe-based confocal laser endomicroscopy
717070|NCT01032044|pCLE|pcle
717071|NCT01032044|Radio-frequency ablation|radio-frequency ablation
717072|NCT01032044|Endoscopic mucosal resection|endoscopic mucosal resection
717073|NCT01032044|Photodynamic therapy|photodynamic therapy
717074|NCT01032057|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
717075|NCT01032057|stage II pancreatic cancer|stage ii pancreatic cancer
717076|NCT01032057|stage III pancreatic cancer|stage iii pancreatic cancer
717077|NCT01032070|phase 2|phase 2
717078|NCT01032070|erlotinib|erlotinib
717079|NCT01032070|pediatric|pediatric
717080|NCT01032070|etoposide|etoposide
717081|NCT01032070|ependymoma|ependymoma
717082|NCT01032083|SSRI antidepressant|ssri antidepressant
717083|NCT01032083|Negative symptoms|negative symptoms
717084|NCT01032083|Schizophrenia|schizophrenia
717085|NCT01032122|melanoma|melanoma
717086|NCT01032122|rituximab|rituximab
717087|NCT01032122|metastatic|metastatic
717088|NCT01032122|stage IIIc/IV|stage iiic/iv
717089|NCT01032122|stem cell|stem cell
717090|NCT01032122|overall survival|overall survival
717091|NCT01032122|disease free interval|disease free interval
717092|NCT01032122|anti-CD20 therapy|anti-cd20 therapy
717093|NCT01032148|Recurrent|recurrent
717094|NCT01032148|Refractory|refractory
717095|NCT01032161|Delirium|delirium
717096|NCT01032161|Postoperative|postoperative
717097|NCT01032161|Non-cardiovascular surgery|non-cardiovascular surgery
717098|NCT01032161|Post-anaesthesia care unit|post-anaesthesia care unit
717099|NCT01032161|patients between 3 to 12 years old|patients between 3 to 12 years old
717100|NCT01032161|undergoing selective non-cardiac surgery|undergoing selective non-cardiac surgery
717101|NCT01032161|under general anesthesia|under general anesthesia
717102|NCT01032161|surgery|surgery
717103|NCT01032161|general anesthesia|general anesthesia
717104|NCT01032174|Azithromycin SR Amoxiclav 1000 mg Maxillary Sinusitis|azithromycin sr amoxiclav 1000 mg maxillary sinusitis
717105|NCT01032187|Visceral leishmaniasis|visceral leishmaniasis
717106|NCT01032187|Amphotericin B deoxycholate|amphotericin b deoxycholate
717107|NCT01032187|Meglumine antimoniate|meglumine antimoniate
717108|NCT01032187|Children|children
717109|NCT01032187|Brazil|brazil
717110|NCT01032200|fatigue|fatigue
717111|NCT01032200|cognitive/functional effects|cognitive/functional effects
717112|NCT01032200|adult giant cell glioblastoma|adult giant cell glioblastoma
717113|NCT01032200|adult glioblastoma|adult glioblastoma
717114|NCT01032200|adult gliosarcoma|adult gliosarcoma
717115|NCT01032200|adult anaplastic astrocytoma|adult anaplastic astrocytoma
717116|NCT01032200|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
717117|NCT01032200|adult mixed glioma|adult mixed glioma
717118|NCT01032200|adult diffuse astrocytoma|adult diffuse astrocytoma
717119|NCT01032200|adult pilocytic astrocytoma|adult pilocytic astrocytoma
717120|NCT01032200|adult pineal gland astrocytoma|adult pineal gland astrocytoma
717121|NCT01032200|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
717122|NCT01032200|adult oligodendroglioma|adult oligodendroglioma
717123|NCT01032200|adult anaplastic ependymoma|adult anaplastic ependymoma
717124|NCT01032200|adult ependymoma|adult ependymoma
717125|NCT01032200|adult myxopapillary ependymoma|adult myxopapillary ependymoma
717126|NCT01032200|adult subependymoma|adult subependymoma
717127|NCT01032200|adult anaplastic meningioma|adult anaplastic meningioma
717128|NCT01032200|adult grade I meningioma|adult grade i meningioma
717129|NCT01032200|adult grade II meningioma|adult grade ii meningioma
717130|NCT01032200|adult grade III meningioma|adult grade iii meningioma
717131|NCT01032200|adult papillary meningioma|adult papillary meningioma
717132|NCT01032200|adult brain stem glioma|adult brain stem glioma
717133|NCT01032239|Severe spasticity in post-stroke patients|severe spasticity in post-stroke patients
717134|NCT01032252|fall prevention|fall prevention
717135|NCT01032252|general practitioners setting|general practitioners setting
717136|NCT01032252|implementation|implementation
717137|NCT01032252|network|network
717138|NCT01032252|community dwelling older adults|community dwelling older adults
717139|NCT01032252|exercise intervention|exercise intervention
717140|NCT01032265|female|female
717141|NCT01032265|stress urinary incontinence|stress urinary incontinence
717142|NCT01032265|treatment|treatment
717143|NCT01032265|pelvic floor muscle training|pelvic floor muscle training
717144|NCT01032265|cognitive behavioral therapy|cognitive behavioral therapy
717145|NCT01032265|internet|internet
717146|NCT01032265|life style|life style
717147|NCT01032265|pamphlet|pamphlet
717148|NCT01032265|eHealth|ehealth
717149|NCT01032278|cardiac toxicity|cardiac toxicity
717150|NCT01032278|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
717151|NCT01032291|Colorectal cancer|colorectal cancer
717152|NCT01032291|Revlimid|revlimid
717153|NCT01032291|Lenalidomide|lenalidomide
717154|NCT01032291|Cetuximab|cetuximab
717155|NCT01032291|Erbitux|erbitux
717156|NCT01032291|KRAS|kras
717157|NCT01032317|Arrhythmia|arrhythmia
717158|NCT01032317|Electrophysiology|electrophysiology
717159|NCT01032317|Fibrillation|fibrillation
717160|NCT01032317|Tachycardia|tachycardia
717161|NCT01032317|Ablation|ablation
717162|NCT01032317|Atrial Fibrillation (AF)|atrial fibrillation (af)
717163|NCT01032317|Ischemic Ventricular Tachycardia (VT)|ischemic ventricular tachycardia (vt)
717164|NCT01032330|intermittent exotropia|intermittent exotropia
717166|NCT01032330|natural history|natural history
717167|NCT01032330|occlusion therapy|occlusion therapy
717168|NCT01032330|occlusion|occlusion
717169|NCT01032330|patching|patching
717170|NCT01032330|strabismus|strabismus
717171|NCT01032330|strabismus treatment|strabismus treatment
717172|NCT01032330|stereoacuity|stereoacuity
717173|NCT01032330|motor alignment|motor alignment
717174|NCT01032343|Immunosuppression|immunosuppression
717175|NCT01032343|Ultraviolet radiation|ultraviolet radiation
717176|NCT01032343|Nickel|nickel
717177|NCT01032343|Contact hypersensitivity|contact hypersensitivity
717178|NCT01032356|Distal Radius fracture|distal radius fracture
717179|NCT01032369|"Over-weight or obese subjects with learning disability who have completed Nitzan Onim two-year training program and live in housing within the community"|"over-weight or obese subjects with learning disability who have completed nitzan onim two-year training program and live in housing within the community"
717180|NCT01032382|leishmaniasis|leishmaniasis
717181|NCT01032382|cutaneous|cutaneous
717182|NCT01032382|WR 279,396|wr 279,396
717183|NCT01032382|paromomycin|paromomycin
717184|NCT01032382|gentamicin|gentamicin
717185|NCT01032382|pharmacokinetics|pharmacokinetics
717186|NCT01032382|safety|safety
717187|NCT01032382|efficacy|efficacy
717188|NCT01032395|H1N1|h1n1
717189|NCT01032395|Pulmonary Disease|pulmonary disease
717190|NCT01032395|Heart Disease|heart disease
717191|NCT01032395|Diabetes|diabetes
717192|NCT01032395|Influenza|influenza
717193|NCT01032395|immunogenicity|immunogenicity
717194|NCT01032395|safety|safety
717195|NCT01032395|tolerability|tolerability
717389|NCT01033110|inactive|inactive
717196|NCT01032408|Influenza A Virus|influenza a virus
717197|NCT01032408|Virus Diseases|virus diseases
717198|NCT01032408|Influenza, Human|influenza, human
717200|NCT01032408|Immunodeficiency Virus|immunodeficiency virus
717201|NCT01032408|H1N1|h1n1
717202|NCT01032408|HIV Infection|hiv infection
717203|NCT01032408|Immunogenicity|immunogenicity
717204|NCT01032408|safety|safety
717205|NCT01032408|tolerability|tolerability
717206|NCT01032421|women admitted to the In Vitro Fertilization unit|women admitted to the in vitro fertilization unit
717207|NCT01032434|sertraline|sertraline
717208|NCT01032434|Polysomnograph|polysomnograph
717209|NCT01032460|airway|airway
717210|NCT01032460|airway device|airway device
717211|NCT01032460|cervical spine immobilisation|cervical spine immobilisation
717212|NCT01032486|Rasagiline|rasagiline
717213|NCT01032486|Sleep|sleep
717214|NCT01032486|Sleepiness|sleepiness
717215|NCT01032486|Parkinson's Disease Sleep Scale|parkinson's disease sleep scale
717216|NCT01032486|Epworth Sleepiness Scale|epworth sleepiness scale
717217|NCT01032499|Acne Vulgaris|acne vulgaris
717218|NCT01032499|Boil|boil
717219|NCT01032499|Taro Elixir|taro elixir
717220|NCT01032512|IMMUNE-ENHANCING|immune-enhancing
717221|NCT01032512|GLUTAMINE|glutamine
717222|NCT01032512|ARGININE|arginine
717223|NCT01032512|OMEGA 3 FATTY ACIDS|omega 3 fatty acids
717224|NCT01032512|ONCOLOGIC SURGERY|oncologic surgery
717225|NCT01032512|PREOPERATIVE NUTRITION|preoperative nutrition
717226|NCT01032525|Crohn's Disease|crohn's disease
717227|NCT01032525|Ulcerative Colitis|ulcerative colitis
717229|NCT01032525|Inflammatory Bowel Disease in Monroe County, NY|inflammatory bowel disease in monroe county, ny
717230|NCT01032538|Unicondylar Knee Replacement|unicondylar knee replacement
717231|NCT01032551|Coronary Angiogram|coronary angiogram
717232|NCT01032551|Decision Aid|decision aid
717233|NCT01032551|Vascular Access|vascular access
717234|NCT01032551|Radial|radial
717235|NCT01032551|Femoral|femoral
717621|NCT01034254|influenza|influenza
717236|NCT01032564|estimate the interest of the measure of cervix elasticity degree by elastography in prediction of premature birth within a population of pregnant women|estimate the interest of the measure of cervix elasticity degree by elastography in prediction of premature birth within a population of pregnant women
717237|NCT01032577|ischemic cardiomyopathy|ischemic cardiomyopathy
717238|NCT01032577|nonischemic cardiomyopathy|nonischemic cardiomyopathy
717239|NCT01032577|implant|implant
717240|NCT01032577|bipolar sensing|bipolar sensing
717241|NCT01032577|extended bipolar sensing|extended bipolar sensing
717242|NCT01032590|weight changes|weight changes
717243|NCT01032590|cancer survivor|cancer survivor
717244|NCT01032590|stage I colon cancer|stage i colon cancer
717245|NCT01032590|stage II colon cancer|stage ii colon cancer
717246|NCT01032590|stage III colon cancer|stage iii colon cancer
717247|NCT01032590|stage I rectal cancer|stage i rectal cancer
717248|NCT01032590|stage II rectal cancer|stage ii rectal cancer
717249|NCT01032590|stage III rectal cancer|stage iii rectal cancer
717250|NCT01032603|IXT|ixt
717251|NCT01032603|Exotropia|exotropia
717252|NCT01032603|Strabismus|strabismus
717253|NCT01032603|Intermittent exotropia|intermittent exotropia
717254|NCT01032616|splanchnic bed|splanchnic bed
717255|NCT01032616|theronine and lysine metabolism uptake|theronine and lysine metabolism uptake
717256|NCT01032616|isotopes|isotopes
717257|NCT01032616|metabolism of two indispensable amino acids, threonine and lysine, by the splanchnic bed by Healthy Males|metabolism of two indispensable amino acids, threonine and lysine, by the splanchnic bed by healthy males
717258|NCT01032629|Diabetes|diabetes
717259|NCT01032629|Type 2 diabetes mellitus|type 2 diabetes mellitus
717260|NCT01032629|Cardiovascular risk|cardiovascular risk
717261|NCT01032629|Cardiovascular outcomes|cardiovascular outcomes
717262|NCT01032629|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
717263|NCT01032629|Placebo|placebo
717264|NCT01032642|infertility fallopian tubes|infertility fallopian tubes
717265|NCT01032655|Helicobacter pylori|helicobacter pylori
717266|NCT01032655|sequential therapy|sequential therapy
717267|NCT01032655|susceptibility-driven|susceptibility-driven
717268|NCT01032655|rescue|rescue
717269|NCT01032655|levofloxacin|levofloxacin
717270|NCT01032655|clarithromycin|clarithromycin
717271|NCT01032655|salvage|salvage
717272|NCT01032655|treatment failure|treatment failure
717273|NCT01032655|those who fail from two standard eradication therapies|those who fail from two standard eradication therapies
717274|NCT01032668|percutaneous coronary intervention, clopidogrel resistance, ASA resistance|percutaneous coronary intervention, clopidogrel resistance, asa resistance
717275|NCT01032681|Solid tumor|solid tumor
717276|NCT01032681|B-Cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
717277|NCT01032681|Immunocytokine|immunocytokine
717278|NCT01032681|interleukin-2|interleukin-2
717279|NCT01032681|immunotherapy|immunotherapy
717280|NCT01032681|Metastatic or Locally Advanced Solid Tumors or B-Cell Non-Hodgkin Lymphoma|metastatic or locally advanced solid tumors or b-cell non-hodgkin lymphoma
717281|NCT01032694|Community-Acquired Pneumonia|community-acquired pneumonia
717282|NCT01032694|Azithromycin SR|azithromycin sr
717283|NCT01032694|Amoxiclav|amoxiclav
717284|NCT01032720|ultrasound|ultrasound
717285|NCT01032720|osteoarthritis|osteoarthritis
717286|NCT01032720|knee|knee
717287|NCT01032720|corticosteroids|corticosteroids
717288|NCT01032720|intra-articular|intra-articular
717289|NCT01032720|injections|injections
717290|NCT01032733|Weight Loss|weight loss
717291|NCT01032733|Physical Function|physical function
717292|NCT01032733|Oxidative Stress|oxidative stress
717293|NCT01032733|Inflammation|inflammation
717294|NCT01032746|colon cancer|colon cancer
717295|NCT01032746|rectal cancer|rectal cancer
717296|NCT01032772|alcohol-exposed pregnancy|alcohol-exposed pregnancy
717297|NCT01032772|tobacco-exposed pregnancy|tobacco-exposed pregnancy
717298|NCT01032772|alcohol|alcohol
717299|NCT01032772|contraception|contraception
717300|NCT01032772|smoking|smoking
717301|NCT01032772|pregnancy|pregnancy
717302|NCT01032785|Patent Foramen Ovale|patent foramen ovale
717303|NCT01032785|Patent Ductus Arteriosus|patent ductus arteriosus
717304|NCT01032785|PFO|pfo
717305|NCT01032785|PDA|pda
717306|NCT01032811|ADHD, childhood cancer|adhd, childhood cancer
717307|NCT01032811|ADHD/Secondary ADHD Among Survivors of Childhood Cancer|adhd/secondary adhd among survivors of childhood cancer
717308|NCT01032824|Complementary Therapies|complementary therapies
717309|NCT01032850|INST 0820|inst 0820
717310|NCT01032850|sorafenib|sorafenib
717311|NCT01032850|capecitabine|capecitabine
717312|NCT01032850|hepatocellular carcinoma|hepatocellular carcinoma
717313|NCT01032850|lung|lung
717314|NCT01032850|nexavar|nexavar
717315|NCT01032850|xeloda|xeloda
717316|NCT01032850|liver cancer|liver cancer
717317|NCT01032863|Chronic musculoskeletal pain|chronic musculoskeletal pain
717318|NCT01032863|Benign joint hypermobility syndrome|benign joint hypermobility syndrome
717319|NCT01032863|Fibromyalgia|fibromyalgia
717320|NCT01032876|Congenital Heart disease|congenital heart disease
717321|NCT01032876|Cardiopulmonary bypass|cardiopulmonary bypass
717322|NCT01032876|Neonatal brain injury|neonatal brain injury
717323|NCT01032876|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
717324|NCT01032876|Antegrade Cerebral Perfusion|antegrade cerebral perfusion
718212|NCT01037933|Distraction|distraction
717325|NCT01032902|Human immunodeficiency virus|human immunodeficiency virus
717326|NCT01032902|Rapid Test|rapid test
717327|NCT01032902|HIV|hiv
717328|NCT01032902|HIV Seronegativity|hiv seronegativity
717329|NCT01032915|Quiescent uveitis|quiescent uveitis
717330|NCT01032915|intermediate uveitis|intermediate uveitis
717331|NCT01032915|panuveitis|panuveitis
717332|NCT01032915|posterior uveitis|posterior uveitis
717333|NCT01032915|uveitis|uveitis
717334|NCT01032928|Swallowing|swallowing
717335|NCT01032928|Dysphagia|dysphagia
717336|NCT01032928|Breathing and swallowing|breathing and swallowing
717337|NCT01032928|Oropharyngeal cancer|oropharyngeal cancer
717338|NCT01032941|Portal Hypertension|portal hypertension
717339|NCT01032941|Portal Pressure Measurement|portal pressure measurement
717340|NCT01032941|VSL3|vsl3
717341|NCT01032941|Cirrhosis|cirrhosis
717342|NCT01032941|End Stage Liver Disease|end stage liver disease
717344|NCT01032954|Botulinum Toxin|botulinum toxin
717345|NCT01032954|Rejuvenation|rejuvenation
717346|NCT01032954|Facial dynamic wrinkles|facial dynamic wrinkles
717347|NCT01032967|squamous cell carcinoma|squamous cell carcinoma
717348|NCT01032967|esophagectomy|esophagectomy
717349|NCT01032967|chemoradiotherapy|chemoradiotherapy
717350|NCT01032967|chemoradiation|chemoradiation
717351|NCT01032967|Squamous cell carcinomas of the esophagus|squamous cell carcinomas of the esophagus
717352|NCT01032980|HUMENZA|humenza
717353|NCT01032980|PANENZA|panenza
717354|NCT01032980|Influenza|influenza
717355|NCT01032980|Swine-Origin Influenza A H1N1 Virus|swine-origin influenza a h1n1 virus
717356|NCT01032980|Influenza virus vaccines|influenza virus vaccines
717357|NCT01032993|CoQ10|coq10
717358|NCT01032993|Statins|statins
717359|NCT01032993|Myalgia|myalgia
717360|NCT01032993|Muscle Pain|muscle pain
717361|NCT01032993|Muscle Weakness|muscle weakness
717362|NCT01033006|Peripheral Nerves|peripheral nerves
717363|NCT01033006|Axillary Block|axillary block
717364|NCT01033006|MRI|mri
717365|NCT01033019|Basal cell carcinomas,|basal cell carcinomas,
717366|NCT01033019|sporadic,|sporadic,
717367|NCT01033019|superficial and nodular,|superficial and nodular,
717368|NCT01033019|skin|skin
717369|NCT01033032|Metastatic Breast Cancer|metastatic breast cancer
717370|NCT01033032|Amrubicin|amrubicin
717371|NCT01033045|Hepatitis C|hepatitis c
717372|NCT01033045|Viral|viral
717373|NCT01033045|Non-A|non-a
717374|NCT01033045|Non-B|non-b
717375|NCT01033045|Parenterally-Transmitted|parenterally-transmitted
717376|NCT01033058|STEMI|stemi
717377|NCT01033058|atorvastatin|atorvastatin
717378|NCT01033058|PCI|pci
717379|NCT01033071|Hypertensive|hypertensive
717380|NCT01033071|Blood Pressure, High|blood pressure, high
717381|NCT01033071|Cardiovascular disease|cardiovascular disease
717382|NCT01033071|Vascular Disease|vascular disease
717383|NCT01033071|Drug Therapy|drug therapy
717384|NCT01033084|Depressive Disorder, Major|depressive disorder, major
717385|NCT01033097|Dermatitis|dermatitis
717386|NCT01033097|inflammatory skin disease|inflammatory skin disease
717387|NCT01033097|itch|itch
717388|NCT01033097|eczema|eczema
717390|NCT01033110|>45 years|>45 years
717391|NCT01033110|female|female
717392|NCT01033123|ovarian|ovarian
717393|NCT01033123|cancer|cancer
717394|NCT01033123|sensitive|sensitive
717395|NCT01033123|PARP|parp
717396|NCT01033123|recurrent|recurrent
717397|NCT01033123|platinum-sensitive recurrent ovarian cancer|platinum-sensitive recurrent ovarian cancer
717398|NCT01033175|COPD|copd
717399|NCT01033175|anemia|anemia
717400|NCT01033175|exercise|exercise
717401|NCT01033175|cytokines|cytokines
717402|NCT01033175|erythropoietin|erythropoietin
717403|NCT01033188|double bundle|double bundle
719828|NCT01041963|ACEI|acei
717404|NCT01033188|hamstring graft|hamstring graft
717405|NCT01033188|ACL reconstruction|acl reconstruction
717406|NCT01033188|single bundle|single bundle
717407|NCT01033201|Lung rejection|lung rejection
717408|NCT01033214|TAA|taa
717409|NCT01033214|Thoracic|thoracic
717410|NCT01033214|Descending Thoracic Aorta|descending thoracic aorta
717411|NCT01033214|TAArget|taarget
717412|NCT01033227|sickle cell disease|sickle cell disease
717413|NCT01033227|sickle cell anemia|sickle cell anemia
717414|NCT01033227|pain crisis|pain crisis
717415|NCT01033227|nitric oxide|nitric oxide
717416|NCT01033227|nitrite|nitrite
717417|NCT01033227|vaso occlusive crisis|vaso occlusive crisis
717418|NCT01033227|pain medication|pain medication
717419|NCT01033227|sickled cells|sickled cells
717420|NCT01033227|blood flow|blood flow
717421|NCT01033227|microcirculation|microcirculation
717422|NCT01033279|Coaguchek|coaguchek
717423|NCT01033279|Portable coagulometer|portable coagulometer
717424|NCT01033279|Self-monitoring|self-monitoring
717425|NCT01033279|Coumadin|coumadin
717426|NCT01033279|Warfarin|warfarin
717427|NCT01033279|Quality of life|quality of life
717428|NCT01033279|Pharmacist|pharmacist
717429|NCT01033292|ovarian|ovarian
717430|NCT01033292|cancer|cancer
717431|NCT01033292|sensitive|sensitive
717432|NCT01033292|PARP|parp
717433|NCT01033292|recurrent|recurrent
717434|NCT01033292|platinum-resistant recurrent ovarian cancer|platinum-resistant recurrent ovarian cancer
717435|NCT01033305|UC|uc
717436|NCT01033318|Hypertension|hypertension
717437|NCT01033331|Spinal Muscular atrophy|spinal muscular atrophy
717438|NCT01033331|Valproic acid|valproic acid
717439|NCT01033331|HMAS|hmas
717440|NCT01033331|MRC scale|mrc scale
717441|NCT01033344|Cat allergy|cat allergy
717442|NCT01033344|Rhinoconjunctivitis|rhinoconjunctivitis
717443|NCT01033344|Exposure chamber|exposure chamber
717444|NCT01033344|Immunotherapy|immunotherapy
717445|NCT01033344|Cat-PAD|cat-pad
717446|NCT01033357|dialysis|dialysis
717447|NCT01033357|hemodialysis|hemodialysis
717448|NCT01033357|neointimal hyperplasia|neointimal hyperplasia
717449|NCT01033370|acute|acute
717450|NCT01033370|aortic|aortic
717451|NCT01033370|emergencies|emergencies
717452|NCT01033370|Aortic dissection|aortic dissection
717736|NCT01027793|Tretinoin|tretinoin
717453|NCT01033396|Allergic rhinitis Environmental exposure unit|allergic rhinitis environmental exposure unit
717454|NCT01033409|Salmonella Typhi|salmonella typhi
717455|NCT01033409|pneumonia|pneumonia
717456|NCT01033409|oral|oral
717457|NCT01033409|vaccine|vaccine
717458|NCT01033422|Glaucoma|glaucoma
717459|NCT01033422|Ocular hypertension|ocular hypertension
717460|NCT01033422|Intraocular hypertension|intraocular hypertension
717461|NCT01033435|Inflammation|inflammation
717462|NCT01033435|Oxidative stress|oxidative stress
717463|NCT01033435|HbA1c|hba1c
717464|NCT01033435|Hemodialysis|hemodialysis
717465|NCT01033461|probiotic|probiotic
717466|NCT01033461|lactobacillus paracasei|lactobacillus paracasei
717467|NCT01033461|calcium|calcium
717468|NCT01033461|faecal microbiota|faecal microbiota
717469|NCT01033461|cholesterol metabolism|cholesterol metabolism
717470|NCT01033474|Infertile Patients|infertile patients
717471|NCT01033487|Safety|safety
717472|NCT01033487|Pharmacokinetics|pharmacokinetics
717473|NCT01033487|Pharmacodynamics|pharmacodynamics
717474|NCT01033487|PF-03635659|pf-03635659
717475|NCT01033487|COPD|copd
717476|NCT01033526|Symptomatic treatment of Common Cold symptoms|symptomatic treatment of common cold symptoms
717477|NCT01033539|Survive|survive
717478|NCT01033539|safety|safety
717479|NCT01033539|lactobacillus Reuteri|lactobacillus reuteri
717480|NCT01033565|Impaired sleep maintenance|impaired sleep maintenance
717481|NCT01033565|Autism Spectrum Disorders|autism spectrum disorders
717482|NCT01033565|Pediatric|pediatric
717483|NCT01033591|Primary Health Care|primary health care
717484|NCT01033591|Family PractiCe|family practice
717485|NCT01033591|Hearth Failure|hearth failure
717486|NCT01033591|Exercise|exercise
717487|NCT01033591|Randomized Controlled Trials|randomized controlled trials
717488|NCT01033591|Multicenter Study|multicenter study
717489|NCT01033591|Quality of life|quality of life
717490|NCT01033617|Stem cells|stem cells
717491|NCT01033617|Cellular therapy|cellular therapy
717492|NCT01033617|Myocardial repair|myocardial repair
717493|NCT01033656|adult-onset Still's disease|adult-onset still's disease
717494|NCT01033656|anakinra|anakinra
717495|NCT01033656|prednisolone|prednisolone
717885|NCT01036217|Selection|selection
717496|NCT01033656|disease-modifying antirheumatic drug|disease-modifying antirheumatic drug
717497|NCT01033656|methotrexate|methotrexate
717498|NCT01033656|efficacy|efficacy
717499|NCT01033656|patients|patients
717500|NCT01033669|Inhalation profiles|inhalation profiles
717501|NCT01033669|asthma|asthma
717502|NCT01033669|COPD|copd
717503|NCT01033695|Endoscopy|endoscopy
717504|NCT01033695|Endoscopic Ultrasound|endoscopic ultrasound
717505|NCT01033695|Endoscopic Sonoelastography|endoscopic sonoelastography
717507|NCT01033695|Interobserver agreement|interobserver agreement
717508|NCT01033708|Psychotherapy|psychotherapy
717509|NCT01033708|PTSD|ptsd
717510|NCT01033708|Borderline personality disorders|borderline personality disorders
717511|NCT01033747|iron overload|iron overload
717512|NCT01033747|iron chelation therapy|iron chelation therapy
717513|NCT01033747|B-thalassemia|b-thalassemia
717514|NCT01033760|Primary HIV-1 infection|primary hiv-1 infection
717515|NCT01033760|antiretroviral treatment|antiretroviral treatment
717516|NCT01033760|HIV reservoirs|hiv reservoirs
717517|NCT01033760|HIV-DNA levels|hiv-dna levels
717518|NCT01033760|randomized|randomized
717519|NCT01033760|Treatment Naive|treatment naive
717520|NCT01033773|Type 2 diabetes mellitus|type 2 diabetes mellitus
717521|NCT01033773|Uncontrolled hyperglycemia|uncontrolled hyperglycemia
717522|NCT01033773|Emergency Department|emergency department
717523|NCT01033799|Probiotic - Lactobacillus casei DN114-001|probiotic - lactobacillus casei dn114-001
717524|NCT01033799|dairy product - infections - shiftworkers|dairy product - infections - shiftworkers
717525|NCT01033799|Common infectious diseases,|common infectious diseases,
717526|NCT01033799|occuring in healthy subjects,|occuring in healthy subjects,
717527|NCT01033799|including upper respiratory tract infections (defined as rhinopharyngitis, sore throat, sinusitis and otitis),|including upper respiratory tract infections (defined as rhinopharyngitis, sore throat, sinusitis and otitis),
717528|NCT01033799|lower respiratory tract infections (defined as bronchitis,|lower respiratory tract infections (defined as bronchitis,
717529|NCT01033799|pneumopathy and flu and flu-like syndromes), and|pneumopathy and flu and flu-like syndromes), and
717530|NCT01033799|gastrointestinal tract infection defined as gastroenteritis.|gastrointestinal tract infection defined as gastroenteritis.
717531|NCT01033812|Networks|networks
717532|NCT01033812|Index recruiter|index recruiter
717533|NCT01033877|Immunisation, active|immunisation, active
717534|NCT01033890|local anesthesia|local anesthesia
717535|NCT01033890|cochlear implant|cochlear implant
717536|NCT01033890|sedation|sedation
717537|NCT01033890|3 patients submitted to cochlear implant surgery with local anesthesia with sedation|3 patients submitted to cochlear implant surgery with local anesthesia with sedation
717538|NCT01033903|Abortion, Spontaneous|abortion, spontaneous
717539|NCT01033903|Randomized Controlled Trial|randomized controlled trial
717540|NCT01033916|Blood Glucose|blood glucose
717541|NCT01033916|Insulin/Administration and Dosage|insulin/administration and dosage
717542|NCT01033916|Coronary Artery Bypass|coronary artery bypass
717543|NCT01033929|tuberculosis|tuberculosis
717544|NCT01033929|ESAT-6|esat-6
717545|NCT01033929|CFP-10|cfp-10
717546|NCT01033929|skin test|skin test
717547|NCT01033929|diagnostic test|diagnostic test
717548|NCT01033942|Pre-exposure prophylaxis|pre-exposure prophylaxis
717549|NCT01033942|HIV Prevention|hiv prevention
717550|NCT01033942|Truvada|truvada
717551|NCT01033942|Many Men, Many Voices|many men, many voices
717552|NCT01033942|Emtricitabine|emtricitabine
717553|NCT01033942|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
717554|NCT01033942|Young men who have sex with men|young men who have sex with men
717555|NCT01033942|HIV Seronegativity|hiv seronegativity
717556|NCT01033955|critical care|critical care
717557|NCT01033955|H1N1/influenza infection|h1n1/influenza infection
717558|NCT01033955|respiration|respiration
717559|NCT01033955|ventilation, artificial|ventilation, artificial
717560|NCT01033955|critically ill patients|critically ill patients
717561|NCT01033955|invasive mechanical ventilation|invasive mechanical ventilation
717562|NCT01033955|H1N1/influenza infection (suspected, probable or confirmed)|h1n1/influenza infection (suspected, probable or confirmed)
717563|NCT01033968|lasers|lasers
717564|NCT01033968|pain measurement|pain measurement
717565|NCT01033968|photocoagulation|photocoagulation
717566|NCT01033968|retina|retina
717567|NCT01033981|cost effectiveness|cost effectiveness
717568|NCT01033981|Sunitinib Central America and Caribbean Metastatic Renal Cell Carcinoma|sunitinib central america and caribbean metastatic renal cell carcinoma
717569|NCT01033994|Knee osteoarthritis|knee osteoarthritis
717570|NCT01033994|Fibroblast growth factor 18|fibroblast growth factor 18
717571|NCT01033994|Sprifermin|sprifermin
717572|NCT01034007|tissue engineered vascular graft|tissue engineered vascular graft
717573|NCT01034020|Nasal Spray|nasal spray
717574|NCT01034020|Attention Network Test|attention network test
717575|NCT01034020|Continuous Performance Test|continuous performance test
717576|NCT01034020|Attentional Blink Test|attentional blink test
717577|NCT01034033|quality of life|quality of life
717578|NCT01034046|Obesity|obesity
717579|NCT01034085|Nicotine|nicotine
717580|NCT01034085|Schizophrenia|schizophrenia
717581|NCT01034085|Cognition|cognition
717582|NCT01034085|Genes|genes
717583|NCT01034085|Smoking|smoking
717584|NCT01034085|Cigarette Smoking|cigarette smoking
717585|NCT01034098|Obesity|obesity
717586|NCT01034098|Postmenopausal women|postmenopausal women
717587|NCT01034098|Mechanical ventilatory constraints|mechanical ventilatory constraints
717588|NCT01034098|Dynamic lung volume|dynamic lung volume
717589|NCT01034098|Expiratory flow limitation|expiratory flow limitation
717590|NCT01034124|warfarin|warfarin
717591|NCT01034124|midazolam|midazolam
717592|NCT01034124|cranberry juice|cranberry juice
717593|NCT01034124|pharmacokinetics|pharmacokinetics
717594|NCT01034137|Treat-to-target, tight control, strategy study, TCZ, MTX|treat-to-target, tight control, strategy study, tcz, mtx
717595|NCT01034163|Phase III randomized|phase iii randomized
717596|NCT01034163|double blind|double blind
717597|NCT01034163|placebo controlled multi-center study|placebo controlled multi-center study
717598|NCT01034163|panobinostat|panobinostat
717599|NCT01034163|Hodgkin's lymphoma|hodgkin's lymphoma
717600|NCT01034163|at risk for relapse|at risk for relapse
717601|NCT01034163|autologous stem cell transplant|autologous stem cell transplant
717602|NCT01034176|BK viremia|bk viremia
717603|NCT01034176|kidney transplantation|kidney transplantation
717604|NCT01034176|BK viremia in kidney transplant recipients|bk viremia in kidney transplant recipients
717605|NCT01034189|Esophageal cancer|esophageal cancer
717606|NCT01034189|Chemoradiotherapy|chemoradiotherapy
717607|NCT01034189|Paclitaxel|paclitaxel
717608|NCT01034189|Cetuximab|cetuximab
717609|NCT01034215|Behavioral|behavioral
717610|NCT01034215|Quality of Life|quality of life
717611|NCT01034215|Breast Cancer|breast cancer
717612|NCT01034228|Diarrhoea|diarrhoea
717613|NCT01034228|L-isoleucine|l-isoleucine
717614|NCT01034228|children|children
717615|NCT01034228|ORS|ors
717616|NCT01034228|Antibacterial peptide|antibacterial peptide
717617|NCT01034241|milk protein|milk protein
717618|NCT01034241|overweight|overweight
717619|NCT01034241|insulin metabolism|insulin metabolism
717620|NCT01034241|substrate partitioning|substrate partitioning
717622|NCT01034254|immunization|immunization
717623|NCT01034254|pregnancy|pregnancy
717624|NCT01034254|efficacy|efficacy
717625|NCT01034254|pertussis|pertussis
717626|NCT01034254|hepatitis E|hepatitis e
717627|NCT01034267|Depression|depression
717628|NCT01034267|Major Depressive Disorder|major depressive disorder
717629|NCT01034280|Down Syndrome|down syndrome
717630|NCT01034280|phenotype|phenotype
717631|NCT01034280|genotype|genotype
717632|NCT01034280|patient family|patient family
717633|NCT01034293|feeding frequency|feeding frequency
717634|NCT01034293|insulin metabolism|insulin metabolism
717635|NCT01034293|glucose metabolism|glucose metabolism
717636|NCT01034293|substrate partitioning|substrate partitioning
717637|NCT01034319|type 2 diabetes|type 2 diabetes
717638|NCT01034319|genetics|genetics
717639|NCT01034319|genetic counseling|genetic counseling
717640|NCT01034319|diabetes prevention|diabetes prevention
717641|NCT01034332|Esophageal cancer|esophageal cancer
717642|NCT01034332|Esophagectomy|esophagectomy
717643|NCT01034332|Paclitaxel|paclitaxel
717644|NCT01034332|Induction chemotherapy|induction chemotherapy
717645|NCT01034345|Sirolimus|sirolimus
717646|NCT01034345|Liver Transplantation|liver transplantation
717647|NCT01034345|Tolerance|tolerance
717648|NCT01034345|Immune responses|immune responses
717649|NCT01034345|Allograft tolerance|allograft tolerance
717650|NCT01034358|inflammatory bowel disease|inflammatory bowel disease
717651|NCT01034358|Crohn disease|crohn disease
717652|NCT01034358|ulcerative colitis|ulcerative colitis
717653|NCT01034358|Papillomavirus vaccines|papillomavirus vaccines
717654|NCT01034371|Coronary Artery Disease; Hybrid Revascularization;|coronary artery disease; hybrid revascularization;
717655|NCT01034371|Percutaneous Coronary Intervention; Coronary Artery Bypass|percutaneous coronary intervention; coronary artery bypass
717656|NCT01027390|neck/shoulder|neck/shoulder
717657|NCT01027403|Heart failure|heart failure
717658|NCT01027403|Adult stem cells|adult stem cells
717659|NCT01027403|Circulating stem cells|circulating stem cells
717660|NCT01027403|Acute decompensated heart failure|acute decompensated heart failure
717661|NCT01027416|ER positive|er positive
717662|NCT01027416|Tamoxifen|tamoxifen
717663|NCT01027429|infant|infant
717664|NCT01027429|newborn|newborn
717665|NCT01027429|sepsis|sepsis
717666|NCT01027429|infection|infection
717667|NCT01027429|community|community
717668|NCT01027442|Stereolithography|stereolithography
717669|NCT01027442|Dental implants,|dental implants,
717670|NCT01027442|Prosthetics|prosthetics
717671|NCT01027442|positioning-errors|positioning-errors
717672|NCT01027442|logistic regression analysis|logistic regression analysis
717673|NCT01027468|bevacizumab, choroidal neovascularization|bevacizumab, choroidal neovascularization
717674|NCT01027481|lucentis, macular edema, branch retinal vein occlusion|lucentis, macular edema, branch retinal vein occlusion
717675|NCT01027494|ear tubes|ear tubes
717676|NCT01027494|ear drainage|ear drainage
717677|NCT01027494|ear infection|ear infection
717678|NCT01027494|ear drops|ear drops
717679|NCT01027494|tympanostomy tubes|tympanostomy tubes
717680|NCT01027520|Hand burn|hand burn
717681|NCT01027520|skin graft|skin graft
717682|NCT01027520|coban dressing|coban dressing
717683|NCT01027520|range of motion|range of motion
717684|NCT01027533|multifocal intraocular lens|multifocal intraocular lens
717685|NCT01027533|visual acuity|visual acuity
717686|NCT01027533|presbiopia|presbiopia
717687|NCT01027546|perioperative blood loss, spinal surgery|perioperative blood loss, spinal surgery
717688|NCT01027559|Major Depression|major depression
751875|NCT01171027|Natural orifice|natural orifice
717689|NCT01027559|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
717690|NCT01027559|Emotional Circuitry|emotional circuitry
717691|NCT01027559|Cognitive Behavioral Therapy|cognitive behavioral therapy
717692|NCT01027572|Vegetative state|vegetative state
717693|NCT01027572|Minimally conscious state|minimally conscious state
717694|NCT01027572|Thalamic stimulation|thalamic stimulation
717695|NCT01027598|Lung Cancer|lung cancer
717696|NCT01027598|Previously Treated Advanced Non Small Cell Lung Cancer|previously treated advanced non small cell lung cancer
717697|NCT01027598|Erlotinib|erlotinib
717698|NCT01027598|Pazopanib|pazopanib
717699|NCT01027611|Effectiveness of topical pain medicine for control of pain associated with intravitreal injections|effectiveness of topical pain medicine for control of pain associated with intravitreal injections
717700|NCT01027611|Eye discomfort|eye discomfort
717701|NCT01027624|Pan South African Survey on the Undertreatment of Hypercholesterolaemia|pan south african survey on the undertreatment of hypercholesterolaemia
717702|NCT01027637|breast reconstruction|breast reconstruction
717703|NCT01027637|tissue expander|tissue expander
717704|NCT01027637|Alloderm|alloderm
717705|NCT01027637|tissue matrix|tissue matrix
717706|NCT01027663|anemia|anemia
717707|NCT01027663|malaria|malaria
717708|NCT01027676|Gefitinib|gefitinib
717709|NCT01027676|Vorinostat|vorinostat
717710|NCT01027689|alprazolam|alprazolam
717711|NCT01027689|bioequivalence|bioequivalence
717712|NCT01027689|sublingual|sublingual
717713|NCT01027702|Donor Lymphocyte Infusion|donor lymphocyte infusion
717714|NCT01027702|Immune Recovery|immune recovery
717715|NCT01027702|T cell depleted transplant|t cell depleted transplant
717716|NCT01027702|Mismatched related donor transplants|mismatched related donor transplants
717717|NCT01027702|Unrelated donor transplants|unrelated donor transplants
717718|NCT01027715|Neonatal Seizures|neonatal seizures
717719|NCT01027715|Neonatal encephalopathy|neonatal encephalopathy
717720|NCT01027754|methadone maintenance|methadone maintenance
717721|NCT01027767|Breast|breast
717723|NCT01027767|Molecular|molecular
717724|NCT01027767|Molecular Breast Imaging|molecular breast imaging
717725|NCT01027767|Dense breast tissue|dense breast tissue
717726|NCT01027767|Surgery|surgery
717727|NCT01027767|Radiation|radiation
717728|NCT01027767|BCT|bct
717729|NCT01027780|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
717730|NCT01027780|MBSR|mbsr
717731|NCT01027780|Seniors|seniors
717732|NCT01027780|immune system|immune system
717733|NCT01027780|keyhole limpet hemocyanin (KLH)|keyhole limpet hemocyanin (klh)
717734|NCT01027793|Stretch marks|stretch marks
717735|NCT01027793|Striae|striae
717737|NCT01027793|Superficial dermabrasion|superficial dermabrasion
717738|NCT01027806|Children|children
717739|NCT01027806|Sleep|sleep
717740|NCT01027806|Obstructive Sleep Apnea|obstructive sleep apnea
717741|NCT01027819|Total knee arthroplasty|total knee arthroplasty
717742|NCT01027819|Mobile bearing|mobile bearing
717743|NCT01027819|Fixed bearing|fixed bearing
717744|NCT01027819|Range of motion|range of motion
717745|NCT01027819|Knee Society Score|knee society score
717746|NCT01034384|fMRI|fmri
717747|NCT01034384|Smoking Withdrawal|smoking withdrawal
717748|NCT01034384|Imaging|imaging
717749|NCT01034384|Memory|memory
717750|NCT01034384|Mood|mood
717751|NCT01034410|AS1411|as1411
717752|NCT01034410|AML|aml
717753|NCT01034410|relapsed|relapsed
717754|NCT01034410|refractory|refractory
717755|NCT01034410|aptamer|aptamer
717756|NCT01034410|nucleolin|nucleolin
717757|NCT01034423|Focus: health effects from omega-3 fatty acids, from fish oil with different quality|focus: health effects from omega-3 fatty acids, from fish oil with different quality
717758|NCT01034449|allo graft|allo graft
717759|NCT01034449|cord blood|cord blood
717760|NCT01034449|expansion|expansion
717761|NCT01034449|reduced-intensity conditioning|reduced-intensity conditioning
717762|NCT01034462|Depression|depression
717763|NCT01034462|Major Depressive Disorder|major depressive disorder
717764|NCT01034475|acute myeloid leukemia|acute myeloid leukemia
717765|NCT01034475|acute lymphoblastic leukemia|acute lymphoblastic leukemia
717766|NCT01034475|multiple myeloma|multiple myeloma
717767|NCT01034475|chronic myeloid\ leukemia in blast phase|chronic myeloid\ leukemia in blast phase
717768|NCT01034501|periodontitis|periodontitis
717769|NCT01034501|photodynamic therapy|photodynamic therapy
717770|NCT01034527|Anterior Cruciate Ligament|anterior cruciate ligament
717771|NCT01034527|Female Athlete|female athlete
717772|NCT01034527|Sports Injuries|sports injuries
717773|NCT01034527|Injury Prevention|injury prevention
717774|NCT01034579|Biomarkers|biomarkers
717775|NCT01034579|Genetic markers|genetic markers
717776|NCT01034618|Diabetes|diabetes
717777|NCT01034618|protein|protein
717778|NCT01034618|protein hydrolysate|protein hydrolysate
717779|NCT01034631|Metastatic Kidney Cancer|metastatic kidney cancer
717780|NCT01034631|BNC105P|bnc105p
717781|NCT01034644|Biomarkers|biomarkers
717782|NCT01034644|Genetic markers|genetic markers
717783|NCT01034657|MDS|mds
717784|NCT01034657|bone marrow|bone marrow
717785|NCT01034657|anemia|anemia
717786|NCT01034657|cytopenia|cytopenia
717787|NCT01034657|transfusion dependance|transfusion dependance
717788|NCT01034657|EPO|epo
717789|NCT01034657|ESA|esa
717790|NCT01034657|erythropoietin|erythropoietin
717791|NCT01034657|LBH589|lbh589
717792|NCT01034657|Myelodysplastic Syndromes|myelodysplastic syndromes
717793|NCT01034657|hematopoietic improvement|hematopoietic improvement
717794|NCT01034657|IPSS Low|ipss low
717795|NCT01034657|IPSS Int-1|ipss int-1
717796|NCT01034657|HI-E|hi-e
717797|NCT01034657|HDAC Inhibitor|hdac inhibitor
717798|NCT01034657|HDAC-I|hdac-i
717799|NCT01034657|DAC-I|dac-i
717800|NCT01034657|Deacetylase-Inhibitor|deacetylase-inhibitor
717801|NCT01034657|Histone Deacetylase-Inhibitor|histone deacetylase-inhibitor
717802|NCT01034657|red blood cell transfusions|red blood cell transfusions
717803|NCT01034709|Cytomegalovirus|cytomegalovirus
717804|NCT01034709|CMV|cmv
717805|NCT01035775|Colonoscopy|colonoscopy
717806|NCT01035775|Adenoma detection|adenoma detection
717807|NCT01035775|Colorectal polyps|colorectal polyps
717808|NCT01035788|PTSD|ptsd
717809|NCT01035788|mindfulness meditation|mindfulness meditation
717810|NCT01035788|cognitive behavior therapy|cognitive behavior therapy
717811|NCT01035788|relationship function|relationship function
717812|NCT01035788|couple therapy|couple therapy
717813|NCT01035944|Chronic wounds|chronic wounds
717814|NCT01035944|Chronic wound debridement|chronic wound debridement
717815|NCT01035944|Debridement|debridement
717816|NCT01035944|Bedside debridement|bedside debridement
717817|NCT01035944|Surgical debridement|surgical debridement
717818|NCT01035944|Wound debridement|wound debridement
717819|NCT01035944|Minimize bacterial re-colonization of wounds|minimize bacterial re-colonization of wounds
717820|NCT01035944|HemCon ChitoGauze Dressings|hemcon chitogauze dressings
717821|NCT01035944|HemCon Dressings|hemcon dressings
717822|NCT01035944|Chitosan-based dressings|chitosan-based dressings
717823|NCT01035983|menstrually associated migraine (MAM), Migraines,Menstrual Migraines, menstrually related migraines|menstrually associated migraine (mam), migraines,menstrual migraines, menstrually related migraines
717824|NCT01035996|Classical Conditioning|classical conditioning
717825|NCT01035996|fMRI|fmri
717826|NCT01035996|Schizophrenia|schizophrenia
717827|NCT01035996|TD Model|td model
717828|NCT01035996|Incentive Salience|incentive salience
717829|NCT01036009|Hematologic|hematologic
717830|NCT01036009|Malignancy|malignancy
717831|NCT01036009|Leukemia|leukemia
717832|NCT01036009|Pre-leukemic|pre-leukemic
717833|NCT01036009|Allogeneic|allogeneic
717834|NCT01036009|Transplant|transplant
717835|NCT01036009|Pediatric|pediatric
717836|NCT01036022|mesalazine|mesalazine
717837|NCT01036022|ulcerative colitis|ulcerative colitis
717838|NCT01036022|pharmacokinetics/dynamics|pharmacokinetics/dynamics
717839|NCT01036022|GSK1399686|gsk1399686
717840|NCT01036035|Tolterodine|tolterodine
717841|NCT01036035|Over active Bladder (OAB)|over active bladder (oab)
717842|NCT01036035|Incontinence|incontinence
717843|NCT01036048|saphenous vein graft|saphenous vein graft
717844|NCT01036048|stent|stent
717845|NCT01036061|compulsive discorders|compulsive discorders
717846|NCT01036061|addiction|addiction
717847|NCT01036074|Drug Abuse|drug abuse
717848|NCT01036074|Cocaine|cocaine
717849|NCT01036074|Cocaine Dependence|cocaine dependence
717850|NCT01036074|Functional MRI|functional mri
717851|NCT01036074|Pharmalogical MRI|pharmalogical mri
717852|NCT01036074|Conditioning|conditioning
717853|NCT01036087|Inflammatory Breast Cancer|inflammatory breast cancer
717854|NCT01036087|IBC|ibc
717855|NCT01036087|Primary breast carcinoma|primary breast carcinoma
717856|NCT01036087|HER2 negative overexpression|her2 negative overexpression
717857|NCT01036087|Panitumumab|panitumumab
717858|NCT01036087|Vectibix|vectibix
717859|NCT01036087|Nab-paclitaxel|nab-paclitaxel
717860|NCT01036087|Paclitaxel|paclitaxel
717861|NCT01036087|Abraxane|abraxane
717862|NCT01036087|Carboplatin|carboplatin
717863|NCT01036087|Paraplatin|paraplatin
717864|NCT01036087|PNC|pnc
717865|NCT01036087|5-fluorouracil|5-fluorouracil
717866|NCT01036087|5-FU|5-fu
717867|NCT01036087|Adrucil|adrucil
717868|NCT01036087|Efudex|efudex
717869|NCT01036087|Epirubicin|epirubicin
717870|NCT01036087|Ellence|ellence
717871|NCT01036087|Cyclophosphamide|cyclophosphamide
717872|NCT01036087|Cytoxan|cytoxan
717873|NCT01036087|Neosar|neosar
717874|NCT01036087|FEC|fec
717875|NCT01036113|EZN-2208 (PEG-SN38)|ezn-2208 (peg-sn38)
717876|NCT01036126|Nicotine|nicotine
717877|NCT01036126|Cocaine|cocaine
717878|NCT01036126|N-Back|n-back
717879|NCT01036126|Craving|craving
717880|NCT01036126|Dependence|dependence
717881|NCT01036139|EDS in Parkinson's Disease|eds in parkinson's disease
717882|NCT01036217|Recruitment|recruitment
717883|NCT01036217|Adult|adult
717884|NCT01036217|Telephone|telephone
717886|NCT01036217|Testing|testing
717887|NCT01036230|fMRI|fmri
717888|NCT01036230|Methylphenidate|methylphenidate
717889|NCT01036230|Taste|taste
717890|NCT01036230|Olfaction|olfaction
717891|NCT01036230|Addiction|addiction
717892|NCT01036243|digestive tolerance|digestive tolerance
717893|NCT01036243|night sleep|night sleep
717894|NCT01036243|crying|crying
717895|NCT01036243|growth|growth
717896|NCT01036308|dietary fibre|dietary fibre
717897|NCT01036308|legumes|legumes
717898|NCT01036308|lupin kernel fibre|lupin kernel fibre
717899|NCT01036308|soy fibre|soy fibre
717900|NCT01036308|bile acids|bile acids
717901|NCT01036308|short-chain fatty acids|short-chain fatty acids
717902|NCT01036308|cholesterol metabolism|cholesterol metabolism
717903|NCT01036308|Subjects|subjects
717904|NCT01036360|Obesity|obesity
717905|NCT01036360|Acute exercise|acute exercise
717906|NCT01036360|Intensity of exercise|intensity of exercise
717907|NCT01036360|Energy balance regulation|energy balance regulation
717908|NCT01036360|Appetite|appetite
717909|NCT01036399|PTCL|ptcl
717910|NCT01036412|Chlorhexidine|chlorhexidine
717911|NCT01036412|Chlorhexidine Gel Therapy|chlorhexidine gel therapy
717912|NCT01036412|1% chlorhexidine gluconate gel|1% chlorhexidine gluconate gel
717913|NCT01036412|Cariogenic Oral Microflora|cariogenic oral microflora
717914|NCT01036412|Irradiated Head and Neck Cancer Patients|irradiated head and neck cancer patients
717915|NCT01036412|caries-forming organisms|caries-forming organisms
717916|NCT01036412|Radiation treatment|radiation treatment
717917|NCT01036412|Mouth Cancer|mouth cancer
717918|NCT01036412|Throat Cancer|throat cancer
717919|NCT01036412|Tooth decay|tooth decay
717920|NCT01036516|Drug Cues|drug cues
717921|NCT01036516|Dopamine Release|dopamine release
717922|NCT01036516|Psychomotor Stimulants|psychomotor stimulants
717923|NCT01036516|D2 Dopamine Receptor Subtype|d2 dopamine receptor subtype
717924|NCT01036516|Neuroimaging|neuroimaging
717925|NCT01036529|Spinal Cord Stimulation|spinal cord stimulation
717926|NCT01036529|Decompression|decompression
717927|NCT01036529|Fusion with or without instrumentation|fusion with or without instrumentation
717928|NCT01036529|Discectomy|discectomy
717929|NCT01036529|Laminectomy|laminectomy
717930|NCT01036529|Laminotomy|laminotomy
717931|NCT01036529|Foraminotomy|foraminotomy
717932|NCT01036568|Psychosis|psychosis
717933|NCT01036568|Smooth Pursuit|smooth pursuit
717934|NCT01036568|Motion Perception|motion perception
717935|NCT01036568|Neurophysiology|neurophysiology
717936|NCT01036568|fMRI|fmri
717937|NCT01036581|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
717938|NCT01036581|Functional Brain Imaging|functional brain imaging
717939|NCT01036581|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
717940|NCT01036581|Diffusion Tensor Imaging|diffusion tensor imaging
717941|NCT01036581|Drug Abuse|drug abuse
717942|NCT01036594|Ketoconazole|ketoconazole
717943|NCT01036594|Dexamethasone|dexamethasone
717944|NCT01036633|mucositis|mucositis
717945|NCT01036646|Patients on stable OAT therapy for at least 3 months.|patients on stable oat therapy for at least 3 months.
717946|NCT01036659|acute angiotensin converting enzyme inhibitor angioedema|acute angiotensin converting enzyme inhibitor angioedema
717947|NCT01036685|Children|children
717948|NCT01036685|fMRI|fmri
717949|NCT01036685|Task Development|task development
717950|NCT01036685|Cognition|cognition
717951|NCT01036711|Attention|attention
717952|NCT01036711|Working Memory|working memory
717953|NCT01036711|Central Executive Processes|central executive processes
717954|NCT01036711|Response Preparation|response preparation
717955|NCT01036711|Cigarettes|cigarettes
717956|NCT01036802|sickle cell disease|sickle cell disease
717957|NCT01036802|pulmonary hypertension|pulmonary hypertension
717958|NCT01036802|coagulation activation|coagulation activation
717959|NCT01036802|platelet activation|platelet activation
717960|NCT01036802|endothelial activation|endothelial activation
717961|NCT01036841|MNE with nocturnal polyuria|mne with nocturnal polyuria
717962|NCT01036841|monosymptomatic nocturnal enuresis with nocturnal polyuria|monosymptomatic nocturnal enuresis with nocturnal polyuria
717963|NCT01036854|Ondansetron, EUR-1025|ondansetron, eur-1025
717964|NCT01036958|Pediatric cGVHD|pediatric cgvhd
717965|NCT01036958|Response Criteria|response criteria
717966|NCT01036958|Symptoms|symptoms
717967|NCT01036958|Quality of Life|quality of life
717968|NCT01036958|Graft-Versus-Host Disease|graft-versus-host disease
717969|NCT01036958|GVHD|gvhd
717970|NCT01036958|Pediatric GVHD|pediatric gvhd
717971|NCT01036971|Physical Examination|physical examination
717972|NCT01036971|Medical Information|medical information
717973|NCT01036971|Assessment|assessment
717974|NCT01036971|Blood Work|blood work
717975|NCT01036971|Screening|screening
717976|NCT01037023|PMS (post-marketing surveillance)|pms (post-marketing surveillance)
717977|NCT01037023|Topotecan|topotecan
717978|NCT01037036|Ocular Hypertension|ocular hypertension
717979|NCT01037036|Open-Angle Glaucoma|open-angle glaucoma
717980|NCT01037036|Xalatan|xalatan
717981|NCT01037036|IOP|iop
717982|NCT01037049|Rectal Cancer|rectal cancer
717983|NCT01037049|6vs12|6vs12
717984|NCT01037049|6 vs 12|6 vs 12
717985|NCT01037049|Cancer|cancer
717987|NCT01037049|Circumferential Resection Margin|circumferential resection margin
717988|NCT01037049|Quality of Life|quality of life
717989|NCT01037049|MRI|mri
717990|NCT01037049|Radiology|radiology
717991|NCT01037049|Abdominoperineal Excision|abdominoperineal excision
717992|NCT01037049|Anterior Resection|anterior resection
717993|NCT01037049|Surgery|surgery
717994|NCT01037049|Pathology|pathology
717995|NCT01037049|Radiotherapy|radiotherapy
717996|NCT01037075|Schizophrenia|schizophrenia
717997|NCT01037075|Dual Diagnosis|dual diagnosis
717998|NCT01037075|Nicotine Nasal Spray|nicotine nasal spray
717999|NCT01037075|Drug Abuse/Dependence|drug abuse/dependence
718000|NCT01037075|Cognitive Processes|cognitive processes
718001|NCT01037088|cannabis|cannabis
718002|NCT01037088|marijuana|marijuana
718003|NCT01037088|neuropathy|neuropathy
718004|NCT01037088|antinociception|antinociception
718006|NCT01037088|cognition|cognition
718007|NCT01037088|neuropathic pain|neuropathic pain
718008|NCT01037101|acrophobia|acrophobia
718009|NCT01037101|virtual reality|virtual reality
718010|NCT01037101|exposure therapy|exposure therapy
753810|NCT01177761|Bone Mineral Density|bone mineral density
718011|NCT01037101|In Vivo Exposure Therapy plus D-Cycloserine|in vivo exposure therapy plus d-cycloserine
718012|NCT01037101|In Vivo Exposure Therapy plus Placebo|in vivo exposure therapy plus placebo
718013|NCT01037101|Virtual Reality Exposure Therapy plus D-Cycloserine|virtual reality exposure therapy plus d-cycloserine
718014|NCT01037101|Virtual Reality Exposure Therapy plus Placebo|virtual reality exposure therapy plus placebo
718015|NCT01037101|Wait-List|wait-list
718016|NCT01037114|Hepatitis A and hepatitis B|hepatitis a and hepatitis b
718017|NCT01037127|GSK1120212|gsk1120212
718018|NCT01037127|BRAF Inhibitor|braf inhibitor
718019|NCT01037127|melanoma|melanoma
718020|NCT01037127|MEK Inhibitor|mek inhibitor
718021|NCT01037153|Intravenous|intravenous
718022|NCT01037153|Rate of Delivery|rate of delivery
718023|NCT01037153|Dose Responses|dose responses
718213|NCT01037933|Comedy|comedy
718024|NCT01037153|Variable Intervals|variable intervals
718025|NCT01037153|Multiple Rapid Injections|multiple rapid injections
718026|NCT01037192|outpatient|outpatient
718027|NCT01037192|skin and soft tissue infections|skin and soft tissue infections
718028|NCT01037192|vancomycin intravenous|vancomycin intravenous
718029|NCT01037231|hyperoxaluria|hyperoxaluria
718030|NCT01037231|oxalate|oxalate
718031|NCT01037231|PH|ph
718032|NCT01037270|Patients with conditions (PE, Afib, DVT) requiring ongoing INR measurements.|patients with conditions (pe, afib, dvt) requiring ongoing inr measurements.
718033|NCT01037283|Bipolar|bipolar
718034|NCT01037283|Depressed|depressed
718035|NCT01037296|catheter ablation|catheter ablation
718036|NCT01037296|robotic navigation|robotic navigation
718037|NCT01037322|crohn's disease|crohn's disease
718038|NCT01037322|ulcerative colitis|ulcerative colitis
718039|NCT01037322|cannabis|cannabis
718040|NCT01037322|cannabidiol|cannabidiol
718041|NCT01037335|bone graft|bone graft
718042|NCT01037335|pain|pain
718043|NCT01037335|chronic|chronic
718044|NCT01037348|Choroidal Neovascularisation|choroidal neovascularisation
718045|NCT01037348|Pathological Myopia|pathological myopia
718046|NCT01037361|Children and Adolescents|children and adolescents
718047|NCT01037361|Motor Control|motor control
718048|NCT01037361|Movement-Related Potential|movement-related potential
718049|NCT01037361|Stereotypic Movement Disorder|stereotypic movement disorder
718050|NCT01037361|Electroencephalogram (EEG)|electroencephalogram (eeg)
718051|NCT01037374|risk|risk
718052|NCT01037374|assessment|assessment
718053|NCT01037374|difficult|difficult
718054|NCT01037374|endotracheal|endotracheal
718055|NCT01037374|intubation|intubation
718056|NCT01037400|Knee Replacement|knee replacement
718057|NCT01037400|Arthroplasty|arthroplasty
718058|NCT01037413|Scarring|scarring
718059|NCT01037426|SND Sinus Node Disease|snd sinus node disease
718060|NCT01037426|Falls|falls
718061|NCT01037426|Fractures|fractures
718062|NCT01037452|Heartburn|heartburn
718063|NCT01037452|antacid|antacid
718065|NCT01037452|Lansoprazole|lansoprazole
718066|NCT01037452|calcium carbonate|calcium carbonate
718067|NCT01037452|magnesium hydroxide|magnesium hydroxide
718068|NCT01037452|Relief of heartburn following ingestion of a heartburn-inducing meal|relief of heartburn following ingestion of a heartburn-inducing meal
718069|NCT01037465|endothelium|endothelium
718070|NCT01037465|cell signaling|cell signaling
718071|NCT01037465|N-acetylcysteine|n-acetylcysteine
718072|NCT01037465|reactive oxygen species|reactive oxygen species
718073|NCT01037478|Hodgkin's Lymphoma|hodgkin's lymphoma
718074|NCT01037478|HDAC|hdac
718075|NCT01037478|4SC-201|4sc-201
718076|NCT01037478|Resminostat|resminostat
718077|NCT01037478|Phase II|phase ii
718078|NCT01037491|aspirin, clopidogrel, peptic ulcer, proton pump inhibitor, rabeprazole, ulcer bleeding|aspirin, clopidogrel, peptic ulcer, proton pump inhibitor, rabeprazole, ulcer bleeding
718079|NCT01037504|safety|safety
718080|NCT01037504|tolerability|tolerability
718081|NCT01037504|healthy|healthy
718082|NCT01037504|inhalation|inhalation
718083|NCT01037504|Healthy volunteers|healthy volunteers
718084|NCT01037517|Myeloma|myeloma
718085|NCT01037517|Multiple Myeloma or Lymphoma Patients undergoing|multiple myeloma or lymphoma patients undergoing
718086|NCT01037517|mobilization for the purpose of autologous stem cell collection|mobilization for the purpose of autologous stem cell collection
718087|NCT01037530|ACE inhibitors|ace inhibitors
718088|NCT01037530|Intermittent claudication|intermittent claudication
718089|NCT01037530|Ramipril|ramipril
718090|NCT01037556|AML|aml
718091|NCT01037556|Acute Myeloid Leukemia|acute myeloid leukemia
718092|NCT01037556|Acute Myelogenous Leukemia|acute myelogenous leukemia
718093|NCT01037556|Refractory AML|refractory aml
718094|NCT01037556|Relapsed AML|relapsed aml
718095|NCT01037556|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
718096|NCT01037556|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
718097|NCT01037556|Refractory Acute Myelogenous Leukemia|refractory acute myelogenous leukemia
718098|NCT01037556|Relapsed Acute Myelogenous Leukemia|relapsed acute myelogenous leukemia
718099|NCT01037556|ALL|all
718100|NCT01037556|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
718101|NCT01037556|Relapsed Acute Lymphocytic Leukemia|relapsed acute lymphocytic leukemia
718102|NCT01037556|Refractory Acute Lymphocytic Leukemia|refractory acute lymphocytic leukemia
718103|NCT01037556|Relapsed ALL|relapsed all
718104|NCT01037556|Refractory ALL|refractory all
718105|NCT01037569|Toxicological Screening|toxicological screening
718106|NCT01037569|Drugs|drugs
718107|NCT01037569|Alternative Matrices|alternative matrices
718108|NCT01037569|Urine|urine
718109|NCT01037569|Children|children
718110|NCT01037595|hemodialysis|hemodialysis
718111|NCT01037595|turmeric|turmeric
718112|NCT01037595|pruritus|pruritus
718113|NCT01037608|Sativex|sativex
718114|NCT01037608|fMRI|fmri
718115|NCT01037608|Alternative Matrices|alternative matrices
718116|NCT01037608|Brain Imaging|brain imaging
718117|NCT01037608|THC|thc
718118|NCT01037621|Herpes simplex type 2|herpes simplex type 2
718119|NCT01037621|Hepatitis C virus|hepatitis c virus
718120|NCT01037621|Valacyclovir|valacyclovir
718718|NCT01031680|diabetes|diabetes
718121|NCT01037621|Herpes Simplex virus type 2 infection|herpes simplex virus type 2 infection
718122|NCT01037634|Avian Influenza|avian influenza
718123|NCT01037634|H1N1 Influenza|h1n1 influenza
718124|NCT01037634|Seasonal Influenza|seasonal influenza
718125|NCT01037647|Type 2 diabetes|type 2 diabetes
718126|NCT01037647|Diabetic dyslipidemia|diabetic dyslipidemia
718127|NCT01037647|VLDL-TG kinetics|vldl-tg kinetics
718128|NCT01037647|VLDL-TG metabolism|vldl-tg metabolism
718129|NCT01037660|endothelium|endothelium
718130|NCT01037660|cardiovascular disease|cardiovascular disease
718131|NCT01037660|dietary fat|dietary fat
718132|NCT01037660|insulin resistance|insulin resistance
718133|NCT01037686|PD|pd
718134|NCT01037686|DBS|dbs
718135|NCT01037699|Ovarian stimulation|ovarian stimulation
718136|NCT01037699|In Vitro Fertilization|in vitro fertilization
718137|NCT01037699|Luteinizing Hormone|luteinizing hormone
718138|NCT01037699|GnRH antagonist|gnrh antagonist
718233|NCT01038037|Triple mutational status|triple mutational status
718234|NCT01038037|KRAS|kras
718139|NCT01037699|Implantation rate in infertile patients undergoing In vitro fertilization and embryo transfer.|implantation rate in infertile patients undergoing in vitro fertilization and embryo transfer.
718140|NCT01037712|Foetuses infection with CMV|foetuses infection with cmv
718141|NCT01037712|neurological handicap of infectious origin.|neurological handicap of infectious origin.
718142|NCT01037725|Healthy volunteer|healthy volunteer
718143|NCT01037725|first time in human|first time in human
718144|NCT01037725|food effect|food effect
718145|NCT01037738|ACL reconstruction|acl reconstruction
718146|NCT01037738|autologous conditioned serum|autologous conditioned serum
718147|NCT01037738|Orthokine|orthokine
718148|NCT01037738|osteoarthritis|osteoarthritis
718149|NCT01037738|interleukin receptor antagonist|interleukin receptor antagonist
718150|NCT01037738|growth factors|growth factors
718151|NCT01037738|WOMAC|womac
718152|NCT01037738|IKDC|ikdc
718153|NCT01037751|Cancer|cancer
718154|NCT01037751|Symptom burden|symptom burden
718155|NCT01037751|M. D. Anderson Symptom Inventory|m. d. anderson symptom inventory
718156|NCT01037751|MDASI-Ovarian Cancer|mdasi-ovarian cancer
718157|NCT01037751|Symptoms|symptoms
718158|NCT01037751|Daily functioning|daily functioning
718159|NCT01037751|Symptom severity|symptom severity
718160|NCT01037751|Questionnaire|questionnaire
718161|NCT01037751|Interview|interview
718162|NCT01037764|acute lymphoid leukemia|acute lymphoid leukemia
718163|NCT01037764|primary complete remission|primary complete remission
718164|NCT01037764|secondary complete remission|secondary complete remission
718165|NCT01037764|postremission therapy|postremission therapy
718166|NCT01037764|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
718167|NCT01037777|individuals at risk for SCA1, SCA2, SCA3, SCA6 and SCA7|individuals at risk for sca1, sca2, sca3, sca6 and sca7
718168|NCT01037803|perioperative sublingual microcirculation SDF|perioperative sublingual microcirculation sdf
718169|NCT01037816|Ankle Sprain|ankle sprain
718170|NCT01037855|Swine Flu H1N1 vaccine|swine flu h1n1 vaccine
718171|NCT01037855|Adjuvanted flu cell culture derived|adjuvanted flu cell culture derived
718172|NCT01037868|depression|depression
718173|NCT01037868|alcohol dependency syndrome|alcohol dependency syndrome
718174|NCT01037868|dual diagnosis|dual diagnosis
718175|NCT01037868|SMS text messages|sms text messages
718279|NCT01038206|drugs|drugs
718176|NCT01037894|Acupuncture,Intracerebral hemorrhage, Stroke|acupuncture,intracerebral hemorrhage, stroke
718177|NCT01037907|Oral treatment for MS|oral treatment for ms
718178|NCT01037907|Oral drug for multiple sclerosis|oral drug for multiple sclerosis
718179|NCT01037907|Oral RRMS|oral rrms
718180|NCT01037907|Oral relapsing remitting multiple sclerosis|oral relapsing remitting multiple sclerosis
718181|NCT01037907|Gamma Linolenic Acid|gamma linolenic acid
718182|NCT01037907|GLA|gla
718183|NCT01037907|Fatty acid|fatty acid
718184|NCT01037907|Triglyceride|triglyceride
718185|NCT01037907|Structured lipid|structured lipid
718186|NCT01037907|MRI|mri
718187|NCT01037907|Magnetic resonance imaging|magnetic resonance imaging
718188|NCT01037907|gadolinium enhancing lesions|gadolinium enhancing lesions
718189|NCT01037907|expanded disability status scale|expanded disability status scale
718190|NCT01037907|EDSS|edss
718191|NCT01037907|Demyelination|demyelination
718192|NCT01037907|Remyelination|remyelination
718193|NCT01037907|TGFB1|tgfb1
718194|NCT01037907|Transforming growth factor beta 1|transforming growth factor beta 1
718195|NCT01037907|cytokines|cytokines
718196|NCT01037907|disease modifying therapy|disease modifying therapy
718197|NCT01037907|immunomodulator|immunomodulator
718198|NCT01037907|Anti inflammatory|anti inflammatory
718199|NCT01037907|Pro inflammatory|pro inflammatory
718200|NCT01037907|TNF alpha|tnf alpha
718201|NCT01037907|interleukin 1 beta|interleukin 1 beta
718202|NCT01037907|interferon gamma|interferon gamma
718203|NCT01037907|Fayaz Master|fayaz master
718204|NCT01037907|Omega 6|omega 6
718205|NCT01037907|Polyunsaturated fatty acid|polyunsaturated fatty acid
718206|NCT01037907|Cytokine balance|cytokine balance
718207|NCT01037907|Pleneva TM|pleneva tm
718208|NCT01037907|BGC20-0134|bgc20-0134
718209|NCT01037907|RRMS|rrms
718210|NCT01037933|Cancer|cancer
718211|NCT01037933|Humor|humor
718214|NCT01037933|Chemotherapy|chemotherapy
718215|NCT01037946|HIV|hiv
718216|NCT01037946|Family interventions|family interventions
718217|NCT01037946|Thailand|thailand
718218|NCT01037959|severe cirrhosis|severe cirrhosis
718219|NCT01037959|Patients with severe cirrhosis|patients with severe cirrhosis
718220|NCT01037972|Galileo|galileo
718221|NCT01037972|Whole body vibration|whole body vibration
718222|NCT01037972|Osteoarthritis|osteoarthritis
718223|NCT01037972|Knee|knee
718224|NCT01037972|Physiotherapy|physiotherapy
718225|NCT01037985|Scarring|scarring
718226|NCT01037998|adenocarcinoma|adenocarcinoma
718227|NCT01037998|non-small-cell lung cancer|non-small-cell lung cancer
718228|NCT01037998|gefitinib|gefitinib
718229|NCT01037998|UFUR|ufur
718230|NCT01038024|antioxidant supplement|antioxidant supplement
718231|NCT01038037|Lung Cancer|lung cancer
718232|NCT01038037|Non small cell lung cancer|non small cell lung cancer
718237|NCT01038050|Endothelial progenitor cell|endothelial progenitor cell
718238|NCT01038050|endothelial function(FMD)|endothelial function(fmd)
718239|NCT01038050|Gingko Biloba Extract|gingko biloba extract
718240|NCT01038050|Type 2 Diabetes mellitus|type 2 diabetes mellitus
718241|NCT01038050|Stable coronary artery disease|stable coronary artery disease
718242|NCT01038050|Endothelial progenitor cells Numbers|endothelial progenitor cells numbers
718243|NCT01038076|HIV|hiv
718244|NCT01038076|AIDS|aids
718245|NCT01038076|adherence|adherence
718246|NCT01038076|antiretroviral|antiretroviral
718247|NCT01038076|aCASI|acasi
718248|NCT01038076|HAART|haart
718249|NCT01038076|Complementary Therapies|complementary therapies
718250|NCT01038076|Adherence Care Manager|adherence care manager
718251|NCT01038089|endothelium|endothelium
718252|NCT01038089|resveratrol|resveratrol
718253|NCT01038089|diabetes mellitus|diabetes mellitus
718254|NCT01038102|Obesity|obesity
718255|NCT01038102|Diabetes|diabetes
718256|NCT01038102|Insulin resistance|insulin resistance
718257|NCT01038102|Fatty liver|fatty liver
718258|NCT01038102|NAFLD|nafld
718259|NCT01038102|Steatosis|steatosis
718260|NCT01038102|Dietary fatty acids|dietary fatty acids
718261|NCT01038115|Catheter Ablation|catheter ablation
718262|NCT01038128|Bulimia nervosa|bulimia nervosa
718263|NCT01038128|Bulimia|bulimia
718264|NCT01038128|Body dysmorphic disorder|body dysmorphic disorder
718265|NCT01038128|Eating disorders|eating disorders
718266|NCT01038128|Body image|body image
718267|NCT01038128|Binge eating|binge eating
718268|NCT01038128|purging|purging
718269|NCT01038154|advanced esophageal cancer and stomach cancer|advanced esophageal cancer and stomach cancer
718270|NCT01038154|Pravastatin|pravastatin
718271|NCT01038154|Survival|survival
718272|NCT01038154|adverse effects|adverse effects
718273|NCT01038167|VX-950|vx-950
718274|NCT01038180|pacemaker|pacemaker
718275|NCT01038180|adverse effects|adverse effects
718276|NCT01038193|Cognition, subarachnoid hemorrhage.|cognition, subarachnoid hemorrhage.
718277|NCT01038206|prevention|prevention
718278|NCT01038206|HIV|hiv
718280|NCT01038206|smoking|smoking
718281|NCT01038206|Hispanic|hispanic
718282|NCT01038206|Adolescent|adolescent
718283|NCT01038206|Familias Unidas|familias unidas
718284|NCT01038206|Parent-Preadolescent Training|parent-preadolescent training
718285|NCT01038206|parent-centered|parent-centered
718286|NCT01038206|unsafe sexual behavior|unsafe sexual behavior
718287|NCT01038206|efficacy|efficacy
718288|NCT01038206|intervention|intervention
720778|NCT01050751|061|061
718289|NCT01038219|fever|fever
718290|NCT01038219|children|children
718291|NCT01038219|SUBJECTIVE ASSESSMENT|subjective assessment
718292|NCT01038232|Distress Tolerance|distress tolerance
718293|NCT01038232|Cocaine Dependence|cocaine dependence
718294|NCT01038232|Relapse|relapse
718295|NCT01038232|Limbic System|limbic system
718296|NCT01038232|Prefrontal Cortex|prefrontal cortex
718297|NCT01038232|Healthy Volunteer|healthy volunteer
718298|NCT01038232|HV|hv
718299|NCT01038245|Receptor Up-Regulation|receptor up-regulation
718300|NCT01038245|Smoking|smoking
718301|NCT01038245|Nicotine|nicotine
718302|NCT01038245|Neuroimaging|neuroimaging
718303|NCT01038258|neoadjuvant chemotherapy|neoadjuvant chemotherapy
718304|NCT01038271|palliative care|palliative care
718305|NCT01038284|Patient Education|patient education
718306|NCT01038284|Drug Toxicity|drug toxicity
718307|NCT01038297|Scarring|scarring
718308|NCT01038310|Parkinson´s disease|parkinson´s disease
718309|NCT01038310|FP-CIT-SPECT|fp-cit-spect
718310|NCT01038323|Fibromyalgia|fibromyalgia
718311|NCT01038323|FMS|fms
718312|NCT01038336|Hearing Loss - Noise-Induced|hearing loss - noise-induced
718313|NCT01038336|Prevention|prevention
718314|NCT01038336|Computer-assisted instruction|computer-assisted instruction
718315|NCT01038362|endothelium|endothelium
718316|NCT01038362|almonds|almonds
718317|NCT01038362|dietary interventions|dietary interventions
718318|NCT01038362|coronary artery disease|coronary artery disease
718319|NCT01038375|hypertension|hypertension
718320|NCT01038375|stroke|stroke
718321|NCT01038375|adherence|adherence
718322|NCT01038388|Multiple Myeloma|multiple myeloma
718323|NCT01038401|HIV infection|hiv infection
718324|NCT01038401|HAART|haart
718325|NCT01038401|Viral DNA test positive-10063306|viral dna test positive-10063306
718326|NCT01038401|Blood HIV RNA 10049826|blood hiv rna 10049826
718327|NCT01038401|Treatment Experienced|treatment experienced
718328|NCT01038427|Rhinitis|rhinitis
718329|NCT01038427|Allergic|allergic
718330|NCT01038427|Seasonal|seasonal
718331|NCT01038427|Mometasone Furoate|mometasone furoate
718332|NCT01038427|Equivalence|equivalence
718333|NCT01038440|Omega 3 fatty acids|omega 3 fatty acids
718334|NCT01038440|Omega 3 Index|omega 3 index
718335|NCT01038440|Stearidonic acid (SDA)|stearidonic acid (sda)
718336|NCT01038440|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
718337|NCT01038440|Red blood cells|red blood cells
718338|NCT01038440|Lipids|lipids
718339|NCT01038440|Inflammation markers|inflammation markers
718340|NCT01038466|CHAT|chat
718341|NCT01038466|breast cancer|breast cancer
718342|NCT01038466|non interventional observational study|non interventional observational study
718343|NCT01038479|Xylitol|xylitol
718344|NCT01038479|Mutans streptococci|mutans streptococci
718345|NCT01038479|Maternal consumption|maternal consumption
718346|NCT01038479|Early childhood tooth decay|early childhood tooth decay
718347|NCT01038479|Early childhood caries|early childhood caries
718348|NCT01038479|Childsmile|childsmile
718349|NCT01038518|epidemiology|epidemiology
718350|NCT01038518|risk factors|risk factors
718351|NCT01038518|micronutrients|micronutrients
718352|NCT01038531|Acute lung injury (ALI)|acute lung injury (ali)
718353|NCT01038531|Adult respiratory distress syndrome (ARDS)|adult respiratory distress syndrome (ards)
718354|NCT01038531|Low-tidal-volume strategy|low-tidal-volume strategy
718355|NCT01038531|ARDS Net|ards net
718356|NCT01038531|airway pressure release ventilation (APRV)|airway pressure release ventilation (aprv)
718357|NCT01038531|biomarkers of lung injury|biomarkers of lung injury
718358|NCT01038544|Esophageal Cancer|esophageal cancer
718359|NCT01038544|Mediastinal lymph nodes|mediastinal lymph nodes
718360|NCT01038544|Staging|staging
718361|NCT01038544|EBUS|ebus
718362|NCT01038544|EUS|eus
718363|NCT01038544|Endobronchial Ultrasound|endobronchial ultrasound
718364|NCT01038544|Endoscopic Ultrasound|endoscopic ultrasound
718365|NCT01038557|frozen|frozen
718366|NCT01038557|red blood cells|red blood cells
718367|NCT01038557|transfusion|transfusion
718368|NCT01038557|trauma|trauma
718369|NCT01038570|Prader Willi syndrome|prader willi syndrome
718370|NCT01038570|adults|adults
718371|NCT01038570|social behaviour|social behaviour
718372|NCT01038570|stress|stress
718373|NCT01038570|anxiety|anxiety
718374|NCT01038570|psychological tests|psychological tests
718375|NCT01038583|Aspirin|aspirin
718376|NCT01038583|Prevention|prevention
718377|NCT01038583|Healthy|healthy
718378|NCT01038583|Over 65 years old|over 65 years old
718379|NCT01038583|ASPREE|aspree
718380|NCT01038583|Aspirin in Reducing Events in the Elderly|aspirin in reducing events in the elderly
718381|NCT01038583|Australia|australia
718382|NCT01038583|Functional disability|functional disability
718383|NCT01038583|Dementia|dementia
718384|NCT01038583|Heart Disease/ Stroke|heart disease/ stroke
718385|NCT01038583|Cancer|cancer
718386|NCT01038583|Bleeding|bleeding
718387|NCT01038596|osteoarthritis, mesenchymal stromal cells, proliferation|osteoarthritis, mesenchymal stromal cells, proliferation
718388|NCT01038609|Postoperative Pain|postoperative pain
718389|NCT01038622|L-arginine|l-arginine
718390|NCT01038622|Nasal NO|nasal no
718391|NCT01038622|Nosocomial infection|nosocomial infection
718392|NCT01038622|Immune function|immune function
718393|NCT01038622|HLA-DR expression|hla-dr expression
718394|NCT01038622|Critically ill|critically ill
718395|NCT01038622|Medical ICU patients|medical icu patients
718396|NCT01038635|5-Azacytidine|5-azacytidine
718397|NCT01038635|5-Aza|5-aza
718398|NCT01038635|Lenalidomide|lenalidomide
718399|NCT01038635|Revlimid|revlimid
718400|NCT01038635|CC-5103|cc-5103
718401|NCT01038635|Myelodysplastic Syndrome|myelodysplastic syndrome
718403|NCT01038635|Acute Myelogenous Leukemia|acute myelogenous leukemia
718404|NCT01038635|AML|aml
718405|NCT01038648|Sitagliptin|sitagliptin
718406|NCT01038648|Type 2 diabetes|type 2 diabetes
718407|NCT01038648|Prevention of type 2 diabetes|prevention of type 2 diabetes
718408|NCT01038687|functional constipation|functional constipation
718409|NCT01038687|bile acid|bile acid
718410|NCT01038700|Circulating endothelial compartment|circulating endothelial compartment
718411|NCT01038700|microparticles|microparticles
718412|NCT01038700|endothelial progenitors cells|endothelial progenitors cells
718413|NCT01038700|circulating endothelial cells|circulating endothelial cells
718414|NCT01038700|transcriptome|transcriptome
718415|NCT01038700|aging|aging
718416|NCT01038700|Healthy volunteers|healthy volunteers
718417|NCT01038726|Healthy Aging|healthy aging
718418|NCT01038752|NSCLC|nsclc
718419|NCT01038752|suramin|suramin
718420|NCT01038752|lung cancer|lung cancer
718421|NCT01038752|chemotherapy|chemotherapy
718422|NCT01038765|Recurrent Major Depressive Disorder|recurrent major depressive disorder
718423|NCT01038765|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
718424|NCT01038765|Randomized Controlled Trial|randomized controlled trial
718425|NCT01038791|chronic hypercapnic respiratory failure|chronic hypercapnic respiratory failure
718426|NCT01038791|COPD|copd
718427|NCT01038791|RTD|rtd
718428|NCT01038791|sleep architecture|sleep architecture
718429|NCT01038791|humidification|humidification
718430|NCT01038804|Breast Cancer|breast cancer
718431|NCT01038804|Metastatic|metastatic
718432|NCT01038804|HER2 Negative|her2 negative
718433|NCT01038804|YM155|ym155
718434|NCT01038817|tooth-decay|tooth-decay
718435|NCT01038817|prevention|prevention
718436|NCT01038817|fluoride-varnish|fluoride-varnish
718437|NCT01038817|institutionalised elderly people|institutionalised elderly people
718438|NCT01038843|VA106483|va106483
718439|NCT01038843|Nocturia|nocturia
718440|NCT01038843|males|males
718441|NCT01038843|nocturnal voids|nocturnal voids
718442|NCT01038843|anti-diuretic|anti-diuretic
718443|NCT01038843|hyponatraemia|hyponatraemia
718444|NCT01030679|Diabetes Mellitus, type 2|diabetes mellitus, type 2
718445|NCT01030679|Glitazone|glitazone
718446|NCT01030692|Cocaine|cocaine
718447|NCT01030692|Rivastigmine|rivastigmine
718448|NCT01030692|Huperzine A|huperzine a
718449|NCT01030705|Bradycardia|bradycardia
718450|NCT01030705|pacemaker|pacemaker
718451|NCT01030731|Renal Dialysis, Ceftobiprole|renal dialysis, ceftobiprole
718452|NCT01030731|Skin and soft tissue Infections|skin and soft tissue infections
718453|NCT01030731|Staphylococcal Skin Infections|staphylococcal skin infections
718454|NCT01030731|Streptococcal Infection|streptococcal infection
718455|NCT01030744|Gestational Diabetes|gestational diabetes
718456|NCT01030744|Self-Monitoring of Blood Glucose|self-monitoring of blood glucose
718457|NCT01030757|Liver Cancer|liver cancer
718458|NCT01030757|Metastatic Liver Cancer|metastatic liver cancer
718459|NCT01030757|Tomotherapy|tomotherapy
718460|NCT01030757|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
718461|NCT01030770|Diabetes|diabetes
718462|NCT01030770|Vitreous Haemorrhages|vitreous haemorrhages
718463|NCT01030809|Crohn's disease|crohn's disease
718464|NCT01030809|community based gastroenterology practices Canada and Belgium|community based gastroenterology practices canada and belgium
718465|NCT01030809|Cluster randomization controlled trial|cluster randomization controlled trial
718466|NCT01030809|Remission|remission
718467|NCT01030809|Corticosteroids|corticosteroids
718468|NCT01030809|Documented diagnosis of Crohn's disease|documented diagnosis of crohn's disease
718469|NCT01030822|Catch-up vaccination|catch-up vaccination
718470|NCT01030822|Safety|safety
718471|NCT01030822|Pneumococcal vaccine|pneumococcal vaccine
718472|NCT01030822|Pneumococcal disease|pneumococcal disease
718473|NCT01030822|Booster vaccination|booster vaccination
718474|NCT01030822|Immunogenicity|immunogenicity
718475|NCT01030835|Screening Protocol|screening protocol
718476|NCT01030835|Comorbidity|comorbidity
718477|NCT01030835|Normal Controls|normal controls
718478|NCT01030835|Substance Use Disorders|substance use disorders
718479|NCT01030835|Substance Abuse Disorders|substance abuse disorders
718480|NCT01030861|type 1 diabetes|type 1 diabetes
718481|NCT01030861|pre-diabetic|pre-diabetic
718482|NCT01030861|autoantibody positive|autoantibody positive
718483|NCT01030861|at risk for type 1 diabetes|at risk for type 1 diabetes
718484|NCT01030861|glucose intolerance|glucose intolerance
718485|NCT01030861|relatives of people with type 1 diabetes|relatives of people with type 1 diabetes
718486|NCT01030874|hypotension, orthostatic|hypotension, orthostatic
718488|NCT01030874|rehabilitation|rehabilitation
718489|NCT01030874|blood pressure|blood pressure
718490|NCT01030874|aging|aging
718491|NCT01030887|Cancer|cancer
718492|NCT01030887|Exercise|exercise
718493|NCT01030887|Physical Activity|physical activity
718494|NCT01030887|Randomized controlled trial|randomized controlled trial
718495|NCT01030900|Immunosuppression|immunosuppression
718496|NCT01030900|Microenvironment|microenvironment
718497|NCT01030900|Hodgkin Lymphoma|hodgkin lymphoma
718498|NCT01030900|B-Cell Lymphoma|b-cell lymphoma
718499|NCT01030900|Microarray|microarray
718500|NCT01030900|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
718501|NCT01030913|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
718502|NCT01030939|Healthy volunteers|healthy volunteers
718503|NCT01030939|Men and women|men and women
718504|NCT01030939|adults and elderly|adults and elderly
718505|NCT01030939|repeat dose|repeat dose
718506|NCT01030952|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
718507|NCT01030952|Nateglinide|nateglinide
718508|NCT01030952|Acarbose|acarbose
718509|NCT01030952|glucose fluctuation|glucose fluctuation
718510|NCT01030965|Chronic Bronchitis|chronic bronchitis
718511|NCT01030965|Anticholinergic|anticholinergic
718512|NCT01030965|Emphysema|emphysema
718513|NCT01030965|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
718514|NCT01030965|COPD|copd
718515|NCT01030978|Impaired Glucose Tolerance|impaired glucose tolerance
718516|NCT01030978|PreDiabetes|prediabetes
718517|NCT01030978|Diabetes Prevention|diabetes prevention
718518|NCT01030991|Heart failure|heart failure
718519|NCT01030991|Ejection fraction|ejection fraction
718520|NCT01030991|Diastolic heart failure|diastolic heart failure
718521|NCT01030991|Diastolic dysfunction|diastolic dysfunction
718522|NCT01030991|Ventricular-arterial coupling|ventricular-arterial coupling
718523|NCT01030991|Exercise testing|exercise testing
718524|NCT01030991|Echocardiography|echocardiography
718525|NCT01030991|Tissue Doppler imaging|tissue doppler imaging
718526|NCT01030991|Arterial tonometry|arterial tonometry
718527|NCT01030991|Genetics|genetics
718528|NCT01030991|Epidemiology|epidemiology
718529|NCT01031017|twin pregnancies|twin pregnancies
718530|NCT01031017|preterm delivery|preterm delivery
718531|NCT01031017|progesterone|progesterone
718532|NCT01031030|stage I breast cancer|stage i breast cancer
718533|NCT01031030|stage II breast cancer|stage ii breast cancer
718534|NCT01031030|stage IIIA breast cancer|stage iiia breast cancer
718535|NCT01031030|stage IIIB breast cancer|stage iiib breast cancer
718536|NCT01031030|stage IIIC breast cancer|stage iiic breast cancer
718537|NCT01031043|IEM|iem
718538|NCT01031069|Cervarix|cervarix
718540|NCT01031069|Immunogenicity|immunogenicity
718541|NCT01031069|Cervical cancer|cervical cancer
718542|NCT01031069|Safety|safety
718543|NCT01031069|HPV vaccine|hpv vaccine
718544|NCT01031095|percutaneous coronary intervention|percutaneous coronary intervention
718545|NCT01031095|low dose intracoronary heparin|low dose intracoronary heparin
718546|NCT01031121|Cigarette Smoking|cigarette smoking
718547|NCT01031121|Biomarkers|biomarkers
718548|NCT01031121|Nicotine|nicotine
718549|NCT01031121|Cotinine|cotinine
718550|NCT01031121|Metabolites|metabolites
718551|NCT01031147|Magnetic resonance angiography|magnetic resonance angiography
718552|NCT01031147|Intracranial aneurysm|intracranial aneurysm
718553|NCT01031147|Digital subtraction angiography|digital subtraction angiography
718554|NCT01031147|Volume rendering|volume rendering
718555|NCT01031160|Adolescence|adolescence
718556|NCT01031160|Obesity|obesity
718557|NCT01031160|Substance Abuse|substance abuse
718558|NCT01031160|Etiology|etiology
718559|NCT01031160|Social and Environmental Contexts|social and environmental contexts
718560|NCT01031160|Health Behaviors|health behaviors
718561|NCT01031173|α galactosidase A|α galactosidase a
718562|NCT01031173|glycosphingolipid storage disorder|glycosphingolipid storage disorder
718563|NCT01031173|agalsidase alfa|agalsidase alfa
718564|NCT01031173|enzyme replacement therapy|enzyme replacement therapy
718565|NCT01031173|Replagal|replagal
718566|NCT01031173|agalsidase beta|agalsidase beta
718567|NCT01031173|Fabrazyme|fabrazyme
718568|NCT01031186|healthy male volunteers|healthy male volunteers
718569|NCT01031186|GSK356278|gsk356278
718570|NCT01031186|first time in man|first time in man
718571|NCT01031186|major depressive disorder|major depressive disorder
718572|NCT01031199|Multiple sclerosis|multiple sclerosis
718573|NCT01031199|Diagnostic imaging|diagnostic imaging
718574|NCT01031199|Neuroinflammation|neuroinflammation
718575|NCT01031199|PET diagnosis|pet diagnosis
718576|NCT01031199|PET tracer|pet tracer
718577|NCT01031212|cancer|cancer
718578|NCT01031212|neoplasms|neoplasms
718579|NCT01031212|adult solid tumor|adult solid tumor
718580|NCT01031212|antineoplastic agents|antineoplastic agents
718582|NCT01031225|STA 9090|sta 9090
718583|NCT01031225|ganetespib)|ganetespib)
718584|NCT01031225|Lung Cancer|lung cancer
718585|NCT01031225|Non Small Cell Lung Cancer|non small cell lung cancer
718586|NCT01031225|NSCLC|nsclc
718587|NCT01031238|PEM Uptake Value|pem uptake value
718588|NCT01031238|PUV|puv
718589|NCT01031238|Standardized Uptake Value|standardized uptake value
718590|NCT01031238|SUV|suv
718591|NCT01031238|Malignancies of the Breast|malignancies of the breast
718592|NCT01031238|[18F]-FDG-PET/CT scanning|[18f]-fdg-pet/ct scanning
718593|NCT01031238|Tumor|tumor
718594|NCT01031238|positron emission tomography/computed tomography|positron emission tomography/computed tomography
718595|NCT01031238|PET/CT scan|pet/ct scan
718596|NCT01031264|social drinkers|social drinkers
718597|NCT01031277|Hypercholesterolemia|hypercholesterolemia
718598|NCT01031277|Update NCEP ATP111|update ncep atp111
718599|NCT01031277|Survey|survey
718600|NCT01031290|Cue-Induced Craving|cue-induced craving
718601|NCT01031290|Cannabis|cannabis
718602|NCT01031290|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
718603|NCT01031290|Repetitive TMS (rTMS)|repetitive tms (rtms)
718604|NCT01031290|Cannabis Craving|cannabis craving
718605|NCT01031303|Diphtheria|diphtheria
718606|NCT01031303|Tetanus|tetanus
718607|NCT01031303|Pertussis|pertussis
718608|NCT01031303|Poliomyelitis|poliomyelitis
718609|NCT01031303|PENTAXIM™|pentaxim™
718610|NCT01031303|TETRAXIM™|tetraxim™
718611|NCT01031316|Echocardiography|echocardiography
718612|NCT01031316|Infant, Premature|infant, premature
718613|NCT01031316|Infant, Very Low Birth Weight|infant, very low birth weight
718614|NCT01031342|Colonoscopy|colonoscopy
718615|NCT01031342|Gastrointestinal bleeding|gastrointestinal bleeding
718616|NCT01031355|Female Contraception|female contraception
718617|NCT01031355|Contraceptives, Oral|contraceptives, oral
718618|NCT01031381|Recurrent|recurrent
718619|NCT01031381|ovarian|ovarian
718620|NCT01031381|fallopian tube|fallopian tube
718621|NCT01031381|primary peritoneal|primary peritoneal
718622|NCT01031381|cancer|cancer
718913|NCT01039402|France|france
718623|NCT01031381|Recurrent ovarian, fallopian tube, primary peritoneal cancer|recurrent ovarian, fallopian tube, primary peritoneal cancer
718624|NCT01031394|exercise|exercise
718625|NCT01031394|resistance training|resistance training
718626|NCT01031407|Adolescents and Adults|adolescents and adults
718627|NCT01031407|Autism|autism
718628|NCT01031407|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
718629|NCT01031407|MEG|meg
718630|NCT01031407|Structural MRI|structural mri
718631|NCT01031407|HV|hv
718632|NCT01031407|Autism Spectrum Disorder|autism spectrum disorder
718633|NCT01031407|ASD|asd
718634|NCT01031407|Autistic Disorder|autistic disorder
718635|NCT01031407|Asperger Syndrome|asperger syndrome
718636|NCT01031407|Mental Retardation|mental retardation
718637|NCT01031407|Healthy Volunteer|healthy volunteer
718638|NCT01031420|bladder|bladder
718639|NCT01031420|cancer|cancer
718640|NCT01031420|invasive|invasive
718641|NCT01031433|Tobacco Craving|tobacco craving
718642|NCT01031433|Virtual Reality|virtual reality
718643|NCT01031433|Schizophrenia|schizophrenia
718644|NCT01031433|Smoking|smoking
718645|NCT01031446|stage IV breast cancer|stage iv breast cancer
718646|NCT01031446|Human epidermal growth factor (HER2)-negative breast cancer|human epidermal growth factor (her2)-negative breast cancer
718647|NCT01031446|triple-negative breast cancer|triple-negative breast cancer
718648|NCT01031446|hormone-resistant breast cancer|hormone-resistant breast cancer
718649|NCT01031472|HIV, relative bioavailability, food effect, GSK2248761, healthy subjects|hiv, relative bioavailability, food effect, gsk2248761, healthy subjects
718650|NCT01031472|HIV Seronegativity|hiv seronegativity
718651|NCT01031485|hypertension|hypertension
718652|NCT01031485|blood pressure|blood pressure
718653|NCT01031485|milk peptides|milk peptides
718654|NCT01031485|bioactive peptides|bioactive peptides
718655|NCT01031485|randomized controlled trial|randomized controlled trial
718656|NCT01031498|Nausea|nausea
718657|NCT01031498|Vomiting|vomiting
718658|NCT01031498|CINV|cinv
718659|NCT01031498|Leukemia|leukemia
718660|NCT01031498|High-risk Myelodysplastic syndrome|high-risk myelodysplastic syndrome
718661|NCT01031498|AML|aml
718662|NCT01031498|Hematologic malignancies|hematologic malignancies
718663|NCT01031498|Hematologic Disorder|hematologic disorder
718664|NCT01031498|Continuous multi-day chemotherapy|continuous multi-day chemotherapy
718665|NCT01031498|High-dose cytarabine|high-dose cytarabine
718666|NCT01031498|Palonosetron|palonosetron
718667|NCT01031498|Aloxi|aloxi
718668|NCT01031498|Ondansetron|ondansetron
718669|NCT01031498|Zofran|zofran
718670|NCT01031511|High-Functioning Autistic Spectrum Disorder|high-functioning autistic spectrum disorder
718671|NCT01031511|Anxiety|anxiety
718672|NCT01031511|Cognitive Behavioural Therapy|cognitive behavioural therapy
718673|NCT01031511|Social Recreational|social recreational
718674|NCT01031511|Parent Stress|parent stress
718675|NCT01031524|Plasmodium falciparum malaria|plasmodium falciparum malaria
718676|NCT01031537|FSME-Immun|fsme-immun
718677|NCT01031537|TBEV|tbev
718678|NCT01031537|TBE Researcher|tbe researcher
718679|NCT01031537|Plavivirus|plavivirus
718680|NCT01031537|Anti-TBEV Levels|anti-tbev levels
718681|NCT01031537|Tic-Borne Encephalitis|tic-borne encephalitis
718682|NCT01031550|liver resection for liver disease|liver resection for liver disease
718683|NCT01031563|Risk Taking|risk taking
718684|NCT01031563|Schizophrenia|schizophrenia
718685|NCT01031563|Drug Abuse/Dependence|drug abuse/dependence
718686|NCT01031563|Comorbidity|comorbidity
718687|NCT01031563|Impulsivity|impulsivity
718688|NCT01031563|Drug Abuse|drug abuse
718689|NCT01031576|Osteoarthritis, posture, knee|osteoarthritis, posture, knee
718690|NCT01031589|TMC278-TiDP15-C158|tmc278-tidp15-c158
718691|NCT01031589|TMC278-C158|tmc278-c158
718692|NCT01031589|TMC278|tmc278
718693|NCT01031589|HIV|hiv
718694|NCT01031589|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
718695|NCT01031589|HIV Seronegativity|hiv seronegativity
718696|NCT01031602|Cancer|cancer
718697|NCT01031602|Gynecology|gynecology
718698|NCT01031602|Sexual Dysfunction|sexual dysfunction
718699|NCT01031602|Depression|depression
718700|NCT01031602|Anxiety|anxiety
718701|NCT01031602|Underserved|underserved
718702|NCT01031602|Minority|minority
718703|NCT01031602|Psychological distress|psychological distress
753811|NCT01177761|CHD-risk|chd-risk
718704|NCT01031615|School age children and adolescents exposed to a potentially traumatic event|school age children and adolescents exposed to a potentially traumatic event
718705|NCT01031628|GIST|gist
718706|NCT01031628|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
718707|NCT01031628|Exon 9|exon 9
718708|NCT01031628|Gleevec|gleevec
718709|NCT01031628|Imatinib blood levels|imatinib blood levels
718710|NCT01031641|Patient-Reported Outcomes|patient-reported outcomes
718711|NCT01031641|Symptoms|symptoms
718712|NCT01031641|Instrument Development|instrument development
718713|NCT01031641|Adverse Events|adverse events
718714|NCT01031641|Questionnaire|questionnaire
718715|NCT01031641|Patient Reported Outcomes|patient reported outcomes
718716|NCT01031667|Patients treated with PCI with stent|patients treated with pci with stent
718717|NCT01031680|dapagliflozin|dapagliflozin
718719|NCT01031680|cardiovascular disease|cardiovascular disease
718720|NCT01031680|hypertension|hypertension
718721|NCT01031693|Nicotine|nicotine
718722|NCT01031693|Cigarettes|cigarettes
718723|NCT01031693|Tobacco|tobacco
718724|NCT01031693|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
718725|NCT01031693|Cue-Induced Craving|cue-induced craving
718726|NCT01031693|Smoking|smoking
718727|NCT01031706|Hypertonic Saline|hypertonic saline
718728|NCT01031706|Pediatrics|pediatrics
718729|NCT01031706|Cystic Fibrosis|cystic fibrosis
718730|NCT01031706|Mucociliary Clearance|mucociliary clearance
718731|NCT01031706|Lung Clearance Index|lung clearance index
718732|NCT01031719|Influenza A Virus|influenza a virus
718733|NCT01031719|Virus Diseases|virus diseases
718734|NCT01031719|Influenza, Human|influenza, human
718735|NCT01031719|H1N1|h1n1
718736|NCT01031719|Immunogenicity|immunogenicity
718737|NCT01031719|safety|safety
718738|NCT01031719|tolerability|tolerability
718739|NCT01031719|tumors|tumors
718740|NCT01031719|oncology|oncology
718741|NCT01031732|Minimally invasive|minimally invasive
718742|NCT01031732|Total hip arthroplasty|total hip arthroplasty
718743|NCT01031732|Functional outcome|functional outcome
718744|NCT01031732|To compare the surgical results of 4 MIS THA techniques|to compare the surgical results of 4 mis tha techniques
718745|NCT01031732|To investigate the functional outcomes of 4 MIS THA techniques|to investigate the functional outcomes of 4 mis tha techniques
718746|NCT01031732|To study the biochemical parameters after the MIS surgeries.|to study the biochemical parameters after the mis surgeries.
718747|NCT01031745|Complementary Therapies|complementary therapies
718748|NCT01031745|Drug Users|drug users
718749|NCT01031758|Low HDL|low hdl
718750|NCT01031758|High HDL|high hdl
718751|NCT01031758|HDL|hdl
718752|NCT01031758|Reverse Cholesterol Transport|reverse cholesterol transport
718753|NCT01031758|RCT|rct
718754|NCT01031758|healthy volunteer|healthy volunteer
718755|NCT01031758|3H|3h
718756|NCT01031758|Average HDL|average hdl
718757|NCT01031771|Cerebral Palsy|cerebral palsy
718758|NCT01031771|Deglutition|deglutition
718759|NCT01031771|Deglutition disorders|deglutition disorders
718760|NCT01031771|Endoscopy|endoscopy
718761|NCT01031784|liver metastasis|liver metastasis
718762|NCT01031784|Liver tumors|liver tumors
718763|NCT01031784|microspheres|microspheres
718764|NCT01031784|holmium|holmium
718765|NCT01031784|toxicity|toxicity
718766|NCT01031797|SLE|sle
718767|NCT01031797|Disease activity score|disease activity score
718768|NCT01031797|QT dispersion|qt dispersion
718769|NCT01031810|Treatment Resistant depression|treatment resistant depression
718770|NCT01031810|Major Depression|major depression
718771|NCT01031810|MDD|mdd
718772|NCT01031810|Depression|depression
718773|NCT01031823|Autism Spectrum Disorder|autism spectrum disorder
718774|NCT01031836|Systemic Lupus Erythematosus|systemic lupus erythematosus
718775|NCT01031836|Japanese|japanese
718777|NCT01031836|safety|safety
718778|NCT01031836|tolerability|tolerability
718779|NCT01031836|MEDI-545|medi-545
718780|NCT01031836|Autoimmune Disease|autoimmune disease
718781|NCT01031836|Immune System Diseases|immune system diseases
718782|NCT01031849|HIV 1 patients|hiv 1 patients
718783|NCT01031862|healthy volunteer|healthy volunteer
718784|NCT01031862|reverse cholesterol transport|reverse cholesterol transport
718785|NCT01031862|RCT|rct
721219|NCT01042197|UVB|uvb
718786|NCT01031862|3H|3h
718787|NCT01031875|recurrent bladder cancer|recurrent bladder cancer
718788|NCT01031875|stage IV bladder cancer|stage iv bladder cancer
718789|NCT01031875|recurrent urethral cancer|recurrent urethral cancer
718790|NCT01031875|distal urethral cancer|distal urethral cancer
718791|NCT01031875|proximal urethral cancer|proximal urethral cancer
718792|NCT01031875|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
718793|NCT01031875|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
718794|NCT01031875|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
718795|NCT01031875|stage IV urethral cancer|stage iv urethral cancer
718796|NCT01031888|Corneal re-epithelialization|corneal re-epithelialization
718797|NCT01031888|Topical insulin application|topical insulin application
718798|NCT01031888|pars planar vitrectomy|pars planar vitrectomy
718799|NCT01031888|diabetic retinopathy|diabetic retinopathy
718800|NCT01031888|penetrating keratoplasty|penetrating keratoplasty
718801|NCT01038882|sedation|sedation
718802|NCT01038882|midazolam|midazolam
718803|NCT01038882|flexible bronchoscopy|flexible bronchoscopy
718804|NCT01038882|tolerance|tolerance
718805|NCT01038895|Hypertension|hypertension
718806|NCT01038895|type 2 diabetes|type 2 diabetes
718807|NCT01038895|aliskiren|aliskiren
718808|NCT01038895|ramipril|ramipril
718809|NCT01038895|microalbuminuria|microalbuminuria
718810|NCT01038895|blood pressure> 130/80 <180/105 mmHg at the end of the wash−out|blood pressure> 130/80 <180/105 mmhg at the end of the wash−out
718811|NCT01038895|type 2 diabetes mellitus well controlled by medication and / or|type 2 diabetes mellitus well controlled by medication and / or
718812|NCT01038895|compliance with diet (HbA1c <7%)|compliance with diet (hba1c <7%)
718813|NCT01038895|Microalbuminuria in the upper range of normal (> 200 <300 mg/24 h)|microalbuminuria in the upper range of normal (> 200 <300 mg/24 h)
718814|NCT01038908|sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
718815|NCT01038908|axillary lymph node dissection (ALND)|axillary lymph node dissection (alnd)
718816|NCT01038908|lymphatics|lymphatics
718817|NCT01038908|blue dye|blue dye
718818|NCT01038921|Blood Pressure|blood pressure
718819|NCT01038921|Glucose levels|glucose levels
718820|NCT01038921|HDL levels|hdl levels
718821|NCT01038921|Triglyceride levels|triglyceride levels
718822|NCT01038921|Waist Circumference|waist circumference
718823|NCT01038934|Buccal Mucosa|buccal mucosa
718824|NCT01038934|DNA|dna
718825|NCT01038934|Polymerase Chain Reaction|polymerase chain reaction
718826|NCT01038960|ICD, training|icd, training
718827|NCT01038986|chronic wound|chronic wound
718828|NCT01038986|refractory wound|refractory wound
718829|NCT01038986|CureXcell|curexcell
719696|NCT01035359|PRWE|prwe
718830|NCT01038986|activated cell suspension|activated cell suspension
718831|NCT01038999|Complementary Therapies|complementary therapies
718832|NCT01039012|bone mineral density|bone mineral density
718833|NCT01039012|osteoporosis|osteoporosis
718834|NCT01039012|exercise|exercise
718835|NCT01039012|bone remodeling|bone remodeling
718836|NCT01039012|biomotion analysis|biomotion analysis
718837|NCT01039025|Myeloma|myeloma
718838|NCT01039025|Topotecan|topotecan
718839|NCT01039025|Hycamtin|hycamtin
718840|NCT01039025|Melphalan|melphalan
718841|NCT01039025|Alkeran|alkeran
718842|NCT01039025|Cyclophosphamide|cyclophosphamide
718843|NCT01039025|Cytoxan|cytoxan
718844|NCT01039025|Neosar|neosar
718845|NCT01039025|Stem Cell Harvest|stem cell harvest
718846|NCT01039025|Peripheral Blood Stem Cells|peripheral blood stem cells
718847|NCT01039038|prostate|prostate
718848|NCT01039038|curietherapy|curietherapy
718849|NCT01039038|radiotherapy|radiotherapy
718850|NCT01039038|intermediate risk|intermediate risk
718851|NCT01039090|Not eligible for deep brain stimulation|not eligible for deep brain stimulation
718852|NCT01039090|Parkinsons's patients|parkinsons's patients
718853|NCT01039103|PEG-liposomal prednisolone sodium phosphate|peg-liposomal prednisolone sodium phosphate
718854|NCT01039116|obesity|obesity
718855|NCT01039116|nutrition|nutrition
718856|NCT01039116|type 2 diabetes|type 2 diabetes
718857|NCT01039116|community-based.|community-based.
718858|NCT01039129|Gallstones|gallstones
718859|NCT01039129|Appendicitis|appendicitis
718860|NCT01039129|Pelvic pain|pelvic pain
718861|NCT01039129|Peritoneal mass|peritoneal mass
718862|NCT01039142|Psoriasis|psoriasis
718863|NCT01039168|Burnout|burnout
718864|NCT01039168|Sick leave|sick leave
718865|NCT01039168|Intervention study|intervention study
718866|NCT01039168|Prospective study|prospective study
718867|NCT01039168|Work|work
718868|NCT01039181|Vitamin D|vitamin d
718869|NCT01039181|Calcitriol|calcitriol
718870|NCT01039181|cholangiocarcinoma|cholangiocarcinoma
718871|NCT01039181|Clinical trial|clinical trial
718872|NCT01039285|Very premature infant|very premature infant
718873|NCT01039285|Surfactant|surfactant
718874|NCT01039285|Respiratory Distress|respiratory distress
718875|NCT01039285|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
718876|NCT01039298|Oral cancer|oral cancer
718877|NCT01039298|fluorescence visualization|fluorescence visualization
718878|NCT01039298|surgical margin|surgical margin
718879|NCT01039298|recurrence|recurrence
718881|NCT01039311|cancer|cancer
718882|NCT01039311|bronchoscopy|bronchoscopy
718883|NCT01039311|optical|optical
718884|NCT01039311|coherence|coherence
718885|NCT01039311|tomography|tomography
718886|NCT01039324|Complex patients|complex patients
718887|NCT01039324|Care transitions|care transitions
718888|NCT01039324|Patient safety|patient safety
718889|NCT01039324|Patient care|patient care
718890|NCT01039324|Health Information Technology|health information technology
718891|NCT01039324|Health Information Exchange|health information exchange
718892|NCT01039324|Clinical Decision Support|clinical decision support
718893|NCT01039324|Care coordination|care coordination
718894|NCT01039324|Data sharing|data sharing
718895|NCT01039337|osteoarthritis|osteoarthritis
718896|NCT01039337|manual therapy|manual therapy
718897|NCT01039337|manipulation|manipulation
718898|NCT01039337|hip school|hip school
718899|NCT01039337|chiropractic|chiropractic
718900|NCT01039337|patient education|patient education
718901|NCT01039350|Myelodysplastic syndrome|myelodysplastic syndrome
718902|NCT01039363|Relapse or refractory acute myeloid leukemia|relapse or refractory acute myeloid leukemia
718903|NCT01039376|maintenance therapy|maintenance therapy
718904|NCT01039376|anti-CD20 monoclonal antibody|anti-cd20 monoclonal antibody
718905|NCT01039376|ofatumumab|ofatumumab
718906|NCT01039389|Coronary Artery Disease|coronary artery disease
718907|NCT01039389|Stable|stable
718908|NCT01039389|Coronary Collaterals|coronary collaterals
718909|NCT01039389|Therapeutic Collateral Promotion|therapeutic collateral promotion
718910|NCT01039389|Arteriogenesis|arteriogenesis
718911|NCT01039389|Bradycardia|bradycardia
718912|NCT01039402|cardiovascular risk|cardiovascular risk
718914|NCT01039402|Observational, descriptive study|observational, descriptive study
718915|NCT01039415|marijuana|marijuana
718916|NCT01039415|marijuana abuse|marijuana abuse
718917|NCT01039415|marijuana dependence|marijuana dependence
718918|NCT01039415|cannabis|cannabis
718919|NCT01039415|substance-related disorder|substance-related disorder
718920|NCT01039415|abstinence|abstinence
718921|NCT01039428|hyperphosphatemia|hyperphosphatemia
718922|NCT01039428|hemodialysis|hemodialysis
718923|NCT01039428|chitosan|chitosan
718924|NCT01039454|Food Reward|food reward
718925|NCT01039454|fMRI|fmri
718926|NCT01039454|Obese|obese
718927|NCT01039454|Cognition|cognition
718928|NCT01039454|Food Addiction|food addiction
718929|NCT01039454|Behaviour|behaviour
718930|NCT01039454|Overweight|overweight
718931|NCT01039454|Food Reinforcement|food reinforcement
718932|NCT01039454|Metabolic endpoints|metabolic endpoints
718933|NCT01039467|Managed Ventricular Pacing|managed ventricular pacing
718934|NCT01039480|pharmacological biomarker|pharmacological biomarker
718935|NCT01039480|compliance monitoring|compliance monitoring
718936|NCT01039480|platelet aggregometry|platelet aggregometry
718937|NCT01039480|resistance|resistance
718938|NCT01039480|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
718939|NCT01039480|Medication Non-Compliance|medication non-compliance
718940|NCT01039506|UGT1A1, irinotecan|ugt1a1, irinotecan
718941|NCT01039519|G.I. Stromal Tumor|g.i. stromal tumor
718943|NCT01039532|Type 2 diabetes mellitus|type 2 diabetes mellitus
718944|NCT01039532|Biphasic human insulin thrice a day|biphasic human insulin thrice a day
718945|NCT01039532|Basal bolus insulin|basal bolus insulin
718946|NCT01039545|Urinary tract infections|urinary tract infections
718947|NCT01039545|Anti-bacterial agents|anti-bacterial agents
718948|NCT01039558|gastroesophageal reflux disease|gastroesophageal reflux disease
718949|NCT01039558|lansoprazole|lansoprazole
718950|NCT01039558|ecabet sodium|ecabet sodium
718951|NCT01039571|rotator cuff tear|rotator cuff tear
718952|NCT01039571|arthroscopic repair|arthroscopic repair
718953|NCT01039571|single row repair|single row repair
718954|NCT01039571|double row repair|double row repair
718955|NCT01039571|retear rate|retear rate
718956|NCT01039584|bioequivalence|bioequivalence
718957|NCT01039584|butoconazole|butoconazole
718958|NCT01039584|vulvovaginal|vulvovaginal
718959|NCT01039584|candidiasis|candidiasis
718961|NCT01039597|Ulcerative colitis|ulcerative colitis
718962|NCT01039610|single dose|single dose
718963|NCT01039610|pharmacokinetics|pharmacokinetics
718964|NCT01039610|GSK945237|gsk945237
718965|NCT01039610|tolerability|tolerability
718966|NCT01039610|safety|safety
718967|NCT01039610|antibiotics|antibiotics
718968|NCT01039610|linezolid|linezolid
718969|NCT01039610|QTc|qtc
718970|NCT01039610|bacterial type II topoisomerase Inhibitors (BTI)|bacterial type ii topoisomerase inhibitors (bti)
718971|NCT01039610|moxifloxacin|moxifloxacin
718972|NCT01039610|repeat dose|repeat dose
718973|NCT01039623|Healthy volunteers|healthy volunteers
718974|NCT01039636|Beta-thalassemia|beta-thalassemia
718975|NCT01039636|Sickle cell anemia|sickle cell anemia
718976|NCT01039636|Transfusional iron overload|transfusional iron overload
718977|NCT01039636|Iron overload|iron overload
718979|NCT01039649|radiation|radiation
718980|NCT01039649|Tomography, Spiral Computed|tomography, spiral computed
718981|NCT01039649|Four-Dimensional Computed Tomography|four-dimensional computed tomography
718982|NCT01039649|Respiratory Function Tests|respiratory function tests
718983|NCT01039675|long-acting beta2-receptor agonist|long-acting beta2-receptor agonist
718984|NCT01039675|Safety and tolerability|safety and tolerability
718985|NCT01039675|pharmacodynamics|pharmacodynamics
718986|NCT01039675|pharmacokinetics|pharmacokinetics
718987|NCT01039675|long-acting muscarinic receptor antagonist|long-acting muscarinic receptor antagonist
718988|NCT01039675|COPD|copd
718989|NCT01039688|oral JAK inhibitor|oral jak inhibitor
718990|NCT01039688|MTX|mtx
718991|NCT01039688|DMARD|dmard
718992|NCT01039688|clinical trial|clinical trial
718993|NCT01039688|joint diseases|joint diseases
718994|NCT01039688|autoimmune diseases|autoimmune diseases
718995|NCT01039688|anti-Inflammatory agents|anti-inflammatory agents
718996|NCT01039688|rheumatic diseases|rheumatic diseases
718997|NCT01039701|safety|safety
718998|NCT01039701|tolerability|tolerability
718999|NCT01039701|mild to moderate Alzheimer's disease|mild to moderate alzheimer's disease
719000|NCT01039701|To determine the safety and tolerability of AZD1446 vs Placebo given as an add-on treatment to Donepezil in patients with mild to moderate Alzheimer's disease|to determine the safety and tolerability of azd1446 vs placebo given as an add-on treatment to donepezil in patients with mild to moderate alzheimer's disease
719001|NCT01039714|Hypocalcemia|hypocalcemia
719002|NCT01039714|Hypoparathyroidism|hypoparathyroidism
719003|NCT01039714|Vitamin D deficiency|vitamin d deficiency
719004|NCT01039714|Total thyroidectomy|total thyroidectomy
719005|NCT01039714|calcium|calcium
719006|NCT01039714|PTH|pth
719007|NCT01039727|Pain [C10.597.617]|pain [c10.597.617]
719008|NCT01039740|Pharmacogenomics|pharmacogenomics
719009|NCT01039740|Prediction of Mirtazapine response|prediction of mirtazapine response
719010|NCT01039740|Depressed patients|depressed patients
719011|NCT01039740|Mirtazapine response|mirtazapine response
719012|NCT01039740|Adverse event|adverse event
719013|NCT01039753|acute kidney injury|acute kidney injury
719014|NCT01039753|renal replacement therapy|renal replacement therapy
719015|NCT01039753|biomarkers|biomarkers
719016|NCT01039766|post traumatic stress disorder|post traumatic stress disorder
719017|NCT01039766|prevention|prevention
719018|NCT01039766|oxytocin|oxytocin
719019|NCT01039779|older fallers|older fallers
719020|NCT01039779|tai chi|tai chi
719021|NCT01039792|Autism|autism
719022|NCT01039792|Pervasive Developmental Disorders|pervasive developmental disorders
719023|NCT01039805|GSK962040|gsk962040
719024|NCT01039805|13C octanoic acid breath test|13c octanoic acid breath test
719025|NCT01039805|pharmacokinetics|pharmacokinetics
719026|NCT01039805|critically ill patients|critically ill patients
719027|NCT01039805|gut motility|gut motility
719028|NCT01039805|pharmacodynamics|pharmacodynamics
719029|NCT01039805|tolerability|tolerability
719030|NCT01039805|single dose|single dose
719031|NCT01039805|gastric emtpying|gastric emtpying
719032|NCT01039818|Graves Disease|graves disease
719033|NCT01039818|Hyperthyroidism|hyperthyroidism
719034|NCT01039818|Radioiodine|radioiodine
719035|NCT01039818|Clinical trial|clinical trial
719036|NCT01039831|PIGD|pigd
719037|NCT01039831|tremor|tremor
719038|NCT01039831|falls|falls
719039|NCT01039831|white matter|white matter
719040|NCT01039844|LOC-paclitaxel Injection|loc-paclitaxel injection
719041|NCT01039844|metastatic Melanoma|metastatic melanoma
719042|NCT01039857|Psychotherapy|psychotherapy
719043|NCT01039857|Depression|depression
719044|NCT01039857|Adjustment Disorders|adjustment disorders
719045|NCT01039857|Neuropsychology|neuropsychology
719046|NCT01039857|Rehabilitation|rehabilitation
719047|NCT01039857|Coping Skills|coping skills
719048|NCT01039857|Stroke|stroke
719049|NCT01039857|Caregivers|caregivers
719050|NCT01039870|postthoracotomy pain|postthoracotomy pain
719051|NCT01039883|Healthy Volunteers|healthy volunteers
719052|NCT01039922|Neuroendocrine Tumors|neuroendocrine tumors
719053|NCT01039922|Registries|registries
719054|NCT01039935|Odor Discrimination|odor discrimination
719055|NCT01039948|Neoplasms|neoplasms
719056|NCT01039948|Carcinoma|carcinoma
719057|NCT01039948|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
719058|NCT01039948|Lung Neoplasms|lung neoplasms
719059|NCT01039948|Respiratory Tract Neoplasms|respiratory tract neoplasms
719060|NCT01039948|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
719061|NCT01039948|Neoplasms by Histological Type|neoplasms by histological type
719062|NCT01039948|Thoracic Neoplasms|thoracic neoplasms
719063|NCT01039948|Neoplasms by Site|neoplasms by site
719064|NCT01039948|Lung Diseases|lung diseases
719065|NCT01039948|Respiratory Tract Diseases|respiratory tract diseases
719066|NCT01039948|Gefitinib|gefitinib
719067|NCT01039948|Antineoplastic Agents|antineoplastic agents
719068|NCT01039948|Therapeutic Uses|therapeutic uses
719069|NCT01039948|Pharmacologic Actions|pharmacologic actions
719070|NCT01039948|Protein Kinase Inhibitors|protein kinase inhibitors
719071|NCT01039948|Enzyme Inhibitors|enzyme inhibitors
719072|NCT01039948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
719073|NCT01039961|healthy volunteers|healthy volunteers
719074|NCT01039961|IV formulation study|iv formulation study
719075|NCT01039974|ketoconazole|ketoconazole
719076|NCT01039974|GSK962040|gsk962040
719077|NCT01039974|Drug-Drug Interaction|drug-drug interaction
719079|NCT01039987|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
719080|NCT01039987|ADPKD|adpkd
719081|NCT01039987|kidney|kidney
719082|NCT01039987|Biomarker|biomarker
719083|NCT01039987|MRI|mri
719084|NCT01040000|NPC-1C|npc-1c
719085|NCT01040000|Monoclonal antibody|monoclonal antibody
719086|NCT01040000|Pancreatic Cancer|pancreatic cancer
719087|NCT01040000|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
719088|NCT01040000|Ductal carcinoma of the pancreas|ductal carcinoma of the pancreas
719089|NCT01040000|Duct cell carcinomas, pancreas|duct cell carcinomas, pancreas
720788|NCT01050816|ACI|aci
719090|NCT01040000|Carcinomas, pancreas duct cell|carcinomas, pancreas duct cell
719091|NCT01040000|Pancreas duct cell carcinoma|pancreas duct cell carcinoma
719092|NCT01040000|Pancreatic duct cell carcinoma|pancreatic duct cell carcinoma
719093|NCT01040000|Adenocarcinoma of the colon|adenocarcinoma of the colon
719094|NCT01040000|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
719095|NCT01040000|Colorectal cancer|colorectal cancer
719096|NCT01040000|Colorectal tumor|colorectal tumor
719097|NCT01040000|Colorectal neoplasm|colorectal neoplasm
719098|NCT01040013|LAPAROSCOPY,|laparoscopy,
719099|NCT01040013|LAPAROTOMY,|laparotomy,
719100|NCT01040013|OXYGENATION,|oxygenation,
719101|NCT01040013|ISCHEMIA-REPERFUSION INJURY|ischemia-reperfusion injury
719102|NCT01040039|HCV|hcv
719103|NCT01040039|HIV|hiv
719104|NCT01040052|Diphtheria|diphtheria
719105|NCT01040052|Tetanus|tetanus
719106|NCT01040052|Pertussis|pertussis
719107|NCT01040052|Adacel®|adacel®
719108|NCT01040065|Acromioclavicular joint arthritis|acromioclavicular joint arthritis
719109|NCT01040065|distal clavicle resection|distal clavicle resection
719110|NCT01040065|Mumford procedure|mumford procedure
719111|NCT01040091|HIV Seronegativity|hiv seronegativity
719112|NCT01040091|Treatment Experienced|treatment experienced
719113|NCT01040104|wound healing|wound healing
719114|NCT01040104|hypertrophic scar|hypertrophic scar
719115|NCT01040104|skin transplantation|skin transplantation
719116|NCT01040104|diabetes mellitus|diabetes mellitus
719117|NCT01040117|Equilibrium|equilibrium
719118|NCT01040117|Rehabilitation|rehabilitation
719119|NCT01040117|Randomized Controlled Trial|randomized controlled trial
719120|NCT01040117|Postural instability|postural instability
719121|NCT01040117|Sensory-motor integration|sensory-motor integration
719122|NCT01040143|Pneumococci|pneumococci
719123|NCT01040143|Streptococcus pneumoniae|streptococcus pneumoniae
719124|NCT01040182|ischemic stroke patients|ischemic stroke patients
719125|NCT01040195|ankylosing spondylitis|ankylosing spondylitis
719126|NCT01040195|undifferentiated spondyloarthropathy|undifferentiated spondyloarthropathy
719127|NCT01040195|spondyloarthropathy|spondyloarthropathy
719128|NCT01040195|inflammatory back pain|inflammatory back pain
719129|NCT01040195|methotrexate|methotrexate
719130|NCT01040195|sulfasalazine|sulfasalazine
719131|NCT01040195|hydroxychloroquine|hydroxychloroquine
719132|NCT01040221|Autism, Autism Spectrum Disorder|autism, autism spectrum disorder
719133|NCT01040221|ASD|asd
719134|NCT01040221|Trichuris Suis Ova|trichuris suis ova
719135|NCT01040221|TSO|tso
719136|NCT01040221|Treatment|treatment
719137|NCT01040221|Clinical Trial|clinical trial
719138|NCT01040234|postoperative pain|postoperative pain
719139|NCT01040234|abdominal surgery|abdominal surgery
719140|NCT01040234|bilateral dual TAP block|bilateral dual tap block
719141|NCT01040247|Infertility|infertility
719142|NCT01040247|Low Responder|low responder
719143|NCT01040247|IVF|ivf
719144|NCT01040247|Embryo Transfer|embryo transfer
719145|NCT01040260|tobacco use disorder|tobacco use disorder
719146|NCT01040286|Subjects, age>21, with Chronic periodontal disease on natural teeth characterized by the presence of at least 2 teeth with periodontal|subjects, age>21, with chronic periodontal disease on natural teeth characterized by the presence of at least 2 teeth with periodontal
719147|NCT01040286|pockets of 5-9 mm in depth demonstrating bleeding on probing without involving the|pockets of 5-9 mm in depth demonstrating bleeding on probing without involving the
719148|NCT01040286|apex of the tooth and confirmed by dental X-ray.|apex of the tooth and confirmed by dental x-ray.
719149|NCT01040299|GangTrainer|gangtrainer
719150|NCT01040299|Gait Rehabilitation|gait rehabilitation
719151|NCT01040299|Cerebrovascular Disorders|cerebrovascular disorders
719152|NCT01040299|Robot assisted|robot assisted
719153|NCT01040299|Transcranial direct current stimulation|transcranial direct current stimulation
719154|NCT01040312|UGT1A1, irinotecan|ugt1a1, irinotecan
719155|NCT01040338|Smoking|smoking
719156|NCT01040338|Tobacco|tobacco
719157|NCT01040338|Nicotine|nicotine
719158|NCT01040338|Dependence|dependence
719159|NCT01040338|Genetics|genetics
719160|NCT01040351|Infertility|infertility
719161|NCT01040351|Hydrosalpinx|hydrosalpinx
719162|NCT01040351|IVF-ET|ivf-et
719163|NCT01040364|Internal hernia|internal hernia
719164|NCT01040364|Mesocolic hernia|mesocolic hernia
719165|NCT01040364|Petersen´s hernia|petersen´s hernia
719166|NCT01040364|Jejunojejunostomy hernia|jejunojejunostomy hernia
719167|NCT01040364|Bowel obstruction|bowel obstruction
719168|NCT01040364|Ischemic bowel|ischemic bowel
719169|NCT01040364|Complication after gastric bypass|complication after gastric bypass
719170|NCT01040364|Re-operative bariatric surgery|re-operative bariatric surgery
719171|NCT01040364|Chronic pain after gastric bypass|chronic pain after gastric bypass
719172|NCT01040377|Inadequate Initial Weight Loss|inadequate initial weight loss
719173|NCT01040377|Inadequate weight loss|inadequate weight loss
719174|NCT01040377|Poor weight loss|poor weight loss
719175|NCT01040377|Failed gastric bypass|failed gastric bypass
719176|NCT01040377|Revision gastric bypass|revision gastric bypass
719177|NCT01040390|Acne Vulgaris|acne vulgaris
719178|NCT01040390|Homoeopathy|homoeopathy
719179|NCT01040390|Lappa Arctium|lappa arctium
719180|NCT01040416|complicated marginal ulcer|complicated marginal ulcer
719181|NCT01040416|complex marginal ulcer|complex marginal ulcer
719182|NCT01040416|complication after gastric bypass|complication after gastric bypass
719183|NCT01040416|gastrointestinal hemorrhage|gastrointestinal hemorrhage
719184|NCT01040429|Adolescent|adolescent
719185|NCT01040429|Clonidine|clonidine
719186|NCT01040429|Autonomic nervous system|autonomic nervous system
719187|NCT01040429|Stress|stress
719188|NCT01040442|Postural Balance|postural balance
719189|NCT01040442|Aging|aging
719190|NCT01040442|Accidental Falls|accidental falls
719191|NCT01040442|Vibration|vibration
719192|NCT01040455|functional dyspepsia|functional dyspepsia
719193|NCT01040455|lansoprazole|lansoprazole
719194|NCT01040455|placebo effect|placebo effect
719195|NCT01040468|Type 2 Diabetes|type 2 diabetes
719196|NCT01040468|Bariatric Surgery|bariatric surgery
719197|NCT01040468|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
719198|NCT01040468|Gastric Banding|gastric banding
719199|NCT01040468|Obesity|obesity
719200|NCT01040468|Weight loss|weight loss
719295|NCT01040845|healthy|healthy
719201|NCT01040468|Insulin sensitivity|insulin sensitivity
719202|NCT01040468|GLP-1|glp-1
719203|NCT01040468|Meal Challenge|meal challenge
719204|NCT01040468|Euglycemic Clamp|euglycemic clamp
719205|NCT01040481|Failed gastric bypass|failed gastric bypass
719206|NCT01040481|Malabsorptive distal gastric bypass|malabsorptive distal gastric bypass
719207|NCT01040481|Distal gastric bypass|distal gastric bypass
719208|NCT01040481|Malabsorptive gastric bypass|malabsorptive gastric bypass
719209|NCT01040481|Adding malabsorption|adding malabsorption
719210|NCT01040481|Increasing malabsorption|increasing malabsorption
719211|NCT01040481|Re-operative bariatric surgery|re-operative bariatric surgery
719212|NCT01040481|Revisional bariatric surgery|revisional bariatric surgery
719213|NCT01040481|Revisional gastric bypass|revisional gastric bypass
719214|NCT01040481|Reoperations|reoperations
719215|NCT01040481|Conversions|conversions
719216|NCT01040494|Aliskiren|aliskiren
719217|NCT01040494|Congestive heart failure|congestive heart failure
719218|NCT01040494|Central hemodynamics|central hemodynamics
719219|NCT01040507|severe obesity|severe obesity
719220|NCT01040507|morbid obesity|morbid obesity
719221|NCT01040507|gastric bypass|gastric bypass
719222|NCT01040507|efficacy of gastric bypass|efficacy of gastric bypass
719223|NCT01040520|CT-based autopsy|ct-based autopsy
719224|NCT01040520|virtual autopsy|virtual autopsy
719225|NCT01040520|medical autopsy|medical autopsy
719226|NCT01040520|quality control|quality control
719227|NCT01040533|Failed jejunoileal bypass|failed jejunoileal bypass
719228|NCT01040533|Complicated jejunoileal bypass|complicated jejunoileal bypass
719229|NCT01040533|Revision gastric bypass|revision gastric bypass
719230|NCT01040533|Revisional surgery|revisional surgery
719231|NCT01040533|Reoperations|reoperations
719232|NCT01040533|Metabolic and nutritional complications|metabolic and nutritional complications
719233|NCT01040546|Obesity|obesity
719234|NCT01040546|Metabolic syndrome|metabolic syndrome
719235|NCT01040546|Weight control educational intervention|weight control educational intervention
719236|NCT01040546|Food intake|food intake
719237|NCT01040572|Obesity recidivism|obesity recidivism
719238|NCT01040572|Weight Regain|weight regain
719239|NCT01040572|Weight recidivism|weight recidivism
719240|NCT01040572|Morbidity|morbidity
719241|NCT01040572|Complication|complication
719242|NCT01040572|Late complications|late complications
719243|NCT01040572|Revisional gastric bypass|revisional gastric bypass
719244|NCT01040572|Re-operative gastric bypass|re-operative gastric bypass
719245|NCT01040572|Revisional bariatric surgery|revisional bariatric surgery
719246|NCT01040572|Re-operative bariatric surgery|re-operative bariatric surgery
719247|NCT01040585|cost effectiveness|cost effectiveness
719248|NCT01040585|linezolid|linezolid
719249|NCT01040585|ventilator acquired pneumonia|ventilator acquired pneumonia
719250|NCT01040585|central america|central america
719251|NCT01040598|Eosinophilic Esophagitis|eosinophilic esophagitis
719252|NCT01040598|Xolair|xolair
719253|NCT01040598|Omalizumab|omalizumab
719254|NCT01040598|Esophagitis|esophagitis
719255|NCT01040598|Eosinophils|eosinophils
719256|NCT01040598|monoclonal antibody|monoclonal antibody
719257|NCT01040611|music therapy|music therapy
719258|NCT01040611|Tuberculosis|tuberculosis
719259|NCT01040611|anxiety|anxiety
719260|NCT01040611|physiological response|physiological response
719261|NCT01040624|Prostate Cancer, Proton Radiation|prostate cancer, proton radiation
719262|NCT01040637|Healthy subjects|healthy subjects
719263|NCT01040676|Diabetes Mellitus|diabetes mellitus
719264|NCT01040676|Telephone|telephone
719265|NCT01040676|Nutrition Support|nutrition support
719266|NCT01040676|Automated|automated
719267|NCT01040676|Low English Proficiency|low english proficiency
719268|NCT01040676|Hispanic|hispanic
719269|NCT01040676|Latino|latino
719270|NCT01040715|Rheumatoid arthritis|rheumatoid arthritis
719271|NCT01040715|anti-drug antibodies|anti-drug antibodies
719272|NCT01040715|Rheumatoid arthritis with secondary loss of efficacy to anti-TNFa antagonists and anti-drug antibodies|rheumatoid arthritis with secondary loss of efficacy to anti-tnfa antagonists and anti-drug antibodies
719273|NCT01040741|Pandemic influenza A (H1N1) vaccine|pandemic influenza a (h1n1) vaccine
719274|NCT01040741|Adjuvanted|adjuvanted
719275|NCT01040767|Ultrasound education|ultrasound education
719276|NCT01040767|Blended learning|blended learning
719277|NCT01040767|Distance education|distance education
719278|NCT01040767|Trauma ultrasound|trauma ultrasound
719279|NCT01040767|FAST|fast
719280|NCT01040780|Efficacy|efficacy
719281|NCT01040780|Safety|safety
719282|NCT01040780|EGFR-TKI|egfr-tki
719283|NCT01040780|phase III|phase iii
719284|NCT01040780|NSCLC|nsclc
719285|NCT01040806|Diabetes|diabetes
719286|NCT01040819|Diabetes Mellitus|diabetes mellitus
719287|NCT01040819|6-Ketoprostaglandin F1 alpha|6-ketoprostaglandin f1 alpha
719288|NCT01040819|15-epi-lipoxin A4|15-epi-lipoxin a4
719289|NCT01040819|Thiazolidinediones|thiazolidinediones
719290|NCT01040819|Pioglitazone|pioglitazone
719291|NCT01040832|Head and Neck Cancer|head and neck cancer
719292|NCT01040832|Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer|recurrent or metastatic squamous cell carcinoma of the head and neck cancer
719293|NCT01040832|Cetuximab|cetuximab
719294|NCT01040832|EMD 1201081|emd 1201081
719296|NCT01040845|pharmacokinetics|pharmacokinetics
719297|NCT01040845|drug-interaction|drug-interaction
719298|NCT01040858|cognitive strategy intervention|cognitive strategy intervention
719299|NCT01040858|cognitive disorders|cognitive disorders
719300|NCT01040897|Obesity prevention|obesity prevention
719301|NCT01040897|Health Literacy|health literacy
719302|NCT01040897|Health Communication|health communication
719303|NCT01040910|cannabis|cannabis
719304|NCT01040910|Crohn's disease|crohn's disease
719305|NCT01040910|Ulcerative colitis|ulcerative colitis
719306|NCT01040910|IBD|ibd
719307|NCT01040923|CAD|cad
719308|NCT01040923|Diagnostic|diagnostic
719309|NCT01040936|acute coronary syndrome|acute coronary syndrome
719310|NCT01040936|intervention|intervention
719311|NCT01040936|outcome|outcome
719312|NCT01040936|patients diagnosed ad Non-ST elevation ACS|patients diagnosed ad non-st elevation acs
719313|NCT01040936|patients received PCI therapy|patients received pci therapy
719314|NCT01040949|smoking cessation|smoking cessation
719315|NCT01040949|pregnant Latinas|pregnant latinas
719316|NCT01040949|couples communication|couples communication
719317|NCT01040949|Latino community|latino community
719318|NCT01040949|couples communication in Latino couples|couples communication in latino couples
719319|NCT01040962|neuropathy|neuropathy
719320|NCT01040962|diabetes|diabetes
719321|NCT01040988|Pacemaker|pacemaker
719322|NCT01040988|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
719323|NCT01041001|Umbilical Cord Blood|umbilical cord blood
719324|NCT01041001|Mesenchymal Stem Cells|mesenchymal stem cells
719325|NCT01041001|cartilage injury|cartilage injury
719326|NCT01041001|osteoarthritis|osteoarthritis
719327|NCT01041014|Limited English proficiency|limited english proficiency
719328|NCT01041014|Cost-effectiveness|cost-effectiveness
719329|NCT01041014|Emergency Departments|emergency departments
719330|NCT01041014|Language Discordance|language discordance
719331|NCT01041014|Satisfaction|satisfaction
719332|NCT01041014|Limited English proficient patients|limited english proficient patients
719333|NCT01041014|Spanish-speaking patients|spanish-speaking patients
719334|NCT01041040|Acute Myeloblastic Leukemia|acute myeloblastic leukemia
719335|NCT01041066|patients who are intubated for general anesthesia|patients who are intubated for general anesthesia
719336|NCT01041079|ulcer disease|ulcer disease
719337|NCT01041079|marginal ulcer|marginal ulcer
719338|NCT01041079|morbidity of gastric bypass|morbidity of gastric bypass
719339|NCT01041079|late morbidity of gastric bypass|late morbidity of gastric bypass
719340|NCT01041079|chronic abdominal pain|chronic abdominal pain
719341|NCT01041079|GI hemorrhage|gi hemorrhage
719342|NCT01041079|Perforation|perforation
719343|NCT01041079|Penetration|penetration
719344|NCT01041079|Obstruction|obstruction
719345|NCT01041105|Obesity|obesity
719346|NCT01041105|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
719347|NCT01041105|Nissen funduplication|nissen funduplication
719348|NCT01041105|Antireflux surgery|antireflux surgery
719349|NCT01041105|Revisional Gastric Bypass|revisional gastric bypass
719350|NCT01041105|Re-operative bariatric surgery|re-operative bariatric surgery
719351|NCT01041105|Bariatric surgery|bariatric surgery
719352|NCT01041105|Nissen|nissen
719353|NCT01041105|Conversion of Nissen to Gastric Bypass|conversion of nissen to gastric bypass
719354|NCT01041131|Obesity|obesity
719355|NCT01041131|Obesity recidivism|obesity recidivism
719356|NCT01041131|Inadequate Initial Weight Loss|inadequate initial weight loss
719357|NCT01041131|Technical bariatric complications|technical bariatric complications
719358|NCT01041131|Complicated gastroplasty|complicated gastroplasty
719359|NCT01041131|Failed gastroplasty|failed gastroplasty
719360|NCT01041131|Gastroesophageal reflux disease|gastroesophageal reflux disease
719361|NCT01041131|Revisional gastric bypass|revisional gastric bypass
719362|NCT01041131|Conversion bariatric surgery|conversion bariatric surgery
719363|NCT01041131|Re-operative bariatric surgery|re-operative bariatric surgery
719364|NCT01041131|Technical complications of vertical gastroplasty|technical complications of vertical gastroplasty
719365|NCT01041131|Complicated vertical gastroplasty|complicated vertical gastroplasty
719366|NCT01041144|Diabetes|diabetes
719367|NCT01041144|PDA|pda
719368|NCT01041144|Internet|internet
719369|NCT01041144|HbA1c|hba1c
719370|NCT01041157|Torticollis|torticollis
719371|NCT01041157|Botulinum Toxins|botulinum toxins
719372|NCT01041170|Rimonabant|rimonabant
719373|NCT01041170|fMRI|fmri
719374|NCT01041170|Alternative Matrices|alternative matrices
719375|NCT01041170|Brain Imaging|brain imaging
719376|NCT01041170|THC|thc
719377|NCT01041183|Oral plus IV ramosetron may be more effective than|oral plus iv ramosetron may be more effective than
719378|NCT01041183|IV ramosetron and oral ramosetron for the prophylaxis of|iv ramosetron and oral ramosetron for the prophylaxis of
719379|NCT01041183|PONV after laparoscopic cholecystectomy|ponv after laparoscopic cholecystectomy
719380|NCT01041196|obesity|obesity
719381|NCT01041196|ulcer disease|ulcer disease
719382|NCT01041196|marginal ulcer|marginal ulcer
719383|NCT01041196|perforation|perforation
719384|NCT01041196|abdominal pain|abdominal pain
719385|NCT01041196|bariatric surgery|bariatric surgery
719386|NCT01041196|weight loss surgery|weight loss surgery
719387|NCT01041209|Pneumonia|pneumonia
719388|NCT01041209|Children|children
719389|NCT01041222|Familial ALS|familial als
719390|NCT01041222|ALS|als
719391|NCT01041222|SOD1 Protein|sod1 protein
719392|NCT01041222|ISIS 333611|isis 333611
719393|NCT01041222|SOD1Rx|sod1rx
719394|NCT01041235|Solid Neoplasms|solid neoplasms
719395|NCT01041235|Carcinoma|carcinoma
719396|NCT01041235|Breast|breast
719397|NCT01041235|Ovarian|ovarian
719398|NCT01041235|Ovary|ovary
719399|NCT01041235|Pancreas|pancreas
719400|NCT01041235|Pancreatic|pancreatic
719401|NCT01041235|Lung|lung
719402|NCT01041235|NSCLC|nsclc
719403|NCT01041235|Non Small Cell Lung|non small cell lung
719404|NCT01041235|Prostate|prostate
719405|NCT01041235|Gastric|gastric
719406|NCT01041235|Head and Neck|head and neck
719407|NCT01041248|Relapsing Polychondritis|relapsing polychondritis
720281|NCT01044758|AD|ad
719408|NCT01041248|Single Patient Study|single patient study
719409|NCT01041248|Tocilizumab|tocilizumab
719410|NCT01041261|Laparoscopic gastric bypass surgery|laparoscopic gastric bypass surgery
719411|NCT01041261|Medical food|medical food
719412|NCT01041261|Body composition|body composition
719413|NCT01041261|Dietary intervention|dietary intervention
719414|NCT01041274|Schizophrenia|schizophrenia
719415|NCT01041274|Citalopram|citalopram
719416|NCT01041274|First episode|first episode
719417|NCT01041274|fMRI|fmri
719418|NCT01041274|Cognitive behavioral therapy|cognitive behavioral therapy
719419|NCT01041274|Psychoeducation|psychoeducation
719420|NCT01041300|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
719421|NCT01041300|TMS|tms
719422|NCT01041300|Motor Threashold|motor threashold
719423|NCT01041300|Multiway|multiway
719424|NCT01041300|Magstim Rapid 2|magstim rapid 2
719425|NCT01041300|Abductor policis brevis|abductor policis brevis
719426|NCT01041300|Figure 8 coil|figure 8 coil
719427|NCT01041300|Double cone coil|double cone coil
719428|NCT01041300|Circular coil|circular coil
719429|NCT01041300|Brainsway|brainsway
719430|NCT01041300|Healthy participants.|healthy participants.
719431|NCT01041313|Adjuvants, pharmaceuticals|adjuvants, pharmaceuticals
719432|NCT01041313|Receptors, N-Methyl-D-Aspartate|receptors, n-methyl-d-aspartate
719433|NCT01041313|Drug tolerance|drug tolerance
719434|NCT01041313|Pain Measurement|pain measurement
719435|NCT01041326|prostatectomy|prostatectomy
719436|NCT01041326|radiation|radiation
719437|NCT01041326|neoadjuvant|neoadjuvant
719438|NCT01041339|LpPLA2|lppla2
719439|NCT01041339|ST elevation|st elevation
719440|NCT01041339|acute pericarditis|acute pericarditis
719441|NCT01041352|anaesthesia|anaesthesia
719442|NCT01041352|laryngeal mask|laryngeal mask
719443|NCT01041352|prone position|prone position
719444|NCT01041365|insulin sensitivity|insulin sensitivity
719445|NCT01041365|vascular function|vascular function
719538|NCT01041755|Cirrhosis|cirrhosis
719446|NCT01041365|flow-mediated dilation|flow-mediated dilation
719447|NCT01041365|arterial stiffness|arterial stiffness
719448|NCT01041365|ethnicity|ethnicity
719449|NCT01041365|adolescents|adolescents
719451|NCT01041365|glucose tolerance|glucose tolerance
719452|NCT01041365|diabetes|diabetes
719453|NCT01041365|hypertension|hypertension
719454|NCT01041365|cardiovascular|cardiovascular
719455|NCT01041378|Pediatric patients (6 months-5 years) scheduled elective day-case orchiopexy|pediatric patients (6 months-5 years) scheduled elective day-case orchiopexy
719456|NCT01041391|Surgical intervention vs Non-Surgical intervention|surgical intervention vs non-surgical intervention
719457|NCT01041417|claudication|claudication
719458|NCT01041430|Ambulatory Surgery|ambulatory surgery
719459|NCT01041430|Aged|aged
719460|NCT01041456|complicated biliopancreatic diversion|complicated biliopancreatic diversion
719461|NCT01041456|failed biliopancreatic diversion|failed biliopancreatic diversion
719462|NCT01041456|revision gastric bypass|revision gastric bypass
719463|NCT01041456|conversion bariatric surgery|conversion bariatric surgery
719464|NCT01041456|revision bariatric surgery|revision bariatric surgery
719465|NCT01041456|re-operative bariatric surgery|re-operative bariatric surgery
719466|NCT01041456|malabsorptive syndrome|malabsorptive syndrome
719467|NCT01041456|protein malnutrition|protein malnutrition
719468|NCT01041456|metabolic bone disease|metabolic bone disease
719469|NCT01041469|Down syndrome, Humans,Clinical study,Immunity, Autoimmunity,|down syndrome, humans,clinical study,immunity, autoimmunity,
719470|NCT01041482|sorafenib|sorafenib
719471|NCT01041482|renal cell carcinoma|renal cell carcinoma
719472|NCT01041482|disease free survival|disease free survival
719473|NCT01041482|Hand food skin reaction|hand food skin reaction
719474|NCT01041495|fibromyalgia|fibromyalgia
719475|NCT01041495|Pain|pain
719476|NCT01041495|Sleep|sleep
719477|NCT01041495|Fatigue|fatigue
719478|NCT01041508|ALL|all
719479|NCT01041508|AML|aml
719480|NCT01041508|Recurrence|recurrence
719481|NCT01041508|Relapsed|relapsed
719482|NCT01041508|Stem Cell Transplant|stem cell transplant
719483|NCT01041508|Non-myeloablastive|non-myeloablastive
719484|NCT01041521|HIV infection|hiv infection
719485|NCT01041521|Dyslipidemia|dyslipidemia
719486|NCT01041521|Elevated Triglyceride level|elevated triglyceride level
719487|NCT01041521|vascular function (BART)|vascular function (bart)
719488|NCT01041521|arterial stiffness|arterial stiffness
719489|NCT01041521|omega three fatty acids|omega three fatty acids
719490|NCT01041521|complementary therapies|complementary therapies
719491|NCT01041534|Adjustable gastric band, morbid obesity, bariatric surgery|adjustable gastric band, morbid obesity, bariatric surgery
719492|NCT01041547|Insulin sensitivity|insulin sensitivity
719493|NCT01041547|Vascular function|vascular function
719494|NCT01041547|Flow-mediated dilation|flow-mediated dilation
719495|NCT01041547|Arterial stiffness|arterial stiffness
719496|NCT01041547|Glucose tolerance|glucose tolerance
719497|NCT01041547|Hypertension|hypertension
719498|NCT01041560|Stroke|stroke
719499|NCT01041560|Tone|tone
719500|NCT01041560|Strength|strength
719501|NCT01041573|Pediatric|pediatric
719502|NCT01041573|Japanese Encephalitis Vaccine|japanese encephalitis vaccine
719503|NCT01041573|endemic countries|endemic countries
719504|NCT01041573|to assess the systemic and local safety profile of purified inactivated Japanese Encephalitis Virus (JEV) vaccine IC51|to assess the systemic and local safety profile of purified inactivated japanese encephalitis virus (jev) vaccine ic51
719505|NCT01041586|Emphysema|emphysema
719506|NCT01041586|COPD|copd
719507|NCT01041586|Lung Volume Reduction|lung volume reduction
719508|NCT01041586|BTVA|btva
719509|NCT01041599|Diabetes Mellitus|diabetes mellitus
719510|NCT01041599|Hypertension|hypertension
719511|NCT01041599|Albuminuria|albuminuria
719512|NCT01041599|vascular stiffness|vascular stiffness
719513|NCT01041612|CBD|cbd
719514|NCT01041612|HBD|hbd
719515|NCT01041612|cancer of bile duct|cancer of bile duct
719516|NCT01041612|pancreatic cancer|pancreatic cancer
719517|NCT01041625|Lichen Planus|lichen planus
719518|NCT01041664|nutrigenomics|nutrigenomics
719519|NCT01041664|admixture|admixture
719520|NCT01041664|Hispanic American|hispanic american
719521|NCT01041664|body composition|body composition
719522|NCT01041664|Association of diet and body composition|association of diet and body composition
719523|NCT01041664|Association between genes and body composition|association between genes and body composition
719524|NCT01041664|Association between gen by diet interaction and body composition|association between gen by diet interaction and body composition
719525|NCT01041677|Obesity|obesity
719526|NCT01041677|Overweight|overweight
719527|NCT01041677|Body Weight|body weight
719528|NCT01041677|Body Size|body size
719529|NCT01041677|Nutritional and Metabolic Diseases|nutritional and metabolic diseases
719530|NCT01041690|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
719531|NCT01041690|Vitrectomy|vitrectomy
719532|NCT01041690|Bevacizumab|bevacizumab
719533|NCT01041716|Carbapenem|carbapenem
719534|NCT01041716|Klebsiella pneumoniae carbapenemase|klebsiella pneumoniae carbapenemase
719535|NCT01041716|Acinetobacter baumannii|acinetobacter baumannii
719536|NCT01041716|Pseudomonas aeruginosa|pseudomonas aeruginosa
719537|NCT01041755|Encephalopathy|encephalopathy
719539|NCT01041768|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
719540|NCT01041781|adenocarcinoma of the lung|adenocarcinoma of the lung
719541|NCT01041781|adenosquamous cell lung cancer|adenosquamous cell lung cancer
719542|NCT01041781|large cell lung cancer|large cell lung cancer
719543|NCT01041781|squamous cell lung cancer|squamous cell lung cancer
719544|NCT01041781|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
719545|NCT01041781|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
719546|NCT01041781|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
719547|NCT01041794|body composition|body composition
719548|NCT01041794|fat distribution|fat distribution
719549|NCT01041794|exercise|exercise
719550|NCT01041794|diet|diet
719551|NCT01034722|Breast Milk|breast milk
719552|NCT01034722|Fat Globules|fat globules
719553|NCT01034735|Saizen®|saizen®
719554|NCT01034735|bioequivalence|bioequivalence
719555|NCT01034735|recombinant human|recombinant human
719556|NCT01034735|Growth Hormone|growth hormone
719557|NCT01034735|treatment of growth failure in children|treatment of growth failure in children
719558|NCT01034735|growth hormone deficiency in adults|growth hormone deficiency in adults
719559|NCT01034748|Radiolabelled|radiolabelled
719560|NCT01034748|Mass Balance|mass balance
719561|NCT01034748|Healthy Volunteers|healthy volunteers
719562|NCT01034748|Pharmacokinetics|pharmacokinetics
719563|NCT01034761|Electronic prescribing|electronic prescribing
719564|NCT01034761|Inappropriate medications|inappropriate medications
719565|NCT01034761|Patient safety|patient safety
719566|NCT01034761|Elderly patients in the hospital|elderly patients in the hospital
719567|NCT01034774|Human volunteers|human volunteers
719568|NCT01034787|CP-675,206|cp-675,206
719569|NCT01034787|Immunotherapy|immunotherapy
719570|NCT01034787|AntiCTLA4|antictla4
719571|NCT01034787|Clinical Trial|clinical trial
719572|NCT01034787|Unresectable or Metastatic|unresectable or metastatic
719573|NCT01034800|HIV Positive|hiv positive
719574|NCT01034813|contractures, range of motion, scar formation|contractures, range of motion, scar formation
719575|NCT01034826|NGT, IGT, diabetes|ngt, igt, diabetes
719576|NCT01034839|acute myeloid leukemia|acute myeloid leukemia
719577|NCT01034839|prognosis|prognosis
719578|NCT01034839|cytarabine|cytarabine
719966|NCT01043536|IMRT|imrt
719579|NCT01034852|Atrial Fibrillation|atrial fibrillation
719580|NCT01034852|Maze|maze
719581|NCT01034852|Ablation|ablation
719582|NCT01034891|BRCA mutation|brca mutation
719583|NCT01034891|benign breast disease|benign breast disease
719584|NCT01034891|family history of breast cancer|family history of breast cancer
719585|NCT01034891|strong family history of breast cancer|strong family history of breast cancer
719586|NCT01034891|atypical ductal hyperplasia|atypical ductal hyperplasia
719587|NCT01034891|atypical lobular hyperplasia|atypical lobular hyperplasia
719588|NCT01034891|high risk for breast cancer|high risk for breast cancer
719589|NCT01034904|Quality of Life|quality of life
719590|NCT01034904|HRQoL|hrqol
719591|NCT01034904|Hemophilia A|hemophilia a
719592|NCT01034904|Helixate FS|helixate fs
719593|NCT01034917|Active Comparator|active comparator
719594|NCT01034917|Placebo Comparator|placebo comparator
719595|NCT01034917|Sham Comparator|sham comparator
719596|NCT01034917|No intervention|no intervention
719597|NCT01034917|Other|other
719598|NCT01034917|Treatment Experienced|treatment experienced
719599|NCT01034930|MANDIBLE|mandible
719600|NCT01034930|IMPLANTS|implants
719601|NCT01034930|OVERDENTURE|overdenture
719602|NCT01034943|radius|radius
719603|NCT01034943|fracture|fracture
719604|NCT01034943|wrist|wrist
719605|NCT01034943|external|external
719606|NCT01034943|fixation|fixation
719607|NCT01034943|volar|volar
719608|NCT01034943|plate|plate
719609|NCT01034943|DASH|dash
719610|NCT01034943|PRWE|prwe
719611|NCT01034956|Soft tissue filler|soft tissue filler
719612|NCT01034956|Dermal filler|dermal filler
719613|NCT01034956|Complications|complications
719614|NCT01034956|Patient satisfaction|patient satisfaction
719615|NCT01034969|Hereditary angioedema|hereditary angioedema
719616|NCT01034982|COPD|copd
719617|NCT01035008|pancreatic cysts|pancreatic cysts
719618|NCT01035047|Acute Coronary Syndrome|acute coronary syndrome
719619|NCT01035047|Chest pain|chest pain
719620|NCT01035047|Cardiac MRI|cardiac mri
719621|NCT01035047|Risk Stratification|risk stratification
719622|NCT01035047|Emergency Department|emergency department
719623|NCT01035086|dietary fibre|dietary fibre
719624|NCT01035086|lupin kernel fibre|lupin kernel fibre
719625|NCT01035086|bile acids|bile acids
719626|NCT01035086|cholesterol metabolism|cholesterol metabolism
719627|NCT01035086|blood lipids|blood lipids
719628|NCT01035086|hypercholesterolemia|hypercholesterolemia
719629|NCT01035086|fibre-enriched food|fibre-enriched food
719630|NCT01035086|moderate hypercholesterolemia|moderate hypercholesterolemia
719631|NCT01035099|Letrozole|letrozole
719632|NCT01035099|IVF (in vitro fertilization)|ivf (in vitro fertilization)
719633|NCT01035099|Cryopreservation|cryopreservation
719634|NCT01035099|Fertility Preservation|fertility preservation
719635|NCT01035099|Breast Cancer|breast cancer
719636|NCT01035125|Self-management|self-management
719637|NCT01035125|Self-efficacy|self-efficacy
719638|NCT01035125|Coping|coping
719639|NCT01035125|Health consumer|health consumer
719640|NCT01035125|Patient education|patient education
719641|NCT01035125|Health related quality of life|health related quality of life
719642|NCT01035151|randomized cluster design|randomized cluster design
719643|NCT01035151|tobacco cessation|tobacco cessation
719644|NCT01035151|smoking cessation|smoking cessation
719645|NCT01035151|African American|african american
719646|NCT01035164|Alzheimer's Disease|alzheimer's disease
719647|NCT01035164|Diagnostic Imaging|diagnostic imaging
719648|NCT01035164|Neuroinflammation|neuroinflammation
719649|NCT01035164|PET Diagnosis|pet diagnosis
719650|NCT01035164|PET Tracer|pet tracer
719651|NCT01035177|Bone Mineral Density (BMD);|bone mineral density (bmd);
719652|NCT01035177|Cortical bone;|cortical bone;
719653|NCT01035177|Hip fracture;|hip fracture;
719654|NCT01035177|Osteoporosis;|osteoporosis;
719655|NCT01035177|Quantitative Computed Tomography (QCT).|quantitative computed tomography (qct).
719656|NCT01035190|Preterm Infants|preterm infants
719657|NCT01035190|Inhaled Corticosteroids|inhaled corticosteroids
719658|NCT01035190|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
719659|NCT01035216|Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)|relapsed or refractory b-cell chronic lymphocytic leukemia (b-cll)
719660|NCT01035229|Hepatocellular carcinoma|hepatocellular carcinoma
719661|NCT01035229|randomized trial|randomized trial
719662|NCT01035229|medical treatment|medical treatment
719663|NCT01035229|RAD001|rad001
719664|NCT01035229|placebo|placebo
719665|NCT01035229|Advanced Hepatocellular Carcinoma (HCC)|advanced hepatocellular carcinoma (hcc)
719666|NCT01035242|OCD|ocd
719667|NCT01035242|obsessions|obsessions
719668|NCT01035242|cognitive|cognitive
719669|NCT01035255|chronic heart failure|chronic heart failure
719670|NCT01035255|cardiovascular death|cardiovascular death
719671|NCT01035255|hospitalization|hospitalization
719672|NCT01035255|outcome study|outcome study
719673|NCT01035255|BNP|bnp
719674|NCT01035255|KCCQ|kccq
719675|NCT01035255|eGFR|egfr
719676|NCT01035268|breast cancer treated by conservative surgery|breast cancer treated by conservative surgery
719677|NCT01035281|Diabetic Neuropathies|diabetic neuropathies
719678|NCT01035281|Neuropathic Pain|neuropathic pain
719679|NCT01035281|Cannabinoids|cannabinoids
719680|NCT01035281|Tree Number C10.668.829.300|tree number c10.668.829.300
719681|NCT01035307|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
719682|NCT01035307|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
719683|NCT01035333|gastric bypass surgery|gastric bypass surgery
719684|NCT01035346|Fever|fever
719685|NCT01035346|antipyretic|antipyretic
719686|NCT01035346|uncomplicated acute viral infection|uncomplicated acute viral infection
719687|NCT01035346|uncomplicated acute bacterial infections|uncomplicated acute bacterial infections
719688|NCT01035359|radius|radius
719689|NCT01035359|fracture|fracture
719690|NCT01035359|wrist|wrist
719691|NCT01035359|external|external
719692|NCT01035359|fixation|fixation
719693|NCT01035359|volar|volar
719694|NCT01035359|plate|plate
719695|NCT01035359|DASH|dash
719697|NCT01035372|healthy older people|healthy older people
719698|NCT01035385|FOFLOX4|foflox4
719699|NCT01035385|resectable liver metastasis from colorectal cancer|resectable liver metastasis from colorectal cancer
719700|NCT01035398|stage 0 esophageal cancer|stage 0 esophageal cancer
719701|NCT01035398|stage I esophageal cancer|stage i esophageal cancer
719702|NCT01035398|stage II esophageal cancer|stage ii esophageal cancer
719703|NCT01035398|stage III esophageal cancer|stage iii esophageal cancer
719704|NCT01035398|stage IV esophageal cancer|stage iv esophageal cancer
719705|NCT01035411|COPD|copd
719706|NCT01035424|Batten Disease|batten disease
719707|NCT01035424|Late Infantile Neuronal Lipofuscinosis|late infantile neuronal lipofuscinosis
719708|NCT01035424|LINCL|lincl
719709|NCT01035437|obstructing|obstructing
719710|NCT01035450|Coronary stent|coronary stent
719711|NCT01035476|ALS|als
719712|NCT01035476|nasal ventilation|nasal ventilation
719713|NCT01035476|data card recording|data card recording
719714|NCT01035489|Pacemaker treatment in heart failure|pacemaker treatment in heart failure
719715|NCT01035489|Cardiac resynchronization therapy|cardiac resynchronization therapy
719716|NCT01035489|DDD pacemakers|ddd pacemakers
719717|NCT01035502|Cancer|cancer
719718|NCT01035502|CP-4055|cp-4055
719719|NCT01035502|elacytarabine|elacytarabine
719720|NCT01035502|combination|combination
719721|NCT01035502|idarubicin|idarubicin
719722|NCT01035502|Acute myeloid leukaemia (AML)|acute myeloid leukaemia (aml)
719723|NCT01035515|Healthy subjects|healthy subjects
719724|NCT01035528|diastolic function, postmeal glucose, insulin glargine|diastolic function, postmeal glucose, insulin glargine
719725|NCT01035541|Major non-cardiac surgery,|major non-cardiac surgery,
719726|NCT01035541|hemodynamic management,|hemodynamic management,
719727|NCT01035541|PiCCO,|picco,
719728|NCT01035541|acute kidney injury,|acute kidney injury,
719729|NCT01035541|renal outcome|renal outcome
719730|NCT01035554|high blood pressure|high blood pressure
719731|NCT01035567|Multivessel coronary artery disease|multivessel coronary artery disease
719732|NCT01035567|Hybrid revascularization|hybrid revascularization
719733|NCT01035567|Coronary Artery Bypass Grafting|coronary artery bypass grafting
719734|NCT01035567|Percutaneous Coronary Interventions|percutaneous coronary interventions
719735|NCT01035567|Drug eluting stents|drug eluting stents
719736|NCT01035580|chemoprevention|chemoprevention
719737|NCT01035580|curcumin|curcumin
719738|NCT01035580|pharmacokinetics|pharmacokinetics
719739|NCT01035580|safety|safety
719740|NCT01035606|attention|attention
719741|NCT01035606|rehabilitation|rehabilitation
719742|NCT01035606|training|training
719743|NCT01035606|functional MRI|functional mri
719744|NCT01035606|executive function|executive function
719745|NCT01035606|brain injury|brain injury
719746|NCT01035619|onchocerciasis; river blindness; moxidectin; pediatric|onchocerciasis; river blindness; moxidectin; pediatric
719747|NCT01035632|Craving|craving
719748|NCT01035632|Incubation|incubation
719749|NCT01035632|Relapse|relapse
719750|NCT01035632|Smoking Cues|smoking cues
719751|NCT01035632|Cortisol|cortisol
719752|NCT01035645|First time in human|first time in human
719753|NCT01035645|Interleukin-18|interleukin-18
719754|NCT01035645|Healthy male subjects|healthy male subjects
719755|NCT01035645|Obese male subjects|obese male subjects
719756|NCT01035645|Monoclonal antibody|monoclonal antibody
719757|NCT01035645|Pharmacokinetics|pharmacokinetics
719758|NCT01035645|Tolerability|tolerability
719759|NCT01035645|Safety|safety
719760|NCT01035645|Pharmacodynamics|pharmacodynamics
719761|NCT01035658|Pazopanib|pazopanib
719762|NCT01035658|Doxil|doxil
719763|NCT01035658|Liposomal doxorubicin|liposomal doxorubicin
719764|NCT01035658|Advanced relapsed|advanced relapsed
719765|NCT01035658|platinum-sensitive|platinum-sensitive
719766|NCT01035658|platinum-resistant|platinum-resistant
719767|NCT01035697|NICHD Neonatal Research Network|nichd neonatal research network
719768|NCT01035697|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
719769|NCT01035697|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
719770|NCT01035697|Prematurity|prematurity
719771|NCT01035697|Pro-inflammatory cytokines|pro-inflammatory cytokines
719772|NCT01035697|Anti-inflammatory cytokines|anti-inflammatory cytokines
719773|NCT01035697|Interleukin-1 (IL-1β)|interleukin-1 (il-1β)
719774|NCT01035697|Interleukin-2 (IL-2)|interleukin-2 (il-2)
719775|NCT01035697|Interleukin-3 (IL-3)|interleukin-3 (il-3)
719776|NCT01035697|Interleukin-8 (IL-8)|interleukin-8 (il-8)
719777|NCT01035697|Interleukin-9 (IL-9)|interleukin-9 (il-9)
719778|NCT01035697|Tumor necrosis factor-α (TNF-α)|tumor necrosis factor-α (tnf-α)
719779|NCT01035697|Regulated upon Activation, Normal T-cell Expressed and Secreted (RANTES)|regulated upon activation, normal t-cell expressed and secreted (rantes)
719780|NCT01035723|Prefrontal Cortex|prefrontal cortex
719781|NCT01035723|Hippocampus|hippocampus
719782|NCT01035723|Amygdala|amygdala
719783|NCT01035723|MRI|mri
719784|NCT01035723|Cognitive Tasks|cognitive tasks
719785|NCT01035749|pandemic influenza|pandemic influenza
719786|NCT01035749|Clinical trial|clinical trial
719787|NCT01035749|H1N1|h1n1
719788|NCT01035749|children|children
719789|NCT01041807|Hypertension|hypertension
719790|NCT01041820|exercise|exercise
720282|NCT01044771|HIV|hiv
719791|NCT01041820|bone marrow adipose tissue|bone marrow adipose tissue
719792|NCT01041820|bone mineral density|bone mineral density
719793|NCT01041820|Children in the intervention condition will complete a supervised physical activity program 3 days/wk for 10 weeks|children in the intervention condition will complete a supervised physical activity program 3 days/wk for 10 weeks
719794|NCT01041820|Control treatment will be provided no intervention|control treatment will be provided no intervention
719795|NCT01041820|All participants will be instructed not to change their current dietary habits during the study period.|all participants will be instructed not to change their current dietary habits during the study period.
719796|NCT01041833|All-trans retinoic acid|all-trans retinoic acid
719797|NCT01041833|non-small cell lung cancer|non-small cell lung cancer
719798|NCT01041833|retinoic acid receptor beta|retinoic acid receptor beta
719799|NCT01041846|Myelodysplastic Syndrome|myelodysplastic syndrome
719800|NCT01041846|Dacogen|dacogen
719801|NCT01041846|Decitabine|decitabine
719802|NCT01041846|Epigenetic therapy|epigenetic therapy
719803|NCT01041846|Hypomethylating agent|hypomethylating agent
719804|NCT01041859|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
719805|NCT01041859|Painful|painful
719806|NCT01041859|Polyneuropathy|polyneuropathy
719807|NCT01041859|Peripheral neuropathy|peripheral neuropathy
719808|NCT01041885|knee cartilage defect repair|knee cartilage defect repair
719809|NCT01041885|cartilage lesion|cartilage lesion
719810|NCT01041885|autologous chondrocyte|autologous chondrocyte
719811|NCT01041885|scaffold|scaffold
719812|NCT01041885|INSTRUCT|instruct
719813|NCT01041898|osteocalcin|osteocalcin
719814|NCT01041898|insulin|insulin
719815|NCT01041898|body composition|body composition
719816|NCT01041898|bone mineral density|bone mineral density
719817|NCT01041898|Evaluate the effect of osteocalcin on bone mineral density|evaluate the effect of osteocalcin on bone mineral density
719818|NCT01041898|Evaluate the effect of osteocalcin on body fat distribution|evaluate the effect of osteocalcin on body fat distribution
719819|NCT01041898|Evaluate the effect of osteocalcin on insulin homeostasis|evaluate the effect of osteocalcin on insulin homeostasis
719820|NCT01041911|Hemorrhoids|hemorrhoids
722324|NCT01046630|Phase I|phase i
719821|NCT01041924|Sleep apnea|sleep apnea
719822|NCT01041924|Periodic breathing|periodic breathing
719823|NCT01041924|Heart Failure|heart failure
719824|NCT01041950|intracerebral hemorrhage|intracerebral hemorrhage
719825|NCT01041950|intraventricular hemorrhage|intraventricular hemorrhage
719826|NCT01041950|hydrocephalus|hydrocephalus
719827|NCT01041950|Intracerebral hemorrhage with severe ventricular involvement and obstructive hydrocephalus|intracerebral hemorrhage with severe ventricular involvement and obstructive hydrocephalus
719829|NCT01041963|ARB|arb
719830|NCT01041963|CAPD|capd
719831|NCT01041963|Peritoneal membrane transport|peritoneal membrane transport
719832|NCT01041976|Veterans|veterans
719833|NCT01041976|Vocational Rehabilitation|vocational rehabilitation
719834|NCT01041989|dementia|dementia
719835|NCT01041989|cognitive impairment|cognitive impairment
719836|NCT01041989|disability|disability
719837|NCT01041989|intervention|intervention
719838|NCT01041989|elderly|elderly
719839|NCT01041989|lifestyle counseling|lifestyle counseling
719840|NCT01042002|High intensity exercise|high intensity exercise
719841|NCT01042002|morbid obesity|morbid obesity
719842|NCT01042002|gastric bypass|gastric bypass
719843|NCT01042015|trauma|trauma
719844|NCT01042015|cardiac arrest|cardiac arrest
719845|NCT01042015|hemorrhagic shock|hemorrhagic shock
719846|NCT01042028|Pancreas cancer|pancreas cancer
719847|NCT01042028|Everolimus|everolimus
719848|NCT01042028|Irinotecan|irinotecan
719849|NCT01042028|Cetuximab|cetuximab
719850|NCT01042028|Capecitabine|capecitabine
719851|NCT01042028|Oxaliplatin|oxaliplatin
719852|NCT01042028|Gemcitabine resistant pancreascancer|gemcitabine resistant pancreascancer
719853|NCT01042054|Postoperative Care|postoperative care
719854|NCT01042054|Enhanced|enhanced
719855|NCT01042054|Recovery|recovery
719856|NCT01042054|Hepatectomy|hepatectomy
719857|NCT01042054|Analgesia|analgesia
719858|NCT01042067|warfarin|warfarin
719859|NCT01042067|genotyping|genotyping
719860|NCT01042067|vitamin K|vitamin k
719861|NCT01042067|dosing|dosing
719862|NCT01042067|adverse events|adverse events
719863|NCT01042067|initial phase of treatment|initial phase of treatment
719864|NCT01042067|algorithm|algorithm
719865|NCT01042080|Mechanical ventilation|mechanical ventilation
719866|NCT01042080|Neurally adjusted ventilatory assist (NAVA)|neurally adjusted ventilatory assist (nava)
719867|NCT01042080|Acute respiratory failure|acute respiratory failure
719868|NCT01042080|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
719869|NCT01042080|Weaning|weaning
719870|NCT01042080|Invasive mechanical ventilation|invasive mechanical ventilation
719871|NCT01042080|Positive Pressure support Ventilation|positive pressure support ventilation
719872|NCT01042093|Analgesia|analgesia
719873|NCT01042093|postoperative pain|postoperative pain
719874|NCT01042093|periarticular|periarticular
719875|NCT01042093|arthroplasty|arthroplasty
719876|NCT01042093|pain management|pain management
719877|NCT01042106|diabetes|diabetes
719878|NCT01042119|botulinum neurotoxin type A|botulinum neurotoxin type a
719879|NCT01042119|BoNT/A|bont/a
719880|NCT01042119|Botox|botox
719881|NCT01042119|overactive bladder syndrome|overactive bladder syndrome
719882|NCT01042132|intramedullary reaming|intramedullary reaming
719883|NCT01042132|inflammatory response|inflammatory response
719884|NCT01042132|human|human
719885|NCT01042132|femoral shaft fracture|femoral shaft fracture
719886|NCT01042132|Reamer-irrigator-aspirator|reamer-irrigator-aspirator
719887|NCT01043198|CGH array technology|cgh array technology
719888|NCT01043198|mental retardation|mental retardation
719889|NCT01043198|chromosomal abnormalities|chromosomal abnormalities
719890|NCT01043198|syndromic obesity|syndromic obesity
719891|NCT01043198|obesity|obesity
719892|NCT01043211|Back Pain|back pain
719893|NCT01043211|Lidocaine|lidocaine
719894|NCT01043237|acoustic|acoustic
719895|NCT01043237|digital|digital
719896|NCT01043237|sound|sound
719897|NCT01043237|vibration|vibration
719898|NCT01043237|coronary|coronary
719899|NCT01043237|auscultation|auscultation
719900|NCT01043237|artery|artery
719901|NCT01043237|diagnosis|diagnosis
719902|NCT01043250|schizophrenia|schizophrenia
719903|NCT01043250|atypical antipsychotics|atypical antipsychotics
719904|NCT01043250|appetite|appetite
719905|NCT01043250|eating behavior|eating behavior
719906|NCT01043276|Healthy|healthy
719907|NCT01043289|light therapy|light therapy
719908|NCT01043289|antepartum depression|antepartum depression
719909|NCT01043289|controlled trial|controlled trial
719910|NCT01043302|lymphoma, intestine, outcome, quality of life|lymphoma, intestine, outcome, quality of life
719911|NCT01043315|Cognitive Function|cognitive function
719912|NCT01043315|Cognitive Impairment|cognitive impairment
719913|NCT01043315|Hospitalization|hospitalization
719914|NCT01043315|Cardiac Disease|cardiac disease
719915|NCT01043328|human papillomavirus|human papillomavirus
719916|NCT01043328|nested PCR|nested pcr
719917|NCT01043328|saliva|saliva
719918|NCT01043328|serum|serum
719919|NCT01043328|oral tissues|oral tissues
719920|NCT01043341|HPV|hpv
719921|NCT01043341|vaccines|vaccines
719922|NCT01043341|knowledge|knowledge
719923|NCT01043341|attitude|attitude
719924|NCT01043354|cholesterol|cholesterol
719925|NCT01043354|diabetes|diabetes
719926|NCT01043354|adherence|adherence
719927|NCT01043367|Depression|depression
719928|NCT01043367|Dietary supplement|dietary supplement
719929|NCT01043367|Deprexil|deprexil
719930|NCT01043380|Heart Diseases|heart diseases
719931|NCT01043380|Hyperlipidemia|hyperlipidemia
719932|NCT01043380|Atorvastatin|atorvastatin
719933|NCT01043380|Ezetimibe|ezetimibe
719934|NCT01043380|Cardiovascular Diseases|cardiovascular diseases
719935|NCT01043380|Hypercholesterolemia|hypercholesterolemia
719936|NCT01043380|Coronary Artery Disease|coronary artery disease
719937|NCT01043380|Dyslipidemias|dyslipidemias
719938|NCT01043380|Intravascular Ultrasound|intravascular ultrasound
719939|NCT01043393|Plaque psoriasis|plaque psoriasis
719940|NCT01043406|Epilepsy|epilepsy
719941|NCT01043406|Seizures|seizures
719942|NCT01043406|Advisory|advisory
719943|NCT01043406|Prediction|prediction
719944|NCT01043419|Xenon Anesthesia|xenon anesthesia
753812|NCT01177774|functional connectivity MRI|functional connectivity mri
719945|NCT01043419|LENOXe™ (xénon 100 % v/v) anesthesia|lenoxe™ (xénon 100 % v/v) anesthesia
719946|NCT01043419|Muscle Sympathetic Activity|muscle sympathetic activity
719947|NCT01043419|Baroreflex reagibility|baroreflex reagibility
719948|NCT01043432|Traumatic Brain Injury|traumatic brain injury
719949|NCT01043432|Suicide|suicide
719950|NCT01043432|Executive Function|executive function
719951|NCT01043445|GPR 119|gpr 119
719952|NCT01043445|GLP-1 secretion|glp-1 secretion
719953|NCT01043445|2-oleoyl-glycerol|2-oleoyl-glycerol
719954|NCT01043445|Dietary supplementation|dietary supplementation
719955|NCT01043458|Pharmacokinetics|pharmacokinetics
719956|NCT01043471|Obesity|obesity
719957|NCT01043484|Resectable rectal cancer|resectable rectal cancer
719958|NCT01043484|Radiotherapy|radiotherapy
719959|NCT01043484|Bevacizumab|bevacizumab
719960|NCT01043484|Capecitabine|capecitabine
719961|NCT01043523|Liver neoplasms|liver neoplasms
719962|NCT01043523|Adenoma|adenoma
719963|NCT01043523|Liver cell carcinoma|liver cell carcinoma
719964|NCT01043523|Hepatocellular|hepatocellular
719965|NCT01043523|Liver abscess|liver abscess
719967|NCT01043536|Radiotherapy escalation dose|radiotherapy escalation dose
719968|NCT01043536|glioblastoma|glioblastoma
719969|NCT01043536|escalation radiotherapy dose|escalation radiotherapy dose
719970|NCT01043549|Gilles de la Tourette syndrome|gilles de la tourette syndrome
719971|NCT01043549|Tics|tics
719972|NCT01043549|Transcranial magnetic stimulation|transcranial magnetic stimulation
719973|NCT01043575|rifapentine, pharmacokinetics, pharmacodynamics, tuberculosis|rifapentine, pharmacokinetics, pharmacodynamics, tuberculosis
719974|NCT01043588|Surgery|surgery
719975|NCT01043588|Prostate|prostate
719976|NCT01043588|Laser 532 nm|laser 532 nm
719977|NCT01043588|Photo selective Vaporization of the Prostate (PVP)|photo selective vaporization of the prostate (pvp)
719978|NCT01043588|TransUrethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
719979|NCT01043588|Men health|men health
719980|NCT01043614|Obesity|obesity
719981|NCT01043614|Obesity Prevention|obesity prevention
719982|NCT01043614|Freshman women|freshman women
719983|NCT01043614|Freshman 15 weight gain|freshman 15 weight gain
719984|NCT01043614|Self efficacy|self efficacy
719985|NCT01043614|Activity and nutrition intervention|activity and nutrition intervention
719986|NCT01043614|Peer education|peer education
719987|NCT01043640|inherited metabolic disorders|inherited metabolic disorders
719988|NCT01043653|recovery|recovery
719989|NCT01043653|serious mental illness|serious mental illness
719990|NCT01043666|Micturition|micturition
719991|NCT01043666|YM178|ym178
719992|NCT01043666|Urinary incontinence|urinary incontinence
719993|NCT01043666|Frequency|frequency
719994|NCT01043666|Overactive Bladder|overactive bladder
719995|NCT01043666|Urgency|urgency
719996|NCT01043666|Urinary urge incontinence|urinary urge incontinence
719997|NCT01043679|Bipolar, Mania|bipolar, mania
719998|NCT01043679|Utapine|utapine
719999|NCT01043679|Seroquel|seroquel
720000|NCT01043692|Chronic Pain > 3 months|chronic pain > 3 months
720001|NCT01043692|Acupuncture|acupuncture
720002|NCT01043692|Acceptability|acceptability
720003|NCT01043692|Geriatrics|geriatrics
720004|NCT01043705|Pacemaker infection|pacemaker infection
720005|NCT01043705|Defibrillator infection|defibrillator infection
720006|NCT01043705|ICD infection|icd infection
720007|NCT01043705|CRT infection|crt infection
720008|NCT01043705|Cardiovascular implantable electronic device infection|cardiovascular implantable electronic device infection
720009|NCT01043705|Infection|infection
720010|NCT01043705|Pacemaker, Artificial|pacemaker, artificial
720011|NCT01043705|Defibrillators|defibrillators
720012|NCT01043718|Obesity|obesity
720013|NCT01043718|Internet|internet
720014|NCT01043744|malaria|malaria
720015|NCT01043744|presumptive treatment|presumptive treatment
720016|NCT01043744|Integrated Management of Childhood Illness|integrated management of childhood illness
720017|NCT01043744|fever|fever
720018|NCT01043757|Sedentary lifestyle|sedentary lifestyle
720019|NCT01043757|physical exercise|physical exercise
720020|NCT01043757|behavioral economics|behavioral economics
720021|NCT01043757|financial incentives|financial incentives
720022|NCT01043757|obesity|obesity
720023|NCT01043770|Metabolic syndrome|metabolic syndrome
720024|NCT01043770|Primary prevention|primary prevention
720025|NCT01043770|Diabetes|diabetes
720026|NCT01043770|Cardiovascular disease|cardiovascular disease
720027|NCT01043770|Patient education|patient education
720028|NCT01043783|Obesity|obesity
720029|NCT01043796|Insecticide treated wall liners|insecticide treated wall liners
720030|NCT01043796|Insecticide treated nets|insecticide treated nets
720031|NCT01043796|Incidence cohort|incidence cohort
720032|NCT01043809|schools|schools
720033|NCT01043809|handwashing|handwashing
720034|NCT01043809|prevention and control|prevention and control
720035|NCT01043809|communicable diseases|communicable diseases
720036|NCT01043809|absenteeism|absenteeism
720037|NCT01043822|Autism|autism
720038|NCT01043822|mental retardation|mental retardation
720039|NCT01043822|pain|pain
720040|NCT01043822|emotion|emotion
720041|NCT01043822|sensory profile|sensory profile
720042|NCT01043822|children|children
720043|NCT01043835|Stomach Neoplasm|stomach neoplasm
720044|NCT01043835|Laparoscopy|laparoscopy
720045|NCT01043835|gastrectomy|gastrectomy
720046|NCT01043848|neurogenic detrusor overactivity|neurogenic detrusor overactivity
720047|NCT01043848|neuromodulation|neuromodulation
720048|NCT01043848|spinal cord injury|spinal cord injury
720049|NCT01043848|pudendal nerve stimulation|pudendal nerve stimulation
720050|NCT01043848|videocystometry|videocystometry
720051|NCT01043848|neurophysiology|neurophysiology
720052|NCT01043848|neuroplasticity|neuroplasticity
720053|NCT01043874|Chronic phase|chronic phase
720054|NCT01043874|Chronic myelogenous leukemia|chronic myelogenous leukemia
720055|NCT01043874|CML|cml
720056|NCT01043874|Philadelphia chromosome positive|philadelphia chromosome positive
720057|NCT01043874|Ph+|ph+
720058|NCT01043874|Nilotinib|nilotinib
720059|NCT01043874|CML-CP|cml-cp
720060|NCT01043874|Suboptimal molecular response|suboptimal molecular response
720061|NCT01043887|Healthy Volunteers|healthy volunteers
720062|NCT01043887|Hepatic Insufficiency|hepatic insufficiency
720063|NCT01043900|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
720064|NCT01043900|rTMS|rtms
720065|NCT01043900|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
720066|NCT01043900|treatment|treatment
720067|NCT01043900|randomized controlled trials|randomized controlled trials
720068|NCT01043913|Fatigue|fatigue
720069|NCT01043913|Breast Neoplasms|breast neoplasms
720070|NCT01043913|Quality of Life|quality of life
720071|NCT01043913|Paullinia|paullinia
720072|NCT01043926|Hepatic Insufficiency|hepatic insufficiency
720073|NCT01043939|childhood cancers|childhood cancers
720074|NCT01043939|cardiovascular disease|cardiovascular disease
720075|NCT01043939|childhood cancer survivor|childhood cancer survivor
720076|NCT01043952|Propofol|propofol
720077|NCT01043952|Remifentanil|remifentanil
720078|NCT01043952|Bispectral Index Monitor|bispectral index monitor
720079|NCT01043965|Diabetes Mellitus|diabetes mellitus
720080|NCT01043965|Myocardial perfusion imaging|myocardial perfusion imaging
720081|NCT01043965|Heart diseases|heart diseases
720473|NCT01045564|Human|human
720082|NCT01043965|Echocardiography|echocardiography
720083|NCT01043965|Endothelium|endothelium
720084|NCT01043991|STEMI|stemi
720085|NCT01043991|AMI,|ami,
720086|NCT01043991|acute myocardial infarct|acute myocardial infarct
720088|NCT01043991|Erythropoietin|erythropoietin
720089|NCT01043991|ischemia-reperfusion|ischemia-reperfusion
720090|NCT01043991|apoptosis|apoptosis
720091|NCT01044030|otitis media|otitis media
720092|NCT01044030|ear infection|ear infection
720093|NCT01044069|Cyclophosphamide|cyclophosphamide
720094|NCT01044069|T cell|t cell
720095|NCT01044069|leukapheresis|leukapheresis
720096|NCT01044069|stem cell transplant|stem cell transplant
720097|NCT01044069|bone marrow transplant|bone marrow transplant
720098|NCT01044069|09-114|09-114
720099|NCT01044082|Postpartum haemorrhage|postpartum haemorrhage
720100|NCT01044082|Third stage of labour|third stage of labour
720101|NCT01044082|Controlled cord traction|controlled cord traction
720102|NCT01044082|Randomized controlled trial|randomized controlled trial
720103|NCT01044082|Prevention|prevention
720104|NCT01044095|seasonal influenza vaccine|seasonal influenza vaccine
720105|NCT01044095|avian influenza H5N1|avian influenza h5n1
720106|NCT01044095|cross reactivity|cross reactivity
720107|NCT01044095|prime boost|prime boost
720108|NCT01044121|mattress|mattress
720109|NCT01044121|pain|pain
720110|NCT01044121|sleep|sleep
720111|NCT01044121|low back pain|low back pain
720112|NCT01044121|back|back
720113|NCT01044121|neck|neck
720114|NCT01044121|arousal|arousal
720115|NCT01044121|pillow|pillow
720116|NCT01044121|kingsdown|kingsdown
720117|NCT01044121|sleep to live|sleep to live
720118|NCT01044121|duke university|duke university
720119|NCT01044121|sleep to live institute|sleep to live institute
720120|NCT01044121|missouri|missouri
720121|NCT01044121|springfield|springfield
720122|NCT01044121|joplin|joplin
720123|NCT01044121|body diagnostic|body diagnostic
720124|NCT01044121|dormo diagnostic|dormo diagnostic
720125|NCT01044121|morning pain|morning pain
720126|NCT01044147|Obesity|obesity
720127|NCT01044147|Internet|internet
720128|NCT01044160|cancer as trauma in children|cancer as trauma in children
720129|NCT01044160|PTG/PTSS/ PTSD in children with cancer vs healthy children|ptg/ptss/ ptsd in children with cancer vs healthy children
720130|NCT01044173|acute abdomen|acute abdomen
720131|NCT01044173|CT|ct
720132|NCT01044173|MRI|mri
720133|NCT01044173|fast imaging|fast imaging
720134|NCT01044186|Deferasirox|deferasirox
720135|NCT01044186|ICL670A|icl670a
720136|NCT01044186|Iron chelators|iron chelators
720137|NCT01044186|Deferiprone|deferiprone
720138|NCT01044186|Transfusional hemosiderosis|transfusional hemosiderosis
720139|NCT01044186|Congenital aplastic anemia (Diamond Blackfan anemia)|congenital aplastic anemia (diamond blackfan anemia)
720140|NCT01044186|Red cell aplasia|red cell aplasia
720141|NCT01044186|Thalassemia|thalassemia
720142|NCT01044186|β thalassemia|β thalassemia
720143|NCT01044199|rabies|rabies
720144|NCT01044199|rabies vaccine|rabies vaccine
720145|NCT01044199|purified cultured embryo chicken rabies vaccine|purified cultured embryo chicken rabies vaccine
720146|NCT01044212|Urogynecology|urogynecology
720147|NCT01044225|newly diagnosed glioblastoma|newly diagnosed glioblastoma
720148|NCT01044238|methamphetamine|methamphetamine
720149|NCT01044238|methylphenidate|methylphenidate
720150|NCT01044238|clinical trial|clinical trial
720151|NCT01044238|random assignment|random assignment
720152|NCT01044238|double blind|double blind
720153|NCT01044238|abstinence|abstinence
720154|NCT01044238|reduction in methamphetamine use|reduction in methamphetamine use
720155|NCT01044251|Medication overuse headache|medication overuse headache
720156|NCT01044251|Rebound headache|rebound headache
720157|NCT01044251|Analgesic overuse headache|analgesic overuse headache
720158|NCT01044251|Transitional therapy|transitional therapy
720159|NCT01044251|Frovatriptan|frovatriptan
720160|NCT01044251|Migraine|migraine
720161|NCT01044264|Acne Vulgaris|acne vulgaris
720162|NCT01044264|bioequivalency|bioequivalency
720163|NCT01044264|clindamycin|clindamycin
720164|NCT01044264|benzoyl peroxide|benzoyl peroxide
720165|NCT01044277|glutathione|glutathione
720166|NCT01044277|gluthathione peroxidases|gluthathione peroxidases
720167|NCT01044277|GSH|gsh
720168|NCT01044290|quality of life|quality of life
720169|NCT01044290|end of life|end of life
720170|NCT01044290|self-disclosure|self-disclosure
720171|NCT01044290|palliative care|palliative care
720172|NCT01044303|Kidney Transplantation|kidney transplantation
720173|NCT01044303|Mycophenolic Acid|mycophenolic acid
720174|NCT01044303|Donor-Specific Antibodies|donor-specific antibodies
720175|NCT01044303|Kidney Rejection|kidney rejection
720176|NCT01044316|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
720177|NCT01044316|Vaccine|vaccine
720178|NCT01044316|Booster|booster
720179|NCT01044342|Healthy Volunteers|healthy volunteers
720180|NCT01044342|EEG|eeg
720181|NCT01044355|Resistant Hypertension|resistant hypertension
720182|NCT01044355|Obstructive Sleep Apnea|obstructive sleep apnea
720183|NCT01044355|24 Hour Blood Pressure|24 hour blood pressure
720184|NCT01044355|Arterial Stiffness|arterial stiffness
720185|NCT01044355|Insulin Resistance|insulin resistance
720186|NCT01044355|CPAP|cpap
720187|NCT01044355|APAP|apap
720188|NCT01044368|Remote Blood Glucose Monitoring System, Type 2 Diabetes|remote blood glucose monitoring system, type 2 diabetes
720189|NCT01044381|Toenail|toenail
720190|NCT01044381|Fungal Infections|fungal infections
720191|NCT01044381|DSO|dso
720192|NCT01044394|colonoscopy|colonoscopy
720193|NCT01044394|bowel preparation|bowel preparation
720194|NCT01044394|polyethylene glycol|polyethylene glycol
720195|NCT01044394|Quality in endoscopy|quality in endoscopy
720196|NCT01044394|Bowel Preparation for colonoscopy|bowel preparation for colonoscopy
720197|NCT01044407|respiration|respiration
720198|NCT01044407|sleep apnea|sleep apnea
720199|NCT01044407|pacemaker|pacemaker
720200|NCT01044446|peritoneal dialysis|peritoneal dialysis
720201|NCT01044446|peritonitis|peritonitis
720202|NCT01044446|CAPD|capd
720203|NCT01044446|end-stage renal disease|end-stage renal disease
720204|NCT01044446|peritonitis outcome and ultrafiltration|peritonitis outcome and ultrafiltration
720205|NCT01044459|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
720206|NCT01044459|COPD|copd
720207|NCT01044459|Chronic Bronchitis|chronic bronchitis
720208|NCT01044459|Emphysema|emphysema
720209|NCT01044459|Airflow Obstruction, Chronic|airflow obstruction, chronic
720210|NCT01044459|Chronic Airflow Obstruction|chronic airflow obstruction
720211|NCT01044459|Chronic Obstructive Airway Disease|chronic obstructive airway disease
720212|NCT01044459|Chronic Obstructive Lung Disease|chronic obstructive lung disease
720213|NCT01044472|CRT-D|crt-d
720214|NCT01044485|HER-2 positive advanced or metastatic breast cancer|her-2 positive advanced or metastatic breast cancer
720215|NCT01044485|dose escalation study|dose escalation study
720216|NCT01044485|lapatinib|lapatinib
720217|NCT01044485|docetaxel|docetaxel
720218|NCT01044511|Esophageal cancer|esophageal cancer
720219|NCT01044511|Cardia cancer|cardia cancer
720220|NCT01044511|Health Related quality of Life|health related quality of life
720221|NCT01044511|SEMS|sems
720222|NCT01044511|Home visits|home visits
720223|NCT01044524|14C labeled ADME (Aborption Distribution Metabolism and Elimination) study|14c labeled adme (aborption distribution metabolism and elimination) study
720224|NCT01044524|Phase I|phase i
720225|NCT01044537|phase 1|phase 1
720226|NCT01044537|safety and tolerability|safety and tolerability
720227|NCT01044537|PK|pk
720228|NCT01044537|PD|pd
720229|NCT01044537|type 2 diabetes mellitus|type 2 diabetes mellitus
720230|NCT01044537|T2DM|t2dm
720231|NCT01044550|Diaphragm injury|diaphragm injury
720232|NCT01044550|Herniation|herniation
720233|NCT01044563|Depression|depression
720234|NCT01044563|Depressive Symptoms|depressive symptoms
720235|NCT01044563|postmenopause|postmenopause
720236|NCT01044563|RSA biofeedback|rsa biofeedback
720237|NCT01044576|Multiple Sclerosis|multiple sclerosis
720238|NCT01044602|Obesity|obesity
720239|NCT01044602|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
720240|NCT01044602|Roux-en-Y Gastric Bypass Surgery|roux-en-y gastric bypass surgery
720241|NCT01044615|Mild Traumatic Brain Injury|mild traumatic brain injury
720242|NCT01044615|Concussion|concussion
720243|NCT01044615|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
720244|NCT01044615|Positron Emission Tomography(PET)|positron emission tomography(pet)
720245|NCT01044615|Computed Tomography (CT)|computed tomography (ct)
720246|NCT01044628|COPD|copd
720247|NCT01044628|CANOX|canox
720248|NCT01044628|Oxygen therapy|oxygen therapy
720249|NCT01044628|Nocturnal|nocturnal
720250|NCT01044628|Desaturation|desaturation
720251|NCT01044641|Colloid Osmotic pressure in interstitial fluid|colloid osmotic pressure in interstitial fluid
720252|NCT01044641|Colloid Osmotic pressure in plasma|colloid osmotic pressure in plasma
720253|NCT01044641|Protein fractions in interstitial fluid|protein fractions in interstitial fluid
720254|NCT01044654|HIV|hiv
720255|NCT01044654|Treatment Experienced|treatment experienced
720256|NCT01044680|fiber|fiber
720257|NCT01044680|metabolic syndrome|metabolic syndrome
720258|NCT01044680|overweight|overweight
720259|NCT01044680|satiety|satiety
720260|NCT01044693|supine Hypertension|supine hypertension
720261|NCT01044693|autonomic failure|autonomic failure
720262|NCT01044693|nitric oxide|nitric oxide
720263|NCT01044693|nebivolol|nebivolol
720264|NCT01044706|Bioequivalency|bioequivalency
720265|NCT01044732|Colorectal|colorectal
720266|NCT01044732|Neoplasms|neoplasms
720267|NCT01044732|Adenomas|adenomas
720268|NCT01044732|Polyps|polyps
720269|NCT01044732|Miss rates|miss rates
720270|NCT01044732|Detection rates|detection rates
720271|NCT01044732|Colonoscope|colonoscope
720272|NCT01044732|Third Eye Retroscope|third eye retroscope
720273|NCT01044758|Mild Cognitive Impairment|mild cognitive impairment
720274|NCT01044758|Amnestic Mild Cognitive Impairment|amnestic mild cognitive impairment
720275|NCT01044758|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
720276|NCT01044758|Levetiracetam|levetiracetam
720277|NCT01044758|Keppra|keppra
720278|NCT01044758|Medial Temporal Lobe|medial temporal lobe
720279|NCT01044758|Memory Impairment|memory impairment
720280|NCT01044758|Alzheimer's Disease|alzheimer's disease
720283|NCT01044771|Human immunodeficiency virus|human immunodeficiency virus
720284|NCT01044771|tenofovir|tenofovir
720285|NCT01044771|viread|viread
720286|NCT01044771|truvada|truvada
720287|NCT01044771|proteinuria|proteinuria
720288|NCT01044784|CRT|crt
720289|NCT01044797|Healthy Volunteer|healthy volunteer
720290|NCT01044797|Given Capsule Manipulation|given capsule manipulation
720291|NCT01044810|HIV|hiv
720292|NCT01044810|efavirenz|efavirenz
720293|NCT01044810|nevirapine|nevirapine
720294|NCT01044810|allergy|allergy
720295|NCT01044810|rash|rash
720296|NCT01044810|Cohort Studies, Historical|cohort studies, historical
720297|NCT01044810|Retrospective Study|retrospective study
720298|NCT01044810|exanthem|exanthem
720299|NCT01044810|Antiretroviral Agents|antiretroviral agents
720300|NCT01044810|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
720301|NCT01044810|HAART|haart
720302|NCT01044810|treatment failure|treatment failure
720303|NCT01044823|RA|ra
720304|NCT01044823|JRA|jra
720305|NCT01044836|Healthy volunteer|healthy volunteer
720306|NCT01044849|Blood Pressure|blood pressure
720307|NCT01044862|Pregnancy|pregnancy
720308|NCT01044862|Infertility|infertility
720309|NCT01044862|Ovarian stimulation|ovarian stimulation
720310|NCT01044862|Aromatase inhibitors|aromatase inhibitors
720311|NCT01044862|Follicle Stimulating Hormone|follicle stimulating hormone
720312|NCT01044875|Diabetic retinopathy|diabetic retinopathy
720313|NCT01044875|Laser treatment|laser treatment
720314|NCT01044875|Complications|complications
720315|NCT01044875|Laser wavelength|laser wavelength
720316|NCT01044888|Heparin responsiveness|heparin responsiveness
720317|NCT01044888|Off-pump coronary artery bypass graft surgery|off-pump coronary artery bypass graft surgery
720318|NCT01044888|Risk factors|risk factors
720319|NCT01044888|Myocardial infarction|myocardial infarction
720320|NCT01044901|Sickle Cell Disease|sickle cell disease
720411|NCT01045317|micro-dose|micro-dose
720321|NCT01044901|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
720322|NCT01044901|Coronary Disease|coronary disease
720323|NCT01044901|Pulmonary Hypertension|pulmonary hypertension
720324|NCT01044927|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
720325|NCT01044927|telemedicine|telemedicine
720326|NCT01044927|COPD|copd
720327|NCT01044940|Colloid Osmotic pressure in interstitial fluid|colloid osmotic pressure in interstitial fluid
720328|NCT01044940|Colloid Osmotic pressure in plasma|colloid osmotic pressure in plasma
720329|NCT01044940|Protein fractions in interstitial fluid|protein fractions in interstitial fluid
720330|NCT01044953|injury incidence|injury incidence
720331|NCT01044953|male professional soccer|male professional soccer
720332|NCT01044953|Change of injury incidence in professional soccer|change of injury incidence in professional soccer
720333|NCT01044966|Glioblastoma|glioblastoma
720334|NCT01044966|Subventricular|subventricular
720335|NCT01044966|gliomagenesis|gliomagenesis
720336|NCT01044966|temozolomide|temozolomide
720337|NCT01044966|depocyt|depocyt
753813|NCT01177774|brain volumetry|brain volumetry
720338|NCT01044979|Colloid osmotic pressure in interstitial fluid|colloid osmotic pressure in interstitial fluid
720339|NCT01044979|Colloid osmotic pressure in plasma|colloid osmotic pressure in plasma
720340|NCT01044979|Protein fractions in interstitial fluid|protein fractions in interstitial fluid
720341|NCT01044992|Multi systemic atrophy|multi systemic atrophy
720342|NCT01044992|Parkinson Disease|parkinson disease
720343|NCT01044992|PET investigation|pet investigation
720344|NCT01044992|Motor control|motor control
720345|NCT01044992|levodopa|levodopa
720346|NCT01044992|MSA|msa
720347|NCT01044992|Comparison with Parkinson disease and dopaminergic challenge.|comparison with parkinson disease and dopaminergic challenge.
720348|NCT01045005|Type 1 diabetes|type 1 diabetes
720349|NCT01045005|Endothelial dysfunction|endothelial dysfunction
720350|NCT01045005|Doppler Ultrasound Velocity Waveforms|doppler ultrasound velocity waveforms
720351|NCT01045018|colitis|colitis
720352|NCT01045018|ulcerative|ulcerative
720353|NCT01045018|ulcerative colitis|ulcerative colitis
720354|NCT01045031|cognitive function, aging, brain-derived neurotrophic factor|cognitive function, aging, brain-derived neurotrophic factor
720355|NCT01045044|Breast cancer|breast cancer
720356|NCT01045044|Magnetic Resonance Imaging|magnetic resonance imaging
721245|NCT01042275|REMEEX|remeex
720357|NCT01045044|Anthracycline based systemic chemotherapy|anthracycline based systemic chemotherapy
720358|NCT01045044|Tumor response|tumor response
720359|NCT01045044|Cognitive Impairment|cognitive impairment
720360|NCT01045044|Chemo Brain|chemo brain
720361|NCT01045057|voice prosthesis, larynx cancer, laryngectomy|voice prosthesis, larynx cancer, laryngectomy
720362|NCT01045070|periodontitis and coronary heart disease|periodontitis and coronary heart disease
720363|NCT01045096|Gastroesophageal Reflux|gastroesophageal reflux
720364|NCT01045096|Erosive Esophagitis|erosive esophagitis
720365|NCT01045096|Pharmacokinetics|pharmacokinetics
720366|NCT01045096|Pediatrics|pediatrics
720367|NCT01045096|Drug Therapy|drug therapy
720368|NCT01045109|prostate|prostate
720369|NCT01045109|cancer|cancer
720370|NCT01045109|vitamin D3|vitamin d3
720371|NCT01045109|early stage|early stage
720372|NCT01045109|active surveillance|active surveillance
720373|NCT01045122|Obstructive Sleep Apnea|obstructive sleep apnea
720374|NCT01045135|Pelvic organ prolapse|pelvic organ prolapse
720375|NCT01045135|Levator hiatus|levator hiatus
720376|NCT01045135|3 and 4 dimensional ultrasound|3 and 4 dimensional ultrasound
720377|NCT01045148|Prostatic Cancer|prostatic cancer
720378|NCT01045148|Prostatic Neoplasms|prostatic neoplasms
720379|NCT01045148|Prostate Neoplasms|prostate neoplasms
720380|NCT01045148|Cancer of the Prostate|cancer of the prostate
720381|NCT01045161|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
720382|NCT01045161|COPD|copd
720383|NCT01045161|Chronic Bronchitis|chronic bronchitis
720384|NCT01045161|Emphysema|emphysema
720385|NCT01045161|Airflow Obstruction, Chronic|airflow obstruction, chronic
720386|NCT01045161|Chronic Airflow Obstruction|chronic airflow obstruction
720387|NCT01045161|Chronic Obstructive Airway Disease|chronic obstructive airway disease
720388|NCT01045161|Chronic Obstructive Lung Disease|chronic obstructive lung disease
720389|NCT01045174|Asthma|asthma
720390|NCT01045174|Pediatric|pediatric
720391|NCT01045174|Emergency department|emergency department
720392|NCT01045174|Nebulizer|nebulizer
720393|NCT01045187|endometrial cancer|endometrial cancer
720394|NCT01045187|Uterine cancer|uterine cancer
720395|NCT01045187|electronic brachytherapy|electronic brachytherapy
720396|NCT01045187|Xoft|xoft
720397|NCT01045200|rectal cancer|rectal cancer
720398|NCT01045200|follow-up|follow-up
720399|NCT01045200|specialist nurse|specialist nurse
720400|NCT01045213|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
720401|NCT01045213|COPD|copd
720402|NCT01045239|Diabetic macular edema|diabetic macular edema
720403|NCT01045239|Diabetic macular oedema|diabetic macular oedema
720404|NCT01045239|micropulse laser|micropulse laser
720405|NCT01045239|laser treatment|laser treatment
720406|NCT01045239|macular thickness|macular thickness
720407|NCT01045252|hemodynamics|hemodynamics
720408|NCT01045252|neonatal|neonatal
720409|NCT01045278|Hepatitis C patients|hepatitis c patients
720410|NCT01045278|Hepacivirus|hepacivirus
720412|NCT01045317|pharmacokinetics|pharmacokinetics
720413|NCT01045317|open label|open label
720414|NCT01045317|PF-04776548|pf-04776548
720415|NCT01045343|heart failure|heart failure
720416|NCT01045343|home monitoring|home monitoring
720417|NCT01045343|integrated diagnostics|integrated diagnostics
720418|NCT01045343|Cardiac Resynchronization Therapy with Defibrillator (CRT D)|cardiac resynchronization therapy with defibrillator (crt d)
720419|NCT01045369|HIV|hiv
720420|NCT01045369|Treatment Naive|treatment naive
720421|NCT01045382|HSC transplantation|hsc transplantation
720422|NCT01045382|HLA-mismatched|hla-mismatched
720423|NCT01045382|Mesenchymal stem cells|mesenchymal stem cells
720424|NCT01045382|GVHD|gvhd
720425|NCT01045382|co-infusion|co-infusion
720426|NCT01045395|Algae|algae
720427|NCT01045395|Psoriasis|psoriasis
720428|NCT01045395|Lipid metabolism|lipid metabolism
720429|NCT01045395|Inflammation|inflammation
720430|NCT01045395|Oxidative stress|oxidative stress
720431|NCT01045408|Helicobacter pylori|helicobacter pylori
720432|NCT01045408|Berry extract|berry extract
720433|NCT01045408|Triple therapy|triple therapy
720434|NCT01045421|NSCLC|nsclc
720435|NCT01045421|SCLC|sclc
720436|NCT01045421|HNSCC|hnscc
720437|NCT01045434|Bioequivalence|bioequivalence
720438|NCT01045434|omeprazole|omeprazole
720439|NCT01045434|crossover|crossover
720440|NCT01045460|Patients with active myeloma (Stage II/III) that have completed induction therapy and are eligible for an autologous stem cell transplant|patients with active myeloma (stage ii/iii) that have completed induction therapy and are eligible for an autologous stem cell transplant
720441|NCT01045473|MIS|mis
720442|NCT01045473|Minimally Invasive Spine Surgery|minimally invasive spine surgery
720443|NCT01045473|Fusion|fusion
720444|NCT01045473|Spine|spine
720445|NCT01045473|SMISS|smiss
720446|NCT01045486|Atopic dermatitis|atopic dermatitis
720447|NCT01045486|Food allergy|food allergy
720448|NCT01045486|Probiotics|probiotics
720449|NCT01045499|adolescent obesity surgery|adolescent obesity surgery
720450|NCT01045499|bariatric surgery|bariatric surgery
720451|NCT01045499|adjustable gastric banding|adjustable gastric banding
720452|NCT01045512|immunosenescence|immunosenescence
720453|NCT01045512|heart rate variability|heart rate variability
720454|NCT01045512|autonomic nervous system|autonomic nervous system
720455|NCT01045512|ageing|ageing
720456|NCT01045512|inflammatory/pathogen burden|inflammatory/pathogen burden
720457|NCT01045512|physical activity|physical activity
720458|NCT01045525|Phlebotomy|phlebotomy
720459|NCT01045525|Dysmetabolic liversiderosis|dysmetabolic liversiderosis
720460|NCT01045525|Hepatic Iron overload|hepatic iron overload
720461|NCT01045538|gastric cancer|gastric cancer
720462|NCT01045538|histone deacetylase inhibitor|histone deacetylase inhibitor
720463|NCT01045538|1st line chemotherapy|1st line chemotherapy
720464|NCT01045551|Inflammatory rosacea|inflammatory rosacea
720465|NCT01045551|Papules and pustules|papules and pustules
720466|NCT01045551|Moderate to severe erythema|moderate to severe erythema
720467|NCT01045551|Telangiectasia|telangiectasia
720468|NCT01045564|Immunogenicity|immunogenicity
720469|NCT01045564|Vaccines|vaccines
720470|NCT01045564|H5N1|h5n1
720471|NCT01045564|Influenza|influenza
720472|NCT01045564|Pandemic|pandemic
720476|NCT01045577|Severe Psoriasis|severe psoriasis
720477|NCT01045577|Kinase Inhibitor|kinase inhibitor
720478|NCT01045577|Masitinib|masitinib
720479|NCT01045603|Instanyl|instanyl
720480|NCT01045603|non-interventional|non-interventional
720481|NCT01045603|breakthrough cancer pain|breakthrough cancer pain
720482|NCT01045603|BTP|btp
720483|NCT01045603|BTCP|btcp
720484|NCT01045603|Intranasal fentanyl spray|intranasal fentanyl spray
720485|NCT01045629|schizophrenia|schizophrenia
720486|NCT01045629|PANSS|panss
720487|NCT01045642|Bioequivalence|bioequivalence
720488|NCT01045642|Omeprazole|omeprazole
720489|NCT01045642|Crossover|crossover
720490|NCT01045655|Depression|depression
720491|NCT01045655|Perinatal care|perinatal care
720492|NCT01045655|Postpartum period|postpartum period
720493|NCT01045655|Pregnancy|pregnancy
720494|NCT01045655|Female|female
720495|NCT01045655|Low-income population|low-income population
720496|NCT01039259|adolescent|adolescent
720497|NCT01039259|body piercing/adverse effects|body piercing/adverse effects
720498|NCT01039259|tongue piercing|tongue piercing
720499|NCT01039259|tongue/microbiology|tongue/microbiology
720500|NCT01039272|oral cancer|oral cancer
720501|NCT01039272|EBV|ebv
720502|NCT01039272|PCR|pcr
720503|NCT01045681|Multiple Myeloma|multiple myeloma
720504|NCT01045681|Elderly patients|elderly patients
720505|NCT01045681|first relapse|first relapse
720506|NCT01045681|refractory to first line therapy|refractory to first line therapy
720507|NCT01045681|Bendamustine Velcade Dexamethasone Association|bendamustine velcade dexamethasone association
720508|NCT01045694|Carpometacarpal Joints|carpometacarpal joints
720509|NCT01045694|Osteoarthritis|osteoarthritis
720510|NCT01045694|Basal thumb joint arthritis|basal thumb joint arthritis
720511|NCT01045694|Trapeziometacarpal arthritis|trapeziometacarpal arthritis
720512|NCT01045720|Schizophrenia|schizophrenia
720513|NCT01045720|clozapine|clozapine
720514|NCT01045720|hypersalivation|hypersalivation
720515|NCT01045720|Suo Quan Wan|suo quan wan
720516|NCT01045720|Wu Lin San|wu lin san
720517|NCT01045733|Cataract|cataract
720519|NCT01045733|IOL|iol
720520|NCT01045733|AcrySof|acrysof
720521|NCT01045733|LRI|lri
720522|NCT01045733|Astigmatism|astigmatism
720523|NCT01045746|whole-body vibration|whole-body vibration
720524|NCT01045746|stochastic resonance Therapy|stochastic resonance therapy
720525|NCT01045746|static balance|static balance
720526|NCT01045746|balance, mobility|balance, mobility
720527|NCT01045746|elderly, reaction time|elderly, reaction time
720528|NCT01045746|The focus of the study is effect of SRT on postural balance|the focus of the study is effect of srt on postural balance
720529|NCT01045759|VENOUS THROMBOSIS|venous thrombosis
720530|NCT01045759|ultrasonography|ultrasonography
720531|NCT01045759|intensive care unit|intensive care unit
720532|NCT01045772|Schnitler syndrome, Muckle-Wells syndrome, anti-IL-1|schnitler syndrome, muckle-wells syndrome, anti-il-1
720533|NCT01045785|aspirin resistance, platelet function assay, dialysis, end stage renal disease|aspirin resistance, platelet function assay, dialysis, end stage renal disease
720534|NCT01045798|Candidiasis|candidiasis
720535|NCT01045798|Invasive Candidiasis|invasive candidiasis
720536|NCT01045798|Fungal Infection|fungal infection
720537|NCT01045798|Empirical Therapy|empirical therapy
720538|NCT01045811|Depression|depression
720539|NCT01045811|Depressive Symptoms|depressive symptoms
720540|NCT01045811|postmenopause|postmenopause
720541|NCT01045811|RSA biofeedback|rsa biofeedback
720542|NCT01045824|Schizophrenia|schizophrenia
720543|NCT01045824|DNA|dna
720544|NCT01045824|MRI|mri
720545|NCT01045837|Celiac disease, steroids, immunohistochemistry|celiac disease, steroids, immunohistochemistry
720546|NCT01045850|coronary stents|coronary stents
720547|NCT01045850|non cardiac surgery|non cardiac surgery
720548|NCT01045850|cardiovascular complications|cardiovascular complications
720549|NCT01045850|hemorrhagic complications|hemorrhagic complications
720550|NCT01045850|antiplatelet agents|antiplatelet agents
720551|NCT01045850|bare metal stent|bare metal stent
720552|NCT01045850|drug eluting stent|drug eluting stent
720553|NCT01045850|surgery|surgery
720554|NCT01045863|volunteer|volunteer
720555|NCT01045876|Randomized controlled trial|randomized controlled trial
720556|NCT01045876|Dexamethasone|dexamethasone
720557|NCT01045876|Single dose|single dose
720558|NCT01045876|Preoperative|preoperative
720559|NCT01045876|Plasma Cortisol level|plasma cortisol level
720560|NCT01045889|HIV|hiv
720561|NCT01045889|non hodgkin lymphoma|non hodgkin lymphoma
720562|NCT01045889|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
720563|NCT01045902|Pulmonary Abscess|pulmonary abscess
720564|NCT01045902|Aspiration Pneumonia|aspiration pneumonia
720565|NCT01045915|Stage IIIB, stage IIIC or stage IV melanoma|stage iiib, stage iiic or stage iv melanoma
720566|NCT01045915|Progressive melanoma not responding to previous treatments|progressive melanoma not responding to previous treatments
720567|NCT01045941|Distal Pancreas|distal pancreas
720568|NCT01045941|Adenocarcinoma|adenocarcinoma
720569|NCT01045941|Laparoscopic|laparoscopic
720570|NCT01045941|Gemcitabine|gemcitabine
720571|NCT01045954|diabetes mellitus type 1|diabetes mellitus type 1
720572|NCT01045954|continuous glucose monitoring|continuous glucose monitoring
720573|NCT01045967|Bioequivalence|bioequivalence
720574|NCT01045967|Healthy Subjects|healthy subjects
720575|NCT01045980|Peritoneal dialysis|peritoneal dialysis
720576|NCT01045980|Impedance, bioelectric|impedance, bioelectric
720577|NCT01045980|Hypertrophy, left ventricular|hypertrophy, left ventricular
720578|NCT01045980|Fluid status|fluid status
720579|NCT01045980|Volume overload|volume overload
720580|NCT01045980|Congestive heart failure|congestive heart failure
720581|NCT01045980|Cardiovascular outcomes|cardiovascular outcomes
720582|NCT01045980|Randomized controlled trial|randomized controlled trial
720583|NCT01045993|Pilot Study to Assess Methodologies|pilot study to assess methodologies
720584|NCT01046006|lymphoma|lymphoma
720585|NCT01046006|Bortezomib|bortezomib
720586|NCT01046006|Rituximab|rituximab
720587|NCT01049984|Parkinson's Disease|parkinson's disease
720589|NCT01049984|Clinical Global Evaluation Illness Severity score|clinical global evaluation illness severity score
720590|NCT01049984|Clinical Global Evaluation Improvement|clinical global evaluation improvement
720591|NCT01049984|B-SIT|b-sit
720592|NCT01049984|SCOPA - Sleep Daytime Sleepiness|scopa - sleep daytime sleepiness
720593|NCT01049984|PDQ -39|pdq -39
720594|NCT01049984|SCOPA - Cognition|scopa - cognition
720595|NCT01049984|Levodopa|levodopa
720596|NCT01049984|rasagiline|rasagiline
720597|NCT01049984|Dopamine Agonist Therapy|dopamine agonist therapy
720598|NCT01049984|monoamine oxidase type B inhibitor|monoamine oxidase type b inhibitor
720599|NCT01049997|Non ST Elevation Myocardial Infarction (NSTEMI)|non st elevation myocardial infarction (nstemi)
720600|NCT01049997|Elderly|elderly
720601|NCT01049997|Frailty|frailty
720602|NCT01050010|rheumatoid arthritis|rheumatoid arthritis
720603|NCT01050010|clinical remission|clinical remission
720604|NCT01050010|synovitis|synovitis
720605|NCT01050010|dedicated extremity MRI|dedicated extremity mri
720606|NCT01050023|venous stasis ulcer|venous stasis ulcer
720607|NCT01050023|wound healing|wound healing
720608|NCT01050023|Provant Wound Closure System|provant wound closure system
720609|NCT01050023|radiofrequency|radiofrequency
720610|NCT01050023|Provant|provant
720611|NCT01050023|pain relief|pain relief
720612|NCT01050036|Leukemia, Myeloid|leukemia, myeloid
720613|NCT01050036|Primary complete remission|primary complete remission
720614|NCT01050036|Favorable karyotype|favorable karyotype
720615|NCT01050036|Autologous hematopoietic cell transplantation|autologous hematopoietic cell transplantation
720616|NCT01050036|Hematopoietic cell transplantation|hematopoietic cell transplantation
720617|NCT01050075|male breast cancer|male breast cancer
720618|NCT01050075|neurotoxicity|neurotoxicity
720619|NCT01050075|recurrent breast cancer|recurrent breast cancer
720620|NCT01050088|clubfoot|clubfoot
720621|NCT01050088|casting|casting
720622|NCT01050088|ponseti|ponseti
720623|NCT01050088|discomfort|discomfort
720624|NCT01050101|Satiety|satiety
720625|NCT01050101|Fiber|fiber
720626|NCT01050101|Nutrition|nutrition
720627|NCT01050101|Pre- and post-menopausal women|pre- and post-menopausal women
720628|NCT01050101|overweight|overweight
720629|NCT01050114|Botulinum Toxin|botulinum toxin
720630|NCT01050114|Oxybutynin|oxybutynin
720631|NCT01050114|Overactive Bladder|overactive bladder
720632|NCT01050114|Spinal Cord Injury|spinal cord injury
720633|NCT01050114|Urinary Incontinence|urinary incontinence
720634|NCT01050114|Nerve Growth Factor|nerve growth factor
720635|NCT01050114|Urine Biomarkers|urine biomarkers
720636|NCT01050127|Pharmacokinetics|pharmacokinetics
720637|NCT01050127|Pharmacodynamics|pharmacodynamics
720638|NCT01050127|Drug Safety|drug safety
720639|NCT01050127|Phase 1 Clinical Trial|phase 1 clinical trial
720640|NCT01050140|fructose|fructose
720641|NCT01050140|fatty liver disease|fatty liver disease
720642|NCT01050140|diet|diet
720643|NCT01050153|Prevention of venous thromboembolism|prevention of venous thromboembolism
720644|NCT01050166|islet transplantation|islet transplantation
720645|NCT01050166|magnetic resonance|magnetic resonance
720646|NCT01050166|Type 1 DM|type 1 dm
720647|NCT01050179|chemosensitivity|chemosensitivity
720648|NCT01050192|Prematurity|prematurity
720649|NCT01050192|Nutrition|nutrition
720650|NCT01050192|Breast Feeding|breast feeding
720651|NCT01050205|Diabetes Prevention|diabetes prevention
720652|NCT01050205|Cardiovascular Risk Reduction|cardiovascular risk reduction
720653|NCT01050205|Lifestyle Intervention|lifestyle intervention
720654|NCT01050205|Group Lifestyle Balance|group lifestyle balance
720655|NCT01050218|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
720656|NCT01050231|stroke|stroke
720657|NCT01050231|cerebrovascular accident|cerebrovascular accident
720658|NCT01050231|robot|robot
720659|NCT01050244|Soy protein|soy protein
720660|NCT01050244|Milk protein|milk protein
720661|NCT01050244|Neuropathic pain|neuropathic pain
720662|NCT01050283|Advanced pancreatic adenocarcinoma|advanced pancreatic adenocarcinoma
720663|NCT01050296|Neuroblastoma|neuroblastoma
720664|NCT01050296|Retinoblastoma|retinoblastoma
720665|NCT01050296|Osteosarcoma|osteosarcoma
720666|NCT01050296|Rhabdomyosarcoma|rhabdomyosarcoma
720667|NCT01050296|Ewing sarcoma|ewing sarcoma
720668|NCT01050296|Non-rhabdomyosarcoma soft tissue sarcoma|non-rhabdomyosarcoma soft tissue sarcoma
720669|NCT01050296|Adrenocortical tumors|adrenocortical tumors
720670|NCT01050296|Liver malignancies|liver malignancies
720671|NCT01050322|receptor HER two positive|receptor her two positive
720672|NCT01050322|lapatinib|lapatinib
720673|NCT01050322|metastatic breast cancer|metastatic breast cancer
720674|NCT01050361|To reduce perioperative morbidity and mortality associated with congestive heart failure for non-cardiac surgeries|to reduce perioperative morbidity and mortality associated with congestive heart failure for non-cardiac surgeries
720675|NCT01050387|Vitamin D Deficiency|vitamin d deficiency
720676|NCT01050387|VDD|vdd
720677|NCT01050387|Vitamin D Supplementation|vitamin d supplementation
720678|NCT01050387|Vitamin D Binding Protein|vitamin d binding protein
720679|NCT01050387|DBP|dbp
720680|NCT01050387|Nutritional rickets|nutritional rickets
720681|NCT01050387|rickets|rickets
720682|NCT01050387|25hydroxyvitamin D|25hydroxyvitamin d
720683|NCT01050387|25OHD|25ohd
720684|NCT01050387|1,25OH2D|1,25oh2d
720685|NCT01050387|vitamin D metabolites|vitamin d metabolites
720686|NCT01050387|PTH|pth
720687|NCT01050387|vitamin D homeostasis|vitamin d homeostasis
720688|NCT01050400|CYP2D6|cyp2d6
720689|NCT01050400|Genetic Polymorphism|genetic polymorphism
720690|NCT01050400|codeine|codeine
720691|NCT01050400|breastfeeding|breastfeeding
720692|NCT01050413|Thymidine Kinase 1 activity|thymidine kinase 1 activity
720693|NCT01050413|diagnosis|diagnosis
720694|NCT01050413|prognosis|prognosis
720695|NCT01050413|follow-up|follow-up
720696|NCT01050439|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
720697|NCT01050439|Unrelated donor|unrelated donor
720698|NCT01050439|Cord blood donor|cord blood donor
720699|NCT01050465|HIV|hiv
720700|NCT01050465|Knee pain|knee pain
720701|NCT01050465|Colonoscopy|colonoscopy
720702|NCT01050465|Mammography|mammography
720703|NCT01050465|Vaccination|vaccination
720704|NCT01050478|acute agitation|acute agitation
720705|NCT01050478|aggression|aggression
720706|NCT01050478|psychosis|psychosis
720707|NCT01050478|paliperidone extended release|paliperidone extended release
720708|NCT01050491|asthma|asthma
720709|NCT01050491|airway remodeling|airway remodeling
720710|NCT01050491|airway obstruction|airway obstruction
720711|NCT01050530|Cirrhosis|cirrhosis
720712|NCT01050530|ascites|ascites
720713|NCT01050530|Tolvaptan|tolvaptan
720714|NCT01050530|OPC-41061|opc-41061
720715|NCT01050556|arsenic|arsenic
720716|NCT01050556|folate|folate
720717|NCT01050556|folic acid|folic acid
720718|NCT01050556|creatine|creatine
720719|NCT01050556|arsenicosis|arsenicosis
720720|NCT01050556|nutrition|nutrition
720721|NCT01050569|Smoking Cessation|smoking cessation
720722|NCT01050569|Nicotine Free Cigarettes|nicotine free cigarettes
720723|NCT01050582|Schizophrenia|schizophrenia
720724|NCT01050582|Bipolar Disorder|bipolar disorder
720725|NCT01050582|Autistic Disorder|autistic disorder
753814|NCT01177774|negative reinforcement|negative reinforcement
720726|NCT01050582|Conduct and Other Disruptive Behavior Disorders|conduct and other disruptive behavior disorders
720727|NCT01050582|Risperidone|risperidone
720728|NCT01050582|RISPERDAL|risperdal
720729|NCT01050582|Antipsychotic Agents|antipsychotic agents
720730|NCT01050582|Prolactin|prolactin
720731|NCT01050582|Pediatrics|pediatrics
720732|NCT01050595|Intensive Care Unit|intensive care unit
720733|NCT01050595|Constipation|constipation
720734|NCT01050595|Bowel Management|bowel management
720735|NCT01050608|Alcohol Rub|alcohol rub
720736|NCT01050608|Hand Hygiene|hand hygiene
720737|NCT01050608|Provider Feedback|provider feedback
720738|NCT01050608|Health Care Associated Infections|health care associated infections
720739|NCT01050621|ascorbic acid|ascorbic acid
720740|NCT01050621|vitamin C|vitamin c
720741|NCT01050621|antioxidants|antioxidants
720742|NCT01050621|redox therapy|redox therapy
720743|NCT01050621|cytotoxic chemotherapy|cytotoxic chemotherapy
720744|NCT01050634|Aromatase inhibitor|aromatase inhibitor
720745|NCT01050634|Switch after Tamoxifen|switch after tamoxifen
720746|NCT01050634|Quality of Life|quality of life
720747|NCT01050634|Safety|safety
720748|NCT01050660|Parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
720749|NCT01050660|Direct bilirubin|direct bilirubin
720750|NCT01050660|Intravenous fat emulsion|intravenous fat emulsion
720751|NCT01050660|Very low birth weight infants|very low birth weight infants
720752|NCT01050660|PNAC|pnac
720753|NCT01050673|VERSAJET hydro-surgical debridement|versajet hydro-surgical debridement
720754|NCT01050673|traumatic wound|traumatic wound
720755|NCT01050686|ileostomy reversal|ileostomy reversal
720756|NCT01050686|subcutaneous drain|subcutaneous drain
720757|NCT01050686|hospital stay|hospital stay
720758|NCT01050686|postoperative wound infection|postoperative wound infection
720759|NCT01050686|patients with elective ileostomy reversal|patients with elective ileostomy reversal
720760|NCT01050699|critical illness|critical illness
720761|NCT01050699|sleep|sleep
720762|NCT01050699|polysomnography|polysomnography
720763|NCT01050699|inflammatory cytokines|inflammatory cytokines
720764|NCT01050699|dexmedetomidine|dexmedetomidine
720765|NCT01050699|acute lung injury|acute lung injury
720766|NCT01050699|acute respiratory distress syndrome|acute respiratory distress syndrome
720767|NCT01050699|midazolam|midazolam
720772|NCT01050725|radiotherapy|radiotherapy
720773|NCT01050725|cancer|cancer
720774|NCT01050751|Bioavailability|bioavailability
720775|NCT01050751|Bioequivalence|bioequivalence
720776|NCT01050751|Lersivirine|lersivirine
720777|NCT01050751|UK-453|uk-453
720779|NCT01050751|Pharmacokinetics|pharmacokinetics
720780|NCT01050777|Cutaneous Leishmaniasis caused by l. tropica|cutaneous leishmaniasis caused by l. tropica
720781|NCT01050790|stage I multiple myeloma|stage i multiple myeloma
720782|NCT01050790|stage II multiple myeloma|stage ii multiple myeloma
720783|NCT01050790|stage III multiple myeloma|stage iii multiple myeloma
720784|NCT01050803|Diabetes Mellitus|diabetes mellitus
720785|NCT01050803|Intervention studies|intervention studies
720786|NCT01050803|Program effectiveness|program effectiveness
720787|NCT01050816|articular cartilage defects|articular cartilage defects
720789|NCT01050816|ankle joint|ankle joint
720790|NCT01050816|chondron|chondron
720791|NCT01050829|Magnetic resonance imaging|magnetic resonance imaging
720792|NCT01050829|Tumor|tumor
720793|NCT01050829|Contrast media|contrast media
720794|NCT01050829|Gadobutrol|gadobutrol
720795|NCT01050855|Non-malignant diseases|non-malignant diseases
720796|NCT01050855|Immune deficiencies|immune deficiencies
720797|NCT01050855|Hemoglobinopathies|hemoglobinopathies
720798|NCT01050855|Reduced Intensity Conditioning(RIC)|reduced intensity conditioning(ric)
720799|NCT01050881|blood donor notification|blood donor notification
720800|NCT01050881|emotional response|emotional response
720801|NCT01050881|variant Creutzfeldt-Jacob Disease|variant creutzfeldt-jacob disease
720802|NCT01050894|osteoarthritis|osteoarthritis
720803|NCT01050907|leishmaniasis|leishmaniasis
720804|NCT01050907|cutaneous disease|cutaneous disease
720805|NCT01050907|mucosal disease|mucosal disease
720806|NCT01050907|miltefosine|miltefosine
720807|NCT01050933|Healthy volunteer|healthy volunteer
720808|NCT01050946|Unrelated Umbilical Cord Blood Transplant(UCB)|unrelated umbilical cord blood transplant(ucb)
720809|NCT01050946|CD34+ Selected mismatched related donor|cd34+ selected mismatched related donor
720810|NCT01050946|Haploidentical donor|haploidentical donor
720811|NCT01050946|hematopoietic stem cell transplantation(HSCT)|hematopoietic stem cell transplantation(hsct)
720812|NCT01050946|ALL|all
720813|NCT01050946|Leukemia, Lymphocytic, Acute|leukemia, lymphocytic, acute
720814|NCT01050946|AML|aml
720815|NCT01050946|Leukemia, Myelocytic, Acute|leukemia, myelocytic, acute
720816|NCT01050946|CML|cml
720817|NCT01050946|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
720818|NCT01050946|NHL|nhl
720819|NCT01050946|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
720820|NCT01050946|HL|hl
720821|NCT01050946|Lymphoma, Hodgkins|lymphoma, hodgkins
720822|NCT01050972|Headache|headache
720823|NCT01050972|Cervical Pain|cervical pain
720824|NCT01050972|Cognitive treatment|cognitive treatment
720825|NCT01050972|Relaxation|relaxation
720826|NCT01050972|Exercise|exercise
720827|NCT01050985|advanced cancer|advanced cancer
720828|NCT01050985|temsirolimus|temsirolimus
720829|NCT01050985|capecitabine|capecitabine
720830|NCT01050998|Rheumatoid Arthritis|rheumatoid arthritis
720831|NCT01050998|Mavrilimumab|mavrilimumab
720832|NCT01050998|CAM-3001|cam-3001
720833|NCT01051024|Dietary supplement|dietary supplement
720834|NCT01051024|Diamel|diamel
720835|NCT01051024|Polycystic Ovary Syndrome|polycystic ovary syndrome
720836|NCT01051024|Female Infertility|female infertility
720837|NCT01051037|lung tumors|lung tumors
720838|NCT01051037|central airways|central airways
720839|NCT01051050|Evidence based medicine|evidence based medicine
720840|NCT01051050|Improving surgical residents skills and application of EBM in surgical practice|improving surgical residents skills and application of ebm in surgical practice
720841|NCT01051063|adult|adult
720842|NCT01051063|WT1|wt1
720843|NCT01051063|ASCI|asci
720844|NCT01051063|complete remission with incomplete blood count recovery|complete remission with incomplete blood count recovery
720845|NCT01051063|partial remission|partial remission
720846|NCT01051063|post-induction therapy|post-induction therapy
720847|NCT01051063|tumor antigen|tumor antigen
720848|NCT01051063|Acute Myeloid Leukemia|acute myeloid leukemia
720849|NCT01051063|Immunotherapy|immunotherapy
720850|NCT01051076|ITI|iti
720851|NCT01051076|Haemophilia A|haemophilia a
720852|NCT01051076|Inhibitors|inhibitors
720853|NCT01051076|Failed ITI|failed iti
720854|NCT01051076|VWF/FVIII concentrates|vwf/fviii concentrates
720855|NCT01051089|type 2 diabetes mellitus|type 2 diabetes mellitus
720856|NCT01051089|lifestyle modification|lifestyle modification
720857|NCT01051115|CLL|cll
720858|NCT01051115|refractory|refractory
720859|NCT01051115|dasatinib|dasatinib
720860|NCT01051115|fludarabine|fludarabine
720861|NCT01051128|neurological disorders|neurological disorders
720862|NCT01051128|multiple sclerosis|multiple sclerosis
720863|NCT01051128|stroke|stroke
720864|NCT01051128|cerebral palsy|cerebral palsy
720865|NCT01051128|spinal cord|spinal cord
720866|NCT01051128|brain injuries|brain injuries
720867|NCT01051128|neurodegenerative diseases|neurodegenerative diseases
720868|NCT01051141|alcohol use|alcohol use
720869|NCT01051141|brief intervention|brief intervention
720870|NCT01051141|risk behaviors|risk behaviors
720871|NCT01051154|Docosahexaenoic acid|docosahexaenoic acid
720872|NCT01051154|Nutritional status|nutritional status
720873|NCT01051154|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
720874|NCT01051154|Long chain polyunsaturated fatty acids|long chain polyunsaturated fatty acids
720875|NCT01051154|n-3 fatty acids|n-3 fatty acids
720876|NCT01051154|Remission-induction phase|remission-induction phase
720877|NCT01051180|HEMORRHOIDS|hemorrhoids
720878|NCT01051180|TREATMENT|treatment
720879|NCT01051180|PILES|piles
720880|NCT01051180|BLEEDING|bleeding
720881|NCT01051180|HALO|halo
720882|NCT01051193|Seizures|seizures
720883|NCT01051193|oxcarbazepine|oxcarbazepine
720884|NCT01051193|child|child
720885|NCT01051219|Losartan|losartan
720886|NCT01051219|Liver fibrosis|liver fibrosis
720887|NCT01051219|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
720888|NCT01051232|filibuvir|filibuvir
720889|NCT01051232|pharmacokinetics|pharmacokinetics
720890|NCT01051232|Japanese|japanese
720891|NCT01051232|Asian|asian
720892|NCT01051245|Diabetes Mellitus, Type 2 [C18.452.394.750.149]|diabetes mellitus, type 2 [c18.452.394.750.149]
720893|NCT01051245|Case Management [N04.590.233.624.250]|case management [n04.590.233.624.250]
720894|NCT01051245|Disease Management [N04.590.607]|disease management [n04.590.607]
720895|NCT01051245|Diabetes Complications [C19.246.099]|diabetes complications [c19.246.099]
720896|NCT01051258|Polymeric Lung Volume Reduction (PLVR)|polymeric lung volume reduction (plvr)
720897|NCT01051258|Biologic Lung Volume Reduction (BLVR)|biologic lung volume reduction (blvr)
720898|NCT01051258|AeriSeal|aeriseal
720899|NCT01051258|treatment|treatment
720900|NCT01051258|device|device
720901|NCT01051258|breathing|breathing
720902|NCT01051258|COPD|copd
720903|NCT01051258|emphysema|emphysema
720904|NCT01051258|heterogeneous|heterogeneous
720905|NCT01051258|homogeneous|homogeneous
720906|NCT01051258|Pathologic Processes|pathologic processes
720907|NCT01051258|Respiratory Tract Diseases|respiratory tract diseases
720908|NCT01051258|Lung Diseases|lung diseases
720909|NCT01051258|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
720910|NCT01051271|metoclopramide|metoclopramide
720911|NCT01051271|akathisia|akathisia
720912|NCT01051271|midazolam|midazolam
720913|NCT01051271|diphenhydramine|diphenhydramine
720914|NCT01051271|metoclopramide induced akathisia|metoclopramide induced akathisia
720915|NCT01051284|Pancreas|pancreas
720916|NCT01051284|Newly diagnosed|newly diagnosed
720917|NCT01051284|Cyberknife|cyberknife
720918|NCT01051284|Gemcitabine|gemcitabine
720919|NCT01051297|Obstructive sleep apnea|obstructive sleep apnea
720920|NCT01051297|venous thrombosis|venous thrombosis
720921|NCT01051297|pulmonary embolism|pulmonary embolism
720922|NCT01051297|venous thromboembolism|venous thromboembolism
720923|NCT01051336|TARIS Placebo|taris placebo
720924|NCT01051336|Bladder|bladder
753815|NCT01177774|OCD|ocd
720925|NCT01051336|Interstitial Cystitis|interstitial cystitis
720926|NCT01051336|Normal Healthy Volunteers|normal healthy volunteers
720928|NCT01051349|Multiple Sclerosis|multiple sclerosis
720929|NCT01051362|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
720930|NCT01051362|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
720931|NCT01051362|Carboplatin|carboplatin
720932|NCT01051362|Chemotherapy|chemotherapy
720933|NCT01051375|anorexia nervosa|anorexia nervosa
720934|NCT01051375|bulimia nervosa|bulimia nervosa
720935|NCT01051375|EDNOS|ednos
720936|NCT01051388|The efficacy of PPI|the efficacy of ppi
720937|NCT01051388|Patients receiving low-dose aspirin for vascular protection|patients receiving low-dose aspirin for vascular protection
720938|NCT01051427|Nasal packing|nasal packing
720939|NCT01051427|Haemostatic matrix|haemostatic matrix
720940|NCT01051427|Epistaxis control|epistaxis control
720941|NCT01051440|lisdexamfetamine|lisdexamfetamine
720942|NCT01051440|vyvanse|vyvanse
720943|NCT01051440|bipolar disorder|bipolar disorder
720944|NCT01051440|depression|depression
720945|NCT01051440|stimulant|stimulant
720946|NCT01051440|magnetic resonance spectroscopy|magnetic resonance spectroscopy
720947|NCT01051440|functional magnetic resonance imaging|functional magnetic resonance imaging
720948|NCT01051440|neuropsychological testing|neuropsychological testing
720949|NCT01051479|PET Positron emission tomography|pet positron emission tomography
720950|NCT01051479|CT X-ray computed tomography|ct x-ray computed tomography
720951|NCT01051479|Patients with Locally Advanced Esophageal Cancer|patients with locally advanced esophageal cancer
720952|NCT01051505|Phase I|phase i
720953|NCT01051505|multiple ascending dose|multiple ascending dose
720954|NCT01051505|Safety|safety
720955|NCT01051505|Tolerability|tolerability
720956|NCT01051505|Healthy Volunteer|healthy volunteer
720957|NCT01051531|Schizophrenia|schizophrenia
720958|NCT01051531|R092670|r092670
720959|NCT01051531|Paliperidone palmitate|paliperidone palmitate
720960|NCT01051531|Diagnostic and Statistical Manual of Mental Disorders, 4th Edition|diagnostic and statistical manual of mental disorders, 4th edition
720961|NCT01051531|Intramuscular injection|intramuscular injection
720962|NCT01051544|ITI|iti
720963|NCT01051544|HAEMOPHILIA A|haemophilia a
720964|NCT01051544|INHIBITORS|inhibitors
720965|NCT01051544|VWF/FVIII Concentrates|vwf/fviii concentrates
721163|NCT01052298|Inhalation|inhalation
720966|NCT01051570|hormone-resistant prostate cancer|hormone-resistant prostate cancer
720967|NCT01051570|recurrent prostate cancer|recurrent prostate cancer
720968|NCT01051570|stage IV prostate cancer|stage iv prostate cancer
720969|NCT01051570|adenocarcinoma of the prostate|adenocarcinoma of the prostate
720970|NCT01051583|Neovascular glaucoma|neovascular glaucoma
720971|NCT01051583|diode laser|diode laser
720972|NCT01051583|cyclophotocoagulation|cyclophotocoagulation
720973|NCT01051583|Avastin|avastin
720974|NCT01051596|metastatic|metastatic
720975|NCT01051596|colorectal cancer|colorectal cancer
720976|NCT01051609|Post Menopausal|post menopausal
720977|NCT01051609|Breast Cancer|breast cancer
720978|NCT01051622|PBMC (Peripheral Blood Mononuclear Cells)|pbmc (peripheral blood mononuclear cells)
720979|NCT01051622|Crohn's Disease|crohn's disease
720980|NCT01051622|SPECT (Single Photon Emission Computerized Tomography)|spect (single photon emission computerized tomography)
720981|NCT01051635|DNA Repair|dna repair
720982|NCT01051635|DNA Damage|dna damage
720983|NCT01051635|Advanced Cancer|advanced cancer
720984|NCT01051635|Advanced Malignancies|advanced malignancies
720985|NCT01051635|Topoisomerase Inhibitor|topoisomerase inhibitor
720986|NCT01051648|Triamcinolone acetenoide|triamcinolone acetenoide
720987|NCT01051648|anterior vitrectomy|anterior vitrectomy
720988|NCT01051648|presence of vitreous in the anterior chamber.|presence of vitreous in the anterior chamber.
720989|NCT01051648|effect of triamcinolone injection on IOP,intraocular infection|effect of triamcinolone injection on iop,intraocular infection
720990|NCT01051661|Influenza|influenza
720991|NCT01051661|H1N1|h1n1
720992|NCT01051661|Pandemic|pandemic
720993|NCT01051674|Obesity|obesity
721095|NCT01052077|OPC-34712|opc-34712
720994|NCT01051674|Type 2 diabetes|type 2 diabetes
720995|NCT01051674|Fiber|fiber
720996|NCT01051674|Dietary fiber|dietary fiber
720997|NCT01051674|Low-carbohydrate diet|low-carbohydrate diet
720998|NCT01051674|High protein diet|high protein diet
720999|NCT01051687|vitiligo|vitiligo
721000|NCT01051700|GW786034|gw786034
721001|NCT01051700|pazopanib|pazopanib
721002|NCT01051700|age-related macular degeneration|age-related macular degeneration
721003|NCT01051700|choroidal neovascularization|choroidal neovascularization
721004|NCT01051700|vascular endothelial growth factor|vascular endothelial growth factor
721005|NCT01051700|platelet derived growth factor|platelet derived growth factor
721006|NCT01051700|stem cell growth factor|stem cell growth factor
721007|NCT01051700|repeat-dose|repeat-dose
721008|NCT01051700|safety|safety
721009|NCT01051700|tolerability|tolerability
721010|NCT01051700|pharmacokinetics|pharmacokinetics
721011|NCT01051713|obesity|obesity
721012|NCT01051713|behavioraladherence|behavioraladherence
721013|NCT01051713|weight loss|weight loss
721014|NCT01051713|smartphone|smartphone
721015|NCT01051726|aromatherapy|aromatherapy
721016|NCT01051726|childbirth|childbirth
721017|NCT01051726|Obstetrics|obstetrics
721018|NCT01051726|Labour|labour
721019|NCT01051726|Complementary Medicine|complementary medicine
721020|NCT01051726|delivery, obstetric|delivery, obstetric
721021|NCT01051739|vision testing|vision testing
721022|NCT01051739|perimetry|perimetry
721023|NCT01051739|glaucoma|glaucoma
721024|NCT01051739|test variability|test variability
721025|NCT01051752|Nontuberculous mycobacterial diseases|nontuberculous mycobacterial diseases
721026|NCT01051752|pharmacokinetics|pharmacokinetics
721027|NCT01051752|pharmacodynamics|pharmacodynamics
721028|NCT01051778|Recurrent abortion|recurrent abortion
721029|NCT01051778|Antiphospholipid syndrome|antiphospholipid syndrome
721030|NCT01051778|unfractionated heparin|unfractionated heparin
721031|NCT01051778|Low Molecular Weight Heparin|low molecular weight heparin
721032|NCT01051791|RAD001|rad001
721033|NCT01051791|Everolimus|everolimus
721034|NCT01051804|Dry eye|dry eye
721035|NCT01051804|Visual Performance|visual performance
721036|NCT01051817|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
721037|NCT01051817|RRMS|rrms
721038|NCT01051843|Maternal Breastfeeding|maternal breastfeeding
721039|NCT01051843|Orofacial Difficulties|orofacial difficulties
721040|NCT01051843|Rooming-in|rooming-in
721041|NCT01051843|Speech and Language Therapy|speech and language therapy
721042|NCT01051869|distal humerus|distal humerus
721043|NCT01051869|fractures|fractures
721044|NCT01051869|ulnar nerve|ulnar nerve
721045|NCT01051869|simple decompression|simple decompression
721046|NCT01051869|anterior transposition|anterior transposition
721047|NCT01051882|Mesenchymal Stromal Cells (MSC)|mesenchymal stromal cells (msc)
721048|NCT01051882|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
721049|NCT01051882|Neuroprotection|neuroprotection
721050|NCT01051882|Neurodegeneration|neurodegeneration
721051|NCT01051882|Stem cells|stem cells
721052|NCT01051882|ALS|als
721053|NCT01051895|Cervical intra-epithelial neoplasia|cervical intra-epithelial neoplasia
721054|NCT01051895|Colposcopy|colposcopy
721055|NCT01051895|HPV DNA testing|hpv dna testing
721056|NCT01051895|treatment failure|treatment failure
721057|NCT01051921|HCV|hcv
721058|NCT01051921|Null Responder|null responder
721059|NCT01051934|Recombinant Immunotoxin|recombinant immunotoxin
721060|NCT01051934|Monoclonal Antibody|monoclonal antibody
721760|NCT01054014|CR016795|cr016795
721061|NCT01051934|Pseudomonas Exotoxin|pseudomonas exotoxin
721062|NCT01051934|Targeted Therapy|targeted therapy
721063|NCT01051934|Lung Cancer|lung cancer
721064|NCT01051934|Non-Small Cell Lung Cancer|non-small cell lung cancer
721065|NCT01051947|Nebivolol|nebivolol
721066|NCT01051947|Metoprolol|metoprolol
721067|NCT01051947|central aortic pressure|central aortic pressure
721068|NCT01051947|hypertension|hypertension
721069|NCT01051960|Systemic Sclerosis|systemic sclerosis
721070|NCT01051960|connective tissue disease|connective tissue disease
721071|NCT01051960|Shortness of breath|shortness of breath
721072|NCT01051960|Pulmonary Hypertension|pulmonary hypertension
721073|NCT01051973|Cognitive behavior therapy|cognitive behavior therapy
721074|NCT01051973|exposure|exposure
721075|NCT01051973|stress management|stress management
721076|NCT01051986|coronary artery bypass|coronary artery bypass
721077|NCT01051986|off-pump surgery|off-pump surgery
721078|NCT01051986|composite graft|composite graft
721079|NCT01051986|saphenous vein|saphenous vein
721080|NCT01051986|internal thoracic artery|internal thoracic artery
721081|NCT01051999|Glutamine|glutamine
721082|NCT01052012|Postoperative pain|postoperative pain
721083|NCT01052012|Post-operative pain|post-operative pain
721084|NCT01052012|Opioid|opioid
721085|NCT01052012|Laparoscopic surgery|laparoscopic surgery
721086|NCT01052012|Bupivacaine|bupivacaine
721087|NCT01052012|Local anesthetic|local anesthetic
721088|NCT01052038|Sore throat|sore throat
721089|NCT01052038|Dexamethasone|dexamethasone
721090|NCT01052038|Pain|pain
721091|NCT01052064|Children|children
721092|NCT01052064|ADHD|adhd
721093|NCT01052064|rTMS|rtms
721094|NCT01052064|Safety|safety
721096|NCT01052077|Major Depressive Disorder|major depressive disorder
721097|NCT01052077|Adjunctive Treatment|adjunctive treatment
721098|NCT01052090|HCV|hcv
721099|NCT01052116|Asthma|asthma
721100|NCT01052116|Soy|soy
723592|NCT01056315|Painful|painful
721101|NCT01052116|Supplement|supplement
721102|NCT01052116|ACRC|acrc
721103|NCT01052116|SOYA|soya
721104|NCT01052129|Bioequivalence|bioequivalence
721105|NCT01052129|Naproxen|naproxen
721106|NCT01052129|crossover|crossover
721107|NCT01052142|Melanoma|melanoma
721108|NCT01052142|Cancer vaccines|cancer vaccines
721109|NCT01052155|Controlled substances|controlled substances
721110|NCT01052155|Opioids|opioids
721111|NCT01052155|Benzodiazepines|benzodiazepines
721112|NCT01052155|Illicit drugs|illicit drugs
721113|NCT01052155|Immunoassay drug testing|immunoassay drug testing
721114|NCT01052155|Point of care (POC) testing|point of care (poc) testing
721115|NCT01052155|Liquid Chromatography Tandem Mass Spectometry|liquid chromatography tandem mass spectometry
721116|NCT01052168|simulation|simulation
721117|NCT01052168|simulators|simulators
721118|NCT01052168|motion metrics|motion metrics
721119|NCT01052168|performance metrics|performance metrics
721120|NCT01052168|skills training|skills training
721121|NCT01052168|proficiency|proficiency
721122|NCT01052168|laparoscopic|laparoscopic
721123|NCT01052181|Vitamin D|vitamin d
721124|NCT01052181|Insulin sensitivity|insulin sensitivity
721125|NCT01052181|Centrally obese|centrally obese
721126|NCT01052194|Rheumatoid Arthritis|rheumatoid arthritis
721127|NCT01052207|Biological Response Modifiers|biological response modifiers
721128|NCT01052207|Endocrinology|endocrinology
721129|NCT01052207|Hormone Dysfunction|hormone dysfunction
721130|NCT01052207|Hormones|hormones
721131|NCT01052207|Neuroendocrinology|neuroendocrinology
721132|NCT01052220|Hypertension|hypertension
721133|NCT01052220|Blood Pressure|blood pressure
721134|NCT01052220|End Stage Renal Disease|end stage renal disease
721135|NCT01052220|Hemodialysis|hemodialysis
721136|NCT01052220|Interdialytic Weight Gain|interdialytic weight gain
721137|NCT01052220|Self-Regulation|self-regulation
721138|NCT01052233|Sham-surgery|sham-surgery
721139|NCT01052233|Development of osteoarthritis|development of osteoarthritis
721140|NCT01052233|Randomized, double-blinded, placebo-controlled|randomized, double-blinded, placebo-controlled
721141|NCT01052246|acne vulgaris|acne vulgaris
721142|NCT01052246|laser surgery|laser surgery
721143|NCT01052246|pulsed dye lasers|pulsed dye lasers
721144|NCT01052246|benzoyl peroxidase|benzoyl peroxidase
721145|NCT01052246|clindamycin|clindamycin
721146|NCT01052246|randomized controlled trial|randomized controlled trial
721147|NCT01052259|Chronic rejection|chronic rejection
721148|NCT01052259|Kidney|kidney
721149|NCT01052259|Transplantation|transplantation
721150|NCT01052259|Immunosuppressive|immunosuppressive
721151|NCT01052272|Diabetes|diabetes
721152|NCT01052272|Acute MI|acute mi
721153|NCT01052272|Ang II type-1 receptor blockade (AT1RB)|ang ii type-1 receptor blockade (at1rb)
721154|NCT01052272|LV remodeling|lv remodeling
721155|NCT01052272|ACE inhibitor therapy|ace inhibitor therapy
721156|NCT01052272|XO inhibitor, Allopurinol|xo inhibitor, allopurinol
721157|NCT01052272|Systolic dysfunction|systolic dysfunction
721158|NCT01052272|Diastolic dysfunction|diastolic dysfunction
721159|NCT01052272|LV dimensions|lv dimensions
721160|NCT01052272|Cardiac MRI|cardiac mri
721161|NCT01052285|Transversus abdominis plane block|transversus abdominis plane block
721162|NCT01052298|Ciprofloxacin|ciprofloxacin
721164|NCT01052298|Pharmacokinetics|pharmacokinetics
721165|NCT01052298|Safety|safety
721166|NCT01052298|Tolerability|tolerability
721167|NCT01052298|COPD|copd
721168|NCT01052311|Coronary artery disease|coronary artery disease
721169|NCT01052311|Endothelial function|endothelial function
721170|NCT01052311|Platelet function|platelet function
721171|NCT01052311|Statins|statins
721172|NCT01052311|Niacin|niacin
721173|NCT01052350|Parkinson disease|parkinson disease
721174|NCT01052350|PET imaging|pet imaging
721175|NCT01052350|PIB|pib
721176|NCT01052350|dementia|dementia
721177|NCT01052363|CNS tumors|cns tumors
721178|NCT01052376|nflammatory bowel diseases (IBD)|nflammatory bowel diseases (ibd)
721179|NCT01052376|Familial adenomatous polyposis (FAP)|familial adenomatous polyposis (fap)
721180|NCT01052389|Schizophrenia|schizophrenia
721181|NCT01052389|Pragmatic RCT|pragmatic rct
721182|NCT01052389|Aripiprazole|aripiprazole
721183|NCT01052389|Olanzapine|olanzapine
721184|NCT01052389|Haloperidol|haloperidol
721185|NCT01052389|Metabolic syndrome|metabolic syndrome
721186|NCT01052389|Drug discontinuation|drug discontinuation
721187|NCT01052415|HIV|hiv
721188|NCT01052415|Stigma|stigma
721189|NCT01052415|POL|pol
721190|NCT01052415|Service providers|service providers
721191|NCT01052415|China|china
721192|NCT01052415|Universal precaution|universal precaution
721193|NCT01052428|Chronic MR|chronic mr
721194|NCT01052428|Volume Overload|volume overload
721195|NCT01052428|Beta-1 receptor blocker|beta-1 receptor blocker
721196|NCT01052428|LV remodelling, LV dimensions|lv remodelling, lv dimensions
721197|NCT01052428|LV systolic function|lv systolic function
721198|NCT01052428|LV diastolic dysfunction|lv diastolic dysfunction
721199|NCT01052428|Cardiac MRI|cardiac mri
721200|NCT01052441|CCTA|ccta
723691|NCT01056783|EoE|eoe
721201|NCT01052441|Coronary Artery Stenosis|coronary artery stenosis
721202|NCT01052441|Iodinated Contrast|iodinated contrast
721203|NCT01052441|Invasive Coronary Angiography|invasive coronary angiography
721204|NCT01052454|hot flashes|hot flashes
721205|NCT01052454|mindfulness|mindfulness
721206|NCT01052454|stress|stress
721207|NCT01042145|Primary Care|primary care
721208|NCT01042145|Treatment|treatment
721209|NCT01042145|Croup|croup
721210|NCT01042145|Corticosteroids|corticosteroids
721211|NCT01042145|Prednisone|prednisone
721212|NCT01042145|Dexamethasone|dexamethasone
721213|NCT01042145|Randomized trial|randomized trial
721214|NCT01042158|Tadalafil|tadalafil
721215|NCT01042158|Ambrisentan|ambrisentan
721216|NCT01042158|Quality of Life|quality of life
721217|NCT01042184|H. pylori infected patients without prior eradication therapy|h. pylori infected patients without prior eradication therapy
721218|NCT01042197|Vitamin D|vitamin d
721220|NCT01042197|Dose-Response|dose-response
721221|NCT01042197|Body surface area|body surface area
721222|NCT01042210|preeclampsia|preeclampsia
721223|NCT01042210|agouti-related peptide|agouti-related peptide
721224|NCT01042210|intrauterine growth|intrauterine growth
721225|NCT01042210|birth weight|birth weight
721226|NCT01042210|Intrauterine growth restriction due to preeclampsia|intrauterine growth restriction due to preeclampsia
721227|NCT01042223|Factors Predisposing or Causing|factors predisposing or causing
721228|NCT01042236|Phase 2 stress urinary incontinence Fesoterodine|phase 2 stress urinary incontinence fesoterodine
721229|NCT01042249|PFMT|pfmt
721230|NCT01042249|Stroke|stroke
721231|NCT01042249|LUTS|luts
721232|NCT01042249|Men|men
721233|NCT01042262|Superoxide dismutase|superoxide dismutase
721234|NCT01042262|Oxygen|oxygen
721235|NCT01042262|Oxygen free radicals|oxygen free radicals
721236|NCT01042262|Labor and delivery|labor and delivery
721237|NCT01042275|stress urinary incontinence|stress urinary incontinence
721238|NCT01042275|retropubic sling|retropubic sling
721239|NCT01042275|transobturator sling|transobturator sling
721240|NCT01042275|tension-free vaginal tape|tension-free vaginal tape
721241|NCT01042275|transobturator tape|transobturator tape
721242|NCT01042275|TVT|tvt
721243|NCT01042275|TVT-O|tvt-o
721244|NCT01042275|TOT|tot
721246|NCT01042275|IVS|ivs
721247|NCT01042288|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
721248|NCT01042288|NSCLC|nsclc
721249|NCT01042288|Panitumumab|panitumumab
721250|NCT01042288|Vectibix|vectibix
721251|NCT01042288|Pemetrexed|pemetrexed
721252|NCT01042288|Alimta|alimta
721253|NCT01042288|Carboplatin|carboplatin
721254|NCT01042327|solute clearances|solute clearances
721255|NCT01042340|nutrition|nutrition
721256|NCT01042340|geriatric|geriatric
721257|NCT01042340|supplement|supplement
721258|NCT01042340|energy|energy
721259|NCT01042366|Melanoma|melanoma
721260|NCT01042379|I-SPY 2|i-spy 2
721261|NCT01042379|Neoadjuvant|neoadjuvant
721262|NCT01042379|Breast|breast
721263|NCT01042379|Cancer|cancer
721264|NCT01042379|Neoplasm|neoplasm
721265|NCT01042379|Adaptive|adaptive
721266|NCT01042379|pCR|pcr
721267|NCT01042379|Pathologic Complete Response|pathologic complete response
721268|NCT01042379|Biomarkers signature|biomarkers signature
721269|NCT01042379|MRI Volume|mri volume
721856|NCT01054443|Splenectomy|splenectomy
721270|NCT01042392|Moderate systolic hypertension - adults - aliskiren -ramipril|moderate systolic hypertension - adults - aliskiren -ramipril
721271|NCT01042418|satiety|satiety
721272|NCT01042418|grain structure|grain structure
721273|NCT01042418|rye|rye
721274|NCT01042431|Nutritional status of ward patients and hospitalization outcome|nutritional status of ward patients and hospitalization outcome
721275|NCT01042444|Heart disease|heart disease
721276|NCT01042444|Embolic Protection Device|embolic protection device
721277|NCT01042444|PCI|pci
721278|NCT01042444|SVG|svg
721279|NCT01042457|trough level|trough level
721280|NCT01042457|therapeutic drug monitoring|therapeutic drug monitoring
721281|NCT01042457|Mycophenolate mofetil|mycophenolate mofetil
721282|NCT01042457|Mycophenolic acid|mycophenolic acid
721283|NCT01042457|lupus nephritis|lupus nephritis
721284|NCT01042470|pelvic organ prolapse|pelvic organ prolapse
721285|NCT01042470|pelvic floor dysfunction|pelvic floor dysfunction
721286|NCT01042470|biomechanics|biomechanics
721287|NCT01042470|aspiration device|aspiration device
721288|NCT01042470|connective tissue|connective tissue
721289|NCT01042483|active stage|active stage
721290|NCT01042483|labor|labor
721291|NCT01042483|progression|progression
721292|NCT01042483|pregnant women during active phases of labor|pregnant women during active phases of labor
721293|NCT01042496|Bipolar|bipolar
721294|NCT01042496|depression|depression
721295|NCT01042509|Chronic Graft vs Host Disease|chronic graft vs host disease
721296|NCT01042509|Alemtuzumab|alemtuzumab
721297|NCT01042509|Rituximab|rituximab
721298|NCT01042509|Low-dose|low-dose
721299|NCT01042509|Alemtuzumab and rituximab combination|alemtuzumab and rituximab combination
721300|NCT01042548|Proteomics|proteomics
721301|NCT01042548|Breast Cancer Markers|breast cancer markers
721302|NCT01042548|Tissue Interstitial Fluid|tissue interstitial fluid
721303|NCT01042561|vitamin d|vitamin d
721304|NCT01042561|prematurity|prematurity
721305|NCT01042561|25(OH)D|25(oh)d
721306|NCT01042561|infant|infant
721307|NCT01042561|CRP|crp
721308|NCT01042561|PTH|pth
721309|NCT01042574|intracranial hemorrhage (ICH)|intracranial hemorrhage (ich)
721310|NCT01042574|subarachnoid hemorrhage (SAH)|subarachnoid hemorrhage (sah)
721311|NCT01042574|intracranial monitoring|intracranial monitoring
721312|NCT01042574|external ventricular drain (ventriculostomy)|external ventricular drain (ventriculostomy)
721313|NCT01042574|hypertension|hypertension
721314|NCT01042587|bright light therapy|bright light therapy
721315|NCT01042587|circadian rhythm,|circadian rhythm,
721316|NCT01042587|entrainment|entrainment
721317|NCT01042600|Respiratory distress syndrome|respiratory distress syndrome
721318|NCT01042600|Surfactant|surfactant
721319|NCT01042600|Tracheal intubation|tracheal intubation
721320|NCT01042600|Laryngeal mask airway|laryngeal mask airway
721321|NCT01042600|Newborn|newborn
721322|NCT01042613|AccuVein AV300 device;|accuvein av300 device;
721323|NCT01042613|Intravenous cannulation|intravenous cannulation
721324|NCT01042626|Receptors, Calcium sensing|receptors, calcium sensing
721325|NCT01042626|Parathyroid Hormone|parathyroid hormone
721326|NCT01042639|osteopenia|osteopenia
721327|NCT01042639|very low birthweight infants|very low birthweight infants
721328|NCT01042639|bone speed of sound|bone speed of sound
721329|NCT01042639|quantitative ultrasound|quantitative ultrasound
721330|NCT01042652|Methadone|methadone
721331|NCT01042652|HIV|hiv
721332|NCT01042652|Raltegravir|raltegravir
721333|NCT01042652|Antiretroviral|antiretroviral
721334|NCT01042652|Intravenous Drug User|intravenous drug user
721335|NCT01042652|Methadone Maintenance|methadone maintenance
721336|NCT01042652|Treatment Naive|treatment naive
721337|NCT01042665|Glaucoma|glaucoma
721338|NCT01042665|intraocular pressure|intraocular pressure
721339|NCT01042665|latanoprost|latanoprost
721340|NCT01042665|retinal ganglion cell|retinal ganglion cell
721341|NCT01042665|pattern electroretinogram|pattern electroretinogram
721342|NCT01042704|Relapsed Myeloma|relapsed myeloma
721343|NCT01042704|Refractory Myeloma|refractory myeloma
721344|NCT01042717|plerixafor|plerixafor
721345|NCT01042717|autologous transplantation|autologous transplantation
721346|NCT01042717|hematopoietic stem cell mobilization|hematopoietic stem cell mobilization
721347|NCT01042717|multiple myeloma|multiple myeloma
721348|NCT01042717|non-Hodgkins lymphoma|non-hodgkins lymphoma
721349|NCT01042730|Pitavastatin|pitavastatin
721350|NCT01042730|Coronary Artery Disease|coronary artery disease
721351|NCT01042730|Cardiovascular Disease|cardiovascular disease
721352|NCT01042743|colon cancer|colon cancer
721353|NCT01042743|robot|robot
721354|NCT01042743|laparoscopy|laparoscopy
721355|NCT01042743|primary, right-side colon cancer|primary, right-side colon cancer
721356|NCT01042743|robot-assisted surgery|robot-assisted surgery
721357|NCT01042782|gastric cancer|gastric cancer
721358|NCT01042782|RAD001|rad001
721359|NCT01042782|Mitomycin C|mitomycin c
721360|NCT01042782|MTD|mtd
721361|NCT01042795|sunitinib|sunitinib
721362|NCT01042795|bladder neoplasm|bladder neoplasm
721363|NCT01042795|adjuvant treatment|adjuvant treatment
721364|NCT01042795|disease free survival|disease free survival
721365|NCT01042795|cystectomy|cystectomy
721366|NCT01042821|anal fistula|anal fistula
721367|NCT01042821|advancement flap|advancement flap
721368|NCT01042821|incontinence|incontinence
721369|NCT01042834|air pollution|air pollution
721370|NCT01042834|autonomic nervous system|autonomic nervous system
721371|NCT01042834|sleep apnea|sleep apnea
721372|NCT01042834|Heart rate variability|heart rate variability
721373|NCT01042834|Healthy volunteers|healthy volunteers
721374|NCT01042847|ovarian|ovarian
721375|NCT01042860|macular pigment|macular pigment
721376|NCT01042860|lutein|lutein
721377|NCT01042860|age-related macular degeneration|age-related macular degeneration
721378|NCT01042860|AMD|amd
721379|NCT01042873|Desensitization|desensitization
721380|NCT01042873|beta adrenergic receptors|beta adrenergic receptors
721381|NCT01042873|Healthy subjects|healthy subjects
721382|NCT01042886|Non-blind, randomized controlled trial|non-blind, randomized controlled trial
721383|NCT01042886|Pilot study|pilot study
721384|NCT01042899|TBI|tbi
721385|NCT01042899|intracranial edema|intracranial edema
721386|NCT01042899|brain edema|brain edema
721387|NCT01042899|craniocerebral trauma|craniocerebral trauma
721388|NCT01042899|head injury|head injury
721389|NCT01042899|brain hemorrhage, traumatic|brain hemorrhage, traumatic
721390|NCT01042899|subdural hematoma|subdural hematoma
721391|NCT01042899|brain concussion|brain concussion
721392|NCT01042899|head injuries, closed|head injuries, closed
721393|NCT01042899|epidural hematoma|epidural hematoma
721394|NCT01042899|extra-axial hemorrhage|extra-axial hemorrhage
721395|NCT01042899|cortical contusion|cortical contusion
721396|NCT01042899|wounds and injuries|wounds and injuries
721397|NCT01042899|disorders of environmental origin|disorders of environmental origin
721686|NCT01053637|pain|pain
721398|NCT01042899|trauma, nervous system|trauma, nervous system
721399|NCT01042899|brain injuries|brain injuries
721400|NCT01042912|diagnosis|diagnosis
721401|NCT01042912|carotid|carotid
721402|NCT01042912|artery|artery
721403|NCT01042912|disease|disease
721404|NCT01042912|auscultation|auscultation
721405|NCT01042912|sound|sound
721406|NCT01042925|HER2 positive breast cancer|her2 positive breast cancer
721407|NCT01042925|breast cancer|breast cancer
721408|NCT01042925|breast tumors|breast tumors
721409|NCT01042925|human mammary carcinoma|human mammary carcinoma
721410|NCT01042938|Radiation dermatitis in breast cancer patients|radiation dermatitis in breast cancer patients
721411|NCT01042951|safety|safety
721412|NCT01042951|immunogenicity|immunogenicity
721413|NCT01042951|Healthy Participants|healthy participants
721414|NCT01042964|platelet adhesion and aggregation|platelet adhesion and aggregation
721415|NCT01042964|acute coronary syndrome|acute coronary syndrome
721416|NCT01042964|myocardial infarction|myocardial infarction
721417|NCT01042964|stroke|stroke
721418|NCT01042964|inhibition of platelet adhesion to plaques|inhibition of platelet adhesion to plaques
721419|NCT01042964|collagen-induced platelet aggregation|collagen-induced platelet aggregation
721420|NCT01042977|dapagliflozin|dapagliflozin
721421|NCT01042977|diabetes|diabetes
721422|NCT01042977|cardiovascular disease|cardiovascular disease
721423|NCT01042990|Stroke|stroke
721424|NCT01042990|Exercise|exercise
721425|NCT01042990|Balance|balance
721426|NCT01042990|Dynamic Gait|dynamic gait
721427|NCT01042990|Cardiovascular Fitness|cardiovascular fitness
721428|NCT01043016|skin cancer|skin cancer
721429|NCT01043016|esophageal cancer|esophageal cancer
721430|NCT01043016|photodynamic therapy|photodynamic therapy
721431|NCT01043042|hypoglycemia among inpatients|hypoglycemia among inpatients
721432|NCT01043042|hyperglycemia among inpatients|hyperglycemia among inpatients
721433|NCT01043055|Breast Cancer Screening|breast cancer screening
721434|NCT01043068|cancer pain|cancer pain
721435|NCT01043068|opioid|opioid
721436|NCT01043068|guideline|guideline
721437|NCT01043081|African American women who have sex with women|african american women who have sex with women
721438|NCT01043081|Sexually transmitted infections|sexually transmitted infections
721439|NCT01043081|Homosexuality|homosexuality
721440|NCT01043081|Human papillomavirus|human papillomavirus
721441|NCT01043081|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
721734|NCT01053923|Anal Cancer|anal cancer
721442|NCT01043081|Herpes simplex virus types 1 and 2|herpes simplex virus types 1 and 2
721443|NCT01043081|Chlamydia|chlamydia
721444|NCT01043081|Gonorrhea|gonorrhea
721445|NCT01043081|Trichomoniasis|trichomoniasis
721446|NCT01043081|Bacterial vaginosis|bacterial vaginosis
721447|NCT01043081|Syphilis|syphilis
721448|NCT01043081|Human immunodeficiency virus|human immunodeficiency virus
721449|NCT01043133|electronic medical records|electronic medical records
721450|NCT01043133|documentation templates|documentation templates
721451|NCT01043133|clinical encounter notes|clinical encounter notes
721452|NCT01043146|anti-beta1 adrenergic receptor|anti-beta1 adrenergic receptor
721453|NCT01043146|autoantibody|autoantibody
721454|NCT01043146|cyclic peptide|cyclic peptide
721455|NCT01043146|heart failure|heart failure
721456|NCT01043185|GERD|gerd
721457|NCT01043185|lesogaberan|lesogaberan
721458|NCT01043185|impedance|impedance
721459|NCT01043185|pH|ph
721460|NCT01043185|pharmacokinetics|pharmacokinetics
721461|NCT01043185|safety|safety
721462|NCT01043185|tolerability|tolerability
721463|NCT01052480|Antiviral|antiviral
721464|NCT01052480|Anti-Influenza Immune Plasma|anti-influenza immune plasma
721465|NCT01052480|Emerging Infectious Disease|emerging infectious disease
721466|NCT01052480|Swine Flu|swine flu
721467|NCT01052493|obesity|obesity
721468|NCT01052493|pancreatic polypeptide|pancreatic polypeptide
721469|NCT01052493|gut hormones|gut hormones
721470|NCT01052506|Human volunteers|human volunteers
721471|NCT01052519|Obesity|obesity
721472|NCT01052519|Esophageal Doppler monitoring|esophageal doppler monitoring
721473|NCT01052519|tissue oxygen tension|tissue oxygen tension
721474|NCT01052532|Mitral Regurgitation|mitral regurgitation
721475|NCT01052532|LV remodeling|lv remodeling
721476|NCT01052532|Reactive nitrogen species|reactive nitrogen species
721477|NCT01052532|Cardiac MRI|cardiac mri
721478|NCT01052532|Adrenergic overdrive|adrenergic overdrive
721479|NCT01052545|urinary tract infection|urinary tract infection
721480|NCT01052545|urinary catheter|urinary catheter
721481|NCT01052545|bacteriuria|bacteriuria
721482|NCT01052545|clinical guidelines|clinical guidelines
721483|NCT01052545|audit-feedback|audit-feedback
721484|NCT01052545|guidelines implementation|guidelines implementation
721485|NCT01052558|Open angle|open angle
721486|NCT01052558|Glaucoma|glaucoma
721487|NCT01052558|Cataract|cataract
721488|NCT01052558|Surgery|surgery
721489|NCT01052558|Intraocular Pressure|intraocular pressure
721490|NCT01052571|Chronic low back pain|chronic low back pain
721491|NCT01052571|Lumbar disc herniation|lumbar disc herniation
721492|NCT01052571|Lower extremity pain|lower extremity pain
721493|NCT01052571|Lumbar radiculitis|lumbar radiculitis
721494|NCT01052571|Local anesthetic|local anesthetic
721495|NCT01052571|Steroid|steroid
721496|NCT01052571|Lumbar transforaminal epidural injection|lumbar transforaminal epidural injection
721498|NCT01052584|therapeutic efficacy|therapeutic efficacy
721499|NCT01052584|in vivo|in vivo
721500|NCT01052584|artemether lumefantrine|artemether lumefantrine
721501|NCT01052584|coartem|coartem
721502|NCT01052584|chloroquine|chloroquine
721503|NCT01052584|Plasmodium falciparum|plasmodium falciparum
721504|NCT01052584|Plasmodium vivax|plasmodium vivax
721505|NCT01052597|Type 2 diabetes|type 2 diabetes
721506|NCT01052597|Metabolic syndrome|metabolic syndrome
721507|NCT01052597|cardiovascular risk|cardiovascular risk
721508|NCT01052610|SLIT|slit
721509|NCT01052610|bronchial asthma|bronchial asthma
721510|NCT01052610|allergic rhinitis|allergic rhinitis
721511|NCT01052623|GH/IGF-1|gh/igf-1
721512|NCT01052623|Ataxia telangiectasia (AT)|ataxia telangiectasia (at)
721513|NCT01052623|IGF-1 Generation Test|igf-1 generation test
721514|NCT01052623|Growth hormone|growth hormone
721515|NCT01052636|Hip fracture|hip fracture
753816|NCT01177774|ADHD|adhd
721516|NCT01052636|Intervention program|intervention program
721517|NCT01052636|Elderly|elderly
721518|NCT01052649|MNC subpopulations|mnc subpopulations
721519|NCT01052649|Gene Expression|gene expression
721520|NCT01052649|Metabolomics|metabolomics
721521|NCT01052649|Immunological Status|immunological status
721522|NCT01052662|Drug Abuse|drug abuse
721523|NCT01052675|Drug and substance problematic use, abuse or dependence|drug and substance problematic use, abuse or dependence
721524|NCT01052688|Down syndrome, aneuploidy, amniocentesis, chorionic villus sampling, Trisomy|down syndrome, aneuploidy, amniocentesis, chorionic villus sampling, trisomy
721525|NCT01052714|Antipsychotic|antipsychotic
721526|NCT01052714|Bipolar|bipolar
721527|NCT01052714|Diabetes|diabetes
721528|NCT01052714|Mental Illness|mental illness
721529|NCT01052714|Nutrition|nutrition
721530|NCT01052714|Obesity|obesity
721531|NCT01052714|Schizoaffective|schizoaffective
721532|NCT01052714|Schizophrenia|schizophrenia
721533|NCT01052714|Weight Gain|weight gain
721534|NCT01052714|Weight Loss|weight loss
721535|NCT01052727|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
721536|NCT01052727|quality of life|quality of life
721537|NCT01052740|Breast Cancer|breast cancer
721538|NCT01052740|Mammography|mammography
721539|NCT01052740|Screening|screening
721540|NCT01052753|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
721541|NCT01052753|executive function|executive function
721542|NCT01052753|endophenotype|endophenotype
721543|NCT01052753|dopaminergic system|dopaminergic system
721544|NCT01052753|noradrenergic system|noradrenergic system
721545|NCT01052753|candidate gene|candidate gene
721546|NCT01052753|Family-based association study|family-based association study
721547|NCT01052766|lung cancer|lung cancer
721548|NCT01052766|PET Scan|pet scan
721549|NCT01052766|CT Scan|ct scan
721550|NCT01052766|BH-PET scan|bh-pet scan
721551|NCT01052766|09-134|09-134
721552|NCT01052779|Iron deficiency anemia|iron deficiency anemia
721553|NCT01052779|chronic kidney disease|chronic kidney disease
721554|NCT01052779|Feraheme|feraheme
721555|NCT01052779|ferumoxytol|ferumoxytol
721556|NCT01052779|iron sucrose|iron sucrose
721557|NCT01052779|iron deficiency anemia (IDA)|iron deficiency anemia (ida)
721558|NCT01052779|chronic kidney disease (CKD)|chronic kidney disease (ckd)
721559|NCT01052792|Bioequivalence|bioequivalence
721560|NCT01052792|Naproxen|naproxen
721561|NCT01052792|crossover|crossover
721562|NCT01052805|nerve|nerve
721563|NCT01052805|myelinated nerve|myelinated nerve
722054|NCT01055262|Safety|safety
721564|NCT01052805|unmyelinated nerve|unmyelinated nerve
721565|NCT01053156|Fragile X syndrome|fragile x syndrome
721566|NCT01053156|minocycline|minocycline
721567|NCT01053156|targeted treatment|targeted treatment
721568|NCT01053169|Coagulopathy|coagulopathy
721569|NCT01053169|Perioperative bleeding|perioperative bleeding
721570|NCT01053169|Prothrombin complex|prothrombin complex
721571|NCT01053169|Liver disease|liver disease
721572|NCT01053182|esophageal cancer|esophageal cancer
721573|NCT01053182|postoperative complications|postoperative complications
721574|NCT01053182|diaphragm|diaphragm
721575|NCT01053182|pulmonary function|pulmonary function
721576|NCT01053195|Diabetes|diabetes
721577|NCT01053195|prevention|prevention
721578|NCT01053195|intervention|intervention
721579|NCT01053208|Bioequivalence,Ibuprofen Diphenhydramine Citrate,Crossover|bioequivalence,ibuprofen diphenhydramine citrate,crossover
721580|NCT01053221|mycophenolate|mycophenolate
721581|NCT01053221|living donor|living donor
721582|NCT01053234|Hyperglycaemia|hyperglycaemia
721583|NCT01053234|Postprandial|postprandial
721584|NCT01053234|Type 2 diabetes|type 2 diabetes
721585|NCT01053234|Cardiovascular risk markers|cardiovascular risk markers
721586|NCT01053247|Atopic Dermatitis|atopic dermatitis
721587|NCT01053260|Contingency Management|contingency management
721588|NCT01053260|Weight Loss|weight loss
721589|NCT01053273|Low back pain|low back pain
721590|NCT01053273|Post lumbar laminectomy syndrome|post lumbar laminectomy syndrome
721591|NCT01053273|Lumbar spinal stenosis|lumbar spinal stenosis
721592|NCT01053273|Local anesthetic steroid|local anesthetic steroid
721593|NCT01053273|Lumbar transforaminal epidural injection|lumbar transforaminal epidural injection
721594|NCT01053273|Percutaneous epidural adhesiolysis|percutaneous epidural adhesiolysis
721595|NCT01053273|Caudal epidural injection|caudal epidural injection
721596|NCT01053286|Dysphagia|dysphagia
721597|NCT01053286|Globus|globus
721598|NCT01053286|Gastroesophageal reflux|gastroesophageal reflux
721599|NCT01053299|Developmental dysplasia of the hip (DDH)|developmental dysplasia of the hip (ddh)
721600|NCT01053299|newborn|newborn
721601|NCT01053299|universal screening|universal screening
721602|NCT01053299|Universal ultrasound-screening for DDH in newborns|universal ultrasound-screening for ddh in newborns
721603|NCT01053299|The accuracy of ultrasound-recording of the hip in newborns|the accuracy of ultrasound-recording of the hip in newborns
721604|NCT01053312|Amyloid|amyloid
721605|NCT01053312|NPH Normal pressure hydrocephalus|nph normal pressure hydrocephalus
721606|NCT01053312|PET Positron Emission Tomography|pet positron emission tomography
721607|NCT01053312|SUVR Standard uptake value ratios|suvr standard uptake value ratios
721608|NCT01053325|Malaria|malaria
721609|NCT01053325|Pregnancy|pregnancy
721610|NCT01053325|Prevention|prevention
721612|NCT01053325|Sub-Sahara Africa|sub-sahara africa
721613|NCT01053338|Bioequivalence,Ibuprofen Diphenhydramine Citrate,Crossover|bioequivalence,ibuprofen diphenhydramine citrate,crossover
721614|NCT01053377|Influenza|influenza
721615|NCT01053377|Tamiflu|tamiflu
721616|NCT01053377|Osteltamivir|osteltamivir
721617|NCT01053377|Transmission|transmission
721618|NCT01053377|Prevention|prevention
721619|NCT01053377|Resistance|resistance
721620|NCT01053377|Post-Exposure Profylaxe|post-exposure profylaxe
721621|NCT01053390|gallbladder neoplasmas|gallbladder neoplasmas
721622|NCT01053390|Gallbladder Neoplasms,Advanced Stage,Chemotherapy,Somatostatin|gallbladder neoplasms,advanced stage,chemotherapy,somatostatin
721623|NCT01053403|MDMA|mdma
721624|NCT01053403|Ecstasy|ecstasy
721625|NCT01053403|MDMA effect on sleep|mdma effect on sleep
721626|NCT01053403|MDMA effect on water homeostasis|mdma effect on water homeostasis
721627|NCT01053403|MDMA effect on neurocognitive function|mdma effect on neurocognitive function
721628|NCT01053403|Recreational Drug Use|recreational drug use
721629|NCT01053403|Drug Abuse|drug abuse
721630|NCT01053416|glaucoma|glaucoma
721631|NCT01053416|pigmentary glaucoma|pigmentary glaucoma
721632|NCT01053416|laser iridotomy|laser iridotomy
721633|NCT01053429|Regulatory Post-Marketing Surveillance|regulatory post-marketing surveillance
721735|NCT01053923|MRI scan|mri scan
721634|NCT01053429|Regulatory Pharmacovigilance|regulatory pharmacovigilance
721635|NCT01053429|ziprasidone|ziprasidone
721636|NCT01053442|iron absorption|iron absorption
721637|NCT01053442|stable isotopes|stable isotopes
721638|NCT01053442|NaFeEDTA|nafeedta
721639|NCT01053442|Non-transferrin-bound iron (NTBI)|non-transferrin-bound iron (ntbi)
721640|NCT01053442|Hepcidin|hepcidin
721641|NCT01053455|Non-invasive ventilation|non-invasive ventilation
721642|NCT01053455|SiPAP|sipap
721643|NCT01053455|CPAP|cpap
721644|NCT01053455|low birth weight infants|low birth weight infants
721645|NCT01053455|respiratory distress syndrome|respiratory distress syndrome
721646|NCT01053468|breast cancer|breast cancer
721647|NCT01053468|physical activity|physical activity
721648|NCT01053468|quality of life|quality of life
721649|NCT01053468|theory of planned behavior|theory of planned behavior
721650|NCT01053468|behavior change|behavior change
721651|NCT01053468|health promotion|health promotion
721652|NCT01053507|Headache|headache
721653|NCT01053507|Post-traumatic headache|post-traumatic headache
721654|NCT01053507|Brain injury|brain injury
721655|NCT01053507|Cognitive impairment|cognitive impairment
721656|NCT01053533|Chinese herbal medicines|chinese herbal medicines
721657|NCT01053533|pandemic H1N1 influenza|pandemic h1n1 influenza
721658|NCT01053533|effectiveness|effectiveness
721659|NCT01053533|safety|safety
721660|NCT01053559|Crohn's|crohn's
721661|NCT01053559|Inflammatory Bowel Disease|inflammatory bowel disease
721662|NCT01053572|Chronic low back pain|chronic low back pain
721663|NCT01053572|Post lumbar laminectomy syndrome|post lumbar laminectomy syndrome
721664|NCT01053572|Lower extremity pain|lower extremity pain
721665|NCT01053572|Local anesthetic|local anesthetic
721666|NCT01053572|Steroid|steroid
721667|NCT01053572|Percutaneous lumbar adhesiolysis|percutaneous lumbar adhesiolysis
721668|NCT01053585|Gastro-esophageal junction, reflux, insertion angle, magnetic resonance imaging, manometry|gastro-esophageal junction, reflux, insertion angle, magnetic resonance imaging, manometry
721669|NCT01053598|Mycobacterium tuberculosis|mycobacterium tuberculosis
721670|NCT01053598|Nitrate Reductase Assay|nitrate reductase assay
721671|NCT01053598|NRA|nra
721672|NCT01053598|REMA|rema
721673|NCT01053598|RETA|reta
721674|NCT01053598|Rezazurine|rezazurine
721675|NCT01053611|composite variability index|composite variability index
721676|NCT01053611|bispectral index|bispectral index
721677|NCT01053611|pain|pain
721678|NCT01053624|Tracheostomy and thoracic surgery|tracheostomy and thoracic surgery
721679|NCT01053624|postoperative complications|postoperative complications
721680|NCT01053624|pulmonary surgical procedures|pulmonary surgical procedures
721681|NCT01053624|respiratory failure|respiratory failure
721682|NCT01053637|lacerations|lacerations
721683|NCT01053637|sutures|sutures
721684|NCT01053637|pediatrics|pediatrics
721685|NCT01053637|child|child
721687|NCT01053637|Anxiety|anxiety
721688|NCT01053650|Healthy volunteers|healthy volunteers
721689|NCT01053650|Open / hidden|open / hidden
721690|NCT01053650|Placebo effect|placebo effect
721691|NCT01053676|Hyperphosphatemia|hyperphosphatemia
721692|NCT01053676|BE|be
721693|NCT01053676|Granule|granule
721694|NCT01053676|Healthy volunteers|healthy volunteers
721695|NCT01053689|Bioequivalence, Glimepiride, Crossover|bioequivalence, glimepiride, crossover
721696|NCT01053715|Hemophilia|hemophilia
721697|NCT01053715|Quality of Life|quality of life
721698|NCT01053754|adrenocortical insufficiency|adrenocortical insufficiency
721699|NCT01053754|prolonged corticotherapy|prolonged corticotherapy
721700|NCT01053767|Group B streptococcus|group b streptococcus
721701|NCT01053767|GBS|gbs
721702|NCT01053767|Vaccine|vaccine
721703|NCT01053780|Intercessory Prayer, pregnants|intercessory prayer, pregnants
721704|NCT01053793|Glycemic index|glycemic index
721705|NCT01053793|Anthocyanin|anthocyanin
721706|NCT01053793|Potato|potato
721707|NCT01053793|Polyphenol|polyphenol
721708|NCT01053806|MDS|mds
721709|NCT01053806|Lenalidomide|lenalidomide
721710|NCT01053806|5-Azacytidine.|5-azacytidine.
721711|NCT01053806|ORR|orr
721712|NCT01053806|PFS|pfs
721713|NCT01053806|myelodysplastic syndrome.High risk.|myelodysplastic syndrome.high risk.
721714|NCT01053819|psoriasis|psoriasis
721715|NCT01053819|melanoma|melanoma
721716|NCT01053819|non-melanoma skin cancer|non-melanoma skin cancer
721717|NCT01053819|etanercept|etanercept
721718|NCT01053819|Enbrel|enbrel
721719|NCT01053832|ventricular pace suppression|ventricular pace suppression
721720|NCT01053832|pacemaker|pacemaker
721721|NCT01053832|efficacy|efficacy
721722|NCT01053832|safety|safety
721723|NCT01053832|support of intrinsic heart rhythm|support of intrinsic heart rhythm
721724|NCT01053845|Neuropathic pain|neuropathic pain
721725|NCT01053858|bevacizumab,triamcinolone, intravitreal injection|bevacizumab,triamcinolone, intravitreal injection
721726|NCT01053871|normal|normal
721727|NCT01053884|Invasive Candidiasis|invasive candidiasis
721728|NCT01053884|invasive fungal disease|invasive fungal disease
721729|NCT01053884|Anidulafungin|anidulafungin
721730|NCT01053897|GBT009|gbt009
721731|NCT01053897|incisional scar|incisional scar
721732|NCT01053897|breast reconstruction|breast reconstruction
721733|NCT01053923|Perianal Cancer|perianal cancer
721736|NCT01053936|Chronic Kidney Disease|chronic kidney disease
721737|NCT01053936|Type 2 diabetes|type 2 diabetes
721738|NCT01053936|Diabetic Nephropathy|diabetic nephropathy
721739|NCT01053949|Multiple myeloma|multiple myeloma
721740|NCT01053949|dexamethasone|dexamethasone
721741|NCT01053949|pomalidomide|pomalidomide
721742|NCT01053949|response|response
721743|NCT01053949|safety|safety
721744|NCT01053962|Chronic Idiopathic Constipation|chronic idiopathic constipation
721745|NCT01053962|Constipation|constipation
721746|NCT01053962|Irritable Bowel Syndrome|irritable bowel syndrome
721747|NCT01053975|RSR|rsr
721748|NCT01053975|SECG|secg
721749|NCT01053975|SPECT|spect
721750|NCT01053975|QCA|qca
721751|NCT01053975|SCAD|scad
721752|NCT01053988|Safety|safety
721753|NCT01053988|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
721754|NCT01053988|Efficacy|efficacy
721755|NCT01053988|FEV1|fev1
721756|NCT01053988|COPD|copd
721757|NCT01054001|prostate cancer|prostate cancer
721758|NCT01054001|prostatectomy|prostatectomy
721759|NCT01054001|erectile dysfunction|erectile dysfunction
721761|NCT01054027|Retinopathy of Prematurity (ROP)|retinopathy of prematurity (rop)
721762|NCT01054027|Eye exams|eye exams
721763|NCT01054027|Premature infants|premature infants
721764|NCT01054027|cyclomydril|cyclomydril
721765|NCT01054040|cardiovascular disease, portion plate|cardiovascular disease, portion plate
721766|NCT01054053|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
721767|NCT01054053|Serum bactericidal activity|serum bactericidal activity
721769|NCT01054066|Chronic Kidney Disease|chronic kidney disease
721770|NCT01054066|Cardiovascular Disease|cardiovascular disease
721771|NCT01054066|Hypertension|hypertension
721772|NCT01054066|Anemia|anemia
721773|NCT01054092|ASP1941|asp1941
721774|NCT01054092|Diabetes mellitus|diabetes mellitus
721775|NCT01054092|Blood glucose|blood glucose
721776|NCT01054092|Food effect|food effect
721777|NCT01054105|Pulmonary hypertension|pulmonary hypertension
721778|NCT01054105|genes|genes
721779|NCT01054105|mutation|mutation
721780|NCT01054105|drug therapy|drug therapy
721781|NCT01054118|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
721782|NCT01054131|peer support|peer support
721783|NCT01054131|peer mentor|peer mentor
721784|NCT01054131|self-management|self-management
721785|NCT01054131|early inflammatory arthritis|early inflammatory arthritis
721786|NCT01054131|chronic disease|chronic disease
721787|NCT01054144|Newly Diagnosed Standard Risk Multiple Myeloma|newly diagnosed standard risk multiple myeloma
721788|NCT01054144|Senior Adults|senior adults
721789|NCT01054170|Chronic|chronic
721790|NCT01054170|obstructive|obstructive
721791|NCT01054170|pulmonary|pulmonary
721792|NCT01054170|lung|lung
721793|NCT01054170|respiratory disease|respiratory disease
721794|NCT01054170|efficacy|efficacy
721795|NCT01054170|placebo-controlled|placebo-controlled
721796|NCT01054170|COPD|copd
721797|NCT01054170|FEV1|fev1
721798|NCT01054170|St Georges Respiratory Questionnaire|st georges respiratory questionnaire
721799|NCT01054170|Computed Tomography|computed tomography
721800|NCT01054170|MSCT|msct
721801|NCT01054183|respiratory failure, intubation, GlideScope, pediatric|respiratory failure, intubation, glidescope, pediatric
721802|NCT01054209|Inadvertent Peri-operative Hypothermia|inadvertent peri-operative hypothermia
721803|NCT01054209|Shivering|shivering
721804|NCT01054209|Caesarean Section|caesarean section
721805|NCT01054209|Elective|elective
721806|NCT01054209|Warming Mattress|warming mattress
721807|NCT01054209|Regional Anaesthesia|regional anaesthesia
721808|NCT01054222|overactive bladder idiopathic|overactive bladder idiopathic
721809|NCT01054222|elderly fesoterodine SOFIA Portugal extension study|elderly fesoterodine sofia portugal extension study
721810|NCT01054235|prenatal care|prenatal care
721811|NCT01054235|community-based randomized controlled trial|community-based randomized controlled trial
721812|NCT01054235|perinatal mortality|perinatal mortality
721813|NCT01054235|China|china
721814|NCT01054248|pregnancy, malaria, artemisinin, vivax, falciparum|pregnancy, malaria, artemisinin, vivax, falciparum
721815|NCT01054261|avanafil, renal, impairment, TA-1790|avanafil, renal, impairment, ta-1790
721816|NCT01054274|esophageal cancer|esophageal cancer
721817|NCT01054274|dysphagia|dysphagia
721818|NCT01054274|stent|stent
721819|NCT01054274|brachytherapy|brachytherapy
721820|NCT01054313|Advanced Malignancies|advanced malignancies
721821|NCT01054313|Taxotere|taxotere
721822|NCT01054313|Docetaxel|docetaxel
721823|NCT01054313|Rapamycin|rapamycin
721824|NCT01054313|Sirolimus|sirolimus
721825|NCT01054313|Rapamune|rapamune
721826|NCT01054313|Prednisone|prednisone
721827|NCT01054313|Resistant to standard therapy|resistant to standard therapy
721828|NCT01054326|arthroscopic subacromial decompression|arthroscopic subacromial decompression
721829|NCT01054326|exercise|exercise
721830|NCT01054326|physical therapy|physical therapy
721831|NCT01054326|rotator cuff|rotator cuff
721832|NCT01054326|shoulder impingement syndrome|shoulder impingement syndrome
721833|NCT01054326|Subacromial impingement after arthroscopic subacromial decompression|subacromial impingement after arthroscopic subacromial decompression
722030|NCT01055171|beta-block|beta-block
721834|NCT01054339|Alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
721835|NCT01054339|Adeno-associated virus vector|adeno-associated virus vector
721836|NCT01054339|AAV|aav
721837|NCT01054339|Gene therapy|gene therapy
721838|NCT01054339|Human gene transfer|human gene transfer
721839|NCT01054352|Seasonal allergies|seasonal allergies
721840|NCT01054352|Allergic rhinitis|allergic rhinitis
721841|NCT01054404|Brain Swelling|brain swelling
721842|NCT01054404|Brain Edema|brain edema
721843|NCT01054404|Dehydration|dehydration
721844|NCT01054417|Appendicitis|appendicitis
721845|NCT01054417|Laparoscopy|laparoscopy
721846|NCT01054417|Appendectomy|appendectomy
721847|NCT01054430|Avanafil|avanafil
721848|NCT01054430|Hepatic|hepatic
721849|NCT01054430|Erectile Dysfunction|erectile dysfunction
721850|NCT01054430|Impairment|impairment
721851|NCT01054443|Blood Platelet Disorders|blood platelet disorders
721852|NCT01054443|Immune Thrombocytopenia (ITP)|immune thrombocytopenia (itp)
721853|NCT01054443|Low Platelet Count|low platelet count
721854|NCT01054443|Thrombocytopaenia|thrombocytopaenia
721855|NCT01054443|S-888711|s-888711
721857|NCT01054443|Thrombopoiesis|thrombopoiesis
721858|NCT01054443|Hematologic Disease|hematologic disease
721859|NCT01054443|Auto-immune thrombocytopenic Purpura|auto-immune thrombocytopenic purpura
721860|NCT01054443|Relapsed Persistent or Chronic ITP|relapsed persistent or chronic itp
721861|NCT01054443|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
721862|NCT01054443|Thrombotic Thrombocytopenic Purpura (TTP)|thrombotic thrombocytopenic purpura (ttp)
721863|NCT01054456|LEC|lec
721864|NCT01054456|Low Emetogenic Chemotherapy|low emetogenic chemotherapy
721865|NCT01054456|Nausea and Vomiting|nausea and vomiting
721866|NCT01054456|Nausea|nausea
721867|NCT01054456|Vomiting|vomiting
721868|NCT01054456|Anti- emetic|anti- emetic
721869|NCT01054469|nephrectomy|nephrectomy
721870|NCT01054482|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
721871|NCT01054482|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
721872|NCT01054495|Acupuncture|acupuncture
721873|NCT01054495|Sham acupuncture|sham acupuncture
721874|NCT01054495|Laser|laser
721875|NCT01054495|Methodology|methodology
721876|NCT01054495|Control intervention|control intervention
721877|NCT01054495|Pilot|pilot
721878|NCT01054495|Nausea and vomiting in early pregnancy|nausea and vomiting in early pregnancy
721879|NCT01054495|Patient's experience of different acu-stimulation|patient's experience of different acu-stimulation
721880|NCT01054495|Blinding in acupuncture research|blinding in acupuncture research
721881|NCT01054521|radiofrequency turbinate reduction|radiofrequency turbinate reduction
721882|NCT01054521|nasal obstruction|nasal obstruction
751876|NCT01171027|Gallbladder removal|gallbladder removal
721883|NCT01054521|Temperature-controlled radiofrequency|temperature-controlled radiofrequency
721884|NCT01054521|Bipolar radiofrequency|bipolar radiofrequency
721885|NCT01054521|chronic rhinitis.|chronic rhinitis.
721886|NCT01054534|urinary incontinence|urinary incontinence
721887|NCT01054547|topical anesthetic|topical anesthetic
721888|NCT01054547|liposomal ropivacaine|liposomal ropivacaine
721889|NCT01054547|dentistry|dentistry
721890|NCT01054560|Ischemic Stroke|ischemic stroke
721891|NCT01054560|SOLITAIRE™ Device|solitaire™ device
721892|NCT01054560|SOLITAIRE™|solitaire™
721893|NCT01054560|MERCI® Device|merci® device
721894|NCT01054560|MERCI®|merci®
721895|NCT01054560|Stroke|stroke
721896|NCT01054560|Ischemic|ischemic
721897|NCT01054560|Mechanical Thrombectomy|mechanical thrombectomy
721898|NCT01054560|Brain|brain
721899|NCT01054560|Brain Clot|brain clot
721900|NCT01054560|Brain Artery Revascularization|brain artery revascularization
721901|NCT01054560|Recanalization|recanalization
721902|NCT01054560|Brain Stroke|brain stroke
721903|NCT01054560|Clot Retriever|clot retriever
721904|NCT01054560|Device|device
721905|NCT01054560|Neurosurgery|neurosurgery
721906|NCT01054560|Neurovascular Intervention|neurovascular intervention
721907|NCT01054560|Interventional Neuroradiology|interventional neuroradiology
721908|NCT01054560|Brain study|brain study
721909|NCT01054560|neurovascular clinical trial|neurovascular clinical trial
721910|NCT01054573|Hepatitis C, Chronic|hepatitis c, chronic
721911|NCT01054573|Telaprevir|telaprevir
721912|NCT01054573|Roll-over study|roll-over study
721913|NCT01054586|antiretroviral therapy|antiretroviral therapy
721914|NCT01054586|hepatic impairment|hepatic impairment
721916|NCT01054599|epilepsy|epilepsy
721917|NCT01054599|memory|memory
721918|NCT01054599|memantine|memantine
721919|NCT01054599|localization related epilepsy|localization related epilepsy
721920|NCT01054599|focal epilepsy|focal epilepsy
721921|NCT01054612|Histology|histology
721922|NCT01054612|Immunohistochemical|immunohistochemical
721923|NCT01054612|Gene Expression|gene expression
721924|NCT01054612|Tissue Sectioning|tissue sectioning
721925|NCT01054625|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
721926|NCT01054625|Head and Neck Cancer|head and neck cancer
721927|NCT01054625|Head and Neck Neoplasms|head and neck neoplasms
721928|NCT01054625|anti-EGFr monoclonal antibody|anti-egfr monoclonal antibody
721929|NCT01054625|Zalutumumab|zalutumumab
721930|NCT01054638|amprenavir|amprenavir
721931|NCT01054638|fosamprenavir|fosamprenavir
721932|NCT01054638|HIV|hiv
721933|NCT01054638|HAART treatment|haart treatment
721934|NCT01054638|Epzicom|epzicom
721935|NCT01054638|Trizivir|trizivir
721936|NCT01054638|Combivir|combivir
721937|NCT01054638|zidovudine|zidovudine
721938|NCT01054638|lamivudine|lamivudine
721939|NCT01054638|cardiovascular disease|cardiovascular disease
721940|NCT01054638|HIV Infections|hiv infections
721941|NCT01054651|Schistosoma mansoni|schistosoma mansoni
721942|NCT01054651|Praziquantel|praziquantel
721943|NCT01054651|Artesunate + Sulfamethoxypyrazine/pyrimethamine|artesunate + sulfamethoxypyrazine/pyrimethamine
721944|NCT01054651|Randomized open-label controlled clinical trial|randomized open-label controlled clinical trial
721945|NCT01054664|liver enzymes|liver enzymes
721946|NCT01054664|peripheral mononuclear blood cells|peripheral mononuclear blood cells
721947|NCT01054664|hemodialysis|hemodialysis
721948|NCT01054664|hepatitis C|hepatitis c
721949|NCT01054664|RNA|rna
721950|NCT01054677|Infections in nursing homes|infections in nursing homes
721951|NCT01054677|especially urinary tract infections|especially urinary tract infections
721952|NCT01054690|Catheterization|catheterization
722154|NCT01055652|phase 1|phase 1
721953|NCT01054690|Urinary Tract Infection|urinary tract infection
721954|NCT01054690|Elective Surgery|elective surgery
721955|NCT01054716|RhD negative|rhd negative
721956|NCT01054716|RhD disease|rhd disease
721957|NCT01054716|fetal nucleic acid|fetal nucleic acid
721958|NCT01054716|fetal DNA|fetal dna
721959|NCT01054716|cell free fetal DNA|cell free fetal dna
721960|NCT01054716|Fetal RHD genotype|fetal rhd genotype
721961|NCT01054729|Chronic Hepatitis C infection Genotype 1|chronic hepatitis c infection genotype 1
721962|NCT01054729|HCV|hcv
721963|NCT01054729|GT1|gt1
721964|NCT01054729|GT 1|gt 1
721965|NCT01054768|Antioxidant|antioxidant
721966|NCT01054768|Inflammation|inflammation
721967|NCT01054768|Sickle Cell Disease|sickle cell disease
721968|NCT01054768|Oxidative Stress|oxidative stress
721969|NCT01054768|Cytokines|cytokines
721970|NCT01054768|anti-inflammatory|anti-inflammatory
721971|NCT01054768|Acetylcarnitine|acetylcarnitine
721972|NCT01054781|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
721973|NCT01054781|rituximab|rituximab
721974|NCT01054781|CHOP|chop
721975|NCT01054794|Gastroparesis|gastroparesis
721976|NCT01054794|Gastric Electrical Stimulation|gastric electrical stimulation
721977|NCT01054820|FLECTORÂ® Patch|flectorâ® patch
721978|NCT01054820|acute back strain|acute back strain
721979|NCT01054846|Bicycle helmet|bicycle helmet
721980|NCT01054872|HIV Seronegativity|hiv seronegativity
721981|NCT01054872|HIV Preventive Vaccine|hiv preventive vaccine
721982|NCT01054885|COPD|copd
721983|NCT01054885|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
721984|NCT01054885|Efficacy|efficacy
721985|NCT01054885|FEV1|fev1
721986|NCT01054885|Safety|safety
721987|NCT01054898|depression|depression
721988|NCT01054898|spouse abuse|spouse abuse
721989|NCT01054898|intervention studies|intervention studies
721990|NCT01054911|GIST|gist
721991|NCT01054911|gastrointestinal stromal tumor|gastrointestinal stromal tumor
721992|NCT01054911|gastrointestinal stomach tumor|gastrointestinal stomach tumor
721993|NCT01054911|Sunitinib|sunitinib
721994|NCT01054937|4SC-203|4sc-203
721995|NCT01054937|Phase I|phase i
721996|NCT01054937|single dose|single dose
721997|NCT01054937|healthy volunteers|healthy volunteers
721998|NCT01054963|early inflammatory arthritis|early inflammatory arthritis
721999|NCT01054963|chronic disease|chronic disease
722000|NCT01054963|peer support|peer support
722001|NCT01054963|peer mentor|peer mentor
722002|NCT01054963|peer counselling|peer counselling
722003|NCT01054976|Alzheimer's disease|alzheimer's disease
722004|NCT01054976|Galantamine|galantamine
722005|NCT01054976|Dementia|dementia
722006|NCT01054989|Healthy adults|healthy adults
722007|NCT01054989|Insulin sensitivity|insulin sensitivity
722008|NCT01055002|Health male volunteers|health male volunteers
722009|NCT01055002|Male volunteers aged 18-45 years|male volunteers aged 18-45 years
722010|NCT01055002|Non-smokers and in good health|non-smokers and in good health
722011|NCT01055015|total knee arthroplasty|total knee arthroplasty
722012|NCT01055054|bariatrics|bariatrics
722013|NCT01055080|type 1 diabetes|type 1 diabetes
722014|NCT01055080|beta-cell autoantibodies|beta-cell autoantibodies
722015|NCT01055080|cow's milk formula|cow's milk formula
722016|NCT01055080|bovine insulin|bovine insulin
722017|NCT01055093|diabetes mellitus|diabetes mellitus
722018|NCT01055093|prospective observational study|prospective observational study
722019|NCT01055093|diabetic complications|diabetic complications
722020|NCT01055106|bacterial vaginosis|bacterial vaginosis
722021|NCT01055106|vaginal infection|vaginal infection
722022|NCT01055106|vaginal discharge|vaginal discharge
722023|NCT01055106|vaginal disease|vaginal disease
722024|NCT01055145|Multidrug-resistant TB, sensitive to levofloxacin and moxifloxacin|multidrug-resistant tb, sensitive to levofloxacin and moxifloxacin
722026|NCT01055171|alcohol dependence|alcohol dependence
722027|NCT01055171|PTSD|ptsd
722028|NCT01055171|propanolol|propanolol
722029|NCT01055171|craving|craving
722031|NCT01055171|cue exposure|cue exposure
722032|NCT01055171|addiction|addiction
722033|NCT01055171|memory|memory
722034|NCT01055171|trauma|trauma
722035|NCT01055171|addictive behavior|addictive behavior
722036|NCT01055184|Influenza|influenza
722037|NCT01055184|H1N1|h1n1
722038|NCT01055197|extensive stage small cell lung cancer|extensive stage small cell lung cancer
722039|NCT01055210|Heart Failure|heart failure
722040|NCT01055210|Pacemakers|pacemakers
722041|NCT01055223|thiazolidinediones|thiazolidinediones
722042|NCT01055223|rosiglitazone|rosiglitazone
722043|NCT01055223|amiloride|amiloride
722044|NCT01055223|pioglitazone|pioglitazone
722045|NCT01055223|fracture|fracture
722046|NCT01055223|Spironolactone|spironolactone
722047|NCT01055236|sedation|sedation
722048|NCT01055249|UVB|uvb
722049|NCT01055249|pain|pain
722050|NCT01055249|inflammation|inflammation
722051|NCT01055249|model|model
722052|NCT01055249|healthy volunteers|healthy volunteers
722053|NCT01055249|Ultraviolet radiation (UVR) induced pain and inflammation in healthy volunteers|ultraviolet radiation (uvr) induced pain and inflammation in healthy volunteers
722055|NCT01055262|tolerability|tolerability
722056|NCT01055262|heatwrap|heatwrap
722057|NCT01055262|lower back|lower back
722058|NCT01055262|healthy subjects|healthy subjects
722059|NCT01055275|iliac aneurysm|iliac aneurysm
722060|NCT01055275|aortic aneurysm|aortic aneurysm
722061|NCT01055275|endovascular grafts|endovascular grafts
722062|NCT01055301|stage I multiple myeloma|stage i multiple myeloma
722063|NCT01055301|stage II multiple myeloma|stage ii multiple myeloma
722064|NCT01055301|stage III multiple myeloma|stage iii multiple myeloma
722065|NCT01055327|Isolated oral clefts|isolated oral clefts
722066|NCT01055327|lamotrigine|lamotrigine
722067|NCT01055327|EUROCAT|eurocat
722068|NCT01055327|congenital malformations|congenital malformations
722069|NCT01055327|anti-epileptic drugs|anti-epileptic drugs
722070|NCT01055340|Ketogenesis|ketogenesis
722071|NCT01055340|Glucose-Dependent Insulin Secretion|glucose-dependent insulin secretion
722072|NCT01055340|Graded Glucose Infusion|graded glucose infusion
722073|NCT01055340|Oxyntomodulin|oxyntomodulin
722074|NCT01055353|Target organs damage|target organs damage
722075|NCT01055353|hypertensive patients|hypertensive patients
722076|NCT01055366|Open angle glaucoma|open angle glaucoma
722077|NCT01055366|OAG|oag
722078|NCT01055366|Elazop|elazop
722079|NCT01055366|Azarga|azarga
722080|NCT01055366|Brinzolamide/Timolol combination|brinzolamide/timolol combination
722081|NCT01055379|Rasagiline|rasagiline
722082|NCT01055379|Depressive Symptoms|depressive symptoms
722084|NCT01055392|mild cognitive impairment|mild cognitive impairment
722085|NCT01055392|Alzheimer's disease|alzheimer's disease
722087|NCT01055392|disease-modification|disease-modification
722088|NCT01055392|cognition|cognition
722089|NCT01055392|early Alzheimer`s disease|early alzheimer`s disease
722090|NCT01055405|Exercise tolerance|exercise tolerance
722091|NCT01055405|COPD|copd
722092|NCT01055405|Pulmonary hypertension|pulmonary hypertension
722093|NCT01055405|Sildenafil|sildenafil
722094|NCT01055418|Vitamin C|vitamin c
722095|NCT01055418|Cognitive performance|cognitive performance
722096|NCT01055418|Cerebral blood flow|cerebral blood flow
722097|NCT01055418|Trans cranial doppler|trans cranial doppler
722098|NCT01055418|Near infrared spectroscopy|near infrared spectroscopy
722099|NCT01055431|iron|iron
722100|NCT01055431|bioavailability|bioavailability
722101|NCT01055431|status|status
722102|NCT01055431|deficiency|deficiency
722103|NCT01055431|anaemia|anaemia
722104|NCT01055431|functional foods|functional foods
722105|NCT01055431|child bearing|child bearing
722106|NCT01055483|Acute myeloid leukemia|acute myeloid leukemia
722107|NCT01055483|AML|aml
722108|NCT01055483|relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
722109|NCT01055483|refractory acute myeloid leukemia|refractory acute myeloid leukemia
722110|NCT01055496|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
722111|NCT01055509|Social Adjustment|social adjustment
722112|NCT01055509|Quality of life|quality of life
722113|NCT01055509|Recurrence|recurrence
722114|NCT01055509|Hospitalization|hospitalization
722115|NCT01055522|Interleukin, IL2, monoclonal, antibody, cytokine, Dacarbazine, metastatic, melanoma, tumor targeting, Dose definition|interleukin, il2, monoclonal, antibody, cytokine, dacarbazine, metastatic, melanoma, tumor targeting, dose definition
722116|NCT01055522|, L19|, l19
722117|NCT01055548|Preterm|preterm
722118|NCT01055548|Perinatal|perinatal
722119|NCT01055548|Ultrasound|ultrasound
722120|NCT01055548|Cerebral palsy|cerebral palsy
722121|NCT01055548|Anxiety|anxiety
722122|NCT01055548|Parents|parents
722123|NCT01055561|Acupuncture|acupuncture
722124|NCT01055561|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
722125|NCT01055561|BPSD|bpsd
722126|NCT01055561|MMSE|mmse
722127|NCT01055561|BEHAVE-AD|behave-ad
722128|NCT01055561|The Questionnaire of Acupuncture Events|the questionnaire of acupuncture events
722129|NCT01055561|healthy volunteers|healthy volunteers
722130|NCT01055574|lumbar disc arthroplasty|lumbar disc arthroplasty
722131|NCT01055574|total disc replacement|total disc replacement
722132|NCT01055574|ProDisc L|prodisc l
722133|NCT01055574|anterior lumbar interbody fusion|anterior lumbar interbody fusion
722134|NCT01055574|lumbar spine surgery outcomes|lumbar spine surgery outcomes
722135|NCT01055587|major abdominal surgery|major abdominal surgery
722136|NCT01055587|severe burn injury|severe burn injury
722137|NCT01055587|infection|infection
722138|NCT01055587|diagnostic|diagnostic
722139|NCT01055600|eltrombopag|eltrombopag
722140|NCT01055600|pharmacokinetics|pharmacokinetics
722141|NCT01055600|PROMACTA|promacta
722142|NCT01055600|lactation|lactation
722143|NCT01055600|milk-only study|milk-only study
722144|NCT01055626|Body mass index|body mass index
722145|NCT01055626|Body fat|body fat
722146|NCT01055626|Obesity|obesity
722147|NCT01055626|Overweight|overweight
722148|NCT01055626|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
722149|NCT01055626|Air displacement plethysmography|air displacement plethysmography
722150|NCT01055639|Chronic Pain|chronic pain
722151|NCT01055639|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
722152|NCT01055652|Type 2 diabetes mellitus|type 2 diabetes mellitus
722153|NCT01055652|Japanese|japanese
722156|NCT01055652|dapagliflozin|dapagliflozin
722157|NCT01055652|Pharmacokinetics|pharmacokinetics
722158|NCT01055652|Drug-drug Interaction|drug-drug interaction
722159|NCT01055652|voglibose|voglibose
722160|NCT01046019|DXA|dxa
722161|NCT01046019|Hip|hip
722162|NCT01046019|Arthroplasty|arthroplasty
722163|NCT01046032|Polycystic ovaries|polycystic ovaries
722164|NCT01046032|Ovarian stimulation|ovarian stimulation
722165|NCT01046032|IVF|ivf
722166|NCT01046032|Ovarian hyperstimulation|ovarian hyperstimulation
722167|NCT01046032|Metformin|metformin
722168|NCT01046045|mammalian target-of-rapamycin inhibitors|mammalian target-of-rapamycin inhibitors
722169|NCT01046045|chronic allograft dysfunction|chronic allograft dysfunction
722170|NCT01046045|everolimus|everolimus
722171|NCT01046045|calcineurin inhibitors|calcineurin inhibitors
722172|NCT01046058|TMC435-TiDP16-C113|tmc435-tidp16-c113
722173|NCT01046058|TMC435-C113|tmc435-c113
722174|NCT01046058|TMC435|tmc435
722175|NCT01046058|HCV|hcv
722176|NCT01046058|Protease Inhibitor|protease inhibitor
722177|NCT01046058|Hepatitis C|hepatitis c
722178|NCT01046071|Transversus abdominis plane block, postoperative pain.|transversus abdominis plane block, postoperative pain.
722179|NCT01046084|Bioequivalence|bioequivalence
722180|NCT01046084|Healthy Subjects|healthy subjects
722181|NCT01046097|Pneumococcal vaccine|pneumococcal vaccine
722182|NCT01046136|common cold|common cold
722183|NCT01046149|Depression|depression
722184|NCT01046149|Depressive Symptoms|depressive symptoms
722185|NCT01046149|postmenopause|postmenopause
722186|NCT01046149|RSA biofeedback|rsa biofeedback
722187|NCT01046162|Alprazolam|alprazolam
722188|NCT01046162|Tafil|tafil
722189|NCT01046162|Xanax|xanax
722190|NCT01046162|Bioequivalence|bioequivalence
722191|NCT01046162|Drug Kinetics|drug kinetics
722192|NCT01046175|Respiratory complications|respiratory complications
722193|NCT01046175|respiratory insufficiency|respiratory insufficiency
722194|NCT01046175|respiratory therapy|respiratory therapy
722195|NCT01046188|Education|education
722196|NCT01046188|Internet|internet
722197|NCT01046188|In vitro fertilization|in vitro fertilization
722198|NCT01046227|Serology|serology
722199|NCT01046227|Monovalent inactivated H1N1 vaccine|monovalent inactivated h1n1 vaccine
722200|NCT01046227|Pediatric haemato-oncology patients|pediatric haemato-oncology patients
722201|NCT01046240|chemotherapy|chemotherapy
722202|NCT01046240|emesis|emesis
722203|NCT01046240|palonosetron|palonosetron
722204|NCT01046253|Bioequivalence|bioequivalence
723991|NCT01058005|MS|ms
722205|NCT01046253|Healthy Subjects|healthy subjects
722206|NCT01046292|Gait, Ginkgo biloba, mild cognitive impairment|gait, ginkgo biloba, mild cognitive impairment
722207|NCT01046305|Chronic Myeloid Leukemia|chronic myeloid leukemia
722208|NCT01046305|CML|cml
722209|NCT01046305|Symptom Burden|symptom burden
722210|NCT01046305|M. D. Anderson Symptom Inventory|m. d. anderson symptom inventory
722211|NCT01046305|MDASI-CML|mdasi-cml
722212|NCT01046305|Severity|severity
722213|NCT01046305|Interference|interference
722214|NCT01046305|Questionnaire|questionnaire
722215|NCT01046305|Interview|interview
722216|NCT01046357|First in human|first in human
722217|NCT01046357|Safety|safety
722218|NCT01046383|NON-SMALL CELL LUNG CANCER PATIENTS|non-small cell lung cancer patients
722219|NCT01046383|WEIGHT LOSS|weight loss
722220|NCT01046383|QUALITY OF LIFE|quality of life
722221|NCT01046383|SURVIVAL|survival
722222|NCT01046383|CHEMOTHERAPY|chemotherapy
722223|NCT01046383|RADIOTHERAPY|radiotherapy
722224|NCT01046383|SURGERY|surgery
722225|NCT01046383|CYSTEINE-RICH WHEY PROTEIN ISOLATE|cysteine-rich whey protein isolate
722226|NCT01046383|IMN1207|imn1207
722227|NCT01046383|CANCER-RELATED WASTING (CACHEXIA)|cancer-related wasting (cachexia)
722228|NCT01046383|BODY WEIGHT|body weight
722229|NCT01046383|NUTRITIONAL PROTEIN SUPPLEMENT|nutritional protein supplement
722230|NCT01046409|Coronary artery disease|coronary artery disease
722231|NCT01046409|Bifurcation|bifurcation
722232|NCT01046409|Myocardial infarction|myocardial infarction
722233|NCT01046409|Myocardial ischemia|myocardial ischemia
722234|NCT01046409|Collateral|collateral
722235|NCT01046435|periodontitis|periodontitis
722236|NCT01046435|cardiovascular disease|cardiovascular disease
722237|NCT01046435|diabetes|diabetes
722238|NCT01046448|Children|children
722239|NCT01046448|chronic renal failure|chronic renal failure
722240|NCT01046448|chronic kidney disease|chronic kidney disease
722241|NCT01046448|cardiovascular disease|cardiovascular disease
722242|NCT01046448|cardiovascular morbidity|cardiovascular morbidity
722243|NCT01046448|left ventricular hypertrophy|left ventricular hypertrophy
722244|NCT01046448|carotid intima media thickness|carotid intima media thickness
722245|NCT01046448|arterial stiffness|arterial stiffness
722246|NCT01046448|pulse wave velocity|pulse wave velocity
722247|NCT01046448|augmentation index|augmentation index
722248|NCT01046448|left ventricular cardiac function|left ventricular cardiac function
722249|NCT01046448|progression|progression
722250|NCT01046448|genetic risk factors|genetic risk factors
722251|NCT01046448|vasculopathy|vasculopathy
722252|NCT01046448|cardiopathy|cardiopathy
722253|NCT01046448|whole genome analysis|whole genome analysis
722254|NCT01046448|haplotype analysis|haplotype analysis
722255|NCT01046448|SNP-screening|snp-screening
722256|NCT01046461|Ramosetron|ramosetron
722257|NCT01046461|aprepitant|aprepitant
722258|NCT01046461|dexamethasone|dexamethasone
722259|NCT01046461|cancer|cancer
722260|NCT01046461|chemotherapy|chemotherapy
722261|NCT01046461|antiemetics|antiemetics
722262|NCT01046461|cisplatin|cisplatin
722263|NCT01046461|nausea|nausea
722264|NCT01046461|vomiting|vomiting
722265|NCT01046461|high dose cisplatin|high dose cisplatin
722266|NCT01046474|school children|school children
722267|NCT01046474|body mass index|body mass index
722268|NCT01046474|sugar intake|sugar intake
722269|NCT01046474|beverage intake|beverage intake
722270|NCT01046487|dermatofibrosarcoma|dermatofibrosarcoma
722271|NCT01046487|cylindroma|cylindroma
722272|NCT01046487|choroid melanoma|choroid melanoma
722273|NCT01046487|gastrointestinal stroma tumor|gastrointestinal stroma tumor
722274|NCT01046487|chordoma|chordoma
722275|NCT01046487|ocular melanoma|ocular melanoma
722276|NCT01046487|conjunctival melanoma|conjunctival melanoma
722277|NCT01046487|malignant melanoma of the anus|malignant melanoma of the anus
722278|NCT01046487|gastric melanoma|gastric melanoma
722279|NCT01046487|desmoid tumor|desmoid tumor
722280|NCT01046500|insulin resistance|insulin resistance
722281|NCT01046500|body mass index|body mass index
722282|NCT01046500|myo-inositol|myo-inositol
722283|NCT01046500|serum triglycerides and cholesterol|serum triglycerides and cholesterol
722284|NCT01046500|blood pressure|blood pressure
722285|NCT01046500|metformin|metformin
722286|NCT01046513|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
722287|NCT01046513|Neuroimaging|neuroimaging
722288|NCT01046513|Positron Emission Tomography (PET)|positron emission tomography (pet)
722289|NCT01046513|Alpha4beta2|alpha4beta2
722290|NCT01046513|Nicotine|nicotine
722291|NCT01046513|Receptor Upregulation|receptor upregulation
722292|NCT01046526|Psychopathology|psychopathology
722293|NCT01046526|Nicotine Patch|nicotine patch
722294|NCT01046526|Eye Tracking|eye tracking
722295|NCT01046526|Attention|attention
722296|NCT01046526|Schizophrenic Participants|schizophrenic participants
722297|NCT01046552|Choledocholithias|choledocholithias
722298|NCT01046552|Common bile duct stones|common bile duct stones
722299|NCT01046552|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
722300|NCT01046552|endoscopic sphincterotomy|endoscopic sphincterotomy
722301|NCT01046552|Preoperative|preoperative
722302|NCT01046552|intraoperative|intraoperative
722303|NCT01046552|Laparoscopic common bile duct exploration|laparoscopic common bile duct exploration
722304|NCT01046578|Folliculogenesis|folliculogenesis
722305|NCT01046578|Letrozole|letrozole
722306|NCT01046578|Aromatase Inhibitor|aromatase inhibitor
722307|NCT01046578|Estrogen|estrogen
722308|NCT01046591|Cleft Palate|cleft palate
722309|NCT01046591|Cleft Lip|cleft lip
722310|NCT01046591|Obstructive Sleep Apnea|obstructive sleep apnea
722311|NCT01046591|Sleep-Disordered Breathing|sleep-disordered breathing
722312|NCT01046591|Behavior|behavior
722313|NCT01046591|Learning|learning
722314|NCT01046604|mitral valve regurgitation|mitral valve regurgitation
722315|NCT01046604|omega 3 fatty acids|omega 3 fatty acids
722316|NCT01046604|fish oil|fish oil
722318|NCT01046604|mitochondria|mitochondria
722319|NCT01046604|apoptosis|apoptosis
722320|NCT01046604|human heart|human heart
722321|NCT01046617|infantile colic|infantile colic
722322|NCT01046617|Lactobacillus reuteri|lactobacillus reuteri
722323|NCT01046617|duration of crying|duration of crying
722325|NCT01046630|BOLD signal|bold signal
722326|NCT01046630|fMRI|fmri
722327|NCT01046630|AZD6765|azd6765
722328|NCT01046630|BOLD signal measured by fMRI|bold signal measured by fmri
722329|NCT01046643|Women|women
722330|NCT01046643|Healthy|healthy
722331|NCT01046643|Menopausal|menopausal
722332|NCT01046643|Hormone treatment|hormone treatment
722333|NCT01046656|nosocomial infection|nosocomial infection
722334|NCT01046656|diarrhea|diarrhea
722534|NCT01047683|Vytorin|vytorin
722335|NCT01046656|Lactobacillus reuteri|lactobacillus reuteri
722336|NCT01046656|gastroenteritis|gastroenteritis
722337|NCT01046656|rotavirus|rotavirus
722339|NCT01046682|Endothelial dysfunction|endothelial dysfunction
722340|NCT01046682|Inflammation|inflammation
722341|NCT01046682|Insulin resistance|insulin resistance
722342|NCT01046695|VATS|vats
722343|NCT01046695|Video-Assisted Thoracotomy|video-assisted thoracotomy
722344|NCT01046695|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
722345|NCT01046708|IUI|iui
722346|NCT01046708|clomiphene citrate|clomiphene citrate
722347|NCT01046708|utrogestan|utrogestan
722348|NCT01046721|blood pressure|blood pressure
722349|NCT01046721|superior mesenteric artery blood flow|superior mesenteric artery blood flow
722350|NCT01046721|cardiovascular effects|cardiovascular effects
722351|NCT01046721|Exenatide|exenatide
722352|NCT01046734|Influenza|influenza
722353|NCT01046734|virus shedding|virus shedding
722354|NCT01046734|infection control|infection control
722355|NCT01046734|swine flu|swine flu
722356|NCT01046747|external fixation|external fixation
722357|NCT01046747|pin tract infection|pin tract infection
722358|NCT01046747|self drilling|self drilling
722359|NCT01046760|epilepsy|epilepsy
722360|NCT01046760|language|language
722361|NCT01046760|childhood|childhood
722362|NCT01046760|praxis|praxis
722363|NCT01046773|Children|children
722364|NCT01046773|Crohn's disease|crohn's disease
722365|NCT01046773|Vitamin D|vitamin d
722366|NCT01046786|spinal cord injury|spinal cord injury
722367|NCT01046786|cord blood mononuclear cell|cord blood mononuclear cell
722368|NCT01046786|Methylprednisolone|methylprednisolone
722369|NCT01046786|Lithium Carbonate|lithium carbonate
722370|NCT01046799|hepatitis B|hepatitis b
722371|NCT01046799|liver transplantation|liver transplantation
722372|NCT01046799|shortterm HBIg|shortterm hbig
722373|NCT01046799|lamivudine resistance|lamivudine resistance
722374|NCT01046812|questionnaire|questionnaire
722375|NCT01046812|halitosis|halitosis
722376|NCT01046812|caphosol|caphosol
722377|NCT01046812|Quality of life questionnaire assessing halitosis|quality of life questionnaire assessing halitosis
722378|NCT01046825|Lymphoma|lymphoma
722379|NCT01046825|Leukemia|leukemia
722380|NCT01046825|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
722381|NCT01046838|Diastolic Heart Failure|diastolic heart failure
722382|NCT01046864|Gastro-Intestinal Cancer, NOS|gastro-intestinal cancer, nos
722383|NCT01046890|Darunavir|darunavir
722384|NCT01046890|Echinacea purpurea|echinacea purpurea
722385|NCT01046890|Interaction|interaction
722386|NCT01046890|Complementary Therapies|complementary therapies
722387|NCT01046903|observational prolonged thromboprophylaxis|observational prolonged thromboprophylaxis
722388|NCT01046929|limonene|limonene
722389|NCT01046929|breast cancer|breast cancer
722390|NCT01046929|cancer prevention|cancer prevention
722391|NCT01046942|Saphenous vein|saphenous vein
722392|NCT01046942|Antiplatelet therapy|antiplatelet therapy
722393|NCT01046942|Hypercoagulable|hypercoagulable
722394|NCT01046942|Clopidogrel resistance|clopidogrel resistance
722395|NCT01046942|Aspirin resistance|aspirin resistance
722396|NCT01046942|Clopidogrel|clopidogrel
722397|NCT01046942|Aspirin|aspirin
722398|NCT01046942|Saphenous vein graft disease|saphenous vein graft disease
722400|NCT01046942|Thrombelastography|thrombelastography
722401|NCT01046942|Multiplate aggregometry|multiplate aggregometry
722402|NCT01046942|Multislice CT|multislice ct
722403|NCT01046942|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
722404|NCT01046942|coagulation status|coagulation status
722405|NCT01046942|graft patency|graft patency
722406|NCT01046942|CABG|cabg
722407|NCT01046955|ESRD|esrd
722408|NCT01046968|Obesity|obesity
722409|NCT01046968|metabolic syndrome|metabolic syndrome
722410|NCT01046968|C-reactive protein|c-reactive protein
722411|NCT01046968|Leptin|leptin
722412|NCT01046981|Surgical site infections|surgical site infections
722413|NCT01046981|Prevention|prevention
722414|NCT01046981|Prophylaxis|prophylaxis
722415|NCT01046981|Tumescent|tumescent
722416|NCT01046981|Intravenous|intravenous
722417|NCT01046981|Antibiotic|antibiotic
722418|NCT01046981|Absorption|absorption
722419|NCT01046981|Pharmacokinetics|pharmacokinetics
722420|NCT01046981|Bioavailability|bioavailability
722421|NCT01047007|Head and Neck Cancer|head and neck cancer
722422|NCT01047007|Esophageal Cancer|esophageal cancer
722423|NCT01047007|Gastric Cancer|gastric cancer
722424|NCT01047020|Impairments of musculoskeletal Health;|impairments of musculoskeletal health;
722425|NCT01047020|Physical activity;|physical activity;
722426|NCT01047020|Motor Proficiency;|motor proficiency;
722427|NCT01047033|Poverty|poverty
722428|NCT01047033|Global health|global health
722429|NCT01047033|International health|international health
722430|NCT01047033|Latin America|latin america
722431|NCT01047033|Peru|peru
722432|NCT01047033|Child health|child health
722433|NCT01047033|Microcredit|microcredit
722434|NCT01047033|Microenterprise|microenterprise
722435|NCT01047033|Microfinance|microfinance
722436|NCT01047046|SNM device|snm device
722532|NCT01047683|rosuvastatin|rosuvastatin
722533|NCT01047683|Trilipix|trilipix
722437|NCT01047046|Chart review of patients with surgical placed SNM device|chart review of patients with surgical placed snm device
722438|NCT01047059|NSCLC|nsclc
722439|NCT01047059|Lung Cancer|lung cancer
722440|NCT01047072|Scleroderma, systemic sclerosis, allogeneic hematopoietic stem cell transplantation|scleroderma, systemic sclerosis, allogeneic hematopoietic stem cell transplantation
722441|NCT01047085|cholecystolithiasis|cholecystolithiasis
722442|NCT01047085|cholecystectomy|cholecystectomy
722443|NCT01047085|gastroesophageal reflux|gastroesophageal reflux
722444|NCT01047085|impedance pH|impedance ph
722445|NCT01047085|The relationship between cholecystolithiasis, cholecystectomy and gastroesophageal reflux by impedance pH-method.|the relationship between cholecystolithiasis, cholecystectomy and gastroesophageal reflux by impedance ph-method.
722446|NCT01047098|Lactation|lactation
722447|NCT01047098|Breastfeeding|breastfeeding
722448|NCT01047098|Iron|iron
722449|NCT01047098|Oxidative stress|oxidative stress
722450|NCT01047098|Iron status and oxidative stress during lactation|iron status and oxidative stress during lactation
722451|NCT01047111|Esophageal Neoplasms|esophageal neoplasms
722452|NCT01047111|Esophagectomy|esophagectomy
722453|NCT01047124|Depression|depression
722454|NCT01047124|Collaborative Care|collaborative care
722455|NCT01047124|Cognitive Behaviour Therapy|cognitive behaviour therapy
722456|NCT01047124|Mental Health Services|mental health services
722457|NCT01047124|Antidepressants|antidepressants
722458|NCT01047137|Urticaria|urticaria
722459|NCT01047137|Hives|hives
722460|NCT01047137|Stress|stress
722461|NCT01047137|Immune dysregulation|immune dysregulation
722462|NCT01047150|Myocardial Perfusion Imaging|myocardial perfusion imaging
722463|NCT01047150|Repeat studies|repeat studies
722464|NCT01047150|Tetrofosmin|tetrofosmin
722465|NCT01047150|Sestamibi|sestamibi
722466|NCT01047163|Muscle soreness|muscle soreness
722467|NCT01047163|Simvastatin|simvastatin
722468|NCT01047163|Men|men
722469|NCT01047163|Muscle Atrophy|muscle atrophy
722470|NCT01047176|Statins|statins
722471|NCT01047176|Coronary Heart Disease|coronary heart disease
722472|NCT01047176|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
722473|NCT01047189|Mild to moderate acne vulgaris|mild to moderate acne vulgaris
722474|NCT01047527|nicotine replacement therapy, smoking cessation, transdermal nicotine|nicotine replacement therapy, smoking cessation, transdermal nicotine
722475|NCT01047553|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
722476|NCT01047553|COPD|copd
722477|NCT01047553|Japanese|japanese
722478|NCT01047553|Phase 3|phase 3
722479|NCT01047553|Safety|safety
722480|NCT01047553|OT|ot
722481|NCT01047553|Oxis|oxis
722482|NCT01047579|Alzheimer's Disease|alzheimer's disease
722483|NCT01047579|Rivastigmine transdermal|rivastigmine transdermal
722484|NCT01047579|caregiver preference|caregiver preference
722485|NCT01047592|Schizophrenia|schizophrenia
722486|NCT01047592|cognitive function|cognitive function
722487|NCT01047592|N-methyl-D-aspartate receptor|n-methyl-d-aspartate receptor
722488|NCT01047605|qEEG|qeeg
722489|NCT01047605|herbal medicine|herbal medicine
722490|NCT01047605|cognitive function|cognitive function
722491|NCT01047605|Neurapas balance|neurapas balance
722492|NCT01047605|Pascoflair|pascoflair
722493|NCT01047605|hypericum|hypericum
722494|NCT01047605|passionflower|passionflower
722495|NCT01047605|valerian|valerian
722496|NCT01047605|Healthy volunteers|healthy volunteers
722497|NCT01047605|Influence on quantitative electro-encephalogram (qEEG).|influence on quantitative electro-encephalogram (qeeg).
722498|NCT01047618|venous thromboembolism|venous thromboembolism
722499|NCT01047644|port|port
722500|NCT01047644|catheter|catheter
722501|NCT01047644|infusion|infusion
722502|NCT01047644|flush|flush
722503|NCT01047644|cleanse|cleanse
722504|NCT01047644|chemotherapy|chemotherapy
722505|NCT01047657|Asthma|asthma
722506|NCT01047657|Obesity|obesity
722507|NCT01047657|weight loss|weight loss
722508|NCT01047670|sepsis, shock, adrenal insufficiency, hydrocortisone, children, paediatric intensive care.|sepsis, shock, adrenal insufficiency, hydrocortisone, children, paediatric intensive care.
722509|NCT01047670|number of days free of vasoactive support in 7 days|number of days free of vasoactive support in 7 days
722510|NCT01047670|days free of mechanical ventilation|days free of mechanical ventilation
722511|NCT01047670|PICU mortality|picu mortality
722512|NCT01047670|mortality among patient with inappropriate response to the ACTH test|mortality among patient with inappropriate response to the acth test
722513|NCT01047670|baseline cortisol/ PIM2 correlation|baseline cortisol/ pim2 correlation
722514|NCT01047683|hypertriglyceridemia|hypertriglyceridemia
722515|NCT01047683|omega-3 fatty acids|omega-3 fatty acids
722516|NCT01047683|statin|statin
722517|NCT01047683|triglycerides|triglycerides
722518|NCT01047683|lipids|lipids
722520|NCT01047683|docosahexaenoic acid|docosahexaenoic acid
722521|NCT01047683|fish|fish
722522|NCT01047683|fatty acids|fatty acids
722523|NCT01047683|fibrates|fibrates
722524|NCT01047683|niacin|niacin
722525|NCT01047683|lipid|lipid
722526|NCT01047683|atorvastatin|atorvastatin
722527|NCT01047683|Lovaza|lovaza
722528|NCT01047683|simvastatin|simvastatin
722529|NCT01047683|lovastatin|lovastatin
722530|NCT01047683|pravastatin|pravastatin
722531|NCT01047683|fluvastatin|fluvastatin
722535|NCT01047683|Simcor|simcor
722536|NCT01047683|Niaspan|niaspan
722537|NCT01047683|ezetimibe|ezetimibe
722538|NCT01047683|Zetia|zetia
722539|NCT01047683|ethyl-EPA|ethyl-epa
722540|NCT01047683|ethyl icosapentate|ethyl icosapentate
722541|NCT01047683|Crestor|crestor
722542|NCT01047683|Zocor|zocor
722543|NCT01047683|Lipitor|lipitor
722544|NCT01047683|LDL|ldl
722545|NCT01047683|HDL|hdl
722546|NCT01047683|cholesterol|cholesterol
722547|NCT01047683|dyslipidemia|dyslipidemia
722548|NCT01047683|VASCEPA|vascepa
722549|NCT01047683|icosapent ethyl|icosapent ethyl
722550|NCT01047722|platelet function test|platelet function test
722551|NCT01047722|platelets|platelets
722552|NCT01047722|in vivo test|in vivo test
722553|NCT01047722|aspirin|aspirin
722554|NCT01047722|aspirin resistance|aspirin resistance
722555|NCT01047722|aspirin non-responsiveness|aspirin non-responsiveness
722556|NCT01047722|in-vivo|in-vivo
722655|NCT01047735|Malignant Neoplasms|malignant neoplasms
723741|NCT01056965|FTLD|ftld
722557|NCT01047722|To assess the specificity and sensitivity of a novel in-vivo diagnostic test of platelet function|to assess the specificity and sensitivity of a novel in-vivo diagnostic test of platelet function
722558|NCT01047722|"To use this test to define and assess aspirin resistance"|"to use this test to define and assess aspirin resistance"
722559|NCT01047735|21+ years old|21+ years old
722560|NCT01047735|Address|address
722561|NCT01047735|Adult|adult
722562|NCT01047735|Amputation|amputation
722563|NCT01047735|Area|area
722564|NCT01047735|Arm|arm
722565|NCT01047735|Atheroscleroses|atheroscleroses
722566|NCT01047735|Atherosclerosis|atherosclerosis
722567|NCT01047735|Atherosclerotic|atherosclerotic
722568|NCT01047735|Cardiovascular Disease|cardiovascular disease
722569|NCT01047735|Bariatrics|bariatrics
722570|NCT01047735|Behavior Conditioning Therapy|behavior conditioning therapy
722571|NCT01047735|Behavior Modification|behavior modification
722572|NCT01047735|Behavior Therapy|behavior therapy
722573|NCT01047735|Behavior Treatment|behavior treatment
722574|NCT01047735|Behavior or Life Style Modifications|behavior or life style modifications
722575|NCT01047735|Behavioral|behavioral
722576|NCT01047735|Behavioral Conditioning Therapy|behavioral conditioning therapy
722577|NCT01047735|Behavioral Modification|behavioral modification
722578|NCT01047735|Behavioral Therapy|behavioral therapy
722579|NCT01047735|Behavioral Treatment|behavioral treatment
722580|NCT01047735|Beta Cell|beta cell
722581|NCT01047735|Blindness|blindness
722582|NCT01047735|Blood Pressure, High|blood pressure, high
722583|NCT01047735|Blood Vessels|blood vessels
722584|NCT01047735|Body Composition|body composition
722585|NCT01047735|Body Weight decreased|body weight decreased
722586|NCT01047735|Cancers|cancers
722587|NCT01047735|Cardiac infarction|cardiac infarction
722588|NCT01047735|Cardiovascular Diseases|cardiovascular diseases
722589|NCT01047735|Care, Health|care, health
722590|NCT01047735|Cause of Death|cause of death
722591|NCT01047735|Cell Function|cell function
722592|NCT01047735|Cell Process|cell process
722593|NCT01047735|Cell physiology|cell physiology
722594|NCT01047735|Cellular Function|cellular function
722595|NCT01047735|Cellular Physiology|cellular physiology
722596|NCT01047735|Cellular Process|cellular process
722597|NCT01047735|Cessation of life|cessation of life
722598|NCT01047735|Clinical|clinical
722599|NCT01047735|Clinical Trials Design|clinical trials design
722600|NCT01047735|Communities|communities
722601|NCT01047735|Conditioning Therapy|conditioning therapy
722602|NCT01047735|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
722603|NCT01047735|Controlled Study|controlled study
722604|NCT01047735|Country|country
722605|NCT01047735|D-Glucose|d-glucose
722606|NCT01047735|Death|death
722607|NCT01047735|Decision Making|decision making
722608|NCT01047735|Dextrose|dextrose
722609|NCT01047735|Diabetes Mellitus|diabetes mellitus
722610|NCT01047735|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
722611|NCT01047735|Diabetes Mellitus, Ketosis-Resistant|diabetes mellitus, ketosis-resistant
722612|NCT01047735|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
722613|NCT01047735|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
722614|NCT01047735|Diabetes Mellitus, Slow-Onset|diabetes mellitus, slow-onset
722615|NCT01047735|Diabetes Mellitus, Stable|diabetes mellitus, stable
722616|NCT01047735|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
722617|NCT01047735|Diabetes Mellitus, Type II|diabetes mellitus, type ii
722618|NCT01047735|Diet|diet
722619|NCT01047735|Disease|disease
722620|NCT01047735|Disease remission|disease remission
722621|NCT01047735|Disorder|disorder
722622|NCT01047735|Drugs|drugs
722623|NCT01047735|Dysfunction|dysfunction
722624|NCT01047735|Effectiveness|effectiveness
722625|NCT01047735|Epidemic|epidemic
722626|NCT01047735|Functional disorder|functional disorder
722627|NCT01047735|Future|future
722628|NCT01047735|Gastric Bypass|gastric bypass
722629|NCT01047735|Glucose|glucose
722630|NCT01047735|Health|health
722631|NCT01047735|Healthcare|healthcare
722632|NCT01047735|Hepatic Disorder|hepatic disorder
722633|NCT01047735|Human, Adult|human, adult
722634|NCT01047735|Hypertension|hypertension
722635|NCT01047735|INFLM|inflm
722636|NCT01047735|Incidence|incidence
722637|NCT01047735|Inflammation|inflammation
722638|NCT01047735|Insulin Cell|insulin cell
722639|NCT01047735|Insulin Resistance|insulin resistance
722640|NCT01047735|Insulin Secreting Cell|insulin secreting cell
722641|NCT01047735|Intestinal|intestinal
722642|NCT01047735|Intestines|intestines
722643|NCT01047735|Intravenous Glucose Tolerance|intravenous glucose tolerance
722644|NCT01047735|Intravenous Glucose Tolerance Test|intravenous glucose tolerance test
722645|NCT01047735|Kidney Failure|kidney failure
722646|NCT01047735|Kidney Insufficiency|kidney insufficiency
722647|NCT01047735|Learning|learning
722648|NCT01047735|Life Style|life style
722649|NCT01047735|Life Style Modification|life style modification
722650|NCT01047735|Lifestyle|lifestyle
722651|NCT01047735|Link|link
722652|NCT01047735|Liver diseases|liver diseases
722653|NCT01047735|Longitudinal Studies|longitudinal studies
722654|NCT01047735|MODY|mody
722656|NCT01047735|Malignant Tumor|malignant tumor
722657|NCT01047735|Maturity-Onset Diabetes Mellitus|maturity-onset diabetes mellitus
722658|NCT01047735|Measures|measures
722659|NCT01047735|Medical|medical
722660|NCT01047735|Medication|medication
722661|NCT01047735|Metabolic|metabolic
722662|NCT01047735|Methods|methods
722663|NCT01047735|Modification|modification
722664|NCT01047735|Morbid Obesity|morbid obesity
722665|NCT01047735|Morbidity|morbidity
722666|NCT01047735|Morbidity - disease rate|morbidity - disease rate
722667|NCT01047735|Mortality|mortality
722668|NCT01047735|Mortality Vital Statistics|mortality vital statistics
722669|NCT01047735|Myocardial Infarct|myocardial infarct
722670|NCT01047735|Myocardial Infarction|myocardial infarction
722671|NCT01047735|NAFLD|nafld
722672|NCT01047735|NASH|nash
722673|NCT01047735|NIDDM|niddm
722674|NCT01047735|Non-Insulin Dependent Diabetes|non-insulin dependent diabetes
722675|NCT01047735|Non-Insulin-Dependent Diabetes Mellitus|non-insulin-dependent diabetes mellitus
722676|NCT01047735|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
722677|NCT01047735|Obesity|obesity
722678|NCT01047735|Obesity, Morbid|obesity, morbid
722679|NCT01047735|Operation|operation
722680|NCT01047735|Operative Procedures|operative procedures
722681|NCT01047735|Operative Surgical Procedures|operative surgical procedures
722682|NCT01047735|Outcome|outcome
722683|NCT01047735|Outcome Measure|outcome measure
722684|NCT01047735|PROV|prov
722685|NCT01047735|Participant|participant
722686|NCT01047735|Patients|patients
722687|NCT01047735|Pharmaceutic Preparations|pharmaceutic preparations
722688|NCT01047735|Pharmaceutical Preparations|pharmaceutical preparations
722689|NCT01047735|Physical activity|physical activity
722690|NCT01047735|Physiopathology|physiopathology
722691|NCT01047735|Pilot Projects|pilot projects
722692|NCT01047735|Population|population
722693|NCT01047735|Procedures|procedures
722694|NCT01047735|Programs (PT)|programs (pt)
722695|NCT01047735|Programs [Publication Type]|programs [publication type]
722696|NCT01047735|Provider|provider
722697|NCT01047735|Psychosocial Factor|psychosocial factor
722698|NCT01047735|Public Health|public health
722699|NCT01047735|RMSN|rmsn
722700|NCT01047735|Randomized|randomized
722701|NCT01047735|Randomized Controlled Clinical Trials|randomized controlled clinical trials
722702|NCT01047735|Randomized Controlled Trials|randomized controlled trials
722703|NCT01047735|Remission|remission
722704|NCT01047735|Renal Failure|renal failure
722705|NCT01047735|Renal Insufficiency|renal insufficiency
722706|NCT01047735|Reporting|reporting
722707|NCT01047735|Resolution|resolution
722708|NCT01047735|Science|science
722709|NCT01047735|Severe obesity|severe obesity
722710|NCT01047735|Structure|structure
722711|NCT01047735|Subcellular Process|subcellular process
722712|NCT01047735|Surgical|surgical
722713|NCT01047735|Surgical Interventions|surgical interventions
722714|NCT01047735|Surgical Procedure|surgical procedure
722715|NCT01047735|T2D|t2d
722716|NCT01047735|T2DM|t2dm
722717|NCT01047735|Testing|testing
722718|NCT01047735|Type 2 diabetes|type 2 diabetes
722719|NCT01047735|Type II diabetes|type ii diabetes
722720|NCT01047735|United States|united states
722721|NCT01047735|Upper arm|upper arm
722722|NCT01047735|Vascular Hypertensive Disease|vascular hypertensive disease
722723|NCT01047735|Vascular Hypertensive Disorder|vascular hypertensive disorder
722724|NCT01047735|Weight|weight
722725|NCT01047735|Weight Loss|weight loss
722726|NCT01047735|Weight Reduction|weight reduction
722727|NCT01047735|Work|work
722728|NCT01047735|adiposity|adiposity
722729|NCT01047735|adult human (21+)|adult human (21+)
722730|NCT01047735|adult onset diabetes|adult onset diabetes
722731|NCT01047735|atheromatosis|atheromatosis
722732|NCT01047735|atherosclerotic vascular disease|atherosclerotic vascular disease
722733|NCT01047735|bariatric surgery|bariatric surgery
722734|NCT01047735|behavior intervention|behavior intervention
722735|NCT01047735|behavioral intervention|behavioral intervention
722736|NCT01047735|blood glucose regulation|blood glucose regulation
722737|NCT01047735|body weight loss|body weight loss
722738|NCT01047735|bowel|bowel
722739|NCT01047735|cardiac infarct|cardiac infarct
722740|NCT01047735|cardiovascular disorder|cardiovascular disorder
722741|NCT01047735|cardiovascular risk|cardiovascular risk
722742|NCT01047735|cardiovascular risk factor|cardiovascular risk factor
722743|NCT01047735|clinical practice|clinical practice
722744|NCT01047735|comparative effectiveness|comparative effectiveness
722745|NCT01047735|coronary attack|coronary attack
722746|NCT01047735|coronary infarct|coronary infarct
722747|NCT01047735|coronary infarction|coronary infarction
722748|NCT01047735|corpulence|corpulence
722749|NCT01047735|corpulency|corpulency
722750|NCT01047735|corpulentia|corpulentia
722751|NCT01047735|design|design
722752|NCT01047735|designing|designing
722753|NCT01047735|diabetes|diabetes
722754|NCT01047735|diabetic patient|diabetic patient
722755|NCT01047735|disease/disorder|disease/disorder
722756|NCT01047735|drug/agent|drug/agent
722757|NCT01047735|effective therapy|effective therapy
723742|NCT01056965|FTD|ftd
722758|NCT01047735|effectiveness research|effectiveness research
722760|NCT01047735|gastric banding|gastric banding
722761|NCT01047735|gastric bypass surgery|gastric bypass surgery
722762|NCT01047735|glucose control|glucose control
722763|NCT01047735|glucose homeostasis|glucose homeostasis
722764|NCT01047735|glucose metabolism|glucose metabolism
722765|NCT01047735|glucose regulation|glucose regulation
722766|NCT01047735|heart attack|heart attack
722767|NCT01047735|heart infarct|heart infarct
722768|NCT01047735|heart infarction|heart infarction
722769|NCT01047735|hepatopathy|hepatopathy
722770|NCT01047735|hyperpiesia|hyperpiesia
722771|NCT01047735|hyperpiesis|hyperpiesis
722772|NCT01047735|hypertensive disease|hypertensive disease
722773|NCT01047735|implantable gastric stimulation banding|implantable gastric stimulation banding
722774|NCT01047735|insulin resistant|insulin resistant
722775|NCT01047735|interest|interest
722776|NCT01047735|ketosis resistant diabetes|ketosis resistant diabetes
722777|NCT01047735|life style intervention|life style intervention
722778|NCT01047735|lifestyle intervention|lifestyle intervention
722779|NCT01047735|liver disorder|liver disorder
722780|NCT01047735|long-term study|long-term study
722781|NCT01047735|malignancy|malignancy
722782|NCT01047735|maturity onset diabetes|maturity onset diabetes
722783|NCT01047735|moderate obesity|moderate obesity
722784|NCT01047735|neoplasm/cancer|neoplasm/cancer
722785|NCT01047735|non-alcohol fatty liver|non-alcohol fatty liver
722786|NCT01047735|non-alcohol induced steatohepatitis|non-alcohol induced steatohepatitis
722787|NCT01047735|non-alcoholic fatty liver|non-alcoholic fatty liver
722788|NCT01047735|non-alcoholic steato-hepatitis|non-alcoholic steato-hepatitis
722789|NCT01047735|nonalcohol fatty liver|nonalcohol fatty liver
722790|NCT01047735|nonalcoholic fatty liver|nonalcoholic fatty liver
722791|NCT01047735|nonalcoholic steato-hepatitis|nonalcoholic steato-hepatitis
722792|NCT01047735|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
722793|NCT01047735|obese|obese
722794|NCT01047735|obese people|obese people
722795|NCT01047735|obese person|obese person
722796|NCT01047735|obese population|obese population
722797|NCT01047735|obesity surgery|obesity surgery
722798|NCT01047735|obesity, extreme|obesity, extreme
722799|NCT01047735|pathophysiology|pathophysiology
722800|NCT01047735|pilot study|pilot study
722801|NCT01047735|programs|programs
722802|NCT01047735|psychosocial|psychosocial
722803|NCT01047735|psychosocial variables|psychosocial variables
722804|NCT01047735|public health medicine (field)|public health medicine (field)
722805|NCT01047735|public health relevance|public health relevance
722806|NCT01047735|randomisation|randomisation
722807|NCT01047735|randomization|randomization
722808|NCT01047735|randomized controlled study|randomized controlled study
722809|NCT01047735|randomized trial|randomized trial
722810|NCT01047735|randomly assigned|randomly assigned
722811|NCT01047735|respiratory|respiratory
722812|NCT01047735|response|response
722813|NCT01047735|stomach bypass|stomach bypass
722814|NCT01047735|stomach stapling|stomach stapling
722815|NCT01047735|surgery|surgery
722816|NCT01047735|trial comparing|trial comparing
722817|NCT01047735|vascular|vascular
722818|NCT01047735|weight loss intervention|weight loss intervention
722819|NCT01047735|weight loss surgery|weight loss surgery
722820|NCT01047735|wt-loss|wt-loss
722821|NCT01047748|abortion|abortion
722822|NCT01047761|Myasthenia Gravis|myasthenia gravis
722823|NCT01047761|Exercise|exercise
722824|NCT01047761|Fitness|fitness
722825|NCT01047761|Body Composition|body composition
722826|NCT01047761|Physical Activity|physical activity
722827|NCT01047761|Pulmonary Function|pulmonary function
722828|NCT01047761|Balance|balance
722829|NCT01047774|soy protein|soy protein
722830|NCT01047774|diet|diet
722831|NCT01047787|Sleep apnea|sleep apnea
722832|NCT01047787|Cheyne-Stokes Respiration|cheyne-stokes respiration
722833|NCT01047787|Congestive Heart Failure|congestive heart failure
722834|NCT01047800|Functional gastrointestinal disorder|functional gastrointestinal disorder
722835|NCT01047800|GERD|gerd
722836|NCT01047800|reflux|reflux
722837|NCT01047800|irritable bowel syndrome|irritable bowel syndrome
722838|NCT01047800|Functional dyspepsia|functional dyspepsia
722839|NCT01047800|postprandial fullness|postprandial fullness
722840|NCT01047800|counseling|counseling
722841|NCT01047800|service|service
722842|NCT01047813|Cognitive performance|cognitive performance
722843|NCT01047813|Type 2 diabetes|type 2 diabetes
722844|NCT01047813|Blood glucose|blood glucose
722845|NCT01047826|Fractured Tibia|fractured tibia
722846|NCT01047826|Expert Tibial Nail|expert tibial nail
722847|NCT01047826|Minimally Invasive Plate Osteosynthesis (M.I.P.O)|minimally invasive plate osteosynthesis (m.i.p.o)
722848|NCT01047826|Intramedullary Nailing|intramedullary nailing
722849|NCT01047826|Locked Plate|locked plate
722850|NCT01047826|distal third|distal third
722851|NCT01047826|43-A|43-a
722852|NCT01047839|Pediatric|pediatric
722853|NCT01047839|Japanese Encephalitis Vaccine|japanese encephalitis vaccine
722854|NCT01047839|non-endemic countries|non-endemic countries
722949|NCT01048294|Seasonal affective disorder|seasonal affective disorder
722855|NCT01047839|to assess immunogenicity of purified inactivated Japanese Encephalitis (JE) vaccine IC51|to assess immunogenicity of purified inactivated japanese encephalitis (je) vaccine ic51
722856|NCT01047852|chronic respiratory disorders|chronic respiratory disorders
722857|NCT01047852|hypercapnic respiratory failure|hypercapnic respiratory failure
722858|NCT01047852|noninvasive ventilation|noninvasive ventilation
722859|NCT01047865|Type 1 Diabetes (T1D)|type 1 diabetes (t1d)
722860|NCT01047865|Autoimmunity|autoimmunity
722861|NCT01047917|Meditation|meditation
722862|NCT01047917|Relaxation Therapy|relaxation therapy
722863|NCT01047917|Quality of Life|quality of life
722864|NCT01047930|Insomnia|insomnia
722865|NCT01047930|Smoking|smoking
722866|NCT01047930|Cue reactivity|cue reactivity
722867|NCT01047930|Exercise timing|exercise timing
722868|NCT01047930|Acute nicotine withdrawal|acute nicotine withdrawal
722869|NCT01047930|Mood disturbances|mood disturbances
722870|NCT01047930|Smoking abstinence|smoking abstinence
722871|NCT01047930|Exercise intensity|exercise intensity
722872|NCT01047930|Altered sleep|altered sleep
722873|NCT01047930|Exercise duration|exercise duration
722874|NCT01047930|Nonpharmacologic behavioral treatment|nonpharmacologic behavioral treatment
722875|NCT01047930|Smoking cessation|smoking cessation
722876|NCT01047930|Exercise Test|exercise test
722877|NCT01047930|Polysomnography|polysomnography
722878|NCT01047956|Methadone|methadone
722879|NCT01047956|NAC|nac
722880|NCT01047956|opioids|opioids
722976|NCT01048372|anti-CD4|anti-cd4
722881|NCT01047969|locally invasive high-risk rectal adenocarcinoma|locally invasive high-risk rectal adenocarcinoma
722882|NCT01047982|gestational diabetes|gestational diabetes
722883|NCT01047982|macrosomia|macrosomia
722884|NCT01047982|hypertension in pregnancy|hypertension in pregnancy
722885|NCT01047982|HOMA-IR|homa-ir
722886|NCT01047982|obesity|obesity
722887|NCT01048008|Glioblastoma multiforme|glioblastoma multiforme
722888|NCT01048008|Advanced cancers|advanced cancers
722889|NCT01048008|Brain Neoplasms, Malignant, Primary|brain neoplasms, malignant, primary
722890|NCT01048008|Brain Tumor, Recurrent|brain tumor, recurrent
722891|NCT01048008|Advanced cancer|advanced cancer
722892|NCT01048021|Measurement of lung mechanics (FEV1, FVC and PEF)|measurement of lung mechanics (fev1, fvc and pef)
723018|NCT01048554|Temodar|temodar
722893|NCT01048034|Myelodysplastic syndrome|myelodysplastic syndrome
722894|NCT01048034|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
722895|NCT01048034|Transfusion therapy|transfusion therapy
722896|NCT01048034|Transfusion dependency|transfusion dependency
722897|NCT01048034|Hypomethylating therapy|hypomethylating therapy
722898|NCT01048034|Azacitidine|azacitidine
722899|NCT01048034|DNA-methylation|dna-methylation
722900|NCT01048034|Epigenetic modifications|epigenetic modifications
722901|NCT01048047|aliskiren|aliskiren
722902|NCT01048047|amlodipine|amlodipine
722903|NCT01048047|hypertension|hypertension
722904|NCT01048047|ankle-foot volume|ankle-foot volume
722905|NCT01048047|mild and moderate hypertension|mild and moderate hypertension
722906|NCT01048073|lower respiratory tract infection|lower respiratory tract infection
722907|NCT01048073|non influenza|non influenza
722908|NCT01048073|PCR assay|pcr assay
722909|NCT01048086|neuroblastoma|neuroblastoma
722910|NCT01048086|neuroendocrine tumor|neuroendocrine tumor
722911|NCT01048086|NET|net
722912|NCT01048086|retinoic acid|retinoic acid
722913|NCT01048099|Breast Cancer|breast cancer
722914|NCT01048099|Metastatic|metastatic
722915|NCT01048099|PRO Onc Assay|pro onc assay
722916|NCT01048099|FISH Testing|fish testing
722917|NCT01048099|HER Negative|her negative
722918|NCT01048099|HER Overexpression|her overexpression
722919|NCT01048099|HER Activation|her activation
722920|NCT01048112|campylobacter|campylobacter
722921|NCT01048112|gastroenteritis|gastroenteritis
722922|NCT01048112|challenge models|challenge models
722923|NCT01048125|Stress-induced cardiomyopathy|stress-induced cardiomyopathy
722924|NCT01048125|Takotsubo cardiomyopathy|takotsubo cardiomyopathy
722925|NCT01048138|Biperiden|biperiden
722926|NCT01048138|Post-traumatic Epilepsy|post-traumatic epilepsy
722927|NCT01048138|Traumatic Brain Injury|traumatic brain injury
722928|NCT01048151|Prostate|prostate
722929|NCT01048151|TNFerade Biologic|tnferade biologic
722930|NCT01048164|Massage|massage
722931|NCT01048164|Relaxation|relaxation
722932|NCT01048177|vulvodynia|vulvodynia
722933|NCT01048177|interstitial cystitis|interstitial cystitis
722934|NCT01048177|pelvic pain|pelvic pain
722935|NCT01048190|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
722936|NCT01048190|Sabin Strains|sabin strains
722937|NCT01048190|poliomyelitis|poliomyelitis
722938|NCT01048203|14C ABR 215050 Metabolism and Mass Balance Study|14c abr 215050 metabolism and mass balance study
722939|NCT01048203|tasquinimod|tasquinimod
722940|NCT01048203|Metabolic pattern of 14C ABR-215050|metabolic pattern of 14c abr-215050
722941|NCT01048216|colorectal liver cancer|colorectal liver cancer
722942|NCT01048216|metastatic|metastatic
722943|NCT01048216|radiation therapy|radiation therapy
722944|NCT01048268|T1DM|t1dm
722945|NCT01048268|T2DM|t2dm
722946|NCT01048268|GIP|gip
722947|NCT01048268|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
722948|NCT01048268|Incretin|incretin
722950|NCT01048294|phototherapy|phototherapy
722951|NCT01048294|circadian rhythms|circadian rhythms
722952|NCT01048294|blue enriched light|blue enriched light
722953|NCT01048294|melanopsin|melanopsin
722954|NCT01048294|Primary disease: Seasonal Affective Disorder, winter type|primary disease: seasonal affective disorder, winter type
722955|NCT01048307|prontosan|prontosan
722956|NCT01048307|wound cleansing|wound cleansing
722957|NCT01048307|wound irrigation|wound irrigation
722958|NCT01048307|phmb|phmb
722959|NCT01048307|polihexanide|polihexanide
722960|NCT01048307|betaine|betaine
722961|NCT01048320|pancreatic cancer|pancreatic cancer
722962|NCT01048320|toxicity|toxicity
722963|NCT01048320|chemotherapy|chemotherapy
722964|NCT01048320|dose finding|dose finding
722965|NCT01048333|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
722966|NCT01048333|Onset of effect|onset of effect
722967|NCT01048333|COPD|copd
722968|NCT01048333|Oxis Turbuhaler|oxis turbuhaler
722969|NCT01048346|employment, disabilities|employment, disabilities
722970|NCT01048359|Drug abuse, injury, trauma, screening, brief intervention.|drug abuse, injury, trauma, screening, brief intervention.
722971|NCT01048372|HIV|hiv
722972|NCT01048372|monoclonal antibody|monoclonal antibody
722973|NCT01048372|immune therapy|immune therapy
722974|NCT01048372|pathogenesis|pathogenesis
722975|NCT01048372|cytotoxic T lymphocyte|cytotoxic t lymphocyte
722977|NCT01048372|anti-self|anti-self
722978|NCT01048372|viral replication|viral replication
722979|NCT01048372|Acute Infection|acute infection
722980|NCT01048385|Mitochondrial dysfunction|mitochondrial dysfunction
722981|NCT01048385|Mitochondrial nutrients|mitochondrial nutrients
722982|NCT01048385|Aneuploidy|aneuploidy
722983|NCT01048385|Meiotic Spindle|meiotic spindle
722984|NCT01048385|Coenzyme Q10|coenzyme q10
722985|NCT01048385|Electron transfer chain|electron transfer chain
722986|NCT01048398|ceophalic version|ceophalic version
722987|NCT01048398|breech presentation|breech presentation
722988|NCT01048398|pregnancy|pregnancy
722989|NCT01048398|remifentanil|remifentanil
722990|NCT01048398|paracetamol|paracetamol
722991|NCT01048411|stroke rehabilitation|stroke rehabilitation
722992|NCT01048411|outcome|outcome
722993|NCT01048411|barthel-index|barthel-index
722994|NCT01048411|geriatrics|geriatrics
722995|NCT01048411|elderly|elderly
722996|NCT01048424|Urinary incontinence|urinary incontinence
722997|NCT01048424|Paced respiration|paced respiration
722998|NCT01048450|arthritis|arthritis
722999|NCT01048450|degeneration|degeneration
723000|NCT01048463|gastric cancer|gastric cancer
723001|NCT01048463|colorectal cancer|colorectal cancer
723002|NCT01048463|chemotherapy|chemotherapy
723003|NCT01048463|eicosapentaenoic acid|eicosapentaenoic acid
723004|NCT01048463|enteral nutrition|enteral nutrition
723006|NCT01048502|healthy volunteer|healthy volunteer
723007|NCT01048515|Caffeine|caffeine
723008|NCT01048515|Physiological Effects of Drugs|physiological effects of drugs
723009|NCT01048515|Central Nervous System Agents|central nervous system agents
723010|NCT01048528|immune response to vaccines|immune response to vaccines
723011|NCT01048528|stress management|stress management
723012|NCT01048528|perceived risk for breast cancer|perceived risk for breast cancer
723013|NCT01048554|Melanoma|melanoma
723014|NCT01048554|Brain mets|brain mets
723015|NCT01048554|Bevacizumab|bevacizumab
723016|NCT01048554|Temozolomide|temozolomide
723017|NCT01048554|Avastin|avastin
723019|NCT01048554|Melanoma with brain mets|melanoma with brain mets
723020|NCT01048567|Antibiotics|antibiotics
723021|NCT01048567|Diarrhea|diarrhea
723022|NCT01048567|Clostridium difficile|clostridium difficile
723023|NCT01048567|Probiotics|probiotics
723024|NCT01048567|Prevention & control|prevention & control
723025|NCT01048580|Perifosine|perifosine
723026|NCT01048580|Capecitabine|capecitabine
723027|NCT01048580|Colon Cancer|colon cancer
723028|NCT01048593|ocular inflammation cataract surgery|ocular inflammation cataract surgery
723029|NCT01048593|post cataract surgery inflammation|post cataract surgery inflammation
723030|NCT01048606|Postmenopause|postmenopause
723031|NCT01048606|Overweight|overweight
723032|NCT01048606|Women|women
723033|NCT01048606|Phytoestrogens|phytoestrogens
723034|NCT01048606|Exercise|exercise
723035|NCT01048606|Cardiovascular Diseases|cardiovascular diseases
723036|NCT01048606|Risk Factors|risk factors
723037|NCT01048606|Aging|aging
723038|NCT01048619|Myelodysplastic Syndrome|myelodysplastic syndrome
723039|NCT01048619|MDS|mds
723040|NCT01048632|Neonates with HLHS or variant with plan to undergo Norwood Procedure|neonates with hlhs or variant with plan to undergo norwood procedure
723041|NCT01048645|All-trans retinoic acid|all-trans retinoic acid
723042|NCT01048645|non-small cell lung cancer|non-small cell lung cancer
723043|NCT01048645|retinoic acid receptor beta|retinoic acid receptor beta
723044|NCT01048645|chemotherapy|chemotherapy
723045|NCT01048658|Sevoflurane|sevoflurane
723046|NCT01048658|anesthesia|anesthesia
723047|NCT01048658|abortion|abortion
723048|NCT01048658|blood loss|blood loss
723049|NCT01048671|HIV|hiv
723050|NCT01048684|Brain tumor|brain tumor
723051|NCT01048684|Intracranial pressure|intracranial pressure
723052|NCT01048697|Obesity|obesity
723053|NCT01048697|Pharmacokinetics|pharmacokinetics
723054|NCT01048697|Pharmacodynamics|pharmacodynamics
723055|NCT01048697|Dose individualization|dose individualization
723056|NCT01048697|Tuberculosis|tuberculosis
723057|NCT01048710|Knee osteoarthritis|knee osteoarthritis
723058|NCT01048710|knee osteonecrosis|knee osteonecrosis
723059|NCT01048710|osteotomy|osteotomy
723060|NCT01048723|Soft Tissue|soft tissue
723061|NCT01048723|Retroperitoneal|retroperitoneal
723062|NCT01048723|resectable|resectable
723063|NCT01048736|obesity|obesity
723064|NCT01048736|exercise|exercise
723065|NCT01048736|intensity|intensity
723066|NCT01048736|weight loss|weight loss
723067|NCT01048736|diet|diet
723068|NCT01048749|Low back pain|low back pain
723069|NCT01048749|nerve root compression|nerve root compression
723070|NCT01048749|spinal height|spinal height
723071|NCT01048762|pulmonary cancer|pulmonary cancer
723072|NCT01048762|radically operated|radically operated
723073|NCT01048762|exercise training|exercise training
723074|NCT01048762|dyspnea counseling|dyspnea counseling
723075|NCT01048762|quality of life|quality of life
723076|NCT01048762|physical therapy|physical therapy
723077|NCT01048775|bispectral index|bispectral index
723078|NCT01048775|cardiac surgery|cardiac surgery
723079|NCT01048775|asymmetry|asymmetry
723080|NCT01048788|Cirrhosis|cirrhosis
723081|NCT01048788|ascites|ascites
723082|NCT01048788|Tolvaptan|tolvaptan
723083|NCT01048788|OPC-41061|opc-41061
723084|NCT01048801|History of fever|history of fever
723085|NCT01048801|measured fever|measured fever
723086|NCT01048827|AML|aml
723087|NCT01048827|autologous transplant|autologous transplant
723088|NCT01048840|Gastroesophageal Reflux|gastroesophageal reflux
723089|NCT01048853|Cervix|cervix
723090|NCT01048853|Stage IA2 or IB1 Carcinoma|stage ia2 or ib1 carcinoma
723091|NCT01048853|Conservative Surgery|conservative surgery
723092|NCT01048853|Cervix Cancer recurrence|cervix cancer recurrence
723093|NCT01048853|Quality of Life Factors|quality of life factors
723094|NCT01048853|Pelvic lymph nodes|pelvic lymph nodes
723095|NCT01048853|Pelvic Lymphadenectomy|pelvic lymphadenectomy
723096|NCT01048853|parametrium|parametrium
723097|NCT01048853|Cervical cone biopsy|cervical cone biopsy
723098|NCT01048853|Endocervical curettage|endocervical curettage
723099|NCT01048853|ECC|ecc
723100|NCT01048879|oseltamivir|oseltamivir
723101|NCT01048879|influenza|influenza
723102|NCT01048879|continuous renal replacement therapy|continuous renal replacement therapy
723103|NCT01048879|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
723104|NCT01048879|pharmacokinetics|pharmacokinetics
723105|NCT01048892|recurrent neuroblastoma|recurrent neuroblastoma
723106|NCT01048892|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
723107|NCT01048892|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
723108|NCT01048892|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
723109|NCT01048892|recurrent retinoblastoma|recurrent retinoblastoma
723110|NCT01048892|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
723111|NCT01048892|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
723112|NCT01048905|Pulmonary Hypertension|pulmonary hypertension
723113|NCT01048905|Sickle Cell Disease|sickle cell disease
723114|NCT01048905|Thalassemia|thalassemia
723115|NCT01048918|Circulating tumor cells in breast cancer|circulating tumor cells in breast cancer
723116|NCT01048931|Single-port, laparoscopic-assisted, vaginal hysterectomy|single-port, laparoscopic-assisted, vaginal hysterectomy
723117|NCT01048944|Electroencephalography|electroencephalography
723118|NCT01048944|nicotine|nicotine
723119|NCT01048944|bupropion|bupropion
723120|NCT01048944|attention|attention
723121|NCT01048944|drug withdrawal symptoms|drug withdrawal symptoms
723122|NCT01048957|Nicotine|nicotine
723123|NCT01048957|Craving|craving
723124|NCT01048957|fMRI|fmri
723125|NCT01048957|EEG|eeg
723126|NCT01048957|Real Time fMRI Feedback|real time fmri feedback
723127|NCT01048970|Lung cancer|lung cancer
723128|NCT01048970|Eicosapentaenoic acid oral supplementation|eicosapentaenoic acid oral supplementation
723129|NCT01048970|Weight loss|weight loss
723130|NCT01048970|Toxicity|toxicity
723131|NCT01048970|Body composition|body composition
723132|NCT01048970|Inflammatory response|inflammatory response
723133|NCT01048983|Lung Cancer|lung cancer
723134|NCT01048983|NSCLC|nsclc
723135|NCT01048983|Concurrent Chemoradiation Therapy|concurrent chemoradiation therapy
723136|NCT01048983|Side Effects|side effects
723137|NCT01048983|Armodafinil|armodafinil
723138|NCT01048983|Nuvigil|nuvigil
723139|NCT01048983|Bupropion|bupropion
723140|NCT01048983|Wellbutrin|wellbutrin
723141|NCT01048983|Wellbutrin SR|wellbutrin sr
723142|NCT01048983|Zyban|zyban
723143|NCT01048983|Curcumin|curcumin
723144|NCT01048983|Minocycline|minocycline
723145|NCT01048983|Dynacin|dynacin
723146|NCT01048983|Minocin|minocin
723147|NCT01048983|Minocin PAC|minocin pac
723148|NCT01048983|Myrac|myrac
723149|NCT01048983|Solodyn|solodyn
723150|NCT01048996|Acute Lung Injury|acute lung injury
723151|NCT01048996|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
723152|NCT01048996|Genetic Variability|genetic variability
723153|NCT01048996|Plasma Biomarkers|plasma biomarkers
723154|NCT01048996|Pediatrics|pediatrics
723155|NCT01049009|Nitric Oxide|nitric oxide
723156|NCT01049009|Adrenergic beta-Antagonists|adrenergic beta-antagonists
723157|NCT01049009|Antihypertensive Agents|antihypertensive agents
723158|NCT01049009|Vasodilator Agents|vasodilator agents
723159|NCT01049009|Anti-Arrhythmia Agents|anti-arrhythmia agents
723160|NCT01049009|Sympatholytics|sympatholytics
723161|NCT01049009|Vascular Resistance|vascular resistance
723162|NCT01049009|Neurotransmitter Agents|neurotransmitter agents
723163|NCT01049009|Cardiovascular Diseases|cardiovascular diseases
723164|NCT01049009|Metoprolol succinate|metoprolol succinate
723165|NCT01049009|Therapeutic Uses|therapeutic uses
723166|NCT01049009|Metoprolol|metoprolol
723167|NCT01049009|Vascular Diseases|vascular diseases
723168|NCT01049009|Nebivolol|nebivolol
723169|NCT01049009|Cardiovascular Agents|cardiovascular agents
723170|NCT01049009|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors
723171|NCT01049022|Pharmacokinetics|pharmacokinetics
723172|NCT01049035|Meningitis|meningitis
723173|NCT01049035|Meningococcal Infection|meningococcal infection
723174|NCT01049035|Neisseria meningitidis|neisseria meningitidis
723175|NCT01049035|Tetravalent Meningococcal Vaccine|tetravalent meningococcal vaccine
723176|NCT01049048|Endothelial Function|endothelial function
723177|NCT01049048|Arterial stiffness|arterial stiffness
723178|NCT01049048|Vitamin D|vitamin d
723179|NCT01049061|Cancer|cancer
723180|NCT01049061|FRα|frα
723181|NCT01049074|Low Back Pain|low back pain
723182|NCT01049074|Acupuncture|acupuncture
723183|NCT01049074|RCT|rct
723184|NCT01049087|plasma volume|plasma volume
723185|NCT01049087|technetium-labeled albumin|technetium-labeled albumin
723186|NCT01049087|radioiodine-labeled albumin|radioiodine-labeled albumin
723187|NCT01049087|Healthy volunteers|healthy volunteers
723188|NCT01049100|Surgical Staging|surgical staging
723189|NCT01049100|Cervical Cancer|cervical cancer
723190|NCT01049100|Chemoradiation|chemoradiation
723191|NCT01049100|Outcome|outcome
723192|NCT01049100|Toxicity|toxicity
723193|NCT01049113|Lymphoma|lymphoma
723194|NCT01049113|B-cell Acute Lymphocytic Leukemia|b-cell acute lymphocytic leukemia
723195|NCT01049113|ALL|all
723196|NCT01049126|Late Stage|late stage
723197|NCT01049139|vaccination|vaccination
723198|NCT01049139|HIV prevention|hiv prevention
723199|NCT01049139|YMSM|ymsm
723200|NCT01049139|youth|youth
723201|NCT01049139|HIV Preventative Vaccine|hiv preventative vaccine
723202|NCT01049152|Diabetes mellitus|diabetes mellitus
723203|NCT01049152|ESRD|esrd
723204|NCT01049152|CGM|cgm
723205|NCT01049152|Inflammation markers|inflammation markers
723206|NCT01049152|Hemodialysis|hemodialysis
723207|NCT01049152|Diabetic patients|diabetic patients
723208|NCT01049152|Nondiabetic patients|nondiabetic patients
723209|NCT01049152|All with ESRD|all with esrd
723210|NCT01049152|All undergone hemodialysis|all undergone hemodialysis
723211|NCT01049178|antioxidant enzymes|antioxidant enzymes
723212|NCT01049178|asthma|asthma
723213|NCT01049178|silymarin|silymarin
723214|NCT01049178|RCT|rct
723215|NCT01049191|Osteoporosis|osteoporosis
723216|NCT01049191|Fracture|fracture
723217|NCT01049191|microMRI|micromri
723218|NCT01049191|Bone architecture|bone architecture
723219|NCT01049191|Bone matrix|bone matrix
723220|NCT01049191|Bone and Bones|bone and bones
723221|NCT01049191|Magnetic Resonance Imaging|magnetic resonance imaging
723222|NCT01049204|HIV|hiv
723223|NCT01049204|HIV-1 Infections|hiv-1 infections
723224|NCT01049217|neuropathy|neuropathy
723225|NCT01049217|pain|pain
723226|NCT01049217|HIV-1|hiv-1
723227|NCT01049217|HIV Infections|hiv infections
723228|NCT01049230|proton beam radiation|proton beam radiation
723229|NCT01049230|CNS germ cell tumor|cns germ cell tumor
723230|NCT01049243|Atopic Dermatitis|atopic dermatitis
723231|NCT01049243|Open-Label|open-label
723232|NCT01049243|Topical|topical
723233|NCT01049243|Cream|cream
723234|NCT01049243|Eczema|eczema
723235|NCT01049243|Vanos|vanos
723236|NCT01049256|Periodic breathing|periodic breathing
723237|NCT01049256|Heart Failure|heart failure
723238|NCT01049256|Chemoreflex|chemoreflex
723239|NCT01049256|Chemosensitivity|chemosensitivity
723240|NCT01049269|Body Scanning|body scanning
723241|NCT01049269|Body Fat|body fat
723242|NCT01049269|Body Volume|body volume
723243|NCT01049269|Obesity|obesity
723244|NCT01049269|No Conditions|no conditions
723245|NCT01049282|safety|safety
723246|NCT01049282|immunogenicity|immunogenicity
723247|NCT01049282|adjuvanted TB subunit vaccine|adjuvanted tb subunit vaccine
723248|NCT01049295|taxanes|taxanes
723249|NCT01049295|breast cancer|breast cancer
723250|NCT01049295|n3 fatty acids|n3 fatty acids
723251|NCT01049295|inflammation|inflammation
723252|NCT01049308|heart failure|heart failure
723253|NCT01049308|cognitive disorders|cognitive disorders
723254|NCT01049308|medication adherence|medication adherence
723255|NCT01049308|patient readmissions|patient readmissions
723350|NCT01049633|Hypoglycemia unawareness|hypoglycemia unawareness
723256|NCT01049321|Dietary Approach to Stop Hypertension|dietary approach to stop hypertension
723257|NCT01049321|weight|weight
723258|NCT01049321|coagulation|coagulation
723259|NCT01049321|DASH eating pattern.|dash eating pattern.
723260|NCT01049347|depression|depression
723261|NCT01049360|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
723262|NCT01049360|COPD|copd
723263|NCT01049360|Chronic Bronchitis|chronic bronchitis
723264|NCT01049360|Emphysema|emphysema
723265|NCT01049360|Airflow Obstruction, Chronic|airflow obstruction, chronic
723266|NCT01049360|Chronic Airflow Obstruction|chronic airflow obstruction
723267|NCT01049360|Chronic Obstructive Airway Disease|chronic obstructive airway disease
723268|NCT01049360|Chronic Obstructive Lung Disease|chronic obstructive lung disease
723269|NCT01049373|low-back|low-back
723270|NCT01049373|pain|pain
723271|NCT01049373|chronic|chronic
723272|NCT01049373|constitution|constitution
723273|NCT01049373|diathesism|diathesism
723274|NCT01049373|homoeopathy|homoeopathy
723275|NCT01049373|fixed combination|fixed combination
723276|NCT01049373|herbal preparation|herbal preparation
723277|NCT01049373|chronic low back pain lasting more than 6 months|chronic low back pain lasting more than 6 months
723278|NCT01049386|intestinal permeability|intestinal permeability
723280|NCT01049386|sugar absorption|sugar absorption
723376|NCT01049724|refractive surgery|refractive surgery
723281|NCT01049386|intestinal permeability examined in different men (lean vs obese) and different conditions (no breakfast and high-fat breakfast)|intestinal permeability examined in different men (lean vs obese) and different conditions (no breakfast and high-fat breakfast)
723282|NCT01049425|anthracycline-free|anthracycline-free
723283|NCT01049425|OncotypDX|oncotypdx
723284|NCT01049425|taxane|taxane
723285|NCT01049425|Her2 negative breast cancer|her2 negative breast cancer
723286|NCT01049438|MRSA|mrsa
723287|NCT01049438|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
723288|NCT01049438|Staphylococcus aureus|staphylococcus aureus
723289|NCT01049438|Skin Infections|skin infections
723290|NCT01049438|Body Decolonization|body decolonization
723291|NCT01049451|Multiple Sclerosis|multiple sclerosis
723292|NCT01049451|ACTH|acth
723293|NCT01049451|Steroids|steroids
723294|NCT01049464|Atrial fibrillation|atrial fibrillation
723295|NCT01049464|Hemodynamically unstable patients|hemodynamically unstable patients
723296|NCT01049464|Magnesium sulfate|magnesium sulfate
723297|NCT01049464|Septic shock|septic shock
723298|NCT01049464|Medical intensive care unit|medical intensive care unit
723299|NCT01049464|New onset atrial fibrillation|new onset atrial fibrillation
723300|NCT01049464|Critically ill patients|critically ill patients
723301|NCT01049477|Pregnancy|pregnancy
723302|NCT01049477|Cesarean Section|cesarean section
723303|NCT01049490|Intradermal vaccination, H1N1, microneedle|intradermal vaccination, h1n1, microneedle
723304|NCT01049503|Dentifrices|dentifrices
723305|NCT01049503|Fluoride|fluoride
723306|NCT01049503|Nails|nails
723307|NCT01049503|Plaque|plaque
723308|NCT01049516|Military|military
723309|NCT01049516|Combat|combat
723310|NCT01049516|Psychological Treatment|psychological treatment
723311|NCT01049516|Psychotherapy|psychotherapy
723312|NCT01049516|Trauma|trauma
723313|NCT01049516|Posttraumatic Stress|posttraumatic stress
723314|NCT01049516|Posttraumatic Stress Disorder|posttraumatic stress disorder
723315|NCT01049516|PTSD|ptsd
723316|NCT01049516|Prolonged Exposure|prolonged exposure
723317|NCT01049516|Exposure therapy|exposure therapy
723318|NCT01049516|Behavior Therapy|behavior therapy
723319|NCT01049516|Cognitive Behavior Therapy|cognitive behavior therapy
723320|NCT01049516|Post-Traumatic Stress Disorders|post-traumatic stress disorders
723321|NCT01049516|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
723322|NCT01049529|Docosahexaenoic acid|docosahexaenoic acid
723323|NCT01049529|n-3 Long Chain Polyunsaturated Fatty Acids|n-3 long chain polyunsaturated fatty acids
723324|NCT01049529|omega 3 fatty acids|omega 3 fatty acids
723325|NCT01049529|neonates|neonates
723326|NCT01049529|clinical outcomes|clinical outcomes
723327|NCT01049529|critically ill patients|critically ill patients
723328|NCT01049529|Inflammatory and antiinflammatory cytokines|inflammatory and antiinflammatory cytokines
723329|NCT01049529|Length of intensive care stay|length of intensive care stay
723330|NCT01049542|Astressin 2B|astressin 2b
723331|NCT01049542|Forearm blood flow|forearm blood flow
723332|NCT01049542|vascular|vascular
723333|NCT01049542|plethysmography|plethysmography
723334|NCT01049542|heart failure|heart failure
723335|NCT01049555|alzheimer|alzheimer
723336|NCT01049555|apathy|apathy
723337|NCT01049555|actigraphy|actigraphy
723338|NCT01049568|HIV|hiv
723339|NCT01049568|Cell phone|cell phone
723340|NCT01049568|HAART|haart
723341|NCT01049581|Gross motor function performance|gross motor function performance
723342|NCT01049581|pediatric aquatic therapy|pediatric aquatic therapy
723343|NCT01049581|spastic cerebral palsy|spastic cerebral palsy
723344|NCT01049607|Patients undergoing hepatic resection|patients undergoing hepatic resection
723345|NCT01049620|XELOX|xelox
723346|NCT01049620|RAD001|rad001
723347|NCT01049620|phase 1|phase 1
723348|NCT01049633|Insulin dependence|insulin dependence
723349|NCT01049633|Hypoglycemia|hypoglycemia
723351|NCT01049633|Islet transplantation|islet transplantation
723352|NCT01049646|renin-angiotensin system|renin-angiotensin system
723353|NCT01049646|apelin|apelin
723354|NCT01049646|systemic haemodynamics|systemic haemodynamics
723355|NCT01049659|pregnancy|pregnancy
723356|NCT01049659|iodine deficiency|iodine deficiency
723357|NCT01049659|neuropsychological development|neuropsychological development
723358|NCT01049685|HIV|hiv
723359|NCT01049685|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
723360|NCT01049685|Efavirenz|efavirenz
723361|NCT01049685|Lopinavir|lopinavir
723362|NCT01049685|Comparative Effectiveness Research|comparative effectiveness research
723363|NCT01049685|Treatment Naive|treatment naive
723364|NCT01049698|Obesity|obesity
723365|NCT01049698|Overweight|overweight
723366|NCT01049698|Older adults|older adults
723367|NCT01049698|resistance training|resistance training
723368|NCT01049698|exercise|exercise
723369|NCT01049711|erythropoietin|erythropoietin
723370|NCT01049711|hemodialysis|hemodialysis
723371|NCT01049711|cost utility|cost utility
723372|NCT01049711|incremental cost-effectiveness ratio|incremental cost-effectiveness ratio
723373|NCT01049711|Quality adjusted life year|quality adjusted life year
723374|NCT01049711|quality of life|quality of life
723375|NCT01049724|Myopia|myopia
723377|NCT01049724|LASIK|lasik
723378|NCT01049724|PRK|prk
723379|NCT01049724|Lacritin|lacritin
723380|NCT01049724|Heparanase|heparanase
723381|NCT01049750|type 2 diabetes mellitus|type 2 diabetes mellitus
723382|NCT01049750|male|male
723383|NCT01049750|erectile dysfunction|erectile dysfunction
723384|NCT01049763|obese adult|obese adult
723385|NCT01049763|non obese healthy volunteers|non obese healthy volunteers
723386|NCT01049763|oseltamivir carboxylate|oseltamivir carboxylate
723387|NCT01049763|pharmacokinetics|pharmacokinetics
723388|NCT01049763|healthy volunteers|healthy volunteers
723389|NCT01049776|Lung Cancer Non Small Cell|lung cancer non small cell
723390|NCT01049789|youth|youth
723391|NCT01049789|HIV|hiv
723392|NCT01049789|Depression|depression
723393|NCT01049789|Cognitive Behavioral Therapy|cognitive behavioral therapy
723394|NCT01049789|Medication management|medication management
723395|NCT01049802|stroke|stroke
723396|NCT01049802|hemiplegia|hemiplegia
723397|NCT01049802|TMS|tms
723398|NCT01049815|hemodialysis|hemodialysis
723399|NCT01049815|intimal media thickness|intimal media thickness
723400|NCT01049828|Tinnitus|tinnitus
723401|NCT01049828|fcMRI|fcmri
723402|NCT01049828|Neural Connectivity|neural connectivity
723403|NCT01049828|Bother|bother
723404|NCT01049841|pediatric|pediatric
723405|NCT01049841|children|children
723406|NCT01049841|perifosine|perifosine
723407|NCT01049841|temsirolimus|temsirolimus
723408|NCT01049841|recurrent|recurrent
723409|NCT01049841|progressive|progressive
723410|NCT01049841|09-124|09-124
723411|NCT01049854|unrelated donor transplant|unrelated donor transplant
723412|NCT01049854|CD34 selection|cd34 selection
723413|NCT01049880|Ascorbic Acid|ascorbic acid
723414|NCT01049880|Gemcitabine|gemcitabine
723415|NCT01049906|foot surgery|foot surgery
723416|NCT01049906|ankle surgery|ankle surgery
723417|NCT01049906|Patients scheduled for foot and ankle surgery|patients scheduled for foot and ankle surgery
723418|NCT01049919|Critical Limb Ischemia|critical limb ischemia
723419|NCT01049919|Peripheral Arterial Disease|peripheral arterial disease
723420|NCT01049919|Peripheral Vascular Disease|peripheral vascular disease
723421|NCT01049919|CLI|cli
723422|NCT01049919|PAD|pad
723423|NCT01049919|PVD|pvd
723424|NCT01049919|Angiogenesis|angiogenesis
723425|NCT01049919|Stem Cells|stem cells
723426|NCT01049919|Cell Therapy|cell therapy
723427|NCT01049919|Limb Salvage|limb salvage
723428|NCT01049919|Amputation|amputation
723429|NCT01049919|Leg Pain|leg pain
723430|NCT01049932|HIV|hiv
723431|NCT01049932|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
723432|NCT01049932|HIV Seronegativity|hiv seronegativity
723433|NCT01049958|asynchrony|asynchrony
723434|NCT01049958|mechanical ventilation|mechanical ventilation
723435|NCT01049958|blunt trauma|blunt trauma
723436|NCT01049971|colorectal surgery|colorectal surgery
723437|NCT01049971|wound infection|wound infection
723438|NCT01049971|wound protector|wound protector
723439|NCT01049971|laparoscopy|laparoscopy
723440|NCT01049971|surgical site infection after laparoscopic colorectal surgery with minilaparotomy|surgical site infection after laparoscopic colorectal surgery with minilaparotomy
723441|NCT01055678|breast cancer|breast cancer
723442|NCT01055678|ductal breast carcinoma in situ|ductal breast carcinoma in situ
723443|NCT01055678|breast cancer in situ|breast cancer in situ
723444|NCT01055678|invasive carcinoma|invasive carcinoma
723445|NCT01055678|invasive ductal carcinoma|invasive ductal carcinoma
723446|NCT01055678|invasive lobular carcinoma|invasive lobular carcinoma
723447|NCT01055691|healthy volunteers|healthy volunteers
723448|NCT01055691|bioequivalence|bioequivalence
723449|NCT01055691|dapagliflozin|dapagliflozin
723450|NCT01055691|metformin|metformin
723451|NCT01055704|Methylnaltrexone|methylnaltrexone
723452|NCT01055704|Codeine|codeine
723453|NCT01055704|Gastrointestinal motility|gastrointestinal motility
723454|NCT01055704|Colonic transit|colonic transit
723455|NCT01055717|avenanthramide|avenanthramide
723456|NCT01055717|enriched|enriched
723458|NCT01055717|phytochemical|phytochemical
723459|NCT01055717|bioavailability|bioavailability
723460|NCT01055730|Pulmonary rehabilitation|pulmonary rehabilitation
723461|NCT01055730|Exercise therapy|exercise therapy
723462|NCT01055730|Interstitial lung disease|interstitial lung disease
723463|NCT01055730|Pulmonary fibrosis|pulmonary fibrosis
723464|NCT01055730|Mobility limitation|mobility limitation
723465|NCT01055730|Dyspnea|dyspnea
723466|NCT01055730|Mental health|mental health
723467|NCT01055743|Fluorouracil Implants|fluorouracil implants
723468|NCT01055743|Hepatocellular carcinoma|hepatocellular carcinoma
723469|NCT01055743|Radical resection|radical resection
723470|NCT01055756|Reduction of signs and symptoms and enhanced nasal flow|reduction of signs and symptoms and enhanced nasal flow
723471|NCT01055756|Nasal Flow|nasal flow
723472|NCT01055769|Bio-equivalence|bio-equivalence
723473|NCT01055769|Linezolid OS|linezolid os
723474|NCT01055769|Linezolid tablet|linezolid tablet
723475|NCT01055782|Colonoscopy|colonoscopy
723476|NCT01055782|Endoguide|endoguide
723477|NCT01055782|Pain perception|pain perception
723763|NCT01057082|Aging|aging
723478|NCT01055782|Colonoscopy to the coecum (success rate)|colonoscopy to the coecum (success rate)
723479|NCT01055782|Patient's perception of pain|patient's perception of pain
723480|NCT01055782|Duration of successful colonoscopies|duration of successful colonoscopies
723481|NCT01055808|Insulin|insulin
723482|NCT01055808|ITR-QOL|itr-qol
723483|NCT01055808|DTSQ|dtsq
723484|NCT01055808|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
723485|NCT01055821|Hepatitis C|hepatitis c
723486|NCT01055821|Vaccine|vaccine
723487|NCT01055821|HCVac|hcvac
723488|NCT01055821|MVA-HCV|mva-hcv
723489|NCT01055834|Insomnia|insomnia
723490|NCT01055834|primary insomnia|primary insomnia
723491|NCT01055834|insomnia associated with psychiatric or physical disorder(s)|insomnia associated with psychiatric or physical disorder(s)
723492|NCT01055847|cystic fibrosis|cystic fibrosis
723493|NCT01055847|CF|cf
723494|NCT01055847|aztreonam|aztreonam
723495|NCT01055847|lung infection|lung infection
723496|NCT01055847|Pseudomonas aeruginosa|pseudomonas aeruginosa
723497|NCT01055860|uterine Prolapse|uterine prolapse
723498|NCT01055860|vaginal prolapse|vaginal prolapse
723499|NCT01055860|mesh erosion|mesh erosion
723500|NCT01055860|urinary incontinence|urinary incontinence
723501|NCT01055860|bowel symptoms|bowel symptoms
723502|NCT01055873|immune status|immune status
723503|NCT01055873|adolescents or young adults infected|adolescents or young adults infected
723504|NCT01055873|impact of viral replication|impact of viral replication
723505|NCT01055886|PTSD|ptsd
723506|NCT01055886|smoking cessation|smoking cessation
723507|NCT01055886|nicotine patch|nicotine patch
723508|NCT01055899|RA|ra
723509|NCT01055912|Congestive Heart Failure|congestive heart failure
723510|NCT01055912|Volume Overload|volume overload
723511|NCT01055951|Insulin pumps|insulin pumps
723512|NCT01055951|Diabetes|diabetes
723513|NCT01055977|statin therapy|statin therapy
723514|NCT01055977|treatment goal|treatment goal
723515|NCT01055977|dyslipidaemia|dyslipidaemia
723516|NCT01055990|pandemic influenza A (H1N1) 2009|pandemic influenza a (h1n1) 2009
723517|NCT01055990|blood fix treatment|blood fix treatment
723518|NCT01055990|influenza A (H1N1) 2009 monovalent vaccine|influenza a (h1n1) 2009 monovalent vaccine
723519|NCT01055990|effectiveness|effectiveness
723520|NCT01055990|immunogenicity|immunogenicity
723521|NCT01055990|safety|safety
723522|NCT01056081|COPD|copd
723523|NCT01056081|inspiratory muscles|inspiratory muscles
723524|NCT01056081|diaphragm|diaphragm
723525|NCT01056107|Constipation, Irritable Bowel Syndrome (IBS), Glucagon Like Peptide analogue|constipation, irritable bowel syndrome (ibs), glucagon like peptide analogue
723526|NCT01056133|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
723527|NCT01056133|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
723528|NCT01056146|TBI|tbi
723529|NCT01056146|intracranial edema|intracranial edema
723530|NCT01056146|brain edema|brain edema
723531|NCT01056146|craniocerebral trauma|craniocerebral trauma
723532|NCT01056146|head injury|head injury
723533|NCT01056146|brain hemorrhage, traumatic|brain hemorrhage, traumatic
723534|NCT01056146|subdural hematoma|subdural hematoma
723535|NCT01056146|brain concussion|brain concussion
723536|NCT01056146|head injuries, closed|head injuries, closed
723537|NCT01056146|epidural hematoma|epidural hematoma
723538|NCT01056146|extra-axial hemorrhage|extra-axial hemorrhage
723539|NCT01056146|cortical contusion|cortical contusion
723540|NCT01056146|Additional relevant MeSH terms:|additional relevant mesh terms:
723541|NCT01056146|Nervous System Diseases|nervous system diseases
723542|NCT01056146|Wounds and Injuries|wounds and injuries
723543|NCT01056146|Disorders of Environmental Origin|disorders of environmental origin
723544|NCT01056146|Central Nervous System Diseases|central nervous system diseases
723545|NCT01056146|Trauma, Nervous System|trauma, nervous system
723546|NCT01056146|Brain Diseases|brain diseases
723547|NCT01056146|Brain Injuries|brain injuries
723548|NCT01056159|asthma|asthma
723549|NCT01056159|dry powder inhaler|dry powder inhaler
723550|NCT01056159|short-acting beta2-agonist|short-acting beta2-agonist
723551|NCT01056159|SABA|saba
723552|NCT01056159|bronchoconstriction|bronchoconstriction
723553|NCT01056159|bronchodilation|bronchodilation
723554|NCT01056159|bronchodilator|bronchodilator
723555|NCT01056159|metered dose inhaler|metered dose inhaler
723556|NCT01056172|Chronic hepatitis C|chronic hepatitis c
723557|NCT01056172|Genotype 2|genotype 2
723558|NCT01056172|Rapid virologic response|rapid virologic response
723559|NCT01056172|Sustained virologic response|sustained virologic response
723560|NCT01056172|Peginterferon alfa-2a|peginterferon alfa-2a
723561|NCT01056172|Ribavirin|ribavirin
723562|NCT01056185|influenza|influenza
723563|NCT01056185|flu|flu
723564|NCT01056185|swine flu|swine flu
723565|NCT01056185|respiratory virus|respiratory virus
723566|NCT01056185|hospitalization|hospitalization
723567|NCT01056185|MERS-CoV|mers-cov
723568|NCT01056185|SARS-CoV|sars-cov
723569|NCT01056198|Diabetic Foot Ulcers|diabetic foot ulcers
723570|NCT01056198|Diabetic Foot Wounds|diabetic foot wounds
723571|NCT01056224|skull pin insertion|skull pin insertion
723572|NCT01056224|remifentanil|remifentanil
723573|NCT01056224|short acting opioid|short acting opioid
723574|NCT01056224|craniotomy|craniotomy
723575|NCT01056224|cervical spine surgery|cervical spine surgery
723576|NCT01056224|hemodynamic changes|hemodynamic changes
723577|NCT01056224|dose requirement|dose requirement
723578|NCT01056224|age related|age related
723579|NCT01056250|cholelithiasis|cholelithiasis
723580|NCT01056263|retrospective trial|retrospective trial
723581|NCT01056263|5-year survival|5-year survival
723582|NCT01056263|metastatic renal cancer cell|metastatic renal cancer cell
723583|NCT01056276|Multiple Myeloma|multiple myeloma
723584|NCT01056276|Bendamustine|bendamustine
723585|NCT01056276|Bortezomib|bortezomib
723586|NCT01056276|Dexamethasone|dexamethasone
723587|NCT01056302|Reconstructive surgical procedures|reconstructive surgical procedures
723588|NCT01056302|visuohaptic|visuohaptic
723589|NCT01056315|Analgesia|analgesia
723590|NCT01056315|Diabetic Neuropathy|diabetic neuropathy
723591|NCT01056315|Neuropathic pain|neuropathic pain
723593|NCT01056315|Chronic pain|chronic pain
723594|NCT01056341|Infantile Hemangioma|infantile hemangioma
723595|NCT01056341|Propranolol|propranolol
723596|NCT01056354|Influenza|influenza
723597|NCT01056354|respiratory virus|respiratory virus
723598|NCT01056354|pandemic|pandemic
723599|NCT01056354|swine flu|swine flu
723600|NCT01056354|infection|infection
723601|NCT01056354|MERS-CoV|mers-cov
723602|NCT01056354|SARS-CoV|sars-cov
723603|NCT01056367|Resistant hypertension|resistant hypertension
723604|NCT01056367|Type-II-Diabetes Mellitus|type-ii-diabetes mellitus
723605|NCT01056367|Arterial stiffness|arterial stiffness
723606|NCT01056367|Ventricular function|ventricular function
723607|NCT01056380|influenza|influenza
723608|NCT01056380|influenza like illness|influenza like illness
723609|NCT01056393|HIV|hiv
723610|NCT01056406|Pregnancy|pregnancy
723611|NCT01056406|Overweight|overweight
723612|NCT01056406|Obese|obese
723613|NCT01056406|Nutrition intervention|nutrition intervention
723614|NCT01056419|Graves' ophthalmopathy|graves' ophthalmopathy
723615|NCT01056419|Total thyroidectomy|total thyroidectomy
723616|NCT01056419|Anti-thyroid drug treatment|anti-thyroid drug treatment
723617|NCT01056419|Clinical activity score|clinical activity score
723618|NCT01056432|osteoporosis, bone fracture risk, bone ultrasonometry|osteoporosis, bone fracture risk, bone ultrasonometry
723619|NCT01056445|Carotid artery stenting|carotid artery stenting
723620|NCT01056445|Hemodynamic Instability|hemodynamic instability
723621|NCT01056445|Valsalva Ratio|valsalva ratio
723622|NCT01056458|acupressure|acupressure
723623|NCT01056458|perimenopause|perimenopause
723624|NCT01056458|menopause|menopause
723625|NCT01056458|anxiety|anxiety
723626|NCT01056458|life quality|life quality
723627|NCT01056458|insomnia|insomnia
723628|NCT01056471|Multiple Sclerosis|multiple sclerosis
723629|NCT01056471|Mesenchymal Stem Cells|mesenchymal stem cells
723630|NCT01056471|Autologous|autologous
723810|NCT01057264|rhuMAb-VEGF|rhumab-vegf
723631|NCT01056484|Alcohol Dependence|alcohol dependence
723632|NCT01056484|Alcoholism|alcoholism
723633|NCT01056484|Substance Use Disorders|substance use disorders
723634|NCT01056484|Substance Abuse|substance abuse
723635|NCT01056497|diabetes|diabetes
723636|NCT01056497|alpha lipoic acid|alpha lipoic acid
723637|NCT01056497|endoplasmic reticulum (ER) stress|endoplasmic reticulum (er) stress
723638|NCT01056497|insulin secretion|insulin secretion
723639|NCT01056497|insulin sensitivity|insulin sensitivity
723640|NCT01056523|AML|aml
723641|NCT01056536|Travel|travel
723642|NCT01056536|casual sexual relationships|casual sexual relationships
723643|NCT01056536|condoms|condoms
723644|NCT01056536|Structured intervention|structured intervention
723645|NCT01056549|Intestinal lipoprotein|intestinal lipoprotein
723646|NCT01056549|Apo B48 and apoB100|apo b48 and apob100
723647|NCT01056549|Pancreatic clamp|pancreatic clamp
723648|NCT01056549|GLP-1 agonist|glp-1 agonist
723649|NCT01056562|Prostate|prostate
723650|NCT01056562|GU|gu
723651|NCT01056562|Urological Oncology|urological oncology
723652|NCT01056588|adolescent smoking|adolescent smoking
723653|NCT01056588|Contingency management|contingency management
723654|NCT01056588|Quit smoking|quit smoking
723655|NCT01056601|insulinoma|insulinoma
723656|NCT01056601|cancer of pancreas|cancer of pancreas
723657|NCT01056601|neoplasms, pancreas|neoplasms, pancreas
723658|NCT01056601|alpha-cell tumor|alpha-cell tumor
723659|NCT01056601|glucagonoma|glucagonoma
723660|NCT01056601|beta-cell tumor|beta-cell tumor
723661|NCT01056601|somatostatinoma|somatostatinoma
723662|NCT01056640|telemonitoring|telemonitoring
723663|NCT01056640|usual care|usual care
723664|NCT01056640|elderly|elderly
723665|NCT01056640|hospitalization|hospitalization
723666|NCT01056640|Emergency room visits|emergency room visits
723667|NCT01056653|father-child relations|father-child relations
723668|NCT01056653|paternal behaviour|paternal behaviour
723669|NCT01056653|early intervention|early intervention
723670|NCT01056653|child-rearing|child-rearing
723671|NCT01056692|Asthma|asthma
723672|NCT01056692|bronchial allergen challenge|bronchial allergen challenge
723673|NCT01056692|sputum eosinophiilia|sputum eosinophiilia
723674|NCT01056705|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
723675|NCT01056705|Sabin Strains|sabin strains
723676|NCT01056705|poliomyelitis|poliomyelitis
723677|NCT01056718|Diastolic Function|diastolic function
723678|NCT01056718|Nebivolol|nebivolol
723679|NCT01056731|high blood pressure|high blood pressure
723680|NCT01056731|aliskiren|aliskiren
723681|NCT01056731|hydrochlorothiazide|hydrochlorothiazide
723682|NCT01056731|control rate|control rate
723683|NCT01056744|coronary stent|coronary stent
723684|NCT01056744|optical coherence tomography|optical coherence tomography
723685|NCT01056744|drug-eluting|drug-eluting
723686|NCT01056744|neointimal proliferation|neointimal proliferation
723687|NCT01056757|metastatic breast cancer|metastatic breast cancer
723688|NCT01056757|ribavirin|ribavirin
723689|NCT01056757|eIF4E|eif4e
723690|NCT01056770|Smallpox vaccine efficacy|smallpox vaccine efficacy
723692|NCT01056796|compression anastomosis|compression anastomosis
723693|NCT01056796|Colorectal cancer|colorectal cancer
723694|NCT01056796|Low anterior resection|low anterior resection
723695|NCT01056796|Radiated to the pelvic area|radiated to the pelvic area
723696|NCT01056796|Radiotherapy|radiotherapy
723697|NCT01056809|Colorectal cancer|colorectal cancer
723698|NCT01056809|Metastases|metastases
723699|NCT01056809|Treatment strategies|treatment strategies
723700|NCT01056809|Colorectal cancer with synchronous metastases|colorectal cancer with synchronous metastases
723701|NCT01056848|Euvolemic Hyponatremia|euvolemic hyponatremia
723702|NCT01056848|Hypervolemic Hyponatremia|hypervolemic hyponatremia
723703|NCT01056848|SIADH|siadh
723704|NCT01056848|Serum Sodium|serum sodium
723705|NCT01056861|cervical dystonia|cervical dystonia
723706|NCT01056861|torticollis|torticollis
723707|NCT01056861|Botulinum toxin|botulinum toxin
723708|NCT01056861|magnetoencephalography|magnetoencephalography
723709|NCT01056861|MEG|meg
723710|NCT01056861|cortical organizational changes detected by MEG after botulinum toxin in patients with torticollis, correlating with improvement in the symptoms|cortical organizational changes detected by meg after botulinum toxin in patients with torticollis, correlating with improvement in the symptoms
723711|NCT01056874|Maraviroc|maraviroc
723712|NCT01056874|Digoxin|digoxin
723713|NCT01056874|P-glycoprotein|p-glycoprotein
723714|NCT01056874|Pharmacokinetics|pharmacokinetics
723715|NCT01056874|Drug Interaction|drug interaction
723716|NCT01056874|HIV|hiv
723717|NCT01056887|diabetes insipidus|diabetes insipidus
723718|NCT01056887|primary polydipsia|primary polydipsia
723719|NCT01056887|copeptin|copeptin
723720|NCT01056887|Utility of plasma copeptin in differential diagnosis of polyuria/ polydipsia while performing a traditional deprivation test|utility of plasma copeptin in differential diagnosis of polyuria/ polydipsia while performing a traditional deprivation test
723721|NCT01056900|articular cartilage defects|articular cartilage defects
723722|NCT01056900|ACI|aci
723723|NCT01056900|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
723724|NCT01056900|Knee joint|knee joint
723725|NCT01056900|chondron|chondron
723726|NCT01056913|anastomotic leakage|anastomotic leakage
723727|NCT01056913|bleeding from the anastomotic region|bleeding from the anastomotic region
723728|NCT01056913|anastomotic stenosis|anastomotic stenosis
723729|NCT01056926|smoking|smoking
723730|NCT01056926|nicotine|nicotine
723731|NCT01056926|Effects of nicotine and non-nicotine factors on continuous working memory.|effects of nicotine and non-nicotine factors on continuous working memory.
723732|NCT01056926|Effects of nicotine and non-nicotine factors on cue reactivity.|effects of nicotine and non-nicotine factors on cue reactivity.
723733|NCT01056926|Use of nicotine patches, placebo patches, and denicotinized cigarettes.|use of nicotine patches, placebo patches, and denicotinized cigarettes.
723734|NCT01056926|memory|memory
723735|NCT01056939|Ventilatory care, children, intensive care, NAVA|ventilatory care, children, intensive care, nava
723736|NCT01056939|Children needing ventilatory care|children needing ventilatory care
723737|NCT01056965|Frontotemporal Dementia|frontotemporal dementia
723738|NCT01056965|Corticobasal Degeneration|corticobasal degeneration
723739|NCT01056965|Progressive Nonfluent Aphasia|progressive nonfluent aphasia
723740|NCT01056965|Progressive Supranuclear Palsy|progressive supranuclear palsy
723746|NCT01056965|Predicted tauopathies, including:|predicted tauopathies, including:
723747|NCT01056965|Progressive Supranuclear Palsy (PSP)|progressive supranuclear palsy (psp)
723748|NCT01056965|(CBS)|(cbs)
723749|NCT01056965|Progressive Nonfluent Aphasia (PNFA)|progressive nonfluent aphasia (pnfa)
723750|NCT01056978|palliative care unit|palliative care unit
723751|NCT01056978|bleeding|bleeding
723752|NCT01056978|thromboembolic|thromboembolic
723753|NCT01056978|hemorrhagic risk|hemorrhagic risk
723754|NCT01056978|antithrombotic prophylaxis|antithrombotic prophylaxis
723755|NCT01057004|heart failure|heart failure
723756|NCT01057017|colorectal cancer|colorectal cancer
723757|NCT01057043|Osteoarthritis|osteoarthritis
723758|NCT01057056|patients in a sub-acute geriatric rehabilitation department|patients in a sub-acute geriatric rehabilitation department
723759|NCT01057069|Neo adjuvant|neo adjuvant
723760|NCT01057069|Triple negative|triple negative
723761|NCT01057069|primary tumor over 2 cm and/or positive lymphnodes|primary tumor over 2 cm and/or positive lymphnodes
723762|NCT01057082|Sarcopenia|sarcopenia
723764|NCT01057082|Muscle|muscle
723765|NCT01057082|Dietary Supplement|dietary supplement
723766|NCT01057082|HMB|hmb
723767|NCT01057082|Arginine|arginine
723768|NCT01057082|Glutamine|glutamine
751877|NCT01171040|left atrial distensibility|left atrial distensibility
726217|NCT01071629|Cardiac rehabilitation|cardiac rehabilitation
726218|NCT01071642|Change in eGFR from baseline to 72 hours following the exposure to the contrast.|change in egfr from baseline to 72 hours following the exposure to the contrast.
726219|NCT01071642|Rate of eGFR decrease>25% from the baseline|rate of egfr decrease>25% from the baseline
723769|NCT01057095|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
723770|NCT01057095|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
723771|NCT01057095|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
723772|NCT01057095|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
723773|NCT01057095|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
723774|NCT01057095|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
723775|NCT01057095|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
723776|NCT01057095|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
723777|NCT01057095|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
723778|NCT01057095|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
723779|NCT01057108|Hyperphosphatemia|hyperphosphatemia
723780|NCT01057108|chronic kidney disease|chronic kidney disease
723781|NCT01057108|salivary phosphorus|salivary phosphorus
723782|NCT01057121|HIV Infections|hiv infections
723783|NCT01057173|Heart Valve Disease|heart valve disease
723784|NCT01057173|Heart Valve Prosthesis|heart valve prosthesis
723785|NCT01057173|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
723786|NCT01057173|Randomized Controlled Trial|randomized controlled trial
723787|NCT01057199|adult acute myeloid leukemia|adult acute myeloid leukemia
723788|NCT01057199|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
723789|NCT01057212|advanced or metastatic non-squamous non-small cell lung cancer (NSCLC)|advanced or metastatic non-squamous non-small cell lung cancer (nsclc)
723790|NCT01057238|mechanical ventilation|mechanical ventilation
723791|NCT01057238|critical care|critical care
723793|NCT01057251|Bystolic TM|bystolic tm
723794|NCT01057251|Hypertension|hypertension
723795|NCT01057251|Stage 2 Hypertension|stage 2 hypertension
723796|NCT01057264|Liver|liver
723797|NCT01057264|Cancer|cancer
723798|NCT01057264|Hepatic arterial infusion|hepatic arterial infusion
723799|NCT01057264|HAI|hai
723800|NCT01057264|Abraxane|abraxane
723801|NCT01057264|Nab-Paclitaxel|nab-paclitaxel
723802|NCT01057264|Paclitaxel|paclitaxel
723803|NCT01057264|ABI-007|abi-007
723804|NCT01057264|Gemcitabine|gemcitabine
723805|NCT01057264|Gemcitabine Hydrochloride|gemcitabine hydrochloride
723806|NCT01057264|Gemzar|gemzar
723807|NCT01057264|Bevacizumab|bevacizumab
723808|NCT01057264|Avastin|avastin
723809|NCT01057264|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
723811|NCT01057264|Filgrastim|filgrastim
723812|NCT01057264|G-CSF|g-csf
723813|NCT01057264|Neupogen|neupogen
723814|NCT01057277|Head and Neck Cancer|head and neck cancer
723815|NCT01057277|Advanced Inoperable Head & Neck Cancer|advanced inoperable head & neck cancer
723816|NCT01057290|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
723817|NCT01057303|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
723818|NCT01057329|TDM|tdm
723819|NCT01057329|Drug|drug
723820|NCT01057329|Psychopharmacology|psychopharmacology
723821|NCT01057329|children|children
723822|NCT01057329|adolescents|adolescents
723823|NCT01057342|extensive stage small cell lung cancer|extensive stage small cell lung cancer
723824|NCT01057355|Intraductal papillary mucinous neoplasm|intraductal papillary mucinous neoplasm
723825|NCT01057355|Mucinous cystic neoplasm|mucinous cystic neoplasm
723826|NCT01057355|Endoscopic ultrasound|endoscopic ultrasound
723827|NCT01057355|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
723828|NCT01057355|Pancreatic cyst|pancreatic cyst
723829|NCT01057355|Pancreas cyst|pancreas cyst
723830|NCT01057355|Alcohol|alcohol
723831|NCT01057381|Adenotonsillectomy|adenotonsillectomy
723832|NCT01057381|Postoperative analgesia|postoperative analgesia
723834|NCT01057394|Atrial Fibrillation|atrial fibrillation
723835|NCT01057407|Hyperphosphatemia|hyperphosphatemia
723836|NCT01057407|hemodialysis|hemodialysis
723837|NCT01057407|CKD|ckd
723838|NCT01057407|ASP1585|asp1585
723839|NCT01057433|Healthy Volunteers|healthy volunteers
723840|NCT01057446|Colonoscopy preparation|colonoscopy preparation
723841|NCT01057446|sennoside|sennoside
723842|NCT01057446|sodium phosphate|sodium phosphate
723843|NCT01057446|the aim is to assess the bowel cleansing effects of two different agents|the aim is to assess the bowel cleansing effects of two different agents
751878|NCT01171040|mortality|mortality
723844|NCT01057459|Stage II Grade 1 Contiguous Follicular Lymphoma|stage ii grade 1 contiguous follicular lymphoma
723845|NCT01057459|Stage II Grade 1 Non-Contiguous Follicular Lymphoma|stage ii grade 1 non-contiguous follicular lymphoma
723846|NCT01057459|Stage II Grade 2 Contiguous Follicular Lymphoma|stage ii grade 2 contiguous follicular lymphoma
723847|NCT01057459|Stage II Grade 2 Non-Contiguous Follicular Lymphoma|stage ii grade 2 non-contiguous follicular lymphoma
723950|NCT01057784|teenager|teenager
723848|NCT01057459|Stage II Grade 3 Contiguous Follicular Lymphoma|stage ii grade 3 contiguous follicular lymphoma
723849|NCT01057459|Stage II Grade 3 Non-Contiguous Follicular Lymphoma|stage ii grade 3 non-contiguous follicular lymphoma
723850|NCT01057459|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
723851|NCT01057459|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
723852|NCT01057459|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
723853|NCT01057459|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
723854|NCT01057459|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
723855|NCT01057459|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
723856|NCT01057472|Repeatability of measurements|repeatability of measurements
723857|NCT01057485|Atrial Fibrillation|atrial fibrillation
723858|NCT01057485|Ablation|ablation
723859|NCT01057511|Crinone|crinone
723860|NCT01057511|progesterone|progesterone
723861|NCT01057511|endometrial progesterone concentration|endometrial progesterone concentration
723862|NCT01057524|Airway clearance|airway clearance
723863|NCT01057524|Cystic fibrosis|cystic fibrosis
723864|NCT01057524|High frequency chest wall oscillation|high frequency chest wall oscillation
723865|NCT01057537|Polypill|polypill
723866|NCT01057537|Red Heart Pill|red heart pill
723867|NCT01057537|Cardiovascular disease|cardiovascular disease
723868|NCT01057537|Adherence|adherence
723869|NCT01057537|Secondary prevention|secondary prevention
723870|NCT01057550|Stress urinary Incontinence|stress urinary incontinence
723871|NCT01057550|autologous slings|autologous slings
723872|NCT01057550|slings|slings
723873|NCT01057550|tvt|tvt
723874|NCT01057550|grafts|grafts
723875|NCT01057550|surgery|surgery
723876|NCT01057563|Coronary artery disease|coronary artery disease
723877|NCT01057563|Neointimal hyperplasia|neointimal hyperplasia
723878|NCT01057563|Drug-eluting balloon|drug-eluting balloon
723879|NCT01057563|Optical coherence tomography|optical coherence tomography
723880|NCT01057576|bioactives|bioactives
723881|NCT01057576|insulin|insulin
723882|NCT01057576|botanicals|botanicals
723883|NCT01057589|Pharynx|pharynx
723884|NCT01057589|Larynx|larynx
723885|NCT01057589|Cervical esophagus|cervical esophagus
723886|NCT01057589|Nose|nose
723887|NCT01057589|Thyroid Gland|thyroid gland
723888|NCT01057589|Parathyroid Gland|parathyroid gland
723889|NCT01057602|Dementia|dementia
723890|NCT01057602|Screening Tests|screening tests
723891|NCT01057602|Cognition|cognition
723892|NCT01057602|Memory|memory
723893|NCT01057602|MOST|most
723894|NCT01057615|Asthma|asthma
723895|NCT01057615|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
723896|NCT01057615|Inflammation|inflammation
723897|NCT01057615|Airway|airway
723898|NCT01057615|Fish Oil|fish oil
723899|NCT01057615|Ascorbic Acid|ascorbic acid
723900|NCT01057628|ASP1941|asp1941
723901|NCT01057628|Diabetes mellitus|diabetes mellitus
723902|NCT01057628|Blood glucose|blood glucose
723903|NCT01057641|PIDLSS, Spacer|pidlss, spacer
723904|NCT01057654|Cholesterol|cholesterol
723905|NCT01057680|Bone|bone
723906|NCT01057680|Muscle|muscle
723907|NCT01057680|Strength|strength
723908|NCT01057680|Kidney|kidney
723909|NCT01057680|Liver|liver
723910|NCT01057680|Creatine|creatine
723911|NCT01057693|Diabetic peripheral neuropathy|diabetic peripheral neuropathy
723912|NCT01057693|Lyrica|lyrica
723913|NCT01057693|pregabalin|pregabalin
723914|NCT01057693|pain|pain
723915|NCT01057706|chiropractic|chiropractic
723916|NCT01057706|exercise|exercise
723917|NCT01057706|seniors|seniors
723918|NCT01057719|cross-over design|cross-over design
723919|NCT01057719|mixed model|mixed model
723920|NCT01057719|multiple sclerosis|multiple sclerosis
723921|NCT01057719|physical performance measures|physical performance measures
723922|NCT01057719|physical therapy|physical therapy
723923|NCT01057719|the Bobath concept|the bobath concept
723924|NCT01057719|warm climate|warm climate
723925|NCT01057719|6-minute walk test|6-minute walk test
723926|NCT01057745|woman|woman
723927|NCT01057745|chemotherapy|chemotherapy
723928|NCT01057745|radiation|radiation
724121|NCT01047397|anemia|anemia
723929|NCT01057745|fertility preservation|fertility preservation
723930|NCT01057745|cryobank|cryobank
723931|NCT01057758|Suspicion of ventilator-associated pneumonia|suspicion of ventilator-associated pneumonia
723932|NCT01057771|meditation|meditation
723933|NCT01057771|exercise|exercise
723934|NCT01057771|immunity|immunity
723935|NCT01057771|respiratory infection|respiratory infection
723936|NCT01057771|influenza|influenza
723937|NCT01057771|flu shot|flu shot
723938|NCT01057771|immunomodulation|immunomodulation
723939|NCT01057784|obesity|obesity
723941|NCT01057784|surgery|surgery
723942|NCT01057784|sleeve|sleeve
723943|NCT01057784|gastric bypass|gastric bypass
723944|NCT01057784|vitamin D|vitamin d
723945|NCT01057784|quality of life|quality of life
723946|NCT01057784|body composition|body composition
723947|NCT01057784|bone density|bone density
723948|NCT01057784|adolescent|adolescent
723949|NCT01057784|child|child
723951|NCT01057784|fertility|fertility
723952|NCT01057784|offspring|offspring
723953|NCT01057784|biomarker|biomarker
723954|NCT01057784|epigenome|epigenome
723955|NCT01057784|gene expression|gene expression
723956|NCT01057797|COPD|copd
723957|NCT01057797|Pulmonary rehabilitation|pulmonary rehabilitation
723958|NCT01057797|Self-efficacy|self-efficacy
723959|NCT01057797|Muscle strength|muscle strength
723960|NCT01057797|Dyspnea|dyspnea
723961|NCT01057797|Exercise adherence|exercise adherence
723962|NCT01057823|aged|aged
723963|NCT01057823|sleep deprivation|sleep deprivation
723964|NCT01057823|actigraphy|actigraphy
723965|NCT01057823|ambulatory monitoring|ambulatory monitoring
723966|NCT01057849|schizophrenia|schizophrenia
723967|NCT01057849|first episode|first episode
723968|NCT01057849|atypical antipsychotics|atypical antipsychotics
723969|NCT01057849|psychosocial intervention|psychosocial intervention
723970|NCT01057849|outcome|outcome
723971|NCT01057849|effectiveness|effectiveness
723972|NCT01057862|Naltrexone|naltrexone
723973|NCT01057862|Pathological Gambling|pathological gambling
723974|NCT01057862|Opioid Antagonist|opioid antagonist
723975|NCT01057888|Immunization status for:|immunization status for:
723976|NCT01057888|Tdap|tdap
723977|NCT01057888|Menactra|menactra
723978|NCT01057888|HPV (if female)|hpv (if female)
723979|NCT01057888|Well child care visit|well child care visit
723980|NCT01057914|Randomized controlled trial|randomized controlled trial
723981|NCT01057914|Malnutrition|malnutrition
723982|NCT01057914|Aged|aged
723983|NCT01057914|Aged 80 and over|aged 80 and over
723984|NCT01057914|Nutrition therapy|nutrition therapy
723985|NCT01057953|Colo-Rectal Cancer|colo-rectal cancer
723986|NCT01057966|Bioavailability|bioavailability
723987|NCT01057966|Ocular Vitamins|ocular vitamins
723988|NCT01057979|exercise|exercise
723989|NCT01057979|college students|college students
723990|NCT01057979|Sedentary college students|sedentary college students
723992|NCT01058018|Cholesterol|cholesterol
723993|NCT01058018|High density lipoprotein|high density lipoprotein
723994|NCT01058018|Atherosclerosis|atherosclerosis
723995|NCT01058018|ApolipoproteinA1|apolipoproteina1
723996|NCT01058018|Stable angina artery disease|stable angina artery disease
723997|NCT01058044|Cancer, Sunitinib, capecitabine, anastrozole, letrozole|cancer, sunitinib, capecitabine, anastrozole, letrozole
723998|NCT01058044|adherence, anticancer treatment|adherence, anticancer treatment
723999|NCT01058057|atorvastatin|atorvastatin
724000|NCT01058057|percutaneous coronary intervention|percutaneous coronary intervention
724001|NCT01058057|periprocedural myocardial infarction|periprocedural myocardial infarction
724002|NCT01058057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
724003|NCT01058070|GERD|gerd
724004|NCT01058096|Acute Mania|acute mania
724005|NCT01058096|Bipolar I Disorder|bipolar i disorder
724006|NCT01058109|bone health, bone density, bone mass|bone health, bone density, bone mass
724007|NCT01058122|Adverse drug reactions in patients on the oncology ward|adverse drug reactions in patients on the oncology ward
724008|NCT01058135|insulin resistance|insulin resistance
724009|NCT01058135|dietary fiber|dietary fiber
724010|NCT01058135|resistant starch|resistant starch
724011|NCT01058148|Cervical Cancer Screening|cervical cancer screening
724012|NCT01058148|Cervical Precancer|cervical precancer
724013|NCT01058148|Self-Collection|self-collection
724014|NCT01058148|Cytology|cytology
724015|NCT01058148|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
724016|NCT01058161|wrist and hand cartilage abnormalities in inflammatory and chronic rheumatisms|wrist and hand cartilage abnormalities in inflammatory and chronic rheumatisms
724017|NCT01058174|Liver transplantation|liver transplantation
724018|NCT01058174|Prophylaxis|prophylaxis
724019|NCT01058174|Prevention|prevention
724020|NCT01058174|Mycoses|mycoses
724021|NCT01058174|Invasive Fungal Infection|invasive fungal infection
724022|NCT01058174|Micafungin|micafungin
724023|NCT01058213|COPD|copd
724024|NCT01058213|Pulmonary rehabilitation|pulmonary rehabilitation
724025|NCT01058213|Resistance Training|resistance training
724026|NCT01058213|Aerobic Training|aerobic training
724027|NCT01058213|Dyspnea|dyspnea
724028|NCT01058226|Experimental malaria challenge|experimental malaria challenge
724029|NCT01058239|bortezomib|bortezomib
724030|NCT01058239|rituximab|rituximab
724031|NCT01058239|PTLD|ptld
724032|NCT01058239|EBV|ebv
724033|NCT01058239|transplantation|transplantation
724034|NCT01058278|Glaucoma|glaucoma
724035|NCT01058278|Ocular Hypertension|ocular hypertension
724036|NCT01058278|Intraocular Pressure|intraocular pressure
724037|NCT01058278|Trabeculectomy|trabeculectomy
724038|NCT01058304|osteoarthritis|osteoarthritis
724039|NCT01058304|knee|knee
724040|NCT01058304|physical therapy (specialty)|physical therapy (specialty)
724041|NCT01058304|veterans|veterans
724042|NCT01058317|respiratory, papilloma, pediatric, juvenile|respiratory, papilloma, pediatric, juvenile
724043|NCT01058330|Neurofibromatosis type 1|neurofibromatosis type 1
724044|NCT01058330|NF1|nf1
724045|NCT01058343|SLE|sle
724046|NCT01058356|antibiotics associated colitis|antibiotics associated colitis
724047|NCT01058356|lactobacilli|lactobacilli
724048|NCT01058356|probiotics|probiotics
724049|NCT01058356|prevention|prevention
724050|NCT01058356|pulmonary infection|pulmonary infection
724051|NCT01058356|Prevention of antibiotics associated colitis|prevention of antibiotics associated colitis
724052|NCT01058356|the role of probiotics for prevention of antibiotics associated colitis|the role of probiotics for prevention of antibiotics associated colitis
724053|NCT01058356|the lactobacilli effect for antibiotics associated colitis|the lactobacilli effect for antibiotics associated colitis
724054|NCT01058356|antibiotic associated colitis on pulmonary infectious disease|antibiotic associated colitis on pulmonary infectious disease
724055|NCT01058382|FET|fet
724056|NCT01058382|Progesterone Support|progesterone support
724057|NCT01058382|Frozen Embryo Transfer|frozen embryo transfer
724058|NCT01058395|Traumatic Brain Injury|traumatic brain injury
724059|NCT01058395|Minocycline|minocycline
724060|NCT01058395|Outcome|outcome
724061|NCT01058408|advanced head and neck cancer|advanced head and neck cancer
724062|NCT01058408|cisplatin|cisplatin
724063|NCT01058408|RAD001|rad001
724064|NCT01058408|radiation|radiation
724065|NCT01058408|HNSCC|hnscc
724066|NCT01058421|mechanical ventilation|mechanical ventilation
724067|NCT01058421|acute respiratory failure|acute respiratory failure
724068|NCT01058421|physical therapy|physical therapy
724069|NCT01058421|critical illness neuropathy|critical illness neuropathy
724070|NCT01058421|critical illness myopathy|critical illness myopathy
724071|NCT01058434|Multiple myeloma|multiple myeloma
724072|NCT01058434|relapsed|relapsed
724073|NCT01058434|refractory|refractory
724074|NCT01058434|t(4;14)|t(4;14)
724075|NCT01058434|FGFR3|fgfr3
724076|NCT01058447|ADME|adme
724077|NCT01058447|Healthy volunteers|healthy volunteers
724078|NCT01058460|Cervical Intraepithelial Neoplasia, Grade III|cervical intraepithelial neoplasia, grade iii
724079|NCT01058460|Cervical Intraepithelial Neoplasia, Grade II|cervical intraepithelial neoplasia, grade ii
724080|NCT01058473|Sickle Cell Disease|sickle cell disease
724081|NCT01058473|Pain|pain
724082|NCT01058473|Assessment|assessment
724083|NCT01058486|Chronic Disease Management|chronic disease management
724084|NCT01058486|Physical Activity|physical activity
724085|NCT01058486|Self-efficacy|self-efficacy
724086|NCT01058486|Self management|self management
724087|NCT01058499|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
724088|NCT01058499|COPD|copd
724089|NCT01058512|hepatitis C|hepatitis c
724090|NCT01058512|chronic HCV|chronic hcv
724091|NCT01058512|viral HCV|viral hcv
724092|NCT01058512|genotype 1|genotype 1
724093|NCT01058512|failed treatment with pegylated interferon plus ribavirin|failed treatment with pegylated interferon plus ribavirin
724094|NCT01058538|Interleukin, IL2, monoclonal, antibody, cytokine, tumour targeting, solid tumours, dose finding, renal cell carcinoma, fusion protein, RCC,|interleukin, il2, monoclonal, antibody, cytokine, tumour targeting, solid tumours, dose finding, renal cell carcinoma, fusion protein, rcc,
724095|NCT01058538|L19|l19
724096|NCT01047215|schizophrenia|schizophrenia
724097|NCT01047215|bipolar|bipolar
724098|NCT01047215|aripiprazole|aripiprazole
724099|NCT01047215|quetiapine|quetiapine
724100|NCT01047241|Painful medical procedures|painful medical procedures
724101|NCT01047267|candidiasis|candidiasis
724102|NCT01047267|invasive fungal disease|invasive fungal disease
724103|NCT01047267|critically ill|critically ill
724104|NCT01047267|anidulafungin|anidulafungin
724105|NCT01047267|pharmacokinetics|pharmacokinetics
724106|NCT01047280|Conjugated linoleic acid|conjugated linoleic acid
724107|NCT01047280|Body weight|body weight
724108|NCT01047280|Body composition|body composition
724109|NCT01047280|Blood lipid profile|blood lipid profile
724110|NCT01047280|Body inflammatory and oxidative status|body inflammatory and oxidative status
724111|NCT01047293|colorectal cancer|colorectal cancer
724112|NCT01047319|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
724113|NCT01047345|Cervical cancer|cervical cancer
724114|NCT01047345|Genital warts|genital warts
724115|NCT01047345|Human papillomavirus vaccine|human papillomavirus vaccine
724116|NCT01047345|GARDASIL™|gardasil™
724117|NCT01047397|hemodialysis|hemodialysis
724118|NCT01047397|tolerability|tolerability
724119|NCT01047397|pharmacokinetics|pharmacokinetics
724120|NCT01047397|safety|safety
724122|NCT01047397|renal impairment|renal impairment
724123|NCT01047397|repeat dose|repeat dose
724124|NCT01047410|physical exercise training|physical exercise training
724125|NCT01047410|quality of life|quality of life
724126|NCT01047410|exercise capacity|exercise capacity
724127|NCT01047410|skeletal muscle strength|skeletal muscle strength
724128|NCT01047410|physical activity level|physical activity level
724129|NCT01047410|costeffectiveness|costeffectiveness
724130|NCT01047410|renal transplantation|renal transplantation
724131|NCT01047410|hemodialysis|hemodialysis
724132|NCT01047410|peritoneal dialysis|peritoneal dialysis
724133|NCT01047410|diet|diet
724134|NCT01047423|Hypertension endothelial dysfunction statin prevention|hypertension endothelial dysfunction statin prevention
724135|NCT01047436|Plasmodium infections|plasmodium infections
724136|NCT01047436|Remittent fever|remittent fever
724137|NCT01047436|Artemether|artemether
724138|NCT01047436|Artemisinins|artemisinins
724139|NCT01047436|quinine|quinine
724140|NCT01047436|Malaria|malaria
724141|NCT01047436|Protozoan Infections|protozoan infections
724142|NCT01047436|Anti-Infective Agents|anti-infective agents
724143|NCT01047436|Antiprotozoal Agents|antiprotozoal agents
724144|NCT01047436|Schistosomicides|schistosomicides
724145|NCT01047436|Pharmacologic Actions|pharmacologic actions
724146|NCT01047436|Malaria, Falciparum|malaria, falciparum
724147|NCT01047436|Antimalarials|antimalarials
724148|NCT01047436|Antiparasitic Agents|antiparasitic agents
724149|NCT01047436|Parasitic Diseases|parasitic diseases
724150|NCT01047436|sublingual|sublingual
724151|NCT01047449|saphenous vein graft patency|saphenous vein graft patency
724152|NCT01047449|fish oil supplementation|fish oil supplementation
724153|NCT01047449|coronary artery bypass surgery|coronary artery bypass surgery
724154|NCT01047449|coronary artery disease|coronary artery disease
724155|NCT01047475|MB-6|mb-6
724156|NCT01047475|FOLFOX4|folfox4
724157|NCT01047475|Metastatic Colorectal Cancer|metastatic colorectal cancer
724158|NCT01047488|polyneuropathy|polyneuropathy
724159|NCT01047488|neuropathic pain|neuropathic pain
724160|NCT01047488|treatment|treatment
724161|NCT01047501|hypertriglyceridemia|hypertriglyceridemia
724162|NCT01047501|omega-3 fatty acids|omega-3 fatty acids
724163|NCT01047501|statin|statin
724164|NCT01047501|triglycerides|triglycerides
724165|NCT01047501|lipids|lipids
724167|NCT01047501|docosahexaenoic acid|docosahexaenoic acid
724168|NCT01047501|fish|fish
724169|NCT01047501|fatty acids|fatty acids
724170|NCT01047501|fibrates|fibrates
724171|NCT01047501|niacin|niacin
724172|NCT01047501|lipid|lipid
724173|NCT01047501|atorvastatin|atorvastatin
724174|NCT01047501|Lovaza|lovaza
724175|NCT01047501|simvastatin|simvastatin
724176|NCT01047501|lovastatin|lovastatin
724177|NCT01047501|pravastatin|pravastatin
724178|NCT01047501|fluvastatin|fluvastatin
724179|NCT01047501|rosuvastatin|rosuvastatin
724180|NCT01047501|Trilipix|trilipix
724181|NCT01047501|Vytorin|vytorin
724182|NCT01047501|Simcor|simcor
724183|NCT01047501|Niaspan|niaspan
724184|NCT01047501|ezetimibe|ezetimibe
724185|NCT01047501|Zetia|zetia
724186|NCT01047501|ethyl-EPA|ethyl-epa
724187|NCT01047501|ethyl icosapentate|ethyl icosapentate
724188|NCT01047501|Crestor|crestor
724189|NCT01047501|Zocor|zocor
724190|NCT01047501|Lipitor|lipitor
724191|NCT01047501|LDL|ldl
724192|NCT01047501|HDL|hdl
724193|NCT01047501|cholesterol|cholesterol
724194|NCT01047501|dyslipidemia|dyslipidemia
724195|NCT01047501|VASCEPA|vascepa
724196|NCT01047501|icosapent ethyl|icosapent ethyl
724197|NCT01052818|Non small-cell lung cancer|non small-cell lung cancer
724198|NCT01052818|Circulating tumor cells|circulating tumor cells
724199|NCT01052818|Carcinoembryonic antigen|carcinoembryonic antigen
724200|NCT01052818|Cytokeratin|cytokeratin
724201|NCT01052831|Compulsive Gambling|compulsive gambling
724202|NCT01052831|Compulsive Buying|compulsive buying
724203|NCT01052831|Compulsive Shopping|compulsive shopping
724204|NCT01052831|Compulsive Eating|compulsive eating
724205|NCT01052831|Hypersexuality|hypersexuality
724206|NCT01052831|Dopamine Agonists|dopamine agonists
724207|NCT01052831|Mirapex|mirapex
724208|NCT01052831|Pramipexole|pramipexole
724209|NCT01052831|Requip|requip
724210|NCT01052831|Ropinirole|ropinirole
724211|NCT01052831|Impulse Control Disorders|impulse control disorders
724212|NCT01052844|Vomiting|vomiting
724213|NCT01052844|Antiemetics|antiemetics
724214|NCT01052844|Dexamethasone|dexamethasone
724215|NCT01052844|Cisplatin|cisplatin
724216|NCT01052844|Antineoplastic combined chemotherapy protocols|antineoplastic combined chemotherapy protocols
724217|NCT01052857|to evaluate acupuncture as possible alternative treatment for induction of labor|to evaluate acupuncture as possible alternative treatment for induction of labor
724218|NCT01052857|Induction|induction
724219|NCT01052857|treatment|treatment
724220|NCT01052857|posterm|posterm
724221|NCT01052870|pharmacogenomics, androgen receptor gene, androgen sensitivity, CAG repeats, androgenetic alopecia|pharmacogenomics, androgen receptor gene, androgen sensitivity, cag repeats, androgenetic alopecia
724222|NCT01052870|Pharmacogenomics in treatment for androgenetic alopecia in women|pharmacogenomics in treatment for androgenetic alopecia in women
724223|NCT01052883|TMC114-TiDP3-C182|tmc114-tidp3-c182
724224|NCT01052883|TMC114-C182|tmc114-c182
724225|NCT01052883|TMC114|tmc114
724226|NCT01052883|HIV|hiv
724227|NCT01052883|HIV Infections|hiv infections
724228|NCT01052896|Dyspepsia|dyspepsia
724229|NCT01052896|Functional|functional
724230|NCT01052909|Bioequivalence, Glimepiride, Crossover|bioequivalence, glimepiride, crossover
724231|NCT01052922|Colorectal Neoplasms|colorectal neoplasms
724232|NCT01052922|Mass Screening|mass screening
724233|NCT01052922|Population Surveillance|population surveillance
724234|NCT01052922|Randomized controlled trial|randomized controlled trial
724235|NCT01052922|Occult Blood|occult blood
724237|NCT01052922|Sigmoidoscopy|sigmoidoscopy
724238|NCT01052922|Health Behavior|health behavior
724239|NCT01052935|Group B streptococcus|group b streptococcus
724240|NCT01052935|GBS|gbs
724241|NCT01052935|Vaccine|vaccine
724242|NCT01052948|dopamine agonists|dopamine agonists
724243|NCT01052948|cabergoline|cabergoline
724244|NCT01052948|Parkinson's disease|parkinson's disease
724245|NCT01052948|hyperprolactinemia|hyperprolactinemia
724246|NCT01052948|epidemiology|epidemiology
724247|NCT01052948|cardiac valvulopathy|cardiac valvulopathy
724248|NCT01052961|severe influenza|severe influenza
724249|NCT01052961|hospitalized adults|hospitalized adults
724250|NCT01052961|oseltamivir treatment|oseltamivir treatment
724251|NCT01052974|femoral neck fracture|femoral neck fracture
724252|NCT01052974|analgesia|analgesia
724253|NCT01052987|Gout|gout
724254|NCT01052987|Hyperuricemia|hyperuricemia
724255|NCT01053000|ACTINIC KERATOSES|actinic keratoses
724256|NCT01053000|HAND|hand
724257|NCT01053000|FOREARM|forearm
724258|NCT01053013|macrobead|macrobead
724259|NCT01053013|biological|biological
724260|NCT01053013|mouse cells|mouse cells
724261|NCT01053026|Angiotensin receptor II antagonist|angiotensin receptor ii antagonist
724262|NCT01053052|Patency Tests, Fallopian Tubes|patency tests, fallopian tubes
724263|NCT01053052|Hysterosalpingography|hysterosalpingography
724264|NCT01053052|Sonography, Medical|sonography, medical
724265|NCT01053065|Atherosclerosis|atherosclerosis
724266|NCT01053065|Macrophages|macrophages
724267|NCT01053065|Carotid arteries|carotid arteries
724268|NCT01053065|Statin|statin
724269|NCT01053078|Type 1 diabetes|type 1 diabetes
724270|NCT01053078|Hypoglycemia unawareness|hypoglycemia unawareness
724271|NCT01053078|low blood sugar|low blood sugar
724272|NCT01053091|exercise-base rehabilitation|exercise-base rehabilitation
724273|NCT01053091|diastolic heart failure|diastolic heart failure
724274|NCT01053091|cardiovascular function|cardiovascular function
724275|NCT01053091|aerobic fitness|aerobic fitness
724276|NCT01053104|Colorectal cancer|colorectal cancer
724277|NCT01053104|Breast cancer|breast cancer
724278|NCT01053104|Capecitabine|capecitabine
724279|NCT01053104|Docetaxel|docetaxel
724280|NCT01053104|Mobile phone|mobile phone
724281|NCT01053104|Toxicity|toxicity
724282|NCT01053104|Metastatic|metastatic
724283|NCT01053117|central venous catheter|central venous catheter
724284|NCT01053117|arteriovenous fistula|arteriovenous fistula
724285|NCT01053117|hemodialysis|hemodialysis
724286|NCT01053117|vascular access|vascular access
724287|NCT01053117|dialysis|dialysis
724288|NCT01053130|obesity|obesity
724289|NCT01053130|bariatric surgery|bariatric surgery
724290|NCT01053130|chronic kidney disease|chronic kidney disease
724291|NCT01053130|weight loss|weight loss
724292|NCT01053130|exercise|exercise
724293|NCT01053143|Influenza|influenza
724294|NCT01053143|Pandemic Influenza|pandemic influenza
724295|NCT01053143|Swine-Origin Influenza A/H1N1 Non-adjuvanted Vaccine|swine-origin influenza a/h1n1 non-adjuvanted vaccine
724296|NCT01053143|Influenza A Virus, H1N1 subtype|influenza a virus, h1n1 subtype
724297|NCT01053143|Adults|adults
724298|NCT01058551|Sleep Apnea|sleep apnea
724299|NCT01058551|Atrial Fibrillation|atrial fibrillation
724300|NCT01058564|GERD|gerd
724301|NCT01058577|diabetes|diabetes
724302|NCT01058590|Inflammation|inflammation
724303|NCT01058590|Adenotonsillectomy|adenotonsillectomy
724304|NCT01058603|Infertility|infertility
724305|NCT01058603|Cell Culture|cell culture
724306|NCT01058603|AECC|aecc
724307|NCT01058603|Endocell|endocell
724308|NCT01058603|IVF|ivf
724309|NCT01058629|Hybrid|hybrid
724310|NCT01058629|contact lens|contact lens
724311|NCT01058629|myopia|myopia
724312|NCT01058629|hyperopia|hyperopia
724313|NCT01058629|near sighted|near sighted
724314|NCT01058629|astigmatism|astigmatism
724315|NCT01058629|far sighted|far sighted
724316|NCT01058642|pain|pain
724317|NCT01058642|delta opioid receptor agonist|delta opioid receptor agonist
724318|NCT01058655|Colorectal Cancer|colorectal cancer
724319|NCT01058668|Acute Mania|acute mania
724320|NCT01058668|Bipolar I Disorder|bipolar i disorder
724321|NCT01058681|LH pulsatility|lh pulsatility
724322|NCT01058681|GnRH regulation|gnrh regulation
724323|NCT01058681|isocaloric nutrition|isocaloric nutrition
724324|NCT01058681|hypercaloric nutrition|hypercaloric nutrition
724325|NCT01058681|euglycemic clamps|euglycemic clamps
724326|NCT01058681|hyperinsulinemic clamps|hyperinsulinemic clamps
724327|NCT01058681|testosterone|testosterone
724328|NCT01058681|LH|lh
724329|NCT01058681|leptine|leptine
724330|NCT01058681|ghrelin|ghrelin
724331|NCT01058681|PYY|pyy
724332|NCT01058681|CCK|cck
724333|NCT01058681|GLP-1|glp-1
724334|NCT01058681|GIP|gip
724335|NCT01058681|cortisol|cortisol
724336|NCT01058694|Mobile phones,|mobile phones,
724337|NCT01058694|Medication Adherence|medication adherence
724338|NCT01058694|Micro-Electrical-Mechanical Systems|micro-electrical-mechanical systems
724339|NCT01058694|HIV Infections|hiv infections
724340|NCT01058707|Solid tumors, MLN0128, TORC1/2 inhibitors|solid tumors, mln0128, torc1/2 inhibitors
724341|NCT01058720|Vitamin D|vitamin d
724342|NCT01058720|Supplementation|supplementation
724343|NCT01058720|Adolescence|adolescence
724344|NCT01058733|semi-automatic response system (SARS)|semi-automatic response system (sars)
724345|NCT01058733|Diabetes Mellitus|diabetes mellitus
724346|NCT01058733|Internet|internet
724347|NCT01058733|ubiquitous health care system|ubiquitous health care system
724348|NCT01058746|pancreas|pancreas
724349|NCT01058746|surgery|surgery
724350|NCT01058746|Pancreaticoduodenectomy|pancreaticoduodenectomy
724351|NCT01058746|Central Pancreatectomy|central pancreatectomy
724352|NCT01058746|Distal Pancreatectomy|distal pancreatectomy
724353|NCT01058746|resection|resection
724354|NCT01058746|IV fluids|iv fluids
724355|NCT01058746|09-185|09-185
724356|NCT01058759|non-small cell lung cancer|non-small cell lung cancer
724357|NCT01058759|NSCLC|nsclc
724358|NCT01058759|Enoxaparin|enoxaparin
724359|NCT01058759|Locally Advanced or Metastatic Non-small Cell Lung Cancer stadium IIIb/IV|locally advanced or metastatic non-small cell lung cancer stadium iiib/iv
724360|NCT01058772|Induced Labour|induced labour
724361|NCT01058772|Expectant Management|expectant management
724362|NCT01058772|C-section rate|c-section rate
724363|NCT01058772|Maternal Outcomes|maternal outcomes
724364|NCT01058772|Neonatal Outcomes|neonatal outcomes
724365|NCT01058785|Gene therapy|gene therapy
724366|NCT01058785|Flow cytometry|flow cytometry
724367|NCT01058785|Immunoenzyme technique|immunoenzyme technique
724368|NCT01058785|Laboratory biomarker analysis|laboratory biomarker analysis
724369|NCT01058785|Tumor cell-derivative vaccine therapy|tumor cell-derivative vaccine therapy
724370|NCT01058798|Neuroblastoma|neuroblastoma
724371|NCT01058798|B4GALNT3|b4galnt3
724372|NCT01058798|Prognosis|prognosis
724373|NCT01058811|lung cancer|lung cancer
724374|NCT01058824|Bioequivalence|bioequivalence
724375|NCT01058824|Lincomycin Hydrocloride|lincomycin hydrocloride
724376|NCT01058837|Sudden Cardiac Death|sudden cardiac death
724377|NCT01058837|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
724378|NCT01058837|Ventricular Fibrillation|ventricular fibrillation
724379|NCT01058876|Smoking|smoking
724380|NCT01058876|nicotine|nicotine
724381|NCT01060020|Aortic valve stenosis|aortic valve stenosis
724382|NCT01060020|Sildenafil|sildenafil
724383|NCT01060020|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
724384|NCT01060020|Hypertension, Pulmonary|hypertension, pulmonary
724385|NCT01060033|Squamous cell cervical cancer|squamous cell cervical cancer
724386|NCT01060046|biologic mesh|biologic mesh
724387|NCT01060046|ventral hernia repair|ventral hernia repair
724388|NCT01060046|breast reconstruction|breast reconstruction
724389|NCT01060046|MMPs|mmps
724390|NCT01060059|diabetes; exenatide; Byetta; basal insulin; Amylin; Lilly|diabetes; exenatide; byetta; basal insulin; amylin; lilly
724391|NCT01060085|Breast Cancer|breast cancer
724392|NCT01060111|Migraine|migraine
724393|NCT01060111|Topiramate|topiramate
724394|NCT01060111|Propranolol|propranolol
724395|NCT01060124|Pain; Cancer|pain; cancer
724396|NCT01060124|TTS-Fentanyl D-trans|tts-fentanyl d-trans
724397|NCT01060124|Durogesic D-trans|durogesic d-trans
724398|NCT01060137|fentanyl matrix|fentanyl matrix
724399|NCT01060150|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
724400|NCT01060150|Methylphenidate hydrochloride|methylphenidate hydrochloride
724497|NCT01060579|Glaucoma|glaucoma
724401|NCT01060150|Methylphenidate|methylphenidate
724402|NCT01060150|CONCERTA|concerta
724403|NCT01060163|Clopidogrel|clopidogrel
724404|NCT01060163|Tranexamic Acid|tranexamic acid
724405|NCT01060163|Cardiac Surgical Procedures|cardiac surgical procedures
724406|NCT01060163|Hemostasis|hemostasis
724407|NCT01060176|tranexamic acid|tranexamic acid
724408|NCT01060176|cardiac surgery procedures|cardiac surgery procedures
724409|NCT01060176|hemostasis|hemostasis
724410|NCT01060176|anti-inflammation|anti-inflammation
724411|NCT01060189|ulinastatin|ulinastatin
724412|NCT01060189|tranexamic acid|tranexamic acid
724413|NCT01060189|cardiac surgery procedures|cardiac surgery procedures
724414|NCT01060189|hemostasis|hemostasis
724415|NCT01060189|anti-inflammation|anti-inflammation
724416|NCT01060202|Multiple Myeloma|multiple myeloma
724417|NCT01060202|Bortezomib|bortezomib
724418|NCT01060202|Velcade|velcade
724419|NCT01060202|QoL|qol
724420|NCT01060202|Proteasome inhibitor|proteasome inhibitor
724421|NCT01060202|EORTC QLQ C30|eortc qlq c30
724422|NCT01060202|EQ 5D|eq 5d
724423|NCT01060215|effusion|effusion
724424|NCT01060215|osteoarthritis|osteoarthritis
724425|NCT01060215|knee|knee
724717|NCT01061541|Tetanus|tetanus
724426|NCT01060228|Paliperidone ER|paliperidone er
724427|NCT01060228|INVEGA|invega
724428|NCT01060228|Divalproex sodium|divalproex sodium
724429|NCT01060228|Depakote ER|depakote er
724430|NCT01060228|Pharmacokinetics|pharmacokinetics
724431|NCT01060228|Valproic Acid|valproic acid
724432|NCT01060228|Human Experimentation|human experimentation
724433|NCT01060241|Remote Blood Glucose Monitoring System, Type 2 Diabetes|remote blood glucose monitoring system, type 2 diabetes
751879|NCT01171040|heart failure|heart failure
724434|NCT01060254|Interstitial cystitis (IC) and/or painful bladder syndrome (PBS)-related pain|interstitial cystitis (ic) and/or painful bladder syndrome (pbs)-related pain
724435|NCT01060254|Moderate to severe chronic bladder pain|moderate to severe chronic bladder pain
724436|NCT01060254|JNJ-42160443|jnj-42160443
724437|NCT01060280|low back pain|low back pain
724438|NCT01060280|physiotherapy|physiotherapy
724439|NCT01060280|exercise|exercise
724440|NCT01060280|active management|active management
724441|NCT01060293|Heart Failure|heart failure
724442|NCT01060293|Dopamine|dopamine
724443|NCT01060293|Furosemide|furosemide
724444|NCT01060293|Worsening Renal Function|worsening renal function
724445|NCT01060293|Hypokalemia|hypokalemia
724446|NCT01060293|Outcomes|outcomes
724447|NCT01060293|Prognosis|prognosis
724448|NCT01060345|DCIS|dcis
724449|NCT01060358|lumbar spine|lumbar spine
724450|NCT01060358|low back pain|low back pain
724451|NCT01060371|Spinocerebellar Ataxia|spinocerebellar ataxia
724452|NCT01060371|Natural History|natural history
724453|NCT01060371|Genetic Modifiers|genetic modifiers
724454|NCT01060371|DNA testing|dna testing
724455|NCT01060397|Alcohol|alcohol
724456|NCT01060397|nurse|nurse
724457|NCT01060397|alcohol dependence|alcohol dependence
724458|NCT01060397|acute hospital|acute hospital
724459|NCT01060397|brief interventions|brief interventions
724460|NCT01060410|Myelosuppression|myelosuppression
724461|NCT01060410|Infection|infection
724462|NCT01060410|Nausea|nausea
724463|NCT01060423|colorectal|colorectal
724464|NCT01060423|liver metastasis|liver metastasis
724465|NCT01060423|KRAS wildtype|kras wildtype
724466|NCT01060423|chemoembolization|chemoembolization
724467|NCT01060423|irinotecan eluting beads|irinotecan eluting beads
724468|NCT01060436|sleep apnea|sleep apnea
724469|NCT01060436|sleep disordered breathing|sleep disordered breathing
724470|NCT01060436|CPAP|cpap
724471|NCT01060436|BiPAP|bipap
724472|NCT01060436|treatment outcomes|treatment outcomes
724473|NCT01060449|cardiac resynchronization therapy|cardiac resynchronization therapy
724474|NCT01060449|congestive heart failure|congestive heart failure
724475|NCT01060462|Defervescence rate|defervescence rate
724476|NCT01060462|Defervescence timing|defervescence timing
724477|NCT01060462|Itraconazole|itraconazole
724478|NCT01060475|Transplant|transplant
724479|NCT01060488|GH secretion tests|gh secretion tests
724480|NCT01060488|adverse effects|adverse effects
724481|NCT01060488|adult growth hormone deficiency|adult growth hormone deficiency
724482|NCT01060488|growth-hormone releasing hormone and arginine test|growth-hormone releasing hormone and arginine test
724483|NCT01060488|insulin tolerance test|insulin tolerance test
724484|NCT01060488|GHRH + Arginine test|ghrh + arginine test
724485|NCT01060501|rectal cancer|rectal cancer
724486|NCT01060501|adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
724487|NCT01060501|5-FU, interferon-alpha|5-fu, interferon-alpha
724488|NCT01060501|Locally advanced resectable rectal cancer (UICC stage II and III)|locally advanced resectable rectal cancer (uicc stage ii and iii)
724489|NCT01060514|Lung cancer|lung cancer
724490|NCT01060514|Breast cancer|breast cancer
724491|NCT01060527|irritable bowel syndrome,protease activity,China|irritable bowel syndrome,protease activity,china
724492|NCT01060540|genetic screening|genetic screening
724493|NCT01060553|Post-traumatic stress disorders|post-traumatic stress disorders
724494|NCT01060553|Acupuncture|acupuncture
724495|NCT01060553|Quality of life|quality of life
724496|NCT01060553|sleep disorder|sleep disorder
724498|NCT01060592|Gastric Band|gastric band
724499|NCT01060592|LapBand|lapband
724500|NCT01060592|Bariatric Surgery|bariatric surgery
724501|NCT01060605|islet transplantation|islet transplantation
724502|NCT01060605|insulin independence|insulin independence
724503|NCT01060605|C-peptide secretion|c-peptide secretion
724504|NCT01060631|bispectral index|bispectral index
724505|NCT01060631|lesions|lesions
724506|NCT01060631|consciousness|consciousness
724507|NCT01060644|Maxillary Sinus|maxillary sinus
724508|NCT01060644|Bone Augmentation|bone augmentation
724509|NCT01060644|Dental Implant|dental implant
724510|NCT01060644|Sinus Membrane|sinus membrane
724511|NCT01060657|X-ray Computed Tomography|x-ray computed tomography
724512|NCT01060657|Coronary vessels|coronary vessels
724513|NCT01060657|Radiation dosage|radiation dosage
724514|NCT01060670|Foot Ulcer|foot ulcer
724515|NCT01060670|Diabetic|diabetic
724516|NCT01060670|Wound Healing|wound healing
724517|NCT01060670|Integra Dermal Regeneration Template|integra dermal regeneration template
724518|NCT01060670|Full Thickness|full thickness
724519|NCT01060670|Neuropathic|neuropathic
724520|NCT01060670|Omnigraft|omnigraft
724521|NCT01060683|hemoglobin|hemoglobin
724522|NCT01060683|Coagulation variables|coagulation variables
724523|NCT01060683|blood chemistry|blood chemistry
724524|NCT01060683|Blood gas analysis|blood gas analysis
724525|NCT01060696|Infertility|infertility
724526|NCT01060696|Saline infusion sonohysterography|saline infusion sonohysterography
724527|NCT01060696|Pain|pain
724528|NCT01060696|Hyoscine|hyoscine
724529|NCT01060696|Mefenamic acid|mefenamic acid
724530|NCT01060696|women|women
724531|NCT01060709|Carbon dioxide|carbon dioxide
724532|NCT01060709|TcC02|tcc02
724533|NCT01060709|Hypoventilation|hypoventilation
724534|NCT01060709|endoscopic|endoscopic
724535|NCT01060709|elective colonoscopy and requiring sedation|elective colonoscopy and requiring sedation
724536|NCT01060722|Healthy Male Volunteers|healthy male volunteers
724537|NCT01060735|Vitamin D|vitamin d
724538|NCT01060735|pregnancy|pregnancy
724539|NCT01060735|children|children
724540|NCT01060735|bone|bone
724541|NCT01060735|quantitative ultrasound|quantitative ultrasound
724542|NCT01060735|Healthy pregnant women|healthy pregnant women
724543|NCT01060748|Vaccination|vaccination
724544|NCT01060748|Challenge|challenge
724545|NCT01060748|Diarrhea|diarrhea
724546|NCT01060748|ETEC illness|etec illness
724547|NCT01060748|Travelers diarrhea|travelers diarrhea
724548|NCT01060748|ETEC|etec
724549|NCT01060748|Enterotoxigenic E.coli|enterotoxigenic e.coli
724550|NCT01060761|cancer|cancer
724551|NCT01060761|Rehabilitation program (patient and a relative together)|rehabilitation program (patient and a relative together)
724552|NCT01060761|counselling|counselling
724553|NCT01060761|retreat weekend|retreat weekend
724554|NCT01060774|Bupivacaine|bupivacaine
724555|NCT01060774|Lidocaine|lidocaine
724556|NCT01060774|Inflammation|inflammation
724557|NCT01060774|Pain|pain
724558|NCT01060774|Local Anesthetic|local anesthetic
724559|NCT01060800|Chiari|chiari
724560|NCT01060800|Chiari Type I|chiari type i
724561|NCT01060800|Chiari Type I Malformation|chiari type i malformation
724562|NCT01060800|Familial Chiari|familial chiari
724563|NCT01060813|cirrhosis|cirrhosis
724564|NCT01060813|exercise|exercise
724565|NCT01060813|leucin|leucin
724566|NCT01060813|glutamine synthetase|glutamine synthetase
724567|NCT01060826|acute pancreatits|acute pancreatits
724568|NCT01060839|counseling|counseling
724569|NCT01060865|hypertension|hypertension
724570|NCT01060865|aliskiren|aliskiren
724571|NCT01060865|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
724572|NCT01060878|Early-stage|early-stage
724573|NCT01060891|patients infected with with multiresistant gram-negative bacteria|patients infected with with multiresistant gram-negative bacteria
724574|NCT01060904|Antibodies, Monoclonal|antibodies, monoclonal
724575|NCT01060904|Antibody-Drug Conjugate|antibody-drug conjugate
724576|NCT01060904|Antigens, CD30|antigens, cd30
724577|NCT01060904|Disease, Hodgkin|disease, hodgkin
724578|NCT01060904|Hematologic Diseases|hematologic diseases
724579|NCT01060904|Immunotherapy|immunotherapy
724580|NCT01060904|Lymphoma|lymphoma
724581|NCT01060904|monomethyl auristatin E|monomethyl auristatin e
724582|NCT01060917|diabetes|diabetes
724583|NCT01060930|Nitric oxide|nitric oxide
724584|NCT01060930|Diesel exhaust|diesel exhaust
724585|NCT01060930|Air pollution|air pollution
724586|NCT01060930|Cardiac output|cardiac output
724587|NCT01060930|Healthy volunteers|healthy volunteers
724588|NCT01060943|injectable collagen filler|injectable collagen filler
724589|NCT01060943|correction of wrinkles and folds|correction of wrinkles and folds
724590|NCT01060943|enrolled : 73|enrolled : 73
724591|NCT01060943|withdrawal : 4|withdrawal : 4
724592|NCT01060943|ongoing : 0|ongoing : 0
724593|NCT01060943|completed : 69|completed : 69
724594|NCT01060956|Urinary tract infection with two bacteria in culture|urinary tract infection with two bacteria in culture
724595|NCT01060969|Acute Mountain Sickness|acute mountain sickness
724596|NCT01060969|travellers|travellers
724597|NCT01060969|Acetazolamide|acetazolamide
724598|NCT01060969|Tadalafil|tadalafil
724599|NCT01060969|Acute Mountain Sickness assessed by Lake Louise score|acute mountain sickness assessed by lake louise score
724600|NCT01060969|High altitude pulmonary edema|high altitude pulmonary edema
724601|NCT01060969|High altitude cerebral edema|high altitude cerebral edema
724602|NCT01060982|Primary hyperparathyroidism|primary hyperparathyroidism
724603|NCT01060982|High Intensity Focused Ultrasound|high intensity focused ultrasound
724604|NCT01060982|Parathyroid tumor|parathyroid tumor
724605|NCT01060982|Parathyroid hormone|parathyroid hormone
724606|NCT01060982|Calcium|calcium
724607|NCT01060995|Informed Consent|informed consent
724608|NCT01060995|Oral Health|oral health
724609|NCT01060995|Patient Decision-making|patient decision-making
724610|NCT01061008|Exercise; arteriovenous fistula; chronic kidney disease|exercise; arteriovenous fistula; chronic kidney disease
724611|NCT01061021|HIV prevention|hiv prevention
724612|NCT01061021|Treatment adherence|treatment adherence
724613|NCT01061021|Treatment for Prevention|treatment for prevention
724614|NCT01061034|pharmacokinetics|pharmacokinetics
724615|NCT01061034|aspirin|aspirin
724616|NCT01061034|proton pump inhiditor|proton pump inhiditor
724617|NCT01061047|patients infected with a bacteria sensible to ertapeneme|patients infected with a bacteria sensible to ertapeneme
724618|NCT01061060|Prostaglandin I2|prostaglandin i2
724619|NCT01061060|Beraprost Na|beraprost na
724620|NCT01061060|Endothelial cell function|endothelial cell function
724621|NCT01061086|Acute Coronary Syndromes|acute coronary syndromes
724622|NCT01061086|Epidemiology|epidemiology
724623|NCT01061086|Management of disease|management of disease
724624|NCT01061086|Outcomes|outcomes
724626|NCT01061099|Type II or Type III Osteogenesis imperfecta|type ii or type iii osteogenesis imperfecta
724627|NCT01061099|OI|oi
724628|NCT01061099|Mesenchymal Stromal Cells|mesenchymal stromal cells
724629|NCT01061099|MSC|msc
724630|NCT01061112|drug interactions|drug interactions
724631|NCT01061112|genetics|genetics
724632|NCT01061112|healthy volunteers|healthy volunteers
724633|NCT01061112|normal controls|normal controls
724634|NCT01061112|CYP2C9|cyp2c9
724635|NCT01061125|atrial fibrillation|atrial fibrillation
724636|NCT01061125|implantable loop recorder|implantable loop recorder
724637|NCT01061125|TTM|ttm
724638|NCT01061138|breast cancer|breast cancer
724639|NCT01061138|screening mammograms|screening mammograms
724640|NCT01061138|breast biopsy|breast biopsy
724641|NCT01061177|Leukemia|leukemia
724642|NCT01061177|myeloid|myeloid
724643|NCT01061177|myelogenous|myelogenous
724644|NCT01061177|chronic BCR-ABL positive|chronic bcr-abl positive
724645|NCT01061177|Nilotinib|nilotinib
724646|NCT01061177|Philadelphia chromosome|philadelphia chromosome
724647|NCT01061177|CML in chronic phase|cml in chronic phase
724648|NCT01061190|Stroke|stroke
724649|NCT01061203|Rhinitis|rhinitis
724650|NCT01061203|allergic|allergic
724651|NCT01061203|Seasonal|seasonal
724652|NCT01061203|grass|grass
724653|NCT01061203|Asthma|asthma
724654|NCT01061216|Diabetes|diabetes
724655|NCT01061216|Insulin Therapy|insulin therapy
724656|NCT01061216|Blood Glucose|blood glucose
724657|NCT01061216|Basal insulin|basal insulin
724658|NCT01061216|Diabetics|diabetics
724659|NCT01061242|Neurocognitive function|neurocognitive function
724660|NCT01061242|Sleep quality|sleep quality
724661|NCT01061242|Critical care|critical care
724662|NCT01061242|Quality Assurance, health care|quality assurance, health care
724663|NCT01061255|Stress|stress
724664|NCT01061255|Cortisol|cortisol
724665|NCT01061255|Clinical reasoning|clinical reasoning
724666|NCT01061255|Ambulatory setting|ambulatory setting
724667|NCT01061255|Medical students|medical students
724668|NCT01061255|Year 6 medical students|year 6 medical students
724669|NCT01061268|Relief of dry eye symptoms following implantation of TMF IOL|relief of dry eye symptoms following implantation of tmf iol
724670|NCT01061281|Aphakia following refractive lensectomy to treat presbyopia|aphakia following refractive lensectomy to treat presbyopia
724671|NCT01061294|Assess the efficacy, predictability and safety of the Advanced CustomVue™ iLASIK procedure.|assess the efficacy, predictability and safety of the advanced customvue™ ilasik procedure.
724672|NCT01061307|Fe deficiency, Zn deficiency, vitamin A deficiency|fe deficiency, zn deficiency, vitamin a deficiency
724673|NCT01061320|Alpha-Tocopherol (Vitamin E)|alpha-tocopherol (vitamin e)
724674|NCT01061320|Contrast induced nephropathy|contrast induced nephropathy
724675|NCT01061320|Chronic kidney disease|chronic kidney disease
724676|NCT01061320|Coronary procedures|coronary procedures
724677|NCT01061346|Fructose|fructose
724678|NCT01061346|Glucose|glucose
724679|NCT01061359|Breast Cancer|breast cancer
724680|NCT01061359|Neoadjuvant Treatment|neoadjuvant treatment
724681|NCT01061359|Chemotherapy|chemotherapy
724682|NCT01061359|Adjuvant|adjuvant
724683|NCT01061359|Epirubicin|epirubicin
724684|NCT01061372|RLS|rls
724685|NCT01061398|cardiac ct|cardiac ct
724686|NCT01061398|stress testing|stress testing
724687|NCT01061398|coronary artery disease|coronary artery disease
724688|NCT01061424|pediatric asthma|pediatric asthma
724689|NCT01061437|H. pylori|h. pylori
724690|NCT01061450|Diastolic dysfunction|diastolic dysfunction
724691|NCT01061450|hypertension|hypertension
724692|NCT01061450|Statins|statins
724693|NCT01061450|ACE inhibitor|ace inhibitor
724694|NCT01061450|Echocardiography|echocardiography
724695|NCT01061463|Radiation cataracts|radiation cataracts
724696|NCT01061463|Lens opacities|lens opacities
724697|NCT01061463|X-rays|x-rays
724698|NCT01061463|Interventional Cardiologists|interventional cardiologists
724699|NCT01061463|Electrophysiologists|electrophysiologists
724700|NCT01061476|sleep apnea|sleep apnea
724701|NCT01061476|treatment|treatment
724702|NCT01061476|collapsibility|collapsibility
724703|NCT01061476|expiratory nasal resistance|expiratory nasal resistance
724704|NCT01061489|neuroplasticity|neuroplasticity
724705|NCT01061489|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
724706|NCT01061489|Alzheimer|alzheimer
724707|NCT01061489|sensory-cognitive training|sensory-cognitive training
724708|NCT01061489|physical fitness|physical fitness
724709|NCT01061502|Burns|burns
724710|NCT01061502|Wounds and Injuries|wounds and injuries
724711|NCT01061502|Skin Grafts, Bioelectric|skin grafts, bioelectric
724712|NCT01061502|Grafting, skin|grafting, skin
724713|NCT01061528|cigarette smoking|cigarette smoking
724714|NCT01061528|smoking cessation|smoking cessation
724715|NCT01061528|nicotine dependence|nicotine dependence
724716|NCT01061541|Pertussis|pertussis
724720|NCT01061541|DTPw-HBV vaccine|dtpw-hbv vaccine
724721|NCT01061541|Tritanrix™-HepB|tritanrix™-hepb
724722|NCT01061541|Haemophilus influenzae type b|haemophilus influenzae type b
724723|NCT01061541|Diphtheria|diphtheria
724724|NCT01061541|Hib vaccine|hib vaccine
724725|NCT01061554|Bioavailability|bioavailability
724726|NCT01061554|Eicosapentaenoic acid|eicosapentaenoic acid
724727|NCT01061554|Docosahexaenoic acid|docosahexaenoic acid
724728|NCT01061554|Soft gel capsules|soft gel capsules
724729|NCT01061554|Gastric stable emulsion|gastric stable emulsion
724731|NCT01061554|Tri-glycerides|tri-glycerides
724732|NCT01061554|Marine phospholipids|marine phospholipids
724733|NCT01061580|Bone Marrow Concentrate|bone marrow concentrate
724734|NCT01061580|CABG|cabg
724735|NCT01061580|Cardiac|cardiac
724736|NCT01061580|Stem Cell|stem cell
724737|NCT01061593|TB|tb
724738|NCT01061593|MDR-TB|mdr-tb
724739|NCT01061593|XDR-TB|xdr-tb
724740|NCT01061593|TB/HIV|tb/hiv
724741|NCT01061619|prediagnostic symptoms|prediagnostic symptoms
724742|NCT01061619|sentinel events|sentinel events
724743|NCT01061619|pathway to diagnosis|pathway to diagnosis
724744|NCT01061632|deadlift|deadlift
724745|NCT01061632|motor control|motor control
724746|NCT01061632|exercises|exercises
724747|NCT01061632|pain|pain
724748|NCT01061632|function|function
724749|NCT01061632|functional capacity|functional capacity
724750|NCT01061645|MDT and DLT|mdt and dlt
724751|NCT01061671|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
724752|NCT01061671|COPD|copd
724753|NCT01061671|Exacerbation|exacerbation
724754|NCT01061671|Lung function|lung function
724755|NCT01061671|Cardiovascular|cardiovascular
724756|NCT01061671|Smoking|smoking
724757|NCT01061671|Statins|statins
724758|NCT01061671|Simvastatin|simvastatin
724759|NCT01061684|fatty liver disease|fatty liver disease
724760|NCT01061684|NASH|nash
724761|NCT01061684|NAFLD|nafld
724762|NCT01061684|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
724763|NCT01061710|Smoking|smoking
724764|NCT01061710|smoking cessation|smoking cessation
724765|NCT01061710|Japanese|japanese
724766|NCT01061710|varenicline|varenicline
724767|NCT01061710|retreatment|retreatment
724768|NCT01061710|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
724769|NCT01061762|Treatment adherence|treatment adherence
724770|NCT01061762|Low literacy skills|low literacy skills
724771|NCT01061762|HIV treatment|hiv treatment
724772|NCT01061775|Hypothalamic Obesity|hypothalamic obesity
724773|NCT01061775|Exenatide|exenatide
724774|NCT01061775|Byetta|byetta
724775|NCT01061775|Craniopharyngioma|craniopharyngioma
724776|NCT01061788|Phase I|phase i
724777|NCT01061788|Solid Tumor|solid tumor
724778|NCT01061788|AMG 479|amg 479
724779|NCT01061788|Panitumumab|panitumumab
724780|NCT01061788|Everolimus|everolimus
724781|NCT01061788|RAD001|rad001
724782|NCT01061788|Duke|duke
724783|NCT01061788|Subjects with refractory advanced solid tumors|subjects with refractory advanced solid tumors
724784|NCT01061788|non-small cell lung cancer|non-small cell lung cancer
724785|NCT01061801|caregivers|caregivers
724786|NCT01061801|cancer|cancer
724787|NCT01061801|emotion|emotion
724788|NCT01061801|protective buffering|protective buffering
724789|NCT01061814|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
724790|NCT01061814|LDL (low density lipoprotein)|ldl (low density lipoprotein)
724791|NCT01061814|mipomersen|mipomersen
724792|NCT01061814|ISIS301012|isis301012
724793|NCT01061814|antisense|antisense
724794|NCT01061827|GMS-package;dementia;depression|gms-package;dementia;depression
724795|NCT01061840|Ewings Sarcoma|ewings sarcoma
724796|NCT01061840|Non Small Cell Lung Cancer|non small cell lung cancer
724797|NCT01061840|Liver Cancer|liver cancer
724798|NCT01061853|Oral lichen planus|oral lichen planus
724799|NCT01061853|chronic inflammatory|chronic inflammatory
724800|NCT01061853|mucous membranes|mucous membranes
725112|NCT01068015|HSV-2|hsv-2
724801|NCT01061853|erosive lesions|erosive lesions
724802|NCT01061866|Thalidomide|thalidomide
724803|NCT01061866|Antiepileptic drugs|antiepileptic drugs
724804|NCT01061866|Refractory epilepsy|refractory epilepsy
724805|NCT01061866|Sedative drugs|sedative drugs
724806|NCT01061879|umbilical cord|umbilical cord
724807|NCT01061879|umbilical cord blood collection|umbilical cord blood collection
724808|NCT01061879|pregnancy|pregnancy
724809|NCT01061905|health behavior|health behavior
724810|NCT01061905|behavioral economics|behavioral economics
724811|NCT01061905|calorie labeling|calorie labeling
724812|NCT01061905|exercise|exercise
724813|NCT01061918|Compare the visual outcomes with bilateral implantation of Tecnis MF and ReSTOR IOLs 6 months post cataract surgery.|compare the visual outcomes with bilateral implantation of tecnis mf and restor iols 6 months post cataract surgery.
724814|NCT01061931|MRI|mri
724815|NCT01061931|left-sided atrial catheter ablation|left-sided atrial catheter ablation
724816|NCT01061931|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
724817|NCT01061931|cryoballoon technique|cryoballoon technique
724818|NCT01061931|mesh ablator catheter|mesh ablator catheter
724819|NCT01061931|stroke|stroke
724820|NCT01061931|silent stroke|silent stroke
724821|NCT01061931|major complications|major complications
724822|NCT01061944|biopsy|biopsy
724823|NCT01061944|tumor biopsy|tumor biopsy
724824|NCT01061944|genetic studies|genetic studies
724825|NCT01061957|Treatment outcome|treatment outcome
724826|NCT01061957|HIV treatment|hiv treatment
724827|NCT01061970|Hypogonadism|hypogonadism
724828|NCT01061970|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
724830|NCT01061983|Deep brain stimulation|deep brain stimulation
724831|NCT01061983|Treatment refractory|treatment refractory
724832|NCT01061983|Ventral internal capsule/ventral striatum|ventral internal capsule/ventral striatum
724833|NCT01061983|Neurosurgery|neurosurgery
724834|NCT01061983|Neuroimaging|neuroimaging
724835|NCT01061996|Ulcerative Colitis|ulcerative colitis
724836|NCT01062022|intervention|intervention
724837|NCT01062022|combat wounded|combat wounded
724838|NCT01062022|family|family
724839|NCT01062022|Focus-CI|focus-ci
724840|NCT01062035|Advanced colon polyp|advanced colon polyp
724841|NCT01062035|Adenomatous colon polyp|adenomatous colon polyp
724842|NCT01062035|Adenoma, villous colon polyp|adenoma, villous colon polyp
724843|NCT01062035|Advanced colorectal adenomas|advanced colorectal adenomas
724844|NCT01062035|Colonic neoplasms|colonic neoplasms
724845|NCT01062035|High grade dysplasia|high grade dysplasia
724846|NCT01062035|Telomere blood testing|telomere blood testing
724847|NCT01062061|Varicella|varicella
724848|NCT01062087|postoperative pain|postoperative pain
724849|NCT01062087|tubal ligation|tubal ligation
724850|NCT01062087|local anesthetic|local anesthetic
724851|NCT01062100|breast cancer|breast cancer
724852|NCT01062100|molecular breast imaging|molecular breast imaging
724853|NCT01062100|MRI|mri
724854|NCT01062100|gamma camera|gamma camera
724855|NCT01062113|Acute pain after oral surgery lateral mandibular Impacted third molar tooth extraction|acute pain after oral surgery lateral mandibular impacted third molar tooth extraction
724856|NCT01062126|Pacemaker|pacemaker
724857|NCT01062126|Advanced Features|advanced features
724858|NCT01062126|Clinical Outcomes|clinical outcomes
724859|NCT01062152|Hematology|hematology
724860|NCT01062152|MDS|mds
724861|NCT01062152|Myelodysplastic Syndrome|myelodysplastic syndrome
724862|NCT01062152|Low risk MDS|low risk mds
724863|NCT01062152|Patients with non-deletion(5q)|patients with non-deletion(5q)
724864|NCT01062152|Non-deletion 5q|non-deletion 5q
724865|NCT01062152|Non del(5q)|non del(5q)
724866|NCT01062152|Revlimid|revlimid
724867|NCT01062152|lenalidomide|lenalidomide
724868|NCT01062152|Telintra|telintra
724869|NCT01062152|ezatiostat hydrochloride|ezatiostat hydrochloride
724870|NCT01062152|ezatiostat|ezatiostat
724871|NCT01062152|TLK199|tlk199
724872|NCT01062152|Glutathione|glutathione
724873|NCT01062152|Glutathione analog|glutathione analog
724874|NCT01062152|Glutathione Transferase|glutathione transferase
724875|NCT01062152|Glutathione Transferase inhibitor|glutathione transferase inhibitor
724876|NCT01062152|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
724877|NCT01062152|GSTp1-1 inhibitor|gstp1-1 inhibitor
724878|NCT01062152|Apoptosis|apoptosis
724879|NCT01062152|Differentiation|differentiation
724880|NCT01062152|Enzyme inhibitor|enzyme inhibitor
724881|NCT01062165|Echinocandin|echinocandin
724883|NCT01062165|Pharmacokinetics|pharmacokinetics
724884|NCT01062165|Pharmacodynamics|pharmacodynamics
724885|NCT01062165|Fungal infection|fungal infection
724886|NCT01062178|Small renal Mass|small renal mass
724887|NCT01062178|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
724888|NCT01062178|Renal Cell Carcinoma|renal cell carcinoma
724889|NCT01062178|noninvasive diagnosis of RCC|noninvasive diagnosis of rcc
724890|NCT01062191|hydrogel|hydrogel
724891|NCT01062191|dressing|dressing
724892|NCT01062191|burn|burn
724893|NCT01062191|joint|joint
724894|NCT01062204|Skin Graft donor sites|skin graft donor sites
724895|NCT01062230|Cancer|cancer
724896|NCT01062230|Hematologic malignancy|hematologic malignancy
724897|NCT01062243|brain injury|brain injury
724898|NCT01062243|family treatment|family treatment
724899|NCT01062256|Cough assessment in upper respiratory infection|cough assessment in upper respiratory infection
724900|NCT01062256|guaifenesin|guaifenesin
724901|NCT01062256|honey|honey
724902|NCT01062269|Bile acid sequestrant|bile acid sequestrant
724903|NCT01062269|Resin|resin
724904|NCT01062269|Cholesterol|cholesterol
724905|NCT01062269|Diabetes mellitus|diabetes mellitus
724906|NCT01062269|Lipids|lipids
724907|NCT01062269|Glucose|glucose
724908|NCT01062269|Bile Acid Sequestrant Acceptability Scale (BASA)validation study|bile acid sequestrant acceptability scale (basa)validation study
724909|NCT01062282|Pulmonary Hypertension|pulmonary hypertension
724910|NCT01062295|passenger,|passenger,
724911|NCT01062295|sleep,|sleep,
724912|NCT01062295|rest,|rest,
724913|NCT01062308|Stroke|stroke
724914|NCT01062308|Taping|taping
724915|NCT01062308|Pain|pain
724916|NCT01062308|Shoulder Injury|shoulder injury
724917|NCT01062321|Hepatitis E Virus|hepatitis e virus
724918|NCT01062321|Cytokines|cytokines
724919|NCT01062321|Pregnancy|pregnancy
725022|NCT01062711|sarcopenia|sarcopenia
724925|NCT01062373|Premature Newborns|premature newborns
724927|NCT01062373|DHA|dha
724928|NCT01062373|Mother-child|mother-child
724929|NCT01062386|prevalence|prevalence
724930|NCT01062386|transmission|transmission
724931|NCT01062386|knowledge|knowledge
724932|NCT01062386|attitude|attitude
724933|NCT01062386|practice|practice
724934|NCT01062399|adult glioblastoma|adult glioblastoma
724935|NCT01062399|adult giant cell glioblastoma|adult giant cell glioblastoma
724936|NCT01062399|adult gliosarcoma|adult gliosarcoma
724937|NCT01062438|localized osteosarcoma|localized osteosarcoma
724938|NCT01062438|metastatic osteosarcoma|metastatic osteosarcoma
724939|NCT01062451|Methamphetamine|methamphetamine
724940|NCT01062451|Perindopril|perindopril
724941|NCT01062451|Candesartan|candesartan
724942|NCT01062451|Angiotensin receptor blocker|angiotensin receptor blocker
724943|NCT01062451|ACE Inhibitor|ace inhibitor
724944|NCT01062477|Diphtheria Tetanus Pertussis Haemophilus Influenzae Type B|diphtheria tetanus pertussis haemophilus influenzae type b
724945|NCT01062490|Treosulfan|treosulfan
724947|NCT01062490|allogeneic stem cell transplantation|allogeneic stem cell transplantation
724948|NCT01062490|leukemia|leukemia
724949|NCT01062490|Conditioning|conditioning
724950|NCT01056003|gastric inlet patch|gastric inlet patch
724951|NCT01056003|prevalence|prevalence
724952|NCT01056003|globus sensations|globus sensations
724953|NCT01056016|ADHD|adhd
724954|NCT01056029|Solid Tumors|solid tumors
724955|NCT01056042|pelvic pain|pelvic pain
724956|NCT01056042|postoperative|postoperative
724957|NCT01056042|medical therapy|medical therapy
724958|NCT01056055|Ankle|ankle
724959|NCT01056055|Chronic lateral instability|chronic lateral instability
724960|NCT01056055|Modified Brostrom procedure|modified brostrom procedure
724961|NCT01056055|Suture anchor|suture anchor
724962|NCT01056055|Bone tunnel|bone tunnel
724963|NCT01062503|Cancer|cancer
724964|NCT01062503|Prostate|prostate
724965|NCT01062503|metastatic|metastatic
724966|NCT01062516|acute coronary syndrome|acute coronary syndrome
724967|NCT01062516|acute myocardial infarction|acute myocardial infarction
724968|NCT01062516|percutaneous coronary intervention|percutaneous coronary intervention
724969|NCT01062516|aspirin|aspirin
724970|NCT01062516|clopidogrel|clopidogrel
724971|NCT01062516|esomeprazole|esomeprazole
724972|NCT01062516|famotidine|famotidine
724973|NCT01062516|platelet function|platelet function
724974|NCT01062529|GH signalling|gh signalling
724975|NCT01062529|insulin resistance|insulin resistance
724976|NCT01062529|somatostatin|somatostatin
724977|NCT01062529|acromegaly|acromegaly
724978|NCT01062568|adolescents|adolescents
724979|NCT01062568|puberty|puberty
724980|NCT01062568|androgens|androgens
724981|NCT01062568|hyperandrogenemia|hyperandrogenemia
724982|NCT01062581|Recipient|recipient
724983|NCT01062581|Donor|donor
724984|NCT01062581|Organ Transplant|organ transplant
724985|NCT01062581|Registry|registry
724986|NCT01062581|University of Minnesota|university of minnesota
724987|NCT01062607|bipolar disorders|bipolar disorders
724988|NCT01062607|everyday setting|everyday setting
724989|NCT01062607|treatment adherence|treatment adherence
724990|NCT01062607|global|global
724991|NCT01062633|dental caries|dental caries
724992|NCT01062633|prevention|prevention
724993|NCT01062633|dietary supplements|dietary supplements
724994|NCT01062646|music therapy|music therapy
724995|NCT01062646|multimodal psychotherapy|multimodal psychotherapy
724996|NCT01062646|children|children
724997|NCT01062646|anxiety disorders|anxiety disorders
724998|NCT01062646|pediatric anxiety|pediatric anxiety
724999|NCT01062659|HCV|hcv
725000|NCT01062659|hepatitis C virus|hepatitis c virus
725001|NCT01062659|CHC|chc
725002|NCT01062659|chronic hepatitis c|chronic hepatitis c
725003|NCT01062659|interferon|interferon
725004|NCT01062659|ribavirin|ribavirin
725005|NCT01062659|Hepatitis, Viral, Human|hepatitis, viral, human
725006|NCT01062659|Anti-Infective Agents|anti-infective agents
725007|NCT01062659|peginterferon alfa-2a|peginterferon alfa-2a
725008|NCT01062659|peginterferon alfa-2b|peginterferon alfa-2b
725009|NCT01062672|plasticity|plasticity
725010|NCT01062672|reorganization|reorganization
725011|NCT01062672|cortical|cortical
725012|NCT01062672|fMRI|fmri
725013|NCT01062672|rehabilitation|rehabilitation
725014|NCT01062685|septic shock|septic shock
725015|NCT01062685|sepsis|sepsis
725016|NCT01062685|St02|st02
725017|NCT01062685|Near Infrared Spectroscopy|near infrared spectroscopy
725018|NCT01062685|NIRS|nirs
725019|NCT01062698|mechanical Thrombectomy|mechanical thrombectomy
725020|NCT01062698|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
725021|NCT01062698|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
725025|NCT01062711|muscle protein synthesis|muscle protein synthesis
725026|NCT01062711|muscle protein breakdown|muscle protein breakdown
725027|NCT01062711|whey|whey
725028|NCT01062711|soy|soy
725029|NCT01062711|casein|casein
725030|NCT01062711|dose response|dose response
725031|NCT01062711|resistance exercise|resistance exercise
725032|NCT01062711|unilateral|unilateral
725033|NCT01062711|knee extension|knee extension
725034|NCT01062711|whole body protein|whole body protein
725035|NCT01062724|Cholestasis|cholestasis
725036|NCT01062724|TPN|tpn
725037|NCT01062724|Neonates|neonates
725038|NCT01062724|Primene|primene
725039|NCT01062724|Trophamine|trophamine
725041|NCT01062724|Cysteine|cysteine
725042|NCT01062724|Taurine|taurine
725043|NCT01062724|Total Parenteral Nutrition|total parenteral nutrition
725044|NCT01062750|Liver Cirrhosis|liver cirrhosis
725045|NCT01062763|hypertension|hypertension
725046|NCT01062763|spironolactone|spironolactone
725047|NCT01062763|antihypertensive treatment|antihypertensive treatment
725048|NCT01062763|Type-2 diabetes|type-2 diabetes
725049|NCT01062776|dehydration|dehydration
725050|NCT01062776|fluid therapy|fluid therapy
725051|NCT01062776|pharmacokinetics|pharmacokinetics
725052|NCT01062776|hemoglobin|hemoglobin
725053|NCT01062789|lung biopsy|lung biopsy
725054|NCT01062789|computed tomograph|computed tomograph
725055|NCT01062789|respiratory motion|respiratory motion
725056|NCT01062789|Controlling respiratory motion in CT guided lung biopsies|controlling respiratory motion in ct guided lung biopsies
725057|NCT01062789|biopsy|biopsy
725058|NCT01062815|PNALD|pnald
725059|NCT01062815|PNAC|pnac
725060|NCT01062815|Parenteral Nutrition-Associated Cholestasis|parenteral nutrition-associated cholestasis
725061|NCT01062815|Congenital Anomalies of Gastrointestinal Tract|congenital anomalies of gastrointestinal tract
725062|NCT01062828|Prematurity|prematurity
725063|NCT01062828|Necrotizing Enterocolitis|necrotizing enterocolitis
725064|NCT01062828|Feeding Intolerance|feeding intolerance
725065|NCT01067833|atrial fibrillation|atrial fibrillation
725067|NCT01067846|cocaine dependence|cocaine dependence
725068|NCT01067846|relapse prevention|relapse prevention
725069|NCT01067846|computerized cognitive behavioral therapy (CBT)|computerized cognitive behavioral therapy (cbt)
725070|NCT01067846|D-cycloserine (DCS)|d-cycloserine (dcs)
725071|NCT01067859|Heart Failure|heart failure
725072|NCT01067885|Nitinol Stent|nitinol stent
725073|NCT01067885|Superficial femoral artery|superficial femoral artery
725074|NCT01067885|SFA|sfa
725075|NCT01067885|Angioplasty|angioplasty
725076|NCT01067885|peripheral artery disease|peripheral artery disease
725077|NCT01067885|peripheral artery obstructive disease|peripheral artery obstructive disease
725078|NCT01067885|PAOD|paod
725079|NCT01067885|PAD|pad
725080|NCT01067885|Peripheral Vascular Disease|peripheral vascular disease
725081|NCT01067898|vitamin D supplementation|vitamin d supplementation
725082|NCT01067898|cholecalciferol|cholecalciferol
725083|NCT01067898|PTH|pth
725084|NCT01067898|bone turnover markers|bone turnover markers
725085|NCT01067898|elderly women|elderly women
725086|NCT01067911|Postprandial lipids|postprandial lipids
725087|NCT01067911|test meal|test meal
725088|NCT01067911|fatty acids|fatty acids
725089|NCT01067924|Type 2 diabetes, motivational interviewing, physical activity maintenance, physical activity adherence|type 2 diabetes, motivational interviewing, physical activity maintenance, physical activity adherence
725090|NCT01067937|Appendicitis|appendicitis
725091|NCT01067937|children|children
725092|NCT01067950|isolated pancreas transplant|isolated pancreas transplant
725093|NCT01067950|intensive insulin therapy|intensive insulin therapy
725094|NCT01067963|self-care|self-care
725095|NCT01067963|self-management|self-management
725096|NCT01067963|health behavior change|health behavior change
725097|NCT01067963|motivational interviewing|motivational interviewing
725098|NCT01067963|computer assisted learning|computer assisted learning
725099|NCT01067976|Breast Cancer|breast cancer
725100|NCT01067976|Gadobutrol-enhanced MRI|gadobutrol-enhanced mri
725101|NCT01067976|Mammography|mammography
725102|NCT01067989|metronomic chemotherapy|metronomic chemotherapy
725103|NCT01067989|anti-angiogenic effect|anti-angiogenic effect
725104|NCT01067989|Breast cancer|breast cancer
725105|NCT01068002|Hypertension Pregnancy|hypertension pregnancy
725106|NCT01068015|MSM|msm
725107|NCT01068015|Intervention|intervention
725108|NCT01068015|Popular Opinion Leader|popular opinion leader
725109|NCT01068015|Male Circumcision|male circumcision
725110|NCT01068015|HIV|hiv
725111|NCT01068015|Syphilis|syphilis
725113|NCT01068028|Healthy volunteer study|healthy volunteer study
725114|NCT01068054|vernal keratoconjunctivitis|vernal keratoconjunctivitis
725115|NCT01068054|FK-506|fk-506
725116|NCT01068054|tacrolimus|tacrolimus
725117|NCT01068054|cyclosporine|cyclosporine
725118|NCT01068054|children|children
725119|NCT01068080|fatty acid metabolism|fatty acid metabolism
725120|NCT01068080|insulin resistance|insulin resistance
725121|NCT01068080|cardiac death|cardiac death
725122|NCT01068080|hemodialysis|hemodialysis
725123|NCT01068080|normal coronary arteries|normal coronary arteries
725221|NCT01068444|Treatment|treatment
725124|NCT01068080|Predictive values of impaired myocardial fatty acid metabolism or insulin resistance for cardiac death of hemodialysis patients with normal coronary arteries|predictive values of impaired myocardial fatty acid metabolism or insulin resistance for cardiac death of hemodialysis patients with normal coronary arteries
725125|NCT01068119|Acute coronary syndrome|acute coronary syndrome
725126|NCT01068119|percutaneous coronary angioplasty|percutaneous coronary angioplasty
725127|NCT01068119|Troponin negative|troponin negative
725128|NCT01068119|cardiac|cardiac
725129|NCT01068132|Colorectal Neoplasms|colorectal neoplasms
725130|NCT01068132|KRAS|kras
725131|NCT01068132|PTEN|pten
725132|NCT01068145|COPD|copd
725133|NCT01068158|Head lice infestation|head lice infestation
725134|NCT01068158|Pediculus humanus capitis|pediculus humanus capitis
725135|NCT01068171|diabetes|diabetes
725136|NCT01068171|foot ulcers|foot ulcers
725137|NCT01068171|off-loading|off-loading
725138|NCT01068171|collagen|collagen
725139|NCT01068171|Wagner 1|wagner 1
725140|NCT01068184|AZD6553|azd6553
725141|NCT01068184|Chronic|chronic
725142|NCT01068184|obstructive|obstructive
725143|NCT01068184|pulmonary|pulmonary
725144|NCT01068184|lung|lung
725145|NCT01068184|respiratory disease|respiratory disease
725146|NCT01068184|placebo-controlled|placebo-controlled
725147|NCT01068184|COPD|copd
725148|NCT01068184|Healthy Volunteers|healthy volunteers
725149|NCT01068184|COPD Patients|copd patients
725150|NCT01068197|Low Glycemic Load diet|low glycemic load diet
725151|NCT01068197|Low Glycemic Index diet|low glycemic index diet
725152|NCT01068197|Low Fat diet|low fat diet
725153|NCT01068197|Obese Hispanic American children and adolescents|obese hispanic american children and adolescents
725154|NCT01068197|At risk for type 2 diabetes mellitus|at risk for type 2 diabetes mellitus
725155|NCT01068210|Exercise Intervention|exercise intervention
725156|NCT01068210|Lung Cancer|lung cancer
725157|NCT01068210|15-215|15-215
725158|NCT01068223|Cetirizine, CR016609|cetirizine, cr016609
725159|NCT01068236|Teen girls|teen girls
725160|NCT01068236|weightloss|weightloss
725161|NCT01068236|healthy lifestyle|healthy lifestyle
725162|NCT01068236|yoga|yoga
725163|NCT01068236|Weight loss and healthy lifestyle|weight loss and healthy lifestyle
725164|NCT01068249|Advanced|advanced
725165|NCT01068249|Recurrent|recurrent
725166|NCT01068249|Progressive|progressive
725167|NCT01068249|Endometrial Cancer|endometrial cancer
725168|NCT01068249|Letrozole|letrozole
725169|NCT01068249|RAD001|rad001
725170|NCT01068249|Afinitor|afinitor
725171|NCT01068249|Everolimus|everolimus
725172|NCT01068249|Femara|femara
725173|NCT01068275|anterior cruciate ligament|anterior cruciate ligament
725174|NCT01068275|pain, postoperative|pain, postoperative
725175|NCT01068275|peripheral nerve catheter|peripheral nerve catheter
725176|NCT01068275|nerve block|nerve block
725177|NCT01068275|Children undergoing anterior cruciate ligament repair|children undergoing anterior cruciate ligament repair
725178|NCT01068288|laparoscopic appendectomy|laparoscopic appendectomy
725179|NCT01068288|open appendectomy|open appendectomy
725180|NCT01068288|expectant management|expectant management
725181|NCT01068288|paediatric|paediatric
725182|NCT01068301|Allogeneic Stem Cell transplantation|allogeneic stem cell transplantation
725183|NCT01068301|Plerixafor|plerixafor
725184|NCT01068301|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
725185|NCT01068301|Acute Myeloid leukemia|acute myeloid leukemia
725186|NCT01068301|Chronic Myeloid leukemia|chronic myeloid leukemia
725187|NCT01068301|Myelodysplastic Syndrome|myelodysplastic syndrome
725188|NCT01068301|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
725189|NCT01068301|Other Leukemia|other leukemia
725190|NCT01068314|Endothelium|endothelium
725191|NCT01068314|Vasodilatation|vasodilatation
725192|NCT01068314|Vein|vein
725193|NCT01068314|Compliance|compliance
725194|NCT01068314|Arteriovenous shunt, surgical|arteriovenous shunt, surgical
725195|NCT01068340|Adhesions|adhesions
725196|NCT01068340|Small Bowel Obstruction|small bowel obstruction
725197|NCT01068340|Ileus|ileus
725198|NCT01068353|Alzheimer's disease|alzheimer's disease
725199|NCT01068353|Dementia|dementia
725200|NCT01068353|TNF-alpha|tnf-alpha
725201|NCT01068353|Etanercept|etanercept
725202|NCT01068366|Nickel Allergic Syndrome|nickel allergic syndrome
725203|NCT01068366|Septal Closure Devices|septal closure devices
725204|NCT01068379|rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
725205|NCT01068379|cryopexy|cryopexy
725206|NCT01068379|photocoagulation|photocoagulation
725207|NCT01068392|relapsed|relapsed
725305|NCT01068938|grid|grid
725208|NCT01068392|marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
725209|NCT01068392|oxaliplatin|oxaliplatin
725210|NCT01068392|prednisolone|prednisolone
725211|NCT01068418|Obesity|obesity
725212|NCT01068418|Renin Angiotensin System|renin angiotensin system
725213|NCT01068418|Vitamin D deficiency|vitamin d deficiency
725214|NCT01068418|Hypertension|hypertension
725215|NCT01068431|lymphedema|lymphedema
725216|NCT01068431|conservative treatment|conservative treatment
725217|NCT01068431|compression therapy|compression therapy
725218|NCT01068431|interface pressure|interface pressure
725219|NCT01068444|NASH|nash
725220|NCT01068444|Pioglitazone|pioglitazone
725222|NCT01068457|persistent pain|persistent pain
725223|NCT01068457|neuropathic pain|neuropathic pain
725224|NCT01068457|Thoracic Surgery, Video Assisted|thoracic surgery, video assisted
725225|NCT01068457|Chronic Pain|chronic pain
725226|NCT01068470|Interleukin-2|interleukin-2
725227|NCT01068470|Melanoma|melanoma
725228|NCT01068470|Kidney Cancer|kidney cancer
725229|NCT01068470|Lymphokine Activated Killer cells|lymphokine activated killer cells
725230|NCT01068483|Advanced solid tumors|advanced solid tumors
725231|NCT01068483|Breast Cancer|breast cancer
725232|NCT01068483|Colon Cancer|colon cancer
725233|NCT01068483|Ovarian Cancer|ovarian cancer
725234|NCT01068483|Endometrium cancer|endometrium cancer
725235|NCT01068509|Cvac|cvac
725236|NCT01068522|Intracranial pressure|intracranial pressure
725237|NCT01068522|Intracranial pressure monitoring|intracranial pressure monitoring
725238|NCT01068522|Head injury|head injury
725239|NCT01068535|metabolic syndrome|metabolic syndrome
725240|NCT01068535|MetS|mets
725241|NCT01068535|premenopausal women|premenopausal women
725242|NCT01068535|vascular risk|vascular risk
725243|NCT01068535|atherosclerosis detection|atherosclerosis detection
725244|NCT01068561|Retinitis pigmentosa|retinitis pigmentosa
725245|NCT01068561|stem cell|stem cell
725246|NCT01068561|bone marrow|bone marrow
725247|NCT01068574|Acute illnesses in children under five|acute illnesses in children under five
725248|NCT01068587|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
725249|NCT01068587|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
725250|NCT01068587|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
725251|NCT01068587|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
725252|NCT01068600|COPD|copd
725253|NCT01068600|Indacaterol|indacaterol
725254|NCT01068613|COPD|copd
725255|NCT01068613|Long acting muscarinic antagonist|long acting muscarinic antagonist
725256|NCT01068691|aortic dissection|aortic dissection
725257|NCT01068691|ambulatory blood pressure|ambulatory blood pressure
725258|NCT01068691|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
725259|NCT01068691|patients undergoing surgery for a dissection of the thoracic aorta|patients undergoing surgery for a dissection of the thoracic aorta
725260|NCT01068769|regorafenib|regorafenib
725261|NCT01068769|GIST|gist
725262|NCT01068782|Glioblastoma|glioblastoma
725263|NCT01068782|Glioma|glioma
725264|NCT01068782|Brain Cancer|brain cancer
725265|NCT01068782|Brain Tumor|brain tumor
725266|NCT01068782|Astrocytoma|astrocytoma
725267|NCT01068795|placental syndrome|placental syndrome
725268|NCT01068795|maternal thromboembolic event|maternal thromboembolic event
725269|NCT01068795|enoxaparin|enoxaparin
725270|NCT01068795|anti-factor Xa|anti-factor xa
725271|NCT01068808|Nonallergic rhinitis|nonallergic rhinitis
725272|NCT01068808|Allergic rhinitis|allergic rhinitis
725273|NCT01068808|Development|development
725274|NCT01068821|Slide|slide
725275|NCT01068821|Trendelenburg's position|trendelenburg's position
725276|NCT01068821|Postoperative|postoperative
725277|NCT01068821|neurologic complaints|neurologic complaints
725278|NCT01068834|Adherence|adherence
725279|NCT01068834|Statins|statins
725280|NCT01068834|Kinesin-like protein 6|kinesin-like protein 6
725281|NCT01068847|Opioid dependence|opioid dependence
725282|NCT01068847|methadone|methadone
725283|NCT01068847|opioid|opioid
725284|NCT01068860|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
725285|NCT01068860|canakinumab|canakinumab
725286|NCT01068860|Pre diabetic|pre diabetic
725287|NCT01068860|glucose intolerant|glucose intolerant
725288|NCT01068860|oral anti diabetic medication|oral anti diabetic medication
725289|NCT01068860|insulin treatment|insulin treatment
725290|NCT01068860|metabolic syndrome|metabolic syndrome
725291|NCT01068873|HIV|hiv
725292|NCT01068873|Protease Inhibitor|protease inhibitor
725293|NCT01068873|CCR5 Co-receptor Antagonist|ccr5 co-receptor antagonist
725294|NCT01068873|treatment naive|treatment naive
725295|NCT01068886|Pancreaticoduodenectomy|pancreaticoduodenectomy
725296|NCT01068899|healthy adults|healthy adults
725297|NCT01068899|healthy children|healthy children
725298|NCT01068912|Influenza|influenza
725299|NCT01068925|healthy volunteer|healthy volunteer
725300|NCT01068925|pharmacokinetics|pharmacokinetics
725301|NCT01068925|HIV, GSK1349572, tipranavir, ritonavir, drug interaction|hiv, gsk1349572, tipranavir, ritonavir, drug interaction
725302|NCT01068938|visual field|visual field
725303|NCT01068938|perimetry|perimetry
725304|NCT01068938|glaucoma progression|glaucoma progression
725306|NCT01068938|POAG and glaucoma suspects with prostaglandin monotherapy|poag and glaucoma suspects with prostaglandin monotherapy
725307|NCT01068951|type 1 diabetes|type 1 diabetes
725308|NCT01068951|mesenchymal stem cells|mesenchymal stem cells
725309|NCT01068951|intervention|intervention
725310|NCT01068990|pneumonia|pneumonia
725311|NCT01069003|Heart Disease|heart disease
725312|NCT01069003|Cardiovascular Disease|cardiovascular disease
725313|NCT01069003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
725314|NCT01069003|Dual Antiplatelet Therapy|dual antiplatelet therapy
725315|NCT01069003|Clopidogrel|clopidogrel
725316|NCT01069003|Prasugrel|prasugrel
725317|NCT01069003|Vascular Disease|vascular disease
725318|NCT01069003|Myocardial Ischemia|myocardial ischemia
725319|NCT01069016|Fecal Incontinence|fecal incontinence
725320|NCT01069016|Colorectal surgery|colorectal surgery
725321|NCT01069016|Sacral nerve stimulation|sacral nerve stimulation
725322|NCT01069016|Pudendal nerve stimulation|pudendal nerve stimulation
725323|NCT01069029|Macular Hole|macular hole
725324|NCT01069029|Cataract surgery|cataract surgery
725325|NCT01069029|Vitreoretinal surgery|vitreoretinal surgery
725326|NCT01069029|Combined surgery|combined surgery
725327|NCT01069029|Idiopathic|idiopathic
725328|NCT01069042|Rho kinase activity|rho kinase activity
725329|NCT01069042|Heart failure|heart failure
725330|NCT01069042|ACE inhibitor|ace inhibitor
725331|NCT01069042|LVEF change|lvef change
725332|NCT01069042|Rho kinase activity change|rho kinase activity change
725333|NCT01069055|inguinal hernia|inguinal hernia
725334|NCT01069055|surgery|surgery
725335|NCT01069055|general anesthesia|general anesthesia
725336|NCT01069055|analgesia|analgesia
725337|NCT01069055|pre-emptive|pre-emptive
725338|NCT01069055|SF36|sf36
725339|NCT01069068|To evaluate the effect of advancing Jaw on airway dimension|to evaluate the effect of advancing jaw on airway dimension
725340|NCT01069081|Metastasis Breast Cancer|metastasis breast cancer
725341|NCT01069081|Proton Pump Inhibitor|proton pump inhibitor
725342|NCT01069081|Chemotherapy|chemotherapy
725343|NCT01069081|Phase II study|phase ii study
725344|NCT01069081|TTP|ttp
725345|NCT01069094|Uterine fibroids|uterine fibroids
725346|NCT01069107|community hospital|community hospital
725347|NCT01069107|alternative acute admissions|alternative acute admissions
725348|NCT01069120|Uterine Fibroids|uterine fibroids
725349|NCT01069133|minimal hepatic encephalopathy|minimal hepatic encephalopathy
725350|NCT01069133|cirrhosis|cirrhosis
725351|NCT01069133|complications|complications
725352|NCT01069146|sepsis,|sepsis,
725353|NCT01069146|septic shock,|septic shock,
725354|NCT01069146|therapeutic hypothermia|therapeutic hypothermia
725355|NCT01069159|Traumatic memory|traumatic memory
725356|NCT01069159|Traumatic memories|traumatic memories
725357|NCT01069159|Traumatic memories and associated symptoms|traumatic memories and associated symptoms
725358|NCT01069159|Posttraumatic Stress Disorder|posttraumatic stress disorder
725359|NCT01069159|PTSD|ptsd
725360|NCT01069172|Cataract|cataract
725361|NCT01069172|Surgery, cataract extraction|surgery, cataract extraction
725362|NCT01069172|Optical devices, laser|optical devices, laser
725363|NCT01069185|Unplanned extubation|unplanned extubation
725364|NCT01069185|Length of stay in PICU|length of stay in picu
725365|NCT01069185|Length of mechanical ventilation|length of mechanical ventilation
725366|NCT01069198|Visceral leishmaniasis|visceral leishmaniasis
725367|NCT01069198|Kala-azar|kala-azar
725368|NCT01069198|Bangladesh|bangladesh
725369|NCT01069198|Malnutrition|malnutrition
725370|NCT01069198|Asymptomatic|asymptomatic
725371|NCT01069198|Albendazole|albendazole
725372|NCT01069198|Iron|iron
725373|NCT01069198|Zinc|zinc
725374|NCT01069198|Vitamin A|vitamin a
725375|NCT01069211|Breast cancer, Letrozole|breast cancer, letrozole
725376|NCT01069211|postmenopause|postmenopause
725502|NCT01069692|Chronic Kidney Disease|chronic kidney disease
725377|NCT01069211|hormone receptor positive breast cancer|hormone receptor positive breast cancer
725378|NCT01069224|rotator cuff|rotator cuff
725379|NCT01069224|synovial fluid|synovial fluid
725380|NCT01069224|proinflammatory cytokines|proinflammatory cytokines
725381|NCT01069237|contact lens wear|contact lens wear
725382|NCT01069237|multi-purpose solution|multi-purpose solution
725383|NCT01069237|corneal staining|corneal staining
725384|NCT01069250|dynamic cerebrovascular autoregulation|dynamic cerebrovascular autoregulation
725385|NCT01069250|static cerebrovascular autoregulation|static cerebrovascular autoregulation
725386|NCT01069250|acute brain injury|acute brain injury
725387|NCT01069250|transcranial Doppler ultrasound|transcranial doppler ultrasound
725388|NCT01069250|critical care|critical care
725389|NCT01069263|Interstitial cystitis|interstitial cystitis
725390|NCT01069263|Painful bladder syndrome|painful bladder syndrome
725391|NCT01069263|Chronic pelvic pain|chronic pelvic pain
725392|NCT01069263|DMSO|dmso
725393|NCT01069263|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
725394|NCT01069276|Stroke|stroke
725395|NCT01069276|prehospital ultrasound|prehospital ultrasound
725396|NCT01069289|Symbicort|symbicort
725397|NCT01069289|Oxis|oxis
725398|NCT01069289|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
725399|NCT01069289|COPD|copd
725400|NCT01069289|Efficacy|efficacy
725401|NCT01069302|Coronary artery disease|coronary artery disease
725402|NCT01069315|open wound|open wound
725403|NCT01069315|solution|solution
725404|NCT01069315|pressure|pressure
725405|NCT01069315|randomized|randomized
725406|NCT01069328|Lung|lung
725407|NCT01069328|cancer|cancer
725408|NCT01069328|NSCLC|nsclc
725409|NCT01069341|Rubeosis|rubeosis
725410|NCT01069341|Neovascularization of iris|neovascularization of iris
725411|NCT01069341|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
725412|NCT01069341|PDR|pdr
725413|NCT01069341|Cataract|cataract
725415|NCT01069367|H1N1 subtype|h1n1 subtype
725416|NCT01069367|Children/adolescent|children/adolescent
725417|NCT01069367|Vaccine|vaccine
725418|NCT01069367|Adjuvant|adjuvant
725419|NCT01069367|Cell culture|cell culture
725420|NCT01069380|resting metabolic rate|resting metabolic rate
725421|NCT01069380|bed ridden, vegetative|bed ridden, vegetative
725422|NCT01069380|low conscious|low conscious
725423|NCT01069380|minimal conscious state|minimal conscious state
725424|NCT01069380|immobilized|immobilized
725425|NCT01069380|resting energy expenditure|resting energy expenditure
725426|NCT01069406|notch|notch
725427|NCT01069406|uterine|uterine
725428|NCT01069406|first|first
725429|NCT01069406|bleeding|bleeding
725430|NCT01069419|Certolizumab Pegol|certolizumab pegol
725431|NCT01069419|Cimzia|cimzia
725432|NCT01069432|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
725433|NCT01069432|CLL|cll
725434|NCT01069432|Normal Volunteers|normal volunteers
725435|NCT01069445|diet|diet
725436|NCT01069445|probiotics|probiotics
725437|NCT01069445|inflammaging|inflammaging
725438|NCT01069445|oxidative stress|oxidative stress
725439|NCT01069445|gut microbiota|gut microbiota
725440|NCT01069445|food complements|food complements
725441|NCT01069458|Dietary intervention|dietary intervention
725442|NCT01069458|Smoking cessation|smoking cessation
725443|NCT01069458|Body weight|body weight
725444|NCT01069471|S.dysenteriae|s.dysenteriae
725445|NCT01069471|Healthy volunteers|healthy volunteers
725446|NCT01069471|Conjugate vaccine|conjugate vaccine
725447|NCT01069471|Safety|safety
725448|NCT01069471|Immunogenicity|immunogenicity
725449|NCT01069471|Dose scaling|dose scaling
725450|NCT01069484|Randomized controlled trial|randomized controlled trial
725451|NCT01069484|Post partum pelvic floor muscle training|post partum pelvic floor muscle training
725452|NCT01069484|Urinary incontinence|urinary incontinence
725453|NCT01069484|Pelvic floor dysfunction|pelvic floor dysfunction
727204|NCT01065688|QOL|qol
725454|NCT01069484|Pelvic floor muscle injury|pelvic floor muscle injury
725455|NCT01069484|Pelvic floor muscle strength|pelvic floor muscle strength
725456|NCT01069484|Pelvic floor muscle morphology|pelvic floor muscle morphology
725457|NCT01069497|Infection control|infection control
725458|NCT01069497|Urinary Tract Infections|urinary tract infections
725459|NCT01069497|Respiratory Tract Infections|respiratory tract infections
725460|NCT01069523|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
725461|NCT01069523|Guanfacine|guanfacine
725462|NCT01069523|Event Related Potentials|event related potentials
725463|NCT01069536|metoclopramide|metoclopramide
725464|NCT01069536|akathisia|akathisia
725465|NCT01069536|nausea|nausea
725466|NCT01069536|vomiting|vomiting
725467|NCT01069536|antiemetic|antiemetic
725468|NCT01069536|improvement of nausea|improvement of nausea
725469|NCT01069549|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
725470|NCT01069549|Diabetic Nephropathy|diabetic nephropathy
725471|NCT01069549|Angiotensin II type 1 receptor gene polymorphism|angiotensin ii type 1 receptor gene polymorphism
725472|NCT01069549|Acetyl coA carboxylase beta gene polymorphism.|acetyl coa carboxylase beta gene polymorphism.
725473|NCT01069562|closed loop control of anesthesia|closed loop control of anesthesia
725474|NCT01069562|isoflurane|isoflurane
725475|NCT01069562|open heart surgery|open heart surgery
725476|NCT01069575|URLC10|urlc10
725477|NCT01069575|CDCA1|cdca1
725478|NCT01069575|KIF20A|kif20a
725479|NCT01069575|lung cancer|lung cancer
725480|NCT01069575|vaccine|vaccine
725481|NCT01069575|HLA-A*2402|hla-a*2402
725482|NCT01069588|bioabsorbable screw|bioabsorbable screw
725483|NCT01069588|acl reconstruction|acl reconstruction
725484|NCT01069601|solid organ transplantation|solid organ transplantation
725485|NCT01069601|bone marrow transplantation|bone marrow transplantation
725486|NCT01069601|adults|adults
725487|NCT01069601|adults with solid organ transplantation|adults with solid organ transplantation
725488|NCT01069601|adults with bone marrow transplantation|adults with bone marrow transplantation
725489|NCT01069614|Equipment and supplies|equipment and supplies
725490|NCT01069640|URLC10|urlc10
725491|NCT01069640|lung cancer|lung cancer
725492|NCT01069640|vaccine|vaccine
725493|NCT01069640|HLA-A*0201|hla-a*0201
725494|NCT01069640|HLA-A*0206|hla-a*0206
725495|NCT01069653|CDCA1|cdca1
725496|NCT01069653|KIF20A|kif20a
725497|NCT01069653|lung cancer|lung cancer
725498|NCT01069653|vaccine|vaccine
725499|NCT01069653|HLA-A*2402|hla-a*2402
725500|NCT01069666|atopic dermatitis|atopic dermatitis
725501|NCT01069666|Thai pediatricians|thai pediatricians
725503|NCT01069692|Hemodialysis|hemodialysis
725504|NCT01069692|Hyperphosphatemia|hyperphosphatemia
725505|NCT01069692|Hyperphosphatemia patients with chronic kidney disease on 3x/week hemodialysis|hyperphosphatemia patients with chronic kidney disease on 3x/week hemodialysis
725506|NCT01069705|Tobramycin Inhalation Powder|tobramycin inhalation powder
725507|NCT01069705|Cystic fibrosis|cystic fibrosis
725508|NCT01069705|Lung diseases|lung diseases
725509|NCT01069705|Anti-Bacterial Agents|anti-bacterial agents
725510|NCT01069705|Treatment of pulmonary infections with P. aeruginosa in cystic fibrosis patients|treatment of pulmonary infections with p. aeruginosa in cystic fibrosis patients
725611|NCT01070173|Ghrelin|ghrelin
725511|NCT01069757|Advanced/recurrent non-small-cell lung cancer|advanced/recurrent non-small-cell lung cancer
725512|NCT01069770|Neoadjuvant Therapy|neoadjuvant therapy
725513|NCT01069770|Sunitinib|sunitinib
725514|NCT01069770|Clear Cell Renal Cell Carcinoma|clear cell renal cell carcinoma
725515|NCT01069770|Metastasis|metastasis
725516|NCT01069783|dyslipidemia|dyslipidemia
725517|NCT01069783|cholesterol|cholesterol
725519|NCT01069796|triple negative|triple negative
725520|NCT01069796|metastatic|metastatic
725521|NCT01069796|breast cancer|breast cancer
725522|NCT01069796|First line chemotherapy|first line chemotherapy
725523|NCT01069822|Midazolam|midazolam
725524|NCT01069822|Pharmacokinetics|pharmacokinetics
725525|NCT01069835|Non small cell lung cancer|non small cell lung cancer
725526|NCT01069835|EGFR mutation|egfr mutation
725527|NCT01069835|NSCLC|nsclc
725528|NCT01069861|PPHN|pphn
725529|NCT01069861|neonates|neonates
725530|NCT01069861|sildanefil IV|sildanefil iv
725531|NCT01069874|Bone Density Conservation Agents|bone density conservation agents
725532|NCT01069874|Cholecalciferol|cholecalciferol
725533|NCT01069874|Communicable Diseases|communicable diseases
725534|NCT01069874|Growth Substances|growth substances
725535|NCT01069874|Housing for the Elderly|housing for the elderly
725536|NCT01069874|Infection|infection
725537|NCT01069874|Micronutrients|micronutrients
725538|NCT01069874|Pharmacologic Actions|pharmacologic actions
725539|NCT01069874|Physiological Effects of Drugs|physiological effects of drugs
725540|NCT01069874|Respiratory Tract Diseases|respiratory tract diseases
725541|NCT01069874|Vitamins|vitamins
725542|NCT01069874|Respiratory Tract Infections/prevention & control*|respiratory tract infections/prevention & control*
725543|NCT01069874|Vitamin D|vitamin d
725544|NCT01069887|febrile events|febrile events
725545|NCT01069887|invasive fungal infections|invasive fungal infections
725546|NCT01069887|hematological patients|hematological patients
725547|NCT01069900|Intra-abdominal infection|intra-abdominal infection
725548|NCT01069900|Pediatric infection|pediatric infection
725549|NCT01069913|Healthy Volunteer|healthy volunteer
725550|NCT01069926|Diabetes|diabetes
725551|NCT01069939|Gastric ulcer|gastric ulcer
725552|NCT01069939|Duodenal ulcer|duodenal ulcer
725553|NCT01069939|Low-dose aspirin|low-dose aspirin
725554|NCT01069952|Deep Brain Stimulation|deep brain stimulation
725555|NCT01069952|Treatment Refractory|treatment refractory
725556|NCT01069952|Neurosurgery|neurosurgery
725557|NCT01069952|Implantable Neurostimulator (INS)|implantable neurostimulator (ins)
725558|NCT01069952|Internal Capsule|internal capsule
725559|NCT01069965|Type 2|type 2
725560|NCT01069991|Asthma|asthma
725561|NCT01069991|Adolescents|adolescents
725562|NCT01069991|Patient Education|patient education
725563|NCT01069991|Schools|schools
725564|NCT01070004|sleepiness|sleepiness
725565|NCT01070004|driving|driving
725566|NCT01070004|countermeasures|countermeasures
725567|NCT01070004|coffee|coffee
725568|NCT01070004|blue light exposure|blue light exposure
725569|NCT01070004|physical activity|physical activity
725570|NCT01070017|Peru|peru
725571|NCT01070017|DOT|dot
725572|NCT01070017|HIV|hiv
725573|NCT01070017|AIDS|aids
725574|NCT01070017|Community based|community based
725575|NCT01070017|social capital|social capital
725576|NCT01070030|Stage II Hypertension, Aliskiren, Amlodipine, Hydrochlorothiazide|stage ii hypertension, aliskiren, amlodipine, hydrochlorothiazide
725577|NCT01070043|Hypertension|hypertension
725578|NCT01070043|valsartan|valsartan
725579|NCT01070043|amlodipine|amlodipine
725580|NCT01070043|high blood pressure|high blood pressure
725581|NCT01070056|Blood Pressure|blood pressure
725582|NCT01070056|Lifestyle Changes|lifestyle changes
725583|NCT01070056|African American|african american
725584|NCT01070069|Percutaneous|percutaneous
725585|NCT01070069|Preclose|preclose
725586|NCT01070069|Endologix|endologix
725587|NCT01070069|Abbott Vascular|abbott vascular
725588|NCT01070069|Endovascular|endovascular
725589|NCT01070069|PEVAR|pevar
725590|NCT01070069|Stent graft|stent graft
725591|NCT01070069|Suture mediated closure devices|suture mediated closure devices
725592|NCT01070082|adult ICU patients|adult icu patients
725593|NCT01070082|procedural pain|procedural pain
725594|NCT01070082|pain intensity|pain intensity
725595|NCT01070082|pain distress|pain distress
725596|NCT01070082|pain behaviors|pain behaviors
725597|NCT01070082|pain|pain
725598|NCT01070082|ICU procedures|icu procedures
725700|NCT01059149|Rehabilitation|rehabilitation
725599|NCT01070108|Preemption, ketamine, escalating, dose, pain, analgesia|preemption, ketamine, escalating, dose, pain, analgesia
725600|NCT01070121|Rheumatoid Arthritis|rheumatoid arthritis
725601|NCT01070121|RA|ra
725602|NCT01070121|Autoimmune Disease|autoimmune disease
725603|NCT01070121|Muscular Skeletal Disease|muscular skeletal disease
725604|NCT01070147|asthma|asthma
725605|NCT01070147|emergency medicine|emergency medicine
725606|NCT01070147|medical informatics|medical informatics
725607|NCT01070147|computerized reminder systems|computerized reminder systems
725608|NCT01070160|Polycystic Ovarian Syndrome (PCOS)|polycystic ovarian syndrome (pcos)
725609|NCT01070160|Metformin|metformin
725610|NCT01070160|Endometrin|endometrin
725612|NCT01070173|short stature|short stature
725613|NCT01070173|failure to thrive|failure to thrive
725614|NCT01070186|nephrectomy|nephrectomy
725615|NCT01070186|T1b|t1b
725616|NCT01070186|T2|t2
725617|NCT01070186|T3|t3
725618|NCT01070186|T4|t4
725619|NCT01070186|N1|n1
725620|NCT01070186|Kidney Cancer|kidney cancer
725621|NCT01070199|obese, liquid, solid, fitness, humans, appetite|obese, liquid, solid, fitness, humans, appetite
725622|NCT01070212|human, chewing, appetite,|human, chewing, appetite,
725623|NCT01070238|Isomaltulose|isomaltulose
725624|NCT01070238|Slow Released Carbohydrates|slow released carbohydrates
725625|NCT01070238|Postprandial Glucose Metabolism|postprandial glucose metabolism
725626|NCT01070238|Type 2 diabetes|type 2 diabetes
725627|NCT01070264|Osteoarthritis|osteoarthritis
725628|NCT01070277|chronic diarrhea|chronic diarrhea
725629|NCT01070277|travelers|travelers
725630|NCT01070277|Parasites|parasites
725631|NCT01070277|albendazole|albendazole
725632|NCT01070277|tinidazole|tinidazole
725633|NCT01070290|gastric carcinoma|gastric carcinoma
725634|NCT01070290|Locally Advanced or Metastatic Gastric Cancer|locally advanced or metastatic gastric cancer
725635|NCT01070303|HUMIRA|humira
725636|NCT01070303|adalimumab|adalimumab
725637|NCT01070303|Inflammatory Bowel Disease|inflammatory bowel disease
725638|NCT01070316|Epilepsy|epilepsy
725639|NCT01070316|Tuberous Sclerosis Complex|tuberous sclerosis complex
725640|NCT01070316|Everolimus|everolimus
725641|NCT01070316|RAD001|rad001
725642|NCT01070316|Mammalian Target of Rapamycin (MTOR)|mammalian target of rapamycin (mtor)
725643|NCT01058889|Diabetes mellitus Type 2|diabetes mellitus type 2
725644|NCT01058889|Telemedicine|telemedicine
725645|NCT01058889|Insulin|insulin
725646|NCT01058902|Non small cell lung cancer|non small cell lung cancer
725647|NCT01058902|survival|survival
725648|NCT01058902|aspirin|aspirin
725649|NCT01058915|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
725650|NCT01058928|Tracheal tube|tracheal tube
725651|NCT01058928|Size|size
725652|NCT01058941|Alzheimer's disease|alzheimer's disease
725653|NCT01058941|fish oil|fish oil
725654|NCT01058941|lipoic acid|lipoic acid
725655|NCT01058967|Code III trauma (highest acuity)|code iii trauma (highest acuity)
725656|NCT01058967|Life Flight aeromedical ambulance service|life flight aeromedical ambulance service
725657|NCT01058980|catheter ablation|catheter ablation
725658|NCT01058980|atrial fibrillation|atrial fibrillation
725659|NCT01058980|adenosine|adenosine
725660|NCT01058993|neutropenia|neutropenia
725661|NCT01058993|myelokathexis|myelokathexis
725662|NCT01058993|WHIM syndrome|whim syndrome
725663|NCT01058993|AMD 3100|amd 3100
725664|NCT01058993|plerixafor|plerixafor
725665|NCT01058993|Myelokathexis syndrome|myelokathexis syndrome
725666|NCT01058993|Neutropenia due to mutations of CXCR-4|neutropenia due to mutations of cxcr-4
725667|NCT01059006|Reflective Surgery|reflective surgery
725668|NCT01059006|Presbyopia|presbyopia
725669|NCT01059006|PresbyLASIK|presbylasik
725670|NCT01059019|Refractive Surgery|refractive surgery
725671|NCT01059019|PRK|prk
725672|NCT01059019|Photorefractive Keratectomy|photorefractive keratectomy
725673|NCT01059019|Omega 3 Fatty Acids|omega 3 fatty acids
725674|NCT01059019|Cornea|cornea
725675|NCT01059058|MI Paste Plus|mi paste plus
725676|NCT01059058|Fluoride Varnish|fluoride varnish
725677|NCT01059058|CPP-ACP|cpp-acp
725678|NCT01059058|White Spot Lesions|white spot lesions
725679|NCT01059058|Remineralization|remineralization
725680|NCT01059058|Orthodontic Treatment|orthodontic treatment
725681|NCT01059071|Refractory Neuroblastoma|refractory neuroblastoma
725682|NCT01059071|Relapsed neuroblastoma|relapsed neuroblastoma
725683|NCT01059084|HIV|hiv
725684|NCT01059084|Valacyclovir|valacyclovir
725685|NCT01059084|Valtrex®|valtrex®
725686|NCT01059110|Occlusive dressings|occlusive dressings
725687|NCT01059110|Salicylate ointment|salicylate ointment
725688|NCT01059110|Cryotherapy|cryotherapy
725689|NCT01059110|Topical 5-fluoro-uracil|topical 5-fluoro-uracil
725690|NCT01059110|Imiquimod|imiquimod
725691|NCT01059110|Randomized clinical trial|randomized clinical trial
725692|NCT01059110|Plantar warts|plantar warts
725693|NCT01059123|Amoxicillin|amoxicillin
725694|NCT01059123|Erysipelas|erysipelas
725695|NCT01059123|Short course|short course
725696|NCT01059136|Myocardial infarction|myocardial infarction
725697|NCT01059136|Outcome|outcome
725698|NCT01059136|Aldosterone|aldosterone
725699|NCT01059136|Spironolactone|spironolactone
725797|NCT01059435|Phase 1|phase 1
725701|NCT01059149|Transcranial magnetic stimulation|transcranial magnetic stimulation
725702|NCT01059149|Brain magnetic stimulation|brain magnetic stimulation
725703|NCT01059149|Repetitive|repetitive
725704|NCT01059149|Stroke|stroke
725705|NCT01059149|Subacute|subacute
725706|NCT01059162|Glaucoma Surgery|glaucoma surgery
725707|NCT01059162|Filtering Surgery|filtering surgery
725708|NCT01059162|Non Penetrating glaucoma surgery|non penetrating glaucoma surgery
725709|NCT01059175|Heart failure|heart failure
725710|NCT01059175|Cardiac resynchronization therapy|cardiac resynchronization therapy
725711|NCT01059175|Biventricular stimulation|biventricular stimulation
726102|NCT01071109|insomnia|insomnia
725712|NCT01059175|Multisite stimulation|multisite stimulation
725713|NCT01059175|Non responders|non responders
725714|NCT01059188|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
725715|NCT01059188|adenocarcinoma of the lung|adenocarcinoma of the lung
725716|NCT01059188|adenosquamous cell lung cancer|adenosquamous cell lung cancer
725717|NCT01059188|large cell lung cancer|large cell lung cancer
725718|NCT01059188|squamous cell lung cancer|squamous cell lung cancer
725719|NCT01059201|Autism Spectrum Disorder|autism spectrum disorder
725720|NCT01059201|Cholesterol|cholesterol
725721|NCT01059201|Exome Sequencing|exome sequencing
725722|NCT01059201|Autistic Spectrum Disorder|autistic spectrum disorder
725723|NCT01059201|ASD|asd
726417|NCT01072474|Sedation|sedation
725724|NCT01059214|Acute Myocardial Infarction|acute myocardial infarction
725725|NCT01059214|Reperfusion|reperfusion
725726|NCT01059214|MRI|mri
725727|NCT01059214|Heart Attack|heart attack
725728|NCT01059227|Treatment|treatment
725729|NCT01059227|Anxiety|anxiety
725730|NCT01059227|Fear|fear
725731|NCT01059227|Fear Potentiated Startle|fear potentiated startle
725732|NCT01059227|Healthy Volunteer|healthy volunteer
725733|NCT01059227|HV|hv
725734|NCT01059240|Survival Motor Neuron 1 (SMN1)|survival motor neuron 1 (smn1)
725735|NCT01059240|Survival Motor Neuron 2 (SMN2)|survival motor neuron 2 (smn2)
725736|NCT01059240|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
725737|NCT01059240|SMN Copy Number in Mali|smn copy number in mali
725738|NCT01059240|Spinal Muscular Antrophy|spinal muscular antrophy
725739|NCT01059240|SMA|sma
725740|NCT01059253|Falls|falls
725741|NCT01059253|Balance|balance
725742|NCT01059253|Elderly|elderly
725743|NCT01059253|Aged|aged
725744|NCT01059266|immunotherapy|immunotherapy
725745|NCT01059266|grass pollen|grass pollen
725746|NCT01059266|seasonal allergy|seasonal allergy
725747|NCT01059266|dose tolerability|dose tolerability
725748|NCT01059279|Familial Mediterranean fever|familial mediterranean fever
725749|NCT01059279|Cytokines|cytokines
725750|NCT01059279|Inflammatory proteins|inflammatory proteins
725751|NCT01059279|MEFV|mefv
725752|NCT01059279|mutations|mutations
725753|NCT01059279|Heat Intolerance|heat intolerance
725754|NCT01059279|Heat Tolerance Test|heat tolerance test
725755|NCT01059292|we have complieted party research|we have complieted party research
725756|NCT01059305|Erlotinib|erlotinib
725757|NCT01059305|Erlotinib Hydrochloride|erlotinib hydrochloride
725758|NCT01059305|OSI-774|osi-774
725759|NCT01059305|Tarceva|tarceva
725760|NCT01059305|Squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
725761|NCT01059305|Aggressive cutaneous squamous cell carcinoma|aggressive cutaneous squamous cell carcinoma
725762|NCT01059305|CSCC|cscc
725763|NCT01059305|Local surgery|local surgery
725764|NCT01059305|Radiation therapy|radiation therapy
725765|NCT01059305|Epidermal growth factor receptor|epidermal growth factor receptor
725766|NCT01059305|EGFR|egfr
725767|NCT01059305|Small Molecule Tyrosine Kinase Inhibitor|small molecule tyrosine kinase inhibitor
725768|NCT01059318|Lymphangioleiomyomatosis,|lymphangioleiomyomatosis,
725769|NCT01059318|High Resolution CT scan,|high resolution ct scan,
725770|NCT01059318|chest x-ray,|chest x-ray,
725771|NCT01059318|6 minute walk test,|6 minute walk test,
725772|NCT01059318|pulse oximetry,|pulse oximetry,
725773|NCT01059318|renal MRI,|renal mri,
725774|NCT01059318|Pikometer|pikometer
725775|NCT01059331|Kidney|kidney
725776|NCT01059344|Mesalamine|mesalamine
725777|NCT01059344|Asacol|asacol
725778|NCT01059344|Ulcerative colitis|ulcerative colitis
725779|NCT01059344|induction therapy|induction therapy
725780|NCT01059344|acute disease|acute disease
725781|NCT01059344|mild to moderate|mild to moderate
725782|NCT01059344|Active Ulcerative Colitis (mild to moderate)|active ulcerative colitis (mild to moderate)
725783|NCT01059370|Autonomic dysfunction|autonomic dysfunction
725784|NCT01059370|Spinal cord injured|spinal cord injured
725785|NCT01059370|Neurogenic bowel|neurogenic bowel
725786|NCT01059370|Neurogenic bladder|neurogenic bladder
725787|NCT01059383|Gastroesophageal Reflux|gastroesophageal reflux
725788|NCT01059383|GERD|gerd
725789|NCT01059383|Nocturnal GERD|nocturnal gerd
725790|NCT01059383|Heartburn|heartburn
725791|NCT01059383|Nighttime Heartburn|nighttime heartburn
725792|NCT01059409|Meniscal Allografts|meniscal allografts
725793|NCT01059409|Osteoarthritis|osteoarthritis
725794|NCT01059435|Amgen|amgen
725795|NCT01059435|First in Human|first in human
725796|NCT01059435|Postmenopausal|postmenopausal
725798|NCT01059448|Amgen|amgen
725799|NCT01059448|RA|ra
725800|NCT01059448|AMG 827|amg 827
725801|NCT01059448|20090061|20090061
725802|NCT01059461|Hypoxic Ischemic Encephalopathy (HIE)|hypoxic ischemic encephalopathy (hie)
725803|NCT01059461|Perinatal Asphyxia|perinatal asphyxia
725804|NCT01059461|Nerve growth factor|nerve growth factor
725805|NCT01059461|Cerebrolysin|cerebrolysin
725806|NCT01059461|Cerebral palsy|cerebral palsy
725807|NCT01059474|DMPS|dmps
725808|NCT01059474|mercury|mercury
725809|NCT01059487|Traditional Chinese Medicine|traditional chinese medicine
725810|NCT01059487|Acupuncture|acupuncture
725811|NCT01059500|Computer-derived, quantitative pretest probability (PTP)|computer-derived, quantitative pretest probability (ptp)
725812|NCT01059500|Overtesting|overtesting
725813|NCT01059500|Radiation|radiation
725814|NCT01059500|Intravenous Contrast|intravenous contrast
725815|NCT01059500|Anticoagulation|anticoagulation
725816|NCT01059513|T1c|t1c
725817|NCT01059513|T2a|t2a
725818|NCT01059513|T2b|t2b
725819|NCT01059526|HAE|hae
725820|NCT01059539|mania|mania
725821|NCT01059539|acute mania|acute mania
725822|NCT01059539|bipolar I disorder|bipolar i disorder
725823|NCT01059552|lung cancer|lung cancer
725824|NCT01059552|locally advanced lung cancer|locally advanced lung cancer
725825|NCT01059565|Cystic Fibrosis|cystic fibrosis
726902|NCT01064310|cancer|cancer
725826|NCT01059565|Aztreonam Lysine|aztreonam lysine
725827|NCT01059565|lung infection|lung infection
725828|NCT01059565|Burkholderia|burkholderia
725829|NCT01059565|CFQ-R|cfq-r
725830|NCT01059565|inhaled antibiotic|inhaled antibiotic
725831|NCT01059578|Nk1 Antagonist and SSRI|nk1 antagonist and ssri
725832|NCT01059578|Safety|safety
725833|NCT01059578|First Time in Humans|first time in humans
725834|NCT01059578|Healthy Subjects|healthy subjects
725835|NCT01059591|NK1 antagonist and SSRI|nk1 antagonist and ssri
725836|NCT01059591|Healthy subjects|healthy subjects
725837|NCT01059591|Safety|safety
725838|NCT01059591|First time in Human|first time in human
725839|NCT01059604|pregnancy outcomes|pregnancy outcomes
725840|NCT01059604|pregnancy|pregnancy
725841|NCT01059604|first trimester|first trimester
725842|NCT01059604|Sumatriptan|sumatriptan
725843|NCT01059604|major congenital malformations|major congenital malformations
725844|NCT01059604|naratriptan|naratriptan
725845|NCT01059604|sumatriptan-naproxen combination|sumatriptan-naproxen combination
725846|NCT01059604|pregnancy registry|pregnancy registry
725847|NCT01059617|Pandemic|pandemic
725848|NCT01059617|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
725849|NCT01059617|H1N1|h1n1
725850|NCT01059617|Influenza|influenza
725851|NCT01059630|follicular|follicular
725852|NCT01059630|follicular lymphoma|follicular lymphoma
725853|NCT01059656|Dermatofibrosarcoma|dermatofibrosarcoma
725854|NCT01059656|Pazopanib¨|pazopanib¨
725855|NCT01059656|Phase II|phase ii
725856|NCT01059669|Chronic pancreatitis|chronic pancreatitis
725857|NCT01059669|Pain|pain
725858|NCT01059669|Exocrine insufficiency|exocrine insufficiency
725859|NCT01059669|Diabetes|diabetes
725860|NCT01059669|Nutrition|nutrition
725861|NCT01059669|Ultrasound|ultrasound
725862|NCT01059695|cervical cancer|cervical cancer
725863|NCT01059695|retrospective|retrospective
725864|NCT01059695|quality of life|quality of life
725865|NCT01059695|treatment|treatment
725866|NCT01059708|outcomes carbon monoxide poisoning children pediatric|outcomes carbon monoxide poisoning children pediatric
725867|NCT01059721|Centralisation|centralisation
725868|NCT01059721|Patella dislocation|patella dislocation
725869|NCT01059721|Open epiphyses|open epiphyses
725870|NCT01059721|Malalignment syndrome|malalignment syndrome
725871|NCT01059721|Relapse rate|relapse rate
725872|NCT01059734|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
725873|NCT01059734|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
725874|NCT01059734|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
725875|NCT01059734|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
725876|NCT01059734|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
725877|NCT01059734|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
725878|NCT01059734|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
725879|NCT01059734|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
725880|NCT01059734|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
725881|NCT01059734|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
725882|NCT01059734|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
725883|NCT01059734|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
725884|NCT01059734|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
725885|NCT01059734|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
725886|NCT01059734|secondary acute myeloid leukemia|secondary acute myeloid leukemia
725887|NCT01059734|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
725983|NCT01070511|Muscular Dystrophy|muscular dystrophy
725888|NCT01059734|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
725889|NCT01059760|Fasting|fasting
725890|NCT01059760|Short-term starvation|short-term starvation
725891|NCT01059760|Diet|diet
725892|NCT01059760|Coronary artery disease|coronary artery disease
725893|NCT01059773|Psoriasis|psoriasis
725894|NCT01059773|Ustekinumab|ustekinumab
725895|NCT01059773|Stelara|stelara
725896|NCT01059773|Methotrexate|methotrexate
725897|NCT01059773|Biologic|biologic
725898|NCT01059786|Monoclonal Antibody|monoclonal antibody
725899|NCT01059786|Purine Analog|purine analog
725900|NCT01059786|Soluble CD25|soluble cd25
726201|NCT01071590|PD|pd
725901|NCT01059786|Minimal Residual Disease MRD|minimal residual disease mrd
725902|NCT01059786|CD20|cd20
725903|NCT01059786|Hairy Cell Leukemia|hairy cell leukemia
725904|NCT01059825|Phase 2|phase 2
725905|NCT01059825|safety and efficacy study with ertugliflozin (PF-04971729, MK-8835)|safety and efficacy study with ertugliflozin (pf-04971729, mk-8835)
725906|NCT01059825|Type 2 diabetes mellitus|type 2 diabetes mellitus
725907|NCT01059838|pediatrics|pediatrics
725908|NCT01059838|cochlear implant|cochlear implant
725909|NCT01059864|cholesterol|cholesterol
725910|NCT01059864|lipids|lipids
725911|NCT01059864|rheumatoid arthritis|rheumatoid arthritis
725912|NCT01059864|CP-690|cp-690
725913|NCT01059864|550|550
725914|NCT01059877|dementia alzheimers frontotemporal lyme,|dementia alzheimers frontotemporal lyme,
726903|NCT01064310|pazopanib|pazopanib
725915|NCT01059877|lewy body cognitive impairment|lewy body cognitive impairment
725916|NCT01059903|Rotigotine|rotigotine
725917|NCT01059903|Neupro®|neupro®
725918|NCT01059903|Transdermal Patch|transdermal patch
725919|NCT01059929|Hypnotics and Sedatives|hypnotics and sedatives
725920|NCT01059929|Respiration, Artificial|respiration, artificial
725921|NCT01059929|Ventilators, Mechanical|ventilators, mechanical
725922|NCT01059929|Critical care|critical care
725923|NCT01059929|Intensive care|intensive care
725924|NCT01059929|Physical therapy|physical therapy
725925|NCT01059929|Occupational therapy|occupational therapy
725926|NCT01059929|Sedative medications|sedative medications
725927|NCT01059942|communication barriers|communication barriers
725928|NCT01059942|clinical competence|clinical competence
725929|NCT01059942|medical education|medical education
725930|NCT01059942|internship and residency|internship and residency
725931|NCT01059942|hospitalist|hospitalist
725932|NCT01059942|Quality Assurance, Healthcare|quality assurance, healthcare
725933|NCT01059942|Patient Care|patient care
725934|NCT01059942|Internal Medicine|internal medicine
725935|NCT01059955|scleritis|scleritis
725936|NCT01059955|anterior scleritis|anterior scleritis
725937|NCT01059955|nodular anterior scleritis|nodular anterior scleritis
725938|NCT01059955|diffuse anterior scleritis|diffuse anterior scleritis
725939|NCT01059968|bone density|bone density
725940|NCT01059968|energy availability|energy availability
725941|NCT01059968|menstrual status|menstrual status
725942|NCT01059968|female|female
725943|NCT01059968|adolescent|adolescent
725944|NCT01059994|fatigue|fatigue
725945|NCT01059994|aging|aging
725946|NCT01070355|Colorectal Neoplasms|colorectal neoplasms
725947|NCT01070355|Fish Oils|fish oils
725948|NCT01070355|Fatty Acids, Omega-3|fatty acids, omega-3
725949|NCT01070355|Eicosapentaenoic Acid|eicosapentaenoic acid
725950|NCT01070355|Liver Metastases|liver metastases
725951|NCT01070355|Randomised Controlled Trial|randomised controlled trial
725952|NCT01070368|skin test|skin test
725953|NCT01070368|open wheat challenge|open wheat challenge
725954|NCT01070394|ADHD|adhd
725955|NCT01070394|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate
725956|NCT01070394|Amphetamine|amphetamine
725957|NCT01070407|Hepatitis C virus|hepatitis c virus
725958|NCT01070407|HCV|hcv
725959|NCT01070407|Adenovirus|adenovirus
725960|NCT01070407|Vaccine|vaccine
725961|NCT01070420|Adenosine|adenosine
725962|NCT01070420|Fractional flow reserve, Hyperemia|fractional flow reserve, hyperemia
725963|NCT01070420|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
725964|NCT01070433|Diabetic Foot Ulcers (DFUs)|diabetic foot ulcers (dfus)
725965|NCT01070446|choline|choline
725966|NCT01070446|cystic fibrosis|cystic fibrosis
725967|NCT01070446|methyl metabolism|methyl metabolism
725968|NCT01070446|fatty acids|fatty acids
725969|NCT01070446|oxidative stress|oxidative stress
725970|NCT01070446|pulmonary function|pulmonary function
725971|NCT01070459|Stroke aerobic exercise daily functioning rehabilitation|stroke aerobic exercise daily functioning rehabilitation
725972|NCT01070472|labor induction at term using a titrated oral misoprostol solution|labor induction at term using a titrated oral misoprostol solution
725973|NCT01070498|peanut hypersensitivity|peanut hypersensitivity
725974|NCT01070498|tree nut hypersensitivity|tree nut hypersensitivity
725975|NCT01070498|allergy|allergy
725976|NCT01070498|Trichuris suis|trichuris suis
725977|NCT01070498|hygiene hypothesis|hygiene hypothesis
725978|NCT01070498|treatment|treatment
725979|NCT01070498|clinical trial|clinical trial
725980|NCT01070498|food/adverse effect|food/adverse effect
725981|NCT01070498|peanut allergy (mild to moderate)|peanut allergy (mild to moderate)
725982|NCT01070498|tree nut allergy (mild to moderate)|tree nut allergy (mild to moderate)
725984|NCT01070511|Tadalafil|tadalafil
725985|NCT01070537|Otolaryngology|otolaryngology
725986|NCT01070537|Equipment and Supplies|equipment and supplies
725987|NCT01070537|Intubation|intubation
725988|NCT01070563|Brain death|brain death
725989|NCT01070563|CT angiography|ct angiography
725990|NCT01070563|Ultrasonography, doppler, transcranial|ultrasonography, doppler, transcranial
725991|NCT01070576|non union|non union
725992|NCT01070576|fracture|fracture
725993|NCT01070576|healing|healing
725994|NCT01070576|arginine|arginine
725995|NCT01070576|NO|no
725996|NCT01070589|Obesity|obesity
725997|NCT01070589|Growth hormone secretion|growth hormone secretion
725998|NCT01070589|Anaerobic exercise|anaerobic exercise
725999|NCT01070602|IFIS|ifis
726000|NCT01070628|Pharmacokinetic|pharmacokinetic
726001|NCT01070641|CARVEDILOL|carvedilol
726002|NCT01070641|VARICEAL BAND LIGATION|variceal band ligation
726003|NCT01070641|PRIMARY PROPHYLAXIS|primary prophylaxis
726004|NCT01070654|ARDS|ards
726005|NCT01070654|Recruitment Manoeuvres|recruitment manoeuvres
726006|NCT01070654|PEEP|peep
726007|NCT01070654|Cytokines|cytokines
726008|NCT01070654|Respiratory Insufficiency|respiratory insufficiency
726009|NCT01070667|PAF|paf
726010|NCT01070667|AF|af
726011|NCT01070667|Dronedarone|dronedarone
726012|NCT01070667|AF Burden|af burden
726013|NCT01070667|AFB|afb
726014|NCT01070667|PPM|ppm
726015|NCT01070667|Permanent Pacemaker|permanent pacemaker
726016|NCT01070667|Atrial Fibrillation Burden in Paroxysmal Atrial Fibrillation|atrial fibrillation burden in paroxysmal atrial fibrillation
726017|NCT01070706|Patients with HER2- stage II/III breast cancer|patients with her2- stage ii/iii breast cancer
726018|NCT01070719|Multiple Sclerosis, relapsing forms|multiple sclerosis, relapsing forms
726019|NCT01070732|Fever|fever
726020|NCT01070732|Infectious diseases|infectious diseases
726021|NCT01070732|Neoplasia|neoplasia
726022|NCT01070732|Pain|pain
726023|NCT01070732|cholecystectomy|cholecystectomy
726024|NCT01070732|Colectomy|colectomy
726025|NCT01070745|PDA|pda
726026|NCT01070745|Indomethacin|indomethacin
726027|NCT01070745|Ibuprofen|ibuprofen
726028|NCT01070758|Congenital hyperinsulinism|congenital hyperinsulinism
726029|NCT01070758|Somatostatin analog|somatostatin analog
726030|NCT01070758|Lanreotide autogel|lanreotide autogel
726031|NCT01070758|Hypoglycemia|hypoglycemia
726032|NCT01070771|Pressure wire|pressure wire
726033|NCT01070771|Fractional flow reserve|fractional flow reserve
726034|NCT01070784|Symbicort|symbicort
726035|NCT01070784|Safety|safety
726036|NCT01070784|Efficacy|efficacy
726037|NCT01070784|COPD|copd
726038|NCT01070784|Japanese|japanese
726039|NCT01070797|Epstein-Barr virus|epstein-barr virus
726040|NCT01070797|CTL|ctl
726041|NCT01070797|cytotoxic T Lymphocytes|cytotoxic t lymphocytes
726042|NCT01070797|CMV|cmv
726043|NCT01070797|Adenovirus Infection|adenovirus infection
726044|NCT01070797|viral infection|viral infection
726045|NCT01070797|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
726046|NCT01070810|Septic Shock|septic shock
726047|NCT01070810|Sepsis|sepsis
726048|NCT01070823|Sample Collection|sample collection
726049|NCT01070823|JCV|jcv
726050|NCT01070823|PML|pml
726051|NCT01070836|JCV|jcv
726052|NCT01070836|Sample Collection|sample collection
726053|NCT01070836|PML|pml
726054|NCT01070836|Antibody|antibody
726055|NCT01070849|exercise|exercise
726056|NCT01070849|physical activity|physical activity
726057|NCT01070862|multiple myeloma, treatment, first line|multiple myeloma, treatment, first line
726058|NCT01070875|Antithrombotic prophylaxis|antithrombotic prophylaxis
726059|NCT01070888|Asthma|asthma
726060|NCT01070888|Exercise Induced Asthma|exercise induced asthma
726061|NCT01070914|Cilia|cilia
726062|NCT01070914|Phenotyping|phenotyping
726063|NCT01070914|Diagnosis|diagnosis
726064|NCT01070914|Nitric Oxide|nitric oxide
726065|NCT01070914|Bronchiectasis|bronchiectasis
726066|NCT01070940|L-NMMA|l-nmma
726067|NCT01070940|blood pressure|blood pressure
726068|NCT01070940|arterial stiffness|arterial stiffness
726069|NCT01070940|pulse wave velocity|pulse wave velocity
726070|NCT01070940|augmentation index|augmentation index
726071|NCT01070940|dose-response|dose-response
726072|NCT01070940|healthy subjects|healthy subjects
726073|NCT01070940|GFR|gfr
726074|NCT01070953|Hypercholesterolemia|hypercholesterolemia
726075|NCT01070966|Atherosclerosis|atherosclerosis
726076|NCT01071005|Decrease serum levels of luteinizing hormone, FSH and Testosterone|decrease serum levels of luteinizing hormone, fsh and testosterone
726077|NCT01071018|locally advanced or metastatic solid tumors|locally advanced or metastatic solid tumors
726078|NCT01071031|Safety|safety
726079|NCT01071031|Tolerability|tolerability
726080|NCT01071031|Immunogenicity|immunogenicity
726081|NCT01071031|Human Immunodeficiency Virus|human immunodeficiency virus
726082|NCT01071031|HIV-1|hiv-1
726083|NCT01071031|Vaccine|vaccine
726084|NCT01071031|CD4|cd4
726085|NCT01071031|Viral Load|viral load
726086|NCT01071031|HIV|hiv
726087|NCT01071044|Chronic Fatigue Syndrome|chronic fatigue syndrome
726088|NCT01071057|opioid-induced pruritus|opioid-induced pruritus
726089|NCT01071057|naloxone|naloxone
726090|NCT01071070|Chronic Kidney Disease|chronic kidney disease
726091|NCT01071070|Secondary hyperparathyroidism|secondary hyperparathyroidism
726092|NCT01071083|MS|ms
726093|NCT01071096|Botox|botox
726094|NCT01071096|OnabotulinumtoxinA|onabotulinumtoxina
726095|NCT01071096|Chronic Migraine|chronic migraine
726096|NCT01071096|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide
726097|NCT01071096|Saliva|saliva
726098|NCT01071109|Therapeutic massage|therapeutic massage
726099|NCT01071109|massage|massage
726100|NCT01071109|inflammation|inflammation
726101|NCT01071109|fatigue|fatigue
726103|NCT01071109|radiation therapy|radiation therapy
726104|NCT01071109|breast cancer|breast cancer
726105|NCT01071109|Breast Cancer patients receiving radiation therapy|breast cancer patients receiving radiation therapy
726106|NCT01071122|Central blood pressure|central blood pressure
726107|NCT01071122|Nifedipine|nifedipine
726108|NCT01071122|Valsartan|valsartan
726109|NCT01071148|Infertility|infertility
726110|NCT01071148|Gonal-f|gonal-f
726111|NCT01071148|Pergoveris|pergoveris
726112|NCT01071148|Luveris|luveris
726113|NCT01071161|chronic cough|chronic cough
726114|NCT01071161|COPD|copd
726115|NCT01071161|Azithromycin|azithromycin
726116|NCT01071161|Zithromax|zithromax
726117|NCT01071161|LCQ|lcq
726118|NCT01071174|HIV infections|hiv infections
726119|NCT01071174|Anti-HIV agents|anti-hiv agents
726120|NCT01071174|HIV-1|hiv-1
726121|NCT01071187|alcohol dependence|alcohol dependence
726122|NCT01071187|addiction|addiction
726123|NCT01071187|alcohol|alcohol
726124|NCT01071187|relapse prevention|relapse prevention
726125|NCT01071200|Reproductive Techniques, Assisted|reproductive techniques, assisted
726250|NCT01071785|Serum lipids|serum lipids
726126|NCT01071200|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
726127|NCT01071200|Recombinant leutinizing hormone (r-hLH)|recombinant leutinizing hormone (r-hlh)
726128|NCT01071226|Malignant and non-malignant diseases|malignant and non-malignant diseases
726129|NCT01071226|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
726130|NCT01071226|Peripheral blood progenitor cell transplant|peripheral blood progenitor cell transplant
726131|NCT01071226|CliniMACS device|clinimacs device
726132|NCT01071226|T cell depletion|t cell depletion
726133|NCT01071239|Fanconi Anemia|fanconi anemia
726134|NCT01071239|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
726135|NCT01071252|Moderate to severe chronic plaque-type psoriasis|moderate to severe chronic plaque-type psoriasis
726136|NCT01071252|AIN457|ain457
726137|NCT01071252|dermatology|dermatology
726138|NCT01071278|Lipid metabolism disorder|lipid metabolism disorder
726139|NCT01071304|Relapsed or refractory advanced cancer, metastatic cancer, locally advanced cancer|relapsed or refractory advanced cancer, metastatic cancer, locally advanced cancer
726140|NCT01071343|muscular atrophy|muscular atrophy
726141|NCT01071343|recovery of function|recovery of function
726142|NCT01071343|rehabilitation|rehabilitation
726143|NCT01071343|Intensive care unit|intensive care unit
726144|NCT01071356|methamphetamine|methamphetamine
726145|NCT01071356|motivational interviewing|motivational interviewing
726146|NCT01071382|Aeromedical Evacuation|aeromedical evacuation
726147|NCT01071382|Repatriation|repatriation
726148|NCT01071395|Parkinson's disease|parkinson's disease
726149|NCT01071395|Dyskinesia|dyskinesia
726150|NCT01071395|Dyskinesia Rating Scales|dyskinesia rating scales
726151|NCT01071395|Amantadine|amantadine
726152|NCT01071395|Placebo|placebo
726153|NCT01071408|chronic care model|chronic care model
726154|NCT01071408|stroke prevention|stroke prevention
726155|NCT01071408|health services research|health services research
726156|NCT01071421|Sleep apnea syndrome|sleep apnea syndrome
726157|NCT01071421|community acquired pneumonia|community acquired pneumonia
726158|NCT01071421|prevalence|prevalence
726159|NCT01071447|Rheumatic diseases|rheumatic diseases
726160|NCT01071447|Biologic treatment|biologic treatment
726161|NCT01071447|Nurse-led|nurse-led
726162|NCT01071460|PAD|pad
726163|NCT01071473|Childhood cancer|childhood cancer
726164|NCT01071473|Anthracyclines|anthracyclines
726165|NCT01071473|Cardiomyopathy|cardiomyopathy
726166|NCT01071486|Busulfan|busulfan
726167|NCT01071486|Glutathione S-transferase|glutathione s-transferase
726168|NCT01071486|Genetic polymorphism|genetic polymorphism
726169|NCT01071486|HVOD|hvod
726170|NCT01071486|GVHD|gvhd
726171|NCT01071499|pharmacokinetics|pharmacokinetics
726172|NCT01071499|pharmacogenetics|pharmacogenetics
726173|NCT01071499|morphine|morphine
726174|NCT01071499|children|children
726175|NCT01071512|MRI|mri
726176|NCT01071512|OCT|oct
726177|NCT01071512|Tysabri|tysabri
726178|NCT01071512|Multiple Sclerosis|multiple sclerosis
726179|NCT01071512|cognition|cognition
726180|NCT01071538|Depressive Disorder, Major|depressive disorder, major
726181|NCT01071538|Late-Life Depression|late-life depression
726182|NCT01071538|Geriatrics|geriatrics
726183|NCT01071538|Buprenorphine|buprenorphine
726184|NCT01071551|Children|children
726185|NCT01071551|Obesity|obesity
726186|NCT01071551|Lifestyle|lifestyle
726187|NCT01071551|LSES|lses
726188|NCT01071551|Caries|caries
726189|NCT01071577|Bone Marrow Stromal Cells|bone marrow stromal cells
726190|NCT01071577|Mesenchymal Stem Cells|mesenchymal stem cells
726191|NCT01071577|Immune Modulation|immune modulation
726192|NCT01071577|Tissue Regeneration|tissue regeneration
726193|NCT01071577|Bone Marrow|bone marrow
726194|NCT01071577|Healthy Volunteer|healthy volunteer
726195|NCT01071577|HV|hv
726196|NCT01071590|Parkinson's Disease|parkinson's disease
726197|NCT01071590|Sensory Input|sensory input
726198|NCT01071590|Gait|gait
726199|NCT01071590|Imagery|imagery
726200|NCT01071590|Parkinson Disease|parkinson disease
726203|NCT01071603|Extrapulmonary TB|extrapulmonary tb
726204|NCT01071603|NTM|ntm
726205|NCT01071603|HRCT|hrct
726206|NCT01071603|MDRTB|mdrtb
726207|NCT01071603|Tuberculosis|tuberculosis
726208|NCT01071616|Cannabinoids|cannabinoids
726209|NCT01071616|Oral Fluid|oral fluid
726210|NCT01071616|Pharmacokinetics|pharmacokinetics
726211|NCT01071616|Stability|stability
726212|NCT01071616|Smoked Cannabis|smoked cannabis
726213|NCT01071629|interval training|interval training
726214|NCT01071629|strength training|strength training
726215|NCT01071629|exercise capacity|exercise capacity
726216|NCT01071629|chronic heart failure|chronic heart failure
726220|NCT01071642|Length of hospitalization.|length of hospitalization.
726221|NCT01071642|Requirement of unplanned therapy for elevated blood pressure|requirement of unplanned therapy for elevated blood pressure
726222|NCT01071655|colorectal cancer|colorectal cancer
726223|NCT01071655|Bevacizumab|bevacizumab
726224|NCT01071655|Oxaliplatin|oxaliplatin
726225|NCT01071655|Irinotecan|irinotecan
726226|NCT01071655|5FU|5fu
726227|NCT01071655|capecitabine|capecitabine
726228|NCT01071668|onset of labor|onset of labor
726229|NCT01071668|metabolomics|metabolomics
726230|NCT01071668|vaginal secretions|vaginal secretions
726231|NCT01071668|urine|urine
726232|NCT01071668|blood|blood
726233|NCT01071681|Arterial hypertension|arterial hypertension
726234|NCT01071694|Multiple Sclerosis,|multiple sclerosis,
726235|NCT01071694|Relapsing-Remitting,|relapsing-remitting,
726236|NCT01071694|Interferon beta-1b,|interferon beta-1b,
726237|NCT01071694|Quality of life|quality of life
726238|NCT01071707|IPF|ipf
726239|NCT01071707|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
726240|NCT01071720|Healthy subjects|healthy subjects
726241|NCT01071759|Pregnancy|pregnancy
726242|NCT01071759|anemia|anemia
726243|NCT01071759|Helicobacter pylori|helicobacter pylori
726244|NCT01071759|Hemoglobin|hemoglobin
726245|NCT01071759|Iron|iron
726246|NCT01071759|Ferritin|ferritin
726247|NCT01071785|Metabolic Syndrome|metabolic syndrome
726248|NCT01071785|diet|diet
726249|NCT01071785|fiber|fiber
726251|NCT01071785|Albuminuria|albuminuria
726252|NCT01071811|Randomized controlled trial|randomized controlled trial
726253|NCT01071811|Pedometer|pedometer
726254|NCT01071811|Physical activity|physical activity
726255|NCT01071811|Health measurement|health measurement
726256|NCT01071811|Self-rated health|self-rated health
726257|NCT01071811|Stress|stress
726258|NCT01071811|Sleep quality|sleep quality
726265|NCT01071837|Glioblastoma Multiforme|glioblastoma multiforme
726266|NCT01071850|Type 2 diabetes|type 2 diabetes
726267|NCT01071850|diabetes|diabetes
726268|NCT01071850|ASP1941|asp1941
726269|NCT01071850|Metformin|metformin
726270|NCT01071876|Sleep disorder|sleep disorder
726271|NCT01071876|obstructive sleep apnea|obstructive sleep apnea
726272|NCT01071876|excessive daytime sleepiness|excessive daytime sleepiness
726273|NCT01071876|patients with OSA treated by CPAP presenting EDS|patients with osa treated by cpap presenting eds
726274|NCT01071889|Healthy Volunteers|healthy volunteers
726275|NCT01071902|ear tubes|ear tubes
726276|NCT01071902|ear drainage|ear drainage
726277|NCT01071902|ear infection|ear infection
726278|NCT01071902|ear drops|ear drops
726279|NCT01071902|acute otitis media|acute otitis media
726280|NCT01071928|Advanced Urothelial Carcinoma|advanced urothelial carcinoma
726281|NCT01071941|rRp450|rrp450
726282|NCT01071941|Herpes virus|herpes virus
726283|NCT01071941|Gene therapy|gene therapy
726284|NCT01071954|Immune thrombocytopenic Purpura|immune thrombocytopenic purpura
726285|NCT01071954|Pediatric|pediatric
726286|NCT01071954|Thrombocytopenia|thrombocytopenia
726287|NCT01071967|Community Health Nursing|community health nursing
726288|NCT01071967|Nursing Care Management|nursing care management
726289|NCT01071967|Aged|aged
726290|NCT01071967|Aged, 80 and over|aged, 80 and over
726291|NCT01071967|Health Services for the Aged|health services for the aged
726292|NCT01071967|Geriatric Nursing|geriatric nursing
726293|NCT01071967|Geriatric Assessment|geriatric assessment
726294|NCT01071967|Longevity|longevity
726295|NCT01071967|Mortality|mortality
726296|NCT01071993|prevention|prevention
726297|NCT01071993|nephropathy|nephropathy
726298|NCT01072006|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
726299|NCT01072006|PTSD|ptsd
726300|NCT01072006|fMRI|fmri
726301|NCT01072006|attention|attention
726302|NCT01072032|EEG|eeg
726303|NCT01072032|Robotics (ankle)|robotics (ankle)
726304|NCT01072032|Motor-learning|motor-learning
726305|NCT01072032|Brain Plasticity|brain plasticity
726306|NCT01072045|Hemangioma|hemangioma
726307|NCT01072045|Proliferative hemangioma|proliferative hemangioma
726308|NCT01072045|Treatment|treatment
726309|NCT01072045|Propranolol|propranolol
726310|NCT01072045|Corticosteroid|corticosteroid
726311|NCT01072058|Infliximab|infliximab
726312|NCT01072058|Adalimumab|adalimumab
726313|NCT01072058|Etanercept|etanercept
726314|NCT01072058|Heart failure|heart failure
726315|NCT01072058|Diastolic disfunction|diastolic disfunction
726318|NCT01072058|Echocardiography|echocardiography
726319|NCT01072058|Tissue doppler imaging|tissue doppler imaging
726320|NCT01072058|Brain Natriuretic Peptide|brain natriuretic peptide
726321|NCT01072058|NT-proBNP|nt-probnp
726322|NCT01072071|abdominal compartment syndrome|abdominal compartment syndrome
726323|NCT01072071|intra-abdominal pressure|intra-abdominal pressure
726324|NCT01072071|furosemide|furosemide
726325|NCT01072071|fluid balance|fluid balance
726326|NCT01072084|food allergy|food allergy
726327|NCT01072084|confocal laser endoscope|confocal laser endoscope
726328|NCT01072084|diagnosis|diagnosis
728734|NCT01085825|electric vacuum aspiration|electric vacuum aspiration
728735|NCT01085838|Erlotinib|erlotinib
728736|NCT01085838|myelodysplastic syndrome|myelodysplastic syndrome
728739|NCT01085851|Lotion|lotion
726329|NCT01072084|Diagnosis of food allergy|diagnosis of food allergy
726330|NCT01072097|PCOS|pcos
726331|NCT01072097|Atorvastatin|atorvastatin
726332|NCT01072097|Androgens|androgens
726333|NCT01072097|Glucose metabolism|glucose metabolism
726334|NCT01072097|Inflammatory markers|inflammatory markers
726335|NCT01072110|Patients with diarrhea|patients with diarrhea
726336|NCT01072136|mucopurulent cervicitis, chlamydia, gonorrhea, women|mucopurulent cervicitis, chlamydia, gonorrhea, women
726337|NCT01072149|COPD|copd
726338|NCT01072149|Safety|safety
726339|NCT01072149|FEV1|fev1
726340|NCT01072149|Efficacy|efficacy
726341|NCT01072162|healthy|healthy
726342|NCT01072162|powder for suspension|powder for suspension
726343|NCT01072162|tablets|tablets
726344|NCT01072162|bioavailibility|bioavailibility
726345|NCT01072162|eltrombopag|eltrombopag
726346|NCT01072175|drug-drug interaction|drug-drug interaction
726347|NCT01072175|BRAF inhibitor|braf inhibitor
726348|NCT01072175|expansion cohorts|expansion cohorts
726349|NCT01072175|melanoma|melanoma
726350|NCT01072175|dose escalation|dose escalation
726351|NCT01072175|MEK inhibitor|mek inhibitor
726352|NCT01072214|Pazopanib|pazopanib
726353|NCT01072214|Tolerability|tolerability
726354|NCT01072214|Pharmacokinetics|pharmacokinetics
726355|NCT01072214|GW786034|gw786034
726356|NCT01072214|Safety|safety
726357|NCT01072227|Non-typeable Haemophilus Influenzae|non-typeable haemophilus influenzae
726358|NCT01072227|Acute Otitis Media|acute otitis media
726359|NCT01072227|Streptococcus Pneumoniae|streptococcus pneumoniae
726360|NCT01072227|Etiology|etiology
726361|NCT01072266|Refractory, Advanced malignancies|refractory, advanced malignancies
726362|NCT01072279|Malnutrition;|malnutrition;
726363|NCT01072279|Infant nutrition;|infant nutrition;
726364|NCT01072279|Fortified food|fortified food
726365|NCT01072279|Linear growth|linear growth
726366|NCT01072279|Cluster randomized controlled trials|cluster randomized controlled trials
726367|NCT01072279|Effectiveness|effectiveness
726368|NCT01072279|Impact evaluation studies|impact evaluation studies
726369|NCT01072279|Burundi|burundi
726370|NCT01072279|Guatemala|guatemala
726371|NCT01072305|fluid restriction|fluid restriction
726372|NCT01072305|fluid therapy|fluid therapy
726373|NCT01072305|intraoperative care|intraoperative care
726374|NCT01072318|Breast cancer|breast cancer
726375|NCT01072318|extended adjuvant hormonal therapy|extended adjuvant hormonal therapy
726376|NCT01072318|letrozole|letrozole
726377|NCT01072318|Toremifene|toremifene
726378|NCT01072331|insulin resistance|insulin resistance
726379|NCT01072344|Anxiety|anxiety
726380|NCT01072344|Chamomile|chamomile
726381|NCT01072344|Herbal Remedy|herbal remedy
726382|NCT01072344|Complementary and Alternative Medicine|complementary and alternative medicine
726383|NCT01072357|High-Risk Corneal Transplantation|high-risk corneal transplantation
726384|NCT01072357|Penetrating Keratoplasty|penetrating keratoplasty
726385|NCT01072357|Neovascularization|neovascularization
726386|NCT01072357|Corneal Blood Vessels|corneal blood vessels
726387|NCT01072357|Avastin|avastin
726388|NCT01072357|Bevacizumab|bevacizumab
726389|NCT01072357|Corneal Graft|corneal graft
726390|NCT01072370|Umbilical Cord Blood|umbilical cord blood
726391|NCT01072370|Stem Cells|stem cells
726392|NCT01072370|Autologous Blood Transfusion|autologous blood transfusion
726393|NCT01072370|Cerebral Palsy|cerebral palsy
726394|NCT01072383|chronic plaque psoriasis|chronic plaque psoriasis
726395|NCT01072383|psoriasis vulgaris|psoriasis vulgaris
726396|NCT01072383|autoimmune disease|autoimmune disease
726397|NCT01072409|Speech perception ability in the CI alone condition|speech perception ability in the ci alone condition
726398|NCT01072422|Smoking|smoking
726399|NCT01072422|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
726400|NCT01072422|Questionnaires|questionnaires
726401|NCT01072422|Nurses|nurses
726402|NCT01072422|Primary Health Care|primary health care
726403|NCT01072435|ERCP|ercp
726404|NCT01072435|patient-controlled sedation|patient-controlled sedation
726405|NCT01072435|target-controlled infusion|target-controlled infusion
726406|NCT01072435|propofol|propofol
726407|NCT01072435|Sedation with propofol for ERCP|sedation with propofol for ercp
726408|NCT01072435|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
726409|NCT01072448|COPD|copd
726410|NCT01072448|indacaterol|indacaterol
726411|NCT01072461|Cerebrovascular Accident|cerebrovascular accident
726412|NCT01072461|Robotics|robotics
726413|NCT01072461|Virtual Reality|virtual reality
726414|NCT01072461|Rehabilitation|rehabilitation
726415|NCT01072461|Neuroplasticity|neuroplasticity
726418|NCT01072474|Gastrointestinal endoscopy|gastrointestinal endoscopy
726419|NCT01072474|Colonoscopy|colonoscopy
726420|NCT01072487|Safety|safety
726421|NCT01072487|Sedation|sedation
726422|NCT01072487|Gastrointestinal endoscopy|gastrointestinal endoscopy
726423|NCT01072487|Colonoscopy|colonoscopy
726424|NCT01072500|Aging|aging
726425|NCT01072500|Physical Activity|physical activity
726426|NCT01072500|Exercise|exercise
726427|NCT01072500|Sedentary Lifestyle|sedentary lifestyle
726428|NCT01072500|Mobility|mobility
726429|NCT01072500|Disability|disability
726430|NCT01072500|Falls|falls
726431|NCT01072500|Cost effectiveness|cost effectiveness
726432|NCT01072500|Behavioral counseling|behavioral counseling
726433|NCT01072513|Semen Analysis, Prostate Cancer, Proton Radiation|semen analysis, prostate cancer, proton radiation
726434|NCT01072526|Dry Eye Syndromes|dry eye syndromes
726435|NCT01072526|Lacrimal Apparatus Diseases|lacrimal apparatus diseases
726436|NCT01072539|infection|infection
726437|NCT01072539|Tygacil|tygacil
726438|NCT01072539|PMS|pms
726439|NCT01072552|recurrent wheezing|recurrent wheezing
726440|NCT01072552|asthma|asthma
726441|NCT01072552|preterm infants|preterm infants
726442|NCT01072552|palivizumab|palivizumab
726443|NCT01072552|atopic diseases|atopic diseases
726444|NCT01072565|Type 2 Diabetes|type 2 diabetes
726445|NCT01072565|A1c|a1c
726446|NCT01072565|Continuous Glucose Monitoring|continuous glucose monitoring
726447|NCT01072565|Blood Glucose|blood glucose
726448|NCT01072578|Healthy volunteers|healthy volunteers
726449|NCT01072578|Inhibition of glucose re-absorption|inhibition of glucose re-absorption
726450|NCT01072578|diabetes|diabetes
726451|NCT01072578|dapagliflozin|dapagliflozin
726452|NCT01072591|anti-NGF|anti-ngf
726453|NCT01072591|OA|oa
726454|NCT01072591|pain|pain
726455|NCT01072604|Aspirin|aspirin
726456|NCT01072604|Acetylsalicylic Acid|acetylsalicylic acid
726457|NCT01072630|Bipolar I Disorder|bipolar i disorder
726458|NCT01072643|Sedation|sedation
726459|NCT01072643|Pulmonary Hypertension|pulmonary hypertension
726460|NCT01072643|Pediatric|pediatric
726461|NCT01072643|Cardiac Catheterization|cardiac catheterization
726462|NCT01072643|Pulmonary Vascular Resistance|pulmonary vascular resistance
726463|NCT01072669|Ambrisentan increases digital micro-vascular flow (measured by LDPI) in patients with Raynaud's phenomenon (RP) and digital ischemia secondary to SSc.|ambrisentan increases digital micro-vascular flow (measured by ldpi) in patients with raynaud's phenomenon (rp) and digital ischemia secondary to ssc.
726464|NCT01072682|Acute Renal Failure|acute renal failure
726465|NCT01072682|Acute tubular necrosis|acute tubular necrosis
726466|NCT01072682|Continuous Renal Replacement Therapy|continuous renal replacement therapy
726467|NCT01072682|Selective cytopheretic device|selective cytopheretic device
726468|NCT01072695|Hepatitis C|hepatitis c
726469|NCT01072695|HCV|hcv
726470|NCT01072695|GS-9256|gs-9256
726471|NCT01072695|GS-9190|gs-9190
726472|NCT01072695|Genotype 1|genotype 1
726473|NCT01072708|Cystic fibrosis -diabetes - glucose tolerance - reversibility - oral glucose tolerance test - predictive factors|cystic fibrosis -diabetes - glucose tolerance - reversibility - oral glucose tolerance test - predictive factors
726474|NCT01072721|Liver|liver
726475|NCT01072721|Fibrosis|fibrosis
726476|NCT01072721|Elastometry|elastometry
726477|NCT01072721|FIBROSCANN|fibroscann
726478|NCT01072721|Children|children
726479|NCT01072734|Lupus|lupus
726480|NCT01072734|CXCR4 on leucocytes of patients with SLE|cxcr4 on leucocytes of patients with sle
726481|NCT01072734|Influenza vaccine|influenza vaccine
726482|NCT01072760|Mallet finger|mallet finger
726483|NCT01072760|extensor tendon|extensor tendon
726484|NCT01072760|Kirschner wire|kirschner wire
726485|NCT01072760|Fracture Fixation|fracture fixation
726486|NCT01072786|Dengue Virus|dengue virus
726487|NCT01072786|Dengue Fever|dengue fever
726488|NCT01072786|Dengue Vaccine|dengue vaccine
726489|NCT01072786|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
726490|NCT01072786|Dengue Shock Syndrome|dengue shock syndrome
726491|NCT01072799|A (H1N1)|a (h1n1)
726492|NCT01072812|Alzheimer's|alzheimer's
726493|NCT01072812|Amnestic Mild Cognitive Impairment|amnestic mild cognitive impairment
726494|NCT01072812|Pharmacokinetics|pharmacokinetics
726495|NCT01072812|Pharmacodynamics|pharmacodynamics
726496|NCT01072812|Biomarkers|biomarkers
726497|NCT01072838|breast cancer|breast cancer
726498|NCT01072838|APBI|apbi
726499|NCT01072838|brachytherapy|brachytherapy
726500|NCT01072838|Contura|contura
726501|NCT01072851|colorectal cancer screening|colorectal cancer screening
726502|NCT01072851|multimedia education|multimedia education
726503|NCT01072851|print education|print education
726504|NCT01072851|culturally competent|culturally competent
726505|NCT01072864|Postmenopausal|postmenopausal
726506|NCT01072877|Varicose Veins|varicose veins
726507|NCT01072890|Temsirolimus, Pazopanib|temsirolimus, pazopanib
726508|NCT01072903|inflammation|inflammation
726509|NCT01072903|colon, irritable|colon, irritable
726510|NCT01072903|Colonic Diseases, Functional|colonic diseases, functional
726511|NCT01072903|Irritable Bowel Syndrome|irritable bowel syndrome
726512|NCT01072916|Colon, Irritable|colon, irritable
726513|NCT01072916|Microbiota|microbiota
726514|NCT01072929|Bipolar I Disorder|bipolar i disorder
726515|NCT01072942|Chronic Obstructive|chronic obstructive
726517|NCT01072942|Pharmacokinetics|pharmacokinetics
726518|NCT01072942|Microbiology|microbiology
726519|NCT01072968|Multicenter|multicenter
726520|NCT01072968|Randomized|randomized
726521|NCT01072968|Double-blind|double-blind
726522|NCT01072968|Efficacy and safety study|efficacy and safety study
726523|NCT01072968|BF2.649 versus placebo|bf2.649 versus placebo
726524|NCT01072968|Patients suffering from Obstructive Sleep Apnea|patients suffering from obstructive sleep apnea
726525|NCT01072968|Complaining from Excessive Daytime Sleepiness|complaining from excessive daytime sleepiness
726526|NCT01072968|Refusing nasal Continuous Positive Airway Pressure|refusing nasal continuous positive airway pressure
726527|NCT01072981|Pancreatic Cancer|pancreatic cancer
726528|NCT01072981|Vaccine Therapy|vaccine therapy
726529|NCT01072994|Myocardium|myocardium
726530|NCT01072994|Phospholipid|phospholipid
726531|NCT01072994|Fish oil|fish oil
726532|NCT01072994|Cardiolipin|cardiolipin
726533|NCT01072994|Transplantation|transplantation
726534|NCT01073007|Acute Stroke|acute stroke
726535|NCT01073007|tissue plasminogen activator|tissue plasminogen activator
726536|NCT01073007|simvastatin|simvastatin
726537|NCT01073020|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
726538|NCT01073020|Obesity|obesity
726539|NCT01073020|Lifestyle|lifestyle
726540|NCT01073020|Bariatric Surgery|bariatric surgery
726541|NCT01073020|Laparoscopic Adjustable Gastric Band|laparoscopic adjustable gastric band
726542|NCT01073020|Laparoscopic Roux-en-Y Gastric Bypass|laparoscopic roux-en-y gastric bypass
726543|NCT01073033|pregnancy|pregnancy
726544|NCT01073033|lactation|lactation
726545|NCT01073033|oral supplement|oral supplement
726546|NCT01073033|probiotics|probiotics
726547|NCT01073033|early infections|early infections
726548|NCT01073046|Naso-Gastric/Jejunal Tube|naso-gastric/jejunal tube
726549|NCT01073046|Sub-total Gastrectomy|sub-total gastrectomy
726550|NCT01073046|Gastric Cancer|gastric cancer
726551|NCT01073046|Decompression|decompression
726552|NCT01073046|Discomfort|discomfort
726553|NCT01073046|Complications|complications
726554|NCT01073059|valproic acid|valproic acid
726555|NCT01073059|ertapenem|ertapenem
726556|NCT01073072|bovine pericardium bioprosthesis|bovine pericardium bioprosthesis
726557|NCT01073072|contamination|contamination
726558|NCT01073072|hernia repair|hernia repair
726559|NCT01073072|abdominal wall reconstruction|abdominal wall reconstruction
726560|NCT01073072|Tutomesh|tutomesh
726561|NCT01073072|Tutopatch|tutopatch
726562|NCT01073072|Potentially Contaminated Hernia Repair|potentially contaminated hernia repair
726563|NCT01073072|Potentially Contaminated Abdominal Wall Reconstruction|potentially contaminated abdominal wall reconstruction
726564|NCT01073137|diabetes|diabetes
726565|NCT01073150|Tea Tree Oil|tea tree oil
726566|NCT01073150|Chronic Blepharitis|chronic blepharitis
726567|NCT01073176|ADHD|adhd
726568|NCT01073176|Executive function|executive function
726569|NCT01073176|Preschool children|preschool children
726570|NCT01073176|Treatment|treatment
726571|NCT01073176|Memory|memory
726572|NCT01073176|Attention|attention
726573|NCT01073176|Training|training
726574|NCT01073176|Cognitive enhancement|cognitive enhancement
726575|NCT01073189|Acute kidney injury|acute kidney injury
726576|NCT01073189|Fenoldopam mesylate|fenoldopam mesylate
726577|NCT01073189|Benephit catheter|benephit catheter
726578|NCT01062841|Long-Term Care|long-term care
726579|NCT01062841|Nursing Homes|nursing homes
726580|NCT01062841|Infection Control|infection control
726581|NCT01062841|Multi-drug resistant pathogens|multi-drug resistant pathogens
726582|NCT01062841|Long-term care residents with in-dwelling devices|long-term care residents with in-dwelling devices
726583|NCT01062854|snoring, sleep disordered breathing, polysomnography, sleep fragmentation|snoring, sleep disordered breathing, polysomnography, sleep fragmentation
726584|NCT01062867|Anaesthetic|anaesthetic
726585|NCT01062893|labor pain treatment|labor pain treatment
726586|NCT01062893|duration analgesia|duration analgesia
726587|NCT01062893|Analgesic duration with normal saline injection.|analgesic duration with normal saline injection.
726588|NCT01062893|Analgesic duration without normal saline injection|analgesic duration without normal saline injection
726589|NCT01062906|intravenous lidocaine|intravenous lidocaine
726590|NCT01062906|postoperative pain|postoperative pain
726591|NCT01062906|laparoscopic surgery|laparoscopic surgery
726592|NCT01062906|opioids|opioids
726691|NCT01063426|Vein|vein
726593|NCT01062906|opioids side-effects|opioids side-effects
726594|NCT01062932|Cycloserine|cycloserine
726595|NCT01062932|Nicotine|nicotine
726596|NCT01062932|Smoking|smoking
726597|NCT01062945|Cocaine|cocaine
726598|NCT01062945|Doxazosin|doxazosin
726599|NCT01062958|Neevo|neevo
726600|NCT01062958|Neevo DHA|neevo dha
726601|NCT01062958|L-methylfolate|l-methylfolate
726602|NCT01062958|anemia during pregnancy|anemia during pregnancy
726603|NCT01062958|folic acid|folic acid
726604|NCT01062958|vitamin B12|vitamin b12
726605|NCT01062958|prenatal vitamins|prenatal vitamins
726606|NCT01062958|hemoglobin|hemoglobin
726607|NCT01062958|iron deficiency|iron deficiency
726608|NCT01062958|Pregnancy|pregnancy
726609|NCT01062971|Open-angle glaucoma|open-angle glaucoma
727485|NCT01066728|premature|premature
726610|NCT01062971|Ocular hypertension|ocular hypertension
726611|NCT01062971|POAG|poag
726612|NCT01062984|Renal Replacement Therapy|renal replacement therapy
726613|NCT01063010|sepsis|sepsis
726614|NCT01063010|septic shock|septic shock
726615|NCT01063010|Bevacizumab|bevacizumab
726616|NCT01063010|Avastin|avastin
726617|NCT01063075|Cancer of Head|cancer of head
726618|NCT01063075|Cancer of Head and Neck|cancer of head and neck
726619|NCT01063075|Cancer of Neck|cancer of neck
726620|NCT01063075|Head and Neck Cancer|head and neck cancer
726621|NCT01063075|Head Cancer|head cancer
726622|NCT01063075|Head Neoplasms|head neoplasms
726623|NCT01063075|Head, Neck Neoplasms|head, neck neoplasms
726624|NCT01063075|Neck Cancer|neck cancer
726625|NCT01063075|Neck Neoplasms|neck neoplasms
726626|NCT01063075|Solid Neoplasm|solid neoplasm
726627|NCT01063075|Carcinoma|carcinoma
726628|NCT01063075|Sarcoma|sarcoma
726629|NCT01063088|Prophylaxis of seasonal influenza in adults|prophylaxis of seasonal influenza in adults
726630|NCT01063114|proton beam radiation|proton beam radiation
726631|NCT01063127|Morbid obesity|morbid obesity
726632|NCT01063127|Insulin resistance|insulin resistance
726633|NCT01063127|Euglycemic clamp|euglycemic clamp
726634|NCT01063140|Rabies Immune Globulin|rabies immune globulin
726635|NCT01063140|Source Plasma Donors|source plasma donors
728359|NCT01075919|Fish oil|fish oil
726636|NCT01063140|Booster Immunization|booster immunization
726637|NCT01063153|ADHD|adhd
726638|NCT01063153|Adults|adults
726639|NCT01063153|Electroencephalography (EEG)|electroencephalography (eeg)
726640|NCT01063153|Concerta|concerta
726641|NCT01063179|Elderly patients|elderly patients
726642|NCT01063179|Bortezomib|bortezomib
726643|NCT01063179|Thalidomide|thalidomide
726644|NCT01063192|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
726645|NCT01063205|Methamphetamine|methamphetamine
726646|NCT01063205|NAC|nac
726647|NCT01063205|N-acetylcysteine|n-acetylcysteine
726648|NCT01063218|Dermatitis, Atopic|dermatitis, atopic
726649|NCT01063218|Corticoids, topic|corticoids, topic
726650|NCT01063218|Corticosteroids|corticosteroids
726651|NCT01063231|Colonic Diseases|colonic diseases
726652|NCT01063231|bowel diseases|bowel diseases
726653|NCT01063244|pregnancy|pregnancy
726654|NCT01063244|induction of Labor|induction of labor
726655|NCT01063244|Cervical ripening|cervical ripening
726656|NCT01063244|Foley balloon|foley balloon
726657|NCT01063257|Myelodysplastic Syndrome|myelodysplastic syndrome
726658|NCT01063270|Hidradenitis Suppurativa|hidradenitis suppurativa
726659|NCT01063270|Antibiotics|antibiotics
726660|NCT01063270|Laser|laser
726661|NCT01063283|Non-squamous Non-Small Cell Lung Cancer|non-squamous non-small cell lung cancer
726662|NCT01063283|Bevacizumab|bevacizumab
726663|NCT01063283|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
726664|NCT01063296|cervical cancer|cervical cancer
726665|NCT01063309|Chronic Granulomatous Disease (CGD)|chronic granulomatous disease (cgd)
726666|NCT01063309|Atherosclerosis|atherosclerosis
726667|NCT01063309|Inflammatory Bowel Disease|inflammatory bowel disease
726668|NCT01063309|Immune Deficiencies|immune deficiencies
726669|NCT01063309|Immune System Deficiences|immune system deficiences
726670|NCT01063309|Chronic Granulomatous Disease|chronic granulomatous disease
726671|NCT01063309|CGD|cgd
726672|NCT01063322|Mitral Regurgitation|mitral regurgitation
726673|NCT01063322|Echocardiography|echocardiography
726674|NCT01063322|Cardiac Magnetic Resonance|cardiac magnetic resonance
726675|NCT01063322|Regurgitant Volume|regurgitant volume
726676|NCT01063322|Mitral Valve Regurgitation|mitral valve regurgitation
726677|NCT01063335|CB1 Receptor|cb1 receptor
726678|NCT01063335|Schizophrenia|schizophrenia
726679|NCT01063335|Positron Emission Tomography (PET)|positron emission tomography (pet)
726680|NCT01063335|Healthy Volunteers|healthy volunteers
726681|NCT01063335|HV|hv
726682|NCT01063348|N-Acetyl Cysteine|n-acetyl cysteine
726683|NCT01063348|Picking|picking
726684|NCT01063348|Impulse Control Disorder|impulse control disorder
726685|NCT01063348|Obsessive Compulsive Disorder|obsessive compulsive disorder
726686|NCT01063387|cervical cancer,semaphorin 4C (Sema4C),|cervical cancer,semaphorin 4c (sema4c),
726687|NCT01063387|Prophylactic Irradiation|prophylactic irradiation
726688|NCT01063413|Behavioral Research|behavioral research
726689|NCT01063413|Community-Based Participatory Research|community-based participatory research
726690|NCT01063426|Statin|statin
726692|NCT01063439|DLBCL|dlbcl
726693|NCT01063439|NHL|nhl
726694|NCT01063452|Urinary Catheterization|urinary catheterization
726695|NCT01063452|Urinary Tract Infections|urinary tract infections
726696|NCT01063465|Achilles|achilles
726697|NCT01063465|Tendon|tendon
726698|NCT01063465|weightbearing|weightbearing
726699|NCT01063478|Non-Small Cell|non-small cell
726700|NCT01063478|Lung Cancer|lung cancer
726701|NCT01063478|Unresectable advanced NSCLC|unresectable advanced nsclc
726702|NCT01063491|coronary artery bypass graft surgery|coronary artery bypass graft surgery
726703|NCT01063491|bypass grafts|bypass grafts
726704|NCT01063491|angiography|angiography
726705|NCT01063491|percutaneous coronary intervention|percutaneous coronary intervention
726706|NCT01063491|coronary imaging|coronary imaging
727486|NCT01066728|infant|infant
726707|NCT01063491|coronary artery bypass graft surgery, bypass graft patency|coronary artery bypass graft surgery, bypass graft patency
726708|NCT01063517|Poly(ADP ribose)|poly(adp ribose)
726709|NCT01063517|polymerase (PARP)|polymerase (parp)
726710|NCT01063517|Gastric cancer|gastric cancer
726711|NCT01063517|olaparib|olaparib
726712|NCT01063517|PARP inhibitor|parp inhibitor
726713|NCT01063517|ATM AZD2281|atm azd2281
726714|NCT01063517|Ku0059436|ku0059436
726715|NCT01063517|Homologous Recombination deficiency (HRD)|homologous recombination deficiency (hrd)
726716|NCT01063517|Recurrent gastric cancer|recurrent gastric cancer
726717|NCT01063517|metastatic gastric cancer|metastatic gastric cancer
726718|NCT01063530|FLuoride|fluoride
726719|NCT01063530|Dental Sensitivity|dental sensitivity
726720|NCT01063530|Abfraction|abfraction
726721|NCT01063530|Cervical lesions|cervical lesions
726722|NCT01063543|fondaparinux|fondaparinux
726723|NCT01063543|orthopedic surgery|orthopedic surgery
726724|NCT01063543|patients with major orthopedic surgery|patients with major orthopedic surgery
726725|NCT01063556|end-stage renal disease hemodialysis donepezil hydrochloride pharmacokinetics Cross-Over Study|end-stage renal disease hemodialysis donepezil hydrochloride pharmacokinetics cross-over study
726726|NCT01063569|Addison's disease|addison's disease
726727|NCT01063569|Glucocorticoid treatment|glucocorticoid treatment
726728|NCT01063569|Continuous subcutaneous hydrocortisone infusion|continuous subcutaneous hydrocortisone infusion
726729|NCT01063569|CSHI|cshi
726730|NCT01063569|Quality of Life|quality of life
726731|NCT01063569|Sleep|sleep
726732|NCT01063582|echocardiogram|echocardiogram
726733|NCT01063582|electrocardiographic|electrocardiographic
726734|NCT01063582|risk factors|risk factors
726735|NCT01063582|noise|noise
726736|NCT01063595|Octaplas LG|octaplas lg
726737|NCT01063595|Octaplas SD|octaplas sd
726738|NCT01063634|malignant biliary obstruction|malignant biliary obstruction
726739|NCT01063634|viaduct|viaduct
726740|NCT01063634|self-expandable metal stents|self-expandable metal stents
726741|NCT01063647|Treosulfan|treosulfan
726742|NCT01063647|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
726743|NCT01063647|Conditioning therapy|conditioning therapy
726744|NCT01063660|Treosulfan|treosulfan
726745|NCT01063660|Fludarabine|fludarabine
726746|NCT01063660|ATG|atg
726747|NCT01063660|AML|aml
726748|NCT01063673|Running, overuse injury, limits humans|running, overuse injury, limits humans
726749|NCT01063686|Pregnancy|pregnancy
726750|NCT01063699|biliary atresia - laparoscopy - kasai - portoenterostomy|biliary atresia - laparoscopy - kasai - portoenterostomy
726751|NCT01063712|Ductus|ductus
726752|NCT01063712|Patent ductus Arterious|patent ductus arterious
726753|NCT01063712|"Nit-Occlud® PDA-R"|"nit-occlud® pda-r"
726754|NCT01063712|Interventional closure of PDA|interventional closure of pda
726755|NCT01063712|Percutaneous closure|percutaneous closure
726756|NCT01063725|menopause|menopause
726757|NCT01063725|hot flashes|hot flashes
726758|NCT01063725|vasomotor symptoms|vasomotor symptoms
726759|NCT01063725|femarelle|femarelle
726760|NCT01063725|soy extract|soy extract
726761|NCT01063725|SERM|serm
726762|NCT01063738|Rehabilitation|rehabilitation
726763|NCT01063738|Intensive Care|intensive care
726764|NCT01063738|Critical illness|critical illness
726765|NCT01063738|Physiotherapy|physiotherapy
726766|NCT01063738|Nutritional supplementation|nutritional supplementation
726767|NCT01063751|Osteoarthritis|osteoarthritis
726768|NCT01063751|Traumatic arthritis|traumatic arthritis
726769|NCT01063751|Avascular Necrosis|avascular necrosis
726770|NCT01063764|Keppra|keppra
726771|NCT01063764|Levetiracetam|levetiracetam
726772|NCT01063764|Children|children
726773|NCT01063764|Epilepsy|epilepsy
726774|NCT01063764|Partial Seizures|partial seizures
726775|NCT01063777|Hip Osteoarthritis, Exercise therapy, Patient Education|hip osteoarthritis, exercise therapy, patient education
726776|NCT01063790|Post-operative pain|post-operative pain
726777|NCT01063790|inguinal hernia repair surgery|inguinal hernia repair surgery
726778|NCT01063790|Patient education|patient education
726779|NCT01063803|Open-label|open-label
726780|NCT01063803|Long-term safety study of ATN-103 in RA|long-term safety study of atn-103 in ra
726781|NCT01063816|PARP Inhibitors|parp inhibitors
726782|NCT01063829|HCMV|hcmv
726783|NCT01063842|Drop-out rate|drop-out rate
726784|NCT01063842|Osteoarthritis|osteoarthritis
726785|NCT01063842|Tolerability|tolerability
726786|NCT01063842|Tramadol|tramadol
726787|NCT01063842|Acetaminophen|acetaminophen
726788|NCT01063855|Erectile Dysfunction|erectile dysfunction
726789|NCT01063855|Sexual Dysfunction|sexual dysfunction
726790|NCT01063855|Dapoxetine hydrochloride|dapoxetine hydrochloride
726791|NCT01063855|PRILIGY|priligy
726792|NCT01063855|Premature ejaculation|premature ejaculation
726793|NCT01063855|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
726794|NCT01063855|Sildenafil (Viagra)|sildenafil (viagra)
726795|NCT01063855|Vardenafil (Levitra)|vardenafil (levitra)
726796|NCT01063855|Tadalafil (Cialis)|tadalafil (cialis)
726797|NCT01063868|Diabetic neuropathy|diabetic neuropathy
726798|NCT01063868|Painful|painful
726799|NCT01063868|Polyneuropathy|polyneuropathy
726800|NCT01063868|Peripheral neuropathy|peripheral neuropathy
726900|NCT01064310|renal cell carcinoma|renal cell carcinoma
726801|NCT01063881|Sexual Dysfunction, physiological|sexual dysfunction, physiological
726802|NCT01063881|R096769|r096769
726803|NCT01063881|Dapoxetine|dapoxetine
726804|NCT01063881|Phase 3b|phase 3b
726805|NCT01063881|Premature Ejaculation|premature ejaculation
726806|NCT01063907|Leukemia|leukemia
726807|NCT01063907|Immunoproliferative Disorder|immunoproliferative disorder
726808|NCT01063907|Neoplasma by Histologic Type|neoplasma by histologic type
726809|NCT01063907|Immune System Diseases|immune system diseases
726810|NCT01063907|Hematologic Diseases|hematologic diseases
726811|NCT01063907|Blood Protein Disorders|blood protein disorders
726812|NCT01063907|Paraproteinemias|paraproteinemias
726813|NCT01063907|Multiple Myeloma|multiple myeloma
726814|NCT01063907|Hematologic Disorders|hematologic disorders
726815|NCT01063907|Leukemia, Chronic, B-cell|leukemia, chronic, b-cell
726816|NCT01063907|Leukemia, B-cell|leukemia, b-cell
726817|NCT01063907|Leukemia, Chronic|leukemia, chronic
726818|NCT01063907|Neoplasms, Plasma Cell|neoplasms, plasma cell
726819|NCT01063907|Monoclonal Gammopathy of unknown significance (MGUS)|monoclonal gammopathy of unknown significance (mgus)
726820|NCT01063920|LT-NS001|lt-ns001
726821|NCT01063920|Gastric Ulcers|gastric ulcers
726822|NCT01063920|NSAID|nsaid
726823|NCT01063920|Osteoarthritis|osteoarthritis
726824|NCT01063920|Naproxen|naproxen
726825|NCT01063933|influenza, Peramivir, children, pharmacokinetic, pharmacodynamic|influenza, peramivir, children, pharmacokinetic, pharmacodynamic
726826|NCT01063959|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
726827|NCT01063959|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
726828|NCT01063985|Skin testing for mouse allergies|skin testing for mouse allergies
726829|NCT01063998|Renal cell|renal cell
726830|NCT01063998|Carcinoma|carcinoma
726831|NCT01063998|Biomarkers|biomarkers
726832|NCT01064024|uUTI|uuti
726833|NCT01064024|Pain or burning associated with Uncomplicated Urinary Tract Infections|pain or burning associated with uncomplicated urinary tract infections
726834|NCT01064037|Heart Failure|heart failure
726835|NCT01064050|tumoral obstruction of the main stem bronchus|tumoral obstruction of the main stem bronchus
726836|NCT01064050|bronchoscopy|bronchoscopy
726837|NCT01064050|silicone stent|silicone stent
726838|NCT01064076|ICD, defibrillator|icd, defibrillator
726839|NCT01064089|HSP990|hsp990
726840|NCT01064089|HSP90|hsp90
726841|NCT01064089|Japan/Korea|japan/korea
726842|NCT01064089|Phase I|phase i
726843|NCT01064089|advanced solid tumors|advanced solid tumors
726844|NCT01064089|dose escalation|dose escalation
726845|NCT01064089|maximum tolerated dose|maximum tolerated dose
726846|NCT01064089|MTD|mtd
726847|NCT01064089|Japanese paatients|japanese paatients
726848|NCT01064089|Korean patients|korean patients
726849|NCT01064128|Single-port|single-port
726850|NCT01064128|Laparoscopy|laparoscopy
726851|NCT01064128|Hysterectomy|hysterectomy
726852|NCT01064128|Pain|pain
726853|NCT01064128|Cosmesis|cosmesis
726854|NCT01064128|Analgesics|analgesics
726855|NCT01064141|Dengue Fever|dengue fever
726856|NCT01064141|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
726857|NCT01064141|CYD Dengue Vaccine|cyd dengue vaccine
726858|NCT01064141|Toddlers|toddlers
726859|NCT01064167|Tranexamic Acid|tranexamic acid
726860|NCT01064167|off-pump coronary Artery Bypass|off-pump coronary artery bypass
726861|NCT01064193|In Vitro Fertilization|in vitro fertilization
726862|NCT01064193|biopsy|biopsy
726863|NCT01064193|pregnancy|pregnancy
726864|NCT01064193|Implantation|implantation
726865|NCT01064193|Embryo|embryo
726866|NCT01064193|first or second IVF tentative|first or second ivf tentative
726867|NCT01064206|thrombangiitis obliterans|thrombangiitis obliterans
726868|NCT01064206|Buerger's disease|buerger's disease
726869|NCT01064206|atheromatous arteritis|atheromatous arteritis
726870|NCT01064206|psychiatric disorders|psychiatric disorders
726871|NCT01064206|personality disorders|personality disorders
726872|NCT01064206|addictive profile|addictive profile
726873|NCT01064206|addiction|addiction
726874|NCT01064206|tobacco|tobacco
726875|NCT01064206|cannabis|cannabis
726876|NCT01064219|hCG|hcg
726877|NCT01064219|Treg cells|treg cells
726878|NCT01064219|implantation|implantation
726879|NCT01064219|pinopodes|pinopodes
726880|NCT01064219|endometrium|endometrium
726881|NCT01064245|Asthma|asthma
726882|NCT01064245|Cough Variant Asthma|cough variant asthma
726883|NCT01064245|Mannitol|mannitol
726884|NCT01064245|Methacholine|methacholine
726885|NCT01064245|Cough|cough
726886|NCT01064245|Hypersensitivity|hypersensitivity
726887|NCT01064258|treatment|treatment
726888|NCT01064258|CPAP|cpap
726889|NCT01064258|sleep apnea|sleep apnea
726890|NCT01064284|Hemophilia A|hemophilia a
726891|NCT01064284|Factor VIII inhibitors|factor viii inhibitors
726892|NCT01064284|vWF/FVIII|vwf/fviii
726893|NCT01064284|rFVIII|rfviii
726894|NCT01064297|Pregnancy registry|pregnancy registry
726895|NCT01064297|Major congenital malformations|major congenital malformations
726896|NCT01064297|Pregnancy outcomes|pregnancy outcomes
726897|NCT01064297|Pregnancy|pregnancy
726898|NCT01064297|First trimester|first trimester
726899|NCT01064297|Lamotrigine|lamotrigine
726901|NCT01064310|Votrient|votrient
726904|NCT01064310|patient preference|patient preference
726905|NCT01064310|quality of life|quality of life
726906|NCT01064323|intermittent pneumatic leg compression|intermittent pneumatic leg compression
726907|NCT01064323|nitric oxide|nitric oxide
726908|NCT01064323|vascular endothelial cells|vascular endothelial cells
726910|NCT01064323|EECP|eecp
726911|NCT01064323|atherosclerosis|atherosclerosis
726912|NCT01064336|Thrombocytopenia|thrombocytopenia
726913|NCT01064336|Pregnancy|pregnancy
726914|NCT01064349|brain metastases|brain metastases
726915|NCT01064349|ErbB2 treatment|erbb2 treatment
726916|NCT01064349|ErbB2+ breast cancer|erbb2+ breast cancer
726917|NCT01064362|Haemorrhage|haemorrhage
726918|NCT01064362|Thromboprophylaxis|thromboprophylaxis
726919|NCT01064375|DNA vaccine|dna vaccine
726920|NCT01064375|Electroporation|electroporation
726921|NCT01064388|Safety|safety
726922|NCT01064414|Canagliflozin|canagliflozin
726923|NCT01064414|JNJ 28431754|jnj 28431754
726924|NCT01064414|Placebo|placebo
726925|NCT01064414|Sodium-Glucose Transporter 2|sodium-glucose transporter 2
726926|NCT01064414|hemoglobin A1c protein, Blood Glucose|hemoglobin a1c protein, blood glucose
726927|NCT01064414|reduced kidney function, Type 2 diabetes mellitus|reduced kidney function, type 2 diabetes mellitus
726928|NCT01064427|breast cancer|breast cancer
726929|NCT01064427|fatigue|fatigue
726930|NCT01064427|adjuvant chemotherapy|adjuvant chemotherapy
726931|NCT01064427|quality of life|quality of life
726932|NCT01064440|Painful legs|painful legs
726933|NCT01064440|Ischemic legs|ischemic legs
726934|NCT01064440|Treatment for Claudication|treatment for claudication
726935|NCT01064440|Gene therapy|gene therapy
726936|NCT01064453|Menopause|menopause
726937|NCT01064453|Menopausal symptoms|menopausal symptoms
726938|NCT01064453|Prevention of osteoporosis in menopausal women|prevention of osteoporosis in menopausal women
726939|NCT01064453|Estrogen deficiency symptoms|estrogen deficiency symptoms
726940|NCT01064453|Hormone replacement therapy|hormone replacement therapy
726941|NCT01064466|SCLC|sclc
726942|NCT01064466|Etoposide|etoposide
726943|NCT01064466|SNP|snp
726944|NCT01064466|Topo|topo
726945|NCT01064466|CYP|cyp
726946|NCT01064466|Genotype|genotype
726947|NCT01064466|Oncology|oncology
726948|NCT01064466|Genetics|genetics
726949|NCT01064466|Lung|lung
726950|NCT01064466|Cancer|cancer
726951|NCT01064479|SCCHN|scchn
726952|NCT01064479|Oral cavity|oral cavity
726953|NCT01064479|Oropharynx|oropharynx
726954|NCT01064479|Hypopharynx|hypopharynx
726955|NCT01064479|Larynx|larynx
726956|NCT01064479|Tarceva|tarceva
726957|NCT01064479|Erlotinib|erlotinib
726958|NCT01064479|OSI-774|osi-774
726959|NCT01064479|Docetaxel|docetaxel
726960|NCT01064479|Taxotere|taxotere
726961|NCT01064479|Cisplatin|cisplatin
726962|NCT01064479|Platinol|platinol
726963|NCT01064479|CDDP|cddp
726964|NCT01064479|Placebo|placebo
726965|NCT01064479|Chemotherapy|chemotherapy
726966|NCT01064505|Ocular Neuroprotection|ocular neuroprotection
726967|NCT01064505|ocular neuroprotectant|ocular neuroprotectant
726968|NCT01064505|NAION|naion
726969|NCT01064505|NAAION|naaion
726970|NCT01064505|Non-arteritic ischemic optic neuropathy|non-arteritic ischemic optic neuropathy
726971|NCT01064505|Non-arteritic anterior ischemic optic neuropathy|non-arteritic anterior ischemic optic neuropathy
726972|NCT01064505|chronic optic nerve atrophy|chronic optic nerve atrophy
726973|NCT01064505|optic nerve atrophy|optic nerve atrophy
726974|NCT01064505|retinal degeneration|retinal degeneration
726975|NCT01064505|optic neuritis|optic neuritis
726976|NCT01064505|end stage glaucoma|end stage glaucoma
726977|NCT01064505|Leber's hereditary optic neuropathy|leber's hereditary optic neuropathy
726978|NCT01064518|Lateral Canthal Lines|lateral canthal lines
726979|NCT01064518|Crow's Feet Wrinkles|crow's feet wrinkles
726980|NCT01064518|Facial Wrinkles|facial wrinkles
726981|NCT01064544|Sleep problems|sleep problems
726982|NCT01064544|melatonin|melatonin
726983|NCT01064544|mood|mood
726984|NCT01064544|Hemodialysis|hemodialysis
726985|NCT01064557|Acute promyelocytic Leukemia|acute promyelocytic leukemia
726986|NCT01064570|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
726987|NCT01064570|APL|apl
726988|NCT01064596|obesity|obesity
726989|NCT01064596|fondaparinux|fondaparinux
726990|NCT01064596|surgery|surgery
726991|NCT01064596|anti-Xa activity|anti-xa activity
726992|NCT01064635|stage IA breast cancer|stage ia breast cancer
726993|NCT01064635|stage IB breast cancer|stage ib breast cancer
726994|NCT01064635|stage II breast cancer|stage ii breast cancer
726995|NCT01064635|stage IIIA breast cancer|stage iiia breast cancer
726996|NCT01064635|stage IIIB breast cancer|stage iiib breast cancer
726997|NCT01064635|stage IIIC breast cancer|stage iiic breast cancer
726998|NCT01064661|Probiotics|probiotics
726999|NCT01064661|abdominal pain|abdominal pain
727000|NCT01064661|abdominal discomfort|abdominal discomfort
727001|NCT01064661|bloating|bloating
727002|NCT01064661|Functional Bowel Disorders|functional bowel disorders
727003|NCT01064674|renal transplantation|renal transplantation
727004|NCT01064674|cardiovascular morbidity|cardiovascular morbidity
727197|NCT01065675|Nurse|nurse
727005|NCT01064674|evaluation before renal transplantation|evaluation before renal transplantation
727007|NCT01064700|Phototherapy|phototherapy
727008|NCT01064700|Psychic Anxiety|psychic anxiety
727009|NCT01064713|Tesetaxel|tesetaxel
727010|NCT01064713|Second-line therapy|second-line therapy
727011|NCT01064713|Metastatic melanoma|metastatic melanoma
727012|NCT01064713|Normal serum LDH|normal serum ldh
727013|NCT01064726|Allergic Rhinitis Nasal Allergen Challenge Inflammatory Markers|allergic rhinitis nasal allergen challenge inflammatory markers
727014|NCT01064739|Healthy Volunteers|healthy volunteers
727015|NCT01064739|Fava bean consumption|fava bean consumption
727016|NCT01064739|L-Dopa content in Fava Beans|l-dopa content in fava beans
727017|NCT01064739|Sodium|sodium
727018|NCT01064739|Potassium|potassium
727019|NCT01064739|Electrolyte Balance|electrolyte balance
727020|NCT01064739|Natriuresis|natriuresis
727021|NCT01064752|Minocycline|minocycline
727022|NCT01064752|HIV-1|hiv-1
727023|NCT01064752|Immune activation|immune activation
727024|NCT01064752|Cerebrospinal fluid|cerebrospinal fluid
727025|NCT01064752|Observational|observational
727026|NCT01064765|Heart failure|heart failure
727027|NCT01064765|Self management|self management
727028|NCT01064765|cognitive dysfunction|cognitive dysfunction
727029|NCT01064765|Self management of heart failure|self management of heart failure
727030|NCT01064778|Glycemic Index|glycemic index
727031|NCT01064778|Brain|brain
727032|NCT01064778|Intake Regulation|intake regulation
727033|NCT01064778|Weight Loss|weight loss
727034|NCT01064778|Hunger|hunger
727035|NCT01064778|Diet|diet
727036|NCT01064791|Renal transplantation|renal transplantation
727037|NCT01064817|glaucoma, trabeculectomy|glaucoma, trabeculectomy
727038|NCT01064830|brittle nail|brittle nail
727039|NCT01064843|Edentulous|edentulous
727040|NCT01064843|Edentulism|edentulism
727041|NCT01064843|Lower denture|lower denture
727042|NCT01064843|Mini dental implant|mini dental implant
727043|NCT01064843|Imtec MDI|imtec mdi
727044|NCT01064843|Denture stabilization|denture stabilization
727045|NCT01064843|Case success rate of overdentures stabilized by MDI|case success rate of overdentures stabilized by mdi
727046|NCT01064843|General satisfaction of patients with this treatment|general satisfaction of patients with this treatment
727047|NCT01064843|Oral health-related quality of life of these patients|oral health-related quality of life of these patients
727048|NCT01064843|Cost estimates|cost estimates
727049|NCT01064856|peripheral spondyloarthritis|peripheral spondyloarthritis
727050|NCT01064856|adalimumab|adalimumab
727051|NCT01064856|humira|humira
727052|NCT01064869|Adherence|adherence
727053|NCT01064869|Asthma|asthma
727054|NCT01064869|medication|medication
727055|NCT01064895|Benephit|benephit
727056|NCT01064895|Acute Kidney Injury|acute kidney injury
727057|NCT01064895|Acute Renal Failure|acute renal failure
727058|NCT01064895|Contrast Induced Nephropathy|contrast induced nephropathy
727059|NCT01064895|Chronic Kidney Disease|chronic kidney disease
727060|NCT01064908|Endarterectomy, Carotid|endarterectomy, carotid
727061|NCT01064908|Carotid stenosis|carotid stenosis
727062|NCT01064908|Oxygen mask|oxygen mask
727063|NCT01064921|oropharyngeal cancer|oropharyngeal cancer
727064|NCT01064921|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
727065|NCT01064934|coronary heart disease|coronary heart disease
727066|NCT01064934|cerebrovascular disease|cerebrovascular disease
727067|NCT01064934|peripheral arterial disease|peripheral arterial disease
727068|NCT01064934|atherosclerosis|atherosclerosis
727069|NCT01064934|hyperlipoproteinemia|hyperlipoproteinemia
727070|NCT01064960|Neoplasms, Connective and Soft Tissue|neoplasms, connective and soft tissue
727071|NCT01064960|Neoplasms, Muscle Tissue|neoplasms, muscle tissue
727072|NCT01064960|Neoplasms|neoplasms
727073|NCT01064960|Myofibroma|myofibroma
727074|NCT01064960|Neoplasms by Histologic Type|neoplasms by histologic type
727075|NCT01064960|Connective Tissue Diseases|connective tissue diseases
727076|NCT01064960|Neoplasms, Connective Tissue|neoplasms, connective tissue
727077|NCT01064960|Leiomyoma|leiomyoma
727078|NCT01064973|autism|autism
727079|NCT01064986|Immune System|immune system
727080|NCT01064999|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
727081|NCT01064999|locally advanced rectal cancer|locally advanced rectal cancer
727082|NCT01064999|intensity-modulated radiation therapy|intensity-modulated radiation therapy
727083|NCT01064999|pathological complete response|pathological complete response
727084|NCT01065025|4SC-205|4sc-205
727085|NCT01065025|Solid tumors|solid tumors
727086|NCT01065025|Lymphomas|lymphomas
727087|NCT01065025|Phase I|phase i
727088|NCT01065051|Pulmonary Hypertension|pulmonary hypertension
727089|NCT01065051|Left ventricular dysfunction|left ventricular dysfunction
727090|NCT01065064|Multifocal IOL|multifocal iol
727091|NCT01065064|ReSTOR IOL|restor iol
727092|NCT01065077|Heart Failure|heart failure
727093|NCT01065090|Capacity for Work Questionnaire|capacity for work questionnaire
727094|NCT01065090|exercise|exercise
727095|NCT01065090|AVONEX|avonex
727096|NCT01065090|SDMT: Symbol Digit Modalities Test|sdmt: symbol digit modalities test
727097|NCT01065090|FSMC: Fatigue Scale for Motor and Cognitive functions|fsmc: fatigue scale for motor and cognitive functions
727098|NCT01065090|effects of exercise|effects of exercise
727099|NCT01065090|EDSS: Expanded Disability Status Scale|edss: expanded disability status scale
727100|NCT01065103|STEMI|stemi
727101|NCT01065103|Primary angioplasty|primary angioplasty
727102|NCT01065103|Non-culprit vessel at STEMI|non-culprit vessel at stemi
727103|NCT01065103|Fractional Flow Reserve|fractional flow reserve
727104|NCT01065103|ST-elevation myocardial infarction|st-elevation myocardial infarction
727105|NCT01065103|Fractional Flow Reserve in non-culprit vessel at STEMI|fractional flow reserve in non-culprit vessel at stemi
727106|NCT01065116|Malaria|malaria
727107|NCT01065142|Heart Failure|heart failure
727108|NCT01065142|Patient Education as Topic|patient education as topic
727109|NCT01065142|Primary Health Care|primary health care
727110|NCT01065142|Quality of Life|quality of life
727111|NCT01065337|peripheral arterial occlusion disease (PAD)|peripheral arterial occlusion disease (pad)
727112|NCT01065337|diabetic foot|diabetic foot
727113|NCT01065337|critical limb ischemia (CLI)|critical limb ischemia (cli)
727114|NCT01065337|stem cell therapy|stem cell therapy
727115|NCT01065350|ketofol|ketofol
727116|NCT01065350|hemodynamics|hemodynamics
727117|NCT01065350|propofol|propofol
727118|NCT01065350|anesthesia|anesthesia
727119|NCT01065363|Hepatitis B virus DNA|hepatitis b virus dna
727120|NCT01065363|Metabolic factor|metabolic factor
727121|NCT01065363|Body mass index|body mass index
727122|NCT01065363|Obesity|obesity
727123|NCT01065363|Insulin resistance|insulin resistance
727124|NCT01065363|Lifestyle factor|lifestyle factor
727125|NCT01065363|Preventive Medicine|preventive medicine
727126|NCT01065363|Health Promotion|health promotion
727127|NCT01065376|IVF|ivf
727128|NCT01065376|OHSS|ohss
727129|NCT01065376|cabergoline|cabergoline
727130|NCT01065389|Intradialysis|intradialysis
727131|NCT01065389|Resistance training|resistance training
727132|NCT01065389|Protein Catabolic Rate|protein catabolic rate
727133|NCT01065389|Urea kinetics|urea kinetics
727134|NCT01065389|Quality of life|quality of life
727135|NCT01065389|VO2 max|vo2 max
727136|NCT01065402|Diabetes mellitus|diabetes mellitus
727137|NCT01065402|continuous glucose monitoring system (CGMS)|continuous glucose monitoring system (cgms)
727138|NCT01065415|Magnetic Resonance Imaging/Positron Emission Tomography|magnetic resonance imaging/positron emission tomography
727139|NCT01065415|Whole body imaging|whole body imaging
727140|NCT01065415|Non-small cell lung cancer|non-small cell lung cancer
727141|NCT01065415|staging|staging
727142|NCT01065415|Diagnostic accuracy|diagnostic accuracy
727143|NCT01065428|neuromechanical efficiency|neuromechanical efficiency
727144|NCT01065428|neuroventilatory efficiency|neuroventilatory efficiency
727145|NCT01065428|weaning|weaning
727146|NCT01065428|Respiration, Artificial|respiration, artificial
727147|NCT01065441|breast cancer|breast cancer
727148|NCT01065441|colorectal cancer|colorectal cancer
727149|NCT01065441|prostate cancer|prostate cancer
727150|NCT01065441|melanoma|melanoma
727151|NCT01065441|ovarian cancer|ovarian cancer
727152|NCT01065441|GI cancer|gi cancer
727153|NCT01065441|Sarcoma|sarcoma
727154|NCT01065441|Renal Cell Carcinoma|renal cell carcinoma
727155|NCT01065454|Pulmonary Hypertension|pulmonary hypertension
727156|NCT01065454|Left ventricular dysfunction|left ventricular dysfunction
727157|NCT01065467|LBH589|lbh589
727158|NCT01065467|panobinostat|panobinostat
727159|NCT01065480|Training|training
727160|NCT01065480|Substance Abuse|substance abuse
727161|NCT01065480|Counseling|counseling
727162|NCT01065480|Motivational Interviewing|motivational interviewing
727163|NCT01065519|Coronary stent|coronary stent
727164|NCT01065519|Optical coherence tomography|optical coherence tomography
727165|NCT01065519|Intravascular ultrasound|intravascular ultrasound
727166|NCT01065532|Restenosis|restenosis
727167|NCT01065532|PCI|pci
727168|NCT01065532|Drug-eluting stent|drug-eluting stent
727169|NCT01065532|Drug-eluting balloon|drug-eluting balloon
727170|NCT01065532|Optical Coherence Tomography|optical coherence tomography
727171|NCT01065545|leukemia|leukemia
727172|NCT01065558|Ecopipam|ecopipam
727173|NCT01065558|Lesch-Nyhan Disease|lesch-nyhan disease
727174|NCT01065558|Safety|safety
727175|NCT01065558|Self-Injurious Behavior|self-injurious behavior
727176|NCT01065571|relapse|relapse
727177|NCT01065571|carrageenan|carrageenan
727178|NCT01065571|inflammation|inflammation
727179|NCT01065584|liver transplantation|liver transplantation
727180|NCT01065584|Patients undergoing liver transplantation|patients undergoing liver transplantation
727851|NCT01074047|Cytarabine|cytarabine
727181|NCT01065597|electroconvulsive therapy|electroconvulsive therapy
727182|NCT01065597|seizure|seizure
727183|NCT01065597|nonconvulsive|nonconvulsive
727184|NCT01065597|subconvulsive|subconvulsive
727185|NCT01065597|major depression|major depression
727186|NCT01065597|bipolar disorder|bipolar disorder
727187|NCT01065623|Phase I|phase i
727188|NCT01065623|Dose escalation|dose escalation
727189|NCT01065623|Immunoconjugate|immunoconjugate
727190|NCT01065649|reflux disease|reflux disease
727191|NCT01065649|heartburn|heartburn
727192|NCT01065662|AZD2171|azd2171
727193|NCT01065662|temsirolimus|temsirolimus
727194|NCT01065662|advanced gynecological malignancies|advanced gynecological malignancies
727195|NCT01065675|Medication Reconciliation|medication reconciliation
727196|NCT01065675|Emergency Department|emergency department
727199|NCT01065675|Certified Pharmacy Technician|certified pharmacy technician
727200|NCT01065675|Medication reconciliation: inpatients admitted from the ED|medication reconciliation: inpatients admitted from the ed
727201|NCT01065688|distal gastrectomy|distal gastrectomy
727202|NCT01065688|Billroth-I reconstruction|billroth-i reconstruction
727203|NCT01065688|gastric cancer|gastric cancer
727205|NCT01065714|Transepidermal water loss|transepidermal water loss
727206|NCT01065714|Epidermal barrier|epidermal barrier
727207|NCT01065714|Skin hydration|skin hydration
727208|NCT01065727|Reemitting aggressive multiple sclerosis|reemitting aggressive multiple sclerosis
727209|NCT01065740|Peripheral arterial disease|peripheral arterial disease
727210|NCT01065740|Patient education|patient education
727211|NCT01065740|Physical activity coaching|physical activity coaching
727212|NCT01065740|Lifestyle modifications|lifestyle modifications
727213|NCT01065740|Walking capacity|walking capacity
727214|NCT01065740|6 minutes walking test|6 minutes walking test
727215|NCT01065753|Rho kinase|rho kinase
727216|NCT01065753|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
727217|NCT01065766|Diabetes Mellitus|diabetes mellitus
727218|NCT01065766|Non-Insulin-Dependent|non-insulin-dependent
727219|NCT01065792|HIV Infection|hiv infection
727220|NCT01065805|18F-FLT|18f-flt
727221|NCT01065805|Positive Emission Tomography|positive emission tomography
727222|NCT01065805|Cancer|cancer
727223|NCT01065818|Esophageal cancer|esophageal cancer
727224|NCT01065818|FLT-PET|flt-pet
727225|NCT01065818|Chemoradiotherapy|chemoradiotherapy
727226|NCT01065831|motivational interviewing, lay health advisers|motivational interviewing, lay health advisers
727227|NCT01065844|Nelfinavir|nelfinavir
727228|NCT01065857|Colonoscopy, Preparation, Evacuating, Bowel Cleansing.|colonoscopy, preparation, evacuating, bowel cleansing.
727229|NCT01065896|spinal cord injury|spinal cord injury
727230|NCT01065896|coronary artery disease|coronary artery disease
727231|NCT01065935|ALN-RSV01|aln-rsv01
727232|NCT01065935|RSV|rsv
727233|NCT01065935|Respiratory Syncytial Virus|respiratory syncytial virus
727234|NCT01065948|subcutaneous glucose monitoring|subcutaneous glucose monitoring
727235|NCT01065948|diabetes|diabetes
727236|NCT01065948|fluorescence|fluorescence
727237|NCT01065948|affinity|affinity
727238|NCT01065948|biosensor|biosensor
727239|NCT01065948|type I Diabetes|type i diabetes
727240|NCT01065948|type II diabetes|type ii diabetes
727241|NCT01065961|anterior|anterior
727242|NCT01065961|cervical|cervical
727243|NCT01065961|fusion|fusion
727244|NCT01065961|swallowing|swallowing
727245|NCT01065961|Swallowing after anterior cervical discectomy and fusion|swallowing after anterior cervical discectomy and fusion
727246|NCT01065961|Bony fusion rates post anterior cervical discectomy and fusion|bony fusion rates post anterior cervical discectomy and fusion
727247|NCT01065974|Nutritional Intake|nutritional intake
727248|NCT01065974|Psychosocial Outcome|psychosocial outcome
727249|NCT01066013|Antimicrobial De escalation|antimicrobial de escalation
727250|NCT01066013|Meropenem|meropenem
727251|NCT01066013|Piperacillin tazobactam|piperacillin tazobactam
727252|NCT01066013|Medical patients|medical patients
727253|NCT01066013|Appropriate use|appropriate use
727254|NCT01066013|Cost savings|cost savings
727255|NCT01066013|Antimicrobial De-escalation strategy|antimicrobial de-escalation strategy
727256|NCT01066026|metallic cannula|metallic cannula
727257|NCT01066026|Hyaluronic acid|hyaluronic acid
727258|NCT01066039|Bisoprolol|bisoprolol
727259|NCT01066039|Hypertension|hypertension
727260|NCT01066039|Diabetes mellitus, Type II|diabetes mellitus, type ii
727261|NCT01066039|Blood pressure|blood pressure
727262|NCT01066039|Glycemic level|glycemic level
727263|NCT01066052|Growth hormone|growth hormone
727264|NCT01066052|Turner syndrome|turner syndrome
727265|NCT01066052|r-hGH|r-hgh
727266|NCT01066052|early treatment|early treatment
727267|NCT01066065|cardiovascular disease|cardiovascular disease
727268|NCT01066065|HIV|hiv
727269|NCT01066065|metabolic disorder|metabolic disorder
727270|NCT01066065|HIV naive patients initiating HAART with Raltegravir or boosted Darunavir|hiv naive patients initiating haart with raltegravir or boosted darunavir
727271|NCT01066078|heart failure - congestive|heart failure - congestive
727272|NCT01066078|Cardiovascular imaging agents/Techniques]|cardiovascular imaging agents/techniques]
727273|NCT01066078|Echocardiography|echocardiography
727274|NCT01066078|Other diagnostic testing|other diagnostic testing
727275|NCT01066078|Other Treatment|other treatment
727276|NCT01066078|Recipients of cardiac resynchronization therapy systems|recipients of cardiac resynchronization therapy systems
727277|NCT01066091|Inflammatory response|inflammatory response
727278|NCT01066091|High-fat meal|high-fat meal
727279|NCT01066091|cytokines|cytokines
727280|NCT01066091|Body composition|body composition
727281|NCT01066117|urinary incontinent|urinary incontinent
727282|NCT01066130|Diabetes Mellitus|diabetes mellitus
727283|NCT01066130|Arthritis, Rheumatoid|arthritis, rheumatoid
727284|NCT01066130|psychosocial aspects|psychosocial aspects
727285|NCT01066130|Patient Adherence|patient adherence
727286|NCT01066130|Social Work|social work
727287|NCT01066130|Coping Behavior|coping behavior
727288|NCT01066130|Coping Skills|coping skills
727289|NCT01066130|Adaptation, Psychological|adaptation, psychological
727291|NCT01066143|Generalized Anxiety Disorder|generalized anxiety disorder
727292|NCT01066143|fMRI|fmri
727293|NCT01066156|Post-traumatic Stress Disorder|post-traumatic stress disorder
727294|NCT01066156|PTSD|ptsd
727295|NCT01066156|Seroquel|seroquel
727296|NCT01066156|fMRI|fmri
727297|NCT01066169|Pandemic Influenza A/H1N1|pandemic influenza a/h1n1
727298|NCT01066169|HIV|hiv
727299|NCT01066169|Antibodies|antibodies
727300|NCT01066169|Replicaton|replicaton
727301|NCT01066182|DHA|dha
727302|NCT01066182|Learning|learning
727303|NCT01066182|Reading|reading
727304|NCT01066182|Memory|memory
727305|NCT01066182|Children|children
727306|NCT01066182|Omega 3|omega 3
727307|NCT01066182|Education|education
727308|NCT01066182|Learning and behaviour in children|learning and behaviour in children
727309|NCT01066195|Non-Small Cell Lung Cancer|non-small cell lung cancer
727310|NCT01066195|Never-Smoker and Adenocarcinoma patients|never-smoker and adenocarcinoma patients
727311|NCT01066195|Pemetrexed (ALIMTA)|pemetrexed (alimta)
727312|NCT01066195|Gefitinib (IRESSA®)|gefitinib (iressa®)
727313|NCT01066208|Classification criteria|classification criteria
727314|NCT01066208|Diagnostic criteria|diagnostic criteria
727315|NCT01066221|clostridium difficile|clostridium difficile
727316|NCT01066234|Microscopic N2 Non-small Cell Lung Cancer|microscopic n2 non-small cell lung cancer
727317|NCT01066234|Paclitaxel|paclitaxel
727318|NCT01066234|Carboplatin|carboplatin
727319|NCT01066234|Cisplatin|cisplatin
727320|NCT01066247|spinal anesthesia|spinal anesthesia
727321|NCT01066247|heart rate variability|heart rate variability
727322|NCT01066247|premedication|premedication
727323|NCT01066247|heart rate|heart rate
727324|NCT01066247|blood pressure|blood pressure
727325|NCT01066260|Probiotics|probiotics
727326|NCT01066260|Energy balance|energy balance
727327|NCT01066286|genome wide SNP-array|genome wide snp-array
727328|NCT01066286|micro-cytogenetic lesion|micro-cytogenetic lesion
727329|NCT01066286|KIT mutation|kit mutation
727330|NCT01066286|core binding factor|core binding factor
727331|NCT01066286|acute myeloid leukemia|acute myeloid leukemia
727332|NCT01066286|The Approval status was changed from Pending to Approved.|the approval status was changed from pending to approved.
727333|NCT01066299|oxytocin|oxytocin
727334|NCT01066299|psychophysiology|psychophysiology
727335|NCT01066299|startle|startle
727336|NCT01066299|anxiety|anxiety
727337|NCT01066299|emotion|emotion
727338|NCT01066299|physiology|physiology
727339|NCT01066312|Muscle testing|muscle testing
727340|NCT01066312|Kinesiology|kinesiology
727341|NCT01066312|Muscles|muscles
727342|NCT01066312|Complementary and Alternative Medicine|complementary and alternative medicine
727343|NCT01066312|Practitioner Experience|practitioner experience
727344|NCT01066312|This study is actually not a randomised controlled trial,|this study is actually not a randomised controlled trial,
727345|NCT01066312|but an assessment of diagnostic test accuracy. We will be|but an assessment of diagnostic test accuracy. we will be
727346|NCT01066312|looking at the accuracy of MMT to distinguish congruent from|looking at the accuracy of mmt to distinguish congruent from
727347|NCT01066312|incongruent statements under varying levels of blinding.|incongruent statements under varying levels of blinding.
727348|NCT01066325|Sit-n-Reach Test|sit-n-reach test
727349|NCT01066325|Flexibility|flexibility
727350|NCT01066325|Hamstring|hamstring
727351|NCT01066325|Mindbody|mindbody
727352|NCT01066325|Complementary and Alternative Medicine|complementary and alternative medicine
727353|NCT01066325|Neuro Emotional Technique (NET)|neuro emotional technique (net)
727354|NCT01066338|SNP array|snp array
727355|NCT01066338|prognosis|prognosis
727356|NCT01066338|acute myeloid leukemia|acute myeloid leukemia
727357|NCT01066338|normal karyotype|normal karyotype
727358|NCT01066338|acute myeloid leukemia with normal karyotype|acute myeloid leukemia with normal karyotype
727359|NCT01066351|acute kidney injury|acute kidney injury
727360|NCT01066351|erythropoietin|erythropoietin
727361|NCT01066351|cardiac surgery|cardiac surgery
727362|NCT01066364|NASH|nash
727363|NCT01066364|NAFLD|nafld
727364|NCT01066364|Steatohepatitis|steatohepatitis
727365|NCT01066364|Nonalcoholic|nonalcoholic
727366|NCT01066364|Fatty Liver Disease|fatty liver disease
727367|NCT01066377|prebiotic|prebiotic
727368|NCT01066377|probiotic|probiotic
727369|NCT01066377|influenza|influenza
727370|NCT01066377|vaccination|vaccination
727371|NCT01066377|ageing|ageing
727372|NCT01066377|immunosenescence|immunosenescence
727373|NCT01066390|stage IIIC/IV melanoma|stage iiic/iv melanoma
727374|NCT01066403|schizophrenia|schizophrenia
727375|NCT01066403|cognitive deficits|cognitive deficits
727376|NCT01066403|dopamine|dopamine
727377|NCT01066403|dopamine agonists|dopamine agonists
727378|NCT01066403|prefrontal cortex|prefrontal cortex
727379|NCT01066403|D1 specific modulation|d1 specific modulation
727380|NCT01066403|pergolide|pergolide
727381|NCT01066403|executive control|executive control
727382|NCT01066403|working memory|working memory
727383|NCT01066403|Influence of pergolide on cognition in Schizophrenia|influence of pergolide on cognition in schizophrenia
727384|NCT01066403|D1-specific modulation of prefrontal functions|d1-specific modulation of prefrontal functions
727489|NCT01066741|Hypopharynx|hypopharynx
727490|NCT01066741|Oropharynx|oropharynx
727385|NCT01066403|Influence of pergolide on psychopathology and depression|influence of pergolide on psychopathology and depression
727386|NCT01066403|Influence of pergolide on extrapyramidal symptoms|influence of pergolide on extrapyramidal symptoms
727387|NCT01066429|poor-prognosis diffuse large B-cell lymphoma|poor-prognosis diffuse large b-cell lymphoma
727388|NCT01066429|dose-adjusted|dose-adjusted
727389|NCT01066429|R-EDOCH-14|r-edoch-14
727390|NCT01066429|rituximab|rituximab
727391|NCT01066429|age-adjusted IPI|age-adjusted ipi
727392|NCT01066429|toxicity|toxicity
727393|NCT01066442|Excessive Daytime Sleepiness (EDS)|excessive daytime sleepiness (eds)
727394|NCT01066442|Parkinson's Disease|parkinson's disease
727395|NCT01066455|Cardiac|cardiac
727396|NCT01066455|Muscular Dystrophy|muscular dystrophy
727397|NCT01066455|Prospective|prospective
727398|NCT01066455|Pediatric|pediatric
727399|NCT01066455|Echocardiogram|echocardiogram
727400|NCT01066468|Chronic myeloid leukemia|chronic myeloid leukemia
727401|NCT01066468|CML|cml
727402|NCT01066468|Philadelphia chromosome positive|philadelphia chromosome positive
727403|NCT01066468|acute lymphoblastic leukemia|acute lymphoblastic leukemia
727404|NCT01066468|PhGlivec,|phglivec,
727405|NCT01066468|Gleevec,|gleevec,
727406|NCT01066468|hypereosinophilic syndrome,|hypereosinophilic syndrome,
727407|NCT01066468|HES,|hes,
727408|NCT01066468|chronic eosinophilic leukemia,|chronic eosinophilic leukemia,
727409|NCT01066468|CEL,|cel,
727410|NCT01066468|myelodysplastic syndrome,|myelodysplastic syndrome,
727411|NCT01066468|MDS,|mds,
727412|NCT01066468|myeloproliferative disease,|myeloproliferative disease,
727413|NCT01066468|MPD+ ALL|mpd+ all
727414|NCT01066481|Alzheimer's disease|alzheimer's disease
727415|NCT01066481|clinical trial|clinical trial
727416|NCT01066481|memory loss|memory loss
727417|NCT01066481|investigational drug|investigational drug
727418|NCT01066481|neurodegenerative disease|neurodegenerative disease
727419|NCT01066481|dementia|dementia
727420|NCT01066494|AML|aml
727421|NCT01066494|Pgp|pgp
727422|NCT01066494|MDR|mdr
727423|NCT01066494|sAML|saml
727424|NCT01066494|AS1413|as1413
727425|NCT01066494|Amonafide|amonafide
727426|NCT01066507|Her2|her2
727427|NCT01066507|FISH|fish
727428|NCT01066507|Breast cancer|breast cancer
727429|NCT01066507|Amplification|amplification
727430|NCT01066520|ankle sprain|ankle sprain
727431|NCT01066520|traumeel|traumeel
727432|NCT01066520|diclofenac|diclofenac
727433|NCT01066520|antiinflammatory|antiinflammatory
727434|NCT01066520|time to normal function|time to normal function
727435|NCT01066533|MTA|mta
727436|NCT01066533|NEC|nec
727437|NCT01066533|Immunohistochemistry|immunohistochemistry
727438|NCT01066533|fibronectin|fibronectin
727439|NCT01066533|tenascin|tenascin
727440|NCT01066546|Delirium|delirium
727441|NCT01066546|Dementia|dementia
727442|NCT01066546|Amnestic|amnestic
727443|NCT01066546|Cognitive Disorders|cognitive disorders
727444|NCT01066546|Mental Disorders|mental disorders
727445|NCT01066546|Nervous System Diseases|nervous system diseases
727446|NCT01066546|Central Nervous System Diseases|central nervous system diseases
727447|NCT01066585|Head lice|head lice
727448|NCT01066585|Pediculus humanus capitis|pediculus humanus capitis
727449|NCT01066598|graft versus host disease|graft versus host disease
727450|NCT01066598|chronic graft versus host disease|chronic graft versus host disease
727451|NCT01066598|cGVHD|cgvhd
727452|NCT01066611|Allergic Rhinitis|allergic rhinitis
727453|NCT01066611|Allergy|allergy
727454|NCT01066611|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
727455|NCT01066624|Mucositis|mucositis
727456|NCT01066624|Multiple myeloma|multiple myeloma
727457|NCT01066624|Autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
727458|NCT01066637|Heart transplant patients|heart transplant patients
727459|NCT01066650|TWENTE|twente
727460|NCT01066650|randomized study|randomized study
727461|NCT01066650|stent|stent
727462|NCT01066650|coronary stent|coronary stent
727463|NCT01066650|drug-eluting stent|drug-eluting stent
727464|NCT01066650|Zotarolimus|zotarolimus
727465|NCT01066650|Everolimus|everolimus
727466|NCT01066650|Xience V|xience v
727467|NCT01066650|Endeavor Resolute|endeavor resolute
727468|NCT01066650|head to head comparison|head to head comparison
727469|NCT01066650|real world patients|real world patients
727852|NCT01074047|Vidaza|vidaza
727470|NCT01066650|target vessel failure|target vessel failure
727471|NCT01066650|investigator initiated study|investigator initiated study
727472|NCT01066650|coronary artery disease|coronary artery disease
727473|NCT01066650|coronary arteries|coronary arteries
727474|NCT01066650|atherosclerosis|atherosclerosis
727475|NCT01066650|non inferiority|non inferiority
727476|NCT01066663|CLL|cll
727477|NCT01066663|SLL|sll
727478|NCT01066663|relapsed|relapsed
727479|NCT01066663|pyrimethamine|pyrimethamine
727480|NCT01066689|kidney transplantation, acute humoral rejection, rituximab|kidney transplantation, acute humoral rejection, rituximab
727481|NCT01066715|Diabetes|diabetes
727482|NCT01066715|Type 2|type 2
727483|NCT01066715|Mellitus|mellitus
727487|NCT01066728|prematurity|prematurity
727488|NCT01066741|Epidermoid carcinoma|epidermoid carcinoma
727494|NCT01066741|Severe Oral mucositis|severe oral mucositis
727495|NCT01066741|Radiotherapy|radiotherapy
727496|NCT01066741|Phytotherapy|phytotherapy
727497|NCT01066780|cochlear implant|cochlear implant
727498|NCT01066780|adults|adults
727499|NCT01066780|HiResolution|hiresolution
727500|NCT01066780|Fidelity 120|fidelity 120
727501|NCT01066780|listening benefits|listening benefits
727502|NCT01066780|noise|noise
727503|NCT01066780|cochlear implant benefit|cochlear implant benefit
727504|NCT01066832|Drug-eluting balloon|drug-eluting balloon
727505|NCT01066832|Paclitaxel|paclitaxel
727506|NCT01066832|DIOR|dior
727507|NCT01066832|short term registry|short term registry
727508|NCT01066832|Valentines Trial|valentines trial
727509|NCT01066832|Drug-eluting balloon treatment of in-stent restenosis|drug-eluting balloon treatment of in-stent restenosis
727510|NCT01066858|tenofovir|tenofovir
727511|NCT01066858|renal and bone toxicity|renal and bone toxicity
727512|NCT01066858|pregnancy|pregnancy
727513|NCT01066858|breastfeeding|breastfeeding
727514|NCT01066858|mother to child transmission|mother to child transmission
727515|NCT01066871|Knee cartilage injury|knee cartilage injury
727516|NCT01066871|fibroblast growth factor 18|fibroblast growth factor 18
727517|NCT01066871|FGF18|fgf18
727518|NCT01066910|Obesity|obesity
727519|NCT01066910|Childhood Obesity|childhood obesity
727520|NCT01066910|Exercise|exercise
727521|NCT01066910|Nutrition|nutrition
727522|NCT01066923|firefighter|firefighter
727523|NCT01066923|heat stress|heat stress
727524|NCT01066923|platelet activation|platelet activation
727525|NCT01066923|aspirin|aspirin
727526|NCT01066949|hemodialysis|hemodialysis
727527|NCT01066949|behavior change|behavior change
727528|NCT01066949|patient adherence|patient adherence
727529|NCT01066949|self management|self management
727530|NCT01066962|HIV-infected antiretroviral naïve subjects|hiv-infected antiretroviral naïve subjects
727531|NCT01066975|loaded backpack|loaded backpack
727532|NCT01066975|unloaded backpack|unloaded backpack
727533|NCT01066988|lipid layer thickness|lipid layer thickness
727534|NCT01067014|Lumbar spinal stenosis|lumbar spinal stenosis
727535|NCT01067014|Decompression|decompression
727536|NCT01067014|Lumbar spinal decompression|lumbar spinal decompression
727537|NCT01067014|Lumbar spinal decompressive surgery|lumbar spinal decompressive surgery
727538|NCT01067027|Colic|colic
727539|NCT01067027|Colic in Breast-fed Infants|colic in breast-fed infants
727540|NCT01067053|Bevacizumab|bevacizumab
727541|NCT01067053|Capecitabine|capecitabine
727542|NCT01067053|Oxaliplatin|oxaliplatin
727543|NCT01067053|Metastatic colorectal cancer|metastatic colorectal cancer
727544|NCT01067066|TPI 287|tpi 287
727545|NCT01067066|microtubule inhibitor|microtubule inhibitor
727546|NCT01067066|Temozolomide|temozolomide
727547|NCT01067066|Temodar|temodar
727548|NCT01067066|cytotoxic agent|cytotoxic agent
727549|NCT01067066|unresectable Stage III|unresectable stage iii
727550|NCT01067066|Stage IV|stage iv
727551|NCT01067066|Metastatic Melanoma|metastatic melanoma
727552|NCT01067079|Rabies vaccine|rabies vaccine
727553|NCT01067079|Long-term Immunogenicity|long-term immunogenicity
727554|NCT01067105|Perennial allergic rhinitis|perennial allergic rhinitis
727555|NCT01067105|allergic rhinitis|allergic rhinitis
727556|NCT01067105|ciclesonide|ciclesonide
727557|NCT01067131|Candida albicans|candida albicans
727558|NCT01067131|Fungal vaginal infection|fungal vaginal infection
727559|NCT01067131|Vulvovaginal candidiasis|vulvovaginal candidiasis
727560|NCT01067131|Candidose|candidose
727561|NCT01067131|Vaccine|vaccine
727562|NCT01067131|Virosome|virosome
727563|NCT01067157|Obesity|obesity
727564|NCT01067157|overweight|overweight
727565|NCT01067157|childhood|childhood
727566|NCT01067157|adolescence|adolescence
727567|NCT01067157|inpatient therapy|inpatient therapy
727568|NCT01067157|lifestyle intervention|lifestyle intervention
727569|NCT01067157|cardiovascular risk|cardiovascular risk
727570|NCT01067157|gene-lifestyle-interaction|gene-lifestyle-interaction
727571|NCT01067157|Obesity and associated cardiovascular risk in childhood and adolescence,|obesity and associated cardiovascular risk in childhood and adolescence,
727572|NCT01067157|health behaviour|health behaviour
727573|NCT01067170|Hemodialysis|hemodialysis
727574|NCT01067170|Intradialytic hypotension|intradialytic hypotension
727575|NCT01067183|stress reduction|stress reduction
727853|NCT01074047|azacitidine|azacitidine
727576|NCT01067183|physician wellness|physician wellness
727577|NCT01067196|Proton Radiation|proton radiation
727578|NCT01067196|Central Nervous System Tumors|central nervous system tumors
727579|NCT01067196|Brain|brain
727580|NCT01067196|Spine|spine
727581|NCT01067196|Cancer|cancer
727582|NCT01067209|Reversal of Obesity-related and Diabetic Cardiomyopathy|reversal of obesity-related and diabetic cardiomyopathy
727583|NCT01067222|Narcolepsy|narcolepsy
727584|NCT01067222|Excessive daytime Sleepiness|excessive daytime sleepiness
727585|NCT01067222|Cataplexy|cataplexy
727586|NCT01067222|Sleep Disorders|sleep disorders
727587|NCT01067222|Sleep attacks|sleep attacks
727588|NCT01067222|Orphan Drug|orphan drug
727589|NCT01067222|Pitolisant|pitolisant
727590|NCT01067235|Narcolespy|narcolespy
727591|NCT01067235|Cataplexy|cataplexy
727871|NCT01074125|ESRD|esrd
727592|NCT01067235|Excesssive daytime Sleepiness|excesssive daytime sleepiness
727593|NCT01067235|Sleep Disorders|sleep disorders
727594|NCT01067235|Sleep attacks|sleep attacks
727595|NCT01067235|Orphan Drug|orphan drug
727596|NCT01067235|Pitolisant|pitolisant
727597|NCT01067248|COPD|copd
727598|NCT01067248|Osteoporosis|osteoporosis
727599|NCT01067248|Pathophysiology|pathophysiology
727600|NCT01067248|Mechanism|mechanism
727601|NCT01067248|Bone markers|bone markers
727602|NCT01067248|Bone turnover|bone turnover
727603|NCT01067248|Protein turnover|protein turnover
727604|NCT01067248|Ageing|ageing
727605|NCT01067248|Endocrinology|endocrinology
727606|NCT01067248|Vitamin D|vitamin d
727607|NCT01067261|Nerve stimulation|nerve stimulation
727608|NCT01067261|TMNS|tmns
727609|NCT01067261|Prostatectomy|prostatectomy
727610|NCT01067261|Prevention|prevention
727611|NCT01067261|Restoration|restoration
727612|NCT01067261|Treatment|treatment
727613|NCT01067261|Vibration|vibration
727614|NCT01067261|Non-invasive|non-invasive
727615|NCT01067274|Acute Myeloid Leukemia|acute myeloid leukemia
727616|NCT01067274|Aged of 65 to 79 years|aged of 65 to 79 years
727617|NCT01067274|Older Patients with Acute Myeloblastic Leukemia|older patients with acute myeloblastic leukemia
727618|NCT01067287|dendritic cell fusion vaccine|dendritic cell fusion vaccine
727619|NCT01067287|CT-011|ct-011
727620|NCT01067287|autologous stem cell transplant|autologous stem cell transplant
727621|NCT01067300|young|young
727622|NCT01067300|acute leukemia in remission|acute leukemia in remission
727623|NCT01067300|Children or young adults (< 35 years) with acute leukemia in remission|children or young adults (< 35 years) with acute leukemia in remission
727624|NCT01067313|Intensive Care Unit|intensive care unit
727625|NCT01067313|continuous hemodialysis|continuous hemodialysis
727626|NCT01067313|continuous hemofiltration|continuous hemofiltration
727627|NCT01067313|High Cut-off membrane|high cut-off membrane
727628|NCT01067313|"Enhanced middle molecule clearance membrane"|"enhanced middle molecule clearance membrane"
727629|NCT01067313|Septic shock|septic shock
727630|NCT01067313|Acute kidney injury|acute kidney injury
727631|NCT01067313|Blood purification|blood purification
727632|NCT01067313|Renal replacement therapy|renal replacement therapy
727633|NCT01067326|Endothelial Dysfunction|endothelial dysfunction
727634|NCT01067326|Endothelial Function|endothelial function
727635|NCT01067326|Tekturna|tekturna
727636|NCT01067326|Endothelial Peripheral Arterial Tomography (EndoPAT)|endothelial peripheral arterial tomography (endopat)
727637|NCT01067326|Progenitor Cells|progenitor cells
727638|NCT01067326|renin inhibition|renin inhibition
727639|NCT01067326|endothelial progenitor cells|endothelial progenitor cells
727640|NCT01067326|early atherosclerosis|early atherosclerosis
727641|NCT01067339|coronary endothelial dysfunction|coronary endothelial dysfunction
727642|NCT01067339|coronary vasospasm|coronary vasospasm
727643|NCT01067352|Infant, small for gestational age|infant, small for gestational age
727644|NCT01067352|Growth hormone|growth hormone
727645|NCT01067352|Saizen|saizen
727646|NCT01067365|Secondary Hypogonadism|secondary hypogonadism
727647|NCT01067378|Interdisciplinary Health Team|interdisciplinary health team
727648|NCT01067378|Training|training
727649|NCT01067391|Hypotension in SCI males|hypotension in sci males
727650|NCT01067391|Erectile Dysfunction|erectile dysfunction
727651|NCT01067404|Influenza vaccines|influenza vaccines
727652|NCT01067404|Infant|infant
727653|NCT01067404|Dose-Response relationship, immunologic|dose-response relationship, immunologic
727654|NCT01067417|Hydroxychloroquine|hydroxychloroquine
727655|NCT01067417|Chloroquine|chloroquine
727656|NCT01067417|HIV Infection|hiv infection
727657|NCT01067417|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
727658|NCT01067417|Immune Activation|immune activation
727659|NCT01067417|inflammation|inflammation
727660|NCT01067417|treatment naive|treatment naive
727661|NCT01067417|disease progression|disease progression
727662|NCT01067430|Rheumatoid Arthritis|rheumatoid arthritis
727663|NCT01067430|Etoricoxib|etoricoxib
727664|NCT01067430|Diclofenac|diclofenac
727665|NCT01067430|Pain|pain
727666|NCT01067430|Stiffness|stiffness
727667|NCT01067443|Phase II|phase ii
727668|NCT01067443|Randomised clinical trial|randomised clinical trial
727669|NCT01067443|Visceral Leishmaniasis|visceral leishmaniasis
727671|NCT01067469|Central Nervous System|central nervous system
727672|NCT01067469|malignant brain tumor|malignant brain tumor
727673|NCT01067469|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
727674|NCT01067469|GBM|gbm
727675|NCT01067469|Bevacizumab|bevacizumab
727676|NCT01067469|Lomustine|lomustine
727677|NCT01067469|CCNU|ccnu
727678|NCT01067482|OCT|oct
727679|NCT01067482|spectral domain cirrus|spectral domain cirrus
727680|NCT01067482|glaucoma|glaucoma
727681|NCT01067482|glaucoma suspect|glaucoma suspect
727682|NCT01067482|normal population|normal population
727683|NCT01067495|stroke|stroke
727684|NCT01067495|rehabilitation|rehabilitation
727685|NCT01067495|exercise|exercise
727686|NCT01067495|walking|walking
727687|NCT01067495|risk factors|risk factors
727688|NCT01067521|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
727689|NCT01067521|Glatiramer Acetate|glatiramer acetate
727690|NCT01067547|Iron deficiency|iron deficiency
727691|NCT01067547|Inflammatory Bowel Disease|inflammatory bowel disease
727692|NCT01067547|Crohn's Disease|crohn's disease
727693|NCT01067547|Ulcerative colitis|ulcerative colitis
727694|NCT01067560|Glucose|glucose
727695|NCT01067560|CSF|csf
727696|NCT01067560|Cesarean section, spinal anesthesia|cesarean section, spinal anesthesia
727697|NCT01067560|Nova Stat Strip|nova stat strip
727698|NCT01067560|Abbott Precision Xtra|abbott precision xtra
727699|NCT01067560|Roche Accucheck Inform 2|roche accucheck inform 2
727700|NCT01067573|MS|ms
727701|NCT01067573|Serum Leptin Levels during relapse|serum leptin levels during relapse
727702|NCT01067573|Multiple sclerosis|multiple sclerosis
727703|NCT01067573|relapse|relapse
727704|NCT01067586|Smokeless Tobacco|smokeless tobacco
727705|NCT01067586|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
727706|NCT01067599|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
727707|NCT01067599|Smokeless Tobacco|smokeless tobacco
727708|NCT01067677|PONV|ponv
727709|NCT01067677|Post operative nausea and vomiting|post operative nausea and vomiting
727710|NCT01067677|rescue emetic therapy|rescue emetic therapy
727711|NCT01067690|classical Kaposi's sarcoma|classical kaposi's sarcoma
727712|NCT01067690|chemotherapy|chemotherapy
727713|NCT01067690|indinavir|indinavir
727714|NCT01067690|HIV protease inhibitor|hiv protease inhibitor
727715|NCT01067690|Advanced classical (non HIV-associated) Kaposi's sarcoma|advanced classical (non hiv-associated) kaposi's sarcoma
727716|NCT01067703|remote ischaemic preconditioning, cardiac surgery|remote ischaemic preconditioning, cardiac surgery
727717|NCT01067729|Burn|burn
727718|NCT01067729|Superficial burns|superficial burns
727719|NCT01067729|Partial thickness burns|partial thickness burns
727720|NCT01067729|Rate of healing|rate of healing
727721|NCT01067729|Infection rate|infection rate
727722|NCT01067729|Pain perception|pain perception
727723|NCT01067729|Non adherence|non adherence
727724|NCT01067729|Scarring|scarring
727725|NCT01067742|Mucolipidosis, retinal dystrophy, mucolipin-1,|mucolipidosis, retinal dystrophy, mucolipin-1,
727726|NCT01067742|lysosomal storage disease, gastrin, mental retardation,|lysosomal storage disease, gastrin, mental retardation,
727727|NCT01067742|dysmyelination, dysplastic corpus callosum,corneal clouding|dysmyelination, dysplastic corpus callosum,corneal clouding
727728|NCT01067755|navigation|navigation
727729|NCT01067755|bronchoscopy|bronchoscopy
727730|NCT01067755|lymphadenopathy|lymphadenopathy
727731|NCT01067768|Urinary Tract Infections|urinary tract infections
727732|NCT01067768|Catheter-associated urinary tract infections|catheter-associated urinary tract infections
727733|NCT01067768|Prevention and control|prevention and control
727734|NCT01067768|Controlled clinical trial|controlled clinical trial
727735|NCT01067781|Prevention of Travelers' Diarrhea|prevention of travelers' diarrhea
727736|NCT01067794|Metastatic|metastatic
727737|NCT01067794|Advanced|advanced
727738|NCT01067794|Stage IIIB-IV|stage iiib-iv
727739|NCT01067794|daily|daily
727740|NCT01067794|hospital|hospital
727741|NCT01067794|practice|practice
727742|NCT01067794|setting|setting
727743|NCT01067807|Pharmacokinetics|pharmacokinetics
727744|NCT01067820|ApolipoproteinA1|apolipoproteina1
727745|NCT01067820|HDL-C|hdl-c
727746|NCT01067820|Atherosclerosis|atherosclerosis
727747|NCT01073215|Adolescents|adolescents
727748|NCT01073215|Obesity|obesity
727749|NCT01073215|Weight Management|weight management
727750|NCT01073215|Family-based Lifestyle Modification|family-based lifestyle modification
727751|NCT01073228|Alzheimer's disease|alzheimer's disease
727752|NCT01073228|Central Nervous System diseases|central nervous system diseases
727753|NCT01073228|Cognition|cognition
727754|NCT01073241|benign prostatic hyperplasia|benign prostatic hyperplasia
727755|NCT01073241|Transurethral Resection of Prostate|transurethral resection of prostate
727756|NCT01073241|transurethral enucleation of prostate|transurethral enucleation of prostate
727757|NCT01073267|Stage IB-IIIA Mycosis fungoides|stage ib-iiia mycosis fungoides
727758|NCT01073267|Total Skin Electron Beam Therapy|total skin electron beam therapy
727759|NCT01073267|TSEBT|tsebt
727760|NCT01073280|Cerebral and subarachnoid biopsy|cerebral and subarachnoid biopsy
727761|NCT01073280|flexible endoscopy|flexible endoscopy
727762|NCT01073280|Patients with neurological findings without diagnosis.|patients with neurological findings without diagnosis.
727763|NCT01073306|Vaccine|vaccine
727961|NCT01074489|GDM|gdm
727764|NCT01073306|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
727765|NCT01073319|Methamphetamine|methamphetamine
727766|NCT01073319|Rivastigmine|rivastigmine
727767|NCT01073345|Patients undergoing elective hepatic resection|patients undergoing elective hepatic resection
727768|NCT01073358|resectable hepatic metastases of colorectal cancer|resectable hepatic metastases of colorectal cancer
727769|NCT01073371|Liposome|liposome
727770|NCT01073371|Prilocaine|prilocaine
727771|NCT01073371|Dental anesthesia|dental anesthesia
727772|NCT01073397|Menopause|menopause
727773|NCT01073397|Hot Flashes|hot flashes
727774|NCT01073397|Vasomotor symptoms|vasomotor symptoms
727775|NCT01073397|Yoga|yoga
727778|NCT01073423|insomnia|insomnia
727779|NCT01073423|yoga|yoga
727780|NCT01073423|music|music
727870|NCT01074125|Hyperphosphatemia|hyperphosphatemia
727781|NCT01073436|diagnosis of Ph+) CML in chronic phase.|diagnosis of ph+) cml in chronic phase.
727782|NCT01073436|prior therapy with interferon-alpha for at least 2 years, and achieved at least a partial cytogenetic response|prior therapy with interferon-alpha for at least 2 years, and achieved at least a partial cytogenetic response
727783|NCT01073436|receiving a TKI (imatinib mesylate, dasatinib, nilotinib)|receiving a tki (imatinib mesylate, dasatinib, nilotinib)
727784|NCT01073436|WBC ≤ 10 x 109/L.|wbc ≤ 10 x 109/l.
727785|NCT01073436|Platelet count < 450,000 x 109/L.|platelet count < 450,000 x 109/l.
727786|NCT01073436|No blasts or promyelocytes in peripheral blood.|no blasts or promyelocytes in peripheral blood.
727787|NCT01073436|No evidence of disease-related symptoms and extramedullary disease|no evidence of disease-related symptoms and extramedullary disease
727788|NCT01073436|complete cytogenetic response (CCyR) on a TKI for a minimum of 1 yr|complete cytogenetic response (ccyr) on a tki for a minimum of 1 yr
727789|NCT01073436|major molecular remission on a TKI for a minimum of 1 yr|major molecular remission on a tki for a minimum of 1 yr
727790|NCT01073436|18 years of age or older|18 years of age or older
729558|NCT01089283|GBA|gba
727791|NCT01073436|ECOG performance status of 0-2 (Appendix 13.1)|ecog performance status of 0-2 (appendix 13.1)
727792|NCT01073436|Informed Consent|informed consent
727793|NCT01073449|Cardiac devices|cardiac devices
727794|NCT01073449|In-Hospital Follow-up|in-hospital follow-up
727795|NCT01073449|Analytical|analytical
727796|NCT01073462|Secondary Hyperparathyroidism (sHPT)|secondary hyperparathyroidism (shpt)
727797|NCT01073462|Paricalcitol|paricalcitol
727798|NCT01073462|Chronic kidney disease stage 5 (CKD stage 5)|chronic kidney disease stage 5 (ckd stage 5)
727799|NCT01073475|Pregnancy|pregnancy
727800|NCT01073475|Maternal mortality|maternal mortality
727801|NCT01073475|Neonatal mortality|neonatal mortality
727802|NCT01073475|Stillbirth|stillbirth
727803|NCT01073475|Maternal Near Miss|maternal near miss
727804|NCT01073475|Maternal Cause of Death|maternal cause of death
727805|NCT01073475|Neonatal Cause of Death|neonatal cause of death
727806|NCT01073488|Pregnancy|pregnancy
727807|NCT01073488|Maternal child health|maternal child health
727808|NCT01073488|Developing countries|developing countries
727809|NCT01073488|Stillbirth|stillbirth
727810|NCT01073488|Neonatal mortality|neonatal mortality
727811|NCT01073488|Maternal mortality|maternal mortality
727812|NCT01073488|Community intervention|community intervention
727813|NCT01073488|Community mobilization|community mobilization
727814|NCT01073488|Home-based Life Saving Skills|home-based life saving skills
727815|NCT01073501|UREMIC PRURITUS|uremic pruritus
727816|NCT01073501|PREGABALIN|pregabalin
727817|NCT01073501|UP|up
727818|NCT01073514|Malignant biliary obstruction (MBO)|malignant biliary obstruction (mbo)
727819|NCT01073527|Child, preschool|child, preschool
727820|NCT01073527|Pediatric emergency department|pediatric emergency department
727821|NCT01073917|Ventilation|ventilation
727822|NCT01073917|General Anesthesia|general anesthesia
727823|NCT01073917|electrical impedance tomography|electrical impedance tomography
727824|NCT01073917|pressure support|pressure support
727825|NCT01073917|spontaneous breathing|spontaneous breathing
727826|NCT01073917|laryngeal mask|laryngeal mask
727827|NCT01073917|Patients who are scheduled for elective knee or ankle surgery|patients who are scheduled for elective knee or ankle surgery
727828|NCT01073930|Bowel Preparation|bowel preparation
727829|NCT01073930|Colonoscopy|colonoscopy
727830|NCT01073943|Bowel Preparation|bowel preparation
727831|NCT01073943|Colonoscopy|colonoscopy
727832|NCT01073956|Subacromial Impingement Syndrome|subacromial impingement syndrome
727833|NCT01073956|Shoulder Pain|shoulder pain
727834|NCT01073956|Physical therapy|physical therapy
727835|NCT01073956|Electrotherapy|electrotherapy
727836|NCT01073956|Ultrasonic therapy|ultrasonic therapy
727837|NCT01073956|Medium-wave 448 kHz therapy|medium-wave 448 khz therapy
727838|NCT01073969|prebiotic study|prebiotic study
727839|NCT01073969|modulating colonic bacteria|modulating colonic bacteria
727840|NCT01073982|pain|pain
727841|NCT01073982|inflammation|inflammation
727842|NCT01073982|osteoarthritis|osteoarthritis
727843|NCT01073995|Radiculopathy|radiculopathy
727844|NCT01073995|Sciatica|sciatica
727845|NCT01073995|Lumbar Disc Herniation|lumbar disc herniation
727846|NCT01073995|Surgical Alternative|surgical alternative
727847|NCT01074021|Nimotuzumab|nimotuzumab
727848|NCT01074021|Nasopharyngeal cancer|nasopharyngeal cancer
727849|NCT01074021|chemoradiation|chemoradiation
727850|NCT01074047|Acute Myeloid Leukemia|acute myeloid leukemia
727854|NCT01074047|Intensive Chemotherapy|intensive chemotherapy
727855|NCT01074047|Low Dose Cytarabine|low dose cytarabine
727856|NCT01074047|Celgene|celgene
727857|NCT01074073|Lithium DDI with Lurasidone HCl|lithium ddi with lurasidone hcl
727858|NCT01074073|Male/Female, Schizophrenia Patients|male/female, schizophrenia patients
727859|NCT01074086|RAD 001 in relapsed AML|rad 001 in relapsed aml
727860|NCT01074112|Ultrasound|ultrasound
727861|NCT01074112|Prehospital|prehospital
727862|NCT01074112|Trauma|trauma
727863|NCT01074112|EMS|ems
727864|NCT01074112|Paramedics|paramedics
727865|NCT01074112|Sonography|sonography
727866|NCT01074112|Ultrasonography|ultrasonography
727867|NCT01074112|Ambulance|ambulance
727868|NCT01074112|FAST|fast
727869|NCT01074112|EFAST|efast
727873|NCT01074125|End Stage Renal Disease|end stage renal disease
727874|NCT01074125|Phosphorus|phosphorus
727875|NCT01074125|Renal|renal
727876|NCT01074125|Kidney|kidney
727877|NCT01074138|CPRC|cprc
727878|NCT01074151|Pregnancy|pregnancy
727879|NCT01074151|pregnant|pregnant
727880|NCT01074151|Cymbalta|cymbalta
727881|NCT01074151|Pregnancy Outcomes|pregnancy outcomes
727882|NCT01074164|eczema|eczema
727883|NCT01074164|atopic dermatitis|atopic dermatitis
727884|NCT01074164|itch|itch
727885|NCT01074164|pruritus|pruritus
727886|NCT01074164|acupressure|acupressure
727887|NCT01074164|acupuncture|acupuncture
727888|NCT01074177|BIBW 2992|bibw 2992
727889|NCT01074177|NSCLC|nsclc
727890|NCT01074190|Epidural Labor Analgesia|epidural labor analgesia
727891|NCT01074190|Pain|pain
727892|NCT01074190|Infant|infant
727893|NCT01074190|Breastfeeding|breastfeeding
727894|NCT01074203|nitazoxanide|nitazoxanide
727895|NCT01074203|liver transplantation|liver transplantation
727896|NCT01074203|HCV recurrence|hcv recurrence
727897|NCT01074216|Vitamin D|vitamin d
727898|NCT01074216|Vitamin D3|vitamin d3
727899|NCT01074216|colon cancer|colon cancer
727900|NCT01074216|rectum cancer|rectum cancer
727901|NCT01074216|Cholecalciferol|cholecalciferol
727902|NCT01074216|09-143|09-143
727903|NCT01074229|Pain|pain
727904|NCT01074229|Post Operative|post operative
727905|NCT01074229|Opioids|opioids
727906|NCT01074229|Laparoscopic|laparoscopic
727907|NCT01074229|Surgery|surgery
727908|NCT01074229|Hysterectomy|hysterectomy
727909|NCT01074242|Gastroenteritis rotavirus|gastroenteritis rotavirus
727910|NCT01074255|Nausea|nausea
727911|NCT01074255|Vomiting|vomiting
727912|NCT01074255|Chemotherapy|chemotherapy
727913|NCT01074255|Post-chemotherapy|post-chemotherapy
727914|NCT01074281|Hypertension|hypertension
727915|NCT01074281|Isolated systolic hypertonia|isolated systolic hypertonia
727916|NCT01074281|Eneas|eneas
727917|NCT01074294|Inattention|inattention
727918|NCT01074294|Hyperactivity|hyperactivity
727919|NCT01074294|Impulsivity|impulsivity
727920|NCT01074294|Distractibility|distractibility
727921|NCT01074294|Procrastination|procrastination
727922|NCT01074294|Disorganized|disorganized
727923|NCT01074294|ADHD|adhd
727924|NCT01074307|Systolic heart failure|systolic heart failure
727925|NCT01074307|Bisoprolol|bisoprolol
727926|NCT01074307|Concor|concor
727927|NCT01074307|Echocardiogram|echocardiogram
727928|NCT01074320|breast cancer|breast cancer
727929|NCT01074320|aromatase inhibitors|aromatase inhibitors
727930|NCT01074320|musculoskeletal symptoms|musculoskeletal symptoms
727931|NCT01074333|Colorectal cancer|colorectal cancer
727932|NCT01074333|Metastasis|metastasis
727933|NCT01074333|Cetuximab|cetuximab
727934|NCT01074333|Erbitux|erbitux
727935|NCT01074333|Epidermal growth factor receptor|epidermal growth factor receptor
727936|NCT01074346|Multiple sclerosis|multiple sclerosis
727937|NCT01074346|Interferon-beta 1-a|interferon-beta 1-a
727938|NCT01074359|A3243G Mitochondrial DNA Point Mutation|a3243g mitochondrial dna point mutation
727939|NCT01074385|Stage IV Colorectal Cancer|stage iv colorectal cancer
727940|NCT01074398|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
727941|NCT01074398|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
727942|NCT01074398|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
727943|NCT01074398|fallopian tube cancer|fallopian tube cancer
727944|NCT01074398|peritoneal cavity cancer|peritoneal cavity cancer
727945|NCT01074424|stage IIB cervical cancer|stage iib cervical cancer
727946|NCT01074424|stage III cervical cancer|stage iii cervical cancer
727947|NCT01074424|stage IVA cervical cancer|stage iva cervical cancer
727948|NCT01074424|cervical adenocarcinoma|cervical adenocarcinoma
727949|NCT01074424|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
727950|NCT01074424|cervical squamous cell carcinoma|cervical squamous cell carcinoma
727951|NCT01074450|Bioequivalence|bioequivalence
727952|NCT01074450|Healthy Subjects|healthy subjects
727953|NCT01074463|Bioequivalence|bioequivalence
727954|NCT01074463|Healthy Subjects|healthy subjects
727955|NCT01074476|Knee osteoarthritis|knee osteoarthritis
727956|NCT01074476|glucosamine|glucosamine
727957|NCT01074476|synovial fluid|synovial fluid
727958|NCT01074476|viscosity|viscosity
727959|NCT01074476|viscoelasticity|viscoelasticity
727960|NCT01074476|WOMAC|womac
727962|NCT01074489|Gestational Diabetes|gestational diabetes
727963|NCT01074489|GTT|gtt
727964|NCT01074489|CGMS|cgms
727965|NCT01074502|acne|acne
727966|NCT01074515|COPD|copd
727967|NCT01074515|Depression|depression
727968|NCT01074515|Inflammation|inflammation
727969|NCT01074515|Genetics|genetics
727970|NCT01074515|Functioning|functioning
727971|NCT01074515|Dyspnea|dyspnea
727972|NCT01074515|Physical activity|physical activity
727973|NCT01074528|cancer patients|cancer patients
727974|NCT01074528|relatives or partners of cancer patients|relatives or partners of cancer patients
727975|NCT01074541|Vitamin D|vitamin d
727976|NCT01074541|UVB|uvb
727977|NCT01074541|Dose-Response|dose-response
727979|NCT01074541|Skin cancer|skin cancer
727980|NCT01074554|sarcoidosis|sarcoidosis
727981|NCT01074554|mycobacteria|mycobacteria
727982|NCT01074554|cutaneous lesions|cutaneous lesions
727983|NCT01074580|Crohn's disease|crohn's disease
727984|NCT01074580|sonography|sonography
727985|NCT01074580|contrast enhanced ultrasound|contrast enhanced ultrasound
727986|NCT01074593|PHARMACOKINETICS AND PHARMACODYNAMICS OF DRUG INTERFERON BETA-1A|pharmacokinetics and pharmacodynamics of drug interferon beta-1a
727987|NCT01074606|Cataract|cataract
727988|NCT01074645|Acute-on -chronic liver failure|acute-on -chronic liver failure
727989|NCT01074645|Reactivation of hepatitis B|reactivation of hepatitis b
727990|NCT01074645|Spontaneous reactivation of chronic hepatitis B presenting as to acute-on-chronic liver failure|spontaneous reactivation of chronic hepatitis b presenting as to acute-on-chronic liver failure
727991|NCT01074658|Advance|advance
727992|NCT01074658|Medtronic CoreValve System|medtronic corevalve system
727993|NCT01074658|International|international
727994|NCT01074658|Interventional|interventional
727995|NCT01074658|Post Market Study|post market study
727996|NCT01074684|diagnosis|diagnosis
727997|NCT01074684|nodules|nodules
727998|NCT01074684|fine needle aspiration|fine needle aspiration
727999|NCT01074697|Randomized Controlled Trial|randomized controlled trial
728000|NCT01074697|Serotonin Agonists|serotonin agonists
728001|NCT01074697|Dexamethasone|dexamethasone
728002|NCT01074697|Receptors, Neurokinin-1|receptors, neurokinin-1
728003|NCT01074697|Radiotherapy|radiotherapy
728004|NCT01074697|Cisplatin|cisplatin
728005|NCT01074697|Prevention & control|prevention & control
728006|NCT01074723|b-cryptoxanthin|b-cryptoxanthin
728007|NCT01074723|cholesterol|cholesterol
728008|NCT01074723|bone markers|bone markers
728009|NCT01074723|Osteoporosis|osteoporosis
728010|NCT01074723|cardiovascular risk|cardiovascular risk
728011|NCT01074723|post-menopausal women|post-menopausal women
728012|NCT01074736|influenza A/H5N1|influenza a/h5n1
728013|NCT01074736|host genetic susceptibility|host genetic susceptibility
728014|NCT01074736|genotyping|genotyping
728015|NCT01074749|AF|af
728016|NCT01074749|Automatic Mode Switch|automatic mode switch
728017|NCT01074749|FFRW|ffrw
728018|NCT01074749|paroxysmal AF|paroxysmal af
728019|NCT01074762|Diabetes mellitus|diabetes mellitus
728020|NCT01074762|Quality of health care|quality of health care
728021|NCT01074762|Health services research|health services research
728022|NCT01074775|innate immunity|innate immunity
728023|NCT01074775|mycobacterium bovis|mycobacterium bovis
728024|NCT01074775|mucosal immunity|mucosal immunity
728025|NCT01074775|adaptive immunity|adaptive immunity
728026|NCT01074775|genomics|genomics
728027|NCT01074788|rehabilitation|rehabilitation
728028|NCT01074788|mind body therapy|mind body therapy
728029|NCT01074788|integrative medicine|integrative medicine
728030|NCT01074801|Closed-loop systems|closed-loop systems
728031|NCT01074801|day-and-night glucose control|day-and-night glucose control
728032|NCT01074814|Metastatic Breast Cancer|metastatic breast cancer
728033|NCT01074814|Molecular profiling|molecular profiling
728034|NCT01074827|Multiple Sclerosis|multiple sclerosis
728035|NCT01074827|Walking ability|walking ability
728036|NCT01074827|Strength|strength
728037|NCT01074827|Balance|balance
728038|NCT01074827|Treadmill walking|treadmill walking
728039|NCT01074840|Food Hypersensitivity|food hypersensitivity
728040|NCT01074840|Hypersensitivity|hypersensitivity
728041|NCT01074840|Immune System Diseases|immune system diseases
728042|NCT01074840|Hypersensitivity, Immediate|hypersensitivity, immediate
728043|NCT01074840|Peanut Hypersensitivity|peanut hypersensitivity
728044|NCT01074840|Food Allergy|food allergy
728045|NCT01074866|Mechanical ventilation|mechanical ventilation
728046|NCT01074866|Non invasive Ventilation|non invasive ventilation
728047|NCT01074866|Patient-ventilator interaction|patient-ventilator interaction
728048|NCT01074866|Pressure support|pressure support
728049|NCT01074866|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
728050|NCT01074879|Elderly|elderly
728051|NCT01074879|protein consumption|protein consumption
728052|NCT01074879|resistance exercise|resistance exercise
728053|NCT01074879|muscle mass|muscle mass
728054|NCT01074892|endometrial hyperplasia treatment MPA per os LNG-IUD|endometrial hyperplasia treatment mpa per os lng-iud
728055|NCT01074905|vivax malaria|vivax malaria
728056|NCT01074905|artesunate|artesunate
728057|NCT01074905|chloroquine|chloroquine
728058|NCT01074905|primaquine|primaquine
728059|NCT01074905|relapse|relapse
728060|NCT01074918|Pre-hypertension|pre-hypertension
728061|NCT01074918|Hypertension|hypertension
728062|NCT01074931|Lopinavir/ritonavir|lopinavir/ritonavir
728063|NCT01074944|Gaucher disease|gaucher disease
728064|NCT01074944|Genz-112638|genz-112638
728065|NCT01074944|beta-glucosidase|beta-glucosidase
728066|NCT01074944|acid β-glucosidase|acid β-glucosidase
728067|NCT01074944|glucocerebrosidase|glucocerebrosidase
728068|NCT01074944|glucosylceramide|glucosylceramide
728069|NCT01074944|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
728070|NCT01074944|substrate reduction therapy|substrate reduction therapy
728077|NCT01074996|S-1|s-1
728078|NCT01074996|S-1 plus Leucovorin|s-1 plus leucovorin
728079|NCT01074996|second-line therapy|second-line therapy
728080|NCT01075009|Antibiotics|antibiotics
728081|NCT01075009|Resistance|resistance
728082|NCT01075009|Epidemiology|epidemiology
728083|NCT01075009|Gram-negative bacteria|gram-negative bacteria
728084|NCT01075009|Epidemiology of antibiotic use|epidemiology of antibiotic use
728085|NCT01075035|Traumatic Brain Injury|traumatic brain injury
728086|NCT01075035|TBI|tbi
728087|NCT01075035|Military|military
728088|NCT01075035|Imaging|imaging
728089|NCT01075035|MEG|meg
728090|NCT01075035|PET/CT|pet/ct
728091|NCT01075035|MRI|mri
728092|NCT01075035|fMRI|fmri
728093|NCT01075035|DTI|dti
728094|NCT01075035|SANIC|sanic
728095|NCT01075035|veteran|veteran
728096|NCT01075048|Colorectal cancer|colorectal cancer
728097|NCT01075048|wild-type KRAS|wild-type kras
728098|NCT01075048|irinotecan|irinotecan
728099|NCT01075048|cetuximab|cetuximab
728100|NCT01075048|second-line therapy|second-line therapy
729816|NCT01090323|ICL670A|icl670a
728101|NCT01075061|Congenital mirror movement, physiopathology, imaging, transcranial magnetic stimulation, candidate gene|congenital mirror movement, physiopathology, imaging, transcranial magnetic stimulation, candidate gene
728102|NCT01075074|Pain|pain
728103|NCT01075074|TAP block|tap block
728104|NCT01075074|Laparoscopic|laparoscopic
728105|NCT01075074|Gynecologic|gynecologic
728106|NCT01075087|TAP Block|tap block
728107|NCT01075087|Pain|pain
728108|NCT01075087|Obesity|obesity
728109|NCT01075087|Surgery|surgery
728110|NCT01075087|Laparoscopic Banding|laparoscopic banding
728111|NCT01075100|metastatic|metastatic
728112|NCT01075100|breast|breast
728113|NCT01075100|cancer|cancer
728114|NCT01075113|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
728115|NCT01075113|advanced adult primary liver cancer|advanced adult primary liver cancer
728116|NCT01075113|recurrent adult primary liver cancer|recurrent adult primary liver cancer
728117|NCT01075126|bipolar affective disorder|bipolar affective disorder
728118|NCT01075126|African American|african american
728119|NCT01075126|antimanic|antimanic
728120|NCT01075126|lithium|lithium
728121|NCT01075126|depakote|depakote
728122|NCT01075139|Motivational interviewing|motivational interviewing
728123|NCT01075139|Physical activity|physical activity
728124|NCT01075139|Diet|diet
728125|NCT01075152|cryptococcal meningitis|cryptococcal meningitis
728126|NCT01075152|cryptococcus|cryptococcus
728127|NCT01075152|cryptococcosis|cryptococcosis
728128|NCT01075152|HIV|hiv
728129|NCT01075152|AIDS|aids
728130|NCT01075152|strategy|strategy
728131|NCT01075165|silicone|silicone
728132|NCT01075165|burn scar|burn scar
728133|NCT01075165|hypertrophic scar|hypertrophic scar
728134|NCT01075165|keloid|keloid
728135|NCT01075165|scar assessment|scar assessment
728136|NCT01075165|abnormal scarring|abnormal scarring
728137|NCT01075165|Burn patients|burn patients
728138|NCT01075178|Infection|infection
728139|NCT01075178|Arrhythmia|arrhythmia
728140|NCT01075178|Death|death
728141|NCT01075178|Palivizumab|palivizumab
728142|NCT01075178|Safety|safety
728143|NCT01075178|Hemodynamically Significant Congenital Heart Disease|hemodynamically significant congenital heart disease
728144|NCT01075178|Pediatric|pediatric
728145|NCT01075178|Observational|observational
728146|NCT01075191|Viral load|viral load
728147|NCT01075191|Resistance|resistance
728148|NCT01075191|Double protease inhibitors|double protease inhibitors
728149|NCT01075191|Mutations|mutations
728150|NCT01075191|Immune system|immune system
728151|NCT01075191|Infection|infection
728152|NCT01075191|Nucleoside Reverse Transcriptase Inhibitors-free|nucleoside reverse transcriptase inhibitors-free
728153|NCT01075191|Human Immunodeficiency Virus|human immunodeficiency virus
728154|NCT01075204|Respiratory Tract Infection|respiratory tract infection
728155|NCT01075204|Clarithromycin|clarithromycin
728156|NCT01075204|Recovery|recovery
728157|NCT01075217|Peripheral arterial occlusive disease (PAOD)|peripheral arterial occlusive disease (paod)
728158|NCT01075230|PRP, TKA, pain scale, hemoglobin, hematocrit, narcotics|prp, tka, pain scale, hemoglobin, hematocrit, narcotics
728159|NCT01075243|dental pain|dental pain
728160|NCT01075243|paracetamol|paracetamol
728161|NCT01075243|Post-surgical dental pain|post-surgical dental pain
728162|NCT01075256|sensitivity|sensitivity
728163|NCT01075256|occlusion|occlusion
728254|NCT01075503|Brachial plexus block|brachial plexus block
728255|NCT01075503|Ropivacaine|ropivacaine
729887|NCT01090648|ETR|etr
728164|NCT01075269|robotic thyroidectomy, comparative study, cosmetic result, postoperative neck discomfort, swallowing symptom|robotic thyroidectomy, comparative study, cosmetic result, postoperative neck discomfort, swallowing symptom
728165|NCT01075269|Robotic thyroidectomy, cosmetic effect, postoperative distress, surgical outcome|robotic thyroidectomy, cosmetic effect, postoperative distress, surgical outcome
728166|NCT01075295|Schizophreniform Disorder|schizophreniform disorder
728167|NCT01075295|Schizophrenia, Schizoaffective disorder|schizophrenia, schizoaffective disorder
728168|NCT01075295|Bipolar I Disorder|bipolar i disorder
728169|NCT01075295|Bipolar II Disorder|bipolar ii disorder
728170|NCT01075295|Major Depressive Disorder with Psychotic Features,|major depressive disorder with psychotic features,
728171|NCT01075295|Substance-Induced Psychoses|substance-induced psychoses
728172|NCT01075295|Psychosis Not Otherwise Specified|psychosis not otherwise specified
728173|NCT01075295|antipsychotic|antipsychotic
728174|NCT01075295|weight gain|weight gain
728175|NCT01075295|body mass index|body mass index
728176|NCT01075295|BMI|bmi
728177|NCT01075295|waist circumference|waist circumference
728178|NCT01075295|WC|wc
728179|NCT01075295|coronary heart disease|coronary heart disease
728180|NCT01075295|CHD|chd
728181|NCT01075308|hormone-resistant prostate cancer|hormone-resistant prostate cancer
728182|NCT01075308|recurrent prostate cancer|recurrent prostate cancer
728183|NCT01075308|stage IV prostate cancer|stage iv prostate cancer
728184|NCT01075308|stage III prostate cancer|stage iii prostate cancer
728185|NCT01075308|adenocarcinoma of the prostate|adenocarcinoma of the prostate
728186|NCT01075334|sperm|sperm
728187|NCT01075334|male infertility|male infertility
728188|NCT01075334|Carnitine|carnitine
728189|NCT01075334|food supplementation|food supplementation
729966|NCT01090973|CLL|cll
728190|NCT01075334|insemination|insemination
728191|NCT01075347|autoserum|autoserum
728192|NCT01075347|ocular surgery|ocular surgery
728193|NCT01075347|corneal epithelium healing|corneal epithelium healing
728194|NCT01075360|Neuroblastoma, MYCN, AHR|neuroblastoma, mycn, ahr
728195|NCT01075373|early stage schizophrenia|early stage schizophrenia
728196|NCT01075373|drug naïve schizophrenia|drug naïve schizophrenia
728197|NCT01075373|treatment response|treatment response
728198|NCT01075373|Aripiprazole|aripiprazole
728199|NCT01075373|pharmacogenetics|pharmacogenetics
728200|NCT01075373|Disrupted-in-Schizophrenia 1 gene (DISC1)|disrupted-in-schizophrenia 1 gene (disc1)
728201|NCT01075373|Neuregulin 1 gene (NRG1)|neuregulin 1 gene (nrg1)
728202|NCT01075373|Dopamine receptor type 2 gene (DRD2)|dopamine receptor type 2 gene (drd2)
728203|NCT01075373|Catechol-O-Methyltransferase gene (COMT)|catechol-o-methyltransferase gene (comt)
728204|NCT01075373|neurocognitive function|neurocognitive function
728205|NCT01075373|event-related evoked potential (ERP)|event-related evoked potential (erp)
728206|NCT01075373|Niacin skin test|niacin skin test
728207|NCT01075373|plasma neurotransmitter level|plasma neurotransmitter level
728208|NCT01075373|plasma cytokine level|plasma cytokine level
728209|NCT01075373|plasma signaling protein level|plasma signaling protein level
728210|NCT01075373|AKT1 protein level in the peripheral lymphocytes|akt1 protein level in the peripheral lymphocytes
728211|NCT01075373|16-45 y/o|16-45 y/o
728212|NCT01075373|without mental retardation or epilepsy|without mental retardation or epilepsy
728213|NCT01075386|Hysterectomy|hysterectomy
728214|NCT01075386|Endometrial cancer|endometrial cancer
728215|NCT01075386|Benign|benign
728216|NCT01075386|Endocrine system|endocrine system
728217|NCT01075386|Tissue collection|tissue collection
728218|NCT01075399|[F 18]HX4|[f 18]hx4
728219|NCT01075399|HX4|hx4
728220|NCT01075399|Hypoxia|hypoxia
728221|NCT01075399|Head/Neck Cancer|head/neck cancer
728222|NCT01075399|Lung Cancer|lung cancer
728223|NCT01075399|Liver Cancer|liver cancer
728224|NCT01075399|Rectal Cancer|rectal cancer
728225|NCT01075399|Cervical Cancer|cervical cancer
728226|NCT01075399|HIF1 alpha|hif1 alpha
728227|NCT01075399|CAIX|caix
728228|NCT01075412|Positron-Emission Tomography|positron-emission tomography
728229|NCT01075412|Radiotherapy, Intensity-Modulated|radiotherapy, intensity-modulated
728230|NCT01075425|leukemia|leukemia
728231|NCT01075425|acute leukemia|acute leukemia
728232|NCT01075425|chronic myelogenous leukemia|chronic myelogenous leukemia
728233|NCT01075425|myelodysplastic syndrome|myelodysplastic syndrome
728234|NCT01075425|relapsed acute leukemia|relapsed acute leukemia
728235|NCT01075425|refractory acute leukemia|refractory acute leukemia
728236|NCT01075425|belinostat|belinostat
728237|NCT01075425|bortezomib|bortezomib
728238|NCT01075425|Velcade|velcade
728239|NCT01075425|PXD-101|pxd-101
728240|NCT01075438|ataxia telangiectasia|ataxia telangiectasia
728241|NCT01075438|Pneumococcal Vaccines|pneumococcal vaccines
728242|NCT01075451|Staphylococcus aureus|staphylococcus aureus
728243|NCT01075451|Antimicrobial Stewardship|antimicrobial stewardship
728244|NCT01075451|Antibacterial resistance|antibacterial resistance
728245|NCT01075451|Vancomycin|vancomycin
728246|NCT01075464|Solid Tumor|solid tumor
728247|NCT01075490|spinal anesthesia|spinal anesthesia
728248|NCT01075490|neonates|neonates
728249|NCT01075490|clonidine|clonidine
728250|NCT01075490|post operative apnea|post operative apnea
728251|NCT01075503|Supraclavicular|supraclavicular
728252|NCT01075503|Interscalene|interscalene
728253|NCT01075503|Infraclavicular|infraclavicular
728256|NCT01075516|Remote Monitoring|remote monitoring
728257|NCT01075516|ICD patients|icd patients
728258|NCT01075516|EQ-5D questionnaire|eq-5d questionnaire
728259|NCT01075516|remote follow up|remote follow up
728260|NCT01075529|major depressive disorder, fluoxetine, Hamilton Rating Scale for Depression (HAM-D-17)|major depressive disorder, fluoxetine, hamilton rating scale for depression (ham-d-17)
728261|NCT01075542|Corneal astigmatism|corneal astigmatism
728262|NCT01075542|Intraocular lens|intraocular lens
728263|NCT01075555|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
728264|NCT01075555|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
728265|NCT01075555|advanced adult primary liver cancer|advanced adult primary liver cancer
728266|NCT01075555|recurrent adult primary liver cancer|recurrent adult primary liver cancer
728267|NCT01075581|Hemodynamic instability|hemodynamic instability
728269|NCT01075594|Dyslipidemia|dyslipidemia
728270|NCT01075594|Target cholesterol|target cholesterol
728271|NCT01075594|Undertreatment|undertreatment
728272|NCT01075607|Lymph fluid collection|lymph fluid collection
728273|NCT01075620|rotating platform|rotating platform
728274|NCT01075620|posterior stabilized|posterior stabilized
728275|NCT01075620|non-posterior stabilized|non-posterior stabilized
728276|NCT01075633|FOBT|fobt
728277|NCT01075633|colonoscopy|colonoscopy
728278|NCT01075633|familiar risk|familiar risk
728279|NCT01075633|colorectal cancer|colorectal cancer
728280|NCT01075633|advanced adenoma|advanced adenoma
728281|NCT01075646|postoperative pain|postoperative pain
728282|NCT01075646|wound infusion|wound infusion
728283|NCT01075646|local anesthesia|local anesthesia
728284|NCT01075659|Smoking Cessation|smoking cessation
728285|NCT01075659|VAS|vas
728286|NCT01075659|Urges to smoke|urges to smoke
728287|NCT01075672|OCD|ocd
728288|NCT01075672|BDD|bdd
728289|NCT01075672|Tourette syndrome|tourette syndrome
728290|NCT01075672|trichotillomania|trichotillomania
728291|NCT01075672|Compulsive Skin Picking|compulsive skin picking
728292|NCT01075672|panic disorder|panic disorder
728293|NCT01075672|social phobia|social phobia
728294|NCT01075672|generalized anxiety disorder|generalized anxiety disorder
728295|NCT01075672|depression|depression
728296|NCT01075672|PTSD|ptsd
728297|NCT01075672|ADHD|adhd
728298|NCT01075672|eating disorder|eating disorder
728299|NCT01075672|Specific Phobia|specific phobia
728300|NCT01075698|Type 2 Diabetes|type 2 diabetes
728301|NCT01075698|Cerebrovascular disease|cerebrovascular disease
728302|NCT01075698|Coronary Artery Disease|coronary artery disease
728303|NCT01075698|Chronic Kidney Disease|chronic kidney disease
728304|NCT01075698|Peripheral Artery Disease|peripheral artery disease
728305|NCT01075711|Arthritis, Rheumatoid|arthritis, rheumatoid
728306|NCT01075711|Prednisone|prednisone
728307|NCT01075724|Perioperative Hypothermia Prevention|perioperative hypothermia prevention
728308|NCT01075724|Accidental Perioperative Hypothermia|accidental perioperative hypothermia
728309|NCT01075737|Multiple sclerosis|multiple sclerosis
728310|NCT01075737|Sclerosis|sclerosis
728311|NCT01075737|Quality of life|quality of life
728312|NCT01075750|hyperkalaemia|hyperkalaemia
728313|NCT01075750|metabolic acidosis|metabolic acidosis
728314|NCT01075750|renal transplantation|renal transplantation
728315|NCT01075750|normal saline|normal saline
728316|NCT01075750|elomel isoton|elomel isoton
728317|NCT01075750|fluid management in renal transplantation|fluid management in renal transplantation
728318|NCT01075763|Alzheimer's|alzheimer's
728319|NCT01075763|Dementia|dementia
728320|NCT01075763|Interferon beta-1a|interferon beta-1a
728321|NCT01075763|Rebif|rebif
728322|NCT01075789|Pain|pain
728323|NCT01075789|Discomfort|discomfort
728324|NCT01075789|Insertion|insertion
728325|NCT01075789|Nasogastric tube|nasogastric tube
728326|NCT01075802|Breast cancer|breast cancer
728327|NCT01075802|Tamoxifen|tamoxifen
728328|NCT01075802|Endoxifen|endoxifen
728329|NCT01075802|polymorphism of CYP2D6|polymorphism of cyp2d6
728330|NCT01075815|Infertility|infertility
728331|NCT01075815|Ovulation induction|ovulation induction
728332|NCT01075815|Luveris|luveris
728333|NCT01075815|Controlled ovarian stimulation|controlled ovarian stimulation
728334|NCT01075815|Reproductive technologies, assisted|reproductive technologies, assisted
728335|NCT01075828|Head and Neck Neoplasms|head and neck neoplasms
728336|NCT01075828|Neoplasms, Squamous Cell|neoplasms, squamous cell
728337|NCT01075828|Cetuximab|cetuximab
728338|NCT01075841|Head and neck neoplasms|head and neck neoplasms
728339|NCT01075841|Carcinoma, squamous cell|carcinoma, squamous cell
728340|NCT01075841|Cetuximab|cetuximab
728341|NCT01075854|Gonal-F|gonal-f
728342|NCT01075854|Multifollicular stimulation|multifollicular stimulation
728343|NCT01075854|Pregnancy|pregnancy
728344|NCT01075854|Ovarian hyperstimulation|ovarian hyperstimulation
728345|NCT01075854|In vitro fertilization|in vitro fertilization
728346|NCT01075854|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
728347|NCT01075854|Infertility|infertility
728348|NCT01075880|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
728349|NCT01075880|Rebif|rebif
728350|NCT01075880|Interferon beta-1a|interferon beta-1a
729403|NCT01087866|treatment|treatment
728351|NCT01075893|Colorectal cancer|colorectal cancer
728352|NCT01075893|Stem cells|stem cells
728353|NCT01075893|Ulcerative colitis|ulcerative colitis
728354|NCT01075893|Polyps|polyps
728355|NCT01075906|pharmacokinetics|pharmacokinetics
728356|NCT01075919|n-3 PUFAs|n-3 pufas
728357|NCT01075919|Cognitive function|cognitive function
728363|NCT01075932|n-3 PUFAs|n-3 pufas
728364|NCT01075932|fish oil|fish oil
728365|NCT01075932|cognitive function|cognitive function
728366|NCT01075945|antimalarials|antimalarials
728367|NCT01075945|ACTs|acts
728368|NCT01075945|Piperaquine|piperaquine
728369|NCT01075945|uncomplicated|uncomplicated
728370|NCT01075958|n-3 PUFAs|n-3 pufas
728371|NCT01075958|Fish oil|fish oil
728372|NCT01075958|Cognitive function|cognitive function
728373|NCT01075958|Healthy young adults|healthy young adults
728374|NCT01075971|Buprenorphine tablet|buprenorphine tablet
728375|NCT01075971|Fast dissolving tablet|fast dissolving tablet
728376|NCT01075971|Opioid dependant patients|opioid dependant patients
728377|NCT01075984|Antifungal Agents pharmacokinetics|antifungal agents pharmacokinetics
728378|NCT01075984|Mycoses prevention and control|mycoses prevention and control
728379|NCT01075997|Diabetes Mellitus|diabetes mellitus
728380|NCT01076023|Diabetes|diabetes
728381|NCT01076023|Cardiovascular disease|cardiovascular disease
728382|NCT01076023|Observational study|observational study
728383|NCT01076023|China|china
728384|NCT01076036|ischemia|ischemia
728385|NCT01076036|stent|stent
728386|NCT01076062|Pregnancy Maintenance|pregnancy maintenance
728387|NCT01076062|Labor, Induced|labor, induced
728388|NCT01076062|spontaneous labor|spontaneous labor
728389|NCT01076062|cesarean delivery|cesarean delivery
728390|NCT01076075|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
728392|NCT01076101|sister|sister
728393|NCT01076101|autoimmune disease|autoimmune disease
728394|NCT01076140|Hypertension as a result of bevacizumab therapy|hypertension as a result of bevacizumab therapy
728395|NCT01076153|Post-marketing observational study|post-marketing observational study
728396|NCT01076153|Upper or lower respiratory tract infection|upper or lower respiratory tract infection
728397|NCT01076153|Klacid MR|klacid mr
728398|NCT01076166|Post-marketing observational study|post-marketing observational study
728399|NCT01076166|Lower respiratory tract infections|lower respiratory tract infections
728400|NCT01076166|Klacid Granules for Oral Suspension|klacid granules for oral suspension
728401|NCT01076179|Infection|infection
728402|NCT01076179|Rilpivirine|rilpivirine
728403|NCT01076179|CCR5 antagonists|ccr5 antagonists
728404|NCT01076179|Etravirine|etravirine
728405|NCT01076179|Human Immunodeficiency Virus|human immunodeficiency virus
728406|NCT01076179|Maraviroc|maraviroc
728407|NCT01076179|Safety and efficacy|safety and efficacy
728408|NCT01076179|Non nucleoside reverse transcriptase inhibitors (NNRTIs)|non nucleoside reverse transcriptase inhibitors (nnrtis)
728409|NCT01076179|Integrase inhibitors|integrase inhibitors
728410|NCT01076179|Raltegravir|raltegravir
728411|NCT01076179|Kaletra|kaletra
728412|NCT01076192|Moderate Psoriasis|moderate psoriasis
728413|NCT01076192|Psoriasis|psoriasis
728414|NCT01076192|Severe Psoriasis|severe psoriasis
728415|NCT01076192|Adalimumab|adalimumab
728416|NCT01076192|Effectiveness|effectiveness
728417|NCT01076192|Safety|safety
728418|NCT01076192|Clinical practice|clinical practice
728424|NCT01076218|Continuous Glucose Monitoring|continuous glucose monitoring
728425|NCT01076218|Accuracy|accuracy
728426|NCT01076218|Continuous Glucose Error-Grid Analysis|continuous glucose error-grid analysis
728427|NCT01076257|brain damage|brain damage
728428|NCT01076257|constraint induced movement therapy|constraint induced movement therapy
728429|NCT01076257|kinematic|kinematic
728430|NCT01076257|function|function
728431|NCT01076257|outcome|outcome
728432|NCT01076257|Quality of life|quality of life
728433|NCT01076283|baclofen|baclofen
728434|NCT01076283|alcoholism|alcoholism
728435|NCT01076283|urge|urge
728436|NCT01076283|craving|craving
728437|NCT01076283|alcohol drinking|alcohol drinking
728438|NCT01076283|biobehavioral mechanisms of baclofen in alcoholism|biobehavioral mechanisms of baclofen in alcoholism
728439|NCT01076309|cataract surgery|cataract surgery
728440|NCT01076309|tamsulosin|tamsulosin
728441|NCT01076309|endothelium cell|endothelium cell
728442|NCT01076335|Neoadjuvant Hormonal Therapy|neoadjuvant hormonal therapy
728443|NCT01076335|Docetaxel|docetaxel
728444|NCT01076335|Taxotere|taxotere
728445|NCT01076335|Chemotherapy|chemotherapy
728446|NCT01076335|Radical Prostatectomy|radical prostatectomy
728447|NCT01076335|Node-positive Prostate Cancer|node-positive prostate cancer
728448|NCT01076335|Androgen-dependent prostate cancer|androgen-dependent prostate cancer
728449|NCT01076335|Lymph node metastases|lymph node metastases
728450|NCT01076348|Epicardial|epicardial
728451|NCT01076348|Pacing Lead|pacing lead
728452|NCT01076361|Epicardial|epicardial
728453|NCT01076361|Pacing Lead|pacing lead
728454|NCT01065168|endometriosis|endometriosis
728455|NCT01065168|endometrioma|endometrioma
728456|NCT01065168|antimullerian hormone|antimullerian hormone
728457|NCT01065168|cystectomy|cystectomy
728458|NCT01065181|shoulder|shoulder
728459|NCT01065181|posterior inferior glenohumeral ligament|posterior inferior glenohumeral ligament
728460|NCT01065181|posterior capsule|posterior capsule
728461|NCT01065181|capsular contracture|capsular contracture
728462|NCT01065181|baseball|baseball
728463|NCT01065181|throwing injury|throwing injury
728464|NCT01065220|Serotonin Transporter|serotonin transporter
728465|NCT01065220|Hormone therapy|hormone therapy
728466|NCT01065220|Gender Dysphoria|gender dysphoria
728467|NCT01065220|Transsexualism|transsexualism
728468|NCT01065246|malignant ascites|malignant ascites
728469|NCT01065246|second cycle|second cycle
728470|NCT01065246|trifunctional|trifunctional
728471|NCT01065259|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
728472|NCT01065259|executive function|executive function
728473|NCT01065259|OROS MPH|oros mph
728474|NCT01065259|atomoxetine|atomoxetine
728475|NCT01065272|Dexamethasone|dexamethasone
728476|NCT01065272|Bronchiolitis|bronchiolitis
728477|NCT01065285|Influenza|influenza
728478|NCT01065285|autoimmune diseases|autoimmune diseases
728479|NCT01065285|vaccination|vaccination
728481|NCT01065311|Depressive Disorder|depressive disorder
728482|NCT01065311|Psychotherapy|psychotherapy
728483|NCT01065324|balloon|balloon
728484|NCT01065324|enteroscopy|enteroscopy
728485|NCT01065324|bacteremia|bacteremia
728486|NCT01070680|ERCP|ercp
728487|NCT01070680|dexmedetomidine|dexmedetomidine
728488|NCT01070680|propofol|propofol
728489|NCT01070680|patient-controlled sedation|patient-controlled sedation
728490|NCT01070680|Chronic Alcoholic pancreatitis|chronic alcoholic pancreatitis
728491|NCT01070693|Inguinal hernia|inguinal hernia
728492|NCT01070693|Open mesh repair|open mesh repair
728493|NCT01070693|Long term outcome|long term outcome
728494|NCT01070693|Recurrence|recurrence
728495|NCT01070693|Discomfort|discomfort
728496|NCT01076374|pacemaker|pacemaker
728497|NCT01076387|Bladder|bladder
728498|NCT01076387|Cystectomy|cystectomy
728499|NCT01076387|Robotic|robotic
728500|NCT01076387|Open Radical|open radical
728501|NCT01076387|10-016|10-016
728502|NCT01076413|gait|gait
728503|NCT01076413|exercise|exercise
728504|NCT01076413|skill-based|skill-based
728505|NCT01076413|aerobic|aerobic
728506|NCT01076426|probiotic|probiotic
728507|NCT01076426|peritoneal dialysis|peritoneal dialysis
728508|NCT01076426|peritonitis|peritonitis
728509|NCT01076426|nutrition status|nutrition status
728510|NCT01076452|Parkinson's Disease|parkinson's disease
728511|NCT01076452|levo-dopa|levo-dopa
728512|NCT01076452|tremor|tremor
728513|NCT01076452|dyskinesia|dyskinesia
728514|NCT01076452|subthalamic nucleus|subthalamic nucleus
728515|NCT01076452|globus pallidus|globus pallidus
728516|NCT01076465|Heart failure|heart failure
728517|NCT01076465|Elderly|elderly
728518|NCT01076465|Disease management|disease management
728519|NCT01076478|Symmetric Diabetic Polyneuropathy|symmetric diabetic polyneuropathy
728520|NCT01076504|SCLC|sclc
728521|NCT01076504|Amrubicin|amrubicin
728522|NCT01076504|Carboplatin|carboplatin
728523|NCT01076504|Pegfilgrastim|pegfilgrastim
728524|NCT01076504|Neulasta|neulasta
728525|NCT01076582|hormone withdrawal associated symptoms|hormone withdrawal associated symptoms
728526|NCT01076595|Multiple sclerosis|multiple sclerosis
728527|NCT01076595|BetaPlus program|betaplus program
728528|NCT01076595|Recurrent/remittent multiple sclerosis patients|recurrent/remittent multiple sclerosis patients
728529|NCT01076595|Adherence to treatment regimen|adherence to treatment regimen
728530|NCT01076608|primary care patients|primary care patients
728531|NCT01076660|Ischemic cardiomyopathy|ischemic cardiomyopathy
728532|NCT01076660|Nonischemic cardiomyopathy|nonischemic cardiomyopathy
728533|NCT01076660|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
728534|NCT01076660|Sudden Cardiac Death|sudden cardiac death
728535|NCT01076660|Ventricular tachycardia|ventricular tachycardia
728536|NCT01076660|Ventricular fibrillation|ventricular fibrillation
728537|NCT01076686|Augmentation mammoplasty|augmentation mammoplasty
728538|NCT01076686|Breast augmentation|breast augmentation
728539|NCT01076686|Postoperative pain|postoperative pain
728540|NCT01076686|Analgesia|analgesia
728541|NCT01076699|abdominal pain|abdominal pain
728542|NCT01076699|bloating|bloating
728543|NCT01076699|diarrhea|diarrhea
728544|NCT01076699|irritable bowel|irritable bowel
728545|NCT01085045|COPD|copd
728546|NCT01085058|Lymphoproliferative diseases (Hodgkin's disease, non-Hodgkin's lymphomas, multiple myelomas) and high-dose therapy|lymphoproliferative diseases (hodgkin's disease, non-hodgkin's lymphomas, multiple myelomas) and high-dose therapy
728547|NCT01085071|intensive care unit|intensive care unit
728548|NCT01085071|potassium|potassium
728549|NCT01085071|atrial fibrillation|atrial fibrillation
728550|NCT01085071|cardiac surgery|cardiac surgery
728551|NCT01085071|Critically ill patients post CABG and/or valvular surgery|critically ill patients post cabg and/or valvular surgery
728552|NCT01085071|Critically ill patients not post CABG and/or valvular surgery|critically ill patients not post cabg and/or valvular surgery
728553|NCT01085071|coronary artery bypass graft|coronary artery bypass graft
728554|NCT01085084|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
728555|NCT01085084|Lupus Arthritis|lupus arthritis
728556|NCT01085084|Laquinimod|laquinimod
728557|NCT01085097|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
728558|NCT01085097|Lupus Nephritis|lupus nephritis
728559|NCT01085097|Laquinimod|laquinimod
728560|NCT01085110|Groin hernia|groin hernia
728561|NCT01085110|Chronic pain|chronic pain
728562|NCT01085110|QST|qst
728563|NCT01085110|Quantitative sensory testing|quantitative sensory testing
728564|NCT01085110|Persistent postoperative pain|persistent postoperative pain
728565|NCT01085110|Laparoscopic inguinal herniotomy|laparoscopic inguinal herniotomy
728566|NCT01085110|Postherniotomy Pain after laparoscopic inguinal herniotomy|postherniotomy pain after laparoscopic inguinal herniotomy
728567|NCT01085110|laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
728568|NCT01085123|Migraine|migraine
728569|NCT01085123|ZOMIG® Rapimelt|zomig® rapimelt
728570|NCT01085149|simvastatin|simvastatin
728571|NCT01085149|alveolar bone|alveolar bone
728572|NCT01085149|tooth extraction|tooth extraction
728573|NCT01085149|remodeling|remodeling
728574|NCT01085149|alveolar bone remodeling|alveolar bone remodeling
728575|NCT01085162|Coronary Artery Disease|coronary artery disease
728576|NCT01085162|PET imaging|pet imaging
728577|NCT01085162|SPECT imaging|spect imaging
728578|NCT01085175|Heart Failure,|heart failure,
728579|NCT01085175|PET Imaging,|pet imaging,
728580|NCT01085175|Implantable Cardioverter-Defibrillator,|implantable cardioverter-defibrillator,
728581|NCT01085175|Sudden Cardiac Death|sudden cardiac death
728582|NCT01085201|lexiscan|lexiscan
728583|NCT01085227|Parkinson's disease|parkinson's disease
728584|NCT01085227|LRRK2|lrrk2
728585|NCT01085227|asymptomatic carriers|asymptomatic carriers
728586|NCT01085253|Parkinson's|parkinson's
728587|NCT01085253|supranuclear palsy|supranuclear palsy
728588|NCT01085253|substantia nigra|substantia nigra
728589|NCT01085253|sub thalamic nucleus|sub thalamic nucleus
728590|NCT01085253|MRI|mri
728591|NCT01085279|fractional laser|fractional laser
728592|NCT01085279|melasma|melasma
728593|NCT01085279|topical bleaching|topical bleaching
728594|NCT01085305|Behavior problems|behavior problems
728595|NCT01085305|Parent-Child Interaction|parent-child interaction
728596|NCT01085305|Locus of control|locus of control
728597|NCT01085305|Psychiatric symptoms|psychiatric symptoms
728598|NCT01085305|Depressive symptoms|depressive symptoms
728599|NCT01085305|Attachment|attachment
728600|NCT01085331|Mek Inhibitor|mek inhibitor
728601|NCT01085331|Metastatic Colorectal Cancer|metastatic colorectal cancer
728602|NCT01085331|K-Ras Mutation|k-ras mutation
728603|NCT01085331|Phase II|phase ii
728604|NCT01085331|Second line K-Ras mutated metastatic colorectal cancer|second line k-ras mutated metastatic colorectal cancer
728605|NCT01085344|hemophilia, prophylaxis, cost effectiveness|hemophilia, prophylaxis, cost effectiveness
728606|NCT01085357|Glaucoma|glaucoma
728607|NCT01085357|Glaucoma device|glaucoma device
728608|NCT01085357|Glaucoma surgery|glaucoma surgery
728609|NCT01085357|Intraocular pressure|intraocular pressure
728610|NCT01085370|posttraumatic stress|posttraumatic stress
728611|NCT01085370|prevention|prevention
728612|NCT01085370|children|children
728613|NCT01085370|acute stress disorder due to burn injury or injuries associated with road traffic accidents|acute stress disorder due to burn injury or injuries associated with road traffic accidents
728614|NCT01085383|Antipsychotic|antipsychotic
728615|NCT01085383|hyperprolactinemia|hyperprolactinemia
728616|NCT01085383|hypogonadism|hypogonadism
728617|NCT01085383|aripiprazole|aripiprazole
728618|NCT01085396|Fiber Optic|fiber optic
728619|NCT01085396|Melanoma|melanoma
728620|NCT01085396|UV Exposure|uv exposure
728621|NCT01085409|experienced utility|experienced utility
728622|NCT01085409|decision utility|decision utility
728623|NCT01085409|subjective well-being|subjective well-being
728624|NCT01085409|experience sampling method|experience sampling method
728625|NCT01085409|day reconstruction method|day reconstruction method
728626|NCT01085409|Quality of life|quality of life
728627|NCT01085422|Prostate Cancer|prostate cancer
728628|NCT01085435|ICD|icd
728629|NCT01085435|defibrillator|defibrillator
728630|NCT01085448|low back pain|low back pain
728631|NCT01085448|core stabilization|core stabilization
728632|NCT01085448|physical therapy|physical therapy
728633|NCT01085474|Asthma|asthma
728634|NCT01085474|Pharmaceutical intervention|pharmaceutical intervention
728635|NCT01085474|Effect of a pharmaceutical intervention on the level of control of the asthmatic patient|effect of a pharmaceutical intervention on the level of control of the asthmatic patient
728636|NCT01085487|Menorrhagia|menorrhagia
728637|NCT01085500|laparoscopic|laparoscopic
728638|NCT01085500|totally extraperitoneal inguinal hernia repair|totally extraperitoneal inguinal hernia repair
729404|NCT01087866|metformin|metformin
728639|NCT01085513|intestinal abnormalities|intestinal abnormalities
728640|NCT01085526|basophil activity|basophil activity
728641|NCT01085526|plasma cells|plasma cells
728642|NCT01085526|IgE|ige
728643|NCT01085526|IgG1|igg1
728644|NCT01085526|IgG4|igg4
728645|NCT01085526|mast cells|mast cells
728646|NCT01085526|IgE receptor|ige receptor
728647|NCT01085526|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
728648|NCT01085526|grass pollen allergy|grass pollen allergy
728649|NCT01085539|neonatal intensive care|neonatal intensive care
728650|NCT01085539|infant pulse oximetry|infant pulse oximetry
728651|NCT01085552|NeoRecormon®|neorecormon®
728652|NCT01085552|Caucasian|caucasian
728653|NCT01085552|Japanese|japanese
728654|NCT01085552|Bioequivalence|bioequivalence
728656|NCT01085565|Bone cancer|bone cancer
728657|NCT01085565|Bone Metastases|bone metastases
728658|NCT01085565|pain palliation|pain palliation
728659|NCT01085565|metastasis|metastasis
728660|NCT01085565|breast cancer|breast cancer
728661|NCT01085565|lung cancer|lung cancer
728662|NCT01085565|prostate cancer|prostate cancer
728663|NCT01085565|cancer related pain|cancer related pain
728664|NCT01085565|tumors|tumors
728665|NCT01085578|healthy male volunteers|healthy male volunteers
728666|NCT01085578|fasted and fed state|fasted and fed state
728667|NCT01085591|CDI|cdi
728668|NCT01085591|Clostridium difficile Infection|clostridium difficile infection
728669|NCT01085591|Diarrhea|diarrhea
728670|NCT01085604|low back pain|low back pain
728671|NCT01085604|clinical instability|clinical instability
728672|NCT01085604|neuromuscular control|neuromuscular control
728673|NCT01085604|core stabilization|core stabilization
728674|NCT01085604|physical therapy|physical therapy
728675|NCT01085617|oral complications|oral complications
728676|NCT01085617|mucositis|mucositis
728677|NCT01085617|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
728678|NCT01085617|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
728679|NCT01085617|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
728680|NCT01085617|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
728681|NCT01085630|epithelial mesothelioma|epithelial mesothelioma
728682|NCT01085630|sarcomatous mesothelioma|sarcomatous mesothelioma
728683|NCT01085630|stage II malignant mesothelioma|stage ii malignant mesothelioma
728684|NCT01085630|stage III malignant mesothelioma|stage iii malignant mesothelioma
728685|NCT01085630|stage IV malignant mesothelioma|stage iv malignant mesothelioma
728686|NCT01085643|IBS|ibs
728687|NCT01085643|Lubiprostone|lubiprostone
728688|NCT01085643|Small Bowel|small bowel
728689|NCT01085643|High Resolution Manometry|high resolution manometry
728690|NCT01085643|Delayed Intestinal Transit|delayed intestinal transit
728691|NCT01085669|Infection rate of VEPTR-Implants|infection rate of veptr-implants
728692|NCT01085669|VEPTR. Vertical Expandable|veptr. vertical expandable
728693|NCT01085669|Prosthetic Titanium Rib|prosthetic titanium rib
728694|NCT01085682|Diabetes prevention|diabetes prevention
728695|NCT01085682|Lifestyle modification|lifestyle modification
728696|NCT01085682|Obesity|obesity
728697|NCT01085682|Impaired glucose tolerance|impaired glucose tolerance
728698|NCT01085682|Diet|diet
728699|NCT01085682|Physical activity|physical activity
728700|NCT01085695|Rabeprazole|rabeprazole
728701|NCT01085695|Japan|japan
728702|NCT01085695|healthy Japanese male|healthy japanese male
728703|NCT01085708|Rabeprazole|rabeprazole
728704|NCT01085708|Japan|japan
728705|NCT01085708|healthy Japanese male|healthy japanese male
728706|NCT01085721|allergic rhinitis|allergic rhinitis
728707|NCT01085721|viral infections of the upper respiratory tract|viral infections of the upper respiratory tract
728708|NCT01085721|dexchlorpheniramine|dexchlorpheniramine
728709|NCT01085721|pseudoephedrine|pseudoephedrine
728710|NCT01085721|guaifenesin|guaifenesin
728711|NCT01085747|Chronic pancreatitis|chronic pancreatitis
728712|NCT01085747|Biliary stricture|biliary stricture
728713|NCT01085747|Endoscopic treatment|endoscopic treatment
728714|NCT01085747|SEMS|sems
728715|NCT01085773|HbA1c|hba1c
728716|NCT01085773|Type 2 Diabetes|type 2 diabetes
728717|NCT01085773|Lifestyle changes|lifestyle changes
728718|NCT01085773|Exercise|exercise
728719|NCT01085786|Helicobacter pylori infection|helicobacter pylori infection
728720|NCT01085799|Educational activities|educational activities
728721|NCT01085799|Cluster-randomized controlled trial|cluster-randomized controlled trial
728722|NCT01085799|Albendazole|albendazole
728723|NCT01085799|Deworming|deworming
728724|NCT01085799|School-age children|school-age children
728725|NCT01085799|Peru|peru
728726|NCT01085799|Ascaris lumbricoides|ascaris lumbricoides
728727|NCT01085799|Trichuris trichiura|trichuris trichiura
728728|NCT01085799|Hookworm|hookworm
728729|NCT01085799|STH infections|sth infections
728730|NCT01085799|Intestinal helminth infections|intestinal helminth infections
728731|NCT01085825|induced abortion|induced abortion
728732|NCT01085825|termination of pregnancy|termination of pregnancy
728733|NCT01085825|manual vacuum aspiration|manual vacuum aspiration
729405|NCT01088620|NSCLC|nsclc
728738|NCT01085851|Dexchlorpheniramine|dexchlorpheniramine
728740|NCT01085851|Cream|cream
728743|NCT01085890|Blood Pressure|blood pressure
728744|NCT01085890|Life Style|life style
728745|NCT01085890|Body Mass Index|body mass index
728746|NCT01085890|Obesity, Abdominal|obesity, abdominal
728747|NCT01085890|Blood Chemical Analysis|blood chemical analysis
728748|NCT01085903|Spatial Neglect|spatial neglect
728749|NCT01085903|Dysphagia|dysphagia
728750|NCT01085903|Arousal|arousal
728751|NCT01085903|Modafinil|modafinil
728752|NCT01085903|Stroke|stroke
728852|NCT01086410|HPA axis|hpa axis
728753|NCT01085916|prevalence of asthma and Rhinitis symptoms among secondary school students in Saudi Arabia|prevalence of asthma and rhinitis symptoms among secondary school students in saudi arabia
728754|NCT01085929|abscess|abscess
728755|NCT01085929|infection|infection
728756|NCT01085929|ultrasound guidance|ultrasound guidance
728757|NCT01085929|incision and drainage|incision and drainage
728758|NCT01085929|needle aspiration|needle aspiration
728759|NCT01085929|skin|skin
728760|NCT01085929|ultrasound|ultrasound
728761|NCT01085942|rotator cuff tear|rotator cuff tear
728762|NCT01085942|asymptomatic|asymptomatic
728763|NCT01085942|natural course|natural course
728764|NCT01085942|tear characteristics|tear characteristics
728765|NCT01085942|Asymptomatic rotator cuff tears|asymptomatic rotator cuff tears
728766|NCT01085942|Natural course of rotator cuff tears|natural course of rotator cuff tears
728767|NCT01085955|peripartum|peripartum
728768|NCT01085955|cardiomyopathy|cardiomyopathy
728769|NCT01085955|post pregnancy|post pregnancy
728770|NCT01085955|myocardial recovery|myocardial recovery
728771|NCT01085955|pregnant women with peripartum cardiomyopathy|pregnant women with peripartum cardiomyopathy
728772|NCT01085968|Parkinson's disease|parkinson's disease
728773|NCT01085968|Cognitive deficits|cognitive deficits
728774|NCT01085968|fMRI|fmri
728775|NCT01085968|neuro rehabilitation|neuro rehabilitation
728776|NCT01085968|Age Matched Controls|age matched controls
728777|NCT01085981|quantitative assessment of the effects of a topically|quantitative assessment of the effects of a topically
728778|NCT01085981|applied vasodilating cream to the clitoris using doppler|applied vasodilating cream to the clitoris using doppler
728779|NCT01085981|flow plethysmography|flow plethysmography
728780|NCT01085994|antibiotics|antibiotics
728781|NCT01085994|resistance|resistance
728782|NCT01085994|bio-marker|bio-marker
728783|NCT01085994|procalcitonin|procalcitonin
728784|NCT01085994|algorithm|algorithm
728785|NCT01085994|critically ill|critically ill
728786|NCT01086007|Groin hernia|groin hernia
728787|NCT01086007|chronic pain|chronic pain
728788|NCT01086007|Persistent postoperative pain|persistent postoperative pain
728789|NCT01086007|Laparoscopic inguinal herniotomy|laparoscopic inguinal herniotomy
728790|NCT01086007|Sexual dysfunction|sexual dysfunction
728791|NCT01086020|IVUS|ivus
728792|NCT01086020|coronary plaque|coronary plaque
728793|NCT01086020|regression|regression
728794|NCT01086033|Evaluation of safety and efficacy|evaluation of safety and efficacy
728795|NCT01086033|Adalimumab treatment|adalimumab treatment
728796|NCT01086033|Rheumatoid Arthritis|rheumatoid arthritis
728797|NCT01086046|platelet|platelet
728798|NCT01086046|thrombozyme|thrombozyme
728799|NCT01086046|ASD|asd
728800|NCT01086046|Heparin|heparin
728801|NCT01086046|Enoxaparin|enoxaparin
728802|NCT01086059|Autoimmune diseases|autoimmune diseases
728803|NCT01086059|adalimumab|adalimumab
728804|NCT01086059|pregnancy|pregnancy
728805|NCT01086059|birth defects|birth defects
728806|NCT01086059|TNF|tnf
728807|NCT01086059|Tumor necrosis factor|tumor necrosis factor
728808|NCT01086098|Pacemakers|pacemakers
728809|NCT01086098|Survival|survival
728810|NCT01086111|type 2 diabetes|type 2 diabetes
728811|NCT01086111|gastric bypass|gastric bypass
728812|NCT01086111|sleeve gastrectomy|sleeve gastrectomy
728813|NCT01086111|clamp study|clamp study
728814|NCT01086111|weight loss surgery|weight loss surgery
728815|NCT01086124|echocardiography|echocardiography
728816|NCT01086124|ST elevation myocardial infarction|st elevation myocardial infarction
728817|NCT01086124|Heart failure|heart failure
728818|NCT01086124|Coronary artery disease|coronary artery disease
728819|NCT01086124|Cardiovascular diseases|cardiovascular diseases
728820|NCT01086137|salivary biomarker|salivary biomarker
728821|NCT01086137|metabolic syndrome|metabolic syndrome
728822|NCT01086137|prediabetes|prediabetes
728823|NCT01086137|diabetes hypertension|diabetes hypertension
728824|NCT01086163|Omacor|omacor
728825|NCT01086163|Simvastatin|simvastatin
728826|NCT01086163|Aspirin|aspirin
728827|NCT01086163|Platelet activity|platelet activity
728828|NCT01086163|Coronary artery disease|coronary artery disease
728829|NCT01086202|irreparable rotator cuff tears|irreparable rotator cuff tears
728830|NCT01086228|Drug eluting stents|drug eluting stents
728831|NCT01086228|Stents|stents
728832|NCT01086228|Angioplasty|angioplasty
728833|NCT01086241|Tomography|tomography
728834|NCT01086241|Mammography|mammography
728835|NCT01086241|Breast Neoplasms|breast neoplasms
728836|NCT01086241|Prevention and Control|prevention and control
728837|NCT01086332|radiotherapy|radiotherapy
728838|NCT01086332|gemcitabine|gemcitabine
728839|NCT01086332|nelfinavir|nelfinavir
728840|NCT01086332|neoplasms|neoplasms
728841|NCT01086345|adult giant cell glioblastoma|adult giant cell glioblastoma
728842|NCT01086345|adult gliosarcoma|adult gliosarcoma
728843|NCT01086345|recurrent adult brain tumor|recurrent adult brain tumor
728844|NCT01086358|productivity|productivity
728845|NCT01086358|migraine|migraine
728846|NCT01086358|Treximet|treximet
728848|NCT01086371|Multiple Sclerosis|multiple sclerosis
728849|NCT01086371|gait|gait
728850|NCT01086397|pneumococcal pneumonia|pneumococcal pneumonia
728851|NCT01086397|community-acquired pneumonia|community-acquired pneumonia
728853|NCT01086423|Infanrix-IPV+Hib|infanrix-ipv+hib
728854|NCT01086436|Human Rotavirus vaccine|human rotavirus vaccine
728855|NCT01086449|safety|safety
728856|NCT01086449|Japanese|japanese
728857|NCT01086449|Herpes Zoster|herpes zoster
728858|NCT01086449|immunogenicity|immunogenicity
728859|NCT01086449|Herpes Zoster in healthy ethnic Japanese adults|herpes zoster in healthy ethnic japanese adults
728860|NCT01086449|Vaccine|vaccine
728861|NCT01086462|GSK2239633|gsk2239633
728862|NCT01086462|RADIOLABEL|radiolabel
728863|NCT01086462|PHARMACOKINETICS|pharmacokinetics
728864|NCT01086462|INTRAVENOUS|intravenous
728865|NCT01086462|MICRODOSE|microdose
728866|NCT01086475|Autism Spectrum Disorder|autism spectrum disorder
728867|NCT01086475|D-cycloserine|d-cycloserine
728868|NCT01086475|Social Skills Training|social skills training
728869|NCT01086488|recurrent or persistent Nasopharyngeal Carcinoma|recurrent or persistent nasopharyngeal carcinoma
728870|NCT01086488|treatment of patients with squamous cell carcinoma of the head and neck|treatment of patients with squamous cell carcinoma of the head and neck
728871|NCT01086488|Foscan-PDT|foscan-pdt
728872|NCT01086488|Brachytherapy|brachytherapy
728873|NCT01086501|open, non-interventional|open, non-interventional
728874|NCT01086514|Breast|breast
728875|NCT01086514|mammography|mammography
728877|NCT01086514|Digital Mammography|digital mammography
728878|NCT01086514|10-024|10-024
728879|NCT01086527|Pharmacogenetics|pharmacogenetics
728880|NCT01086527|Singulair|singulair
728881|NCT01086527|montelukast|montelukast
728882|NCT01086527|Leukotriene Antagonists|leukotriene antagonists
728883|NCT01086527|Anti-Asthmatic Agents|anti-asthmatic agents
728884|NCT01086527|Intestinal Absorption|intestinal absorption
728885|NCT01086527|pharmacokinetics|pharmacokinetics
728886|NCT01086527|absorption|absorption
728887|NCT01086527|biochemical transport|biochemical transport
728888|NCT01086527|Membrane Transport Proteins|membrane transport proteins
728889|NCT01086540|Systemic Sclerosis-Associated Pulmonary Arterial Hypertension|systemic sclerosis-associated pulmonary arterial hypertension
728890|NCT01086540|Autoimmune Disease|autoimmune disease
728891|NCT01086540|Systemic Scleroderma|systemic scleroderma
728892|NCT01086540|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
728893|NCT01086553|Crohn´s disease|crohn´s disease
728894|NCT01086553|budesonide|budesonide
728895|NCT01086553|induction of remission|induction of remission
728896|NCT01086566|Influenza, H5N1, avian influenza, parent protocol|influenza, h5n1, avian influenza, parent protocol
728897|NCT01086579|paclitaxel PTCA drug-eluting balloon|paclitaxel ptca drug-eluting balloon
728898|NCT01086579|provisional spot stenting|provisional spot stenting
728899|NCT01086579|coronary artery disease|coronary artery disease
728900|NCT01086579|Late Lumen Loss|late lumen loss
728901|NCT01086579|Minimal lumen diameter|minimal lumen diameter
728902|NCT01086579|coronary artery disease in a small vessel|coronary artery disease in a small vessel
728903|NCT01086592|Aged|aged
728904|NCT01086592|Strength|strength
728905|NCT01086592|Balance|balance
728906|NCT01086592|Electrotherapy|electrotherapy
728907|NCT01086592|Quality of life|quality of life
728908|NCT01086605|HER2-negative breast cancer|her2-negative breast cancer
728909|NCT01086605|male breast cancer|male breast cancer
728910|NCT01086605|recurrent breast cancer|recurrent breast cancer
728911|NCT01086605|stage IV breast cancer|stage iv breast cancer
728912|NCT01086605|stage IIIC breast cancer|stage iiic breast cancer
728913|NCT01086618|stage IV colon cancer|stage iv colon cancer
728914|NCT01086618|stage IV rectal cancer|stage iv rectal cancer
728915|NCT01086631|Autoimmune Retinopathy|autoimmune retinopathy
728916|NCT01086631|RITUXAN|rituxan
728917|NCT01086631|Rituximab|rituximab
728918|NCT01086631|Immunosuppression|immunosuppression
728919|NCT01086657|Bird Flu|bird flu
728920|NCT01086657|Avian Influenza|avian influenza
728921|NCT01086657|Healthy|healthy
728922|NCT01086657|Immunity|immunity
728923|NCT01086657|Prevention|prevention
728924|NCT01086657|Healthy Volunteer|healthy volunteer
728925|NCT01086657|HV|hv
728926|NCT01086670|Coordination|coordination
728927|NCT01086670|Neuroimaging|neuroimaging
728928|NCT01086670|Motion Analysis|motion analysis
728929|NCT01086670|Locomotor|locomotor
728930|NCT01086670|Cerebral Palsy|cerebral palsy
728931|NCT01086670|Pediatrics|pediatrics
728932|NCT01086683|neoplasms|neoplasms
728933|NCT01086683|rehabilitation|rehabilitation
728934|NCT01086683|intervention|intervention
728935|NCT01086683|quality of life|quality of life
728936|NCT01086683|lifestyle|lifestyle
728937|NCT01086696|PET Imaging|pet imaging
728938|NCT01086696|F-18 Paclitaxel (FPAC)|f-18 paclitaxel (fpac)
728939|NCT01086696|Breast Cancer|breast cancer
728940|NCT01086696|Lung Cancer|lung cancer
728941|NCT01086696|Renal and Adrenal Cancers|renal and adrenal cancers
728942|NCT01086696|Kidney Cancer|kidney cancer
728943|NCT01086696|Adrenal Cancer|adrenal cancer
728944|NCT01086709|Human Papillomavirus|human papillomavirus
728945|NCT01086709|Vaccine|vaccine
728949|NCT01086735|hematological malignancy|hematological malignancy
728950|NCT01086735|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
728951|NCT01086735|donor lymphocyte infusion|donor lymphocyte infusion
728952|NCT01086735|antitumor immunotherapy|antitumor immunotherapy
728953|NCT01086735|graft-versus-tumor effect|graft-versus-tumor effect
728954|NCT01086735|gene therapy|gene therapy
728955|NCT01086735|relapse|relapse
728956|NCT01086735|adult|adult
728957|NCT01086774|Dry eye|dry eye
728958|NCT01086774|Tear Film Stability|tear film stability
728959|NCT01086787|Heart failure|heart failure
728960|NCT01086787|Bone marrow|bone marrow
728961|NCT01086787|Bone marrow mononuclear cells|bone marrow mononuclear cells
728962|NCT01086787|Surgery|surgery
728963|NCT01086787|Orthopedic surgery|orthopedic surgery
728964|NCT01086787|Cardiac surgery|cardiac surgery
728965|NCT01086813|Safety|safety
728966|NCT01086813|Tolerability|tolerability
728967|NCT01086813|Pharmacokinetics|pharmacokinetics
728968|NCT01086813|Sedation|sedation
728969|NCT01086839|Cystic Fibrosis|cystic fibrosis
728970|NCT01086839|chronic rhinosinusitis|chronic rhinosinusitis
728971|NCT01086852|Factor X deficiency|factor x deficiency
728972|NCT01086852|surgery|surgery
728973|NCT01086852|Factor X deficiency subjects requiring surgery|factor x deficiency subjects requiring surgery
728974|NCT01086865|inappetence|inappetence
728975|NCT01086865|apetiviton BC|apetiviton bc
728976|NCT01086878|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
728977|NCT01086878|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
728978|NCT01086878|anemia|anemia
728979|NCT01086878|neutropenia|neutropenia
728980|NCT01086878|safety|safety
728981|NCT01086878|hematologic toxicity|hematologic toxicity
728982|NCT01086904|renal transplantation|renal transplantation
728983|NCT01086904|immunosuppression|immunosuppression
728984|NCT01086904|inflenza A (H1N1)|inflenza a (h1n1)
728985|NCT01086904|vaccine|vaccine
728986|NCT01086917|Malaria Challenge|malaria challenge
728987|NCT01086917|Plasmodium falciparum|plasmodium falciparum
728988|NCT01086917|Controlled human malaria infection|controlled human malaria infection
728989|NCT01086917|PfSPZ Challenge|pfspz challenge
728990|NCT01086956|patients of prostatic cancer aged more than 65 years|patients of prostatic cancer aged more than 65 years
728991|NCT01086969|Meningococcal Infection|meningococcal infection
728992|NCT01086969|Meningitis, Bacterial|meningitis, bacterial
728993|NCT01086969|Menactra®|menactra®
728994|NCT01086995|extubation|extubation
728995|NCT01086995|weaning|weaning
728996|NCT01086995|mechanical ventilation|mechanical ventilation
728997|NCT01087008|Multiple Myeloma|multiple myeloma
728998|NCT01087008|Zoledronic acid|zoledronic acid
728999|NCT01087034|Infantile scoliosis|infantile scoliosis
729000|NCT01087034|bracing|bracing
729001|NCT01087034|acoustic reflection method|acoustic reflection method
729002|NCT01087034|EOS™|eos™
729003|NCT01087034|noninvasive|noninvasive
729004|NCT01087034|upper airways|upper airways
729005|NCT01087034|thoracic penetration index|thoracic penetration index
729006|NCT01087034|Idiopathic juvenile evolutive thoracic scoliosis|idiopathic juvenile evolutive thoracic scoliosis
729007|NCT01087047|Pregnancy|pregnancy
729008|NCT01087047|Upper airways|upper airways
729009|NCT01087047|Acoustic reflection method|acoustic reflection method
729010|NCT01087073|Healthcare Disparities|healthcare disparities
729011|NCT01087073|Health Care Quality Improvement|health care quality improvement
729012|NCT01087073|Shared Decision-Making|shared decision-making
729013|NCT01087073|Patient Education|patient education
729014|NCT01087073|Patient Activation|patient activation
729015|NCT01087073|Community Outreach|community outreach
729016|NCT01087073|Provider Training|provider training
729017|NCT01087086|Metabolic syndrome|metabolic syndrome
729018|NCT01087086|Oxidative stress|oxidative stress
729019|NCT01087086|Proinflammatory state|proinflammatory state
729020|NCT01087086|Insulin resistance|insulin resistance
729021|NCT01087086|Hypertension|hypertension
729022|NCT01087086|Dyslipidemia|dyslipidemia
729023|NCT01087086|Mediterranean diet|mediterranean diet
729024|NCT01087086|Glycemic index|glycemic index
729025|NCT01087086|Hypocaloric diet|hypocaloric diet
729026|NCT01087086|Hyperproteic diet|hyperproteic diet
729027|NCT01087086|Macronutrient distribution|macronutrient distribution
729028|NCT01087086|Antioxidant capacity of the diet|antioxidant capacity of the diet
729029|NCT01087086|Crononutrition|crononutrition
729030|NCT01087086|Dietary and psychological support|dietary and psychological support
729031|NCT01087086|Waist circumference|waist circumference
729032|NCT01087112|MIP|mip
729033|NCT01087112|RCT|rct
729034|NCT01087112|postnatal depression|postnatal depression
729035|NCT01087112|Mother-child relationship|mother-child relationship
729036|NCT01087138|bone health|bone health
729037|NCT01087138|bone density|bone density
729038|NCT01087138|bone mass|bone mass
729039|NCT01087151|Rituxan|rituxan
729040|NCT01087151|Apoptosis|apoptosis
729041|NCT01087151|BCl-2|bcl-2
729042|NCT01087164|Vaccine acceptance|vaccine acceptance
729043|NCT01087164|human papillomavirus|human papillomavirus
729044|NCT01087164|brief messages|brief messages
729045|NCT01087164|social compliance|social compliance
729046|NCT01087164|Message sidedness|message sidedness
729047|NCT01087177|Smoking|smoking
729048|NCT01087177|Tobacco|tobacco
729049|NCT01087177|Pediatrics|pediatrics
729050|NCT01087190|kidney|kidney
729051|NCT01087190|transplantation|transplantation
729052|NCT01087190|tuberculosis|tuberculosis
729053|NCT01087190|ELISPOT|elispot
729054|NCT01087190|isoniazid|isoniazid
729055|NCT01087203|diabetic peripheral neuropathy|diabetic peripheral neuropathy
729056|NCT01087203|tanezumab|tanezumab
729057|NCT01087203|diabetic neuropathies|diabetic neuropathies
729058|NCT01087203|diabetic polyneuropathy|diabetic polyneuropathy
729059|NCT01087203|diabetic neuropathy painful|diabetic neuropathy painful
729060|NCT01087242|Tang-min Lin pills|tang-min lin pills
729061|NCT01087242|type 2 diabetes|type 2 diabetes
729062|NCT01087242|liver and stomach heat retention|liver and stomach heat retention
729063|NCT01087242|Evaluate the safety and efficacy of Tang-min Lin pills|evaluate the safety and efficacy of tang-min lin pills
729064|NCT01087255|Caregiver-based interventions|caregiver-based interventions
729065|NCT01087255|Chronic Kidney Disease|chronic kidney disease
729066|NCT01087255|Medication Adherence|medication adherence
729067|NCT01087268|gastrointestinal complications|gastrointestinal complications
729068|NCT01087268|radiation toxicity|radiation toxicity
729069|NCT01087268|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
729070|NCT01087268|stage I rectal cancer|stage i rectal cancer
729071|NCT01087268|stage II rectal cancer|stage ii rectal cancer
729072|NCT01087268|stage III rectal cancer|stage iii rectal cancer
729073|NCT01087268|stage I prostate cancer|stage i prostate cancer
729074|NCT01087268|stage IIB prostate cancer|stage iib prostate cancer
729075|NCT01087268|stage IIA prostate cancer|stage iia prostate cancer
729076|NCT01087268|stage III prostate cancer|stage iii prostate cancer
729077|NCT01087268|stage IV prostate cancer|stage iv prostate cancer
729078|NCT01087268|stage I bladder cancer|stage i bladder cancer
729079|NCT01087268|stage II bladder cancer|stage ii bladder cancer
729080|NCT01087268|stage III bladder cancer|stage iii bladder cancer
729081|NCT01087268|stage IV bladder cancer|stage iv bladder cancer
729082|NCT01087268|stage IA cervical cancer|stage ia cervical cancer
729083|NCT01087268|stage IB cervical cancer|stage ib cervical cancer
729084|NCT01087268|stage IIA cervical cancer|stage iia cervical cancer
729085|NCT01087268|stage IIB cervical cancer|stage iib cervical cancer
729086|NCT01087268|stage III cervical cancer|stage iii cervical cancer
729087|NCT01087268|stage I vaginal cancer|stage i vaginal cancer
729088|NCT01087268|stage II vaginal cancer|stage ii vaginal cancer
729089|NCT01087268|stage III vaginal cancer|stage iii vaginal cancer
729090|NCT01087268|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
729091|NCT01087268|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
729092|NCT01087268|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
729093|NCT01087268|stage I endometrial carcinoma|stage i endometrial carcinoma
729094|NCT01087268|stage II endometrial carcinoma|stage ii endometrial carcinoma
729095|NCT01087268|stage III endometrial carcinoma|stage iii endometrial carcinoma
729096|NCT01087268|stage I uterine sarcoma|stage i uterine sarcoma
729097|NCT01087268|stage II uterine sarcoma|stage ii uterine sarcoma
729098|NCT01087268|stage III uterine sarcoma|stage iii uterine sarcoma
729099|NCT01087268|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
729100|NCT01087268|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
729101|NCT01087268|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
729102|NCT01087268|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
729103|NCT01087268|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
729104|NCT01087268|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
729105|NCT01087268|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
729106|NCT01087268|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
729107|NCT01087268|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
729108|NCT01087268|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
729109|NCT01087268|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
729110|NCT01087268|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
729111|NCT01087268|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
729112|NCT01087268|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
729113|NCT01087268|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
729114|NCT01087268|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
729115|NCT01087268|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
729116|NCT01087268|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
729117|NCT01087281|Visual Attention|visual attention
729118|NCT01087281|Visual Cortex|visual cortex
729119|NCT01087281|Focal Lesions|focal lesions
729120|NCT01087281|Neurological Disorder|neurological disorder
729121|NCT01087281|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
729122|NCT01087281|Focal Brain Lesion|focal brain lesion
729123|NCT01087281|Healthy Volunteer|healthy volunteer
729125|NCT01087294|CD19|cd19
729126|NCT01087294|Chimeric-Antigen-Receptor|chimeric-antigen-receptor
729127|NCT01087294|Gene Therapy|gene therapy
729620|NCT01089504|neonate|neonate
729128|NCT01087294|Adoptive T Cell Therapy|adoptive t cell therapy
729129|NCT01087294|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
729130|NCT01087294|B Cell Cancer|b cell cancer
729131|NCT01087294|Allogenic Stem Cell Transplant|allogenic stem cell transplant
729132|NCT01087307|Biospecimen|biospecimen
729133|NCT01087307|Registry|registry
729134|NCT01087307|Assay Development|assay development
729135|NCT01087307|Assay Validation|assay validation
729136|NCT01087307|Specimen Collection|specimen collection
729137|NCT01087320|Genetic Counseling|genetic counseling
729138|NCT01087320|Genetic Disorders|genetic disorders
729139|NCT01087320|Genetic Testing|genetic testing
729140|NCT01087320|Genetic/Genomic Researchers|genetic/genomic researchers
729141|NCT01087320|Human Genetic Variation|human genetic variation
729142|NCT01087320|Congenital Disorders|congenital disorders
729143|NCT01087320|Inherited Diseases|inherited diseases
729144|NCT01087333|Cytotoxicity Assay|cytotoxicity assay
729145|NCT01087333|Neutralizing Antibodies|neutralizing antibodies
729146|NCT01087333|Apheresis|apheresis
729147|NCT01087333|Flow Cytometry|flow cytometry
729148|NCT01087333|Hemolytic Uremic Syndrome (HUS)|hemolytic uremic syndrome (hus)
729149|NCT01087333|Leukemia|leukemia
729150|NCT01087333|Lymphoma|lymphoma
729151|NCT01087333|Hairy Cell Leukemia|hairy cell leukemia
729152|NCT01087333|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
729153|NCT01087333|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
729154|NCT01087333|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
729155|NCT01087333|Adult T Cell Lymphoma|adult t cell lymphoma
729156|NCT01087346|Parents|parents
729157|NCT01087346|Obesity|obesity
729158|NCT01087346|Family History|family history
729159|NCT01087346|Healthy Volunteer|healthy volunteer
729160|NCT01087346|HV|hv
729161|NCT01087372|Stress hyperglycemia|stress hyperglycemia
729162|NCT01087372|Incretins|incretins
729163|NCT01087372|GLP-1|glp-1
729164|NCT01087372|GIP|gip
729165|NCT01087372|glucoregulatory hormones|glucoregulatory hormones
729166|NCT01087385|peripheral arterial occlusive disease|peripheral arterial occlusive disease
729167|NCT01087385|mortality|mortality
729168|NCT01087385|cardiovascular events|cardiovascular events
729169|NCT01087385|amputation|amputation
729170|NCT01087385|peripheral arterial revascularization|peripheral arterial revascularization
729171|NCT01087398|Osteopetrosis|osteopetrosis
729172|NCT01087398|HSCT|hsct
729173|NCT01087411|accelerometry|accelerometry
729174|NCT01087411|physical activity|physical activity
729175|NCT01087411|obesity|obesity
729176|NCT01087411|children|children
729177|NCT01087411|cardiovascular risk markers|cardiovascular risk markers
729178|NCT01087411|metabolic risk markers|metabolic risk markers
729179|NCT01087411|DXA|dxa
729180|NCT01087411|obesity prevention|obesity prevention
729181|NCT01087411|omega 3|omega 3
729182|NCT01087411|fish liver oil|fish liver oil
729183|NCT01087411|motivational interviewing|motivational interviewing
729184|NCT01087424|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
729185|NCT01087437|Distraction osteogenesis|distraction osteogenesis
729186|NCT01087450|Erythropoietin|erythropoietin
729187|NCT01087450|Sepsis|sepsis
729188|NCT01087450|Septic shock|septic shock
729189|NCT01087450|Orthogonal Polarization Spectroscopy|orthogonal polarization spectroscopy
729190|NCT01087450|Severe sepsis or Septic shock|severe sepsis or septic shock
729191|NCT01087476|oral mucositis|oral mucositis
729192|NCT01087476|chemotherapy|chemotherapy
729193|NCT01087476|acute leukemia|acute leukemia
729194|NCT01087476|salivary flow.|salivary flow.
729195|NCT01087489|pain|pain
729196|NCT01087489|discomfort|discomfort
729197|NCT01087489|anesthetic drugs|anesthetic drugs
729198|NCT01087489|topical drug administration|topical drug administration
729199|NCT01087489|injections, intraocular|injections, intraocular
729200|NCT01087489|lidocaine|lidocaine
729201|NCT01087489|intraocular pressure|intraocular pressure
729202|NCT01087489|keratopathy|keratopathy
729203|NCT01073566|Autoimmune Diseases|autoimmune diseases
729204|NCT01073566|Diabetes Mellitus|diabetes mellitus
729205|NCT01073566|Endocrine System Diseases|endocrine system diseases
729206|NCT01073566|Glucose Metabolism Disorders|glucose metabolism disorders
729207|NCT01073566|Immune System Diseases|immune system diseases
729208|NCT01073566|Insulin|insulin
729209|NCT01073566|Metabolic Diseases|metabolic diseases
729210|NCT01073579|Cryptogenic Infantile Spasms|cryptogenic infantile spasms
729211|NCT01073579|Cryptogenic West Syndrome|cryptogenic west syndrome
729212|NCT01073579|Hypsarrhythmia|hypsarrhythmia
729213|NCT01073579|Infantile Spasms|infantile spasms
729214|NCT01073579|Symptomatic Infantile Spasms|symptomatic infantile spasms
729215|NCT01073579|Symptomatic West Syndrome|symptomatic west syndrome
729216|NCT01073579|West Syndrome|west syndrome
729217|NCT01073579|Refractory Complex Partial Seizures|refractory complex partial seizures
729218|NCT01073579|Complex Partial Epilepsy|complex partial epilepsy
729219|NCT01073579|Complex Partial Seizure Disorder|complex partial seizure disorder
729220|NCT01073579|Cryptogenic Partial Complex Epilepsy|cryptogenic partial complex epilepsy
729221|NCT01073579|Disorder, Complex Partial Seizures|disorder, complex partial seizures
729222|NCT01073579|Epilepsy, Cryptogenic, Partial Complex|epilepsy, cryptogenic, partial complex
729223|NCT01073579|Epilepsy, Psychic Equivalent|epilepsy, psychic equivalent
729224|NCT01073579|Epilepsy, Psychomotor|epilepsy, psychomotor
729225|NCT01073579|Epilepsy, Symptomatic, Partial Complex|epilepsy, symptomatic, partial complex
729326|NCT01087554|Zolinza|zolinza
729226|NCT01073579|Partial Complex Epilepsy, Cryptogenic|partial complex epilepsy, cryptogenic
729227|NCT01073579|Partial Complex Epilepsy, Symptomatic|partial complex epilepsy, symptomatic
729228|NCT01073579|Seizure Disorder, Complex Partial|seizure disorder, complex partial
729229|NCT01073579|Symptomatic Partial Complex Epilepsy|symptomatic partial complex epilepsy
729231|NCT01073592|CNV|cnv
729232|NCT01073592|AMD|amd
729233|NCT01073592|PHP|php
729234|NCT01073592|HPHP|hphp
729235|NCT01073592|FORESEE HOME|foresee home
729236|NCT01073605|Short height|short height
729237|NCT01073605|intra-uterine growth retardation|intra-uterine growth retardation
729238|NCT01073605|Genotonorm|genotonorm
729239|NCT01073605|continuous treatment|continuous treatment
729240|NCT01073605|intermittent treatment|intermittent treatment
729241|NCT01073618|voriconazole|voriconazole
729242|NCT01073618|Korea|korea
729243|NCT01073618|invasive fungal infection|invasive fungal infection
729244|NCT01073631|voriconazole|voriconazole
729245|NCT01073631|Korea|korea
729246|NCT01073631|invasive fungal infection|invasive fungal infection
729247|NCT01073644|imatinib resistant or intolerant|imatinib resistant or intolerant
729248|NCT01073657|Rehabilitation|rehabilitation
729249|NCT01073670|NSAIDs|nsaids
729250|NCT01073670|bleeding|bleeding
729251|NCT01073670|thromboelastography|thromboelastography
729252|NCT01073670|cardiac surgery|cardiac surgery
729253|NCT01073670|Indomethacin|indomethacin
729254|NCT01073670|acetaminophen|acetaminophen
729255|NCT01073683|TPF|tpf
729256|NCT01073683|INDUCTION CHEMOTHERAPY|induction chemotherapy
729257|NCT01073683|LARYNX PRESERVATION|larynx preservation
729258|NCT01073683|SUPACRICOID LARYNGECTOMY|supacricoid laryngectomy
729259|NCT01073683|Stage 3 and 4 larynx cancer|stage 3 and 4 larynx cancer
729260|NCT01073696|Sancuso|sancuso
729261|NCT01073696|granisetron|granisetron
729262|NCT01073696|Pharmacokinetics|pharmacokinetics
729263|NCT01073709|Acetaminophen fasting study|acetaminophen fasting study
729264|NCT01073722|thoracic surgery|thoracic surgery
729265|NCT01073722|one-lung ventilation|one-lung ventilation
729266|NCT01073722|double lumen tube|double lumen tube
729267|NCT01073722|endobronchial blocker|endobronchial blocker
729268|NCT01073735|Needs assessment|needs assessment
729269|NCT01073735|Health-related needs|health-related needs
729270|NCT01073735|Childhood cancer survivors|childhood cancer survivors
729271|NCT01073748|Asthma|asthma
729272|NCT01073748|Acetaminophen|acetaminophen
729273|NCT01073748|paracetamol|paracetamol
729274|NCT01073748|FeNO|feno
729275|NCT01073748|Spirometry|spirometry
729276|NCT01073748|Lung function|lung function
729277|NCT01073774|breast cancer couples coping|breast cancer couples coping
729278|NCT01073787|migraine|migraine
729279|NCT01073787|headache|headache
729280|NCT01073787|pediatric|pediatric
729281|NCT01073787|children|children
729282|NCT01073787|Emergency Department|emergency department
729283|NCT01073800|atorvastatin|atorvastatin
729284|NCT01073800|vascular occlusion|vascular occlusion
729285|NCT01073800|myocardial infarction|myocardial infarction
729286|NCT01073800|stroke|stroke
729287|NCT01073800|renal failure|renal failure
729288|NCT01073800|critically ill|critically ill
729289|NCT01073800|Vascular occlusive events among the critically ill|vascular occlusive events among the critically ill
729290|NCT01073813|Minocycline|minocycline
729291|NCT01073813|Retinal nerve fibre layer thickness|retinal nerve fibre layer thickness
729292|NCT01073813|Macular volume|macular volume
729293|NCT01073813|Visual outcomes|visual outcomes
729294|NCT01073852|Chronic Urticaria|chronic urticaria
729295|NCT01073852|Hives|hives
729296|NCT01073852|Hydroxychloroquine|hydroxychloroquine
729297|NCT01073865|ZOLADEX|zoladex
729298|NCT01073865|Pre-menopausal|pre-menopausal
729299|NCT01073865|Oestrogen Receptor|oestrogen receptor
729300|NCT01073865|Advanced Breast Cancer|advanced breast cancer
729301|NCT01073865|Progression Free Survival|progression free survival
729302|NCT01073878|Urinary Urge Incontinence|urinary urge incontinence
729303|NCT01073878|Urinary Stress Incontinence|urinary stress incontinence
729304|NCT01073878|Urinary Mixed Incontinence|urinary mixed incontinence
729305|NCT01073891|Pharmacokinetics|pharmacokinetics
729306|NCT01073891|Bioavailability|bioavailability
729307|NCT01073891|Food effect|food effect
729308|NCT01073891|Oral liquid formulation|oral liquid formulation
729309|NCT01087528|Colonic Diseases|colonic diseases
729310|NCT01087528|bowel diseases|bowel diseases
729311|NCT01087528|large bowel diseases|large bowel diseases
729312|NCT01087541|Patient's Safety|patient's safety
729313|NCT01087541|Diabetes mellitus|diabetes mellitus
729314|NCT01087541|Public Health for professionals|public health for professionals
729315|NCT01087541|Safety|safety
729316|NCT01087541|Public health|public health
729317|NCT01087554|Advanced Cancer|advanced cancer
729318|NCT01087554|Sirolimus|sirolimus
729319|NCT01087554|Rapamune|rapamune
729320|NCT01087554|mTOR Inhibitor|mtor inhibitor
729321|NCT01087554|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
729322|NCT01087554|Vorinostat|vorinostat
729323|NCT01087554|SAHA|saha
729324|NCT01087554|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
729325|NCT01087554|MSK-390|msk-390
729327|NCT01087554|Everolimus|everolimus
729328|NCT01087554|Afinitor|afinitor
729329|NCT01087554|Zortress|zortress
729330|NCT01087554|RAD001|rad001
729331|NCT01087554|Temsirolimus|temsirolimus
729332|NCT01087554|CCI-779|cci-779
729333|NCT01087554|Torisel|torisel
729334|NCT01087567|diabetes|diabetes
729335|NCT01087567|insulin|insulin
729336|NCT01087567|rescue therapy|rescue therapy
729337|NCT01087580|Prostate Cancer|prostate cancer
729338|NCT01087580|non metastatic prostate cancer|non metastatic prostate cancer
729339|NCT01087580|oligometastatic prostate cancer|oligometastatic prostate cancer
729340|NCT01087593|estrogen|estrogen
729341|NCT01087593|substitution|substitution
729342|NCT01087593|pain|pain
729343|NCT01087593|hormonal levels|hormonal levels
729344|NCT01087593|quantitative sensory testing|quantitative sensory testing
729345|NCT01087619|Hyperparathyroidism, primary|hyperparathyroidism, primary
729346|NCT01087619|Aged 66 years or older|aged 66 years or older
729347|NCT01087619|Mild hypercalcaemia|mild hypercalcaemia
729348|NCT01087619|Surgical Procedures, Elective|surgical procedures, elective
729349|NCT01087619|Indication|indication
729350|NCT01087619|Osteoporosis|osteoporosis
729351|NCT01087619|Cognitive function|cognitive function
729352|NCT01087619|Atherosclerosis|atherosclerosis
729353|NCT01087619|Follow-up|follow-up
729354|NCT01087619|Randomized trial|randomized trial
729355|NCT01087632|Metabolic Syndrome Insulin-resistance Endothelial Function|metabolic syndrome insulin-resistance endothelial function
729356|NCT01087684|Glaucoma|glaucoma
729357|NCT01087684|laser trabeculoplasty|laser trabeculoplasty
729358|NCT01087684|intraocular pressure|intraocular pressure
729359|NCT01087697|bladder cancer|bladder cancer
729360|NCT01087697|radical cystectomy|radical cystectomy
729361|NCT01087697|incontinent urinary diversion|incontinent urinary diversion
729362|NCT01087723|EUROMAX|euromax
729363|NCT01087723|STEMI|stemi
729364|NCT01087723|STE-ACS|ste-acs
729365|NCT01087723|UFH|ufh
729366|NCT01087723|bivalirudin|bivalirudin
729367|NCT01087723|PCI|pci
729368|NCT01087723|ambulance study|ambulance study
729369|NCT01087723|STE-MI participants|ste-mi participants
729370|NCT01087736|PTSD|ptsd
729371|NCT01087736|Alcohol abuse|alcohol abuse
729372|NCT01087736|Alcoholism|alcoholism
729373|NCT01087736|Topiramate|topiramate
729374|NCT01087736|Stress Disorder, Post Traumatic|stress disorder, post traumatic
729375|NCT01087736|Chronic Post-Traumatic Stress Disorder|chronic post-traumatic stress disorder
729376|NCT01087762|Certolizumab Pegol|certolizumab pegol
729377|NCT01087762|Cimzia|cimzia
729378|NCT01087788|Certolizumab Pegol|certolizumab pegol
729379|NCT01087788|Cimzia|cimzia
729380|NCT01087801|Genetic End Marker|genetic end marker
729381|NCT01087814|efavirenz|efavirenz
729382|NCT01087814|Sustiva|sustiva
729383|NCT01087814|pharmacokinetics|pharmacokinetics
729384|NCT01087827|oscillometric blood pressure|oscillometric blood pressure
729385|NCT01087827|cuff site|cuff site
729386|NCT01087827|forearm blood pressure|forearm blood pressure
729387|NCT01087827|upper arm blood pressure|upper arm blood pressure
729388|NCT01087827|anthropometric measurements|anthropometric measurements
729389|NCT01087827|tonometry|tonometry
729390|NCT01087827|site of blood pressure measurement|site of blood pressure measurement
729391|NCT01087827|measurement accuracy|measurement accuracy
729392|NCT01087840|HIV|hiv
729393|NCT01087840|nonoccupational|nonoccupational
729394|NCT01087840|postexposure|postexposure
729395|NCT01087840|prophylaxis|prophylaxis
729396|NCT01087840|HIV Seronegativity|hiv seronegativity
729397|NCT01087853|Fluid Therapy|fluid therapy
729398|NCT01087853|Water Electrolyte Imbalance|water electrolyte imbalance
729399|NCT01087853|Acid Base Imbalance|acid base imbalance
729400|NCT01087853|Renal Circulation|renal circulation
729401|NCT01087853|Magnetic Resonance Imaging|magnetic resonance imaging
729402|NCT01087866|Gestational diabetes mellitus|gestational diabetes mellitus
729406|NCT01088620|Stage IIIb or IV|stage iiib or iv
729407|NCT01088620|Nonsquamous|nonsquamous
729408|NCT01088620|KRAS-Wildtype|kras-wildtype
729409|NCT01088633|COPD|copd
729410|NCT01088646|capsule endoscopy|capsule endoscopy
729411|NCT01088646|small bowel disease|small bowel disease
729412|NCT01088646|inflammatory bowel disease|inflammatory bowel disease
729413|NCT01088646|Subjects indicated for EGD endoscopy|subjects indicated for egd endoscopy
729414|NCT01088672|Stroke|stroke
729415|NCT01088672|Ischemic|ischemic
729416|NCT01088672|Thrombus|thrombus
729417|NCT01088672|Embolectomy|embolectomy
729418|NCT01088672|Thrombectomy|thrombectomy
729419|NCT01088672|Concentric|concentric
729420|NCT01088672|Embolus|embolus
729421|NCT01088672|Mechanical|mechanical
729422|NCT01088672|Trevo|trevo
729423|NCT01088698|psoriasis|psoriasis
729424|NCT01088698|golimumab|golimumab
729425|NCT01088698|TNF-alpha inhibition|tnf-alpha inhibition
729908|NCT01090752|diabetes|diabetes
729426|NCT01088698|phototherapy|phototherapy
729427|NCT01088698|311-nm|311-nm
729428|NCT01088711|Type 2 diabetes (T2D)|type 2 diabetes (t2d)
729429|NCT01088737|Lentigo maligna|lentigo maligna
729430|NCT01088737|melanoma|melanoma
729431|NCT01088737|imiquimod|imiquimod
729432|NCT01088737|prevention|prevention
729433|NCT01088750|childhood nodular lymphocyte predominant Hodgkin lymphoma|childhood nodular lymphocyte predominant hodgkin lymphoma
729434|NCT01088750|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
729435|NCT01088750|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
729437|NCT01088776|hypertriglyceridemia|hypertriglyceridemia
729438|NCT01088776|Fatty Acid Supplementation|fatty acid supplementation
729439|NCT01088776|Children|children
729440|NCT01088776|Omega-3|omega-3
729441|NCT01088789|Adenocarcinoma|adenocarcinoma
729442|NCT01088789|Cyclophosphamide|cyclophosphamide
729443|NCT01088789|Immunotherapy|immunotherapy
729444|NCT01088789|Neo-Adjuvant|neo-adjuvant
729445|NCT01088789|Pancreatic tumor vaccine|pancreatic tumor vaccine
729446|NCT01088789|GM-CSF|gm-csf
729447|NCT01088789|Randomize|randomize
729448|NCT01088802|Squamous Cell Carcinoma|squamous cell carcinoma
729449|NCT01088802|Oropharynx|oropharynx
729450|NCT01088815|Adenocarcinoma|adenocarcinoma
729451|NCT01088815|Hedgehog|hedgehog
729452|NCT01088815|Neoplasms|neoplasms
729453|NCT01088815|Digestive System Diseases|digestive system diseases
729454|NCT01088815|Neoplasms by Site|neoplasms by site
729455|NCT01088815|Digestive System Neoplasms|digestive system neoplasms
729456|NCT01088815|Neoplasms by Histologic Type|neoplasms by histologic type
729457|NCT01088815|Pancreatic Neoplasms|pancreatic neoplasms
729458|NCT01088815|Pancreatic Diseases|pancreatic diseases
729459|NCT01088815|Carcinoma|carcinoma
729460|NCT01088828|MRI, clubfoot, CTEV, Congenital Talipes Equinovarus|mri, clubfoot, ctev, congenital talipes equinovarus
729461|NCT01088867|Pain|pain
729462|NCT01088867|Acupuncture|acupuncture
729463|NCT01088867|DNIC|dnic
729464|NCT01088867|Electroacupuncture|electroacupuncture
729465|NCT01088880|Familial Mediterranean Fever|familial mediterranean fever
729466|NCT01088880|canakinumab|canakinumab
729467|NCT01088880|colchicine resistance|colchicine resistance
729468|NCT01088893|everolimus|everolimus
729469|NCT01088893|neoadjuvant|neoadjuvant
729470|NCT01088893|m-TOR inhibitor|m-tor inhibitor
729471|NCT01088906|Phalcis|phalcis
729472|NCT01088906|BRCA1|brca1
729473|NCT01088906|RAP80|rap80
729474|NCT01088906|TS|ts
729475|NCT01088906|First line|first line
729476|NCT01088906|Non-squamous|non-squamous
729477|NCT01088919|ASP1941|asp1941
729478|NCT01088919|Actos|actos
729479|NCT01088919|pioglitazone hydrochloride|pioglitazone hydrochloride
729480|NCT01088932|Safety in Healthy Volunteers|safety in healthy volunteers
729481|NCT01088945|Infant, Premature, Diseases|infant, premature, diseases
729482|NCT01088958|Kenya|kenya
729483|NCT01088958|Child Nutrition Disorders|child nutrition disorders
729484|NCT01088958|Social marketing|social marketing
729485|NCT01088997|Persistent pulmonary hypertension of newborn|persistent pulmonary hypertension of newborn
729486|NCT01088997|PPHN|pphn
729487|NCT01088997|Persistent pulmonary hypertension|persistent pulmonary hypertension
729488|NCT01088997|Pulmonary hypertension|pulmonary hypertension
729489|NCT01088997|Pulmonary hypertension of newborn|pulmonary hypertension of newborn
729490|NCT01089036|ECMO|ecmo
729491|NCT01089036|cardiogenic shock|cardiogenic shock
729492|NCT01089036|ROS|ros
729493|NCT01089036|GPx|gpx
729494|NCT01089036|cytokines|cytokines
729495|NCT01089049|Urinary Estrogen Metabolites|urinary estrogen metabolites
729496|NCT01089049|2-OH Estrone|2-oh estrone
729497|NCT01089049|16-alpha-OH Estrone|16-alpha-oh estrone
729498|NCT01089049|Urinary 2/16a Estrogen Metabolite Ratio|urinary 2/16a estrogen metabolite ratio
729499|NCT01089062|Healthy volunteers|healthy volunteers
729500|NCT01089075|neuropsychological effects of hydrocortisone replacement|neuropsychological effects of hydrocortisone replacement
729501|NCT01089088|recurrent urethral cancer|recurrent urethral cancer
729502|NCT01089088|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
729599|NCT01089400|acute respiratory distress syndrome|acute respiratory distress syndrome
729503|NCT01089088|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
729504|NCT01089088|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
729505|NCT01089088|posterior urethral cancer|posterior urethral cancer
729506|NCT01089088|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
729507|NCT01089088|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
729508|NCT01089088|stage IV bladder cancer|stage iv bladder cancer
729509|NCT01089088|recurrent bladder cancer|recurrent bladder cancer
729510|NCT01089088|anterior urethral cancer|anterior urethral cancer
729511|NCT01089114|Cardiac Imaging|cardiac imaging
729512|NCT01089114|MR Spectroscopy|mr spectroscopy
729513|NCT01089114|HIV|hiv
729514|NCT01089114|Lipid Metabolism|lipid metabolism
729515|NCT01089114|HIV Infection|hiv infection
729516|NCT01089114|Cardiovascular Disease|cardiovascular disease
729517|NCT01089114|HIV Infections|hiv infections
729518|NCT01089127|Indacaterol|indacaterol
729519|NCT01089127|COPD|copd
729520|NCT01089127|salmeterol|salmeterol
729521|NCT01089140|pediatrics|pediatrics
729522|NCT01089140|scoliosis|scoliosis
729523|NCT01089140|tranexamic acid|tranexamic acid
729524|NCT01089140|Investigating non-idiopathic scoliosis|investigating non-idiopathic scoliosis
729525|NCT01089153|human blood, urine and fecal samples|human blood, urine and fecal samples
729526|NCT01089218|bronchoscopy|bronchoscopy
729527|NCT01089218|post-bronchoscopy fever|post-bronchoscopy fever
729528|NCT01089218|pneumonia|pneumonia
729529|NCT01089218|cytokines|cytokines
729530|NCT01089218|amoxicillin/clavulanate|amoxicillin/clavulanate
729531|NCT01089218|prophylaxis|prophylaxis
729532|NCT01089231|Hyperlipidemia|hyperlipidemia
729533|NCT01089231|coronary heart disease|coronary heart disease
729534|NCT01089231|gene expression|gene expression
729535|NCT01089231|fish oil|fish oil
729536|NCT01089231|DHA, EPA|dha, epa
729537|NCT01089244|Low grade glioma|low grade glioma
729538|NCT01089244|Astrocytoma|astrocytoma
729539|NCT01089244|Molecular imaging|molecular imaging
729540|NCT01089244|FET PET|fet pet
729541|NCT01089244|Therapy monitoring|therapy monitoring
729542|NCT01089244|Temodar|temodar
729543|NCT01089257|Cardiovascular risks|cardiovascular risks
729544|NCT01089257|Oxidative stress|oxidative stress
729545|NCT01089257|Systemic inflammation|systemic inflammation
729546|NCT01089257|Endothelial function|endothelial function
729547|NCT01089257|Peripheral Arterial Tone|peripheral arterial tone
729548|NCT01089257|Positive Airway Pressure|positive airway pressure
729549|NCT01089270|Parkinson|parkinson
729550|NCT01089270|fdg pet-ct|fdg pet-ct
729551|NCT01089270|i123 dat scan|i123 dat scan
729552|NCT01089270|first degree relatives of diagnosed Parkinson patients|first degree relatives of diagnosed parkinson patients
729553|NCT01089270|with no clinical evidence of movement disorders|with no clinical evidence of movement disorders
729554|NCT01089283|parkinson|parkinson
729555|NCT01089283|fdg pet-ct|fdg pet-ct
729556|NCT01089283|i123 dat scan|i123 dat scan
729557|NCT01089283|LRRK2|lrrk2
729559|NCT01089283|parkinson patients with known genetic characteristic|parkinson patients with known genetic characteristic
729560|NCT01089296|Infants born preterm|infants born preterm
729561|NCT01089296|Early physiotherapy intervention|early physiotherapy intervention
729562|NCT01089296|Motor development|motor development
729563|NCT01089296|Parental participation|parental participation
729564|NCT01089296|Parental competency|parental competency
729565|NCT01089309|Aldosterone Blockade|aldosterone blockade
729566|NCT01089309|Arterial elasticity|arterial elasticity
729567|NCT01089309|Glycemic control|glycemic control
729568|NCT01089322|SEVERE ASTHMA|severe asthma
729569|NCT01089322|RISK FACTORS|risk factors
729570|NCT01089322|CHARACTERIZATION|characterization
729571|NCT01089322|CLINICAL CONTROL|clinical control
729572|NCT01089322|INFLAMMATORY MARKERS|inflammatory markers
729573|NCT01089322|SEVERE|severe
729574|NCT01089322|CONTROL|control
729575|NCT01089335|Sentinel node|sentinel node
729576|NCT01089335|Thyroid cancer|thyroid cancer
729577|NCT01089335|Thyroid neoplasia|thyroid neoplasia
729578|NCT01089335|Follicular neoplasia|follicular neoplasia
729579|NCT01089348|Vaginosis, Bacterial|vaginosis, bacterial
729580|NCT01089348|Prebiotics|prebiotics
729581|NCT01089348|Lactofiltrum|lactofiltrum
729582|NCT01089348|Therapy|therapy
729583|NCT01089361|systemic inflammatory syndrome|systemic inflammatory syndrome
729584|NCT01089361|sepsis syndrome|sepsis syndrome
729585|NCT01089361|septic shock|septic shock
729586|NCT01089361|Cytokine|cytokine
729587|NCT01089361|Ketamine|ketamine
729588|NCT01089374|Phyllodes|phyllodes
729589|NCT01089387|radical prostatectomy|radical prostatectomy
729590|NCT01089400|influenza|influenza
729591|NCT01089400|H1N1|h1n1
729592|NCT01089400|lymphocytes|lymphocytes
729593|NCT01089400|T cell|t cell
729595|NCT01089400|CD8|cd8
729596|NCT01089400|cytokine|cytokine
729597|NCT01089400|serology|serology
729598|NCT01089400|broncho-alveolar lavage|broncho-alveolar lavage
729600|NCT01089400|ventilation|ventilation
729601|NCT01089400|intensive care unit|intensive care unit
729602|NCT01089426|Pediatric patients with Parenteral Nutrition (PN) induced Liver Injury|pediatric patients with parenteral nutrition (pn) induced liver injury
729603|NCT01089439|Nitric oxide|nitric oxide
729604|NCT01089452|Mild to moderate hypertension|mild to moderate hypertension
729605|NCT01089465|Bed bugs|bed bugs
729607|NCT01089465|insects|insects
729608|NCT01089465|bites|bites
729609|NCT01089478|Back pain|back pain
729610|NCT01089478|Low back pain|low back pain
729611|NCT01089478|Cytology|cytology
729612|NCT01089478|Epiduroscopy|epiduroscopy
729613|NCT01089478|Pain|pain
729614|NCT01089478|Radiculopathy|radiculopathy
729615|NCT01089491|Low back pain|low back pain
729616|NCT01089491|Epiduroscopy|epiduroscopy
729617|NCT01089491|Cytology|cytology
729618|NCT01089491|Electrical stimulation|electrical stimulation
729619|NCT01089504|phenobarbital|phenobarbital
729621|NCT01089504|antiepileptic drugs|antiepileptic drugs
729622|NCT01089504|neurodevelopmental outcome|neurodevelopmental outcome
729623|NCT01089504|seizure|seizure
729624|NCT01089530|Fibrinogen|fibrinogen
729625|NCT01089530|Cholesterol|cholesterol
729626|NCT01089530|Cardiovascular risk factors|cardiovascular risk factors
729627|NCT01089530|Primary prevention|primary prevention
729728|NCT01089933|Analgesia|analgesia
729628|NCT01089530|High levels fibrinogen|high levels fibrinogen
729629|NCT01089530|High plasma fibrinogen|high plasma fibrinogen
729630|NCT01089543|dyspepsia|dyspepsia
729631|NCT01089543|rabeprazole|rabeprazole
729632|NCT01089543|Japan|japan
729633|NCT01089569|diabetes|diabetes
729634|NCT01089569|continuous glucose monitoring|continuous glucose monitoring
729635|NCT01089569|exenatide|exenatide
729636|NCT01089569|insulin glargine|insulin glargine
729637|NCT01089582|non-interventional|non-interventional
729638|NCT01089582|mild to moderate Alzheimer's|mild to moderate alzheimer's
729639|NCT01089582|ARICEPT.|aricept.
729640|NCT01089595|Imatinib Resistance|imatinib resistance
729641|NCT01089595|GIST|gist
729642|NCT01089595|Advanced Disease|advanced disease
729643|NCT01089595|Nilotinib|nilotinib
729644|NCT01089608|Azyter in patients affected by chronic blepharitis.|azyter in patients affected by chronic blepharitis.
729645|NCT01089634|LV measurement|lv measurement
729646|NCT01089634|CRT|crt
729647|NCT01089634|Concerto|concerto
729648|NCT01089634|LVCM|lvcm
729649|NCT01089634|LV threshold|lv threshold
729650|NCT01089634|new CRT|new crt
729651|NCT01089647|OSA|osa
729652|NCT01089647|Medical treatment|medical treatment
729653|NCT01089660|Influenza|influenza
729654|NCT01089660|Pandemic Flu|pandemic flu
729655|NCT01089660|Swine-origin Influenza|swine-origin influenza
729656|NCT01089660|Inactivated split-virion vaccine|inactivated split-virion vaccine
729657|NCT01089673|retrospective data collection|retrospective data collection
729658|NCT01089686|Chronic Cerebrospinal Venous Insufficiency|chronic cerebrospinal venous insufficiency
729659|NCT01089699|breast cancer|breast cancer
729660|NCT01089699|support groups|support groups
729661|NCT01089699|Primary diagnosis of breast cancer within the past three years.|primary diagnosis of breast cancer within the past three years.
729662|NCT01089712|Infection|infection
729663|NCT01089712|Cardiac Surgery|cardiac surgery
729664|NCT01089712|Post Operative Cardiac Surgery Infection|post operative cardiac surgery infection
729665|NCT01089712|Management Practices|management practices
729666|NCT01089725|safety|safety
729667|NCT01089725|efficacy|efficacy
729668|NCT01089725|parallel group|parallel group
729669|NCT01089725|double-blind|double-blind
729670|NCT01089725|multicenter|multicenter
729671|NCT01089725|injection|injection
729672|NCT01089725|infusion|infusion
729673|NCT01089725|osteoarthritis|osteoarthritis
729674|NCT01089725|bridging|bridging
729675|NCT01089725|subcutaneous|subcutaneous
729676|NCT01089725|intravenous|intravenous
729677|NCT01089725|tanezumab|tanezumab
729678|NCT01089738|mulitple dose|mulitple dose
729679|NCT01089738|pharmacokinetics|pharmacokinetics
729680|NCT01089738|safety|safety
729681|NCT01089738|healthy elderly volunteers|healthy elderly volunteers
729682|NCT01089764|breast neoplasm|breast neoplasm
729683|NCT01089764|breast cancer|breast cancer
729684|NCT01089764|behavioral intervention|behavioral intervention
729685|NCT01089764|online support|online support
729686|NCT01089764|relationship distress|relationship distress
729687|NCT01089764|dyadic coping|dyadic coping
729688|NCT01089803|laryngectomy|laryngectomy
729689|NCT01089803|larynx|larynx
729690|NCT01089803|hypopharynx|hypopharynx
729691|NCT01089816|Influenza infections|influenza infections
729692|NCT01089816|Orthomyxoviridae infections|orthomyxoviridae infections
729693|NCT01089816|Influenza Human|influenza human
729694|NCT01089829|CKD|ckd
729695|NCT01089829|Foot Ulceration|foot ulceration
729696|NCT01089829|Diabetes|diabetes
729697|NCT01089842|Secondary Prevention|secondary prevention
729698|NCT01089842|Health Promotion|health promotion
729699|NCT01089842|Behavioral Medicine|behavioral medicine
729700|NCT01089842|Exercise Therapy|exercise therapy
729701|NCT01089855|Neuropathic Pain|neuropathic pain
729702|NCT01089855|Brief Pain Inventory|brief pain inventory
729703|NCT01089855|DN4 questionnaire|dn4 questionnaire
729704|NCT01089855|ElectroCardioGram|electrocardiogram
729705|NCT01089868|Glioblastoma multiforme|glioblastoma multiforme
729706|NCT01089868|Microsurgery|microsurgery
729707|NCT01089868|Stereotactic biopsy|stereotactic biopsy
729708|NCT01089868|Radiochemotherapy|radiochemotherapy
729709|NCT01089868|Temodar|temodar
729710|NCT01089868|FET PET|fet pet
729711|NCT01089868|Molecular imaging|molecular imaging
729712|NCT01089881|prostate cancer|prostate cancer
729713|NCT01089881|18F-fluorocholine|18f-fluorocholine
729714|NCT01089881|PET|pet
729715|NCT01089881|recurrence|recurrence
729716|NCT01089881|metastases|metastases
729717|NCT01089894|18F-FLT|18f-flt
729718|NCT01089894|PET|pet
729719|NCT01089894|non-small cell lung cancer|non-small cell lung cancer
729720|NCT01089894|cell proliferation|cell proliferation
729721|NCT01089894|therapeutic response|therapeutic response
729907|NCT01090739|Surgical mesh|surgical mesh
729722|NCT01089894|18F-3'-fluoro-3'-deoxy-L-thymidine (18F-FLT)|18f-3'-fluoro-3'-deoxy-l-thymidine (18f-flt)
729723|NCT01089907|genomic|genomic
729724|NCT01089907|childhood|childhood
729725|NCT01089907|acute lymphoblastic leukemia|acute lymphoblastic leukemia
729726|NCT01089933|Anesthesia|anesthesia
729727|NCT01089933|Local Anesthetics|local anesthetics
729729|NCT01089933|Quality of life|quality of life
729730|NCT01089933|Paravertebral blocks|paravertebral blocks
729731|NCT01089933|Arm morbidity|arm morbidity
729732|NCT01089946|Mobilization|mobilization
729733|NCT01089946|Hip arthroplasty|hip arthroplasty
729734|NCT01089946|cardiovascular|cardiovascular
729735|NCT01089959|Acid re-flux,GERD|acid re-flux,gerd
729736|NCT01089959|sleep related arousals due to GERD|sleep related arousals due to gerd
729737|NCT01089959|Treatment of acid reflux during sleep in patients with GERD.|treatment of acid reflux during sleep in patients with gerd.
729738|NCT01089972|radial artery|radial artery
729739|NCT01089972|ulnar artery|ulnar artery
729740|NCT01089972|catheterization|catheterization
729741|NCT01089972|regional blood flow|regional blood flow
729742|NCT01089998|Neoplasm|neoplasm
729743|NCT01089998|PET/CT diagnosis|pet/ct diagnosis
729744|NCT01089998|PET tracer|pet tracer
729745|NCT01089998|Inflammation|inflammation
729746|NCT01090037|ESRD|esrd
729747|NCT01090037|Chronic Renal Failure|chronic renal failure
729748|NCT01090037|Prostaglandin|prostaglandin
729749|NCT01090037|Prostacyclin|prostacyclin
729750|NCT01090037|Asian Multinational Study|asian multinational study
729751|NCT01090050|Chronic Migraine|chronic migraine
729752|NCT01090050|Migraine|migraine
729753|NCT01090050|Treximet|treximet
729754|NCT01090050|naproxen|naproxen
729755|NCT01090050|sumatriptan|sumatriptan
729756|NCT01090063|Palmar Plantar Psoriasis|palmar plantar psoriasis
729757|NCT01090076|Pressure Ulcer Wound|pressure ulcer wound
729758|NCT01090076|Specialized Amino Acid Mixture|specialized amino acid mixture
729759|NCT01090141|Micafungin|micafungin
729760|NCT01090141|Body Weight|body weight
729761|NCT01090141|Anti-Infective Agents|anti-infective agents
729762|NCT01090141|Signs and Symptoms|signs and symptoms
729763|NCT01090141|Mycoses|mycoses
729764|NCT01090141|Therapeutic Uses|therapeutic uses
729765|NCT01090141|Antifungal Agents|antifungal agents
729766|NCT01090141|Overnutrition|overnutrition
729767|NCT01090141|Pharmacologic Actions|pharmacologic actions
729768|NCT01090154|Ulcerative colitis|ulcerative colitis
729769|NCT01090154|UC|uc
729770|NCT01090154|Inflammatory Bowel Disease|inflammatory bowel disease
729771|NCT01090180|PTSD|ptsd
729772|NCT01090180|combat|combat
729773|NCT01090180|stress disorders|stress disorders
729774|NCT01090180|veteran|veteran
729775|NCT01090193|Obstructive jaundice|obstructive jaundice
729776|NCT01090193|kidney histopathology|kidney histopathology
729777|NCT01090193|lactulose|lactulose
729778|NCT01090206|Hemophilia|hemophilia
729779|NCT01090206|Vitamin D|vitamin d
729780|NCT01090219|Inguinal Hernia|inguinal hernia
729781|NCT01090219|contraction of two different meshes in the repair of inguinal hernias in men|contraction of two different meshes in the repair of inguinal hernias in men
729782|NCT01090245|contingency management|contingency management
729783|NCT01090245|substance abuse treatment|substance abuse treatment
729784|NCT01090245|criminal justice populations|criminal justice populations
729785|NCT01090245|substance abuse treatment retention|substance abuse treatment retention
729786|NCT01090245|HIV prevention in criminal justice settings|hiv prevention in criminal justice settings
729787|NCT01090245|voucher based reinforcement therapy|voucher based reinforcement therapy
729788|NCT01090245|Parole treatment admission for substance abusing parolees|parole treatment admission for substance abusing parolees
729789|NCT01090245|Parole treatment retention for substance abusing parolees|parole treatment retention for substance abusing parolees
729790|NCT01090245|HIV testing and counseling for substance abusing parolees|hiv testing and counseling for substance abusing parolees
729791|NCT01090258|cardiac surgery|cardiac surgery
729792|NCT01090258|mechanical ventilation|mechanical ventilation
729793|NCT01090258|automation|automation
729794|NCT01090258|weaning|weaning
729795|NCT01090271|Subacromial impingement syndrome|subacromial impingement syndrome
729886|NCT01090648|Etravirine|etravirine
729796|NCT01090271|Muscle Strength|muscle strength
729797|NCT01090271|Resistance Training|resistance training
729798|NCT01090284|Inguinal hernia|inguinal hernia
729799|NCT01090284|Immune system|immune system
729800|NCT01090284|Cytokines|cytokines
729801|NCT01090284|Prosthetic repair|prosthetic repair
729802|NCT01090284|Oxidative Stress|oxidative stress
729803|NCT01090297|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
729804|NCT01090297|Blood pressure|blood pressure
729805|NCT01090297|Continuous Positive Airway Pressure|continuous positive airway pressure
729806|NCT01090310|Quiescent uveitis|quiescent uveitis
729807|NCT01090310|intermediate uveitis|intermediate uveitis
729808|NCT01090310|panuveitis|panuveitis
729809|NCT01090310|posterior uveitis|posterior uveitis
729810|NCT01090310|uveitis|uveitis
729811|NCT01090310|NVS Definition: Words or phrases that best describe the protocol. Keywords help users find studies in the database.|nvs definition: words or phrases that best describe the protocol. keywords help users find studies in the database.
729812|NCT01090310|Avoid acronyms, abbreviations and trade names.|avoid acronyms, abbreviations and trade names.
729813|NCT01090310|Examples: Heart failure, aliskiren, heart attack, cardiovascular diseases|examples: heart failure, aliskiren, heart attack, cardiovascular diseases
729814|NCT01090310|Psoriasis, inflammatory skin disease, scaly patches|psoriasis, inflammatory skin disease, scaly patches
729815|NCT01090323|Deferasirox|deferasirox
729817|NCT01090323|Iron chelators|iron chelators
729818|NCT01090323|Sickle Cell Disease|sickle cell disease
729819|NCT01090323|Transfusional Hemosiderosis|transfusional hemosiderosis
729820|NCT01090336|platelet aggregation inhibition|platelet aggregation inhibition
729821|NCT01090336|prasugrel|prasugrel
729822|NCT01090336|clopidogrel|clopidogrel
729824|NCT01090349|ICD, CRTD, Remote Care|icd, crtd, remote care
729825|NCT01090362|Atrial fibrillation|atrial fibrillation
729826|NCT01090362|Anticoagulation|anticoagulation
729827|NCT01090362|Stroke|stroke
729828|NCT01090362|Stroke prevention|stroke prevention
729829|NCT01090362|Health Economics|health economics
729830|NCT01090375|osteoarthritis|osteoarthritis
729831|NCT01090375|biochemical markers|biochemical markers
729832|NCT01090375|cartilage|cartilage
729833|NCT01090375|inflammation|inflammation
729834|NCT01090375|microdialysis|microdialysis
729835|NCT01090388|Cross-sectional survey|cross-sectional survey
729836|NCT01090388|Health-related quality of life|health-related quality of life
729837|NCT01090388|Symptom management|symptom management
729838|NCT01090414|Idelalisib|idelalisib
729839|NCT01090414|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
729840|NCT01090414|Non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
729841|NCT01090414|Phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
729842|NCT01090427|Ustekinumab|ustekinumab
729843|NCT01090427|Injection|injection
729844|NCT01090427|CNTO 1275|cnto 1275
729845|NCT01090427|Stelara|stelara
729846|NCT01090427|Pediatric psoriasis|pediatric psoriasis
729847|NCT01090427|Adolescents|adolescents
729848|NCT01090440|schizophrenia|schizophrenia
729849|NCT01090440|GSK1144814|gsk1144814
729850|NCT01090440|effect of food|effect of food
729851|NCT01090440|healthy subjects|healthy subjects
729852|NCT01090440|depressive disorder|depressive disorder
729853|NCT01090440|pharmacokinetics|pharmacokinetics
729854|NCT01090466|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
729855|NCT01090466|recurrent bladder cancer|recurrent bladder cancer
729856|NCT01090466|recurrent urethral cancer|recurrent urethral cancer
729857|NCT01090466|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
729858|NCT01090466|stage IV bladder cancer|stage iv bladder cancer
729859|NCT01090466|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
729860|NCT01090466|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
729861|NCT01090466|distal urethral cancer|distal urethral cancer
729862|NCT01090466|proximal urethral cancer|proximal urethral cancer
729863|NCT01090466|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
729864|NCT01090466|stage IV urethral cancer|stage iv urethral cancer
729865|NCT01090479|Surgical site infections|surgical site infections
729866|NCT01090479|Chlorhexidine|chlorhexidine
729867|NCT01090479|Shoulder surgery|shoulder surgery
729868|NCT01090492|Raynaud's phenomenon|raynaud's phenomenon
729869|NCT01090492|vasospasm|vasospasm
729870|NCT01090492|scleroderma|scleroderma
729871|NCT01090492|systemic sclerosis|systemic sclerosis
729872|NCT01090492|CREST|crest
729873|NCT01090492|phosphodiesterase inhibitor|phosphodiesterase inhibitor
729874|NCT01090544|COPD|copd
729875|NCT01090544|TNI|tni
729876|NCT01090544|PaCO2|paco2
729877|NCT01090583|Cytokines|cytokines
729878|NCT01090583|Pregnancy|pregnancy
729879|NCT01090583|Cesarean|cesarean
729880|NCT01090609|Coronary Stent|coronary stent
729881|NCT01090609|Cobalt-Chromium coronary stent|cobalt-chromium coronary stent
729882|NCT01090635|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
729883|NCT01090648|TMC125HIV1083|tmc125hiv1083
729884|NCT01090648|TMC125|tmc125
729885|NCT01090648|HIV|hiv
729888|NCT01090648|Intelence|intelence
729889|NCT01090648|HIV Infections|hiv infections
729890|NCT01090661|antisense|antisense
729891|NCT01090661|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
729892|NCT01090661|LDL (low density lipoprotein)|ldl (low density lipoprotein)
729893|NCT01090661|thorough QT|thorough qt
729894|NCT01090674|Diaphragmatic force|diaphragmatic force
729895|NCT01090674|mobility|mobility
729896|NCT01090687|breast cancer, CT scans, mammography|breast cancer, ct scans, mammography
729897|NCT01090700|TMC435-TiDP16-C112|tmc435-tidp16-c112
729898|NCT01090700|TMC435-C112|tmc435-c112
729899|NCT01090700|TMC435|tmc435
729901|NCT01090700|Hepatitis C|hepatitis c
729902|NCT01090739|Fecal incontinence|fecal incontinence
729903|NCT01090739|Accidental bowel leakage|accidental bowel leakage
729904|NCT01090739|Failure conservative therapy|failure conservative therapy
729905|NCT01090739|Women|women
729906|NCT01090739|Class III medical device|class iii medical device
729909|NCT01090752|blood pressure|blood pressure
729910|NCT01090752|pioglitazone|pioglitazone
729911|NCT01090752|sodium|sodium
729912|NCT01090752|insulin resistance, renal function, sodium, pioglitazone|insulin resistance, renal function, sodium, pioglitazone
729913|NCT01090765|Prostate|prostate
729914|NCT01090765|Tumor|tumor
729915|NCT01090765|Cancer|cancer
729916|NCT01090765|Hormone|hormone
729917|NCT01090765|Androgen|androgen
729918|NCT01090765|Prostate Cancer|prostate cancer
729919|NCT01090778|growth hormone deficiency|growth hormone deficiency
729920|NCT01090778|circadian variation|circadian variation
729921|NCT01090791|critically ill patient|critically ill patient
729922|NCT01090804|BreatheMAX breathing device|breathemax breathing device
729923|NCT01090804|Secretion clearance|secretion clearance
729924|NCT01090804|Ventilatory dependence|ventilatory dependence
729925|NCT01090804|Intubated patients|intubated patients
729926|NCT01090817|mesenchymal stromal cells|mesenchymal stromal cells
729927|NCT01090817|ileitis|ileitis
729928|NCT01090817|colitis|colitis
729929|NCT01090830|Non small cell lung cancer|non small cell lung cancer
729930|NCT01090830|Belinostat|belinostat
729931|NCT01090830|carboplatin|carboplatin
729932|NCT01090830|Paclitaxel|paclitaxel
729933|NCT01090830|Bevacizumab|bevacizumab
729934|NCT01090830|chemotherapy|chemotherapy
729935|NCT01090830|Maximum Tolerated Dose|maximum tolerated dose
729936|NCT01090830|Neoplasms, Pulmonary|neoplasms, pulmonary
729937|NCT01090830|Lung Cancer|lung cancer
729938|NCT01090830|Event Free Survival|event free survival
729939|NCT01090830|Disease free survival|disease free survival
729940|NCT01090830|Progression Free Survival|progression free survival
729941|NCT01090830|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
729942|NCT01090830|Treatment Efficacy|treatment efficacy
729943|NCT01090843|Obscure digestive bleeding (ODB)|obscure digestive bleeding (odb)
729944|NCT01090843|Chronic anaemia of unknown origin|chronic anaemia of unknown origin
729945|NCT01090843|Chronic diarrhoea|chronic diarrhoea
729946|NCT01090856|Bifurcations|bifurcations
729947|NCT01090856|Drug eluting-stents|drug eluting-stents
729948|NCT01090856|Provisional stenting|provisional stenting
729949|NCT01090882|Local anaesthetic|local anaesthetic
729950|NCT01090882|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
729951|NCT01090882|Pain scores|pain scores
729952|NCT01090882|Bupivocaine|bupivocaine
729953|NCT01090882|Day case surgery|day case surgery
729954|NCT01090895|Percutaneous Coronary Intervention|percutaneous coronary intervention
729955|NCT01090895|Vitamin C|vitamin c
729956|NCT01090895|Biomarkers|biomarkers
729957|NCT01090895|Magnetic Risonance|magnetic risonance
729958|NCT01090921|Multiple Myeloma|multiple myeloma
729959|NCT01090921|Bortezomib|bortezomib
729960|NCT01090921|Newly diagnosed|newly diagnosed
729961|NCT01090921|Newly diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
729962|NCT01090934|Diagnosis|diagnosis
729963|NCT01090934|Partial Epilepsy|partial epilepsy
729964|NCT01090973|relapsed|relapsed
729965|NCT01090973|refractory|refractory
729967|NCT01090973|chronic lymphocytic leukemia|chronic lymphocytic leukemia
729968|NCT01090973|MCL|mcl
729969|NCT01090973|mantle cell lymphoma|mantle cell lymphoma
729970|NCT01090986|Restrictive pulmonary disease with hypercapnic chronic respiratory failure.|restrictive pulmonary disease with hypercapnic chronic respiratory failure.
729971|NCT01090986|COPD patients who need NIV hypercapnic chronic respiratory failure.|copd patients who need niv hypercapnic chronic respiratory failure.
729972|NCT01090999|COPD|copd
729973|NCT01090999|Pulmonary Rehabilitation|pulmonary rehabilitation
729974|NCT01091025|Adults|adults
729975|NCT01091025|Cystic Fibrosis Related Diabetes|cystic fibrosis related diabetes
729976|NCT01091025|Screening|screening
729977|NCT01091025|Oral glucose tolerance test|oral glucose tolerance test
729978|NCT01091025|Royal Brompton & Harefield Foundation Trust|royal brompton & harefield foundation trust
729979|NCT01091038|Adverse drug events|adverse drug events
729980|NCT01091038|medical errors|medical errors
729981|NCT01091038|computerized physician order entry|computerized physician order entry
729982|NCT01091038|clinical decision support|clinical decision support
729983|NCT01091051|Ustekinumab, Palmo-Plantar, Pustular Psoriasis, Pustulosis|ustekinumab, palmo-plantar, pustular psoriasis, pustulosis
729984|NCT01091077|dietary supplement|dietary supplement
729985|NCT01076725|ProSeal LMA|proseal lma
729986|NCT01076725|standard insertion|standard insertion
729987|NCT01076725|rotational insertion|rotational insertion
729988|NCT01076777|Panic disorder|panic disorder
729989|NCT01076777|Physical exercise|physical exercise
729990|NCT01076777|Cognitive-behavioral therapy|cognitive-behavioral therapy
729991|NCT01076777|Manualized|manualized
729992|NCT01076790|Nociception|nociception
729993|NCT01076790|Dexmedetomidine|dexmedetomidine
729994|NCT01076790|Electroencephalogram|electroencephalogram
729995|NCT01076790|Electromyogram|electromyogram
729996|NCT01076790|Entropy Index|entropy index
729997|NCT01076790|Bispectral Index|bispectral index
729998|NCT01076790|Electrocardiogram|electrocardiogram
729999|NCT01076790|Plethysmogram|plethysmogram
730000|NCT01076790|Heart|heart
730001|NCT01076790|Heart rate|heart rate
730002|NCT01076790|Heart rate variability|heart rate variability
730004|NCT01076803|Malignant intestinal obstruction in inoperable patients|malignant intestinal obstruction in inoperable patients
730005|NCT01076816|Patients with single-organ failure in need of mechanical ventilation|patients with single-organ failure in need of mechanical ventilation
730006|NCT01076829|MDA|mda
730007|NCT01076829|Spice|spice
730008|NCT01076842|Diabetes|diabetes
730009|NCT01076868|vivax|vivax
730010|NCT01076868|malaria|malaria
730011|NCT01076868|relapse|relapse
730012|NCT01076894|pain|pain
730013|NCT01076894|thoracotomy|thoracotomy
730014|NCT01076894|pulmonary function|pulmonary function
730015|NCT01076894|epidural anesthesia|epidural anesthesia
730016|NCT01076894|intercostal nerve block|intercostal nerve block
730017|NCT01076907|colonoscopy|colonoscopy
730018|NCT01076907|polyps|polyps
730019|NCT01079000|asthma|asthma
730020|NCT01079000|exacerbation|exacerbation
730021|NCT01079000|emergency department|emergency department
730022|NCT01079000|relapse|relapse
730023|NCT01079026|biomarker|biomarker
730024|NCT01079026|epidural steroid|epidural steroid
730025|NCT01079026|radiculopathy|radiculopathy
730026|NCT01079026|hnp|hnp
730027|NCT01079052|Famotidine tablets fed study|famotidine tablets fed study
730028|NCT01079065|Famotidine tablets fasting study|famotidine tablets fasting study
730029|NCT01079078|Acetaminophen fed study|acetaminophen fed study
730030|NCT01079091|Liver failure|liver failure
730031|NCT01079091|Hepatic insufficiency|hepatic insufficiency
730032|NCT01079091|Liver Cirrhosis|liver cirrhosis
730033|NCT01079091|Artificial liver|artificial liver
730034|NCT01079091|Albumin dialysis|albumin dialysis
730035|NCT01079104|Liver failure|liver failure
730036|NCT01079104|Hepatic insufficiency|hepatic insufficiency
730037|NCT01079104|Artificial liver|artificial liver
730038|NCT01079104|Albumin dialysis|albumin dialysis
730039|NCT01079117|Opiate|opiate
730040|NCT01079117|Methadone|methadone
730041|NCT01079117|Slow Release Oral Morphine (SORM)|slow release oral morphine (sorm)
730042|NCT01079117|Sevre-Long™|sevre-long™
730043|NCT01079130|Indacaterol|indacaterol
730044|NCT01079130|asthma|asthma
730045|NCT01079130|salmeterol|salmeterol
730046|NCT01079143|De Novo renal transplantation|de novo renal transplantation
730047|NCT01079169|urinary tract infection|urinary tract infection
730048|NCT01079169|prevention|prevention
730049|NCT01079169|rehabilitation|rehabilitation
730050|NCT01079169|spinal cord injury|spinal cord injury
730051|NCT01079182|Daily practice|daily practice
730052|NCT01079182|Humira|humira
730053|NCT01079182|Efficacy|efficacy
730054|NCT01079182|Safety|safety
730055|NCT01079182|Ankylosing spondylitis|ankylosing spondylitis
730056|NCT01079195|Effectiveness and tolerability of Tarka|effectiveness and tolerability of tarka
730057|NCT01079195|Hypertensive patients|hypertensive patients
730058|NCT01079195|Diabetes mellitus|diabetes mellitus
730059|NCT01079195|Observational study|observational study
730060|NCT01079208|infant formula, synbiotics, probiotics, nutrition|infant formula, synbiotics, probiotics, nutrition
730061|NCT01079221|exercise|exercise
730062|NCT01079221|Knee extensor|knee extensor
730063|NCT01079247|Burn|burn
730064|NCT01079247|Transfusion|transfusion
730065|NCT01079247|blood|blood
730066|NCT01079247|hemoglobin|hemoglobin
730067|NCT01079260|Malnourished|malnourished
730068|NCT01079260|Elderly|elderly
730069|NCT01079260|Nutrition support|nutrition support
730070|NCT01079273|Influenza|influenza
730071|NCT01079273|Vaccines|vaccines
730072|NCT01079273|A/H1N1|a/h1n1
730073|NCT01079273|Influenza Vaccines|influenza vaccines
730074|NCT01079286|mTOR inhibition|mtor inhibition
730075|NCT01079286|advanced malignancies|advanced malignancies
730076|NCT01079286|pharmacokinetics|pharmacokinetics
730077|NCT01079286|Akt inhibition|akt inhibition
730078|NCT01079286|Advanced malignancies, including metastatic renal cell cancer|advanced malignancies, including metastatic renal cell cancer
730079|NCT01079299|venous ulcer|venous ulcer
730080|NCT01079299|secondary lymphedema|secondary lymphedema
730081|NCT01079299|chronic lower leg ulceration|chronic lower leg ulceration
730082|NCT01079312|ERCP|ercp
730083|NCT01079312|patient-controlled sedation|patient-controlled sedation
730084|NCT01079312|propofol|propofol
730085|NCT01079312|remifentanil|remifentanil
730086|NCT01079312|sedation level|sedation level
730087|NCT01079325|Diabetic neuropathy|diabetic neuropathy
730088|NCT01079325|Diabetes Type 1 or 2|diabetes type 1 or 2
730089|NCT01079325|Moderately severe sensorimotor diabetic polyneuropathy|moderately severe sensorimotor diabetic polyneuropathy
730090|NCT01079338|sensitivity to caffeine|sensitivity to caffeine
730091|NCT01079351|Epilepsy|epilepsy
730092|NCT01079351|Intravenous Carbamazepine|intravenous carbamazepine
730093|NCT01079351|Oral Carbamazepine|oral carbamazepine
730094|NCT01079377|Adolescents|adolescents
730095|NCT01079377|Bariatric Surgery|bariatric surgery
730096|NCT01079377|Psychological Symptoms|psychological symptoms
730097|NCT01079377|Cognitive Behavioral Therapy|cognitive behavioral therapy
730098|NCT01079377|Telemedicine|telemedicine
730099|NCT01079377|Longitudinal|longitudinal
730100|NCT01079390|acupuncture|acupuncture
730101|NCT01079390|osteoarthritis|osteoarthritis
730102|NCT01079390|fMRI|fmri
730103|NCT01079416|Esophageal Capsule Endoscopy, Screening|esophageal capsule endoscopy, screening
730104|NCT01079429|Monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
730105|NCT01079429|MGUS|mgus
730106|NCT01079429|Smoldering myeloma|smoldering myeloma
730107|NCT01079429|SMM|smm
730108|NCT01079429|Multiple myeloma|multiple myeloma
730109|NCT01079442|postoperative ileus after colonic resections|postoperative ileus after colonic resections
730110|NCT01079455|Coxarthrosis|coxarthrosis
730111|NCT01079455|Hip|hip
730112|NCT01079455|Infiltration|infiltration
730113|NCT01079455|Hyaluronic Acid|hyaluronic acid
730114|NCT01079455|Corticosterone|corticosterone
730115|NCT01079468|Transient cognitive decline following orthopaedic surgery|transient cognitive decline following orthopaedic surgery
730116|NCT01079481|Relapsed or Refractory Small Cell Lung Cancer|relapsed or refractory small cell lung cancer
730117|NCT01079481|Paclitaxel|paclitaxel
730118|NCT01079481|Everolimus|everolimus
730119|NCT01079494|Uncontrolled blood pressure|uncontrolled blood pressure
730120|NCT01079507|single nucleotide polymorphism|single nucleotide polymorphism
730121|NCT01079507|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
730122|NCT01079520|Cancer|cancer
730123|NCT01079520|Lung Cancer|lung cancer
730124|NCT01079520|Ultrasound|ultrasound
730125|NCT01079520|Surgery|surgery
730126|NCT01079533|Colorectal Neoplasms|colorectal neoplasms
730127|NCT01079533|Mass Screening|mass screening
730128|NCT01079533|Patient Compliance|patient compliance
731802|NCT01078467|HV|hv
730129|NCT01079533|Intervention Studies|intervention studies
730130|NCT01079533|Clinical Trial|clinical trial
730131|NCT01079546|HPV, Israel, Squamous cell carcinoma of head and neck|hpv, israel, squamous cell carcinoma of head and neck
730132|NCT01079559|total knee arthroplasty|total knee arthroplasty
730133|NCT01079559|infection|infection
730134|NCT01079559|antibiotic bone cement|antibiotic bone cement
730135|NCT01079572|osteoarthritis|osteoarthritis
730136|NCT01079572|arthroplasty|arthroplasty
730137|NCT01079572|web-based|web-based
730138|NCT01079572|electronic follow-up|electronic follow-up
730139|NCT01079598|IPV|ipv
730140|NCT01079598|RadioFrequency|radiofrequency
730141|NCT01079598|QOL|qol
730142|NCT01079624|Incretin hormones|incretin hormones
730143|NCT01079624|Glucose-insulinotropic peptide|glucose-insulinotropic peptide
730144|NCT01079624|Glucagon-like peptide-1|glucagon-like peptide-1
730145|NCT01079624|Gastric emptying|gastric emptying
730146|NCT01079624|Appetite|appetite
730147|NCT01079624|Glucose disposal|glucose disposal
730148|NCT01079624|Gut hormones|gut hormones
730149|NCT01079637|Sella and Barrete Stage 0 1 or 2|sella and barrete stage 0 1 or 2
730150|NCT01079650|children|children
730151|NCT01079689|basic science|basic science
730152|NCT01079689|healthy volunteers|healthy volunteers
730153|NCT01079715|Newborn|newborn
730154|NCT01079715|Retinal Diseases|retinal diseases
730155|NCT01079715|Angiogenesis Modulating Agents|angiogenesis modulating agents
730156|NCT01079715|Adrenergic beta-Antagonists|adrenergic beta-antagonists
730157|NCT01079728|ischemic stroke|ischemic stroke
730158|NCT01079728|stroke-associated pneumonia|stroke-associated pneumonia
730159|NCT01079728|prediction|prediction
730160|NCT01079728|immune and infection parameters|immune and infection parameters
730161|NCT01079741|Melanoma|melanoma
730162|NCT01079741|Skin Cancer|skin cancer
730163|NCT01079741|Adjuvant Therapy|adjuvant therapy
730164|NCT01079741|Oncogenesis|oncogenesis
730165|NCT01079741|LAGE|lage
730166|NCT01079741|Cancer Immunity|cancer immunity
730167|NCT01079741|Neoplasms|neoplasms
730168|NCT01079741|Immunogenicity|immunogenicity
730169|NCT01079741|Vaccine|vaccine
730170|NCT01079741|Immunotherapy|immunotherapy
730171|NCT01079754|Spinal morphine 0.05 mg|spinal morphine 0.05 mg
730172|NCT01079754|Spinal morphine|spinal morphine
730173|NCT01079767|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
730174|NCT01079767|advanced adult primary liver cancer|advanced adult primary liver cancer
730175|NCT01079767|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
730176|NCT01079767|recurrent adult primary liver cancer|recurrent adult primary liver cancer
730177|NCT01079780|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
730178|NCT01079780|recurrent colon cancer|recurrent colon cancer
730179|NCT01079780|signet ring adenocarcinoma of the colon|signet ring adenocarcinoma of the colon
730180|NCT01079780|stage III colon cancer|stage iii colon cancer
730181|NCT01079780|stage IV colon cancer|stage iv colon cancer
730182|NCT01079780|mucinous adenocarcinoma of the rectum|mucinous adenocarcinoma of the rectum
730183|NCT01079780|recurrent rectal cancer|recurrent rectal cancer
730184|NCT01079780|signet ring adenocarcinoma of the rectum|signet ring adenocarcinoma of the rectum
730185|NCT01079780|stage III rectal cancer|stage iii rectal cancer
730186|NCT01079780|stage IV rectal cancer|stage iv rectal cancer
730187|NCT01079793|adenocarcinoma of the prostate|adenocarcinoma of the prostate
730188|NCT01079793|stage III prostate cancer|stage iii prostate cancer
730189|NCT01079845|Diet|diet
730190|NCT01079845|Nutrition|nutrition
730191|NCT01079845|Adolescent|adolescent
730192|NCT01079845|Young Adult|young adult
730193|NCT01079845|Overweight|overweight
730194|NCT01079845|Obesity|obesity
730379|NCT01080742|Lodoz|lodoz
730195|NCT01079858|Meibomian Gland Dysfunction|meibomian gland dysfunction
730196|NCT01079858|Dry Eye|dry eye
730197|NCT01079871|Sjogren's Syndrome|sjogren's syndrome
730198|NCT01079871|Dry Eye|dry eye
730199|NCT01079897|Atopic dermatitis|atopic dermatitis
730200|NCT01079897|Ectoine|ectoine
730201|NCT01079897|Treatment|treatment
730202|NCT01079897|Atopiclair|atopiclair
730203|NCT01079897|Medical device|medical device
730204|NCT01079910|Plaque|plaque
730205|NCT01079910|Toothpaste|toothpaste
730206|NCT01079910|Gingivitis|gingivitis
730207|NCT01079923|healthy volunteers|healthy volunteers
730208|NCT01079923|healthy subjects|healthy subjects
730209|NCT01079923|vitamin D|vitamin d
730210|NCT01079923|cholecalciferol|cholecalciferol
730211|NCT01079923|vitamin D3|vitamin d3
730212|NCT01079923|total vitamin D|total vitamin d
730213|NCT01079936|Multiple Myeloma|multiple myeloma
730214|NCT01079936|Lenalidomide|lenalidomide
730215|NCT01079936|Revlimid|revlimid
730216|NCT01079936|Melphalan|melphalan
730217|NCT01079936|Alkeran|alkeran
730218|NCT01079936|Autologous stem cell transplantation|autologous stem cell transplantation
730219|NCT01079936|High-dose chemotherapy|high-dose chemotherapy
730220|NCT01079949|Infertility|infertility
730221|NCT01079949|Ovulation induction|ovulation induction
730222|NCT01079949|Luveris|luveris
730223|NCT01079949|Lutropin alfa|lutropin alfa
730224|NCT01079949|Controlled ovarian stimulation|controlled ovarian stimulation
730225|NCT01079949|Reproductive technologies, Assisted|reproductive technologies, assisted
730226|NCT01079962|Bisoprolol|bisoprolol
730227|NCT01079962|Atenolol|atenolol
730228|NCT01079962|Hypertension|hypertension
730229|NCT01079962|Blood pressure|blood pressure
730230|NCT01079975|Multiple sclerosis|multiple sclerosis
730231|NCT01079975|Depression|depression
730232|NCT01079988|Psoriasis|psoriasis
730233|NCT01079988|Discontinuation of efalizumab|discontinuation of efalizumab
730234|NCT01079988|Managing inflammatory recurrence|managing inflammatory recurrence
730235|NCT01080001|Multiple sclerosis|multiple sclerosis
730236|NCT01080001|Multiple sclerosis, Relapsing-remitting|multiple sclerosis, relapsing-remitting
730237|NCT01080001|Expanded Disability Status Scale|expanded disability status scale
730238|NCT01080001|Fatigue|fatigue
730239|NCT01080001|Hamilton Depression Inventory|hamilton depression inventory
730240|NCT01080001|Depression|depression
730241|NCT01080014|Relapsing-remitting multiple sclerosis (RRMS)|relapsing-remitting multiple sclerosis (rrms)
730242|NCT01080014|primary progressive multiple sclerosis (PPMS)|primary progressive multiple sclerosis (ppms)
730243|NCT01080014|secondary progressive multiple sclerosis (SPMS)|secondary progressive multiple sclerosis (spms)
730244|NCT01080014|Multiple Sclerosis Functional Composite (MSFC)|multiple sclerosis functional composite (msfc)
730245|NCT01080014|Expanded Disability Status Scale (EDSS)|expanded disability status scale (edss)
730246|NCT01080027|Multiple sclerosis|multiple sclerosis
730247|NCT01080027|Relapsing remitting|relapsing remitting
730248|NCT01080027|Rebif|rebif
730249|NCT01080040|Multiple Sclerosis, Relapsing Remitting|multiple sclerosis, relapsing remitting
730250|NCT01080040|Quality of life|quality of life
730251|NCT01080053|Multiple Sclerosis, Relapsing Remitting|multiple sclerosis, relapsing remitting
730252|NCT01080053|Sexual dysfunction|sexual dysfunction
730253|NCT01080066|Carcinoma|carcinoma
730254|NCT01080066|Squamous cell|squamous cell
730255|NCT01080066|Erbitux|erbitux
730256|NCT01080066|cetuximab|cetuximab
730257|NCT01080066|Head|head
730258|NCT01080066|Neck|neck
730259|NCT01080079|Onychomycosis|onychomycosis
730260|NCT01080092|smokers|smokers
730261|NCT01080105|Depression Prevention|depression prevention
730262|NCT01080105|Prevention|prevention
730263|NCT01080105|Major Depressive Disorder|major depressive disorder
730264|NCT01080105|Internet|internet
730265|NCT01080105|Technology Assisted|technology assisted
730266|NCT01080118|Teaching|teaching
730267|NCT01080118|Video Scope|video scope
730268|NCT01080118|Intubation|intubation
730269|NCT01080131|Frequent flares|frequent flares
730270|NCT01080131|Gout|gout
730271|NCT01080131|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
730272|NCT01080144|Cirrhosis|cirrhosis
730273|NCT01080144|TIPS (Transjugular intrahepatic portosystemic shunt)|tips (transjugular intrahepatic portosystemic shunt)
730274|NCT01080144|Encephalopathy|encephalopathy
730275|NCT01080157|Diabetes|diabetes
730276|NCT01080157|Diabetes Screening|diabetes screening
730277|NCT01080157|Experimental Medical Device|experimental medical device
730278|NCT01080170|Aromatase Inhibitor|aromatase inhibitor
730279|NCT01080170|Anastrazole|anastrazole
730280|NCT01080170|Arimidex|arimidex
730281|NCT01080170|Heart disease|heart disease
730282|NCT01080170|Lipids|lipids
730283|NCT01080170|Body composition|body composition
730284|NCT01080170|Breast cancer.|breast cancer.
730285|NCT01080183|Health-related quality of life|health-related quality of life
730286|NCT01080183|physical activity|physical activity
730287|NCT01080196|Falling risk|falling risk
730288|NCT01080196|muscle conditioning|muscle conditioning
730289|NCT01080196|whole muscle volume|whole muscle volume
730290|NCT01080196|isometric strength and concentric power|isometric strength and concentric power
730380|NCT01080742|Bisoprolol|bisoprolol
730291|NCT01080196|Incidence in falls following a 3 month multi-component fall reduction exercise program|incidence in falls following a 3 month multi-component fall reduction exercise program
730292|NCT01080222|VX-950|vx-950
730293|NCT01080235|quality improvement|quality improvement
730294|NCT01080235|geriatric care|geriatric care
730295|NCT01080235|residency training|residency training
730296|NCT01080248|Pancreas|pancreas
730297|NCT01080261|Atherosclerosis|atherosclerosis
730298|NCT01080261|Coronary Artery Disease|coronary artery disease
730299|NCT01080274|ergometry|ergometry
730300|NCT01080274|vitamin d|vitamin d
730301|NCT01080274|zinc|zinc
730302|NCT01080287|autonomic|autonomic
730303|NCT01080287|orthostatic|orthostatic
730304|NCT01080287|syncope|syncope
730306|NCT01080287|prevalence of autonomic dysfunction in migraineurs with orthostatic intolerance|prevalence of autonomic dysfunction in migraineurs with orthostatic intolerance
730307|NCT01080287|characterize autonomic findings utilizing neurocardiac testing, neurophysiological testing and skin biopsies to analyze autonomic fibers in the dermis|characterize autonomic findings utilizing neurocardiac testing, neurophysiological testing and skin biopsies to analyze autonomic fibers in the dermis
730308|NCT01080300|Hot Flushes|hot flushes
730309|NCT01080300|Vasomotor Symptoms|vasomotor symptoms
730310|NCT01080300|Menopausal Hot Flashes|menopausal hot flashes
730311|NCT01080326|ulcer repair surgery|ulcer repair surgery
730312|NCT01080326|transluminal omental patch|transluminal omental patch
730313|NCT01080339|insulin resistance|insulin resistance
730314|NCT01080339|cardiovascular risk|cardiovascular risk
730315|NCT01080339|physical activity|physical activity
730316|NCT01080339|child|child
730317|NCT01080352|Prostate cancer|prostate cancer
730318|NCT01080352|palliative care|palliative care
730319|NCT01080352|antioxidants|antioxidants
730320|NCT01080352|ascorbic acid|ascorbic acid
730321|NCT01080352|rna expression|rna expression
730322|NCT01080391|Multiple Myeloma|multiple myeloma
730323|NCT01080404|Obstructive sleep apnea|obstructive sleep apnea
730324|NCT01080404|Obesity|obesity
730325|NCT01080404|Metabolism|metabolism
730326|NCT01080404|Bariatric surgery|bariatric surgery
730327|NCT01080404|CPAP|cpap
730328|NCT01080417|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
730329|NCT01080430|vestibular|vestibular
730330|NCT01080430|vertigo|vertigo
730331|NCT01080430|rehabilitation|rehabilitation
730332|NCT01080430|rotation|rotation
730333|NCT01080430|balance|balance
730334|NCT01080443|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
730335|NCT01080456|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
730336|NCT01080469|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
730337|NCT01080482|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
730338|NCT01080495|left ventricular function|left ventricular function
730339|NCT01080495|radial strain|radial strain
730340|NCT01080495|fractional shortening|fractional shortening
730341|NCT01080495|fractional area change|fractional area change
730342|NCT01080508|pressure pattern|pressure pattern
730343|NCT01080508|esophageal and tracheal ventilation.|esophageal and tracheal ventilation.
730344|NCT01080508|esophageal intubation.|esophageal intubation.
730345|NCT01080534|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
730346|NCT01080560|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
730347|NCT01080573|Multiple sclerosis|multiple sclerosis
730348|NCT01080573|Rebif|rebif
730349|NCT01080573|Interferon beta-1a|interferon beta-1a
730350|NCT01080586|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
730351|NCT01080599|obturator nerve block in TURB|obturator nerve block in turb
730352|NCT01080612|pregabalin|pregabalin
730353|NCT01080612|pharmacokinetics|pharmacokinetics
730354|NCT01080612|bioavailability|bioavailability
730355|NCT01080625|postreperfusion syndrome|postreperfusion syndrome
730356|NCT01080625|phenylephrine|phenylephrine
730357|NCT01080625|epinephrine|epinephrine
730358|NCT01080625|liver transplantation|liver transplantation
730359|NCT01080638|abciximab|abciximab
730360|NCT01080638|Myocardial Infarction|myocardial infarction
730361|NCT01080638|angioplasty|angioplasty
730362|NCT01080638|Platelet|platelet
730363|NCT01080664|AS703569|as703569
730364|NCT01080664|Aurora Kinase Inhibitor|aurora kinase inhibitor
730365|NCT01080664|Haematological malignancies|haematological malignancies
730366|NCT01080690|endosonography, right side abdominal pain|endosonography, right side abdominal pain
730367|NCT01080690|Endosonography (diagnostic value in right side abdominal pain)|endosonography (diagnostic value in right side abdominal pain)
730368|NCT01080703|Lung Transplant|lung transplant
730369|NCT01080703|Quadriceps Strength|quadriceps strength
730370|NCT01080703|Quality of Life|quality of life
730371|NCT01080703|Patients with pulmonary disease awaiting lung transplant.|patients with pulmonary disease awaiting lung transplant.
730372|NCT01080729|Ovulation induction|ovulation induction
730373|NCT01080729|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
730374|NCT01080729|Multifollicular stimulation|multifollicular stimulation
730375|NCT01080729|Pregnancy|pregnancy
730376|NCT01080729|Sperm injections, intracytoplasmic|sperm injections, intracytoplasmic
730377|NCT01080729|Fertility|fertility
730378|NCT01080742|Hypertension|hypertension
730381|NCT01080742|Hydrochlorothiazide|hydrochlorothiazide
730382|NCT01080755|Adult Growth Hormone Deficiency|adult growth hormone deficiency
730383|NCT01080755|Pituitary|pituitary
730384|NCT01080755|Saizen|saizen
730385|NCT01080755|Somatropin|somatropin
730386|NCT01080755|Growth Hormone|growth hormone
730387|NCT01080768|Pedal edema|pedal edema
730388|NCT01080768|hypertension|hypertension
730389|NCT01080768|aliskiren|aliskiren
732768|NCT01082419|ARFI|arfi
730390|NCT01080768|amlodipine|amlodipine
730391|NCT01080781|Cardiomyopathy|cardiomyopathy
730392|NCT01080781|Ephrin-B1 expression|ephrin-b1 expression
730393|NCT01080781|cell-cell junctions|cell-cell junctions
730394|NCT01080781|heart rate variability|heart rate variability
730395|NCT01080781|right appendage|right appendage
730396|NCT01080794|Parkinson's Disease|parkinson's disease
730397|NCT01080794|Depression|depression
730398|NCT01080794|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
730399|NCT01080820|Healthy adult volunteers|healthy adult volunteers
730400|NCT01080820|Pharmacokinetics|pharmacokinetics
730402|NCT01080833|ERCP|ercp
730403|NCT01080833|Training|training
730404|NCT01080833|Trainees|trainees
730405|NCT01080846|Primary postpartum hemorrhage|primary postpartum hemorrhage
730407|NCT01080846|uterine atony|uterine atony
730408|NCT01080846|high fever|high fever
730409|NCT01080846|hyperpyrexia|hyperpyrexia
730410|NCT01080859|titanium|titanium
730411|NCT01080859|everolimus|everolimus
730413|NCT01080859|acute coronary syndrome|acute coronary syndrome
730414|NCT01080859|stent|stent
730415|NCT01080859|pci|pci
730416|NCT01080859|stenting|stenting
730417|NCT01080872|acute coronary syndrome|acute coronary syndrome
730418|NCT01080872|coronary flow reserve|coronary flow reserve
730419|NCT01080872|OCT|oct
730420|NCT01080872|healing|healing
730421|NCT01080872|drug eluting stent|drug eluting stent
730422|NCT01080885|Prevention|prevention
730423|NCT01080885|Prevention of unhealthy weight gain|prevention of unhealthy weight gain
730424|NCT01080898|Age - Related Macular Degeneration|age - related macular degeneration
730425|NCT01080898|Optical Coherence Tomography|optical coherence tomography
730426|NCT01080898|Choroidal neovascularization|choroidal neovascularization
730427|NCT01080898|FLORESCEIN Angiography|florescein angiography
730428|NCT01080898|Fundus photographs|fundus photographs
730429|NCT01080911|Spinal morphine|spinal morphine
730430|NCT01080911|Vaginal hysterectomy|vaginal hysterectomy
730431|NCT01080937|acute heart failure|acute heart failure
730432|NCT01080950|zinc|zinc
730433|NCT01080950|sepsis|sepsis
730434|NCT01080950|fever|fever
730435|NCT01080950|vitamin d|vitamin d
730436|NCT01080963|Prophylaxis|prophylaxis
730437|NCT01080963|Antibiotic|antibiotic
730438|NCT01080963|Sternotomy|sternotomy
730439|NCT01080963|Heart-Lung Machine|heart-lung machine
730440|NCT01080989|solomon islands|solomon islands
730441|NCT01080989|malaria|malaria
730442|NCT01080989|flavivirus|flavivirus
730443|NCT01080989|alphavirus|alphavirus
730444|NCT01080989|parasite|parasite
730445|NCT01080989|leptospirosis|leptospirosis
730446|NCT01081002|Propofol|propofol
730447|NCT01081002|Conscious sedation|conscious sedation
730448|NCT01081002|Topical pharyngeal anesthesia|topical pharyngeal anesthesia
730449|NCT01081002|Anesthetics, Local|anesthetics, local
730450|NCT01081002|Gastrointestinal Endoscopy|gastrointestinal endoscopy
730451|NCT01081015|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
730452|NCT01081015|CLL|cll
730453|NCT01081015|disease registry|disease registry
730454|NCT01081015|Connect™|connect™
730455|NCT01081028|Multiple Myeloma|multiple myeloma
730456|NCT01081028|MM|mm
730457|NCT01081028|disease registry|disease registry
730458|NCT01081028|Connect®|connect®
730459|NCT01081054|Diverticulitis|diverticulitis
730460|NCT01081054|Not complicated diverticulitis|not complicated diverticulitis
730461|NCT01081080|cardiac|cardiac
730462|NCT01081080|muscle|muscle
730463|NCT01081080|pediatric|pediatric
730464|NCT01081080|dystrophy|dystrophy
730465|NCT01081093|Hypertrophic Cardiomyopathy Diastolic Ventricular Interaction|hypertrophic cardiomyopathy diastolic ventricular interaction
730466|NCT01081093|Biventricular Pacemaker cardiac surgery aortic valve replacement|biventricular pacemaker cardiac surgery aortic valve replacement
730467|NCT01081106|Breast Cancer|breast cancer
730468|NCT01081119|adolescent|adolescent
730469|NCT01081119|middle school|middle school
730470|NCT01081119|prevention|prevention
730471|NCT01081119|alcohol|alcohol
730472|NCT01081119|cigarettes|cigarettes
730473|NCT01081119|marijuana|marijuana
730474|NCT01081184|primary Sjögren syndrome|primary sjögren syndrome
730475|NCT01081184|neurotrophins|neurotrophins
730476|NCT01081184|B cell|b cell
730477|NCT01081184|sicca syndrome|sicca syndrome
730478|NCT01081184|T cell|t cell
730479|NCT01081197|heart failure|heart failure
730480|NCT01081197|liver|liver
730481|NCT01081197|depression|depression
730482|NCT01081197|neuropathy|neuropathy
730483|NCT01081210|Echocardiography|echocardiography
730484|NCT01081210|Heart failure|heart failure
730485|NCT01081210|Kidney|kidney
730488|NCT01081223|Brain Neoplasms|brain neoplasms
730489|NCT01081223|Central Nervous System Neoplasms|central nervous system neoplasms
730490|NCT01081223|Brain Diseases|brain diseases
730491|NCT01081223|Neoplasms|neoplasms
730492|NCT01081223|Nervous System Neoplasms|nervous system neoplasms
730493|NCT01081223|Glioblastoma|glioblastoma
730494|NCT01081223|Astrocytoma|astrocytoma
730495|NCT01081223|Nervous System Diseases|nervous system diseases
730496|NCT01081223|Central Nervous System Diseases|central nervous system diseases
730497|NCT01081223|Glioma|glioma
730498|NCT01081223|Recurrent astrocytoma|recurrent astrocytoma
730499|NCT01081223|Recurrent glioma|recurrent glioma
730500|NCT01081223|Cancer vaccine|cancer vaccine
730501|NCT01081223|Immunotherapy|immunotherapy
730502|NCT01081223|Killer T cells|killer t cells
730503|NCT01081223|Activated T cells|activated t cells
730504|NCT01081223|GM-CSF|gm-csf
730505|NCT01081223|Low dose IL-2|low dose il-2
730506|NCT01081223|Activated lymphocytes|activated lymphocytes
730507|NCT01081236|liver cirrhosis|liver cirrhosis
730508|NCT01081236|intestinal permeability|intestinal permeability
730509|NCT01081236|microbiota|microbiota
730510|NCT01081236|complications|complications
730511|NCT01081249|psychotherapy|psychotherapy
730512|NCT01081275|Multiple Sclerosis|multiple sclerosis
730513|NCT01081275|MS|ms
730514|NCT01081275|CI Therapy|ci therapy
730515|NCT01081275|CIMT|cimt
730516|NCT01081275|Constraint-Induced Movement Therapy|constraint-induced movement therapy
730517|NCT01081275|Complementary and Alternative Medicine|complementary and alternative medicine
730518|NCT01081275|CAM|cam
730519|NCT01081275|Physical Therapy|physical therapy
730520|NCT01081275|Occupational Therapy|occupational therapy
730521|NCT01081275|Relaxation|relaxation
730522|NCT01081275|Exercise|exercise
730523|NCT01081275|Massage|massage
730524|NCT01081275|Yoga|yoga
730525|NCT01081275|Pool Therapy|pool therapy
730526|NCT01081275|Aquatherapy|aquatherapy
730527|NCT01081275|Aquatic Therapy|aquatic therapy
730528|NCT01081288|Breast cancer|breast cancer
730529|NCT01081288|Breast screening|breast screening
730530|NCT01081288|Mammography|mammography
730531|NCT01081288|Routine screening programme|routine screening programme
730532|NCT01081301|hope|hope
730533|NCT01081301|quality of life|quality of life
730534|NCT01081301|caregivers|caregivers
730535|NCT01081327|Atrial Fibrillation|atrial fibrillation
730536|NCT01081327|Warfarin|warfarin
730537|NCT01081327|Safety|safety
730538|NCT01081340|gestational weight gain|gestational weight gain
730539|NCT01081340|postpartum weight loss|postpartum weight loss
730540|NCT01081340|breastfeeding|breastfeeding
730541|NCT01081340|overfeeding|overfeeding
730542|NCT01081353|Aspirin|aspirin
730543|NCT01081353|Acetylsalicylic Acid|acetylsalicylic acid
730544|NCT01081379|Cytomegalovirus Infections|cytomegalovirus infections
730545|NCT01081379|Pregnancy|pregnancy
730546|NCT01081379|T-Lymphocytes|t-lymphocytes
730547|NCT01081379|Transmission|transmission
730548|NCT01081392|LPS|lps
730549|NCT01081392|endotoxin|endotoxin
730550|NCT01081392|inflammatory markers|inflammatory markers
730551|NCT01081392|healthy volunteers|healthy volunteers
730552|NCT01081392|neutrophils in sputum|neutrophils in sputum
730553|NCT01081405|ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION|allogeneic hematopoietic cell transplantation
730554|NCT01081405|TOTAL LYMPHOID IRRADIATION|total lymphoid irradiation
730555|NCT01081405|ANTI-THYMOCYTE GLOBULIN|anti-thymocyte globulin
730556|NCT01081418|Schizophrenia, assertive community treatment, quetiapine|schizophrenia, assertive community treatment, quetiapine
730557|NCT01081431|Myelodysplastic Syndromes|myelodysplastic syndromes
730558|NCT01081431|MDS|mds
730559|NCT01081431|deletion 5q|deletion 5q
730560|NCT01081431|del 5q|del 5q
730561|NCT01081431|IPSS|ipss
730562|NCT01081431|low risk|low risk
730563|NCT01081431|intermediate-1 risk|intermediate-1 risk
730564|NCT01081431|GMIHO|gmiho
730565|NCT01081431|ClinAssess|clinassess
730566|NCT01081431|Germing|germing
730567|NCT01081431|Düsseldorf|düsseldorf
730568|NCT01081431|MDS-LE-MON-5|mds-le-mon-5
730569|NCT01081431|Lenalidomide|lenalidomide
730570|NCT01081431|Revlimid|revlimid
730571|NCT01081444|repetitive transcranial stimulation|repetitive transcranial stimulation
730572|NCT01081457|Parkinson's disease|parkinson's disease
730573|NCT01081457|deep brain stimulation|deep brain stimulation
730574|NCT01081457|GI motility|gi motility
730575|NCT01081483|Healthy Volunteers|healthy volunteers
730576|NCT01081483|HCV Infections|hcv infections
730577|NCT01081496|EGFR mutation, Non-small cell lung carcinoma, Spain|egfr mutation, non-small cell lung carcinoma, spain
730578|NCT01081496|Evaluate the prevalence of EGFR mutation status in patients with newly diagnosed locally advanced or metastatic NSCLC|evaluate the prevalence of egfr mutation status in patients with newly diagnosed locally advanced or metastatic nsclc
730579|NCT01081509|adherence|adherence
730580|NCT01081509|early breast cancer|early breast cancer
730581|NCT01081509|Arimidex|arimidex
730582|NCT01081509|Therapy adherence|therapy adherence
730583|NCT01081535|Pediatric patients (6 months-5 years) scheduled elective ureteroneocystostomy|pediatric patients (6 months-5 years) scheduled elective ureteroneocystostomy
730584|NCT01081574|Allergic Rhinitis|allergic rhinitis
730682|NCT01081782|ONO-4641|ono-4641
730585|NCT01081574|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
730586|NCT01081574|Perennial Allergic Rhinitis|perennial allergic rhinitis
730587|NCT01081574|Urticaria|urticaria
730588|NCT01081574|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
730589|NCT01081574|Allergy|allergy
730590|NCT01081574|Sneezing|sneezing
730591|NCT01081574|Nasal Itching|nasal itching
730592|NCT01081574|Rhinorrhea|rhinorrhea
730593|NCT01081574|Nasal Congestion|nasal congestion
730594|NCT01081574|Wheals|wheals
730595|NCT01081574|Hives|hives
730596|NCT01081574|Skin itching|skin itching
730597|NCT01081574|Flare|flare
730598|NCT01081574|Erythema|erythema
730599|NCT01081587|Non MeSH terms:|non mesh terms:
730600|NCT01081587|Children|children
730601|NCT01081587|Malnutrition|malnutrition
730602|NCT01081587|Computer Clinical Decision Support System|computer clinical decision support system
730603|NCT01081587|Cluster randomized trial|cluster randomized trial
730604|NCT01081587|Healthcare workers|healthcare workers
730605|NCT01081587|Guideline adherence|guideline adherence
730606|NCT01081587|Patient safety|patient safety
730607|NCT01081587|MeSH terms:|mesh terms:
730608|NCT01081587|Nutrition Surveys|nutrition surveys
730609|NCT01081587|Secondary Prevention|secondary prevention
730610|NCT01081587|Pediatrics|pediatrics
730611|NCT01081587|Child Care|child care
730612|NCT01081587|Health Personnel|health personnel
730613|NCT01081587|Reminder Systems|reminder systems
730614|NCT01081587|Intervention Studies|intervention studies
730615|NCT01081587|Quality of Health Care|quality of health care
730616|NCT01081600|Heat shock protein|heat shock protein
730617|NCT01081600|breast cancer|breast cancer
730618|NCT01081600|PET imaging|pet imaging
730619|NCT01081600|trastuzumab|trastuzumab
730620|NCT01081613|heat shock protein|heat shock protein
730621|NCT01081613|breast cancer|breast cancer
730622|NCT01081613|PET imaging|pet imaging
730623|NCT01081613|bevacizumab|bevacizumab
730624|NCT01081626|Infertility|infertility
730625|NCT01081626|Ovulation induction|ovulation induction
730626|NCT01081626|Gonal-f|gonal-f
730627|NCT01081626|Follitropin alpha|follitropin alpha
730628|NCT01081626|Polycystic ovarian syndrome|polycystic ovarian syndrome
730629|NCT01081626|Anovulatory infertility|anovulatory infertility
730630|NCT01081639|Follitropin alfa|follitropin alfa
730631|NCT01081639|Follitropin beta|follitropin beta
730632|NCT01081639|Fertilization, in vitro|fertilization, in vitro
730633|NCT01081639|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
730634|NCT01081639|Assisted reproductive techniques|assisted reproductive techniques
730635|NCT01081639|Polycystic ovary syndrome|polycystic ovary syndrome
730636|NCT01081652|Fertilisation, In vitro|fertilisation, in vitro
730637|NCT01081652|Embryo transfer|embryo transfer
730638|NCT01081652|progesterone|progesterone
730639|NCT01081652|Reproductive technologies, Assisted|reproductive technologies, assisted
730640|NCT01081665|Chronic Kidney Failure|chronic kidney failure
730641|NCT01081665|Secondary Hyperparathyroidism|secondary hyperparathyroidism
730642|NCT01081665|Paricalcitol IV treatment|paricalcitol iv treatment
730643|NCT01081665|Safety and efficacy assessment|safety and efficacy assessment
730644|NCT01081678|AMG 785|amg 785
730645|NCT01081678|Proximal Femur|proximal femur
730646|NCT01081678|Fracture Healing|fracture healing
730647|NCT01081678|Hip Fracture|hip fracture
730648|NCT01081691|CNTO 5825|cnto 5825
730649|NCT01081691|Safety|safety
730650|NCT01081691|Phase I|phase i
730651|NCT01081691|Healthy adults|healthy adults
730652|NCT01081691|Healthy Atopic adults|healthy atopic adults
730653|NCT01081704|Healthy volunteer|healthy volunteer
730654|NCT01081704|Chinese male|chinese male
730655|NCT01081704|Stelara|stelara
730656|NCT01081717|Rheumatoid arthritis|rheumatoid arthritis
730657|NCT01081717|psoriatic arthritis|psoriatic arthritis
730658|NCT01081717|ankylosing spondylitis|ankylosing spondylitis
730659|NCT01081717|golimumab|golimumab
730660|NCT01081717|anti-TNF biologics|anti-tnf biologics
730661|NCT01081717|non-anti-TNF biologics|non-anti-tnf biologics
731444|NCT01077323|Lilly|lilly
730662|NCT01081717|non-biological treatments|non-biological treatments
730663|NCT01081730|psoriasis|psoriasis
730664|NCT01081730|ustekinumab|ustekinumab
730665|NCT01081730|anti-TNF biologics|anti-tnf biologics
730666|NCT01081730|non-anti-TNF biologics|non-anti-tnf biologics
730667|NCT01081730|systemic non-biological treatments|systemic non-biological treatments
730668|NCT01081743|Alzheimer|alzheimer
730669|NCT01081743|Dementia|dementia
730670|NCT01081743|Mild to moderately severe|mild to moderately severe
730671|NCT01081743|New diagnosis|new diagnosis
730672|NCT01081743|Prevention of behavioural problems|prevention of behavioural problems
730673|NCT01081756|Reproductive technology; Assisted|reproductive technology; assisted
730674|NCT01081756|recombinant human chorionic hormone (r-hCG)|recombinant human chorionic hormone (r-hcg)
730675|NCT01081769|Schizophrenia|schizophrenia
730676|NCT01081769|paliperidone palmitate|paliperidone palmitate
730677|NCT01081769|Invega|invega
730678|NCT01081769|Intramuscular injection|intramuscular injection
730679|NCT01081769|Oral antipsychotics|oral antipsychotics
730680|NCT01081769|Relapse|relapse
730681|NCT01081782|Multiple Sclerosis|multiple sclerosis
730690|NCT01081808|Epidermal Growth Factor Receptor|epidermal growth factor receptor
730691|NCT01081808|Aldesleukin|aldesleukin
730692|NCT01081808|Lymphocytes|lymphocytes
730693|NCT01081808|Autologous|autologous
730694|NCT01081808|Recurrent|recurrent
730695|NCT01081808|Refractory|refractory
730696|NCT01081808|Metastatic|metastatic
730697|NCT01081808|Immunotherapy|immunotherapy
730698|NCT01081808|Antibodies|antibodies
730699|NCT01081808|Neoplasms by Site|neoplasms by site
731095|NCT01083927|Pterygium|pterygium
730700|NCT01081808|Anti-Retroviral Agents|anti-retroviral agents
730701|NCT01081808|Therapeutic Uses|therapeutic uses
730702|NCT01081808|Anti-Infective Agents|anti-infective agents
730703|NCT01081808|Neoplasms by Histologic Type|neoplasms by histologic type
730704|NCT01081808|Antineoplastic Agents|antineoplastic agents
730705|NCT01081808|Antiviral Agents|antiviral agents
730706|NCT01081808|Pharmacologic Actions|pharmacologic actions
730707|NCT01081808|Carcinoma|carcinoma
730708|NCT01081808|Neoplasms|neoplasms
730709|NCT01081821|JNJ 39758979|jnj 39758979
730710|NCT01081821|Japanese descent|japanese descent
730711|NCT01081834|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
730712|NCT01081834|Canagliflozin|canagliflozin
730714|NCT01081834|Hemoglobin A1c|hemoglobin a1c
730715|NCT01081834|Type 2 diabetes mellitus|type 2 diabetes mellitus
730717|NCT01081847|Synthetic peptides|synthetic peptides
732375|NCT01095237|PAD|pad
730718|NCT01081847|Plasmodium vivax|plasmodium vivax
730719|NCT01081847|Human volunteers|human volunteers
730720|NCT01081860|Carpal tunnel syndrome|carpal tunnel syndrome
730721|NCT01081860|CTS|cts
730722|NCT01081860|Skinstiffness|skinstiffness
730723|NCT01081860|Jointstiffness|jointstiffness
730724|NCT01082575|Post Op Patients|post op patients
730725|NCT01082575|Continuous Pulse Oximetry Monitoring|continuous pulse oximetry monitoring
730726|NCT01082575|Major Surgery|major surgery
730727|NCT01082588|schizophrenia|schizophrenia
730728|NCT01082588|pravastatin|pravastatin
730729|NCT01082588|inflammation|inflammation
730730|NCT01082588|cognition|cognition
730731|NCT01082588|antipsychotics|antipsychotics
730732|NCT01082588|cholesterol|cholesterol
730733|NCT01082601|Catheter Ablation|catheter ablation
730734|NCT01082601|Atrial Fibrillation|atrial fibrillation
730735|NCT01082601|Congestive heart failure|congestive heart failure
730736|NCT01082627|Somatostatin small bowel obstruction|somatostatin small bowel obstruction
730737|NCT01082640|Gout|gout
730738|NCT01082640|physiology|physiology
730739|NCT01082640|Hyperuricemia|hyperuricemia
730740|NCT01082640|Uric Acid|uric acid
730741|NCT01082640|Drug Therapy|drug therapy
730742|NCT01082653|ALS|als
730743|NCT01082653|Lou Gehrig's Disease|lou gehrig's disease
730744|NCT01082666|Cuff pressure|cuff pressure
730745|NCT01082666|microaspiration|microaspiration
730746|NCT01082666|pepsin|pepsin
730747|NCT01082666|VAP|vap
730748|NCT01082666|Mechanical ventilation|mechanical ventilation
730749|NCT01082679|opioid dependent|opioid dependent
730750|NCT01082679|methadone|methadone
730751|NCT01082679|Suboxone|suboxone
730752|NCT01082679|buprenorphine|buprenorphine
730753|NCT01082692|HIV Infection|hiv infection
730754|NCT01082692|DNA vaccine|dna vaccine
730755|NCT01082692|Electroporation|electroporation
730756|NCT01082692|HIV therapeutic vaccine|hiv therapeutic vaccine
730757|NCT01082705|malaria|malaria
730758|NCT01082705|treatment|treatment
730759|NCT01082705|artemisinin combination therapy|artemisinin combination therapy
730760|NCT01082705|Tanzania|tanzania
730761|NCT01082705|P. falciparum malaria in children age 6-59 months|p. falciparum malaria in children age 6-59 months
730762|NCT01082718|Malaria|malaria
730763|NCT01082718|Pregnancy|pregnancy
730764|NCT01082718|Pharmacokinetics|pharmacokinetics
730766|NCT01082731|Malaria|malaria
730767|NCT01082731|Plasmodium falciparum|plasmodium falciparum
730768|NCT01082731|Treatment|treatment
730769|NCT01082731|Brazil|brazil
730770|NCT01082744|Paravertebral Block|paravertebral block
730771|NCT01082744|Regional Anesthesia|regional anesthesia
730772|NCT01082744|Anesthetics Local|anesthetics local
730773|NCT01082744|Ropivacaine|ropivacaine
730774|NCT01082744|Sufentanil|sufentanil
730775|NCT01082744|Pain Postoperative|pain postoperative
730776|NCT01082744|Chronic Pain|chronic pain
730777|NCT01082744|Thoracic Surgery Video-Assisted.|thoracic surgery video-assisted.
730778|NCT01082757|Colorectal neoplasms|colorectal neoplasms
730779|NCT01082757|metastasis|metastasis
730780|NCT01082757|colorectal cancer|colorectal cancer
730781|NCT01082783|stroke-induced immunodepression|stroke-induced immunodepression
730782|NCT01082783|acute media infarct|acute media infarct
730783|NCT01082783|acute intracerebral bleeding|acute intracerebral bleeding
730784|NCT01082783|leucocytes|leucocytes
730785|NCT01082783|autoaggressive T-cells|autoaggressive t-cells
730786|NCT01082783|acute media infarct or acute intracerebral bleeding|acute media infarct or acute intracerebral bleeding
730787|NCT01082809|advanced biliary tract carcinoma|advanced biliary tract carcinoma
730788|NCT01082809|Sunitinib|sunitinib
730789|NCT01082822|cell sheet PDLSC periodontitis|cell sheet pdlsc periodontitis
730790|NCT01082835|Chinese herbs|chinese herbs
730791|NCT01082861|1998 female birth cohort eligible for HPV vaccination in 2011 within the Dutch NIP|1998 female birth cohort eligible for hpv vaccination in 2011 within the dutch nip
730792|NCT01082874|Randomized Controlled Trial|randomized controlled trial
730793|NCT01082874|Blinded|blinded
730794|NCT01082874|Clonidine|clonidine
730795|NCT01082874|acetyl-salicylic acid (ASA)|acetyl-salicylic acid (asa)
730796|NCT01082874|Perioperative vascular complications|perioperative vascular complications
730797|NCT01082874|Noncardiac surgery|noncardiac surgery
730897|NCT01083186|Chronic Kidney Failure|chronic kidney failure
730798|NCT01082887|Immunotherapy TIL (Tumor Infiltrating Lymphocytes)|immunotherapy til (tumor infiltrating lymphocytes)
730799|NCT01082887|Intra-tumoral injection|intra-tumoral injection
730800|NCT01082887|Interferon gamma-adenovirus(Ad-IFNg)|interferon gamma-adenovirus(ad-ifng)
730801|NCT01082887|Metastatic melanoma|metastatic melanoma
730802|NCT01082887|A stage IIIc/IV metastatic melanoma with nodal relapse|a stage iiic/iv metastatic melanoma with nodal relapse
730803|NCT01082887|in transit metastasis|in transit metastasis
730804|NCT01082887|cutaneous unresectable metastases|cutaneous unresectable metastases
730805|NCT01082887|visceral metastases|visceral metastases
730806|NCT01082900|Transient Tachypnea of the Newborn|transient tachypnea of the newborn
730807|NCT01082900|Elective Cesarean section|elective cesarean section
730808|NCT01082900|Late preterm|late preterm
730809|NCT01082900|CPAP|cpap
730810|NCT01082900|Delivery Room|delivery room
730811|NCT01082926|adult anaplastic astrocytoma|adult anaplastic astrocytoma
730812|NCT01082926|adult anaplastic ependymoma|adult anaplastic ependymoma
730813|NCT01082926|adult anaplastic meningioma|adult anaplastic meningioma
730814|NCT01082926|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
730815|NCT01082926|adult brain stem glioma|adult brain stem glioma
730816|NCT01082926|adult ependymoblastoma|adult ependymoblastoma
730817|NCT01082926|adult giant cell glioblastoma|adult giant cell glioblastoma
730818|NCT01082926|adult glioblastoma|adult glioblastoma
730819|NCT01082926|adult gliosarcoma|adult gliosarcoma
730820|NCT01082926|adult grade III meningioma|adult grade iii meningioma
730821|NCT01082926|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
730822|NCT01082926|adult mixed glioma|adult mixed glioma
730823|NCT01082926|adult pineal gland astrocytoma|adult pineal gland astrocytoma
730824|NCT01082926|recurrent adult brain tumor|recurrent adult brain tumor
730825|NCT01082926|Los Angeles|los angeles
730826|NCT01082939|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
730827|NCT01082939|Refractory CLL|refractory cll
730828|NCT01082939|CFAR|cfar
730829|NCT01082939|Alemtuzumab|alemtuzumab
730830|NCT01082939|Campath-1H|campath-1h
730831|NCT01082939|Campath|campath
730832|NCT01082939|Cyclophosphamide|cyclophosphamide
730833|NCT01082939|Cytoxan|cytoxan
730834|NCT01082939|Neosar|neosar
730835|NCT01082939|Fludarabine|fludarabine
730836|NCT01082939|Fludara|fludara
730837|NCT01082939|Fludarabine Phosphate|fludarabine phosphate
730838|NCT01082939|Rituximab|rituximab
730839|NCT01082939|Rituxan|rituxan
730841|NCT01082965|ASL MRI|asl mri
730842|NCT01082965|perfusion|perfusion
730843|NCT01082965|cognition|cognition
730844|NCT01082965|donepezil|donepezil
730845|NCT01082965|alzheimer's disease|alzheimer's disease
730846|NCT01082965|translational medicine|translational medicine
730847|NCT01082978|Quality of Life|quality of life
730848|NCT01082978|Health Care Quality and Safety|health care quality and safety
730849|NCT01082978|Randomized controlled trial|randomized controlled trial
730850|NCT01083004|dye|dye
730851|NCT01083004|internal limiting membrane|internal limiting membrane
730852|NCT01083004|macular hole|macular hole
730853|NCT01083004|macular pucker|macular pucker
730854|NCT01083030|pAVK|pavk
730855|NCT01083030|PTA|pta
730856|NCT01083030|drug coated balloon|drug coated balloon
730857|NCT01083043|Glycemic Variability|glycemic variability
730858|NCT01083043|Endothelial Dysfunction|endothelial dysfunction
730859|NCT01083056|retina|retina
730860|NCT01083056|gliosis|gliosis
730861|NCT01083056|macula|macula
730862|NCT01083056|membrane|membrane
730863|NCT01083056|ILM|ilm
730864|NCT01083069|Sudden cardiac arrest|sudden cardiac arrest
730865|NCT01083069|hypothermia|hypothermia
730866|NCT01083069|neurological outcome|neurological outcome
730867|NCT01083082|lifestyles|lifestyles
730868|NCT01083082|diet|diet
730869|NCT01083082|exercise|exercise
730870|NCT01083082|central blood pressure|central blood pressure
730871|NCT01083082|arterial stiffness|arterial stiffness
730872|NCT01083082|endothelial dysfunction|endothelial dysfunction
730873|NCT01083082|Healthy people|healthy people
730874|NCT01083095|Malaria|malaria
730875|NCT01083095|Sporozoite|sporozoite
730876|NCT01083095|Challenge Model|challenge model
730877|NCT01083095|Plasmodium vivax|plasmodium vivax
730878|NCT01083095|Human Volunteers|human volunteers
730879|NCT01083108|Behavioral Weight Loss Treatment|behavioral weight loss treatment
730880|NCT01083108|Bariatric Surgery|bariatric surgery
730881|NCT01083108|Diabetes Type II|diabetes type ii
730882|NCT01083108|Obesity|obesity
730883|NCT01083108|Adult|adult
730884|NCT01083108|Type 2 Diabetes|type 2 diabetes
730885|NCT01083121|Postmarketing Drug Surveillance|postmarketing drug surveillance
730886|NCT01083134|CAD|cad
731273|NCT01084785|Cancer|cancer
730887|NCT01083147|Intermediate AMD|intermediate amd
730888|NCT01083160|Rheumatoid Arthritis|rheumatoid arthritis
730889|NCT01083160|Anti-TNF|anti-tnf
730890|NCT01083160|Adalimumab|adalimumab
730891|NCT01083160|Infliximab|infliximab
730892|NCT01083160|Etanercept|etanercept
730893|NCT01083173|Postmarketing Drug Surveillance|postmarketing drug surveillance
730894|NCT01083173|HIV-1 infection|hiv-1 infection
730895|NCT01083173|Kaletra|kaletra
730896|NCT01083186|Secondary Hyperparathyroidism|secondary hyperparathyroidism
730898|NCT01083199|Prostate Cancer|prostate cancer
730899|NCT01083199|Radical Prostatectomy|radical prostatectomy
730900|NCT01083199|Vesico-Urethral Anastomosis|vesico-urethral anastomosis
730901|NCT01083212|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
730902|NCT01083212|Gemfibrozil|gemfibrozil
730903|NCT01083238|pharmacokinetics|pharmacokinetics
730904|NCT01083238|fasting or after a high fat meal|fasting or after a high fat meal
730905|NCT01083238|adult|adult
730906|NCT01083238|elderly adult|elderly adult
730907|NCT01083238|COPD|copd
730908|NCT01083251|HBV|hbv
730909|NCT01083251|VITAMIN D|vitamin d
730910|NCT01083251|PEGITERFERON|pegiterferon
730911|NCT01083251|Telbivudine|telbivudine
730912|NCT01083264|Pharmacokinetics|pharmacokinetics
730913|NCT01083277|oxygenation|oxygenation
730914|NCT01083277|ventilation|ventilation
730915|NCT01083277|tidal volume|tidal volume
730916|NCT01083277|patterns of breathing|patterns of breathing
730917|NCT01083277|variable ventilation|variable ventilation
730918|NCT01083277|mechanical ventilation|mechanical ventilation
730919|NCT01083290|spironolactone|spironolactone
730920|NCT01083290|linearity of pharmacokinetics|linearity of pharmacokinetics
730921|NCT01083290|Healthy volunteers|healthy volunteers
730922|NCT01083303|energy expenditure|energy expenditure
730923|NCT01083303|hypothermia|hypothermia
730924|NCT01083303|body temperature|body temperature
730925|NCT01083303|weaning|weaning
730926|NCT01083303|preterm infants|preterm infants
730927|NCT01083316|Amyloid|amyloid
730928|NCT01083316|Amyloidosis|amyloidosis
730929|NCT01083316|AL Amyloidosis|al amyloidosis
730930|NCT01083316|Primary Amyloidosis|primary amyloidosis
730931|NCT01083316|Stem Cell Transplant|stem cell transplant
730932|NCT01083329|nicotinic acid|nicotinic acid
730933|NCT01083329|lipolysis|lipolysis
730934|NCT01083329|training program|training program
730935|NCT01083329|adipose tissue inflammation|adipose tissue inflammation
730936|NCT01083329|obese|obese
730937|NCT01083342|primary CNS lymphoma|primary cns lymphoma
730938|NCT01083342|MTX: Methotrexate,Leucovorin|mtx: methotrexate,leucovorin
730939|NCT01083342|MVD: Methotrexate,Vincristine,Dexamethasone|mvd: methotrexate,vincristine,dexamethasone
730940|NCT01083342|VIA: VP-16 (Etoposide),Ifosfamide,Mesna, Cytarabine (ara-C)|via: vp-16 (etoposide),ifosfamide,mesna, cytarabine (ara-c)
730941|NCT01083342|Newly diagnosed primary CNS lymphoma patients|newly diagnosed primary cns lymphoma patients
730942|NCT01083355|Variable ventilation|variable ventilation
730943|NCT01083355|Pressure regulated volume control ventilation|pressure regulated volume control ventilation
730944|NCT01083355|Airway pressure release ventilation|airway pressure release ventilation
730945|NCT01083368|adenocarcinoma of the prostate|adenocarcinoma of the prostate
730946|NCT01083368|hormone-resistant prostate cancer|hormone-resistant prostate cancer
730947|NCT01083368|recurrent prostate cancer|recurrent prostate cancer
730948|NCT01083368|stage IV prostate cancer|stage iv prostate cancer
730949|NCT01083381|Schizophrenia treatment MS14 randomized clinical trial|schizophrenia treatment ms14 randomized clinical trial
730950|NCT01083394|PTA|pta
730951|NCT01083394|paclitaxel|paclitaxel
730952|NCT01083394|restenosis|restenosis
730953|NCT01083407|Oral care.|oral care.
730954|NCT01083407|Chlorhexidine.|chlorhexidine.
730955|NCT01083407|Pediatric Nursing|pediatric nursing
730956|NCT01083407|Intensive Care|intensive care
730957|NCT01083407|Nosocomial infection|nosocomial infection
730958|NCT01083407|Pneumonia|pneumonia
730959|NCT01083407|Oropharyngeal colonization|oropharyngeal colonization
730960|NCT01083407|Tracheal colonization|tracheal colonization
730961|NCT01083420|Oral lichen planus|oral lichen planus
730962|NCT01083420|Minocycline|minocycline
730963|NCT01083420|Dexamethasone|dexamethasone
730964|NCT01083433|Continuous Glucose Monitor|continuous glucose monitor
730965|NCT01083433|Adherence|adherence
730966|NCT01083433|Adolescents|adolescents
730967|NCT01083433|Diabetes Education|diabetes education
730968|NCT01083446|Encephalopathy|encephalopathy
730969|NCT01083446|Cirrhotics|cirrhotics
730970|NCT01083472|dehiscence|dehiscence
730971|NCT01083472|laparotomy|laparotomy
730972|NCT01083472|Hernia repair|hernia repair
730973|NCT01083472|surgical wound|surgical wound
730974|NCT01083472|surgical mesh|surgical mesh
730975|NCT01083485|Oxycodone|oxycodone
730976|NCT01083485|Naloxone|naloxone
730977|NCT01083485|Postoperative pain|postoperative pain
730978|NCT01083485|Arthroplasty|arthroplasty
730979|NCT01083485|Efficacy|efficacy
730980|NCT01083498|Becker's nevus|becker's nevus
730981|NCT01083498|ablative fractional laser therapy|ablative fractional laser therapy
730982|NCT01083498|randomized controlled trial|randomized controlled trial
731274|NCT01084785|genomics|genomics
730983|NCT01083498|split-lesion design|split-lesion design
730984|NCT01083511|Influenza|influenza
730985|NCT01083511|Influenza A|influenza a
730986|NCT01083511|Influenza B|influenza b
730987|NCT01083511|Swine Influenza A/H1N1|swine influenza a/h1n1
730988|NCT01083511|Respiratory Virus|respiratory virus
730989|NCT01083524|Pulmonary arterial hypertension|pulmonary arterial hypertension
730990|NCT01083524|Pulmonary hypertension|pulmonary hypertension
730991|NCT01083524|Dichloroacetate|dichloroacetate
730992|NCT01083524|Dichloroacetate Sodium|dichloroacetate sodium
730993|NCT01083524|DCA|dca
730994|NCT01083537|malignant bowel obstruction|malignant bowel obstruction
730995|NCT01083537|ovarian cancer|ovarian cancer
730996|NCT01083537|Peritoneal cancer|peritoneal cancer
730997|NCT01083537|Fallopian Tube cancer|fallopian tube cancer
730998|NCT01083550|thyroid carcinoma|thyroid carcinoma
730999|NCT01083550|thyroid cancer|thyroid cancer
731000|NCT01083550|therapeutic radioisotopes|therapeutic radioisotopes
731001|NCT01083550|radioactive iodine|radioactive iodine
731002|NCT01083563|TNF|tnf
731003|NCT01083563|CD20|cd20
731004|NCT01083563|RA|ra
731005|NCT01083576|leishmaniasis|leishmaniasis
731006|NCT01083576|cutaneous|cutaneous
731007|NCT01083576|WR 279,396|wr 279,396
731008|NCT01083576|paromomycin|paromomycin
731009|NCT01083576|gentamicin|gentamicin
732704|NCT01082172|TAA|taa
731010|NCT01083576|pharmacokinetics|pharmacokinetics
731011|NCT01083576|safety|safety
731012|NCT01083576|efficacy|efficacy
731013|NCT01083589|Lung Cancer|lung cancer
731014|NCT01083589|Metastatic NSCLC|metastatic nsclc
731015|NCT01083589|Tumor|tumor
731016|NCT01083589|Imatinib Mesylate|imatinib mesylate
731017|NCT01083589|Gleevec|gleevec
731018|NCT01083589|Docetaxel|docetaxel
731019|NCT01083589|Taxotere|taxotere
731020|NCT01083602|Multiple Myeloma|multiple myeloma
731021|NCT01083602|Relapsed Multiple Myeloma|relapsed multiple myeloma
731022|NCT01083602|Refractory Multiple Myeloma|refractory multiple myeloma
731023|NCT01083615|CRPC patients with cancer related pain|crpc patients with cancer related pain
731024|NCT01083615|CRPC|crpc
731025|NCT01083615|HRPC|hrpc
731026|NCT01083641|Breast Cancer|breast cancer
731027|NCT01083654|Smoking|smoking
731028|NCT01083654|Smoking cessation|smoking cessation
731029|NCT01083667|ALS|als
731030|NCT01083667|Familial ALS|familial als
731031|NCT01083667|SOD1 Gene Mutation|sod1 gene mutation
731032|NCT01083680|Routine clinical setting|routine clinical setting
731033|NCT01083680|Long-term efficacy and safety|long-term efficacy and safety
731034|NCT01083680|Crohn's Disease|crohn's disease
731035|NCT01083680|Humira®|humira®
731036|NCT01083680|Adalimumab|adalimumab
731037|NCT01083693|Monoclonals|monoclonals
731038|NCT01083693|Antibodies|antibodies
731039|NCT01083693|Ankylosing Spondylitis|ankylosing spondylitis
731040|NCT01083693|Antirheumatic Agents|antirheumatic agents
731041|NCT01083693|Quality of Life|quality of life
731042|NCT01083693|Adalimumab|adalimumab
731043|NCT01083693|rheumatoid arthritis|rheumatoid arthritis
731044|NCT01083693|psoriatic arthritis|psoriatic arthritis
731045|NCT01083719|Glioblastoma|glioblastoma
731046|NCT01083719|FDG-PET|fdg-pet
731047|NCT01083719|MRI|mri
731048|NCT01083784|Cardiac arrest|cardiac arrest
731049|NCT01083784|Prophylactic anticonvulsant|prophylactic anticonvulsant
731050|NCT01083797|Sedation|sedation
731051|NCT01083797|Electroencephalography|electroencephalography
731052|NCT01083797|Dexmedetomidine|dexmedetomidine
731053|NCT01083797|Chloral hydrate|chloral hydrate
731054|NCT01083810|Human Immunodeficiency Virus|human immunodeficiency virus
731055|NCT01083810|Infection|infection
731056|NCT01083810|Kaletra|kaletra
731057|NCT01083810|Resistance|resistance
731058|NCT01083810|Mutations|mutations
731772|NCT01078415|Multicenter|multicenter
731059|NCT01083810|alternative Therapy regimen|alternative therapy regimen
731060|NCT01083823|Mental health telemetry|mental health telemetry
731061|NCT01083823|Mood telemetry|mood telemetry
731062|NCT01083823|Mood|mood
731063|NCT01083823|Bipolar disorder|bipolar disorder
731064|NCT01083823|Affective instability|affective instability
731065|NCT01083823|Cyclothymia|cyclothymia
731066|NCT01083823|Electronic diaries|electronic diaries
731067|NCT01083823|Mood diaries|mood diaries
731068|NCT01083823|Mood swings|mood swings
731069|NCT01083849|Observational study|observational study
731070|NCT01083849|Paricalcitol|paricalcitol
731071|NCT01083849|Treatment of Hyperparathyroidism|treatment of hyperparathyroidism
731072|NCT01083849|Chronic kidney disease stage 3, 4 and 5 (CKD stage 3, 4 and 5)|chronic kidney disease stage 3, 4 and 5 (ckd stage 3, 4 and 5)
731073|NCT01083849|Chronic Kidney Disease|chronic kidney disease
731074|NCT01083849|Zemplar|zemplar
731075|NCT01083849|sHPT|shpt
731076|NCT01083849|Secondary|secondary
731077|NCT01083862|Health literacy|health literacy
731078|NCT01083862|patient education|patient education
731079|NCT01083862|health behaviors|health behaviors
731080|NCT01083862|chronic disease management|chronic disease management
731081|NCT01083862|shared decision-making|shared decision-making
731082|NCT01083862|patient-centered decision making|patient-centered decision making
731083|NCT01083875|Radiation|radiation
731084|NCT01083875|mucositis|mucositis
731085|NCT01083875|head and neck carcinoma|head and neck carcinoma
731086|NCT01083875|oral rinse|oral rinse
731087|NCT01083875|amlexanox|amlexanox
731088|NCT01083875|MuGard|mugard
731089|NCT01083888|Pharmacokinetics|pharmacokinetics
731090|NCT01083888|Safety and tolerability|safety and tolerability
731091|NCT01083888|Plasma concentration|plasma concentration
731092|NCT01083888|ASP1517|asp1517
731093|NCT01083888|FG-4592|fg-4592
731094|NCT01083914|extracorporeal circulation, off-pump CABG|extracorporeal circulation, off-pump cabg
731096|NCT01083953|end tidal concentration|end tidal concentration
731097|NCT01083966|Vestibular|vestibular
731098|NCT01083966|Schwannoma|schwannoma
731099|NCT01083966|earing-loss|earing-loss
731100|NCT01083966|brain-tumor|brain-tumor
731101|NCT01083966|Acoustic|acoustic
731102|NCT01083966|Neuroma|neuroma
731103|NCT01083992|NAFLD|nafld
731104|NCT01083992|Galvus|galvus
731105|NCT01083992|vitamin D|vitamin d
731106|NCT01084018|acute postoperative pain|acute postoperative pain
731107|NCT01084018|nursing intervention|nursing intervention
731108|NCT01084070|early feeding|early feeding
731109|NCT01084070|postoperative care|postoperative care
731110|NCT01084070|emergency surgery|emergency surgery
731111|NCT01084083|human papilloma virus infection|human papilloma virus infection
731112|NCT01084083|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
731113|NCT01084083|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
731114|NCT01084083|tongue cancer|tongue cancer
731115|NCT01084096|Antenatal Corticosteroids, Preterm Birth, Diffusion|antenatal corticosteroids, preterm birth, diffusion
731116|NCT01084109|Complementary feeding|complementary feeding
731117|NCT01084109|Infant growth|infant growth
731118|NCT01084109|Developing countries|developing countries
731119|NCT01084122|Intravenous iron sucrose|intravenous iron sucrose
731120|NCT01084122|Anemia|anemia
731121|NCT01084122|Transfusion|transfusion
731122|NCT01084135|Clinical trial|clinical trial
731123|NCT01084135|Down syndrome|down syndrome
731124|NCT01084135|adolescents|adolescents
731125|NCT01084135|cognitive|cognitive
731126|NCT01084135|rivastigmine|rivastigmine
731127|NCT01084174|Peanut Allergy|peanut allergy
731128|NCT01084187|erectile dysfunction|erectile dysfunction
731129|NCT01084187|arterial hypertension|arterial hypertension
731130|NCT01084187|flow mediated vasodilation|flow mediated vasodilation
731131|NCT01084187|endothelial dysfunction|endothelial dysfunction
731132|NCT01084187|carotid intima media thickness|carotid intima media thickness
731133|NCT01084187|vardenafil|vardenafil
731134|NCT01084200|Postoperative pain|postoperative pain
731135|NCT01084200|Sevoflurane|sevoflurane
731136|NCT01084200|Propofol|propofol
731137|NCT01084200|Female|female
731138|NCT01084200|Elective gynaecological surgery|elective gynaecological surgery
731139|NCT01084200|Laparoscopic and hysteroscopic surgery|laparoscopic and hysteroscopic surgery
731140|NCT01084200|Female patients|female patients
731141|NCT01084200|Undergoing elective laparoscopic and hysteroscopic surgery|undergoing elective laparoscopic and hysteroscopic surgery
731142|NCT01084213|Low birth weight|low birth weight
731143|NCT01084213|Placenta malaria|placenta malaria
731144|NCT01084213|Anaemia|anaemia
731145|NCT01084213|Intermittent preventive treatment|intermittent preventive treatment
731146|NCT01084213|Intermittent screening and treatment|intermittent screening and treatment
731147|NCT01084213|Rapid diagnostic test|rapid diagnostic test
731148|NCT01084226|Rye fiber|rye fiber
731149|NCT01084226|Alkylresorcinols|alkylresorcinols
731150|NCT01084226|Plant sterols|plant sterols
731151|NCT01084226|Cholesterol|cholesterol
731152|NCT01084226|Antioxidant|antioxidant
731153|NCT01084226|Effects of plant sterols in rye bread on serum lipids|effects of plant sterols in rye bread on serum lipids
731154|NCT01084226|Effects of alkylresorcinols in rye fiber on LDL particles|effects of alkylresorcinols in rye fiber on ldl particles
731155|NCT01084239|acute chest pain|acute chest pain
731156|NCT01084239|emergency department|emergency department
731157|NCT01084239|cardiac computed tomography|cardiac computed tomography
731158|NCT01084265|Hypogonadism|hypogonadism
731159|NCT01084265|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
731160|NCT01084265|Recombinant leutinizing hormone (r-hLH)|recombinant leutinizing hormone (r-hlh)
731161|NCT01084291|Vaccine|vaccine
731162|NCT01084291|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
731163|NCT01084304|Pregnancy|pregnancy
731164|NCT01084304|Ovulation tests|ovulation tests
731165|NCT01084304|stress|stress
731166|NCT01084304|Wishing to become pregnant|wishing to become pregnant
731167|NCT01084317|asthma|asthma
731168|NCT01084317|children|children
731169|NCT01084317|delay in asthma diagnosis|delay in asthma diagnosis
731170|NCT01084330|gastric cancer|gastric cancer
731416|NCT01077245|Colitis|colitis
731171|NCT01084330|metastatic gastric cancer|metastatic gastric cancer
731172|NCT01084330|advanced gastric cancer|advanced gastric cancer
731173|NCT01084343|vaccination|vaccination
731174|NCT01084343|prophylaxis|prophylaxis
731175|NCT01084356|CZT|czt
731176|NCT01084356|sentinel node|sentinel node
731177|NCT01084356|osseous processes|osseous processes
731275|NCT01084785|proteomics|proteomics
731178|NCT01084369|Type 2 diabetes|type 2 diabetes
731179|NCT01084369|Hypogonadism|hypogonadism
731180|NCT01084369|Testosterone|testosterone
731181|NCT01084369|Endothelial dysfunction|endothelial dysfunction
731182|NCT01084382|Arthrospira platensis|arthrospira platensis
731183|NCT01084382|female HIV patient|female hiv patient
731184|NCT01084382|Yaounde|yaounde
731185|NCT01084382|Redox potential|redox potential
731186|NCT01084382|Life quality|life quality
731187|NCT01084382|female patient infected by HIV in Yaounde: Cameroon|female patient infected by hiv in yaounde: cameroon
731188|NCT01084395|Parent|parent
731189|NCT01084395|Adolescent|adolescent
731190|NCT01084395|Mexico|mexico
731191|NCT01084395|Safer Sex Communication|safer sex communication
731192|NCT01084395|Randomized Controlled Trial|randomized controlled trial
731193|NCT01084395|HIV/AIDS|hiv/aids
731194|NCT01084395|STD|std
731195|NCT01084395|Sexual Behavior|sexual behavior
731196|NCT01084408|de-novo|de-novo
731197|NCT01084408|coronary stenoses|coronary stenoses
731198|NCT01084408|PEPCAD|pepcad
731199|NCT01084408|DEBonly|debonly
731200|NCT01084408|Paclitaxel|paclitaxel
731201|NCT01084421|Adolescents|adolescents
731202|NCT01084421|Parents|parents
731203|NCT01084421|Computer Based|computer based
731204|NCT01084421|Latino|latino
731205|NCT01084421|Sexual Communication|sexual communication
731206|NCT01084447|obesity|obesity
731207|NCT01084447|gastroplasty|gastroplasty
731208|NCT01084447|respiratory muscle training|respiratory muscle training
731209|NCT01084447|muscle strength|muscle strength
731210|NCT01084447|physical therapy|physical therapy
731211|NCT01084460|Gastrointestinal stromal tumor,endoscopic ultrasound,submucosal tumor|gastrointestinal stromal tumor,endoscopic ultrasound,submucosal tumor
731212|NCT01084473|Dexmedetomidine|dexmedetomidine
731213|NCT01084473|gastric emptying|gastric emptying
731214|NCT01084473|oro-cecal transit time|oro-cecal transit time
731215|NCT01084473|Sedation in intensive care|sedation in intensive care
731216|NCT01084473|Gastrointestinal effects of sedation|gastrointestinal effects of sedation
731217|NCT01084486|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
731218|NCT01084486|Pulse wave velocity|pulse wave velocity
731219|NCT01084486|augmentation index|augmentation index
731220|NCT01084486|metformin|metformin
731221|NCT01084499|Healthy Subjects|healthy subjects
731222|NCT01084512|kinematic analysis,|kinematic analysis,
731223|NCT01084512|three-compartment model,|three-compartment model,
731224|NCT01084512|chest wall motion,|chest wall motion,
731225|NCT01084512|spinal cord injury.|spinal cord injury.
731226|NCT01084525|Meniere's Disease|meniere's disease
731227|NCT01084525|Vertigo|vertigo
731228|NCT01084525|Definitive vertigo|definitive vertigo
731229|NCT01084525|Vertigo episodes|vertigo episodes
731230|NCT01084525|Vertigo frequency|vertigo frequency
731231|NCT01084525|Tinnitus|tinnitus
731232|NCT01084525|Hearing loss|hearing loss
731233|NCT01084525|Aural Fullness|aural fullness
731234|NCT01084538|paricalcitol iv|paricalcitol iv
731235|NCT01084538|vitamin D|vitamin d
731236|NCT01084538|secondary hyperparathyroidism|secondary hyperparathyroidism
731237|NCT01084538|hemodialysis|hemodialysis
731238|NCT01084564|Cost-effectiveness analysis|cost-effectiveness analysis
731239|NCT01084564|Colombia|colombia
731240|NCT01084590|Prevention|prevention
731241|NCT01084590|Obesity|obesity
731242|NCT01084590|Safety|safety
731243|NCT01084590|Unhealthy weight gain|unhealthy weight gain
731244|NCT01084590|Injury prevention|injury prevention
731245|NCT01084603|Smoking Cessation|smoking cessation
731246|NCT01084603|Nicotine pharmacokinetics|nicotine pharmacokinetics
731247|NCT01084629|Barrett's Esophagus|barrett's esophagus
731248|NCT01084629|Surveillance|surveillance
731249|NCT01084642|Survey|survey
731250|NCT01084642|Sexual Health Issues|sexual health issues
731251|NCT01084642|10-034|10-034
731252|NCT01084668|moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
731253|NCT01084668|adalimumab|adalimumab
731254|NCT01084668|Psoriasis Area and Severity Index (PASI)|psoriasis area and severity index (pasi)
731255|NCT01084668|Disease Life Quality Index (DLQI)|disease life quality index (dlqi)
731256|NCT01084668|Nail Psoriasis Severity Index (NAPSI)|nail psoriasis severity index (napsi)
731257|NCT01084668|biologic disease modifying anti-rheumatic drug (BDMARD)|biologic disease modifying anti-rheumatic drug (bdmard)
731258|NCT01084668|antibodies|antibodies
731259|NCT01084668|monoclonals|monoclonals
731260|NCT01084681|SILK flow diverter, intracranial stents, intracranial aneurysms|silk flow diverter, intracranial stents, intracranial aneurysms
731261|NCT01084694|HSCT|hsct
731262|NCT01084694|Caregiver|caregiver
731263|NCT01084694|Caregiver Burden|caregiver burden
731264|NCT01084694|Allogeneic Transplant|allogeneic transplant
731265|NCT01084694|Autologous Transplant|autologous transplant
731266|NCT01084694|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
731267|NCT01084707|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
731268|NCT01084746|Colorectal Cancer Screening|colorectal cancer screening
731269|NCT01084746|Computer Interactive Intervention|computer interactive intervention
731270|NCT01084746|Predictors|predictors
731271|NCT01084746|Cost Effective Analysis|cost effective analysis
731272|NCT01084746|Transtheoretical Model|transtheoretical model
731276|NCT01084798|Multiple sclerosis|multiple sclerosis
731277|NCT01084798|Expanded Disability Status Scale|expanded disability status scale
731278|NCT01084798|Sclerosis|sclerosis
731279|NCT01084824|Warts|warts
731280|NCT01084824|Verruca vulgaris|verruca vulgaris
731281|NCT01084824|Liquid Nitrogen|liquid nitrogen
731282|NCT01084824|Cantharidin|cantharidin
731283|NCT01084824|combination treatment|combination treatment
731284|NCT01084837|Multiple myeloma|multiple myeloma
731285|NCT01084837|Renal failure|renal failure
731286|NCT01084850|Corneal endothelium|corneal endothelium
731287|NCT01084850|diabetes mellitus|diabetes mellitus
731288|NCT01084850|corneal thickness|corneal thickness
731289|NCT01084863|Herceptin|herceptin
731290|NCT01084863|Her 2-positive|her 2-positive
731291|NCT01084863|metastatic breast cancer|metastatic breast cancer
731292|NCT01084863|CT-P6|ct-p6
731293|NCT01084876|Herceptin|herceptin
731294|NCT01084876|metastatic breast cancer|metastatic breast cancer
731295|NCT01084876|CT-P6|ct-p6
731296|NCT01084889|polypropylene mesh|polypropylene mesh
731297|NCT01084889|Prolapse|prolapse
731298|NCT01084889|Cystocele|cystocele
731299|NCT01084889|Surgical Mesh|surgical mesh
731300|NCT01084902|POAG|poag
731301|NCT01084902|OH|oh
731302|NCT01084902|Xalatan|xalatan
731303|NCT01084902|Azopt|azopt
731304|NCT01084902|Primary Open Angle Study|primary open angle study
731305|NCT01084915|Weight loss after SAGB VC band placement|weight loss after sagb vc band placement
731306|NCT01084928|diabetes|diabetes
731307|NCT01084928|obesity|obesity
731308|NCT01084928|pre-diabetes|pre-diabetes
731309|NCT01084928|South Asian|south asian
731310|NCT01084941|pregnancy|pregnancy
731311|NCT01084941|weight gain|weight gain
731312|NCT01084941|obesity|obesity
731313|NCT01084941|pregnancy and weight gain|pregnancy and weight gain
731314|NCT01084954|HIV validation helicase-dependent amplification|hiv validation helicase-dependent amplification
731315|NCT01084967|obesity|obesity
731316|NCT01084967|metabolic syndrome|metabolic syndrome
731317|NCT01084967|genetic risk markers|genetic risk markers
731318|NCT01084967|copy number variation|copy number variation
731319|NCT01084980|minimal change disease|minimal change disease
731320|NCT01084980|tacrolimus|tacrolimus
731321|NCT01084980|corticosteroid|corticosteroid
731322|NCT01084993|Coronary artery stenting, transradial, intracoronary|coronary artery stenting, transradial, intracoronary
731323|NCT01085006|cesarean delivery|cesarean delivery
731324|NCT01085006|Tranexamic acid|tranexamic acid
731325|NCT01085006|hemorrhage|hemorrhage
731326|NCT01085006|Spinal analgesia|spinal analgesia
731327|NCT01085006|1-the amount of hemorrhage during cesarean delivery|1-the amount of hemorrhage during cesarean delivery
731328|NCT01085006|2-the amount of hemorrhage in the first 2 hours of cesarean delivery|2-the amount of hemorrhage in the first 2 hours of cesarean delivery
731329|NCT01085006|3-the amount of hemorrhage in the first 24 hour after cesarean delivery|3-the amount of hemorrhage in the first 24 hour after cesarean delivery
731330|NCT01085019|Endothelial function|endothelial function
731331|NCT01085019|Cardiovascular risk factors|cardiovascular risk factors
731332|NCT01085019|Spices|spices
731333|NCT01085019|Herbs|herbs
731334|NCT01085019|Antioxidant|antioxidant
731335|NCT01085032|Smoking Cessation|smoking cessation
731336|NCT01085032|Substance Withdrawal Syndrome|substance withdrawal syndrome
731337|NCT01085032|Depression|depression
731338|NCT01076933|Borderline Personality Disorder|borderline personality disorder
731339|NCT01076933|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
731340|NCT01076933|Neuropsychological Test|neuropsychological test
731341|NCT01076933|Randomised Control Trial|randomised control trial
731342|NCT01076946|ballooning|ballooning
731343|NCT01076946|TLVBS|tlvbs
731344|NCT01076959|Rheumatoid Arthritis|rheumatoid arthritis
731345|NCT01076972|Human Immunodeficiency Virus|human immunodeficiency virus
731346|NCT01076985|Human Immunodeficiency Virus|human immunodeficiency virus
731347|NCT01076998|Dry eye|dry eye
731348|NCT01076998|artificial tears|artificial tears
731349|NCT01077011|Dry eye|dry eye
731350|NCT01077011|artificial tears|artificial tears
731351|NCT01077024|Stimulant treatment|stimulant treatment
731352|NCT01077024|Smoking Cessation|smoking cessation
731353|NCT01077063|Pleurx catheter|pleurx catheter
731354|NCT01077063|malignant ascites|malignant ascites
731355|NCT01077076|Gastric Acid|gastric acid
731356|NCT01077076|Human Experimentation|human experimentation
731357|NCT01077089|traumatic brain injury|traumatic brain injury
731358|NCT01077089|In-hospital transport|in-hospital transport
731359|NCT01077102|COPD|copd
731360|NCT01077102|eccentric exercise training|eccentric exercise training
731361|NCT01077102|cycle ergometer|cycle ergometer
731362|NCT01077102|muscle function|muscle function
731363|NCT01077115|Cholecystectomy|cholecystectomy
731364|NCT01077115|Cholecystitis|cholecystitis
731365|NCT01077115|Laparoscopy|laparoscopy
731366|NCT01077115|Cholelithiasis|cholelithiasis
731367|NCT01077115|Operative trauma|operative trauma
731368|NCT01077128|Psoriasis|psoriasis
731369|NCT01077128|Quality of life|quality of life
731370|NCT01077154|Early Stage Breast Cancer|early stage breast cancer
731371|NCT01077154|Bone Metastasis|bone metastasis
731998|NCT01093599|Mindfulness|mindfulness
731376|NCT01077154|Stage III breast cancer|stage iii breast cancer
731377|NCT01077154|Stage IIA breast cancer|stage iia breast cancer
731378|NCT01077154|Stage IIB breast cancer|stage iib breast cancer
731379|NCT01077154|Stage IIIA breast cancer|stage iiia breast cancer
731380|NCT01077154|Stage IIIB breast cancer|stage iiib breast cancer
731381|NCT01077154|Stage IIIC breast cancer|stage iiic breast cancer
731382|NCT01077154|Early breast cancer|early breast cancer
731384|NCT01077154|Breast Neoplasms|breast neoplasms
732115|NCT01094158|Liver Fat|liver fat
731385|NCT01077167|Omecamtiv mecarbil|omecamtiv mecarbil
731386|NCT01077167|pharmacokinetics|pharmacokinetics
731387|NCT01077193|Bariatric|bariatric
731388|NCT01077193|Obesity|obesity
731389|NCT01077206|Aneurysm|aneurysm
731390|NCT01077206|statin|statin
731391|NCT01077206|subarachnoid hemorrhage|subarachnoid hemorrhage
731392|NCT01077219|healthy female|healthy female
731398|NCT01077245|Clostridium difficile|clostridium difficile
731399|NCT01077245|Clostridium Infections|clostridium infections
731400|NCT01077245|Gram-Positive Bacterial Infections|gram-positive bacterial infections
731401|NCT01077245|Bacterial Infections|bacterial infections
731402|NCT01077245|Anti-Infective Agents|anti-infective agents
731403|NCT01077245|Clostridium butyricum|clostridium butyricum
731404|NCT01077245|Metronidazole|metronidazole
731405|NCT01077245|Vancomycin|vancomycin
731406|NCT01077245|Gastrointestinal Diseases|gastrointestinal diseases
731407|NCT01077245|Physiological Effects of Drugs|physiological effects of drugs
731408|NCT01077245|Colonic Diseases|colonic diseases
731409|NCT01077245|Enterocolitis, Pseudomembranous|enterocolitis, pseudomembranous
731410|NCT01077245|Intestinal Diseases|intestinal diseases
731411|NCT01077245|Enterocolitis|enterocolitis
731412|NCT01077245|Pharmacologic Actions|pharmacologic actions
731413|NCT01077245|Digestive System Diseases|digestive system diseases
731414|NCT01077245|Therapeutic Uses|therapeutic uses
731415|NCT01077245|Gastroenteritis|gastroenteritis
731417|NCT01077245|Diarrhea|diarrhea
731418|NCT01077245|Probiotics|probiotics
731419|NCT01077245|Gastrointestinal Agents|gastrointestinal agents
731420|NCT01077258|Safety|safety
731421|NCT01077258|Long-term observation|long-term observation
731422|NCT01077258|Routine Clinical Setting|routine clinical setting
731423|NCT01077258|Rheumatoid Arthritis|rheumatoid arthritis
731424|NCT01077258|Effectiveness|effectiveness
731425|NCT01077271|Premature infants|premature infants
731426|NCT01077271|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
731427|NCT01077271|Compliance|compliance
731428|NCT01077271|Palivizumab|palivizumab
731429|NCT01077284|Kidney Calculi|kidney calculi
731430|NCT01077284|Kidney Stones|kidney stones
731431|NCT01077284|Nephrolithiasis|nephrolithiasis
731432|NCT01077284|Drug Therapy|drug therapy
731433|NCT01077284|Uric Acid|uric acid
731435|NCT01077310|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
731436|NCT01077310|Alcohol dependence|alcohol dependence
731437|NCT01077310|CD4|cd4
731438|NCT01077310|HIV-1 RNA|hiv-1 rna
731439|NCT01077310|Alcohol treatment outcomes|alcohol treatment outcomes
731440|NCT01077323|pancreatitis|pancreatitis
731441|NCT01077323|exenatide|exenatide
731442|NCT01077323|Byetta|byetta
731443|NCT01077323|Amylin|amylin
731445|NCT01077336|susceptibility testing|susceptibility testing
731446|NCT01077349|Cardiac surgery|cardiac surgery
731447|NCT01077349|Shock|shock
731448|NCT01077349|Continuous Veno-Venous Haemofiltration|continuous veno-venous haemofiltration
731449|NCT01077349|Continuous Renal Replacement Therapy|continuous renal replacement therapy
731450|NCT01077349|Renal Insufficiency|renal insufficiency
731451|NCT01077349|Acute|acute
731452|NCT01077362|Ustekinumab|ustekinumab
731453|NCT01077362|CNTO 1275|cnto 1275
731454|NCT01077362|Stelara|stelara
731455|NCT01077362|Psoriatic Arthritis|psoriatic arthritis
731456|NCT01077362|Psoriasis|psoriasis
731457|NCT01077362|TNF alpha|tnf alpha
731458|NCT01077375|Milnacipran|milnacipran
731459|NCT01077375|Duloxetine|duloxetine
731460|NCT01077375|Switch|switch
731461|NCT01077375|Forest Research Institute|forest research institute
731462|NCT01077388|CVD|cvd
731463|NCT01077388|uncontrolled HTN|uncontrolled htn
731464|NCT01077401|Diabetic|diabetic
731465|NCT01077401|edema|edema
731466|NCT01077401|DME|dme
731467|NCT01077414|Psychosocial Functioning|psychosocial functioning
731468|NCT01077414|Psychosocial Stress|psychosocial stress
731469|NCT01077414|Palliative Care|palliative care
731470|NCT01077414|Spirituality|spirituality
731471|NCT01077414|Cancer|cancer
731472|NCT01077427|pancreatic cancer|pancreatic cancer
731473|NCT01077427|adjuvant treatment|adjuvant treatment
731474|NCT01077427|hyperthermia|hyperthermia
731475|NCT01077440|cancer survivor|cancer survivor
731476|NCT01077440|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
731477|NCT01077440|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
731478|NCT01077440|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
731479|NCT01077440|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
731480|NCT01077440|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
731481|NCT01077440|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
731482|NCT01077440|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
731483|NCT01077440|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
731484|NCT01077440|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
731485|NCT01077440|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
731486|NCT01077440|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
731487|NCT01077440|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
731488|NCT01077440|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
731489|NCT01077440|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
731490|NCT01077440|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
731491|NCT01077440|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
731492|NCT01077440|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
731493|NCT01077440|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
731494|NCT01077440|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
731495|NCT01077440|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
731496|NCT01077440|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
731497|NCT01077440|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
731498|NCT01077440|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
731499|NCT01077440|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
731500|NCT01077440|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
731501|NCT01077440|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
731502|NCT01077440|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
731503|NCT01077440|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
731504|NCT01077440|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
731505|NCT01077440|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
731506|NCT01077440|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
731507|NCT01077440|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
731508|NCT01077440|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
731509|NCT01077440|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
731510|NCT01077440|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
731511|NCT01077440|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
731512|NCT01077440|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
731513|NCT01077440|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
731514|NCT01077440|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
731515|NCT01077440|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
731516|NCT01077440|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
731517|NCT01077440|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
731518|NCT01077440|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
731519|NCT01077440|splenic marginal zone lymphoma|splenic marginal zone lymphoma
731520|NCT01077440|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
731873|NCT01078714|Autism|autism
731521|NCT01077440|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
731522|NCT01077440|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
731523|NCT01077440|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
731524|NCT01077440|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
731525|NCT01077440|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
731526|NCT01077440|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
731527|NCT01077440|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
731528|NCT01077440|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
731529|NCT01077440|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
731530|NCT01077440|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
731531|NCT01077440|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
731532|NCT01077440|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
731533|NCT01077440|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
731534|NCT01077440|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
731535|NCT01077440|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
731536|NCT01077440|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
731537|NCT01077440|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
731538|NCT01077440|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
731539|NCT01077440|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
731540|NCT01077440|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
731541|NCT01077440|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
731542|NCT01077440|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
731543|NCT01077440|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
731544|NCT01077440|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
731545|NCT01077440|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
731546|NCT01077440|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
731547|NCT01077440|refractory hairy cell leukemia|refractory hairy cell leukemia
731548|NCT01077440|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
731549|NCT01077440|secondary acute myeloid leukemia|secondary acute myeloid leukemia
731550|NCT01077440|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
731551|NCT01077440|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
731552|NCT01077440|chronic eosinophilic leukemia|chronic eosinophilic leukemia
731553|NCT01077440|primary myelofibrosis|primary myelofibrosis
731554|NCT01077440|chronic neutrophilic leukemia|chronic neutrophilic leukemia
731555|NCT01077440|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
731556|NCT01077440|disseminated neuroblastoma|disseminated neuroblastoma
731557|NCT01077440|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
731558|NCT01077440|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
731559|NCT01077440|recurrent neuroblastoma|recurrent neuroblastoma
731560|NCT01077440|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
731561|NCT01077440|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
731562|NCT01077440|stage I multiple myeloma|stage i multiple myeloma
731563|NCT01077440|stage II multiple myeloma|stage ii multiple myeloma
731564|NCT01077440|stage III multiple myeloma|stage iii multiple myeloma
731565|NCT01077440|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
731566|NCT01077440|refractory multiple myeloma|refractory multiple myeloma
731567|NCT01077466|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
731568|NCT01077466|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
731569|NCT01077466|Natalizumab|natalizumab
731570|NCT01077466|Treatment|treatment
731571|NCT01077466|Safety|safety
731572|NCT01077466|Efficacy|efficacy
731573|NCT01077466|Cerebrospinal fluid|cerebrospinal fluid
731574|NCT01077466|Osteopontin|osteopontin
731575|NCT01077479|body fat mass gain|body fat mass gain
731576|NCT01077479|Insulin resistance|insulin resistance
731577|NCT01077492|lung cancer|lung cancer
731578|NCT01077492|mediastinal lymph nodes|mediastinal lymph nodes
731579|NCT01077492|TBNA|tbna
731580|NCT01077492|staging lung cancer|staging lung cancer
731581|NCT01077505|pharmacokinetics|pharmacokinetics
731582|NCT01077505|GSK716155|gsk716155
731583|NCT01077505|Brevicon|brevicon
731584|NCT01077505|albiglutide|albiglutide
731585|NCT01077505|healthy female volunteers|healthy female volunteers
731586|NCT01077505|oral contraceptive|oral contraceptive
731587|NCT01077518|Refractory|refractory
731588|NCT01077518|Safety|safety
731589|NCT01077518|Efficacy|efficacy
731590|NCT01077518|Rituximab refractory|rituximab refractory
731591|NCT01077518|Oncology|oncology
731592|NCT01077531|Rheumatoid arthritis|rheumatoid arthritis
731593|NCT01077531|intravenous infusion|intravenous infusion
731594|NCT01077531|long-term followup|long-term followup
731595|NCT01077544|Chronic Myeloid Leukemia|chronic myeloid leukemia
731596|NCT01077544|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
731597|NCT01077544|Ph+ CML|ph+ cml
731598|NCT01077544|Ph+ ALL|ph+ all
731599|NCT01077544|pediatric|pediatric
731600|NCT01077544|nilotinib|nilotinib
731601|NCT01077544|imatinib|imatinib
731602|NCT01077544|chronic phase|chronic phase
731603|NCT01077544|accelerated phase|accelerated phase
731604|NCT01077544|newly diagnosed Ph+ CML|newly diagnosed ph+ cml
731605|NCT01077544|dasatinib|dasatinib
731606|NCT01077557|Combivir (Zidovudine+Lamivudine)|combivir (zidovudine+lamivudine)
731607|NCT01077557|Trizivir (Abacavir+Lamivudine+Zidovudine)|trizivir (abacavir+lamivudine+zidovudine)
731608|NCT01077557|Zidovudine|zidovudine
731609|NCT01077557|Epzicom (Abacavir+Lamivudine)|epzicom (abacavir+lamivudine)
731610|NCT01077557|Fracture|fracture
731611|NCT01077557|Amprenavir|amprenavir
731612|NCT01077557|human immunodeficiency virus (HIV) infection|human immunodeficiency virus (hiv) infection
731613|NCT01077557|antiretroviral (ARV) therapy|antiretroviral (arv) therapy
731614|NCT01077557|Lamivudine|lamivudine
731615|NCT01077557|incidence|incidence
731616|NCT01077557|Abacavir|abacavir
731617|NCT01077557|risk|risk
731618|NCT01077557|Fosamprenavir|fosamprenavir
731619|NCT01077583|Pregnancy test|pregnancy test
731620|NCT01077583|Wishing to become pregnant|wishing to become pregnant
731621|NCT01077596|Carcinogenicity|carcinogenicity
731622|NCT01077596|Case control|case control
731623|NCT01077596|Bupropion|bupropion
731624|NCT01077609|Intranasal steroids|intranasal steroids
731625|NCT01077609|beclometasone diproprionate|beclometasone diproprionate
731626|NCT01077609|steroid-related outcomes|steroid-related outcomes
731628|NCT01077635|Antiretroviral therapy|antiretroviral therapy
731629|NCT01077635|protease inbitor|protease inbitor
731630|NCT01077635|fosamprenavir|fosamprenavir
731631|NCT01077635|paediatrics|paediatrics
731632|NCT01077648|Breast Cancer|breast cancer
731633|NCT01077648|Treatment|treatment
731634|NCT01077648|Brain metastases|brain metastases
731635|NCT01077648|ErbB2 expression|erbb2 expression
731636|NCT01077661|Nebivolol|nebivolol
731637|NCT01077661|PMS (post-marketing surveillance)|pms (post-marketing surveillance)
731638|NCT01077674|Electroencephalogram|electroencephalogram
731640|NCT01077674|BIS|bis
731641|NCT01077674|Sevoflurane|sevoflurane
731642|NCT01077687|schizophrenia|schizophrenia
731643|NCT01077687|genome-wide association study (GWAS)|genome-wide association study (gwas)
731644|NCT01077687|single-nucleotide polymorphisms (SNPs)|single-nucleotide polymorphisms (snps)
731645|NCT01077687|Han Chinese population|han chinese population
731646|NCT01077687|trio families|trio families
731647|NCT01077687|Schizophrenia with trio families|schizophrenia with trio families
731648|NCT01077752|Pain, postoperative|pain, postoperative
731649|NCT01077752|Local infiltration|local infiltration
731650|NCT01077752|Hyperalgesia, postoperative|hyperalgesia, postoperative
753917|NCT01178281|Primary Myelofibrosis|primary myelofibrosis
731651|NCT01077752|Local anesthetic, ropivacaine, lidocaine|local anesthetic, ropivacaine, lidocaine
731652|NCT01077752|Colorectal laparoscopic surgery|colorectal laparoscopic surgery
731653|NCT01077752|Pain management after colorectal laparoscopic surgery|pain management after colorectal laparoscopic surgery
731654|NCT01077765|HIV-associated Lipodystrophy|hiv-associated lipodystrophy
731655|NCT01077765|Polyacrylamide hydrogel|polyacrylamide hydrogel
731656|NCT01077778|Magnetic Resonance Imaging/methods|magnetic resonance imaging/methods
731657|NCT01077778|Magnetic Resonance Angiography|magnetic resonance angiography
731658|NCT01077778|Perfusion Imaging|perfusion imaging
731659|NCT01077778|Pulmonary Embolism/diagnosis|pulmonary embolism/diagnosis
731660|NCT01077791|Schizophrenia|schizophrenia
731661|NCT01077791|social cognition|social cognition
731662|NCT01077791|theory of mind|theory of mind
731663|NCT01077791|cognitive therapy|cognitive therapy
731664|NCT01077791|therapeutic trial|therapeutic trial
731665|NCT01077791|magnetoencephalography (MEG)|magnetoencephalography (meg)
731666|NCT01077830|New Incidence of Cancer|new incidence of cancer
731667|NCT01077843|Ankylosing Spondylitis|ankylosing spondylitis
731668|NCT01077856|congenital anomaly|congenital anomaly
731669|NCT01077856|pregnancy|pregnancy
731670|NCT01077856|GARDASIL®|gardasil®
731671|NCT01077856|Nordic|nordic
731672|NCT01077856|population-based|population-based
731673|NCT01077869|oropharynx and lymph node metastases from an unknown primary tumor|oropharynx and lymph node metastases from an unknown primary tumor
731674|NCT01077882|Moderate and severe psoriasis and atopic dermatitis|moderate and severe psoriasis and atopic dermatitis
731675|NCT01077895|Critically ill patients with positive fluid balance, IAH and AKI requiring RRT|critically ill patients with positive fluid balance, iah and aki requiring rrt
731676|NCT01077908|Adoptive cellular therapy|adoptive cellular therapy
731677|NCT01077908|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
731678|NCT01077921|sickle|sickle
731679|NCT01077921|adhesion|adhesion
731680|NCT01077921|propranolol|propranolol
731681|NCT01077934|All Patients admitted to Grady Memorial Hospital with Unilateral Lower leg injury at risk for compartment syndrome|all patients admitted to grady memorial hospital with unilateral lower leg injury at risk for compartment syndrome
731682|NCT01077947|low back pain|low back pain
731683|NCT01077947|spinal fusion|spinal fusion
731684|NCT01077947|Primarily axial low back pain|primarily axial low back pain
731685|NCT01077960|Serostim|serostim
731686|NCT01077960|HARS|hars
731687|NCT01077973|Headache|headache
731688|NCT01077986|mTOR inhibition|mtor inhibition
731689|NCT01077986|EGFR inhibition|egfr inhibition
731690|NCT01077986|pancreatic cancer|pancreatic cancer
731691|NCT01077986|pharmacodynamics|pharmacodynamics
731692|NCT01077999|chemoradiation|chemoradiation
731693|NCT01077999|panitumumab|panitumumab
731694|NCT01077999|esophageal cancer|esophageal cancer
731695|NCT01077999|Resectable squamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma of the intrathoracic esophagus or gastro esophageal junction|resectable squamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma of the intrathoracic esophagus or gastro esophageal junction
731696|NCT01078025|transvaginal access for cholecystectomy|transvaginal access for cholecystectomy
731697|NCT01078038|Coronary Artery Disease|coronary artery disease
731698|NCT01078038|Stent|stent
731699|NCT01078051|chronic total occlusion|chronic total occlusion
731700|NCT01078051|stent|stent
731701|NCT01078051|medical therapy|medical therapy
731702|NCT01078064|Gastroesophageal reflux disease, gastric motility|gastroesophageal reflux disease, gastric motility
731703|NCT01078077|healthy females ages twentyfive through sixty|healthy females ages twentyfive through sixty
731704|NCT01078090|Safety|safety
731705|NCT01078090|Rheumatoid Arthritis|rheumatoid arthritis
731999|NCT01093599|Meditation|meditation
731706|NCT01078090|Effectiveness|effectiveness
731707|NCT01078103|Diabetes Mellitus|diabetes mellitus
731708|NCT01078103|cornea endothelium|cornea endothelium
731709|NCT01078103|cell loss|cell loss
731710|NCT01078103|cataract surgery|cataract surgery
731711|NCT01078116|Rheumatoid Arthritis|rheumatoid arthritis
731712|NCT01078116|Adalimumab treatment|adalimumab treatment
751880|NCT01171040|atrial fibrillation|atrial fibrillation
731713|NCT01078116|Evaluation of the patients' Health Related Quality of Life|evaluation of the patients' health related quality of life
731714|NCT01078116|Cost of the disease management|cost of the disease management
731715|NCT01078129|cognitive deficits|cognitive deficits
731716|NCT01078142|temsirolimus|temsirolimus
731717|NCT01078142|bendamustine|bendamustine
731718|NCT01078142|rituximab|rituximab
731719|NCT01078142|mantle cell lymphoma|mantle cell lymphoma
731720|NCT01078142|follicular lymphoma|follicular lymphoma
731721|NCT01078155|Bone mineral density|bone mineral density
731722|NCT01078155|Bone turnover markers|bone turnover markers
731723|NCT01078155|Rheumatoid arthritis|rheumatoid arthritis
731724|NCT01078155|Osteoporosis|osteoporosis
731725|NCT01078168|Alzheimer`s Disease|alzheimer`s disease
731726|NCT01078181|gastric bypass|gastric bypass
731727|NCT01078181|banded gastric bypass|banded gastric bypass
731728|NCT01078181|weight loss|weight loss
731729|NCT01078181|weight regain|weight regain
731730|NCT01078181|bariatric surgery|bariatric surgery
731731|NCT01078194|Weight regain|weight regain
731732|NCT01078194|Weight loss failure|weight loss failure
731733|NCT01078194|Gastric bypass|gastric bypass
731734|NCT01078220|Human Papillomavirus (HPV)|human papillomavirus (hpv)
731735|NCT01078233|HIV|hiv
731736|NCT01078233|antiretroviral treatment|antiretroviral treatment
731737|NCT01078233|HIV Cohort|hiv cohort
731738|NCT01078233|Treatment|treatment
731739|NCT01078246|HIV|hiv
731740|NCT01078272|Coronary Atherosclerosis|coronary atherosclerosis
731741|NCT01078272|Percutaneous Coronary Intervention|percutaneous coronary intervention
731742|NCT01078272|Coronary Stenting|coronary stenting
731743|NCT01078272|Coronary Stenosis|coronary stenosis
731744|NCT01078272|Remote Ischemic Preconditioning|remote ischemic preconditioning
731745|NCT01078285|Integrated program on adherence using counseling|integrated program on adherence using counseling
731746|NCT01078285|support services including cost-sharing where appropriate and educational materials mailed monthly.|support services including cost-sharing where appropriate and educational materials mailed monthly.
731747|NCT01078298|smoking|smoking
731748|NCT01078298|smoking cessation|smoking cessation
731749|NCT01078298|smoking cessation in depressed subjects|smoking cessation in depressed subjects
731750|NCT01078311|Patients with advanced hepatocellular cancer|patients with advanced hepatocellular cancer
731751|NCT01078350|Lymphoma|lymphoma
731752|NCT01078350|Hodgkin Disease|hodgkin disease
731753|NCT01078363|Heart Transplantation|heart transplantation
731754|NCT01078376|Pediatrics|pediatrics
731755|NCT01078376|Blood Pressure, High|blood pressure, high
731756|NCT01078376|Drug Therapy|drug therapy
731757|NCT01078389|Gout|gout
731758|NCT01078389|Hyperuricemia|hyperuricemia
731759|NCT01078389|Uric Acid|uric acid
731760|NCT01078389|Drug Therapy|drug therapy
731761|NCT01078402|Treatment compliance and tolerability of Humira in patients|treatment compliance and tolerability of humira in patients
731762|NCT01078402|Eastern European countries|eastern european countries
731763|NCT01078402|Rheumatoid Arthritis|rheumatoid arthritis
731764|NCT01078402|Psoriatic Arthritis|psoriatic arthritis
731765|NCT01078402|Adalimumab|adalimumab
731766|NCT01078402|Ankylosing Spondylitis|ankylosing spondylitis
731767|NCT01078402|Evaluation of clinical outcome|evaluation of clinical outcome
731768|NCT01078415|HCC|hcc
731769|NCT01078415|Hepatocellular Carcinoma|hepatocellular carcinoma
731770|NCT01078415|Early Stage|early stage
731771|NCT01078415|Prospective|prospective
731773|NCT01078415|Irreversible Electroporation (IRE)|irreversible electroporation (ire)
731774|NCT01078415|Electroporation|electroporation
731775|NCT01078415|Low Energy Direct Current|low energy direct current
731776|NCT01078415|LEDC|ledc
731777|NCT01078415|Nonthermal ablation|nonthermal ablation
731778|NCT01078415|NTIRE (nonthermal IRE)|ntire (nonthermal ire)
731779|NCT01078415|Ablation|ablation
731780|NCT01078415|Soft Tissue|soft tissue
731781|NCT01078428|Hypertrophic scars|hypertrophic scars
731782|NCT01078428|Topical silicone gel|topical silicone gel
731783|NCT01078428|Scar thickness|scar thickness
731784|NCT01078428|Scar Color|scar color
731785|NCT01078428|Scar pliability|scar pliability
731786|NCT01078428|Scar appearance|scar appearance
731787|NCT01078441|Bortezomib|bortezomib
731788|NCT01078441|Liposomal Doxorubicin|liposomal doxorubicin
731789|NCT01078441|Dexamethasone|dexamethasone
731790|NCT01078441|Cyclophosphamide|cyclophosphamide
731791|NCT01078441|refractory multiple myeloma|refractory multiple myeloma
731792|NCT01078454|Melphalan|melphalan
731793|NCT01078454|Dexamethasone|dexamethasone
731794|NCT01078454|Bortezomib|bortezomib
731795|NCT01078454|Systemic Light-chain (AL) Amyloidosis|systemic light-chain (al) amyloidosis
731796|NCT01078467|Wound Healing|wound healing
731797|NCT01078467|Oral Wounds|oral wounds
731798|NCT01078467|Cutaneous Wounds|cutaneous wounds
731799|NCT01078467|Gene Array Analysis|gene array analysis
731800|NCT01078467|Proteomic Analysis|proteomic analysis
731801|NCT01078467|Healthy Volunteer|healthy volunteer
731803|NCT01078480|Fracture|fracture
731804|NCT01078480|Collar bone|collar bone
731805|NCT01078493|Platelet rich plasma|platelet rich plasma
731806|NCT01078493|PRP|prp
731807|NCT01078493|wrinkles|wrinkles
731808|NCT01078493|MyCells®|mycells®
731809|NCT01078493|CREATE|create
731810|NCT01078493|Life Source Medical Centre|life source medical centre
731811|NCT01078493|Dr Tan Kok leong|dr tan kok leong
731812|NCT01078506|Chinese|chinese
731813|NCT01078506|intracranial aneurysm|intracranial aneurysm
731814|NCT01078506|magnetic resonance imaging|magnetic resonance imaging
731815|NCT01078519|Fever|fever
731816|NCT01078519|anesthesia|anesthesia
731817|NCT01078519|Labor|labor
731818|NCT01078532|medically complex diseases that increase cardiovascular risk|medically complex diseases that increase cardiovascular risk
732311|NCT01094951|Depression|depression
731819|NCT01078545|Prostate cancer|prostate cancer
731820|NCT01078545|Lower urinary tract symptoms|lower urinary tract symptoms
731821|NCT01078545|Hormonotherapy|hormonotherapy
731822|NCT01078545|LHRH analogue|lhrh analogue
731823|NCT01078545|Androgen deprivation therapy (ADT)|androgen deprivation therapy (adt)
731824|NCT01078558|Multicenter study|multicenter study
731825|NCT01078571|Rheumatoid Arthritis|rheumatoid arthritis
731826|NCT01078571|Biologic|biologic
731827|NCT01078571|Tumor Necrosis Factors blockers agents Monoclonal antibody|tumor necrosis factors blockers agents monoclonal antibody
731828|NCT01078584|Uncontrolled hypertension|uncontrolled hypertension
731829|NCT01078584|trandolapril|trandolapril
731830|NCT01078597|anti-MCV|anti-mcv
731831|NCT01078597|anti-CCP|anti-ccp
731832|NCT01078597|Biomarkers|biomarkers
731833|NCT01078597|Rheumatoid Arthritis|rheumatoid arthritis
731834|NCT01078610|Psoriatic Arthritis|psoriatic arthritis
731835|NCT01078610|Long-term Observation|long-term observation
731836|NCT01078610|Humira|humira
731837|NCT01078610|Safety|safety
731838|NCT01078610|Effectiveness|effectiveness
731839|NCT01078610|Quality of Life|quality of life
731840|NCT01078610|Work Productivity|work productivity
731841|NCT01078623|Bronchitis|bronchitis
731842|NCT01078623|Chronic|chronic
731843|NCT01078623|Emphysema|emphysema
731844|NCT01078636|amyloid|amyloid
731845|NCT01078636|plaques|plaques
731846|NCT01078636|imaging|imaging
731847|NCT01078636|early detection|early detection
731848|NCT01078636|Amnestic MCI|amnestic mci
731849|NCT01078636|pre-dementia|pre-dementia
731850|NCT01078649|cancer|cancer
731851|NCT01078649|solid tumors|solid tumors
731852|NCT01078649|lymphoma|lymphoma
731853|NCT01078649|smac mimetic|smac mimetic
731854|NCT01078649|IAP inhibitor|iap inhibitor
731855|NCT01078649|Phase I|phase i
731856|NCT01078649|Dose escalation|dose escalation
731857|NCT01078662|olaparib|olaparib
731858|NCT01078662|PARP inhibitors|parp inhibitors
731859|NCT01078662|genetic BRCA1 mutation|genetic brca1 mutation
731860|NCT01078662|BRCA2 mutation|brca2 mutation
731861|NCT01078662|solid tumour refractory|solid tumour refractory
731862|NCT01078675|Familial Hypercholesterolaemia|familial hypercholesterolaemia
731863|NCT01078675|pediatric|pediatric
731864|NCT01078688|Limitations of activities|limitations of activities
731865|NCT01078688|persistent asthma|persistent asthma
731866|NCT01078688|general practitioner|general practitioner
731867|NCT01078688|frequency of limitations of activities|frequency of limitations of activities
731868|NCT01078688|depending on gender and age-group|depending on gender and age-group
731869|NCT01078701|live attenuated flu vaccines|live attenuated flu vaccines
731870|NCT01078701|Influenza A (H1N1)|influenza a (h1n1)
731871|NCT01078701|intranasal application|intranasal application
731872|NCT01078701|replication-deficient influenza virus|replication-deficient influenza virus
731874|NCT01078714|Bumetanide|bumetanide
731875|NCT01078714|GABA|gaba
731876|NCT01078714|NKCC1|nkcc1
731877|NCT01078727|Thermal Stimulation|thermal stimulation
731878|NCT01078727|Upper Extremity|upper extremity
731879|NCT01078727|Motor Recovery|motor recovery
731880|NCT01078727|Stroke|stroke
731881|NCT01078740|cystic fibrosis|cystic fibrosis
731882|NCT01078740|cystic fibrosis transmembrane conductance regulator|cystic fibrosis transmembrane conductance regulator
731883|NCT01078740|biomarkers|biomarkers
731884|NCT01078740|Intestinal Current Measurement|intestinal current measurement
731885|NCT01078766|cerebral palsy|cerebral palsy
731886|NCT01078779|Influenza|influenza
731887|NCT01078779|Prevention|prevention
731888|NCT01078779|Chloroquine|chloroquine
731889|NCT01078779|Randomised controlled trial|randomised controlled trial
731890|NCT01078779|Respiratory virus infection|respiratory virus infection
731891|NCT01078818|Cardiac surgery|cardiac surgery
731892|NCT01078818|Extracorporeal circulation|extracorporeal circulation
731893|NCT01078818|Anaemia|anaemia
731894|NCT01078818|Intravenous iron|intravenous iron
731895|NCT01078818|Oral Iron|oral iron
731896|NCT01078844|Autism|autism
731897|NCT01078844|Asperger's Disorder|asperger's disorder
731898|NCT01078844|Pervasive Developmental Disorder NOS|pervasive developmental disorder nos
731899|NCT01078844|Adult|adult
731900|NCT01078844|Memantine|memantine
731901|NCT01078857|Chronic kidney disease|chronic kidney disease
731902|NCT01078857|Small-fiber neuropathy|small-fiber neuropathy
731903|NCT01078857|Skin biopsy|skin biopsy
731904|NCT01078857|Contact heat evoked potential|contact heat evoked potential
731905|NCT01078857|Autonomic neuropathy|autonomic neuropathy
731906|NCT01078857|Neuropathy in late stage chronic kidney disease|neuropathy in late stage chronic kidney disease
731907|NCT01078870|Negative symptom|negative symptom
731908|NCT01078883|Lung cancer|lung cancer
731909|NCT01078883|Respiratory muscle strength|respiratory muscle strength
731911|NCT01078883|Functional capacity|functional capacity
731912|NCT01078909|Cardiovascular disease|cardiovascular disease
731913|NCT01078909|Inflammation|inflammation
731914|NCT01078909|Fish Oil|fish oil
731915|NCT01078909|Omega-3 Fatty Acids|omega-3 fatty acids
731916|NCT01078909|LPS|lps
731917|NCT01078909|Endotoxin|endotoxin
731918|NCT01078922|ofatumumab diffuse B cell non hodgkins lymphoma DLBCL|ofatumumab diffuse b cell non hodgkins lymphoma dlbcl
731919|NCT01078922|refractory DLBCL|refractory dlbcl
731920|NCT01078922|relapsed DLBCL|relapsed dlbcl
731921|NCT01078935|Crohn's disease activity index|crohn's disease activity index
731922|NCT01078935|CDAI|cdai
731923|NCT01078948|tDCS|tdcs
731924|NCT01078948|transcranial direct current stimulation|transcranial direct current stimulation
731925|NCT01078948|major depression|major depression
731926|NCT01078948|double-blind|double-blind
731927|NCT01078948|randomized|randomized
731928|NCT01078948|placebo-controlled|placebo-controlled
731929|NCT01078948|treatment|treatment
731930|NCT01078961|bortezomib|bortezomib
731931|NCT01078961|sorafenib|sorafenib
731932|NCT01078961|advanced melanoma|advanced melanoma
731933|NCT01078974|WM|wm
731934|NCT01078974|pomalidomide|pomalidomide
731935|NCT01078974|dexamethasone|dexamethasone
731936|NCT01078974|rituximab|rituximab
731937|NCT01078987|Nephrogenic Fibrosing Dermopathy (NFD)|nephrogenic fibrosing dermopathy (nfd)
731938|NCT01078987|Nephrogenic Systemic Fibrosis (NSF)|nephrogenic systemic fibrosis (nsf)
731939|NCT01091090|Smoking cessation|smoking cessation
731940|NCT01091090|Nicotine dependence|nicotine dependence
731941|NCT01091090|Chronic pain|chronic pain
731942|NCT01091116|Injections, Intra-Articular|injections, intra-articular
731943|NCT01091129|hyperhidrosis|hyperhidrosis
731944|NCT01091155|Colon Anastomosis|colon anastomosis
731945|NCT01091155|Rectum Anastomosis|rectum anastomosis
731946|NCT01091155|Intestine|intestine
731947|NCT01091155|Colorectal Surgery|colorectal surgery
731948|NCT01091155|Colorectal Anastomosis|colorectal anastomosis
731949|NCT01091181|Caesarean|caesarean
731950|NCT01091194|Heart Transplantation|heart transplantation
731951|NCT01091194|Aerobic Exercise|aerobic exercise
731952|NCT01091194|Exercise, Physical|exercise, physical
731953|NCT01091194|Exercise Test|exercise test
731954|NCT01091194|Treadmill Test|treadmill test
731955|NCT01091194|VO2 peak|vo2 peak
731956|NCT01091194|Muscle Strength|muscle strength
731957|NCT01091194|Quality of Life|quality of life
731958|NCT01091194|Reinnervation|reinnervation
731959|NCT01091194|Heart Rate|heart rate
731960|NCT01091194|Myocardial Function|myocardial function
731961|NCT01091207|Sorafenib|sorafenib
731962|NCT01091207|GIST|gist
731963|NCT01091207|Refractory|refractory
731964|NCT01091207|advanced GIST failed after both imatinib and sunitinib|advanced gist failed after both imatinib and sunitinib
731965|NCT01091220|certolizumab pegol|certolizumab pegol
731966|NCT01091220|Cimzia®|cimzia®
731967|NCT01091220|healthy male volunteers|healthy male volunteers
731968|NCT01091220|sperm|sperm
731969|NCT01091233|Critically ill patients|critically ill patients
731970|NCT01091233|liver cirrhosis|liver cirrhosis
731971|NCT01091233|ascites requiring Paracentesis|ascites requiring paracentesis
731972|NCT01091259|antibody therapy|antibody therapy
731973|NCT01091259|chemotherapy|chemotherapy
731974|NCT01091259|biologic therapy|biologic therapy
731975|NCT01091259|combination therapy|combination therapy
731976|NCT01091272|healthy volunteer|healthy volunteer
731977|NCT01091272|safety|safety
731978|NCT01091272|pharmacokinetic|pharmacokinetic
731979|NCT01091298|Safety of vaccine|safety of vaccine
731980|NCT01091311|Meibomian Gland Dysfunction|meibomian gland dysfunction
731981|NCT01091324|CKD, proteinuria, dextromethorphan, silymarin|ckd, proteinuria, dextromethorphan, silymarin
731982|NCT01091324|patients with 15 ml<eGFR< 60ml and 0.5 g/day<proteinuria<3g/day|patients with 15 ml<egfr< 60ml and 0.5 g/day<proteinuria<3g/day
731983|NCT01091363|smoking cessation|smoking cessation
731984|NCT01091363|tobacco dependence treatment|tobacco dependence treatment
731985|NCT01091363|cultural adaptation|cultural adaptation
731986|NCT01091363|Asian Americans|asian americans
731987|NCT01091376|Non-small cell lung cancer|non-small cell lung cancer
731988|NCT01091376|EGFR-TKI|egfr-tki
731989|NCT01091376|Erlotinib|erlotinib
731990|NCT01091376|Radiotherapy|radiotherapy
731991|NCT01091389|Atrial Fibrillation|atrial fibrillation
731992|NCT01091389|Totally Thoracoscopic PV isolation|totally thoracoscopic pv isolation
731993|NCT01091402|autologous serum skin test, IL-18|autologous serum skin test, il-18
731994|NCT01093599|Smoking|smoking
731995|NCT01093599|Smoking cessation|smoking cessation
731996|NCT01093599|Nicotine|nicotine
731997|NCT01093599|Tobacco|tobacco
732001|NCT01093599|Mindfulness Training|mindfulness training
732002|NCT01093599|Behavioral Intervention|behavioral intervention
732003|NCT01093599|Nicotine Patch|nicotine patch
732004|NCT01093599|Quit Line|quit line
732005|NCT01093599|Phone counseling|phone counseling
732006|NCT01093612|HER2-positive breast cancer|her2-positive breast cancer
751881|NCT01171040|stroke|stroke
751882|NCT01171040|prognosis|prognosis
732007|NCT01093690|chemotherapy induced nausea and vomiting, metoclopramide|chemotherapy induced nausea and vomiting, metoclopramide
732008|NCT01093703|kidney transplantation|kidney transplantation
732010|NCT01093703|chronotherapy|chronotherapy
732011|NCT01093703|graft function|graft function
732012|NCT01093703|circadian pattern|circadian pattern
732013|NCT01093716|Alcohol dependence|alcohol dependence
732015|NCT01093716|rTMS|rtms
732016|NCT01093716|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
732017|NCT01093729|Exendin-4|exendin-4
732018|NCT01093742|Healthy|healthy
732019|NCT01093755|Barrett's Esophagus|barrett's esophagus
732020|NCT01093755|Radiofrequency ablation|radiofrequency ablation
732021|NCT01093755|Patients post-radiofrequency ablation for Barrett's Esophagus.|patients post-radiofrequency ablation for barrett's esophagus.
732022|NCT01093768|Oxytocin|oxytocin
732023|NCT01093768|Vasopressin|vasopressin
732024|NCT01093768|Autism|autism
732025|NCT01093768|Amygdala|amygdala
732026|NCT01093768|Social Cognition|social cognition
732027|NCT01093768|Autism Spectrum Disorders|autism spectrum disorders
732028|NCT01093768|ASD|asd
732029|NCT01093768|Healthy Volunteer|healthy volunteer
732030|NCT01093768|HV|hv
732031|NCT01093781|membranous nephropathy aliskiren proteinuria, glomerulonephritis|membranous nephropathy aliskiren proteinuria, glomerulonephritis
732032|NCT01093794|Type 2 Diabetes|type 2 diabetes
732033|NCT01093807|Hypertension|hypertension
732034|NCT01093807|Lercanidipine|lercanidipine
732035|NCT01093807|Calcium antagonist|calcium antagonist
732036|NCT01093807|Enalapril|enalapril
732037|NCT01093820|acute myocardial infarction|acute myocardial infarction
732038|NCT01093820|continuous erythropoetin receptor activator|continuous erythropoetin receptor activator
732039|NCT01093820|Mircera|mircera
732040|NCT01093820|hemoglobin kinetics|hemoglobin kinetics
732041|NCT01093833|Diabetes|diabetes
732042|NCT01093833|Type 1 diabetes|type 1 diabetes
732043|NCT01093833|Type 2 diabetes|type 2 diabetes
732044|NCT01093833|Diabetes mellitus|diabetes mellitus
732045|NCT01093833|Blood glucose|blood glucose
732046|NCT01093833|Continuous blood glucose monitoring|continuous blood glucose monitoring
732047|NCT01093833|CGM|cgm
732048|NCT01093846|uveitis|uveitis
732049|NCT01093859|acetylcholinesterase|acetylcholinesterase
732050|NCT01093911|Lupus|lupus
732051|NCT01093911|SLE|sle
732052|NCT01093924|Behavioral weight loss maintenance intervention|behavioral weight loss maintenance intervention
732053|NCT01093924|Weight loss|weight loss
732054|NCT01093924|Weight loss maintenance|weight loss maintenance
732055|NCT01093937|Bipolar disorder|bipolar disorder
732056|NCT01093937|Bipolar-I|bipolar-i
732057|NCT01093937|Varenicline|varenicline
732058|NCT01093937|Champix|champix
732059|NCT01093937|Chantix|chantix
732060|NCT01093937|Nicotine|nicotine
732061|NCT01093937|Nicotinic receptor|nicotinic receptor
732062|NCT01093937|Nicotinic receptor dysregulation|nicotinic receptor dysregulation
732063|NCT01093937|Dopamine|dopamine
732064|NCT01093937|Acetylcholine|acetylcholine
732065|NCT01093937|Cigarette|cigarette
732066|NCT01093937|Smoking|smoking
732067|NCT01093937|Tobacco|tobacco
732068|NCT01093937|Dependence|dependence
732069|NCT01093937|Neuropsychological function|neuropsychological function
732070|NCT01093950|anthropometric|anthropometric
732071|NCT01093950|white light scanner|white light scanner
732072|NCT01093950|extraction profiles|extraction profiles
732073|NCT01093950|Body lipodystrophy|body lipodystrophy
732074|NCT01093976|Skin Picking|skin picking
732075|NCT01093976|OCD|ocd
732076|NCT01093976|Trichotillomania|trichotillomania
732077|NCT01093976|Pathological Skin Picking|pathological skin picking
732078|NCT01094002|OCCUPATIONAL THERAPY|occupational therapy
732079|NCT01094002|RANDOMISED CLINICAL TRIAL|randomised clinical trial
732080|NCT01094002|AGED|aged
732081|NCT01094002|PATIENT CARE|patient care
732082|NCT01094015|hysteroscopy|hysteroscopy
732083|NCT01094015|local anaesthetic|local anaesthetic
732084|NCT01094015|pain relief|pain relief
732085|NCT01094015|gynecological pathology|gynecological pathology
732086|NCT01094028|Blood loss in the third and fourth stage of labor and the duration of third stage of labor|blood loss in the third and fourth stage of labor and the duration of third stage of labor
732087|NCT01094041|Gluten|gluten
732088|NCT01094041|Diarrhea or diarrhea predominant irritable bowel syndrome|diarrhea or diarrhea predominant irritable bowel syndrome
732089|NCT01094041|Colonic permeability|colonic permeability
732090|NCT01094041|Small bowel permeability|small bowel permeability
732091|NCT01094041|Colonic inflammatory response|colonic inflammatory response
732092|NCT01094041|Small bowel inflammatory response|small bowel inflammatory response
732093|NCT01094080|fully formula fed|fully formula fed
732094|NCT01094080|fully breast fed|fully breast fed
732095|NCT01094093|Amgen|amgen
732096|NCT01094093|AMG 139|amg 139
732097|NCT01094106|postoperative pain|postoperative pain
732098|NCT01094106|infiltration analgesia|infiltration analgesia
732099|NCT01094106|ropivacaine|ropivacaine
732100|NCT01094106|Caesarean Section|caesarean section
732101|NCT01094119|heated blanket|heated blanket
732102|NCT01094119|heated pad|heated pad
732103|NCT01094132|cervical cancer|cervical cancer
732104|NCT01094132|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
732105|NCT01094132|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
732106|NCT01094132|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
732107|NCT01094132|Nonmalignant Condition|nonmalignant condition
732108|NCT01094145|(light to moderate)|(light to moderate)
732109|NCT01094158|NAFLD|nafld
732110|NCT01094158|NASH|nash
732111|NCT01094158|Fatty Liver|fatty liver
732112|NCT01094158|Metabolic Syndrome|metabolic syndrome
732113|NCT01094158|Endothelial Dysfunction|endothelial dysfunction
732114|NCT01094158|Insulin Resistance|insulin resistance
732116|NCT01094171|poliomyelitis|poliomyelitis
732117|NCT01094171|diphtheria|diphtheria
732118|NCT01094171|Primary immunization|primary immunization
732119|NCT01094171|pertussis|pertussis
732120|NCT01094171|Children|children
732121|NCT01094171|tetanus|tetanus
732122|NCT01094197|Transfusion-associated microchimerism|transfusion-associated microchimerism
732123|NCT01094197|Injuries|injuries
732124|NCT01094197|Leukocytes|leukocytes
732125|NCT01094210|Anti-erosion dental benefits|anti-erosion dental benefits
732126|NCT01094223|Stimulant|stimulant
732127|NCT01094223|Addiction|addiction
732128|NCT01094223|Mindfulness|mindfulness
732129|NCT01094223|Treatment|treatment
732130|NCT01094236|behavior management|behavior management
732131|NCT01094236|academic performance|academic performance
732132|NCT01094236|playground supervision|playground supervision
732133|NCT01094236|harm reduction|harm reduction
732134|NCT01094236|Behavioral Research|behavioral research
732135|NCT01094249|Paliperidone ER|paliperidone er
732136|NCT01094249|INVEGA|invega
732137|NCT01094249|Divalproex sodium|divalproex sodium
732138|NCT01094249|Depakote ER|depakote er
732139|NCT01094249|Valproic acid|valproic acid
732140|NCT01094249|Pharmacokinetics|pharmacokinetics
732141|NCT01094249|R076477BIM1004|r076477bim1004
732142|NCT01094262|Osteoarthritis pain of the knee|osteoarthritis pain of the knee
732143|NCT01094262|Osteoarthritis|osteoarthritis
732144|NCT01094262|Osteoarthritis, Knee|osteoarthritis, knee
732145|NCT01094262|Pain|pain
732146|NCT01094262|Arthralgia|arthralgia
732147|NCT01094262|Joint Pain|joint pain
732148|NCT01094262|JNJ-42160443|jnj-42160443
732149|NCT01094275|drug resistance|drug resistance
732150|NCT01094275|gene polymorphism|gene polymorphism
732151|NCT01094301|electrical stimulation|electrical stimulation
732152|NCT01094301|neurostimulation|neurostimulation
732153|NCT01094301|neuromodulation|neuromodulation
732154|NCT01094301|shoulder pain|shoulder pain
732155|NCT01094301|post-stroke shoulder pain|post-stroke shoulder pain
732156|NCT01094301|hemiplegic shoulder pain|hemiplegic shoulder pain
732157|NCT01094327|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
732158|NCT01094353|Urodynamic Stress urinary incontinence|urodynamic stress urinary incontinence
732159|NCT01094353|Minisling|minisling
732160|NCT01094353|Ophira™|ophira™
732161|NCT01094353|Unitape™|unitape™
732162|NCT01094366|Paracervical Block|paracervical block
732163|NCT01094366|pain control|pain control
732164|NCT01094366|abortion|abortion
732165|NCT01094379|cholecystectomy|cholecystectomy
732166|NCT01094379|laparoscopic|laparoscopic
732167|NCT01094379|pain|pain
732168|NCT01094379|single incision|single incision
732169|NCT01094392|ALL|all
732170|NCT01094392|PEG-asparaginase|peg-asparaginase
732171|NCT01094392|prolonged treatment|prolonged treatment
732172|NCT01094392|Thrombosis|thrombosis
732173|NCT01094392|Central venous line|central venous line
732174|NCT01094392|Echocardiography|echocardiography
732175|NCT01094405|NPC with persistent, recurrent or metastatic disease patients|npc with persistent, recurrent or metastatic disease patients
732176|NCT01094418|polyneuropathy|polyneuropathy
732177|NCT01094418|Nerve conduction study|nerve conduction study
732178|NCT01094418|Impaired glucose tolerance test|impaired glucose tolerance test
732179|NCT01094418|Diabetes mellitus|diabetes mellitus
732180|NCT01094431|Fever|fever
732181|NCT01094431|Etiology|etiology
732182|NCT01094431|Children under five years of age|children under five years of age
732183|NCT01094431|IMCI|imci
732184|NCT01094444|Vitamin K3 lotion|vitamin k3 lotion
732185|NCT01094444|Cetuximab induced folliculitis|cetuximab induced folliculitis
732186|NCT01094457|antiplatelet therapy|antiplatelet therapy
732187|NCT01094457|clopidogrel low responsiveness|clopidogrel low responsiveness
732188|NCT01094457|acute coronary syndromes|acute coronary syndromes
732189|NCT01094457|percutaneous coronary intervention|percutaneous coronary intervention
732190|NCT01094457|cilostazol|cilostazol
732191|NCT01094470|gait|gait
732192|NCT01094470|ambulation|ambulation
732193|NCT01094470|kinematics|kinematics
732194|NCT01094483|Thromboxane B2|thromboxane b2
732679|NCT01082042|Exercise|exercise
732195|NCT01094496|bladder cancer|bladder cancer
732196|NCT01094496|immunotherapy|immunotherapy
732197|NCT01094496|cystectomy|cystectomy
732198|NCT01094496|cancer vaccine|cancer vaccine
732199|NCT01094496|human chorionic gonadotropin|human chorionic gonadotropin
732201|NCT01094496|urogenital neoplasms|urogenital neoplasms
732202|NCT01094496|urinary bladder neoplasms|urinary bladder neoplasms
732204|NCT01094496|non-metastatic|non-metastatic
732205|NCT01094496|transitional cell (urothelial) bladder cancer|transitional cell (urothelial) bladder cancer
732206|NCT01094535|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
732207|NCT01094535|Synthetic human secretin|synthetic human secretin
732208|NCT01094535|Secretin-enhanced MRCP|secretin-enhanced mrcp
732209|NCT01094535|Pancreatic insufficiency|pancreatic insufficiency
732210|NCT01094535|Endoscopic Pancreatic Function Test (ePFT)|endoscopic pancreatic function test (epft)
732211|NCT01094535|Endocrine pancreatic function test|endocrine pancreatic function test
732212|NCT01094535|Exocrine pancreatic function test|exocrine pancreatic function test
732499|NCT01095640|adapalene|adapalene
732213|NCT01094548|L-BLP25 liposome|l-blp25 liposome
732214|NCT01094548|Multiple myeloma|multiple myeloma
732215|NCT01094561|Family history of pancreatic cancer|family history of pancreatic cancer
732216|NCT01094561|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
732217|NCT01094561|Imaging techniques|imaging techniques
732218|NCT01094561|Synthetic human secretin|synthetic human secretin
732219|NCT01094561|Pancreatic abnormalities|pancreatic abnormalities
732220|NCT01094561|Early detection and prevention|early detection and prevention
732221|NCT01094600|Pancreatic cancer|pancreatic cancer
732222|NCT01094600|Pancreatic resection|pancreatic resection
732223|NCT01094600|Synthetic human secretin|synthetic human secretin
732224|NCT01094600|Secretin-enhanced MRCP|secretin-enhanced mrcp
732225|NCT01094600|Endoscopic pancreatic function test|endoscopic pancreatic function test
732226|NCT01094600|Pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
732227|NCT01094613|Crohn's Disease|crohn's disease
732228|NCT01094613|Delayed Release|delayed release
732229|NCT01094613|Targeted Ileal Delivery|targeted ileal delivery
732230|NCT01094626|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
732231|NCT01094626|Intraductal papillary mucinous neoplasm|intraductal papillary mucinous neoplasm
732232|NCT01094626|Imaging techniques|imaging techniques
732233|NCT01094626|Pancreatic surgical resection|pancreatic surgical resection
732234|NCT01094626|Synthetic human secretin|synthetic human secretin
732235|NCT01094652|Adolescent|adolescent
732236|NCT01094652|Whole grain|whole grain
732237|NCT01094652|Digestive health|digestive health
732238|NCT01094652|Dietary fiber|dietary fiber
732239|NCT01094652|Grain|grain
732240|NCT01094652|Microbiota|microbiota
732241|NCT01094652|Inflammation|inflammation
732242|NCT01094652|Mucosal Immunity|mucosal immunity
732243|NCT01094678|Peripheral Aterial Disease (PAD)|peripheral aterial disease (pad)
732244|NCT01094678|Peripheral Vascular Disease|peripheral vascular disease
732245|NCT01094678|Drug-Eluting Stent|drug-eluting stent
732246|NCT01094678|Drug-Coated Stent|drug-coated stent
732247|NCT01094678|Vascular Diseases|vascular diseases
732248|NCT01094678|Cardiovascular Diseases|cardiovascular diseases
732249|NCT01094704|cystic fibrosis|cystic fibrosis
732250|NCT01094704|mucociliary clearance|mucociliary clearance
732251|NCT01094704|hypertonic saline|hypertonic saline
732252|NCT01094717|psoriasis|psoriasis
732253|NCT01094717|excimer|excimer
732254|NCT01094717|acitretin|acitretin
732255|NCT01094717|tazarotene|tazarotene
732256|NCT01094756|Obesity|obesity
732257|NCT01094782|Pain|pain
732258|NCT01094782|Pain management|pain management
732259|NCT01094808|pregabalin|pregabalin
732260|NCT01094808|motor|motor
732261|NCT01094808|sensation|sensation
732262|NCT01094808|colon|colon
732263|NCT01094808|pain|pain
732264|NCT01094808|gas|gas
732265|NCT01094821|Healthy volunteers|healthy volunteers
732266|NCT01094821|ATI-7505|ati-7505
732267|NCT01094821|Scintigraphy|scintigraphy
732268|NCT01094821|Gastrointestinal transit|gastrointestinal transit
732269|NCT01094860|Relapsed/Refractory Lymphoid Malignancies|relapsed/refractory lymphoid malignancies
732270|NCT01094860|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
732271|NCT01094860|CLL|cll
732272|NCT01094860|Small lymphocytic lymphoma|small lymphocytic lymphoma
732273|NCT01094860|SLL|sll
732274|NCT01094860|B-prolymphocytic leukemia|b-prolymphocytic leukemia
732275|NCT01094860|Follicular lymphoma|follicular lymphoma
732276|NCT01094860|Mantle cell lymphoma|mantle cell lymphoma
732277|NCT01094860|Lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
732278|NCT01094860|Marginal zone lymphoma|marginal zone lymphoma
732279|NCT01094860|T-cell prolymphocytic leukemia|t-cell prolymphocytic leukemia
732280|NCT01094860|large granular lymphocyte leukemia|large granular lymphocyte leukemia
732281|NCT01094860|mycosis fungoides|mycosis fungoides
732282|NCT01094860|Sezary syndrome|sezary syndrome
732283|NCT01094860|peripheral T-cell lymphoma|peripheral t-cell lymphoma
732284|NCT01094860|Chemotherapy|chemotherapy
732285|NCT01094860|Monoclonal antibody therapy|monoclonal antibody therapy
732286|NCT01094860|T-cell or B-cell acute lymphoblastic leukemia (ALL)|t-cell or b-cell acute lymphoblastic leukemia (all)
732287|NCT01094860|Continuous Infusion Nelarabine|continuous infusion nelarabine
732288|NCT01094860|Arranon|arranon
732289|NCT01094873|Hepatitis C|hepatitis c
732290|NCT01094873|HCV|hcv
732291|NCT01094873|Adenovirus|adenovirus
732292|NCT01094873|Vaccine|vaccine
732293|NCT01094886|Total Hip Replacement|total hip replacement
732294|NCT01094886|Total Knee Replacement|total knee replacement
732295|NCT01094886|Hip Implant|hip implant
732296|NCT01094886|Knee Implant|knee implant
732297|NCT01094886|Joint Prosthesis|joint prosthesis
732298|NCT01094886|Orthopedic Surgery|orthopedic surgery
732299|NCT01094886|Rivaroxaban|rivaroxaban
732300|NCT01094886|Xarelto|xarelto
732301|NCT01094886|Blood Clot|blood clot
732302|NCT01094899|diabetes|diabetes
732303|NCT01094899|osteopenia|osteopenia
732304|NCT01094899|neuropathy|neuropathy
732305|NCT01094899|foot|foot
732306|NCT01094899|AGE|age
732307|NCT01094912|Cancer pain|cancer pain
732308|NCT01094925|Cesarean section|cesarean section
732309|NCT01094925|Gabapentin|gabapentin
732310|NCT01094938|Aortic aneurysm repair|aortic aneurysm repair
732312|NCT01094964|recurrent bladder cancer|recurrent bladder cancer
732313|NCT01094964|stage 0 bladder cancer|stage 0 bladder cancer
732314|NCT01094964|stage I bladder cancer|stage i bladder cancer
732315|NCT01094964|adenocarcinoma of the bladder|adenocarcinoma of the bladder
732316|NCT01094964|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
732317|NCT01094977|Blood Loss and Transfusion|blood loss and transfusion
732318|NCT01094977|Craniosynostoses|craniosynostoses
732319|NCT01094977|Tranexamic Acid|tranexamic acid
732320|NCT01094977|Children|children
732321|NCT01094990|crossover; double blinded; intrathecal chemotherapy; dexamethasone; ketamine;vomiting|crossover; double blinded; intrathecal chemotherapy; dexamethasone; ketamine;vomiting
732322|NCT01095029|Positron emission tomography (PET)|positron emission tomography (pet)
732323|NCT01095029|Idiopathic Faecal Incontinence|idiopathic faecal incontinence
732324|NCT01095029|Bilateral Sacral Nerve Stimulation|bilateral sacral nerve stimulation
732325|NCT01095029|Sacral Nerve Stimulation|sacral nerve stimulation
732326|NCT01095029|Sacral Nervemodulation|sacral nervemodulation
732327|NCT01095042|HRV|hrv
732328|NCT01095042|emotion|emotion
732329|NCT01095042|cognition|cognition
732330|NCT01095042|stress|stress
732331|NCT01095042|cortisol|cortisol
732332|NCT01095042|Autonomic nervous system|autonomic nervous system
732333|NCT01095094|adult brain tumor|adult brain tumor
732334|NCT01095094|adult anaplastic astrocytoma|adult anaplastic astrocytoma
732335|NCT01095094|adult anaplastic ependymoma|adult anaplastic ependymoma
732336|NCT01095094|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
732337|NCT01095094|adult brain stem glioma|adult brain stem glioma
732338|NCT01095094|adult giant cell glioblastoma|adult giant cell glioblastoma
732339|NCT01095094|adult glioblastoma|adult glioblastoma
732340|NCT01095094|adult gliosarcoma|adult gliosarcoma
732341|NCT01095094|adult mixed glioma|adult mixed glioma
732342|NCT01095094|recurrent adult brain tumor|recurrent adult brain tumor
732343|NCT01095107|Determining whether adjustments in the amounts of fat grams within the current inpatient protocol meal plans will lead to a change in the hospital stay duration|determining whether adjustments in the amounts of fat grams within the current inpatient protocol meal plans will lead to a change in the hospital stay duration
732344|NCT01095107|Alter their recovery by affecting vital signs|alter their recovery by affecting vital signs
732345|NCT01095107|Rate of weight change or need for supplemental feeds/medications|rate of weight change or need for supplemental feeds/medications
732346|NCT01095107|Effect gastrointestinal symptoms (bloating, gastroesophageal reflux, constipation, diarrhea, abdominal pain|effect gastrointestinal symptoms (bloating, gastroesophageal reflux, constipation, diarrhea, abdominal pain
732445|NCT01095471|13 valent Pneumococcal conjugate vaccine|13 valent pneumococcal conjugate vaccine
732347|NCT01095107|And/or effect their perceived body image or cause any changes in their mood.|and/or effect their perceived body image or cause any changes in their mood.
732348|NCT01095133|Gastroesophageal reflux disease|gastroesophageal reflux disease
732349|NCT01095133|Heartburn|heartburn
732350|NCT01095146|MAS|mas
732351|NCT01095146|Hemophagocytosis|hemophagocytosis
732352|NCT01095146|Reactive HLH|reactive hlh
732353|NCT01095146|Macrophage activation syndrome|macrophage activation syndrome
732354|NCT01095146|Systemic onset juvenile idiopathic arthritis|systemic onset juvenile idiopathic arthritis
732355|NCT01095146|SoJIA|sojia
732356|NCT01095146|JIA|jia
732357|NCT01095159|TVTO|tvto
732358|NCT01095159|TVTSecur|tvtsecur
732359|NCT01095159|Mini sling|mini sling
732360|NCT01095159|stress urinary incontinence|stress urinary incontinence
732361|NCT01095172|Immunosuppression|immunosuppression
732362|NCT01095172|Rituximab|rituximab
732363|NCT01095172|B cell|b cell
732364|NCT01095198|vaginal self collection|vaginal self collection
732365|NCT01095198|human papillomavirus (hpv)|human papillomavirus (hpv)
732366|NCT01095198|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
732367|NCT01095211|folic acid|folic acid
732368|NCT01095211|homocysteine|homocysteine
732369|NCT01095211|MMSE scores|mmse scores
732370|NCT01095211|methyl malonic acid|methyl malonic acid
732371|NCT01095211|betaine|betaine
732372|NCT01095224|HIV Preventive Vaccine|hiv preventive vaccine
732373|NCT01095237|Peripheral Arterial Disease|peripheral arterial disease
732374|NCT01095237|Peripheral Vascular Disease|peripheral vascular disease
732376|NCT01095237|vascular prosthesis|vascular prosthesis
732377|NCT01095237|revascularization|revascularization
732378|NCT01095237|patency|patency
732379|NCT01095237|blood vessel|blood vessel
732380|NCT01095237|Rutherford|rutherford
732382|NCT01095237|Ankle Brachial Index|ankle brachial index
732383|NCT01095237|Vascular Graft|vascular graft
732384|NCT01095237|Carbothane|carbothane
732385|NCT01095237|ProEndoTecc|proendotecc
732386|NCT01095237|implantation|implantation
732387|NCT01095250|Active uveitis|active uveitis
732388|NCT01095250|intermediate uveitis|intermediate uveitis
732389|NCT01095250|panuveitis|panuveitis
732390|NCT01095250|posterior uveitis|posterior uveitis
732391|NCT01095250|uveitis|uveitis
732392|NCT01095276|Mechanical Ventilation|mechanical ventilation
732393|NCT01095276|Extubation|extubation
732394|NCT01095276|dornase alpha|dornase alpha
732395|NCT01095276|oxygenation|oxygenation
732396|NCT01095276|chest x ray|chest x ray
732397|NCT01095289|electromyography|electromyography
732398|NCT01095289|laryngeal neoplasms|laryngeal neoplasms
732399|NCT01095289|masticatory muscles|masticatory muscles
732400|NCT01095328|Q fever|q fever
732401|NCT01095328|Pregnancy|pregnancy
732402|NCT01095328|Screening|screening
732403|NCT01095328|Cost-effectiveness|cost-effectiveness
732404|NCT01095341|hyperthyroidism|hyperthyroidism
732405|NCT01095341|tertiary hyperparathyroidism|tertiary hyperparathyroidism
732406|NCT01095341|palpation thyroiditis|palpation thyroiditis
732407|NCT01095341|parathyroidectomy|parathyroidectomy
732408|NCT01095341|thyroglobulin|thyroglobulin
732409|NCT01095341|rate of postoperative hyperthyroidism|rate of postoperative hyperthyroidism
732410|NCT01095354|pediatric|pediatric
732411|NCT01095354|lung ventilation inhomogeneity|lung ventilation inhomogeneity
732412|NCT01095367|Adhesion barrier sheets|adhesion barrier sheets
732413|NCT01095367|ovarian cancer|ovarian cancer
732414|NCT01095367|Advanced stage epithelial ovarian cancer|advanced stage epithelial ovarian cancer
732415|NCT01095380|task-specific training|task-specific training
732416|NCT01095380|walking|walking
732417|NCT01095380|locomotion|locomotion
732418|NCT01095380|function|function
732419|NCT01095380|body weight support|body weight support
732420|NCT01095380|Individuals with motor-incomplete spinal cord injury|individuals with motor-incomplete spinal cord injury
732421|NCT01095393|Certolizumab Pegol|certolizumab pegol
732422|NCT01095393|CZP|czp
732423|NCT01095393|Cimzia®|cimzia®
732424|NCT01095393|NDB|ndb
732425|NCT01095393|registry|registry
732426|NCT01095406|Weaning|weaning
732427|NCT01095406|closed loop|closed loop
732428|NCT01095406|mechanical ventilation|mechanical ventilation
732429|NCT01095406|children|children
732430|NCT01095419|massage therapy|massage therapy
732431|NCT01095419|sleep quality|sleep quality
732432|NCT01095419|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
732433|NCT01095419|Patients after Coronary Artery Bypass Graft Surgery|patients after coronary artery bypass graft surgery
732434|NCT01095432|Colonoscopy|colonoscopy
732435|NCT01095432|Flexible Sigmoidoscopy|flexible sigmoidoscopy
732436|NCT01095445|hepatitis C|hepatitis c
732437|NCT01095445|genotype 3|genotype 3
732438|NCT01095445|end of treatment response|end of treatment response
732439|NCT01095445|relapse rate|relapse rate
732440|NCT01095445|rapid virologic response|rapid virologic response
732441|NCT01095445|complete early virologic response|complete early virologic response
732442|NCT01095458|Obesity|obesity
732443|NCT01095458|Phone vs Clinical methods|phone vs clinical methods
732444|NCT01095471|7 valent Pneumococcal conjugate vaccine|7 valent pneumococcal conjugate vaccine
732446|NCT01095471|PCV13|pcv13
732447|NCT01095471|PCV7|pcv7
732448|NCT01095484|Rotigotine|rotigotine
732449|NCT01095484|Neupro®|neupro®
732451|NCT01095497|C1 inhibitor (C1INH)|c1 inhibitor (c1inh)
732452|NCT01095497|Subcutaneous|subcutaneous
732453|NCT01095510|HAE|hae
732454|NCT01095510|CINRYZE|cinryze
732455|NCT01095510|C1 INH|c1 inh
732456|NCT01095510|C1 inhibitor|c1 inhibitor
732457|NCT01095510|Pediatric|pediatric
732458|NCT01095510|PK/PD|pk/pd
732459|NCT01095523|Colon Cancer|colon cancer
732460|NCT01095523|Rectal Cancer|rectal cancer
732461|NCT01095523|Peritoneal Perfusion|peritoneal perfusion
732462|NCT01095523|Metastatic Cancer|metastatic cancer
732463|NCT01095523|Recurrence|recurrence
732464|NCT01095523|Colorectal Cancer|colorectal cancer
732465|NCT01095536|laparoscopic cholecystectomy, elective|laparoscopic cholecystectomy, elective
732466|NCT01095536|anesthesia, general|anesthesia, general
732467|NCT01095536|shoulder pain|shoulder pain
732468|NCT01095536|nausea|nausea
732469|NCT01095536|vomiting|vomiting
732470|NCT01095536|laparoscopic cholecystectomy|laparoscopic cholecystectomy
732471|NCT01095536|general anesthesia|general anesthesia
732472|NCT01095549|ankle-brachial index (ABI)|ankle-brachial index (abi)
732473|NCT01095549|brachial-ankle pulse wave velocity (baPWV)|brachial-ankle pulse wave velocity (bapwv)
732474|NCT01095549|far infrared therapy (FIR)|far infrared therapy (fir)
732475|NCT01095549|hemodialysis (HD)|hemodialysis (hd)
732476|NCT01095549|peripheral artery disease (PAD)|peripheral artery disease (pad)
732477|NCT01095549|Peripheral artery disease in hemodialysis|peripheral artery disease in hemodialysis
732478|NCT01095575|Epidural|epidural
732479|NCT01095575|Morphine|morphine
732480|NCT01095575|Preoperative|preoperative
732481|NCT01095575|Postoperative|postoperative
732482|NCT01095575|Analgesia|analgesia
732483|NCT01095575|Tolerance|tolerance
732484|NCT01095575|Preoperative, Postoperative Analgesia|preoperative, postoperative analgesia
732486|NCT01095601|avanafil|avanafil
732487|NCT01095601|absoprion|absoprion
732488|NCT01095601|bioavailability|bioavailability
732489|NCT01095601|food effect|food effect
732490|NCT01095601|dose-proportionality|dose-proportionality
732491|NCT01095601|TA-1790|ta-1790
732492|NCT01095601|Pharmacokinetics of avanafil|pharmacokinetics of avanafil
732493|NCT01095614|Women|women
732494|NCT01095614|Hormonal status|hormonal status
732495|NCT01095614|Exercise|exercise
732496|NCT01095614|Substrate utilization|substrate utilization
732497|NCT01095614|Women Hormonal Status (with oral contraception or without any contraception)|women hormonal status (with oral contraception or without any contraception)
732498|NCT01095640|acne|acne
732500|NCT01095640|Differin|differin
732501|NCT01095679|CHEYNE Stokes respiration|cheyne stokes respiration
732502|NCT01095679|Periodic ventilation|periodic ventilation
732503|NCT01095679|baclofen|baclofen
732504|NCT01095679|hypoxia|hypoxia
732505|NCT01095679|healthy subject|healthy subject
732506|NCT01095692|Occult stress Incontinence,|occult stress incontinence,
732507|NCT01095692|Pelvic Organ Prolapse,|pelvic organ prolapse,
732508|NCT01095692|Prevention of stress urinary incontinence,|prevention of stress urinary incontinence,
732509|NCT01095692|Postoperative incontinence,|postoperative incontinence,
732510|NCT01095692|Sub-urethral tape|sub-urethral tape
732511|NCT01095705|Hypnosis|hypnosis
732512|NCT01095705|Transesophageal Echocardiography|transesophageal echocardiography
732513|NCT01095705|Efficiency of Hypnosis|efficiency of hypnosis
732514|NCT01095731|aneurysm|aneurysm
732515|NCT01095731|aneurysmal|aneurysmal
732516|NCT01095731|subarachnoid|subarachnoid
732517|NCT01095731|hemorrhage|hemorrhage
732518|NCT01095731|haemorrhage|haemorrhage
732519|NCT01095731|neuroprotection|neuroprotection
732520|NCT01095731|3-aminopropanal|3-aminopropanal
732521|NCT01095731|3AP|3ap
732522|NCT01095731|polyamine oxidase|polyamine oxidase
732523|NCT01095731|spermine|spermine
732524|NCT01095731|spermidine|spermidine
732525|NCT01095731|vasospasm|vasospasm
732526|NCT01095731|cerebral ischemia|cerebral ischemia
732527|NCT01095731|neurosurgery|neurosurgery
732528|NCT01095731|neurological intensive care unit|neurological intensive care unit
732529|NCT01095731|NICU|nicu
732530|NCT01095731|Tiopronin|tiopronin
732531|NCT01095731|Thiola|thiola
732532|NCT01095731|FDA|fda
732533|NCT01095731|Thiopronin|thiopronin
732534|NCT01095731|Thiosol|thiosol
732535|NCT01095731|Tioglis|tioglis
732536|NCT01095731|Acadione|acadione
732537|NCT01095731|Capen|capen
732538|NCT01095731|Captimer|captimer
732539|NCT01095731|Epatiol|epatiol
732540|NCT01095731|Vincol|vincol
732541|NCT01095731|Mucolysin|mucolysin
732542|NCT01095731|Sutilan|sutilan
732543|NCT01095731|Meprin|meprin
732544|NCT01095731|Thiolpropionamidoacetic acid|thiolpropionamidoacetic acid
732545|NCT01095731|Mercaptopropionyl glycine|mercaptopropionyl glycine
732546|NCT01095731|2 MPG|2 mpg
732547|NCT01095744|PIB imaging,|pib imaging,
732548|NCT01095744|brain atrophy|brain atrophy
732549|NCT01095744|cognitive impairment|cognitive impairment
732550|NCT01095744|Pet imaging|pet imaging
732551|NCT01095744|Alzheimer's disease|alzheimer's disease
732552|NCT01095744|amyloid protein|amyloid protein
732553|NCT01095757|Myeloma|myeloma
732554|NCT01095757|Lymphoma|lymphoma
732555|NCT01095757|Stem cell transplantation|stem cell transplantation
732556|NCT01095770|Atrial Fibrillation|atrial fibrillation
732557|NCT01095770|Atrial Fibrillation Ablation|atrial fibrillation ablation
732558|NCT01095770|Atrial Fibrillation monitoring|atrial fibrillation monitoring
732559|NCT01095770|Ablation Frontiers|ablation frontiers
732560|NCT01095770|Reveal XT|reveal xt
732561|NCT01095770|LASSO|lasso
732562|NCT01095783|low back pain|low back pain
732563|NCT01095783|physiotherapy|physiotherapy
732564|NCT01095783|hemodialysis|hemodialysis
732565|NCT01095783|end-stage renal disease|end-stage renal disease
732566|NCT01095796|Treatment Naive|treatment naive
732567|NCT01095796|HIV 1 Infected|hiv 1 infected
732568|NCT01095822|Diabetes|diabetes
732569|NCT01095822|Hypertension|hypertension
732570|NCT01095822|Platelets|platelets
732571|NCT01095822|Hemostasis|hemostasis
732572|NCT01095822|Aliskiren|aliskiren
732573|NCT01095822|Valsartan|valsartan
732574|NCT01095848|vaccine|vaccine
732575|NCT01095848|cancer|cancer
732576|NCT01095848|ovarian|ovarian
732577|NCT01095848|breast|breast
732578|NCT01095848|prostate|prostate
732579|NCT01095848|tumor|tumor
732580|NCT01095848|Immunotherapy|immunotherapy
732581|NCT01095861|endotracheal tube|endotracheal tube
732582|NCT01095874|myelodysplasia|myelodysplasia
732583|NCT01095874|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
732584|NCT01095874|Survival|survival
732585|NCT01095874|Transplantation|transplantation
732586|NCT01095887|ABO incompatibility|abo incompatibility
732587|NCT01095887|living donor kidney transplant|living donor kidney transplant
732588|NCT01095887|kidney transplant|kidney transplant
732589|NCT01095887|ABO blood type incompatible|abo blood type incompatible
732590|NCT01095900|Pain after treatment|pain after treatment
732591|NCT01095900|healing of fissure after treatment|healing of fissure after treatment
732592|NCT01095900|continence scores after treatment|continence scores after treatment
732593|NCT01095913|Near-Infrared Imaging|near-infrared imaging
732594|NCT01095913|Fluorescent Dyes|fluorescent dyes
732595|NCT01095913|Lymph Node Mapping|lymph node mapping
732596|NCT01095913|Indocyanine green|indocyanine green
732597|NCT01095913|IC-Green|ic-green
732598|NCT01095913|nonradioactive optical imaging|nonradioactive optical imaging
732599|NCT01095913|fluorescent contrast agent|fluorescent contrast agent
732600|NCT01095913|ICG|icg
732601|NCT01095913|lymph nodes|lymph nodes
732602|NCT01095913|axillary nodal dissection|axillary nodal dissection
732705|NCT01082185|abdominal|abdominal
732603|NCT01095926|pharmacokinetic|pharmacokinetic
732604|NCT01095926|doxorubicin|doxorubicin
732605|NCT01095926|cancer|cancer
732606|NCT01095926|troponin|troponin
732607|NCT01095926|natriuretic peptide|natriuretic peptide
732608|NCT01095926|cardiotoxicity|cardiotoxicity
732609|NCT01095926|anthracyclines|anthracyclines
732610|NCT01095926|Ewing|ewing
732611|NCT01095926|ALL|all
753918|NCT01178294|hemophilia A|hemophilia a
732612|NCT01095939|Renal function consecutive to pre-eclampsia|renal function consecutive to pre-eclampsia
732613|NCT01095952|atrial fibrillation|atrial fibrillation
732614|NCT01095952|inappropriate shock|inappropriate shock
732615|NCT01095952|AV-node stimulation|av-node stimulation
732616|NCT01095952|ventricular arrhythmia|ventricular arrhythmia
732617|NCT01095965|Nutrition education intervention|nutrition education intervention
732618|NCT01095965|Type 2 diabetes mellitus|type 2 diabetes mellitus
732619|NCT01095978|Klacid SR|klacid sr
732620|NCT01095978|Clarithromycin|clarithromycin
732621|NCT01095978|Respiratory tract infections|respiratory tract infections
732622|NCT01095978|Bronchitis|bronchitis
732623|NCT01095978|Pneumonia|pneumonia
732624|NCT01095991|Type 2 Diabetes Mellitus, Sitagliptin|type 2 diabetes mellitus, sitagliptin
732625|NCT01096004|Pharmacodynamic method evaluation|pharmacodynamic method evaluation
732626|NCT01096017|Terbutaline|terbutaline
732627|NCT01096017|Turbuhaler|turbuhaler
732628|NCT01096017|Efficacy|efficacy
732629|NCT01096017|Asthma|asthma
732630|NCT01096017|Japanese|japanese
732631|NCT01096017|salbutamol|salbutamol
732632|NCT01096017|Bricanyl|bricanyl
732633|NCT01096030|Regorafenib|regorafenib
732634|NCT01096030|Advanced|advanced
732635|NCT01096030|Refractory solid tumors|refractory solid tumors
732636|NCT01096043|Heart Failure|heart failure
732637|NCT01096043|ADHF|adhf
732638|NCT01096056|Children|children
732639|NCT01096056|Influenza|influenza
732640|NCT01096056|Safety|safety
732641|NCT01096056|Immunogenicity|immunogenicity
732642|NCT01096056|Vaccine|vaccine
732643|NCT01081873|Multicenter study|multicenter study
732644|NCT01081886|Total knee arthroplasty|total knee arthroplasty
732645|NCT01081886|PlasmaBlade|plasmablade
732646|NCT01081886|Electrosurgery|electrosurgery
732647|NCT01081886|PEAK Surgical|peak surgical
732648|NCT01081886|Medtronic Advanced Energy|medtronic advanced energy
732649|NCT01081886|Medtronic|medtronic
732650|NCT01081899|dying patients|dying patients
732651|NCT01081899|cancer|cancer
732652|NCT01081899|hospital|hospital
732653|NCT01081899|Liverpool Care Pathways|liverpool care pathways
732654|NCT01081912|chronic pain|chronic pain
732655|NCT01081912|back pain|back pain
732656|NCT01081925|Congestive Heart Failure|congestive heart failure
732657|NCT01081925|Cardiac Failure|cardiac failure
732658|NCT01081951|Poly(ADP ribose)|poly(adp ribose)
732659|NCT01081951|polymerisation (PARP)|polymerisation (parp)
732660|NCT01081951|Platinum sensitive|platinum sensitive
732661|NCT01081951|Advanced Serous Ovarian cancer|advanced serous ovarian cancer
732662|NCT01081951|olaparib|olaparib
732663|NCT01081951|PARP inhibitors|parp inhibitors
732664|NCT01081951|Platinum Sensitive Advanced Serous Ovarian Cancer|platinum sensitive advanced serous ovarian cancer
732665|NCT01081964|pneumonia|pneumonia
732666|NCT01081964|Community acquired pneumonia of moderate severity|community acquired pneumonia of moderate severity
732667|NCT01081977|Delayed cord clamping|delayed cord clamping
732668|NCT01081977|Ferritin|ferritin
732669|NCT01081977|Hemoglobin|hemoglobin
732670|NCT01081977|Neonatal anemia|neonatal anemia
732671|NCT01081977|Postpartum haemorrhage|postpartum haemorrhage
732672|NCT01081977|Neonatal jaundice|neonatal jaundice
732673|NCT01082003|Capsular contractures in breast cancer patients|capsular contractures in breast cancer patients
732674|NCT01082016|Sleep|sleep
732675|NCT01082016|Critical Illness|critical illness
732676|NCT01082016|Sleep promotion during recovery form illness|sleep promotion during recovery form illness
732677|NCT01082042|Balance, postural|balance, postural
732678|NCT01082042|Aged, over 70|aged, over 70
732680|NCT01082042|Accidental falls|accidental falls
732681|NCT01082055|Cardiac|cardiac
732682|NCT01082055|Dysrhythmia|dysrhythmia
732683|NCT01082055|Safety|safety
732684|NCT01082068|HER2 negative|her2 negative
732685|NCT01082068|Hormone Receptor Positive|hormone receptor positive
732686|NCT01082068|Breast Neoplasms|breast neoplasms
732688|NCT01082081|dental pain|dental pain
732689|NCT01082081|Post-surgical dental pain|post-surgical dental pain
732690|NCT01082094|Ischemic heart failure|ischemic heart failure
732691|NCT01082094|Congestive heart failure|congestive heart failure
732692|NCT01082094|Stromal cell-derived factor 1|stromal cell-derived factor 1
732693|NCT01082094|SDF-1|sdf-1
732694|NCT01082094|Gene therapy|gene therapy
732695|NCT01082120|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
732696|NCT01082120|Pioglitazone|pioglitazone
732697|NCT01082133|Fanconi Anemia|fanconi anemia
732698|NCT01082146|pharmacokinetics, lurasidone|pharmacokinetics, lurasidone
732699|NCT01082159|Spinal Stenosis|spinal stenosis
732700|NCT01082159|Lumbar Spinal Stenosis|lumbar spinal stenosis
732701|NCT01082172|thoracic|thoracic
732702|NCT01082172|aortic|aortic
732703|NCT01082172|aneurysm|aneurysm
732706|NCT01082185|aortic|aortic
732707|NCT01082185|aneurysm|aneurysm
732708|NCT01082185|AAA|aaa
732709|NCT01082198|stage III melanoma|stage iii melanoma
732710|NCT01082211|invasive ductal breast carcinoma|invasive ductal breast carcinoma
732711|NCT01082211|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
732712|NCT01082211|invasive lobular breast carcinoma|invasive lobular breast carcinoma
732713|NCT01082211|tubular ductal breast carcinoma|tubular ductal breast carcinoma
732714|NCT01082211|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
732715|NCT01082211|ductal breast carcinoma in situ|ductal breast carcinoma in situ
732716|NCT01082211|lobular breast carcinoma in situ|lobular breast carcinoma in situ
732717|NCT01082211|recurrent breast cancer|recurrent breast cancer
732718|NCT01082224|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
732719|NCT01082224|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
732720|NCT01082224|recurrent adult primary liver cancer|recurrent adult primary liver cancer
732721|NCT01082237|Major Depressive Disorder|major depressive disorder
732722|NCT01082237|EEG|eeg
732723|NCT01082237|SSRI|ssri
732724|NCT01082250|Bioequivalence|bioequivalence
732725|NCT01082250|Male/Female Patient|male/female patient
732726|NCT01082250|Reference/Test Formulation|reference/test formulation
732727|NCT01082250|Schizophrenia Patients|schizophrenia patients
732728|NCT01082263|DDI study between Midazolam and Lurasidone HCl|ddi study between midazolam and lurasidone hcl
732729|NCT01082263|Male and Female|male and female
732730|NCT01082276|Rifampin DDI with Lurasidone HCl|rifampin ddi with lurasidone hcl
732731|NCT01082289|Lurasidone|lurasidone
732732|NCT01082289|Schizophrenia|schizophrenia
732733|NCT01082289|Latuda|latuda
732734|NCT01082302|green tea extract|green tea extract
732735|NCT01082302|Polyphenon E|polyphenon e
732736|NCT01082302|Pharmacokinetics|pharmacokinetics
732737|NCT01082315|Colorectal cancer|colorectal cancer
732738|NCT01082315|Neoplasm metastasis|neoplasm metastasis
732739|NCT01082315|Cetuximab|cetuximab
732740|NCT01082315|Erbitux|erbitux
732741|NCT01082315|EGFR|egfr
732742|NCT01082328|Phenylketonuria (PKU)|phenylketonuria (pku)
732743|NCT01082328|Hyperphenylalaninemia (HPA)|hyperphenylalaninemia (hpa)
732744|NCT01082328|Kuvan®|kuvan®
732745|NCT01082328|Sapropterin dihydrochloride|sapropterin dihydrochloride
732746|NCT01082328|Kuvan responder|kuvan responder
732747|NCT01082328|Tetrahydrobiopterin (BH4)|tetrahydrobiopterin (bh4)
732748|NCT01082341|GCP Good Clinical Practice|gcp good clinical practice
732749|NCT01082341|IFAT Indirect Immunofluorescence antibody test|ifat indirect immunofluorescence antibody test
732750|NCT01082341|MFA Membrane Feeding Assay|mfa membrane feeding assay
732751|NCT01082341|N Number (typically refers to subjects)|n number (typically refers to subjects)
732752|NCT01082341|RBC Red Blood Cells|rbc red blood cells
732753|NCT01082341|SOP Standard Operating Procedure|sop standard operating procedure
732754|NCT01082341|TBS Thick blood smear|tbs thick blood smear
732755|NCT01082341|P. Vivax|p. vivax
732756|NCT01082341|irradiated sporozoite vaccination.|irradiated sporozoite vaccination.
732757|NCT01082354|Infant, Low birth weight|infant, low birth weight
732758|NCT01082354|Infant, Low birth height|infant, low birth height
732759|NCT01082354|Infant, Small for Gestational Age|infant, small for gestational age
732760|NCT01082367|Tobramycin Inhalation solution|tobramycin inhalation solution
732761|NCT01082367|Cystic fibrosis|cystic fibrosis
732762|NCT01082367|Lung disease|lung disease
732763|NCT01082367|anti-bacterial agents|anti-bacterial agents
732764|NCT01082380|radiolabeled|radiolabeled
732765|NCT01082380|healthy volunteers|healthy volunteers
732766|NCT01082393|vitiligo|vitiligo
732767|NCT01082419|Liver stiffness measurement|liver stiffness measurement
732769|NCT01082419|fibrosis|fibrosis
732770|NCT01082419|hepatopathy|hepatopathy
732771|NCT01082432|thumb|thumb
732772|NCT01082432|Ulnar collateral ligament|ulnar collateral ligament
732773|NCT01082432|superimposed electrical stimulation|superimposed electrical stimulation
732774|NCT01082432|stiffness|stiffness
732775|NCT01082432|adhesions|adhesions
732777|NCT01082445|grade 0 (Texas University)|grade 0 (texas university)
732778|NCT01082458|Patients scheduled to undergo thyroidectomy|patients scheduled to undergo thyroidectomy
732779|NCT01082471|Morphine 6-glucuronide|morphine 6-glucuronide
732780|NCT01082471|Morphine|morphine
732781|NCT01082471|Patient Controlled Analgesia|patient controlled analgesia
732782|NCT01082471|Post Operative Nausea and Vomiting|post operative nausea and vomiting
732783|NCT01082484|Healthy volunteers|healthy volunteers
732784|NCT01082484|iontophoresis|iontophoresis
732785|NCT01082497|Mindfulness|mindfulness
732787|NCT01082497|Burnout|burnout
732788|NCT01082497|Ward atmosphere|ward atmosphere
732789|NCT01082497|Stress and burnout among staff, psychosocial atmosphere at the ward|stress and burnout among staff, psychosocial atmosphere at the ward
732790|NCT01082510|UFT|uft
732791|NCT01082510|BCG|bcg
732792|NCT01082536|Pediatrics|pediatrics
732793|NCT01082536|Congenital heart disease|congenital heart disease
732794|NCT01082536|NIRS|nirs
732795|NCT01082536|Brain oxygenation|brain oxygenation
732796|NCT01082549|Patients with Previously Untreated Advanced Squamous Cell Lung Cancer|patients with previously untreated advanced squamous cell lung cancer
732985|NCT01088581|hepatectomy|hepatectomy
732797|NCT01087879|oral glucose tolerance test|oral glucose tolerance test
732798|NCT01087879|hormonal contraception|hormonal contraception
732799|NCT01087879|androgens|androgens
732800|NCT01087879|crp|crp
732801|NCT01087905|Smoking|smoking
732802|NCT01087905|Smoking cessation|smoking cessation
732803|NCT01087905|Medication adherence|medication adherence
732804|NCT01087918|ASIA C and D|asia c and d
732805|NCT01087931|Local anesthetic|local anesthetic
732806|NCT01087931|Iliac crest bone harvest|iliac crest bone harvest
732807|NCT01087931|Patients undergoing spine surgery that require use of iliac crest bone autograft|patients undergoing spine surgery that require use of iliac crest bone autograft
732808|NCT01087970|Pharynx|pharynx
732809|NCT01087970|Larynx|larynx
732810|NCT01087970|Nose|nose
732811|NCT01087970|Parathyroid|parathyroid
732812|NCT01087983|Metastatic cancer|metastatic cancer
732813|NCT01087983|Lapatinib|lapatinib
732814|NCT01087983|Tykerb|tykerb
732815|NCT01087983|Metformin|metformin
732816|NCT01087983|Glucophage|glucophage
732817|NCT01087983|Sirolimus|sirolimus
732818|NCT01087983|Rapamune|rapamune
732819|NCT01087996|Chronic Ischemic Left Ventricular|chronic ischemic left ventricular
732820|NCT01088009|chronic hepatitis B|chronic hepatitis b
732821|NCT01088022|the complete response (CR) rate defined as the number of patients with no emetic episodes and no rescue medication in the first 120 hours post-chemotherapy|the complete response (cr) rate defined as the number of patients with no emetic episodes and no rescue medication in the first 120 hours post-chemotherapy
732822|NCT01088035|Childhood ependymoma|childhood ependymoma
732823|NCT01088035|Ependymoma|ependymoma
732824|NCT01088035|Survivin|survivin
732825|NCT01088048|CLL|cll
732826|NCT01088048|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
732827|NCT01088048|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
732828|NCT01088048|phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
732829|NCT01088048|bendamustine|bendamustine
732830|NCT01088048|CD20 mAb|cd20 mab
732831|NCT01088048|rituximab|rituximab
732832|NCT01088048|CAL-101|cal-101
732833|NCT01088048|Ofatumumab|ofatumumab
732834|NCT01088048|indolent non-Hodgkin lymphoma (iNHL)|indolent non-hodgkin lymphoma (inhl)
732835|NCT01088048|fludarabine|fludarabine
732836|NCT01088048|everolimus|everolimus
732837|NCT01088048|bortezomib|bortezomib
732838|NCT01088048|chlorambucil|chlorambucil
732839|NCT01088048|lenalidomide|lenalidomide
732840|NCT01088074|Total Knee Replacement|total knee replacement
732841|NCT01088074|Closure Methods|closure methods
732842|NCT01088100|POCD|pocd
732843|NCT01088100|clock-gene genotypes|clock-gene genotypes
732844|NCT01088100|HPER3|hper3
732845|NCT01088113|Tai Chi|tai chi
732846|NCT01088113|Qigong|qigong
732847|NCT01088113|Heart rate variability|heart rate variability
732848|NCT01088113|Near Infrared Spectroscopy|near infrared spectroscopy
732849|NCT01088113|blood pressure|blood pressure
732850|NCT01088139|Nutritional support|nutritional support
732851|NCT01088139|Rehabilitation outcomes|rehabilitation outcomes
732852|NCT01088152|Celiac disease|celiac disease
732853|NCT01088152|Education|education
732854|NCT01088152|Sweden|sweden
732855|NCT01088152|Gluten-free diet|gluten-free diet
732856|NCT01088165|Psoriasis|psoriasis
732857|NCT01088165|Cardiovascular Diseases|cardiovascular diseases
732858|NCT01088165|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
732859|NCT01088165|Adalimumab|adalimumab
732860|NCT01088165|Fumaric acid esters|fumaric acid esters
732861|NCT01088178|Long-Acting Reversible Contraception|long-acting reversible contraception
732862|NCT01088178|Contraceptive Agents|contraceptive agents
732863|NCT01088178|Therapeutic Uses|therapeutic uses
732864|NCT01088178|Contraceptive Agents, Female|contraceptive agents, female
732865|NCT01088178|Reproductive Control Agents|reproductive control agents
732866|NCT01088178|Pharmacologic Actions|pharmacologic actions
732867|NCT01088178|Levonorgestrel|levonorgestrel
732868|NCT01088191|Acute Anterior Cruciate Ligament Injury|acute anterior cruciate ligament injury
732869|NCT01088191|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
732870|NCT01088191|Adult Stem Cells|adult stem cells
732871|NCT01088191|Mesenchymal precursor cells|mesenchymal precursor cells
732872|NCT01088217|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
732873|NCT01088217|Familial Pulmonary Fibrosis|familial pulmonary fibrosis
732874|NCT01088217|Idiopathic Interstitial Pneumonia|idiopathic interstitial pneumonia
732875|NCT01088217|Familial Interstitial Pneumonia|familial interstitial pneumonia
732876|NCT01088217|Pulmonary Fibrosis|pulmonary fibrosis
732877|NCT01088230|hemiparesis|hemiparesis
732878|NCT01088230|robotics|robotics
732879|NCT01088230|stroke|stroke
732880|NCT01088230|Botox®|botox®
732881|NCT01088230|rehabilitation|rehabilitation
732882|NCT01088230|wrist spasticity|wrist spasticity
732883|NCT01088243|Berylliosis|berylliosis
732884|NCT01088243|Beryllium Disease|beryllium disease
732885|NCT01088256|CRPS|crps
732886|NCT01088256|Morbus Sudeck|morbus sudeck
732887|NCT01088256|Causalgia|causalgia
732888|NCT01088256|Etoricoxib|etoricoxib
732889|NCT01088256|Polyneuropathy|polyneuropathy
732890|NCT01088256|post herpetic neuralgia|post herpetic neuralgia
732891|NCT01088256|peripheral nerve injury|peripheral nerve injury
733125|NCT01098396|gait|gait
732892|NCT01088256|radiculopathy|radiculopathy
732893|NCT01088256|Nervenverletzung|nervenverletzung
732894|NCT01088256|postherpetische Neuralgie|postherpetische neuralgie
732895|NCT01088256|COX-2-Inhibitor|cox-2-inhibitor
732896|NCT01088269|Blood Pressure Measurement|blood pressure measurement
732897|NCT01088269|Atrial Fibrillation|atrial fibrillation
732898|NCT01088269|Blood pressure measurement in atrial fibrillation|blood pressure measurement in atrial fibrillation
732899|NCT01088269|Atrial Fibrillation diagnosis|atrial fibrillation diagnosis
732900|NCT01088282|Diffractive multifocal IOL|diffractive multifocal iol
732901|NCT01088295|Metabolic|metabolic
732902|NCT01088295|HIV|hiv
732903|NCT01088295|Fat accumulation|fat accumulation
732904|NCT01088295|AIDS|aids
732905|NCT01088295|Metabolic abnormalities in HIV infection|metabolic abnormalities in hiv infection
732906|NCT01088295|HIV Infections|hiv infections
732907|NCT01088334|Idiopathic venous thromboembolism|idiopathic venous thromboembolism
732908|NCT01088334|Malignancy|malignancy
732909|NCT01088334|screening|screening
732910|NCT01088347|TRAIL|trail
732911|NCT01088347|TRM1|trm1
732912|NCT01088347|advanced cervical cancer|advanced cervical cancer
732913|NCT01088347|mapatumumab|mapatumumab
732914|NCT01088347|Uterine cervical neoplasm|uterine cervical neoplasm
732915|NCT01088347|Radiotherapy|radiotherapy
732916|NCT01088347|Cisplatin|cisplatin
732917|NCT01088425|vitrification|vitrification
732918|NCT01088425|2PN oocyte|2pn oocyte
732919|NCT01088425|maternal and infant health|maternal and infant health
732920|NCT01088425|embryo survival, clinical pregnancy rate|embryo survival, clinical pregnancy rate
732921|NCT01088425|mode of delivery|mode of delivery
732922|NCT01088425|injury during delivery|injury during delivery
732923|NCT01088425|infant development|infant development
732924|NCT01088425|infant morbidity|infant morbidity
732925|NCT01088425|slow- rate freezing|slow- rate freezing
732926|NCT01088438|medical education|medical education
732927|NCT01088438|decision making|decision making
732928|NCT01088438|diagnostic error|diagnostic error
732929|NCT01088438|contextualization|contextualization
732930|NCT01088451|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
732931|NCT01088451|Prandial Glycemia|prandial glycemia
732932|NCT01088451|Rapid Acting Insulin Analogue|rapid acting insulin analogue
732933|NCT01088451|Human Insulin|human insulin
732934|NCT01088464|Human Immunoglobulin Gamma-1 (IgG1)|human immunoglobulin gamma-1 (igg1)
732935|NCT01088464|Monoclonal Antibody (MAb)|monoclonal antibody (mab)
732936|NCT01088464|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
732937|NCT01088464|Advanced Solid Tumors|advanced solid tumors
732938|NCT01088477|Acquired anti-hormonal resistant breast cancer|acquired anti-hormonal resistant breast cancer
732939|NCT01088490|Hydrogen sulfide|hydrogen sulfide
732940|NCT01088490|critically ill|critically ill
732941|NCT01088490|mortality|mortality
732942|NCT01088516|Human Immunodeficiency Virus|human immunodeficiency virus
732943|NCT01088516|Vertical Transmission|vertical transmission
732944|NCT01088516|Pregnancy|pregnancy
732945|NCT01088516|Breastfeeding|breastfeeding
732946|NCT01088516|Prevention of mother to child transmission|prevention of mother to child transmission
732947|NCT01088516|HAART|haart
732948|NCT01088516|Aluvia|aluvia
732949|NCT01088516|Lopinavir|lopinavir
732950|NCT01088516|Africa|africa
732951|NCT01088516|Infectious Disease Transmission, Vertical|infectious disease transmission, vertical
732952|NCT01088529|Neoadjuvant Prostate Cancer|neoadjuvant prostate cancer
732953|NCT01088529|Abiraterone Acetate|abiraterone acetate
732954|NCT01088529|LHRHa|lhrha
732955|NCT01088529|high risk prostate cancer|high risk prostate cancer
732956|NCT01088529|Radical prostatectomy|radical prostatectomy
732957|NCT01088529|Prednisone|prednisone
732958|NCT01088529|Luteinizing Hormone-Releasing Hormone|luteinizing hormone-releasing hormone
732959|NCT01088529|LHRH analogue|lhrh analogue
732960|NCT01088542|substance use|substance use
732961|NCT01088542|delinquency|delinquency
732962|NCT01088542|risky sexual behavior|risky sexual behavior
732963|NCT01088542|risk factors|risk factors
732964|NCT01088542|protective factors|protective factors
732965|NCT01088542|prevention|prevention
732966|NCT01088542|community coalitions|community coalitions
732967|NCT01088542|systems transformation|systems transformation
732968|NCT01088542|violence|violence
732969|NCT01088555|nephrolithiasis|nephrolithiasis
732970|NCT01088555|calcium stones|calcium stones
732971|NCT01088555|kidney stones|kidney stones
732972|NCT01088555|hypercalciuria|hypercalciuria
732973|NCT01088555|sodium thiosulfate|sodium thiosulfate
732974|NCT01088555|Calcium containing kidney stones|calcium containing kidney stones
732975|NCT01088568|Keratomileusis, laser in situ|keratomileusis, laser in situ
732976|NCT01088568|Phakic Intraocular Lenses|phakic intraocular lenses
732977|NCT01088568|myopia|myopia
732978|NCT01088568|astigmatism|astigmatism
732979|NCT01088568|Implantable Collamer Lens, Toric|implantable collamer lens, toric
732980|NCT01088581|hepatocellular carcinoma|hepatocellular carcinoma
732981|NCT01088581|hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
732982|NCT01088581|5-fluorouracil|5-fluorouracil
732983|NCT01088581|cisplatin|cisplatin
732984|NCT01088581|adjuvant chemotherapy|adjuvant chemotherapy
732986|NCT01088594|urinary sodium excretion|urinary sodium excretion
732987|NCT01088594|Pioglitazone|pioglitazone
732988|NCT01088594|Rosiglitazone|rosiglitazone
732989|NCT01088594|Methodological study|methodological study
732990|NCT01088607|Primary sclerosing cholangitis|primary sclerosing cholangitis
732991|NCT01088607|Autoimmune hepatitis|autoimmune hepatitis
732992|NCT01088607|Cholestatic liver disease|cholestatic liver disease
732993|NCT01088607|Cirrhosis|cirrhosis
732994|NCT01088607|Children|children
732995|NCT01088607|Primary Sclerosing Cholangitis/Autoimmune Hepatitis Overlap|primary sclerosing cholangitis/autoimmune hepatitis overlap
732996|NCT01096069|Rituximab, rheumatoid arthritis, CD55, CD59|rituximab, rheumatoid arthritis, cd55, cd59
732997|NCT01096082|spinocerebellar ataxia|spinocerebellar ataxia
732998|NCT01096082|Treatment|treatment
732999|NCT01096082|Lithium carbonate|lithium carbonate
733001|NCT01096095|Spinocerebellar Ataxia|spinocerebellar ataxia
733002|NCT01096095|Sodium Phenylbutyrate|sodium phenylbutyrate
733003|NCT01096095|Machado-Joseph Disease|machado-joseph disease
733004|NCT01096095|Treatment|treatment
733005|NCT01096108|Smoking cessation|smoking cessation
733006|NCT01096108|Quit smoking|quit smoking
733007|NCT01096108|Quit & Win|quit & win
733008|NCT01096121|Angiotensin-converting enzyme inhibitors (ACE)|angiotensin-converting enzyme inhibitors (ace)
733009|NCT01096121|Renal disease|renal disease
733010|NCT01096121|Microalbuminemia|microalbuminemia
733011|NCT01096147|FBSS|fbss
733012|NCT01096147|chronic pain|chronic pain
733013|NCT01096147|leg pain|leg pain
733014|NCT01096147|low back pain|low back pain
733015|NCT01096147|spinal cord stimulation|spinal cord stimulation
733016|NCT01096160|Hypertension|hypertension
733017|NCT01096173|Sputum|sputum
733018|NCT01096173|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
733019|NCT01096186|motor Symptoms|motor symptoms
733020|NCT01096186|efficacy|efficacy
733021|NCT01096186|IPX066|ipx066
733022|NCT01096186|Parkinson's Disease|parkinson's disease
733023|NCT01096199|The purpose of the study is to evaluate the safety and feasibility of combining TS-1/CDDP with RAD001. Primary|the purpose of the study is to evaluate the safety and feasibility of combining ts-1/cddp with rad001. primary
733024|NCT01096199|Objectives|objectives
733025|NCT01096199|To determine the MTD/recommended phase II dose of TS-1/CDDP/RAD001 combination —To determine|to determine the mtd/recommended phase ii dose of ts-1/cddp/rad001 combination —to determine
733026|NCT01096199|the safety of TS-1/CDDP/RAD001 combination Secondary Objectives —To preliminarily describe any clinical activity in|the safety of ts-1/cddp/rad001 combination secondary objectives —to preliminarily describe any clinical activity in
733027|NCT01096199|platinum refractory disease|platinum refractory disease
733028|NCT01096199|To assess to effect of concurrent TS-1/CDDP on RAD001 pharmacokinetics —To explore|to assess to effect of concurrent ts-1/cddp on rad001 pharmacokinetics —to explore
733029|NCT01096199|the relationship of tumour biomarkers and treatment response|the relationship of tumour biomarkers and treatment response
733030|NCT01096212|Efficacy|efficacy
733031|NCT01096212|Minimum alveolar concentration|minimum alveolar concentration
733032|NCT01096212|Safety|safety
733033|NCT01096212|Sevoflurane|sevoflurane
733034|NCT01096225|the antibody response|the antibody response
733035|NCT01096225|T-cell response|t-cell response
733036|NCT01096225|S-OIV|s-oiv
733037|NCT01096225|vaccine|vaccine
733038|NCT01096225|Immunogenicity assessment|immunogenicity assessment
733039|NCT01096238|The immunogenicity of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in adults after half a year will be analyzed and discussed.|the immunogenicity of influenza virus vaccine, adimflu-s (a/h1n1), in adults after half a year will be analyzed and discussed.
733040|NCT01096251|Obesity|obesity
733041|NCT01096251|Binge Eating Disorder|binge eating disorder
733042|NCT01096251|Cognitive Behavioural Therapy|cognitive behavioural therapy
733043|NCT01096251|Brief Strategic Therapy|brief strategic therapy
733044|NCT01096251|Telepsychology|telepsychology
733045|NCT01096264|Arterial stiffness|arterial stiffness
733046|NCT01096264|Pulse wave velocity|pulse wave velocity
733047|NCT01096264|Ultrafastecho|ultrafastecho
733048|NCT01096264|Supersonic shear imaging|supersonic shear imaging
735414|NCT01104129|Intraductal Papillary Mucinous Neoplasm (IPMN)|intraductal papillary mucinous neoplasm (ipmn)
735539|NCT01104987|Osteoporosis|osteoporosis
733049|NCT01096290|constipation|constipation
733050|NCT01096290|lubiprostone|lubiprostone
733051|NCT01096290|healthy volunteers|healthy volunteers
733053|NCT01096303|pulmonary function|pulmonary function
733054|NCT01096303|tobacco and marihuana smoking|tobacco and marihuana smoking
733055|NCT01096316|mood disorders|mood disorders
733056|NCT01096316|depressive disorder|depressive disorder
733057|NCT01096316|women|women
733058|NCT01096316|depression|depression
733059|NCT01096329|postmenopausal|postmenopausal
733060|NCT01096329|hormone replacement therapy|hormone replacement therapy
733061|NCT01096381|cardiovascular complications|cardiovascular complications
733062|NCT01096381|stage I breast cancer|stage i breast cancer
733063|NCT01096381|stage II breast cancer|stage ii breast cancer
733064|NCT01096381|stage IIIA breast cancer|stage iiia breast cancer
733065|NCT01096381|stage IIIB breast cancer|stage iiib breast cancer
733066|NCT01096381|stage IIIC breast cancer|stage iiic breast cancer
733067|NCT01096381|stage IV breast cancer|stage iv breast cancer
733068|NCT01096381|stage I colon cancer|stage i colon cancer
733069|NCT01096381|stage II colon cancer|stage ii colon cancer
733070|NCT01096381|stage III colon cancer|stage iii colon cancer
733071|NCT01096381|stage IV colon cancer|stage iv colon cancer
733072|NCT01096381|stage I rectal cancer|stage i rectal cancer
733073|NCT01096381|stage II rectal cancer|stage ii rectal cancer
733074|NCT01096381|stage III rectal cancer|stage iii rectal cancer
733075|NCT01096381|stage IV rectal cancer|stage iv rectal cancer
733076|NCT01096381|stage I non-small cell lung cancer|stage i non-small cell lung cancer
733077|NCT01096381|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
733078|NCT01096381|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
733079|NCT01096381|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
733080|NCT01096381|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
733081|NCT01096381|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
733082|NCT01096381|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
733083|NCT01096381|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
733084|NCT01096381|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
733085|NCT01096381|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
733314|NCT01099150|Platelet function|platelet function
733086|NCT01096381|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
733087|NCT01096381|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
733088|NCT01096381|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
733089|NCT01096381|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
733090|NCT01096381|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
733091|NCT01096381|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
733092|NCT01096381|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
733093|NCT01096381|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
733094|NCT01096381|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
733095|NCT01096381|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
733172|NCT01098591|meta-analysis|meta-analysis
733096|NCT01096381|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
733097|NCT01096381|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
733098|NCT01096381|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
733099|NCT01096381|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
733100|NCT01096381|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
733101|NCT01096381|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
733102|NCT01096381|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
733103|NCT01096381|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
733104|NCT01096381|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
733105|NCT01096381|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
733106|NCT01096381|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
733107|NCT01096381|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
733108|NCT01096381|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
733109|NCT01096381|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
735517|NCT01104857|Myosin|myosin
733110|NCT01096381|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
733198|NCT01098708|non ambulatory|non ambulatory
733111|NCT01096381|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
733112|NCT01096381|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
733113|NCT01096381|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
733114|NCT01096381|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
733115|NCT01096381|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
733116|NCT01096381|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
733117|NCT01096381|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
733118|NCT01096381|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
733119|NCT01096381|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
733120|NCT01096381|fallopian tube cancer|fallopian tube cancer
733121|NCT01096381|peritoneal cavity cancer|peritoneal cavity cancer
733122|NCT01096394|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
733123|NCT01096394|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
733124|NCT01098396|parkinson disease|parkinson disease
733126|NCT01098409|sodium nitrite|sodium nitrite
733127|NCT01098409|coronary artery bypass surgery|coronary artery bypass surgery
733128|NCT01098409|cardioprotection|cardioprotection
733129|NCT01098409|myocardial injury|myocardial injury
733130|NCT01098422|liver|liver
733131|NCT01098422|colorectal|colorectal
733132|NCT01098422|metastasis|metastasis
733133|NCT01098422|carcinoma|carcinoma
733134|NCT01098422|Yttrium-90|yttrium-90
733135|NCT01098422|microspheres|microspheres
733136|NCT01098435|Binge eating disorder|binge eating disorder
733137|NCT01098435|RDC-0313|rdc-0313
733138|NCT01098448|Amoxicillin|amoxicillin
733139|NCT01098448|antibiotics|antibiotics
733140|NCT01098448|chronic periodontitis|chronic periodontitis
733141|NCT01098448|local drug delivery|local drug delivery
733142|NCT01098448|metronidazol|metronidazol
733143|NCT01098448|randomized controlled trial|randomized controlled trial
733144|NCT01098448|subgingival scaling|subgingival scaling
733145|NCT01098448|surgery|surgery
733146|NCT01098448|tetracycline|tetracycline
733147|NCT01098448|moderate to advanced chronic periodontitis|moderate to advanced chronic periodontitis
733148|NCT01098461|dose-ranging|dose-ranging
733149|NCT01098461|pharmacokinetics|pharmacokinetics
733150|NCT01098461|GSK716155|gsk716155
733151|NCT01098461|Japan|japan
733152|NCT01098461|albiglutide|albiglutide
733153|NCT01098474|Tuberculosis vaccine|tuberculosis vaccine
733154|NCT01098487|Immune (idiopathic) thrombocytopenic purpura (ITP)|immune (idiopathic) thrombocytopenic purpura (itp)
733155|NCT01098487|bone marrow fibers|bone marrow fibers
733156|NCT01098487|eltrombopag olamine|eltrombopag olamine
733157|NCT01098487|thrombopoietin receptor agonist|thrombopoietin receptor agonist
733158|NCT01098500|Liver function|liver function
733159|NCT01098500|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
733160|NCT01098513|HIV|hiv
733161|NCT01098513|healthy|healthy
733162|NCT01098513|GSK1349572|gsk1349572
733163|NCT01098526|GSK1349572|gsk1349572
733164|NCT01098526|efavirenz|efavirenz
733165|NCT01098526|integrase|integrase
733166|NCT01098526|pharmacokinetics|pharmacokinetics
733167|NCT01098539|sitagliptin|sitagliptin
733168|NCT01098539|albiglutide|albiglutide
733169|NCT01098539|renal impairment|renal impairment
733170|NCT01098552|Prostate Cancer|prostate cancer
733171|NCT01098578|Posterior Epistaxis|posterior epistaxis
733173|NCT01098591|stem cell|stem cell
733174|NCT01098591|cardiac|cardiac
733175|NCT01098591|remodeling|remodeling
733176|NCT01098591|MESS|mess
733177|NCT01098617|endoscopic sphincterotomy|endoscopic sphincterotomy
733178|NCT01098617|hemorrhage|hemorrhage
733179|NCT01098617|nonsteroidal antiinflammatory agents|nonsteroidal antiinflammatory agents
733180|NCT01098617|antiaggregants|antiaggregants
733181|NCT01098617|anticoagulants|anticoagulants
733182|NCT01098617|Endoscopic biliary sphincterotomy induced bleeding|endoscopic biliary sphincterotomy induced bleeding
733183|NCT01098643|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
733184|NCT01098656|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
733185|NCT01098656|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
733186|NCT01098656|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
733187|NCT01098656|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
733442|NCT01099462|fever|fever
733188|NCT01098656|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
733189|NCT01098656|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
733190|NCT01098669|cancer survivor|cancer survivor
733191|NCT01098669|lymphedema|lymphedema
733192|NCT01098669|head and neck cancer|head and neck cancer
733193|NCT01098695|parenting interventions|parenting interventions
733194|NCT01098695|Family Check-Up|family check-up
733195|NCT01098695|Early Intervention|early intervention
733196|NCT01098695|Self-Regulation|self-regulation
733199|NCT01098721|plaque psoriasis|plaque psoriasis
733200|NCT01098721|skin diseases|skin diseases
733201|NCT01098721|anti-inflammatory|anti-inflammatory
733202|NCT01098721|non-steroid|non-steroid
733203|NCT01098721|topical cream|topical cream
733204|NCT01098734|non-steroid|non-steroid
733205|NCT01098734|anti-inflammatory|anti-inflammatory
733206|NCT01098734|skin disease|skin disease
733207|NCT01098734|topical cream|topical cream
733208|NCT01098734|small molecule|small molecule
733209|NCT01098734|atopic dermatitis|atopic dermatitis
733211|NCT01098747|Pain following third molar extraction|pain following third molar extraction
733212|NCT01098760|Sorafenib|sorafenib
733213|NCT01098760|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
733214|NCT01098773|Weaning from mechanical ventilation|weaning from mechanical ventilation
733216|NCT01098773|Lung ultrasound|lung ultrasound
733217|NCT01098773|Echocardiography|echocardiography
733218|NCT01098786|Influenza A|influenza a
733219|NCT01098786|H1N1 subtype|h1n1 subtype
733220|NCT01098786|Vaccine|vaccine
733221|NCT01098786|Adjuvant|adjuvant
733222|NCT01098786|Cell culture|cell culture
733223|NCT01098799|Urotensin II,Chronic renal disease|urotensin ii,chronic renal disease
733224|NCT01098812|Cataract, Intraocular lens|cataract, intraocular lens
733225|NCT01098825|vaccine hesitancy|vaccine hesitancy
733226|NCT01098825|vaccine refusal|vaccine refusal
733227|NCT01098838|Cancer|cancer
733228|NCT01098838|adults|adults
733229|NCT01098838|solid tumor|solid tumor
733230|NCT01098838|apoptosis|apoptosis
733231|NCT01098838|programmed cell death|programmed cell death
733232|NCT01098838|LCL161|lcl161
733233|NCT01098851|Obstructive Sleep Apnea|obstructive sleep apnea
733234|NCT01098851|Pulse Oximetry|pulse oximetry
733235|NCT01098864|Behavior|behavior
733236|NCT01098864|Impulsivity|impulsivity
733237|NCT01098864|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
733238|NCT01098877|Phase1|phase1
733239|NCT01098877|pharmacokinetics|pharmacokinetics
733240|NCT01098877|safety|safety
733241|NCT01098877|toleration|toleration
733242|NCT01098877|pharmacodynamics|pharmacodynamics
733243|NCT01098903|sunitinib|sunitinib
733244|NCT01098903|cancer|cancer
733245|NCT01098903|pharmacogenomics|pharmacogenomics
733246|NCT01098903|pharmacokinetics|pharmacokinetics
733247|NCT01098903|Patients who have a malignancy and are going to be treated with sunitinib|patients who have a malignancy and are going to be treated with sunitinib
733248|NCT01098903|doseindividualism|doseindividualism
733249|NCT01098916|hospital at home|hospital at home
733250|NCT01098916|radiology at home|radiology at home
733251|NCT01098916|frail elderly|frail elderly
733252|NCT01098929|genes|genes
733253|NCT01098929|genetic|genetic
733254|NCT01098929|chromosome|chromosome
733255|NCT01098929|chromosome microarray|chromosome microarray
733256|NCT01098942|bariatric surgery|bariatric surgery
733257|NCT01098955|Cancer|cancer
733258|NCT01098955|Smoking Cessation Treatment|smoking cessation treatment
733259|NCT01098955|Acceptance and Commitment Therapy|acceptance and commitment therapy
733260|NCT01098955|ACT Theory|act theory
733261|NCT01098955|Motivational and Behavioral Counseling|motivational and behavioral counseling
733262|NCT01098955|MBC|mbc
733263|NCT01098955|abstinence|abstinence
733264|NCT01098955|Varenicline|varenicline
733265|NCT01098955|Chantix|chantix
733266|NCT01098994|Type 1 diabetes|type 1 diabetes
733267|NCT01098994|Haptoglobin genotype|haptoglobin genotype
733268|NCT01098994|HDL function|hdl function
733269|NCT01098994|Heart disease|heart disease
733270|NCT01098994|Feasibility of clinical trial|feasibility of clinical trial
733271|NCT01099007|Women|women
733272|NCT01099007|Menopause|menopause
733273|NCT01099007|Cardiovascular Disease|cardiovascular disease
733274|NCT01099007|Physical Activity|physical activity
733275|NCT01099007|Weight Loss|weight loss
733276|NCT01099020|Subjects receiving large volumes of Radiation|subjects receiving large volumes of radiation
733277|NCT01099033|hiatal hernia|hiatal hernia
733278|NCT01099033|paraesophageal hernia|paraesophageal hernia
733279|NCT01099033|biologic mesh|biologic mesh
733280|NCT01099033|MMPs|mmps
733281|NCT01099033|Hiatal/Paraesophageal hernia|hiatal/paraesophageal hernia
733282|NCT01099046|Meniere's disease|meniere's disease
733283|NCT01099046|stress management|stress management
733284|NCT01099046|vasopressin|vasopressin
733285|NCT01099046|V2 receptor|v2 receptor
733286|NCT01099046|water intake|water intake
733287|NCT01099046|tympanic tubing|tympanic tubing
733288|NCT01099046|regular sleep under dark|regular sleep under dark
733289|NCT01099059|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
733290|NCT01099059|Clinical Trial|clinical trial
733291|NCT01099059|Amantadine|amantadine
733292|NCT01099059|Methylphenidate|methylphenidate
733293|NCT01099072|ADHD|adhd
733294|NCT01099072|carnitine|carnitine
733295|NCT01099072|methylphenidate|methylphenidate
733296|NCT01099085|gastric cancer, unresectable/metastatic|gastric cancer, unresectable/metastatic
733297|NCT01099098|People who have fibrosis or nodules in their upper lobe of the lung|people who have fibrosis or nodules in their upper lobe of the lung
733298|NCT01099111|IBS|ibs
733299|NCT01099111|UC|uc
733304|NCT01099124|Phase I Trial|phase i trial
733305|NCT01099124|Advanced NSCLC|advanced nsclc
733306|NCT01099124|Recurrent NSCLC|recurrent nsclc
733307|NCT01099137|Diabetes|diabetes
733308|NCT01099137|Vildagliptin|vildagliptin
733309|NCT01099137|insulin|insulin
733310|NCT01099137|C-peptide|c-peptide
733311|NCT01099150|Platelets|platelets
733312|NCT01099150|Platelet aggregation|platelet aggregation
733313|NCT01099150|Platelet activation|platelet activation
733315|NCT01099150|Light transmission aggregometry|light transmission aggregometry
733316|NCT01099150|Platelet Function Analyzer-100 (PFA-100)|platelet function analyzer-100 (pfa-100)
733317|NCT01099150|P-selectin|p-selectin
733318|NCT01099150|Fibrinogen receptor|fibrinogen receptor
733319|NCT01099150|Glycoprotein IIb-IIIa|glycoprotein iib-iiia
733320|NCT01099150|Chocolate|chocolate
733321|NCT01099150|Cocoa|cocoa
733322|NCT01099150|Flavan-3-ols|flavan-3-ols
733323|NCT01099150|Procyanidins|procyanidins
733324|NCT01099163|Diabetes mellitus|diabetes mellitus
733325|NCT01099163|CLA|cla
733326|NCT01099163|Antioxidant|antioxidant
733327|NCT01099163|Glycemic control|glycemic control
733328|NCT01099176|hyperlipidemia|hyperlipidemia
733329|NCT01099176|impaired fasting glycemia|impaired fasting glycemia
733330|NCT01099176|adipokines|adipokines
733331|NCT01099176|atorvastatin|atorvastatin
733332|NCT01099176|fenofibrate|fenofibrate
733333|NCT01099189|Histology|histology
733334|NCT01099189|Compliance|compliance
733335|NCT01099189|Dialysis|dialysis
733336|NCT01099189|Arteriovenous access fistula|arteriovenous access fistula
733337|NCT01099189|vein|vein
733338|NCT01099202|Procrit|procrit
733339|NCT01099202|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
733340|NCT01099202|Lymphoblastic Lymphoma|lymphoblastic lymphoma
733341|NCT01099202|Burkitt's|burkitt's
733342|NCT01099202|Chemotherapy|chemotherapy
733343|NCT01099202|Hyper-CVAD|hyper-cvad
733344|NCT01099202|augmented BFM|augmented bfm
733345|NCT01099202|Epoetin alfa|epoetin alfa
733346|NCT01099202|Epogen|epogen
733347|NCT01099202|Erythropoietin|erythropoietin
733348|NCT01099215|peripheral artery disease|peripheral artery disease
733349|NCT01099215|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
733350|NCT01099215|stent|stent
733351|NCT01099215|balloon/stent|balloon/stent
733352|NCT01099215|superficial femoral artery|superficial femoral artery
733353|NCT01099228|Neuroendocrine Tumor|neuroendocrine tumor
733354|NCT01099228|Imaging|imaging
733355|NCT01099241|CVP|cvp
733356|NCT01099241|US|us
733357|NCT01099241|Ultrasonography|ultrasonography
733358|NCT01099254|CVP|cvp
733359|NCT01099254|US|us
733360|NCT01099254|Trendelenburg position|trendelenburg position
733361|NCT01099254|Ultrasound|ultrasound
733362|NCT01099254|Head Down Tilt|head down tilt
733363|NCT01099267|MDS|mds
733364|NCT01099280|induction of labor in term|induction of labor in term
733365|NCT01099280|premature rupture of membranes|premature rupture of membranes
733366|NCT01099280|dinoprostone|dinoprostone
733367|NCT01099280|oxytocin|oxytocin
733368|NCT01099293|Hepatic Encephalopathy|hepatic encephalopathy
733369|NCT01099293|Psychometric Hepatic Encephalopathy Score|psychometric hepatic encephalopathy score
733370|NCT01099293|Critical Flicker Frequency|critical flicker frequency
733371|NCT01099293|Cerebrovascular Reactivity|cerebrovascular reactivity
733372|NCT01099293|Endotoxemia|endotoxemia
733373|NCT01099293|Transcranial Doppler|transcranial doppler
733374|NCT01099293|Liver Cirrhosis|liver cirrhosis
733375|NCT01099319|Dietary supplement|dietary supplement
733376|NCT01099319|Renalof|renalof
733377|NCT01099319|gallstones|gallstones
733378|NCT01099319|elderly|elderly
733379|NCT01099332|Alzheimer's disease|alzheimer's disease
733380|NCT01099332|Mild Cognitive Impairment|mild cognitive impairment
733381|NCT01099332|Copper metabolism|copper metabolism
733382|NCT01099332|Zinc metabolism|zinc metabolism
733383|NCT01099332|Ceruloplasmin|ceruloplasmin
733384|NCT01099345|OAB|oab
733385|NCT01099345|Nocturia|nocturia
733386|NCT01099345|Bladder function|bladder function
733387|NCT01099345|cystometry|cystometry
733388|NCT01099345|polysomnography|polysomnography
733389|NCT01099358|Cancer of Head|cancer of head
733390|NCT01099358|Cancer of Head and Neck|cancer of head and neck
733391|NCT01099358|Cancer of Neck|cancer of neck
733392|NCT01099358|Cancer of the Head|cancer of the head
733393|NCT01099358|Cancer of the Head and Neck|cancer of the head and neck
733394|NCT01099358|Cancer of the Neck|cancer of the neck
733395|NCT01099358|Head and Neck Cancer|head and neck cancer
733396|NCT01099358|Head Cancer|head cancer
733397|NCT01099358|Head Neoplasms|head neoplasms
733398|NCT01099358|Head, Neck Neoplasms|head, neck neoplasms
733399|NCT01099358|Neck Cancer|neck cancer
733400|NCT01099358|Neck Neoplasms|neck neoplasms
733401|NCT01099358|Solid Neoplasm|solid neoplasm
735808|NCT01105988|GBM|gbm
733402|NCT01099358|Carcinoma|carcinoma
733403|NCT01099358|Sarcoma|sarcoma
733404|NCT01099371|Knee|knee
733405|NCT01099371|Osteoarthritis|osteoarthritis
733406|NCT01099371|Exercise|exercise
733407|NCT01099397|Glucose|glucose
733408|NCT01099397|Glucose Tolerance Test|glucose tolerance test
733890|NCT01091974|CBT|cbt
733409|NCT01099397|Insulin Resistance|insulin resistance
733410|NCT01099397|Metabolic adverse effects|metabolic adverse effects
733411|NCT01099397|Hypertension|hypertension
733412|NCT01099397|Beta-blocker|beta-blocker
733413|NCT01099397|Atenolol|atenolol
733414|NCT01099397|Diuretic|diuretic
733415|NCT01099397|Hydrochlorothiazide|hydrochlorothiazide
733416|NCT01099397|Blood pressure|blood pressure
733417|NCT01099410|macrophages, alveolar|macrophages, alveolar
733418|NCT01099410|monocytes|monocytes
733419|NCT01099410|Receptor Protein-Tyrosine Kinases|receptor protein-tyrosine kinases
733420|NCT01099410|Humans|humans
733421|NCT01099410|Phagocytosis|phagocytosis
733422|NCT01099410|Lung|lung
733423|NCT01099410|in vitro|in vitro
733424|NCT01099423|clear cell renal cell carcinoma|clear cell renal cell carcinoma
733425|NCT01099423|stage IV renal cell cancer|stage iv renal cell cancer
733426|NCT01099436|HER2-negative breast cancer|her2-negative breast cancer
733427|NCT01099436|stage II breast cancer|stage ii breast cancer
733428|NCT01099436|stage IIIA breast cancer|stage iiia breast cancer
733429|NCT01099436|stage IIIB breast cancer|stage iiib breast cancer
733430|NCT01099436|stage IIIC breast cancer|stage iiic breast cancer
733431|NCT01099449|neurotoxicity|neurotoxicity
733432|NCT01099449|neuropathy|neuropathy
735459|NCT01104350|Bladder|bladder
733433|NCT01099449|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
733434|NCT01099449|stage II colon cancer|stage ii colon cancer
733435|NCT01099449|stage III colon cancer|stage iii colon cancer
733436|NCT01099449|stage IV colon cancer|stage iv colon cancer
733437|NCT01099449|stage II rectal cancer|stage ii rectal cancer
733438|NCT01099449|stage III rectal cancer|stage iii rectal cancer
733439|NCT01099449|stage IV rectal cancer|stage iv rectal cancer
733440|NCT01099449|adenocarcinoma of the colon|adenocarcinoma of the colon
733441|NCT01099449|adenocarcinoma of the rectum|adenocarcinoma of the rectum
733443|NCT01099462|Ibuprofen|ibuprofen
733444|NCT01099475|liver surgery|liver surgery
733445|NCT01099475|pringle manoeuvre|pringle manoeuvre
733446|NCT01099475|hepatocellular damage|hepatocellular damage
733447|NCT01099475|surgical complications|surgical complications
733448|NCT01099475|patients requiring liver surgery|patients requiring liver surgery
733449|NCT01099488|Immunological assays|immunological assays
733450|NCT01099501|Mechanical Ventilation|mechanical ventilation
733451|NCT01099527|gastric cancer|gastric cancer
733452|NCT01099527|refractory|refractory
733453|NCT01099527|metastatic|metastatic
733454|NCT01099540|neuroendocrine tumor|neuroendocrine tumor
733455|NCT01099553|Educational video|educational video
733456|NCT01099553|colonoscopy|colonoscopy
733457|NCT01099553|bowel preparation|bowel preparation
733458|NCT01099553|Bowel preparation for colonoscopy|bowel preparation for colonoscopy
733459|NCT01099566|human endotoxemia|human endotoxemia
733460|NCT01099566|tissue factor induced coagulation|tissue factor induced coagulation
733461|NCT01099566|platelet activation|platelet activation
733462|NCT01099566|thienopyridines|thienopyridines
733463|NCT01099579|HIV, Pediatric|hiv, pediatric
733464|NCT01099605|hemorrhoidectomy|hemorrhoidectomy
733465|NCT01099605|pain management|pain management
733466|NCT01099631|Salmonella typhimurium|salmonella typhimurium
733467|NCT01099631|unresectable hepatic cancer|unresectable hepatic cancer
733468|NCT01099631|attenuated Salmonella typhimurium|attenuated salmonella typhimurium
733469|NCT01099631|IL-2|il-2
733470|NCT01099644|Peritoneum|peritoneum
733471|NCT01099644|Desmoplastic Small Round Cell Tumors|desmoplastic small round cell tumors
733472|NCT01099644|Intraperitoneal Radioimmunotherapy|intraperitoneal radioimmunotherapy
733473|NCT01099644|131 I-8H9|131 i-8h9
733475|NCT01099696|abdominal discomfort and bloating|abdominal discomfort and bloating
733476|NCT01099709|healthy subjects|healthy subjects
733477|NCT01099709|opioid|opioid
733478|NCT01099722|moderate to severe persistent reversible asthma|moderate to severe persistent reversible asthma
733479|NCT01099735|Bariatric Surgery|bariatric surgery
733480|NCT01099735|Sleep Apnea|sleep apnea
733481|NCT01099735|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
733482|NCT01099735|GERD|gerd
733483|NCT01099748|Drug interaction|drug interaction
733484|NCT01099748|pharmacokinetics|pharmacokinetics
733485|NCT01099748|lersivirine|lersivirine
733486|NCT01099748|methadone|methadone
733487|NCT01099800|asthma|asthma
733488|NCT01099800|health disparities|health disparities
733489|NCT01099800|illness representations|illness representations
733490|NCT01099800|CAM|cam
733491|NCT01099800|Latino|latino
733492|NCT01099813|Critical Illness|critical illness
733493|NCT01099813|Sepsis|sepsis
733494|NCT01099813|Duration|duration
733495|NCT01099813|Severity of Illness Scores|severity of illness scores
733496|NCT01099813|Trajectory|trajectory
733497|NCT01099826|colorectal cancer screening|colorectal cancer screening
733498|NCT01099826|tailored education|tailored education
733499|NCT01099826|motivational interview|motivational interview
733500|NCT01099826|patient education|patient education
733501|NCT01099839|ASP1941|asp1941
733502|NCT01099839|Miglitol|miglitol
733503|NCT01099852|dengue|dengue
733504|NCT01099852|fever|fever
733505|NCT01099852|dengue hemorrhagic fever|dengue hemorrhagic fever
733506|NCT01099852|dengue virus|dengue virus
733507|NCT01099852|Chikungunya virus|chikungunya virus
733508|NCT01099852|Zika Virus|zika virus
733509|NCT01099852|Joint pain|joint pain
733510|NCT01099878|Cycling Exercise|cycling exercise
733511|NCT01099878|Functional Electrical Stimulation|functional electrical stimulation
733512|NCT01099878|Stroke|stroke
733513|NCT01099917|MDS|mds
733514|NCT01099917|Maitake|maitake
733515|NCT01099917|mushroom|mushroom
733516|NCT01099917|09-094|09-094
733517|NCT01099930|immunoablation|immunoablation
733518|NCT01099930|stem cell transplantation|stem cell transplantation
733519|NCT01099956|type 1 diabetes|type 1 diabetes
733520|NCT01099956|children|children
733521|NCT01099956|low grade inflammation|low grade inflammation
733522|NCT01099956|cytokine|cytokine
733523|NCT01099956|CRP|crp
733524|NCT01099969|Endotrol Endotracheal tube|endotrol endotracheal tube
733525|NCT01099969|Regular endotracheal tube|regular endotracheal tube
733526|NCT01099969|glide rite stylet|glide rite stylet
733527|NCT01099969|McGarth video laryngoscope|mcgarth video laryngoscope
733528|NCT01099969|Glidescope|glidescope
733529|NCT01099969|comparison of endotrol endotracheal tube to regular endotracheal tube with video laryngoscopes Glidescope and McGrath|comparison of endotrol endotracheal tube to regular endotracheal tube with video laryngoscopes glidescope and mcgrath
733914|NCT01092091|Neoplasm|neoplasm
733530|NCT01099982|Congestive Heart Failure|congestive heart failure
733531|NCT01099982|Left Ventricular Assist Device|left ventricular assist device
733532|NCT01099982|LVAD|lvad
733533|NCT01099982|Myocardium|myocardium
733534|NCT01099982|Remodeling|remodeling
733535|NCT01099982|Microvasculature|microvasculature
733536|NCT01099982|Fibrosis|fibrosis
733537|NCT01099982|Cardiac Transplant|cardiac transplant
733538|NCT01099995|domestic accident|domestic accident
733539|NCT01099995|coma|coma
733540|NCT01099995|carbon monoxide|carbon monoxide
733541|NCT01099995|intoxication|intoxication
733542|NCT01099995|acute domestic carbon monoxide poisoning|acute domestic carbon monoxide poisoning
733543|NCT01100008|Pulmonary arterial hypertension|pulmonary arterial hypertension
733544|NCT01100008|cardiac MRI (magnetic resonance imaging)|cardiac mri (magnetic resonance imaging)
733545|NCT01100008|severity|severity
733546|NCT01100008|prognosis|prognosis
733547|NCT01100034|pediatric psoriasis|pediatric psoriasis
733548|NCT01100034|etanercept|etanercept
733549|NCT01100034|PASS|pass
733550|NCT01100034|safety|safety
733551|NCT01100034|effectiveness|effectiveness
733552|NCT01100047|Phase I|phase i
733553|NCT01100047|Japanese healthy volunteer|japanese healthy volunteer
733554|NCT01100047|AZD5069|azd5069
733555|NCT01100060|Azithromycin|azithromycin
733556|NCT01100060|chloroquine|chloroquine
733557|NCT01100060|microsphere|microsphere
733558|NCT01100060|pharmacokinetics|pharmacokinetics
733559|NCT01100060|bioavailability|bioavailability
733560|NCT01100086|Healthy subjects|healthy subjects
733561|NCT01100086|Opioid|opioid
733562|NCT01100099|Celiac disease.|celiac disease.
733563|NCT01100099|Food intolerance.|food intolerance.
733564|NCT01100099|Gluten intolerance without celiac disease.|gluten intolerance without celiac disease.
733565|NCT01100112|ulcerative colitis|ulcerative colitis
733566|NCT01100112|Budesonide|budesonide
733567|NCT01100125|Diabetes|diabetes
733568|NCT01100125|Sitagliptin|sitagliptin
733569|NCT01100125|insulin|insulin
733570|NCT01100125|C-peptide|c-peptide
733571|NCT01100151|Opioid-induced constipation|opioid-induced constipation
733572|NCT01100151|RDC-1036|rdc-1036
733573|NCT01100151|ALKS 37|alks 37
733574|NCT01100164|INSOMNIA|insomnia
733575|NCT01100164|FOR THE TREATMENT OF INSOMNIA|for the treatment of insomnia
733576|NCT01100177|Patients with non resectable Glioblastoma who have only a|patients with non resectable glioblastoma who have only a
733577|NCT01100177|biopsy as surgical treatment|biopsy as surgical treatment
733578|NCT01100190|Facelift|facelift
733579|NCT01100190|Rhytidectomy|rhytidectomy
733580|NCT01100190|Ptosis|ptosis
733581|NCT01100203|aldosterone receptor inhibition|aldosterone receptor inhibition
733582|NCT01100203|arterial stiffness|arterial stiffness
733583|NCT01100203|ambulatory arterial stiffness index|ambulatory arterial stiffness index
733584|NCT01100216|smokeless tobacco|smokeless tobacco
733585|NCT01100216|nicotine|nicotine
733586|NCT01100216|snus|snus
733587|NCT01100216|snuff|snuff
733588|NCT01100216|chewing tobacco|chewing tobacco
733589|NCT01100216|oral tobacco|oral tobacco
733590|NCT01100242|Renal Cell Carcinoma|renal cell carcinoma
733591|NCT01100242|metastatic renal cell cancer|metastatic renal cell cancer
733592|NCT01100242|kidney cancer|kidney cancer
733593|NCT01100255|OCD|ocd
733594|NCT01100268|Hoarding|hoarding
733595|NCT01100281|prefrontal cortex|prefrontal cortex
733596|NCT01100294|Influenza|influenza
733597|NCT01100294|Pandemic vaccine|pandemic vaccine
733598|NCT01100294|Seasonal vaccine|seasonal vaccine
733599|NCT01100294|Prevention|prevention
733600|NCT01100294|Influenza vaccine|influenza vaccine
733601|NCT01100294|Influenza in humans|influenza in humans
733602|NCT01100294|Pandemic influenza in humans|pandemic influenza in humans
733603|NCT01100294|Influenza vaccine for children|influenza vaccine for children
733604|NCT01100307|diabetic macular edema|diabetic macular edema
733606|NCT01100307|sham-controlled study|sham-controlled study
733607|NCT01100320|Healthy subjects|healthy subjects
733608|NCT01100320|Opioid|opioid
733609|NCT01100333|Infertility|infertility
733610|NCT01100333|Reproductive technologies, Assisted|reproductive technologies, assisted
733611|NCT01100333|r-hFSH|r-hfsh
733612|NCT01100333|Gonal-f|gonal-f
733613|NCT01100346|Ovulation induction|ovulation induction
733614|NCT01100346|Intrauterine insemination|intrauterine insemination
733615|NCT01100346|Gonal-f|gonal-f
733616|NCT01100346|Controlled ovarian stimulation|controlled ovarian stimulation
733617|NCT01100346|Infertility|infertility
733618|NCT01100359|endometrial clear cell carcinoma|endometrial clear cell carcinoma
733619|NCT01100359|recurrent endometrial carcinoma|recurrent endometrial carcinoma
733620|NCT01100359|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
733621|NCT01100359|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
733622|NCT01100359|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
733623|NCT01100359|stage IVA endometrial carcinoma|stage iva endometrial carcinoma
733624|NCT01100359|stage IVB endometrial carcinoma|stage ivb endometrial carcinoma
733625|NCT01100372|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
733626|NCT01100372|recurrent fallopian tube cancer|recurrent fallopian tube cancer
734116|NCT01093001|Lead size|lead size
733627|NCT01100372|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
733628|NCT01100385|Healthy adults|healthy adults
733629|NCT01100398|Fatty liver disease|fatty liver disease
733630|NCT01100411|Contact lenses, myopia, lens geometry|contact lenses, myopia, lens geometry
733631|NCT01100424|Contact lenses|contact lenses
733632|NCT01100424|Contact lens solution|contact lens solution
733633|NCT01100424|Corneal staining|corneal staining
733634|NCT01100437|opioid|opioid
733635|NCT01100437|morphine|morphine
733636|NCT01100437|naltrexone|naltrexone
733637|NCT01100437|withdrawal signs|withdrawal signs
733638|NCT01100437|withdrawal symptoms|withdrawal symptoms
733639|NCT01100450|bariatric surgery|bariatric surgery
733640|NCT01100450|class III obesity|class iii obesity
733641|NCT01100450|resistance training|resistance training
733642|NCT01100450|strength|strength
733643|NCT01100450|fitness|fitness
733644|NCT01100463|HFS, Hand-Foot Syndrome, Capecitabine, Breast Cancer|hfs, hand-foot syndrome, capecitabine, breast cancer
733645|NCT01100476|Closure Device|closure device
733646|NCT01100476|endovascular procedures|endovascular procedures
733647|NCT01100476|sealing femoral arterial access|sealing femoral arterial access
733648|NCT01100476|Mynx M5|mynx m5
733649|NCT01100502|Antigens, CD30|antigens, cd30
733650|NCT01100502|Antibody-Drug Conjugate|antibody-drug conjugate
733651|NCT01100502|Antibodies, Monoclonal|antibodies, monoclonal
733652|NCT01100502|Disease, Hodgkin|disease, hodgkin
733653|NCT01100502|Drug Therapy|drug therapy
733654|NCT01100502|Hematologic Diseases|hematologic diseases
733655|NCT01100502|Immunotherapy|immunotherapy
733656|NCT01100502|Lymphoma|lymphoma
733657|NCT01100502|Monomethylauristatin E|monomethylauristatin e
733658|NCT01100515|intoxication|intoxication
733659|NCT01100515|carbon monoxide|carbon monoxide
733660|NCT01100515|adults|adults
733661|NCT01100515|domestic accident|domestic accident
733662|NCT01100515|acute domestic carbon monoxide poisoning|acute domestic carbon monoxide poisoning
733663|NCT01100541|Therapeutic Hyperthermia|therapeutic hyperthermia
733664|NCT01100541|Thermotherapy|thermotherapy
733665|NCT01100541|Polymers|polymers
733666|NCT01100541|Castor Oil|castor oil
733667|NCT01100567|skeletal health|skeletal health
733668|NCT01100567|bone turnover|bone turnover
733669|NCT01100567|bone geometry|bone geometry
733670|NCT01100567|malnutrition|malnutrition
733671|NCT01100580|Low-salt diet|low-salt diet
733672|NCT01100580|calciuria|calciuria
733673|NCT01100580|blood pressure|blood pressure
733674|NCT01100580|nephrolithiasis|nephrolithiasis
733675|NCT01100580|hypertension|hypertension
733676|NCT01100580|BMI|bmi
733677|NCT01100580|urinary stone risk factors|urinary stone risk factors
733678|NCT01100593|Ultrasound|ultrasound
733679|NCT01100593|IV catheters|iv catheters
733680|NCT01100593|Extravasation|extravasation
733681|NCT01100606|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
733682|NCT01100606|Infants with CF|infants with cf
733683|NCT01100671|atherosclerosis|atherosclerosis
733684|NCT01100671|vascular inflammation|vascular inflammation
733685|NCT01100671|MDCT|mdct
733686|NCT01100671|18FDG-PET|18fdg-pet
733687|NCT01100684|diarrhea predominant irritable bowel syndrome|diarrhea predominant irritable bowel syndrome
733688|NCT01100697|prenatal diagnosis|prenatal diagnosis
733689|NCT01100697|ultrasound|ultrasound
733690|NCT01100697|outcome|outcome
733691|NCT01100697|spina bifida|spina bifida
733692|NCT01100697|neural tube defect|neural tube defect
733693|NCT01100710|Age Gender left ventricular mass high sensitive Troponin T|age gender left ventricular mass high sensitive troponin t
733694|NCT01100723|secondary hyperparathyroidism|secondary hyperparathyroidism
733695|NCT01100723|calcium|calcium
733696|NCT01100723|phosphorus|phosphorus
733697|NCT01100723|ESRD|esrd
733698|NCT01100723|CKD|ckd
733699|NCT01100723|mineral disorder|mineral disorder
733700|NCT01100736|Forearm Blood Flow|forearm blood flow
733701|NCT01100736|Vasodilation|vasodilation
733702|NCT01100736|Vasoconstriction|vasoconstriction
733703|NCT01100736|Endothelin System|endothelin system
733704|NCT01100736|Endothelin-1|endothelin-1
733705|NCT01100736|Endothelin-3|endothelin-3
733706|NCT01100736|Endothelin antagonists|endothelin antagonists
733707|NCT01100736|Bosentan|bosentan
733708|NCT01100736|Sitaxsentan|sitaxsentan
733709|NCT01100736|Endothelin|endothelin
733710|NCT01100736|Regional Blood Flow|regional blood flow
733711|NCT01100749|Hepatitis C|hepatitis c
733712|NCT01100749|Genotype 3|genotype 3
733713|NCT01100749|Demographics|demographics
733714|NCT01100749|Genetics|genetics
733715|NCT01100749|Metabolic status|metabolic status
733716|NCT01100762|Parkinson's Disease|parkinson's disease
733717|NCT01100762|Cranial Electric Stimulation|cranial electric stimulation
733718|NCT01100762|Gait|gait
733719|NCT01100775|Galantamine|galantamine
733720|NCT01100775|Schizophrenia|schizophrenia
733721|NCT01100775|working memory|working memory
733722|NCT01100775|cognitive|cognitive
733723|NCT01100801|advanced|advanced
733724|NCT01100801|metastatic|metastatic
733725|NCT01100827|EGFR mutation status in patients with advanced stage adenocarcinoma NSCLC|egfr mutation status in patients with advanced stage adenocarcinoma nsclc
733726|NCT01100827|The association between EGFR mutation status and demographic data in advanced stage adenocarcinoma NSCLC patients.|the association between egfr mutation status and demographic data in advanced stage adenocarcinoma nsclc patients.
733727|NCT01100853|amphetamine dependence|amphetamine dependence
733728|NCT01100853|amphetamine injection|amphetamine injection
733729|NCT01100853|VIVITROL/VIVITROL placebo|vivitrol/vivitrol placebo
733730|NCT01100853|amphetamine craving|amphetamine craving
733731|NCT01100866|clinically localized Prostate Cancer|clinically localized prostate cancer
733732|NCT01100866|low and intermediate risk for relapse|low and intermediate risk for relapse
733733|NCT01100866|candidates for radical prostatectomy|candidates for radical prostatectomy
733734|NCT01100879|Anemia|anemia
733735|NCT01100879|Lymphoproliferative Disorders|lymphoproliferative disorders
733736|NCT01100879|Chemotherapy|chemotherapy
733737|NCT01100879|ferric carboxymaltose|ferric carboxymaltose
733738|NCT01100879|iron|iron
733739|NCT01091428|RECIST: Response Evaluation Criteria in Solid Tumors|recist: response evaluation criteria in solid tumors
733740|NCT01091428|OC: Ovarian Cancer|oc: ovarian cancer
733741|NCT01091428|GCIG: Gynecologic Cancer Intergroup|gcig: gynecologic cancer intergroup
733742|NCT01091428|Breast carcinoma (Phase 1)|breast carcinoma (phase 1)
733743|NCT01091441|therapeutic education|therapeutic education
733744|NCT01091454|stage IV breast cancer|stage iv breast cancer
733745|NCT01091454|triple-negative breast cancer|triple-negative breast cancer
733746|NCT01091454|male breast cancer|male breast cancer
733747|NCT01091467|Heart Failure|heart failure
733748|NCT01091467|Ejection Fraction|ejection fraction
733749|NCT01091467|Echocardiography|echocardiography
733750|NCT01091480|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
733751|NCT01091480|Observatory|observatory
733752|NCT01091480|LVH|lvh
733753|NCT01091493|COPD|copd
733754|NCT01091506|L-methylfolate|l-methylfolate
733755|NCT01091506|Deplin|deplin
733756|NCT01091506|schizophrenia|schizophrenia
733757|NCT01091506|folate|folate
733758|NCT01091506|folic acid|folic acid
733759|NCT01091506|homocysteine|homocysteine
733760|NCT01091506|methionine|methionine
733761|NCT01091506|MTHFR genotype|mthfr genotype
733762|NCT01091506|C677T mutation|c677t mutation
733763|NCT01091506|vitamin B6|vitamin b6
733764|NCT01091506|vitamin B12|vitamin b12
733765|NCT01091506|psychotic symptoms|psychotic symptoms
733766|NCT01091506|MTHFR C677T Polymorphism|mthfr c677t polymorphism
733767|NCT01091519|Non-interventional study fesoterodine educational materials|non-interventional study fesoterodine educational materials
733768|NCT01091545|breast cancer|breast cancer
733769|NCT01091545|screening|screening
733770|NCT01091545|sensitivity|sensitivity
733771|NCT01091545|tomosynthesis|tomosynthesis
733772|NCT01091558|ulcerative colitis|ulcerative colitis
733773|NCT01091558|colon cancer|colon cancer
733774|NCT01091558|endoscopy|endoscopy
733775|NCT01091558|screening|screening
733776|NCT01091571|Adenosine|adenosine
733777|NCT01091571|Endotoxin|endotoxin
733778|NCT01091571|Innate Immunity|innate immunity
733779|NCT01091571|Dipyridamole|dipyridamole
733780|NCT01091610|retrospective study|retrospective study
733781|NCT01091610|wounds and injuries/epidemiology|wounds and injuries/epidemiology
733782|NCT01091610|emergency medical technicians|emergency medical technicians
733783|NCT01091610|human|human
733784|NCT01091610|emergency medical services|emergency medical services
733785|NCT01091610|ambulance|ambulance
733786|NCT01091610|health personnel|health personnel
733787|NCT01091610|emergency medicine|emergency medicine
733788|NCT01091610|risk factors|risk factors
733789|NCT01091623|improvement of exercise capacity in patients with COPD|improvement of exercise capacity in patients with copd
733790|NCT01091649|Pharmacokinetics, Safety|pharmacokinetics, safety
733791|NCT01091662|Seizures|seizures
733792|NCT01091662|Epilepsy|epilepsy
733793|NCT01091662|Anticonvulsant|anticonvulsant
733794|NCT01091662|Monotherapy|monotherapy
733795|NCT01091662|Historical control|historical control
734091|NCT01092923|induction|induction
733796|NCT01091675|ankylosing spondylitis|ankylosing spondylitis
733797|NCT01091675|biologic therapies|biologic therapies
733798|NCT01091675|ASAS|asas
733799|NCT01091675|ASASBIO|asasbio
733800|NCT01091675|etoricoxib|etoricoxib
733801|NCT01091675|NSAIDs|nsaids
733802|NCT01091675|COX-2 Inhibitor|cox-2 inhibitor
733803|NCT01091675|ARCOXIA 90 mg|arcoxia 90 mg
733804|NCT01091675|BASDAI Bath Ankylosing Spondylitis Disease Activity Index|basdai bath ankylosing spondylitis disease activity index
733805|NCT01091688|neonatal|neonatal
733806|NCT01091688|discharge planning|discharge planning
733807|NCT01091688|health transition|health transition
733808|NCT01091688|educational needs assessment|educational needs assessment
733809|NCT01091688|Intensive care, neonatal|intensive care, neonatal
733810|NCT01091701|Ischemic Cerebral Stroke|ischemic cerebral stroke
733811|NCT01091727|Neurogenic|neurogenic
733812|NCT01091727|Detrusor|detrusor
733813|NCT01091727|Overactive|overactive
733814|NCT01091727|Overactivity|overactivity
733815|NCT01091727|Bladder|bladder
733816|NCT01091727|Spinal|spinal
733817|NCT01091727|Cord|cord
733818|NCT01091727|Injury|injury
733819|NCT01091740|Drug eluting stent|drug eluting stent
733820|NCT01091740|Tomography, optical coherence|tomography, optical coherence
733821|NCT01091753|Non-dipper HTN patient|non-dipper htn patient
733822|NCT01091766|local anaesthetics toxicity|local anaesthetics toxicity
733823|NCT01091766|heart arrhythmia|heart arrhythmia
733824|NCT01091766|heart rate|heart rate
733825|NCT01091766|heart conduction|heart conduction
733826|NCT01091766|regional anaesthesia|regional anaesthesia
733827|NCT01091766|paediatric anaesthesia|paediatric anaesthesia
733828|NCT01091766|cardio-vascular system|cardio-vascular system
733829|NCT01091766|prevention|prevention
733830|NCT01091779|Male patients scheduled to have spinal anaesthesia for TURP|male patients scheduled to have spinal anaesthesia for turp
733831|NCT01091792|GBM|gbm
733832|NCT01091792|Grade IV|grade iv
733833|NCT01091792|glioma|glioma
733834|NCT01091818|To see if sedation with dexmedetomidine results in faster emergence after end of intensive care treatment in children|to see if sedation with dexmedetomidine results in faster emergence after end of intensive care treatment in children
733835|NCT01091818|treatment|treatment
733836|NCT01091831|Multiple Myeloma|multiple myeloma
733837|NCT01091831|Lenalidomide|lenalidomide
733838|NCT01091831|High dose melphalan|high dose melphalan
733839|NCT01091831|Mobilization|mobilization
733840|NCT01091831|CD 34|cd 34
733841|NCT01091831|Newly Diagnosed patients|newly diagnosed patients
733842|NCT01091844|voiding trial, urinary retention, catheterization|voiding trial, urinary retention, catheterization
733843|NCT01091844|Urinary retention after gynecologic surgery|urinary retention after gynecologic surgery
733844|NCT01091857|Exercise|exercise
733845|NCT01091857|Transdisciplinary|transdisciplinary
733846|NCT01091857|Physiology|physiology
733847|NCT01091857|Mood|mood
733848|NCT01091857|Motivation|motivation
733849|NCT01091870|Aneurysm|aneurysm
733850|NCT01091870|Vasospasm|vasospasm
733851|NCT01091870|sildenafil|sildenafil
733852|NCT01091870|Viagra|viagra
733853|NCT01091883|Bone cancer|bone cancer
733854|NCT01091883|Bone Metastases|bone metastases
733855|NCT01091883|pain palliation|pain palliation
733856|NCT01091883|metastasis|metastasis
733857|NCT01091883|breast cancer|breast cancer
733858|NCT01091883|lung cancer|lung cancer
733957|NCT01092260|Cystatin C|cystatin c
733859|NCT01091883|prostate cancer|prostate cancer
733860|NCT01091883|cancer related pain|cancer related pain
733861|NCT01091883|tumors|tumors
733862|NCT01091896|bevacizumab|bevacizumab
733863|NCT01091896|vitreous hemorrhage|vitreous hemorrhage
733864|NCT01091896|diabetes mellitus|diabetes mellitus
733865|NCT01091909|type 2 diabetes|type 2 diabetes
733866|NCT01091909|wound healing|wound healing
733867|NCT01091909|neutrophil count|neutrophil count
733868|NCT01091909|dental extraction|dental extraction
733869|NCT01091922|flavonoids|flavonoids
733870|NCT01091922|flavanols|flavanols
733871|NCT01091922|bacteria|bacteria
733872|NCT01091935|Lidocaine,Intravenous Infusions,Neuropathic Pain,Side Effects|lidocaine,intravenous infusions,neuropathic pain,side effects
733873|NCT01091948|elective general surgery|elective general surgery
733874|NCT01091948|orotracheal intubation|orotracheal intubation
733875|NCT01091948|Patients would be eligible for inclusion if they were at least 18 years old and scheduled for elective surgery requiring orotracheal intubation.|patients would be eligible for inclusion if they were at least 18 years old and scheduled for elective surgery requiring orotracheal intubation.
733876|NCT01091961|ACE inhibitor|ace inhibitor
733877|NCT01091961|ARB|arb
733878|NCT01091961|Non-cardiac surgery|non-cardiac surgery
733879|NCT01091961|Perioperative|perioperative
733880|NCT01091961|Preoperative|preoperative
733881|NCT01091961|Hypotension|hypotension
733882|NCT01091961|Congestive heart failure|congestive heart failure
733883|NCT01091961|Hypertension|hypertension
733884|NCT01091961|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
733885|NCT01091961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
733886|NCT01091961|Perioperative Care|perioperative care
733887|NCT01091974|Insomnia|insomnia
733888|NCT01091974|Fatigue|fatigue
733889|NCT01091974|QOL|qol
733891|NCT01091974|Breast cancer|breast cancer
733892|NCT01091974|Survivors|survivors
733893|NCT01091974|Chemotherapy|chemotherapy
733894|NCT01091987|Insomnia|insomnia
733895|NCT01092000|Health Promotion, Dietary Guidelines, Physical Activity Guidelines|health promotion, dietary guidelines, physical activity guidelines
733896|NCT01092039|Common Cold|common cold
733897|NCT01092039|Cold Virus|cold virus
733898|NCT01092039|Feeling sick|feeling sick
733899|NCT01092039|Influenza|influenza
733900|NCT01092052|Phase I study|phase i study
733901|NCT01092052|Advanced/Metastatic Solid Tumors|advanced/metastatic solid tumors
733902|NCT01092052|Cdc7 kinase inhibitor|cdc7 kinase inhibitor
733903|NCT01092065|Parkinson's Disease|parkinson's disease
733904|NCT01092065|Dyskinesia|dyskinesia
733905|NCT01092065|Drug-induced|drug-induced
733906|NCT01092065|Levodopa|levodopa
733907|NCT01092065|L-dopa|l-dopa
733908|NCT01092078|hypertension|hypertension
733909|NCT01092078|colon cancer screening|colon cancer screening
733910|NCT01092078|african american|african american
733911|NCT01092078|men|men
733912|NCT01092078|motivational interviewing|motivational interviewing
733913|NCT01092078|patient navigation|patient navigation
733915|NCT01092091|Hepatocellular Carcinoma|hepatocellular carcinoma
733916|NCT01092117|abdominal|abdominal
733917|NCT01092117|aortic|aortic
733918|NCT01092117|aneurysm|aneurysm
733919|NCT01092130|Heart failure|heart failure
733920|NCT01092130|Vitamin D|vitamin d
733921|NCT01092130|Plasma renin activity|plasma renin activity
733922|NCT01092130|Renin angiotensin system|renin angiotensin system
733923|NCT01092156|Nipple pain during lactation|nipple pain during lactation
733924|NCT01092182|Microarray|microarray
733925|NCT01092182|Toxicity|toxicity
733926|NCT01092182|Therapeutic Index|therapeutic index
733927|NCT01092182|HIV Positive|hiv positive
733928|NCT01092182|HIV Negative|hiv negative
733929|NCT01092182|Lymphoma|lymphoma
733930|NCT01092182|Burkitt Lymphoma|burkitt lymphoma
733931|NCT01092182|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
733932|NCT01092182|HIV Infections|hiv infections
733933|NCT01092195|Women's Health|women's health
733934|NCT01092195|Genital Precancer|genital precancer
733935|NCT01092195|Stem Cell Donor|stem cell donor
733936|NCT01092195|Cervical Cytology|cervical cytology
733937|NCT01092195|Healthy Volunteers|healthy volunteers
733938|NCT01092195|Stem Cell Transplant|stem cell transplant
733939|NCT01092195|Healthy Volunteer|healthy volunteer
733940|NCT01092195|HV|hv
733941|NCT01092208|Autism|autism
733942|NCT01092208|iPS Cells|ips cells
733943|NCT01092208|Fibroblasts|fibroblasts
733944|NCT01092208|Gene Networks|gene networks
733945|NCT01092208|Tuberous Sclerosis|tuberous sclerosis
733946|NCT01092208|Healthy Volunteer|healthy volunteer
733947|NCT01092208|HV|hv
733948|NCT01092221|mania, allopurinol, add-on treatment|mania, allopurinol, add-on treatment
733949|NCT01092234|Observational units|observational units
733950|NCT01092234|Length of stay (LOS)|length of stay (los)
733951|NCT01092234|Readmission|readmission
733952|NCT01092247|Patients with malignant tumors|patients with malignant tumors
733953|NCT01092260|Glomerular Filtration Rate|glomerular filtration rate
733954|NCT01092260|Kidney disease|kidney disease
733955|NCT01092260|Child|child
733956|NCT01092260|Iohexol|iohexol
733958|NCT01092260|Measurement of kidney function in children|measurement of kidney function in children
733959|NCT01092273|Glaucoma and Ocular Hypertension|glaucoma and ocular hypertension
733960|NCT01092286|Knee injury|knee injury
733961|NCT01092286|ankle sprain|ankle sprain
733962|NCT01092286|anterior cruciate ligament|anterior cruciate ligament
733963|NCT01092286|adolescent|adolescent
733964|NCT01092286|soccer|soccer
733965|NCT01092286|basketball|basketball
733966|NCT01092286|prevention|prevention
733967|NCT01092299|Phase I|phase i
733968|NCT01092299|Relative bioavailability|relative bioavailability
733969|NCT01092299|Pharmacokinetic study|pharmacokinetic study
733970|NCT01092299|AZD1446|azd1446
733971|NCT01092299|healthy volunteers|healthy volunteers
733972|NCT01092312|knee|knee
733973|NCT01092312|arthroplasty|arthroplasty
733974|NCT01092325|Heart Failure|heart failure
733975|NCT01092338|Human Immunodeficiency Virus|human immunodeficiency virus
733976|NCT01092338|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
733977|NCT01092338|Vitamin D|vitamin d
733979|NCT01092338|Complementary therapies|complementary therapies
733980|NCT01092351|urinary tract infection|urinary tract infection
733981|NCT01092351|nitrofurantoin|nitrofurantoin
733982|NCT01092364|Young adults|young adults
733983|NCT01092390|randomized trial|randomized trial
733984|NCT01092390|omega three fatty acids|omega three fatty acids
733986|NCT01092416|Severely calcified lesion|severely calcified lesion
733987|NCT01092429|CAD|cad
733988|NCT01092442|Pulmonary Valve|pulmonary valve
733989|NCT01092442|Right Ventricular Outflow Tract Reconstruction|right ventricular outflow tract reconstruction
733990|NCT01092442|Ross Procedure|ross procedure
733991|NCT01092455|End Stage Renal Disease|end stage renal disease
733992|NCT01092455|Renal Dialysis|renal dialysis
733993|NCT01092455|Hemodialysis therapy|hemodialysis therapy
733994|NCT01092455|Heparin|heparin
733995|NCT01092455|Citrasate|citrasate
733996|NCT01092455|Anticoagulant|anticoagulant
733997|NCT01092468|cancer|cancer
733998|NCT01092468|reconstruction|reconstruction
733999|NCT01092468|free flap|free flap
734000|NCT01092468|surgery|surgery
734001|NCT01092481|Adjuvant FOLFOX or CAPOX Therapy|adjuvant folfox or capox therapy
734002|NCT01092481|Stage II/III Colon Cancer|stage ii/iii colon cancer
734003|NCT01092481|Adjuvant Therapy|adjuvant therapy
734004|NCT01092494|Endometrioma recurrence|endometrioma recurrence
734005|NCT01092494|oral contraceptives|oral contraceptives
734006|NCT01092494|gonadotropin-releasing hormone agonist|gonadotropin-releasing hormone agonist
734007|NCT01092507|Encephalitis|encephalitis
734008|NCT01092507|Japanese Encephalitis|japanese encephalitis
734009|NCT01092507|Japanese Encephalitis Vaccines|japanese encephalitis vaccines
734010|NCT01092507|Infant|infant
734011|NCT01092520|Gabapentin|gabapentin
734012|NCT01092520|Burn Injuries in Children|burn injuries in children
734013|NCT01092520|pruritus|pruritus
734014|NCT01092546|Amyloid|amyloid
734015|NCT01092546|Normal pressure hydrocephalus (NPH)|normal pressure hydrocephalus (nph)
734016|NCT01092546|Positron Emission Tomography (PET)|positron emission tomography (pet)
734017|NCT01092546|Standard uptake value ratios (SUVR)|standard uptake value ratios (suvr)
734018|NCT01092559|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
734019|NCT01092572|cystic fibrosis|cystic fibrosis
734020|NCT01092572|adult cystic fibrosis|adult cystic fibrosis
734021|NCT01092611|long-term follow-up study|long-term follow-up study
734022|NCT01092611|HIV-infected subjects|hiv-infected subjects
734023|NCT01092611|HIV therapeutic vaccine|hiv therapeutic vaccine
734024|NCT01092624|voiding dysfunction|voiding dysfunction
734025|NCT01092624|defecatory dysfunction|defecatory dysfunction
734026|NCT01092624|vaginal bulge symptoms|vaginal bulge symptoms
734027|NCT01092650|Tobacco toxicants|tobacco toxicants
734028|NCT01092650|Polycyclic aromatic hydrocarbons|polycyclic aromatic hydrocarbons
734029|NCT01092650|Smoking|smoking
734030|NCT01092663|Colesevelam|colesevelam
734031|NCT01092663|type 2 diabetes|type 2 diabetes
734032|NCT01092663|sitagliptin|sitagliptin
734033|NCT01092663|glucose metabolism|glucose metabolism
734034|NCT01092676|Pediatrics|pediatrics
734035|NCT01092676|Emergency|emergency
734036|NCT01092689|heterocyclic amines|heterocyclic amines
734037|NCT01092689|PhIP|phip
734038|NCT01092689|Meat|meat
734039|NCT01092689|pancreas neoplasms|pancreas neoplasms
734040|NCT01092702|Tobacco Dependence|tobacco dependence
734041|NCT01092702|Smoking|smoking
734042|NCT01092702|Tobacco Cessation|tobacco cessation
734043|NCT01092715|Neck pain|neck pain
734044|NCT01092715|Spinal manipulation|spinal manipulation
734045|NCT01092715|Massage|massage
734046|NCT01092728|Acral lentiginous melanoma|acral lentiginous melanoma
734047|NCT01092728|Mucosal melanoma|mucosal melanoma
734048|NCT01092728|Chronic sun-damaged melanoma|chronic sun-damaged melanoma
734049|NCT01092728|Surgically removed tumor|surgically removed tumor
734050|NCT01092728|biopsied|biopsied
734051|NCT01092728|Sprycel|sprycel
734052|NCT01092728|Dasatinib|dasatinib
734053|NCT01092741|Leukemia|leukemia
734054|NCT01092741|Gleevec|gleevec
734055|NCT01092741|STI571|sti571
734056|NCT01092741|CML|cml
734057|NCT01092741|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
734058|NCT01092754|brain, spine, liver, MRI, Pediatric|brain, spine, liver, mri, pediatric
734059|NCT01092767|Thoracic Aneurysm|thoracic aneurysm
734060|NCT01092767|Thoracic Transection|thoracic transection
734061|NCT01092767|Endovascular Aortic Repair|endovascular aortic repair
734062|NCT01092793|Fish oil|fish oil
734063|NCT01092793|Krill|krill
734064|NCT01092793|CAD|cad
734065|NCT01092806|tacrolimus|tacrolimus
734066|NCT01092806|pharmacokinetics|pharmacokinetics
734067|NCT01092806|formulations|formulations
734068|NCT01092806|once daily|once daily
734069|NCT01092806|twice daily|twice daily
734070|NCT01092806|renal transplant recipients|renal transplant recipients
734071|NCT01092806|Kidney transplantation|kidney transplantation
734072|NCT01092819|acute ischemic stroke, large vessel occlusion, natural history, functional outcome|acute ischemic stroke, large vessel occlusion, natural history, functional outcome
734073|NCT01092832|Invasive Candidiasis Candidemia Esophageal Candidiasis|invasive candidiasis candidemia esophageal candidiasis
734074|NCT01092845|Double-Blind|double-blind
734075|NCT01092845|Randomized|randomized
734076|NCT01092845|Placebo-Controlled|placebo-controlled
736398|NCT01107782|FGR|fgr
734077|NCT01092845|2-Way Crossover|2-way crossover
734078|NCT01092845|Polysomnographic Endpoints|polysomnographic endpoints
734079|NCT01092858|Testosterone undecanoate|testosterone undecanoate
734080|NCT01092858|Hypogonadism|hypogonadism
734081|NCT01092884|melasma|melasma
734082|NCT01092884|sunscreen|sunscreen
734083|NCT01092884|polypodium leucotomos|polypodium leucotomos
734084|NCT01092910|Sensorineural|sensorineural
734085|NCT01092910|Hearing Loss|hearing loss
734086|NCT01092923|Nitrous Oxide|nitrous oxide
734087|NCT01092923|washin|washin
734088|NCT01092923|washout|washout
734089|NCT01092923|second gas effect|second gas effect
734090|NCT01092923|sevoflurane|sevoflurane
734093|NCT01092936|Comparative fit index|comparative fit index
734094|NCT01092936|Movement Disorders' Society|movement disorders' society
734095|NCT01092936|Unified Parkinson's Disease Rating Scale|unified parkinson's disease rating scale
734096|NCT01092949|Placenta|placenta
734097|NCT01092949|perfusion|perfusion
734099|NCT01092949|spin tagging|spin tagging
734100|NCT01092949|Gadolinium|gadolinium
734101|NCT01092949|placental insufficiency|placental insufficiency
734102|NCT01092949|urinary tract, sexual organs and pregnancy conditions|urinary tract, sexual organs and pregnancy conditions
734103|NCT01092962|Children|children
734104|NCT01092962|Mycophenolate mofetil|mycophenolate mofetil
734105|NCT01092962|Cyclophosphamide|cyclophosphamide
734106|NCT01092962|Idiopathic nephrotic steroid sensitive syndrome|idiopathic nephrotic steroid sensitive syndrome
734107|NCT01092975|radiotherapy|radiotherapy
734108|NCT01092988|Uterine Fibroids|uterine fibroids
734109|NCT01092988|Bleeding|bleeding
734110|NCT01092988|Pain|pain
734111|NCT01092988|Quality of life|quality of life
734112|NCT01092988|MR guided focused ultrasound|mr guided focused ultrasound
734113|NCT01093001|Reduce Tricuspid Regurgitation|reduce tricuspid regurgitation
734114|NCT01093001|Reduce Right Ventricular pacing|reduce right ventricular pacing
734115|NCT01093001|Lead position|lead position
734117|NCT01093014|Quadriceps Muscle|quadriceps muscle
734118|NCT01093014|RNA, Messenger|rna, messenger
734119|NCT01093014|Hypertrophy|hypertrophy
734120|NCT01093014|Electric Stimulation Therapy|electric stimulation therapy
734121|NCT01093027|Essential Tremor|essential tremor
734122|NCT01093027|Cooling|cooling
734123|NCT01093027|Temperature|temperature
734124|NCT01093027|Patients with Essential Tremor involving the upper limbs with at least moderate tremor.|patients with essential tremor involving the upper limbs with at least moderate tremor.
734125|NCT01093053|Mind-Body Therapies|mind-body therapies
734126|NCT01093066|urothelial carcinoma|urothelial carcinoma
734127|NCT01093066|TURB|turb
734128|NCT01093066|chemotherapy|chemotherapy
734129|NCT01093079|Renal tumor, RCC, Partial nephrectomy, Laparoscopy|renal tumor, rcc, partial nephrectomy, laparoscopy
734130|NCT01093105|Leukodystrophy, Globoid Cell|leukodystrophy, globoid cell
734131|NCT01093105|Classic Globoid Cell Leukodystrophy|classic globoid cell leukodystrophy
734132|NCT01093105|Early-Onset Globoid Cell Leukodystrophy|early-onset globoid cell leukodystrophy
734133|NCT01093105|Globoid Cell Leukodystrophy|globoid cell leukodystrophy
734134|NCT01093105|Globoid Cell Leukoencephalopathy|globoid cell leukoencephalopathy
734135|NCT01093105|Infantile Globoid Cell Leukodystrophy|infantile globoid cell leukodystrophy
734136|NCT01093105|Late-Onset Globoid Cell Leukodystrophy|late-onset globoid cell leukodystrophy
734137|NCT01093105|Leukodystrophy, Globoid Cell, Classic|leukodystrophy, globoid cell, classic
734138|NCT01093105|Leukodystrophy, Globoid Cell, Early-Onset|leukodystrophy, globoid cell, early-onset
734139|NCT01093105|Leukodystrophy, Globoid Cell, Infantile|leukodystrophy, globoid cell, infantile
734140|NCT01093105|Leukodystrophy, Globoid Cell, Late-Onset|leukodystrophy, globoid cell, late-onset
734141|NCT01093105|Psychosine|psychosine
734142|NCT01093105|galactosylsphingosine (psychosine) beta-galactosidase|galactosylsphingosine (psychosine) beta-galactosidase
734143|NCT01093105|Psychosine-UDP galactosyltransferase|psychosine-udp galactosyltransferase
734144|NCT01093105|Krabbe Disease|krabbe disease
734145|NCT01093105|Krabbe Leukodystrophy|krabbe leukodystrophy
734146|NCT01093105|Krabbe's Disease|krabbe's disease
734147|NCT01093105|Krabbe's Leukodystrophy|krabbe's leukodystrophy
734148|NCT01093118|Distal subungual onychomycosis|distal subungual onychomycosis
734149|NCT01093131|Contrast induced nephropathy|contrast induced nephropathy
734150|NCT01093131|Percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
734151|NCT01093131|chronic kidney disease|chronic kidney disease
734152|NCT01093131|Prevention|prevention
734153|NCT01093131|Equivalence|equivalence
734154|NCT01093144|Delivery mode|delivery mode
734155|NCT01093144|pelvic measurement|pelvic measurement
734156|NCT01093157|Kidney disease, Glomerulonephritis|kidney disease, glomerulonephritis
734157|NCT01093196|Multiple Myeloma|multiple myeloma
734158|NCT01093196|Elderly Patients|elderly patients
734159|NCT01093196|Diagnosis|diagnosis
734160|NCT01093196|Lenalidomide|lenalidomide
734161|NCT01093196|Prednisone|prednisone
734162|NCT01093196|Melphalan|melphalan
734163|NCT01093196|Dexamethasone|dexamethasone
734164|NCT01093196|Cyclophosphamide|cyclophosphamide
734165|NCT01093209|Carpal Tunnel Syndrome|carpal tunnel syndrome
736491|NCT01108289|Ghana|ghana
734166|NCT01093209|Interferential laser therapy|interferential laser therapy
734167|NCT01093209|Low-level laser therapy|low-level laser therapy
734168|NCT01093209|Neuropathic pain|neuropathic pain
734169|NCT01093209|Median nerve compression|median nerve compression
734170|NCT01093235|cardiac toxicity|cardiac toxicity
734171|NCT01093235|perioperative/postoperative complications|perioperative/postoperative complications
734172|NCT01093235|HER2-negative breast cancer|her2-negative breast cancer
734173|NCT01093235|male breast cancer|male breast cancer
734174|NCT01093235|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
734175|NCT01093235|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
734176|NCT01093235|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
734177|NCT01093235|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
734178|NCT01093235|stage II breast cancer|stage ii breast cancer
734179|NCT01093235|stage IIIA breast cancer|stage iiia breast cancer
734180|NCT01093235|stage IIIB breast cancer|stage iiib breast cancer
734181|NCT01093235|inflammatory breast cancer|inflammatory breast cancer
734182|NCT01093261|trauma|trauma
734183|NCT01093261|trauma brain injury|trauma brain injury
734184|NCT01093261|multiple trauma|multiple trauma
734185|NCT01093261|head trauma|head trauma
734186|NCT01093261|hydrocortisone|hydrocortisone
734187|NCT01093261|fludrocortisone|fludrocortisone
734188|NCT01093261|glucocorticoid insufficiency related to ICU|glucocorticoid insufficiency related to icu
734189|NCT01093261|adrenal Insufficiency|adrenal insufficiency
734190|NCT01093261|pneumonia|pneumonia
734191|NCT01093261|intensive care unit|intensive care unit
734192|NCT01093261|shock|shock
734193|NCT01093261|neurological recovery|neurological recovery
734194|NCT01093274|colonoscopy|colonoscopy
734195|NCT01093274|Cathartics|cathartics
734196|NCT01093274|Sodium picosulfate|sodium picosulfate
734197|NCT01093274|Polyethylene Glycol|polyethylene glycol
734198|NCT01093339|GERD|gerd
734199|NCT01093339|SLEEP DEPRIVATION|sleep deprivation
734200|NCT01093339|APPETITE REGULATION|appetite regulation
734201|NCT01093339|GHRELIN|ghrelin
734202|NCT01093339|LEPTIN|leptin
734203|NCT01093352|Alveolar-decortication|alveolar-decortication
734204|NCT01093352|Corticotomy assisted orthodontics|corticotomy assisted orthodontics
734205|NCT01093352|Palatally impacted canine|palatally impacted canine
734206|NCT01093352|Surgical exposure of canines|surgical exposure of canines
734207|NCT01093352|Velocity of tooth movement|velocity of tooth movement
734208|NCT01093365|Schizophrenia|schizophrenia
734209|NCT01093365|Schizoaffective Disorder|schizoaffective disorder
734210|NCT01093365|Varenicline|varenicline
734211|NCT01093365|Champix|champix
734212|NCT01093365|Chantix|chantix
734213|NCT01093365|Nicotine|nicotine
734214|NCT01093365|Nicotinic receptor|nicotinic receptor
734215|NCT01093365|Dopamine|dopamine
734216|NCT01093365|Acetylcholine|acetylcholine
734217|NCT01093365|Cigarette|cigarette
734218|NCT01093365|Smoking|smoking
734219|NCT01093365|Tobacco|tobacco
734220|NCT01093365|Executive function|executive function
734221|NCT01093365|Working memory|working memory
734222|NCT01093365|Verbal memory|verbal memory
734223|NCT01093365|Cognitive function|cognitive function
734224|NCT01093365|Neuropsychological function|neuropsychological function
734225|NCT01093378|Infertility|infertility
734226|NCT01093378|Obesity|obesity
734227|NCT01093378|Dietary intake|dietary intake
734228|NCT01093378|Fertility|fertility
734229|NCT01093378|nutrition|nutrition
734230|NCT01093378|diet|diet
734231|NCT01093378|weight|weight
734232|NCT01093391|coronary artery|coronary artery
734233|NCT01093391|thrombosis|thrombosis
734234|NCT01093391|stent|stent
734235|NCT01093404|Heart disease|heart disease
734236|NCT01093404|Myocardial infarction|myocardial infarction
734237|NCT01093404|Angioplasty|angioplasty
734238|NCT01093404|Thrombus aspiration|thrombus aspiration
734239|NCT01093417|Vitamin D|vitamin d
734240|NCT01093417|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
734241|NCT01093417|Complementary Therapies|complementary therapies
734242|NCT01093430|Gynecological surgery|gynecological surgery
734243|NCT01093430|laparoscopic ports|laparoscopic ports
734244|NCT01093430|neuropathy|neuropathy
734246|NCT01093443|ICSI|icsi
734247|NCT01093443|GnRH antagonist|gnrh antagonist
734248|NCT01093443|pretreatment|pretreatment
734249|NCT01093456|diurnal variation|diurnal variation
734250|NCT01093456|peritoneal dialysis|peritoneal dialysis
734251|NCT01093456|uremic retention solutes|uremic retention solutes
734252|NCT01093456|phosphorous|phosphorous
734253|NCT01093456|indoxyl sulfate|indoxyl sulfate
734254|NCT01093456|p-cresol sulfate|p-cresol sulfate
734255|NCT01093469|Atopic Dermatitis|atopic dermatitis
734256|NCT01093469|Wake Forest|wake forest
734257|NCT01093469|Dermatology|dermatology
734258|NCT01093469|Skin|skin
734259|NCT01093469|Over-the-counter|over-the-counter
734260|NCT01093469|Moisturizer|moisturizer
734261|NCT01093469|Children|children
734262|NCT01093482|mechanical ventilation|mechanical ventilation
734263|NCT01093482|epidemiology|epidemiology
734264|NCT01093482|outcomes|outcomes
734265|NCT01093482|mortality|mortality
734266|NCT01093482|weaning|weaning
734267|NCT01093482|sedation|sedation
734268|NCT01093482|non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
734269|NCT01093495|Nasal Continuous positive Airway pressure|nasal continuous positive airway pressure
734270|NCT01093495|Nasal Cannula|nasal cannula
734271|NCT01093495|CPAP|cpap
734272|NCT01093495|Premature|premature
734274|NCT01093495|HMD|hmd
734275|NCT01093495|NICU|nicu
734276|NCT01093521|IV Gallium|iv gallium
734277|NCT01093521|Gallium|gallium
734278|NCT01093521|Ganite|ganite
734279|NCT01093521|Cystic Fibrosis|cystic fibrosis
734280|NCT01093521|Gallium Infusion|gallium infusion
734281|NCT01093534|Vesicare|vesicare
734283|NCT01093534|Detrusor Overactivity|detrusor overactivity
734284|NCT01093534|Urinary Nerve Growth Factor|urinary nerve growth factor
734285|NCT01093534|Overactive Bladder|overactive bladder
734286|NCT01093534|Bladder wall thickness|bladder wall thickness
734287|NCT01093560|metabolic syndrome|metabolic syndrome
734288|NCT01093560|premenopausal women|premenopausal women
734289|NCT01093560|fat feeding|fat feeding
734290|NCT01093573|Untreated myelodysplastic syndromes|untreated myelodysplastic syndromes
734291|NCT01100892|Pediatrics|pediatrics
734292|NCT01100892|Pancreas|pancreas
734293|NCT01100905|Iron|iron
734294|NCT01100905|Iron status|iron status
734295|NCT01100905|Iron deficiency|iron deficiency
734296|NCT01100905|Iron deficiency anemia|iron deficiency anemia
734297|NCT01100918|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
734298|NCT01100918|Tissue Doppler Imaging|tissue doppler imaging
734299|NCT01100918|Dyssynchrony|dyssynchrony
734300|NCT01100931|NSCLC|nsclc
734301|NCT01100931|Solid Tumors|solid tumors
734302|NCT01100931|YM155|ym155
734303|NCT01100931|Survivin|survivin
734304|NCT01100931|Non Small-Cell Lung Cancer|non small-cell lung cancer
734305|NCT01100931|Solid Tumor|solid tumor
734306|NCT01100944|Gene Expression|gene expression
734307|NCT01100944|HDAC Class I and II enzymes|hdac class i and ii enzymes
734308|NCT01100944|Thymoma|thymoma
734309|NCT01100944|Chemotherapy|chemotherapy
734310|NCT01100944|Hydroxamic Acid Deacetylase Inhibitor|hydroxamic acid deacetylase inhibitor
734311|NCT01100944|Thymic Cancer|thymic cancer
734312|NCT01100970|Caesarean section|caesarean section
734313|NCT01100970|cortisol|cortisol
734314|NCT01100970|stress|stress
734315|NCT01100970|unipolar electric needle|unipolar electric needle
734316|NCT01100970|bipolar electric needle|bipolar electric needle
734317|NCT01100996|enteral nutrition|enteral nutrition
734318|NCT01100996|endotoxemia|endotoxemia
734319|NCT01100996|innate immunity|innate immunity
734320|NCT01100996|nutritional anti-inflammatory pathway|nutritional anti-inflammatory pathway
734321|NCT01100996|intestinal damage|intestinal damage
734322|NCT01101009|Sevikar®|sevikar®
734323|NCT01101009|Central Arterial Blood Pressure|central arterial blood pressure
734324|NCT01101035|cardiovascular outcomes|cardiovascular outcomes
734325|NCT01101035|heart attack|heart attack
734326|NCT01101035|stroke|stroke
734327|NCT01101035|Drug Therapy|drug therapy
734328|NCT01101035|physiology|physiology
734329|NCT01101035|Hyperuricemia|hyperuricemia
734330|NCT01101035|Uric Acid|uric acid
734331|NCT01101048|Amgen|amgen
734332|NCT01101048|Phase 1b|phase 1b
734333|NCT01101048|Postmenopausal|postmenopausal
734334|NCT01101048|Bone Mineral Density|bone mineral density
734335|NCT01101061|Amgen|amgen
734336|NCT01101061|Phase 1|phase 1
734337|NCT01101061|Postmenopausal|postmenopausal
734338|NCT01101061|Japanese|japanese
734339|NCT01101074|Swine Flu A (H1N1) vaccine|swine flu a (h1n1) vaccine
734340|NCT01101074|Adjuvanted flu egg derived|adjuvanted flu egg derived
734341|NCT01101074|Novel influenza A (H1N1): a new flu virus of swine origin|novel influenza a (h1n1): a new flu virus of swine origin
734342|NCT01101087|Dialysis|dialysis
734343|NCT01101100|Psoriasis|psoriasis
734344|NCT01101113|peritoneal dialysis|peritoneal dialysis
734345|NCT01101126|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
734346|NCT01101126|Asthma|asthma
734347|NCT01101152|Antidepressant|antidepressant
734348|NCT01101152|healthy volunteers|healthy volunteers
734349|NCT01101152|desvenlafaxine succinate|desvenlafaxine succinate
734350|NCT01101152|norepinephrine reuptake|norepinephrine reuptake
734351|NCT01101152|serotonin reuptake|serotonin reuptake
734352|NCT01101152|tyramine test|tyramine test
734353|NCT01101165|Healthy subjects|healthy subjects
734354|NCT01101165|Opioid|opioid
734355|NCT01101165|Healthy volunteers|healthy volunteers
734356|NCT01101178|Healthy subjects|healthy subjects
734357|NCT01101178|Opioid|opioid
734358|NCT01101178|Healthy volunteers|healthy volunteers
734359|NCT01101191|Healthy subjects|healthy subjects
734360|NCT01101191|Opioid|opioid
734361|NCT01101191|Healthy volunteers|healthy volunteers
734362|NCT01101217|hemocystein zinc renal failure|hemocystein zinc renal failure
734363|NCT01101555|Rheumatoid arthritis|rheumatoid arthritis
734364|NCT01101555|repeat dose|repeat dose
734365|NCT01101555|pharmacodynamics|pharmacodynamics
736682|NCT01109082|gait|gait
734366|NCT01101555|pharmacokinetics|pharmacokinetics
734367|NCT01101555|subcutaneous|subcutaneous
734368|NCT01101555|safety|safety
734369|NCT01101555|Otelixizumab|otelixizumab
734370|NCT01101555|long term follow up|long term follow up
734371|NCT01101555|tolerability|tolerability
734372|NCT01101568|GSK1292263, rosuvastatin, simvastatin, pharmacokinetics, drug interaction|gsk1292263, rosuvastatin, simvastatin, pharmacokinetics, drug interaction
734373|NCT01101581|Diffuse Large cell NHL|diffuse large cell nhl
734374|NCT01101581|Mantle cell NHL|mantle cell nhl
734375|NCT01101581|Lymphoblastic lymphoma|lymphoblastic lymphoma
734376|NCT01101581|Diffuse mixed cell lymphoma|diffuse mixed cell lymphoma
734377|NCT01101581|Diffuse large cell lymphoma|diffuse large cell lymphoma
734378|NCT01101581|large noncleaved cell lymphoma|large noncleaved cell lymphoma
734379|NCT01101594|Treatment|treatment
734684|NCT01103037|Mild|mild
734380|NCT01101594|Multiple Myeloma|multiple myeloma
734381|NCT01101594|Relapsed, refractory multiple myeloma|relapsed, refractory multiple myeloma
734382|NCT01101607|Pediatrics|pediatrics
734383|NCT01101607|Distal Forearm fractures|distal forearm fractures
734384|NCT01101607|Pediatric Emergency Medicine|pediatric emergency medicine
734385|NCT01101607|Pediatric Orthopedics|pediatric orthopedics
734386|NCT01101633|Appetite|appetite
734387|NCT01101633|Energy intake|energy intake
734388|NCT01101633|gastric emptying|gastric emptying
734389|NCT01101633|well being|well being
734390|NCT01101633|Body weight|body weight
734391|NCT01101646|Rabeprazole sodium|rabeprazole sodium
734392|NCT01101646|Pharmacokinetics|pharmacokinetics
734393|NCT01101646|Biological Availability|biological availability
734394|NCT01101646|Safety|safety
734395|NCT01101646|Adult|adult
734396|NCT01101659|Activity of JNJ-40411813|activity of jnj-40411813
734397|NCT01101659|Challenge study|challenge study
734398|NCT01101672|Single port laparoscopic colectomy|single port laparoscopic colectomy
734399|NCT01101685|non-dysphoric|non-dysphoric
734400|NCT01101685|Dysphoric|dysphoric
734401|NCT01101698|Vitamin K|vitamin k
734402|NCT01101698|chronic kidney disease|chronic kidney disease
734403|NCT01101698|coronary artery calcification|coronary artery calcification
734404|NCT01101698|intima media thickness|intima media thickness
734405|NCT01101724|mild traumatic brain injury|mild traumatic brain injury
734406|NCT01101724|Concussion|concussion
734407|NCT01101724|postconcussive syndrome|postconcussive syndrome
734408|NCT01101737|Hypertension, clinical trial, nurse-led clinic, primary care|hypertension, clinical trial, nurse-led clinic, primary care
734409|NCT01101750|Gardasil|gardasil
734411|NCT01101750|transplant|transplant
734412|NCT01101750|adolescent|adolescent
734413|NCT01101750|prevention|prevention
734414|NCT01101750|vaccine|vaccine
734415|NCT01101750|immunogenicity|immunogenicity
734416|NCT01101750|vaccination|vaccination
734417|NCT01101776|Multiple Sclerosis, relapsing|multiple sclerosis, relapsing
734418|NCT01101776|Rebif New Formulation|rebif new formulation
734419|NCT01101776|Interferon beta-1a|interferon beta-1a
734420|NCT01101789|surgical wound infection|surgical wound infection
734421|NCT01101789|triclosan-coated suture|triclosan-coated suture
734422|NCT01101802|SLE|sle
734423|NCT01101802|Atherosclerosis|atherosclerosis
734424|NCT01101802|Endothelial function|endothelial function
734425|NCT01101802|Mycophenolate mofetil|mycophenolate mofetil
734426|NCT01101815|Viral Loads|viral loads
734427|NCT01101815|Naltrexone|naltrexone
734428|NCT01101815|HIV Risk|hiv risk
734429|NCT01101815|Substance Abuse|substance abuse
734430|NCT01101841|Vasomotor Symptoms|vasomotor symptoms
734431|NCT01101841|Menopause|menopause
734432|NCT01101841|Hot Flashes|hot flashes
734433|NCT01101841|Perimenopause|perimenopause
734434|NCT01101841|Nonhormonal therapies|nonhormonal therapies
734435|NCT01101841|Climacteric symptoms|climacteric symptoms
734436|NCT01101841|Mesafem|mesafem
734437|NCT01101841|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
734438|NCT01101854|gene expression in wounds|gene expression in wounds
734439|NCT01101854|healing wounds|healing wounds
734440|NCT01101854|non-healing wounds|non-healing wounds
734441|NCT01101854|punch biopsy|punch biopsy
734442|NCT01101854|debridement|debridement
734443|NCT01101867|diabetes|diabetes
734445|NCT01101867|hospital|hospital
734446|NCT01101893|GSK2248761, raltegravir, drug interaction, pharmacokinetics|gsk2248761, raltegravir, drug interaction, pharmacokinetics
734447|NCT01101906|OSI-906|osi-906
734448|NCT01101906|HCC|hcc
734449|NCT01101906|Hepatocellular Carcinoma|hepatocellular carcinoma
734450|NCT01101919|Rheumatoid Arthritis|rheumatoid arthritis
734451|NCT01101932|Safety|safety
734452|NCT01101932|Tolerability|tolerability
734453|NCT01101932|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
734454|NCT01101932|Rheumatoid Arthritis|rheumatoid arthritis
734455|NCT01101932|healthy volunteers|healthy volunteers
734456|NCT01101945|diabetes|diabetes
734457|NCT01101945|DPP4 inhibitor|dpp4 inhibitor
734458|NCT01101945|dutogliptin|dutogliptin
734459|NCT01101945|PHX1149|phx1149
734460|NCT01101971|Education, Medical|education, medical
734461|NCT01101971|Students, Medical|students, medical
734463|NCT01101971|Physical Examination|physical examination
734464|NCT01101971|Computer-Assisted Instruction|computer-assisted instruction
734465|NCT01101997|Lipolysis|lipolysis
734466|NCT01101997|Cryolipolysis|cryolipolysis
734467|NCT01101997|Fat Reduction|fat reduction
734468|NCT01102010|Blood transfusion|blood transfusion
734469|NCT01102010|Hip fracture|hip fracture
734470|NCT01102010|Elderly|elderly
734471|NCT01102010|Geriatrics|geriatrics
734472|NCT01102010|Hospitalization|hospitalization
734473|NCT01102010|Frail elderly|frail elderly
734474|NCT01102036|Transit time|transit time
734475|NCT01102036|constipation|constipation
734476|NCT01102036|gut regularity|gut regularity
734477|NCT01102036|defecation frequency|defecation frequency
734478|NCT01102036|Colonic transit time|colonic transit time
734479|NCT01102075|Obesity|obesity
734480|NCT01102075|Electroacupuncture|electroacupuncture
734481|NCT01102075|Sham electroacupuncture|sham electroacupuncture
734482|NCT01102075|Waist circumference|waist circumference
734483|NCT01102075|Thickness of subcutaneous fat|thickness of subcutaneous fat
734484|NCT01102088|Cancer|cancer
734485|NCT01102088|Gastroesophageal|gastroesophageal
734486|NCT01102088|Simultaneous Integrated Boost|simultaneous integrated boost
734487|NCT01102088|SIB|sib
734488|NCT01102088|5-Fluorouracil|5-fluorouracil
734489|NCT01102088|5-FU|5-fu
734490|NCT01102088|Adrucil|adrucil
734491|NCT01102088|Efudex|efudex
734492|NCT01102088|Docetaxel|docetaxel
734493|NCT01102088|Taxotere|taxotere
734494|NCT01102088|Radiation|radiation
734495|NCT01102088|chemoradiation|chemoradiation
734496|NCT01102101|Remifentanil|remifentanil
734497|NCT01102101|Hyperalgesia|hyperalgesia
734498|NCT01102101|Zoster|zoster
734499|NCT01102101|Postherpetic neuralgia|postherpetic neuralgia
734500|NCT01102114|Smoking Cessation|smoking cessation
734501|NCT01102114|NicVAX|nicvax
734502|NCT01102114|Smoking Vaccine|smoking vaccine
734503|NCT01102114|Smoking Abstinence|smoking abstinence
734504|NCT01102114|Smoking|smoking
734505|NCT01102114|Tobacco Cessation|tobacco cessation
734506|NCT01102127|elastography|elastography
734507|NCT01102127|thyroid nodule|thyroid nodule
734508|NCT01102127|fine-needle aspiration|fine-needle aspiration
734509|NCT01102140|Cardiomyopathy|cardiomyopathy
734510|NCT01102140|Heart Failure|heart failure
734511|NCT01102153|sudden cardiac arrest|sudden cardiac arrest
734512|NCT01102153|Hypothermia|hypothermia
734513|NCT01102153|Coolgard|coolgard
734514|NCT01102153|arctic sun|arctic sun
734515|NCT01102153|neurological outcome|neurological outcome
734516|NCT01102153|neuron specific enolase|neuron specific enolase
734517|NCT01102166|This study was conducted in healthy subjects|this study was conducted in healthy subjects
734518|NCT01102192|Myasthenia gravis|myasthenia gravis
734519|NCT01102192|Thymoma|thymoma
734520|NCT01102192|T-cells|t-cells
734521|NCT01102192|Thymectomy|thymectomy
734522|NCT01102218|Anemia, ESRD|anemia, esrd
734523|NCT01102244|blepharitis|blepharitis
734524|NCT01102244|moderate to severe chronic blepharitis|moderate to severe chronic blepharitis
734525|NCT01102257|Dry Eye Disease|dry eye disease
734526|NCT01102257|DED|ded
734527|NCT01102257|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
734528|NCT01102257|Omega-3|omega-3
734529|NCT01102270|Obstructive sleep apnea|obstructive sleep apnea
734530|NCT01102270|Arousal threshold|arousal threshold
734531|NCT01102270|Sedative medication|sedative medication
734532|NCT01102270|upper airway|upper airway
734533|NCT01102283|Colonic obstruction|colonic obstruction
734534|NCT01102296|hepatitis A vaccine|hepatitis a vaccine
734535|NCT01102296|male homosexual|male homosexual
734536|NCT01102296|HIV infection|hiv infection
734537|NCT01102296|male homosexuals who are seronegative for hepatitis A virus|male homosexuals who are seronegative for hepatitis a virus
734538|NCT01102309|cerebrovascular accident|cerebrovascular accident
734539|NCT01102309|hemiparesis|hemiparesis
734540|NCT01102309|recovery of function|recovery of function
734541|NCT01102309|rehabilitation|rehabilitation
734542|NCT01102309|robotics|robotics
734543|NCT01102309|subacute therapy|subacute therapy
734544|NCT01102309|training|training
734545|NCT01102322|Acute respiratory distress syndrome|acute respiratory distress syndrome
734546|NCT01102335|hepatitis B virus|hepatitis b virus
734547|NCT01102335|Antiviral Agents|antiviral agents
734548|NCT01102335|Liver Neoplasms|liver neoplasms
734549|NCT01102335|Drug Toxicity|drug toxicity
734550|NCT01102335|Survival|survival
734551|NCT01102348|Critically Ill|critically ill
734552|NCT01102348|Nutrition Therapy|nutrition therapy
734553|NCT01102348|Enteral Nutrition|enteral nutrition
734554|NCT01102374|Vitamin D Deficiency|vitamin d deficiency
734555|NCT01102374|Respiratory Infection|respiratory infection
734556|NCT01102374|Nursing Home Residents|nursing home residents
734557|NCT01102374|Geriatrics|geriatrics
734558|NCT01102374|Immunosenescence|immunosenescence
734559|NCT01102374|Prevention|prevention
734560|NCT01102387|Candida infections in intertriginous areas|candida infections in intertriginous areas
734561|NCT01102400|cancer|cancer
734562|NCT01102400|tumor|tumor
734563|NCT01102400|hepatocellular carcinoma|hepatocellular carcinoma
734564|NCT01102426|Multiple Myeloma|multiple myeloma
734565|NCT01102426|Aplidin|aplidin
734566|NCT01102426|plitidepsin|plitidepsin
734567|NCT01102426|dexamethasone|dexamethasone
734568|NCT01102439|Clopidogrel|clopidogrel
734569|NCT01102439|Aspirin|aspirin
734570|NCT01102439|Interaction|interaction
734571|NCT01102491|postoperative nausea and vomiting|postoperative nausea and vomiting
734572|NCT01102504|carotid atheroma|carotid atheroma
734573|NCT01102504|plaque vulnerability|plaque vulnerability
734574|NCT01102504|stroke risk|stroke risk
734575|NCT01102517|NSCLC|nsclc
734576|NCT01102517|Clinical|clinical
734577|NCT01102517|Early-stage|early-stage
734578|NCT01102543|pulmonary surfactant|pulmonary surfactant
734579|NCT01102543|Respiratory distress syndrome|respiratory distress syndrome
734580|NCT01102543|Newborn|newborn
734581|NCT01102543|prophylaxis|prophylaxis
734582|NCT01102556|Pancreatic Cancer|pancreatic cancer
734583|NCT01102556|Pre-Neoplastic Lesions|pre-neoplastic lesions
734584|NCT01102556|Pancreatic Cancer Surgery|pancreatic cancer surgery
734585|NCT01102556|High-Risk for Pancreatic Cancer|high-risk for pancreatic cancer
734586|NCT01102556|Tissue and Blood Bank for Pancreatic Cancer|tissue and blood bank for pancreatic cancer
734587|NCT01102556|Pancreatic Cancer Questionnaire|pancreatic cancer questionnaire
734588|NCT01102569|Hereditary pancreatic cancer|hereditary pancreatic cancer
734589|NCT01102569|Breast and Ovarian Cancer Syndrome|breast and ovarian cancer syndrome
734590|NCT01102569|BRCA1/2|brca1/2
734591|NCT01102569|Ashkenazi Jewish patients|ashkenazi jewish patients
734592|NCT01102582|Parkinson's disease dementia, neuropsychiatric symptoms|parkinson's disease dementia, neuropsychiatric symptoms
734593|NCT01102595|Unresectable/inoperable glioblastomas|unresectable/inoperable glioblastomas
734594|NCT01102608|sarcoma|sarcoma
734595|NCT01102608|ifosfamide|ifosfamide
734596|NCT01102621|hearing loss|hearing loss
734597|NCT01102621|head and neck cancer|head and neck cancer
734598|NCT01102621|radiotherapy|radiotherapy
734599|NCT01102621|hearing complaint|hearing complaint
734600|NCT01102621|Hearing loss due to the exposure of radiotherapy|hearing loss due to the exposure of radiotherapy
734601|NCT01102660|Knee osteoarthritis|knee osteoarthritis
734602|NCT01102660|clinical trial|clinical trial
734603|NCT01102660|cross-over|cross-over
734604|NCT01102673|phase 1|phase 1
734605|NCT01102673|safety and tolerability|safety and tolerability
734607|NCT01102673|T2DM|t2dm
734608|NCT01102673|type 2 diabetes mellitus|type 2 diabetes mellitus
734609|NCT01102686|Late-onset GM2-gangliosidosis|late-onset gm2-gangliosidosis
734610|NCT01102686|pyrimethamine|pyrimethamine
734611|NCT01102699|Diabetes|diabetes
734612|NCT01102699|stem cells|stem cells
734613|NCT01102699|bone marrow|bone marrow
734614|NCT01102699|mobilization|mobilization
734615|NCT01102712|Emphysema|emphysema
734616|NCT01102712|COPD|copd
734617|NCT01102712|Lung Volume Reduction|lung volume reduction
734618|NCT01102712|BTVA|btva
734619|NCT01102725|Colon Surgery|colon surgery
734620|NCT01102725|Rectal Surgery|rectal surgery
734621|NCT01102725|Colorectal Surgery|colorectal surgery
734622|NCT01102751|fibroblast growth factor 23|fibroblast growth factor 23
734623|NCT01102751|Osteomalacia|osteomalacia
734624|NCT01102751|vitamin D|vitamin d
734625|NCT01102764|Anxiety Disorders: PTSD|anxiety disorders: ptsd
734626|NCT01102764|Prolong Exposure (PE)|prolong exposure (pe)
734627|NCT01102764|Telemedicine|telemedicine
734628|NCT01102764|cost effectiveness|cost effectiveness
734629|NCT01102764|deployment related problems|deployment related problems
734630|NCT01102764|mental health care delivery|mental health care delivery
734631|NCT01102777|internet|internet
734632|NCT01102777|walking|walking
734633|NCT01102790|HIT|hit
734634|NCT01102803|Phobias|phobias
734635|NCT01102803|Anxiety Disorders|anxiety disorders
734636|NCT01102803|D-Cycloserine|d-cycloserine
734637|NCT01102803|Phobic Disorders|phobic disorders
734638|NCT01102803|Mental Disorders|mental disorders
734639|NCT01102803|Heights|heights
734640|NCT01102803|Acrophobia|acrophobia
734641|NCT01102816|hemodialysis|hemodialysis
734642|NCT01102816|end-stage renal disease|end-stage renal disease
734643|NCT01102816|pain|pain
734644|NCT01102816|acupuncture|acupuncture
734645|NCT01102829|Knee Joint|knee joint
734646|NCT01102829|Arthroplasty|arthroplasty
734647|NCT01102829|Replacement|replacement
734648|NCT01102829|Knee|knee
734649|NCT01102881|Healthy adults|healthy adults
734650|NCT01102907|Appetite|appetite
734651|NCT01102907|Satiety|satiety
734652|NCT01102907|Gastric Emptying Time|gastric emptying time
734653|NCT01102907|Food Intake|food intake
734654|NCT01102907|Food Form|food form
734655|NCT01102920|Obstructive sleep apnea|obstructive sleep apnea
734656|NCT01102920|Obesity|obesity
734657|NCT01102920|Behavioural medicine|behavioural medicine
734658|NCT01102920|Physical therapy|physical therapy
734659|NCT01102920|Health behaviour change|health behaviour change
734660|NCT01102920|Physical activity|physical activity
734661|NCT01102920|Eating habits|eating habits
734662|NCT01102946|proliferative diabetic retinopathy|proliferative diabetic retinopathy
734663|NCT01102946|retinal neovascularization|retinal neovascularization
734664|NCT01102946|Angiogenesis Inhibitors|angiogenesis inhibitors
734665|NCT01102946|ranibizumab|ranibizumab
734666|NCT01102946|laser|laser
734667|NCT01102959|EDUCATION|education
734668|NCT01102959|DIABETES MELLITUS|diabetes mellitus
734669|NCT01102959|ADOLESCENT|adolescent
734670|NCT01102959|DIABETIC DIET|diabetic diet
734671|NCT01102972|HIV-1|hiv-1
734672|NCT01102972|HIV|hiv
734673|NCT01102985|exercise|exercise
734674|NCT01102985|physical activity|physical activity
734675|NCT01102985|intervention|intervention
734676|NCT01102985|cancer survivor|cancer survivor
734677|NCT01102998|Sleep complaints|sleep complaints
734678|NCT01102998|Brain Tumor Survivors|brain tumor survivors
734679|NCT01103024|Active uveitis|active uveitis
734680|NCT01103024|intermediate uveitis|intermediate uveitis
734681|NCT01103024|panuveitis|panuveitis
734682|NCT01103024|posterior uveitis|posterior uveitis
734683|NCT01103024|uveitis|uveitis
734687|NCT01103050|Allergic inflammation|allergic inflammation
734688|NCT01103050|Seasonal rhinitis|seasonal rhinitis
734689|NCT01103063|P. falciparum malaria|p. falciparum malaria
734690|NCT01103063|IPTp|iptp
734691|NCT01103076|Immune dysfunction|immune dysfunction
734692|NCT01103076|Hemodialysis|hemodialysis
734693|NCT01103076|HBV|hbv
734694|NCT01103076|Vaccination|vaccination
734695|NCT01103076|Immune response|immune response
734696|NCT01103089|NSCLC|nsclc
734697|NCT01103089|EGFR|egfr
734698|NCT01103089|gefitinib|gefitinib
734699|NCT01103089|observational|observational
734700|NCT01103102|Gingivitis|gingivitis
734701|NCT01103102|Biological Markers|biological markers
734702|NCT01103115|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
734703|NCT01103115|AIS|ais
734704|NCT01103115|low bone mass|low bone mass
734705|NCT01103115|osteopenia|osteopenia
734706|NCT01103115|bone health|bone health
734707|NCT01103115|bone density|bone density
734708|NCT01103128|Pancreatic Cancer|pancreatic cancer
734709|NCT01103128|Pre-neoplastic lesions|pre-neoplastic lesions
734710|NCT01103128|Breast and Ovarian Cancer Syndrome|breast and ovarian cancer syndrome
734711|NCT01103128|BRCA1/2|brca1/2
734712|NCT01103128|Mouse model for pancreatic cancer|mouse model for pancreatic cancer
734713|NCT01103141|Vascular Surgical Procedures|vascular surgical procedures
734714|NCT01103141|Angioplasty|angioplasty
735289|NCT01097915|BMI|bmi
734715|NCT01103141|Radiology, Interventional|radiology, interventional
734716|NCT01103154|beta blocker|beta blocker
734717|NCT01103154|variceal rebleeding|variceal rebleeding
734718|NCT01103154|efficacy and safety in reducing variceal rebleeding|efficacy and safety in reducing variceal rebleeding
734719|NCT01103167|body composition|body composition
734720|NCT01103167|blood pressure|blood pressure
734721|NCT01103167|hemodialysis|hemodialysis
734722|NCT01103180|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
734723|NCT01103180|Escitalopram|escitalopram
734724|NCT01103180|Borderline Personality Disorder|borderline personality disorder
734725|NCT01103180|Major Depressive Disorder|major depressive disorder
734726|NCT01103180|Self-harm|self-harm
734727|NCT01103193|ASA class I/II patients, with surgery under general anesthesia|asa class i/ii patients, with surgery under general anesthesia
734728|NCT01103206|Parathyroid hormone|parathyroid hormone
734729|NCT01103206|Cinacalcet|cinacalcet
734730|NCT01103206|Primary hyperparathyroidism|primary hyperparathyroidism
734731|NCT01103206|Diagnosis|diagnosis
734732|NCT01103219|VLBW|vlbw
734733|NCT01103219|nutrition|nutrition
734734|NCT01103219|vitamin A|vitamin a
734735|NCT01103219|long-chain unsaturated fatty acids|long-chain unsaturated fatty acids
734736|NCT01103219|growth|growth
734737|NCT01103219|cognitive functions|cognitive functions
734738|NCT01103219|Very low birth weight infants (birth weight below 1,500 grams).|very low birth weight infants (birth weight below 1,500 grams).
734739|NCT01103232|Cross education|cross education
734740|NCT01103232|Muscle training|muscle training
734741|NCT01103245|Glucose|glucose
734742|NCT01103245|Insulin|insulin
734836|NCT01103622|Diabetes|diabetes
734743|NCT01103258|Incompetence of the great saphenous vein.|incompetence of the great saphenous vein.
734744|NCT01103271|depression|depression
734745|NCT01103271|placebo effect|placebo effect
734746|NCT01103271|complementary therapies|complementary therapies
734747|NCT01103271|alternative therapies|alternative therapies
734748|NCT01103284|beta-cells|beta-cells
734749|NCT01103284|autoimmune|autoimmune
734750|NCT01103284|Diabetes|diabetes
734751|NCT01103284|immunomodulation|immunomodulation
734752|NCT01103297|Distal radius fracture|distal radius fracture
734753|NCT01103297|Double row plate|double row plate
734754|NCT01103297|Volar approach|volar approach
734755|NCT01103297|DVR plate|dvr plate
734756|NCT01103297|Postoperative complications [MeSH]|postoperative complications [mesh]
734757|NCT01103310|Neoplasm|neoplasm
734758|NCT01103310|PET/CT diagnosis|pet/ct diagnosis
734759|NCT01103310|PET tracer|pet tracer
734760|NCT01103323|Metastatic Colorectal Cancer|metastatic colorectal cancer
734761|NCT01103336|Patients with chronic renal failure undergoing coronary angiography|patients with chronic renal failure undergoing coronary angiography
734762|NCT01103388|Rituximab|rituximab
734764|NCT01103388|Lymphoma|lymphoma
734765|NCT01103388|High dose chemotherapy|high dose chemotherapy
734766|NCT01103388|Autologous transplantation|autologous transplantation
734767|NCT01103388|Autologous stem cell transplant|autologous stem cell transplant
734768|NCT01103388|ASCT|asct
734769|NCT01103414|Diabetes|diabetes
734770|NCT01103427|smoking cessation|smoking cessation
734771|NCT01103427|telemedicine|telemedicine
734772|NCT01103427|smoking|smoking
734773|NCT01103427|prevention intervention|prevention intervention
734774|NCT01103427|internet-based|internet-based
734775|NCT01103427|text messages|text messages
734776|NCT01103427|behavioral|behavioral
734777|NCT01103440|Major Adverse Cardiovascular Event|major adverse cardiovascular event
734778|NCT01103440|MACE|mace
734779|NCT01103440|Death|death
734780|NCT01103440|MI|mi
734781|NCT01103440|CK MB greater 3x Normal|ck mb greater 3x normal
734782|NCT01103440|Urgent Revascularization|urgent revascularization
735554|NCT01105052|Insomnia|insomnia
734783|NCT01103440|Stent Thrombosis|stent thrombosis
734784|NCT01103440|Bleeding|bleeding
734785|NCT01103453|MCI|mci
734786|NCT01103453|Executive Function|executive function
734787|NCT01103453|ADL|adl
734788|NCT01103453|Virtual Supermarket|virtual supermarket
734789|NCT01103466|Ileostomy base plate|ileostomy base plate
734790|NCT01103479|Early Detection of Cancer|early detection of cancer
734791|NCT01103479|Colorectal Cancer Screening|colorectal cancer screening
734792|NCT01103492|prostate cancer|prostate cancer
734793|NCT01103492|endometrial cancer|endometrial cancer
734794|NCT01103492|radiation proctitis|radiation proctitis
734795|NCT01103492|pelvic radiotherapy|pelvic radiotherapy
734796|NCT01103492|rectal bleeding|rectal bleeding
734797|NCT01103505|AMD|amd
734798|NCT01103505|CNV|cnv
734799|NCT01103518|Menstrual irregularity|menstrual irregularity
734800|NCT01103518|Menstruation disturbances|menstruation disturbances
734801|NCT01103518|Hyperandrogenism|hyperandrogenism
734802|NCT01103531|Methamphetamine|methamphetamine
734803|NCT01103531|Methamphetamine Dependence|methamphetamine dependence
734804|NCT01103531|Methamphetamine Treatment|methamphetamine treatment
734805|NCT01103531|Aerobic Exercise|aerobic exercise
734806|NCT01103531|Resistance Exercise|resistance exercise
734807|NCT01103531|Brain Imaging|brain imaging
734808|NCT01103531|D2 and D3 receptor availability|d2 and d3 receptor availability
734809|NCT01103544|TCCU|tccu
734810|NCT01103544|advanced TCCU|advanced tccu
734811|NCT01103544|metastatic TCCU|metastatic tccu
734812|NCT01103544|transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
734813|NCT01103544|advanced transitional cell carcinoma of the urothelium|advanced transitional cell carcinoma of the urothelium
734814|NCT01103544|metastatic transitional cell carcinoma of the urothelium|metastatic transitional cell carcinoma of the urothelium
734815|NCT01103544|Cisplatinum failure|cisplatinum failure
734816|NCT01103544|Vinflunine|vinflunine
734817|NCT01103544|Javlor|javlor
734818|NCT01103544|daily routine|daily routine
734819|NCT01103544|concomitant antiemetic treatment|concomitant antiemetic treatment
734820|NCT01103544|concomitant antiobstipative treatment|concomitant antiobstipative treatment
734821|NCT01103544|concomitant antiobstipative diet|concomitant antiobstipative diet
734822|NCT01103544|patient compliance|patient compliance
734823|NCT01103544|quality of life|quality of life
734824|NCT01103544|non-interventional study|non-interventional study
734825|NCT01103544|Germany|germany
734826|NCT01103544|Advanced / metastatic TCCU after Cisplatinum-failure|advanced / metastatic tccu after cisplatinum-failure
734827|NCT01103557|Papillary thyroid carcinoma with neck metastasis|papillary thyroid carcinoma with neck metastasis
734828|NCT01103557|neck dissection|neck dissection
734829|NCT01103570|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
734830|NCT01103570|Intra-operative cholangiography|intra-operative cholangiography
734831|NCT01103596|Evaluation of the impact of Kaletra on antiretroviral resistance|evaluation of the impact of kaletra on antiretroviral resistance
734832|NCT01103609|Diabetes|diabetes
734833|NCT01103609|Type 2|type 2
734834|NCT01103609|Warfarin|warfarin
734835|NCT01103609|drug-drug interaction|drug-drug interaction
734837|NCT01103622|Type 2|type 2
734838|NCT01103622|Digoxin|digoxin
734839|NCT01103622|drug-drug interaction|drug-drug interaction
734840|NCT01103648|Prediabetes|prediabetes
734841|NCT01103648|Statin|statin
734842|NCT01103648|Ezetimibe|ezetimibe
734843|NCT01103648|Pleiotropic effects|pleiotropic effects
734844|NCT01103648|Cardiometabolic risk|cardiometabolic risk
734845|NCT01103661|Longstanding Persistent Atrial Fibrillation|longstanding persistent atrial fibrillation
734846|NCT01103661|AF|af
734847|NCT01103661|Chronic AF|chronic af
734848|NCT01103661|RF Ablation|rf ablation
734849|NCT01103661|nContact Surgical|ncontact surgical
734850|NCT01103661|Therapy Cool Path Ablation Catheter|therapy cool path ablation catheter
734851|NCT01103661|St. Jude Medical|st. jude medical
734852|NCT01103674|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
734853|NCT01103674|AF|af
734854|NCT01103674|Atrial Fibrillation|atrial fibrillation
734855|NCT01103674|RF ablation|rf ablation
734856|NCT01103687|HIV Preventive Vaccine|hiv preventive vaccine
737166|NCT01111968|pandemic influenza A|pandemic influenza a
737168|NCT01111968|safety|safety
734857|NCT01103700|Quality of dying and death of terminal cancer patients|quality of dying and death of terminal cancer patients
734858|NCT01103713|P. falciparum malaria|p. falciparum malaria
734859|NCT01103713|asymptomatic parasitemia|asymptomatic parasitemia
734860|NCT01103713|parasitological clearance|parasitological clearance
734861|NCT01103713|Intermittent Preventive Treatment of Falciparum Malaria in Pregnant Women (IPTp)|intermittent preventive treatment of falciparum malaria in pregnant women (iptp)
734862|NCT01103726|FDG-PET|fdg-pet
734863|NCT01103726|regional cerebral glucose metabolism|regional cerebral glucose metabolism
734864|NCT01103726|striatum|striatum
734865|NCT01103726|PDE10 inhibitor|pde10 inhibitor
734866|NCT01103739|pharmacokinetics|pharmacokinetics
734867|NCT01103739|drug-drug interaction|drug-drug interaction
734868|NCT01103765|Post-dilatation|post-dilatation
734869|NCT01103765|noncompliant balloon|noncompliant balloon
734870|NCT01103765|optimal stent deployment of drug-eluting stent|optimal stent deployment of drug-eluting stent
734871|NCT01103765|Intravascular ultrasound (IVUS)|intravascular ultrasound (ivus)
734973|NCT01096654|primary hyperaldosteronism|primary hyperaldosteronism
734974|NCT01096654|aldosterone|aldosterone
734872|NCT01103765|Optimal stent deployment defined by intravascular ultrasound analysis|optimal stent deployment defined by intravascular ultrasound analysis
734873|NCT01103778|Chronic kidney disease|chronic kidney disease
734874|NCT01103778|IgA nephropathy|iga nephropathy
734875|NCT01103778|Velcade®|velcade®
734876|NCT01103778|Proteinuria|proteinuria
734877|NCT01103778|Bortezomib|bortezomib
734878|NCT01103778|Proteasome inhibitor|proteasome inhibitor
734879|NCT01103804|GerdQ questionnaire|gerdq questionnaire
734880|NCT01103817|Type 1 Diabetes|type 1 diabetes
734881|NCT01103817|Adolescents and Young Adults|adolescents and young adults
734882|NCT01103817|Vitamin D|vitamin d
734883|NCT01103817|Cardiovascular Disease|cardiovascular disease
734884|NCT01103830|P. falciparum Malaria, Eurartesim, ACT|p. falciparum malaria, eurartesim, act
734885|NCT01103843|Coronary artery disease|coronary artery disease
734886|NCT01103843|clopidogrel|clopidogrel
734887|NCT01103843|prasugrel|prasugrel
734888|NCT01103843|Verify Now|verify now
734889|NCT01103843|PRU measurements|pru measurements
734890|NCT01103843|Drug eluting stents (EDS)|drug eluting stents (eds)
734891|NCT01103843|P2Y12|p2y12
734892|NCT01103843|Platelet reactivity|platelet reactivity
734893|NCT01103856|HIV|hiv
734894|NCT01103856|adherence to care|adherence to care
735585|NCT01105221|Acupuncture|acupuncture
734895|NCT01103856|retention in care|retention in care
734896|NCT01103856|patient navigation|patient navigation
734897|NCT01103895|cardiac output|cardiac output
734898|NCT01103895|cardiopulmonary bypass|cardiopulmonary bypass
734899|NCT01103895|ultrasound dilution|ultrasound dilution
734900|NCT01103908|cardiac output|cardiac output
734901|NCT01103908|cardiopulmonary bypass|cardiopulmonary bypass
734902|NCT01103908|ultrasound dilution|ultrasound dilution
734903|NCT01103921|sugar|sugar
734904|NCT01103921|fructose|fructose
734905|NCT01103921|glucose|glucose
734906|NCT01103921|HFCS|hfcs
734907|NCT01103921|metabolism|metabolism
734908|NCT01103947|Anesthesia induction|anesthesia induction
734909|NCT01103947|Facemask|facemask
734910|NCT01103947|surgery|surgery
734911|NCT01103973|IVF, Mind/Body|ivf, mind/body
734912|NCT01103986|health literacy|health literacy
734913|NCT01103986|consumer health information|consumer health information
734914|NCT01103986|patient education as topics/methods|patient education as topics/methods
734915|NCT01103986|patient participation|patient participation
734916|NCT01103999|spleen|spleen
734917|NCT01096407|pain|pain
734918|NCT01096407|arthralgia|arthralgia
734919|NCT01096407|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
734920|NCT01096420|chronic migraine|chronic migraine
734921|NCT01096420|acupuncture|acupuncture
734922|NCT01096420|Topiramate|topiramate
734923|NCT01096420|Randomized trial|randomized trial
734924|NCT01096433|Sleep apnea|sleep apnea
734925|NCT01096433|CPAP|cpap
734926|NCT01096433|Prostaglandins|prostaglandins
734927|NCT01096433|Circadian variations|circadian variations
734928|NCT01096459|spina|spina
734929|NCT01096459|bifida|bifida
734930|NCT01096459|restore|restore
734931|NCT01096459|urinary|urinary
734932|NCT01096459|function|function
734933|NCT01096459|nerve|nerve
734934|NCT01096459|reroute|reroute
734935|NCT01096472|Tinea pedis|tinea pedis
734936|NCT01096511|Moxifloxacin,|moxifloxacin,
734937|NCT01096511|cIAI|ciai
734938|NCT01096511|non-interventional|non-interventional
734939|NCT01096524|Kneehab|kneehab
734940|NCT01096524|NMES|nmes
734941|NCT01096524|Total Knee Arthroplasty|total knee arthroplasty
734942|NCT01096524|Total Knee Replacement|total knee replacement
734943|NCT01096524|TKA|tka
734944|NCT01096524|Disuse atrophy|disuse atrophy
734945|NCT01096524|muscle hypertrophy|muscle hypertrophy
734946|NCT01096524|TKR|tkr
734947|NCT01096524|Atrophy Prevention|atrophy prevention
734948|NCT01096537|incidence|incidence
734949|NCT01096537|young workers|young workers
734950|NCT01096537|occupations at risk|occupations at risk
734951|NCT01096537|public health|public health
734952|NCT01096537|epidemiology|epidemiology
734953|NCT01096537|polymorphisms|polymorphisms
734954|NCT01096537|gentic|gentic
734955|NCT01096550|opioid dependence|opioid dependence
734956|NCT01096550|outpatient treatment|outpatient treatment
734957|NCT01096550|intensive outpatient treatment|intensive outpatient treatment
734958|NCT01096563|Phase I|phase i
734959|NCT01096563|Japanese healthy volunteer|japanese healthy volunteer
734960|NCT01096563|AZD9164|azd9164
734961|NCT01096589|lymphoedema|lymphoedema
734962|NCT01096589|lymphedema|lymphedema
734963|NCT01096602|Dendritic Cell/AML vaccine|dendritic cell/aml vaccine
734964|NCT01096602|CT-011|ct-011
734965|NCT01096615|Allergic rhinitis-Probiotic Lactobacillus paracasei LP-33-|allergic rhinitis-probiotic lactobacillus paracasei lp-33-
734966|NCT01096628|adolescent|adolescent
734967|NCT01096628|low back pain|low back pain
734968|NCT01096628|chiropractic|chiropractic
734969|NCT01096628|exercise|exercise
734970|NCT01096641|Fatigued disease-free Cancer Patients|fatigued disease-free cancer patients
734971|NCT01096641|cancer treatment finished > one year and < ten years ago|cancer treatment finished > one year and < ten years ago
734972|NCT01096654|endocrine hypertension|endocrine hypertension
735263|NCT01097772|aortic|aortic
734975|NCT01096654|aldosterone-producing adenoma|aldosterone-producing adenoma
734976|NCT01096654|bilateral adrenal hyperplasia|bilateral adrenal hyperplasia
734977|NCT01096654|computed tomography|computed tomography
734978|NCT01096654|adrenal vein sampling|adrenal vein sampling
734979|NCT01096667|type 2 diabetes|type 2 diabetes
734980|NCT01096667|hypertension|hypertension
734981|NCT01096667|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
734982|NCT01096693|Urocortin 2|urocortin 2
734983|NCT01096693|Urocortin 3|urocortin 3
734984|NCT01096693|Astressin 2B|astressin 2b
734985|NCT01096693|forearm blood flow|forearm blood flow
734986|NCT01096693|plethysmography|plethysmography
734987|NCT01096693|vascular|vascular
734988|NCT01096693|heart failure|heart failure
734989|NCT01096706|Urocortin 2|urocortin 2
734990|NCT01096706|Urocortin 3|urocortin 3
734991|NCT01096706|Nitric Oxide|nitric oxide
734992|NCT01096706|Plethysmography|plethysmography
734993|NCT01096706|Forearm blood flow|forearm blood flow
734994|NCT01096706|Vascular|vascular
734995|NCT01096706|Heart failure|heart failure
734996|NCT01096706|endothelium|endothelium
734997|NCT01096706|Cyclo-oxygenase pathway|cyclo-oxygenase pathway
734998|NCT01096706|EDHF|edhf
734999|NCT01096719|Weight|weight
735000|NCT01096719|Dietary intake|dietary intake
735001|NCT01096719|Energy Density|energy density
735002|NCT01096719|Behavioral|behavioral
735003|NCT01096719|Satiety|satiety
735004|NCT01096719|Deprivation|deprivation
735005|NCT01096719|Hunger|hunger
735006|NCT01096719|Fruit|fruit
735007|NCT01096719|Vegetable|vegetable
735008|NCT01096732|Pancreatic|pancreatic
735009|NCT01096732|adenocarcinoma|adenocarcinoma
735010|NCT01096732|cancer|cancer
735011|NCT01096745|Gemcitabine|gemcitabine
735012|NCT01096745|Cisplatin|cisplatin
735014|NCT01096745|bile duct cancer|bile duct cancer
735015|NCT01096758|PKU|pku
735016|NCT01096758|phenylketonuria|phenylketonuria
735017|NCT01096758|adult|adult
735018|NCT01096758|patient|patient
735019|NCT01096758|development|development
735020|NCT01096758|nutritional deficiencies|nutritional deficiencies
735021|NCT01096758|neurological outcome|neurological outcome
735022|NCT01096758|psychological and neurological development|psychological and neurological development
735023|NCT01096758|comparison with healthy adults|comparison with healthy adults
735024|NCT01096758|longitudinal development|longitudinal development
735025|NCT01096758|quality of life|quality of life
735026|NCT01096771|ARDS|ards
735027|NCT01096771|Parenteral|parenteral
735028|NCT01096771|Pharmaconutrition|pharmaconutrition
735029|NCT01096784|insulin-like growth factor|insulin-like growth factor
735030|NCT01096784|ROP|rop
735031|NCT01096784|IGF-I|igf-i
735032|NCT01096784|BPD|bpd
735033|NCT01096784|bronchopulmonary dysplasia|bronchopulmonary dysplasia
735034|NCT01096784|retinopathy of prematurity|retinopathy of prematurity
735035|NCT01096810|Asymptomatic|asymptomatic
735036|NCT01096823|Rheumatoid Arthritis|rheumatoid arthritis
735037|NCT01096823|Yoga|yoga
735038|NCT01096823|Adolescents|adolescents
735039|NCT01096823|Young Adults|young adults
735040|NCT01096836|resistance exercise|resistance exercise
735041|NCT01096836|body mass index|body mass index
735042|NCT01096836|hypertrophy|hypertrophy
735043|NCT01096836|endothelial function|endothelial function
735044|NCT01096836|blood lipids|blood lipids
735045|NCT01096849|urinary tract infection|urinary tract infection
735046|NCT01096849|UTI|uti
735047|NCT01096849|cUTI|cuti
735048|NCT01096849|pyelonephritis|pyelonephritis
735049|NCT01096849|AP|ap
735050|NCT01096849|ACHN-490|achn-490
735051|NCT01096862|Psoriasis|psoriasis
735052|NCT01096862|ASP015K|asp015k
735053|NCT01096875|Endothelial progenitor cells|endothelial progenitor cells
735054|NCT01096875|Atorvastatin|atorvastatin
735055|NCT01096875|Coronary surgery|coronary surgery
735056|NCT01096888|WIC|wic
735057|NCT01096888|Weight loss|weight loss
735058|NCT01096888|Overweight|overweight
735059|NCT01096888|Post Partum|post partum
735060|NCT01096888|Internet based weight loss intervention for Mothers in the WIC program.|internet based weight loss intervention for mothers in the wic program.
735061|NCT01096927|Lower Abdominal Pain|lower abdominal pain
735062|NCT01096927|Right Iliac Fossa Pain|right iliac fossa pain
735063|NCT01096927|Acute Appendicitis|acute appendicitis
735064|NCT01096927|Antibiotic Therapy|antibiotic therapy
735065|NCT01096927|Conservative Management|conservative management
735066|NCT01096927|Appendectomy|appendectomy
735067|NCT01096927|Recurrence|recurrence
735068|NCT01096927|Length of hospital stay|length of hospital stay
735069|NCT01096927|Sick leave time|sick leave time
735070|NCT01096927|Short and Long Term Abdominal pain evaluation|short and long term abdominal pain evaluation
735071|NCT01096940|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
735072|NCT01096940|Glucose lowering|glucose lowering
735073|NCT01096953|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
735074|NCT01096953|ADHD|adhd
735075|NCT01096953|attention deficit|attention deficit
735076|NCT01096966|chronic low back pain|chronic low back pain
735264|NCT01097772|aneurysm|aneurysm
735077|NCT01096979|Subcutaneous Adipose Tissue Reduction|subcutaneous adipose tissue reduction
735078|NCT01096992|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
735079|NCT01096992|CLL|cll
735080|NCT01096992|Bendamustine|bendamustine
735081|NCT01096992|Fludarabine|fludarabine
735082|NCT01096992|Fludara|fludara
735083|NCT01096992|Fludarabine Phosphate|fludarabine phosphate
735084|NCT01096992|Rituximab|rituximab
735085|NCT01096992|Rituxan|rituxan
735086|NCT01097005|Mycobacterium Infections, Atypical|mycobacterium infections, atypical
735087|NCT01097031|blood pressure|blood pressure
735088|NCT01097031|pediatric|pediatric
735089|NCT01097031|nursing|nursing
735090|NCT01097031|maintenance arterial catheter|maintenance arterial catheter
735091|NCT01097044|Erythropoietic Protoporphyria|erythropoietic protoporphyria
735092|NCT01097044|EPP|epp
735093|NCT01097044|Afamelanotide|afamelanotide
735094|NCT01097083|Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma|patients with child-pugh c unresectable hepatocellular carcinoma
735095|NCT01097083|Patients who are unfit for standard therapy|patients who are unfit for standard therapy
735096|NCT01097096|Active immunization|active immunization
735097|NCT01097096|Alzheimer disease|alzheimer disease
735098|NCT01097096|Antibody|antibody
735099|NCT01097096|Central Nervous System Diseases|central nervous system diseases
735100|NCT01097096|Neurodegenerative diseases|neurodegenerative diseases
735101|NCT01097096|Vaccine|vaccine
735102|NCT01097109|Effect of Somatic Dysfunctions of Pelvis|effect of somatic dysfunctions of pelvis
735103|NCT01097109|Effect of Somatic Dysfunctions of Sacrum|effect of somatic dysfunctions of sacrum
735104|NCT01097109|Effect of Somatic Dysfunctions of Lower Lumbar Spine|effect of somatic dysfunctions of lower lumbar spine
735105|NCT01097109|Weight-Bearing|weight-bearing
735106|NCT01097122|bone|bone
735107|NCT01097122|motor neuron excitability|motor neuron excitability
735108|NCT01097122|forearm vibration|forearm vibration
735109|NCT01097122|mechanical loading|mechanical loading
735110|NCT01097122|muscle electrical activity|muscle electrical activity
735111|NCT01097148|Obese|obese
735112|NCT01097148|Atracurium|atracurium
735113|NCT01097148|Cefazolin|cefazolin
735114|NCT01097148|Morfine|morfine
735115|NCT01097148|Nadroparin|nadroparin
735116|NCT01097161|Stuttering|stuttering
735117|NCT01097161|Apraxia of speech|apraxia of speech
735118|NCT01097161|Motor control|motor control
735119|NCT01097161|Prosody|prosody
735120|NCT01097161|Pitch range|pitch range
735121|NCT01097161|Speech rate|speech rate
735122|NCT01097161|fluency disorders|fluency disorders
735123|NCT01097174|Glaucoma|glaucoma
735124|NCT01097174|Glaucoma device|glaucoma device
735125|NCT01097174|Glaucoma surgery|glaucoma surgery
735126|NCT01097174|Intraocular pressure|intraocular pressure
735127|NCT01097200|sacrocolpopexy|sacrocolpopexy
735128|NCT01097200|meshes|meshes
735129|NCT01097200|sacrospinous ligament|sacrospinous ligament
735130|NCT01097226|Dietary intervention|dietary intervention
735131|NCT01097226|bioavailability|bioavailability
735132|NCT01097226|Healthy volunteers|healthy volunteers
735133|NCT01097239|High Intensity Focused Ultrasound|high intensity focused ultrasound
735134|NCT01097239|HIFU|hifu
735135|NCT01097239|Rectal Cancer|rectal cancer
735136|NCT01097239|Sonablate 500|sonablate 500
735137|NCT01097239|Transrectal|transrectal
735138|NCT01097252|Cervical Neoplasm|cervical neoplasm
735139|NCT01097252|chemoradiation|chemoradiation
735140|NCT01097252|compliance|compliance
735141|NCT01097252|toxicity|toxicity
735142|NCT01097265|stage I colon cancer|stage i colon cancer
735143|NCT01097265|stage II colon cancer|stage ii colon cancer
735144|NCT01097278|breast cancer|breast cancer
735145|NCT01097278|ductal breast carcinoma in situ|ductal breast carcinoma in situ
735146|NCT01097278|lobular breast carcinoma in situ|lobular breast carcinoma in situ
735147|NCT01097278|BRCA1 mutation carrier|brca1 mutation carrier
735148|NCT01097278|BRCA2 mutation carrier|brca2 mutation carrier
735149|NCT01097317|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
735150|NCT01097317|musculoskeletal complications|musculoskeletal complications
735151|NCT01097317|fatigue|fatigue
735152|NCT01097317|stage I non-small cell lung cancer|stage i non-small cell lung cancer
735153|NCT01097317|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
735154|NCT01097317|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
735155|NCT01097317|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
735156|NCT01097317|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
735157|NCT01097317|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
735158|NCT01097330|Defibrillators, Implantable|defibrillators, implantable
735159|NCT01097330|Tachycardia, Ventricular|tachycardia, ventricular
735160|NCT01097330|Catheter Ablation|catheter ablation
735161|NCT01097330|Amiodarone|amiodarone
735162|NCT01097343|Clopidogrel pharmacogenomics study|clopidogrel pharmacogenomics study
735163|NCT01097343|Performing genetic study looking at clopidogrel resistance|performing genetic study looking at clopidogrel resistance
735164|NCT01097395|ribavirin|ribavirin
735165|NCT01097395|pharmacokinetics|pharmacokinetics
735166|NCT01097395|Hepatitis C virus|hepatitis c virus
735265|NCT01097798|muscle injury|muscle injury
735266|NCT01097811|Hepatic Encephalopathy|hepatic encephalopathy
735167|NCT01097447|Diagnosis of keratoconus, post-LASIK ectasia, FFKC, or pellucid marginal degeneration|diagnosis of keratoconus, post-lasik ectasia, ffkc, or pellucid marginal degeneration
735168|NCT01097460|HER2/HER3|her2/her3
735169|NCT01097460|Bispecific Antibody|bispecific antibody
735170|NCT01097460|Breast Cancer|breast cancer
735171|NCT01097460|Advanced Breast Cancer|advanced breast cancer
735172|NCT01097460|Metastatic Breast Cancer|metastatic breast cancer
735173|NCT01097460|HER2 Positive Breast Cancer|her2 positive breast cancer
735174|NCT01097460|Trastuzumab|trastuzumab
735175|NCT01097460|Herceptin|herceptin
735176|NCT01097486|Cervical Degenerative Disc Disease|cervical degenerative disc disease
735177|NCT01097486|Degenerative Spondylolisthesis|degenerative spondylolisthesis
735178|NCT01097486|Spinal Stenosis|spinal stenosis
735179|NCT01097486|Stem cells|stem cells
735180|NCT01097486|Adult Stem Cells|adult stem cells
735181|NCT01097486|Anterior cervical discectomy and Fusion (ACDF)|anterior cervical discectomy and fusion (acdf)
735182|NCT01097486|Cervical Allograft Spacer|cervical allograft spacer
735183|NCT01097486|Anterior Cervical Plate Fixation|anterior cervical plate fixation
735184|NCT01097499|Dental implant initial stability|dental implant initial stability
735185|NCT01097499|Initial bone resorption post implant placement|initial bone resorption post implant placement
735481|NCT01104766|Schizophrenia|schizophrenia
735186|NCT01097499|Analgesia effect of LED intervention|analgesia effect of led intervention
735187|NCT01097512|AS703569|as703569
735188|NCT01097512|MSC1992371A|msc1992371a
735189|NCT01097512|Aurora kinase inhibitor|aurora kinase inhibitor
735190|NCT01097512|Cancer treatable with gemcitabine|cancer treatable with gemcitabine
735191|NCT01097538|exercise|exercise
735192|NCT01097538|rehabilitation|rehabilitation
735193|NCT01097538|progressive multiple sclerosis|progressive multiple sclerosis
735194|NCT01097538|functional ability|functional ability
735195|NCT01097538|fatigue|fatigue
735196|NCT01097538|quality of life|quality of life
735197|NCT01097551|Type 1 diabetes mellitus|type 1 diabetes mellitus
735198|NCT01097551|Diabetic retinopathy|diabetic retinopathy
735199|NCT01097551|Pathogenesis|pathogenesis
735200|NCT01097551|Dynamic Vessel Analyser|dynamic vessel analyser
735201|NCT01097551|Endothelial dysfunction|endothelial dysfunction
735202|NCT01097564|Genetic|genetic
735203|NCT01097564|Cerebral angiopathy|cerebral angiopathy
735204|NCT01097564|Retinal angiopathy|retinal angiopathy
735205|NCT01097564|COL4A1 gene|col4a1 gene
735206|NCT01097564|Infantile Cerebral Palsy|infantile cerebral palsy
735207|NCT01097564|Congenital porencephaly|congenital porencephaly
735208|NCT01097564|Congenital cataract|congenital cataract
735209|NCT01097564|Leukoencephalopathy|leukoencephalopathy
735210|NCT01097564|COL4A1 gene related cerebra-retinal angiopathy|col4a1 gene related cerebra-retinal angiopathy
735211|NCT01097577|photorefractive keratectomy|photorefractive keratectomy
735212|NCT01097577|excimer laser|excimer laser
735214|NCT01097577|pain, postoperative|pain, postoperative
735215|NCT01097577|pregabalin|pregabalin
735216|NCT01097590|ulcerative colitis|ulcerative colitis
735217|NCT01097590|leukapheresis treatment|leukapheresis treatment
735218|NCT01097603|Non-Invasive Blood Pressure|non-invasive blood pressure
735219|NCT01097655|Tablets|tablets
735220|NCT01097655|Infection|infection
735221|NCT01097655|Non Nucleoside Reverse Transcriptase Inhibitor|non nucleoside reverse transcriptase inhibitor
735222|NCT01097655|Tolerability|tolerability
735223|NCT01097655|Viral load|viral load
735224|NCT01097655|Human immunodeficiency Virus|human immunodeficiency virus
735225|NCT01097655|Effectiveness|effectiveness
735226|NCT01097655|Treatment-naïve|treatment-naïve
735227|NCT01097668|Multiple sclerosis|multiple sclerosis
735228|NCT01097668|Immunomodulation|immunomodulation
735229|NCT01097668|Phase 1|phase 1
735230|NCT01097681|ASP1941|asp1941
735231|NCT01097681|Diabetes mellitus|diabetes mellitus
735232|NCT01097681|Urinary glucose excretion|urinary glucose excretion
735233|NCT01097694|cKIT inhibition in Asthma|ckit inhibition in asthma
735234|NCT01097694|Efficacy of Imatinib in severe resistent asthma.|efficacy of imatinib in severe resistent asthma.
735235|NCT01097720|Valproate|valproate
735236|NCT01097720|Lamotrigine|lamotrigine
735237|NCT01097720|Carbamazepine|carbamazepine
735238|NCT01097720|Anticonvulsant|anticonvulsant
735239|NCT01097720|Antiepileptic|antiepileptic
735240|NCT01097720|Teratogen|teratogen
735241|NCT01097720|Autism|autism
735242|NCT01097720|Developmental Delay|developmental delay
735243|NCT01097746|Cancer|cancer
735244|NCT01097746|Fallopian Tube|fallopian tube
735245|NCT01097746|Ovary|ovary
735246|NCT01097746|Peritoneum|peritoneum
735247|NCT01097746|Epithelial ovarian|epithelial ovarian
735248|NCT01097746|Paclitaxel|paclitaxel
735249|NCT01097746|Carboplatin|carboplatin
735250|NCT01097746|Bevacizumab|bevacizumab
735251|NCT01097746|Taxol|taxol
735252|NCT01097746|Avastin|avastin
735253|NCT01097746|Paraplatin|paraplatin
735254|NCT01097746|Carcinoma|carcinoma
735255|NCT01097746|Surgery|surgery
735256|NCT01097759|hemorrhoids|hemorrhoids
735257|NCT01097759|prolapsed|prolapsed
735258|NCT01097759|hemorrhoidectomy|hemorrhoidectomy
735259|NCT01097759|Hemorrhoidopexy|hemorrhoidopexy
735260|NCT01097759|LigaSure|ligasure
735261|NCT01097759|Stapled|stapled
735262|NCT01097772|abdominal|abdominal
735267|NCT01097811|Hypertension, Portal|hypertension, portal
735268|NCT01097811|Liver Cirrhosis|liver cirrhosis
735269|NCT01097811|Bacterial Overgrowth Syndrome|bacterial overgrowth syndrome
735270|NCT01097837|Epilepsy|epilepsy
735271|NCT01097837|Contraceptive|contraceptive
735272|NCT01097837|Birth Control|birth control
735273|NCT01097837|Seizure|seizure
735274|NCT01097837|This study is looking at the use of different birth control measures in women with epilepsy.|this study is looking at the use of different birth control measures in women with epilepsy.
735275|NCT01097850|hand foot skin syndrome|hand foot skin syndrome
735276|NCT01097850|palmar plantar erythrodysesthesia|palmar plantar erythrodysesthesia
735277|NCT01097850|doxorubicin|doxorubicin
735278|NCT01097850|capecitabine|capecitabine
735279|NCT01097876|healthy volunteer|healthy volunteer
735280|NCT01097876|pharmacokinetic|pharmacokinetic
735281|NCT01097876|safety|safety
735282|NCT01097889|United Nations World Food Programme|united nations world food programme
735283|NCT01097889|blended food (CSB)|blended food (csb)
735284|NCT01097889|ready-to-use supplementary foods (RUSF)|ready-to-use supplementary foods (rusf)
735285|NCT01097889|Plumpy®|plumpy®
735286|NCT01097915|PROP taste sensitivity|prop taste sensitivity
735287|NCT01097915|Gustin (CAVI) polymorphism|gustin (cavi) polymorphism
735288|NCT01097915|Salivary zinc|salivary zinc
735290|NCT01097915|Electrophysiological recording from the tongue|electrophysiological recording from the tongue
735291|NCT01097941|Influenza|influenza
735292|NCT01097941|H1N1|h1n1
735293|NCT01097954|Exercise induced asthma|exercise induced asthma
735294|NCT01097954|Exercise induced bronchospasm|exercise induced bronchospasm
735295|NCT01097954|exhaled Nitric Oxide|exhaled nitric oxide
735296|NCT01097967|Sleep disordered breathing|sleep disordered breathing
735297|NCT01097967|Continuous Positive Airway Pressure|continuous positive airway pressure
735298|NCT01097967|Sleep apnoea|sleep apnoea
735299|NCT01097967|Markers of atherosclerosis|markers of atherosclerosis
735300|NCT01097980|trazodone|trazodone
735301|NCT01097980|SSRI|ssri
735302|NCT01097980|sexual dysfunction|sexual dysfunction
735303|NCT01097980|5-HT2A polymorphism|5-ht2a polymorphism
735304|NCT01098006|Immunological assays|immunological assays
735305|NCT01098006|Chronic hepatitis B|chronic hepatitis b
735306|NCT01098019|Notalgia paresthetica|notalgia paresthetica
735307|NCT01098019|Xeomin|xeomin
735308|NCT01098019|Botulinum Toxin A|botulinum toxin a
735309|NCT01098019|Pruritus|pruritus
735310|NCT01098019|Upper Back|upper back
735311|NCT01098019|Hyperpigmentation|hyperpigmentation
735312|NCT01098032|Contrast media|contrast media
735313|NCT01098032|Kidney|kidney
735314|NCT01098032|Complication|complication
735315|NCT01098045|HIV|hiv
735316|NCT01098045|fat redistribution|fat redistribution
735317|NCT01098045|brown adipose tissue|brown adipose tissue
735318|NCT01098045|PET|pet
735319|NCT01098058|Adult attention deficit hyperactivity disorder|adult attention deficit hyperactivity disorder
735320|NCT01098058|cognitive-behavioural therapy|cognitive-behavioural therapy
735321|NCT01098058|randomised controlled trial|randomised controlled trial
735322|NCT01098084|Decitabine, chronic myelomonocytic leukemia|decitabine, chronic myelomonocytic leukemia
735323|NCT01098136|Pelvic girdle pain|pelvic girdle pain
735324|NCT01098136|Chiropractic|chiropractic
735325|NCT01098136|Single-blinded|single-blinded
735326|NCT01098136|Outcome study|outcome study
735327|NCT01098149|Haemodialysis treatment tolerance|haemodialysis treatment tolerance
735328|NCT01098149|acetate free biofiltration|acetate free biofiltration
735329|NCT01098149|frequency of hypotensive events during dialysis|frequency of hypotensive events during dialysis
735330|NCT01098149|nurse intervention during dialysis|nurse intervention during dialysis
735331|NCT01098162|Lacosamide|lacosamide
735332|NCT01098162|Vimpat®|vimpat®
735333|NCT01098162|Epilepsy|epilepsy
735334|NCT01098162|Partial-Onset Seizures|partial-onset seizures
735335|NCT01098162|Adjunctive therapy|adjunctive therapy
735336|NCT01098175|laparotomy|laparotomy
735337|NCT01098175|thoracotomy|thoracotomy
735338|NCT01098175|peritoneal conditioning|peritoneal conditioning
735339|NCT01098175|humidification|humidification
735340|NCT01098175|temperature control|temperature control
735341|NCT01098201|Certolizumab|certolizumab
735342|NCT01098201|TNF|tnf
735343|NCT01098201|RA|ra
735344|NCT01098201|Cizmia|cizmia
735345|NCT01098214|Normal pregnancy|normal pregnancy
735346|NCT01098214|Amniotic fluid|amniotic fluid
735347|NCT01098214|Cytokines|cytokines
735348|NCT01098214|Biomarkers|biomarkers
735349|NCT01098227|RSV Bronchiolitis|rsv bronchiolitis
735350|NCT01098227|Lower Respiratory Viral infection|lower respiratory viral infection
735351|NCT01098227|Exhaled Nitric Oxide|exhaled nitric oxide
735352|NCT01098240|Antidepressant Augmentation|antidepressant augmentation
735353|NCT01098253|adherence|adherence
735354|NCT01098253|diabetes mellitus|diabetes mellitus
735355|NCT01098253|depression|depression
735356|NCT01098253|primary health care|primary health care
735357|NCT01098266|MPM|mpm
735358|NCT01098266|NGR-hTNF|ngr-htnf
735359|NCT01098266|NGR-hTNF plus BIC|ngr-htnf plus bic
735360|NCT01098266|Randomized double-blind phase III study|randomized double-blind phase iii study
735361|NCT01098279|Interstitial Cystitis|interstitial cystitis
735362|NCT01098279|Chronic Prostatitis|chronic prostatitis
735363|NCT01098279|Urological Chronic Pelvic Pain|urological chronic pelvic pain
735364|NCT01098279|Painful Bladder Syndrome|painful bladder syndrome
735365|NCT01098292|Fibromyalgia|fibromyalgia
735366|NCT01098292|Irritable Bowel Syndrome|irritable bowel syndrome
735367|NCT01098292|Chronic Fatigue Syndrome|chronic fatigue syndrome
735368|NCT01098292|Interstitial Cystitis|interstitial cystitis
735369|NCT01098292|Chronic Prostatitis|chronic prostatitis
735370|NCT01098292|Urological Chronic Pelvic Pain|urological chronic pelvic pain
735371|NCT01098292|Painful Bladder Syndrome|painful bladder syndrome
735372|NCT01098305|nicotine smokeless tobacco chewing tobacco varenicline|nicotine smokeless tobacco chewing tobacco varenicline
735373|NCT01098318|Depression|depression
735374|NCT01098318|Antidepressant Therapy|antidepressant therapy
735375|NCT01098318|Herbal Treatment|herbal treatment
735376|NCT01098318|Rhodiola rosea|rhodiola rosea
735377|NCT01098318|Alternative Therapy|alternative therapy
735378|NCT01098331|stage I prostate cancer|stage i prostate cancer
735379|NCT01098331|stage IIB prostate cancer|stage iib prostate cancer
735380|NCT01098331|stage IIA prostate cancer|stage iia prostate cancer
735381|NCT01098344|stage III pancreatic cancer|stage iii pancreatic cancer
735382|NCT01098344|stage IV pancreatic cancer|stage iv pancreatic cancer
735482|NCT01104766|Acute Schizophrenia|acute schizophrenia
735383|NCT01098344|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
735384|NCT01098357|rhPDGF, diabetic foot ulcer,|rhpdgf, diabetic foot ulcer,
735385|NCT01098383|Autism|autism
735386|NCT01104025|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
735387|NCT01104025|hybrid immunotherapy|hybrid immunotherapy
735388|NCT01104025|dexamethasone|dexamethasone
735389|NCT01104025|Etoposide|etoposide
735390|NCT01104025|ATG,rabbit|atg,rabbit
735391|NCT01104038|physical activity|physical activity
735392|NCT01104038|cardiometabolic risk|cardiometabolic risk
735393|NCT01104038|children|children
735394|NCT01104064|Stroke|stroke
735395|NCT01104077|Pancreatic Cancer|pancreatic cancer
735396|NCT01104077|Family History|family history
735397|NCT01104077|Pre-cancerous lesion|pre-cancerous lesion
735398|NCT01104077|Intraductal Papillary Mucinous Neoplasm (IPMN)|intraductal papillary mucinous neoplasm (ipmn)
735399|NCT01104077|Intraductal Papillary Mucinous Neoplasm|intraductal papillary mucinous neoplasm
735400|NCT01104090|C-MAC|c-mac
735401|NCT01104090|direct laryngoscopy|direct laryngoscopy
735402|NCT01104090|indirect laryngoscopy|indirect laryngoscopy
735403|NCT01104090|to determine the safety and efficacy of the C-MAC|to determine the safety and efficacy of the c-mac
735404|NCT01104103|Catheterization, Peripheral|catheterization, peripheral
735405|NCT01104103|Disposable Equipment|disposable equipment
735406|NCT01104103|Emergency Medical Technicians|emergency medical technicians
735407|NCT01104103|Emergency Nursing|emergency nursing
735408|NCT01104116|Pancreatic Cancer|pancreatic cancer
735409|NCT01104116|Intraductal Papillary Mucinous Neoplasm|intraductal papillary mucinous neoplasm
735410|NCT01104116|Pre-cancerous pancreatic lesion|pre-cancerous pancreatic lesion
735411|NCT01104116|PET Scan|pet scan
735412|NCT01104116|Pancreatic Cancer Screening|pancreatic cancer screening
735413|NCT01104129|Pancreatic Cancer|pancreatic cancer
735509|NCT01104818|Foster Care|foster care
735415|NCT01104129|Stool-based digital melt curve (DMC) assay|stool-based digital melt curve (dmc) assay
735416|NCT01104129|Surgical resection for pancreatic cancer|surgical resection for pancreatic cancer
735417|NCT01104129|Hereditary Pancreatic Cancer Syndrome|hereditary pancreatic cancer syndrome
735418|NCT01104129|Genetic mutations linked to pancreatic cancer|genetic mutations linked to pancreatic cancer
735419|NCT01104155|NSCLC|nsclc
735420|NCT01104168|diabetes|diabetes
735421|NCT01104168|elderly|elderly
735422|NCT01104168|nursing home resident|nursing home resident
735423|NCT01104181|Anal HPV|anal hpv
735424|NCT01104181|Anal Dysplasia|anal dysplasia
735425|NCT01104181|Ana Cancer|ana cancer
735426|NCT01104194|depression|depression
735427|NCT01104194|cognition|cognition
735428|NCT01104194|heart rate variability|heart rate variability
735429|NCT01104194|omega-3 fatty acids|omega-3 fatty acids
735430|NCT01104194|Depression (in remission) (vulnerability to depression)|depression (in remission) (vulnerability to depression)
735431|NCT01104207|tinnitus|tinnitus
735433|NCT01104207|transcranial magnetic stimulation|transcranial magnetic stimulation
735437|NCT01104233|Video-assisted Thoracoscopic Surgery|video-assisted thoracoscopic surgery
735438|NCT01104233|Soft spreading|soft spreading
735439|NCT01104233|LAP Protector|lap protector
735440|NCT01104246|Hypogonadism|hypogonadism
735441|NCT01104246|Testosterone|testosterone
735442|NCT01104246|Hormone replacement therapy|hormone replacement therapy
735443|NCT01104272|Ultrasound Treatment of Subcutaneous Adipose Tissue|ultrasound treatment of subcutaneous adipose tissue
735444|NCT01104298|metastatic STS|metastatic sts
735445|NCT01104298|Trabectedin|trabectedin
735446|NCT01104298|doxorrubicin|doxorrubicin
735447|NCT01104298|soft tissue sarcoma|soft tissue sarcoma
735448|NCT01104298|non operable sarcoma|non operable sarcoma
735449|NCT01104311|Blood Pressure|blood pressure
735450|NCT01104311|Atherosclerosis|atherosclerosis
735451|NCT01104311|Brain Ischemia|brain ischemia
735452|NCT01104324|bone health|bone health
735453|NCT01104324|Osteonecrosis|osteonecrosis
735454|NCT01104324|acute lymphoblastic leukemia|acute lymphoblastic leukemia
735455|NCT01104337|paracetamol|paracetamol
735456|NCT01104337|warfarin|warfarin
735457|NCT01104337|drug interaction|drug interaction
735458|NCT01104337|pathogenic mechanism|pathogenic mechanism
735460|NCT01104350|Radiotherapy|radiotherapy
735461|NCT01104350|Gemcitabine|gemcitabine
735462|NCT01104350|Chemotherapy|chemotherapy
735463|NCT01104350|10-031|10-031
735464|NCT01104623|ADHD|adhd
735465|NCT01104649|Spinocerebellar ataxia|spinocerebellar ataxia
735466|NCT01104649|Friedreich ataxia|friedreich ataxia
735467|NCT01104675|ovarian|ovarian
735468|NCT01104675|platinum resistant ovarian cancer|platinum resistant ovarian cancer
735469|NCT01104688|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
735470|NCT01104688|Wall Stress|wall stress
735471|NCT01104688|Shear Stress|shear stress
735472|NCT01104688|Inflammation|inflammation
735473|NCT01104688|Magnetic Resonance Imaging|magnetic resonance imaging
735474|NCT01104701|Exenatide|exenatide
735475|NCT01104701|Amylin|amylin
735476|NCT01104701|Lilly|lilly
735477|NCT01104701|Byetta|byetta
735478|NCT01104701|Exenatide Once Weekly|exenatide once weekly
735479|NCT01104727|SINGLE PORT SURGERY|single port surgery
735480|NCT01104727|LAPAROSCOPY, CHOLECYSTECTOMY|laparoscopy, cholecystectomy
735483|NCT01104766|Psychotropic Drugs|psychotropic drugs
735484|NCT01104766|Aripiprazole|aripiprazole
735485|NCT01104766|Antipsychotic Agents|antipsychotic agents
735486|NCT01104766|Mental Disorders|mental disorders
735487|NCT01104766|Dopamine Agents|dopamine agents
735488|NCT01104766|Central Nervous System Agents|central nervous system agents
735489|NCT01104779|Schizophrenia|schizophrenia
735490|NCT01104779|Acute Schizophrenia|acute schizophrenia
735491|NCT01104779|Psychotropic Drugs|psychotropic drugs
735492|NCT01104779|Antipsychotic Agents|antipsychotic agents
735493|NCT01104779|Mental Disorders|mental disorders
735494|NCT01104779|Dopamine Agents|dopamine agents
735495|NCT01104779|Central Nervous System Agents|central nervous system agents
735496|NCT01104792|Schizophrenia|schizophrenia
735497|NCT01104792|Acute Schizophrenia|acute schizophrenia
735498|NCT01104792|Psychotropic Drugs|psychotropic drugs
735499|NCT01104792|Antipsychotic Agents|antipsychotic agents
735500|NCT01104792|Mental Disorders|mental disorders
735501|NCT01104792|Dopamine Agents|dopamine agents
735502|NCT01104792|Central Nervous System Agents|central nervous system agents
735503|NCT01104805|Drug Abuse|drug abuse
735504|NCT01104805|Substance Abuse|substance abuse
735505|NCT01104805|Substance Use Disorder|substance use disorder
735506|NCT01104805|Addiction|addiction
735507|NCT01104805|Behavioral Treatment|behavioral treatment
735508|NCT01104818|Sibling relationship quality|sibling relationship quality
735510|NCT01104818|Parent Management Training|parent management training
735511|NCT01104818|Mental health outcomes|mental health outcomes
735512|NCT01104831|Tibial Plateau Fracture|tibial plateau fracture
735513|NCT01104831|AO/OTA 41|ao/ota 41
735514|NCT01104844|dental pain|dental pain
735515|NCT01104844|Analgesia|analgesia
735516|NCT01104857|Respiratory muscle|respiratory muscle
735518|NCT01104857|Mechanical ventilation|mechanical ventilation
735519|NCT01104883|Adductor-Canal-Blockade|adductor-canal-blockade
735520|NCT01104883|postoperative pain|postoperative pain
735521|NCT01104883|US-guided nerve block|us-guided nerve block
735522|NCT01104883|total knee arthroplasty|total knee arthroplasty
735523|NCT01104896|Cigarette|cigarette
735524|NCT01104896|tobacco|tobacco
735525|NCT01104896|mechanical ventilation|mechanical ventilation
735526|NCT01104896|nicotine|nicotine
735527|NCT01104909|Dry weight|dry weight
735528|NCT01104909|Blood Pressure|blood pressure
735529|NCT01104909|Chronic Kidney disease|chronic kidney disease
735530|NCT01104922|Re-irradiation with Fractionated Stereotactic Radiosurgery for Head and Neck|re-irradiation with fractionated stereotactic radiosurgery for head and neck
735531|NCT01104961|Bacterial infection|bacterial infection
735532|NCT01104961|Loss of epithelial cells|loss of epithelial cells
735534|NCT01104974|HIV providers|hiv providers
735535|NCT01104974|Infectious Disease|infectious disease
735536|NCT01104974|HIV and pregnancy|hiv and pregnancy
735537|NCT01104987|Ankylosing spondylitis|ankylosing spondylitis
735538|NCT01104987|spondarthritis|spondarthritis
735540|NCT01104987|Bone mineral density|bone mineral density
735541|NCT01104987|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
735542|NCT01104987|Quantitative computed tomography|quantitative computed tomography
735544|NCT01105000|HPV vaccine|hpv vaccine
735545|NCT01105013|fungal infections|fungal infections
735546|NCT01105013|tinea|tinea
735547|NCT01105013|tonaftato|tonaftato
735548|NCT01105026|alveolar ridge preservation, bioactive glass, tooth extraction, graft material|alveolar ridge preservation, bioactive glass, tooth extraction, graft material
735549|NCT01105039|Pain pattern|pain pattern
735550|NCT01105039|overall pain|overall pain
735551|NCT01105039|incisional pain|incisional pain
735552|NCT01105039|shoulder pain|shoulder pain
735553|NCT01105039|visceral pain|visceral pain
735558|NCT01105052|Bibliotherapy|bibliotherapy
735559|NCT01105065|Normal Pressure Glaucoma|normal pressure glaucoma
735560|NCT01105078|cardiopulmonary bypass flow rate outcome tissue perfusion oxygenation l/min/m2|cardiopulmonary bypass flow rate outcome tissue perfusion oxygenation l/min/m2
735561|NCT01105091|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
735562|NCT01105091|PAH|pah
735563|NCT01105091|EPITOME-1|epitome-1
735564|NCT01105117|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
735565|NCT01105117|PAH|pah
735566|NCT01105117|EPITOME-1|epitome-1
735567|NCT01105130|radiation toxicity|radiation toxicity
735568|NCT01105130|male erectile disorder|male erectile disorder
735569|NCT01105130|prostate cancer|prostate cancer
735570|NCT01105143|weight loss|weight loss
735571|NCT01105143|muscle mass|muscle mass
735572|NCT01105156|Gastric band|gastric band
735573|NCT01105156|Questionnaire|questionnaire
735574|NCT01105156|Post operative management|post operative management
735575|NCT01105156|Adjustment|adjustment
735576|NCT01105169|Personalized prevention|personalized prevention
735577|NCT01105169|Colorectal cancer|colorectal cancer
735578|NCT01105169|Investigational Nutrigenetic Studies|investigational nutrigenetic studies
737261|NCT01112449|PSA|psa
735579|NCT01105169|Magnesium|magnesium
735580|NCT01105169|Gene polymorphism|gene polymorphism
735581|NCT01105182|Radiofrequency Ablation|radiofrequency ablation
735582|NCT01105195|DuraPrep|duraprep
735583|NCT01105195|ChloraPrep|chloraprep
735584|NCT01105195|Lumbar Spine|lumbar spine
735586|NCT01105221|Dry eye|dry eye
735587|NCT01105221|Artificial tear drop|artificial tear drop
735588|NCT01105221|Mixed method approach|mixed method approach
735589|NCT01105221|Qualitative study|qualitative study
735590|NCT01105221|Cost effectiveness analysis|cost effectiveness analysis
735591|NCT01105221|Tear cytokine analysis|tear cytokine analysis
735592|NCT01105234|Healthy volunteers|healthy volunteers
735593|NCT01105247|PCI-32765|pci-32765
735594|NCT01105247|Lymphoma, B-Cell|lymphoma, b-cell
735595|NCT01105247|Leukemia, Lymphoid|leukemia, lymphoid
735596|NCT01105247|Leukemia, B-Cell|leukemia, b-cell
735597|NCT01105247|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
735598|NCT01105260|early reconditioning program|early reconditioning program
735599|NCT01105260|spinal cord injury|spinal cord injury
735600|NCT01105260|early rehabilitation|early rehabilitation
735601|NCT01105260|wheelchair|wheelchair
735602|NCT01105273|Aplastic anemia|aplastic anemia
735603|NCT01105273|Fludarabine|fludarabine
735604|NCT01105273|CD3±CD19 depletion|cd3±cd19 depletion
735605|NCT01105273|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
735606|NCT01105299|bioequivalence|bioequivalence
735607|NCT01105299|anastrozole|anastrozole
735608|NCT01105299|Healthy subjects|healthy subjects
735609|NCT01105299|Antineoplastic Agents|antineoplastic agents
735610|NCT01105299|Therapeutic Uses|therapeutic uses
735611|NCT01105299|Enzyme Inhibitors|enzyme inhibitors
735612|NCT01105312|male breast cancer|male breast cancer
735613|NCT01105312|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
735614|NCT01105312|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
735615|NCT01105312|HER2-negative breast cancer|her2-negative breast cancer
735616|NCT01105312|HER2-positive breast cancer|her2-positive breast cancer
735617|NCT01105312|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
735618|NCT01105312|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
735619|NCT01105312|triple-negative breast cancer|triple-negative breast cancer
735620|NCT01105312|recurrent breast cancer|recurrent breast cancer
735621|NCT01105312|stage IV breast cancer|stage iv breast cancer
735622|NCT01105325|acute coronary syndrome|acute coronary syndrome
735623|NCT01105325|treatment compliance|treatment compliance
735624|NCT01105325|cardiac intensive care unit|cardiac intensive care unit
735625|NCT01105325|secondary prevention|secondary prevention
735626|NCT01105325|cardiac intensive care unit (CIC)|cardiac intensive care unit (cic)
735627|NCT01105325|compliance|compliance
735628|NCT01105325|intensive care|intensive care
735629|NCT01105338|prostate cancer|prostate cancer
735630|NCT01105351|Folate|folate
735631|NCT01105351|MTHFR|mthfr
735632|NCT01105351|Homocysteine|homocysteine
735633|NCT01105364|recurrent renal cell cancer|recurrent renal cell cancer
735634|NCT01105364|stage IV renal cell cancer|stage iv renal cell cancer
735635|NCT01105364|liver metastases|liver metastases
735636|NCT01105403|Hematopoietic stem cells|hematopoietic stem cells
735637|NCT01105403|Mobilisation|mobilisation
735638|NCT01105403|Autologous transplantation|autologous transplantation
735639|NCT01105416|Pediatric Emergency Department|pediatric emergency department
735640|NCT01105416|Parental monitoring|parental monitoring
735641|NCT01105416|Adolescent|adolescent
735642|NCT01105416|Parents|parents
735643|NCT01105416|Communication|communication
735644|NCT01105416|Alcohol Drinking|alcohol drinking
735645|NCT01105442|Post-operative pain treatment|post-operative pain treatment
735646|NCT01105442|Fast-track colonic surgery patients|fast-track colonic surgery patients
735647|NCT01105442|Surgery|surgery
735648|NCT01105455|Randomized clinical trial|randomized clinical trial
735649|NCT01105455|Gestational diabetes|gestational diabetes
735650|NCT01105455|Carbohydrates|carbohydrates
735651|NCT01105455|Glycemic index|glycemic index
735652|NCT01105468|Breath gas analysis|breath gas analysis
735653|NCT01105468|Volatile components in exhaled breath|volatile components in exhaled breath
735654|NCT01105481|treatment-resistant schizophrenia|treatment-resistant schizophrenia
735655|NCT01105481|clozapine|clozapine
735656|NCT01105481|amisulpride|amisulpride
735657|NCT01105507|Canakinumab|canakinumab
735658|NCT01105507|Cryopyrin-associated periodic syndromes|cryopyrin-associated periodic syndromes
735659|NCT01105507|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
735660|NCT01105507|Familial Cold Urticaria (FCU)|familial cold urticaria (fcu)
735661|NCT01105507|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
735662|NCT01105507|Neonatal-Onset Multisystem Inflammatory Disease (NOMID)|neonatal-onset multisystem inflammatory disease (nomid)
735663|NCT01105507|Chronic Infantile Neurological|chronic infantile neurological
735664|NCT01105507|Cutaneous|cutaneous
735665|NCT01105507|Articular Syndrome (CINCA)|articular syndrome (cinca)
735666|NCT01105507|Treatment of patients diagnosed with CAPS (Cryopyrin associated periodic syndrome)|treatment of patients diagnosed with caps (cryopyrin associated periodic syndrome)
735667|NCT01105520|Intraspinal processes (tumor or vascular malformation AVM)|intraspinal processes (tumor or vascular malformation avm)
735668|NCT01105533|VGEF inhibitor|vgef inhibitor
735669|NCT01105533|Anti angiogenesis|anti angiogenesis
735670|NCT01105533|Advanced Solid Tumors|advanced solid tumors
735671|NCT01105546|hemophilia A|hemophilia a
735672|NCT01105546|inhibitors|inhibitors
735673|NCT01105546|prophylaxis|prophylaxis
735674|NCT01105546|immune tolerance induction|immune tolerance induction
735675|NCT01105559|Diphtheria|diphtheria
735676|NCT01105559|Tetanus|tetanus
735677|NCT01105559|Whooping cough|whooping cough
735678|NCT01105559|Hepatitis B|hepatitis b
735679|NCT01105559|Poliomyelitis|poliomyelitis
735680|NCT01105559|Diphtheria-Tetanus-acellular Pertussis Vaccines|diphtheria-tetanus-acellular pertussis vaccines
735681|NCT01105572|Congestive Heart Failure|congestive heart failure
735682|NCT01105585|Cataracts|cataracts
735683|NCT01105585|aspheric|aspheric
735684|NCT01105585|IOL|iol
735685|NCT01105585|ocular aberrations|ocular aberrations
735686|NCT01105611|HIV|hiv
735687|NCT01105611|Hepatitis C|hepatitis c
735688|NCT01105611|Co-infection|co-infection
735689|NCT01105611|Intravenous drug users|intravenous drug users
735690|NCT01105611|Treatment-naïve|treatment-naïve
735691|NCT01105611|Methadone|methadone
735692|NCT01105637|burn injuries|burn injuries
735693|NCT01105637|exercise|exercise
735694|NCT01105650|recurrent ovarian cancer|recurrent ovarian cancer
735695|NCT01105650|recurrent fallopian tube cancer|recurrent fallopian tube cancer
735696|NCT01105650|recurrent primary peritoneal cancer|recurrent primary peritoneal cancer
735697|NCT01105650|refractory ovarian cancer|refractory ovarian cancer
735698|NCT01105650|refractory fallopian tube cancer|refractory fallopian tube cancer
735699|NCT01105650|refractory peritoneal cancer|refractory peritoneal cancer
735700|NCT01105650|metastatic breast cancer|metastatic breast cancer
735701|NCT01105663|sedated|sedated
735702|NCT01105663|intubated|intubated
735703|NCT01105663|mechanically ventilated|mechanically ventilated
735704|NCT01105663|pediatric|pediatric
735705|NCT01105663|lung injury|lung injury
735706|NCT01105676|vascular malformation|vascular malformation
735707|NCT01105676|vascular anomalies|vascular anomalies
735708|NCT01105676|abnormalities of growth|abnormalities of growth
735709|NCT01105676|overgrowth|overgrowth
735710|NCT01105676|subjects with vascular malformations abnormalities of growth.|subjects with vascular malformations abnormalities of growth.
735711|NCT01105689|Urine Calcium to Creatinine Ratio|urine calcium to creatinine ratio
735712|NCT01105689|Hypocalciuria|hypocalciuria
735713|NCT01105689|Infants|infants
735714|NCT01105689|Toddlers|toddlers
735715|NCT01105702|brain tumor|brain tumor
735716|NCT01105702|brain cancer|brain cancer
735717|NCT01105702|glioma|glioma
735718|NCT01105715|Rheumatoid Arthritis|rheumatoid arthritis
735719|NCT01105715|cLDL|cldl
735720|NCT01105715|Cardiovascular disease|cardiovascular disease
735721|NCT01105728|Gastric subepitelial mass|gastric subepitelial mass
735722|NCT01105728|Endoscopic full thickness resection|endoscopic full thickness resection
735723|NCT01105741|Crohn's disease|crohn's disease
735724|NCT01105741|Adalimumab|adalimumab
735725|NCT01105741|Metabolome|metabolome
735726|NCT01105767|Staphylococcus aureus|staphylococcus aureus
735727|NCT01105767|MRSA Skin Infection|mrsa skin infection
735728|NCT01105767|Staphylococcal Skin Infections|staphylococcal skin infections
735729|NCT01105767|Chlorhexidine gluconate|chlorhexidine gluconate
735730|NCT01105780|Healthy Volunteers|healthy volunteers
735731|NCT01105780|Healthy|healthy
735732|NCT01105780|Japanese|japanese
735733|NCT01105780|Pharmacokinetics|pharmacokinetics
735734|NCT01105780|JNJ-41443532|jnj-41443532
735735|NCT01105793|cyclic mastalgia|cyclic mastalgia
735736|NCT01105793|cyclic breast pain|cyclic breast pain
735737|NCT01105793|fibrocystic breast disease|fibrocystic breast disease
735738|NCT01105806|advance directive|advance directive
735739|NCT01105806|CPR Intervention|cpr intervention
735740|NCT01105806|Video|video
735741|NCT01105806|Narrative|narrative
735742|NCT01105806|10-043|10-043
735744|NCT01105819|Lactobacillus plantarum 299|lactobacillus plantarum 299
735745|NCT01105819|Ventilator-associated pneumonia VAP|ventilator-associated pneumonia vap
735746|NCT01105819|Chlorhexidine|chlorhexidine
735747|NCT01105819|Tracheal secretions|tracheal secretions
735748|NCT01105819|Oropharyngeal secretions|oropharyngeal secretions
735749|NCT01105832|Teriparatide|teriparatide
735750|NCT01105832|fracture healing|fracture healing
735751|NCT01105832|proximal humeral fractures|proximal humeral fractures
735752|NCT01105845|Motor Learning|motor learning
735753|NCT01105845|Genetic Analysis|genetic analysis
735754|NCT01105845|BDNF|bdnf
735755|NCT01105845|Parkinson Disease|parkinson disease
735756|NCT01105845|Movement Disorders|movement disorders
735757|NCT01105845|Dystonia|dystonia
735758|NCT01105845|Healthy Volunteer|healthy volunteer
735760|NCT01105858|Diabetes Mellitus|diabetes mellitus
735761|NCT01105858|Obesity|obesity
735762|NCT01105858|Diabetic Complications|diabetic complications
735763|NCT01105858|Genetics|genetics
735764|NCT01105858|Molecular Profiling|molecular profiling
735765|NCT01105871|Pain relief|pain relief
735766|NCT01105884|Wound healing, type 2 diabetes, diabetic foot ulcers, different dressings|wound healing, type 2 diabetes, diabetic foot ulcers, different dressings
735767|NCT01105897|endometriosis|endometriosis
735768|NCT01105897|deep endometriosis|deep endometriosis
735769|NCT01105897|surgery|surgery
735770|NCT01105897|laparoscopy|laparoscopy
735771|NCT01105897|chronic pain|chronic pain
735772|NCT01105897|quality of life|quality of life
735773|NCT01105897|sexual function|sexual function
735774|NCT01105897|complications|complications
735775|NCT01105897|recurrence|recurrence
735776|NCT01105910|Dry Eye, Post Menopausal dry eye|dry eye, post menopausal dry eye
735777|NCT01105936|osteoarthritis|osteoarthritis
735778|NCT01105936|pain|pain
735779|NCT01105936|paracetamol|paracetamol
735780|NCT01105936|Blood-Oxygen-Level-Dependent functional magnetic resonance imaging|blood-oxygen-level-dependent functional magnetic resonance imaging
735781|NCT01105949|nasal patency|nasal patency
735782|NCT01105949|acoustic rhinometry|acoustic rhinometry
735783|NCT01105949|nasal strip|nasal strip
735784|NCT01105962|traumatic|traumatic
735785|NCT01105962|brain|brain
735786|NCT01105962|injury|injury
735787|NCT01105962|post-traumatic|post-traumatic
735788|NCT01105962|stress|stress
735789|NCT01105962|hyperbaric|hyperbaric
735790|NCT01105962|oxygen|oxygen
735791|NCT01105962|HBOT|hbot
735793|NCT01105962|PTSD|ptsd
735794|NCT01105975|Dyslipidemias|dyslipidemias
735795|NCT01105975|Mixed dyslipidemia|mixed dyslipidemia
735796|NCT01105975|Hypercholesterolemia|hypercholesterolemia
735797|NCT01105975|Atherosclerosis|atherosclerosis
735798|NCT01105975|Atorvastatin|atorvastatin
735799|NCT01105975|Simvastatin|simvastatin
735800|NCT01105975|Rosuvastatin|rosuvastatin
735801|NCT01105975|Metabolic Diseases|metabolic diseases
735802|NCT01105975|Antilipemic Agents|antilipemic agents
735803|NCT01105975|Enzyme Inhibitors|enzyme inhibitors
735804|NCT01105975|Anticholesteremic Agents|anticholesteremic agents
735805|NCT01105975|Cholesteryl Ester Transfer Protein Inhibitors|cholesteryl ester transfer protein inhibitors
735806|NCT01105975|Cholesteryl Ester|cholesteryl ester
735807|NCT01105975|Lipid Metabolism Disorders|lipid metabolism disorders
735809|NCT01105988|PET scans|pet scans
735810|NCT01105988|MRI scans|mri scans
735811|NCT01106001|total hip arthroplasty|total hip arthroplasty
735812|NCT01106001|periarticular injection|periarticular injection
735813|NCT01106001|pain|pain
735814|NCT01106014|pulmonary arterial hypertension|pulmonary arterial hypertension
735816|NCT01106040|Lymphoseek|lymphoseek
735817|NCT01106040|Breast Cancer|breast cancer
735818|NCT01106040|Melanoma|melanoma
735819|NCT01106040|Experimental|experimental
735820|NCT01106053|Binge eating disorder|binge eating disorder
735821|NCT01106053|Food craving|food craving
735822|NCT01106053|Obesity|obesity
735823|NCT01106053|Pramipexole|pramipexole
735824|NCT01106053|Mirapex|mirapex
735825|NCT01106053|Binge|binge
735826|NCT01106079|Early psoriatic arthritis|early psoriatic arthritis
735827|NCT01106079|Tight control|tight control
735828|NCT01106079|Intensive management|intensive management
735829|NCT01106157|Autoimmune, Diabetes Mellitus, Glucose Metabolism|autoimmune, diabetes mellitus, glucose metabolism
735830|NCT01106196|Influenza, Human|influenza, human
735831|NCT01106196|Influenza, Human/complications|influenza, human/complications
735832|NCT01106196|Myocardial infarction/etiology|myocardial infarction/etiology
735833|NCT01106196|Cardiovascular Diseases/mortality|cardiovascular diseases/mortality
735834|NCT01106209|premature infants|premature infants
735835|NCT01106209|polymorphonuclear leukocytes|polymorphonuclear leukocytes
735836|NCT01106209|PMNs|pmns
735837|NCT01106209|neutrophil extracellular traps|neutrophil extracellular traps
735838|NCT01106209|NET formation|net formation
735839|NCT01106209|necrotizing enterocolitis|necrotizing enterocolitis
735840|NCT01106248|tumor|tumor
735841|NCT01106326|Asthma|asthma
735842|NCT01106339|humans|humans
735843|NCT01106339|patients|patients
735844|NCT01106339|somatoform disorders|somatoform disorders
735845|NCT01106339|fibromyalgia|fibromyalgia
735846|NCT01106339|myofascial pain syndrome diffuse|myofascial pain syndrome diffuse
735847|NCT01106339|depression|depression
735848|NCT01106339|chronic fatigue syndrome|chronic fatigue syndrome
735849|NCT01106339|inflammation|inflammation
735850|NCT01106339|inflammatory response|inflammatory response
735851|NCT01106339|biomarkers|biomarkers
735852|NCT01106339|cytokines|cytokines
735853|NCT01106339|cell surface markers|cell surface markers
735854|NCT01106339|functional polymorphisms|functional polymorphisms
735855|NCT01106352|The target population is patients with bone metastasis from castration-resistant prostate cancer intended for treatment with docetaxel|the target population is patients with bone metastasis from castration-resistant prostate cancer intended for treatment with docetaxel
735856|NCT01106365|multiple sclerosis|multiple sclerosis
735857|NCT01106365|fatigue|fatigue
735858|NCT01106365|depressivity|depressivity
735859|NCT01106365|repetitive deep transcranial magnetic stimulation|repetitive deep transcranial magnetic stimulation
735860|NCT01106378|Coronary artery disease|coronary artery disease
735861|NCT01106378|drug-eluting stents|drug-eluting stents
735862|NCT01106378|sirolimus-eluting coronary stents|sirolimus-eluting coronary stents
735863|NCT01106391|Abdominal aortic aneurysm|abdominal aortic aneurysm
735864|NCT01106391|AAA|aaa
735865|NCT01106391|Safety|safety
735866|NCT01106391|Performance|performance
735867|NCT01106391|Stent graft system|stent graft system
735868|NCT01106391|First in Human|first in human
735869|NCT01106391|Endovascular repair|endovascular repair
735870|NCT01106417|Cervical Degenerative Disc Disease|cervical degenerative disc disease
735871|NCT01106417|Degenerative Spondylolisthesis|degenerative spondylolisthesis
735872|NCT01106417|Spinal Stenosis|spinal stenosis
735873|NCT01106417|Stem cells|stem cells
735874|NCT01106417|Adult Stem Cells|adult stem cells
735875|NCT01106417|Anterior cervical discectomy and Fusion (ACDF)|anterior cervical discectomy and fusion (acdf)
735876|NCT01106417|Anterior Cervical Plate Fixation|anterior cervical plate fixation
735877|NCT01106430|ADHD|adhd
735878|NCT01106443|Indeterminate thyroid nodule|indeterminate thyroid nodule
735879|NCT01106443|fine needle aspirate biopsy|fine needle aspirate biopsy
735880|NCT01106443|thyroidectomy|thyroidectomy
735881|NCT01106443|central lymph node dissection|central lymph node dissection
735882|NCT01106469|Healthy Volunteers|healthy volunteers
735883|NCT01106469|Healthy|healthy
735884|NCT01106469|JNJ-41443532|jnj-41443532
735885|NCT01106469|Pharmacokinetics|pharmacokinetics
735886|NCT01106482|TBE|tbe
735887|NCT01106482|Tick Borne Encephalitis|tick borne encephalitis
735888|NCT01106495|Atherosclerosis|atherosclerosis
735889|NCT01106495|Vascular Endothelium|vascular endothelium
735890|NCT01106495|Counterpulsation, External|counterpulsation, external
735891|NCT01106508|Advanced solid tumors|advanced solid tumors
735892|NCT01106508|recurrent or refractory medulloblastoma|recurrent or refractory medulloblastoma
735893|NCT01106508|locally advanced or metastatic basal cell carcinoma|locally advanced or metastatic basal cell carcinoma
735894|NCT01106508|hedgehog pathway inhibitor|hedgehog pathway inhibitor
735895|NCT01106521|Infiltrating ductal carcinoma|infiltrating ductal carcinoma
735896|NCT01106521|Brachytherapy|brachytherapy
735897|NCT01106534|drug eluting stents|drug eluting stents
735899|NCT01106534|Angioplasty|angioplasty
735900|NCT01106534|Stent thrombosis|stent thrombosis
735901|NCT01106534|antiplatelet treatment|antiplatelet treatment
735902|NCT01106547|abdominal hysterectomy|abdominal hysterectomy
735903|NCT01106547|glucocorticoids|glucocorticoids
735904|NCT01106547|rehabilitation|rehabilitation
735905|NCT01106547|postoperative pain|postoperative pain
735906|NCT01106547|analgetics|analgetics
735907|NCT01106573|Diabetes Mellitus|diabetes mellitus
735908|NCT01106573|Arteriosclerosis|arteriosclerosis
735909|NCT01106573|Intima media thickness|intima media thickness
735910|NCT01106573|arterial stiffness|arterial stiffness
735911|NCT01106573|pulsewave velocity|pulsewave velocity
735913|NCT01106586|HIV 1 Infection|hiv 1 infection
735914|NCT01106586|Treatment Naive|treatment naive
735915|NCT01106612|randomized controlled trial|randomized controlled trial
735916|NCT01106612|controlled clinical trial|controlled clinical trial
735917|NCT01106612|comparative effectiveness research|comparative effectiveness research
735918|NCT01106612|chest pain|chest pain
735919|NCT01106612|angina pectoris|angina pectoris
735920|NCT01106612|non-invasive cardiac imaging|non-invasive cardiac imaging
735921|NCT01106612|nuclear stress testing|nuclear stress testing
735922|NCT01106612|coronary CT angiography|coronary ct angiography
735923|NCT01106612|coronary catheterization|coronary catheterization
735924|NCT01106612|coronary revascularization|coronary revascularization
735925|NCT01106625|Canagliflozin|canagliflozin
735926|NCT01106625|Placebo|placebo
735927|NCT01106625|Metformin|metformin
735928|NCT01106625|Sulphonylurea|sulphonylurea
735929|NCT01106625|Hemoglobin A1c|hemoglobin a1c
735930|NCT01106625|Type 2 diabetes mellitus|type 2 diabetes mellitus
735931|NCT01106638|HIV|hiv
735932|NCT01106638|AIDS|aids
735933|NCT01106638|Smoking|smoking
735934|NCT01106638|Tobacco|tobacco
735935|NCT01106638|Cessation|cessation
735936|NCT01106638|Tobacco use in persons living with HIV/AIDS|tobacco use in persons living with hiv/aids
736344|NCT01107327|cancer|cancer
735937|NCT01106651|Canagliflozin|canagliflozin
735938|NCT01106651|Placebo|placebo
735939|NCT01106651|Hemoglobin A1c|hemoglobin a1c
735940|NCT01106651|Bone|bone
735941|NCT01106651|Type 2 diabetes mellitus|type 2 diabetes mellitus
735942|NCT01106664|ONO-7746|ono-7746
735943|NCT01106664|Healthy adult subjects|healthy adult subjects
735944|NCT01106677|Type 2 diabetes mellitus|type 2 diabetes mellitus
735945|NCT01106677|Canagliflozin|canagliflozin
735946|NCT01106677|Placebo|placebo
735947|NCT01106677|Sitagliptin|sitagliptin
735948|NCT01106677|Januvia|januvia
735949|NCT01106677|Metformin Immediate Release (IR)|metformin immediate release (ir)
735950|NCT01106677|Hemoglobin A1c|hemoglobin a1c
735951|NCT01106690|Canagliflozin|canagliflozin
735952|NCT01106690|Placebo|placebo
735953|NCT01106690|Sitagliptin (Januvia)|sitagliptin (januvia)
735954|NCT01106690|Metformin|metformin
735955|NCT01106690|Pioglitazone (Actos)|pioglitazone (actos)
735956|NCT01106690|Hemoglobin A1c|hemoglobin a1c
735957|NCT01106690|Type 2 diabetes mellitus|type 2 diabetes mellitus
735958|NCT01106703|atopy, IgE|atopy, ige
735959|NCT01106716|Lidocaine|lidocaine
735960|NCT01106716|Lignocaine|lignocaine
735961|NCT01106716|Analgesics. Non-narcotic / therapeutic use|analgesics. non-narcotic / therapeutic use
735962|NCT01106716|Neuralgia, Postherpetic|neuralgia, postherpetic
735963|NCT01106716|Pain|pain
735964|NCT01106716|Pain measurement / drug effect|pain measurement / drug effect
735965|NCT01106716|Pain postoperative / drug therapy|pain postoperative / drug therapy
735966|NCT01106716|PHN|phn
735967|NCT01106729|Flavonoids|flavonoids
735968|NCT01106729|Anthocyanin|anthocyanin
735969|NCT01106729|Cyanidin 3 glucoside|cyanidin 3 glucoside
735970|NCT01106729|Acute feeding trial|acute feeding trial
735971|NCT01106729|Stable isotope|stable isotope
735972|NCT01106729|Metabolism|metabolism
735973|NCT01106729|Clearance|clearance
735974|NCT01106729|Bioavailability|bioavailability
735975|NCT01106729|Pharmacokinetics|pharmacokinetics
735976|NCT01106742|Inflammatory|inflammatory
735977|NCT01106742|AbM|abm
735978|NCT01106742|IBD|ibd
735979|NCT01106755|kinematic|kinematic
735980|NCT01106755|hemiparesis|hemiparesis
735981|NCT01106755|gait|gait
735982|NCT01106755|Body weight support|body weight support
735983|NCT01106755|Functional electrical stimulation|functional electrical stimulation
735984|NCT01106768|oral health needs|oral health needs
735985|NCT01106768|children|children
735986|NCT01106768|attention deficit disorder with or without hyperactivity|attention deficit disorder with or without hyperactivity
735987|NCT01106781|EGFR mutation test|egfr mutation test
735988|NCT01106781|NSCLC|nsclc
735989|NCT01106781|Non-Interventional Study|non-interventional study
735990|NCT01106781|EGFR mutation status|egfr mutation status
735991|NCT01106794|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
735992|NCT01106794|DIPG|dipg
735993|NCT01106794|childhood brainstem glioma|childhood brainstem glioma
735994|NCT01106794|pediatric brainstem glioma|pediatric brainstem glioma
735995|NCT01106794|brainstem glioma|brainstem glioma
735996|NCT01106794|BSG|bsg
735997|NCT01106833|Chronic Graft-versus-Host Disease (cGVHD)|chronic graft-versus-host disease (cgvhd)
735998|NCT01106846|Ketamine|ketamine
735999|NCT01106846|Anesthesia|anesthesia
736000|NCT01106846|Pain|pain
736001|NCT01106846|Outpatient surgery|outpatient surgery
736002|NCT01106859|insomnia|insomnia
736003|NCT01106872|Sarcoma|sarcoma
736004|NCT01106872|Soft Tissue Sarcoma|soft tissue sarcoma
736005|NCT01106872|Locally Advanced Sarcoma|locally advanced sarcoma
736006|NCT01106872|Unresectable Sarcoma|unresectable sarcoma
736007|NCT01106872|Metastatic Sarcoma|metastatic sarcoma
736008|NCT01106872|Valproic Acid|valproic acid
736009|NCT01106872|Bevacizumab|bevacizumab
736010|NCT01106872|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
736011|NCT01106885|Diabetes|diabetes
736012|NCT01106885|Depression|depression
736013|NCT01106885|Telephone Care Management|telephone care management
736014|NCT01106885|Medication Care Management (MCM)|medication care management (mcm)
736015|NCT01106885|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
736016|NCT01106911|digital breast tomosynthesis|digital breast tomosynthesis
736017|NCT01106911|baseline screening mammography|baseline screening mammography
736018|NCT01106911|recall rates|recall rates
736019|NCT01106924|Probiotics, Weight control, Body composition|probiotics, weight control, body composition
736020|NCT01106950|acute myelogenous leukemia|acute myelogenous leukemia
736021|NCT01106950|primary acute myelogenous leukemia|primary acute myelogenous leukemia
736022|NCT01106950|secondary acute myelogenous leukemia|secondary acute myelogenous leukemia
736023|NCT01106950|relapsed acute myelogenous leukemia|relapsed acute myelogenous leukemia
736024|NCT01106963|knee|knee
736025|NCT01106963|tibial fractures|tibial fractures
736026|NCT01106963|pain|pain
736027|NCT01106963|osteosynthesis|osteosynthesis
736028|NCT01106963|intramedullary nailing|intramedullary nailing
736029|NCT01106976|PET|pet
736030|NCT01106976|acetylcholine|acetylcholine
736031|NCT01107002|infertility|infertility
736032|NCT01107002|Embryo transfer|embryo transfer
736033|NCT01107015|Diabetes|diabetes
736034|NCT01107015|Glucose control|glucose control
736035|NCT01107015|Diabetes monitoring|diabetes monitoring
736036|NCT01107015|Care management|care management
736037|NCT01107015|Electronic communication|electronic communication
736038|NCT01107015|Mobile phone technology|mobile phone technology
736039|NCT01107015|Self care|self care
736040|NCT01107028|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
736041|NCT01107028|Dyspnea|dyspnea
736042|NCT01107028|Functional capacity|functional capacity
736043|NCT01107028|Quality of life|quality of life
736044|NCT01107041|Depression|depression
736045|NCT01107041|Technology Assisted|technology assisted
736046|NCT01107041|Mobile Phone|mobile phone
736047|NCT01107054|QTC|qtc
736048|NCT01107067|hypogonadism|hypogonadism
736049|NCT01107067|paraoxonase|paraoxonase
736050|NCT01107067|Hipogonadism|hipogonadism
736051|NCT01107080|breast cancer|breast cancer
736052|NCT01107080|breast carcinoma in situ|breast carcinoma in situ
736053|NCT01107080|ductal breast carcinoma in situ|ductal breast carcinoma in situ
736054|NCT01107080|invasive carcinoma|invasive carcinoma
736055|NCT01107080|invasive ductal carcinoma|invasive ductal carcinoma
736056|NCT01107080|invasive lobular carcinoma|invasive lobular carcinoma
736057|NCT01101230|Cardiovascular disease|cardiovascular disease
736058|NCT01101230|cholesterol|cholesterol
736059|NCT01101230|low-density|low-density
736060|NCT01101230|lipoprotein|lipoprotein
736061|NCT01101230|high-density lipoprotein|high-density lipoprotein
736062|NCT01101230|triglycerides|triglycerides
736063|NCT01101243|Vitamin D|vitamin d
736064|NCT01101243|UVB|uvb
736065|NCT01101243|Frequency|frequency
736066|NCT01101243|Body surface area|body surface area
736067|NCT01101243|Dose-Response|dose-response
736068|NCT01101269|Diabetic nephropathy|diabetic nephropathy
736069|NCT01101282|PEP|pep
736070|NCT01101282|exacerbation|exacerbation
736071|NCT01101282|physiotherapy|physiotherapy
736072|NCT01101282|airway clearance|airway clearance
736073|NCT01101282|sputum|sputum
736074|NCT01101282|physical Therapy modalities|physical therapy modalities
736075|NCT01101295|Immune Thrombocytopenia|immune thrombocytopenia
736076|NCT01101295|Rituximab|rituximab
736077|NCT01101295|side effects|side effects
736078|NCT01101295|tolerance|tolerance
736079|NCT01101295|safety|safety
736080|NCT01101295|splenectomy|splenectomy
736081|NCT01101295|serum sickness|serum sickness
736082|NCT01101308|Healthy subjects|healthy subjects
736083|NCT01101308|Opioid|opioid
736084|NCT01101308|Healthy volunteers|healthy volunteers
736085|NCT01101321|Healthy subjects|healthy subjects
736086|NCT01101321|Opioid|opioid
736087|NCT01101321|Healthy volunteers|healthy volunteers
736088|NCT01101334|NSCLC|nsclc
736089|NCT01101360|port wine stains|port wine stains
736090|NCT01101360|radiofrequency|radiofrequency
736091|NCT01101360|Pulse Dye Laser|pulse dye laser
736092|NCT01101373|Limbic surgery|limbic surgery
736093|NCT01101373|Stereotactic surgery|stereotactic surgery
736094|NCT01101373|Major Depressive Disorder: Treatment Refractory|major depressive disorder: treatment refractory
736095|NCT01101386|Voriconazole|voriconazole
736096|NCT01101386|SBECD|sbecd
736097|NCT01101386|pharmacokinetics|pharmacokinetics
736098|NCT01101386|Renal Failure|renal failure
736099|NCT01101399|Anemia|anemia
736100|NCT01101399|Lymphoproliferative Disorders|lymphoproliferative disorders
736101|NCT01101399|Chemotherapy|chemotherapy
736102|NCT01101399|ferric carboxymaltose|ferric carboxymaltose
736103|NCT01101399|iron|iron
736104|NCT01101412|infection|infection
736105|NCT01101412|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
736106|NCT01101412|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
736107|NCT01101412|acute undifferentiated leukemia|acute undifferentiated leukemia
736108|NCT01101412|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
736109|NCT01101412|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
736110|NCT01101412|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
736111|NCT01101412|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
736112|NCT01101412|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
736113|NCT01101412|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
736114|NCT01101412|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
736115|NCT01101412|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
736116|NCT01101412|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
736117|NCT01101412|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
736118|NCT01101412|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
736119|NCT01101412|mast cell leukemia|mast cell leukemia
736120|NCT01101412|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
736121|NCT01101412|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
736122|NCT01101412|prolymphocytic leukemia|prolymphocytic leukemia
736123|NCT01101412|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
736124|NCT01101412|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
736125|NCT01101412|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
736126|NCT01101412|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
736127|NCT01101412|refractory hairy cell leukemia|refractory hairy cell leukemia
736128|NCT01101412|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
736129|NCT01101412|secondary acute myeloid leukemia|secondary acute myeloid leukemia
736130|NCT01101412|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
736131|NCT01101412|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
736132|NCT01101412|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
736133|NCT01101412|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
736134|NCT01101412|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
736135|NCT01101412|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
736136|NCT01101412|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
736137|NCT01101412|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
736138|NCT01101412|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
736139|NCT01101412|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
736140|NCT01101412|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
736141|NCT01101412|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
736142|NCT01101412|untreated hairy cell leukemia|untreated hairy cell leukemia
736143|NCT01101412|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
736144|NCT01101412|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
736145|NCT01101412|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
736146|NCT01101412|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
736147|NCT01101412|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
736148|NCT01101412|anaplastic large cell lymphoma|anaplastic large cell lymphoma
736149|NCT01101412|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
736150|NCT01101412|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
736151|NCT01101412|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
736152|NCT01101412|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
736153|NCT01101412|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
736154|NCT01101412|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
736155|NCT01101412|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
736156|NCT01101412|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
736157|NCT01101412|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
736158|NCT01101412|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
736159|NCT01101412|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
736160|NCT01101412|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
736161|NCT01101412|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
736162|NCT01101412|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
736163|NCT01101412|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
736164|NCT01101412|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
736165|NCT01101412|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
736166|NCT01101412|splenic marginal zone lymphoma|splenic marginal zone lymphoma
736167|NCT01101412|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
736168|NCT01101412|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
751883|NCT01171053|Cognitive behavior therapy|cognitive behavior therapy
736169|NCT01101412|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
736170|NCT01101412|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
736171|NCT01101412|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
736172|NCT01101412|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
736173|NCT01101412|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
736174|NCT01101412|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
736175|NCT01101412|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
736176|NCT01101412|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
736177|NCT01101412|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
736178|NCT01101412|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
736179|NCT01101412|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
736180|NCT01101412|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
736181|NCT01101412|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
736182|NCT01101412|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
736183|NCT01101412|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
736184|NCT01101412|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
736185|NCT01101412|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
736186|NCT01101412|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
737515|NCT01113398|bevacizumab|bevacizumab
736187|NCT01101412|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
736188|NCT01101412|stage I mantle cell lymphoma|stage i mantle cell lymphoma
736189|NCT01101412|stage I marginal zone lymphoma|stage i marginal zone lymphoma
736190|NCT01101412|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
736191|NCT01101412|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
736192|NCT01101412|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
736193|NCT01101412|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
736194|NCT01101412|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
736195|NCT01101412|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
736196|NCT01101412|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
736197|NCT01101412|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
736198|NCT01101412|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
736199|NCT01101412|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
736200|NCT01101412|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
736201|NCT01101412|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
736202|NCT01101412|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
736203|NCT01101412|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
736367|NCT01107704|Surrogates|surrogates
736204|NCT01101412|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
736205|NCT01101412|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
736206|NCT01101412|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
736207|NCT01101412|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
736208|NCT01101412|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
736209|NCT01101412|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
736210|NCT01101412|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
736211|NCT01101412|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
736212|NCT01101412|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
736213|NCT01101412|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
736214|NCT01101412|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
736215|NCT01101412|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
736216|NCT01101412|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
736217|NCT01101412|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
736218|NCT01101412|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
736219|NCT01101412|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
736220|NCT01101412|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
736221|NCT01101412|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
736222|NCT01101412|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
736223|NCT01101412|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
736224|NCT01101412|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
736225|NCT01101412|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
736226|NCT01101412|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
736227|NCT01101412|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
751884|NCT01171053|Internet|internet
738565|NCT01117038|ED|ed
736228|NCT01101412|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
736229|NCT01101412|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
736230|NCT01101412|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
736231|NCT01101412|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
736232|NCT01101412|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
736233|NCT01101412|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
736234|NCT01101412|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
736235|NCT01101412|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
736236|NCT01101412|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
736237|NCT01101412|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
736238|NCT01101412|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
736239|NCT01101412|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
736240|NCT01101412|intraocular lymphoma|intraocular lymphoma
736241|NCT01101412|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
736242|NCT01101412|chronic eosinophilic leukemia|chronic eosinophilic leukemia
736243|NCT01101412|chronic neutrophilic leukemia|chronic neutrophilic leukemia
736244|NCT01101412|primary myelofibrosis|primary myelofibrosis
736245|NCT01101412|essential thrombocythemia|essential thrombocythemia
736246|NCT01101412|polycythemia vera|polycythemia vera
736247|NCT01101412|extramedullary plasmacytoma|extramedullary plasmacytoma
736248|NCT01101412|isolated plasmacytoma of bone|isolated plasmacytoma of bone
736249|NCT01101412|stage I multiple myeloma|stage i multiple myeloma
736250|NCT01101412|stage II multiple myeloma|stage ii multiple myeloma
736251|NCT01101412|stage III multiple myeloma|stage iii multiple myeloma
736252|NCT01101412|primary systemic amyloidosis|primary systemic amyloidosis
736253|NCT01101412|refractory multiple myeloma|refractory multiple myeloma
736254|NCT01101412|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
736255|NCT01101412|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
736256|NCT01101412|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
736257|NCT01101412|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
736258|NCT01101425|male|male
736259|NCT01101425|breast cancer|breast cancer
736260|NCT01101438|stage I breast cancer|stage i breast cancer
736261|NCT01101438|stage II breast cancer|stage ii breast cancer
736262|NCT01101438|stage IIIA breast cancer|stage iiia breast cancer
736263|NCT01101438|stage IIIC breast cancer|stage iiic breast cancer
736264|NCT01101438|male breast cancer|male breast cancer
736265|NCT01101438|HER2-negative breast cancer|her2-negative breast cancer
736266|NCT01101438|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
736267|NCT01101438|HER2-positive breast cancer|her2-positive breast cancer
736268|NCT01101438|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
736269|NCT01101477|Target-controlled infusion,|target-controlled infusion,
736270|NCT01101477|bronchoscopy,|bronchoscopy,
736271|NCT01101477|sedation,|sedation,
736272|NCT01101477|propofol|propofol
736368|NCT01107704|Family Members|family members
736273|NCT01101490|To compare the change of cerebral oxygen saturation and blood flow between right and left side in lateral decubitus position during nephrectomy|to compare the change of cerebral oxygen saturation and blood flow between right and left side in lateral decubitus position during nephrectomy
736274|NCT01101503|Newly diagnosed type 2 diabetes|newly diagnosed type 2 diabetes
736275|NCT01101503|Endothelial dysfunction|endothelial dysfunction
736276|NCT01101503|Intensive therapy|intensive therapy
736277|NCT01101503|Metabolic Memorial Effect|metabolic memorial effect
736278|NCT01101529|Chemotherapy-induced nausea and vomiting CINV|chemotherapy-induced nausea and vomiting cinv
736279|NCT01101542|Post-marketing surveillance|post-marketing surveillance
736280|NCT01101542|Human papillomavirus|human papillomavirus
736281|NCT01101542|Korea|korea
736282|NCT01101542|Safety|safety
736283|NCT01101542|Prescribing Information|prescribing information
736284|NCT01107106|Contraceptive Methods|contraceptive methods
736285|NCT01107106|Female Contraception|female contraception
736286|NCT01107119|Frail elderly|frail elderly
736287|NCT01107119|Chronic illness|chronic illness
736288|NCT01107119|Integrated care model|integrated care model
736289|NCT01107119|Clinical pathways|clinical pathways
736290|NCT01107119|Home care services|home care services
736291|NCT01107145|Plasmodium|plasmodium
736293|NCT01107145|Malaria|malaria
736294|NCT01107145|Pregnancy|pregnancy
736295|NCT01107145|Brazil|brazil
736296|NCT01107145|Treatment|treatment
736297|NCT01107171|Tang-min-ling pills;|tang-min-ling pills;
736298|NCT01107171|overweight type 2 diabetes mellitus;|overweight type 2 diabetes mellitus;
736299|NCT01107171|blood glucose|blood glucose
736300|NCT01107171|Traditional Chinese Medicine|traditional chinese medicine
736301|NCT01107171|Clinical Trial|clinical trial
736302|NCT01107171|Intervention Studies|intervention studies
736303|NCT01107184|Remote ischemic conditioning|remote ischemic conditioning
736304|NCT01107184|CABG surgery|cabg surgery
736305|NCT01107184|Atrial fibrillation|atrial fibrillation
736306|NCT01107184|Coronary Artery Bypass|coronary artery bypass
736307|NCT01107184|Ischemic Preconditioning|ischemic preconditioning
736308|NCT01107197|Pressure ulcers|pressure ulcers
736310|NCT01107197|Malnutrition|malnutrition
736311|NCT01107197|Nutritional support|nutritional support
736312|NCT01107197|Micronutrients|micronutrients
736313|NCT01107210|stroke|stroke
736314|NCT01107210|physical fitness|physical fitness
736315|NCT01107210|evolution|evolution
736316|NCT01107210|determinants|determinants
736317|NCT01107223|Antibiotic|antibiotic
736318|NCT01107223|Prescribing behaviour|prescribing behaviour
736319|NCT01107223|Guidelines|guidelines
736320|NCT01107223|Respiratory tract infections|respiratory tract infections
736321|NCT01107223|Non-antibiotic prescription|non-antibiotic prescription
736322|NCT01107236|Healthy subjects|healthy subjects
736323|NCT01107249|esophageal|esophageal
736324|NCT01107249|stenting|stenting
736325|NCT01107249|perforations|perforations
736326|NCT01107249|gastric|gastric
736327|NCT01107249|esophageal stenting|esophageal stenting
736328|NCT01107262|H5N1 Subtype|h5n1 subtype
736329|NCT01107262|Avian viruses|avian viruses
736330|NCT01107262|Highly pathogenic avian influenza (HPAI)|highly pathogenic avian influenza (hpai)
736331|NCT01107275|Rabies|rabies
736332|NCT01107275|PCECV|pcecv
736333|NCT01107275|pre-exposure immunization|pre-exposure immunization
736334|NCT01107275|intradermal|intradermal
736335|NCT01107275|children|children
736336|NCT01107288|Aged|aged
736337|NCT01107288|Balance|balance
736338|NCT01107288|Dual-task|dual-task
736339|NCT01107288|Exercise|exercise
736340|NCT01107288|Falls|falls
736341|NCT01107288|Gait|gait
736342|NCT01107288|Music|music
736343|NCT01107301|ADHD|adhd
736345|NCT01107366|lupiae techinque|lupiae techinque
736346|NCT01107366|aortic aneurism|aortic aneurism
736347|NCT01107366|aortic dissection|aortic dissection
736348|NCT01107626|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
736349|NCT01107626|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
736350|NCT01107626|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
736351|NCT01107626|adenocarcinoma of the lung|adenocarcinoma of the lung
736352|NCT01107626|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
736353|NCT01107626|large cell lung cancer|large cell lung cancer
736354|NCT01107639|stage IIB esophageal cancer|stage iib esophageal cancer
736355|NCT01107639|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
738191|NCT01116141|MTX|mtx
736356|NCT01107639|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
736357|NCT01107639|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
736358|NCT01107639|stage IIIA esophageal cancer|stage iiia esophageal cancer
736359|NCT01107639|stage IIIB esophageal cancer|stage iiib esophageal cancer
736360|NCT01107639|stage IIIC esophageal cancer|stage iiic esophageal cancer
736361|NCT01107665|pazopanib|pazopanib
736362|NCT01107665|paclitaxel|paclitaxel
736363|NCT01107665|melanoma|melanoma
736364|NCT01107678|YMCA; Preventative child obesity|ymca; preventative child obesity
736365|NCT01107691|resistance and weight loss training|resistance and weight loss training
736366|NCT01107704|Intensive Care Units|intensive care units
736369|NCT01107704|Physicians|physicians
736370|NCT01107704|Critically Ill|critically ill
736371|NCT01107704|Depression|depression
736372|NCT01107704|Anxiety|anxiety
736373|NCT01107704|Emotional|emotional
736374|NCT01107704|Support|support
736375|NCT01107704|Multi-faceted communication|multi-faceted communication
736376|NCT01107704|Grief|grief
736377|NCT01107704|Prognosis|prognosis
736378|NCT01107704|Family Support Counselor|family support counselor
736379|NCT01107717|type 2 diabetes|type 2 diabetes
736380|NCT01107717|new onset|new onset
736381|NCT01107717|combination therapy|combination therapy
736382|NCT01107717|new onset type 2 diabetes|new onset type 2 diabetes
736383|NCT01107730|Atrial fibrillation|atrial fibrillation
736384|NCT01107730|Cardiac valve repair|cardiac valve repair
736385|NCT01107730|Aneurysm repair|aneurysm repair
736386|NCT01107730|CABG|cabg
736387|NCT01107730|On-pump|on-pump
736388|NCT01107730|Cardiac surgery|cardiac surgery
736389|NCT01107730|Vitamin C|vitamin c
736390|NCT01107743|Hypertension|hypertension
736391|NCT01107743|Angina pectoris|angina pectoris
736392|NCT01107743|Hypercholesterolemia|hypercholesterolemia
736393|NCT01107743|Familial hypercholesterolemia|familial hypercholesterolemia
736394|NCT01107743|Japanese|japanese
736395|NCT01107743|caduet|caduet
736396|NCT01107743|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
736397|NCT01107782|sildenafil|sildenafil
736399|NCT01107808|Adolescents|adolescents
736400|NCT01107808|African American|african american
736401|NCT01107808|Female|female
736402|NCT01107821|Pressure sores grade III and IV|pressure sores grade iii and iv
736403|NCT01107821|Traumatic wounds with considerable soft tissue loss|traumatic wounds with considerable soft tissue loss
736404|NCT01107821|Wounds after necrotizing fasciitis|wounds after necrotizing fasciitis
736405|NCT01107821|Abdominal wounds|abdominal wounds
736406|NCT01107834|HIV|hiv
736407|NCT01107834|heart function|heart function
736408|NCT01107834|HAART|haart
736409|NCT01107834|in utero|in utero
736410|NCT01107834|children|children
736411|NCT01107847|electrical impedance tomography|electrical impedance tomography
736412|NCT01107847|EIT|eit
736413|NCT01107847|acute lung injury|acute lung injury
736414|NCT01107847|regional lung opening pressure|regional lung opening pressure
736415|NCT01107847|regional lung closing pressure|regional lung closing pressure
736416|NCT01107873|Twenty (ASA status I) unpremedicated children, ages 1 to 5 yr old|twenty (asa status i) unpremedicated children, ages 1 to 5 yr old
736417|NCT01107886|Risk of cardiovascular disease and death in patients with type 2 diabetes mellitus|risk of cardiovascular disease and death in patients with type 2 diabetes mellitus
736418|NCT01107899|Acute Coronary Syndromes|acute coronary syndromes
736419|NCT01107899|Angina|angina
736420|NCT01107899|Platelet Function|platelet function
736421|NCT01107899|Coronary Angiography|coronary angiography
736422|NCT01107899|Clinical Symptoms of Angina|clinical symptoms of angina
736423|NCT01107899|Positive Stress Test|positive stress test
736424|NCT01107912|Platelet function|platelet function
736425|NCT01107925|Platelet function|platelet function
736426|NCT01107938|GERD|gerd
736427|NCT01107951|Rituximab|rituximab
736428|NCT01107951|Dexamethasone|dexamethasone
736429|NCT01107951|Low-dose|low-dose
736430|NCT01107951|ITP|itp
736431|NCT01107964|Dry Eye Syndrome|dry eye syndrome
736432|NCT01107964|Recent Diagnosis of Dry Eye Syndrome|recent diagnosis of dry eye syndrome
736433|NCT01108029|Parkinson's disease|parkinson's disease
736434|NCT01108029|Freezing of Gait|freezing of gait
736435|NCT01108029|Memantine|memantine
736436|NCT01108029|NMDA receptor|nmda receptor
736437|NCT01108029|glutamate|glutamate
736438|NCT01108029|No Dementia|no dementia
736439|NCT01108068|Osteoporosis-pseudoglioma syndrome, OPPG, LRP5 mutation|osteoporosis-pseudoglioma syndrome, oppg, lrp5 mutation
736440|NCT01108081|Sleep apnea|sleep apnea
736441|NCT01108081|Sleep symptoms|sleep symptoms
736442|NCT01108081|Quality of Life|quality of life
736443|NCT01108107|Colon cancer|colon cancer
736444|NCT01108107|Neoadjuvant treatment|neoadjuvant treatment
736445|NCT01108107|KRAS mutation|kras mutation
736446|NCT01108107|BRAF mutation|braf mutation
736447|NCT01108107|PIK3CA mutation|pik3ca mutation
736448|NCT01108107|Possibly avoid chemotherapy after operation|possibly avoid chemotherapy after operation
736449|NCT01108120|diabetic foot ulcer|diabetic foot ulcer
736450|NCT01108120|artery mini-pump|artery mini-pump
736451|NCT01108120|continuous infusion of urokinase|continuous infusion of urokinase
736452|NCT01108120|femoral artery|femoral artery
736453|NCT01108133|Posttraumatic Stress Disorder|posttraumatic stress disorder
736454|NCT01108133|Traumatic Memories|traumatic memories
736455|NCT01108133|fMRI|fmri
736456|NCT01108185|treatment with Klacid®SR|treatment with klacid®sr
736457|NCT01108185|tracheitis|tracheitis
736458|NCT01108185|tracheobronchitis|tracheobronchitis
736459|NCT01108185|bronchitis|bronchitis
736460|NCT01108185|chronic bronchitis|chronic bronchitis
736461|NCT01108185|community-acquired pneumonia|community-acquired pneumonia
736462|NCT01108198|phimosis,|phimosis,
736463|NCT01108198|non-retractable foreskin|non-retractable foreskin
736464|NCT01108198|topical steroids|topical steroids
736465|NCT01108198|children|children
736466|NCT01108211|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
736467|NCT01108211|AIS|ais
736468|NCT01108211|Vibration Therapy|vibration therapy
736469|NCT01108211|Low bone mass|low bone mass
736470|NCT01108211|osteopenia|osteopenia
736471|NCT01108224|Quality of life|quality of life
736472|NCT01108224|Coping|coping
736473|NCT01108224|Social relations|social relations
736474|NCT01108224|Survival|survival
736475|NCT01108224|Psychotherapy|psychotherapy
736476|NCT01108237|Arthroplasties, Knee Replacement|arthroplasties, knee replacement
736477|NCT01108237|Arthroplasties, Replacement, Knee|arthroplasties, replacement, knee
736478|NCT01108237|Arthroplasty, Knee Replacement|arthroplasty, knee replacement
736479|NCT01108237|Knee Replacement Arthroplasties|knee replacement arthroplasties
736480|NCT01108237|Knee Replacement Arthroplasty|knee replacement arthroplasty
736481|NCT01108237|Knee Replacement, Total|knee replacement, total
736482|NCT01108237|Replacement Arthroplasties, Knee|replacement arthroplasties, knee
736483|NCT01108237|Replacement Arthroplasty, Knee|replacement arthroplasty, knee
736484|NCT01108237|Replacement, Total Knee|replacement, total knee
736485|NCT01108237|Total Knee Replacement|total knee replacement
736486|NCT01108289|hemorrhage|hemorrhage
736487|NCT01108289|uterotonic|uterotonic
736488|NCT01108289|oxytocin|oxytocin
736489|NCT01108289|blood loss|blood loss
736490|NCT01108289|community|community
736492|NCT01108289|randomized trial|randomized trial
736493|NCT01108302|uterotonic|uterotonic
736494|NCT01108302|oxytocin|oxytocin
736495|NCT01108302|randomized trial|randomized trial
736496|NCT01108302|India|india
736497|NCT01108302|community|community
736498|NCT01108302|hemorrhage|hemorrhage
736499|NCT01108315|Patient Reported Outcomes (PRO)|patient reported outcomes (pro)
736500|NCT01108315|Web-based|web-based
736501|NCT01108315|Phone-based|phone-based
736502|NCT01108315|Breast Cancer|breast cancer
736504|NCT01108328|fibre|fibre
736505|NCT01108328|polysaccharide|polysaccharide
736506|NCT01108328|blood glucose|blood glucose
736507|NCT01108328|postprandial|postprandial
736508|NCT01108328|appetite|appetite
736509|NCT01108328|hunger|hunger
736510|NCT01108328|satiety|satiety
736511|NCT01108380|Liver cirrhosis|liver cirrhosis
736512|NCT01108380|liver regeneration|liver regeneration
736513|NCT01108380|liver volume|liver volume
736514|NCT01108380|liver function|liver function
736515|NCT01108380|hepatocellular carcinoma, extensive|hepatocellular carcinoma, extensive
736516|NCT01108380|hepatectomy|hepatectomy
736517|NCT01108393|Obsessive Compulsive Disorder|obsessive compulsive disorder
736518|NCT01108393|Agomelatine|agomelatine
736519|NCT01108406|Hearing Loss|hearing loss
736520|NCT01108406|Unilateral Hearing Loss|unilateral hearing loss
736521|NCT01108406|Single Sided Deafness|single sided deafness
736522|NCT01108419|healthy adults|healthy adults
736523|NCT01108432|Tobacco cessation counseling|tobacco cessation counseling
736524|NCT01108445|cancer|cancer
736525|NCT01108445|kidney cancer|kidney cancer
736526|NCT01108445|sutent|sutent
736527|NCT01108445|everolimus|everolimus
736528|NCT01108445|renal cancer|renal cancer
736529|NCT01108445|papillary renal cell|papillary renal cell
736530|NCT01108445|chromophobe renal cell|chromophobe renal cell
736531|NCT01108445|papillary|papillary
736532|NCT01108445|chromophobe|chromophobe
736533|NCT01108471|cesarean section; hemoglobin; postpartum hemorrhage;|cesarean section; hemoglobin; postpartum hemorrhage;
736534|NCT01108484|Cancer survivors, exercise, diet, emotional support|cancer survivors, exercise, diet, emotional support
736535|NCT01108510|Treatment Naive|treatment naive
736536|NCT01108510|HIV 1 Infected|hiv 1 infected
737516|NCT01113398|AMG 102|amg 102
736537|NCT01108523|Moisture Associated Skin Damage|moisture associated skin damage
736538|NCT01108536|prosthetics|prosthetics
736539|NCT01108536|socket comfort|socket comfort
736540|NCT01108536|amputation stump|amputation stump
736541|NCT01108536|amputee rehabilitation|amputee rehabilitation
736542|NCT01108549|Fibromyalgia|fibromyalgia
736543|NCT01108549|Chronic Fatigue Syndrome|chronic fatigue syndrome
736544|NCT01108549|D-ribose|d-ribose
736545|NCT01108549|fatigue|fatigue
736546|NCT01108562|postoperative pain management|postoperative pain management
736547|NCT01108575|Mechanical ventilation|mechanical ventilation
736548|NCT01108575|mechanical ventilation weaning|mechanical ventilation weaning
753919|NCT01178294|haemophilia A|haemophilia a
736549|NCT01108575|inspiratory muscle strength training|inspiratory muscle strength training
736550|NCT01108575|Patients admitted to a surgical intensive care unit who are expected to receive mechanical ventilation for more than three days.|patients admitted to a surgical intensive care unit who are expected to receive mechanical ventilation for more than three days.
736551|NCT01108601|Ringer's|ringer's
736552|NCT01108601|lactate|lactate
736553|NCT01108601|cisplatin|cisplatin
736554|NCT01108601|ototoxicity|ototoxicity
736555|NCT01108601|hearing loss|hearing loss
736556|NCT01108614|Methadone maintenance treatment|methadone maintenance treatment
736557|NCT01108614|drug users|drug users
736558|NCT01108614|heroin|heroin
736559|NCT01108614|HIV|hiv
736560|NCT01108614|HCV|hcv
736561|NCT01108614|Syphilis|syphilis
736562|NCT01108614|HSV-2|hsv-2
736755|NCT01109394|Sarcoma|sarcoma
736563|NCT01108653|Cardiovascular diseases|cardiovascular diseases
736564|NCT01108653|Heart diseases|heart diseases
736565|NCT01108653|Myocardial infarction|myocardial infarction
736566|NCT01108653|Rehabilitation|rehabilitation
736567|NCT01108653|Health Economy|health economy
736568|NCT01108653|Randomized controlled trials|randomized controlled trials
736569|NCT01108653|Non ST Elevation Myocardial Infarction (NSTEMI)|non st elevation myocardial infarction (nstemi)
736570|NCT01108653|Cost analysis|cost analysis
736571|NCT01108653|Sick-leave|sick-leave
736572|NCT01108653|Quality of Life|quality of life
736573|NCT01108666|Adult subjects with a confirmed diagnosis of Stage IIIA or IIIB NSCLC, with adequate bone marrow, liver and renal function.|adult subjects with a confirmed diagnosis of stage iiia or iiib nsclc, with adequate bone marrow, liver and renal function.
736574|NCT01108692|atrial fibrillation|atrial fibrillation
736575|NCT01108692|supraventricular arrhythmia|supraventricular arrhythmia
736576|NCT01108692|antithrombotic treatment|antithrombotic treatment
736577|NCT01108692|antiarrhythmic drugs|antiarrhythmic drugs
736578|NCT01108692|medical reaction time|medical reaction time
736579|NCT01108692|telecardiology|telecardiology
736580|NCT01108692|early detection|early detection
736581|NCT01108692|holters memories|holters memories
736582|NCT01108692|Pacemaker|pacemaker
736583|NCT01108718|Mattress|mattress
736584|NCT01108718|Tempur-Pedic|tempur-pedic
736585|NCT01108718|Fibromyalgia|fibromyalgia
736586|NCT01108718|Sleep patterns|sleep patterns
736587|NCT01108744|clinical trial|clinical trial
736588|NCT01108744|mannitol|mannitol
736589|NCT01108744|intracranial pressure (ICP)|intracranial pressure (icp)
736590|NCT01108744|hypertonic saline|hypertonic saline
736591|NCT01108744|cerebral edema|cerebral edema
736592|NCT01108744|traumatic brain injury (TBI)|traumatic brain injury (tbi)
736593|NCT01108757|catheter|catheter
738955|NCT01118494|RAS|ras
736594|NCT01108757|urinary tract infection|urinary tract infection
736595|NCT01108770|HED|hed
736596|NCT01108770|XLHED|xlhed
736597|NCT01108770|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
736598|NCT01108783|Rhinitis|rhinitis
736599|NCT01108783|Allergic|allergic
736600|NCT01108783|Seasonal|seasonal
736601|NCT01108783|Hay Fever|hay fever
736602|NCT01108783|Pollen Allergy|pollen allergy
736603|NCT01108783|Pollinosis|pollinosis
736604|NCT01108783|Rhinoconjunctivitis|rhinoconjunctivitis
736605|NCT01108783|Sneezing|sneezing
736606|NCT01108783|Nasal itching|nasal itching
736607|NCT01108783|Nasal Congestion|nasal congestion
736608|NCT01108783|Rhinorrhea|rhinorrhea
736609|NCT01108783|Ocular itching|ocular itching
736610|NCT01108783|Ocular redness|ocular redness
736611|NCT01108783|Tearing|tearing
736612|NCT01108835|COPD|copd
736613|NCT01108835|Comprehensive care|comprehensive care
736614|NCT01108848|C1-esterase Inhibitor|c1-esterase inhibitor
736615|NCT01108848|Hereditary angioedema|hereditary angioedema
736616|NCT01108848|Acute HAE attack|acute hae attack
736617|NCT01108861|Peripheral Vascular Disease|peripheral vascular disease
736618|NCT01108861|In-stent restenosis|in-stent restenosis
736619|NCT01108861|Endoprosthesis|endoprosthesis
736620|NCT01108861|Plain old balloon angioplasty|plain old balloon angioplasty
736621|NCT01108874|Cesarean section|cesarean section
736622|NCT01108874|Hypotension|hypotension
736623|NCT01108874|Metaraminol|metaraminol
736624|NCT01108874|Vasoconstrictor Agents|vasoconstrictor agents
736625|NCT01108874|Adult|adult
736626|NCT01108874|Female|female
736627|NCT01108874|Pregnancy|pregnancy
736628|NCT01108874|Anesthesia, Obstetrical/adverse effects|anesthesia, obstetrical/adverse effects
736629|NCT01108874|Anesthesia,Spinal|anesthesia,spinal
736630|NCT01108874|Blood Pressure/drug effects|blood pressure/drug effects
736631|NCT01108874|Nausea|nausea
736632|NCT01108874|Vomiting|vomiting
736633|NCT01108887|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
736634|NCT01108887|RebiSmart|rebismart
736635|NCT01108887|Rebif|rebif
736636|NCT01108887|Interferon beta-1a|interferon beta-1a
736637|NCT01108900|Erectile Dysfunction udenafil sildenafil treatment satisfaction|erectile dysfunction udenafil sildenafil treatment satisfaction
736638|NCT01108913|COPD|copd
736639|NCT01108939|Malaria, Iron absorption, Iron utilization, Benin|malaria, iron absorption, iron utilization, benin
736640|NCT01108952|Chemotherapy|chemotherapy
736641|NCT01108952|Memory|memory
736642|NCT01108952|Methotrexate|methotrexate
736643|NCT01108952|Glucocorticoids|glucocorticoids
736644|NCT01108952|Trauma|trauma
736645|NCT01108952|pediatric oncology|pediatric oncology
736646|NCT01108952|traumatization|traumatization
736647|NCT01108965|Hydrocephalus|hydrocephalus
736648|NCT01108965|Shunt Dysfunction|shunt dysfunction
736649|NCT01108965|Shunt Flow|shunt flow
736650|NCT01108978|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
736651|NCT01108978|Cardiovascular Disease|cardiovascular disease
736652|NCT01108978|hypercholesterolemia|hypercholesterolemia
736653|NCT01108991|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
736654|NCT01108991|Randomized controlled trial|randomized controlled trial
736655|NCT01108991|Self-management support|self-management support
736656|NCT01108991|Physical activity|physical activity
736657|NCT01109004|Symptomatic Multiple Myeloma|symptomatic multiple myeloma
736658|NCT01109004|Lenalidomide|lenalidomide
736659|NCT01109004|Anti-Myeloma Agents|anti-myeloma agents
736660|NCT01109004|Hematologic Disorders|hematologic disorders
736661|NCT01109004|Maintenance Therapy|maintenance therapy
736662|NCT01109004|Progression|progression
736663|NCT01109004|Autologous Transplant|autologous transplant
736664|NCT01109004|RVD Consolidation|rvd consolidation
736665|NCT01109030|Major depressive disorder|major depressive disorder
736666|NCT01109030|pioglitazone|pioglitazone
736667|NCT01109030|double blind|double blind
736668|NCT01109030|placebo controlled|placebo controlled
736669|NCT01109043|Hypertension|hypertension
736670|NCT01109043|Bisoprolol|bisoprolol
736671|NCT01109043|Antihypertensive drugs|antihypertensive drugs
736672|NCT01109043|Blood pressure|blood pressure
736673|NCT01109043|Quality of life|quality of life
736674|NCT01109043|Diabetes|diabetes
736675|NCT01109043|Ketohexokinase|ketohexokinase
736676|NCT01109069|PCI-32765|pci-32765
736677|NCT01109069|Lymphoma, B-Cell|lymphoma, b-cell
736678|NCT01109069|Leukemia, Lymphoid|leukemia, lymphoid
736679|NCT01109069|Leukemia, B-Cell|leukemia, b-cell
736680|NCT01109069|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
736681|NCT01109082|Scoliosis|scoliosis
736683|NCT01109082|posture|posture
736684|NCT01109082|balance|balance
736685|NCT01109095|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
736686|NCT01109095|HER2|her2
736687|NCT01109095|CMV|cmv
736688|NCT01109095|Brain Cancer|brain cancer
736689|NCT01109095|Autologous HER2.CAR CMV-specific cytotoxic CTL|autologous her2.car cmv-specific cytotoxic ctl
736690|NCT01109095|CMV-specific cytotoxic CTL|cmv-specific cytotoxic ctl
736691|NCT01109108|pneumococcal vaccine|pneumococcal vaccine
736692|NCT01109108|nasopharyngeal carriage|nasopharyngeal carriage
736693|NCT01109121|Moderate to severe gout|moderate to severe gout
736694|NCT01109121|Hyperuricemia|hyperuricemia
736695|NCT01109134|primary angioplasty|primary angioplasty
736696|NCT01109134|tirofiban|tirofiban
736697|NCT01109134|microcirculation|microcirculation
736698|NCT01109147|Schizophrenic Disorders|schizophrenic disorders
736699|NCT01109147|Schizophrenia|schizophrenia
736700|NCT01109147|Affect|affect
736701|NCT01109147|Emotional Blunting|emotional blunting
736702|NCT01109160|azithromycin|azithromycin
736703|NCT01109160|lymphocytic bronchitis or bronchiolitis|lymphocytic bronchitis or bronchiolitis
736704|NCT01109160|lung transplantation|lung transplantation
736705|NCT01109160|acute allograft rejection|acute allograft rejection
736706|NCT01109160|chronic allograft rejection|chronic allograft rejection
736707|NCT01109160|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
736708|NCT01109186|patient with a kidney transplantation since less than 30 days|patient with a kidney transplantation since less than 30 days
736709|NCT01109199|viscous|viscous
736710|NCT01109199|fibre|fibre
736711|NCT01109199|polysaccharide|polysaccharide
736712|NCT01109199|appetite|appetite
736713|NCT01109199|hunger|hunger
736714|NCT01109199|satiety|satiety
736715|NCT01109199|weight management|weight management
736716|NCT01109212|Type 2-Diabetic Nephrophaty|type 2-diabetic nephrophaty
736717|NCT01109212|bindarit|bindarit
736718|NCT01109212|albuminuria|albuminuria
736719|NCT01109212|MCP-1|mcp-1
736720|NCT01109225|aldosterone|aldosterone
736721|NCT01109225|myocardial infarction|myocardial infarction
736722|NCT01109225|cardiac remodeling|cardiac remodeling
736723|NCT01109238|Refractory Neuroblastoma|refractory neuroblastoma
736724|NCT01109238|Relapsed Neuroblastoma|relapsed neuroblastoma
736725|NCT01109264|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
736726|NCT01109264|Bendamustine Hydrochloride|bendamustine hydrochloride
736727|NCT01109264|Chlorambucil|chlorambucil
736728|NCT01109303|ankle fracture with syndesmotic ligament rupture|ankle fracture with syndesmotic ligament rupture
736729|NCT01109303|ankle syndesmosis rupture|ankle syndesmosis rupture
736730|NCT01109329|Vaccine|vaccine
736731|NCT01109342|HIV Prevention|hiv prevention
736732|NCT01109342|Vaccine|vaccine
736733|NCT01109342|Recombinant Adenovirus-5|recombinant adenovirus-5
736734|NCT01109342|HIV Preventative Vaccine|hiv preventative vaccine
736735|NCT01109355|PEEP|peep
736736|NCT01109355|Patients with hemorrhage stroke under mechanical ventilation|patients with hemorrhage stroke under mechanical ventilation
736737|NCT01109368|Autosomal Dominant Familial Hypercholesterolemia|autosomal dominant familial hypercholesterolemia
736738|NCT01109381|bacterial infections|bacterial infections
736739|NCT01109381|anti-infective agents|anti-infective agents
736740|NCT01109381|gastrointestinal agents|gastrointestinal agents
736741|NCT01109381|antibacterial agents|antibacterial agents
736742|NCT01109381|omeprazole|omeprazole
736743|NCT01109381|lauric acid|lauric acid
736744|NCT01109381|n-acetylcysteine|n-acetylcysteine
736745|NCT01109381|helicobacter infections|helicobacter infections
736746|NCT01109381|helicobacter pylori|helicobacter pylori
736747|NCT01109381|non-antibiotic treatment|non-antibiotic treatment
736748|NCT01109394|Genomics|genomics
736749|NCT01109394|Proteomics|proteomics
736750|NCT01109394|Tissue Repository|tissue repository
736751|NCT01109394|Omics|omics
736752|NCT01109394|Cell Lines|cell lines
736753|NCT01109394|Pediatric Cancer|pediatric cancer
736754|NCT01109394|Solid Tumor|solid tumor
736756|NCT01109394|Kidney Cancer|kidney cancer
736757|NCT01109394|Neuroblastoma|neuroblastoma
736758|NCT01109407|Plasma Cell Neoplasm|plasma cell neoplasm
736759|NCT01109407|Natural History|natural history
736760|NCT01109407|Translational Studies|translational studies
736761|NCT01109407|Gene Expression Profiling|gene expression profiling
736762|NCT01109407|Protein Markers|protein markers
736763|NCT01109407|Smoldering Myeloma|smoldering myeloma
736764|NCT01109407|SMM|smm
736765|NCT01109407|Monoclonal Gammopathy of Undetermined Significance|monoclonal gammopathy of undetermined significance
736766|NCT01109407|MGUS|mgus
736767|NCT01109420|Hereditary Cancer|hereditary cancer
736768|NCT01109420|Susceptibility Gene(s) for Thyroid Cancer|susceptibility gene(s) for thyroid cancer
736769|NCT01109420|Screening at Risk Family Members|screening at risk family members
736770|NCT01109420|Inherited Thyroid Cancer|inherited thyroid cancer
736771|NCT01109420|Thyroid Cancer|thyroid cancer
736772|NCT01109433|Behcet's Disease|behcet's disease
736773|NCT01109433|Intermediate Uveitis|intermediate uveitis
736774|NCT01109433|Uveitis|uveitis
736775|NCT01109433|Immunogenetics|immunogenetics
736776|NCT01109446|Lateral Epicondylitis|lateral epicondylitis
736777|NCT01109446|Tennis Elbow|tennis elbow
736778|NCT01109446|Epicondylitis Lateralis|epicondylitis lateralis
736779|NCT01109459|preschool|preschool
736780|NCT01109459|screening|screening
736781|NCT01109459|cluster randomized|cluster randomized
736782|NCT01109459|physician practice patterns|physician practice patterns
736783|NCT01109459|behavior|behavior
736784|NCT01109459|knowledge|knowledge
736785|NCT01109459|attitudes|attitudes
736786|NCT01109459|guideline adherence|guideline adherence
736787|NCT01109485|Allergic conjunctivitis|allergic conjunctivitis
736789|NCT01109498|Lipoprotein Lipase Deficiency|lipoprotein lipase deficiency
736790|NCT01109498|Chylomicronaemia|chylomicronaemia
736791|NCT01109498|Genetherapy|genetherapy
736792|NCT01109498|AAV|aav
736793|NCT01109498|Alipogene Tiparvovec|alipogene tiparvovec
736794|NCT01109498|AMT-011|amt-011
736795|NCT01109498|Lipoprotein Lipase|lipoprotein lipase
736796|NCT01109537|Restless Legs Syndrome (RLS)|restless legs syndrome (rls)
736797|NCT01109537|GABA|gaba
736798|NCT01109537|Glutamate|glutamate
736799|NCT01109537|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
736800|NCT01109563|cannabis use disorder|cannabis use disorder
736801|NCT01109563|marijuana|marijuana
736802|NCT01109563|motivational enhancement treatment|motivational enhancement treatment
736803|NCT01109563|cognitive behavioral treatment|cognitive behavioral treatment
736804|NCT01109563|continuing care|continuing care
736805|NCT01109576|deafness-blindness|deafness-blindness
736806|NCT01109576|pilot study|pilot study
736807|NCT01109576|self management education|self management education
736808|NCT01109576|dual sensory loss|dual sensory loss
736809|NCT01109576|rehabilitation|rehabilitation
736810|NCT01109576|peer support groups|peer support groups
736811|NCT01109576|age related|age related
736812|NCT01109589|antibiotics|antibiotics
736813|NCT01109589|prescriptions|prescriptions
736814|NCT01109589|pregnancy|pregnancy
736815|NCT01109589|children|children
736816|NCT01109602|Stroke|stroke
736817|NCT01109602|accidental falls|accidental falls
736818|NCT01109602|Yoga|yoga
736819|NCT01109602|Blood pressure|blood pressure
736820|NCT01109602|Range of Motion|range of motion
736821|NCT01109602|Rehabilitation|rehabilitation
736822|NCT01109602|Exercise|exercise
736823|NCT01109602|balance|balance
736824|NCT01109602|quality of life|quality of life
736825|NCT01109602|mobility|mobility
736826|NCT01109615|Colorectal cancer|colorectal cancer
736827|NCT01109615|Metastatic colorectal cancer|metastatic colorectal cancer
736828|NCT01109615|Treatment resistant|treatment resistant
736829|NCT01109615|Chemotherapy refractory|chemotherapy refractory
736830|NCT01109615|KRAS mutation|kras mutation
736831|NCT01109628|sarcopenia|sarcopenia
736832|NCT01109628|frail elderly|frail elderly
736833|NCT01109628|protein drink|protein drink
736834|NCT01109628|skeletal muscle mass|skeletal muscle mass
736835|NCT01109628|muscle mass in elderly|muscle mass in elderly
736836|NCT01109654|Fertilization in Vitro|fertilization in vitro
736837|NCT01109654|Reproductive Techniques, Assisted|reproductive techniques, assisted
736838|NCT01109654|Follicle Stimulating Hormone|follicle stimulating hormone
736839|NCT01109654|Cetrotide|cetrotide
736840|NCT01109654|Gonal-f|gonal-f
736841|NCT01109667|Thromboplastin, Prothrombin, Diagnostic Reagent Kits, International Normalized Ratio, Laboratory Tests.|thromboplastin, prothrombin, diagnostic reagent kits, international normalized ratio, laboratory tests.
736842|NCT01109706|Acute coronary syndrome|acute coronary syndrome
736843|NCT01109706|PCSK9|pcsk9
736844|NCT01109706|cardiovascular safety|cardiovascular safety
736845|NCT01109719|Protocol|protocol
736846|NCT01109719|Critical pathway|critical pathway
736847|NCT01109719|Intensive care units|intensive care units
736848|NCT01109745|Asthma|asthma
736849|NCT01109745|health-related quality of life|health-related quality of life
736850|NCT01109745|patient-centred care|patient-centred care
736851|NCT01109758|Fenofibrate|fenofibrate
736852|NCT01109758|Gene Expression|gene expression
736853|NCT01109758|DNA methylation|dna methylation
736854|NCT01109771|Ventral hernia|ventral hernia
736855|NCT01109784|coronary angioplasty|coronary angioplasty
736856|NCT01109784|clopidogrel resistance|clopidogrel resistance
736857|NCT01109784|prasugrel|prasugrel
736858|NCT01109823|Patients hospitalized at Intensive Care Unit treated with levofloxacin IV|patients hospitalized at intensive care unit treated with levofloxacin iv
736859|NCT01109836|prevention|prevention
736860|NCT01109836|cognitive decline|cognitive decline
736861|NCT01109836|post-stroke dementia|post-stroke dementia
736862|NCT01109836|life-style intervention|life-style intervention
736863|NCT01109836|vascular risk factors|vascular risk factors
736864|NCT01109836|polyintervention|polyintervention
736865|NCT01109836|multifactorial treatment|multifactorial treatment
736866|NCT01109849|ADHD|adhd
736867|NCT01109849|growth|growth
736868|NCT01109849|BMI|bmi
736869|NCT01109849|stimulant medication|stimulant medication
736870|NCT01109862|Femoral neck fractures|femoral neck fractures
736871|NCT01109862|Hip fractures|hip fractures
736872|NCT01109862|Elderly|elderly
736873|NCT01109862|Total hip arthroplasty|total hip arthroplasty
736874|NCT01109862|Bipolar hemiarthroplasty|bipolar hemiarthroplasty
736875|NCT01109901|Cubital tunnel,subcutaneous transposition,submuscular|cubital tunnel,subcutaneous transposition,submuscular
736876|NCT01109914|Renal transplantation|renal transplantation
736877|NCT01109914|Immunosuppression|immunosuppression
736878|NCT01109914|ETEC|etec
736879|NCT01109914|Dukoral|dukoral
736880|NCT01109914|Vaccination|vaccination
736881|NCT01109914|Immunity, Humoral|immunity, humoral
736882|NCT01109940|Ankylosing spondylitis|ankylosing spondylitis
736883|NCT01109940|IgG1K monoclonal antibody|igg1k monoclonal antibody
736884|NCT01109940|Interleukin -17A neutralizing|interleukin -17a neutralizing
736886|NCT01109953|PET/CT scan|pet/ct scan
736887|NCT01109953|10-054|10-054
736888|NCT01109966|Allergy|allergy
736889|NCT01109966|Cow's Milk|cow's milk
736890|NCT01109966|Infants|infants
736891|NCT01109966|Food Allergy|food allergy
736892|NCT01109979|Cardiovascular, vascular|cardiovascular, vascular
736893|NCT01109992|coronary artery disease|coronary artery disease
736894|NCT01109992|exercise|exercise
736895|NCT01109992|regadenoson|regadenoson
736896|NCT01109992|positron emission tomography|positron emission tomography
736897|NCT01110005|D5LR|d5lr
736898|NCT01110005|glucose containing IV solution|glucose containing iv solution
736899|NCT01110005|LR|lr
736900|NCT01110005|non glucose IV solution|non glucose iv solution
736901|NCT01110018|Tolerability|tolerability
736902|NCT01110018|COPD|copd
736903|NCT01110018|Safety|safety
736904|NCT01110018|Muscarinic receptor (mAChR) antagonist|muscarinic receptor (machr) antagonist
736905|NCT01110018|GSK573719|gsk573719
736906|NCT01110018|Healthy subjects|healthy subjects
736907|NCT01110018|Pharmacokinetics|pharmacokinetics
736908|NCT01110018|IV study|iv study
736909|NCT01110031|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
736910|NCT01110031|Cardiac Repolarization (QTc)|cardiac repolarization (qtc)
736911|NCT01110044|Neonatal vaccination|neonatal vaccination
736912|NCT01110057|p38 kinase inhibitor|p38 kinase inhibitor
736913|NCT01110057|male and female|male and female
736914|NCT01110057|patients|patients
736915|NCT01110070|articular|articular
736916|NCT01110070|cartilage|cartilage
736917|NCT01110070|microfracture|microfracture
736918|NCT01110070|knee pain|knee pain
736919|NCT01110070|cartilage repair|cartilage repair
736920|NCT01110070|Subjects with an articular cartilage defect in the knee.|subjects with an articular cartilage defect in the knee.
736921|NCT01110083|Phase 1|phase 1
736922|NCT01110083|advanced solid tumors|advanced solid tumors
737517|NCT01113398|rilotumumab|rilotumumab
736923|NCT01110083|refractory to standard therapy|refractory to standard therapy
736924|NCT01110083|Patients with solid tumors, either refractory to standard therapy or for which no effective standard therapy is available|patients with solid tumors, either refractory to standard therapy or for which no effective standard therapy is available
736925|NCT01110096|Obesity|obesity
736926|NCT01110096|Child|child
736927|NCT01110096|Parent|parent
736928|NCT01110096|Family|family
736929|NCT01104363|Dental implants|dental implants
736930|NCT01104376|Cytochrome P450|cytochrome p450
736931|NCT01104376|CYP2B6|cyp2b6
736932|NCT01104376|Voriconazole|voriconazole
736933|NCT01104376|Efavirenz|efavirenz
736934|NCT01104376|Pharmacokinetics|pharmacokinetics
736935|NCT01104376|Drug-Interactions|drug-interactions
736936|NCT01104376|Pharmacogenetics|pharmacogenetics
736937|NCT01104376|Healthy volunteers|healthy volunteers
736938|NCT01104402|telemedicine|telemedicine
736939|NCT01104402|spirometer|spirometer
736940|NCT01104402|CF|cf
736941|NCT01104402|pulmonary|pulmonary
736942|NCT01104402|home monitoring|home monitoring
736943|NCT01104415|Carcinoid syndrome|carcinoid syndrome
736944|NCT01104428|Hench-schonlein purpura|hench-schonlein purpura
736945|NCT01104428|Renal damage|renal damage
736946|NCT01104428|Relapse|relapse
736947|NCT01104428|End event|end event
736948|NCT01104428|TCM syndrome|tcm syndrome
736949|NCT01104441|critical limb ischaemia|critical limb ischaemia
736950|NCT01104441|Aspirin resistance|aspirin resistance
737547|NCT01113528|IL-10|il-10
736951|NCT01104454|healthy pregnant women|healthy pregnant women
736952|NCT01104467|Acute Ischemic Stroke|acute ischemic stroke
736953|NCT01104467|Desmoteplase|desmoteplase
736954|NCT01104467|Japan|japan
736955|NCT01104467|Safety|safety
736956|NCT01104467|Stroke|stroke
736957|NCT01104467|Tolerability|tolerability
736958|NCT01104480|Relapsing Polychondritis|relapsing polychondritis
736959|NCT01104480|Unremitting|unremitting
736960|NCT01104480|Inflammation|inflammation
736961|NCT01104480|IL6|il6
736962|NCT01104532|ASP1941|asp1941
736963|NCT01104532|Januvia|januvia
736964|NCT01104532|sitagliptin|sitagliptin
736965|NCT01104558|Bisoprolol|bisoprolol
736966|NCT01104558|Chronic Heart failure|chronic heart failure
736967|NCT01104571|HER2-positive breast cancer|her2-positive breast cancer
736968|NCT01104571|stage IA breast cancer|stage ia breast cancer
736969|NCT01104571|stage IB breast cancer|stage ib breast cancer
736970|NCT01104571|stage II breast cancer|stage ii breast cancer
736971|NCT01104571|stage IIIA breast cancer|stage iiia breast cancer
736972|NCT01104571|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
736973|NCT01104571|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
736974|NCT01104584|Breast Cancer|breast cancer
736975|NCT01104584|Gadobutrol-enhanced MRI|gadobutrol-enhanced mri
736976|NCT01104584|Mammography|mammography
736977|NCT01104584|Diagnostic Imaging|diagnostic imaging
736978|NCT01104597|Healthy Asian Indians and Caucasians|healthy asian indians and caucasians
736979|NCT01110109|Adult|adult
736980|NCT01110109|Surgery|surgery
739365|NCT01119924|Smilon|smilon
736981|NCT01110109|Endotracheal Tube|endotracheal tube
736982|NCT01110109|Ventilator|ventilator
736983|NCT01110109|Pneumonia|pneumonia
736984|NCT01110109|Suctioning|suctioning
736985|NCT01110122|Muscle recovery|muscle recovery
736986|NCT01110122|Intermittent exercise|intermittent exercise
736987|NCT01110122|Whey protein|whey protein
736988|NCT01110122|Soccer|soccer
736989|NCT01110148|skin biopsy|skin biopsy
736990|NCT01110148|informed consent|informed consent
736991|NCT01110148|patient education|patient education
736992|NCT01110148|video education|video education
736993|NCT01110148|patients requiring skin biopsies|patients requiring skin biopsies
736994|NCT01110161|Abdominal Fat|abdominal fat
736995|NCT01110161|Visceral Fat|visceral fat
736996|NCT01110161|Subcutaneous Fat|subcutaneous fat
736997|NCT01110161|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
736998|NCT01110161|DXA|dxa
736999|NCT01110161|Computed Tomography|computed tomography
737000|NCT01110161|CT|ct
737001|NCT01110161|Body Mass Index|body mass index
737002|NCT01110161|Body composition|body composition
737003|NCT01110161|Percent fat|percent fat
737004|NCT01110161|Waist circumference|waist circumference
737005|NCT01110161|Hip circumference|hip circumference
737006|NCT01110187|Lacosamide|lacosamide
737007|NCT01110187|Fosphenytoin|fosphenytoin
737008|NCT01110187|traumatic brain injury|traumatic brain injury
737009|NCT01110187|Glasgow coma scale|glasgow coma scale
737010|NCT01110187|Disability Rating Scale|disability rating scale
737011|NCT01110187|Resource Utilization Questionnaire|resource utilization questionnaire
737012|NCT01110187|Continuous EEG|continuous eeg
737013|NCT01110187|seizures|seizures
737014|NCT01110200|Hospitalization|hospitalization
737015|NCT01110200|Exacerbations of COPD|exacerbations of copd
737016|NCT01110200|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
737017|NCT01110213|Aging|aging
737018|NCT01110213|physical activity|physical activity
737019|NCT01110213|diet|diet
737020|NCT01110213|goal setting|goal setting
737021|NCT01110226|non small cell lung cancer|non small cell lung cancer
737518|NCT01113398|recurrent|recurrent
737022|NCT01110226|small cell lung cancer|small cell lung cancer
737023|NCT01110226|Platinum Responsive|platinum responsive
737024|NCT01110226|solid tumor malignancies|solid tumor malignancies
737025|NCT01110239|limb preconditioning|limb preconditioning
737026|NCT01110239|remote preconditioning|remote preconditioning
737027|NCT01110239|ischemic preconditioning|ischemic preconditioning
737028|NCT01110252|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
738726|NCT01111136|Hives|hives
737029|NCT01110252|Emphysema|emphysema
737030|NCT01110252|Cell therapy|cell therapy
737031|NCT01110252|Bone marrow mononuclear cells|bone marrow mononuclear cells
737032|NCT01110252|stem cells|stem cells
737033|NCT01110278|Urge Urinary Incontinence|urge urinary incontinence
737034|NCT01110278|Magnetic Resonance Imaging|magnetic resonance imaging
737035|NCT01110278|Diffusion Tensor Imaging|diffusion tensor imaging
737036|NCT01110278|Brain Connectivity|brain connectivity
737037|NCT01110278|Bladder Control|bladder control
737038|NCT01110278|fMRI|fmri
737039|NCT01110291|docetaxel toxicity|docetaxel toxicity
737040|NCT01110291|CYP3A activity|cyp3a activity
737041|NCT01110291|CYP3A5|cyp3a5
737042|NCT01110291|MDR1|mdr1
737043|NCT01110291|peroral midazolam|peroral midazolam
737044|NCT01110304|acromio-clavicular joint dislocation|acromio-clavicular joint dislocation
737045|NCT01110304|type III acromio-clavicular joint dislocation|type iii acromio-clavicular joint dislocation
737046|NCT01110304|joint dislocation|joint dislocation
737047|NCT01110304|clavicle hook plate|clavicle hook plate
737048|NCT01110317|Paliperidone palmitate|paliperidone palmitate
737049|NCT01110317|R092670PSY1001|r092670psy1001
737050|NCT01110317|Pharmacokinetics|pharmacokinetics
737051|NCT01110317|Risperdal (CONSTA)|risperdal (consta)
737052|NCT01110317|Risperidone, Paliperidone|risperidone, paliperidone
737053|NCT01110330|Tinea Pedis|tinea pedis
737054|NCT01110330|Ketoconazole (NIZORAL)|ketoconazole (nizoral)
737055|NCT01110330|Antifungal Agents|antifungal agents
737056|NCT01110330|Miconazole (DAKTARIN)|miconazole (daktarin)
737057|NCT01110343|parent stress|parent stress
737058|NCT01110343|parent coping|parent coping
737059|NCT01110343|parent anxiety|parent anxiety
737060|NCT01110343|parent health|parent health
737061|NCT01110343|parent depression|parent depression
737062|NCT01110369|sarcopenia|sarcopenia
737063|NCT01110369|frail elderly|frail elderly
737064|NCT01110369|protein drink|protein drink
737065|NCT01110369|resistance exercise|resistance exercise
737066|NCT01110369|Skeletal muscle mass|skeletal muscle mass
737067|NCT01110369|muscle mass in elderly|muscle mass in elderly
737068|NCT01110382|Anti-Infective Agents|anti-infective agents
737069|NCT01110382|Doripenem|doripenem
737070|NCT01110382|Meropenem|meropenem
737071|NCT01110382|Child, Hospitalized|child, hospitalized
737072|NCT01110382|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
737073|NCT01110408|Antibiotic|antibiotic
737074|NCT01110408|Child, Hospitalized|child, hospitalized
737075|NCT01110408|Complicated Urinary Tract Infection|complicated urinary tract infection
737076|NCT01110408|Pyelonephritis|pyelonephritis
737077|NCT01110408|Doripenem|doripenem
737078|NCT01110408|Cefepime|cefepime
737079|NCT01110421|Doripenem|doripenem
737080|NCT01110421|Child, Hospitalized|child, hospitalized
737081|NCT01110421|Cefepime|cefepime
737082|NCT01110421|Infusions, Intravenous|infusions, intravenous
737083|NCT01110421|Severe community acquired pneumonia|severe community acquired pneumonia
737084|NCT01110421|Nosocomial pneumonia|nosocomial pneumonia
737085|NCT01110421|Ventilator associated pneumonia|ventilator associated pneumonia
737086|NCT01111630|chronic renal failure|chronic renal failure
737088|NCT01111656|Multi-center|multi-center
737089|NCT01111656|randomized|randomized
737090|NCT01111656|prospective|prospective
737091|NCT01111656|parallel-group|parallel-group
737092|NCT01111656|rater-blinded|rater-blinded
737093|NCT01111656|RR-MS|rr-ms
737094|NCT01111669|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
737095|NCT01111669|Tranexamic Acid|tranexamic acid
737096|NCT01111682|traumatic brain injury|traumatic brain injury
737097|NCT01111682|hypertonic saline therapy|hypertonic saline therapy
737098|NCT01111682|intracranial pressure|intracranial pressure
737099|NCT01111695|wound healing|wound healing
737100|NCT01111695|granulation tissue|granulation tissue
737101|NCT01111695|Varicose Ulcer|varicose ulcer
737102|NCT01111721|Sexually Transmitted Diseases|sexually transmitted diseases
737103|NCT01111721|HIV Infections|hiv infections
737104|NCT01111721|Genital Diseases, Female|genital diseases, female
737105|NCT01111721|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
737106|NCT01111721|Risk Reduction Behavior|risk reduction behavior
737107|NCT01111721|HIV prevention|hiv prevention
737108|NCT01111734|self harm|self harm
737109|NCT01111734|self injury|self injury
737110|NCT01111734|self mutilation|self mutilation
737111|NCT01111734|N-Acetylcysteine|n-acetylcysteine
737112|NCT01111734|adolescents|adolescents
737113|NCT01111734|impulse control disorder|impulse control disorder
737114|NCT01111734|borderline personality disorder|borderline personality disorder
737115|NCT01111734|fMRI|fmri
737116|NCT01111747|platelet-rich plasma|platelet-rich plasma
737519|NCT01113398|Duke|duke
737117|NCT01111747|patellar ligament|patellar ligament
737118|NCT01111747|regeneration|regeneration
737119|NCT01111747|growth substances|growth substances
737120|NCT01111760|cardiovascular disease|cardiovascular disease
737121|NCT01111760|heart CT scan|heart ct scan
737122|NCT01111760|CT scan|ct scan
737123|NCT01111760|pulmonary embolisms|pulmonary embolisms
737124|NCT01111760|aortography|aortography
737125|NCT01111773|Patellar tendonitis|patellar tendonitis
737126|NCT01111786|scleroderma|scleroderma
737127|NCT01111786|skin|skin
737128|NCT01111786|tightness|tightness
737129|NCT01111786|durometer|durometer
737130|NCT01111799|endometrial biopsy|endometrial biopsy
737131|NCT01111799|implantation|implantation
737132|NCT01111799|uterine receptivity|uterine receptivity
737133|NCT01111799|infertility|infertility
737134|NCT01111799|controled ovarian hyperstimulation|controled ovarian hyperstimulation
737135|NCT01111799|intra uterine insemination|intra uterine insemination
737136|NCT01111812|overweight|overweight
737137|NCT01111812|obese|obese
737138|NCT01111812|children|children
737139|NCT01111812|weighing|weighing
737140|NCT01111812|weight|weight
737141|NCT01111825|HKI-272 (NERATINIB)|hki-272 (neratinib)
737142|NCT01111825|TEMSIROLIMUS (CCI-779)|temsirolimus (cci-779)
737143|NCT01111825|HER2-Amplified|her2-amplified
737144|NCT01111825|Triple-negative|triple-negative
737949|NCT01114958|Stage III|stage iii
737145|NCT01111825|invasive adenocarcinoma|invasive adenocarcinoma
737146|NCT01111825|10-005|10-005
737147|NCT01111838|STA-9090|sta-9090
737148|NCT01111838|colon|colon
737149|NCT01111838|rectal|rectal
737150|NCT01111838|10-029|10-029
737151|NCT01111851|NK1-receptor occupancy|nk1-receptor occupancy
737152|NCT01111877|ear tubes|ear tubes
737153|NCT01111877|ear drainage|ear drainage
737154|NCT01111877|ear infection|ear infection
737155|NCT01111877|ear drops|ear drops
737156|NCT01111877|tympanostomy tubes|tympanostomy tubes
737157|NCT01111877|Pediatric patients|pediatric patients
737158|NCT01111929|Emergency contraception|emergency contraception
737159|NCT01111929|pregnancy during breastfeeding|pregnancy during breastfeeding
737160|NCT01111929|Lactational amenorrhea Method|lactational amenorrhea method
737161|NCT01111929|unplanned pregnancy|unplanned pregnancy
737162|NCT01111942|head and neck cancer|head and neck cancer
737163|NCT01111942|chemotherapy|chemotherapy
737164|NCT01111942|radiation|radiation
737165|NCT01111968|vaccine|vaccine
737658|NCT01114009|ARDS|ards
737169|NCT01111981|alopecia|alopecia
737170|NCT01111981|CCCA - Central Centrifugal Cicatricial Alopecia|ccca - central centrifugal cicatricial alopecia
737171|NCT01111994|hyperpigmentation|hyperpigmentation
737172|NCT01112007|Insulin Resistance|insulin resistance
737173|NCT01112007|Hypertension|hypertension
737174|NCT01112007|Blood pressure|blood pressure
737175|NCT01112007|Aldosterone|aldosterone
737176|NCT01112007|Renin|renin
737177|NCT01112020|Chlorhexidine digluconate (CHG)|chlorhexidine digluconate (chg)
737178|NCT01112020|Biopatch Protective Disk|biopatch protective disk
737179|NCT01112020|Tegaderm CHG IV (intravenous) Securement Dressing|tegaderm chg iv (intravenous) securement dressing
737180|NCT01112020|parachloroaniline (PCA)|parachloroaniline (pca)
737181|NCT01112020|No condition being studied.|no condition being studied.
737182|NCT01112020|Assessing components of CHG-containing dressings after use.|assessing components of chg-containing dressings after use.
737183|NCT01112033|biliverdin reductase|biliverdin reductase
737184|NCT01112033|BLVRA|blvra
737185|NCT01112033|hepatitis C|hepatitis c
737186|NCT01112033|HCV|hcv
737187|NCT01112033|peripheral blood mononuclear cells|peripheral blood mononuclear cells
737188|NCT01112033|PBMC|pbmc
737189|NCT01112033|liver|liver
737190|NCT01112033|genetic polymorphisms|genetic polymorphisms
737191|NCT01112046|Early colorectal neoplasms|early colorectal neoplasms
737192|NCT01112059|cystic fibrosis|cystic fibrosis
737193|NCT01112072|keratoconus|keratoconus
737194|NCT01112072|corneal ectasia|corneal ectasia
737195|NCT01112072|collagen crosslinking|collagen crosslinking
737196|NCT01112072|riboflavin|riboflavin
737197|NCT01112072|cornea|cornea
737198|NCT01112072|ultraviolet|ultraviolet
737199|NCT01112085|Diabetic macular edema|diabetic macular edema
737200|NCT01112085|Ranibizumab|ranibizumab
737201|NCT01112124|Typical|typical
737202|NCT01112124|Development|development
737203|NCT01112124|Microwave|microwave
737204|NCT01112124|Children|children
737205|NCT01112124|Behavior|behavior
737206|NCT01112150|Edema|edema
737207|NCT01112150|Heart failure|heart failure
737208|NCT01112150|Pulmonary hypertension|pulmonary hypertension
737209|NCT01112150|Edema in legs|edema in legs
737210|NCT01112163|ischemic heart disease|ischemic heart disease
737211|NCT01112176|Strain|strain
737212|NCT01112176|Ejection fraction|ejection fraction
737213|NCT01112176|Diastolic function|diastolic function
737214|NCT01112189|Lymphedema|lymphedema
737215|NCT01112189|Stem cells|stem cells
737216|NCT01112189|Mastectomy|mastectomy
737217|NCT01112189|Breast Cancer|breast cancer
737218|NCT01112202|direct thrombin inhibitors|direct thrombin inhibitors
737219|NCT01112202|Dabigatran|dabigatran
737220|NCT01112202|Coagulation parameters|coagulation parameters
737520|NCT01113398|Pro00022491|pro00022491
737222|NCT01112215|non-renal manifestations|non-renal manifestations
737223|NCT01112241|Obliterative bronchiolitis|obliterative bronchiolitis
737224|NCT01112241|Bronchodilator responsiveness|bronchodilator responsiveness
737225|NCT01112241|Partial forced expiratory flow|partial forced expiratory flow
737226|NCT01112241|Lung volumes|lung volumes
737227|NCT01112254|Ductal Carcinoma In Situ (DCIS) breast cancer|ductal carcinoma in situ (dcis) breast cancer
737228|NCT01112267|Chronic low back pain|chronic low back pain
737229|NCT01112267|Tramadol Hydrochloride (HCl)|tramadol hydrochloride (hcl)
737230|NCT01112267|acetaminophen|acetaminophen
737231|NCT01112280|Colorectal neoplasm|colorectal neoplasm
737232|NCT01112280|Colonoscopy|colonoscopy
737233|NCT01112280|chromoendoscopy|chromoendoscopy
737234|NCT01112280|cap-assisted colonoscopy|cap-assisted colonoscopy
737235|NCT01112293|Subjects who have pleural malignant mesothelioma|subjects who have pleural malignant mesothelioma
737239|NCT01112319|COLD HOT or Electrotherapy treatment|cold hot or electrotherapy treatment
737240|NCT01112345|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
737241|NCT01112345|Interferon-beta|interferon-beta
737242|NCT01112358|Lutropin alfa|lutropin alfa
737243|NCT01112358|Fertilization in vitro|fertilization in vitro
737244|NCT01112358|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
737245|NCT01112358|Reproductive techniques, assisted|reproductive techniques, assisted
737246|NCT01112371|scars after abdominal Caesarean section|scars after abdominal caesarean section
737247|NCT01112397|Jak2|jak2
737248|NCT01112397|cancer|cancer
737249|NCT01112397|jak 1|jak 1
737250|NCT01112397|stat 3|stat 3
737251|NCT01112397|Phase 1|phase 1
737252|NCT01112410|Bronchiectasis|bronchiectasis
737253|NCT01112410|Hypertonic saline|hypertonic saline
737254|NCT01112436|Pain|pain
737255|NCT01112436|preemptive|preemptive
737256|NCT01112436|Postoperative|postoperative
737257|NCT01112436|delirium|delirium
737258|NCT01112449|selenium|selenium
737259|NCT01112449|oxidative stress|oxidative stress
737260|NCT01112449|prostate cancer|prostate cancer
737262|NCT01112449|glucose|glucose
737263|NCT01112462|Nasal congestion, Headache|nasal congestion, headache
737264|NCT01112488|stroke|stroke
737265|NCT01112488|patient engagement programme|patient engagement programme
737266|NCT01112488|community rehabilitation|community rehabilitation
737267|NCT01112488|new carer|new carer
737268|NCT01112501|Diagnosis|diagnosis
737269|NCT01112501|Dementia|dementia
737270|NCT01112501|Imaging|imaging
737271|NCT01112514|ICG|icg
737272|NCT01112514|indocyanine green|indocyanine green
737273|NCT01112527|PF-00299804|pf-00299804
751825|NCT01170624|The study will particularly focus on a new-based diagnostic feature, called PhD-Clinical Status (PhD)|the study will particularly focus on a new-based diagnostic feature, called phd-clinical status (phd)
751826|NCT01170650|cancer|cancer
737274|NCT01112540|to evaluate the anal. efficacy of IV morph. vs. place. for elderly presenting to the ED with UAP and determine if it has an impact on diag. accu. and phy. exam|to evaluate the anal. efficacy of iv morph. vs. place. for elderly presenting to the ed with uap and determine if it has an impact on diag. accu. and phy. exam
737275|NCT01112553|Acute Migraine|acute migraine
737276|NCT01112553|Treximet|treximet
737278|NCT01112553|fMRI|fmri
737279|NCT01112553|Pain|pain
737280|NCT01112553|Heat Stimulus|heat stimulus
737281|NCT01112592|NETs|nets
737282|NCT01112592|Infections|infections
737283|NCT01112592|Neutrophil function|neutrophil function
737284|NCT01112605|achilles tendon|achilles tendon
737285|NCT01112605|sural nerve|sural nerve
737286|NCT01112605|distance|distance
737287|NCT01112605|US|us
737288|NCT01112605|ultrasound|ultrasound
737289|NCT01112605|Distance between Sural nerve and the Achilles tendon|distance between sural nerve and the achilles tendon
737290|NCT01112618|Infertility|infertility
737291|NCT01112618|Reproductive technologies, Assisted|reproductive technologies, assisted
737292|NCT01112618|r-hFSH|r-hfsh
737293|NCT01112618|r-hLH|r-hlh
737294|NCT01112618|Pergoveris|pergoveris
737295|NCT01112631|NSCLC,|nsclc,
737296|NCT01112631|PORT,|port,
737297|NCT01112631|Quality of Life,|quality of life,
737298|NCT01112631|Pulmonary function after RT|pulmonary function after rt
737299|NCT01112657|Multiple Sclerosis|multiple sclerosis
737300|NCT01112657|Clinical isolated syndrome|clinical isolated syndrome
737301|NCT01112657|Demyelination|demyelination
737302|NCT01112670|Healthy volunteers|healthy volunteers
737303|NCT01112683|Down syndrome|down syndrome
737304|NCT01112683|Trisomy 21|trisomy 21
737305|NCT01112683|Pattern Recognition Memory (PRM)|pattern recognition memory (prm)
737306|NCT01112683|Paired Associates Learning (PAL)|paired associates learning (pal)
737307|NCT01112683|California Verbal Learning Test (CVLT)|california verbal learning test (cvlt)
737308|NCT01112683|Test of Reception of Grammar (TROG-II)|test of reception of grammar (trog-ii)
737309|NCT01112683|Peabody Picture Vocabulary Test (PPVT-III)|peabody picture vocabulary test (ppvt-iii)
737310|NCT01112683|Scales of Independent Behavior revised (SIB-R)|scales of independent behavior revised (sib-r)
737311|NCT01112696|diabetes|diabetes
737312|NCT01112696|glucose sensor|glucose sensor
737313|NCT01112696|CGM|cgm
737314|NCT01112709|Diabetes|diabetes
737315|NCT01112709|Prediabetes|prediabetes
737316|NCT01112709|Resistance training|resistance training
737317|NCT01112709|behavior|behavior
737318|NCT01112709|behavioral change theory|behavioral change theory
737319|NCT01112722|honeybee toxin|honeybee toxin
737320|NCT01112722|Apitox|apitox
737321|NCT01112722|pain|pain
737322|NCT01112722|inflammation|inflammation
737323|NCT01112722|osteoarthritis|osteoarthritis
737324|NCT01112722|Apitoxin|apitoxin
737325|NCT01112735|Abdominoplasty|abdominoplasty
737326|NCT01112735|Flap adherence in subjects undergoing abdominoplasty to eliminate dead space and reduce seroma/hematoma formation|flap adherence in subjects undergoing abdominoplasty to eliminate dead space and reduce seroma/hematoma formation
737327|NCT01112748|Focal neuropathic pain|focal neuropathic pain
737328|NCT01112761|Athletes|athletes
737329|NCT01112761|Multiple Concussions|multiple concussions
737330|NCT01112761|Transcranial Stimulation|transcranial stimulation
737331|NCT01112774|Transcranial direct current stimulation|transcranial direct current stimulation
737332|NCT01112774|Spinal cord injury|spinal cord injury
737333|NCT01112774|Chronic pain|chronic pain
737334|NCT01112774|Brain excitability|brain excitability
737335|NCT01112787|Healthy Volunteer Subjects|healthy volunteer subjects
737336|NCT01112800|Anthracycline|anthracycline
737337|NCT01112800|Cardiac Muscle Injury|cardiac muscle injury
737338|NCT01112800|Doxorubicin|doxorubicin
737339|NCT01112800|Doppler Imaging|doppler imaging
737340|NCT01112800|Intermediate non-rhabdomyosarcoma soft tissue sarcomas|intermediate non-rhabdomyosarcoma soft tissue sarcomas
737341|NCT01112800|High-risk non-rhabdomyosarcoma soft tissue sarcomas|high-risk non-rhabdomyosarcoma soft tissue sarcomas
737342|NCT01112813|Stroke|stroke
737343|NCT01112813|lithium|lithium
737344|NCT01112813|MRI|mri
737345|NCT01112813|gray matter|gray matter
737346|NCT01112826|triple-negative breast cancer|triple-negative breast cancer
737347|NCT01112826|metronomic chemotherapy|metronomic chemotherapy
737348|NCT01112826|capecitabine (xeloda)|capecitabine (xeloda)
737349|NCT01112839|Overweight|overweight
737350|NCT01112839|Obese|obese
737351|NCT01112839|Breast cancer survivors|breast cancer survivors
737352|NCT01112839|Weight loss|weight loss
737353|NCT01112839|Exercise|exercise
737354|NCT01112839|Physical activity|physical activity
737355|NCT01112852|control of bleed|control of bleed
737356|NCT01112865|Growth Hormone Deficiency|growth hormone deficiency
737357|NCT01112865|Somatropin|somatropin
737358|NCT01112865|Injection Pen|injection pen
737359|NCT01112865|Medical Device|medical device
737360|NCT01112865|Cross Over Study|cross over study
737361|NCT01112865|Preference|preference
737362|NCT01112865|Convenience|convenience
737363|NCT01112865|Children|children
737364|NCT01112865|Dyads|dyads
737365|NCT01112865|Adults|adults
737366|NCT01112878|Shoulder arthroscopy|shoulder arthroscopy
737367|NCT01112878|Knee arthroscopy|knee arthroscopy
737368|NCT01112878|Clonidine|clonidine
737369|NCT01112878|Gabapentin|gabapentin
737370|NCT01112878|Pain management|pain management
737371|NCT01112878|Ambulatory surgery|ambulatory surgery
737372|NCT01112878|Perioperative outcome|perioperative outcome
737373|NCT01112878|Analgesia|analgesia
737374|NCT01112891|Vitamin D|vitamin d
737375|NCT01112891|Infant|infant
737376|NCT01112891|Lactation|lactation
737377|NCT01112891|Dose-Response|dose-response
737378|NCT01112904|essential fatty acids|essential fatty acids
737379|NCT01112904|DHA status|dha status
737380|NCT01112904|preschool children|preschool children
737381|NCT01112904|gestation|gestation
737382|NCT01112930|essential fatty acids|essential fatty acids
737383|NCT01112930|DHA|dha
737384|NCT01112930|preschool children|preschool children
737385|NCT01112930|docosahexanoic acid (DHA)|docosahexanoic acid (dha)
737386|NCT01112943|Acupuncture, Pulmonary Rehabilitation, Inflammation, COPD|acupuncture, pulmonary rehabilitation, inflammation, copd
737387|NCT01112956|HSV-2|hsv-2
737388|NCT01112956|HSV-1|hsv-1
737389|NCT01112956|Sensitivity|sensitivity
737390|NCT01112956|Specificity|specificity
737391|NCT01112956|Testing algorithm|testing algorithm
737392|NCT01112956|Test evaluation|test evaluation
737393|NCT01112969|Internet-based supportive coaching|internet-based supportive coaching
737394|NCT01112969|guided self-help|guided self-help
737395|NCT01112969|Caregivers|caregivers
737396|NCT01112969|Brain Injury|brain injury
737397|NCT01112969|Caregiver Burden|caregiver burden
737398|NCT01112969|Coping|coping
737399|NCT01112969|Stress|stress
737400|NCT01112969|Depression|depression
737401|NCT01112982|Gout|gout
737402|NCT01112982|Synovial pannus|synovial pannus
737403|NCT01112982|Magnetic resonance imaging|magnetic resonance imaging
737404|NCT01112995|Probiotic|probiotic
737405|NCT01112995|Lactobacillus|lactobacillus
737406|NCT01112995|Antibiotic resistance|antibiotic resistance
737407|NCT01113008|Myocardial Reperfusion Injury/mortality|myocardial reperfusion injury/mortality
737408|NCT01113008|Coronary angioplasty|coronary angioplasty
737409|NCT01113008|Reperfusion|reperfusion
737410|NCT01113008|Myocardial Reperfusion Injury/prevention & control|myocardial reperfusion injury/prevention & control
737411|NCT01113034|Asthma|asthma
737412|NCT01113034|Bronchiectasis|bronchiectasis
737413|NCT01113047|Hypertension|hypertension
737414|NCT01113047|Aliskiren|aliskiren
737415|NCT01113047|Amlodipine|amlodipine
737416|NCT01113060|Coronary Artery Disease|coronary artery disease
737417|NCT01113060|Aspirin|aspirin
737418|NCT01113060|Secondary Prevention|secondary prevention
737419|NCT01113073|pulse pressure variation|pulse pressure variation
737420|NCT01113073|hemodynamic monitoring|hemodynamic monitoring
737421|NCT01113073|fluid responsiveness|fluid responsiveness
737422|NCT01113073|mechanical ventilation|mechanical ventilation
737423|NCT01113073|fluid therapy|fluid therapy
737424|NCT01113086|Parkinson|parkinson
737425|NCT01113086|Transcranial direct current stimulation|transcranial direct current stimulation
737426|NCT01113086|Motor function|motor function
737427|NCT01113086|Cognitive function|cognitive function
737428|NCT01113086|Affective function|affective function
737429|NCT01113112|Ovarian Neoplasms|ovarian neoplasms
737430|NCT01113125|hypertrophic scar|hypertrophic scar
737432|NCT01113125|central venous catheter|central venous catheter
737433|NCT01113125|children|children
737434|NCT01113125|cancer|cancer
737435|NCT01113138|Clearance|clearance
737436|NCT01113138|Half-life|half-life
737437|NCT01113138|Absorption fraction|absorption fraction
737438|NCT01113138|Pharmacokinetics|pharmacokinetics
737439|NCT01113151|Steroid-resistant|steroid-resistant
737440|NCT01113151|Severe asthmatics|severe asthmatics
737441|NCT01113151|Annual symptoms|annual symptoms
737442|NCT01113151|Daily magnesium supplement|daily magnesium supplement
737443|NCT01113151|ACT (asthma control test)|act (asthma control test)
737444|NCT01113164|ondansetron|ondansetron
737445|NCT01113164|sertraline|sertraline
737446|NCT01113164|lab studies|lab studies
737447|NCT01113164|alcoholism|alcoholism
737448|NCT01113164|alcohol dependence|alcohol dependence
737449|NCT01113177|Mandibular growth temporomandibular arthritis|mandibular growth temporomandibular arthritis
737450|NCT01113203|resistance training|resistance training
737451|NCT01113203|blood pressure|blood pressure
737452|NCT01113203|hemodynamics|hemodynamics
737453|NCT01113203|autonomic|autonomic
737454|NCT01113203|Elderly Subjects|elderly subjects
737455|NCT01113216|CF|cf
737456|NCT01113216|CFRD|cfrd
737457|NCT01113216|Diabetes|diabetes
737458|NCT01113216|Genetic Modifiers|genetic modifiers
737459|NCT01113229|Post Partum Haemorrhage,|post partum haemorrhage,
737460|NCT01113229|oxytocin,|oxytocin,
737461|NCT01113229|misoprostol,|misoprostol,
737462|NCT01113229|prevention,|prevention,
737463|NCT01113229|delivery.|delivery.
737464|NCT01113242|Parkinson Disease Dementia|parkinson disease dementia
737465|NCT01113242|Observational|observational
737466|NCT01113242|Case control|case control
737467|NCT01113242|Neuropsychological assessment|neuropsychological assessment
737468|NCT01113255|VENTILATORS|ventilators
737469|NCT01113255|BENCH EVALUATION|bench evaluation
737470|NCT01113255|MECHANICAL VENTILATION|mechanical ventilation
737471|NCT01113268|Patient collection|patient collection
737472|NCT01113268|Cardiac remodelling|cardiac remodelling
737473|NCT01113268|Echography|echography
737474|NCT01113268|Magnetic Resonance Imaging|magnetic resonance imaging
737475|NCT01113268|Gene polymorphisms|gene polymorphisms
737476|NCT01113268|Biomarkers|biomarkers
737477|NCT01113281|Tuberculosis|tuberculosis
737478|NCT01113281|Vaccine|vaccine
737479|NCT01113281|Live Vaccine|live vaccine
737480|NCT01113281|rBCG|rbcg
737481|NCT01113307|Chronic ulcers|chronic ulcers
737482|NCT01113307|pressure ulcers|pressure ulcers
737483|NCT01113307|venous ulcers|venous ulcers
737484|NCT01113307|diabetic foot ulcers|diabetic foot ulcers
737485|NCT01113307|post operative ulcers|post operative ulcers
737486|NCT01113307|hard to heal ulcers|hard to heal ulcers
737487|NCT01113320|Safinamide - Parkinson's disease - Levodopa induced dyskinesia|safinamide - parkinson's disease - levodopa induced dyskinesia
737488|NCT01113320|Advanced idiopathic PD patients treated with L-dopa and suffering from temporally predictable L-dopa induced peak-dose dyskinesia.|advanced idiopathic pd patients treated with l-dopa and suffering from temporally predictable l-dopa induced peak-dose dyskinesia.
737489|NCT01113346|enterosorbent|enterosorbent
737490|NCT01113346|sorbent|sorbent
737491|NCT01113346|gastrointestinal decontamination|gastrointestinal decontamination
737492|NCT01113346|viral diarrhea|viral diarrhea
737493|NCT01113346|rotavirus|rotavirus
737494|NCT01113346|Filtrum|filtrum
737495|NCT01113346|Filtrum-STI|filtrum-sti
737496|NCT01113346|lignin|lignin
737497|NCT01113359|HCMV infection|hcmv infection
737498|NCT01113359|Hypertension|hypertension
737499|NCT01113359|The Potential Link Between HCMV Infection and Essential Hypertension|the potential link between hcmv infection and essential hypertension
737500|NCT01113372|Coronary, Disease|coronary, disease
737501|NCT01113385|Nephrotic syndrome|nephrotic syndrome
737502|NCT01113385|Focal Segmental glomerulosclerosis|focal segmental glomerulosclerosis
737503|NCT01113385|FSGS|fsgs
737504|NCT01113385|Minimal change|minimal change
737505|NCT01113385|Steroid resistant|steroid resistant
737506|NCT01113385|Pediatric|pediatric
737507|NCT01113385|Proteinuria|proteinuria
737508|NCT01113385|Galactose|galactose
737509|NCT01113385|FSPF|fspf
737510|NCT01113398|glioblastoma multiforme|glioblastoma multiforme
737511|NCT01113398|gliosarcoma|gliosarcoma
737512|NCT01113398|malignant glioma|malignant glioma
737513|NCT01113398|glioma|glioma
737514|NCT01113398|Avastin|avastin
737521|NCT01113411|humerus fracture|humerus fracture
737522|NCT01113411|locked plate|locked plate
737523|NCT01113424|Smoking Cessation|smoking cessation
737524|NCT01113424|Nicotine pharmacokinetics|nicotine pharmacokinetics
737525|NCT01113437|Bronchial Asthma|bronchial asthma
737526|NCT01113437|Allergy|allergy
737527|NCT01113450|hearing, newborn, screening|hearing, newborn, screening
737528|NCT01113463|Brain Tumor|brain tumor
737529|NCT01113463|Central Nervous System|central nervous system
737530|NCT01113463|CNS|cns
737531|NCT01113463|Glioblastoma Multiforme|glioblastoma multiforme
737532|NCT01113463|GBM|gbm
737533|NCT01113463|TPI 287|tpi 287
737534|NCT01113463|Radiation Therapy|radiation therapy
737535|NCT01113463|Temozolomide|temozolomide
737536|NCT01113463|Chemotherapy|chemotherapy
737537|NCT01113463|taxanes|taxanes
737538|NCT01113476|Advanced Malignancies|advanced malignancies
737539|NCT01113476|Nab-paclitaxel|nab-paclitaxel
737540|NCT01113476|Gemcitabine|gemcitabine
737541|NCT01113476|Bevacizumab|bevacizumab
737542|NCT01113515|Diabetic foot ulcer|diabetic foot ulcer
737543|NCT01113515|Diabetic wound|diabetic wound
737544|NCT01113515|chronic non healing ulcer|chronic non healing ulcer
737545|NCT01113528|Bone allograft|bone allograft
737546|NCT01113528|IL-1|il-1
737548|NCT01113528|periodontal regeneration|periodontal regeneration
737549|NCT01113528|omega-3|omega-3
737550|NCT01113528|aspirin|aspirin
737551|NCT01113541|Ziprasidone|ziprasidone
737552|NCT01113541|Bipolar Disorder|bipolar disorder
737553|NCT01113541|Metabolic Syndrome|metabolic syndrome
737554|NCT01113567|Hepatic Encephalopathy|hepatic encephalopathy
737555|NCT01113567|Liver Cirrhosis|liver cirrhosis
737556|NCT01113567|Disaccharides|disaccharides
737557|NCT01113567|Lactose|lactose
737558|NCT01113567|Quality of Life|quality of life
737559|NCT01113593|COPD|copd
737560|NCT01113606|Moderate to severe facial photo damage|moderate to severe facial photo damage
737857|NCT01114646|Press Fit|press fit
737561|NCT01113606|Periocular or perioral fine wrinkles|periocular or perioral fine wrinkles
737562|NCT01113619|lactose maldigestion|lactose maldigestion
737563|NCT01113619|dairy intolerance|dairy intolerance
737564|NCT01113619|intolerance to milk|intolerance to milk
737565|NCT01113619|intolerance to dairy|intolerance to dairy
737566|NCT01113619|milk intolerance|milk intolerance
737567|NCT01113619|GI disorder|gi disorder
737568|NCT01113619|lactose metabolism|lactose metabolism
737569|NCT01113619|GI symptoms after dairy ingestion|gi symptoms after dairy ingestion
737570|NCT01113632|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
737571|NCT01113632|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
737572|NCT01113632|Ofatumumab|ofatumumab
737573|NCT01113645|Decompressive craniectomy|decompressive craniectomy
737574|NCT01113645|Cranioplasty|cranioplasty
737575|NCT01113645|Cerebral blood flow|cerebral blood flow
737576|NCT01113645|Cerebral hemodynamic|cerebral hemodynamic
737577|NCT01113645|Neurological-cognitive test GOS, FAB, MMSE,|neurological-cognitive test gos, fab, mmse,
737578|NCT01113645|Transcranial Doppler|transcranial doppler
737579|NCT01113658|negative pressure wound therapy|negative pressure wound therapy
737580|NCT01113658|NPWT|npwt
737581|NCT01113658|Spiracur|spiracur
737582|NCT01113658|SNaP Wound Care System|snap wound care system
737583|NCT01113671|Diabetes Mellitus type 2|diabetes mellitus type 2
737584|NCT01113671|Haptoglobin phenotype|haptoglobin phenotype
737585|NCT01113671|Vitamin E|vitamin e
737586|NCT01113697|allergen challenge|allergen challenge
737587|NCT01113697|blood draw|blood draw
737588|NCT01113697|gene expression analysis|gene expression analysis
737589|NCT01113697|protein analysis|protein analysis
737590|NCT01113697|genetics|genetics
737591|NCT01113710|Rotigotine|rotigotine
737592|NCT01113710|Neupro®|neupro®
737593|NCT01113710|Restless Legs Syndrome|restless legs syndrome
737594|NCT01113723|C-MAC|c-mac
737595|NCT01113723|Fiberoptic bronchoscope|fiberoptic bronchoscope
737596|NCT01113723|Laryngoscopy|laryngoscopy
737597|NCT01113723|Cervical spine injury|cervical spine injury
737598|NCT01113723|Glottic view|glottic view
737599|NCT01113723|Tracheal intubation|tracheal intubation
737600|NCT01113736|Ileostomy|ileostomy
737601|NCT01113736|Stenosis|stenosis
737602|NCT01113736|Surgical Wound Dehiscence|surgical wound dehiscence
737603|NCT01113736|Peritoneal|peritoneal
737604|NCT01113736|Colorectal Surgery|colorectal surgery
737605|NCT01113749|Dementia|dementia
737606|NCT01113749|Nutrition|nutrition
737607|NCT01113749|Feeding|feeding
737608|NCT01113762|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
737609|NCT01113762|Bone Density|bone density
737610|NCT01113762|Rehabilitation|rehabilitation
737611|NCT01113762|T-Lymphocytes|t-lymphocytes
737612|NCT01113762|Chromium Alloys|chromium alloys
737613|NCT01113775|pulmonary embolism|pulmonary embolism
737614|NCT01113775|computed tomography|computed tomography
737615|NCT01113788|atrial flutter, tricuspid isthmus, ablation|atrial flutter, tricuspid isthmus, ablation
737616|NCT01113801|Chronic Kidney Disease|chronic kidney disease
737617|NCT01113801|Diabetic Kidney Disease|diabetic kidney disease
737618|NCT01113801|End-Stage Renal Disease|end-stage renal disease
737718|NCT01107613|relapse|relapse
737619|NCT01113801|Transforming Growth Factor beta 1 Monoclonal Antibody|transforming growth factor beta 1 monoclonal antibody
737620|NCT01113801|Type 1 Diabetes|type 1 diabetes
737621|NCT01113801|Type 2 Diabetes|type 2 diabetes
737622|NCT01113827|Olive|olive
737623|NCT01113827|antioxidant|antioxidant
737624|NCT01113827|exercise|exercise
737625|NCT01113827|inflammation|inflammation
737626|NCT01113827|recovery|recovery
737627|NCT01113827|Healthy men|healthy men
737628|NCT01113840|elderly|elderly
737629|NCT01113840|heart failure|heart failure
737630|NCT01113840|exercise|exercise
737631|NCT01113840|diastolic dysfunction|diastolic dysfunction
737632|NCT01113853|asthma|asthma
737633|NCT01113853|exhaled nitric oxide|exhaled nitric oxide
737634|NCT01113853|lung function|lung function
737635|NCT01113879|rehabilitation|rehabilitation
737636|NCT01113879|aphasia|aphasia
737637|NCT01113879|exercise|exercise
737638|NCT01113879|fMRI|fmri
737639|NCT01113879|BDNF|bdnf
737640|NCT01113905|Fatigue|fatigue
737641|NCT01113905|Breast Cancer|breast cancer
737642|NCT01113918|Obesity,|obesity,
737643|NCT01113918|PCOS,|pcos,
737645|NCT01113918|CVD|cvd
737646|NCT01113931|Chlamydia|chlamydia
737647|NCT01113957|Ovarian Cancer|ovarian cancer
737648|NCT01113970|breast cancer|breast cancer
737649|NCT01113970|Indibulin|indibulin
737650|NCT01113970|unresectable, locally advanced breast cancer|unresectable, locally advanced breast cancer
737651|NCT01113983|SAPIEN XT Valve, Cardiovascular Disease, Valvular Heart Disease, Aortic Stenosis, Heart Valve Therapy, Transapical, Transcatheter, Transfemoral|sapien xt valve, cardiovascular disease, valvular heart disease, aortic stenosis, heart valve therapy, transapical, transcatheter, transfemoral
737652|NCT01113996|Obesity|obesity
737653|NCT01113996|Gastric by-pass|gastric by-pass
737654|NCT01113996|Body composition|body composition
737655|NCT01113996|Nutrition|nutrition
737656|NCT01113996|Physical activity|physical activity
737657|NCT01114009|recruitment maneuvers|recruitment maneuvers
737659|NCT01114009|lung protective strategy|lung protective strategy
737660|NCT01114009|ARDS, Human|ards, human
737661|NCT01114022|Acute respiratory failure|acute respiratory failure
737662|NCT01114035|intestinal epithelial dysplasia|intestinal epithelial dysplasia
737663|NCT01114035|characterization phenotypic|characterization phenotypic
737664|NCT01114035|genetic study|genetic study
751827|NCT01170650|ovarian|ovarian
737665|NCT01114035|"or  tufting enteropathy "|"or  tufting enteropathy "
737666|NCT01114048|age under 65|age under 65
737667|NCT01114048|Previous untreated|previous untreated
737668|NCT01114061|diabetes|diabetes
737669|NCT01114061|postprandial glucose level|postprandial glucose level
737670|NCT01114061|insulin pharmacodynamics|insulin pharmacodynamics
737671|NCT01114061|Insulin Pharmacokinetics|insulin pharmacokinetics
737672|NCT01114074|Thrombosis|thrombosis
737673|NCT01114074|Blood coagulation|blood coagulation
737674|NCT01114074|Perfusion flow experiments|perfusion flow experiments
737675|NCT01114074|Factor XII|factor xii
737676|NCT01114074|Factor XI|factor xi
737677|NCT01114074|Prekallikrein|prekallikrein
737678|NCT01114074|High molecular weight kininogen|high molecular weight kininogen
737679|NCT01114087|Spermatogenesis|spermatogenesis
737680|NCT01114087|Inhibitors of tyrosine kinase|inhibitors of tyrosine kinase
737681|NCT01114087|Fragmentation of the spermatic DNA|fragmentation of the spermatic dna
737682|NCT01107431|glucose|glucose
737683|NCT01107431|insulin|insulin
737684|NCT01107431|L-arabinose|l-arabinose
737685|NCT01107431|Chromium|chromium
737686|NCT01107457|Moderate|moderate
737687|NCT01107457|Severe|severe
737688|NCT01107457|Plaque|plaque
737689|NCT01107457|Chronic|chronic
737690|NCT01107470|Infertility IVF ART|infertility ivf art
737691|NCT01107483|endotoxaemia|endotoxaemia
737692|NCT01107509|Renal cell carcinoma|renal cell carcinoma
737693|NCT01107509|Metastatic|metastatic
737694|NCT01107509|everolimus|everolimus
737695|NCT01107509|neo-adjuvant|neo-adjuvant
737696|NCT01107509|biomarkers|biomarkers
737697|NCT01107509|nephrectomy|nephrectomy
737698|NCT01107509|Locally advanced clear cell renal carcinoma|locally advanced clear cell renal carcinoma
737699|NCT01107509|Metastatic clear cell renal carcinoma|metastatic clear cell renal carcinoma
737700|NCT01107509|Clear Cell Renal Carcinoma|clear cell renal carcinoma
737701|NCT01107535|Synagis (palivizumab) immunoprophylaxis|synagis (palivizumab) immunoprophylaxis
737702|NCT01107535|Respiratory syncytial virus infection|respiratory syncytial virus infection
737703|NCT01107535|Preterm infants|preterm infants
737704|NCT01107561|cricothyroidotomy|cricothyroidotomy
737705|NCT01107561|intubation|intubation
737706|NCT01107561|airway|airway
737707|NCT01107561|emergency medicine|emergency medicine
737708|NCT01107561|education|education
737709|NCT01107574|Chronic Pain, tenderpoints, insomnia, mood disorder, fatigue|chronic pain, tenderpoints, insomnia, mood disorder, fatigue
737710|NCT01107587|Human rotavirus vaccine|human rotavirus vaccine
737711|NCT01107600|Dental Implants, Single-Tooth|dental implants, single-tooth
737712|NCT01107600|Bone Regeneration|bone regeneration
737713|NCT01107600|Dental Restoration|dental restoration
737714|NCT01107600|Socket preservation|socket preservation
737715|NCT01107613|opinion leader|opinion leader
737716|NCT01107613|COPD|copd
737717|NCT01107613|Emergency Department|emergency department
737720|NCT01107613|evidence-based guidelines|evidence-based guidelines
737721|NCT01107613|Exacerbation of COPD|exacerbation of copd
737722|NCT01114100|chest pain|chest pain
737723|NCT01114100|panic attacks|panic attacks
737724|NCT01114100|palpitations|palpitations
737725|NCT01114100|depression|depression
737726|NCT01114100|panic disorder|panic disorder
737727|NCT01114100|depressive disorder|depressive disorder
737728|NCT01114100|non cardiac chest pain|non cardiac chest pain
737729|NCT01114113|IBS-D|ibs-d
737730|NCT01114113|Post meal Diarrhea|post meal diarrhea
737731|NCT01114113|Trigger meals|trigger meals
737732|NCT01114126|Neu-P11|neu-p11
737733|NCT01114126|Insomnia|insomnia
737734|NCT01114126|PSG|psg
737735|NCT01114126|safety|safety
737736|NCT01114139|Iron deficiency anemia|iron deficiency anemia
737737|NCT01114139|Feraheme|feraheme
737738|NCT01114139|ferumoxytol|ferumoxytol
737739|NCT01114139|AUB|aub
737740|NCT01114139|cancer|cancer
737741|NCT01114139|GI disorders|gi disorders
737742|NCT01114139|postpartum anemia|postpartum anemia
737743|NCT01114139|The treatment of iron deficiency anemia (IDA)|the treatment of iron deficiency anemia (ida)
737744|NCT01114152|AZD9742|azd9742
737950|NCT01114958|Stage 3|stage 3
737745|NCT01114152|Japanese Healthy Volunteers|japanese healthy volunteers
737746|NCT01114152|Phase I|phase i
737747|NCT01114152|Single and Multiple Ascending Dose|single and multiple ascending dose
737748|NCT01114165|Neutropenia|neutropenia
737749|NCT01114165|Febrile Neutropenia|febrile neutropenia
737750|NCT01114165|Sepsis|sepsis
737751|NCT01114165|Polymerase Chain Reaction|polymerase chain reaction
737752|NCT01114178|questionnaire|questionnaire
737753|NCT01114178|peripheral artery disease|peripheral artery disease
737754|NCT01114178|exercise|exercise
737755|NCT01114204|Iron deficiency anemia|iron deficiency anemia
737756|NCT01114204|Feraheme|feraheme
737757|NCT01114204|ferumoxytol|ferumoxytol
737758|NCT01114204|iron sucrose|iron sucrose
737759|NCT01114204|Venofer|venofer
737760|NCT01114204|AUB|aub
737761|NCT01114204|cancer|cancer
737762|NCT01114204|GI disorders|gi disorders
737763|NCT01114204|postpartum anemia|postpartum anemia
737764|NCT01114204|The treatment of iron deficiency anemia (IDA)|the treatment of iron deficiency anemia (ida)
737765|NCT01114217|Iron deficiency anemia|iron deficiency anemia
737766|NCT01114217|Feraheme|feraheme
737767|NCT01114217|ferumoxytol|ferumoxytol
737768|NCT01114217|AUB|aub
737769|NCT01114217|cancer|cancer
737770|NCT01114217|GI disorders|gi disorders
737771|NCT01114217|postpartum anemia|postpartum anemia
737772|NCT01114217|The treatment of iron deficiency anemia (IDA)|the treatment of iron deficiency anemia (ida)
737773|NCT01114230|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
737774|NCT01114230|Advanced Kidney Cancer|advanced kidney cancer
737775|NCT01114230|AGS-16M8F|ags-16m8f
737776|NCT01114269|Coronary Artery Disease|coronary artery disease
737777|NCT01114269|Sudden Cardiac Death|sudden cardiac death
737778|NCT01114269|Myocardial Infarction|myocardial infarction
737779|NCT01114269|Percutaneous Coronary Intervention|percutaneous coronary intervention
737780|NCT01114269|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
737781|NCT01114295|overt|overt
737782|NCT01114295|obscure|obscure
737783|NCT01114295|gastrointestinal|gastrointestinal
737784|NCT01114295|bleeding|bleeding
737785|NCT01114295|hemorrhage|hemorrhage
737786|NCT01114308|opioid dependence|opioid dependence
737787|NCT01114308|opioid addiction|opioid addiction
737788|NCT01114308|buprenorphine|buprenorphine
737789|NCT01114308|implant|implant
737790|NCT01114308|methadone|methadone
737791|NCT01114308|heroin|heroin
737792|NCT01114308|suboxone|suboxone
737793|NCT01114308|opioid pain medication|opioid pain medication
737794|NCT01114308|opioid withdrawal|opioid withdrawal
737795|NCT01114321|Idiopathic Parkinson's disease|idiopathic parkinson's disease
737796|NCT01114321|Glucose intolerance|glucose intolerance
737797|NCT01114321|Diabetes|diabetes
737798|NCT01114321|OGTT|ogtt
737799|NCT01114321|Patient with an Idiopathic Parkinson's disease|patient with an idiopathic parkinson's disease
737800|NCT01114360|Melatonin|melatonin
737801|NCT01114360|Hypertension|hypertension
737802|NCT01114360|Blood Pressure|blood pressure
737803|NCT01114360|Cardiovascular|cardiovascular
737804|NCT01114360|Sleep|sleep
737805|NCT01114360|Nighttime|nighttime
737806|NCT01114360|Nocturnal|nocturnal
737807|NCT01114360|Catecholamines|catecholamines
737808|NCT01114360|Sympathetic Nervous System|sympathetic nervous system
737809|NCT01114360|Endothelial function|endothelial function
737810|NCT01114360|African American|african american
737811|NCT01114373|Melatonin|melatonin
737812|NCT01114373|Hypertension|hypertension
737813|NCT01114373|Blood Pressure|blood pressure
737814|NCT01114373|Cardiovascular|cardiovascular
737815|NCT01114373|Sleep|sleep
737816|NCT01114373|Nighttime|nighttime
737817|NCT01114373|Nocturnal|nocturnal
737818|NCT01114373|Catecholamines|catecholamines
737819|NCT01114373|Sympathetic Nervous System|sympathetic nervous system
737820|NCT01114373|Endothelial Function|endothelial function
737821|NCT01114373|African American|african american
737822|NCT01114386|Smoking|smoking
737826|NCT01114399|Cardiovascular Disease|cardiovascular disease
737827|NCT01114399|Cardiovascular Disease risk (mild to moderate)|cardiovascular disease risk (mild to moderate)
737828|NCT01114399|Cholesterol|cholesterol
737829|NCT01114399|Ambulatory blood pressure|ambulatory blood pressure
737830|NCT01114399|Arterial Stiffness|arterial stiffness
737831|NCT01114412|focus groups|focus groups
737832|NCT01114412|overactive bladder|overactive bladder
737833|NCT01114412|bladder sensations|bladder sensations
737960|NCT01114984|Pain management|pain management
737834|NCT01114425|tolerability of post exposure to HIV infection prophylaxis|tolerability of post exposure to hiv infection prophylaxis
737835|NCT01114568|Relative Bioavailability|relative bioavailability
737836|NCT01114568|Pharmacokinetics|pharmacokinetics
737837|NCT01114568|Pharmacodynamics|pharmacodynamics
737838|NCT01114581|Acute Respiratory Infection|acute respiratory infection
737839|NCT01114581|Mucociliary|mucociliary
737840|NCT01114581|Cough Clearance|cough clearance
737841|NCT01114581|Guaifenesin|guaifenesin
737842|NCT01114594|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
737843|NCT01114594|Autosomal Dominant Polycystic Kidney Disease (ADPKD)|autosomal dominant polycystic kidney disease (adpkd)
737844|NCT01114607|GSK1605786|gsk1605786
737845|NCT01114607|relative bioavailability|relative bioavailability
737846|NCT01114607|CCR9 receptor antagonist|ccr9 receptor antagonist
737847|NCT01114620|elderly|elderly
737848|NCT01114620|post-marketing|post-marketing
737849|NCT01114620|H1N1|h1n1
737850|NCT01114620|Clinical trial|clinical trial
737851|NCT01114620|pandemic influenza|pandemic influenza
737852|NCT01114633|PCOS|pcos
737853|NCT01114633|Acne|acne
737854|NCT01114633|Hirsutism|hirsutism
737855|NCT01114646|Hemiarthroplasty|hemiarthroplasty
737856|NCT01114646|Cemented|cemented
737858|NCT01114646|Mortality|mortality
737859|NCT01114646|Morbidity|morbidity
737860|NCT01114646|Functional Status|functional status
737861|NCT01114646|Displaced femoral neck fracture|displaced femoral neck fracture
737862|NCT01114672|Pruritis in hemodialysis patients|pruritis in hemodialysis patients
737863|NCT01114672|25-Vitamin D in chronic kidney disease|25-vitamin d in chronic kidney disease
737864|NCT01114698|Depression|depression
737865|NCT01114698|Major Depressive Disorder|major depressive disorder
737866|NCT01114698|Venlafaxine XR (EFFEXOR XR)|venlafaxine xr (effexor xr)
737867|NCT01114698|26489112|26489112
737868|NCT01114698|JNJ26489112|jnj26489112
737869|NCT01114711|Menstrual Migraine|menstrual migraine
737870|NCT01114711|Frova|frova
737871|NCT01114711|Imaging|imaging
737872|NCT01114711|fMRI|fmri
737873|NCT01114711|Pain|pain
737874|NCT01114724|Thoracic dissection|thoracic dissection
737875|NCT01114724|Endovascular aortic repair|endovascular aortic repair
737876|NCT01114737|Phenylketonuria|phenylketonuria
737878|NCT01114737|Kuvan|kuvan
737879|NCT01114737|Sapropterin dihydrochloride|sapropterin dihydrochloride
737880|NCT01114737|Neuropsychiatric disorder|neuropsychiatric disorder
737881|NCT01114737|ADHD|adhd
737882|NCT01114750|blood glucose|blood glucose
737883|NCT01114750|blood insulin|blood insulin
737884|NCT01114750|dextran|dextran
737885|NCT01114750|diabetes|diabetes
737886|NCT01114750|hyperglycemia|hyperglycemia
737887|NCT01114750|hypoglycemia|hypoglycemia
737888|NCT01114750|oral delivery|oral delivery
737889|NCT01114750|portal delivery|portal delivery
737890|NCT01114763|Metabolic Syndrome|metabolic syndrome
737891|NCT01114763|Oxidized Low Density Lipoprotein|oxidized low density lipoprotein
737892|NCT01114763|Arterial Elasticity|arterial elasticity
737893|NCT01114763|Diabetes Mellitus|diabetes mellitus
737894|NCT01114763|Cardiovascular Diseases|cardiovascular diseases
737895|NCT01114789|chronic renal failure|chronic renal failure
737896|NCT01114789|hemodialysis|hemodialysis
737897|NCT01114789|obesity|obesity
737898|NCT01114789|proteolysis|proteolysis
737899|NCT01114802|Cancer survivors|cancer survivors
737900|NCT01114802|Anxiety|anxiety
737901|NCT01114802|Depression|depression
737902|NCT01114802|Technology Assisted|technology assisted
737903|NCT01114802|Internet|internet
737904|NCT01114815|CADASIL|cadasil
737905|NCT01114815|cerebral|cerebral
737906|NCT01114815|autosomal dominant|autosomal dominant
737907|NCT01114815|arteriopathy|arteriopathy
737908|NCT01114815|subcortical infarcts|subcortical infarcts
737909|NCT01114815|leukoencephalopathy|leukoencephalopathy
737910|NCT01114828|Cirrhosis|cirrhosis
737911|NCT01114828|ascites|ascites
737912|NCT01114828|Tolvaptan|tolvaptan
737913|NCT01114828|OPC-41061|opc-41061
737914|NCT01114841|Healthy Volunteer Subjects|healthy volunteer subjects
737915|NCT01114867|ultrasound|ultrasound
737916|NCT01114867|penis length|penis length
737917|NCT01114867|corpus cavernosum|corpus cavernosum
737918|NCT01114867|length of fetal penis and fetal corpus cavernosum|length of fetal penis and fetal corpus cavernosum
737919|NCT01114880|ankylosing spondylitis|ankylosing spondylitis
737920|NCT01114880|China|china
737921|NCT01114906|Asthma|asthma
737922|NCT01114906|Resource use|resource use
737923|NCT01114919|Problem drinking|problem drinking
737924|NCT01114919|Alcohol dependence|alcohol dependence
737925|NCT01114919|Alcohol abuse|alcohol abuse
738431|NCT01116531|tramadol|tramadol
737926|NCT01114919|Internet based intervention|internet based intervention
737927|NCT01114919|Treatment|treatment
737928|NCT01114919|Alcohol Use Disorders Identification Test|alcohol use disorders identification test
737929|NCT01114932|pre-oxygenation|pre-oxygenation
737930|NCT01114932|body mass index|body mass index
737931|NCT01114932|end-tidal O2|end-tidal o2
737932|NCT01114932|anesthesia induction|anesthesia induction
737933|NCT01114945|Direct Laryngoscopy|direct laryngoscopy
737934|NCT01114945|Video-Mac|video-mac
737935|NCT01114945|GlideScope|glidescope
737936|NCT01114945|McGrath|mcgrath
737937|NCT01114945|Laryngoscopy|laryngoscopy
737938|NCT01114945|Bariatrics|bariatrics
737939|NCT01114945|Glottic view|glottic view
737940|NCT01114945|Airway intubating devices|airway intubating devices
737941|NCT01114945|Tracheal intubation|tracheal intubation
737942|NCT01114958|Lung cancer|lung cancer
737943|NCT01114958|Non-small cell lung cancer|non-small cell lung cancer
737944|NCT01114958|Small-cell lung cancer|small-cell lung cancer
737945|NCT01114958|Lung metastases|lung metastases
737946|NCT01114958|Metastatic cancer|metastatic cancer
737947|NCT01114958|Stage IIIA|stage iiia
737948|NCT01114958|Stage IIIB|stage iiib
737951|NCT01114971|Labetalol|labetalol
737952|NCT01114971|Esmolol|esmolol
737953|NCT01114971|Fentanyl|fentanyl
737954|NCT01114971|Anesthetic adjuvant|anesthetic adjuvant
737955|NCT01114971|Ambulatory surgery|ambulatory surgery
737956|NCT01114971|Outpatient surgery|outpatient surgery
737957|NCT01114971|Pain management|pain management
737958|NCT01114971|Hemodynamic stability|hemodynamic stability
737959|NCT01114971|Perioperative outcomes|perioperative outcomes
737961|NCT01114984|Radical mastectomy|radical mastectomy
738367|NCT01116310|Hot flushes|hot flushes
737962|NCT01114984|Breast surgery|breast surgery
737963|NCT01114984|post-operative pain|post-operative pain
737964|NCT01114997|Lidocaine Infusion|lidocaine infusion
737965|NCT01114997|Esmolol Infusion|esmolol infusion
737966|NCT01114997|Anesthetic adjuvant|anesthetic adjuvant
737967|NCT01114997|Abdominal surgery|abdominal surgery
737968|NCT01114997|Pain management|pain management
737969|NCT01114997|Hemodynamic stability|hemodynamic stability
737970|NCT01114997|Perioperative outcomes|perioperative outcomes
737971|NCT01115010|intubation rate|intubation rate
737972|NCT01115010|intubation time|intubation time
737973|NCT01115010|stiffening device|stiffening device
737974|NCT01115010|stiffening wire|stiffening wire
737975|NCT01115023|iron deficiency anemia|iron deficiency anemia
737976|NCT01115023|dietary intervention|dietary intervention
737977|NCT01115023|To evaluate a cheap and sustainable dietary intervention to improve the iron status of the entire family of the index case of non-severe iron deficiency anemia.|to evaluate a cheap and sustainable dietary intervention to improve the iron status of the entire family of the index case of non-severe iron deficiency anemia.
737978|NCT01115036|glioblastoma|glioblastoma
737979|NCT01115036|recurrent|recurrent
737980|NCT01115036|surgical resection|surgical resection
737981|NCT01115062|Pain|pain
737982|NCT01115062|Children|children
737983|NCT01115062|Local anesthetics|local anesthetics
737984|NCT01115075|Leptin|leptin
737985|NCT01115075|Changes in leptin may precede the|changes in leptin may precede the
737986|NCT01115075|phasing of oscillations of dietary fat intake|phasing of oscillations of dietary fat intake
737987|NCT01115101|pain after cesarean|pain after cesarean
737988|NCT01115101|visual analog scale|visual analog scale
737989|NCT01115101|oxycodon|oxycodon
737990|NCT01115101|piritramid|piritramid
737991|NCT01115127|pre-menopause|pre-menopause
737992|NCT01115127|melatonin|melatonin
737993|NCT01115127|myo-inositol|myo-inositol
737994|NCT01115140|Folate|folate
737995|NCT01115140|Metformin|metformin
737996|NCT01115140|PCOS|pcos
737997|NCT01115140|Pregnancy|pregnancy
737998|NCT01115140|Trophoblastic invasion|trophoblastic invasion
737999|NCT01115140|Uterine artery velocimetry|uterine artery velocimetry
738000|NCT01115153|Acute appendicitis|acute appendicitis
738001|NCT01115153|Antibiotic prophylaxis|antibiotic prophylaxis
738002|NCT01115153|Wound infection|wound infection
738003|NCT01115153|Nosocomial infection|nosocomial infection
738004|NCT01115166|blood volume|blood volume
738005|NCT01115179|propofol|propofol
738006|NCT01115179|inflammation|inflammation
738007|NCT01115179|perioperative|perioperative
738008|NCT01115179|lipids|lipids
738009|NCT01115179|Apolipoprotein A-I|apolipoprotein a-i
738010|NCT01115205|Exercise, Walking, Type 2 diabetes, Therapy|exercise, walking, type 2 diabetes, therapy
738011|NCT01115218|Glaucoma|glaucoma
738012|NCT01115231|Age-Related Macular Degeneration|age-related macular degeneration
738013|NCT01115231|Age-Related Maculopathies|age-related maculopathies
738014|NCT01115231|Age-Related Maculopathy|age-related maculopathy
738015|NCT01115231|Macular Dystrophy|macular dystrophy
738016|NCT01115231|Maculopathies, Age-Related|maculopathies, age-related
738017|NCT01115231|Maculopathy, Age-Related|maculopathy, age-related
738018|NCT01115244|Dermatitis herpetiformis|dermatitis herpetiformis
738019|NCT01115244|Dapsone|dapsone
738020|NCT01115257|severe proliferative diabetic retinopathy|severe proliferative diabetic retinopathy
738021|NCT01115257|vitrectomy|vitrectomy
738022|NCT01115257|panretinalphotocoagulation|panretinalphotocoagulation
738023|NCT01115270|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
738024|NCT01115283|amblyopia treatment|amblyopia treatment
738025|NCT01115283|neural plasticity|neural plasticity
738026|NCT01115283|perceptual learning|perceptual learning
738027|NCT01115283|vision therapy|vision therapy
738028|NCT01115283|spatial vision|spatial vision
738029|NCT01115283|video games|video games
738030|NCT01115283|occlusion therapy|occlusion therapy
738031|NCT01115296|Helicobacter Pylori|helicobacter pylori
738032|NCT01115296|gastritis|gastritis
738033|NCT01115296|Probiotics|probiotics
738034|NCT01115296|Lactobacillus Reuteri|lactobacillus reuteri
738035|NCT01115309|Sinusitis|sinusitis
738036|NCT01115322|Healthy volunteer study|healthy volunteer study
738037|NCT01115322|phototoxicity|phototoxicity
738038|NCT01115335|neonatal male circumcision|neonatal male circumcision
738039|NCT01115335|Gomco|gomco
738040|NCT01115335|Plastibell|plastibell
738041|NCT01115335|Mogen|mogen
738042|NCT01115335|Safety|safety
738043|NCT01115335|Uptake|uptake
738044|NCT01115335|Acceptability|acceptability
738045|NCT01115335|Feasibility|feasibility
738046|NCT01115335|Zambia|zambia
738047|NCT01115361|family planning|family planning
738048|NCT01115361|postpartum|postpartum
738049|NCT01115361|immunization|immunization
738050|NCT01115361|integration|integration
738051|NCT01115361|Contraceptive behavior|contraceptive behavior
738052|NCT01115387|Age-related macular degeneration|age-related macular degeneration
738053|NCT01115387|AMD|amd
738054|NCT01115387|Genetic risk|genetic risk
738055|NCT01115387|Environmental risk factors|environmental risk factors
738056|NCT01115387|Complex genetic disorder|complex genetic disorder
738057|NCT01115387|Age-related maculopathy|age-related maculopathy
738058|NCT01115387|Risk modeling|risk modeling
738059|NCT01115387|Smoking|smoking
738060|NCT01115387|Light exposure|light exposure
738061|NCT01115387|Sleep apnea|sleep apnea
738062|NCT01115387|Fundus Photography|fundus photography
738063|NCT01115387|Macula|macula
738064|NCT01115387|Drusen|drusen
738065|NCT01115387|Wet AMD|wet amd
738066|NCT01115387|Dry AMD|dry amd
738067|NCT01115387|Geographic atrophy|geographic atrophy
738068|NCT01115387|Vitamins & supplements|vitamins & supplements
738069|NCT01115400|Abdominal Wall Hernia|abdominal wall hernia
738070|NCT01115400|quality of life|quality of life
738071|NCT01115413|teenage|teenage
738072|NCT01115413|pregnancy|pregnancy
738073|NCT01115413|obstetrical risk|obstetrical risk
738074|NCT01115439|falciparum malaria|falciparum malaria
738075|NCT01115439|artemisinin combination treatments|artemisinin combination treatments
738076|NCT01115452|potassium nitrate|potassium nitrate
738077|NCT01115452|tooth sensitivity|tooth sensitivity
738078|NCT01115452|dentin sensitivity|dentin sensitivity
738079|NCT01115465|Stress Urinary Incontinence|stress urinary incontinence
738080|NCT01115465|silicone elastomer|silicone elastomer
738081|NCT01115478|Malaria|malaria
738082|NCT01115478|Low birth weight|low birth weight
738083|NCT01115478|Anemia|anemia
738084|NCT01115478|Perinatal mortality|perinatal mortality
738085|NCT01115478|Vitamin A|vitamin a
738086|NCT01115478|Zinc|zinc
738087|NCT01115504|Thiamine|thiamine
738088|NCT01115504|heart failure|heart failure
738089|NCT01115569|chronic pain|chronic pain
738090|NCT01115582|Inborn Errors|inborn errors
738091|NCT01115582|Bile Acid|bile acid
738092|NCT01115582|Pediatrics|pediatrics
738093|NCT01115582|Liver Disease|liver disease
738094|NCT01115595|Allergic rhinitis|allergic rhinitis
738095|NCT01115595|Allergen injection immunotherapy|allergen injection immunotherapy
738096|NCT01115595|Efficacy|efficacy
738097|NCT01115608|Preventive Health Services|preventive health services
738098|NCT01115634|Fibroblast|fibroblast
738099|NCT01115634|Cell transplantation|cell transplantation
738100|NCT01115634|Facial deformities|facial deformities
738101|NCT01115647|Malnutrition|malnutrition
738102|NCT01115647|Nutritional intervention|nutritional intervention
738103|NCT01115647|Behavioural intervention|behavioural intervention
738104|NCT01115647|Burkina Faso|burkina faso
738105|NCT01115647|Cluster randomize trial|cluster randomize trial
738106|NCT01115660|stroke|stroke
738107|NCT01115660|patient education|patient education
738108|NCT01115660|medication adherence|medication adherence
738109|NCT01115699|Depression|depression
738110|NCT01115699|rTMS|rtms
738111|NCT01115712|Healthy Volunteers|healthy volunteers
738112|NCT01115725|Follitropin alfa|follitropin alfa
738113|NCT01115725|Fertilization in vitro|fertilization in vitro
738114|NCT01115725|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
738115|NCT01115725|Reproductive techniques, assisted|reproductive techniques, assisted
738116|NCT01115738|Plavix, Effient|plavix, effient
738117|NCT01115751|Advanced Cancer|advanced cancer
738118|NCT01115751|Metastatic Cancer|metastatic cancer
738119|NCT01115751|Solid Tumors|solid tumors
738120|NCT01115764|diastolic dysfunction|diastolic dysfunction
738121|NCT01115777|Pediatric patients|pediatric patients
739828|NCT01122303|EGF|egf
738122|NCT01115777|treated with|treated with
738123|NCT01115777|radiation therapy|radiation therapy
738124|NCT01115777|for brain tumors|for brain tumors
738125|NCT01115777|and non-CNS malignancies|and non-cns malignancies
738126|NCT01115803|Advanced Cancer|advanced cancer
738127|NCT01115803|Metastatic Cancer|metastatic cancer
738128|NCT01115803|Non-Small Cell Lung Cancer|non-small cell lung cancer
738129|NCT01115803|Renal Cell Carcinoma|renal cell carcinoma
738130|NCT01115803|Neuroendocrine Tumors|neuroendocrine tumors
738131|NCT01115842|Vitamin D|vitamin d
738132|NCT01115842|Acute coronary syndrome|acute coronary syndrome
738133|NCT01115842|inflammatory cytokines|inflammatory cytokines
738134|NCT01115855|Double-blind|double-blind
738135|NCT01115855|eplerenone|eplerenone
738136|NCT01115855|Japanese|japanese
738137|NCT01115881|To examine the relationship between signal strength and macular thickness measured by stratus OCT|to examine the relationship between signal strength and macular thickness measured by stratus oct
738138|NCT01115894|problem drinking|problem drinking
738139|NCT01115894|alcohol|alcohol
738140|NCT01115907|Aortic|aortic
738141|NCT01115907|Valve replacement|valve replacement
738142|NCT01115920|Drug Safety|drug safety
738143|NCT01115920|Clinical Trial, Phase I|clinical trial, phase i
738144|NCT01115920|Nontherapeutic Human Experimentation|nontherapeutic human experimentation
738550|NCT01116947|Meals|meals
738145|NCT01115920|Heading Pharmacokinetics|heading pharmacokinetics
738146|NCT01115920|Phase I Safety and Tolerability|phase i safety and tolerability
738147|NCT01115933|drug eluting stents|drug eluting stents
738148|NCT01115933|small vessel|small vessel
738149|NCT01115933|Stents|stents
738150|NCT01115933|Everolimus|everolimus
738151|NCT01115933|Angioplasty|angioplasty
738152|NCT01115946|ASP1585|asp1585
738153|NCT01115946|Drug-drug interaction|drug-drug interaction
738154|NCT01115946|enalapril|enalapril
738155|NCT01115946|Healthy volunteer|healthy volunteer
738156|NCT01115972|ASP1585|asp1585
738157|NCT01115972|Drug-drug interaction|drug-drug interaction
738158|NCT01115972|valsartan|valsartan
738159|NCT01115972|Healthy volunteer|healthy volunteer
738160|NCT01115985|ASP1585|asp1585
738161|NCT01115985|Drug-drug interaction|drug-drug interaction
738162|NCT01115985|Atorvastatin|atorvastatin
738163|NCT01115985|Healthy volunteer|healthy volunteer
738164|NCT01115998|cerebral palsy|cerebral palsy
738165|NCT01115998|wheelchair|wheelchair
738166|NCT01115998|disabled children|disabled children
738167|NCT01116011|Phase I|phase i
738168|NCT01116011|Japanese Healthy volunteer|japanese healthy volunteer
738169|NCT01116024|Diseased Heart Valve, Replacement, Aortic|diseased heart valve, replacement, aortic
738170|NCT01116037|Diseased Heart Valve, Replacement, Aortic, Stentless|diseased heart valve, replacement, aortic, stentless
738171|NCT01116063|COPD, Pulmonary hypertension|copd, pulmonary hypertension
738172|NCT01116089|Cystic fibrosis, tobramycin,nebulizer, PK|cystic fibrosis, tobramycin,nebulizer, pk
738173|NCT01116102|dehydration|dehydration
738174|NCT01116102|fluid therapy|fluid therapy
738175|NCT01116102|hyaluronoglucosaminidase|hyaluronoglucosaminidase
738176|NCT01116102|hyaluronidase|hyaluronidase
738177|NCT01116102|hypodermoclysis|hypodermoclysis
738178|NCT01116102|clysis|clysis
738179|NCT01116102|subcutaneous hydration|subcutaneous hydration
738180|NCT01116102|subcutaneous rehydration|subcutaneous rehydration
738181|NCT01116102|hyaluronan|hyaluronan
738182|NCT01116102|rHuPH20|rhuph20
738183|NCT01116115|Term Infants|term infants
738184|NCT01116115|Intestine flora|intestine flora
738185|NCT01116115|Stool characteristics|stool characteristics
738186|NCT01116128|relapsed/refractory myeloma patients|relapsed/refractory myeloma patients
738187|NCT01116128|Progression free survival|progression free survival
738188|NCT01116128|Overall survival|overall survival
738189|NCT01116128|dasatinib|dasatinib
738190|NCT01116141|rheumatoid arthritis|rheumatoid arthritis
738192|NCT01116141|CH-405|ch-405
738193|NCT01116141|antifolates|antifolates
738194|NCT01116167|Polycystic Ovary Syndrome|polycystic ovary syndrome
738195|NCT01116180|Type 1 diabetes|type 1 diabetes
738196|NCT01116180|Hypoglycaemia|hypoglycaemia
738197|NCT01116180|genetic susceptibility|genetic susceptibility
738198|NCT01116180|Renin angiotensin system activity|renin angiotensin system activity
738199|NCT01116193|antileukemic therapy|antileukemic therapy
738200|NCT01116193|lymphoblastic leukemia|lymphoblastic leukemia
738201|NCT01116193|lenalidomide|lenalidomide
738202|NCT01116193|dexamethasone|dexamethasone
738203|NCT01116206|Constipation|constipation
738204|NCT01116206|Prucalopride|prucalopride
738205|NCT01116206|Resolor|resolor
738206|NCT01116219|adenocarcinoma of the lung|adenocarcinoma of the lung
738207|NCT01116219|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
738208|NCT01116219|large cell lung cancer|large cell lung cancer
738209|NCT01116219|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
738210|NCT01116219|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
738211|NCT01116232|graft versus host disease|graft versus host disease
738212|NCT01116232|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
738213|NCT01116232|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
753920|NCT01178294|blood coagulation disorders|blood coagulation disorders
738214|NCT01116232|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
738432|NCT01116531|duloxetine|duloxetine
738215|NCT01116232|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
738216|NCT01116232|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
738217|NCT01116232|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
738218|NCT01116232|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
738219|NCT01116232|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
738220|NCT01116232|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
738221|NCT01116232|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
738222|NCT01116232|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
738223|NCT01116232|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
738224|NCT01116232|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
738225|NCT01116232|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
738226|NCT01116232|prolymphocytic leukemia|prolymphocytic leukemia
738227|NCT01116232|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
738228|NCT01116232|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
738229|NCT01116232|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
738230|NCT01116232|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
738231|NCT01116232|refractory hairy cell leukemia|refractory hairy cell leukemia
738232|NCT01116232|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
738233|NCT01116232|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
738234|NCT01116232|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
738235|NCT01116232|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
738236|NCT01116232|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
738368|NCT01116310|Hot flashes|hot flashes
738237|NCT01116232|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
738238|NCT01116232|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
738239|NCT01116232|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
738240|NCT01116232|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
738241|NCT01116232|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
738242|NCT01116232|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
738243|NCT01116232|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
738244|NCT01116232|untreated hairy cell leukemia|untreated hairy cell leukemia
738245|NCT01116232|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
738246|NCT01116232|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
738247|NCT01116232|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
738248|NCT01116232|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
738249|NCT01116232|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
738250|NCT01116232|anaplastic large cell lymphoma|anaplastic large cell lymphoma
738251|NCT01116232|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
738252|NCT01116232|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
738253|NCT01116232|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
738254|NCT01116232|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
738255|NCT01116232|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
738256|NCT01116232|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
738257|NCT01116232|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
738258|NCT01116232|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
738259|NCT01116232|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
738260|NCT01116232|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
738261|NCT01116232|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
738262|NCT01116232|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
738263|NCT01116232|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
738264|NCT01116232|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
738265|NCT01116232|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
738266|NCT01116232|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
738267|NCT01116232|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
738268|NCT01116232|splenic marginal zone lymphoma|splenic marginal zone lymphoma
738269|NCT01116232|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
738270|NCT01116232|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
738271|NCT01116232|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
738272|NCT01116232|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
752594|NCT01173276|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
738273|NCT01116232|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
738274|NCT01116232|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
738275|NCT01116232|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
738276|NCT01116232|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
738277|NCT01116232|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
738278|NCT01116232|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
738279|NCT01116232|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
738280|NCT01116232|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
738281|NCT01116232|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
738282|NCT01116232|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
738283|NCT01116232|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
738284|NCT01116232|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
738285|NCT01116232|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
738286|NCT01116232|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
738287|NCT01116232|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
738288|NCT01116232|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
738289|NCT01116232|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
738290|NCT01116232|stage I mantle cell lymphoma|stage i mantle cell lymphoma
738291|NCT01116232|stage I marginal zone lymphoma|stage i marginal zone lymphoma
738292|NCT01116232|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
738293|NCT01116232|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
738294|NCT01116232|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
738295|NCT01116232|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
738296|NCT01116232|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
738297|NCT01116232|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
738298|NCT01116232|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
738299|NCT01116232|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
751828|NCT01170650|platinum-resistant|platinum-resistant
738300|NCT01116232|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
738301|NCT01116232|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
738302|NCT01116232|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
738303|NCT01116232|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
738304|NCT01116232|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
738305|NCT01116232|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
738306|NCT01116232|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
738307|NCT01116232|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
738308|NCT01116232|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
738309|NCT01116232|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
738310|NCT01116232|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
738311|NCT01116232|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
738312|NCT01116232|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
738313|NCT01116232|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
738314|NCT01116232|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
738315|NCT01116232|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
738316|NCT01116232|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
738317|NCT01116232|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
738318|NCT01116232|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
738319|NCT01116232|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
738320|NCT01116232|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
738321|NCT01116232|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
738322|NCT01116232|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
738323|NCT01116232|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
738324|NCT01116232|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
738325|NCT01116232|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
738326|NCT01116232|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
738327|NCT01116232|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
738328|NCT01116232|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
738329|NCT01116232|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
738330|NCT01116232|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
738331|NCT01116232|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
752735|NCT01173913|MTD|mtd
752736|NCT01173913|DLT|dlt
738332|NCT01116232|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
738333|NCT01116232|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
738334|NCT01116232|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
738335|NCT01116232|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
738336|NCT01116232|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
738433|NCT01116531|pregabalin|pregabalin
738337|NCT01116232|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
738338|NCT01116232|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
738339|NCT01116232|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
738340|NCT01116232|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
738341|NCT01116232|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
738342|NCT01116232|intraocular lymphoma|intraocular lymphoma
738343|NCT01116232|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
738344|NCT01116232|chronic eosinophilic leukemia|chronic eosinophilic leukemia
738345|NCT01116232|chronic neutrophilic leukemia|chronic neutrophilic leukemia
738346|NCT01116232|primary myelofibrosis|primary myelofibrosis
738347|NCT01116232|stage I multiple myeloma|stage i multiple myeloma
738348|NCT01116232|stage II multiple myeloma|stage ii multiple myeloma
738349|NCT01116232|stage III multiple myeloma|stage iii multiple myeloma
738350|NCT01116232|refractory multiple myeloma|refractory multiple myeloma
738351|NCT01116232|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
738352|NCT01116232|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
738353|NCT01116232|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
738354|NCT01116245|Cervical Intraepithelial Neoplasia Stage 2/3|cervical intraepithelial neoplasia stage 2/3
738355|NCT01116258|Safety|safety
738356|NCT01116271|colorectal|colorectal
738357|NCT01116271|second line therapy|second line therapy
738358|NCT01116271|K-ras or B-raf mutations|k-ras or b-raf mutations
738359|NCT01116271|response rate|response rate
738360|NCT01116271|Progression Free Survival|progression free survival
738361|NCT01116284|Weight Loss|weight loss
738362|NCT01116284|Obesity|obesity
738363|NCT01116284|Gastric Bypass|gastric bypass
738364|NCT01116297|breast reconstruction|breast reconstruction
738365|NCT01116297|breast cancer|breast cancer
738366|NCT01116297|near infrared imaging|near infrared imaging
738369|NCT01116310|menopause|menopause
738370|NCT01116310|postmenopause|postmenopause
738372|NCT01116310|Red clover|red clover
738373|NCT01116310|Equol|equol
738374|NCT01116323|Adverse events|adverse events
738375|NCT01116323|Adverse effects|adverse effects
738376|NCT01116323|Emergency Service, Hospital|emergency service, hospital
738377|NCT01116323|Emergency department|emergency department
738378|NCT01116323|Crowding|crowding
738379|NCT01116336|Pre-cancerous conditions|pre-cancerous conditions
738380|NCT01116336|Head and neck tumors|head and neck tumors
738381|NCT01116336|Cancer of head and neck|cancer of head and neck
738382|NCT01116349|humeral diaphysis fracture|humeral diaphysis fracture
738383|NCT01116349|plate and screws for humeral diaphysis fracture|plate and screws for humeral diaphysis fracture
738384|NCT01116349|nailing for humerus diaphysis fracture|nailing for humerus diaphysis fracture
738385|NCT01116349|Hanging Support System|hanging support system
738386|NCT01116362|ulna|ulna
738387|NCT01116362|median|median
738388|NCT01116362|repair|repair
738389|NCT01116362|primary|primary
738390|NCT01116375|Obesity|obesity
738392|NCT01116375|PAP therapy|pap therapy
738393|NCT01116388|Autism|autism
738394|NCT01116388|Gastrointestinal Disorders|gastrointestinal disorders
738395|NCT01116388|Food Allergy|food allergy
738396|NCT01116388|Gluten free, casein free diet|gluten free, casein free diet
738397|NCT01116388|Diarrhea|diarrhea
738398|NCT01116388|Constipation|constipation
738399|NCT01116388|Reflux|reflux
738400|NCT01116388|Abdominal pain|abdominal pain
738401|NCT01116388|Pain after eating|pain after eating
738402|NCT01116388|Self injurious behavior|self injurious behavior
738403|NCT01116401|Hot Flashes|hot flashes
738404|NCT01116401|Sleep disturbance|sleep disturbance
738405|NCT01116401|Lupron|lupron
738406|NCT01116401|Menopause|menopause
738407|NCT01116427|MS|ms
738408|NCT01116427|multiple sclerosis|multiple sclerosis
738409|NCT01116427|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
738410|NCT01116427|RRMS|rrms
738411|NCT01116440|Menstrual pain|menstrual pain
738412|NCT01116440|Refractory endometriosis|refractory endometriosis
738413|NCT01116440|Pelvic pain|pelvic pain
738414|NCT01116453|dysmenorrhea|dysmenorrhea
738415|NCT01116453|acupuncture|acupuncture
738416|NCT01116453|randomized controlled trial|randomized controlled trial
738417|NCT01116479|Anaemia, transfusion, cancer, chemotherapy, Quality of life|anaemia, transfusion, cancer, chemotherapy, quality of life
738418|NCT01116492|SILS|sils
738419|NCT01116492|Inflammatory reaction|inflammatory reaction
738420|NCT01116492|a-defensins|a-defensins
738421|NCT01116492|SILS vs standard laparoscopic cholecystectomy|sils vs standard laparoscopic cholecystectomy
738422|NCT01116505|Celiac disease|celiac disease
738423|NCT01116505|Endomysial antibodies|endomysial antibodies
738424|NCT01116505|Gluten-free diet|gluten-free diet
738425|NCT01116505|Screen-detected|screen-detected
738426|NCT01116505|Asymptomatic|asymptomatic
738427|NCT01116505|Bone mineral density|bone mineral density
738428|NCT01116531|Pharmacokinetics|pharmacokinetics
738429|NCT01116531|Pharmacodynamics|pharmacodynamics
738430|NCT01116531|Interaction|interaction
738435|NCT01116544|Cerebrovascular Accident|cerebrovascular accident
738436|NCT01116544|Chronic Stroke|chronic stroke
738437|NCT01116544|Rehabilitation|rehabilitation
738438|NCT01116544|Upper Extremity|upper extremity
738439|NCT01116544|Biofeedback|biofeedback
738440|NCT01116557|radiofrequency|radiofrequency
738441|NCT01116557|ablation|ablation
738442|NCT01116557|atrial fibrillation|atrial fibrillation
738443|NCT01116557|CARTO|carto
738444|NCT01116557|THERMOCOOL|thermocool
738445|NCT01116557|LASSO|lasso
738446|NCT01116557|PVAC|pvac
738447|NCT01116570|Muscular Dystrophy|muscular dystrophy
738448|NCT01116570|Facioscapulohumeral|facioscapulohumeral
738449|NCT01116570|Physical training|physical training
738450|NCT01116570|Exercise|exercise
738451|NCT01116583|Gabapentin|gabapentin
738452|NCT01116583|Thoracotomy|thoracotomy
738453|NCT01116583|Pain, Postoperative|pain, postoperative
738454|NCT01116583|Analgesia|analgesia
738455|NCT01116583|Recovery of Function|recovery of function
738456|NCT01116583|Quality of Life|quality of life
738457|NCT01116596|Glutathione|glutathione
738458|NCT01116596|Paracetamol|paracetamol
738459|NCT01116596|elderly people|elderly people
738460|NCT01116609|Phenylalanine|phenylalanine
738461|NCT01116609|Palmitate|palmitate
738462|NCT01116609|hyperinsulinemic-euglycemic-clamp|hyperinsulinemic-euglycemic-clamp
738463|NCT01116609|Effects of epinephrine in healthy volunteers|effects of epinephrine in healthy volunteers
738464|NCT01116622|Aerodigestive|aerodigestive
738465|NCT01116622|Targretin|targretin
738466|NCT01116622|Tarceva|tarceva
738467|NCT01116635|chemoembolization|chemoembolization
738468|NCT01116635|drug eluting microsphere|drug eluting microsphere
738469|NCT01116635|hepato|hepato
738470|NCT01116635|embolotherapy|embolotherapy
738471|NCT01116635|downstage|downstage
738472|NCT01116661|glioma|glioma
738473|NCT01116661|high grade glioma, low grade glioma|high grade glioma, low grade glioma
751829|NCT01170650|Phase III|phase iii
751830|NCT01170650|EC145|ec145
751831|NCT01170650|EC20|ec20
738474|NCT01116674|Intensive critical care, glycemic control, hypoglycemia, hyperglycemia , insulin treatment, intensive care outcomes, pediatrics|intensive critical care, glycemic control, hypoglycemia, hyperglycemia , insulin treatment, intensive care outcomes, pediatrics
738475|NCT01116700|Epilepsy|epilepsy
738476|NCT01116700|Dexmedetomidine|dexmedetomidine
738478|NCT01116713|Mastectomy|mastectomy
738479|NCT01116713|Breast cancer|breast cancer
738480|NCT01116713|Postoperative pain|postoperative pain
738481|NCT01116713|Postoperative nausea and vomiting|postoperative nausea and vomiting
738482|NCT01116752|Intensive Care|intensive care
738483|NCT01116752|Critical care|critical care
738484|NCT01116752|Glycemic Control|glycemic control
738485|NCT01116752|Hypoglycemia|hypoglycemia
738486|NCT01116752|Hyperglycemia|hyperglycemia
738487|NCT01116752|Insulin treatment|insulin treatment
738488|NCT01116752|Organ Function|organ function
738489|NCT01116752|PELOD|pelod
738490|NCT01116752|Outcomes|outcomes
738491|NCT01116752|Pediatrics|pediatrics
738492|NCT01116765|preterm infants born between 26 to 29 weeks of gestation age.|preterm infants born between 26 to 29 weeks of gestation age.
738493|NCT01116778|perennial allergic rhinitis|perennial allergic rhinitis
738494|NCT01116778|probiotics|probiotics
738495|NCT01116778|Lactobacillus paracasei GMNL-32 (eN-Lac®)|lactobacillus paracasei gmnl-32 (en-lac®)
738496|NCT01116778|efficacy and safety|efficacy and safety
738497|NCT01116791|cytoreductive surgery|cytoreductive surgery
738498|NCT01116791|peritoneal chemotherapy|peritoneal chemotherapy
738499|NCT01116791|cisplatin|cisplatin
738500|NCT01116791|cancer|cancer
738501|NCT01116791|gastric|gastric
738502|NCT01116791|biliary|biliary
738503|NCT01116791|pancreas|pancreas
738504|NCT01116791|peritoneal metastases|peritoneal metastases
738505|NCT01116791|liver metastases|liver metastases
738506|NCT01116791|peritoneal carcinomatosis from upper gastrointestinal cancer|peritoneal carcinomatosis from upper gastrointestinal cancer
738507|NCT01116804|Primary liver cancer|primary liver cancer
738508|NCT01116817|Long-term Lopinavir/ritonavir monotherapy|long-term lopinavir/ritonavir monotherapy
738509|NCT01116817|neurocognitive performance|neurocognitive performance
738510|NCT01116817|ultrasensitive CSF-viraemia|ultrasensitive csf-viraemia
738511|NCT01116843|Oral cavity cancer|oral cavity cancer
738512|NCT01116843|No prior treatment|no prior treatment
738513|NCT01116856|Exercise|exercise
738514|NCT01116856|Training|training
738515|NCT01116856|Obesity|obesity
738516|NCT01116856|Overweight|overweight
738517|NCT01116856|Body composition|body composition
738518|NCT01116856|Lipidic profile|lipidic profile
738519|NCT01116856|Nutrition|nutrition
738520|NCT01116856|Polymorphisms|polymorphisms
738521|NCT01116869|MBC|mbc
738522|NCT01116869|Healthy|healthy
738523|NCT01116869|Benign disease|benign disease
738524|NCT01116869|Confirmed metastatic breast cancer patient with at least one measurable solid tumor according to the RECIST guideline|confirmed metastatic breast cancer patient with at least one measurable solid tumor according to the recist guideline
738525|NCT01116869|Medical examinations detect no breast benign and malignant tumors|medical examinations detect no breast benign and malignant tumors
738526|NCT01116869|Benign Breast Disease|benign breast disease
738527|NCT01116869|Pathology diagnosed breast benign tumor disease|pathology diagnosed breast benign tumor disease
738528|NCT01116882|PCI|pci
738529|NCT01116882|heart disease|heart disease
738530|NCT01116882|ischemic heart disease|ischemic heart disease
738531|NCT01116895|Psoriasis Vulgaris|psoriasis vulgaris
738532|NCT01116895|Systemic|systemic
738533|NCT01116895|Anti-psoriatic|anti-psoriatic
738534|NCT01116908|Diarrhea|diarrhea
738535|NCT01116908|Water|water
738536|NCT01116908|Household Water Treatment|household water treatment
738537|NCT01116908|HIV|hiv
738538|NCT01116908|Infant Health|infant health
738539|NCT01116921|laryngeal mask airway|laryngeal mask airway
738540|NCT01116921|surfactant|surfactant
738541|NCT01116921|respiratory distress syndrome|respiratory distress syndrome
738542|NCT01116921|neonate|neonate
738543|NCT01116934|blood culture, IL-1β, IL-6, IL-8, IP-10, interferon-gamma|blood culture, il-1β, il-6, il-8, ip-10, interferon-gamma
738544|NCT01116947|Hypoalbuminemia|hypoalbuminemia
738545|NCT01116947|Hyperphosphatemia|hyperphosphatemia
738546|NCT01116947|Phosphorus|phosphorus
738547|NCT01116947|Protein|protein
738548|NCT01116947|CKD|ckd
738549|NCT01116947|Dialysis|dialysis
738551|NCT01116947|Lanthanum|lanthanum
738552|NCT01116947|End-Stage Renal Disease (ESRD)|end-stage renal disease (esrd)
738553|NCT01116947|Dietary Protein Intake (DPI)|dietary protein intake (dpi)
738554|NCT01116947|Dietary Phosphorus Binding (DPB)|dietary phosphorus binding (dpb)
738555|NCT01116947|Protein-Energy Wasting (PEW)|protein-energy wasting (pew)
738556|NCT01116947|Sources of Dietary Phosphorus|sources of dietary phosphorus
738557|NCT01116960|P4P|p4p
738558|NCT01116973|CVP monitoring compared with peripheral monitoring|cvp monitoring compared with peripheral monitoring
738559|NCT01116986|Smoking|smoking
738560|NCT01116986|Smoking Cessation|smoking cessation
738561|NCT01116986|Nicotine|nicotine
738850|NCT01117155|Imaging|imaging
738562|NCT01117025|Resistant hypertension|resistant hypertension
738563|NCT01117025|Atrial Fibrillation|atrial fibrillation
738564|NCT01117025|Percutaneous renal denervation|percutaneous renal denervation
738566|NCT01117038|Erectile Dysfunction|erectile dysfunction
738567|NCT01117051|Opioid induced constipation/prucalopride chronic non-cancer pain|opioid induced constipation/prucalopride chronic non-cancer pain
738568|NCT01117051|Subjects with chronic non-cancer pain suffering from OIC|subjects with chronic non-cancer pain suffering from oic
738569|NCT01110447|Hepatic Encephalopathy, probiotics|hepatic encephalopathy, probiotics
738570|NCT01110512|Improvement of CVI parameters|improvement of cvi parameters
738571|NCT01110525|Phase I|phase i
738572|NCT01110525|Drug-drug interaction|drug-drug interaction
738573|NCT01110525|Oral contraceptives|oral contraceptives
738574|NCT01110525|AZD 1981|azd 1981
738575|NCT01110551|Dengue, vaccine, flavivirus|dengue, vaccine, flavivirus
738576|NCT01110564|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
738577|NCT01110564|daily symptom variability|daily symptom variability
738578|NCT01110564|effects of symptom on morning activities|effects of symptom on morning activities
738579|NCT01110577|MRI|mri
738580|NCT01110577|Hepatic Steatosis Study|hepatic steatosis study
738581|NCT01110590|Erectile Dysfunction|erectile dysfunction
738582|NCT01110603|Cancer|cancer
738583|NCT01110603|Advanced Solid Tumors|advanced solid tumors
738584|NCT01110616|EEG Standardization|eeg standardization
738585|NCT01110629|Chronic kidney disease not on dialysis|chronic kidney disease not on dialysis
738586|NCT01110629|Lanthanum carbonate|lanthanum carbonate
738587|NCT01110655|Exercise-associated hyponatremia|exercise-associated hyponatremia
738588|NCT01110655|Randomized treatment trial|randomized treatment trial
738589|NCT01110655|Endurance runners|endurance runners
738590|NCT01110668|Unresectable|unresectable
738591|NCT01110668|metastatic gastrointestinal stromal tumor|metastatic gastrointestinal stromal tumor
738592|NCT01110668|disease progression|disease progression
738593|NCT01110668|progression-free survival|progression-free survival
738594|NCT01110694|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
738595|NCT01110694|Interstitial lung disease|interstitial lung disease
738596|NCT01110694|Prognosis|prognosis
738597|NCT01110694|Biomarkers|biomarkers
738598|NCT01110694|Mortality|mortality
738599|NCT01110694|Acute exacerbations|acute exacerbations
738600|NCT01110707|Reproductive technology, Assisted|reproductive technology, assisted
738601|NCT01110707|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
738602|NCT01110707|Recombinant leutinizing hormone (r-hLH)|recombinant leutinizing hormone (r-hlh)
738603|NCT01110707|Ovulation induction|ovulation induction
738604|NCT01110707|Infertility|infertility
738605|NCT01110733|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
738606|NCT01110733|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
738607|NCT01110733|Lymphoma|lymphoma
738608|NCT01110759|pain management|pain management
738609|NCT01110759|ambulatory surgery|ambulatory surgery
738610|NCT01110759|opioid|opioid
738611|NCT01110759|local anesthesia|local anesthesia
738612|NCT01110759|hand surgery|hand surgery
738613|NCT01110759|postoperative pain|postoperative pain
738614|NCT01110772|Surgical site infection|surgical site infection
738615|NCT01110772|Skin preparation|skin preparation
738616|NCT01110772|Cost analysis|cost analysis
738617|NCT01110785|recurrent colon cancer|recurrent colon cancer
738618|NCT01110785|stage III colon cancer|stage iii colon cancer
738619|NCT01110785|stage IV colon cancer|stage iv colon cancer
738620|NCT01110785|recurrent rectal cancer|recurrent rectal cancer
738621|NCT01110785|stage III rectal cancer|stage iii rectal cancer
738622|NCT01110785|stage IV rectal cancer|stage iv rectal cancer
738623|NCT01110798|perioperative/postoperative complications|perioperative/postoperative complications
738624|NCT01110798|gastrointestinal complications|gastrointestinal complications
738625|NCT01110798|adenocarcinoma of the rectum|adenocarcinoma of the rectum
738626|NCT01110798|stage I rectal cancer|stage i rectal cancer
738627|NCT01110798|stage II rectal cancer|stage ii rectal cancer
738628|NCT01110798|stage III rectal cancer|stage iii rectal cancer
738629|NCT01110811|GERD|gerd
738630|NCT01110811|Esophagitis|esophagitis
738631|NCT01110811|Fundoplication|fundoplication
738632|NCT01110811|Anti-reflux surgery|anti-reflux surgery
738633|NCT01110811|PPI dependent|ppi dependent
738634|NCT01110824|Prevention|prevention
738635|NCT01110824|ventricular dysfunction|ventricular dysfunction
738636|NCT01110824|chemotherapy|chemotherapy
738637|NCT01110824|acute myeloid leukemia|acute myeloid leukemia
738638|NCT01110824|precursor-cell lymphoblastic leukemia|precursor-cell lymphoblastic leukemia
738639|NCT01110824|multiple myeloma|multiple myeloma
738640|NCT01110824|lymphoma|lymphoma
738641|NCT01110824|ejection fraction|ejection fraction
738642|NCT01110824|Autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
738643|NCT01110837|Allergic rhinitis|allergic rhinitis
738644|NCT01110837|Allergen|allergen
738645|NCT01110850|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
738646|NCT01110863|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
738647|NCT01110876|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
738648|NCT01110876|GBM|gbm
738649|NCT01110876|Brain|brain
738650|NCT01110876|Central Nervous Center|central nervous center
738651|NCT01110876|Malignant glioma|malignant glioma
738652|NCT01110876|Glioblastoma multiforme|glioblastoma multiforme
738653|NCT01110876|Gliosarcoma|gliosarcoma
738654|NCT01110876|Anaplastic astrocytoma|anaplastic astrocytoma
738655|NCT01110876|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
738656|NCT01110876|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
738657|NCT01110876|Vorinostat|vorinostat
738658|NCT01110876|SAHA|saha
738659|NCT01110876|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
738660|NCT01110876|MSK-390|msk-390
738661|NCT01110876|Zolinza|zolinza
738662|NCT01110876|Erlotinib|erlotinib
738663|NCT01110876|Erlotinib Hydrochloride|erlotinib hydrochloride
738664|NCT01110876|OSI-774|osi-774
738665|NCT01110876|Tarceva|tarceva
738666|NCT01110876|Temozolomide|temozolomide
738667|NCT01110876|Temodar|temodar
738668|NCT01110889|Agomelatine|agomelatine
738669|NCT01110889|Major Depressive Disorder|major depressive disorder
738670|NCT01110889|MDD|mdd
738671|NCT01110889|depression|depression
738672|NCT01110902|Agomelatine|agomelatine
738673|NCT01110902|Major Depressive Disorder|major depressive disorder
738674|NCT01110902|MDD|mdd
738675|NCT01110902|depression|depression
738676|NCT01110941|S-1|s-1
738677|NCT01110941|leucovorin|leucovorin
738678|NCT01110941|oxaliplatin|oxaliplatin
738679|NCT01110941|colorectal cancer|colorectal cancer
738680|NCT01110941|SOL|sol
738681|NCT01110941|unresectable or recurrent colorectal cancer|unresectable or recurrent colorectal cancer
738682|NCT01110980|Head and Neck neoplasms|head and neck neoplasms
738683|NCT01110980|Radiotherapy|radiotherapy
738684|NCT01110980|Diet counselling|diet counselling
738685|NCT01110980|Swallow therapy|swallow therapy
738686|NCT01110980|Food intake|food intake
738687|NCT01110993|Multiple Sclerosis, Interferon-beta 1-a|multiple sclerosis, interferon-beta 1-a
738688|NCT01111006|Electronic toilet|electronic toilet
738689|NCT01111006|Bidet|bidet
738690|NCT01111006|Anorectal resting pressure|anorectal resting pressure
738691|NCT01111019|Hypochondroplasia|hypochondroplasia
738692|NCT01111019|Skeletal dysplasia|skeletal dysplasia
738693|NCT01111019|Growth|growth
738694|NCT01111019|Growth Hormone|growth hormone
738695|NCT01111019|Recombinant-human Growth Hormone|recombinant-human growth hormone
738696|NCT01111032|Treadmill|treadmill
738697|NCT01111032|Exercise|exercise
738698|NCT01111032|Cancer|cancer
738699|NCT01111032|Validity|validity
738700|NCT01111032|Reliability|reliability
738701|NCT01111058|Squamous Cell Cancer|squamous cell cancer
738702|NCT01111071|hospital variation|hospital variation
738703|NCT01111071|30 day mortality|30 day mortality
738704|NCT01111071|in hospital mortality|in hospital mortality
738705|NCT01111071|acute coronary syndrome|acute coronary syndrome
738706|NCT01111071|myocardial infarction|myocardial infarction
738707|NCT01111071|unstable angina|unstable angina
738708|NCT01111071|hospital performance|hospital performance
738709|NCT01111071|trends|trends
738710|NCT01111084|Ovulation induction|ovulation induction
738711|NCT01111084|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
738712|NCT01111084|Pregnancy|pregnancy
738713|NCT01111084|Fertility|fertility
738714|NCT01111097|Brain tumors, Glioblastoma and DCA|brain tumors, glioblastoma and dca
738715|NCT01111097|Brain tumor,Glioblastoma recurrent|brain tumor,glioblastoma recurrent
738716|NCT01111123|plaque psoriasis|plaque psoriasis
738717|NCT01111123|lac-hydrin|lac-hydrin
738718|NCT01111123|ammonium lactate|ammonium lactate
738719|NCT01111123|Ultravate|ultravate
738720|NCT01111123|halobetasol propionate|halobetasol propionate
738721|NCT01111123|weekend only application|weekend only application
738722|NCT01111123|topical therapy|topical therapy
738723|NCT01111123|topical corticosteroid|topical corticosteroid
738724|NCT01111123|class I steroid|class i steroid
738725|NCT01111136|Urticaria|urticaria
738727|NCT01111136|Stress|stress
738728|NCT01111149|Schizophrenia|schizophrenia
738729|NCT01111149|Smoking cessation|smoking cessation
738730|NCT01111149|Varenicline|varenicline
738731|NCT01111149|Bupropion|bupropion
738732|NCT01111162|HIV|hiv
738733|NCT01111162|H1N1 vaccination|h1n1 vaccination
738734|NCT01111162|HIV infected individuals|hiv infected individuals
738735|NCT01111175|Locally recurrent breast cancer|locally recurrent breast cancer
738736|NCT01111201|Autologous Bone Marrow Transplant|autologous bone marrow transplant
738737|NCT01111201|Breast|breast
738738|NCT01111201|Lymphoma|lymphoma
738739|NCT01111201|International travel|international travel
738740|NCT01111201|questionnaire|questionnaire
738741|NCT01111201|Hematopoietic Stem Cell Transplant (HSCT) recipients|hematopoietic stem cell transplant (hsct) recipients
738742|NCT01111214|Invasive Pneumococcal Disease (IPD)|invasive pneumococcal disease (ipd)
738743|NCT01111214|pneumococcal serotypes|pneumococcal serotypes
738744|NCT01111227|cytokines|cytokines
738745|NCT01111227|propofol|propofol
738746|NCT01111227|isoflurane|isoflurane
738747|NCT01111227|flow cytometry|flow cytometry
738748|NCT01111227|Types of General Anesthesia|types of general anesthesia
738749|NCT01111240|Humira|humira
738851|NCT01117155|FLT|flt
738750|NCT01111240|Long-term safety and effectiveness|long-term safety and effectiveness
738751|NCT01111240|Psoriatic Arthritis|psoriatic arthritis
738752|NCT01111253|multicenter randomized, open label, clinical trial|multicenter randomized, open label, clinical trial
738753|NCT01111253|acute uncomplicated (mild) diverticulitis|acute uncomplicated (mild) diverticulitis
738754|NCT01111253|treatment strategies|treatment strategies
738755|NCT01111253|management of diverticulitis|management of diverticulitis
738756|NCT01111253|antibiotics|antibiotics
738757|NCT01111253|observation and supportive care|observation and supportive care
738758|NCT01111253|cost analysis|cost analysis
738759|NCT01111253|economic evaluation|economic evaluation
738760|NCT01111266|in vivo KUF|in vivo kuf
738761|NCT01111266|ß2M|ß2m
738762|NCT01111266|leptin|leptin
738763|NCT01111305|Filariasis|filariasis
738764|NCT01111305|Post-Treatment Reactions|post-treatment reactions
738765|NCT01111305|Monoclonal Antibody|monoclonal antibody
738766|NCT01111305|Loa Loa|loa loa
738767|NCT01111305|Loiasis|loiasis
738768|NCT01111344|Dietary supplement|dietary supplement
738769|NCT01111344|Anogenital warts|anogenital warts
738770|NCT01111344|Viusid|viusid
738771|NCT01111344|Glizigen|glizigen
738772|NCT01111357|Rheumatoid Arthritis|rheumatoid arthritis
738773|NCT01111357|Rheumatoid Arthritis according to ACR criteria of diagnosis|rheumatoid arthritis according to acr criteria of diagnosis
738774|NCT01111370|diabetes mellitus requiring insulin|diabetes mellitus requiring insulin
738775|NCT01111383|cystic fibrosis|cystic fibrosis
738776|NCT01111383|P. aeruginosa|p. aeruginosa
738777|NCT01111383|tobramycin|tobramycin
738778|NCT01111396|ALL|all
738779|NCT01111396|GMALL 2003|gmall 2003
738780|NCT01111396|Chemotherapy|chemotherapy
738781|NCT01111396|Hippocampus|hippocampus
738782|NCT01111422|Antioxidant|antioxidant
738783|NCT01111422|Epithelial to Mesenchymal Transition|epithelial to mesenchymal transition
738784|NCT01111422|peritoneal fibrosis|peritoneal fibrosis
738785|NCT01111422|Peritoneal Dialysis, Continuous Ambulatory|peritoneal dialysis, continuous ambulatory
738786|NCT01111448|Myelodysplastic Syndromes of all IPSS subgroups|myelodysplastic syndromes of all ipss subgroups
738787|NCT01111461|Advanced Endometrial Cancer|advanced endometrial cancer
738788|NCT01111474|dentin hypersensitivity|dentin hypersensitivity
738789|NCT01111474|cyanoacrylate|cyanoacrylate
738790|NCT01111474|laser|laser
738791|NCT01111487|COPD|copd
738792|NCT01111487|Electromyography|electromyography
738793|NCT01111487|Inspiratory muscles|inspiratory muscles
738794|NCT01111513|knee surgery|knee surgery
738795|NCT01111513|total knee arthroplasty|total knee arthroplasty
738796|NCT01111513|total knee replacement|total knee replacement
738797|NCT01111513|ropivacaine|ropivacaine
738798|NCT01111513|femoral nerve block|femoral nerve block
738799|NCT01111526|Graft versus host disease|graft versus host disease
738800|NCT01111526|GVHD|gvhd
738801|NCT01111526|allogeneic transplant|allogeneic transplant
738802|NCT01111526|acute GVHD|acute gvhd
738803|NCT01111526|chronic GVHD|chronic gvhd
738804|NCT01111539|Major Depressive Disorder|major depressive disorder
738805|NCT01111539|MDD|mdd
738806|NCT01111539|Depression|depression
738807|NCT01111552|Major Depressive Disorder|major depressive disorder
738808|NCT01111552|MDD|mdd
738809|NCT01111552|Depression|depression
738810|NCT01111565|Major Depressive Disorder|major depressive disorder
738811|NCT01111565|MDD|mdd
738812|NCT01111565|Depression|depression
738813|NCT01111591|Cyclooxygenase-2 inhibitor (Celecoxib)|cyclooxygenase-2 inhibitor (celecoxib)
738814|NCT01111591|Extrahepatic bile duct cancer|extrahepatic bile duct cancer
738815|NCT01111591|Pancreas cancer|pancreas cancer
738816|NCT01111604|Colonic Neoplasms|colonic neoplasms
738817|NCT01111604|Rectal Neoplasms|rectal neoplasms
738818|NCT01111604|Adenocarcinoma|adenocarcinoma
738819|NCT01111604|Antibodies, Monoclonal|antibodies, monoclonal
738820|NCT01117064|Sleep Apnea|sleep apnea
738821|NCT01117064|OSA|osa
738822|NCT01117064|CPAP|cpap
738823|NCT01117077|liver transplantation|liver transplantation
738824|NCT01117077|aspergillus infection|aspergillus infection
738825|NCT01117077|interleukin-17|interleukin-17
738826|NCT01117077|Treg cell|treg cell
738827|NCT01117077|immune tolerance|immune tolerance
738828|NCT01117090|Feasibility|feasibility
738829|NCT01117090|SynchroMed II|synchromed ii
738830|NCT01117090|Intrathecal catheter|intrathecal catheter
738831|NCT01117090|Baclofen|baclofen
738832|NCT01117103|Type 2 diabetes|type 2 diabetes
738833|NCT01117103|Diabetes Mellitus|diabetes mellitus
738834|NCT01117103|Glucophage|glucophage
738835|NCT01117103|Metformin|metformin
738836|NCT01117142|CLL|cll
738837|NCT01117142|MBL|mbl
738838|NCT01117142|SLL|sll
738839|NCT01117142|MCL|mcl
738840|NCT01117142|Growth|growth
738841|NCT01117142|Development|development
738842|NCT01117142|Aging|aging
738843|NCT01117142|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
738844|NCT01117142|Monoclonal B-Cell Lymphocytosis|monoclonal b-cell lymphocytosis
738845|NCT01117142|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
738846|NCT01117142|Mantle Cell Lymphoma|mantle cell lymphoma
738847|NCT01117142|Healthy Volunteer|healthy volunteer
738848|NCT01117142|HV|hv
738849|NCT01117155|Brain Tumor|brain tumor
738852|NCT01117155|FDG|fdg
738853|NCT01117155|Spectroscopy|spectroscopy
738854|NCT01117155|Glioma|glioma
738855|NCT01117155|Glioblastoma Multiforme|glioblastoma multiforme
738856|NCT01117155|Astrocytoma|astrocytoma
738857|NCT01117168|Children's Oncology Group|children's oncology group
738858|NCT01117168|Pediatric Oncology|pediatric oncology
738859|NCT01117168|Pediatric Cancer|pediatric cancer
738860|NCT01117168|Registration|registration
738861|NCT01117168|Leukemia|leukemia
738862|NCT01117168|Brain Tumor|brain tumor
738863|NCT01117168|Sarcoma|sarcoma
738864|NCT01117181|Alzheimer's disease|alzheimer's disease
738865|NCT01117181|Apathy|apathy
738866|NCT01117181|Methylphenidate|methylphenidate
738867|NCT01117181|Dopaminergic agents|dopaminergic agents
738868|NCT01117181|Apathy Evaluation Scale|apathy evaluation scale
738869|NCT01117181|Dementia|dementia
738870|NCT01117220|pediatric|pediatric
738871|NCT01117220|bipolar|bipolar
738872|NCT01117233|Healthy volunteers|healthy volunteers
738874|NCT01117233|PD|pd
738875|NCT01117233|safety and toleration|safety and toleration
738876|NCT01117246|bone metastasis|bone metastasis
738877|NCT01117246|pain palliation|pain palliation
738878|NCT01117272|PCOS|pcos
738879|NCT01117272|hyperprolactinemia|hyperprolactinemia
738880|NCT01117272|obesity|obesity
738881|NCT01117272|hyperandrogenic|hyperandrogenic
738882|NCT01117285|Occupational Therapy|occupational therapy
738883|NCT01117285|Evidence-Based Practice|evidence-based practice
738884|NCT01117285|Continuing Education|continuing education
738885|NCT01117285|utilization|utilization
738886|NCT01117285|Guideline|guideline
738887|NCT01117285|Dementia|dementia
738888|NCT01117285|Guideline implementation|guideline implementation
738889|NCT01117298|Raynaud's phenomenon|raynaud's phenomenon
738890|NCT01117298|ischemic ulcers|ischemic ulcers
738891|NCT01117298|digital ulcers|digital ulcers
738892|NCT01117298|digital infarcts|digital infarcts
738893|NCT01117298|gangrene|gangrene
738894|NCT01117298|vasodilators|vasodilators
738895|NCT01117298|endothelial dysfunction|endothelial dysfunction
738896|NCT01117298|scleroderma|scleroderma
738897|NCT01117311|Vagus|vagus
738898|NCT01117311|Diabetes|diabetes
738899|NCT01117311|Obesity|obesity
738900|NCT01117324|Bone density|bone density
738901|NCT01117324|infant of diabetic mother|infant of diabetic mother
738902|NCT01117324|large birth weight|large birth weight
738903|NCT01117337|Hernia, laparoscopic, recurrence, pain, inguinal|hernia, laparoscopic, recurrence, pain, inguinal
738904|NCT01117363|Appetite whole grain|appetite whole grain
738905|NCT01117376|Gastroparesis|gastroparesis
738906|NCT01117376|Erythromycin|erythromycin
738907|NCT01117376|Methylnaltrexone|methylnaltrexone
738908|NCT01117376|ICU|icu
738909|NCT01117389|Human Papillomavirus Vaccination|human papillomavirus vaccination
738910|NCT01117389|Childhood cancer survivors|childhood cancer survivors
738911|NCT01117389|cervical cancer|cervical cancer
738912|NCT01117389|sexually transmitted infection|sexually transmitted infection
738913|NCT01117402|recurrent carcinoma cervix|recurrent carcinoma cervix
738914|NCT01117402|Vault carcinoma|vault carcinoma
738915|NCT01117402|Tomotherapy|tomotherapy
738916|NCT01117402|Brachytherapy|brachytherapy
738917|NCT01117415|Gall Bladder|gall bladder
738918|NCT01117415|Cholecystectomy|cholecystectomy
738919|NCT01118325|Stable Coronary Artery Disease|stable coronary artery disease
739422|NCT01120288|Solid Tumor|solid tumor
738920|NCT01118325|Platelet Aggregation|platelet aggregation
738921|NCT01118364|Social circumstances|social circumstances
738922|NCT01118390|telangiectasias|telangiectasias
738923|NCT01118390|leg|leg
738924|NCT01118390|sclerotherapy|sclerotherapy
738925|NCT01118390|laser|laser
738926|NCT01118390|glycose|glycose
738927|NCT01118403|Ventilator associated pneumonia|ventilator associated pneumonia
738928|NCT01118403|Coma|coma
738929|NCT01118403|Brain Injuries|brain injuries
738930|NCT01118403|Intensive care units|intensive care units
738931|NCT01118403|antibiotic prophylaxis|antibiotic prophylaxis
738932|NCT01118416|sexual risk|sexual risk
738933|NCT01118416|substance use|substance use
738934|NCT01118416|HIV|hiv
738935|NCT01118416|prevention|prevention
738936|NCT01118416|intervention|intervention
738937|NCT01118416|Motivational Enhancement Therapy|motivational enhancement therapy
738938|NCT01118416|young men who have sex with men|young men who have sex with men
738939|NCT01118429|hyperhidrosis|hyperhidrosis
738940|NCT01118429|axillary|axillary
738941|NCT01118429|osmidrosis|osmidrosis
738942|NCT01118429|oxybutynin|oxybutynin
738943|NCT01118442|Aortic Stenosis|aortic stenosis
738944|NCT01118442|Coronary Flow|coronary flow
738945|NCT01118442|Wave Intensity Analysis|wave intensity analysis
738946|NCT01118468|Competitive Flow|competitive flow
738947|NCT01118468|Coronary artery bypass|coronary artery bypass
738948|NCT01118468|Wave Intensity Analysis|wave intensity analysis
738949|NCT01118481|Coronary stenosis|coronary stenosis
738950|NCT01118481|Wave intensity analysis|wave intensity analysis
738951|NCT01118481|Instantaneous Flow Reserve|instantaneous flow reserve
738952|NCT01118481|iFR|ifr
738953|NCT01118481|Fractional Flow Reserve|fractional flow reserve
738954|NCT01118494|CKD|ckd
738956|NCT01118494|AGT|agt
738957|NCT01118507|Trisomy of chromosome 21 diagnosis|trisomy of chromosome 21 diagnosis
738958|NCT01118507|first trimester of pregnancy|first trimester of pregnancy
738959|NCT01118507|maternal blood|maternal blood
738960|NCT01118507|High output shotgun sequencing|high output shotgun sequencing
738961|NCT01118520|abdominal aortic aneurysm|abdominal aortic aneurysm
738962|NCT01118520|ACE Inhibition|ace inhibition
738964|NCT01118533|Sore throat|sore throat
738965|NCT01118533|Blades|blades
738966|NCT01118533|Laryngoscopy|laryngoscopy
738967|NCT01118533|Morbidity|morbidity
738968|NCT01118546|aspirin|aspirin
738969|NCT01118546|coronary artery disease|coronary artery disease
738970|NCT01118546|hypersensitivity|hypersensitivity
738971|NCT01118546|Platelet aggregation|platelet aggregation
738972|NCT01118559|YM150|ym150
738973|NCT01118559|Food effect|food effect
738974|NCT01118559|Healthy volunteer|healthy volunteer
738975|NCT01118572|Celecoxib|celecoxib
738976|NCT01118572|Celecox|celecox
738977|NCT01118572|Pain|pain
738978|NCT01118572|Surgery|surgery
738979|NCT01118572|NSAIDs|nsaids
738980|NCT01118585|GERD|gerd
738981|NCT01118585|Esophagitis|esophagitis
738982|NCT01118585|Fundoplication|fundoplication
738983|NCT01118585|Anti-reflux surgery|anti-reflux surgery
738984|NCT01118585|PPI dependent|ppi dependent
738985|NCT01118598|PCOS|pcos
738986|NCT01118611|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
738987|NCT01118624|Female|female
738988|NCT01118624|Advanced|advanced
738989|NCT01118624|Metastatic|metastatic
738990|NCT01118637|trichotillomania|trichotillomania
738991|NCT01118637|self-help|self-help
738992|NCT01118637|web-based|web-based
738993|NCT01118637|habit reversal|habit reversal
738994|NCT01118637|behavior therapy|behavior therapy
738995|NCT01118650|Inattention|inattention
738996|NCT01118650|Hyperactivity|hyperactivity
738997|NCT01118650|Impulsivity|impulsivity
738998|NCT01118663|Acetaminophen overdose; induced hepatotoxicity, liver injury|acetaminophen overdose; induced hepatotoxicity, liver injury
738999|NCT01118676|locally advanced non small cell lung cancer (NSCLC), locally advanced, Phase I, Cilengitide, concomitant radiochemotherapy|locally advanced non small cell lung cancer (nsclc), locally advanced, phase i, cilengitide, concomitant radiochemotherapy
739000|NCT01118702|Pharmacokinetic|pharmacokinetic
739001|NCT01118702|Methylphenidate|methylphenidate
739002|NCT01118702|Novo-methylphenidate ER-C|novo-methylphenidate er-c
739003|NCT01118702|Ritalin-SR|ritalin-sr
739004|NCT01118702|CONCERTA|concerta
739005|NCT01118702|Plasma profile|plasma profile
739006|NCT01118715|distal radius fracture|distal radius fracture
739007|NCT01118715|post-traumatic carpal tunnel syndrome|post-traumatic carpal tunnel syndrome
739008|NCT01118715|complex regional pain syndrome|complex regional pain syndrome
739009|NCT01118715|compression glove|compression glove
739010|NCT01118715|edema glove|edema glove
739011|NCT01118741|Rising PSA|rising psa
739012|NCT01118741|Recurrent Non Metastatic Prostate Cancer|recurrent non metastatic prostate cancer
739013|NCT01118754|Santen|santen
739014|NCT01118754|Dry|dry
739015|NCT01118754|Eye|eye
739016|NCT01118767|Adherence|adherence
739017|NCT01118767|Appointment|appointment
739018|NCT01118767|Cell Phone|cell phone
739019|NCT01118767|Cellular Phone|cellular phone
739020|NCT01118767|Clinic|clinic
739021|NCT01118767|Computers|computers
739022|NCT01118767|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
739023|NCT01118767|HIV/AIDS|hiv/aids
739024|NCT01118767|Health Informatics|health informatics
739025|NCT01118767|Health behavior|health behavior
739026|NCT01118767|Information Technology|information technology
739027|NCT01118767|Internet|internet
739028|NCT01118767|Intervention|intervention
739029|NCT01118767|Medication|medication
739030|NCT01118767|Patient Satisfaction|patient satisfaction
739031|NCT01118767|Patient Self-Report|patient self-report
739032|NCT01118767|Patients|patients
739033|NCT01118767|Peru|peru
739034|NCT01118767|Phone|phone
739035|NCT01118767|Public Health|public health
739036|NCT01118767|Public Health Informatics|public health informatics
739037|NCT01118767|Randomized|randomized
739038|NCT01118767|Randomized Controlled Clinical Trials|randomized controlled clinical trials
739039|NCT01118767|Randomized Controlled Trials|randomized controlled trials
739040|NCT01118767|Research|research
739041|NCT01118767|Secondary Prevention|secondary prevention
739042|NCT01118767|Self-Report|self-report
739043|NCT01118767|Sex Behavior|sex behavior
739044|NCT01118767|Sexual Behavior|sexual behavior
739045|NCT01118767|Sexually Transmitted Diseases|sexually transmitted diseases
739046|NCT01118767|Sexually Transmitted Infection|sexually transmitted infection
739047|NCT01118767|Survey Instrument|survey instrument
739048|NCT01118767|Surveys|surveys
739049|NCT01118767|Telephone|telephone
739050|NCT01118767|Telephone, Cellular|telephone, cellular
739051|NCT01118767|Text|text
739052|NCT01118767|Unprotected Sex|unprotected sex
739053|NCT01118767|Viral Load result|viral load result
739054|NCT01118767|Vulnerable Populations|vulnerable populations
739056|NCT01118767|anti-retroviral therapy|anti-retroviral therapy
739057|NCT01118767|consumer informatics|consumer informatics
739058|NCT01118767|evidence base|evidence base
739059|NCT01118767|follow-up|follow-up
739060|NCT01118767|medication adherence|medication adherence
739061|NCT01118767|medication compliance|medication compliance
739062|NCT01118767|randomization|randomization
739063|NCT01118767|randomized controlled study|randomized controlled study
739064|NCT01118767|randomized trial|randomized trial
739065|NCT01118767|randomly assigned|randomly assigned
739066|NCT01118767|safer sex|safer sex
739067|NCT01118767|treatment adherence|treatment adherence
739068|NCT01118767|user centered design|user centered design
739070|NCT01118767|world wide web|world wide web
739071|NCT01118780|GAD|gad
739072|NCT01118780|Generalized Anxiety Disorder|generalized anxiety disorder
739073|NCT01118780|Anxiety|anxiety
739074|NCT01118819|Phase I|phase i
739075|NCT01118819|Metastatic Disease|metastatic disease
739076|NCT01118819|Solid Tumor|solid tumor
739077|NCT01118819|Malignancy|malignancy
739078|NCT01118819|Metastases|metastases
739079|NCT01118819|Clinical trial|clinical trial
739080|NCT01118819|Hypoxia|hypoxia
739081|NCT01118819|Necrosis|necrosis
739082|NCT01118832|Thermography|thermography
739083|NCT01118845|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
739084|NCT01118845|Lymphoma, Large B-Cell|lymphoma, large b-cell
739085|NCT01118845|Diffuse, Mantle cell lymphoma, Lymphoma|diffuse, mantle cell lymphoma, lymphoma
739086|NCT01118845|Follicular, Lymphoma|follicular, lymphoma
739087|NCT01118845|Large B-Cell, Diffuse|large b-cell, diffuse
739088|NCT01118858|CYP2D6|cyp2d6
739089|NCT01118858|CYP3A4|cyp3a4
739090|NCT01118858|cytochrome P450|cytochrome p450
739091|NCT01118858|children|children
739092|NCT01118858|pediatrics|pediatrics
739093|NCT01118858|dextromethorphan|dextromethorphan
739094|NCT01118858|phenotype|phenotype
739095|NCT01118858|genotype|genotype
739096|NCT01118871|Treatment experienced|treatment experienced
739097|NCT01118884|Midazolam|midazolam
739098|NCT01118884|Nitrous oxide|nitrous oxide
739099|NCT01118884|Behaviour management|behaviour management
739100|NCT01118897|Gall bladder|gall bladder
739101|NCT01118897|Pancreatic cancers|pancreatic cancers
739102|NCT01118897|Tomotherapy|tomotherapy
739103|NCT01118910|Intertrigo|intertrigo
739104|NCT01118910|Vusion|vusion
739105|NCT01118923|Bronchial challenge test|bronchial challenge test
739106|NCT01118923|Hyperreactivity|hyperreactivity
739107|NCT01118923|PD20 for metacholine|pd20 for metacholine
739108|NCT01118923|Daily magnesium supplement|daily magnesium supplement
739109|NCT01118936|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
739110|NCT01118936|Daily magnesium supplement|daily magnesium supplement
739111|NCT01118936|EQ-5D|eq-5d
739112|NCT01118949|Primary Generalized Tonic-Clonic (PGTC) Seizures|primary generalized tonic-clonic (pgtc) seizures
739113|NCT01118949|Absence Seizures|absence seizures
739114|NCT01118949|Myoclonic Seizures|myoclonic seizures
739115|NCT01118949|Idiopathic Generalized Epilepsy (IGE)|idiopathic generalized epilepsy (ige)
739116|NCT01118962|Primary Generalized Tonic-Clonic (PGTC) Seizures|primary generalized tonic-clonic (pgtc) seizures
739117|NCT01118962|Absence Seizures|absence seizures
739118|NCT01118962|Myoclonic Seizures|myoclonic seizures
739119|NCT01118962|Idiopathic Generalized Epilepsy (IGE)|idiopathic generalized epilepsy (ige)
739120|NCT01118975|lapatinib ditosylate|lapatinib ditosylate
739121|NCT01118975|Zolinza (vorinostat)|zolinza (vorinostat)
739122|NCT01118975|Cancer Stem Cells|cancer stem cells
739123|NCT01118988|Peer Support|peer support
739124|NCT01118988|Social Support|social support
739125|NCT01118988|Chronic Pain|chronic pain
739126|NCT01118988|Behavioral Interventions for Pain|behavioral interventions for pain
739127|NCT01118988|Adolescents|adolescents
739128|NCT01118988|Children|children
739129|NCT01118988|Pediatric|pediatric
739130|NCT01118988|Mentorship|mentorship
739131|NCT01118988|Complementary and Alternative Medicine|complementary and alternative medicine
739132|NCT01118988|CAM|cam
739133|NCT01118988|Pain|pain
739134|NCT01118988|Pain Management|pain management
739135|NCT01118988|Behavioral|behavioral
739136|NCT01119014|Aripiprazole|aripiprazole
739137|NCT01119014|Quetiapine|quetiapine
739138|NCT01119014|Psychosis|psychosis
739139|NCT01119014|Child|child
739140|NCT01119014|Adolescent|adolescent
739141|NCT01119027|Laparoscopic Colectomy|laparoscopic colectomy
739142|NCT01119027|Colorectal Skills Training|colorectal skills training
739143|NCT01119040|Dislodged PEG tube|dislodged peg tube
739144|NCT01119040|NOTES|notes
739145|NCT01119053|VNS|vns
739146|NCT01119053|Depression|depression
739147|NCT01119053|Personality-Disorder|personality-disorder
739148|NCT01119053|Stimulation|stimulation
739149|NCT01119066|Leukemia|leukemia
739150|NCT01119066|Multiple Myeloma|multiple myeloma
739151|NCT01119066|radiation|radiation
739152|NCT01119066|Thiotepa|thiotepa
739153|NCT01119066|cyclophosphamide|cyclophosphamide
739154|NCT01119066|fludarabine|fludarabine
739155|NCT01119066|Clofarabine|clofarabine
739156|NCT01119066|CliniMACS device|clinimacs device
739157|NCT01119066|GCSF|gcsf
741571|NCT01131975|Lamotrigine (chewable, dispersible)|lamotrigine (chewable, dispersible)
741572|NCT01131988|Bioavailability, crossover, tacrolimus|bioavailability, crossover, tacrolimus
741577|NCT01132014|tumor harvesting and prior to enrollment.|tumor harvesting and prior to enrollment.
739158|NCT01119066|10-050|10-050
739159|NCT01119079|labor pain|labor pain
739160|NCT01119079|epidural|epidural
739161|NCT01119092|Ankle Sprain|ankle sprain
739162|NCT01119092|Joint Mobilization|joint mobilization
739163|NCT01119092|Manual Therapy|manual therapy
739164|NCT01119092|Range of Motion|range of motion
739165|NCT01119105|acute bacterial skin and skin structure infection|acute bacterial skin and skin structure infection
739166|NCT01119105|bacteria|bacteria
739167|NCT01119118|Metastatic|metastatic
739168|NCT01119118|castrate-resistant prostate cancer|castrate-resistant prostate cancer
739169|NCT01119118|bone metastasis|bone metastasis
739170|NCT01119131|Vitamin D|vitamin d
739171|NCT01119131|Parkinson disease|parkinson disease
739172|NCT01119131|accidental falls|accidental falls
739173|NCT01119144|Orbital|orbital
739174|NCT01119144|fractures|fractures
739175|NCT01119144|enophthalmos|enophthalmos
739176|NCT01119144|diplopia|diplopia
739178|NCT01119157|influenza vaccine|influenza vaccine
739179|NCT01119157|cellular immune response|cellular immune response
739180|NCT01119157|humoral immune response|humoral immune response
739181|NCT01119170|nutrition|nutrition
739182|NCT01119170|infant formula|infant formula
739183|NCT01119170|probiotics|probiotics
739184|NCT01119183|Patient understanding and counseling|patient understanding and counseling
739185|NCT01119196|Peritoneal Dialysis|peritoneal dialysis
739186|NCT01119196|Insulin resistance|insulin resistance
739187|NCT01119209|Hip fracture|hip fracture
739188|NCT01119209|intertrochanteric|intertrochanteric
739189|NCT01119222|Cold pain methodology|cold pain methodology
739190|NCT01119222|Healthy male volunteers|healthy male volunteers
739191|NCT01119222|gabapentin|gabapentin
739192|NCT01119222|Diphenhydramine|diphenhydramine
739193|NCT01119222|morphine|morphine
739194|NCT01119235|Pharmacokinetics|pharmacokinetics
739195|NCT01119235|tablet performance|tablet performance
739196|NCT01119235|healthy volunteers|healthy volunteers
739197|NCT01119235|open label|open label
739198|NCT01119248|Children MRI General Anesthesia|children mri general anesthesia
739199|NCT01119261|Venous thromboembolism (VTE)|venous thromboembolism (vte)
739200|NCT01119261|Atrial fibrillation (AF)|atrial fibrillation (af)
739201|NCT01119287|Conjunctivitis|conjunctivitis
739202|NCT01119287|ocular allergy|ocular allergy
739203|NCT01119300|Venous Thromboembolism (VTE)|venous thromboembolism (vte)
739204|NCT01119300|Atrial Fibrillation (AF)|atrial fibrillation (af)
739205|NCT01119326|scar prevention|scar prevention
739206|NCT01119326|healing|healing
739207|NCT01119326|tissue|tissue
739208|NCT01119326|AFT|aft
739209|NCT01119326|scar analysis|scar analysis
739210|NCT01119339|psoriasis|psoriasis
739211|NCT01119339|topical|topical
739212|NCT01119339|psoriasis plaques test|psoriasis plaques test
739213|NCT01119352|Safety|safety
739214|NCT01119352|tolerability|tolerability
739215|NCT01119352|PK|pk
739216|NCT01119352|healthy|healthy
739217|NCT01119352|overweight|overweight
739218|NCT01119352|obese|obese
739219|NCT01119365|Healthy controls|healthy controls
739220|NCT01119378|Post menopausal|post menopausal
739221|NCT01119378|Vitamin D sufficiency|vitamin d sufficiency
739222|NCT01119378|Calcium absorption efficiency|calcium absorption efficiency
739223|NCT01119378|Dual isotope technique|dual isotope technique
739224|NCT01119391|IVF|ivf
739225|NCT01119391|Lifestyle habits|lifestyle habits
739226|NCT01119404|Metabolic Syndrome|metabolic syndrome
739227|NCT01119404|Coronary Heart Disease|coronary heart disease
739228|NCT01119404|Erectile Dysfunction|erectile dysfunction
739229|NCT01119404|Arterial Elasticity|arterial elasticity
739230|NCT01119404|Oxidized Low Density Lipoprotein|oxidized low density lipoprotein
739231|NCT01119404|Cardiovascular Diseases|cardiovascular diseases
739232|NCT01119404|Risk Assessment|risk assessment
739233|NCT01119404|Endothelial Dysfunction|endothelial dysfunction
739234|NCT01119404|Diabetes Mellitus|diabetes mellitus
739235|NCT01119404|Surrogate Markers|surrogate markers
739236|NCT01119404|Risk Factors|risk factors
739237|NCT01119417|supine Hypertension|supine hypertension
739238|NCT01119417|autonomic failure|autonomic failure
739239|NCT01119417|BQ123|bq123
739240|NCT01119417|BQ-123|bq-123
739241|NCT01119417|endothelin|endothelin
739242|NCT01119430|major depression|major depression
739243|NCT01119430|DU 125530|du 125530
739244|NCT01119430|Treatment depression|treatment depression
739443|NCT01120418|screening|screening
739245|NCT01119430|Latency antidepressant|latency antidepressant
739246|NCT01119456|Tumors|tumors
739247|NCT01119456|Macrophage stimulating 1 receptor, human|macrophage stimulating 1 receptor, human
739248|NCT01119456|RON protein|ron protein
751832|NCT01170663|Metastatic Adenocarcinoma|metastatic adenocarcinoma
739249|NCT01119456|RON receptor protein tyrosine kinase|ron receptor protein tyrosine kinase
739250|NCT01119469|Hypochondriasis|hypochondriasis
739251|NCT01119469|Health Anxiety|health anxiety
739252|NCT01119469|randomized controlled trial|randomized controlled trial
739253|NCT01119469|Cognitive Therapy|cognitive therapy
739254|NCT01119469|Exposure Therapy|exposure therapy
739255|NCT01119482|Serogroup A meningococcal vaccine|serogroup a meningococcal vaccine
739256|NCT01119482|meningococcal carriage|meningococcal carriage
739257|NCT01119482|incidence|incidence
739258|NCT01119482|prevalence|prevalence
739259|NCT01119508|Advanced|advanced
739260|NCT01119508|Inoperable|inoperable
739261|NCT01119508|Melanoma|melanoma
739262|NCT01119508|Ipilimumab|ipilimumab
739263|NCT01119508|MDX010|mdx010
739264|NCT01119508|BMS-734016|bms-734016
739265|NCT01119508|Temozolomide|temozolomide
739266|NCT01119508|Temodar|temodar
739268|NCT01119508|skin|skin
739269|NCT01119508|mucosal|mucosal
739270|NCT01119521|South Africa,tuberculosis,vaccine|south africa,tuberculosis,vaccine
739271|NCT01119534|Cough treatment|cough treatment
739272|NCT01119547|Musculoskeletal Diseases|musculoskeletal diseases
739273|NCT01119547|Osteoarthritis|osteoarthritis
739274|NCT01119547|Joint Diseases|joint diseases
739275|NCT01119547|Arthritis|arthritis
739276|NCT01119547|Rheumatic Diseases|rheumatic diseases
739277|NCT01119573|stage I endometrial carcinoma|stage i endometrial carcinoma
739278|NCT01119573|stage III endometrial carcinoma|stage iii endometrial carcinoma
739279|NCT01119586|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
739280|NCT01119586|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
739281|NCT01119586|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
739282|NCT01119586|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
739283|NCT01119612|Malaria|malaria
739284|NCT01119612|Iron|iron
739285|NCT01119612|Pregnancy|pregnancy
739286|NCT01119612|Anemia|anemia
739287|NCT01119612|Birth Weight|birth weight
739288|NCT01119625|safety|safety
739289|NCT01119625|Streptococcus pneumoniae|streptococcus pneumoniae
739290|NCT01119625|immunogenicity|immunogenicity
739291|NCT01119625|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
739292|NCT01119625|Haemophilus influenzae|haemophilus influenzae
739293|NCT01119638|Alzheimer's disease|alzheimer's disease
739294|NCT01119638|BPSD|bpsd
739295|NCT01119638|escitalopram|escitalopram
739296|NCT01119638|Risperidone|risperidone
739297|NCT01119638|Agitation|agitation
739298|NCT01119638|Psychosis|psychosis
739299|NCT01119638|Dementia|dementia
739300|NCT01119638|Elderly|elderly
739301|NCT01119651|Healthy Volunteer Subjects|healthy volunteer subjects
739302|NCT01119664|Adult subjects with malignant pleural mesothelioma who present for first (front) line or second line chemotherapy,|adult subjects with malignant pleural mesothelioma who present for first (front) line or second line chemotherapy,
739303|NCT01119690|Dietary|dietary
739304|NCT01119690|Cross-Over Study|cross-over study
739305|NCT01119690|Lipids|lipids
739306|NCT01119690|Rapeseed oil|rapeseed oil
739307|NCT01119690|Butter|butter
739308|NCT01119690|Milk Fat|milk fat
739309|NCT01119690|Unsaturated Fat|unsaturated fat
739310|NCT01119690|Saturated Fat|saturated fat
739311|NCT01119690|Oxidized LDL|oxidized ldl
739312|NCT01119690|Platelet Function|platelet function
739313|NCT01119690|Arterial Elasticity|arterial elasticity
739314|NCT01119703|Vaccine Hyporesponse|vaccine hyporesponse
739315|NCT01119716|Atrial Fibrillation|atrial fibrillation
739316|NCT01119716|Afib|afib
739317|NCT01119716|cardioversion|cardioversion
739318|NCT01119716|normal sinus rhythm|normal sinus rhythm
739319|NCT01119716|arrhythmia|arrhythmia
739320|NCT01119716|AF|af
739321|NCT01119729|Cardiac Diseases • HIV-Infection • AIDS • Antiretroviral Therapy|cardiac diseases • hiv-infection • aids • antiretroviral therapy
739322|NCT01119742|Tinea Pedis|tinea pedis
739323|NCT01119742|Interdigital|interdigital
739324|NCT01119755|TREATMENT OF HYPERTENSION|treatment of hypertension
739326|NCT01119768|Nexium|nexium
739327|NCT01119768|Phase IV|phase iv
739328|NCT01119768|Co-diagnosed NERD|co-diagnosed nerd
739329|NCT01119794|B-cell small lymphocytic lymphoma|b-cell small lymphocytic lymphoma
739330|NCT01119794|marginal zone lymphoma|marginal zone lymphoma
739331|NCT01119794|follicular lymphoma|follicular lymphoma
739332|NCT01119794|mantle cell lymphoma|mantle cell lymphoma
739333|NCT01119794|Waldenström macroglobulinemia.|waldenström macroglobulinemia.
739334|NCT01119794|Low Grade B cell Non-Hodgkins Lymphoma|low grade b cell non-hodgkins lymphoma
739335|NCT01119807|Intraosseous infusion|intraosseous infusion
739336|NCT01119807|Emergency Medical Services|emergency medical services
739337|NCT01119820|elective obstetric or gynecologic surgery|elective obstetric or gynecologic surgery
739338|NCT01119833|Sickle Cell Disease|sickle cell disease
739339|NCT01119846|Tolerability|tolerability
739340|NCT01119846|Pharmacokinetics|pharmacokinetics
739341|NCT01119846|Safety|safety
739342|NCT01119846|Pharmacodynamics|pharmacodynamics
739343|NCT01119846|Glucose|glucose
739344|NCT01119872|Positive-Pressure Respiration|positive-pressure respiration
739345|NCT01119872|Respiration, Artificial|respiration, artificial
739346|NCT01119885|chronic pain|chronic pain
739347|NCT01119885|fentanyl matrix|fentanyl matrix
739348|NCT01119885|arthritis|arthritis
739349|NCT01119885|osteoarthritis|osteoarthritis
739350|NCT01119898|Osteoarthritis|osteoarthritis
739351|NCT01119898|Arthritis|arthritis
739352|NCT01119898|NSAIDs|nsaids
739353|NCT01119898|Topical NSAID|topical nsaid
739354|NCT01119898|Diclofenac|diclofenac
739355|NCT01119898|PENNSAID|pennsaid
739356|NCT01119911|Blood sampling|blood sampling
739357|NCT01119911|Venipuncture|venipuncture
739358|NCT01119911|Peripheral venous catheter|peripheral venous catheter
739359|NCT01119911|Complete blood count|complete blood count
739360|NCT01119911|Basic chemistry|basic chemistry
739361|NCT01119911|Hemolysis|hemolysis
739362|NCT01119911|Peripheral venous catheter replaces venipuncture.|peripheral venous catheter replaces venipuncture.
739363|NCT01119911|Peripheral venous catheter blood sampling reduces pain.|peripheral venous catheter blood sampling reduces pain.
739364|NCT01119924|Mirtazapine|mirtazapine
739366|NCT01119924|Depression|depression
739367|NCT01119924|Pain|pain
739368|NCT01119937|COPD|copd
739369|NCT01119937|NVA237|nva237
739370|NCT01119950|COPD|copd
739371|NCT01119963|Preterm delivery|preterm delivery
739372|NCT01119989|hepatic fat content|hepatic fat content
739373|NCT01119989|hepatic de novo lipogenesis|hepatic de novo lipogenesis
739374|NCT01120002|mild to moderate Alzheimer's Disease|mild to moderate alzheimer's disease
739375|NCT01120015|OA|oa
739376|NCT01120015|knee|knee
739377|NCT01120054|Traumatic Brain Injury|traumatic brain injury
739378|NCT01120054|Homelessness|homelessness
739379|NCT01120067|Psychology|psychology
739380|NCT01120067|Pain|pain
739381|NCT01120067|Veterans|veterans
739382|NCT01120067|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
739383|NCT01120080|Smoking|smoking
739384|NCT01120080|Tobacco|tobacco
739385|NCT01120080|Drinking|drinking
739386|NCT01120093|COPD|copd
739387|NCT01120106|levosimendan|levosimendan
739388|NCT01120106|pediatric cardiac surgery|pediatric cardiac surgery
739389|NCT01120106|low cardiac output syndrome|low cardiac output syndrome
739390|NCT01120106|transposition of the great arteries|transposition of the great arteries
739391|NCT01120145|Malaria|malaria
739392|NCT01120145|Pregnancy|pregnancy
739393|NCT01120145|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
739394|NCT01120158|Breast cancer|breast cancer
739395|NCT01120158|Elderly|elderly
739396|NCT01120158|Chemotherapy|chemotherapy
739397|NCT01120158|Anti-angiogenesis therapy|anti-angiogenesis therapy
739398|NCT01120171|Breast cancer|breast cancer
739399|NCT01120171|Elderly|elderly
739400|NCT01120171|Chemotherapy|chemotherapy
739401|NCT01120171|Cardiotoxicity|cardiotoxicity
739402|NCT01120197|randomized controlled trial|randomized controlled trial
739403|NCT01120197|osteoporosis|osteoporosis
739404|NCT01120197|moderate-intensity circuit exercises|moderate-intensity circuit exercises
739405|NCT01120197|balance|balance
739406|NCT01120197|health-related quality of life|health-related quality of life
739407|NCT01120210|Heart Failure|heart failure
739408|NCT01120210|Cardiac Failure|cardiac failure
739409|NCT01120249|stage I renal cell cancer|stage i renal cell cancer
739410|NCT01120249|stage II renal cell cancer|stage ii renal cell cancer
739411|NCT01120249|stage III renal cell cancer|stage iii renal cell cancer
739412|NCT01120249|clear cell renal cell carcinoma|clear cell renal cell carcinoma
739413|NCT01120249|papillary renal cell carcinoma|papillary renal cell carcinoma
739414|NCT01120262|recurrent prostate cancer|recurrent prostate cancer
739415|NCT01120262|stage IV prostate cancer|stage iv prostate cancer
739416|NCT01120288|Anti-Angiogenesis|anti-angiogenesis
739417|NCT01120288|Targeted Therapy|targeted therapy
739418|NCT01120288|HIF|hif
739419|NCT01120288|Antisense|antisense
739420|NCT01120288|VEGF|vegf
739421|NCT01120288|Cancer|cancer
739423|NCT01120288|Liver Metastasis|liver metastasis
739424|NCT01120301|stroke|stroke
739425|NCT01120353|Childhood cancer|childhood cancer
739426|NCT01120353|Young Children|young children
739427|NCT01120353|Adults|adults
739428|NCT01120379|drug eluting stents|drug eluting stents
739429|NCT01120379|Stents|stents
739430|NCT01120379|Angioplasty|angioplasty
739431|NCT01120379|Stent thrombosis|stent thrombosis
739432|NCT01120392|Parkinson's disease|parkinson's disease
739433|NCT01120392|Physical therapy|physical therapy
739434|NCT01120392|Virtual Reality|virtual reality
739435|NCT01120392|Quality of life|quality of life
739436|NCT01120392|Motor performance|motor performance
739437|NCT01120405|Xenon|xenon
739438|NCT01120405|Cardiac safety|cardiac safety
739439|NCT01120405|Cardiovascular risk|cardiovascular risk
739440|NCT01120405|Non cardiac surgery|non cardiac surgery
739441|NCT01120405|Atherosclerotic vascular surgery|atherosclerotic vascular surgery
739442|NCT01120418|Endothelial cell density|endothelial cell density
739444|NCT01120431|dehydration|dehydration
739445|NCT01120431|fluid therapy|fluid therapy
739446|NCT01120431|hyaluronoglucosaminidase|hyaluronoglucosaminidase
739447|NCT01120431|hyaluronidase|hyaluronidase
739448|NCT01120431|hypodermoclysis|hypodermoclysis
739449|NCT01120431|clysis|clysis
739450|NCT01120431|subcutaneous hydration|subcutaneous hydration
739451|NCT01120431|subcutaneous rehydration|subcutaneous rehydration
739452|NCT01120431|hyaluronan|hyaluronan
739453|NCT01120431|rHuPH20|rhuph20
739454|NCT01120431|pediatric|pediatric
739455|NCT01120431|ORT|ort
739456|NCT01120444|Diabetes|diabetes
739457|NCT01120444|Insulin|insulin
739458|NCT01120444|Blood Glucose|blood glucose
739459|NCT01120470|Castration Resistant|castration resistant
739460|NCT01120470|Prostate Cancer|prostate cancer
739461|NCT01120470|OGX-427|ogx-427
739462|NCT01120483|mortality|mortality
739463|NCT01120483|functional status|functional status
739464|NCT01120496|Hypertonic saline solution, bronchiolitis, RSV|hypertonic saline solution, bronchiolitis, rsv
739465|NCT01120509|Vena Cava|vena cava
739466|NCT01120509|Vena Cava Filter|vena cava filter
739467|NCT01120509|Pulmonary Embolism|pulmonary embolism
739468|NCT01120509|Venous Thromboembolism|venous thromboembolism
739469|NCT01120509|Risk of Pulmonary Embolism|risk of pulmonary embolism
739470|NCT01120522|Vena Cava|vena cava
739471|NCT01120522|Vena Cava Filter|vena cava filter
739472|NCT01120522|Pulmonary Embolism|pulmonary embolism
739473|NCT01120522|Venous Thromboembolism|venous thromboembolism
739474|NCT01120522|Risk of Pulmonary Embolism|risk of pulmonary embolism
739475|NCT01120535|Vena Cava|vena cava
739476|NCT01120535|Vena Cava Filter|vena cava filter
739477|NCT01120535|Pulmonary Embolism|pulmonary embolism
739478|NCT01120535|Venous Thromboembolism|venous thromboembolism
739479|NCT01120535|Risk of Pulmonary Embolism|risk of pulmonary embolism
739480|NCT01120548|CARDIAC REHABILITATION|cardiac rehabilitation
739481|NCT01120548|Nocturnal Ventilation|nocturnal ventilation
739482|NCT01120548|Apnea hypopnea index is > 15/h|apnea hypopnea index is > 15/h
739483|NCT01120561|TDM-1 EAP|tdm-1 eap
739484|NCT01120561|T-DM1 EAP|t-dm1 eap
739485|NCT01120561|TDM1 EAP|tdm1 eap
739486|NCT01120561|Trastuzumab-MCC-DM1 EAP|trastuzumab-mcc-dm1 eap
739487|NCT01120561|Trastuzumab emtansine|trastuzumab emtansine
739488|NCT01120561|EAP|eap
739489|NCT01120561|T-PAS|t-pas
739490|NCT01120574|Nocturnal hypercapnic response to oxygen|nocturnal hypercapnic response to oxygen
739491|NCT01120574|Home mechanical ventilation|home mechanical ventilation
739492|NCT01120574|COPD|copd
739493|NCT01120587|Deglutition|deglutition
739494|NCT01120587|Fluoroscopy|fluoroscopy
739495|NCT01120613|Nocturnal Hypertension|nocturnal hypertension
739496|NCT01120613|Nondipping|nondipping
739497|NCT01120613|Renal Transplant|renal transplant
739498|NCT01120613|Chronotherapy|chronotherapy
739499|NCT01120665|women's health|women's health
739500|NCT01120665|hormone replacement therapy|hormone replacement therapy
739501|NCT01120665|exercise|exercise
739502|NCT01120678|cytokines|cytokines
739503|NCT01120678|late-onset neonatal sepsis|late-onset neonatal sepsis
739504|NCT01120678|neonatal sepsis|neonatal sepsis
739505|NCT01120678|diagnosis of sepsis|diagnosis of sepsis
739506|NCT01120678|bacteremia|bacteremia
739507|NCT01120678|blood culture|blood culture
739508|NCT01120678|clinical sepsis|clinical sepsis
739509|NCT01120691|QVA149|qva149
739510|NCT01120691|NVA237|nva237
739511|NCT01120691|COPD|copd
739512|NCT01120691|exacerbation|exacerbation
739513|NCT01120691|combination bronchodilator|combination bronchodilator
739514|NCT01120704|Smoking|smoking
739515|NCT01120704|Smoking Cessation|smoking cessation
739516|NCT01120704|Adherence|adherence
739517|NCT01120704|Nicotine|nicotine
739518|NCT01120704|Motivation|motivation
739519|NCT01120717|QVA149|qva149
739520|NCT01120717|COPD|copd
739521|NCT01120717|combination bronchodilator|combination bronchodilator
739522|NCT01120743|liver failure|liver failure
739523|NCT01120743|cytokines|cytokines
739524|NCT01120743|hemodynamic instability|hemodynamic instability
739525|NCT01120756|executive dysfunction|executive dysfunction
739526|NCT01120756|brain injury|brain injury
739527|NCT01120756|attention|attention
739528|NCT01120756|rehabilitation|rehabilitation
739529|NCT01120756|fMRI|fmri
739530|NCT01120769|Myocardial Infarction|myocardial infarction
739531|NCT01120769|Percutaneous Coronary Intervention|percutaneous coronary intervention
739532|NCT01120769|Acetaminophen|acetaminophen
739533|NCT01120769|Lipid Peroxidation|lipid peroxidation
739534|NCT01114451|Cesarean delivery|cesarean delivery
739535|NCT01114451|Obesity|obesity
739536|NCT01114451|Skin staples|skin staples
739537|NCT01114451|Wound complications|wound complications
739538|NCT01114464|Breast cancer|breast cancer
739539|NCT01114464|Ovarian reserve|ovarian reserve
739540|NCT01114464|Anti-Mullerian Hormone (AMH)|anti-mullerian hormone (amh)
739541|NCT01114464|Chemotherapy|chemotherapy
739542|NCT01114477|Transcranial magnetic stimulation|transcranial magnetic stimulation
739543|NCT01114477|TMS|tms
739544|NCT01114477|Observational study|observational study
739545|NCT01114477|Major Depression|major depression
739546|NCT01114490|Hepatic Insufficiency|hepatic insufficiency
739547|NCT01114503|GSK2136525|gsk2136525
739548|NCT01114503|Pharmacodynamics|pharmacodynamics
739549|NCT01114503|Safety|safety
739550|NCT01114503|Otelixizumab|otelixizumab
739551|NCT01114503|Thyroid eye disease|thyroid eye disease
739552|NCT01114503|Graves' ophthalmopathy|graves' ophthalmopathy
739553|NCT01114503|Repeat dose|repeat dose
739554|NCT01114503|Intravenous infusion|intravenous infusion
739555|NCT01114503|Tolerability|tolerability
739556|NCT01114503|EUGOGO|eugogo
739557|NCT01114516|cervical insufficiency|cervical insufficiency
739558|NCT01114529|de novo renal allograft recipients|de novo renal allograft recipients
739559|NCT01114529|renal allograft function|renal allograft function
739560|NCT01114529|CNI-free regimen|cni-free regimen
739561|NCT01114555|Bevacizumab|bevacizumab
739562|NCT01114555|Irinotecan|irinotecan
739563|NCT01114555|Temozolomide|temozolomide
739564|NCT01114555|10-015|10-015
739566|NCT01120834|diffuse large b cell lymphoma|diffuse large b cell lymphoma
739567|NCT01120860|Cognitive Aging|cognitive aging
739568|NCT01120860|Apolipoproteins E|apolipoproteins e
739569|NCT01120860|Magnetic Resonance Imaging|magnetic resonance imaging
739570|NCT01120873|Hyperglycemia|hyperglycemia
739571|NCT01120873|dyslipidemia|dyslipidemia
739572|NCT01120873|Hypertension|hypertension
739573|NCT01120873|Obesity|obesity
739574|NCT01120886|Ion channelopathy,|ion channelopathy,
739575|NCT01120886|Still birth|still birth
739576|NCT01120886|Sudden death|sudden death
739577|NCT01120899|Diabetic Macular Edema|diabetic macular edema
739578|NCT01120899|Microglia|microglia
739579|NCT01120899|Minocycline|minocycline
739580|NCT01120899|Diabetes|diabetes
739581|NCT01120912|oral insulin|oral insulin
739582|NCT01120925|Cirrhotic|cirrhotic
739583|NCT01120925|Stem Cells|stem cells
739584|NCT01120925|Bone marrow stem cells|bone marrow stem cells
739585|NCT01120925|Decompensate Cirrhotic Patients|decompensate cirrhotic patients
739586|NCT01120938|AIrways, Patency, Infant death|airways, patency, infant death
739587|NCT01120951|Respiratory rate R8 Anaxsys|respiratory rate r8 anaxsys
739588|NCT01120990|Blood pressure measuring devices|blood pressure measuring devices
739589|NCT01120990|Essential Hypertension|essential hypertension
739590|NCT01120990|Automated blood pressure measurement|automated blood pressure measurement
739591|NCT01121003|Fructose|fructose
739592|NCT01121003|VLDL-triglycerides|vldl-triglycerides
739593|NCT01121003|de novo lipogenesis|de novo lipogenesis
739594|NCT01121003|Human metabolism|human metabolism
739595|NCT01121016|NAEB, chronic cough, montelukast, induced sputum|naeb, chronic cough, montelukast, induced sputum
739596|NCT01121055|Fiberoptic Bronchoscopy|fiberoptic bronchoscopy
739597|NCT01121055|Patient|patient
739598|NCT01121055|Satisfaction|satisfaction
739599|NCT01121055|Lorazepam|lorazepam
739600|NCT01121068|IGRA|igra
739601|NCT01121068|variability|variability
739602|NCT01121068|Long-term variability of IGRA|long-term variability of igra
739603|NCT01121081|Male or female subjects|male or female subjects
739604|NCT01121081|≥18 to ≤75 years of age|≥18 to ≤75 years of age
739605|NCT01121081|who have a diagnosis of plaque or guttate psoriasis|who have a diagnosis of plaque or guttate psoriasis
739606|NCT01121094|Liver, spleen , T2* , MRI, fetus|liver, spleen , t2* , mri, fetus
739607|NCT01121107|Heart Failure|heart failure
739608|NCT01121107|Decompensated Heart Failure|decompensated heart failure
739609|NCT01121107|Acute Decompensated Heart Failure|acute decompensated heart failure
739610|NCT01121107|Hemodynamic Monitoring|hemodynamic monitoring
739611|NCT01121107|Implantable Pressure Monitor|implantable pressure monitor
739612|NCT01121107|Left Atrial Pressure Monitoring|left atrial pressure monitoring
739613|NCT01121120|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
739614|NCT01121120|Hodgkin Disease|hodgkin disease
739615|NCT01121120|Multiple myeloma|multiple myeloma
739616|NCT01121120|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
739617|NCT01121120|Autologous Peripheral Blood Stem Cell Transplant|autologous peripheral blood stem cell transplant
739618|NCT01121120|Limited re-infusion of CD34+ cells|limited re-infusion of cd34+ cells
739619|NCT01121445|Sleep apnea|sleep apnea
739620|NCT01121445|CPAP|cpap
739932|NCT01122758|COPD|copd
739621|NCT01121445|Saline irrigation|saline irrigation
739622|NCT01121458|pulmonary artery|pulmonary artery
739623|NCT01121458|vascular resistance|vascular resistance
739624|NCT01121471|diabetes|diabetes
739625|NCT01121471|conjugated linoleic acid|conjugated linoleic acid
739626|NCT01121497|Sedation|sedation
739627|NCT01121497|Cognitive decline|cognitive decline
739628|NCT01121497|Physostigmine|physostigmine
739629|NCT01121497|Colonoscopy|colonoscopy
739630|NCT01121510|vascular closure device|vascular closure device
739631|NCT01121523|Prematurity|prematurity
739632|NCT01121523|massage|massage
739633|NCT01121523|stress|stress
739634|NCT01121523|parenting|parenting
739635|NCT01121523|infancy|infancy
739636|NCT01121523|sleep|sleep
739637|NCT01121523|intervention|intervention
739638|NCT01121536|Bipolar I Disorder|bipolar i disorder
739639|NCT01121549|Prospective|prospective
739640|NCT01121549|non-comparative|non-comparative
739642|NCT01121549|600|600
739643|NCT01121549|postmenopausal|postmenopausal
739644|NCT01121549|hormone-receptor|hormone-receptor
739645|NCT01121549|positive|positive
739646|NCT01121549|EBC|ebc
742072|NCT01124799|HCV|hcv
739647|NCT01121549|tamoxifen|tamoxifen
739648|NCT01121549|current medical practice.|current medical practice.
739649|NCT01121562|Neuroendocrine tumors|neuroendocrine tumors
739650|NCT01121575|Phase 1 acquired resistance to erlotinib or gefitinib cMET inhibitor EGFR inhibitor panHER inhibitor combination trial Crizotinib|phase 1 acquired resistance to erlotinib or gefitinib cmet inhibitor egfr inhibitor panher inhibitor combination trial crizotinib
739651|NCT01121588|neoplasm malignant|neoplasm malignant
739652|NCT01121588|lymphoma|lymphoma
739653|NCT01121588|neuroblastoma|neuroblastoma
739654|NCT01121588|Crizotinib|crizotinib
739655|NCT01121588|anaplastic lymphoma kinase|anaplastic lymphoma kinase
739657|NCT01121614|Harmonic scalpel|harmonic scalpel
739658|NCT01121614|ultrasonic scalpel|ultrasonic scalpel
739659|NCT01121614|LOTUS|lotus
739660|NCT01121614|LigaSure|ligasure
739661|NCT01121614|vessel sealing|vessel sealing
739662|NCT01121614|burst pressure|burst pressure
739663|NCT01121614|collateral damage|collateral damage
739664|NCT01121627|Computerized Cognitive training|computerized cognitive training
739665|NCT01121627|Quality of life|quality of life
739666|NCT01121627|Gait Function|gait function
739667|NCT01121627|Executive Function|executive function
739668|NCT01121640|Ovarian Cancer|ovarian cancer
739669|NCT01121640|Screening|screening
739670|NCT01121640|Biomarkers|biomarkers
739671|NCT01121653|Neuropathic pain, magnesium|neuropathic pain, magnesium
739672|NCT01121666|Assisted reproductive treatment|assisted reproductive treatment
739673|NCT01121666|Superovulation|superovulation
739674|NCT01121666|Follitropin alfa|follitropin alfa
739675|NCT01121666|r-hFSH|r-hfsh
739676|NCT01121666|AFOLIA|afolia
739677|NCT01121679|Older patients|older patients
739678|NCT01121679|Aged, 80 and Over|aged, 80 and over
739679|NCT01121679|Cardiology|cardiology
739680|NCT01121692|Couples|couples
739681|NCT01121692|Alcohol use|alcohol use
739682|NCT01121692|HIV risk|hiv risk
739683|NCT01121692|Outreach|outreach
739684|NCT01121705|genotype 3|genotype 3
739685|NCT01121705|Combination treatment|combination treatment
739686|NCT01121705|Short treatment|short treatment
739687|NCT01121718|lymph node|lymph node
739688|NCT01121731|Chronic Hepatitis C Viral Infection|chronic hepatitis c viral infection
739689|NCT01121731|Interferon alfa-5|interferon alfa-5
739690|NCT01121731|Interferon|interferon
739691|NCT01121744|Coronary Artery Disease|coronary artery disease
739692|NCT01121744|Drug Eluting Stents (DES)|drug eluting stents (des)
739693|NCT01121744|Pharmacokinetic (PK)|pharmacokinetic (pk)
739694|NCT01121757|relapsed|relapsed
739695|NCT01121757|refractory|refractory
739696|NCT01121757|lymphoma|lymphoma
739697|NCT01121757|follicular|follicular
739698|NCT01121757|marginal zone|marginal zone
739699|NCT01121809|Raltegravir|raltegravir
739700|NCT01121809|etravirine|etravirine
739701|NCT01121809|pharmacokinetics|pharmacokinetics
739702|NCT01121809|intracellular|intracellular
739703|NCT01121822|Influenza|influenza
739704|NCT01121822|Influenza vaccine|influenza vaccine
739705|NCT01121822|Influenza virus|influenza virus
739706|NCT01121822|Intramuscular|intramuscular
739707|NCT01121861|efficacy|efficacy
739708|NCT01121861|safety|safety
739709|NCT01121861|predictability|predictability
739710|NCT01121861|stability|stability
739711|NCT01121861|toric IOL|toric iol
739712|NCT01121861|refractive astigmatism|refractive astigmatism
739713|NCT01121861|phacoemulsification|phacoemulsification
739714|NCT01121874|CMC arthritis|cmc arthritis
739715|NCT01121874|thumb carpometacarpal arthritis|thumb carpometacarpal arthritis
739716|NCT01121874|basal joint arthritis|basal joint arthritis
739717|NCT01121874|thumb CMC arthritis|thumb cmc arthritis
739718|NCT01121887|smoking cessation|smoking cessation
739719|NCT01121887|telephone counselling|telephone counselling
739720|NCT01121887|motivational interviewing|motivational interviewing
739721|NCT01121887|treatment integrity|treatment integrity
739722|NCT01121887|Tobacco Smoking|tobacco smoking
739723|NCT01121900|Healthy subjects|healthy subjects
739724|NCT01121913|Healthy subjects|healthy subjects
739725|NCT01121926|Healthy subjects|healthy subjects
739726|NCT01121926|Bioavailability|bioavailability
739727|NCT01121926|Pharmacokinetics|pharmacokinetics
739728|NCT01121926|Trazodone|trazodone
739729|NCT01121926|Steady-state|steady-state
739730|NCT01121939|advanced neuroendocrine|advanced neuroendocrine
739731|NCT01121939|Gastrointestinal|gastrointestinal
739732|NCT01121939|Bevacizumab|bevacizumab
739733|NCT01121939|Avastin|avastin
739734|NCT01121939|Pertuzumab|pertuzumab
739735|NCT01121939|Omnitarg|omnitarg
739736|NCT01121939|2C4|2c4
739737|NCT01121939|Sandostatin|sandostatin
739738|NCT01121939|Octreotide|octreotide
739739|NCT01121952|Ankle joint|ankle joint
739740|NCT01121952|Talo-crural joint|talo-crural joint
739741|NCT01121952|Vertical jump|vertical jump
739742|NCT01121952|Chiropractic manipulation (HVLA)|chiropractic manipulation (hvla)
739743|NCT01121952|ROM|rom
739744|NCT01121952|Proprioception|proprioception
739745|NCT01121952|Pain|pain
739746|NCT01121965|macular hole|macular hole
739747|NCT01121965|impending macular hole|impending macular hole
742086|NCT01124825|Surgery|surgery
739748|NCT01121965|stage 1 macular hole|stage 1 macular hole
739749|NCT01121978|macular tractional maculopathy|macular tractional maculopathy
739750|NCT01121978|pathologic myopia|pathologic myopia
739751|NCT01121991|Infertility|infertility
739752|NCT01121991|Ovarian Stimulation|ovarian stimulation
739753|NCT01121991|Luveris|luveris
739754|NCT01121991|Lutropin alpha|lutropin alpha
739755|NCT01121991|Controlled ovarian stimulation|controlled ovarian stimulation
739756|NCT01121991|Reproductive techniques, assisted|reproductive techniques, assisted
739757|NCT01122030|Chronic pain|chronic pain
739758|NCT01122030|Opioid physical dependence|opioid physical dependence
739759|NCT01122043|Endoglide|endoglide
739760|NCT01122043|Endothelial Keratoplasty|endothelial keratoplasty
739761|NCT01122043|Donor Insertion|donor insertion
739763|NCT01122043|Corneal Transplant|corneal transplant
739764|NCT01122043|Patients with Bullous Keratopathy|patients with bullous keratopathy
739765|NCT01122056|Multiple Sclerosis|multiple sclerosis
739766|NCT01122056|b1b-interferon|b1b-interferon
739767|NCT01122056|Fatigue|fatigue
739768|NCT01122056|Exercise|exercise
739769|NCT01122082|energy intake|energy intake
739770|NCT01122082|energy expenditure|energy expenditure
739771|NCT01122082|macronutrient selection|macronutrient selection
739772|NCT01122095|Psoriasis|psoriasis
739773|NCT01122095|Cardiovascular risk|cardiovascular risk
739774|NCT01122108|Bile Acid Sequestrant|bile acid sequestrant
739775|NCT01122108|Resin|resin
739776|NCT01122108|Lipids|lipids
739777|NCT01122108|Glucose|glucose
739778|NCT01122108|Cholesterol|cholesterol
739779|NCT01122108|Diabetes Mellitus|diabetes mellitus
739780|NCT01122108|Bile Acid Sequestrant Acceptability Scale|bile acid sequestrant acceptability scale
739781|NCT01122121|Drug Therapy|drug therapy
739782|NCT01122121|Radiotherapy|radiotherapy
739783|NCT01122134|severe|severe
739784|NCT01122134|malaria|malaria
739785|NCT01122134|artesunate|artesunate
739786|NCT01122134|intravenous|intravenous
739787|NCT01122147|Aphthous stomatitis; Herbal medicines; Matricaria Chamomilla|aphthous stomatitis; herbal medicines; matricaria chamomilla
739788|NCT01122160|anthocyanin|anthocyanin
739789|NCT01122160|omeprazole|omeprazole
739790|NCT01122160|Prilosec|prilosec
739791|NCT01122160|gastric pH|gastric ph
739792|NCT01122160|proton pump inhibitor|proton pump inhibitor
739793|NCT01122160|PPI|ppi
739794|NCT01122160|nutrition|nutrition
739795|NCT01122173|Atrial Fibrillation|atrial fibrillation
739796|NCT01122173|Robotic Control|robotic control
739797|NCT01122173|Remote Control|remote control
739798|NCT01122186|Medication Adherence|medication adherence
739799|NCT01122186|Methamphetamine Use|methamphetamine use
739800|NCT01122186|Sexual Risk|sexual risk
739801|NCT01122186|Poly-substance Use|poly-substance use
739802|NCT01122186|HIV|hiv
739803|NCT01122186|Treatment|treatment
739804|NCT01122186|Motivational Interviewing|motivational interviewing
739805|NCT01122186|Cognitive Behavioral Skills Training|cognitive behavioral skills training
739806|NCT01122186|Men Who Have Sex With Men|men who have sex with men
739807|NCT01122212|intracerebral hemorrhage|intracerebral hemorrhage
739808|NCT01122212|ct scans|ct scans
739809|NCT01122212|protein s100|protein s100
739810|NCT01122212|inpatient treatment|inpatient treatment
739811|NCT01122225|septic shock|septic shock
739812|NCT01122225|medical intensive care|medical intensive care
739813|NCT01122238|Smoking|smoking
739814|NCT01122238|Smoking Cessation|smoking cessation
739815|NCT01122238|Motivation|motivation
739816|NCT01122238|Nicotine Dependence|nicotine dependence
739817|NCT01122251|hypertension|hypertension
739818|NCT01122251|lercanidipine|lercanidipine
739819|NCT01122251|valsartan|valsartan
739820|NCT01122264|Erectile Dysfunction|erectile dysfunction
739821|NCT01122277|Volume therapy|volume therapy
739822|NCT01122277|Fluid therapy|fluid therapy
739823|NCT01122277|Patients in ICU|patients in icu
739824|NCT01122290|Emotional eating|emotional eating
739825|NCT01122290|Eating in the absence of hunger|eating in the absence of hunger
739826|NCT01122290|emotion induction|emotion induction
739832|NCT01122303|Stevens-Johnson syndrome|stevens-johnson syndrome
739834|NCT01122316|Heart Failure|heart failure
739835|NCT01122316|Diabetes|diabetes
739836|NCT01122316|Metformin|metformin
739837|NCT01122329|dementia|dementia
739838|NCT01122342|Testosterone|testosterone
739839|NCT01122342|Vaginal administration|vaginal administration
739840|NCT01122342|Aromatase inhibitors|aromatase inhibitors
739846|NCT01122381|headache, migraine|headache, migraine
739847|NCT01122381|depression|depression
739848|NCT01122381|disability evaluation|disability evaluation
739849|NCT01122381|weight gain|weight gain
739850|NCT01122394|stroke|stroke
739851|NCT01122394|recurrence|recurrence
739852|NCT01122394|blood pressure|blood pressure
739853|NCT01122394|prevention|prevention
739854|NCT01122420|Obesity|obesity
739855|NCT01122433|difficult airway|difficult airway
739856|NCT01122433|indirect laryngoscopy|indirect laryngoscopy
739857|NCT01122433|C-MAC video laryngoscope|c-mac video laryngoscope
739858|NCT01122446|Alum-GAD|alum-gad
739859|NCT01122446|Type 1 diabetes|type 1 diabetes
739860|NCT01122446|prevention|prevention
739861|NCT01122446|immune tolerance|immune tolerance
739862|NCT01122446|glucose tolerance|glucose tolerance
739863|NCT01122446|glutamate decarboxylase autoantibodies|glutamate decarboxylase autoantibodies
739864|NCT01122459|Perioperative intravenous fluids|perioperative intravenous fluids
739865|NCT01122472|lenalidomide (Revlimid)|lenalidomide (revlimid)
739866|NCT01122472|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
739867|NCT01122472|phase III study|phase iii study
739868|NCT01122472|after R-CHOP|after r-chop
739869|NCT01122472|Maintenance treatment|maintenance treatment
739870|NCT01122472|Maintenance|maintenance
739871|NCT01122524|Trisomy 21|trisomy 21
739872|NCT01122537|Meningitis|meningitis
739873|NCT01122537|infection|infection
739874|NCT01122537|cerebrospinal fluid|cerebrospinal fluid
739875|NCT01122537|procalcitonin|procalcitonin
739876|NCT01122537|adenosine deaminase|adenosine deaminase
739877|NCT01122550|OABSS|oabss
739878|NCT01122550|IPSS|ipss
739879|NCT01122550|PPBC|ppbc
739880|NCT01122550|3-day micturition diary|3-day micturition diary
739881|NCT01122563|OABSS|oabss
739882|NCT01122563|IPSS|ipss
739883|NCT01122563|PPBC|ppbc
739884|NCT01122563|3-day micturition diary|3-day micturition diary
739885|NCT01122563|Solifenacin|solifenacin
739886|NCT01122576|Intra Ocular Lens|intra ocular lens
739887|NCT01122576|Ocular surgery|ocular surgery
739888|NCT01122576|Phacoemulsification|phacoemulsification
739889|NCT01122589|Smoking Abstinence|smoking abstinence
739890|NCT01122589|Smoking Cessation|smoking cessation
739891|NCT01122602|Aspirin|aspirin
739892|NCT01122615|Kidney|kidney
739893|NCT01122615|metastatic renal cell carcinoma|metastatic renal cell carcinoma
739895|NCT01122615|Sunitinib|sunitinib
739896|NCT01122615|Sunitinib Malate|sunitinib malate
739897|NCT01122615|Sutent|sutent
739898|NCT01122615|Temsirolimus|temsirolimus
739899|NCT01122615|Torisel|torisel
739900|NCT01122628|Distal Radial Fracture|distal radial fracture
739901|NCT01122628|Volar Locking Plate|volar locking plate
739902|NCT01122641|Insulin resistance|insulin resistance
739903|NCT01122641|incretins|incretins
739904|NCT01122641|DPP4 inhibitors|dpp4 inhibitors
739905|NCT01122641|vildagliptin|vildagliptin
739906|NCT01122641|microcirculation|microcirculation
739907|NCT01122667|Renal Insufficiency|renal insufficiency
739908|NCT01122693|Regional Anesthesia|regional anesthesia
739909|NCT01122693|Pain Medicine|pain medicine
739910|NCT01122693|Ultrasound|ultrasound
739911|NCT01122693|Nerve Blocks|nerve blocks
739912|NCT01122706|tai ji|tai ji
739913|NCT01122706|psychosocial stress|psychosocial stress
739914|NCT01122706|primary prevention|primary prevention
739915|NCT01122706|Trier Social Stress Test|trier social stress test
739916|NCT01122706|salivary cortisol|salivary cortisol
739917|NCT01122706|salivary alpha amylase|salivary alpha amylase
739918|NCT01122706|heart rate variability|heart rate variability
739919|NCT01122706|stress management|stress management
739920|NCT01122719|Optima|optima
739921|NCT01122719|Tacrolimus|tacrolimus
739922|NCT01122719|Drug eluting stent|drug eluting stent
739923|NCT01122732|nerve block|nerve block
739924|NCT01122732|continuous catheter|continuous catheter
739925|NCT01122732|shoulder surgery|shoulder surgery
739926|NCT01122732|pain control after total shoulder arthroplasty|pain control after total shoulder arthroplasty
739927|NCT01122745|continuous block|continuous block
739928|NCT01122745|single shot|single shot
739929|NCT01122745|interscalene|interscalene
739930|NCT01122745|rotator cuff surgery|rotator cuff surgery
739931|NCT01122758|Cohort|cohort
739933|NCT01122758|Natural history|natural history
739934|NCT01122758|Phenotyping|phenotyping
739935|NCT01122758|Smoking|smoking
739936|NCT01122771|visceral leishmaniasis|visceral leishmaniasis
739937|NCT01122771|phase III|phase iii
739938|NCT01122771|randomised ccontrolled trial|randomised ccontrolled trial
739939|NCT01122771|Bangladesh|bangladesh
739940|NCT01122771|Combination treatment|combination treatment
739941|NCT01122771|Ambisome|ambisome
739942|NCT01122771|miltefosine|miltefosine
739943|NCT01122771|paromomycin|paromomycin
739944|NCT01122784|Plague|plague
739945|NCT01122784|Vaccine|vaccine
739946|NCT01122797|PNPLA3|pnpla3
739947|NCT01122797|fibrosis|fibrosis
739948|NCT01122797|cirrhosis|cirrhosis
739949|NCT01122797|alcoholic liver disease|alcoholic liver disease
739950|NCT01122810|Diagnostic accuracy of coronary angiography|diagnostic accuracy of coronary angiography
739951|NCT01122810|Transplant heart patients|transplant heart patients
739952|NCT01122810|X-Ray and contrast agent exposure|x-ray and contrast agent exposure
739953|NCT01122810|Coronary stenosis|coronary stenosis
739954|NCT01122823|Chronic Disease Self-Management Program (CDSMP)|chronic disease self-management program (cdsmp)
739955|NCT01122836|Massage|massage
739956|NCT01122836|Chronic Neck Pain|chronic neck pain
739957|NCT01122836|Dosing Study|dosing study
739958|NCT01122849|trouble with sleep|trouble with sleep
739959|NCT01122849|night time nasal congestion|night time nasal congestion
739960|NCT01122862|tooth plaque|tooth plaque
739961|NCT01122914|Kineret|kineret
739962|NCT01122914|Anakinra|anakinra
739963|NCT01122914|Atopic Dermatitis|atopic dermatitis
739964|NCT01122914|Eczema|eczema
739965|NCT01122914|Allergic Disease|allergic disease
739966|NCT01122927|schizophrenia|schizophrenia
739967|NCT01122927|adolescent|adolescent
739968|NCT01122927|bipolar|bipolar
739969|NCT01122940|Bioequivalence|bioequivalence
739970|NCT01122940|Phenytoin|phenytoin
739971|NCT01122940|Epamin|epamin
739972|NCT01122953|Bioequivalence|bioequivalence
739973|NCT01122953|EPAMIN|epamin
739974|NCT01122953|PHENYTOIN|phenytoin
739975|NCT01122966|trabeculectomy|trabeculectomy
739976|NCT01122992|Limbal relaxing incision|limbal relaxing incision
739977|NCT01122992|Astigmatic correction|astigmatic correction
739978|NCT01122992|Phacoemulsification surgery|phacoemulsification surgery
739979|NCT01122992|Chinese eyes|chinese eyes
739980|NCT01123018|Memory Loss|memory loss
739981|NCT01123057|keratoconus|keratoconus
739982|NCT01123057|collagen cross-linking|collagen cross-linking
739983|NCT01123057|LASIK ectasia|lasik ectasia
739984|NCT01123057|keratoconus,lasik ectasia|keratoconus,lasik ectasia
739985|NCT01123083|new onset type 1 diabetes|new onset type 1 diabetes
739986|NCT01123083|juvenile diabetes|juvenile diabetes
739987|NCT01123083|T1DM|t1dm
739988|NCT01123083|Type 1 diabetes|type 1 diabetes
739989|NCT01123096|Stress urinary incontinence|stress urinary incontinence
739990|NCT01123109|nulliparous women|nulliparous women
739991|NCT01123135|urodynamic stress incontinence|urodynamic stress incontinence
739992|NCT01123135|postmenopausal women|postmenopausal women
739993|NCT01123148|Brain computer interface|brain computer interface
739994|NCT01123148|wheelchair control|wheelchair control
739995|NCT01123161|Hypothermia|hypothermia
739996|NCT01123161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
739997|NCT01123161|Cerebral Infarction|cerebral infarction
739998|NCT01123161|Hematologic Agents|hematologic agents
739999|NCT01123161|Stroke|stroke
740000|NCT01123161|Nervous System Diseases|nervous system diseases
740001|NCT01123161|Vascular Diseases|vascular diseases
740002|NCT01123161|Tissue Plasminogen Activator|tissue plasminogen activator
740003|NCT01123161|Central Nervous System Diseases|central nervous system diseases
740004|NCT01123161|Fibrinolytic Agents|fibrinolytic agents
740005|NCT01123161|Cardiovascular Agents|cardiovascular agents
740006|NCT01123161|Body Temperature Changes|body temperature changes
740007|NCT01123161|Brain Diseases|brain diseases
740008|NCT01123161|Cerebrovascular Disorders|cerebrovascular disorders
740009|NCT01123161|Pharmacologic Actions|pharmacologic actions
740010|NCT01123161|Signs and Symptoms|signs and symptoms
740011|NCT01123161|Fibrin Modulating Agents|fibrin modulating agents
740012|NCT01123161|Therapeutic Uses|therapeutic uses
740013|NCT01123161|Brain Ischemia|brain ischemia
740014|NCT01123161|Cardiovascular Diseases|cardiovascular diseases
740015|NCT01123161|Brain Infarction|brain infarction
740016|NCT01123161|Plasminogen|plasminogen
740017|NCT01123161|cooling|cooling
740019|NCT01123161|thrombolysis|thrombolysis
740020|NCT01123174|Suicide|suicide
740021|NCT01123174|case management algorithm|case management algorithm
740022|NCT01123174|suicidal behaviors|suicidal behaviors
740023|NCT01123174|prevention of suicide|prevention of suicide
740024|NCT01123187|diabetes type 1|diabetes type 1
740025|NCT01123187|kidney transplantation|kidney transplantation
740026|NCT01123187|islet|islet
740027|NCT01123187|hypoglycemia|hypoglycemia
740028|NCT01123213|pelvic organ prolapse|pelvic organ prolapse
740029|NCT01123213|pessary fitting|pessary fitting
740030|NCT01123239|Healthcare Disparities|healthcare disparities
740031|NCT01123252|Lactobacillus casei|lactobacillus casei
740032|NCT01123265|PsA|psa
740033|NCT01123265|methotrexate|methotrexate
740034|NCT01123265|Anti-TNF|anti-tnf
740035|NCT01123265|TNF|tnf
740036|NCT01123265|DC-Stamp|dc-stamp
740037|NCT01123278|Adiponectin|adiponectin
740038|NCT01123278|Resistin|resistin
740039|NCT01123278|Adipocytes|adipocytes
740040|NCT01123278|Testosterone|testosterone
740041|NCT01123278|Aging|aging
740042|NCT01123278|HOMA-IR|homa-ir
740043|NCT01123278|Insulin|insulin
740044|NCT01123278|Hypogonadism|hypogonadism
740045|NCT01123278|Metabolic Syndrome|metabolic syndrome
740046|NCT01123278|Obesity|obesity
740047|NCT01123278|Erectile Dysfunction|erectile dysfunction
740048|NCT01123291|follow-up coronary angiography|follow-up coronary angiography
740049|NCT01123304|melanoma|melanoma
740050|NCT01123317|Schizophrenia|schizophrenia
740051|NCT01123317|PET|pet
740052|NCT01123317|Oxytocin|oxytocin
740053|NCT01123343|limbal relaxing incision|limbal relaxing incision
740054|NCT01123343|LRI|lri
740055|NCT01123343|capsulorhexis|capsulorhexis
740056|NCT01123343|surgical guidance|surgical guidance
740057|NCT01123343|3d visualization|3d visualization
740058|NCT01123356|Relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
740059|NCT01123369|Sickle Cell Disease|sickle cell disease
740060|NCT01123382|Stroke|stroke
740061|NCT01123382|Shoulder pain|shoulder pain
740062|NCT01123382|Electrical stimulation|electrical stimulation
740063|NCT01123382|Neuromuscular stimulation|neuromuscular stimulation
740064|NCT01123382|Intramuscular stimulation|intramuscular stimulation
740065|NCT01123395|bioavailability|bioavailability
740066|NCT01123408|schizophrenia|schizophrenia
740067|NCT01123408|aggression|aggression
740068|NCT01123408|clozapine|clozapine
740069|NCT01123408|olanzapine|olanzapine
740070|NCT01123421|osteoporosis|osteoporosis
740071|NCT01123421|fracture risk|fracture risk
740072|NCT01123421|aging|aging
740073|NCT01123421|tibia|tibia
740074|NCT01123421|sonometer|sonometer
740075|NCT01123421|ultrasound|ultrasound
740076|NCT01123421|BMD|bmd
740077|NCT01123421|bone mineral density|bone mineral density
740078|NCT01123421|DXA|dxa
740079|NCT01123421|3D-HRpQT|3d-hrpqt
740080|NCT01123421|waveform profiles|waveform profiles
740081|NCT01123434|prostate cancer|prostate cancer
740082|NCT01123434|adjuvant|adjuvant
740083|NCT01123434|hormonal|hormonal
740084|NCT01123460|non-small cell lung cancer|non-small cell lung cancer
740085|NCT01123473|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
740086|NCT01123473|adenocarcinoma of the stomach|adenocarcinoma of the stomach
740087|NCT01123473|stage IIIA gastric cancer|stage iiia gastric cancer
740088|NCT01123473|stage IIIB gastric cancer|stage iiib gastric cancer
740089|NCT01123473|stage IIIC gastric cancer|stage iiic gastric cancer
740090|NCT01123473|stage IV gastric cancer|stage iv gastric cancer
740091|NCT01123486|Intravenous opioids|intravenous opioids
740092|NCT01123486|Patient Controlled Analgesia|patient controlled analgesia
740093|NCT01123486|volunteer pharmacokinetic-pharmacodynamic study|volunteer pharmacokinetic-pharmacodynamic study
740094|NCT01123499|G-CSF|g-csf
740095|NCT01123499|Plerixafor|plerixafor
740096|NCT01123499|Normal Volunteer|normal volunteer
740097|NCT01123499|Apheresis|apheresis
740098|NCT01123499|Healthy Volunteer|healthy volunteer
740099|NCT01123499|HV|hv
740100|NCT01123512|Vertebral Compression Fracture|vertebral compression fracture
740101|NCT01123512|Kyphoplasty|kyphoplasty
740102|NCT01123512|Spine|spine
740103|NCT01123512|Vertebral Body Compression Fracture|vertebral body compression fracture
740104|NCT01123512|Back Pain|back pain
740105|NCT01123551|Nebulized morphine|nebulized morphine
740106|NCT01123551|Intravenous morphine|intravenous morphine
740107|NCT01123551|Post traumatic|post traumatic
740108|NCT01123551|Pain|pain
740109|NCT01123551|Emergency department|emergency department
740110|NCT01123564|macular edema secondary to retinal vein occlusion|macular edema secondary to retinal vein occlusion
740111|NCT01123577|Self Blood Pressure Monitoring|self blood pressure monitoring
740112|NCT01123577|SBPM|sbpm
740113|NCT01123577|Randomized Control Trial|randomized control trial
740114|NCT01123577|Hypertension (HTN)|hypertension (htn)
740115|NCT01123577|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
740116|NCT01123577|HTN|htn
740117|NCT01123577|CVD|cvd
740118|NCT01123590|Thymoma|thymoma
740119|NCT01123590|Autoimmune diseases|autoimmune diseases
740120|NCT01123590|Immunodeficiency|immunodeficiency
740121|NCT01123603|frequency|frequency
740122|NCT01123603|women|women
740123|NCT01123603|fibroids|fibroids
740124|NCT01123603|uterine artery embolization|uterine artery embolization
740125|NCT01123603|myomectomy|myomectomy
740126|NCT01123603|hysterectomy|hysterectomy
740127|NCT01123616|surgical site infection|surgical site infection
740128|NCT01123616|elective colorectal surgery|elective colorectal surgery
740129|NCT01123616|level of surgical site infection|level of surgical site infection
740130|NCT01123616|complication of surgical site infection|complication of surgical site infection
740131|NCT01123616|type of changed bandage|type of changed bandage
740132|NCT01123616|frequency of bandage changing|frequency of bandage changing
741162|NCT01129453|Salmonella|salmonella
740133|NCT01123642|post-traumatic stress disorder|post-traumatic stress disorder
740134|NCT01123642|depressive disorder|depressive disorder
740135|NCT01123642|alcoholism|alcoholism
740136|NCT01123642|Longitudinal studies|longitudinal studies
740137|NCT01123642|readjustment|readjustment
740138|NCT01123668|Smoking|smoking
740139|NCT01123668|ADHD|adhd
740140|NCT01123668|Nicotine|nicotine
740141|NCT01123668|Methylphenidate|methylphenidate
740142|NCT01123668|function Magnetic Resonance Imaging|function magnetic resonance imaging
740143|NCT01123668|Neurobiological basis of abstinence-induced deficits in response inhibition|neurobiological basis of abstinence-induced deficits in response inhibition
740144|NCT01123681|Respiration, Artificial|respiration, artificial
740145|NCT01123681|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
740146|NCT01123681|Critical Illness|critical illness
740147|NCT01123694|xeroderma pigmentosum|xeroderma pigmentosum
740148|NCT01123694|quality of life|quality of life
740149|NCT01123694|DLQI|dlqi
740150|NCT01123694|CDLQI|cdlqi
740151|NCT01123707|Major Depressive Disorder|major depressive disorder
740152|NCT01123707|MDD|mdd
740153|NCT01123707|Depression|depression
740154|NCT01123733|Baby-friendly hospitals|baby-friendly hospitals
740155|NCT01123733|Non baby-friendly hospitals|non baby-friendly hospitals
740156|NCT01123733|Breastfeeding|breastfeeding
740157|NCT01123733|Ten steps for successful breastfeeding|ten steps for successful breastfeeding
740158|NCT01123746|Seizure|seizure
740159|NCT01123746|electrolyte|electrolyte
740160|NCT01123746|risk factor|risk factor
740161|NCT01123759|Fish|fish
740162|NCT01123759|mercury|mercury
740163|NCT01123759|omega-3 fatty acids|omega-3 fatty acids
740164|NCT01123759|infant|infant
740165|NCT01123759|brain development|brain development
740166|NCT01123759|pregnancy|pregnancy
740167|NCT01123759|nursing mother|nursing mother
740168|NCT01123759|dietary recommendations|dietary recommendations
740169|NCT01123759|Hair mercury|hair mercury
740170|NCT01123759|Blood mercury|blood mercury
740171|NCT01123759|Recommendations for pregnant or nursing women|recommendations for pregnant or nursing women
740172|NCT01123759|Infant brain health|infant brain health
740173|NCT01123772|adenosine agonist|adenosine agonist
740174|NCT01123772|eye drop|eye drop
740175|NCT01123772|elderly volunteer|elderly volunteer
740176|NCT01123772|older healthy volunteer|older healthy volunteer
740177|NCT01123785|glaucoma|glaucoma
740178|NCT01123785|ocular hypertension|ocular hypertension
740179|NCT01123785|adenosine agonist|adenosine agonist
740180|NCT01123785|eye drop|eye drop
740181|NCT01123785|primary open angle glaucoma|primary open angle glaucoma
740182|NCT01123798|near infrared spectroscopy|near infrared spectroscopy
740183|NCT01123798|lower extremity injury|lower extremity injury
740184|NCT01123811|adenocarcinoma|adenocarcinoma
740185|NCT01123811|gastric cancer|gastric cancer
740186|NCT01123811|esophagogastric junction cancer|esophagogastric junction cancer
740187|NCT01123824|healthy subjects|healthy subjects
740188|NCT01123850|CopiOs|copios
740189|NCT01123850|Degenerative spondylolisthesis,|degenerative spondylolisthesis,
740190|NCT01123850|stenosis with instability, or|stenosis with instability, or
740191|NCT01123850|degenerative disc disease as diagnosed by radicular signs and/or imaging studies|degenerative disc disease as diagnosed by radicular signs and/or imaging studies
740192|NCT01123863|Neuro cognitive deficits;|neuro cognitive deficits;
740193|NCT01123863|Brigance pre-school screen;|brigance pre-school screen;
740194|NCT01123876|Gastric Cancer|gastric cancer
740195|NCT01123889|subacromial impingement|subacromial impingement
740196|NCT01123889|partial thickness rotator cuff|partial thickness rotator cuff
740198|NCT01123889|platelet rich plasma|platelet rich plasma
740199|NCT01123902|Breathlessness|breathlessness
740200|NCT01123902|Dyspnea|dyspnea
740201|NCT01123902|Hand-held fan|hand-held fan
740202|NCT01123902|Palliative Care|palliative care
740203|NCT01117428|Advanced solid tumors|advanced solid tumors
740204|NCT01117428|Metastatic colorectal Cancer|metastatic colorectal cancer
740205|NCT01117454|Catecholaminergic Polymorphic Ventricular Tachycardia|catecholaminergic polymorphic ventricular tachycardia
740206|NCT01117454|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
740207|NCT01117454|flecainide|flecainide
740208|NCT01117467|Simulation|simulation
740209|NCT01117467|Learning|learning
740210|NCT01117467|Medical Students|medical students
740211|NCT01117467|Empathy|empathy
740212|NCT01117467|Anxiety|anxiety
740213|NCT01117480|Moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
740214|NCT01117480|Rheumatoid Arthritis|rheumatoid arthritis
740215|NCT01117480|Severe Rheumatoid Arthritis|severe rheumatoid arthritis
740216|NCT01117480|Adalimumab|adalimumab
740217|NCT01117480|Clinical Effectiveness|clinical effectiveness
740218|NCT01117506|Angina|angina
740219|NCT01117506|Myocardial Ischemia|myocardial ischemia
740220|NCT01117506|Molecular Genetics|molecular genetics
740221|NCT01117506|Atherosclerosis|atherosclerosis
740222|NCT01117519|fluid and volume management|fluid and volume management
740223|NCT01117519|acid-base balance|acid-base balance
740224|NCT01117519|goal-directed therapy|goal-directed therapy
752837|NCT01174394|Apoplexy|apoplexy
740225|NCT01117519|transoesophageal doppler|transoesophageal doppler
740226|NCT01117532|students,|students,
740227|NCT01117532|depression,|depression,
740228|NCT01117532|group therapy,|group therapy,
740229|NCT01117532|EFT (Emotional Freedom Techniques),|eft (emotional freedom techniques),
740230|NCT01117532|energy psychology|energy psychology
740231|NCT01117545|veterans,|veterans,
740232|NCT01117545|PTSD,|ptsd,
740233|NCT01117545|EFT (Emotional Freedom Techniques),|eft (emotional freedom techniques),
740234|NCT01117545|depression,|depression,
740235|NCT01117545|anxiety|anxiety
740236|NCT01117558|PCOS,|pcos,
740237|NCT01117558|DM,|dm,
740238|NCT01117558|Hypertension,|hypertension,
740239|NCT01117558|CVD|cvd
740240|NCT01117571|knee|knee
740241|NCT01117571|osteoarthritis|osteoarthritis
740242|NCT01117571|unicompartmental|unicompartmental
740243|NCT01117571|arthroplasty|arthroplasty
740244|NCT01117584|Type 2 diabetes|type 2 diabetes
740245|NCT01117584|diabetes|diabetes
740246|NCT01117584|ASP1941|asp1941
740247|NCT01117584|metformin|metformin
740248|NCT01117597|Healthy subjects|healthy subjects
740249|NCT01117610|pain|pain
740250|NCT01117610|preemptive|preemptive
740251|NCT01117610|postoperative|postoperative
740252|NCT01117610|epidural injection|epidural injection
740253|NCT01117610|laminectomy|laminectomy
740254|NCT01117623|Oncology patients with advanced disease|oncology patients with advanced disease
740255|NCT01117623|BAY73-4506|bay73-4506
740256|NCT01117636|Aspirin|aspirin
740257|NCT01117649|PVR|pvr
740258|NCT01117649|HES 130|hes 130
740259|NCT01117649|pancreatic head|pancreatic head
740260|NCT01117649|goal-directed|goal-directed
740261|NCT01117649|intraoperative PVR in elective surgery of the pancreatic head|intraoperative pvr in elective surgery of the pancreatic head
740262|NCT01117662|transplantation|transplantation
740263|NCT01117662|acute rejection|acute rejection
740265|NCT01117675|Telemedicine|telemedicine
740266|NCT01117675|Home care|home care
740267|NCT01117675|Chronic HIV infection|chronic hiv infection
740268|NCT01117675|HIV-infected patients|hiv-infected patients
740269|NCT01117688|Ureteroscopy|ureteroscopy
740270|NCT01117714|Lung cancer|lung cancer
740271|NCT01117714|Lung neoplasm|lung neoplasm
740272|NCT01117714|Pulmonary cancer|pulmonary cancer
740273|NCT01117714|Pulmonary neoplasm|pulmonary neoplasm
740274|NCT01117714|Lung cancer staging|lung cancer staging
740275|NCT01117740|Malignant Pleural Effusions|malignant pleural effusions
740276|NCT01117740|MPE|mpe
740277|NCT01117740|Lungs|lungs
740278|NCT01117740|Quality of Life|quality of life
740279|NCT01117740|M. D. Anderson Symptom Inventory|m. d. anderson symptom inventory
740280|NCT01117740|MDASI|mdasi
740281|NCT01117740|Indwelling Pleural Catheters|indwelling pleural catheters
740282|NCT01117740|Thoracoscopic Pleurodesis|thoracoscopic pleurodesis
740283|NCT01117740|Symptom burden|symptom burden
740284|NCT01117740|Pleurodesis efficacy|pleurodesis efficacy
740285|NCT01117740|Complications|complications
740286|NCT01117740|Health care resource utilization|health care resource utilization
740287|NCT01117766|Methodology|methodology
740288|NCT01117766|Quantitative Sensory Testing|quantitative sensory testing
740289|NCT01117766|Neuropathies Pain|neuropathies pain
740290|NCT01117766|Pregabalin|pregabalin
740291|NCT01117779|kidney tumors|kidney tumors
740292|NCT01117779|renal tumors|renal tumors
740293|NCT01117779|renal cell carcinoma|renal cell carcinoma
740294|NCT01117779|kidney lesions|kidney lesions
740295|NCT01117779|renal lesions|renal lesions
740296|NCT01117779|cryoablation|cryoablation
740297|NCT01117779|cryotherapy|cryotherapy
740298|NCT01117779|cryosurgery|cryosurgery
740300|NCT01117831|Diabetes mellitus|diabetes mellitus
740301|NCT01117870|chronic|chronic
740302|NCT01117870|pain|pain
740303|NCT01117870|lumbar|lumbar
740304|NCT01117870|Radicular|radicular
740305|NCT01117883|Perfusion pressures|perfusion pressures
740306|NCT01117883|central venous pressure|central venous pressure
740307|NCT01117883|cardiac output|cardiac output
740308|NCT01117883|CPR|cpr
740309|NCT01117883|cardiac arrest|cardiac arrest
740310|NCT01117883|Leaning|leaning
740311|NCT01117883|incomplete release|incomplete release
740312|NCT01117896|CPR|cpr
740313|NCT01117896|Rescuer fatigue|rescuer fatigue
740314|NCT01117896|Chest Compression effectiveness|chest compression effectiveness
740315|NCT01117909|ankle sprain|ankle sprain
740316|NCT01117909|athletic injury|athletic injury
740317|NCT01117909|arthritis|arthritis
740318|NCT01117922|preterm birth|preterm birth
740319|NCT01117922|interconceptional intervention|interconceptional intervention
740320|NCT01117922|pregnancy outcomes|pregnancy outcomes
740321|NCT01117935|IMRT|imrt
740322|NCT01117935|prostate cancer|prostate cancer
740323|NCT01117935|radiation therapy|radiation therapy
740324|NCT01117935|external beam|external beam
740325|NCT01117935|recurrent prostate cancer|recurrent prostate cancer
740326|NCT01117961|Excessive gestational weight gain|excessive gestational weight gain
740327|NCT01117987|Pulmonary arterial hypertension, imatinib, 6MWD, pulmonary hypertension|pulmonary arterial hypertension, imatinib, 6mwd, pulmonary hypertension
740328|NCT01118000|ischemic preconditioning,serum proteins,human|ischemic preconditioning,serum proteins,human
740329|NCT01118013|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
740330|NCT01118013|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
740331|NCT01118013|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
740332|NCT01118013|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
740333|NCT01118013|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
740334|NCT01118013|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
740335|NCT01118013|prolymphocytic leukemia|prolymphocytic leukemia
740336|NCT01118013|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
740337|NCT01118013|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
740338|NCT01118013|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
740339|NCT01118013|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
740340|NCT01118013|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
740341|NCT01118013|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
740342|NCT01118013|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
740343|NCT01118013|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
740344|NCT01118013|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
740345|NCT01118013|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
740501|NCT01123967|smoking cessation|smoking cessation
751833|NCT01170663|Gastric Adenocarcinoma|gastric adenocarcinoma
740346|NCT01118013|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
740347|NCT01118013|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
740348|NCT01118013|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
740349|NCT01118013|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
740350|NCT01118013|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
740351|NCT01118013|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
740352|NCT01118013|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
740353|NCT01118013|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
740354|NCT01118013|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
740355|NCT01118013|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
740356|NCT01118013|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
740357|NCT01118013|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
740358|NCT01118013|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
740359|NCT01118013|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
740360|NCT01118013|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
740361|NCT01118013|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
740362|NCT01118013|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
740363|NCT01118013|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
740364|NCT01118013|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
740365|NCT01118013|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
740366|NCT01118013|stage I multiple myeloma|stage i multiple myeloma
740367|NCT01118013|stage II multiple myeloma|stage ii multiple myeloma
740368|NCT01118013|stage III multiple myeloma|stage iii multiple myeloma
740369|NCT01118013|refractory multiple myeloma|refractory multiple myeloma
740370|NCT01118013|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
740371|NCT01118013|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
740372|NCT01118013|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
740373|NCT01118013|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
740374|NCT01118013|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
740375|NCT01118013|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
740376|NCT01118013|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
740377|NCT01118013|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
740378|NCT01118013|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
740379|NCT01118013|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
740380|NCT01118013|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
740381|NCT01118013|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
740382|NCT01118013|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
740383|NCT01118013|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
740384|NCT01118013|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
740385|NCT01118013|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
740386|NCT01118013|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
740387|NCT01118013|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
752838|NCT01174394|CVA|cva
740388|NCT01118013|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
740389|NCT01118013|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
740390|NCT01118013|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
740391|NCT01118013|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
740392|NCT01118013|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
740393|NCT01118013|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
740394|NCT01118013|childhood Burkitt lymphoma|childhood burkitt lymphoma
740395|NCT01118013|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
740396|NCT01118013|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
740397|NCT01118013|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
740398|NCT01118013|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
740399|NCT01118013|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
740400|NCT01118013|splenic marginal zone lymphoma|splenic marginal zone lymphoma
740401|NCT01118013|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
740402|NCT01118026|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
740403|NCT01118026|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
740404|NCT01118026|adult favorable prognosis Hodgkin lymphoma|adult favorable prognosis hodgkin lymphoma
740405|NCT01118026|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
740406|NCT01118026|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
740602|NCT01127152|Hypotension|hypotension
740407|NCT01118026|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
740408|NCT01118026|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
740409|NCT01118026|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
740410|NCT01118039|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
740411|NCT01118039|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
740412|NCT01118039|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
740413|NCT01118039|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
740414|NCT01118039|distal urethral cancer|distal urethral cancer
740415|NCT01118039|proximal urethral cancer|proximal urethral cancer
740416|NCT01118039|recurrent urethral cancer|recurrent urethral cancer
740417|NCT01118039|recurrent bladder cancer|recurrent bladder cancer
740418|NCT01118039|stage IV bladder cancer|stage iv bladder cancer
740419|NCT01118039|stage III bladder cancer|stage iii bladder cancer
740420|NCT01118039|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
740421|NCT01118039|stage III urethral cancer|stage iii urethral cancer
740422|NCT01118039|stage IV urethral cancer|stage iv urethral cancer
740423|NCT01118065|anaplastic thyroid cancer|anaplastic thyroid cancer
740424|NCT01118065|recurrent thyroid cancer|recurrent thyroid cancer
740425|NCT01118065|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
740426|NCT01118065|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
740427|NCT01118065|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
740428|NCT01118065|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
740429|NCT01118065|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
740430|NCT01118091|Immunotherapy|immunotherapy
740431|NCT01118091|Metastatic Melanoma|metastatic melanoma
740433|NCT01118091|Cell Therapy|cell therapy
740434|NCT01118091|Skin Cancer|skin cancer
740435|NCT01118091|Melanoma|melanoma
740436|NCT01118117|atherosclerotic stenosis|atherosclerotic stenosis
740437|NCT01118117|occlusions|occlusions
740438|NCT01118117|Superficial Femoral Artery|superficial femoral artery
740440|NCT01118130|Genetics|genetics
740441|NCT01118130|genomics|genomics
740442|NCT01118130|Multiple Sclerosis|multiple sclerosis
740443|NCT01118130|beta-interferons|beta-interferons
740444|NCT01118156|Suicide Nomenclature|suicide nomenclature
740445|NCT01118169|Personal values|personal values
740446|NCT01118169|Suicidal thoughts|suicidal thoughts
740447|NCT01118182|Traumatic Brain Injury|traumatic brain injury
740448|NCT01118182|Veterans|veterans
740449|NCT01118182|Psychiatric Disorders|psychiatric disorders
740450|NCT01118182|Suicide|suicide
740451|NCT01118208|Medication adherence|medication adherence
740452|NCT01118208|Accidental overdose|accidental overdose
740453|NCT01118208|Deliberate overdose|deliberate overdose
740454|NCT01118208|Suicide, attempted|suicide, attempted
740455|NCT01118221|oxidant stress|oxidant stress
740456|NCT01118221|exercise|exercise
740457|NCT01118234|CLL|cll
740458|NCT01118234|Rituximab|rituximab
740459|NCT01118234|Maintenance|maintenance
740460|NCT01118247|Uncemented THA|uncemented tha
740461|NCT01118247|alumina-on-alumina|alumina-on-alumina
740462|NCT01118247|survival|survival
740463|NCT01118247|HHS|hhs
740464|NCT01118247|Patient satisfaction|patient satisfaction
740465|NCT01118260|prostata hyperplasia|prostata hyperplasia
740466|NCT01118260|transurethral resection|transurethral resection
740467|NCT01118260|TIVA|tiva
740468|NCT01118260|spinal anaesthesia|spinal anaesthesia
740469|NCT01118273|Naproxen sodium|naproxen sodium
740470|NCT01118273|Diphenhydramine|diphenhydramine
740471|NCT01118273|Drugs, Investigational|drugs, investigational
740472|NCT01118286|Hypertension|hypertension
740473|NCT01118286|Drug therapy, combination|drug therapy, combination
740474|NCT01118312|Asthma|asthma
740475|NCT01118312|Rhinitis|rhinitis
740476|NCT01118312|Sinusitis|sinusitis
740477|NCT01118312|Chronic|chronic
740478|NCT01118312|ACRC|acrc
740479|NCT01118312|STAN|stan
740480|NCT01118312|Nasal steroid|nasal steroid
740481|NCT01118312|Mometasone|mometasone
740482|NCT01118312|Nasal spray|nasal spray
740483|NCT01123915|HIV|hiv
740484|NCT01123915|Therapeutic|therapeutic
740485|NCT01123915|Immunotherapy|immunotherapy
740486|NCT01123915|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
740487|NCT01123915|Virus Diseases|virus diseases
740488|NCT01123915|Lentivirus Infections|lentivirus infections
740489|NCT01123915|Human Immunodeficiency Virus|human immunodeficiency virus
740490|NCT01123928|cataract|cataract
740491|NCT01123928|counseling|counseling
740492|NCT01123928|surgical uptake|surgical uptake
740493|NCT01123928|follow-up|follow-up
740494|NCT01123941|Typhoid fever|typhoid fever
740495|NCT01123941|Glycoconjugate vaccine|glycoconjugate vaccine
740496|NCT01123941|Carrier protein|carrier protein
740497|NCT01123941|Immunogenicity|immunogenicity
740498|NCT01123954|Seasonal influenza|seasonal influenza
740499|NCT01123954|Vaccine|vaccine
740500|NCT01123967|nicotine replacement therapy|nicotine replacement therapy
740502|NCT01123967|tobacco dependent|tobacco dependent
740503|NCT01123993|Thai traditional music|thai traditional music
740504|NCT01123993|dementia|dementia
740505|NCT01123993|Cognitive function|cognitive function
740506|NCT01123993|behavioural problem|behavioural problem
740507|NCT01123993|sleep quality|sleep quality
740508|NCT01123993|psychological health|psychological health
740509|NCT01123993|quality of sleep|quality of sleep
740510|NCT01124019|Women undergoing screening mammography will be chosen if they are between the ages of 40 and 65.|women undergoing screening mammography will be chosen if they are between the ages of 40 and 65.
740511|NCT01124045|Pediatric|pediatric
740512|NCT01124045|Cataracts|cataracts
740513|NCT01124045|Inflammation|inflammation
740514|NCT01124045|Durezol|durezol
740515|NCT01124045|Pred Forte|pred forte
740516|NCT01124045|Difluprednate|difluprednate
740517|NCT01124045|Prednisolone|prednisolone
740518|NCT01124058|restarting warfarin|restarting warfarin
740519|NCT01124058|time to therapeutic INR|time to therapeutic inr
740520|NCT01124071|Korean Diet|korean diet
740521|NCT01124097|post herpetic neuralgia|post herpetic neuralgia
740522|NCT01124110|Operating Engineers|operating engineers
740523|NCT01124110|Smoking Cessation|smoking cessation
740524|NCT01124123|Pharmacokinetics|pharmacokinetics
740525|NCT01124123|Oral bioavailability|oral bioavailability
740526|NCT01124123|absorption|absorption
740527|NCT01124123|AUC|auc
740528|NCT01124123|Bioequivalence|bioequivalence
740529|NCT01124123|Bioavailability study|bioavailability study
740530|NCT01124136|Chronic Heart Failure|chronic heart failure
740531|NCT01124136|Neurostimulation|neurostimulation
740532|NCT01124162|Bioequivalence|bioequivalence
740533|NCT01124162|Healthy Subjects|healthy subjects
740534|NCT01124175|Bioequivalence|bioequivalence
740535|NCT01124175|Healthy Subjects|healthy subjects
740536|NCT01124188|Geriatric psychiatry|geriatric psychiatry
740537|NCT01124188|Aged|aged
740538|NCT01124188|Elderly|elderly
740539|NCT01124188|Venlafaxine|venlafaxine
740540|NCT01124188|Self efficacy|self efficacy
740541|NCT01124188|Pain|pain
740542|NCT01124188|Psychotherapy|psychotherapy
740543|NCT01124188|Effexor|effexor
740544|NCT01124201|low back pain|low back pain
740545|NCT01124201|clinical trial|clinical trial
740546|NCT01124201|stabilization|stabilization
740547|NCT01124201|muscle stretching exercises|muscle stretching exercises
740548|NCT01124201|exercise therapy|exercise therapy
740549|NCT01124214|Barrett's|barrett's
740550|NCT01124214|BE|be
740551|NCT01124214|esophageal cancer|esophageal cancer
740552|NCT01124214|esophageal dysplasia|esophageal dysplasia
740553|NCT01124227|Congestive Heart Failure|congestive heart failure
740554|NCT01124227|Peritoneal Dialysis|peritoneal dialysis
740555|NCT01124227|Symptomatic improvement|symptomatic improvement
740556|NCT01124227|Renal function|renal function
740557|NCT01124240|Glioblastoma Multiforme|glioblastoma multiforme
740558|NCT01126970|reduced calorie diet|reduced calorie diet
740559|NCT01126970|orlistat|orlistat
740560|NCT01126970|velneperit|velneperit
740561|NCT01126996|MenC conjugate vaccine|menc conjugate vaccine
740562|NCT01126996|Healthy children previously vaccinated against MenC|healthy children previously vaccinated against menc
740563|NCT01127022|Pregnancy|pregnancy
740564|NCT01127022|Lactation|lactation
740565|NCT01127022|Choline|choline
740566|NCT01127022|Cognition|cognition
740567|NCT01127022|Biomarkers|biomarkers
740568|NCT01127035|allergic rhinitis|allergic rhinitis
740569|NCT01127035|alternaria alternata|alternaria alternata
740570|NCT01127035|symptom score|symptom score
740571|NCT01127048|bronchitis|bronchitis
740572|NCT01127048|coughing|coughing
740573|NCT01127048|children|children
740574|NCT01127048|Ivy|ivy
740575|NCT01127048|Hedera helix L.|hedera helix l.
741163|NCT01129453|Vaccine|vaccine
740576|NCT01127061|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
740577|NCT01127061|Exercise|exercise
740578|NCT01127061|Oxygen consumption|oxygen consumption
740579|NCT01127074|metastatic breast cancer|metastatic breast cancer
740580|NCT01127074|breast cancer stage IV|breast cancer stage iv
740581|NCT01127074|vaccination|vaccination
740582|NCT01127074|CD80|cd80
740583|NCT01127074|immunotherapy|immunotherapy
740584|NCT01127087|Hyperoxaluria|hyperoxaluria
740585|NCT01127087|Oxazyme|oxazyme
740586|NCT01127087|oxalate|oxalate
740587|NCT01127087|enteric hyperoxaluria|enteric hyperoxaluria
740588|NCT01127100|neuropathic pain|neuropathic pain
740589|NCT01127100|gabapentin|gabapentin
740590|NCT01127100|transdermal fentanyl matrix|transdermal fentanyl matrix
740591|NCT01127100|multicenter|multicenter
740592|NCT01127100|non-inferiority trial|non-inferiority trial
740593|NCT01127113|Myocardial infarction|myocardial infarction
740594|NCT01127113|Magnetic resonance imaging|magnetic resonance imaging
740595|NCT01127113|Nanoparticles|nanoparticles
740596|NCT01127113|Mononuclear cells|mononuclear cells
740597|NCT01127113|Cell tracking|cell tracking
740598|NCT01127139|Essential hypertension|essential hypertension
740599|NCT01127152|Noradrenalin relays|noradrenalin relays
740600|NCT01127152|Automatic relays|automatic relays
740601|NCT01127152|Manual relays|manual relays
740603|NCT01127152|Intensive care unit|intensive care unit
740604|NCT01127191|military exercises|military exercises
740605|NCT01127191|neuromuscular fatigue|neuromuscular fatigue
740606|NCT01127191|physiological responses|physiological responses
740607|NCT01127191|biomechanical responses|biomechanical responses
740608|NCT01127191|simulated military effort|simulated military effort
740609|NCT01127191|high load carriage|high load carriage
740610|NCT01127191|Healthy voluntary|healthy voluntary
740612|NCT01127204|Antiretroviral therapy|antiretroviral therapy
740613|NCT01127204|Infant|infant
740614|NCT01127204|Sub Saharian Africa|sub saharian africa
740615|NCT01127217|amlodipine|amlodipine
740616|NCT01127217|losartan|losartan
740617|NCT01127217|hypertension|hypertension
740618|NCT01127217|stage 2|stage 2
740619|NCT01127230|ADRC|adrc
740620|NCT01127230|adipocyte derived regenerative cells|adipocyte derived regenerative cells
740621|NCT01127230|stem cells|stem cells
740622|NCT01127230|liposuction|liposuction
740623|NCT01127230|Cytori|cytori
740624|NCT01127230|Celution|celution
740748|NCT01127802|symptoms distress|symptoms distress
740625|NCT01127230|Lipoaspirate is obtained from patients who have opted for liposuction and consent to donate the lipoasirate for this study, which would otherwise be discarded.|lipoaspirate is obtained from patients who have opted for liposuction and consent to donate the lipoasirate for this study, which would otherwise be discarded.
740626|NCT01127243|Hysterectomy|hysterectomy
740627|NCT01127243|laparoscopy|laparoscopy
740628|NCT01127243|day-case surgery|day-case surgery
740629|NCT01127243|quality of life|quality of life
740630|NCT01127243|Ambulatory Surgical Procedures|ambulatory surgical procedures
740631|NCT01127282|influenza|influenza
740632|NCT01127282|vitamin|vitamin
740633|NCT01127282|improvement of symptom|improvement of symptom
740634|NCT01127295|Pharmacokinetics|pharmacokinetics
740635|NCT01127295|Pharmacogenetic|pharmacogenetic
740636|NCT01127295|tamoxifen|tamoxifen
740637|NCT01127295|anti-aromatases|anti-aromatases
740638|NCT01127295|breast cancer|breast cancer
740639|NCT01127295|pharmacodynamy|pharmacodynamy
740640|NCT01127295|Observance|observance
740641|NCT01127308|Absorption|absorption
740642|NCT01127308|Distribution|distribution
740643|NCT01127308|Metabolism|metabolism
740644|NCT01127308|and Excretion|and excretion
740645|NCT01127308|Mass Balance|mass balance
740646|NCT01127308|Metabolic Profile|metabolic profile
740647|NCT01127308|Radiolabel Study|radiolabel study
740648|NCT01127321|Systemic lupus erythematosus|systemic lupus erythematosus
740649|NCT01127321|SLE|sle
740650|NCT01127321|MEDI-570|medi-570
740651|NCT01127334|Dyssynchrony|dyssynchrony
740652|NCT01127334|Cardiac resynchronization therapy|cardiac resynchronization therapy
740653|NCT01127360|Anti-VEGF|anti-vegf
740654|NCT01127360|Ranibizumab|ranibizumab
740655|NCT01127360|Bevacizumab|bevacizumab
740656|NCT01127360|exudative|exudative
740657|NCT01127360|macular degeneration|macular degeneration
740658|NCT01127373|Breast|breast
740659|NCT01127373|Radiation|radiation
740660|NCT01127373|Multi-Beam Intensity-Modulated Radiation|multi-beam intensity-modulated radiation
740661|NCT01127373|post mastectomy|post mastectomy
740662|NCT01127373|post partial mastectomy|post partial mastectomy
740663|NCT01127373|node-positive breast cancer|node-positive breast cancer
740664|NCT01127373|10-025|10-025
740665|NCT01127412|overweight|overweight
740666|NCT01127412|physical activity|physical activity
740667|NCT01127412|infancy|infancy
740668|NCT01127412|body composition|body composition
740669|NCT01127412|motor development|motor development
740670|NCT01127412|motor activity|motor activity
740671|NCT01127425|nursing hours|nursing hours
740672|NCT01127425|length of hospital stay|length of hospital stay
740673|NCT01127425|reconvalescence|reconvalescence
740674|NCT01127425|colorectal surgery|colorectal surgery
740675|NCT01127425|laparoscopic|laparoscopic
740676|NCT01127425|sigmoid neoplasms|sigmoid neoplasms
740677|NCT01127438|Monitored anesthesia care sedation|monitored anesthesia care sedation
740678|NCT01127451|Neoplasms|neoplasms
740679|NCT01127464|HIV-1|hiv-1
740680|NCT01127464|HIV preventative vaccine|hiv preventative vaccine
740681|NCT01127464|Healthy Volunteers|healthy volunteers
740682|NCT01127477|Hypovolemia, surgical blood loss|hypovolemia, surgical blood loss
740683|NCT01127503|Patients with velocardiofacial syndrome and psychosis|patients with velocardiofacial syndrome and psychosis
740684|NCT01127516|Susceptibility testing|susceptibility testing
740685|NCT01127516|Antimicrobial stewardship|antimicrobial stewardship
740686|NCT01127555|Biliary Tract Cancer|biliary tract cancer
740687|NCT01127555|Salvage therapy|salvage therapy
740688|NCT01127555|FOLFOX|folfox
740689|NCT01127568|Post-Traumatic Stress Disorders|post-traumatic stress disorders
740690|NCT01127568|Posttraumatic Stress Disorders|posttraumatic stress disorders
740691|NCT01127568|PTSD|ptsd
740692|NCT01127568|Stress Disorder, Post Traumatic|stress disorder, post traumatic
740693|NCT01127568|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
740694|NCT01127568|Chronic Post Traumatic Stress Disorder|chronic post traumatic stress disorder
740695|NCT01127581|Misoprostol vaginal insert|misoprostol vaginal insert
743052|NCT01136200|Surgical and medical wards|surgical and medical wards
740696|NCT01127581|Dinoprostone vaginal insert|dinoprostone vaginal insert
740697|NCT01127581|Cervidil|cervidil
740698|NCT01127581|Cervical ripening|cervical ripening
740699|NCT01127581|Induction of labor|induction of labor
740700|NCT01127581|Rate of cesarean section|rate of cesarean section
740701|NCT01127594|Melanoma|melanoma
740702|NCT01127607|parenting|parenting
740703|NCT01127620|Allergic Rhinoconjunctivitis|allergic rhinoconjunctivitis
740704|NCT01127620|Persistent allergic rhinitis|persistent allergic rhinitis
740705|NCT01127620|Hay fever|hay fever
740706|NCT01127620|Allergic Rhinitis|allergic rhinitis
740707|NCT01127620|Sneezing|sneezing
740708|NCT01127620|Nasal congestion|nasal congestion
740709|NCT01127620|Rhinorrhea|rhinorrhea
740710|NCT01127620|Nasal itching|nasal itching
740711|NCT01127620|Ocular itching|ocular itching
740712|NCT01127620|Ocular tearing|ocular tearing
740713|NCT01127620|Antihistamine|antihistamine
740714|NCT01127659|diabetes|diabetes
740715|NCT01127659|hypogonadism|hypogonadism
740716|NCT01127659|obesity|obesity
740717|NCT01127659|testosterone|testosterone
740718|NCT01127659|insulin sensitivity|insulin sensitivity
740719|NCT01127659|inflammation|inflammation
740720|NCT01127672|plantar fasciitis|plantar fasciitis
740721|NCT01127672|PRP|prp
740722|NCT01127672|platelet rich plasma|platelet rich plasma
740723|NCT01127685|weight bearing|weight bearing
740724|NCT01127685|acl|acl
740725|NCT01127724|Vitamin B12|vitamin b12
740726|NCT01127724|Aphthous stomatitis|aphthous stomatitis
740727|NCT01127724|Cobalamin|cobalamin
740728|NCT01127724|Doses|doses
740729|NCT01127737|SCCs|sccs
740730|NCT01127737|Squamous Cell Carcinoma|squamous cell carcinoma
740731|NCT01127737|Skin Self Exam|skin self exam
740732|NCT01127737|SSE|sse
740733|NCT01127737|Organ Transplant|organ transplant
740734|NCT01127737|Performance of SSE with our written educational intervention|performance of sse with our written educational intervention
740735|NCT01127737|Time after organ transplantation to deliver intervention|time after organ transplantation to deliver intervention
740736|NCT01127737|Evaluate internation information|evaluate internation information
740737|NCT01127750|Relapsing multiple sclerosis|relapsing multiple sclerosis
740738|NCT01127750|MS|ms
740739|NCT01127750|safety|safety
740740|NCT01127750|tolerability|tolerability
740741|NCT01127750|health outcomes|health outcomes
740742|NCT01127763|metastatic|metastatic
740743|NCT01127763|breast|breast
740744|NCT01127763|cancer|cancer
740745|NCT01127776|patient after bi-trimalleolar fracture of ankle|patient after bi-trimalleolar fracture of ankle
740746|NCT01127802|CABG|cabg
740747|NCT01127802|functional status|functional status
740749|NCT01127802|quality of life|quality of life
740750|NCT01127802|the trajectory of functional status|the trajectory of functional status
740751|NCT01127802|the changes of symptoms distress|the changes of symptoms distress
740752|NCT01127802|the changes of quality of life|the changes of quality of life
740753|NCT01127815|Peritoneal washing cytology|peritoneal washing cytology
740754|NCT01127815|pancreatic cancer|pancreatic cancer
740755|NCT01127815|peritoneal metastasis|peritoneal metastasis
740756|NCT01127815|anoikis|anoikis
740757|NCT01127815|to determine the relationship between PWC results and clinicopathologic parameters of pancreatic cancers|to determine the relationship between pwc results and clinicopathologic parameters of pancreatic cancers
740758|NCT01127815|to identify the predictive value of PWC and postoperative drainage cytology on the peritoneal recurrence or outcomes|to identify the predictive value of pwc and postoperative drainage cytology on the peritoneal recurrence or outcomes
740759|NCT01127815|to dissect the molecular mechanism of peritoneal recurrence, especially on the PWC-inducing peritoneal seeding process.|to dissect the molecular mechanism of peritoneal recurrence, especially on the pwc-inducing peritoneal seeding process.
740760|NCT01127828|IBS (Irritable Bowel Syndrome)|ibs (irritable bowel syndrome)
740761|NCT01127828|Probiotic yoghurt|probiotic yoghurt
740762|NCT01127828|Symptom severity|symptom severity
740763|NCT01127854|kidney stone|kidney stone
740764|NCT01127854|urolithiasis|urolithiasis
740765|NCT01127854|calcium oxalate kidney stone|calcium oxalate kidney stone
740766|NCT01127854|calcium oxalate stone|calcium oxalate stone
740767|NCT01127854|calcium oxalate|calcium oxalate
740768|NCT01127880|Traumatic Hemopneumothorax|traumatic hemopneumothorax
740769|NCT01127880|Thoracotomy|thoracotomy
740770|NCT01127880|Antibiotics|antibiotics
740771|NCT01127893|Musculoskeletal Diseases|musculoskeletal diseases
740772|NCT01127893|Joint Diseases|joint diseases
740773|NCT01127893|Arthritis|arthritis
740774|NCT01127893|Rheumatic Diseases|rheumatic diseases
740775|NCT01127906|Healthy Volunteers|healthy volunteers
740776|NCT01127906|cross-over|cross-over
740777|NCT01127906|randomized|randomized
740778|NCT01127906|placebo and active controlled|placebo and active controlled
740779|NCT01127906|heat pain|heat pain
740780|NCT01127906|UVB-Induced pain model|uvb-induced pain model
740781|NCT01127919|Exercise|exercise
740782|NCT01127919|Activity|activity
740783|NCT01127919|Adherence|adherence
740784|NCT01127919|Genetics|genetics
740785|NCT01127932|Cognitive Behavioral Therapy|cognitive behavioral therapy
740786|NCT01127958|In-stent restenosis|in-stent restenosis
740787|NCT01127958|Minimal lumen diameter|minimal lumen diameter
740788|NCT01127958|Drug eluting balloon|drug eluting balloon
740789|NCT01127958|Drug eluting stent|drug eluting stent
740790|NCT01127971|patients|patients
740791|NCT01127971|receiving|receiving
740792|NCT01127971|irradiation|irradiation
740793|NCT01127971|device|device
740794|NCT01127971|External Beam|external beam
740795|NCT01127984|pacemaker|pacemaker
740796|NCT01127984|pocket haematoma|pocket haematoma
740797|NCT01127984|antiplatelet therapy|antiplatelet therapy
740798|NCT01127984|fibrin glue|fibrin glue
740799|NCT01128023|myocardial perfusion imaging|myocardial perfusion imaging
740800|NCT01128023|rubidium-82|rubidium-82
740801|NCT01128023|medical isotope production|medical isotope production
740802|NCT01128023|Positron emission tomography|positron emission tomography
740803|NCT01128023|clinically useful|clinically useful
740804|NCT01128036|Congestive Heart failure|congestive heart failure
740805|NCT01128036|Cardiomyopathy|cardiomyopathy
740806|NCT01128049|Aqueous deficient dry eye (ADDE)|aqueous deficient dry eye (adde)
740807|NCT01128049|Meibomium Gland Dysfunction (MGD)|meibomium gland dysfunction (mgd)
740808|NCT01128049|Normal/Control (Non Dry Eye)|normal/control (non dry eye)
740809|NCT01128062|Canthaxanthin retinopathy|canthaxanthin retinopathy
740810|NCT01128075|RebiSmart|rebismart
740811|NCT01128075|Rebif|rebif
740812|NCT01128075|Adherence|adherence
740813|NCT01128075|Multidose|multidose
740814|NCT01128075|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
740815|NCT01128075|RMS|rms
740816|NCT01128088|Enhanced recovery program in laparoscopic surgery|enhanced recovery program in laparoscopic surgery
740817|NCT01128101|spironolactone|spironolactone
740818|NCT01128101|chronic kidney disease|chronic kidney disease
740819|NCT01128101|dialysis|dialysis
740820|NCT01128101|LHV|lhv
740821|NCT01128114|Acute bipolar mania|acute bipolar mania
740822|NCT01128114|Seroquel XR|seroquel xr
740823|NCT01128114|Quetiapine fumarate|quetiapine fumarate
740824|NCT01128114|Add-on therapy|add-on therapy
740825|NCT01128127|knowledge translation|knowledge translation
740826|NCT01128127|prescription|prescription
740827|NCT01128127|primary care|primary care
740828|NCT01128127|NSAID|nsaid
740829|NCT01128127|PPI|ppi
740830|NCT01128127|Gastrointestinal damage|gastrointestinal damage
740831|NCT01128127|Inappropriate prescription|inappropriate prescription
740832|NCT01128140|motivational enhancement therapy|motivational enhancement therapy
740833|NCT01128153|Type 2 Diabetes|type 2 diabetes
740834|NCT01128153|Inadequate Glycaemic Control|inadequate glycaemic control
740835|NCT01128153|Saxagliptin|saxagliptin
740836|NCT01128153|Metformin|metformin
740837|NCT01128153|Sulfonylurea|sulfonylurea
740838|NCT01128153|Triple Oral Therapy|triple oral therapy
740839|NCT01128166|Heart Failure|heart failure
740840|NCT01128166|Decompensation|decompensation
740841|NCT01128166|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
740842|NCT01128205|diabetes|diabetes
740843|NCT01128205|cardiovascular risk factors|cardiovascular risk factors
740844|NCT01128205|blood pressure|blood pressure
740845|NCT01128205|blood lipid|blood lipid
740846|NCT01128205|blood glucose|blood glucose
740847|NCT01128218|Brain Neoplasms|brain neoplasms
740848|NCT01128218|5-ALA|5-ala
740849|NCT01128218|Aminolevulinic acid|aminolevulinic acid
740850|NCT01128218|Fluorescence|fluorescence
740851|NCT01128218|Gliomas|gliomas
740852|NCT01128218|Glioblastoma|glioblastoma
740853|NCT01128218|Surgery|surgery
740854|NCT01128244|oral contraceptives|oral contraceptives
740855|NCT01128244|Vitamin B6|vitamin b6
740856|NCT01128244|birth control pills|birth control pills
740857|NCT01128244|amino acids|amino acids
740858|NCT01128244|Vitamin B6 deficiency|vitamin b6 deficiency
740859|NCT01128244|Vitamin B6 deficiency in women on oral contraceptives|vitamin b6 deficiency in women on oral contraceptives
740860|NCT01128270|Dichloroacetate|dichloroacetate
740861|NCT01128270|Chloral Hydrate|chloral hydrate
740862|NCT01128270|Metabolism|metabolism
740863|NCT01128283|Sepsis|sepsis
740864|NCT01128283|organ failure|organ failure
740865|NCT01128283|cytokines|cytokines
740866|NCT01128283|clotting factors|clotting factors
740867|NCT01128296|high risk stage IIb or III adenocarcinoma of the pancreas|high risk stage iib or iii adenocarcinoma of the pancreas
740868|NCT01128322|CKD-828|ckd-828
740869|NCT01128322|Hypertension|hypertension
740870|NCT01128322|Primary Hypertension|primary hypertension
740871|NCT01128322|S-Amlodipine|s-amlodipine
740872|NCT01128322|Telmisartan|telmisartan
740873|NCT01128322|Amlodipine|amlodipine
740874|NCT01128322|Factorial|factorial
740875|NCT01128322|Phase 2|phase 2
740876|NCT01128335|Liver transplantation|liver transplantation
740877|NCT01128335|HCV-negative recipient|hcv-negative recipient
740878|NCT01128335|deceased donor|deceased donor
740879|NCT01128335|sotrastaurin|sotrastaurin
740880|NCT01128335|oran transplantation|oran transplantation
740881|NCT01128335|tacrolimus|tacrolimus
740882|NCT01128348|asthma|asthma
740883|NCT01128348|adherence|adherence
740884|NCT01128348|quality of life|quality of life
740885|NCT01128348|health literacy|health literacy
740886|NCT01128348|health disparities|health disparities
740887|NCT01128374|Periodontal disease|periodontal disease
740888|NCT01128374|Nonsurgical therapy|nonsurgical therapy
740889|NCT01128374|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
740890|NCT01128374|Bacterial burden|bacterial burden
740891|NCT01128374|Gene polymorphisms|gene polymorphisms
740892|NCT01128387|esophageal cancer|esophageal cancer
740893|NCT01128387|Locally advanced esophageal cancer|locally advanced esophageal cancer
740895|NCT01128400|orlistat|orlistat
740896|NCT01128400|taste perception|taste perception
740897|NCT01128413|Shock|shock
740898|NCT01128413|Resuscitation|resuscitation
740899|NCT01128413|Hemodynamics|hemodynamics
740900|NCT01128413|Emergencies|emergencies
740901|NCT01128413|Critical Care|critical care
740902|NCT01128413|Lactic Acid|lactic acid
740903|NCT01128413|Plasma volume|plasma volume
740904|NCT01128426|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
740905|NCT01128439|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
740906|NCT01128452|Treatment-Resistant Depression|treatment-resistant depression
740907|NCT01128465|propofol|propofol
740908|NCT01128465|awake craniotomy|awake craniotomy
740909|NCT01128465|patients requiring an awake craniotomy for brain tumor/lesion resection|patients requiring an awake craniotomy for brain tumor/lesion resection
740910|NCT01128478|Acute pancreatitis|acute pancreatitis
740911|NCT01128478|Enteral nutrition|enteral nutrition
740912|NCT01128478|Pancreas rest|pancreas rest
740913|NCT01128517|Maternal education|maternal education
740914|NCT01128517|Complementary food|complementary food
740915|NCT01128517|Infant growth|infant growth
740916|NCT01128530|cSSSI|csssi
740917|NCT01128530|complicated skin and skin structure infections|complicated skin and skin structure infections
740918|NCT01128530|acute bacterial skin and skin structure infections|acute bacterial skin and skin structure infections
740919|NCT01128530|abscess|abscess
740920|NCT01128530|cellulitis|cellulitis
740921|NCT01128530|bacterial infections|bacterial infections
740922|NCT01128530|anti-bacterial agents|anti-bacterial agents
740923|NCT01128530|anti-infective agents|anti-infective agents
740924|NCT01128530|skin diseases, infectious|skin diseases, infectious
740925|NCT01128530|skin diseases|skin diseases
740926|NCT01128530|wound infection|wound infection
740927|NCT01128543|lapatinib|lapatinib
740928|NCT01128543|breast cancer|breast cancer
740929|NCT01128556|allergic conjunctivitis|allergic conjunctivitis
740930|NCT01128556|histamine skin testing|histamine skin testing
740931|NCT01128569|mild asthma|mild asthma
740932|NCT01128569|allergen challenge|allergen challenge
740933|NCT01128569|early asthmatic response|early asthmatic response
740934|NCT01128582|GERD|gerd
740935|NCT01128582|Insomnia|insomnia
740936|NCT01128582|Acid Reflux|acid reflux
740937|NCT01128582|Heartburn|heartburn
740938|NCT01128595|allergen challenge|allergen challenge
740939|NCT01128595|early asthmatic response|early asthmatic response
740940|NCT01128595|mild asthma|mild asthma
740941|NCT01128595|late asthmatic response|late asthmatic response
740942|NCT01128608|GERD|gerd
740943|NCT01128608|Heartburn|heartburn
740944|NCT01128608|Acid Reflux|acid reflux
740945|NCT01128621|Pharmacokinetics|pharmacokinetics
740946|NCT01128621|Glucose|glucose
740947|NCT01128621|Safety|safety
740948|NCT01128621|Male|male
740949|NCT01128621|Female|female
740950|NCT01128621|Metformin|metformin
740951|NCT01128621|Pharmacodynamics|pharmacodynamics
740952|NCT01128621|Tolerability|tolerability
740953|NCT01128621|Type II Diabetes|type ii diabetes
740954|NCT01128634|Verapamil|verapamil
742664|NCT01134380|stent|stent
740955|NCT01128634|Anticholinergic, β2 agonist|anticholinergic, β2 agonist
740956|NCT01128634|P-GP|p-gp
740957|NCT01128634|LABA|laba
740958|NCT01128634|Muscarinic Receptor Antagonist|muscarinic receptor antagonist
740959|NCT01128634|LAMA|lama
740960|NCT01128660|Prescription, General practitioner, Pharmacy|prescription, general practitioner, pharmacy
740961|NCT01128673|Hypoxic Ischemic encephalopathy|hypoxic ischemic encephalopathy
740962|NCT01128673|Magnet resonance imaging|magnet resonance imaging
740963|NCT01128673|Selective Head cooling|selective head cooling
740964|NCT01128673|Therapeutic hypothermia|therapeutic hypothermia
740965|NCT01128686|retrospective|retrospective
740966|NCT01128686|naïve Chronic Hepatitis B (CHB) patients|naïve chronic hepatitis b (chb) patients
740967|NCT01128686|cohort study|cohort study
740968|NCT01128686|lamivudine|lamivudine
740969|NCT01128699|Ahmed valve|ahmed valve
740970|NCT01128699|Neovascular Glaucoma|neovascular glaucoma
740971|NCT01128699|Uveitic glaucoma|uveitic glaucoma
740972|NCT01128699|Failed glaucoma|failed glaucoma
740973|NCT01128699|VEGF-A|vegf-a
740974|NCT01128699|Intraocular pressure|intraocular pressure
740975|NCT01128699|Subconjunctival Avastin|subconjunctival avastin
740976|NCT01128738|Neuromuscular Agents|neuromuscular agents
740977|NCT01128738|Botulinum Toxin Type A|botulinum toxin type a
740978|NCT01128738|Sweating|sweating
740979|NCT01128738|Sweat Gland Disease|sweat gland disease
740980|NCT01128738|Axillary Hyperhidrosis|axillary hyperhidrosis
740981|NCT01128738|Skin Disease|skin disease
740982|NCT01128751|Cognition|cognition
740983|NCT01128751|Neuroprotection|neuroprotection
740984|NCT01128751|Cardiopulmonary bypass|cardiopulmonary bypass
740985|NCT01128751|Aortic valve replacement|aortic valve replacement
740986|NCT01128751|Micro-emboli|micro-emboli
740987|NCT01128777|depression|depression
740988|NCT01128777|anxiety|anxiety
740989|NCT01128777|family conflict|family conflict
740990|NCT01128777|behavior problems|behavior problems
740991|NCT01128790|exercise|exercise
740992|NCT01128790|remote ischemic preconditioning|remote ischemic preconditioning
740993|NCT01128790|heart failure|heart failure
740994|NCT01128790|left ventricular dysfunction|left ventricular dysfunction
740995|NCT01128803|Hepatocellular carcinoma|hepatocellular carcinoma
740996|NCT01128803|immunotherapy|immunotherapy
740997|NCT01128803|alpha foetoprotein|alpha foetoprotein
740998|NCT01128803|dendritic cells|dendritic cells
740999|NCT01128816|obstructive sleep apnea|obstructive sleep apnea
741000|NCT01128816|central sleep apnea|central sleep apnea
741001|NCT01128816|heart failure|heart failure
741002|NCT01128816|congestive heart failure|congestive heart failure
741003|NCT01128816|adaptive servo ventilation|adaptive servo ventilation
741004|NCT01128816|ASV|asv
741005|NCT01128829|obesity|obesity
741006|NCT01128829|diabetes|diabetes
741007|NCT01128829|artificial sweeteners|artificial sweeteners
741008|NCT01128842|Neratinib|neratinib
741009|NCT01128842|Capecitabine|capecitabine
741010|NCT01128842|Combination|combination
741011|NCT01128842|Solid Tumor|solid tumor
741012|NCT01128855|Duchenne|duchenne
741013|NCT01128855|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
741014|NCT01128855|DMD|dmd
741015|NCT01128855|968|968
741016|NCT01128868|Reverse oblique intertrochanteric fractures|reverse oblique intertrochanteric fractures
741017|NCT01128868|Reverse oblique subtrochanteric fractures|reverse oblique subtrochanteric fractures
741018|NCT01128894|GSK716155|gsk716155
741019|NCT01128894|liraglutide|liraglutide
741020|NCT01128894|albiglutide|albiglutide
741021|NCT01128894|open-label|open-label
741022|NCT01128907|Invasive Aspergillosis in neutropenic patients|invasive aspergillosis in neutropenic patients
741023|NCT01128920|bacterial infections|bacterial infections
741024|NCT01128920|skin infections|skin infections
741025|NCT01128920|HIV|hiv
741026|NCT01128920|Hepatitis C|hepatitis c
741027|NCT01128920|risk reduction intervention|risk reduction intervention
741028|NCT01128933|Fractional flow reserve|fractional flow reserve
741029|NCT01128933|Revascularization|revascularization
741030|NCT01128933|Prognosis|prognosis
741031|NCT01128933|Hemodynamics|hemodynamics
741032|NCT01128933|Hypertension|hypertension
741033|NCT01128946|Enamel remineralization|enamel remineralization
741034|NCT01128946|Fluoride|fluoride
741035|NCT01128946|caries|caries
741036|NCT01128959|Epilepsy|epilepsy
741037|NCT01128959|Intravenous Carbamazepine|intravenous carbamazepine
741038|NCT01128959|Oral Carbamazepine|oral carbamazepine
741039|NCT01128972|enamel erosion|enamel erosion
741040|NCT01128972|tooth remineralization|tooth remineralization
741041|NCT01128972|tooth erosion|tooth erosion
741042|NCT01128985|Canagliflozin|canagliflozin
741043|NCT01128985|Placebo|placebo
741044|NCT01128985|Type 2 diabetes mellitus|type 2 diabetes mellitus
741045|NCT01128985|Pharmacokinetic|pharmacokinetic
741046|NCT01128985|Pharmacodynamic|pharmacodynamic
741047|NCT01128998|Sorafenib|sorafenib
741048|NCT01128998|S1|s1
741049|NCT01128998|Advanced Solid Tumors|advanced solid tumors
741050|NCT01128998|RD|rd
741051|NCT01128998|MTD|mtd
741052|NCT01128998|DLT|dlt
741053|NCT01128998|PK|pk
741054|NCT01128998|PG|pg
741055|NCT01128998|Biomarker|biomarker
741056|NCT01129011|NSAID|nsaid
741057|NCT01129011|gastric ulcers|gastric ulcers
741058|NCT01129011|Vimovo|vimovo
741059|NCT01129011|Esomeprazole|esomeprazole
741060|NCT01129011|Naproxen|naproxen
741061|NCT01129024|Splenectomy|splenectomy
741062|NCT01129024|Low Platelet Count|low platelet count
741063|NCT01129024|Thrombopoiesis|thrombopoiesis
741064|NCT01129024|Thrombocytopaenia|thrombocytopaenia
741065|NCT01129024|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
741066|NCT01129024|Immune Thrombocytopenia (ITP)|immune thrombocytopenia (itp)
741067|NCT01129024|Thrombotic Thrombocytopenic Purpura (ITP)|thrombotic thrombocytopenic purpura (itp)
741068|NCT01129024|Hematologic Disease|hematologic disease
741069|NCT01129024|Auto-immune Thrombocytopenic Purpura|auto-immune thrombocytopenic purpura
741070|NCT01129024|S-888711|s-888711
741071|NCT01129024|Blood Platelet Disorders|blood platelet disorders
741072|NCT01129024|Relapsed Persistent or Chronic ITP|relapsed persistent or chronic itp
741073|NCT01129024|ITP|itp
741074|NCT01129037|Oncology|oncology
741075|NCT01129050|Fish oil|fish oil
741076|NCT01129050|Omega-3 fatty acids|omega-3 fatty acids
741077|NCT01129050|Metabolic syndrome|metabolic syndrome
741078|NCT01129050|Adults|adults
741079|NCT01129076|Thalassemia Major|thalassemia major
741080|NCT01129076|Stigma|stigma
741081|NCT01129076|Singapore|singapore
741082|NCT01129076|Qualitative|qualitative
741083|NCT01129089|Acceptability|acceptability
741084|NCT01129089|Lipid-based nutrient supplements|lipid-based nutrient supplements
741085|NCT01129089|Micronutrient powder|micronutrient powder
741086|NCT01129089|Malnutrition|malnutrition
741087|NCT01129128|Echinacea|echinacea
741088|NCT01129128|immune modulation|immune modulation
741089|NCT01129128|prevention|prevention
741090|NCT01129141|Tinnitus|tinnitus
741091|NCT01129141|Traumatic Brain Injury Counseling|traumatic brain injury counseling
741092|NCT01129141|Counseling|counseling
741093|NCT01129141|Education|education
741094|NCT01129141|Evaluation studies|evaluation studies
741095|NCT01129141|Quality of health care|quality of health care
741096|NCT01129154|Squamous cell carcinoma|squamous cell carcinoma
741097|NCT01129167|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
741098|NCT01129167|Local invasion by pancreatic adenocarcinoma|local invasion by pancreatic adenocarcinoma
741099|NCT01129167|Recurrence of pancreatic cancer|recurrence of pancreatic cancer
741100|NCT01129167|Surgical resection of pancreatic cancer|surgical resection of pancreatic cancer
741101|NCT01129180|T-Cell Lymphoma|t-cell lymphoma
741102|NCT01129206|Gastroesophageal Cancer|gastroesophageal cancer
741103|NCT01129206|Gastroesophageal Carcinoma|gastroesophageal carcinoma
741104|NCT01129206|Adenocarcinoma|adenocarcinoma
741105|NCT01129219|Strength|strength
741106|NCT01129219|Function|function
741107|NCT01129219|Mobility|mobility
741109|NCT01129245|Celebrex|celebrex
741110|NCT01129245|prostoglandin inhibitor|prostoglandin inhibitor
741111|NCT01129245|ovulation|ovulation
741112|NCT01129245|emergency contraception|emergency contraception
741113|NCT01129258|phase 1|phase 1
741114|NCT01129258|safety and tolerability|safety and tolerability
741115|NCT01129258|pharmacokinetics|pharmacokinetics
741116|NCT01129258|PK|pk
741117|NCT01129258|pharmacodynamics|pharmacodynamics
741118|NCT01129258|PD|pd
741119|NCT01129258|type 2 diabetes mellitus|type 2 diabetes mellitus
741120|NCT01129284|Treatment Resistance|treatment resistance
741121|NCT01129284|Nephrotic Syndrome|nephrotic syndrome
741122|NCT01129284|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
741123|NCT01129284|lipoid nephrosis|lipoid nephrosis
741124|NCT01129284|Membranous nephropathy|membranous nephropathy
741125|NCT01129284|IgA nephropathy|iga nephropathy
741126|NCT01129284|proteinuria|proteinuria
741127|NCT01129297|Obesity|obesity
741128|NCT01129297|surgery|surgery
741129|NCT01129297|genetic expression|genetic expression
741130|NCT01129297|collection of samples|collection of samples
741131|NCT01129310|irinotecan|irinotecan
741132|NCT01129310|capecitabine|capecitabine
741133|NCT01129310|oxaliplatin|oxaliplatin
741134|NCT01129310|health-related quality of life|health-related quality of life
741135|NCT01129310|gastroesophageal(GE) junction adenocarcinoma|gastroesophageal(ge) junction adenocarcinoma
741136|NCT01129323|Anemia, Severe, Aplastic, Reduced-Intensity, Allogeneic, Stem, Cell, Transplantation|anemia, severe, aplastic, reduced-intensity, allogeneic, stem, cell, transplantation
741137|NCT01129336|HER2-negative|her2-negative
741138|NCT01129336|HER2|her2
741139|NCT01129336|Metastatic breast cancer|metastatic breast cancer
741140|NCT01129336|First Line breast cancer|first line breast cancer
741141|NCT01129336|Second Line breast cancer|second line breast cancer
741142|NCT01129336|Breast cancer|breast cancer
741143|NCT01129336|Metastatic|metastatic
741144|NCT01129336|Stage IV breast cancer|stage iv breast cancer
741145|NCT01129336|Progression free survival|progression free survival
741146|NCT01129336|PFS|pfs
741147|NCT01129336|Circulating Tumor Cells|circulating tumor cells
741148|NCT01129336|CTCs|ctcs
741149|NCT01129336|Zoledronic acid|zoledronic acid
741150|NCT01129336|HER2-negative metastatic breast cancer patients without bone metastasis|her2-negative metastatic breast cancer patients without bone metastasis
741151|NCT01129349|Solid Tumors|solid tumors
741152|NCT01129362|Pertussis|pertussis
741153|NCT01129362|Whooping Cough|whooping cough
741154|NCT01129362|Pertussis Vaccine|pertussis vaccine
741155|NCT01129401|methamphetamine|methamphetamine
741156|NCT01129401|men who have sex with men|men who have sex with men
741157|NCT01129401|HIV/AIDS|hiv/aids
741158|NCT01129440|Children|children
741159|NCT01129440|Fluoride varnish|fluoride varnish
741160|NCT01129440|Glass ionomer sealant|glass ionomer sealant
741161|NCT01129440|Prevention|prevention
741165|NCT01121146|Polyethylene|polyethylene
741166|NCT01121146|Crosslinked Polyethylene|crosslinked polyethylene
741167|NCT01121146|Total Hip Replacement|total hip replacement
741169|NCT01121185|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
741170|NCT01121185|Liver transplantation|liver transplantation
741171|NCT01121185|Human Monoclonal Antibody|human monoclonal antibody
741172|NCT01121198|Food effect|food effect
741173|NCT01121211|Testosterone|testosterone
741174|NCT01121211|Hormones|hormones
741175|NCT01121211|Mental Health|mental health
741176|NCT01121224|Saphenous vein graft|saphenous vein graft
741177|NCT01121224|Percutaneous coronary intervention|percutaneous coronary intervention
741178|NCT01121224|Stents|stents
741179|NCT01121237|chronic kidney disease|chronic kidney disease
741180|NCT01121237|end-stage renal disease|end-stage renal disease
741181|NCT01121237|renal anaemia|renal anaemia
741182|NCT01121237|epoetin alfa|epoetin alfa
741183|NCT01121250|Combat disorders|combat disorders
741184|NCT01121250|Spouses|spouses
741185|NCT01121250|Support|support
741186|NCT01121250|Military personnel|military personnel
741187|NCT01121263|coronary arteriosclerosis|coronary arteriosclerosis
741188|NCT01121263|coronary heart disease|coronary heart disease
741189|NCT01121263|coronary artery bypass|coronary artery bypass
742298|NCT01125787|hematology|hematology
741190|NCT01121263|coronary artery bypass, off-pump|coronary artery bypass, off-pump
741191|NCT01121263|coronary angiography|coronary angiography
741192|NCT01121263|drug-eluting stents|drug-eluting stents
741193|NCT01121302|AZD5213|azd5213
741194|NCT01121302|Phase 1|phase 1
741195|NCT01121302|Safety|safety
741196|NCT01121315|Epidemiological|epidemiological
741197|NCT01121315|Diabetes|diabetes
741198|NCT01121315|Glucose Lowering Drug Treatment in Primary care|glucose lowering drug treatment in primary care
741199|NCT01121315|CVD|cvd
741200|NCT01121328|Preterm neonates.|preterm neonates.
741201|NCT01121328|Autologous cord blood transfusion.|autologous cord blood transfusion.
741202|NCT01121341|Endoscopic vein harvesting|endoscopic vein harvesting
741203|NCT01121341|Saphenous vein|saphenous vein
741204|NCT01121341|Conventional vein harvesting|conventional vein harvesting
741205|NCT01121354|Cefazolin|cefazolin
741206|NCT01121354|Caphalosporin|caphalosporin
741207|NCT01121354|antibiotic|antibiotic
741208|NCT01121354|gram positive|gram positive
741209|NCT01121354|Infection control|infection control
741210|NCT01121367|emphysema; pulmonary fibrosis;chemokine;sputum|emphysema; pulmonary fibrosis;chemokine;sputum
741211|NCT01121380|Healthy|healthy
741212|NCT01121380|Volunteers|volunteers
741213|NCT01121419|Neuroblastoma|neuroblastoma
741214|NCT01121419|IMP3|imp3
741215|NCT01121419|Prognosis|prognosis
741216|NCT01129479|Aphasia|aphasia
741217|NCT01129479|treatment|treatment
741218|NCT01129479|cholinesterase inhibitor|cholinesterase inhibitor
741219|NCT01129479|stroke|stroke
741220|NCT01129492|Autoimmune Thyroiditis, Laser, Therapy, Thyroid, Ultrasound|autoimmune thyroiditis, laser, therapy, thyroid, ultrasound
741221|NCT01129505|pregnancy|pregnancy
741222|NCT01129505|intervention|intervention
741223|NCT01129505|exercise|exercise
741224|NCT01129505|nutrition|nutrition
741225|NCT01129505|infants|infants
741226|NCT01129518|meningococcal serogroup C|meningococcal serogroup c
741227|NCT01129518|vaccine|vaccine
741228|NCT01129518|conjugate|conjugate
741229|NCT01129544|Severe combined immunodeficiency|severe combined immunodeficiency
741230|NCT01129544|SCID|scid
741231|NCT01129544|XSCID|xscid
741232|NCT01129544|SCID-X1|scid-x1
741233|NCT01129583|Botulinum Toxin|botulinum toxin
741234|NCT01129583|Elbow Stiffness|elbow stiffness
741235|NCT01129609|Post-approval observation of patients being treated according to the indications for use for the Talent Converter Stent Graft|post-approval observation of patients being treated according to the indications for use for the talent converter stent graft
741236|NCT01129622|Letrozole|letrozole
741237|NCT01129622|Breast MRI|breast mri
741238|NCT01129622|Postmenopausal women|postmenopausal women
741239|NCT01129635|Heart failure|heart failure
741240|NCT01129635|Cardiac resynchronization therapy|cardiac resynchronization therapy
741241|NCT01129635|Regional left ventricular dyssynchrony|regional left ventricular dyssynchrony
741242|NCT01129635|CRT|crt
741243|NCT01129648|Hyperuricemia, gout|hyperuricemia, gout
741244|NCT01129700|rectal cancer, short-course, chemoradiotherapy|rectal cancer, short-course, chemoradiotherapy
741246|NCT01129713|Acid Reflux|acid reflux
741247|NCT01129713|Heartburn|heartburn
741248|NCT01129713|Regurgitation|regurgitation
741249|NCT01129713|Indigestion|indigestion
741250|NCT01129726|Transillumination-guided|transillumination-guided
741251|NCT01129726|Fiberoptic Intubation|fiberoptic intubation
741252|NCT01129726|time|time
741253|NCT01129726|success rate|success rate
741254|NCT01129726|intubation|intubation
741255|NCT01129739|Bone Marrow Disease|bone marrow disease
741256|NCT01129739|MDS-RA|mds-ra
741257|NCT01129739|MDS-RARS|mds-rars
741258|NCT01129739|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
741259|NCT01129739|Transplant|transplant
741260|NCT01129765|Nasal suction|nasal suction
741261|NCT01129765|Nasal aspiration|nasal aspiration
741262|NCT01129765|Nasal saline irrigation|nasal saline irrigation
741263|NCT01129765|Nasal lavage|nasal lavage
741264|NCT01129791|Lactose intolerance|lactose intolerance
741265|NCT01129791|Dairy products|dairy products
741266|NCT01129791|Raw milk|raw milk
741267|NCT01129791|Adults|adults
741268|NCT01129804|Alcohol dependence|alcohol dependence
741269|NCT01129804|Network Support|network support
741270|NCT01129804|Cognitive-behavioral treatment|cognitive-behavioral treatment
741271|NCT01129804|Relapse prevention|relapse prevention
741272|NCT01129804|Consequences of drinking|consequences of drinking
741273|NCT01129804|Social network development|social network development
741274|NCT01130727|diabetes mellitus|diabetes mellitus
741275|NCT01130727|diabetic nephropathy|diabetic nephropathy
741276|NCT01130727|hypertension|hypertension
741277|NCT01130727|green tea|green tea
741278|NCT01130727|cocoa|cocoa
741279|NCT01130727|polyphenol|polyphenol
741280|NCT01130727|nitric oxide|nitric oxide
741281|NCT01130740|Osteoarthritis|osteoarthritis
741282|NCT01130740|Exercise|exercise
741283|NCT01130740|Diet|diet
741284|NCT01130740|Coping Skills|coping skills
741285|NCT01130740|Education, Medical|education, medical
741286|NCT01130766|Non-small Cell Lung Cancer|non-small cell lung cancer
741287|NCT01130766|Asymptomatic brain metastasis|asymptomatic brain metastasis
741288|NCT01130766|Stereotactic radiosurgery (SRS)|stereotactic radiosurgery (srs)
741289|NCT01130779|Non-small Cell Lung Cancer|non-small cell lung cancer
741290|NCT01130779|Erlotinib|erlotinib
741291|NCT01130779|brain metastasis|brain metastasis
741292|NCT01130792|rotavirus|rotavirus
741293|NCT01130792|cryptosporidium|cryptosporidium
741294|NCT01130792|probiotics|probiotics
741295|NCT01130792|intestinal function|intestinal function
741296|NCT01130792|immune response|immune response
741297|NCT01130805|gastric cancer pazopanib capecitabine, oxaliplatin|gastric cancer pazopanib capecitabine, oxaliplatin
741298|NCT01130805|Metastatic or recurrent gastric cancer|metastatic or recurrent gastric cancer
741299|NCT01130818|Safety|safety
741300|NCT01130818|Tolerability|tolerability
741301|NCT01130818|Pharmacokinetics|pharmacokinetics
741302|NCT01130818|Bioavailability (solid vs solution, fasting vs fed)|bioavailability (solid vs solution, fasting vs fed)
741303|NCT01130818|Young healthy subjects|young healthy subjects
741304|NCT01130818|Elderly healthy subjects|elderly healthy subjects
741305|NCT01130870|Fecal incontinence|fecal incontinence
741306|NCT01130870|Sacral nerve stimulation|sacral nerve stimulation
741307|NCT01130870|Quality of life|quality of life
741308|NCT01130870|DR15.9 Incontinentia alva|dr15.9 incontinentia alva
741309|NCT01130883|acute tracheitis|acute tracheitis
741310|NCT01130883|acute tracheobronchitis or acute bronchitis|acute tracheobronchitis or acute bronchitis
741311|NCT01130883|acute exacerbation of chronic bronchitis|acute exacerbation of chronic bronchitis
741312|NCT01130883|mild community-acquired pneumonia|mild community-acquired pneumonia
741313|NCT01130896|MRI, pacemakers, Defibrillator|mri, pacemakers, defibrillator
741314|NCT01130909|Healthy|healthy
741315|NCT01130909|Effect of a single dose on gamma-band qEEG|effect of a single dose on gamma-band qeeg
741316|NCT01130922|Roux-and-Y gastric bypass surgery|roux-and-y gastric bypass surgery
741317|NCT01130922|stable body weight|stable body weight
741318|NCT01130935|GERD|gerd
741319|NCT01130935|gastric and duodenal ulcers|gastric and duodenal ulcers
741320|NCT01130935|NSAID therapy|nsaid therapy
741321|NCT01130948|hypoxia|hypoxia
741322|NCT01130948|altitude|altitude
741323|NCT01130948|sleep|sleep
741324|NCT01130948|sleep apnea|sleep apnea
741325|NCT01130948|periodic breathing|periodic breathing
741326|NCT01130948|vigilance|vigilance
741327|NCT01130948|psychomotor|psychomotor
741328|NCT01130948|endothelial function|endothelial function
741329|NCT01130961|Advanced NSCLC|advanced nsclc
741330|NCT01130961|Gefitinib|gefitinib
741331|NCT01130961|Thai patient|thai patient
741332|NCT01130987|resident|resident
741333|NCT01130987|intern|intern
741334|NCT01130987|patient safety|patient safety
741335|NCT01130987|medical error|medical error
741336|NCT01130987|time motion|time motion
741337|NCT01130987|handoff|handoff
741338|NCT01130987|sign-out|sign-out
741339|NCT01130987|Resident Workflow|resident workflow
741340|NCT01130987|Resident Communications|resident communications
741341|NCT01131026|Helicobacter pylori|helicobacter pylori
741342|NCT01131026|levofloxacin|levofloxacin
741343|NCT01131026|amoxicillin|amoxicillin
741344|NCT01131026|lansoprazole|lansoprazole
741345|NCT01131026|efficacy|efficacy
741346|NCT01131026|safety|safety
741347|NCT01131026|triple therapy|triple therapy
741348|NCT01131039|Ovarian Cancer|ovarian cancer
741349|NCT01131052|elderly populations|elderly populations
741350|NCT01131052|diabetes|diabetes
741351|NCT01131065|Hepatitis B|hepatitis b
741353|NCT01131065|Orthotopic liver transplantation|orthotopic liver transplantation
741354|NCT01131065|Liver transplantation|liver transplantation
741355|NCT01131065|Recurrence|recurrence
741356|NCT01131065|Reinfection|reinfection
741357|NCT01131065|Protective titers|protective titers
741358|NCT01131065|HBsAb|hbsab
741359|NCT01131065|Hepatitis B virus immune globulin|hepatitis b virus immune globulin
741360|NCT01131065|Niuliva|niuliva
741361|NCT01131104|NAION|naion
741365|NCT01131130|Contact lens|contact lens
741366|NCT01131143|Urban community centers|urban community centers
741367|NCT01131143|Obesity|obesity
741368|NCT01131143|Obesity counseling|obesity counseling
741369|NCT01131143|Low-cost intervention|low-cost intervention
741370|NCT01131156|postpartum|postpartum
741371|NCT01131156|smoking|smoking
741372|NCT01131156|relapse|relapse
741373|NCT01131156|breastfeeding|breastfeeding
741374|NCT01131169|Myeloma|myeloma
741375|NCT01131169|Busulfan|busulfan
741376|NCT01131169|Melphalan|melphalan
741377|NCT01131169|Fludarabine|fludarabine
741378|NCT01131169|T-Cell|t-cell
741379|NCT01131169|Stem Cell Transplantation|stem cell transplantation
741380|NCT01131169|10-051|10-051
741381|NCT01131195|HER2-negative breast cancer|her2-negative breast cancer
741382|NCT01131195|recurrent breast cancer|recurrent breast cancer
741383|NCT01131195|stage IIIB breast cancer|stage iiib breast cancer
741384|NCT01131195|stage IIIC breast cancer|stage iiic breast cancer
741385|NCT01131195|stage IV breast cancer|stage iv breast cancer
741386|NCT01131208|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
741387|NCT01131208|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
741388|NCT01131208|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
742685|NCT01134445|Cementless|cementless
741389|NCT01131208|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
741390|NCT01131208|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
741391|NCT01131208|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
741392|NCT01131221|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
741393|NCT01131221|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
741394|NCT01131221|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
741395|NCT01131221|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
741396|NCT01131221|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
741397|NCT01131221|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
741398|NCT01131221|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
741399|NCT01131221|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
741400|NCT01131221|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
741401|NCT01131221|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
741402|NCT01131221|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
741403|NCT01131221|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
741404|NCT01131247|CLL|cll
741405|NCT01131247|bendamustine|bendamustine
741406|NCT01131247|ofatumumab|ofatumumab
741407|NCT01131247|blood cancer|blood cancer
741408|NCT01131247|leukemia|leukemia
741409|NCT01131247|lymphoma|lymphoma
741410|NCT01131247|lymphocyte|lymphocyte
741411|NCT01131247|refractory|refractory
741412|NCT01131247|Advanced|advanced
741413|NCT01131247|relapsed|relapsed
741414|NCT01131247|hematologic|hematologic
741415|NCT01131247|hematology|hematology
741416|NCT01131247|antibody|antibody
741417|NCT01131247|non-Hodgkin lymphoma|non-hodgkin lymphoma
741418|NCT01131247|small lymphocytic lymphoma|small lymphocytic lymphoma
741419|NCT01131247|nevada cancer institute|nevada cancer institute
741420|NCT01131247|cephalon|cephalon
741421|NCT01131247|Glaxosmithkline|glaxosmithkline
741422|NCT01131260|STAN|stan
741423|NCT01131260|Fetal monitoring|fetal monitoring
741424|NCT01131260|Fetal acidosis|fetal acidosis
741425|NCT01131260|Fetal heart rate monitoring|fetal heart rate monitoring
741426|NCT01131260|Perinatology|perinatology
741427|NCT01131273|buprenorphine injecting|buprenorphine injecting
741428|NCT01131273|opiate dependence|opiate dependence
741429|NCT01131273|HIV risk|hiv risk
741430|NCT01131273|treatment outcome|treatment outcome
741431|NCT01131273|opiate dependence with buprenorphine injecting|opiate dependence with buprenorphine injecting
741432|NCT01131299|HDL|hdl
741433|NCT01131299|Cholesterol|cholesterol
741434|NCT01131299|Lipoproteins|lipoproteins
741435|NCT01131299|Serum Lipids|serum lipids
741436|NCT01131299|Alpha-Cyclodextrin|alpha-cyclodextrin
741437|NCT01131299|Atherosclerosis|atherosclerosis
741438|NCT01131299|Heart Disease|heart disease
741439|NCT01131312|Cervix|cervix
741440|NCT01131312|CIN|cin
741441|NCT01131312|HPV|hpv
741442|NCT01131312|Triage|triage
741443|NCT01131312|ASCUS/LSIL|ascus/lsil
741444|NCT01131312|Pap Smear|pap smear
741445|NCT01131312|HPV Test|hpv test
741446|NCT01131325|Philadelphia chromosome positive|philadelphia chromosome positive
741447|NCT01131325|Ph+|ph+
741448|NCT01131325|chronic myelogenous leukemia chronic phase|chronic myelogenous leukemia chronic phase
741449|NCT01131325|CML-CP|cml-cp
741450|NCT01131325|low imatinib trough levels|low imatinib trough levels
741451|NCT01131351|MDR-TB|mdr-tb
741452|NCT01131351|Dose Escalation|dose escalation
741453|NCT01131351|Phase II|phase ii
741454|NCT01131351|Open Label|open label
741455|NCT01131351|Non Controlled|non controlled
741550|NCT01131871|obesity|obesity
741456|NCT01131351|Pulmonary Multidrug-Resistant Tuberculosis (MDR TB)|pulmonary multidrug-resistant tuberculosis (mdr tb)
741457|NCT01131364|Interleukin|interleukin
741458|NCT01131364|IL2|il2
741459|NCT01131364|F16|f16
741460|NCT01131364|monoclonal|monoclonal
741461|NCT01131364|antibody|antibody
741462|NCT01131364|cytokine|cytokine
741463|NCT01131364|doxorubicin|doxorubicin
741464|NCT01131364|breast cancer|breast cancer
741465|NCT01131364|solid tumour|solid tumour
741466|NCT01131364|Phase I: Advanced Solid Tumour Patients|phase i: advanced solid tumour patients
741467|NCT01131364|Phase II: Breast Cancer Patients Amenable to anthracyclin Therapy|phase ii: breast cancer patients amenable to anthracyclin therapy
741468|NCT01131377|mechanical ventilation weaning phase patients with metabolic alkalosis|mechanical ventilation weaning phase patients with metabolic alkalosis
741469|NCT01131403|IL-1α, skin care; baby wet wipes; full-term newborn; skin barrier function|il-1α, skin care; baby wet wipes; full-term newborn; skin barrier function
741470|NCT01131429|mutation analysis|mutation analysis
741471|NCT01131429|first-line|first-line
741472|NCT01131429|second-line|second-line
741473|NCT01131429|targeted therapy|targeted therapy
741474|NCT01131442|immune|immune
741475|NCT01131468|ototoxicity|ototoxicity
741476|NCT01131468|aminoglycoside|aminoglycoside
741477|NCT01131468|vancomycine|vancomycine
741478|NCT01131468|peritoneal dialysis|peritoneal dialysis
741479|NCT01131468|peritonitis|peritonitis
741480|NCT01131481|cataracts,glistenings,intraocular lenses.|cataracts,glistenings,intraocular lenses.
741481|NCT01131494|Parkinson's disease|parkinson's disease
741482|NCT01131494|Dysphagia|dysphagia
741483|NCT01131494|Treatment|treatment
741484|NCT01131507|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
741485|NCT01131507|Infants with CF|infants with cf
741486|NCT01131520|SBIRT|sbirt
741487|NCT01131520|Drug abuse|drug abuse
741488|NCT01131546|Essential Hypertension|essential hypertension
741489|NCT01131546|Levamlodipine Besylate|levamlodipine besylate
741490|NCT01131546|Amlodipine Maleate|amlodipine maleate
741491|NCT01131559|bipolar disorder|bipolar disorder
741492|NCT01131559|manic depression|manic depression
741493|NCT01131559|depression|depression
741494|NCT01131559|Bipolar I or II|bipolar i or ii
741495|NCT01131585|Diabetic macular edema|diabetic macular edema
741497|NCT01131585|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
741498|NCT01131585|PDR|pdr
741499|NCT01131585|ranibizumab|ranibizumab
741500|NCT01131585|laser|laser
741501|NCT01131598|ALI|ali
741502|NCT01131598|SDRA|sdra
741503|NCT01131611|Spinal Stenosis|spinal stenosis
741504|NCT01131611|Rehabilitation|rehabilitation
741505|NCT01131611|Physical Therapy (specialty)|physical therapy (specialty)
741506|NCT01131611|Cognitive Behavior Therapy|cognitive behavior therapy
741507|NCT01131611|Behavioral Research|behavioral research
741508|NCT01131624|Iron deficiency|iron deficiency
741509|NCT01131637|chronic heart failure|chronic heart failure
741510|NCT01131637|rhNRG-1|rhnrg-1
741511|NCT01131637|mortality|mortality
741512|NCT01131650|Prevalence of diabetic retinopathy|prevalence of diabetic retinopathy
741513|NCT01131650|Diabetes|diabetes
741514|NCT01131650|Retinopathy|retinopathy
741515|NCT01131650|Prevalence|prevalence
741516|NCT01131650|Population|population
741517|NCT01131663|Infants, aerosol, acceptance, face mask, drug delivery|infants, aerosol, acceptance, face mask, drug delivery
741518|NCT01131689|metastatic HCC|metastatic hcc
741519|NCT01131702|Bioequivalence|bioequivalence
741520|NCT01131702|Crossover|crossover
741521|NCT01131702|Ranitidine|ranitidine
741522|NCT01131715|Qualitetive interview|qualitetive interview
741523|NCT01131715|Coronary heart disease (CHD)|coronary heart disease (chd)
741524|NCT01131715|Patient experience|patient experience
741525|NCT01131715|Patient perception|patient perception
741526|NCT01131728|Bioequivalence|bioequivalence
741527|NCT01131728|Crossover|crossover
741528|NCT01131728|Naproxen Sodium and Pseudoephedrine Hydrochloride|naproxen sodium and pseudoephedrine hydrochloride
741529|NCT01131741|anesthesia, general|anesthesia, general
741530|NCT01131741|blood pressure|blood pressure
741531|NCT01131741|epinephrine|epinephrine
741532|NCT01131741|heart rate|heart rate
741533|NCT01131741|injections, intravenous|injections, intravenous
741534|NCT01131754|Peripheral venous catheter complications|peripheral venous catheter complications
741535|NCT01131754|PVC occlusion|pvc occlusion
741536|NCT01131754|PVC phlebitis|pvc phlebitis
741537|NCT01131767|Bioequivalence|bioequivalence
741538|NCT01131767|Crossover|crossover
741539|NCT01131767|Naproxen Sodium and Pseudoephedrine Hydrochloride|naproxen sodium and pseudoephedrine hydrochloride
741540|NCT01131780|Bioequivalence|bioequivalence
741541|NCT01131780|Crossover|crossover
741542|NCT01131780|Ibuprofen and Pseudoephedrine|ibuprofen and pseudoephedrine
752839|NCT01174420|ologen|ologen
741543|NCT01131793|Coronary Artery Chronic Total Occlusion In-Stent|coronary artery chronic total occlusion in-stent
741544|NCT01131806|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
741545|NCT01131806|lung function change FEV1 FVC|lung function change fev1 fvc
741546|NCT01131806|acute exacerbation|acute exacerbation
741547|NCT01131806|life quality questionnaire|life quality questionnaire
741548|NCT01131819|Trans-tibial Amputation|trans-tibial amputation
741549|NCT01131832|Cholesterol, Plant sterols, Non-response, SNPs,|cholesterol, plant sterols, non-response, snps,
741552|NCT01131884|ASIA A or ASIA B Spinal Cord Injury|asia a or asia b spinal cord injury
741553|NCT01131897|Bioavailability|bioavailability
741554|NCT01131897|Crossover|crossover
741555|NCT01131897|Levetiracetam|levetiracetam
741556|NCT01131910|Rheumatoid arthritis|rheumatoid arthritis
741557|NCT01131910|TBE-vaccine|tbe-vaccine
741558|NCT01131910|Immunosuppression|immunosuppression
741559|NCT01131923|Bioequivalence|bioequivalence
741560|NCT01131923|Amlodipine Besylate|amlodipine besylate
741561|NCT01131936|Bioequivalence|bioequivalence
741562|NCT01131936|Amlodipine Besylate|amlodipine besylate
741563|NCT01131949|Bioequivalence|bioequivalence
741564|NCT01131949|Crossover|crossover
741565|NCT01131949|Lamotrigine (chewable, dispersible)|lamotrigine (chewable, dispersible)
741566|NCT01131962|esophageal varices|esophageal varices
741567|NCT01131962|hematemesis|hematemesis
741568|NCT01131962|endoscopy|endoscopy
741569|NCT01131975|Bioequivalence|bioequivalence
741570|NCT01131975|Crossover|crossover
741573|NCT01132014|Subjects with recurrent ovarian, fallopian tube or primary peritoneal cancer,|subjects with recurrent ovarian, fallopian tube or primary peritoneal cancer,
741574|NCT01132014|from whom solid tumor or ascites have been harvested and are available and|from whom solid tumor or ascites have been harvested and are available and
741673|NCT01132547|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
742787|NCT01134926|misoprostol|misoprostol
741575|NCT01132014|sufficient for tumorlysate preparation;and whose largest tumor nodule is 4.5|sufficient for tumorlysate preparation;and whose largest tumor nodule is 4.5
741576|NCT01132014|cm. Subjects may have undergone chemotherapy or other therapy following|cm. subjects may have undergone chemotherapy or other therapy following
741578|NCT01132027|Bioavailability, crossover, tacrolimus|bioavailability, crossover, tacrolimus
741579|NCT01132040|Bioequivalence|bioequivalence
741580|NCT01132040|Crossover|crossover
741581|NCT01132040|Primidone|primidone
741582|NCT01132053|JC Virus|jc virus
741583|NCT01132066|swallowing|swallowing
741584|NCT01132066|stroke|stroke
741585|NCT01132079|atopic dermatitis|atopic dermatitis
741586|NCT01132079|barrier function|barrier function
741587|NCT01132079|pimecrolimus|pimecrolimus
741588|NCT01132092|Evoked Potentials, Adult, Hearing Loss|evoked potentials, adult, hearing loss
741589|NCT01132118|rheumatoid arthritis|rheumatoid arthritis
741590|NCT01132118|insulin resistance|insulin resistance
741591|NCT01132118|hydroxychloroquine|hydroxychloroquine
741592|NCT01132118|cholesterol|cholesterol
741593|NCT01132131|Urinary tract infection|urinary tract infection
741594|NCT01132131|Cystitis|cystitis
741595|NCT01132131|Bacteruria|bacteruria
741596|NCT01132144|Reproductive Techniques|reproductive techniques
741597|NCT01132144|Embryo Implantation|embryo implantation
741598|NCT01132144|Endometrium|endometrium
741599|NCT01132144|Ultrasonography|ultrasonography
741600|NCT01132157|Healthy Kidney Donors and Their Recipients with End Stage Renal Disease|healthy kidney donors and their recipients with end stage renal disease
741601|NCT01132170|Bioequivalence|bioequivalence
741602|NCT01132170|Crossover|crossover
741603|NCT01132170|Divalproex Sodium|divalproex sodium
741604|NCT01132196|Bioequivalence|bioequivalence
741605|NCT01132196|Crossover|crossover
741606|NCT01132196|Divalproex Sodium|divalproex sodium
741607|NCT01132209|surgery|surgery
741608|NCT01132209|incisional hernia|incisional hernia
741609|NCT01132209|woundinfection|woundinfection
741610|NCT01132209|burst abdomen|burst abdomen
741611|NCT01132209|pain|pain
741612|NCT01132222|Bioequivalence|bioequivalence
741613|NCT01132222|Crossover|crossover
741614|NCT01132222|Ibuprofen and Pseudoephedrine|ibuprofen and pseudoephedrine
741615|NCT01132248|schistosomiasis, schistosoma haematobium|schistosomiasis, schistosoma haematobium
741616|NCT01132274|Supraventricular arrhythmia catheter ablation|supraventricular arrhythmia catheter ablation
741617|NCT01132287|Contact lens wear|contact lens wear
741618|NCT01132287|lubricant eye drops|lubricant eye drops
741619|NCT01132326|Symptomatic NOH|symptomatic noh
741620|NCT01132339|Adverse reactions to Gadolinium-based contrast agents.|adverse reactions to gadolinium-based contrast agents.
741621|NCT01132339|Adverse reactions to Iodine-basedcontrast agents.|adverse reactions to iodine-basedcontrast agents.
741622|NCT01132352|Bioavailability|bioavailability
741623|NCT01132352|Crossover|crossover
741624|NCT01132352|Levetiracetam|levetiracetam
741625|NCT01132365|knee arthroplasty|knee arthroplasty
741626|NCT01132378|Total knee arthroplasty|total knee arthroplasty
741627|NCT01132391|anal fissure|anal fissure
741628|NCT01132391|nitroglycerin|nitroglycerin
741629|NCT01132391|medical treatment|medical treatment
741630|NCT01132417|Tigecycline, MDR|tigecycline, mdr
741631|NCT01132417|Patient infected with multidrug resistance bacteria|patient infected with multidrug resistance bacteria
741632|NCT01132430|ADHERENCE|adherence
741633|NCT01132430|ASTHMA CONTROL|asthma control
741634|NCT01132430|ASTHMA QUALITY OF LIFE|asthma quality of life
741635|NCT01132430|MOTIVATIONAL INTERVIEWING|motivational interviewing
741636|NCT01132456|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
741637|NCT01132456|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
741638|NCT01132456|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
741639|NCT01132456|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
741640|NCT01132456|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
741641|NCT01132456|STENT THROMBOSIS|stent thrombosis
741642|NCT01132456|RESTENOTIC LESION|restenotic lesion
741874|NCT01132755|gastric|gastric
741643|NCT01132456|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
741644|NCT01132456|LONG LESION|long lesion
741645|NCT01132456|DUAL VESSEL|dual vessel
741651|NCT01132495|Stable angina|stable angina
741652|NCT01132495|angina pectoris|angina pectoris
741653|NCT01132495|PCI|pci
741654|NCT01132495|FAME|fame
741655|NCT01132495|FAME II|fame ii
741656|NCT01132495|FFR|ffr
741657|NCT01132495|Fractional Flow Reserve|fractional flow reserve
741658|NCT01132495|Pressure wire|pressure wire
741659|NCT01132508|Tibial plateau fracture|tibial plateau fracture
741660|NCT01132508|Orthopaedic Trauma Association (OTA) B2 B3 C3|orthopaedic trauma association (ota) b2 b3 c3
741661|NCT01132508|Bone Void|bone void
741662|NCT01132521|ulinastatin|ulinastatin
741663|NCT01132521|severe acute pancreatitis|severe acute pancreatitis
741664|NCT01132534|OGD|ogd
741665|NCT01132534|NBI|nbi
741666|NCT01132534|AFI|afi
741667|NCT01132534|Videoendoscopy|videoendoscopy
741668|NCT01132534|Narrow Band Imaging|narrow band imaging
741669|NCT01132534|Autofluorescence Imaging|autofluorescence imaging
741671|NCT01132547|weight changes|weight changes
741672|NCT01132547|nausea and vomiting|nausea and vomiting
742296|NCT01125787|leukemia|leukemia
741674|NCT01132547|anaplastic osteosarcoma|anaplastic osteosarcoma
741675|NCT01132547|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
741676|NCT01132547|childhood angiosarcoma|childhood angiosarcoma
741677|NCT01132547|childhood epithelioid sarcoma|childhood epithelioid sarcoma
741678|NCT01132547|childhood fibrosarcoma|childhood fibrosarcoma
741679|NCT01132547|childhood gliosarcoma|childhood gliosarcoma
741680|NCT01132547|childhood leiomyosarcoma|childhood leiomyosarcoma
741681|NCT01132547|childhood liposarcoma|childhood liposarcoma
741682|NCT01132547|childhood neurofibrosarcoma|childhood neurofibrosarcoma
741683|NCT01132547|childhood synovial sarcoma|childhood synovial sarcoma
741684|NCT01132547|chondrosarcoma|chondrosarcoma
741685|NCT01132547|chondrosarcomatous osteosarcoma|chondrosarcomatous osteosarcoma
741686|NCT01132547|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
741687|NCT01132547|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
741688|NCT01132547|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
741689|NCT01132547|endometrial stromal sarcoma|endometrial stromal sarcoma
741690|NCT01132547|extraosseous Ewing sarcoma|extraosseous ewing sarcoma
741691|NCT01132547|peripheral primitive neuroectodermal tumor|peripheral primitive neuroectodermal tumor
741692|NCT01132547|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
741693|NCT01132547|localized Ewing sarcoma|localized ewing sarcoma
741694|NCT01132547|localized osteosarcoma|localized osteosarcoma
741695|NCT01132547|mast cell sarcoma|mast cell sarcoma
741696|NCT01132547|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
741697|NCT01132547|metastatic Ewing sarcoma|metastatic ewing sarcoma
741698|NCT01132547|metastatic osteosarcoma|metastatic osteosarcoma
741699|NCT01132547|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
741700|NCT01132547|mixed osteosarcoma|mixed osteosarcoma
741701|NCT01132547|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
741702|NCT01132547|osteoblastic osteosarcoma|osteoblastic osteosarcoma
741703|NCT01132547|ovarian carcinosarcoma|ovarian carcinosarcoma
741704|NCT01132547|ovarian sarcoma|ovarian sarcoma
741705|NCT01132547|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
741706|NCT01132547|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
741707|NCT01132547|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
741708|NCT01132547|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
741709|NCT01132547|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
741710|NCT01132547|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
741711|NCT01132547|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
741712|NCT01132547|recurrent Ewing sarcoma|recurrent ewing sarcoma
741713|NCT01132547|recurrent osteosarcoma|recurrent osteosarcoma
741714|NCT01132547|recurrent uterine sarcoma|recurrent uterine sarcoma
741715|NCT01132547|small intestine leiomyosarcoma|small intestine leiomyosarcoma
741716|NCT01132547|stage I uterine sarcoma|stage i uterine sarcoma
741717|NCT01132547|stage II uterine sarcoma|stage ii uterine sarcoma
741718|NCT01132547|stage III uterine sarcoma|stage iii uterine sarcoma
741719|NCT01132547|stage IV uterine sarcoma|stage iv uterine sarcoma
741720|NCT01132547|telangiectatic osteosarcoma|telangiectatic osteosarcoma
741721|NCT01132547|untreated childhood gliosarcoma|untreated childhood gliosarcoma
741722|NCT01132547|uterine carcinosarcoma|uterine carcinosarcoma
741723|NCT01132547|uterine leiomyosarcoma|uterine leiomyosarcoma
752840|NCT01174420|Mitomycin-C|mitomycin-c
741724|NCT01132547|localized resectable neuroblastoma|localized resectable neuroblastoma
741725|NCT01132547|localized unresectable neuroblastoma|localized unresectable neuroblastoma
741726|NCT01132547|recurrent neuroblastoma|recurrent neuroblastoma
741727|NCT01132547|regional neuroblastoma|regional neuroblastoma
741728|NCT01132547|stage 4S neuroblastoma|stage 4s neuroblastoma
741729|NCT01132547|recurrent Wilms tumor|recurrent wilms tumor
741730|NCT01132547|childhood kidney tumors|childhood kidney tumors
741731|NCT01132547|stage III Wilms tumor|stage iii wilms tumor
741732|NCT01132547|stage IV Wilms tumor|stage iv wilms tumor
741733|NCT01132547|childhood hepatoblastoma|childhood hepatoblastoma
741734|NCT01132547|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
741735|NCT01132547|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
741736|NCT01132547|childhood gonadal germ cell tumor|childhood gonadal germ cell tumor
741737|NCT01132547|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
741738|NCT01132547|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
742081|NCT01124812|lung|lung
741739|NCT01132547|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
741740|NCT01132547|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
741741|NCT01132547|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
741742|NCT01132547|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
741743|NCT01132547|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
741744|NCT01132547|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
741745|NCT01132547|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
741746|NCT01132547|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
742297|NCT01125787|lymphocyte|lymphocyte
741747|NCT01132547|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
741748|NCT01132547|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
741749|NCT01132547|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
741750|NCT01132547|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
741751|NCT01132547|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
741752|NCT01132547|untreated childhood medulloblastoma|untreated childhood medulloblastoma
741753|NCT01132547|childhood ependymoblastoma|childhood ependymoblastoma
741754|NCT01132547|childhood infratentorial ependymoma|childhood infratentorial ependymoma
741755|NCT01132547|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
741756|NCT01132547|recurrent childhood ependymoma|recurrent childhood ependymoma
741757|NCT01132547|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
741758|NCT01132547|untreated childhood subependymal giant cell astrocytoma|untreated childhood subependymal giant cell astrocytoma
741759|NCT01132547|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
741760|NCT01132547|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
741761|NCT01132547|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
741762|NCT01132547|recurrent childhood brain tumor|recurrent childhood brain tumor
741763|NCT01132547|untreated childhood brain stem glioma|untreated childhood brain stem glioma
741764|NCT01132547|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
741765|NCT01132547|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
741766|NCT01132547|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
741767|NCT01132547|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
741768|NCT01132547|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
741769|NCT01132547|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
741770|NCT01132547|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
741771|NCT01132547|untreated childhood anaplastic astrocytoma|untreated childhood anaplastic astrocytoma
741772|NCT01132547|untreated childhood anaplastic oligoastrocytoma|untreated childhood anaplastic oligoastrocytoma
741773|NCT01132547|untreated childhood anaplastic oligodendroglioma|untreated childhood anaplastic oligodendroglioma
741774|NCT01132547|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
741775|NCT01132547|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
741776|NCT01132547|recurrent childhood astrocytoma|recurrent childhood astrocytoma
741777|NCT01132547|other tumor of glial origin|other tumor of glial origin
741778|NCT01132547|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
741779|NCT01132547|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
741780|NCT01132547|recurrent childhood diffuse astrocytoma|recurrent childhood diffuse astrocytoma
741781|NCT01132547|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
741782|NCT01132547|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
741783|NCT01132547|recurrent childhood oligoastrocytoma|recurrent childhood oligoastrocytoma
741784|NCT01132547|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
741785|NCT01132547|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
741786|NCT01132547|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
752841|NCT01174420|Collagen Matrix|collagen matrix
741787|NCT01132547|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
741788|NCT01132547|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
741789|NCT01132547|untreated childhood cerebral astrocytoma|untreated childhood cerebral astrocytoma
741790|NCT01132547|untreated childhood diffuse astrocytoma|untreated childhood diffuse astrocytoma
741791|NCT01132547|untreated childhood fibrillary astrocytoma|untreated childhood fibrillary astrocytoma
741792|NCT01132547|untreated childhood gemistocytic astrocytoma|untreated childhood gemistocytic astrocytoma
741793|NCT01132547|untreated childhood oligoastrocytoma|untreated childhood oligoastrocytoma
741875|NCT01132755|pancreas|pancreas
741794|NCT01132547|untreated childhood pilocytic astrocytoma|untreated childhood pilocytic astrocytoma
741795|NCT01132547|untreated childhood pilomyxoid astrocytoma|untreated childhood pilomyxoid astrocytoma
741796|NCT01132547|untreated childhood pleomorphic xanthoastrocytoma|untreated childhood pleomorphic xanthoastrocytoma
741797|NCT01132547|untreated childhood protoplasmic astrocytoma|untreated childhood protoplasmic astrocytoma
741798|NCT01132547|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
741799|NCT01132547|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
742273|NCT01125696|Tenofovir|tenofovir
741800|NCT01132547|recurrent childhood visual pathway|recurrent childhood visual pathway
741801|NCT01132547|hypothalamic glioma|hypothalamic glioma
741802|NCT01132547|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
751885|NCT01171053|Cost-effectiveness|cost-effectiveness
741803|NCT01132547|untreated childhood gliomatosis cerebri|untreated childhood gliomatosis cerebri
741804|NCT01132547|untreated childhood oligodendroglioma|untreated childhood oligodendroglioma
741805|NCT01132547|untreated childhood visual pathway|untreated childhood visual pathway
741806|NCT01132547|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
741807|NCT01132547|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
741808|NCT01132547|recurrent childhood glioblastoma|recurrent childhood glioblastoma
741809|NCT01132547|untreated childhood giant cell glioblastoma|untreated childhood giant cell glioblastoma
741810|NCT01132547|untreated childhood glioblastoma|untreated childhood glioblastoma
741811|NCT01132547|childhood choroid plexus tumor|childhood choroid plexus tumor
741812|NCT01132547|childhood grade I meningioma|childhood grade i meningioma
741813|NCT01132547|childhood grade II meningioma|childhood grade ii meningioma
741814|NCT01132547|childhood grade III meningioma|childhood grade iii meningioma
741815|NCT01132547|minimally differentiated myeloid leukemia (M0)|minimally differentiated myeloid leukemia (m0)
741816|NCT01132547|myeloblastic leukemia with maturation (M2)|myeloblastic leukemia with maturation (m2)
741817|NCT01132547|myeloblastic leukemia without maturation (M1)|myeloblastic leukemia without maturation (m1)
741818|NCT01132547|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
741819|NCT01132547|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
741820|NCT01132547|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
741821|NCT01132547|untreated childhood acute myeloid leukemia|untreated childhood acute myeloid leukemia
741822|NCT01132547|other myeloid malignancies|other myeloid malignancies
741823|NCT01132547|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
741824|NCT01132547|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
741825|NCT01132547|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
741826|NCT01132547|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
741827|NCT01132547|unspecified childhood solid tumor|unspecified childhood solid tumor
741828|NCT01132560|ductal breast carcinoma in situ|ductal breast carcinoma in situ
741829|NCT01132599|stage IV prostate cancer|stage iv prostate cancer
741830|NCT01132612|Chronic plaque-type psoriasis|chronic plaque-type psoriasis
741831|NCT01132612|AIN457|ain457
741832|NCT01132612|dermatology|dermatology
741833|NCT01132612|Moderate to severe chronic plaque-type psoriasis|moderate to severe chronic plaque-type psoriasis
741834|NCT01132625|HSP90|hsp90
741835|NCT01132625|molecular chaperone|molecular chaperone
741836|NCT01132625|advanced solid tumors|advanced solid tumors
741837|NCT01132625|Japan|japan
741838|NCT01132638|Gastroesophageal|gastroesophageal
741839|NCT01132638|Pantoprazole|pantoprazole
741840|NCT01132638|erosive|erosive
741841|NCT01132638|Erosive GERD grades A-D, acc. to Los Angeles classification|erosive gerd grades a-d, acc. to los angeles classification
741842|NCT01132651|eczema|eczema
741843|NCT01132651|itch|itch
741844|NCT01132651|pruritus|pruritus
741845|NCT01132651|head|head
741846|NCT01132651|neck|neck
741847|NCT01132664|HER2|her2
741848|NCT01132664|BKM120|bkm120
741849|NCT01132664|PIK3|pik3
741850|NCT01132664|metastatic breast cancer|metastatic breast cancer
741851|NCT01132664|brain metastases|brain metastases
741852|NCT01132664|Herceptin|herceptin
741853|NCT01132664|trastuzumab|trastuzumab
741854|NCT01132664|capecitabine|capecitabine
741855|NCT01132664|open-label|open-label
741856|NCT01132664|maximum tolerated dose|maximum tolerated dose
741857|NCT01132664|Phase I/Phase ll|phase i/phase ll
741858|NCT01132677|OA of Knee|oa of knee
741859|NCT01132677|Osteoarthritis of Knee|osteoarthritis of knee
741860|NCT01132677|Viscosupplementation and Osteoarthritis|viscosupplementation and osteoarthritis
741861|NCT01132677|Viscosupplementation and OA|viscosupplementation and oa
741862|NCT01132677|Hyaluronic Acid|hyaluronic acid
741863|NCT01132677|Corticosteroid injection versus hyaluronic acid|corticosteroid injection versus hyaluronic acid
741864|NCT01132677|Synvisc One and Knee OA|synvisc one and knee oa
741865|NCT01132677|viscosupplementation and knee pain|viscosupplementation and knee pain
741866|NCT01132677|knee Pain from OA|knee pain from oa
741867|NCT01132690|gaucher disease|gaucher disease
741868|NCT01132690|pediatric|pediatric
741869|NCT01132742|Malnutrition|malnutrition
741870|NCT01132742|children|children
741871|NCT01132742|Hospital Stay|hospital stay
741872|NCT01132742|Screening Tools|screening tools
741873|NCT01132742|Anthropometry|anthropometry
741877|NCT01132755|peritoneal lavage|peritoneal lavage
741878|NCT01132755|10-011|10-011
741879|NCT01132755|gastric and pancreatic cancer|gastric and pancreatic cancer
741880|NCT01132781|rhinosinusitis|rhinosinusitis
741881|NCT01132781|asthma|asthma
741882|NCT01132781|allergic rhinitis|allergic rhinitis
741883|NCT01132781|theophylline|theophylline
741884|NCT01132794|Pain relief and sedation condition|pain relief and sedation condition
741885|NCT01132807|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
741886|NCT01132807|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
741887|NCT01132833|thromboembolism|thromboembolism
741888|NCT01132833|stage I multiple myeloma|stage i multiple myeloma
741889|NCT01132833|stage II multiple myeloma|stage ii multiple myeloma
741890|NCT01132833|stage III multiple myeloma|stage iii multiple myeloma
741891|NCT01132859|Specimen Collection|specimen collection
741892|NCT01132859|Mucosal Immunity|mucosal immunity
741893|NCT01132859|Immune Responses|immune responses
741894|NCT01132859|Immunity|immunity
741895|NCT01132859|Vaccines|vaccines
741896|NCT01132859|Healthy Volunteer|healthy volunteer
741898|NCT01132872|Serotonin 1A Receptor|serotonin 1a receptor
741899|NCT01132872|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
741900|NCT01132872|Dosimetry|dosimetry
741901|NCT01132872|Healthy Volunteer|healthy volunteer
741902|NCT01132872|HV|hv
741903|NCT01132885|MRI|mri
741904|NCT01132885|Children|children
741905|NCT01132885|Williams Syndrome|williams syndrome
741906|NCT01132885|Phenotype|phenotype
741907|NCT01132885|Brain|brain
741908|NCT01132885|Healthy Volunteer|healthy volunteer
741909|NCT01132885|HV|hv
741910|NCT01132898|Traumatic Brain Injury|traumatic brain injury
741911|NCT01132898|Biomarkers|biomarkers
741912|NCT01132898|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
741913|NCT01132898|DTI|dti
741914|NCT01132898|Functional Capacity|functional capacity
741915|NCT01132898|TBI|tbi
741916|NCT01132911|Solid Tumors|solid tumors
741917|NCT01132911|Maximum Tolerated Dose|maximum tolerated dose
741918|NCT01132911|Lymphoma|lymphoma
741919|NCT01132911|Dose Escalation|dose escalation
741920|NCT01132911|Pharmacokinetics|pharmacokinetics
741921|NCT01132911|Pediatric Cancer|pediatric cancer
741922|NCT01132911|Solid Tumor|solid tumor
741923|NCT01132911|Sarcoma|sarcoma
741924|NCT01132911|Wilms Tumor|wilms tumor
741925|NCT01132911|Neuroblastoma|neuroblastoma
741926|NCT01132924|Early Pregnancy|early pregnancy
741927|NCT01132924|Gestational Age|gestational age
741928|NCT01132924|Fecundability|fecundability
741929|NCT01132924|Ovulation|ovulation
741930|NCT01132924|Recall|recall
741931|NCT01132937|Diffusion/Perfusion-MRI|diffusion/perfusion-mri
741932|NCT01132937|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
741933|NCT01132937|Traumatic Brain Injury|traumatic brain injury
741934|NCT01132937|Brain Imaging|brain imaging
741935|NCT01132937|Brain Injuries|brain injuries
741936|NCT01132937|TBI|tbi
741937|NCT01132976|Personality disorders|personality disorders
741938|NCT01132976|Personal Concerns Inventory|personal concerns inventory
741939|NCT01132976|Non completion|non completion
741940|NCT01132989|Patients with cutaneous T cell lymphoma|patients with cutaneous t cell lymphoma
741941|NCT01133015|FFR|ffr
741942|NCT01133015|IVUS|ivus
741943|NCT01133015|MLA|mla
741944|NCT01133028|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
741945|NCT01133054|Coronary Vessel Anomalies|coronary vessel anomalies
741946|NCT01133067|lung cancer|lung cancer
741947|NCT01133067|followup|followup
741948|NCT01133067|physical follow up|physical follow up
741949|NCT01133067|telephonic followup|telephonic followup
741950|NCT01133093|Cardiovascular risk factors|cardiovascular risk factors
741951|NCT01133093|Nutritional assessment|nutritional assessment
741952|NCT01133093|Epidemiology|epidemiology
741953|NCT01133106|stroke recovery|stroke recovery
741954|NCT01133106|quality of life|quality of life
741955|NCT01133119|cardiac catheterization|cardiac catheterization
741956|NCT01133119|local anesthetic|local anesthetic
741957|NCT01133119|pain experienced post-operatively|pain experienced post-operatively
741958|NCT01133119|pediatric patients|pediatric patients
741959|NCT01133132|Colon cancer patients who have completed treatment|colon cancer patients who have completed treatment
741960|NCT01133145|composite tissue allotransplantation|composite tissue allotransplantation
741961|NCT01133145|hand transplantation|hand transplantation
741962|NCT01133145|knee transplantation|knee transplantation
741963|NCT01133145|face transplantation|face transplantation
741964|NCT01133158|Follicular non-Hodgkin's lymphoma in relapse or refractory to standard first-line immunochemotherapy|follicular non-hodgkin's lymphoma in relapse or refractory to standard first-line immunochemotherapy
741965|NCT01133171|Cardiovascular Disease|cardiovascular disease
741966|NCT01133171|Stroke|stroke
741967|NCT01133184|HBV transmission PreS1/PreS2/S HBV vaccine|hbv transmission pres1/pres2/s hbv vaccine
741968|NCT01133197|thumb|thumb
741969|NCT01133197|arthritis|arthritis
741970|NCT01133197|Impact of thumb arthritis on health|impact of thumb arthritis on health
741971|NCT01133210|hypertriglyceridemia|hypertriglyceridemia
741972|NCT01133210|triglyceride|triglyceride
741973|NCT01133210|cholesterol|cholesterol
741976|NCT01124487|inflammation|inflammation
741977|NCT01124487|lipids|lipids
741978|NCT01124487|total cholesterol|total cholesterol
741979|NCT01124487|Triglycerides|triglycerides
741980|NCT01124487|insulin sensitivity|insulin sensitivity
741981|NCT01124500|methylphenidate|methylphenidate
741982|NCT01124500|transdermal patch|transdermal patch
741983|NCT01124500|placebo|placebo
741984|NCT01124500|fatigue|fatigue
741985|NCT01124500|10-020|10-020
741986|NCT01124513|Melanin Index|melanin index
741987|NCT01124513|Fitzpatrick Skin Phototype|fitzpatrick skin phototype
741988|NCT01124513|Videodermoscopy|videodermoscopy
741989|NCT01124513|Spectrophotometry|spectrophotometry
741990|NCT01124526|R F C treatment in patients with Non Hodgkin Lymphoma|r f c treatment in patients with non hodgkin lymphoma
741991|NCT01124539|Adult Patients|adult patients
741992|NCT01124539|Recurrence of Glioblastoma Multiforme|recurrence of glioblastoma multiforme
741993|NCT01124539|Recurrence of GBM|recurrence of gbm
741994|NCT01124539|Gliosarcoma|gliosarcoma
741995|NCT01124552|Lateral Canthal Lines|lateral canthal lines
741996|NCT01124552|Crow's Feet Wrinkles|crow's feet wrinkles
741997|NCT01124552|Facial Wrinkles|facial wrinkles
741998|NCT01124565|Lateral Canthal Lines|lateral canthal lines
741999|NCT01124565|Crow's Feet|crow's feet
742000|NCT01124565|Facial Wrinkles|facial wrinkles
742001|NCT01124578|Ventilators, Mechanical|ventilators, mechanical
742003|NCT01124604|Low Back Pain|low back pain
742004|NCT01124604|Back Pain|back pain
742005|NCT01124604|Osteoarthritis, Knee|osteoarthritis, knee
742006|NCT01124604|Tapentadol|tapentadol
742007|NCT01124604|Tapentadol Hydrochloride Extended Release|tapentadol hydrochloride extended release
742008|NCT01124617|Chronic pain|chronic pain
742009|NCT01124617|Diabetic Neuropathic Pain|diabetic neuropathic pain
742010|NCT01124617|Neuralgia, Postherpetic|neuralgia, postherpetic
742011|NCT01124617|Tapentadol hydrochloride extended-release|tapentadol hydrochloride extended-release
742012|NCT01124617|JNS024ER|jns024er
742013|NCT01124617|Placebo|placebo
742014|NCT01124643|Replagal|replagal
742015|NCT01124643|Agalsidase alfa|agalsidase alfa
742016|NCT01124643|Alpha-Galactosidase|alpha-galactosidase
742017|NCT01124643|Enzyme Replacement Therapy|enzyme replacement therapy
742018|NCT01124656|angiotensin II receptor blocker|angiotensin ii receptor blocker
742019|NCT01124656|thiazolidinediones|thiazolidinediones
742020|NCT01124656|combination|combination
742021|NCT01124656|Actos|actos
742022|NCT01124656|HbA1c|hba1c
742023|NCT01124656|Type 2 diabetes|type 2 diabetes
742024|NCT01124656|Drug Therapy|drug therapy
742025|NCT01124656|Hypertension|hypertension
742026|NCT01124669|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
742027|NCT01124669|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
742028|NCT01124669|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
742029|NCT01124682|adenocarcinoma of the bladder|adenocarcinoma of the bladder
742030|NCT01124682|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
742031|NCT01124682|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
742032|NCT01124682|recurrent bladder cancer|recurrent bladder cancer
742033|NCT01124682|stage II bladder cancer|stage ii bladder cancer
742034|NCT01124682|stage III bladder cancer|stage iii bladder cancer
742035|NCT01124682|stage IV bladder cancer|stage iv bladder cancer
742036|NCT01124695|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
742037|NCT01124695|male breast cancer|male breast cancer
742038|NCT01124695|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
742039|NCT01124695|recurrent breast cancer|recurrent breast cancer
742040|NCT01124695|stage IV breast cancer|stage iv breast cancer
742041|NCT01124708|ADHD|adhd
742042|NCT01124708|Attention Deficit Hyperactive Disorder|attention deficit hyperactive disorder
742043|NCT01124721|Cognitive training|cognitive training
742044|NCT01124734|metastatic melanoma|metastatic melanoma
742045|NCT01124747|ASP1585|asp1585
742046|NCT01124747|Healthy Volunteers|healthy volunteers
742047|NCT01124760|open label|open label
742048|NCT01124760|2-consecutive-group|2-consecutive-group
742049|NCT01124760|2-period|2-period
742050|NCT01124760|1-sequence crossover study|1-sequence crossover study
742051|NCT01124773|cognition|cognition
742052|NCT01124773|memory|memory
742053|NCT01124773|hormone therapy|hormone therapy
742055|NCT01124786|metastatic|metastatic
742056|NCT01124786|pancreatic|pancreatic
742057|NCT01124786|pancreas|pancreas
742058|NCT01124786|adenocarcinoma|adenocarcinoma
742059|NCT01124786|gemcitabine|gemcitabine
742060|NCT01124786|human equilibrative nucleoside transporter-1 (hENT1)|human equilibrative nucleoside transporter-1 (hent1)
742061|NCT01124786|CO-1.01|co-1.01
742062|NCT01124786|CO-101|co-101
742063|NCT01124786|CO101|co101
742064|NCT01124786|Stage 4|stage 4
742065|NCT01124786|Stage IV|stage iv
742066|NCT01124799|Hepatitis C virus|hepatitis c virus
742067|NCT01124799|TMC435-TiDP16-C125|tmc435-tidp16-c125
742068|NCT01124799|TMC435-C125|tmc435-c125
742069|NCT01124799|TMC435|tmc435
742070|NCT01124799|TMC435350|tmc435350
742071|NCT01124799|protease inhibitor|protease inhibitor
742073|NCT01124799|Hepatitis C|hepatitis c
742074|NCT01124799|photosensitivity|photosensitivity
742075|NCT01124799|phototoxicity|phototoxicity
742076|NCT01124812|I131|i131
742077|NCT01124812|L19|l19
742078|NCT01124812|antibody|antibody
742079|NCT01124812|monoclonal|monoclonal
742082|NCT01124812|tumor targeting|tumor targeting
742083|NCT01124812|radioimmunotherapy|radioimmunotherapy
742084|NCT01124812|Patients with newly diagnosed inoperable, locally-advanced (stage III) NSCLC|patients with newly diagnosed inoperable, locally-advanced (stage iii) nsclc
742085|NCT01124825|Anesthesia induction and maintenance|anesthesia induction and maintenance
742087|NCT01124838|Uveitis|uveitis
742088|NCT01124851|Sleep disorder|sleep disorder
742089|NCT01124864|Non-small-cell lung cancer|non-small-cell lung cancer
742090|NCT01124864|HSP90|hsp90
742091|NCT01124864|2nd to 3rd line treatment|2nd to 3rd line treatment
742092|NCT01124877|Children and Adolescents with Bipolar I Disorder (manic or mixed)|children and adolescents with bipolar i disorder (manic or mixed)
742093|NCT01124890|acute myocardial infarction|acute myocardial infarction
742094|NCT01124890|thrombolysis|thrombolysis
742095|NCT01124890|percutaneous coronary interention|percutaneous coronary interention
742096|NCT01124903|dehydration|dehydration
742097|NCT01124903|hypohydration|hypohydration
742098|NCT01124903|diagnostic accuracy|diagnostic accuracy
742099|NCT01124903|biological variation|biological variation
742100|NCT01124903|hydration assessment|hydration assessment
742101|NCT01124903|body mass|body mass
742102|NCT01124903|osmolality|osmolality
742103|NCT01124903|plasma|plasma
742104|NCT01124903|saliva|saliva
742105|NCT01124903|urine|urine
742106|NCT01124916|incontinence|incontinence
742107|NCT01124916|prolapse|prolapse
742108|NCT01124916|Abdominal sacrocolpopexy|abdominal sacrocolpopexy
742109|NCT01124929|Intestinal tuberculosis|intestinal tuberculosis
742110|NCT01124929|Tuberculous peritonitis|tuberculous peritonitis
742111|NCT01124929|Abdominal tuberculosis|abdominal tuberculosis
742112|NCT01124955|treatment|treatment
742113|NCT01124955|acupuncture|acupuncture
742114|NCT01124955|spine|spine
742115|NCT01124968|User-Computer Interface|user-computer interface
742116|NCT01124968|Office Visits|office visits
742117|NCT01124968|Primary Health Care|primary health care
742118|NCT01124968|Patient Satisfaction|patient satisfaction
742119|NCT01124968|Job Satisfaction|job satisfaction
742120|NCT01124968|Health Services Research|health services research
742121|NCT01124981|Fibrinogen concentrate|fibrinogen concentrate
742122|NCT01124981|Coagulopathy|coagulopathy
742123|NCT01124994|Barrett's oesophagus|barrett's oesophagus
742124|NCT01124994|High grade intraepithelial neoplasia (HGIEN)|high grade intraepithelial neoplasia (hgien)
742125|NCT01125007|Dental plaque|dental plaque
742126|NCT01125007|Gingival abrasion|gingival abrasion
742127|NCT01125007|toothbrushing|toothbrushing
742128|NCT01125033|Dialysis, Restless legs syndrome, Ascorbic acid, Vitamin E|dialysis, restless legs syndrome, ascorbic acid, vitamin e
742129|NCT01125059|hydromorphone|hydromorphone
742130|NCT01125059|lumbar posterior spinal fusion|lumbar posterior spinal fusion
742131|NCT01125059|lumbosacral spondylosis|lumbosacral spondylosis
742132|NCT01125059|Spinal Fusion|spinal fusion
742133|NCT01125072|chest pain|chest pain
742134|NCT01125072|echocardiography|echocardiography
742135|NCT01125072|strain imaging|strain imaging
742136|NCT01125085|I131|i131
742137|NCT01125085|L19|l19
742138|NCT01125085|antibody|antibody
742139|NCT01125085|monoclonal|monoclonal
742140|NCT01125085|multiple brain metastasis|multiple brain metastasis
742141|NCT01125085|tumor targeting|tumor targeting
742142|NCT01125085|radioimmunotherapy|radioimmunotherapy
742143|NCT01125085|Patients with brain metastases of solid tumors (>1), who are not amenable for surgical excision or stereotactic radiosurgery.|patients with brain metastases of solid tumors (>1), who are not amenable for surgical excision or stereotactic radiosurgery.
742144|NCT01125098|COPD|copd
742145|NCT01125098|PRO-CT|pro-ct
742146|NCT01125098|antibiotics|antibiotics
742147|NCT01125124|Pleurodesis|pleurodesis
742148|NCT01125124|Malignant pleural effusion|malignant pleural effusion
742149|NCT01125124|Silver Nitrate|silver nitrate
742150|NCT01125124|Pain|pain
742151|NCT01125137|Keloid|keloid
742152|NCT01125137|MMP|mmp
742153|NCT01125137|Matrix metalloproteinase|matrix metalloproteinase
742154|NCT01125137|dermatology|dermatology
742155|NCT01125150|diffuse reflectance spectroscopy|diffuse reflectance spectroscopy
742156|NCT01125163|very low birth weight infants|very low birth weight infants
742157|NCT01125163|anemia|anemia
742158|NCT01125163|iron supplementation|iron supplementation
742159|NCT01125176|CLL|cll
742160|NCT01125202|Intervention studies|intervention studies
742161|NCT01125202|Computers, handheld|computers, handheld
742162|NCT01125202|Randomized controlled trial|randomized controlled trial
742163|NCT01125202|Sodium, dietary|sodium, dietary
742164|NCT01125215|Painful diabetic neuropathy|painful diabetic neuropathy
742165|NCT01125215|Capsaicin|capsaicin
742166|NCT01125215|Nanoparticle|nanoparticle
742167|NCT01125215|Quantitative Sensory Testing|quantitative sensory testing
742168|NCT01125228|AIDS|aids
742169|NCT01125228|Antiretroviral|antiretroviral
742170|NCT01125228|Kaposi's Sarcoma|kaposi's sarcoma
742171|NCT01125241|wuling capsule|wuling capsule
742174|NCT01125241|superiority clinical research|superiority clinical research
742175|NCT01125254|thalassemia major|thalassemia major
742176|NCT01125254|calcium channel blockade|calcium channel blockade
742177|NCT01125254|magnetic resonance imaging|magnetic resonance imaging
742178|NCT01125267|medication adherence|medication adherence
742179|NCT01125267|schizophrenia|schizophrenia
742180|NCT01125267|Mexican American|mexican american
742181|NCT01125267|multifamily groups|multifamily groups
742182|NCT01125280|Small bowel occlusion|small bowel occlusion
742183|NCT01125280|Conservative treatment for small bowel occlusion|conservative treatment for small bowel occlusion
751886|NCT01171053|Irritable bowel syndrome|irritable bowel syndrome
742184|NCT01125280|Surgical treatment for small bowel occlusion|surgical treatment for small bowel occlusion
742185|NCT01125280|Small bowel resection|small bowel resection
742186|NCT01125280|Score of severity of small bowel occlusion|score of severity of small bowel occlusion
742187|NCT01125293|everolimus|everolimus
742188|NCT01125293|rituximab|rituximab
742189|NCT01125293|bortezomib|bortezomib
742190|NCT01125293|RAD001|rad001
742191|NCT01125293|Rituxan|rituxan
742192|NCT01125293|Velcade|velcade
742193|NCT01125306|Drug consumption|drug consumption
742194|NCT01125306|The Xal-Ease device|the xal-ease device
742195|NCT01125306|Patient's compliance|patient's compliance
742196|NCT01125306|Using a novel Pfizer-Pharmacia device to facilitate the Xalatan/Xalacom instillation and to avoid loss of eye drops|using a novel pfizer-pharmacia device to facilitate the xalatan/xalacom instillation and to avoid loss of eye drops
742197|NCT01125345|hydrophobic acrylic|hydrophobic acrylic
742198|NCT01125345|PCO|pco
742199|NCT01125345|posterior capsule opacification|posterior capsule opacification
742200|NCT01125345|hydrophilic acrylic IO|hydrophilic acrylic io
742201|NCT01125371|Hazardous alcohol use|hazardous alcohol use
742202|NCT01125371|Binge drinking|binge drinking
742203|NCT01125371|High risk sexual behaviors|high risk sexual behaviors
742204|NCT01125371|HIV risk reduction|hiv risk reduction
742205|NCT01125397|bariatric surgery|bariatric surgery
742206|NCT01125397|behavioral weight management|behavioral weight management
742207|NCT01125397|psychosocial outcomes following bariatric surgery|psychosocial outcomes following bariatric surgery
742208|NCT01125410|Fluomizin|fluomizin
742209|NCT01125410|Dequalinium chloride|dequalinium chloride
742210|NCT01125410|Bacterial vaginosis|bacterial vaginosis
742211|NCT01125410|vaginal therapy|vaginal therapy
742212|NCT01125423|Female|female
742213|NCT01125423|age 18 to 70|age 18 to 70
742214|NCT01125449|ascorbic acid|ascorbic acid
742215|NCT01125449|vitamin C|vitamin c
742216|NCT01125449|antioxidants|antioxidants
742217|NCT01125449|vitamins|vitamins
742218|NCT01125462|Ovulation Induction|ovulation induction
742219|NCT01125462|Infertility|infertility
742220|NCT01125462|Gonal-f|gonal-f
742221|NCT01125462|FertiQoL|fertiqol
742222|NCT01125462|Quality of Life|quality of life
742223|NCT01125475|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
742224|NCT01125475|RebiSmart|rebismart
742225|NCT01125475|Rebif|rebif
742226|NCT01125475|Adherence|adherence
742227|NCT01125488|Maintenance therapy|maintenance therapy
742228|NCT01125488|LNG-IUS|lng-ius
742229|NCT01125488|recurrence,endometriosis|recurrence,endometriosis
742230|NCT01125488|Recurrence|recurrence
742231|NCT01125514|Heart failure,|heart failure,
742232|NCT01125514|aliskiren,|aliskiren,
742233|NCT01125514|furosemide,|furosemide,
742234|NCT01125514|diuretic efficacy,|diuretic efficacy,
742235|NCT01125514|interaction|interaction
742236|NCT01125527|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
742237|NCT01125527|Vaccine|vaccine
742238|NCT01125527|Anti PRP antibody|anti prp antibody
742239|NCT01125540|Allergic conjunctivitis|allergic conjunctivitis
742240|NCT01125579|nervousness|nervousness
742241|NCT01125579|restlessness|restlessness
742242|NCT01125579|depression|depression
742243|NCT01125579|affective disorder|affective disorder
742244|NCT01125592|assess the ability of the IonCleanse machine to remove heavy metals through the feet|assess the ability of the ioncleanse machine to remove heavy metals through the feet
742245|NCT01125605|PASCONAL|pasconal
742246|NCT01125605|nervousness|nervousness
742247|NCT01125605|nervosity|nervosity
742248|NCT01125605|sleep disorder|sleep disorder
742249|NCT01125618|child mortality|child mortality
742250|NCT01125618|intervention|intervention
742251|NCT01125618|Poverty|poverty
742252|NCT01125618|Africa|africa
742253|NCT01125618|Millennium Development Goal|millennium development goal
742254|NCT01125618|Millennium Development Goals|millennium development goals
742255|NCT01125631|Alzheimer's disease|alzheimer's disease
742256|NCT01125631|amyloid|amyloid
742257|NCT01125631|antibody|antibody
742258|NCT01125631|Japanese|japanese
742259|NCT01125644|necrotic pulmonary infections|necrotic pulmonary infections
742260|NCT01125657|YM150|ym150
742261|NCT01125657|bioequivalence study|bioequivalence study
742262|NCT01125670|YM150|ym150
742263|NCT01125670|Food effect|food effect
742264|NCT01125683|Phase II|phase ii
742265|NCT01125683|Alzheimer's disease|alzheimer's disease
742266|NCT01125683|EEG|eeg
742267|NCT01125683|cognition|cognition
742268|NCT01125683|pharmacodynamic|pharmacodynamic
742269|NCT01125696|mother-to-child transmission|mother-to-child transmission
742272|NCT01125696|Pregnant women|pregnant women
742274|NCT01125696|Infants|infants
742275|NCT01125709|Neuromuscular disease|neuromuscular disease
742276|NCT01125709|Duchenne|duchenne
742277|NCT01125709|Muscular Dystrophy|muscular dystrophy
742278|NCT01125709|DMD|dmd
742279|NCT01125709|Strength assessment|strength assessment
742280|NCT01125709|CINRG Quantitative Measurement System|cinrg quantitative measurement system
742281|NCT01125709|CQMS|cqms
742282|NCT01125709|Hand Held Myometry|hand held myometry
742283|NCT01125709|HHM|hhm
742284|NCT01125722|Urinary Incontinence|urinary incontinence
742285|NCT01125722|Overactive Bladder|overactive bladder
742286|NCT01125722|Frequency|frequency
742288|NCT01125761|Allergic dermatitis|allergic dermatitis
742289|NCT01125774|Menstrually related migraine|menstrually related migraine
742290|NCT01125774|migraine|migraine
742291|NCT01125774|Premenstrual migraine|premenstrual migraine
742292|NCT01125787|CLL|cll
742293|NCT01125787|bendamustine|bendamustine
742294|NCT01125787|ofatumumab|ofatumumab
742295|NCT01125787|blood cancer|blood cancer
742299|NCT01125787|non-Hodgkin lymphoma|non-hodgkin lymphoma
742300|NCT01125787|small lymphocytic lymphoma|small lymphocytic lymphoma
742301|NCT01125787|nevada cancer institute|nevada cancer institute
742302|NCT01125787|cephalon|cephalon
742303|NCT01125787|Glaxosmithkline|glaxosmithkline
742304|NCT01125800|Recurrent,|recurrent,
742305|NCT01125800|refractory,|refractory,
742306|NCT01125800|medulloblastoma,|medulloblastoma,
742307|NCT01125800|rhabdomyosarcoma,|rhabdomyosarcoma,
742308|NCT01125800|neuroblastoma,|neuroblastoma,
742309|NCT01125800|hepatoblastoma,|hepatoblastoma,
742310|NCT01125800|astrocytoma,|astrocytoma,
742311|NCT01125800|children,|children,
742312|NCT01125800|pediatric,|pediatric,
742313|NCT01125800|hedgehog pathway inhibitor, adult|hedgehog pathway inhibitor, adult
742314|NCT01125839|osteomyelitis|osteomyelitis
742315|NCT01125839|16S rRNA|16s rrna
742316|NCT01125839|spine|spine
742317|NCT01125839|Magnetic resonance imaging|magnetic resonance imaging
742318|NCT01125852|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
742319|NCT01125852|Peptic ulcer bleeding|peptic ulcer bleeding
742320|NCT01125852|Angiographic embolization|angiographic embolization
742321|NCT01125852|Arterial embolization|arterial embolization
742322|NCT01125852|Angiography|angiography
742323|NCT01125865|Malignant hilar stricture|malignant hilar stricture
742324|NCT01125878|satiety|satiety
742325|NCT01125878|appetite|appetite
742326|NCT01125878|fiber|fiber
742327|NCT01125878|starch|starch
742328|NCT01125878|nutrition|nutrition
742329|NCT01125891|gemcitabine hydrochloride|gemcitabine hydrochloride
742330|NCT01125891|Gemzar|gemzar
742331|NCT01125891|ON 01910.Na|on 01910.na
742332|NCT01125904|Crizotinib|crizotinib
742333|NCT01125917|Low back pain|low back pain
742334|NCT01125917|Opioid|opioid
742335|NCT01125917|Transdermal|transdermal
742336|NCT01125930|rosacea|rosacea
742337|NCT01125930|tretinoin|tretinoin
742338|NCT01125930|atralin|atralin
742339|NCT01125956|Diabetes|diabetes
742340|NCT01125956|Diabetes mellitus|diabetes mellitus
742341|NCT01125956|HbA1c|hba1c
742342|NCT01125969|diabetes|diabetes
742343|NCT01125969|glucose|glucose
742344|NCT01125969|peer mentor|peer mentor
742345|NCT01125969|incentives|incentives
742346|NCT01125969|behavioral economics|behavioral economics
742347|NCT01125969|cost-effectiveness|cost-effectiveness
742348|NCT01125995|limited disease|limited disease
742349|NCT01126008|locally advanced Squamous cell carcinoma|locally advanced squamous cell carcinoma
742350|NCT01126021|Senior citizens|senior citizens
742351|NCT01126021|mental acuity|mental acuity
742352|NCT01126021|memory|memory
742353|NCT01126034|Metoclopramide|metoclopramide
742354|NCT01126034|Randomized Controlled Trial|randomized controlled trial
742355|NCT01126047|Lung Diseases|lung diseases
742356|NCT01126060|Neck dissection|neck dissection
742357|NCT01126073|niacin/laropiprant|niacin/laropiprant
742358|NCT01126073|endothelial function|endothelial function
742359|NCT01126099|double-blind|double-blind
742360|NCT01126099|treatment|treatment
742361|NCT01126099|prazosin|prazosin
742362|NCT01126099|Disruptive behaviors in Alzheimer's Disease|disruptive behaviors in alzheimer's disease
742363|NCT01126112|advanced colorectal cancer; K-RAS; panitumumab|advanced colorectal cancer; k-ras; panitumumab
742364|NCT01126112|advanced Wild Type K-RAS colorectal cancer|advanced wild type k-ras colorectal cancer
742365|NCT01126125|iodine|iodine
742366|NCT01126125|infant|infant
742367|NCT01126125|breastfeeding|breastfeeding
742368|NCT01126125|deficiency|deficiency
742369|NCT01126138|unresectable|unresectable
742370|NCT01126138|locally advanced|locally advanced
742371|NCT01126138|metastatic|metastatic
742372|NCT01126138|breast cancer|breast cancer
742373|NCT01126151|drinking|drinking
742374|NCT01126151|alcohol consequences|alcohol consequences
742375|NCT01126164|parents|parents
742376|NCT01126164|peer|peer
742377|NCT01126164|basics|basics
742378|NCT01126164|college student drinking|college student drinking
742379|NCT01126177|asthma|asthma
742380|NCT01126203|Pseudoexfoliation|pseudoexfoliation
742381|NCT01126203|Glaucoma|glaucoma
742382|NCT01126203|Ocular Hypertension|ocular hypertension
742384|NCT01126203|Selective Laser Trabeculoplasy (SLT)|selective laser trabeculoplasy (slt)
742385|NCT01126203|Argon Laser Trabeculoplasty (ALT)|argon laser trabeculoplasty (alt)
742386|NCT01126216|Radiochemotherapy|radiochemotherapy
742387|NCT01126216|head and neck cancer|head and neck cancer
742388|NCT01126216|Paclitaxel|paclitaxel
742389|NCT01126216|Cisplatin|cisplatin
742391|NCT01126229|Resveratrol|resveratrol
742392|NCT01126229|Grape|grape
742393|NCT01126229|Aging|aging
742394|NCT01126229|functional MRI (fMRI)|functional mri (fmri)
742395|NCT01126229|Anti-Aging therapeutic|anti-aging therapeutic
742396|NCT01126229|Oxidative Stress|oxidative stress
742397|NCT01126229|Functional Performance|functional performance
742398|NCT01126242|Ankle|ankle
742399|NCT01126242|ligament injuries|ligament injuries
742400|NCT01126242|non-surgical treatment|non-surgical treatment
742401|NCT01126242|tape|tape
742402|NCT01126242|brace|brace
742403|NCT01126242|orthotic device|orthotic device
742404|NCT01126242|bandage|bandage
742405|NCT01126242|cost-effectiveness|cost-effectiveness
742406|NCT01126242|randomized trial|randomized trial
742407|NCT01126255|vulvar lichen sclerosus|vulvar lichen sclerosus
742408|NCT01126255|progesterone|progesterone
742409|NCT01126255|clobetasol|clobetasol
742410|NCT01126255|randomized controlled trial|randomized controlled trial
742411|NCT01126268|Eczema|eczema
742412|NCT01126268|Atopic dermatitis|atopic dermatitis
742413|NCT01126268|Infection|infection
742414|NCT01126268|Impetigo|impetigo
742415|NCT01126268|Folliculitis|folliculitis
742416|NCT01126294|lumbar laminectomy, melatonin, perioperative, pain, anxiety, analgesia, VAS score|lumbar laminectomy, melatonin, perioperative, pain, anxiety, analgesia, vas score
742417|NCT01126307|refractory epilepsy- greater than 4 seizures in 2 month baseline period|refractory epilepsy- greater than 4 seizures in 2 month baseline period
742418|NCT01126320|VAP|vap
742419|NCT01126333|Nephrotoxicity, Kidney Transplantation, Graft Survival|nephrotoxicity, kidney transplantation, graft survival
742420|NCT01126333|Kidney transplant survival.|kidney transplant survival.
742421|NCT01126359|Wound Vacuum Assisted Dressings|wound vacuum assisted dressings
742422|NCT01126359|Lidocaine|lidocaine
742423|NCT01126359|Dressing change|dressing change
742424|NCT01126359|Pain management|pain management
742425|NCT01126359|palliative care|palliative care
742426|NCT01126372|Prostaglandin-dependent Congenital Heart Disease|prostaglandin-dependent congenital heart disease
742427|NCT01126372|Prematurity|prematurity
742428|NCT01126372|Feeding intolerances|feeding intolerances
742429|NCT01126372|Necrotizing Enterocolitis|necrotizing enterocolitis
742430|NCT01126372|Regional Oxygen Saturation|regional oxygen saturation
742431|NCT01126372|Near Infrared Spectroscopy|near infrared spectroscopy
742432|NCT01126372|Somanetics INVOS Oxyalert|somanetics invos oxyalert
742433|NCT01126385|Spinal Diseases|spinal diseases
742434|NCT01126385|Bone strength|bone strength
742435|NCT01126385|Transpedicular fixation|transpedicular fixation
742436|NCT01126385|Dorsal instrumentation|dorsal instrumentation
742437|NCT01126385|DensiProbe|densiprobe
742438|NCT01126411|pulmonary hypertension|pulmonary hypertension
742439|NCT01126411|autoantibodies|autoantibodies
742440|NCT01126411|immunoadsorption|immunoadsorption
742441|NCT01126411|immunoglobulin substitution|immunoglobulin substitution
742442|NCT01126411|right ventricular function|right ventricular function
742443|NCT01126424|Anti-muscarinics|anti-muscarinics
742444|NCT01126424|Anti-cholinergics|anti-cholinergics
742445|NCT01126424|Cognition|cognition
742446|NCT01126424|Solifenacin|solifenacin
742447|NCT01126450|recurrent colon cancer|recurrent colon cancer
742448|NCT01126450|recurrent rectal cancer|recurrent rectal cancer
742449|NCT01126463|Hepatocellular carcinomas|hepatocellular carcinomas
742450|NCT01126463|lipiodol|lipiodol
742451|NCT01126463|rhenium|rhenium
742452|NCT01126463|Non operable Hepatocellular carcinomas|non operable hepatocellular carcinomas
742453|NCT01126476|Adults with non-CNS recurrent tumors who have been previously irradiated|adults with non-cns recurrent tumors who have been previously irradiated
742454|NCT01126476|and have a tumor recurrence in or near prior radiation fields|and have a tumor recurrence in or near prior radiation fields
742455|NCT01126515|brain injury|brain injury
742456|NCT01126515|sequelae|sequelae
742457|NCT01126515|stroke|stroke
742458|NCT01126515|anoxia|anoxia
742459|NCT01126515|trauma|trauma
742460|NCT01126528|Vitamin D|vitamin d
742461|NCT01126528|cholecalciferol|cholecalciferol
742462|NCT01126528|Micronutrients|micronutrients
742463|NCT01126528|Developing countries|developing countries
742464|NCT01126528|Bangladesh|bangladesh
742465|NCT01126528|Infant, Newborn|infant, newborn
742466|NCT01126528|Reproductive Health|reproductive health
742467|NCT01126528|Infant, Newborn, Diseases|infant, newborn, diseases
742468|NCT01126528|Perinatology|perinatology
742469|NCT01126528|Immunology|immunology
742470|NCT01126528|cathelicidin|cathelicidin
742471|NCT01126528|Maternal Nutrition Physiology|maternal nutrition physiology
742472|NCT01126554|Prognostic value|prognostic value
742660|NCT01134380|Acute coronary syndrome|acute coronary syndrome
742473|NCT01126567|Phase 1 Clinical Trials, Cerebrospinal Fluid, Biomarker|phase 1 clinical trials, cerebrospinal fluid, biomarker
742474|NCT01126619|Psoriasis|psoriasis
742475|NCT01126632|Colonoscopy|colonoscopy
742476|NCT01126645|Liver|liver
742478|NCT01126658|pressure-volume curve|pressure-volume curve
742479|NCT01126658|intracranial pressure|intracranial pressure
742480|NCT01126658|volume pressure response|volume pressure response
742481|NCT01126658|pressure-volume relationship|pressure-volume relationship
742482|NCT01126658|mathematical model|mathematical model
742483|NCT01126671|vitamin D|vitamin d
742484|NCT01126684|essential hypertension|essential hypertension
742485|NCT01126697|Cardiac|cardiac
742486|NCT01126697|Muscular Dystrophy|muscular dystrophy
742487|NCT01126697|Randomized|randomized
742488|NCT01126710|infiltration|infiltration
742489|NCT01126710|extravasation|extravasation
742490|NCT01126710|optical monitoring|optical monitoring
742491|NCT01126736|neoplams|neoplams
742492|NCT01126736|lung neoplasms|lung neoplasms
742493|NCT01126736|Stage IIIB|stage iiib
742494|NCT01126736|IV Nonsquamous Non Small Cell Lung Cancer|iv nonsquamous non small cell lung cancer
742587|NCT01133483|Fexofenadine Hydrochloride + Pseudoephedrine Hydrochloride|fexofenadine hydrochloride + pseudoephedrine hydrochloride
742495|NCT01126749|Locally Advanced or Metastatic Bladder Cancer, including other transitional cell cancers of the urothelium (prostate, urethra, ureter, and renal pelvis)|locally advanced or metastatic bladder cancer, including other transitional cell cancers of the urothelium (prostate, urethra, ureter, and renal pelvis)
742496|NCT01126762|Docosahexaenoic acid|docosahexaenoic acid
742497|NCT01126762|fish|fish
742498|NCT01126762|pregnancy|pregnancy
742499|NCT01126762|methylmercury|methylmercury
742500|NCT01126762|n-3 polyunsaturated fatty acid|n-3 polyunsaturated fatty acid
742501|NCT01126775|Systematic prevention, stroke, vascular dementia, silent strokes, cerebral microangiopathy.|systematic prevention, stroke, vascular dementia, silent strokes, cerebral microangiopathy.
742502|NCT01126814|Gleevec|gleevec
742503|NCT01126814|c-kit|c-kit
742504|NCT01126814|aml|aml
742505|NCT01126827|Bipolar Disorder|bipolar disorder
742506|NCT01126827|Mood Disorders|mood disorders
742507|NCT01126827|Residual Symptoms|residual symptoms
742508|NCT01126827|Depression|depression
742509|NCT01126827|Mania|mania
742510|NCT01126827|Hypomania|hypomania
742511|NCT01126827|Bipolar|bipolar
742512|NCT01126827|Bipolar I|bipolar i
742513|NCT01126827|Bipolar II|bipolar ii
742514|NCT01126840|Lynch Syndrome|lynch syndrome
742515|NCT01126840|Families|families
742516|NCT01126840|Quality of life|quality of life
742517|NCT01126840|QOL|qol
742518|NCT01126840|First-degree relatives|first-degree relatives
742519|NCT01126840|Questionnaire|questionnaire
742520|NCT01126840|Interview|interview
742521|NCT01126853|Immunization|immunization
742522|NCT01126853|Immunity|immunity
742523|NCT01126853|Prevention|prevention
742524|NCT01126866|advanced colorectal carcinoma|advanced colorectal carcinoma
742525|NCT01126866|CRC|crc
742526|NCT01126866|UICC Stages IV|uicc stages iv
742527|NCT01126866|liver and/or lung only metastases|liver and/or lung only metastases
742528|NCT01126892|Advanced Disease,|advanced disease,
742529|NCT01126892|Resistance,|resistance,
742530|NCT01126892|Intolerance|intolerance
742531|NCT01126905|Reticulated Haemoglobin Equivalent|reticulated haemoglobin equivalent
742532|NCT01126905|Functional Iron Deficiency|functional iron deficiency
742533|NCT01126905|Response to therapy|response to therapy
742534|NCT01126905|Iron deficiency|iron deficiency
742535|NCT01126918|Eating Disorders|eating disorders
742536|NCT01126918|Obesity|obesity
742537|NCT01126918|Body Dissatisfaction|body dissatisfaction
742538|NCT01126918|Female|female
742539|NCT01126931|Crohn disease|crohn disease
742540|NCT01126931|Involuntary weight loss in cancer|involuntary weight loss in cancer
742541|NCT01126931|IgA nephropathy|iga nephropathy
742542|NCT01126931|Depression with reduced appetite|depression with reduced appetite
742543|NCT01126944|heart failure|heart failure
742544|NCT01126944|resynchronization|resynchronization
742545|NCT01126944|left ventricular assist device|left ventricular assist device
742546|NCT01133223|Stroke, mecanical thrombectomy|stroke, mecanical thrombectomy
742547|NCT01133236|Salt restriction|salt restriction
742548|NCT01133236|Fluid restriction|fluid restriction
742549|NCT01133236|Congestion|congestion
742550|NCT01133236|Heart Failure|heart failure
742551|NCT01133249|total hip|total hip
742552|NCT01133301|Borderline Personality Disorder|borderline personality disorder
742553|NCT01133301|Dissociation|dissociation
742554|NCT01133301|Naltrexone|naltrexone
742555|NCT01133327|Carotid Artery Stenting|carotid artery stenting
742556|NCT01133327|High Risk patient|high risk patient
742557|NCT01133327|Carotid artery stenosis|carotid artery stenosis
742558|NCT01133327|stroke|stroke
742559|NCT01133327|Carotid artery disease|carotid artery disease
742560|NCT01133327|ASTI study|asti study
742561|NCT01133327|Adapt Carotid Stent system|adapt carotid stent system
742562|NCT01133327|FilterWire EZ Embolic Protection System|filterwire ez embolic protection system
742563|NCT01133340|RADIOTHERAPY|radiotherapy
742564|NCT01133340|CT simulation|ct simulation
742565|NCT01133340|MRI simulation|mri simulation
742566|NCT01133340|Endoscopic clip placement|endoscopic clip placement
742567|NCT01133340|Rectal cancer|rectal cancer
743252|NCT01130103|PTSD|ptsd
742568|NCT01133340|Accuracy of MRI Simulation for target delineation and planning|accuracy of mri simulation for target delineation and planning
742569|NCT01133366|ISIS301012|isis301012
742570|NCT01133366|antisense|antisense
742571|NCT01133366|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
742572|NCT01133366|LDL (low density lipoprotein)|ldl (low density lipoprotein)
742573|NCT01133366|mipomersen|mipomersen
742574|NCT01133392|insulin|insulin
742575|NCT01133392|lispro|lispro
742576|NCT01133431|CKD-501|ckd-501
742577|NCT01133431|Glimepiride|glimepiride
742578|NCT01133431|Placebo|placebo
742579|NCT01133431|Healthy male volunteer|healthy male volunteer
742580|NCT01133431|Pharmacokinetic|pharmacokinetic
742581|NCT01133431|Metabolite|metabolite
742582|NCT01133444|Bioequivalence,Finasteride,Crossover|bioequivalence,finasteride,crossover
742583|NCT01133457|Bioequivalence,Finasteride,Crossover|bioequivalence,finasteride,crossover
742584|NCT01133470|Bioequivalence|bioequivalence
742585|NCT01133470|Fexofenadine Hydrochloride + Pseudoephedrine Hydrochloride|fexofenadine hydrochloride + pseudoephedrine hydrochloride
742586|NCT01133483|Bioequivalence|bioequivalence
742588|NCT01133496|Bioequivalence|bioequivalence
742975|NCT01135771|diabetes|diabetes
742589|NCT01133496|Alendronate Sodium|alendronate sodium
742590|NCT01133496|crossover|crossover
742591|NCT01133522|AMG145|amg145
742592|NCT01133522|Multiple Dose|multiple dose
742593|NCT01133522|Statin|statin
742594|NCT01133522|Ascending|ascending
742595|NCT01133548|testosterone, hypogonadal, males|testosterone, hypogonadal, males
742596|NCT01134042|Fluticasone propionate|fluticasone propionate
742597|NCT01134042|asthma|asthma
742598|NCT01134042|vilanterol|vilanterol
742599|NCT01134042|GW642444|gw642444
742600|NCT01134042|Fluticasone furoate|fluticasone furoate
742601|NCT01134055|ranibizumab|ranibizumab
742602|NCT01134055|wet AMD|wet amd
742603|NCT01134055|MD7110852|md7110852
742604|NCT01134055|age related macular degeneration|age related macular degeneration
742605|NCT01134055|age-related macular degeneration|age-related macular degeneration
742606|NCT01134055|macular degeneration|macular degeneration
742607|NCT01134055|pazopanib|pazopanib
742608|NCT01134068|D-dimer|d-dimer
742609|NCT01134068|Pulmonary embolism|pulmonary embolism
742610|NCT01134068|Diagnostic strategy|diagnostic strategy
742611|NCT01134068|Safety of ruling PE with and age-adjusted DD cut-off|safety of ruling pe with and age-adjusted dd cut-off
742612|NCT01134081|gum|gum
742613|NCT01134081|recession|recession
742614|NCT01134094|Undisplaced|undisplaced
742615|NCT01134094|Ankle Fracture|ankle fracture
742616|NCT01134094|Weber B|weber b
742617|NCT01134146|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
742618|NCT01134146|IMRT|imrt
742619|NCT01134146|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
742620|NCT01134146|Radical Pleurectomy|radical pleurectomy
742621|NCT01134146|Decortication|decortication
742622|NCT01134146|PD|pd
742623|NCT01134146|pleurectomy|pleurectomy
742624|NCT01134146|lung surgery|lung surgery
742625|NCT01134146|pleura|pleura
742626|NCT01134172|Sociodemographic|sociodemographic
742627|NCT01134172|Ethnicity|ethnicity
742628|NCT01134172|Work-related|work-related
742629|NCT01134172|Health system|health system
742630|NCT01134172|QOL|qol
742631|NCT01134172|Questionnaires|questionnaires
742632|NCT01134172|10-071|10-071
742633|NCT01134185|Two groups of 8 hepatically impaired subjects, one group of 8 matched healthy subjects|two groups of 8 hepatically impaired subjects, one group of 8 matched healthy subjects
742634|NCT01134198|Cocaine Dependence|cocaine dependence
742635|NCT01134237|non-surgical rate|non-surgical rate
742636|NCT01134250|Interleukin, IL2, F16, monoclonal, antibody, cytokine Paclitaxel, breast cancer,solid tumour|interleukin, il2, f16, monoclonal, antibody, cytokine paclitaxel, breast cancer,solid tumour
742637|NCT01134250|metastatic melanoma, non-small cell lung cancer (NSCLC)|metastatic melanoma, non-small cell lung cancer (nsclc)
742638|NCT01134263|Dengue Fever|dengue fever
742639|NCT01134263|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
742640|NCT01134263|CYD Dengue Vaccine|cyd dengue vaccine
742641|NCT01134263|Lot Consistency|lot consistency
742642|NCT01134289|complex regional pain syndrome|complex regional pain syndrome
742643|NCT01134289|lumbar sympathetic blockade|lumbar sympathetic blockade
742644|NCT01134289|photoplethysmography|photoplethysmography
742645|NCT01134289|diagnostic lumbar sympathetic blockade|diagnostic lumbar sympathetic blockade
742646|NCT01134302|Hybrid|hybrid
742647|NCT01134302|Norwood|norwood
742648|NCT01134302|congenital heart disease|congenital heart disease
742649|NCT01134302|single ventricle|single ventricle
742650|NCT01134315|Evaluating incidence of hypercalcemia in pediatric patients|evaluating incidence of hypercalcemia in pediatric patients
742651|NCT01134341|Relapsed|relapsed
742652|NCT01134341|Refractory|refractory
742653|NCT01134354|Validation study|validation study
742654|NCT01134354|Outcome Measures|outcome measures
742655|NCT01134354|Patient Outcomes Assessment|patient outcomes assessment
742656|NCT01134354|Patient expectations|patient expectations
742657|NCT01134354|Physician patient relationship|physician patient relationship
742759|NCT01134770|Prenatal Substance Use|prenatal substance use
742658|NCT01134367|gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
742659|NCT01134380|Percutaneous coronary intervention|percutaneous coronary intervention
742661|NCT01134380|Dual antiplatelet therapy|dual antiplatelet therapy
742662|NCT01134380|clopidogrel/prasugrel|clopidogrel/prasugrel
742663|NCT01134380|genotyping|genotyping
742665|NCT01134380|compliance|compliance
742666|NCT01134406|Osteoarthritis|osteoarthritis
742667|NCT01134406|knee|knee
742668|NCT01134419|Patient Safety|patient safety
742669|NCT01134419|Medical Errors|medical errors
742671|NCT01134419|Sign-out|sign-out
742672|NCT01134419|Resident|resident
742673|NCT01134419|Intern|intern
742674|NCT01134419|Graduate Medical Education|graduate medical education
742675|NCT01134432|autoimmune hemolytic anemia|autoimmune hemolytic anemia
742676|NCT01134432|hemolytic anemia|hemolytic anemia
742677|NCT01134432|Rituximab|rituximab
742678|NCT01134432|Treatment of autoimmune hemolytic anemia|treatment of autoimmune hemolytic anemia
742679|NCT01134432|warm antibody dependant autoimmune hemolytic anemia|warm antibody dependant autoimmune hemolytic anemia
742680|NCT01134445|Arthroplasty|arthroplasty
742681|NCT01134445|Replacement|replacement
742682|NCT01134445|Hip|hip
742683|NCT01134445|Conservative|conservative
742684|NCT01134445|Anatomic|anatomic
742686|NCT01134458|cardiovascular disease|cardiovascular disease
742687|NCT01134484|autologous stem cell transplantation|autologous stem cell transplantation
742688|NCT01134484|complete remission|complete remission
742689|NCT01134484|bortezomib|bortezomib
742690|NCT01134484|thalidomide|thalidomide
742691|NCT01134484|progression free survival|progression free survival
742692|NCT01134484|induction and consolidation therapy|induction and consolidation therapy
742693|NCT01134510|Kidney transplantation|kidney transplantation
742694|NCT01134523|positive lymph node|positive lymph node
742695|NCT01134536|Pain, Postoperative|pain, postoperative
742696|NCT01134536|Postoperative Pain|postoperative pain
742697|NCT01134536|Tapentadol|tapentadol
742698|NCT01134536|NUCYNTA|nucynta
742699|NCT01134536|CG5503|cg5503
742700|NCT01134536|R331333|r331333
742701|NCT01134536|Pharmacokinetics|pharmacokinetics
742702|NCT01134536|Postsurgical pain|postsurgical pain
742703|NCT01134536|Children|children
742704|NCT01134536|Adolescents|adolescents
742705|NCT01134562|Clinical Trial, Phase 1|clinical trial, phase 1
742706|NCT01134562|Renal Dialysis|renal dialysis
742707|NCT01134562|Secondary Hyperparathyroidism|secondary hyperparathyroidism
742708|NCT01134562|Parathyroid hormone|parathyroid hormone
742709|NCT01134575|Relapsed|relapsed
742710|NCT01134575|Refractory|refractory
742711|NCT01134575|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
742712|NCT01134575|ALL|all
742713|NCT01134575|Burkitt's lymphoma|burkitt's lymphoma
742714|NCT01134575|Lymphoblastic lymphoma|lymphoblastic lymphoma
742715|NCT01134575|CMC-544|cmc-544
742716|NCT01134575|Inotuzumab Ozogamycin|inotuzumab ozogamycin
742717|NCT01134575|Rituxan|rituxan
742718|NCT01134575|Rituximab|rituximab
742719|NCT01134601|Rectal Cancer|rectal cancer
742720|NCT01134601|Radiation Therapy|radiation therapy
742721|NCT01134601|Capecitabine|capecitabine
742722|NCT01134601|AZD6244|azd6244
742723|NCT01134627|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
742724|NCT01134627|Interferon-β|interferon-β
742725|NCT01134627|Rebif®|rebif®
742726|NCT01134627|Minocycline|minocycline
742727|NCT01134640|metastatic colorectal cancer|metastatic colorectal cancer
742728|NCT01134640|mCRC|mcrc
742729|NCT01134640|post marketing surveillance|post marketing surveillance
742730|NCT01134640|Erbitux|erbitux
742731|NCT01134640|Cetuximab|cetuximab
742732|NCT01134640|KRAS|kras
742733|NCT01134653|Acute ankle sprain in children and young adults|acute ankle sprain in children and young adults
742734|NCT01134666|Colorectal neoplasms|colorectal neoplasms
742735|NCT01134666|Intestinal neoplasms|intestinal neoplasms
742736|NCT01134666|Neoplasms|neoplasms
742737|NCT01134666|cetuximab|cetuximab
742738|NCT01134666|Erbitux|erbitux
742739|NCT01134679|Drug Eluting Stent|drug eluting stent
742740|NCT01134679|Clopidogrel|clopidogrel
742741|NCT01134679|Aspirin|aspirin
742742|NCT01134692|Patients with cirrhosis who have large esophageal varices with No history of upper GI bleeding in the past|patients with cirrhosis who have large esophageal varices with no history of upper gi bleeding in the past
742743|NCT01134718|TMC435-TiDP16-C119|tmc435-tidp16-c119
742744|NCT01134718|TMC435-C119|tmc435-c119
742745|NCT01134718|TMC435|tmc435
742746|NCT01134718|Protease inhibitor|protease inhibitor
742747|NCT01134718|HCV|hcv
742748|NCT01134718|Hepatitis C|hepatitis c
742749|NCT01134718|Bioavailability|bioavailability
742750|NCT01134731|depression|depression
742751|NCT01134731|suicidality|suicidality
742752|NCT01134731|Major Depressive Disorder, current episode, with suicidality|major depressive disorder, current episode, with suicidality
742753|NCT01134744|CXray|cxray
742754|NCT01134757|EAR|ear
742755|NCT01134757|LAR|lar
742756|NCT01134757|BHR|bhr
742757|NCT01134757|house dust mite|house dust mite
742758|NCT01134757|alternaria|alternaria
742761|NCT01134770|Cigarette Smoking|cigarette smoking
742762|NCT01134770|Mothers|mothers
742763|NCT01134770|Pregnant women|pregnant women
742764|NCT01134770|Smoking Mothers|smoking mothers
742765|NCT01134809|Major abdominal surgery|major abdominal surgery
742766|NCT01134822|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
742767|NCT01134822|IPF|ipf
742768|NCT01134822|Lung Fibrosis|lung fibrosis
742769|NCT01134822|Biomarkers|biomarkers
742770|NCT01134848|Bile ducts|bile ducts
742771|NCT01134848|Sphincter of Oddi|sphincter of oddi
742772|NCT01134848|Pancreatic ducts|pancreatic ducts
742773|NCT01134861|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
742774|NCT01134861|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
742775|NCT01134861|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
742776|NCT01134887|hypertension|hypertension
742777|NCT01134887|physician-patient relations|physician-patient relations
742778|NCT01134887|communication|communication
742779|NCT01134900|Medication Errors|medication errors
742780|NCT01134900|Adverse Drug Events|adverse drug events
742781|NCT01134900|Decision Support Systems, Clinical|decision support systems, clinical
742782|NCT01134913|ACS|acs
742783|NCT01134913|Acute Coronary Syndrome|acute coronary syndrome
742784|NCT01134913|Emergency Department|emergency department
742785|NCT01134926|Retained products of conception|retained products of conception
742786|NCT01134926|residua|residua
742788|NCT01134926|expectant management|expectant management
742789|NCT01134952|sirolimus|sirolimus
742790|NCT01134952|everolimus|everolimus
742791|NCT01134952|mycophenolic acid|mycophenolic acid
742792|NCT01134952|hepatitis C virus|hepatitis c virus
742793|NCT01134952|tacrolimus|tacrolimus
742794|NCT01134952|viral load|viral load
742795|NCT01134978|repeated measures design|repeated measures design
742796|NCT01134978|random assignment to groups|random assignment to groups
742797|NCT01134991|rosacea|rosacea
742798|NCT01134991|topical|topical
742799|NCT01134991|minocycline|minocycline
742800|NCT01134991|foam|foam
742801|NCT01134991|phase II|phase ii
742802|NCT01135004|pneumothorax|pneumothorax
742803|NCT01135004|thoracoscopy|thoracoscopy
742804|NCT01135004|pathogenesis|pathogenesis
742805|NCT01135004|blebs|blebs
742806|NCT01135004|surgery|surgery
742807|NCT01135030|total knee arthroplasty|total knee arthroplasty
742808|NCT01135043|acceptable sputum|acceptable sputum
742809|NCT01135043|AFB culture|afb culture
742810|NCT01135043|pulmonary tuberculosis|pulmonary tuberculosis
742811|NCT01135056|Hepatocellular Carcinoma|hepatocellular carcinoma
742812|NCT01135056|Randomized|randomized
742813|NCT01135056|Open-label|open-label
742814|NCT01135056|Multi-Centre|multi-centre
742815|NCT01135056|Phase III|phase iii
742816|NCT01135056|Sorafenib|sorafenib
742817|NCT01135056|SIR-Spheres|sir-spheres
742818|NCT01135082|immunogenicity|immunogenicity
742819|NCT01135082|safety|safety
742820|NCT01135082|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
742821|NCT01135082|HIV infected children|hiv infected children
742822|NCT01135082|objective of this study is to assess the safety and immunogenicity of a 7 - valent PCV vaccine among HIV - infected compared with HIV - exposed children|objective of this study is to assess the safety and immunogenicity of a 7 - valent pcv vaccine among hiv - infected compared with hiv - exposed children
742823|NCT01135095|Myocardial perfusion|myocardial perfusion
742824|NCT01135095|Low radiation dose|low radiation dose
742825|NCT01135095|Single photon emission computed tomography|single photon emission computed tomography
742826|NCT01135108|Analgesics. Non-narcotic / therapeutic use|analgesics. non-narcotic / therapeutic use
742827|NCT01135108|Spinal Cord Injuries|spinal cord injuries
742828|NCT01135108|Pain|pain
742829|NCT01135108|Pain measurement / drug effect|pain measurement / drug effect
742830|NCT01135108|Pain postoperative / drug therapy|pain postoperative / drug therapy
742831|NCT01135160|weight bearing|weight bearing
742832|NCT01135160|pain|pain
742833|NCT01135160|total hip arthroplasty|total hip arthroplasty
742834|NCT01135160|total knee arthroplasty|total knee arthroplasty
742835|NCT01135160|weight bearing after TKA or THA|weight bearing after tka or tha
742836|NCT01135173|Smoking Cessation, Waterpipe|smoking cessation, waterpipe
742837|NCT01135212|Hypertension|hypertension
742838|NCT01135212|ARB|arb
742839|NCT01135212|Fimasartan|fimasartan
742840|NCT01135225|Drug-eluting stent|drug-eluting stent
742841|NCT01135225|Percutaneous coronary intervention|percutaneous coronary intervention
742842|NCT01135225|Stent implantation|stent implantation
742843|NCT01135225|Evolution Stent System|evolution stent system
742844|NCT01135225|Biodegradable polymer coating|biodegradable polymer coating
742845|NCT01135225|Feasibility study|feasibility study
742846|NCT01135238|adrenalectomy|adrenalectomy
742847|NCT01135238|metastasis|metastasis
742848|NCT01135238|morbidity|morbidity
742849|NCT01135238|mortality|mortality
742850|NCT01135238|survival|survival
742851|NCT01135251|Neuropathic pain|neuropathic pain
742852|NCT01135251|AIDS|aids
742853|NCT01135251|Dimiracetam|dimiracetam
742854|NCT01135251|Treatment related painful neuropathy in AIDS patients|treatment related painful neuropathy in aids patients
743447|NCT01136759|Prevention|prevention
742949|NCT01135641|Adult patients (≥18 years)|adult patients (≥18 years)
742950|NCT01135641|first allogeneic stem cell transplantation|first allogeneic stem cell transplantation
742855|NCT01135290|The management of post-treatment symptoms for subjects that had either a medium grade chemical peel or fractional resurfacing|the management of post-treatment symptoms for subjects that had either a medium grade chemical peel or fractional resurfacing
742856|NCT01135303|Sleep Apnea Syndromes|sleep apnea syndromes
742857|NCT01135303|Polysomnography|polysomnography
742858|NCT01135303|Holter ECG|holter ecg
752063|NCT01171638|INVOS|invos
742859|NCT01135303|Thoracic impedance|thoracic impedance
742860|NCT01135303|Heart rate variability|heart rate variability
742861|NCT01135316|NSF, Ablavar, Kidney Disease, Magnetic Resonance Imaging (MRI),|nsf, ablavar, kidney disease, magnetic resonance imaging (mri),
742862|NCT01135329|Lymphoma|lymphoma
742863|NCT01135329|Hodgkin's lymphoma|hodgkin's lymphoma
742864|NCT01135329|Non hodgkin's lymphoma|non hodgkin's lymphoma
742865|NCT01135329|Leukemia|leukemia
742866|NCT01135329|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
742867|NCT01135329|Acute lymphoblastic leukemia(ALL)|acute lymphoblastic leukemia(all)
742868|NCT01135329|Chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
742869|NCT01135329|Chronic Myelomonocytic (CMML)|chronic myelomonocytic (cmml)
742870|NCT01135329|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
742871|NCT01135329|High-risk acute leukemia in first remission|high-risk acute leukemia in first remission
742872|NCT01135329|Relapsed leukemia in remission|relapsed leukemia in remission
742873|NCT01135329|Cyclophosphamide|cyclophosphamide
742874|NCT01135329|High-dose cyclophosphamide|high-dose cyclophosphamide
742875|NCT01135329|Fludarabine|fludarabine
742876|NCT01135329|Busulfan|busulfan
742877|NCT01135329|Allogeneic|allogeneic
742878|NCT01135329|Nonmyeloablative|nonmyeloablative
742879|NCT01135329|Reduced intensity|reduced intensity
742880|NCT01135329|Haploidentical|haploidentical
742881|NCT01135329|Bone marrow transplant (BMT)|bone marrow transplant (bmt)
742882|NCT01135342|Insomnia|insomnia
742883|NCT01135342|Weight loss|weight loss
742884|NCT01135342|Adults|adults
742885|NCT01135368|GERD|gerd
742886|NCT01135368|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
742887|NCT01135368|Drug Therapy|drug therapy
742888|NCT01135381|care transitions|care transitions
742889|NCT01135381|information technology|information technology
742890|NCT01135394|Pioglitazone|pioglitazone
742891|NCT01135394|Type 2 diabetes|type 2 diabetes
742892|NCT01135394|Insulin sensitivity|insulin sensitivity
742893|NCT01135394|Healthy adults|healthy adults
742894|NCT01135394|Thiazolidinediones|thiazolidinediones
742895|NCT01135394|Pharmacogenetics|pharmacogenetics
742896|NCT01135407|Parkinson's disease|parkinson's disease
742897|NCT01135407|Deep brain stimulation|deep brain stimulation
742898|NCT01135407|Subthalamic nucleus|subthalamic nucleus
742899|NCT01135407|Levodopa|levodopa
742900|NCT01135407|Selective visual attention|selective visual attention
742901|NCT01135407|Basal ganglia diseases|basal ganglia diseases
742902|NCT01135433|ASP1941|asp1941
742903|NCT01135433|Diabetes mellitus|diabetes mellitus
742904|NCT01135433|Metformin|metformin
742905|NCT01135459|Lupus|lupus
742906|NCT01135472|NEXIUM|nexium
742907|NCT01135472|HEALTHY VOLUNTEERS|healthy volunteers
742908|NCT01135472|BLOOD DRAW|blood draw
742909|NCT01135472|to measure gastrin levels in healthy volunteers while taking nexium|to measure gastrin levels in healthy volunteers while taking nexium
742910|NCT01135511|Dry eye|dry eye
742911|NCT01135524|Osteoarthritis|osteoarthritis
742912|NCT01135524|Opioid|opioid
742913|NCT01135524|Transdermal|transdermal
742914|NCT01135537|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
742915|NCT01135537|pharmacokinetics|pharmacokinetics
742916|NCT01135537|pediatrics|pediatrics
742917|NCT01135550|Pediatrics|pediatrics
742918|NCT01135550|Vomiting|vomiting
742919|NCT01135550|Headache|headache
742920|NCT01135550|Radiation Therapy|radiation therapy
742921|NCT01135563|pediatrics|pediatrics
742922|NCT01135563|Solid Tumors|solid tumors
742923|NCT01135563|CNS Tumors|cns tumors
742924|NCT01135563|Vinblastine|vinblastine
742925|NCT01135563|Sirolimus|sirolimus
742926|NCT01135563|Recurrent|recurrent
742927|NCT01135563|Refractory|refractory
742928|NCT01135576|Ferric pyrophosphate|ferric pyrophosphate
742929|NCT01135576|Fortification|fortification
742930|NCT01135576|Fruit juice|fruit juice
742931|NCT01135576|Functional food|functional food
742932|NCT01135576|Bioavailability|bioavailability
742933|NCT01135576|iron status|iron status
742934|NCT01135576|Women|women
742935|NCT01135576|iron-deficiency anemia|iron-deficiency anemia
742936|NCT01135589|pediatric|pediatric
742937|NCT01135589|adolescent|adolescent
742938|NCT01135589|micafungin|micafungin
742939|NCT01135602|Alcohol dependence|alcohol dependence
742940|NCT01135602|Alcoholism|alcoholism
742941|NCT01135602|Topiramate|topiramate
742942|NCT01135615|FGF-23, endothelial dysfunction, sevelamer|fgf-23, endothelial dysfunction, sevelamer
742943|NCT01135628|Hepatic cirrhosis|hepatic cirrhosis
742944|NCT01135628|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
742945|NCT01135628|Hyperproteic and fiber-rich diet|hyperproteic and fiber-rich diet
742946|NCT01135628|Lactobacillus reuteri|lactobacillus reuteri
742947|NCT01135628|Psychometric Hepatic Encephalopathy Score (PHES)|psychometric hepatic encephalopathy score (phes)
742948|NCT01135628|Critical Flicker Frequency (CFF)|critical flicker frequency (cff)
742951|NCT01135641|first episode of chronic GVHD requiring systemic immunosuppressive therapy|first episode of chronic gvhd requiring systemic immunosuppressive therapy
742952|NCT01135654|alcohol dependence|alcohol dependence
742953|NCT01135654|unhealthy drinking|unhealthy drinking
742954|NCT01135654|SBIRT|sbirt
742955|NCT01135667|clopidogrel|clopidogrel
742956|NCT01135667|prasugrel|prasugrel
742957|NCT01135667|low responder|low responder
742958|NCT01135667|multiplate|multiplate
742959|NCT01135667|verify now|verify now
742960|NCT01135693|Section 136|section 136
742961|NCT01135693|Mental Health Act 1983|mental health act 1983
742962|NCT01135693|Police|police
742963|NCT01135693|Detention|detention
742964|NCT01135693|Failure of community care|failure of community care
742965|NCT01135706|Pulmonary Hypertension|pulmonary hypertension
742966|NCT01135706|Fractal dimension|fractal dimension
742967|NCT01135719|Myopia|myopia
742968|NCT01135719|Hyperopia|hyperopia
742969|NCT01135719|Astigmatism|astigmatism
742970|NCT01135719|PRK|prk
742971|NCT01135719|LASIK|lasik
742972|NCT01135732|late development cholangiocarcinoma|late development cholangiocarcinoma
742973|NCT01135758|depression, ketamine, fMRI|depression, ketamine, fmri
742974|NCT01135771|glucose monitoring|glucose monitoring
742976|NCT01135771|glucose monitoring in patients with diabetes|glucose monitoring in patients with diabetes
742977|NCT01135810|healthy subjects|healthy subjects
742978|NCT01135836|Shoulder pain|shoulder pain
742979|NCT01135836|Gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
742980|NCT01135836|Nausea|nausea
742981|NCT01135836|Vomiting|vomiting
742982|NCT01135836|Abdominal fullness|abdominal fullness
742983|NCT01135875|GBM|gbm
742984|NCT01135875|Brain Tumor|brain tumor
742985|NCT01135875|Brain Neoplasm|brain neoplasm
742986|NCT01135875|Control|control
742987|NCT01135875|Normal Control|normal control
742988|NCT01135875|Volunteer|volunteer
742989|NCT01135888|hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
742990|NCT01135888|exertional hyperthermia|exertional hyperthermia
742991|NCT01135888|cooling device|cooling device
742992|NCT01135901|prevention|prevention
742993|NCT01135901|public health|public health
742994|NCT01135901|community health services|community health services
742995|NCT01135901|Norway|norway
742996|NCT01135914|DME|dme
742997|NCT01135914|visual impairment|visual impairment
742998|NCT01135914|diabetes|diabetes
742999|NCT01135914|macular edema|macular edema
743000|NCT01135914|diabetic macular edema|diabetic macular edema
743001|NCT01135914|ranibizumab|ranibizumab
743002|NCT01135914|laser|laser
743003|NCT01135914|photocoagulation|photocoagulation
743004|NCT01135914|retinopathy|retinopathy
743005|NCT01135914|retina|retina
743006|NCT01135940|neuromuscular scoliosis|neuromuscular scoliosis
743007|NCT01135940|dermabond|dermabond
743008|NCT01135940|infection|infection
743009|NCT01135940|wound closure|wound closure
743010|NCT01135953|Brain excitation|brain excitation
743011|NCT01135953|transcranial Direct Stimulation|transcranial direct stimulation
743012|NCT01135953|administration pattern|administration pattern
743013|NCT01135966|COPD|copd
743014|NCT01135966|Whole Body Vibration training|whole body vibration training
743015|NCT01135966|Conventional resistance training|conventional resistance training
743016|NCT01136005|receptor, epidermal growth factor|receptor, epidermal growth factor
743017|NCT01136005|skin toxicity|skin toxicity
743018|NCT01136005|quality of life|quality of life
743019|NCT01136005|adherence|adherence
743020|NCT01136031|advanced gastric cancer|advanced gastric cancer
743021|NCT01136031|1st-line failure|1st-line failure
743022|NCT01136044|tensor fasciae latae|tensor fasciae latae
743023|NCT01136044|septocutaneous perforators|septocutaneous perforators
743024|NCT01136070|Psychological Functioning in Burn Patients|psychological functioning in burn patients
743025|NCT01136083|Tumor|tumor
743026|NCT01136083|Angiogenesis|angiogenesis
743027|NCT01136083|Exercise training|exercise training
743028|NCT01136083|VEGF|vegf
743029|NCT01136083|Myostatin|myostatin
743030|NCT01136096|diabetes|diabetes
743031|NCT01136096|physical activity|physical activity
743032|NCT01136096|adiponectin|adiponectin
743033|NCT01136096|metabolic risks|metabolic risks
743034|NCT01136096|exercise|exercise
743035|NCT01136096|primary prevention|primary prevention
743036|NCT01136135|Heart transplant rejection|heart transplant rejection
743037|NCT01136135|cardiac MRI|cardiac mri
743038|NCT01136135|diagnosis|diagnosis
743039|NCT01136148|Mental Health|mental health
743040|NCT01136148|Aged|aged
743041|NCT01136148|Hospitals, general|hospitals, general
743042|NCT01136148|Dementia|dementia
743043|NCT01136148|Delirium|delirium
743044|NCT01136148|Dementia and confusion|dementia and confusion
743045|NCT01136161|LTBI (Latent Tuberculosis Infection)|ltbi (latent tuberculosis infection)
743046|NCT01136161|TB (Tuberculosis)|tb (tuberculosis)
743047|NCT01136161|Vaccine|vaccine
743048|NCT01136187|Myocardial infarction|myocardial infarction
743049|NCT01136187|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
743050|NCT01136187|Radial|radial
743051|NCT01136187|Bleeding|bleeding
743054|NCT01136200|Antimicrobial therapy|antimicrobial therapy
743055|NCT01136226|Prostate Cancer|prostate cancer
743056|NCT01136239|COPD|copd
743057|NCT01136239|N-acetylcysteine|n-acetylcysteine
743058|NCT01136239|airtrapping|airtrapping
743059|NCT01136239|airway resistance|airway resistance
743060|NCT01136239|antioxidant|antioxidant
743061|NCT01136265|dual-time PET/CT|dual-time pet/ct
743062|NCT01136265|sentinel node|sentinel node
743063|NCT01136278|MDMA|mdma
743064|NCT01136278|norepinephrine|norepinephrine
743065|NCT01136278|alpha2 receptor|alpha2 receptor
743066|NCT01136278|Ecstasy|ecstasy
743067|NCT01136278|stimulant|stimulant
743068|NCT01136291|pregnancy|pregnancy
743069|NCT01136291|obesity|obesity
743070|NCT01136291|physical exercise|physical exercise
743071|NCT01136291|quality of life|quality of life
743072|NCT01136304|Gaucher disease|gaucher disease
743073|NCT01136304|Imiglucerase|imiglucerase
743074|NCT01136304|Cerezyme|cerezyme
743075|NCT01136304|Severity score|severity score
743076|NCT01136330|Myotonic dystrophy|myotonic dystrophy
743077|NCT01136330|Prognosis|prognosis
743078|NCT01136330|Sudden death|sudden death
743079|NCT01136330|Respiratory failure|respiratory failure
743080|NCT01136343|women|women
743081|NCT01136343|middle age|middle age
743082|NCT01136343|risk factor|risk factor
743083|NCT01136356|opioid pharmacology|opioid pharmacology
743084|NCT01136356|buprenorphine|buprenorphine
743085|NCT01136356|morphine|morphine
743086|NCT01136356|withdrawal|withdrawal
743087|NCT01136356|human research|human research
743088|NCT01136369|metastasis|metastasis
743089|NCT01136369|molecular pathology|molecular pathology
743090|NCT01136382|asthma, children, budesonide pMDI|asthma, children, budesonide pmdi
743091|NCT01136395|Kidney Transplantation|kidney transplantation
743092|NCT01136395|Rituximab|rituximab
743093|NCT01136395|Living Donor|living donor
743094|NCT01136395|ABO Incompatible Transplantation|abo incompatible transplantation
743095|NCT01136395|Immunology|immunology
743097|NCT01136395|EBV|ebv
743098|NCT01136395|Polyomavirus|polyomavirus
743099|NCT01136421|COPD exacerbation|copd exacerbation
743100|NCT01136421|Magnesium sulfate|magnesium sulfate
743101|NCT01136421|Ipratropium bromide|ipratropium bromide
743102|NCT01136421|Emergency departement|emergency departement
743105|NCT01136460|Primary congenital glaucoma|primary congenital glaucoma
743106|NCT01136460|neonatal|neonatal
743107|NCT01136460|Genotype correlation|genotype correlation
743108|NCT01136460|Phenotype correlation|phenotype correlation
743109|NCT01136473|congenital cataract|congenital cataract
743110|NCT01136473|aphakic|aphakic
743111|NCT01136473|pseudophakic glaucoma|pseudophakic glaucoma
743112|NCT01136473|pediatric patients|pediatric patients
743113|NCT01136486|head trauma; traumatic brain injury|head trauma; traumatic brain injury
743114|NCT01136499|Sarcoma|sarcoma
743115|NCT01136499|Safety|safety
743116|NCT01136499|Efficacy|efficacy
743117|NCT01136499|PANOBINOSTAT|panobinostat
743118|NCT01136512|metformin|metformin
743119|NCT01136512|vitamin B12|vitamin b12
743120|NCT01136512|type 2 diabetes|type 2 diabetes
743121|NCT01136512|methylmalonic acid|methylmalonic acid
743122|NCT01136512|deficiency|deficiency
743123|NCT01124253|adjuvant therapy|adjuvant therapy
743124|NCT01124253|non-small cell lung cancer|non-small cell lung cancer
743125|NCT01124253|vinorelbine|vinorelbine
743126|NCT01124253|cisplatin|cisplatin
743127|NCT01124253|recombinant human endostatin|recombinant human endostatin
743128|NCT01124253|endostar|endostar
743129|NCT01124266|polyp|polyp
743130|NCT01124266|adenoma|adenoma
743131|NCT01124266|screening|screening
743132|NCT01124266|colonoscopy|colonoscopy
743133|NCT01124266|diagnosis|diagnosis
743134|NCT01124279|Amgen|amgen
743135|NCT01124279|Healthy|healthy
743136|NCT01124279|Adult|adult
743137|NCT01124292|Disability|disability
743138|NCT01124292|Quadriplegia|quadriplegia
743139|NCT01124292|Paralysis|paralysis
743140|NCT01124292|Assistive technology|assistive technology
743141|NCT01124292|Quality of life|quality of life
743142|NCT01124292|Computer access|computer access
743143|NCT01124292|Wheeled mobility|wheeled mobility
743144|NCT01124305|Total Knee Arthroplasty|total knee arthroplasty
743145|NCT01124305|Instrumentation|instrumentation
743146|NCT01124318|Lactofiltrum|lactofiltrum
743147|NCT01124318|atopic dermatitis|atopic dermatitis
743148|NCT01124318|itching|itching
743149|NCT01124318|Dermatological Index of Life Quality|dermatological index of life quality
743150|NCT01124318|SCORAD|scorad
743151|NCT01124318|Behavioral Rating Scores|behavioral rating scores
743152|NCT01124331|prospective meta-analysis|prospective meta-analysis
743153|NCT01124331|preterm infant|preterm infant
743154|NCT01124331|pulse oximetry|pulse oximetry
743155|NCT01124331|oxygen saturation|oxygen saturation
743156|NCT01124357|Heavy menstrual bleeding|heavy menstrual bleeding
743157|NCT01124357|menorrhagia|menorrhagia
743448|NCT01136759|Microbicide|microbicide
743158|NCT01124357|ThermachoiceTM|thermachoicetm
743159|NCT01124357|NovaSureTM|novasuretm
743160|NCT01124357|Endometrail Ablation|endometrail ablation
743161|NCT01124370|Sleep Disordered Breathing|sleep disordered breathing
743162|NCT01124370|Cheyne Stokes Respiration|cheyne stokes respiration
743163|NCT01124370|Periodic Breathing|periodic breathing
743164|NCT01124370|Sleep Apnea|sleep apnea
743165|NCT01124370|Central Sleep Apnea|central sleep apnea
745394|NCT01144208|Postoperative complications|postoperative complications
745395|NCT01144208|Colles' fracture|colles' fracture
745396|NCT01144208|Intraoperative complications|intraoperative complications
743166|NCT01124383|Glycine absorption|glycine absorption
743167|NCT01124383|Operative hysteroscopy|operative hysteroscopy
743168|NCT01124383|Endometrial resection|endometrial resection
743169|NCT01124383|General anesthesia|general anesthesia
743170|NCT01124383|Local anesthesia|local anesthesia
743171|NCT01124409|IGRT|igrt
743172|NCT01124409|3DCRT|3dcrt
743173|NCT01124409|EPID|epid
743174|NCT01124409|CBCT|cbct
743175|NCT01124409|HNSCC|hnscc
743176|NCT01124422|endurance shuttle walk test|endurance shuttle walk test
743177|NCT01124422|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
743178|NCT01124422|fluticasone propionate|fluticasone propionate
743179|NCT01124422|dyspnea|dyspnea
743180|NCT01124422|exercise endurance time|exercise endurance time
743181|NCT01124422|tiotropium|tiotropium
743182|NCT01124422|salmeterol|salmeterol
743183|NCT01124422|exercise inspiratory capacity|exercise inspiratory capacity
743184|NCT01124422|quality of life|quality of life
743185|NCT01124435|Carboplatin plus Celecoxib|carboplatin plus celecoxib
743186|NCT01124435|Pre-treated Recurrent Ovarian Cancer Patients|pre-treated recurrent ovarian cancer patients
743187|NCT01124435|The antitumor activity and potential adverse effects|the antitumor activity and potential adverse effects
743188|NCT01124435|tumor response rate|tumor response rate
743189|NCT01124435|toxicity|toxicity
743190|NCT01124435|progression free survival|progression free survival
743191|NCT01124435|duration of response|duration of response
743192|NCT01124435|quality of life|quality of life
743193|NCT01124461|Malignant Brain Tumors|malignant brain tumors
743194|NCT01124461|Cancer of the Brain|cancer of the brain
743195|NCT01129817|Cognitive Functional Therapy|cognitive functional therapy
743196|NCT01129817|Manual Therapy and Exercise|manual therapy and exercise
743197|NCT01129817|Chronic Low Back Pain|chronic low back pain
743198|NCT01129817|Randomized Controlled Trial|randomized controlled trial
743199|NCT01129817|Subclassification|subclassification
743200|NCT01129830|ovarian reserve|ovarian reserve
743201|NCT01129830|FSH|fsh
743202|NCT01129830|anti-mullerian hormone|anti-mullerian hormone
743203|NCT01129830|estradiol|estradiol
743204|NCT01129830|oocyte|oocyte
743205|NCT01129830|IVF|ivf
743206|NCT01129830|embryo transfer|embryo transfer
743207|NCT01129843|anemia|anemia
743208|NCT01129843|iron deficiency|iron deficiency
743209|NCT01129843|nutritional|nutritional
743210|NCT01129843|iron supplementation|iron supplementation
743211|NCT01129843|cluster randomized control trial|cluster randomized control trial
743212|NCT01129856|Dry eye|dry eye
743213|NCT01129856|Keratoconjunctivitis sicca|keratoconjunctivitis sicca
743214|NCT01129856|Iontophoresis|iontophoresis
743215|NCT01129856|Ophthalmic drug delivery|ophthalmic drug delivery
743216|NCT01129856|EGP-437|egp-437
743217|NCT01129856|Dexamethasone phosphate|dexamethasone phosphate
743218|NCT01129869|Survey|survey
743219|NCT01129869|Perception|perception
743220|NCT01129869|Perception of Clinical Research Participation|perception of clinical research participation
743221|NCT01129869|Research Participant Perception|research participant perception
743222|NCT01129882|Schizophrenia|schizophrenia
743223|NCT01129908|oral health in children with celiac disease|oral health in children with celiac disease
743224|NCT01129921|Lumbar Spine Stenosis|lumbar spine stenosis
743225|NCT01129921|Decompression|decompression
743226|NCT01129934|Low Back Pain,|low back pain,
743227|NCT01129934|Emergency medicine,|emergency medicine,
743228|NCT01129934|Promethazine,|promethazine,
743229|NCT01129934|Morphine,|morphine,
743230|NCT01129934|Pain relief|pain relief
743231|NCT01129960|Diabetic Neuropathic Pain|diabetic neuropathic pain
743232|NCT01129973|speech and language|speech and language
743233|NCT01129973|phonoaudiology|phonoaudiology
743234|NCT01129973|marketing|marketing
743235|NCT01129986|venous ulcer Dermastream|venous ulcer dermastream
752842|NCT01174420|trabeculectomy|trabeculectomy
743236|NCT01129999|smoking cessation, CBT, hypnotherapy|smoking cessation, cbt, hypnotherapy
743237|NCT01130012|Gestational diabetes mellitus|gestational diabetes mellitus
743238|NCT01130012|Lifestyle intervention|lifestyle intervention
743239|NCT01130012|Oral glucose tolerance test|oral glucose tolerance test
743240|NCT01130012|Insulin treatment|insulin treatment
743241|NCT01130012|Pregnancy outcomes|pregnancy outcomes
743242|NCT01130038|Characteristic of play|characteristic of play
743243|NCT01130038|DCD|dcd
743244|NCT01130038|children|children
743245|NCT01130038|Typical Development|typical development
743246|NCT01130038|Whether there are any differences in the issue of Characteristic of play between Children with DCD and Children with Typical Development|whether there are any differences in the issue of characteristic of play between children with dcd and children with typical development
743247|NCT01130051|bioavailability|bioavailability
743248|NCT01130064|Asthma|asthma
743249|NCT01130064|QAX576|qax576
743250|NCT01130077|Pediatric glioma|pediatric glioma
743251|NCT01130077|Vaccine therapy|vaccine therapy
752064|NCT01171651|Vaccinia|vaccinia
745514|NCT01144806|BIA|bia
743253|NCT01130103|anxiety disorders|anxiety disorders
743254|NCT01130103|trauma|trauma
743255|NCT01130129|Flavonoids|flavonoids
743256|NCT01130129|Platelets|platelets
743257|NCT01130155|Antimalarials|antimalarials
743258|NCT01130155|Diagnosis|diagnosis
743259|NCT01130155|Access to treatment|access to treatment
743260|NCT01130155|Quality of care|quality of care
743261|NCT01130194|follicular lymphoma|follicular lymphoma
743262|NCT01130194|radioimmunotherapy|radioimmunotherapy
743263|NCT01130194|rituximab|rituximab
743264|NCT01130194|C-MOPP-R|c-mopp-r
743265|NCT01130194|autologous transplant|autologous transplant
743266|NCT01130207|Obesity|obesity
743267|NCT01130207|Diabetes|diabetes
743268|NCT01130207|Periodontal disease|periodontal disease
743269|NCT01130220|Brain Tumor|brain tumor
743270|NCT01130220|Brain Neoplasm|brain neoplasm
743271|NCT01130233|rectal cancer|rectal cancer
743272|NCT01130259|mTNBC|mtnbc
743273|NCT01130259|triple negative breast cancer|triple negative breast cancer
743274|NCT01130259|metastatic triple negative breast cancer|metastatic triple negative breast cancer
743275|NCT01130259|metastatic breast cancer that is ER-, PR-, and HER2-negative|metastatic breast cancer that is er-, pr-, and her2-negative
743276|NCT01130272|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
743277|NCT01130272|Irritable bowel syndrome|irritable bowel syndrome
743278|NCT01130272|Diarrhea predominant irritable bowel syndrome|diarrhea predominant irritable bowel syndrome
743279|NCT01130272|Colonic diseases|colonic diseases
743280|NCT01130272|Colonic diseases, functional|colonic diseases, functional
743281|NCT01130272|Digestive system disease|digestive system disease
743282|NCT01130272|Gastrointestinal disease|gastrointestinal disease
743283|NCT01130272|Intestinal disease|intestinal disease
743284|NCT01130272|Colonic pseudo-obstruction|colonic pseudo-obstruction
743285|NCT01130272|Diarrhea|diarrhea
743286|NCT01130272|Signs and Symptoms, Digestive|signs and symptoms, digestive
743287|NCT01130285|Lung Cancer|lung cancer
743288|NCT01130298|testosterone, replacement, therapy|testosterone, replacement, therapy
743289|NCT01130324|VIBATIV|vibativ
743290|NCT01130324|telavancin|telavancin
743291|NCT01130324|Pregnancy|pregnancy
743292|NCT01130324|Registry|registry
743293|NCT01130363|Proton Pump Inhibitor|proton pump inhibitor
743294|NCT01130363|Gastric carcinoid tumors|gastric carcinoid tumors
743295|NCT01130363|Gastric cancer|gastric cancer
743296|NCT01130363|Fundic Gland Polyps|fundic gland polyps
743297|NCT01130376|Immune based therapy|immune based therapy
743298|NCT01130376|Therapeutic vaccination|therapeutic vaccination
743299|NCT01130376|cytokine therapy|cytokine therapy
743300|NCT01130376|HIV therapeutic vaccine|hiv therapeutic vaccine
743301|NCT01130389|ONJ|onj
743302|NCT01130402|age|age
743303|NCT01130402|lymphadenopathy|lymphadenopathy
743304|NCT01130402|fine needle aspiration|fine needle aspiration
743305|NCT01130402|sonography|sonography
743306|NCT01130415|Sacral neuromodulation|sacral neuromodulation
743307|NCT01130415|Screening|screening
743308|NCT01130415|Percutaneous nerve evaluation|percutaneous nerve evaluation
743309|NCT01130415|Tined lead|tined lead
743310|NCT01130428|Mechanical stimulation|mechanical stimulation
743311|NCT01130428|Vibration platform|vibration platform
743312|NCT01130428|Bone metabolism|bone metabolism
743313|NCT01130428|ATP release|atp release
743314|NCT01130441|adolescent behavior|adolescent behavior
743315|NCT01130441|harm reduction|harm reduction
743316|NCT01130454|Unfavorable effect of environmental factors, stressors|unfavorable effect of environmental factors, stressors
743317|NCT01130467|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
743318|NCT01130467|Attention Deficit Disorder|attention deficit disorder
743319|NCT01130467|Event related potential|event related potential
743320|NCT01130519|Advanced HLRCC|advanced hlrcc
743321|NCT01130519|Sporadic Papillary Renal Cell Cancer|sporadic papillary renal cell cancer
743322|NCT01130519|Papillary Kidney Cancer|papillary kidney cancer
743323|NCT01130519|Bevacizumab|bevacizumab
743324|NCT01130519|Erlotinib|erlotinib
743325|NCT01130519|Kidney Cancer|kidney cancer
743326|NCT01130519|Renal Cell Cancer|renal cell cancer
743327|NCT01130519|Hereditary Leiomyomatosis and Renal Cell Cancer|hereditary leiomyomatosis and renal cell cancer
743328|NCT01130519|HLRCC|hlrcc
743329|NCT01130532|Erectile Dysfunction|erectile dysfunction
743330|NCT01130532|ED|ed
743331|NCT01130532|Impotence|impotence
743332|NCT01130545|Magnetic Resonance Imaging|magnetic resonance imaging
743333|NCT01130545|Gadolinium|gadolinium
743334|NCT01130545|Healthy Volunteer|healthy volunteer
743335|NCT01130545|HV|hv
743336|NCT01130558|type 2 diabetes mellitus|type 2 diabetes mellitus
743337|NCT01130558|basal-bolus insulin|basal-bolus insulin
743338|NCT01130558|insulin ordering|insulin ordering
743339|NCT01130584|Cancer Patients|cancer patients
743340|NCT01130597|HF|hf
743341|NCT01130597|Heart failure|heart failure
743342|NCT01130597|hyperkalemia|hyperkalemia
743343|NCT01130597|chronic kidney disease|chronic kidney disease
743344|NCT01130597|prevention of hyperkalemia in heart failure participants|prevention of hyperkalemia in heart failure participants
743345|NCT01130610|preoperative period|preoperative period
743346|NCT01130610|preoperative care|preoperative care
743347|NCT01130610|anesthesia|anesthesia
743348|NCT01130610|program evaluation|program evaluation
743349|NCT01130623|VEGF Inhibitor|vegf inhibitor
743350|NCT01130623|Maximum Tolerated Dose|maximum tolerated dose
743351|NCT01130623|Dose Escalation|dose escalation
743352|NCT01130623|Pharmacokinetics|pharmacokinetics
743353|NCT01130623|Antitumor Activity|antitumor activity
743354|NCT01130623|Pediatric Cancer|pediatric cancer
743355|NCT01130623|Solid Tumor|solid tumor
743356|NCT01130623|Sarcoma|sarcoma
743357|NCT01130623|Neuroblastoma|neuroblastoma
743358|NCT01130623|Wilms Tumor|wilms tumor
743359|NCT01130623|Osteosarcoma|osteosarcoma
743360|NCT01130623|Brain Tumor|brain tumor
743361|NCT01130636|oseltamivir carboxylate|oseltamivir carboxylate
743362|NCT01130636|oseltamivir phosphate|oseltamivir phosphate
743363|NCT01130636|Tamiflu pharmacokinetics in lactating women with influenza|tamiflu pharmacokinetics in lactating women with influenza
743364|NCT01130649|Epilepsy|epilepsy
743365|NCT01130649|Tracking|tracking
743366|NCT01130649|Electronic diary|electronic diary
743367|NCT01130662|acute myeloid leukemia|acute myeloid leukemia
743368|NCT01130662|AML|aml
743369|NCT01130662|Relapsed AML|relapsed aml
743370|NCT01130662|Refractory AML|refractory aml
743371|NCT01130688|Leukemia|leukemia
743372|NCT01130688|Zileuton|zileuton
743373|NCT01130688|myeloproliferative neoplasm|myeloproliferative neoplasm
743374|NCT01130701|Pancreatic Cancer|pancreatic cancer
743375|NCT01130701|Neoadjuvant|neoadjuvant
743376|NCT01130701|Panitumumab|panitumumab
743377|NCT01130701|Capecitabine|capecitabine
743378|NCT01130714|inflammation|inflammation
743379|NCT01130714|chemotherapy|chemotherapy
743380|NCT01130714|lung cancer|lung cancer
743381|NCT01136525|Bioequivalence|bioequivalence
743382|NCT01136525|Crossover|crossover
743383|NCT01136525|Valacyclovir Hydrochloride|valacyclovir hydrochloride
743384|NCT01136538|Bioequivalence|bioequivalence
743385|NCT01136538|Crossover|crossover
743386|NCT01136538|Valacyclovir Hydrochloride|valacyclovir hydrochloride
743387|NCT01136551|Pharmacokinetic profile of controlled release formulation of Huperzine A|pharmacokinetic profile of controlled release formulation of huperzine a
743388|NCT01136551|Bioequivalence of Huperzine A IR formulation and CR formulation|bioequivalence of huperzine a ir formulation and cr formulation
743389|NCT01136564|paricalcitol|paricalcitol
743390|NCT01136564|vitamin d|vitamin d
743391|NCT01136564|kidney disease|kidney disease
743392|NCT01136564|renin|renin
743393|NCT01136564|proteinuria|proteinuria
743394|NCT01136577|Jaundice|jaundice
743395|NCT01136577|Hyperbilirubinemia|hyperbilirubinemia
743396|NCT01136577|Phototherapy|phototherapy
743397|NCT01136577|term newborn|term newborn
743398|NCT01136577|LED|led
743399|NCT01136577|Fluorescent lamps|fluorescent lamps
743400|NCT01136590|Spinal deformity correction|spinal deformity correction
743401|NCT01136590|Surgical bleeding|surgical bleeding
743402|NCT01136590|Transfusion practice|transfusion practice
743403|NCT01136590|Spinal Fusion|spinal fusion
743404|NCT01136590|Antifibrinolytic Agents|antifibrinolytic agents
743405|NCT01136590|Hemorrhage|hemorrhage
743406|NCT01136590|Blood Transfusion|blood transfusion
743407|NCT01136603|Abdominal wall defects|abdominal wall defects
743408|NCT01136603|Inflammation reactions|inflammation reactions
743409|NCT01136603|Amount of tissue ingrowth|amount of tissue ingrowth
743410|NCT01136603|Adhesion formation|adhesion formation
743411|NCT01136603|Shrinkage profiles of the implant|shrinkage profiles of the implant
743412|NCT01136616|Nasal fracture|nasal fracture
743413|NCT01136616|Nasal buttresses|nasal buttresses
743414|NCT01136616|Septal deviation|septal deviation
743415|NCT01136616|Nasal morphology|nasal morphology
743416|NCT01136616|CT Scan|ct scan
743417|NCT01136629|Hyper-pigmented spots|hyper-pigmented spots
743418|NCT01136629|Lentigines|lentigines
743419|NCT01136629|Mealsma|mealsma
743420|NCT01136629|RNA extraction|rna extraction
743421|NCT01136629|Isolation of Keratinocytes|isolation of keratinocytes
743422|NCT01136629|Isolation of Melanocytes|isolation of melanocytes
743423|NCT01136642|Nicotine|nicotine
743424|NCT01136642|Nicotine Nasal Spray|nicotine nasal spray
743425|NCT01136642|Attention|attention
743426|NCT01136642|Smoking|smoking
743427|NCT01136655|asthmatic children|asthmatic children
743428|NCT01136655|Symbicort|symbicort
743429|NCT01136655|Foradil|foradil
743430|NCT01136668|pediatrics|pediatrics
743431|NCT01136668|Transversus Abdominis Plane Block|transversus abdominis plane block
743432|NCT01136668|Ostomy Surgery|ostomy surgery
743433|NCT01136668|Anesthesia|anesthesia
743434|NCT01136668|Regional Anesthetic|regional anesthetic
743435|NCT01136681|Anonymised Electronic Cohort|anonymised electronic cohort
743436|NCT01136681|Record Linkage|record linkage
743437|NCT01136681|Routine Data|routine data
743438|NCT01136681|Environment|environment
743439|NCT01136681|Childhood Obesity|childhood obesity
743440|NCT01136681|Low birth weight|low birth weight
743441|NCT01136681|Premature birth|premature birth
743442|NCT01136733|Unresectable advanced or metastatic renal cell carcinoma|unresectable advanced or metastatic renal cell carcinoma
743443|NCT01136746|Hyperglycemia|hyperglycemia
743444|NCT01136746|Diabetes|diabetes
743446|NCT01136746|Diabetic|diabetic
743449|NCT01136759|Mother-to-Child-Transmission|mother-to-child-transmission
743450|NCT01136759|Pregnancy|pregnancy
743451|NCT01136798|slow wave sleep|slow wave sleep
743452|NCT01136798|exenatide and sleep|exenatide and sleep
743453|NCT01136824|Sarcoma|sarcoma
743454|NCT01136824|questionnaire|questionnaire
743455|NCT01136824|doxorubicin plus ifosfamide (AI)|doxorubicin plus ifosfamide (ai)
743456|NCT01136850|Plasmodium falciparum|plasmodium falciparum
743457|NCT01136850|Plasmodium vivax|plasmodium vivax
743458|NCT01136850|azithromycin|azithromycin
743459|NCT01136850|sulphadoxine pyrimethamine|sulphadoxine pyrimethamine
743460|NCT01136850|low birth weight|low birth weight
743461|NCT01136850|haemoglobin|haemoglobin
743462|NCT01136850|Chlamydia trachomatis|chlamydia trachomatis
743463|NCT01136850|Neisseria gonorrhoeae|neisseria gonorrhoeae
743464|NCT01136850|Treponema pallidum|treponema pallidum
743465|NCT01137513|Chest Pain|chest pain
743466|NCT01137513|Acute coronary syndrome|acute coronary syndrome
743467|NCT01137513|AMI|ami
743468|NCT01137539|urinary incontinence|urinary incontinence
743469|NCT01137539|stress urinary incontinence|stress urinary incontinence
743470|NCT01137539|mid-urethral slings|mid-urethral slings
743471|NCT01137539|Tension-free vaginal taping|tension-free vaginal taping
743472|NCT01137539|TVT|tvt
743473|NCT01137552|First-In-Human|first-in-human
743474|NCT01137552|Dose Escalation|dose escalation
743475|NCT01137552|Dose Expansion|dose expansion
743476|NCT01137552|Advance Solid Tumors|advance solid tumors
743477|NCT01137552|Anti-Angiopoietin|anti-angiopoietin
743478|NCT01137552|Advance Malignancy|advance malignancy
743479|NCT01137552|Cancer|cancer
743480|NCT01137552|Oncology|oncology
743481|NCT01137552|Oncology Patients|oncology patients
743482|NCT01137552|Phase 1|phase 1
743483|NCT01137552|Clinical Trial|clinical trial
743484|NCT01137552|Tumors|tumors
743485|NCT01137552|Solid Tumors|solid tumors
743486|NCT01137552|Angiogenesis Inhibitors|angiogenesis inhibitors
743487|NCT01137565|Amgen|amgen
743488|NCT01137565|Adolescent|adolescent
743489|NCT01137565|Safety|safety
743490|NCT01137591|Acetaminophen|acetaminophen
743491|NCT01137591|Acetylcysteine|acetylcysteine
743492|NCT01137591|Antidotes|antidotes
743493|NCT01137630|seborrhoeic dermatitis|seborrhoeic dermatitis
743494|NCT01137630|scalp|scalp
743495|NCT01137630|K40a|k40a
743496|NCT01137630|K40b|k40b
743497|NCT01137643|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
743498|NCT01137643|acute undifferentiated leukemia|acute undifferentiated leukemia
743499|NCT01137643|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
743500|NCT01137643|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
743501|NCT01137643|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
743502|NCT01137643|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
743503|NCT01137643|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
743504|NCT01137643|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
743505|NCT01137643|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
743506|NCT01137643|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
743507|NCT01137643|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
743508|NCT01137643|mast cell leukemia|mast cell leukemia
743509|NCT01137643|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
743510|NCT01137643|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
743511|NCT01137643|prolymphocytic leukemia|prolymphocytic leukemia
743512|NCT01137643|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
743513|NCT01137643|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
743514|NCT01137643|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
743515|NCT01137643|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
743516|NCT01137643|refractory hairy cell leukemia|refractory hairy cell leukemia
743517|NCT01137643|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
743518|NCT01137643|secondary acute myeloid leukemia|secondary acute myeloid leukemia
743519|NCT01137643|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
743520|NCT01137643|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
743521|NCT01137643|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
743522|NCT01137643|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
743523|NCT01137643|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
743524|NCT01137643|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
743525|NCT01137643|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
743526|NCT01137643|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
743527|NCT01137643|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
743528|NCT01137643|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
743529|NCT01137643|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
743530|NCT01137643|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
743531|NCT01137643|untreated hairy cell leukemia|untreated hairy cell leukemia
743532|NCT01137643|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
743533|NCT01137643|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
743534|NCT01137643|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
743535|NCT01137643|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
743536|NCT01137643|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
743537|NCT01137643|anaplastic large cell lymphoma|anaplastic large cell lymphoma
743538|NCT01137643|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
743539|NCT01137643|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
743540|NCT01137643|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
743541|NCT01137643|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
743542|NCT01137643|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
743543|NCT01137643|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
743544|NCT01137643|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
744825|NCT01141452|initiate|initiate
743545|NCT01137643|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
743546|NCT01137643|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
743547|NCT01137643|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
743548|NCT01137643|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
743549|NCT01137643|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
743550|NCT01137643|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
743551|NCT01137643|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
743552|NCT01137643|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
743553|NCT01137643|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
743554|NCT01137643|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
743555|NCT01137643|splenic marginal zone lymphoma|splenic marginal zone lymphoma
743556|NCT01137643|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
743557|NCT01137643|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
743558|NCT01137643|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
743559|NCT01137643|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
743560|NCT01137643|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
743561|NCT01137643|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
743562|NCT01137643|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
743563|NCT01137643|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
743564|NCT01137643|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
743565|NCT01137643|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
743566|NCT01137643|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
743567|NCT01137643|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
743568|NCT01137643|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
743569|NCT01137643|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
743570|NCT01137643|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
743571|NCT01137643|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
743572|NCT01137643|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
743573|NCT01137643|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
743574|NCT01137643|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
743575|NCT01137643|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
743576|NCT01137643|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
743577|NCT01137643|stage I mantle cell lymphoma|stage i mantle cell lymphoma
743578|NCT01137643|stage I marginal zone lymphoma|stage i marginal zone lymphoma
743579|NCT01137643|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
743580|NCT01137643|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
743581|NCT01137643|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
743582|NCT01137643|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
743583|NCT01137643|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
743584|NCT01137643|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
743585|NCT01137643|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
743586|NCT01137643|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
743587|NCT01137643|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
743588|NCT01137643|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
743589|NCT01137643|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
743660|NCT01137695|glucose|glucose
743590|NCT01137643|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
743591|NCT01137643|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
743592|NCT01137643|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
743593|NCT01137643|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
743594|NCT01137643|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
743595|NCT01137643|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
743596|NCT01137643|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
743597|NCT01137643|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
743598|NCT01137643|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
743599|NCT01137643|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
743600|NCT01137643|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
743601|NCT01137643|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
743602|NCT01137643|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
743603|NCT01137643|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
744924|NCT01141855|Asthma|asthma
743604|NCT01137643|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
743605|NCT01137643|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
743606|NCT01137643|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
743607|NCT01137643|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
743608|NCT01137643|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
743609|NCT01137643|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
743610|NCT01137643|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
743611|NCT01137643|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
743612|NCT01137643|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
743613|NCT01137643|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
743614|NCT01137643|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
743615|NCT01137643|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
743616|NCT01137643|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
743617|NCT01137643|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
743618|NCT01137643|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
743619|NCT01137643|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
743620|NCT01137643|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
743621|NCT01137643|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
743622|NCT01137643|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
743623|NCT01137643|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
743624|NCT01137643|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
743625|NCT01137643|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
743626|NCT01137643|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
743627|NCT01137643|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
743628|NCT01137643|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
743629|NCT01137643|intraocular lymphoma|intraocular lymphoma
743630|NCT01137643|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
743631|NCT01137643|chronic eosinophilic leukemia|chronic eosinophilic leukemia
743632|NCT01137643|chronic neutrophilic leukemia|chronic neutrophilic leukemia
743633|NCT01137643|primary myelofibrosis|primary myelofibrosis
743634|NCT01137643|essential thrombocythemia|essential thrombocythemia
743635|NCT01137643|polycythemia vera|polycythemia vera
743636|NCT01137643|extramedullary plasmacytoma|extramedullary plasmacytoma
743637|NCT01137643|isolated plasmacytoma of bone|isolated plasmacytoma of bone
743638|NCT01137643|stage I multiple myeloma|stage i multiple myeloma
743639|NCT01137643|stage II multiple myeloma|stage ii multiple myeloma
743640|NCT01137643|stage III multiple myeloma|stage iii multiple myeloma
752843|NCT01174420|glaucoma|glaucoma
743641|NCT01137643|primary systemic amyloidosis|primary systemic amyloidosis
743642|NCT01137643|refractory multiple myeloma|refractory multiple myeloma
743643|NCT01137643|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
743644|NCT01137643|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
743645|NCT01137643|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
743646|NCT01137643|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
743647|NCT01137643|aplastic anemia|aplastic anemia
743648|NCT01137656|Blood storage|blood storage
743649|NCT01137656|Blood transfusion|blood transfusion
743650|NCT01137656|Aged blood|aged blood
743651|NCT01137656|Blood Forearm|blood forearm
743652|NCT01137656|Storage lesion in blood|storage lesion in blood
743653|NCT01137669|immunocompromised,parent protocol,shingles,varicella-zoster virus,ZOSTAVAX®|immunocompromised,parent protocol,shingles,varicella-zoster virus,zostavax®
743654|NCT01137682|Acromegaly|acromegaly
743655|NCT01137682|hormone disorder|hormone disorder
743656|NCT01137682|growth hormone|growth hormone
743657|NCT01137682|insulin like growth factor-1|insulin like growth factor-1
743658|NCT01137682|pituitary tumor|pituitary tumor
743659|NCT01137695|pramlintide|pramlintide
743661|NCT01137695|type 2 diabetes mellitus|type 2 diabetes mellitus
743662|NCT01137695|amylin|amylin
743663|NCT01137708|drug interactions|drug interactions
743664|NCT01137708|CYP3A|cyp3a
743665|NCT01137708|oral contraceptive|oral contraceptive
743666|NCT01137708|anti-rheumatic agents|anti-rheumatic agents
743667|NCT01137721|magnetic resonance imaging|magnetic resonance imaging
743668|NCT01137721|sickle cell disease|sickle cell disease
743669|NCT01137721|hydroxyurea therapy|hydroxyurea therapy
743670|NCT01137734|Heart Diseases|heart diseases
743671|NCT01137734|Heart Valve Diseases|heart valve diseases
743672|NCT01137734|Cardiovascular Diseases|cardiovascular diseases
743673|NCT01137747|carfilzomib|carfilzomib
743674|NCT01137747|acute myeloid leukemia|acute myeloid leukemia
743675|NCT01137747|acute lymphoblastic leukemia|acute lymphoblastic leukemia
743676|NCT01137747|phase I|phase i
743677|NCT01137760|adults|adults
743678|NCT01137760|fiber|fiber
743679|NCT01137760|cold|cold
743681|NCT01137760|stress|stress
743682|NCT01137760|microbiota|microbiota
743683|NCT01137773|SAH (Subarachnoid Hemorrhage)|sah (subarachnoid hemorrhage)
743684|NCT01137773|Brain Hemorrhage|brain hemorrhage
743685|NCT01137773|Traumatic Brain Injury|traumatic brain injury
743686|NCT01137773|SAH|sah
743687|NCT01137773|ICH|ich
743688|NCT01137799|symptomatic treatment|symptomatic treatment
743689|NCT01137799|cognition|cognition
743690|NCT01137799|cognitive deficits|cognitive deficits
743691|NCT01137799|schizophrenia|schizophrenia
743692|NCT01137799|Alzheimer's Disease|alzheimer's disease
743693|NCT01137812|Canagliflozin|canagliflozin
743694|NCT01137812|Sitagliptin (Januvia)|sitagliptin (januvia)
743695|NCT01137812|Metformin|metformin
743696|NCT01137812|Sulphonylurea|sulphonylurea
743697|NCT01137812|Hemoglobin A1c|hemoglobin a1c
743698|NCT01137812|Type 2 diabetes mellitus|type 2 diabetes mellitus
743699|NCT01137825|cognitive/functional effects|cognitive/functional effects
743700|NCT01137825|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
743701|NCT01137825|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
743702|NCT01137825|acute undifferentiated leukemia|acute undifferentiated leukemia
743703|NCT01137825|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
743704|NCT01137825|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
743705|NCT01137825|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
743706|NCT01137825|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
743707|NCT01137825|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
743708|NCT01137825|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
743709|NCT01137825|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
743710|NCT01137825|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
743711|NCT01137825|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
743712|NCT01137825|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
743713|NCT01137825|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
743714|NCT01137825|mast cell leukemia|mast cell leukemia
743715|NCT01137825|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
743716|NCT01137825|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
743717|NCT01137825|prolymphocytic leukemia|prolymphocytic leukemia
743718|NCT01137825|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
743719|NCT01137825|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
743720|NCT01137825|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
743721|NCT01137825|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
743722|NCT01137825|refractory hairy cell leukemia|refractory hairy cell leukemia
743723|NCT01137825|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
743724|NCT01137825|secondary acute myeloid leukemia|secondary acute myeloid leukemia
743725|NCT01137825|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
743726|NCT01137825|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
743727|NCT01137825|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
743728|NCT01137825|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
743729|NCT01137825|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
743730|NCT01137825|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
743731|NCT01137825|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
743732|NCT01137825|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
743733|NCT01137825|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
743734|NCT01137825|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
752065|NCT01171651|Vaccinia Virus|vaccinia virus
746161|NCT01147653|CP|cp
743735|NCT01137825|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
743736|NCT01137825|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
743737|NCT01137825|untreated hairy cell leukemia|untreated hairy cell leukemia
743738|NCT01137825|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
743739|NCT01137825|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
743740|NCT01137825|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
744052|NCT01138410|Melanoma|melanoma
743741|NCT01137825|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
743742|NCT01137825|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
743743|NCT01137825|anaplastic large cell lymphoma|anaplastic large cell lymphoma
743744|NCT01137825|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
743745|NCT01137825|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
743746|NCT01137825|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
743747|NCT01137825|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
743748|NCT01137825|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
743749|NCT01137825|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
743750|NCT01137825|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
743751|NCT01137825|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
745993|NCT01146730|Anxiety|anxiety
743752|NCT01137825|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
743753|NCT01137825|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
743754|NCT01137825|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
743755|NCT01137825|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
743756|NCT01137825|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
743757|NCT01137825|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
743758|NCT01137825|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
743759|NCT01137825|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
743760|NCT01137825|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
743761|NCT01137825|splenic marginal zone lymphoma|splenic marginal zone lymphoma
743762|NCT01137825|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
743763|NCT01137825|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
743764|NCT01137825|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
743765|NCT01137825|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
743766|NCT01137825|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
743767|NCT01137825|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
743768|NCT01137825|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
743769|NCT01137825|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
743770|NCT01137825|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
743771|NCT01137825|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
743772|NCT01137825|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
743773|NCT01137825|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
743774|NCT01137825|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
743775|NCT01137825|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
743776|NCT01137825|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
743777|NCT01137825|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
743778|NCT01137825|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
743779|NCT01137825|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
743780|NCT01137825|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
743781|NCT01137825|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
743782|NCT01137825|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
743783|NCT01137825|stage I mantle cell lymphoma|stage i mantle cell lymphoma
743784|NCT01137825|stage I marginal zone lymphoma|stage i marginal zone lymphoma
743785|NCT01137825|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
743786|NCT01137825|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
743787|NCT01137825|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
743788|NCT01137825|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
743789|NCT01137825|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
743790|NCT01137825|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
743791|NCT01137825|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
743792|NCT01137825|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
743793|NCT01137825|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
743794|NCT01137825|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
743795|NCT01137825|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
743796|NCT01137825|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
743797|NCT01137825|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
743798|NCT01137825|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
743799|NCT01137825|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
743800|NCT01137825|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
743801|NCT01137825|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
743802|NCT01137825|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
743803|NCT01137825|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
743804|NCT01137825|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
743805|NCT01137825|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
743806|NCT01137825|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
743807|NCT01137825|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
743808|NCT01137825|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
743809|NCT01137825|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
743810|NCT01137825|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
743811|NCT01137825|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
743812|NCT01137825|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
743813|NCT01137825|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
743814|NCT01137825|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
743815|NCT01137825|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
743816|NCT01137825|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
743817|NCT01137825|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
743818|NCT01137825|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
743819|NCT01137825|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
743820|NCT01137825|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
743821|NCT01137825|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
743822|NCT01137825|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
743823|NCT01137825|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
743824|NCT01137825|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
743825|NCT01137825|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
743826|NCT01137825|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
743827|NCT01137825|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
743828|NCT01137825|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
743829|NCT01137825|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
743830|NCT01137825|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
743831|NCT01137825|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
743832|NCT01137825|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
743833|NCT01137825|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
743834|NCT01137825|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
743835|NCT01137825|intraocular lymphoma|intraocular lymphoma
743836|NCT01137825|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
743837|NCT01137825|chronic eosinophilic leukemia|chronic eosinophilic leukemia
743838|NCT01137825|chronic neutrophilic leukemia|chronic neutrophilic leukemia
743839|NCT01137825|primary myelofibrosis|primary myelofibrosis
743840|NCT01137825|essential thrombocythemia|essential thrombocythemia
743841|NCT01137825|polycythemia vera|polycythemia vera
743842|NCT01137825|extramedullary plasmacytoma|extramedullary plasmacytoma
743843|NCT01137825|isolated plasmacytoma of bone|isolated plasmacytoma of bone
743844|NCT01137825|stage I multiple myeloma|stage i multiple myeloma
743845|NCT01137825|stage II multiple myeloma|stage ii multiple myeloma
743846|NCT01137825|stage III multiple myeloma|stage iii multiple myeloma
743847|NCT01137825|primary systemic amyloidosis|primary systemic amyloidosis
743848|NCT01137825|refractory multiple myeloma|refractory multiple myeloma
743849|NCT01137825|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
743850|NCT01137825|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
743851|NCT01137825|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
743852|NCT01137825|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
743853|NCT01137864|Emergency wards|emergency wards
743854|NCT01137864|Hospitalization|hospitalization
743855|NCT01137864|Adults|adults
743856|NCT01137864|Antimicrobial therapy|antimicrobial therapy
743857|NCT01137890|cocaine|cocaine
743858|NCT01137890|addiction|addiction
743859|NCT01137890|drug dependence|drug dependence
743860|NCT01137890|anticonvulsant|anticonvulsant
743861|NCT01137890|zonisamide|zonisamide
743862|NCT01137890|drug self-administration|drug self-administration
743863|NCT01137890|nicotine withdrawal|nicotine withdrawal
743864|NCT01137890|neurocognition|neurocognition
743865|NCT01137903|Diabetic foot|diabetic foot
743866|NCT01137903|Osteomyelitis|osteomyelitis
743867|NCT01137903|Diabetic foot ulcers|diabetic foot ulcers
743868|NCT01137903|Foot infections|foot infections
743869|NCT01137929|Vesicoureteral reflux|vesicoureteral reflux
743870|NCT01137929|Kidney|kidney
743871|NCT01137929|Renal Scar|renal scar
743872|NCT01137929|Urinary tract infection|urinary tract infection
743873|NCT01137942|helicobacter pylori|helicobacter pylori
743874|NCT01137942|eradication failure|eradication failure
743875|NCT01137955|Gastrointestinal Symptom Rating Scale (GSRS)|gastrointestinal symptom rating scale (gsrs)
743876|NCT01137955|Poorly responsive|poorly responsive
743877|NCT01137955|Refractory|refractory
743878|NCT01137955|Small intestine bacterial overgrowth|small intestine bacterial overgrowth
743879|NCT01137955|Breath test|breath test
743880|NCT01137968|imetelstat|imetelstat
743881|NCT01137968|imetelstat sodium|imetelstat sodium
743882|NCT01137968|GRN163L|grn163l
743883|NCT01137968|telomerase inhibitor|telomerase inhibitor
743884|NCT01137968|telomerase inhibition|telomerase inhibition
743885|NCT01137968|maintenance therapy|maintenance therapy
743886|NCT01137968|non-small cell lung cancer|non-small cell lung cancer
743887|NCT01137968|relapsed non-small cell lung cancer|relapsed non-small cell lung cancer
743888|NCT01137968|advanced non-small cell lung cancer|advanced non-small cell lung cancer
743889|NCT01137968|NSCLC, cancer stem cells|nsclc, cancer stem cells
743890|NCT01137968|Bevacizumab|bevacizumab
745994|NCT01146730|Depression|depression
743891|NCT01137968|post induction chemotherapy|post induction chemotherapy
743892|NCT01137981|Combivir (Zidovudine+Lamivudine)|combivir (zidovudine+lamivudine)
743893|NCT01137981|Antiretrovirals|antiretrovirals
743894|NCT01137981|ARV|arv
743895|NCT01137981|HAART|haart
743896|NCT01137981|Maraviroc|maraviroc
743897|NCT01137981|Delavirdine|delavirdine
743898|NCT01137981|Lamivudine|lamivudine
743899|NCT01137981|Antiretroviral Pregnancy Registry|antiretroviral pregnancy registry
743900|NCT01137981|Fosamprenavir|fosamprenavir
743901|NCT01137981|APR|apr
743902|NCT01137981|Zidovudine|zidovudine
743903|NCT01137981|pregnancy registry|pregnancy registry
743904|NCT01137981|Amprenavir|amprenavir
743905|NCT01137981|HIV|hiv
743906|NCT01137981|Trizivir (Abacavir+Lamivudine+Zidovudine)|trizivir (abacavir+lamivudine+zidovudine)
743907|NCT01137981|Epzicom (Abacavir+Lamivudine)|epzicom (abacavir+lamivudine)
743908|NCT01137994|ErbB2|erbb2
743909|NCT01137994|Trastuzumab|trastuzumab
743910|NCT01137994|p95HER2|p95her2
743911|NCT01137994|Metastatic Breast Cancer|metastatic breast cancer
743912|NCT01137994|HER2|her2
743913|NCT01137994|Lapatinib|lapatinib
743914|NCT01138007|Bupropion|bupropion
743915|NCT01138007|323U66 Sustained Release (SR)|323u66 sustained release (sr)
743916|NCT01138007|MDD (Major Depressive Disorder)|mdd (major depressive disorder)
743917|NCT01138007|IVRS HAM-D|ivrs ham-d
743918|NCT01138007|IDS-SR|ids-sr
743919|NCT01138007|MADRS|madrs
743920|NCT01138020|Rehabilitation Outcome|rehabilitation outcome
743921|NCT01138020|Cognitive treatment|cognitive treatment
743922|NCT01138020|TBI|tbi
743923|NCT01138033|pharmacodynamics|pharmacodynamics
743924|NCT01138033|cancer|cancer
743925|NCT01138033|focal adhesion kinase inhibitor|focal adhesion kinase inhibitor
743926|NCT01138033|pharmacokinetics|pharmacokinetics
743927|NCT01138033|solid tumors|solid tumors
743928|NCT01138033|Phase 1|phase 1
743929|NCT01138046|advanced/metastatic breast cancer|advanced/metastatic breast cancer
743930|NCT01138046|lapatinib|lapatinib
743931|NCT01138046|ErbB2|erbb2
743932|NCT01138046|ErbB2-overexpressing|erbb2-overexpressing
743933|NCT01138046|pharmacokinetics|pharmacokinetics
743934|NCT01138046|dual kinase inhibitor|dual kinase inhibitor
743935|NCT01138046|HER-2/neu|her-2/neu
743936|NCT01138046|EGFR|egfr
743937|NCT01138046|ErbB1|erbb1
743938|NCT01138059|Acute ischemic stroke with unclear onset time|acute ischemic stroke with unclear onset time
743939|NCT01138072|GSK2248761, atorvastatin, rosuvastatin, simvastatin, drug interaction, pharmacokinetics|gsk2248761, atorvastatin, rosuvastatin, simvastatin, drug interaction, pharmacokinetics
743940|NCT01138085|Triple negative breast cancer|triple negative breast cancer
743941|NCT01138085|BRAF wild-type melanoma|braf wild-type melanoma
743942|NCT01138085|Solid tumors|solid tumors
743943|NCT01138085|Endometrial Cancer|endometrial cancer
743944|NCT01138085|Oncology|oncology
743945|NCT01138085|GSK2141795|gsk2141795
743946|NCT01138085|AKT Inhibitor|akt inhibitor
743947|NCT01138085|GSK1120212|gsk1120212
743948|NCT01138098|Persistence|persistence
743949|NCT01138098|challenge dose|challenge dose
743950|NCT01138098|Engerix-B|engerix-b
743951|NCT01138098|immune response|immune response
743952|NCT01138111|Florbetaben|florbetaben
743953|NCT01138111|Amyloid beta-protein|amyloid beta-protein
743954|NCT01138111|MCI|mci
743955|NCT01138111|Alzheimer's disease|alzheimer's disease
743956|NCT01138124|renal cell carcinoma|renal cell carcinoma
743957|NCT01138124|epidemiology|epidemiology
743958|NCT01138124|pancreatic cancer|pancreatic cancer
743959|NCT01138124|renal cancer|renal cancer
743960|NCT01138124|renal pelvis cancer|renal pelvis cancer
743961|NCT01138124|GPRD|gprd
743962|NCT01138124|case-control|case-control
743963|NCT01138124|Gapabentin|gapabentin
743964|NCT01138137|ovarian cancer|ovarian cancer
743965|NCT01138137|epithelial ovarian cancer|epithelial ovarian cancer
743966|NCT01138137|peritoneal cancer|peritoneal cancer
743967|NCT01138150|migraine, headache, sumatriptan, naproxen sodium|migraine, headache, sumatriptan, naproxen sodium
743968|NCT01138163|NSCLC|nsclc
743969|NCT01138163|second-line|second-line
743970|NCT01138163|lung cancer|lung cancer
743971|NCT01138163|non small cell lung cancer|non small cell lung cancer
743972|NCT01138163|bavituximab|bavituximab
744430|NCT01133561|psoriasis|psoriasis
743973|NCT01138163|monoclonal antibody|monoclonal antibody
744525|NCT01140009|Vaccine|vaccine
743974|NCT01138176|Neonatal encephalopathy|neonatal encephalopathy
743975|NCT01138176|Therapeutic hypothermia|therapeutic hypothermia
743976|NCT01138176|Phase changing material|phase changing material
743977|NCT01138176|MR imaging|mr imaging
743978|NCT01138189|Wavefront-guided LASIK.|wavefront-guided lasik.
743979|NCT01138189|Wavefront-optimized LASIK.|wavefront-optimized lasik.
743980|NCT01138189|Custom LASIK|custom lasik
743981|NCT01138202|pharmacokinetics|pharmacokinetics
743982|NCT01138202|safety|safety
743983|NCT01138202|efficacy|efficacy
743984|NCT01138202|Lopinavir/ritonavir|lopinavir/ritonavir
743985|NCT01138202|HIV/TB|hiv/tb
743986|NCT01138202|rifampicin containing anti-tuberculosis therapy|rifampicin containing anti-tuberculosis therapy
744066|NCT01138449|Infant mortality|infant mortality
744067|NCT01138462|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
743987|NCT01138202|Pharmacokinetics and safety of Lopinavir/ritonavir with rifampicin containing anti-tuberculosis therapy|pharmacokinetics and safety of lopinavir/ritonavir with rifampicin containing anti-tuberculosis therapy
743988|NCT01138215|varicella-zoster virus vaccine|varicella-zoster virus vaccine
743989|NCT01138215|varicella-zoster virus antibody|varicella-zoster virus antibody
743990|NCT01138215|immunogenicity|immunogenicity
743991|NCT01138215|safety and efficacy|safety and efficacy
743992|NCT01138215|HIV-infected children|hiv-infected children
743993|NCT01138215|Assess protective VZV Antibody|assess protective vzv antibody
743994|NCT01138215|Adverse events from VZV vaccine|adverse events from vzv vaccine
743995|NCT01138228|intravenous cannulation|intravenous cannulation
743996|NCT01138228|vein identification|vein identification
743997|NCT01138228|vascular identification|vascular identification
743998|NCT01138228|vein cannulation|vein cannulation
743999|NCT01138241|HIV|hiv
744000|NCT01138241|Chronic kidney disease|chronic kidney disease
744001|NCT01138241|Glomerular Filtration Rate (GFR)|glomerular filtration rate (gfr)
744002|NCT01138241|Tenofovir|tenofovir
744003|NCT01138241|Serum creatinine (sCr)|serum creatinine (scr)
744004|NCT01138241|24 hr urine creatinine clearance|24 hr urine creatinine clearance
744005|NCT01138241|Serum Cystatin C[40]|serum cystatin c[40]
744006|NCT01138241|Modification of Diet in Renal Disease (MDRD)|modification of diet in renal disease (mdrd)
744007|NCT01138241|Cockcroft Gault Equation|cockcroft gault equation
744008|NCT01138241|Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)|chronic kidney disease epidemiology collaboration (ckd-epi)
744009|NCT01138241|99mTc-diethylenetriaminepentaacetic acid (Tc-99m DTPA) scan|99mtc-diethylenetriaminepentaacetic acid (tc-99m dtpa) scan
744010|NCT01138241|Validate which renal function assessments can accurately detect GFR and assess the effect of TDF concentration on renal function|validate which renal function assessments can accurately detect gfr and assess the effect of tdf concentration on renal function
744011|NCT01138254|flow,echocardiography,far infrared therapy,nitric oxide|flow,echocardiography,far infrared therapy,nitric oxide
744012|NCT01138267|pharmacogenomics|pharmacogenomics
744013|NCT01138267|ATV|atv
744014|NCT01138267|EFV|efv
744015|NCT01138267|pharmacogenomics of ATV and EFV|pharmacogenomics of atv and efv
744016|NCT01138280|biofilm formation|biofilm formation
744017|NCT01138280|proinflammatory cytokines|proinflammatory cytokines
744018|NCT01138280|high sensitive c reactive protein|high sensitive c reactive protein
744019|NCT01138280|cardiovascular events|cardiovascular events
744020|NCT01138280|overall mortality|overall mortality
744021|NCT01138280|hemodialysis|hemodialysis
744022|NCT01138293|differences between patients´ self-assessment and objective perception of physical activity and eating habits|differences between patients´ self-assessment and objective perception of physical activity and eating habits
744023|NCT01138306|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
744024|NCT01138319|adult acute myeloid leukemia|adult acute myeloid leukemia
744025|NCT01138319|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
744026|NCT01138332|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
744027|NCT01138345|cancer survivor|cancer survivor
744028|NCT01138345|stage I breast cancer|stage i breast cancer
744029|NCT01138345|stage II breast cancer|stage ii breast cancer
744030|NCT01138345|stage IIIA breast cancer|stage iiia breast cancer
744031|NCT01138345|stage IIIB breast cancer|stage iiib breast cancer
744032|NCT01138345|stage IIIC breast cancer|stage iiic breast cancer
744033|NCT01138358|dyspnea|dyspnea
744034|NCT01138358|lung metastases|lung metastases
744035|NCT01138358|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
744036|NCT01138358|recurrent small cell lung cancer|recurrent small cell lung cancer
752066|NCT01171651|JX-594|jx-594
744037|NCT01138358|extensive stage small cell lung cancer|extensive stage small cell lung cancer
744038|NCT01138358|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
744039|NCT01138358|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
744040|NCT01138358|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
744041|NCT01138371|LDL apheresis|ldl apheresis
744042|NCT01138371|Familial hypercholesterolemia|familial hypercholesterolemia
744043|NCT01138371|Inflammatory markers|inflammatory markers
744044|NCT01138371|Hyperlipidemia|hyperlipidemia
744045|NCT01138371|Cardiovascular disease|cardiovascular disease
744046|NCT01138384|Breast Cancer|breast cancer
744047|NCT01138397|Influenza|influenza
744048|NCT01138397|Influenza vaccine|influenza vaccine
744049|NCT01138397|Influenza virus|influenza virus
744050|NCT01138397|Intradermal|intradermal
744520|NCT01134016|Lung cancer|lung cancer
744051|NCT01138410|Immunotherapy|immunotherapy
744053|NCT01138410|Gene therapy|gene therapy
744054|NCT01138410|DNA plasmid|dna plasmid
744055|NCT01138410|Cancer vaccine|cancer vaccine
744056|NCT01138410|Electroporation|electroporation
744057|NCT01138410|CTL response|ctl response
744058|NCT01138423|Hypertension|hypertension
744059|NCT01138423|Metabolic Syndrome X|metabolic syndrome x
744060|NCT01138423|Obesity|obesity
744061|NCT01138423|Adiposity|adiposity
744062|NCT01138423|Clinical trial|clinical trial
744063|NCT01138436|Venous Leg Ulcers, VLU|venous leg ulcers, vlu
744064|NCT01138449|Vitamin A|vitamin a
744065|NCT01138449|Neonatal mortality|neonatal mortality
744166|NCT01138904|irinotecan|irinotecan
744068|NCT01138462|Decolonisation|decolonisation
744069|NCT01138462|Nursing homes|nursing homes
744070|NCT01138462|Infection Control|infection control
744071|NCT01138475|PTH|pth
744072|NCT01138475|Gastric bypass surgery|gastric bypass surgery
744073|NCT01138475|vitamin D|vitamin d
744074|NCT01138475|paricalcitol|paricalcitol
744075|NCT01138527|multi-parametric MRI approach|multi-parametric mri approach
744076|NCT01138540|VAP|vap
744077|NCT01138553|biomarker|biomarker
744078|NCT01138553|breast cancer|breast cancer
744079|NCT01138553|antiprogesterone|antiprogesterone
744080|NCT01138566|community-onset urinary tract infections caused by Enterobacteriaceae|community-onset urinary tract infections caused by enterobacteriaceae
744081|NCT01138579|FBTA05|fbta05
744082|NCT01138579|CD20|cd20
744083|NCT01138579|CLL|cll
744084|NCT01138579|NHL|nhl
744085|NCT01138579|DLI|dli
744086|NCT01138579|allogeneic transplantation|allogeneic transplantation
744087|NCT01138579|CD20 positive chronic lymphocytic leukemia (CLL)|cd20 positive chronic lymphocytic leukemia (cll)
744088|NCT01138579|low and high grade non-Hodgkin´s lymphoma (NHL) after allogeneic stem cell transplantation with active disease|low and high grade non-hodgkin´s lymphoma (nhl) after allogeneic stem cell transplantation with active disease
744089|NCT01138605|TMC114|tmc114
744090|NCT01138605|TMC114-TiDP29-C232|tmc114-tidp29-c232
744091|NCT01138605|TMC114-C232|tmc114-c232
744092|NCT01138605|Darunavir|darunavir
744093|NCT01138605|PREZISTA|prezista
744094|NCT01138618|Clozapine|clozapine
744095|NCT01138618|hematological monitoring|hematological monitoring
744096|NCT01138618|CHEMPAQ|chempaq
744097|NCT01138618|Granulocytes|granulocytes
744098|NCT01138618|WBC|wbc
744099|NCT01138631|IVF, Infertility, embryo selection, embryoscope, time-lapse|ivf, infertility, embryo selection, embryoscope, time-lapse
744100|NCT01138644|Atrial Fibrillation|atrial fibrillation
744101|NCT01138644|Atrial Flutter|atrial flutter
744102|NCT01138657|inflammation of uvea|inflammation of uvea
744103|NCT01138683|Acute decompensated heart failure|acute decompensated heart failure
744104|NCT01138683|ultrafiltration|ultrafiltration
744105|NCT01138683|diuretics|diuretics
744106|NCT01138683|AKI|aki
744107|NCT01138696|ACL|acl
744108|NCT01138722|early stage non-small cell lung cancer|early stage non-small cell lung cancer
744109|NCT01138722|hypofractionated radiation therapy|hypofractionated radiation therapy
744110|NCT01138748|inoperable early stage non-small cell lung cancer|inoperable early stage non-small cell lung cancer
744111|NCT01138748|radiation therapy|radiation therapy
744112|NCT01138761|pediatric atopic dermatitis|pediatric atopic dermatitis
744113|NCT01138761|EASI|easi
744114|NCT01138761|REALM-SF|realm-sf
744115|NCT01138761|nurse instruction|nurse instruction
744116|NCT01138761|health literacy|health literacy
744117|NCT01138774|Obesity|obesity
744118|NCT01138774|Calorie restriction|calorie restriction
744119|NCT01138774|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
744120|NCT01138774|Lipoic acid|lipoic acid
744121|NCT01138774|Weight loss|weight loss
744122|NCT01138774|Insulin sensitivity|insulin sensitivity
744123|NCT01138774|Lipid metabolism|lipid metabolism
744124|NCT01138774|Adipokines|adipokines
744125|NCT01138774|Inflammation|inflammation
744126|NCT01138774|Oxidative stress|oxidative stress
744127|NCT01138774|Adipose tissue gene profile|adipose tissue gene profile
744128|NCT01138774|Metabolomic profile|metabolomic profile
744129|NCT01138813|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
744130|NCT01138813|lactate editing|lactate editing
744131|NCT01138813|metabolite content|metabolite content
746564|NCT01149044|PCI|pci
744132|NCT01138813|glioma|glioma
744133|NCT01138826|biological availability|biological availability
744134|NCT01138826|bioavailability|bioavailability
744135|NCT01138826|amlodipine|amlodipine
744136|NCT01138826|orally disintegrating tablet|orally disintegrating tablet
744137|NCT01138826|ODT|odt
744138|NCT01138826|tablets|tablets
744139|NCT01138839|HELLP 1|hellp 1
744140|NCT01138839|Dexamethasone|dexamethasone
744141|NCT01138839|Clinical trial|clinical trial
744142|NCT01138852|post-cesarean infections|post-cesarean infections
744143|NCT01138852|ampicillin-sulbactam|ampicillin-sulbactam
744144|NCT01138852|cefuroxime|cefuroxime
744145|NCT01138852|cesarean|cesarean
744146|NCT01138865|Obstructive sleep apnea|obstructive sleep apnea
744147|NCT01138865|Cytokine levels|cytokine levels
744148|NCT01138865|Insulin resistance|insulin resistance
744149|NCT01138865|Hypertension|hypertension
744150|NCT01138865|Dyslipidemia|dyslipidemia
744151|NCT01138865|Albumin-creatinine ratio|albumin-creatinine ratio
744152|NCT01138865|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
744154|NCT01138878|testing|testing
744155|NCT01138878|non traditional settings|non traditional settings
744156|NCT01138878|acceptability|acceptability
744157|NCT01138878|feasibility|feasibility
744158|NCT01138891|Breast implants|breast implants
744159|NCT01138891|capsular contraction|capsular contraction
744160|NCT01138891|sonication|sonication
744161|NCT01138891|biofilm|biofilm
744162|NCT01138891|Complications|complications
744163|NCT01138891|surgery|surgery
744164|NCT01138904|gastric cancer|gastric cancer
744165|NCT01138904|oxaliplatin|oxaliplatin
744167|NCT01138904|sequential treatment|sequential treatment
744168|NCT01138930|Polycystic Ovary Syndrome|polycystic ovary syndrome
744169|NCT01138930|Obesity|obesity
744170|NCT01138943|Chlorhexidine mouthrinse|chlorhexidine mouthrinse
744171|NCT01138943|Plaque control|plaque control
744172|NCT01138956|Visceral leishmaniasis|visceral leishmaniasis
744173|NCT01138956|N-acetylcysteine|n-acetylcysteine
744174|NCT01138956|Antimony|antimony
744175|NCT01138956|Immune response|immune response
744176|NCT01138969|proton pump inhibitor|proton pump inhibitor
744177|NCT01138969|peptic ulcer|peptic ulcer
744178|NCT01138969|clopidogrel|clopidogrel
744179|NCT01138969|prevention|prevention
744180|NCT01138982|Youth mentoring|youth mentoring
744181|NCT01138982|Effectiveness|effectiveness
744182|NCT01138982|Sweden|sweden
744183|NCT01138982|low-risk youth|low-risk youth
744184|NCT01138995|Poststroke/CVA hemiparesis|poststroke/cva hemiparesis
744185|NCT01138995|Drop Foot|drop foot
744186|NCT01138995|Gait Disorders, Neurological|gait disorders, neurological
744187|NCT01138995|Gait, Drop foot|gait, drop foot
744188|NCT01139021|Children|children
744189|NCT01139021|Meningococcal disease|meningococcal disease
744190|NCT01139021|Prevention|prevention
744191|NCT01139021|Vaccination|vaccination
744192|NCT01139060|chronic or recurrent depression|chronic or recurrent depression
744193|NCT01139073|Halitosis|halitosis
744194|NCT01139086|chronic heart failure|chronic heart failure
744195|NCT01139086|isokinetic test|isokinetic test
744196|NCT01139086|near-infrared spectroscopy|near-infrared spectroscopy
744197|NCT01139086|laser Doppler flowmetry|laser doppler flowmetry
744198|NCT01139086|endothelial function|endothelial function
744199|NCT01139112|Necrotizing Fasciitis, Klebsiella Pneumoniae|necrotizing fasciitis, klebsiella pneumoniae
744200|NCT01139138|Colorectal Cancer|colorectal cancer
744201|NCT01139138|Colorectal Carcinoma|colorectal carcinoma
744202|NCT01139138|Colorectal Tumors|colorectal tumors
744203|NCT01139138|Neoplasms, Colorectal|neoplasms, colorectal
744204|NCT01139151|Advanced Hematologic Malignancies|advanced hematologic malignancies
744205|NCT01139151|4'-Thio-araC|4'-thio-arac
744206|NCT01139151|Thiarabine|thiarabine
744207|NCT01139151|4'-thio-â-D-arabinofuranosylcytosine|4'-thio-â-d-arabinofuranosylcytosine
744208|NCT01139151|deoxycytidine nucleoside analog|deoxycytidine nucleoside analog
744209|NCT01139151|poor-risk myelodysplasia|poor-risk myelodysplasia
744210|NCT01139151|MDS|mds
744211|NCT01139151|refractory anemia|refractory anemia
744212|NCT01139151|Excess blasts|excess blasts
744213|NCT01139151|RAEB-1|raeb-1
744214|NCT01139151|RAEB-2|raeb-2
746015|NCT01146847|ICU|icu
744215|NCT01139151|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
744216|NCT01139151|CMML|cmml
744217|NCT01139151|Relapsed/refractory leukemia|relapsed/refractory leukemia
744218|NCT01139151|Acute non-lymphocytic leukemia|acute non-lymphocytic leukemia
744219|NCT01139151|AML|aml
744220|NCT01139151|Acute lymphocytic leukemia|acute lymphocytic leukemia
744221|NCT01139151|ALL|all
744222|NCT01139151|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
744223|NCT01139151|CLL|cll
744224|NCT01139151|Chronic myelogenous leukemia|chronic myelogenous leukemia
744225|NCT01139151|CML|cml
744226|NCT01139151|blast crisis|blast crisis
744227|NCT01139164|high-risk hematological malignancies|high-risk hematological malignancies
744228|NCT01139177|Peripheral vascular disease - SFA and popliteal arteries.|peripheral vascular disease - sfa and popliteal arteries.
752067|NCT01171651|Jennerex|jennerex
744229|NCT01139190|NSAID-induced gastroduodenal ulcerations or erosion|nsaid-induced gastroduodenal ulcerations or erosion
744230|NCT01139203|HBV recurrence|hbv recurrence
744231|NCT01139203|entecavir|entecavir
744232|NCT01139216|Digestive system diseases|digestive system diseases
744233|NCT01139216|Gastrointestinal diseases|gastrointestinal diseases
744234|NCT01139216|Intestinal diseases|intestinal diseases
744235|NCT01139216|Colonic inertia|colonic inertia
744236|NCT01139229|Esophagogastrostomy|esophagogastrostomy
744237|NCT01139229|Circular everted anastomosis|circular everted anastomosis
744238|NCT01139229|Side-side anastomosis|side-side anastomosis
744239|NCT01139229|Randomized clinical trial|randomized clinical trial
744240|NCT01139242|CRC screening status|crc screening status
744241|NCT01139242|physical activity level|physical activity level
744242|NCT01139242|fruit and vegetable consumption|fruit and vegetable consumption
744243|NCT01139242|Early Detection of Cancer|early detection of cancer
744244|NCT01139242|Colorectal Cancer (CRC) screening status|colorectal cancer (crc) screening status
744245|NCT01139268|embryo viability|embryo viability
744246|NCT01139281|Ear protection|ear protection
744247|NCT01139281|Ginkgo Biloba Extract|ginkgo biloba extract
744248|NCT01139281|Distortion-product otoacoustic emission|distortion-product otoacoustic emission
744249|NCT01139281|Ototoxicity|ototoxicity
744250|NCT01139281|Cisplatin|cisplatin
744251|NCT01139294|cardiac output|cardiac output
744252|NCT01139294|dehydration|dehydration
744253|NCT01139294|pediatrics|pediatrics
744254|NCT01139307|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
744255|NCT01139307|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
744256|NCT01139307|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
744257|NCT01139307|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
744258|NCT01139307|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
744259|NCT01139307|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
744260|NCT01139320|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
744261|NCT01139333|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
744262|NCT01139346|carcinoma|carcinoma
744264|NCT01139346|metastatic|metastatic
744265|NCT01139346|solid tumor|solid tumor
744266|NCT01139359|Lymphoma|lymphoma
744267|NCT01139359|Darinaparsin|darinaparsin
744268|NCT01139359|CHOP|chop
744269|NCT01139359|Frontline|frontline
744270|NCT01139359|PTCL|ptcl
744271|NCT01139359|B-cell|b-cell
744272|NCT01139372|Dry eye, artificial tears|dry eye, artificial tears
744273|NCT01139398|Cholesterol|cholesterol
744274|NCT01139398|LDL-cholesterol|ldl-cholesterol
744275|NCT01139398|Coronary artery disease|coronary artery disease
744276|NCT01139398|Red yeast rice|red yeast rice
744277|NCT01139398|Plants extract|plants extract
744278|NCT01139398|Cholesterol excess.|cholesterol excess.
744279|NCT01139424|surgical leak|surgical leak
744280|NCT01139424|endoscopic suturing|endoscopic suturing
744281|NCT01139424|Anastomotic leakage|anastomotic leakage
744282|NCT01139424|esophageal or gastric resection|esophageal or gastric resection
744283|NCT01139437|Vaccine|vaccine
744284|NCT01139437|HPIV2|hpiv2
744285|NCT01139437|Infants|infants
744286|NCT01139450|Atopic Dermatitis|atopic dermatitis
744287|NCT01139463|antipsychotics|antipsychotics
744288|NCT01139463|lactates|lactates
744289|NCT01139463|side effects|side effects
744290|NCT01139476|Multiple Myeloma|multiple myeloma
744291|NCT01139476|MGUS|mgus
744292|NCT01139476|Leukemia|leukemia
744293|NCT01139476|Biorepository|biorepository
744294|NCT01139489|Procalcitonin|procalcitonin
744295|NCT01139489|antibiotic therapy|antibiotic therapy
744296|NCT01139489|antibiotics|antibiotics
744297|NCT01139489|sepsis|sepsis
744298|NCT01139489|infections|infections
744299|NCT01139489|biomarker|biomarker
744300|NCT01139502|schizophrenia spectrum disorders|schizophrenia spectrum disorders
744301|NCT01139502|work rehabilitation|work rehabilitation
744302|NCT01139502|cognitive therapy|cognitive therapy
744303|NCT01139502|cognitive training|cognitive training
744304|NCT01139502|Adaptation to work|adaptation to work
744305|NCT01139502|Work as a treatment factor|work as a treatment factor
744306|NCT01139515|pharmacokinetic|pharmacokinetic
744307|NCT01139515|eletriptan|eletriptan
744308|NCT01139515|Korean|korean
744309|NCT01139515|crossover|crossover
744310|NCT01139528|Fracture|fracture
744311|NCT01139528|5th metacarpal bone|5th metacarpal bone
744312|NCT01139528|Bouquet pinning|bouquet pinning
744313|NCT01139528|Fractures of the neck of the 5th metacarpal bone|fractures of the neck of the 5th metacarpal bone
744314|NCT01139567|Diabetic Wounds|diabetic wounds
744315|NCT01139567|Hyperbaric Oxygen|hyperbaric oxygen
744316|NCT01139567|Laser Speckle Imaging|laser speckle imaging
744317|NCT01139567|Hyperbaric Oxygenation|hyperbaric oxygenation
744318|NCT01139580|Plaque Psoriasis|plaque psoriasis
744319|NCT01139580|Psoriasis|psoriasis
744320|NCT01139593|IVF|ivf
744321|NCT01139593|ICSI|icsi
744322|NCT01139593|gonadotropin|gonadotropin
744323|NCT01139593|am dose|am dose
744324|NCT01139593|pm dose|pm dose
744325|NCT01139593|pregnancy|pregnancy
744326|NCT01139593|implantation|implantation
744327|NCT01139593|live birth|live birth
744328|NCT01139619|Biopsy Mapping|biopsy mapping
744329|NCT01139619|Non small cell lung cancer|non small cell lung cancer
744330|NCT01139619|NSCLC|nsclc
744331|NCT01139619|Lung cancer diagnosis|lung cancer diagnosis
744332|NCT01139619|Retrospective|retrospective
744333|NCT01139619|Inoperable Non Small Cell Lung Cancer|inoperable non small cell lung cancer
744334|NCT01139632|NAFLD|nafld
744335|NCT01139632|lP-pla2|lp-pla2
744336|NCT01139632|Coronary Arthery Disease|coronary arthery disease
744337|NCT01139645|Calcium|calcium
744338|NCT01139645|bone|bone
744339|NCT01139645|metabolism|metabolism
744340|NCT01139645|Proton Pump Inhibitors|proton pump inhibitors
744341|NCT01139645|Rabeprazole|rabeprazole
744342|NCT01139645|Esomeprazole|esomeprazole
744343|NCT01139645|Lanzoprazole|lanzoprazole
744344|NCT01139645|Vitamin D|vitamin d
744345|NCT01139645|bone and bones|bone and bones
744346|NCT01139671|Remifentanil|remifentanil
744347|NCT01139671|Sufentanil|sufentanil
744348|NCT01139671|Surgical removal of three to four wisdom teeth|surgical removal of three to four wisdom teeth
744349|NCT01139671|General anaesthesia|general anaesthesia
744350|NCT01139671|Ambulatory oral surgery|ambulatory oral surgery
744351|NCT01139671|Target Controlled Infusion (TCI)|target controlled infusion (tci)
744352|NCT01139671|Opioid induced hyperalgesia|opioid induced hyperalgesia
744353|NCT01139671|Postoperative nausea and vomiting|postoperative nausea and vomiting
744354|NCT01139671|Postoperative Morphine consumption|postoperative morphine consumption
744355|NCT01139671|Under General anaesthesia|under general anaesthesia
744356|NCT01139671|In Ambulatory surgery|in ambulatory surgery
744357|NCT01139684|Exercise test|exercise test
744358|NCT01139697|Heart failure|heart failure
744359|NCT01139697|Cortisol|cortisol
744360|NCT01139697|Testosterone|testosterone
744361|NCT01139710|SARCOIDOSIS|sarcoidosis
744362|NCT01139710|PULMONARY HYPERTENSION|pulmonary hypertension
744363|NCT01139710|outpatients clinic at Meir medical center|outpatients clinic at meir medical center
744364|NCT01139736|Irritable bowel syndrome|irritable bowel syndrome
744365|NCT01139736|IBS|ibs
744366|NCT01139736|probiotics|probiotics
744367|NCT01139736|rectal sensitivity|rectal sensitivity
744368|NCT01139736|gut flora|gut flora
744369|NCT01139736|gut bacteria|gut bacteria
744370|NCT01139749|oral isotretinoin|oral isotretinoin
744371|NCT01139749|sebaceous secretion|sebaceous secretion
744372|NCT01139749|seborrhea|seborrhea
744373|NCT01139749|seborrheic dermatitis|seborrheic dermatitis
744374|NCT01139749|quality of life|quality of life
744375|NCT01139749|Malassezia|malassezia
744376|NCT01139762|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
744377|NCT01139762|Enlarged Prostate|enlarged prostate
744378|NCT01139775|solid tumors|solid tumors
744379|NCT01139775|Mesothelioma|mesothelioma
744380|NCT01139775|Carcinoma|carcinoma
744381|NCT01139788|Cancer|cancer
744382|NCT01139801|Cervical Ripening|cervical ripening
744383|NCT01139801|Rate of Cesearean Section|rate of cesearean section
744384|NCT01139814|atrial flutter|atrial flutter
744385|NCT01139814|AVNRT|avnrt
744386|NCT01139814|right sided accessory pathway|right sided accessory pathway
744387|NCT01139814|ventricular tachycardia|ventricular tachycardia
744388|NCT01139814|Patients who have one or more standard indications for a right-sided diagnostic electrophysiology procedure.|patients who have one or more standard indications for a right-sided diagnostic electrophysiology procedure.
744389|NCT01139827|atherosclerosis|atherosclerosis
744390|NCT01139827|inflammation|inflammation
744391|NCT01139827|hsCRP|hscrp
744392|NCT01139827|Framingham risk score|framingham risk score
744393|NCT01139827|positron emission tomography|positron emission tomography
744394|NCT01139827|inflammation in FDG-PET|inflammation in fdg-pet
744395|NCT01139840|vitamin D2|vitamin d2
744396|NCT01139840|vitamin D3|vitamin d3
744397|NCT01139840|ergocalciferol|ergocalciferol
744398|NCT01139840|cholecalciferol|cholecalciferol
744399|NCT01139840|vitamin D status|vitamin d status
744400|NCT01139840|To determine relative potency of vitamins D2 and D3 under conditions of continuous administration|to determine relative potency of vitamins d2 and d3 under conditions of continuous administration
744401|NCT01139840|To determine change in vitamin D content of subcutaneous fat after 12 weeks' administration|to determine change in vitamin d content of subcutaneous fat after 12 weeks' administration
744402|NCT01139853|pyloric stenosis|pyloric stenosis
744403|NCT01139853|nasogastric tube|nasogastric tube
744404|NCT01139853|pyloromyotomy|pyloromyotomy
744405|NCT01139866|Long-term Safety|long-term safety
744406|NCT01139866|Shoulder Surgery|shoulder surgery
744407|NCT01139866|bupivacaine|bupivacaine
744408|NCT01139879|Pressure Ulcer treatment Mattresses|pressure ulcer treatment mattresses
744409|NCT01139879|Home Care|home care
744410|NCT01139879|Extended Care|extended care
744411|NCT01139879|Wound measurements|wound measurements
744412|NCT01139892|Unruptured aneurysm|unruptured aneurysm
744413|NCT01139892|endovascular treatment|endovascular treatment
744414|NCT01139892|surgical treatment|surgical treatment
744415|NCT01139892|randomized|randomized
744416|NCT01139892|intracranial aneurysm|intracranial aneurysm
744417|NCT01139905|Lopinavir/ritonavir|lopinavir/ritonavir
744418|NCT01139905|pharmacokinetic|pharmacokinetic
744419|NCT01139905|low dose|low dose
744420|NCT01139905|HIV-infected children|hiv-infected children
744421|NCT01139905|pharmacokinetics of low-dose lopinavir/ritonavir in HIV-1 infected Thai children.|pharmacokinetics of low-dose lopinavir/ritonavir in hiv-1 infected thai children.
744422|NCT01139918|psoriatic arthritis|psoriatic arthritis
744423|NCT01139918|psoriasis|psoriasis
744424|NCT01139918|Quality of life|quality of life
744425|NCT01139931|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
744426|NCT01139944|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
744427|NCT01139944|stage I non-small cell lung cancer|stage i non-small cell lung cancer
744428|NCT01139944|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
744429|NCT01139944|squamous cell lung cancer|squamous cell lung cancer
744431|NCT01133561|insulin resistance|insulin resistance
744432|NCT01133561|metabolic syndrome|metabolic syndrome
744433|NCT01133561|pioglitazone|pioglitazone
744434|NCT01133561|randomized control trial|randomized control trial
744435|NCT01133574|Healthy volunteers|healthy volunteers
744437|NCT01133574|Phase I|phase i
744438|NCT01133574|SRDT|srdt
744439|NCT01133587|Schizophrenia|schizophrenia
744440|NCT01133587|bipolar disorder|bipolar disorder
744441|NCT01133587|Long term care|long term care
744442|NCT01133587|patient admission|patient admission
744443|NCT01133652|Venipuncture|venipuncture
744444|NCT01133652|Randomized Controlled Trial|randomized controlled trial
744445|NCT01133652|Intravenous access|intravenous access
744446|NCT01133652|Children|children
744447|NCT01133652|Pediatric Emergency Department|pediatric emergency department
744448|NCT01133652|Peripheral intravenous catheterization|peripheral intravenous catheterization
744449|NCT01133652|Catheterization, Peripheral Phlebotomy|catheterization, peripheral phlebotomy
744450|NCT01133665|Head and Neck, Squamous Cell|head and neck, squamous cell
744451|NCT01133665|Recurrent or metastatic squamous cell or undifferentiated carcinoma of the head and neck that is not amenable to curative therapy|recurrent or metastatic squamous cell or undifferentiated carcinoma of the head and neck that is not amenable to curative therapy
744452|NCT01133678|Squamous Cell Carcinoma|squamous cell carcinoma
744453|NCT01133691|gastric emptying|gastric emptying
744454|NCT01133691|children|children
744455|NCT01133691|gastric fluid volume|gastric fluid volume
744456|NCT01133691|preoperative fasting|preoperative fasting
744457|NCT01133704|asymptomatic metastatic hormone-refractory prostate cancer|asymptomatic metastatic hormone-refractory prostate cancer
744458|NCT01133717|Sleep Apnea|sleep apnea
744459|NCT01133717|Cerebrovascular Reactivity|cerebrovascular reactivity
744460|NCT01133730|supraclavicular nerve block|supraclavicular nerve block
744461|NCT01133730|regional anesthesia|regional anesthesia
744462|NCT01133730|transversalis fascia plane block|transversalis fascia plane block
744463|NCT01133730|ultrasound guided|ultrasound guided
744464|NCT01133730|opioid consumption|opioid consumption
744465|NCT01133730|iliac crest bone harvest|iliac crest bone harvest
744466|NCT01133730|hand surgery|hand surgery
744467|NCT01133730|wrist surgery|wrist surgery
744468|NCT01133730|Upper limb surgery combined with iliac crest bone harvest.|upper limb surgery combined with iliac crest bone harvest.
744469|NCT01133743|Lenalidomide|lenalidomide
744470|NCT01133743|Dexamethasone|dexamethasone
744471|NCT01133743|Immunomodulatory Drugs(IMiD™)|immunomodulatory drugs(imid™)
744472|NCT01133743|Thalidomide analogues|thalidomide analogues
744473|NCT01133769|Clavicle fracture|clavicle fracture
744474|NCT01133769|fixation|fixation
744475|NCT01133769|polytrauma|polytrauma
744476|NCT01133769|Clavicle fracture patients with chest injury|clavicle fracture patients with chest injury
744477|NCT01133795|cirrhosis|cirrhosis
744478|NCT01133795|renal failure|renal failure
744479|NCT01133795|hepatorenal syndrome|hepatorenal syndrome
744480|NCT01133795|albumine|albumine
744481|NCT01133795|midodrine|midodrine
744482|NCT01133808|diarrhea|diarrhea
744483|NCT01133808|childhood|childhood
744484|NCT01133808|rotavirus|rotavirus
744485|NCT01133808|vaccine|vaccine
744486|NCT01133808|Nicaragua|nicaragua
744487|NCT01133821|Bipolar II Disorder|bipolar ii disorder
744488|NCT01133821|Bipolar II Depression|bipolar ii depression
744489|NCT01133821|Psychotherapy|psychotherapy
744490|NCT01133821|IPSRT|ipsrt
744491|NCT01133821|Seroquel|seroquel
744492|NCT01133821|Quetiapine|quetiapine
744493|NCT01133821|Placebo|placebo
744494|NCT01133821|Sugar Pill|sugar pill
744495|NCT01133834|meningococcal disease|meningococcal disease
744496|NCT01133834|cytokines|cytokines
744497|NCT01133860|inherited thrombocytopenia|inherited thrombocytopenia
744498|NCT01133860|MYH9 mutations|myh9 mutations
744499|NCT01133860|eltrombopag|eltrombopag
744500|NCT01133899|strength, anaerobic performance, recovery, ergogenic|strength, anaerobic performance, recovery, ergogenic
744501|NCT01133912|Patients with HER2 Positive Operable Breast Cancer|patients with her2 positive operable breast cancer
744502|NCT01133925|Coronary Artery Disease|coronary artery disease
744503|NCT01133925|Percutaneous Coronary Intervention|percutaneous coronary intervention
744504|NCT01133925|Drug Eluting Stent|drug eluting stent
744505|NCT01133925|Optical Coherence Tomography|optical coherence tomography
744506|NCT01133925|Thrombosi|thrombosi
744507|NCT01133925|Long lesions in native vessels requiring overlap|long lesions in native vessels requiring overlap
744508|NCT01133951|Helicobacter Infections|helicobacter infections
744509|NCT01133951|Helicobacter pylori|helicobacter pylori
744510|NCT01133951|Drug Therapy|drug therapy
744511|NCT01133951|Precancerous Conditions|precancerous conditions
744512|NCT01133951|Stomach Neoplasms|stomach neoplasms
744513|NCT01133951|Incidence|incidence
744514|NCT01133964|Dairy proteins|dairy proteins
744515|NCT01133964|Appetite regulation|appetite regulation
744516|NCT01133964|Energy expenditure|energy expenditure
744517|NCT01134003|Gynecare Prolift|gynecare prolift
744518|NCT01134003|Pelvic organ prolapse|pelvic organ prolapse
744519|NCT01134003|forming a large database of women who have recieve Gynecare prolift system|forming a large database of women who have recieve gynecare prolift system
744521|NCT01134016|NSCLC|nsclc
744522|NCT01134029|obesity|obesity
744523|NCT01134029|weight management and cardiovascular risk factors|weight management and cardiovascular risk factors
744524|NCT01139983|osteosarcoma|osteosarcoma
744526|NCT01140009|Seasonal Influenza vaccine|seasonal influenza vaccine
744527|NCT01140009|Influenza vaccine|influenza vaccine
744528|NCT01140009|Vaccine safety|vaccine safety
744529|NCT01140009|Vaccine immunogenicity|vaccine immunogenicity
744530|NCT01140009|Fluviral 2010/11|fluviral 2010/11
744531|NCT01140022|Chlamydia, Screening, young women, kiosk, computer module|chlamydia, screening, young women, kiosk, computer module
744532|NCT01140035|Insulin|insulin
744533|NCT01140035|Deceased donors|deceased donors
744534|NCT01140035|Renal Allograft Function|renal allograft function
744535|NCT01140035|Transplanted Allograft Outcomes|transplanted allograft outcomes
744536|NCT01140048|Asthma|asthma
744736|NCT01141101|Neonatal|neonatal
744537|NCT01140074|acute diarrhoea, children|acute diarrhoea, children
744538|NCT01140087|Face Transplant|face transplant
744539|NCT01140087|Composite Tissue Allograft|composite tissue allograft
744540|NCT01140087|Facial Allotransplantation|facial allotransplantation
744541|NCT01140113|hemoconcentration|hemoconcentration
744542|NCT01140113|ultrafiltration|ultrafiltration
744543|NCT01140113|coronary artery disease|coronary artery disease
744544|NCT01140126|HIV-1, CD4, antibody, immunotherapy|hiv-1, cd4, antibody, immunotherapy
744545|NCT01140152|intestinal transplantation|intestinal transplantation
744546|NCT01140152|rejection|rejection
744547|NCT01140152|proteomics|proteomics
744548|NCT01140152|innate immunity|innate immunity
744549|NCT01140178|Photodynamic Therapy|photodynamic therapy
744550|NCT01140178|Oral dysplasia|oral dysplasia
744551|NCT01140178|oral cavity carcinoma|oral cavity carcinoma
744552|NCT01140178|oropharynx carcinoma.|oropharynx carcinoma.
744553|NCT01140191|leishmaniasis|leishmaniasis
744554|NCT01140191|cutaneous|cutaneous
744555|NCT01140191|WR 279,396|wr 279,396
744556|NCT01140191|paromomycin|paromomycin
744557|NCT01140191|gentamicin|gentamicin
744558|NCT01140191|pharmacokinetics|pharmacokinetics
744559|NCT01140191|safety|safety
744560|NCT01140191|efficacy|efficacy
744561|NCT01140191|military|military
744562|NCT01140204|stent|stent
744563|NCT01140204|contrast media|contrast media
744564|NCT01140204|paclitaxel|paclitaxel
744565|NCT01140204|stent implantation|stent implantation
744566|NCT01140217|contraception|contraception
744567|NCT01140217|pregnancy|pregnancy
744568|NCT01140230|rotator cuff tear|rotator cuff tear
744569|NCT01140230|rotator cuff repair|rotator cuff repair
744570|NCT01140230|age|age
744571|NCT01140230|timing to surgery|timing to surgery
744572|NCT01140243|fat formulation|fat formulation
744573|NCT01140256|Zinc|zinc
744574|NCT01140256|SGA|sga
744575|NCT01140256|AGA|aga
744576|NCT01140256|stable isotope|stable isotope
744577|NCT01140269|Burn|burn
744578|NCT01140269|Sepsis|sepsis
744579|NCT01140269|Infection|infection
744580|NCT01140282|cancer survivor|cancer survivor
744581|NCT01140295|Preparation|preparation
744582|NCT01140295|Pediatric|pediatric
744583|NCT01140295|Colonoscopy|colonoscopy
744584|NCT01140308|Statin Myopathy|statin myopathy
744585|NCT01140308|CoEnzyme Q10|coenzyme q10
744586|NCT01140308|CoQ10|coq10
744587|NCT01140308|Statin Myalgia|statin myalgia
744588|NCT01140438|Latent autoimmune diabetes|latent autoimmune diabetes
744589|NCT01140438|adults|adults
744590|NCT01140438|Beta cell rest|beta cell rest
744591|NCT01140438|Insulin secretion|insulin secretion
744592|NCT01140464|Adolescents|adolescents
744593|NCT01140490|Hemodialysis|hemodialysis
744594|NCT01140490|Sub-total Parathyroidectomy|sub-total parathyroidectomy
744595|NCT01140516|Antenatal|antenatal
744596|NCT01140529|Dexmedetomidine|dexmedetomidine
744597|NCT01140542|Diabetes Mellitus Type 2|diabetes mellitus type 2
744598|NCT01140542|Roflumilast|roflumilast
744599|NCT01140568|glioma|glioma
744600|NCT01140568|PDGFR|pdgfr
744601|NCT01140568|kinase|kinase
744602|NCT01140568|inhibitor|inhibitor
744603|NCT01140568|malignant|malignant
744604|NCT01140568|nilotinib|nilotinib
744605|NCT01140620|NMDA receptor antagonism|nmda receptor antagonism
744606|NCT01140620|cognitive processes|cognitive processes
744607|NCT01140620|healthy volunteers|healthy volunteers
744608|NCT01140620|dopamine antagonist|dopamine antagonist
744609|NCT01140620|schizophrenia|schizophrenia
744611|NCT01140633|pediatric|pediatric
744612|NCT01140633|wireless adherence monitoring|wireless adherence monitoring
744613|NCT01140633|HIV Infections|hiv infections
744614|NCT01140646|Hot flashes, dietary supplements, symptom management|hot flashes, dietary supplements, symptom management
744615|NCT01140659|Hyperhidrosis|hyperhidrosis
744616|NCT01140659|Thoracic sympathectomy|thoracic sympathectomy
744617|NCT01140659|Objective measurement of sweat|objective measurement of sweat
744618|NCT01140672|Healthy volunteers|healthy volunteers
744619|NCT01140672|pharmacokinetics|pharmacokinetics
744620|NCT01140672|safety|safety
744621|NCT01140672|tolerability|tolerability
744622|NCT01140672|multiple dosing|multiple dosing
744623|NCT01140672|Diabetic Nephropathies|diabetic nephropathies
744624|NCT01140685|mucus-stimulated (induced sputum)|mucus-stimulated (induced sputum)
744625|NCT01140685|lung disease (asthma, COPD, ILD and OLD)|lung disease (asthma, copd, ild and old)
744626|NCT01140685|HO-1 (heme oxigenase-1)|ho-1 (heme oxigenase-1)
745492|NCT01144689|smoking|smoking
744627|NCT01140685|oxidative stress|oxidative stress
744628|NCT01140685|CO (carbon monoxide)|co (carbon monoxide)
744629|NCT01140685|The oxidative stress in lung diseases|the oxidative stress in lung diseases
744630|NCT01140724|pain|pain
744631|NCT01140724|genes|genes
744632|NCT01140724|morphine|morphine
744633|NCT01140724|respiratory depression|respiratory depression
744634|NCT01140724|tonsillectomy|tonsillectomy
744635|NCT01140724|children|children
744636|NCT01140724|Opioid adverse effects|opioid adverse effects
744637|NCT01140724|Pharmacogenetics of morphine|pharmacogenetics of morphine
744638|NCT01140724|Pharmacokinetics of morphine|pharmacokinetics of morphine
744639|NCT01140724|Personalizing analgesia|personalizing analgesia
744640|NCT01140737|advanced soft tissue sarcoma|advanced soft tissue sarcoma
744641|NCT01140750|Heart Rate Variability|heart rate variability
744642|NCT01140750|Temperature Curve Complexity|temperature curve complexity
744643|NCT01140750|Autonomic Dysfunction|autonomic dysfunction
744644|NCT01140750|Prolonged Mechanical Ventilation|prolonged mechanical ventilation
744645|NCT01140750|Failure to Wean|failure to wean
744646|NCT01140763|metastasis|metastasis
744647|NCT01140776|metastasis|metastasis
744648|NCT01140776|molecular pathology|molecular pathology
744649|NCT01140802|First degree relatives|first degree relatives
744650|NCT01140802|Crohn's disease|crohn's disease
744651|NCT01140802|Ulcerative colitis|ulcerative colitis
744652|NCT01140802|Healthy control|healthy control
744653|NCT01140815|Total Knee Arthroplasty|total knee arthroplasty
744654|NCT01140815|Bicompartmental Knee Arthroplasty|bicompartmental knee arthroplasty
744655|NCT01140828|Arthritis|arthritis
744656|NCT01140828|Bone pain|bone pain
744657|NCT01140828|dyspepsia|dyspepsia
744658|NCT01140841|Dyskinesia|dyskinesia
744659|NCT01140854|hypertension|hypertension
744660|NCT01140854|hypotension|hypotension
744661|NCT01140854|cognitive|cognitive
744662|NCT01140854|neurocognitive|neurocognitive
744663|NCT01140854|cognitive dysfunction|cognitive dysfunction
744664|NCT01140854|postoperative cognitive dysfunction (POCD)|postoperative cognitive dysfunction (pocd)
744665|NCT01140854|neuropsychometric|neuropsychometric
744666|NCT01140880|Methamphetamine|methamphetamine
744667|NCT01140880|Amphetamine|amphetamine
744668|NCT01140880|Cocaine|cocaine
744669|NCT01140880|HIV|hiv
744670|NCT01140880|Post-exposure prophylaxis|post-exposure prophylaxis
744671|NCT01140880|HIV seronegativity|hiv seronegativity
744672|NCT01140893|Type 2 diabetes|type 2 diabetes
744673|NCT01140893|CSII|csii
744674|NCT01140893|Exenatide|exenatide
744675|NCT01140893|Double Blind Placebo Controlled Study|double blind placebo controlled study
744676|NCT01140906|Major depressive disorder|major depressive disorder
744677|NCT01140906|Placebo-controlled|placebo-controlled
744678|NCT01140906|Active reference|active reference
744679|NCT01140906|Multicenter study|multicenter study
744680|NCT01140906|Randomised study|randomised study
744681|NCT01140906|Acute treatment|acute treatment
744682|NCT01140932|Retina|retina
744683|NCT01140932|Electroretinography|electroretinography
744684|NCT01140932|Diabetes Mellitus|diabetes mellitus
744685|NCT01140932|Glucose Intolerance|glucose intolerance
744686|NCT01140932|Physiology|physiology
744687|NCT01140958|lung cancer|lung cancer
744688|NCT01140958|pharmacoeconomics|pharmacoeconomics
744689|NCT01140958|new agents|new agents
744690|NCT01140971|Balloon dilatation,|balloon dilatation,
744691|NCT01140971|misoprostol,|misoprostol,
744692|NCT01140971|cervical ripening,|cervical ripening,
744693|NCT01140971|obstetric labor,|obstetric labor,
744694|NCT01140971|labor induced.|labor induced.
744695|NCT01140984|acute graft versus host disease|acute graft versus host disease
744696|NCT01140984|intra arterial steroid infusion|intra arterial steroid infusion
744697|NCT01140984|steroid resistant acute hepatic graft versus host disease|steroid resistant acute hepatic graft versus host disease
744698|NCT01140997|HCV|hcv
744699|NCT01140997|CHC|chc
744700|NCT01140997|Hepatitis C, Chronic|hepatitis c, chronic
744701|NCT01140997|Liver Diseases|liver diseases
744702|NCT01140997|Hepatitis, Chronic|hepatitis, chronic
744703|NCT01140997|Hepatitis, Viral, Human|hepatitis, viral, human
744704|NCT01140997|Hepadnaviridae Infections|hepadnaviridae infections
744705|NCT01140997|Antiviral Agents|antiviral agents
744706|NCT01140997|Virus Diseases|virus diseases
744707|NCT01140997|Peginterferon alfa|peginterferon alfa
744708|NCT01141010|Linguistic|linguistic
744709|NCT01141010|Stress response|stress response
744710|NCT01141010|Corticosteroid|corticosteroid
744711|NCT01141010|Cesarean section|cesarean section
744712|NCT01141010|Anxiety|anxiety
744713|NCT01141010|Depression|depression
744714|NCT01141010|Maternal psychosis|maternal psychosis
744715|NCT01141023|Parkinson|parkinson
744716|NCT01141023|Bio-markers|bio-markers
744717|NCT01141023|Neurodegenerative disorder|neurodegenerative disorder
744718|NCT01141023|Imaging|imaging
744719|NCT01141023|Prodromal|prodromal
744720|NCT01141036|Propofol|propofol
744721|NCT01141036|Midazolam|midazolam
744722|NCT01141036|sedation|sedation
744723|NCT01141036|cirrhosis|cirrhosis
744724|NCT01141036|endoscopy|endoscopy
744725|NCT01141036|recovery time|recovery time
745493|NCT01144689|stress|stress
744726|NCT01141036|efficacy and safety of sedation|efficacy and safety of sedation
744727|NCT01141036|patient satisfaction|patient satisfaction
744728|NCT01141036|return to baseline function|return to baseline function
744729|NCT01141036|saturation of oxygen|saturation of oxygen
744730|NCT01141049|Alcohol Withdrawal|alcohol withdrawal
744731|NCT01141049|Reducing Alcohol Consumption|reducing alcohol consumption
744732|NCT01141049|Promoting abstinence in alcohol-dependent patients|promoting abstinence in alcohol-dependent patients
744733|NCT01141049|Gabapentin|gabapentin
744734|NCT01141062|Uterine Fibroids|uterine fibroids
744735|NCT01141101|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
744737|NCT01141101|Vertical transmission|vertical transmission
744738|NCT01141101|Horizontal transmission|horizontal transmission
744739|NCT01141101|MRSA colonization in enrolled infants|mrsa colonization in enrolled infants
744740|NCT01141101|MRSA colonization obtained from maternal source|mrsa colonization obtained from maternal source
744741|NCT01141101|MRSA colonization obtained from source other that mother|mrsa colonization obtained from source other that mother
744742|NCT01141114|community health centers|community health centers
744743|NCT01141114|colorectal cancer screening|colorectal cancer screening
744744|NCT01141114|urban health|urban health
744745|NCT01141127|tranexamic acid in pediatric surgery|tranexamic acid in pediatric surgery
744746|NCT01141127|fibrinolysis and paediatric cardiac surgery|fibrinolysis and paediatric cardiac surgery
744747|NCT01141153|atrial fibrillation|atrial fibrillation
744748|NCT01141153|Coronary Stent implantation|coronary stent implantation
744749|NCT01141153|Low-moderate risk of stroke|low-moderate risk of stroke
744750|NCT01141153|dual antiplatelet therapy|dual antiplatelet therapy
744751|NCT01141153|anticoagulation|anticoagulation
744752|NCT01141166|ELDERLY|elderly
744753|NCT01141166|NUTRITION|nutrition
744754|NCT01141192|vitamin D status|vitamin d status
744755|NCT01141192|25-OH D|25-oh d
744756|NCT01141192|ionized calcium|ionized calcium
744757|NCT01141192|fasting glucose|fasting glucose
744758|NCT01141192|hemoglobin A1c|hemoglobin a1c
744759|NCT01141192|fasting insulin|fasting insulin
744760|NCT01141192|glucose metabolism|glucose metabolism
744761|NCT01141192|HOMA index|homa index
744762|NCT01141192|blood lipids|blood lipids
744763|NCT01141192|type 2 diabetes|type 2 diabetes
744764|NCT01141192|PTH|pth
744765|NCT01141192|adiposity|adiposity
744766|NCT01141192|body fat percentage|body fat percentage
744767|NCT01141192|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
744768|NCT01141192|pulse wave velocity|pulse wave velocity
744769|NCT01141192|arterial stiffness|arterial stiffness
744770|NCT01141192|flow-mediated dilation|flow-mediated dilation
744771|NCT01141192|African American|african american
744772|NCT01141192|inflammatory markers|inflammatory markers
744773|NCT01141205|AIDS vaccines|aids vaccines
744774|NCT01141205|HIV-1 vaccine|hiv-1 vaccine
744775|NCT01141205|Therapeutic vaccine|therapeutic vaccine
744776|NCT01141205|Cellular immunity|cellular immunity
744777|NCT01141218|non-small cell lung cancer|non-small cell lung cancer
744778|NCT01141231|hypopharyngeal cancer|hypopharyngeal cancer
744779|NCT01141231|laryngeal cancer|laryngeal cancer
744780|NCT01141231|lip and oral cavity cancer|lip and oral cavity cancer
744781|NCT01141231|nasopharyngeal cancer|nasopharyngeal cancer
744782|NCT01141231|oropharyngeal cancer|oropharyngeal cancer
744783|NCT01141231|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
744784|NCT01141231|salivary gland cancer|salivary gland cancer
744785|NCT01141231|radiation toxicity|radiation toxicity
744786|NCT01141231|xerostomia|xerostomia
744787|NCT01141231|long-term effects of cancer treatment|long-term effects of cancer treatment
744788|NCT01141231|oral complications of radiation therapy|oral complications of radiation therapy
744789|NCT01141257|Angiocal®; PRS-050-PEG40; Solid tumor; Phase I|angiocal®; prs-050-peg40; solid tumor; phase i
744790|NCT01141270|recombinant human follicle stimulating hormone|recombinant human follicle stimulating hormone
744791|NCT01141270|pharmacokinetics|pharmacokinetics
747262|NCT01152710|phase II study|phase ii study
747263|NCT01152723|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
747265|NCT01152749|Smoking Cessation|smoking cessation
744792|NCT01141270|bioequivalence|bioequivalence
744793|NCT01141283|Osteoarthritis|osteoarthritis
744794|NCT01141283|Opioid|opioid
744795|NCT01141283|Transdermal|transdermal
744796|NCT01141309|Everolimus|everolimus
744797|NCT01141309|Sorafenib|sorafenib
744798|NCT01141309|Thyroid|thyroid
744799|NCT01141309|10-060|10-060
744800|NCT01141322|drug-induced liver injury|drug-induced liver injury
744801|NCT01141322|hepatitis, toxic|hepatitis, toxic
744802|NCT01141322|ursodeoxycholic acid|ursodeoxycholic acid
744803|NCT01141335|shrinkage|shrinkage
744804|NCT01141335|postoperative pain and discomfort|postoperative pain and discomfort
744805|NCT01141361|Claudication|claudication
744806|NCT01141361|Artery|artery
744807|NCT01141361|Ambulatory technique|ambulatory technique
744808|NCT01141361|GPS|gps
744809|NCT01141374|Stress|stress
744810|NCT01141426|depression|depression
744811|NCT01141426|treatment-resistance|treatment-resistance
744812|NCT01141426|psychodynamic psychotherapy|psychodynamic psychotherapy
744813|NCT01141426|Treatment refractory depression|treatment refractory depression
744814|NCT01141439|Primary care|primary care
744815|NCT01141439|Asthma management|asthma management
744816|NCT01141439|Inhaled corticosteroids|inhaled corticosteroids
744817|NCT01141439|Beclomethasone dipropionate|beclomethasone dipropionate
744818|NCT01141439|Fluticasone propionate|fluticasone propionate
744819|NCT01141439|Metred dose inhaler|metred dose inhaler
744820|NCT01141439|Extra-fine hydrofluoroalkane|extra-fine hydrofluoroalkane
744821|NCT01141439|Chlorofluorocarbon|chlorofluorocarbon
744822|NCT01141452|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
744823|NCT01141452|inhaled corticosteroid|inhaled corticosteroid
744824|NCT01141452|increase|increase
744826|NCT01141452|exacerbations|exacerbations
744827|NCT01141452|treatment success|treatment success
744828|NCT01141465|Primary care|primary care
744829|NCT01141465|Asthma management|asthma management
744830|NCT01141465|Combined therapy|combined therapy
744831|NCT01141465|Real-world|real-world
744832|NCT01141465|Effectiveness|effectiveness
744833|NCT01141465|Control|control
744834|NCT01141465|Exacerbations|exacerbations
744835|NCT01141478|Carcinoma, Hepatocellular|carcinoma, hepatocellular
744836|NCT01141478|Proton Beam Radiotherapy|proton beam radiotherapy
744837|NCT01141478|Sorafenib|sorafenib
744838|NCT01141491|Sarcoma|sarcoma
744839|NCT01141491|Metastatic|metastatic
744840|NCT01141491|Vaccine|vaccine
744841|NCT01141491|Adjuvant|adjuvant
744842|NCT01141504|Supplemental ATP|supplemental atp
744843|NCT01141504|Muscle Work Performed|muscle work performed
744844|NCT01141504|Muscle Fatigue|muscle fatigue
744845|NCT01141517|adolescent quit-smoking program.|adolescent quit-smoking program.
744846|NCT01141530|Identify novel genes and predict putative proteins in breast cancer.|identify novel genes and predict putative proteins in breast cancer.
744847|NCT01141530|Find biomarkers that can be used for early detection, diagnosis, and prognosis.|find biomarkers that can be used for early detection, diagnosis, and prognosis.
744848|NCT01141543|Plerixafor injection|plerixafor injection
744849|NCT01141556|selenium|selenium
744850|NCT01141556|clinical outcome|clinical outcome
744851|NCT01141556|heart surgery|heart surgery
744852|NCT01141621|HS|hs
744853|NCT01141621|congenital hemolytic anemia|congenital hemolytic anemia
744854|NCT01141621|splenectomy|splenectomy
744855|NCT01141621|quality of life|quality of life
744856|NCT01141634|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
744857|NCT01141634|Attention Deficit Disorder|attention deficit disorder
744858|NCT01141634|ADHD|adhd
744859|NCT01141634|ADD|add
744860|NCT01141634|Homeopathy|homeopathy
744861|NCT01141647|Adult|adult
744862|NCT01141647|Depression|depression
744863|NCT01141647|Supported Employment|supported employment
744864|NCT01141647|Health Service|health service
744865|NCT01141647|Humans|humans
744866|NCT01141647|Outcomes|outcomes
744867|NCT01141647|Quality of Life|quality of life
744868|NCT01141647|Veterans/rh (rehabilitation)|veterans/rh (rehabilitation)
744869|NCT01141647|Workplace|workplace
744870|NCT01141647|Spinal Cord Injuries|spinal cord injuries
744871|NCT01141673|FLT3-ITD|flt3-itd
744872|NCT01141673|acute myeloid leukemia|acute myeloid leukemia
744873|NCT01141673|FLT3|flt3
744874|NCT01141673|D835|d835
744875|NCT01141686|lung cancer|lung cancer
744876|NCT01141699|women health behaviors|women health behaviors
744877|NCT01141712|HIV|hiv
744878|NCT01141712|B-cell Lymphoma|b-cell lymphoma
744879|NCT01141712|Burkitt's Lymphoma|burkitt's lymphoma
744880|NCT01141712|Follicular Lymphoma|follicular lymphoma
744881|NCT01141712|Hodgkin's Lymphoma|hodgkin's lymphoma
744882|NCT01141738|stroke|stroke
744883|NCT01141738|caregiver|caregiver
744884|NCT01141738|depression|depression
744885|NCT01141738|mediators|mediators
744886|NCT01141738|problem-solving|problem-solving
744887|NCT01141751|Multiple sclerosis|multiple sclerosis
744888|NCT01141751|Expanded Disability Status Scale|expanded disability status scale
744889|NCT01141751|Multiple Sclerosis, Relapsing-Remitting; Rebif|multiple sclerosis, relapsing-remitting; rebif
744890|NCT01141751|Beta-1, interferon|beta-1, interferon
744891|NCT01141764|pediatrics|pediatrics
744892|NCT01141764|Epilepsy|epilepsy
744893|NCT01141764|Deep Brain Stimulation|deep brain stimulation
744894|NCT01141764|Positron Emission Tomography|positron emission tomography
744895|NCT01141777|Spirulina platensis|spirulina platensis
744896|NCT01141777|Insulin resistance|insulin resistance
744897|NCT01141777|HIV/AIDS|hiv/aids
744898|NCT01141777|HAART|haart
744899|NCT01141777|Soya beans|soya beans
744900|NCT01141790|Glasgow Coma Scale|glasgow coma scale
744901|NCT01141790|Glasgow Outcome Scale|glasgow outcome scale
744902|NCT01141790|Ethics|ethics
744903|NCT01141803|Apple|apple
744904|NCT01141803|Apple pomace|apple pomace
744905|NCT01141803|Metabolomics|metabolomics
744906|NCT01141803|Gene expression|gene expression
744907|NCT01141803|Lipid metabolism|lipid metabolism
744908|NCT01141803|Prevention|prevention
744909|NCT01141803|Antiinflammatory effect|antiinflammatory effect
744910|NCT01141816|renal cell carcinoma|renal cell carcinoma
744911|NCT01141816|radiofrequency ablation|radiofrequency ablation
745202|NCT01136993|Telestroke|telestroke
744912|NCT01141816|contrast enhanced ultrasound|contrast enhanced ultrasound
744913|NCT01141816|monitoring|monitoring
744914|NCT01141816|follow up|follow up
744915|NCT01141829|NADPH oxidase|nadph oxidase
744916|NCT01141842|lung cancer|lung cancer
744917|NCT01141842|exhalation analysis|exhalation analysis
744918|NCT01141842|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
744919|NCT01141842|cancer screening test|cancer screening test
744920|NCT01141855|Cardiovascular Diseases|cardiovascular diseases
744921|NCT01141855|Peripheral Vascular Diseases|peripheral vascular diseases
744922|NCT01141855|Cerebrovascular Stroke|cerebrovascular stroke
744923|NCT01141855|Lung Diseases, Obstructive|lung diseases, obstructive
744925|NCT01141855|Tobacco Use Disorder|tobacco use disorder
744926|NCT01141855|Smoking|smoking
744927|NCT01141855|Smoking Cessation|smoking cessation
744928|NCT01141868|insomnia|insomnia
744929|NCT01141868|breast cancer survivor|breast cancer survivor
744930|NCT01141868|Internet intervention|internet intervention
744931|NCT01141881|Tissue Plasminogen activator,|tissue plasminogen activator,
744932|NCT01141881|Clinically significant macular edema,|clinically significant macular edema,
744933|NCT01141881|Refractory Diabetic macular edema ,|refractory diabetic macular edema ,
744934|NCT01141881|posterior vitreous detachment|posterior vitreous detachment
744935|NCT01141894|Proximal Femoral Fracture|proximal femoral fracture
744936|NCT01141907|heart failure|heart failure
744937|NCT01141907|self care|self care
744938|NCT01141907|decision support|decision support
744939|NCT01141907|telemonitoring|telemonitoring
744940|NCT01141907|navigator|navigator
744941|NCT01141920|treatment retention|treatment retention
744942|NCT01141920|methadone maintenance|methadone maintenance
744943|NCT01141920|treatment induction|treatment induction
744944|NCT01141920|Retention in methadone maintenance treatment|retention in methadone maintenance treatment
744945|NCT01141933|Creating meaning|creating meaning
744946|NCT01141933|Therapy|therapy
744947|NCT01141933|Cancer|cancer
744948|NCT01141933|Oncology|oncology
744949|NCT01141933|Existential|existential
744950|NCT01141933|Spirituality|spirituality
744951|NCT01141933|Quality of life|quality of life
744952|NCT01141933|QOL|qol
744953|NCT01141933|Psycho-oncology|psycho-oncology
744954|NCT01141933|French-canadian|french-canadian
744955|NCT01141933|Cognitive therapy|cognitive therapy
744956|NCT01141933|Existentialism|existentialism
744957|NCT01141946|lung cancer|lung cancer
744958|NCT01141946|pleural effusion|pleural effusion
744959|NCT01141946|post-op care|post-op care
744960|NCT01141946|diaphragmatic ultrasound|diaphragmatic ultrasound
744961|NCT01141959|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
744962|NCT01141959|cyclophosphamide|cyclophosphamide
744963|NCT01141959|fludarabine|fludarabine
744964|NCT01141959|mycophenolate mofetil|mycophenolate mofetil
744965|NCT01141959|mycophenolic acid|mycophenolic acid
744966|NCT01141959|biomarkers|biomarkers
744967|NCT01141972|Vitamin D|vitamin d
744968|NCT01141972|Obesity|obesity
744969|NCT01141972|Menopause|menopause
744970|NCT01141972|Hot Flashes|hot flashes
744971|NCT01141985|cataract|cataract
744972|NCT01141985|cornea|cornea
744973|NCT01141985|keratoplasty|keratoplasty
744974|NCT01142011|Waldenstroms|waldenstroms
744975|NCT01142011|Belimumab|belimumab
744976|NCT01142011|anti Blys|anti blys
744977|NCT01142011|monoclonal antibody|monoclonal antibody
744978|NCT01142024|contrast medium induced nephropathy|contrast medium induced nephropathy
744979|NCT01142024|polymorphism of oxidative stress genes|polymorphism of oxidative stress genes
744980|NCT01142024|antioxidant prevention|antioxidant prevention
744981|NCT01142037|Healthy volunteer|healthy volunteer
744982|NCT01142050|stem cells;|stem cells;
744983|NCT01142050|diabetes mellitus;|diabetes mellitus;
744984|NCT01142050|treatment.|treatment.
744985|NCT01142063|Neratinib|neratinib
744986|NCT01142076|adiposity|adiposity
744987|NCT01142089|traveler's|traveler's
744988|NCT01142089|diarrhea|diarrhea
744989|NCT01142102|Bladder|bladder
744990|NCT01142102|Radiotherapy|radiotherapy
744991|NCT01142102|Online|online
744992|NCT01142102|Adaptive|adaptive
744993|NCT01142154|Cockayne Syndrome|cockayne syndrome
744994|NCT01142154|Ageing|ageing
744995|NCT01142154|pediatrics|pediatrics
744996|NCT01142154|Pharmacokinetics|pharmacokinetics
744997|NCT01142154|Prodarsan|prodarsan
744998|NCT01142154|Dwarfism|dwarfism
744999|NCT01142154|Genetic disease, inborn|genetic disease, inborn
745000|NCT01142154|DNA Repair-Deficiency Disorders|dna repair-deficiency disorders
745001|NCT01142154|Tolerability|tolerability
745002|NCT01142154|Safety|safety
745003|NCT01142167|Ultra-thin colonoscope|ultra-thin colonoscope
745004|NCT01142180|Bleeding peptic ulcer|bleeding peptic ulcer
745005|NCT01142180|Active bleeding|active bleeding
745006|NCT01142180|Trans-arterial angiographic embolization|trans-arterial angiographic embolization
745007|NCT01142193|Epilepsy|epilepsy
745008|NCT01142193|partial onset seizure|partial onset seizure
745009|NCT01142193|adjunctive therapy|adjunctive therapy
745010|NCT01142206|Obesity|obesity
745011|NCT01142206|Weight Loss|weight loss
745012|NCT01142206|Leisure-time activities|leisure-time activities
745013|NCT01142206|Physical Activity|physical activity
745014|NCT01142206|Television watching|television watching
745015|NCT01142206|Dietary Intake|dietary intake
745016|NCT01142206|Energy|energy
745017|NCT01142206|Behavioral|behavioral
745018|NCT01142206|Healthy Eating|healthy eating
745019|NCT01142219|sickle cell disease|sickle cell disease
745020|NCT01142219|L-arginine|l-arginine
745021|NCT01142219|hemolysis|hemolysis
745022|NCT01142219|nitric oxide|nitric oxide
745023|NCT01142219|pulmonary arterial hypertension|pulmonary arterial hypertension
745024|NCT01142232|autologous stem cell transplantation|autologous stem cell transplantation
745025|NCT01142245|ulcer bleeding|ulcer bleeding
745026|NCT01142245|endoscopic therapy|endoscopic therapy
745027|NCT01142258|Sleep Disturbances|sleep disturbances
745028|NCT01142258|Alzheimer disease|alzheimer disease
745029|NCT01142258|Insomnia|insomnia
745030|NCT01142258|Trazodone|trazodone
745031|NCT01142258|Treatment|treatment
745032|NCT01142271|Distal gastrectomy|distal gastrectomy
745033|NCT01142271|Reconstruction|reconstruction
745034|NCT01142271|Reflux|reflux
745035|NCT01142271|subtotal gastrectomy|subtotal gastrectomy
745036|NCT01142284|Biomarker|biomarker
745037|NCT01142284|Endothelial Function|endothelial function
745038|NCT01142284|Peripheral Artery Disease|peripheral artery disease
745039|NCT01142284|Coronary Artery Disease|coronary artery disease
745040|NCT01142284|Flow Mediated Dilation|flow mediated dilation
745041|NCT01142284|Cilostazol|cilostazol
745042|NCT01142284|Probucol|probucol
745043|NCT01142297|dental implant|dental implant
745044|NCT01142297|implant stabilization|implant stabilization
745045|NCT01142297|type 2 diabetes|type 2 diabetes
745046|NCT01142297|glycated hemoglobin 8.0-12.0%|glycated hemoglobin 8.0-12.0%
745047|NCT01142336|Alzheimer's Disease|alzheimer's disease
745048|NCT01142336|Prevention|prevention
745049|NCT01142336|Spinal Fluid|spinal fluid
745050|NCT01142336|Biomarkers|biomarkers
745051|NCT01142336|Simvastatin|simvastatin
745052|NCT01142349|Arthritis|arthritis
745053|NCT01142349|Group Program|group program
745054|NCT01142349|Pain|pain
745055|NCT01142349|Insomnia|insomnia
745056|NCT01142349|Pain dysfunction and sleep disturbance among older adults with osteoarthritis.|pain dysfunction and sleep disturbance among older adults with osteoarthritis.
745057|NCT01142362|H5N1|h5n1
745058|NCT01142362|Avian Influenza|avian influenza
745059|NCT01142362|DNA Vaccine|dna vaccine
745060|NCT01142362|Intramuscular (IM) Injection|intramuscular (im) injection
745061|NCT01142362|Electroporation|electroporation
745062|NCT01142362|Healthy Adults|healthy adults
745063|NCT01142375|AML|aml
745064|NCT01142414|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
745065|NCT01142414|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
745066|NCT01142414|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
745067|NCT01142414|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
745068|NCT01142414|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
745069|NCT01142414|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
745070|NCT01142414|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
745071|NCT01142414|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
745072|NCT01142414|tongue cancer|tongue cancer
745073|NCT01142453|Multiple sclerosis|multiple sclerosis
745074|NCT01142453|Rebif|rebif
745075|NCT01142453|Interferon|interferon
745076|NCT01142466|Multiple sclerosis|multiple sclerosis
745077|NCT01142466|Expanded Disability Status Scale|expanded disability status scale
745078|NCT01142466|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
745080|NCT01142466|Beta-1, interferon|beta-1, interferon
745081|NCT01142479|Breast Cancer|breast cancer
745082|NCT01142479|Radiotherapy|radiotherapy
745083|NCT01142479|Chinese herbal medicine|chinese herbal medicine
745084|NCT01142479|TPE-1|tpe-1
745085|NCT01142479|Leukopenia|leukopenia
745086|NCT01142492|Interferon beta|interferon beta
745087|NCT01142492|Multiple Sclerosis|multiple sclerosis
745088|NCT01142505|wheeze|wheeze
745089|NCT01142505|preschool|preschool
745090|NCT01142505|leukotriene|leukotriene
745091|NCT01142505|montelukast|montelukast
745092|NCT01142505|5-lipoxygenase|5-lipoxygenase
745093|NCT01142518|Interferon beta-1a|interferon beta-1a
745094|NCT01142518|Multiple Sclerosis|multiple sclerosis
745095|NCT01142544|acute lung injury|acute lung injury
745096|NCT01142544|incidence|incidence
745097|NCT01142544|lung damage|lung damage
745098|NCT01142544|PaO2/FiO2 ratio|pao2/fio2 ratio
745099|NCT01142557|Multiple sclerosis|multiple sclerosis
745100|NCT01142557|Rebif|rebif
745101|NCT01142557|Interferon-beta|interferon-beta
745102|NCT01142570|Mechanical Ventilation|mechanical ventilation
745103|NCT01142583|Multiple sclerosis|multiple sclerosis
745104|NCT01142583|Expanded Disability Status Scale|expanded disability status scale
745105|NCT01142583|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
745106|NCT01142609|Web based videoconferencing|web based videoconferencing
745107|NCT01142609|methadone|methadone
745108|NCT01142609|substance abuse counseling|substance abuse counseling
745109|NCT01142622|Ovarian Cysts|ovarian cysts
745110|NCT01142622|Nebulization|nebulization
745111|NCT01142622|Ropivacaine|ropivacaine
745112|NCT01142635|Electroencephalogram|electroencephalogram
745113|NCT01142635|Electromyogram|electromyogram
745114|NCT01142635|Entropy Index|entropy index
745115|NCT01142635|Bispectral Index|bispectral index
745116|NCT01142635|Neuromuscular blockade; rocuronium|neuromuscular blockade; rocuronium
745117|NCT01142635|Propofol|propofol
745118|NCT01142635|Intubation|intubation
745119|NCT01142648|Electroencephalogram|electroencephalogram
746591|NCT01149161|thyroid|thyroid
745120|NCT01142648|Electromyogram|electromyogram
745121|NCT01142648|Entropy Index|entropy index
745122|NCT01142648|Bispectral Index|bispectral index
745123|NCT01142648|Reversal of neuromuscular blockade|reversal of neuromuscular blockade
745124|NCT01142661|Advanced breast cancer refractory to all commercially available therapies|advanced breast cancer refractory to all commercially available therapies
745125|NCT01142674|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
745126|NCT01142674|Prognosis|prognosis
745127|NCT01142674|Outcome|outcome
745128|NCT01142674|International Cooperation|international cooperation
745129|NCT01142674|Biological Characteristics|biological characteristics
745130|NCT01142674|Heterogeneity|heterogeneity
745131|NCT01142674|Rare Diseases|rare diseases
745132|NCT01142687|Resting energy expenditure (REE)|resting energy expenditure (ree)
745133|NCT01142687|metabolic rate|metabolic rate
745134|NCT01142713|Small Bowel Radiotherapy Dose|small bowel radiotherapy dose
745135|NCT01142713|This is a prospective non-randomized open study to evaluate the impact of patient's positioning and use of belly board in rectal radiotherapy|this is a prospective non-randomized open study to evaluate the impact of patient's positioning and use of belly board in rectal radiotherapy
745136|NCT01142765|Vaccine|vaccine
745137|NCT01142765|Safety|safety
745138|NCT01142765|Immunogenicity|immunogenicity
745139|NCT01142765|Protection|protection
745140|NCT01142765|Sporozoite challenge|sporozoite challenge
745141|NCT01142791|Uterine fibroids|uterine fibroids
745142|NCT01142791|MRgFUS|mrgfus
745143|NCT01142791|ExAblate|exablate
745144|NCT01142791|Focused Ultrasound|focused ultrasound
745145|NCT01142791|Symptomatic uterine fibroids|symptomatic uterine fibroids
745146|NCT01142804|Walking programs|walking programs
745147|NCT01142804|Physical Activity|physical activity
745148|NCT01142804|Behavior Modification|behavior modification
745149|NCT01142804|Social Support|social support
745150|NCT01142817|HIV|hiv
745151|NCT01142817|Women|women
745152|NCT01142817|Menopause|menopause
745153|NCT01142817|Dyslipidemia|dyslipidemia
745154|NCT01142817|Bone Mineral Density|bone mineral density
745155|NCT01142830|Craniotomy|craniotomy
745156|NCT01142830|Pain|pain
745157|NCT01142830|Children|children
745158|NCT01142843|clinical trial|clinical trial
745159|NCT01142843|mouthwash|mouthwash
745160|NCT01142843|green propolis|green propolis
745161|NCT01142843|dental plaque|dental plaque
745162|NCT01142843|gingivitis|gingivitis
745163|NCT01142869|Carcinoma, Squamous Cell|carcinoma, squamous cell
745164|NCT01142869|Erbitux|erbitux
745165|NCT01142869|Neoplasms, Squamous Cell|neoplasms, squamous cell
745166|NCT01142882|adolescent HIV prevention|adolescent hiv prevention
745167|NCT01142882|web-based interventions|web-based interventions
745168|NCT01142882|adolescent substance abuse treatment|adolescent substance abuse treatment
745169|NCT01142882|comparative effectiveness research|comparative effectiveness research
745170|NCT01142882|HIV prevention|hiv prevention
745171|NCT01142882|hepatitis prevention|hepatitis prevention
745172|NCT01142882|STI prevention|sti prevention
745173|NCT01142908|Cardiovascular Disease|cardiovascular disease
745174|NCT01142908|Hypertension|hypertension
745176|NCT01142908|Hyperlipidemia|hyperlipidemia
745177|NCT01142908|Adherence|adherence
745178|NCT01136863|hypertension|hypertension
745179|NCT01136863|felodipine|felodipine
745180|NCT01136863|moderate to high risk patients|moderate to high risk patients
745181|NCT01136889|PFMT|pfmt
745182|NCT01136889|Vaginal pessary|vaginal pessary
745183|NCT01136889|Pelvic Organ Prolapse|pelvic organ prolapse
745184|NCT01136902|Diabetes Mellitus|diabetes mellitus
745185|NCT01136902|Retinal Vessels|retinal vessels
745186|NCT01136902|Physiology|physiology
745187|NCT01136928|Antiretroviral therapy|antiretroviral therapy
745188|NCT01136928|American ginseng|american ginseng
745189|NCT01136928|Efavirenz|efavirenz
745190|NCT01136928|Cytochrome P450 enzymes|cytochrome p450 enzymes
745191|NCT01136928|Complementary and Alternative Medicine|complementary and alternative medicine
745192|NCT01136928|Herbal|herbal
745193|NCT01136928|Pharmacikinetics|pharmacikinetics
745194|NCT01136928|Healthy volunteers|healthy volunteers
745195|NCT01136980|GERD|gerd
745196|NCT01136980|Esophagitis|esophagitis
745197|NCT01136980|Fundoplication|fundoplication
745198|NCT01136980|Anti-reflux surgery|anti-reflux surgery
745199|NCT01136980|PPI dependent|ppi dependent
745200|NCT01136993|Stroke|stroke
745201|NCT01136993|Thrombolysis|thrombolysis
745203|NCT01137006|Melanoma|melanoma
745204|NCT01137006|Phase I|phase i
745205|NCT01137006|antibody|antibody
745206|NCT01137006|melanin|melanin
745207|NCT01137006|tyrosinase related protein 1|tyrosinase related protein 1
745208|NCT01137006|glycoprotein|glycoprotein
745209|NCT01137006|20D7S|20d7s
745210|NCT01137019|Drug-eluting stents|drug-eluting stents
745211|NCT01137019|Tomography, Optical Coherence|tomography, optical coherence
745212|NCT01137032|Psoriasis|psoriasis
745213|NCT01137032|Atopic Dermatitis|atopic dermatitis
745214|NCT01137045|rabies vaccine|rabies vaccine
745215|NCT01137045|vero cells|vero cells
745216|NCT01137045|serology|serology
745217|NCT01137045|safety|safety
745218|NCT01137110|Subarachnoid Hemorrhage|subarachnoid hemorrhage
745219|NCT01137110|Seizure Prophylaxis|seizure prophylaxis
745220|NCT01137110|Levetiracetam|levetiracetam
745221|NCT01137123|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
745222|NCT01137149|Adolescent Depression|adolescent depression
745223|NCT01137149|Treatment of depression in adolescents|treatment of depression in adolescents
745224|NCT01137149|Behavioral activation treatment for depressed adolescents|behavioral activation treatment for depressed adolescents
745225|NCT01137175|Rickettsioses|rickettsioses
745226|NCT01137175|Scrub Typhus|scrub typhus
745227|NCT01137175|Q fever|q fever
745228|NCT01137175|Typhus fever|typhus fever
745229|NCT01137175|Spotted fever|spotted fever
745230|NCT01137175|Rickettsioses reported cases|rickettsioses reported cases
745231|NCT01137201|Small bowel obstruction|small bowel obstruction
745232|NCT01137201|Laparoscopic gastric bypass|laparoscopic gastric bypass
745233|NCT01137201|Internal Hernia|internal hernia
745234|NCT01137201|Mesenteric defect|mesenteric defect
745235|NCT01137201|Morbid obesity|morbid obesity
745236|NCT01137214|complex sleep apnea|complex sleep apnea
745237|NCT01137227|Physical activity|physical activity
745238|NCT01137227|Epidemiology|epidemiology
745239|NCT01137227|Questionnaire|questionnaire
745240|NCT01137227|Cross-sectional study|cross-sectional study
745241|NCT01137240|subjects suffering from mitochondrial disorders with one or more gastrointestinal symptoms would be the focus of the study|subjects suffering from mitochondrial disorders with one or more gastrointestinal symptoms would be the focus of the study
745242|NCT01137253|Nitric Oxide|nitric oxide
745243|NCT01137253|Autonomic Nervous System|autonomic nervous system
745244|NCT01137266|chronic pain osteo-arthritis in one or both knees, adults|chronic pain osteo-arthritis in one or both knees, adults
745245|NCT01137292|observational study|observational study
745246|NCT01137292|voriconazole|voriconazole
745247|NCT01137292|high-risk patients|high-risk patients
745248|NCT01137305|Virtual reality|virtual reality
745249|NCT01137305|surgical training|surgical training
745250|NCT01137305|Health Care [N]|health care [n]
745251|NCT01137318|ADHD|adhd
745252|NCT01137318|Impairment|impairment
745253|NCT01137318|Treatment|treatment
745254|NCT01137318|Cognitive Remediation|cognitive remediation
745255|NCT01137318|Behavioral Parent Training|behavioral parent training
745256|NCT01137331|seborrhoeic eczema|seborrhoeic eczema
745257|NCT01137331|scalp|scalp
745258|NCT01137331|dandruff|dandruff
745259|NCT01137331|K301|k301
745260|NCT01137331|K40|k40
745261|NCT01137383|Hepatitis C|hepatitis c
745262|NCT01137435|Adacel|adacel
745263|NCT01137435|Diphtheria|diphtheria
745264|NCT01137435|Tetanus|tetanus
745265|NCT01137435|Pertussis|pertussis
745266|NCT01137448|Psoriasis|psoriasis
745267|NCT01137448|Obesity|obesity
745268|NCT01137461|Female infertility with indication of oocyte reception|female infertility with indication of oocyte reception
745269|NCT01137474|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
745270|NCT01137474|Diabetes Mellitus|diabetes mellitus
745271|NCT01137474|Endocrine System Diseases|endocrine system diseases
745272|NCT01137474|Glucose Metabolism Disorders|glucose metabolism disorders
745273|NCT01137474|Metabolic Diseases|metabolic diseases
745274|NCT01137474|Angiotensin Receptor Antagonists|angiotensin receptor antagonists
745275|NCT01137474|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
745276|NCT01137474|Hypoglycemic Agents|hypoglycemic agents
745277|NCT01137474|Pharmacologic Actions|pharmacologic actions
745278|NCT01137474|Physiological Effects of Drugs|physiological effects of drugs
745279|NCT01137487|mechanical ventilation|mechanical ventilation
745280|NCT01137487|enteral nutrition|enteral nutrition
745281|NCT01137487|Ventilation-Associated Pneumonia|ventilation-associated pneumonia
745282|NCT01137487|residual gastric volume measurement|residual gastric volume measurement
745284|NCT01137487|gastro-oesophageal reflux|gastro-oesophageal reflux
745285|NCT01137487|early enteral nutrition|early enteral nutrition
745286|NCT01137487|Intensive care unit|intensive care unit
745287|NCT01137487|Enteral Feeding|enteral feeding
745288|NCT01142921|Stent Occlusion|stent occlusion
745289|NCT01142921|Biliary Bleeding|biliary bleeding
745290|NCT01142921|Biliary Perforation|biliary perforation
745291|NCT01142934|Catheter-related bloodstream infections|catheter-related bloodstream infections
745292|NCT01142934|Chlorhexidine|chlorhexidine
745293|NCT01142934|Transparent dressings|transparent dressings
745294|NCT01142947|Inhaled corticosteroids|inhaled corticosteroids
745295|NCT01142947|Asthma|asthma
745296|NCT01142947|Pharmacogenomics|pharmacogenomics
745297|NCT01142947|Genome wide association study|genome wide association study
745298|NCT01142947|Admixture mapping|admixture mapping
745299|NCT01142947|Continental population groups|continental population groups
745300|NCT01142986|Methadone|methadone
745301|NCT01142986|Syringe exchange|syringe exchange
745302|NCT01142986|Treatment retention|treatment retention
745303|NCT01142986|Voucher incentives|voucher incentives
745304|NCT01143012|Group eczema education|group eczema education
745305|NCT01143025|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
745306|NCT01143025|Nebulization|nebulization
745307|NCT01143025|Ropivacaine|ropivacaine
745308|NCT01143038|ITP|itp
745309|NCT01143051|Asthma|asthma
745310|NCT01143051|Pharmacokinetics|pharmacokinetics
745311|NCT01143051|Epinephrine|epinephrine
745312|NCT01143051|Bronchodilator|bronchodilator
745313|NCT01143051|metered dose inhaler|metered dose inhaler
745314|NCT01143064|Brain Injury|brain injury
745315|NCT01143064|Trauma|trauma
745316|NCT01143077|Lurasidone|lurasidone
745317|NCT01143077|Schizophrenia|schizophrenia
745318|NCT01143077|Latuda|latuda
745319|NCT01143090|Schizophrenia|schizophrenia
745320|NCT01143090|Lurasidone|lurasidone
745321|NCT01143090|Latuda|latuda
745322|NCT01143103|Respiratory therapy in neurologic disorder|respiratory therapy in neurologic disorder
745323|NCT01143129|Atrial fibrillation|atrial fibrillation
745324|NCT01143129|Cardiac surgery|cardiac surgery
745325|NCT01143129|Cardiopulmonary bypass|cardiopulmonary bypass
745326|NCT01143129|New-onset|new-onset
745327|NCT01143142|Human papillomavirus|human papillomavirus
745328|NCT01143142|HPV|hpv
745329|NCT01143142|Prevention|prevention
745330|NCT01143142|Tailoring|tailoring
745331|NCT01143142|Persuasive communication|persuasive communication
745332|NCT01143142|Adolescent|adolescent
745333|NCT01143155|Pneumonia|pneumonia
745334|NCT01143155|Community-acquired pneumonia|community-acquired pneumonia
745335|NCT01143155|Healthcare-associated pneumonia|healthcare-associated pneumonia
745336|NCT01143155|Failure|failure
745337|NCT01143155|Cardiovascular events|cardiovascular events
745338|NCT01143155|Outcome|outcome
745339|NCT01143168|stem cells;|stem cells;
745340|NCT01143168|diabetes mellitus;|diabetes mellitus;
745341|NCT01143168|treatment.|treatment.
745342|NCT01143181|CMV, ADV, HSV, VAVC, VARV|cmv, adv, hsv, vavc, varv
745343|NCT01143181|life threatening|life threatening
745344|NCT01143194|Attention|attention
745345|NCT01143194|Vigilance|vigilance
745346|NCT01143194|Concentration|concentration
745347|NCT01143194|Memory|memory
745348|NCT01143194|Healthy Volunteer|healthy volunteer
745349|NCT01143207|AE adverse event|ae adverse event
745350|NCT01143207|DCF data collection forms|dcf data collection forms
745351|NCT01143207|DMC Data Monitoring Committee|dmc data monitoring committee
745352|NCT01143207|FDA U.S.) Food and Drug Administration|fda u.s.) food and drug administration
745353|NCT01143207|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
745354|NCT01143207|ICH International Conference of Harmonisation|ich international conference of harmonisation
745355|NCT01143207|IND Investigational New Drug Application|ind investigational new drug application
745356|NCT01143207|IRB Institutional Review Board|irb institutional review board
745357|NCT01143207|IU International units|iu international units
745358|NCT01143207|mg milligram(s)|mg milligram(s)
745359|NCT01143207|SAE serious adverse event|sae serious adverse event
745360|NCT01143207|µg microgram|µg microgram
745361|NCT01143207|ULN upper limit of the normal range|uln upper limit of the normal range
745362|NCT01143220|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
745363|NCT01143220|Heart Failure|heart failure
745364|NCT01143220|Pathologic Processes|pathologic processes
745365|NCT01143220|Heart Diseases|heart diseases
745366|NCT01143220|Tachycardia|tachycardia
745367|NCT01143220|Cardiovascular Diseases|cardiovascular diseases
745368|NCT01143220|Ventricular Flutter|ventricular flutter
745369|NCT01143220|Tachycardia, Ventricular|tachycardia, ventricular
745370|NCT01143220|Ventricular Fibrillation|ventricular fibrillation
745371|NCT01143220|Arrhythmias, Cardiac|arrhythmias, cardiac
745372|NCT01143220|Ease of Use|ease of use
745373|NCT01143246|Hepatorenal syndrome|hepatorenal syndrome
745374|NCT01143246|Renal failure|renal failure
745375|NCT01143246|Cirrhosis|cirrhosis
745376|NCT01143246|Alcoholic hepatitis|alcoholic hepatitis
745377|NCT01143246|Ascites|ascites
745378|NCT01144156|Crohn's disease|crohn's disease
745379|NCT01144156|Small bowel|small bowel
745380|NCT01144156|Mucosal healing|mucosal healing
745381|NCT01144156|Capsule endoscopy|capsule endoscopy
745382|NCT01144156|Adalimumab|adalimumab
745383|NCT01144156|Small bowel Crohn's disease|small bowel crohn's disease
745384|NCT01144169|Renal cell carcinoma|renal cell carcinoma
745385|NCT01144169|Hydroxychloroquine|hydroxychloroquine
745386|NCT01144169|Nephrectomy|nephrectomy
745387|NCT01144169|Autophagy|autophagy
745388|NCT01144182|heart failure|heart failure
745389|NCT01144182|quality of life|quality of life
745390|NCT01144182|readmissions|readmissions
745391|NCT01144208|Radius fracture|radius fracture
745392|NCT01144208|Adverse effects|adverse effects
745393|NCT01144208|Wrist|wrist
745397|NCT01144208|Osteoporosis|osteoporosis
745398|NCT01144208|Dual-energy x-ray absorptiometry (DXA)|dual-energy x-ray absorptiometry (dxa)
745399|NCT01144208|Bone Density|bone density
745400|NCT01144221|Chronic Ischemic Heart Disease|chronic ischemic heart disease
745401|NCT01144234|Prevention of mother-to-child transmission of HIV-1|prevention of mother-to-child transmission of hiv-1
745402|NCT01144247|Recurrent Grade III or Grade IV Gliomas|recurrent grade iii or grade iv gliomas
745403|NCT01144247|anaplastic astrocytoma|anaplastic astrocytoma
745404|NCT01144247|anaplastic oligodendroglioma|anaplastic oligodendroglioma
745405|NCT01144247|anaplastic mixed glioma|anaplastic mixed glioma
745406|NCT01144247|glioblastoma multiforme|glioblastoma multiforme
745407|NCT01144247|biotherapy|biotherapy
745408|NCT01144247|malignant meningioma|malignant meningioma
745410|NCT01144260|leukemia|leukemia
746592|NCT01149161|dissection|dissection
745411|NCT01144260|chronic lymphocytic leukemia|chronic lymphocytic leukemia
745412|NCT01144286|VVC|vvc
745413|NCT01144286|candidiasis|candidiasis
745414|NCT01144286|vaginal candidiasis|vaginal candidiasis
745415|NCT01144299|Influenza|influenza
745416|NCT01144312|LDLT|ldlt
745417|NCT01144325|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
745422|NCT01144351|MS|ms
745423|NCT01144351|SPMS|spms
745424|NCT01144351|RRMS|rrms
745425|NCT01144351|Relapsing Forms of Secondary Progressive Multiple Sclerosis (SPMS)|relapsing forms of secondary progressive multiple sclerosis (spms)
745426|NCT01144351|or Relapsing-Remitting Multiple Sclerosis (RRMS)|or relapsing-remitting multiple sclerosis (rrms)
745427|NCT01144377|osteoporosis|osteoporosis
745428|NCT01144390|heroin dependence|heroin dependence
745429|NCT01144390|community-based|community-based
745430|NCT01144390|MMT|mmt
745431|NCT01144416|Reproductive Techniques, Assisted|reproductive techniques, assisted
745432|NCT01144416|Follicle Stimulating Hormone, Human|follicle stimulating hormone, human
745433|NCT01144416|Fertilization In Vitro|fertilization in vitro
745434|NCT01144429|Allergic Rhinitis +- intermittent asthma|allergic rhinitis +- intermittent asthma
745435|NCT01144429|Allergic Rhinoconjunctivitis +- intermittent asthma|allergic rhinoconjunctivitis +- intermittent asthma
745436|NCT01144429|Specific Immunotherapy|specific immunotherapy
745437|NCT01144442|recurrent ovarian cancer|recurrent ovarian cancer
745438|NCT01144442|recurrent fallopian tube cancer|recurrent fallopian tube cancer
745439|NCT01144442|recurrent peritoneal carcinoma|recurrent peritoneal carcinoma
745440|NCT01144455|Locally Advanced Unresectable Pancreatic Adenocarcinoma|locally advanced unresectable pancreatic adenocarcinoma
745441|NCT01144455|Metastatic Pancreatic Adenocarcinoma|metastatic pancreatic adenocarcinoma
745442|NCT01144455|Locally Advanced Unresectable or Metastatic Pancreatic Adenocarcinoma|locally advanced unresectable or metastatic pancreatic adenocarcinoma
745443|NCT01144468|breast cancer prevention|breast cancer prevention
745444|NCT01144468|osteoporosis|osteoporosis
745445|NCT01144481|bone metastasis|bone metastasis
745446|NCT01144481|breast cancer|breast cancer
745447|NCT01144481|skeletal related event|skeletal related event
745448|NCT01144481|HR-pQCT|hr-pqct
745449|NCT01144481|VFA|vfa
745450|NCT01144494|Aqueous Humor Dynamics|aqueous humor dynamics
745451|NCT01144494|Aqueous Humor Dynamics and Circadian Rhythms|aqueous humor dynamics and circadian rhythms
745452|NCT01144507|Cystic Fibrosis|cystic fibrosis
745453|NCT01144507|Pancreatic insufficiency|pancreatic insufficiency
745454|NCT01144546|Passive leg raising|passive leg raising
745455|NCT01144546|FloTrac/Vigileo|flotrac/vigileo
745456|NCT01144546|Anesthesia hypotension|anesthesia hypotension
745457|NCT01144559|Femoral|femoral
745458|NCT01144559|Nerve Block|nerve block
745459|NCT01144559|Bolus|bolus
745460|NCT01144559|Continuous Infusion|continuous infusion
745462|NCT01144559|Perineural Catheter|perineural catheter
745463|NCT01144559|Volunteer|volunteer
745464|NCT01144559|lower extremity nerve blocks|lower extremity nerve blocks
745465|NCT01144572|Quality of Life|quality of life
745466|NCT01144572|postmenopausal HR(+)|postmenopausal hr(+)
745467|NCT01144572|Early Breast Cancer|early breast cancer
745468|NCT01144572|adjuvant AI treatment|adjuvant ai treatment
745469|NCT01144572|Quality of Life in Chinese postmenopausal HR(+) EBC patients during adjuvant Aromatase Inhibitors(AIs) treatment|quality of life in chinese postmenopausal hr(+) ebc patients during adjuvant aromatase inhibitors(ais) treatment
745470|NCT01144585|RIPC|ripc
745471|NCT01144585|lung protection|lung protection
745472|NCT01144585|ischemic reperfusion injury|ischemic reperfusion injury
745473|NCT01144585|cardiopulmonary bypass|cardiopulmonary bypass
745474|NCT01144598|Rheumatoid Arthritis|rheumatoid arthritis
745475|NCT01144598|Disease-Modifying Anti-Rheumatic Drug|disease-modifying anti-rheumatic drug
745476|NCT01144598|Work Limitation|work limitation
745477|NCT01144611|valve replacement|valve replacement
745478|NCT01144611|CABG|cabg
745479|NCT01144611|SIRTS|sirts
745480|NCT01144611|Combined aortic valve replacement and CABG surgery|combined aortic valve replacement and cabg surgery
745481|NCT01144624|TNF neutralisation|tnf neutralisation
745482|NCT01144650|Dapsone|dapsone
745483|NCT01144650|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
745484|NCT01144650|Neuroprotection|neuroprotection
745485|NCT01144663|Infants|infants
745486|NCT01144663|conjugate vaccine|conjugate vaccine
745487|NCT01144663|immunogenicity|immunogenicity
745488|NCT01144663|meningococcal vaccine|meningococcal vaccine
745489|NCT01144663|non-inferiority|non-inferiority
745490|NCT01144663|co-administration|co-administration
745491|NCT01144689|mindfulness|mindfulness
745495|NCT01144702|Plasmodium falciparum|plasmodium falciparum
745496|NCT01144702|artesunate and mefloquine combination (ASMQ)|artesunate and mefloquine combination (asmq)
745497|NCT01144702|treatment|treatment
745498|NCT01144702|Juruá Valley|juruá valley
745499|NCT01144702|Brazil|brazil
745500|NCT01144702|multidrug resistance 1 gene of Plasmodium falciparum -Pfmdr1|multidrug resistance 1 gene of plasmodium falciparum -pfmdr1
745501|NCT01144715|Stroke Rehabilitation|stroke rehabilitation
745502|NCT01144715|Home rehabilitation|home rehabilitation
745503|NCT01144715|robotic therapy|robotic therapy
745504|NCT01144741|rehabilitation|rehabilitation
745505|NCT01144741|surgery|surgery
745506|NCT01144741|therapy|therapy
745507|NCT01144741|Quality Of Life|quality of life
745508|NCT01144741|Health-Related Quality Of Life|health-related quality of life
745509|NCT01144741|Health Status|health status
745510|NCT01144741|Depressive Symptoms|depressive symptoms
745511|NCT01144741|Situational Depression|situational depression
745513|NCT01144806|RUTF|rutf
745515|NCT01144806|D2O|d2o
745516|NCT01144806|Children with severe malnutrition|children with severe malnutrition
745517|NCT01144819|STEMI|stemi
745518|NCT01144819|Acute myocardial infarction|acute myocardial infarction
745519|NCT01144819|Antiplatelet therapy|antiplatelet therapy
745520|NCT01144819|aspirin|aspirin
745521|NCT01144819|clopidogrel|clopidogrel
745522|NCT01144819|VerifyNow aggregometry|verifynow aggregometry
745523|NCT01144819|Multiplate aggregometry|multiplate aggregometry
745524|NCT01144832|visceral hypersensitivity|visceral hypersensitivity
745525|NCT01144832|mast cells|mast cells
745526|NCT01144845|Thoracotomy|thoracotomy
745527|NCT01144845|Thoracic Surgery|thoracic surgery
745528|NCT01144845|Thoracic Surgical Procedures|thoracic surgical procedures
745529|NCT01144845|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
745530|NCT01144845|Lung Neoplasms|lung neoplasms
745531|NCT01144845|Thoracic Nerves|thoracic nerves
745532|NCT01144858|atrial fibrillation|atrial fibrillation
745533|NCT01144858|ablation catheter|ablation catheter
745534|NCT01144858|left atrial appendage peak emptying velocity|left atrial appendage peak emptying velocity
745535|NCT01144858|tool for predicting successful catheter ablation|tool for predicting successful catheter ablation
745536|NCT01144871|adolescent|adolescent
745537|NCT01144871|reproductive health|reproductive health
745538|NCT01144871|parents|parents
745539|NCT01144871|STIs|stis
745540|NCT01144871|confidentiality|confidentiality
745541|NCT01144871|Examine parental knowledge/attitudes of confidential health services/STI care for adolescents.|examine parental knowledge/attitudes of confidential health services/sti care for adolescents.
745542|NCT01144871|Examine how parental knowledge/attitudes affects parent's behavioral intentions to support adolescent's access to confidential care.|examine how parental knowledge/attitudes affects parent's behavioral intentions to support adolescent's access to confidential care.
745543|NCT01144871|Identify key mechanisms to form an intervention to parents knowledge/skills to facilitate teen's access to confidential STI services.|identify key mechanisms to form an intervention to parents knowledge/skills to facilitate teen's access to confidential sti services.
745544|NCT01144884|Neck pain|neck pain
745545|NCT01144884|education|education
745546|NCT01144884|exercise|exercise
745547|NCT01144884|clinical prediction rule|clinical prediction rule
745548|NCT01144897|Castrate resistant|castrate resistant
745549|NCT01144897|Prostate cancer|prostate cancer
745550|NCT01144897|Docetaxel|docetaxel
745551|NCT01144897|Taxotere|taxotere
745552|NCT01144897|PET Acetate|pet acetate
745553|NCT01144910|asthma|asthma
745554|NCT01144910|preschool child|preschool child
745555|NCT01144910|bronchial hyperresponsiveness|bronchial hyperresponsiveness
745556|NCT01144910|methacholine challenge test|methacholine challenge test
745557|NCT01144910|atopy|atopy
745558|NCT01144923|epidural steroid injection|epidural steroid injection
745559|NCT01144923|neck pain|neck pain
745560|NCT01144923|pharmacotherapy|pharmacotherapy
745561|NCT01144923|radiculopathy|radiculopathy
745562|NCT01144949|ureteral calculi|ureteral calculi
745563|NCT01144949|renal colic|renal colic
745564|NCT01144949|ureteral stones|ureteral stones
745565|NCT01144949|kidney stones|kidney stones
745566|NCT01144949|medical expulsive therapy|medical expulsive therapy
745567|NCT01144962|Crohn's Disease|crohn's disease
745568|NCT01144962|Fistula|fistula
745569|NCT01144962|Mesenchymal Stem Cell|mesenchymal stem cell
745570|NCT01144962|Mesenchymal Stromal Cell|mesenchymal stromal cell
745571|NCT01144962|MSC|msc
745572|NCT01144962|IBD|ibd
745573|NCT01144975|Diabetes|diabetes
745574|NCT01144975|Type 2|type 2
745575|NCT01144975|Mellitus|mellitus
745576|NCT01144988|Recurrent Malignant Glioma|recurrent malignant glioma
745577|NCT01144988|Bevacizumab / Irinotecan|bevacizumab / irinotecan
745578|NCT01144988|Functional MR Imaging|functional mr imaging
745579|NCT01144988|Metabolic Imaging (FET/FLT-PET)|metabolic imaging (fet/flt-pet)
745580|NCT01145001|smoking|smoking
745581|NCT01145001|adolescents|adolescents
745582|NCT01145001|contingency management|contingency management
745583|NCT01145001|nicotine replacement therapy|nicotine replacement therapy
745584|NCT01145027|Capillary recruitment|capillary recruitment
745585|NCT01145027|Cephalic Phase of Insulin Secretion|cephalic phase of insulin secretion
745586|NCT01145027|Dietary Intake|dietary intake
745786|NCT01145963|pasta|pasta
745587|NCT01145040|Overt primary hypothyroidism|overt primary hypothyroidism
745588|NCT01145040|Overt primary hyperthyroidism|overt primary hyperthyroidism
745589|NCT01145040|Thyrotropic feedback control|thyrotropic feedback control
745590|NCT01145040|Mathematical modelling|mathematical modelling
745591|NCT01145040|Nonlinear modelling|nonlinear modelling
745592|NCT01145040|Thyroid|thyroid
745593|NCT01145040|Pituitary|pituitary
745594|NCT01145040|Physiological cybernetics|physiological cybernetics
745595|NCT01145040|Full-dose levothyroxine substitution therapy|full-dose levothyroxine substitution therapy
745596|NCT01145040|Syndrome T|syndrome t
745597|NCT01145066|diabetes|diabetes
745598|NCT01145066|metabolic syndrome|metabolic syndrome
745599|NCT01145066|inflammation|inflammation
745600|NCT01145066|botanical oils|botanical oils
745601|NCT01145092|type 2 diabetes|type 2 diabetes
745602|NCT01145092|exercise training|exercise training
745603|NCT01145092|ATP-synthesis|atp-synthesis
745604|NCT01145092|intramyocellular lipids|intramyocellular lipids
745605|NCT01145092|hepatocellular lipids|hepatocellular lipids
745606|NCT01145092|first degree relatives of T2DM patients|first degree relatives of t2dm patients
745607|NCT01145105|Low back pain|low back pain
745608|NCT01145105|Sciatica|sciatica
745609|NCT01145105|Pain|pain
745610|NCT01145105|Physiotherapy|physiotherapy
745611|NCT01145118|Plantar Fasciitis|plantar fasciitis
745612|NCT01145118|Physiotherapy|physiotherapy
745613|NCT01145131|muscle|muscle
745614|NCT01145131|FSR|fsr
745615|NCT01145131|protein|protein
745616|NCT01145131|meat|meat
745617|NCT01145144|Dehydroepiandrosterone|dehydroepiandrosterone
745618|NCT01145144|DHEA|dhea
745619|NCT01145144|IVF outcome|ivf outcome
745620|NCT01145144|long protocol IVF|long protocol ivf
745621|NCT01145144|poor-responder|poor-responder
745622|NCT01145144|recombinant LH|recombinant lh
745623|NCT01145144|embryo quality|embryo quality
745624|NCT01145144|pregnancy rate|pregnancy rate
745625|NCT01145144|live birth rate|live birth rate
745626|NCT01145144|poor response to ovarian stimulation|poor response to ovarian stimulation
745627|NCT01145157|knee|knee
745628|NCT01145157|arthroplasty|arthroplasty
745629|NCT01145170|brainstem gliomas|brainstem gliomas
745630|NCT01145170|pediatric patients|pediatric patients
745631|NCT01145183|Cocaine Dependence|cocaine dependence
745632|NCT01145183|Substance Related Disorders|substance related disorders
745633|NCT01145183|genotype|genotype
745634|NCT01145196|Retinal Disease|retinal disease
745635|NCT01145196|Plaquenil-Induced|plaquenil-induced
745636|NCT01145209|Arzerra|arzerra
745637|NCT01145209|Chemoimmunotherapy|chemoimmunotherapy
745638|NCT01145209|CLL (Chronic Lymphocytic Leukemia)|cll (chronic lymphocytic leukemia)
745639|NCT01145209|SLL|sll
745640|NCT01145209|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
745641|NCT01145222|CNS 7056|cns 7056
745642|NCT01145222|Procedural Sedation|procedural sedation
745643|NCT01145222|Colonoscopy|colonoscopy
745644|NCT01145235|Breast augmentation with Macrolane|breast augmentation with macrolane
745645|NCT01145248|Cholangiocellular Carcinoma|cholangiocellular carcinoma
745646|NCT01145261|Anxiety,|anxiety,
745647|NCT01145261|Emotional Regulation|emotional regulation
745648|NCT01145274|allopurinol|allopurinol
745649|NCT01145274|chronic kidney diseae|chronic kidney diseae
745650|NCT01145287|Celiac disease|celiac disease
745651|NCT01145287|Gluten-free diet|gluten-free diet
745652|NCT01145287|Screen-detected|screen-detected
745653|NCT01145287|Asymptomatic|asymptomatic
745654|NCT01145287|Quality of life|quality of life
745655|NCT01145287|Self-perceived health|self-perceived health
745656|NCT01145287|Healthcare resource utilization|healthcare resource utilization
745657|NCT01145300|COPD|copd
745658|NCT01145300|Inflammation|inflammation
745659|NCT01145300|Small airways|small airways
745660|NCT01145326|venipuncture|venipuncture
745661|NCT01145326|phlebotomy|phlebotomy
745662|NCT01145326|pain perception|pain perception
745663|NCT01145352|Enbrel-JIA|enbrel-jia
745664|NCT01145365|Crohns|crohns
745665|NCT01145365|Fistula|fistula
745666|NCT01145365|Perianal Abscess|perianal abscess
745667|NCT01145365|Perianal|perianal
745668|NCT01145391|hypertension|hypertension
745669|NCT01145391|blood pressure|blood pressure
745670|NCT01145391|primary care|primary care
745671|NCT01145391|patient centered medical home|patient centered medical home
745672|NCT01145391|health information technology|health information technology
745673|NCT01145391|clinical inertia|clinical inertia
745674|NCT01145404|Her2 Gastro Gastric Esophageal Cancer|her2 gastro gastric esophageal cancer
745675|NCT01145417|peripheral neuropathic pain|peripheral neuropathic pain
745676|NCT01145417|pregabalin|pregabalin
745677|NCT01145417|safety|safety
745678|NCT01145443|Organizational models|organizational models
745679|NCT01145443|Intensive care units|intensive care units
745680|NCT01145443|Physicians|physicians
745681|NCT01145443|Staffing and scheduling|staffing and scheduling
745682|NCT01145443|Burnout, professional|burnout, professional
745683|NCT01145443|Job satisfaction|job satisfaction
745684|NCT01145469|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
745785|NCT01145950|healthy volunteers|healthy volunteers
745685|NCT01145469|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
745686|NCT01145469|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
745687|NCT01145469|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
745688|NCT01145469|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
745689|NCT01145482|Memory Disorders|memory disorders
745690|NCT01145482|Alzheimer's Disease|alzheimer's disease
745691|NCT01145534|diabetes,|diabetes,
745692|NCT01145534|medicinal plants,|medicinal plants,
745693|NCT01145534|glucose|glucose
745694|NCT01145547|glycemic index|glycemic index
745695|NCT01145547|Diabetes Mellitus|diabetes mellitus
746899|NCT01144026|THYMON|thymon
745696|NCT01145547|continuous glucose monitoring|continuous glucose monitoring
745697|NCT01145560|severe sepsis|severe sepsis
745698|NCT01145560|TNF neutralisation|tnf neutralisation
745699|NCT01145560|septic shock patients|septic shock patients
745700|NCT01145573|calcium|calcium
745701|NCT01145573|vitamin D|vitamin d
745702|NCT01145573|bone|bone
745703|NCT01145573|pregnancy|pregnancy
745704|NCT01145612|Aortic dilation|aortic dilation
745705|NCT01145612|Marfan syndrome|marfan syndrome
745706|NCT01145612|Losartan|losartan
745707|NCT01145612|Atenolol|atenolol
745708|NCT01145625|Female Pattern Baldness|female pattern baldness
745709|NCT01145638|cancer|cancer
745710|NCT01145638|chemotherapy induced anaemia|chemotherapy induced anaemia
745711|NCT01145638|iron|iron
745712|NCT01145638|Patients with non-myeloid malignancies and Chemotherapy Induced Anaemia (CIA)|patients with non-myeloid malignancies and chemotherapy induced anaemia (cia)
745714|NCT01145664|Chinese medicines|chinese medicines
745715|NCT01145664|Severe hand-foot-mouth diseases|severe hand-foot-mouth diseases
745716|NCT01145664|effectiveness|effectiveness
745717|NCT01145664|safety|safety
745718|NCT01145677|Alcohol dependence|alcohol dependence
745719|NCT01145677|Alcoholism|alcoholism
745720|NCT01145677|Topiramate|topiramate
745721|NCT01145690|cognitive behaviour therapy|cognitive behaviour therapy
745722|NCT01145703|Body Composition|body composition
745723|NCT01145703|Cardiovascular Risk|cardiovascular risk
745724|NCT01145703|Cognitive Function|cognitive function
745725|NCT01145716|TFCC injuries|tfcc injuries
745726|NCT01145716|Distal radius fractures|distal radius fractures
745727|NCT01145729|Biomarker feedback|biomarker feedback
745728|NCT01145729|Smoking cessation|smoking cessation
745729|NCT01145729|Childhood secondhand smoke exposure|childhood secondhand smoke exposure
745730|NCT01145742|Type 2 diabetes|type 2 diabetes
745731|NCT01145742|Hypertension|hypertension
745732|NCT01145742|Health services research|health services research
745733|NCT01145742|Health disparities|health disparities
745734|NCT01145742|Behavior change|behavior change
745735|NCT01145755|Depression|depression
745736|NCT01145768|Double-blind|double-blind
745737|NCT01145768|randomized|randomized
745738|NCT01145768|placebo-controlled|placebo-controlled
745739|NCT01145768|parallel-group study|parallel-group study
745740|NCT01145768|Safety|safety
745741|NCT01145768|pharmacokinetics|pharmacokinetics
745742|NCT01145781|ectocervical CIN lesions|ectocervical cin lesions
745743|NCT01145794|SHS|shs
745744|NCT01145807|Distal Subungual Toenail Onychomycosis|distal subungual toenail onychomycosis
745745|NCT01145820|third molar|third molar
745746|NCT01145820|trauma|trauma
745747|NCT01145820|pain|pain
745748|NCT01145820|wound healing|wound healing
745749|NCT01145820|post operative morbidity|post operative morbidity
745750|NCT01145820|acute trauma|acute trauma
745751|NCT01145820|short-term wound healing|short-term wound healing
745752|NCT01145833|obesity|obesity
745753|NCT01145833|guided self help treatment|guided self help treatment
745754|NCT01145833|treatment method|treatment method
745755|NCT01145833|overweight|overweight
745756|NCT01145833|overweight children and parents|overweight children and parents
745757|NCT01145833|families with overweight child|families with overweight child
745758|NCT01145833|efficacy|efficacy
745759|NCT01145833|body mass index|body mass index
745760|NCT01145833|weight|weight
745761|NCT01145859|Venous Thrombosis|venous thrombosis
745762|NCT01145859|Pediatrics|pediatrics
745763|NCT01145872|Mindfulness|mindfulness
745764|NCT01145872|clinical trial|clinical trial
745765|NCT01145872|intervention|intervention
745766|NCT01145872|prevention|prevention
745767|NCT01145898|Glaucoma|glaucoma
745768|NCT01145898|Cosopt|cosopt
745769|NCT01145898|blood flow|blood flow
745770|NCT01145898|progression|progression
745771|NCT01145911|Glaucoma|glaucoma
745772|NCT01145911|Blood Flow|blood flow
745773|NCT01145911|Progression|progression
745774|NCT01145924|bronchoscopy|bronchoscopy
745775|NCT01145924|endobronchial ultrasound|endobronchial ultrasound
745776|NCT01145924|transbronchial needle aspiration|transbronchial needle aspiration
745777|NCT01145924|lung cancer|lung cancer
745778|NCT01145924|staging|staging
745779|NCT01145937|Keratoconus|keratoconus
745780|NCT01145937|Corneal grafting|corneal grafting
745781|NCT01145937|Corneal transplantation|corneal transplantation
745782|NCT01145937|Anterior Lamellar Keratoplasty|anterior lamellar keratoplasty
745783|NCT01145950|Etanercept|etanercept
745784|NCT01145950|Enbrel|enbrel
745791|NCT01145963|Psychological Phenomena and Processes|psychological phenomena and processes
745792|NCT01145976|aplastic anemia, fludarabine, cyclophosphamide, thymoglobulin|aplastic anemia, fludarabine, cyclophosphamide, thymoglobulin
745793|NCT01145989|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
745794|NCT01146002|Attention-deficit/hyperactivity disorder, primarily inattentive or combined type.|attention-deficit/hyperactivity disorder, primarily inattentive or combined type.
745795|NCT01146015|Influenza|influenza
745796|NCT01146015|Vaccine|vaccine
745797|NCT01146015|CHMP criteria|chmp criteria
745798|NCT01146041|Bioequivalence|bioequivalence
745799|NCT01146067|Bioequivalence|bioequivalence
745800|NCT01146080|drug eluting stent|drug eluting stent
745801|NCT01146080|everolimus eluting stent|everolimus eluting stent
745802|NCT01146080|optical coherence tomography|optical coherence tomography
745803|NCT01146080|intravascular ultrasound|intravascular ultrasound
745804|NCT01146119|HAI|hai
745805|NCT01146119|Influenza|influenza
745806|NCT01146119|prime|prime
745807|NCT01146119|boost|boost
745808|NCT01146119|immune response|immune response
745809|NCT01146119|seroconversion|seroconversion
745810|NCT01146119|universal|universal
745811|NCT01146119|vaccine|vaccine
745812|NCT01146132|Nutrition|nutrition
745813|NCT01146132|Physical activity|physical activity
745814|NCT01146132|Cerebrovascular disease|cerebrovascular disease
745815|NCT01146132|wine consumption|wine consumption
745816|NCT01146132|BMI|bmi
745817|NCT01146132|Pulse transit time|pulse transit time
745818|NCT01146132|transcranial Doppler sonography|transcranial doppler sonography
745819|NCT01146145|postoperative|postoperative
745820|NCT01146145|pain|pain
745821|NCT01146145|analgesia|analgesia
745822|NCT01146145|morphine|morphine
745823|NCT01146145|titration|titration
745824|NCT01146145|ketamine|ketamine
745825|NCT01146158|Axillary dissection|axillary dissection
745826|NCT01146184|Cholelithiasis|cholelithiasis
745827|NCT01146184|Single Incision|single incision
745828|NCT01146184|Flexible Endoscope|flexible endoscope
745829|NCT01146184|Ethicon Manually Articulating Device|ethicon manually articulating device
745830|NCT01146184|Pain|pain
745831|NCT01146197|Hypokalemia|hypokalemia
745832|NCT01146197|Hypomagnesemia|hypomagnesemia
745833|NCT01146197|Salt loosing nephropathy|salt loosing nephropathy
745834|NCT01146236|Surgical|surgical
745835|NCT01146236|Infection|infection
745836|NCT01146236|Post-operative|post-operative
745837|NCT01146236|Sutures|sutures
745838|NCT01146236|Staples|staples
745839|NCT01146249|Multisensorial integration|multisensorial integration
745840|NCT01146249|Postural control|postural control
745841|NCT01146249|Visual reliance|visual reliance
745842|NCT01146262|Antitumoral immune response after autologous dendritic cells vaccination|antitumoral immune response after autologous dendritic cells vaccination
752408|NCT01172912|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
745843|NCT01146275|Patients who participated in pilot study (31GB0601) and performed breast augmentation with previous formulation of Macrolane|patients who participated in pilot study (31gb0601) and performed breast augmentation with previous formulation of macrolane
745844|NCT01146288|obesity|obesity
745845|NCT01146288|acetazolamide|acetazolamide
745846|NCT01146288|furosemide|furosemide
745847|NCT01146301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
745848|NCT01146301|Coronary Artery Bypass Grafting|coronary artery bypass grafting
745849|NCT01146314|family-focused intervention|family-focused intervention
745850|NCT01146314|pediatric obesity|pediatric obesity
745851|NCT01146314|diabetes prevention|diabetes prevention
745852|NCT01146327|Multiple Dose Study in Overweight Healthy Subjects|multiple dose study in overweight healthy subjects
745853|NCT01146327|body weight|body weight
745854|NCT01146340|Prostatic Neoplasms|prostatic neoplasms
745855|NCT01146340|Radiotherapy|radiotherapy
745856|NCT01146340|Hypofractionation|hypofractionation
745857|NCT01146340|Low and Intermediate Risk Prostate Cancer|low and intermediate risk prostate cancer
745858|NCT01146353|peramivir|peramivir
745859|NCT01146353|CVVH|cvvh
745860|NCT01146353|CRRT|crrt
745861|NCT01146353|CVVHD|cvvhd
745862|NCT01146353|influenza|influenza
745863|NCT01146353|sieving coefficient|sieving coefficient
745864|NCT01146353|clearance|clearance
745865|NCT01146366|Early stage lung cancer|early stage lung cancer
745866|NCT01146366|Cervical mediastinoscopy|cervical mediastinoscopy
746163|NCT01147653|Cord Blood|cord blood
745867|NCT01146366|Observational study|observational study
745868|NCT01146366|clinical stage T2N0M0 and select T1N0M0 (suvMAX on FDG-PET of >/=10)|clinical stage t2n0m0 and select t1n0m0 (suvmax on fdg-pet of >/=10)
745869|NCT01146379|stroke|stroke
745870|NCT01146379|upper extremity|upper extremity
745871|NCT01146379|paresis|paresis
745872|NCT01146379|function|function
745873|NCT01146379|translational research|translational research
745874|NCT01146392|Epidemiological|epidemiological
745875|NCT01146392|COPD health care|copd health care
745876|NCT01146392|treatment in primary care|treatment in primary care
745877|NCT01146405|Laparoscopic|laparoscopic
745878|NCT01146418|Reproductive Techniques, Assisted|reproductive techniques, assisted
745879|NCT01146418|Follicle Stimulating Hormone, Human|follicle stimulating hormone, human
745880|NCT01146418|Fertilization In Vitro|fertilization in vitro
745881|NCT01146444|Sunscreening Agents|sunscreening agents
746182|NCT01147679|Young-Onset|young-onset
745882|NCT01146457|Obstetric anesthesia|obstetric anesthesia
745883|NCT01146457|labor analgesia|labor analgesia
745884|NCT01146457|morphine|morphine
745885|NCT01146457|epidural analgesia|epidural analgesia
745886|NCT01146496|Pesticide poisoning|pesticide poisoning
745887|NCT01146496|Suicide|suicide
745888|NCT01146496|Unintentional poisoning|unintentional poisoning
745889|NCT01146496|Prevention|prevention
745890|NCT01146496|Cluster randomised controlled trial|cluster randomised controlled trial
745891|NCT01146509|migraine|migraine
745892|NCT01146509|headache|headache
745893|NCT01146522|Familial hyperchylomicronemia|familial hyperchylomicronemia
745894|NCT01146522|Lipoprotein lipase deficiency|lipoprotein lipase deficiency
745895|NCT01146522|Hyperlipoproteinemia|hyperlipoproteinemia
745896|NCT01146522|Triglycerides|triglycerides
745897|NCT01146522|Hypertriglyceridemia|hypertriglyceridemia
745898|NCT01146522|LCQ908|lcq908
745899|NCT01146522|Hyperlipoproteinemia associated with lipoprotein lipase deficiency|hyperlipoproteinemia associated with lipoprotein lipase deficiency
745900|NCT01146535|interferon-alpha|interferon-alpha
745901|NCT01146535|oseltamivir|oseltamivir
745902|NCT01146535|drug therapy, combination|drug therapy, combination
745903|NCT01146535|influenza|influenza
745904|NCT01146535|therapies, investigational|therapies, investigational
745905|NCT01146548|Fluoxetine effect|fluoxetine effect
745906|NCT01146548|Multiple System Atrophy|multiple system atrophy
745908|NCT01146574|End-Stage Renal Disease|end-stage renal disease
745909|NCT01146574|Anemia|anemia
745910|NCT01146574|Hemodialysis|hemodialysis
745911|NCT01146574|Renal Anemia|renal anemia
745912|NCT01146574|ESRD|esrd
745913|NCT01146587|Stroke|stroke
745914|NCT01146587|Robotics|robotics
745915|NCT01146587|Gait|gait
745916|NCT01146587|Rehabilitation|rehabilitation
745917|NCT01146600|Primary hypersomnia|primary hypersomnia
745918|NCT01146600|CNS hypersomnia|cns hypersomnia
745919|NCT01146600|hypersomnia|hypersomnia
745920|NCT01146600|idiopathic hypersomnia|idiopathic hypersomnia
745921|NCT01146600|narcolepsy without cataplexy|narcolepsy without cataplexy
745922|NCT01146600|clarithromycin|clarithromycin
745923|NCT01146613|Alcohol|alcohol
745924|NCT01146613|Alcohol abuse|alcohol abuse
745925|NCT01146613|Alcoholism|alcoholism
745926|NCT01146613|Alcohol Dependence|alcohol dependence
745927|NCT01146613|Varenicline|varenicline
745928|NCT01146613|Drinking|drinking
745929|NCT01146626|Vitamin D|vitamin d
745930|NCT01146626|Hepatitis C|hepatitis c
745931|NCT01146626|Genotype2,3|genotype2,3
745932|NCT01146626|SVR|svr
745933|NCT01146626|Naive|naive
745934|NCT01146626|RVR rate|rvr rate
745935|NCT01146626|EVR rate|evr rate
745936|NCT01146626|SVR rate|svr rate
745937|NCT01140321|Thalassemia|thalassemia
745938|NCT01140321|Neridronate|neridronate
745939|NCT01140321|Osteopenia|osteopenia
745940|NCT01140321|Osteoporosis|osteoporosis
745941|NCT01140334|Psychiatric adherence|psychiatric adherence
745942|NCT01140334|Voucher incentives|voucher incentives
745943|NCT01140334|Methadone treatment|methadone treatment
745944|NCT01140347|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
745945|NCT01140347|recombinant human immunoglobulin G|recombinant human immunoglobulin g
745946|NCT01140347|subclass 1 (IgG1) monoclonal antibody (MAb)|subclass 1 (igg1) monoclonal antibody (mab)
745947|NCT01140347|Hepatocellular Carcinoma (HCC) following First-Line Therapy With Sorafenib|hepatocellular carcinoma (hcc) following first-line therapy with sorafenib
745949|NCT01140373|Prostate|prostate
745950|NCT01140373|Autologous T Cells|autologous t cells
745951|NCT01140373|Castrate Metastatic Prostate Cancer|castrate metastatic prostate cancer
745952|NCT01140373|cyclophosphamide|cyclophosphamide
745953|NCT01140373|09-036|09-036
745954|NCT01140386|venous thromboembolism|venous thromboembolism
745955|NCT01140386|duplex ultrasound|duplex ultrasound
745956|NCT01140386|pediatric population|pediatric population
745957|NCT01140386|Vascular lab duplex ultrasound database|vascular lab duplex ultrasound database
745958|NCT01140386|Inpatient hospital admission/discharge ICD-9 database|inpatient hospital admission/discharge icd-9 database
745959|NCT01140386|PTSF pediatric trauma database|ptsf pediatric trauma database
745960|NCT01140399|1 Acute Decompensated Heart Failure|1 acute decompensated heart failure
745961|NCT01140399|2 Cardiorenal Syndrome|2 cardiorenal syndrome
745962|NCT01140399|3 Ultrafiltration|3 ultrafiltration
745963|NCT01140399|4 Dopamine|4 dopamine
745964|NCT01140412|maraviroc|maraviroc
745965|NCT01140412|fosamprenavir|fosamprenavir
745966|NCT01140412|drug interaction|drug interaction
745967|NCT01140412|pharmacokinetics|pharmacokinetics
745968|NCT01140412|HIV|hiv
745969|NCT01140412|AIDS|aids
745970|NCT01140412|CCR5|ccr5
745971|NCT01140412|protease inhibitor|protease inhibitor
745972|NCT01140425|PF-00232798|pf-00232798
745973|NCT01140425|CCR5|ccr5
745974|NCT01140425|QT|qt
745975|NCT01140425|QTc|qtc
745976|NCT01140425|pharmacokinetics|pharmacokinetics
745977|NCT01146639|EVAR DynaCT|evar dynact
745978|NCT01146665|alcohol consumption|alcohol consumption
745979|NCT01146665|personalized assessment feedback|personalized assessment feedback
745980|NCT01146665|youth|youth
745981|NCT01146665|emergency department|emergency department
745982|NCT01146691|Organizational models|organizational models
745983|NCT01146691|Intensive care units|intensive care units
745984|NCT01146691|Physicians|physicians
745985|NCT01146691|Staffing and scheduling|staffing and scheduling
745986|NCT01146691|Burnout, professional|burnout, professional
745987|NCT01146691|Job satisfaction|job satisfaction
745988|NCT01146691|Education, medical|education, medical
745989|NCT01146691|Patient satisfaction|patient satisfaction
745990|NCT01146704|Obesity|obesity
745991|NCT01146717|Mild Cognitive Impairment|mild cognitive impairment
745992|NCT01146717|Exercise|exercise
745995|NCT01146730|Vocational Rehabilitation|vocational rehabilitation
745996|NCT01146730|Common Mental Disorders|common mental disorders
745997|NCT01146730|Mental Health Problems|mental health problems
745998|NCT01146730|Work Related Therapy|work related therapy
745999|NCT01146743|EUS-guided transmural cholecystostomy|eus-guided transmural cholecystostomy
746000|NCT01146756|MEK inhibitor|mek inhibitor
746001|NCT01146756|thoracic radiotherapy|thoracic radiotherapy
746002|NCT01146756|lung cancer|lung cancer
746003|NCT01146769|Cancer of rectum|cancer of rectum
746004|NCT01146769|Physiotherapy|physiotherapy
746005|NCT01146808|Vaccination|vaccination
746006|NCT01146808|Immunocompromised Host|immunocompromised host
746007|NCT01146808|Antiviral Agents|antiviral agents
746008|NCT01146808|Drug Resistance, Viral|drug resistance, viral
746009|NCT01146808|Resource Allocation|resource allocation
746010|NCT01146847|algorithm|algorithm
746011|NCT01146847|tight glycemic control|tight glycemic control
746012|NCT01146847|glucose control|glucose control
746013|NCT01146847|intensive care|intensive care
746014|NCT01146847|insulin|insulin
746016|NCT01146860|BNO 1016, acute rhinosinusitis|bno 1016, acute rhinosinusitis
746017|NCT01146899|influenza, vaccine, clinical decision support|influenza, vaccine, clinical decision support
746018|NCT01146912|Influenza, text message, vaccination|influenza, text message, vaccination
746019|NCT01146925|Acute Kidney Injury|acute kidney injury
746020|NCT01146925|Contrast-Induced Nephropathy|contrast-induced nephropathy
746021|NCT01146925|Labile Iron|labile iron
746022|NCT01146925|Iron Chelation|iron chelation
746023|NCT01146925|Deferiprone|deferiprone
746024|NCT01146938|fimasartan|fimasartan
746025|NCT01146938|hepatic impairment|hepatic impairment
746026|NCT01146951|Epilepsy|epilepsy
746027|NCT01146951|Seizures|seizures
746028|NCT01146964|Age related cataract|age related cataract
746029|NCT01146964|Phacoemulsification|phacoemulsification
746030|NCT01146964|Manual super small incision cataract surgery|manual super small incision cataract surgery
746031|NCT01147133|Platelet aggregation|platelet aggregation
746032|NCT01147133|Generic|generic
746033|NCT01147133|Clopidogrel|clopidogrel
746034|NCT01147133|Comparison|comparison
746035|NCT01147133|VASP-PRI|vasp-pri
746036|NCT01147146|transurethral surgery|transurethral surgery
746037|NCT01147172|Nasolabial Folds|nasolabial folds
746038|NCT01147172|Cosmetic|cosmetic
746039|NCT01147172|Injectable Dermal Filler|injectable dermal filler
746040|NCT01147172|Hyaluronic Acid with Lidocaine|hyaluronic acid with lidocaine
746041|NCT01147185|Spinal Cord Injuries, Locomotor training, Dose-Response|spinal cord injuries, locomotor training, dose-response
746042|NCT01147198|Moderate|moderate
746043|NCT01147198|Wasting|wasting
746044|NCT01147198|Malnutrition|malnutrition
746045|NCT01147198|Ready to Use Food|ready to use food
746046|NCT01147198|Fortified Blended Flour|fortified blended flour
746047|NCT01147211|dose defining|dose defining
746048|NCT01147211|MK-2206|mk-2206
746049|NCT01147211|NSCLC With EGFR Mutation|nsclc with egfr mutation
746050|NCT01147211|NSCLC|nsclc
746051|NCT01147224|Asthma|asthma
746052|NCT01147224|Allergy|allergy
746053|NCT01147224|Ciclesonide|ciclesonide
746054|NCT01147224|Alvesco|alvesco
746055|NCT01147224|Inhaled steroids|inhaled steroids
746056|NCT01147263|Fibromyalgia|fibromyalgia
746057|NCT01147263|Autonomic dysfunction|autonomic dysfunction
746058|NCT01147263|Tachycardia|tachycardia
746059|NCT01147263|Palpitations|palpitations
746060|NCT01147276|DPP-4|dpp-4
746061|NCT01147276|GLP-1|glp-1
746062|NCT01147276|Glucagon|glucagon
746273|NCT01147939|CLAVELA|clavela
746063|NCT01147276|Catecholamines|catecholamines
746064|NCT01147276|Counterregulation|counterregulation
746065|NCT01147276|Type 1 diabetes|type 1 diabetes
746066|NCT01147289|lumbar sciatic pain|lumbar sciatic pain
746067|NCT01147289|moderate to severe lumbar sciatic pain within the last three days|moderate to severe lumbar sciatic pain within the last three days
746068|NCT01147315|mandibular osteoradionecrosis|mandibular osteoradionecrosis
746069|NCT01147315|hybrid bone substitution|hybrid bone substitution
746070|NCT01147315|calcium-phosphate ceramic biomaterial|calcium-phosphate ceramic biomaterial
746071|NCT01147315|autologous bone marrow|autologous bone marrow
746072|NCT01147328|Health information technology|health information technology
746073|NCT01147328|Health information exchange|health information exchange
746074|NCT01147328|Virtual health record|virtual health record
746075|NCT01147328|Health care utilization|health care utilization
746076|NCT01147341|rheumatoid arthritis|rheumatoid arthritis
746077|NCT01147341|anti-TNF therapy|anti-tnf therapy
746078|NCT01147354|Hemodialysis|hemodialysis
746079|NCT01147354|oxidative stress|oxidative stress
746080|NCT01147354|selenium|selenium
746081|NCT01147354|inflammation|inflammation
746082|NCT01147367|exercise|exercise
746083|NCT01147367|breast cancer|breast cancer
746084|NCT01147367|physical activity|physical activity
746085|NCT01147367|fatigue|fatigue
746086|NCT01147367|sleep dysfunction|sleep dysfunction
746087|NCT01147367|cytokines|cytokines
746088|NCT01147367|muscle strength|muscle strength
746089|NCT01147367|inflammation|inflammation
746090|NCT01147419|critical limb ischemia|critical limb ischemia
746900|NCT01144052|Natalizumab|natalizumab
746091|NCT01147419|peripheral artery occlusive disease|peripheral artery occlusive disease
746092|NCT01147419|femoropopliteal artery bypass|femoropopliteal artery bypass
746093|NCT01147419|Stent|stent
746094|NCT01147432|Healthy male volunteers|healthy male volunteers
746095|NCT01147432|capsaicin challenge|capsaicin challenge
746096|NCT01147432|safety|safety
746097|NCT01147432|toleration|toleration
746098|NCT01147445|Enterotoxigenic Escherichia coli, vaccine|enterotoxigenic escherichia coli, vaccine
746099|NCT01147458|Cross-over|cross-over
746100|NCT01147458|safety|safety
746101|NCT01147458|efficacy|efficacy
746102|NCT01147458|tolerability|tolerability
746103|NCT01147458|osteoarthritis|osteoarthritis
746104|NCT01147458|knee|knee
746105|NCT01147458|pain|pain
746106|NCT01147471|flail chest|flail chest
746107|NCT01147471|rib fixation|rib fixation
746108|NCT01147484|Breast Cancer|breast cancer
746109|NCT01147497|IUD insertion|iud insertion
746110|NCT01147497|nulliparous women|nulliparous women
746111|NCT01147497|contraception|contraception
746112|NCT01147497|family planning|family planning
746113|NCT01147497|IUD insertion in nulliparous women|iud insertion in nulliparous women
746114|NCT01147510|asthma control in elderly patients|asthma control in elderly patients
746115|NCT01147510|age 60-75|age 60-75
746116|NCT01147523|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
746117|NCT01147523|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
746118|NCT01147523|adipokines|adipokines
746119|NCT01147523|spironolactone|spironolactone
746120|NCT01147523|vitamin E|vitamin e
746121|NCT01147523|adiponectin|adiponectin
746122|NCT01147523|visfatin|visfatin
746123|NCT01147523|leptin|leptin
746124|NCT01147523|resistin|resistin
746125|NCT01147523|TNF-alpha|tnf-alpha
746126|NCT01147523|IL-6|il-6
746127|NCT01147523|IL-1|il-1
746128|NCT01147549|ADME|adme
746129|NCT01147562|Lung cancer|lung cancer
746130|NCT01147562|Biopsy|biopsy
746131|NCT01147562|Biomarker|biomarker
746132|NCT01147562|Tissue Collection|tissue collection
746133|NCT01147575|Rett Syndrome, Randomized, Methylation|rett syndrome, randomized, methylation
746134|NCT01147588|open label|open label
746135|NCT01147588|randomized|randomized
746136|NCT01147588|4-treatment|4-treatment
746137|NCT01147588|3-period|3-period
746138|NCT01147588|crossover|crossover
746139|NCT01147588|interaction study|interaction study
746140|NCT01147588|Safety|safety
746141|NCT01147588|tolerability|tolerability
746142|NCT01147588|pharmacokinetics|pharmacokinetics
746143|NCT01147588|pharmacodynamics|pharmacodynamics
746144|NCT01147601|topical 0.5% Timolol|topical 0.5% timolol
746145|NCT01147601|infantile hemangioma (IH)|infantile hemangioma (ih)
746147|NCT01147614|adolescent|adolescent
746148|NCT01147614|anxiety|anxiety
746149|NCT01147614|depression|depression
746150|NCT01147614|internalizing|internalizing
746151|NCT01147614|cognitive behavioral therapy|cognitive behavioral therapy
746152|NCT01147614|pediatric primary care|pediatric primary care
746153|NCT01147627|diabetes mellitus, type 2|diabetes mellitus, type 2
746154|NCT01147627|newly diagnosed|newly diagnosed
746155|NCT01147627|exenatide|exenatide
746156|NCT01147627|premixed insulin analog|premixed insulin analog
746157|NCT01147627|thiazolidinedione|thiazolidinedione
746158|NCT01147627|β-cell function|β-cell function
746159|NCT01147627|glycemic control|glycemic control
746160|NCT01147653|Cerebral Palsy|cerebral palsy
746162|NCT01147653|Spastic Cerebral Palsy|spastic cerebral palsy
746164|NCT01147653|Umbilical Cord Blood|umbilical cord blood
746165|NCT01147653|Autologous Cord Blood|autologous cord blood
746166|NCT01147666|Kidney|kidney
746167|NCT01147666|End Stage Renal Disease|end stage renal disease
746168|NCT01147666|ESRD|esrd
746169|NCT01147666|Chronic Kidney Disease|chronic kidney disease
746170|NCT01147666|CKD|ckd
746171|NCT01147666|Renal|renal
746172|NCT01147666|Anemia|anemia
746173|NCT01147666|Oral anemia treatment|oral anemia treatment
746174|NCT01147666|Hemoglobin levels|hemoglobin levels
746175|NCT01147666|Blood count|blood count
746176|NCT01147666|Erythropoietin|erythropoietin
746177|NCT01147666|Hemodialysis|hemodialysis
746178|NCT01147666|Normoresponder|normoresponder
746179|NCT01147666|Hyporesponder|hyporesponder
746180|NCT01147679|Frontotemporal dementia|frontotemporal dementia
746181|NCT01147679|Alzheimer's disease|alzheimer's disease
746183|NCT01147679|Frontotemporal degeneration|frontotemporal degeneration
746184|NCT01147679|control|control
746185|NCT01147679|social|social
746186|NCT01147679|behavior|behavior
746187|NCT01147679|observation|observation
746188|NCT01147679|emotion|emotion
746189|NCT01147679|morality|morality
746190|NCT01147679|dementia|dementia
746191|NCT01147679|brain|brain
746192|NCT01147679|relationships|relationships
746193|NCT01147679|caregiver|caregiver
746194|NCT01147679|MRI|mri
746195|NCT01147679|neurology|neurology
746196|NCT01147692|albiglutide|albiglutide
746197|NCT01147692|simvastatin|simvastatin
746198|NCT01147692|healthy volunteers|healthy volunteers
746199|NCT01147692|pharmacokinetics|pharmacokinetics
747103|NCT01152073|Niacin|niacin
746200|NCT01147705|Peripheral arterial disease|peripheral arterial disease
746201|NCT01147705|Allopurinol|allopurinol
746202|NCT01147718|pharmacokinetics|pharmacokinetics
746203|NCT01147718|albiglutide|albiglutide
746204|NCT01147718|Healthy volunteer|healthy volunteer
746205|NCT01147718|digoxin|digoxin
746206|NCT01147731|pharmacokinetics|pharmacokinetics
746207|NCT01147731|albiglutide|albiglutide
746208|NCT01147731|warfarin|warfarin
746209|NCT01147731|Healthy volunteers|healthy volunteers
746210|NCT01147744|Efficacy|efficacy
746211|NCT01147744|Asthma|asthma
746212|NCT01147744|Safety|safety
746213|NCT01147744|Fluticasone Propionate|fluticasone propionate
746214|NCT01147744|FLAP|flap
746215|NCT01147744|Beta-agonists|beta-agonists
746216|NCT01147744|GSK2190915|gsk2190915
746217|NCT01147744|Montelukast|montelukast
746218|NCT01147744|Placebo|placebo
746219|NCT01147744|FLAIR|flair
746220|NCT01147757|pediatric patients (ASA physical status I or II) aged between|pediatric patients (asa physical status i or ii) aged between
746221|NCT01147770|progesterone|progesterone
746222|NCT01147770|antagonist|antagonist
746223|NCT01147770|rec FSH|rec fsh
746224|NCT01147770|IVF|ivf
746225|NCT01147770|pregnancy|pregnancy
746226|NCT01147796|Thrombus|thrombus
746227|NCT01147796|computed tomography|computed tomography
746228|NCT01147796|Transoesophageal echocardiography|transoesophageal echocardiography
746229|NCT01147809|Solid Tumor|solid tumor
746230|NCT01147809|Eltrombopag|eltrombopag
746231|NCT01147809|chemotherapy-induced thrombocytopenia|chemotherapy-induced thrombocytopenia
746232|NCT01147809|Thrombocytopenia|thrombocytopenia
746233|NCT01147822|SUTENT|sutent
746234|NCT01147822|GW76034|gw76034
746235|NCT01147822|Sunitinib|sunitinib
746236|NCT01147822|Renal cell carcinoma|renal cell carcinoma
746237|NCT01147822|Pazopanib|pazopanib
746238|NCT01147835|Herbal lollipops|herbal lollipops
746239|NCT01147835|Asthma|asthma
746240|NCT01147835|Dental Caries|dental caries
746241|NCT01147835|Streptococcus mutans levels|streptococcus mutans levels
746242|NCT01147835|DMFT/dmft scores|dmft/dmft scores
746243|NCT01147848|Salmeterol|salmeterol
746244|NCT01147848|fluticasone furoate|fluticasone furoate
746245|NCT01147848|Vilanterol|vilanterol
746246|NCT01147848|fluticasone propionate|fluticasone propionate
746247|NCT01147848|GW642444|gw642444
746248|NCT01147861|T2DM|t2dm
746249|NCT01147861|Pharmacodynamics|pharmacodynamics
746250|NCT01147861|GSK256073|gsk256073
746252|NCT01147874|interventional|interventional
746253|NCT01147887|26489112|26489112
746254|NCT01147887|Omeprazole|omeprazole
746255|NCT01147887|Tolbutamide|tolbutamide
746256|NCT01147900|Immune persistence|immune persistence
746257|NCT01147900|Boostrix|boostrix
746258|NCT01147900|dTpa booster study|dtpa booster study
746259|NCT01147913|Major Depression|major depression
746260|NCT01147913|Depression|depression
746261|NCT01147913|Anxiety|anxiety
746262|NCT01147913|Dysthymia|dysthymia
746263|NCT01147926|Constipation|constipation
746264|NCT01147926|Male|male
746265|NCT01147939|Acute Myeloid Leukaemia|acute myeloid leukaemia
746266|NCT01147939|AML|aml
746267|NCT01147939|Haematology|haematology
746268|NCT01147939|Investigator's Choice|investigator's choice
746269|NCT01147939|Elacytarabine|elacytarabine
746270|NCT01147939|Refractory or relapsed AML|refractory or relapsed aml
746271|NCT01147939|Phase III|phase iii
746272|NCT01147939|Randomized|randomized
746274|NCT01147939|CP4055-306|cp4055-306
746275|NCT01147939|Elacyt|elacyt
746276|NCT01147952|angina|angina
746277|NCT01147952|gene expression|gene expression
746278|NCT01147952|depression|depression
746279|NCT01147952|anxiety|anxiety
746280|NCT01147965|Colon Cancer|colon cancer
746281|NCT01147965|Lung Cancer|lung cancer
746282|NCT01147965|Breast Cancer|breast cancer
746283|NCT01147965|CEA|cea
746284|NCT01147978|ICU|icu
746285|NCT01147978|Anxiety|anxiety
746286|NCT01147978|Depression|depression
746287|NCT01147978|PTSD|ptsd
746288|NCT01147991|Epstein-Barr virus infection|epstein-barr virus infection
746289|NCT01147991|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
746290|NCT01147991|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
746291|NCT01147991|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
746292|NCT01147991|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
746293|NCT01147991|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
746294|NCT01147991|stage I gastric cancer|stage i gastric cancer
746295|NCT01147991|stage II gastric cancer|stage ii gastric cancer
746296|NCT01147991|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
746297|NCT01147991|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
746298|NCT01147991|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
746299|NCT01147991|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
746300|NCT01147991|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
746301|NCT01147991|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
746302|NCT01148004|HIV|hiv
746303|NCT01148004|Hypertriglyceridemia|hypertriglyceridemia
746304|NCT01148004|Protease Inhibitors|protease inhibitors
746305|NCT01148004|Healthy Volunteer|healthy volunteer
746306|NCT01148004|HV|hv
746307|NCT01148017|Meningococcal|meningococcal
746308|NCT01148017|ACWY|acwy
746309|NCT01148017|Conjugate Vaccine|conjugate vaccine
746310|NCT01148017|Meningitis|meningitis
746311|NCT01148017|Children|children
746312|NCT01148017|Persistence|persistence
746313|NCT01148017|Booster dose|booster dose
746314|NCT01148056|IMRT|imrt
746315|NCT01148056|radiation therapy|radiation therapy
746316|NCT01148069|IMRT-IGRT|imrt-igrt
746317|NCT01148069|radiotherapy toxicity|radiotherapy toxicity
746318|NCT01148069|seminal vesicles|seminal vesicles
746319|NCT01148082|Carcinomas (including Squamous Cell and Adenocarcinoma)|carcinomas (including squamous cell and adenocarcinoma)
746320|NCT01148095|AZD2516|azd2516
746321|NCT01148095|Phase 1|phase 1
746322|NCT01148095|Healthy volunteer|healthy volunteer
746323|NCT01148095|pharmacokinetics|pharmacokinetics
746324|NCT01148095|safety|safety
746325|NCT01148095|tolerability|tolerability
746326|NCT01148095|Multiple ascending doses|multiple ascending doses
746327|NCT01148108|NHL|nhl
746328|NCT01148108|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
746329|NCT01148108|Lymphoma|lymphoma
746330|NCT01148108|Mantle Cell|mantle cell
746331|NCT01148108|Diffuse Large B Cell|diffuse large b cell
746332|NCT01148108|Multiple Myeloma|multiple myeloma
746333|NCT01148108|Telcyta|telcyta
746334|NCT01148108|canfosfamide|canfosfamide
746335|NCT01148108|TLK286|tlk286
746336|NCT01148108|Prodrug|prodrug
746337|NCT01148108|Enzyme activated drug|enzyme activated drug
746338|NCT01148108|Glutathione Transferase P1-1 activated drug|glutathione transferase p1-1 activated drug
746339|NCT01148108|GSTp1-1 activated drug|gstp1-1 activated drug
746340|NCT01148108|Glutathione Transferase activated drug|glutathione transferase activated drug
746341|NCT01148108|Glutathione|glutathione
746342|NCT01148108|Glutathione analong|glutathione analong
746343|NCT01148147|Adenosine|adenosine
746344|NCT01148147|randomized trial|randomized trial
746345|NCT01148147|periprocedural myocardial necrosis|periprocedural myocardial necrosis
746346|NCT01148147|elective coronary angioplasty|elective coronary angioplasty
746347|NCT01148160|voriconazole|voriconazole
746348|NCT01148160|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
746349|NCT01148160|hematologic malignancy|hematologic malignancy
746350|NCT01148160|therapeutic drug monitoring|therapeutic drug monitoring
746351|NCT01148160|genetic polymorphism|genetic polymorphism
746352|NCT01148160|efficacy|efficacy
746353|NCT01148160|safety|safety
746354|NCT01148173|CNS relapse|cns relapse
746355|NCT01148173|aggressive lymphoma|aggressive lymphoma
746356|NCT01148173|HD-ASCT|hd-asct
746357|NCT01148186|Polypharmacy|polypharmacy
746358|NCT01148186|Benzodiazepine use|benzodiazepine use
746359|NCT01148186|Oxybutynin use|oxybutynin use
746360|NCT01148186|cognition disorders/drug therapy|cognition disorders/drug therapy
746361|NCT01148186|incontinence|incontinence
746362|NCT01148199|biliary anastomotic stricture|biliary anastomotic stricture
746363|NCT01148199|orthotopic liver transplantation|orthotopic liver transplantation
746364|NCT01148199|ERCP|ercp
746365|NCT01148225|Non-infectious Uveitis|non-infectious uveitis
746366|NCT01148225|Active Uveitis|active uveitis
746367|NCT01148225|Posterior-Uveitis|posterior-uveitis
746368|NCT01148225|Uveitis|uveitis
746369|NCT01148225|Pan-uveitis|pan-uveitis
746756|NCT01143506|EEG|eeg
746370|NCT01148225|Intermediate-Uveitis|intermediate-uveitis
746371|NCT01148238|Autoimmune diabetes|autoimmune diabetes
746372|NCT01148238|LADA|lada
746373|NCT01148238|T-reg|t-reg
746374|NCT01148238|cytokine|cytokine
746375|NCT01148264|break-through|break-through
746376|NCT01148264|emesis|emesis
746377|NCT01148264|break through emesis after prophylaxis with dexamethasone, 5-HT 3RA and aprepitant|break through emesis after prophylaxis with dexamethasone, 5-ht 3ra and aprepitant
746378|NCT01148277|Endoscopies|endoscopies
746379|NCT01148277|Liver diseases|liver diseases
746380|NCT01148277|Propofol|propofol
746381|NCT01148277|Midazolam and remifentanyl|midazolam and remifentanyl
746382|NCT01148290|bulking agent|bulking agent
746383|NCT01148290|emivulvectomy|emivulvectomy
746384|NCT01148290|radical vulvectomy|radical vulvectomy
746385|NCT01148290|TVT|tvt
746386|NCT01148290|urinary incontinence|urinary incontinence
746488|NCT01148706|thorax|thorax
746387|NCT01148290|vulvar cancer|vulvar cancer
746388|NCT01148303|Headache|headache
746389|NCT01148303|Fasting|fasting
746390|NCT01148303|Fasting Headache|fasting headache
746391|NCT01148303|Ramadan|ramadan
746392|NCT01148303|Ramadan Headache|ramadan headache
746393|NCT01148303|Yom Kippur|yom kippur
746394|NCT01148303|Yom Kippur Headache|yom kippur headache
746395|NCT01148316|Developmental Psychiatry|developmental psychiatry
746396|NCT01148316|Sequential Randomized Clinical Trial|sequential randomized clinical trial
746397|NCT01148316|Obsessive-Compulsive Disorder D009771|obsessive-compulsive disorder d009771
746398|NCT01148329|Coronary stenting|coronary stenting
746399|NCT01148329|Drug-eluting stent|drug-eluting stent
746400|NCT01148329|Post-market surveillance study|post-market surveillance study
747396|NCT01153295|diagnosis|diagnosis
746401|NCT01148329|Promus Element stent|promus element stent
746402|NCT01148342|Ecstacy|ecstacy
746403|NCT01148342|fMRI|fmri
746404|NCT01148342|Alternative Matrices|alternative matrices
746405|NCT01148342|Cognitive Training|cognitive training
746406|NCT01148342|Brain Imaging|brain imaging
746407|NCT01148355|Craving|craving
746408|NCT01148355|Moods|moods
746409|NCT01148355|Adolescents|adolescents
746410|NCT01148355|Nicotine|nicotine
746411|NCT01148355|Reinforcement|reinforcement
746412|NCT01148368|fimasartan|fimasartan
746413|NCT01148368|renal impairment|renal impairment
746414|NCT01148368|hypertension|hypertension
746415|NCT01148381|Genotype|genotype
746416|NCT01148381|Phenotype|phenotype
746417|NCT01148381|Characterization|characterization
746418|NCT01148394|Colorectal surgery|colorectal surgery
746419|NCT01148394|multimodal rehabilitation|multimodal rehabilitation
746420|NCT01148394|fast track|fast track
746421|NCT01148394|early feeding|early feeding
746422|NCT01148407|breast cancer|breast cancer
746423|NCT01148407|platelets|platelets
746424|NCT01148407|metastatic cancer|metastatic cancer
746425|NCT01148407|malignancy|malignancy
746426|NCT01148446|DLBCL|dlbcl
746427|NCT01148446|R-CHOP|r-chop
746428|NCT01148446|R-CEOP|r-ceop
746429|NCT01148446|Elderly patients|elderly patients
746430|NCT01148459|Plasmodium falciparum|plasmodium falciparum
746431|NCT01148459|schedule|schedule
746432|NCT01148459|HIV|hiv
746433|NCT01148459|malaria vaccine|malaria vaccine
746434|NCT01148459|EPI|epi
746435|NCT01148459|Africa|africa
746436|NCT01148472|Depressive disorder, major|depressive disorder, major
746437|NCT01148472|Randomized controlled trials|randomized controlled trials
746438|NCT01148472|Antidepressive agents|antidepressive agents
748218|NCT01156740|randomized clinical trial|randomized clinical trial
746439|NCT01148485|- Staphylococcus aureus Carriage among Athletes|- staphylococcus aureus carriage among athletes
746440|NCT01148511|Macula degeneration|macula degeneration
746441|NCT01148511|Ranibizumab|ranibizumab
746442|NCT01148511|Choroidal neovascularisation|choroidal neovascularisation
746443|NCT01148511|Treat and extend|treat and extend
746444|NCT01148511|Treat and observe|treat and observe
746445|NCT01148524|Meningococcal disease|meningococcal disease
746446|NCT01148524|Vaccines|vaccines
746447|NCT01148524|Adolescents|adolescents
746448|NCT01148537|Healthy subjects|healthy subjects
746449|NCT01148537|Opioid|opioid
746450|NCT01148537|Transdermal|transdermal
746451|NCT01148550|neonatal acute liver failure|neonatal acute liver failure
746452|NCT01148550|late-onset liver failure|late-onset liver failure
746453|NCT01148550|cholestasis,|cholestasis,
746454|NCT01148550|fatty liver,|fatty liver,
746455|NCT01148550|liver dysfunction,|liver dysfunction,
746456|NCT01148550|cirrhosis|cirrhosis
746457|NCT01148563|congestive heart failure|congestive heart failure
746458|NCT01148563|systolic|systolic
746459|NCT01148563|chronic disease|chronic disease
746460|NCT01148563|heart failure|heart failure
746461|NCT01148576|hepatic steatosis, chronic hepatitis B, entecavir|hepatic steatosis, chronic hepatitis b, entecavir
746462|NCT01148602|Acute stroke|acute stroke
746463|NCT01148602|Emergency departments|emergency departments
746464|NCT01148602|Quality Improvement|quality improvement
746465|NCT01148602|Improved Processes|improved processes
746466|NCT01148602|tPA|tpa
746467|NCT01148602|door-to-needle|door-to-needle
746468|NCT01148602|door-to-treatment|door-to-treatment
746469|NCT01148641|Lipid-based supplements|lipid-based supplements
746470|NCT01148641|LNS|lns
746471|NCT01148641|Acceptability|acceptability
746472|NCT01148641|Infant nutrition|infant nutrition
746473|NCT01148641|Guatemala|guatemala
746474|NCT01148641|Malnutrition|malnutrition
746475|NCT01148654|preterm birth|preterm birth
746476|NCT01148654|preterm labor|preterm labor
746477|NCT01148654|PTB|ptb
746478|NCT01148654|PTL|ptl
746479|NCT01148667|atopic dermatitis|atopic dermatitis
746480|NCT01148667|barrier function|barrier function
746481|NCT01148667|gut|gut
746482|NCT01148667|probiotics|probiotics
746483|NCT01148667|skin|skin
746484|NCT01148680|Islet Cell Transplantation|islet cell transplantation
746485|NCT01148680|Metabolic Diseases|metabolic diseases
746486|NCT01148680|Endocrine System Diseases|endocrine system diseases
746487|NCT01148693|Cholangitis; Cholangiopancreatography, Endoscopic Retrograde; stents; cholestasis|cholangitis; cholangiopancreatography, endoscopic retrograde; stents; cholestasis
746490|NCT01148719|Heart Failure|heart failure
746491|NCT01148719|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
746492|NCT01148719|Dyspnea|dyspnea
746493|NCT01148719|Elderly|elderly
746494|NCT01148719|Diagnosis|diagnosis
746495|NCT01148719|Primary health care|primary health care
746496|NCT01148732|Endotracheal tube|endotracheal tube
746497|NCT01148732|ultrasonography|ultrasonography
746498|NCT01148771|Pharmacokinetics|pharmacokinetics
746499|NCT01148771|Safety|safety
746500|NCT01148784|anterior cruciate ligament tear|anterior cruciate ligament tear
746501|NCT01148784|ACL|acl
746502|NCT01148784|ligament|ligament
746503|NCT01148784|knee|knee
746504|NCT01148784|allograft|allograft
746505|NCT01148797|FMF, Colchicine resistant|fmf, colchicine resistant
746506|NCT01148797|Colchicine intolerant|colchicine intolerant
746507|NCT01148797|Flare rate|flare rate
746508|NCT01148797|Canakinumab|canakinumab
746509|NCT01148810|Inflammatory muscle disease|inflammatory muscle disease
746510|NCT01148810|Muscle weakness|muscle weakness
746511|NCT01148810|Myositis|myositis
746512|NCT01148823|breast|breast
746513|NCT01148823|plastic surgery|plastic surgery
746514|NCT01148823|bandages|bandages
746515|NCT01148823|surgical site infection|surgical site infection
746516|NCT01148823|skin colonization|skin colonization
746517|NCT01148836|Coenzyme Q-10|coenzyme q-10
746518|NCT01148836|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
746519|NCT01148836|Pulmonary Arterial Hypertension Class I (Venice 2003)|pulmonary arterial hypertension class i (venice 2003)
746520|NCT01148849|HER2 positive|her2 positive
746521|NCT01148849|breast cancer|breast cancer
746522|NCT01148849|gastric cancer|gastric cancer
746523|NCT01148862|ASPIRE (Automation to Simulate Pancreatic Insulin Response)|aspire (automation to simulate pancreatic insulin response)
746524|NCT01148862|X54|x54
746525|NCT01148862|Medtronic Diabetes|medtronic diabetes
746526|NCT01148862|Diabetes Mellitus|diabetes mellitus
746527|NCT01148862|Type 1|type 1
746528|NCT01148875|breast cancer screening|breast cancer screening
746529|NCT01148875|mammography adherence|mammography adherence
746530|NCT01148875|non-adherent|non-adherent
746531|NCT01148888|pediatrics|pediatrics
746532|NCT01148888|Anaesthesia|anaesthesia
746533|NCT01148888|Scoliosis|scoliosis
746534|NCT01148888|Magnesium|magnesium
746535|NCT01148901|Ankylosing spondylitis|ankylosing spondylitis
746536|NCT01148901|Hip arthritis|hip arthritis
746537|NCT01148901|Infliximab|infliximab
746538|NCT01148914|Inflammatory biomarkers|inflammatory biomarkers
746539|NCT01148914|Atrial fibrillation|atrial fibrillation
746540|NCT01148914|Catheter ablation|catheter ablation
746541|NCT01148914|To assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome|to assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome
746542|NCT01148914|To evaluate the inflammatory activation following catheter ablation and examine its predictive role in procedure success|to evaluate the inflammatory activation following catheter ablation and examine its predictive role in procedure success
746543|NCT01148914|To determine if a change in the baseline level of biomarkers at 3-months follow-up has any correlation with long-term outcome|to determine if a change in the baseline level of biomarkers at 3-months follow-up has any correlation with long-term outcome
746544|NCT01148914|To study the association of certain biomarkers with specific types of AF (paroxysmal or persistent or long standing persistent)|to study the association of certain biomarkers with specific types of af (paroxysmal or persistent or long standing persistent)
746545|NCT01148940|sickle cell trait|sickle cell trait
746546|NCT01148940|thrombosis|thrombosis
746547|NCT01148940|D-Dimer|d-dimer
746548|NCT01148979|Major Depressive Disorder|major depressive disorder
746549|NCT01148979|Cognitive Impairment|cognitive impairment
746550|NCT01148979|Partial Response|partial response
746551|NCT01148979|Residual Symptoms|residual symptoms
746552|NCT01149005|Normal Glucose Tolerance Test|normal glucose tolerance test
746553|NCT01149005|Mixed Meal Tolerance Test|mixed meal tolerance test
746554|NCT01149005|Cystic Fibrosis|cystic fibrosis
746555|NCT01149005|Pulmonary Exacerbation|pulmonary exacerbation
746556|NCT01149005|Impaired Glucose Tolerance Test|impaired glucose tolerance test
746557|NCT01149005|Insulin Therapy|insulin therapy
746558|NCT01149018|Fibromyalgia|fibromyalgia
746559|NCT01149018|Tetrahydrocannabinol|tetrahydrocannabinol
746560|NCT01149018|Chronic Widespread Pain|chronic widespread pain
746561|NCT01149031|Provoked Vestibulodynia|provoked vestibulodynia
746562|NCT01149031|Low Level Laser Therapy|low level laser therapy
746563|NCT01149044|Acute Coronary Syndrome|acute coronary syndrome
746565|NCT01149044|Percutaneous Coronary Intervention|percutaneous coronary intervention
746566|NCT01149044|STEMI|stemi
746567|NCT01149044|Thrombectomy|thrombectomy
746568|NCT01149070|Infertility|infertility
746569|NCT01149070|Controlled ovarian stimulation|controlled ovarian stimulation
746570|NCT01149070|Reproductive techniques, assisted|reproductive techniques, assisted
746571|NCT01149070|Sperm injections, intracytoplasmic|sperm injections, intracytoplasmic
746572|NCT01149070|Gonal-f|gonal-f
746573|NCT01149070|Ovitrelle|ovitrelle
746574|NCT01149109|MGMT promotor status|mgmt promotor status
746575|NCT01149109|overall survival|overall survival
746576|NCT01149122|unresectable, metastatic biliary tract carcinoma|unresectable, metastatic biliary tract carcinoma
746675|NCT01149590|Angina|angina
746577|NCT01149122|Gemcitabine/Oxaliplatin (GEMOX)|gemcitabine/oxaliplatin (gemox)
746578|NCT01149122|Erlotinib|erlotinib
746579|NCT01149135|Seasonal Affective Disorder|seasonal affective disorder
746580|NCT01149135|phototherapy|phototherapy
746581|NCT01149135|circadian rhythms|circadian rhythms
746582|NCT01149135|blue enriched light|blue enriched light
746583|NCT01149135|melanopsin|melanopsin
746584|NCT01149135|low intensity|low intensity
746585|NCT01149148|Aortic Surgeries|aortic surgeries
746586|NCT01149148|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
746587|NCT01149161|neck dissection|neck dissection
746588|NCT01149161|sentinel lymph node|sentinel lymph node
746589|NCT01149161|Carcinoma|carcinoma
746590|NCT01149161|Papillary|papillary
746593|NCT01149174|intravesical chemotherapy|intravesical chemotherapy
746594|NCT01149174|early single instillation|early single instillation
746595|NCT01149174|mitomycin-C|mitomycin-c
746596|NCT01149174|electromotive drug administration|electromotive drug administration
746597|NCT01149200|Irritable Bowel Syndrome|irritable bowel syndrome
746598|NCT01149200|IBS-C|ibs-c
746599|NCT01149213|Major depressive disorder|major depressive disorder
746600|NCT01149213|follow-up|follow-up
746601|NCT01149213|relapse|relapse
746602|NCT01149213|remission|remission
746603|NCT01149213|transcranial direct current stimulation|transcranial direct current stimulation
746604|NCT01149226|pediatric patients|pediatric patients
746605|NCT01149226|ASA physical status I or II|asa physical status i or ii
746606|NCT01149226|aged between 1-5 yrs|aged between 1-5 yrs
746607|NCT01149252|Psoriasis|psoriasis
746608|NCT01149291|high sensitivity C-reactive protein (hsCRP)|high sensitivity c-reactive protein (hscrp)
746609|NCT01149291|cardiorenal|cardiorenal
746610|NCT01149291|end stage renal disease (ESRD)|end stage renal disease (esrd)
746611|NCT01149291|Secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
746612|NCT01149291|dialysis|dialysis
746613|NCT01149291|paricalcitol|paricalcitol
746614|NCT01149291|osteodystrophy|osteodystrophy
746615|NCT01149291|selective Vitamin D receptor activators (sVDRA)|selective vitamin d receptor activators (svdra)
746616|NCT01149291|chronic kidney disease|chronic kidney disease
746617|NCT01149304|brachytherapy|brachytherapy
746618|NCT01149304|liver metastases|liver metastases
746619|NCT01149304|irradiation|irradiation
746620|NCT01149304|radiation induced liver disease|radiation induced liver disease
746621|NCT01149304|dosimetry|dosimetry
746622|NCT01149317|acupuncture|acupuncture
746623|NCT01149317|health services research|health services research
746624|NCT01149317|chronic pain|chronic pain
746625|NCT01149317|health disparities|health disparities
746626|NCT01149330|Adapalene|adapalene
746627|NCT01149330|Benzoyl Peroxide|benzoyl peroxide
746628|NCT01149330|Acne Vulgaris|acne vulgaris
746629|NCT01149343|PRAME|prame
746630|NCT01149343|Cancer immunotherapeutic|cancer immunotherapeutic
746631|NCT01149343|Malignant melanoma|malignant melanoma
746632|NCT01149343|ASCI (Antigen-Specific Cancer Immunotherapeutic)|asci (antigen-specific cancer immunotherapeutic)
746633|NCT01149369|gastroparesis|gastroparesis
746634|NCT01149369|nausea|nausea
746635|NCT01149369|vomiting|vomiting
746636|NCT01149382|flu shot|flu shot
746637|NCT01149382|islet cell transplant recipients|islet cell transplant recipients
746638|NCT01149395|Heartburn|heartburn
746639|NCT01149395|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
746640|NCT01149408|AML|aml
746641|NCT01149408|Decitabine|decitabine
746642|NCT01149408|Acute Myeloid Leukemia|acute myeloid leukemia
746643|NCT01149408|Elderly Patients|elderly patients
746644|NCT01149408|Cancer|cancer
746645|NCT01149421|Type 2 Diabetes|type 2 diabetes
746646|NCT01149421|Diabetes|diabetes
746647|NCT01149421|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
746648|NCT01149421|ABPM|abpm
746649|NCT01149421|Blood Pressure|blood pressure
746650|NCT01149421|Heart Rate|heart rate
746651|NCT01149434|Low grade endocrine tumors|low grade endocrine tumors
746652|NCT01149434|ovarian cancers|ovarian cancers
746653|NCT01149434|K-RAS mutant colon cancers|k-ras mutant colon cancers
746654|NCT01149447|cryptogenic stroke|cryptogenic stroke
746655|NCT01149447|percutaneous closure of PFO|percutaneous closure of pfo
746656|NCT01149447|follow-up exams|follow-up exams
746657|NCT01149473|Bioequivalence|bioequivalence
746658|NCT01149473|Healthy Subjects|healthy subjects
746659|NCT01149486|Bioequivalence|bioequivalence
746660|NCT01149486|Healthy Subjects|healthy subjects
746661|NCT01149525|Multiple Sclerosis/complications|multiple sclerosis/complications
746662|NCT01149525|Fatigue Syndrome|fatigue syndrome
746663|NCT01149525|Chronic/drug therapy|chronic/drug therapy
746664|NCT01149538|FASD|fasd
746665|NCT01149538|FAS|fas
746666|NCT01149538|Alcohol|alcohol
746667|NCT01149538|Prenatal Alcohol|prenatal alcohol
746668|NCT01149551|Schizophrenia|schizophrenia
746669|NCT01149551|Bipolar disorder|bipolar disorder
746670|NCT01149551|Genetic research|genetic research
746671|NCT01149577|Olanzapine|olanzapine
746672|NCT01149577|Schizophrenia|schizophrenia
746673|NCT01149577|Polysomnography|polysomnography
746674|NCT01149577|Slow wave sleep|slow wave sleep
746676|NCT01149590|Coronary Heart Disease|coronary heart disease
746677|NCT01149590|Computed Tomography|computed tomography
746678|NCT01149590|Angiogram|angiogram
746679|NCT01149590|Coronary Artery Calcium Score|coronary artery calcium score
746680|NCT01149590|Chest Pain|chest pain
746681|NCT01149590|Angina Pectoris due to Coronary Heart Disease|angina pectoris due to coronary heart disease
746682|NCT01149603|failing Fontan|failing fontan
746683|NCT01149603|single-ventricle|single-ventricle
746684|NCT01149603|destination therapy|destination therapy
746685|NCT01149603|HeartMate II|heartmate ii
746686|NCT01149603|HMII|hmii
746687|NCT01149603|cardiac congenital anomaly|cardiac congenital anomaly
746688|NCT01149603|ventricular assist device|ventricular assist device
746689|NCT01149603|VAD|vad
746690|NCT01143259|Ileus|ileus
746691|NCT01143259|Post operative ileus|post operative ileus
746692|NCT01143272|antibiotic|antibiotic
746693|NCT01143272|associated|associated
746694|NCT01143272|diarrhoea|diarrhoea
746695|NCT01143272|saccharomyces boulardii|saccharomyces boulardii
746696|NCT01143272|Antibiotic-associated diarrhoea (AAD)|antibiotic-associated diarrhoea (aad)
746697|NCT01143272|Clostridium difficile-associated-diarrhoea (CDAD)|clostridium difficile-associated-diarrhoea (cdad)
746698|NCT01143285|Active nutritional and dietary management|active nutritional and dietary management
746699|NCT01143285|Metastatic colorectal cancer|metastatic colorectal cancer
746700|NCT01143285|Non surgical metastatic colorectal cancer|non surgical metastatic colorectal cancer
746701|NCT01143324|Single or double level instrumented fusion|single or double level instrumented fusion
746702|NCT01143324|Degenerative lumbar spine|degenerative lumbar spine
746703|NCT01143324|PLIF|plif
746704|NCT01143324|TLIF|tlif
746705|NCT01143324|MAST procedure|mast procedure
746706|NCT01143337|Rheumatoid Arthritis|rheumatoid arthritis
746707|NCT01143363|Obesity|obesity
746708|NCT01143363|exercise|exercise
746709|NCT01143363|appetite|appetite
746710|NCT01143363|hunger|hunger
746711|NCT01143363|satiety|satiety
746712|NCT01143363|food intake|food intake
746713|NCT01143376|Obesity|obesity
746714|NCT01143376|exercise|exercise
746715|NCT01143376|body composition|body composition
746716|NCT01143376|insulin sensitivity|insulin sensitivity
746717|NCT01143376|appetite|appetite
746718|NCT01143376|food intake|food intake
746719|NCT01143389|Keratoconus|keratoconus
746720|NCT01143389|Ectasia|ectasia
746721|NCT01143389|cross linking|cross linking
746722|NCT01143389|collagen cross linking|collagen cross linking
746723|NCT01143428|Motor Neuron Disease|motor neuron disease
746724|NCT01143428|Primary Lateral Sclerosis|primary lateral sclerosis
746725|NCT01143428|Oxidative Stress|oxidative stress
746726|NCT01143428|Physiology|physiology
746727|NCT01143428|PLS|pls
746728|NCT01143441|Multiple Sclerosis|multiple sclerosis
746729|NCT01143441|Daclizumab|daclizumab
746730|NCT01143454|Cardiac Disease|cardiac disease
746731|NCT01143454|iPS Cells|ips cells
746732|NCT01143454|Cardiac Risk Factors|cardiac risk factors
746733|NCT01143454|Cardiac Disease Discovery|cardiac disease discovery
746734|NCT01143454|Heart Disease|heart disease
746735|NCT01143454|Heart Disease Risk|heart disease risk
746736|NCT01143467|Fatigue|fatigue
746737|NCT01143467|Mitochondria|mitochondria
746738|NCT01143467|Mitochondrial Abnormality|mitochondrial abnormality
746739|NCT01143467|Oxidative Stress|oxidative stress
746740|NCT01143467|Gene Expression|gene expression
746741|NCT01143467|Prostate Cancer|prostate cancer
746742|NCT01143480|Endotoxin|endotoxin
746743|NCT01143480|Cytokines|cytokines
746744|NCT01143480|Gene Association|gene association
746745|NCT01143480|Inflammatory Response|inflammatory response
746746|NCT01143480|Healthy Volunteer|healthy volunteer
746747|NCT01143480|HV|hv
746748|NCT01143493|Genetic Polymorphism|genetic polymorphism
746749|NCT01143493|Glucocorticoid|glucocorticoid
746750|NCT01143493|Health Volunteer|health volunteer
746751|NCT01143493|HV|hv
746752|NCT01143506|Sense of Agency|sense of agency
746753|NCT01143506|Ulnar Nerve Block|ulnar nerve block
746754|NCT01143506|Healthy Volunteer|healthy volunteer
746755|NCT01143506|fMRI|fmri
746757|NCT01143519|p53|p53
746758|NCT01143519|Inflammatory Response|inflammatory response
746759|NCT01143519|Gene Association|gene association
746760|NCT01143519|Nutlin|nutlin
746761|NCT01143519|Doxorubicin|doxorubicin
746762|NCT01143519|Healthy Volunteer|healthy volunteer
746763|NCT01143519|HV|hv
746764|NCT01143532|African-Americans|african-americans
746765|NCT01143532|MYH9|myh9
746766|NCT01143532|Chronic Kidney Disease|chronic kidney disease
746767|NCT01143532|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
746768|NCT01143532|Proteinuria|proteinuria
746769|NCT01143532|Kidney Disease|kidney disease
746770|NCT01143532|Kidney Transplant|kidney transplant
746771|NCT01143532|African-American|african-american
746772|NCT01143545|Cancer Vaccine|cancer vaccine
746773|NCT01143545|Immunotherapy|immunotherapy
746774|NCT01143545|Adjuvant Therapy|adjuvant therapy
746775|NCT01143545|Surgical Intervention|surgical intervention
746776|NCT01143545|Lung Cancer|lung cancer
746777|NCT01143545|Esophageal Cancer|esophageal cancer
746778|NCT01143545|Thymic Carcinoma|thymic carcinoma
746779|NCT01143545|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
746780|NCT01143558|Borrelia Burgdorferi|borrelia burgdorferi
746781|NCT01143558|Xenodiagnosis|xenodiagnosis
746782|NCT01143558|Ticks|ticks
746783|NCT01143558|Skin Biopsy|skin biopsy
746784|NCT01143558|Lyme Disease|lyme disease
746785|NCT01143571|Microbiome|microbiome
746786|NCT01143571|Samples|samples
746787|NCT01143584|Prolactin|prolactin
746788|NCT01143584|Cabergoline|cabergoline
746789|NCT01143584|Macroadenomas|macroadenomas
746790|NCT01143584|escalation|escalation
746791|NCT01143597|task-specific training|task-specific training
746792|NCT01143597|arm and hand function|arm and hand function
746793|NCT01143597|corticomotor plasticity|corticomotor plasticity
746794|NCT01143597|individuals with motor-incomplete spinal cord injury|individuals with motor-incomplete spinal cord injury
746795|NCT01143610|Root coverage|root coverage
746796|NCT01143610|Graft|graft
746797|NCT01143610|Soft tissue|soft tissue
746798|NCT01143610|Periodontal regeneration|periodontal regeneration
746799|NCT01143623|antibiotic|antibiotic
746800|NCT01143623|diarrhea|diarrhea
746801|NCT01143623|probiotic|probiotic
746802|NCT01143636|Transcranial direct current stimulation|transcranial direct current stimulation
746803|NCT01143636|Chronic Pelvic Pain|chronic pelvic pain
746804|NCT01143649|Stroke|stroke
746805|NCT01143649|Transcranial direct current stimulation|transcranial direct current stimulation
746806|NCT01143649|Motor function|motor function
746807|NCT01143662|peginterferon|peginterferon
746808|NCT01143662|interferon|interferon
746809|NCT01143662|Pegasys|pegasys
746810|NCT01143662|HBV|hbv
746811|NCT01143662|Hepatitis B|hepatitis b
746812|NCT01143662|HBeAg positive|hbeag positive
746813|NCT01143675|Humerus fractures|humerus fractures
746814|NCT01143675|Tomography, x-ray computed|tomography, x-ray computed
746815|NCT01143675|Bone and bones|bone and bones
746816|NCT01143675|Orthopedic fixation devices|orthopedic fixation devices
746817|NCT01143675|Surgery|surgery
746818|NCT01143675|Postoperative complications|postoperative complications
746819|NCT01143675|Osteoporosis|osteoporosis
746820|NCT01143675|Intraoperative complications|intraoperative complications
746821|NCT01143675|Bone density|bone density
746822|NCT01143675|Radiography, dual-energy scanned projection|radiography, dual-energy scanned projection
746823|NCT01143766|Sedation|sedation
746824|NCT01143766|Gabapentin|gabapentin
746825|NCT01143766|ERCP|ercp
746826|NCT01143766|Endoscopy|endoscopy
746827|NCT01143779|Advanced Malignancy|advanced malignancy
746828|NCT01143779|FLT-PET Scan|flt-pet scan
746829|NCT01143779|[F-18]-fluoro-L-thymidine|[f-18]-fluoro-l-thymidine
746830|NCT01143779|FLT|flt
746831|NCT01143779|Positron emission tomography|positron emission tomography
746832|NCT01143779|PET|pet
746833|NCT01143779|Imaging Biomarker|imaging biomarker
746834|NCT01143779|Temsirolimus|temsirolimus
746835|NCT01143779|Topotecan|topotecan
746836|NCT01143779|Bortezomib|bortezomib
746837|NCT01143792|Substance abuse|substance abuse
746838|NCT01143792|Homelessness|homelessness
746839|NCT01143792|HIV risk behavior|hiv risk behavior
746840|NCT01143805|Absolute Bioavailability|absolute bioavailability
746841|NCT01143805|Rheumatoid Arthritis|rheumatoid arthritis
746843|NCT01143831|Vitamin K|vitamin k
746844|NCT01143831|Thrombosis|thrombosis
746845|NCT01143844|Oncofertility|oncofertility
746846|NCT01143844|Fertility|fertility
746847|NCT01143844|Late effects|late effects
746848|NCT01143844|cancer|cancer
746849|NCT01143844|chemotherapy|chemotherapy
746850|NCT01143844|radiation therapy|radiation therapy
746851|NCT01143844|survivor|survivor
746852|NCT01143844|ovarian reserve|ovarian reserve
746853|NCT01143844|premature ovarian failure|premature ovarian failure
746854|NCT01143844|early menopause|early menopause
746855|NCT01143844|healthy volunteers|healthy volunteers
746856|NCT01143844|perimenopause|perimenopause
746857|NCT01143844|middle age|middle age
746858|NCT01143844|pediatric survivors|pediatric survivors
746859|NCT01143844|healthy women|healthy women
746860|NCT01143883|All patients undergoing a colorectal resection|all patients undergoing a colorectal resection
746861|NCT01143883|surgical site infections|surgical site infections
746862|NCT01143896|Hepatitis C|hepatitis c
746863|NCT01143896|Depression|depression
746864|NCT01143896|Collaborative care|collaborative care
746865|NCT01143896|Antiviral treatment|antiviral treatment
746866|NCT01143909|Fresh frozen plasma|fresh frozen plasma
746867|NCT01143909|Coagulopathy|coagulopathy
746868|NCT01143909|Intensive care|intensive care
746869|NCT01143909|Adverse effects|adverse effects
746870|NCT01143909|Lung injury|lung injury
746871|NCT01143922|Intraoperative ultrasound|intraoperative ultrasound
746872|NCT01143922|GI tract malignancies|gi tract malignancies
746873|NCT01143922|modality|modality
746874|NCT01143922|ultrasound|ultrasound
746875|NCT01143922|staging modality|staging modality
746876|NCT01143935|Liver volume estimation|liver volume estimation
746877|NCT01143935|Indian population|indian population
746878|NCT01143948|Diabetes|diabetes
746879|NCT01143948|Cirrhosis|cirrhosis
746882|NCT01143961|Positive pressure ventilation|positive pressure ventilation
746883|NCT01143961|Electrical impedance tomography|electrical impedance tomography
746884|NCT01143974|progress free survival|progress free survival
746885|NCT01143974|response rate|response rate
746886|NCT01143974|safety|safety
746887|NCT01143987|hyperparathyroidism|hyperparathyroidism
746888|NCT01143987|pulse wave velocity|pulse wave velocity
746889|NCT01143987|end-stage renal disease|end-stage renal disease
746890|NCT01143987|arterial stiffness|arterial stiffness
746891|NCT01144000|Prosthetic joint infection|prosthetic joint infection
746892|NCT01144000|daptomycin|daptomycin
746893|NCT01144000|staphylococcus|staphylococcus
746894|NCT01144026|HIV|hiv
746895|NCT01144026|vaccine|vaccine
746896|NCT01144026|lipopeptide|lipopeptide
746897|NCT01144026|Tat|tat
746898|NCT01144026|TUTI-16|tuti-16
746901|NCT01144052|Interferon-beta 1b|interferon-beta 1b
746902|NCT01144052|De-escalation|de-escalation
746903|NCT01144052|Ticino|ticino
746904|NCT01144065|Myocardial infarction|myocardial infarction
746905|NCT01144065|Cortisol|cortisol
746906|NCT01144065|Testosterone|testosterone
746907|NCT01144078|Adiposity|adiposity
746908|NCT01144078|Exercise training|exercise training
746909|NCT01144078|Older adults|older adults
746910|NCT01144091|diabetes mellitus|diabetes mellitus
746911|NCT01144091|creatinin level|creatinin level
746912|NCT01144091|contrast induced nephropathy|contrast induced nephropathy
746913|NCT01144091|prevention contrast induced nephropathy in high risk patients|prevention contrast induced nephropathy in high risk patients
746914|NCT01144117|Progressive Multiple Sclerosis|progressive multiple sclerosis
746915|NCT01144143|Mild to moderate osteoarthritis of the knee|mild to moderate osteoarthritis of the knee
746916|NCT01149629|Droxidopa|droxidopa
746917|NCT01149629|Randomized|randomized
746918|NCT01149629|Crossover|crossover
746919|NCT01149629|Open Label|open label
746920|NCT01149629|Bioequivalence|bioequivalence
746921|NCT01149629|Fed Fast|fed fast
746922|NCT01149629|TID|tid
746923|NCT01149655|Adolescent|adolescent
746924|NCT01149655|Schizophrenia|schizophrenia
746925|NCT01149668|PCI-24781|pci-24781
746926|NCT01149668|Lymphoma|lymphoma
746927|NCT01149668|Non-Hodgkin's|non-hodgkin's
746928|NCT01149668|Hodgkin Disease|hodgkin disease
746929|NCT01149668|Multiple Myeloma|multiple myeloma
746930|NCT01149668|Leukemia|leukemia
746931|NCT01149668|Lymphocytic|lymphocytic
746932|NCT01149668|Chronic|chronic
746933|NCT01149681|Aplidin|aplidin
746934|NCT01149681|Plitidepsin|plitidepsin
746935|NCT01149681|Myelofibrosis|myelofibrosis
746936|NCT01149681|Pharma Mar|pharma mar
746937|NCT01149694|PurGenesis Technologies Inc.|purgenesis technologies inc.
746938|NCT01149694|PUR 0110 rectal enema|pur 0110 rectal enema
746939|NCT01149694|Ulcerative colitis|ulcerative colitis
746940|NCT01149694|Distal|distal
746941|NCT01149694|Normal healthy volunteers|normal healthy volunteers
746942|NCT01149707|PUR 0110|pur 0110
746943|NCT01149707|PUR 0110 Rectal Enema|pur 0110 rectal enema
746944|NCT01149707|Distal Ulcerative Colitis|distal ulcerative colitis
746945|NCT01149707|Left-Sided Ulcerative Colitis|left-sided ulcerative colitis
746947|NCT01149707|Moderate|moderate
746948|NCT01149720|Relative bioavailability|relative bioavailability
746949|NCT01149720|ARQ 197|arq 197
746950|NCT01149759|Atopic Dermatitis|atopic dermatitis
746951|NCT01149759|Eczema|eczema
746952|NCT01149772|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
746953|NCT01149772|Heart Failure|heart failure
746954|NCT01149772|Anxiety|anxiety
746955|NCT01149772|Depression|depression
746956|NCT01149785|crizotinib|crizotinib
746957|NCT01149785|healthy volunteers|healthy volunteers
746958|NCT01149785|ketoconazole|ketoconazole
746959|NCT01149785|pharmacokinetics|pharmacokinetics
746960|NCT01149785|single dose|single dose
746961|NCT01149798|metastatic breast cancer|metastatic breast cancer
747163|NCT01152294|Menopause|menopause
746962|NCT01149798|combined chemotherapy|combined chemotherapy
746963|NCT01149811|Dyskinesia|dyskinesia
746964|NCT01149824|Salvia divinorum|salvia divinorum
746965|NCT01149824|Salvinorin A|salvinorin a
746966|NCT01149837|HTLV|htlv
746967|NCT01149837|HTLV I|htlv i
746968|NCT01149837|HTLV II|htlv ii
746969|NCT01149837|HTLV Type I and/or HTLV Type II antibody|htlv type i and/or htlv type ii antibody
746970|NCT01149850|adult giant cell glioblastoma|adult giant cell glioblastoma
746971|NCT01149850|adult glioblastoma|adult glioblastoma
746972|NCT01149850|adult gliosarcoma|adult gliosarcoma
746973|NCT01149863|Autologous Transplantation|autologous transplantation
746974|NCT01149915|Advanced Leukemias|advanced leukemias
746975|NCT01149915|Relapsed/Refractory Leukemias|relapsed/refractory leukemias
746976|NCT01149915|AML|aml
746977|NCT01149915|ALL|all
746978|NCT01149915|CML|cml
746979|NCT01149915|MDS|mds
746980|NCT01149915|CLL|cll
746981|NCT01149915|MF|mf
746982|NCT01149915|Evofosfamide|evofosfamide
746983|NCT01149928|Fetal lung fluid|fetal lung fluid
746984|NCT01149928|Pulmonary adaptation|pulmonary adaptation
746985|NCT01149928|Transient tachypnea of the newborn|transient tachypnea of the newborn
746986|NCT01149928|Epinephrine|epinephrine
746987|NCT01149928|Stress hormones|stress hormones
746988|NCT01149941|Bioequivalence|bioequivalence
746989|NCT01149941|Crossover|crossover
746990|NCT01149941|Ibuprofen|ibuprofen
746991|NCT01151644|H1N1 VACCINE|h1n1 vaccine
746992|NCT01151644|INFLUENZA|influenza
746993|NCT01151644|RHEUMATIC DISEASES|rheumatic diseases
746994|NCT01151644|ANTI-H1N1 IMMUNIZATION|anti-h1n1 immunization
746995|NCT01151657|IBS|ibs
746996|NCT01151657|Irritable bowel syndrome|irritable bowel syndrome
746997|NCT01151657|Probiotics|probiotics
746998|NCT01151657|Treatment|treatment
746999|NCT01151657|Adequate relief|adequate relief
747000|NCT01151670|radiation therapy|radiation therapy
747001|NCT01151670|cognitive dysfunction|cognitive dysfunction
747002|NCT01151670|brain tumor|brain tumor
747003|NCT01151670|memory problems|memory problems
747004|NCT01151670|short term memory loss|short term memory loss
747005|NCT01151683|hypertension|hypertension
747006|NCT01151683|endothelial dysfunction|endothelial dysfunction
747007|NCT01151696|Pain|pain
747008|NCT01151696|morphine|morphine
747009|NCT01151696|hydroxyzine|hydroxyzine
747010|NCT01151696|acute pain|acute pain
747011|NCT01151696|traumatic pain|traumatic pain
747013|NCT01151696|post trauma stress|post trauma stress
747014|NCT01151696|post trauma anxiety|post trauma anxiety
747015|NCT01151696|post trauma disorders|post trauma disorders
747016|NCT01151709|Gout|gout
747017|NCT01151709|Chronic condition management|chronic condition management
747018|NCT01151709|Gout management|gout management
747019|NCT01151735|Angioedema|angioedema
747020|NCT01151735|Hereditary Diseases|hereditary diseases
747021|NCT01151735|Orphan Disease|orphan disease
747022|NCT01151735|HAE|hae
747023|NCT01151787|migraine|migraine
747024|NCT01151800|ACS|acs
747025|NCT01151800|Interactive Voice Response Technology|interactive voice response technology
747026|NCT01151800|Best Practice Guidelines|best practice guidelines
747027|NCT01151800|Health Care Utilization|health care utilization
747028|NCT01151800|Outcome Assessment|outcome assessment
747029|NCT01151826|Lung transplantation|lung transplantation
747030|NCT01151826|Primary Graft Dysfunction|primary graft dysfunction
747031|NCT01151826|Extravascular Lung Water|extravascular lung water
747032|NCT01151826|Receptor for Advanced Glycation Endproducts (RAGE)|receptor for advanced glycation endproducts (rage)
747033|NCT01151826|Intercellular Adhesion Molecule-1 (ICAM-1)|intercellular adhesion molecule-1 (icam-1)
747034|NCT01151839|Esophagus|esophagus
747035|NCT01151839|squamous cell carcinoma|squamous cell carcinoma
747036|NCT01151839|neoadjuvant chemoradiation|neoadjuvant chemoradiation
747037|NCT01151852|Imatinib|imatinib
747038|NCT01151852|Re-challenge|re-challenge
747039|NCT01151865|Delirium|delirium
747040|NCT01151865|Intensive Care Unit|intensive care unit
747041|NCT01151865|Dexmedetomidine|dexmedetomidine
747042|NCT01151878|constipation|constipation
747043|NCT01151878|children|children
747044|NCT01151891|Pedal puncture wounds|pedal puncture wounds
747045|NCT01151891|Infection in pedal puncture wounds|infection in pedal puncture wounds
747046|NCT01151891|Diabetes education and pedal puncture wounds|diabetes education and pedal puncture wounds
747047|NCT01151917|Bilio-pancreatic diversion|bilio-pancreatic diversion
747048|NCT01151917|morbid obesity|morbid obesity
747049|NCT01151917|insulin resistance|insulin resistance
747050|NCT01151917|proteomics|proteomics
747051|NCT01151930|Advanced solid tumor failed with standard therapy|advanced solid tumor failed with standard therapy
747052|NCT01151943|cesarean section|cesarean section
747053|NCT01151943|continuous wound infiltration|continuous wound infiltration
747054|NCT01151943|transversus abdominis plane block|transversus abdominis plane block
747055|NCT01151956|observational study|observational study
747056|NCT01151956|actinic keratosis|actinic keratosis
747057|NCT01151956|imiquimod|imiquimod
747058|NCT01151969|Health Service Misuse|health service misuse
747059|NCT01151969|Overutilization of Health Services|overutilization of health services
747060|NCT01151969|Primary Health Care|primary health care
747061|NCT01151969|Cost Effectiveness|cost effectiveness
747062|NCT01151969|Quality of life|quality of life
747063|NCT01151969|Randomised Controlled Trial|randomised controlled trial
747064|NCT01151969|Multilevel analysis|multilevel analysis
747065|NCT01151982|Depression|depression
747066|NCT01151982|Primary prevention.|primary prevention.
747067|NCT01151982|Primary health care.|primary health care.
747068|NCT01151982|Randomised controlled trial.|randomised controlled trial.
747069|NCT01151995|Clinical Trial Monitoring|clinical trial monitoring
747070|NCT01151995|Effectiveness of remote monitoring|effectiveness of remote monitoring
747071|NCT01151995|Efficiency of remote monitoring|efficiency of remote monitoring
747072|NCT01151995|Costs of remote monitoring|costs of remote monitoring
747073|NCT01152008|Microcirculation|microcirculation
747074|NCT01152008|laser flowmetry|laser flowmetry
747075|NCT01152008|Skin|skin
747076|NCT01152008|Physiology|physiology
747077|NCT01152021|dexmedetomidine|dexmedetomidine
747078|NCT01152021|propofol|propofol
747079|NCT01152021|sedation|sedation
747080|NCT01152021|MRI|mri
747081|NCT01152021|scanning|scanning
747084|NCT01152021|Magnetic Resonance Imaging|magnetic resonance imaging
747085|NCT01152034|Bipolar disorder|bipolar disorder
747086|NCT01152034|psychosocial intervention|psychosocial intervention
747087|NCT01152034|group therapy|group therapy
747088|NCT01152034|relapse prevention|relapse prevention
747089|NCT01152034|parasuicide|parasuicide
747090|NCT01152034|Recurrence|recurrence
747091|NCT01152034|hospitalization|hospitalization
747092|NCT01152034|Medication adherence|medication adherence
747093|NCT01152034|Self-Injurious Behavior|self-injurious behavior
747094|NCT01152034|Quality of Life|quality of life
747095|NCT01152047|oxytocin|oxytocin
747096|NCT01152047|satiety|satiety
747097|NCT01152047|dyspepsia|dyspepsia
747098|NCT01152060|remission of proteinuria|remission of proteinuria
747099|NCT01152060|HBVe-antigen|hbve-antigen
747100|NCT01152073|Cholesterol|cholesterol
747101|NCT01152073|Statin|statin
747102|NCT01152073|Nutraceuticals|nutraceuticals
747104|NCT01152073|Hyperlipidemia|hyperlipidemia
747105|NCT01152073|Liquid|liquid
747106|NCT01152086|Physical activity|physical activity
747107|NCT01152086|mountain hiking|mountain hiking
747108|NCT01152086|exercise|exercise
747109|NCT01152086|training program|training program
747110|NCT01152086|hopelessness|hopelessness
747111|NCT01152086|chronic suicidality|chronic suicidality
747112|NCT01152086|depression|depression
747113|NCT01152086|suicide attempt|suicide attempt
747114|NCT01152086|suicide|suicide
747115|NCT01152099|Postmastectomy|postmastectomy
747116|NCT01152112|morcellator|morcellator
747117|NCT01152112|hysteroscope|hysteroscope
747118|NCT01152112|myomectomy|myomectomy
747119|NCT01152112|polypectomy|polypectomy
747120|NCT01152112|uterine fibroids|uterine fibroids
747121|NCT01152112|uterine polyps|uterine polyps
747122|NCT01152112|office|office
747123|NCT01152112|cost|cost
747124|NCT01152112|local anesthetic|local anesthetic
747125|NCT01152112|cervical block|cervical block
747126|NCT01152112|pain management|pain management
747127|NCT01152125|Osteoarthritis|osteoarthritis
747128|NCT01152125|stem cell implantation|stem cell implantation
747129|NCT01152125|bone marrow|bone marrow
747130|NCT01152125|autologous|autologous
747131|NCT01152138|Acute myocardial infarction|acute myocardial infarction
747132|NCT01152138|Closed cell stent|closed cell stent
747133|NCT01152138|Open cell stent|open cell stent
747134|NCT01152138|primary percutaneous coronary intervention|primary percutaneous coronary intervention
747135|NCT01152151|Heading Health Plan Implementation|heading health plan implementation
747136|NCT01152151|General Practice|general practice
747137|NCT01152151|Point of care testing|point of care testing
747138|NCT01152151|education|education
747139|NCT01152164|quality of life|quality of life
747140|NCT01152164|rectal cancer|rectal cancer
747141|NCT01152177|Heading Health Plan Implementation|heading health plan implementation
747142|NCT01152177|General Practice|general practice
747143|NCT01152177|Point of care testing|point of care testing
747144|NCT01152177|education|education
749514|NCT01160601|NSCLC|nsclc
747145|NCT01152203|Bendamustine|bendamustine
747146|NCT01152203|Bevacizumab|bevacizumab
747147|NCT01152242|Insulin|insulin
747148|NCT01152255|Treatment of HIV-1 Infection|treatment of hiv-1 infection
747149|NCT01152268|sperm banking|sperm banking
747150|NCT01152268|Adolescent males|adolescent males
747151|NCT01152268|Infertility|infertility
747152|NCT01152268|Adolescents diagnosed with cancer|adolescents diagnosed with cancer
747153|NCT01152281|retention|retention
747154|NCT01152281|attrition|attrition
747155|NCT01152281|empowering|empowering
747156|NCT01152281|reactance|reactance
747157|NCT01152281|motivational|motivational
747158|NCT01152281|goals|goals
747159|NCT01152281|Basic control|basic control
747160|NCT01152281|Control with stories of people with AIDS|control with stories of people with aids
747161|NCT01152281|Instrumental|instrumental
747162|NCT01152281|Instrumental and Empowering|instrumental and empowering
747164|NCT01152294|Decision making|decision making
747165|NCT01152294|Decision aids|decision aids
747166|NCT01152294|Decision quality instrument|decision quality instrument
747167|NCT01152307|Depression|depression
747168|NCT01152307|Depressive disorder|depressive disorder
747169|NCT01152307|Decision Making|decision making
747170|NCT01152307|Decision Aids|decision aids
747171|NCT01152307|Decision Quality Instrument|decision quality instrument
747172|NCT01152320|Asthma|asthma
747173|NCT01152320|Spirometry|spirometry
747174|NCT01152320|Pediatric|pediatric
747175|NCT01152320|Primary Health Care|primary health care
747176|NCT01152320|Education, Distance|education, distance
747177|NCT01152346|Bioequivalence|bioequivalence
747178|NCT01152346|Myelodysplastic Syndrome|myelodysplastic syndrome
747179|NCT01152346|MDS|mds
747180|NCT01152346|Azacitidine|azacitidine
747181|NCT01152359|obesity|obesity
747182|NCT01152359|diet, low carbohydrate|diet, low carbohydrate
747183|NCT01152359|diet, fat-restricted|diet, fat-restricted
747184|NCT01152359|food preferences|food preferences
747185|NCT01152359|quality of life|quality of life
747186|NCT01152359|patient compliance|patient compliance
747187|NCT01152385|Type 2 diabetes mellitus|type 2 diabetes mellitus
747192|NCT01152385|dose regimen|dose regimen
747193|NCT01152385|pharmacokinetics|pharmacokinetics
747194|NCT01152398|Breast cancer|breast cancer
747195|NCT01152398|Vaccine|vaccine
747196|NCT01152398|Metastatic|metastatic
747197|NCT01152398|HER-2-positive|her-2-positive
747198|NCT01152398|Phase I|phase i
747199|NCT01152398|HER-2 Positive Breast Cancer|her-2 positive breast cancer
747200|NCT01152411|Renal Failure|renal failure
747201|NCT01152411|Chronic Kidney Disease|chronic kidney disease
747202|NCT01152411|Chronic Renal Failure|chronic renal failure
747203|NCT01152424|Acute eosinophilic pneumonia|acute eosinophilic pneumonia
747204|NCT01152424|Exhaled nitric oxide|exhaled nitric oxide
747205|NCT01152463|thoracic ultrasound (US)|thoracic ultrasound (us)
747206|NCT01152463|post-op care|post-op care
747207|NCT01152463|pneumothorax|pneumothorax
747208|NCT01152463|pleural effusion|pleural effusion
747395|NCT01153295|Irritable bowel syndrome|irritable bowel syndrome
747209|NCT01152476|healthy pediatric patients undergoing tonsillectomy and adenoidectomy|healthy pediatric patients undergoing tonsillectomy and adenoidectomy
747210|NCT01152489|Pain|pain
747211|NCT01152502|Post operative conditions, paracetamol metabolites|post operative conditions, paracetamol metabolites
747212|NCT01152515|safety and efficacy of maintaining a remifentanil infusion during extubation in propofol-remifentanil sedated patients after surgery|safety and efficacy of maintaining a remifentanil infusion during extubation in propofol-remifentanil sedated patients after surgery
747213|NCT01152528|bacterial vaginosis|bacterial vaginosis
747214|NCT01152528|screening|screening
747215|NCT01152528|abortion|abortion
747216|NCT01152528|preterm delivery|preterm delivery
747217|NCT01152541|Keratoconus|keratoconus
747218|NCT01152541|Corneal Ectasia|corneal ectasia
747219|NCT01152541|Collagen Crosslinking|collagen crosslinking
747220|NCT01152541|Riboflavin|riboflavin
747221|NCT01152554|Major Depressive Disorder|major depressive disorder
747222|NCT01152554|MDD|mdd
747223|NCT01152554|Depression|depression
747224|NCT01152554|Safety|safety
747225|NCT01152554|add-on therapy|add-on therapy
747226|NCT01152567|Hypertension|hypertension
747227|NCT01152567|ACE|ace
747228|NCT01152567|ARB|arb
747229|NCT01152567|real life data|real life data
747230|NCT01152567|CVD|cvd
747231|NCT01152567|cost effectiveness|cost effectiveness
747232|NCT01152580|melatonin|melatonin
747233|NCT01152580|menopause|menopause
747234|NCT01152580|perimenopause|perimenopause
747235|NCT01152580|sleep|sleep
747236|NCT01152580|osteoporosis|osteoporosis
747237|NCT01152580|osteopenia|osteopenia
747238|NCT01152580|anxiety|anxiety
747239|NCT01152580|depression|depression
747240|NCT01152580|hypertension|hypertension
747241|NCT01152632|acupuncture|acupuncture
747242|NCT01152632|migraine|migraine
747243|NCT01152632|specific acupoints|specific acupoints
747244|NCT01152632|brain network|brain network
747245|NCT01152645|Advanced/recurrent gastric cancer|advanced/recurrent gastric cancer
747246|NCT01152658|Partial supraspinatus tear|partial supraspinatus tear
747247|NCT01152658|partial tear ssp per echo|partial tear ssp per echo
747248|NCT01152684|CAM|cam
747249|NCT01152684|HIV-Positive|hiv-positive
747250|NCT01152684|Latinos|latinos
747251|NCT01152684|US-Mexico Border region|us-mexico border region
747252|NCT01152684|San Diego-Tijuana|san diego-tijuana
747253|NCT01152684|Identify the nature and extent of complementary and alternative medicine use among HIV-positive Latinos in the US-Mexico border region|identify the nature and extent of complementary and alternative medicine use among hiv-positive latinos in the us-mexico border region
747254|NCT01152697|nonadherence|nonadherence
747255|NCT01152697|noncompliance|noncompliance
747256|NCT01152697|homeless|homeless
747257|NCT01152697|schizophrenia|schizophrenia
747258|NCT01152697|schizoaffective|schizoaffective
747259|NCT01152710|capecitabine|capecitabine
747260|NCT01152710|chemoradiation|chemoradiation
747261|NCT01152710|rectal cancer|rectal cancer
747264|NCT01152736|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
747266|NCT01152749|Nicotine pharmacokinetics|nicotine pharmacokinetics
747267|NCT01152762|Physiotherapy, COPD, effectiveness, primary care|physiotherapy, copd, effectiveness, primary care
747268|NCT01152775|partnered surgical decision-making|partnered surgical decision-making
747269|NCT01152775|impact of multimedia-based teaching|impact of multimedia-based teaching
747270|NCT01152775|patient education|patient education
747271|NCT01152775|understanding and retention by patients|understanding and retention by patients
747272|NCT01152801|mRCC,|mrcc,
747273|NCT01152801|everolimus,|everolimus,
747274|NCT01152801|mTOR,|mtor,
747275|NCT01152801|intolerant of VEGF-therapies|intolerant of vegf-therapies
747276|NCT01152814|Seasonal influenza|seasonal influenza
747277|NCT01152814|Vaccine|vaccine
747278|NCT01152827|Pheochromocytoma|pheochromocytoma
747279|NCT01152827|extra-adrenal paraganglioma|extra-adrenal paraganglioma
747280|NCT01152827|non-functioning carcinoid|non-functioning carcinoid
747281|NCT01152827|RAD001|rad001
747282|NCT01152840|Adenoid cystic carcinoma|adenoid cystic carcinoma
747283|NCT01152840|RAD001|rad001
747284|NCT01152853|advanced gastric cancer|advanced gastric cancer
747285|NCT01152853|HER2|her2
747286|NCT01152853|PF00299804|pf00299804
747287|NCT01152866|Multifollicular stimulation|multifollicular stimulation
747288|NCT01152866|Pregnancy|pregnancy
747289|NCT01152866|Reproductive Techniques, Assisted|reproductive techniques, assisted
747290|NCT01152866|Fertilization in Vitro|fertilization in vitro
747291|NCT01152866|Infertility|infertility
747292|NCT01152879|Parenteral Nutrition|parenteral nutrition
747293|NCT01152879|Quality of Life|quality of life
747294|NCT01152892|end stage renal disease|end stage renal disease
747295|NCT01152892|chronic kidney disease|chronic kidney disease
747296|NCT01152892|cardiovascular event|cardiovascular event
747297|NCT01152892|sudden cardiac death|sudden cardiac death
747298|NCT01152892|autonomic function|autonomic function
747299|NCT01152905|Neuromuscular blockade|neuromuscular blockade
747300|NCT01152905|Neuromuscular blocking agents|neuromuscular blocking agents
747301|NCT01152905|Atracurium|atracurium
747302|NCT01152905|Nitrous oxide|nitrous oxide
747303|NCT01152918|HIV Prevention|hiv prevention
747304|NCT01152918|HIV Treatment|hiv treatment
747305|NCT01152918|HIV Test and Treat Model of Prevention|hiv test and treat model of prevention
747306|NCT01152918|ART for Prevention|art for prevention
747307|NCT01152918|Prevention for HIV Positives|prevention for hiv positives
747308|NCT01152918|Financial Incentives|financial incentives
747309|NCT01152918|Computer-delivered risk-reduction counseling|computer-delivered risk-reduction counseling
747310|NCT01152931|Antioxidants|antioxidants
747311|NCT01152931|Micronutrients|micronutrients
747312|NCT01152931|Malaria|malaria
747313|NCT01152931|focus is to determine the effect of antioxidant micronutrients in malaria|focus is to determine the effect of antioxidant micronutrients in malaria
747314|NCT01152944|Symptomatic intracranial atherosclerotic disease enrolled in the medical arm of SAMMPRIS|symptomatic intracranial atherosclerotic disease enrolled in the medical arm of sammpris
747315|NCT01152957|diabetes|diabetes
747316|NCT01152957|cardiovascular|cardiovascular
747317|NCT01152957|chronic|chronic
747318|NCT01152957|Community Health Workers|community health workers
747319|NCT01152957|behavioral|behavioral
747320|NCT01152957|social|social
747321|NCT01152957|diet|diet
747322|NCT01152957|exercise|exercise
747323|NCT01152957|patient|patient
747324|NCT01152957|cholesterol|cholesterol
747325|NCT01152957|A1C|a1c
747326|NCT01152957|glucose|glucose
747327|NCT01152983|Finger sticks|finger sticks
747328|NCT01152983|Rapid Ring|rapid ring
747329|NCT01152983|Finger sticks method of obtaining blood for diagnostic testing|finger sticks method of obtaining blood for diagnostic testing
747330|NCT01152996|Depression|depression
747331|NCT01152996|Melancholia|melancholia
747332|NCT01152996|Paraphrenia|paraphrenia
747333|NCT01152996|Drug Therapy|drug therapy
747334|NCT01153009|Major Depressive Disorder|major depressive disorder
747335|NCT01153009|Depression|depression
747336|NCT01153009|Melancholia|melancholia
747337|NCT01153009|Drug Therapy|drug therapy
747338|NCT01153022|Musculoskeletal manipulations|musculoskeletal manipulations
747339|NCT01153022|Muscle spasticity|muscle spasticity
752171|NCT01172028|stage IV breast cancer|stage iv breast cancer
747344|NCT01153048|Intensification of Education|intensification of education
747345|NCT01153048|learning nest methodology|learning nest methodology
747347|NCT01153048|type 2 diabetes|type 2 diabetes
747348|NCT01153048|Mali|mali
747349|NCT01153048|the focus of this study is on the intensification of education on the treatment of type 2 diabetes|the focus of this study is on the intensification of education on the treatment of type 2 diabetes
747350|NCT01153074|Bronchopleural fistula|bronchopleural fistula
747351|NCT01153074|Bronchoscopy|bronchoscopy
747352|NCT01153100|Diabetes|diabetes
747353|NCT01153113|adenocarcinoma of the prostate|adenocarcinoma of the prostate
747354|NCT01153113|metastatic prostate adenocarcinoma, Stage (T1-4, N+, M0) or (T1-4, N0-3, M+)|metastatic prostate adenocarcinoma, stage (t1-4, n+, m0) or (t1-4, n0-3, m+)
747355|NCT01153113|rising PSA levels while maintained on LHRH analogues|rising psa levels while maintained on lhrh analogues
747356|NCT01153126|Diagnostic Imaging|diagnostic imaging
747357|NCT01153126|Breast Screening|breast screening
747358|NCT01153126|Breast Cancer|breast cancer
747359|NCT01153126|To be eligible for the study, subjects must:|to be eligible for the study, subjects must:
747360|NCT01153126|Be females at least 18 years of age,|be females at least 18 years of age,
747361|NCT01153126|Have had their screening mammogram performed at the UW Breast Center,|have had their screening mammogram performed at the uw breast center,
747362|NCT01153126|Be able to read and write English at the 6th grade level (as shown by their, ability to understand the informed consent),|be able to read and write english at the 6th grade level (as shown by their, ability to understand the informed consent),
747363|NCT01153126|Have access to a computer with internet capability.|have access to a computer with internet capability.
747364|NCT01153139|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
747365|NCT01153139|Depression|depression
747366|NCT01153139|Theta Burst Stimulation|theta burst stimulation
747367|NCT01153152|wisdom teeth|wisdom teeth
747368|NCT01153152|acute pulpitis|acute pulpitis
747369|NCT01153152|extraction|extraction
747370|NCT01153152|pain|pain
747371|NCT01153152|Pain Following Removal of Wisdom Teeth with Acute Pulpitis|pain following removal of wisdom teeth with acute pulpitis
747372|NCT01153165|Refractory|refractory
747373|NCT01153165|Asthma|asthma
747374|NCT01153165|Depression|depression
747375|NCT01153191|colorectal surgery|colorectal surgery
747376|NCT01153204|Erectile Dysfunction|erectile dysfunction
747377|NCT01153204|Group Psychotherapy|group psychotherapy
747378|NCT01153204|Sildenafil [Substance Name]|sildenafil [substance name]
747379|NCT01153204|Patient Satisfaction|patient satisfaction
747380|NCT01153204|Efficacy|efficacy
747381|NCT01153204|Randomized Controlled Trial [Publication Type]|randomized controlled trial [publication type]
747382|NCT01153217|Tenofovir|tenofovir
747383|NCT01153217|HIV-infection|hiv-infection
747385|NCT01153217|Osteoporosis|osteoporosis
747386|NCT01153217|Osteopenia|osteopenia
747387|NCT01153230|PQ|pq
747388|NCT01153243|inflammatory markers|inflammatory markers
747389|NCT01153269|Human Immunodeficiency Virus|human immunodeficiency virus
747390|NCT01153269|Co-infection with Hepatitis B or Hepatitis C|co-infection with hepatitis b or hepatitis c
747391|NCT01153269|Tolerability|tolerability
747392|NCT01153269|Effectiveness|effectiveness
747393|NCT01153282|Breast Cancer patients|breast cancer patients
747394|NCT01153295|IBS|ibs
747397|NCT01153295|safety|safety
747398|NCT01153295|Health related quality of life|health related quality of life
747399|NCT01153308|Morbid Obesity|morbid obesity
747400|NCT01153308|Obesity|obesity
747401|NCT01153308|Weight Loss|weight loss
747402|NCT01153308|Bariatric Surgery|bariatric surgery
747403|NCT01153321|Respiratory disease|respiratory disease
747404|NCT01153321|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
747405|NCT01153347|Major Depressive Disorder|major depressive disorder
747406|NCT01153347|MDD|mdd
747407|NCT01153347|Depression|depression
747408|NCT01153347|Safety|safety
747409|NCT01153347|add-on therapy|add-on therapy
747410|NCT01153373|Detection of tobacco, alcohol, and drug use.|detection of tobacco, alcohol, and drug use.
747411|NCT01153386|Pulmonary arterial hypertension|pulmonary arterial hypertension
747412|NCT01153386|Treprostinil|treprostinil
747413|NCT01153386|Pharmacokinetics|pharmacokinetics
747414|NCT01153399|Non Small Cell Lung Cancer|non small cell lung cancer
747415|NCT01153399|EGFR mutations|egfr mutations
747416|NCT01153425|Osteoporosis|osteoporosis
747417|NCT01153425|Osteopenia|osteopenia
747418|NCT01153425|Fracture Risk|fracture risk
747419|NCT01153425|teriparatide or Forteo|teriparatide or forteo
747420|NCT01153425|zoledronic acid or Reclast|zoledronic acid or reclast
747421|NCT01153438|Diabetes|diabetes
747422|NCT01153438|Obesity|obesity
747423|NCT01153438|Bariatric surgery|bariatric surgery
747424|NCT01153438|Gut hormones|gut hormones
747425|NCT01153438|Glucagon like peptide 1|glucagon like peptide 1
747426|NCT01153438|Insulin|insulin
747427|NCT01153451|Pending tests|pending tests
747428|NCT01153451|Discharge|discharge
747429|NCT01153451|Awareness|awareness
747430|NCT01153451|Care transitions|care transitions
747431|NCT01153490|Quetiapine|quetiapine
747432|NCT01153490|Psychotic experiences|psychotic experiences
747433|NCT01153490|Cannabis dependence|cannabis dependence
747434|NCT01153490|Craving|craving
747435|NCT01153490|Mood|mood
747436|NCT01153490|Substance use|substance use
747437|NCT01153503|Postoperative pain, TAP block, Hysterectomy|postoperative pain, tap block, hysterectomy
747438|NCT01153516|Type 2 diabetes|type 2 diabetes
747439|NCT01153516|Bariatric surgery|bariatric surgery
747440|NCT01153516|Obesity|obesity
747441|NCT01153516|Weight loss|weight loss
747442|NCT01153529|PTSD|ptsd
747443|NCT01153568|Vitamin D|vitamin d
747444|NCT01153568|osteoporosis|osteoporosis
747445|NCT01153568|african american women|african american women
747446|NCT01153594|Substance Use Disorders|substance use disorders
747447|NCT01153594|Relapse|relapse
747448|NCT01153594|Recovery|recovery
747449|NCT01153594|Disease Management|disease management
747450|NCT01153594|Long term outcomes|long term outcomes
747451|NCT01153594|Addiction Treatment|addiction treatment
747452|NCT01153607|Alzheimer's disease|alzheimer's disease
747453|NCT01153607|Diagnostic imaging|diagnostic imaging
747454|NCT01153607|PET diagnosis|pet diagnosis
747455|NCT01153607|PET tracer|pet tracer
747456|NCT01153620|Acute traumatic wounds|acute traumatic wounds
747457|NCT01153646|HIV|hiv
747458|NCT01153646|Gene Transfer|gene transfer
747459|NCT01153646|T-Cell Immunotherapy|t-cell immunotherapy
747460|NCT01153646|HIV-1 infected patients who have failed anti-retroviral therapy|hiv-1 infected patients who have failed anti-retroviral therapy
747461|NCT01153659|rabeprazole|rabeprazole
747462|NCT01153659|esomeprazole|esomeprazole
747463|NCT01153659|h. pylori-negative|h. pylori-negative
747464|NCT01153659|nocturnal acid breakthrough|nocturnal acid breakthrough
747465|NCT01153659|intragastric pH, PK/PD|intragastric ph, pk/pd
747466|NCT01153659|effect on gastric pH in healthy, H. pylori-Negative subjects|effect on gastric ph in healthy, h. pylori-negative subjects
747467|NCT01153685|Fluviral®Influenza|fluviral®influenza
747468|NCT01153737|Neck pain|neck pain
747469|NCT01153737|Primary Health Care|primary health care
747470|NCT01153737|Manual Therapy|manual therapy
747471|NCT01153737|TENS|tens
747472|NCT01153750|cholangiocellular carcinoma|cholangiocellular carcinoma
747473|NCT01153750|bile duct cancer|bile duct cancer
747474|NCT01153763|Metastatic melanoma|metastatic melanoma
747475|NCT01153763|BRAF mutant|braf mutant
747476|NCT01153763|Melanoma|melanoma
748115|NCT01156415|MDD|mdd
747477|NCT01153763|BRAF mutant metastatic melanoma|braf mutant metastatic melanoma
747478|NCT01153776|Arterial switch operation|arterial switch operation
747479|NCT01153776|Transposition of the great arteries|transposition of the great arteries
747480|NCT01153776|Congenital heart diseases|congenital heart diseases
747481|NCT01153776|CT coronary angiography|ct coronary angiography
747482|NCT01153789|Vergence-accommodation evaluation|vergence-accommodation evaluation
747483|NCT01153789|Vergence and postural control|vergence and postural control
747484|NCT01153789|Dynamic visual acuity|dynamic visual acuity
747485|NCT01153802|Positron Emission Tomography|positron emission tomography
747486|NCT01153802|serotonin|serotonin
747487|NCT01153802|inhibitor of the neurotransmitters|inhibitor of the neurotransmitters
747488|NCT01153802|safety of single oral doses|safety of single oral doses
747489|NCT01153802|norepinephrine|norepinephrine
747490|NCT01153802|dopamine|dopamine
747491|NCT01153815|efficacy|efficacy
747492|NCT01153815|Spasticity, Post-Stroke|spasticity, post-stroke
747493|NCT01153815|safety|safety
747494|NCT01153815|Botulinum toxin type A|botulinum toxin type a
747495|NCT01153815|placebo|placebo
747496|NCT01153815|spasticity|spasticity
747497|NCT01153828|Altargo|altargo
747498|NCT01153828|Bactroban|bactroban
747499|NCT01153828|Fucidin|fucidin
747500|NCT01153828|Fusidic acid|fusidic acid
747501|NCT01153828|Mupirocin|mupirocin
747502|NCT01153828|topical|topical
747503|NCT01153828|Retapamulin|retapamulin
747504|NCT01153828|United Kingdom|united kingdom
747505|NCT01153841|Pneumococcal vaccine|pneumococcal vaccine
747506|NCT01153854|acute diarrhea|acute diarrhea
747507|NCT01153854|Acute diarrhea (three or more watery or semi-watery bowel movements for at least one day lasting no more than 5 days before being admitted)|acute diarrhea (three or more watery or semi-watery bowel movements for at least one day lasting no more than 5 days before being admitted)
747508|NCT01153867|Schema Focused Therapy|schema focused therapy
747509|NCT01153867|Chronic Depression|chronic depression
747510|NCT01153867|Mechanisms of Change|mechanisms of change
747511|NCT01153880|Altabax|altabax
747512|NCT01153880|United States|united states
747513|NCT01153880|topical|topical
747514|NCT01153880|Mupirocin|mupirocin
747515|NCT01153880|Retapamulin|retapamulin
747516|NCT01153880|Bactroban|bactroban
747517|NCT01153893|Pneumococcal disease|pneumococcal disease
747518|NCT01153893|Pneumococcal vaccine|pneumococcal vaccine
747519|NCT01153893|Catch-up vaccination|catch-up vaccination
747520|NCT01153893|Immunogenicity|immunogenicity
747521|NCT01153893|Booster vaccination|booster vaccination
747522|NCT01153893|Safety|safety
747523|NCT01153906|autoimmune diseases|autoimmune diseases
747524|NCT01153906|HPV vaccine|hpv vaccine
747525|NCT01153906|papillomavirus|papillomavirus
747526|NCT01153906|human papillomavirus|human papillomavirus
747527|NCT01153906|HPV|hpv
747528|NCT01153932|968|968
747529|NCT01153932|muscular dystrophy|muscular dystrophy
747530|NCT01153932|duchenne|duchenne
747531|NCT01153932|DMD|dmd
747532|NCT01153945|Hypothyroid and non hypothyroid|hypothyroid and non hypothyroid
747533|NCT01153958|Vaginosis, Bacterial|vaginosis, bacterial
747534|NCT01153958|Colposeptine|colposeptine
747535|NCT01153958|Metronidazole|metronidazole
747536|NCT01154010|PEMF|pemf
747537|NCT01154010|iritis|iritis
747538|NCT01154010|anterior uveitis|anterior uveitis
747539|NCT01154023|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
747540|NCT01154023|Behavior Therapy|behavior therapy
747541|NCT01154049|Schistosomiasis|schistosomiasis
747542|NCT01154049|Vaccine|vaccine
747543|NCT01154049|sm14|sm14
747544|NCT01154062|age-related macular degeneration|age-related macular degeneration
747545|NCT01154062|pazopanib|pazopanib
747546|NCT01154062|choroidal neovascularization|choroidal neovascularization
747547|NCT01154062|GW786034|gw786034
747548|NCT01154075|Liver transplant|liver transplant
747549|NCT01154075|Adherence|adherence
747550|NCT01154075|Compliance|compliance
747551|NCT01154075|Tacrolimus|tacrolimus
747552|NCT01154088|Adolescent|adolescent
747553|NCT01154088|Vaccine, conjugate|vaccine, conjugate
747554|NCT01154088|Adult|adult
747555|NCT01154088|Neisseria meningitidis|neisseria meningitidis
747556|NCT01154088|Immunogenicity|immunogenicity
747557|NCT01154088|Meningococcal vaccine|meningococcal vaccine
747558|NCT01154088|Safety|safety
747559|NCT01146977|CBF(+)|cbf(+)
747560|NCT01146990|17P Efficacy Trial Follow up|17p efficacy trial follow up
747561|NCT01147003|Seizure frequency|seizure frequency
747562|NCT01147003|nervous system diseases|nervous system diseases
747563|NCT01147003|brain diseases|brain diseases
747564|NCT01147003|neurologic manifestations|neurologic manifestations
747565|NCT01147003|adjunctive treatment|adjunctive treatment
747566|NCT01147003|AEDs|aeds
747567|NCT01147003|antiepileptic drug|antiepileptic drug
747568|NCT01147016|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
747569|NCT01147016|HER2-negative breast cancer|her2-negative breast cancer
747570|NCT01147016|male breast cancer|male breast cancer
747571|NCT01147016|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
747572|NCT01147016|recurrent breast cancer|recurrent breast cancer
748116|NCT01156415|depression|depression
747573|NCT01147016|stage IIA breast cancer|stage iia breast cancer
747574|NCT01147016|stage IIB breast cancer|stage iib breast cancer
747575|NCT01147016|stage IIIA breast cancer|stage iiia breast cancer
747576|NCT01147016|stage IIIB breast cancer|stage iiib breast cancer
747577|NCT01147016|triple-negative breast cancer|triple-negative breast cancer
747578|NCT01147029|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
747579|NCT01147042|NADPH Oxidase|nadph oxidase
747580|NCT01147042|CGD|cgd
747581|NCT01147042|Gene Mutation|gene mutation
747582|NCT01147042|Superoxide by Phagocytes|superoxide by phagocytes
747583|NCT01147042|IFN-Gamma|ifn-gamma
747584|NCT01147042|Chronic Granulomatous Disease|chronic granulomatous disease
747585|NCT01147055|crizotinib|crizotinib
747586|NCT01147055|healthy volunteers|healthy volunteers
747587|NCT01147055|rifampin|rifampin
747588|NCT01147055|pharmacokinetics|pharmacokinetics
747589|NCT01147055|single dose|single dose
747590|NCT01147068|Influenza|influenza
747591|NCT01147081|Influenza vaccine|influenza vaccine
747592|NCT01147081|Vaccine|vaccine
747593|NCT01147107|HIV/HCV co-infection|hiv/hcv co-infection
747594|NCT01147107|Antiretroviral therapy|antiretroviral therapy
747595|NCT01154114|healthy volunteer|healthy volunteer
747596|NCT01154114|hepatic impairment|hepatic impairment
747597|NCT01154114|darapladib|darapladib
747598|NCT01154114|atherosclerosis|atherosclerosis
747599|NCT01154127|NVA237|nva237
747600|NCT01154127|COPD|copd
747601|NCT01154127|bronchodilator|bronchodilator
747602|NCT01154127|exercise endurance|exercise endurance
747603|NCT01154140|open label|open label
747604|NCT01154140|randomized Phase 3|randomized phase 3
747605|NCT01154140|first line treatment|first line treatment
747606|NCT01154140|non squamous lung cancer|non squamous lung cancer
747607|NCT01154140|ALK translocation event positive|alk translocation event positive
747608|NCT01154179|permissive underfeeding|permissive underfeeding
747609|NCT01154179|hypocaloric feeding|hypocaloric feeding
747610|NCT01154179|artificial nutrition|artificial nutrition
747611|NCT01154192|PCOS|pcos
747612|NCT01154192|oligomenorrhea|oligomenorrhea
747613|NCT01154192|irregular menses|irregular menses
747614|NCT01154192|hyperandrogenemia|hyperandrogenemia
747615|NCT01154192|elevated testosterone|elevated testosterone
747616|NCT01154192|adolescents|adolescents
747617|NCT01154192|androgens|androgens
747618|NCT01154192|ovary|ovary
747619|NCT01154192|LH|lh
747620|NCT01154218|bioequivalence|bioequivalence
747621|NCT01154218|food effect|food effect
747622|NCT01154218|pharmacokinetics|pharmacokinetics
747623|NCT01154218|crizotinib|crizotinib
747624|NCT01154231|BeneFIX Regulatory Post Marketing Commitment Plan|benefix regulatory post marketing commitment plan
747625|NCT01154244|Insulin resistance|insulin resistance
747626|NCT01154244|Insulin deficiency|insulin deficiency
747627|NCT01154244|HOMA-IR|homa-ir
747628|NCT01154244|Drug naive|drug naive
747629|NCT01154244|Diabetes mellitus, type II|diabetes mellitus, type ii
747630|NCT01154257|Dental plaque|dental plaque
747631|NCT01154257|Gingivitis|gingivitis
747632|NCT01154270|cancer of the salivary glands|cancer of the salivary glands
747633|NCT01154270|radiation|radiation
747634|NCT01154270|carbon ion therapy|carbon ion therapy
747635|NCT01154296|HIV|hiv
747636|NCT01154296|Rapid Testing|rapid testing
747637|NCT01154296|Counseling|counseling
747638|NCT01154296|STD|std
747639|NCT01154296|U.S.|u.s.
747640|NCT01154309|Depression|depression
747641|NCT01154309|Substance Use|substance use
747642|NCT01154309|Group Cognitive Behavioral Therapy|group cognitive behavioral therapy
747643|NCT01154335|refractory metastatic colorectal cancer|refractory metastatic colorectal cancer
747644|NCT01154348|Metformin|metformin
747645|NCT01154361|ACE inhibitor induced angioedema|ace inhibitor induced angioedema
747646|NCT01154361|Bradykinin|bradykinin
747647|NCT01154361|Non-itching edema|non-itching edema
747648|NCT01154361|Non-allergic angioedema|non-allergic angioedema
747649|NCT01154361|Quincke edema|quincke edema
747650|NCT01154361|Drug induced angioedema|drug induced angioedema
747651|NCT01154361|Bradykinin B2 receptor antagonist|bradykinin b2 receptor antagonist
747652|NCT01154361|Icatibant|icatibant
747653|NCT01154361|HOE 140|hoe 140
747654|NCT01154374|Diabetic Foot Ulcers (DFUs)|diabetic foot ulcers (dfus)
747655|NCT01154387|Kidney|kidney
747656|NCT01154387|Renal|renal
747657|NCT01154387|Transplant|transplant
747658|NCT01154387|Kidney Transplant|kidney transplant
747659|NCT01154387|Kidney Failure|kidney failure
747660|NCT01154387|Induction|induction
747661|NCT01154387|Monoclonal|monoclonal
747662|NCT01154387|Antibody|antibody
747663|NCT01154387|T cell|t cell
747664|NCT01154387|Anti-rejection|anti-rejection
747665|NCT01154387|Immunosuppression|immunosuppression
747666|NCT01154400|casein protein|casein protein
747667|NCT01154400|whey protein|whey protein
747668|NCT01154400|hydrolysates|hydrolysates
747669|NCT01154400|leucine|leucine
747670|NCT01154400|protein metabolism|protein metabolism
747671|NCT01154400|COPD|copd
747672|NCT01154764|healthy male volunteers|healthy male volunteers
747673|NCT01154777|Neurofeedback|neurofeedback
748516|NCT01150552|HPAI virus|hpai virus
747674|NCT01154777|Braintraining|braintraining
747675|NCT01154777|Autism|autism
747676|NCT01154777|Mild|mild
747677|NCT01154777|Moderate|moderate
747678|NCT01154777|Mild to Moderate Autism|mild to moderate autism
747679|NCT01154790|healthy volunteers|healthy volunteers
747680|NCT01154803|Supplementation|supplementation
747681|NCT01154803|RUTF|rutf
747682|NCT01154803|Micronutrients|micronutrients
747683|NCT01154803|Plumpynut|plumpynut
747684|NCT01154803|Mixme|mixme
747685|NCT01154803|sprinkles|sprinkles
747686|NCT01154803|convalescence|convalescence
747687|NCT01154803|weight|weight
747688|NCT01154803|morbidity|morbidity
747689|NCT01154829|dopamine|dopamine
747690|NCT01154829|first episode|first episode
747691|NCT01154829|reward|reward
747692|NCT01154829|cognition|cognition
747693|NCT01154829|MRI|mri
747694|NCT01154829|fMRI|fmri
747695|NCT01154829|PPI|ppi
747696|NCT01154829|P300|p300
747697|NCT01154829|P50 gating|p50 gating
747698|NCT01154829|endophenotypes|endophenotypes
747699|NCT01154842|FGF-23|fgf-23
747700|NCT01154842|Dialysis|dialysis
747701|NCT01154842|plasma FGF-23 levels|plasma fgf-23 levels
747702|NCT01154842|echocardiography|echocardiography
747703|NCT01154855|Periodontal disease|periodontal disease
747704|NCT01154855|Gum disease|gum disease
747705|NCT01154855|Dental|dental
747706|NCT01154855|Inflammation|inflammation
747707|NCT01154855|Microorganisms|microorganisms
747708|NCT01154855|Bacteria|bacteria
747709|NCT01154894|arachidonic acid|arachidonic acid
747710|NCT01154894|autism spectrum disorders|autism spectrum disorders
747711|NCT01154894|social interaction|social interaction
747712|NCT01154894|randomized controlled trial|randomized controlled trial
747713|NCT01154894|DHA|dha
747714|NCT01154907|Uro-genital schistosomiasis|uro-genital schistosomiasis
747715|NCT01154907|Female|female
747716|NCT01154907|South Africa|south africa
747717|NCT01154907|Rural|rural
747718|NCT01154907|Sexually transmitted diseases|sexually transmitted diseases
747719|NCT01154920|Head and Neck Cancer|head and neck cancer
747720|NCT01154920|HNSCC|hnscc
747721|NCT01154920|Paclitaxel|paclitaxel
747722|NCT01154920|Carboplatin|carboplatin
747723|NCT01154920|Cetuximab|cetuximab
747724|NCT01154920|Docetaxel|docetaxel
747725|NCT01154920|Taxotere|taxotere
747726|NCT01154920|Cisplatin|cisplatin
747727|NCT01154920|Platinol-AQ|platinol-aq
747728|NCT01154920|Platinol|platinol
747729|NCT01154920|CDDP|cddp
747730|NCT01154920|Fluorouracil|fluorouracil
747731|NCT01154920|5-FU|5-fu
747732|NCT01154920|Adrucil|adrucil
747733|NCT01154920|Efudex|efudex
747734|NCT01154920|chemotherapy|chemotherapy
747735|NCT01154920|radiation|radiation
747736|NCT01154920|Chemoradiotherapy|chemoradiotherapy
747737|NCT01154933|type 2 diabetes|type 2 diabetes
747738|NCT01154933|obesity|obesity
747739|NCT01154946|detrusor after-contraction|detrusor after-contraction
747740|NCT01154946|urodynamic|urodynamic
747741|NCT01154946|LUTS|luts
747742|NCT01154946|urinary bladder, overactive|urinary bladder, overactive
747743|NCT01154946|bladder dysfunction|bladder dysfunction
747744|NCT01154959|Pulmonary TB|pulmonary tb
747745|NCT01154959|Immune response|immune response
747746|NCT01154959|ATT|att
747747|NCT01154959|Immune responses in pulmonary tuberculosis|immune responses in pulmonary tuberculosis
747748|NCT01154959|Predictors for relapse|predictors for relapse
747749|NCT01154972|breast|breast
747750|NCT01154972|cancer|cancer
747751|NCT01154972|sentinel lymph node|sentinel lymph node
747752|NCT01154985|omega-3 fatty acids|omega-3 fatty acids
747753|NCT01154985|alanine transaminase|alanine transaminase
747754|NCT01154985|triglycerides|triglycerides
747755|NCT01154985|lipids|lipids
747756|NCT01154985|EPA|epa
747757|NCT01154985|ethyl-EPA|ethyl-epa
747758|NCT01154985|ethyl icosapentate|ethyl icosapentate
747759|NCT01154985|Non Alcoholic steatohepatitis|non alcoholic steatohepatitis
747760|NCT01154985|Non Alcoholic fatty liver disease|non alcoholic fatty liver disease
747761|NCT01154985|fatty acids|fatty acids
747762|NCT01154998|non-specific interstitial pneumonia|non-specific interstitial pneumonia
747763|NCT01155011|Older adults|older adults
747764|NCT01155011|physical activity|physical activity
747765|NCT01155011|sedentary|sedentary
747766|NCT01155011|retirement communities|retirement communities
747767|NCT01155011|advocacy|advocacy
747768|NCT01155011|built environment|built environment
747769|NCT01155011|peer mentoring|peer mentoring
747770|NCT01155011|walkability|walkability
747771|NCT01155024|Lower extremity amputation|lower extremity amputation
747772|NCT01155024|Prosthetic Sockets|prosthetic sockets
747773|NCT01155024|Direct Manufactured (DM)|direct manufactured (dm)
747774|NCT01155037|HIV, influenza A H1N1, vaccine|hiv, influenza a h1n1, vaccine
747775|NCT01155050|overweight|overweight
747776|NCT01155050|obese|obese
747777|NCT01155050|type II diabetes|type ii diabetes
747778|NCT01155050|hypertension|hypertension
747779|NCT01155063|Exemestane|exemestane
747780|NCT01155063|Adjuvant Treatment In Postmenopausal Women|adjuvant treatment in postmenopausal women
748604|NCT01150955|SIRT1|sirt1
747781|NCT01155063|Estrogen Receptor Positive Early Breast Cancer|estrogen receptor positive early breast cancer
747782|NCT01155063|Tamoxifen|tamoxifen
747783|NCT01155115|pediatrics|pediatrics
747784|NCT01155115|CF|cf
747785|NCT01155115|PCD|pcd
747786|NCT01155115|exacerbation|exacerbation
747787|NCT01155115|inflammatory markers|inflammatory markers
747788|NCT01155115|induced sputum|induced sputum
747789|NCT01155128|physical activity|physical activity
747790|NCT01155128|exercise|exercise
747791|NCT01155128|sedentarism|sedentarism
747792|NCT01155128|chronic renal disease|chronic renal disease
747793|NCT01155128|failure renal chronic|failure renal chronic
747794|NCT01155128|proteinuria|proteinuria
747795|NCT01155128|progression|progression
747796|NCT01155128|Renal Protective Effects of Exercise|renal protective effects of exercise
747797|NCT01155128|quality of life changes with exercise in CKD|quality of life changes with exercise in ckd
747978|NCT01155921|Risperidone|risperidone
747798|NCT01155128|Endothelial progenitor cells in CKD|endothelial progenitor cells in ckd
747799|NCT01155128|Chronic Kidney Disease and Ankle Brachial Index|chronic kidney disease and ankle brachial index
747800|NCT01155154|wounds and lacerations|wounds and lacerations
747801|NCT01155154|hand|hand
747802|NCT01155154|infection|infection
747803|NCT01155154|Antibiotics|antibiotics
747804|NCT01155154|antibacterial agents|antibacterial agents
747805|NCT01155167|radial artery spasm|radial artery spasm
747806|NCT01155193|Children|children
747807|NCT01155193|Pre-term infants|pre-term infants
747808|NCT01155193|Congenital heart disease|congenital heart disease
747809|NCT01155193|Infection|infection
747810|NCT01155193|Respiratory syncytial virus|respiratory syncytial virus
747811|NCT01155206|glucagon,|glucagon,
747812|NCT01155206|high physiological dose and basal dose of glucagon|high physiological dose and basal dose of glucagon
747813|NCT01155206|hepatic lipoprotein production,|hepatic lipoprotein production,
747814|NCT01155206|free fatty acid|free fatty acid
747815|NCT01155206|intestinal lipoprotein production|intestinal lipoprotein production
747816|NCT01155206|particle|particle
752844|NCT01174420|filtering surgery|filtering surgery
747817|NCT01155206|glucagon affects production of fat in intestine and liver.|glucagon affects production of fat in intestine and liver.
747818|NCT01155219|Bilateral Glaucoma|bilateral glaucoma
747819|NCT01155219|Bilateral ocular hypertension|bilateral ocular hypertension
747820|NCT01155219|Bilateral primary open angle glaucoma|bilateral primary open angle glaucoma
747821|NCT01155219|Bilateral ocular hypertension already treated and controlled by mono-therapy of Xalatan® (1drop per day)|bilateral ocular hypertension already treated and controlled by mono-therapy of xalatan® (1drop per day)
747822|NCT01155219|With local intolerance signs in at least one eye|with local intolerance signs in at least one eye
747823|NCT01155232|osteoporosis|osteoporosis
747824|NCT01155232|Forteo|forteo
747825|NCT01155232|Parathyroid hormone|parathyroid hormone
747826|NCT01155232|HR-pQCT|hr-pqct
747827|NCT01155245|osteoporosis|osteoporosis
747828|NCT01155245|HR-pQCT|hr-pqct
747829|NCT01155245|PTH|pth
747830|NCT01155284|diabetes|diabetes
747831|NCT01155284|HGB A1C|hgb a1c
747832|NCT01155284|Beta Cell Regeneration|beta cell regeneration
747833|NCT01155297|Quality of Life|quality of life
747834|NCT01155297|Biological Markers|biological markers
747835|NCT01155297|Renal Insufficiency|renal insufficiency
747836|NCT01155297|Resistance Training|resistance training
747837|NCT01155297|Exercise|exercise
747838|NCT01155297|Chronic Kidney Failure|chronic kidney failure
747839|NCT01155310|Exacerbation of COPD|exacerbation of copd
747840|NCT01155310|Helium/Oxygen|helium/oxygen
747841|NCT01155310|ICU|icu
747842|NCT01155310|Non-Invasive Ventilation|non-invasive ventilation
747843|NCT01155310|Patient with known or suspected COPD|patient with known or suspected copd
747844|NCT01155310|patient Admitted in an ICU|patient admitted in an icu
747845|NCT01155310|Patient presenting current exacerbation of COPD|patient presenting current exacerbation of copd
747846|NCT01155336|Acute Coronary Syndrome|acute coronary syndrome
747847|NCT01155336|Fish Oils|fish oils
747848|NCT01155336|Platelet Function Tests|platelet function tests
747849|NCT01155336|Cardiac Electrophysiology|cardiac electrophysiology
747850|NCT01155349|brain fitness|brain fitness
747851|NCT01155349|cognitive training|cognitive training
747852|NCT01155349|cognitive intervention|cognitive intervention
747853|NCT01155349|speed of processing training|speed of processing training
747854|NCT01155349|Parkinson's disease|parkinson's disease
747855|NCT01155362|Human Placenta-Derived Cells for the Treatment of Moderate-to-Severe Crohn's Disease|human placenta-derived cells for the treatment of moderate-to-severe crohn's disease
747856|NCT01155375|Iron deficiency anemia|iron deficiency anemia
747857|NCT01155375|Feraheme|feraheme
747858|NCT01155375|ferumoxytol|ferumoxytol
747860|NCT01155375|pediatric|pediatric
747861|NCT01155375|dialysis-dependent|dialysis-dependent
747862|NCT01155375|non-dialysis dependent|non-dialysis dependent
747863|NCT01155375|The treatment of iron deficiency anemia in pediatric subjects with chronic kidney disease.|the treatment of iron deficiency anemia in pediatric subjects with chronic kidney disease.
747864|NCT01155388|Iron deficiency anemia|iron deficiency anemia
747865|NCT01155388|Feraheme|feraheme
747866|NCT01155388|ferumoxytol|ferumoxytol
747867|NCT01155388|CKD|ckd
747868|NCT01155388|pediatric|pediatric
747869|NCT01155388|nondialysis-dependent|nondialysis-dependent
748117|NCT01156428|Nephritic syndrome|nephritic syndrome
747870|NCT01155388|The treatment of iron deficiency anemia in pediatric subjects with nondialysis dependent chronic kidney disease|the treatment of iron deficiency anemia in pediatric subjects with nondialysis dependent chronic kidney disease
747871|NCT01155401|acute upper gastrointestinal bleeding|acute upper gastrointestinal bleeding
747872|NCT01155401|patients with drug-induced upper gastrointestinal bleeding|patients with drug-induced upper gastrointestinal bleeding
747873|NCT01155401|routine management|routine management
747874|NCT01155440|60 patients scheduled to have a colorectal surgery|60 patients scheduled to have a colorectal surgery
747875|NCT01155440|recruit at Montreal General Hospital|recruit at montreal general hospital
747876|NCT01155453|BKM120|bkm120
747877|NCT01155453|RAS RAF mutations,|ras raf mutations,
747878|NCT01155453|triple negative breast cancer,|triple negative breast cancer,
747879|NCT01155453|pancreatic cancer,|pancreatic cancer,
747880|NCT01155453|PI3K inhibitor,|pi3k inhibitor,
747881|NCT01155453|MEK inhibitor|mek inhibitor
747882|NCT01155466|Idiopathic Parkinson Disease|idiopathic parkinson disease
747883|NCT01155466|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
747884|NCT01155492|lipopolysaccharides|lipopolysaccharides
747885|NCT01155492|etiology|etiology
747886|NCT01155492|inflammation|inflammation
747887|NCT01155492|colonic bacteria|colonic bacteria
747888|NCT01155492|intestinal permeability|intestinal permeability
747889|NCT01155518|hypogonadism|hypogonadism
747890|NCT01155518|diabetes|diabetes
747891|NCT01155518|spermatogenesis|spermatogenesis
747892|NCT01155518|insulin resistance|insulin resistance
747893|NCT01155531|Obesity|obesity
747894|NCT01155531|Overweight|overweight
747895|NCT01155531|Sertraline|sertraline
747896|NCT01155531|Telenzepine|telenzepine
747897|NCT01155531|Decrease appetite|decrease appetite
747898|NCT01155531|Reduce appetite|reduce appetite
747899|NCT01155531|Lose weight|lose weight
747900|NCT01155544|Aripiprazole|aripiprazole
747901|NCT01155544|Psychotic experiences|psychotic experiences
749688|NCT01161953|PBC|pbc
747902|NCT01155544|Substance abuse|substance abuse
747903|NCT01155544|Substance dependence|substance dependence
747904|NCT01155544|Craving|craving
747905|NCT01155544|Mood|mood
747906|NCT01155544|Substance use|substance use
747907|NCT01155557|Tension-Type Headache|tension-type headache
747908|NCT01155557|Strength Capacity|strength capacity
747909|NCT01155557|Neck and Shoulder|neck and shoulder
747910|NCT01155570|Psoriasis|psoriasis
747911|NCT01155596|Acute respiratory failure patients in medical ICUs.|acute respiratory failure patients in medical icus.
747912|NCT01155622|Hypothermia, induced|hypothermia, induced
747913|NCT01155622|Cardiac arrest|cardiac arrest
747914|NCT01155622|Disability evaluation|disability evaluation
747915|NCT01155622|Cardiac arrhythmia|cardiac arrhythmia
747916|NCT01155622|Ventricular function|ventricular function
747917|NCT01155622|Internal cooling|internal cooling
747918|NCT01155622|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
747919|NCT01155622|Post-cardiac arrest syndrome|post-cardiac arrest syndrome
747920|NCT01155635|Myocardial infarction|myocardial infarction
747921|NCT01155635|Adrenergic beta-Antagonists|adrenergic beta-antagonists
747922|NCT01155635|Percutaneous coronary intervention|percutaneous coronary intervention
747923|NCT01155648|Mechanical ventilation|mechanical ventilation
747924|NCT01155648|Chest physiotherapy|chest physiotherapy
747925|NCT01155648|Chest wall compression|chest wall compression
747926|NCT01155674|Innate immunity|innate immunity
747927|NCT01155674|Neutrophils|neutrophils
747928|NCT01155674|Band forms|band forms
747929|NCT01155687|afghanistan|afghanistan
747930|NCT01155687|depression|depression
747931|NCT01155687|anxiety|anxiety
747932|NCT01155687|social stress|social stress
747933|NCT01155687|counseling|counseling
747934|NCT01155687|medication|medication
747935|NCT01155687|psychotherapy|psychotherapy
747936|NCT01155687|mental health|mental health
747937|NCT01155700|omalizumab|omalizumab
747938|NCT01155700|allergic asthma|allergic asthma
747939|NCT01155700|pediatric patients|pediatric patients
747940|NCT01155713|Neoplasms|neoplasms
747941|NCT01155713|Cancer|cancer
747942|NCT01155713|Tumors|tumors
747943|NCT01155713|Administration, oral|administration, oral
747944|NCT01155713|Capsules|capsules
747945|NCT01155713|CHIR258, CHIR-258, CHIR 258, TKI258, TKI-258, TKI 258,|chir258, chir-258, chir 258, tki258, tki-258, tki 258,
747946|NCT01155713|Bioavailability,|bioavailability,
747947|NCT01155713|Food|food
747948|NCT01155752|sinusitis|sinusitis
747949|NCT01155752|cystic fibrosis|cystic fibrosis
747950|NCT01155752|therapy|therapy
747951|NCT01155765|Clopidogrel Resistance|clopidogrel resistance
747952|NCT01155765|prasugrel|prasugrel
747953|NCT01155765|Hemodialysis|hemodialysis
747954|NCT01155778|Sanfilippo Syndrome Type A (MPS IIIA)|sanfilippo syndrome type a (mps iiia)
747955|NCT01155778|Recombinant Human Heparan N-Sulfatase (rhHNS)|recombinant human heparan n-sulfatase (rhhns)
747956|NCT01155778|Lysosomal Storage Disease (LSD)|lysosomal storage disease (lsd)
747957|NCT01155778|Intrathecal Drug Delivery Device (IDDD)|intrathecal drug delivery device (iddd)
747958|NCT01155804|preparation of the delivery|preparation of the delivery
747959|NCT01155804|lumbago|lumbago
747960|NCT01155804|anxiety|anxiety
747961|NCT01155804|urinary incontinence|urinary incontinence
747962|NCT01155830|inflammatory cytokines|inflammatory cytokines
747963|NCT01155830|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
747964|NCT01155830|ECMO|ecmo
747965|NCT01155856|telemedicine|telemedicine
747966|NCT01155856|COPD|copd
747967|NCT01155869|alcohol dependence|alcohol dependence
747968|NCT01155869|homelessness|homelessness
747969|NCT01155869|naltrexone|naltrexone
747970|NCT01155895|Bioavailability|bioavailability
747971|NCT01155895|10 mg Amlopdipine besylate /20 mg Benazepril Hydrochloride|10 mg amlopdipine besylate /20 mg benazepril hydrochloride
747972|NCT01155895|Crossover|crossover
747973|NCT01155908|Bioavailability|bioavailability
747974|NCT01155908|10 mg Amlodipine besylate/20 mg benazepril hydrochloride capsules|10 mg amlodipine besylate/20 mg benazepril hydrochloride capsules
747975|NCT01155908|Crossover|crossover
747976|NCT01155921|Bioavailability|bioavailability
747977|NCT01155921|Crossover|crossover
747979|NCT01155934|Bioavailability|bioavailability
747980|NCT01155934|Crossover|crossover
747981|NCT01155934|Risperidone|risperidone
747982|NCT01155947|Bioavailability|bioavailability
747983|NCT01155947|Anastrozole|anastrozole
747984|NCT01155947|Crossover|crossover
747985|NCT01155960|Bioavailability|bioavailability
747986|NCT01155960|Anastrozole|anastrozole
747987|NCT01155960|Crossover|crossover
747988|NCT01155973|Hypertension.|hypertension.
747989|NCT01155973|Cardiovascular risk.|cardiovascular risk.
747990|NCT01155973|Monitoring.|monitoring.
747991|NCT01155973|Primary health care.|primary health care.
747992|NCT01155973|Randomised controlled trial.|randomised controlled trial.
747993|NCT01155973|Cluster analysis|cluster analysis
747994|NCT01155986|analgesic|analgesic
747995|NCT01155986|analgesics|analgesics
747996|NCT01155986|pain|pain
747997|NCT01155986|chronic pain|chronic pain
747998|NCT01155986|localized pain|localized pain
747999|NCT01155986|focal pain|focal pain
748000|NCT01155986|neuropathic pain|neuropathic pain
748001|NCT01155986|postoperative pain|postoperative pain
748002|NCT01155986|topical analgesia|topical analgesia
748003|NCT01156025|GV550|gv550
748004|NCT01156025|Acute adenoviral keratoconjunctivitis|acute adenoviral keratoconjunctivitis
748005|NCT01156038|Atopy patch test|atopy patch test
748006|NCT01156051|ADHD|adhd
748007|NCT01156051|ADD|add
748008|NCT01156051|sleep disturbance|sleep disturbance
748009|NCT01156064|Endoscopy|endoscopy
748010|NCT01156064|Confocal laser endomicroscopy|confocal laser endomicroscopy
748011|NCT01156064|Digestive Diseases|digestive diseases
748012|NCT01156077|antibiotic|antibiotic
748013|NCT01156077|Adolescents receiving antibiotics|adolescents receiving antibiotics
748014|NCT01156090|vectibix|vectibix
748015|NCT01156103|obesity|obesity
748016|NCT01156103|minority|minority
748017|NCT01156103|child|child
748018|NCT01156103|physical fitness|physical fitness
748019|NCT01156103|school|school
748020|NCT01156103|physical activity|physical activity
748021|NCT01156116|CPAP|cpap
748022|NCT01156116|diabetes|diabetes
748023|NCT01156116|sleep apnea|sleep apnea
748024|NCT01156129|liver transplant|liver transplant
748025|NCT01156129|liver resection|liver resection
748026|NCT01156142|oral complications of radiation therapy|oral complications of radiation therapy
748027|NCT01156142|mucositis|mucositis
748028|NCT01156142|pain|pain
748029|NCT01156142|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
748030|NCT01156142|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
748031|NCT01156142|squamous cell carcinoma of the hypopharynx|squamous cell carcinoma of the hypopharynx
748032|NCT01156142|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
748033|NCT01156142|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
748034|NCT01156142|squamous cell carcinoma of the larynx|squamous cell carcinoma of the larynx
748035|NCT01156142|verrucous carcinoma of the larynx|verrucous carcinoma of the larynx
748036|NCT01156142|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
748037|NCT01156142|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
748038|NCT01156142|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
748039|NCT01156142|adenoid cystic carcinoma of the oral cavity|adenoid cystic carcinoma of the oral cavity
748040|NCT01156142|mucoepidermoid carcinoma of the oral cavity|mucoepidermoid carcinoma of the oral cavity
748041|NCT01156142|verrucous carcinoma of the oral cavity|verrucous carcinoma of the oral cavity
748042|NCT01156142|squamous cell carcinoma of the lip and oral cavity|squamous cell carcinoma of the lip and oral cavity
748043|NCT01156142|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
748044|NCT01156142|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
748045|NCT01156142|basal cell carcinoma of the lip|basal cell carcinoma of the lip
748046|NCT01156142|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
748047|NCT01156142|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
748048|NCT01156142|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
748049|NCT01156142|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
748050|NCT01156142|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
748051|NCT01156142|lymphoepithelioma of the nasopharynx|lymphoepithelioma of the nasopharynx
748052|NCT01156142|squamous cell carcinoma of the nasopharynx|squamous cell carcinoma of the nasopharynx
748053|NCT01156142|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
748054|NCT01156142|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
748055|NCT01156142|lymphoepithelioma of the oropharynx|lymphoepithelioma of the oropharynx
748056|NCT01156142|squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
748057|NCT01156142|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
748131|NCT01156467|Edi-signal|edi-signal
748058|NCT01156142|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
748059|NCT01156142|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
748060|NCT01156142|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
748061|NCT01156142|esthesioneuroblastoma of the paranasal sinus and nasal cavity|esthesioneuroblastoma of the paranasal sinus and nasal cavity
748062|NCT01156142|inverted papilloma of the paranasal sinus and nasal cavity|inverted papilloma of the paranasal sinus and nasal cavity
748063|NCT01156142|midline lethal granuloma of the paranasal sinus and nasal cavity|midline lethal granuloma of the paranasal sinus and nasal cavity
748064|NCT01156142|squamous cell carcinoma of the paranasal sinus and nasal cavity|squamous cell carcinoma of the paranasal sinus and nasal cavity
748065|NCT01156142|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
748066|NCT01156142|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
748067|NCT01156142|recurrent salivary gland cancer|recurrent salivary gland cancer
748068|NCT01156142|salivary gland acinic cell tumor|salivary gland acinic cell tumor
748069|NCT01156142|salivary gland adenocarcinoma|salivary gland adenocarcinoma
748070|NCT01156142|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
748071|NCT01156142|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
748072|NCT01156142|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
748073|NCT01156142|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
748074|NCT01156142|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
748075|NCT01156142|salivary gland cancer|salivary gland cancer
748076|NCT01156142|tongue cancer|tongue cancer
748077|NCT01156155|rheumatoid arthritis|rheumatoid arthritis
748078|NCT01156155|osteoarthritis|osteoarthritis
748079|NCT01156155|periodontal disease|periodontal disease
748080|NCT01156168|male breast cancer|male breast cancer
748081|NCT01156168|stage IV breast cancer|stage iv breast cancer
748082|NCT01156168|recurrent breast cancer|recurrent breast cancer
748083|NCT01156181|Cervical mucus, Embryo transfer, ICSI cycle, Pregnancy rate|cervical mucus, embryo transfer, icsi cycle, pregnancy rate
748084|NCT01156194|third stage, labor, postpartum hemorrhage, homeopathy, arnica, bellis perennis|third stage, labor, postpartum hemorrhage, homeopathy, arnica, bellis perennis
748085|NCT01156207|To establish the coupling between components of arterial load ( and components of LV myocardial deformations at baseline and 6 months after randomization.|to establish the coupling between components of arterial load ( and components of lv myocardial deformations at baseline and 6 months after randomization.
748086|NCT01156207|To establish the role of EPCs on modulation of the components of arterial load and LV myocardial deformations and their coupling.|to establish the role of epcs on modulation of the components of arterial load and lv myocardial deformations and their coupling.
748210|NCT01156714|Exercise|exercise
748087|NCT01156220|gender, diuretics, furosemide, aminohippuric acid|gender, diuretics, furosemide, aminohippuric acid
748088|NCT01156233|evaluating precision of tube tip position with two methods|evaluating precision of tube tip position with two methods
748089|NCT01156246|Healthy volunteers|healthy volunteers
748090|NCT01156246|Dapagliflozin|dapagliflozin
748091|NCT01156246|Diabetes Type 2|diabetes type 2
748092|NCT01156246|Food interaction|food interaction
748093|NCT01156259|B cell cll/lymphoma, human|b cell cll/lymphoma, human
748094|NCT01156272|Isolated aortic valve replacement|isolated aortic valve replacement
748095|NCT01156272|heart valve|heart valve
748096|NCT01156311|BG00012|bg00012
748097|NCT01156311|MS|ms
748098|NCT01156311|RRMS|rrms
748099|NCT01156324|IVF|ivf
748100|NCT01156324|Stress management|stress management
748101|NCT01156337|Heart failure III NYHA class|heart failure iii nyha class
748102|NCT01156337|Furosemide|furosemide
748103|NCT01156337|Sodium|sodium
748104|NCT01156337|water restriction|water restriction
748105|NCT01156337|decompensated heart failure|decompensated heart failure
748106|NCT01156337|Hypertonic saline solution|hypertonic saline solution
748107|NCT01156337|Moderate sodium restriction|moderate sodium restriction
748108|NCT01156350|Neuroblastoma - Haplo HSCT - Reduced Intensity Conditioning - immunotherapy NK|neuroblastoma - haplo hsct - reduced intensity conditioning - immunotherapy nk
748109|NCT01156389|malaria|malaria
748110|NCT01156389|artemisinin-based combination therapy|artemisinin-based combination therapy
748111|NCT01156402|Obesity|obesity
748112|NCT01156402|Pediatric Obesity|pediatric obesity
748113|NCT01156415|agomelatine|agomelatine
748114|NCT01156415|Major Depressive Disorder|major depressive disorder
748118|NCT01156428|Nephrotic syndrome|nephrotic syndrome
748119|NCT01156428|Proteinuria|proteinuria
748120|NCT01156428|Acute kidney injury|acute kidney injury
748121|NCT01156428|Chronic kidney disease|chronic kidney disease
748122|NCT01156428|Lupus nephritis|lupus nephritis
748123|NCT01156441|Myocardial Infarction|myocardial infarction
748124|NCT01156441|Mitral Regurgitation|mitral regurgitation
748125|NCT01156441|Percutaneous Coronary Intervention|percutaneous coronary intervention
748126|NCT01156454|sentinel lymph node dissection|sentinel lymph node dissection
748127|NCT01156454|radiology|radiology
748128|NCT01156454|X-ray identification of nodes in a surgical specimen|x-ray identification of nodes in a surgical specimen
748129|NCT01156467|Neurally adjusted ventilatory assist NAVA|neurally adjusted ventilatory assist nava
748130|NCT01156467|Premature infant|premature infant
748132|NCT01156480|necrotizing enterocolitis|necrotizing enterocolitis
748133|NCT01156480|NEC|nec
748134|NCT01156480|premature|premature
748135|NCT01156480|hydrocortisone|hydrocortisone
748136|NCT01156480|steroids|steroids
748137|NCT01156480|anti-inflammatory|anti-inflammatory
748138|NCT01156493|feeding intolerance|feeding intolerance
748139|NCT01156493|prematurity|prematurity
748140|NCT01156506|quality of life|quality of life
748141|NCT01156506|patient education|patient education
748142|NCT01156506|rehabilitation|rehabilitation
748143|NCT01156506|focus group interview|focus group interview
748144|NCT01156519|Infra-clinic cortisol adenoma|infra-clinic cortisol adenoma
748145|NCT01156519|Salivary cortisol|salivary cortisol
748146|NCT01156519|Obesity|obesity
748147|NCT01156532|adalimumab therapy|adalimumab therapy
748148|NCT01156532|Psoriasis|psoriasis
748149|NCT01156532|observational study|observational study
748150|NCT01156545|BIBW 2992|bibw 2992
748151|NCT01156545|Simvastatin|simvastatin
748152|NCT01156545|NSCLC|nsclc
748153|NCT01156545|advanced stage|advanced stage
748154|NCT01156545|previously treated patients|previously treated patients
748155|NCT01156545|non-adenocarcinoma|non-adenocarcinoma
748156|NCT01156584|glioma|glioma
748157|NCT01156584|glioblastoma|glioblastoma
748158|NCT01156584|glioblastoma multiforme|glioblastoma multiforme
748159|NCT01156584|Grade IV astrocytoma|grade iv astrocytoma
748160|NCT01156584|brain cancer|brain cancer
748161|NCT01156584|recurrent glioblastoma|recurrent glioblastoma
748162|NCT01156584|GBM|gbm
748163|NCT01156584|AA|aa
748164|NCT01156584|AOD|aod
748165|NCT01156584|anaplastic astrocytoma|anaplastic astrocytoma
748166|NCT01156584|anaplastic oligodendroglioma|anaplastic oligodendroglioma
748167|NCT01156584|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
748168|NCT01156584|malignant glioma|malignant glioma
748169|NCT01156584|high grade glioma|high grade glioma
748170|NCT01156597|diabetes|diabetes
748171|NCT01156597|dyslipidemia|dyslipidemia
748172|NCT01156597|pioglitazone|pioglitazone
748173|NCT01156597|HDL-Cholesterol|hdl-cholesterol
748174|NCT01156597|Reverse cholesterol transport|reverse cholesterol transport
748175|NCT01156610|Smoking|smoking
748176|NCT01156610|Smoking Cessation|smoking cessation
748177|NCT01156610|Electronic Health Record|electronic health record
748178|NCT01156610|Telephone|telephone
748179|NCT01156623|EBUS-TBNA|ebus-tbna
748180|NCT01156623|NSCLC|nsclc
748181|NCT01156623|Mediastinal lymph node|mediastinal lymph node
748182|NCT01156623|tuberculosis|tuberculosis
748183|NCT01156636|Diastolic Heart Failure|diastolic heart failure
748184|NCT01156636|Pulmonary Hypertension|pulmonary hypertension
748185|NCT01156649|Obstructive sleep apnea|obstructive sleep apnea
748186|NCT01156649|neurocognitive function|neurocognitive function
748187|NCT01156649|cognition|cognition
748188|NCT01156649|pediatrics|pediatrics
748189|NCT01156649|children|children
748190|NCT01156649|continuous positive airway pressure therapy|continuous positive airway pressure therapy
748191|NCT01156649|sham treatment|sham treatment
748192|NCT01156649|randomized clinical trial|randomized clinical trial
748193|NCT01156649|behavior|behavior
748194|NCT01156649|treatment|treatment
748195|NCT01156662|Thrombus aspiration|thrombus aspiration
748196|NCT01156662|Percutaneous coronary intervention|percutaneous coronary intervention
748197|NCT01156675|Back pain|back pain
748198|NCT01156675|Pain|pain
748199|NCT01156675|Spinal Diseases|spinal diseases
748200|NCT01156675|Spinal Stenosis|spinal stenosis
748201|NCT01156675|Lumbar Vertebrae|lumbar vertebrae
748202|NCT01156675|Spinal Canal|spinal canal
748203|NCT01156688|medical abortion for pregnancy of less than 9 weeks gestation|medical abortion for pregnancy of less than 9 weeks gestation
748204|NCT01156701|Influenza|influenza
748205|NCT01156701|Zanamivir|zanamivir
748206|NCT01156701|Influenza prophylaxis|influenza prophylaxis
748207|NCT01156701|Relenza|relenza
748208|NCT01156714|Parkinson's Disease|parkinson's disease
748209|NCT01156714|Treadmill Training|treadmill training
748211|NCT01156714|Cognitive Training|cognitive training
748212|NCT01156714|Executive Function|executive function
748213|NCT01156714|Dual Task|dual task
748214|NCT01156727|OEF/OIF|oef/oif
748215|NCT01156727|Mental Health|mental health
748216|NCT01156727|Veterans|veterans
748217|NCT01156740|streptococcal pharyngitis|streptococcal pharyngitis
748223|NCT01156753|metastatic breast cancer|metastatic breast cancer
748224|NCT01156753|breast cancer|breast cancer
748226|NCT01156753|GPNMB|gpnmb
748227|NCT01156753|Targeted treatment for breast cancer|targeted treatment for breast cancer
748228|NCT01156753|Locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
748229|NCT01156766|Fracture|fracture
748230|NCT01156766|Radius|radius
748231|NCT01156766|Osteosynthesis|osteosynthesis
748232|NCT01156766|Metaphyseal|metaphyseal
748233|NCT01156766|Pinning|pinning
748234|NCT01156766|Locking anterior plate|locking anterior plate
748235|NCT01156779|SR-Exenatide|sr-exenatide
748236|NCT01156792|asthma|asthma
748237|NCT01156792|GSK2190915|gsk2190915
748238|NCT01156805|Children|children
748239|NCT01156805|School-based program|school-based program
748240|NCT01156805|Obesity|obesity
748241|NCT01156818|Wheeze measurements|wheeze measurements
748242|NCT01156831|Esophageal cancer|esophageal cancer
748243|NCT01156831|PET-CT planning|pet-ct planning
748244|NCT01156844|Indacaterol|indacaterol
748245|NCT01156844|Asthma|asthma
748246|NCT01156844|Bronchodilation|bronchodilation
748247|NCT01156844|Beta-agonist|beta-agonist
748252|NCT01156896|Non-transferrin-bound iron|non-transferrin-bound iron
748253|NCT01156896|Iron stable isotopes|iron stable isotopes
748254|NCT01156896|Iron deficiency|iron deficiency
748255|NCT01156896|Malaria|malaria
748256|NCT01156896|Iron supplementation|iron supplementation
748257|NCT01156896|Iron fortification|iron fortification
748258|NCT01156909|Chronic fatigue syndrome|chronic fatigue syndrome
748259|NCT01156909|CFS|cfs
748260|NCT01156909|Myalgic encephalomyelitis|myalgic encephalomyelitis
748261|NCT01156909|Rituximab|rituximab
748262|NCT01156909|B-cell depletion|b-cell depletion
748263|NCT01156922|Chronic fatigue syndrome|chronic fatigue syndrome
748264|NCT01156922|CFS|cfs
748265|NCT01156922|Myalgic encephalomyelitis|myalgic encephalomyelitis
748266|NCT01156922|Rituximab|rituximab
748267|NCT01156922|B-cell depletion|b-cell depletion
748268|NCT01156935|Neoplasm|neoplasm
748269|NCT01156935|Laugh-Yoga|laugh-yoga
748270|NCT01156935|Mood|mood
748271|NCT01156935|Quality of life|quality of life
748272|NCT01156948|misoprostol|misoprostol
748273|NCT01156948|nulliparous|nulliparous
748274|NCT01156948|hysteroscopy|hysteroscopy
748275|NCT01156974|care management|care management
748276|NCT01156974|chronic disease|chronic disease
748277|NCT01156974|outpatient|outpatient
748278|NCT01157000|Canagliflozin|canagliflozin
748279|NCT01157000|Pharmacokinetic|pharmacokinetic
748280|NCT01157000|Bioavailability|bioavailability
748281|NCT01157013|Positron Emission Tomography|positron emission tomography
748282|NCT01157013|Hepatocellular carcinoma|hepatocellular carcinoma
748283|NCT01157013|Liver Cancer|liver cancer
748284|NCT01157013|Sorafenib|sorafenib
748285|NCT01157013|Response Evaluation|response evaluation
748286|NCT01157026|Breast cancer|breast cancer
748287|NCT01157026|Tocotrienol-rich fraction with tamoxifen|tocotrienol-rich fraction with tamoxifen
748288|NCT01157039|glutamine|glutamine
748289|NCT01157039|oxaliplatin|oxaliplatin
748290|NCT01157039|adverse effects|adverse effects
748291|NCT01157052|magnesium|magnesium
748292|NCT01157052|calcium|calcium
748293|NCT01157052|adverse effects|adverse effects
748294|NCT01157052|kinetics, drug|kinetics, drug
748295|NCT01157065|Wet AMD|wet amd
748296|NCT01157065|Intravitreal Injection|intravitreal injection
748297|NCT01157065|Macular Degeneration|macular degeneration
748298|NCT01157065|VEGF treatment|vegf treatment
748299|NCT01157078|Major Depressive Disorder|major depressive disorder
748301|NCT01157078|Depression|depression
748302|NCT01157078|Safety|safety
748303|NCT01157078|add-on therapy|add-on therapy
748304|NCT01157104|HCV|hcv
748305|NCT01157104|Hepatitis C|hepatitis c
748306|NCT01157117|food allergy|food allergy
748307|NCT01157130|Breast Cancer|breast cancer
748308|NCT01157130|Exercise|exercise
748309|NCT01157130|CRP|crp
748310|NCT01157130|C-reactive protein|c-reactive protein
748311|NCT01157130|BMI|bmi
748312|NCT01157130|Nevada Cancer Institute|nevada cancer institute
748313|NCT01157130|Rehabilitation|rehabilitation
748314|NCT01157130|Prescriptive exercise|prescriptive exercise
748315|NCT01157130|Physical Activity|physical activity
748316|NCT01157130|DEXA|dexa
748317|NCT01157130|Obesity|obesity
748318|NCT01157130|lifestyle intervention|lifestyle intervention
748414|NCT01150201|eGFR|egfr
748319|NCT01157130|Early Stage Breast Cancer Patients (stage 0-III)|early stage breast cancer patients (stage 0-iii)
748320|NCT01157169|Bioequivalence|bioequivalence
748321|NCT01157169|Healthy|healthy
748322|NCT01157182|Healthy|healthy
748323|NCT01157182|Bioequivalence|bioequivalence
748324|NCT01157182|Post-Menopausal|post-menopausal
748325|NCT01157195|stroke|stroke
748326|NCT01157195|chronic|chronic
748327|NCT01157195|arm|arm
748328|NCT01157195|rehabilitation|rehabilitation
748329|NCT01157195|tele-health|tele-health
748330|NCT01157208|chronic pain|chronic pain
748331|NCT01157208|headache|headache
748332|NCT01157208|nutrition|nutrition
748333|NCT01157208|inflammation|inflammation
748334|NCT01157208|complementary medicine|complementary medicine
748335|NCT01149954|Bioequivalence|bioequivalence
748336|NCT01149954|Crossover|crossover
748337|NCT01149954|Ibuprofen|ibuprofen
748338|NCT01149967|Bioequivalence|bioequivalence
748339|NCT01149967|Citalopram|citalopram
748340|NCT01149967|Crossover|crossover
748341|NCT01149980|Bioequivalence|bioequivalence
748342|NCT01149980|Crossover|crossover
748343|NCT01149980|Citalopram|citalopram
748344|NCT01149993|living donation|living donation
748345|NCT01149993|kidney transplantation|kidney transplantation
748346|NCT01149993|delayed graft function|delayed graft function
748347|NCT01149993|ischemia reperfusion injury|ischemia reperfusion injury
748348|NCT01150006|atherosclerosis|atherosclerosis
748349|NCT01150006|vascular inflammation|vascular inflammation
748350|NCT01150006|adipocyte fatty acid binding protein|adipocyte fatty acid binding protein
748351|NCT01150006|adiponectin|adiponectin
748352|NCT01150006|leptin|leptin
748353|NCT01150006|18FDG-PET|18fdg-pet
748354|NCT01150019|atherosclerosis|atherosclerosis
748355|NCT01150019|vascular inflammation|vascular inflammation
748356|NCT01150019|resistin|resistin
748357|NCT01150019|adiponectin|adiponectin
748358|NCT01150019|18FDG-PET|18fdg-pet
748359|NCT01150032|Osteoporosis|osteoporosis
748360|NCT01150032|Fracture|fracture
748361|NCT01150032|Bone microarchitecture|bone microarchitecture
748362|NCT01150045|adenocarcinoma of the colon|adenocarcinoma of the colon
748363|NCT01150045|stage III colon cancer|stage iii colon cancer
748364|NCT01150058|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
748365|NCT01150058|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
748366|NCT01150058|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
748367|NCT01150058|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
748368|NCT01150058|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
748369|NCT01150058|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
748370|NCT01150058|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
748371|NCT01150058|adult acute myeloid leukemia|adult acute myeloid leukemia
748372|NCT01150071|extremely premature infant|extremely premature infant
748373|NCT01150071|follow-up|follow-up
748374|NCT01150071|behavior|behavior
748375|NCT01150071|growth|growth
748376|NCT01150071|mental health|mental health
748377|NCT01150071|lung function|lung function
748378|NCT01150071|spirometry|spirometry
748379|NCT01150071|muscle mass|muscle mass
748380|NCT01150071|bone density|bone density
748479|NCT01150396|outcome|outcome
748381|NCT01150071|magnetic Resonance imaging|magnetic resonance imaging
748382|NCT01150084|increasing physical activity in sedentary employees|increasing physical activity in sedentary employees
748383|NCT01150097|Liver transplantation|liver transplantation
748384|NCT01150097|Everolimus|everolimus
748385|NCT01150097|Calcineurin inhibitors|calcineurin inhibitors
748386|NCT01150097|Tacrolimus|tacrolimus
748387|NCT01150097|Renal function|renal function
748388|NCT01150097|Progression of HCV related allograft fibrosis|progression of hcv related allograft fibrosis
748389|NCT01150110|Temporomandibular disorders|temporomandibular disorders
748390|NCT01150110|occlusal splints|occlusal splints
748391|NCT01150110|electromyography|electromyography
748392|NCT01150110|TMD (muscle and joint dysfunction)|tmd (muscle and joint dysfunction)
748393|NCT01150110|masseteres e anterior temporalis muscles.|masseteres e anterior temporalis muscles.
748394|NCT01150123|Group B streptococcus|group b streptococcus
748395|NCT01150123|GBS|gbs
748396|NCT01150123|Vaccine|vaccine
748397|NCT01150123|Group B streptococcus (GBS) disease|group b streptococcus (gbs) disease
748398|NCT01150136|choline|choline
748399|NCT01150136|cystic fibrosis|cystic fibrosis
748400|NCT01150136|methyl metabolism|methyl metabolism
748401|NCT01150136|oxidative stress|oxidative stress
748402|NCT01150149|Influenza|influenza
748403|NCT01150149|Humans|humans
748404|NCT01150149|Experimental|experimental
748405|NCT01150149|Challenge|challenge
748406|NCT01150175|END-HF|end-hf
748407|NCT01150188|aging|aging
748408|NCT01150188|lipid metabolism|lipid metabolism
748409|NCT01150188|very low density lipoproteins|very low density lipoproteins
748410|NCT01150188|amino acids|amino acids
748411|NCT01150188|dietary supplements|dietary supplements
748412|NCT01150201|CKD|ckd
748413|NCT01150201|proteinuria|proteinuria
748415|NCT01150201|Progression of chronic kidney disease|progression of chronic kidney disease
748416|NCT01150214|atrial fibrillation|atrial fibrillation
748417|NCT01150214|af|af
748418|NCT01150214|magnetic resonance imaging|magnetic resonance imaging
748419|NCT01150214|mri|mri
748420|NCT01150214|left atrium|left atrium
748421|NCT01150214|fibrosis|fibrosis
748422|NCT01150214|structural remodeling|structural remodeling
748423|NCT01150240|Primary Immunodeficiency Disease|primary immunodeficiency disease
748424|NCT01150266|stroke|stroke
748425|NCT01150266|ischemia|ischemia
748426|NCT01150266|thrombolysis|thrombolysis
748427|NCT01150266|thrombolytics|thrombolytics
748428|NCT01150266|tPA|tpa
748429|NCT01150266|rt-PA|rt-pa
748430|NCT01150266|t-PA|t-pa
748431|NCT01150266|Activase®|activase®
748432|NCT01150266|Alteplase|alteplase
748433|NCT01150266|wake-up stroke|wake-up stroke
748434|NCT01150266|waking onset stroke|waking onset stroke
748435|NCT01150266|sleep|sleep
748436|NCT01150279|medical abortion|medical abortion
748437|NCT01150279|Medical Abortion Follow Up Care|medical abortion follow up care
748438|NCT01150292|DHA supplementation|dha supplementation
748439|NCT01150292|Type 2 diabetic patient|type 2 diabetic patient
748440|NCT01150292|Platelet function|platelet function
748441|NCT01150305|Autosomal dominant inheritance|autosomal dominant inheritance
748442|NCT01150305|Mutation|mutation
748443|NCT01150305|Prevalence|prevalence
748444|NCT01150318|Male|male
748445|NCT01150318|Infertility|infertility
748446|NCT01150318|Radioisotopes Therapy|radioisotopes therapy
748447|NCT01150318|Follicular thyroid cancer|follicular thyroid cancer
748448|NCT01150331|status epilepticus|status epilepticus
748449|NCT01150331|generalised convulsive status epilepticus|generalised convulsive status epilepticus
748450|NCT01150331|first line treatments|first line treatments
748451|NCT01150331|double-blind randomized controlled trial|double-blind randomized controlled trial
748452|NCT01150331|prehospital treatment|prehospital treatment
748453|NCT01150344|Multicentric study|multicentric study
748454|NCT01150344|Antimalarial|antimalarial
748455|NCT01150344|P. falciparum|p. falciparum
748456|NCT01150344|Efficacy|efficacy
748457|NCT01150344|Failures|failures
748458|NCT01150344|Malarone|malarone
748459|NCT01150344|RIAMET|riamet
748460|NCT01150357|Pediatric hypertension|pediatric hypertension
748461|NCT01150357|primary hypertension|primary hypertension
748462|NCT01150357|secondary hypertension|secondary hypertension
748463|NCT01150370|male circumcision|male circumcision
748464|NCT01150370|HIV|hiv
748465|NCT01150370|Rwanda|rwanda
748466|NCT01150370|HIV Seronegativity|hiv seronegativity
748467|NCT01150383|Lung Diseases, Obstructive|lung diseases, obstructive
748468|NCT01150383|Respiratory Tract Diseases|respiratory tract diseases
748469|NCT01150383|Lung Diseases|lung diseases
748470|NCT01150383|Respiration Disorders|respiration disorders
748471|NCT01150383|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
748472|NCT01150383|COPD|copd
748473|NCT01150383|Chronic Obstructive Lung Disease|chronic obstructive lung disease
748474|NCT01150383|Chronic Obstructive Airway Disease|chronic obstructive airway disease
748475|NCT01150383|Chronic Airflow Obstruction|chronic airflow obstruction
748476|NCT01150383|oxygen|oxygen
748477|NCT01150383|oxygen supplementation|oxygen supplementation
748478|NCT01150396|extremely premature infant|extremely premature infant
748480|NCT01150396|follow-up|follow-up
748481|NCT01150409|Sepsis|sepsis
748482|NCT01150409|hydrocortisone|hydrocortisone
748483|NCT01150422|medical abortion|medical abortion
748484|NCT01150448|Paliperidone palmitate|paliperidone palmitate
748485|NCT01150448|paliperidone ER (INVEGA)|paliperidone er (invega)
748486|NCT01150448|R092670PSY1008|r092670psy1008
748487|NCT01150448|Risperidone|risperidone
748488|NCT01150448|Risperdal (RISPERDAL CONSTA)|risperdal (risperdal consta)
748489|NCT01150448|Pharmacokinetics|pharmacokinetics
748490|NCT01150461|Hypertrophic nonobstructive cardiomyopathy|hypertrophic nonobstructive cardiomyopathy
748491|NCT01150474|Belladonna|belladonna
748492|NCT01150474|Morphine|morphine
748493|NCT01150474|Suppositories|suppositories
748494|NCT01150474|Vaginal|vaginal
748495|NCT01150474|Surgery|surgery
748496|NCT01150474|Postoperative|postoperative
748497|NCT01150474|Pain|pain
748498|NCT01150487|kidney transplant|kidney transplant
748499|NCT01150500|Medtronic|medtronic
748500|NCT01150500|Japan|japan
748501|NCT01150500|Arterial Occlusive Diseases|arterial occlusive diseases
748502|NCT01150500|Myocardial Ischemia|myocardial ischemia
748503|NCT01150500|Cardiovascular Diseases|cardiovascular diseases
748504|NCT01150500|Coronary Artery Disease|coronary artery disease
748505|NCT01150500|Small Vessel Stent|small vessel stent
748506|NCT01150513|TRIPLE-NEGATIVE|triple-negative
748507|NCT01150513|BREAST CANCER|breast cancer
748508|NCT01150526|Acute Exercise|acute exercise
748509|NCT01150526|Muscle Inflammation|muscle inflammation
748510|NCT01150526|CaHMB|cahmb
748511|NCT01150526|HMB Free Acid Gel|hmb free acid gel
748512|NCT01150526|Healthy Subjects|healthy subjects
748513|NCT01150552|Serology|serology
748514|NCT01150552|Poultry|poultry
748515|NCT01150552|H5N1 virus|h5n1 virus
748520|NCT01150578|regadenoson|regadenoson
748521|NCT01150578|Myocardial ischemia|myocardial ischemia
748522|NCT01150578|Myocardial perfusion imaging|myocardial perfusion imaging
748523|NCT01150578|cost and cost analysis|cost and cost analysis
748524|NCT01150578|Cardiac-Gated SPECT Imaging|cardiac-gated spect imaging
748525|NCT01150578|Echocardiography|echocardiography
748526|NCT01150604|Cognitive Behavioral Therapy|cognitive behavioral therapy
748527|NCT01150604|Mood Management|mood management
748528|NCT01150604|Self-help|self-help
748529|NCT01150604|Internet|internet
748530|NCT01150617|Type 2 diabetes mellitus|type 2 diabetes mellitus
748531|NCT01150617|Normoglycemia|normoglycemia
748532|NCT01150617|Peripheral angioplasty|peripheral angioplasty
748536|NCT01150643|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
748537|NCT01150643|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
748538|NCT01150643|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
748539|NCT01150643|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
748540|NCT01150656|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
748541|NCT01150682|endometrial adenocarcinoma|endometrial adenocarcinoma
748542|NCT01150682|stage II endometrial carcinoma|stage ii endometrial carcinoma
748543|NCT01150682|stage III endometrial carcinoma|stage iii endometrial carcinoma
748544|NCT01150682|stage IV endometrial carcinoma|stage iv endometrial carcinoma
748545|NCT01150682|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
748546|NCT01150682|endometrial clear cell carcinoma|endometrial clear cell carcinoma
751531|NCT01170130|Mydriasis|mydriasis
748547|NCT01150682|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
748548|NCT01150695|vaccine, Francisella tularensis, Tularemia, rabbit fever, parent protocol|vaccine, francisella tularensis, tularemia, rabbit fever, parent protocol
748549|NCT01150708|Syringomyelia|syringomyelia
748550|NCT01150708|Magnetic Resonance Imaging|magnetic resonance imaging
748551|NCT01150708|Natural History Study|natural history study
748552|NCT01150708|Neurological Examination|neurological examination
748553|NCT01150721|Atypical Mycobacterium Infection|atypical mycobacterium infection
748554|NCT01150721|Microbial Tests|microbial tests
748555|NCT01150721|Molecular Tests|molecular tests
748556|NCT01150721|Inflammation|inflammation
748557|NCT01150721|Respiratory Secretions|respiratory secretions
748558|NCT01150734|differences of Muscle evoked potentials (MEP) in psychiatric illnesses|differences of muscle evoked potentials (mep) in psychiatric illnesses
748559|NCT01150734|differences in neuromodulation|differences in neuromodulation
748560|NCT01150734|normalization of neuromodulation after pharmacological treatment|normalization of neuromodulation after pharmacological treatment
748561|NCT01150760|GI recovery after bowel resection|gi recovery after bowel resection
748562|NCT01150760|morbidity after bowel resection|morbidity after bowel resection
748563|NCT01150760|mortality|mortality
748564|NCT01150760|readmission|readmission
748565|NCT01150760|length of stay|length of stay
748566|NCT01150786|inflammation|inflammation
748567|NCT01150786|oxidative stress|oxidative stress
748568|NCT01150786|selenium|selenium
748569|NCT01150786|hemodialysis|hemodialysis
748570|NCT01150812|First time in man|first time in man
748571|NCT01150812|healthy|healthy
748572|NCT01150812|thrombin inhibitor|thrombin inhibitor
748573|NCT01150825|STEMI|stemi
748574|NCT01150825|NSTEMI|nstemi
748575|NCT01150825|acute ischemia|acute ischemia
748576|NCT01150825|non-invasive diagnosis|non-invasive diagnosis
748577|NCT01150825|elevated troponin|elevated troponin
748578|NCT01150838|intubation of children without neuromuscular blockade|intubation of children without neuromuscular blockade
748705|NCT01151397|Hepatitis C|hepatitis c
748579|NCT01150864|Hot water humidifier, Passive heat and moisture exchangers|hot water humidifier, passive heat and moisture exchangers
748580|NCT01150877|Vitamin D|vitamin d
748581|NCT01150877|Vitamin D3|vitamin d3
748582|NCT01150877|colon cancer|colon cancer
748583|NCT01150877|rectal cancer|rectal cancer
748584|NCT01150877|Cholecalciferol|cholecalciferol
748585|NCT01150890|Ileal Crohn's Disease|ileal crohn's disease
748586|NCT01150890|Ileo-colonic Crohn's Disease|ileo-colonic crohn's disease
748587|NCT01150890|Colonic Chron's Disease|colonic chron's disease
748588|NCT01150903|erectile dysfunction|erectile dysfunction
748589|NCT01150903|phosphodiesterase inhibitor|phosphodiesterase inhibitor
748590|NCT01150903|cardiovascular diseases|cardiovascular diseases
748591|NCT01150916|natriuretic peptide|natriuretic peptide
748592|NCT01150916|heart failure|heart failure
748593|NCT01150916|ascites|ascites
748594|NCT01150916|liver cirrhosis|liver cirrhosis
748595|NCT01150929|Knee arthroplasty|knee arthroplasty
748598|NCT01150929|Gait analysis|gait analysis
748599|NCT01150929|Motion analysis|motion analysis
748600|NCT01150942|JEV|jev
748601|NCT01150942|vero cell|vero cell
748602|NCT01150955|Resveratrol|resveratrol
748603|NCT01150955|Diabetes|diabetes
748607|NCT01150955|Growth hormone|growth hormone
748609|NCT01150955|Longevity|longevity
748610|NCT01150955|Substrate metabolism|substrate metabolism
748611|NCT01150955|Calorie restriction|calorie restriction
748612|NCT01150994|Suicide screening among ED patients|suicide screening among ed patients
748613|NCT01151007|Kras mutation|kras mutation
748614|NCT01151007|colorectal carcinoma|colorectal carcinoma
748615|NCT01151007|Martinique|martinique
748616|NCT01151020|Aortic Aneurysm|aortic aneurysm
748617|NCT01151020|Aneurysm|aneurysm
748618|NCT01151020|Vascular Prosthesis|vascular prosthesis
748619|NCT01151020|Vascular Disease|vascular disease
748620|NCT01151020|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
748621|NCT01151033|ProNOVA XR Polymer Free Drug Eluting Coronary Stent System|pronova xr polymer free drug eluting coronary stent system
748622|NCT01151033|DES|des
748623|NCT01151033|stent|stent
748624|NCT01151033|coronary artery lesions|coronary artery lesions
748625|NCT01151033|ProNOVA|pronova
748626|NCT01151033|stent implantation|stent implantation
748627|NCT01151046|Breast Cancer|breast cancer
748628|NCT01151046|Her2 negative|her2 negative
748629|NCT01151046|Estrogen Receptor Positive|estrogen receptor positive
748630|NCT01151046|Progesterone Receptor Positive|progesterone receptor positive
748631|NCT01151046|MM-121|mm-121
748632|NCT01151046|Exemestane|exemestane
748633|NCT01151046|Postmenopausal Women|postmenopausal women
748634|NCT01151059|seasonal influenza|seasonal influenza
748635|NCT01151059|vaccine|vaccine
748636|NCT01151085|Systemic Mycosis|systemic mycosis
748637|NCT01151085|Aspergillus infection|aspergillus infection
748638|NCT01151085|Candidiasis|candidiasis
748639|NCT01151085|Cryptococcal infections|cryptococcal infections
748640|NCT01151085|Japanese|japanese
748641|NCT01151085|voriconazole|voriconazole
748642|NCT01151085|VFEND|vfend
748643|NCT01151085|Regulatory Post Marketing Commitment Plan.|regulatory post marketing commitment plan.
751532|NCT01170130|Lidocaine|lidocaine
748644|NCT01151098|Chronic nonmalignant pain|chronic nonmalignant pain
748645|NCT01151098|Opioid|opioid
748646|NCT01151098|Transdermal|transdermal
748647|NCT01151098|Butrans (BTDS)|butrans (btds)
748648|NCT01151111|Parkinson's disease|parkinson's disease
748649|NCT01151111|Relaxation|relaxation
748650|NCT01151111|Visual imagery|visual imagery
748651|NCT01151111|Motor fluctuations|motor fluctuations
748652|NCT01151111|Treatment|treatment
748653|NCT01151163|Fibromyalgia, Peripheral arterial tonometry, sleep|fibromyalgia, peripheral arterial tonometry, sleep
748654|NCT01151176|Intensive Insulin Therapy|intensive insulin therapy
748655|NCT01151176|Glucose control|glucose control
748656|NCT01151176|Acute Coronary Syndrome|acute coronary syndrome
748657|NCT01151176|Intensive Care|intensive care
748658|NCT01151189|HIV|hiv
748659|NCT01151189|Tuberculosis|tuberculosis
748660|NCT01151189|Vaccine|vaccine
748661|NCT01151202|acute upper respiratory tract infection, chronic inflamatory bronchitis|acute upper respiratory tract infection, chronic inflamatory bronchitis
748662|NCT01151215|Cancer|cancer
748663|NCT01151215|tumour|tumour
748664|NCT01151215|breast cancer|breast cancer
748665|NCT01151215|metastatic|metastatic
748666|NCT01151215|secondary|secondary
748667|NCT01151215|locally advanced|locally advanced
748668|NCT01151228|gastroscopy|gastroscopy
748669|NCT01151228|ultrasound|ultrasound
748670|NCT01151228|stomach volume|stomach volume
748671|NCT01151228|patients having gastroscopy|patients having gastroscopy
748672|NCT01151241|elbow surgery|elbow surgery
748673|NCT01151241|infraclavicular nerve block|infraclavicular nerve block
748674|NCT01151241|continuous passive motion|continuous passive motion
748675|NCT01151241|ultrasound guided regional anesthesia|ultrasound guided regional anesthesia
748676|NCT01151241|early discharge|early discharge
748677|NCT01151254|Cardiac Surgery|cardiac surgery
748678|NCT01151254|Sedation|sedation
748679|NCT01151254|Intensive care|intensive care
748680|NCT01151254|Volatile anesthesia|volatile anesthesia
748681|NCT01151254|Intravenous anesthesia|intravenous anesthesia
748682|NCT01151254|Pre and post conditioning after cardiac surgery|pre and post conditioning after cardiac surgery
748683|NCT01151267|Isocapnic hyperpnoea (IH)|isocapnic hyperpnoea (ih)
748684|NCT01151267|Anesthesia|anesthesia
748685|NCT01151267|Accelerate elimination of inhalation agents|accelerate elimination of inhalation agents
748686|NCT01151267|Recovery from anesthesia|recovery from anesthesia
748687|NCT01151293|Type D personality|type d personality
748688|NCT01151293|diabetes|diabetes
748689|NCT01151293|medical compliance|medical compliance
748690|NCT01151293|HbA1c|hba1c
748691|NCT01151293|complication|complication
748692|NCT01151293|mortality|mortality
748693|NCT01151293|T2DM|t2dm
748694|NCT01151345|diltiazem|diltiazem
748695|NCT01151345|angiotrofin|angiotrofin
748696|NCT01151345|bioequivalence|bioequivalence
748697|NCT01151358|radioimmunotherapy|radioimmunotherapy
748698|NCT01151358|follicular non-Hodgkin´s lymphoma|follicular non-hodgkin´s lymphoma
748699|NCT01151358|FDG-PET|fdg-pet
748700|NCT01151358|prognostic factors|prognostic factors
748701|NCT01151358|multicenter study|multicenter study
748702|NCT01151384|Cancer Patients|cancer patients
748703|NCT01151397|SVR|svr
748704|NCT01151397|VITAMIN D|vitamin d
748706|NCT01151397|Genotype 2,3|genotype 2,3
748707|NCT01151397|Naive|naive
748708|NCT01151397|RVR|rvr
748709|NCT01151410|Pediatric hypertension|pediatric hypertension
748710|NCT01151410|primary hypertension|primary hypertension
748711|NCT01151410|secondary|secondary
748712|NCT01151410|hypertension|hypertension
748713|NCT01151436|Facial wrinkle correction|facial wrinkle correction
748714|NCT01151462|Postnatal HCMV infection in very preterm infants|postnatal hcmv infection in very preterm infants
748715|NCT01151462|Neurodevelopmental disabilities|neurodevelopmental disabilities
748716|NCT01151462|Hearing loss|hearing loss
748717|NCT01151462|Mental retardation|mental retardation
748718|NCT01151462|Microcephaly|microcephaly
748719|NCT01151462|Chorioretinitis|chorioretinitis
748720|NCT01151462|Growth|growth
748721|NCT01151475|liver cirrhosis|liver cirrhosis
748722|NCT01151475|hepatic encephalopathy|hepatic encephalopathy
748723|NCT01151475|ammonia|ammonia
748724|NCT01151475|cerebral blood flow|cerebral blood flow
748725|NCT01151501|acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
748726|NCT01151501|intermittent positive-pressure ventilation|intermittent positive-pressure ventilation
748727|NCT01151501|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
748728|NCT01151501|ventilator weaning|ventilator weaning
748729|NCT01151514|No referral|no referral
748730|NCT01151514|Late referral|late referral
748731|NCT01151514|Acute kidney injury|acute kidney injury
748732|NCT01151514|Intensive care unit|intensive care unit
748733|NCT01151514|In-hospital mortality|in-hospital mortality
748734|NCT01151514|Renal outcome|renal outcome
748735|NCT01151514|Requirement for renal replacement therapy|requirement for renal replacement therapy
748736|NCT01151514|Length of hospital stay|length of hospital stay
748737|NCT01151514|Impact|impact
748738|NCT01151514|Incidence|incidence
748739|NCT01151540|Epilepsy|epilepsy
748740|NCT01151540|Seizures|seizures
748741|NCT01151553|Cardiology|cardiology
748742|NCT01151553|Cardiomyopathy|cardiomyopathy
748743|NCT01151553|Cardiovascular Disease|cardiovascular disease
748744|NCT01151553|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
748745|NCT01151566|Ultrasound|ultrasound
748746|NCT01151566|Contrast enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
748747|NCT01151566|Nephrotoxicity|nephrotoxicity
748748|NCT01151566|CT contrast agents|ct contrast agents
748749|NCT01151579|Tachycardia|tachycardia
748750|NCT01151579|tachyarrhythmias|tachyarrhythmias
748751|NCT01151579|bronchodilator therapy|bronchodilator therapy
748752|NCT01151579|Critically ill patients|critically ill patients
748753|NCT01151592|Iron deficiency anemia in Chronic Kidney Disease Patients|iron deficiency anemia in chronic kidney disease patients
748754|NCT01157234|Hypertension|hypertension
748755|NCT01157234|Kidney transplantation|kidney transplantation
748756|NCT01157234|Renal function|renal function
748757|NCT01157234|Nitric Oxide|nitric oxide
748758|NCT01157234|Nebivolol|nebivolol
748759|NCT01157247|Anesthetic techniques|anesthetic techniques
748760|NCT01157247|regional, spinal|regional, spinal
748761|NCT01157247|Pain|pain
748762|NCT01157247|lumbar puncture|lumbar puncture
748763|NCT01157247|Analgesia, local|analgesia, local
748764|NCT01157247|Analgesia, intravenous|analgesia, intravenous
748765|NCT01157260|Indoxyl sulfate|indoxyl sulfate
748766|NCT01157260|AST-120|ast-120
748767|NCT01157273|Behavior|behavior
748768|NCT01157273|Anxiety|anxiety
748769|NCT01157273|Communication|communication
748770|NCT01157273|Voice|voice
748771|NCT01157286|OBSTRUCTIVE SLEEP APNEA LARINGECTOMY CPAP|obstructive sleep apnea laringectomy cpap
748772|NCT01157299|Hemodynamics|hemodynamics
751189|NCT01168921|SLL|sll
748773|NCT01157299|Pediatric Intensive Care Unit|pediatric intensive care unit
748774|NCT01157299|Low cardiac output|low cardiac output
748775|NCT01157299|Thermodilution|thermodilution
748776|NCT01157299|Stroke volume|stroke volume
748777|NCT01157299|Global end-diastolic volume|global end-diastolic volume
748778|NCT01157299|Fluid responsiveness|fluid responsiveness
748779|NCT01157299|Passive leg raising|passive leg raising
748780|NCT01157299|Infant|infant
748781|NCT01157312|Polycystic ovary syndrome|polycystic ovary syndrome
748782|NCT01157312|clomiphene citrate|clomiphene citrate
748783|NCT01157312|minimal stimulation|minimal stimulation
748784|NCT01157312|infertility treatment|infertility treatment
748785|NCT01157325|Epidural analgesia|epidural analgesia
748786|NCT01157325|Latent analgesia|latent analgesia
748787|NCT01157325|Active analgesia|active analgesia
748788|NCT01157325|Cesarean section|cesarean section
748789|NCT01157338|Catheter|catheter
748790|NCT01157338|coronary artery disease|coronary artery disease
748791|NCT01157338|embolus|embolus
748792|NCT01157338|stroke|stroke
748793|NCT01157338|retinal emboli|retinal emboli
748794|NCT01157351|Schizophrenia|schizophrenia
748795|NCT01157351|Risperidone|risperidone
748796|NCT01157351|Risperdal|risperdal
748797|NCT01157351|Paliperidone palmitate|paliperidone palmitate
748798|NCT01157351|Aripiprazole|aripiprazole
748799|NCT01157351|Haloperidol|haloperidol
748800|NCT01157351|Olanzapine|olanzapine
748801|NCT01157351|Paliperidone|paliperidone
748802|NCT01157351|Perphenazine|perphenazine
748803|NCT01157351|Quetiapine|quetiapine
748805|NCT01157390|sn-2 palmitic acid|sn-2 palmitic acid
748806|NCT01157390|infant formula|infant formula
748807|NCT01157403|mesenchymal stem cells|mesenchymal stem cells
748808|NCT01157416|Cognitive Behavior Therapy|cognitive behavior therapy
748809|NCT01157416|Children|children
748810|NCT01157416|Pharmacotherapy|pharmacotherapy
748811|NCT01157429|Cognitive Behavior Therapy|cognitive behavior therapy
748812|NCT01157429|Children|children
748813|NCT01157429|Adolescents|adolescents
748814|NCT01157429|Pharmacotherapy|pharmacotherapy
748815|NCT01157442|prevention of maternal to child transmission of HIV|prevention of maternal to child transmission of hiv
748816|NCT01157442|mhealth|mhealth
748817|NCT01157442|access to antenatal care|access to antenatal care
748818|NCT01157442|pregnancy|pregnancy
748819|NCT01157455|Stent|stent
748820|NCT01157455|Coronary artery diseases|coronary artery diseases
748821|NCT01157468|Systemic Lupus Erythematosus in Martinique|systemic lupus erythematosus in martinique
748822|NCT01157468|Hydrolase and DNase activities|hydrolase and dnase activities
748823|NCT01157481|Diastolic Heart Failure|diastolic heart failure
748824|NCT01157481|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
748825|NCT01157481|nifedipine|nifedipine
748826|NCT01157494|cerebral palsy|cerebral palsy
748827|NCT01157494|hemiplegia|hemiplegia
748828|NCT01157494|upper limb|upper limb
748829|NCT01157494|assessment|assessment
748830|NCT01157494|classification system|classification system
748831|NCT01157507|Botulinum A toxin|botulinum a toxin
748832|NCT01157507|Painful Bladder Syndrome (PBS)|painful bladder syndrome (pbs)
748833|NCT01157507|Bladder overdistention|bladder overdistention
748834|NCT01157533|Vancomycin|vancomycin
748835|NCT01157533|Pharmacokinetic testing|pharmacokinetic testing
748836|NCT01157533|PK|pk
748837|NCT01157819|swimmer's ear|swimmer's ear
748838|NCT01157819|ear drops|ear drops
748839|NCT01157819|ear foam|ear foam
748840|NCT01157819|otic foam|otic foam
665625|NCT00837499|Survey|survey
748841|NCT01157819|ear infection|ear infection
748842|NCT01157819|ear pain|ear pain
748843|NCT01157819|ear inflammation|ear inflammation
748844|NCT01157832|water pipe smoking acute effect|water pipe smoking acute effect
748845|NCT01157858|liver cyst|liver cyst
748846|NCT01157884|body composition|body composition
748847|NCT01157884|obesity|obesity
748848|NCT01157884|kidney transplantation|kidney transplantation
748849|NCT01157897|Malaria|malaria
748850|NCT01157897|Plasmodium Vivax|plasmodium vivax
748851|NCT01157897|Vaccine|vaccine
748852|NCT01157910|Ear infection|ear infection
748853|NCT01157910|Chronic|chronic
748854|NCT01157923|Type 1 diabetes|type 1 diabetes
748855|NCT01157923|Insulin Pump Therapy|insulin pump therapy
748856|NCT01157936|hypertension|hypertension
748857|NCT01157936|hyperuricemia|hyperuricemia
748858|NCT01157936|metabolic syndrome|metabolic syndrome
748859|NCT01157962|Sentinel Concept|sentinel concept
748860|NCT01157962|Lymphadenectomy|lymphadenectomy
748861|NCT01157962|Early Stage Cervical Cancer|early stage cervical cancer
748862|NCT01157962|Overall Survive|overall survive
748863|NCT01157962|Improvement Therapy|improvement therapy
748864|NCT01157988|bulky diffuse large B cell lymphoma|bulky diffuse large b cell lymphoma
749219|NCT01159652|Sonata|sonata
748865|NCT01157988|90Y-ibritumomab tiuxetan|90y-ibritumomab tiuxetan
748866|NCT01157988|clinical response|clinical response
748867|NCT01157988|Safety and toxicity|safety and toxicity
748868|NCT01158001|Posttraumatic stress disorders|posttraumatic stress disorders
748869|NCT01158001|Telemedicine|telemedicine
748870|NCT01158001|Psychotherapy|psychotherapy
748871|NCT01158001|Neuropsychological test|neuropsychological test
748872|NCT01158001|Depression|depression
748873|NCT01158014|pterygium|pterygium
748874|NCT01158014|conjunctival graft|conjunctival graft
748875|NCT01158014|recurrence|recurrence
748876|NCT01158014|primary pterygium|primary pterygium
748877|NCT01158040|Maternal intrapartum glycemic control|maternal intrapartum glycemic control
748878|NCT01158040|Pregestational diabetes|pregestational diabetes
748879|NCT01158066|NAFLD|nafld
748880|NCT01158066|Calcium score|calcium score
748881|NCT01158066|Liver Fat|liver fat
748882|NCT01158066|Visceral fat|visceral fat
748883|NCT01158066|excessive visceral fat|excessive visceral fat
748884|NCT01158066|excessive liver fat accumulation|excessive liver fat accumulation
748885|NCT01158066|Biomarkers of insulin resistance (HOMA), inflammation (CRP) and (MDA-Paraoxonase)|biomarkers of insulin resistance (homa), inflammation (crp) and (mda-paraoxonase)
748886|NCT01158079|Liver|liver
748887|NCT01158079|Solid Tumors|solid tumors
748888|NCT01158079|Advanced Solid Tumors with Liver Involvement|advanced solid tumors with liver involvement
748889|NCT01158105|Steroid refractory chronic graft vs host disease (cGVHD)|steroid refractory chronic graft vs host disease (cgvhd)
748890|NCT01158105|Bortezomib|bortezomib
748891|NCT01158105|Velcade|velcade
748892|NCT01158118|Precursor Cell Lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
748893|NCT01158118|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
748894|NCT01158131|Gestational diabetes mellitus (GDM) in the most recent pregnancy|gestational diabetes mellitus (gdm) in the most recent pregnancy
748895|NCT01158144|Non-small cell lung cancer|non-small cell lung cancer
748896|NCT01158144|Locally advanced|locally advanced
748897|NCT01158144|Radiotherapy|radiotherapy
748898|NCT01158144|Concomitant Chemotherapy|concomitant chemotherapy
748899|NCT01158144|Endostar|endostar
748900|NCT01158170|nonsmall cell lung cancer|nonsmall cell lung cancer
748901|NCT01158170|brain metastasis|brain metastasis
748902|NCT01158170|prophylactic cranial irradiation|prophylactic cranial irradiation
748903|NCT01158183|Outcomes|outcomes
748904|NCT01158183|real world and web tool|real world and web tool
748905|NCT01158183|electronic data capture|electronic data capture
748906|NCT01158196|laser|laser
748907|NCT01158196|keloid|keloid
748908|NCT01158196|scar|scar
748909|NCT01158235|MRSA|mrsa
748910|NCT01158235|nose|nose
748911|NCT01158248|cervical adenocarcinoma|cervical adenocarcinoma
748912|NCT01158248|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
748913|NCT01158248|cervical small cell carcinoma|cervical small cell carcinoma
748914|NCT01158248|stage IB cervical cancer|stage ib cervical cancer
748915|NCT01158248|stage IIA cervical cancer|stage iia cervical cancer
748916|NCT01158248|stage IIB cervical cancer|stage iib cervical cancer
748917|NCT01158248|stage III cervical cancer|stage iii cervical cancer
748918|NCT01158248|cervical squamous cell carcinoma|cervical squamous cell carcinoma
748919|NCT01158261|hemostasis|hemostasis
748920|NCT01158287|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
748921|NCT01158287|recurrent esophageal cancer|recurrent esophageal cancer
748922|NCT01158287|recurrent gastric cancer|recurrent gastric cancer
748923|NCT01158287|adenocarcinoma of the stomach|adenocarcinoma of the stomach
748924|NCT01158300|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
748925|NCT01158300|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
748926|NCT01158300|recurrent childhood brain tumor|recurrent childhood brain tumor
748927|NCT01158300|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
749102|NCT01159145|Healthy volunteer|healthy volunteer
748928|NCT01158300|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
748929|NCT01158300|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
748930|NCT01158300|recurrent childhood ependymoma|recurrent childhood ependymoma
748931|NCT01158300|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
748932|NCT01158300|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
748933|NCT01158300|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
748934|NCT01158300|recurrent childhood spinal cord neoplasm|recurrent childhood spinal cord neoplasm
748935|NCT01158300|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
748936|NCT01158300|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
748937|NCT01158300|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
748938|NCT01158300|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
748939|NCT01158300|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
748940|NCT01158300|childhood central nervous system germinoma|childhood central nervous system germinoma
748941|NCT01158300|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
749064|NCT01158885|AML|aml
748942|NCT01158300|childhood central nervous system teratoma|childhood central nervous system teratoma
748943|NCT01158300|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
748944|NCT01158300|childhood astrocytoma|childhood astrocytoma
748945|NCT01158300|childhood medulloepithelioma|childhood medulloepithelioma
748946|NCT01158300|childhood meningioma|childhood meningioma
748947|NCT01158300|childhood mixed glioma|childhood mixed glioma
748948|NCT01158300|childhood oligodendroglioma|childhood oligodendroglioma
748949|NCT01158300|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
748950|NCT01158326|reducing symptoms|reducing symptoms
748951|NCT01158326|events|events
748952|NCT01158326|Common Cold|common cold
748953|NCT01158326|flu syndrome|flu syndrome
748954|NCT01158326|Symptomatic treatment of the Common Cold and Flu syndrome|symptomatic treatment of the common cold and flu syndrome
748955|NCT01158339|Low back pain|low back pain
748956|NCT01158339|Cognitive behavioural therapy|cognitive behavioural therapy
748957|NCT01158339|Group therapy|group therapy
748958|NCT01158339|Exposure in session|exposure in session
748959|NCT01158352|Growth|growth
748960|NCT01158352|Low weight|low weight
748961|NCT01158352|Low height|low height
748962|NCT01158352|Nutritional Formula|nutritional formula
748963|NCT01158378|Adherus Dural Sealant|adherus dural sealant
748964|NCT01158378|Adherus AutoSpray Dural Sealant|adherus autospray dural sealant
748965|NCT01158391|Premature Birth|premature birth
748966|NCT01158404|Metastatic Cancer|metastatic cancer
748967|NCT01158404|Solid Tumors|solid tumors
748968|NCT01158417|Type 2 Diabetes|type 2 diabetes
748969|NCT01158417|Obesity|obesity
748970|NCT01158417|Insulin Resistance|insulin resistance
748971|NCT01158417|Resveratrol|resveratrol
748972|NCT01158417|Inflammation|inflammation
748973|NCT01158430|Hypochondriasis|hypochondriasis
748974|NCT01158430|Acceptance and Commitment Therapy|acceptance and commitment therapy
748975|NCT01158430|ACT|act
748976|NCT01158443|HIV+|hiv+
748977|NCT01158443|fatigue|fatigue
748978|NCT01158443|return to work|return to work
748979|NCT01158456|smoking|smoking
748981|NCT01158456|ethnic racial differences|ethnic racial differences
748982|NCT01158456|tobacco specific nitrosamines|tobacco specific nitrosamines
748983|NCT01158456|metabolism of carcinogens|metabolism of carcinogens
748984|NCT01158508|cerebral aneurysm|cerebral aneurysm
748985|NCT01158508|cerebral vasospasm|cerebral vasospasm
748986|NCT01158508|subarachnoid hemorrhage|subarachnoid hemorrhage
748987|NCT01158508|remote ischemic preconditioning|remote ischemic preconditioning
748988|NCT01158534|recurrent renal cell cancer|recurrent renal cell cancer
748989|NCT01158560|upper respiratory tract infections|upper respiratory tract infections
748990|NCT01158560|rhinovirus infections|rhinovirus infections
748991|NCT01158560|vitamin D|vitamin d
748992|NCT01158573|Asthma|asthma
748993|NCT01158573|Obesity|obesity
748994|NCT01158586|post total knee replacement|post total knee replacement
748995|NCT01158586|patient control|patient control
748996|NCT01158586|epidural analgesia|epidural analgesia
748997|NCT01158599|Japanese Encephalitis|japanese encephalitis
748998|NCT01158599|Vaccination|vaccination
748999|NCT01158599|Ixiaro|ixiaro
749000|NCT01158599|elderly population|elderly population
749001|NCT01158638|Physical Activity Enhancement|physical activity enhancement
749002|NCT01158651|NF1|nf1
749003|NCT01158651|low-grade glioma|low-grade glioma
749004|NCT01158651|progressive|progressive
749005|NCT01158651|children|children
749006|NCT01158651|Participants studied have NF Type 1 and a low grade glioma that has either not responded to one or more standard treatments.|participants studied have nf type 1 and a low grade glioma that has either not responded to one or more standard treatments.
749007|NCT01158664|dental implants|dental implants
749008|NCT01158664|different tread pitch design|different tread pitch design
749009|NCT01158677|meniscectomy|meniscectomy
749010|NCT01158690|Intimate partner violence|intimate partner violence
749011|NCT01158703|aspirin|aspirin
749012|NCT01158703|clopidogrel|clopidogrel
749694|NCT01162044|PTSD|ptsd
749013|NCT01158703|coronary artery bypass graft|coronary artery bypass graft
749014|NCT01158703|Plavix|plavix
749015|NCT01158716|percutaneous coronary intervention|percutaneous coronary intervention
749016|NCT01158716|remote ischemic preconditioning|remote ischemic preconditioning
749017|NCT01158729|Antithrombin III|antithrombin iii
749018|NCT01158729|Postoperative Hemorrhage|postoperative hemorrhage
749019|NCT01158729|Cardiopulmonary Bypass|cardiopulmonary bypass
749020|NCT01158729|Pediatrics|pediatrics
749021|NCT01158729|Blood Transfusion|blood transfusion
749022|NCT01158742|Glomerular Filtration Rate|glomerular filtration rate
749023|NCT01158755|Meningitis, tuberculous|meningitis, tuberculous
749024|NCT01158755|Intensified Regimen|intensified regimen
749025|NCT01158755|PK/PD and tolerability|pk/pd and tolerability
749026|NCT01158755|Outcome|outcome
752987|NCT01175044|Arthroplasty|arthroplasty
749027|NCT01158768|domestic violence in childhood/adolescence|domestic violence in childhood/adolescence
749028|NCT01158768|comorbidities|comorbidities
749029|NCT01158768|climactery|climactery
749030|NCT01158768|domestic violence against women|domestic violence against women
749031|NCT01158768|trauma questionnaire|trauma questionnaire
749032|NCT01158768|Violence|violence
749033|NCT01158781|TBI|tbi
749034|NCT01158781|motor learning|motor learning
749035|NCT01158781|robotics|robotics
749220|NCT01159652|Ambien|ambien
749036|NCT01158781|Functional electrical stimulation|functional electrical stimulation
749037|NCT01158794|Iron overload|iron overload
749038|NCT01158794|Blood Transfusion|blood transfusion
749039|NCT01158807|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
749040|NCT01158807|Cerebral arteriovenous malformations|cerebral arteriovenous malformations
749041|NCT01158820|bronchoscopy|bronchoscopy
749042|NCT01158833|Cerebral palsy|cerebral palsy
749043|NCT01158833|diplegia|diplegia
749044|NCT01158833|gait|gait
749045|NCT01158833|classification|classification
749046|NCT01158846|STEMI|stemi
749047|NCT01158846|Primary PCI|primary pci
749048|NCT01158846|anticoagulants|anticoagulants
749049|NCT01158846|antiplatelets|antiplatelets
749050|NCT01158859|Anesthesia, General|anesthesia, general
749051|NCT01158859|Propofol|propofol
749052|NCT01158859|Pregabalin|pregabalin
749053|NCT01158859|Preoperative care|preoperative care
749054|NCT01158859|Laparoscopic surgery|laparoscopic surgery
749055|NCT01158885|relapsed|relapsed
749056|NCT01158885|relapse|relapse
749057|NCT01158885|refractory|refractory
749058|NCT01158885|Minimal Residual disease|minimal residual disease
749059|NCT01158885|MRD|mrd
749060|NCT01158885|MRD positive|mrd positive
749061|NCT01158885|MRD+|mrd+
749062|NCT01158885|ALL|all
749063|NCT01158885|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
749065|NCT01158885|Acute myelogenous leukemia|acute myelogenous leukemia
749066|NCT01158885|Relapsed AML|relapsed aml
749067|NCT01158898|Mild to moderate asthma|mild to moderate asthma
749068|NCT01158898|Allergen inhalation challenge|allergen inhalation challenge
749069|NCT01158911|kidney disease|kidney disease
749070|NCT01158911|uric acid|uric acid
749071|NCT01158911|outcomes|outcomes
749072|NCT01158911|cardiovascular|cardiovascular
749073|NCT01158911|mortality|mortality
749074|NCT01158911|kidney failure|kidney failure
749075|NCT01158911|Uric Acid levels in patients with Chronic Kidney Disease|uric acid levels in patients with chronic kidney disease
749077|NCT01158937|cystic fibrosis|cystic fibrosis
749078|NCT01158937|extended infusion|extended infusion
749079|NCT01158937|pharmacokinetic|pharmacokinetic
749080|NCT01158989|Critical care|critical care
749081|NCT01158989|Endoscopy, Video Capsule|endoscopy, video capsule
749082|NCT01158989|Nutrition, Enteral|nutrition, enteral
749083|NCT01159002|Endoscopy, Video Capsule|endoscopy, video capsule
749084|NCT01159002|Motility, Gastrointestinal|motility, gastrointestinal
749085|NCT01159028|Liposomal Grb-2 treatment of CML, AML, CLL, MDS|liposomal grb-2 treatment of cml, aml, cll, mds
749086|NCT01159028|Liposomal Grb-2 with LDAC for AML|liposomal grb-2 with ldac for aml
749087|NCT01159041|Depression, children, adolescent, family|depression, children, adolescent, family
749088|NCT01159067|hematopoietic stem cell transplant, iron overload, deferasirox, labile plasma iron|hematopoietic stem cell transplant, iron overload, deferasirox, labile plasma iron
749089|NCT01159080|immunosuppression control in kidney transplantation|immunosuppression control in kidney transplantation
749090|NCT01159093|Clinical Decision Support Systems|clinical decision support systems
749091|NCT01159106|Positive Pressure Ventilation|positive pressure ventilation
749092|NCT01159106|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
749093|NCT01159106|Patient/ventilator Asynchrony|patient/ventilator asynchrony
749094|NCT01159106|Pediatric patient|pediatric patient
749095|NCT01159106|Infant|infant
749096|NCT01159119|Chronic Abdominal Pain|chronic abdominal pain
749097|NCT01159119|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
749098|NCT01159132|pharmacokinetics|pharmacokinetics
749099|NCT01159132|low dose raltegravir|low dose raltegravir
749101|NCT01159132|To study the pharmacokinetics profile of low dose raltegravir (RAL) (400mg OD and 800mg OD) and standard dose of 400mg BID in Thai HIV-infected patients.|to study the pharmacokinetics profile of low dose raltegravir (ral) (400mg od and 800mg od) and standard dose of 400mg bid in thai hiv-infected patients.
749695|NCT01162044|prevention|prevention
749103|NCT01159145|Japanese males|japanese males
749104|NCT01159145|homo-EM/hetero-EM/PM|homo-em/hetero-em/pm
749105|NCT01159184|stress|stress
749106|NCT01159184|coping methods|coping methods
749107|NCT01159184|social support|social support
749108|NCT01159184|diabetes mellitus|diabetes mellitus
749109|NCT01159197|sleep disturbance|sleep disturbance
749110|NCT01159197|cognitive behavioral therapy|cognitive behavioral therapy
749111|NCT01159197|inflammation|inflammation
749112|NCT01159197|oxidative stress|oxidative stress
749113|NCT01159197|hemodialysis|hemodialysis
749114|NCT01159223|atazanavir / ritonavir|atazanavir / ritonavir
749115|NCT01159223|low dose|low dose
749116|NCT01159223|noninferiority|noninferiority
749117|NCT01159223|safety and efficacy|safety and efficacy
752988|NCT01175044|Betadine|betadine
749118|NCT01159223|efficacy and safety of lower dose atazanavir/ritonavir in suppressed HIV-infected adults|efficacy and safety of lower dose atazanavir/ritonavir in suppressed hiv-infected adults
749119|NCT01159236|Gene signatures|gene signatures
749120|NCT01159236|HER-2 normal stage I-III breast cancer|her-2 normal stage i-iii breast cancer
749121|NCT01159236|Estrogen Receptor|estrogen receptor
749122|NCT01159236|ER-positive|er-positive
749123|NCT01159236|ER-negative|er-negative
749124|NCT01159236|RCB categories II-III|rcb categories ii-iii
749125|NCT01159236|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
749126|NCT01159236|adjuvant systemic therapy|adjuvant systemic therapy
749127|NCT01159236|molecular testing|molecular testing
749128|NCT01159236|Fluorouracil|fluorouracil
749129|NCT01159236|5-fluorouracil|5-fluorouracil
749130|NCT01159236|5-FU|5-fu
749131|NCT01159236|Doxorubicin|doxorubicin
749132|NCT01159236|Adriamycin|adriamycin
749133|NCT01159236|Rubex|rubex
749134|NCT01159236|Epirubicin|epirubicin
749135|NCT01159236|Ellence|ellence
749136|NCT01159236|Cyclophosphamide|cyclophosphamide
749137|NCT01159236|Cytoxan|cytoxan
749138|NCT01159236|Neosar|neosar
749139|NCT01159236|Bevacizumab|bevacizumab
749140|NCT01159236|Avastin|avastin
749141|NCT01159236|Anti-VEGF monoclonal|anti-vegf monoclonal
749142|NCT01159236|rhu-MAb-VEGF|rhu-mab-vegf
749143|NCT01159249|Vildagliptin, Type 2 Diabetes, HbA1c, Fasting Plasma Glucose, Long-Term Safety|vildagliptin, type 2 diabetes, hba1c, fasting plasma glucose, long-term safety
749144|NCT01159262|Initially intubated and mechanically ventilated neonates|initially intubated and mechanically ventilated neonates
749145|NCT01159275|lopinavir/ritonavir|lopinavir/ritonavir
749146|NCT01159275|pharmacokinetics|pharmacokinetics
749147|NCT01159275|HIV-1 infected adults|hiv-1 infected adults
749148|NCT01159275|aim to investigate the lower dose of boosted lopinavir in Thais and to compare the levels of lopinavir/ritonavir from Abbot and GPO|aim to investigate the lower dose of boosted lopinavir in thais and to compare the levels of lopinavir/ritonavir from abbot and gpo
749149|NCT01159288|Advanced unresectable non small cell lung cancer|advanced unresectable non small cell lung cancer
749150|NCT01159288|Responding or stabilized after induction chemotherapy|responding or stabilized after induction chemotherapy
749151|NCT01159314|glaucoma|glaucoma
749152|NCT01159314|Baerveldt Implants|baerveldt implants
749153|NCT01159327|Sorafenib (nexavar)|sorafenib (nexavar)
749154|NCT01159327|ED-SCLC|ed-sclc
749155|NCT01159327|Maintenance|maintenance
749156|NCT01159327|Extensive Disease Small cell lung cancer|extensive disease small cell lung cancer
749157|NCT01159366|myocardial infarction|myocardial infarction
749158|NCT01159366|coronary occlusion|coronary occlusion
749262|NCT01159899|Osteoarthritis|osteoarthritis
749159|NCT01159366|myocardial revascularization|myocardial revascularization
749160|NCT01159366|collaterals|collaterals
749161|NCT01159366|prognosis|prognosis
749162|NCT01159379|IgE-mediated allergy|ige-mediated allergy
749163|NCT01159379|Beta-lactams|beta-lactams
749164|NCT01159379|Ertapenem|ertapenem
749165|NCT01159379|Cross-reactivity|cross-reactivity
749166|NCT01159379|Immediate-type skin tests|immediate-type skin tests
749167|NCT01159379|Intravenous tolerance tests|intravenous tolerance tests
749168|NCT01159392|brain injury|brain injury
749169|NCT01159392|mechanical ventilation|mechanical ventilation
749170|NCT01159392|acute lung injury|acute lung injury
749171|NCT01159392|lung recruitment|lung recruitment
749172|NCT01159418|solid tumors|solid tumors
749173|NCT01159418|Panobinostat|panobinostat
749174|NCT01159418|histone deacetylase inhibitors|histone deacetylase inhibitors
749175|NCT01159431|partial seizures|partial seizures
749176|NCT01159431|poorly controlled epilepsy|poorly controlled epilepsy
749177|NCT01159431|intractable epilepsy|intractable epilepsy
749178|NCT01159431|treatment resistant epilepsy|treatment resistant epilepsy
749179|NCT01159431|Trigeminal Nerve|trigeminal nerve
749180|NCT01159431|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
749181|NCT01159444|noninvasive ventilation|noninvasive ventilation
749182|NCT01159444|ventilator software|ventilator software
749183|NCT01159444|ventilator settings|ventilator settings
749184|NCT01159444|domiciliary ventilation|domiciliary ventilation
749185|NCT01159457|Celiac Disease|celiac disease
749186|NCT01159457|Hepatitis B vaccination|hepatitis b vaccination
749187|NCT01159470|CRP velocity|crp velocity
749188|NCT01159483|safety|safety
749189|NCT01159483|tolerability|tolerability
749190|NCT01159483|pharmacokinetics|pharmacokinetics
750078|NCT01157767|exercise|exercise
749191|NCT01159509|hypertrophic pyloric stenosis|hypertrophic pyloric stenosis
749192|NCT01159509|sodium intake|sodium intake
749193|NCT01159509|Healthy children with no chronic diseases|healthy children with no chronic diseases
749194|NCT01159509|Status post HPS|status post hps
749195|NCT01159522|Advanced Solid Tumors Who Have Failed Standard Therapy|advanced solid tumors who have failed standard therapy
749196|NCT01159535|substance use|substance use
749197|NCT01159535|addiction|addiction
749198|NCT01159535|meditation|meditation
749199|NCT01159535|mindfulness|mindfulness
749200|NCT01159535|relapse prevention|relapse prevention
749201|NCT01159613|SVR|svr
749202|NCT01159613|Cholesterol level|cholesterol level
749203|NCT01159613|fibrosis score|fibrosis score
749204|NCT01159613|HDL|hdl
749205|NCT01159626|Phase1|phase1
749206|NCT01159626|Pharmacokinetics|pharmacokinetics
749207|NCT01159626|Healthy Male|healthy male
749208|NCT01159626|Japanese|japanese
749209|NCT01159626|Schizophrenia|schizophrenia
749210|NCT01159639|aspirin resistance|aspirin resistance
749211|NCT01159639|coronary artery bypass grafting|coronary artery bypass grafting
749212|NCT01159639|multiple electrode aggregometry|multiple electrode aggregometry
749213|NCT01159639|multiplate|multiplate
749214|NCT01159652|sleep|sleep
749215|NCT01159652|memory|memory
749216|NCT01159652|hypnotics|hypnotics
749217|NCT01159652|zaleplon|zaleplon
749218|NCT01159652|zolpidem|zolpidem
749221|NCT01159652|Hypnotics and Sedatives|hypnotics and sedatives
749222|NCT01159652|Polysomnography|polysomnography
749223|NCT01159652|Monitoring, sleep|monitoring, sleep
749225|NCT01159691|Neupro®|neupro®
749226|NCT01159691|Parkinson's disease|parkinson's disease
749227|NCT01159691|Gastrointestinal|gastrointestinal
749228|NCT01159691|Switch from oral therapy to patch|switch from oral therapy to patch
749229|NCT01159704|HIV infection|hiv infection
749230|NCT01159704|Intervention|intervention
749231|NCT01159704|Risk-reduction|risk-reduction
749232|NCT01159704|Injection drug users|injection drug users
749233|NCT01159743|lipodystrophy|lipodystrophy
749234|NCT01159743|Lipoatrophy|lipoatrophy
749235|NCT01159743|antiretroviral treatment|antiretroviral treatment
749236|NCT01159756|Travacom|travacom
749237|NCT01159756|Glaucoma|glaucoma
749238|NCT01159756|Travoprost|travoprost
749239|NCT01159756|Timolol|timolol
749240|NCT01159769|Allergic conjunctivitis|allergic conjunctivitis
749241|NCT01159795|Respiratory Syncytial Virus|respiratory syncytial virus
749242|NCT01159795|Infant|infant
749243|NCT01159795|Interferon|interferon
749244|NCT01159808|Safety and Pharmacokinetics|safety and pharmacokinetics
749245|NCT01159821|31001074|31001074
749246|NCT01159821|Paroxetine|paroxetine
749247|NCT01159821|CYP2D6 inhibitor|cyp2d6 inhibitor
749248|NCT01159834|HPV infection|hpv infection
749249|NCT01159834|Cervical cancer|cervical cancer
749250|NCT01159834|HPV vaccine|hpv vaccine
749251|NCT01159847|sitagliptin|sitagliptin
749252|NCT01159847|LADA|lada
749253|NCT01159847|C-Peptide|c-peptide
749254|NCT01159847|Flow Cytometry|flow cytometry
749255|NCT01159847|ELISPOT|elispot
749256|NCT01159860|seborrheic keratoses|seborrheic keratoses
749257|NCT01159860|cryosurgery|cryosurgery
749258|NCT01159860|curettage|curettage
749259|NCT01159886|Tuberculosis|tuberculosis
749260|NCT01159886|IBD|ibd
749261|NCT01159886|endoscopy|endoscopy
749555|NCT01161303|TNF alpha|tnf alpha
749263|NCT01159899|knee arthritis|knee arthritis
749264|NCT01159899|Knee arthrosis|knee arthrosis
749265|NCT01159899|articular cartilage defects|articular cartilage defects
749266|NCT01159899|osteochondral defects|osteochondral defects
749267|NCT01159899|mesenchymal stem cells|mesenchymal stem cells
749268|NCT01159899|stem cells|stem cells
749269|NCT01159899|cellules souches,|cellules souches,
749271|NCT01159899|arthrose genou|arthrose genou
749272|NCT01159899|PRP platelet rich plasma|prp platelet rich plasma
749273|NCT01159899|thérapie cellulaire|thérapie cellulaire
749274|NCT01159899|implantation cellules souches mésenchymateuses|implantation cellules souches mésenchymateuses
749275|NCT01159899|régénération cartilage|régénération cartilage
749276|NCT01159899|cicatrisation ménisque|cicatrisation ménisque
749277|NCT01159899|ligament|ligament
749278|NCT01159899|plasma riche plaquettaire|plasma riche plaquettaire
749279|NCT01159899|platelet rich plasma|platelet rich plasma
749280|NCT01159899|stem cell|stem cell
749281|NCT01159899|regrowt cartilage|regrowt cartilage
749282|NCT01159899|cellules souches|cellules souches
749283|NCT01159899|PRP|prp
749284|NCT01159912|fluticasone propionate|fluticasone propionate
749285|NCT01159912|Fluticasone furoate|fluticasone furoate
749286|NCT01159964|Antigen-Specific Cancer Immunotherapeutic (ASCI)|antigen-specific cancer immunotherapeutic (asci)
749287|NCT01159964|PRAME|prame
749288|NCT01159964|PRAME-positive stage IB, II or IIIA Non-Small Cell Lung Cancer patients after complete surgical resection|prame-positive stage ib, ii or iiia non-small cell lung cancer patients after complete surgical resection
749289|NCT01159964|Non-Small Cell Lung Cancer|non-small cell lung cancer
749290|NCT01159990|HIV Preventive Vaccine|hiv preventive vaccine
749291|NCT01159990|HIV Seronegativity|hiv seronegativity
749292|NCT01160003|ACTH stimulation test|acth stimulation test
750079|NCT01157767|lymphedema|lymphedema
749293|NCT01160003|Pharmacokinetics|pharmacokinetics
749294|NCT01160003|Nebules|nebules
749295|NCT01160003|Cortisol|cortisol
749296|NCT01160094|Trastuzumab|trastuzumab
749297|NCT01160094|Metastatic Breast Cancer|metastatic breast cancer
749298|NCT01160094|Breast Cancer|breast cancer
749299|NCT01160094|Observational Study|observational study
749300|NCT01160094|Lapatinib|lapatinib
749301|NCT01160107|Diagnosis|diagnosis
749302|NCT01160107|Elderly Patients|elderly patients
749303|NCT01160107|Imids|imids
749304|NCT01160107|Chemotherapy|chemotherapy
749305|NCT01160120|fixed dose combinations|fixed dose combinations
749306|NCT01160120|tenofovir|tenofovir
749307|NCT01160120|lamivudine|lamivudine
749308|NCT01160120|efavirenz|efavirenz
749309|NCT01160120|therapeutic drug levels|therapeutic drug levels
749310|NCT01160120|safety and efficacy|safety and efficacy
749311|NCT01160120|HIV|hiv
749312|NCT01160120|To evaluation new formulations of FDC of TDF/3TC/EFV|to evaluation new formulations of fdc of tdf/3tc/efv
749313|NCT01160133|Systane|systane
749314|NCT01160133|Refresh Tears|refresh tears
749315|NCT01160133|Dry Eye|dry eye
749316|NCT01160133|Moderate to Severe Dry Eye|moderate to severe dry eye
749317|NCT01160146|Obestiy|obestiy
749318|NCT01160146|Over weight|over weight
749319|NCT01160146|referral patterns|referral patterns
749409|NCT01154621|Phase I|phase i
749320|NCT01160146|Continuing Medical Education|continuing medical education
749321|NCT01160159|Venous thrombosis|venous thrombosis
749322|NCT01160159|Women|women
749323|NCT01160159|Vasodilatation endothelium-dependent|vasodilatation endothelium-dependent
749325|NCT01160159|Arterial stiffness|arterial stiffness
749326|NCT01160159|Arterial compliance|arterial compliance
749327|NCT01160159|Capillary density|capillary density
749328|NCT01160172|vaccine|vaccine
749329|NCT01160172|young adults|young adults
749330|NCT01160172|Staphylococcus aureus|staphylococcus aureus
749331|NCT01160211|1st line MBC|1st line mbc
749332|NCT01160211|MBC|mbc
749333|NCT01160211|hormone receptor positive|hormone receptor positive
749334|NCT01160211|lapatinib|lapatinib
749335|NCT01160211|trastuzumab|trastuzumab
749336|NCT01160211|HER2 positive|her2 positive
749337|NCT01160211|aromatase inhibitor|aromatase inhibitor
749338|NCT01160224|Asthma|asthma
749339|NCT01160224|CCR3 receptor antagonists|ccr3 receptor antagonists
749340|NCT01160224|GW766944|gw766944
749341|NCT01160237|H1N1|h1n1
749342|NCT01160237|Pandemrix|pandemrix
749343|NCT01160237|Fluarix|fluarix
749344|NCT01160237|Influenza|influenza
749345|NCT01160263|ALS|als
749346|NCT01160263|serotonin|serotonin
749347|NCT01160263|dopamine|dopamine
749348|NCT01160276|renal graft|renal graft
749349|NCT01160276|colchicine|colchicine
749350|NCT01160276|drug interaction|drug interaction
749351|NCT01160276|cyclosporine|cyclosporine
749352|NCT01160276|tacrolimus|tacrolimus
749353|NCT01160276|renal transplantation|renal transplantation
749354|NCT01160276|renal transplant|renal transplant
749355|NCT01160276|ABCB1|abcb1
749356|NCT01160276|CYP3A5|cyp3a5
749357|NCT01160276|SLCO1B1|slco1b1
749358|NCT01160302|cancer|cancer
749359|NCT01160315|ovarian failure, chemotherapy, lymphoma, GnRH agonist|ovarian failure, chemotherapy, lymphoma, gnrh agonist
749360|NCT01154439|secondary acute myeloid leukemia|secondary acute myeloid leukemia
749361|NCT01154439|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
749362|NCT01154439|adult acute basophilic leukemia|adult acute basophilic leukemia
749363|NCT01154439|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
749364|NCT01154439|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
749365|NCT01154439|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
749366|NCT01154439|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
749367|NCT01154439|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
749368|NCT01154439|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
749369|NCT01154439|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
749370|NCT01154439|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
749371|NCT01154439|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
749372|NCT01154439|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
749373|NCT01154439|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
749374|NCT01154439|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
749375|NCT01154439|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
749376|NCT01154439|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
749377|NCT01154465|Central venous catheterization|central venous catheterization
749378|NCT01154465|Obese|obese
749379|NCT01154465|Ultrasound guidance|ultrasound guidance
749380|NCT01154465|Jugular|jugular
749381|NCT01154465|Randomized|randomized
749382|NCT01154465|Intensive Care Unit|intensive care unit
749383|NCT01154478|polyphenols omega-3 postprandial lipemia adipose tissue|polyphenols omega-3 postprandial lipemia adipose tissue
749384|NCT01154491|hip fractures|hip fractures
749385|NCT01154491|blood substitutes|blood substitutes
749386|NCT01154491|blood transfusion|blood transfusion
749387|NCT01154491|intravenous infusion|intravenous infusion
749388|NCT01154491|erythropoietin, recombinant|erythropoietin, recombinant
749389|NCT01154491|frail elderly|frail elderly
749390|NCT01154504|adrenomedullin|adrenomedullin
749391|NCT01154504|heart failure|heart failure
749392|NCT01154504|ultrafiltration|ultrafiltration
749393|NCT01154504|hemofiltration|hemofiltration
749394|NCT01154530|Gastroscopy|gastroscopy
749395|NCT01154530|Bacteria|bacteria
749396|NCT01154530|Chlorhexidine|chlorhexidine
749397|NCT01154530|General surgery|general surgery
749398|NCT01154543|Recurrent genital Herpes Simplex Virus|recurrent genital herpes simplex virus
749399|NCT01154556|Antiretroviral therapy experienced|antiretroviral therapy experienced
749400|NCT01154556|failed NNRTI regime|failed nnrti regime
749401|NCT01154569|drug absorption|drug absorption
749402|NCT01154569|azithromycin|azithromycin
749403|NCT01154569|obesity|obesity
749404|NCT01154569|bariatric surgery|bariatric surgery
749405|NCT01154582|ingestive behavior|ingestive behavior
749406|NCT01154595|moderate acute malnutrition, prevention, Lipid-based supplement|moderate acute malnutrition, prevention, lipid-based supplement
749407|NCT01154608|Protein absorption in pancreatitis|protein absorption in pancreatitis
749408|NCT01154608|Protein metabolism in pancreatitis|protein metabolism in pancreatitis
749410|NCT01154621|Double-blind|double-blind
749411|NCT01154621|Randomized|randomized
749412|NCT01154621|Placebo-controlled study|placebo-controlled study
749413|NCT01154621|Safety and tolerability of single intravenous dose of AZD9742 in healthy elderly volunteers|safety and tolerability of single intravenous dose of azd9742 in healthy elderly volunteers
749414|NCT01154634|Pharmacodynamic effect|pharmacodynamic effect
749415|NCT01154634|Reflux inhibition|reflux inhibition
749416|NCT01154660|any operation that required for general anesthesia|any operation that required for general anesthesia
749417|NCT01154699|Asthma|asthma
749418|NCT01154699|Nocturnal Asthma|nocturnal asthma
749419|NCT01154699|Lung volumes|lung volumes
749420|NCT01154699|Deep inspiration|deep inspiration
749421|NCT01154699|Obstructive sleep apnea|obstructive sleep apnea
749422|NCT01154712|Gambling|gambling
749423|NCT01154712|Deep TMS|deep tms
749424|NCT01154712|addiction|addiction
749425|NCT01154712|Brain stimulation|brain stimulation
749426|NCT01154725|Patient education|patient education
749427|NCT01154725|Health-Related Quality of Life|health-related quality of life
749428|NCT01154725|patients with stomas|patients with stomas
749429|NCT01154725|stomatherapy|stomatherapy
749430|NCT01154725|health economics|health economics
749431|NCT01154751|Femoral artery stenosis|femoral artery stenosis
749432|NCT01154751|Peripheral vascular Disease|peripheral vascular disease
749433|NCT01160328|Regional Fat Storage|regional fat storage
749434|NCT01160328|Fat Oxidation|fat oxidation
749435|NCT01160328|Testosterone|testosterone
749436|NCT01160328|Male|male
749437|NCT01160341|Metabolic syndrome|metabolic syndrome
749438|NCT01160341|Hypogonadism|hypogonadism
749439|NCT01160341|Testosterone|testosterone
749440|NCT01160354|Leukemia|leukemia
749441|NCT01160354|AML|aml
749442|NCT01160354|Clofarabine|clofarabine
749443|NCT01160354|Plerixafor|plerixafor
749444|NCT01160354|elderly patients|elderly patients
749445|NCT01160354|previously untreated|previously untreated
749857|NCT01162655|Telehealth|telehealth
749446|NCT01160354|unfavorable prognostic factors|unfavorable prognostic factors
749447|NCT01160380|cancer related fatigue|cancer related fatigue
749448|NCT01160380|fatigue|fatigue
749449|NCT01160380|multiple myeloma|multiple myeloma
749450|NCT01160380|cancer|cancer
749451|NCT01160380|quality of life|quality of life
749452|NCT01160393|Atrial fibrillation|atrial fibrillation
749453|NCT01160393|Cardiac surgery|cardiac surgery
749454|NCT01160393|Prevention|prevention
749455|NCT01160393|Conventional bypass system|conventional bypass system
749456|NCT01160393|Miniaturized bypass system|miniaturized bypass system
749457|NCT01160393|Arrhythmia|arrhythmia
749458|NCT01160393|The Incidence of atrial fibrillation after cardiac surgery|the incidence of atrial fibrillation after cardiac surgery
749459|NCT01160406|silent paroxysmal atrial fibrillation|silent paroxysmal atrial fibrillation
749460|NCT01160406|stroke|stroke
749461|NCT01160406|tele ECG|tele ecg
749462|NCT01160432|opiate dependence|opiate dependence
749463|NCT01160432|methadone|methadone
749464|NCT01160432|naloxone|naloxone
749465|NCT01160432|withdrawal symptom|withdrawal symptom
749466|NCT01160432|substitution treatment|substitution treatment
749467|NCT01160445|Metastatic Melanoma|metastatic melanoma
749468|NCT01160445|Metastatic Kidney Cancer|metastatic kidney cancer
749469|NCT01160445|Clinical Performance|clinical performance
749470|NCT01160445|Tumor Regression|tumor regression
749471|NCT01160445|Toxicity|toxicity
749472|NCT01160458|Monoclonal Antibody|monoclonal antibody
749473|NCT01160458|Pleural Mesothelioma|pleural mesothelioma
749474|NCT01160458|Peritoneal Mesothelioma|peritoneal mesothelioma
749475|NCT01160471|Heart Failure|heart failure
749476|NCT01160471|Computed Tomography|computed tomography
749477|NCT01160471|Ultrasound|ultrasound
749478|NCT01160471|Fibrosis|fibrosis
749479|NCT01160471|Biomarker|biomarker
749480|NCT01160484|multiple myeloma|multiple myeloma
749481|NCT01160484|refractory|refractory
749482|NCT01160484|relapsed|relapsed
749483|NCT01160484|bortezomib|bortezomib
749484|NCT01160484|doxil|doxil
749485|NCT01160510|Breast|breast
749486|NCT01160510|Mammographic Density|mammographic density
749487|NCT01160523|Podoconiosis|podoconiosis
749488|NCT01160523|Genetic Education|genetic education
749489|NCT01160523|Primary Prevention|primary prevention
749490|NCT01160523|Ethiopa|ethiopa
749491|NCT01160523|Youth|youth
749492|NCT01160536|Hypertrophic Cardiomyopathy (HCM)|hypertrophic cardiomyopathy (hcm)
749493|NCT01160536|Genetic Testing|genetic testing
749494|NCT01160549|Pregnancy|pregnancy
749495|NCT01160549|Hormones|hormones
749496|NCT01160549|Mongolia|mongolia
749497|NCT01160549|Asian|asian
749498|NCT01160549|Breast Cancer|breast cancer
749499|NCT01160562|Prevalence|prevalence
749500|NCT01160562|Incidence|incidence
749501|NCT01160562|Children|children
749502|NCT01160562|Adults|adults
749503|NCT01160562|Global Positioning system|global positioning system
749504|NCT01160575|Counseling|counseling
749505|NCT01160575|Epidemiology|epidemiology
749506|NCT01160575|HIV|hiv
749507|NCT01160575|AIDS|aids
749508|NCT01160575|Prevention|prevention
749509|NCT01160588|Anxiety|anxiety
749510|NCT01160588|Social Phobia|social phobia
749511|NCT01160588|Social Anxiety|social anxiety
749512|NCT01160588|Generalized Anxiety|generalized anxiety
749513|NCT01160588|Separation Anxiety|separation anxiety
749515|NCT01160601|lung cancer|lung cancer
749516|NCT01160601|non small cell lung cancer|non small cell lung cancer
749517|NCT01160601|bavituximab|bavituximab
749518|NCT01160601|monoclonal antibody|monoclonal antibody
749519|NCT01160614|Pediatric|pediatric
749520|NCT01160614|Post-operative|post-operative
749521|NCT01160614|Nonsurgical|nonsurgical
749522|NCT01160614|patients|patients
749523|NCT01160614|Opioid|opioid
749524|NCT01160627|CIN STEMI|cin stemi
749525|NCT01160640|PID|pid
749526|NCT01160640|Pelvic Inflammatory Disease|pelvic inflammatory disease
749527|NCT01160653|stroke|stroke
749528|NCT01160653|Gait training|gait training
749529|NCT01160653|Cognitive Training|cognitive training
749530|NCT01160666|Belimumab|belimumab
749531|NCT01160666|Sjögren's syndrome|sjögren's syndrome
749532|NCT01160666|Sjögren disease|sjögren disease
749533|NCT01161251|Atrial Fibrillation|atrial fibrillation
749534|NCT01161251|ABI|abi
749535|NCT01161251|PAD|pad
749536|NCT01161251|Registry|registry
749537|NCT01161251|Italian|italian
749538|NCT01161264|Elderly|elderly
749539|NCT01161264|Influenza|influenza
749540|NCT01161264|Immunogenicity|immunogenicity
749541|NCT01161264|Safety|safety
749542|NCT01161264|Influenza vaccine|influenza vaccine
749543|NCT01161277|Aripiprazole|aripiprazole
749544|NCT01161277|Haloperidol|haloperidol
749545|NCT01161277|Ventral striatum|ventral striatum
749546|NCT01161277|Reward|reward
749547|NCT01161277|fMRI|fmri
749548|NCT01161290|Telemedicine|telemedicine
749549|NCT01161290|Internet|internet
749550|NCT01161290|Dyspnea|dyspnea
749551|NCT01161290|Self care|self care
749552|NCT01161290|Breathing Exercises|breathing exercises
749553|NCT01161290|Real-Time Systems|real-time systems
749554|NCT01161303|Asthma|asthma
749556|NCT01161303|epithelial cell culture|epithelial cell culture
749557|NCT01161316|metastatic colorectal cancer|metastatic colorectal cancer
749558|NCT01161316|wild-type KRAS tumours|wild-type kras tumours
749559|NCT01161316|cetuximab|cetuximab
749560|NCT01161316|mFOLFOX-6|mfolfox-6
749561|NCT01161329|stroke|stroke
749562|NCT01161329|physical activity|physical activity
749563|NCT01161329|balance|balance
749564|NCT01161329|muscle-strength|muscle-strength
749565|NCT01161342|Malnutrition|malnutrition
749566|NCT01161342|Aged|aged
749567|NCT01161342|Aged 80 and over|aged 80 and over
749568|NCT01161342|Prevalence|prevalence
749569|NCT01161342|Mortality|mortality
749570|NCT01161355|Safety|safety
749571|NCT01161355|tolerability|tolerability
749572|NCT01161355|healthy|healthy
749573|NCT01161355|microdose|microdose
749574|NCT01161368|Metastatic Breast Cancer|metastatic breast cancer
749575|NCT01161381|OSAHS|osahs
749576|NCT01161381|nonlinear analysis|nonlinear analysis
749577|NCT01161381|polysomnography|polysomnography
749578|NCT01161381|biosignal analysis|biosignal analysis
749580|NCT01161381|APEN|apen
749581|NCT01161381|LLE|lle
749582|NCT01161420|tongue|tongue
749583|NCT01161420|surgery|surgery
749584|NCT01161420|neurostimulation|neurostimulation
749585|NCT01161420|hypoglossal nerve|hypoglossal nerve
749586|NCT01161420|upper airway stimulation|upper airway stimulation
749587|NCT01161433|Asthma|asthma
749588|NCT01161433|Spirometry|spirometry
749589|NCT01161433|Pediatric|pediatric
749590|NCT01161433|Primary Health Care|primary health care
749591|NCT01161433|Education, Distance|education, distance
749592|NCT01161446|HIV|hiv
749593|NCT01161446|Home testing|home testing
749594|NCT01161446|Self-testing|self-testing
749595|NCT01161446|HIV Infections/diagnosis|hiv infections/diagnosis
749596|NCT01161446|HIV Infections/prevention and control|hiv infections/prevention and control
749597|NCT01161446|AIDS Serodiagnosis|aids serodiagnosis
749598|NCT01161446|Oral fluids|oral fluids
749599|NCT01161446|Homosexuality, Male|homosexuality, male
749600|NCT01161446|Sexually transmitted diseases|sexually transmitted diseases
749601|NCT01161446|Sexual behavior|sexual behavior
749602|NCT01161459|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
749603|NCT01161459|Treatment|treatment
749604|NCT01161459|FK506|fk506
749605|NCT01161459|Tripterygium wilfordii|tripterygium wilfordii
749606|NCT01161485|HIV Infections|hiv infections
749607|NCT01161485|Treatment|treatment
749608|NCT01161485|Methamphetamine|methamphetamine
749609|NCT01161498|squamous cell|squamous cell
749610|NCT01161498|OncoVEX^GM-CSF|oncovex^gm-csf
749611|NCT01161498|Oncovex|oncovex
749612|NCT01161498|chemoradiation|chemoradiation
749613|NCT01161498|Cisplatin|cisplatin
749614|NCT01161511|CLL|cll
749615|NCT01161511|SLL|sll
749616|NCT01161511|CD19|cd19
749617|NCT01161563|palliative treatment|palliative treatment
749618|NCT01161563|prostate cancer|prostate cancer
749619|NCT01161576|Batten Disease|batten disease
749620|NCT01161576|Late Infantile Neuronal Lipofuscinosis|late infantile neuronal lipofuscinosis
749621|NCT01161576|gene transfer|gene transfer
749622|NCT01161589|sensing|sensing
749623|NCT01161589|S-ICD|s-icd
749624|NCT01161589|ICD|icd
749626|NCT01161602|Symptoms of Gastroesophageal Reflux Disease (GERD)|symptoms of gastroesophageal reflux disease (gerd)
749627|NCT01161615|tendonitis and/or bursitis of the shoulder|tendonitis and/or bursitis of the shoulder
749628|NCT01161615|acute tendonitis and/or bursitis of the shoulder|acute tendonitis and/or bursitis of the shoulder
749629|NCT01161628|Chronic Graft versus Host Disease|chronic graft versus host disease
749630|NCT01161628|allogeneic stem cell transplant|allogeneic stem cell transplant
749631|NCT01161641|Protein Losing Enteropathy|protein losing enteropathy
749632|NCT01161680|Cross sectional and Longitudinal Observational study|cross sectional and longitudinal observational study
749633|NCT01161693|Cesarean section|cesarean section
749634|NCT01161693|spinal anesthesia|spinal anesthesia
749635|NCT01161693|CSE|cse
749636|NCT01161693|ramped up position|ramped up position
749637|NCT01161693|TROOP pillow|troop pillow
749638|NCT01161693|elevation pillow|elevation pillow
749639|NCT01161693|maternal comfort|maternal comfort
749640|NCT01161693|Maternal Comfort after CSE during elective Cesarean Section in relation to adequate height of Anesthetic Block|maternal comfort after cse during elective cesarean section in relation to adequate height of anesthetic block
749641|NCT01161706|vegetable juice|vegetable juice
749642|NCT01161706|cardiovascular|cardiovascular
749643|NCT01161706|blood pressure|blood pressure
749644|NCT01161719|ADHD|adhd
749645|NCT01161719|Parent training|parent training
749646|NCT01161719|Videoconference|videoconference
749647|NCT01161732|aortic stenosis|aortic stenosis
749648|NCT01161732|surgery, survival|surgery, survival
749649|NCT01161745|sepsis|sepsis
749650|NCT01161758|physical therapy|physical therapy
749651|NCT01161758|pain threshold|pain threshold
749652|NCT01161758|electromyography|electromyography
749653|NCT01161758|musculoskeletal manipulation|musculoskeletal manipulation
749654|NCT01161758|neck muscles|neck muscles
749655|NCT01161784|Functional constipation|functional constipation
749656|NCT01161784|Probiotic|probiotic
749657|NCT01161784|Probiotic microorganism|probiotic microorganism
749658|NCT01161784|Lactobacillus casei Shirota (LcS)|lactobacillus casei shirota (lcs)
749659|NCT01161797|1,5-Anhydroglucitol|1,5-anhydroglucitol
749660|NCT01161810|Burn|burn
749661|NCT01161810|Rehabilitation|rehabilitation
749662|NCT01161849|lactate|lactate
749663|NCT01161849|urgent surgery|urgent surgery
749664|NCT01161849|major surgery|major surgery
749665|NCT01161849|surgical complications|surgical complications
749666|NCT01161849|possum|possum
749667|NCT01161849|sapsII|sapsii
749668|NCT01161849|relaparotomy|relaparotomy
749669|NCT01161862|Closed-loop|closed-loop
749670|NCT01161862|Artificial pancreas|artificial pancreas
749671|NCT01161862|Bi-hormonal|bi-hormonal
749672|NCT01161862|Insulin|insulin
749673|NCT01161862|Glucagon|glucagon
749674|NCT01161862|Diabetes mellitus type 1|diabetes mellitus type 1
749675|NCT01161901|ARDS|ards
749676|NCT01161901|Plasmatic biomarkers|plasmatic biomarkers
749677|NCT01161901|Lung Morphology|lung morphology
749678|NCT01161901|Mechanical ventilation|mechanical ventilation
749679|NCT01161901|CT scan|ct scan
749680|NCT01161914|Type I Gaucher|type i gaucher
749681|NCT01161927|Bioavailability|bioavailability
749682|NCT01161927|Nizatidine|nizatidine
749683|NCT01161927|Crossover|crossover
749684|NCT01161940|Bioavailability|bioavailability
749685|NCT01161940|Nizatidine|nizatidine
749686|NCT01161940|Crossover|crossover
749687|NCT01161953|Primary Biliary Cirrhosis|primary biliary cirrhosis
749689|NCT01161953|Cholestatic Liver Disease|cholestatic liver disease
749690|NCT01161992|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
749691|NCT01161992|PSC|psc
749692|NCT01161992|Cholestatic Liver Disease|cholestatic liver disease
749693|NCT01162005|Primary Nephrotic syndrome|primary nephrotic syndrome
749696|NCT01162057|Hemodialysis|hemodialysis
749697|NCT01162057|Hearing|hearing
749698|NCT01162057|Hemodialysis patients|hemodialysis patients
749699|NCT01162070|Uveitis|uveitis
749700|NCT01162070|etiological diagnosis|etiological diagnosis
749701|NCT01162070|standardized strategy|standardized strategy
749702|NCT01162083|Exercise Physiology|exercise physiology
749703|NCT01162083|Cardiopulmonary Interaction|cardiopulmonary interaction
749704|NCT01162083|Heart Failure|heart failure
749705|NCT01162096|Reduced Intensity Haploidentical Transplant|reduced intensity haploidentical transplant
749706|NCT01162109|Zinc|zinc
749707|NCT01162109|sepsis|sepsis
749708|NCT01162109|critical illness|critical illness
749709|NCT01162109|mechanical ventilation|mechanical ventilation
749710|NCT01162109|ICU|icu
749711|NCT01162122|Elderly|elderly
749712|NCT01162122|Influenza|influenza
749713|NCT01162122|Immunogenicity|immunogenicity
749714|NCT01162122|Safety|safety
749715|NCT01162122|Adjuvant|adjuvant
749716|NCT01162122|Adjuvanted|adjuvanted
749717|NCT01162122|Adjuvants|adjuvants
749718|NCT01162122|Vaccines|vaccines
749719|NCT01162135|Digoxin|digoxin
750201|NCT01164644|rhinoplasty|rhinoplasty
749720|NCT01162135|Recurrent Prostate Cancer|recurrent prostate cancer
749721|NCT01162135|Prostate Specific Antigen|prostate specific antigen
749722|NCT01162148|inspiratory muscle training|inspiratory muscle training
749723|NCT01162148|pulmonary rehabilitation|pulmonary rehabilitation
749724|NCT01162161|sphingolipid|sphingolipid
749725|NCT01162161|ceramide|ceramide
749726|NCT01162161|sphingomyelinase|sphingomyelinase
749727|NCT01162174|Flavanols|flavanols
749728|NCT01162174|cardiovascular|cardiovascular
749729|NCT01162187|secondary prevention|secondary prevention
749730|NCT01162187|aspirin|aspirin
749731|NCT01162187|beta blocker|beta blocker
749732|NCT01162187|ACE inhibitor|ace inhibitor
749733|NCT01162187|statin|statin
749734|NCT01162187|acute coronary syndrome|acute coronary syndrome
749735|NCT01162187|myocardial infarction|myocardial infarction
749736|NCT01162187|unstable angina|unstable angina
749737|NCT01162187|trends|trends
749738|NCT01162213|Postmenopausal Women|postmenopausal women
749739|NCT01162213|Healthy Males|healthy males
749740|NCT01162213|Cardiovascular|cardiovascular
749741|NCT01162213|Flavanols|flavanols
749742|NCT01162226|gait|gait
749743|NCT01162226|movement disorders|movement disorders
749744|NCT01162226|balance|balance
749745|NCT01162226|function|function
749746|NCT01162239|smoking|smoking
749747|NCT01162239|tobacco|tobacco
749748|NCT01162239|nicotine|nicotine
749749|NCT01162239|smoking cessation|smoking cessation
749750|NCT01162252|psoriasis|psoriasis
749751|NCT01162252|mindfulness|mindfulness
749752|NCT01162252|MBSR|mbsr
749753|NCT01162252|stress|stress
749754|NCT01162252|living well|living well
749755|NCT01162265|Tuberculosis|tuberculosis
749756|NCT01162265|IGRA|igra
749757|NCT01162265|latent|latent
749758|NCT01162278|liver metastases|liver metastases
749759|NCT01162278|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
749760|NCT01162291|intramuscular|intramuscular
749761|NCT01162291|distribution|distribution
749762|NCT01162291|NaCl|nacl
749763|NCT01162291|botulinum toxin|botulinum toxin
749764|NCT01162291|muscle|muscle
749765|NCT01162291|volume|volume
749766|NCT01162291|movement|movement
749767|NCT01162291|biceps brachii|biceps brachii
749768|NCT01162291|primary distribution of intramuscular NaCl representative for primary distribution of intramuscular botulinum toxin|primary distribution of intramuscular nacl representative for primary distribution of intramuscular botulinum toxin
749769|NCT01162291|shift from extracellular to intracellular viewed by DTI technology|shift from extracellular to intracellular viewed by dti technology
749770|NCT01162291|effect of volume|effect of volume
749771|NCT01162291|effect of muscle movement|effect of muscle movement
749772|NCT01162304|Chronic Pain|chronic pain
749773|NCT01162304|This clinical trial will compare immediate-release (IR)|this clinical trial will compare immediate-release (ir)
749774|NCT01162304|oxycodone and extended-release (ER) oxycodone in the|oxycodone and extended-release (er) oxycodone in the
749775|NCT01162304|management of chronic pain|management of chronic pain
749776|NCT01162317|Acupuncture|acupuncture
749777|NCT01162317|Sleep|sleep
749778|NCT01162317|Traumatic brain injury|traumatic brain injury
749779|NCT01162330|Screening|screening
749780|NCT01162330|Congenital Cytomegalovirus|congenital cytomegalovirus
749782|NCT01162330|Hearing loss|hearing loss
749783|NCT01162343|Delirium, diagnosis, elderly, hospitalization|delirium, diagnosis, elderly, hospitalization
749784|NCT01162356|Vitrectomy|vitrectomy
749785|NCT01162356|Glaucoma|glaucoma
749786|NCT01162356|Macula|macula
749787|NCT01162356|Optic nerve|optic nerve
749788|NCT01162356|Ocular Coherence Tomography|ocular coherence tomography
749789|NCT01162369|Delirium, diagnosis, elderly, hospitalization|delirium, diagnosis, elderly, hospitalization
749790|NCT01162382|transcranial magnetic stimulation|transcranial magnetic stimulation
749791|NCT01162382|TMS|tms
749792|NCT01162382|rTMS|rtms
749793|NCT01162382|depression|depression
749794|NCT01162382|fcMRI|fcmri
749795|NCT01162382|EEG|eeg
749796|NCT01162395|Prostate Cancer|prostate cancer
749797|NCT01162395|Tumour|tumour
749798|NCT01162395|Castration Resistant|castration resistant
749799|NCT01162395|Prostate Androgen Receptor Down Regulator|prostate androgen receptor down regulator
749800|NCT01162395|Metastatic|metastatic
749801|NCT01162408|ICU|icu
749802|NCT01162421|Rheumatoid Arthritis|rheumatoid arthritis
749803|NCT01162421|Anti-Inflammatory|anti-inflammatory
749804|NCT01162421|Biological Therapy|biological therapy
749805|NCT01162421|adalimumab|adalimumab
749806|NCT01162421|Disease-Modifying Antirheumatic Drugs|disease-modifying antirheumatic drugs
749807|NCT01162421|Antirheumatic Agents|antirheumatic agents
749808|NCT01162421|Agents|agents
749809|NCT01162434|Treatment resistant depression|treatment resistant depression
749810|NCT01162434|Deep brain stimulation|deep brain stimulation
749811|NCT01162434|Brain volumetric analysis|brain volumetric analysis
749812|NCT01162447|BMP- 4 and 7, polycystic ovarian syndrome|bmp- 4 and 7, polycystic ovarian syndrome
749813|NCT01162473|Food hypersensitivity|food hypersensitivity
749814|NCT01162473|Milk hypersensitivity|milk hypersensitivity
749815|NCT01162473|Milk allergy|milk allergy
749816|NCT01162473|Food allergy|food allergy
749817|NCT01162486|Anti-infective agents|anti-infective agents
749818|NCT01162486|Anti-bacterial agents|anti-bacterial agents
749819|NCT01162486|Rifampin|rifampin
749820|NCT01162486|Rifapentine|rifapentine
749821|NCT01162486|Midazolam|midazolam
749822|NCT01162486|Molecular mechanisms of pharmacological action|molecular mechanisms of pharmacological action
749823|NCT01162486|Antitubercular agents|antitubercular agents
749824|NCT01162486|Pharmacologic actions|pharmacologic actions
749825|NCT01162499|Post prandial hypoglycemia|post prandial hypoglycemia
749826|NCT01162499|hypoglycemia|hypoglycemia
749827|NCT01162499|Nissen fundoplication|nissen fundoplication
749828|NCT01162499|Dumping|dumping
749829|NCT01162512|physical activity|physical activity
749830|NCT01162512|obesity|obesity
749831|NCT01162512|adolescents|adolescents
749832|NCT01162512|telephone|telephone
749833|NCT01162512|BMI|bmi
749834|NCT01162512|body mass index|body mass index
749835|NCT01162525|Fecal Incontinence|fecal incontinence
749836|NCT01162525|Fecal Urge Incontinence|fecal urge incontinence
749837|NCT01162525|Percutaneous tibial nerve stimulation|percutaneous tibial nerve stimulation
749838|NCT01162538|Raltegravir, non B subtype, naive patients|raltegravir, non b subtype, naive patients
749839|NCT01162551|Leukemia|leukemia
749840|NCT01162551|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
749841|NCT01162577|Weight|weight
749842|NCT01162577|Smoking|smoking
749843|NCT01162577|Quitline|quitline
749844|NCT01162590|Human Rotavirus vaccine|human rotavirus vaccine
749845|NCT01162616|iron absorption|iron absorption
749846|NCT01162616|polyphenols|polyphenols
749847|NCT01162616|sodium iron EDTA|sodium iron edta
749848|NCT01162616|sorghum|sorghum
749849|NCT01162629|bounded saddles|bounded saddles
749850|NCT01162629|missing teeth|missing teeth
749851|NCT01162629|dental implants|dental implants
749852|NCT01162629|Tooth, Nonvital|tooth, nonvital
749853|NCT01162642|Healthy moderately heavy smokers|healthy moderately heavy smokers
749854|NCT01162655|Insomnia|insomnia
749855|NCT01162655|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
749856|NCT01162655|Internet|internet
749858|NCT01162668|bariatric surgery|bariatric surgery
749859|NCT01162668|obesity|obesity
749860|NCT01162668|outcomes|outcomes
749861|NCT01162681|SLE|sle
749862|NCT01162681|Lupus|lupus
749863|NCT01162681|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
749864|NCT01162681|Autoimmune Diseases|autoimmune diseases
749865|NCT01162681|A-623|a-623
749866|NCT01162681|Blisibimod|blisibimod
749867|NCT01162694|Remote Blood Glucose Monitoring System,|remote blood glucose monitoring system,
749868|NCT01162694|Continuous Glucose Monitoring System,|continuous glucose monitoring system,
749869|NCT01162694|Type 2 Diabetes|type 2 diabetes
749870|NCT01162720|Primary knee replacement|primary knee replacement
749871|NCT01162720|Unilateral knee replacement|unilateral knee replacement
749872|NCT01162733|Vancomycin|vancomycin
749873|NCT01162733|Therapeutic Levels|therapeutic levels
749874|NCT01162733|Infectious Disease|infectious disease
749875|NCT01162733|Recommendations|recommendations
749876|NCT01162759|hypertension, intervention|hypertension, intervention
749877|NCT01162785|BCG Refractory Superficial Bladder Cancer|bcg refractory superficial bladder cancer
749878|NCT01162785|SCH 721015|sch 721015
749879|NCT01162785|Syn3|syn3
749880|NCT01162785|novel excipient|novel excipient
749881|NCT01162785|interferon -alpha-2b|interferon -alpha-2b
749882|NCT01162785|Intravesical|intravesical
749883|NCT01162785|urine IFNa|urine ifna
749884|NCT01162785|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
749885|NCT01162785|superficial non-muscle invasive tumor|superficial non-muscle invasive tumor
749886|NCT01162798|infant formula|infant formula
749887|NCT01162798|premature infants|premature infants
749888|NCT01162798|Growth and Development|growth and development
749889|NCT01162811|Visualization|visualization
749890|NCT01162811|relaxation|relaxation
749891|NCT01162811|self hypnotic relaxation|self hypnotic relaxation
749892|NCT01162811|hypnosis|hypnosis
750863|NCT01167075|sepsis|sepsis
749893|NCT01162811|invasive medical procedures|invasive medical procedures
749894|NCT01162811|atrial fibrillation|atrial fibrillation
749895|NCT01162811|ablation|ablation
749896|NCT01162811|catheter ablation|catheter ablation
749897|NCT01162811|pain|pain
749898|NCT01162811|anxiety|anxiety
749899|NCT01162824|Endothelial Dysfunction|endothelial dysfunction
749900|NCT01162824|Microvascular dysfunction|microvascular dysfunction
749901|NCT01162824|Coronary artery spasm|coronary artery spasm
749902|NCT01162824|Inflammation|inflammation
749903|NCT01162824|CD4+CD28null T cells|cd4+cd28null t cells
749904|NCT01162824|Myocardial ischemia|myocardial ischemia
749905|NCT01162824|Early atherosclerosis|early atherosclerosis
749906|NCT01162837|Acne|acne
749907|NCT01162850|Melasma|melasma
749908|NCT01162863|IBSC|ibsc
749909|NCT01162863|irritable bowel syndrome|irritable bowel syndrome
749910|NCT01162863|constipation|constipation
749911|NCT01162876|Diabetes, Type 2|diabetes, type 2
749912|NCT01162889|pharmacokinetics|pharmacokinetics
749913|NCT01162889|Crohn's disease|crohn's disease
749914|NCT01162915|Spinal Cord Injury|spinal cord injury
750202|NCT01164644|nose job|nose job
749915|NCT01162928|critically ill, mechanically ventilated patients requiring enteral and parenteral nutritional support|critically ill, mechanically ventilated patients requiring enteral and parenteral nutritional support
749916|NCT01162941|ITP|itp
749917|NCT01162954|Eye drop, Dry eye|eye drop, dry eye
749918|NCT01162980|ACE inhibitors|ace inhibitors
749919|NCT01162980|ARBs|arbs
749920|NCT01162993|Electric stimulation therapy|electric stimulation therapy
749921|NCT01162993|Diabetic Neuropathies|diabetic neuropathies
749922|NCT01163019|Chest pain|chest pain
749923|NCT01163019|acute coronary syndrome|acute coronary syndrome
749924|NCT01163019|Emergency department|emergency department
749925|NCT01163019|speckle tracking imaging|speckle tracking imaging
749926|NCT01163019|2D strain|2d strain
749927|NCT01163019|Echocardiography|echocardiography
749928|NCT01163032|Blindness|blindness
749929|NCT01163032|Eye Diseases|eye diseases
749930|NCT01163032|Nap Disorders|nap disorders
749931|NCT01163032|Circadian Rhythm Disorders|circadian rhythm disorders
749932|NCT01163032|Sleep disorders|sleep disorders
749933|NCT01163032|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
749934|NCT01163032|Dyssomnias|dyssomnias
749935|NCT01163032|Nervous System Diseases|nervous system diseases
749936|NCT01163045|neurostimulation|neurostimulation
749937|NCT01163045|intraoperative neuromonitoring|intraoperative neuromonitoring
749938|NCT01163045|recurrent laryngeal nerve|recurrent laryngeal nerve
749939|NCT01163045|palsy of recurrent laryngeal nerve|palsy of recurrent laryngeal nerve
749940|NCT01163045|RCT|rct
749941|NCT01163123|Subclinical infection of Japanese encephalitis virus|subclinical infection of japanese encephalitis virus
749942|NCT01163136|Parental decision making|parental decision making
749943|NCT01163136|Decision Making in Serious Pediatric Illness (DSPI)|decision making in serious pediatric illness (dspi)
749944|NCT01163136|palliative care decision making|palliative care decision making
749945|NCT01163149|Hypophosphatasia|hypophosphatasia
749946|NCT01163149|HPP|hpp
749947|NCT01163149|Bone Disease|bone disease
749948|NCT01163149|Soft Bones|soft bones
749949|NCT01163149|Low Alkaline Phosphatase|low alkaline phosphatase
749950|NCT01163149|genetic metabolic disorder|genetic metabolic disorder
749951|NCT01163149|alkaline phosphatase|alkaline phosphatase
749952|NCT01163149|tissue-specific alkaline phosphatase (TNSALP)|tissue-specific alkaline phosphatase (tnsalp)
749953|NCT01163149|rickets|rickets
749954|NCT01163149|osteomalacia|osteomalacia
749955|NCT01163162|Chronic Kidney Disease|chronic kidney disease
749956|NCT01163162|Vitamin D|vitamin d
749957|NCT01163175|Cardiovascular disease|cardiovascular disease
749958|NCT01163175|Trans fatty acids|trans fatty acids
749959|NCT01163175|Ruminant|ruminant
749960|NCT01163175|Blood lipids|blood lipids
749961|NCT01163188|very low birthweight/ very preterm children|very low birthweight/ very preterm children
749962|NCT01163188|Bavarian Longitudinal Study (BLS)|bavarian longitudinal study (bls)
749963|NCT01163188|Quality of life and social adjustment in adulthood|quality of life and social adjustment in adulthood
749964|NCT01163227|Hallucinations,|hallucinations,
749965|NCT01163227|psychotic,|psychotic,
749966|NCT01163227|delusions,|delusions,
749967|NCT01163227|cognitive deficits|cognitive deficits
749968|NCT01163240|hepatitis B|hepatitis b
749969|NCT01163240|HBV|hbv
749970|NCT01163240|chronic hepatitis B|chronic hepatitis b
749971|NCT01163240|pediatric|pediatric
749972|NCT01163253|chronic|chronic
749973|NCT01163253|severe|severe
749974|NCT01163253|treatment|treatment
749975|NCT01163253|safety|safety
749976|NCT01163253|CP-690,55|cp-690,55
749977|NCT01163253|Plaque Psoriasis|plaque psoriasis
749978|NCT01163253|Psoriasis Vulgaris|psoriasis vulgaris
749979|NCT01163253|Xeljanz|xeljanz
749980|NCT01163253|Tofacitinib|tofacitinib
749981|NCT01163266|Major Depressive Disorder|major depressive disorder
749982|NCT01163266|Depression|depression
749983|NCT01163266|Melancholia|melancholia
749984|NCT01163266|Drug Therapy|drug therapy
749985|NCT01163279|Age-related changes|age-related changes
749986|NCT01163292|Rheumatoid Arthritis|rheumatoid arthritis
751240|NCT01169051|Lung Cancer|lung cancer
749987|NCT01163305|Identifying an early indicator of drug efficacy|identifying an early indicator of drug efficacy
749988|NCT01163318|Rheumatoid Arthritis|rheumatoid arthritis
749989|NCT01163331|Parkinson's Disease, voice quality, vocal strength, voice loudness|parkinson's disease, voice quality, vocal strength, voice loudness
749990|NCT01163344|Gait, balance, Parkinson's Disease|gait, balance, parkinson's disease
749991|NCT01163370|creatine supplementation|creatine supplementation
749992|NCT01163370|resistance training|resistance training
749993|NCT01163370|osteopenia|osteopenia
749994|NCT01163370|osteoporosis|osteoporosis
749995|NCT01163370|bone mineral density|bone mineral density
749996|NCT01163383|Refractory Neuroblastoma|refractory neuroblastoma
749997|NCT01163383|Recurrent Neuroblastoma|recurrent neuroblastoma
749998|NCT01163383|Neuroblastoma|neuroblastoma
749999|NCT01163383|stage IV neuroblastoma|stage iv neuroblastoma
750000|NCT01163383|metastatic pheochromocytoma|metastatic pheochromocytoma
750001|NCT01163383|paraganglioma|paraganglioma
750002|NCT01163409|juvenile fibromyalgia|juvenile fibromyalgia
750003|NCT01163409|acupuncture|acupuncture
750004|NCT01163409|exercise training|exercise training
750005|NCT01163422|Right ventricular failure|right ventricular failure
750006|NCT01163422|Pacemaker|pacemaker
750007|NCT01163422|Cardiac resynchronization therapy|cardiac resynchronization therapy
750008|NCT01163422|Pulmonary hypertension|pulmonary hypertension
750009|NCT01163435|Helicobacter pylori|helicobacter pylori
750010|NCT01163435|antibiotic resistance|antibiotic resistance
750011|NCT01163435|high dose dual therapy|high dose dual therapy
750012|NCT01163435|sequential therapy|sequential therapy
750013|NCT01163435|clarithromycin-based triple therapy|clarithromycin-based triple therapy
750014|NCT01163435|levofloxacin-based triple therapy|levofloxacin-based triple therapy
750015|NCT01163448|Prostate|prostate
750016|NCT01163448|Radiation|radiation
750017|NCT01163448|Radical prostatectomy|radical prostatectomy
750018|NCT01163448|09-013|09-013
750019|NCT01163474|Telemedicine|telemedicine
750020|NCT01163474|Surgery, Cardiac|surgery, cardiac
750021|NCT01163513|ethnicity|ethnicity
750022|NCT01163513|prognosis|prognosis
750023|NCT01163552|pleural metastases|pleural metastases
750024|NCT01163565|Thyroidectomy|thyroidectomy
750025|NCT01163578|Transplantation|transplantation
750026|NCT01163578|Rejection|rejection
750027|NCT01163591|Diabetes|diabetes
750028|NCT01163591|Nephropathy|nephropathy
750029|NCT01163591|Screening|screening
750030|NCT01163604|Argatroban|argatroban
750031|NCT01163604|intracranial artery stenting|intracranial artery stenting
750032|NCT01163604|extracranial artery stenting|extracranial artery stenting
750033|NCT01163604|occlusion|occlusion
750034|NCT01163604|restenosis|restenosis
750035|NCT01163617|Rheumatoid|rheumatoid
750036|NCT01163617|Arthritis|arthritis
750037|NCT01163630|open label, randomized|open label, randomized
750038|NCT01163630|single-center|single-center
750039|NCT01163630|2-way crossover|2-way crossover
750040|NCT01163630|food interaction study|food interaction study
750041|NCT01163656|Neonate|neonate
750042|NCT01163656|Laryngoscopes|laryngoscopes
750043|NCT01163669|hyperparathyroidism|hyperparathyroidism
750044|NCT01163682|Taxane induced neuropathy|taxane induced neuropathy
750045|NCT01163695|economic empowerment model, orphans, sub-Saharan Africa|economic empowerment model, orphans, sub-saharan africa
750046|NCT01157572|Aortic valve insufficiency|aortic valve insufficiency
750047|NCT01157572|Beta-blocker|beta-blocker
750048|NCT01157598|gastric adenoma|gastric adenoma
750049|NCT01157598|early gastric cancer|early gastric cancer
750050|NCT01157611|online based mentoring program,|online based mentoring program,
750051|NCT01157611|type 1 diabetes,|type 1 diabetes,
750052|NCT01157611|blood glucose,|blood glucose,
750053|NCT01157611|satisfaction score|satisfaction score
750054|NCT01157624|hypoxia or hypercarbia during surgery under the drape|hypoxia or hypercarbia during surgery under the drape
750055|NCT01157650|Fistulizing Crohn's disease|fistulizing crohn's disease
750056|NCT01157650|stem cells implant|stem cells implant
750057|NCT01157663|Functional ankle instability|functional ankle instability
750058|NCT01157676|open cystectomy|open cystectomy
750059|NCT01157676|robotic assisted radical cystectomy|robotic assisted radical cystectomy
750060|NCT01157676|bladder cancer|bladder cancer
750061|NCT01157689|malaria|malaria
750062|NCT01157689|children|children
750063|NCT01157689|Guinea-Bissau|guinea-bissau
750064|NCT01157689|artemether|artemether
750065|NCT01157689|lumefantrine|lumefantrine
750066|NCT01157689|effectiveness|effectiveness
750067|NCT01157715|KH902|kh902
750068|NCT01157715|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
750069|NCT01157715|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
750070|NCT01157715|intravitreal injection|intravitreal injection
750071|NCT01157715|best corrected visual acuity (BCVA)|best corrected visual acuity (bcva)
750072|NCT01157715|central retinal thickness|central retinal thickness
750073|NCT01157728|Multiple sclerosis|multiple sclerosis
750074|NCT01157728|Cognitive impairment|cognitive impairment
750075|NCT01157741|Community based follow up, severely underweight children|community based follow up, severely underweight children
750076|NCT01157754|Infertility patients requiring IVF|infertility patients requiring ivf
750077|NCT01157754|good prognosis|good prognosis
750080|NCT01157767|post-operative chemotherapy|post-operative chemotherapy
750081|NCT01157767|post-operative radiation|post-operative radiation
750082|NCT01157767|10-062|10-062
750083|NCT01157780|Fish oil|fish oil
750084|NCT01157793|Dwarfism|dwarfism
750085|NCT01157793|Growth hormone deficiency|growth hormone deficiency
750086|NCT01157793|Growth hormone|growth hormone
750087|NCT01157806|rectal cancer|rectal cancer
750088|NCT01157806|unresectable synchronous metastases|unresectable synchronous metastases
750089|NCT01157806|pelvic radiochemotherapy|pelvic radiochemotherapy
750090|NCT01163721|Type 2 diabetes mellitus|type 2 diabetes mellitus
750091|NCT01163721|T2DM|t2dm
750092|NCT01163721|Ranolazine|ranolazine
750093|NCT01163721|Ranexa|ranexa
750094|NCT01163721|HbA1c|hba1c
750095|NCT01163734|Heart Failure with Preserved Ejection Fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
750096|NCT01163734|Coronary Artery Disease (CAD)|coronary artery disease (cad)
750097|NCT01163773|Cardiovascular disease|cardiovascular disease
750098|NCT01163773|Milk|milk
750099|NCT01163773|Metabolic syndrome|metabolic syndrome
750100|NCT01163773|Blood lipids|blood lipids
750101|NCT01163773|Menopausal women|menopausal women
750102|NCT01163786|Bortezomib GVHD Bronchiolitis Obliterans|bortezomib gvhd bronchiolitis obliterans
750103|NCT01163799|Kidney|kidney
750104|NCT01163799|Transplant|transplant
750105|NCT01163799|Northwestern|northwestern
750106|NCT01163799|Calcineurin Inhibitor|calcineurin inhibitor
750107|NCT01163799|Corticosteroids|corticosteroids
750108|NCT01163799|Steroid avoidance|steroid avoidance
750109|NCT01163812|D2 lymph node dissection|d2 lymph node dissection
750110|NCT01163838|Hypercholesterolemia|hypercholesterolemia
750111|NCT01163838|Dyslipidemia|dyslipidemia
750113|NCT01163838|Cholesterol|cholesterol
750114|NCT01163838|High Cholesterol|high cholesterol
750115|NCT01163851|Hypercholesterolemia|hypercholesterolemia
750116|NCT01163851|Dyslipidemia|dyslipidemia
750117|NCT01163851|LDL|ldl
750118|NCT01163851|Cholesterol|cholesterol
750119|NCT01163851|High Cholesterol|high cholesterol
750120|NCT01163851|PF-04950615|pf-04950615
750121|NCT01163851|RN316|rn316
750122|NCT01163864|smoking|smoking
750123|NCT01163864|smoking relapse|smoking relapse
750124|NCT01163864|smoking cessation|smoking cessation
750125|NCT01163864|pregnancy|pregnancy
750126|NCT01163864|smoking cessation in pregnant women|smoking cessation in pregnant women
750127|NCT01163877|iron absorption|iron absorption
750128|NCT01163877|iron utilization|iron utilization
750129|NCT01163877|malaria|malaria
750130|NCT01163877|helminth|helminth
750131|NCT01163877|Ivory Coast|ivory coast
750132|NCT01163877|Acute symptomatic uncomplicated falciparum malaria|acute symptomatic uncomplicated falciparum malaria
750133|NCT01163877|Asymptomatic falciparum malaria|asymptomatic falciparum malaria
750134|NCT01163877|Moderate to heavy hookworm infection|moderate to heavy hookworm infection
750135|NCT01163877|Heavy Schistosoma haematobium infection|heavy schistosoma haematobium infection
750136|NCT01163890|Depression|depression
750137|NCT01163890|Work Performance and Productivity|work performance and productivity
750138|NCT01163890|Worksite Intervention|worksite intervention
750139|NCT01163903|Advanced solid tumours|advanced solid tumours
750140|NCT01163903|Pantoprazole|pantoprazole
750144|NCT01163903|no standard treatment options|no standard treatment options
750145|NCT01163903|dose-escalation schedule|dose-escalation schedule
750146|NCT01163903|Phase I|phase i
750147|NCT01163903|single-centre|single-centre
750148|NCT01163903|open label|open label
750149|NCT01163903|dose finding|dose finding
750150|NCT01163903|recommended phase II dose|recommended phase ii dose
750151|NCT01163903|proton pump inhibitor|proton pump inhibitor
750152|NCT01163903|advanced cancer|advanced cancer
750153|NCT01163903|anthracycline|anthracycline
750154|NCT01163903|gastric acid secretion|gastric acid secretion
750155|NCT01163916|Rheumatoid Arthritis|rheumatoid arthritis
750156|NCT01163916|Psoriatic Arthritis|psoriatic arthritis
750157|NCT01163916|Ankylosing Spondylitis|ankylosing spondylitis
750158|NCT01163929|breast cancer|breast cancer
750159|NCT01163929|HER2 positive|her2 positive
750160|NCT01163929|Phase II|phase ii
750161|NCT01163929|RAD001|rad001
750162|NCT01163929|paclitaxel|paclitaxel
750163|NCT01163929|trastuzumab|trastuzumab
750164|NCT01163929|everolimus|everolimus
750165|NCT01163955|Posture analysis|posture analysis
750166|NCT01163955|Video gaming|video gaming
750167|NCT01163955|Forward Head Position|forward head position
750168|NCT01163955|Rounded Shoulder Position|rounded shoulder position
750169|NCT01163955|Spine Posture|spine posture
750170|NCT01163968|Weight reduction|weight reduction
750171|NCT01163968|Cardiac revascularization|cardiac revascularization
750172|NCT01163968|Percutaneous Coronary Intervention|percutaneous coronary intervention
750173|NCT01163968|Cardiac Rehabilitation|cardiac rehabilitation
750174|NCT01163968|Rural|rural
750175|NCT01163981|duplex Ultrasound|duplex ultrasound
750176|NCT01163981|Haemodialysis|haemodialysis
750177|NCT01163981|Vascular Access|vascular access
750178|NCT01163994|erythema migrans|erythema migrans
750179|NCT01163994|Lyme borreliosis|lyme borreliosis
750180|NCT01163994|ceftriaxone treatment|ceftriaxone treatment
750181|NCT01163994|doxycycline treatment|doxycycline treatment
750182|NCT01163994|outcome|outcome
750183|NCT01163994|subjective symptoms|subjective symptoms
750184|NCT01164020|cognition|cognition
750185|NCT01164020|supplementation creatine|supplementation creatine
750186|NCT01164020|resistance training|resistance training
750187|NCT01164020|aging|aging
750188|NCT01164605|NRTI-regimen|nrti-regimen
750189|NCT01164605|Raltegravir|raltegravir
750190|NCT01164605|Elvitegravir|elvitegravir
750191|NCT01164605|HIV-1 integrase inhibitor|hiv-1 integrase inhibitor
750192|NCT01164605|Fat Waste|fat waste
750193|NCT01164618|pediatrics|pediatrics
750194|NCT01164618|Remote ischemic preconditioning|remote ischemic preconditioning
750195|NCT01164631|Sleep Apnea Syndrome|sleep apnea syndrome
750196|NCT01164631|Orthodontics|orthodontics
750197|NCT01164631|Tonsillectomy|tonsillectomy
750198|NCT01164631|Child|child
750199|NCT01164644|ecchymosis|ecchymosis
750200|NCT01164644|bruising|bruising
750203|NCT01164644|arnica|arnica
750204|NCT01164644|arnica montana|arnica montana
750205|NCT01164657|upright position|upright position
750206|NCT01164657|birth position|birth position
750207|NCT01164657|childbirth|childbirth
750208|NCT01164657|instrumental deliveries|instrumental deliveries
750209|NCT01164657|primiparous|primiparous
750210|NCT01164683|sleep apnea|sleep apnea
750211|NCT01164683|adherence|adherence
750212|NCT01164696|Quality of Life, Health Care Costs|quality of life, health care costs
750213|NCT01164709|refractory multiple myeloma|refractory multiple myeloma
750214|NCT01164709|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
750215|NCT01164709|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
750216|NCT01164709|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
750217|NCT01164709|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
750218|NCT01164709|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
750219|NCT01164709|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
750220|NCT01164709|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
750221|NCT01164709|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
750222|NCT01164709|peripheral T-cell lymphoma|peripheral t-cell lymphoma
750223|NCT01164709|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
750224|NCT01164709|anaplastic large cell lymphoma|anaplastic large cell lymphoma
750225|NCT01164709|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
750226|NCT01164709|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
750227|NCT01164709|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
750228|NCT01164709|aggressive NK-cell leukemia|aggressive nk-cell leukemia
750229|NCT01164709|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
750230|NCT01164709|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
750231|NCT01164709|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
750232|NCT01164709|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
750233|NCT01164709|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
750330|NCT01165177|safety|safety
750234|NCT01164709|secondary acute myeloid leukemia|secondary acute myeloid leukemia
750235|NCT01164709|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
750236|NCT01164709|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
750237|NCT01164709|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
750238|NCT01164709|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
750239|NCT01164709|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
750240|NCT01164709|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
750241|NCT01164709|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
750242|NCT01164709|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
750243|NCT01164709|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
750244|NCT01164709|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
750245|NCT01164709|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
750246|NCT01164709|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
750247|NCT01164709|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
750248|NCT01164709|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
750249|NCT01164709|prolymphocytic leukemia|prolymphocytic leukemia
750250|NCT01164722|anal cancer|anal cancer
750251|NCT01164722|HIV infection|hiv infection
750252|NCT01164722|human papilloma virus infection|human papilloma virus infection
750253|NCT01164722|neoplasm of uncertain malignant potential|neoplasm of uncertain malignant potential
750254|NCT01164722|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
750255|NCT01164761|Bioavailability|bioavailability
750256|NCT01164761|Crossover|crossover
750257|NCT01164761|Ramipril|ramipril
750258|NCT01164774|Bioavailability|bioavailability
750259|NCT01164774|Crossover|crossover
750260|NCT01164774|Ramipril|ramipril
750261|NCT01164787|Bioequivalence|bioequivalence
750262|NCT01164787|Crossover|crossover
750263|NCT01164787|Trandolapril|trandolapril
750264|NCT01164800|Bioequivalence|bioequivalence
750265|NCT01164800|Crossover|crossover
750266|NCT01164800|Trandolapril|trandolapril
750267|NCT01164813|Bioequivalence|bioequivalence
750268|NCT01164813|Crossover|crossover
750269|NCT01164813|Nabumetone|nabumetone
750270|NCT01164826|Bioequivalence|bioequivalence
750271|NCT01164826|Crossover|crossover
750272|NCT01164826|Nabumetone|nabumetone
750273|NCT01164839|coronary artery|coronary artery
750274|NCT01164839|CT angiography|ct angiography
750275|NCT01164839|image quality|image quality
750276|NCT01164839|multicenter trial|multicenter trial
750277|NCT01164865|Soft Contact lens|soft contact lens
750278|NCT01164865|Multi-Purpose Solution|multi-purpose solution
750279|NCT01164865|Hydrogen Peroxide|hydrogen peroxide
750280|NCT01164878|Cholestasis|cholestasis
750281|NCT01164878|Liver damage|liver damage
750282|NCT01164878|Parenteral Nutrition|parenteral nutrition
750283|NCT01164878|Aggressive Nutrition|aggressive nutrition
750285|NCT01164878|Extreme low birth weight infant|extreme low birth weight infant
750286|NCT01164878|Parenteral Nutrition Associated Cholestasis|parenteral nutrition associated cholestasis
750287|NCT01164904|Inflammatory Bowel Disease|inflammatory bowel disease
750288|NCT01164904|Amgen|amgen
750289|NCT01164917|Lupus|lupus
750290|NCT01164917|Discoid Lupus|discoid lupus
750291|NCT01164917|Cutaneous Lupus|cutaneous lupus
750292|NCT01164956|methylphenidate|methylphenidate
750293|NCT01164956|fatigue|fatigue
750294|NCT01164995|MK-1775|mk-1775
750295|NCT01164995|Carboplatin|carboplatin
750296|NCT01164995|epithelial ovarian cancer|epithelial ovarian cancer
750297|NCT01164995|p53|p53
750298|NCT01165060|X-ALD|x-ald
750299|NCT01165060|AMN|amn
750300|NCT01165060|adrenomyeloneuropathy phenotype|adrenomyeloneuropathy phenotype
750301|NCT01165073|Cirrhosis|cirrhosis
750302|NCT01165073|Malnutrition|malnutrition
750303|NCT01165073|Enteral nutrition|enteral nutrition
750304|NCT01165099|acupuncture|acupuncture
750305|NCT01165099|induced labour|induced labour
750306|NCT01165099|labour outcome|labour outcome
750307|NCT01165099|nulliparae|nulliparae
750308|NCT01165099|pain-relief|pain-relief
750309|NCT01165099|epidural during labour|epidural during labour
750310|NCT01165125|pharmacodynamics|pharmacodynamics
750311|NCT01165125|drug interaction|drug interaction
750312|NCT01165125|ketoconazole|ketoconazole
750313|NCT01165125|pharmacokinetics|pharmacokinetics
750314|NCT01165125|Fluticasone furoate|fluticasone furoate
750315|NCT01165125|GW642444|gw642444
750316|NCT01165138|GW642444|gw642444
750317|NCT01165138|Vilanterol|vilanterol
750318|NCT01165138|Asthma|asthma
750319|NCT01165138|Fluticasone Furoate|fluticasone furoate
750320|NCT01165151|obesity|obesity
750321|NCT01165151|weight loss|weight loss
750322|NCT01165151|group size|group size
750323|NCT01165164|Dry eye|dry eye
750324|NCT01165164|artificial tears|artificial tears
750325|NCT01165177|subjects 50 years and older|subjects 50 years and older
750326|NCT01165177|vaccine|vaccine
750327|NCT01165177|immunogenicity|immunogenicity
750328|NCT01165177|efficacy|efficacy
750329|NCT01165177|Herpes Zoster|herpes zoster
750331|NCT01165203|immunogenicity|immunogenicity
750332|NCT01165203|vaccine|vaccine
750333|NCT01165203|safety|safety
750334|NCT01165203|HIV|hiv
750335|NCT01165203|Herpes Zoster|herpes zoster
750336|NCT01165229|Immunogenicity|immunogenicity
750337|NCT01165229|Subjects 70 years and older|subjects 70 years and older
750338|NCT01165229|Efficacy|efficacy
750339|NCT01165229|Herpes Zoster|herpes zoster
750340|NCT01165229|Safety|safety
750341|NCT01165229|Adults|adults
750342|NCT01165229|Vaccine|vaccine
750343|NCT01165242|Neisseria meningitidis|neisseria meningitidis
750344|NCT01165242|Adult|adult
750345|NCT01165242|Adolescent|adolescent
750346|NCT01165242|Safety|safety
750347|NCT01165242|Vaccines, conjugate|vaccines, conjugate
750348|NCT01165242|Meningococcal vaccines|meningococcal vaccines
750349|NCT01165242|Immunogenicity|immunogenicity
750350|NCT01165255|congenital malformation|congenital malformation
750351|NCT01165255|cardiovascular malformation|cardiovascular malformation
750352|NCT01165255|cardiovascular defect|cardiovascular defect
750353|NCT01165255|antidepressants|antidepressants
750354|NCT01165255|pregnancy|pregnancy
750355|NCT01165255|first trimester|first trimester
750356|NCT01165255|Bupropion|bupropion
750357|NCT01165255|prevalence|prevalence
750358|NCT01165281|Pain|pain
750359|NCT01165281|R331333 (JNS024ER, CG5503), tapentadol (NUCYNTA)|r331333 (jns024er, cg5503), tapentadol (nucynta)
750360|NCT01165281|Opioid analgesic|opioid analgesic
750361|NCT01165281|Oxycodone CR (OXYCONTIN CR)|oxycodone cr (oxycontin cr)
750362|NCT01165281|Chronic malignant tumor related cancer pain|chronic malignant tumor related cancer pain
750363|NCT01165294|Ketamine|ketamine
750364|NCT01165307|Menorrhagia|menorrhagia
750365|NCT01165307|Endometrial ablation|endometrial ablation
750366|NCT01165307|Heavy menstrual bleeding|heavy menstrual bleeding
750367|NCT01165333|Paediatric oncology|paediatric oncology
750368|NCT01165333|Cilengitide|cilengitide
750369|NCT01165333|Glioma|glioma
750370|NCT01165346|liver cancer|liver cancer
750371|NCT01165346|hepatocellular carcinoma|hepatocellular carcinoma
750372|NCT01165372|Malaria|malaria
750373|NCT01165372|Drug resistance|drug resistance
750374|NCT01165385|Relapsed or refractory solid tumors|relapsed or refractory solid tumors
750375|NCT01165385|Pazopanib|pazopanib
750376|NCT01165385|Cisplatin|cisplatin
750377|NCT01165398|Education|education
750378|NCT01165398|central lines|central lines
750379|NCT01165398|infections|infections
750380|NCT01165398|complications|complications
750381|NCT01165398|Bundles|bundles
750382|NCT01165411|Central Catheterization|central catheterization
750383|NCT01165411|Central Line|central line
750384|NCT01165411|Database|database
750385|NCT01165411|Registry|registry
750386|NCT01165411|Registries|registries
750387|NCT01165437|Peripheral|peripheral
750388|NCT01165437|Arterial|arterial
750389|NCT01165437|Vascular|vascular
750876|NCT01167114|STA-9090|sta-9090
750390|NCT01165450|persistent epithelial defect|persistent epithelial defect
750392|NCT01165463|Aging|aging
750393|NCT01165463|Healthy|healthy
750394|NCT01165476|treprostinil|treprostinil
750395|NCT01165476|bioavailability|bioavailability
750396|NCT01165476|bioequivalence|bioequivalence
750397|NCT01165489|Laryngomalacia|laryngomalacia
750398|NCT01165489|Congenital Anomalies|congenital anomalies
750399|NCT01165489|Associated Health Problems|associated health problems
750400|NCT01165502|MAD study CM3.1-AC100|mad study cm3.1-ac100
750401|NCT01165502|Healthy men, age 18 - 50|healthy men, age 18 - 50
750402|NCT01165554|Amyloid|amyloid
750403|NCT01165554|PET-Positron Emission Tomography|pet-positron emission tomography
750404|NCT01165554|SUVR-Standard uptake value ratios|suvr-standard uptake value ratios
750405|NCT01165645|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
750406|NCT01165658|non-small cell lung cancer|non-small cell lung cancer
750407|NCT01165658|NSCLC|nsclc
750408|NCT01165658|small cell lung cancer|small cell lung cancer
750409|NCT01165658|SCLC|sclc
750410|NCT01165658|carcinoid|carcinoid
750411|NCT01165658|thymic cancer|thymic cancer
750412|NCT01165658|lung cancer|lung cancer
750413|NCT01165658|radiation therapy|radiation therapy
750414|NCT01165658|radiotherapy|radiotherapy
750415|NCT01165658|proton therapy|proton therapy
750416|NCT01165671|Primary Glioblastoma|primary glioblastoma
750417|NCT01165697|Fabry Disease|fabry disease
750418|NCT01165697|vascular disease|vascular disease
750419|NCT01165697|storage endotheliopathy|storage endotheliopathy
750420|NCT01165710|Irregular heart beat|irregular heart beat
750421|NCT01165723|safety|safety
750422|NCT01165723|tolerability|tolerability
750423|NCT01165723|pharmacokinetics|pharmacokinetics
750424|NCT01165723|pharmacodynamics|pharmacodynamics
750425|NCT01165723|chronic pain|chronic pain
750426|NCT01165736|pharmacokinetics|pharmacokinetics
750427|NCT01165736|safety|safety
750428|NCT01165736|tolerability|tolerability
750429|NCT01165736|Chronic Pain|chronic pain
750430|NCT01165788|Blood and Marrow Transplant (BMT)|blood and marrow transplant (bmt)
750431|NCT01165801|AMD|amd
750432|NCT01165801|Cataract surgery|cataract surgery
750434|NCT01165801|Influence of cataract surgery on AMD Size|influence of cataract surgery on amd size
750435|NCT01165814|Pain control after cesarean section|pain control after cesarean section
750436|NCT01165827|Aortic Valve Insufficiency|aortic valve insufficiency
750437|NCT01165827|Aortic Valve Stenosis|aortic valve stenosis
750438|NCT01165827|Aortic Valve Valvuloplasty|aortic valve valvuloplasty
750439|NCT01165827|Aortic valve Replacement|aortic valve replacement
750440|NCT01165827|Aortic valve Intervention|aortic valve intervention
750441|NCT01165840|Obesity|obesity
750442|NCT01165840|Pharmacokinetics|pharmacokinetics
750443|NCT01165840|Dapsone|dapsone
750444|NCT01165840|Leprosy|leprosy
750445|NCT01165840|Tuberculosis|tuberculosis
750446|NCT01165866|Ondansetron|ondansetron
750447|NCT01165866|Metoclopramide|metoclopramide
750448|NCT01165866|Gastroenteritis|gastroenteritis
750449|NCT01165879|Pregnancy|pregnancy
750450|NCT01165879|Term|term
750451|NCT01165879|Preterm|preterm
750452|NCT01165879|Uterine Contractions|uterine contractions
750453|NCT01165892|Pulmonary embolism|pulmonary embolism
750454|NCT01165892|contrast agent|contrast agent
750455|NCT01165905|cancer|cancer
750456|NCT01165905|solid malignancy|solid malignancy
750457|NCT01165905|tumor|tumor
750458|NCT01165905|malignant neoplasm|malignant neoplasm
750459|NCT01165905|histologically confirmed solid malignancy|histologically confirmed solid malignancy
750460|NCT01165931|Coronary artery disease|coronary artery disease
750461|NCT01165944|Post transplant diabetes mellitus|post transplant diabetes mellitus
750462|NCT01165957|Knee replacement|knee replacement
750463|NCT01165957|Mobile and fixed bearings|mobile and fixed bearings
750464|NCT01165957|Volumetric wear|volumetric wear
750465|NCT01165957|Micro-CT analysis|micro-ct analysis
750466|NCT01165957|Articular and backside wear|articular and backside wear
750467|NCT01165970|enamel|enamel
750468|NCT01165970|dentin|dentin
750469|NCT01165970|saliva substitute|saliva substitute
750470|NCT01165970|demineralization|demineralization
750471|NCT01165970|remineralization|remineralization
750472|NCT01165996|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
750473|NCT01165996|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
750474|NCT01166009|Data Collection|data collection
750475|NCT01166009|CIBMTR|cibmtr
750476|NCT01166009|NMDP|nmdp
750477|NCT01166009|Stem Cell Transplantation|stem cell transplantation
750478|NCT01166022|Spinal Muscular Atrophy|spinal muscular atrophy
750479|NCT01166022|Exercise|exercise
750480|NCT01166022|Conditioning|conditioning
750481|NCT01166022|Strengthening|strengthening
750482|NCT01166035|Solid tumors|solid tumors
750483|NCT01166035|Lenalidomide|lenalidomide
750484|NCT01166035|Cetuximab|cetuximab
750485|NCT01166035|Colorectal Cancer|colorectal cancer
750486|NCT01166035|Non-Small Cell Lung Cancer|non-small cell lung cancer
750487|NCT01166035|Head and Neck Cancer|head and neck cancer
750488|NCT01166048|Chronic Low Back Pain|chronic low back pain
750489|NCT01166048|Radicular component|radicular component
750490|NCT01166048|neuropathic pain|neuropathic pain
750491|NCT01166048|duloxetine|duloxetine
750492|NCT01166048|CLBP|clbp
750493|NCT01166061|Grass Allergy|grass allergy
750494|NCT01166061|Immunotherapy|immunotherapy
750495|NCT01166061|Rhinoconjunctivitis|rhinoconjunctivitis
750496|NCT01166061|ToleroMune Grass|toleromune grass
750497|NCT01166087|Bioequivalence|bioequivalence
750498|NCT01166087|Crossover|crossover
750499|NCT01166087|Fluoxetine Hydrochloride|fluoxetine hydrochloride
750500|NCT01166100|Bioequivalence|bioequivalence
750501|NCT01166100|Crossover|crossover
750502|NCT01166100|Fluoxetine Hydrochloride|fluoxetine hydrochloride
750503|NCT01166113|Pomalidomide|pomalidomide
750504|NCT01166113|Relapsed/Refractory to Lenalidomide|relapsed/refractory to lenalidomide
750505|NCT01166139|Systemic Sclerosis|systemic sclerosis
750506|NCT01166152|autistic spectrum disorders|autistic spectrum disorders
750507|NCT01166152|developmental disorders|developmental disorders
750508|NCT01166165|Hypertension|hypertension
750509|NCT01166165|blood pressure|blood pressure
750510|NCT01166165|vitamin d|vitamin d
750511|NCT01166165|winter|winter
750512|NCT01166165|cholecalciferol|cholecalciferol
750513|NCT01166165|arterial stiffness|arterial stiffness
750514|NCT01166165|renin|renin
750515|NCT01166165|angiotensin|angiotensin
750516|NCT01166165|aldosterone|aldosterone
750517|NCT01166165|calcium|calcium
750518|NCT01166178|Multiple Sclerosis|multiple sclerosis
750519|NCT01166178|Osteoporosis|osteoporosis
750520|NCT01166178|Zoledronic Acid|zoledronic acid
750521|NCT01166191|Radiotherapy|radiotherapy
750522|NCT01166191|SCLC|sclc
750523|NCT01166204|Radiotherapy|radiotherapy
750524|NCT01166204|NSCLC|nsclc
750525|NCT01166217|Single Dose Study in Healthy Subjects|single dose study in healthy subjects
750526|NCT01166243|Hemostasis|hemostasis
750527|NCT01166256|respiratory failure|respiratory failure
750528|NCT01166269|grass-pollen allergy|grass-pollen allergy
750529|NCT01166282|inflammatory back pain|inflammatory back pain
750530|NCT01166282|ankylosing spondylitis|ankylosing spondylitis
750531|NCT01166282|sacroiliitis|sacroiliitis
750532|NCT01166282|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
750535|NCT01166308|Recurrent Glioma|recurrent glioma
750536|NCT01166321|Atypical Meningioma|atypical meningioma
750537|NCT01166334|Smoking|smoking
750538|NCT01166334|Smoke|smoke
750539|NCT01166334|Cigarette|cigarette
750540|NCT01166334|Cessation|cessation
750541|NCT01166334|Quit|quit
750542|NCT01166334|Online|online
750544|NCT01166334|Stop|stop
750545|NCT01166360|Risk prediction|risk prediction
750546|NCT01166360|Euroscore|euroscore
750547|NCT01166360|GDF-15|gdf-15
750548|NCT01166360|hsTnT|hstnt
750549|NCT01166360|cardiac surgery|cardiac surgery
750550|NCT01166373|prolapse|prolapse
750551|NCT01166373|urinary incontinence|urinary incontinence
750552|NCT01166373|uterosacral vaginal vault ligament suspension|uterosacral vaginal vault ligament suspension
750553|NCT01166373|sacrospinous ligament fixation|sacrospinous ligament fixation
750554|NCT01166373|behavioral therapy|behavioral therapy
750555|NCT01166373|pelvic muscle training|pelvic muscle training
750556|NCT01166386|rehabilitation|rehabilitation
750557|NCT01166386|brain injury|brain injury
750558|NCT01166399|Fecal Incontinence,|fecal incontinence,
750559|NCT01166399|bowel incontinence,|bowel incontinence,
750560|NCT01166399|pelvic floor disorder|pelvic floor disorder
750561|NCT01166438|incontinence|incontinence
750562|NCT01166438|overactive bladder|overactive bladder
750563|NCT01166438|botox|botox
750564|NCT01166438|anticholinergic|anticholinergic
750565|NCT01166451|iron deficiency anemia|iron deficiency anemia
750566|NCT01166451|cognitive development|cognitive development
750567|NCT01166451|motor development|motor development
750568|NCT01166464|tobacco|tobacco
750569|NCT01166464|smoking|smoking
750570|NCT01166464|text message|text message
750571|NCT01166464|therapy|therapy
750572|NCT01166490|Monomethyl auristatin E (MMAE)|monomethyl auristatin e (mmae)
750573|NCT01166490|Immunotherapy|immunotherapy
750574|NCT01166490|AGS-5 Antigen|ags-5 antigen
750575|NCT01166490|SLC44A4 Antigen|slc44a4 antigen
750576|NCT01166490|Gastric Neoplasms|gastric neoplasms
750577|NCT01166490|Pancreatic Neoplasms|pancreatic neoplasms
750578|NCT01166490|Antibody-Drug Conjugate|antibody-drug conjugate
750579|NCT01166490|Antibodies, Monoclonal|antibodies, monoclonal
750580|NCT01166490|Drug Therapy|drug therapy
750581|NCT01166503|pediatrics|pediatrics
750582|NCT01166503|Esotropia|esotropia
750583|NCT01166503|Surgery|surgery
750584|NCT01166516|Prolonged air leak|prolonged air leak
750585|NCT01166516|lobectomy|lobectomy
750586|NCT01166516|segmentectomy|segmentectomy
750587|NCT01166516|lung volume reduction surgery (LVRS)|lung volume reduction surgery (lvrs)
750588|NCT01166542|carcinoma|carcinoma
750589|NCT01166542|squamous cell|squamous cell
750590|NCT01166542|head|head
750591|NCT01166542|neck|neck
751255|NCT01169116|metastases|metastases
750592|NCT01166542|REOLYSIN (Reovirus Type 3 Dearing)|reolysin (reovirus type 3 dearing)
750593|NCT01166542|chemotherapy|chemotherapy
750594|NCT01166542|Carboplatin|carboplatin
750595|NCT01166542|Paclitaxel|paclitaxel
750596|NCT01166542|metastatic|metastatic
750597|NCT01166542|recurrent|recurrent
750598|NCT01166555|Safety and tolerability|safety and tolerability
750599|NCT01166555|Pharmacokinetics|pharmacokinetics
750600|NCT01166555|PF-04236921|pf-04236921
750601|NCT01166555|Rheumatoid Arthritis|rheumatoid arthritis
750602|NCT01166568|Presbyopia|presbyopia
750603|NCT01166568|Reading Vision|reading vision
750604|NCT01166568|Near Vision|near vision
750605|NCT01166581|early stage breast cancer|early stage breast cancer
750606|NCT01166581|preoperative breast MRI|preoperative breast mri
750607|NCT01166581|mastectomy|mastectomy
750608|NCT01166594|Glaucoma|glaucoma
750609|NCT01166594|Elevated Intraocular Pressure (IOP)|elevated intraocular pressure (iop)
750610|NCT01166594|Optic Neuropathy|optic neuropathy
750611|NCT01166594|Bleb Failure|bleb failure
750612|NCT01166594|Avastin (Bevacizumab)|avastin (bevacizumab)
750613|NCT01166633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
750614|NCT01166633|hyperlipidemia|hyperlipidemia
750615|NCT01166659|Glaucoma|glaucoma
750616|NCT01166659|Glaucoma device|glaucoma device
750617|NCT01166659|Glaucoma surgery|glaucoma surgery
750618|NCT01166659|Intraocular pressure|intraocular pressure
750619|NCT01166672|obese women (BMI greater than or equal to 30), do not already have a diagnosis of lymphedema, who are done|obese women (bmi greater than or equal to 30), do not already have a diagnosis of lymphedema, who are done
750620|NCT01166672|with surgery, chemotherapy, and radiation therapy, and who were diagnosed with breast cancer within the|with surgery, chemotherapy, and radiation therapy, and who were diagnosed with breast cancer within the
750621|NCT01166672|past 2 years will be invited to participate.|past 2 years will be invited to participate.
750622|NCT01166685|coronary artery disease|coronary artery disease
750623|NCT01166685|drug-eluting stent|drug-eluting stent
750624|NCT01166685|anti-thrombotic therapy|anti-thrombotic therapy
750625|NCT01166685|bare-metal stent|bare-metal stent
750626|NCT01166685|long-term outcome|long-term outcome
750627|NCT01166698|Safety|safety
750628|NCT01166698|tolerability|tolerability
750629|NCT01166698|healthy|healthy
750630|NCT01166698|inhalation|inhalation
750631|NCT01166724|Kidney transplant|kidney transplant
750632|NCT01166737|Ovarian Cancer|ovarian cancer
750633|NCT01166737|Cancer of the fallopian tube|cancer of the fallopian tube
750634|NCT01166737|Primary peritoneal cancer|primary peritoneal cancer
750635|NCT01166737|Recurrent disease|recurrent disease
750636|NCT01166737|Platinum-sensitive|platinum-sensitive
750637|NCT01166737|Surgery|surgery
750638|NCT01166737|Chemotherapy|chemotherapy
750639|NCT01166737|Quality of Life|quality of life
750640|NCT01166737|First recurrence of platinum sensitive:|first recurrence of platinum sensitive:
750641|NCT01166737|Fallopian Tube Cancer|fallopian tube cancer
750642|NCT01166737|or Ovarian Cancer|or ovarian cancer
750643|NCT01166737|or Peritoneal Cavity Cancer|or peritoneal cavity cancer
750644|NCT01166763|breast atypia|breast atypia
750645|NCT01166763|high risk for breast cancer|high risk for breast cancer
750646|NCT01166763|random periareolar fine needle aspiration|random periareolar fine needle aspiration
750647|NCT01166763|RPFNA|rpfna
750648|NCT01166763|breast epithelial hyperplasia|breast epithelial hyperplasia
750649|NCT01166763|ki-67|ki-67
750650|NCT01166763|chemoprevention|chemoprevention
750651|NCT01166763|vitamin D3|vitamin d3
750652|NCT01166763|Additional relevant MeSH terms:|additional relevant mesh terms:
750653|NCT01166763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
750654|NCT01166763|Physiological Effects of Drugs|physiological effects of drugs
750655|NCT01166763|Breast Neoplasms|breast neoplasms
750656|NCT01166763|Pharmacologic Actions|pharmacologic actions
750657|NCT01166763|Hyperplasia|hyperplasia
750658|NCT01166763|high risk for development of breast cancer|high risk for development of breast cancer
750659|NCT01166763|Neoplasms|neoplasms
750660|NCT01166763|Neoplasms by Site|neoplasms by site
750661|NCT01166763|Pathologic Processes|pathologic processes
750662|NCT01166763|Antirheumatic Agents|antirheumatic agents
750663|NCT01166763|Breast Diseases|breast diseases
750664|NCT01166776|Wharton's jelly|wharton's jelly
750665|NCT01166776|umbilical cord|umbilical cord
750666|NCT01166776|decellularization|decellularization
750667|NCT01166789|IBS|ibs
750668|NCT01166789|pain threshold|pain threshold
750669|NCT01166789|constipation|constipation
750670|NCT01166802|questionnaire development|questionnaire development
750671|NCT01166802|hypervigilance|hypervigilance
750672|NCT01166802|pain sensitivity|pain sensitivity
750673|NCT01166815|diarrhea morbidity|diarrhea morbidity
750674|NCT01166815|malaria incidence|malaria incidence
750675|NCT01166815|zinc supplementation|zinc supplementation
750676|NCT01166828|Spinal cord injury|spinal cord injury
750677|NCT01166828|telehealth|telehealth
750678|NCT01166828|pressure ulcers|pressure ulcers
750679|NCT01166828|quality of life|quality of life
750680|NCT01166841|minimally invasive cardiac surgery|minimally invasive cardiac surgery
750681|NCT01166841|cardiac surgery|cardiac surgery
750682|NCT01166841|near infrared spectroscopy|near infrared spectroscopy
750683|NCT01166841|mitral valve repair|mitral valve repair
750684|NCT01166841|mitral valve replacement|mitral valve replacement
750685|NCT01166854|muscle and bone disease|muscle and bone disease
750687|NCT01166880|assessment|assessment
750688|NCT01166893|burn wound|burn wound
750689|NCT01166906|pain blocking|pain blocking
750690|NCT01166932|pneumonia|pneumonia
750691|NCT01166932|children|children
750692|NCT01166932|antibiotics|antibiotics
750693|NCT01166945|Child|child
750694|NCT01166945|Child, preschool|child, preschool
750695|NCT01166945|Sinusitis|sinusitis
750696|NCT01166945|Antimicrobial agents|antimicrobial agents
750697|NCT01166971|presbyopia|presbyopia
750698|NCT01166971|intraocular lens|intraocular lens
750699|NCT01166984|sepsis|sepsis
750700|NCT01166984|septic shock|septic shock
750701|NCT01166997|Pulmonary embolism|pulmonary embolism
750702|NCT01166997|Pulmonary thromboembolism|pulmonary thromboembolism
750703|NCT01166997|anticoagulation|anticoagulation
750704|NCT01166997|thrombolysis|thrombolysis
750705|NCT01166997|ultrasound accelerated thrombolysis|ultrasound accelerated thrombolysis
750706|NCT01167023|Sickle Cell Disease|sickle cell disease
750707|NCT01167023|Sickle Cell Anemia|sickle cell anemia
750708|NCT01167023|Adult|adult
750709|NCT01167036|Myofascial pain syndrome|myofascial pain syndrome
750710|NCT01167036|Trigger points, Myofascial|trigger points, myofascial
750711|NCT01167036|Chiropractic|chiropractic
750712|NCT01167036|Massage|massage
750713|NCT01167036|Musculoskeletal manipulation|musculoskeletal manipulation
750714|NCT01167049|gastric cancer with liver metastasis|gastric cancer with liver metastasis
750715|NCT01160679|anhedonic features in patients with schizophrenia|anhedonic features in patients with schizophrenia
750716|NCT01160692|Memory|memory
750717|NCT01160692|Cognitive Function|cognitive function
750718|NCT01160692|Elderly|elderly
750719|NCT01160692|Gingko|gingko
750720|NCT01160692|Age Associated Memory Impairment (AAMI)|age associated memory impairment (aami)
750721|NCT01160705|adenocarcinoma of the prostate|adenocarcinoma of the prostate
750722|NCT01160705|recurrent prostate cancer|recurrent prostate cancer
750723|NCT01160705|stage III prostate cancer|stage iii prostate cancer
750724|NCT01160705|stage IV prostate cancer|stage iv prostate cancer
750725|NCT01160705|bone metastases|bone metastases
750726|NCT01160705|liver metastases|liver metastases
750727|NCT01160705|lung metastases|lung metastases
750728|NCT01160705|hormone-resistant prostate cancer|hormone-resistant prostate cancer
750729|NCT01160718|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
750730|NCT01160718|HER2-positive breast cancer|her2-positive breast cancer
750731|NCT01160718|HER2-negative breast cancer|her2-negative breast cancer
750732|NCT01160718|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
750733|NCT01160718|recurrent breast cancer|recurrent breast cancer
750734|NCT01160718|stage IIIA breast cancer|stage iiia breast cancer
750735|NCT01160718|stage IIIB breast cancer|stage iiib breast cancer
750736|NCT01160718|stage IIIC breast cancer|stage iiic breast cancer
750737|NCT01160718|stage IV breast cancer|stage iv breast cancer
750738|NCT01160731|extensive stage small cell lung cancer|extensive stage small cell lung cancer
750739|NCT01160744|Lung neoplasms|lung neoplasms
750740|NCT01160744|Lung cancer|lung cancer
750741|NCT01160744|Non-small Cell Lung Cancer|non-small cell lung cancer
750742|NCT01160744|pemetrexed|pemetrexed
750743|NCT01160744|ALIMTA®|alimta®
750744|NCT01160744|squamous|squamous
750745|NCT01160744|nonsquamous|nonsquamous
750746|NCT01160770|Lennox-Gastaut Syndrome (LGS)|lennox-gastaut syndrome (lgs)
750747|NCT01160770|Epilepsy|epilepsy
750748|NCT01160770|Drop Seizures|drop seizures
750749|NCT01160770|Clobazam|clobazam
750750|NCT01160783|Autism|autism
750751|NCT01160783|Asperger's Syndrome|asperger's syndrome
750752|NCT01160783|Asperger Syndrome|asperger syndrome
750753|NCT01160783|Autistic Disorder|autistic disorder
750754|NCT01160783|Autism Spectrum Disorder|autism spectrum disorder
750755|NCT01160783|Pervasive Developmental Disorders|pervasive developmental disorders
750756|NCT01160783|PDD-NOS|pdd-nos
750757|NCT01160783|Child Development Disorders, Pervasive|child development disorders, pervasive
750758|NCT01160783|Pervasive Developmental Disorder-Not Otherwise Specified|pervasive developmental disorder-not otherwise specified
750759|NCT01160809|Malaria|malaria
750760|NCT01160809|Mosquito repellent|mosquito repellent
750761|NCT01160809|LLINs|llins
750762|NCT01160822|Osteo arthritis|osteo arthritis
750763|NCT01160822|pain control|pain control
750764|NCT01160822|intra- articular injections|intra- articular injections
750765|NCT01160822|Knee OA|knee oa
750766|NCT01160835|total knee arthroplasty|total knee arthroplasty
750767|NCT01160835|minimally invasive|minimally invasive
750768|NCT01160835|quadriceps-sparing|quadriceps-sparing
750769|NCT01160835|Quadriceps-sparing total knee arthroplasty|quadriceps-sparing total knee arthroplasty
750770|NCT01160848|Moderate to severe Acne Vulgaris|moderate to severe acne vulgaris
752989|NCT01175044|Lavage|lavage
752990|NCT01175044|Infection|infection
750771|NCT01160874|Attention Deficit Disorder / Hyperactivity (ADHD)|attention deficit disorder / hyperactivity (adhd)
750772|NCT01160874|Cognition|cognition
750773|NCT01160874|Sleepiness|sleepiness
750774|NCT01160874|Driving|driving
750775|NCT01160900|cardiovascular diseases|cardiovascular diseases
750776|NCT01160900|heart disease|heart disease
750777|NCT01160900|hemorrhage|hemorrhage
750778|NCT01160900|coronary angioplasty|coronary angioplasty
750779|NCT01160900|drug eluting stents|drug eluting stents
750780|NCT01160926|rectal cancer|rectal cancer
750781|NCT01160926|capecitabine|capecitabine
750782|NCT01160926|radiotherapy|radiotherapy
750783|NCT01160926|AZD6244|azd6244
750784|NCT01160926|MEK inhibitor|mek inhibitor
750785|NCT01160926|AZD2171|azd2171
750786|NCT01160926|Cediranib|cediranib
750787|NCT01160926|VEGFR inhibitor|vegfr inhibitor
750788|NCT01160926|FLT-PET (fluoro-l-pyrimidine positron emission tomography)|flt-pet (fluoro-l-pyrimidine positron emission tomography)
750789|NCT01160926|DCE-MRI (dynamic contrast enhanced magnetic resonance imaging)|dce-mri (dynamic contrast enhanced magnetic resonance imaging)
750790|NCT01160939|Exercise|exercise
750791|NCT01160939|heart failure|heart failure
750792|NCT01160939|rehabilitation|rehabilitation
750793|NCT01160952|primary prophylaxis|primary prophylaxis
750794|NCT01160952|itraconazole|itraconazole
750795|NCT01160952|stem cell transplantation|stem cell transplantation
750796|NCT01160965|epidural top-up|epidural top-up
750797|NCT01160965|emergency Caesarean section|emergency caesarean section
750798|NCT01160978|Transplantation|transplantation
750799|NCT01160978|Simvastatin treatment|simvastatin treatment
750800|NCT01160978|Ischemia-reperfusion injury|ischemia-reperfusion injury
750801|NCT01160978|Lung failure|lung failure
750802|NCT01160991|schizophrenia|schizophrenia
750803|NCT01160991|olanzapine|olanzapine
750804|NCT01160991|atypical antipsychotic drugs|atypical antipsychotic drugs
750805|NCT01160991|amisulpride|amisulpride
750806|NCT01160991|diabetes|diabetes
750807|NCT01160991|insulin resistance|insulin resistance
750808|NCT01160991|insulin secretion|insulin secretion
750809|NCT01160991|glucose|glucose
750810|NCT01160991|euglycemic hyperinsulinemic clamp|euglycemic hyperinsulinemic clamp
750811|NCT01160991|hyperglycemic clamp|hyperglycemic clamp
750812|NCT01161017|migraine patients|migraine patients
750813|NCT01161043|diabetes|diabetes
750814|NCT01161043|glucose|glucose
750815|NCT01161043|sensor|sensor
750816|NCT01161069|phase 1|phase 1
750817|NCT01161069|healthy young adult volunteers|healthy young adult volunteers
750818|NCT01161069|healthy elderly adult volunteers|healthy elderly adult volunteers
750819|NCT01161095|Intrauterine Device|intrauterine device
750820|NCT01161095|Postpartum contraception|postpartum contraception
750821|NCT01161095|Long-acting reversible contraception|long-acting reversible contraception
750822|NCT01161108|Pediatrics|pediatrics
750823|NCT01161108|Epilepsy|epilepsy
750824|NCT01161108|Insomnia|insomnia
750825|NCT01161108|Melatonin|melatonin
750826|NCT01161121|Fractional flow reserve|fractional flow reserve
750827|NCT01161121|adenosine|adenosine
750828|NCT01161121|regadenoson|regadenoson
750829|NCT01161160|H1N1|h1n1
750830|NCT01161160|Influenza|influenza
750831|NCT01161160|Pandemic|pandemic
750832|NCT01161160|GSK Bio's influenza vaccines GSK2340274A and GSK234072A|gsk bio's influenza vaccines gsk2340274a and gsk234072a
750833|NCT01161186|pancreas|pancreas
750834|NCT01161186|cancer|cancer
750835|NCT01161186|abraxane|abraxane
750836|NCT01161186|metastatic|metastatic
750837|NCT01161186|gemcitabine|gemcitabine
750838|NCT01161186|capecitabine|capecitabine
750839|NCT01161186|adenocarcinoma|adenocarcinoma
750841|NCT01161199|latent reservoir|latent reservoir
750842|NCT01161199|functional cure|functional cure
750843|NCT01161199|leukapheresis|leukapheresis
750844|NCT01161212|body mass index|body mass index
750845|NCT01161212|health-related quality of life|health-related quality of life
750846|NCT01161212|physical education|physical education
750847|NCT01161212|children|children
750848|NCT01161212|cluster randomized controlled trial|cluster randomized controlled trial
750849|NCT01161212|prevention|prevention
750850|NCT01161212|Child|child
750851|NCT01161212|French|french
750852|NCT01161212|Schoolchildren|schoolchildren
750853|NCT01161225|Adolescents|adolescents
750854|NCT01161225|Peer leader program|peer leader program
750855|NCT01161225|asthma camp|asthma camp
750856|NCT01161225|asthma control|asthma control
750857|NCT01161225|quality of life|quality of life
750858|NCT01161225|self-efficacy|self-efficacy
750859|NCT01161225|knowledge|knowledge
750860|NCT01161225|attitudes|attitudes
750861|NCT01161225|barrier perceptions|barrier perceptions
750862|NCT01167075|critically ill|critically ill
750864|NCT01167075|antioxidants|antioxidants
750865|NCT01167075|enteral nutrition|enteral nutrition
750866|NCT01167075|SIRS (APACHE score 10-30)|sirs (apache score 10-30)
750867|NCT01167075|enteral feeding within 48 h of admission|enteral feeding within 48 h of admission
750868|NCT01167088|Double-blind|double-blind
750869|NCT01167088|Placebo-controlled|placebo-controlled
750870|NCT01167088|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
750871|NCT01167088|NAFLD|nafld
750872|NCT01167101|Rebamipide|rebamipide
750873|NCT01167101|gastric ulcer|gastric ulcer
750874|NCT01167101|healing rate|healing rate
750875|NCT01167101|iatrogenic gastric ulcer after endoscopic submucosal dissection|iatrogenic gastric ulcer after endoscopic submucosal dissection
750877|NCT01167127|Oxycodone/naloxone|oxycodone/naloxone
750878|NCT01167127|pain relief|pain relief
750879|NCT01167127|bowel function|bowel function
750880|NCT01167127|moderate to severe non-malignant pain|moderate to severe non-malignant pain
750881|NCT01167153|Hypertension|hypertension
750882|NCT01167153|Valsartan Amlodipine single pill combination|valsartan amlodipine single pill combination
750883|NCT01167153|BP control|bp control
750884|NCT01167153|ABPM|abpm
750885|NCT01167153|Hypertensive patients not adequately controlled by mono antihypertensive drugs|hypertensive patients not adequately controlled by mono antihypertensive drugs
750886|NCT01167166|Acute Myelocytic Leukemia|acute myelocytic leukemia
750887|NCT01167166|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
750888|NCT01167166|Myeloproliferative Disease|myeloproliferative disease
750889|NCT01167166|Myelofibrosis|myelofibrosis
750890|NCT01167166|Essential thrombocythemia|essential thrombocythemia
750891|NCT01167166|Polycythemia vera|polycythemia vera
750892|NCT01167166|Chronic Myeloid Leukemia|chronic myeloid leukemia
750893|NCT01167179|head and neck cancer|head and neck cancer
750894|NCT01167179|nurse-led care|nurse-led care
750895|NCT01167179|follow-up care|follow-up care
750896|NCT01167179|professional-patient relations|professional-patient relations
750897|NCT01167179|psychosocial adjustment|psychosocial adjustment
750898|NCT01167179|quasi-experimental|quasi-experimental
750899|NCT01167179|prospective|prospective
750900|NCT01167179|quality of life|quality of life
750901|NCT01167205|Healthy adults with BMI over 25.0 kg/m2|healthy adults with bmi over 25.0 kg/m2
750902|NCT01167218|verify now assay for hematological disorders|verify now assay for hematological disorders
750903|NCT01167231|Diabetes|diabetes
750904|NCT01167231|Acarbose|acarbose
750905|NCT01167257|Overactive bladder|overactive bladder
750906|NCT01167257|Detrusor overactivity|detrusor overactivity
750907|NCT01167257|Liposome|liposome
750908|NCT01167257|Botulinum toxin A|botulinum toxin a
750909|NCT01167270|Infant Diet|infant diet
750910|NCT01167270|Toddler Diet|toddler diet
750911|NCT01167270|Responsive Feeding|responsive feeding
750912|NCT01167270|Infant Temperament|infant temperament
750913|NCT01167270|Parent competency|parent competency
750914|NCT01167270|Childhood Obesity prevention|childhood obesity prevention
750915|NCT01167270|Rapid infant weight gain|rapid infant weight gain
750916|NCT01167283|COPD|copd
750917|NCT01167296|Intrauterine adhesion|intrauterine adhesion
750918|NCT01167296|Cook balloon uterine stent|cook balloon uterine stent
750919|NCT01167309|Safety and tolerability of LEO 27847|safety and tolerability of leo 27847
750920|NCT01167322|NPC-07, 5-ALA, photodynamic diagnosis, pharmacokinetics|npc-07, 5-ala, photodynamic diagnosis, pharmacokinetics
750921|NCT01167335|partial onset seizure|partial onset seizure
750922|NCT01167335|seizure frequency|seizure frequency
750923|NCT01167335|nervous system diseases|nervous system diseases
750924|NCT01167335|central nervous system diseases|central nervous system diseases
750925|NCT01167335|CNS|cns
750926|NCT01167335|brain diseases|brain diseases
750927|NCT01167335|neurologic manifestations|neurologic manifestations
750928|NCT01167335|adjunctive treatment|adjunctive treatment
750929|NCT01167335|AEDs|aeds
750930|NCT01167335|antiepileptic drug|antiepileptic drug
750931|NCT01167348|auricular acupressure|auricular acupressure
750932|NCT01167348|obesity|obesity
750933|NCT01167348|schizophrenia|schizophrenia
750934|NCT01167348|body weight|body weight
750935|NCT01167361|upper respiratory tract infection|upper respiratory tract infection
750936|NCT01167361|lower respiratory tract infection|lower respiratory tract infection
750937|NCT01167374|HCC|hcc
750938|NCT01167387|carbohydrate|carbohydrate
750939|NCT01167387|glucose metabolism|glucose metabolism
750940|NCT01167387|surgery, outcome|surgery, outcome
750941|NCT01167387|major elective surgery|major elective surgery
750942|NCT01167387|urology|urology
750943|NCT01167387|hyperglicemia|hyperglicemia
750944|NCT01167400|exercise|exercise
750945|NCT01167400|executive function|executive function
750946|NCT01167400|older adults|older adults
750947|NCT01167855|Pediatric Asthma|pediatric asthma
750948|NCT01167855|Low-income|low-income
750949|NCT01167855|Arkansas Delta Region|arkansas delta region
750950|NCT01167868|fostamatinib disodium|fostamatinib disodium
750951|NCT01167868|FosD|fosd
750952|NCT01167868|Japanese|japanese
750953|NCT01167868|Healthy volunteers|healthy volunteers
750954|NCT01167868|Phase 1|phase 1
750955|NCT01167868|Single and Multiple Ascending Dose Study|single and multiple ascending dose study
667151|NCT00847236|PMR|pmr
750956|NCT01167868|Healthy Japanese volunteers|healthy japanese volunteers
750957|NCT01167868|Healthy White volunteers|healthy white volunteers
750958|NCT01167894|Bioequivalence|bioequivalence
750959|NCT01167894|Crossover|crossover
750960|NCT01167894|Simvastatin|simvastatin
750961|NCT01167907|ankle|ankle
750962|NCT01167907|arthrodesis|arthrodesis
750963|NCT01167907|internal fixation|internal fixation
752760|NCT01174069|NOTES|notes
750964|NCT01167907|bi/tri malleolar fracture|bi/tri malleolar fracture
750965|NCT01167920|High Blood Pressure|high blood pressure
750966|NCT01167920|Hypertension|hypertension
750967|NCT01167920|Home Blood Pressure Measurements|home blood pressure measurements
750968|NCT01167920|Wireless communication of measurements|wireless communication of measurements
751443|NCT01169649|MK-2206|mk-2206
750969|NCT01167920|Wireless communication of blood pressure measurements|wireless communication of blood pressure measurements
750970|NCT01167933|Bioequivalence|bioequivalence
750971|NCT01167933|Crossover|crossover
750972|NCT01167933|Simvastatin|simvastatin
750973|NCT01167946|Alopecia Areata|alopecia areata
750974|NCT01167946|Alopecia totalis|alopecia totalis
750975|NCT01167946|Alopecia Universalis|alopecia universalis
750976|NCT01167946|Ophiasic alopecia|ophiasic alopecia
750977|NCT01167946|Oral Pulse steroid|oral pulse steroid
750978|NCT01167946|Methylprednisolone|methylprednisolone
750979|NCT01167959|Obesity|obesity
750980|NCT01167959|Diabetes|diabetes
750981|NCT01167959|Bariatric surgery|bariatric surgery
750982|NCT01167972|M + mutation|m + mutation
750983|NCT01167972|Non Small Cell Lung Cancer adenocarcinoma|non small cell lung cancer adenocarcinoma
750984|NCT01167972|To determine the proportion of patients with M + mutation status among patients with NSCLC adenocarcinoma|to determine the proportion of patients with m + mutation status among patients with nsclc adenocarcinoma
750985|NCT01167985|antibacterial polyethyleneimine nanoparticles|antibacterial polyethyleneimine nanoparticles
750986|NCT01167985|quaternary ammonium|quaternary ammonium
750987|NCT01167985|dental|dental
750988|NCT01167985|Endodotnic|endodotnic
750989|NCT01167985|pulp|pulp
750990|NCT01167985|bacteria|bacteria
750991|NCT01167985|Root canal sealer|root canal sealer
750992|NCT01167985|temporary filling|temporary filling
750993|NCT01167985|provisional restoration|provisional restoration
750994|NCT01168024|Acute Kidney Injury|acute kidney injury
750995|NCT01168024|Iodinated Contrast Agent Retrieval|iodinated contrast agent retrieval
750996|NCT01168024|Coronary Sinus Cannulation|coronary sinus cannulation
750997|NCT01168037|Aorta|aorta
750998|NCT01168037|Aneurysm|aneurysm
750999|NCT01168037|endovascular|endovascular
751000|NCT01168037|stent-graft|stent-graft
751001|NCT01168050|Malignant Skin Melanoma T0|malignant skin melanoma t0
751002|NCT01168050|stage III unresectable melanomas,|stage iii unresectable melanomas,
751003|NCT01168050|or stage IV melanomas with c-KIT mutation|or stage iv melanomas with c-kit mutation
751004|NCT01168050|or amplification.|or amplification.
751005|NCT01168063|Helicobacter pylori|helicobacter pylori
751006|NCT01168063|Diagnostic molecular testing|diagnostic molecular testing
751007|NCT01168063|Antibiotic resistance|antibiotic resistance
751008|NCT01168063|Treatment protocols|treatment protocols
751009|NCT01168128|Enteral Nutrition|enteral nutrition
751010|NCT01168128|Parenteral Nutrition|parenteral nutrition
751011|NCT01168128|Critically ill|critically ill
751012|NCT01168128|Nutrition Therapy|nutrition therapy
751013|NCT01168128|Nutrition Support|nutrition support
751014|NCT01168128|Practice Guidelines as Topic|practice guidelines as topic
751015|NCT01168128|Guideline Adherence|guideline adherence
751016|NCT01168128|Quality Assurance, Health Care|quality assurance, health care
751017|NCT01168128|Nutrition Surveys|nutrition surveys
751018|NCT01168128|Questionnaires|questionnaires
751019|NCT01168141|Castrate-resistant prostate cancer with bone metastasis|castrate-resistant prostate cancer with bone metastasis
751020|NCT01168154|Diverticula|diverticula
751021|NCT01168154|Diverticular disease|diverticular disease
751022|NCT01168154|Diverticulitis|diverticulitis
751023|NCT01168154|Probiotics|probiotics
751024|NCT01168167|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
751026|NCT01168167|HIV-1 DNA species|hiv-1 dna species
751027|NCT01168167|viral slope|viral slope
751028|NCT01168167|Ribonucleic Acid|ribonucleic acid
751029|NCT01168167|DNA, Complementary|dna, complementary
751030|NCT01168180|Traditional Thai Massage|traditional thai massage
751031|NCT01168180|Scapulocostal Syndrome|scapulocostal syndrome
751032|NCT01168193|surgery|surgery
751033|NCT01168193|post operative|post operative
751034|NCT01168193|complications|complications
751035|NCT01168193|length of stay|length of stay
751036|NCT01168245|Alzheimer Disease|alzheimer disease
751037|NCT01168245|Dementia|dementia
751038|NCT01168245|Brain Diseases|brain diseases
751039|NCT01168245|Central Nervous System Diseases|central nervous system diseases
751040|NCT01168245|Nervous System Disease|nervous system disease
751041|NCT01168245|Cognitive Training|cognitive training
751042|NCT01168245|Cortical Reorganization|cortical reorganization
751043|NCT01168245|Brain Plasticity|brain plasticity
751044|NCT01168258|Diabetic Retinopathy|diabetic retinopathy
751045|NCT01168258|Diabetes|diabetes
751046|NCT01168258|Single Nucleotide Polymorphism (SNP)|single nucleotide polymorphism (snp)
751047|NCT01168258|Diabetic Macular Edema|diabetic macular edema
751048|NCT01168271|Observational|observational
751049|NCT01168271|Newborns|newborns
751050|NCT01168271|Hospitalized|hospitalized
751051|NCT01168271|Febrile|febrile
751052|NCT01168271|Resistance|resistance
751053|NCT01168284|Autism Spectrum Disorders|autism spectrum disorders
751054|NCT01168297|Obesity|obesity
751055|NCT01168297|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
751056|NCT01168297|Genetics|genetics
751057|NCT01168297|Energy Expenditure|energy expenditure
751058|NCT01168297|Physical Activity|physical activity
751059|NCT01168310|Pulmonary, Obstructive, lungs, COPD|pulmonary, obstructive, lungs, copd
751060|NCT01168323|Medical Education|medical education
751540|NCT01170195|licorice|licorice
751061|NCT01168323|Educational Technology|educational technology
751062|NCT01168323|Clinical Practice Guideline|clinical practice guideline
751063|NCT01168323|Prostate specific antigen|prostate specific antigen
751064|NCT01168336|betahistine olanzapine weight sleepiness|betahistine olanzapine weight sleepiness
751065|NCT01168336|olanzapine induced weight gain and sleepiness|olanzapine induced weight gain and sleepiness
751066|NCT01168362|coronary artery disease|coronary artery disease
751067|NCT01168362|cardiovascular risk|cardiovascular risk
751068|NCT01168362|pericardial fat|pericardial fat
751069|NCT01168388|Dystonia|dystonia
751070|NCT01168388|Hemifacial spasm|hemifacial spasm
751071|NCT01168388|Cervical dystonia|cervical dystonia
751072|NCT01168388|Blepharospasm|blepharospasm
751073|NCT01168401|Prevention of acute gastroenteritis due to infection with noroviruses|prevention of acute gastroenteritis due to infection with noroviruses
751074|NCT01168440|von Hippel-Lindau|von hippel-lindau
751076|NCT01168440|sunitinib|sunitinib
751077|NCT01168453|jugular vein|jugular vein
751078|NCT01168453|anatomy|anatomy
751079|NCT01168453|ultrasonography|ultrasonography
751080|NCT01168466|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
751081|NCT01168466|EEG Biofeedback|eeg biofeedback
751082|NCT01168466|Cerebral oxygenation biofeedback|cerebral oxygenation biofeedback
751083|NCT01168466|Peak Alpha Rhythm Biofeedback|peak alpha rhythm biofeedback
751084|NCT01168466|Frontotemporal Dementia|frontotemporal dementia
751085|NCT01168479|prostate cancer|prostate cancer
751086|NCT01168479|external beam radiotherapy|external beam radiotherapy
751087|NCT01168479|dose escalation|dose escalation
751088|NCT01168479|dose painting|dose painting
751089|NCT01168479|95Gy in 35 fractions|95gy in 35 fractions
751090|NCT01168479|MRI|mri
751091|NCT01168479|FLAME|flame
751092|NCT01168492|pediatric|pediatric
751093|NCT01168492|gastroscopy|gastroscopy
751094|NCT01168492|colonoscopy|colonoscopy
751095|NCT01168492|sedation|sedation
751096|NCT01168492|ketamine|ketamine
751097|NCT01168518|Evaluate the Sorin Group new passive- and active- fixation pacing leads|evaluate the sorin group new passive- and active- fixation pacing leads
751098|NCT01168531|patients undergoing lumbar spinal surgery|patients undergoing lumbar spinal surgery
751099|NCT01168544|Vitamin D|vitamin d
751100|NCT01168544|Colecalciferol|colecalciferol
751101|NCT01168544|Nursing home|nursing home
751102|NCT01168544|Loading dose|loading dose
751103|NCT01168557|electric impedance tomography|electric impedance tomography
751104|NCT01168557|stress-echocardiography|stress-echocardiography
751105|NCT01168557|ventilation|ventilation
751106|NCT01168557|perfusion|perfusion
751107|NCT01168570|familial Mediterranean fever|familial mediterranean fever
751108|NCT01168570|amyloidosis AA|amyloidosis aa
751109|NCT01168570|serum amyloid A|serum amyloid a
751110|NCT01168570|renal failure|renal failure
751111|NCT01168570|nephrotic syndrome|nephrotic syndrome
751112|NCT01168596|Parkinson's Disease|parkinson's disease
751113|NCT01168596|Fatigue|fatigue
751114|NCT01168609|Left atrial distensibility|left atrial distensibility
751115|NCT01168609|left ventricular filling pressure|left ventricular filling pressure
751116|NCT01168609|tissue Doppler|tissue doppler
751117|NCT01168609|prognosis|prognosis
751118|NCT01168609|acute myocardial infarction|acute myocardial infarction
751119|NCT01168635|Asthma|asthma
751120|NCT01168635|Spirometry|spirometry
751121|NCT01168635|Pediatric|pediatric
751122|NCT01168635|Primary Health Care|primary health care
751123|NCT01168635|Education, Distance|education, distance
751124|NCT01168648|Yoga|yoga
751125|NCT01168648|Stress|stress
751126|NCT01168648|Stress management|stress management
751127|NCT01168648|Hypothalamus-pituitary-adrenal axis|hypothalamus-pituitary-adrenal axis
751128|NCT01168661|Stress|stress
751129|NCT01168661|Burnout|burnout
751130|NCT01168661|Anxiety|anxiety
751131|NCT01168661|Depression|depression
751132|NCT01168674|Major Depressive Disorder|major depressive disorder
751133|NCT01168674|MDD|mdd
751134|NCT01168674|Bipolar Disorder|bipolar disorder
751135|NCT01168674|BD|bd
751136|NCT01168674|Depression|depression
751137|NCT01168674|Major Depressive Disorder with Bipolar features|major depressive disorder with bipolar features
751138|NCT01168687|keppra|keppra
751139|NCT01168687|levetiracetam|levetiracetam
751140|NCT01168687|alcoholism|alcoholism
751141|NCT01168687|genetics|genetics
751142|NCT01168687|subjective report|subjective report
751241|NCT01169051|Esophageal Cancer|esophageal cancer
751143|NCT01168700|Metabolic syndrome, Aged Garlic Extract, Insulin, inflammation, endothelium.|metabolic syndrome, aged garlic extract, insulin, inflammation, endothelium.
751144|NCT01168713|Adults with Community-Acquired Bacterial Pneumonia|adults with community-acquired bacterial pneumonia
751145|NCT01168739|thermotolerance|thermotolerance
751146|NCT01168739|heat acclimation|heat acclimation
751147|NCT01168739|quercetin|quercetin
752941|NCT01174862|aspirin|aspirin
751148|NCT01168739|exertional heat illness|exertional heat illness
751149|NCT01168739|gastrointestinal barrier permeability|gastrointestinal barrier permeability
751150|NCT01168752|Cancer|cancer
751151|NCT01168752|solid tumour|solid tumour
751152|NCT01168752|lymphoma|lymphoma
751153|NCT01168752|dose-escalation|dose-escalation
751154|NCT01168752|Hsp90 inhibitor|hsp90 inhibitor
751254|NCT01169116|brain metastasis|brain metastasis
751155|NCT01168765|Physical Activity, Mexican-American, Obesity, Diabetes, Nutrition, Border Health|physical activity, mexican-american, obesity, diabetes, nutrition, border health
751156|NCT01168791|Metastatic|metastatic
751157|NCT01168791|Front line|front line
751158|NCT01168804|multiple myeloma|multiple myeloma
751159|NCT01168804|bendamustine|bendamustine
751160|NCT01168804|bortezomib|bortezomib
751161|NCT01168804|dexamethasone|dexamethasone
751162|NCT01168817|Combination Drug Therapy|combination drug therapy
751163|NCT01168817|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
751164|NCT01168869|Manifestation|manifestation
751165|NCT01168869|Coronary Heart Disease|coronary heart disease
751166|NCT01168869|Myocardial infarction|myocardial infarction
751167|NCT01168869|Angina pectoris|angina pectoris
751168|NCT01168869|Unheralded|unheralded
751169|NCT01168869|General Practice Research Database|general practice research database
751170|NCT01168869|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
751171|NCT01168869|CALIBER|caliber
751172|NCT01168882|RGB-286638|rgb-286638
751173|NCT01168882|Hematological Malignancies|hematological malignancies
751174|NCT01168895|75 mg dose strength|75 mg dose strength
751175|NCT01168895|Safety|safety
751176|NCT01168895|Pharmacokinetics|pharmacokinetics
751177|NCT01168908|Clinical trial|clinical trial
751178|NCT01168908|Revatio|revatio
751179|NCT01168908|Sildenafil|sildenafil
751180|NCT01168908|Muscular Dystrophy|muscular dystrophy
751181|NCT01168908|Duchenne|duchenne
751182|NCT01168908|Becker|becker
751183|NCT01168908|Adult|adult
751184|NCT01168908|Adolescent|adolescent
751185|NCT01168921|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
751187|NCT01168921|Thrombocytopenia|thrombocytopenia
751188|NCT01168921|Small lymphocytic lymphoma|small lymphocytic lymphoma
751190|NCT01168921|Eltrombopag|eltrombopag
751191|NCT01168921|Promacta|promacta
751192|NCT01168921|thrombopoietin (TPO)-receptor agonist|thrombopoietin (tpo)-receptor agonist
751193|NCT01168921|platelets|platelets
751194|NCT01168934|healthy volunteers|healthy volunteers
751195|NCT01168934|crizotinib|crizotinib
751196|NCT01168934|absolute bioavailability|absolute bioavailability
751197|NCT01168934|pharmacokinetics|pharmacokinetics
751198|NCT01168947|sodium|sodium
751199|NCT01168947|hypertension|hypertension
751200|NCT01168947|fluid overload|fluid overload
751201|NCT01168947|hemodialysis|hemodialysis
751202|NCT01168947|dialysate|dialysate
751203|NCT01168947|interdialytic weight gain|interdialytic weight gain
751204|NCT01168947|intradialytic hypotension|intradialytic hypotension
751205|NCT01168973|second line|second line
751206|NCT01168973|non small cell lung cancer|non small cell lung cancer
751207|NCT01168973|NSCLC|nsclc
751208|NCT01168973|phase 3|phase 3
751209|NCT01168973|ramucirumab|ramucirumab
751210|NCT01168973|lung cancer|lung cancer
751211|NCT01168973|docetaxel|docetaxel
751212|NCT01168973|taxotere|taxotere
751213|NCT01168986|neck pain|neck pain
751214|NCT01168986|manual therapy|manual therapy
751215|NCT01168986|exercise|exercise
751216|NCT01168999|low back pain|low back pain
751217|NCT01168999|spinal manipulation|spinal manipulation
751218|NCT01168999|manual therapy|manual therapy
751219|NCT01168999|placebo|placebo
751220|NCT01169012|Myelodysplastic syndrome|myelodysplastic syndrome
751221|NCT01169012|Acute Myeloid Leukemia|acute myeloid leukemia
751222|NCT01169012|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
751223|NCT01169012|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
751224|NCT01169012|Clofarabine|clofarabine
751225|NCT01169012|Clolar|clolar
751226|NCT01169012|University of North Carolina at Chapel Hill|university of north carolina at chapel hill
751227|NCT01169012|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
751228|NCT01169025|Analgesia|analgesia
751229|NCT01169025|Pain|pain
751230|NCT01169038|sarcoidosis|sarcoidosis
751231|NCT01169038|mycobacteria|mycobacteria
751232|NCT01169038|lung|lung
751233|NCT01169038|pulmonary|pulmonary
751234|NCT01169038|radiographic improvement|radiographic improvement
751235|NCT01169051|Esophagectomy|esophagectomy
751236|NCT01169051|Pulmonary wedge resection|pulmonary wedge resection
751237|NCT01169051|Pulmonary lobectomy|pulmonary lobectomy
751238|NCT01169051|Pulmonary pneumonectomy|pulmonary pneumonectomy
751239|NCT01169051|Thoracic Surgery|thoracic surgery
751242|NCT01169064|Wound infection prevention|wound infection prevention
751243|NCT01169064|Silver-containing surgical dressing|silver-containing surgical dressing
751244|NCT01169064|Cesarean delivery infection prevention|cesarean delivery infection prevention
751245|NCT01169077|malaria, plasmodium falciparum, electroporation|malaria, plasmodium falciparum, electroporation
751246|NCT01169103|Obesity|obesity
751247|NCT01169103|Adolescent|adolescent
751248|NCT01169103|Insulin resistance|insulin resistance
751249|NCT01169103|Growth hormone|growth hormone
751250|NCT01169103|Visceral fat|visceral fat
751251|NCT01169103|Adolescent obesity|adolescent obesity
751252|NCT01169116|radiotherapy|radiotherapy
751253|NCT01169116|radiation oncology|radiation oncology
751256|NCT01169116|radiosurgery|radiosurgery
751257|NCT01169116|neurosurgery|neurosurgery
751258|NCT01169116|hypofractionation|hypofractionation
751259|NCT01169116|stereotaxy|stereotaxy
751260|NCT01169129|brain metastases|brain metastases
751261|NCT01169129|radiosurgery|radiosurgery
751262|NCT01169129|neurosurgery|neurosurgery
751263|NCT01169129|surgery|surgery
751264|NCT01169129|radiotherapy|radiotherapy
751265|NCT01169129|resectable brain metastases|resectable brain metastases
751266|NCT01169142|Vitamin D|vitamin d
751267|NCT01169142|Schizophrenia|schizophrenia
751268|NCT01169142|Severely Mentally Ill|severely mentally ill
751269|NCT01169155|Smoke inhalation injury|smoke inhalation injury
751270|NCT01169155|Burns|burns
751271|NCT01169155|Injuries|injuries
751272|NCT01169168|fibrinogen|fibrinogen
751273|NCT01169168|SIRS|sirs
751274|NCT01169168|sepsis|sepsis
751275|NCT01169168|liver disease|liver disease
751276|NCT01169168|chronic liver disease|chronic liver disease
751277|NCT01169168|septic shock|septic shock
751278|NCT01169181|Stroke|stroke
751279|NCT01169181|Cerebrovascular Accident|cerebrovascular accident
751280|NCT01169181|Plegia|plegia
751281|NCT01169181|Upper Extremity|upper extremity
751282|NCT01169181|rTMS|rtms
751283|NCT01169181|tDCS|tdcs
751284|NCT01169194|Inflammatory Bowel Disease|inflammatory bowel disease
751285|NCT01169194|Crohn's Disease|crohn's disease
751286|NCT01169194|Ulcerative Colitis|ulcerative colitis
751287|NCT01169194|Indeterminate Colitis|indeterminate colitis
751289|NCT01169194|African American IBD|african american ibd
751290|NCT01169194|African American CD|african american cd
751291|NCT01169194|African American UC|african american uc
751292|NCT01169194|Black IBD|black ibd
751293|NCT01169194|Black CD|black cd
751294|NCT01169194|Black UC|black uc
751295|NCT01169194|African American Inflammatory Bowel Disease|african american inflammatory bowel disease
751296|NCT01169194|African American Crohn's Disease|african american crohn's disease
751297|NCT01169194|African American Ulcerative Colitis|african american ulcerative colitis
751298|NCT01169194|Black Inflammatory Bowel Disease|black inflammatory bowel disease
751299|NCT01169194|Black Crohn's Disease|black crohn's disease
751300|NCT01169194|Black Ulcerative Colitis|black ulcerative colitis
751301|NCT01169207|Inflammatory Bowel Disease|inflammatory bowel disease
751302|NCT01169207|Crohn's Disease|crohn's disease
751303|NCT01169207|Ulcerative Colitis|ulcerative colitis
751304|NCT01169207|Indeterminate Colitis|indeterminate colitis
751310|NCT01169220|Bowel preparation|bowel preparation
751311|NCT01169233|Sleep|sleep
751312|NCT01169233|Alertness|alertness
751313|NCT01169233|fatigue|fatigue
751314|NCT01169233|performance|performance
751315|NCT01169233|spaceflight|spaceflight
751316|NCT01169233|isolation|isolation
751317|NCT01169233|light|light
751318|NCT01169233|Sleep , alertness and performance during a simulated spaceflight mission|sleep , alertness and performance during a simulated spaceflight mission
751319|NCT01169246|ATP,CRT, ICD PARADYM|atp,crt, icd paradym
751320|NCT01169259|vitamin D3|vitamin d3
751321|NCT01169259|omega-3 fatty acids|omega-3 fatty acids
751322|NCT01169259|fish oil|fish oil
751323|NCT01169259|cardiovascular disease|cardiovascular disease
751324|NCT01169259|cancer|cancer
751325|NCT01169259|primary prevention|primary prevention
751326|NCT01169272|ICD CRT 9770 - PARADYM RF ICD - SonR atrial lead|icd crt 9770 - paradym rf icd - sonr atrial lead
751327|NCT01169285|Burn Department Nursing Staff|burn department nursing staff
751328|NCT01169298|Adult T-cell Leukemia-Lymphoma|adult t-cell leukemia-lymphoma
751329|NCT01169298|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
751330|NCT01169298|PTCL|ptcl
751331|NCT01169298|HTLV-1|htlv-1
751332|NCT01169311|Hemorrhoids|hemorrhoids
751333|NCT01169311|Hemorrhoid|hemorrhoid
751334|NCT01169311|grade II, III, IV|grade ii, iii, iv
751335|NCT01169324|Parkinson's disease|parkinson's disease
751336|NCT01169324|Tremor|tremor
751337|NCT01169324|Dystonia|dystonia
751338|NCT01169324|DBS|dbs
751339|NCT01169324|Sleep|sleep
751340|NCT01169363|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
751341|NCT01169363|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
751342|NCT01169363|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
751343|NCT01169363|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
751344|NCT01169363|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
751430|NCT01169610|Alcohol|alcohol
751431|NCT01169610|Smoking|smoking
751345|NCT01169363|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
751346|NCT01169363|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
751347|NCT01169363|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
751348|NCT01169363|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
751349|NCT01169363|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
751350|NCT01169363|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
752014|NCT01171495|CD4 count|cd4 count
751351|NCT01169363|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
752172|NCT01172028|recurrent breast cancer|recurrent breast cancer
751352|NCT01169363|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
751353|NCT01169363|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
751354|NCT01169363|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
751355|NCT01169363|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
751356|NCT01169376|disseminated neuroblastoma|disseminated neuroblastoma
751357|NCT01169376|localized resectable neuroblastoma|localized resectable neuroblastoma
751358|NCT01169376|localized unresectable neuroblastoma|localized unresectable neuroblastoma
751359|NCT01169376|regional neuroblastoma|regional neuroblastoma
751360|NCT01169376|stage 4S neuroblastoma|stage 4s neuroblastoma
751361|NCT01169402|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
751363|NCT01169402|extracorporeal life support|extracorporeal life support
751364|NCT01169402|fluconazole|fluconazole
751365|NCT01169402|diflucan|diflucan
751366|NCT01169402|pharmacokinetics|pharmacokinetics
751367|NCT01169402|pharmacodynamics|pharmacodynamics
751368|NCT01169415|Randomized|randomized
751369|NCT01169415|Dexamethasone|dexamethasone
751370|NCT01169415|Abbreviated|abbreviated
751371|NCT01169415|Protracted|protracted
751372|NCT01169415|Post-operatively|post-operatively
751373|NCT01169428|Mindfulness-Based Weight Loss Maintenance|mindfulness-based weight loss maintenance
751374|NCT01169428|prevention of weight regain|prevention of weight regain
751375|NCT01169428|Obesity|obesity
751376|NCT01169441|ICD leads|icd leads
751377|NCT01169441|Removal|removal
751378|NCT01169441|Extraction|extraction
751379|NCT01169441|Ventricular leads|ventricular leads
751380|NCT01169441|Extract|extract
751381|NCT01169441|laser|laser
751382|NCT01169441|Observe the lead with x-ray during movement and collect information on current ways of removing an ICD lead.|observe the lead with x-ray during movement and collect information on current ways of removing an icd lead.
751383|NCT01169454|Cerebral Spinal Fluid|cerebral spinal fluid
751384|NCT01169454|Ventriculostomy|ventriculostomy
751385|NCT01169454|Subarachnoid hemorrhage|subarachnoid hemorrhage
751386|NCT01169454|Vasospasm|vasospasm
751387|NCT01169454|Human Subjects|human subjects
751388|NCT01169480|Massage|massage
751389|NCT01169480|Therapist, Massage|therapist, massage
751390|NCT01169480|DASS|dass
751391|NCT01169480|Depression|depression
751392|NCT01169480|Anxiety, State|anxiety, state
751393|NCT01169480|Anxiety, Trait|anxiety, trait
751394|NCT01169480|Stress|stress
751395|NCT01169480|Touch|touch
751396|NCT01169480|Therapeutic Relationship|therapeutic relationship
751397|NCT01169493|Heart Failure|heart failure
751398|NCT01169493|Right Bundle-Branch Block|right bundle-branch block
751399|NCT01169493|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
751400|NCT01169506|blood gas analysis|blood gas analysis
751401|NCT01169506|ventilatory insufficiency|ventilatory insufficiency
751402|NCT01169519|Hypoplastic left heart syndrome|hypoplastic left heart syndrome
751403|NCT01169519|Hypoplastic right heart syndrome|hypoplastic right heart syndrome
751404|NCT01169519|Superior cavopulmonary anastomosis|superior cavopulmonary anastomosis
751405|NCT01169519|Total cavopulmonary anastomosis|total cavopulmonary anastomosis
751406|NCT01169519|Children with single ventricle anatomy|children with single ventricle anatomy
751407|NCT01169545|any type of cancer|any type of cancer
751408|NCT01169571|Initially intubated|initially intubated
751409|NCT01169571|Mechanically ventilated|mechanically ventilated
751410|NCT01169571|Post-surgical|post-surgical
751411|NCT01169584|Phase I|phase i
751412|NCT01169584|advanced metastatic pediatric solid tumors|advanced metastatic pediatric solid tumors
751413|NCT01169584|pediatric|pediatric
751414|NCT01169584|vaccinia virus|vaccinia virus
751415|NCT01169584|oncolytic virus|oncolytic virus
751416|NCT01169584|neuroblastoma|neuroblastoma
751417|NCT01169584|rhabdomyosarcoma|rhabdomyosarcoma
751418|NCT01169584|lymphoma|lymphoma
751419|NCT01169584|Wilm's tumor|wilm's tumor
751420|NCT01169584|Ewing's sarcoma|ewing's sarcoma
751421|NCT01169584|osteosarcoma|osteosarcoma
751422|NCT01169584|non-rhabdomyosarcoma soft tissue sarcomas|non-rhabdomyosarcoma soft tissue sarcomas
751423|NCT01169584|malignant peripheral nerve sheath tumors|malignant peripheral nerve sheath tumors
751424|NCT01169584|Pexa-Vec|pexa-vec
751425|NCT01169597|polymyalgia rheumatica|polymyalgia rheumatica
751426|NCT01169597|prednisone|prednisone
751427|NCT01169597|clinical examination|clinical examination
751428|NCT01169597|remission|remission
751429|NCT01169597|ultrasonography|ultrasonography
751432|NCT01169623|Supportive leadership behaviour|supportive leadership behaviour
751433|NCT01169623|Nurse Performance|nurse performance
751434|NCT01169623|Educational Intervention|educational intervention
751435|NCT01169636|Chemotherapy|chemotherapy
751436|NCT01169636|Panobinostat|panobinostat
751437|NCT01169636|Ifosfamide|ifosfamide
751438|NCT01169636|Mesna|mesna
751439|NCT01169636|Etoposide|etoposide
751440|NCT01169636|Carboplatin|carboplatin
751441|NCT01169636|Pegfilgrastim|pegfilgrastim
751442|NCT01169636|ICE|ice
751444|NCT01169649|Neuroendocrine Tumors|neuroendocrine tumors
751446|NCT01169688|Cataract Surgery|cataract surgery
751447|NCT01169688|Pupillary Dilation|pupillary dilation
751448|NCT01169701|Renal transplant, everolimus, cardiovascular profile, CNI-free immunosuppression, left ventricular hypertrophy, biopsy proved acute rejection (BPAR)|renal transplant, everolimus, cardiovascular profile, cni-free immunosuppression, left ventricular hypertrophy, biopsy proved acute rejection (bpar)
751449|NCT01169714|multiple dose|multiple dose
751450|NCT01169714|healthy volunteer|healthy volunteer
751451|NCT01169714|healthy elderly volunteer|healthy elderly volunteer
751452|NCT01169714|safety|safety
751453|NCT01169714|pharmacokinetic|pharmacokinetic
751454|NCT01169727|COPD and CCQ score|copd and ccq score
751455|NCT01169727|Changes in PEF,overall CCQ score|changes in pef,overall ccq score
751456|NCT01169740|Hyperbilirubinemia|hyperbilirubinemia
751457|NCT01169740|Neonatal|neonatal
751458|NCT01169740|Serum bilirubin|serum bilirubin
751459|NCT01169740|Transcutaneous bilirubin|transcutaneous bilirubin
751460|NCT01169740|Skin color|skin color
751461|NCT01169753|Chronic Myeloid Leukemia|chronic myeloid leukemia
751463|NCT01169753|Nuvigil|nuvigil
751464|NCT01169753|Armodafinil|armodafinil
751465|NCT01169753|Fatigue|fatigue
751466|NCT01169792|Tamoxifen|tamoxifen
751467|NCT01169792|Cytochrome P-450 CYP2D6|cytochrome p-450 cyp2d6
751468|NCT01169792|Polymorphism|polymorphism
751469|NCT01169792|Single nucleotide|single nucleotide
751470|NCT01169792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
751471|NCT01169844|Psoriatic arthritis|psoriatic arthritis
751472|NCT01169844|IgG1K monoclonal antibody|igg1k monoclonal antibody
751473|NCT01169844|Interleukin -17A neutralizing|interleukin -17a neutralizing
751474|NCT01169857|Proliferative lupus nephritis|proliferative lupus nephritis
751475|NCT01169857|WHO class III/IV/V lupus nephritis|who class iii/iv/v lupus nephritis
751476|NCT01169857|Proteinuria|proteinuria
751477|NCT01169857|Hematuria|hematuria
751478|NCT01169857|Velcade|velcade
751479|NCT01169857|SLE|sle
751480|NCT01169857|Bortezomib|bortezomib
751481|NCT01169857|Proteasome inhibitor|proteasome inhibitor
751482|NCT01169870|metastatic|metastatic
751483|NCT01169883|adherence|adherence
751484|NCT01169883|asthma|asthma
751485|NCT01169883|pediatrics|pediatrics
751486|NCT01169883|behavioral intervention|behavioral intervention
751487|NCT01169883|inner city|inner city
751488|NCT01169896|Impact of ventricular pacing on the incidence of VT/VF episodes for each models|impact of ventricular pacing on the incidence of vt/vf episodes for each models
751489|NCT01169909|Pterygium|pterygium
751490|NCT01169935|MRI|mri
751491|NCT01169935|SPIO|spio
751492|NCT01169935|Healthy Volunteer|healthy volunteer
751493|NCT01169948|Coronary disease|coronary disease
751494|NCT01169948|Coronary artery bypass|coronary artery bypass
751495|NCT01169948|Cardiac surgery|cardiac surgery
751496|NCT01169948|Computed tomography|computed tomography
751497|NCT01169948|Coronary angiography|coronary angiography
751498|NCT01169961|IRON OVERLOAD IN HEMODIALYSIS PATIENTS|iron overload in hemodialysis patients
751499|NCT01169974|Microcirculation|microcirculation
751500|NCT01169974|laser flowmetry|laser flowmetry
751501|NCT01169974|Skin|skin
751502|NCT01169974|Physiology|physiology
751503|NCT01169987|Multicenter study|multicenter study
751504|NCT01170013|substance use|substance use
751505|NCT01170013|adolescents|adolescents
751506|NCT01170013|initiation|initiation
751507|NCT01170026|substance use|substance use
751508|NCT01170026|adolescents|adolescents
751509|NCT01170026|intervention|intervention
751510|NCT01170026|truancy|truancy
751511|NCT01170026|sexual risk behavior|sexual risk behavior
751512|NCT01170039|Constipation|constipation
751513|NCT01170039|Diabetes|diabetes
751514|NCT01170039|Lubiprostone|lubiprostone
751515|NCT01170039|Amitiza|amitiza
751516|NCT01170039|African Americans|african americans
751517|NCT01170052|Relapsed Mantle Cell Lymphoma|relapsed mantle cell lymphoma
751518|NCT01170052|Refractory Mantle Cell Lymphoma|refractory mantle cell lymphoma
751519|NCT01170052|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
751520|NCT01170052|Temsirolimus|temsirolimus
751521|NCT01170052|Bendamustine|bendamustine
751522|NCT01170052|Phase 1/2|phase 1/2
751523|NCT01170078|chronic renal failure requiring hemodialysis|chronic renal failure requiring hemodialysis
751524|NCT01170104|Hepatocellular Carcinoma|hepatocellular carcinoma
751525|NCT01170104|Sorafenib|sorafenib
751526|NCT01170104|TACE|tace
751527|NCT01170104|locally, advanced Hepatocellular Carcinoma|locally, advanced hepatocellular carcinoma
751528|NCT01170117|Eating Disorders|eating disorders
751529|NCT01170117|Anorexia Nervosa|anorexia nervosa
751530|NCT01170130|Cataract|cataract
751533|NCT01170143|IIB-IIIB Breast Cancer|iib-iiib breast cancer
751534|NCT01170143|Her2 positive|her2 positive
751535|NCT01170156|deep sedation|deep sedation
751536|NCT01170156|respiratory resuscitation|respiratory resuscitation
751537|NCT01170156|Hi-Lo Evac tube|hi-lo evac tube
751538|NCT01170156|suctioning manoeuvre|suctioning manoeuvre
751539|NCT01170195|Postmenopausal|postmenopausal
751541|NCT01170195|vaginal complaints|vaginal complaints
751542|NCT01170208|insulin|insulin
754020|NCT01178593|IBS|ibs
751543|NCT01170208|dosage software|dosage software
751544|NCT01170221|ABSSSI|absssi
751545|NCT01170221|Tedizolid Phosphate|tedizolid phosphate
751546|NCT01170221|TR-701|tr-701
751547|NCT01170221|Acute Bacterial Skin and Skin Structure Infections|acute bacterial skin and skin structure infections
751548|NCT01170234|Exhaled nitric oxide|exhaled nitric oxide
751549|NCT01170234|Eosinophilic esophagitis|eosinophilic esophagitis
751550|NCT01170247|Procedural Sedation|procedural sedation
751551|NCT01170273|aged|aged
751552|NCT01170273|vitamin d deficiency|vitamin d deficiency
751553|NCT01170286|Food allergy|food allergy
751554|NCT01170286|Immediate hypersensitivity|immediate hypersensitivity
751555|NCT01170286|Whole peanut extract|whole peanut extract
751556|NCT01170286|Allergenic product|allergenic product
751557|NCT01170286|Specific Immunotherapy|specific immunotherapy
751558|NCT01170286|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
751559|NCT01170286|Safety|safety
751560|NCT01170299|radiation toxicity|radiation toxicity
751561|NCT01170299|gastrointestinal complications|gastrointestinal complications
751562|NCT01170299|cervical cancer|cervical cancer
751563|NCT01170299|fallopian tube cancer|fallopian tube cancer
751564|NCT01170299|ovarian epithelial cancer|ovarian epithelial cancer
751565|NCT01170299|ovarian germ cell tumor|ovarian germ cell tumor
751566|NCT01170299|ovarian sarcoma|ovarian sarcoma
751567|NCT01170299|ovarian stromal cancer|ovarian stromal cancer
751568|NCT01170299|uterine sarcoma|uterine sarcoma
751569|NCT01170299|bladder cancer|bladder cancer
751570|NCT01170299|colon cancer|colon cancer
751571|NCT01170299|rectal cancer|rectal cancer
751572|NCT01170299|anal cancer|anal cancer
751573|NCT01170312|Arthroscopic repair|arthroscopic repair
751574|NCT01170312|Rotator cuff|rotator cuff
751575|NCT01170312|Platelet rich plasma|platelet rich plasma
751576|NCT01170312|Randomized|randomized
751577|NCT01170312|Pilot|pilot
751578|NCT01170325|Valproic Acid|valproic acid
751579|NCT01170325|Divalproex|divalproex
751580|NCT01170325|Autism|autism
751582|NCT01170325|Electroencephalogram (EEG)|electroencephalogram (eeg)
751583|NCT01170325|Depakote|depakote
751584|NCT01164046|anticoagulants|anticoagulants
751585|NCT01164046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
751586|NCT01164046|4-Hydroxycoumarins|4-hydroxycoumarins
751587|NCT01164046|recurrent venous thrombosis|recurrent venous thrombosis
751588|NCT01164059|Schizophrenia|schizophrenia
751589|NCT01164059|atypical antipsychotic drugs|atypical antipsychotic drugs
751590|NCT01164059|conventional antipsychotic drugs|conventional antipsychotic drugs
751591|NCT01164059|olanzapine|olanzapine
751592|NCT01164059|quetiapine|quetiapine
751593|NCT01164059|aripiprazole|aripiprazole
751594|NCT01164059|haloperidol|haloperidol
751595|NCT01164059|flupentixol|flupentixol
751596|NCT01164072|electronic cigarette|electronic cigarette
751597|NCT01164072|nicotine|nicotine
751598|NCT01164072|smoking cessation|smoking cessation
751599|NCT01164072|smoking reduction|smoking reduction
751600|NCT01164085|Inflammation|inflammation
751601|NCT01164085|Macular Edema|macular edema
751602|NCT01164111|osteoarthritis|osteoarthritis
751603|NCT01164111|hip arthroplasty|hip arthroplasty
751604|NCT01164111|resistance training|resistance training
751605|NCT01164111|preoperative training|preoperative training
751606|NCT01164124|extremely low birth weight|extremely low birth weight
751607|NCT01164124|probiotics|probiotics
751608|NCT01164124|growth|growth
751609|NCT01164124|nutrition|nutrition
751610|NCT01164124|premature infants|premature infants
751611|NCT01164124|growth in extremely low birth weight infants|growth in extremely low birth weight infants
751612|NCT01164137|Adverse Drug Events|adverse drug events
751613|NCT01164137|Medication Reconciliation|medication reconciliation
751614|NCT01164137|Pharmacist-led Intervention|pharmacist-led intervention
751615|NCT01164150|gastrointestinal complications|gastrointestinal complications
751616|NCT01164150|urinary complications|urinary complications
751617|NCT01164150|radiation toxicity|radiation toxicity
751618|NCT01164150|recurrent endometrial carcinoma|recurrent endometrial carcinoma
751619|NCT01164150|endometrial adenocarcinoma|endometrial adenocarcinoma
751620|NCT01164150|stage IA endometrial carcinoma|stage ia endometrial carcinoma
751621|NCT01164150|stage IB endometrial carcinoma|stage ib endometrial carcinoma
751622|NCT01164150|stage II endometrial carcinoma|stage ii endometrial carcinoma
751623|NCT01164150|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
751624|NCT01164150|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
751625|NCT01164150|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
751626|NCT01164163|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
751707|NCT01164371|coronary disease|coronary disease
751627|NCT01164163|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
751628|NCT01164163|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
751629|NCT01164163|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
751630|NCT01164163|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
751631|NCT01164163|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
751632|NCT01164163|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
751633|NCT01164163|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
751634|NCT01164163|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
751635|NCT01164163|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
751636|NCT01164163|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
751637|NCT01164163|polycythemia vera|polycythemia vera
751638|NCT01164163|essential thrombocythemia|essential thrombocythemia
751639|NCT01164163|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
751640|NCT01164163|acute myeloid leukemia/transient myeloproliferative disorder|acute myeloid leukemia/transient myeloproliferative disorder
751641|NCT01164163|primary myelofibrosis|primary myelofibrosis
751642|NCT01164176|anaplastic thyroid cancer|anaplastic thyroid cancer
751643|NCT01164176|insular thyroid cancer|insular thyroid cancer
751644|NCT01164176|recurrent thyroid cancer|recurrent thyroid cancer
751645|NCT01164176|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
751646|NCT01164176|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
751647|NCT01164176|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
751648|NCT01164176|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
751649|NCT01164176|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
751650|NCT01164189|adult anaplastic astrocytoma|adult anaplastic astrocytoma
751651|NCT01164189|adult diffuse astrocytoma|adult diffuse astrocytoma
751652|NCT01164189|adult pilocytic astrocytoma|adult pilocytic astrocytoma
751653|NCT01164189|adult pineal gland astrocytoma|adult pineal gland astrocytoma
751654|NCT01164189|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
751655|NCT01164189|adult oligodendroglioma|adult oligodendroglioma
751656|NCT01164189|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
751657|NCT01164189|recurrent adult brain tumor|recurrent adult brain tumor
751658|NCT01164189|adult giant cell glioblastoma|adult giant cell glioblastoma
751659|NCT01164189|adult glioblastoma|adult glioblastoma
751660|NCT01164189|adult gliosarcoma|adult gliosarcoma
751661|NCT01164189|adult mixed glioma|adult mixed glioma
751662|NCT01164202|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
751663|NCT01164202|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
751664|NCT01164202|advanced adult primary liver cancer|advanced adult primary liver cancer
751665|NCT01164215|neutropenia|neutropenia
751666|NCT01164215|diarrhea|diarrhea
751667|NCT01164215|stage I colon cancer|stage i colon cancer
751668|NCT01164215|stage II colon cancer|stage ii colon cancer
751669|NCT01164215|stage III colon cancer|stage iii colon cancer
751670|NCT01164215|stage IV colon cancer|stage iv colon cancer
751671|NCT01164215|recurrent colon cancer|recurrent colon cancer
751672|NCT01164215|stage I rectal cancer|stage i rectal cancer
751673|NCT01164215|stage II rectal cancer|stage ii rectal cancer
751674|NCT01164215|stage III rectal cancer|stage iii rectal cancer
751675|NCT01164215|stage IV rectal cancer|stage iv rectal cancer
751676|NCT01164215|recurrent rectal cancer|recurrent rectal cancer
751677|NCT01164228|recurrent renal cell cancer|recurrent renal cell cancer
751678|NCT01164228|stage IV renal cell cancer|stage iv renal cell cancer
751679|NCT01164228|clear cell renal cell carcinoma|clear cell renal cell carcinoma
751680|NCT01164228|papillary renal cell carcinoma|papillary renal cell carcinoma
751681|NCT01164228|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
751682|NCT01164241|Eczema|eczema
751683|NCT01164241|Allergy|allergy
751684|NCT01164241|Immunodeficiency|immunodeficiency
751685|NCT01164241|Netherton's Syndrome|netherton's syndrome
751686|NCT01164241|Piebaldism|piebaldism
751687|NCT01164254|Exposure Assessment|exposure assessment
751688|NCT01164254|Web-Based Dietary Assessment|web-based dietary assessment
751689|NCT01164254|Web-Based Physical Activity Assessment|web-based physical activity assessment
751690|NCT01164293|Atopy patch test|atopy patch test
751691|NCT01164306|LifeSkills Training|lifeskills training
751692|NCT01164306|Tobacco prevention|tobacco prevention
751693|NCT01164306|Tobacco cessation|tobacco cessation
751694|NCT01164306|Healthy lifestyles|healthy lifestyles
751695|NCT01164306|Tobacco control|tobacco control
751696|NCT01164319|Atrial fibrillation|atrial fibrillation
751697|NCT01164319|Percutaneous continous monitoring|percutaneous continous monitoring
751698|NCT01164319|ablation|ablation
751699|NCT01164345|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
751700|NCT01164345|Hodgkin's lymphoma|hodgkin's lymphoma
751701|NCT01164345|stem cell mobilization|stem cell mobilization
751702|NCT01164345|autologous stem cell transplantation|autologous stem cell transplantation
751703|NCT01164358|Presbyopia|presbyopia
751704|NCT01164358|INTRACOR|intracor
751705|NCT01164358|patient satisfaction|patient satisfaction
751706|NCT01164358|long term|long term
751708|NCT01164371|cardiovascular disease|cardiovascular disease
751709|NCT01164371|cardiovascular risk|cardiovascular risk
751710|NCT01164371|cardiovascular risk management|cardiovascular risk management
751711|NCT01164371|primary care|primary care
751712|NCT01164371|angina|angina
751713|NCT01164371|stable angina|stable angina
751714|NCT01164371|angina pectoris|angina pectoris
583320|NCT00511290|Primary disease or condition being studied: Asthma -COPD-Interstitial Lung Diseases-Occupational Lung Diseases|primary disease or condition being studied: asthma -copd-interstitial lung diseases-occupational lung diseases
583321|NCT00511303|Philadelphia chromosome|philadelphia chromosome
583322|NCT00511303|protein-tyrosine kinases|protein-tyrosine kinases
583323|NCT00511329|growth hormone|growth hormone
583324|NCT00511329|short stature|short stature
583325|NCT00511329|growth failure|growth failure
583326|NCT00511329|chronic illness|chronic illness
583327|NCT00511368|HIV|hiv
583328|NCT00511368|treatment experienced|treatment experienced
583329|NCT00511368|AIDS|aids
583330|NCT00511381|Hearing Loss|hearing loss
583331|NCT00511381|Late-Onset Hearing Loss|late-onset hearing loss
583332|NCT00511381|Deafness|deafness
583333|NCT00511394|Decompensated Cirrhosis with Ascites|decompensated cirrhosis with ascites
583334|NCT00511407|Acute renal failure|acute renal failure
583335|NCT00511407|Bioartificial kidney|bioartificial kidney
583336|NCT00511407|Cell therapy|cell therapy
583337|NCT00511407|Hemofiltration|hemofiltration
583338|NCT00511407|Septic shock|septic shock
583618|NCT00512434|tibial|tibial
584174|NCT00514982|HPS|hps
584915|NCT00516633|Asthma|asthma
585119|NCT00518570|PMS|pms
586041|NCT00523302|TMS|tms
586442|NCT00524641|Asthma|asthma
586757|NCT00525005|S-1|s-1
587814|NCT00521508|IgA|iga
587945|NCT00522015|PSP|psp
588232|NCT00536458|primary|primary
588904|NCT00525876|Rituxan|rituxan
589214|NCT00527553|AMD|amd
590973|NCT00527007|ICU|icu
591072|NCT00533702|ImClone|imclone
591573|NCT00535561|anemia|anemia
594016|NCT00551031|Elderly|elderly
597872|NCT00556634|HIV|hiv
599420|NCT00575042|PBC|pbc
599778|NCT00579709|Athymia|athymia
599884|NCT00580177|Surgery|surgery
600689|NCT00583167|HIV|hiv
602178|NCT00588679|06-035|06-035
602176|NCT00588679|MRI|mri
602260|NCT00589225|PH|ph
604825|NCT00592761|SEMG|semg
605207|NCT00601978|EEG|eeg
605412|NCT00603018|PET|pet
605669|NCT00590044|DKA|dka
605760|NCT00590447|CHOP|chop
606847|NCT00601081|HMF|hmf
606942|NCT00607113|Avastin|avastin
607550|NCT00613093|Temodar|temodar
609379|NCT00619944|HIV|hiv
609449|NCT00620217|FGF|fgf
611590|NCT00619645|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
611591|NCT00619645|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
611592|NCT00619645|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
611593|NCT00619645|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
611594|NCT00619645|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
611595|NCT00619645|secondary acute myeloid leukemia|secondary acute myeloid leukemia
611757|NCT00629577|cervical cancer|cervical cancer
611772|NCT00629629|Morbidity|morbidity
612906|NCT00633295|GIST|gist
614452|NCT00636909|AML|aml
615883|NCT00645775|Leptin|leptin
616849|NCT00648232|HIV|hiv
616894|NCT00650741|FMD|fmd
617235|NCT00651885|UT-15C|ut-15c
619595|NCT00653536|stroke|stroke
619963|NCT00660946|INR|inr
620505|NCT00662766|Fiber|fiber
621003|NCT00665288|CPR|cpr
622095|NCT00669045|AMI|ami
622179|NCT00669422|ChemoFx|chemofx
622403|NCT00664053|balance|balance
623361|NCT00673114|MDS|mds
624013|NCT00677014|HF|hf
625711|NCT00682877|Stomach|stomach
627679|NCT00690976|gay|gay
629613|NCT00701246|growth|growth
632254|NCT00702598|RCT|rct
633034|NCT00714402|UTI|uti
633124|NCT00706134|placebo|placebo
633221|NCT00706576|HCC|hcc
633513|NCT00707850|Hepatitis C|hepatitis c
636210|NCT00724126|IBS|ibs
637378|NCT00721578|Safety|safety
637865|NCT00732485|PPAR|ppar
638054|NCT00733109|CIN2|cin2
638369|NCT00725673|BMD|bmd
638456|NCT00726050|HV|hv
639445|NCT00736463|statin|statin
641559|NCT00747383|GLP1|glp1
641812|NCT00738660|ARB|arb
642042|NCT00739401|AAA|aaa
643962|NCT00751361|AMD|amd
644441|NCT00752999|SLE|sle
646740|NCT00756912|BMT|bmt
646847|NCT00757315|AK|ak
648462|NCT00771719|VAP|vap
649572|NCT00774163|reuteri|reuteri
649682|NCT00774592|HIV|hiv
649764|NCT00774852|SLE|sle
650804|NCT00780806|MnB|mnb
652130|NCT00779402|PSA|psa
652744|NCT00795093|GERD|gerd
655201|NCT00791648|aki|aki
656079|NCT00801658|SLT|slt
657700|NCT00808444|Safety|safety
657623|NCT00808080|AML|aml
658150|NCT00810095|Left sided weakness|left sided weakness
658151|NCT00810095|Right Sided weakness|right sided weakness
658152|NCT00810108|HIV/AIDS|hiv/aids
659411|NCT00814398|IVF|ivf
664190|NCT00825357|sepsis|sepsis
664789|NCT00834782|PK|pk
667278|NCT00847691|sarcoma|sarcoma
667668|NCT00841256|SIT|sit
669532|NCT00853827|CAD|cad
670282|NCT00856440|SCI|sci
670390|NCT00856856|CAD|cad
671446|NCT00860756|sleep|sleep
672051|NCT00865683|DHA|dha
672641|NCT00867542|ECC|ecc
673238|NCT00871533|Surrogate Endpoints|surrogate endpoints
673239|NCT00871533|Surrogate Marker|surrogate marker
673240|NCT00871533|Surrogate Markers|surrogate markers
673241|NCT00871533|Viral Marker|viral marker
673242|NCT00871533|Viral Markers|viral markers
673244|NCT00871585|bicalutamide|bicalutamide
673383|NCT00862433|HV|hv
673653|NCT00863395|itch|itch
674548|NCT00874237|QTc|qtc
675283|NCT00876018|physical performance|physical performance
675284|NCT00876018|micronutrients|micronutrients
675285|NCT00876018|physical fitness|physical fitness
675480|NCT00876798|SIADH|siadh
676932|NCT00883688|Avastin|avastin
677240|NCT00884949|LSD|lsd
677422|NCT00885651|SNP|snp
677559|NCT00886249|Eye|eye
678081|NCT00881335|flutter|flutter
678157|NCT00881712|Non-small cell lung Cancer|non-small cell lung cancer
678158|NCT00881712|Proton Radiation|proton radiation
678159|NCT00881712|Stage III|stage iii
678160|NCT00881725|Metformin|metformin
678161|NCT00881725|Prostate Cancer|prostate cancer
678828|NCT00890097|GA|ga
679280|NCT00891293|Lovaza|lovaza
679842|NCT00893997|MDS|mds
680141|NCT00895765|Kidney|kidney
680756|NCT00897715|CKD|ckd
683047|NCT00894816|Obesity|obesity
685208|NCT00901836|Sarcoma|sarcoma
685916|NCT00914953|empathy|empathy
686418|NCT00907127|CAN|can
687041|NCT00919893|male|male
689428|NCT00925652|CM|cm
690907|NCT00930371|diet|diet
691197|NCT00931619|HV|hv
691296|NCT00931957|Uveitis|uveitis
691950|NCT00937742|Tomato|tomato
692088|NCT00929214|RT|rt
692465|NCT00939991|GBM|gbm
693155|NCT00934908|ALL|all
695036|NCT00949390|CAM|cam
695382|NCT00941733|BTK|btk
695689|NCT00953160|Thigh|thigh
696407|NCT00946231|BNP|bnp
696545|NCT00946374|TBI|tbi
698009|NCT00951288|AMD|amd
698504|NCT00952354|MLU|mlu
699247|NCT00964847|yoga|yoga
699621|NCT00965588|vaccine|vaccine
699721|NCT00966329|Tropism|tropism
699936|NCT00967252|surgery|surgery
700008|NCT00967434|statins|statins
700217|NCT00968253|G-CSF|g-csf
700859|NCT00962715|CLL|cll
702736|NCT00968760|SLL|sll
702296|NCT00975689|NPC|npc
703595|NCT00980174|male|male
704382|NCT00982904|africa|africa
705525|NCT00979173|Duke|duke
705633|NCT00985621|OA|oa
708144|NCT00989235|NOS|nos
709246|NCT00993733|hemodiafiltration|hemodiafiltration
710716|NCT01005875|HCC|hcc
711008|NCT01007058|Fluorescence in situ hybridization|fluorescence in situ hybridization
711009|NCT01007058|FISH|fish
711010|NCT01007084|pain|pain
711011|NCT01007084|trauma|trauma
711012|NCT01007084|propranolol|propranolol
711013|NCT01007097|Diabetes Mellitus, Non Insulin Dependent|diabetes mellitus, non insulin dependent
711014|NCT01007097|Diabetes Mellitus, Type II|diabetes mellitus, type ii
711015|NCT01007097|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
711016|NCT01007097|Drug Therapy|drug therapy
711017|NCT01007110|DHA|dha
711018|NCT01007123|Chronic idiopathic constipation|chronic idiopathic constipation
712276|NCT01016093|BMT|bmt
713162|NCT01011998|CML|cml
713569|NCT01021423|CC-5013|cc-5013
713685|NCT01021956|CNV|cnv
714648|NCT01010490|SAFETY|safety
716117|NCT01021098|flu|flu
716202|NCT01027052|MDA|mda
716494|NCT01028898|IBS|ibs
717165|NCT01032330|IXT|ixt
718064|NCT01037452|PPI|ppi
718960|NCT01039597|IBD|ibd
720087|NCT01043991|Epo|epo
720588|NCT01049984|UPDRS|updrs
721768|NCT01054053|Menbvac|menbvac
722338|NCT01046682|HIV|hiv
722759|NCT01047735|fitness|fitness
723457|NCT01055717|oat|oat
724730|NCT01061554|Omega-3|omega-3
724920|NCT01062334|Anastomotic leakage after LAR|anastomotic leakage after lar
724921|NCT01062347|To identify a new bio-marker for zinc status|to identify a new bio-marker for zinc status
724926|NCT01062373|Human Milk|human milk
725518|NCT01069783|LDL|ldl
727978|NCT01074541|UV intensity|uv intensity
728075|NCT01074983|Prehospital, Oxygen, Trauma, Hypoxemia|prehospital, oxygen, trauma, hypoxemia
728076|NCT01074996|Pancreatic cancer|pancreatic cancer
728358|NCT01075919|Healthy young adults|healthy young adults
728360|NCT01075919|Mood|mood
728361|NCT01075932|cerebral blood flow|cerebral blood flow
728362|NCT01075932|NIRS|nirs
728391|NCT01076101|SLE|sle
728655|NCT01085552|Ethnic|ethnic
729230|NCT01073592|HMP|hmp
730406|NCT01080846|PPH|pph
730713|NCT01081834|Placebo|placebo
731372|NCT01077154|Adjuvant treatment|adjuvant treatment
731373|NCT01077154|Neoadjuvant treatment|neoadjuvant treatment
731374|NCT01077154|Denosumab|denosumab
731375|NCT01077154|Stage II breast cancer|stage ii breast cancer
731434|NCT01077310|HIV|hiv
731910|NCT01078883|Dyspnea|dyspnea
732014|NCT01093716|Craving|craving
732200|NCT01094496|hCG|hcg
732776|NCT01082445|stage C|stage c
734098|NCT01092949|MRI|mri
735013|NCT01096745|S-1|s-1
735432|NCT01104207|TMS|tms
735759|NCT01105845|HV|hv
737431|NCT01113125|keloid|keloid
738391|NCT01116375|OSA|osa
739325|NCT01119768|GI|gi
739641|NCT01121549|NIS|nis
739827|NCT01122303|Autologous serum eye drops|autologous serum eye drops
739829|NCT01122303|TGF-β1|tgf-β1
739830|NCT01122303|TGF-β2|tgf-β2
739831|NCT01122303|Fibronectin|fibronectin
739833|NCT01122303|Dry eye|dry eye
741168|NCT01121146|CT|ct
742477|NCT01126645|HCC|hcc
745409|NCT01144260|CLL|cll
748219|NCT01156740|amoxicillin|amoxicillin
748220|NCT01156740|intramuscular benzathine penicillin G.|intramuscular benzathine penicillin g.
748221|NCT01156753|CR011-vcMMAE|cr011-vcmmae
748222|NCT01156753|locally advanced breast cancer|locally advanced breast cancer
748225|NCT01156753|CDX-011|cdx-011
748517|NCT01150578|Echocardiography, 2D|echocardiography, 2d
748518|NCT01150578|speckle tracking|speckle tracking
748519|NCT01150578|Lexiscan|lexiscan
748596|NCT01150929|RSA|rsa
748608|NCT01150955|NAFLD|nafld
749270|NCT01159899|genou|genou
751025|NCT01168167|MK 0518|mk 0518
751734|NCT01164423|ICU|icu
752503|NCT01167452|PCP|pcp
752836|NCT01174394|Stroke|stroke
751957|NCT01171339|cluster-randomised controlled trial|cluster-randomised controlled trial
751958|NCT01171339|pragmatic trial|pragmatic trial
751959|NCT01171352|hemodialysis|hemodialysis
751960|NCT01171352|dialysis|dialysis
751961|NCT01171352|hypotension|hypotension
751962|NCT01171352|CritLine|critline
751963|NCT01171352|PiCCO|picco
751964|NCT01171352|Thermodilution|thermodilution
751965|NCT01171352|CVVHDF|cvvhdf
751966|NCT01171352|IHD|ihd
751969|NCT01171365|Therapeutic Uses|therapeutic uses
751970|NCT01171365|Pulmonary Eosinophilia|pulmonary eosinophilia
751971|NCT01171365|Nitric Oxide|nitric oxide
751972|NCT01171365|Lung Diseases|lung diseases
751973|NCT01171365|Respiratory Tract Diseases|respiratory tract diseases
751974|NCT01171378|Richter's Syndrome|richter's syndrome
751975|NCT01171378|High-grade transformation in patients with B cell chronic lymphocytic leukemia|high-grade transformation in patients with b cell chronic lymphocytic leukemia
751976|NCT01171378|Feasibility|feasibility
751977|NCT01171378|Ofatumumab Induction and maintenance|ofatumumab induction and maintenance
751978|NCT01171378|CHOP|chop
751979|NCT01171378|CHOP-0|chop-0
751980|NCT01171378|CHOP-OR|chop-or
751981|NCT01171378|Non Hodgkin's lymphoma|non hodgkin's lymphoma
751982|NCT01171391|Nocturia|nocturia
751983|NCT01171391|Pharmacokinetics|pharmacokinetics
751984|NCT01171391|Pharmacodynamics|pharmacodynamics
751985|NCT01171391|Water-loading|water-loading
751986|NCT01171391|Females|females
751987|NCT01171404|Acute coronary syndrome|acute coronary syndrome
751988|NCT01171404|heart attack|heart attack
751989|NCT01171404|myocardial infarction|myocardial infarction
751990|NCT01171404|ACS long-tem follow up|acs long-tem follow up
751991|NCT01171404|antithrombotic management|antithrombotic management
751992|NCT01171404|quality of life|quality of life
751993|NCT01171404|Antithrombotic|antithrombotic
751994|NCT01171417|Fulvestrant|fulvestrant
751995|NCT01171417|Exemestane|exemestane
751996|NCT01171417|postmenopausal patients|postmenopausal patients
751997|NCT01171417|advanced HR+ breast cancer|advanced hr+ breast cancer
751998|NCT01171417|Hormone Receptor positive|hormone receptor positive
751999|NCT01171417|advanced breast cancer|advanced breast cancer
752000|NCT01171430|multiple myeloma|multiple myeloma
752001|NCT01171430|Autologous Stem Cell Transplantation|autologous stem cell transplantation
752003|NCT01171456|Gestational Diabetes|gestational diabetes
752004|NCT01171456|Diabetes|diabetes
752005|NCT01171456|Pregnancy|pregnancy
752006|NCT01171469|Brain tumor|brain tumor
752007|NCT01171469|Immunotherapy|immunotherapy
752008|NCT01171469|Glioma|glioma
752009|NCT01171495|HIV/AIDS|hiv/aids
752010|NCT01171495|Nutrition Therapy|nutrition therapy
752011|NCT01171495|Dietary Supplement|dietary supplement
752012|NCT01171495|Antioxidant|antioxidant
752013|NCT01171495|Immunity|immunity
752015|NCT01171495|Anthropometry|anthropometry
752016|NCT01171495|Body Mass Index|body mass index
752017|NCT01171508|Circadian Rhythm Disorders|circadian rhythm disorders
752018|NCT01171508|Breast Neoplasms Surgery|breast neoplasms surgery
752019|NCT01171508|Sleep|sleep
752020|NCT01171508|Heart Rate|heart rate
752021|NCT01171547|pharmacokinetics|pharmacokinetics
752022|NCT01171560|EZ Blocker|ez blocker
752023|NCT01171560|Double-lumen Tube|double-lumen tube
752024|NCT01171560|Airway|airway
752025|NCT01171560|thoracic surgery|thoracic surgery
752026|NCT01171560|time for intubation|time for intubation
752027|NCT01171560|blind insertion|blind insertion
752028|NCT01171560|conditions of surgery|conditions of surgery
752029|NCT01171560|postoperative sore throat|postoperative sore throat
752030|NCT01171560|postoperative hoarseness|postoperative hoarseness
752031|NCT01171573|Polymyositis|polymyositis
752032|NCT01171573|Dermatomyositis|dermatomyositis
752033|NCT01171573|Inclusion Body Myositis|inclusion body myositis
752034|NCT01171586|Obesity|obesity
752035|NCT01171586|overweight|overweight
752036|NCT01171586|weight loss|weight loss
753928|NCT01178307|Quality of Life|quality of life
752037|NCT01171586|weight maintenance|weight maintenance
752038|NCT01171586|SMS|sms
752039|NCT01171586|technology|technology
752040|NCT01171586|cell phone|cell phone
752041|NCT01171586|physical activity|physical activity
752042|NCT01171586|nutrition|nutrition
752043|NCT01171599|Weight Loss|weight loss
752044|NCT01171599|Obesity|obesity
752045|NCT01171599|Overweight|overweight
752046|NCT01171599|Physical Activity|physical activity
752047|NCT01171599|Nutrition|nutrition
752048|NCT01171599|Youth|youth
752049|NCT01171599|Adolescent|adolescent
752050|NCT01171599|Technology|technology
752051|NCT01171612|Coronary Stent|coronary stent
752052|NCT01171612|BMS stent|bms stent
752053|NCT01171612|DES stent|des stent
752054|NCT01171612|Date of stent implantation|date of stent implantation
752055|NCT01171612|cardiac event|cardiac event
752056|NCT01171612|neurovascular event|neurovascular event
752057|NCT01171612|Bleeding|bleeding
752058|NCT01171612|transfusion|transfusion
752059|NCT01171625|PERIMOUNT, Aortic valve replacement/regurgitation|perimount, aortic valve replacement/regurgitation
752060|NCT01171638|near infrared spectroscopy|near infrared spectroscopy
752061|NCT01171638|compartment syndrome|compartment syndrome
752062|NCT01171638|fasciotomy|fasciotomy
752068|NCT01171651|Primary Hepatocellular Carcinoma|primary hepatocellular carcinoma
752069|NCT01171651|Primary Liver Cancer|primary liver cancer
752071|NCT01171651|Sorafenib|sorafenib
752072|NCT01171651|Nexavar|nexavar
752079|NCT01171677|cognitive function|cognitive function
752080|NCT01171677|mood|mood
752081|NCT01171677|self efficacy|self efficacy
752082|NCT01171690|Hypoparathyroidism|hypoparathyroidism
752083|NCT01171703|Critical limb ischemia|critical limb ischemia
752084|NCT01171703|Diabetes|diabetes
752085|NCT01171703|Femoropopliteal artery bypass|femoropopliteal artery bypass
752086|NCT01171703|Stent|stent
752087|NCT01171716|overweight, protein intake, satiety, eating, meal patterns|overweight, protein intake, satiety, eating, meal patterns
752088|NCT01171729|Prostate cancer|prostate cancer
752089|NCT01171729|PSA|psa
752090|NCT01171729|Hormone refractory prostatic cancer|hormone refractory prostatic cancer
752091|NCT01171768|Vascular endothelial growth factor|vascular endothelial growth factor
752092|NCT01171768|angiopoietin-2|angiopoietin-2
752093|NCT01171807|Ulcerative colitis|ulcerative colitis
752094|NCT01171807|Steroid-dependency|steroid-dependency
752095|NCT01171807|Steroid adverse events|steroid adverse events
752096|NCT01171807|Erythrocytes|erythrocytes
752097|NCT01171820|drug eluting stents|drug eluting stents
752098|NCT01171820|stents|stents
752099|NCT01171820|Angioplasty|angioplasty
752100|NCT01171820|coronary artery disease|coronary artery disease
752101|NCT01171820|total coronary occlusion|total coronary occlusion
752102|NCT01171820|coronary artery restenosis|coronary artery restenosis
752103|NCT01171820|stent thrombosis|stent thrombosis
752104|NCT01171820|vascular disease|vascular disease
752105|NCT01171820|myocardial ischemia|myocardial ischemia
752106|NCT01171820|coronary artery stenosis|coronary artery stenosis
752107|NCT01171833|Anesthetic induction|anesthetic induction
752108|NCT01171833|Desflurane|desflurane
752109|NCT01171833|Isoflurane|isoflurane
752110|NCT01171833|Sevoflurane|sevoflurane
752111|NCT01171833|Ventilation|ventilation
752112|NCT01171846|prevention|prevention
752113|NCT01171846|pelvic floor muscle training|pelvic floor muscle training
752114|NCT01171846|prolapse symptoms|prolapse symptoms
752115|NCT01171846|urinary symptoms|urinary symptoms
752116|NCT01171846|sexual function|sexual function
752117|NCT01171846|randomised controlled trial|randomised controlled trial
752118|NCT01171859|amyloidosis|amyloidosis
752119|NCT01171859|transthyretin|transthyretin
752120|NCT01171859|doxycycline|doxycycline
752121|NCT01171859|Tauroursodeoxycholic acid|tauroursodeoxycholic acid
752122|NCT01171872|Inflammatory Bowel Disease|inflammatory bowel disease
752123|NCT01171872|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
752124|NCT01171872|Crohn's Disease|crohn's disease
752125|NCT01171872|Ulcerative Colitis|ulcerative colitis
752126|NCT01171872|Indeterminate Colitis|indeterminate colitis
752127|NCT01171872|IBD|ibd
752128|NCT01171872|CD|cd
752129|NCT01171872|UC|uc
752130|NCT01171872|IC|ic
752131|NCT01171885|Superficial cervical block|superficial cervical block
752132|NCT01171885|Thyroidectomy|thyroidectomy
752133|NCT01171885|Pain|pain
752134|NCT01171898|Non-Metastatic|non-metastatic
752135|NCT01171898|Rising PSA|rising psa
752136|NCT01171898|Castration-Resistant|castration-resistant
752137|NCT01171898|Treatment-Naive|treatment-naive
752138|NCT01171898|Post-abiraterone|post-abiraterone
752139|NCT01171911|Endothelial shear stress|endothelial shear stress
752140|NCT01171911|Calcium channel blocker|calcium channel blocker
752141|NCT01171924|Head and Neck Cancer|head and neck cancer
752142|NCT01171924|Liver Cancer|liver cancer
752143|NCT01171924|Breast Cancer|breast cancer
752144|NCT01171924|Gastric Cancer|gastric cancer
752145|NCT01171924|Non-Small Cell Lung Cancer|non-small cell lung cancer
752146|NCT01171924|EGFR|egfr
752147|NCT01171924|HDAC|hdac
752148|NCT01171924|Her2|her2
752149|NCT01171924|CUDC-101|cudc-101
752150|NCT01171937|ages 8-16|ages 8-16
752151|NCT01171937|Repetitive Behaviors|repetitive behaviors
752152|NCT01171950|Thoratec Corporation|thoratec corporation
752153|NCT01171963|Liquid human retrovirus vaccine|liquid human retrovirus vaccine
752154|NCT01171976|DME|dme
752155|NCT01171976|Diabetic macula edema|diabetic macula edema
752156|NCT01171976|RETAIN|retain
752157|NCT01171976|ranibizumab|ranibizumab
752158|NCT01171989|booster vaccination|booster vaccination
752159|NCT01171989|combined vaccine|combined vaccine
752160|NCT01172002|Lupus Nephritis|lupus nephritis
752161|NCT01172002|Leflunomide|leflunomide
752162|NCT01172002|Azathioprine|azathioprine
752163|NCT01172028|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
752164|NCT01172028|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
752165|NCT01172028|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
752166|NCT01172028|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
752167|NCT01172028|male breast cancer|male breast cancer
752168|NCT01172028|stage IIIA breast cancer|stage iiia breast cancer
752169|NCT01172028|stage IIIB breast cancer|stage iiib breast cancer
752170|NCT01172028|stage IIIC breast cancer|stage iiic breast cancer
752179|NCT01172028|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
752180|NCT01172028|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
752181|NCT01172028|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
752182|NCT01172028|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
752183|NCT01172028|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
752184|NCT01172028|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
752185|NCT01172028|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
752186|NCT01172028|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
752187|NCT01172028|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
752188|NCT01172028|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
752189|NCT01172028|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
752190|NCT01172028|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
752191|NCT01172028|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
752192|NCT01172028|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
752193|NCT01172028|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
752194|NCT01172028|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
752195|NCT01172028|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
752196|NCT01172028|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
752197|NCT01172028|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
752382|NCT01172743|Diabetes|diabetes
752198|NCT01172028|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
752199|NCT01172028|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
752200|NCT01172028|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
752201|NCT01172028|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
752202|NCT01172028|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
752203|NCT01172028|recurrent salivary gland cancer|recurrent salivary gland cancer
752204|NCT01172028|stage III salivary gland cancer|stage iii salivary gland cancer
752205|NCT01172028|stage IV salivary gland cancer|stage iv salivary gland cancer
752206|NCT01172028|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
752207|NCT01172028|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
752208|NCT01172028|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
752209|NCT01172028|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
752210|NCT01172028|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
752211|NCT01172028|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
752212|NCT01172028|stage III gastric cancer|stage iii gastric cancer
752213|NCT01172028|stage IV gastric cancer|stage iv gastric cancer
752214|NCT01172028|recurrent gastric cancer|recurrent gastric cancer
752215|NCT01172028|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
752216|NCT01172028|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
752217|NCT01172028|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
752218|NCT01172028|recurrent laryngeal cancer|recurrent laryngeal cancer
752219|NCT01172028|stage III laryngeal cancer|stage iii laryngeal cancer
752220|NCT01172028|stage IV laryngeal cancer|stage iv laryngeal cancer
752221|NCT01172054|influenza vaccine recombinant|influenza vaccine recombinant
751715|NCT01164371|acute coronary syndrome|acute coronary syndrome
751716|NCT01164371|coronary death|coronary death
751717|NCT01164371|unheralded acute coronary syndrome|unheralded acute coronary syndrome
751718|NCT01164371|unheralded coronary death|unheralded coronary death
751719|NCT01164371|gender differences|gender differences
751720|NCT01164371|sex differences|sex differences
751721|NCT01164371|myocardial infarction|myocardial infarction
751722|NCT01164371|ST elevation myocardial infarction|st elevation myocardial infarction
751723|NCT01164371|non ST elevation myocardial infarction|non st elevation myocardial infarction
751724|NCT01164371|STEMI|stemi
751725|NCT01164371|nSTEMI|nstemi
751726|NCT01164371|unstable angina|unstable angina
751727|NCT01164397|Hypercholesterolemia|hypercholesterolemia
751728|NCT01164397|Statins|statins
751729|NCT01164423|algorithm|algorithm
751730|NCT01164423|tight glycemic control|tight glycemic control
751731|NCT01164423|glucose control|glucose control
751732|NCT01164423|intensive care|intensive care
751733|NCT01164423|insulin|insulin
751735|NCT01164449|algorithm|algorithm
751736|NCT01164449|tight glycemic control|tight glycemic control
751737|NCT01164449|glucose control|glucose control
751738|NCT01164449|intensive care|intensive care
751739|NCT01164449|insulin|insulin
751740|NCT01164449|ICU|icu
751741|NCT01164514|bacterial sepsis, septicemia, vaccine|bacterial sepsis, septicemia, vaccine
751742|NCT01164540|Deep venous thrombosis|deep venous thrombosis
751743|NCT01164540|Pulmonary embolism|pulmonary embolism
751744|NCT01164540|rosuvastatin treatment|rosuvastatin treatment
751745|NCT01164553|influenza, pediatric, vaccine|influenza, pediatric, vaccine
751746|NCT01164579|Early Rheumatoid Arthritis|early rheumatoid arthritis
751747|NCT01164579|Joint Structure|joint structure
751748|NCT01164579|Magnetic Resonance Imaging|magnetic resonance imaging
751749|NCT01164579|Janus Kinase (JAK) Inhibitor|janus kinase (jak) inhibitor
751750|NCT01164579|Tasocitinib|tasocitinib
751751|NCT01164579|Tofacitinib|tofacitinib
751752|NCT01164592|Heart failure (HF)|heart failure (hf)
751753|NCT01164592|Sleep disordered breathing (SDB)|sleep disordered breathing (sdb)
754132|NCT01179100|lidocaine|lidocaine
752222|NCT01172067|CRT|crt
752223|NCT01172067|heart failure|heart failure
752224|NCT01172067|optimization|optimization
752225|NCT01172067|Timing cycle optimization methods|timing cycle optimization methods
752226|NCT01172080|colonoscopy|colonoscopy
752227|NCT01172080|adherence|adherence
752228|NCT01172080|reminders|reminders
752229|NCT01172080|quality|quality
752230|NCT01172093|obstructive sleep apnea|obstructive sleep apnea
752231|NCT01172093|prevalence|prevalence
752232|NCT01172093|diabetes mellitus|diabetes mellitus
752233|NCT01172093|Chinese|chinese
752234|NCT01172106|Postpartum psychosis|postpartum psychosis
752235|NCT01172106|Perceived social support|perceived social support
752236|NCT01172106|Family psychoeducation|family psychoeducation
752237|NCT01172119|Coronary Disease, Coronary Stenosis, Angioplasty, Coronary restenosis, Drug Eluting Stent|coronary disease, coronary stenosis, angioplasty, coronary restenosis, drug eluting stent
752238|NCT01172132|Leukemia|leukemia
752239|NCT01172132|Lymphoma|lymphoma
752070|NCT01171651|Liver Cancer|liver cancer
752452|NCT01173029|Stroke|stroke
752580|NCT01167777|CT|ct
752983|NCT01175018|Heart Failure|heart failure
753562|NCT01176721|NMS|nms
753955|NCT01178385|Anxiety|anxiety
752240|NCT01172132|Bone-Marrow Transplant|bone-marrow transplant
752241|NCT01172132|Neutropenia|neutropenia
752242|NCT01172132|Acute respiratory failure|acute respiratory failure
752341|NCT01172574|Kyphosis|kyphosis
752243|NCT01172132|Mechanical ventilation|mechanical ventilation
752244|NCT01172132|Post ICU burden|post icu burden
752245|NCT01172132|ICU triage|icu triage
752246|NCT01172132|Dialysis|dialysis
752250|NCT01172145|activities of daily living performance|activities of daily living performance
752251|NCT01172145|caregiver burden|caregiver burden
752252|NCT01172158|forgotten ureteral stents, SMS Reminder|forgotten ureteral stents, sms reminder
752253|NCT01172171|Ischemia-reperfusion injury|ischemia-reperfusion injury
752254|NCT01172171|Acute Myocardial Infarction|acute myocardial infarction
752255|NCT01172171|Intracoronary melatonin|intracoronary melatonin
752256|NCT01172184|Left atrial distensibility|left atrial distensibility
752257|NCT01172184|Left ventricular filling pressure|left ventricular filling pressure
752258|NCT01172184|Severe mitral regurgitation|severe mitral regurgitation
752259|NCT01172184|Prognosis|prognosis
752260|NCT01172184|Post-operation (mitral valve replacement or valvuloplasty) atrial fibrillation|post-operation (mitral valve replacement or valvuloplasty) atrial fibrillation
752261|NCT01172197|local anesthetic|local anesthetic
752262|NCT01172197|levobupivacaine|levobupivacaine
752263|NCT01172197|ropivacaine|ropivacaine
752264|NCT01172197|femoral perineural block|femoral perineural block
752265|NCT01172223|HER2-positive|her2-positive
752266|NCT01172223|early breast cancer|early breast cancer
752267|NCT01172249|Osteoarthritis|osteoarthritis
752268|NCT01172249|Knee|knee
752269|NCT01172249|Glucosamine|glucosamine
752270|NCT01172249|Chondroitin|chondroitin
752271|NCT01172262|Tinnitus|tinnitus
752272|NCT01172262|MRI|mri
752273|NCT01172262|fMRI|fmri
752274|NCT01172262|task based MRI|task based mri
752275|NCT01172262|Otolaryngology|otolaryngology
752276|NCT01172275|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
752277|NCT01172275|OCD|ocd
752278|NCT01172288|Tic disorders,|tic disorders,
752279|NCT01172288|Tourette syndrome|tourette syndrome
752280|NCT01172288|Chronic Tic Disorders|chronic tic disorders
752281|NCT01172301|CF|cf
752282|NCT01172301|protein metabolism|protein metabolism
752283|NCT01172301|essential amino acid intake|essential amino acid intake
752284|NCT01172314|NSCLC|nsclc
752285|NCT01172314|Weight loss|weight loss
752286|NCT01172314|protein metabolism|protein metabolism
752287|NCT01172314|essential amino acid intake|essential amino acid intake
752288|NCT01172340|behavioral|behavioral
752289|NCT01172340|diet|diet
752290|NCT01172340|exercise|exercise
752291|NCT01172353|contras-induced nephropathy|contras-induced nephropathy
752292|NCT01172366|Open label, single dose, pharmacokinetic study|open label, single dose, pharmacokinetic study
752293|NCT01172405|Headache|headache
752294|NCT01172405|Migraine|migraine
752295|NCT01172405|Ibuprofen|ibuprofen
752296|NCT01172405|Caffeine|caffeine
752297|NCT01172418|adult|adult
752298|NCT01172418|primary kidney transplant recipient|primary kidney transplant recipient
752299|NCT01172431|hypertension|hypertension
752300|NCT01172431|renal insufficiency|renal insufficiency
752301|NCT01172431|indapamide|indapamide
752302|NCT01172431|hydrochlorothiazide|hydrochlorothiazide
752303|NCT01172444|Mild to Moderate Ulcerative Proctitis|mild to moderate ulcerative proctitis
752304|NCT01172457|low back pain|low back pain
752305|NCT01172457|failed back surgery syndrome (FBSS)|failed back surgery syndrome (fbss)
752306|NCT01172457|epidural fibrosis|epidural fibrosis
752307|NCT01172457|ozone therapy|ozone therapy
752308|NCT01172457|oxygen therapy|oxygen therapy
752309|NCT01172457|epiduroscopy|epiduroscopy
752310|NCT01172457|spinal endoscopy|spinal endoscopy
752311|NCT01172470|Recurrent head and neck cancer|recurrent head and neck cancer
752312|NCT01172470|larynx, lip, oral cavity and pharynx|larynx, lip, oral cavity and pharynx
752313|NCT01172483|primary care|primary care
752314|NCT01172483|physical and aquatic exercises|physical and aquatic exercises
752315|NCT01172483|promotion physical activity|promotion physical activity
752316|NCT01172483|chronic disorders|chronic disorders
752317|NCT01172509|plasticity|plasticity
752318|NCT01172509|excitatory|excitatory
752319|NCT01172509|inhibitory|inhibitory
752320|NCT01172509|synaptic plasticity|synaptic plasticity
752321|NCT01172509|R-Baclofen|r-baclofen
752322|NCT01172509|TMS|tms
752323|NCT01172509|transcranial magnetic stimulation|transcranial magnetic stimulation
752324|NCT01172509|biomarker|biomarker
752325|NCT01172509|autism|autism
752326|NCT01172522|Under eye dark circles|under eye dark circles
752327|NCT01172522|Under eye puffiness|under eye puffiness
752328|NCT01172535|Lopinavir/ritonavir|lopinavir/ritonavir
752471|NCT01173146|Primary prostate cancer undergoing prostatectomy|primary prostate cancer undergoing prostatectomy
752472|NCT01173159|Parenteral Nutrition|parenteral nutrition
752473|NCT01173159|Cholestasis|cholestasis
752474|NCT01173172|Boron neutron capture therapy (BNCT)|boron neutron capture therapy (bnct)
752475|NCT01173172|Head and neck cancer|head and neck cancer
752476|NCT01173172|toxicities|toxicities
752477|NCT01173172|response rate|response rate
752478|NCT01173198|LOW TO MODERATE MYOPIC PATIENTS|low to moderate myopic patients
752479|NCT01173211|pregnant, women, influenza, vaccine|pregnant, women, influenza, vaccine
752480|NCT01173224|influenza, DAS181, antiviral|influenza, das181, antiviral
752481|NCT01173237|tracheal intubation|tracheal intubation
752482|NCT01173237|proseal laryngeal mask airway|proseal laryngeal mask airway
752483|NCT01173237|neonate|neonate
752484|NCT01173237|surfactant|surfactant
752485|NCT01173237|respiratory distress syndrome|respiratory distress syndrome
752486|NCT01173250|total proctocolectomy with ileal pouch anal anastomosis with and without ileostomy|total proctocolectomy with ileal pouch anal anastomosis with and without ileostomy
752487|NCT01167426|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
752488|NCT01167426|RRMS|rrms
752489|NCT01167426|Clinically Isolated Syndrome|clinically isolated syndrome
752491|NCT01167426|Copaxone|copaxone
752492|NCT01167426|glatiramer acetate|glatiramer acetate
752493|NCT01167426|Autoject 2|autoject 2
752494|NCT01167439|OPMD, dysphagia|opmd, dysphagia
752495|NCT01167439|Dysphagia severity|dysphagia severity
752496|NCT01167439|Nutritional state|nutritional state
752497|NCT01167439|Speech quality|speech quality
752498|NCT01167439|Upper esophageal sphincter myotomy|upper esophageal sphincter myotomy
752499|NCT01167452|Obesity|obesity
752500|NCT01167452|Pharmacokinetics|pharmacokinetics
752501|NCT01167452|MRSA|mrsa
752502|NCT01167452|Tuberculosis|tuberculosis
752504|NCT01167465|Diaper Dermatitis|diaper dermatitis
752505|NCT01167465|Diaper Rash|diaper rash
752506|NCT01167465|Erythema|erythema
752507|NCT01167478|Exercise|exercise
752508|NCT01167478|Caffeine|caffeine
752509|NCT01167478|Reserve|reserve
752510|NCT01167491|Wegener|wegener
752511|NCT01167491|CD4+ T cells|cd4+ t cells
752512|NCT01167491|DAP12|dap12
752513|NCT01167491|NKG2D|nkg2d
752514|NCT01167504|saliva|saliva
752515|NCT01167504|food|food
752516|NCT01167504|sensory|sensory
752517|NCT01167504|oral health|oral health
752518|NCT01167504|film|film
752519|NCT01167504|pellicle|pellicle
752520|NCT01167517|Breast milk|breast milk
752521|NCT01167517|Feeding|feeding
752522|NCT01167517|Prematurity|prematurity
752523|NCT01167517|Low birth weight infant|low birth weight infant
752524|NCT01167517|Low maternal breast milk feeding|low maternal breast milk feeding
752525|NCT01167530|Everolimus|everolimus
752526|NCT01167530|Radiotherapy|radiotherapy
752527|NCT01167530|Chemotherapy|chemotherapy
752528|NCT01167556|Family intervention|family intervention
752529|NCT01167556|Recent-onset schizophrenia|recent-onset schizophrenia
752530|NCT01167556|Motivational Interviewing|motivational interviewing
752531|NCT01167556|Cannabis use|cannabis use
752532|NCT01167569|Free Radicals|free radicals
752533|NCT01167569|Ascorbic Acid|ascorbic acid
752534|NCT01167569|Cardiac Surgery|cardiac surgery
752535|NCT01167569|Prevention of Reperfusion Injury|prevention of reperfusion injury
752536|NCT01167582|blood transfusion|blood transfusion
752537|NCT01167582|red blood cell transfusion|red blood cell transfusion
752538|NCT01167582|myocardial infarction|myocardial infarction
752539|NCT01167582|acute coronary syndrome|acute coronary syndrome
752540|NCT01167582|anemia|anemia
752541|NCT01167595|Critically ill|critically ill
752542|NCT01167595|Nutrition therapy|nutrition therapy
752543|NCT01167595|Enteral nutrition|enteral nutrition
752544|NCT01167608|Parkinson's disease|parkinson's disease
752545|NCT01167608|Depression|depression
752546|NCT01167608|Anxiety|anxiety
752547|NCT01167608|Treatment|treatment
752548|NCT01167621|Refractory Acute Respiratory Distress Syndrome|refractory acute respiratory distress syndrome
752549|NCT01167621|Indexed Extra-vascular Lung Water|indexed extra-vascular lung water
752550|NCT01167621|HFO-ventilation|hfo-ventilation
752551|NCT01167634|Weight Loss|weight loss
752552|NCT01167634|Motivation|motivation
752553|NCT01167634|Contracts|contracts
752554|NCT01167647|Tuberculosis, culture, bronchoscopy|tuberculosis, culture, bronchoscopy
752555|NCT01167660|Coagulation tests|coagulation tests
752556|NCT01167660|Neonates|neonates
752557|NCT01167660|Non invasive|non invasive
752558|NCT01167673|irritable bowel syndrome|irritable bowel syndrome
752559|NCT01167673|selenium|selenium
752560|NCT01167673|curcumin|curcumin
752561|NCT01167673|green tea|green tea
752562|NCT01167686|Respiratory infection|respiratory infection
752563|NCT01167686|Viral infection|viral infection
752564|NCT01167686|Food supplement|food supplement
752565|NCT01167686|Goldtrain Plus (GT+)|goldtrain plus (gt+)
752566|NCT01167699|Oxycodone/naloxone|oxycodone/naloxone
752567|NCT01167699|patient preference|patient preference
752568|NCT01167699|WHO step I/II|who step i/ii
752569|NCT01167699|Moderate to severe non-malignant pain|moderate to severe non-malignant pain
752991|NCT01175057|feasibility|feasibility
752633|NCT01173406|Continuous Positive Airway Pressure treatment|continuous positive airway pressure treatment
752634|NCT01173406|Adherence|adherence
752635|NCT01173406|Education|education
752636|NCT01173419|Great Saphenous Vein|great saphenous vein
752637|NCT01173432|obstructive sleep apnea|obstructive sleep apnea
752638|NCT01173432|metabolic dysfunction|metabolic dysfunction
752639|NCT01173432|metabolic syndrome|metabolic syndrome
752640|NCT01173432|adipocyte fatty acid binding protein|adipocyte fatty acid binding protein
752641|NCT01173445|cancer|cancer
752642|NCT01173445|kidney|kidney
752643|NCT01173445|renal cell|renal cell
752644|NCT01173445|tumor cells|tumor cells
752645|NCT01173445|circulating tumor cells|circulating tumor cells
752646|NCT01173445|circulating endothelial cells|circulating endothelial cells
752647|NCT01173458|cancer|cancer
752648|NCT01173458|lung|lung
752649|NCT01173458|small cell|small cell
752650|NCT01173471|Raised intraocular pressure|raised intraocular pressure
752651|NCT01173484|Idiopathic gastroparesis|idiopathic gastroparesis
752652|NCT01173484|Vomiting|vomiting
752653|NCT01173484|Dyspepsia|dyspepsia
752654|NCT01173484|GERD|gerd
752655|NCT01173497|Triple negative breast cancer|triple negative breast cancer
752656|NCT01173497|Brain metastasis|brain metastasis
752657|NCT01173497|BSI-201|bsi-201
752658|NCT01173497|iniparib|iniparib
752659|NCT01173510|HIV|hiv
752660|NCT01173510|AIDS|aids
752661|NCT01173510|Atripla|atripla
752662|NCT01173510|Truvada|truvada
752663|NCT01173510|Raltegravir|raltegravir
752664|NCT01173510|Human Immunodeficiency Virus|human immunodeficiency virus
752665|NCT01173510|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
752666|NCT01173523|Hsp90 Inhibitor|hsp90 inhibitor
752667|NCT01173523|relapsed|relapsed
752668|NCT01173523|refractory|refractory
752669|NCT01173549|Canagliflozin|canagliflozin
752670|NCT01173549|Pharmacodynamic|pharmacodynamic
752671|NCT01173549|Glucose absorption|glucose absorption
752672|NCT01173549|Glucose metabolism|glucose metabolism
752673|NCT01173562|Healthy volunteers|healthy volunteers
752674|NCT01173562|Parasitic Diseases|parasitic diseases
752675|NCT01173562|Mebendazole (VERMOX)|mebendazole (vermox)
752676|NCT01173562|Anthelmintics|anthelmintics
752677|NCT01173562|Antiparasitic Agents|antiparasitic agents
752678|NCT01173562|Soil-transmitted helminth (STH) infections|soil-transmitted helminth (sth) infections
752679|NCT01173562|Pediatric|pediatric
752680|NCT01173588|bowel function|bowel function
752681|NCT01173588|functional foods|functional foods
752682|NCT01173718|Hemodialysis|hemodialysis
752683|NCT01173718|Vascular Graft|vascular graft
752684|NCT01173731|Parkinson Disease|parkinson disease
752685|NCT01173731|L-dopa|l-dopa
752686|NCT01173731|Levodopa|levodopa
752687|NCT01173731|Dyskinesia|dyskinesia
752688|NCT01173731|involuntary movement|involuntary movement
752689|NCT01173731|motor complication|motor complication
752690|NCT01173744|Intertrochanteric femoral fractures - unstable|intertrochanteric femoral fractures - unstable
752691|NCT01173757|Healthy Volunteers|healthy volunteers
752692|NCT01173783|Heart failure|heart failure
752693|NCT01173783|Cardiac insufficiency|cardiac insufficiency
752694|NCT01173783|Implantable Cardioverter/Defibrillator|implantable cardioverter/defibrillator
752695|NCT01173783|Cardiac Resynchronization therapy|cardiac resynchronization therapy
752696|NCT01173783|ICD|icd
752697|NCT01173783|CRT|crt
752698|NCT01173783|Register|register
752699|NCT01173809|AF|af
752700|NCT01173809|Catheter Ablation|catheter ablation
752701|NCT01173809|Recurrence of AF|recurrence of af
752702|NCT01173809|Amiodarone|amiodarone
752703|NCT01173822|cardiopulmonary bypass|cardiopulmonary bypass
752704|NCT01173822|hemorrhage|hemorrhage
752705|NCT01173822|trials|trials
752706|NCT01173822|surgery|surgery
752707|NCT01173835|Adolescent tobacco use|adolescent tobacco use
752708|NCT01173835|Tobacco Free and Win|tobacco free and win
752709|NCT01173835|Incentive-based intervention|incentive-based intervention
752710|NCT01173835|Contingency Management|contingency management
752711|NCT01173835|Smoking Prevention|smoking prevention
752712|NCT01173835|Smoking cessation|smoking cessation
752713|NCT01173848|CKD|ckd
752714|NCT01173848|Vitamin D|vitamin d
752715|NCT01173874|Cognition|cognition
752716|NCT01173874|Function|function
752717|NCT01173874|Attention|attention
752718|NCT01173874|Vigilance|vigilance
752719|NCT01173874|Verbal Memory|verbal memory
752720|NCT01173874|Visual Memory|visual memory
752721|NCT01173874|Processing Speed|processing speed
752722|NCT01173874|Problem Solving|problem solving
752723|NCT01173874|Social Cognition|social cognition
752724|NCT01173900|human papillomavirus|human papillomavirus
752725|NCT01173900|vaccine|vaccine
752726|NCT01173900|school girls|school girls
752727|NCT01173900|Tanzania|tanzania
752728|NCT01173900|acceptability|acceptability
752729|NCT01173900|vaccine coverage|vaccine coverage
752730|NCT01173900|Cervical cancer prevention|cervical cancer prevention
752731|NCT01173913|oral docetaxel|oral docetaxel
752732|NCT01173913|ModraDoc|modradoc
752733|NCT01173913|pharmacokinetics|pharmacokinetics
752734|NCT01173913|safety|safety
752737|NCT01173939|Hypercholesterolemia with concomitant type 2 diabetes and hypertension|hypercholesterolemia with concomitant type 2 diabetes and hypertension
752738|NCT01173978|Incretin hormones|incretin hormones
752740|NCT01173978|Insulin/c-peptide|insulin/c-peptide
752741|NCT01173978|Plasma glucose|plasma glucose
752742|NCT01173978|Insulin resistance|insulin resistance
752743|NCT01173978|Deteriorated glucose homeostasis|deteriorated glucose homeostasis
752744|NCT01173978|Inactivity|inactivity
752745|NCT01173991|carbohydrate counting|carbohydrate counting
752746|NCT01173991|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
752747|NCT01173991|type 1 diabetes mellitus|type 1 diabetes mellitus
752751|NCT01174017|seed migration in the first month after brachytherapy|seed migration in the first month after brachytherapy
752752|NCT01174043|Leukemia, Myelomonocytic, Acute|leukemia, myelomonocytic, acute
752753|NCT01174043|Erlotinib|erlotinib
752754|NCT01174056|Lung inflammation|lung inflammation
752755|NCT01174056|positron emission tomography|positron emission tomography
752756|NCT01174056|fluorodeoxyglucose|fluorodeoxyglucose
752757|NCT01174056|rosiglitazone|rosiglitazone
752758|NCT01174056|zileuton|zileuton
752759|NCT01174056|lung anti-inflammatory therapy|lung anti-inflammatory therapy
752761|NCT01174069|cholecystectomy|cholecystectomy
752762|NCT01174069|endoscopic|endoscopic
752763|NCT01174082|Multiple Myeloma|multiple myeloma
752764|NCT01174082|Vaccine|vaccine
752765|NCT01174082|Lymphocyte Infusion|lymphocyte infusion
752766|NCT01174095|Diffuse Coronary Artery Disease|diffuse coronary artery disease
752767|NCT01174095|Ischemic Myocardium|ischemic myocardium
752768|NCT01174095|Ischemia|ischemia
752769|NCT01174108|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
752770|NCT01174108|Severe Aplastic Anemia|severe aplastic anemia
752771|NCT01174108|Pure Red Cell Aplasia|pure red cell aplasia
752772|NCT01174108|Paroxysmal Nocturnal Hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
752773|NCT01174108|Miltenyi CD34 Reagent System|miltenyi cd34 reagent system
752774|NCT01174108|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
752775|NCT01174121|Digestive Tract Cancers|digestive tract cancers
752776|NCT01174121|Breast Cancer|breast cancer
752777|NCT01174121|Cell Therapy|cell therapy
752778|NCT01174121|Ovarian/Endometrial Cancer|ovarian/endometrial cancer
752779|NCT01174121|Urothelial Cancers|urothelial cancers
752780|NCT01174160|Atrial Fibrillation|atrial fibrillation
752781|NCT01174173|Angina|angina
752782|NCT01174173|Right Ventricular Ischemia|right ventricular ischemia
752931|NCT01174810|PD|pd
752783|NCT01174173|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
752784|NCT01174173|Pulmonary Hypertension|pulmonary hypertension
752785|NCT01174212|revision|revision
752786|NCT01174212|infection|infection
752787|NCT01174212|knee|knee
752788|NCT01174212|hip|hip
752789|NCT01174212|replacement|replacement
752790|NCT01174212|antibiotics|antibiotics
752791|NCT01174225|Copper IUD|copper iud
752792|NCT01174225|Nova T 200|nova t 200
752793|NCT01174225|Flexi T 380|flexi t 380
752794|NCT01174225|expulsion|expulsion
752795|NCT01174225|contraception satisfaction|contraception satisfaction
752796|NCT01174225|post-abortion contraception|post-abortion contraception
752797|NCT01174238|Melanoma|melanoma
752798|NCT01174238|Axitinib|axitinib
752799|NCT01174238|Carboplatin|carboplatin
752800|NCT01174238|Paclitaxel|paclitaxel
752801|NCT01174251|general anesthesia|general anesthesia
752802|NCT01174251|electrocardiography|electrocardiography
752803|NCT01174251|long QT syndrome, acquired|long qt syndrome, acquired
752804|NCT01174277|chronic graft versus host disease|chronic graft versus host disease
752805|NCT01174277|transplant|transplant
752806|NCT01174277|stem cell|stem cell
752807|NCT01174290|subsyndromal delirium|subsyndromal delirium
752808|NCT01174290|delirium|delirium
752809|NCT01174290|haloperidol|haloperidol
752810|NCT01174290|antipsychotic|antipsychotic
752811|NCT01174290|randomized controlled trial|randomized controlled trial
752812|NCT01174290|placebo-controlled|placebo-controlled
752813|NCT01174290|intensive care unit|intensive care unit
752814|NCT01174290|critical care|critical care
752815|NCT01174290|subsyndromal delirium in the intensive care unit|subsyndromal delirium in the intensive care unit
752816|NCT01174316|Acute exacerbation|acute exacerbation
752817|NCT01174316|Respiratory insufficiency|respiratory insufficiency
752818|NCT01174316|Respiratory failure|respiratory failure
752819|NCT01174316|Hypercapnia|hypercapnia
752820|NCT01174316|Hypoventilation|hypoventilation
752821|NCT01174316|Sleep|sleep
752822|NCT01174316|Hypoxia|hypoxia
752823|NCT01174316|Titration|titration
752824|NCT01174316|Non Invasive Ventilation|non invasive ventilation
752825|NCT01174342|Intraocular pressure|intraocular pressure
752826|NCT01174342|Ocular tonometry|ocular tonometry
752827|NCT01174342|Obstetric delivery|obstetric delivery
752828|NCT01174381|Non communicable disease|non communicable disease
752829|NCT01174381|Lifestyle Modification|lifestyle modification
752830|NCT01174381|Community Based organization|community based organization
752831|NCT01174381|community based study|community based study
752832|NCT01174394|Acupuncture|acupuncture
752833|NCT01174394|Post Stroke Depression|post stroke depression
752834|NCT01174394|Depressive Disorder|depressive disorder
752835|NCT01174394|Cardiovascular Accident|cardiovascular accident
752885|NCT01174615|Blood/bone marrow collection, hematologic diseases, leukemia|blood/bone marrow collection, hematologic diseases, leukemia
752886|NCT01174628|Exercise Tolerance|exercise tolerance
752887|NCT01174628|Venous Thrombosis|venous thrombosis
752888|NCT01174628|Pulmonary Embolism|pulmonary embolism
752889|NCT01174628|Quality of Life (QOL)|quality of life (qol)
752890|NCT01174641|unilateral neglect|unilateral neglect
752891|NCT01174641|TMS intervention|tms intervention
752892|NCT01174667|Myofascial pain|myofascial pain
752893|NCT01174667|Trigger points|trigger points
752894|NCT01174680|cardiogoniometry|cardiogoniometry
752895|NCT01174680|stable angina pectoris patients|stable angina pectoris patients
752896|NCT01174693|prospective|prospective
752897|NCT01174693|randomized|randomized
752898|NCT01174693|open label|open label
752899|NCT01174693|multi-center|multi-center
752900|NCT01174693|double-blind for CYP2C19 genotypes|double-blind for cyp2c19 genotypes
752901|NCT01174706|infections|infections
752902|NCT01174706|flu|flu
752903|NCT01174706|abdominal pain|abdominal pain
752904|NCT01174706|chest pain|chest pain
752905|NCT01174706|cold|cold
752906|NCT01174706|fever|fever
752907|NCT01174706|different acute care conditions|different acute care conditions
752908|NCT01174719|Hydroxyethylstarch|hydroxyethylstarch
752909|NCT01174719|Humanalbumin|humanalbumin
752910|NCT01174719|Ringer Lactate|ringer lactate
752911|NCT01174719|patients undergoing cardiac surgery|patients undergoing cardiac surgery
752912|NCT01174732|asthma|asthma
752913|NCT01174732|bronchospasm|bronchospasm
752914|NCT01174732|COPD|copd
752915|NCT01174732|chronic respiratory disease|chronic respiratory disease
752916|NCT01174758|balance|balance
752917|NCT01174758|mobility|mobility
752918|NCT01174758|ON/OFF Levodopa|on/off levodopa
752919|NCT01174771|Transcranial magnetic stimulation|transcranial magnetic stimulation
752920|NCT01174771|Cortical excitability|cortical excitability
752921|NCT01174771|parkinsonism|parkinsonism
752922|NCT01174771|Progressive Supranuclear Palsy|progressive supranuclear palsy
752923|NCT01174771|Corticobasal Degeneration|corticobasal degeneration
752924|NCT01174771|PSP|psp
752925|NCT01174771|CBD|cbd
752926|NCT01174771|CBGD|cbgd
752927|NCT01174784|Chronic Total Occlusions|chronic total occlusions
752928|NCT01174784|Superficial Femoral Artery|superficial femoral artery
752929|NCT01174784|Popliteal Artery|popliteal artery
752930|NCT01174810|Parkinson's Disease|parkinson's disease
752932|NCT01174810|Moderate Parkinson's Disease|moderate parkinson's disease
752933|NCT01174836|CT utilization|ct utilization
752934|NCT01174836|physician attitudes|physician attitudes
752935|NCT01174849|otitis media|otitis media
752936|NCT01174849|pneumococcal vaccines|pneumococcal vaccines
752937|NCT01174849|randomised controlled trial|randomised controlled trial
752938|NCT01174849|high-risk children|high-risk children
752939|NCT01174849|indigenous|indigenous
752940|NCT01174849|Australia|australia
752942|NCT01174862|aspirin responsiveness|aspirin responsiveness
752943|NCT01174862|long-term outcome|long-term outcome
752944|NCT01174862|CABG|cabg
752945|NCT01174875|Epigenetics|epigenetics
752946|NCT01174875|Development|development
752947|NCT01174875|Metabolic|metabolic
752948|NCT01174875|Neurodevelopment|neurodevelopment
752949|NCT01174888|Acute Myeloid Leukemia|acute myeloid leukemia
752950|NCT01174888|AML|aml
752951|NCT01174901|cephalalgia|cephalalgia
752952|NCT01174901|copeptins|copeptins
752953|NCT01174901|biomarkers|biomarkers
752954|NCT01174901|headache|headache
752955|NCT01174901|C-terminal provasopression|c-terminal provasopression
752956|NCT01174901|physiological stress response|physiological stress response
752957|NCT01174927|Substance use disorder|substance use disorder
752958|NCT01174927|Stress|stress
752959|NCT01174940|myelogenous leukemia|myelogenous leukemia
752960|NCT01174940|lymphocytic leukemia|lymphocytic leukemia
752961|NCT01174940|lymphoblastic leukemia|lymphoblastic leukemia
752962|NCT01174940|myelodysplastic syndrome|myelodysplastic syndrome
752963|NCT01174940|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
752964|NCT01174940|Hodgkin's disease|hodgkin's disease
752965|NCT01174953|prostate cancer|prostate cancer
752966|NCT01174966|oxygen challenge test|oxygen challenge test
752967|NCT01174966|shock|shock
752968|NCT01174966|mortality|mortality
752969|NCT01174966|Oxygen Delivery Index|oxygen delivery index
752970|NCT01174966|cardiac output index|cardiac output index
752971|NCT01174979|Morbus Meniere|morbus meniere
752972|NCT01174979|Sudden hearing loss|sudden hearing loss
752973|NCT01174979|Blast injury|blast injury
752974|NCT01174979|Presbyacusis|presbyacusis
752975|NCT01174979|Chron. Otitis Media|chron. otitis media
752976|NCT01174992|Fibrin sealant|fibrin sealant
752977|NCT01174992|CSF leak|csf leak
752978|NCT01175005|Fever|fever
752979|NCT01175005|Central venous catheter|central venous catheter
752980|NCT01175005|Procalcitonin|procalcitonin
752981|NCT01175005|Fever with a central venous catheter|fever with a central venous catheter
752982|NCT01175018|Acute myocardial infarction|acute myocardial infarction
752984|NCT01175018|Cardiac Remodeling|cardiac remodeling
752985|NCT01175044|Revision|revision
752986|NCT01175044|Knee|knee
753035|NCT01175174|metacholine provocation test|metacholine provocation test
753036|NCT01175174|pediatric emergency department|pediatric emergency department
753037|NCT01175187|evron|evron
753038|NCT01175226|Human rhinovirus|human rhinovirus
753039|NCT01175226|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
753040|NCT01175226|Aviragen Therapeutics|aviragen therapeutics
753041|NCT01175226|Aviragen|aviragen
753042|NCT01175239|X-linked severe combined immunodeficiency, gene therapy|x-linked severe combined immunodeficiency, gene therapy
753043|NCT01175239|Patients will be enrolled following diagnosis and referral to Great Ormond Street Immunology Service.|patients will be enrolled following diagnosis and referral to great ormond street immunology service.
753044|NCT01175252|Gastroenteritis|gastroenteritis
753045|NCT01175265|clinically stable|clinically stable
753046|NCT01175265|COPD (GOLD-classification I-IV)|copd (gold-classification i-iv)
753047|NCT01175265|COPD|copd
753048|NCT01175265|breathing retraining|breathing retraining
753049|NCT01175265|pulmonary rehabilitation|pulmonary rehabilitation
753050|NCT01175265|cardiac autonomic function|cardiac autonomic function
753051|NCT01175265|quality of life|quality of life
753052|NCT01175265|exercise capacity|exercise capacity
753053|NCT01175265|pulmonary function|pulmonary function
753054|NCT01175278|vertebral|vertebral
753055|NCT01175278|compression|compression
753056|NCT01175278|fracture|fracture
753057|NCT01175278|VCF|vcf
753058|NCT01175278|kyphoplasty|kyphoplasty
753059|NCT01175278|spine|spine
753060|NCT01175291|colon|colon
753061|NCT01175291|rectum|rectum
753062|NCT01175291|colorectal|colorectal
753063|NCT01175291|metastatic|metastatic
753064|NCT01175291|adenocarcinoma|adenocarcinoma
753065|NCT01175304|sleep|sleep
753066|NCT01175304|sleep apnea|sleep apnea
753067|NCT01175304|work|work
753068|NCT01175304|sleep habits|sleep habits
753069|NCT01175304|sleepiness|sleepiness
753070|NCT01175317|Hemodynamic optimization|hemodynamic optimization
753071|NCT01175317|Enhanced recovery after surgery|enhanced recovery after surgery
753072|NCT01175317|Goal-directed fluid|goal-directed fluid
753073|NCT01175330|Omega-3 fatty acid|omega-3 fatty acid
753074|NCT01175330|Ischemic Heart Disease|ischemic heart disease
753075|NCT01175330|Atrial Fibrillation|atrial fibrillation
753177|NCT01175772|Ovary|ovary
753076|NCT01175330|Subcutaneous cardiac monitoring|subcutaneous cardiac monitoring
753077|NCT01175369|Asthma|asthma
753082|NCT01175395|Choroidal neovascular membranes|choroidal neovascular membranes
753083|NCT01175395|CNV|cnv
753084|NCT01175395|AMD|amd
753085|NCT01175395|Age-relate Macular Degeneration|age-relate macular degeneration
753086|NCT01175395|CNVM|cnvm
753087|NCT01175395|subfoveal|subfoveal
753088|NCT01175408|Remote Blood Glucose Monitoring System,|remote blood glucose monitoring system,
753089|NCT01175408|Continuous Glucose Monitoring System,|continuous glucose monitoring system,
753090|NCT01175408|Self Monitoring Blood Glucose,|self monitoring blood glucose,
753091|NCT01175408|Strip Counting,|strip counting,
753092|NCT01175408|Type 2 Diabetes|type 2 diabetes
753093|NCT01175421|snoring|snoring
753094|NCT01175421|sleep apnea|sleep apnea
753095|NCT01175421|sleep study|sleep study
753096|NCT01175421|cardiovascular outcomes|cardiovascular outcomes
753097|NCT01175434|Asthma|asthma
753098|NCT01175447|S-1|s-1
753099|NCT01175447|radiation|radiation
753100|NCT01175447|esophageal Cancer|esophageal cancer
753101|NCT01175460|esophageal Cancer|esophageal cancer
753102|NCT01175460|radiation|radiation
753103|NCT01175460|s-1|s-1
753104|NCT01175460|nedaplatin|nedaplatin
753105|NCT01175486|thiazolidinediones|thiazolidinediones
753106|NCT01175486|diabetes|diabetes
753107|NCT01175486|retinopathy|retinopathy
753108|NCT01175486|nephropathy|nephropathy
753109|NCT01175499|laryngoscopy|laryngoscopy
753110|NCT01175499|Laryngoscopic Surgery|laryngoscopic surgery
753111|NCT01175499|laryngoscopes|laryngoscopes
753112|NCT01175499|upper aerodigestive tract lesions|upper aerodigestive tract lesions
753113|NCT01175499|endoscopy|endoscopy
753114|NCT01175499|biopsy|biopsy
753115|NCT01175538|Hepatic encephalopathy|hepatic encephalopathy
753116|NCT01175538|Lactulose|lactulose
753117|NCT01175551|Preterm Birth|preterm birth
753118|NCT01175551|Cervix|cervix
753119|NCT01175551|Cervical Shortening|cervical shortening
753120|NCT01175551|Cervical remodeling|cervical remodeling
753121|NCT01175551|PTB|ptb
753122|NCT01175564|TC-5214|tc-5214
753123|NCT01175564|safety|safety
753124|NCT01175564|pharmacokinetics|pharmacokinetics
753125|NCT01175564|single dose|single dose
753126|NCT01175564|repeated dose|repeated dose
753127|NCT01175564|Japanese|japanese
753128|NCT01175564|healthy subjects|healthy subjects
753129|NCT01175577|mixed carotenes|mixed carotenes
753130|NCT01175603|depression, African American, home visiting, prevention|depression, african american, home visiting, prevention
753131|NCT01175616|Depression|depression
753132|NCT01175616|Adults|adults
753133|NCT01175629|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
753134|NCT01175629|Depression|depression
753135|NCT01175629|Diabetes|diabetes
753136|NCT01175629|Cardiovascular Disease|cardiovascular disease
753137|NCT01175629|Depressive Disorder|depressive disorder
753138|NCT01175629|Behavioral Symptoms|behavioral symptoms
753149|NCT01175681|degenerated heart valve disease|degenerated heart valve disease
753150|NCT01175681|heart valve prolapse|heart valve prolapse
753151|NCT01175694|Brachytherapy|brachytherapy
753152|NCT01175694|APBI|apbi
753153|NCT01175694|dose modification|dose modification
753154|NCT01175694|local recurrences|local recurrences
753155|NCT01175694|side effects|side effects
753156|NCT01175694|cosmetic result|cosmetic result
753157|NCT01175720|gingival recession|gingival recession
753158|NCT01175720|acellular dermal matrix graft|acellular dermal matrix graft
753159|NCT01175720|root coverage|root coverage
753160|NCT01175733|Panitumumab|panitumumab
753161|NCT01175733|Chemoradiation|chemoradiation
753162|NCT01175733|Pancreatic cancer|pancreatic cancer
753163|NCT01175733|Locally advanced|locally advanced
753164|NCT01175733|Inoperable|inoperable
753165|NCT01175746|healthy adult patients|healthy adult patients
753166|NCT01175746|ASA class I|asa class i
753167|NCT01175746|hypotensive anesthesia|hypotensive anesthesia
753168|NCT01175759|Unexplained Recurrent Pregnancy Loss|unexplained recurrent pregnancy loss
753169|NCT01175759|Recurrent Abortions|recurrent abortions
753170|NCT01175759|Recurrent Miscarriages|recurrent miscarriages
753171|NCT01175759|Hormones|hormones
753172|NCT01175759|Skin tests|skin tests
753173|NCT01175759|Allergen|allergen
753174|NCT01175759|Immunotherapy|immunotherapy
753175|NCT01175759|Hypersensitivity|hypersensitivity
753176|NCT01175759|Skin reaction|skin reaction
753178|NCT01175772|Carcinoma|carcinoma
753179|NCT01175772|Maintenance|maintenance
753180|NCT01175772|Metronomic|metronomic
753181|NCT01175772|Chemotherapy|chemotherapy
753182|NCT01175772|Time to Progression|time to progression
753183|NCT01175772|overall survival|overall survival
753184|NCT01175798|Vitamin D deficiency|vitamin d deficiency
753207|NCT01175915|Mild type of hand, foot and mouth disease|mild type of hand, foot and mouth disease
753208|NCT01175915|Reduning Injection|reduning injection
753209|NCT01175915|Effectiveness|effectiveness
753210|NCT01175915|Safety|safety
753211|NCT01175928|Diabetic polyneuropathy|diabetic polyneuropathy
753212|NCT01175928|Pneumatic Compression Device|pneumatic compression device
753213|NCT01175954|Partial Epilepsy|partial epilepsy
753214|NCT01175967|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
753215|NCT01175967|perioperative/postoperative complications|perioperative/postoperative complications
753552|NCT01176721|split mind|split mind
753216|NCT01175967|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
753217|NCT01175967|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
753218|NCT01175993|Motor Training|motor training
753219|NCT01175993|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
753220|NCT01175993|Balance|balance
753221|NCT01176006|DOCK8|dock8
753222|NCT01176006|Molluscum|molluscum
753223|NCT01176006|Transplant|transplant
753224|NCT01176006|Immunodeficiency|immunodeficiency
753225|NCT01176019|Amniocentesis|amniocentesis
753226|NCT01176019|Chorionic Villus Sampling|chorionic villus sampling
753227|NCT01176019|First trimester screening|first trimester screening
753228|NCT01176019|Down syndrome|down syndrome
753229|NCT01176032|Aliskiren|aliskiren
753230|NCT01176032|hypertension|hypertension
753231|NCT01176032|concentric LVH|concentric lvh
753232|NCT01176032|LV remodeling|lv remodeling
753234|NCT01176032|biomarkers|biomarkers
753235|NCT01176032|PICP|picp
753236|NCT01176032|CT-1|ct-1
753237|NCT01176032|MMP-1|mmp-1
753238|NCT01176032|TIMP-1|timp-1
753239|NCT01176032|AnxA5|anxa5
753240|NCT01176032|Aldosterone|aldosterone
753241|NCT01176032|Essential hypertension with concentric left ventricle hypertrophy|essential hypertension with concentric left ventricle hypertrophy
753242|NCT01176045|Dry Eye Disease|dry eye disease
753243|NCT01176045|Osmolarity|osmolarity
753244|NCT01176045|Refractive Surgery|refractive surgery
753245|NCT01176045|Lasik|lasik
753246|NCT01176045|TearLab|tearlab
753247|NCT01176058|Phase 3b|phase 3b
753248|NCT01176058|Efficacy and Safety evaluation of Anidulafungin|efficacy and safety evaluation of anidulafungin
753249|NCT01176058|ICC|icc
753250|NCT01176071|galactomannan|galactomannan
753251|NCT01176071|beta-D-glucan|beta-d-glucan
753252|NCT01176071|aspergillosis|aspergillosis
753253|NCT01176071|outcome|outcome
753254|NCT01176084|low carbohydrate diet|low carbohydrate diet
753255|NCT01176084|obesity|obesity
753256|NCT01176084|moderate exercise|moderate exercise
753257|NCT01176084|men|men
753258|NCT01176097|First in man study evaluating AZD5658 in Type 2 Diabetics.|first in man study evaluating azd5658 in type 2 diabetics.
753259|NCT01176097|Effect of fasting|effect of fasting
753260|NCT01176097|Safety|safety
753261|NCT01176097|Tolerability|tolerability
753262|NCT01176110|hypothermia|hypothermia
753263|NCT01176110|minimal invasive valve replacement|minimal invasive valve replacement
753264|NCT01176123|Cognitive behavioral therapy|cognitive behavioral therapy
753265|NCT01176123|Insomnia|insomnia
753266|NCT01176123|Traumatic Stress|traumatic stress
753267|NCT01176136|ADHD|adhd
753268|NCT01176136|School-Based|school-based
753269|NCT01176136|Organizational Skills|organizational skills
753270|NCT01176136|Homework|homework
753273|NCT01176149|Self monitoring blood glucose|self monitoring blood glucose
753274|NCT01176162|Non Invasive measurement|non invasive measurement
753275|NCT01176162|Preterm infants|preterm infants
753276|NCT01176162|Aldosterone resistance|aldosterone resistance
753277|NCT01176175|Progesterone|progesterone
753278|NCT01176175|Microspheres|microspheres
753279|NCT01176175|postmenopausal|postmenopausal
753280|NCT01176175|Luteal phase support|luteal phase support
753281|NCT01176188|Pediatric Intensive Care Unit|pediatric intensive care unit
753282|NCT01176188|Environmental Stressors|environmental stressors
753283|NCT01176188|Sleep|sleep
753284|NCT01176188|Psychological Outcomes|psychological outcomes
753285|NCT01176188|Pediatrics|pediatrics
753286|NCT01170676|asthma|asthma
753287|NCT01170676|smoking|smoking
753288|NCT01170676|teens|teens
753289|NCT01170689|Schizophrenia|schizophrenia
753290|NCT01170689|inpatient|inpatient
753291|NCT01170689|obesity|obesity
753292|NCT01170689|prevalence|prevalence
753293|NCT01170702|Cesarean Delivery|cesarean delivery
753294|NCT01170702|Ropivicaine|ropivicaine
753295|NCT01170702|TAP block|tap block
753296|NCT01170715|Psoriasis|psoriasis
753297|NCT01170715|Co morbidities|co morbidities
753298|NCT01170715|Inflammation|inflammation
753299|NCT01170728|Male Sling|male sling
753300|NCT01170728|Fixation|fixation
753301|NCT01170728|Stress Urinary Incontinence|stress urinary incontinence
753302|NCT01170728|Urinary incontinence|urinary incontinence
753303|NCT01176201|SLV337|slv337
753304|NCT01176201|Diabetes|diabetes
753305|NCT01176201|Relative bioavailability|relative bioavailability
753306|NCT01176201|ADME|adme
753307|NCT01176214|supratentorial intracerebral hemorrhage|supratentorial intracerebral hemorrhage
753324|NCT01176240|standing/walking for a short time|standing/walking for a short time
753325|NCT01176240|standing/walking for a long time|standing/walking for a long time
753326|NCT01176240|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
753327|NCT01176240|falls|falls
753328|NCT01176240|NOH|noh
753329|NCT01176240|Parkinson's disease|parkinson's disease
753330|NCT01176240|weakness|weakness
753331|NCT01176253|Type I DM|type i dm
753332|NCT01176266|Hypophosphatasia|hypophosphatasia
753333|NCT01176266|HPP|hpp
753334|NCT01176266|Bone Disease|bone disease
753335|NCT01176266|Soft Bones|soft bones
753336|NCT01176266|Low Alkaline Phosphatase|low alkaline phosphatase
753337|NCT01176266|genetic metabolic disorder|genetic metabolic disorder
753338|NCT01176266|alkaline phosphatase|alkaline phosphatase
753339|NCT01176266|tissue-specific alkaline phosphatase (TNSALP)|tissue-specific alkaline phosphatase (tnsalp)
753340|NCT01176266|rickets|rickets
753341|NCT01176266|osteomalacia|osteomalacia
753342|NCT01176279|Critical illness|critical illness
753343|NCT01176279|Hyperglycemia|hyperglycemia
753344|NCT01176279|Catheters, Indwelling|catheters, indwelling
753345|NCT01176279|Intensive care unit|intensive care unit
753346|NCT01176292|total knee replacement|total knee replacement
753347|NCT01176292|high flexion|high flexion
753348|NCT01176292|range of motion|range of motion
753349|NCT01176292|rotating platform|rotating platform
753350|NCT01176292|TKA|tka
753351|NCT01176305|Thromboembolic event|thromboembolic event
753352|NCT01176318|cough|cough
753353|NCT01176318|exacerbation|exacerbation
753354|NCT01176318|quality of life|quality of life
753355|NCT01176344|Vitamin D supplementation|vitamin d supplementation
753356|NCT01176344|Osteoarthritis|osteoarthritis
753357|NCT01176344|Knee|knee
753358|NCT01176344|Randomised clinical trial (RCT)|randomised clinical trial (rct)
753359|NCT01176344|Cartilage|cartilage
753360|NCT01176344|MRI|mri
753361|NCT01176357|Coronary artery disease (CAD)|coronary artery disease (cad)
753362|NCT01176357|atherosclerosis|atherosclerosis
753363|NCT01176357|mediastinal adipose tissue|mediastinal adipose tissue
753364|NCT01176357|adiponectin, inflammatory mediators|adiponectin, inflammatory mediators
753365|NCT01176370|Heart Failure|heart failure
753366|NCT01176370|Device|device
753367|NCT01176370|Implantable|implantable
753368|NCT01176370|Active|active
753369|NCT01176370|Class III and Class IV|class iii and class iv
753370|NCT01176370|Counterpulsation|counterpulsation
753371|NCT01176383|Nicotine addiction|nicotine addiction
753372|NCT01176383|Behaviour|behaviour
753373|NCT01176383|Gene test|gene test
753374|NCT01176383|Lung cancer|lung cancer
753375|NCT01176383|Lifetime risk of lung cancer in smokers|lifetime risk of lung cancer in smokers
753376|NCT01176396|Dental Caries|dental caries
753377|NCT01176396|Preventive Dentistry|preventive dentistry
753378|NCT01176396|Dental Prophylaxis|dental prophylaxis
753379|NCT01176396|Dental Care|dental care
753380|NCT01176422|AML|aml
753381|NCT01176422|MDS|mds
753382|NCT01176435|Levodopa|levodopa
753383|NCT01176435|Albinism|albinism
753384|NCT01176435|Vision|vision
753385|NCT01176448|Cicatrix|cicatrix
753386|NCT01176448|Dermabrasion|dermabrasion
753387|NCT01176448|Coagulation, Laser|coagulation, laser
753388|NCT01176461|recurrent melanoma|recurrent melanoma
753389|NCT01176461|stage IIIA melanoma|stage iiia melanoma
753390|NCT01176461|stage IIIB melanoma|stage iiib melanoma
753395|NCT01176487|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
753396|NCT01176487|recurrent small cell lung cancer|recurrent small cell lung cancer
753397|NCT01176487|extensive stage small cell lung cancer|extensive stage small cell lung cancer
753398|NCT01176487|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
753399|NCT01176487|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
753400|NCT01176487|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
753401|NCT01176500|PET Imaging|pet imaging
753402|NCT01176500|(18F)Fluciclatide|(18f)fluciclatide
753403|NCT01176500|Anti-Angiogenic Therapies|anti-angiogenic therapies
753404|NCT01176500|Solid Tumors|solid tumors
753405|NCT01176513|Prostate Cancer|prostate cancer
753406|NCT01176513|MRI|mri
753407|NCT01176513|PET|pet
753408|NCT01176513|GE-148 (18F)|ge-148 (18f)
753409|NCT01176526|Coping|coping
753410|NCT01176526|Quality of Life|quality of life
753411|NCT01176526|Prostate Cancer|prostate cancer
753412|NCT01179191|chronic pain|chronic pain
753413|NCT01179191|Embeda|embeda
753414|NCT01179191|opioid|opioid
753415|NCT01179191|moderate pain|moderate pain
753416|NCT01179191|severe pain|severe pain
753417|NCT01179191|conversion|conversion
753418|NCT01179191|converting|converting
753419|NCT01179191|switching|switching
753420|NCT01179191|morphine|morphine
753421|NCT01179191|aberrant behavior|aberrant behavior
753422|NCT01179191|Pain (DT) + Chronic Disease (DT)|pain (dt) + chronic disease (dt)
753423|NCT01179217|Sickle Cell Anemia|sickle cell anemia
753431|NCT01179230|Myocardial perfusion imaging|myocardial perfusion imaging
753432|NCT01179243|microcirculatory alterations|microcirculatory alterations
753433|NCT01179243|SDF imaging|sdf imaging
753434|NCT01179256|ASTHMA|asthma
753435|NCT01179269|Non-small cell lung cancer|non-small cell lung cancer
753436|NCT01179269|Pazopanib|pazopanib
753437|NCT01179269|Stage IIIB/IV non small cell lung cancer|stage iiib/iv non small cell lung cancer
753438|NCT01179282|DUST MITE ALLERGIES|dust mite allergies
753439|NCT01179295|MEK inhibitor|mek inhibitor
753440|NCT01179295|BAY86-9766|bay86-9766
753441|NCT01179295|RDEA 119|rdea 119
753442|NCT01179295|Solid tumor|solid tumor
753443|NCT01179308|regional analgesia|regional analgesia
753926|NCT01178307|GIST|gist
753444|NCT01179308|routine general anesthesia|routine general anesthesia
753445|NCT01179308|immune system response|immune system response
753446|NCT01179308|lung cancer (stage 1-3)|lung cancer (stage 1-3)
753447|NCT01179334|Pulmonary Hypertension|pulmonary hypertension
753448|NCT01179334|Riociguat|riociguat
753449|NCT01179334|Blood Pressure|blood pressure
753450|NCT01179360|Locally advanced|locally advanced
753451|NCT01179360|HNSCC|hnscc
753452|NCT01179386|methylphenidate|methylphenidate
753453|NCT01179386|ADHD|adhd
753454|NCT01179386|driving|driving
753455|NCT01179386|simulator|simulator
753456|NCT01179386|pressure|pressure
753457|NCT01179386|adolescent|adolescent
753458|NCT01179425|marijuana|marijuana
753459|NCT01179425|dependence|dependence
753460|NCT01179425|cognition|cognition
753461|NCT01179425|stress|stress
753462|NCT01179477|Left heart pacing lead|left heart pacing lead
753463|NCT01179477|Cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
753464|NCT01179477|Heart failure|heart failure
753465|NCT01179490|Multiple Myeloma|multiple myeloma
753466|NCT01179503|vitamin D|vitamin d
753467|NCT01179503|physical performance|physical performance
753468|NCT01179516|Major Depressive Disorder|major depressive disorder
753469|NCT01179516|Depression|depression
753470|NCT01179516|Drug Therapy|drug therapy
753471|NCT01179529|Atopic dermatitis (atopic eczema)|atopic dermatitis (atopic eczema)
753472|NCT01179542|iugr pet eIF4E Translation Initiation Factor|iugr pet eif4e translation initiation factor
753473|NCT01179542|4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR|4e (eif4e) in human placental implantation and in the pathological pregnancies: preeclampsia and iugr
753474|NCT01179555|Diabetic Complications|diabetic complications
753475|NCT01179555|Intervention Studies|intervention studies
753476|NCT01179555|African Americans|african americans
753477|NCT01179555|Vision Screening|vision screening
753478|NCT01179555|Vision, Low|vision, low
753479|NCT01179555|Geriatric Assessment|geriatric assessment
753480|NCT01179555|Outcomes Assessment|outcomes assessment
753481|NCT01179555|Cultural Characteristics|cultural characteristics
753482|NCT01179555|Cultural Competency|cultural competency
753483|NCT01179555|Appointment Adherence|appointment adherence
753484|NCT01179555|Cost-effectiveness|cost-effectiveness
753485|NCT01179555|Personalization of care|personalization of care
753486|NCT01179555|Follow-up Care|follow-up care
753487|NCT01179568|Grief|grief
753488|NCT01179568|Bereavement|bereavement
753489|NCT01179568|Psychotherapy|psychotherapy
753490|NCT01179568|Medication|medication
753491|NCT01179568|Treatment study|treatment study
753492|NCT01179581|Safety|safety
753493|NCT01179581|Tolerability|tolerability
753494|NCT01179581|Pharmacokinetics|pharmacokinetics
753495|NCT01179620|Hemodialysis, Certoparin|hemodialysis, certoparin
753496|NCT01179646|Bioequivalency|bioequivalency
753497|NCT01179659|Single dose crossover BE study|single dose crossover be study
753498|NCT01179672|Diabetic Peripheral Neuropathic Pain|diabetic peripheral neuropathic pain
753499|NCT01179698|computer-assisted surgery|computer-assisted surgery
753500|NCT01179698|bone tumor|bone tumor
753501|NCT01179698|We will evaluate whether computer-assisted surgery|we will evaluate whether computer-assisted surgery
753502|NCT01179698|will be feasible and safe for bone tumor resection|will be feasible and safe for bone tumor resection
753503|NCT01179711|accommodative esotropia|accommodative esotropia
753504|NCT01173627|Bioequivalence|bioequivalence
753505|NCT01173627|Fentanyl|fentanyl
753506|NCT01173640|drug interactions|drug interactions
753507|NCT01173640|midazolam|midazolam
753508|NCT01173640|cytochrome P450|cytochrome p450
753509|NCT01173640|resveratrol|resveratrol
753510|NCT01173640|pharmacokinetics|pharmacokinetics
753511|NCT01173653|smoking|smoking
753512|NCT01173653|smoking cessation|smoking cessation
753513|NCT01173653|health behavior|health behavior
753514|NCT01173666|RAS|ras
753515|NCT01173666|LVMI|lvmi
753516|NCT01173666|Renal revascularization|renal revascularization
753517|NCT01173679|CLL|cll
753518|NCT01173679|fludarabine|fludarabine
753519|NCT01173679|rituximab|rituximab
753520|NCT01173679|dasatinib|dasatinib
753521|NCT01173679|refractory|refractory
753522|NCT01173679|relapsed|relapsed
753523|NCT01173692|Oropharynx Cancer|oropharynx cancer
753524|NCT01173692|Radiation Therapy|radiation therapy
753525|NCT01173692|XRT|xrt
753526|NCT01173692|Radiotherapy|radiotherapy
753527|NCT01173692|Minocycline|minocycline
753535|NCT01176682|Non-steroid anti-inflammatory drug (NSAID)|non-steroid anti-inflammatory drug (nsaid)
753536|NCT01176682|Gastrointestinal events (GI events)|gastrointestinal events (gi events)
753537|NCT01176682|Proton Pump Inhibitors (PPI)|proton pump inhibitors (ppi)
753538|NCT01176708|liver transplantation|liver transplantation
753539|NCT01176708|kidney transplanted|kidney transplanted
753540|NCT01176708|glucagon-like peptide-1|glucagon-like peptide-1
753541|NCT01176708|insulin secretion|insulin secretion
753542|NCT01176708|vagotomy|vagotomy
753543|NCT01176721|schizophrenic disorders|schizophrenic disorders
753544|NCT01176721|psychosis|psychosis
753545|NCT01176721|psychotic|psychotic
753546|NCT01176721|dementia|dementia
753547|NCT01176721|delusional|delusional
753548|NCT01176721|delusions|delusions
753549|NCT01176721|hallucinations|hallucinations
753550|NCT01176721|residual-type schizophrenia|residual-type schizophrenia
753551|NCT01176721|illusions|illusions
753553|NCT01176721|mental health disorder|mental health disorder
753554|NCT01176721|schizoid|schizoid
753555|NCT01176721|paranoid-type schizophrenia|paranoid-type schizophrenia
753556|NCT01176721|disorganized-type schizophrenia|disorganized-type schizophrenia
753557|NCT01176721|undifferentiated-type schizophrenia|undifferentiated-type schizophrenia
753558|NCT01176721|catatonic-type schizophrenia|catatonic-type schizophrenia
753559|NCT01176721|mental illness|mental illness
753560|NCT01176721|tardive dyskinesia|tardive dyskinesia
753561|NCT01176721|neuroleptic malignant syndrome|neuroleptic malignant syndrome
753563|NCT01176721|antipsychotics|antipsychotics
753564|NCT01176721|atypical antipsychotics|atypical antipsychotics
753565|NCT01176721|psychosocial treatments|psychosocial treatments
753566|NCT01176721|rehabilitation|rehabilitation
753567|NCT01176734|Pulsatile Tinnitus|pulsatile tinnitus
753568|NCT01176734|Ringing-Buzzing-Tinnitus|ringing-buzzing-tinnitus
753569|NCT01176734|Spontaneous Oto-Acoustic Emission Tinnitus|spontaneous oto-acoustic emission tinnitus
753570|NCT01176734|Tensor Palatini Induced Tinnitus|tensor palatini induced tinnitus
753571|NCT01176734|Tensor Tympani Induced Tinnitus|tensor tympani induced tinnitus
753572|NCT01176734|Tinnitus of Vascular Origin|tinnitus of vascular origin
753573|NCT01176734|Tinnitus, Clicking|tinnitus, clicking
753574|NCT01176734|Tinnitus, Leudet|tinnitus, leudet
753575|NCT01176734|Tinnitus, Leudet's|tinnitus, leudet's
753576|NCT01176734|Tinnitus, Noise Induced|tinnitus, noise induced
753577|NCT01176734|Tinnitus, Objective|tinnitus, objective
753578|NCT01176734|Tinnitus, Spontaneous Oto-Acoustic Emission|tinnitus, spontaneous oto-acoustic emission
753579|NCT01176734|Tinnitus, Subjective|tinnitus, subjective
753580|NCT01176734|Tinnitus, Tensor Palatini Induced|tinnitus, tensor palatini induced
753581|NCT01176734|Tinnitus, Tensor Tympani Induced|tinnitus, tensor tympani induced
753582|NCT01176734|Vascular Origin Tinnitus|vascular origin tinnitus
753583|NCT01176760|vagotomy|vagotomy
753584|NCT01176760|vagus|vagus
753585|NCT01176760|GLP-1|glp-1
753586|NCT01176760|Insulin secretion|insulin secretion
753587|NCT01176786|infection|infection
753588|NCT01176786|tissue expander|tissue expander
753589|NCT01176786|breast implant|breast implant
753590|NCT01176786|breast reconstruction|breast reconstruction
753591|NCT01176786|Infections rates|infections rates
753592|NCT01176799|Breast cancer patients with measurable primary breast cancer tumor.|breast cancer patients with measurable primary breast cancer tumor.
753593|NCT01176812|Facialwasting|facialwasting
753594|NCT01176812|Juvederm|juvederm
753595|NCT01176812|Restylane|restylane
753596|NCT01176825|bipolar disorder|bipolar disorder
753597|NCT01176825|cognitive behavior therapy|cognitive behavior therapy
753598|NCT01176825|alcohol abuse|alcohol abuse
753599|NCT01176825|drug abuse|drug abuse
753603|NCT01176838|Breast Cancer Quality of Life Survey|breast cancer quality of life survey
753604|NCT01176851|None (study in healthy volunteers)|none (study in healthy volunteers)
753605|NCT01176864|Small-Bowel Disorders|small-bowel disorders
753606|NCT01176864|Double-balloon enteroscopy|double-balloon enteroscopy
753607|NCT01176864|Single-balloon enteroscopy|single-balloon enteroscopy
753608|NCT01176890|truncal vagotomy|truncal vagotomy
753609|NCT01176890|GLP-1|glp-1
753610|NCT01176890|gastric emptying|gastric emptying
753611|NCT01176890|appetite|appetite
753612|NCT01176890|food intake|food intake
753613|NCT01176916|breast cancer|breast cancer
753614|NCT01176916|Aromasin|aromasin
753615|NCT01176916|adjuvant chemotherapy|adjuvant chemotherapy
753616|NCT01176916|endocrine therapy|endocrine therapy
753617|NCT01176929|Suicide, Attempted|suicide, attempted
753618|NCT01176929|prevention suicidal act|prevention suicidal act
753619|NCT01176929|telephone contact|telephone contact
753620|NCT01176929|professional coordination|professional coordination
753621|NCT01176955|Acne|acne
753622|NCT01176955|Acne vulgaris|acne vulgaris
753623|NCT01176955|Adherence|adherence
753624|NCT01176955|Compliance|compliance
753625|NCT01176955|MEMS|mems
753626|NCT01176955|Benzoyl peroxide|benzoyl peroxide
753627|NCT01176968|Eplerenone|eplerenone
753635|NCT01176994|Patients with skin lesions that are treated by dermatologists with destructive modalities without histological evaluation.|patients with skin lesions that are treated by dermatologists with destructive modalities without histological evaluation.
753636|NCT01177007|Gastrointestinal Diseases|gastrointestinal diseases
753637|NCT01177007|Colonic Diseases|colonic diseases
753638|NCT01177007|Intestinal Diseases|intestinal diseases
753639|NCT01177007|Rectal Diseases|rectal diseases
753640|NCT01177007|Neoplastic Processes|neoplastic processes
753641|NCT01177007|Pathologic Processes|pathologic processes
753642|NCT01177007|Neuroendocrine Tumors|neuroendocrine tumors
753643|NCT01177007|Neuroectodermal Tumors|neuroectodermal tumors
753644|NCT01177007|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
753645|NCT01177007|Adenocarcinoma|adenocarcinoma
753646|NCT01177007|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
753647|NCT01177007|Liver Diseases|liver diseases
753648|NCT01177007|Neoplasms|neoplasms
753649|NCT01177007|Carcinoma|carcinoma
753650|NCT01177007|Colorectal Neoplasms|colorectal neoplasms
753651|NCT01177007|Neoplasm Metastasis|neoplasm metastasis
753652|NCT01177007|Carcinoma, Neuroendocrine|carcinoma, neuroendocrine
753653|NCT01177007|Liver Neoplasms|liver neoplasms
753654|NCT01177007|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
753655|NCT01177007|Neoplasms by Histologic Type|neoplasms by histologic type
753656|NCT01177007|Intestinal Neoplasms|intestinal neoplasms
753657|NCT01177007|Gastrointestinal Neoplasms|gastrointestinal neoplasms
753658|NCT01177007|Digestive System Neoplasms|digestive system neoplasms
753659|NCT01177007|Neoplasms by Site|neoplasms by site
753660|NCT01177007|Digestive System Diseases|digestive system diseases
753661|NCT01177046|Women receiving labour epidural for most recent delivery|women receiving labour epidural for most recent delivery
753662|NCT01177059|Gene Therapy|gene therapy
753663|NCT01177059|Anti-HIV-1 Ribozyme|anti-hiv-1 ribozyme
753664|NCT01177059|OZ1|oz1
753665|NCT01177059|HIV-1 Infections|hiv-1 infections
753666|NCT01177072|PTSD|ptsd
753667|NCT01177085|obesity|obesity
753668|NCT01177085|weight|weight
753669|NCT01177085|weight-loss|weight-loss
753670|NCT01177085|mushroom|mushroom
753671|NCT01177085|oxidative|oxidative
753672|NCT01177085|stress|stress
753673|NCT01177085|immune|immune
753674|NCT01177085|function|function
753675|NCT01177085|inflammation|inflammation
753676|NCT01177124|Breast cancer|breast cancer
753677|NCT01177124|Survivors|survivors
753678|NCT01177124|Mindfulness-Based Stress Reduction (MBSR)|mindfulness-based stress reduction (mbsr)
753679|NCT01177124|Symptoms|symptoms
753680|NCT01177124|Immune markers|immune markers
753681|NCT01177137|tinnitus|tinnitus
753682|NCT01177137|tinnitus retraining therapy|tinnitus retraining therapy
753683|NCT01177137|standard of care|standard of care
753684|NCT01177137|directive counseling|directive counseling
753685|NCT01177137|sound therapy|sound therapy
753686|NCT01177137|tinnitus questionnaire|tinnitus questionnaire
753687|NCT01177137|tinnitus handicap inventory|tinnitus handicap inventory
753688|NCT01177150|Sodium-Glucose Transporter 2|sodium-glucose transporter 2
753689|NCT01177150|Canagliflozin|canagliflozin
753690|NCT01177150|Pharmacodynamic|pharmacodynamic
753691|NCT01177150|Pharmacokinetic|pharmacokinetic
753692|NCT01177150|Safety|safety
753693|NCT01177150|Tolerability|tolerability
753694|NCT01177163|Type 2 diabetes mellitus|type 2 diabetes mellitus
753695|NCT01177163|Canagliflozin|canagliflozin
753696|NCT01177163|JNJ-28431754|jnj-28431754
753697|NCT01177163|Insulin|insulin
753698|NCT01177163|Pharmacokinetic|pharmacokinetic
753699|NCT01177163|Pharmacodynamic|pharmacodynamic
753700|NCT01177163|SGLT-1|sglt-1
753701|NCT01177176|Cigarette smoking|cigarette smoking
753702|NCT01177176|Tobacco smoking|tobacco smoking
753703|NCT01177189|Oxidative Stress|oxidative stress
753704|NCT01177189|Free radicals|free radicals
753705|NCT01177189|Aging|aging
753710|NCT01177241|retrospective chronic low back pain|retrospective chronic low back pain
753711|NCT01177254|retrospective chronic low back pain|retrospective chronic low back pain
753712|NCT01177267|retrospective database analysis in osteoarthritis patients|retrospective database analysis in osteoarthritis patients
753713|NCT01177280|retrospective chronic low back pain|retrospective chronic low back pain
753714|NCT01177293|biological availability|biological availability
753715|NCT01177293|bioavailability|bioavailability
753716|NCT01177293|amlodipine|amlodipine
753717|NCT01177293|orally disintegrating tablet|orally disintegrating tablet
753718|NCT01177293|ODT|odt
753719|NCT01177293|tablets|tablets
753720|NCT01177306|ADHD, working memory|adhd, working memory
753721|NCT01177319|Parkinson's Disease|parkinson's disease
753722|NCT01177319|Glutathione|glutathione
753723|NCT01177332|FFA|ffa
753724|NCT01177332|Liver|liver
753725|NCT01177332|steatosis|steatosis
753726|NCT01177332|exercise|exercise
753727|NCT01177358|Scar|scar
753728|NCT01177358|Botox|botox
753729|NCT01177384|Type 2 diabetes mellitus|type 2 diabetes mellitus
753730|NCT01177384|T2DM|t2dm
753731|NCT01177397|Advanced solid malignant neoplasms,Non-Hodgkin Lymphoma,|advanced solid malignant neoplasms,non-hodgkin lymphoma,
753732|NCT01177397|Multiple Myeloma|multiple myeloma
753733|NCT01177410|IBS|ibs
753734|NCT01177410|Diarrhea|diarrhea
753735|NCT01177410|IBS-D|ibs-d
753736|NCT01177410|Irritable Bowel Syndrome|irritable bowel syndrome
753737|NCT01177410|Abdominal pain|abdominal pain
753738|NCT01177410|Bloating|bloating
753739|NCT01177423|restorative odontology|restorative odontology
753740|NCT01177423|Patients cared in restorative odontology department|patients cared in restorative odontology department
753741|NCT01177436|prostate cancer|prostate cancer
753742|NCT01177436|benign prostatic hypertrophy|benign prostatic hypertrophy
753743|NCT01177449|prolotherapy|prolotherapy
753744|NCT01177462|coordinate system|coordinate system
753745|NCT01177462|normal|normal
753746|NCT01177475|kidney-transplant recipients|kidney-transplant recipients
753747|NCT01177488|Military|military
753748|NCT01177488|Health Service Delivery|health service delivery
753749|NCT01177488|Behavioral Symptoms|behavioral symptoms
753750|NCT01177488|Telepsychology|telepsychology
753751|NCT01177488|Behavioral Activation|behavioral activation
753752|NCT01177488|Exposure Therapy|exposure therapy
753753|NCT01177488|Veterans|veterans
753754|NCT01177488|Telemedicine|telemedicine
753755|NCT01177501|Ovarian cancer|ovarian cancer
753756|NCT01177501|Topotecan|topotecan
753757|NCT01177501|Carboplatine|carboplatine
753758|NCT01177501|Higt dose chemotherapy|higt dose chemotherapy
753759|NCT01177514|Refractive surgery|refractive surgery
753760|NCT01177514|PRK|prk
753761|NCT01177514|PAIN|pain
753762|NCT01177514|Gabapentin|gabapentin
753763|NCT01177527|Waldenstrom|waldenstrom
753764|NCT01177527|myeloma|myeloma
753765|NCT01177527|smoldering|smoldering
753766|NCT01177527|lymphoma|lymphoma
753767|NCT01177527|MGUS|mgus
753768|NCT01177527|distinct B-cell lymphoproliferative disorder|distinct b-cell lymphoproliferative disorder
753769|NCT01177553|Intrauterine Growth Retardation in Monochorionic Twins|intrauterine growth retardation in monochorionic twins
753770|NCT01177566|Atopic dermatitis|atopic dermatitis
753771|NCT01177566|Elidel|elidel
753772|NCT01177566|pimecrolimus cream 1%|pimecrolimus cream 1%
753773|NCT01177566|Eletone|eletone
753774|NCT01177566|medical device cream|medical device cream
753775|NCT01177566|topical calcineurin inhibitor|topical calcineurin inhibitor
753776|NCT01177579|Bariatric surgery, copper deficiency, biomarkers|bariatric surgery, copper deficiency, biomarkers
753777|NCT01177618|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
753778|NCT01177618|COPD|copd
753779|NCT01177618|Emphysema|emphysema
753780|NCT01177618|Chronic Bronchitis|chronic bronchitis
753781|NCT01177618|Genetics|genetics
753782|NCT01177618|Association Studies|association studies
753783|NCT01177631|Carcinoma, hepatocellular|carcinoma, hepatocellular
753784|NCT01177631|Portal vein|portal vein
753785|NCT01177631|Proteomics|proteomics
753786|NCT01177670|Adiana Permanent Contraception System|adiana permanent contraception system
753787|NCT01177670|women seeking permanent sterilization.|women seeking permanent sterilization.
753788|NCT01177696|caregivers|caregivers
753789|NCT01177696|Family Health|family health
753790|NCT01177696|Psychotherapeutic|psychotherapeutic
753791|NCT01177696|Primary Health Care|primary health care
753792|NCT01177709|schizophrenia|schizophrenia
753793|NCT01177709|antipsychotics|antipsychotics
753794|NCT01177709|obesity|obesity
753795|NCT01177709|diabetes|diabetes
753796|NCT01177722|Diphtheria|diphtheria
753797|NCT01177722|Tetanus|tetanus
753798|NCT01177722|Whooping cough|whooping cough
753799|NCT01177722|Hepatitis B|hepatitis b
753800|NCT01177722|Poliomyelitis|poliomyelitis
753801|NCT01177722|Diphtheria-Tetanus-acellular Pertussis Vaccines|diphtheria-tetanus-acellular pertussis vaccines
753802|NCT01177735|Pomalidomide|pomalidomide
753803|NCT01177735|multiple myeloma|multiple myeloma
753804|NCT01177735|relapsed|relapsed
753805|NCT01177748|Stroke|stroke
753806|NCT01177748|Cardiac Monitoring|cardiac monitoring
753807|NCT01177761|Osteoporosis|osteoporosis
753817|NCT01177787|cryolipolysis fat zeltiq thigh Korean women|cryolipolysis fat zeltiq thigh korean women
753818|NCT01177800|Psoriasis|psoriasis
753819|NCT01177800|Infliximab|infliximab
753820|NCT01177800|Remicade|remicade
753821|NCT01177826|Hospitalized|hospitalized
753822|NCT01177826|Rotavirus|rotavirus
753823|NCT01177826|Children|children
753824|NCT01177826|effectiveness|effectiveness
753825|NCT01177826|Gastroenteritis|gastroenteritis
753826|NCT01177852|cough, acute rhinitis, common cold, nasal symptoms, children.|cough, acute rhinitis, common cold, nasal symptoms, children.
753827|NCT01177852|Acute inflammation upper airway|acute inflammation upper airway
753828|NCT01177865|adenocarcinoma of the prostate|adenocarcinoma of the prostate
753833|NCT01177956|Recurrent and/or metastatic squamous cell carcinoma of the head and neck|recurrent and/or metastatic squamous cell carcinoma of the head and neck
753834|NCT01177956|1st-line|1st-line
753835|NCT01177956|Cetuximab|cetuximab
753836|NCT01177956|Chemotherapy|chemotherapy
753837|NCT01177956|EMR 62241 -055|emr 62241 -055
753838|NCT01177956|Merck KGaA|merck kgaa
753839|NCT01177956|Recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)|recurrent and/or metastatic squamous cell carcinoma of the head and neck (scchn)
753840|NCT01177969|Autism|autism
753841|NCT01177969|Anxiety|anxiety
753842|NCT01177969|Asperger's Syndrome|asperger's syndrome
753843|NCT01177969|Cognitive-behavioral therapy|cognitive-behavioral therapy
753844|NCT01177969|Treatment|treatment
753845|NCT01177969|Obsessive-compulsive disorder|obsessive-compulsive disorder
753846|NCT01177969|Fears|fears
753847|NCT01177982|pregnancy, opioid, cocaine, alcohol, benzodiazepines, neonate|pregnancy, opioid, cocaine, alcohol, benzodiazepines, neonate
753848|NCT01178008|Insomnia|insomnia
753849|NCT01178008|Post-partum Depression|post-partum depression
753850|NCT01178008|Electroacupuncture|electroacupuncture
753851|NCT01178008|Acupuncture|acupuncture
753852|NCT01178008|Randomized Clinical Trial|randomized clinical trial
753853|NCT01178008|Traditional Chinese Medicine|traditional chinese medicine
753854|NCT01178021|malaria|malaria
753855|NCT01178021|vivax|vivax
753856|NCT01178021|relapse|relapse
753857|NCT01178034|Warfarin|warfarin
753858|NCT01178034|Dose|dose
753859|NCT01178034|Pharmacogenetic|pharmacogenetic
753860|NCT01178034|INR|inr
753861|NCT01178060|Stroke|stroke
753862|NCT01178060|Risk|risk
753863|NCT01178060|Communication|communication
753864|NCT01178060|Cardiovascular Disease Knowledge|cardiovascular disease knowledge
753865|NCT01178060|Improve Risk Communication|improve risk communication
753967|NCT01178411|melanoma|melanoma
753866|NCT01178073|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
753867|NCT01178073|Ambrisentan|ambrisentan
753868|NCT01178073|Sponsor Rest of World: GSK|sponsor rest of world: gsk
753869|NCT01178073|Tadalafil|tadalafil
753870|NCT01178073|PAH|pah
753871|NCT01178073|Sponsor US: Gilead|sponsor us: gilead
753872|NCT01178112|Metastasis|metastasis
753873|NCT01178112|Carboplatin|carboplatin
753874|NCT01178112|Trientine|trientine
753875|NCT01178112|Chemotherapy|chemotherapy
753876|NCT01178125|Pregnancy Prevention|pregnancy prevention
753877|NCT01178125|Oral Contraceptives|oral contraceptives
753878|NCT01178138|substance abuse|substance abuse
753879|NCT01178151|Peutz-Jeghers syndrome|peutz-jeghers syndrome
753880|NCT01178151|mTOR inhibition|mtor inhibition
753881|NCT01178151|cancer|cancer
753882|NCT01178164|chronic pains|chronic pains
753883|NCT01178164|unknown aetiology|unknown aetiology
753884|NCT01178177|Invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
753885|NCT01178177|Solid organ transplantation|solid organ transplantation
753886|NCT01178177|Hematologic disease|hematologic disease
753887|NCT01178190|narrow band imaging|narrow band imaging
753888|NCT01178190|malignant lesion|malignant lesion
753889|NCT01178190|lung cancer|lung cancer
753890|NCT01178190|NBI|nbi
753891|NCT01178203|Endodontics|endodontics
753892|NCT01178203|pain|pain
753893|NCT01178203|visual analogue scale|visual analogue scale
753894|NCT01178203|NSAIDs|nsaids
753895|NCT01178216|Kidney transplant|kidney transplant
753896|NCT01178216|highly sensitized|highly sensitized
753897|NCT01178229|Sleep bruxism|sleep bruxism
753898|NCT01178229|Airway remodeling|airway remodeling
753899|NCT01178229|Physical therapy modalities|physical therapy modalities
753900|NCT01178229|Child preschool.|child preschool.
753901|NCT01178242|Labial mucous membrane|labial mucous membrane
753902|NCT01178242|symblepharon|symblepharon
753903|NCT01178242|dry eye|dry eye
753904|NCT01178242|Stevens -Johnson syndrome|stevens -johnson syndrome
753905|NCT01178242|salivary gland|salivary gland
753906|NCT01178242|ocular surface disease|ocular surface disease
753907|NCT01178242|transplantation|transplantation
753908|NCT01178255|depression|depression
753909|NCT01178255|homoeopathy|homoeopathy
753910|NCT01178268|Drug eluting stents|drug eluting stents
753911|NCT01178268|Stents|stents
753912|NCT01178268|Angioplasty|angioplasty
753913|NCT01178281|Myelofibrosis|myelofibrosis
753914|NCT01178281|Post-polycythemia vera myelofibrosis|post-polycythemia vera myelofibrosis
753915|NCT01178281|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
753916|NCT01178281|RBC-transfusion-dependence|rbc-transfusion-dependence
753922|NCT01178294|coagulation protein disorder|coagulation protein disorder
753923|NCT01178294|hematologic diseases|hematologic diseases
753924|NCT01178294|Acquired Hemophilia A|acquired hemophilia a
753925|NCT01178307|GI cancers|gi cancers
753927|NCT01178307|Symptom Severity|symptom severity
753929|NCT01178307|Questionnaire|questionnaire
753930|NCT01178307|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
753954|NCT01178385|Cognitive-behavioral therapy|cognitive-behavioral therapy
753956|NCT01178385|Children|children
753957|NCT01178385|Therapy|therapy
753958|NCT01178398|fish|fish
753959|NCT01178398|pregnancy|pregnancy
753960|NCT01178398|nutrition|nutrition
753961|NCT01178398|mercury|mercury
753962|NCT01178398|focus group|focus group
753963|NCT01178398|omega-3 fatty acid|omega-3 fatty acid
753964|NCT01178398|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
753965|NCT01178411|hepatocellular carcinoma|hepatocellular carcinoma
753966|NCT01178411|renal cell carcinoma|renal cell carcinoma
753968|NCT01178411|non-small cell lung cancer|non-small cell lung cancer
753969|NCT01178411|breast cancer|breast cancer
753970|NCT01178411|ovarian cancer|ovarian cancer
753971|NCT01178411|MiT tumors|mit tumors
753972|NCT01178424|Unipolar depression|unipolar depression
753973|NCT01178424|Mindfulness based cognitive therapy|mindfulness based cognitive therapy
753974|NCT01178424|Cognitive behavioural Therapy|cognitive behavioural therapy
753975|NCT01178424|Functional magnetic resonance imaging|functional magnetic resonance imaging
753976|NCT01178424|Relapse|relapse
753977|NCT01178424|Depressive relapse|depressive relapse
753978|NCT01178424|Dysphoric|dysphoric
753979|NCT01178424|Cognitive reactivity|cognitive reactivity
753980|NCT01178424|Serotonin transporter gene|serotonin transporter gene
753981|NCT01178437|seizure disorder,|seizure disorder,
753982|NCT01178437|seizures,|seizures,
753983|NCT01178437|convulsions,|convulsions,
753984|NCT01178437|grand mal,|grand mal,
753985|NCT01178437|petit mal,|petit mal,
753986|NCT01178437|absence seizures,|absence seizures,
753987|NCT01178437|repeated seizures,|repeated seizures,
753988|NCT01178437|children's seizures,|children's seizures,
753989|NCT01178437|secondary epilepsy,|secondary epilepsy,
753990|NCT01178437|symptomatic epilepsy,|symptomatic epilepsy,
753991|NCT01178437|generalized seizures,|generalized seizures,
753992|NCT01178437|partial seizure,|partial seizure,
753993|NCT01178437|focal seizure,|focal seizure,
753994|NCT01178437|partial complex seizure,|partial complex seizure,
753995|NCT01178437|anticonvulsant medication|anticonvulsant medication
753996|NCT01178450|Renal transplant|renal transplant
753997|NCT01178450|Hypercalcemia|hypercalcemia
753998|NCT01178515|epidemiological risk|epidemiological risk
753999|NCT01178515|diet|diet
754000|NCT01178515|fat intake|fat intake
754001|NCT01178528|heart failure|heart failure
754002|NCT01178528|heart rate|heart rate
754003|NCT01178528|ivabradine|ivabradine
754004|NCT01178528|carvedilol|carvedilol
754005|NCT01178541|ventricles|ventricles
754006|NCT01178541|fetal|fetal
754007|NCT01178541|brain|brain
754008|NCT01178541|asymmetry|asymmetry
754009|NCT01178554|anxiety disorders|anxiety disorders
754010|NCT01178554|depression|depression
754011|NCT01178554|depressive disorders|depressive disorders
754012|NCT01178554|disruptive behavioral problems|disruptive behavioral problems
754013|NCT01178554|conduct problems|conduct problems
754014|NCT01178567|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
754015|NCT01178567|Gastrectomy|gastrectomy
754016|NCT01178567|Pulmonary Complications|pulmonary complications
754017|NCT01178580|fibrinolytic activity|fibrinolytic activity
754018|NCT01178580|Community acquired pneumonia (CAP)|community acquired pneumonia (cap)
754019|NCT01178580|Pleural effusion|pleural effusion
754021|NCT01178593|RCT|rct
754022|NCT01178593|psychology|psychology
754023|NCT01178593|hypnosis|hypnosis
754024|NCT01178593|psychotherapy|psychotherapy
754025|NCT01178593|group therapy|group therapy
754026|NCT01178606|echogenic halo around lateral fetal ventricles|echogenic halo around lateral fetal ventricles
754027|NCT01178619|IUGR fetuses|iugr fetuses
754028|NCT01178619|symmetrical IUGR|symmetrical iugr
754029|NCT01178619|asymmetrical IUGR|asymmetrical iugr
754030|NCT01178632|Herbal|herbal
754031|NCT01178632|Phytotherapy|phytotherapy
754032|NCT01178632|Passiflora|passiflora
754033|NCT01178632|Valeriana|valeriana
754034|NCT01178632|Anxiety|anxiety
754035|NCT01178671|PTSD|ptsd
754036|NCT01178671|trauma|trauma
754037|NCT01178671|anxiety disorder|anxiety disorder
754038|NCT01178671|medication|medication
754039|NCT01178671|sertraline|sertraline
754040|NCT01178671|mirtazapine|mirtazapine
754041|NCT01178671|pharmacotherapy|pharmacotherapy
754042|NCT01178684|ENFD|enfd
754043|NCT01178684|epidermal nerve fiber density|epidermal nerve fiber density
754044|NCT01178684|HIV|hiv
754045|NCT01178684|HIV-infection|hiv-infection
754046|NCT01178723|breakfast size|breakfast size
754047|NCT01178723|blood glucose balance|blood glucose balance
754048|NCT01178723|hormonal profile|hormonal profile
754049|NCT01178723|appetite hormones|appetite hormones
754050|NCT01178723|adipokines|adipokines
754072|NCT01178801|The clinical data of the patients with liver cancer.|the clinical data of the patients with liver cancer.
754073|NCT01178840|female condom|female condom
754074|NCT01178840|condom|condom
754075|NCT01178840|clinical failure|clinical failure
754076|NCT01178840|prostate-specific antigen|prostate-specific antigen
754077|NCT01178840|semen exposure|semen exposure
754078|NCT01178840|acceptability|acceptability
754079|NCT01178840|Prevention of semen exposure|prevention of semen exposure
754080|NCT01178853|Healthy Volunteers|healthy volunteers
754081|NCT01178866|thoracic surgery|thoracic surgery
754082|NCT01178866|myocardial revascularization|myocardial revascularization
754083|NCT01178866|left ventricular dysfunction|left ventricular dysfunction
754084|NCT01178866|tissue perfusion|tissue perfusion
754085|NCT01178866|prognosis|prognosis
754086|NCT01178879|Telehealth|telehealth
754087|NCT01178879|nurse consultation|nurse consultation
754088|NCT01178879|outpatient clinic|outpatient clinic
754089|NCT01178892|Hot Flashes|hot flashes
754090|NCT01178892|Menopause|menopause
754091|NCT01178892|Vasomotor symptoms|vasomotor symptoms
754092|NCT01178892|Yoga|yoga
754093|NCT01178892|Exercise|exercise
754094|NCT01178892|Omega-3|omega-3
754095|NCT01178892|Fish oil|fish oil
754096|NCT01178905|Postnatal CMV infection of preterm infants|postnatal cmv infection of preterm infants
754097|NCT01178905|breast milk|breast milk
754098|NCT01178918|Influenza H1N1|influenza h1n1
754099|NCT01178918|Vaccine|vaccine
754100|NCT01178918|Adjuvant|adjuvant
754101|NCT01178918|T Lymphocytes|t lymphocytes
754102|NCT01178918|Non-specific response|non-specific response
754103|NCT01178918|Interleukin-2|interleukin-2
754104|NCT01178918|Non-specific T cell responce|non-specific t cell responce
754105|NCT01178931|IVF|ivf
754106|NCT01178931|luteal phase support|luteal phase support
754107|NCT01178931|oral progesterone|oral progesterone
754108|NCT01178931|vaginal progesterone|vaginal progesterone
754109|NCT01178931|pregnancy rate|pregnancy rate
754110|NCT01178931|safety|safety
754111|NCT01178931|tolerability|tolerability
754112|NCT01178957|Type 1 diabetes|type 1 diabetes
754113|NCT01178957|Very-Low-Density-Lipoprotein(VLDL)|very-low-density-lipoprotein(vldl)
754114|NCT01178957|Hyperglycemia|hyperglycemia
754115|NCT01178983|work related musculoskeletal disorders (WRMSD) among computer operators|work related musculoskeletal disorders (wrmsd) among computer operators
754116|NCT01179009|depression|depression
754117|NCT01179022|Bacteremia|bacteremia
754118|NCT01179022|Argon Plasma Coagulation|argon plasma coagulation
754119|NCT01179022|Endobronchial Lesions|endobronchial lesions
754120|NCT01179035|Post-release, community health|post-release, community health
754121|NCT01179061|Apelin|apelin
754122|NCT01179061|Heart failure|heart failure
754123|NCT01179061|Pulmonary artery pressure|pulmonary artery pressure
754124|NCT01179061|Inotropic|inotropic
754125|NCT01179061|Diuretic|diuretic
754126|NCT01179074|palliation inoperable oesophageal cancer|palliation inoperable oesophageal cancer
754127|NCT01179087|sleep disordered breathing|sleep disordered breathing
754128|NCT01179087|lung transplantation|lung transplantation
754130|NCT01179100|general anesthesia|general anesthesia
754131|NCT01179100|lidocaine infusion|lidocaine infusion
754133|NCT01179100|local anesthetic|local anesthetic
754134|NCT01179100|pain management|pain management
754135|NCT01179100|cognitive function|cognitive function
754136|NCT01179113|Laminectomy|laminectomy
754137|NCT01179113|Esmolol Infusion|esmolol infusion
754138|NCT01179113|Quality of recovery|quality of recovery
754139|NCT01179113|beta-blockers|beta-blockers
754140|NCT01179113|Pain management|pain management
754141|NCT01179113|Postoperative pain|postoperative pain
754142|NCT01179113|Opioid requirements|opioid requirements
754143|NCT01179113|Intraoperative esmolol infusion|intraoperative esmolol infusion
754144|NCT01179113|Return to normal activities of daily living|return to normal activities of daily living
754145|NCT01179126|myocardial infarction|myocardial infarction
754146|NCT01179126|primary angioplasty|primary angioplasty
754147|NCT01179126|multivessel disease|multivessel disease
754148|NCT01179126|stress echocardiography|stress echocardiography
754149|NCT01179139|CRS|crs
754150|NCT01179152|asthma, september epidemic, children, preventive|asthma, september epidemic, children, preventive
754151|NCT01176552|Kidney Cancer|kidney cancer
754152|NCT01176552|Renal cell carcinoma|renal cell carcinoma
754153|NCT01176552|High risk|high risk
754154|NCT01176552|Adjuvant therapy|adjuvant therapy
754155|NCT01176565|Acute hypertensive response|acute hypertensive response
754156|NCT01176565|intracerebral hemorrhage|intracerebral hemorrhage
754157|NCT01176565|blood pressure|blood pressure
754158|NCT01176565|outcome|outcome
754159|NCT01176565|nicardipine|nicardipine
754160|NCT01176591|Cocaine and alcohol dependence (CAD)|cocaine and alcohol dependence (cad)
754161|NCT01176604|Hepatocellular carcinoma (HCC) of the liver|hepatocellular carcinoma (hcc) of the liver
754162|NCT01176604|Hepatocellular cancer|hepatocellular cancer
754163|NCT01176604|Hepatocellular carcinoma|hepatocellular carcinoma
754164|NCT01176604|Liver cancer|liver cancer
754165|NCT01176604|HCC|hcc
754166|NCT01176604|Humanitarian Device Exemption|humanitarian device exemption
754167|NCT01176604|Liver Diseases|liver diseases
754168|NCT01176604|(HDE)|(hde)
754178|NCT01176630|metabolic syndrome, ESRD patient|metabolic syndrome, esrd patient
754179|NCT01176643|SLE|sle
754180|NCT01176643|Yoga|yoga
754181|NCT01176656|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
754182|NCT01176656|Hypoglycemia|hypoglycemia
754183|NCT01176669|Apatinib|apatinib
754184|NCT01176669|Triple-Negative Breast Cancer|triple-negative breast cancer
754185|NCT01176669|Metastatic Breast Cancer|metastatic breast cancer
754186|NCT01176669|ER/PR Negative|er/pr negative
754187|NCT01176669|Her2/Neu Negative|her2/neu negative
